<SEC-DOCUMENT>0001060955-23-000007.txt : 20230224
<SEC-HEADER>0001060955-23-000007.hdr.sgml : 20230224
<ACCEPTANCE-DATETIME>20230224163441
ACCESSION NUMBER:		0001060955-23-000007
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		162
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230224
DATE AS OF CHANGE:		20230224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		23667956

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>iclr-20221231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:7508de12-69a9-4818-9ec7-00b38a2cb3e7,g:60b4642b-da77-4b86-962d-2e89e6dd7ade,d:e4aba65474ca49f18d29b38d717fb5d4--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iclr="http://www.iconplc.com/20221231" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iclr-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF8xLTEtMS0xLTE0MzI4Ng_f2a89cb6-6243-45aa-89fe-e5d0b24e486d">false</ix:nonNumeric><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF8yLTEtMS0xLTE0MzI4Ng_8bb44446-fcd8-4f12-af68-b8129f4c9841">2022</ix:nonNumeric><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF8zLTEtMS0xLTE0MzI4Ng_c5b2b91f-e7fd-4746-9934-09dc033eef29">FY</ix:nonNumeric><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF80LTEtMS0xLTE0MzI4Ng_fbb24c5b-17e1-4dfd-a029-4df000ba7846">0001060955</ix:nonNumeric><ix:nonNumeric contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_4e96e968-9c11-40fd-a303-2bb58d8fbc29">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_7797f20c-d0da-447d-8e1d-a6a60da2da46">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iclr-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia06e61e30b434302889007f7159b05f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib7e5ed959ca1442c959fca1bf9fa7721_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9fbbf07b0e4449ea3a2f6cd81f22401_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a880fd5d814e9092b5ca671bb8d41b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8965558006f4684a7fc1512daffa72e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2dc7dff39c546919fdaf6c9f59e5e5e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c028363c21c48d5bdb88ba826d38299_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d1a9ae0fba46c192371319b4901064_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0a7d988df847dc9a616929e7ace798_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c05ec529b64737a2cf079cbb19be5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i940965b309ab4ce497c779391f42b662_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8d96ff5211446f09d3fabef56b1bb6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5629eb301d784ca99de6ddbf87220b6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80faf766e38749ef9bf49c0793bed5d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e29b8c979344a0bbaf83ef3e7130d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ae0c3dbbc541b3aa82c3713e418873_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i630de7cf74954c889cb5f55191084e94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69908ebb3c9340018ae4adb8ef47236e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib11a3b57f4ac4425a287a5353f3e2695_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0d85418de1a4b0a817652360cfe0815_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib227c36803504cc68f096847a5faff4a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4addd48255bb44beb36787ed5df4e0bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe1a0341a694fcf9f094af87a903fe5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e931e0964047f1b6a05248f9f9ae86_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea7296eec334826b983a9b2012723a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b2495a48164218a19af1d3f594f087_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87251223f7f94618a9d593180c9e6f6b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>iclr:Employee</xbrli:measure></xbrli:unit><xbrli:unit id="location"><xbrli:measure>iclr:Location</xbrli:measure></xbrli:unit><xbrli:unit id="country"><xbrli:measure>iclr:Country</xbrli:measure></xbrli:unit><xbrli:context id="i25b768baea2347c69afde3c3be439fd8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i92bd1d25d98e4448ad3ea7952d2ee232_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d681611048348019dc67e17504b3c0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e66e1c160f148649eb21d89bbf2625a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f8a2c39e7124f16b49ad2a09d9b25af_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aa76511dda54693974dbb4e12681b0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c614a0351ee4d65b7706dbb34ed6783_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cc8557895694ddda58a406b0e47873c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i423bdb53508049b790b135a49d542ab9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff41f4c3905c417bbe6fbf9952151d95_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff6c4c1b4574a40829f531f7210e9bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb366a4aaf994d7e840ad3fff4c1fe43_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bb660dc51543a1937c2ecfd5d7b2b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MeDiNovaResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b703a470aec45d6b7cc535d913a035b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i380e176b9dde4914abac25ae65cca717_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1998d53019114a92910d0b987e09e9eb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79832711688241cdbc03301d09dc65ed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b4f29d3e2b241b690b68915c03d5e7d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia706efb7e7544d30a249a2933512bbd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdedac9e58504241a677dd5e16834802_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56f70ffa378f4eb6b7bea34717f35edc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d0066899c49400d88bd9e23928ccc84_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id595e6ca907842c5ad25832951a08162_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70f2210593f144b18961bb25bb1f64c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8bcfc7e9ad4cd49adf68eaea5ab3c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44ee1247f39e40e095600c4da686996e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f0ea2e03f744609e1793a8709bb329_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbc54966d15445729a0ed93be99fdbd0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff7ba07c4dd648098208327ed22330c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23de17af5ea240e78dfcd77718adcfbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34237e03be942cc9cc2d0552e1de455_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc3e32cee5c4cfcbaa4850d89f898d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68cade11881441f999fe48a8b78fa866_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050bc2a0894b4b519c23ad5dce7c546e_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65f325e72d854376869d44f5fabc8e75_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13749761bedc4da99e05caac9043517b_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d23344e0fb3451da6613835547ccb77_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80606786953145dfbdfda1d4010d7f1f_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib000d5e1b7c444a98c09c3082b538879_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ea9f2d8c19438a8322337241492d6e_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d00b00550d4bf9a90bced55d00862b_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785f8636543e4f9b9285f8e0d63b6d2b_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17edec93a2294c3e907c490cbb645326_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202108Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545583d261e248808f2d3bb26a97013b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4b3262da32f4ec8a9c378573864a2a9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e66629c475a4b72b7b830a3e6cb2836_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i978c79fbe78442ada8654ab753363b19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f84f639a8649b7a29a53533025129f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be311173d9c44eaafe06fb2c2cbcb3c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90e03c93c3749469a8dfb4fe97cb995_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30afec82ea9e4d6a8f448ccc557ea553_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19fb8c40650e450eb5e1d079288ab103_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1dd30bace194434bd26b61b92a84a73_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22508cde176416eab9afbb5c12f542f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia559e02117534d508ae08e434af35be9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b4df5e6293480bb188a651b53aa3c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eac6e85f2054a39b9b4982e267fcdef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09cfcf09c5a4518ae153515930d8057_I20200724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d39bd6a1934626911076815f36ce28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia961c12b79494b50a3b7b747a2ce04be_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf5fe76c69e241d7915327e838e9518c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic314749132274d02aea042862e1ff17e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f27ae8e7bb4ec5971a6b2ef9dd55a9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a1a18520e4146e3bf6b3a13e3cda74a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b7882f940f48d3bc7d90326129e9b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65d528e27c0d424aac74d9e73663d3ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdec972de61b4fbd8c3f8f4491dbed10_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia25ff6d598af43409a6d48cb1b0d9f54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i316a10f3c60140a48775f64331d68546_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9f6a75108b4d089ed6659cb9248d3f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f3e6836101246c5bd0e37de3cea7ad5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58f1d881a21f42408d4bd3c83abd2de9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i039aaafb5ef843fb87c3be6202c32cb9_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc1a2a8295744e79af710d3f51492b51_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc15efef07d4621bf232d0f905e24d3_D20210702-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b1b179f187445baaff8a1b7341bce6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id74f7c384d114c429cd9f1b01c113138_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eb8fbd8473746a0b208ab4cd0032180_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9e575e36904396a0c52344f4a1fe00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide0a04931f8947b899f8a0add7253478_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a12d28f277f4f588bf639313db05a59_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10cb599ff8ed4f01b9d901f229fe45d0_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2dee78f7f644cb9cf3be42bf7515de_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052ec038b97a434685e03cb2338cefaa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd8ae45a3c84a79b7b93908eb3e3fe9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4749ad89af054d8e90ce981f202f2a6f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aef30afb12349bb8e0ae5fbd3b724d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad4568f232b4720a904bbd4f0c5c5d2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dfcce19405042819f3d7cea53081ae1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e2abed11d6d469e981a5915d01e0802_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74787ba7e2484b3abeeb226f25f7e944_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-30</xbrli:startDate><xbrli:endDate>2022-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-30</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-29</xbrli:startDate><xbrli:endDate>2021-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i371d9f7891584afea9de5a762c9f6442_D20210927-20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54726d34a41d4914b87f6221632a03b8_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide8dd376ffe34328bce020b65607602b_I20221129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="instrument"><xbrli:measure>iclr:instrument</xbrli:measure></xbrli:unit><xbrli:context id="iae02d67aa86647b19a16902930f2619d_I20221129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if39e82a87e3d497b96438f71c9904738_I20221129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27a87a7700d4f5fa4a149e379b8f150_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84bd4efdef4d4094902c5e2aee086859_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>iclr:tranche</xbrli:measure></xbrli:unit><xbrli:context id="ibba1eb9117d6498ba61cd2ffd7a3dcc5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf34dd45633475d9db22cc8203941ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id197fe0d372441f4971e65ae556f9189_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>iclr:vote</xbrli:measure></xbrli:unit><xbrli:context id="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0d3c91746049cfa76770f5e2f12ef5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i323bd4358f4848aba9899c235c5c8a82_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5098738b6444670841da7baa2b82cff_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac28acede97e485190e5dcb59f035565_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica93147573064c84b3ee259a15e2e86a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd327ac55d2743019d27972465de1bc4_D20160722-20160722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-22</xbrli:startDate><xbrli:endDate>2016-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia70e95571e0e491fb52ce293ea601a70_I20161003"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-10-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1daa0ef8b314dee8ee404337020c563_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10eee8543f7046e0859ad96971a954da_I20190108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46b3eb0a83849c2b0342cf7b18e0188_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if26c855530ab4ea6a07f994ef03a005f_D20191231-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-31</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb051d6f08042e1a54eb9849cdeac83_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872f74854a654470a5eb159ba754c7ca_D20220218-20220218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-18</xbrli:startDate><xbrli:endDate>2022-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1811161bef0541d1b314fa8f7e974b09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196c76a3559d419d89bd5d2125a62e0f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee316e05b53a4b06a0345a352d600919_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1db08719244443188a87bd4495f32a5e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i267c8ec957d64d7687d93c7466134972_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055498de74b44ecb8deea65136b4d3b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33fe4880dae64f308692e5d9bd2761fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305536a3cd1f49ec9167bd9bc8104484_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d7582e0e7b3484491b75a376c0695c8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2023To2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243aa952befc42c99e33d30e034ad490_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2023To2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c198a29dee44519b861db8ccd7b511_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20332041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d61fb6235784d39b1c898fa148b0af0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20332041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e44759c2a854bc0910676ada44d73bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i770c5f02dbff40efa1458e69fb1e60a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022To2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67dddc1be99b46a6ac8672b42f7fb4b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2029To2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e0b74245524351afc9b509e585fb1c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie343632514b54c28a4d376a3c9298cfe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f25427924a2406292894864e22c91dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44caf25e9f21476690747f57e50f9aa0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AcquiredEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6674f8abb9143528db74c781bd4f419_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47bb526e18f463db1bed028cf43f0ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64338787f17e44159195780f1ed3a4e3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10c7a471fc164535ab1f5501d22dd648_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf91caf53cac409b8da970cacfe56918_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f00760e31240959ce3972bf544992d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i569507f611d548c49b8650b70c94c2fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if733533a187d46cfb46437f0574bd48b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07132bfad9184874a360f6352a964e49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825154864e984f849f9034999b633fbe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcb24a7a223049669f10a43260fb3f9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4ccd74632f9452c9fc7c4c727e7cbc6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e0d42fa9c04d3fbc41dc023095bf98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21482250291473491b179d1e9638496_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97b87f6afcb34559a2f4576b1a188c7a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2401c0c85e74845af9e260c7e7cde74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d8837cc7bc34a82948378f474d993cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506afdb62b6645c28768481748bbcbd5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i062ad9be3f9e465db1f49eeeced971fe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fe6c6b53ea94d49965d0ca81e095c39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7871cec33a7b4f3883e3e6c9cddf204a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc40275d8744c9793904bf596955616_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1531dcf96765414a87b044843515f2fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422b56f7af8b490e859596ef6dbce65b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie835ce8081ec4f4ca739bd71e6565c20_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7471376d2a4fbe9b259e2a8ce7278f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96aa6b711ab446a3a14f6536ac6ba863_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd9a11dcfb642da959b07ec79751954_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b52a3900c584d009b5d05b00cfe85c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc4210481bdb451ba035a20efdc271b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d097939710f4e2face7b10bdd140ba4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17a0752301494fecba30d3ccd834c133_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4f6a845a66843d79b61cba68f576f33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie34f24ef293946839ccb0115382374cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d40dd88a404685bf76258b0e90d0a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9862be84bb6f492bb811a70c03726aeb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09c56c86bbb747b1a07d20615ebedb0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0784352491d144cd972226c028844591_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31374c47a6bb44ba914a1d8045381bed_I20140507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AptivSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab1778648b342b9ada86a5f677d6289_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66389d7f3c194c0a9461035acba0b147_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1682825f41f34d8ca4c4852e0ba2f96d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbde31e88d4849f8badda657229d3344_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic768660976f74ad5af5a5fff5ef0bb5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if32d9c6312d342eea532c63c70cd41c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i641bf226224d4002a6b87b5dcb9ef829_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c58dceb3ee34f9fab1c82b8d0e2e8d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84a1032d1909414c8deb46ff92fb05d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69612ff6be104bbda9eb34a7111229cc_I20170213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic45259ceacfa45dbaa829284ba61ed4f_I20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440197ff0132449083f0216f9fc3c298_I20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbe4c2a486a4b5482f3723aed979671_D20170214-20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4163e2475cb34804afe0a1d2c5088f79_D20170214-20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aa49a2d22f444b7a13c77919382a1df_D20170214-20170214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibef2001f3bff4594b125b1b4c70d6047_D19970101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1997-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0820a150dcb1422fbec11ed3af8c5b71_I20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a566fd41cfd4b69a2174efb24d4ec3b_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id76920b1711b412f9e74d6864364e113_I20130923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:A2013LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c67eb08e5524f1389812b02c4f529e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if241526f99db43fc9bf9c882609b6aea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i940aa8c093bc4589896acef14854ea63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibedfb53eb84140b7b0f014f3448deedd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5255d861c7cc46d69f217fa72de308c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c9a65dc7c694265ae542cee4cbfbd16_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9d6a1d2ef345eebaf944a19f58d97d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46f308bc7dd44c64acb450333790b112_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee5eabbcadca4ea7bef29df09e08e94c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcafc41c97334a6f89312cdf786a9995_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892854d05a8b4db7a71a9f8ce561bbbe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ccb139c1f534009823e7282d53f1fcf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f37b14a260342dcb3444d2efa44c6d5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06d8c0caffa4a54b55eeaec6990c14f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a249b6708e444acb6a9b4b67484f49c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad01622a145456eb95aa151f08ca887_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba8cd0f91c4543c384cf5fd3022523c9_D20150511-20150511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-05-11</xbrli:startDate><xbrli:endDate>2015-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff4a5c52ce754d49b998568670340ed9_I20150511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d0262e215cd4dfbb0898a63d51486be_I20190516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca1cb86a7554779a455148669f8224b_D20190101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50c7dd932b404320af63f5c9a2cf9cd5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4f5700181945938fdaecb063f3bc23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd4d35cf1d84f78909a24f1716a0841_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i128b02150c364303957cd379df2d66a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec59b41573649288593eff6d1ebb047_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4030627d459479f9bcfc2485f408af1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie70ef1e52b8445e8a30d1732702cac38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1d7729620b245f3b3d86355af31bf15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i385b3308021d4f8dab296ba9a3b672ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31d66e89c6ac44c985d3b33f217a8215_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82f9a1a05fa24a3281257719ca8fb6c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7478ddf969574f3ebf520346092b5404_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc58fa5272343979b1281d284fd5100_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cafc75e45844d94a5699609ed9c0e1a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04e0493d819470faef53855bcf56280_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f815c05b36c45c2bbeedbecb796cd4b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4ee9a12489e4e4d945f923b1fef04b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb23e34b2494ebeadf5c82112b1cc16_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>iclr:segment</xbrli:measure></xbrli:unit><xbrli:context id="ie8b94a05494d4a9aafad89fefcf5ec5e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7e7fb2e8754f13959c968948055905_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51c60ed11834e3489b68644df728ad3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id74698b742ce45b48de3dd6ca0e41f58_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i095fb057614e484690d7c8e6855aa257_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i470b5734b0ec4cdcb5d2d8b7192a224d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2573b70385e24cddbc2849d005657d46_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be2313371ae40d6abc4a3f42b6751ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f7fbd571c7848e2a658e6b23259ae2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3911e749f50947d4b21832b72052d785_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93cae0d23f394e31b3abce80e3e3687f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5d2064ec2c49afba73bfde8e3bacd0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6988db3dbc8a4435b967b2307aada5cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45448a33be2443fd93dedd1a7d14df2a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebdfade2d1334535803b379eaf1d7a23_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4715e63da19c4cd897a34f13c13f0b3b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb773a2b86147749b4c3538c0035971_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied4aaa8f5f68454db087c1b69e5131a0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4158ffec277a4decaff6ea55e3ac1007_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9985b94712864f2290305ffd2981067f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac4e36329b842e7b8b1b172ef93c1f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89cec313ee54d428d8f32c7d6f723f5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc5b0b8e9eb4cd182c4c104a6637ab6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if58aadd9086f43b2a3767b622c4f2dc0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fb8e5b432b4ab3a94979ed99d87911_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_1"></div><div style="min-height:31.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WASHINGTON, D.C.20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">______________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM5_9e9c52c7-b395-463b-96b9-1de295e0a1d7">20-F</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTE3_e878e81e-183a-4681-b305-10f2abeafee5">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration statement pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTQw_ce1c4020-12c8-4e0d-8b89-119229dc8cc5">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Annual report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zODc_733b56d6-61a0-43b3-8a81-f3e2c3f9a014"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zODc_18d7217e-e138-473d-b878-df3ab671d0e1">December&#160;31</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM0_f39ece63-1a20-4ee9-aea6-3faf897a21fa">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTE4_9324e222-8640-4ff6-90d3-b7e8c8d2ef35">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> Shell company report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTQx_43e680a1-9c9e-438a-b21c-8ddd8940c69d">333-08704</ix:nonNumeric> </span></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"></td><td style="width:28.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ICON PUBLIC LIMITED COMPANY</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of Registrant as Specified in its Charter)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM18xLTEtMS0xLTE0MzI4Ng_c7a1f836-fff6-4d44-9980-ea3faabe62f8">ICON PLC</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Translation of Registrant&#8217;s name into English)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM180LTEtMS0xLTE0MzI4Ng_2f5c7528-b308-4426-9f30-115ee1db13ea">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM183LTEtMS0xLTE0MzI4Ng_237d89a5-baee-4e0f-9586-9b780a7d7b2e">South County Business Park,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM184LTEtMS0xLTE0MzI4Ng_ecfbb772-bb29-481a-af1d-8906c05111a5">Leopardstown,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM18xMi0yLTEtMS0xNzcwMTg_c4b7ded9-294a-4ef6-9424-5a5d9aa8b56a">Dublin 18, D18 X5R3</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM185LTEtMS0xLTE0MzI4Ng_b3826304-77dc-4dc8-94a7-24a6c1940d53">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:ContactPersonnelName" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM1_bd005257-758b-4d81-87a2-ca15eae8607b">Brendan Brennan</ix:nonNumeric>, Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI0_8cd22877-b379-4c1f-b695-5e4f6efd833b">South County Business Park</ix:nonNumeric>, <ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI3_22f3c2cd-ddc2-45d3-8f49-0797254a16b4">Leopardstown</ix:nonNumeric>, <ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTQy_563f32bc-8766-4e5e-81dc-036d538a47bd">Dublin 18</ix:nonNumeric>, <ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM2_0e9cd568-3f78-4ab8-876d-962a5be2282f"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM2_92f0af64-8812-4ce6-9986-d7525d9ab4d9">D18 X5R3</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMx_df68f9cc-2972-4412-8108-e3f1af462740">Ireland</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:ContactPersonnelEmailAddress" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTE5_5d3730a3-7f23-401c-92a1-a7d987e54c8e">Brendan.Brennan@iconplc.com</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM3_47dde466-f356-42df-94d5-efe9ccce2aec">353</ix:nonNumeric>-<ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI4_ee99c62a-490a-46eb-a201-89d7eb608640">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTIw_ff1ca314-cbc0-435f-9503-323000d77874">291-2000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, telephone number, email and/or facsimile number and address of Company contact person)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;Trading symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6Zjk5ZGUyOWUyZjJmNDg0MWFlZjVlOTU1YTk5MWNmNjQvdGFibGVyYW5nZTpmOTlkZTI5ZTJmMmY0ODQxYWVmNWU5NTVhOTkxY2Y2NF8xLTAtMS0xLTE0MzI4Ng_37f622d0-3a9b-43b6-b209-5932a3e19afa">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6Zjk5ZGUyOWUyZjJmNDg0MWFlZjVlOTU1YTk5MWNmNjQvdGFibGVyYW5nZTpmOTlkZTI5ZTJmMmY0ODQxYWVmNWU5NTVhOTkxY2Y2NF8xLTEtMS0xLTE0MzI4Ng_c132edcc-b942-4e75-9fc8-dc32e00df67d">ICLR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6Zjk5ZGUyOWUyZjJmNDg0MWFlZjVlOTU1YTk5MWNmNjQvdGFibGVyYW5nZTpmOTlkZTI5ZTJmMmY0ODQxYWVmNWU5NTVhOTkxY2Y2NF8xLTItMS0xLTE0MzI4Ng_8b78de02-e944-4782-a75d-1b19f6b3de7d">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities registered or to be registered pursuant to section 12(g) of the Act:</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NONE</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NONE&#160;</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction unitRef="shares" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8xMjIw_6aad0b2f-eff7-4326-86e7-112439b5343d">81,723,555</ix:nonFraction> Ordinary Shares.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as determined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTIx_b721a723-97af-4ac1-b8a0-7c5ab01472b6">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160; &#160; <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI2_e29d6dfa-e608-4b13-89ea-b0065f046d03">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM4_7c6a1fd3-7c72-4bd8-93a7-87ce8d3986de">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI1_3d92ddeb-5997-410e-9689-8dca31b36751">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer or an emerging growth company.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI5_94de3d24-0821-4f12-9ae0-9b8bac560017">Large accelerated filer</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMw_ed38afaf-83e0-4c4d-b4f9-b511f732c2da">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTIy_994aeeca-116b-45f6-9df3-0c716e055734">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:DocumentAccountingStandard" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMy_b1bd83be-6a63-4332-805d-0343bb05049c">U.S. GAAP</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; International Financial Reporting Standards as issued &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     &#160;&#160;&#160;&#160;Other </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-indent:164.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> by the International Accounting Standards Board </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> Item 18 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMz_9110ec5b-4e6e-49eb-81f9-754142783def">&#9746;</ix:nonNumeric></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_10">General Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_13">Cautionary Statement</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_13">1</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_19">Item 1. Identity of Directors, Senior Management and Advisors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_22">Item 2. Offer Statistics and Expected Timetable</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_25">Item 3. Key Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_25">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_52">Item 4. Information on the Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_52">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_55">Item 4A. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_55">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_58">Item 5. Operating and Financial Review and Prospects</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_58">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_61">Item 6. Directors, Senior Management and Employees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_61">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_64">Item 7. Major Shareholders and Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_64">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_67">Item 8. Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_67">80</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_70">Item 9. The Offer and Listing</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_70">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_73">Item 10. Additional Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_73">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_76">Item 11. Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_76">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_79">Item 12. Description of Securities Other than Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_79">90</a></span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_85">Item 13. Defaults, Dividend Arrearages and Delinquencies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_85">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_88">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_88">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_91">Item 15. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_91">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_94">Item 16. Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_94">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_97">Item 16A. Audit Committee Financial Expert</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_97">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_100">Item 16B. Code of Ethical Conduct</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_100">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_103">Item 16C. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_103">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_106">Item 16D. Exemptions from the Listing Standards for Audit Committees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_106">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_109">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_109">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_112">Item 16F. Changes in Registrant&#8217;s Certifying Accountant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_112">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_115">Item 16G. Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_115">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_118">Item 16H. Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_118">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_2100">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_2100">93</a></span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_124">Item 17. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_124">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_127">Item 18. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_127">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Item 19. Exhibits</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_133">147</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_259">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_259">148</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, &#8220;ICON plc&#8221;, &#8220;ICON&#8221;, "ICON Group", the &#8220;Company&#8221; and &#8220;we&#8221;, "our" or &#8220;us&#8221; refer to ICON public limited company and its consolidated subsidiaries, unless the context requires otherwise.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless otherwise indicated, ICON plc&#8217;s financial statements and other financial data contained in this Form 20-F are presented in United States dollars (&#8220;$&#8221;) and are prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In this Form 20-F, references to "U.S. dollars", "U.S.$" or "$" are to the lawful currency of the United States, references to &#8220;euro&#8221; or &#8220;&#8364;&#8221; are to the European single currency adopted by nineteen members of the European Union, references to "pound sterling", "sterling", "&#163;", "pence" or "p" are to the lawful currency of the United Kingdom. ICON publishes its consolidated financial statements in U.S. dollars.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 1, 2021, the Company completed the Acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA and its subsidiaries became wholly owned subsidiaries within the ICON Group. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The financial information presented in this Form 20-F reflect the results of the combined Company for the year ended December&#160;31, 2022. The financial information presented for the years ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2021 and December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160; are as previously reported and do not reflect the pre-Merger results of PRA before July 1, 2021, other than where clearly stated and required by GAAP.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> Cautionary Statement Regarding Forward-looking Statements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Statements included herein which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;).&#160;Forward-looking statements may be identified by the use of future tense or other forward looking words such as &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;may&#8221;, &#8220;strategy&#8221;, or other variations or comparable terminology. The forward looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, our results could be materially adversely affected. The risks and uncertainties include, but are not limited to, dependence on the pharmaceutical industry and certain clients, the need to regularly win projects and then to execute them efficiently and correctly, the challenges presented by rapid growth, our expectations concerning the ongoing impact of the novel coronavirus identified as 'COVID-19' on our operational results, the challenges associated with the integration of PRA,  competition and the continuing consolidation of the industry, the dependence on certain key executives, changes in the regulatory environment, exchange rate fluctuations, inflation and rising labor costs, the conflict in Ukraine, and other factors identified in the Company&#8217;s United States Securities and Exchange Commission filings and in the &#8220;Risk Factors&#8221; included on pages 3 through 21. The Company has no obligation under the PSLRA to update any forward looking statements and does not intend to do so.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part I</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_19"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Identity of Directors, Senior Management and Advisers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_22"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Offer Statistics and Expected Timetable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">.&#160; Key Information.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">[Reserved]</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.    Capitalization and indebtedness</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents our capitalization as of December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total debt, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,654,187</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,436,312</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share Capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,840,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,733,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,497,963</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,066,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Capitalization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,152,150</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,503,139</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The Company drew down debt of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$6,015 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in order to finance the cash portion of the Merger consideration. ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities") of wh</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ich, $1,314 million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has been repaid as of December&#160;31, 2022 from cash generated by the Company in the period since the completion of the Merger. In addition to the Senior Secured Credit F</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">acilities, the Company, issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes in a private offering ("Senior Secured Notes").</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Reasons for the offer and use of proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Risk Factors</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Various risk factors that are relevant to our business and the services we provide are outlined below. The occurrence of any of these events may materially and adversely affect our business operations, financial condition and results of operations and future prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_28"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Below is a summary of some of the principal risks that could adversely affect our business, operations and financial results:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The inability of biotechnology customers to raise adequate financing or funding could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may face challenges retaining employees which could cause disruption to our integration plans and day-to-day activities which may result in additional costs to the business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A disease outbreak, epidemic or pandemic such as COVID-19, could adversely affect our business performance. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may be unable to realize anticipated cost and tax synergies and expect to incur substantial expenses related to the Merger.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Improper performance of our services could adversely impact our reputation and our financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in a highl</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">y competitive and dynamic market.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior pe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">riods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our exposure to exchange rate fluctuations could adversely affect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Inflation and rising labor costs could adversely affect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Changes in accounting standards may adv</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ersely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the combined Company&#8217;s business, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on the unhedged balance of our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of d</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ebt.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Borrowings under our Senior Secured Credit Facilities bear interest at a variable rate that is based on the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which may have consequences for us that cannot be reasonably predicted and may adversely affect our liquidity, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business opportunities as a result of health care reform and the expansion of managed care organizations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The conflict in Ukraine could adversely affect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business as a result of changes in the regulatory environment.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We are subject to political, regulatory, operational and legal risks associated with our international operations and any changes or uncertainty in the regulatory regime (including changes in trade compliance laws and regulations as a result of the ongoing conflict in Ukraine) could disrupt our business in the region or the results of our operations as a result of increased compliance costs. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Environmental, social and governance matters may impact our business and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">An investor's return may be reduced if we lose our foreign private issuer status. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_2037"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clients may discontinue using our services completely or cancel some projects either without notice or upon short notice. The termination or delay of a large contract, or of multiple contracts, could have a material adverse effect on our revenue and profitability. Historically, clients have canceled or discontinued projects and may in the future cancel their contracts with us for reasons including, amongst others:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">the failure of products being tested to satisfy safety or efficacy requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">unexpected or undesired clinical results of the product;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decision that a particular study is no longer necessary or viable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">poor project performance, quality concerns, insufficient patient enrollment or investigator recruitment; and&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">production problems resulting in shortages of the drug.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result, contract terminations, delays or other changes are part of our clinical services business. In the event of termination, our contracts often provide for fees for winding down the trial but these fees may not be sufficient for us to maintain our margins, and termination may result in lower resource utilization rates. In addition, we may not realize the full benefits of our unsatisfied performance obligation of contractually committed services if our clients cancel, delay or reduce their commitments under our contracts with them.  Therefore, the loss, early termination or delay of a large contract or contracts could adversely affect our revenues and profitability.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is dependent on our ability to generate new business awards from new and existing customers and maintain existing customer contracts. If we were unable to generate new business awards on a timely basis and contract for those awards, that could have a material impact on our business, financial condition, results of operations or cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While no customers individually contributed more than 10% of our revenues during the years ended December&#160;31, 2022 and December&#160;31, 2021, our top five customers represented 28.3% and 31.6% of our revenues, respectively. The loss of, or a significant decrease in, business from one or more of these key customers could have a material adverse impact on our results of operations and financial results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">The inability of biotechnology customers to raise adequate financing or funding could affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A portion of our revenue is generated from sales and services to the biotechnology industry. The clients we serve are commonly subject to financial pressures, including, but not limited to, the ability to obtain adequate financing or generate sufficient funding. To the extent our clients face such pressures, or they change how they utilize our offerings, the demand for our services, or the prices our clients are willing to pay for those services, may decline. Any such decline could have a material adverse effect on our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Many of our contracts are long-term fixed price or fixed unit price contracts for services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Revenue recognized on these service contracts are based on an assessment of progress towards completion being the cost of time and other third party costs as a percentage of total estimated time and other third party costs to deliver our services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Estimating time and costs to complete requires judgment and includes consideration of the complexity of the study, the number of geographical sites where trials are to be conducted and the number of patients to be recruited at each site. We regularly review the estimated hours on each contract to determine if the budget accurately reflects the agreed tasks to be performed, taking into account the state of progress at the time of review. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We bear the risk of cost overruns unless the scope of activity is revised from the contract specifications and we are able to negotiate a contract modification. We endeavor to ensure that any changes in scope are appropriately monitored and change orders or contract modifications are promptly negotiated and documented for changes in scope.&#160;If we fail to successfully negotiate change orders for changes in the resources required or the scope of the work to be performed, and the costs of performance of these contracts exceeded their fixed fees, it could materially adversely affect our operations and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A key element of our growth strategy is the successful development and marketing of new services or entering new markets that complement or expand our existing business.  As we develop new services or enter new markets, we may not have or be able to adequately build the competencies necessary to perform such services satisfactorily, may not receive market acceptance for such services or may face increased competition. If we are unable to succeed in developing new services, entering new markets or attracting a client base for our new services or in new markets, we will be unable to implement this element of our growth strategy, and our future business, reputation, results of operations could be adversely impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business, future success and ability to continue to expand operations depends upon our ability to attract, hire, train and retain qualified professional, scientific and technical operating people. We compete for qualified professionals with other Clinical Research Organizations (&#8220;CROs&#8221;), temporary staffing agencies and the in-house departments of pharmaceutical, biotechnology and medical device companies. An inability to attract and retain a sufficient number of high caliber clinical research professionals (in particular, key personnel and executives) at an acceptable cost would impact our ability to provide our services, our future performance and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may face challenges retaining employees which could cause disruption to our integration plans and day-to-day activities, which may result in additional costs to the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The attraction, development and retention of our talent is critical to the success of the Company, and we are working to strengthen processes around these areas to minimize retention risk and support a successful integration. The Company, led by the Chief Human Resource Officer, is taking meaningful action to retain employees. Through our annual Talent Review process we have identified opportunities for improvement as it relates to employee retention. Our People Plans have set specific goals for each functional area in terms of three critical areas: talent attraction, development and retention. However, we can provide no assurances that our efforts in this respect will be successful.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business. We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. Our success depends on the knowledge, capabilities, and quality of our people.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The successful completion of clinical trials is dependent upon the ability to recruit suitable and willing patients on which to test the drug under study. The availability of suitable patients for enrollment in studies is dependent upon many factors including, amongst others, the size of the patient population, the design of the study protocol, eligibility criteria, the referral practices of physicians, the perceived risks and benefits of the drug under study and the availability of alternative medication, including medication undergoing separate clinical trials.&#160;Insufficient or inappropriate patient enrollment may result in the termination or delay of a study which could have a material adverse impact on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is focused on continuing to develop its expertise in patient recruitment with the establishment in 2020 of Accellacare, a global clinical research network, offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The focus is on making it easier for the site and the patient to actively participate in a trial to ensure increased predictability, enrollment and retention. Our site and patient solutions group includes upfront planning of site and patient management including identification, enrollment and engagement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Improved site selection is achieved through:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">leading technology to identify where the patients are that match the protocol;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">assessment of the qualification of sites based on real data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">partnerships with leading technology vendors and developing the capability to enable EMR interrogation into clinical insights such as sub-populations and larger pre-screened pool where the technology and regulations are enabled.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The burden on the site, in ensuring patient enrollment and engagement, is achieved through integrated site networks. ICON has a number of site alliance partners. During 2018, we enhanced our site and patient recruitment capabilities with an expansion of the PMG Research network through a partnership with the DuPage Medical Group. During 2019, we further enhanced our site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN. In 2020, ICON announced the launch of Accellacare, a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research, MeDiNova and CRN. Also in 2020, we entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates as a specialized oncology site network in the US and EMEA regions. The new site network is focused on implementing a range of commercial models with specialist oncology healthcare providers in the US and EMEA, to accelerate the recruitment and retention of patients into oncology trials. The oncology site network operates as a joint venture between the Company and a third party company which has extensive experience in developing and running a site network. We also use digital solutions to drive site performance, including pre-screening, eConsent, learning management, document tracking and management with key applications.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians located in hospitals, clinics or other similar sites, who serve as investigators in conducting clinical trials to test new drugs on their patients. Investigators supervise administration of the study drug to patients during the course of the clinical trial. The successful conduct of a clinical trial is dependent upon the integrity, experience and capabilities of the investigators conducting the trial. Insufficient investigator recruitment, which in turn may lead to insufficient or inappropriate patient enrollment, may result in the termination or delay of a study which could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In recent years, extreme weather events and changing weather patterns such as storms, flooding, droughts and temperature changes have become more common. As a result, we are potentially exposed to varying natural disaster or extreme weather risks such as hurricanes, tornadoes, droughts or floods, or other events that may result from the impact of climate change on the environment, such as sea level rise. As a result, we could experience increased costs, business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations. The potential impacts of climate change may also include increased operating costs associated with additional regulatory requirements and investments in reducing energy, water use and greenhouse gas emissions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A disease outbreak, epidemic or pandemic such as COVID-19, could adversely affect our business performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A disease outbreak, such as influenza or coronavirus, could negatively impact our operations. We could experience restrictions on our ability to travel, or the ability of patients or other service providers to travel, to monitor our clinical trials and to ensure laboratory samples are collected and analyzed on time as a result of an outbreak. The potential impact of an epidemic or pandemic may also result in increased operating costs and result in a requirement to increase investment in impact prevention. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">COVID-19 has affected, and may continue to affect, our business performance and could adversely affect the economies and financial markets worldwide, resulting in an economic downturn that could impact our business, financial condition and results of operations. We may be required, or choose, to take temporary measures intended to help minimize the risk of infection from the virus for our employees, which could negatively affect our business and cannot presently be predicted with confidence.  </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the global nature of our business and our reliance on information systems to provide our services, we use web-enabled and other integrated information systems in delivering our services. We will continue to increase the use of these systems&#160;and such systems will either be developed internally or provided in conjunction with third parties. We also provide access to similar information systems to certain clients in connection with the services we provide them. As the use, scope and complexity of our information systems continue to grow, we are exposed to, and will increasingly be exposed to, the risks inherent in the development, integration and ongoing operation of evolving information systems, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disruption or failure of data centers, telecommunications facilities or other key infrastructure platforms;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber attacks or other failures or malfunctions in our application or information systems or their associated hardware or other systems that we have access to, or that we rely upon, or that have access to our systems; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber attacks or malfunctions with key suppliers or partners who we rely on to provide services to customers; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">excessive costs, excessive delays or other deficiencies in, or problems with, systems development and deployment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The materialization of any of these risks may impede our ability to provide services, the processing of data, the delivery of databases and services and the day-to-day management of our business and could result in the corruption, loss or unauthorized disclosure of proprietary, confidential or other data, as well as reputational harm. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While we have cybersecurity controls and disaster recovery plans in place, they might not adequately protect us in the event of a system failure, security breach or cyber attack. To date, no cyber attacks have had a material impact on operations or financial reporting. Additionally, despite any precautions we take, damage from fire, floods, hurricanes, power loss, telecommunications failures, computer viruses, information system security breaches, cyber attacks and similar events that impact our various computer facilities could result in interruptions in the flow of data to our servers and from our servers to our clients. Corruption or loss of data may result in the need to repeat a trial at no cost to the client, but at significant cost to us, or result in the termination of one or more contracts, legal proceedings or claims against us or damage to our reputation. Additionally, significant delays in system enhancements or inadequate performance of new or upgraded systems once completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events such as security breaches, cyber attacks, natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, could adversely affect our business.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unauthorized disclosure of sensitive or confidential data, whether through system failure or employee negligence, fraud or misappropriation, could damage our reputation and cause us to lose clients. Similarly, despite investing in information and cybersecurity controls, there is a risk that unauthorized access to our information systems or those we develop for our clients, whether by our employees or third parties, including a cyber attack by computer programmers and hackers who may attack ICON systems, develop and deploy viruses, worms, ransomware or other malicious software programs, could result in negative publicity, significant remediation costs, legal liability, loss of customers and damage to our reputation and could have a material adverse effect on our results of operations and financial results. In addition, our liability insurance might not be sufficient in type, the cover provided or amount to adequately cover us against claims related to security breaches, cyber attacks and other related breaches. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our information systems, and those of third parties which we utilize, may face increased cybersecurity risks due to the COVID-19 pandemic, including from the significant number of employees that are working remotely or otherwise impacted by stay-at-home orders.&#160;Additional remote access points provide new potential vulnerabilities to cybercriminals. Employees of ICON and third parties may be more susceptible to social engineering efforts, and to phishing attempts which can disguise malware as a legitimate effort to circulate important information relating to COVID-19.&#160; </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additionally, ICON completed the Merger with PRA on July 1, 2021 and, as a result, the IT landscape and physical footprint of the Company has increased significantly. As the organization invests in the consolidation of offices, data centers, IT systems and business services a significant amount of due diligence has been completed to understand the IT landscape and increased attack surface. While the organization continues with substantial integration efforts, a failure to effectively manage these activities in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Continued efficient operation of our business requires that we implement standardized global business processes and evolve our information systems to enable this implementation. We have continued to undertake significant programs to optimize business processes with respect to our services. A failure to effectively manage the implementation and adapt to new processes designed into these new or upgraded systems in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have entered into agreements with certain vendors to provide systems development and integration services that develop or license to us the IT platform for programs to optimize our business processes. If such vendors fail to perform as required or if there are substantial delays in developing, implementing and updating the IT platform, our customer delivery may be impaired and we may have to make substantial further investments, internally or with third parties, to achieve our objectives. Additionally, our progress may be limited by parties with existing or claimed patents who seek to prevent us from using preferred technology or seek license payments from us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Meeting our objectives is dependent on a number of factors which may not take place as we anticipate, including obtaining adequate technology-enabled services, creating IT-enabled services that our customers will find desirable and implementing our business model with respect to these services. We are continuing to develop opportunities for automation across ICON using state of the art automation tools including Robotic Process Automation (RPA), the development of new applications and capabilities, and enabling deeper integration across our digital ecosystem. To remain competitive within our industry and keep pace with the rapid evolution of the technological landscape, it is critical that we continue to innovate and expand the capabilities of our current technologies. This applies in particular to our ICONIK, Firecrest, ADDPLAN, Integrated Dataverse (IDV&#174;) and One Search services. Also, increased requirements for investment in information technology may negatively impact our financial condition, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to pursue business transformation initiatives to embed technology and innovation and deliver operational efficiencies. As part of these initiatives, we seek to improve our productivity, flexibility, quality, functionality and cost savings by our on-going investment in global technologies, continuous improvement of our business processes and functions to deliver economies of scale. These initiatives may not deliver their intended gains or be completed in a timely manner which may adversely impact our competitiveness and our ability to meet our growth objectives and therefore, could adversely affect our business and operating results, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We develop and maintain computer run and web based interactive response technologies to automatically manage the randomization of patients in trials, assign the study drug and adjust the dosage when required for patients enrolled in trials we support. An error in the design, programming or validation of these systems could lead to inappropriate assignment or dosing of patients, which could give rise to patient safety issues and invalidation of the trial and/or liability claims against the Company, amongst other things, any of which could have a material effect on our financial condition and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A failure to identify and successfully close and integrate strategic acquisition targets could adversely im</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">pact our ongoing business and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made a number of acquisitions, including the Merger, and continue to review new acquisition opportunities. If we are unable to identify suitable acquisition targets, complete an acquisition or successfully integrate an acquired company or business, our business may be disrupted. The success of an acquisition will depend upon, among other things, our ability to:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">effectively and quickly assimilate the operations and services or products of the acquired company or business;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">integrate acquired personnel;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">retain and motivate key employees;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">retain customers; and&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">minimize the diversion of management's attention from other business concerns.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event that the operations of an acquired company or business do not meet our performance expectations, we may have to restructure the acquired company or business or write-off the value of some, or all, of the assets of the acquired company or business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to realize anticipated cost and tax synergies and expect to incur substantial expenses related to the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to generate run rate cost synergies of approximately $150 million and tax savings from the combined target effective tax rate; both to be realized within approximately four years after completion of the Merger. Since completion of the Merger, we have progressed many of our key integration plans including rationalization of our office footprint, targeted headcount reductions to improve efficiency and key system integrations. The actions completed to date are ahead of our original plan such that we now anticipate realizing our run rate cost synergies by the end of 2023. Our ability to achieve such cost and tax synergies in the timeframe described, is subject to various assumptions by management, which may or may not prove to be accurate, as well as the incurrence of costs in our operations that offset all or a portion of such cost synergies. As a consequence, we may not be able to realize all of these cost and tax synergies within the timeframe expected. Failure to achieve the expected cost and tax synergies could significantly reduce the expected benefits associated with the Merger. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to continue to incur non-recurring costs associated with the combination of the two companies and achieving the desired cost synergies. These fees and costs have been, and will continue to be, substantial. Such costs, as well as other unanticipated costs and expenses, could have a material adverse effect on our financial condition and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Improper performance of our services could adversely impact our reputation and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The performance of clinical development services is complex and time-consuming. We may make mistakes in conducting a clinical trial that could negatively impact or damage the usefulness of the clinical trial or cause the results to be reported improperly.  If the clinical trial results are compromised, we could be subject to significant costs or liability, which could have an adverse impact on our ability to perform our services. Large clinical trials are costly, and while we endeavor to contractually limit our exposure to such risks, improper performance of our services could have an adverse effect on our financial condition, damage our reputation and result in the cancellation of current contracts or failure to obtain new contracts from affected or other clients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry is highly competitive, with biopharmaceutical companies each seeking to persuade payers, providers and patients that their drug therapies are better and more cost-effective than competing therapies marketed or being developed by competing companies. In addition to the adverse competitive interests that biopharmaceutical companies have with each other, biopharmaceutical companies also have adverse interests with respect to drug selection and reimbursement with other participants in the healthcare industry, including payers and providers. Biopharmaceutical companies also compete to be first to market with new drug therapies. We regularly provide services to biopharmaceutical companies who compete with each other and we sometimes provide services to such customers regarding competing drugs in development. Our existing or future relationships with our biopharmaceutical customers may therefore deter other biopharmaceutical customers from using our services or may result in our customers seeking to place limits on our ability to serve other biopharmaceutical industry participants. In addition, our further expansion into the broader healthcare market may adversely impact our relationships with biopharmaceutical customers and such customers may elect not to use our services, reduce the scope of services that we provide to them or seek to place restrictions on our ability to serve customers in the broader healthcare market with interests that are adverse to theirs. Any loss of customers or reductions in the level of revenues from a customer could have a material adverse effect on our results of operations, business and prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends, in part, upon our ability to develop, use and protect our proprietary methodologies, analytics, systems, technologies and other intellectual property. Existing laws of the various countries in which we provide services or solutions offer only limited protection of our intellectual property rights, and the protection in some countries may be very limited. We rely upon a combination of trade secrets, confidentiality policies, non-disclosure, invention assignment and other contractual arrangements and patent, copyright and trademark laws, to protect our intellectual property rights. These laws are subject to change at any time and certain agreements may not be fully enforceable, which could further restrict our ability to protect our innovations. Intellectual property rights may not prevent competitors from independently developing services similar to, or duplicative of, ours. Further, the steps we take in this regard might not be adequate to prevent or deter infringement or other misappropriation of our intellectual property by competitors, former employees or other third parties and we might not be able to detect unauthorized use of, or take appropriate and timely steps to enforce our intellectual property rights. Enforcing our rights might also require considerable time, money and oversight and we may not be successful in enforcing our rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry has a history of intellectual property litigation, and these lawsuits will likely continue in the future. Accordingly, we may face patent infringement legal proceedings by companies that have patents for similar business processes or other legal proceedings alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive, take significant time and divert management&#8217;s attention from other business concerns, regardless of the outcome of the litigation. If we do not prevail in an infringement lawsuit brought against us, we might have to pay substantial damages and we could be required to stop the infringing activity or obtain a license to use technology on unfavorable terms. Any infringement or other legal processing related to intellectual property could have a material adverse effect on our operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We act as authorized representative pursuant to Medical Devices Directive 93/42/EEC (&#8220;MDD&#8221;),  Medical Devices Regulation 2017/745 (&#8220;MDR&#8221;) and Active Implantable Medical Devices Directive 90/385/EEC (&#8220;AIMD&#8221;) for certain clients who are located outside of the European Union. As authorized representative, we act on behalf of medical device manufacturers in relation to specified tasks with regard to their obligations under MDR. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also act as legal representative pursuant to European Clinical Trials Directive (2021/20/EC) (&#8220;CTD&#8221;), EU Clinical Trials Regulation (No.536/2014) (&#8220;CTR&#8221;), MDD, MDR and AIMD, for certain clients who are located outside of the European Union with respect to clinical trials being carried out by those clients in the European Union. We also perform similar legal representative services for certain clients in other non-EU jurisdictions where client is located outside the relevant local jurisdiction, ICON has an established local legal entity and analogous local regulations have a similar requirement for a local legal representative for clinical trials being carried out in those jurisdictions. As legal representative, we are responsible for ensuring compliance with the client&#8217;s obligations pursuant to CTD, CTR and MDR or analogous local legislation and we are the addressee for all communications with the client provided for under CTD, CTR and MDR or analogous local legislation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide these services subject to certain terms and conditions which are contained in our agreements with clients pertaining to these services. We aim to reduce any potential liability associated with these activities by seeking contractual </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">indemnification from our clients and by maintaining an appropriate level of insurance cover. However, there is no guarantee that the specific insurance will be available or that a client will fulfill its obligations in relation to their indemnity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our services are derived from, or include, the use of data we collect from third parties. We have several data suppliers that provide us with a broad and diverse scope of information that we collect, use in our business and sell.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We generally enter into long-term contractual arrangements with many of our data suppliers. At the time we enter into a new data supply contract or renew an existing contract, suppliers may increase our cost to obtain and use the data provided by such supplier, increase restrictions on our ability to use or sell such data, or altogether refuse to license the data to us. Also, our data suppliers may fail to meet or adhere to our quality control standards or fail to deliver the data to us. Although no single supplier is material to our business, if suppliers that collectively provide a significant amount of the data we receive or use were to increase our costs to obtain or use such data, further restrict our access to or use of such data, fail to meet or adhere to our quality control standards, refuse to provide or fail to deliver data to us, our ability to provide data-dependent services to our clients may be adversely impacted, which could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We depend on certain third parties to provide us with products and services critical to our business. Such services include, among others, suppliers of drugs for patients participating in trials, suppliers of kits for use in our laboratories, suppliers of reagents for use in our testing equipment and providers of maintenance services for our equipment. The failure of any of these third parties to adequately provide the required products or services, or to do so in compliance with applicable regulatory requirements, could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Some of our services rely on intellectual property, technology and other similar property owned and/or controlled by third parties. Our licenses to this property and technology could terminate or expire and we might not be able to replace these licenses in a timely manner. Also, we might not be able to renew these licenses on similar terms and conditions. Failure to renew these licenses, or renewals of these licenses on less advantageous terms, could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are dependent upon the ability and willingness of the pharmaceutical, biotechnology and medical device companies to continue to spend on research and development and to outsource the services that we provide. We are therefore subject to risks, uncertainties and trends that affect companies in these industries that we do not control. We have benefited to date from the tendency of pharmaceutical, biotechnology and medical device companies to outsource clinical research projects. Any downturn in these industries or reduction in spending or outsourcing could materially adversely affect our business. The following could each result in such a downturn:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if pharmaceutical, biotechnology or medical device companies expanded upon their in-house clinical or development capabilities, they would be less likely to utilize our services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if governmental regulations were changed, it could affect the ability of our clients to operate profitably, which may lead to a decrease in research spending and therefore this could have a material adverse effect on our business; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if unfavorable economic conditions or disruptions in the credit and capital markets negatively impacted our clients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large pharmaceutical companies are continually seeking to drive efficiencies in their development processes to both reduce costs associated with the development of new drug candidates and accelerate time to market. As a result, large pharmaceutical companies, in particular, are increasingly looking to consolidate the number of outsource providers with which they engage, with many entering strategic partnership arrangements with a limited number of outsource providers.&#160;The failure to enter strategic partnership arrangements with customers or the loss of existing customers as a result of them entering strategic partnership arrangements with our competitors could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain pharmaceutical companies have begun to collaborate in seeking to develop new drug candidates. Increased collaboration amongst pharmaceutical companies may lead to fewer research opportunities, which in turn may lead to fewer outsource opportunities for companies within the CRO industry. A reduction in outsource opportunities as a result of this increased collaboration could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive and dynamic market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly competitive. In particular, we compete with other large global CROs for strategic relationships with large pharmaceutical companies. If we are unable to retain and renew existing strategic relationships and win new strategic relationships, there could be a material adverse impact on our results. Similarly, we compete with other CROs for work which comes outside of these strategic relationships and being unable to win work outside of these strategic relationships would have a material adverse impact on our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The type and depth of services provided by CROs has changed in recent years. Failure to develop and market new services or expand existing service offerings could adversely affect our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New entrants may also enter the market which would further increase competition and could adversely affect our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide services to biopharmaceutical, biotechnology, medical device and government organizations and our revenue is dependent on expenditures by these customers.  Our business could therefore be adversely impacted by mergers, consolidation, business failures, distress in financial markets or other factors resulting in a decrease in the number of potential customers or therapeutic products being developed through the drug development progress. There has been consolidation in the biopharmaceutical market in recent years. If the number of our potential customers were to decline in the future, they may be able to negotiate price discounts or other terms for services that are less favorable to us than they have been historically. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_40"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations in any quarter can fluctuate or differ from expected or forecast results depending upon or due to, among other things, the number and scope of ongoing client projects, the commencement, postponement, variation,&#160;cancellation or termination of projects in a quarter, the mix of activity, cost overruns, employee hiring, employee attrition and other factors. Our revenue in any period is directly related to the number of employees who were working on billable projects together with investigator activity during that period. We may be unable to compensate for periods of under-utilization during one part of a fiscal period by earning revenue during another part of that period. We believe that operating results for any particular quarter are not necessarily a meaningful indicator of future results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Also, if in future quarters, we are unable to continue to deliver operational efficiencies and our expenses grow faster than our revenues, our operating margins, profitability and overall financial condition may be materially adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our exposure to exchange rate fluctuations could adversely affect our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contracts with clients are sometimes denominated in currencies other than the currency in which we incur expenses related to such contracts. Where expenses are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material adverse effect on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we are also subject to translation exposures as our consolidated financial results are presented in U.S. dollars, while the local results of a certain number of our subsidiaries are prepared in currencies other than U.S. dollars, including, amongst others, the pound sterling and the euro. Accordingly, changes in exchange rates between the U.S. dollar and those other currencies will affect the translation of subsidiary companies' financial results into U.S. dollars in reporting our consolidated financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Inflation and rising labor costs could adversely affect our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inflation and rising labor costs may result in significant increases to the cost of our services, which we may not be able to recover from our customers. Our contracts with clients are often fixed price or fixed price-per-unit contracts. If macroeconomic forces, such as inflation, cause the cost of inputs required to deliver these contracts to increase significantly, we may be unable to pass along these cost to our customers. A sustained increase in these costs may require us to increase the price of future service offerings. These actions could adversely affect our future revenue, gross margin, or both.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our quarterly effective tax rate has depended and will continue to depend on the geographic distribution of our taxable earnings amongst the multiple tax jurisdictions (such as Ireland, United States and United Kingdom) in which we operate and the tax law in those jurisdictions. Changes in the geographic mix of our results of operations amongst these jurisdictions may have a significant impact on our effective tax rate from quarter-to-quarter. Changes in tax law in one or more jurisdictions could also have a significant impact on our tax rate and results. In addition, as we operate in multiple tax jurisdictions, we may be subject to audits in certain jurisdictions. These audits may involve complex issues which could require an extended time period before being resolved. The resolution of audit issues may lead to additional taxes, interest as well as fines and/or penalties being imposed which could have a material adverse impact on our effective tax rate and our consolidated financial results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation is the amount of awards that has not yet converted to revenue. This value is not necessarily a meaningful predictor of future results due to the potential for the cancellation or delay of projects included in the unsatisfied performance obligation.&#160;No assurances can be given that we will be able to realize this unsatisfied performance obligation in full as revenue. A failure to realize these awards could have a material adverse impact on our results of operations. In addition, as the length and complexity of projects increases, the rate at which awards convert to revenue may be slower than in the past. A significant reduction in the rate of conversion could have a material impact on our results of operations.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s treasury function manages our available cash resources and invests significant cash balances in various financial institutions to try to ensure optimum returns for our surplus cash balances.&#160;These balances are classified as cash and cash equivalents or short term investments depending on the maturity of the related investment. Cash and cash equivalents comprise cash and highly liquid investments with maturities of three months or less.&#160;Short term investments comprise highly liquid investments with maturities of greater than three months and minimum &#8220;A-&#8221; rated fixed and floating rate securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;Given the global nature of our business, we are exposed to various risks in relation to these balances including liquidity risk, credit risk associated with the counterparties with whom we invest, interest rate risk on floating rate securities, sovereign risk (our principle sovereign risk relates to investments in U.S. Treasury funds) and other factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we have not recognized any significant losses to date on our cash and cash equivalents or short term investments, any significant declines in their market values could have a material adverse effect on our financial position and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We prepare our financial statements in accordance with generally accepted accounting principles in the United States of America ("US GAAP") which are revised on an on-going basis by the authoritative bodies. It is possible that future accounting standard updates may require changes to the accounting treatment that we apply in preparation of our financial statements. These changes may also require significant changes to our reporting systems. These updates may result in unexpected variability in the timing of recognition of revenue or expenses and therefore in our operating results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_46"></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the combined Company&#8217;s business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following completion of the Merger and the other transactions contemplated by the Merger Agreement, the Company has a substantial amount of debt. ICON borrowed approximately $6,015 million in order to pay PRA stockholders the cash consideration due to them as merger consideration under the Merger Agreement, pay related fees and transaction costs in connection with the transactions, and refinance existing indebtedness. The total remaining transaction related debt balance at December&#160;31, 2022 was $4,701 million. This level of borrowings could adversely affect the Company in a number of ways, including, but not limited to, by placing us at a competitive disadvantage compared to our competitors that have less debt, causing us to incur substantial fees from time to time in connection with debt amendments or refinancing, making it more difficult for the Company to satisfy its obligations with respect to its debt or to its trade or other creditors, requiring a substantial portion of the Company&#8217;s cash flows from operations for the payment of interest on the Company&#8217;s debt, reducing the Company&#8217;s flexibility to respond to changing business and economic conditions, and reducing funds available for the Company&#8217;s investments in research and development, capital expenditures and other activities. If ICON cannot service its debt, it may have to take actions such as selling assets, seeking additional debt or equity, or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, ICON&#8217;s increased level of indebtedness could adversely affect ICON&#8217;s credit rating, which could result in increased borrowing costs for the Company in the future. No assurances can be made that ICON will be able to refinance any indebtedness incurred in connection with the Merger on terms acceptable to it or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities and the indenture include certain customary covenants that limit our ability to, amongst other things, subject to certain exceptions:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">make dividends, investments and other restricted payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into sale and leaseback transactions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">engage in share buybacks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">incur or assume liens or additional debt;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">engage in mergers or reorganizations; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into certain types of transactions with affiliates.</span></div><div style="text-align:justify;text-indent:43.2pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The revolving credit facility also includes a financial covenant that requires us to comply with a maximum consolidated leverage ratio. Our ability to comply with this financial covenant may be affected by events beyond our control.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the original principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.50%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> At December&#160;31, 2022, no amounts were outstanding under the revolving loan facility with the exception of $4.5&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because the Company has variable rate debt, fluctuations in interest rates affect our business.  We attempt to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate cap and interest rate swap derivative financial instruments.  We have entered into certain interest rate cap and interest rate swap agreements with three financial institutions with respect to a portion of our outstanding debt.  Accordingly, any change in market value associated with these agreements is offset by the opposite market impact on the portion of the debt covered by such agreements. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note 14 - Derivatives</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Borrowings under our Senior Secured Credit Facilities bear interest at a variable rate that is based on the Secured Overnight Financing Rate (&#8220;SOFR&#8221;), which may have consequences for us that cannot be reasonably predicted and may adversely affect our liquidity, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 27, 2017, the U.K. Financial Conduct Authority (the &#8220;FCA&#8221;) announced that it intended to end the use of LIBOR effective after December 31, 2021 as the benchmark rate that many banks and issuers use to set interest rates for loans, securities, derivative contracts and other financial instruments. Recognizing the need to replace LIBOR, authorities in the United States convened the Alternative Reference Rates Committee (&#8220;ARRC&#8221;) in 2014 to identify a replacement for LIBOR with respect to indebtedness denominated in U.S. Dollars. In 2017, the ARRC identified SOFR, and in April 2018, the Federal Reserve Bank of New York began publishing SOFR. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. Although the U.S. Treasury-backed overnight repo market is highly liquid, there is currently no robust market for determining forward-looking SOFR term rates. Because SOFR is an overnight risk-free rate, whereas LIBOR has various terms and an embedded credit charge, the transition from LIBOR to SOFR will require adjustments, which may continue to vary for certain forms of indebtedness and financial instruments as the relevant markets adapt to SOFR&#8217;s implementation. Similar alternative benchmark replacements will be required to be implemented in respect of indebtedness and other financial instruments that are currently based on LIBOR quotes for currencies other than the U.S. Dollar.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or other base rate (as elected by the borrower), plus an applicable margin.  The credit agreement also provides that LIBOR may be replaced by a SOFR-based rate for borrowings in U.S. Dollars upon (i) the FCA ceasing to provide LIBOR for U.S. Dollars or announcing that LIBOR is no longer representative or (ii) an early election by the Company and the administrative agent under our credit agreement to transition from LIBOR.  On November 29, 2022, the Company agreed with its lenders to the adoption of SOFR as the benchmark rate within the Credit Agreement.  The possible volatility of and uncertainty around SOFR as a LIBOR replacement rate and the applicable credit adjustment could result in higher borrowing costs for us, which would adversely affect our liquidity, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_43"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business opportunities as a result of healthcare reform and the expansion of managed care organizations.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Numerous governments, including the U.S. government, have undertaken efforts to control growing healthcare costs through legislation, regulation and voluntary agreements with medical care providers and drug companies. If these efforts are successful, pharmaceutical, biotechnology and medical device companies may react by spending less on research and development and therefore this could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to healthcare reform proposals, the expansion of managed care organizations in the health care market may result in reduced spending on research and development. Managed care organizations' efforts to cut costs by limiting expenditures on pharmaceuticals and medical devices could result in pharmaceutical, biotechnology and medical device companies spending less on research and development. If this were to occur, we would have fewer business opportunities and our revenues could decrease, possibly materially.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations and financial conditions could be affected by changes in healthcare spending and policy.&#160; The healthcare industry is subject to changing political, regulatory and other influences. It is possible that legislation will be introduced and passed in the United States repealing, modifying or invalidating the current healthcare reform legislation, in whole or in part, and signed into law. Because of the continued uncertainty about the implementation of the current healthcare reform legislation, including the potential for further legal challenges or repeal of that legislation, we cannot quantify or predict with any certainty the likely impact of the&#160;current&#160;healthcare&#160;reform legislation&#160;or its repeal on the healthcare sector, on our customers and ultimately on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">several tax incentives to promote clean energy, which will go into effect in 2023. The Company is continuing to assess the potential impact of these changes.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The conflict in Ukraine could adversely affect our future results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The current conflict in Ukraine has led to, among other things, hardship and the imposition of international economic sanctions aimed at the region. While the situation is subject to change, there remains the possibility of additional and harsher sanctions if the conflict intensifies. If that were to happen, our operations in the region may be severely curtailed or eliminated, which could adversely affect our results of operations. In addition, if the current unrest broadens or further escalates, our operations may be severely curtailed, which could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business as a result of changes in the regulatory environment</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Various regulatory bodies throughout the world may enact legislation, rules and guidance which could introduce changes to the regulatory environment for drug development and research. The adoption and implementation of such legislation, rules and guidance is difficult to predict and therefore could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration, ("FDA"), and other regulatory and government authorities and agencies inspect and audit us from time to time to ensure that we comply with their regulations and guidelines, including environmental, health and safety matters, and other requirements imposed in connection with the performance of government contracts.&#160; We must comply with the applicable regulatory requirements governing the conduct of clinical trials and contracting with the government in all countries in which we operate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we fail to comply with any of these requirements we could suffer some or all of:&#160;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">termination of or delay in any research;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disqualification of data;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">denial of the right to conduct business;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">criminal penalties;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">financial penalties;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other enforcement actions including debarment from government contracts;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">loss of clients and/or business; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation from clients and/or patients and/or regulatory authorities and/or other affected third parties, and resulting material penalties, damages and costs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of a small group of organizations with the capability and expertise to conduct clinical trials on a global basis. We believe that this capability to provide our services globally in most major and developing pharmaceutical markets enhances our ability to compete for new business from large multinational pharmaceutical, biotechnology and medical device companies. We have expanded geographically in the past and intend to continue expanding in regions that have the potential to increase our client base or increase our investigator and patient populations. We expect that revenues earned in emerging markets will continue to account for an increasing portion of our total revenues.&#160;However, emerging market operations may present several risks, including civil disturbances, health concerns, cultural differences such as employment, regulatory and business practices, compliance with economic sanctions, laws and regulations, volatility in gross domestic product, economic and governmental instability, the potential for nationalization of private assets and the imposition of exchange controls. In addition, operating globally means the Company faces the challenges associated with coordinating its services across different countries, time zones and cultures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the political and regulatory environment in the international markets in which we operate such as price or exchange controls could impact our revenue and profitability and could lead to penalties, sanctions and reputational damages if we are not compliant with those regulations. Political uncertainty and a lack of institutional continuity in some of the emerging, developing or other countries in which we operate could affect the orderly operation of markets in these economies.&#160;In addition, in countries with a large and complicated structure of government and administration, national, regional, local and other governmental bodies may issue inconsistent decisions and opinions that could increase our cost of regulatory compliance and/or have a material adverse effect on our business. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states.  These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Uncertainty of the legal environment in some emerging countries could also limit our ability to enforce our rights.&#160;In certain emerging and developing countries we enjoy less comprehensive protection for some of our rights, including intellectual </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">property rights, which could undermine our competitive position. Proceedings to enforce our future patent rights, if any, in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If any of the above risks or similar risks associated with our international operations were to materialize, our results of operations and financial condition could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FCPA, UK Bribery Act of 2010 and similar anti-corruption laws in other jurisdictions prohibit us and our officers, directors, employees and third parties acting on our behalf, including agents, from corruptly offering, promising, authorizing, or providing anything of value to a "foreign official" for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. In addition, the FCPA imposes certain books, records and accounting control obligations on public companies and other issuers. The UK Bribery Act also prohibits "commercial" bribery and accepting bribes. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global business operations also must be conducted in compliance with applicable export controls and economic sanctions laws and regulations, including those administered by the U.S. Department of the Treasury&#8217;s (the &#8220;U.S. Treasury&#8221;) Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury and other relevant trade compliance authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our internal policies mandate compliance with these anti-corruption and trade compliance laws and regulations. We also operate in many jurisdictions in which bribery or corruption can be common and compliance with anti-bribery laws may conflict with local customs and practices. Despite our training and compliance program safeguards, we cannot assure that our internal control policies, procedures and safeguards will protect us from acts in violation of anti-corruption and trade compliance laws and regulations committed by employees or other third parties associated with us and our continued expansion, including in developing countries, could increase such risk in the future. Violations of anti-corruption, economic sanctions and trade control laws and regulations, or even allegations of such violations, could disrupt our business and result in a material adverse effect on our financial condition, results of operations, cash flows and reputation. For example, violations of anti-corruption and trade compliance laws can result in restatements of, or irregularities in, our financial statements, disgorgement of profits, related stockholder lawsuits as well as severe criminal or civil sanctions. In some cases, companies that violate anti-corruption and trade compliance laws might be debarred by the U.S. government and/or lose their U.S. export privileges. In addition, the U.S. government or other governments may seek to hold us liable based on successor liability for violations of anti-corruption and trade compliance laws committed by companies that we acquire or in which we invest. Changes in anti-corruption and trade compliance laws or enforcement priorities could also result in increased compliance requirements and related costs which could materially adversely affect our business, financial condition, results of operations and cash flows. The recent increase in economic sanctions and trade controls, particularly relating to our ongoing operations in Russia, Ukraine and Belarus, has increased the amount of resources necessary to ensure compliance in this area.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a strong privacy posture, driven by the implementation of a core privacy governance strategy and the adoption of policies and procedures designed to help ensure that ICON, including our employees and contractors, can comply with applicable data protection laws (including, but not limited to, the General Data Protection Regulation (&#8220;GDPR&#8221;) (EU) 2016/679). Notwithstanding these measures, failure to comply with applicable data protection laws may occur and could result in increased risk of liability or increased costs to us or could limit our service offerings. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative fines</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The GDPR introduced a new regime of administrative fines for data protection infringements and provided for a tiered penalty structure based on the nature of the infringement. The EU supervisory authorities for the GDPR can directly impose fines on organizations found to be in breach of the GDPR. Lower tier administrative fines allow for fines of up to 2% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines allow for fines of up to 4% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines are more likely to be levied for major infringements of the GDPR and core data protection principles (e.g. transparency, data retention, accountability). </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Penalties</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The GDPR also permits Member States to implement rules on other penalties applicable to infringements of the GDPR, in particular, for infringements which are not subject to administrative fines under the GDPR itself. Therefore, Member States may legislate for further fines or penalties that may be criminal in nature. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any fines levied under the GDPR must be effective, proportionate, and dissuasive. Supervisory authorities have been strengthening enforcement activities across the EU in recent years in respect of breaches of GDPR. The risk of fines and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">penalties under the GDPR carries increased risk of liability to ICON and can result in increased costs and disruption to the delivery of our services. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Right to compensation of data subjects</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. In addition to the risk of administrative and criminal penalties, the GDPR also provides that any person who has suffered material or non-material damage as a result of an infringement of the GDPR shall have the right to receive compensation for the damage suffered, from the controller or processor responsible for the infringement. The level of award of damages is set by the competent court in the applicable EU Member State. This carries increased risk of liability for ICON. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">Corrective Powers of the supervisory authorities.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">  Each supervisory authority across the Member States of the EU also has corrective powers. Supervisory authorities have the power to order ICON to bring processing operations into compliance with the provisions of the GDPR in a specified manner within a specified time period, or to impose a temporary or definitive limitation including a ban on processing, and to order the suspension of data flows to a recipient in a third country or to an international organization. Supervisory authorities also have powers to conduct audits and investigations of ICON and instruct ICON to take certain actions. The exercise of these powers by supervisory authorities has the potential to increase costs for ICON and cause disruption to the business and delivery of our services. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From a US perspective, the confidentiality, collection, use and disclosure of personal data, including clinical trial patient-specific information, is subject to governmental regulation generally in the country that the personal data was collected or used. For example, United States federal regulations under the Health Insurance Portability and Accountability Act of 1996, or ("HIPAA"), and as amended in 2014 by the Health Information Technology for Economic and Clinical Health (&#8220;HITECH&#8221;) Act, require individuals&#8217; written authorization, in addition to any required informed consent, before Protected Health Information may be used for research. HIPAA specifies standards for de-identifications and for limited data sets. We are both directly and indirectly affected by the privacy provisions surrounding individual authorizations because many investigators and organizations with whom we are involved in clinical trials and in our services are directly subject to them as a HIPAA &#8220;covered entity&#8221; and because we obtain identifiable health information from third parties that are subject to such regulations. As there are some instances where we are a HIPAA &#8220;business associate&#8221; of a &#8220;covered entity&#8221;, we can also be directly liable to the covered entity contractually for mishandling protected health information and, under HIPAA&#8217;s enforcement scheme, we can be subject to up to $1.9 million per year in civil money penalties for identical HIPAA violations. The per violation penalties and calendar year cap on penalties are adjusted annually for inflation under the Federal Civil Penalties Inflation Adjustment Act.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foundational principles of the GDPR have helped shape the development of many other privacy laws globally. Internationally, data protection laws continue to be introduced at a rapid rate, with greater protections afforded to personal data than ever before, and greater risk of liability to organizations processing that personal data. As a global organization, ICON must ensure that our privacy posture continues to adapt to these new laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional legislation or regulation of this type might, among other things, require us to implement new security measures and processes which may require substantial expenditures or limit our ability to offer some of our services. Additionally, if we violate applicable laws, regulations or duties relating to the use, processing or security of personal data, we could be subject to civil liability or criminal prosecution, be forced to alter our business practices or suffer reputational harm. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with governmental regulations, comply with federal and state healthcare fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies or data or documentation fraud or manipulation, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines or other sanctions.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with our government co</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">ntracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues from our government customers are derived from sales to federal, state and local governmental departments and agencies through various contracts. Sales to public segment customers are highly regulated. Noncompliance with contract provisions, government procurement regulations or other applicable laws or regulations (including but not limited to the False Claims Act) could result in civil, criminal and administrative liability, including substantial monetary fines or damages, termination of government contracts or other public segment customer contracts, and suspension, debarment or ineligibility from doing business with the government and other customers in the public segment. In addition, generally contracts in the public segment are terminable at any time for convenience of the contracting agency or upon default. The effect of any of these possible actions by any governmental department or agency could adversely affect our business, results of operations or cash flows. In addition, the adoption</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of new or modified procurement regulations and other requirements may increase our compliance costs and reduce our gross margins, which could have a negative effect on our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may face legal claims involving stockholders, consumers, clinical trial subjects, competitors, regulators and other parties. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Legal Proceedings'</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in Part A, Item 8 of this Form 20-F. Litigation and other legal proceedings are inherently uncertain, and adverse rulings could occur, including monetary damages, or an injunction stopping us from engaging in business practices, or requiring other remedies, including, but not limited to, compulsory licensing of patents. In addition, the combined Company may be exposed to increased litigation from stockholders, customers, suppliers, consumers and other third parties due to the combination of ICON&#8217;s business and PRA&#8217;s business following the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Customer Claims</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we breach the terms of an agreement with a customer (for example if we fail to comply with the agreement, all applicable regulations or Good Clinical Practice) this could result in claims against us for substantial damages which could have a material adverse effect on our business. As we provide staff to deliver our services, there is a risk that our management, quality and control structures fail to quickly detect a failure by one or more employees or contractors to comply with all applicable regulations and Good Clinical Practice and our internal requirements and standard operating procedures thereby exposing us to the risk of claims by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims relating to Investigators</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians who serve as investigators in conducting clinical trials to test new drugs on their patients. These patients will generally have underlying health conditions and this testing creates the risk of liability for personal injury to the patient or the risk of a serious adverse event occurring. Although investigators are generally required by law to maintain their own liability insurance, we could be named in lawsuits and incur expenses arising from any professional malpractice or other actions brought against the investigators with whom we contract.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indemnification from Customers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indemnifications provided by our customers&#160;against the risk of liability for personal injury to or death of the patients arising from a study drug vary from customer to customer and from trial to trial and may not be sufficient in scope or amount, or our customer&#160;may not have the financial ability to fulfill their indemnification obligations. Furthermore, we would be liable for our own negligence and negligence of our employees which could lead to litigation from customers or action or enforcement by regulatory authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Insurance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain what we believe is an appropriate level of worldwide Professional Liability/Error and Omissions Insurance. In the future we may be unable to maintain or continue our current insurance coverage on the same or similar terms. If we are liable for a claim or settlement that is beyond the level of insurance coverage, we may be responsible for paying all or part of any award or settlement amount. Also, the insurance policies contain exclusions which mean that the policy will not respond or provide cover in certain circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims to Date</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To date, we have not been subject to any liability claims that are expected to have a material effect on our business; however, there can be no assurance that we will not become subject to such claims in the future or that such claims will not have a material effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance matters may impact our business and reputation.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Increasingly, in addition to th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance ('ESG') matters, which are considered to contribute to the long-term sustainability of companies&#8217; performance. A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. Customers may have specific ESG related requirements or targets and if we fail to meet these targets we may lose business. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the Company&#8217;s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">mpany&#8217;s board of directors in supervising various sustainability issues. We actively manage a broad range of such ESG matters, taking into consideration their expected impact on the sustainability of our business over time, and the potential impact of our business on society and the environment. However, in light of investors&#8217; increased focus on ESG matters, there can be no certainty that we will manage such issues successfully, or that we will successfully meet society&#8217;s perceived expectations as to our proper role. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, share price, financial condition, or results of operations, including the sustainability of our business over time.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The market price of our common stock has experienced volatility in the past and may experience volatility in the future which could lead to losses for investors. Factors impacting volatility in the market price of our common stock include, amongst others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">general market and economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our results of operations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">issuance of new or changed securities analysts&#8217; reports or recommendations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">developments impacting the industry or our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">declines in the market prices of stocks generally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">strategic actions by us or our competitors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.81pt">announcements by us or our competitors of significant contracts, new products, acquisitions, joint marketing relationships, joint ventures, other strategic relationships or capital commitments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">the public's reaction to press releases, other public announcements by us or third parties, including our filings with the SEC;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">guidance, if any, that we provide to the public, any changes in this guidance or failure to meet this guidance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changes in the credit rating of our debt;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">sale, or anticipated sale, of large blocks of our stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">additions or departures of key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">regulatory or political developments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our performance on ESG matters</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation and governmental investigations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changing economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">exchange rate fluctuations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">changes in accounting principles; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other events or factors, including those resulting from natural disasters, war, acts of terrorism or responses to those events.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, stock markets have from time to time experienced significant price and volume fluctuations unrelated to the operating performance of particular companies. Future fluctuations in stock markets may lead to volatility in the market price of our common stock which could lead to losses by investors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investment returns may be reduced if we lose our foreign private issuer status. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer,&#8221; as such term is defined in Rule 405 under the U.S. Securities Act 1933, and, therefore, we are not required to file quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC. In addition, the proxy rules and Section 16 reporting and short-swing profit recapture rules are not applicable to us. If we lose our status as a foreign private issuer by our election or otherwise and we become subject to the full reporting regime of the United States securities laws, we will be subject to additional reporting obligations and proxy solicitation obligations under the Exchange Act and our officers, directors and 10% shareholders would become subject to the short-swing profit rules. The imposition of these reporting rules would increase our costs and the obligations of those affected by the short-swing rules.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We currently do not expect to declare dividends on our common stock and have not done so in the past. We continue to anticipate that our earnings will be used to provide working capital, to support operations, to make debt repayments and to finance the growth and development of our business. They may also be used to continue our share repurchase program. Any determination to declare or pay dividends in the future will be at the discretion of our board of directors, subject to relevant laws and dependent on a number of factors, including our earnings, capital requirements and overall financial condition. Therefore, the only opportunity for stockholders to achieve a return on their investment may be if the market price of our common stock appreciates and shares are sold at a profit. The market price for our common stock may not appreciate and may fall below the price stockholders paid for such common stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transfers of ICON ordinary shares effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC") should not be subject to Irish stamp duty where ICON ordinary shares are traded through DTC, either directly or through brokers that hold such shares on behalf of customers through DTC. However, if ICON ordinary shares are held as of record rather than beneficially through DTC, any transfer of ICON ordinary shares could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. The potential for Irish stamp duty to arise could adversely affect the price of ICON ordinary shares.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Information on the Company.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">History and development</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON public limited company (&#8220;ICON plc&#8221;) is a clinical research organization (&#8220;CRO&#8221;), founded in Dublin, Ireland in 1990. Over thirty years we have grown significantly to become a leading global provider of outsourced development and &#160;&#160;&#160;&#160; services to pharmaceutical, biotechnology, medical device and government and public health organizations.  Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a public limited company in Ireland and operate under the Irish Companies Acts. Our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000. Our website is www.iconplc.com. Additionally, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our service offering includes clinical development, functional outsourcing and laboratory services. Our clinical development services include all phases of development (Phases I-IV), peri and post approval, data solutions and site and patient access services. Our laboratory services include a range of high value testing services, including bionanalytical, biomarker, vaccine, good manufacturing practice ('GMP') and central laboratory services. We also offer full-service and functional service partnerships to our customers.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since ICON was founded, the Company has expanded through organic growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process and to broaden the service portfolio and add scale to existing services. </span></div><div><span><br/></span></div><div><img src="iclr-20221231_g1.jpg" alt="iclr-20221231_g1.jpg" style="height:282px;margin-bottom:5pt;vertical-align:text-bottom;width:718px"/></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recent investments, which continue to strengthen our service offerings to meet the needs of our customers include: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA became a wholly owned subsidiary within the ICON Group. The Acquisition has transformed the scale and capabilities of the Company. The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The combined Company retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Acquisition has brought together two high-quality, innovative, growing organizations with similar cultures and values to create the world's leading clinical research organization with a singular focus on clinical research and commercialization. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The total value of the Merger consideration is $12.0&#160;billion and has resulted in the recognition of goodwill of $8.1&#160;billion, intangible assets of $4.9&#160;billion and an associated deferred tax liability of $1.1&#160;billion. The accounting for the Merger was final as of June 30, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on the London Interbank Offered Rate ("LIBOR") or other base rate (as elected by the borrower), plus an applicable margin. On November 29, 2022, the Company agreed with its lenders to the adoption of the Secured Overnight Financing Rate ("SOFR") as the benchmark rate within the Senior Secured Credit Facilities, thus LIBOR is no longer the benchmark rate available to the Company under the terms of the Senior Secured Credit Facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company repaid $800 million and $513.8 million of the senior secured term loan facility for the years ended December 31, 2022 and 2021, respectively. At December&#160;31, 2022 and 2021, no amounts were outstanding under the senior secured revolving loan facility with the exception of $4.5&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The financial information presented in this Form 20-F reflect the results of the combined Company for the year ended December&#160;31, 2022. The financial information presented for the years ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2021 and December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160; are as previously reported and do not reflect the pre-Merger results of PRA before July 1, 2021, other than where clearly stated and required by GAAP.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2019, we further enhanced our site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN. In 2020, ICON announced the launch of Accellacare, a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research, MeDiNova and CRN. Also in 2020, we entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates as a specialized oncology site network in the US and EMEA regions. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> employees across the globe, the new ICON has established relationships with a majority of the world&#8217;s top pharmaceutical and biotech companies. We believe the Company now has the expertise, technology, and data assets to lead the industry into a new paradigm for bringing clinical research to more patients and enabling expanded capabilities for customers. We believe the Merger will deliver a transformational effect on ICON through:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Scale:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> With a deeper clinical, commercialization and consulting services portfolio, a broader geographic footprint, depth in therapeutic expertise, and data-driven healthcare technology, the Company can deliver enhanced globally scaled expertise &amp; solutions for all customers and patients.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Focus:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company will have a singular focus on clinical research and commercialization, leveraging transformational technology and innovation to execute clinical trials from Phase 1 to post-approval studies with the highest quality, expertise and speed. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Speed to market</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Our extensive services portfolio, digital and data technology capabilities, and enhanced access to more diverse patient populations, have been combined with flexible delivery approaches and partnership models &#8211; all with the aim of reducing development time and costs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Flexible partnership models:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON has partnerships with a majority of world&#8217;s top biopharma and biotech companies worldwide. ICON is a global leader in Functional Service Provision and a top global provider of full service clinical research. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Differentiated DCT platform, healthcare intelligence &amp; technology:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The new ICON can deliver differentiated decentralized and hybrid trial solutions through a suite of capabilities, including mobile health, commercial connected health platforms, real world data and information solutions, a global site network, home health services and wearables expertise.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Access to patients:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The new ICON offers customers enhanced access to a larger global pool of more diverse patients through its global site network (Accellacare), specialized oncology network (Oncacare), a pediatric site network, in-home clinical services and a network of six Phase I clinical research units across the United States and Europe. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company has entered into derivative financial instruments to manage exposures to interest rate fluctuations. On November 29, 2022, the Company entered into two interest rate cap agreements and one interest rate swap agreement with notional amounts of $2,100.6 million and $1,100.6 million, respectively. These derivative financial instruments are used to limit the Company's exposure to changes in the variable interest rate on its Senior Secured Credit Facilities by fixing the interest rates on approximately 48% of ICON's term loan facility at that date.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 18, 2022, the Board authorized the repurchase of up to $100 million of the Company's common stock. The share repurchase program was completed during the year ended&#160;December&#160;31, 2022 with a total of 420,530 ordinary shares redeemed by the Company for a total consideration of $100.0 million. All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required by Irish Company law.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ukraine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 24, 2022 Russia invaded Ukraine, creating significant instability and unrest in the region. Since that time, the Company's key focus has been on the safety of our employees and their families, patients, investigators and on the mitigation of adverse impacts on ongoing clinical trials. The Company has worked to ensure the safety of employees and their families based in Ukraine through the implementation of a number of employee assistance programs. These programs aim to provide affected emp</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">loyees and their families with transportation, accommodation in neighboring countries, financial assistance, communications and other support services as needed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operations in these affected regions have been significantly curtailed as a result of these events. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states. These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations. The financial impact of the conflict was not material to the  Company during the year ended December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Foreign exchange</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company prepares its financial statements in United States dollars while the local results of a certain number of our subsidiaries are prepared in currencies other than United States dollars, including, amongst others, the pound sterling and the euro. In addition, the Company's contracts with clients are sometimes denominated in currencies other than the United States dollar. Finally, the Company is exposed to a wider variety of currencies in the expenses line due to most expenses being incurred in the local currencies of where our global operations are based. Accordingly, changes in exchange rates between the United States dollar and those other currencies could have a material adverse effect on the Company&#8217;s financial results. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2022, the Company recorded foreign currency gains of $26.0 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Business Overview</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is a leading global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer a full range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV clinical studies. We earn revenue by providing a number of different services to our customers. Those services are integral components of the clinical development process and include clinical trial management, consulting, contract staffing, data solutions and laboratory services. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><img src="iclr-20221231_g2.jpg" alt="iclr-20221231_g2.jpg" style="height:342px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development. We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in the major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full-service solution. In order to achieve this vision, we are capitalizing on the enhanced scale, technology and data analytics capabilities that the recent acquisition of PRA Health Sciences delivered. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains a sustained focus on research and development and developing industry-leading technologies and processes to support our clients. We continue to enhance our portfolio of data solutions and decentralized clinical trial technology. ICON is leading the industry transformation through four key levers: transforming clinical trials, site and patient centricity, healthcare intelligence and applied innovation, and seamless, integrated service delivery.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we employed approximately 41,100 employees in 111 locations in 53 countries. During the year ended December&#160;31, 2022, we derived approximately </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.2%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.5%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.3%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of our revenue in the United States, Europe and Rest of World, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The ICON strategy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have achieved strong growth since our foundation in 1990, as a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations.  We focus our innovation on those factors that are critical to our clients - reducing time to market, reducing cost and increasing quality. Our global team has extensive experience in a broad range of therapeutic areas. ICON has been recognized as one of the world's leading Contract Research Organizations (''CROs") through a number of high-profile industry awards (see www.iconplc.com/awards).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As our market has evolved, biopharmaceutical companies are tackling productivity challenges, increasing budget constraints and greater demands to demonstrate product value; all of which are placing increased pressure on their revenues and levels of profitability. However, these trends have generally been positive for CROs, as increased outsourcing has been adopted by these companies as they seek to create greater efficiencies in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory and reimbursement pressures will increase the emphasis on late stage (post marketing) research, while increasing requirements to demonstrate the economic value of new treatments. As a result, outcomes and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should create further growth opportunities for both biopharma companies and their outsource development partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect that continued outsourcing will be a core strategy of clients in the near term as they respond to the increased pressures on their revenues and profitability. Larger clients were the first to form strategic partnerships with global CROs in an effort to reduce the number of outsource partners with whom they engage and to reduce inefficiencies in their current drug </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">development models. More recently we have seen the increasing adoption of this partner model with mid-tier pharmaceutical and biotechnology firms as they also seek to drive development efficiencies. As outsourcing penetration increases, we believe clients may seek a greater level of integration of service offerings from CROs, although some will continue to purchase services on a stand-alone basis. Creating greater connectivity and &#8220;seamlessness&#8221; between our services and the sharing of &#8220;real-time&#8221; clinical, operational and &#8220;real world&#8221; data with clients will therefore become increasingly important for CROs. ICON will seek to benefit from this increased outsourcing by clients to grow our business by increasing market share with our existing client base and adding new clients within the Phase I-IV outsourced development services market; the aim being to ensure we will be considered for all major Phase I-IV projects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access &amp; Engagement (ii) Career Development &amp; Employer of choice (iii) Enduring Customer Partnerships and (iv) Healthcare Intelligence &amp; Applied Innovation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><img src="iclr-20221231_g3.jpg" alt="iclr-20221231_g3.jpg" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient Access &amp; Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a focused patient, site and data strategy, which is helping us to improve site identification, study placement and patient recruitment and retention. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare is ICON's global clinical research network offering customers a wide range of stand-alone and integrated solutions at the site or in patients' homes as part of decentralized trials. Our patient centric approach accelerates study start-up and increases patient recruitment and retention for pharmaceutical, biotechnology and medical device industries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Accellacare Site Network encompasses more th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">an 76 sites across 6 countries covering the</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> United States and Europe. Accellacare offers a quality focused clinical research infrastructure delivering value and benefits to sponsors. Accellacare supports customers with faster start-up. The time from site selected to site initiation visit is on average 30% faster when compared to other sites. Also, Accellacare achieves an average of 40% more patients per site when compared to other sites.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare In-Home Services takes study visits directly to patients where they live, work, study or play in all phases and therapeutic areas of clinical trials. By bringing trial visits directly to patients, we ease the burden of participating in clinical research to increase patient recruitment, retention and diversity. Accellacare In-Home Services has experience in more than 400 clinical trials, tailoring our services to fit each study's specific requirements across more than 55 countries. This cohesive approach is leading to higher patient recruitment and retention rates. Accellacare is also achieving faster study start-up for its customers through efficiencies gained in central process management including budget and contracting, which can otherwise be a source of delay. This combined with a finely tuned feasibility approach allows the network to identify and recruit more patients to studies, in a wide range of therapeutic areas, in a shorter time frame. Accellacare is an important part of the integrated patient, site and data strategy, helping us to improve patient recruitment and retention. Through Accellacare we are committed to delivering on the promise of patient centricity in clinical research. It is also providing investigators with innovative treatments for their patients with a quality-focused clinical research infrastructure supported by experienced professionals globally.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In 2021, Accellacare entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities. Agreements with Asclepes Research and Olympian Clinical Research in the U.S., Curiositas ad Sanum and Intermed in Germany, Quironsalud in Spain, and KO-MED in Poland. Through these new partnerships, Accellacare is also enhancing its capability in the central nervous system (CNS) and immune-inflammation therapeutic areas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 the continued expansion of the Accellacare Site Network increases access and engagement with investigative sites and its patients, with the goal of faster recruitment and reducing the overall time and cost associated with drug development for customers. Accellacare now has access to more than 9 million patients.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finding and engaging suitable patients to conduct clinical trials is one of the biggest issues facing the drug development industry today. Less than 1% of the US population participates in clinical trials and the performance of investigative sites that do take part in research is uneven, hard to predict and many trials do not meet the initial recruitment goals. The current market challenge in patient enrollment creates an opportunity for ICON to differentiate its service offering and we are working to reduce patient recruitment times through enhanced site and investigator selection based on key performance metrics and through use of our proprietary FIRECREST technology which is used to train and support sites during the development process. Our Accellacare and Oncacare site network alliances enhances our ability to enroll patients onto the clinical studies we perform. We have also developed strategic alliances with investigator site groups and healthcare systems in all major global research markets. In partnership with others, we are pioneering patient recruitment solutions that leverage cognitive computing to transform clinical trial matching and allow a data-driven approach to deliver the right patients for trials. One Search is our intuitive, integrated workflow and interrogation tool that enables access to multiple data sources and provides the visualization and tools necessary for optimum&#160;site identification&#160;based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Career development and employer of choice</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Enduring customer partnerships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to focus on expanding and deepening our partnerships with existing customers, while also developing new customer relationships. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Strategic client relationships will increasingly manifest themselves in many different forms. Many of these relationships will require innovative forms of collaboration across ICON service areas and departments and will therefore require increased flexibility to offer services on both a standalone functional basis and as part of a fully integrated service solution. To support this objective, we continue to evolve our collaboration and delivery models, invest in technology that will enable closer data integration across our service areas and enhance our project and program management capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To meet the evolving needs of both our existing and new clients we continue to enhance our capabilities through both organic service development and targeted acquisitions.   </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year, we continued to enhance our scientific and therapeutic expertise to support our customers in specific areas including oncology, orphan and rare diseases, CNS, dermatology, infectious disease and women's health. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has extensive experience in vaccine clinical development for commercial businesses, governments and NGOs, having participated in over 160 vaccine studies in the past five years. This experience enabled us to play a significant role in the search for vaccines and treatments for COVID-19. ICON is currently or has already conducted a total of over 130 COVID-19 related trials.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Of particular note was our work in partnering with Pfizer and BioNTech on their investigational COVID-19 vaccine program - the first to announce positive efficacy results from a Phase 3, late-stage study of a COVID-19 vaccine and to receive Emergency Use Authorization in individuals 16 years of age or older from the U.S. Food and Drug Administration.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON mobilized a large global team of therapeutic and operational specialists to partner on the implementation of Pfizer&#8216;s and BioNTech&#8217;s strategic plan and framework for the monitoring of the trial, which included a high level of remote clinical monitoring and source data verification in addition to on-site monitoring, safeguarding data quality and integrity in the evolving pandemic environment. The team combined the benefits of full service and functional service provider clinical operating models to increase efficiency and ensure rapid study start-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON worked with 153 sites in the US, Europe, South Africa and Latin America to ensure the recruitment of more than 44,000 trial participants over a four-month period in late 2020. ICON provided site training, document management and operational support for patient Informed Consent Form review, coordinated eConsent in most countries, and assisted with clinical supply management services. Achieving the unprecedented trial timelines, while maintaining high standards of quality, undertaken in response to the pandemic required collaboration and strong communication between the ICON and companies&#8217; project teams.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to target growth in under-penetrated CRO market segments. Penetration within medical device companies has lagged that of bio-pharma firms but is beginning to accelerate. EU regulatory reform enacted in 2017 is a further catalyst to growth in this segment as it included stricter requirements to perform clinical evaluations and post-sale surveillance. In early 2020, ICON acquired MedPass which has further enhanced our value offering in this area.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also invested significantly in our site and patient network (Accellacare), and consider our expertise and offering in this area as one of our strategic pillars effective from 2021.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Healthcare intelligence and applied innovation</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients&#8217; drug and device development programs, providing true transparency across all areas of a study.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is focused on applying innovation that can help our customers improve their development outcomes. We are focusing this innovation in three critical areas: improving clinical trial design and execution; faster and more predictable patient recruitment; and evolving clinical trials to be more patient centric which includes data collection and analysis directly from patient&#8217;s digital devices. Our approach to developing solutions to these challenges incorporates partnering with best-in-class technology providers but is also supported by a suite of differentiated ICON proprietary technologies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have continued to invest in building our capabilities in the gathering, analysis and application of real world patient data within both the clinical trial and post-trial observational study environments. Alongside expanding internal capabilities, we continue to develop innovative partnerships with providers of real world data including TriNetX. During 2018, we signed an agreement with Intel to deploy the Intel&#174; Pharma Analytics Platform for use in clinical trials. The Intel platform is an artificial intelligence solution that enables remote monitoring and continuous capture of clinical data from study subjects using sensors and wearable devices and can apply machine learning techniques to objectively measure symptoms and quantify the impact of new therapies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON&#8217;s proprietary One Search tool helps identify optimum trial sites the first time. It synthesizes multiple data sources, applying AI machine learning and rich data visualization for optimum site identification, resulting in improved study start-up and site cycle times, significant reductions in the percentage of low performing sites and increasing the percentage of studies meeting planned First Patient In (FPI).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FIRECREST is ICON&#8217;s proprietary comprehensive site performance management system. It is a web-based solution which enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to investigative sites. It allows site behavior to be tracked to ensure training is understood, procedures are being followed and that timelines and study parameters are met. It can significantly reduce the number of data queries originated from investigator sites. FIRECREST is now integrated into the ICON Safety Reporting Solution and provides a Site Question Management Tool. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has also developed a patient engagement platform to support improved patient experience and enrollment in clinical trials. The web-based patient engagement platform, provides patients with study specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases visibility of potential </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">study participants for sponsors and sites. An easy to navigate, user friendly interface guides the patient to new and ongoing studies in their particular indication and a pre-qualification questionnaire helps to determine if the study is a right fit for them. If the patient decides to register interest, they are given the option to select their nearest investigative site. This establishes connection with the site and the patient can then choose to contact the site or ask to be contacted for pre-screening.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We positively impact patients&#8217; lives by understanding their journeys and how they can benefit from drugs currently in development and on the market. We do this by developing a holistic, global data environment across pharmaceutical and biotech companies (development to commercial) that gives insights into patients, and how best to serve them. Alongside the application of these technology solutions we are also focused on innovation through the redesign and where appropriate the automation of current clinical trial processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operational excellence, quality and delivery</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality is the foundation of our success. The quality of our work is vital to our mission of bringing better medications to patients around the world. We are committed to maintaining, supporting, checking and improving our quality systems to meet or exceed the quality standards demanded by our clients, patients and regulatory authorities. We focus our innovation on the factors that are critical to our clients &#8211; reducing time to market, reducing cost and increasing quality &#8211; and our global team of experts has extensive experience in a broad range of therapeutic areas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality project execution underpins all that we do and we have an ongoing focus on developing our people and&#160;processes to continue to&#160;enhance our service delivery. We also deploy supporting technologies which we believe will enable faster and deeper insights into the quality of trial data.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on operational excellence across our support functions, and we operate a global business support infrastructure across functions including finance, information technology, facilities, human resources and legal. This enables us to enhance the service levels across these support areas whilst driving down the costs of the service provision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Capabilities and service offerings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives.&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With an expansive portfolio of integrated clinical, commercialization and consulting services, global presence, depth in therapeutic expertise, and data-driven healthcare technology, we deliver globally scaled expertise &amp; solutions for all customers and patients. Solutions span the Clinical Development lifecycle from compound selection to Phase I-IV clinical studies and post approval outcome research and market access consulting solutions, and can be adapted to suit local trials or large global programs: </span><img src="iclr-20221231_g4.jpg" alt="iclr-20221231_g4.jpg" style="height:863px;margin-bottom:5pt;vertical-align:text-bottom;width:666px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Industry overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry provides independent product development solutions and services for the pharmaceutical, biotechnology and medical device industries. Companies in these industries outsource services to CROs in order to manage the drug and device development process more efficiently and to bring both patent-protected bio-similars and medical devices to market faster to enhance patient well-being and maximize their return on investment. The CRO industry has evolved since the 1970s from a small number of companies that provided limited clinical development services to a larger number of CROs that offer a range of services that encompass the entire research and development process, including pre-clinical development, clinical trials management, clinical data management, study design, bio statistical analyses, post market surveillance, regulatory affairs, central laboratory and market access services. CROs are required to provide services in accordance with good clinical and laboratory practices, as governed by the applicable regulatory authorities.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly fragmented, consisting of several hundred small, limited-service providers, medium sized CROs and a small number of large CROs with global operations. Although there are few barriers to entry for small, specialist service providers, we believe there are significant barriers to becoming a CRO with global capabilities and expertise. These barriers include the infrastructure and experience necessary to serve the global demands of clients (sponsors), the ability to recruit sites and patients globally, the simultaneous management of complex clinical trials, the ability to offer customers a variety of delivery models, broad therapeutic expertise and the development and maintenance of the complex information technology systems required to integrate these capabilities. In recent years, the CRO industry has experienced consolidation, resulting in the emergence of a select group of CROs that have the capital, technical resources, integrated global capabilities, data and expertise to manage the development programs of pharmaceutical, biotechnology and medical device companies. We believe that large and medium-sized pharmaceutical companies are selecting a limited number of CRO service providers with which they deal rather than utilizing many, in order to form strategic partnerships with global CROs in an effort to drive incremental development efficiencies and leverage the scientific and medical expertise. We believe that this trend will continue to concentrate the market share among the larger CROs with a track record of quality, speed, flexibility, responsiveness, global capabilities and access to patients and overall development experience and expertise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New drug development overview </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> ethical pharmaceuticals and biologics</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Before a new drug or biologic may be marketed, it must undergo extensive testing and regulatory review to determine that it is safe and effective. The following discussion primarily relates to the FDA approval process for such products. Similar procedures must be followed for product development with other global regulatory agencies. The stages of this development process are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Preclinical Research</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8220;In vitro&#8221; (test tube) and animal studies must be conducted in accordance with applicable regulations to establish the relative toxicity of the drug over a wide range of doses and to detect any potential to cause birth defects, affect vital organs, cause mutations or cancer. Many of these tests must be performed before a new investigational therapy can progress into human studies. If results warrant continuing development of the drug or biologic, the sponsor or owner of the asset will file for an Investigational New Drug Application, or ("IND"), which must be approved by the FDA before starting the proposed clinical trials.  However, preclinical studies will continue to be conducted in parallel with the clinical trials, some of which can take up to 3 years to complete. Preclinical research is not commonly provided by ICON as a service to its customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials (approximately 3.5 to 7 years)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Exploratory development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase I</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 6 months to 1 year)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> consists of basic safety and tolerability testing in small numbers of human subjects, initially in healthy volunteers, and includes studies which may show the drug is having an effect on the body, if it is safe, how it is affected by other drugs, where it goes in the body, how long it remains active and how it is broken down by and eliminated from the body. After single and multiple dose studies have been conducted, the asset can progress into Phase II, however, Phase I studies will continue to be done to help support the development of the asset in new populations such as children or the elderly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase II</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 2 to 3 years</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) includes basic efficacy and dose-range testing in a limited patient population (usually) 100 to 200 patients to help provide preliminary safety and evidence that the drug is likely to be effective in the target disease. If the Phase II results are satisfactory the sponsor may decide to proceed to Phase III studies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Confirmatory development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase III </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">(2 years or greater)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consists of efficacy and safety studies in several hundred to a few thousand patients at multiple investigational sites (hospitals and clinics), often in multiple geographies. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FDA approval, through submission of an IND, is necessary for all clinical trials, regardless of the phase of development. In addition, parallel independent committee approval is also required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">NDA or BLA Preparation and Submission.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Upon completion of Phase III trials, the sponsor assembles the statistically analyzed data from all phases of development into a single large submission along with the Chemistry, Manufacturing and Controls (CMC) and preclinical data and the proposed labelling into the New Drug Application (NDA), or Biologics License Application (BLA) and submits them for assessment and approval by the relevant division of the FDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Expanded Access Programs (EAPs).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Sometimes a study drug may continue to be provided to subjects after completion of a clinical trial, also called compassionate use. EAPs refer to the regulated use of a study drug outside of a clinical trial by patients with serious or life-threatening conditions where there is no alternative therapy available. In this context the FDA may allow the sponsor to make the study drug available to a larger number of patients for treatment use. </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">FDA review and approval of NDA or BLA (1 to 1.5 years).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Data from all phases of development is scrutinized to confirm that the applicant company has complied with all applicable regulations and that the benefit to risk ratio for the drug or biologic is positive for the specific use (or &#8220;indication&#8221;) under study. The FDA may refuse to accept the NDA or BLA if the application has administrative or content criteria which do not meet FDA standards. The FDA may also deny approval of the drug or biologic product if applicable regulatory requirements are not satisfied, if the drug has not adequately shown to be effective or if there are safety concerns. Often a company will be required to conduct specific studies after the approval of a drug. These are called post approval commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Post-market surveillance, Phase IV studies and health outcomes.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Once approved by the FDA, it requires the drug or biologic license holder to collect and periodically report to them additional safety (and perhaps efficacy) data on the drug or biologic for as long as the license holder markets it (post-market surveillance, including pharmacovigilance). If the product is marketed outside the U.S., these reports must include data from all countries in which the drug is sold. Additional studies (Phase III and Phase IV) may be undertaken after initial approval to find new uses for the drug, to test new dosage formulations, or to confirm selected non-clinical benefits, e.g., increased cost-effectiveness or improved quality of life. Additionally, the FDA and other regulatory agencies require license holders of drugs or biologics to prepare risk management plans that are aimed at assessing areas of product risk and actively managing such risks throughout the product lifecycle.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Key trends affecting the CRO industry</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs derive substantially all their revenue from the research and development expenditures of pharmaceutical, biotechnology and medical device companies. We believe that the following trends create further growth opportunities for global CROs, although there is no assurance that growth will materialize.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Continued innovation and development of enabling technologies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Innovation driving new drug development activity </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New technologies together with improved understanding of disease pathology (driven by scientific advances such as the mapping of the human genome) have increased the number of new drug candidates being investigated in early development. This has greatly broadened the number of biological mechanisms being targeted, which increasingly include rare or orphan diseases that currently have no effective treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These developments should lead to increased activity in both preclinical and Phase I development and in turn lead to more treatments in Phase II-III clinical trials. As the number of trials that need to be performed increases and these trials become focused in indications where finding suitable patients is increasingly challenging, we believe that drug developers will increasingly rely on CROs to manage these trials to leverage their global expertise and to continue to focus their own competences on drug discovery and sales and marketing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Decentralized and hybrid trials</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Decentralized and hybrid trials have existed for quite some time, but the coronavirus pandemic accelerated the demand when the pharma industry was challenged to move to remote models to protect patient safety and ensure data integrity for COVID-19 vaccine trials and other ongoing trials. The pandemic has provided an opportunity to move many technologies and remote patient care solutions from pilot phase to supporting patients and research. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As an industry, we have an opportunity to make decentralized and hybrid the standard moving forward. The ways the industry have been conducting clinical research in a traditional site-based approach need to flex so we can implement these tools, techniques and processes in everyday research to bring about a more patient-centric approach. Each new element needs to be evaluated to assess the impact for the individual patients and study sites. Recent experiences in the industry have shown:</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Using fewer countries and fewer sites can reduce costs, decrease timelines for start-up and minimize the risk of disruption during and post pandemic. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Hybrid studies, utilizing digital health, in-home health, and telehealth, can reduce the number and frequency of onsite patient visits and therefore reduce patient burden.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Home-based patient visits and direct-to-patient contacts can increase patient satisfaction, compliance and retention, providing greater trial resilience. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Harmonizing data from disparate data sources will provide real-time access and consistent data visibility, helping to improve safety monitoring and enabling the visualization of data trends. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory easement has resulted in a number of positive changes to clinical trial procedures, enabling studies to continue and in some case progress at a faster pace, and improvements to the process of CTA and IND approvals despite the restrictions imposed by the current COVID-19 pandemic. However, the regulatory authorities have been clear that regulatory easement will be discontinued once the pandemic recedes so it remains to be seen how many of these improvements will endure and become standard practice in the longer term. It is hoped that we can hold on to some of the improvements for the benefit of the patient and healthcare advancement. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ultimately, we are trying to increase the speed at which drugs can meet approval guidelines and help treatable populations. By using decentralized tools, technologies and processes, we will reduce the burden on patients, increase satisfaction and provide them with the same standard of care during a virtual or home visit that they would receive in a clinic, thereby fulfilling the promise of clinical research as a care option. While reduced costs may not be seen in the early phase of adoption (in fact investment may be required initially) choosing the right solution for the specific study characteristics has the potential to increase patient recruitment and retention which can result in reduced overall research costs and quicker time to market. To find the best clinical trial design to suit their needs, sponsors will need to take patient centricity into consideration from the outset and at every step along the way, because what benefits the patient will ultimately benefit the sponsor in outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">New technology enabling more efficient development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Technology innovation is playing an increasingly important role in helping to support more efficient drug development. Leveraging differentiated technology solutions and data collaborations drives better execution in clinical trials. The larger CROs have been at the forefront of this innovation developing technology solutions that support the integration of trial data across multiple systems, data repositories that enable sponsors to get real time clinical insights on the performance of their drugs and tools that support better trial designs and operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The emergence of modern healthcare technologies ("mHealth") that build on the global prevalence of mobile and digital technologies also have an influence on drug development. It is now possible to capture health data using mobile devices and wearables. This enables sponsors to gather new clinical and &#8220;real-world&#8221; patient insights and will also be used to enhance patient engagement and adherence throughout the development process. As these devices mature it will also be possible to complete more &#8220;decentralized and hybrid trials&#8221; based on remote monitoring of patients in their home environment which may drive further efficiencies in the trial process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Social media is also becoming an important platform for life sciences companies to strengthen patient engagement programs and collaborate with other stakeholders in the healthcare system. Many sufferers of specific diseases are forming patient groups and actively collaborating using social media. These groups represent an important potential source of patients for new clinical studies but can also provide valuable insights into effectiveness and safety of new treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the influence of technology on drug development grows, it broadens the potential number of partners that CROs will work with in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Expanded use of new patient data sources  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical companies are looking to access a variety of new healthcare data sources containing medical and prescribing records to help improve development programs and to get better evidence of the value their treatments are bringing to patients once they are launched in the market. The larger global CROs have significant data management experience which can be leveraged to support these efforts and have invested in analytics capabilities to help deliver better insights for customers during the product lifecycle. Global CROs are also forging collaborations to access specific data sets that can provide further patient insights to support better matching of patients to the clinical trial process. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Improving productivity and operating efficiencies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Continuing focus on productivity within research and development programs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical and biotechnology companies continue to seek ways to improve the productivity of their development efforts and increasingly see the use of CROs as a strategic component of these efforts. They are leveraging the expertise with CROs to help identify the most promising drug candidates in early development and discontinue developing those that have safety issues, limited efficacy or that will have significant reimbursement challenges. These companies are also initiating programs to drive more efficiency in their development programs. One example of this has been the efforts to achieve a more seamless transition across development phases, particularly Phase I-III. In parallel, regulatory initiatives such as the 21</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">st</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Century Cures Act and the emergence of clinical trial techniques such as adaptive trial design, risk based clinical trial monitoring, decentralized and hybrid trials are enhancing development, allowing effective treatments to get to patients quicker at reduced development costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost containment pressures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Over the past several years, drug companies have sought more efficient ways of conducting business due to margin pressures stemming from patent expirations, greater acceptance of generic drugs, pricing pressures caused by the impact of managed care, purchasing alliances and regulatory consideration of the economic benefit of new drugs. Consequently, drug companies are centralizing research and development, streamlining their internal structures and outsourcing certain functions to CROs, thereby converting previously fixed costs to variable costs. Larger companies (and more recently medium sized companies) are actively entering strategic partnerships with a limited number of CROs in an effort to drive increased efficiencies. The CRO industry and, in particular, large CROs with global capabilities, considerable scientific knowledge and expertise are often able to perform the needed services with greater focus and at a lower cost than the client could perform internally, although CRO companies themselves are facing increased cost containment pressures as drug companies seek to further reduce their cost base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Global trends influencing the CRO industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pressure to accelerate time to markets and globalization of the marketplace</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reducing product development time maximizes the client&#8217;s potential period of patent exclusivity, which in turn maximizes potential economic returns. We believe that clients are increasingly using CROs that have the appropriate expertise and innovation to improve the speed of product development to assist them in improving economic returns. In addition, applying for regulatory approval in multiple markets and for multiple indications simultaneously, rather than sequentially, reduces product development time and thereby maximizes economic returns. We believe that CROs with global capabilities, considerable knowledge and experience in a broad range of therapeutic areas are key resources to support a global regulatory approval strategy. Alongside this, the increasing need to access pools of new patients is leading to the conduct of clinical trials in new &#8220;emerging regions&#8221; such as Eastern Europe, Latin America, Asia-Pacific and South America. We believe that having access to both traditional and emerging clinical research markets gives global CROs a competitive advantage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Growth within the biotechnology sector</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of the drugs being developed is continuing to change. Biotechnology is enabling the development of targeted drugs with diagnostic tests to determine whether a drug will be effective given a patient&#8217;s genomic profile. An increasing proportion of research and development expenditure is being spent on the development of highly technical drugs to treat very specific therapeutic areas in sectors of unmet medical need. Much of this discovery expertise is found in biotechnology firms. We believe that it is to these organizations that the large pharmaceutical companies will look for an increasing proportion of their new drug pipelines. Whether it is through licensing agreements, joint ventures or equity investment, we believe we may see the emergence of more strategic relationships between small discovery firms and the larger pharmaceutical groups. As the majority of these biotechnology companies do not have a clinical development infrastructure, we believe that the services offered by CROs will continue to be in demand from such companies providing they have the necessary funding. ICON has over 8,000 staff exclusively dedicated to working with biotech clients.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing number of large long-term studies and an increasing requirement to show the economic value of new treatments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that to establish competitive claims and demonstrate product value, to obtain reimbursement authorization from bodies such as the National Institute for Health and Clinical Excellence in the UK, and to encourage drug prescription by physicians in some large and competitive categories, more clients need to conduct outcome studies to demonstrate, for example, that mortality rates are reduced by certain drugs. To verify such outcomes, very large patient numbers are required, and they must be monitored over long time periods. We believe that as these types of studies increase there will be a commensurate increase in demand for the services of CROs who have the ability to quickly assemble large patient populations, globally if necessary, and manage this complex process throughout its duration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rising costs of healthcare in most developed countries also means there is an increasing pressure to show that new medical treatments are more cost effective and deliver better patient outcomes than existing treatment regimes. This also means that sponsors need to increasingly generate outcome data both as part of the product approval submissions and as part of post-approval research programs. This is creating opportunities for CROs who can offer support in developing and interpreting this data.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">A focus on long-term product safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical trial approval process can only detect major and common adverse side effects of drugs; less common but no less serious side effects may only become apparent after many years of use. As a result, there is an increase in the number of drugs given &#8220;conditional approvals&#8221; where further &#8216;post-approval&#8217; studies are being mandated. In addition, prudent sponsors undertake similar studies to detect early warning signs of any potential problems with their products. Such studies may take the form of prospective long-term safety studies, simpler observational studies or registries where patients meeting specific criteria for disease or drug use are followed for long periods to detect any safety issues. CROs are well positioned to perform these studies on behalf of sponsors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing regulatory demands</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory agencies increasingly require more data to support new drug approvals and are seeking more evidence that new drugs are safer and more effective than existing products. As a result, the complexity of clinical trials, the number of procedures required to be conducted in these trials and the size of regulatory submissions are driving the demand for services provided by CROs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Environment, Social and Governance ('ESG')</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We are passionate about providing innovative solutions for customers, we are better together working as one team, we value diversity and care about the success of our people, and we care about doing the right thing. We are advancing clinical research while offering customers broader and deeper experience, scale, and focus, complemented by continuity of delivery and speed to market. Our business model is described in the preceding sections. Consistent with our values, we seek to not only operate in compliance with applicable laws but also to positively influence our global workforce, the communities that we operate in, the environment and society as a whole. Doing so makes us a stronger, more resilient organization by every measure.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values underpin our mission and drive a culture and mind-set of ownership at ICON. "OwnIt@ICON", as set out below, is a statement of values that has remained at the very heart of ICON&#8217;s culture, encouraging our people to seize the opportunity and bring flexibility, innovation, and determination to every situation. We believe our culture of ownership personifies who we are as a company &#8212; it also helps us apply our expertise, collaborate to get things done, and succeed at our mission.  </span></div><div style="text-align:center"><img src="iclr-20221231_g5.jpg" alt="iclr-20221231_g5.jpg" style="height:447px;margin-bottom:5pt;vertical-align:text-bottom;width:436px"/></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our values underpin how we work together to deliver on our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. These values and our Code of Ethical Conduct, which underpins these values, form the core of what we do, and how we do it. It applies to all of our officers, directors, employees, consultants and agents globally. All employees and temporary workers are mandated to complete global ethics training.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, we care about conducting business sustainably. We care about our people, patients, and the communities in which we live. We care about doing the right thing and we are committed to working to the highest ethical standards and demonstrating our commitment to honesty, transparency, and quality. As a testament to our commitment, we launched our &#8220;ICON Cares&#8221; program at the start of 2023 which incorporates all our Environment, Social and Governance (ESG), Diversity, Inclusion and Belonging (DIB), and CSR initiatives into one program. ICON&#8217;s Environment, Social, and Governance Committee ('ESG Committee') brings together all these initiatives and efforts under one umbrella to ensure consistency, enhance monitoring, reveal areas for development and facilitate reporting to the Board. The ESG Committee is chaired by the Chief Administrative Officer and General Counsel (CAO), who is responsible for reporting to the ICON executive leadership team, the Nominating, Sustainability and Governance Committee and the Board on ESG matters. In February 2022, the Board delegated oversight responsibilities of the Company's strategies, activities, and risks in respect to ESG matters to the Nominating and Governance Committee, which was renamed the &#8220;Nominating, Sustainability and Governance Committee&#8221; in April 2022. Accordingly, the CAO reports on ESG matters to the Nominating, Sustainability and Governance Committee and reports to the Board on an annual basis whilst also providing periodic ESG updates to the executive leadership team.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ESG Committee is focused on developing our strategy and initiatives relating to the environment, social matters, health and safety, community engagement, corporate governance, sustainability, and other public policy matters relevant to the Company. The ESG Committee is a cross-functional management committee of the Company including representation from facilities, health and safety, corporate communications, finance, legal, investor relations, procurement, commercial, marketing, and human resources departments. The Committee assists and supports executive management and the Nominating, Sustainability and Governance Committee of the Company in:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">determining and setting the strategy relating to ESG matters;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">developing, implementing and monitoring initiatives and policies based on that strategy; and</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">communicating these strategies, initiatives, and their results.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to building and developing our ESG strategies and reporting. In 2020 we launched our ESG page on the ICON website and have an internal ESG page on our MyICON intranet portal to engage with our employees and provide information and updates relating to ESG matters and our commitment to sustainability. In 2021, as a testament to our commitment to managing ICON responsibly and sustainably, we became a participant in the United Nations Global Compact (UNGC), a set of Ten Principles covering the areas of human rights, labor, environment, and anti-corruption. In our 2021 ESG report, released in 2022, we reported under the newest Global Reporting Initiative (GRI) standards and the Task Force on Climate-Related Financial Disclosures (TCFD). Our report summarizes our current policies, priorities, and commitments in respect to ESG matters. During 2022, ICON received a silver medal from EcoVadis in recognition of our environment, social and governance efforts throughout ICON. The ESG page on our website is available at https://www.iconplc.com/about/esg/.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The global landscape in respect to regulatory and legislative requirements relating to ESG reporting and disclosure requirements is rapidly evolving, and we are monitoring potential requirements so that we are positioned to adhere to any additional requirements in due course.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Building a sustainable future &#8211; our commitment to the United Nations Sustainable Development Goals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a global company, we maintain an ethical and sustainable presence in hundreds of locations worldwide. At its core, ICON&#8217;s mission is to improve health and lives. We are also committed to contributing to the 2030 United Nations Sustainable Development Goals (SDGs) and are proud that our work contributes to their advancement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our research, our work with customers and patients and our on-the-ground efforts to meet the diverse needs across our communities align with the SDGs. These efforts, however, focus on a subset of themes where we have the greatest opportunity to effect change and further details are set out in our ESG Report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Environment: Conducting business sustainably</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to delivering excellence in care to our communities. To improve our overall sustainability, this commitment means tracking and improving our environmental performance across all business activities. We achieve this by pursuing sustainability strategies that recognize the impact of our operations as a CRO on the environment, addressing greenhouse gas (GHG) emissions, energy use, waste generation and procurement-related activities. Our employees, directors, officers, contractors, and temporary workers are expected to support our sustainability objectives.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Environmental Management Policy and Environmental Management Plan is our program for managing environmental sustainability initiatives. The implementation of the program is led by our facilities team, reporting to our Chief Administrative Officer and General Counsel (CAO). The CAO is responsible for reporting on the program to the ICON executive leadership team and Nominating, Sustainability and Governance Committee and the Board.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON set environmental goals around the use of renewable energy and carbon emissions in 2019 and we are working towards achieving these goals which are as follows: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">100% renewable electricity by 2025</span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">20% reduction in kilowatt hours (kWh) of electricity by 2030</span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Net zero carbon emissions on Scope 1 &amp; 2 by 2030</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have programs in place to manage and minimize climate impacts of business activities. To continue to improve processes and reduce our environmental impact, we track, calculate, and report our GHG footprint. We apply the GHG Protocol Corporate Standard, which is the global corporate accounting and reporting standard for calculating carbon emissions. Carbon Trust provides annual verification of our emissions data. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In line with carbon reduction targets, ICON&#8217;s combined Scope 1 and 2 GHG emissions, relative to revenue and the number of employees, have fallen year on year since 2018. Since 2018, following our reduction efforts, the pandemic-related closure of many of our facilities and a reduction in business travel, GHG emissions across our operations declined significantly. Since 2021, as more normal operations resumed, we have seen a decrease in combined Scope 1 and 2 emissions with an overall increase in our total GHG emissions due to an increase in business travel (Scope 3).  As the pandemic recovery continues, and we have resumed more normal operations, we are evaluating additional opportunities to continue to reduce our carbon emissions across our organization to develop and improve our environment program.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CDP (formerly the Carbon Disclosure Project) provides a globally recognized system that enables companies to measure and manage their environmental impacts. ICON continues to be committed to improving its current scoring of a C.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on reducing energy use across our global operations. For example, reducing energy use and shifting to renewable energy are components of our specific environment goals. Waste reduction is embedded into our environment policies and practices and is one of the objectives of ICON&#8217;s Environmental Management Policy. We will seek new opportunities to reduce waste by increasing recycling volumes, reducing consumption of primary materials, and decreasing use of disposable products in our offices and facilities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority of our sites are leased, and we work closely with our landlords and leasing agents to implement measures to ensure we operate in an environmentally sustainable manner. The Acquisition of PRA expanded our global real estate footprint and our real estate group worked with other business leaders to understand the sustainability implications and opportunities of this new footprint and find ways to continue to advance our collective sustainability goals. During 2022, we continued to integrate offices and reduce our footprint which resulted in downsizing or closing 31 locations to align with new working styles and business needs. When selecting new locations for offices and planning building modifications, experts from our real estate team factor in environmental considerations. In addition, we have implemented a series of measures globally to reduce the local footprint of our offices, such as installing energy-efficient LED lighting, using motion detectors to reduce energy use, purchasing recycled office supplies, and reducing paper consumption by promoting paperless office processes, or where printing is necessary, enabling double-sided output. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our office design has efficiency in mind, utilizing space to provide the maximum number of desks and functional provisions while still providing comfortable, safe spaces for our employees. Our strategies include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Perimeter glazing of meeting rooms, offices, and other spaces which allow in natural light.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Recycling areas built into business centers and kitchen/ canteens which reduce waste sent to landfills.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Planted green spaces which contribute to internal air quality, temperature, and humidity.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Building materials and vendors which we select for low environmental impact.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also require our suppliers to abide by our Global Supplier Code of Conduct which includes a commitment to comply with applicable environment laws and regulations, our expectations around waste management and sustainable use of resources.  </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Community Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to making a positive impact on the communities in which we work and live and we have aligned our community efforts to a broader vision for social impact, including by aligning priorities with our organizational goals of diversity, inclusion, and belonging.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our community engagement activities are focused on two core areas:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Supporting education and building closer ties between industry and academia.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Improving the welfare of people in the communities in which we live.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Supporting education and building closer ties between industry and academia </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A core area of community support includes building ties between industry and academia to inspire the next generation of leaders in business and science. Our existing partnerships continue with the following organizations:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9642;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.81pt">The ICON-McKeon Research Fellowship in Motor Neuron Disease ('MND')</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in honor of Mr. Declan McKeon, former Board member, acting Chairman, Lead Independent Director and Chair of the ICON Audit committee. The ICON-McKeon Research Fellow in MND carries out research in the areas of machine-learning and artificial intelligence to derive insights from multimodal clinical, imaging neuro-electric signaling, in the context of the neurodegenerative disease of ALS. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9642;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.81pt">Partnership with Trinity Centre for People with Intellectual Disabilities ('TCPID')</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> - TCPID situated within the School of Education, Trinity College Dublin, aims to promote the inclusion of people with intellectual disabilities in education and society. The Centre provides people who have intellectual disabilities with the opportunity to participate in a higher education program designed to enhance their capacity to fully participate in society as independent adults. The 2-year education program includes work placements and internships to enable students to experience and participate in the work environment. In 2022, ICON facilitated a 12-month internship in our Laboratory and Facilities departments for one of the TCPID graduates and our aim is to continue to offer work placements and internships as part of this partnership in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:14.85pt">Partnership with Junior Achievement to inspire schoolchildren.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Junior Achievement encourages young people to remain in education and teaches them the skills they need to succeed in a changing world. ICON volunteers take time out of their working day to deliver Junior Achievement programs, teaching primary and secondary-level students valuable business, STEM and entrepreneurship skills that will serve them throughout their professional lives. ICON expanded its partnership with Junior Achievement to include an additional three locations in the United States and the United Kingdom in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022, we further expanded our industry-academia partnerships through the creation of a new ICON scholarship program to provide increased opportunities for underrepresented groups to study STEM (Science, Technology, Engineering &amp; Mathematics) courses and to build a more diverse graduate pool of talented and ambitious STEM professionals who can help to ensure the future success of the life sciences industry. Through the program, ICON is partnering with three universities in Ireland &#8211; Dublin City University (DCU), Trinity College Dublin (TCD) and the University of Limerick (UL) &#8211; as well as with the Thurgood Marshall College Fund (TMCF) in the US, to fund 33 scholarships for students of STEM courses. TMCF is a not-for-profit organization that supports nearly 300,000 students attending its 47 member-schools that include publicly-supported Historically Black Colleges and Universities (HBCUs).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improving the welfare of people in the communities in which we live</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Through volunteering, donations and other charitable initiatives, our employees across the world are making a positive difference to their communities. We support causes that are important to our employees and have several programs that support the welfare of people in our local communities. In 2022, 540 employees across the world participated in Run in the Dark, an annual event organized by the Mark Pollock Foundation to bring people together and fundraise to help find a cure for paralysis. ICON was the largest global corporate team to participate in the event and helped to raise $10,000 for the cause. A team of 90 ICON cyclists from 19 countries also participated in our annual ICON cycle challenge, which raised funds for the International Committee for the Red Cross.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since 2012, ICON&#8217;s annual employee-nominated charity donation program has supported over 90 charities, donating $10,000 to each organization. The selected organizations focus on a range of critical issues, from relieving poverty and homelessness to improving child welfare through education and enhancing the lives of people living with a variety of diseases. The organizations were chosen to align with our ESG goals. In addition, to support ongoing humanitarian efforts in Ukraine, we also made a donation to the Children of Heroes charity fund in Ukraine to support children who have been severely impacted by the war in that region.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Talent and People </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people are core to our ability to deliver our services and drive better patient outcomes. Through diversity, inclusion and belonging, industry-leading talent management practices, a sincere attention to our employees&#8217; needs, well-being and health and safety, we continue to power the potential of together. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">At the core of our strategy is our people </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Learning and development of our staff is a key focus for us</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader where talented people come to do important work and where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs. During 2022, this also included diversity, inclusion and belonging training for everyone on our talent acquisition team and many of our People Leaders.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our People Leader development program focuses on providing our People Leaders with the relevant skills to effectively manage themselves, their team and their business, including psychometrics to raise their awareness of their behavioral preferences and the preference of others.  ICON also invested in Harvard Manage Mentor, an online learning platform providing People Leaders with access to learning available at any time with topics ranging from change management, diversity &amp; inclusion, retaining employees and developing employees.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide our people with a personalized and flexible learning experience, delivered through a combination of in-person and technology-driven programs that suit their learning styles and can flex to suit their schedules. Through our industry leading CareerHub, ICON employees are encouraged to broaden their scientific, technical, leadership, and business knowledge. By tapping into development programs and partnerships with leading academic institutions, team members can use the hub to develop competencies that advance their careers. We also collaborate with UCD Smurfit School Executive Development to deliver customized leadership development programs for global employees.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">As an organization we are keen to hear directly from our employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To attract and retain the best talent, we must listen and respond to employees&#8217; needs. This begins with a focus on diversity, inclusion and belonging, and extends to every aspect of our work, from recruitment and onboarding, to training, engagement, enablement, and reward. We pursue best-in-class approaches to building employee engagement and these include, among others:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Comprehensive global employee surveys, which measure how people feel about their work and whether they feel they have the tools to do their jobs well. Feedback from these studies informs detailed action plans at the group, function, and team level.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Pulse check surveys, which are smaller-scale studies designed to measure employee sentiment on specific topics and initiatives.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Fostering an environment of diversity, inclusion and belonging where everyone is valued.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Stay interviews to help managers understand why staff stay and to uncover what might put them at risk of departing.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13.8pt">Skip-level meetings to develop trust and rapport between senior leaders and employees.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our listening strategy supports our efforts to reduce employee turnover, which we monitor closely through analytics. Qualitative information is collected through formal exit interviews and, where we believe they&#8217;ll make an impact, we intervene via retention plans and related efforts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employee well-being </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s commitment to improving health and enriching lives extends beyond the work we do with our customers. Employees across the globe have direct access to locally relevant information and resources to support every facet of their well-being, including physical, social, psychological, and environmental.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global Employee Assistance Program (EAP) ensures that all employees, and their families, have access to a range of different, confidential resources and experts to help them better manage their working life and personal life. The EAP also delivers a web-based and mobile app platform with access to toolkits providing advice and resources in local languages.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health and safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, the health and safety of our employees, customers and clinical trial patients are our most important priorities. We take guidance from global and regional health authorities and governments to protect the safety and welfare of employees, as well as abide by government directives. Our global health and safety management system ensures we deliver on all local and national requirements. Our priority objectives are the safety of our staff, clinical trial patients, protecting the environment, maintaining business continuity, and ensuring all sensitive health and safety data is protected.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to providing a safe working environment for our people. We achieve this goal by working in ways that protect the safety, health, and welfare of all our employees, clinical trial patients, and visitors. Risk assessment is the basis of the safety management system, and we work to identify, mitigate, and monitor existing and emerging health or environment risks that may be associated with our business activities. We work to identify, mitigate, and monitor existing and emerging health or environment risks that may be associated with our business activities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fostering diversity, inclusion and belonging</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe in a workplace culture that embraces diverse perspectives and empowers our team members to grow, whether at work, at home or in their communities. The diversity of our teams is critical to our success. As a global operation, we deliberately structure teams to be diverse to support the delivery of our customers&#8217; clinical development programs across multiple geographies and communities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diversity, inclusion, and belonging (DIB) are fundamental to our culture and values. Diversity makes us more innovative and more creative, which helps us better serve our patients, our customers, and our communities. We recognize the critical importance of diversity in clinical trials ensuring all types of patients who will eventually receive therapies are represented on clinical trials, as well as offering clinical trials as a care option for those who may not otherwise have access to medical treatment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to being a workplace where all employees are included and feel a sense of belonging. To achieve this, we acknowledge and celebrate our differences in gender, ethnicity, culture, and abilities. As a values-driven organization, respect for diverse points is foundational to how we interact with each other, as well as with customers, patients, and suppliers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s approach to DIB is a key focus area. To reflect this, inclusion is one of our core values and our DIB strategy is now organized into four key ambitions:</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="iclr-20221231_g6.jpg" alt="iclr-20221231_g6.jpg" style="height:318px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s DIB practices and programs are viewed through the lens of our four DIB ambitions. Each ambition has sponsors from our executive leadership team to support and drive the agenda and provide leadership. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe in a workplace culture that embraces diverse perspectives and empowers our team members to grow &#8212; at work, at home and in their communities. The key areas of focus for our diversity, inclusion, and belonging agenda include talent management, country-level inclusion policies, rewards, training, and communications.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We established a Diversity, Inclusion &amp; Belonging Steering Committee in 2019 which brings together individuals from across ICON to develop and execute work streams under each of the four ambitions, with a central team overseeing the overarching efforts. ICON has Diversity, Inclusion &amp; Belonging advocates from across our global employee population to better understand local needs, build local presence and awareness, and to give a voice to every corner of the company across the world. These individuals play a key role in supporting the Diversity, Inclusion &amp; Belonging Steering Committee and in aligning activities across the organization. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The DIB community groups we have at ICON are:</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20221231_g7.jpg" alt="iclr-20221231_g7.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DAWN:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Disability Awareness Network is a community group striving to develop and foster a mindset towards creating an inclusive workplace and working environment where everyone is treated equally with respect and dignity, irrespective of any visible or hidden disabilities.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20221231_g8.jpg" alt="iclr-20221231_g8.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EmbRACE:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supporting all race and ethnic backgrounds in creating an inclusive workplace culture.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20221231_g9.jpg" alt="iclr-20221231_g9.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOW@ICON:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Networking Organization for Women at ICON is committed to inspiring and connecting current and potential leaders through an inclusive environment of targeted initiatives and supportive mentorship.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20221231_g10.jpg" alt="iclr-20221231_g10.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pride@ICON:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supporting LGBTQ+ colleagues and allies, ensuring that no matter where employees are in the world, our offices are a safe space where they are welcomed, respected, and valued.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="iclr-20221231_g11.jpg" alt="iclr-20221231_g11.jpg" style="height:77px;margin-bottom:5pt;vertical-align:text-bottom;width:77px"/></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SPACE:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supporting Parents and Carers Everywhere to create a workplace where stepping out of careers due to personal commitments for a period is wholly accepted and not career limiting, and where stepping back into their career is an organic and positive process.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a testament to our commitment to diversity, ICON are aiming for gender parity at the VP level and above by 2025. As at February&#160;24, 2023, women represent 44% of the positions at the VP level and above.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is focused on building an inclusive culture where employees feel supported by a fair system supporting pay equity.  We have a long track record of developing talent and filling vacancies through internal hires. Using best-in-class analysis, we conduct regular reviews of salary ranges to ensure fair pay, irrespective of gender, race, or ethnicity whilst considering legitimate business factors that explain differences such as performance, tenure, and experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continuously monitor and seek to maintain pay equity for our employees. We have structured our pay principles so that individual differences not related to tenure, experience or performance criteria are not a factor in how we deliver rewards. ICON has made significant investments in organizational design structures, tools and education that uphold and support our pay principles.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to ensuring fair employment practices. For every jurisdiction in which we operate, we act in compliance with relevant laws relating to labor rights and labor relations as well as market competitive benefits. We believe in fair and equal treatment for all our people, without regard to gender, race, ethnicity, sexual orientation, marital status, physical or mental disability, age, pregnancy, veteran status, nationality, religion, or any other legally protected status. We do not tolerate our employees being subjected to physical, sexual, racial, psychological, verbal, or any other form of harassment. We encourage our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">employees to report any issues of harassment or discrimination. We prohibit retaliation against any employee who rejects, protests, or complains about unlawful discrimination or harassment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Human rights</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to human rights and in 2021, ICON became a participant in the UN Global Compact (UNGC), signaling our commitment to uphold the UNGC&#8217;s 10 Principles, including those related to human rights across our global operations. Our business model and our policies, including our Global Code of Ethical Conduct and Global Supplier Code of Conduct, are intended to fully comply with applicable human rights legislation in the countries where we operate. Our zero-tolerance policy on forced labor, slavery, and human trafficking is defined clearly in these policies, which are available to employees, suppliers, customers, and the public.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are opposed to forced labor, slavery, and human trafficking. We will not knowingly support or conduct business with any organization involved in such activities. We do not employ anyone below the minimum employment age in the jurisdictions in which we operate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Supplier Code of Conduct incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for responsible supply chain management, including for labor. Before doing business with ICON, suppliers must certify that they will comply with the ICON Global Supplier Code of Conduct or their own materially equivalent internal code, which includes human rights protections. We perform pre-engagement due diligence on our suppliers, including in relation to labor issues, which we support through periodic re-screening. We hold our suppliers accountable for meeting their contractual obligations. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ethics and Compliance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s commitment to ethics and integrity is embedded in our company values. We act with integrity and integrate ethical principles into our business practices and culture. ICON&#8217;s Global Code of Ethical Conduct (the Code) establishes our core principles and standards for honest, fair, and ethical behavior. This Code addresses the core values expected of our people in our internal interactions with each other as well as in external dealings with patients, customers, healthcare professionals, regulators, investors, vendors and other third parties.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Ethics and Compliance program builds on the principles established in the Code to define and drive business conduct consistent with company values and the laws, rules and regulations that apply to our business. The Ethics &amp; Compliance Team (E&amp;C) provides day-to-day independent oversight for the program. The team is independent of the business and reports to the Chief Administrative Officer and General Counsel (CAO). The CAO reports on the program to ICON&#8217;s executive leadership team, the Nominating, Sustainability and Governance Committee and the Board. The program supports all functional areas globally and is dedicated to the implementation of standardized global policies, procedures, training, guidance, communications, monitoring, investigations, issue management, assessing compliance-related risk and mitigations, and reporting to ensure the overall compliance program is effectively functioning. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has incorporated a third-party system, Ethics Line, for employees and third parties to confidentially report ethics and compliance questions, as well as concerns, and to track reports through follow-up and resolution. These tools also provide visibility into our risks while highlighting opportunities to address them. ICON&#8217;s compliance and ethics program will continue to grow and evolve in response to changes in our business and in the global business climate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All employees are required to complete mandatory training in key areas which support our values and our ways of working. The training incorporates the key principles of our policies and codes and includes interactive scenarios where applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, we promote a Speak Up culture that encourages compliance, openness, and accountability without retaliation. The Speak Up Policy aims to support our culture and values and seeks to encourage the prompt reporting or surfacing of concerns or violations. Reported ethics concerns and other ethics and compliance-related data are reported via the CAO to the Board as appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Anti-bribery and Corruption</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is guided by the foundational principle that we do not tolerate bribery or any other form of corruption or fraud. Our anti-bribery and anti-corruption (ABAC) program is a key element of our Ethics and Compliance Program. ICON and all ICON directors, employees, consultants, agents and all third parties acting on ICON's behalf must act in compliance with international laws and regulations relating to bribery, corruption, and illicit payments, including the US Foreign Corrupt Practices Act and the UK Bribery Act 2010.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains the ISO 37001:2016 certification for our Anti-Bribery Management System, which establishes the framework for the controls that prevent, detect and mitigate the risk of bribery. Our program is designed to ensure our compliance with anti-corruption laws, including due diligence, training, policies, procedures, and internal controls.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Bribery and corruption remain a business risk as we conduct our business across the globe and enter partnerships and collaborations. There is no certainty that all employees and third-party business partners (including our vendors, suppliers, agents, contractors, and other partners) will comply with anti-bribery laws. When working with third parties, we are committed to working with only those who embrace high standards of ethical behavior consistent with our own. Bribery and corruption risks are a focus of our third-party diligence and management process. We hold our suppliers accountable for meeting their contractual obligations with ICON, including commitments that are made with regard to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business with ICON. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's internal audit teams conduct ABAC Program audits. Internal Audit focuses on testing for compliance and design effectiveness of the overall ABAC Program. Internal Audit incorporates an assessment of ABAC measures in all audits, as appropriate. In this approach, bribery and corruption risks are incorporated into the risk assessment and scoping process of each audit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Information Security and Privacy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Data privacy and information security are fundamental to our business and key to retaining customers, building investors&#8217; trust, protecting patients, and complying with global and regional regulations. We recognize and respect that our customers, employees, patients, and all those who do business with us expect that we will protect their personal information in accordance with our legal obligations and policy commitments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our cybersecurity strategy and program protect our systems and data from an evolving threat landscape. The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. Our processes and range of information security policies are certified to ISO 27001 and are independently audited twice annually. ICON also maintains the Cyber Essentials certification. During an acquisition process, we conduct security and privacy due diligence and risk assessments, implement policies, deliver employee training, and securely integrate IT systems.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Data Protection Policy regulates the processing of personal data in accordance with the applicable data protection laws of the countries where we operate, including Europe&#8217;s General Data Protection Regulation (GDPR) framework. This policy governs ICON&#8217;s and its employees&#8217; obligations concerning the processing of personal data, including core privacy issues such as how we address data subject rights, data protection impact assessments and our obligations to maintain records of processing activities (ROPAs).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a separate Personal Data Incident and Breach Response Policy and Process that governs the management of personal data incidents and breaches within ICON. The policy requires incidents to be reported to ICON&#8217;s Global Data Protection Officer (DPO) and Privacy Team, who manage them in collaboration with relevant internal stakeholders (e.g., IT Security, Quality &amp; Compliance), to ensure we comply with our legal and contractual obligations, including our reporting obligations. Our privacy program is overseen by the CAO.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people and partners play a critical role in safeguarding data. ICON has training in place for all employees and contingent workers on information security and privacy practices so that they understand their responsibilities with respect to data security and privacy.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sustainable procurement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains policies and practices to support responsible, sustainable, and ethical business practices. Our goal is to source from suppliers whose values align with our own, including suppliers who are committed to diversity and inclusion, and are socially and environmentally responsible and conscious.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We manage our suppliers through our Global Procurement department. The onboarding of new suppliers is completed through a centrally managed due diligence process. Environmental sustainability, bribery, and corruption risks are a focus of our collective third-party diligence and management process. We require our suppliers to abide by our Global Supplier Code of Conduct which incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for Responsible Supply Chain Management and sets out our standards and expectations regarding:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Ethics and compliance</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Labor and human rights</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Health and safety</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Environmental stewardship</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON performs pre-engagement due diligence on our suppliers. This includes screening of sanctions lists, debarment, and adverse media. Suppliers are continuously monitored against sanctions and debarment lists and are periodically re-screened. Suppliers deemed higher risk are subject to enhanced due diligence and controls, which may include periodic training, auditing, and assessments. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We hold our suppliers accountable for meeting their contractual obligations, including commitments relating to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship and exclusion from future business with our company.    </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have also engaged with EcoVadis, CDP and Supplier IO to assess our key suppliers and allow us to take ESG status into our decision making on vendor selection. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our marketing strategy is focused on building a differentiated brand position for ICON and supporting our business development efforts to develop and build relationships with pharmaceutical, biotechnology, medical device, and government and public health organizations. Our marketing activities are coordinated centrally to ensure a consistent and differentiated market positioning for ICON and to ensure all marketing efforts align to the overall strategic objectives of the business. Our business development teams are located throughout the Americas, Europe and Asia Pacific regions. Business development activities are carried out by account executives with assigned territories and global account directors supporting our large accounts. Specialized business development teams focus on growing each of our business areas. Collectively, our business development team, senior executives and project team leaders share responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our client base to gain repeat business and enable us new opportunities to penetrate into other therapeutic indications and adjacent service lines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is fragmented, consisting of many small, niche service providers, a declining number of medium-sized providers and a smaller number of large CROs, including ICON, that are differentiated by the scale of their&#160;global operations, breadth of service portfolios and supporting technology infrastructure. The need to conduct complex research and access patients on a global basis is driving market share to these global CROs. When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., the Covance Drug Development business of LabCorp and Syneos Health. In some specific markets, for example biotech and mid-tier pharma, ICON may also compete against mid-tier CROs. Competition also exists for acquisition candidates in addition to competition for customers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs generally compete on the basis of previous product experience, the ability to recruit patients on a global basis, the depth of therapeutic and scientific expertise, the strength of project teams, price and increasingly on the ability to apply new innovation that can drive significant time and cost savings throughout the development process. An evolving area of competition is the need to provide services that can help generate the evidence of the economic value of new treatments that payers and regulators require. This requires access to new data sources which includes information to support the identification of suitable investigator sites and patient populations as well as data on the value delivered by new products following marketing approval. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we compete favorably in all these areas and we continue to invest in our capabilities to ensure that we remain competitive in the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Customers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, revenue was earned from a wide range of clients.&#160;During the year ended December&#160;31, 2022, 28.3% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.8% of revenue for the year.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, 31.6% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.0% of revenue for the year ended December&#160;31, 2022.  &#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, 39.1% of our revenues were derived from our top five customers, with one customers individually contributing more than 10% of our revenues during the period (12.1%). No other customer contributed more than 10% of our revenues during this period.  &#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The loss of, or a significant decrease in business from one or more of these key customers could have a material adverse impact on our results of operations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unsatisfied Performance Obligation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation consists of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2022 we had contracted unsatisfied performance obligations of $13.7 billion.&#160;We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize this unsatisfied performance obligation as revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information Systems</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Having access to accurate and timely information is critical in the management, delivery and quality of all aspects of drug development. ICON utilizes an extensive range of both on premise and cloud based applications that support its services including clinical trial design and planning, site and patient identification and recruitment, site start-up, patient consent, site payments, content management, clinical data analysis and real world evidence generation, customer relationship management (CRM), performance management, compliance and safety reporting and master data management. These solutions are to allow healthcare companies to manage, optimize and execute their clinical and commercial strategies in an orchestrated manner while addressing their regulatory obligations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has developed an informatics strategy built around key platforms including ICONIK and Health Cloud, web-based information platforms that enable the management, reporting, analysis and visualization of all data relating to drug development. The ICONIK and Health Cloud platforms collect, manage and standardize study data from multiple sources, including Electronic Data Capture (EDC), patient engagement, EMR/EHR, mobile health, Telehealth, Wearables, central laboratories, Symphony Health and Imaging platforms to provide a single view of study information. ICONIK and Health Cloud enable ICON to deliver services such as Risk Based Monitoring (RBM) which uses near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to managing clinical data, ICONIK and Health Cloud collect operational data, such as project management, clinical trials management system (CTMS) and metrics information to drive trial efficiency and transparency. Investigator data, such as payments, site details and performance, can also be incorporated. ICONIK and Health Cloud can be accessed via a portal that allows clients access to study-related information via a secure web-based environment. Data analysis from ICONIK and Health Cloud Informatics Hubs and CDRP allows us to enhance the design and delivery of our projects, through stronger engagement with investigators and patients. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Data management and collection is a key business process for Symphony Health through its Integrated Dataverse (IDV&#174;) platform. Integrated Dataverse (IDV&#174;) is a comprehensive and longitudinal source of healthcare data in the industry, bringing together our vast claims resources &#8211; medical, hospital, and prescription &#8211; with our rich point-of-sale prescription data, non-retail invoice data, and demographic data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Firecrest, our site management and training technology, is another important component of our informatics strategy. Firecrest provides an on-line web-based portal to access visit by visit study guides which drive site performance and quality. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON also utilizes a range of enterprise applications that enable the delivery of our business services in a global environment. The focus is to provide ease of access and capture of study information for our staff and clients globally. Our current information systems are built on open standards and leading commercial business applications from vendors including Microsoft, Amazon, Oracle, Dell, SAS, Veeva, Dassault, Salesforce and BOX. IT expenditure is authorized by strict IT governance policies requiring senior level approval of all strategic IT expenditure based on defined business strategy and measurable business benefits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In Clinical Operations, we have deployed a suite of software applications that assist in the management and tracking of our clinical trial activities. These software applications are both internally developed and commercially available applications from external vendors. These include a clinical trial management application that tracks all relevant data in a trial and automates all management and reporting processes. In our Data Management function, we have both leading clinical data management solutions including EDC and Clinical Data Warehouse solutions from external vendors as well as our proprietary EDC capability NEXTrials Prism eClinical. This allows us to guarantee the integrity of client data and provide consolidated information across client studies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within Clinical Operations, we also provide the ICON Digital Platform enabling the delivery of Decentralized and Hybrid Clinical Trial services, maximizing patient recruitment and retention and at the same time expanding access to diverse and remote patient populations. We develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximize safety and efficiency and make data-driven decisions for every study.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our clinical trials management area, Firecrest Clinical provides a comprehensive site performance management system that improves compliance, consistency and efficient execution of activities at investigative sites. The web-based solution enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">quickly and simultaneously to sites. Site behavior can then be tracked to ensure training is understood, procedures are being followed, timelines are met and study parameters are maintained. As well as meeting day to day operational requirements, this system feeds data into the ICONIK and Health Cloud platforms.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide interactive response technology (IXR) to enable centralized patient randomization, drug inventory management, patient diary collection, providing our clients with a fully flexible multi-channel data retrieval solution which can be utilized via telephone, internet browser or a mobile device. In our central laboratory business, we utilize a comprehensive suite of software, including a laboratory information management system (LIMS), a kit / sample management system and a web interface system to allow clients to review results online. Our Laboratory also utilizes IMRA, a web based laboratory review application that allows global access to the latest laboratory data on a study. IMRA facilitates detailed analysis of any trends, signals, alerts or patient-specific data on a real-time basis. ICON provides imaging services through the use of its internally developed MIRA platform and also utilizes Medidata&#8217;s Rave Commercial Imaging for collecting, managing and processing data to support its imaging capabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its Pharmacovigilance Services using Oracle&#8217;s ARGUS safety database. The system is FDA regulation 21 CFR Part 11 compliant and generates all the standard regulatory required reports, as well the periodic reports required to support operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON supports Population Pharmacokinetics and Pharmacokinetic Pharmacodynamic modeling through the use of its proprietary software NONMEM&#174;. NONMEM&#174; is a nonlinear mixed effects modeling tool that can be used to fit models to many different types of data. Statistical analysis with NONMEM&#174; using the appropriate model helps pharmaceutical companies determine appropriate dosing strategies for their products, and increase their understanding of drug mechanisms and interactions. NONMEM&#174; can also be accompanied with PDx-Pop proprietary software. PDx-Pop software is a graphical interface for NONMEM&#174; which has its own automation methodology which expedites the iterative process of population pharmacokinetic modeling and analysis. ICON also utilizes PREDPP, which is a powerful package of subroutines handling population PK data, as well as general linear and nonlinear models, which can free the user from coding standard kinetic-type equations while simultaneously allowing complicated patient-type data to be easily analyzed. Finally, ICON utilizes NM-TRAN, which is a preprocessor allowing control and other needed inputs to be specified in a user-friendly manner. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's configurable Real World Data &#8220;Evidence&#8221; platform is a fit-for-purpose solution to support and enhance observational research. The platform gathers disparate real world data assets into a common data model, provides analytics to support multiple audiences across the product lifecycle, and serves as a central repository and analytic platform for all Real World Data assets.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s Integrated Dataverse (IDV&#174;) is one of the largest integrated repositories of healthcare data consisting of 280 million patient lives, 1.8 million prescribers and 16 thousand health plans provides powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. We transform data into decisions and give deeper insight into the relationships that sponsor brands have with the market by allowing a holistic view of the impacts of payer, prescriber, and patient behavior. Our proprietary Tokenisation technology Synoma&#174; simplifies the anonymization, exchange and connection of industry data sources to provide an integrated view of a patient&#8217;s data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s strategy of using technology to enhance our global processes is evident from our deployment of platforms like ICONIK, Health Cloud, Veeva EDMS/QMS (our global SOP Document Management system), iLearn and Cornerstone (our Web-based training delivery solution), ServiceNow (workflow and automation platform), Sailpoint (identity management and governance), and Pega and ARGUS (pharmacovigilance). The Electronic Trial Master File is delivered via ICON&#8217;s proprietary software ICOMaster or the Wingspan and PhlexGlobal software platforms. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s global finance operations utilize Oracle&#8217;s eBusiness suite, with the integrated Excel4Apps reporting tool, to serve the organization&#8217;s financial and project accounting requirements. Workday is used to fulfill our HR people management requirements. Our business development and contracting teams use Salesforce CRM.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our IT systems are operated from two data center hubs in Europe (Dublin, Ireland; Groningen, Netherlands), four in North America (Philadelphia, Pennsylvania; Lenexa, Kansas; Charlottesville, Virginia; Dallas, Texas) and one in Asia (Singapore). These hubs reside within purpose-built data center facility locations. Other offices are linked to these hubs through a network managed by Verizon, a tier one global telecommunications provider. This network provides global connectivity for our applications and allows collaboration and communication using tools like Microsoft Teams, Cisco Jabber, Sharepoint and Box. Mobile staff can also access all systems via secure remote access facilities. A global corporate intranet portal provides access to all authorized data and applications for our internal staff as well as providing an internal platform for company-wide communication. IT systems are protected with robust information security controls which are independently audited biannually as part of maintaining ICON&#8217;s ISO27001:2013 certification. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON enables its patient site and data strategy through the services delivered via Accellacare and through our partnerships with Oncacare and Veradigm Allscripts. We also work with biopharmaceutical companies and other life science providers (e.g. medical devices companies) to develop and deploy bespoke stakeholder engagement solutions. ICON&#8217;s patient </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">engagement services enable site staff to engage directly with patients to help improve their disease and medication understanding through interventional and non-interventional support.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides molecular diagnostic laboratory capabilities that enables the development and commercialization of precision medicines in oncology. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is the leading provider of Functional Service Provision (FSP) globally. Our team of operational, functional and therapeutic specialists offer a range of FSP models. We offer FSP solutions across all major functions from clinical monitoring and project management through data management, statistical programming and beyond. Our teams leverage either Sponsor or ICON&#8217;s IT Infrastructure to deliver services. Our team has extensive experience managing the migration of systems and can support system upgrades as part of the ramp-up phase.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides molecular diagnostic laboratory capabilities that enables the development and commercialization of precision medicines in oncology. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other key innovations and new technologies include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">FLEX ADVANTAGE, our interactive response technology platform (accessible through the web and web-enabled mobile devices) for managing patient randomization, investigator sites and clinical suppliers.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">PubsHub brings speed and efficiency to medical teams by delivering easy-to-use, web-based solutions that bridge process gaps for system harmonization across companies. ICON utilizes PubsHub to automate medical and scientific communications and publications management.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The ICON Patient Engagement Platform features an easy to navigate, user friendly website enabling patients to explore new and ongoing studies available, opt-in and connect with their nearest clinical research site.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">One Search, an intuitive, integrated workflow and interrogation tool from ICON, enables access to multiple data sources and provides the visualization and tools necessary for optimum site identification based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">ADDPLAN for simulation and design of exploratory/pilot and confirmatory/pivotal adaptive clinical trials (ADDPLAN&#174; DF (Dose Finder), ADDPLAN&#174; Base, ADDPLAN&#174; MC (Multiple Comparison) and ADDPLAN&#174; PE (Population Enrichment)).</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">AptivAdvantage which is an integrated platform comprising EDC, randomization and drug supply management specifically created for execution of adaptive clinical trials and used to deliver risk-based monitoring; and Aptiv Insite which is a novel approach to risk-based monitoring, using Verification by Statistical Sampling (VSS) to manage data quality and site related risks.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Sample Inventory Management System (SIMS) is an interactive reporting module in ICOLabs for use by sponsors and study teams. It offers near real time, high level traceability of all patient samples in a clinical trial as they move from accessioning through disposition. SIMS provides detailed sample inventory reports and summaries of sample status and location with drill down capabilities. It helps locate samples more rapidly, particularly at critical study junctures.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">APECS for Investigator Payments ensures timely and accurate payments to sites for the work performed in the care and management of patients as they participate within clinical trials.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The PredictivvTM platform is a fully integrated solution for designing, planning, managing and optimizing the execution of global clinical studies. Designed around a unified Sales Force platform that harmonizes data, processes, and people across every aspect of a clinical study, PredictivvTM enables unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">EXACT&#8482; allows users quickly to construct re-usable programs for data extraction, data transformation, statistical reporting and electronic publishing, in a visual environment with limited code writing. The EXACT&#8482; system is used to simplify and automate the production of multiple Clinical Data Interchange Standards Consortium (CDISC) guidelines as well as tables, figures and listings in trial reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Contractual Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are generally awarded projects based upon our responses to requests for proposals received from companies in the pharmaceutical, biotechnology and medical device industries, or through strategic partnership agreements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues on long term contracts are recognized based on an assessment of progress towards completion. Payment terms usually provide either for payments based on the delivery of certain identified milestones, units delivered or monthly payments, according to a contracted payment schedule over the life of the contract. Where there are changes in the scope of a trial or in the services to be provided by us, a change order or amendment is issued which may result either in an increase or decrease in the contract value. We also contract on a "fee-for-service" or "time and materials" basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contract periods may range from several weeks to several years depending on the nature of the work to be performed. In most cases, an upfront portion of the contract fee is paid at the time the study or trial is started. The balance of the contract fee is generally payable in installments over the study or trial duration and may be based on the completion of certain performance targets or "milestones", on units delivered, or on a fixed monthly payment schedule. For instance, installment payments may be based on patient enrollment progress or delivery of the study database. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The progress towards completion for clinical service contracts is measured based on total project costs (direct fees are therefore inclusive of third party costs). Reimbursable costs include payments to investigators, travel and accommodation costs and various other expenses incurred over the course of the clinical trial which are fully reimbursable by the client. Reimbursable expenses are included within the contract and are invoiced on a monthly basis based on actual expenses incurred. Expenses incurred are determined by reference to activity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred, we usually negotiate currency fluctuation clauses in our contracts which allow for price adjustments if changes in the relative value of those currencies exceed predetermined tolerances.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our contracts are terminable immediately by the client with justifiable cause or with 30 to 90 days&#8217; notice without cause. In the event of termination, we are usually entitled to all sums owed for work performed and expenses incurred through the notice of termination and certain costs associated with termination of the study. Termination or delay in the performance of a contract occurs for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client's decision to de-emphasize a particular trial, inadequate patient enrollment or investigator recruitment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Chief Executive Officer and other members of the executive management team are responsible for day-to-day risk management of the Company and our Board oversees management's activities through both the full Board and its committees. Our Chief Executive Officer and other members of the executive management team are members of ICON&#8217;s Quality and Risk Forum, which reviews risk. Our executive management team regularly reports to the Board and its Committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. The Board oversees general business and market risk management, our Audit Committee oversees risk management with respect to financial statements, accounting and financial controls and our Compensation and Organization Committee oversees risk management with respect to our compensation plans, policies and procedures and our Nominating, Sustainability and Governance Committee oversees risks relating to ESG matters. Internal audit reports functionally and administratively to our Chief Financial Officer and directly to the Audit Committee. With respect to non-financial risk management, including cybersecurity, legal compliance, privacy and enterprise risk, the Board and its Committees receive updates from the appropriate executives on the primary risks facing the Company and the measures the Company is taking to mitigate such risks. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government Regulation  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical investigation of new drugs is highly regulated by government agencies. The standard for the conduct of clinical research and development studies is Good Clinical Practice (&#8220;GCP&#8221;), which stipulates procedures designed to ensure the quality and integrity of data obtained from clinical testing and to protect the rights and safety of clinical subjects. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FDA and other prominent regulators have promulgated regulations and guidelines that pertain to applications to initiate trials of products, the approval and conduct of studies, report and record retention, informed consent, applications for the approval of drugs and post-marketing requirements. Pursuant to these regulations and guidelines, service providers that assume the obligations of a drug sponsor are required to comply with applicable regulations and are subject to regulatory action for failure to comply with such regulations and guidelines. In the United States and Europe, the trend has been in the direction of increased regulation and enforcement by the applicable regulatory authority. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In providing services in the United States, we are obligated to comply with FDA requirements governing such activities. These include ensuring that the study is approved by an appropriate Independent Review Board (&#8220;IRB&#8221;) and Ethics Committee, obtaining patient informed consents, verifying qualifications of investigators, reporting patients&#8217; adverse reactions to drugs and maintaining thorough and accurate records. We must maintain critical documents for each study for specified periods, and such documents may be reviewed by the study sponsor and the FDA.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The services we provide outside the United States are ultimately subject to similar regulation by the relevant regulatory authority. In addition, our activities in Europe are affected by the European Medicines Agency.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We must retain records for each study for specified periods for inspection by the client and by the applicable regulatory authority during audits. If we fail to comply with applicable regulations and guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines, debarment, termination or suspension of ongoing research, the disqualification of data or litigation by clients, any of which could also result in a material adverse effect.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Potential Liability and Insurance &#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our business exposes us to potential liability including, but not limited to, potential liability for (i) breach of contract or negligence claims by our customers; and, (ii) third party (such as patients) claims in respect of our performance of services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, although we do not believe we are legally responsible for acts of third party investigators (physicians running trials), we could be subject to claims arising as a result of the actions of these investigators.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We try to reduce this potential liability by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.85pt">Seeking contractual indemnification from customers in relation to certain activities. However, the terms and scope of indemnification varies from customer to customer and project to project and the performance of these indemnities is not secured. As a result, we bear the risk that indemnification may not be relevant or sufficient or that the indemnifying party may not have the financial ability to fulfill its indemnification obligations. This indemnification does not protect us against our own acts or omissions such as our negligence or where our performance does not reach the required contractual, industry or regulatory standard.</span></div><div style="padding-left:45pt;text-indent:-9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.85pt">Maintaining worldwide professional liability insurance. While we maintain the types and amounts of insurance we view as customary in the industries and countries in which we operate, there is no guarantee that we will continue to be able to maintain such insurance coverage on terms acceptable to us, if at all, or that the relevant policy will respond and provide cover when we want it to.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We could be materially adversely affected if ICON is required to pay damages or bear the costs of defending or settling any claim which a) is outside the scope of or in excess of a contractual indemnification provision, b) an indemnifying party does not fulfill its indemnification obligations, c) the claim is in excess of the level of our insurance coverage or d) the relevant circumstances are not covered by our insurance policies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Organizational Structure </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Details of the Company&#8217;s significant subsidiaries or entities under the Company's control at December&#160;31, 2022 are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research PTY Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medpass International Pty Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Pty Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Austria GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Austria GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Bel, FLLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belarus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Belgium N.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Belgium B.V. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Bermuda,&#160;Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bermuda</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON Pesquisas Cl&#237;nicas LTDA.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ltda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS do Brasil Servi&#231;os de Pesquisas LTDA.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS China Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Virgin Islands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research EOOD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Bulgaria EOOD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Canada) Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3065613 Nova Scotia Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates ULC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services de Recherche Pharmaceutique Srl</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oxford Outcomes LTD.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Life Sciences Canada Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Chile Limitada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Chile SpA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing No.2) Co., Ltd </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing) Co., Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences China, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Colombia Ltda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Costa Rica, LTDA.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ispitivanja ICON d.o.o                                           <br/>ICON Research Ltd. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates d.o.o. za klinicka ispitivanja</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates CZ, s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Nordic Countries A/S</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Denmark ApS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Egypt (Limited Liability Company)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Estonia O&#220;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estonia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Finland Oy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Finland Oy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.R.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Research Trust*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services France S.A.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics Georgia LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Georgia LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Averion Europe GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Germany GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Greece A.E.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Guatemala, S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guatemala</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Hong Kong Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences (Hong Kong) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Klinikai Kutat&#243; Korl&#225;tolt Felel&#337;ss&#233;g&#369; T&#225;rsas&#225;g (ICON Clinical Research Limited Liability Company)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Magyarorsz&#225;g Kutat&#225;s-Fejleszt&#233;si Korl&#225;tolt Felel&#337;ss&#233;g&#369; T&#225;rsas&#225;g (Pharmaceutical Research Associates Hungary Research and Development Ltd.)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Iceland ehf.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Iceland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research India Private Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates India Private Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Resourcing Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical International Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Development (Ireland) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Holdings (Ireland) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Clinical Research International Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Five Unlimited Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Four Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services (Outsourcing Ireland) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Clinical Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (Ireland) Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Israel LTD.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Israel Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Italy S.r.l.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Development Center KK</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences KK</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Japan K.K.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jersey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Kenya Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenya</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latvia SIA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latvia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UAB RPS Lithuania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lithuania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON CRO Malaysia SDN. BHD.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Malaysia Sdn. Bhd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research M&#233;xico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Mexico S. de R.L. de C. V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research M&#233;xico, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Servicios, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">M&#233;xico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International B.V. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Group B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Operations B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services Netherlands B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (New Zealand) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates New Zealand Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Norway AS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Panama Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Per&#250; S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per&#250;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Per&#250; S.A.C.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per&#250;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Services Philippines, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Philippines,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Poland Sp. z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Clinical Research Sp zoo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Sp. z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Portugal, Unipessoal, Lda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Puerto Rico,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.R.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Romania S.R.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Rus) LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joint Stock Company IMP Logistics </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research d.o.o. Beograd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates doo Belgrade</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Pte) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Life Sciences Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Slovakia, s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates SK s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Pharmaceutical S A (Proprietary) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research South Africa (Proprietary) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare South Africa (PTY) LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Korea Yuhan Hoesa/ ICON Clinical Research Korea Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Korea Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Espa&#241;a, S.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Espa&#241;a, S.A.U.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS ReSearch Ib&#233;rica, S.L.U.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Spain S.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Espa&#241;a S.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Sweden AB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Sweden AB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Switzerland GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Switzerland) GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Switzerland AG</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Taiwan Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Taiwan,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Thailand) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research (Thailand) Co.,&#160;Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Ankara Klinik Arastirma Dis Ticaret Anonim Sirketi</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pra Turkey Sa&#287;lik Ara&#351;tirma Ve Geli&#351;tirme Limited &#350;irketi </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Ukraine LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Ukraine, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ukraine, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aptiv Solutions (UK) Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 2 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 3 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 4 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 5 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Development Solutions Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments (UK) Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Improving Treatments Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medeval Group Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Lakeside Clinical Research Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Merc (UK) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VSK (Kenilworth) Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics UK Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates (UK) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sterling Synergy Systems Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (U.K.) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 6 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latin America S.A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Early Phase Services, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ClinStar LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nextrials, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates CIS, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Eastern Europe, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN North America, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research, LP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addplan, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beacon Bioscience, Inc </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">C4 MedSolutions, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHC Group, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN Holdings, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Pharmaceutical Strategies Group, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Investments, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Tennessee, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON US Holdings Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Consulting, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MolecularMD Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PriceSpective LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PubsHub LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI NewCo,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI Worldwide, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Medical Technical Consultants, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Parallel 6, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Early Development Research, Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Holdings,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Receivables, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roy RPS Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global Holdings,&#160;LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Parent Holding LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Source Healthcare Analytics, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunset Hills, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Christie Clinic, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Resource Network, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Global, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Care Strategic Solutions, L.L.C. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI International, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charlotte, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Hickory, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Raleigh, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Rocky Mount, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Salisbury, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Wilmington, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Winston-Salem, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare US Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Healthcare Communications LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Publication Solutions, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:53.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charleston, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Bristol, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lifetree Clinical Research, LC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Government and Public Health Solutions, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Mapi Research Trust is an association, its members are ICON Subsidiary entities. </span></td></tr></table></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_55"></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Description of Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal executive offices are </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">located in South County Business Park, Leopardstown, Dublin, Republic of Ireland, where we own an office facility of approximately 15,000 squ</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are meters. We lease all other properties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain fifty-three offices in Europe; ten of our offices are in the UK, seven in Germany, five in The Netherlands, four in Spain, two in each of the Czech Republic, France, Hungary, Ireland, Poland, Russia, Sweden, Turkey and Ukraine, and one in each of Belarus, Belgium, Bulgaria, Georgia, Israel, Italy, Latvia, Romania, and Slovakia. We maintain thirty-three offices in North America; twenty-nine in the United States, two in Canada and two in Mexico. We have sixteen offices in Asia; five in China (including one in Hong Kong), three in India, two in each of Japan and Singapore, and one in each of South Korea, Taiwan, Thailand and The Philippines. We have two offices in Australia and one in New Zealand.  We have five offices in South America; one in each of Argentina, Brazil, Chile, Columbia and Peru. We maintain one office in South Africa.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4A. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Operating and Financial Review and Prospects.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis sh</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">ould be read in conjunction with our consolidated financial statements, accompanying notes and other financial information, appearing in Item 18. The consolidated financial statements have been prepared in accordance with U.S. GAAP. The information included in the discussion and analysis below provides details on the information for the years ended December&#160;31, 2022 and December&#160;31, 2021. Information related to the year ended December&#160;31, 2020 has not been included. It can be found in the Company's filing of the form 20-F for the year ended December&#160;31, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a CRO, providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated &#8220;full-service&#8221; solution. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">we employed approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> employees, in </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">111 locations in 53 co</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">untries. During the year ende</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe, and the rest of the world, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue consists of fees earned under contracts with third-party clients. In most cases, a portion of the contract fee is paid at the time the study or trial is started, with the balance of the contract fee generally payable in installments over the study or trial duration, based on the delivery of certain performance targets or milestones. Revenue from long term contracts is recognized on a proportional performance method based on the relationship between cost incurred and the total estimated costs of the trial or on a fee-for-service basis according to the particular circumstances of the contract. As is customary in the CRO industry, we contract with third party investigators in connection with clinical trials. Investigator costs and certain other third party costs are included in our assessment of progress towards completion and costs incurred in measuring revenue. Where these costs are reimbursed by clients, they are included in the total contract value recognized over time, based on our assessment of progress towards completion. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the nature of our business involves the management of projects, the majority of which have a duration of one to four years, the commencement or completion of projects in a fiscal year can have a material impact on revenues earned with the relevant clients in such years. In addition, as we typically work with some, but not all divisions of a client, fluctuations in the number and status of available projects within such divisions can also have a material impact on revenues earned from such clients from year to year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Termination or delay in the performance of an individual contract may occur for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client&#8217;s decision to de-emphasize a particular trial or inadequate patient enrollment or investigator recruitment. In the event of termination the Company is usually entitled to all sums owed for work performed through the notice of termination and certain costs associated with the termination of the study. In addition, contracts generally contain provisions for renegotiation in the event of changes in the scope, nature, duration, or volume of services of the contract.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation comprises our assessment of contracted revenue yet to be earned from projects awarded by clien</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ts. At December&#160;31, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">we had unsatisfied performance obligations of approximately $13.7 billion.&#160;We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results, due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize the unsatisfied performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON announced the completion of its Merger with PRA creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations. The management's discussion and analysis below reflects the operating results of the Group for the year ended December&#160;31, 2022 which incorporates the results of PRA and results in large variances when comparing to the year ended December&#160;31, 2021. The results of PRA prior to July 1, 2021 are not reflected. Where applicable, management have included commentary on specific one-time charges related to the Merger in order to provide an understanding of the normal operations of the Group. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we are domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be materially affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to translation exposures, we are also subject to transaction exposures because the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred.&#160;Our operations in the United States are not materially exposed to such currency differences as the majority of our revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts are usually priced in a single currency, most often U.S. dollars or euros, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging, due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our currency exposures.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we conduct operations on a global basis, our effective tax rate has depended and will depend on the geographic distribution of our revenue and earnings among locations with varying tax rates. Our results therefore may be affected by changes in the tax rates of the various jurisdictions. In particular, as the geographic mix of our results of operations among various tax jurisdictions changes, our effective tax rate may vary significantly from period to period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;Operating Results</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, certain financial data as a percentage of revenue and the percentage change in these items compared to the prior comparable period. The trends illustrated in the following table may not be indicative of future results.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage Increase/(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Year ende</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">d December&#160;31, 2022 compared to year ended December&#160;31, 2021</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,260,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue for the year ended December&#160;31, 2022 increased by $2,260.6 million, or 41.2%, to $7,741.4 million, compared to $5,480.8 million for the year ended December&#160;31, 2021. Revenue increased by 45.4% in constant currency terms. The increase in revenues in the year ended December&#160;31, 2022 is due to the Merger and continued organic growth across the Company's markets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year en</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ded December&#160;31, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the Company derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World respectively. Revenues from our top five customers amounted to $2,189.6 million in the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> compared </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to $1,733.1 million in</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> or 28.3% and 31.6% respectively.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in Ireland increased by $618.7 million in the year ended December&#160;31, 2022, to $1,984.6 million, compared to $1,365.9 million for the year ended December&#160;31, 2021.&#160;Revenue in Ireland during the year ended December&#160;31, 2022 increased by 45.3% compared to an overall increase in Group revenue of 41.2%.&#160;Revenue in Ireland is principally a function of our global contracting model.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in the Rest of Europe increased by $442.8 million or 37.7%, to $1,618.4 million, compared to $1,175.5 million for the year ended December&#160;31, 2021. Revenue in the U.S. increased by $993.6 million or 38.5%, to $3,574.6 million, compared to $2,581.0 million for the year ended December&#160;31, 2021. Revenue in our Rest of World (&#8216;Other&#8217;) region increased by $205.5 million or 57.3%, to $563.9 million, compared to $358.4 million for the year ended December&#160;31, 2021. Revenue has increased across all regions due to the completion of the Merger and continued organic growth across the Company's markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:50.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,527,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,972,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,554,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs for the year ended December&#160;31, 2022 increased by $1,554.4 million, or 39.1%, to $5,527.0 million, compared to $3,972.6 million for the year ended December&#160;31, 2021. Direct costs consist primarily of investigator and other reimbursable costs, compensation, associated fringe benefits and share based compensation expense for project-related employees and other direct project driven costs. The increase in direct costs during the year ended December&#160;31, 2022 arose due to an increase in headcount and an increase in personnel related expenditure of $926.5 million combined with an increase in other direct project related costs of $179.7 million, an increase in laboratory costs of $10.0 million  and an increase in travel related costs of $5.6 million. There was an increase in third party investigator and other reimbursable costs of $434.5 million.&#160;The decrease in direct costs as a percentage of revenue reflect the different activity mix for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021, as well as the realization of integration synergies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:51.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.760%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">585,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year ended December&#160;31, 2022 increased by $193.4 million, or 33.0%, to $778.8 million, compared to $585.3 million for the year ended December&#160;31, 2021. Selling, general and administrative expenses comprise primarily of compensation, related fringe benefits and routine share based compensation expense for non-project-related employees, recruitment expenditures, professional service costs, advertising costs and all costs related to facilities and information systems. As a percentage of revenue, selling, general and administrative expenses decreased to 10.0% of revenue during the year ended December&#160;31, 2022, compared to 10.7% of  revenue for the year ended December&#160;31, 2021. During the year ended December&#160;31, 2022, the increase in selling, general and administrative expenses relates to an increase in general overhead costs of $47.3 million, an increase of $42.9 million in facilities related costs, an increase of $88.0 million in personnel related expenditure, an increase of $24.0 million in professional fees and an increase of $3.7 million in marketing fees. These increases were partly offset by foreign exchange gains for the year ended December&#160;31, 2022 of $26.0 million ($14.3 million for the year ended December&#160;31, 2021) driven mainly by the movement in the Euro to U.S. dollar exchange rate. Finally, share based compensation expense recognized during the years ended December&#160;31, 2022 and December&#160;31, 2021 were $70.5 million and $133.8 million, respectively. Share based compensation expenses are part of personnel related expenditure in direct costs and selling, general and administrative expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:51.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation expense for the year increased by $30.9 million or 41.0%, to $106.4 million, compared to $75.5 million for the year ended December&#160;31, 2021. The depreciation charge reflects the impact of the acquisition and investments in facilities, information systems and equipment supporting the Company&#8217;s continued growth. As a percentage of revenue, the depreciation expense remained consistent at 1.4% of revenues, for the year ended December&#160;31, 2022 and December&#160;31, 2021.&#160;The increase in the depreciation charge for the years ended December&#160;31, 2022 is due to the increase in our depreciable asset base acquired through the Merger as well as additional spend related to computer hardware and software. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense for the year ended December&#160;31, 2022 increased by $223.6 million or 93.4%, to $463.1 million, compared to $239.5 million for the year ended December&#160;31, 2021. The amortization expense represents the amortization of intangible assets acquired during business combinations. The increase in amortization expense for the year reflects the amortization of newly acquired intangibles resulting from the Merger.&#160;As a percentage of revenue, the amortization expense increased to 6.0% for the year ended December&#160;31, 2022, compared to  4.4% of revenue for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, transaction and integration-related expenses associated with the Merger</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158,568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the Company incurred $70.8 million for restructuring, transaction and integration-related expenses primarily associated with the Merger. The charge includes transaction and integration costs of $39.7 million associated with advisory costs, severance arrangements, retention agreements and ongoing integration activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has also undertaken a restructuring program following the announcement of the Merger to review its global office footprint, optimize its locations to best fit the requirements of the Company and reorganize its workforce to drive future growth. This program has resulted in a charge of $31.1 million in the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. In the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, a restructuring charge of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$31.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> was recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to incur some additional expenses associated with the Merger; however, the timing and the amount of these expenses depends on various factors such as, but not limited to, the execution of integration activities and the aggregate amount of synergies we achieve from these activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income from operations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations increased by $416.7 million, or 110.1%, to $795.2 million, compared to $378.5 million for the year ended December&#160;31, 2021. As a percentage of revenue, income from operations increased to 10.3% of revenues compared to 6.9% of revenues for year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations in Ireland increased to $218.1 million compared to $132.0 million for the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the Rest of Europe region, income from operations increased to $253.8 million compared to $177.9 million for the year ended December&#160;31, 2021. As a percentage of  revenues, income from operations in the Rest of Europe region increased to 15.7% compared to 15.1% for the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the U.S. region, income from operations increased by $215.7 million, to $254.8 million, compared to $39.1 million for the year ended December&#160;31, 2021. As a percentage of revenues, income from operations in the U.S. region increased to 7.1% compared to 1.5% for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In other regions, income from operations increased by $38.9 million to $68.5 million compared to $29.6 million for the year ended December&#160;31, 2021. As percentage of  revenues, income from operations in the other regions increased to 12.1% compared to 8.3% for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest income and expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.367%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">308.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182,423)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense increased to $229.7 million compared to $182.4 million for the year ended December&#160;31, 2021. The increase in the year reflects the impact of financing costs associated with the Merger and the average gross amount of outstanding borrowing and the impact of rising interest rates during the year. Interest income for the year ended December&#160;31, 2022 increased to $2.3 million, compared to $0.6 million for the year ended December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for income taxes for the year increased to $59.4 million compared to $41.3 million for the year ended December&#160;31, 2021.&#160;The Company&#8217;s effective tax rate for the year ended December&#160;31, 2022 was 10.5%&#160;compared to</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 21.0% fo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">r the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2021 primarily due to the full year amortization impact of acquired intangible assets and non-deductive expenditures incurred in 2021 related to the Merger. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate remains principally a function of the distribution of pre-tax profits amongst the territories in which it operates.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B. &#160;&#160;&#160;&#160;Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is generally not capital intensive. The Group&#8217;s principal operating cash needs are payment of salaries, office rents, travel expenditures and payments to investigators. Investing activities primarily reflect capital expenditures for facilities and information systems enhancements, the purchase and sale of short term investments and acquisitions. Financing activities primarily reflect the servicing of the Company's external debt.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clinical research and development contracts are generally fixed price with some variable components and range in duration from a few weeks to several years. Revenue from contracts is generally recognized as income on the basis of the relationship between costs incurred and the total estimated contract costs. The cash flow from contracts typically consists of a small down payment at the time the contract is entered into, with the balance paid in installments over the contract duration, in some cases on the achievement of certain milestones. Therefore, cash receipts do not correspond to costs incurred and revenue recognized on contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash and cash equivalents and net borrowings</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Drawn<br/>down)/<br/>repaid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash inflow/</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(outflow)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other non-cash adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of exchange rates</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">dollars in thousands</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(446,725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">288,768</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities &amp; Senior Secured Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,436,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4,654,187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash and cash equivalents and borrowings </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4,682,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">800,000</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(446,724)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(17,875)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16,720)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4,363,706)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents and available for sale investments at December&#160;31, 2022 amounted to $290.5 million compared with cash and available for sale investments of $753.9 million at December&#160;31, 2021.&#160;The Company&#8217;s </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cash and available for sale investments at December&#160;31, 2022 comprised cash and cash equivalents of $288.8 million and available for sale investments of $1.7 million. The Company&#8217;s cash and available for sale investments at December&#160;31, 2021 comprised cash and cash equivalents of $752.2 million and available for sale investments of $1.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a Senior Secured Credit Facilities providing for a senior secured term loan facility of $5,515.0&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300.0&#160;million. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. At December&#160;31, 2022 and December&#160;31, 2021, no amounts were outstanding under the revolving loan facility with the exception of $4.5&#160;million letters of credit given to landlords to guarantee lease arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit F</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">acilities, on July 1, 2021, the Company, issued $500.0&#160;million in aggregate principal amount of 2.875% senior secured notes in a private offering. The senior secured notes will mature on July 15, 2026.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March&#160;31, 2022 the Company repaid $300.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $35.1&#160;million. On June&#160;30, 2022 the Company repaid $100.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $39.4&#160;million. On September&#160;30, 2022 the Company repaid $200.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $53.6&#160;million. On December&#160;30, 2022 the Company repaid $200.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $66.1&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has contractual liabilities for lease arrangements of $189.7&#160;million which will be predominantly settled over the next five year period through cash payments.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash from operating activities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities decreased by $265.8 million to $563.3 million for the year ended December&#160;31, 2022 as compared to net cash provided by operating activities of $829.1 million for the year ended December&#160;31, 2021. The decrease in net cash provided by operating activities of $265.8&#160;million is due to changes in working capital of $685.2&#160;million, offset by increases in cash inflows from net income of $419.4&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The change in working capital is primarily attributable to increases in Accounts Receivable of $534.2&#160;million and Unbilled Revenue of $314.9&#160;million, offset by increases in Unearned Revenue of $262.1&#160;million. These changes result from differences in timing of revenue recognition and billing on clinical trials. The days&#8217; revenue outstanding at December&#160;31, 2022 was&#160;54 days  compared to 31 days at December&#160;31, 2021. Cash generated from working capital and days&#8217; revenue outstanding may be positively or negatively impacted by, amongst others, the scheduling of contractual milestones over a study or trial duration, the achievement of a particular milestone during the period, the timing of receipt of invoices from third parties for reimbursable costs and the timing of cash receipts from customers. Contract fees are generally payable in installments based on the achievement of certain performance targets or &#8220;milestones&#8221; (e.g. target patient enrollment rates, clinical testing sites initiated or case report forms completed), such milestones being specific to the terms of each individual contract, while revenues on contracts are recognized as contractual obligations are performed.&#160;A decrease in the number of days&#8217; revenue outstanding during a period will result in cash inflows to the Company while an increase in days revenue outstanding will lead to cash outflows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash used in investing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities was $145.9 million for the year ended December&#160;31, 2022 compared to net cash used in investing activities of $6,024.2 million for the year ended December&#160;31, 2021. Net cash used in investing activities for the year ended December&#160;31, 2022 were primarily related to cash outflows of $142.2 million for capital expenditures made mainly relating to investment in facilities and IT infrastructure and $5.6 million in relation to investments in long-term equity. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ended December&#160;31, 2021, net cash used in investing activities of $6,024.2 million was largely attributable to the cash element of the Merger consideration of $5,914.5 million (net of cash acquired). During the year, capital expenditure of $93.8 million was made mainly related to the investment in facilities and IT infrastructure. Further cash outflow of $2.5 million was made in respect of the Company's investment in Oncacare, a loan of $10.0 million was provided to Oncacare and $4.1 million in relation to investments in</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> long-term equity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash used in financing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in financing activities amounted to $864.2 million for the year ended December&#160;31, 2022 compared with net cash provided by financing activities of $5,114.7 million for the year ended December&#160;31, 2021. In the year ended December&#160;31, 2022, the Company repaid external financing of $800.0 million and repurchased shares to the value of $100.0 million. This was offset by $35.8 million that was received by the Company from the exercise of share options. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2021, the Company drew down external financing of $6,015.0 million to fund the completion of the Merger. This was offset by debt discount and certain debt issue costs of $109.9 million. As part of the external </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">financing, the Company paid financing professional fees of $30.3 million and made payments of principal on the external debt of $513.8 million. The Company also repaid the 2020 Senior Notes on July 1, 2021, including early repayment charges, totaling $364.0 million. During the year ended December&#160;31, 2021, $118.6 million was received by the Company from the exercise of share options.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Net cash outflow</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of these cash flows, cash and cash equivalents decreased by $463.4 million for the year ended December&#160;31, 2022 compared to a decrease of $88.1 million for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C. &#160;&#160;&#160;&#160;Research and development, patents and licenses</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plays a critical role in new drug development by undertaking activities in each of the different stages of the drug development process. Clinical trials result in an advancement in the field of medical science as they establish the safety and efficacy of new drugs, thus resolving scientific uncertainty. As one of a number of world leaders in clinical research and commercialization, ICON is a trusted partner for pharmaceutical and medical device companies in helping them to accelerate the development of drugs and devices that save lives and improve the quality of life. ICON's role in ensuring that the trial design is scientifically valid is a crucial part of the design and involves scientists, medical doctors and biostatisticians. ICON works with the sponsors in designing the conduct of the clinical research trial. ICON's role of conducting clinical trials is an integral part of the research and development process leading ultimately to a decision as to whether or not each drug is safe for human consumption, has the desired effect on targeted diseases and the best means of delivering that drug to the patient. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D. &#160;&#160;&#160;&#160;Trend information</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, or commitments or events sinc</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e December&#160;31, 2022 that are reasonably likely to have a material adverse effect on our revenues, income, profitability, liquidity </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or capital resources, or that would cause the reported financial information in this annual report to be not necessarily indicative of future operating results or financial conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E. &#160;&#160;&#160;&#160;Critical Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 2 to the audited consolidated financial statements provided elsewhere in this Form 20-F describes the significant accounting policies used in the preparation of the consolidated financial statements. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the period.  We base our estimates and judgments on historical experience and on the other factors that we believe are reasonable under current circumstances. Actual results may differ from these estimates if these assumptions prove to be incorrect or if conditions develop other than as assumed for the purposes of such estimates. The following is a discussion of the critical accounting estimates and judgments used by management. The application of these critical accounting estimates is discussed with the Audit Committee of the Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition - Clinical Trial Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Clinical trial services are a single performance obligation satisfied over time i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. We have concluded that ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research project. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. An assessment of the realizable contract value is judgmental in nature. The realizable value assessment is updated at each reporting period, having regard to (i) contract terms and (ii) customer experience.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized on a percentage completion basis as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured therefore based on an input measure being total project costs (inclusive of third party costs) at each reporting period. Measurement of the progress towards completion involves judgment and estimation.  Assessment of completion requires an evaluation of labor and related time cost incurred at the reporting date and third party costs incurred at the reporting date. The assessment of third party costs incurred (principally investigator costs) requires a review of activity performed and recorded by the third party services providers. The timing of payments to third parties in respect of cost incurred reflect invoicing by third parties. The timing difference between the activity performed and receipt of invoices from third parties may result in significant accrued amounts at reporting periods.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assessment of progress towards completion also requires an up to date evaluation of the forecast costs to complete in respect of these projects. Given the long-term nature of the clinical trials, and the complex nature of those trials, the forecast costs to complete (being internal direct costs and costs that will be incurred by third parties (principally investigators)) is judgmental.  Forecast time (and related costs) is determined by reference to (i) contract terms and (ii) past experience. Forecast third party costs to complete are determined by project by reference to (i) contract terms and (ii) past experience. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use the acquisition method to account for business combinations, and accordingly, the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree are recorded at their estimated fair values on the date of the acquisition. We use significant judgments, estimates and assumptions in determining the estimated fair value of assets acquired, liabilities assumed and non-controlling interest. Estimated fair values were based on various valuation methodologies, including an income approach using primarily discounted cash flow techniques for the customer relationships intangible assets. The aforementioned income methods utilize management's estimates of future operating results and cash flows discounted using a weighted-average cost of capital that reflects market participant assumptions. We have recorded and allocated to our reporting units the excess of the purchase price over the fair value of the net assets acquired, known as goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Goodwill and Long-Lived Assets</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company assesses its goodwill for impairment annually or when events or circumstances indicate a possible impairment. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In performing a qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#8217;s annual and multi-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income-based fair value methodology requires management's assumptions and judgments regarding economic conditions in the markets in which the Company operates and conditions in the capital markets, many of which are outside of management's control. At the reporting unit level, fair value estimation requires management's assumptions and judgments regarding the effects of overall economic conditions on the specific reporting unit, along with assessment of the reporting unit's strategies and forecasts of future cash flows, terminal growth rates and discount rates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the market-based fair value methodology, judgment is required in evaluating market multiples and recent transactions. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company completed its most recent annual goodwill impairment testing as of September 30,  2022, a date which is consistent with the prior year. For the years ended December 31, 2022 and 2021, the Company determined that there was no impairment of goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other long lived assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company assesses long-lived assets (such as intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group might not be recoverable. If indicators of impairment are present, we evaluate the carrying value of long-lived asset in relation to estimates of future undiscounted cash flows. Any future impairment could have a material adverse effect on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Taxation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Given the global nature of our business and the multiple taxing jurisdictions in which we operate, the determination of the Company&#8217;s provision for income taxes requires significant judgments and estimates, the ultimate tax outcome of which may not be certain.  Although we believe our estimates are reasonable, the final outcome of these matters may be different than those reflected in our historical income tax provisions and accruals.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The provision for income taxes includes federal, state, local and foreign taxes. We apply the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. We account for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and therefore have not provided for deferred taxes in respect of this item. Recognition of deferred income tax assets is based on management&#8217;s belief that it is more likely than not that the income tax benefit associated with certain temporary differences, income tax operating loss, capital loss carryforwards, and income tax credits, would be realized. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. We recognize the effect of income tax positions only if those positions will more likely than not be sustained. We determined the amount of the valuation allowance based, in part, on our assessment of future taxable income and in light of our ongoing income tax strategies. If our estimate of future taxable income or tax strategies changes at any time in the future, we would record an adjustment to our valuation allowance. Recording such an adjustment could have a material effect on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6. Directors, Senior Management and Employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Directors and Senior Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table and accompanying biographies set forth certain information concerning each of ICON plc&#8217;s Directors, officers and other key employees as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;24, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Age</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray </span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and Director </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler (1)(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan (1)(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (2)(3)(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (2)(4) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (3)(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (3)(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais (2) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diarmaid Cunningham </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Administrative Officer, General Counsel &amp; Company Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Named Executive Officer of the Company.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Compensation and Organization Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Audit Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Nominating, Sustainability and Governance Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Execution Committee.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ciaran Murray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray graduated with a Bachelor of Commerce degree from University College Dublin in 1982. Mr. Murray subsequently qualified as a chartered accountant with PwC.&#160;Following qualification, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Murray gained extensive global experience working as an executive in the fast moving consumer goods and technology sectors in Ireland, Italy, the UK and the US.&#160;Mr. Murray has been the Chair of ICON plc since March 2017 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and an outside Director since May 2018.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Mr. Murray served as Chief Executive Officer from October 2011 until March 2017 and was Chief Financial Officer from joining I</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CON plc in 2005 until his appointment as Chief Executive Officer in 2011.&#160;During his time with ICON plc, Mr. Murray was recognized for his leadership of ICON and the CRO industry.&#160; Mr. Murray served as Chair of the Association of Clinical Research Organizations (ACRO) which represents the CRO industry globally. In addition, Mr. Murray was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the bio pharma industry.&#160;University College Dublin awarded Mr. Murray an honorary degree of Doctor of Laws in 2013 for his support of third level research and innovation in Ireland. In 2018, the Royal Dublin Society awarded Mr. Murray the RDS Gold Medal for Enterprise for making an exceptional impact on Irish industry and commerce. Mr. Murray is also a member of the advisory Board of UCD Smurfit Business School. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017, having previously served as Chief Operating Officer from January 2014. Dr. Cutler served as Group President of Clinical Research Services since November 2011 until his appointment as Chief Operating Officer.&#160;Dr. Cutler was appointed to the Board of ICON plc in November 2015. Prior to joining the Company, Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer.&#160;Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe, as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. Dr. Cutler holds a B.Sc. and a Ph.D. from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Brendan Brennan</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan has served as Chief Financial Officer since February 2012. Mr. Brennan has developed his career over the last  20+ years from experience in various industries. Mr. Brennan joined ICON in 2006 and he has served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. Prior to this he developed his broad financial experience in Cement Roadstone Holdings, a major Irish building materials organization. Mr. Brennan also spent a number of years in public accounting with PwC. Mr. Brennan is a Fellow of the Institute of Chartered Accountants in Ireland and holds a bachelor&#8217;s degree in Accounting and Finance from Dublin City University. Over his years in the CRO industry, Mr. Brennan has been involved in many industry organizations and developments including ACRO (Association of Clinical Research Organizations) where he was the founding Chairman of the industry CFO round table group, a group formed to aid CROs dealing with the various industry challenges. Mr. Brennan held the position of Chairman&#160;of the round table from its foundation in 2017 to December 31, 2019.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">R&#243;n&#225;n Murphy</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as an outside Director of the Company since October 2016.&#160;He was appointed as Lead Independent Director in January 2019. Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992. Mr. Murphy is presently Chairman of Greencoat Renewables PLC and a non-executive Director of Davy Stockbrokers. Mr. Murphy currently serves as a council member of the ESRI and as Chair of Business in the Community Ireland. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Dr. John Climax</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009 and as Chief Executive Officer from June 1990 to October 2002.&#160;Since January 2010 he has held a position as an outside Director of the Company.&#160;Dr. Climax has over 30 years of experience in the clinical research industry. Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his Ph.D. in pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland and an honorary professorship at the National University of Singapore. He is currently Executive Chairman of DS Biopharma and CEO of Afimmune, both of which are private companies.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Joan Garahy&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Joan Garahy was appointed as an outside Director of ICON plc in November 2017. Ms. Garahy is a Non-Executive Director of UNICEF Ireland, Irish Residential Properties REIT plc, and IPB Insurance CLG. Ms. Garahy&#8217;s previous executive roles include founder and CEO of ClearView Investment &amp; Pensions Limited, a financial advisory company, Managing Director of HBCL Investment &amp; Pensions Ltd, Director of Investments at HC Financial Services Group, Head  of Research at the Irish National Pension Reserve Fund,  Head of Research at Hibernian Investment Managers and her equity analyst roles with Goodbody Stockbrokers and NCB Group. Ms. Garahy was also previously Senior Independent non-executive Director of Kerry Group plc and a non executive director at Galway University Foundation and she is currently a member of the board of The Irish Chamber Orchestra. Ms. Garahy is a Qualified Financial Advisor, she holds a Bachelor of Science degree from University College Galway, a Master of Science from University College Dublin and a Diploma in Accounting &amp; Finance from ACCA.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Eugene McCague</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague was appointed as an outside Director of the Company in October 2017. Mr. McCague was a corporate partner of Arthur Cox, one of Ireland&#8217;s premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and chairman of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations. Mr. McCague currently serves on the board of the Irish branch of AON Insurance and he also serves as chairman of Ibec, Ireland&#8217;s leading business representative association. Mr. McCague&#8217;s previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, chairman of the governing body of the Dublin Institute of Technology, chairman of the Dublin Institute of Technology Foundation and chairman of the governing authority of University College Dublin and director of Fly Leasing Limited. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006. Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin.&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Julie O&#8217;Neill</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O&#8217;Neill has served as an outside Director of ICON plc since July 2019. Ms. O&#8217;Neill was formerly Executive Vice President, Global Operations of Alexion Pharmaceuticals, Inc., where she was responsible for global manufacturing operations and expanding and improving supply chain and quality operations in the US, Europe, and Asia. Before joining Alexion, Ms. O&#8217;Neill was Vice President of Operations and General Manager for Ireland at Gilead Sciences and earlier in her career, Ms. O'Neill held leadership positions in operations, manufacturing and quality functions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. Ms. O&#8217;Neill serves as a Board Member of DBV Technologies, Hookipa Pharma Inc.,ILC Dover, Achilles Therapeutics plc and Angus Chemical Company. She also chairs the board of Ireland&#8217;s National Institute for Bioprocessing Research and Training. Ms. O&#8217;Neill holds a Bachelor of Science in Pharmacy from Trinity College Dublin, a Masters of Business Administration from University College Dublin and is a Chartered Director of The Institute of Directors in Ireland. Ms. O'Neill is also a member of the Strategy Committee of the State Claims Agency.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as an outside Director of ICON plc since July 2021 having previously served as a member of the PRA Health Sciences board from October 2015 to July 2021. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc. from June 2012 to December 2017. Prior to her employment by Ocera, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich &amp; Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Corvus Pharmaceuticals and Arca Biopharma, Inc. and sits on the compensation and audit committees of Arca Biopharma, Inc. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Diarmaid Cunningham</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel and Company Secretary. Mr. Cunningham joined the Company as General Counsel in November 2009.  From 2009 until 2013, Mr. Cunningham was based in the Company&#8217;s global headquarters in Dublin.  In 2013, Mr. Cunningham was seconded to the Company&#8217;s US headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin. In July 2016, Mr. Cunningham&#8217;s role expanded to include Chief Administrative Officer in addition to General Counsel. This expansion of his role means Mr. Cunningham has responsibility to the Company&#8217;s Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company&#8217;s Legal group. Mr. Cunningham graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997, qualified as a lawyer in 2001 and completed the Stanford Executive Program at Stanford University in California in 2015.  Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013, 2014, 2020 and 2021. ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups. Prior to joining the Company, Mr. Cunningham spent 10 years with A&amp;L Goodbody, one of Ireland's premier corporate law firms. In January 2021, Mr. Cunningham was appointed as a non-executive director of the Irish charity The Jack &amp; Jill Foundation. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board Diversity Matrix</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.690%"><tr><td style="width:1.0%"></td><td style="width:51.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board Diversity Matrix (As of February 24, 2023)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Number of Directors</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part I: Gender Identity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Male</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part II: Demographic Background</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LGBTQ+</span></td><td colspan="6" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Did Not Disclose Demographic Background</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:67.690%"><tr><td style="width:1.0%"></td><td style="width:51.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board Diversity Matrix (As of July 27, 2022)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Number of Directors</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part I: Gender Identity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Female</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Male</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part II: Demographic Background</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asian</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">White</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LGBTQ+</span></td><td colspan="6" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Did Not Disclose Demographic Background</span></td><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Compensation Discussion &amp; Analysis </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Remuneration policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Organization Committee seeks to achieve the following goals with the Company&#8217;s executive compensation programs: to attract, motivate and retain key executives and to reward executives for value creation. The Committee seeks to foster a performance-oriented environment by ensuring that a significant portion of each executive&#8217;s cash and equity compensation is based on the achievement of performance targets that are important to the Company, its shareholders and other stakeholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executive compensation program has three main elements: base salary, a bonus plan and equity incentives in the form of share related awards granted under the Company&#8217;s equity incentive plans. All elements of key executives&#8217; compensation are determined by the Compensation and Organization Committee based on the achievement of the Group&#8217;s and individual performance objectives. Base salary, bonus awards and Directors&#8217; fees were determined by the Compensation and Organization Committee in U.S. dollars or euro.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outside Directors&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are remunerated by way of Directors&#8217; fees and are also eligible for participation in the share equity incentive schemes. During 2022, each outside Director (excluding the Board Chairman) was paid an annual retainer of $90,000 and additional fees for Board Committee service. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Murray&#8217;s Executive Chairman term expired on May 12, 2018 and he transitioned to the outside Director role of Chair. The current arrangement with the Chair provides for payment of &#8364;330,000 (translated at average rate for the year: $346,891) annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019 and receives an additional annual </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">fee of $25,000 for this </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">role.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are not eligible for performance related bonuses and no pension contributions are made on their behalf. The Compensation and Organization Committee sets outside Directors' remuneration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Executive Directors&#8217; and Key Executive Officers&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash compensation is divided into a base salary portion and a bonus incentive portion. The Committee targets total cash compensation with regard to healthcare/biopharmaceutical companies of similar market capitalization and peer CRO companies, adjusted upward or downward based on individual performance and experience and level of responsibility. The Compensation and Organization Committee believes that the higher the executive&#8217;s level of responsibility within the Company, the greater the percentage of the ex</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ecutive&#8217;s compensation that should be tied to the Company&#8217;s performance. Target bonus incentive for executive officers range between 60% and 125% with actual pay outs for 2022 ranging from 48% to 100%, of salary, based on Group and individual performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A total bon</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">us of $1.5 million was awarded to the following individuals; Dr. Steve Cutler Chief Executive Officer ($1.2 million) and Mr. Brendan Brennan Chief Financial Officer ($0.3 million) to reflect their contribution to the performance of the Company during 202</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.&#160;These amounts were approved by the Compensation and Organization Committee and will be paid during the year ended December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executives are eligible to receive equity incentives, including stock options, Restricted Share Units and Performance Share Units, granted under the Company&#8217;s equity incentive plans. If executives receive equity incentive grants, they are normally approved annually at the first scheduled meeting of the Committee in the fiscal year. The grant date and value is determined by the Committee and the number of units granted is determined based on the closing price of the Company's shares on the day of grant. Newly hired executives may receive sign-on grants. In addition, the Committee may, at its discretion, issue additional equity incentive awards to executives if the Committee determines such awards are necessary to ensure appropriate incentives are in place. The equity awards granted to each participant are determined by the Committee at the start of each year based on peer group data, advice from independent compensation consultants, and Committee judgment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All executive officers are eligible to participate in applicable pension plans. The Company&#8217;s contributions are generally a fixed percentage of their annual compensation, supplementing contributions by the executive. The Company has the discretion to make additional contributions if deemed appropriate by the Committee. The Company&#8217;s contributions are determined at the peer group median of comparable Irish companies and peer CRO companies. Contributions to this plan are recorded as an expense in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Third party Agreements and Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has not identified any arrangements or agreements relating to compensation or other payments provided by a third party to ICON&#8217;s directors or director nominees in connection with their candidacy or board service as required to be disclosed pursuant to NASDAQ Rule&#160;5250(b)(3).</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2022</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.477%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension<br/>contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,724</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,515</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">195</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,495</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,132</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,671</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2021</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary *</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension<br/>contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,973&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,753</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,214</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">197</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,300</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,574</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director Compensation</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2022</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:19.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>Compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hugh Brady*</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Climax</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William Hall*</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast*</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colin Shannon**</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linda Grais</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,204</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,497</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,140</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,354</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,991</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Professor Hugh Brady, Professor William Hall and Ms. Mary Pendergast resigned from the Board on July 26, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Mr. Colin Shannon resigned from the Board on December 9, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Summary compensation table - Year ended December&#160;31, 2021</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:19.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.199%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary *</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>Compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hugh Brady</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John Climax</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William Hall</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colin Shannon*</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linda Grais*</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,331</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,598</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,011</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,326</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,935</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Mr. Colin Shannon and Dr. Linda Grais were appointed to the Board on July 1, 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of Compensation Agreements</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employment Contracts, Termination of Employment and Change in Control Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does not have any termination or change of control agreements with its named executive officers other than as set out below and in the agreements relating to their equity incentives which provide for accelerated vesting on change of control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; and Executive Officers&#8217; service agreements and letters of engagement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following information reflects the agreements in effect as of December&#160;31, 2022.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Ciaran Murray</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray has served as Chair of the Board of Directors since May 2018 having served as Executive Chairman of the Board of Directors from March 2017 until May 2018. Mr. Murray served as Chief Executive Officer of the Company from October 2011 until March 2017. Mr. Murray has served as a Director of the Company since September 2011. He previously served as Chief Financial Officer of the Company from October 2005 until October 2011. Mr. Murray entered into an agreement with the Company in respect of his role as Executive Chairman which was effective from March 2017. Mr. Murray&#8217;s Executive Chairman term expired on May 1</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2, 20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 and he transitioned to Chair.  The current arrangement with Mr. Murray provides for the payment to him of fees of  &#8364;330,000 (translated at average rate for the year: $346,891) per annum in respect of his position as Chairman. His prev</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ious service agreement as Executive Chairman included termination pr</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ovisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions which still apply. As Chief Financial Officer, Chief Executive and Executive Chairman, Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units.  The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018 were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018. He was previously granted and held at February&#160;24, 2023 58,646 ordinary share options at exercise prices ranging from $71.95 to $125.74 per share and 1,388 Restricted Share Units, which vest in May 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler has served as Chief Executive Officer since March 2017 having served as Chief Operating Officer of the Company from January 2014 until March 2017. Prior to his appointment as Chief Operating Officer he served as Group President Clinical Research Services since November 2011. He has served as an Executive Director of the Company since November 2015. The Chief Executive Officer service agreement with Dr. Cutler is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Dr. Cutler is entitled to receive an annual sala</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ry of $1,173,251 effective from April 1, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension contribution, a car allowance of $12,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February&#160;24, 2023 208,885 ordinary share options at exercise prices ranging from $71.95 to $231.68 per share, 18,173 Restricted Share Units which vest on various dates between March 2023 and March 2025 and 32,121 (up to a maximum of 64,242) Performance Share Units which vest between March 2023 and March 2025 subject to the fulfillment of certain performance conditions. His Chief Executive Officer service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside director positions authorized by the Company. The agreement with Dr. Cutler includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions. Dr. Cutler has a separate agreement with the Company in respect to his role as a director of ICON plc. Under the terms of this agreement he is entitled to receive an annual fee of $44,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Brendan Brennan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan has served as Chief Financial Officer since February 2012 having previously served as acting Chief Financial Officer since October 2011.&#160;Prior to this appointment, he served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. The service agreement with Mr. Brennan is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Mr. Brennan is entitled to receive an annual </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">sala</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ry of $621,467 (&#8364;532,032) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">effective from April 1, 2022 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension contribution, a car allowance of &#8364;20,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February&#160;24, 2023 53,105 ordinary share options at exercise prices ranging from $83.47 to $231.68 per share, 3,958 Restricted Share Units, which vest on various dates between March 2023 and March 2025, and 7,048 (up to a maximum of 14,096) Performance Share Units which vest between March 2023 and March 2025 subject to the fulfillment of certain performance conditions. His service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside Director positions authorized by the Board. The agreement with Mr. Brennan includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as Lead Independent Director from January 2019 having served as an outside Director of the Company since October 2016. The current arrangements with Mr. Murphy provide for the payment to him of Directors fees of $147,500 per annum. He was previously granted and held at February&#160;24, 2023 9,622 ordinary share options at an exercise prices ranging from $90.03 to $125.74 and 925 Restricted Share Units, which vest in May 2023.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. John Climax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009. He also served as Chief Executive Officer of the Company from June 1990 to October 2002 and is currently an outside Director of the Company. The current arrangements with Dr. Climax provide for the payment to him of Directors fees of $90,000 per annum. He was previously granted and held at February&#160;24, 2023 33,255 ordinary share options at exercise prices ranging from $65.60 to $125.74 per share and 925 Restricted Share Units, which vest in May 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Joan Garahy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Joan Garahy has served as an outside Director of the Company since November 2017. The current arrangements with Ms. Garahy provide for the payment to her of Directors fees of $122,500 per annum. She was previously granted and held at February&#160;24, 2023 5,005 ordinary share options at an exercise price of $125.74 and 925 Restricted Share Units, which vest in May 2023.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Mr. Eugene McCague</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has served as an outside Director of the Company since October 2017. The current arrangements with Mr. McCague provide for the payment to him of Directors fees of $122,500 per annum. He was previously granted and held at February&#160;24, 2023 5,005 ordinary share options at an exercise price of $125.74 and 925 Restricted Share Units, which vest in May 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ms. Julie O'Neill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O'Neill </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has served as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">an outside Director of the Company since July 2019. The current arrangements with Ms. O'Neill provide for the payment to her of Directors fees of $115,000 per annum. She was previously granted and held at February&#160;24, 2023 925 Restricted Share Units, which vest in May 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">an outside</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Director of the Company since July 2021 having served as a member of the PRA Health Sciences, Inc. board since October 2015. The current arrangements with Dr. Grais provide for the payment to her of Director fees of $102,500 per annum. She was previously granted and held at February&#160;24, 2023 925 Restricted Share Units, which vest in May 2023. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Board Practices</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board of Directors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">business of the Company is managed by the Directors who may exercise all the powers of the Company which are not required by the Companies Act 2014 of Ireland or by the Constitution of the Company to be exercised by the Company in general meeting.  A meeting of Directors, at which a quorum is present, may exercise all powers exercisable by the Directors. The Directors may delegate (with power to sub-delegate) to any Director holding any executive office and to any Committee consisting of one or more Directors, together with such other persons as may be appointed to such Committee by the Directors, provided that a majority of the members of each Committee appointed by the Directors shall at all times consist of Directors and that no resolution of any such Committee shall be effective unless two of the members of the Committee present at the meeting at which it was passed are Directors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board comprises one executive and seven outside Directors at the date of this report.&#160;T</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">he outside Directors bring independent judgment to bear on issues of strategy, performance, resources, key appointments and standards.&#160;The Company considers all of its outside Directors to be of complementary skills, experience and knowledge and each outside Director has specific skills, experience and knowledge that are valuable to the Company. The Board members between them have strong financial, pharmaceutical, CRO, scientific, medical and other skills and knowledge which are harnessed to address the challenges facing the Group. The Board meets regularly throughout the year and all Directors have full and timely access to the information necessary for them to discharge their duties.  The Directors have acces</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s to the advice and services of the Company Secretary and may seek external independent professional advice where required. The Board considers its current size (8 Directors) to be adequate but continues to look for suitable qualified potential candidates to join the Board.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As set out below, certain other matters are delegated to Board Committees and all Board Committees report to the Board. The Company maintains what it considers an appropriate level of insurance cover in respect of legal action against its Directors. The Board, through the Nominating, Sustainability and Governance Committee, engages in succession planning for the Board and in so doing considers the strength and depth of the Board and the levels of knowledge, skills and experience of the Directors necessary for the Company to achieve its objectives. The Board meets at least four times each year. During the year ended December&#160;31, 2022 the Board held five board meetings. All Directors allocated sufficient time to the Company during the year ended December&#160;31, 2022 to effectively discharge their responsibilities to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; retirement and re-election</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company&#8217;s Constitution provides that, unless otherwise determined by the Company at a general meeting, the number of Directors shall not be more than 15 nor less than 3. The Constitution also provides that one third of the Directors who are subject to retirement by rotation, rounded down to the next whole number if it is a fractional number, shall retire from office at each annual general meeting. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Board of Directors adopted a Non-Executive Director Policy for Service on April 24, 2018. The Policy was amended on April 21, 2020 and provides that, subject to individual waiver by the Board, an outside Director of ICON plc shall serve on the Board of the Directors for an initial term which expires at the fourth annual general meeting after their appointment. Each outside director may serve a further term of 3 years, subject to the Board&#8217;s approval. After the second 3 year term the Board may request that the outside Director serve up to 3 further terms of 1 year each. After a third 1 year term the Board may request that the outside director serve for further 1 year terms in the event that the Board has particular requirement or desire for the outside director&#8217;s skill, knowledge or experience. For an outside Director who previously served as an executive of the Company, the initial 3 year term referred to in this policy is deemed to commence on the date that he/she is determined to be independent as per the NASDAQ Rules. This policy does not apply to Dr. John Climax as he is a founder of the Company.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at the Annual General Meeting (AGM). Accordingly, at the AGM of the Company to be held in 2023, all directors will retire and offer themselves for re-election.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Lead Independent Director </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors adopted a Lead Independent Director Charter on February 14, 2017 which provides that in circumstances where the Chairman of the Board is not independent, the independent members of the Board of Directors shall appoint, from among their number, a Lead Independent Director. The Lead Independent Director shall generally assist in optimizing the effectiveness and independence of the Board of Directors by performing such duties as described in the charter, on behalf of the Board of Directors, including coordinating the meetings of the other non-employee and independent directors, and such other duties as determined from time to time by the Board of Directors and/or its independent members. Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board Committees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Board has delegated some of its responsibilities to Board Committees. There are currently four Committees. These are the Audit Committee, the Compensation and Organization Committee, the Nominating, Sustainability and Governance Committee and the Execution Committee. The Integration Committee was retired by the Board on April 26, 2022. Each Committee has been charged with specific responsibilities and each has written terms of reference that are reviewed periodically. Minutes of Committee meetings are available to all members of the Board. The Company Secretary is available to act as secretary to each of the Board Committees if required. Appropriate key executives are regularly invited to attend meetings of the Board Committe</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">es. The Audit Committee, Compensation and Organization Committee and Nominating, Sustainability and Governance Committee each completed a self-evaluation of the performance of the Committee in respect to th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">e year ended December 31, 2021 and each </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Committee was satisfied with their performance. The evaluations in respect to the year ended December&#160;31, 2022 will be completed in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee meets a minimum of four times a year. It reviews the quarterly and annual financial statements, the effectiveness of the system of internal control and recommends the appointment and removal of the external auditors. It monitors the adequacy of internal accounting practices and addresses all issues raised and recommendations made by the external auditors.  The Audit Committee pre-approves all audit and non-audit services provided to the Company by its external auditors on a quarterly basis. The Audit Committee, on a case by case basis, may approve additional services not covered by the quarterly pre-approval, as the need for such services arises. The Audit Committee reviews all services which are provided by the external auditor to review the independence and objectivity of the external auditor, taking into consideration relevant professional and regulatory requirements. The Chief Financial Officer, the Head of Internal Audit, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Chief Administrative Officer and General Counsel</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and the external auditors normally attend all meetings of the Audit Committee and have direct access to the Committee Chairperson at all times. The Audit Committee is currently comprised of three independent Directors: R&#243;n&#225;n Murphy (Chairperson), Eugene McCague and Julie O'Neill. On April 26, 2022, Hugh Brady stepped down as a member of the Committee and Julie O'Neill joined the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Organization Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Organization Committee is responsible for senior executive remuneration. The Committee aims to ensure that remuneration packages are competitive so that individuals are appropriately rewarded relative to their responsibility, experience and value to the Company.  Annual bonuses for the executive Directors and senior executive management are determined by the Committee based on the achievement of the Company&#8217;s objectives. The Committee also oversees succession planning for the Company&#8217;s senior management. The Compensation and Organization Committee is currently comprised of the following independent Directors:  Joan Garahy (Chairperson), R&#243;n&#225;n Murphy and  Linda Grais. On April 26, 2022, William Hall and Mary Pendergast stepped down as members of the Committee and Linda Grais joined the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Nominating, Sustainability and Governance Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Nominating, Sustainability and Governance Committee is responsible for Board succession, oversight of the Board and committee composition and performance and oversight of the Company's corporate governance and business ethics initiatives and strategies and activities in respect to environmental, social and governance (ESG) matters.  The Committee reviews the membership of the Board of the Company and Board Committees on an ongoing basis. As part of this, it regularly evaluates the balance of skills, knowledge and experience on the Board and then, based on this evaluation, identifies and, if appropriate, recommends individuals to join the Board of the Company. The Committee uses external search consultants as needed to assist it in identifying potential new outside Directors. Once potential suitable candidates are identified either by the external search consultants or by members of the Nominating, Sustainability and Governance Committee, the Committee then discusses and considers the skills, knowledge and experience of the potential candidate. The Committee will assess if the Board of the Company requires and would benefit from the potential candidate&#8217;s skills, knowledge and experience and, if it decides the potential candidate is suitable, the Committee would recommend to the Board of the Company that the potential candidate be appointed. The Board of the Company then decides whether or not to appoint the candidate. The Committee considers diversity of the Board members when making recommendations to the Board of the Company. The Committee Charter was updated in February 2022 to include specific responsibilities in respect to the oversight of the Company's strategic plans, objectives and risks relating to ESG matters. The Committee changed its name to Nominating, Sustainability and Governance Committee in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">April 2022.  The Nominating, Sustainability and Governance Committee currently comprises the following independent Directors: Eugene McCague (Chairperson), Joan Garahy and Julie O'Neill. On April 26, 2022, William Hall stepped down as a member of the Committee and Julie O'Neill joined the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Integration Committee </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Integration Committee was set up in April 2021 to assist the Board with its oversight responsibilities in relation to the integration of PRA Health Sciences into the ICON Group. The Integration Committee was retired by the Board on April 26, 2022. Matters that were in the remit of the Integration Committee are now delivered by Management to the full Board.  During 2022, up to its retirement in April, the Integration Committee was comprised of the following independent Directors: Ciaran Murray (Chairperson), R&#243;n&#225;n Murphy, Eugene McCague and Julie O'Neill. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Execution Committee</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The primary function of the Execution Committee is to exercise the powers and authority of the Board in intervals between meetings of the Board within the limits set out in the Charter of the Execution Committee. The Execution Committee exercises business judgment to act in what the Committee members reasonably believe to be in the best interest of the Company and its shareholders. All powers exercised by the Execution Committee are ratified at board meetings. This Committee convenes as often as it determines to be necessary or appropriate. The Execution Committee is currently comprised of the following Directors and Officers: Steve Cutler (Chairperson), R&#243;n&#225;n Murphy and Brendan Brennan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attendance at Board and Committee meetings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Attendance at Board and Committee meetings by the Directors who held office during 2022 are set out as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Directors&#8217; Attendance Table</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation<br/>and<br/>Organization</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating, Sustainability<br/>and<br/>Governance</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Integration (3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director</span></td><td colspan="15" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of meetings attended / number of meetings eligible to attend as a Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prof. Hugh Brady (1) (4)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prof. William Hall (1) </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary Pendergast (1) </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colin Shannon (5)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais (1)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">Independent Director as defined under NASDAQ Rule 5605(a)(2). </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">All decisions by the Execution Committee were made by written resolution and therefore no meetings were held.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">The Integration Committee was retired on April 26, 2022. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">Professor Hugh Brady, Professor William Hall and Ms. Mary Pendergast resigned from the Board on July 26, 2022.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%;padding-left:7.02pt">Mr. Colin Shannon resigned from the Board on December 9, 2022.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 we employed approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">tely 41,100, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38,330 and 15,730 people respectively. Our employees are not unionized and we believe we have a satisfactory relationship with our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Share Ownership</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Shares</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information a</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s of February&#160;24, 2023 reg</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">arding beneficial ownership of our ordinary shares by all of our current Directors and executive officers. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>Shares (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">509,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Julie O'Neill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in these tables, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e. the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;24, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> regarding beneficial ownership of Restricted Share Units (&#8220;RSUs&#8221;) and Performance Share Units (&#8220;PSUs&#8221;) which have been issued to our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>RSUs </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,388</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,202&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,425&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">622</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">622</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy </span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 21, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:7.02pt">Of the issued PSUs, performance conditions will determine how many vest. If performance targets are exceeded, additional PSUs will be issued and will vest in accordance with the terms of the relevant PSU award. The PSUs vest based on service and specified EPS targets over the periods 2020 &#8211; 2022, 2021 &#8211; 2023 and 2022 - 2024. Depending on the actual amount of EPS from 2020 to 2024, up to a maximum of 39,169 additional PSUs may also be granted to Dr. Steve Cutler and Mr. Brendan Brennan.</span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information a</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s of February&#160;24, 2023 reg</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">arding options to acquire ordinary shares of the Company by all of our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Ciaran Murray</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,948&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$71.95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="7" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,128&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$71.95&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 4, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$83.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$115.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$231.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2030</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="6" style="border-top:1pt solid #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Brendan Brennan</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$83.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$115.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$231.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2030</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. R&#243;n&#225;n Murphy </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,617&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="4" style="border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$68.39&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #929292;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 18, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$65.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 20, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ms. Joan Garahy</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #6d6d6d;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mr. Eugene McCague</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:1pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:1pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:1pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:1pt solid #929292;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:1pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The title of securities covered by all of the above options are </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">non-qualified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2018, the Board approved the appointment of Mr. Murray as Chair of the Board of Directors with effect from May 12, 2018. Mr. Murray ceased to be an employee of the Company as of this date. Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units as Chief Financial Officer, Chief Executive Officer and Executive Chairman. The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee (May 12, 2018) were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 31. 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018.     </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or Non-Executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to Non-Executive Directors vest over twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the &#8220;2013 RSU Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan.&#160;On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of ordinary shares that can be issued under the RSU Plan by 2.5 million shares.&#160;Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the &#8220;2008 Employee Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the &#8220;2008 Consultants Plan&#8221;), pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any consultant, adviser or Non-Executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the &#8220;2008 Option Plans&#8221;) were amended and restated in order to increase the number of options&#160;that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan under which a limit of 1.0 million shares applies.&#160;Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans will be a nonqualified stock option, or NSO and not an incentive stock option as described in Section 422&#160;of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however, option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share option awards are granted with an exercise price equal to the market price of the Company&#8217;s shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. Share options granted to Non-Executive Directors during 2018 vest over 12 months and expire eight years from the date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Legacy PRA Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021 as to grants of future awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#8220;the 2020 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#8220;2014 Plan&#8221;). On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2013 Stock Incentive Plan for Key Employees of PRA Health Sciences and its Subsidiaries was amended and restated and assumed by the Registrant effective as of July 1, 2021 (the &#8220;2013 Plan&#8221;). On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_64"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 7. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Major Shareholders and Related Party Transactions.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Major Shareholders</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information regarding beneficial ownership of ICON's ordinary shares as of February&#160;24, 2023&#160;(i) by each person that beneficially owns more than 5% of the outstanding ordinary shares, based upon information known to</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> us and publicly available information; and (ii) by all of our current Directors, officers and other key employees as a group. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law. None of the persons listed below have voting rights that differ from any other person listed below.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.044%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 (4)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 (5)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 (6)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or Identity of Group</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Massachusetts Financial Services Company (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,119,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,228,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,268,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">WCM Investment Management (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,885,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,179,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,976,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Directors, officers and other key employees as a group&#160;(3)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,129,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,152,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in this table, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Neither the Company nor any of its officers, Directors or affiliates holds any voting power in this entity.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes 401,416 ordinary shares issuable upon the exercise of stock options granted by the Company, 31,940 RSUs awarded by the Company to Directors, officers and other key employees and 88,074 PSUs awarded by the Company to Directors, officers and other key employees. Of the PSUs, performance conditions determine how many of them will vest and, if performance targets are exceeded, additional PSUs will be issued and vest in accordance with the terms of the relevant PSU award, the figure included is the maximum amount of PSUs that may be issued.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No. 2, filed with the SEC by Massachusetts Financial Services Company on February 8, 2023 for shares held on December 30, 2022; and the Schedule 13G/ Amendment No. 8 filed with the SEC by WCM Investment Management on February 10, 2023 for shares held on December 31, 2022, respectively.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No. 1, filed with the SEC by Massachusetts Financial Services Co on February 2, 2022 for shares held on December 31, 2021; and the Schedule 13F filed with the SEC by WCM Investment Management on January 26, 2022 for shares held on December 31, 2021; respectively.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13F/ Amendment No. 1 filed with the SEC by  Massachusetts Financial Services Company on May 12, 2021 for shares held on December 31, 2020; and the Schedule 13F, Amendment No. 1, filed with the SEC by WCM Investment Management on February 23, 2021 for shares held on December 31, 2020; respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc, is not directly or indirectly, owned or controlled by another corporation or by any government. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Related Party Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $2,000 (December&#160;31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year ended December&#160;31, 2022. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December&#160;31, 2022 (December&#160;31, 2021: $12,000).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $235,000 (December&#160;31, 2021: $551,000) from Afimmune Limited during the year ended December&#160;31, 2022. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December&#160;31, 2022 (December&#160;31, 2021: $197,000).&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year ended December&#160;31, 2022. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December&#160;31, 2022 (December&#160;31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December&#160;31, 2022 (December&#160;31, 2021: $264,000).&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1&#160;million and $2.2&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3&#160;million of pro rata losses.  The remaining $0.8&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare to $9.2 million. At December&#160;31, 2022  accrued interest of $183,000 remained outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Interests of experts and counsel</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_67"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 8. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Financial Information.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Consolidated Statements and Other Financial Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 18.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We do not expect any current litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Dividend Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have not paid cash dividends on our ordinary shares and do not currently intend to pay cash dividends on our ordinary shares in the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Significant Changes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no significant changes to our business that we believe could reasonably be expected to have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 9. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; The Offer and Listing.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Offer and listing details</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.&#160;ICON plc&#8217;s American Depositary Receipt ("ADR") program was terminated on January 31, 2013 and ICON plc&#8217;s ordinary shares began directly trading on NASDAQ on February 4, 2013.&#160;Prior to that date, ICON plc&#8217;s American Depositary Shares ("ADSs") were traded on NASDAQ and ICON plc&#8217;s Depository for the ADSs was The Bank of New York Mellon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Plan of distribution</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Markets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Selling shareholders</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Dilution </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Expenses of the issue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> Additional Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Share Capital</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Memorandum and articles of association </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Constitution </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We hereby incorporate by reference our Constitution, as amended, located under the heading &#8220;Constitution of the Company&#8221; in Exhibit 3.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of certain provisions of the current Constitution of the Company. This summary does not purport to be complete and is qualified in its entirety by reference to the complete text of the Constitution of the Company, which are included as an exhibit to this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Objects</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is incorporated under the name ICON&#160;plc, and is registered in Ireland under registered number&#160;145835. The Company's objects, which are detailed in the Constitution of the Company, are broad and include, but are not limited to the carrying on the business of an investment holding company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subject to certain exceptions, Directors may not vote on matters in which they have a material interest. Any Director who holds any executive office, serves on any Committee or otherwise performs services, which, in the opinion of the Directors, are outside the scope of the ordinary duties of a Director, may be paid such extra remuneration as the Directors may determine. The Directors may exercise all the powers of the Company to borrow money. These powers may be amended by special resolution of the shareholders.  There is no requirement for Directors to hold shares set out in the Constitution. The Directors are not required to retire at any particular age. The Constitution provides that one-third of the Directors must retire and offer themselves for re-election at each Annual General Meeting ("AGM") of the Company and that the Directors to retire by rotation are those who have been longest in office since their last appointment or reappointment. However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at each AGM. All of the shareholders entitled to attend and vote at the AGM may vote on the re-election of Directors.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Rights, Preferences and Dividends Attaching to Shares </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Action Necessary to Change the Rights of Shareholders </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Annual and General Meetings</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Limitations on the Right to Own Shares </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no limitations on the right to own shares in the Constitution of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Share Ownership </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Provisions of the Constitution</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no provisions in the Constitution of the Company:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares; or</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Material Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of each contract (not being a contract entered into in the ordinary course of business) that has been entered into: (a) within the two years immediately preceding the date of this Form 20-F which are, or may be, material to us; or (b) at any time which contain obligations or entitlements which is, or may be, material to us as at the date of this Form 20-F:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Agreement and Plan of Merge</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">r</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 24, 2021, we entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with PRA Health Sciences, Inc. (&#8220;PRA&#8221;), ICON US Holdings Inc., a Delaware corporation and subsidiary of ICON (&#8220;US HoldCo&#8221;), and Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON and US HoldCo (&#8220;Merger Subsidiary&#8221;). On July 1, 2021 (the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;Closing Date&#8221;), pursuant to the terms and subject to the conditions of the Merger Agreement, Merger Sub was merged with and into PRA, with PRA surviving as a subsidiary of ICON and US HoldCo.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of the Merger, each share of PRA common stock issued and outstanding immediately prior to the completion of the Merger (other than shares held by any shareholder who properly demands and perfects his, her or its appraisal rights with respect to such shares and treasury shares held by PRA) was canceled and converted into the right to receive: (i) from ICON, 0.4125 of one ICON ordinary share and (ii) from US Holdco and the surviving corporation $80.00 in cash, without interest.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Equity awards of PRA that are outstanding prior to the effective time of the Merger were generally treated as follows (subject to the terms and conditions set forth in the Merger Agreement):</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Each outstanding PRA stock option and restricted stock unit was assumed by ICON on the same terms and conditions (including vesting conditions) and converted to a stock option or restricted stock unit based on ICON ordinary shares with the number of ICON ordinary shares and exercise price in the case of stock options determined at a conversion ratio as set forth under the Merger Agreement; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Each outstanding share of PRA restricted stock was vested at the Closing and was canceled and converted into the right to receive the per share merger consideration.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foregoing description of the Merger and the Merger Agreement, and the related transactions contemplated thereby, does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Merger Agreement which is attached as Exhibit 2.1 to ICON&#8217;s Current Report on Form 6-K filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 24, 2021 and incorporated herein by reference herein.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's senior secured notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity.  The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25% (with a step up of 0.25% if the first lien net leverage ratio exceeds 4.00 to 1.00). The senior secured term loan facility is subject to a floor of 0.50%. The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facilities) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. In addition, the revolving credit loan facility contains a financial covenant that requires ICON to maintain a Total Net Leverage Ratio (as defined in the Senior Secured Credit Facilities) of 5.75:1.00 prior to June 30, 2023 and 4.50:1.00 on and after June 30, 2023, subject to a step-down of 0.50:1.00 following a Material Acquisition (as defined in the Senior Secured Credit Facilities), which will be tested at the end of any fiscal quarter only if amounts are drawn under the revolving credit loan facility (excluding cash collateralized and backstopped letters of credit) in excess of 30% of the revolving commitments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities provide that, upon the occurrence of certain events of default, the obligations thereunder may be accelerated. Such events of default will include payment defaults to the lenders thereunder, material inaccuracies of representations and warranties, covenant defaults, cross-defaults to other material indebtedness, voluntary and involuntary bankruptcy proceedings, material money judgments, material pension-plan events, change of control and other customary events of default.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, Indigo Merger Sub, Inc. (which was merged with and into PRA Health Sciences, Inc.) (the &#8220;Issuer&#8221;), a wholly-owned subsidiary of the Company, issued $500.0 million in aggregate principal amount of 2.875% senior secured notes due July 2026 (the &#8220;Senior Secured Notes&#8221;) in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. The Issuer will pay interest on the Senior Secured Notes on January 15 and July 15 of each year. Interest on the Senior Secured Notes will accrue at a rate of 2.875% per annum.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries that guarantee the Senior Secured Credit Facilities. The Senior Secured Notes are secured by a lien on substantially all of ICON&#8217;s, the Issuer&#8217;s and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Notes have a first-priority lien on such assets, which rank pari passu with the liens securing the Senior Secured Credit Facilities, subject to other permitted liens.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At any time prior to July 15, 2023, the Issuer may redeem all or part of the Senior Secured Notes at a redemption price equal to 100% of the principal amount of the Notes plus an applicable make whole premium and accrued and unpaid interest to, but not including the redemption date. At any time prior to July 15, 2023, the Issuer may, with the proceeds of certain equity offerings, redeem up to 40% of the aggregate principal amount of the Senior Secured Notes at a redemption price of 102.875% of the principal amount plus accrued and unpaid interest to, but not including, the date of redemption. In addition, at any time and from time to time prior to July 15, 2023, the Issuer may redeem up to 10% per annum of the aggregate principal amount of the Senior Secured Notes at a redemption price of 103.000% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Indenture contains contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. The Indenture contains customary events of default and remedies.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Exchange Controls and Other Limitations Affecting Security Holders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Irish exchange control regulations ceased to apply from and after December 31, 1992. Except as indicated below, there are no restrictions on non-residents of Ireland dealing in domestic securities, which includes shares or depository receipts of Irish companies. Except as indicated below, dividends and redemption proceeds also continue to be freely transferable to non-resident holders of such securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 gives power to the Minister for Finance of Ireland to make provision for the restriction of financial transfers between Ireland and other countries and persons. Financial transfers are broadly defined, and include all transfers which would be movements of capital or payments within the meaning of the treaties governing the European Communities. The acquisition or disposal of shares issued by an Irish incorporated company and associated payments may fall within this definition. In addition, dividends or payments on redemption or purchase of shares and payments on a liquidation of an Irish incorporated company would fall within this definition.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 prohibits financial transfers involving a number of persons, entities and bodies, which is subject to amendment on an ongoing, regular basis and currently includes, but is not limited to: certain persons and activities in Belarus, Bosnia &amp; Herzegovina, Burundi, Sudan, South Sudan, the Central African Republic, Libya, Lebanon, Mali, the Democratic People's Republic of Korea, Myanmar/Burma, Tunisia, Zimbabwe, Venezuela, certain persons, entities and bodies in the Syrian Arab Republic, the Republic of Guinea-Bissau, Nicaragua, Democratic Republic of Congo, Iran, Ukraine and Russia; persons associated with the Taliban in Afghanistan, associated with ISIL (Da&#8217;esh) and Al-Qaeda, associated with Turkey&#8217;s unauthorized drilling activities in the Eastern Mediterranean and certain known terrorists and terrorist groups and countries that harbor certain terrorist groups, without the prior permission of the Central Bank of Ireland.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no restrictions under the Company&#8217;s Constitution or under Irish Law that limit the right of non-residents or foreign owners to hold the Company&#8217;s ordinary shares or vote at general meetings of the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Taxation </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The following discussion is based on existing Irish tax law, Irish court decisions and the practice of the Revenue Commissioners of Ireland, and the convention between the United States and Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to taxes on income and capital gains (the "Treaty"). This discussion does not purport to deal with the tax consequences of owning the ordinary shares for all categories of investors, some of which may be subject to special rules. Prospective purchasers of ordinary shares are advised to consult their own tax advisors concerning the overall tax consequences arising in their own particular situations under Irish law. Each prospective investor should understand that future legislative, administrative and judicial changes could modify the tax consequences described below, possibly with retroactive effect.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As used herein, the term "U.S. Holder" means a beneficial owner of ordinary shares that (i) owns the ordinary shares as capital assets; (ii) is a U.S. citizen or resident, a U.S. corporation, an estate the income of which is subject to U.S. federal income taxation regardless of its source or a trust that meets the following two tests: (A) a U.S. court is able to exercise primary supervision over the administration of the trust, and (B) one or more U.S. persons have the authority to control all substantial decisions of the trust; and for the purpose of the discussion under Irish Taxation of U.S. Holders (A) is not a resident of, or ordinarily resident in, Ireland for the purposes of Irish tax; and (B) is not engaged in trade or business in Ireland through a permanent establishment.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">AS USED HEREIN, REFERENCES TO THE ORDINARY SHARES SHALL INCLUDE SHARES HELD IN THE ACCOUNTS OF PARTICIPANTS THROUGH THE DEPOSITARY TRUST COMPANY (&#8220;THE DTC&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Irish Taxation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish corporation tax on income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON is a public limited company incorporated and resident for tax purposes in Ireland by virtue of its place of central management and control being in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Companies which are resident in the Republic of Ireland ("Ireland") are subject to Irish corporation tax on their total profits (wherever arising and, generally, whether or not remitted to Ireland). The question of residence, by virtue of management and control, is essentially one of fact. It is the present intention of the Company's management to continue to manage and control the Company from Ireland, so that the Company will continue to be resident in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The standard rate of Irish corporation tax on trading income (with certain exceptions) is currently 12.5%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">A research and development tax credit is available in Ireland where an Irish resident company incurs qualifying expenditure on research and development activities. Qualifying expenditure incurred in a particular accounting period results in a tax credit of 25% of that expenditure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Corporation tax is charged at the rate of 25% on a company's non-trading income and certain types of trading income not eligible for the lower rate of 12.5% referred to above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capital gains arising to an Irish resident company are liable to tax at 33%. However, a capital gains tax exemption is available in Ireland for qualifying Irish resident companies in respect of disposals of certain qualifying shareholdings.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The exemption from capital gains tax on the disposal of shares by an Irish resident company will apply where certain conditions are met. These conditions principally are:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:13.8pt">The company claiming the exemption must hold (directly or indirectly) at least 5% of the ordinary share capital of the company in which the interest is being disposed of, throughout a continuous period of at least 12 months, in the two-year period prior to disposal;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:13.8pt">The shares being disposed of must be in a company, which at the date of disposal, is resident in a Member State of the European Communities or in a country with which Ireland has signed or made specific arrangements to sign a double tax agreement (together a &#8220;Relevant Territory&#8221;);</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must be in a company which is primarily a trading company or the company making the disposal together with its &#8220;5% plus subsidiaries&#8221; should be primarily a trading group; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must not derive the greater part of their value from land or mineral rights in Ireland.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish withholding tax on dividends</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Unless specifically exempted, all dividends paid by the Company, will be subject to Irish withholding tax. The current rate for dividend withholding tax is 25%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An individual shareholder who is neither resident nor ordinarily resident for tax purposes in Ireland but is resident in a country with which Ireland has a double tax treaty (which includes the U.S.), or in a member state of the European Communities, other than Ireland (together, a Relevant Territory), will be exempt from withholding tax provided he or she makes the requisite declaration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident corporate shareholders will be exempt from withholding tax. Where the shareholding held by the recipient company, in the company paying the dividend is not 51% or greater a declaration must be made to avail of the exemption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-Irish resident corporate shareholders will be exempt from withholding tax on the production of the appropriate certificates and declarations where they:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are resident in a Relevant Territory and are not controlled (directly or indirectly) by Irish residents;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are ultimately controlled (directly or indirectly) by residents of a Relevant Territory;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">have the principal class of their shares, or shares of a 75% parent, substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are wholly owned by two or more companies, each of whose principal class of shares is substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. holders of ordinary shares should note, however, that detailed documentation requirements may need to be complied with. Special arrangements are available in the case of an interest in shares held in Irish companies through a depositary or in accounts of participants through the DTC. In certain cases, the depositary or the DTC can receive and pass on a dividend from an Irish company without deducting withholding tax, provided the depositary or the DTC is a qualifying intermediary, and provided the person beneficially entitled to the distribution would meet the same conditions outlined above for the withholding tax exemption to apply and has provided the qualifying intermediary with the appropriate declarations. The depositary or the DTC shall be regarded as a qualifying intermediary provided the following conditions are met:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC is resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have entered into a qualifying intermediary agreement with the Irish tax authorities (Irish Revenue Commissioners); and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have been authorized by the Irish Revenue Commissioners as a qualifying intermediary and such authorization has not expired or been revoked.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish income tax on dividends</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will generally be liable to Irish income tax on dividend income at their marginal rate of income tax. This income may also be liable to Pay Related Social Insurance (&#8220;PRSI&#8221;) of up to 4% and the Universal Social Charge (&#8220;USC&#8221;) of up to 11% (up to 15% in total).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under certain circumstances, non-Irish resident shareholders will be subject to Irish income tax on dividend income. Where withholding tax of 25% has been deducted, this will fully satisfy the non-Irish resident shareholder&#8217;s tax liability. No PRSI or USC should apply in these circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">However, a non-Irish resident shareholder will not have an Irish income tax liability on dividends from the Company if the holder is neither resident nor ordinarily resident in Ireland and the holder is:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">an individual resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is ultimately controlled by person(s) resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation whose principal class of shares (or its 75% or greater parent&#8217;s principal class of shares) is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation resident in another EU member state or in a Relevant Territory, which is not controlled directly or indirectly by Irish residents; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is wholly owned by two or more corporations each of whose principal class of shares is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. Holders who do not qualify for the above income tax exemption may be able to obtain treaty benefits under the Treaty.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish domicile levy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certain non-Irish resident individuals that are domiciled in Ireland will be subject to an annual levy of &#8364;200,000 if the market value of their Irish-located property on 31 December exceeds &#8364;5,000,000, their worldwide annual income exceeds &#8364;1,000,000 and their liability to Irish income tax in that year is less than &#8364;200,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish capital gains tax on disposal of shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will be liable to capital gains tax at 33% on gains arising from the disposal or part disposal of their shareholding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A person who is not resident or ordinarily resident in Ireland, who has not been an Irish resident within the past five years and who does not carry on a trade in Ireland through a branch or agency will not be subject to Irish capital gains tax on the disposal of ordinary shares or shares held in accounts of participants through the DTC, so long as the shares do not derive the greater part of their value from Irish land or mineral rights</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There are provisions to subject a person who disposes of an interest in a company while temporarily being non-Irish resident, to Irish capital gains tax. This treatment will apply to Irish domiciled individuals:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who cease to be Irish resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who beneficially own the relevant assets when they cease to be resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">if there are not more than 5 years of assessment between the last year of Irish tax residence prior to becoming temporarily non-resident and the tax year that he/she resumes Irish tax residency;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who dispose of the relevant assets during this temporary non-residence; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the interest disposed of represents 5% or greater of the issued share capital of the company or is worth at least &#8364;500,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In these circumstances the person will be deemed, for Irish capital gains tax purposes, to have sold and immediately reacquired the interest in the company on the date of his or her departure and will be subject to tax at 33% of the taxable gain.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Irish capital acquisitions tax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish capital acquisitions tax (referred to as CAT) applies to gifts and inheritances. Subject to certain tax-free thresholds, gifts and inheritances are liable to tax at 33%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Where a gift or inheritance is taken under a disposition made after December 1, 1999 it will be within the charge to CAT:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">to the extent that the property of which the gift or inheritance consists is situated in Ireland at the date of the gift or inheritance;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person making the gift or inheritance is or was resident or ordinarily resident in Ireland at the date of the disposition under which the gift or inheritance is taken;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">in the case of a gift taken under a discretionary trust where the person from whom the gift is taken was resident or ordinarily resident in Ireland at the date he/she made the settlement, or at the date of the gift or, if he/she is dead at the date of the gift, at the date of his/her death; or</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person receiving the gift or inheritance is resident or ordinarily resident in Ireland at the date of the gift or inheritance. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">For these purposes a non-Irish domiciled individual will not be regarded as resident or ordinarily resident in the Republic of Ireland on a particular date unless they are resident or ordinarily resident in Ireland on that date and have been resident for the 5 consecutive tax years immediately preceding the year of assessment in which the date falls.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person who receives the gift or inheritance (&#8220;the beneficiary&#8221;) is primarily liable for CAT. In the case of an inheritance, where a beneficiary and personal representative of the deceased are both non-residents, a solicitor must be appointed to be responsible for paying inheritance tax. Taxable gifts or inheritances received by an individual since December 5, 1991 from donors in the same threshold class are aggregated and only the excess over a specified tax-free threshold is taxed. The tax-free threshold is dependent on the relationship between the donor and the beneficiary and the aggregation since December 5, 1991 of all previous gifts and inheritances, within the same tax threshold.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The tax-free threshold amounts that apply are:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;16,250 in the case of persons who are not related to one another;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;32,500 in the case of gifts or inheritances received from inter alia a brother or sister or from a brother or sister of a parent or from a grandparent; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;335,000 in the case of gifts and inheritances received from a parent (or from a grandparent by a minor child of a deceased child) and specified inheritances received by a parent from a child for gifts or inheritances taken on or after October 9, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gifts and inheritances passing between spouses are exempt from CAT.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A gift or inheritance of the ordinary shares or American Depositary Shares (ADSs) in the Company will be within the charge to CAT, notwithstanding that the person from whom or by whom the gift or inheritance is received is domiciled or resident outside Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Estate Tax Convention between Ireland and the United States generally provides for CAT paid on inheritances in Ireland to be credited against U.S. Federal Estate tax payable in the U.S. and for tax paid in the U.S. to be credited against tax payable in Ireland, based on priority rules set forth in the Estate Tax Convention. The Estate Tax Convention does not apply to CAT paid on gifts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish stamp duty </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish stamp duty, which is a tax on certain documents, is payable on all transfers of ordinary shares (other than between spouses) whenever a document of transfer is executed. Where the transfer is attributable to a sale of shares, stamp duty will be charged at a rate of 1%, rounded to the nearest euro. The stamp duty is calculated on the amount or value of the consideration (i.e. purchase price) or, if the transfer is by way of a gift (subject to certain exceptions) or for consideration less than the market value, on the market value of the shares. Where the consideration for the sale is expressed in a currency other than euro, the duty will be charged on the euro equivalent calculated at the rate of exchange prevailing on the date of the transfer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers through the DTC of book entry interests in shares are not subject to Irish stamp duty.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A transfer of ordinary shares by a shareholder to a depositary or custodian for deposit and a transfer of ordinary shares from the depositary or the custodian for the purposes of the withdrawal of the underlying ordinary shares in accordance with the terms of a deposit agreement will be subject to stamp duty at the 1% rate if the transfer relates to a sale, a contemplated sale, a gift or any other change in the beneficial ownership of such ordinary shares. However, transfers of ordinary shares into or out of the DTC are not subject to Irish stamp duty where no change in beneficial ownership of the shares has occurred and provided a contract for sale in respect of the transferring shares is not in place.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person accountable for payment of stamp duty is normally the transferee or, in the case of a transfer by way of gift, or for a consideration less than the market value, all parties to the transfer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers of ordinary shares between associated companies (broadly, companies within a 90% group relationship and subject to the satisfaction of certain conditions) are exempt from stamp duty in Ireland. In the case of transfers of ordinary shares where no beneficial interest passes (e.g. a transfer of shares from a beneficial owner to his nominee), no stamp duty arises.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">No stamp duty shall arise on the transfer of ordinary shares where the consideration for the transfer does not exceed &#8364;1,000, provided the instrument contains a statement certifying that the transaction does not form part of a larger transaction or a series of larger transactions, in respect of which the amount of the total consideration attributable to the shares would exceed &#8364;1,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Dividends and paying agents</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">G.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:8.5pt">Statement by experts</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">H.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Documents on Display</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and file reports and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC at http://www.sec.gov.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We &#8220;incorporate by reference&#8221; information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">report and more recent information automatically updates and supersedes more dated information contained or incorporated by reference in this report. Our SEC file number for Exchange Act reports is 333-08704.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a foreign private issuer, we are exempt from certain rules under the Exchange Act, including prescribing the furnishing and content of proxy statements to shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We will provide without charge to each person, including any beneficial owner, on the written or oral request of such person, a copy of any or all documents referred to above which have been or may be incorporated by reference in this report (not including exhibits to such incorporated information that are not specifically incorporated by reference into such information). Requests for such copies should be directed to us at the following address: ICON plc, South County Business Park, Leopardstown, Dublin 18, Ireland, D18 X5R3 Attention: Corporate Governance, email: corporate.governance@iconplc.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:13pt">Subsidiary Information</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exemptions From Corporate Governance Listing Requirements Under the NASDAQ Marketplace Rules</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ may provide exemptions from certain NASDAQ corporate governance standards to a foreign private issuer if, among other reasons those standards are contrary to a law, rule or regulation of a public authority exercising jurisdiction over such issuer or contrary to generally accepted business practices in the issuer&#8217;s home country of domicile, provided, that, the foreign private issuer properly notifies NASDAQ and makes the required disclosure except to the extent that such exemptions would be contrary to United States federal securities laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The exemptions that the Company relies on, and the practices the Company adheres to, are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5620(c), which requires each issuer (other than limited partnerships) to provide for a quorum in its by-laws for any meeting of the holders of common stock, which shall in no case be less than 33.33% of the outstanding shares of the issuer&#8217;s common voting stock. The Company&#8217;s Constitution requires that only 3 members be present, in person or by proxy, at a shareholder meeting to constitute a quorum. This quorum requirement is in accordance with Irish law and generally accepted business practices in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5635(c) which requires (other than for certain specified exceptions) shareholder approval prior to the establishment or material amendment of a stock option or purchase plan or other equity compensation arrangement made or materially amended, pursuant to which stock may be acquired by officers, Directors, employees or consultants. Irish law does not require shareholder approval with respect to equity compensation arrangements. Accordingly, the 2019 Consultants and Directors Restricted Share Unit Plan, the 2013 Employees Restricted Share Unit Plan and the amendments to the Employee Share Option Plan 2008 and Consultants Share Option Plan 2008 were adopted by the Board of Directors without shareholder approval.</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5605(b)(2), which requires independent Directors to hold regularly scheduled meetings at which only independent Directors are present. Irish law does not require independent Directors to hold regularly scheduled meetings at which only independent Directors are present. The Company holds regularly scheduled meetings which all of the Directors may attend and the Lead Independent Director may call meetings of the independent Directors and non-employee Directors of the Board, as appropriate, in accordance with the Lead Independent Director Charter.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_76"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Quantitative and Qualitative Disclosures about Market Risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The principal market risks (i.e. risk of loss arising from adverse changes in market rates and prices) to which we are exposed include foreign currency risk and interest rate risk.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a number of foreign currency risks given the global nature of our operations. The principal foreign currency risks to which the business is subject to includes both foreign currency translation risk and foreign currency transaction risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are also subject to foreign currency transaction exposures as the currency in which our contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts may be priced in a single currency, most often U.S. dollars, or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our foreign currency exposures and enter into forward currency contracts to manage our expos</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ure. We had no open foreign currency contracts at December&#160;31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following significant exchange rates applied during the year:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Rate</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro:USD</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.0512</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.0705</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pound Sterling:USD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.2347</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.2083</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to interest rate risk in respect of our cash and cash equivalents and available for sale investments. Our treasury function actively manages our available cash resources and invests surplus cash balances to ensure optimum returns for the Company. Financial instruments are classified either as cash and cash equivalents or available for sale investments depending upon the maturity of the related investment. Funds may be invested in the form of floating rate notes and medium term minimum &#8220;A-&#8221; rated corporate securities. We may be subject to interest rate risk in respect of interest rate changes on amounts invested. Interest rate risk is managed by monitoring the composition of the Company&#8217;s investment portfolio on an ongoing basis having regard to current market interest rates and future trends.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because the Company has variable rate debt, fluctuations in interest rates affect our business.  We attempt to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate cap and interest rate swap derivative agreements.  We have entered into certain inter</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">est rate cap and interest rate swap agreements with three financial institutions with respect to a portion of our outstanding debt.  Accordingly, any change in market value associated with these agreements is offset by the opposite market impact on the portion of the debt covered by such agreements.  As December&#160;31, 2022, we have interest rate cap agreements with a notional value of $2.1&#160;billion to minimize interest rate risk on approximately $4.7&#160;billion of variable rate indebtedness.  Because we do not attempt to hedge all of our variable rate debt, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">we may incur higher interest costs for the portions of our unhedged debt. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We regularly evaluate our debt arrangements, as well as market conditions, and we will explore the opportunity to modify our existing arrangements or pursue additional financing arrangements that may result in the issuance of new debt securities by us or our affiliates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sensitivity analysis below represents the hypothetical change in the net interest payable of a 1% movement in market interest rates.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest for the year ended December 31, 2022 (in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% increase in<br/>market interest rate<br/>(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% decrease in<br/>market interest rate<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,322&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($229,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($277,546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="background-color:#cceeff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($181,982)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($227,386)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($269,224)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($181,981)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*8% of the interest costs fixe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d due to high yield bond issuance. $20.5&#160;million financing fees have been allocated to interest cost which are not impacted by a change in interest rate. </span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_79"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Description of Securities Other than Equity Securities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_82"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part II</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Defaults, Dividend Arrearages and Delinquencies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 14.  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Material Modifications to the Rights of Security Holders and Use of Proceeds.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_91"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 15.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Disclosure controls and procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures as at December&#160;31, 2022. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Management's Annual Report on Internal Accounting Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 95 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Attestation Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 98 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Changes in Internal Controls over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There were no changes in our internal controls over financial reporting during the period covered by this Form 20-F that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reserved.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_97"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16A. Audit Committee Financial Expert</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy acts as the Audit Committee financial expert serving on our Audit Committee and Board of Directors. The Board has determined that Mr. Murphy is independent. </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_100"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16B. Code of Ethical Conduct </span></div><div style="text-align:justify;text-indent:-40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Code of Ethical Conduct applies to all officers, directors (including a non-executive director when carrying out their duties as a director of ICON plc), and employees of ICON plc, its subsidiaries and branches. There are no waivers from the provisions of the Code of Ethical Conduct that are required to be disclosed. This Code of Ethical Conduct is available on our website at: </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">https://investor.iconplc.com/corporate-governance/governance-documents</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16C. Principal Accountant Fees and Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal accountants for the years ended December&#160;31, 2022 and December&#160;31, 2021 were KPMG, Dublin, Ireland (Audit firm ID: <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xMDMvZnJhZzoyZjliNGE0ZTIxOWU0MjE0YTI3YjA3N2I2NzQ3YjMxYy90ZXh0cmVnaW9uOjJmOWI0YTRlMjE5ZTQyMTRhMjdiMDc3YjY3NDdiMzFjXzE1NA_ed68c6ec-949f-4ed6-9d50-ce4b0119d9c2">1116</ix:nonNumeric>). The table below summarizes the fees for professional services rendered by KPMG for the audit of our annual financial statements for the years ended December&#160;31, 2022 and December&#160;31, 2021 and fees billed for other services rendered by KPMG.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2022 <br/>(in thousands)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended <br/>December 31, 2021 <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit fees (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit related fees (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax fees (3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other fees (4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Audit fees include annual audit fees for the Company and its subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Audit related fees principally consist of fees for financial due diligence services, fees for the audit of employee benefit plans and fees for pension reviews. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3) Tax fees are fees for tax compliance and tax consultation services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4) All other fees include the aggregate fees billed for products and services other than the services reported in items (1) through (3) above. There were no other fees amounts billed to the company in the years ended December&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee pre-approves all audit and non-audit services provided to the Company by its auditors.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_106"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16D. Exemptions from the Listing Standards for Audit Committees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2022, 420,530 ordinary shares were redeemed by the Company for a total consideration of $100.0 million. All ordinary shares that are redeemed under the buyback program were canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number<br/>of Shares Purchased</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Price<br/>Paid for Shares Purchased  (in thousands)</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 03/01/2022 - 03/31/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$237.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$99,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$237.75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$99,983&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No ordinary shares were redeemed by the Company during the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the repurchase programs, a broker purchased the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The programs are designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information, applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker were irrevocable and the trading decisions in respect of the repurchase programs were made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the programs. In addition, acquisitions under the programs may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the programs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16F. Changes in Registrant's Certifying Accountant</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_115"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16G. Corporate Governance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 10 "Exemptions from Corporate Governance Listing Requirements under the NASDAQ Marketplace Rules".</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16H. Mine Safety Disclosure</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_2100"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part III</span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 17. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See item 18.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Financial Statements.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following consolidated financial statements of ICON plc and its subsidiaries, and the independent registered public accounting firm's report thereon, are included in Part III, Item 18 of this Annual Report: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_136">Management's Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_136">95</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_139">Reports of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_139">96</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_142">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_142">99</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_145">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_145">100</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_148">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_148">101</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_151">Consolidated Statements of Shareholders' Equity and Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_151">102</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_154">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_154">105</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_157">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_157">106</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's internal control over financial reporting is a process designed by, or under the supervision of, the Company's executive and financial officers and effected by the Company's board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorization of management and Directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the inherent limitation due to, for example, the potential for human error or circumvention of control, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company's </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">internal control over financial reporting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as of December&#160;31, 2022. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework 2013</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Based upon the assessment performed, we determined that, as of December&#160;31, 2022 the Company's internal control over financial reporting was effective.</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes in the Company's internal control over financial reporting during 2022 that have materially affected, or are reasonably likely to affect materially, the Group's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">KPMG, an independent registered public accounting firm, has audited the consolidated financial statements of ICON plc and subsidiaries as of and for the year ended December&#160;31, 2022, included herein, and has issued an audit report on the effectiveness of our internal control over financial reporting, which is included below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:174%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Opinion on the Consolidated Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of ICON plc and subsidiaries (the Company) as of December&#160;31, 2022 and 2021, the related consolidated statements of operation, comprehensive income, shareholders&#8217; equity, and cash flows for each of the years in the three&#8209;year period ended December&#160;31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended December&#160;31, 2022, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February&#160;24, 2023 expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Critical Audit Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition for clinical trial service contracts.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As discussed in Note 3 to the consolidated financial statements, the Company recognized revenue of US$7,741,386 thousand for the year ended 31 December 2022, a portion of which relates to clinical trial service revenue. As discussed in Note 2 to the consolidated financial statements, clinical trial service revenue is recognized over time, using an input measure, being total project costs (inclusive of third-party costs, principally pass-through/ reimbursable expenses) incurred at each reporting period as a percentage of forecasted total project costs, to measure progress towards satisfying the Company&#8217;s performance obligation. The transaction price is based on the contract or latest change order value, adjusted to reflect the estimated realizable contract value.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We identified the evaluation of revenue recognition for clinical trial service revenue as a critical audit matter. Complex and subjective auditor judgment was required to evaluate the Company&#8217;s estimate of total forecast project costs and the estimated realizable contract values.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We evaluated the design and tested the operating effectiveness of certain internal controls related to the revenue process, including controls over total forecast project costs and estimated realizable contract values.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We tested the total forecast project costs and the realizable contract values for a selection of clinical trial service contracts, by evaluating:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">direct costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the direct costs by comparing the amounts to source data</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">third-party costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the third-party costs incurred by comparing the costs to invoices received</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">findings from interviews with operational personnel of the Company to assess progress to date, the estimate of remaining costs to be incurred and factors impacting the amount of time and costs to complete the selected contracts, including an understanding of the nature and complexity of the work to be performed</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">correspondence of amendments to the scope or contract value, if any, between the Company and the customer for the selected contracts as part of our evaluation of contract progress</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">quarterly movements in forecast project costs and project margins and investigating the reasons for those movements, and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:13pt">the reasonableness of the Company&#8217;s adjustments from total contract value to arrive at realizable contract value. We confirmed total contract value with customers and compared the assumptions used to derive the adjustments from total contract value to realizable contract value to underlying records.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also evaluated the Company&#8217;s methods, assumptions and data used to accurately estimate total forecast project costs and realizable contract values, by comparing historical estimates developed at contract inception to actual results for a selection of clinical trial service contracts.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(signed) <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xMzkvZnJhZzo2OGNjZDZmMzEwYWI0M2U5YWM4YWQxZWE2ZDdjMjYxYi90ZXh0cmVnaW9uOjY4Y2NkNmYzMTBhYjQzZTlhYzhhZDFlYTZkN2MyNjFiXzE0MjI1_2b623cc2-6c30-430c-9c8e-fc7054fb7ab1">KPMG</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 1990.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xMzkvZnJhZzo2OGNjZDZmMzEwYWI0M2U5YWM4YWQxZWE2ZDdjMjYxYi90ZXh0cmVnaW9uOjY4Y2NkNmYzMTBhYjQzZTlhYzhhZDFlYTZkN2MyNjFiXzE0MjI2_f67758c9-5e7c-421b-bfdd-1b5db9d5bb4d">Dublin, Ireland</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;24, 2023</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Opinion on Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited ICON plc and subsidiaries&#8217; (the Company) internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2022, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity, and cash flows for each of the years in the three-year period ended December&#160;31, 2022, and the related notes (collectively, the consolidated financial statements), and our report dated February&#160;24, 2023, expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(signed) KPMG</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dublin, Ireland</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;24, 2023</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="6" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMtMS0xLTEtMTQzMjg2_3abae8fe-97e3-47b1-a00d-6a9c4d87952c">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMtMi0xLTEtMTQzMjg2_1af3e668-e25e-46d9-b6c6-e70cfbc3c98c">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (Note 8a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQtMS0xLTEtMTQzMjg2_a0bfbe9a-e101-482e-ba7a-4ded7c6916d9">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQtMi0xLTEtMTQzMjg2_7ea93692-50ab-4eb5-8a63-8627adb1eb8b">1,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUtMS0xLTEtMTQzMjg2_89a7d0f7-7b43-4343-8057-33bfccdf766c">1,731,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUtMi0xLTEtMTQzMjg2_ba2c1ed0-de7e-4b9b-bc6a-802fab91b6ca">1,342,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled revenue (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzYtMS0xLTEtMTQzMjg2_1dfc7e88-d156-4b00-a14a-e901fb50e084">957,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzYtMi0xLTEtMTQzMjg2_e239eda0-ab72-424d-953f-1bd9c82f41d1">623,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzctMS0xLTEtMTQzMjg2_58f3d6ad-e1df-4d60-b5f0-025784d6b6a1">63,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzctMi0xLTEtMTQzMjg2_11d73f0b-6c02-4216-a1bb-2b85d285543b">56,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzgtMS0xLTEtMTQzMjg2_d99c99a1-b3cf-4af0-a8a7-85910a1777c0">137,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzgtMi0xLTEtMTQzMjg2_44a5acba-b6a9-4be5-b100-4ca03373c619">114,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzktMS0xLTEtMTQzMjg2_b317ba99-cdc4-4a2a-8473-8a09252afd47">48,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzktMi0xLTEtMTQzMjg2_77c8a34f-b72d-4fd4-a297-c15d266b40b8">50,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEwLTEtMS0xLTE0MzI4Ng_18e82c5d-f41e-4f28-ba75-595b2a8cbec0">3,229,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEwLTItMS0xLTE0MzI4Ng_97ea6ae4-939b-44a6-aaf9-7fcabfa82164">2,941,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEyLTEtMS0xLTE0MzI4Ng_aceb9edc-0dd4-4852-a6de-c4154398d342">350,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEyLTItMS0xLTE0MzI4Ng_0c64c44c-c7de-4a4c-8ee8-93b812a9fe9f">336,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill (Note 10)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEzLTEtMS0xLTE0MzI4Ng_229dee58-71fe-49f1-93bc-5ede97380bc1">8,971,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEzLTItMS0xLTE0MzI4Ng_77cfc617-e100-4646-b1ad-19c99532f0fa">9,037,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE0LTEtMS0xLTE0MzI4Ng_f8a35823-0f30-4f30-99dd-d9c24ae1ef5f">4,278,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE0LTItMS0xLTE0MzI4Ng_c545ac20-6053-4815-a509-c21a4ed75d88">4,710,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use assets (Note 15)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE1LTEtMS0xLTE0MzI4Ng_e90cf5fa-0059-4926-9bd5-4e5e849c31f4">153,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE1LTItMS0xLTE0MzI4Ng_8b1d6c0d-7447-48f9-93b6-4412bab7d485">198,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE2LTEtMS0xLTE0MzI4Ng_f56fe0e8-697d-4fd7-bc98-022942564afe">70,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE2LTItMS0xLTE0MzI4Ng_94035fcf-6c23-41e9-b5be-1042727ad8f7">70,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE3LTEtMS0xLTE0MzI4Ng_3613ee58-e0d7-4f29-bd78-53a8c5981d62">21,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE3LTItMS0xLTE0MzI4Ng_760b09c0-0dce-43b3-8ccc-dcdf674346bc">18,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax asset (Note 20)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE4LTEtMS0xLTE0MzI4Ng_0b341612-fd3e-43e9-abe4-d02c38e90d84">76,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE4LTItMS0xLTE0MzI4Ng_e887ae9d-6251-403e-8cdf-ac9bca6f43ad">48,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method investments (Note 8c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE5LTEtMS0xLTE0MzI4Ng_3e146d1f-2288-4a72-9a7c-7605638004e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE5LTItMS0xLTE0MzI4Ng_3c1daecd-6799-4cc0-a54a-629444a95b5a">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity-long term (Note 8b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIwLTEtMS0xLTE0MzI4Ng_c23c9e40-954d-4ccb-8b19-cb150ebcea74">32,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIwLTItMS0xLTE0MzI4Ng_65889e5f-a2a3-4287-9d34-73f3395f47a2">22,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIyLTEtMS0xLTE0MzI4Ng_21a0af7b-bd1e-4604-97a0-6965f31dfb35">17,185,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIyLTItMS0xLTE0MzI4Ng_a87074f5-020f-46ff-bef3-dca806162338">17,387,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI1LTEtMS0xLTE0MzI4Ng_6bfda336-0ba4-4814-818f-57759947e159">81,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI1LTItMS0xLTE0MzI4Ng_924dda10-e6fe-48da-8734-9ff551af7757">90,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI2LTEtMS0xLTE0MzI4Ng_e8e8af3a-a98b-485d-9b7e-94bd3b7e1b22">1,507,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI2LTItMS0xLTE0MzI4Ng_08a3b540-9758-4fc5-8d28-3cad8930603e">1,323,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities (Note 12)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI3LTEtMS0xLTE0MzI4Ng_3f711904-3713-46ad-a069-5a68a4255d69">1,005,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI3LTItMS0xLTE0MzI4Ng_b25c2b04-b054-4dea-ae6f-89755defce6d">949,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI4LTEtMS0xLTE0MzI4Ng_bc8b8e5c-1e3f-45da-a03d-6818793fc0b7">41,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI4LTItMS0xLTE0MzI4Ng_e1312e11-c2aa-4172-8e96-f933942f0cd9">59,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current bank credit lines and loan facilities (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI5LTEtMS0xLTE0MzI4Ng_17e59221-4718-40fa-8e0c-aa7ebe3968eb">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI5LTItMS0xLTE0MzI4Ng_4888f8cd-d8b8-4062-b106-870e6775c311">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMwLTEtMS0xLTE0MzI4Ng_da7d6887-049b-4fe3-bbe9-4c83c59687d7">2,690,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMwLTItMS0xLTE0MzI4Ng_72da06c1-e4d2-4d81-99d6-3aa960248f52">2,478,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current bank credit lines and loan facilities (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMyLTEtMS0xLTE0MzI4Ng_c2a504a2-4cd9-4ea2-bab0-3819818c1431">4,599,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMyLTItMS0xLTE0MzI4Ng_a6306a7d-6151-454c-b8f6-21c542a25ab4">5,381,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities (Note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMzLTEtMS0xLTE0MzI4Ng_554c3c81-10c1-4b6c-9177-9bbf7a75aee7">131,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMzLTItMS0xLTE0MzI4Ng_31c54954-2019-438b-b424-d05ca9e652c8">159,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (Note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM0LTEtMS0xLTE0MzI4Ng_77cc15ec-3399-4cc4-908d-da2d1c98e86c">38,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM0LTItMS0xLTE0MzI4Ng_f8214338-3aa1-4d36-86fb-ccd3ed54858a">42,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM2LTEtMS0xLTE0MzI4Ng_ed10d838-fd13-4b96-a392-436a30e8a0dd">239,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM2LTItMS0xLTE0MzI4Ng_0bd8fb3c-21a2-41c3-922e-e2bf96c0630f">172,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability (Note 20)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM3LTEtMS0xLTE0MzI4Ng_e052d9b5-1aad-47ab-96d5-84965a22b645">988,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM3LTItMS0xLTE0MzI4Ng_d4cae769-8f7b-4c89-8eb0-4ae800c9e10e">1,085,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 17)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM4LTEtMS0xLTE0MzI4Ng_bd42ab90-5b46-4ff7-b0fa-c54d9fa572fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM4LTItMS0xLTE0MzI4Ng_dd773053-15e5-4b88-8a83-c48f84a179c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM5LTEtMS0xLTE0MzI4Ng_1083e10d-1988-4595-8b67-394187fe5798">8,687,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM5LTItMS0xLTE0MzI4Ng_7e5d10c7-93c7-4177-9ac9-4a78571afae0">9,320,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders' Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares par value <ix:nonFraction unitRef="eurPerShare" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTc0_05d6c7c2-59a7-4a55-9c85-f72528e2438c"><ix:nonFraction unitRef="eurPerShare" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTc0_a8a026f0-97f1-40e9-90e9-240b5c4ecfbd">6</ix:nonFraction></ix:nonFraction> euro cents per share;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTk4_04cb91d1-dfed-43e4-91bf-96c709cdd0ca"><ix:nonFraction unitRef="shares" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTk4_561d2db3-02ef-4c0d-be19-81a5f48c1b57">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized (Note 18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzQ_3f72b410-ea45-4eb7-8201-3bc33e470bde"><ix:nonFraction unitRef="shares" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzQ_8147ef30-0f00-4aca-b545-51456e668ee3">81,723,555</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2022 and<br/><ix:nonFraction unitRef="shares" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzYy_44916416-5d6a-4242-b0ce-29ef290f0bb2"><ix:nonFraction unitRef="shares" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzYy_7a61356a-cd31-476b-9f37-25be41801377">81,554,683</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2021.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTEtMS0xLTE0MzI4Ng_d8475986-d3fa-4a79-82c8-b32d0991732d">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTItMS0xLTE0MzI4Ng_1900a5bd-f567-4ff2-b376-283492fff36b">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQzLTEtMS0xLTE0MzI4Ng_973f3ffc-a94c-4cd2-a92d-add7d4b28c21">6,840,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQzLTItMS0xLTE0MzI4Ng_f2ebd953-3502-4a17-9a51-3d9d22d84bba">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital (Note 18b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ0LTEtMS0xLTE0MzI4Ng_749cda2b-976e-4caa-b2df-27f4de47de22">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ0LTItMS0xLTE0MzI4Ng_0ee16a4f-9763-4697-a8be-9383f96123f5">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (Note 25)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ1LTEtMS0xLTE0MzI4Ng_ef74c26d-f73e-4979-ba45-82aa7a4a4f22">171,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ1LTItMS0xLTE0MzI4Ng_0c3c5acc-f438-4b54-9109-a3c624de737e">90,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ2LTEtMS0xLTE0MzI4Ng_a0988f27-f10a-480c-93be-9baa52de753b">1,821,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ2LTItMS0xLTE0MzI4Ng_8a077252-7919-442f-a34c-9f80692833fd">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Shareholders' Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ3LTEtMS0xLTE0MzI4Ng_95a3d313-f466-4cba-8edb-1c861454c246">8,497,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ3LTItMS0xLTE0MzI4Ng_60cfe0ad-bd8f-4d33-9bfb-1701306bb98f">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUwLTEtMS0xLTE0MzI4Ng_96b8a031-37f6-4d24-b007-dd6910291725">17,185,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUwLTItMS0xLTE0MzI4Ng_a7df10d1-9f1f-4104-96d0-fd3f7727b697">17,387,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzYtMS0xLTEtMTQzMjg2_f44f4244-9122-489f-a160-875f5060f3b3">7,741,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzYtMi0xLTEtMTQzMjg2_1ccd87fe-481a-46b8-ae75-ff65d3ef13ab">5,480,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzYtMy0xLTEtMTQzMjg2_2a00195f-d354-418a-9e9a-8cdf4efa13de">2,797,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs (excluding depreciation and amortization) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEwLTEtMS0xLTE0MzI4Ng_6d02ec81-4dd1-46d2-bac1-fc7f28741e2c">5,527,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEwLTItMS0xLTE0MzI4Ng_0db2608e-ed17-46a2-a5b4-9e7db0f9b138">3,972,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEwLTMtMS0xLTE0MzI4Ng_5431e8fb-bcfd-4f83-80a9-d42633639316">1,979,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzExLTEtMS0xLTE0MzI4Ng_7bac0778-fbae-4a13-94ef-74a4feef9e35">778,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzExLTItMS0xLTE0MzI4Ng_147dc1e5-b1b1-4479-a4d8-f6bd5d0ac162">585,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzExLTMtMS0xLTE0MzI4Ng_783da2a4-a133-4ac7-84e8-375ada8127c5">342,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEyLTEtMS0xLTE0MzI4Ng_748b9d68-d9a5-4889-a577-308be4d0655d">569,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEyLTItMS0xLTE0MzI4Ng_bb93f457-be5d-43cb-b100-012670f7ae79">314,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEyLTMtMS0xLTE0MzI4Ng_5eb18f91-2e59-47b8-aaea-111a3591ec7c">66,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:BusinessCombinationIntegrationRelatedCostsCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEzLTEtMS0xLTE0MzI4Ng_4078baab-8c43-40ad-919d-b6f7f06a5732">39,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:BusinessCombinationIntegrationRelatedCostsCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEzLTItMS0xLTE0MzI4Ng_f7f3ff09-a6f4-4dde-bcb3-be8013c29cfc">198,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="iclr:BusinessCombinationIntegrationRelatedCostsCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEzLTMtMS0xLTE0MzI4Ng_65852224-2cce-4bc3-a11d-b9bb1d0436f8">759</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring (Note 19)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE0LTEtMS0xLTE0MzI4Ng_26fa7304-9978-48d8-a7e7-c2745ea565f4">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE0LTItMS0xLTE0MzI4Ng_0b9663c1-5d0e-4d13-94a9-bd7cf78c52bd">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE0LTMtMS0xLTE0MzI4Ng_a32f2600-df6f-4f2a-a3b8-3fed9a00264d">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE1LTEtMS0xLTE0MzI4Ng_811a248b-a6f8-44f6-8070-27f76d4af66c">6,946,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE1LTItMS0xLTE0MzI4Ng_aeab1ea8-d7bf-4eea-b397-4606dc6f9f0a">5,102,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE1LTMtMS0xLTE0MzI4Ng_397521c4-d0e7-4262-9d40-f09c1ce5fcee">2,405,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE3LTEtMS0xLTE0MzI4Ng_96f1ab17-721b-4c84-a4b1-6971a8be3bbd">795,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE3LTItMS0xLTE0MzI4Ng_6764a936-773b-405d-b743-18cf8a738efb">378,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE3LTMtMS0xLTE0MzI4Ng_1fdc48f4-bff6-44cc-bf8f-795d17bfd36b">391,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE4LTEtMS0xLTE0MzI4Ng_8e88d42e-d5e0-43d2-881e-85a2cdc3bdcc">2,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE4LTItMS0xLTE0MzI4Ng_43d45fa8-36ed-437b-a95b-406bc615619c">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE4LTMtMS0xLTE0MzI4Ng_4562b23f-8270-4bb9-bdee-09682f4e197f">2,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE5LTEtMS0xLTE0MzI4Ng_b883875b-54dd-406b-b30a-e9a00c29041b">229,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE5LTItMS0xLTE0MzI4Ng_de488128-0c63-4bd2-80ba-3e322adc3a0b">182,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE5LTMtMS0xLTE0MzI4Ng_d7599d2f-083b-406c-888f-42f8e4983a55">13,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIxLTEtMS0xLTE0MzI4Ng_42fccc84-3d39-4c69-9e59-7cbd18262f9e">567,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIxLTItMS0xLTE0MzI4Ng_59939205-36b2-42fc-ade3-fcae97a7deb3">196,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIxLTMtMS0xLTE0MzI4Ng_d4735b70-5b69-4339-8d53-fa3cc78826d0">381,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (Note 20)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIyLTEtMS0xLTE0MzI4Ng_f4227271-fc36-48f4-9157-62d5c50bbdad">59,411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIyLTItMS0xLTE0MzI4Ng_836e85c7-3696-45b3-8c0d-2cb6beeb97b8">41,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIyLTMtMS0xLTE0MzI4Ng_17b28adf-1c8b-44e5-9c94-58665102335c">47,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before share of earnings from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI0LTEtMS0xLTE0MzI4Ng_0e52cebc-19a0-4f52-b8c4-261ded4407ca">508,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI0LTItMS0xLTE0MzI4Ng_2e627668-976a-41a4-af47-688159d5773a">155,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI0LTMtMS0xLTE0MzI4Ng_180bd563-46b6-4581-83d4-ebc90a864b48">333,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI1LTEtMS0xLTE0MzI4Ng_c1a5a5a4-cbfe-461b-a5ef-90a51db5fbcc">3,136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI1LTItMS0xLTE0MzI4Ng_fe759d06-9089-4d2f-9c8b-eaf3b6deb53b">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI1LTMtMS0xLTE0MzI4Ng_4137021f-deae-44a6-973f-eda6d9d8bd7e">366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI3LTEtMS0xLTE0MzI4Ng_3a1d9790-86f8-4364-b2a5-321a151ba552">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI3LTItMS0xLTE0MzI4Ng_ee4a41c6-2f1c-4dd3-9960-338ef09e8b33">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI3LTMtMS0xLTE0MzI4Ng_4a4451ca-19b1-4f1f-a081-7ca1fb8e65c9">332,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI4LTEtMS0xLTE0MzI4Ng_ccd2556d-b6ed-44ef-a3b1-2180cfa0eebe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI4LTItMS0xLTE0MzI4Ng_636bf309-4395-428a-9c7e-5a54d0cda5a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI4LTMtMS0xLTE0MzI4Ng_dad69b6e-4db6-4416-a7f5-26a7cfc0ac23">633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI5LTEtMS0xLTE0MzI4Ng_31490c30-8df7-4d41-9710-d0ad12494801">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI5LTItMS0xLTE0MzI4Ng_b372d28d-ec64-4048-b18a-2d7d3e85d302">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI5LTMtMS0xLTE0MzI4Ng_2a703cf7-8941-411f-866c-d45f6bfc0831">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per Ordinary Share attributable to the Group (Note 24):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzMzLTEtMS0xLTE0MzI4Ng_c3678de3-d9ee-4a11-8305-2ed00af04ef2">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzMzLTItMS0xLTE0MzI4Ng_e68ef2dc-13a4-4975-995b-c7bd7ec771e2">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzMzLTMtMS0xLTE0MzI4Ng_010287d8-adf5-41b3-a1e8-1fdec2c189d1">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM0LTEtMS0xLTE0MzI4Ng_5233d070-b250-4099-82af-0642aa82c1d7">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM0LTItMS0xLTE0MzI4Ng_c9124056-e21c-4b43-a538-4ddc08689f13">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM0LTMtMS0xLTE0MzI4Ng_ea695c98-0080-440b-8a41-a3633ec60e76">6.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic (Note 2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM3LTEtMS0xLTE0MzI4Ng_ea60144a-c005-4ca2-a001-92bdb5a5f13e">81,532,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM3LTItMS0xLTE0MzI4Ng_9e5ea08b-3a08-40cc-a553-c7b8894ea022">67,110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM3LTMtMS0xLTE0MzI4Ng_1b187434-4e44-4b5c-902f-ee6050ec3a0e">52,859,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted (Note 2)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM4LTEtMS0xLTE0MzI4Ng_1aebc954-ad4f-45cd-901b-44bbb4bc7991">82,468,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM4LTItMS0xLTE0MzI4Ng_d78dad20-3830-4d49-9ed2-e1a0b7bc3a3a">68,068,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM4LTMtMS0xLTE0MzI4Ng_a831d349-6eec-4c44-acc0-9f060e748a5f">53,283,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzMtMS0xLTEtMTQzMjg2_3a1d9790-86f8-4364-b2a5-321a151ba552">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzMtMi0xLTEtMTQzMjg2_1029309a-c2da-4f11-a113-f770f649bae3">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzMtMy0xLTEtMTQzMjg2_68b9f74e-1bd8-45c2-888e-355a36531b4a">332,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzUtMS0xLTEtMTQzMjg2_d2ce52da-14ce-46ff-b6e8-23e7407bfd4e">89,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzUtMi0xLTEtMTQzMjg2_2ac0b29c-e24f-41c1-b685-09e999cda7d7">60,617</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzUtMy0xLTEtMTQzMjg2_bc965249-8a62-4c70-8c12-708b0095bca1">46,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital loss - investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzctMS0xLTEtMTQzMjg2_18ad5e3b-bcbb-4529-ae9b-4085a98305b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzctMi0xLTEtMTQzMjg2_57e45ef7-16b2-49e9-8c9f-c372984289d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzctMy0xLTEtMTQzMjg2_c7c07c82-3f6d-421e-9111-7ed8d4492c21">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzgtMS0xLTEtMTQzMjg2_e6c1f994-0c64-49e0-aba4-ded41a1f445e">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzgtMi0xLTEtMTQzMjg2_cc557a00-e914-4f6d-a100-decf994e3eab">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzgtMy0xLTEtMTQzMjg2_2e3c465b-e8dd-4ed1-8e4e-4b4c9552a025">4,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzktMS0xLTEtMTQzMjg2_970f1503-b5e6-4176-9808-25caa0cde8be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzktMi0xLTEtMTQzMjg2_e65da590-4e1c-47d8-8366-8fa5fa6a2959">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzktMy0xLTEtMTQzMjg2_1ef956c1-6cf7-4f47-b8aa-711e7e2eb11d">910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss)/gain on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEwLTEtMS0xLTE0MzI4Ng_05940f9e-3a22-491a-9ded-b90780d28b8b">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEwLTItMS0xLTE0MzI4Ng_184cf73f-0bfb-40d1-a600-3e396d7469e9">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEwLTMtMS0xLTE0MzI4Ng_ac9a52dd-dad0-4d0d-ba16-3d25f28011b8">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzExLTEtMS0xLTE0MzI4Ng_a578d4a7-5dc2-4b24-9a05-9a55d02da7f9">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzExLTItMS0xLTE0MzI4Ng_b73871f9-c649-4256-80ec-843349a05dc5">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzExLTMtMS0xLTE0MzI4Ng_7c6aa10b-0472-4a93-8fba-aa21c1f1f38d">373,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less net income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEyLTEtMS0xLTE0MzI4Ng_05eae667-5cb8-4ec0-b165-f6f3fdb96668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEyLTItMS0xLTE0MzI4Ng_a209558b-b755-4222-9d15-3c126386ac87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEyLTMtMS0xLTE0MzI4Ng_ab5d3f88-7b33-4aad-9dcd-bcbc3cbfc47d">633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income attributable to the Group</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEzLTEtMS0xLTE0MzI4Ng_33dc3a51-c39b-4b32-b37a-1d7eb071d3f9">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEzLTItMS0xLTE0MzI4Ng_18b91baf-ad38-444b-a869-45d66d5b1974">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEzLTMtMS0xLTE0MzI4Ng_9032dd3b-13e1-4189-8437-260bc73ff4b1">372,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interest</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7e5ed959ca1442c959fca1bf9fa7721_I20191231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtMS0xLTEtMTQzMjg2_bb28de84-4f38-40a7-afe5-80ac0997bbc8">53,622,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7e5ed959ca1442c959fca1bf9fa7721_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtMi0xLTEtMTQzMjg2_657005a2-179a-406e-a12e-43dba85858ed">4,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9fbbf07b0e4449ea3a2f6cd81f22401_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtMy0xLTEtMTQzMjg2_5a56d80c-2186-4228-9130-4dfaafedc049">577,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19a880fd5d814e9092b5ca671bb8d41b_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNC0xLTEtMTQzMjg2_7f0f24a5-5e4d-40e0-ad56-604f42563bf3">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8965558006f4684a7fc1512daffa72e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNS0xLTEtMTQzMjg2_e6de3467-38f6-4572-a7da-ff68754a55ee">75,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2dc7dff39c546919fdaf6c9f59e5e5e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNi0xLTEtMTQzMjg2_905ce4d1-943b-4e5e-85b3-16c81fc48165">1,110,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c028363c21c48d5bdb88ba826d38299_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNy0xLTEtMTQzMjg2_d68d1d73-03a5-492c-8691-777b8f5dfba3">1,618,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d1a9ae0fba46c192371319b4901064_I20191231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtOC0xLTEtMTQzMjg2_fbbb78d2-3447-4018-ad3f-7e14fa11d1a9">39,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive Income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzktNi0xLTEtMTQzMjg2_4650b533-f66f-434d-8658-d7fe8e229605">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzktNy0xLTEtMTQzMjg2_430be811-6279-4aa9-878e-013c55ffa184">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzktOC0xLTEtMTQzMjg2_b69d463b-4f9f-4c3a-9cd7-5f39db574b54">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEwLTUtMS0xLTE0MzI4Ng_e246595d-29bd-4e9c-a98b-b95f5d49cb2b">46,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEwLTctMS0xLTE0MzI4Ng_ce78146d-f7e4-4105-92af-98ce3378fd08">46,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized capital loss - investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEyLTUtMS0xLTE0MzI4Ng_462e9a9f-ed04-4e27-adef-7dade9059e5e">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEyLTctMS0xLTE0MzI4Ng_d77aaca4-f95e-45a0-8b16-4034809966da">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss on defined benefit pension plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEzLTUtMS0xLTE0MzI4Ng_017a5832-b0fd-4699-87eb-91daf6f84dbc">4,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEzLTctMS0xLTE0MzI4Ng_ba9f6bb3-6e00-449c-9abb-c202f2686152">4,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE0LTUtMS0xLTE0MzI4Ng_8172086e-6f06-4c7f-8905-5dbec89807cb">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE0LTctMS0xLTE0MzI4Ng_378f461c-0eae-472b-a258-36cd26b3a922">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE1LTUtMS0xLTE0MzI4Ng_d0b859ee-c508-4953-85ef-39727b05ab3f">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE1LTctMS0xLTE0MzI4Ng_75bb5e4f-70ee-49cb-a439-1f5b7a06c743">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE2LTctMS0xLTE0MzI4Ng_c9f06c00-7a4c-4c04-9e14-4a1218491526">372,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTEtMS0xLTE0MzI4Ng_cc1b57d8-a205-41c3-bb5e-a8bb9c475f26">193,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTItMS0xLTE0MzI4Ng_e77b5285-d344-44d7-8989-965ec996cce5">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTMtMS0xLTE0MzI4Ng_f28aa356-bbdd-45cd-9749-b295fc4040bf">13,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTctMS0xLTE0MzI4Ng_bcf399d5-85f1-4d6a-8f57-00427e8d0db1">13,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE4LTEtMS0xLTE0MzI4Ng_4d99b7c2-b1f7-4543-99cb-cb8a94ffda8d">207,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE4LTItMS0xLTE0MzI4Ng_889d7496-4020-4a05-8c0c-5ff7b43d960e">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE4LTctMS0xLTE0MzI4Ng_316c9eae-e024-4a4f-938c-43c95d52733d">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE5LTMtMS0xLTE0MzI4Ng_1897ad53-cdae-4dfe-b6ce-140f5a3d4222">25,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE5LTctMS0xLTE0MzI4Ng_bebac4db-7126-4ebb-9599-7c56267c1f76">25,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIwLTMtMS0xLTE0MzI4Ng_0e3303de-5023-467a-a5c5-20c5d0dbaae5">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIwLTctMS0xLTE0MzI4Ng_328cc83c-c6d3-4330-85ac-720766a3276d">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTEtMS0xLTE0MzI4Ng_74188986-2c5d-4c53-9c1f-a98d2fd776a3">1,235,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTItMS0xLTE0MzI4Ng_c61993cd-c77f-4c8d-b805-0e6a55b7fcb9">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0a7d988df847dc9a616929e7ace798_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTQtMS0xLTE0MzI4Ng_a36eb3cf-1ba6-4bc5-b481-cf12a0f61f96">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTYtMS0xLTE0MzI4Ng_35b0af90-9fc2-4cdd-b97d-7176d608225f">175,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTctMS0xLTE0MzI4Ng_265120c3-d1c8-47fc-be55-ca2f66bd6231">175,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIyLTYtMS0xLTE0MzI4Ng_785a4a4f-de5a-408d-8e7d-edc136077552">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIyLTctMS0xLTE0MzI4Ng_44c057c3-7314-4d37-98fa-9e626be1b96b">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231" decimals="-3" sign="-" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIzLTYtMS0xLTE0MzI4Ng_5ca7925b-f1ba-4a4d-9e06-303bba1f1e2b">4,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIzLTctMS0xLTE0MzI4Ng_c73c074c-e7f7-407a-b03c-a854f5401bad">4,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231" decimals="-3" name="iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIzLTgtMS0xLTE0MzI4Ng_22e2143f-7e50-403b-beeb-2a5e563ba85e">4,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of call option on noncontrolling interest shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI0LTgtMS0xLTE0MzI4Ng_1a2c06b8-ec56-4d4c-b632-b50cd835b950">44,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTEtMS0xLTE0MzI4Ng_3b52abfb-273e-4d38-b606-2e867697d0bf">52,788,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTItMS0xLTE0MzI4Ng_6bfb6e6c-348c-4da5-bad2-4837fa00925f">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c05ec529b64737a2cf079cbb19be5c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTMtMS0xLTE0MzI4Ng_97c677fb-384e-4209-be3f-4e1a6464bcb6">617,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940965b309ab4ce497c779391f42b662_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTQtMS0xLTE0MzI4Ng_1ef7879b-2b4f-4223-b0d4-a1ba90730a18">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8d96ff5211446f09d3fabef56b1bb6d_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTUtMS0xLTE0MzI4Ng_ec33e11d-6b49-4d9b-81a2-d9e4098608f7">35,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5629eb301d784ca99de6ddbf87220b6f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTYtMS0xLTE0MzI4Ng_859f6b8b-3d44-42db-8787-9c4f9c0ee3d6">1,262,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTctMS0xLTE0MzI4Ng_75ebcc3b-3be4-47c9-89be-73231675ca68">1,850,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80faf766e38749ef9bf49c0793bed5d9_I20201231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTgtMS0xLTE0MzI4Ng_2848c88b-5601-4ca6-b134-0da0e240ec23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Group</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctMS0xLTEtMTQzMjg2_10ef286c-20f3-41b6-81e4-24895f9d944b">52,788,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctMi0xLTEtMTQzMjg2_1fc952d0-508d-4897-8c4f-070cc35f9f2f">4,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32c05ec529b64737a2cf079cbb19be5c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctMy0xLTEtMTQzMjg2_101ce675-ecf4-4881-b2e6-9626661eb174">617,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940965b309ab4ce497c779391f42b662_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNC0xLTEtMTQzMjg2_384c6787-032c-4a11-b893-6091f537e809">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8d96ff5211446f09d3fabef56b1bb6d_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNS0xLTEtMTQzMjg2_c742673f-de44-4e3f-af03-c279e04b29d0">35,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5629eb301d784ca99de6ddbf87220b6f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNi0xLTEtMTQzMjg2_19fe2d0b-6562-4268-a7e0-75845469cc0b">1,262,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNy0xLTEtMTQzMjg2_64f42024-582b-4def-ac56-1f6cfaf3c2e2">1,850,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e29b8c979344a0bbaf83ef3e7130d2_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzktNi0xLTEtMTQzMjg2_0d9973e2-5de9-43e2-9e66-bea04d0535ac">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzktNy0xLTEtMTQzMjg2_62a7acae-501b-4049-a1ef-2222f566138a">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzEwLTUtMS0xLTE0MzI4Ng_9d5cb3e7-4916-45ec-a788-e0b2be96bff1">60,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzEwLTctMS0xLTE0MzI4Ng_c3b6ca99-9a60-4349-80a7-187d31951668">60,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE0LTUtMS0xLTE0MzI4Ng_83928609-5d6f-449b-b471-fd36de26bf3c">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE0LTctMS0xLTE0MzI4Ng_22e00d20-610a-4368-8673-3e77ce73fcc2">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE1LTUtMS0xLTE0MzI4Ng_e576b82a-c847-4ff1-a6ae-d7e763cb450c">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE1LTctMS0xLTE0MzI4Ng_f3f01620-a4ee-4820-8697-74398c9d3053">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement of cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE2LTUtMS0xLTE0MzI4Ng_b1fc6a30-bad9-485b-a410-8fcf7816d933">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE2LTctMS0xLTE0MzI4Ng_54e5c08d-31b9-4e32-8f41-2c620df112b3">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE4LTctMS0xLTE0MzI4Ng_26fac597-14ee-4e9b-8e05-e9275e231d90">97,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTEtMS0xLTE0MzI4Ng_f0226ef8-0cf1-4330-859e-baf8b30d29ea">1,065,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTItMS0xLTE0MzI4Ng_5ef45a2f-75e7-46f5-be59-a2e777b2cf5f">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTMtMS0xLTE0MzI4Ng_67b94124-f39f-4c83-8024-3d27c9ae9056">118,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTctMS0xLTE0MzI4Ng_9d342b84-727b-4e36-a4a4-51de513ad60f">118,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIxLTEtMS0xLTE0MzI4Ng_b51c7e56-e48e-4194-b090-819fb52ab74b">328,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIxLTItMS0xLTE0MzI4Ng_44dfe586-6544-4157-9163-c8f092afb177">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIxLTctMS0xLTE0MzI4Ng_517379f5-3eb9-4629-8ac8-ecf60b457487">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIyLTMtMS0xLTE0MzI4Ng_408ecaf1-7e5e-4786-8d27-93c9fd8ebce3">133,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIyLTctMS0xLTE0MzI4Ng_737bec90-207d-4e62-ab3a-49f0f9dc6503">133,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIzLTMtMS0xLTE0MzI4Ng_d44e9f8a-f55f-4a28-a150-3f8edae8ae9b">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIzLTctMS0xLTE0MzI4Ng_6fe4bfa5-6700-4c03-979c-0727c76c3965">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of shares associated with a business combination</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTEtMS0xLTE0MzI4Ng_f8978661-3d8c-4065-ab83-ad2ad2ff4145">27,372,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTItMS0xLTE0MzI4Ng_68a9fd5b-3cce-4bb2-ae0c-334745f916d4">1,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTMtMS0xLTE0MzI4Ng_aa91e2a8-e688-4dc8-8517-a55fc7d2abb7">5,656,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTctMS0xLTE0MzI4Ng_21bbc0cc-e1d6-42e8-9c5f-262cc075c962">5,658,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI1LTMtMS0xLTE0MzI4Ng_be4e883c-a16d-4b11-8190-6d094f54eb8d">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI1LTctMS0xLTE0MzI4Ng_7e0ca0b4-f692-4d6f-b420-8e064678e6a2">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTEtMS0xLTE0MzI4Ng_16ce63f4-d0ba-4124-9c51-3d54e6ee6ebe">81,554,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTItMS0xLTE0MzI4Ng_b3a8fd53-3f1c-4ff0-8bf0-3b70d7b2dfb8">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630de7cf74954c889cb5f55191084e94_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTMtMS0xLTE0MzI4Ng_4dabc7ee-c43c-413b-b3f4-bd05788502da">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69908ebb3c9340018ae4adb8ef47236e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTQtMS0xLTE0MzI4Ng_00760ebd-fc38-4eda-a983-e17d997f71c3">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib11a3b57f4ac4425a287a5353f3e2695_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTUtMS0xLTE0MzI4Ng_5089ac0b-b62c-4a3a-adc6-45119728ab8c">90,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d85418de1a4b0a817652360cfe0815_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTYtMS0xLTE0MzI4Ng_830076ba-710b-4cc9-bf67-ff69d9c0395b">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTctMS0xLTE0MzI4Ng_7daf6266-0c60-492b-9eb2-1402e84459a4">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</span></td></tr><tr><td colspan="24" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Group</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other<br/>Undenominated<br/>Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctMS0xLTEtMTQzMjg2_8dcd936b-88f0-442b-8a43-f7c4256a8b22">81,554,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctMi0xLTEtMTQzMjg2_a67bd1ab-bafe-4aa4-a060-18eed4ebc93b">6,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630de7cf74954c889cb5f55191084e94_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctMy0xLTEtMTQzMjg2_2f1654bc-92c4-46bb-a5f7-21f003345bff">6,733,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69908ebb3c9340018ae4adb8ef47236e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNC0xLTEtMTQzMjg2_9b8c9100-3202-4e15-b21e-7aa4135e3bc7">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib11a3b57f4ac4425a287a5353f3e2695_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNS0xLTEtMTQzMjg2_283614cd-d773-4508-9495-87164bf820b9">90,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d85418de1a4b0a817652360cfe0815_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNi0xLTEtMTQzMjg2_60fa4ed6-5940-4e34-b9b7-139d27ee61bd">1,416,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNy0xLTEtMTQzMjg2_36b7c939-cd11-471c-83ad-74d7b4d759f0">8,066,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzktNi0xLTEtMTQzMjg2_97506e09-cf28-4958-9642-193a42b42c63">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzktNy0xLTEtMTQzMjg2_005b9b8b-db1f-4b09-9eac-0681295fa4ca">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib227c36803504cc68f096847a5faff4a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEwLTUtMS0xLTE0MzI4Ng_26d1cc31-bc10-4f68-afb1-e74a06236130">89,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEwLTctMS0xLTE0MzI4Ng_2b7a22a3-ee01-421f-a94f-d593ec2d3c6c">89,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain on defined benefit pension plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib227c36803504cc68f096847a5faff4a_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEyLTUtMS0xLTE0MzI4Ng_da162235-c65a-48eb-9707-ff439eb06282">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEyLTctMS0xLTE0MzI4Ng_be7655a5-6216-4593-9bcc-aae4a1f5bacf">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib227c36803504cc68f096847a5faff4a_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEzLTUtMS0xLTE0MzI4Ng_9c2bd80f-dc06-4b98-95b7-230155498aa5">3,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEzLTctMS0xLTE0MzI4Ng_0d4e7353-fed0-4af7-ae35-8457f0444894">3,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzE4LTctMS0xLTE0MzI4Ng_313d5ff0-267f-4bb8-8bb7-3daab705faae">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTEtMS0xLTE0MzI4Ng_b4ec1941-1256-45ef-bc6c-5387c2216f58">348,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTItMS0xLTE0MzI4Ng_ad989b2c-1783-44f3-922e-5f28cbd236f5">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTMtMS0xLTE0MzI4Ng_a9edc0b2-635a-41fd-af69-463e860865b3">35,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTctMS0xLTE0MzI4Ng_31dec23b-dce6-42c9-854e-6d6200f042a9">35,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIxLTEtMS0xLTE0MzI4Ng_375e14ed-0d15-4df8-82ac-6c30120571f9">241,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIxLTItMS0xLTE0MzI4Ng_0cf43db1-c57d-47f3-87bf-1137986d11ec">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIxLTctMS0xLTE0MzI4Ng_46ff829c-9f91-4b32-a5f7-a27d1e17fdfb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIyLTMtMS0xLTE0MzI4Ng_d5b69d4d-862e-4721-869f-ef975b630832">70,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIyLTctMS0xLTE0MzI4Ng_9fe77957-89da-40c2-86e0-7e3dba7e997b">70,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIzLTMtMS0xLTE0MzI4Ng_f5844d2b-a6d3-47d3-b144-3717bccd0a7f">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIzLTctMS0xLTE0MzI4Ng_b87491d7-1fb0-4920-adfc-f15b5d86b4d9">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTEtMS0xLTE0MzI4Ng_67034938-c479-4188-bfab-ae72ad0320a3">420,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTItMS0xLTE0MzI4Ng_6407f5e7-13b8-467e-888a-9e40212e1366">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4addd48255bb44beb36787ed5df4e0bb_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTQtMS0xLTE0MzI4Ng_f19ccea0-03ac-4712-9f20-3e277d3c6e74">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTYtMS0xLTE0MzI4Ng_2739a70c-abe3-4197-9fe9-6df63909fd12">99,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTctMS0xLTE0MzI4Ng_155264b4-e0d9-4185-89ea-55152a38441a">99,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI1LTYtMS0xLTE0MzI4Ng_7261cdc0-a990-4c89-a93a-3f45b66e6277">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:AdjustmentToRetainedEarningShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI1LTctMS0xLTE0MzI4Ng_10d4c44b-3c92-4e1e-8b5d-4b70a50f92cf">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fe1a0341a694fcf9f094af87a903fe5_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTEtMS0xLTE0MzI4Ng_19a17bf0-f6de-4643-b676-9050ce8b06a3">81,723,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe1a0341a694fcf9f094af87a903fe5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTItMS0xLTE0MzI4Ng_08432650-6fde-4019-ba05-2c86676237e8">6,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e931e0964047f1b6a05248f9f9ae86_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTMtMS0xLTE0MzI4Ng_3dedd513-c105-42d0-ad92-faa1f93bca55">6,840,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea7296eec334826b983a9b2012723a7_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTQtMS0xLTE0MzI4Ng_6af46885-c10a-4c37-93fa-dba9cbf3beb6">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b2495a48164218a19af1d3f594f087_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTUtMS0xLTE0MzI4Ng_57611f4f-65d6-4a5a-a646-d5a08a7d8cd6">171,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87251223f7f94618a9d593180c9e6f6b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTYtMS0xLTE0MzI4Ng_a2651259-7a19-4e51-8e76-4df60e9b5c29">1,821,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTctMS0xLTE0MzI4Ng_ea128b0b-911d-474c-9bf4-760a18325c62">8,497,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_154"></div><hr style="page-break-after:always"/><div style="min-height:21.6pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMtMS0xLTEtMTQzMjg2_fece4e2c-2611-419d-bd21-c04371ac8171">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMtMi0xLTEtMTQzMjg2_005805db-2e5c-4689-b719-dd7cf80fac7b">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMtMy0xLTEtMTQzMjg2_ecaab474-cbb3-4382-8f1e-866554c45a04">332,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzYtMS0xLTEtMTQzMjg2_5a077a15-2999-466e-8b4c-6c2ff9a944df">569,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzYtMi0xLTEtMTQzMjg2_a2c4a052-89aa-41d8-8099-38a35aa3e6e6">314,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzYtMy0xLTEtMTQzMjg2_8fe7b692-7605-4820-a48e-6fa147f6ec98">66,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Impairment of long lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzctMS0xLTEtMTQzMjg2_1dc0c022-e60c-4ec7-b88c-7dbe5a1d911a">28,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzctMi0xLTEtMTQzMjg2_ec3944b3-c7ce-4ee2-bdf4-d4cd20578025">20,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzctMy0xLTEtMTQzMjg2_ee02e606-c7cb-4703-bcfc-6a386e9e835a">5,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Reduction in carrying value of operating right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzgtMS0xLTEtMTQzMjg2_08727cf5-a879-42a6-8945-64af608e994a">45,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzgtMi0xLTEtMTQzMjg2_2ad6e9e2-e399-4ddb-bb04-e2f4dde3ba08">45,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzgtMy0xLTEtMTQzMjg2_315111d0-4636-4c89-8c90-f232ff953662">28,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzktMS0xLTEtMTQzMjg2_8378a123-7903-4a3b-956b-ce8531732f2b">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzktMi0xLTEtMTQzMjg2_613c7639-6dab-4725-a567-caca52f475b7">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzktMy0xLTEtMTQzMjg2_5e935d5d-4985-4bff-a672-7c033198eb68">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Amortization of financing costs and debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzExLTEtMS0xLTE0MzI4Ng_d7b4e5d8-bf31-447a-b5df-44825cdf4392">17,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzExLTItMS0xLTE0MzI4Ng_0ee759ca-6508-4ee0-82bc-4a35293fedf3">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzExLTMtMS0xLTE0MzI4Ng_e6107fea-71f5-4617-8c7f-b85b3bff8a10">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEyLTEtMS0xLTE0MzI4Ng_233452bc-511a-4874-a863-123cbd5f3ac9">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEyLTItMS0xLTE0MzI4Ng_5528f8a3-0601-41ee-9345-8e7fafa2ff43">133,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEyLTMtMS0xLTE0MzI4Ng_af006bb0-f630-464e-9775-8a300bca7a5b">26,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEzLTEtMS0xLTE0MzI4Ng_ec41d7ef-981c-4102-a233-88901c411ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEzLTItMS0xLTE0MzI4Ng_fc68916c-baf0-4511-824e-d80cacbe5017">14,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEzLTMtMS0xLTE0MzI4Ng_a99a6b12-1483-4f04-bc13-73e824122496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss on issuance of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:GainLossOnIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTEtMS0xLTE0ODQxNw_bc5429e7-dfc9-430c-a885-4a40254e2c21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="iclr:GainLossOnIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTItMS0xLTE0ODQxNw_70fbe340-9eda-4837-b957-8aad35abda1b">59,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="iclr:GainLossOnIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTMtMS0xLTE0ODQxNw_0fa44418-4e2c-4f9f-a795-c56fcc0218b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTEtMS0xLTE0MzI4Ng_480a26f4-c30a-421e-8e85-21c3d08bc2c9">124,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTItMS0xLTE0MzI4Ng_2c40e475-6860-4857-a29b-03cbcc6259ad">60,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTMtMS0xLTE0MzI4Ng_1ac5cb1e-fc2d-4b90-b65c-db8deacc49f0">927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unrealized foreign exchange (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE1LTEtMS0xLTE0MzI4Ng_994741c7-116c-4f3f-bc0a-64fcafaf83ca">13,009</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE1LTItMS0xLTE0MzI4Ng_64f57583-0223-453a-bd9c-0fd1898093cf">6,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE1LTMtMS0xLTE0MzI4Ng_6243aec2-d4ee-4fb2-894d-cb819217ad61">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE2LTEtMS0xLTE0MzI4Ng_aa635079-3e8a-4a06-bb18-b07116f13afd">11,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE2LTItMS0xLTE0MzI4Ng_fb606b99-1600-49a2-be35-a895bc29df6b">4,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE2LTMtMS0xLTE0MzI4Ng_06f7fc5d-6749-47d2-a7ab-bc1fa7b671b8">7,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE4LTEtMS0xLTE0MzI4Ng_c96228a7-2597-4925-9c69-3f4ace7fd5cc">420,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE4LTItMS0xLTE0MzI4Ng_1f6a5340-62b4-46d2-ae82-2f0931e7a379">113,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE4LTMtMS0xLTE0MzI4Ng_6ed5da77-2437-4e99-a7ad-d0ea753b48b6">175,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE5LTEtMS0xLTE0MzI4Ng_4c5b3e87-cf67-4dfa-8cd8-4e83f39fc602">332,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE5LTItMS0xLTE0MzI4Ng_ad98cb84-a701-4160-987c-744debe588a1">17,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE5LTMtMS0xLTE0MzI4Ng_cfeaf7e3-c75b-4e9c-84b4-82e23457c47d">5,748</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIwLTEtMS0xLTE0MzI4Ng_81e1d698-42b1-428a-880b-95ee7fa29328">192,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIwLTItMS0xLTE0MzI4Ng_2f2a2ca8-e66f-4cc0-a6f1-f48447309069">69,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIwLTMtMS0xLTE0MzI4Ng_b24d283d-a170-418f-bb30-89fd9b83bf98">291,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other net assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIxLTEtMS0xLTE0MzI4Ng_ee917800-d586-4b3f-8f93-5f65390a6c5b">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIxLTItMS0xLTE0MzI4Ng_95d919b3-8d58-4a5d-9d0b-9d027fe54182">108,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIxLTMtMS0xLTE0MzI4Ng_b20f1b98-8c2a-4127-ba09-f6c0e32e9bca">2,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIyLTEtMS0xLTE0MzI4Ng_915038cc-9011-4919-a9ef-1d77ab975ecd">563,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIyLTItMS0xLTE0MzI4Ng_5faab328-3cc4-41d7-93f2-b8e8428c552e">829,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIyLTMtMS0xLTE0MzI4Ng_62a5e6df-a95a-42e4-b377-edaa052eea0a">568,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI0LTEtMS0xLTE0MzI4Ng_c04e9fa2-0dee-430f-abf2-227f125b24c9">142,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI0LTItMS0xLTE0MzI4Ng_bf2d313d-ac10-4bf7-988c-d2011013a9fe">93,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI0LTMtMS0xLTE0MzI4Ng_ea2028d9-bad6-43df-9b94-49cae3ed7ffc">40,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of subsidiary undertakings (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI1LTEtMS0xLTE0MzI4Ng_2a199cc4-9ff5-4877-954b-f79ba2d4f137">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI1LTItMS0xLTE0MzI4Ng_19498092-c62d-4d4a-9d2e-9b290efa3b02">5,914,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI1LTMtMS0xLTE0MzI4Ng_29b1e2fa-e3e6-43de-a51f-0a69cb6a7cfe">47,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Investment in equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI2LTEtMS0xLTE0MzI4Ng_9cc86743-952c-4143-b16c-716fd48efbfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI2LTItMS0xLTE0MzI4Ng_e88452c9-71de-4ce8-8fa2-fdd4b554f975">2,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI2LTMtMS0xLTE0MzI4Ng_3875509a-0b50-48fc-ba43-bdb9c009555f">2,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loan to equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI3LTEtMS0xLTE0MzI4Ng_4e8caf99-5447-4b7b-bf28-b7929cc06126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI3LTItMS0xLTE0MzI4Ng_f2438984-760a-4e56-a513-45463b689d17">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI3LTMtMS0xLTE0MzI4Ng_5e39fc79-1e7e-4a1c-b8e7-d438b59f68a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Sale of available for sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI4LTEtMS0xLTE0MzI4Ng_75f4fd5a-e396-47fd-b1e5-7699de6477e5">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI4LTItMS0xLTE0MzI4Ng_8030214c-1811-40c0-9329-f9bdd1a27289">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI4LTMtMS0xLTE0MzI4Ng_beda3267-cf9b-4775-aa8b-80af01353894">47,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of available for sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTEtMS0xLTE0MzI4Ng_31bc056d-ca12-4afc-b474-955c9883f829">482</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTItMS0xLTE0MzI4Ng_77cfe261-53d1-41be-82ac-a142b30a9aaf">480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTMtMS0xLTE0MzI4Ng_a87014e5-85e2-4f67-88d5-cfd4d093f116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from investments in equity - long term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTEtMS0xLTE3NjY0MQ_524f16bf-55a1-4409-a873-3bc8178c4ef7">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTItMS0xLTE3NjY0MQ_0921c34f-ebab-4230-ab86-cc83f7067cdb">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTMtMS0xLTE3NjY0MQ_00febdf0-f77c-4207-aa3d-a68f2a95aece">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of investments in equity - long term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMwLTEtMS0xLTE0MzI4Ng_7d3c7b06-ae0e-4ff9-a704-e2d0647ecc25">5,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMwLTItMS0xLTE0MzI4Ng_3a27e672-0b4e-45fa-8a62-8aece0908636">4,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMwLTMtMS0xLTE0MzI4Ng_9e67f0cc-331e-42c5-bb55-46896d41106f">3,299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMxLTEtMS0xLTE0MzI4Ng_b861397f-ad95-4ed9-b290-c6d421b78585">145,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMxLTItMS0xLTE0MzI4Ng_6e3dcb30-0716-425c-927e-7b3ece4ea278">6,024,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMxLTMtMS0xLTE0MzI4Ng_8196e4c0-5094-41f2-ac62-bdde3f0d29a8">46,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMzLTEtMS0xLTE0MzI4Ng_7164d390-21c7-4d5c-9d04-1a8c2e441a3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMzLTItMS0xLTE0MzI4Ng_6f812cc5-3b9d-4318-8f64-39f70b7dff68">30,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMzLTMtMS0xLTE0MzI4Ng_7a191365-8abb-4156-ad61-f840fca734af">1,554</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Drawdown of credit lines and facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM0LTEtMS0xLTE0MzI4Ng_d98cdaf2-4081-4e1a-821d-6629616d5863">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM0LTItMS0xLTE0MzI4Ng_fd829a81-c105-4033-8086-11d865feb06f">5,905,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM0LTMtMS0xLTE0MzI4Ng_82c05966-31bc-4169-b128-e658dc0faf88">350,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Repayment of credit lines and facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM1LTEtMS0xLTE0MzI4Ng_0cdd624f-c6bd-42d2-9623-c7a635ee18f1">875,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM1LTItMS0xLTE0MzI4Ng_0ca4c8ac-5ec2-42ca-8e9c-2471ff14ba31">877,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM1LTMtMS0xLTE0MzI4Ng_d3913996-5596-4260-bb60-74bc56e88674">350,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchase of noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM2LTEtMS0xLTE0MzI4Ng_5b121eee-417e-40c9-b52a-0193866c0c2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM2LTItMS0xLTE0MzI4Ng_7fa15b6f-bb44-42bb-949c-ae252ab85a37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM2LTMtMS0xLTE0MzI4Ng_d4b02847-9072-4bd1-8d40-4dd8ce63abfc">43,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from the exercise of equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM3LTEtMS0xLTE0MzI4Ng_f8b16c4b-d8ee-4c56-afd8-34b5fbaafa3f">35,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM3LTItMS0xLTE0MzI4Ng_49219da1-fa4b-4c4c-90af-86949bae76c1">118,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM3LTMtMS0xLTE0MzI4Ng_b13f206d-32b0-4584-82be-0a582b2840db">13,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM4LTEtMS0xLTE0MzI4Ng_1da21f34-7be7-4f90-a9b6-9f443a1134bf">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM4LTItMS0xLTE0MzI4Ng_c22c95f9-7a7d-4235-bed4-7a590d7ea419">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM4LTMtMS0xLTE0MzI4Ng_b6290ad5-5bb9-4bef-8767-863f3a94e5db">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQwLTEtMS0xLTE0MzI4Ng_9b465a14-2391-4371-8b2c-422bcecdb064">99,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQwLTItMS0xLTE0MzI4Ng_8e963708-a18b-4dcd-a198-fab91042dd85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQwLTMtMS0xLTE0MzI4Ng_5665efe8-3437-4ff3-8fb4-8c9db230a63f">175,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQxLTEtMS0xLTE0MzI4Ng_154c3bee-cf86-4e40-9de7-4bfe82a3063f">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQxLTItMS0xLTE0MzI4Ng_b03c41ed-8063-4856-93f9-08453c27f52e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="iclr:PaymentsForShareRepurchaseCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQxLTMtMS0xLTE0MzI4Ng_4a8f536d-40d9-4f0d-b822-1f969b117f5e">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Settlement of cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQzLTEtMS0xLTE0MzI4Ng_ce6386e0-6c95-45f1-ab86-9a2fd0156daa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQzLTItMS0xLTE0MzI4Ng_a29f4c26-dbee-4857-be19-181bcb281d1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQzLTMtMS0xLTE0MzI4Ng_2175764a-1cc1-44da-91db-3faebd383dc3">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash (used in)/provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ0LTEtMS0xLTE0MzI4Ng_ea3f6271-6fea-4fd4-ae15-7183eac4819f">864,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ0LTItMS0xLTE0MzI4Ng_782ab0be-1b78-4efb-abb4-7d73f256ee31">5,114,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ0LTMtMS0xLTE0MzI4Ng_12b3373b-a5ab-42d5-b297-6a95b64c97ec">208,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Effect of exchange rate movements on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ1LTEtMS0xLTE0MzI4Ng_5e180055-b15e-483b-9867-e01030869294">16,720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ1LTItMS0xLTE0MzI4Ng_ae8ca87d-a743-4b85-bb84-5800b1fdd0a1">7,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ1LTMtMS0xLTE0MzI4Ng_10263126-30e8-493f-8b8a-614c46650e15">6,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Net (decrease)/increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ2LTEtMS0xLTE0MzI4Ng_2383d45e-3d75-49ee-a2a5-51f23348b5c1">463,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ2LTItMS0xLTE0MzI4Ng_905eb834-3bea-4e38-ba10-0d480fc199bb">88,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ2LTMtMS0xLTE0MzI4Ng_dcebccc7-5623-4ad5-a811-bed9e73ae1f0">319,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ3LTEtMS0xLTE0MzI4Ng_c2039843-da6f-4bff-9f6b-20f23a3bac3c">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ3LTItMS0xLTE0MzI4Ng_319f984b-60f9-4343-928b-7a31cbaa5ce8">840,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c028363c21c48d5bdb88ba826d38299_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ3LTMtMS0xLTE0MzI4Ng_294bb409-638d-47d2-8d19-a7b7590898c0">520,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ4LTEtMS0xLTE0MzI4Ng_abc6fe5c-119d-4399-8d9e-df29bd4dbe38">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ4LTItMS0xLTE0MzI4Ng_0c315cfc-b3bb-4f02-8e64-00115dcf9c18">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ4LTMtMS0xLTE0MzI4Ng_e185071b-8c1e-409a-8995-f260857f1521">840,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzE2NzM_6b096649-bb17-4b6e-a97c-6eda7db1c0f0" continuedAt="i6fd4fa1afbac423083f1a730c5364d9a" escape="true">Description of Business </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6fd4fa1afbac423083f1a730c5364d9a"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2022 we had approximately <ix:nonFraction unitRef="employee" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="0" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4Xzk0Mg_4f8c521b-c3ea-485f-8821-a0a15727c2d1">41,100</ix:nonFraction> employees, in <ix:nonFraction unitRef="location" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="iclr:NumberOfLocations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4Xzk1OQ_e57ccfd0-dd6d-4f65-9dfd-62c79d3614a1">111</ix:nonFraction> locations in <ix:nonFraction unitRef="country" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4Xzk3NQ_1872f9ff-7d90-47e1-a124-3ddf4a9373b9">53</ix:nonFraction> countries. During the year ended December&#160;31, 2022, we derived approximately <ix:nonFraction unitRef="number" contextRef="i25b768baea2347c69afde3c3be439fd8_D20220101-20221231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzEwNDA_4a9d731d-7019-4b9f-beec-5b611a83c904">46.2</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i92bd1d25d98e4448ad3ea7952d2ee232_D20220101-20221231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzEwNDQ_78f241aa-ea6c-41a0-955a-8b8ade1a1dfc">46.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i5d681611048348019dc67e17504b3c0b_D20220101-20221231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzEwNTE_8111bdf4-b608-45a4-aed5-7fcc6b59108d">7.3</ix:nonFraction>% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div></ix:continuation><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_163"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDE1_318de0d4-8c1c-41a9-a178-888e0b794a69" continuedAt="ib4767492ca0f44ae91f61b7f52543bc5" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib4767492ca0f44ae91f61b7f52543bc5" continuedAt="i5f7d7b12da2a41bdb9d4740ab97831b4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NTIx_652a8b02-97b7-424b-8148-7da450ca0205" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NTA0_c88fa34a-c26f-4f31-b861-13a3aace3856" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2Njg0NTI_28352958-4235-469d-bbd0-4fb35d042a0b" continuedAt="i104d5891225d466d9cd320015db857b1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i5f7d7b12da2a41bdb9d4740ab97831b4" continuedAt="i7c66d89bf78e499bb8d7593e7b60fc9a"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i104d5891225d466d9cd320015db857b1">The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2MzQ_f5e05077-91ff-43df-9e68-c08c69def94d" continuedAt="i14e60d71ee264cab840849d10f2eb963" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2MzU_a3bebd50-7d41-4d8f-b672-721695fde314" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ForeignCurrencyDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2NDA_a125e393-992f-496f-b29a-89ca58fd930e" continuedAt="i03c47a7c01df4b54934b5126e076b147" escape="true">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="i03c47a7c01df4b54934b5126e076b147"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTpmZmUwNGNiYjNiYTA0OWVmYmZkYTBjMTU4NTlhOTc1Zi90YWJsZXJhbmdlOmZmZTA0Y2JiM2JhMDQ5ZWZiZmRhMGMxNTg1OWE5NzVmXzMtMS0xLTEtMTYxNTM1_a01210bb-ac11-4b8a-be91-7e79403ebf3e">25,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTpmZmUwNGNiYjNiYTA0OWVmYmZkYTBjMTU4NTlhOTc1Zi90YWJsZXJhbmdlOmZmZTA0Y2JiM2JhMDQ5ZWZiZmRhMGMxNTg1OWE5NzVmXzMtMi0xLTEtMTYxNTM1_d55d459a-27ad-475e-a76b-a27337f33911">14,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTpmZmUwNGNiYjNiYTA0OWVmYmZkYTBjMTU4NTlhOTc1Zi90YWJsZXJhbmdlOmZmZTA0Y2JiM2JhMDQ5ZWZiZmRhMGMxNTg1OWE5NzVmXzMtMy0xLTEtMTYxNTM1_24503e87-649f-4143-8cca-c5486a35fa75">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDIy_cc6a5489-a302-483a-918c-e817464f4695" continuedAt="icc5ebbff2a874556abecceab4e8f3785" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7c66d89bf78e499bb8d7593e7b60fc9a" continuedAt="i2394bebf1c634e6f94c0b4c5cdc76492"><ix:continuation id="icc5ebbff2a874556abecceab4e8f3785" continuedAt="ie5822df5381e4a1c8d066bb58035d6d1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2394bebf1c634e6f94c0b4c5cdc76492" continuedAt="i4ab639e256944fee9e1e3161eba62975"><ix:continuation id="ie5822df5381e4a1c8d066bb58035d6d1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDI5_c8e77d38-b313-48d9-a0b0-e622a39cbd99" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDgw_00b391a5-83c4-4379-a3eb-072adb5e172a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDE5_d0522630-540b-4f4e-a1bb-17e9c7c9de9f" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4ab639e256944fee9e1e3161eba62975" continuedAt="i7da8b33ea38d4c2582719229d762e62b"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDky_b54f1ac1-1a5e-4336-8e06-7f45548e5b70" continuedAt="idb736c09c42a45789be7d355afc05d98" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="idb736c09c42a45789be7d355afc05d98" continuedAt="ifc4bf3ad7ccd4807a1d1bd2ddfc0c691"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ifc4bf3ad7ccd4807a1d1bd2ddfc0c691"> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDk4_9b1307a5-ce35-4595-a5d8-59ff76b47962" continuedAt="if341b5acbe1d4ff2bb33b30f3d0d15d5" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDUz_c4889692-63dc-4d4e-8028-762f9fce1b09" continuedAt="i35eb289350314da59ec860ad40afcb95" escape="true">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i35eb289350314da59ec860ad40afcb95"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzEtMS0xLTEtMTQzMjg2_f63dac4f-f468-47a7-b6fc-5fa612fd0407">40</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7e66e1c160f148649eb21d89bbf2625a_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzItMS0xLTEtMTQzMjg2L3RleHRyZWdpb246MTY5OGM4YzdlOGFiNGU2NzgzZWZkNmNjZTk4Y2Q1MmZfNA_da570dcd-0ba5-48b3-bf54-c7e8d1cfd5b2">2</ix:nonNumeric>-<ix:nonNumeric contextRef="i2f8a2c39e7124f16b49ad2a09d9b25af_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzItMS0xLTEtMTQzMjg2L3RleHRyZWdpb246MTY5OGM4YzdlOGFiNGU2NzgzZWZkNmNjZTk4Y2Q1MmZfNw_ffb42a75-3eaf-434e-a057-f822be98c98d">8</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8aa76511dda54693974dbb4e12681b0e_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzMtMS0xLTEtMTQzMjg2_857e9494-5922-4897-90ad-10bf7d9a9ac9">8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2c614a0351ee4d65b7706dbb34ed6783_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzQtMS0xLTEtMTQzMjg2_95dd5e15-3ad8-4bd7-b9dd-2de20651d95a">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0cc8557895694ddda58a406b0e47873c_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzUtMS0xLTEtMTQzMjg2_f8b8ade1-ffd0-4eac-9c32-1eed33e62c48">5</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="if341b5acbe1d4ff2bb33b30f3d0d15d5">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDY4_03d3ea48-d7d4-468e-9b73-4cc690316411" continuedAt="iee9258448b484d74a7b617681d652df8" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2022 and December&#160;31, 2021, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7da8b33ea38d4c2582719229d762e62b" continuedAt="i76deb451bd1248869695d65fb6466fac"><div style="text-align:justify;text-indent:36pt"><ix:continuation id="iee9258448b484d74a7b617681d652df8"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2MzY_414e4612-0673-46b8-b457-95a1ae622e60" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives.  The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2NDI_67c0846d-dd30-4259-9ca5-d47e363df033" continuedAt="id05f553aecda433fb83b37e5e0238f26" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i423bdb53508049b790b135a49d542ab9_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzEtMS0xLTEtMTY3NTEx_1834c3ff-4653-4cbc-ac55-b934ac646bd5">23</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff41f4c3905c417bbe6fbf9952151d95_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzItMS0xLTEtMTY3NTEx_c39a35e3-1c3f-462f-b097-2a5448704b9b">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4ff6c4c1b4574a40829f531f7210e9bc_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzMtMS0xLTEtMTY3NTEx_a2cb844b-bc9c-4cd4-8aea-508417698ef8">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idb366a4aaf994d7e840ad3fff4c1fe43_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzQtMS0xLTEtMTY3NTEx_f93c64d7-6f75-4bda-ad8e-09340e9a2902">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69bb660dc51543a1937c2ecfd5d7b2b5_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzUtMS0xLTEtMTY3NTEx_a6ba9457-6745-4aa2-8170-15db75d0f9e5">5</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2Mzc_044e6118-121c-4778-b4f9-9d3d4c895882" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2MzMyNzA_e9b6a36e-f02d-4276-808c-263775dfef43" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2Mzg_f4ab55f9-4ec4-4432-8bd8-493bfede05b3" continuedAt="ib13f3b9006d74e40b501d51249bf2203" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i76deb451bd1248869695d65fb6466fac" continuedAt="ia4fdd42ce0c94a79ad3c19fd035049c3"><ix:continuation id="ib13f3b9006d74e40b501d51249bf2203"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDI3_ba1a2b4a-4761-48e4-962e-e2f8fc3a34a5" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:GovernmentGrantsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDI4_3f050551-d648-43f7-aaeb-0a09b5c4ffe4" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ResearchandDevelopmentCreditsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDg5_217b3110-6d5c-4452-9bb1-2dc7a8806af3" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDA1_1dd29467-03a4-481d-8ef8-914ff0ae9dc7" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NTEz_4f4b122b-590c-421b-8180-eb450797fdbf" continuedAt="ie6536639ed3643629eec6a11bca9fe94" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation &#8211; Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ia4fdd42ce0c94a79ad3c19fd035049c3" continuedAt="i49bce0ac81dd4cef874d26468f44723c"><ix:continuation id="ie6536639ed3643629eec6a11bca9fe94"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div></ix:continuation><div><span><br/></span></div><ix:continuation id="i14e60d71ee264cab840849d10f2eb963"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDk3_25c6b92c-455b-47e5-bf26-9435a457d8f1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2MzMyNzE_3711d120-89cf-4019-8430-453e85c30642" continuedAt="ie6ba0e3541f4432291b2dc58c3622c62" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Redeemable noncontrolling interests and equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took <ix:nonFraction unitRef="number" contextRef="i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309" decimals="INF" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzgyNDYzMzczOTcwMzg_f2441008-9e63-4545-a6cc-915b66a07630">100</ix:nonFraction>% ownership of MeDiNova. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie6ba0e3541f4432291b2dc58c3622c62">Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2Mzk_6cc0da4c-bf8b-428e-a90f-df0b2cd198ca" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i49bce0ac81dd4cef874d26468f44723c"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDQ0_38556d43-9e46-4e25-9fc5-c9b5d6b07dbe" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#8217;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#8217;s presentation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2Njk2MTE_02518b0e-8090-4ee9-b28f-c10212decdc7" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#8217;s consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_217"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90ZXh0cmVnaW9uOmZlNWQxZWRiZjFkYTQwZWRhYmQ4NWUxZjQ2YjdjZmI1XzIzMA_4cdd1eff-2cfc-4d41-a1b8-90ecab6bafa4" continuedAt="i1ac711988c194568a99d1fe503bfd953" escape="true">Disaggregation of Revenue</ix:nonNumeric></span></div><ix:continuation id="i1ac711988c194568a99d1fe503bfd953" continuedAt="i17d8143079de42a099893fe19daf2cff"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90ZXh0cmVnaW9uOmZlNWQxZWRiZjFkYTQwZWRhYmQ4NWUxZjQ2YjdjZmI1XzIzMw_ec614642-ff4e-4b17-9600-b506dda9ab66" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b703a470aec45d6b7cc535d913a035b_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzMtMS0xLTEtMTQzMjg2_b2c493b7-d1a1-42d2-a482-625bdd0fec70">683,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i380e176b9dde4914abac25ae65cca717_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzMtMi0xLTEtMTQzMjg2_abb84147-0e82-4fc7-b070-a4220be610fe">441,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1998d53019114a92910d0b987e09e9eb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzMtMy0xLTEtMTQzMjg2_ff81b933-a468-4655-80ff-738128dd391c">337,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79832711688241cdbc03301d09dc65ed_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzQtMS0xLTEtMTQzMjg2_8d03eda6-6d6f-4557-a841-11b0e1517ee3">1,506,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4f29d3e2b241b690b68915c03d5e7d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzQtMi0xLTEtMTQzMjg2_1c42973e-e8a2-4221-b069-8836e152d736">1,291,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia706efb7e7544d30a249a2933512bbd5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzQtMy0xLTEtMTQzMjg2_259faf80-944c-45a7-811b-7cc5c5746d10">754,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdedac9e58504241a677dd5e16834802_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzUtMS0xLTEtMTQzMjg2_af22f1ed-79f0-49cc-8515-5d30518ad467">1,112,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56f70ffa378f4eb6b7bea34717f35edc_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzUtMi0xLTEtMTQzMjg2_812c7a3c-46cd-4ee4-b0e3-a7e1214e8cae">752,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d0066899c49400d88bd9e23928ccc84_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzUtMy0xLTEtMTQzMjg2_726a9f5a-d5ba-438f-afaa-041326fd378c">350,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id595e6ca907842c5ad25832951a08162_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzYtMS0xLTEtMTQzMjg2_ebcdf243-0fda-43fa-a0c9-0844f03f7c63">1,585,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f2210593f144b18961bb25bb1f64c3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzYtMi0xLTEtMTQzMjg2_f59576a9-9325-4a03-9016-445135cf6dc2">1,077,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8bcfc7e9ad4cd49adf68eaea5ab3c5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzYtMy0xLTEtMTQzMjg2_22900b68-a910-4a3e-a465-28bed2aa0444">501,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ee1247f39e40e095600c4da686996e_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzctMS0xLTEtMTQzMjg2_b3464f29-8524-4a72-b886-607773c07eef">2,853,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f0ea2e03f744609e1793a8709bb329_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzctMi0xLTEtMTQzMjg2_bca10b50-ab57-45d1-afdd-02e52e716500">1,918,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc54966d15445729a0ed93be99fdbd0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzctMy0xLTEtMTQzMjg2_5eb73432-bb1f-4cc3-ba13-f88399f792d0">851,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzgtMS0xLTEtMTQzMjg2_38b429ee-f74d-42ef-9c04-cb50edbf71f7">7,741,386</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzgtMi0xLTEtMTQzMjg2_3d72eaf7-6e9f-4f81-92b4-68701ec4504e">5,480,826</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzgtMy0xLTEtMTQzMjg2_7d124df7-ac52-4422-9090-7a9f33adbd80">2,797,288</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i17d8143079de42a099893fe19daf2cff" continuedAt="id4a1486000284badaf9db70956b85738">Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.</ix:continuation>  </span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_220"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4. <ix:continuation id="id4a1486000284badaf9db70956b85738" continuedAt="ie6cb1e16f97c4bd0a702e1c74cfa60f5">Contract Balances</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="ie6cb1e16f97c4bd0a702e1c74cfa60f5" continuedAt="ie5fb38d697fd48bda6db2e904ed3b2dc"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMzMjQ_1c2303eb-838b-4871-b450-1e7935d49675" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzItMS0xLTEtMTQzMjg2_6e5a7861-a13f-449d-8ffc-210699a119a1">1,751,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzItMy0xLTEtMTQzMjg2_16978593-e423-4fd7-8106-855ba2a0b0ca">1,349,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzMtMS0xLTEtMTQzMjg2_447c3030-fcba-483e-910d-386f1410d163">20,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzMtMy0xLTEtMTQzMjg2_231d2327-c0c2-450c-804b-f9498248dbe0">7,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzQtMS0xLTEtMTQzMjg2_d5921fb1-a175-4ba8-a385-8493446cd635">1,731,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzQtMy0xLTEtMTQzMjg2_c7e0988b-fc09-474c-a60d-24a859fbf978">1,342,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzUtMS0xLTEtMTQzMjg2_1dfc7e88-d156-4b00-a14a-e901fb50e084">957,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzUtMy0xLTEtMTQzMjg2_e239eda0-ab72-424d-953f-1bd9c82f41d1">623,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzYtMS0xLTEtMTQzMjg2_bf8c14e0-71e9-44db-86c4-551b1fe82ad5">2,689,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzYtMy0xLTEtMTQzMjg2_534a0d45-d1f3-4039-b200-72da0acdd2fd">1,965,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItMS0xLTEtMTQzMjg2_f6c6fa15-08a0-45c3-95b4-033d7af8df1e">957,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItMy0xLTEtMTQzMjg2_262ae3ba-be41-4090-aca0-4a88871f4ec0">623,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItNS0xLTEtMTQzMjg2_caad8733-f2e7-48c3-9bc3-9712ec0d87f6">334,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="3" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItNy0xLTEtMTQzMjg2_3d13c088-6253-431c-843d-43393d481c7a">53.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtMS0xLTEtMTQzMjg2_71c06302-e215-4c74-b43d-3b55a9a348d7">1,507,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtMy0xLTEtMTQzMjg2_27fc2cfd-ebc9-470a-9e99-79e2380dd7a2">1,323,961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtNS0xLTEtMTQzMjg2_d06ffff6-2bc2-4bcf-874f-99e2104d9c26">183,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="3" name="iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtNy0xLTEtMTQzMjg2_f596ff54-a54d-4655-8203-f70a408a0079">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtMS0xLTEtMTQzMjg2_2ad12574-1cc6-4875-aab1-ceefd608aa9b">549,794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtMy0xLTEtMTQzMjg2_5df867f0-42cc-4bbe-af88-5b123ea8e7e3">700,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtNS0xLTEtMTQzMjg2_a5312ef8-4413-47a8-ab09-54a2ed74819b">151,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="3" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtNy0xLTEtMTQzMjg2_00af337f-7336-44ba-8216-e24b178d43a4">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie5fb38d697fd48bda6db2e904ed3b2dc" continuedAt="iefefbbde8c504354979db23dc4de93ce"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzU0OTc1NTgxNDIyMTg_2007f106-d6ae-4167-8ba4-4a0f623da344">406.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzU0OTc1NTgxNDIyMDk_f51af9a2-4894-40d0-bd5f-0b17d58d580f">323.6</ix:nonFraction>&#160;million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2022 increased by $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzIwMTQ_f419355a-f7b5-499a-84e8-bce564063e1f">334.5</ix:nonFraction> million as compared to December&#160;31, 2021. Unearned revenue increased by $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzIwNTk_0fd938c4-db6d-43b6-9b0b-234da28b00bb">183.5</ix:nonFraction> million over the same period resulting in a decrease of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzIxMTA_de31cc8e-f27e-4c05-9d61-f45da25b0337">151.0</ix:nonFraction> million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2021 and December&#160;31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzI5MTk_efcb0d3b-c5ad-4fb1-9f0e-6b00e9b18f81">17.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzI5MjY_48fa965e-b1d4-455f-9471-9fbc57b159aa">0.9</ix:nonFraction>&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iefefbbde8c504354979db23dc4de93ce">As of December&#160;31, 2022 approximately $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMwMDY_12dde4dd-15c2-49eb-88ba-e1f11da696b9">13.7</ix:nonFraction> billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzE2NDkyNjc0NDU3MDk_a8946e72-08b4-4ef4-a795-22791127f2aa">13.3</ix:nonFraction>&#160;billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately <ix:nonFraction unitRef="number" contextRef="iff7ba07c4dd648098208327ed22330c8_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMxNzI_c196a26b-53ab-4952-bd24-e4fd392e9514">52</ix:nonFraction>% of the unrealized performance obligation over the next <ix:nonNumeric contextRef="iff7ba07c4dd648098208327ed22330c8_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMyMzA_73e66060-9ceb-4483-88dc-0381d87bb496"><ix:nonNumeric contextRef="i23de17af5ea240e78dfcd77718adcfbe_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMyMzA_e6b9392d-f6e6-4215-834f-68a930f71614">twelve months</ix:nonNumeric></ix:nonNumeric> compared to <ix:nonFraction unitRef="number" contextRef="i23de17af5ea240e78dfcd77718adcfbe_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzE2NDkyNjc0NDU3MjQ_f2bdd836-fc0c-4cef-8311-006424c32494">48</ix:nonFraction>% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.</ix:continuation>  </span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_223"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:AllowanceForDoubtfulAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90ZXh0cmVnaW9uOmYzZWI4YTBiM2Q4ZDQ0OTNhODhjMzcwYmEzYTRlZmRiXzE3Nw_13f3e736-ae99-4a5e-89c6-00a5c169a58c" continuedAt="i0dc8f0a7d00f49ba93f6b4b4d6a60f73" escape="true">Allowance for Credit Losses</ix:nonNumeric></span></div><ix:continuation id="i0dc8f0a7d00f49ba93f6b4b4d6a60f73"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:AllowanceForDoubtfulAccountsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90ZXh0cmVnaW9uOmYzZWI4YTBiM2Q4ZDQ0OTNhODhjMzcwYmEzYTRlZmRiXzE3Ng_00ce16ee-585a-435a-8595-5f7658416ed5" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2022 and December&#160;31, 2021 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzItMS0xLTEtMTQzMjg2_6ba04d3a-fd3b-448d-95e4-05ae70abaa2d">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzItMi0xLTEtMTQzMjg2_f7f601ee-4e83-47a5-9c99-e8ed2a9b0754">7,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzMtMS0xLTEtMTQzMjg2_d8fa3e33-d57f-43d6-babd-77572bce3b65">3,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzMtMi0xLTEtMTQzMjg2_d39ba66b-e58b-464c-a013-41a0dab618ac">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzQtMS0xLTEtMTQzMjg2_0798b657-3b55-4377-9d6a-9e0f804496ee">17,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzQtMi0xLTEtMTQzMjg2_b7abbe1f-897b-4d27-a227-8643015c643c">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:AccountsReceivableCreditLossReversal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzUtMS0xLTEtMTQzMjg2_900be7e4-550a-4284-9370-15e7b1f7bd0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:AccountsReceivableCreditLossReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzUtMi0xLTEtMTQzMjg2_d2328935-7963-45bc-b59d-551d629c35c3">544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzYtMS0xLTEtMTQzMjg2_defb8781-4162-4116-b2ea-a9e08538f47d">406</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzYtMi0xLTEtMTQzMjg2_a4f60601-6e53-43ac-87b2-35ff4e59b532">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzctMS0xLTEtMTQzMjg2_4a767eef-1951-45e4-94cf-32a6b26eb979">20,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzctMi0xLTEtMTQzMjg2_5a7e18b4-7f6e-4607-bbd8-c3627fa474f7">7,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">115</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxNDM_181d565e-f096-4b41-a4b0-c56fa245059d" continuedAt="if4c8bbd9a3364d30861b75fb32ac9a94" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if4c8bbd9a3364d30861b75fb32ac9a94" continuedAt="i0dfd23b664e24f1f8af7d53cce53452b"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately <ix:nonFraction unitRef="employee" contextRef="id34237e03be942cc9cc2d0552e1de455_I20210701" decimals="-3" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzQ3Mw_e33da7a2-e07d-4b4d-b447-9cbd1932cf28">38,000</ix:nonFraction> (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $<ix:nonFraction unitRef="usdPerShare" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="INF" name="iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzEzNDM_be14dbf6-91fd-4a4e-aa0c-d47ef4eab87c">80</ix:nonFraction> in cash and <ix:nonFraction unitRef="shares" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="4" name="iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzEzNTg_7a64b294-6327-45ed-ad9e-747715a77d2f">0.4125</ix:nonFraction> shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2022 and 2021, the Company incurred Merger-related expenses of $<ix:nonFraction unitRef="usd" contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzEwOTk1MTE2NDYxNzk_a16acadb-a5dd-444b-a776-be28c60776dd">39.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzcxNDY4MjU1OTE5Njg_22dd51ca-db81-42a4-aa93-2725f08f8787">198.3</ix:nonFraction> million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in transaction and integration costs in the years ended December&#160;31, 2022 and 2021 are acquisition related costs (as defined by ASC 805) of $<ix:nonFraction unitRef="usd" contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzE2NDkyNjc0NjM1MTI_563338c4-0452-4d71-97ca-a58905ce89a0">0.8</ix:nonFraction>&#160;million and  $<ix:nonFraction unitRef="usd" contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzE2NDkyNjc0NjM1MjY_877569d1-5b01-4e2f-8529-0e3d41ce6b5d">57.1</ix:nonFraction>&#160;million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also incurred approximately $<ix:nonFraction unitRef="usd" contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231" decimals="-5" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzIxOTc_5f0b7840-f5f6-48dc-9285-e5e70b1709d1">86.7</ix:nonFraction> million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations for the year ended December&#160;31, 2021. During the year ended December&#160;31, 2021, the Company deferred </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i8fc3e32cee5c4cfcbaa4850d89f898d9_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzQzOTgwNDY1MjIyNzU_558bee53-65f1-438b-b70c-5cb719ab7e79">76.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxMzg_2e483972-a418-47c9-94a0-0a2e92967713" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzEtMS0xLTEtMTQzMjg2_b75bc7ff-4ab3-4cb2-8daa-5de972f9ece8">5,308,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzItMS0xLTEtMTQzMjg2_2489d1e2-6d3c-485f-9589-aca1d105f4da">5,658,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredOther1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzMtMS0xLTEtMTQzMjg2_66a893e2-f98a-4c60-b37a-35ad92376be8">209,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzQtMS0xLTEtMTQzMjg2_31543dce-71d3-48e9-acc5-75b8b08601a1">865,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzUtMS0xLTEtMTQzMjg2_a90f8eb1-efe9-4110-8255-a32c606ef548">12,041,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $<ix:nonFraction unitRef="usd" contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701" decimals="-5" name="iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzI5MjQ_1e58767b-2fa9-45e9-8eba-b46baec4a6fd">401.6</ix:nonFraction>&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0dfd23b664e24f1f8af7d53cce53452b" continuedAt="ifccf3dce0528447387b663d99da1d31b"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxNDI_6f37706b-300b-4b6a-a25f-67ad2a3e86d7" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:84.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzMtMS0xLTEtMTQzMjg2_8f4ee08a-3e9e-4e46-b3b1-1f6ddb3d024a">259,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzQtMS0xLTEtMTQzMjg2_410bbc62-f6bd-4f61-b891-36e5f2d80eba">934,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzUtMS0xLTEtMTQzMjg2_cd23df19-b54f-4da0-a2b5-b8cd4220ae7f">125,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzYtMS0xLTEtMTQzMjg2_79d98fcc-3331-4138-8227-ca7e9a337059">156,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzctMS0xLTEtMTQzMjg2_5dd92be9-4bbf-4c54-bb22-ad10cfeb8c02">180,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzgtMS0xLTEtMTQzMjg2_6a3c1e8b-e2fb-424e-b962-371f1f6f7d06">8,084,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzktMS0xLTEtMTQzMjg2_91b4a6cf-df49-4662-80a9-6d268e54eb2e">4,919,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzEwLTEtMS0xLTE0MzI4Ng_8831a6c8-2edf-4e36-a8cb-59c76dc2db2f">25,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzExLTEtMS0xLTE0MzI4Ng_3d216ce8-1832-4d5e-9fce-6930be4923ce">33,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzEyLTEtMS0xLTE0MzI4Ng_dcef7fbb-b543-4439-be8f-684c0a2d1678">50,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzEzLTEtMS0xLTE0MzI4Ng_4f44d2b6-84a1-4bef-a850-219c62d01e1b">380,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE0LTEtMS0xLTE0MzI4Ng_a438fbc3-6103-407a-bee2-6c8b7a1f4317">36,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE1LTEtMS0xLTE0MzI4Ng_26bbfd2c-e01e-49ea-855a-df219d245de8">739,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE2LTEtMS0xLTE0MzI4Ng_c4832870-c756-4694-bd75-7d67e8527cc1">147,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE3LTEtMS0xLTE0MzI4Ng_ce8f857f-dd70-4309-b7a3-57f1d5bd337f">1,119,762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE4LTEtMS0xLTE0MzI4Ng_ae194dda-4e48-4a4e-92e3-25c40f04892e">204,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzIwLTEtMS0xLTE0MzI4Ng_a8a67cce-458c-48c5-9111-02b80f3dae08">12,041,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. <ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="INF" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzM1MTA_0bb97346-29b5-4e8e-838c-73e1cf7e7105">None</ix:nonFraction> of the goodwill recognized is deductible for income tax purposes.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxNDE_0998c78b-8000-4f5e-b278-7708437e7d96" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68cade11881441f999fe48a8b78fa866_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzEtMS0xLTEtMTQzMjg2_f4c7cbf8-8c97-4479-b065-71d1915cde7a">3,938,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i050bc2a0894b4b519c23ad5dce7c546e_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzEtMi0xLTEtMTQzMjg2_d312e9c6-ddcf-4bd9-b8ff-4bc532c1c7ff">23</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65f325e72d854376869d44f5fabc8e75_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzItMS0xLTEtMTQzMjg2_9ec86a56-4a0d-4f69-a15f-e34fbdbb8909">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i13749761bedc4da99e05caac9043517b_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzItMi0xLTEtMTQzMjg2_8427942c-1757-4788-85cc-d055b629d533">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d23344e0fb3451da6613835547ccb77_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzMtMS0xLTEtMTQzMjg2_3722fe83-6721-4aa1-9e04-859e236b3ed5">202,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80606786953145dfbdfda1d4010d7f1f_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzMtMi0xLTEtMTQzMjg2_9c82a5ec-ad7c-4eb6-b123-0e939343a353">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib000d5e1b7c444a98c09c3082b538879_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzQtMS0xLTEtMTQzMjg2_c7862559-5a76-4069-806d-0d91a270d14f">168,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8ea9f2d8c19438a8322337241492d6e_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzQtMi0xLTEtMTQzMjg2_60b788f5-cf48-44d9-9de1-a0ca8e336b87">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d00b00550d4bf9a90bced55d00862b_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzUtMS0xLTEtMTQzMjg2_e69ccfe8-8a5c-4101-a6af-bd3cb9ebda39">111,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i785f8636543e4f9b9285f8e0d63b6d2b_D20210701-20210701" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzUtMi0xLTEtMTQzMjg2_70fdf6d1-e989-4626-8ad5-708316823770">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzYtMS0xLTEtMTQzMjg2_44195621-7d33-4ac3-8244-e9b01c24aaf1">4,919,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ifccf3dce0528447387b663d99da1d31b"><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzE2NDkyNjc0NjE1ODM_49763e8d-a344-4c6c-b8c9-e89a08ee5894" continuedAt="ie2626f8459a64790b9fcc79149f5ec1f" escape="true">In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:</ix:nonNumeric></span></div><ix:continuation id="ie2626f8459a64790b9fcc79149f5ec1f"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzMtMS0xLTEtMTY0OTk1_174b3026-428f-4596-b341-24776502154c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzQtMS0xLTEtMTY0OTk1_862516d9-1f20-401f-8190-c85d4af0a851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzUtMS0xLTEtMTY0OTk1_d4a6f762-b988-4f87-a9fb-7167ceff32b0">14,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzYtMS0xLTEtMTY0OTk1_af62878e-e748-4b6f-9304-2901b0a797d0">6,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzctMS0xLTEtMTY0OTk1_c9fc0d91-337c-4eb2-b091-eb0f61dee8de">11,744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzgtMS0xLTEtMTY0OTk1_1fce7796-22fa-4d5f-93ca-daa78c8b4114">70,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzktMS0xLTEtMTY0OTk1_46db5bee-ff76-4819-900c-412879f142b2">44,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzEwLTEtMS0xLTE2NDk5NQ_4bb9c910-2f8b-4879-93f0-4c5f11c53a2f">147,039</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzExLTEtMS0xLTE2NDk5NQ_6e426b5a-3d39-422b-85f0-7e532337c4ff">1,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzEyLTEtMS0xLTE2NDk5NQ_9d0500a6-9e7a-4f8e-b7ac-f93b94f5fe85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzEzLTEtMS0xLTE2NDk5NQ_9ba4d2e7-ba49-42e9-8342-4dd1255491f6">37,496</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE0LTEtMS0xLTE2NDk5NQ_b7e5efbb-7a04-4a5d-b3f9-193222fd978d">1,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE1LTEtMS0xLTE2NDk5NQ_27e934b8-db2d-4343-97f6-ddf5a2cc8969">19,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE2LTEtMS0xLTE2NDk5NQ_c39e5bc1-e837-485e-a330-36d64cd00bc4">10,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE3LTEtMS0xLTE2NDk5NQ_7b33160c-207e-49a8-bf73-834f6d9537cc">193,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231" decimals="-3" sign="-" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE4LTEtMS0xLTE2NDk5NQ_bd01ebf7-d7ee-4b1b-8103-32e4ccd45db8">151,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December&#160;31, 2022, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231" decimals="-3" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzM4NDgyOTA3MTcxMzg_99a6da18-5660-4b1f-a1a9-86e8bc1eebde">2.2</ix:nonFraction>&#160;million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $<ix:nonFraction unitRef="usd" contextRef="i17edec93a2294c3e907c490cbb645326_D20220101-20221231" decimals="-3" name="iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzM4NDgyOTA3MTcxNTI_6811d942-8879-4641-9a46-f2cf7a760f61">16.0</ix:nonFraction>&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div></ix:continuation></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_199"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzMyNDc_91619d44-3483-44ad-9620-4b9ae406cc29" continuedAt="i6b89aa0142c446ee9a5348adc40257ed" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6b89aa0142c446ee9a5348adc40257ed" continuedAt="i7fa08f0683694e06abbe7b9e51611d71"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7fa08f0683694e06abbe7b9e51611d71"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzE2NDkyNjc0NTY4NjA_19526bd0-61d5-435c-8b98-fcc0f86cd396" escape="true"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzE2NDkyNjc0NTY4NjQ_5cee5acd-07ea-4b62-bcb9-003ed49b4945" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545583d261e248808f2d3bb26a97013b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItMS0xLTEtMTY5NDYy_05c47629-f696-448b-88dc-fa4bcde4ecec">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItMi0xLTEtMTY5NDYy_7fb673c3-f5ee-410e-90a2-8eef0f533a00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItMy0xLTEtMTY5NDYy_bb022c26-d2d6-4ffa-9f03-cce88aee44a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItNC0xLTEtMTY5NDYy_e523855a-2c58-48c4-b25c-4d28b8365c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItNS0xLTEtMTY5NDYy_187ff815-aa75-4bba-8e91-32039b669987">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545583d261e248808f2d3bb26a97013b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtMS0xLTEtMTY5NDYy_b966648d-04a2-49db-9e9b-e580a0d4d435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtMi0xLTEtMTY5NDYy_209f1771-286a-4128-94df-087e9d498c39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtMy0xLTEtMTY5NDYy_f40e92fa-9dad-4d78-abb6-df56e5b0cffc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtNC0xLTEtMTY5NDYy_267846e6-5797-4813-8ee8-ded704909dc2">32,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtNS0xLTEtMTY5NDYy_71298aef-763f-4f21-8121-ca7c46122011">32,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978c79fbe78442ada8654ab753363b19_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMS0xLTEtMTcwNzQ0_8e202975-c44c-4b84-a7ba-d27957f64d9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i84f84f639a8649b7a29a53533025129f_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMi0xLTEtMTcwNjU5_b85f2592-4666-4d20-bb0f-8eaefcc6755d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be311173d9c44eaafe06fb2c2cbcb3c_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMy0xLTEtMTcwNzQ0_e0864b11-747f-41aa-9edb-c64771245837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90e03c93c3749469a8dfb4fe97cb995_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNC0xLTEtMTcwNzQ0_aed8326c-bd8e-4686-8ad9-6ccf92d1669e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30afec82ea9e4d6a8f448ccc557ea553_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNS0xLTEtMTcwNzQ0_e2a6ee4f-6d97-4bd2-9544-0208fc93f4e4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545583d261e248808f2d3bb26a97013b_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMS0xLTEtMTY5NDYy_f7c9b320-60e2-4f6b-9c7f-51157913d61d">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMi0xLTEtMTY5NDYy_b8476acb-69be-444a-a296-8075f794fb4f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMy0xLTEtMTY5NDYy_bffe0939-8101-478e-8500-b55efd44e1fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNC0xLTEtMTY5NDYy_f7b63c1b-fc2d-47a6-83f6-4fbb4249b510">32,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNS0xLTEtMTY5NDYy_088968d4-a76c-4bcc-a06f-dbbfcd29ab3b">34,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i978c79fbe78442ada8654ab753363b19_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctMS0xLTEtMTY5NDYy_7fcb559e-5a2b-4a45-bed5-bac4c597ab43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i84f84f639a8649b7a29a53533025129f_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctMi0xLTEtMTY5NDYy_843759fb-49e0-45d1-b094-ab156525f21b">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i3be311173d9c44eaafe06fb2c2cbcb3c_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctMy0xLTEtMTY5NDYy_76262551-b3ab-407a-bb4e-5d69e3e7ec81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if90e03c93c3749469a8dfb4fe97cb995_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctNC0xLTEtMTY5NDYy_8c4fc710-40bb-498b-a46e-921950f1b630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30afec82ea9e4d6a8f448ccc557ea553_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctNS0xLTEtMTY5NDYy_0c216717-33ca-46f9-bae0-137a14b10886">3,670</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545583d261e248808f2d3bb26a97013b_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtMS0xLTEtMTY5NDYy_2d4933ff-0018-4806-8fc2-81c4b139322d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtMi0xLTEtMTY5NDYy_2024e986-6233-4596-adde-a8467674336f">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtMy0xLTEtMTY5NDYy_12340e53-81a4-4cd4-90d7-6c8444981bc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtNC0xLTEtMTY5NDYy_ca14c2d6-0cbe-48f6-a302-da609c078bb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtNS0xLTEtMTY5NDYy_ae6a2707-96bb-40fa-a21e-3fd060ebb421">3,670</ix:nonFraction></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19fb8c40650e450eb5e1d079288ab103_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItMS0xLTEtMTY5NTA0_ce8c4749-a130-48b7-b866-5b98e69caecf">1,712</ix:nonFraction></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dd30bace194434bd26b61b92a84a73_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItMi0xLTEtMTY5NTA0_e959f695-17c0-4a0d-ae64-41fdd3dbb25b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22508cde176416eab9afbb5c12f542f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItMy0xLTEtMTY5NTA0_3424dc99-9b53-42af-854a-7fa5106e8be6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia559e02117534d508ae08e434af35be9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItNC0xLTEtMTY5NTA0_4195744b-f6b6-40e9-97c2-9e906fe1b678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItNS0xLTEtMTY5NTA0_60bab802-ebe5-42eb-9753-4802fb7b6f73">1,712</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19fb8c40650e450eb5e1d079288ab103_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtMS0xLTEtMTY5NTA0_12f60bf1-3e3e-4419-a503-5c08841a74d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dd30bace194434bd26b61b92a84a73_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtMi0xLTEtMTY5NTA0_1d69e49b-1388-40e6-8af2-61e1a0824f22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22508cde176416eab9afbb5c12f542f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtMy0xLTEtMTY5NTA0_2e352843-3d64-4ccb-a898-22fb3c3a13fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia559e02117534d508ae08e434af35be9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtNC0xLTEtMTY5NTA0_d3edb7b8-4151-40d2-a4de-e63120c80f55">20,579</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtNS0xLTEtMTY5NTA0_f64da89e-eec3-4e1e-ad45-fc1e3879d348">20,579</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19fb8c40650e450eb5e1d079288ab103_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtMS0xLTEtMTY5NTIx_cd08e471-4dee-4b03-90c9-38e49efd654e">1,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dd30bace194434bd26b61b92a84a73_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtMi0xLTEtMTY5NTIx_a76deec1-2935-4612-8d8c-6f35a539271c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22508cde176416eab9afbb5c12f542f_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtMy0xLTEtMTY5NTIx_019a3b40-5a34-4530-902e-abb6eb21f7cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia559e02117534d508ae08e434af35be9_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtNC0xLTEtMTY5NTIx_3a2bdb16-9e8a-408e-86d1-af3df781835e">20,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtNS0xLTEtMTY5NTIx_9c88cc9e-a0b8-443a-bf66-164e16490656">22,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2022, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ia1b4df5e6293480bb188a651b53aa3c9_I20221231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzE5MzA_e75e5b39-cb06-4c70-8d17-6adae8f51af2">13,250.4</ix:nonFraction> million and are identified as Level 3 assets. These assets are comprised of goodwill of $<ix:nonFraction unitRef="usd" contextRef="ia1b4df5e6293480bb188a651b53aa3c9_I20221231" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzMwNDk_d8a9f6d3-79bd-489d-8f2b-b7b3799f0ee5">8,971.7</ix:nonFraction> million and identifiable intangible assets, net of $<ix:nonFraction unitRef="usd" contextRef="i9eac6e85f2054a39b9b4982e267fcdef_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzE5Mzg_9e041bf7-ebf4-472b-b65c-3d80fc2d8be3">4,278.7</ix:nonFraction> million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the fair value of total debt approximated $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzU5Mzg_daade98a-c779-4102-9d01-6725e1c1d936">4,650.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzU5NDY_4657cbf2-efa6-49f4-a38d-8128d5560fe7">5,507.2</ix:nonFraction>&#160;million, respectively, as determined under Level 2 measurement for these financial instruments.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE2MzU_eb2cf38c-2681-464c-972b-b8227443ea84" continuedAt="i06cee0f1225b4c28b23fb735b038d1cf" escape="true">Investments</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i06cee0f1225b4c28b23fb735b038d1cf" continuedAt="i701cf6411bad4529a03291d9839a19fb"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Available for sale investments (short-term)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company held $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzcxNDY4MjU1ODI0Mjc_40fcbefe-9a39-4584-a01c-fa61603bf5ec"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzcxNDY4MjU1ODI0Mjc_e2454544-3e4d-43eb-b624-711913d5b06b">1.7</ix:nonFraction></ix:nonFraction>&#160;million of available for sale investments at both December&#160;31, 2022 and December&#160;31, 2021.  The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short term investments at December&#160;31, 2022 have an average maturity of <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzEwOTk1MTE2Mjk0MTg_1ed4ae41-4feb-427c-8192-8418596a3be2">2.8</ix:nonNumeric> years compared to <ix:nonNumeric contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" name="iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzM2Ng_56534adf-3993-46d0-a375-fc38118616ef">2.7</ix:nonNumeric> years at December&#160;31, 2021. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Available for sale investments (long-term)</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i701cf6411bad4529a03291d9839a19fb" continuedAt="ic3e9ab3bcbd94a3aa3a0341b5763af35"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. Capital totaling $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzEwMDU_47103bfe-0f0e-4791-a73f-a6f5505e25e8">20.6</ix:nonFraction> million had been advanced under the terms of the subscription agreements at December&#160;31, 2022 (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzEwODQ_569da785-4c7d-4431-8815-38fcd9233d92">16.9</ix:nonFraction> million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE0MTI_23b708d8-cd32-4660-b194-d918428c6323">6.3</ix:nonFraction> million (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE0MjA_4cb3794d-9aa3-4567-b754-4fcb84c4fd03">3.2</ix:nonFraction> million) recognized in net income during the year bringing the carrying value of the subscriptions to $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE1MTc_aed770d4-3530-4e3f-b72d-fec2097ce110">32.6</ix:nonFraction> million at December&#160;31, 2022 (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE1MzE_d9221a46-2db3-4dbc-8c1b-6ccf33b60347">22.6</ix:nonFraction> million).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic3e9ab3bcbd94a3aa3a0341b5763af35" continuedAt="i5f6648ce79ab41fbbf8e0237b9c749d7">December&#160;31, 2022, the Company had committed to future investments of $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="iclr:CommitmentToAcquireLongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE1OTQ_be81d66b-5837-4afc-ab39-ab8b20485694">23.3</ix:nonFraction> million in respect of these funds.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_169"></div><ix:continuation id="i5f6648ce79ab41fbbf8e0237b9c749d7"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160; Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has invested $<ix:nonFraction unitRef="usd" contextRef="ia09cfcf09c5a4518ae153515930d8057_I20200724" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzYx_1d7833c6-06b1-490c-9768-602e4867ced8">4.9</ix:nonFraction> million to obtain a <ix:nonFraction unitRef="number" contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzc2_2bcd9847-d90b-4301-9177-0d506e9be680">49</ix:nonFraction>% interest in the voting share capital of Oncacare. The Company&#8217;s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor has the right to sell the <ix:nonFraction unitRef="number" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzYxMg_599f0408-2546-468e-92f8-de17493de51d">51</ix:nonFraction>% majority voting share capital exclusively to the Company in an <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEzNzA_a812eb9d-1e00-45ac-83c7-a6099fe49c8a">eighteen month</ix:nonNumeric> period, commencing January 1, 2023 and ICON also has the right to acquire the <ix:nonFraction unitRef="number" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzc2NQ_599f0408-2546-468e-92f8-de17493de51d">51</ix:nonFraction>% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEzNzE_fc0b471b-a54e-4030-975e-fb329198d4dc" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90YWJsZTowMWI5YjVjOTlkOWM0Nzg5OTlkMzlhMWVlY2VhNGZhYS90YWJsZXJhbmdlOjAxYjliNWM5OWQ5YzQ3ODk5OWQzOWExZWVjZWE0ZmFhXzQtMS0xLTEtMTQzMjg2_d34c8135-d804-4f9c-a427-a7b1ba07ba3f">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90YWJsZTowMWI5YjVjOTlkOWM0Nzg5OTlkMzlhMWVlY2VhNGZhYS90YWJsZXJhbmdlOjAxYjliNWM5OWQ5YzQ3ODk5OWQzOWExZWVjZWE0ZmFhXzQtMi0xLTEtMTQzMjg2_5d972b9e-eb7c-4de1-9245-0713da09f5a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90YWJsZTowMWI5YjVjOTlkOWM0Nzg5OTlkMzlhMWVlY2VhNGZhYS90YWJsZXJhbmdlOjAxYjliNWM5OWQ5YzQ3ODk5OWQzOWExZWVjZWE0ZmFhXzQtMy0xLTEtMTQzMjg2_def29e18-3ad3-453a-a6d1-45e0a3e5bb32">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company provided a loan of $<ix:nonFraction unitRef="usd" contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231" decimals="-6" name="us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzExNDM_bdc3ff16-bd07-4f7a-9450-568f229a7658">10</ix:nonFraction>&#160;million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at <ix:nonFraction unitRef="number" contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231" decimals="3" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEyNjU_ae2b44cc-cfca-4465-bd24-9268f389504a">1.6</ix:nonFraction>% and the loan is repayable on June 30, 2025. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded losses of $<ix:nonFraction unitRef="usd" contextRef="ia961c12b79494b50a3b7b747a2ce04be_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzIwODkwNzIwOTMxNzUw_187d48ae-b1b9-4f5b-8796-2a593e943fc8">3.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idf5fe76c69e241d7915327e838e9518c_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzIwODkwNzIwOTMxNzU4_d152ae39-b8af-40b6-affa-12e465ab62fc">2.2</ix:nonFraction>&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $<ix:nonFraction unitRef="usd" contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231" decimals="-5" sign="-" name="iclr:IncreaseDecreaseInEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzcxNDY4MjU1ODM2ODI_022c9384-55ec-491e-968b-acaf0eb99758">2.3</ix:nonFraction>&#160;million of pro rata losses.  The remaining $<ix:nonFraction unitRef="usd" contextRef="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231" decimals="-5" name="iclr:EquityMethodInvestmentDecreaseInLoanReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEwOTk1MTE2MzIwNDM_7786fe85-be3e-439a-a649-70c0d4d47502">0.8</ix:nonFraction>&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare.  The outstanding balance of the Company's loan receivable with Oncacare at December&#160;31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="ic314749132274d02aea042862e1ff17e_I20221231" decimals="-3" name="us-gaap:LoansAndLeasesReceivableRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzE2NDkyNjc0NDcwNjQ_69c2b9ce-a3d2-4a48-9500-72e203ff891f">9.2</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90ZXh0cmVnaW9uOmEyZjZjYTM4NzEzYzQ2MGM4ZDQyNGFmMzhmZTM3NmQ5XzI3MA_a58592e8-e1da-48c0-a146-28985b00f0bb" continuedAt="i0f868ed9e6bd4dba8f9926b1354ca5bd" escape="true">Property, Plant and Equipment, net</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0f868ed9e6bd4dba8f9926b1354ca5bd"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90ZXh0cmVnaW9uOmEyZjZjYTM4NzEzYzQ2MGM4ZDQyNGFmMzhmZTM3NmQ5XzI3NA_d016f560-d24c-4633-a9a3-1e4c4faa6820" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzMtMS0xLTEtMTQzMjg2_f154cb2b-7411-4107-89e6-dc924f4e25d2">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzMtMi0xLTEtMTQzMjg2_03fc10fb-62ef-4d08-bc4f-8faeaee7fc47">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzQtMS0xLTEtMTQzMjg2_49de2735-f018-4aed-9861-11e064b35c71">70,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzQtMi0xLTEtMTQzMjg2_286d6979-c08c-4d8f-a24a-7e94b7454d03">82,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzUtMS0xLTEtMTQzMjg2_2abb6d08-af57-42c4-bd46-d4dc50b276c3">500,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzUtMi0xLTEtMTQzMjg2_69bb529c-108b-44ad-aefc-72059f0105a1">506,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzYtMS0xLTEtMTQzMjg2_e6812300-53f6-4638-a198-8b73d8ebe813">50,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzYtMi0xLTEtMTQzMjg2_ccda11a1-a7aa-4b15-8973-79bc67f6aff5">107,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzctMS0xLTEtMTQzMjg2_3f124f17-d3de-4ec6-8798-810553e59458">59,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzctMi0xLTEtMTQzMjg2_b27e03ae-1e02-4184-aabc-a6dc92279ec4">29,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzgtMS0xLTEtMTQzMjg2_b2d44084-dd66-4744-bd96-43c114fe42a9">65,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzgtMi0xLTEtMTQzMjg2_35c6b877-9837-4be0-a55d-d6cef50fa8e5">70,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:VehiclesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzktMS0xLTEtMTQzMjg2_5a93665d-0905-4cd3-947f-92bec6be9216">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:VehiclesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzktMi0xLTEtMTQzMjg2_708e39ec-17a5-4aaa-befb-5ed23c1b6c67">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzExLTEtMS0xLTE0MzI4Ng_792f5602-d23d-48cd-8e70-3658c358e5fd">750,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzExLTItMS0xLTE0MzI4Ng_da90a622-d581-4bcb-bd0a-4ef90cd44e23">798,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzEyLTEtMS0xLTE0MzI4Ng_485a1fc8-dfa2-42fc-a8f9-1d4f48b3fd47">400,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzEyLTItMS0xLTE0MzI4Ng_793a3bfa-4662-476f-a4d1-c8090bf8083a">462,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzE0LTEtMS0xLTE0MzI4Ng_0b78756a-03c9-4931-a631-f32c43311f17">350,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzE0LTItMS0xLTE0MzI4Ng_de74b289-23ba-4ae1-9caf-1ec38102ea2a">336,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment depreciation expense is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTplZTY0NWQ0MjM1MDQ0NTdjOWRjNDA5ZjBlZThhMGE4Zi90YWJsZXJhbmdlOmVlNjQ1ZDQyMzUwNDQ1N2M5ZGM0MDlmMGVlOGEwYThmXzItMS0xLTEtMTcyMTU5_b9d904a7-974f-43f2-bd6d-0dc8a9bfd78c">106,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTplZTY0NWQ0MjM1MDQ0NTdjOWRjNDA5ZjBlZThhMGE4Zi90YWJsZXJhbmdlOmVlNjQ1ZDQyMzUwNDQ1N2M5ZGM0MDlmMGVlOGEwYThmXzItMi0xLTEtMTcyMTU5_2099266b-7c89-4853-95ee-43ef222f57e5">75,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2022 and the year ended December&#160;31, 2021, certain fully depreciated assets were written off as they were no longer used in the Company.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_172"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzgwMQ_df7d0752-26a1-45de-98c5-b0b66a92db03" continuedAt="i088fde898ef940c9961ddd2c1e530c32" escape="true">Goodwill</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i088fde898ef940c9961ddd2c1e530c32"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzc5NA_2351a227-b193-4d60-a0d0-3f0ec5cabe02" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of Goodwill for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzItMS0xLTEtMTQzMjg2_9e910779-d256-4f33-a440-fc843e14fea8">9,037,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzItMi0xLTEtMTQzMjg2_58cc647f-a078-46cf-aebc-6c6093715d68">936,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzMtMS0xLTEtMTQzMjg2_2fc6d08e-84d2-4ff7-af4f-26b598d1375d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzMtMi0xLTEtMTQzMjg2_f510adcc-0df5-4974-9faf-da4d12c3df5d">8,120,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzQtMS0xLTEtMTQzMjg2_d9401f94-0832-43b8-9f8b-c2e300a6c375">35,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzQtMi0xLTEtMTQzMjg2_e4ab3f44-f46f-459f-af08-10a3cd73e978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzUtMS0xLTEtMTQzMjg2_810341ef-8b7b-4d1a-8a2a-a5851300fddc">30,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzUtMi0xLTEtMTQzMjg2_aeee00fc-4f53-4481-b4d2-451014dfde2d">18,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzYtMS0xLTEtMTQzMjg2_91f30120-9a3e-4b9e-b8a6-73cb505f214a">8,971,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzYtMi0xLTEtMTQzMjg2_a292bef6-ad7a-494d-b1d6-d32754257cf9">9,037,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzI1Mjg4NzY3NDQyMTg0_c4845588-ad15-4dd3-9cfa-8c3e9db8dc0f"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzI1Mjg4NzY3NDQyMTg0_cf7f0f38-7e5a-47cf-abb8-21fd08a9950d">no</ix:nonFraction></ix:nonFraction> goodwill impairment losses for the years ended December&#160;31, 2022 and 2021.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzEzNDE_179e1b4c-df2c-4191-b9d9-ba8596e7b1aa" continuedAt="i5b70642946b747e789946b1ea59fa73a" escape="true">Intangible Assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i5b70642946b747e789946b1ea59fa73a"><ix:continuation id="id05f553aecda433fb83b37e5e0238f26"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f27ae8e7bb4ec5971a6b2ef9dd55a9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzItMS0xLTEtMTQzMjg2_924c2205-5096-43a0-9b04-a74fe092127f">4,076,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a1a18520e4146e3bf6b3a13e3cda74a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzItMi0xLTEtMTQzMjg2_dedcefe3-29ed-42ff-a1dc-760455e7521b">4,056,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b7882f940f48d3bc7d90326129e9b4_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzMtMS0xLTEtMTQzMjg2_d9728e5e-7d72-48be-b483-f184af2a05ac">536,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d528e27c0d424aac74d9e73663d3ea_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzMtMi0xLTEtMTQzMjg2_b9631468-072b-4659-9f35-259b3401a38a">528,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdec972de61b4fbd8c3f8f4491dbed10_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzQtMS0xLTEtMTQzMjg2_9bc69344-8037-4c38-8d77-0d02902efac2">204,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia25ff6d598af43409a6d48cb1b0d9f54_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzQtMi0xLTEtMTQzMjg2_8877f178-1553-419b-a035-78e75cf8d0de">204,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316a10f3c60140a48775f64331d68546_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzUtMS0xLTEtMTQzMjg2_5468a1ae-2d7f-4985-b487-97382b12a5f5">170,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife9f6a75108b4d089ed6659cb9248d3f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzUtMi0xLTEtMTQzMjg2_be19e883-5aaa-4fef-a0ec-ea366e0bc2a0">170,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f3e6836101246c5bd0e37de3cea7ad5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzYtMS0xLTEtMTQzMjg2_4543e490-7c26-42bc-86af-0150bf4e27f7">120,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58f1d881a21f42408d4bd3c83abd2de9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzYtMi0xLTEtMTQzMjg2_f1e2f4b1-2dcc-4915-852b-57f0696043a6">121,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzctMS0xLTEtMTQzMjg2_e0d893a2-aa82-43f3-94d7-19c77d5fbfcf">5,109,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzctMi0xLTEtMTQzMjg2_a9e1f5fd-14c7-4957-a842-9f0ed1991085">5,081,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzktMS0xLTEtMTQzMjg2_70954413-a390-4792-b32d-af3c9e222904">830,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzktMi0xLTEtMTQzMjg2_26ffe5cf-90fe-4772-b99e-bfec937681b4">370,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzEwLTEtMS0xLTE0MzI4Ng_1bc4fb33-6509-4d93-93ed-c275a5da4646">4,278,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzEwLTItMS0xLTE0MzI4Ng_40a7e0fd-7f4b-4e7a-85bb-a604785e51d4">4,710,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $<ix:nonFraction unitRef="usd" contextRef="i68cade11881441f999fe48a8b78fa866_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzE3NQ_38bcd672-b0da-4527-822a-f49e54bb35af">3,938.0</ix:nonFraction>&#160;million, Order backlog of $<ix:nonFraction unitRef="usd" contextRef="i65f325e72d854376869d44f5fabc8e75_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzE4NQ_d46140b4-5178-4539-8510-e967099ed486">500.0</ix:nonFraction>&#160;million, Trade names of $<ix:nonFraction unitRef="usd" contextRef="i1d23344e0fb3451da6613835547ccb77_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzE5NQ_1c492e51-dd6c-4a2b-b53e-5e07a26e16f3">202.0</ix:nonFraction>&#160;million, Patient database of $<ix:nonFraction unitRef="usd" contextRef="ib000d5e1b7c444a98c09c3082b538879_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzIwNQ_4011ea8f-396f-4bde-9559-fab2c96aefc1">168.0</ix:nonFraction>&#160;million and Technology assets of $<ix:nonFraction unitRef="usd" contextRef="if7d00b00550d4bf9a90bced55d00862b_I20210701" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzIxOA_a49a8f75-1da9-4089-ae33-a826d567935f">111.0</ix:nonFraction>&#160;million. These assets will be amortized over their expected useful lives of between <ix:nonNumeric contextRef="i039aaafb5ef843fb87c3be6202c32cb9_D20210701-20210701" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzI5Nw_6b6cb4a8-46ef-40a9-a2e9-d47e362f78cf">3</ix:nonNumeric> and <ix:nonNumeric contextRef="ifc1a2a8295744e79af710d3f51492b51_D20210701-20210701" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzMwNA_81775cdd-1000-4a96-aaad-62df2f08af32">23</ix:nonNumeric> years. The valuation of these assets were finalized in June 30, 2022. In total, $<ix:nonFraction unitRef="usd" contextRef="i4cc15efef07d4621bf232d0f905e24d3_D20210702-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzQzOTgwNDY1MTI2MDI_7efff294-7ced-4af4-9099-c441c9ab9662">677.1</ix:nonFraction>&#160;million has been amortized in the period since the date of acquisition, $<ix:nonFraction unitRef="usd" contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzQzOTgwNDY1MTUyMDQ_99281482-533e-4e7b-8c60-40dab8ef3b05">453.6</ix:nonFraction>&#160;million has been amortized in the year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzEzNDA_c792149f-384e-4383-afc2-e399a2ccd191" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzItMS0xLTEtMTQzMjg2_3ffdd053-3db3-4caa-a410-fdc4323003f2">460,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzMtMS0xLTEtMTQzMjg2_00469b32-b4a6-4259-b92b-15d1ce2ee0b2">339,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzQtMS0xLTEtMTQzMjg2_016551c5-abf3-4aed-8f6d-32c2ab1bef55">223,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzUtMS0xLTEtMTQzMjg2_6045a0a3-17b5-444e-bf28-9849f1068b7e">209,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzYtMS0xLTEtMTQzMjg2_1ac3dad8-ca93-4eb9-abe1-2980f6951251">198,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzctMS0xLTEtMTQzMjg2_343500f1-18d7-4688-bd41-e00e6085bf78">1,432,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">122</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzE1MA_736ae395-0d72-4c20-8e17-33445888c611" continuedAt="i693ade34d3e44f41ac1009ef9c8677f8" escape="true">Other Liabilities</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i693ade34d3e44f41ac1009ef9c8677f8"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzE1OA_411c46b6-2da5-4aa3-b767-07ea837963ba" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzItMS0xLTEtMTQzMjg2_626f97a8-8250-4da8-829f-9718994fe9ac">530,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzItMi0xLTEtMTQzMjg2_676113d5-6df3-4ba2-be8a-1c4bd60908a3">459,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzMtMS0xLTEtMTQzMjg2_94520b1b-2374-41e0-95dd-70b11770336d">395,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzMtMi0xLTEtMTQzMjg2_c3d633f1-da06-4707-9375-6a568d8b47bc">413,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzQtMS0xLTEtMTQzMjg2_ce09f512-8d45-4d9e-b7d5-0188b73c332b">43,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzQtMi0xLTEtMTQzMjg2_bc9e9aa0-a249-45b8-ac71-4214a6e0df4d">49,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzUtMS0xLTEtMTQzMjg2_1affe33d-3d01-4e5b-93d8-b87b217f9fda">16,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzUtMi0xLTEtMTQzMjg2_e3c53bf7-1d62-48fb-b27e-5a63c5516187">12,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzYtMS0xLTEtMTQzMjg2_716db9d2-36b8-4cab-bd0d-a1b0a0af6479">12,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzYtMi0xLTEtMTQzMjg2_b4bd588f-3699-4993-a86a-927c015621ea">7,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:RestructuringReserveandOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzctMS0xLTEtMTQzMjg2_f33bc2b2-dd68-454a-8315-66d618140279">5,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:RestructuringReserveandOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzctMi0xLTEtMTQzMjg2_d762daa4-29e4-4955-b44a-6b4e1fdf3a9c">7,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:CapitalGovernmentGrantsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzgtMS0xLTEtMTQzMjg2_b3fd62a8-c1bc-4945-bd5a-a32b5dcf6742">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:CapitalGovernmentGrantsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzgtMi0xLTEtMTQzMjg2_55371d98-6547-42b9-a414-244b293e382c">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzktMS0xLTEtMTQzMjg2_ac230516-6d1c-4872-a5dd-465b93f03c94">1,005,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzktMi0xLTEtMTQzMjg2_8755f2c6-57e4-40a3-bb69-a0f36976d75e">949,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzYwNDczMTM5NTI5NjE_2007f106-d6ae-4167-8ba4-4a0f623da344">406.3</ix:nonFraction> million at December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzYwNDczMTM5NTI5NTE_f51af9a2-4894-40d0-bd5f-0b17d58d580f">323.6</ix:nonFraction> million at December&#160;31, 2021.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_241"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDY_31439f13-7dc7-47f4-813c-5581d672ab67" continuedAt="i27006cc75bb940e686303c5dfb96ee5c" escape="true">Non-current Bank Credit Lines and Loan Facilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i27006cc75bb940e686303c5dfb96ee5c" continuedAt="idc0d4586d8564f4cb9ce395de38851aa"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDI_7f17c3ad-6402-487a-9e0c-981b29087abf" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2022 and 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24b1b179f187445baaff8a1b7341bce6_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMS0xLTEtMTQzMjg2_d6bfb97b-1274-4277-8633-99182f29813f">7.092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id74f7c384d114c429cd9f1b01c113138_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMi0xLTEtMTQzOTk3_f3fd9286-2ae9-4087-a028-c324d3a5126b">2.750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b1b179f187445baaff8a1b7341bce6_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMi0xLTEtMTQzMjg2_67080e51-e1ee-4545-8ac5-06f2636ac3f6">4,201,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id74f7c384d114c429cd9f1b01c113138_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMy0xLTEtMTQzMjg2_488ed078-9e2c-4357-9e09-f4436dd5dfb4">5,001,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0eb8fbd8473746a0b208ab4cd0032180_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMS0xLTEtMTQzMjg2_44e625cb-37bb-4c5a-96cc-4562941a4246">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c9e575e36904396a0c52344f4a1fe00_I20211231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMi0xLTEtMTQ0MDE0_8b4bc8bf-f35a-46f8-b8c9-dc6c5d4adcf7">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8fbd8473746a0b208ab4cd0032180_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMi0xLTEtMTQzMjg2_0936d48b-87e2-4a48-bad8-aa778fcaa62b">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9e575e36904396a0c52344f4a1fe00_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMy0xLTEtMTQzMjg2_0e71b525-8e67-4c83-9092-1e896908adb4">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEwLTItMS0xLTE0MzI4Ng_4421890a-6dbe-4e70-ad84-7a16f7f8def7">4,701,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEwLTMtMS0xLTE0MzI4Ng_e0a009d8-a3e3-44bd-9ad5-7e88ce71ed7e">5,501,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEyLTItMS0xLTE0MzI4Ng_108721f8-fadf-4426-a611-2f4c3b43b460">55,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEyLTMtMS0xLTE0MzI4Ng_4b0c0db2-8ccf-4dad-8ca9-1ee4a266c9b3">55,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEzLTItMS0xLTE0MzI4Ng_7eaef659-bfa0-4adf-a8e8-249435a73d07">4,646,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEzLTMtMS0xLTE0MzI4Ng_6a2e51bf-499a-4881-bec4-28884879cc4d">5,446,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less long-term portion of debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE0LTItMS0xLTE0MzI4Ng_4431c873-485e-406d-93c5-af60affc6a9d">47,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE0LTMtMS0xLTE0MzI4Ng_ee72c6d2-5451-4a26-8cad-d1eba48c51bb">64,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE1LTItMS0xLTE0MzI4Ng_26f735b2-7ea0-419d-b95d-0e583b1cb59b">4,599,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE1LTMtMS0xLTE0MzI4Ng_634a8ec0-7198-4423-b383-f0e6e62899e5">5,381,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company paid a $<ix:nonFraction unitRef="usd" contextRef="ide0a04931f8947b899f8a0add7253478_I20210701" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzE0Nw_efb9eebd-4e66-4ab8-bc2a-54cd1a5d64a3">27.6</ix:nonFraction> million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes on July 1, 2021.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="idc0d4586d8564f4cb9ce395de38851aa" continuedAt="i2d3007184bec4607b7fddf1b38e75041"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2022,  December&#160;31, 2021 and December&#160;31, 2020 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2022 and December&#160;31, 2021, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzUzMw_bd0f1223-a297-4d7e-a1c5-15ea9bfba179">17.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MTg2OTk_3ca775a6-7b71-4ba8-a93b-cd00addf7c03">86.7</ix:nonFraction> million of transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDg_e3b9f822-bdc0-477b-a73c-570d3f1cf93c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzQtMS0xLTEtMTQzMjg2_7b4ad6ba-a0f0-4782-9e87-088e1821e91f">209,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzQtMi0xLTEtMTQzMjg2_33fb5a20-cf15-49aa-a043-4f73e863fcc9">93,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzQtMy0xLTEtMTQzMjg2_1b7effa1-4621-4ae4-be7f-122b9c247817">13,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzUtMS0xLTEtMTQzMjg2_c138f317-5bc5-4927-ba29-c2e2c91b7a66">17,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzUtMi0xLTEtMTQzMjg2_6efef989-6ab9-4ba4-b285-3099816f17ee">12,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzUtMy0xLTEtMTQzMjg2_934f13b0-3d34-4731-b0f1-fd6ed187c27d">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzYtMS0xLTEtMTQzMjg2_ff00832f-a18d-4acf-a060-e74e74d2ec17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzYtMi0xLTEtMTQzMjg2_5a9d3f3a-cfc1-44df-8a44-d6262c248e0d">75,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="iclr:TransactionAndOneTimeFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzYtMy0xLTEtMTQzMjg2_c774909d-2dbc-4b54-b214-b4377eb5e13e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:InterestExpenseCreditOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzctMS0xLTEtMTQzMjg2_1f18e492-cde1-41be-a010-b41f1253d90a">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:InterestExpenseCreditOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzctMi0xLTEtMTQzMjg2_a18c31bf-b9cd-4001-8673-6ca78c3a5c57">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="iclr:InterestExpenseCreditOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzctMy0xLTEtMTQzMjg2_fc5e3d81-a1e7-4582-bfee-5ebed9fc68e8">910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzgtMS0xLTEtMTQzMjg2_b9fdc5f7-3c72-462e-afe0-895e53d3f9a4">229,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzgtMi0xLTEtMTQzMjg2_f0977155-0055-447b-b41a-e3c44d2a3bbe">182,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzgtMy0xLTEtMTQzMjg2_134dc067-059a-46b7-87e6-221ab2c24fbb">13,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDM_d5ed8903-7565-495d-b049-bad272b41e73" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzEtNC0xLTEtMTQzMjg2_6ed0d7e0-b923-4288-9667-01030cbe7193">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzItNC0xLTEtMTQzMjg2_3a6e1ea6-b906-4c24-b900-061f3679c364">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzMtNC0xLTEtMTQzMjg2_5f39da8d-a686-47e3-bd20-92c6223d3df9">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzQtNC0xLTEtMTQzMjg2_c5f7cae6-5b67-4105-b6fa-521e4a4b295d">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:LongTermDebtMaturityYearFiveAndThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzUtNC0xLTEtMTQzMjg2_57987990-60b1-4eb8-94be-99a1ff5f73cc">4,480,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzYtNC0xLTEtMTQzMjg2_ebbe1cbd-8220-4437-9054-2a7f6dfbee83">4,701,213</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $<ix:nonFraction unitRef="usd" contextRef="i7a12d28f277f4f588bf639313db05a59_I20210701" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzEyODM_67bbf7f5-e534-4b3e-b2ce-d4d82842fc10">5,515</ix:nonFraction>&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i10cb599ff8ed4f01b9d901f229fe45d0_I20210701" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzEzNzU_c157bf83-0c28-4c42-98da-5962e1858a6e">300</ix:nonFraction>&#160;million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#8217;s existing credit facilities and (ii) the Company's notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the senior secured revolving loan facility will mature in July 2026. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin.  On the 29th of November 2022, the Company agreed with its lenders to the early adoption of Term SOFR as the reference rate within the Credit Agreement ahead of the June 2023 USD LIBOR cessation date. LIBOR is no longer an applicable reference rate available to the Company under the terms of the Credit Agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i7a12d28f277f4f588bf639313db05a59_I20210701" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MjUzNzY_f68920f3-f3f8-4af3-a175-36de40a4e79d">1.00</ix:nonFraction>% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i0b2dee78f7f644cb9cf3be42bf7515de_D20210701-20210701" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MjUzODA_1e715649-4b6a-41da-b489-b51cf780e769">2.25</ix:nonFraction>%. The senior secured term loan facility is subject to a floor of <ix:nonFraction unitRef="number" contextRef="i052ec038b97a434685e03cb2338cefaa_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MjUzOTM_97a8cf4e-78d3-47f0-8c88-ef59448f56d7">0.50</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i5dd8ae45a3c84a79b7b93908eb3e3fe9_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI2MjI_2267b2ba-b471-4706-be91-ed6afb31d2d3">1.00</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i4749ad89af054d8e90ce981f202f2a6f_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI2MjY_e734d4e7-5543-4c19-bdc8-03f27532b63e">0.60</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="i2aef30afb12349bb8e0ae5fbd3b724d0_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI2MzI_5af0f23c-a5b0-4f88-b59b-e5c5347cb955">0.25</ix:nonFraction>% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="i6ad4568f232b4720a904bbd4f0c5c5d2_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI4MzM_1f6fd266-1e75-468a-b808-b2f03cecbb0c">2.00</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i9dfcce19405042819f3d7cea53081ae1_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI4Mzc_8fe3819a-7bff-4b5e-8a84-51e4d37c3859">1.60</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="i6e2abed11d6d469e981a5915d01e0802_D20220101-20221231" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI4NDM_535817ac-ed3e-4d76-b5cb-927dae007368">1.25</ix:nonFraction>% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i74787ba7e2484b3abeeb226f25f7e944_I20221231" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTQyMjk_31df2325-ffdd-41f0-bc11-3dc532ebfb2d">300.0</ix:nonFraction>&#160;million remained undrawn under the senior secured revolving loan facility.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i2d3007184bec4607b7fddf1b38e75041"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;30, 2022, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkzNDI_6fd3eefe-0520-4052-a1f5-d08d5c871b08">200.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkzNDY_42327063-735d-4766-8beb-124540eea22c">66.1</ix:nonFraction>&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkzNTA_66b016b1-9c23-466d-a9ae-3765893a7e14">1.8</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September&#160;30, 2022, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5MTM_2586ec40-b84b-4cc3-b917-74c362935dd5">200.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5MzQ_dbb5e4db-3d57-4ec2-ae1c-31dc462c3bd0">53.6</ix:nonFraction>&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5NTM_56c31e53-5c17-4e3f-9243-ddf52057d7c4">1.9</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On June&#160;30, 2022, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5OTA_d4818cc7-722f-437e-b069-464672b9d5c0">100.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwMDY_51db39c0-07a3-4bf2-8a0b-aabac5c4b8bc">39.4</ix:nonFraction>&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwMzA_1eddafa8-026c-4029-910b-16b288dd091c">0.9</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March&#160;31, 2022, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwNzE_5ea76270-4db5-4e62-81a2-a2dc35bf88ad">300.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwODc_dfc53d13-3567-41cf-a0ce-67ec0703ccdd">35.1</ix:nonFraction>&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkxMDI_877bee61-8437-451d-b6c1-9ad79b43ffb3">3.2</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;29, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDk5ODg_d71dd092-4be1-494b-8b10-4523a980a45c">500.0</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwMDg_f8342ec5-372a-48c1-b684-7dfdba9e66da">40.8</ix:nonFraction>&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229" decimals="-5" name="us-gaap:PaymentsOfDebtRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwMjk_98ed9a5b-6100-4f58-8176-36cfbd3679e1">5.6</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September&#160;27, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i371d9f7891584afea9de5a762c9f6442_D20210927-20210927" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwNzI_1e82100b-63b6-48ed-8687-6584184b6a3d">13.8</ix:nonFraction>&#160;million of the senior secured term loan facility and made a quarterly interest payment of $<ix:nonFraction unitRef="usd" contextRef="i371d9f7891584afea9de5a762c9f6442_D20210927-20210927" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwOTI_a05d6a2a-c17e-4a45-8d74-0c890f1f1578">40.4</ix:nonFraction>&#160;million. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $<ix:nonFraction unitRef="usd" contextRef="i54726d34a41d4914b87f6221632a03b8_I20210701" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzUxMjI_192c14dd-4b3c-4993-9b8c-c7eaa3ff658f">500</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i54726d34a41d4914b87f6221632a03b8_I20210701" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzUxNTg_79182ccb-b4d7-4eb0-bfc0-1c291e6ac05f">2.875</ix:nonFraction>% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzczMjc_daade98a-c779-4102-9d01-6725e1c1d936">4,650.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzcxNDY4MjU1OTU5MjU_4657cbf2-efa6-49f4-a38d-8128d5560fe7">5,507.2</ix:nonFraction>&#160;million at December&#160;31, 2022 and December&#160;31, 2021, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_1935"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">14. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NDg2NDM1_e4fd5635-3ba1-4c9b-917d-5d70493687b5" continuedAt="i139d8fd27e974f808164cbc4a9534f2e" escape="true">Derivatives</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i139d8fd27e974f808164cbc4a9534f2e" continuedAt="i9e09c45dd29642508ee9ec568e8d272b"><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as Cash Flow Hedges.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into <ix:nonFraction unitRef="instrument" contextRef="ide8dd376ffe34328bce020b65607602b_I20221129" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODU0_1f3d3a7d-1503-4cb6-97f4-65baa907ae50">two</ix:nonFraction> interest rate cap agreements ("2022 Caps") with an initial total notional value of $<ix:nonFraction unitRef="usd" contextRef="ide8dd376ffe34328bce020b65607602b_I20221129" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5NzczNTUxMA_0c176a15-873b-4115-a73a-fb79f6607df0">2,101</ix:nonFraction>&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate cap expires on December 31, 2024. The Company pays a fixed rate of <ix:nonFraction unitRef="number" contextRef="ide8dd376ffe34328bce020b65607602b_I20221129" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTEwMjM1_63fd413f-b5c8-430e-b389-2eef6020f72d">0.42</ix:nonFraction>% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds <ix:nonFraction unitRef="number" contextRef="iae02d67aa86647b19a16902930f2619d_I20221129" decimals="4" name="iclr:DerivativeVariableInterestRateReferenceRateInExcessOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODU4_217e266f-b165-40f8-8027-09ea5097f8c4">4.75</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $<ix:nonFraction unitRef="usd" contextRef="if39e82a87e3d497b96438f71c9904738_I20221129" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5NzczNTU0OQ_44a448fa-c422-454d-9c41-f9c04aa74e69">1,101</ix:nonFraction>&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swaps begins accruing on December 31, 2024 and the interest rate swap expires on December 31, 2026. The Company pays a fixed rate of <ix:nonFraction unitRef="number" contextRef="if39e82a87e3d497b96438f71c9904738_I20221129" decimals="3" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODY1_658a5c87-11df-40ff-9a24-eef7427fc800">3.4</ix:nonFraction>% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The critical terms of the caps and swap are substantially the same as the underlying borrowings. The interest rate caps and swap are accounted for as cash flow hedges as these transactions were executed to hedge the Company's interest payments and for accounting purposes are considered highly effective. As such, the effective portion of the hedges is recorded as unrealized gains (losses) on derivatives in Accumulated Other Comprehensive Income.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of these cash flow hedges represents the present value of the anticipated net payments the Company will make to the counterparty, which, when they occur, are reflected as interest expense on the consolidate statement of income.  </span></div></ix:continuation><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i9e09c45dd29642508ee9ec568e8d272b"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NDg2NDM3_8a94b1d2-3787-4cdb-a0b4-f40e10869307" escape="true"><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company&#8217;s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:20.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="if27a87a7700d4f5fa4a149e379b8f150_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTItMS0xLTE1NTc5OA_3b4f4f91-0609-46ad-828f-2aecac4d2a8e">12</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="if27a87a7700d4f5fa4a149e379b8f150_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTMtMS0xLTE1NTc5OA_f0f0a49c-2b0c-4c9d-8448-b167d307e09e">3,363</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if27a87a7700d4f5fa4a149e379b8f150_I20221231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTQtMS0xLTE1NTc5OA_6c5e9e9d-c3c5-47b8-b098-d29d13a533f1">2,100,606</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i84bd4efdef4d4094902c5e2aee086859_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTItMS0xLTE1MjQ4Ng_84b27938-2ce9-4b19-82c8-387a4597dcf8">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i84bd4efdef4d4094902c5e2aee086859_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTMtMS0xLTE1MjQ5OA_003e40e9-e7fe-4a77-a511-359ccc27b8d7">307</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i84bd4efdef4d4094902c5e2aee086859_I20221231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTQtMS0xLTE1MjQ5OA_a31f1293-e191-4664-991c-9784f291daea">1,100,606</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i84f84f639a8649b7a29a53533025129f_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV83LTItMS0xLTE1MjUzNg_b85f2592-4666-4d20-bb0f-8eaefcc6755d">12</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i84f84f639a8649b7a29a53533025129f_I20221231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV83LTMtMS0xLTE1MjUzNg_843759fb-49e0-45d1-b094-ab156525f21b">3,670</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i30afec82ea9e4d6a8f448ccc557ea553_I20221231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV83LTQtMS0xLTE1MjUzNg_18bd6649-dc76-432c-98cd-a888b88c985b">3,201,213</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During 2023, the Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV84MjQ2MzM3MjY5NzI1_44a943bf-1373-4390-add7-428d305ca6c5">3.3</ix:nonFraction> million will be reflected as interest expense in the consolidated statements.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December 31, 2021 the fair value of the Company's derivative financial instruments was $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5Nzc0MDY5MA_e9fb27c6-9d48-4e35-81db-e30d5d10ede3">nil</ix:nonFraction> as the Company had <ix:nonFraction unitRef="tranche" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5Nzc0MDczMQ_276b6206-a1c9-4432-8fd0-7689622f8b4c">no</ix:nonFraction>  outstanding derivative financial instruments. </span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODkx_4e5ead9a-3c8b-41e2-9c7a-836996be0ca3">0.1</ix:nonFraction>&#160;million of gain within OCI and reclassified $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODc3_3af5c02e-88ef-4281-818b-d9278e038453">0.1</ix:nonFraction>&#160;million of gain from OCI to the income statement for the year end December 31, 2022.</span></div></ix:continuation><div style="text-indent:14.25pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_238"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MDk_795b4d99-8e7c-4bc3-bedb-6fc44d6179ca" continuedAt="i64ddebcfd83b4eb3b2f2d679e14ed196" escape="true">Operating Leases</ix:nonNumeric></span></div><ix:continuation id="i64ddebcfd83b4eb3b2f2d679e14ed196" continuedAt="i242bb4cf9856482fb7e54941576da5c3"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTA_79bfac44-58fd-4da8-94d6-253c57211d0d" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases as of December&#160;31, 2022 and  2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzQtMS0xLTEtMTQzMjg2_05c6af2e-e5b0-4ac6-b9cd-b58109ecabb0">53,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzQtMi0xLTEtMTQzMjg2_97a9a406-fa87-469f-9e1a-61197c76dd3a">51,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzUtMS0xLTEtMTQzMjg2_213ed31e-f1a7-4362-bfd6-1075f1a1723c">1,165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzUtMi0xLTEtMTQzMjg2_fedc2079-1a46-4180-af64-80eed0ef5226">1,338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzYtMS0xLTEtMTQzMjg2_a1dcf57d-da1b-43ee-a727-f052da68cd73">52,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzYtMi0xLTEtMTQzMjg2_7aebc8dd-7cc4-43eb-b6a5-b114ee8e26f7">49,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzExMA_870b8881-749f-4e9e-9284-481346b7d083">52.7</ix:nonFraction> million incurred in the year ended December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="ibba1eb9117d6498ba61cd2ffd7a3dcc5_D20220101-20221231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzEzNg_9e4725b9-0b0a-4ec1-81a0-bdc65edc2647">48.3</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzIwNA_f58c180a-1a69-4dcd-b645-1802138c228d">4.4</ix:nonFraction> million is recorded within direct costs. Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzI2MQ_c9ba614d-31a5-4033-8942-ce45bb1dd03e">49.9</ix:nonFraction>&#160;million incurred in the year ended December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="ifdf34dd45633475d9db22cc8203941ed_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzI4Nw_bd9aab7c-bfdb-4e68-8c51-c2128d065e3e">47.5</ix:nonFraction> million is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="id197fe0d372441f4971e65ae556f9189_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzM1NQ_acc0943a-0f6a-4d4f-a225-70ecbb6b778a">2.4</ix:nonFraction> million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December&#160;31, 2022 and December&#160;31, 2021 totaled $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzY3NA_7a255758-82cb-43f0-8e85-9f633ecab745">28.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzY4MQ_268429e8-ebbd-464c-8b7f-5f32b940f922">10.2</ix:nonFraction> million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and December&#160;31, 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzI3NDg3NzkwNzIyMDM_1956d944-a67c-4927-9d8c-6de33ad91aa2">24.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzU0OTc1NTgxNDA1MjA_0c080580-bf6d-448c-95f6-6436f7c8cec9">15.4</ix:nonFraction> million, respectively, as part of an office consolidation program (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 19 - Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2022 were <ix:nonNumeric contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzExMDM_34610a03-290f-4ad8-8a18-ea1d8e705041">6.90</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzExMTA_19c8edc2-63a9-4cd6-80b5-a7cadf2478bd">2.45</ix:nonFraction>%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2021 were <ix:nonNumeric contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzEyMTY_9fc00897-dc1a-451b-bb39-8df1afcf6b4b">6.91</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzEyMjM_3c5419da-9505-4086-b87a-4c93ffeb6031">2.51</ix:nonFraction>%, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i242bb4cf9856482fb7e54941576da5c3"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTI_f6374681-076e-4be2-b3ac-5de0368c2d21" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2022 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzMtMS0xLTEtMTQzMjg2_423f3211-1dfc-4205-98ce-927f8c455c5d">47,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzQtMS0xLTEtMTQzMjg2_b727f1ae-bbd5-4ad2-9c6a-446d557860f2">34,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzUtMS0xLTEtMTQzMjg2_d608569b-fe4f-4330-9034-271b21eb19ac">25,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzYtMS0xLTEtMTQzMjg2_b254e0e9-83c1-4a16-80a9-89d8045a82ce">20,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzctMS0xLTEtMTQzMjg2_bc817466-8903-45f0-a1bc-9327dce9b6ef">17,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzgtMS0xLTEtMTQzMjg2_7b4bf099-800e-4349-848d-e703a8b188e8">45,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzktMS0xLTEtMTQzMjg2_490192c0-b5f9-48e4-a14a-8a326ef34714">189,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzEwLTEtMS0xLTE0MzI4Ng_e5a2933c-c2b1-4329-a400-6cee045d0072">14,367</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzExLTEtMS0xLTE0MzI4Ng_d0f73ef2-74e3-4305-8634-028ef2f8a68c">175,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE0Mjk_beef677b-1067-4f37-b955-59de5cd2f1de">43.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE0MzY_25b167c1-0d63-4258-a97b-3d90d5d6fe57">49.9</ix:nonFraction> million have been included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_4e96e968-9c11-40fd-a303-2bb58d8fbc29"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_7797f20c-d0da-447d-8e1d-a6a60da2da46">other liabilities</span></span> as at December&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_187"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90ZXh0cmVnaW9uOmI5MzNkYzIxNjZiYTRjNTVhNjNkMjhkMjUxYWRjYWM0XzUw_f6eb812d-dd47-4e2e-8fb2-29ab6eb1b841" continuedAt="ie50e5a69bc204776a656a09082fcb42d" escape="true">Non-current other liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie50e5a69bc204776a656a09082fcb42d"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90ZXh0cmVnaW9uOmI5MzNkYzIxNjZiYTRjNTVhNjNkMjhkMjUxYWRjYWM0XzU0_690c0597-32b8-4c59-a6a9-a5ed40866e58" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzItMS0xLTEtMTQzMjg2_61f46805-bbf5-4d44-a6b2-71b4a69930a8">13,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzItMi0xLTEtMTQzMjg2_c0c44f8c-7bdf-455d-999b-f1d1eddba70b">16,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzMtMS0xLTEtMTQzMjg2_55823128-9540-4940-adb6-4128b67d6578">25,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzMtMi0xLTEtMTQzMjg2_2b7015f3-9996-4b5f-9459-0a8d38ce1184">26,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzQtMS0xLTEtMTQzMjg2_77e67c30-7adb-4c9f-9c48-0a5040864f35">38,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzQtMi0xLTEtMTQzMjg2_923f23d1-0fc3-4ecd-8bcd-92671ad361f0">42,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_214"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTQvZnJhZzo2MmE0MWZmM2ZjZjE0ZDE1OTcxMmZlNjhmZmRkOTRiNS90ZXh0cmVnaW9uOjYyYTQxZmYzZmNmMTRkMTU5NzEyZmU2OGZmZGQ5NGI1Xzg4Mw_b39321fb-d426-40cf-8fc6-32020796f5c1" continuedAt="ia9a1893e952f4e4e9c7569afa16d1255" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia9a1893e952f4e4e9c7569afa16d1255"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next <ix:nonNumeric contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTQvZnJhZzo2MmE0MWZmM2ZjZjE0ZDE1OTcxMmZlNjhmZmRkOTRiNS90ZXh0cmVnaW9uOjYyYTQxZmYzZmNmMTRkMTU5NzEyZmU2OGZmZGQ5NGI1XzU5Ng_4113fa2c-fc3b-4688-8d70-b9de1b356f4b">twelve years</ix:nonNumeric>. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2022 and December&#160;31, 2021 and future minimum rental commitments as of December&#160;31, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_202"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzQ5Mjg_1948880d-ef2d-4210-a293-1578c0726d97" continuedAt="i42f9ae2439954dd8a4470a2ed47699c2" escape="true">Share Capital</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i42f9ae2439954dd8a4470a2ed47699c2" continuedAt="ie47e01b7732e4e38b39eac31d20e3f4d">Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have <ix:nonFraction unitRef="vote" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzY3MQ_fee05acc-1801-41cb-b685-0a54f3eac8aa">one</ix:nonFraction> vote, for each ordinary share held with no individual having more than <ix:nonFraction unitRef="vote" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzc0NQ_54144ee7-651a-4f77-84cf-a00eb4fe460f">one</ix:nonFraction> vote. </ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ie47e01b7732e4e38b39eac31d20e3f4d"><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Employee share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzEwNDI_4e0248af-282a-40a3-97e4-8a0aa549b53c">348,286</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzExMTM_c7d423e6-58aa-4b04-8895-5140462c0aa4">102.87</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzExNDg_49b049e5-3fc4-43e3-b37a-386025a71808">35.8</ix:nonFraction> million. During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzExNzg_ef97c907-34b4-4058-8b31-cab8c87dcceb">195,029</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzEyNDA_41304718-4647-46d2-b23d-a5c4dab955ae">46,087</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzEzNTI_6983491d-0361-4776-ac86-6e6380daed1b">1,065,529</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE0MjM_1bf843f2-cfc3-4c09-bc72-b01b55e11a15">111.29</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE0NTg_e7205e4f-906c-43d5-bc98-08ed41c52da6">118.6</ix:nonFraction> million. During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="iec0d3c91746049cfa76770f5e2f12ef5_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE0ODg_065ad85b-66ad-4cbd-8094-566be0f16f52">446,404</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="i323bd4358f4848aba9899c235c5c8a82_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE1NTA_c1d118de-2c5d-42ff-8f16-50cc3bd8db1f">44,132</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued <ix:nonFraction unitRef="shares" contextRef="ia5098738b6444670841da7baa2b82cff_D20210701-20210701" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI3NDg3NzkwNzU0NTA_24483423-10bd-4a86-95fc-48e445c771fb">27,372,427</ix:nonFraction> shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE2NjQ_118fb0c0-f643-4dcf-8969-292b8744e910">193,417</ix:nonFraction> options were exercised by employees at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE3MzU_ba30ee17-d445-4e67-9f15-669d84f45117">68.19</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE3NzA_21461407-ffd5-47d2-ab8a-4dc525f2066b">13.2</ix:nonFraction> million. During the year ended December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="iac28acede97e485190e5dcb59f035565_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE4MDA_abcea9a6-40b6-41c0-8101-a540681f7405">144,172</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="ica93147573064c84b3ee259a15e2e86a_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE4NjI_f371e18d-337f-4025-aef1-97071fd3090e">63,516</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to <ix:nonFraction unitRef="number" contextRef="ibd327ac55d2743019d27972465de1bc4_D20160722-20160722" decimals="INF" name="iclr:StockRepurchaseProgramAuthorizedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzIxNzg_eef9e612-38d2-426d-aef0-57769d529857">10</ix:nonFraction>% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020, July 20, 2021 and July 26, 2022.&#160;On October 3, 2016, the Company commenced a share buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="ia70e95571e0e491fb52ce293ea601a70_I20161003" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI0Mzk_8cd8f922-a48b-4812-bd4a-e6d2730eece3">400</ix:nonFraction> million. The share buyback program was completed during the year ended December 31, 2018 with a total of <ix:nonFraction unitRef="shares" contextRef="if1daa0ef8b314dee8ee404337020c563_D20180101-20181231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI1Mzk_eaef2be2-abc8-4812-9a3e-ef0ae26b9acd">4,026,576</ix:nonFraction> ordinary shares redeemed for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="if1daa0ef8b314dee8ee404337020c563_D20180101-20181231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI1OTY_5603ed2f-eff9-47a0-86ee-44b352f5a07b">372.1</ix:nonFraction>&#160;million. On January 8, 2019, the Company commenced a further share buyback program of up to <ix:nonFraction unitRef="shares" contextRef="i10eee8543f7046e0859ad96971a954da_I20190108" decimals="INF" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI2ODM_9426e6ec-1a31-4ae4-bf27-8b4d629e952e">1.0</ix:nonFraction>&#160;million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="ic46b3eb0a83849c2b0342cf7b18e0188_D20190101-20191231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI4MzQ_74d4b447-30fe-4505-9535-47be12c8663d">141.6</ix:nonFraction>&#160;million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, <ix:nonFraction unitRef="shares" contextRef="if26c855530ab4ea6a07f994ef03a005f_D20191231-20191231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI5MzY_6c99dad7-d95d-415b-b4bb-781b18eb506b">35,100</ix:nonFraction> ordinary shares were redeemed by the Company for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="if26c855530ab4ea6a07f994ef03a005f_D20191231-20191231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzMwMTM_0fcbbb0c-0698-4405-9717-9bd5d47f9559">5.3</ix:nonFraction>&#160;million. During the year ended December 31, 2020, <ix:nonFraction unitRef="shares" contextRef="iceb051d6f08042e1a54eb9849cdeac83_D20200101-20201231" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzMwNTg_94fbe638-d3c4-4703-b4ba-e0fc99136566">1,235,218</ix:nonFraction> ordinary shares were redeemed by the Company under this buyback program for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="iceb051d6f08042e1a54eb9849cdeac83_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzMxNjI_9ce6efde-c6d4-45e2-b68e-77f17259dd2f">175.0</ix:nonFraction>&#160;million. On February 18, 2022, the Company commenced a share buyback program which was fully complete at&#160;March 31, 2022. Under this buyback program, <ix:nonFraction unitRef="shares" contextRef="i872f74854a654470a5eb159ba754c7ca_D20220218-20220218" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI3NDg3NzkwNzQ2MjM_e32b876b-1fd2-4744-9ff0-ae98cd2d1682">420,530</ix:nonFraction> ordinary shares were redeemed by the Company for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i872f74854a654470a5eb159ba754c7ca_D20220218-20220218" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI3NDg3NzkwNzQ2OTk_9e5c5437-eeba-493e-b25d-5a2f4aef972a">100.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_208"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2Nw_0c88dced-7dde-456f-ad0d-c548b2ed2447" continuedAt="i07033c3fc12a44dbba99fb85285f817d" escape="true">Restructuring Charges</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i07033c3fc12a44dbba99fb85285f817d"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A restructuring charge of $<ix:nonFraction unitRef="usd" contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzU4_038418df-8654-402b-ae1f-33d283c69494">31.1</ix:nonFraction>&#160;million was recognized during the year ended December&#160;31, 2022 under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $<ix:nonFraction unitRef="usd" contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzY1OTcwNjk3NzAyNTQ_0c2ddf2e-a75f-42ee-900d-4d3f30a91533">2.7</ix:nonFraction>&#160;million relating to workforce reductions, an impairment of right-of-use assets and associated unavoidable costs totaling $<ix:nonFraction unitRef="usd" contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231" decimals="-5" name="us-gaap:OtherRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzY1OTcwNjk3NzAyNzY_f8ba094d-9582-4aa9-b230-9549f4d26cfb">24.5</ix:nonFraction>&#160;million  and fixed asset impairment of $<ix:nonFraction unitRef="usd" contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzI3NDg3NzkwNzMwODM_84228cdc-5771-4d68-96e8-97b19aee7243">4.0</ix:nonFraction>&#160;million. It is company policy to disclose operating right-of-use asset impairment as a restructuring charge when it is part of a coordinated program to decommission space.</span></div><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2MA_55e91d0a-da56-45eb-ba35-070549b0f469" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzMtMS0xLTEtMTQzMjg2_1be71a20-7155-4d5e-b2e6-b5b059717a26">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzMtMi0xLTEtMTQzMjg2_d56c407e-c0e6-4385-8f17-5fa0aec08314">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzMtMy0xLTEtMTQzMjg2_050f4d1f-b3dd-4b00-b677-f7b19a5bb5dc">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzQtMS0xLTEtMTQzMjg2_1b4df8bd-8944-4cd2-b53e-bf9b377c06dc">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzQtMi0xLTEtMTQzMjg2_75d4fe24-218c-4f9e-94b0-60a59c81553e">31,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzQtMy0xLTEtMTQzMjg2_1168998d-d5ec-4af0-8c5b-290ca0195ee4">18,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022, a total liability of $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzU4Mg_7c33b510-09f8-4627-bfc7-31e26873532b">6.0</ix:nonFraction> million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $<ix:nonFraction unitRef="usd" contextRef="i1811161bef0541d1b314fa8f7e974b09_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzY5MA_70d70339-0cd2-4c78-8435-6f0104df55c6">1.4</ix:nonFraction> million of facilities related liabilities of which $<ix:nonFraction unitRef="usd" contextRef="i1811161bef0541d1b314fa8f7e974b09_I20221231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk4OTU2MDQ2NTE5Mzk_b2726e84-a3b9-448d-8a07-04d2fe031f40">0.9</ix:nonFraction> million is included within other liabilities and $<ix:nonFraction unitRef="usd" contextRef="i1811161bef0541d1b314fa8f7e974b09_I20221231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk4OTU2MDQ2NTE5NDc_7559b762-4faf-4228-a67f-4f75fa1f134f">0.5</ix:nonFraction> million is included within non-current other liabilities. The remaining provision of $<ix:nonFraction unitRef="usd" contextRef="i196c76a3559d419d89bd5d2125a62e0f_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk4OTU2MDQ2NTE1NTI_aba2fcfb-27c9-4e31-8d04-308a720ee499">4.6</ix:nonFraction> million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" xsi:nil="true" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2Mw_029ca6ba-7de3-4191-bb10-d0f13a9e69b1" escape="true"></ix:nonNumeric><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2NQ_d43f216f-041f-4081-86a9-13c484b038d4" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.106%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzQtMS0xLTEtMTQzMjg2_32d93166-7369-4dcb-b332-fe8cc0fd62cf">10,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzQtMi0xLTEtMTQzMjg2_77064d09-6b04-4115-ac93-248c942513fc">4,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzUtMS0xLTEtMTQzMjg2_868d16e5-4b2c-4cb9-92fb-00b4dd741b1c">4,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzUtMi0xLTEtMTQzMjg2_9e31da8a-fd81-4ab5-a0b5-211f5fb6cccc">11,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzYtMS0xLTEtMTQzMjg2_aef06136-740f-468c-af7a-c097e5d99212">8,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzYtMi0xLTEtMTQzMjg2_0489f65d-5a06-44da-a941-757d7271b0b7">5,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzctMS0xLTEtMTQzMjg2_8822e927-c4c8-475a-811d-9eb6127be673">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzctMi0xLTEtMTQzMjg2_3898f76f-beb2-4f3a-8df2-c92f2725ae7d">10,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_205"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4ODc_f5cf4c3c-a792-476e-8804-6f092dbc28e2" continuedAt="iaf6855ded6284e63b39cc09f095c652a" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iaf6855ded6284e63b39cc09f095c652a" continuedAt="i1835eac09d354281aac537c7886c9843"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:IncomeBeforeIncomeTaxTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4ODk_976103e1-1d6a-4b03-94df-c5f9d8cdc60d" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzMtMS0xLTEtMTQzMjg2_06e15224-0e75-4cd1-b34f-55afb5770564">432,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzMtMi0xLTEtMTQzMjg2_49b63d31-9e5c-44fe-b4b6-e5ef1c05b996">231,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzMtMy0xLTEtMTQzMjg2_95cff3d8-a06e-49e0-8367-641d5cf8d6fc">280,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzQtMS0xLTEtMTQzMjg2_9352b50f-af25-4767-a48c-986719eb4942">270,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzQtMi0xLTEtMTQzMjg2_3de18094-80d7-4a71-b12b-a4222fa364c5">278,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzQtMy0xLTEtMTQzMjg2_62c85350-6170-49ac-b5c2-f954b0fe2dc6">41,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzUtMS0xLTEtMTQzMjg2_d2c51a94-a132-4c57-b313-e3fd6419bdfe">405,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzUtMi0xLTEtMTQzMjg2_b019e32e-7d9a-4201-b070-cee4df8b88c6">243,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267c8ec957d64d7687d93c7466134972_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzUtMy0xLTEtMTQzMjg2_c4e0d511-fa2c-4554-9d54-01512d94ba77">58,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzYtMS0xLTEtMTQzMjg2_12ff2d93-b328-4481-b562-0ea349dc5a6d">567,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzYtMi0xLTEtMTQzMjg2_05e27f13-c992-4a01-b1bc-3d252aa2204d">196,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzYtMy0xLTEtMTQzMjg2_4732f047-1559-46b0-906b-6a5c509b8d22">381,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i1835eac09d354281aac537c7886c9843" continuedAt="i55ca0624d7204144bebafd4620da2d2e"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4Nzk_bbe3b40f-f48d-4953-bd44-90be92be2d36" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzUtMS0xLTEtMTQzMjg2_3877ca5f-9cc0-4611-aef3-785966980ebe">53,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzUtMi0xLTEtMTQzMjg2_8b34b5de-b4dd-4bc0-b2a9-6fc77618fc08">18,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzUtMy0xLTEtMTQzMjg2_f595a9eb-67c1-4462-8b00-502c5ee14eb3">28,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzYtMS0xLTEtMTQzMjg2_69c4c7f0-d686-481b-976a-d89f0a21f3c4">60,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzYtMi0xLTEtMTQzMjg2_304d41c3-7041-4da3-8038-2a70a44eb1a1">35,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzYtMy0xLTEtMTQzMjg2_98378da8-8ba1-4003-abf5-ee09e6bb02d1">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzctMS0xLTEtMTQzMjg2_6b2ea08f-1c8a-405b-9642-7f295c8f6911">70,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzctMi0xLTEtMTQzMjg2_5986c41b-7843-49c9-bdc9-be345c58b1e9">48,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i267c8ec957d64d7687d93c7466134972_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzctMy0xLTEtMTQzMjg2_3f44963d-6cc4-422b-bf6c-547affa1e243">14,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzgtMS0xLTEtMTQzMjg2_d44b2878-a5c3-4db9-b141-309d9ec1281a">184,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzgtMi0xLTEtMTQzMjg2_3cfdd2ed-d212-4cab-b140-05afda8d383d">101,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzgtMy0xLTEtMTQzMjg2_d71624db-572e-4b24-af39-933d7f3c0655">46,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzExLTEtMS0xLTE0MzI4Ng_399a4656-10da-417e-942a-d2010972b0ae">6,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzExLTItMS0xLTE0MzI4Ng_07e5787b-a2ed-4900-9432-f8c673c73a3b">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzExLTMtMS0xLTE0MzI4Ng_b59e4894-7f01-4e81-9315-443a04033c7d">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEyLTEtMS0xLTE0MzI4Ng_c67088e1-8270-4ae3-8a75-d61530d97178">118,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEyLTItMS0xLTE0MzI4Ng_055f75dc-13dc-450b-b52b-1289e52cbeaf">52,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEyLTMtMS0xLTE0MzI4Ng_74e93b3e-9938-4a29-b679-c63d4f20fbd6">4,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEzLTEtMS0xLTE0MzI4Ng_1b3dffc7-c703-43c6-9a56-905c57341a68">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEzLTItMS0xLTE0MzI4Ng_c3018c16-34f2-4e5e-8449-9c654e4a0119">8,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i267c8ec957d64d7687d93c7466134972_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEzLTMtMS0xLTE0MzI4Ng_b450ad6b-2df4-4434-a2b3-a8e892bbd9cd">5,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE0LTEtMS0xLTE0MzI4Ng_100ff81b-36f5-4556-9150-db492e31c24e">124,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE0LTItMS0xLTE0MzI4Ng_6a8037cd-ee98-40d5-a2d6-0f3e42f02e0f">60,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE0LTMtMS0xLTE0MzI4Ng_a47120ce-68d1-4fae-b30f-2d636bc2b2fa">927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE2LTEtMS0xLTE0MzI4Ng_0ed5fd77-4bb9-4720-8227-1859ac8e9e4e">59,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE2LTItMS0xLTE0MzI4Ng_d8946b5f-ef2a-4db2-abf6-61377c3110b7">41,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE2LTMtMS0xLTE0MzI4Ng_9e7a70a2-c177-4c8b-8171-696433b58931">47,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIwLTEtMS0xLTE0MzI4Ng_35b19dbf-0398-4b38-8a95-1203cc644150">7,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIwLTItMS0xLTE0MzI4Ng_61039d5a-b6d9-4dee-b773-d1217988026a">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIwLTMtMS0xLTE0MzI4Ng_1e3792b3-28fc-454f-b3ed-c902b3411175">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIzLTEtMS0xLTE0MzI4Ng_00b123a2-2794-4230-9a68-ecda4187c374">66,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIzLTItMS0xLTE0MzI4Ng_1c6fdddb-3ca9-4b2a-8590-2bad112a5f20">43,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIzLTMtMS0xLTE0MzI4Ng_08087caa-e3dc-4c6e-8cc3-27d293d2f9ef">47,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory income tax rate is 12.5%. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4NzY_829a81aa-383f-47cb-9074-6baed7278267" continuedAt="ibdc4691375974c5595200cd009f1e55f" escape="true">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="ibdc4691375974c5595200cd009f1e55f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzMtMS0xLTEtMTQzMjg2_0e09f9bc-963e-441e-8fa8-494b16503e65">70,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzMtMi0xLTEtMTQzMjg2_4bc2ae0a-1400-46eb-8585-35efc62f4eb3">24,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzMtMy0xLTEtMTQzMjg2_f5e4ef30-fc28-47c1-b58b-412a4acc3dc5">47,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMS0xLTEtMTcyNzYw_612aa205-2cff-49e8-ac15-9872d1c12316">59,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMi0xLTEtMTcyNzYw_159b7d3f-3343-4632-996a-303c1a01b850">31,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMy0xLTEtMTcyNzYw_58726f77-7049-46f9-917c-5b80d64f8aee">2,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMS0xLTEtMTQzMjg2_b1ae3e38-2525-4d9c-a8ae-306775270826">52,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMi0xLTEtMTQzMjg2_d8f5ad65-72e8-42f1-af36-e3f61498a6cb">51,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMy0xLTEtMTQzMjg2_f38ef3dc-32a5-4241-bc6e-e56d39f33bdc">10,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzUtMS0xLTEtMTQzMjg2_fb7945db-9b73-46b8-9b39-8429dd66b048">2,608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzUtMi0xLTEtMTQzMjg2_90474d4a-cb4a-42c4-9635-f417982c64c5">3,120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzUtMy0xLTEtMTQzMjg2_602d8442-88b8-441b-9b3f-c05de3fbf818">1,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzYtMS0xLTEtMTQzMjg2_42a63452-cf1d-42d1-bbe3-89865617da02">777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzYtMi0xLTEtMTQzMjg2_86ca5456-d7bc-4e2e-b31e-b7ad83944a03">3,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzYtMy0xLTEtMTQzMjg2_ccb4f71a-58bc-41b0-9a15-d0e38c934f52">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzctMS0xLTEtMTQzMjg2_9ce87cd8-77d4-40b0-9b6f-8aaec0a66d3b">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzctMi0xLTEtMTQzMjg2_d9cd1f43-b883-4b1c-beef-a5ceaf7a5673">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzctMy0xLTEtMTQzMjg2_2cd63ed8-e13e-4b8c-b766-be479eda6d81">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzgtMS0xLTEtMTQzMjg2_ca8f6714-fc44-4198-968d-391716e7e2b0">8,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzgtMi0xLTEtMTQzMjg2_58f23074-79f3-4dc2-b342-533943919090">5,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzgtMy0xLTEtMTQzMjg2_5c31e0c5-ff7a-4a82-9792-f1754e9903c8">1,672</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzktMS0xLTEtMTQzMjg2_bf488db5-318b-4a41-86e2-5a7926a2ad73">8,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzktMi0xLTEtMTQzMjg2_80cabba0-91a8-4fc8-9bfb-1f711ffcbe4b">9,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzktMy0xLTEtMTQzMjg2_23f6a25f-09bd-4fd8-b73c-6452ad0f65cc">5,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzExLTEtMS0xLTE0MzI4Ng_5fefd7ad-c199-4dc3-92d4-972607091410">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzExLTItMS0xLTE0MzI4Ng_88f1160a-de97-4005-aa51-087b55114935">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzExLTMtMS0xLTE0MzI4Ng_4f5d15b4-edb4-4b46-a793-a598b9cd0458">3,343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzEyLTEtMS0xLTE0MzI4Ng_1455e03d-6d18-4844-a313-7d4bf250f9d8">59,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzEyLTItMS0xLTE0MzI4Ng_f1acbd24-47d4-4ca6-b54d-693fe632bacb">41,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzEyLTMtMS0xLTE0MzI4Ng_0acfe125-9361-471e-a248-16b67f4a2719">47,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i55ca0624d7204144bebafd4620da2d2e" continuedAt="ic78799bd57464641aa38c70d101a3365"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4Njk_a59addaa-f9c5-49b8-9ddb-5ad671d29a49" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzMtMS0xLTEtMTQzMjg2_9d88d8a6-2d7a-4187-8287-3e8445ed841c">10,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzMtMi0xLTEtMTQzMjg2_23eaf706-f5ef-4554-8ee1-5b50bf326317">19,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzQtMS0xLTEtMTQzMjg2_27a83e6c-1614-4f85-ac29-beca4d7e7ff8">23,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzQtMi0xLTEtMTQzMjg2_9aa2ce4c-5ae2-4a57-8449-c252306d6e7d">33,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzUtMS0xLTEtMTQzMjg2_cd98808f-294a-4d24-8465-4e19d4958980">37,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzUtMi0xLTEtMTQzMjg2_827e722a-2892-4586-bd83-6be20226347d">33,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzYtMS0xLTEtMTQzMjg2_346c6891-a204-4621-aca0-2e7f0e3e3f65">1,078,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzYtMi0xLTEtMTQzMjg2_84d86e62-2234-4c0e-92b6-8133fedca60d">1,201,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzctMS0xLTEtMTQzMjg2_3e006f0e-09df-48be-aa41-e41e4bb7b8c7">9,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzctMi0xLTEtMTQzMjg2_491bd967-462f-4287-8f26-60a921794ed4">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzgtMS0xLTEtMTQzMjg2_aa419a8e-2f3c-49e7-91f6-161b00a011ba">1,158,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzgtMi0xLTEtMTQzMjg2_126d62dc-e5a4-4cc5-8b16-c7d654780934">1,289,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzExLTEtMS0xLTE0MzI4Ng_62f58b8b-fdea-4a42-a911-78d6c05a92c9">88,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzExLTItMS0xLTE0MzI4Ng_3934cf1a-6ba0-43f5-b09f-03b554e19572">86,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEyLTEtMS0xLTE0MzI4Ng_ba24e7f8-a6e3-4d91-b836-63a09cc44f0c">6,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEyLTItMS0xLTE0MzI4Ng_0415a35e-739e-4115-a1e0-b039b05048ef">5,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEzLTEtMS0xLTE0MzI4Ng_01daa481-f20c-4e2c-8974-04d21030c2f7">27,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEzLTItMS0xLTE0MzI4Ng_6d44d476-c70c-4251-a650-c4ff094ca536">36,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE0LTEtMS0xLTE0MzI4Ng_1e1acee8-d16f-46ed-acd2-ad55e4c35d0b">3,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE0LTItMS0xLTE0MzI4Ng_e6eb9196-160e-4575-a59f-0160e1784160">4,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE1LTEtMS0xLTE0MzI4Ng_d76a0942-8dcb-44b5-95f4-be7d30db6342">64,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE1LTItMS0xLTE0MzI4Ng_828bf783-bb56-4f09-819f-4ebfa6f5df25">69,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE2LTEtMS0xLTE0MzI4Ng_d88ffe9f-eca9-4b0d-874f-12871446f363">21,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE2LTItMS0xLTE0MzI4Ng_9a0fee5a-6e09-400b-bdeb-391ef553eb62">25,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE3LTEtMS0xLTE0MzI4Ng_6c79723a-8cc7-4be4-aa45-89a0e5e4a772">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE3LTItMS0xLTE0MzI4Ng_58b8c338-f32e-453a-9630-0c7e1e233e75">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE4LTEtMS0xLTE0MzI4Ng_a8643e2c-8e25-4b73-b527-aa7cf5bc8597">66,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE4LTItMS0xLTE0MzI4Ng_c5f383f8-df5a-4ebf-b755-e1db158e93fa">64,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE5LTEtMS0xLTE0MzI4Ng_c2b3042e-424e-4007-822c-a4545351dac4">9,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE5LTItMS0xLTE0MzI4Ng_3df5365e-d631-40c0-ab42-8157b0f9e9cd">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIwLTEtMS0xLTE0MzI4Ng_43d8b657-0edc-473f-acd1-a1f139ef2ddf">290,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIwLTItMS0xLTE0MzI4Ng_63b39524-efbd-4ae2-b105-9ae309d62e86">297,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIxLTEtMS0xLTE0MzI4Ng_239ad656-28f4-45d9-8d88-09c472513d5c">43,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIxLTItMS0xLTE0MzI4Ng_e8aa31a8-9c0d-487e-a8a2-2dbaaaf9d616">45,495</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIyLTEtMS0xLTE0MzI4Ng_859f5b6e-5136-43fb-bade-94dc2e6fff92">247,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIyLTItMS0xLTE0MzI4Ng_bbd9be54-8cbb-43dc-b0cc-ce380af29218">251,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIzLTEtMS0xLTE0MzI4Ng_eb7614ce-727b-4b1f-ba7f-91b3c310b4af">911,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIzLTItMS0xLTE0MzI4Ng_f26609ab-4e1f-488c-9179-633ecb2bbdae">1,037,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="i055498de74b44ecb8deea65136b4d3b8_I20221231" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzkyMg_38e13c2f-c8fb-4712-9ecb-0e97818a0b9d">16.6</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzEwMzY_3c38c1c0-dc90-46fd-9e3c-f8a177c9837d">5.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzEwNDM_68422f2a-b905-4d7b-81d4-7a07fbb1e62f">401.9</ix:nonFraction> million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $<ix:nonFraction unitRef="usd" contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzExODU_3c38c1c0-dc90-46fd-9e3c-f8a177c9837d">5.4</ix:nonFraction> million U.S. federal NOLs, approximately $<ix:nonFraction unitRef="usd" contextRef="i305536a3cd1f49ec9167bd9bc8104484_I20221231" decimals="-5" name="iclr:OperatingLossCarryforwardsUSFederal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzEyMjE_baee807f-27e3-4666-82da-5f3e1bae399f">3.5</ix:nonFraction> million is available for offset against future U.S. federal taxable income in 2023. The subsidiaries' ability to use the  remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $<ix:nonFraction unitRef="usd" contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzE1NzM_396ef3de-4ae1-4910-829a-79bec60c784a">5.3</ix:nonFraction> million are limited by Section 382 for the years 2023 - 2036. As of December&#160;31, 2022, U.S subsidiaries also had disallowed interest carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzE3NDA_b9537967-830d-411c-84d1-9ab520c7c86d">93.0</ix:nonFraction>&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ic78799bd57464641aa38c70d101a3365" continuedAt="i6a884d4b616b4e22a15d50ebc2c03d3c"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4NzU_8ba64679-6480-4304-a573-41ff29574bfe" continuedAt="ifc07ee528bce419ca158a8cd83e0e0fd" escape="true">The expected expiry dates of the US NOLs are as follows:&#160;</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ifc07ee528bce419ca158a8cd83e0e0fd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023-2036</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d7582e0e7b3484491b75a376c0695c8_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzItMS0xLTEtMTQzMjg2_7caf0ca2-a370-4c24-a2f5-1dc73cc0947e">5,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243aa952befc42c99e33d30e034ad490_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzItMi0xLTEtMTQzMjg2_3272c03e-f37d-4c9e-82cd-758148c12a6d">249,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033-2041</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c198a29dee44519b861db8ccd7b511_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzMtMS0xLTEtMTQzMjg2_786f9e1d-7222-490d-8e3f-fd14970e7e93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d61fb6235784d39b1c898fa148b0af0_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzMtMi0xLTEtMTQzMjg2_ba66bc83-b764-4570-9d64-ff7c17c196fb">145,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzQtMS0xLTEtMTQzMjg2_9b32daab-5540-4324-bc66-0088606215a8">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzQtMi0xLTEtMTQzMjg2_4b5897cc-f12f-4269-bff7-91c151c9364a">6,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzYtMS0xLTEtMTQzMjg2_9fcf8e82-4400-46a5-99da-c8f486b1f878">5,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzYtMi0xLTEtMTQzMjg2_e8439919-4e26-4046-98d5-6d1679dc61ec">401,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i305536a3cd1f49ec9167bd9bc8104484_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzI3NTg_93157fa1-853c-48ea-bb51-1f67a711fa75">0.8</ix:nonFraction> million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $<ix:nonFraction unitRef="usd" contextRef="i3e44759c2a854bc0910676ada44d73bd_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzU3MDU_b9844249-49d1-4178-b7b3-c4d8801f3f8e">37.9</ix:nonFraction> million. At December&#160;31, 2022 those subsidiaries also had additional operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i770c5f02dbff40efa1458e69fb1e60a5_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzU3ODg_168dbb4f-3476-4e44-94fc-bb70f7142bc5">14.8</ix:nonFraction> million which are due to expire between 2023 and 2029 and operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i67dddc1be99b46a6ac8672b42f7fb4b8_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzU4NzQ_b084777d-50ae-4a49-8dc3-254e24f59595">18.2</ix:nonFraction> million which are due to expire between 2030 and 2039. In addition, at December&#160;31, 2022 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="i86e0b74245524351afc9b509e585fb1c_I20221231" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzYxMjI_4b162ae5-c0b7-4de9-ae45-d495c78789d8">4.7</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2022 was approximately $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzI5ODY_2d05e674-12df-4d15-94c3-ea42785570cc">43.4</ix:nonFraction> million. The valuation allowance for deferred tax assets as of December&#160;31, 2021 and December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMwNTg_76639762-e498-4e88-bc5f-a0a6cf013064">45.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMwNjU_d6b004a7-f204-4d43-bfe4-4852111adacf">32.8</ix:nonFraction> million respectively. The net change in the total valuation allowance was a decrease of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMxNDk_b491d4dc-5a45-41b0-81c2-10e4706d4283">2.1</ix:nonFraction> million during 2022 and an increase of $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMxODE_ca02f01d-d79f-4372-a048-29d190c7434d">12.8</ix:nonFraction> million during 2021. Of the total decrease of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMyMjA_b491d4dc-5a45-41b0-81c2-10e4706d4283">2.1</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie343632514b54c28a4d376a3c9298cfe_D20220101-20221231" decimals="INF" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMyNjg_f03d1991-a8b9-4fc3-88db-28ed06f03047">0.8</ix:nonFraction> million was recognized within income tax expense and a decrease of $<ix:nonFraction unitRef="usd" contextRef="i7f25427924a2406292894864e22c91dd_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMzMzA_4d32b241-b225-4df7-8297-8115d6f33484">1.3</ix:nonFraction> million was recognized in Other Comprehensive Income. Of the total increase of $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzM0MDQ_ca02f01d-d79f-4372-a048-29d190c7434d">12.8</ix:nonFraction> million in 2021, $<ix:nonFraction unitRef="usd" contextRef="i44caf25e9f21476690747f57e50f9aa0_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzgyNDYzMzcyMTU1MzA_f65ce980-eeea-4a6e-bf32-9c207eb51978">9.3</ix:nonFraction> million was in respect of an acquired entity, $<ix:nonFraction unitRef="usd" contextRef="ia6674f8abb9143528db74c781bd4f419_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzM0MTQ_65f759e8-10d7-4ee1-8f6e-cc89b09a122b">4.4</ix:nonFraction> million was recognized within income tax expenses, and $<ix:nonFraction unitRef="usd" contextRef="if47bb526e18f463db1bed028cf43f0ef_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzM0Njg_5c94382f-a4f1-490c-9176-0060e6eeb08d">0.9</ix:nonFraction> million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2022 and December&#160;31, 2021 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recognized a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzQ2MDM_f8f78003-f238-487b-bb7f-586276084c3b">1.6</ix:nonFraction> million (2021: $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzQ2MTE_2f90b10c-1df8-471e-b810-7bf588b823b6">0.8</ix:nonFraction> million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6a884d4b616b4e22a15d50ebc2c03d3c"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4NzM_b509f69a-ed03-4f44-a9e6-b8a2a7e301e6" escape="true"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzItMS0xLTEtMTQzMjg2_4acf9f92-020d-4ad6-a451-e191f0d4b9ff">202,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzItMi0xLTEtMTQzMjg2_ce20c151-eb32-43bf-b980-951319fc76b4">19,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c028363c21c48d5bdb88ba826d38299_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzItMy0xLTEtMTQzMjg2_5148753c-24da-43e3-a10b-514f9f523991">20,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" xsi:nil="true" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzMtMS0xLTEtMTQzMjg2_fc12c447-2228-4809-8869-21b5d6c4a486"></ix:nonFraction></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzMtMi0xLTEtMTQzMjg2_397217fb-37be-4bf4-b42c-09ffa3c20d8c">170,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzMtMy0xLTEtMTQzMjg2_1f26cdfe-5280-4b6e-b3fb-23ff9d30511c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzQtMS0xLTEtMTQzMjg2_e53513a6-6975-4c8e-a090-8ef36c5fd540">16,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzQtMi0xLTEtMTQzMjg2_eaba5e38-f41d-42f1-a4ab-44ef1351e644">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzQtMy0xLTEtMTQzMjg2_b1a90051-00a4-41c1-9214-d373df40e63a">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzUtMS0xLTEtMTQzMjg2_b39b6455-81f7-4175-901f-3c19ba6093a9">5,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzUtMi0xLTEtMTQzMjg2_2a31c371-712b-4e7b-bd7a-f380d1fdc25e">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzUtMy0xLTEtMTQzMjg2_2e09eaad-3905-4fa3-93cb-5f5e8a2b2a00">1,271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzYtMS0xLTEtMTQzMjg2_111f2801-6da6-47ae-bd4f-479a9de33c24">5,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzYtMi0xLTEtMTQzMjg2_7e710bac-bafa-4639-82c0-0becf6866dd0">18,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzYtMy0xLTEtMTQzMjg2_b2ec3501-3d7f-408a-b38c-48d139e28bac">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzctMS0xLTEtMTQzMjg2_a05d1fd6-debf-4715-b763-c76acbad74c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzctMi0xLTEtMTQzMjg2_cb31f1a6-5e56-456c-9049-7d870be05b7a">844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzctMy0xLTEtMTQzMjg2_b0c7dbf2-0142-4f0f-8c53-27e03c0c8a0b">369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzgtMS0xLTEtMTQzMjg2_af19f20d-7c73-46ea-9a5d-5849c63f9b66">838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzgtMi0xLTEtMTQzMjg2_436cb29b-6f0b-4405-9688-4324e3c7f9d3">3,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzgtMy0xLTEtMTQzMjg2_79b45803-7391-43bd-9fbe-c91ebe101f8c">2,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzktMS0xLTEtMTQzMjg2_2ff89e8b-4b06-4ba5-aeb4-0628a9ea7f24">217,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzktMi0xLTEtMTQzMjg2_8bdfe5d8-80a9-415c-8302-9d1be9a4fcbc">202,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzktMy0xLTEtMTQzMjg2_3a340b78-9a37-47f8-b2c4-3542143954cc">19,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzU2ODU_d917c01c-3ca8-4c95-9e93-10fef83ee8cb">37.9</ix:nonFraction> million could potentially expire during 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2022 were potential benefits of $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzU4MjA_27fb00a2-a531-448e-bba6-a4124161095d">217.6</ix:nonFraction> million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2021 and December&#160;31, 2020 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYxMDU_20d151e4-0fb2-497a-bd46-70615c85f959">202.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYxMTI_7c345879-bc54-497a-8d27-a9140a7cfab2">19.1</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2022 amounted to a net charge of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYyMTc_7b5d4b7f-0da5-4b6e-91fe-ae5da6f19613">7.1</ix:nonFraction> million (2021: $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYyMjY_d1ea334a-3350-4639-9df5-2f0d48ee26a4">1.9</ix:nonFraction> million, 2020: ($<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYyMzU_cc43ed03-340a-4380-9787-cfd5302b5d13">0.6</ix:nonFraction> million)) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYzNDU_cc68f30b-a128-41fb-a0da-fb2f7eab785f">22.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYzNTI_72674e3f-55c7-477a-8f6f-d63606beec76">15.5</ix:nonFraction> million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_190"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0MjE_c23f9c91-6983-47ee-967f-c5ef92f9c37d" continuedAt="i583c4b002d194706b01074ad1c6d76a8" escape="true">Employee Benefits</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i583c4b002d194706b01074ad1c6d76a8" continuedAt="icdb16be694fc4d1ca09963ee89a94e10"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of <ix:nonFraction unitRef="number" contextRef="i64338787f17e44159195780f1ed3a4e3_D20220101-20221231" decimals="3" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEwOTQ_1dc07570-5fe0-4676-9313-fef99f51935f">4.5</ix:nonFraction>% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i64338787f17e44159195780f1ed3a4e3_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEzMjI_87016c87-f580-4f0a-951a-00575e003724">30.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i10c7a471fc164535ab1f5501d22dd648_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEzMjY_d34883d6-008b-476f-b3f3-6bab6c20c5fe">23.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibf91caf53cac409b8da970cacfe56918_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEzMzM_0a37e710-9509-4b59-8836-bc1a1ce697e1">17.0</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pension and Postretirement Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzE2NDkyNjc0NjIxMDM_76e8ab77-601a-4837-84eb-077c4f3a39e9" continuedAt="i127138b6a120454089ad25aba671359a" escape="true">The balances recorded to the balance sheet are as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i127138b6a120454089ad25aba671359a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f00760e31240959ce3972bf544992d_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzEtMS0xLTEtMTY4MTQz_87b0c7bc-be04-4691-80f5-4ae881591f14">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i569507f611d548c49b8650b70c94c2fd_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzEtMi0xLTEtMTY4MTQz_f0aaa1ab-d326-432f-942e-9fa2958e3cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4f00760e31240959ce3972bf544992d_I20221231" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzItMS0xLTEtMTY4MTQz_fd47f9cb-bab4-49cc-a50a-1a42567d87fb">13,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i569507f611d548c49b8650b70c94c2fd_I20211231" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzItMi0xLTEtMTY4MTQz_a4bfcb40-37a0-43e4-80b5-543207a164f7">16,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icdb16be694fc4d1ca09963ee89a94e10" continuedAt="i4b66dea5304a49b8a959f75e34734758"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the specific defined-benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $<ix:nonFraction unitRef="usd" contextRef="if733533a187d46cfb46437f0574bd48b_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzE2NTk_e34efbbe-5249-4e67-bc4d-a70add06dcd7">11.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i07132bfad9184874a360f6352a964e49_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzE2NDkyNjc0NjIxMjk_f1129c1d-b69a-4e19-a701-bfab4c4a43f0">8.0</ix:nonFraction>&#160;million recorded to non-current liabilities as of December 31, 2022 and December 31, 2021, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> 'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0MDk_ef8efff4-d57c-473c-8aa4-96001e01cf55" continuedAt="i08bdb95586324cefbd452bf1fa7404a7" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzItMS0xLTEtMTQzMjg2_2056d3a0-8b89-4790-ab5c-ca357bfb522a">19,558</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzItMi0xLTEtMTQzMjg2_3f0e47de-51a6-4f04-9153-3b000ae38a7e">41,813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzMtMS0xLTEtMTQzMjg2_01c67e8f-c675-4597-bba4-586eb0e50b44">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzMtMi0xLTEtMTQzMjg2_a39b3ce1-508c-4b3b-b743-44435e22723b">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzQtMS0xLTEtMTQzMjg2_61a5fd3a-cc5f-440a-bf84-300580652367">6,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzQtMi0xLTEtMTQzMjg2_82f3486c-d548-45ec-89c9-b844820b5ccc">5,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December&#160;31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzItMS0xLTEtMTQzMjg2_daac6baf-74e2-4c60-9b89-b195073be70e">41,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb24a7a223049669f10a43260fb3f9e_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzItMi0xLTEtMTQzMjg2_361b991e-5dc2-4b16-bfa3-737dd85dfeb5">43,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzMtMS0xLTEtMTQzMjg2_e747d7c0-0eb6-488e-a5b5-ecc2d514e4b1">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzMtMi0xLTEtMTQzMjg2_d5350ccb-a87b-489b-bbe3-3653089a28e2">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzQtMS0xLTEtMTQzMjg2_0bcd7b4c-df6d-476b-9a3f-da9635399cd8">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzQtMi0xLTEtMTQzMjg2_2763d10e-8dc3-4a59-a4e8-d6b042cd9adb">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzUtMS0xLTEtMTQzMjg2_c863ea58-563b-462f-92d6-986fd55c699e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzUtMi0xLTEtMTQzMjg2_6ed581d3-89ed-40d3-83af-5a63ff8f9a9f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzctMS0xLTEtMTQzMjg2_1906a086-07b0-4214-bd5d-6dbf588a5698">514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzctMi0xLTEtMTQzMjg2_60d63cc9-125a-482b-9ca1-61fb3ca3f6e7">489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzgtMS0xLTEtMTQzMjg2_36fb1e43-3489-4b27-9e73-a5bbc2d223c2">18,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzgtMi0xLTEtMTQzMjg2_4cbfacbf-1575-422a-bbe4-37293d9a907f">2,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzktMS0xLTEtMTQzMjg2_6151642e-a1a7-443e-80e5-2d69da207766">3,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzktMi0xLTEtMTQzMjg2_647b1194-25aa-4b69-8bb7-68b6cef6c050">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzEwLTEtMS0xLTE0MzI4Ng_fc6cb2df-5d2d-4002-802c-4b4da907b603">19,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzEwLTItMS0xLTE0MzI4Ng_6d16a63c-8324-49ed-8643-c71c8481b97d">41,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzItMS0xLTEtMTQzMjg2_806fb236-2e06-47dc-8780-2bb3325240f7">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb24a7a223049669f10a43260fb3f9e_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzItMi0xLTEtMTQzMjg2_ed52b33a-b782-4229-b1fa-2f10956231a8">34,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMS0xLTEtMTczMDA5_f565fe35-1b0d-4473-9796-2ba01fbd82b3">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMi0xLTEtMTczMDA5_9c7e894a-8f8f-4edd-93dc-8da071995abf">1,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMS0xLTEtMTQzMjg2_bc99f310-6beb-46d3-9647-ce8fc3b40213">7,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMi0xLTEtMTQzMjg2_99921f44-01bc-43ba-9ae3-4619be2668b8">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzQtMS0xLTEtMTQzMjg2_19b24498-690e-44a9-b0d6-6f70bd209f3d">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzQtMi0xLTEtMTQzMjg2_bafa4ed4-9c5c-435c-91c4-f5bcbd104c56">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzUtMS0xLTEtMTQzMjg2_2986737c-ce02-4fa3-9227-5aa87d0c9223">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzUtMi0xLTEtMTQzMjg2_aeeac832-57a9-4360-a255-0d7abff41543">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzYtMS0xLTEtMTQzMjg2_8a6989fd-74fb-4d80-beb7-8ff2cc96f695">514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzYtMi0xLTEtMTQzMjg2_5f0738ed-f1f9-449c-901b-b702467ee378">489</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzctMS0xLTEtMTQzMjg2_2121d636-818c-42f3-943a-7450575389fe">3,676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzctMi0xLTEtMTQzMjg2_fb8cc7b7-fe8c-4dc6-ba68-9ad4e8b640fc">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzgtMS0xLTEtMTQzMjg2_11b41cb4-e98c-4036-a96e-91ced66271b2">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzgtMi0xLTEtMTQzMjg2_073989a7-897e-46e9-9150-81501caff82a">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4b66dea5304a49b8a959f75e34734758" continuedAt="i74b15ce767a0408d9a83a8a68b264c0d"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NDg_7d5bfce6-1f7f-4f80-b22e-691240188345" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzItMS0xLTEtMTQzMjg2_6ade9dd4-0ddd-4821-a8c3-dd9ffb0c96c2">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzItMi0xLTEtMTQzMjg2_1cfc48ca-1676-473f-8ef2-65647501fbaf">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzItMy0xLTEtMTQzMjg2_38a324ad-54d2-4883-a66c-35cd50ee6801">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzMtMS0xLTEtMTQzMjg2_3f6478f0-f8f0-45ac-bd9b-72ddb650e942">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzMtMi0xLTEtMTQzMjg2_fddb8835-7e5f-4511-af71-aa76e5593911">665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzMtMy0xLTEtMTQzMjg2_527d831c-6f14-42cf-9061-5f42d5822794">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzQtMS0xLTEtMTQzMjg2_9123bfcc-3a6d-437e-a742-d61374bfc58e">1,258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzQtMi0xLTEtMTQzMjg2_6ee595f1-a360-48f4-93c4-9770c0af39a1">1,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzQtMy0xLTEtMTQzMjg2_949b98bc-7cd0-44e7-ab0f-dd6d372358f7">1,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzUtMS0xLTEtMTQzMjg2_90ae8a9a-d587-407a-a339-de2c806d1192">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzUtMi0xLTEtMTQzMjg2_ad94d8c6-ba6c-4ad0-8b14-f13fa1eddc6c">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzUtMy0xLTEtMTQzMjg2_36c94886-f785-4c69-875a-ad44c4e2c0fb">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzctMS0xLTEtMTQzMjg2_ca21bf45-0fd8-4580-aab0-f1b10990097f">241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzctMi0xLTEtMTQzMjg2_75919655-b0cd-4497-b7c9-6e41b99477f9">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzctMy0xLTEtMTQzMjg2_0520b08b-63b7-4d3e-89e7-abe063ffe757">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0Mzk_cad5fc3e-554d-4be8-b71f-a9fc147cb0a4" continuedAt="i7b44937edff5482c9ff86db870861a49" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzEtMS0xLTEtMTQzMjg2_3eb74377-b614-4658-894e-eb5f0239f7ef">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzEtMi0xLTEtMTQzMjg2_59938a54-7dd4-46b1-9a65-4123d27cd528">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzEtMy0xLTEtMTQzMjg2_914b9873-ca47-496d-b46e-d54ac54c22a5">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzItMS0xLTEtMTQzMjg2_91e2f308-edfe-4ab9-a18d-610200cf7df1">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzItMi0xLTEtMTQzMjg2_cb212c2b-2104-4e0f-9931-0d970eacb61d">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzItMy0xLTEtMTQzMjg2_7dafc45b-f8aa-49c0-8195-bb7f72a0d994">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzMtMS0xLTEtMTQzMjg2_2c7ba936-7325-4fe7-ad0d-af93c28ee080">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzMtMi0xLTEtMTQzMjg2_840cf8e4-4be2-4d80-8c59-195408cda634">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzMtMy0xLTEtMTQzMjg2_13c571d5-ac12-41de-8460-3669ef6d7b5e">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NTA_8dff247f-7918-4723-ad55-5c0eff372d1c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzItMS0xLTEtMTQzMjg2_2b1bec22-3398-4aaa-bfb4-535bbb5f66ea">18,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzItMi0xLTEtMTQzMjg2_3f1d4914-cf74-472f-9ddc-4278f26a36cc">2,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzItMy0xLTEtMTQzMjg2_be91e7c4-54f1-4946-9909-9e009c31e889">5,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) &#8211; plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzMtMS0xLTEtMTQzMjg2_1e763b90-c062-4e07-ae8a-00a551a5b593">7,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzMtMi0xLTEtMTQzMjg2_0a46e817-40de-40c1-9e5b-69e4f4ac6373">1,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzMtMy0xLTEtMTQzMjg2_25500e1a-093c-4241-8128-d1efc49207de">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzQtMS0xLTEtMTQzMjg2_722a0577-1c36-4d7b-a99b-7ff30580a4fc">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzQtMi0xLTEtMTQzMjg2_b0bddb11-72b5-45a0-9023-c66f4242e4c5">625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" name="iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzQtMy0xLTEtMTQzMjg2_bbf103a4-c9fd-4f86-9a3c-81449bab5a57">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzUtMS0xLTEtMTQzMjg2_5f7be09d-c923-4b21-b6c9-e47d0f722a16">11,559</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzUtMi0xLTEtMTQzMjg2_5b537c29-7a28-470b-ad38-474899f70a95">3,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzUtMy0xLTEtMTQzMjg2_17112bec-9623-40fa-b73b-c78ac18e9a40">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $<ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzMxMTk_fc4d5865-99ce-4d3a-910f-fcc2b847c868">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzMxMjY_9b03b609-3af4-4897-b855-3855094ea2bd">Nil</ix:nonFraction> respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7b44937edff5482c9ff86db870861a49"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzEtMS0xLTEtMTQzMjg2_8c879052-1cca-4b94-a455-c5c8f9b13ff5">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzEtMi0xLTEtMTQzMjg2_f883b402-2ea4-41de-8287-e6af44c9c9b3">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzItMS0xLTEtMTQzMjg2_949f43d0-ac4e-4e42-b019-aea64170c05e">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzItMi0xLTEtMTQzMjg2_364f3f41-aefe-4146-91d6-c7f0c2dcf62c">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a <ix:nonNumeric contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" name="iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NTE_256b27d8-939d-4903-831e-aa1839ddcc7a">19</ix:nonNumeric> year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2022 resulted from changes in the assumptions compared to those adopted at December 2021. Changes in the assumptions reflect the changes in market conditions from December 2021 to December 2022 and the actuarial gain is primarily due to the change in</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> the discount rate.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i74b15ce767a0408d9a83a8a68b264c0d" continuedAt="iffc56a9ef5b64bd4b3ebc223029da859"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NDA_c8953cc3-b0ea-445a-835d-3987ec4b6518" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4ccd74632f9452c9fc7c4c727e7cbc6_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMS0xLTEtMTY0MDk3_a4b9c1c8-d87b-488d-b923-2d5cba331975">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52e0d42fa9c04d3fbc41dc023095bf98_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMi0xLTEtMTY0MDk3_7087ff0d-5b51-4f28-a112-75f702913e20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie21482250291473491b179d1e9638496_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMS0xLTEtMTY0MDk3_79ffc5c2-b659-4fac-9a43-c90aceba2681">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97b87f6afcb34559a2f4576b1a188c7a_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMi0xLTEtMTY0MDk3_2cd238c1-8714-4249-a506-c088d3f7d4e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2401c0c85e74845af9e260c7e7cde74_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMS0xLTEtMTQzMjg2_7c2f1915-b801-4f99-94ab-cbbce79bccb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d8837cc7bc34a82948378f474d993cd_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMi0xLTEtMTQzMjg2_0ec6c225-3ca7-4502-aa2e-64175163a17e">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i506afdb62b6645c28768481748bbcbd5_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMS0xLTEtMTQzMjg2_31c3acbf-671b-4beb-ab46-968d66b422e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i062ad9be3f9e465db1f49eeeced971fe_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMi0xLTEtMTQzMjg2_0e5c45c1-2533-4cea-a173-f750be500c0d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8fe6c6b53ea94d49965d0ca81e095c39_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzMtMS0xLTEtMTQzMjg2_ee02d5cc-a7eb-4069-b922-f57618cf188a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7871cec33a7b4f3883e3e6c9cddf204a_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzMtMi0xLTEtMTQzMjg2_496422d9-8280-4c5a-b345-1d83999fecf7">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bc40275d8744c9793904bf596955616_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzYtMS0xLTEtMTQzMjg2_8cf7ac17-3ed3-436e-a3f3-4502f5557a4f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1531dcf96765414a87b044843515f2fc_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzYtMi0xLTEtMTQzMjg2_d31c5e2d-ddc5-42fd-82a0-b816375555a8">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company&#8217;s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is <ix:nonFraction unitRef="number" contextRef="i422b56f7af8b490e859596ef6dbce65b_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzgyNDYzMzcyMjc3MjY_c9237406-6c2c-42d3-be7f-8cb81871e731"><ix:nonFraction unitRef="number" contextRef="ie835ce8081ec4f4ca739bd71e6565c20_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzgyNDYzMzcyMjc3MjY_db3c73fb-d1b1-4062-b254-49ed4ec182aa">3.8</ix:nonFraction></ix:nonFraction>% at December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0Mjk_398d9f83-95ca-4907-ba32-42114d650696" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7471376d2a4fbe9b259e2a8ce7278f_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzMtMS0xLTEtMTY4MTY4_593a7082-4e2d-4dfa-9bee-9175d5deaf95">22,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96aa6b711ab446a3a14f6536ac6ba863_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzMtMi0xLTEtMTY4MTY4_8f537e0c-5836-41f1-ac31-e33aebd38d3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd9a11dcfb642da959b07ec79751954_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzUtMS0xLTEtMTQzMjg2_cc768d40-5a9c-4d5a-8523-4f0cbf9d844b">3,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b52a3900c584d009b5d05b00cfe85c8_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzUtMi0xLTEtMTQzMjg2_52571607-721e-43de-979c-a39c842bd367">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc4210481bdb451ba035a20efdc271b6_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzYtMS0xLTEtMTQzMjg2_e01b802a-1bd4-4447-a685-6105f5441c78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d097939710f4e2face7b10bdd140ba4_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzYtMi0xLTEtMTQzMjg2_abde9879-9631-4f41-b0c0-d33d4f62d525">8,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a0752301494fecba30d3ccd834c133_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzctMS0xLTEtMTQzMjg2_d63ce436-1ea0-4dfc-a4f1-b14ff43ec762">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f6a845a66843d79b61cba68f576f33_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzctMi0xLTEtMTQzMjg2_8c365483-c1de-452a-976f-e69e5d29e6d4">13,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34f24ef293946839ccb0115382374cc_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzgtMS0xLTEtMTQzMjg2_b9cadc6f-73c8-460d-a6f6-7c02acd18391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d40dd88a404685bf76258b0e90d0a6_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzgtMi0xLTEtMTQzMjg2_cf117616-87ed-4a73-a16d-5532ae64aed7">13,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9862be84bb6f492bb811a70c03726aeb_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzEyLTEtMS0xLTE0MzI4Ng_2c94e47d-8937-4d5c-8a9a-832fb0f283cc">26,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c56c86bbb747b1a07d20615ebedb0b_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzEyLTItMS0xLTE0MzI4Ng_92394d78-762c-4b64-a695-fa26e35ceacd">36,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of assets held by the plan are represented by quoted prices in active markets for identical assets  and are therefore classified as level 1 investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $<ix:nonFraction unitRef="usd" contextRef="i825154864e984f849f9034999b633fbe_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzU0NzA_92f53e77-125a-4664-9606-07768deb74d4">0.1</ix:nonFraction> million to the pension fund in the year ending December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0MzU_9ea42546-9af6-4759-be69-3a85d918dfdb" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784352491d144cd972226c028844591_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzEtMS0xLTEtMTQzMjg2_3524f22e-5727-41c7-b1cc-42d8581bf33a">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784352491d144cd972226c028844591_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzItMS0xLTEtMTQzMjg2_8be169d5-80f6-4a37-8229-a1b6deaecb6f">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784352491d144cd972226c028844591_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzMtMS0xLTEtMTQzMjg2_319d30b1-559b-46e8-95fc-d82c81c4ccaf">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784352491d144cd972226c028844591_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzQtMS0xLTEtMTQzMjg2_4e9a2a67-7514-4673-8c76-b20bfe7869f0">703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784352491d144cd972226c028844591_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzUtMS0xLTEtMTQzMjg2_40a7820e-6a5d-4ba8-8795-76e81541868e">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2028 - 2032</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0784352491d144cd972226c028844591_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzYtMS0xLTEtMTQzMjg2_a8173beb-bc3d-4682-9a46-eceabf105269">3,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next <ix:nonNumeric contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231" name="iclr:ExpectedRetirementPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzU3Mzg_1df34ad6-5cc6-4086-84e9-46180df113b0">10</ix:nonNumeric> years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="iffc56a9ef5b64bd4b3ebc223029da859" continuedAt="i290606fd0fb342a48c1c8d32f4c1c106"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired <ix:nonFraction unitRef="number" contextRef="i31374c47a6bb44ba914a1d8045381bed_I20140507" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzYyOTA_84eb1ce6-1ce9-44ac-b702-886621e5f241">100</ix:nonFraction>% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022 and December&#160;31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i08bdb95586324cefbd452bf1fa7404a7" continuedAt="id6b04007ba4d44568df450cdab0930d3"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzItMS0xLTEtMTQzMjg2_e6a041af-3e45-49d3-8dd4-d92426b824a0">5,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzItMi0xLTEtMTQzMjg2_f55af9e5-7ac1-4b7f-90a7-92af99db690b">7,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzMtMS0xLTEtMTQzMjg2_efc8fe9f-13b6-4cfb-88c7-3d76684b5429">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzMtMi0xLTEtMTQzMjg2_3ec765ea-577b-4832-8383-78146d50159e">6,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzQtMS0xLTEtMTQzMjg2_d5cfbcfd-f97a-4f47-a302-ec4d22d9af9b">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzQtMi0xLTEtMTQzMjg2_4bc651d3-99f8-4a45-8191-c8cec5b5e8fb">679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table.  The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 were <ix:nonFraction unitRef="number" contextRef="i1682825f41f34d8ca4c4852e0ba2f96d_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTY5_c4d03f86-42db-4a4a-9c40-a07bc1c081b3">2.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icbde31e88d4849f8badda657229d3344_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTc1_f60c5b2a-4d67-4323-8a00-69d998ad1404">0.4</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzItMS0xLTEtMTQzMjg2_73ad0a1b-da89-4bfb-8b15-907dc9be994a">7,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic768660976f74ad5af5a5fff5ef0bb5b_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzItMi0xLTEtMTQzMjg2_fb9fd6b7-05d6-4b28-b1c5-27149650cf1b">8,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzMtMS0xLTEtMTQzMjg2_39b1273b-aad2-4581-a4a4-a7a17257e004">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzMtMi0xLTEtMTQzMjg2_99fd13a0-383e-4aba-9ab1-db1c1d3e74d3">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzQtMS0xLTEtMTQzMjg2_d1ce3601-23ca-4959-9ede-734567cd1c9c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzQtMi0xLTEtMTQzMjg2_23bc4062-098a-4482-b302-9df2ee25ba4a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzUtMS0xLTEtMTQzMjg2_17e60426-cb46-4b82-8920-3675f3e603dd">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzUtMi0xLTEtMTQzMjg2_dfc388d8-1285-44eb-b2c2-242b9487dec3">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzYtMS0xLTEtMTQzMjg2_9ef201af-2917-4a22-bf17-50b8c3a79fe0">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzYtMi0xLTEtMTQzMjg2_08ae9bef-0f44-4405-9dfb-bdd2cbde6248">483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzctMS0xLTEtMTQzMjg2_0f3eaa08-4b1a-4b5e-b62f-a12b3f04d179">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzctMi0xLTEtMTQzMjg2_50f0797a-69f1-4ef0-bc1e-979a7898bef2">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzgtMS0xLTEtMTQzMjg2_07231c54-7e39-4748-8738-0cf41fbde149">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzgtMi0xLTEtMTQzMjg2_2e0f8e48-452c-4214-8026-8c3376cfce2c">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzktMS0xLTEtMTQzMjg2_b2e6e447-c673-440d-b806-37f6d6d88a42">1,527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzktMi0xLTEtMTQzMjg2_0b93ef64-570f-496f-9a75-265b450df2bb">484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzEwLTEtMS0xLTE0MzI4Ng_d3836dd3-e49c-4e97-b949-057c140a2dd0">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzEwLTItMS0xLTE0MzI4Ng_b592773c-8319-4239-8488-c20ab1ab93b0">261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzExLTEtMS0xLTE0MzI4Ng_d5d65a9a-ac53-4c6a-9092-dbe222655c8a">5,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzExLTItMS0xLTE0MzI4Ng_ce6f04ea-65c7-433e-995b-1e8ea241892b">7,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzMtMS0xLTEtMTQzMjg2_68233132-b4c7-498d-bae8-98bb83b0c682">6,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic768660976f74ad5af5a5fff5ef0bb5b_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzMtMi0xLTEtMTQzMjg2_af7f6e07-bb04-4faf-8d53-86b686c0d46e">7,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzQtMS0xLTEtMTQzMjg2_bb01e883-4a7b-48df-82d9-a34679f03436">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzQtMi0xLTEtMTQzMjg2_8a1dc21f-81b6-4739-b5d0-bbccb622aa96">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzUtMS0xLTEtMTQzMjg2_cdb55a10-4675-4761-9ff8-937267552a18">987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzUtMi0xLTEtMTQzMjg2_07cb123c-2a64-4d14-a6ce-fca80936f273">238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzYtMS0xLTEtMTQzMjg2_a4df727b-a04f-4f17-a4b4-c1943e8adfac">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="iclr:DefinedBenefitPlanSchemeContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzYtMi0xLTEtMTQzMjg2_3a6eceea-098d-4a58-85c6-81f23f4bd86b">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzctMS0xLTEtMTQzMjg2_d284413f-275f-474b-9d93-1a103d22fec7">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzctMi0xLTEtMTQzMjg2_30c8f9b2-819c-4c18-8b18-f6e24b077685">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzgtMS0xLTEtMTQzMjg2_b40c1c0c-4f7a-44f0-8473-ba5ef0d69832">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" sign="-" name="iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzgtMi0xLTEtMTQzMjg2_0e53eaca-126a-4056-92f1-20f659e93cad">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzktMS0xLTEtMTQzMjg2_9cf102c8-d351-456e-9924-36517a162324">218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzktMi0xLTEtMTQzMjg2_424d7498-973d-4ca4-ad22-8297f8f4d0b0">483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzEwLTEtMS0xLTE0MzI4Ng_c9c6ab9d-c7a6-4ff3-af04-31304dc4a6e1">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzEwLTItMS0xLTE0MzI4Ng_022a30f8-d2d6-42c9-8d36-2b7f15078fc2">230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzExLTEtMS0xLTE0MzI4Ng_21d73a3a-9bd7-4658-a98c-aee6562a3096">5,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzExLTItMS0xLTE0MzI4Ng_97c5cb2c-48ab-45e7-aabf-e421f82a041c">6,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i290606fd0fb342a48c1c8d32f4c1c106"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022 consist of units held in independently administered funds. <ix:continuation id="id6b04007ba4d44568df450cdab0930d3" continuedAt="ice417a458eac48f1a08cba2ab78f8ce9">The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </ix:continuation></span><ix:continuation id="ice417a458eac48f1a08cba2ab78f8ce9" continuedAt="ibd1f34495d6d42fd873f5b4be645590f"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ibd1f34495d6d42fd873f5b4be645590f"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzItMS0xLTEtMTQzMjg2_ea3673c5-82d7-4ca3-bf36-38a1a40e44e4">5,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzItMi0xLTEtMTU5NzI3_44c1b071-4707-49f5-93d1-1acca5f33994">4,990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzMtMS0xLTEtMTQzMjg2_1cd2fb7a-ef6c-42ec-9f0a-5be52e2f9e22">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzMtMi0xLTEtMTU5ODY1_11d17e4f-2dd1-42b4-b997-2b1588216f8b">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzQtMS0xLTEtMTQzMjg2_46df35e8-137a-4e8a-9222-256250864727">1,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzQtMi0xLTEtMTU5ODY5_8f182611-63fa-4350-9f0c-4757bd533342">1,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table.  The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 was <ix:nonFraction unitRef="number" contextRef="i641bf226224d4002a6b87b5dcb9ef829_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTgx_c368ad8b-d342-4ab4-86ae-bc3d72a632b3">2.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i8c58dceb3ee34f9fab1c82b8d0e2e8d7_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTg3_573a6887-2dd3-4a62-aa64-fd189551ee29">0.4</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzItMS0xLTEtMTQzMjg2_c17dc451-3e09-46dc-a24b-9f6ffa32ba19">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a1032d1909414c8deb46ff92fb05d9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzItMi0xLTEtMTU5NzMy_82c65647-0fbd-4901-8fb4-d4a205eeb47f">4,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzMtMS0xLTEtMTQzMjg2_e46fcb79-550c-4e89-bca8-d8e48d89cc0f">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzMtMi0xLTEtMTU5NzMy_5a1e9232-77c2-4eed-a493-95c2788e8255">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzQtMS0xLTEtMTQzMjg2_73942e97-a43c-4308-be32-0152666c5013">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzQtMi0xLTEtMTU5NzMy_b95f8b36-76c4-4b1e-972a-300a0a2712b2">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzUtMS0xLTEtMTQzMjg2_d7447b6c-42b0-4a47-abe8-74afe7c2c79b">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzUtMi0xLTEtMTU5NzMy_e24cb624-b862-4573-8614-d7f8fd66a628">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMS0xLTEtMTYwODU5_5e5f959d-b4d6-48e5-8f16-b55862b33a7c">844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMi0xLTEtMTU5OTAw_af1a3f78-51fd-424f-b606-fcd5829cc87d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMS0xLTEtMTQzMjg2_0a369066-5597-4c26-bc8a-9b1b81d57741">946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMi0xLTEtMTU5NzMy_f02e4e22-e0ee-4277-ba9a-af65fe167d9c">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzktMS0xLTEtMTQzMjg2_6d3fee79-5385-4665-81fc-12398fc2a978">627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzktMi0xLTEtMTU5NzMy_db7a0ff6-9862-4b6f-aefe-2adfc23032c3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzEwLTEtMS0xLTE0MzI4Ng_41719f3a-5772-4c3b-80a3-af890a36e9c0">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzEwLTItMS0xLTE1OTczMg_24787e25-0105-4a2a-a000-7531a220d6aa">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzExLTEtMS0xLTE0MzI4Ng_4703174f-632b-4f2e-b6ad-4c30dd1bc0b1">5,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzExLTItMS0xLTE1OTczNw_fc4a9d2e-6931-40ca-b050-0950f621ef5c">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzMtMS0xLTEtMTQzMjg2_718f0ccb-f1a6-4147-8f4f-75b8ab738e95">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a1032d1909414c8deb46ff92fb05d9_I20201231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzItMi0xLTEtMTU5OTIw_16dc5672-b7be-46c6-a0d9-246b32e4afa0">2,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzQtMS0xLTEtMTQzMjg2_a4baf085-9993-4748-bcd8-0b4b617b408a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzMtMi0xLTEtMTU5OTIw_d50da8d3-e093-48de-b357-305e07b5ae08">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzUtMS0xLTEtMTU5OTMx_0769544a-8f9a-4660-91dd-366027424e8f">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzUtMi0xLTEtMTU5OTMx_10e32c02-8cb9-4421-bb47-43ec729d0640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzYtMS0xLTEtMTQzMjg2_9a64deda-c7e3-4896-ac35-e0157cdc0342">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzUtMi0xLTEtMTU5OTIw_62f22b57-2912-4775-8d42-304b2caa4379">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzctMS0xLTEtMTQzMjg2_59cd7702-4a86-47e5-be3c-268270ba86f0">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzYtMi0xLTEtMTU5OTIw_4bac61af-23fd-4b2b-9007-2bb7b706f403">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzgtMS0xLTEtMTQzMjg2_8b499ffb-c4b7-423c-b27a-0a63c163e18b">946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzctMi0xLTEtMTU5OTIw_ed59a68f-67e2-4c2b-bbc0-a4d8aa1797a0">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEwLTEtMS0xLTE2MDg2NQ_7a026f97-b386-473c-b919-371c5d0fdabd">844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEwLTItMS0xLTE2MDg2OQ_e6c9310b-99e6-4900-9be4-908bffb71728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEwLTEtMS0xLTE0MzI4Ng_e7c91a03-be2e-4c7b-90c3-9c48182ea846">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzktMi0xLTEtMTU5OTIw_958b8752-5d53-448f-8f48-bbb2c035c94d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzExLTEtMS0xLTE0MzI4Ng_e8c628a1-25e7-4539-8838-5fff2f26fec6">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEyLTItMS0xLTE2MDg2OQ_e093f0c5-f0eb-483a-873a-c298bf310a4c">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzE2NDkyNjc0NTY5ODI_46d51398-0e60-413b-b135-c574cf9f1a2c" continuedAt="i395b14f7ba574a4886b30eb52058acf9" escape="true">Equity Incentive Schemes and Stock Compensation Charges</ix:nonNumeric></span></div><ix:continuation id="i395b14f7ba574a4886b30eb52058acf9" continuedAt="i9f8b82b82d7b402a8f72e35da356e3aa"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from <ix:nonFraction unitRef="shares" contextRef="i69612ff6be104bbda9eb34a7111229cc_I20170213" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwMzk_f6bdf95d-10f6-4227-80e8-8332ee0ff369">0.4</ix:nonFraction> million to <ix:nonFraction unitRef="shares" contextRef="ic45259ceacfa45dbaa829284ba61ed4f_I20170214" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDU_3c8095fc-cb23-4402-8453-147be6001684">1.0</ix:nonFraction> million and to extend the date for options to be granted under the 2008 Option Plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An aggregate of <ix:nonFraction unitRef="shares" contextRef="i440197ff0132449083f0216f9fc3c298_I20170214" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNDQ_615a4e5f-382c-4929-be1c-22afb8bfa389">6.0</ix:nonFraction> million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of <ix:nonFraction unitRef="shares" contextRef="i5fbe4c2a486a4b5482f3723aed979671_D20170214-20170214" decimals="-5" name="iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEzNDQ_4bb7b29c-193a-4e5e-9d00-4d21ddb78ce8">1.0</ix:nonFraction> million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be <ix:nonFraction unitRef="shares" contextRef="i4163e2475cb34804afe0a1d2c5088f79_D20170214-20170214" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzE1NDI_b61160e9-4c00-4efc-8b22-fc86521dfc6f">0.4</ix:nonFraction> million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than <ix:nonFraction unitRef="number" contextRef="i7aa49a2d22f444b7a13c77919382a1df_D20170214-20170214" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzIxMTA_02f13328-c832-4ed0-a1f7-04ecfdac79e4">100</ix:nonFraction>% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of <ix:nonNumeric contextRef="ibef2001f3bff4594b125b1b4c70d6047_D19970101-20171231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzMzMTA_6adbe4f1-51da-4994-99b2-61965fd86fcf">five years</ix:nonNumeric> from date of grant and expire <ix:nonNumeric contextRef="ibef2001f3bff4594b125b1b4c70d6047_D19970101-20171231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzMzNDM_3afa1500-7be2-478e-af9e-fdff8d32e4b3">eight years</ix:nonNumeric> from date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#8221;), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan")  were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="i0820a150dcb1422fbec11ed3af8c5b71_I20200518" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzE2NDkyNjc0NzA2NjI_89ebb324-111a-4368-a294-3acddb18b847">2.5</ix:nonFraction>&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="i5a566fd41cfd4b69a2174efb24d4ec3b_I20180531" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzUzNzk_ba2468d0-afca-46dd-a124-69939aa171db">2</ix:nonFraction> million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was <ix:nonFraction unitRef="number" contextRef="id76920b1711b412f9e74d6864364e113_I20130923" decimals="3" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzY2MTk_28b0c762-2f08-49b3-8687-2bdf3d06daa8">12.5</ix:nonFraction>% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="id76920b1711b412f9e74d6864364e113_I20130923" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzY3MjY_f2766bed-a289-47e7-8a88-37db515c00b0">2,052,909</ix:nonFraction> shares of common stock.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i9f8b82b82d7b402a8f72e35da356e3aa" continuedAt="i3ff2f7916c974b21b7ce68f30aa77c53"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTM4_b883345d-8450-4c6d-b18e-94c053e64b6f" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c67eb08e5524f1389812b02c4f529e7_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEtMS0xLTEtMTQzMjg2_1670b028-e6f7-48d2-abbb-f24023d3eeed">656,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c67eb08e5524f1389812b02c4f529e7_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEtMy0xLTEtMTQzMjg2_502227be-7d8d-4779-9b74-704b83089b50">87.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzItMS0xLTEtMTQzMjg2_b7710573-defc-4be3-9d7d-5bf3b4869f14">107,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzItMy0xLTEtMTQzMjg2_c70ad5a5-0629-4269-99be-75ff0aa66fdb">159.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzMtMS0xLTEtMTQzMjg2_a5135a24-86bd-43c7-a1ba-f128fb38f496">193,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzMtMy0xLTEtMTQzMjg2_5acbfbdc-1452-4636-b6b5-f83fe18e0af4">68.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzQtMS0xLTEtMTQzMjg2_dca9065e-b309-4585-8938-0f60fb891f92">16,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzQtMy0xLTEtMTQzMjg2_49d50bf8-b399-4ec0-b6a7-d88d61538fd1">92.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if241526f99db43fc9bf9c882609b6aea_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzUtMS0xLTEtMTQzMjg2_dde158e0-5b51-4637-b6b4-1271fe082624">553,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if241526f99db43fc9bf9c882609b6aea_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzUtMy0xLTEtMTQzMjg2_26a5ad2f-c008-4e3e-9224-4d636c9a04aa">108.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="INF" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMS0xLTEtMTQ4NjE2_787e4f9d-f950-4175-9e01-cdd5d2a59330">2,177,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMy0xLTEtMTQ4NjE2_cd34395c-7e91-4d53-8eb0-2b8560278a13">108.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMS0xLTEtMTQzMjg2_b8e0e0a0-0e5f-4f60-8338-a0fe70eb2ce5">100,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMy0xLTEtMTQzMjg2_e0899c1a-a531-4207-afea-c98fb90fcdb0">177.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzctMS0xLTEtMTQzMjg2_019fe3a3-e77c-45ca-8e9d-d4ca1e13b114">1,065,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzctMy0xLTEtMTQzMjg2_73b57913-2fae-44d9-9805-f79574fe6341">111.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzgtMS0xLTEtMTQzMjg2_f29301c2-3e53-40bc-b369-e0af70261830">70,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzgtMy0xLTEtMTQzMjg2_a95aceb4-9c2a-4152-8e9b-f77478629b05">128.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i940aa8c093bc4589896acef14854ea63_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzktMS0xLTEtMTQzMjg2_05cb337c-9406-4f33-99d1-6b7e06df0543">1,695,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i940aa8c093bc4589896acef14854ea63_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzktMy0xLTEtMTQzMjg2_b931bd44-d0dc-4f4c-8328-585f01ea5492">110.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzExLTEtMS0xLTE0MzI4Ng_1d0dc671-d12d-4ede-922e-4492ac1e82ec">108,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzExLTMtMS0xLTE0MzI4Ng_855b3183-5689-4f57-aa66-ad8aa0cb58a8">229.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEyLTEtMS0xLTE0MzI4Ng_8c8abd59-c78e-49f0-8ed6-b8b0e9019b51">348,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEyLTMtMS0xLTE0MzI4Ng_039b09fd-8074-4f3f-a2ba-0a19f96b3ad8">102.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEzLTEtMS0xLTE0MzI4Ng_d5400745-f54a-4b55-b37b-ae54b29ca02b">77,698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEzLTMtMS0xLTE0MzI4Ng_980ad816-8747-410f-a296-f7adef1a79a2">143.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE0LTEtMS0xLTE0MzI4Ng_6847ebea-e577-436e-a591-2122e426f96f">1,378,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE0LTMtMS0xLTE0MzI4Ng_f0dea0a5-ae7c-4748-9389-1cab1d9918b1">119.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE1LTEtMS0xLTE0MzI4Ng_a2f12b94-ad67-44e8-8eba-ebdd669686a0">1,047,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE1LTMtMS0xLTE0MzI4Ng_04ffd7f2-bd16-4906-a4d3-4c4e9ef2c03f">102.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2022, was <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcwNzA_f06c490e-ea65-4585-b6fe-cd5596ce035e">4.69</ix:nonNumeric> years and <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcwNzc_8258a480-d45b-4fb9-8476-d351b9abb518">4.25</ix:nonNumeric> years respectively (2021: <ix:nonNumeric contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcwOTg_87809364-3813-43fe-81f0-052b1661aecb">5.39</ix:nonNumeric> years and <ix:nonNumeric contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcxMDU_b931b305-5225-4e90-b5f6-e0772ef58fa0">4.55</ix:nonNumeric> years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outstanding and exercisable share options:</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTUz_5a8904f4-bf20-4f4c-a417-d16ee19b4b03" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5255d861c7cc46d69f217fa72de308c6_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ZjU5MDQxYThiOThmNDc1YTkwZWQzZGJlMWE0MjE4N2NfNA_21b1a292-ff72-4427-91dd-d51a3328d6a3">14.88</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i5255d861c7cc46d69f217fa72de308c6_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ZjU5MDQxYThiOThmNDc1YTkwZWQzZGJlMWE0MjE4N2NfOQ_7323b57f-6142-4b33-9350-6bf856248e38">96.15</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c9a65dc7c694265ae542cee4cbfbd16_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMS0xLTEtMTQzMjg2_0763a011-f16d-4e1c-9594-2f4807ae895a">494,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ica9d6a1d2ef345eebaf944a19f58d97d_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMi0xLTEtMTQzMjg2_923c990b-2c4b-4bec-b3ee-66bd983b2a41">2.70</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c9a65dc7c694265ae542cee4cbfbd16_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtNS0xLTEtMTQzMjg2_541fb9f6-eaf7-47e9-aad6-97bc280ec063">494,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46f308bc7dd44c64acb450333790b112_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ODM2YTkxYmMwNTUxNGM4ZTg1MjkyN2YxY2I1OTQ2MmVfNA_d275ae19-dd1a-40ba-841b-04eedbb77337">103.81</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i46f308bc7dd44c64acb450333790b112_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ODM2YTkxYmMwNTUxNGM4ZTg1MjkyN2YxY2I1OTQ2MmVfOQ_f4d3f14b-a0d8-4e4a-8026-c210779c82eb">124.00</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee5eabbcadca4ea7bef29df09e08e94c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMS0xLTEtMTQzMjg2_07f68700-44b2-4861-ab02-48fab24e6eb3">226,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcafc41c97334a6f89312cdf786a9995_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMi0xLTEtMTQzMjg2_dae56aef-e02a-401f-9405-cb1ff8c1c719">5.58</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee5eabbcadca4ea7bef29df09e08e94c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtNS0xLTEtMTQzMjg2_0c7b4cf4-979c-40af-b18c-26a389ecebb5">203,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i892854d05a8b4db7a71a9f8ce561bbbe_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YmNiNWYxZjU4YTIzNDRlNmJjNTY0NGYzYjY5OWU1ODZfNA_1d3415f3-b245-4022-b1b9-6cbfcb16da37">125.74</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i892854d05a8b4db7a71a9f8ce561bbbe_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YmNiNWYxZjU4YTIzNDRlNmJjNTY0NGYzYjY5OWU1ODZfOQ_ecff1e83-a0ba-447a-abeb-81e2894d31a6">147.26</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ccb139c1f534009823e7282d53f1fcf_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMS0xLTEtMTQzMjg2_0802b320-441f-4f42-b5df-1c9d0ec468b9">386,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f37b14a260342dcb3444d2efa44c6d5_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMi0xLTEtMTQzMjg2_f9ef107d-bf0d-4e44-a88d-988631938d7f">5.65</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ccb139c1f534009823e7282d53f1fcf_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtNS0xLTEtMTQzMjg2_79e376ad-c94b-4da4-a0b5-359730192bfe">303,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie06d8c0caffa4a54b55eeaec6990c14f_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246MTM1MGY4NjdmNDJmNGQzNGJlZjgxOTMzZTY1OTVkODJfNA_e544ffda-1aa2-492e-ae5e-079443cc5e50">159.33</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="ie06d8c0caffa4a54b55eeaec6990c14f_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246MTM1MGY4NjdmNDJmNGQzNGJlZjgxOTMzZTY1OTVkODJfOQ_a66f6daf-5b6c-424d-9f3e-62e3e6ef68c3">231.68</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a249b6708e444acb6a9b4b67484f49c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMS0xLTEtMTQzMjg2_0da27920-b89e-48f1-b4c9-7d41b1d00b87">270,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibad01622a145456eb95aa151f08ca887_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMi0xLTEtMTQzMjg2_45ab9df5-351c-4066-8823-f88954c1f581">6.24</ix:nonNumeric></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a249b6708e444acb6a9b4b67484f49c_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtNS0xLTEtMTQzMjg2_6e11f612-28cc-4528-a2c3-0a890c3cb468">46,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YzVjNGY3MDNjYzViNGZiMDk3NmM3MWFlMmZkZGQ2MGRfNA_b22058a3-5e25-402c-9940-446f655f99a5">14.88</ix:nonFraction> - <ix:nonFraction unitRef="usdPerShare" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YzVjNGY3MDNjYzViNGZiMDk3NmM3MWFlMmZkZGQ2MGRfOQ_0403548a-7349-4c54-a080-ac8bbf819a8a">231.68</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMS0xLTEtMTQzMjg2_01c2d7ed-3b61-4f32-820e-c676fcbf1eb1">1,378,119</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMi0xLTEtMTQzMjg2_ed75166e-9501-4d59-8545-8ad9e526bba5">4.69</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMy0xLTEtMTQzMjg2_f0dea0a5-ae7c-4748-9389-1cab1d9918b1">119.86</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtNS0xLTEtMTQzMjg2_ca6bf6be-7541-4a65-9c41-eae3adb5cf7e">1,047,803</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtNi0xLTEtMTQzMjg2_04ffd7f2-bd16-4906-a4d3-4c4e9ef2c03f">102.29</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December&#160;31, 2022. Options exercisable represent options which have vested at December&#160;31, 2022. From the date of grant, substantially all options vest over a <ix:nonNumeric contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzIxOTkwMjMyNzE4Njk_a52aea0b-489a-4fd5-ba58-bec3efaa8e89">five year</ix:nonNumeric> period.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3ff2f7916c974b21b7ce68f30aa77c53" continuedAt="i41dd236f13bc4ff08542c587308524a4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 was calculated using the Black-Scholes option pricing model. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTI5_54a3270d-ae54-473e-b72b-ffbad3292be7" continuedAt="i6813e43a2429414d86f525c549a5f145" escape="true">The weighted average fair values and assumptions were as follows:</ix:nonNumeric></span></div><ix:continuation id="i6813e43a2429414d86f525c549a5f145"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzItMS0xLTEtMTQzMjg2_b6564a6c-8095-436a-b9e3-22c4ced2f145">68.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzItMi0xLTEtMTQzMjg2_08bc157e-2dba-4c16-8bbc-65d2dcfa1ec9">49.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzItMy0xLTEtMTQzMjg2_b6d57bee-8288-4e24-8fcf-970348b8a506">42.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzUtMS0xLTEtMTQzMjg2_3203f8ed-7dcb-4f8c-bb2f-dab2f1a171d2">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzUtMi0xLTEtMTQzMjg2_cc59ce2e-9b80-4d1d-8047-3899193efea1">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzUtMy0xLTEtMTQzMjg2_8f1b6019-240b-4ba1-869e-9c5fce38f0d0">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzYtMS0xLTEtMTQzMjg2_111f4295-b645-49ba-832e-bc4ebb084198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzYtMi0xLTEtMTQzMjg2_c2dfef2b-8f4c-44e3-acc1-f78d0bcecf0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzYtMy0xLTEtMTQzMjg2_535991d3-9677-480b-a2ba-95dd0c207cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzctMS0xLTEtMTQzMjg2_3e2d8443-7c6b-4686-8b85-2a607965dc90">1.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzctMi0xLTEtMTQzMjg2_4eb31fbc-f241-4c79-b1d2-1aa442843a95">0.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzctMy0xLTEtMTQzMjg2_c84451b2-714c-489a-a04b-1c27fe4ecad9">0.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzgtMS0xLTEtMTQzMjg2_794b27dc-6720-4fae-a776-d24e606c0af7">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzgtMi0xLTEtMTQzMjg2_581fc7d2-2acc-4388-9bab-5943e7775d60">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzgtMy0xLTEtMTQzMjg2_0aa69584-4d29-47d1-b8e9-95fa638e8714">5.0</ix:nonNumeric> years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzEtMS0xLTEtMTQzMjg2_dcca35a2-d155-4d26-962d-bc01d4ec40f3">107.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzMtMS0xLTEtMTQzMjg2_54c5d666-b072-4198-a11a-d85faa54bc2a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzQtMS0xLTEtMTQzMjg2_07c19e6c-a0d0-4598-9dfa-1e5aa515df12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzUtMS0xLTEtMTQzMjg2_221ee0b4-e1ce-4ff7-b566-ae8e28e7ea47">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzYtMS0xLTEtMTQzMjg2_18d07f34-f2b4-47e9-9ca3-98d5ef60d3cc">3.5</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by <ix:nonFraction unitRef="shares" contextRef="iba8cd0f91c4543c384cf5fd3022523c9_D20150511-20150511" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzkxMTU_ec0fe15d-f1ed-4c4c-be6c-c33485c5983c">2.5</ix:nonFraction> million shares. Accordingly, an aggregate of <ix:nonFraction unitRef="shares" contextRef="iff4a5c52ce754d49b998568670340ed9_I20150511" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzkxNTU_40b80f54-d5e1-4154-a758-d5b4dae931d6">4.1</ix:nonFraction> million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.  No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. <ix:nonFraction unitRef="shares" contextRef="i7d0262e215cd4dfbb0898a63d51486be_I20190516" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0Xzk4MDU_753b06c7-8654-44d6-a4f1-2b5079347d3a">250,000</ix:nonFraction> ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over <ix:nonNumeric contextRef="ifca1cb86a7554779a455148669f8224b_D20190101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwMDI2_ee01e968-230c-402b-beb8-2fedfa5f7be3">twelve months</ix:nonNumeric>. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i41dd236f13bc4ff08542c587308524a4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTM0_43b63791-cab1-4c0c-8f6c-16dcded854a7" continuedAt="i73a934a39b824dce95cd4c88b54150f1" escape="true">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i73a934a39b824dce95cd4c88b54150f1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50c7dd932b404320af63f5c9a2cf9cd5_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtMS0xLTEtMTQzMjg2_b38083ff-0e80-4eb8-ab0e-c1b4088cd1e7">154,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i50c7dd932b404320af63f5c9a2cf9cd5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtMi0xLTEtMTQzMjg2_c69eaf7c-c132-40c4-bb49-9d894932b2f4">160.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a4f5700181945938fdaecb063f3bc23_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtNC0xLTEtMTQzMjg2_477b5924-9857-4920-b3f2-2242b9b522e3">572,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5a4f5700181945938fdaecb063f3bc23_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtNS0xLTEtMTQzMjg2_3af6de68-5d87-49a2-bc16-da0a853f271d">191.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtMS0xLTEtMTQzMjg2_435d2fe4-7a11-43a9-92d8-c0f69a6b6ac0">64,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtMi0xLTEtMTQzMjg2_8b1a5cbd-84a9-4f13-a21a-b48bf5353c5f">229.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtNC0xLTEtMTQzMjg2_f9decba8-5e4a-48e8-828f-87de05a98709">302,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtNS0xLTEtMTQzMjg2_574e6aa5-7c3b-44ad-bdc6-0d087190cd24">216.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtMS0xLTEtMTQzMjg2_70c89189-6ec6-43ff-8d2a-cfb6b90e3e76">46,087</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtMi0xLTEtMTQzMjg2_402f6aa8-e8c1-4f07-91e2-93cb77543561">140.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtNC0xLTEtMTQzMjg2_35937007-ea15-4a56-a77f-06c524aa9a67">195,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtNS0xLTEtMTQzMjg2_c0fff327-3e4d-4960-a309-772d5df7c372">174.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtMS0xLTEtMTQzMjg2_632f22eb-b505-4f00-895f-d45f92ec8d2e">20,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtMi0xLTEtMTQzMjg2_7e5303d9-b684-48ec-ab5c-9f0ed4b6a1a0">185.90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtNC0xLTEtMTQzMjg2_ac499fc3-561f-418c-91c0-1340c64da9c9">97,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtNS0xLTEtMTQzMjg2_3386450e-6acd-41bc-8bda-9198edea7e25">205.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cd4d35cf1d84f78909a24f1716a0841_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtMS0xLTEtMTQzMjg2_adbd1855-2a73-40aa-96fa-88aee0be00c9">152,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6cd4d35cf1d84f78909a24f1716a0841_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtMi0xLTEtMTQzMjg2_4d9ed645-0a6c-4aa4-8b39-256df9dccf4c">192.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i128b02150c364303957cd379df2d66a6_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtNC0xLTEtMTQzMjg2_ce08e4b6-352a-4df7-9b9f-33f5dcd857c9">582,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i128b02150c364303957cd379df2d66a6_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtNS0xLTEtMTQzMjg2_6868abf4-4d2c-4747-82b0-7c19aaa04312">207.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDA2_b880d0a1-02ad-4825-8920-3ff35fb0515d">34.1</ix:nonFraction> million (2021: $<ix:nonFraction unitRef="usd" contextRef="iec0d3c91746049cfa76770f5e2f12ef5_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDE0_9220c77c-e891-4941-b857-cddff991e892">83.5</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="i6ec59b41573649288593eff6d1ebb047_I20221231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDU4_8b5468f8-c03a-4158-a3d9-e62509005b47">137.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="ia4030627d459479f9bcfc2485f408af1_I20221231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDYz_3c4fa55e-33ed-4ec5-84c6-f8ae58bdf752">265.96</ix:nonFraction> (2021: $<ix:nonFraction unitRef="usdPerShare" contextRef="ie70ef1e52b8445e8a30d1732702cac38_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDcx_e5f2adc9-822b-4c18-af1b-ca30f1feff02">115.11</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="ie1d7729620b245f3b3d86355af31bf15_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDc2_d0ffe53f-df7d-4c46-bef8-421f74a4fca1">206.71</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTQy_fef4e3f7-92d9-49af-ab5f-0fcfa411db42">6.5</ix:nonFraction> million (2021: $<ix:nonFraction unitRef="usd" contextRef="i323bd4358f4848aba9899c235c5c8a82_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTUw_a681f27a-ca52-423b-96c9-532b02ea99e8">5.1</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="i385b3308021d4f8dab296ba9a3b672ca_I20221231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTk0_5ef1acbc-8e5c-4db1-b836-15404b37f534">137.47</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i31d66e89c6ac44c985d3b33f217a8215_I20221231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTk5_19f95af7-1e41-49d9-9873-a699c1d3a09b">166.51</ix:nonFraction> (2021: $<ix:nonFraction unitRef="usdPerShare" contextRef="i82f9a1a05fa24a3281257719ca8fb6c8_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNjA3_9b0606e4-adb4-4cfc-af72-915268b1b3e3">115.11</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i7478ddf969574f3ebf520346092b5404_I20211231" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNjEy_6a69e96d-6c34-4f82-aa04-38e35c6593c5">125.74</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period  2021 &#8211; 2023 and 2022 &#8211; 2024. Depending on the actual amount of EPS from 2021 to 2024, up to an additional <ix:nonFraction unitRef="shares" contextRef="icbc58fa5272343979b1281d284fd5100_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwODEw_b05f9738-f4af-419e-8e82-5898dfae4128">76,210</ix:nonFraction> PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-cash stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2022 is stated after charging $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwOTQ3_2980fc41-5c3b-42b5-87dc-8a138d5e5fd9">70.5</ix:nonFraction> million in respect of non-cash stock compensation expense. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTU2_ce7a02f9-6842-42ad-b64e-e0e06926c5b7" continuedAt="ida7e75b4d8cb46cca3f3172c4310eb91" escape="true">Non-cash stock compensation expense has been allocated as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ida7e75b4d8cb46cca3f3172c4310eb91"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzMtMS0xLTEtMTQzMjg2_2a284d6c-c87c-458b-bd1c-665e4c83109b">22,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id197fe0d372441f4971e65ae556f9189_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzMtMi0xLTEtMTQzMjg2_b4756c02-60a4-443e-b380-30daca2be4b6">18,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cafc75e45844d94a5699609ed9c0e1a_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzMtMy0xLTEtMTQzMjg2_8ccc7961-96e7-48b5-b39f-b9803a5a0149">8,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba1eb9117d6498ba61cd2ffd7a3dcc5_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzQtMS0xLTEtMTQzMjg2_5211222d-7842-486c-9ff9-40089ee39027">47,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdf34dd45633475d9db22cc8203941ed_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzQtMi0xLTEtMTQzMjg2_aad1e186-1d97-4821-b372-c2679dbb380a">41,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04e0493d819470faef53855bcf56280_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzQtMy0xLTEtMTQzMjg2_37ad6b1a-c2e6-4d68-ae07-a88d8ebd2ace">17,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f815c05b36c45c2bbeedbecb796cd4b_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzUtMS0xLTEtMTQzMjg2_8f932988-657c-47ab-9235-e9b890d7f502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ee9a12489e4e4d945f923b1fef04b6_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzUtMi0xLTEtMTQzMjg2_6d25a68d-2306-441e-9f5a-397839719278">73,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb23e34b2494ebeadf5c82112b1cc16_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzUtMy0xLTEtMTQzMjg2_8eb928ca-402d-4a49-8607-37fdfdeaca02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzYtMS0xLTEtMTQzMjg2_3e955a7d-a8d7-4aeb-9bb1-9bb182b35514">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzYtMi0xLTEtMTQzMjg2_95ff154c-5af1-49fa-bebe-af125c281b69">133,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzYtMy0xLTEtMTQzMjg2_e84bf130-20ab-45a5-8553-d450edcbaf1b">26,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExMjcy_8377bb49-a8d1-4b5d-823e-fd6bda4143bc">12.9</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $<ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNDI4_e901afad-4440-472b-9305-8720c4fa7e1f">7.7</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNTE0_6178e287-2726-463c-a006-4e8746a3a4aa">22.7</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $<ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNjcw_1da3dde4-e9bd-4587-92e2-05cad92a92b5">23.9</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2020 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNzU2_b1b2dd8b-5fb8-40a9-b245-65a00b2d6684">6.9</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2020 was $<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTIz_4406a20e-1d62-443a-974f-c3662fd85e2c">2.5</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_226"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">23. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzU1NzY_d70e70e5-012e-4ecb-bace-12f13d98b1fd" continuedAt="i9f54b14e5602461f839307654240cb42" escape="true">Business Segment and Geographical Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9f54b14e5602461f839307654240cb42" continuedAt="i6e359b213236467e955cfe5b5ba4c62e"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#8216;CODM&#8217;) in accordance with ASC 280 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Segment Reporting'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i6e359b213236467e955cfe5b5ba4c62e" continuedAt="i8bcf660441a64005a043fca5dda54af5"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzEyNTA_9d13732f-9cdb-463f-8a73-112a849e552d">one</ix:nonFraction> reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzU1ODE_d208a26c-0276-4428-9f62-3dc1916e2075" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December&#160;31, 2022 and December&#160;31, 2021 and for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzQtMS0xLTEtMTQzMjg2_c1bb85b0-7cf5-42b6-a095-6171c3cd57be">1,984,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzQtMi0xLTEtMTQzMjg2_1449f182-d35b-451f-8e8b-3d93596a3015">1,365,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzQtMy0xLTEtMTQzMjg2_6403e2f4-32e8-4723-92c1-09df24746b89">1,181,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b94a05494d4a9aafad89fefcf5ec5e_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzUtMS0xLTEtMTQzMjg2_0424984a-75e5-42f0-a8b1-376ba2d06665">1,618,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7e7fb2e8754f13959c968948055905_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzUtMi0xLTEtMTQzMjg2_a6026597-85db-492a-98a9-bde73080e95b">1,175,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51c60ed11834e3489b68644df728ad3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzUtMy0xLTEtMTQzMjg2_10eb8669-26ca-4e3b-a591-9a9ba0162f29">416,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzYtMS0xLTEtMTQzMjg2_aa63531c-1004-464a-b24e-f2e248ae4d8b">3,574,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzYtMi0xLTEtMTQzMjg2_af6d320d-e0fb-4349-9a99-5e49267ecf68">2,581,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzYtMy0xLTEtMTQzMjg2_7e81fcdf-f843-411d-b225-2e275c537e91">925,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id74698b742ce45b48de3dd6ca0e41f58_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzctMS0xLTEtMTQzMjg2_878b4368-32d6-4f15-8b15-0f6b33a27609">563,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095fb057614e484690d7c8e6855aa257_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzctMi0xLTEtMTQzMjg2_face26e4-1347-494a-9f35-c75e1e3b35a8">358,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i470b5734b0ec4cdcb5d2d8b7192a224d_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzctMy0xLTEtMTQzMjg2_4e9044df-7e35-4cd7-a1d6-fb43062c894a">273,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzgtMS0xLTEtMTQzMjg2_af825732-759f-4806-8ee0-4cee1546f546">7,741,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzgtMi0xLTEtMTQzMjg2_02f02141-208c-480a-b9ab-07d1c8063397">5,480,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzgtMy0xLTEtMTQzMjg2_0d75aebd-a029-4722-95b3-17d1b2277f3a">2,797,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:OperatingIncomeByGeographyTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzE2NDkyNjc0NjM4MDI_6dd3e116-710a-468a-a5a1-05479f9df103" continuedAt="iac4857a95cb042bab4224f606990ca55" escape="true">The distribution of income from operations (including Restructuring) by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div><ix:continuation id="iac4857a95cb042bab4224f606990ca55" continuedAt="i8d11fc82254d427f9c1b499490b8d90b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzMtMS0xLTEtMTYzMjg3_62da508f-abe2-4567-a550-d49a364714ed">218,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzMtMi0xLTEtMTYzMjg3_f4ad7d44-e1c8-4fe5-b5df-e1be1f909122">131,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzMtMy0xLTEtMTYzMjg3_51fa541c-aeda-4dac-b75e-fd15beb8f342">276,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b94a05494d4a9aafad89fefcf5ec5e_D20220101-20221231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzQtMS0xLTEtMTYzMjg3_0a7d28ea-7e46-4bf0-a7d9-fd9343099bd0">253,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7e7fb2e8754f13959c968948055905_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzQtMi0xLTEtMTYzMjg3_6e9348f1-1290-41c0-848a-44f288e26a93">177,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51c60ed11834e3489b68644df728ad3_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzQtMy0xLTEtMTYzMjg3_00b86559-16ed-4dce-b1ce-bff6d72e8453">35,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzUtMS0xLTEtMTYzMjg3_073a8bc3-987b-4f05-9152-62d2c90b61ca">254,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzUtMi0xLTEtMTYzMjg3_af80ca91-a05b-4ae6-8b8f-4cd1bb1bd1ab">39,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzUtMy0xLTEtMTYzMjg3_c312238a-92a9-4eb7-a1bd-dbbe38cb97a2">58,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id74698b742ce45b48de3dd6ca0e41f58_D20220101-20221231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzYtMS0xLTEtMTYzMjg3_7892a850-4e61-4633-95c0-e8939149e81b">68,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095fb057614e484690d7c8e6855aa257_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzYtMi0xLTEtMTYzMjg3_efde4972-7cbb-4698-9d88-6c5b524c4660">29,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i470b5734b0ec4cdcb5d2d8b7192a224d_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzYtMy0xLTEtMTYzMjg3_c16c5a90-13bb-4027-91d6-ff71a330e17d">21,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzctMS0xLTEtMTYzMjg3_34229b37-6697-4bd2-bc22-d312b3dab4b9">795,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzctMi0xLTEtMTYzMjg3_cc2161ac-1c6b-483b-8f48-9fe727f5927a">378,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzctMy0xLTEtMTYzMjg3_982a0a22-f0f7-415e-b5c3-7864e4949d8a">391,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:continuation id="i8d11fc82254d427f9c1b499490b8d90b">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i8bcf660441a64005a043fca5dda54af5"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzU1NzQ_6a4962fc-b6a0-4906-a70d-cdd1161f2673" continuedAt="i6bd0c4593a7d487f885e00c7ff426e1e" escape="true">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i6bd0c4593a7d487f885e00c7ff426e1e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2573b70385e24cddbc2849d005657d46_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzItMS0xLTEtMTQzMjg2_8145581e-7f25-442b-90cd-b0674228e6d9">143,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be2313371ae40d6abc4a3f42b6751ed_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzItMi0xLTEtMTQzMjg2_0e70c8f4-613e-4c53-abf0-7aaec9fa8cc8">118,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7fbd571c7848e2a658e6b23259ae2e_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzMtMS0xLTEtMTQzMjg2_ef99fb55-775a-446b-a895-9d58a5724793">99,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3911e749f50947d4b21832b72052d785_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzMtMi0xLTEtMTQzMjg2_92176571-b156-47e4-b1a1-fc053080913d">121,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305536a3cd1f49ec9167bd9bc8104484_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzQtMS0xLTEtMTQzMjg2_13545f2f-0efe-4852-bd7b-3ae34c9bb64f">213,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cae0d23f394e31b3abce80e3e3687f_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzQtMi0xLTEtMTQzMjg2_e5a4b038-7a49-4cfc-865b-871dc2f75641">239,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5d2064ec2c49afba73bfde8e3bacd0_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzUtMS0xLTEtMTQzMjg2_de8119f7-381c-4833-bd49-4c6dc5f432b0">48,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6988db3dbc8a4435b967b2307aada5cb_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzUtMi0xLTEtMTQzMjg2_36969885-52ea-431e-9229-0240d52027f9">55,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzYtMS0xLTEtMTQzMjg2_ee1210b6-60df-4e5a-9629-bdc3d1e0d363">504,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzYtMi0xLTEtMTQzMjg2_34fb29a4-d40f-461f-95c8-0a51e772a0df">534,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_250"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90ZXh0cmVnaW9uOjhjZWQzMjQxOWI3YTQzM2FhNjBhZGFmZjVjZTVkZjMyXzE0NDc_ec4b8b09-a850-405a-83f0-7a8a8f6add37" continuedAt="if85e44e98eae47b3952d5cdaeb13a21b" escape="true">Net Income Per Ordinary Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if85e44e98eae47b3952d5cdaeb13a21b" continuedAt="i3725647d8bb04dc998815333f8aba766"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted net income per ordinary share attributable to the Group for the year ended December&#160;31, 2020 includes an adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the years ended December 31, 2022 and December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90ZXh0cmVnaW9uOjhjZWQzMjQxOWI3YTQzM2FhNjBhZGFmZjVjZTVkZjMyXzE0NDg_2c86d112-f587-4253-9661-53258e4fce09" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzEtMS0xLTEtMTQzMjg2_ea60144a-c005-4ca2-a001-92bdb5a5f13e">81,532,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzEtMi0xLTEtMTQzMjg2_e0ac59f5-30e4-418d-9350-9496b1d799a6">67,110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzEtMy0xLTEtMTQzMjg2_e0421f80-4650-4698-82bc-a90076f5faa6">52,859,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzItMS0xLTEtMTQzMjg2_d9a21214-7fa5-49d2-ad9d-574b97c04a9a">936,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzItMi0xLTEtMTQzMjg2_d72fc749-6798-449b-b9e0-864355c5b2fd">958,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzItMy0xLTEtMTQzMjg2_10135959-3bfe-43f4-b91e-d4a1718c62d4">423,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzMtMS0xLTEtMTQzMjg2_1aebc954-ad4f-45cd-901b-44bbb4bc7991">82,468,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzMtMi0xLTEtMTQzMjg2_fab44bc0-2328-4a33-a993-4323ea2009ab">68,068,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzMtMy0xLTEtMTQzMjg2_7dd209cb-1025-4527-ab9a-1d6d19076680">53,283,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i3725647d8bb04dc998815333f8aba766"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90ZXh0cmVnaW9uOjhjZWQzMjQxOWI3YTQzM2FhNjBhZGFmZjVjZTVkZjMyXzE0NDk_ca8300d0-7d55-4727-8cda-372e7d6a50a5" escape="true"><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzItMS0xLTEtMTQzMjg2_31490c30-8df7-4d41-9710-d0ad12494801">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzItMi0xLTEtMTQzMjg2_b372d28d-ec64-4048-b18a-2d7d3e85d302">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzItMy0xLTEtMTQzMjg2_2a703cf7-8941-411f-866c-d45f6bfc0831">332,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzMtMS0xLTEtMTQzMjg2_d0a0e1dd-1ca5-4aad-950b-8294a457429e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzMtMi0xLTEtMTQzMjg2_753ea5d5-cf04-4b7a-bbbb-b5c313f25e2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzMtMy0xLTEtMTQzMjg2_31279d02-a43f-4d6e-8117-07a262c05d93">4,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzQtMS0xLTEtMTQzMjg2_b346fc97-b6a5-4d5c-9a7c-dad22dbd2b02">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzQtMi0xLTEtMTQzMjg2_e67fd138-428e-4cf7-af61-eea8f460addf">153,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzQtMy0xLTEtMTQzMjg2_3b031fdb-81d5-4c22-8a4c-55955514b9f3">327,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzgtMS0xLTEtMTQzMjg2_e5ebe8e4-817b-4e4e-811c-a2a5b50af2fe">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzgtMi0xLTEtMTQzMjg2_eaf4374f-e8c1-46cc-ba42-d95fe3853957">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzgtMy0xLTEtMTQzMjg2_b61f863c-49bf-4ca4-a924-c8769dde9ea6">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzktMS0xLTEtMTQzMjg2_57469747-cb0e-4b96-b3ac-720a7ea187fa">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzktMi0xLTEtMTQzMjg2_1811cb5c-a8a5-42df-a592-6bc5f28f46c9">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzktMy0xLTEtMTQzMjg2_ca551c29-9cf8-4c43-886f-2e49806a5baa">6.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_235"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">25. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90ZXh0cmVnaW9uOjQzYmE1MTQ2MWU1YjQ5YzNhMTVhMzI2ZWU1ZjMzNzk0XzUw_626e2e83-012c-4645-a204-c6349c1c562b" continuedAt="i07e825fe263a45789a6ed95b190a3586" escape="true">Accumulated Other Comprehensive Income</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i07e825fe263a45789a6ed95b190a3586"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90ZXh0cmVnaW9uOjQzYmE1MTQ2MWU1YjQ5YzNhMTVhMzI2ZWU1ZjMzNzk0XzU1_da20bf51-ae37-4790-9ea0-14bba414356b" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzMtMS0xLTEtMTQzMjg2_56d6e895-5637-43f1-8cea-e9b8ec728688">175,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzMtMi0xLTEtMTQzMjg2_aa8d1ca3-090b-4831-aa43-68f5e8eec1ff">85,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan (note 21)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzUtMS0xLTEtMTQzMjg2_c87d4663-3616-4345-accf-80798dfab0be">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzUtMi0xLTEtMTQzMjg2_c095f9e0-1c18-48c2-9a97-94817cba6c37">5,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzktMS0xLTEtMTQzMjg2_f97dad7b-3750-480a-8f63-0250f59f3f17">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzktMi0xLTEtMTQzMjg2_df7501c3-d2c6-4532-9cb3-21426b5b0e15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" name="iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzExLTEtMS0xLTE0MzI4Ng_97aa8a38-5f27-4e15-a982-1754cba99b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" name="iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzExLTItMS0xLTE0MzI4Ng_c09e1ec1-6a8d-4ea0-898b-020a1f3d52b5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzEyLTEtMS0xLTE0MzI4Ng_d1001a24-2f23-4d83-a5b4-8d994a006595">171,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzEyLTItMS0xLTE0MzI4Ng_cd06de82-6a03-4b72-94e5-ffd53649b56c">90,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_232"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">26. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90ZXh0cmVnaW9uOjgyMjVhMTZjNWUyNzQxYzU4ODQwMzE1ZGFkYmI3MWI3XzYx_09b84db3-3bb3-40ad-b9e8-d52aee7123b7" continuedAt="ia40e8cddeee041edb125095e160e5cc8" escape="true">Supplemental Disclosure of Cash Flow Information</ix:nonNumeric></span></div><div><ix:continuation id="ia40e8cddeee041edb125095e160e5cc8"><ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90ZXh0cmVnaW9uOjgyMjVhMTZjNWUyNzQxYzU4ODQwMzE1ZGFkYmI3MWI3XzY2_3353cfe6-ab58-44bf-8824-6f2d88274cbc" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzMtMS0xLTEtMTQzMjg2_1d93708d-9aee-43a9-8822-984ac422e55b">210,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzMtMi0xLTEtMTQzMjg2_b4eee8b5-0d4f-4c0d-9cba-10e2c18cbee5">106,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzMtMy0xLTEtMTQzMjg2_323e0e91-9fb5-450d-bb3b-29682ee440ba">13,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzQtMS0xLTEtMTQzMjg2_40df81fa-9b77-4c9b-b027-ca56f5b5ca12">116,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzQtMi0xLTEtMTQzMjg2_8aeccdd9-d370-4092-b8a7-befb21f5c5bb">55,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzQtMy0xLTEtMTQzMjg2_fa3b19f6-1726-401d-bf34-bcc7dda03ba7">27,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:3pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_247"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">27. <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzE1ODI_09e2bf52-753c-48e0-a788-e98e8cbec070" continuedAt="ia3a80ca8ec3b441b8782268267e81cbf" escape="true">Related Parties </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia3a80ca8ec3b441b8782268267e81cbf" continuedAt="i84d081df7ca14c758f6bef17440a6510"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="i45448a33be2443fd93dedd1a7d14df2a_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NjE_20705ae4-696e-4a01-9116-153c4e059fb3">2,000</ix:nonFraction> (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="iebdfade2d1334535803b379eaf1d7a23_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ4ODg_cd9731af-e5a0-4f51-92e4-e4f36dde45e8">30,000</ix:nonFraction>) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $<ix:nonFraction unitRef="usd" contextRef="i4715e63da19c4cd897a34f13c13f0b3b_I20221231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NTc_33359442-4940-4f6b-ba6f-060141209975">12,000</ix:nonFraction> was recorded as due from DS Biopharma Limited at December&#160;31, 2022 (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i0fb773a2b86147749b4c3538c0035971_I20211231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5MTU_8b4b7c99-b9dd-452e-8135-60a15a0e7f43">12,000</ix:nonFraction>).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="ied4aaa8f5f68454db087c1b69e5131a0_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NzU_7b4274ad-5fdb-4590-9094-8267d02baaf0">235,000</ix:nonFraction> (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i4158ffec277a4decaff6ea55e3ac1007_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NzE_9731c5d0-9a4d-427c-8f64-a12560e84f10">551,000</ix:nonFraction>) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $<ix:nonFraction unitRef="usd" contextRef="i9985b94712864f2290305ffd2981067f_I20221231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5OTI_57ad492f-06eb-4f0c-b9c4-d305d0603dcf">263,000</ix:nonFraction> was recorded as due from Afimmune Limited at December&#160;31, 2022 (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i6ac4e36329b842e7b8b1b172ef93c1f2_I20211231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5ODc_4cf84260-7b90-473e-9a0b-1c1f9513f8e6">197,000</ix:nonFraction>).&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="ib89cec313ee54d428d8f32c7d6f723f5_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzYyODM_433355bd-ccf8-48b1-b27a-6b08e6a22133">428,000</ix:nonFraction> from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $<ix:nonFraction unitRef="usd" contextRef="i8dc5b0b8e9eb4cd182c4c104a6637ab6_I20221231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzY0NDY_f8eaef08-4b38-4df6-8519-a2bbaf4944b2">231,000</ix:nonFraction> was recorded as due from Corvus Pharmaceuticals at December&#160;31, 2022. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i84d081df7ca14c758f6bef17440a6510"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $<ix:nonFraction unitRef="usd" contextRef="ia09cfcf09c5a4518ae153515930d8057_I20200724" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzE4NjkxNjk3Njg0NDky_1d7833c6-06b1-490c-9768-602e4867ced8">4.9</ix:nonFraction>&#160;million to obtain a <ix:nonFraction unitRef="number" contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMTg_2bcd9847-d90b-4301-9177-0d506e9be680">49</ix:nonFraction>% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $<ix:nonFraction unitRef="usd" contextRef="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMDA_f5edf949-44ab-4c0d-b608-865446092cd9">451,000</ix:nonFraction> during the year ended December&#160;31, 2022 (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMzA_22e30e52-afc2-4ac3-a3fe-6248d326619b">465,000</ix:nonFraction>). $<ix:nonFraction unitRef="usd" contextRef="if58aadd9086f43b2a3767b622c4f2dc0_I20221231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMzc_8fa43a6c-9a7d-42a2-9153-ddc771bf619e">715,000</ix:nonFraction> was recorded as due from Oncacare at December&#160;31, 2022 (December&#160;31, 2021: $<ix:nonFraction unitRef="usd" contextRef="i16fb8e5b432b4ab3a94979ed99d87911_I20211231" decimals="-3" name="us-gaap:DueFromRelatedParties" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwNTE_7d776108-9959-4aff-aaf1-85605d608bc3">264,000</ix:nonFraction>).&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $<ix:nonFraction unitRef="usd" contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231" decimals="-6" name="us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwNjA_17321ed4-c097-4861-a189-d728c97e9525">10</ix:nonFraction> million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at <ix:nonFraction unitRef="number" contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231" decimals="3" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwNzQ_ae2b44cc-cfca-4465-bd24-9268f389504a">1.6</ix:nonFraction>% and the loan is repayable on June 30, 2025. The Company has recorded losses of $<ix:nonFraction unitRef="usd" contextRef="ia961c12b79494b50a3b7b747a2ce04be_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUzNDY_187d48ae-b1b9-4f5b-8796-2a593e943fc8">3.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idf5fe76c69e241d7915327e838e9518c_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUzNTQ_d152ae39-b8af-40b6-affa-12e465ab62fc">2.2</ix:nonFraction>&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $<ix:nonFraction unitRef="usd" contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231" decimals="-5" sign="-" name="iclr:IncreaseDecreaseInEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzU1Mzk_022c9384-55ec-491e-968b-acaf0eb99758">2.3</ix:nonFraction>&#160;million of pro rata losses.  The remaining $<ix:nonFraction unitRef="usd" contextRef="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231" decimals="-5" name="iclr:EquityMethodInvestmentDecreaseInLoanReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzU1Nzg_7786fe85-be3e-439a-a649-70c0d4d47502">0.8</ix:nonFraction>&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. At December&#160;31, 2022  accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ic314749132274d02aea042862e1ff17e_I20221231" decimals="-3" name="iclr:InterestReceivableRelatedPartyLoans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzU5ODY_a613c147-aa04-4825-a3b4-4e19784628e0">183,000</ix:nonFraction> remained outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the <ix:nonFraction unitRef="number" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ2Njc_3547f1db-1741-45cf-b6b8-9ecd870ba779">51</ix:nonFraction>% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the <ix:nonFraction unitRef="number" contextRef="ia06e61e30b434302889007f7159b05f5_I20221231" decimals="2" name="iclr:EquityMethodInvestmentMajorityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ4Mjc_3547f1db-1741-45cf-b6b8-9ecd870ba779">51</ix:nonFraction>% majority voting share capital from August 1, 2025.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_253"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">28.  <ix:nonNumeric contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTMvZnJhZzo0YjIxNzE1ZDNmNzM0NjkwOGQ5OGY0YjhlNjdhMTBhMy90ZXh0cmVnaW9uOjRiMjE3MTVkM2Y3MzQ2OTA4ZDk4ZjRiOGU2N2ExMGEzXzEzMzM_455bdfba-8e17-4b60-ad85-ec1be6039309" continuedAt="iac964438af6443d7aa1d7ac55310de0b" escape="true">Subsequent Events</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="iac964438af6443d7aa1d7ac55310de0b"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough February&#160;24, 2023, the date at which the consolidated financial statements were available to be issued. The Company has determined that there are no items to disclose.</span></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">146</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 19. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibits of ICON plc and subsidiaries</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121006002/nc10020781x8_ex2-1.htm">2.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of February 24, 2021, by and among ICON plc, ICON US Holdings Inc., Indigo Merger Sub, Inc and PRA Health Sciences, Inc. (incorporated by reference to exhibit 2.1 to the Form 6K (file No. 333-08704) filed on February 24, 2021.</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-2022.htm">2.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of Securities Registered Under Section 12 of the Exchange Act.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-1.htm">2.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Credit Agreement, dated as of July 1, 2021, by and among ICON Luxembourg, S.&#192; R.L., ICON Clinical Investments, LLC, Indigo Merger Sub, Inc. (which, after giving effect to the Merger on the Closing Date was succeeded by PRA Health Sciences, Inc.), ICON Public Limited Company, the other borrowers party thereto from time to time, the subsidiary guarantors party thereto from time to time, lenders party thereto Citibank, N.A., as administrative agent, and Citibank, N.A., London Branch, as collateral agent (incorporated by reference to exhibit 99.1 to the Form 6K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-2.htm">2.4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of July 1, 2021, by and among Indigo Merger Sub, Inc., PRA Health Sciences, Inc., the guarantors party thereto and Citibank, N.A., London Branch as trustee, notes collateral agent, paying agent, transfer agent and registrar (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 1, 2021).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit25-2022.htm">2.5*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amendment No. 1 to the Credit Agreement referred to at Exhibit 2.3, dated as of November 29, 2022, by and among ICON Public Limited Company and Citibank, N.A., as administrative agent.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1060955/000115752316006157/a51386268ex99_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description of the Constitution of the Company (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 25, 2016).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit121-2022.htm">12.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 302 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit122-2022.htm">12.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Section 906 certifications.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4aba65474ca49f18d29b38d717fb5d4_52">21.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">List of Subsidiaries (incorporated by reference to Item 4 of Form 20-F filed herewith).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2022.htm">23.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consent of KPMG, Independent Registered Public Accounting Firm.</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interactive Data Files (Inline XBRL &#8211; Related Documents).</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* &#160; Filed herewith</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="ie4aba65474ca49f18d29b38d717fb5d4_259"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;Brendan Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date: February&#160;24, 2023 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">148</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>exhibit22-2022.htm
<DESCRIPTION>EX-2.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i99818b0bc33a49d3b09945c2e76eeeae_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 2.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Description of Securities  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">    Registered Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 ICON plc (&#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had the following series of securities registered pursuant to Section 12(b) of the Exchange Act&#58; </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares, nominal value &#8364;0.06 per share</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICLR</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NASDAQ Global Select Market<br></font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Ordinary Shares </font></div><div style="padding-left:180pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.General</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.1. Limitations or qualifications </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.2. Other rights </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.3. Type and class of securities </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each ICON plc share has nominal value of &#8364;0.06 per share. The respective number of shares that have been issued as of December&#160;31, 2022 is given in the Consolidated Balance Sheet of the annual report on Form 20-F for the fiscal year ended December&#160;31, 2022. All ICON shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities or profit-sharing certificates have been issued. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.4. Pre-emptive rights</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.B Memorandum and articles of association</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> 10.B.1 Shareholder Rights, Preferences and Dividends Attaching to Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.2. Action Necessary to Change the Rights of Shareholders </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.3  Annual and General Meetings</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.4 Limitations on the Right to Own Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no limitations on the right to own shares in the Constitution of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.5 Disclosure of Share Ownership </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.5
<SEQUENCE>3
<FILENAME>exhibit25-2022.htm
<DESCRIPTION>EX-2.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_145"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 2.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FIRST AMENDMENT TO CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This FIRST AMENDMENT to the Credit Agreement referred to below, dated as of November 29, 2022 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by and among ICON PUBLIC LIMITED COMPANY, an Irish public limited company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and CITIBANK, N.A., as Administrative Agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Capitalized terms not otherwise defined in this First Amendment have the same meanings as specified in the Credit Agreement, as amended by this First Amendment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amended Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, ICON LUXEMBOURG, S.&#192; R.L., a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">R.C.S. Luxembourg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) under number B66588 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), ICON Clinical Investments, LLC, a Delaware limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lux U.S. Subsidiary Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), PRA Health Sciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, and together with the Lux Borrower and Lux U.S. Subsidiary Borrower, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Holdings, the other parties party thereto, and the several financial institutions parties from time to time, as lender (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Administrative Agent, entered into that certain Credit Agreement, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, Holdings has requested and the Administrative Agent hereby provides notice to each of the other parties to the Credit Agreement, that pursuant to clause (i)(a) of the defined term USD Early Opt-in Election of the Credit Agreement, at least five currently outstanding Dollar denominated syndicated credit facilities in the U.S. syndicated loan market on or about the date hereof contain (as a result of amendment or originally executed) a USD SOFR-based rate as a benchmark rate&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Administrative Agent and Holdings have jointly elected to declare that an USD Early Opt-in Election has occurred pursuant to clause (ii) of the defined term Early Opt-in Election of the Credit Agreement and have determined in accordance with the Credit Agreement that USD LIBOR should be replaced with USD Term SOFR as a benchmark rate for purposes of the Credit Agreement and the other Loan Documents&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, in accordance with Section 2.14(a) of the Credit Agreement, Holdings and the Administrative Agent  are willing to effect the amendments set forth herein and agree to the terms of the Amended Credit Agreement, in each case, on the terms and subject to the terms and conditions in this First Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the covenants and agreements contained herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AMENDMENTS TO CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Early-Opt In Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In accordance with clauses (i) and (ii) of the defined term Early Opt-in Election of the Credit Agreement, at the request of Holdings, the Administrative Agent has provided notice to the parties under the Credit Agreement, and the Administrative Agent and Holdings have jointly elected to declare that an USD Early Opt-in Election has occurred and have elected to replace, in accordance with clause (i)(A) of the definition of USD Benchmark Replacement, the USD LIBOR-based rate with a USD SOFR-based rate as set forth in the Amended Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Amendment of Existing Credit Agreement&#59; Existing Term Loans.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. On the First Amendment Effective Date, the Borrower and the Administrative Agent hereto agree that the Credit Agreement shall hereby be amended in accordance with Section 2.14(a) and the definition of USD Benchmark Replacement Conforming Changes, to delete the stricken text (indicated textually in the same manner as the following example&#58; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and to add the double-underlined text (indicated textually in the same manner as the following example&#58; </font><font style="color:#0f14e1;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">double-underlined text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) as set forth in the Amended Credit Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, subject to the satisfaction of the conditions precedent set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Existing Credit Agreement is hereby amended and restated in its entirety in the form set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Existing Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent and Holdings confirm and agree that the Term Loans and Revolving Loans outstanding on the date hereof as Eurocurrency Rate Loans (as defined in the Credit Agreement prior to giving effect to this First Amendment) with an Interest Period ending after the First Amendment Effective Date, may remain outstanding as such until the conclusion of such applicable Interest Period, at which point such Term Loans and Revolving Loans, as applicable, shall be converted to USD Term SOFR Loans bearing interest at a rate determined by reference to the USD Adjusted Term SOFR in accordance with the terms of the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.74pt"><br><br>CONDITIONS TO EFFECTIVENESS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The effectiveness of this First Amendment will occur as set forth below.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.    The effectiveness of the Amendments contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> are subject to the satisfaction (or written waiver) of the following conditions (the date of satisfaction of such conditions being referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received this First Amendment, executed and delivered by Holdings and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall have given notice to the Lenders of the Early Opt-in Election represented by this First Amendment on November 17, 2022, and shall have not received by 5&#58;00 p.m. (New York City time) on November 28, 2022, written notice of objection to this First Amendment from Lenders comprising the Required Lenders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article III</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To induce the other parties hereto to enter into this First Amendment, Holdings represents and warrants to each of the Lenders and the Administrative Agent that, as of the First Amendment Effective Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">this First Amendment has been duly authorized, executed and delivered by Holdings and constitutes, and the Amended Credit Agreement constitutes, the legal, valid and binding obligation of Holdings, enforceable against Holdings in accordance with its terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no Default or Event of Default shall have occurred and be continuing on the First Amendment Effective Date both before and after giving effect to the transactions contemplated hereunder.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.07pt"><br><br>EFFECTS ON LOAN DOCUMENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as specifically amended herein or contemplated hereby, all Loan Documents shall continue to be in full force and effect and are hereby in all respects ratified and confirmed.  Except as specifically amended herein or contemplated hereby, the execution, delivery and effectiveness of this First Amendment shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of the Loan Documents or in any way limit, impair or otherwise affect the rights and remedies of the Lenders or the Administrative Agent under the Loan Documents.  Holdings acknowledges and agrees that, on and after the First Amendment Effective Date, this First Amendment shall constitute a Loan Document for all purposes of the Amended Credit Agreement.  On and after the First Amendment Effective Date, each reference in the Amended Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to &#8220;Credit Agreement&#8221;, &#8220;thereunder&#8221;, &#8220;thereof&#8221; or words of like import referring to the Credit Agreement shall mean and be a reference to the Amended Credit Agreement, and this First Amendment and the Amended Credit Agreement shall be read together and construed as a single instrument.  Nothing herein shall be deemed to entitle the Borrower to a further consent to, or a further waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Amended Credit Agreement or any other Loan Document in similar or different circumstances. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.06pt"><br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Execution by the Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrative Agent is entering into, and signing, this First Amendment  in respect of the amendments set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Article I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereof, in accordance with the definition of Early Opt-in Election.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower hereby confirms that the indemnification provisions set forth in Section 9.03 of the Amended Credit Agreement shall apply to this First Amendment and the transactions contemplated hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Reaffirmation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Holdings, on behalf of each of the Loan Parties, each as party to the Credit Agreement, the Collateral Documents and the other Loan Documents to which it is a party, in each case as amended, supplemented or otherwise modified from time to time, hereby (i) reaffirms (A) each Lien granted by it to the Administrative Agent for the benefit of the Secured Parties and (B) any guaranties made by it pursuant to the Credit Agreement, and (ii) acknowledges and agrees that the grants of security interests by the Loan Parties contained in the Collateral Documents shall remain in full force and effect after giving effect to the First Amendment.  Nothing contained in this First Amendment shall be construed as substitution or novation of the obligations outstanding under the Credit Agreement or the other Loan Documents, which shall remain in full force and effect, except to any extent modified hereby. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Amendments&#59; Execution in Counterparts&#59; Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">This First Amendment may not be amended nor may any provision hereof be waived except pursuant to a writing signed by Holdings and the Administrative Agent, in each case to the extent required by the Amended Credit Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Any provision of this First Amendment that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Governing Law&#59; Waiver of Jury Trial&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.   EACH PARTY HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS FIRST AMENDMENT, THE AMENDED CREDIT AGREEMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN. The provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">9.09 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the Amended Credit Agreement are incorporated herein by reference, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Section headings in this First Amendment are included herein for convenience of reference only, are not part of this First Amendment and are not to affect the construction of, or to be taken into consideration in interpreting, this First Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This First Amendment may be executed by one or more of the parties to this First Amendment on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument.  Delivery of an executed counterpart of a signature page of this First Amendment by facsimile transmission or electronic transmission (e.g., &#8220;pdf&#8221; or &#8220;tif&#8221;) shall be effective as delivery of a manually executed counterpart of this First Amendment. Without limitation of the foregoing, the words </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;execution&#8221;, &#8220;executed&#8221;, &#8220;signed&#8221;, &#8220;signature&#8221; and words of like import shall be deemed to include electronic signatures, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transaction Act. </font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Remainder of page intentionally left blank.&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_148"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to be duly executed and delivered by their respective proper and duly authorized officers as of the day and year first above written.</font></div><div style="margin-bottom:12pt;padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ICON PUBLIC LIMITED COMPANY, as Holdings</font></div><div style="margin-bottom:12pt;padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">__ &#47;s&#47; Brendan Brennan______________________</font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Brendan Brennan</font></div><div style="padding-left:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;   Chief Financial Officer, ICON plc</font></div><div style="padding-left:198pt"><font><br></font></div><div style="padding-left:198pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Page to First Amendment to Credit Agreement&#93;</font></div><div><font><br></font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_151"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Administrative Agent&#58;</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CITIBANK N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as Administrative Agent </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:238.3pt;text-indent:-22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">_______&#47;s&#47; Louise O&#8217;Mara_____________<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;   Louise O&#8217;Mara<br>Title&#58;     Managing Director</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:238.3pt;text-indent:-22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Page to First Amendment to Credit Agreement&#93;</font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_154"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amended Credit Agreement</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;See attached.&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT B</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit I - Form of Borrowing Request</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;See attached.&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_1"></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Execution Version</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:2pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CREDIT AGREEMENT <br><br>dated as of<br><br>July 1, 2021</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">(as amended by the First Amendment, dated as of November 29, 2022)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">among</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ICON LUXEMBOURG, S.&#192; R.L.,<br>INDIGO MERGER SUB, INC.,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ICON CLINICAL RESEARCH LIMITED,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ICON GLOBAL TREASURY UNLIMITED COMPANY,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ICON US HOLDINGS INC.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">and ICON CLINICAL INVESTMENTS, LLC,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Borrowers</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ICON PUBLIC LIMITED COMPANY,</font></div><div style="margin-bottom:11pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Holdings and a Guarantor,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THE SUBSIDIARY GUARANTORS PARTY HERETO,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Subsidiary Guarantors</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br>The Lenders Party Hereto,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CITIBANK, N.A.,<br>as Administrative Agent</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">and </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CITIBANK, N.A., LONDON BRANCH,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Collateral Agent</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">_______________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CITIGROUP GLOBAL MARKETS INC. and</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">J.P. MORGAN SECURITIES PLC,<br>as Joint Bookrunners,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CITIGROUP GLOBAL MARKETS INC.,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BANCO SANTANDER S.A.,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HSBC CONTINENTAL EUROPE SA,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">J.P. MORGAN SECURITIES PLC and</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">MORGAN STANLEY BANK INTERNATIONAL LIMITED,</font></div><div style="margin-bottom:11pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">as Joint Lead Arrangers</font></div></td></tr><tr style="height:27pt"><td colspan="3" style="border-bottom:2pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">&#124;</font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_4"></div><hr style="page-break-after:always"><div style="min-height:85.68pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE I DEFINITIONS&#160;&#160;&#160;&#160;1</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.01&#160;&#160;&#160;&#160;Defined Terms&#160;&#160;&#160;&#160;1</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.02&#160;&#160;&#160;&#160;Classification of Loans and Borrowings&#160;&#160;&#160;&#160;78</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.03&#160;&#160;&#160;&#160;Terms Generally&#160;&#160;&#160;&#160;78</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.04&#160;&#160;&#160;&#160;Accounting Terms&#59; GAAP&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">78</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">79</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.05&#160;&#160;&#160;&#160;&#91;Reserved&#93;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">79</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">80</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.06&#160;&#160;&#160;&#160;Special Luxembourg Provisions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">79</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">80</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.07&#160;&#160;&#160;&#160;Certain Conditions, Calculations and Tests&#160;&#160;&#160;&#160;80</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.08&#160;&#160;&#160;&#160;Divisions&#160;&#160;&#160;&#160;83</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II THE CREDITS&#160;&#160;&#160;&#160;83</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.01&#160;&#160;&#160;&#160;Commitments and Loans&#160;&#160;&#160;&#160;83</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.02&#160;&#160;&#160;&#160;Loans and Borrowings&#160;&#160;&#160;&#160;84</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.03&#160;&#160;&#160;&#160;Requests for Borrowings&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">84</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">85</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.04&#160;&#160;&#160;&#160;Determination of Dollar Amounts&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">85</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">86</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.05&#160;&#160;&#160;&#160;Swingline Loans&#160;&#160;&#160;&#160;86</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.06&#160;&#160;&#160;&#160;Letters of Credit&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">88</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.07&#160;&#160;&#160;&#160;Funding of Borrowings&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">92</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">93</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.08&#160;&#160;&#160;&#160;Interest Elections&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">94</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.09&#160;&#160;&#160;&#160;Termination and Reduction of Commitments&#160;&#160;&#160;&#160;95</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.10&#160;&#160;&#160;&#160;Repayment of Loans&#59; Evidence of Debt&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">95</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">96</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.11&#160;&#160;&#160;&#160;Prepayment of Loans&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">96</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">97</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.12&#160;&#160;&#160;&#160;Fees&#160;&#160;&#160;&#160;101</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.13&#160;&#160;&#160;&#160;Interest&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">102</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">103</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.14&#160;&#160;&#160;&#160;Benchmark Replacement Setting&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">103</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">104</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.15&#160;&#160;&#160;&#160;Increased Costs&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">106</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">107</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.16&#160;&#160;&#160;&#160;Break Funding Payments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">107</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">108</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.17&#160;&#160;&#160;&#160;Taxes.&#160;&#160;&#160;&#160;108</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.18&#160;&#160;&#160;&#160;Payments Generally&#59; Allocations of Proceeds&#59; Pro Rata Treatment&#59; Sharing of Set-offs.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">112</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">113</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.19&#160;&#160;&#160;&#160;Mitigation Obligations&#59; Replacement of Lenders.&#160;&#160;&#160;&#160;115</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.20&#160;&#160;&#160;&#160;Incremental Credit Extensions.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">115</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">116</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.21&#160;&#160;&#160;&#160;Judgment Currency.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">119</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">120</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.22&#160;&#160;&#160;&#160;Extensions of Loans and Commitments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">119</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">120</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.23&#160;&#160;&#160;&#160;Loan Repurchases.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">122</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">123</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.24&#160;&#160;&#160;&#160;Refinancing Amendment.&#160;&#160;&#160;&#160;124</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.25&#160;&#160;&#160;&#160;Illegality.&#160;&#160;&#160;&#160;125</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.26&#160;&#160;&#160;&#160;Defaulting Lenders.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">125</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">126</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III REPRESENTATIONS AND WARRANTIES&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">127</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">128</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.68pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Table of Contents<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01&#160;&#160;&#160;&#160;Organization&#59; Powers&#59; Subsidiaries&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">127</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">128</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02&#160;&#160;&#160;&#160;Authorization&#59; Enforceability&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">129</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03&#160;&#160;&#160;&#160;Governmental Approvals&#59; No Conflicts&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">129</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.04&#160;&#160;&#160;&#160;Financial Condition&#59; No Material Adverse Change&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">129</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.05&#160;&#160;&#160;&#160;Properties&#160;&#160;&#160;&#160;129</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06&#160;&#160;&#160;&#160;Litigation, Environmental and Labor Matters&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">129</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">130</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07&#160;&#160;&#160;&#160;Compliance with Laws and Agreements&#160;&#160;&#160;&#160;130</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08&#160;&#160;&#160;&#160;Investment Company Status&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">130</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">131</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.09&#160;&#160;&#160;&#160;Taxes&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">130</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">131</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.10&#160;&#160;&#160;&#160;ERISA&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">130</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">131</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.11&#160;&#160;&#160;&#160;Disclosure&#160;&#160;&#160;&#160;131</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.12&#160;&#160;&#160;&#160;Federal Reserve Regulations&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">131</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">132</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.13&#160;&#160;&#160;&#160;Security Interest in Collateral&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">131</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">132</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.14&#160;&#160;&#160;&#160;Solvency&#160;&#160;&#160;&#160;132</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.15&#160;&#160;&#160;&#160;Compliance with Anti-Corruption Laws and Sanctions&#160;&#160;&#160;&#160;132</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.16&#160;&#160;&#160;&#160;No Irish Financial Assistance&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">133</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.17&#160;&#160;&#160;&#160;Luxembourg Matters&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">133</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.18&#160;&#160;&#160;&#160;PATRIOT Act, etc&#160;&#160;&#160;&#160;133</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV CONDITIONS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">133</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">134</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4.01&#160;&#160;&#160;&#160;Conditions Precedent to the Closing Date&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">133</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">134</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4.02&#160;&#160;&#160;&#160;Each Credit Event after the Closing Date&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">137</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">138</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V AFFIRMATIVE COVENANTS&#160;&#160;&#160;&#160;138</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.01&#160;&#160;&#160;&#160;Financial Statements and Other Information&#160;&#160;&#160;&#160;138</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.02&#160;&#160;&#160;&#160;Notices of Material Events&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">140</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">141</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.03&#160;&#160;&#160;&#160;Existence&#59; Conduct of Business&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">140</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">141</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.04&#160;&#160;&#160;&#160;Payment of Obligations&#160;&#160;&#160;&#160;141</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.05&#160;&#160;&#160;&#160;Maintenance of Properties&#59; Insurance&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">141</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">142</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.06&#160;&#160;&#160;&#160;Books and Records&#59; Inspection Rights&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">141</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">142</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.07&#160;&#160;&#160;&#160;Compliance with Laws&#160;&#160;&#160;&#160;142</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.08&#160;&#160;&#160;&#160;Use of Proceeds&#160;&#160;&#160;&#160;142</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.09&#160;&#160;&#160;&#160;Subsidiary Guarantors&#59; Pledges&#59; Additional Collateral&#59; Further Assurances&#59; Guarantor Coverage Test&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">142</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">143</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.10&#160;&#160;&#160;&#160;Designation of Subsidiaries&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">145</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.11&#160;&#160;&#160;&#160;Maintenance of Ratings&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">145</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.12&#160;&#160;&#160;&#160;Transactions with Affiliates&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">145</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.13&#160;&#160;&#160;&#160;Fiscal Periods&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">148</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.14&#160;&#160;&#160;&#160;Anti-Terrorism and Anti-Money Laundering&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">148</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.15&#160;&#160;&#160;&#160;Post-Closing Schedule&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">148</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.68pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Table of Contents<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI NEGATIVE COVENANTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">148</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.01&#160;&#160;&#160;&#160;Indebtedness&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">148</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.02&#160;&#160;&#160;&#160;Liens&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">153</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">154</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.03&#160;&#160;&#160;&#160;Asset Sales&#160;&#160;&#160;&#160;154</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.04&#160;&#160;&#160;&#160;Restricted Payments, Investments, Loans, Advances, Guarantees and Acquisitions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">154</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">155</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.05&#160;&#160;&#160;&#160;&#91;Reserved&#93;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">159</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">160</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.06&#160;&#160;&#160;&#160;&#91;Reserved&#93;&#160;&#160;&#160;&#160;160</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.07&#160;&#160;&#160;&#160;Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries&#160;&#160;&#160;&#160;160</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.08&#160;&#160;&#160;&#160;Amendments to Subordinated Indebtedness and Certain Other Documents, etc&#160;&#160;&#160;&#160;162</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.09&#160;&#160;&#160;&#160;Sale and Leaseback Transactions&#160;&#160;&#160;&#160;162</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.10&#160;&#160;&#160;&#160;&#91;Reserved&#93;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">162</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">163</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.11&#160;&#160;&#160;&#160;Merger, Consolidation or Sale of Assets&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">162</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">163</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.12&#160;&#160;&#160;&#160;Financial Covenant&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">163</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">164</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII EVENTS OF DEFAULT AND REMEDIES&#160;&#160;&#160;&#160;164</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7.01&#160;&#160;&#160;&#160;Events of Default&#160;&#160;&#160;&#160;164</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7.02&#160;&#160;&#160;&#160;Borrowers&#8217; Right to Cure&#160;&#160;&#160;&#160;167</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII THE AGENTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">168</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">169</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 8.01&#160;&#160;&#160;&#160;The Agents&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">168</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">169</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 8.02&#160;&#160;&#160;&#160;Erroneous Payments&#160;&#160;&#160;&#160;173</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX MISCELLANEOUS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">175</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">176</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.01&#160;&#160;&#160;&#160;Notices&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">175</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">176</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.02&#160;&#160;&#160;&#160;Waivers&#59; Enforcement&#59; Amendments&#160;&#160;&#160;&#160;177</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.03&#160;&#160;&#160;&#160;Expenses&#59; Indemnity&#59; Damage Waiver&#160;&#160;&#160;&#160;180</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.04&#160;&#160;&#160;&#160;Successors and Assigns&#160;&#160;&#160;&#160;182</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.05&#160;&#160;&#160;&#160;Survival&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">187</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">188</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.06&#160;&#160;&#160;&#160;Counterparts&#59; Integration&#59; Effectiveness&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">187</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">188</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.07&#160;&#160;&#160;&#160;Severability&#160;&#160;&#160;&#160;188</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.08&#160;&#160;&#160;&#160;Right of Setoff&#160;&#160;&#160;&#160;188</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.09&#160;&#160;&#160;&#160;Governing Law&#59; Jurisdiction&#59; Consent to Service of Process&#59; Foreign Process Agent.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">188</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">189</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.10&#160;&#160;&#160;&#160;WAIVER OF JURY TRIAL&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">189</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">190</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.11&#160;&#160;&#160;&#160;Headings&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">189</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">190</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.12&#160;&#160;&#160;&#160;Confidentiality&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">189</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">190</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.13&#160;&#160;&#160;&#160;Release of Liens and Guarantees.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">190</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">191</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.14&#160;&#160;&#160;&#160;USA PATRIOT Act&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">191</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">192</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.15&#160;&#160;&#160;&#160;Appointment for Perfection&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">191</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">192</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.68pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Table of Contents<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.16&#160;&#160;&#160;&#160;No Fiduciary Relationship&#160;&#160;&#160;&#160;192</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.17&#160;&#160;&#160;&#160;Interest Rate Limitation&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">192</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">193</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.18&#160;&#160;&#160;&#160;Acknowledgement and Consent to Bail-In of Affected Financial Institutions.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">192</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">193</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.19&#160;&#160;&#160;&#160;Certain ERISA Matters.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">193</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">194</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.20&#160;&#160;&#160;&#160;Acknowledgement Regarding Any Supported QFCs&#160;&#160;&#160;&#160;194</font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:36pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE X THE GUARANTY&#160;&#160;&#160;&#160;195</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.01&#160;&#160;&#160;&#160;The Guarantee&#160;&#160;&#160;&#160;195</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.02&#160;&#160;&#160;&#160;Obligations Unconditional&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">195</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">196</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.03&#160;&#160;&#160;&#160;Reinstatement&#160;&#160;&#160;&#160;197</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.04&#160;&#160;&#160;&#160;Certain Additional Waivers&#160;&#160;&#160;&#160;197</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.05&#160;&#160;&#160;&#160;Remedies&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">197</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">198</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.06&#160;&#160;&#160;&#160;Rights of Contribution&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">197</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">198</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.07&#160;&#160;&#160;&#160;Guaranty of Payment&#59; Continuing Guarantee&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">197</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">198</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.08&#160;&#160;&#160;&#160;Guarantee Limitations&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">197</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">198</font></div><div style="margin-bottom:6pt;padding-left:126pt;padding-right:36pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.09&#160;&#160;&#160;&#160;Keepwell&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">198</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">199</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iv</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.68pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Table of Contents<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(continued)</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 1.01A &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Agreed Guarantee and Security Principles</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 1.01B &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Existing Investments</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 1.01C &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Existing Liens<br>Schedule 1.01D&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Excluded Subsidiaries</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 1.01E &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Foreign Security Documents</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 1.01F&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Subsidiary Guarantors</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 2.01 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Commitments</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.01 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Subsidiaries</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.03 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Certain Existing Indebtedness</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.05 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Material Intellectual Property Litigation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.06 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Material Litigation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.07 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Compliance with Laws</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.10 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Prohibited Transactions</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 3.13 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Existing Liens to be Released at Closing</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 5.15 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Post-Closing Schedule <br>Schedule 6.01 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Existing Indebtedness </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Schedule 6.07 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Existing Restrictions</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit A &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit B&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Auction Procedures</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit C&#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of Solvency Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit D &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of Joinder Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit E-1 &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of First Lien Intercreditor Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit E-2 &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of First-Second Lien Intercreditor Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit F &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of U.S. Security Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G-1 &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G-2 &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G-3 &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit G-4 &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of U.S. Tax Compliance Certificate</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit H &#160;&#160;&#160;&#160;&#8211; &#160;&#160;&#160;&#160;Form of Irish Qualifying Lender Confirmation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit I&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Borrowing Request</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit J&#160;&#160;&#160;&#160;&#8211;&#160;&#160;&#160;&#160;Form of Perfection Certificate Supplement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">v</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_7"></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CREDIT AGREEMENT, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), among ICON LUXEMBOURG, S.&#192; R.L., a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">R.C.S. Luxembourg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) under number B66588 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), ICON Clinical Investments, LLC, a Delaware limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux U.S. Subsidiary Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), INDIGO MERGER SUB, INC., a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and, prior to the consummation of the Acquisition, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by PRA Health Sciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Target</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and, following the consummation of the Acquisition, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), ICON PUBLIC LIMITED COMPANY, an Irish public limited company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Revolving Borrowers (as such term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), each Additional Borrower, the Subsidiary Guarantors (as such term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) party hereto, the LENDERS from time to time party hereto, CITIBANK, N.A., as Administrative Agent, and CITIBANK, N.A., LONDON BRANCH, as Collateral Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:35.08pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As used in this Agreement, the following terms have the meanings specified below&#58;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ABR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to a Loan, or the Loans comprising such Borrowing, bearing interest at a rate determined by reference to the Alternate Base Rate.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accepting Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.11(e).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ACH Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Indebtedness incurred in the ordinary course of business arising in connection with any automated clearinghouse transfers of funds or other payment processing service.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the merger of Merger Sub with and into the Target, with the Target as the surviving corporation, as provided for in the Acquisition Agreement and the related transactions.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Agreement and Plan of Merger dated as of February 24, 2021 among Holdings, U.S. Holdco, Merger Sub and the Target (including, without limitation, all exhibits, schedules and disclosure letters thereto), as the same may be altered, amended, changed, supplemented or with any provision or condition therein waived.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition Agreement Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means such representations and warranties made by or with respect to the Target and its subsidiaries in the Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that Holdings (or its applicable subsidiaries) have the right (taking into account any applicable cure periods) to terminate its obligation to consummate the Acquisition under the Acquisition Agreement or the right not to consummate the Acquisition pursuant to the Acquisition Agreement as a result of a breach of such representations and warranties, in each case in accordance with the terms thereof.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Acquisition Agreement and any other documents executed or issued, or to be executed or issued, by or on behalf of the Target and&#47;or the U.S. Borrower in respect of the Acquisition (but excluding the Loan Documents).</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any one or more Restricted Subsidiaries that is or becomes a Subsidiary Guarantor designated by Holdings as a borrower of any Incremental Loans hereunder, Revolving Loans or Other Refinancing Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that only Restricted Subsidiaries organized under the laws of Ireland, Luxembourg, England and Wales and&#47;or a jurisdiction located in the United States may be designated by Holdings as Additional Borrowers&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Additional Borrower shall have satisfied the requirements set forth in Section 4.01(c), and for such purposes, any reference to the Closing Date in such Section 4.01(c) shall be deemed to be a reference to the date on which such Subsidiary Guarantor becomes an Additional Borrower.  For the avoidance of doubt, any Restricted Subsidiary designated as an Additional Borrower shall cease to be an &#8220;Additional Borrower&#8221; upon the repayment of all Loans (or, in the case of an Additional Borrower that is a Revolving Borrower, the repayment of all Loans and termination of all Revolving Commitments) in respect of which such Restricted Subsidiary was designated as an &#8220;Additional Borrower&#8221; and shall be deemed to be a Guarantor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.20(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted EURIBOR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Eurocurrency Borrowing denominated in euros, for any Interest Period, an interest rate per annum (rounded upwards, if necessary, to the next 1&#47;16 of 1%) equal to the sum of (a) the EURIBOR Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate&#59; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, with respect to Revolving Loans, such rate shall not be less than zero</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Adjusted LIBO Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, with respect to any Eurocurrency Borrowing denominated in any Agreed Currency other than euros, for any Interest Period, an interest rate per annum (rounded upwards, if necessary, to the next 1&#47;16 of 1%) equal to the sum of (a) the LIBO Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate&#59; </font><font style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> that (i) with respect to Revolving Loans, such rate shall not be less than zero and (ii) with respect to the Initial Term Loans, such rate shall not be less than 0.50%</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Citibank, N.A., in its capacity as administrative agent for the Lenders hereunder.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.01(c).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 8.01.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreed Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) Dollars, (ii) euro (solely with respect to Revolving Loans and Letters of Credit), (iii) Pounds Sterling (solely with respect to Revolving Loans and Letters of Credit) and (iv) any other Foreign Currency agreed to by the Administrative Agent, each of the Lenders and each Issuing Bank of the applicable Class of Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreed Guarantee and Security Principles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Agreed Guarantee and Security Principles set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1.01A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For the avoidance of doubt, the Agreed Guarantee and Security Principles shall only apply to Guarantees proposed to be granted by, assets of, and Equity Interests in, Holdings and the Foreign Subsidiaries.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the preamble hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Base Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, a rate per annum equal to the greatest of (a) the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for a one month Interest Period on such day (or if such day is not a Business Day, the immediately preceding Business Day) plus 1%, (b) the Prime Rate in effect on such day, (c) the Federal Funds Effective Rate in effect on such day plus &#189; of 1% and (d) 1%</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, that for the avoidance of doubt, the Eurocurrency Rate for any day shall be based on the rate appearing on the applicable Bloomberg screen page (or on any successor or substitute page of such page) at approximately 11&#58;00 a.m. London time on such day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any change in the Alternate Base Rate due to a change in the Prime Rate, the Federal Funds Effective Rate or the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be effective from and including the effective date of such change in the Prime Rate, the Federal Funds Effective Rate or the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, respectively.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all Agreed Currencies other than Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall mean, with respect to any Eurocurrency Loan denominated in an Alternate Currency or any RFR Loan, the sum of&#58; (a) the alternate benchmark rate (which may be an Alternate Currency SOFR-Based Rate) that has been selected by the Administrative Agent and Holdings giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the applicable Eurocurrency Rate or Daily Simple RFR for syndicated credit facilities denominated in such Alternate Currency at such time and (b) the Alternate Currency Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With respect to Eurocurrency Loans denominated in an Alternate Currency and RFR Loans, if the Alternate Currency Benchmark Replacement would be less than the &#8220;floor&#8221;, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or removal of this Agreement or otherwise) with respect to Eurocurrency Loans denominated in such Alternate Currency or RFR Loans, the Alternate Currency Benchmark Replacement with respect to such Alternate Currency will be deemed to be the &#8220;floor&#8221; for the purposes of this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Replacement Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any replacement of applicable Eurocurrency Rate or Daily Simple RFR with an Alternate Currency Unadjusted Benchmark Replacement for any applicable Interest Period, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and Holdings giving due consideration to (i) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the applicable Eurocurrency Rate or Daily Simple RFR with the applicable Alternate Currency Unadjusted Benchmark Replacement by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the applicable Eurocurrency Rate or Daily Simple RFR with the applicable Alternate Currency Unadjusted Benchmark Replacement for syndicated credit facilities at such time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Alternate Currency Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;Interest Period,&#8221; timing and frequency of determining rates and making payments of interest and other administrative matters) that the Administrative Agent, in consultation with Holdings, decides may be appropriate to reflect the adoption and implementation of such Alternate Currency Benchmark Replacement and </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of the Alternate Currency Benchmark Replacement exists, in such other manner of administration as the Administrative Agent, in consultation with Holdings, decides is reasonably necessary in connection with the administration of this Agreement).</font></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the earlier to occur of the following events with respect to the applicable Eurocurrency Rate or Daily Simple RFR&#58; </font></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;in the case of clause (1) or (2) of the definition of &#8220;Alternate Currency Benchmark Transition Event,&#8221; the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of the applicable Eurocurrency Rate or Daily Simple RFR permanently or indefinitely ceases to provide the applicable Eurocurrency Rate or Daily Simple RFR&#59; or</font></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;in the case of clause (3) of the definition of &#8220;Alternate Currency Benchmark Transition Event,&#8221; the date of the public statement or publication of information referenced therein.</font></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the occurrence of one or more of the following events with respect to the applicable Eurocurrency Rate or Daily Simple RFR&#58;</font></div><div style="margin-bottom:12pt;padding-left:60pt;padding-right:5.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">a public statement or publication of information by or on behalf of the administrator of the applicable Eurocurrency Rate or Daily Simple RFR announcing that such administrator has ceased or will cease to provide the applicable Eurocurrency Rate or Daily Simple RFR, permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, at the time of such statement or publication, there is no successor administrator that will continue to provide the applicable Eurocurrency Rate or Daily Simple RFR&#59;</font></div><div style="margin-bottom:12pt;padding-left:60pt;padding-right:5.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">a public statement or publication of information by the regulatory supervisor for the administrator of the applicable Eurocurrency Rate or Daily Simple RFR, the U.S. Federal Reserve System, an insolvency official with jurisdiction over the administrator for the applicable Eurocurrency Rate or Daily Simple RFR, a resolution authority with jurisdiction over the administrator for the applicable Eurocurrency Rate or Daily Simple RFR or a court or an entity with similar insolvency or resolution authority over the administrator for the applicable Eurocurrency Rate or Daily Simple RFR, which states that the administrator of the applicable Eurocurrency Rate or Daily Simple RFR has ceased or will cease to provide the applicable Eurocurrency Rate or Daily Simple RFR permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, at the time of such statement or publication, there is no successor administrator that will continue to provide the applicable Eurocurrency Rate or Daily Simple RFR&#59; or</font></div><div style="margin-bottom:12pt;padding-left:60pt;padding-right:6.1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">a public statement or publication of information by the regulatory supervisor for the administrator of the applicable Eurocurrency Rate or Daily Simple RFR announcing that the applicable Eurocurrency Rate or Daily Simple RFR is no longer representative.</font></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Transition Start Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) in the case of an Alternate Currency Benchmark Transition Event, the earlier of (i) the applicable Alternate </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Currency Benchmark Replacement Date and (ii) if such Alternate Currency Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90th day prior to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or publication) and (b) in the case of an Alternate Currency Early Opt-in Election, the date specified by the Administrative Agent or the Required Lenders, as applicable, by notice to the Borrower, the Administrative Agent (in the case of such notice by the Required Lenders) and the Lenders.</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, if an Alternate Currency Benchmark Transition Event and its related Alternate Currency Benchmark Replacement Date have occurred with respect to the applicable Eurocurrency Rate or Daily Simple RFR and solely to the extent that the applicable Eurocurrency Rate or Daily Simple RFR has not been replaced with an Alternate Currency Benchmark Replacement, the period (x) beginning at the time that such Alternate Currency Benchmark Replacement Date has occurred if, at such time, no Alternate Currency Benchmark Replacement has replaced the applicable Eurocurrency Rate or Daily Simple RFR for all purposes hereunder in accordance with Section 2.14 and (y) ending at the time that an Alternate Currency Benchmark Replacement has replaced the applicable Eurocurrency Rate or Daily Simple RFR for all purposes hereunder pursuant to Section 2.14.</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Compounded SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the compounded average of Alternate Currency SOFR for the applicable Alternate Currency Corresponding Tenor, with the rate, or methodology for this rate, and conventions for this rate (which may include compounding in arrears with a lookback and&#47;or suspension period as a mechanism to determine the interest amount payable prior to the end of each Interest Period) being established by the Administrative Agent in accordance with&#58;</font></div><div style="margin-bottom:12pt;padding-left:58.5pt;padding-right:5.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1) &#160;&#160;&#160;&#160;the rate, or methodology for this rate, and conventions for this rate selected or recommended by the Relevant Governmental Body for determining compounded Alternate Currency SOFR&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:58.5pt;padding-right:5.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;if, and to the extent that, the Administrative Agent determines that Alternate Currency Compounded SOFR cannot be determined in accordance with clause (1) above, then the rate, or methodology for this rate, and conventions for this rate that the Administrative Agent determines are substantially consistent with prevailing market convention for determining Alternate Currency Compounded SOFR for syndicated credit facilities at such time (as a result of amendment or as originally executed)&#59; </font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if the Administrative Agent decides that any such rate, methodology or convention determined in accordance with clause (1) or clause (2) is not administratively feasible for the Administrative Agent, then Alternate Currency Compounded SOFR will be deemed unable to be determined for purposes of the definition of &#8220;Alternate Currency Benchmark Replacement.&#8221;</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Corresponding Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; with respect to an Alternate Currency Benchmark Replacement means a tenor (including overnight) having approximately the same length (disregarding business day adjustment) as the applicable tenor for the applicable Interest Period with respect to the applicable Eurocurrency Rate or Daily Simple RFR.</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for any day, Alternate Currency SOFR, with the conventions for this rate (which may include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">recommended by the Relevant Governmental Body for determining &#8220;Alternate Currency Daily Simple SOFR&#8221; for syndicated business loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.</font></div><div style="margin-bottom:12pt;padding-left:37.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Early Opt-in Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the occurrence of&#58;</font></div><div style="margin-bottom:12pt;padding-left:59pt;padding-right:5.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">(i) a determination by the Administrative Agent or (ii) a notification by the Required Lenders to the Administrative Agent (with a copy to the Borrower) that the Required Lenders have determined that syndicated credit facilities denominated in the applicable Alternate Currency being executed at such time, or that include language similar to that contained in Section 2.14, are being executed or amended, as applicable, to incorporate or adopt a new benchmark interest rate to replace the applicable Eurocurrency Rate or Daily Simple RFR, and</font></div><div style="margin-bottom:12pt;padding-left:59pt;padding-right:5.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">(i) the election by the Administrative Agent or (ii) the election by the Required Lenders to declare that an Alternate Currency Early Opt-in Election has occurred and the provision, as applicable, by the Administrative Agent of written notice of such election to Holdings and the Lenders or by the Required Lenders of written notice of such election to the Administrative Agent and Holdings.</font></div><div style="margin-bottom:12pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, with respect to any amount denominated in Dollars, the Equivalent Amount thereof in the applicable Alternate Currency as determined by the Administrative Agent or the applicable Issuing Bank, as the case may be, at such time on the basis of the spot rate (determined in respect of the most recent Computation Date) for the purchase of such Alternate Currency with Dollars.</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; with respect to any day means the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark, (or a successor administrator) on the Federal Reserve Bank of New York&#8217;s Website.</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency SOFR-Based Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Alternate Currency SOFR, Alternate Currency Daily Simple SOFR, Alternate Currency Compounded SOFR or Alternate Currency Term SOFR.</font></div><div style="margin-bottom:12pt;padding-left:1.95pt;padding-right:5.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the forward-looking term rate based on Alternate Currency SOFR that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Currency Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Alternate Currency Benchmark Replacement excluding the Alternate Currency Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Incremental Facility Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of senior secured notes or loans or unsecured notes or loans that are issued or made in lieu of the Incremental Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) if such Indebtedness is secured, such Indebtedness is secured by all or a portion of the Collateral on a pari passu or junior basis with the Obligations and is not secured by any property or assets of Holdings or any Restricted Subsidiary other than the Collateral, (ii) such Indebtedness does not mature prior to the Latest Maturity Date at the time such Indebtedness is incurred or have a Weighted Average Life to Maturity that is shorter than the remaining Weighted Average Life to Maturity of the Term Loans maturing on the Latest Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">this clause (ii) shall not apply to (x) Term A Facilities and (y) customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (ii)), (iii) such Indebtedness is not guaranteed by any of Holdings&#8217; Restricted Subsidiaries other than the Loan Parties, (iv) if such Indebtedness is secured, a Designated Representative acting on behalf of the holders of such Indebtedness shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement or a First-Second Lien Intercreditor Agreement, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if no such intercreditor agreement is then in effect, then Holdings, the Borrowers, the Subsidiary Guarantors, the Administrative Agent, the Collateral Agent and the Designated Representative for such Indebtedness shall have executed and delivered a First Lien Intercreditor Agreement or a First-Second Lien Intercreditor Agreement, as applicable, (v) such Indebtedness shall contain covenants and events of default that are either (x) no more restrictive (taken as a whole) to Holdings and its Restricted Subsidiaries than those included in this Agreement in all material respects as determined by Holdings in good faith or (y) are on market terms at the time of issuance, as determined by Holdings in good faith, which terms shall also be implemented for the benefit of the Initial Term Loans and the Revolving Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Indebtedness in the form of Term A Facilities or Revolving Commitments may contain one or more financial maintenance covenants (and related events of default) irrespective of whether or not such covenants (and related events of default) are included in this Agreement for the benefit of the Term Loans (but such covenants shall be included for the benefit of the other Revolving Commitments), (vi) to the extent such Alternative Incremental Facility Indebtedness is incurred prior to the date that is 24 months after the Closing Date and is comprised of term loans funded in Dollars that are secured pari passu with the Obligations, the provisions set forth in Section 2.20(b)(A)(iv) shall apply as if such Alternative Incremental Facility Indebtedness had been incurred as Incremental Term Loans under Section 2.20 and (vii) such Alternative Incremental Facility Indebtedness may participate on a pro rata basis or a less than pro rata basis (but not a greater than pro rata basis) than the Initial Term Loans in mandatory prepayments pursuant to Sections 2.11(c)(i) and (c)(iii) under this Agreement (or offers to purchase in circumstances similar to those described in Section 2.11(c)(i) and (c)(iii)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that notwithstanding the foregoing, the terms and conditions applicable to such Indebtedness may provide for any additional or different covenants or events of default that are applicable only during periods after the Latest Maturity Date that is in effect on the date such Indebtedness is issued, incurred or obtained, include Permitted Conversion Provisions and require the repurchase or repayment upon a change of control, fundamental change, delisting or similar events.  Alternative Incremental Facility Indebtedness will include any Registered Equivalent Notes issued in exchange therefor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, and regulations of any jurisdiction applicable to Holdings or its Subsidiaries from time to time concerning or relating to bribery or corruption.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to the Lux Term Loans, the Lux Borrower and the Lux U.S. Subsidiary Borrower, (b) with respect to the U.S. Term Loans, the U.S. Borrower, (c) with respect to any Revolving Loan, the Revolving Borrower to which such Revolving Loan was made, (d) with respect to any Swingline Loan, the Revolving Borrower to which such Swingline Loan was made, and (e) with respect to any Incremental Loan or any Other Refinancing Loan, the Borrower or Borrowers to which such Loan is made.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.06(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">means, for any day,</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) with respect to the Initial Term Loans, (x) from the Closing Date until the first Business Day following delivery of the Compliance Certificate for the first fiscal quarter ending after the Closing Date pursuant to Section 5.01(c), (a) for any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Initial Term </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, 2.50% per annum and (b) for any ABR Initial Term Loan, 1.50% per </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">annum and (y) thereafter, the following percentages per annum, based upon the First Lien Net Leverage Ratio as specified in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 5.01(c)&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">First Lien Net Leverage Ratio</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11pt;text-align:center"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Initial Term Loans </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">ABR Initial Term Loans</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#62; 4.00 to 1.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2.50%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.50%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8804; 4.00 to 1.00</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2.25%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.25%</font></td></tr></table></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) with respect to (a) any Eurocurrency Initial Revolving Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Initial Revolving Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Initial Revolving Loan and (b) any ABR Initial Revolving Loan, the following percentages per annum based on the current corporate family rating assigned by S&#38;P to Holdings&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">S&#38;P Rating</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurocurrency Initial Revolving Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Initial Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> and RFR Initial Revolving Loans</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">ABR Initial Revolving Loans</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BB+ (or higher)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.25%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0.25%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BB</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.60%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0.60%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BB- (or lower)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2.00%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1.00%</font></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) with respect to any other Loan, as specified in the applicable Extension Amendment (to the extent such Extension Amendment specifies a different rate from the rate then applicable to the Loans being so extended), Incremental Amendment or Refinancing Amendment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any increase or decrease in the Applicable Margin under clause (i) above resulting from a change in the First Lien Net Leverage Ratio shall become effective as of the first Business Day after the date on which a Compliance Certificate is delivered pursuant to Section 5.01(c).  Any increase or decrease in the Applicable Margin under clause (ii) above resulting from a change in Holdings&#8217; corporate family rating from S&#38;P shall become effective as of the first Business Day following the date on which a notice of a change in rating has been delivered by Holdings pursuant to Section 5.01(g).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any Revolving Lender in respect of a Revolving Credit Event, its Revolving Percentage and (b) with respect to any Term Lender, a percentage equal to a fraction the numerator of which is the outstanding principal amount of such Lender&#8217;s Term Loans and the denominator of which is the aggregate outstanding amount of the Term Loans of all Term Lenders.  When references herein to the &#8220;Applicable Percentage&#8221; refer to the aggregate outstandings hereunder, the Applicable Percentage of each Lender shall be determined in a manner consistent with the foregoing, but taking into account all of their relevant </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Commitments (or related Revolving Credit Exposures) and outstanding Term Loans hereunder.  In making the foregoing determinations, if any of the relevant amounts are denominated in a currency other than Dollars, the Dollar Amounts thereof (as determined by the Administrative Agent in good faith) shall be utilized. If the context indicates that the &#8220;Applicable Percentage&#8221; is to be determined for a relevant Class or Tranche, then only the respective Class or Tranche shall be included as otherwise provided above in determining the relevant Applicable Percentages. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Utilization Fee Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means on any date, with respect to the Revolving Commitments, the applicable rate per annum set forth below based upon the Average Revolving Utilization&#58;</font></div><div style="padding-left:45.35pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.223%"><tr><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Level</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:7.9pt;padding-right:7.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Average Revolving Utilization</font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Applicable Utilization Fee Rate</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;text-align:center;text-indent:2.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:7.9pt;padding-right:7.9pt;text-align:center;text-indent:2.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#60; 33.34%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;text-align:center;text-indent:4.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.10%</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;text-align:center;text-indent:2.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">II</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:7.9pt;padding-right:7.9pt;text-align:center;text-indent:2.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8805; 33.34% but &#8804; 66.66%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;text-align:center;text-indent:4.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.20%</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;text-align:center;text-indent:2.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">III</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:7.9pt;padding-right:7.9pt;text-align:center;text-indent:2.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#62; 66.66%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;text-align:center;text-indent:4.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.40%</font></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.04(b).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Asset Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Disposition (or series of related Dispositions) by Holdings or any Restricted Subsidiary of&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any shares of Equity Interests of a Restricted Subsidiary (other than directors&#8217; qualifying shares or shares required by applicable law to be held by a Person other than Holdings or a Restricted Subsidiary)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">all or substantially all the assets of any division or line of business of Holdings or any Restricted Subsidiary&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any other assets of Holdings or any Restricted Subsidiary outside of the ordinary course of business of Holdings or such Restricted Subsidiary, </font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other than, in the case of clauses (1), (2) and (3) above&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">a Disposition by a Restricted Subsidiary to Holdings or by Holdings or a Restricted Subsidiary to a Restricted Subsidiary&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">for purposes of Section 6.03 only, a Disposition that constitutes a Restricted Payment (or would constitute a Restricted Payment but for the exclusions from the definition thereof) that is not prohibited by Section 6.04 or that constitutes a Permitted Investment&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">a Disposition of all or substantially all the assets of Holdings and its Restricted Subsidiaries, taken as a whole, in accordance with Section 6.11 or any disposition that constitutes a Change of Control pursuant to this Agreement&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">a Disposition of assets with a fair market value of less than or equal to $30,000,000 (as determined in good faith by Holdings or its Subsidiaries, as applicable) in any single transaction or series of related transactions&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Dispositions of damaged, expired, short-dated, worn-out or obsolete equipment or assets in the ordinary course of business that, in Holdings&#8217; reasonable judgment, are no longer either used or useful in the business of Holdings or its Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the non-exclusive license or sublicense of intellectual property or other general intangibles and licenses, leases or subleases of other property, in each case, in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">to the extent allowable under Section 1031 of the Code, any exchange of like property (excluding any boot thereon) for use in a Permitted Business&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any issuance or sale by any Restricted Subsidiary of Equity Interests to Holdings or another Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">foreclosures, condemnation, expropriation or any similar action on assets of Holdings or any of its Restricted Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">the sale or discount of inventory, accounts receivable or notes receivable in the ordinary course of business or the conversion of accounts receivable to notes receivable&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">any surrender or waiver of contract rights or the settlement, release or surrender of contract rights or other litigation claims in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">the unwinding, settlement or termination of any obligations under or in respect of any Swap Agreements (including any Permitted Equity Derivatives, Permitted Hedging Obligations and Swap Obligations)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Dispositions of Investments in joint ventures made in the ordinary course of business or to the extent required by, or made pursuant to, buy&#47;sell arrangements between the joint venture parties set forth in joint venture arrangements and similar binding arrangements&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">the lapse or abandonment of intellectual property rights in the ordinary course of business, or which are not, individually or in the aggregate, useful or material to the conduct of the business of Holdings and its Restricted Subsidiaries taken as a whole&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">Dispositions of cash or Cash Equivalents&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">a Disposition in connection with a co-development or collaboration agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">the creation of a Permitted Lien (but not the sale or other disposition of the property subject to such Lien)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Dispositions of Equity Interests in any Subsidiary prior to the time such Subsidiary becomes a wholly-owned Subsidiary, in each case pursuant to any stock appreciation rights plans, equity incentive or achievement plans or any similar plans or the exercise of warrants, options or other securities convertible into or exchangeable for the Equity Interests of such Subsidiary, so long as such rights, plans, warrants, options or other securities were not entered into or issued in connection with or in contemplation of such person becoming a Subsidiary&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">a sale, assignment or other transfer of Securitization Assets in connection with a Qualified Securitization Financing or a Qualified Receivables Factoring&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">Dispositions of Investments made in Drug Development Funds not exceeding, for any individual or series of related Dispositions, the greater of $120,000,000 and 10% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such Disposition(s)&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">any Sale and Leaseback Transaction provided that the Capital Lease Obligations arising in connection therewith would be permitted under Section 6.01&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">discounting of customer invoices in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">Disposition of any assets made to obtain the approval of any applicable antitrust authority in connection with any acquisition or other Investment not prohibited by this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.08pt">any Sale and Leaseback Transaction related to the Headquarters&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.03pt">the issuance of directors&#8217; qualifying shares and shares issued to foreign nationals as required by applicable law&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">Dispositions of property to the extent that (i) such property is exchanged for credit against the purchase price of similar replacement property that is promptly purchased or (ii) the proceeds of such Asset Sale are promptly applied to the purchase price of such replacement property (which replacement property is actually promptly purchased)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt">Dispositions that otherwise constitute a Permitted Investment or otherwise constitute a Restricted Payment permitted by Section 6.04 or a Permitted Lien.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an assignment and assumption agreement entered into by a Lender and an assignee (with the consent of any party whose consent is required by Section 9.04), and accepted by the Administrative Agent, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other form approved by the Administrative Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Attributable Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction including any period for which such lease has been extended or may, at the option of the lessor, be extended. Such present value shall be calculated using a discount rate equal to the rate of interest implicit in such transaction, determined in accordance with GAAP.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auction Manager</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.23(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auction Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the auction procedures with respect to Purchase Offers set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auto Renewal Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.06(c).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Availability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Tranche of Revolving Commitments, the period from and including the Closing Date to but excluding the earlier of the Maturity Date with respect to the Revolving Commitments of such Tranche and the date of termination of all of the Revolving Commitments of such Tranche.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time with respect to any Lender, the Revolving Commitments of such Lender then in effect minus the Revolving Credit Exposure of such Lender at such time&#59; it being understood and agreed that any Lender&#8217;s Swingline Exposure shall not be deemed to be a component of the Revolving Credit Exposure for purposes of calculating the commitment fee under Section 2.12(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Average Revolving Utilization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on the last day of each fiscal quarter, the percentage equal to a fraction the numerator of which is the average daily outstanding principal amount of all Revolving Loans and the total LC Exposure during such fiscal quarter and the denominator of which is the aggregate Revolving Commitments of all Revolving Lenders.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom,  Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Title 11 of the United States Code entitled &#8220;Bankruptcy&#8221;, as now or hereafter in effect, and any successor thereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, regulations, codes, ordinances, or binding orders, decrees, judgments, injunctions, notices or agreements issued, promulgated or entered into by any Governmental Authority, relating to Plans, Multiemployer Plans, Non-U.S. Plans and Irish Pension Schemes, including without limitation, ERISA and any other comparable law, rule or regulation relating to Non-U.S. Plans and Irish Pension Schemes.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System of the United States of America.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">with respect to a corporation, the board of directors of the corporation or any committee thereof duly authorized to act on behalf of such board&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">with respect to a partnership, the Board of Directors of the general partner of the partnership&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">with respect to a limited liability company managed by the member or members, the managing member or members or any controlling committee of managing members thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">with respect to a limited liability company managed by a manager or managers, the manager or managers and any controlling committee of managers&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">with respect to any other Person, the board or committee of such Person serving a similar function.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the final paragraph of Section 5.01.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Lux Borrower, the U.S. Borrower, each Revolving Borrower, the Lux U.S. Subsidiary Borrower and each Additional Borrower. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) Revolving Loans of the same Class, Type and currency made, converted or continued on the same date and, in the case of Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans meeting the foregoing requirements under this clause (a), as to which a single Interest Period is in effect, (b) Term Loans of the same Class and Type made on the same date and, in the case of Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans meeting the foregoing requirements under this clause (b), as to which a single Interest Period is in effect or (c) a Swingline Loan.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a request by the Applicable Borrower for a Borrowing, in substantially the form of Exhibit I hereto, in accordance with Section 2.03.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day that is not a Saturday, Sunday or other day on which commercial banks in New York City or London, United Kingdom or, if such day relates to the payment of any obligation or the performance of any covenant, duty or obligation of (x) a Borrower organized in Luxembourg or (y) a Borrower incorporated in Ireland, are authorized or required by law to remain closed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, when used in connection with a Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall also exclude any day on which banks are not open for dealings in the relevant Agreed Currency in the London </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interbank market or the principal financial center of the country of such Agreed Currency (and, if the Borrowings or LC Disbursements which are the subject of a borrowing, drawing, payment, reimbursement or rate selection are denominated in euros, the term &#8220;Business Day&#8221; shall also exclude any day on which the TARGET payment system is not open for the settlement of payments in euro).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Lease Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any Person means the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that all obligations of any person that are or would be characterized as operating lease obligations in accordance with GAAP on December 31, 2015 (whether or not such operating lease obligations were in effect on such date) shall continue to be accounted for as operating lease obligations (and not as Capital Lease Obligations) for purposes of this Agreement regardless of any change in GAAP following December 31, 2015 that would otherwise require such obligations to be recharacterized (on a prospective or retroactive basis or otherwise) as Capital Lease Obligations.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Markets Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) any Indebtedness consisting of bonds, debentures, Notes or other similar debt securities issued in (a) a public offering registered under the Securities Act or (b) a private placement to institutional investors that is resold in accordance with Rule 144A or Regulation S of the Securities Act, whether or not it includes registration rights entitling the holders of such debt securities to registration thereof with the SEC and (ii) any Indebtedness consisting of term loan facilities.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capitalized Software Expenditures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period, the aggregate of all expenditures (whether paid in cash or accrued as liabilities) by Holdings and the Restricted Subsidiaries during such period in respect of licensed or purchased software or internally developed software and software enhancements that, in conformity with GAAP, are or are required to be reflected as capitalized costs on the consolidated balance sheet of Holdings and the Restricted Subsidiaries.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateralized</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, as of any date, that the Applicable Borrower shall have deposited in the LC Collateral Account, in the name of the Administrative Agent and for the benefit of the Lenders, an amount in cash equal to 102% of the LC Exposure as of such date plus any accrued and unpaid interest thereon pursuant to such documentation and arrangements as are reasonably satisfactory to the Administrative Agent.  &#8220;Cash Collateralize&#8221; shall have the correlative meaning.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">(i) United States dollars, Canadian dollars, euro, Pounds Sterling, Yen, Swiss Francs or any national currency of any member state of the European Union, (ii) with respect to Holdings or any Restricted Subsidiary, the national currency of the jurisdiction in which such Person is organized or domiciled, and (iii) any other foreign currency held by Holdings and the Restricted Subsidiaries in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United States of America or a member state of the European Union (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United States of America or such member state), in each case maturing within eighteen months from the date of acquisition thereof&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">investments in commercial paper maturing within 270 days from the date of acquisition thereof and having, at such date of acquisition, the highest credit rating obtainable from S&#38;P or from Moody&#8217;s&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from the date of acquisition, demand deposits, bankers&#8217; acceptances with maturities not exceeding one year and overnight bank deposits, in each case with any domestic or foreign commercial bank having capital and surplus of not less than $250,000,000 in the case of U.S. banks and $250,000,000 (or the foreign currency equivalent as of the date of determination) in the case of non-U.S. banks&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">fully collateralized repurchase agreements with a term of not more than thirty (30) days for securities described in clauses (b) and (d) above and entered into with a financial institution satisfying the criteria described in clause (d) above&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">marketable short-term money market and similar liquid funds having a rating of at least P-2 or A-2 from either Moody&#8217;s or S&#38;P, respectively (or, if at any time neither Moody&#8217;s nor S&#38;P shall be rating such obligations, an equivalent rating from another nationally recognized statistical rating agency)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Investments with average maturities of 24 months or less from the date of acquisition in money market funds and similar liquid funds rated AA- (or the equivalent thereof) or better by S&#38;P or Aa3 (or the equivalent thereof) or better by Moody&#8217;s (or, if at any time neither Moody&#8217;s nor S&#38;P shall be rating such obligations, an equivalent rating from another nationally recognized statistical rating agency)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">securities issued or fully guaranteed by any state, commonwealth or territory of the United States of America or by any political subdivision (including any municipality) or taxing authority of any such state, commonwealth or territory, the securities of which state, commonwealth, territory, political subdivision or taxing authority (as the case may be) are rated at least &#8220;A&#8221; (or A-1, SP1 or other then equivalent grade) by S&#38;P or at least &#8220;A1&#8221; (or &#8220;Prime-1&#8221; or MIG-1 or other then equivalent grade) by Moody&#8217;s as of the date of acquisition and, in each case, with a maturity of not more than two years from the date of acquisition thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">investment funds investing substantially all of their assets in securities of the types described in clauses (a) through (h) above&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">in the case of any Holdings or Foreign Subsidiary, other short-term investments that are analogous to the foregoing, are of comparable credit quality and are customarily used by companies in the jurisdiction of Holdings or such Foreign Subsidiary for cash management purposes.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in currencies other than those set forth in clause (a) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such amounts are converted into any currency listed in clause (a) above as promptly as practicable and in any event within ten business days following the receipt of such amounts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any agreement to provide cash management services, including treasury, depository, overdraft, netting, foreign exchange facilities, credit or debit card, electronic funds transfer and other cash management arrangements.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Cash Management Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person (A) that is a Lender, an Agent or a Lead Arranger (or an Affiliate of a Lender, an Agent or a Lead Arranger) and any Person who was a </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender, an Agent or a Lead Arranger (or any Affiliate of a Lender, an Agent or a Lead Arranger) at the time it entered into a Cash Management Agreement, in each case, in its capacity as a party to such Cash Management Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Person is (or was, at the time it entered into a Cash Management Agreement) an Affiliate of a Lender, an Agent or a Lead Arranger (other than any such Person that is an Affiliate of Citibank, N.A.), such person shall deliver to the Administrative Agent a letter agreement pursuant to which such person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 and Section 10 of the U.S. Security Agreement as if it were a Lender or (B) that is designated in writing by Holdings to the Administrative Agent as a &#8220;Cash Management Bank&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Person is not a Lender, Agent or Lead Arranger, such Person executes and delivers to the Administrative Agent and Holdings a letter agreement in form and substance reasonably acceptable to the Administrative agent and Holdings pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 hereof and Section 10 of the U.S. Security Agreement as if it were a Lender. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England&#8217;s Bank Rate as published by the Bank of England from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, in relation to the Central Bank Rate prevailing at close of business on any RFR Business Day, the 20% trimmed arithmetic mean (calculated by the Administrative Agent) of the Central Bank Rate Spreads for the 5 most immediately preceding RFR Business Days for which the RFR is available.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate Spread</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, in relation to any RFR Business Day, the difference (expressed as a percentage rate per annum) calculated by the Administrative Agent of (x) the RFR for such RFR Business Day and (y) the Central Bank Rate prevailing at close of business on such RFR Business Day.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;controlled foreign corporation&#8221; within the meaning of Section 957 of the Code.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the Closing Date, of any of the following&#58; (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rules, guideline, requirement or directive (whether or not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements and directives thereunder, issued in connection therewith or in implementation thereof shall be deemed to be a &#8220;Change in Law&#8221; regardless of the date enacted, adopted, issued or implemented and (ii) all reports, notes, guidelines, rules, requests and directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, shall, in each case, be deemed to be a &#8220;Change in Law&#8221; regardless of the date enacted, adopted, issued or implemented.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the acquisition of beneficial ownership, directly or indirectly, by any Person or group (within the meaning of the Securities Exchange Act of 1934 and the rules of the SEC thereunder as in effect on the Closing Date), of Equity Interests representing more than 50% of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of Holdings&#59; (b) the occurrence of a change of control, or other similar provision, as defined in any agreement or instrument evidencing any Material Indebtedness triggering a default or mandatory prepayment, which default or mandatory </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">prepayment has not been waived in writing (other than Indebtedness subject to repayment on the Closing Date in connection with the Transactions)&#59; or (c) any Borrower ceasing to be either a direct or indirect wholly-owned subsidiary of Holdings.  For the avoidance of doubt, none of the Transactions shall be deemed a Change of Control so long as, after giving effect thereto, clauses (a) through (c) above are complied with.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, a transaction will not be deemed to constitute a Change of Control if (x) Holdings becomes a direct or indirect wholly-owned Subsidiary of a holding company and (y)(i) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of Holdings&#8217; issued and outstanding Equity Interests immediately prior to that transaction or (ii) immediately following that transaction no Person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, when used in reference to (a) any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are Loans of a particular Tranche&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Loans within a Tranche having different Maturity Dates, Applicable Margins, currency of denomination (except pursuant to a Class of revolving commitments allowing extensions of credit thereunder in multiple currencies), repayments or other terms shall be regarded as separate Classes of Loans and Borrowings for purposes of this Agreement, (b) any Commitment, refers to whether such Commitment is a Commitment of a particular Tranche&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Commitments within a Tranche having different Maturity Dates, Applicable Margins, currency of denomination (except pursuant to a Class of revolving commitments allowing extensions of credit thereunder in multiple currencies), repayments or other terms shall be regarded as separate Classes of Commitments for purposes of this Agreement and (c) any Lender, refers to whether such Lender is a Lender of a particular Tranche&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Lender holding Loans or Commitments within a Tranche having different Maturity Dates, Applicable Margins, currency of denomination (except pursuant to a Class of revolving commitments allowing extensions of credit thereunder in multiple currencies), repayments or other terms shall be regarded as a Lender with respect to separate Classes of Loans and&#47;or Commitments (as applicable) for purposes of this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means July 1, 2021.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the United States Internal Revenue Code of 1986, as amended from time to time (unless otherwise provided herein).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all property owned, leased or operated by a Loan Party on which Liens are purported to be granted pursuant to the Collateral Documents as security for the Secured Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Collateral shall exclude Excluded Assets.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Citibank, N.A., London Branch in its capacity as collateral agent for the Secured Parties.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the U.S. Security Agreement, each Foreign Security Document and all other agreements, instruments and documents executed in connection with this Agreement that are intended to create or evidence Liens to secure the Secured Obligations, and shall also include, without limitation, all other security agreements, pledge agreements, deeds of trust, intercreditor agreements, collateral assignments and any agreements entered into for the purposes of perfection, now, or hereafter executed by Holdings or any of its Restricted Subsidiaries and delivered to the Collateral Agent.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Lender, such Lender&#8217;s Revolving Commitment, Term Loan Commitment, Extended Revolving Commitment, Other Refinancing Commitment and Incremental Commitment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commodity Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Commodity Exchange Act (7 U.S.C. &#167; 1 et seq.), as amended from time to time, and any successor statute.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Companies Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Companies Act 2014 of Ireland.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in clause (c) of Section 5.01.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Computation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning assigned to such term in Section 2.04.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Depreciation and Amortization Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any period, the total amount of depreciation and amortization expense, including any amortization of deferred financing fees, accretion of royalty liabilities, amortization in relation to terminated Swap Obligations and amortization of intangibles, including, but not limited to, goodwill, of the Group for such period on a consolidated basis and otherwise determined in accordance with GAAP.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any Test Period, Consolidated Net Income </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, without duplication, and, other than clauses (vii) and (viii), solely to the extent deducted (and not otherwise excluded) in determining Consolidated Net Income, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">expense for Taxes paid or accrued, to the extent accounted for as Income Taxes under GAAP, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">consolidated interest expense and charges and deferred financing fees, losses on hedging obligations or other derivative instruments entered into for the purpose of hedging interest rate risk, net of gains on such hedging obligations, and costs of surety bonds in connection with financing activities,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Consolidated Depreciation and Amortization Expense, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">non-cash charges recorded in respect of purchase accounting and non-cash exchange, translation or performance losses relating to any foreign currency hedging transactions or currency fluctuations, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any other non-cash charges, expenses or losses, including, without limitation, (x) any non-cash compensation expense, non-cash translation loss and non-cash expense relating to the vesting of warrants and (y) pursuant to any management equity plan or stock plan or pursuant to Statement of Financial Accounting Standards 158 (codified under Accounting Standards Codification 715)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that accruals or reserves for potential cash items in any future period may or may not (at the election of Holdings) be added back in such period and, to the extent added back, the cash payment in respect of such accrual or reserve in a future period shall be subtracted from Consolidated EBITDA in such future period,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">expenses with respect to casualty events,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">the amount of Run-rate cost savings, synergies and operating expense reductions projected by Holdings to be realized as a result of any </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Transactions, any Permitted Acquisition, any other Investment, dispositions, divestitures, restructurings, operating improvements, cost savings initiatives and other similar initiatives projected by Holdings in good faith to result from actions taken, committed to be taken or with respect to which substantial steps have been taken or are expected in good faith to be taken, other than in the case of the Transactions, within 24 months of such transaction, initiative or event, in each case, calculated as though such cost savings, synergies and operating expense reductions had been realized on the first day of the applicable Test Period and net of the amount of actual benefits received during such period from such transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that (A) such cost savings and synergies are factually supportable in the good faith judgment of Holdings and (B) no cost savings or synergies shall be added pursuant to this clause (vii) to the extent duplicative of any expenses or charges otherwise added to Consolidated EBITDA or Consolidated Net Income, whether through a pro forma adjustment or otherwise, for such period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Synergies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (1) the aggregate amount of any adjustments under this clause (vii) permitted to be made in respect of the Transactions when calculating Consolidated EBITDA for any Test Period ending after the second anniversary of the Closing Date shall not exceed the greater of (x) $150,000,000 and (y) the amount of such adjustments made in respect of the Transactions pursuant to this clause (vii) prior to such date and (2) the aggregate amount of any adjustments made pursuant to this clause (vii) for any period shall not exceed in the aggregate 25% of Consolidated EBITDA for such period (before giving effect to any such adjustments), </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">(i) to the extent covered by insurance and actually reimbursed within 365 days of the first date of determination by Holdings that there exists reasonable evidence that such amount will in fact be reimbursed by the insurer, expenses with respect to liability or casualty or business interruption and (ii) to the extent actually reimbursed, expenses incurred to the extent covered by indemnification provisions in any agreement in connection with any acquisition permitted under this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">cash charges and legal expenses in connection with litigation to the extent not constituting an extraordinary, non-recurring or unusual loss, charge or expense in an aggregate amount for any Test Period not to exceed $5 million,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">all reserves taken during such period on account of contingent cash payments that may be required in future periods,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">&#91;reserved&#93;,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">the amount of any minority interest expense consisting of Subsidiary income attributable to minority equity interests of third parties in any non-wholly-owned Subsidiary deducted (and not added back) in such period in calculating Consolidated Net Income,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">the amount of loss or discount on sales of receivables, Securitization Assets and related assets to any Securitization Subsidiary in connection with a Qualified Securitization Financing or to any other Person in connection with a Qualified Receivables Factoring,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">restructuring costs (including in connection with any tax related restructuring), integration costs, retention, recruiting, relocation and signing or completion bonuses and expenses, stock option and other equity-based </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">compensation expenses and the amount of payments made to option holders in connection with, or as a result of, any distribution being made to shareholders, severance costs, systems establishment costs, costs relating to entry into a new market or to exiting a market, costs associated with office and facility openings, pre-openings, closings, expansions and consolidations (including but not limited to termination costs, moving costs and legal costs), new operation costs, unused warehouse space costs, new contract or corporate development costs, software and other intellectual property development costs, project start-up costs, costs relating to early termination of rights fee arrangements, consulting fees, curtailments or modifications to pension and post-retirement employee benefits and any costs attributable to the undertaking and&#47;or implementation of new initiatives, business optimization activities, cost savings initiatives, cost rationalization programs, operating expense reductions, synergies and&#47;or similar initiatives or programs (including, without limitation, in connection with the Transactions or any inventory optimization program, integration, restructuring or transition, any reconstruction, decommissioning, recommissioning or reconfiguration of fixed assets for alternative uses, any facility opening and&#47;or pre-opening, any implementation of operational and reporting systems and technology initiatives (including any expense relating to the implementation of enhanced accounting or IT functions or new system designs)), any employee ramp-up charges or any charges related to underutilized personnel (including duplicative personnel),</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">extraordinary, unusual, special, exceptional or non-recurring charges, expenses or losses (as determined by Holdings in good faith),</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">any add backs and other adjustments consistent with Regulation S-X, </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">fees, costs and expenses (including, without limitation, premium) incurred in connection with the Transactions and other transaction fees, costs, accruals and expenses (including rationalization, legal, tax and other costs and expenses) incurred in connection with any acquisition, investment, dividend, restricted payment, disposition, recapitalization, merger, consolidation or amalgamation, issuance, exchange or repayment of Indebtedness, option buyouts, refinancing, amendments or other modifications of debt instruments, early extinguishment of debt, hedging agreements or other derivative instruments (in each case whether or not such transaction was successfully completed),</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">without limiting the generality of clause (v) above, any costs or expense incurred by Holdings or a Restricted Subsidiary pursuant to any management equity plan or stock option or phantom equity plan or any other management or employee benefit plan or agreement or any stock subscription or shareholder agreement, to the extent that such cost or expenses are funded with cash proceeds contributed to the capital of Holdings or net cash proceeds of an issuance of Equity Interests of Holdings (other than Disqualified Equity Interests) solely to the extent that such net cash proceeds are excluded from the calculation set forth in Section 6.04(a)(ii)(C),</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">without limiting the generality of clause (v) above, the amount of expenses relating to payments made to option, phantom equity or profits interest holders of Holdings or any of its direct or indirect Subsidiaries or parent companies in connection with, or as a result of, any distribution being made to equity holders of such Person or its direct or indirect parent companies, which </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">payments are being made to compensate such option, phantom equity or profits interest holders as though they were equity holders at the time of, and entitled to share in, such distribution, in each case to the extent permitted under this Agreement and expenses relating to distributions made to equity holders of such Person or its direct or indirect parent companies resulting from the application of Financial Accounting Standards Codification Topic 718&#8212; Compensation &#8212; Stock Compensation (formerly Financial Accounting Standards Board Statement No. 123 (Revised 2004)), and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any net pension or other post-employment benefit costs representing amortization of unrecognized prior service costs, actuarial losses, including amortization of such amounts arising in prior periods, amortization of the unrecognized net obligation (and loss or cost) existing at the date of initial application of FASB Accounting Standards Codification Topic 715&#8212;Compensation&#8212;Retirement Benefits and any other items of a similar nature to the extent deducted (and not added back) in calculating Consolidated Net Income, </font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the extent included in Consolidated Net Income and without duplication, </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any unusual, infrequent or extraordinary income or gains, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any other non-cash income (except to the extent representing an accrual for future cash income)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent non-cash gains are deducted pursuant to this clause (2) for any previous period and not otherwise added back to Consolidated EBITDA, Consolidated EBITDA shall be increased by the amount of any cash receipts (or any netting arrangements resulting in reduced cash expenses) in respect of such non-cash gains received in subsequent periods to the extent not already included therein,</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">all calculated for Holdings and its Restricted Subsidiaries in accordance with GAAP (to the extent applicable) on a consolidated basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent included in Consolidated Net Income, (A) currency translation gains and losses shall be excluded in determining Consolidated EBITDA (including the net loss or gain resulting from swap agreements for currency exchange risk) and (B) any adjustments resulting from the application of Statement of Financial Accounting Standards 133 (codified under Accounting Standards Codification 815) shall be excluded in determining Consolidated EBITDA.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, the foregoing additions to, and subtractions from, Consolidated EBITDA shall not give effect to any items attributable to the Unrestricted Subsidiaries, other than as set forth in the last sentence of Section 1.04(a).  For the purposes of calculating Consolidated EBITDA for any Test Period, if during such Test Period or after such Test Period but prior to the applicable date of determination, Holdings or any Restricted Subsidiary shall have made any Specified Transaction, converted any Restricted Subsidiary into an Unrestricted Subsidiary, or converted any Unrestricted Subsidiary into a Restricted Subsidiary, Consolidated EBITDA shall be calculated for such Test Period after giving effect thereto on a Pro Forma Basis in accordance with Section 1.07, as if such Specified Transaction or conversion, and any related incurrence or repayment of Indebtedness, occurred on the first day of such Test Period.  If since the beginning of such Test Period any Person (that subsequently became a Restricted Subsidiary or was merged with or into Holdings or any Restricted Subsidiary since the beginning of such period but prior to the end of such Test Period) shall have made any Specified Transaction or such conversions that would have required adjustment pursuant to this definition, then the Consolidated EBITDA shall be calculated on a Pro Forma Basis in accordance with Section 1.07 for such period as if such Specified Transaction or conversion had occurred on the first day of such Test Period.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with reference to any period, the sum, without duplication, of the interest expense paid in cash of the Group calculated on a consolidated basis for such period in accordance with GAAP, including, without limitation, interest expense under Capital Lease Obligations that is treated as interest in accordance with GAAP, imputed interest with respect to Attributable Debt and net payments, if any, pursuant to interest rate Permitted Hedging Obligations, but excluding any (i) non-cash interest expense attributable to the movement in mark-to-market valuation of Permitted Hedging Obligations or other derivative  instruments pursuant to Statement of Financial Accounting Standards No. 133 (codified under Accounting Standards Codification  815), (ii) non-cash interest expense attributable to the amortization of gains or losses resulting from the termination of Permitted Hedging Obligations prior to or reasonably contemporaneously with the Closing Date, (iii) amortization of deferred financing fees, (iv) expensing of commitment, bridge or other financing fees and (v) interest expense arising out of the amortization of debt discount under Accounting Standards Codification 470-20&#59; less interest income of the Group for such period (including income pursuant to any Permitted Hedging Obligations).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with reference to any period, the net income (or loss) of the Group calculated in accordance with GAAP on a consolidated basis (without duplication) for such period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that there shall be excluded&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any income (or loss) of any Person other than Holdings or a Restricted Subsidiary, but any such income so excluded may be included in such period or any later period to the extent of any cash dividends or distributions actually paid in the relevant period to Holdings or any Restricted Subsidiary of Holdings,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">solely for the purpose of determining the amount available for Restricted Payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(a)(ii)(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and for the purpose of determining the amount of Excess Cash Flow, the income of, and any amounts referred to in clause (a) of this proviso paid to, any Subsidiary (other than a Guarantor) to the extent that, on the date of determination, the declaration or payment of cash dividends or other cash distributions by such Subsidiary of that income is not at the time permitted by applicable law or any agreement or instrument applicable to such Subsidiary, unless such restriction with respect to the payment of cash dividends or other cash distributions has been legally waived or otherwise released&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Consolidated Net Income of the referent Person will be increased by the amount of dividends or other distributions or other payments actually paid in cash (or to the extent converted into cash) or Cash Equivalents to such Person or a Restricted Subsidiary thereof in respect of such period, to the extent not already included therein,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any fees, costs and expenses (including, without limitation, any premium) directly incurred or paid during such period, or any amortization thereof for such period, in connection with (x) the Transactions, (y) any other Permitted Acquisition or other acquisition not prohibited under this Agreement, and, to the extent permitted hereunder, any other Investments  and any Dispositions, and (z) to the extent permitted hereunder, issuances or incurrence of Indebtedness, issuances of Equity Interests or refinancing transactions and modifications of instruments of Indebtedness (in each case, including any such transaction consummated prior to the Closing Date, and any such transaction undertaken but not completed) and any charges or non-recurring costs incurred during such period as a result of such transaction,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">at the option of Holdings, the effects of discontinued operations (but if such operations are classified as discontinued due to the fact that they are subject to an agreement to dispose of such operations or in contemplation of the same, or are otherwise classified as &#8220;held for sale&#8221; under GAAP, only when and to the extent such operations are </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">actually disposed of) and any net after-tax gains or losses from asset dispositions (other than in the ordinary course of business (as determined by Holdings in good faith)),</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any non-cash amounts included in Consolidated Interest Expense, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">non-cash compensation expense incurred with any issuance of equity interests to an employee of such Person or any Restricted Subsidiary, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any income (loss) for such period attributable to the early extinguishment of Indebtedness, together with any related provision for Taxes on any such income,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any gain or loss realized as a result of the cumulative effect of a change in accounting principles,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any gains or losses resulting from any reappraisal, revaluation or write-up or write-down of assets or liabilities (including any gains and losses attributable to movement in the mark-to-market valuation of any convertible indebtedness, any related call options or warrant transactions and any other derivatives and Deferred Acquisition Consideration), </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any non-cash charges recorded in respect of intangible assets, including goodwill, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the effect of any purchase allocation accounting adjustments in respect of any acquisition consummated prior to the Closing Date, the Transactions and any acquisition permitted under this Agreement, and the amortization or write-off of any amounts in respect thereof, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any unusual, infrequent or extraordinary loss or charge and any restructuring charges or reserves, including write-downs and write-offs, any costs incurred in connection with the Transactions, Permitted Investments and Dispositions, costs related to the closure, consolidation and integration of facilities, information technology infrastructure and legal entities, and severance and retention bonuses, any charges to establish accruals and reserves or to make payments associated with the reassessment or realignment of the business and operations of Holdings and its Subsidiaries (including, without limitation, the sale or closing of facilities, severance, stay bonuses and curtailments or modifications to pension and post-retirement employee benefit plans, asset impairments or asset disposals (including leased facilities), charges for purchase and lease commitments, start-up costs for new facilities, reserves for excess, obsolete or unbalanced inventories, relocation costs which are not otherwise capitalized, and any related promotional costs of exiting products or product lines, start up, transition, integration and other restructuring and business optimization costs, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">any amortization of debt discount under Accounting Standards Codification 470-20,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any non-cash foreign translation gains and losses including, without limitation, in respect of Swap Agreements,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">accruals and reserves (including contingent liabilities) that are established or adjusted within twelve months after the Closing Date that are so required to be established as a result of the Transactions or other Permitted Acquisitions in accordance with GAAP, or changes as a result of adoption of modification of accounting policies, and</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any deferred tax expense associated with tax deductions or net operating losses arising as a result of the Transactions, or the release of any valuation allowance related to such items.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Total Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means at any time the sum, without duplication, of the aggregate Indebtedness of Holdings and its Restricted Subsidiaries consisting of obligations for borrowed money, Capital Lease Obligations and purchase money debt obligations and obligations evidenced by bonds, debentures, notes or similar instruments (other than Indebtedness with respect to Cash Management Agreements, Swap Agreements and intercompany Indebtedness), in each case that is of a type that would be reflected on a consolidated balance sheet of Holdings prepared as of such time in accordance with GAAP.  For the avoidance of doubt and notwithstanding anything to the contrary contained above, Consolidated Total Indebtedness excludes (x) all Indebtedness incurred under a Qualified Securitization Financing or a Qualified Receivables Factoring and (y) letters of credit other than to the extent drawn and not reimbursed after two (2) Business Days.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as at any date of determination, the excess of Current Assets over Current Liabilities.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.  &#8220;Controlling&#8221; and &#8220;Controlled&#8221; have meanings correlative thereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlled Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 3.15.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Convertible Debt Security</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means debt securities or other Indebtedness, the terms of which provide for conversion into, or exchange for, Equity Interests (other than Disqualified Equity Interests) of Holdings, cash in lieu thereof or a combination of Equity Interests and cash in lieu thereof.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; mean each of the United States (including any state or subdivision thereof), Luxembourg, Ireland and any other jurisdiction designated by Holdings and approved by the Administrative Agent, acting reasonably and in good faith.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement Refinancing Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any (a) Permitted Pari Passu Secured Refinancing Debt, (b) Permitted Junior Secured Refinancing Debt, (c) Permitted Unsecured Refinancing Debt or (d) Indebtedness incurred pursuant to a Refinancing Amendment, in each case, issued, incurred or otherwise obtained (including by means of the extension or renewal of existing Indebtedness) in exchange for, or to extend, renew, replace or refinance, in whole or part, existing Loans and Commitments (including any successive Credit Agreement Refinancing Indebtedness) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinanced Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such exchanging, extending, renewing, replacing or refinancing Indebtedness (including, if such Indebtedness includes any Other Refinancing Revolving Commitments, the unused portion of such Other Refinancing Revolving Commitments) is in an original aggregate principal amount not greater than the aggregate principal amount of the Refinanced Debt (and, in the case of Refinanced Debt consisting, in whole or in part, of unused Revolving Commitments, Incremental Revolving Commitments, Extended Revolving Commitments or Other Refinancing Revolving Commitments, the amount thereof) plus unpaid accrued interest and premium (including tender premium) thereon, any committed and undrawn amounts associated with, upfront fees and original issue discount (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OID</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) on, and underwriting discounts, fees, commissions and expenses incurred in connection with, such exchanging, extending, renewing, replacing or refinancing Indebtedness, (ii) such Indebtedness has a final maturity date equal to or later than, and, except in the case of Other Refinancing Revolving Commitments, a Weighted Average Life to Maturity </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">equal to or greater than, the Refinanced Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (ii) shall not apply to (x) Permitted Pari Passu Secured Refinancing Debt in the form of Term A Facilities and (y) customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (ii)), (iii) such Indebtedness shall contain covenants and events of default that are either (x) no more restrictive (taken as a whole) to Holdings and its Restricted Subsidiaries than those included in this Agreement in all material respects as determined by Holdings in good faith or (y) are on market terms at the time of issuance, as determined by Holdings in good faith, which terms shall also be implemented for the benefit of the Initial Term Loans and the Revolving Loans&#59; provided that Credit Agreement Refinancing Indebtedness in the form of Term A Facilities or revolving facilities may contain one or more financial maintenance covenants (and related events of default) irrespective of whether or not such covenants (and related events of default) are included in this Agreement for the benefit of the Term Loans (but such covenants shall be included for the benefit of the other Revolving Commitments), (iv) such Credit Agreement Refinancing Indebtedness may participate on a pro rata basis or a less than pro rata basis (but not a greater than pro rata basis) than the Initial Term Loans in mandatory prepayments under this Agreement and (v) such Refinanced Debt shall be repaid, defeased or satisfied and discharged, and all accrued interest, fees and premiums (if any) in connection therewith shall be paid, on the date such Credit Agreement Refinancing Indebtedness is issued, incurred or obtained.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Borrowing, the issuance, extension or increase in amount of a Letter of Credit, an LC Disbursement or any of the foregoing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender at any time, the sum of (a) such Lender&#8217;s Revolving Credit Exposure at such time, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) an amount equal to the aggregate principal amount of its Term Loans outstanding at such time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cure Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 7.02(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cure Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 7.02(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Current Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the consolidated current assets (other than cash and Cash Equivalents, the current portion of current and deferred Taxes, permitted loans made to third parties, assets held for sale, available for sale Investments, pension assets, deferred bank and financing fees and derivative financial instruments including any Swap Agreements) of Holdings and its Restricted Subsidiaries.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Current Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the consolidated current liabilities of Holdings and its Restricted Subsidiaries at such time, but excluding, without duplication, (a) the current portion of any long-term Indebtedness or any Swap Agreements, (b) outstanding revolving loans and undrawn letters of credit, (c) the current portion of interest expense, (d) the current portion of any Capital Lease Obligations, (e) the current portion of current and deferred Taxes, (f) liabilities in respect of unpaid earn-outs, (g) the current portion of any other long-term liabilities, (h) accruals relating to restructuring reserves, (i) liabilities in respect of funds of third parties on deposit with Holdings and its Restricted Subsidiaries, (j) deferred revenue arising from cash receipts and (k) advances and deposits from customers accounted for as unearned income.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple RFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Interest Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), an interest rate per annum equal to (x) SONIA for the day that is 5 RFR Business Days prior to (i) if such RFR Interest Day is an RFR Business Day, such RFR Interest Day or (ii) if such RFR Interest Day is not an RFR Business Day, the RFR Business Day immediately preceding such RFR Interest Day (such RFR Business Day determined pursuant to each of subclauses (i) and (ii), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Lookback Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (y) if SONIA is not available for the RFR Lookback Day determined pursuant to clause (x) above, the Daily Simple RFR for such RFR Lookback Day shall be the percentage </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">rate per annum which is the aggregate of (I) the Central Bank Rate for such RFR Lookback Day and (II) the applicable Central Bank Rate Adjustment or (z) if clause (y) applies but the Central Bank Rate for the applicable RFR Lookback Day is not available, the Daily Simple RFR for such RFR Lookback Day shall be the percentage rate per annum which is the aggregate of (I) the most recent Central Bank Rate for an RFR Business Day which is no more than five RFR Business Days before that RFR Lookback Day and (II) the applicable Central Bank Rate Adjustment&#59; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, with respect to Revolving Loans, such rate shall not be less than zero</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debtor Relief Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bankruptcy Code, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, examinership or similar debtor relief laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Declined Prepayment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.11(e).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Declining Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.11(e).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any event or condition which constitutes an Event of Default or which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, subject to Section 2.26, any Lender that (a) has failed within two (2) Business Days of the date required to be funded or paid, to (i) fund all or any portion of its Loans, (ii) fund all or any portion of its participations in Letters of Credit or Swingline Loans or (iii) pay over to any Secured Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent and the Applicable Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) has notified the Applicable Borrower and the Administrative Agent in writing that it does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has failed, within three (3) Business Days after written request by the Administrative Agent or the Applicable Borrower, to confirm in writing to the Administrative Agent and the Applicable Borrower that it will comply with its prospective funding obligations hereunder (provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by the Administrative Agent and the Applicable Borrower), or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any Debtor Relief Law, (ii) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity, or (iii) become the subject of a Bail-In Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.  Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (d) above shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender (subject to Section 2.26) upon delivery of written notice of such determination to the Applicable Borrower and each Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Deferred Acquisition Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any purchase price adjustments, contingent or other deferred payment payments of a similar nature (including any non-compete payments and consulting payments) made in connection with any Permitted Acquisition or other acquisition permitted under this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Non-Cash Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the fair market value of non-cash consideration received by Holdings or a Restricted Subsidiary in connection with a Disposition pursuant to Section 6.03(a) that is designated as Designated Non-Cash Consideration pursuant to a certificate of Holdings, setting forth the basis of such valuation (which amount will be reduced by the fair market value of the portion of the non-cash consideration converted to cash or Cash Equivalents within one hundred eighty (180) days following the consummation of the applicable Disposition&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such consideration once converted to cash and&#47;or Cash Equivalents, shall be deemed to constitute Net Proceeds received on the date such applicable Designated Non-Cash Consideration was converted to cash and&#47;or Cash Equivalents and shall be subject to Section 2.11(c)(i)).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any series of Alternative Incremental Facility Indebtedness, Permitted Pari Passu Secured Refinancing Debt, Permitted Junior Secured Refinancing Debt or Ratio Debt, the trustee, administrative agent, collateral agent, security agent or similar agent hereunder or under the agreement pursuant to which such Indebtedness is issued, incurred or otherwise obtained, as the case may be, and each of their successors in such capacities.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a sale, transfer, lease, disposition or exclusive license, including any &#8220;Disposition&#8221; by means of a merger, consolidation or similar transaction. &#8220;Dispose&#8221; and &#8220;Disposed&#8221; as to any assets subject to a Disposition shall have a corollary meaning.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disposition Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means for any Disposition, the aggregate fair market value of any assets sold, transferred, leased, licensed or otherwise disposed of.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disqualified Equity Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any Equity Interest in such Person that by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable, either mandatorily or at the option of the holder thereof), or upon the happening of any event or condition&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">matures or is mandatorily redeemable (other than solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity Interests and cash in lieu of fractional shares of such Equity Interests), whether pursuant to a sinking fund obligation or otherwise&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">is convertible or exchangeable at the option of the holder thereof for Indebtedness or Equity Interests (other than solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity Interests and cash in lieu of fractional shares of such Equity Interests)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">is or may be redeemable (other than solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity Interests and cash in lieu of fractional shares of such Equity Interests) or is or may be required to be repurchased by such Person or any of its Affiliates (other than, at the option of such Person, solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interests and cash in lieu of fractional shares of such Equity Interests), in whole or in part, at the option of the holder thereof&#59;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in each case, on or prior to the date that occurs 91 days after the Latest Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that any Equity Interests that would not constitute Disqualified Equity Interest but for provisions thereof giving holders thereof the right to require such Person to purchase or redeem such Equity Interests upon the occurrence of an &#8220;asset sale,&#8221; &#8220;fundamental change&#8221; or &#8220;change of control&#8221; occurring prior to the date that is 91 days after the Latest Maturity Date shall not constitute Disqualified Equity Interest if the &#8220;asset sale,&#8221; &#8220;fundamental change&#8221; or &#8220;change of control&#8221; provisions applicable to such Equity Interests are not more favorable to the holders of such Equity Interests than Section 6.03 and the provisions relating to a Change of Control contained herein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that if such Equity Interests is issued to any plan for the benefit of directors, managers, employees or consultants of Holdings or its Subsidiaries or by any such plan to such directors, managers, employees or consultants, such Equity Interests shall not constitute Disqualified Equity Interest solely because it may be required to be repurchased by Holdings or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations or as a result of such employee&#8217;s, director&#8217;s, officer&#8217;s, management member&#8217;s or consultant&#8217;s termination, death or disability.</font></div><div style="margin-bottom:10pt;padding-right:3.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The amount of any Disqualified Equity Interest that does not have a fixed redemption, repayment or repurchase price will be calculated in accordance with the terms of such Disqualified Equity Interest as if such Disqualified Equity Interest were redeemed, repaid or repurchased by the issuer thereof on any date on which the amount of such Disqualified Equity Interest is to be determined hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that if such Disqualified Equity Interest could not be required to be repurchased by the issuer thereof at the time of such determination, the repurchase price will be the book value of such Disqualified Equity Interest as reflected in the most recent financial statements of such Person.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disqualified Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) certain banks, financial institutions and other institutional lenders that have been specified by Holdings in writing to Citi prior to March 18, 2021, (b) any of Holdings, the Target&#8217;s or their respective Subsidiaries&#8217; competitors that have been specified to (i) the Lead Arrangers by Holdings in writing before the Closing Date or (ii) to the Administrative Agent by Holdings in writing after the Closing Date at any time and from time to time and (c) in the case of each of clauses (a) and (b), any of their respective affiliates (other than any bona fide debt funds) that are either (x) identified in writing to the Lead Arrangers or, after the Closing Date, the Administrative Agent by Holdings from time to time or (y) clearly identifiable as affiliates of such persons on the basis of such affiliate&#8217;s name&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing provisions shall not apply retroactively to disqualify any person if such person shall have become a Lender or participant prior to such person&#8217;s designation as a Disqualified Lender, but shall disqualify such person from taking any further assignment, transfer, allocation or participation after such designation.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any currency at any date means (i) the amount of such currency if such currency is Dollars or (ii) the equivalent in such currency of Dollars if such currency is a Foreign Currency, calculated on the basis of the Exchange Rate for such currency, on or as of the most recent Computation Date provided for in Section 2.04.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in any Alternate Currency, the Equivalent Amount thereof in Dollars as determined by the Administrative Agent or relevant Issuing Bank, as applicable, at such time on the basis of the spot rate (determined in respect of the most recent Computation Date or other applicable date of determination) for the purchase of Dollars with such Alternate Currency.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; refers to lawful money of the United States of America.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Subsidiary organized under the laws of the United States, any state thereof or the District of Columbia.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Drug Development Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a fund, the primary business purpose of which is to invest in the development of pharmaceutical products or investigational medicinal products or devices, in which Holdings or any of its Restricted Subsidiaries owns a minority of the Equity Interests.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ECF Payment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.11(c)(iii). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ECP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an &#8220;eligible contract participant&#8221; as defined in the Commodity Exchange Act and the regulations thereunder.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the member states of the European Union, Iceland, Liechtenstein and Norway.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Yield</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Loans of any Class, the effective yield on such Loans as determined by Holdings in good faith, taking into account the applicable interest rate margins, any interest rate floors or similar devices, all recurring fees and other fees, including upfront or similar fees or original issue discount (amortized over the shorter of (x) the Weighted Average Life to Maturity of such Loans and (y) the four years following the date of incurrence thereof) payable generally to Lenders making such Loans, but excluding (i) any arrangement, structuring, commitment, ticking, underwriting or similar fees or other fees payable in connection therewith that are not generally shared with the Lenders thereunder and (ii) any customary consent fees paid generally to consenting Lenders.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an &#8220;accredited investor&#8221; (as defined in regulation D of the Securities Act) that (w) is not a natural person, (x) is not a Defaulting Lender, in each case at the time of the respective assignment or participation to such Person, (y) has provided any documentation required pursuant to the provisions of Section 2.17 and (z) is not a Disqualified Lender. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Enforcement Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Schedule 1.01A.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all applicable laws, rules, regulations, codes, ordinances, or binding orders, decrees, judgments, injunctions, notices or agreements issued, promulgated or entered into by any Governmental Authority, relating to pollution or protection of the environment, including management or reclamation of natural resources, and the management, Release or threatened Release of any Hazardous Material or to occupational health and safety matters, as such occupational health and safety matters relate to exposure or handling of Hazardous Materials.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), directly </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or indirectly resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage or treatment of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the Release or threatened Release of any Hazardous Materials into the environment or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means shares of capital stock, partnership interests, membership interests in a limited liability company, shares (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">parts sociales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) in a Luxembourg private limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that &#8220;Equity Interests&#8221; shall not include Convertible Debt Securities. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Equivalent Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any currency with respect to any amount of Dollars at any date shall mean the equivalent in such currency of such amount of Dollars, calculated on the basis of the Exchange Rate for such other currency at 11&#58;00 a.m., London time, on the date on or as of which such amount is to be determined.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any trade or business (whether or not incorporated) that, together with Holdings, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any &#8220;reportable event&#8221;, as defined in Section 4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30-day notice period is waived)&#59; (b) failure to satisfy the minimum funding standard under Section 412 of the Code or Section 302 of ERISA, whether or not waived&#59; (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan&#59; (d) the incurrence by Holdings or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan other than any PBGC premiums due but not delinquent under Section 4007 of ERISA&#59; (e) a determination that any Plan is, or is reasonably expected to be, considered an at-risk plan within the meaning of Section 430 of the Code or Section 303 of ERISA&#59; (f) the receipt by Holdings or any ERISA Affiliate from the PBGC or a plan administrator of any written notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan&#59; (g) the incurrence by Holdings or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal of Holdings or any of its ERISA Affiliates from any Multiemployer Plan&#59; (h) the receipt by Holdings or any ERISA Affiliate of any notice that a Multiemployer Plan is, or is expected to be insolvent within the meaning of Title IV of ERISA&#59; or (i) the receipt by Holdings or any ERISA Affiliate of any notice that a Multiemployer Plan is in endangered or critical status under Section 432 of the Code or Section 305 of ERISA&#59; (j) the occurrence of any event which triggers the full or partial wind up of any occupational pension scheme (within the meaning of section 2 of the Irish Pensions Act 1990 (as amended) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pensions Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)) sponsored by Holdings or its Subsidiaries (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Pension Scheme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; (k) the failure by an Irish Pension Scheme to meet the funding standard prescribed by Part IV of the Pensions Act as at a date in relation to which the trustees of the Irish Pension Scheme are required to cause an actuarial funding certificate to be prepared in accordance with the Pensions Act&#59; (l) where any funding proposal (within the meaning of section 49 of the Pensions Act) which has been put in place to address a deficit within an Irish Pension Scheme goes off track (within the meaning of the Irish Pensions Authority&#8217;s prescribed guidance under section 49 of the Pensions Act, &#8220;the Irish Pensions Authority&#8221; being the body established under Part II of the Pensions Act)&#59; (m) where a prosecution for an offence is brought under section 3 of the Pensions Act against the sponsoring employer or trustees concerning an Irish Pension Scheme or where the Irish Pensions </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Authority brings proceedings before the Irish High Court concerning an Irish Pension Scheme under Part IX of the Pensions Act&#59; (n) where the Irish Pensions Authority commences an investigation of or appoints an authorised officer over an Irish Pension Scheme in accordance with its powers under Part II of the Pensions Act, or where the Irish Pensions Authority issues to the trustees of an Irish Pension Scheme an advisory notice (within the meaning of section 26M of the Pensions Act) or a notice to trustees to provide an external report (within the meaning of section 26N of the Pensions Act)&#59; (o) where the Irish Financial Services and Pensions Ombudsman (being the person appointed as the &#8220;Ombudsman&#8221; under section 8(1)(a) of the Financial Services and Pensions Ombudsman Act 2017 (as amended)) either makes a determination against or brings enforcement proceedings against the sponsoring employer or the trustees concerning an Irish Pension Scheme&#59; (p) where any arbitration proceedings or proceedings before the Irish High Court are initiated relating to a dispute between the sponsoring employer and&#47;or the trustees and&#47;or members (whether potential or actual) and&#47;or beneficiaries (whether potential or actual) of an Irish Pension Scheme&#59; or (q) the failure by Holdings or its Subsidiaries to remit contributions to an Irish Pension Scheme within the prescribed period set out in section 58A of the Pensions Act or failure by Holdings or its Subsidiaries to pay any other contributions to an Irish Pension Scheme which may be required under the terms of the Irish Pensions Scheme within a reasonable period after the due date for payment of such contributions.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 8.02(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Deficiency Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 8.02(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Impacted Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 8.02(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Return Deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 8.02(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Subrogation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 8.02(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the European Union.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any Interest Period when used in reference to any Loan or Borrowing denominated in euros, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) the rate of interest (rounded upwards, if necessary, to the nearest 1&#47;100th) appearing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">on the applicable Bloomberg screen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or on any successor or substitute page of such service, or any successor to such service as determined by Administrative Agent) (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR Screen Rate</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as the Euro interbank offered rate for deposits in Euros for a term comparable to such Interest Period, at approximately 11&#58;00 a.m. (Brussels time) on the date which is two Business Days prior to the commencement of such Interest Period (but if more than one rate is specified on such page, the rate will be an arithmetic average of all such rates) and (b) if such rate is not available at such time for any reason, then the &#8220;EURIBOR Rate&#8221; for such Interest Period shall be the interest rate </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reasonably determined by the Administrative Agent in good faith to be the rate </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">per annum</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at which deposits in euros for delivery on the first day of such Interest Period in immediately available funds in the approximate amount of the Eurocurrency Rate Loan being made, continued or converted by the Administrative Agent and with a term equivalent to such Interest Period would be offered to the Administrative Agent by major banks in the London or other offshore interbank market for Euros at their request at approximately 11&#58;00 a.m. (Brussels time) two Business Days prior to the commencement of such Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, to the extent that an interest rate is not ascertainable pursuant to the foregoing </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provisions of this definition, &#8220;EURIBOR Rate&#8221; shall be the interest rate per annum equal to the Interpolated Screen Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR Screen Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;EURIBOR Rate&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and&#47;or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EUR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the single currency of the Participating Member States.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurocurrency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; when used in reference to a currency, means an Agreed Currency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> (other than Dollars)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and when used in reference to any Loan or Borrowing, means that such Loan, or the Loans comprising such Borrowing, bears interest at a rate determined by reference to the Eurocurrency Rate (other than any ABR Loan or ABR Borrowing).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurocurrency Payment Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of the Administrative Agent means, for each Foreign Currency, the office, branch, affiliate or correspondent bank of the Administrative Agent for such currency as specified from time to time by the Administrative Agent to Holdings and each Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurocurrency Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> (a) in the case of Loans denominated in an Agreed Currency other than euros and Pounds Sterling, the Adjusted LIBO Rate or (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the case of Loans denominated in euros, the Adjusted EURIBOR Rate.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 7.01.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excess Cash Flow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period, an amount equal to the excess of&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">the sum, without duplication, of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.57pt">Consolidated Net Income of the Group for such period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">an amount equal to the amount of all non-cash charges (including depreciation and amortization) to the extent deducted in arriving at such Consolidated Net Income, but excluding any such non-cash charges representing an accrual or reserve for potential cash items in any future period and excluding amortization of a prepaid cash item that was paid in a prior period&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.03pt">decreases in Consolidated Working Capital for such period (measured as the decrease, if any, of Consolidated Working Capital at the beginning of such Excess Cash Flow Period compared to Consolidated Working Capital at the end of such Excess Cash Flow Period)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such decreases arising from acquisitions or dispositions by Holdings and its Restricted Subsidiaries completed during such period and the effect of reclassification during such period of current assets to long-term assets and current liabilities to long-term liabilities shall be excluded&#59; over</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">the sum, without duplication, of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.57pt">an amount equal to the amount of all non-cash credits included in arriving at such Consolidated Net Income (but excluding any non-cash credit to the extent representing the reversal of an accrual or reserve described in clause (a)(ii) above) and cash charges, expenses and losses excluded by virtue of clauses (a) through (p) of the definition of &#8220;Consolidated Net Income&#59;&#8221;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">without duplication of amounts deducted pursuant to this clause (ii) in prior fiscal years, the aggregate amount of all principal payments of Indebtedness of </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Holdings and its Restricted Subsidiaries (including (A) the principal component of payments in respect of Capital Lease Obligations and (B) the amount of any scheduled repayment of Term Loans pursuant to Section 2.10 and mandatory prepayment of Term Loans pursuant to Section 2.11 to the extent required due to a Disposition or casualty event that resulted in an increase to such Consolidated Net Income and not in excess of the amount of such increase, but excluding (W) all other prepayments of Term Loans (other than prepayments referred to in clause (B) above)), (X) all prepayments of Revolving Loans and Swingline Loans, except to the extent there is an equivalent permanent reduction in commitments thereunder, (Y) all prepayments in respect of any other revolving credit facility, except to the extent there is an equivalent permanent reduction in commitments thereunder and (Z) payments of any Subordinated Indebtedness (except to the extent permitted to be paid pursuant to Section 6.04) made during such period and, at the election of Holdings, made after such period but prior to the date of the applicable Excess Cash Flow payment, in each case of clauses (A) and (B) above, except to the extent financed with the proceeds of other long term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness))&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.03pt">an amount equal to the aggregate net non-cash gain on dispositions by Holdings and its Restricted Subsidiaries during such period (other than dispositions in the ordinary course of business) to the extent included in arriving at such Consolidated Net Income&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.57pt">increases in Consolidated Working Capital for such period (measured as the increase, if any, of Consolidated Working Capital at the beginning of such Excess Cash Flow Period compared to Consolidated Working Capital at the end of such Excess Cash Flow Period)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (x) any such increases arising from acquisitions or dispositions by Holdings and its Restricted Subsidiaries completed during such period and the effect of reclassification during such period of current assets to long-term assets and current liabilities to long-term liabilities shall be excluded&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">cash payments by Holdings and its Restricted Subsidiaries during such period in respect of long-term liabilities of Holdings and its Restricted Subsidiaries (other than Indebtedness) to the extent such payments are not expensed during such period or are not deducted in calculating Consolidated Net Income, except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.57pt">without duplication of amounts deducted under Sections 2.11(c)(iii)(b)(3), (4) and (5), the aggregate amount of expenditures actually made by Holdings and its Restricted Subsidiaries from internally generated cash flow of Holdings and its Restricted Subsidiaries in cash during such period (including expenditures for the payment of financing fees) to the extent that such expenditures are not expensed during such period or are not deducted (or were excluded) in calculating Consolidated Net Income&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the aggregate amount of any premium, make-whole or penalty payments actually paid in cash by Holdings and its Restricted Subsidiaries during such period that are made in connection with any prepayment of Indebtedness to the extent such payments are not expensed during such period or are not deducted in calculating Consolidated Net Income&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.03pt">the amount of cash Taxes paid or payable in respect of the period which have been accrued at the end of the period under GAAP, together with any increase in reserves which have been set aside (without duplication) in such period, to the extent they </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">exceed the amount of tax expense deducted in determining Consolidated Net Income for such period&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.57pt">cash expenditures in respect of Swap Agreements during such fiscal year to the extent not deducted in arriving at such Consolidated Net Income&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">the amount of Restricted Payments pursuant to clauses (i), (iv), (v), (vi), (xiv), (xviii), (xxii) and (xxvii) of Section 6.04(b) paid in cash during such period, in each case, to the extent such Restricted Payments were financed with internally generated cash flow of Holdings and its Restricted Subsidiaries.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary herein, for purposes of calculating &#8220;Excess Cash Flow&#8221;, Consolidated Net Income shall not be calculated on a Pro Forma Basis and for the avoidance of doubt, the Consolidated Net Income of a Person acquired in any Permitted Acquisition or other acquisition during an Excess Cash Flow Period shall be included in such calculation for such Excess Cash Flow Period only from and after the date of the consummation of such Permitted Acquisition or similar acquisition.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excess Cash Flow Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each fiscal year of Holdings commencing with the fiscal year ended December 31, 2022.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any day, with respect to any Foreign Currency, the rate at which such Foreign Currency may be exchanged into Dollars, as set forth at approximately 11&#58;00 a.m., Local Time, on such date on the applicable Bloomberg screen page for such Foreign Currency.  In the event that such rate does not appear on any Bloomberg screen page, the Exchange Rate with respect to such Foreign Currency shall be determined by reference to such other publicly available service for displaying exchange rates as may be reasonably selected by the Administrative Agent or, in the event no such service is selected, such Exchange Rate shall instead be calculated on the basis of the arithmetical mean of the buy and sell spot rates of exchange of the Administrative Agent for such Foreign Currency on the London market at 11&#58;00 a.m., Local Time, on such date for the purchase of Dollars with such Foreign Currency, for delivery two (2) Business Days later&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent, after consultation with Holdings, may use any reasonable method it deems appropriate to determine such rate, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) accounts used exclusively for payroll, (ii) accounts used exclusively for payroll taxes and&#47;or withheld income taxes, (iii) accounts used exclusively for employee wage and benefit payments, (iv) escrow accounts and trust accounts, in each case entered into in the ordinary course of business and consistent with prudent business practice conduct where the applicable Loan Party holds the funds exclusively for the benefit of one or more unaffiliated third parties, (v) accounts exclusively used to secure letters of credit, bank guarantees, obligations under Cash Management Agreements and obligations under Swap Agreements, in each case, to the extent constituting Permitted Liens and (vi) accounts exclusively used to hold deposits from customers that are required pursuant to agreements with such customers to be held in a segregated account that, pursuant to such agreements, is not permitted to be subject to a Lien securing the Obligations.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) any fee-owned real property and any leasehold interests in real property (other than the Headquarters)&#59; (ii) motor vehicles and other assets subject to certificates of title&#59; (iii) pledges and security interests prohibited by applicable law, rule or regulation (including any requirement to obtain the consent of any governmental authority or third party) after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or similar provisions under applicable law and other than proceeds and receivables thereof </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the assignment of which is expressly deemed effective under the Uniform Commercial Code or other applicable law notwithstanding such prohibition (iv) Margin Stock and Equity Interests in any Person other than wholly-owned Subsidiaries, to the extent a pledge of such Equity Interests is prohibited by the Organizational Documents, or agreements with other equity holders, of such equity&#59; (v) voting Equity Interests in any Restricted Subsidiary of any U.S. Corporate Subsidiary that is a CFC or FSHCO to the extent such Equity Interest exceeds 65% of the outstanding voting Equity Interests of such CFC or FSHCO&#59; (vi) assets to the extent a security interest in such assets could reasonably result in a material adverse Tax consequence to Holdings or any of its Restricted Subsidiaries (including as a result of the operation of Section 956 of the Code or any similar law or regulation in any applicable jurisdiction) as reasonably determined by the Borrowers in consultation with the Administrative Agent&#59; (vii) any lease, license or other agreement and any property subject to a permitted purchase money security interest or similar permitted arrangement or Lien permitted by clauses (4), (5), (7) (solely in respect of Liens referenced in clauses (4), (5) and (11) of the definition of &#8220;Permitted Liens&#8221;), (9) (with respect to cash collateral or deposits), (11), (16), (19), (22) (with respect to cash collateral or deposits  with a value not in excess of $50,000,000), (27) and (34) of the definition of &#8220;Permitted Liens&#8221; to the extent that a grant of a security interest therein would violate or invalidate such lease, license, contract, property right or agreement or purchase money arrangement or the documents governing such Permitted Lien or create a right of termination in favor of any other party thereto (other than a Loan Party), in each case (other than with respect to property subject to such purchase money interests or similar arrangements or Lien permitted by clauses (4), (5), (7) (solely in respect of Liens referenced in clauses (4), (5) and (11) of the definition of &#8220;Permitted Liens&#8221;) or (11) of the definition of &#8220;Permitted Liens&#8221;), after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or similar provisions under applicable law other than proceeds and receivables thereof and only so long as the applicable provision giving rise to such violation or invalidity or such right of termination was not incurred in anticipation of this Agreement&#59; (viii) those assets as to which the Administrative Agent and the Borrowers reasonably agree that the cost (including, without limitation, costs of notarization, taxes, stamp duties, registration or other applicable fees), consequences or burden of obtaining such a security interest or perfection thereof are excessive in relation to the benefit to the Lenders of the security to be afforded thereby&#59; (ix) any of the capital stock of Restricted Subsidiaries not owned directly by a Loan Party&#59; (x) any governmental licenses or state or local franchises, charters and authorizations, to the extent security interests in such licenses, franchises, charters or authorizations are prohibited or restricted thereby after giving effect to the applicable anti-assignment provisions of the UCC or similar provisions under applicable law, and other than proceeds and receivables thereof, the assignment of which is expressly deemed effective under the Uniform Commercial Code or other applicable law notwithstanding such prohibition (xi) any assets to the extent expressly excluded pursuant to the Agreed Guarantee and Security Principles&#59; (xii) any &#8220;intent-to-use&#8221; applications for trademarks or service marks filed in the United States Patent and Trademark Office (&#8220;PTO&#8221;), or any successor office thereto or any successor office thereto, prior to the filing and acceptance of a &#8220;Statement of Use&#8221; or &#8220;Amendment to Allege Use&#8221; with respect thereto, only to the extent, if any, that, and solely during the period, if any, in which, the grant of a security interest therein would impair the validity or enforceability of such intent-to-use application or any registration that issues from such intent-to-use application under applicable federal Law&#59; (xiii) any Excluded Accounts&#59; (xiv) letter-of-credit rights (except to the extent a security interest therein can be perfected by the filing of UCC financing statements or similar filings under applicable law) (it being understood that no actions shall be required to perfect a security interest in letter of credit rights, other than the filing of a Uniform Commercial Code financing statement or applicable filings under applicable law)&#59; (xv) any commercial tort claim with a value not in excess of $10,000,000&#59; (xvi) &#91;reserved&#93;&#59; (xvii) &#91;reserved&#93;&#59; (xviii) Equity Interests in Unrestricted Subsidiaries&#59; and (xiv) Equity Interests in Securitization Subsidiaries, to the extent a pledge of such Equity Interests is prohibited by the applicable Qualified Securitization Financing and Securitization Assets sold or pledged pursuant to a Qualified Securitization Financing or a Qualified Receivables Factoring. In addition notwithstanding anything to the contrary herein or in any Loan Documents, the following assets shall not be required to be subject to a fixed charge in Ireland&#58; (a)  all plant and equipment, in </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">each case, located in Ireland and (b) customer contracts or other agreements with third parties (including, without limitation, distribution agreements, license agreements or similar agreements)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, for the avoidance of doubt, the Headquarters shall be subject to a fixed charge in Ireland. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any Foreign Subsidiary of any U.S. Corporate Subsidiary and, in the case of any such Foreign Subsidiary that is a CFC, any Subsidiary of such CFC&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (a) shall not apply at any time after the Closing Date to any entity that is a Restricted Subsidiary of Holdings on the Closing Date unless this clause (a) applied to such entity on the Closing Date, (b) any Domestic Subsidiary of any U.S. Corporate Subsidiary that has no material assets other than equity interests and&#47;or indebtedness of one or more (1) Foreign Subsidiaries of any U.S. Corporate Subsidiary that are excluded under clause (a) or (2) entities described in clause (b)(1) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FSHCO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (c) any Subsidiary that is prohibited or restricted by applicable law, rule or regulation or by any contractual obligation existing on the Closing Date or at the time of acquisition thereof after the Closing Date and not in contemplation thereof, in each case, from guaranteeing the Loans or which would require governmental (including regulatory) consent, approval, license or authorization to provide a guarantee unless such consent, approval, license or authorization has been received or a Subsidiary a guarantee from which could reasonably result in a material adverse Tax consequence to Holdings or any of its Subsidiaries (including as a result of the operation of Section 956 of the Code or any similar law or regulation in any applicable jurisdiction) as reasonably determined by the Borrowers, in consultation with the Administrative Agent, (d) not-for-profit Subsidiaries, if any, (e) certain special purpose entities, (f) captive insurance companies, if any, (g) any Subsidiary where the Administrative Agent and the Borrowers agree the cost, consequences or burden of obtaining a guarantee by such Subsidiary would be excessive in light of the practical benefit to the Lenders afforded thereby, (h) each Subsidiary listed on Schedule 1.01D hereto, (i) any non-wholly-owned Subsidiaries, (j) at the option of Holdings, any Subsidiary that is not a Material Subsidiary and (k) any Securitization Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Swap Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Guarantor, (x) as it relates to all or a portion of the Guarantee of such Guarantor, any Swap Obligation if, and to the extent that, such Swap Obligation (or any Guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor&#8217;s failure for any reason to constitute an &#8220;eligible contract participant&#8221; as defined in the Commodity Exchange Act and the regulations thereunder at the time the Guarantee of such Guarantor becomes effective with respect to such Swap Obligation or (y) as it relates to all or a portion of the grant by such Guarantor of a security interest, any Swap Obligation if, and to the extent that, such Swap Obligation (or such security interest in respect thereof)  is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor&#8217;s failure for any reason to constitute an &#8220;eligible contract participant&#8221; as defined in the Commodity Exchange Act and the regulations thereunder at the time the security interest of such Guarantor becomes effective with respect to such Swap Obligation. If a Swap Obligation arises under a master agreement governing more than one swap, such exclusion shall apply only to the portion of such Swap Obligation that is attributable to swaps for which such Guarantee or security interest is or becomes illegal.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any payments made to the Administrative Agent, any Lender or any other recipient of any payment to be made by or on account of any obligation of any Loan Party under any Loan Document, (a) Taxes imposed on (or measured by) net income, franchise or similar Taxes, and branch profits Taxes (in each case, however denominated), in each case imposed by the jurisdiction under the laws of which such recipient is organized, or in which it carries on a trade or business or is deemed to be a resident for tax purposes, or in which its principal office is located or, in the case of any Lender, in which its </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">applicable lending office is located or as a result of any other present or former connection between such recipient and the jurisdiction (other than a connection arising solely as a result of it having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document), (b) in the case of a Lender, any U.S. federal withholding Tax that is imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan, Letter of Credit or Commitment pursuant to a Legal Requirement in effect on the date on which (i) such Lender acquires such interest in the Loan, Letter of Credit or Commitment (other than pursuant to an assignment request by Holdings under Section 2.19(b)) or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 2.17(a), amounts with respect to such Taxes were payable either to such Lender's assignor immediately before such Lender acquired such applicable interest in the applicable Loan, Letter of Credit or Commitment or to such Lender immediately before it changed its lending office, (c) any Taxes attributable to such Person's failure to comply with Section 2.17(e) or (h), (d) any Tax that is imposed pursuant to FATCA, (e) in the case of a Revolving Lender, solely with respect to any Revolving Loan, Extended Revolving Loan or Incremental Revolving Loan, in each case, extended to a Revolving Borrower that is tax resident in the Republic of Ireland, any Irish Tax that would not have been imposed (i) if the Revolving Lender had been an Irish Qualifying Lender but on that date the Revolving Lender is not or has ceased to be an Irish Qualifying Lender other than as a result of any change after the date it became a Revolving Lender under this Agreement in (or in the interpretation, administration or application of) any law or Treaty or any law or published practice or concession of any relevant tax authority or (ii) where the relevant Revolving Lender is an Irish Qualifying Lender solely on account of being an Irish Treaty Lender and that Lender has not complied with its obligations under Section 2.17(e), (f)(i) any Luxembourg withholding tax due under the so-called Luxembourg Relibi Law dated 23 December 2005 by the Grand-Duchy of Luxembourg and (ii) Luxembourg registration duties (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">droits d&#8217;enregistrement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) payable due to a registration, submission or filing by the Administrative Agent, a Lender or an Issuing Bank of any Loan Document, except if such registration, submission or filing is required to maintain, establish, enforce or preserve the rights of the Administrative Agent, a Lender or an Issuing Bank under such Loan Document, and (g) any U.S. federal backup withholding tax imposed under Section 3406 of the Code (or any successor provision).  For the avoidance of doubt, (1) for purposes of this definition of &#8220;Excluded Taxes,&#8221; the terms &#8220;Lender&#8221; and &#8220;Revolving Lender&#8221; shall include any Issuing Bank and any Swingline Lender and (2) for purposes of clause (e) of this definition of &#8220;Excluded Taxes,&#8221; the term &#8220;Revolving Loan&#8221; shall include any Letter of Credit and any Swingline Loan.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Order No. 13224</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001, as the same as been, or shall hereafter be, renewed, extended, amended or replaced.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Revolving Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Multicurrency Revolving Facility Agreement, dated as of March 12, 2018, by and among Icon Public Limited Company, Icon Investments Five Unlimited Company, Santander UK PLC, as agent, and the lenders party thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Extended Term Loan Commitments and the Extended Revolving Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Extended Term Loans and the Extended Revolving Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(a)(iii).</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Revolving Loans made by one or more Lenders to the Borrowers pursuant to Section 2.22.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(a)(ii). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Term Loan Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the commitment of any Lender, established pursuant to Section 2.22, to make Extended Term Loans to the Applicable Borrower. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(a)(iii).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any amendment entered into pursuant to Section 2.22(c).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the office or offices through which the Lender will perform its obligations under this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof, any agreements entered into pursuant to current Section 1471(b)(1) of the Code (or any amended or successor version described above) and any intergovernmental agreement, treaty, convention or similar agreement among Governmental Authorities (and related legislation, official regulations or other administrative guidance) implementing any of the foregoing. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, the weighted average (rounded upwards, if necessary, to the next 1&#47;100 of 1%) of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average (rounded upwards, if necessary, to the next 1&#47;100 of 1%) of the quotations for such day for such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the covenant specified in Section 6.12(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant Cross Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 7.01(d). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 7.01(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an acquisition (or series of related acquisitions (being acquisitions which form part of the same overall sale and purchase transaction)) within the six month period prior to the relevant Test Period by any member of the Group where the aggregate consideration of such acquisition or related acquisitions is greater than $50.0 million.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the chief financial officer, principal accounting officer, treasurer or controller of Holdings.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment&#8221; means the First Amendment to the Credit Agreement, dated as of November 29, 2022, by and among Holdings and the Administrative Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;First Amendment Effective Date&#8221; shall have</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> the meaning assigned to such term in the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Lien Intercreditor Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;pari passu&#8221; Intercreditor Agreement, among the Collateral Agent, the Administrative Agent and one or more Designated Representatives for holders of Indebtedness that is secured by Collateral on a basis pari passu with the Liens securing the Obligations, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other form approved by Holdings, the Administrative Agent and the Collateral Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Lien Net Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Test Period, the ratio of (i) Consolidated Total Indebtedness secured by a Lien on the Collateral that ranks pari passu with the Liens on the Collateral securing the Obligations, net of Unrestricted Cash, as of the last day of such Test Period, to (ii) Consolidated EBITDA for such Test Period.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First-Second Lien Intercreditor Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a &#8220;junior lien&#8221; Intercreditor Agreement, among the Collateral Agent, the Administrative Agent and one or more Designated Representatives for holders of Indebtedness that is secured by Liens on the Collateral that are junior to the Liens securing the Obligations, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other form approved by Holdings, the Administrative Agent and the Collateral Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning assigned to such term in Section 1.07(g).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Charge Coverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any Test Period, the ratio of Consolidated EBITDA of the Group to Fixed Charges of the Group. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person for any Test Period, the sum, without duplication, of&#58; (a) Consolidated Interest Expense for such period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the amount of all dividend payments on any series of Preferred Equity or Disqualified Equity Interests of Holdings or any Restricted Subsidiary (other than dividends paid or accrued in Equity Interests of Holdings (other than Disqualified Equity Interests) or dividends paid or accrued to Holdings or any Restricted Subsidiary) paid in cash during such period (without duplication). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.20(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Agreed Currencies other than Dollars.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency LC Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a) the Dollar Amount of the aggregate undrawn and unexpired amount of all outstanding Foreign Currency Letters of Credit at such time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the aggregate Dollar Amount of all LC Disbursements in respect of Foreign Currency Letters of Credit that have not yet been reimbursed at such time. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Letter of Credit denominated in a Foreign Currency.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Lender that is not a United States person within the meaning of Section 7701(a)(30) of the Code.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Holdings, Lux Borrower and each Foreign Subsidiary that is a Borrower or a Subsidiary Guarantor.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Security Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each security document set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1.01E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Subsidiary which is not a Domestic Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Subsidiary Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Subsidiary Guarantor which is a Foreign Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FSHCO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Excluded Subsidiary&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United States of America.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the government of the United States of America, any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Holdings and its Restricted Subsidiaries.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of or by any Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) means any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness or obligation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business or customary and reasonable indemnity obligations in effect on the Closing Date or entered into in connection with any acquisition or Disposition of assets permitted under this Agreement (other than such obligations with respect to Indebtedness).  The amount of any Guarantee shall be deemed to be an amount equal to the lesser of (a) the stated or determinable amount of the primary payment obligation in respect of which such Guarantee is made and (b) the maximum amount for which the guaranteeing Person may be liable pursuant to the terms of the instrument embodying such Guarantee (or as set forth in Section 10.08 hereto, as applicable), unless such primary payment obligation and the maximum amount for which such guaranteeing Person may be liable are not stated or determinable, in which case the amount of the Guarantee shall be such guaranteeing Person&#8217;s maximum reasonably possible liability in respect thereof as reasonably determined by Holdings in good faith.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each Borrower (with respect to the primary obligations of each other Loan Party), Holdings and the other Subsidiary Guarantors.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor Coverage Test</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means confirmation that (by reference to the latest annual audited financial statements delivered to the Administrative Agent pursuant to Section 5.01(a))&#58; (1) the Consolidated EBITDA of the Borrowers and Guarantors equals or exceeds 80.0% of Consolidated EBITDA (in each case, calculated prior to making pro forma adjustments (including clause (vii) of the definition of &#8220;Consolidated EBITDA&#8221;), except that pro forma effect shall be </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">given to the Acquisition (other than any pro forma adjustments with respect thereto pursuant to clause (vii) of the definition of &#8220;Consolidated EBITDA&#8221;) of the Group or (2) if the test set out in clause (1) cannot be satisfied on the first Guarantor Coverage Test Date after the Closing Date, the aggregate assets of Borrowers and Guarantors equals or exceeds 80.0% of the Total Assets of the Group, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, solely for purposes of calculating the Guarantor Coverage test&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">to the extent any Borrower or Guarantor generates negative EBITDA, such Borrower or Guarantor shall be deemed to have zero (0) EBITDA, for the purpose of calculating the numerator of the Guarantor Coverage Test, and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">unless otherwise elected by Holdings, to the extent that any Subsidiary of Holdings (w) is an Unrestricted Subsidiary, (x) is incorporated or organized under the laws of Russia, Ukraine, China, India or France, (y) is otherwise not required to (or is unable to) become a Guarantor under clause (c), (d), (e), (f), (h) or (i) of &#8220;Excluded Subsidiaries&#8221; above or under the Agreed Guarantee and Security Principles or (z) the Consolidated EBITDA of such Subsidiary is less than 1.0% of Consolidated EBITDA of the Group, such Subsidiaries shall be deemed to have zero (0) EBITDA and zero (0) assets for the purpose of calculating the denominator of the Guarantor Coverage Test.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor Coverage Test Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the date of delivery of each Compliance Certificate with respect to annual financial statements required to be delivered pursuant to Section 5.01(a) in respect of each fiscal year ending after the Closing Date.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Guarantee set forth in Article X.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, infectious or medical wastes and all other substances or wastes of similar nature regulated pursuant to any, or which may give rise to liability under, Environmental Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Headquarters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the corporate headquarters of Holdings as of the Closing Date, located in Dublin, Ireland.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Hedge Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each counterparty to a Swap Agreement that is (A) a Lender, an Agent or a Lead Arranger (or an Affiliate of a Lender, an Agent or a Lead Arranger) and each other Person if, at the date of entering into such Swap Agreement, such Person was a Lender, an Agent or a Lead Arranger (or an Affiliate of a Lender, an Agent or a Lead Arranger)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Person is not a Lender, an Agent or a Lead Arranger (other than any such Person that is an Affiliate of Citibank, N.A.), such Person delivers to the Administrative Agent a letter agreement pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 and Section 10 of the U.S. Security Agreement as if it were a Lender or (B) that is designated in writing by Holdings to the Administrative Agent as a &#8220;Hedge Bank&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Person is not a Lender, Agent or Lead Arranger, such Person executes and delivers to the Administrative Agent and Holdings a letter agreement in form and substance reasonably acceptable to the Administrative agent and Holdings pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 hereof and Section 10 of the U.S. Security Agreement as if it were a Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the preamble hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">IFRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 1.04(a).</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">IGPHS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means ICON Government and Public Health Solutions, Inc.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Immediate Family Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any individual, such individual&#8217;s child, stepchild, grandchild or more remote descendant, parent, stepparent, grandparent, spouse, former spouse, qualified domestic partner, sibling, mother-in-law, father-in-law, son-in-law and daughter-in-law (including adoptive relationships) and any trust, partnership or other bona fide estate-planning vehicle the only beneficiaries of which are any of the foregoing individuals or any private foundation or fund that is controlled by any of the foregoing individuals or any donor-advised fund of which any such individual is the donor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Incremental Amendment among the Applicable Borrower, any Additional Borrower, the Administrative Agent and one or more Incremental Term Lenders, Incremental Term Lenders and&#47;or Incremental Revolving Lenders, as applicable, entered into pursuant to Section 2.20.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Incremental Term Loan Commitments and the Incremental Revolving Commitments, collectively.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Incremental Term Lender or an Incremental Revolving Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Incremental Term Loans and the Incremental Revolving Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.20(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Lender with an Incremental Revolving Commitment or an outstanding Incremental Revolving Loan.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means revolving loans made by one or more lenders to one or more Borrowers pursuant to such lenders&#8217; Incremental Revolving Commitments. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Lender with an Incremental Term Loan Commitment or an outstanding Incremental Term Loan.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loan Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.20(a). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Term Loans made by one or more Term Lenders to any Borrower pursuant to such Term Lenders&#8217; Incremental Term Loan Commitments.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incurrence-Based Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 1.07(g).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incurrence-Based Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.20(d).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any Person means, without duplication, (a) the principal component of all obligations of such Person for borrowed money, (b) the principal component of all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person (excluding trade accounts payable and accrued expenses arising in the ordinary course of business and licenses entered into in the ordinary course of business), (d) the principal component of all obligations of such Person in respect of the deferred purchase price of property </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or services if and to the extent such obligation would appear as a liability upon the balance sheet of the specified Person in accordance with GAAP (including payments or other arrangements representing acquisition consideration, in each case entered into in connection with an acquisition, but excluding (i) accounts payable, accrued interest or other liability to trade creditors incurred in the ordinary course of business, (ii) deferred revenue, deferred compensation and severance, pension, health and welfare retirement and equivalent benefits to current or former employees, directors or managers  of such Person and its Subsidiaries, and (iii) any Deferred Acquisition Consideration), (e) all Capital Lease Obligations of such Person, (f) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty, (g) all obligations, contingent or otherwise, of such Person in respect of bankers&#8217; acceptances, (h) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if such Person has not assumed or otherwise become liable in respect of such Indebtedness, such obligations shall be deemed to be in an amount equal to the lesser of (i) the amount of such Indebtedness and (ii) fair market value of such property at the time of determination (in the Borrowers&#8217; good faith estimate), (i) all Guarantees by such Person of Indebtedness of others and (j) all Disqualified Equity Interests (excluding any accrued dividends), in each case of clause (a) through (g), to the extent such Indebtedness would appear as a liability upon the balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP.  The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person&#8217;s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor.  For the avoidance of doubt, deferred revenue and advances and deposits received from customers shall not constitute Indebtedness.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Taxes imposed on or with respect to any payments made by or on account of any obligation of any Loan Party under any Loan Document other than (i) Excluded Taxes and (ii) Other Taxes.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in section 6.02. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Revolving Lender, its Revolving Commitment as of the Closing Date, as may be increased or decreased from time to time in accordance with this Agreement.  The amount of each Revolving Lender&#8217;s Initial Revolving Commitment as of the Closing Date is set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The aggregate principal Dollar Amount of the Initial Revolving Commitments on the Closing Date is $300,000,000.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Loans made by Revolving Lenders pursuant to Section 2.01(c). Each Initial Revolving Loan shall be a Eurocurrency Loan denominated in an Agreed Currency (other than Pounds Sterling</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">), an</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Dollars), a USD Term SOFR Loan, a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> RFR Loan denominated in Pounds Sterling or an ABR Loan denominated in Dollars. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Lux Term Loans and the U.S. Term Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Insolvency or Liquidation Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, (a) any voluntary or involuntary case or proceeding under any Debtor Relief Law with respect to any such Person, (b) any other voluntary or involuntary insolvency, reorganization or bankruptcy case or proceeding, or any receivership, liquidation, reorganization, examinership, administration or other similar event, case, process, action or proceeding or private or judicial foreclosure with respect to any such Person or with respect to all or any material portion of its assets, (c) any liquidation, dissolution, examinership, reorganization or winding up of any such Person whether voluntary or involuntary or otherwise and whether or not involving insolvency or bankruptcy or </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) any assignment for the benefit of creditors or any other marshalling of all or any material part of the assets and liabilities of any such Person.  In addition, in respect of any Luxembourg Loan Party, &#8220;Insolvency or Liquidation Proceeding&#8221; shall also mean a Luxembourg Insolvency Event.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intercompany Subordination Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain intercompany subordination agreement entered into on the Closing Date by Holdings and certain of its Restricted Subsidiaries (as amended, restated, amended and restated, supplemented or otherwise modified from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any modification that is materially adverse to the Senior Creditors (as defined therein) shall only be permitted if such modification is reasonably acceptable to the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that it is understood and agreed that the joinder of Obligors (as defined therein) or Subordinated Creditors (as defined therein) to the Intercompany Subordination Agreement is not materially adverse to the Senior Creditors and shall not require the consent of the Administrative Agent).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intercreditor Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a First Lien Intercreditor Agreement or a First-Second Lien Intercreditor Agreement, as applicable.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Election Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a request by the applicable Borrower to convert or continue a Borrowing in accordance with Section 2.08.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any ABR Loan (other than a Swingline Loan), the last Business Day of each March, June, September and December and the applicable Maturity Date, (b) with respect to any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan, the last day of the Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Eurocurrency Borrowing </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or USD Term SOFR Borrowing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with an Interest Period of more than three months&#8217; duration, each day prior to the last day of such Interest Period that occurs at intervals of three months&#8217; duration after the first day of such Interest Period and the applicable Maturity Date and (c) with respect to any Swingline Loan, the day that such Loan is required to be repaid and the latest Maturity Date with respect to any Revolving Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one, three or six months thereafter (or, if acceptable to each participating Lender therein, twelve months thereafter or less than one month thereafter), as the Applicable Borrower may elect and (b) with respect to any RFR Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one or three months thereafter, as the Applicable Borrower may elect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless, in the case of a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing only, such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day and (ii) any Interest Period pertaining to a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period.  For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interpolated Screen Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Eurocurrency Loan denominated in any currency for any Interest Period, a rate per annum which results from interpolating on a linear basis between (a) the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">applicable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Screen Rate for the longest maturity for which a </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Screen Rate is available that is shorter than such Interest Period and (b) the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">applicable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Screen Rate for the shortest maturity for which a </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Screen Rate is </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">available that is longer than such Interest Period, in each case as of approximately 11&#58;00 a.m. (London time) on the Quotation Day.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, all direct or indirect investments by such Person in other Persons (including Affiliates) in the forms of loans (including Guarantees or other obligations), advances or capital contributions (excluding accounts receivable, credit card and debit card receivables, trade credit, advances to customers, commission, travel and similar advances to officers and employees, in each case, created or made in the ordinary course of business), purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities, together with all items that are or would be classified as investments on a balance sheet prepared in accordance with GAAP.  If Holdings or any Restricted Subsidiary sells or otherwise disposes of any Equity Interests of any direct or indirect Restricted Subsidiary such that, after giving effect to any such sale or disposition, such Person is no longer a Restricted Subsidiary, Holdings will be deemed to have made an Investment on the date of any such sale or disposition equal to the fair market value of Holdings&#8217; Investments in such Subsidiary that were not sold or disposed of in an amount determined as provided in the penultimate paragraph of Section 6.04.  The acquisition by Holdings or any Restricted Subsidiary of a Person that holds an Investment in a third Person will be deemed to be an Investment by Holdings or such Restricted Subsidiary in such third Person in an amount equal to the fair market value of the Investments held by the acquired Person in such third Person in an amount determined as provided in the penultimate paragraph of Section 6.04.  Except as otherwise provided in this Agreement, the amount of an Investment will be determined at the time the Investment is made and without giving effect to subsequent changes in value, less any amounts paid, repaid, refinanced, distributed or otherwise received in cash in respect of such Investment.  For the avoidance of doubt, Permitted Equity Derivatives and acquisitions of or licenses for intellectual property or tangible assets used or useful in a Permitted Business do not constitute Investments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Ireland</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Republic of Ireland.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Pension Scheme</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;ERISA Event&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Qualifying Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Lender or Participant, as the case may be, that is beneficially entitled to interest in respect of a Loan advanced to a Borrower that is tax resident in Ireland under this Agreement and is&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a bank within the meaning of Section 246 of the TCA whose Facility Office is located in Ireland and is carrying on a bona fide banking business in Ireland for the purposes of Section 246(3)(a) of the TCA&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(a)&#160;&#160;&#160;&#160;a company (within the meaning of Section 246 of the TCA) that is resident for the purposes of tax (residence for these purposes to be determined in accordance with the laws of the territory of which the Lender or Participant, as the case may be, claims to be resident) in a member state of the European Communities (other than Ireland) or in a territory with which Ireland has concluded a Treaty where&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;that member state or territory imposes a tax that generally applies to interest receivable in that member state or territory by companies from sources outside that member state or territory&#59; or </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;where that member state or territory imposes a tax that generally applies to interest received in that member state or territory from sources outside </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that member state or territory and the interest is payable into an account located in that member state or territory&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">a company (within the meaning of Section 246 of the TCA) where interest payable in respect of an advance&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;is exempted from the charge to income tax under a Treaty that is in effect by virtue of the procedures set out in Section 826(1) of the TCA&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;would be exempted from the charge to income tax under a Treaty if such Treaty was in effect by virtue of the procedures set out in Section 826(1) of the TCA but such Treaty is not in effect at the date the interest is paid&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">a corporation established in the United States of America and subject to U.S. federal income tax on its worldwide income&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a limited liability company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) established in the United States of America, provided that the ultimate recipients of the interest for Irish tax purposes would, if they were themselves Lenders, be Irish Qualifying Lenders within the meaning of paragraph (2)(a) or (2)(b) or (2)(c) of this definition and the business conducted through the LLC is so structured for market reasons and not for tax avoidance purposes&#59;</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provided that in each case at (a), (b), (c) or (d) the Lender or Participant, as the case may be, is not carrying on a trade or business in Ireland through an agency or branch with which the interest payment is connected&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">an Irish Treaty Lender&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a company (within the meaning of Section 4 of the TCA)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">which advances money in the ordinary course of a trade which includes the lending of money&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">in whose hands any interest payable in respect of money so advanced is taken into account in computing the trading income of the company for Irish corporation tax purposes&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">which has complied with all of the provisions of Section 246(5)(a) of the TCA including making the appropriate notifications thereunder to the Borrowers and the Revenue Commissioners&#59; and </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">whose Facility Office is located in Ireland&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">a qualifying company within the meaning of Section 110 of the TCA and whose Facility Office is located in Ireland&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">an investment undertaking within the meaning of Section 739B of the TCA and whose Facility Office is located in Ireland.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Qualifying Lender Confirmation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.17(h).</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Treaty Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, a Lender or Participant, as the case may be, that is a resident of an Irish Treaty State for the purposes of a Treaty and that does not carry on a business in Ireland through a permanent establishment with which a Loan under this Agreement is effectively connected and subject to completion of any procedural formalities, is entitled under the Treaty to receive payments of interest in respect of this Agreement without deduction of Irish tax.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Treaty State</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a jurisdiction that has a double taxation agreement with Ireland (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Treaty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that is in effect and makes provision for full exemption from withholding tax imposed by Ireland on interest.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Citibank, N.A. and any other Lender designated by the Revolving Borrowers as an &#8220;Issuing Bank&#8221; hereunder that has agreed to such designation (and is reasonably acceptable to the Administrative Agent), each in its capacity as the issuer of one or more Letters of Credit hereunder, and its successors in such capacity as provided in Section 2.06(i), in each case so long as such Person shall remain an Issuing Bank hereunder.  All references contained in this Agreement and the other Loan Documents to the &#8220;Issuing Bank&#8221; shall be deemed to apply equally to each of the institutions referred to in the foregoing sentence of this definition in their respective capacities as issuers of any and all Letters of Credit issued by each such institution.  Each Issuing Bank may, in its discretion, arrange for one or more Letters of Credit to be issued by branches or Affiliates of such Issuing Bank, in which case the term &#8220;Issuing Bank&#8221; shall include any such branch or Affiliate with respect to Letters of Credit issued by such branch or Affiliate.  Each Issuing Bank may cause Letters of Credit to be issued by unaffiliated financial institutions and such Letters of Credit shall be treated as issued by such Issuing Bank for all purposes under the Loan Documents. Notwithstanding anything to the contrary herein, Citibank, N.A. shall not be obligated to issue trade letters of credit.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Joinder Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 5.09(f).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Latest Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any date of determination, the latest Maturity Date applicable to any Loan or Commitment hereunder at such time, including the latest maturity date of any Other Refinancing Loan, any Other Refinancing Commitment, any Other Term Loan, any Extended Loan, any Extended Loan Commitment, any Incremental Loan or any Incremental Commitment in each case as extended in accordance with this Agreement from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Collateral Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.06(j).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Disbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a payment made by an Issuing Bank pursuant to a Letter of Credit. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a) the aggregate undrawn Dollar Amount of all outstanding Letters of Credit at such time </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the aggregate Dollar Amount of all LC Disbursements that have not yet been reimbursed at such time.  The LC Exposure of any Revolving Lender at any time shall be its Revolving Percentage of the total LC Exposure at such time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.06(b).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LCT Test Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 1.07(f).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lead Arrangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Citigroup Global Markets Inc., Banco Santander S.A., HSBC Continental Europe SA, J.P. Morgan Securities Plc and Morgan Stanley Bank International Limited.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Person, the Organizational Documents of such person, and any treaty, law (including the common law), statute, ordinance, code, rule, regulation, guidelines, license, permit requirement, judgment, decree, verdict, order, consent order, consent decree, writ, declaration or injunction or determination of an arbitrator or a court or other Governmental Authority, and the interpretation or administration thereof, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject, in each case whether or not having the force of law.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Reservations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the principle that equitable remedies are remedies which may be granted or refused at the discretion of the court, the limitation of enforcement by laws relating to bankruptcy, insolvency, court protection, liquidation, reorganization, court schemes, moratoria, examinership, administration and other laws generally affecting the rights of creditors, the time barring of claims, the possibility that an undertaking to assume liability for or to indemnify a person against non-payment of stamp duty may be void, defenses of set-off or counterclaim, (b) any payment made in compensation for a breach of the Loan Documents may be a penalty and may not be enforceable in whole or in part and (c) similar principles, rights and defenses under the laws of any relevant jurisdiction.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Persons listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and any other Person that shall have become a Lender hereunder pursuant to Section 2.20, Section 2.24 or pursuant to an Assignment and Assumption, other than any such Person that ceases to be a party hereto pursuant to an Assignment and Assumption.  Unless the context otherwise requires, the term &#8220;Lenders&#8221; includes the Swingline Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any standby or trade letter of credit issued under the Revolving Commitments pursuant to this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBO Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, for any Interest Period when used in reference to any Loan or Borrowing denominated in any Agreed Currency other than euros, the greater of (i) (x) in the case of Revolving Loans, 0% per annum and (y) in the case of Initial Term Loans, 0.50% per annum and (ii) rate per annum determined by the Administrative Agent at approximately 11&#58;00 a.m. (London time) on the date that is two (2) Business Days prior to the commencement of such Interest Period by reference to the ICE Benchmark Administration Interest Settlement Rates (or by reference to the rates provided by any Person that takes over the administration of such rate if the ICE Benchmark Administration is no longer making a &#8220;LIBO Rate&#8221; rate available) for deposits in the relevant Agreed Currency (as set forth by the Bloomberg Information Service or any successor thereto or any other service selected by the Administrative Agent that has been nominated by the ICE Benchmark Administration (or any successor thereto) as an authorized information vendor for the purpose of displaying such rates) for a period equal to such Interest Period (the &#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBO Screen Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;)&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> that, to the extent that an interest rate is not ascertainable pursuant to the foregoing provisions of this definition, &#8220;LIBO Rate&#8221; shall be the interest rate per annum equal to the Interpolated Screen Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBO Screen Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> the meaning assigned to such term in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">definition of &#8220;LIBO Rate&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any asset, (a) any mortgage, deed of trust, lien, license, pledge, hypothecation, encumbrance, assignment, charge or security interest in, on or of such asset, (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset and (c) in the case of securities, any purchase option, call or similar right of a third party with respect to such securities&#59; provided that any </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">precautionary UCC financing statements or similar filings (including  any filing of a UCC financing statement or other filing with a Governmental Authority in respect of an operating lease or a consignment) and any filings with any Governmental Authority in respect of any license shall not constitute Liens to the extent that such operating lease, consignment or license to which the filings relate are otherwise Permitted Liens hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in no event shall any operating lease or any non-exclusive license, sub-license or cross-license to intellectual property be deemed to constitute a Lien.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limited Condition Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any (a) any Permitted Acquisition or Investment which Holdings or any of its Restricted Subsidiaries is contractually committed to consummate, which commitment is not conditioned on the availability of, or on obtaining, third party financing, or (b) redemption or repayment of Indebtedness requiring irrevocable advance notice or any irrevocable offer to purchase Indebtedness that is not subject to obtaining financing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limited Originator Recourse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a letter of credit, cash collateral account or other such credit enhancement issued in connection with the incurrence of Indebtedness by a Securitization Subsidiary under a Qualified Securitization Financing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means this Agreement, any promissory notes issued pursuant to Section 2.10(e) of this Agreement, any Letter of Credit applications, the Collateral Documents, any Intercreditor Agreement, any Joinder Agreement, any Incremental Amendment, Extension Amendment or Refinancing Amendment, and any intercreditor agreements and subordination agreements.  Any reference in the Agreement or any other Loan Document to a Loan Document shall include all appendices, exhibits or schedules thereto, and all amendments, restatements, supplements or other modifications thereto, and shall refer to the Agreement or such Loan Document as the same may be in effect at any and all times such reference becomes operative.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, Holdings, the Borrowers and the Subsidiary Guarantors.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the loans made by the Lenders to the Borrowers pursuant to this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Local Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) New York City time in the case of a Loan, Borrowing or LC Disbursement denominated in Dollars and (ii) local time in the case of a Loan, Borrowing or LC Disbursement denominated in a Foreign Currency (it being understood that such local time shall mean London, England time, unless otherwise notified by the Administrative Agent).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the preamble hereto or any Additional Borrower organized under the laws of Luxembourg.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux U.S. Subsidiary Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the preamble hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Luxembourg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Grand Duchy of Luxembourg.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Luxembourg Companies Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Luxembourg Register of Commerce and Companies (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">R.C.S. Luxembourg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Luxembourg Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 10.08.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Luxembourg Insolvency Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, in relation to any entity incorporated or existing under the laws of Luxembourg or any of their assets, any corporate action, legal proceedings or other procedure or step in relation to bankruptcy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), insolvency, judicial or voluntary liquidation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">liquidation judiciaire ou volontaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), composition with creditors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">concordat pr&#233;ventif </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">de la faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), moratorium or reprieve from payment (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">sursis de paiement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), controlled management (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">gestion contr&#244;l&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), fraudulent conveyance (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">action paulienne</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), general settlement with creditors, the appointment of a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">juge d&#233;l&#233;gu&#233;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">commissaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> juge-commissaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> mandataire ad hoc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, an</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> administrateur provisoire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> liquidateur </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> curateur </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> reorganization or similar laws affecting the rights of creditors generally.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Luxembourg Loan Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Lux Borrower or any Luxembourg Guarantor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to each Term Lender, the commitment, if any, of such Term Lender to make Lux Term Loans hereunder, as such commitment may be (a) reduced or terminated from time to time pursuant to Section 2.09 and (b) reduced or increased from time to time pursuant to assignments by or to such Term Lender pursuant to Section 9.04. The amount of each Term Lender&#8217;s Lux Term Loan Commitment as of the Closing Date is set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or in the Assignment and Assumption (or other documentation contemplated by this Agreement) pursuant to which such Term Lender shall have assumed its Lux Term Loan Commitment, as applicable, and any other Refinancing Commitments and any Incremental Term Loan Commitments of Lux Term Loan Commitments. The aggregate principal amount of the Lux Term Loan Commitments on the Closing Date is $4,415,000,000. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Term Loan Repayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.10(a)(i). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the term loans made by the Term Lenders to the Lux Borrower and the Lux U.S. Subsidiary Borrower on the Closing Date pursuant to Section 2.01. Each Lux Term Loan shall be a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan denominated in Dollars or an ABR Loan denominated in Dollars.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Majority in Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, (i) in the case of the Revolving Lenders, Lenders having Revolving Credit Exposures and unused aggregate Revolving Commitments representing more than 50% of the sum of the aggregate Revolving Credit Exposures and the unused Revolving Commitments at such time and (ii) in the case of the Term Lenders, Lenders holding outstanding Loans representing more than 50% of all Term Loans outstanding at such time.  In making the above calculations, the Dollar Amounts (as determined in good faith by the Administrative Agent) of all amounts denominated in currencies other than Dollars shall be utilized.  If the context indicates that the &#8220;Majority in Interest&#8221; is to be determined for a relevant Class or Tranche, then only the respective Class or Tranche shall be included as otherwise provided above in determining the applicable Majority in Interest.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Margin Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Regulation U of the Board.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Market Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an amount equal to (i) the total number of issued and outstanding shares of common Equity Interests of Holdings or any one of the Borrowers&#8217; other parent entities that are traded on a securities exchange on the date of the declaration of a Restricted Payment, multiplied by (ii) the arithmetic mean of the closing prices per share of such common Equity Interests on the principal securities exchange on which such common Equity Interests are traded for the 30 consecutive trading days immediately preceding the date of declaration of such Restricted Payment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Permitted Acquisition that involves the payment of acquisition consideration by Holdings and its Restricted Subsidiaries in excess of $50,000,000.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a material adverse effect on (a) the business, assets, property or financial condition of Holdings and its Restricted Subsidiaries taken as a whole or (b) </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the rights or remedies of the Administrative Agent and the Lenders hereunder and under the other Loan Documents.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Asset Sale that involves payment of Disposition Consideration to Holdings or any of its Restricted Subsidiaries in excess of $50,000,000.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Indebtedness (other than (i) the Loans and Letters of Credit or (ii) any intercompany Indebtedness between or among members of the Group) of any one or more of Holdings and its Restricted Subsidiaries in an aggregate principal amount exceeding the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination.  For purposes of determining Material Indebtedness, the &#8220;principal amount&#8221; of the obligations of Holdings or any Restricted Subsidiary in respect of any Swap Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that Holdings or such Restricted Subsidiary would be required to pay if such Swap Agreement were terminated at such time.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean intellectual property that is material to the business of Holdings and its Subsidiaries, taken as a whole, as determined by Holdings in good faith.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each Restricted Subsidiary (i) which, as of the most recent fiscal quarter of Holdings, for the period of four consecutive fiscal quarters then ended, for which financial statements have been delivered pursuant to Section 5.01, contributed greater than five percent (5%) of Consolidated EBITDA of the Group for such period or (ii) which contributed greater than five percent (5%) of Total Assets of the Group as of such date.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to the Term Loans that have not been extended pursuant to Section 2.22, the date occurring seven years after the Closing Date, (ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with respect to the Initial Revolving Loans and Initial Revolving Commitments of the Revolving Lenders that have not been extended pursuant to Section 2.22, the date occurring five years after the Closing Date and (iii) with respect to any other tranche of Loans (including any Incremental Loans, Extended Loans, and Other Refinancing Loans), the maturity dates specified therefor in the applicable Incremental Amendment, Extension Amendment or Refinancing Amendment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that if any such day is not a Business Day, the Maturity Date shall be the Business Day immediately succeeding such day.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the preamble hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Extension Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(b).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Tranche Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Section 2.22(b).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc., and any successor to its rating agency business.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Net Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any event, (a) the cash proceeds received in respect of such event including (i) any cash received in respect of any non-cash proceeds (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise, but excluding any interest and royalty payments), but only as and when received, (ii) in the case of a casualty, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">insurance proceeds and (iii) in the case of a condemnation or similar event, condemnation awards and similar payments, net of (b) the sum of (i) all reasonable fees and out-of-pocket expenses paid to third parties (other than Affiliates) in connection with such event, (ii) in the case of a Disposition of an asset (including pursuant to a Sale and Leaseback Transaction or a casualty or a condemnation or similar proceeding), the amount of all payments required to be made as a result of such event to repay Indebtedness (other than Loans and limited to such Indebtedness&#8217; proportionate share of such prepayment) secured by such asset or otherwise subject to mandatory prepayment as a result of such event and (iii) the amount of all taxes paid (or reasonably estimated to be payable) and the amount of any reserves established to fund contingent liabilities reasonably estimated to be payable, in each case that are directly attributable to such event (as determined reasonably and in good faith by a Financial Officer)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on the date on which such reserve is no longer required to be maintained, the remaining amount of such reserve shall then be deemed to be Net Proceeds.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">New Loan Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 5.09(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">New Note Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the New Notes Indenture and the New Notes, as each such document may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">New Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the $500 million aggregate principal amount of 2.875% Senior Secured Notes due 2026 issued on July 1, 2021 by Merger Sub.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">New Notes Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain indenture, dated as of July 1, 2021, between Merger Sub and Citibank, N.A., London Branch, as trustee and collateral agent, relating to the New Notes.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any plan, fund or other similar program established, contributed to (regardless of whether through direct contributions or through employee withholding) or maintained outside the United States of America by Holdings or any one or more of its Subsidiaries primarily for the benefit of employees of Holdings or such Subsidiaries residing outside the United States of America </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other than an Irish Pension Scheme or any plans, funds or other similar programs that are maintained exclusively by a Governmental Authority), which plan, fund or other similar program provides, or results in, retirement income or a deferral of income in contemplation of retirement, and which plan is not subject to ERISA or the Code. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) all unpaid principal of and accrued and unpaid interest on the Loans (including any Loans (plus any accrued and unpaid interest) held by the Administrative Agent as a result of an Erroneous Payment Deficiency Assignment in accordance with Section 8.02(d) with respect to which it has Erroneous Payment Subrogation Rights), all LC Exposure, all accrued and unpaid fees and all expenses, reimbursements, indemnities and other obligations and indebtedness (including interest accruing during the pendency of any bankruptcy, insolvency, receivership, examinership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), obligations and liabilities of any of Holdings, the Borrowers and the other Loan Parties to any of the Lenders, the Administrative Agent, the Collateral Agent, any Issuing Bank or any indemnified party, individually or collectively, existing on the Closing Date or arising thereafter, direct or indirect, joint or several, absolute or contingent, matured or unmatured, liquidated or unliquidated, secured or unsecured, arising by contract, operation of law or otherwise, arising or incurred under this Agreement or any of the other Loan Documents or in respect of any of the Loans made or reimbursement or other obligations incurred or any of the Letters of Credit or other instruments at any time evidencing any thereof and (b) the payment of all obligations of Holdings and its Restricted Subsidiaries under each Cash Management Agreement and Swap Agreement entered into with any counterparty that is a Secured Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding anything to the contrary, the Obligations shall exclude any Excluded Swap Obligations.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Office of Foreign Assets Control of the United States Department of the Treasury.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OID</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Credit Agreement Refinancing Indebtedness&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Organizational Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, (i) in the case of any corporation, the certificate of incorporation, articles of incorporation, constitution or deed of incorporation and by-laws (or similar documents) of such Person, (ii) in the case of any limited liability company, the constitution, certificate or articles of formation or organization or deed of incorporation and operating agreement or memorandum and articles of association or constitution (or similar constituent documents) of such Person, (iii) in the case of any limited partnership, the certificate of formation and limited partnership agreement (or similar constituent documents) of such Person (and, where applicable, the equityholders or shareholders registry of such Person), (iv) in the case of any general partnership, the partnership agreement (or similar constituent document) of such Person, (v) in any other case, the functional equivalent of the foregoing, and (vi) any shareholder, voting trust or similar agreement between or among any holders of Equity Interests of such Person.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Refinancing Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Other Refinancing Term Commitments and the Other Refinancing Revolving Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Refinancing Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Other Refinancing Term Loans and the Other Refinancing Revolving Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Refinancing Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means one or more Classes of Revolving Commitments hereunder that result from a Refinancing Amendment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Refinancing Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the revolving loans made pursuant to any Other Refinancing Revolving Commitment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Refinancing Term Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means one or more Classes of Term Loan Commitments hereunder that result from a Refinancing Amendment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Refinancing Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means one or more Classes of Term Loans that result from a Refinancing Amendment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Revolving Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.20(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Incremental Revolving Loans made pursuant to Other Revolving Loan Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all present or future stamp, court, filing, intangible, recording or documentary Taxes or any other similar Taxes arising from any payment made under any Loan Document or from the execution, delivery, performance, registration or enforcement of, from the receipt or perfection of a security interest under, or otherwise with respect to, this Agreement or any other Loan Document, other than (1) Luxembourg registration duties (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">droits d&#8217;enregistrement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) payable due to a registration, submission or filing by the Administrative Agent, the Collateral Agent a Lender or an Issuing Bank of any Loan Document, except if such registration, submission or filing is required to maintain, establish, enforce or preserve the rights of the Administrative Agent, the Collateral Agent, a Lender or an Issuing Bank under such Loan Document or (2) such Taxes that are imposed with respect to an assignment or change in lending office (other than an assignment made pursuant to Section 2.19(b)) as a result of a present or former connection between the assignor, assignee or Lender and the jurisdiction imposing such Taxes (other than a connection arising solely as a result of it having executed, delivered, become </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.20(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Incremental Term Loans made pursuant to Other Term Loan Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Foreign Currency Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any amount payable in a Foreign Currency, the rate of interest per annum as determined by the Administrative Agent at which overnight or weekend deposits in the relevant currency (or if such amount due remains unpaid for more than three (3) Business Days, then for such other period of time as the Administrative Agent may elect) for delivery in immediately available and freely transferable funds would be offered by the Administrative Agent to major banks in the interbank market upon request of such major banks for the relevant currency as determined above and in an amount comparable to the unpaid principal amount of the related Credit Event, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> any taxes, levies, imposts, duties, deductions, charges or withholdings imposed upon, or charged to, the Administrative Agent by any relevant correspondent bank in respect of such amount in such relevant currency.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 9.04(c)(i).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 9.04(c)(ii).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participating Member State</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any member state of the EU that has the euro as its lawful currency in accordance with the legislation of the EU and relating to the Economic and Monetary Union.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing similar functions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Perfection Certificate Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Perfection Certificate with respect to Loan Parties in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or such other form as is reasonably satisfactory to Holdings and the Administrative Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Perfection Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the making or procuring of appropriate registrations, filings, endorsements, notarizations, acknowledgement, stampings and&#47;or notifications of any Loan Document (and&#47;or any Liens created under it) customary or necessary for the enforceability, fixing of priority, or production in evidence of the relevant Loan Document and&#47;or Lien.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Investment permitted under clause (4) of the definition of &#8220;Permitted Investments&#8221; and any other Investment permitted under this Agreement that constitutes the purchase or other acquisition, in one transaction or a series of transactions, by Holdings or any Restricted Subsidiary of all or substantially all the assets constituting a business unit, division, product line (including rights in respect of any drug or other pharmaceutical product) or line of business of, another Person, in a single transaction or a series of related transactions, such Person will be a Restricted Subsidiary and in any event, only to the extent that such assets or such Person will be owned and&#47;or licensed by Holdings or a Restricted Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the business and any services, activities or businesses incidental, or reasonably related or complementary or similar to, any line of business engaged in by Holdings and its Subsidiaries as of the Closing Date or any business activity that is a reasonable extension, development or expansion thereof or ancillary thereto.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Conversion Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means provisions permitting holders to convert or exchange Indebtedness into or for Equity Interests of Holdings (and cash in lieu of fractional shares) or at the option of Holdings or the issuer of such Indebtedness, Equity Interests of Holdings, cash or any combination of the foregoing (provided that any payment of any such cash shall be subject to compliance with the provisions set forth in this agreement, including those set forth in Article VI).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 6.01(b).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Equity Derivatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any forward purchase, accelerated share purchase, call option, warrant transaction or other equity derivative transactions relating to the Equity Interests of Holdings entered into by Holdings or any Restricted Subsidiary provided that any Restricted Payment made in connection with such transaction is permitted pursuant to Section 6.04, including any Swap Agreements executed in connection therewith (or deemed executed therewith).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Hedging Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means obligations of Holdings or any Restricted Subsidiary in respect of non-speculative Swap Agreements entered into (i) to hedge or mitigate risks to which Holdings or any Restricted Subsidiary has actual exposure (other than those in respect of Equity Interests of Holdings or any of its Restricted Subsidiaries but excluding Convertible Debt Securities) or (ii) in order to effectively cap, collar or exchange interest rates (from fixed to floating rates, from one floating rate to another floating rate or otherwise) with respect to any interest-bearing liability or investment of Holdings or any Restricted Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the Transactions&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Investment in Holdings by a Restricted Subsidiary or any Investment by Holdings or a Restricted Subsidiary in a Restricted Subsidiary (including, for the avoidance of doubt, the purchase of Equity Interests of non-wholly owned Restricted Subsidiaries)&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Investment in cash and Cash Equivalents&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Investment by Holdings or any Restricted Subsidiary in a Person, if as a result of such Investment&#58; (a) such Person becomes a Restricted Subsidiary&#59; or (b) such Person is merged, consolidated or amalgamated with or into, or transfers or conveys substantially all of its assets to, or is liquidated into, Holdings or a Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Investment made as a result of the receipt of non-cash consideration from (i) an Asset Sale that was made pursuant to and in compliance with Section 6.03 or (ii) a Disposition of assets not constituting an Asset Sale&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Investments to the extent made in exchange for the issuance of Equity Interests (other than Disqualified Equity Interests) of Holdings or any of its direct or indirect parent companies&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Investments received in settlement, satisfaction, compromise or resolution of (A) obligations of trade creditors or customers or other debts that were incurred in the ordinary course of business of Holdings or any of its Restricted Subsidiaries, including pursuant to any plan of reorganization or similar arrangement upon the bankruptcy or insolvency </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of any trade creditor or customer&#59; or (B) judgments, litigation, arbitration or other disputes&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Investments represented by Swap Obligations, Permitted Hedging Obligations and Permitted Equity Derivatives&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(a) loans and advances to, or guarantees of Indebtedness of officers, directors, employees, consultants and members of management not in excess of $25,000,000 outstanding at any one time, in the aggregate and (b) other loans and advances to employees, directors, officers, members of management and consultants for business-related travel expenses, moving expenses and other similar expenses or payroll advances, in each case incurred in the ordinary course of business or consistent with past practices or to future, present and former employees, directors, officers, members of management and consultants (and their Controlled Affiliates and Immediate Family Members) to fund such Person&#8217;s purchase of Equity Interests of Holdings or any direct or indirect parent company thereof&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">&#91;reserved&#93;&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any guarantee of Indebtedness permitted to be incurred by Section 6.01 and performance guarantees provided in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any Investment existing on, or made pursuant to binding commitments existing on, the date hereof and any Investment consisting of an extension, modification or renewal of any Investment existing on, or made pursuant to a binding commitment existing on, the date hereof, which, in the case of Investments with a fair market value (as determined by Holdings in good faith) in excess of $5,000,000, is set forth on Schedule 1.01B&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the amount of any such Investment may be increased (a) as required by the terms of such Investment as in existence on the date hereof or (b) as otherwise permitted under this Agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments of any Person in existence at the time such Person becomes a Restricted Subsidiary, or is merged, consolidated or amalgamated with or into, or transfers or conveys substantially all of its assets to, or is liquidated into, Holdings or a Restricted Subsidiary&#59; provided such Investment was not made in connection with or in anticipation of such Person becoming a Restricted Subsidiary and, to the extent in an amount not greater than such Investment as existing on the date such Person became a Restricted Subsidiary, any modification, replacement, renewal or extension thereof&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments in the ordinary course of business in prepaid expenses, negotiable instruments held for collection and lease, utility and worker&#8217;s compensation, performance and other similar deposits provided to third parties&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">receivables owing to Holdings or any Restricted Subsidiary if created or acquired in the ordinary course of business and payable or dischargeable in accordance with customary trade terms&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that such trade </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">terms may include such concessionary trade terms as Holdings or any such Restricted Subsidiary deems reasonable under the circumstances&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">advances, loans or extensions of trade or other credit (including to officers, directors, consultants and employees of Holdings, its Subsidiaries or its direct and indirect parent companies) in the ordinary course of business by Holdings or any of its Restricted Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">lease, utility and similar deposits in the ordinary course of business and other deposits constituting Permitted Liens&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments in the ordinary course of business consisting of endorsements for collection or deposit&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments among Holdings and its Subsidiaries in the ordinary course of business for purposes of funding the working capital and maintenance capital expenditure requirements and research and development activities of Holdings and its Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments consisting of purchases and acquisitions of inventory, supplies, materials and equipment or purchases of contract rights or licenses or leases of intellectual property, in each case in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any customary upfront, milestone, marketing or other funding payment in the ordinary course of business to another Person in connection with obtaining a right to receive royalty or other payments in the future&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments in any joint ventures in an amount outstanding at any one time not to exceed the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (with the fair market value as determined in good faith by Holdings of each Investment (other than any Investment consisting of a guarantee) being measured at the time made and without giving effect to subsequent changes in value)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if any Investment pursuant to this clause (22) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (2) above and shall cease to have been made pursuant to this clause (22) for so long as such Person continues to be a Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(23)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments in a Permitted Business in an aggregate amount, taken together with all other Investments made pursuant to this clause (23) that are at that time outstanding, not to exceed the greater of $290,000,000 and 25% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if any Investment pursuant to this clause (23) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (2) above and shall cease to have been made pursuant </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to this clause (23) for so long as such Person continues to be a Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(24)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments consisting of co-development agreements or consisting of the licensing or contribution of intellectual property, new drug applications or similar assets pursuant to development, marketing or manufacturing agreements, alliances or arrangements or similar agreements or arrangements with other Persons&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(25)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">other Investments in any Person having an aggregate fair market value (measured on the date each such Investment was made and without giving effect to subsequent changes in value), when taken together with all other Investments made pursuant to this clause (25) that are at the time outstanding, not to exceed the greater of $290,000,000 and 25% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if any Investment pursuant to this clause (25) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (2) above and shall cease to have been made pursuant to this clause (25) for so long as such Person continues to be a Restricted Subsidiary&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(26)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments in or relating to a Securitization Subsidiary that, in the good faith determination of Holdings, are necessary or advisable to effect or maintain any Qualified Securitization Financing or any repurchase obligation in connection therewith&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(27)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments in IGPHS to fund its cash management and working capital requirements&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(28)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">(x) Investments in Drug Development Funds, (y) Investments in Oncacare Limited to fund its cash management and working capital requirements and (z) loans made to Oncacare Limited pursuant to the shareholders agreement thereof, in an aggregate amount, taken together with all other Investments made pursuant to this clause (28) that are at that time outstanding, not to exceed the greater of $580,000,000 and 50% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(29)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments consisting of purchases and acquisitions of assets or services in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(30)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Investments made in the ordinary course of business in connection with obtaining, maintaining or renewing client contacts and loans or advances made to distributors in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(31)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Guarantees by Holdings or any of its Restricted Subsidiaries of leases (other than capitalized leases) or of other obligations that do not constitute Indebtedness, in each case entered into in the ordinary course of business and consistent with past practice&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(32)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any Investment in any Subsidiary or any joint venture in connection with intercompany cash management arrangements or related activities arising in the ordinary course of business and consistent with past practice&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(33)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">&#91;reserved&#93;&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(34)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any Investment by Holdings or any of its Restricted Subsidiaries so long as the Total Net Leverage Ratio on a Pro Forma Basis is less than or equal to 4.25&#58;1.00.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Junior Secured Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any secured Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of second-lien secured notes or second-lien secured loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Indebtedness is secured by all or a portion of the Collateral on a junior-priority basis with the Obligations and is not secured by any property or assets of Holdings or any Subsidiary other than the Collateral, (ii) such Indebtedness constitutes Credit Agreement Refinancing Indebtedness, (iii) such Indebtedness does not mature or have scheduled amortization or scheduled payments of principal prior to the maturity date of the Credit Agreement Refinancing Indebtedness at the time such Indebtedness is incurred&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (iii) shall not apply to customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)), (iv) such Indebtedness is not guaranteed by any of Holdings&#8217; Subsidiaries other than the Loan Parties and (v) a Designated Representative acting on behalf of the holders of such Indebtedness shall have become party to or otherwise subject to the provisions of a First-Second Lien Intercreditor Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Indebtedness is the initial Permitted Junior Secured Refinancing Debt incurred after the Closing Date, then Holdings, the Borrowers, the Subsidiary Guarantors, the Administrative Agent, the Collateral Agent and the Designated Representative for such Indebtedness shall have executed and delivered a First-Second Lien Intercreditor Agreement.  Permitted Junior Secured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens to secure the Secured Obligations (including any Incremental Loans)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens on assets of Foreign Subsidiaries or non-Guarantor Subsidiaries securing Indebtedness (and other related obligations) of such Foreign Subsidiary or non-Guarantor Subsidiary that was incurred pursuant to Section 6.01(b)(xi) and Liens securing Indebtedness (and other related obligations) incurred pursuant to Section 6.01(b)(xvi)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens in favor of Holdings or any Restricted Subsidiary&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens on property or Equity Interests of another Person existing at the time such other Person becomes a Subsidiary of Holdings or is merged with or into or consolidated with Holdings or any Subsidiary of Holdings&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Liens (a) are not incurred in contemplation thereof and (b) do not extend to any other property owned by Holdings or any of its Restricted Subsidiaries (other than after acquired property of such Person (to the extent required to become subject to such Liens under the terms of the applicable agreements as in effect at the time such Person becomes a Subsidiary of Holdings) and assets and property affixed or appurtenant thereto)&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens on property (including Equity Interests) existing at the time of acquisition of the property by Holdings or any Subsidiary of Holdings&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Liens were in existence prior to such acquisition and not incurred in contemplation of, such acquisition&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Lien on any property or asset of Holdings or any Restricted Subsidiary existing on the date hereof which, in the case of Liens securing Indebtedness with an outstanding principal amount in excess of $5,000,000, shall be set forth on Schedule 1.01C&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens granted in replacement of or substitute for, or to secure any refinancing (or successive refinancings), as a whole or in part, of any Indebtedness or other obligation secured by, a Lien referred to in clause (4), (5), (6), (11), (33), (37) or (38) hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the new Lien is limited to all or part of the same property and assets that secured or, under the written agreements pursuant to which the original Lien arose, could secure the refinanced Indebtedness (plus improvements and accessions to, such property or proceeds or distributions thereof)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens on the Equity Interests of Unrestricted Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens (a) to secure the performance of, or arising in connection with, public or statutory obligations (including worker&#8217;s compensation laws, unemployment insurance laws or similar legislation), insurance, surety or appeal bonds, performance bonds or other obligations of a like nature, good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases, deposits as security for contested taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business (including Liens to secure letters of credit issued to assure payment or performance of such obligations), (b) in respect of letters of credit, bank guarantees or similar instruments issued for the account of Holdings or any Subsidiary supporting obligations of the type set forth in clause (a) above and (c) Liens on cash and Cash Equivalents securing letters of credit issued in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on securities that are the subject of repurchase agreements permitted hereunder&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(11)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens to secure Indebtedness (and related obligations) permitted by Section 6.01(b)(x) covering only the assets acquired with, improved, constructed, leased or financed by such Indebtedness and the proceeds thereof&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(12)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens for taxes, assessments or other governmental charges or claims that are (i) not yet delinquent or (ii) being contested in good faith by appropriate proceedings and with respect to which adequate reserves have been established in accordance with, and to the extent required by, applicable accounting standards&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens imposed by law, such as carriers&#8217;, warehousemen&#8217;s, landlord&#8217;s and mechanics&#8217; Liens, in each case, either (i) incurred in the ordinary course of business or (ii) for sums not yet due or being contested in good faith by appropriate proceedings&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">survey exceptions, encumbrances, easements or reservations of, or rights of others for, licenses, rights-of-way, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real property or Liens incidental to the conduct of the business of such Person or to the ownership of their properties which were not incurred in connection with Indebtedness and that do not in the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">aggregate materially adversely affect the value of said properties or materially impair their use in the operation of the business of such Person&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens to secure any Ratio Debt, Alternative Incremental Facility Indebtedness, Permitted Pari Passu Secured Refinancing Debt and any Permitted Junior Secured Refinancing Debt and any Permitted Refinancing Indebtedness in respect thereof, in each case contemplated to be secured thereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (15) shall be subject to the applicable Intercreditor Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on insurance policies, premiums and proceeds thereof, or other deposits, to secure insurance premium financings and other liabilities to insurance carriers&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens securing or arising out of judgments, decrees, orders, awards or notices of lis pendens and associated rights related to litigation with respect to which Holdings or any Subsidiary shall then be proceeding with an appeal or other proceedings for review, or in respect of which the period within which such appeal or proceedings may be initiated shall not have expired&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens arising by virtue of any statutory or common law provisions relating to banker&#8217;s liens and rights of set-off or similar rights and remedies as to deposit accounts or other funds maintained with a depository or financial institution or as to purchase orders and other agreements entered into with customers in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(19)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on cash, Cash Equivalents or other property arising in connection with the defeasance, discharge or redemption of Indebtedness&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(20)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on specific items of inventory or other goods (and the proceeds thereof) of Holdings or any Restricted Subsidiary securing such Person&#8217;s obligations in respect of bankers&#8217; acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods entered into in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(22)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens securing obligations in an aggregate amount not to exceed $50,000,000 in respect of obligations under or in respect of Swap Agreements (including Permitted Hedging Obligations)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(23)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(24)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on equipment or inventory of Holdings or any Restricted Subsidiary granted in the ordinary course of business to Holdings&#8217; or such Restricted Subsidiary&#8217;s supplier at which such equipment or inventory is located&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(25)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">usual and customary Liens incurred to secure ACH Indebtedness, business credit card programs, and netting services, overdrafts and related liabilities arising from treasury, depositary and cash management services  and Liens in the nature of the right of setoff in favor of counterparties to contractual agreements with the Loan Parties in the ordinary course of business&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">61</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(26)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any encumbrance or restriction (including put and call arrangements) with respect to Equity Interests of any joint venture, minority investment or similar arrangement pursuant to any joint venture, shareholders, investor rights or similar agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(27)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens (i) consisting of deposits or advances made by Holdings or any of its Restricted Subsidiaries in connection with any letter of intent or purchase agreement in respect of any Permitted Acquisition or Investment permitted under this Agreement or (ii) consisting of an option or agreement to Dispose of any property permitted to be sold pursuant to Section 6.03&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(28)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">leases, subleases, non-exclusive licenses or non-exclusive sublicenses granted to third parties (a) entered into in the ordinary course of business which do not materially interfere with the conduct of the business of Holdings and its Restricted Subsidiaries and which do not secure any Indebtedness, or (b) that are not otherwise prohibited by Section 6.03&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(29)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens (i) of a collection bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection and (ii) attaching to commodity trading accounts or other commodities brokerage accounts incurred in the ordinary course of business, including Liens encumbering reasonable customary initial deposits and margin deposits&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(30)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">ground leases in respect of real property on which facilities owned or leased by Holdings or any of its Subsidiaries are located and other Liens affecting the interest of any landlord (and any underlying landlord) of any real property leased by Holdings or any Subsidiary&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(31)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">any interest or title of a lessor or licensor under any lease, sublease, license or sublicense entered into by Holdings or any Restricted Subsidiary (A) existing on the date hereof (but not created in contemplation hereof), (B) entered into in the ordinary course of its business or (C) entered into in connection with a Permitted Acquisition&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(32)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens to secure contractual payments (contingent or otherwise) payable by Holdings or its Subsidiaries to a seller after the consummation of an acquisition of a product, business, license or other assets&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(33)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">other Liens securing Indebtedness to the extent such Indebtedness, when taken together with all other Indebtedness secured by Liens incurred pursuant to this clause (33) that are at that time outstanding and the Indebtedness secured by Liens pursuant to clause (7) above with respect to the refinancing indebtedness originally secured by Liens pursuant to this clause (33), does not exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such Liens on the Collateral incurred pursuant to this clause (33) securing Capital Markets Indebtedness shall be junior to the Liens securing the Obligations and subject to the First-Second Lien Intercreditor Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(34)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on any assets held by a trustee (i) under any indenture or other debt instrument where the proceeds thereof of the securities issued thereunder are held in escrow pursuant to customary escrow arrangements pending the release thereof, and (ii) under any indenture pursuant to customary discharge, redemption or defeasance provisions&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(35)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on Securitization Assets in connection with Qualified Securitization Financing or a Qualified Receivables Factoring or Liens existing by reason of other contractual requirements of a Securitization Subsidiary or any Qualified Securitization Financing or Qualified Receivables Factoring&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(36)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens on deposits or other amounts held in escrow to secure payments (contingent or otherwise) payable by Holdings or any of its Restricted Subsidiaries with respect to the settlement, satisfaction, compromise or resolution or judgments, litigation, arbitration or other disputes&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(37)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens securing the Obligations under the New Notes Indenture and Permitted Refinancing Indebtedness thereof, subject to a First Lien Intercreditor Agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(38)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">purchase options, calls and similar rights of, and restrictions for the benefit of, a third party with respect to Equity Interests held by Holdings or any Restricted Subsidiary in joint ventures&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(39)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Liens securing Indebtedness permitted under Section 6.01(b)(iv) and Permitted Refinancing Indebtedness thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Indebtedness shall be secured solely by Liens existing at the time such Restricted Subsidiary is acquired by Holdings or a Restricted Subsidiary of Holdings and shall not extend to any other property owned by Holdings or any of its other Restricted Subsidiaries (other than after acquired property of such Person (to the extent required to become subject to such Liens under the terms of the applicable agreements as in effect at the time such Person becomes a Subsidiary of Holdings))&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(40)&#160;&#160;&#160;&#160;Liens securing the Headquarters arising as a result of a Sale and Leaseback Transaction thereof.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this definition, (A) Permitted Liens need not be incurred solely by reference to one category of Permitted Liens described above but are permitted to be incurred in part under any combination thereof and (B) in the event that a Lien (or any portion thereof) meets the criteria of one or more of the categories of Permitted Liens described above, Holdings may, in its sole discretion, classify or reclassify such item of Permitted Liens (or any portion thereof) in any manner that complies with this definition and Holdings may divide and classify a Lien in more than one of the types of Permitted Liens in one of the above clauses.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Pari Passu Secured Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any secured Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of senior secured notes or loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Indebtedness is secured by all or a portion of the Collateral on a pari passu basis with the Obligations and is not secured by any property or assets of Holdings or any Subsidiary other than the Collateral, (ii) such Indebtedness constitutes Credit Agreement Refinancing Indebtedness, (iii) such Indebtedness does not mature or have scheduled amortization or scheduled payments of principal prior to the maturity date of the Refinanced Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (iii) shall not apply to (x) Term A Facilities and (y) customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)), (iv) such Indebtedness is not guaranteed by any of Holdings&#8217; Subsidiaries other than the Loan Parties and (v) a Designated Representative acting on behalf of the holders of such Indebtedness shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Indebtedness is the initial Permitted </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">63</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pari Passu Secured Refinancing Debt incurred after the Closing Date, then Holdings, the Borrowers, the Subsidiary Guarantors, the Administrative Agent, the Collateral Agent and the Designated Representative for such Indebtedness shall have executed and delivered a First Lien Intercreditor Agreement.  Permitted Pari Passu Secured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Refinancing Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Indebtedness issued in exchange for, or the net proceeds of which are used to extend, refinance, renew, replace, defease or refund (collectively, to &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">refinance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), other Indebtedness&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (a) the principal amount (or accreted value, if applicable) of such Permitted Refinancing Indebtedness does not exceed the principal amount (or accreted value, if applicable) of the Indebtedness so refinanced (plus unpaid accrued interest and premium (including tender premium) thereon, any committed or undrawn amounts associated with, OID or upfront fees on, and underwriting discounts, fees, commissions and expenses incurred in connection with, such Permitted Refinancing Indebtedness), (b) the final maturity date of such Permitted Refinancing Indebtedness is no earlier than the maturity date for the Indebtedness being refinanced (it being understood that, in each case, any mandatory prepayment provision or provision requiring an offer to purchase such Indebtedness as a result of a change of control, fundamental change, delisting, asset sale or similar provision or any Permitted Conversion Provisions shall not violate the foregoing restriction), (c) if the Indebtedness (including any Guarantee thereof) being refinanced is by its terms subordinated in right of payment to the Secured Obligations, such Permitted Refinancing Indebtedness (including any Guarantee thereof) shall be subordinated in right of payment to the Secured Obligations on terms at least as favorable to the Lenders as those contained in the documentation governing the Indebtedness being refinanced, taken as a whole (as determined in good faith by the Board of Directors of Holdings), (d) such Permitted Refinancing Indebtedness contains mandatory prepayment or redemption (or similar provisions), if any, covenants, if any, and events of default, if any, and is benefited by guarantees, if any, which are customary for Indebtedness of such type (reasonably determined in good faith by the Board of Directors of Holdings), (e) no Permitted Refinancing Indebtedness shall have direct obligors or contingent obligors that were not the direct obligors or contingent obligors (or that would not have been required to become direct obligors or contingent obligors) in respect of the Indebtedness being refinanced, (f) if the Indebtedness being refinanced is secured, such Permitted Refinancing Indebtedness may be secured on terms no less favorable, taken as a whole, to the Secured Parties than those contained in the documentation (including any intercreditor agreement) governing the Indebtedness being refinanced (as determined in good faith by the Board of Directors of Holdings) and (g) if the Indebtedness being refinanced was subject to an Intercreditor Agreement, and if the respective Permitted Refinancing Indebtedness is to be secured by the Collateral, the Permitted Refinancing Indebtedness shall likewise be subject to an appropriate Intercreditor Agreement. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Unsecured Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any unsecured Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of unsecured notes or loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Indebtedness is not secured by any property or assets of Holdings or any Subsidiary, (ii) such Indebtedness constitutes Credit Agreement Refinancing Indebtedness, (iii) such Indebtedness does not mature or have scheduled amortization or scheduled payments of principal prior to the maturity date of the Refinanced Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (iii) shall not apply to customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)), and (iv) such Indebtedness is not guaranteed by any of Holdings&#8217; Subsidiaries other than the Loan Parties.  Permitted Unsecured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">64</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Sections 412 or 430 of the Code or Sections 302 or 303 of ERISA, and in respect of which Holdings or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section 3(5) of ERISA.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the final paragraph of Section 5.01.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pounds Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the lawful currency of the United Kingdom.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Preferred Equity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Equity Interests of any Person, Equity Interests of any class of classes (however designated) which is preferred as to the payment of dividends or distributions, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such Person, over shares of Equity Interests of any other class of such Person.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayment Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58; </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1) any Asset Sale (other than </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(x) Asset Sales resulting in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Net Proceeds </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">that,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">which</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> together with the aggregate amount of Net Proceeds received from all </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such sales, transfers or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Asset Sales</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">dispositions (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> occurring in the same fiscal year of Holdings, do not exceed $100,000,000 or (y) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any individual </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Asset Sale resulting in Net Proceeds that</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">transaction,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> do not exceed $25,000,000) or&#59;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2) any casualty or other insured damage to, or any taking under power of eminent domain or by condemnation or similar proceeding of, any property or asset of Holdings or any Restricted Subsidiary with a fair market value immediately prior to such event greater than (x) $100,000,000 in any fiscal year of Holdings or (y) $25,000,000 with respect to any individual event&#59; or</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3) the incurrence by Holdings or any Restricted Subsidiary of any Indebtedness, other than Indebtedness permitted under Section 6.01 or permitted by the Required Lenders pursuant to Section 9.02.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the rate of interest per annum publicly announced from time to time by Citibank, N.A. as its prime rate in effect at its principal office in New York City&#59; each change in the Prime Rate shall be effective from and including the date such change is publicly announced as being effective.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Basis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; mean, with respect to compliance with any test or covenant or calculation of any ratio hereunder, the determination or calculation of such test, covenant or ratio (including in connection with Specified Transactions) in accordance with Section 1.07. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Synergies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Consolidated EBITDA&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.09(e).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the final paragraph of Section 5.01.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">65</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.23(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Purchasing Borrower Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Borrower that desires to effect a Purchase Offer pursuant to Section 2.23.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC Credit Support</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.20.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified ECP Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, in respect of any Swap Obligation, each Guarantor that has total assets exceeding $10,000,000 at the time the relevant Guarantee or grant of the relevant security interest becomes effective with respect to such Swap Obligation or such other person as constitutes an &#8220;eligible contract participant&#8221; under the Commodity Exchange Act or any regulations promulgated thereunder and can cause another person to qualify as an &#8220;eligible contract participant&#8221; at such time by entering into a keepwell under Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Equity Interest that are not Disqualified Equity Interests.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Receivables Factoring</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any transaction or series of transactions that may be entered into by Holdings or any Restricted Subsidiary pursuant to which Holdings or such Subsidiary may sell, convey, assign or otherwise transfer Securitization Assets (which may include a backup or precautionary grant of security interest in such Securitization Assets so sold, conveyed, assigned or otherwise transferred or purported to be so sold, conveyed, assigned or otherwise transferred) to any Person other than a Securitization Subsidiary, which may include Standard Securitization Undertakings.  The grant of a security interest in any accounts receivable of Holdings or any of its Restricted Subsidiaries to secure the Obligations shall not be deemed to be a Qualified Receivables Factoring.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Securitization Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Securitization Financing of a Securitization Subsidiary that meets the following conditions&#58; (a) such Qualified Securitization Financing (including financing terms, covenants, termination events and other provisions) is in the aggregate economically fair and reasonable to Holdings and the Securitization Subsidiary as determined by Holdings in good faith and (b) all sales and&#47;or contributions of Securitization Assets and related assets to the Securitization Subsidiary are made at fair market value as determined by Holdings in good faith.  The grant of a security interest in any Securitization Assets of Holdings or any of the Restricted Subsidiaries (other than a Securitization Subsidiary) to secure Indebtedness under this Agreement prior to engaging in any Securitization Financing shall not be deemed a Qualified Securitization Financing. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Quotation Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Eurocurrency Borrowing and any Interest Period, the Business Day on which it is market practice in the London interbank market for the Administrative Agent to give quotations for deposits in the Agreed Currency of such Eurocurrency Borrowing for delivery on the first day of such Interest Period.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Ratio Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Indebtedness incurred pursuant to Section 6.01(a). </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Repurchase Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any obligation of a seller of receivables in a Qualified Receivables Factoring or Qualified Securitization Financing to repurchase receivables arising as a result of a breach of a representation, warranty or covenant or otherwise, including as a result of a receivable or portion thereof becoming subject to any asserted defense, dispute, off-set or counterclaim of any kind as a result of any action taken by, any failure to take action by or any other event relating to the seller, in each case, that are customary (as determined in good faith by Holdings) for non-recourse receivables financings.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinanced Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Credit Agreement Refinancing Indebtedness&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the repayment in full of, and the termination of any commitment to make extensions of credit, all indebtedness (other than contingent obligations not then due and that by their terms expressly survive the termination of the foregoing) outstanding under (v) the Existing Revolving Credit Agreement, (w) the Target Credit Agreement, (x) the Target Receivables Financing Agreement, (y) the Series A Notes and (z) the Series B Notes.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an amendment to or an amendment and restatement of this Agreement in form and substance reasonably satisfactory to the Administrative Agent and the Borrowers executed by each of (a) Holdings, the Borrowers and the Subsidiary Guarantors, (b) the Administrative Agent, (c) the Issuing Banks and the Swingline Lender (in the case of Other Refinancing Revolving Commitments or Other Refinancing Revolving Loans), and (d) each Refinancing Lender and Lender that agrees to provide any portion of the Credit Agreement Refinancing Indebtedness being incurred pursuant thereto, in accordance with Section 2.24.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, any bank, insurance company, financial institution or institutional lender or Approved Fund (with respect to the foregoing) that, in any case, is not an existing Lender (and that is not Holdings or any of its Subsidiaries or Affiliates) and that agrees to provide any portion of any Credit Agreement Refinancing Indebtedness pursuant to a Refinancing Amendment in accordance with Section 2.24&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that each Refinancing Lender (other than any Person that is a Lender, an Affiliate of a Lender or an Approved Fund of a Lender at such time) shall be subject to the approval of the Administrative Agent and the Issuing Banks and the Swingline Lender (in the case of Other Refinancing Revolving Commitments or Other Refinancing Revolving Loans) (such approval not to be unreasonably withheld or delayed), in each case to the extent any such consent would be required from the Administrative Agent and the Issuing Banks and the Swingline Lender (in the case of Other Refinancing Revolving Commitments or Other Refinancing Revolving Loans) under Section 9.04(b)(i) for an assignment of Loans or Commitments to such Refinancing Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 9.04(b)(iv).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Registered Equivalent Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any notes originally issued in a Rule 144A or other private placement transaction under the Securities Act, substantially identical notes (having the same Guarantees) issued in a dollar-for-dollar exchange therefor pursuant to an exchange offer registered with the SEC.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal, dispersal, leaching or migration of Hazardous Materials into or through the environment (including, without limitation, ambient air, surface water, groundwater and surface or subsurface strata).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to a USD Benchmark Replacement in respect of Dollars, the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto. and (b) with respect to an Alternate Currency Benchmark Replacement in respect of any Alternate Currency, (1) the central bank for the currency in which such amounts are denominated hereunder or any central bank or other supervisor which is responsible for supervising either (A) such</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> USD Benchmark Replacement or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Alternate Currency Benchmark </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">67</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Replacement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, as applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (B) the administrator of such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">USD Benchmark Replacement or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternate Currency Benchmark Replacement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, as applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (2) any working group or committee officially endorsed or convened by (A) the central bank for the currency in which such amounts are denominated, (B) any central bank or other supervisor that is responsible for supervising either (i) such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">USD Benchmark Replacement or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternate Currency Benchmark Replacement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, as applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (ii) the administrator of such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">USD Benchmark Replacement or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternate Currency Benchmark Replacement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, as applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (C) a group of those central banks or other supervisors or (D) the Financial Stability Board or any part thereof.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repricing Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the incurrence by any Loan Party of any new or replacement bank indebtedness comprised of term loans that are secured pari passu with the Initial Term Loans (including, without limitation, any new or additional term loans under this Agreement, whether incurred directly or by way of the conversion of Initial Term Loans into a new tranche of replacement term loans under this Agreement), (i) the primary purpose of which is to have an Effective Yield that is less than the applicable Effective Yield for Initial Term Loans and (ii) the proceeds of which are used to prepay (or, in the case of a conversion, deemed to prepay or replace), in whole or in part, the outstanding principal of the Initial Term Loans or (b) any amendment or waiver, the primary purpose of which is to reduce the Effective Yield of any Initial Term Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in no event shall any prepayment or repayment of Initial Term Loans in connection with a Change of Control, Transformative Acquisition or Transformative Disposition constitute a Repricing Event. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, Lenders having Credit Exposures and unused Commitments representing more than 50% of the sum of the total Credit Exposures and unused Commitments at such time.  The total Credit Exposure and Commitments of any Defaulting Lender shall be disregarded in determining Required Lenders at any time.  For all purposes of determining the Required Lenders hereunder, if any relevant Credit Exposures or unused Commitments are denominated in currencies other than Dollars, the respective Dollar Amounts (as determined in good faith by the Administrative Agent) thereof shall be utilized.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Net Proceeds Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, (i) in the case of any Prepayment Event described in clause (1) or clause (2) of the definition thereof, (a) 100% if the First Lien Net Leverage Ratio is greater than 4.50&#58;1.00, (b) 50% if the First Lien Net Leverage Ratio is less than or equal to 4.50&#58;1.00 and greater than 4.00&#58;1.00 and (c) 0% if the First Lien Net Leverage Ratio is less than or equal to 4.00&#58;1.00 and (ii) in the case of any Prepayment Event described in clause (3) of the definition thereof, 100%.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, Lenders having Revolving Credit Exposures and unused Revolving Commitments representing more than 50% of the sum of the total Revolving Credit Exposures and unused Revolving Commitments at such time. The total Revolving Credit Exposure and Revolving Commitments of any Defaulting Lender shall be disregarded in determining Required Revolving Lenders at any time.  For all purposes of determining the Required Revolving Lenders hereunder, if any relevant Revolving Credit Exposures or unused Revolving Commitments are denominated in currencies other than Dollars, the respective Dollar Amounts (as determined in good faith by the Administrative Agent) thereof shall be utilized.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the chief executive officer, president, authorized signatory, an executive vice president or senior vice president or a Financial Officer of Holdings.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Investment that is not a Permitted Investment.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) any dividend or any other payment or distribution on account of Holdings&#8217; or any of its Restricted Subsidiaries&#8217; Equity Interests (including, without limitation, any payment in connection with any merger or consolidation involving Holdings or any of its Restricted Subsidiaries, other than any such merger or consolidation constituting a Permitted Investment) or to the direct or indirect holders of Holdings&#8217; or any of its Restricted Subsidiaries&#8217; Equity Interests in their capacity as such (other than (A) dividends or distributions payable in Equity Interests (other than Disqualified Equity Interests) of Holdings, (B) dividends or other payments and distributions payable to Holdings or a Restricted Subsidiary, (C) dividends or distributions payable to other holders of Equity Interests of a Restricted Subsidiary on no more than a pro rata basis and (D) payments on account of the transfer or issuance of any Restricted Subsidiary&#8217;s Equity Interests to Holdings or any other Restricted Subsidiary), (ii) any purchase, redemption or other acquisition or retirement for value, directly or indirectly (including, without limitation, in connection with any merger or consolidation involving the  Holdings), any Equity Interests of Holdings, (iii) any principal payment on or with respect to, or purchase, redemption, defeasance or other acquisition or retirement for value any Subordinated Indebtedness (excluding any intercompany Indebtedness between or among members of the Group) or any Indebtedness (excluding any intercompany Indebtedness between or among members of the Group) of Holdings or any Restricted Subsidiary that is secured by Liens that are junior to the Liens securing the Obligations, except a payment of principal at, or within 365 days of, the stated maturity thereof or (iv) any Restricted Investment. Notwithstanding the foregoing, a &#8220;Restricted Payment&#8221; shall not include any of the payments or other transactions contemplated by the Transactions.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Subsidiary of Holdings other than an Unrestricted Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revenue Commissioners</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Revenue Commissioners of Ireland.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Borrowers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Lux Borrower, Merger Sub (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by Target), ICON CLINICAL RESEARCH LIMITED, a limited liability company incorporated under the laws of Ireland with registration number 201978 and with registered address at South County Business Park, Leopardstown, Dublin 18, Ireland, ICON GLOBAL TREASURY UNLIMITED COMPANY, an unlimited liability company incorporated under the laws of Ireland with registration number 649443 and with registered address at South Country Business Park, Leopardstown, Dublin 18, Ireland, and ICON US HOLDINGS INC., a Delaware corporation, and each Additional Borrower that becomes a Revolving Borrower.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Borrowing comprised of Revolving Loans of any Class.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Revolving Lender, the commitment, if any, of such Revolving Lender to make Revolving Loans and to acquire participations in Letters of Credit hereunder, as such commitment may be (a) reduced or terminated from time to time pursuant to Section 2.09, (b) increased from time to time pursuant to Section 2.20 and (c) reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04.  For the avoidance of doubt, &#8220;Revolving Commitments&#8221; includes the Initial Revolving Commitments, any Incremental Revolving Commitments, any Extended Revolving Commitments and any Other Refinancing Revolving Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment Increases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.20(a).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Revolving Borrowing of any Class, the issuance, extension or increase in amount of a Letter of Credit, an LC Disbursement with respect to a Letter of Credit or any of the foregoing.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">69</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Revolving Lender at any time, and without duplication, the sum of the outstanding principal amount of such Revolving Lender&#8217;s Revolving Loans and its LC Exposure and Swingline Exposure at such time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, each Lender that has a Revolving Commitment or, if the Revolving Commitments have terminated or expired, a Lender with Revolving Credit Exposure.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Initial Revolving Loan, any Extended Revolving Loan, any Other Refinancing Revolving Loan and any Incremental Revolving Loan.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; the percentage equal to a fraction the numerator of which is such Lender&#8217;s Revolving Commitment and the denominator of which is the aggregate Revolving Commitments of all Revolving Lenders (if the Revolving Commitments of any Class have terminated or expired, the Revolving Percentages shall be determined based upon the Revolving Commitments of such Class most recently in effect, giving effect to any assignments)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that when a Defaulting Lender shall exist, the Revolving Commitments of such Defaulting Lender shall be excluded from the denominator in calculating the &#8220;Revolving Percentage.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any Obligations consisting of any interest, fees or other amounts denominated in Pounds Sterling, SONIA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day except for (a) a Saturday, (b) a Sunday or (c) a day on which banks are closed for general business in London.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Interest Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Daily Simple RFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on Daily Simple RFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Lookback Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the definition of &#8220;Daily Simple RFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Run-rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the full recurring benefit for a period that is associated with any action taken, committed to be taken or with respect to which substantial steps have been taken or are expected to be taken (in the good faith determination of Holdings) (including any savings expected to result from the elimination of a public target&#8217;s compliance costs with public company requirements).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means S&#38;P Global Ratings, and any successor to its rating agency business.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any sale or other transfer of any property or asset by any Person with the intent to lease such property or asset as lessee.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, a country or territory that is itself the target of Sanctions (at the time of this Agreement, the Crimea region of Ukraine, Cuba, Iran, North Korea, and Syria).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by OFAC, the U.S. Department of State, the United Nations Security Council, the European Union or any EU member state, Her Majesty&#8217;s Treasury of the United Kingdom, (b) any Person operating, organized or resident in a Sanctioned Country or (c) any Person controlled or owned 50.0% or more by one or more of such Persons.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State, or (b) the United Nations Security Council, the European Union or any EU member state, or Her Majesty&#8217;s Treasury of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Screen Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the LIBO Screen Rate or the EURIBOR Screen Rate, as applicable.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the United States Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 82</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 3.16.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Net Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Test Period, the ratio of (a) Consolidated Total Indebtedness secured by a Lien on Collateral, net of Unrestricted Cash, as of the last day of such Test Period to (b) Consolidated EBITDA for such Test Period.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all Obligations&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding anything to the contrary, the Secured Obligations shall exclude (i) any Excluded Swap Obligations, (ii) each Cash Management Agreement and Swap Agreement entered into with any counterparty that is not a Secured Party and (iii) Obligations in respect of any Cash Management Agreement or Swap Agreement that has been designated by each of the parties to such Cash Management Agreement or Swap Agreement (including, for the avoidance of doubt, the applicable Secured Party) as not constituting &#8220;Secured Obligations.&#8221;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the holders of the Secured Obligations from time to time and shall include (i) each Lender and Issuing Bank in respect of its Loans and LC Exposure respectively, (ii) the Administrative Agent, the Collateral Agent, the Issuing Banks and the Lenders in respect of all other present and future obligations and liabilities of Holdings and each Restricted Subsidiary of every type and description arising under or in connection with this Agreement or any other Loan Document, (iii) each Hedge Bank, (iv) each indemnified party under Section 9.03 in respect of the obligations and liabilities of any Borrower to such Person hereunder and under the other Loan Documents, (v) each Cash Management Bank and (vi) their respective successors and (in the case of a Lender, permitted) transferees and assigns.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the United States Securities Act of 1933, as amended from time to time and any successor statute.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securitization Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the accounts receivable, royalty or other revenue streams and other rights to payment and other assets related thereto and the proceeds thereof and (b) contract rights, lockbox accounts and records with respect to such accounts receivable and any other assets customarily transferred together with accounts receivable in a securitization financing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securitization Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means distributions or payments made directly or by means of discounts with respect to any participation interest issued or sold in connection with, and other fees and expenses (including reasonable fees and expenses of legal counsel) paid to a Person that is not a Securitization Subsidiary in connection with any Qualified Securitization Financing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securitization Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any transaction or series of transactions that may be entered into by Holdings or any of its Subsidiaries pursuant to which Holdings or any of its Subsidiaries may sell, convey or otherwise transfer to (a) a Securitization Subsidiary (in the case of a transfer by Holdings or any of its Subsidiaries) or (b) any other Person (in the case of a transfer by a Securitization Subsidiary), or may grant a security interest in (which in either case </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">may include a backup or precautionary grant) any Securitization Assets of Holdings or any of its Subsidiaries, and any assets related thereto, including all collateral securing such Securitization Assets, all contracts and all guarantees or other obligations in respect of such Securitization Assets, proceeds of such Securitization Assets and other assets that are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving Securitization Assets.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securitization Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a wholly-owned Subsidiary of Holdings (or another Person formed for the purposes of engaging in a Qualified Securitization Financing in which Holdings or any Subsidiary of Holdings makes an investment and to which Holdings or any Subsidiary of Holdings transfers Securitization Assets and related assets) that engages in no activities other than in connection with the financing of Securitization Assets of Holdings or its Subsidiaries, all proceeds thereof and all rights (contingent and other), collateral and other assets relating thereto, and any business or activities incidental or related to such business, and which is designated by the Board of Directors or such other Person (as provided below) as a Securitization Subsidiary. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Series A Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the 2.32% Series A Senior Notes due December 8, 2023 issued by Icon Investments Five Unlimited Company on December 8, 2020.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Series B Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the 2.43% Series B Senior Notes due December 8, 2025 issued by Icon Investments Five Unlimited Company on December 8, 2020.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Solvent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to Holdings and its Subsidiaries, on the Closing Date, after giving effect to the consummation of the Transactions, and after giving effect to the application of the proceeds of such indebtedness under such Transactions&#58;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The amount of the fair saleable value of the assets of Holdings and its Subsidiaries on a consolidated basis exceeds&#58;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;the value of all liabilities of Holdings and its Subsidiaries (on a consolidated basis), including contingent and other liabilities, as generally determined in accordance with applicable United States federal laws governing determinations of the insolvency of debtors&#59; and</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the amount that will be required to pay the probable liabilities of Holdings and its Subsidiaries on its existing debts (including contingent liabilities) as such debts become absolute and matured&#59;</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Holdings and its Subsidiaries (on a consolidated basis) do not have an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged&#59; and</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Holdings and its Subsidiaries (on a consolidated basis) will be able to pay its liabilities, including contingent and other liabilities, as they mature.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any RFR Business Day, a rate per annum equal to the Sterling Overnight Index Average for such RFR Business Day published by the SONIA Administrator on the SONIA Administrator&#8217;s Website. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England (or any successor administrator of the Sterling Overnight Index Average). </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England&#8217;s website, currently at http&#58;&#47;&#47;www.bankofengland.co.uk, or any successor source for the Sterling Overnight Index Average identified as such by the SONIA Administrator from time to time.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the representations and warranties set forth in Sections 3.01 (as it relates to organizational existence of the Loan Parties), 3.02 (as it relates to the due authorization, execution and delivery of the Loan Documents), 3.03 (as it relates to no conflicts with or violations of Organizational Documents), 3.08, 3.12, 3.14 (limited to execution, delivery and performance of the Loan Documents), 3.15 and 3.16.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) at the option of Holdings, any designation of operations or assets of Holdings or a Restricted Subsidiary as discontinued operations (as defined under GAAP), (b) at the option of Holdings, any Investment that results in a Person becoming a Restricted Subsidiary, (c) any designation of a Subsidiary as a Restricted Subsidiary or an Unrestricted Subsidiary, (d) any Material Acquisition, (e) any Material Disposition that results in a Restricted Subsidiary ceasing to be a Subsidiary of Holdings or any Disposition of a business unit, line of business or division or product line of Holdings, in each case whether by merger, consolidation, amalgamation or otherwise, (f) or any incurrence or repayment of Indebtedness (other than Indebtedness incurred or repaid under any revolving credit facility or line of credit in the ordinary course of business for working capital purposes) that by the terms of this Agreement requires such test to be calculated on a Pro Forma Basis or after giving Pro Forma Effect and (g) the Transactions.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Standard Securitization Undertakings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means representations, warranties, covenants and indemnities entered into by Holdings or any Subsidiary of Holdings that are customary (as determined by Holdings in good faith) in a Securitization Financing or a Qualified Receivables Factoring, including without limitation those relating to the servicing of the assets of a Securitization Subsidiary, it being understood that a Receivables Repurchase Obligations shall be deemed to be a Standard Securitization Undertaking.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Statutory Reserve Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any currency, a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one minus the aggregate of the maximum reserve, liquid asset, fees or similar requirements (including any marginal, special, emergency or supplemental reserves or other requirements) established by any central bank, monetary authority, the Board, the Financial Conduct Authority or the Prudential Regulatory Authority of the United Kingdom, the European Central Bank or other Governmental Authority for any category of deposits or liabilities customarily used to fund loans in such currency, expressed in the case of each such requirement as a decimal.  Such reserve, liquid asset, fees or similar requirements shall, in the case of Dollar denominated Loans, include those imposed pursuant to Regulation D of the Board.  Eurocurrency Loans and RFR Loans shall be deemed to be subject to such reserve, liquid asset, fee or similar requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under any applicable law, rule or regulation, including Regulation D of the Board.  The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve, liquid asset or similar requirement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subordinated Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Indebtedness of Holdings or any Restricted Subsidiary the payment of which is contractually subordinated in right of payment of the obligations under the Loan Documents (excluding intercompany Indebtedness between or among members of the Group).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) at any date, (i) any corporation, limited liability company, partnership, association or other entity the accounts of which would be consolidated with those of the parent in the parent&#8217;s consolidated financial statements if such financial statements were prepared in accordance with GAAP as of such date, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as well as any other corporation, limited liability company, partnership, association or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or, in the case of a partnership, more than 50% of the general partnership interests are, as of such date, owned, Controlled or held&#59; and (ii) in the case of any Person incorporated in Ireland, any subsidiary of that Person within the meaning of Section 7 of the Companies Act or Regulation 4 of the European Communities (Companies Group Accounts) Regulations 1992.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any subsidiary of Holdings (unless a contrary intention appears herein).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each Subsidiary that is party to this Agreement from time to time.  The Subsidiary Guarantors as of the Closing Date will be each Subsidiary of Holdings as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1.01F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything herein or in any other Loan Document to the contrary, no Excluded Subsidiary or Unrestricted Subsidiary shall be required to be a Subsidiary Guarantor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Holdings shall be required to comply with the provisions set forth in Section 5.09(f). Notwithstanding the foregoing, Holdings may elect to cause any Restricted Subsidiary that is not otherwise required to be a Subsidiary Guarantor to provide a Guarantee by causing such Restricted Subsidiary to execute a Joinder Agreement (or, in the case of any Foreign Subsidiary, a guaranty of the Secured Obligations (which may be the Guarantee or, if reasonably required by the Administrative Agent in order to create a legally enforceable Guarantee, a guaranty governed by the laws of the applicable country in which such Foreign Subsidiary is incorporated or organized) and all documents, financing statements, agreements, instruments, certificates, notices and acknowledgements and filings which the Administrative Agent may reasonably request to ensure the creation, perfection and priority of the Liens on the assets of such Foreign Subsidiary, in each case (i) in a form reasonably acceptable to the Administrative Agent, (ii) governed by the laws of the applicable country in which such Foreign Subsidiary is incorporated or organized and (iii) subject to the Agreed Guarantee and Security Principles and customary exceptions for transactions of this type in such applicable country), and any such Restricted Subsidiary shall be a Loan Party and Subsidiary Guarantor for all purposes hereunder. In the event that Holdings elects to cause a Foreign Subsidiary to be a Subsidiary Guarantor in accordance with the foregoing, such Foreign Subsidiary shall cease to be an Excluded Subsidiary for purposes of the Loan Documents. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Supported QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.20.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swap Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of Holdings or its Restricted Subsidiaries shall be a Swap Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swap Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any and all obligations of Holdings or any Restricted Subsidiary, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor), under (a) any and all Swap Agreements with a Hedge Bank, (b) any and all cancellations, buy backs, reversals, terminations or assignments of any such Swap Agreement transaction and (c) any obligation to pay or perform under any agreement, contract or transaction that constitutes a &#8220;swap&#8221; within the meaning of section 1a(47) of the Commodity Exchange Act.  For the avoidance of doubt, Permitted Equity Derivatives shall not constitute Swap Obligations.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, the aggregate principal amount of all Swingline Loans outstanding at such time.  The Swingline Exposure of any Lender at any time shall be its Revolving Percentage of the total Swingline Exposure at such time. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Citibank, N.A. (acting through itself or one of its designated affiliates or branch offices), in its capacity as lender of Swingline Loans hereunder and any other Lender designated by the Applicable Borrower as a &#8220;Swingline Lender&#8221; hereunder that has agreed to such designation (and is reasonably acceptable to the Administrative Agent).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan made pursuant to Section 2.05.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Target</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means PRA Health Sciences, Inc., a Delaware corporation, and its Subsidiaries (prior to consummation of the Acquisition).  References to Target herein and in the other Loan Documents shall, from and after the Closing Date, mean PRA Health Sciences, Inc.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">TARGET</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Trans-European Automated Real-time Gross Settlement Express Transfer (TARGET) payment system (or, if such payment system ceases to be operative, such other payment system (if any) reasonably determined by the Administrative Agent to be a suitable replacement) for the settlement of payments in euro.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Target Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Credit Agreement, dated October 28, 2019, by and among the Target, PNC Bank, National Association, as administrative agent, the lenders party thereto and the other parties thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Target Receivables Financing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Receivables Financing Agreement, dated as of March 22, 2016, by and among the Target, PNC Capital Markets LLC, as structuring agent, the lenders party thereto and the other parties thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all present or future taxes, levies, imposts, duties, assessments, withholdings or similar charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 6.04(b)(xxii).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">TCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Taxes Consolidation Act 1997 of Ireland.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term A Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Indebtedness with amortization in excess of 1% and less than or equal to 10% per year that is marketed principally to regulated commercial banks (as determined by Holdings) in an aggregate principal amount for all Term A Facilities outstanding at any time not to exceed the greater of $1,160,000,000 and 100% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, each Lender that holds Term Loan Commitments or Term Loans. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Lux Term Loan Commitments, the U.S. Term Loan Commitments, the Extended Term Loan Commitments, the Incremental Term Loan Commitments and the Other Refinancing Term Commitments.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loan Increases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means one or more new Incremental Term Loan Commitments which are in the same Tranche as any outstanding Term Loans.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Lux Term Loans, the U.S. Term Loans, any Incremental Term Loan (including any Other Term Loan), any Other Refinancing Term Loans of the applicable Class or any Extended Term Loan.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Test Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any date of determination, the most recently completed four consecutive fiscal quarters ending on or prior to such date for which financial statements are available.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the total assets of the Group, as shown on the most recent balance sheet of Holdings for which financial statements are available on which any calculation of Total Assets is being made, calculated on a Pro Forma Basis in accordance with Section 1.07 to give effect to any Material Acquisition or Material Disposition since the date of such balance sheet. For the avoidance of doubt, any Indebtedness or Lien incurred, Investment or Restricted Payment made in each case was permitted under this Agreement at the time of such incurrence, making or receipt, shall continue to be permitted hereunder, regardless of any subsequent decrease in Total Assets.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Net Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Test Period, the ratio of (a) Consolidated Total Indebtedness net of Unrestricted Cash as of the last day of such Test Period to (b) Consolidated EBITDA for such Test Period.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a category of Commitments and extensions of credit thereunder (e.g. Lux Term Loans, U.S. Term Loans and Incremental Term Loans).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) the execution, delivery and performance by the Loan Parties of this Agreement and the other Loan Documents, (b) the borrowing of Loans and other credit extensions and the use of the proceeds thereof, (c) the granting of Liens pursuant to the Collateral Documents, (d) the Acquisition (including the execution of the Acquisition Documents, the payment of the Deferred Acquisition Consideration and the other transactions contemplated by the Acquisition Documents), (e) the execution, delivery and performance of the New Note Documents and the issuance of the New Notes thereunder, (f) the Refinancing, (g) any other transactions related to or entered into in connection with any of the foregoing, including without limitation each of the transactions described in the memorandum prepared by KPMG and provided to the Administrative Agent prior to the Closing Date and (h) the payment of the fees and expenses incurred in connection with any of the foregoing.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transformative Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any acquisition by Holdings, any Borrower or any other Restricted Subsidiary that (i) is not permitted by the terms of the Loan Documents immediately prior to the consummation of such acquisition or (ii) if permitted by the terms of the Loan Documents immediately prior to the consummation of such acquisition, would not provide Holdings, any Borrower and the other Restricted Subsidiaries with adequate flexibility under the Loan Documents for the continuation and&#47;or expansion of their combined operations following such consummation, as determined by the Borrowers acting in good faith.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transformative Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Disposition by Holdings, any Borrower or any other Restricted Subsidiary that (i) is not permitted by the terms of the Loan Documents immediately prior to the consummation of such disposition or (ii) if permitted by the terms of the Loan Documents immediately prior to the consummation of such disposition, would not provide Holdings, the Borrowers and the other Restricted Subsidiaries with adequate flexibility under the Loan Documents for the continuation and&#47;or expansion of their combined operations following such consummation, as determined by the Borrowers acting in good faith.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to Loans or Borrowings in a single currency and whether the rate of interest on such Loan, or on the Loans comprising </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such Borrowing, is determined by reference to the Eurocurrency Rate, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Daily Simple RFR or the Alternate Base Rate.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">UCC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Uniform Commercial Code as in effect from time to time in the State of New York or any other state the laws of which are required to be applied in connection with the issue of perfection of security interests.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unliquidated Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Secured Obligations (or portion thereof) that are contingent in nature or unliquidated at such time, including any Secured Obligation that is&#58; (i) an obligation to reimburse a bank for drawings not yet made under a letter of credit issued by it&#59; (ii) any other obligation (including any guarantee) that is contingent in nature at such time&#59; and (iii) an obligation to provide collateral to secure any of the foregoing types of obligations.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unrestricted Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means at any time the sum of (i) unrestricted cash and Cash Equivalents whether or not held in a pledged account plus (ii) cash and Cash Equivalents restricted in favor of the Obligations (which may also include cash and Cash Equivalents securing other Indebtedness secured by a Lien on the Collateral along with the Obligations at such time), in each case, such unrestricted cash and restricted cash and Cash Equivalents to be determined in accordance with GAAP. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unrestricted Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (1) IGPHS, (2) each Securitization Subsidiary, (3) any Subsidiary that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors of Holdings in accordance with Section 5.10 and (4) any Subsidiary of an Unrestricted Subsidiary.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;USD Adjusted Term SOFR&#8221; means, for purposes of any calculation, the rate per annum equal to (a) USD Term SOFR for such calculation plus (b) the USD Term SOFR Adjustment&#59; provided that if USD Adjusted Term SOFR as so determined shall ever</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> be less than the USD Floor, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">then  USD Adjusted Term SOFR shall</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> be deemed to be the USD Floor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Available Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination and with respect to any then-current Benchmark for any currency, as applicable, (x) if any then-current USD Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference to such USD Benchmark, as applicable, pursuant to this Agreement as of such date.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, initially, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> USD </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if a</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> replacement of an initial or subsequent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> USD Benchmark</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> has occurred pursuant to Section 2.14, then &#8220;USD Benchmark&#8221; means the applicable USD Benchmark Replacement to the extent that such USD Benchmark Replacement has replaced such prior benchmark rate. Any reference to &#8220;USD Benchmark&#8221; shall include, as applicable, the published component used in the calculation thereof.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any USD Available Tenor</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#58;(i)&#160;&#160;&#160;&#160;For</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> purposes of Section 2.14(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">a), the first alternative set forth below that can be determined by the Administrative Agent&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(A)&#160;&#160;&#160;&#160;the sum of&#58; (i) USD Term SOFR and (ii) 0.11448% (11.448 basis points) for a USD Available Tenor of one-month&#8217;s duration, 0.26161% (26.161 basis points) for a USD Available Tenor of three-months&#8217; duration and 0.42826% (42.826 basis points) for a USD Available Tenor of six-months&#8217; duration, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(B)&#160;&#160;&#160;&#160;the sum of&#58; (i) USD Daily Simple SOFR and (ii) the spread adjustment selected or recommended by the Relevant Governmental Body for the replacement of the tenor of USD LIBOR with a USD SOFR-based rate having approximately the same length as the interest payment period specified in Section 2.14(a)&#59; and(ii)&#160;&#160;&#160;&#160;For purposes of 2.14(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">b), the sum of (a) the alternate benchmark rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> that has been selected by the Administrative Agent and Holdings giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (b) an adjustment (which may be a positive or negative value or zero), in each case, that has been selected by the Administrative Agent and Holdings as the replacement for such USD Available Tenor of such USD Benchmark giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by the Relevant Governmental Body, for Dollar-denominated syndicated credit facilities at such time in the U.S. syndicated loan market</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> that, if the USD Benchmark Replacement as determined pursuant to clause (i) or (ii) above would</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> be less than the USD Floor, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the USD Benchmark Replacement will</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> be deemed to be the USD Floor</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> for the purposes of this Agreement and the other Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any USD Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;ABR,&#8221; the definition of &#8220;Business Day,&#8221;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> the definition of &#8220;U.S. Government Securities Business Day,&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the definition of &#8220;Interest Period,&#8221;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or any similar or analogous definition (or the addition of a concept of &#8220;interest period&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions and other technical, administrative or operational matters) that the Administrative Agent, in consultation with Holdings, decides may be appropriate to reflect the adoption and implementation of such USD Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such USD Benchmark Replacement exists, in such other manner of administration as the Administrative Agent, in consultation with Holdings, decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any then-current USD Benchmark</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> other than USD LIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the occurrence of one or more of the following events&#58; a public statement or publication of information by or on behalf of the administrator of any then-current USD Benchmark, the regulatory supervisor for the administrator of such USD </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">78</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benchmark, the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such USD Benchmark, a resolution authority with jurisdiction over the administrator for such USD Benchmark or a court or an entity with similar insolvency or resolution authority over the administrator for such USD Benchmark, announcing or stating that (a) such administrator has ceased or will cease on a specified date to provide all USD Available Tenors of such USD Benchmark, permanently or indefinitely, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any USD Available Tenor of such USD Benchmark or (b) all USD Available Tenors of such USD Benchmark are or will no longer be representative of the underlying market and economic reality that such USD Benchmark is intended to measure and that representativeness will not be restored.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">USD Daily Simple SOFR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, for any day, USD SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate recommended by the Relevant Governmental Body for determining &#8220;USD Daily Simple SOFR&#8221; for syndicated business loans&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> in its reasonable discretion</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">USD Early Opt-in Effective Date</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, with respect to any USD Early Opt-in Election, the sixth (6</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:line-through">th</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">) Business Day after the date notice of such USD Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such USD Early Opt-in Election is provided to the Lenders, written notice of objection to such USD Early Opt-in Election from Lenders comprising the Required Lenders.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">USD Early Opt-in Election</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, in the case of Loans denominated in Dollars, if the then-current USD Benchmark is USD LIBOR, the occurrence of the following&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(i)&#160;&#160;&#160;&#160;(a) a notification by the Administrative Agent to (or the request by Holdings to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding Dollars denominated syndicated credit facilities in the U.S. syndicated loan market at such time contain (as a result of amendment or as originally executed) a USD SOFR-based rate (including USD SOFR, a term USD SOFR or any other rate based upon USD SOFR) as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(ii)&#160;&#160;&#160;&#160;the joint election by the Administrative Agent and Holdings to trigger a fallback from USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Lenders.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Floor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to the</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> initial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> USD Benchmark, which is 0% with respect to the Initial Revolving Loans and 0.50% with respect to the Initial Term Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">USD LIBOR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the London interbank offered rate for Dollars.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">USD SOFR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means a rate per annum equal to the secured overnight financing rate for such Business Day published by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate) on the website of the Federal Reserve Bank of New York, currently at http&#58;&#47;&#47;www.newyorkfed.org</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(or any successor source for the secured </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">overnight financing rate identified as such by the administrator of the secured overnight financing rate from time to time).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;USD SOFR&#8221; means a rate equal to the secured overnight financing rate as administered by the USD Term SOFR Administrator.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;USD Term SOFR&#8221; means, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(a) &#160;&#160;&#160;&#160;for any calculation with respect to a USD SOFR Loan, the USD Term SOFR Reference Rate for a tenor comparable to the applicable Interest Period on the day (such day, the &#8220;USD Periodic Term SOFR Determination Day&#8221;) that is two (2) U.S. Government Securities Business Days prior to the first day of such Interest Period, as such rate is published by the USD Term SOFR Administrator&#59; provided, however, that if as of 5&#58;00 p.m. (New York City time) on any USD Periodic Term SOFR Determination Day the USD Term SOFR Reference Rate for the applicable tenor has not been published by the USD Term SOFR Administrator and a USD Benchmark Replacement Date with respect to the  USD Term SOFR Reference Rate has not occurred, then USD Term SOFR will be the USD Term SOFR Reference Rate for such tenor as published by the USD Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such USD Term SOFR Reference Rate for such tenor was published by the USD Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such USD Periodic Term SOFR Determination Day, and</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;for any calculation with respect to an ABR Loan on any day, the USD Term SOFR Reference Rate for a tenor of one month on the day (such day, the &#8220;ABR Term SOFR Determination Day&#8221;) that is two (2) U.S. Government Securities Business Days prior to such day, as such rate is published by the USD Term SOFR Administrator&#59; provided, however, that if as of 5&#58;00 p.m. (New York City time) on any ABR Term SOFR Determination Day the USD Term SOFR Reference Rate for the applicable tenor has not been published by the USD Term SOFR Administrator and a USD Benchmark Replacement Date with respect to the USD Term SOFR Reference Rate has not occurred, then USD Term SOFR will be the USD Term SOFR Reference Rate for such tenor as published by the USD Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such USD Term SOFR Reference Rate for such tenor was published by the USD Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such ABR SOFR Determination Day.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;USD Term SOFR Adjustment&#8221; means, for any calculation with respect to a USD Term SOFR Loan, a percentage per annum as set forth below for the applicable Interest Period therefor&#58;</font></div><div style="padding-left:66.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.804%"><tr><td style="width:1.0%"></td><td style="width:48.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ccccff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Period</font></div></td><td colspan="3" style="background-color:#ccccff;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Percentage</font></div></td></tr><tr><td colspan="3" style="background-color:#ccccff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">One month</font></div></td><td colspan="3" style="background-color:#ccccff;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">0.11448 %</font></div></td></tr><tr><td colspan="3" style="background-color:#ccccff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Three months</font></div></td><td colspan="3" style="background-color:#ccccff;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">0.26161%</font></div></td></tr><tr><td colspan="3" style="background-color:#ccccff;border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Six months</font></div></td><td colspan="3" style="background-color:#ccccff;border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">0.42826%</font></div></td></tr></table></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;USD Term SOFR Administrator&#8221; means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the USD Term SOFR Reference Rate selected by the Administrative Agent</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> in its reasonable discretion</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">).</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">80</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;USD Term SOFR Loan&#8221; means a Loan that bears interest at a rate based on Adjusted Term SOFR, other than pursuant to clause (c) of the definition of &#8220;Alternate Base Rate&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, for the applicable corresponding tenor,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the forward-looking term rate based on USD SOFR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> that has been selected or recommended by the Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in the preamble hereto or any Additional Borrower organized under the laws of the United States, any state thereof or the District of Columbia.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Corporate Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Domestic Subsidiary of Holdings that is treated as a corporation for U.S. federal income tax purposes. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;U.S. Government Securities Business Day&#8221; means any day except for (a) a Saturday, (b) a Sunday or (c) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Holdco</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means ICON US Holdings, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Holdings.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person that is a &#8220;United States person&#8221; as defined in Section 7701(a)(30) of the Code.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Security Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain Pledge and Security Agreement (including any and all supplements thereto), substantially in the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, dated as of the Closing Date (or such earlier date to the extent executed prior to the Closing Date by certain of the Foreign Grantors (as defined therein) party thereto), between the U.S. Borrower, each other Domestic Subsidiary that is a Subsidiary Guarantor and each Foreign Grantor (as defined therein) party thereto and the Collateral Agent, for the benefit of the Collateral Agent and the other Secured Parties, and any other pledge or security agreement entered into after the date hereof by any other Loan Party that is a Domestic Subsidiary (as required by this Agreement or any other Loan Document), or by any Foreign Loan Party with respect to Domestic Pledged Equity (each as defined in the U.S. Security Agreement), with the Collateral Agent. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Special Resolution Regime</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.20.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Tax Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.17(e)(i)(A)(iii).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to each Term Lender, the commitment, if any, of such Term Lender to make U.S. Term Loans hereunder, as such commitment may be (a) reduced or terminated from time to time pursuant to Section 2.09 and (b) reduced or increased from time to time pursuant to assignments by or to such Term Lender pursuant to Section 9.04. The amount of each Term Lender&#8217;s U.S. Term Loan Commitment as of the Closing Date is set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or in the Assignment and Assumption (or other documentation contemplated by this Agreement) pursuant to which such Term Lender shall have assumed its U.S. Term Loan Commitment, as applicable, and any other Refinancing Commitments and any Incremental Term Loan Commitments. The aggregate principal amount of the U.S. Term Loan Commitments on the Closing Date is $1,100,000,000.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Term Loan Repayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 2.10(a)(ii).</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">81</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the term loans made by the Term Lenders to the U.S. Borrower on the Closing Date pursuant to Section 2.01. Each U.S. Term Loan shall be a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan denominated in Dollars or an ABR Loan denominated in Dollars. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to such term in Section 9.14.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any specified Person means as of any date the Equity Interests of such Person of the class or classes that has the general voting power under ordinary circumstances to elect at least a majority of the Board of Directors of such Person (irrespective of whether or not at the time Equity Interests of any other class or classes shall have or might have voting power by reason of the happening of any contingency).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted Average Life to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, when applied to any Indebtedness at any date, the number of years obtained by dividing&#58;  (a) the sum of the products obtained by multiplying (i) the amount of each then remaining installment, sinking fund, serial maturity or other required payments of principal, including payment at final maturity, in respect thereof, by (ii) the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such payment&#59; by (b) the then outstanding principal amount of such Indebtedness.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom,  any powers of the applicable Resolution Authority  under the Bail-In Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or other financial institution or affiliate of a bank, investment firm or other financial institution, to cancel, reduce, modify or change the form of a liability of any UK Financial Institution  or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Classification of Loans and Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, Loans may be classified and referred to by Class (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a &#8220;Term Loan&#8221;) or by Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a &#8220;Eurocurrency Loan&#8221;) or by Class and Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a &#8220;Eurocurrency Term Loan&#8221;).  Borrowings also may be classified and referred to by Class (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a &#8220;Term Loan Borrowing&#8221;) or by Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a &#8220;Eurocurrency Borrowing&#8221;) or by Class and Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a &#8220;Term Loan Eurocurrency Borrowing&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Terms Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined.  Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.  The words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation&#8221;.  The word &#8220;will&#8221; shall be construed to have the same meaning and effect as the word &#8220;shall&#8221;.  The word &#8220;law&#8221; shall be construed as referring to all statutes, rules, regulations, codes and other laws (including official rulings and interpretations thereunder having the force of law or with which affected Persons customarily comply), and all judgments, orders and decrees, of all Governmental Authorities.  Unless the context requires otherwise (a) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, restated, supplemented or otherwise modified (subject to any restrictions on such amendments, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">82</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">restatements, supplements or modifications set forth herein), (b) any definition of or reference to any statute, rule or regulation shall be construed as referring thereto as from time to time amended, supplemented or otherwise modified (including by succession of comparable successor laws), (c) any reference herein to any Person shall be construed to include such Person&#8217;s successors and assigns (subject to any restrictions on assignment set forth herein) and, in the case of any Governmental Authority, any other Governmental Authority that shall have succeeded to any or all functions thereof, (d) the words &#8220;herein&#8221;, &#8220;hereof&#8221; and &#8220;hereunder&#8221;, and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (e) all references herein to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to, this Agreement and (f) the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights.  Any references in this Agreement or any other Loan Document to &#8220;Permitted Liens&#8221; is not intended to subordinate or postpone, and shall not be interpreted as subordinating or postponing, or as any agreement to subordinate or postpone, any Lien created by any of the Loan Documents to any Permitted Lien.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Accounting Terms&#59; GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if Holdings notifies the Administrative Agent that Holdings requests an amendment to any provision hereof to eliminate the effect of any change occurring after the Closing Date in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies Holdings that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  At any time after the Closing Date, Holdings may elect (by written notice to the Administrative Agent) to change its financial reporting (both hereunder and for its audited financial statements generally) from GAAP to International Financial Reporting Standards (as issued by the International Accounting Standards Board and the International Financial Reporting Standards Interpretations Committee and&#47;or adopted by the European Union (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">IFRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)), as in effect from time to time, in which case all references herein to GAAP (except for historical financial statements theretofore prepared in accordance with GAAP) shall instead be deemed references to the IFRS and the related accounting standards as shown in the first set of audited financial statements prepared in accordance therewith and delivered pursuant to this Agreement&#59; provided that, if Holdings notifies the Administrative Agent that Holdings requests an amendment to any provision hereof to eliminate the effect of any change occurring as a result of the adoption of IFRS or in the application thereof on the operation of such provision (or if the Administrative Agent notifies Holdings that the Administrative Agent or the Required Lenders request an amendment to any provision hereof for such purpose), then such provision shall be interpreted on the basis of GAAP as otherwise required above (and without regard to this sentence) until such notice shall have been withdrawn or such provision amended in accordance herewith&#59; provided further that, if, after the adoption of IFRS by Holdings, Holdings notifies the Administrative Agent that Holdings requests an amendment to any provision hereof to eliminate the effect of any change in IFRS occurring after such adoption of IFRS or in the application thereof on the operation of such provision (or if the Administrative Agent notifies Holdings that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in IFRS or in the application thereof, then such provision shall be interpreted on the basis of IFRS as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made (i) </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">83</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">without giving effect to any election under Accounting Standards Codification 825-10-25 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of Holdings or any Subsidiary at &#8220;fair value&#8221;, as defined therein, (ii) without giving effect to any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof and (iii) for the avoidance of doubt, except as provided in the definition of &#8220;Consolidated Net Income&#8221;, without giving effect to the financial condition, results and performance of the Unrestricted Subsidiaries.  For purposes of calculating Consolidated Net Income, Total Assets and Consolidated EBITDA under this Agreement and any other Loan Document, IGPHS shall be treated as a Restricted Subsidiary of Holdings, notwithstanding the fact that IGPHS is an Unrestricted Subsidiary for all other purposes of the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Special Luxembourg Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Words in the English language used in this Agreement to describe Luxembourg law concepts only intend to describe such concepts and the consequences of the use of those words in English law or any other foreign law are to be disregarded.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without prejudice to the generality of any provision of this Agreement, to the extent this Agreement relates to any Luxembourg Loan Party or any entity incorporated or existing under the laws of Luxembourg, a reference to&#58; (a) a winding-up, administration or dissolution includes, without limitation, bankruptcy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), insolvency, liquidation, composition with creditors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">concordat pr&#233;ventif de la faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), moratorium or reprieve from payment (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">sursis de paiement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), controlled management (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">gestion contr&#244;l&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), fraudulent conveyance (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">actio pauliana</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), general settlement with creditors, reorganization or similar laws affecting the rights of creditors generally&#59; (b) a receiver, administrative receiver, administrator, trustee, custodian, sequestrator, conservator or similar officer appointed for the reorganization or liquidation of the business of a Person includes, without limitation, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">juge d&#233;l&#233;gu&#233;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">commissaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">juge-commissaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">mandataire ad hoc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">administrateur provisoire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">liquidateur </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> curateur</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; (c) a lien or security interest includes any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">hypoth&#232;que, nantissement, gage, privil&#232;ge, s&#251;ret&#233; r&#233;elle, droit de r&#233;tention </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and any type of security in rem (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">s&#251;ret&#233; r&#233;elle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or agreement or arrangement having a similar effect and any transfer of title by way of security&#59; (d) a person being unable to pay its debts includes that person being in a state of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">cessation de paiements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; (e) creditors process means an executory attachment (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">saisie ex&#233;cutoire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or conservatory attachment (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">saisie conservatoire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; (f) by-laws or constitutional documents includes its up-to-date (restated) articles of association (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">statuts coordonn&#233;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and (g) a director, a manager or authorized officer includes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">administrateur </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">g&#233;rant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Certain Conditions, Calculations and Tests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary herein, financial ratios and tests, including the First Lien Net Leverage Ratio, the Secured Net Leverage Ratio, the Total Net Leverage Ratio, the Fixed Charge Coverage Ratio and the determination of any basket or covenant based on Consolidated EBITDA or Total Assets shall be calculated in the manner prescribed by this Section 1.07&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that notwithstanding anything to the contrary in clause (b) of this Section 1.07, when calculating the Secured Net Leverage Ratio, the First Lien Net Leverage Ratio and the Total Net Leverage Ratio, each as applicable, for purposes of (i) the definition of &#8220;Applicable Margin&#8221;, (ii) the definition of &#8220;ECF Payment Amount&#8221; and (iii) Section 6.12 (other than for the purpose of determining pro forma compliance with Section 6.12), the events described in this Section 1.07 that occurred subsequent to the end of the applicable Test Period shall not be given Pro Forma Effect. In addition, whenever a financial ratio or test or </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">84</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">determination of Consolidated EBITDA or Total Assets is to be calculated on a Pro Forma Basis, the reference to &#8220;Test Period&#8221; for purposes of calculating such financial ratio or test or determination of Consolidated EBITDA or Total Assets shall be deemed to be a reference to, and shall be based on, the most recently ended Test Period for which internal financial statements of Holdings are available (as determined in good faith by Holdings). For the avoidance of doubt, the provisions of the foregoing sentence shall not apply for purposes of calculating the Secured Net Leverage Ratio, the First Lien Net Leverage Ratio or the Total Net Leverage Ratio, each as applicable, for purposes of (i) the definition of &#8220;ECF Payment Amount&#8221; and (ii) Section 6.12 (other than for the purpose of determining pro forma compliance with Section 6.12), each of which shall be based on the financial statements delivered pursuant to Section 5.01(a) or (b), as applicable, for the relevant Test Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">For purposes of calculating any financial ratio or test (or Consolidated EBITDA or Total Assets), Specified Transactions (with any incurrence or repayment of any Indebtedness in connection therewith to be subject to clause (d) of this Section 1.07) that have been made (i) during the applicable Test Period or (ii) if applicable as described in clause (a) above, subsequent to such Test Period and prior to or simultaneously with the event for which the calculation of any such ratio or test (or Consolidated EBITDA or Total Assets) is made shall be calculated on a Pro Forma Basis assuming that all such Specified Transactions (and any increase or decrease in Consolidated EBITDA and the component financial definitions used therein attributable to any Specified Transaction) had occurred on the first day of the applicable Test Period (or, in the case of Consolidated EBITDA or Total Assets, on the last day of the applicable Test Period).  If since the beginning of any applicable Test Period any Person that subsequently became a Restricted Subsidiary or was merged, amalgamated or consolidated with or into Holdings or any of its Restricted Subsidiaries since the beginning of such Test Period shall have made any Specified Transaction that would have required adjustment pursuant to this Section 1.07, then such financial ratio or test (or Consolidated EBITDA or Total Assets) shall be calculated to give Pro Forma Effect thereto in accordance with this Section 1.07.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Whenever Pro Forma Effect is to be given to a Specified Transaction, the pro forma calculations shall be made in good faith by a responsible financial or accounting officer of Holdings and may include, for the avoidance of doubt, the amount of Run-rate cost savings, synergies and operating expense reductions projected by Holdings to be realized as a result of any Specified Transaction (including the Transactions) which is being given Pro Forma Effect that have been realized or are expected to be realized and for which the actions necessary to realize such cost savings, operating expense reductions and synergies are taken, committed to be taken or with respect to which substantial steps have been taken or are expected in good faith to be taken (calculated on a Pro Forma Basis as though such cost savings, operating expense reductions and synergies had been realized on the first day of such period and as if such cost savings, operating expense reductions and synergies were realized during the entirety of such period and net of the amount of actual benefits realized during such period from such actions, and any such adjustments shall be included in the initial pro forma calculations of such financial ratios or tests and during any subsequent Test Period in which the effects thereof are expected to be realized) relating to such Specified Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) such amounts are reasonably identifiable and factually supportable in the good faith judgment of Holdings, (B) the aggregate amount of cost savings, synergies and operating expense reductions, when aggregated with the addbacks being made for such Test Period pursuant to clause (vii) of the definition of Consolidated EBITDA, shall not exceed the cap set forth therein, (C) any cost savings, synergies and operating expense reductions included pursuant to this Section 1.08(c) shall be subject to the other limitations set forth in clause (vii) of the definition of Consolidated EBITDA and (D) no amounts shall be added to the extent duplicative of any amounts that are otherwise added back in computing Consolidated EBITDA (or any other components thereof), whether through a pro forma adjustment or otherwise, with respect to such period.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">85</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In the event that (w) Holdings or any Restricted Subsidiary incurs (including by assumption or guarantees) or repays (including by redemption, repayment, retirement or extinguishment) any Indebtedness (other than Indebtedness incurred or repaid under any revolving credit facility (including, without limitation, the Revolving Loans) in the ordinary course of business for working capital purposes), (x) Holdings or any Restricted Subsidiary issues, repurchases or redeems Disqualified Equity Interests or (y) any Restricted Subsidiary issues, repurchases or redeems Preferred Equity, (i) during the applicable Test Period or (ii) if applicable as described in clause (a) above, subsequent to the end of the applicable Test Period and prior to or simultaneously with the event for which the calculation of any such ratio is made, then such financial ratio or test shall be calculated giving Pro Forma Effect to such incurrence or repayment of Indebtedness, or such issuance or redemption of Disqualified Equity Interests or Preferred Equity, in each case to the extent required, as if the same had occurred on the last day of the applicable Test Period (except in the case of the Fixed Charge Coverage Ratio (or similar ratio), in which case such incurrence, assumption, guarantee, redemption, repayment, retirement or extinguishment of Indebtedness or such issuance, repurchase or redemption of Disqualified Equity Interests or Preferred Equity will be given effect, as if the same had occurred on the first day of the applicable Test Period).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If any Indebtedness bears a floating rate of interest and is being given Pro Forma Effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the date of the event for which the calculation of the Fixed Charge Coverage Ratio is made had been the applicable margin for the entire period (taking into account any interest hedging arrangements applicable to such Indebtedness). Interest on a Capital Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a Responsible Officer of Holdings to be the rate of interest implicit in such Capital Lease Obligation in accordance with GAAP. For purposes of the computation above, interest on any Indebtedness under a revolving credit facility computed on a Pro Forma Basis shall be computed on the average daily balances of such Indebtedness during the applicable period. Interest on Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rate, shall be determined to have been based upon the rate actually chosen, or if none, then based upon such optional rate chosen as Holdings or Restricted Subsidiary may designate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Solely for purposes of determining (i) compliance on a Pro Forma Basis with any provision of this Agreement that requires the calculation of the First Lien Net Leverage Ratio, Secured Net Leverage Ratio, Total Net Leverage Ratio, Fixed Charge Coverage Ratio, Total Assets or Consolidated EBITDA or (ii) whether a Default or an Event of Default has occurred and is continuing, in each case in connection with any determination as to whether a Limited Condition Transaction or any Indebtedness and Liens to be incurred in connection with such Limited Condition Transaction is permitted to be consummated, the date of determination of whether such Limited Condition Transaction or any Indebtedness and Liens to be incurred in connection with such Limited Condition Transaction is permitted hereunder shall, at the option of Holdings, be the date on which the definitive agreements for such Limited Condition Transaction are entered into or the date such irrevocable notice or offer for such Limited Condition Transaction is delivered, as applicable (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LCT Test Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Holdings exercise such option by delivering to the Administrative Agent a certificate of a Responsible Officer on or prior to the LCT Test Date), with such determination to give Pro Forma Effect to such Limited Condition Transaction and the other transactions to be entered into in connection therewith (including any incurrence of Indebtedness or Liens and the use of proceeds thereof) as if they had occurred at the beginning of the most recent Test Period ending prior to the LCT Test Date.  For the avoidance of doubt, (x) if Holdings has exercised such option and any of the tests, ratios, baskets or amounts for which compliance was determined or tested as of the LCT Test Date are exceeded as a result of fluctuations in any such test, ratio, basket or amount, including due to fluctuations in Total Assets or Consolidated EBITDA or total assets of Holdings or the Person subject to such Limited Condition Transaction, at or prior to the consummation of the Limited </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">86</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Condition Transaction, such test, ratios, baskets and amounts will not be deemed to have been exceeded as a result of such fluctuations solely for purposes of determining whether the Limited Condition Transaction is permitted to be consummated and (y) if any Default or Event of Default occurs following the LCT Test Date and prior to the consummation of such Limited Condition Transaction, any such Default or Event of Default shall be deemed not to have occurred or be continuing for purposes of determining whether any action being taken in connection with such Limited Condition Transaction is permitted.  If Holdings has exercised such option for any Limited Condition Transaction, then, in connection with any subsequent calculation of such test, ratios, baskets or amounts on or following the relevant LCT Test Date and prior to the earlier of (i) the date on which such Limited Condition Transaction is consummated and (ii) the date that the definitive agreements for such Limited Condition Transaction are terminated or expire without consummation of such Limited Condition Transaction, any such test, ratio basket or basket shall be calculated on a Pro Forma Basis assuming such Limited Condition Transaction and the other transactions in connection therewith (including any incurrence of Indebtedness or Liens and the use of proceeds thereof) have been consummated&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if Holdings elects to have such determinations occur at the time of entry into such definitive agreement or the date such irrevocable notice or offer for such Limited Condition Transaction is delivered, as applicable, any indebtedness to be incurred (and any associated lien) shall be deemed incurred at the time of such election (until such time as the indebtedness is actually incurred or the applicable acquisition agreement is terminated without actually consummating the applicable acquisition) and outstanding thereafter for purposes of pro forma compliance with any applicable financial test.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding anything to the contrary herein, with respect to any amounts incurred or transactions (or series of transactions) entered into (or consummated) in reliance on a provision within the same covenant of this Agreement that does not require compliance with a financial ratio or test (any such amounts, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) substantially concurrently or in a series of related transactions with any amounts incurred or transactions entered into (or consummated) in reliance on a provision within the same covenant of this Agreement that requires compliance with any such financial ratio or test (including any First Lien Net Leverage Ratio test, any Secured Net Leverage Ratio, any Total Net Leverage Ratio, any Fixed Charge Coverage Ratio or the amount of Consolidated EBITDA) (any such amounts, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incurrence-Based Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), it is understood and agreed that (a) the Fixed Amounts under such covenant shall be disregarded in the calculation of the financial ratio or test applicable to any substantially concurrent utilization of the Incurrence-Based Amounts and (b) the entire transaction (or series of related transactions) shall be calculated on a Pro Forma Basis (including the use of proceeds of all Indebtedness to be incurred and any repayments, repurchases and redemptions of Indebtedness&#59; provided that, for purposes of such calculations, Unrestricted Cash shall not include the cash proceeds of any Indebtedness the incurrence of which is the specified transaction or that is incurred to finance the specified transaction). Notwithstanding anything herein to the contrary, if at any time any applicable ratio or financial test for any category based on an Incurrence-Based Amount permits Indebtedness, Liens, Restricted Payments, Asset Sales, and Investments, as applicable, previously incurred under a category based on a Fixed Amount, such Indebtedness, Liens, Restricted Payments, Asset Sales, and Investments, as applicable, shall be deemed to have been automatically reclassified as incurred under such category based on an Incurrence-Based Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Divisions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#8217;s laws)&#58; (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of its Equity Interests at such time. </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">87</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.42pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Credits</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Commitments and Loans.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to the terms and conditions set forth herein, each Term Lender agrees, severally and not jointly, to make a Lux Term Loan to the Lux Borrower and the Lux U.S. Subsidiary Borrower on the Closing Date in a principal amount not to exceed its Lux Term Loan Commitment.  The full amount of the Lux Term Loan Commitments must be drawn in a single drawing on the Closing Date and amounts repaid or prepaid in respect of Lux Term Loans may not be reborrowed.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Subject to the terms and conditions set forth herein, each Term Lender agrees, severally and not jointly, to make a U.S. Term Loan to the U.S. Borrower on the Closing Date in a principal amount not to exceed its U.S. Term Loan Commitment.  The full amount of the U.S. Term Loan Commitments must be drawn in a single drawing on the Closing Date and amounts repaid or prepaid in respect of U.S. Term Loans may not be reborrowed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to the term and conditions set forth herein, each Revolving Lender agrees to make Revolving Loans to any Revolving Borrower in Agreed Currencies from time to time during the Availability Period in an aggregate principal amount that will not result in (i) subject to Sections 2.04 and 2.11(c), the Dollar Amount of such Lender&#8217;s Revolving Credit Exposure exceeding such Lender&#8217;s Revolving Commitment and (ii) subject to Sections 2.04 and 2.11(c), the sum of the Dollar Amount of the total Revolving Credit Exposures exceeding the aggregate Revolving Commitments.  Within the foregoing limits and subject to the terms and conditions set forth herein, each Revolving Borrower may borrow, prepay and reborrow Revolving Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each Borrower hereunder shall only be liable as a primary obligor for the Loans made to such Borrower and shall not be jointly and severally liable for Loans made to any other Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding the foregoing, the Lux Borrower and the Lux U.S. Subsidiary Borrower shall be jointly and severally liable for the Lux Term Loans made pursuant to Section 2.01(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">For the avoidance of doubt, at the Closing Date, each Term Lender shall fund an equal percentage of the principal amount of the total U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of the total U.S. Term Loans funded by each Term Lender shall equal the percentage of the principal amount of the Lux Term Loans funded by such Term Lender).  As provided in Section 9.04(b)(ii)(G), at all times after the Closing Date, the U.S. Term Loans and the Lux Term Loans shall trade as a strip, and each assignment of Initial Term Loans from any Term Lender to an assignee shall consist of an equal percentage of the respective principal amounts of such assignor&#8217;s U.S. Term Loans and Lux Term Loans  (i.e., the percentage of the principal amount of an assignor&#8217;s U.S. Term Loans that are assigned shall equal the percentage of the principal amount of such assignor&#8217;s Lux Term Loans that are assigned).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Loans and Borrowings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Loan (other than a Swingline Loan) shall be made as part of a Borrowing consisting of Loans of the same Class and Type made under a single Tranche and shall be made by the Lenders of such Class under such Tranche ratably in accordance with their respective Commitments in respect of the applicable Class and in respect of the applicable Tranche.  The failure of any Lender to make any Loan required to be made by it shall not relieve any other Lender of its obligations hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Commitments of the Lenders are </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">88</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">several and no Lender shall be responsible for any other Lender&#8217;s failure to make Loans as required. Any Swingline Loan shall be made in accordance with the procedures set forth in Section 2.05.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Subject to Section 2.14, (i) each Revolving Borrowing shall be comprised entirely of ABR Loans, Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans and (ii) each Lux Term Loan Borrowing and each U.S. Term Loan Borrowing shall be comprised entirely of ABR Loans or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, in each case, as the Applicable Borrower may request in accordance herewith&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that each ABR Loan shall only be made in Dollars.  Each Swingline Loan shall be an ABR Loan.  Subject to Section 2.19, each Lender at its option may make any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan (and in the case of a branch or Affiliate, the provisions of Sections 2.14, 2.15, 2.16 and 2.17 (including, for the avoidance of doubt, the requirements and limitations of such sections) shall apply to such branch or Affiliate to the same extent as if it were a Lender)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) any exercise of such option shall not affect the obligation of the Applicable Borrower to repay such Loan in accordance with the terms of this Agreement, (y) if the respective branch or Affiliate is a Foreign Lender, the same shall comply with the requirements of Section 2.17 and (z) with respect to any Loans incurred by a Borrower that is organized or tax resident in Ireland, the branch or Affiliate, whether or not a Foreign Lender, shall comply with the requirements of Section 2.17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">At the commencement of each Interest Period for any Borrowing of Eurocurrency Revolving Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Revolving Loans, such Borrowing shall be in an aggregate amount that is an integral multiple of $500,000 (or, if such Borrowing is denominated in a Foreign Currency, 500,000 units of such currency) and not less than $2,000,000 (or, if such Borrowing is denominated in a Foreign Currency, 2,000,000 units of such currency).  At the time that each ABR Revolving Borrowing is made, such Borrowing shall be in an aggregate amount that is an integral multiple of $500,000 and not less than $1,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that an ABR Revolving Borrowing may be in an aggregate amount that is equal to the entire unused balance of the aggregate Revolving Commitments of the relevant Class, or that is required to finance the reimbursement of an LC Disbursement as contemplated by Section 2.06(e).  Each Swingline Loan shall be in an amount that is an integral multiple of $500,000 and not less than $1,000,000.  Borrowings of more than one Type and Class and under more than one Tranche may be outstanding at the same time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that there shall not at any time be more than a total of eight (8) Eurocurrency Revolving Borrowings</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Revolving Borrowings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and RFR Revolving Borrowings outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding any other provision of this Agreement, the Applicable Borrower shall not be entitled to request, or to elect to convert or continue, any Borrowing of any Class if the Interest Period requested with respect thereto would end after the Maturity Date of such Class.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Requests for Borrowings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  To request a Borrowing, the Applicable Borrower shall notify the Administrative Agent of such request (a) in the case of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Borrowing</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> denominated in Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, by telephonic notice not later than 11&#58;00 a.m., New York City time, three (3) Business Days before the date of the proposed Borrowing, (b) in the case of a Eurocurrency Borrowing denominated in an Agreed Currency other than Dollars or an RFR Borrowing, by telephonic notice not later than 11&#58;00 a.m., New York City time, four (4) Business Days before the date of the proposed Borrowing or (c) in the case of an ABR Borrowing, by telephonic notice not later than 11&#58;00 a.m., New York City time, one (1) Business Day before the date of the proposed Borrowing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) any such notice of an ABR Revolving Borrowing to finance the reimbursement of an LC Disbursement as contemplated by Section 2.06(e) may be given not later than 10&#58;00 a.m., New York City time, on the date of the proposed Borrowing and (y) any notice with respect to Borrowings to be made on </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">89</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Closing Date may be given with such shorter time than the deadline described in clause (a), (b) or (c), as applicable, as the Administrative Agent may agree in its sole discretion.  Each such telephonic Borrowing Request shall be irrevocable and shall be confirmed promptly by email to the Administrative Agent of a written Borrowing Request in a form approved by the Administrative Agent and signed by the Applicable Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in respect of the Loans to be borrowed on the Closing Date, any written Borrowing Request may be provided by the Applicable Borrower on a conditional basis (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (1) to the extent the Applicable Borrower does not borrow any Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans set forth in such conditional Borrowing Request, the Applicable Borrower shall be required to compensate the Lenders under Section 2.16 for the losses, costs or expenses related thereto and (2) any such Borrowing Request shall be irrevocable once funding of the Borrowings has been initiated by the Administrative Agent), and such Borrowing Request may be provided no later than 2&#58;00 pm, New York City Time, on the Business Day prior to such Borrowing.  Each telephonic and written Borrowing Request shall specify the following information in compliance with Section 2.02&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the aggregate amount of the requested Borrowing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the date of such Borrowing, which shall be a Business Day&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Class of such Borrowing and whether such Borrowing is to be an ABR Borrowing, a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or an RFR Borrowing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in the case of a Eurocurrency Borrowing or an RFR Borrowing, the Agreed Currency and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term &#8220;Interest Period&#8221; and (ii) in the case of a USD Term SOFR Borrowing,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term &#8220;Interest Period&#8221;&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Applicable Borrower and the location and number of the Applicable Borrower&#8217;s account to which funds are to be disbursed, which shall comply with the requirements of Section 2.07.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If no election as to the Type of Borrowing is specified, then, in the case of a Borrowing denominated in Dollars, the requested Borrowing shall be an ABR Borrowing.  If no Interest Period is specified with respect to any requested Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing, then the Applicable Borrower shall be deemed to have selected an Interest Period of one month&#8217;s duration.  Promptly following receipt of a Borrowing Request in accordance with this Section 2.03, the Administrative Agent shall advise each applicable Lender of the details thereof and of the amount of such Lender&#8217;s Loan to be made as part of the requested Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Determination of Dollar Amounts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Administrative Agent will determine the Dollar Amount of&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">each Revolving Borrowing utilizing Revolving Commitments as of the date two (2) Business Days prior to the date of such Borrowing or, if applicable, the date of conversion&#47;continuation of any such Borrowing as a Revolving Borrowing,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the LC Exposure as of the date of each request for the issuance, amendment, renewal or extension of any Letter of Credit, and</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">90</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">all outstanding Revolving Credit Exposure on and as of the last Business Day of each calendar month and, during the continuation of an Event of Default, on any other Business Day elected by the Administrative Agent in its discretion or upon instruction by the Required Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each day upon or as of which the Administrative Agent determines Dollar Amounts as described in the preceding clauses (a), (b) and (c) is herein described as a &#8220;Computation Date&#8221; with respect to each Credit Event for which a Dollar Amount is determined on or as of such day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to the terms and conditions set forth herein, the Swingline Lender agrees to make Swingline Loans in Dollars to the Applicable Borrower from time to time during the Availability Period, in an aggregate principal amount at any time outstanding that will not result in (i) the aggregate principal amount of outstanding Swingline Loans exceeding $25,000,000 or (ii) the Dollar Amount of the total Revolving Credit Exposures exceeding the aggregate Revolving Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Swingline Lender shall not be required to make a Swingline Loan to refinance an outstanding Swingline Loan.  Within the foregoing limits and subject to the terms and conditions set forth herein, the Applicable Borrower may borrow, prepay and reborrow Swingline Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To request a Swingline Loan, the Applicable Borrower shall notify the Administrative Agent of such request by telephone (confirmed by telecopy), not later than 2&#58;00 p.m., New York City time, on the day of a proposed Swingline Loan.  Each such notice shall be irrevocable and shall specify the requested date (which shall be a Business Day) and amount of the requested Swingline Loan.  The Administrative Agent will promptly advise the Swingline Lender of any such notice received from the Applicable Borrower.  The Swingline Lender shall make each Swingline Loan available to the Applicable Borrower by means of a credit to the general deposit account of such Applicable Borrower with the Swingline Lender (or, in the case of a Swingline Loan made to finance the reimbursement of an LC Disbursement as provided in Section 2.06(e), by remittance to the applicable Issuing Banks) by 2&#58;00 p.m., New York City time, on the requested date of such Swingline Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Swingline Lender may by written notice given to the Administrative Agent not later than 10&#58;00 a.m., New York City time, on any Business Day require the Revolving Lenders to acquire participations on such Business Day in all or a portion of the Swingline Loans outstanding.  Such notice shall specify the aggregate amount of Swingline Loans in which Revolving Lenders will participate.  Promptly upon receipt of such notice, the Administrative Agent will give notice thereof to each Revolving Lender, specifying in such notice such Lender&#8217;s Revolving Percentage of such Swingline Loan or Loans.  Each Revolving Lender hereby absolutely and unconditionally agrees, upon receipt of notice as provided above, to pay to the Administrative Agent, for the account of the Swingline Lender, such Revolving Lender&#8217;s Revolving Percentage (after giving effect to the reallocation provisions of paragraph (d) below) of such Swingline Loan or Loans.  Each Revolving Lender acknowledges and agrees that its obligation to acquire participations in Swingline Loans pursuant to this paragraph in an amount equal to its Revolving Percentage thereof is absolute and unconditional and shall not be affected by any circumstance whatsoever, including the occurrence and continuance of a Default or reduction or termination of the Revolving Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.  Each Revolving Lender shall comply with its obligation under this paragraph by wire transfer of immediately available funds, in the same manner as provided in Section 2.07 with respect to Loans made by such Lender (and Section 2.07 shall apply, mutatis mutandis, to the payment obligations of the Revolving Lenders), and the Administrative Agent shall promptly pay to the Swingline Lender the amounts so received by it from the Revolving Lenders.  The Administrative Agent shall notify </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">91</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Applicable Borrower of any participations in any Swingline Loan acquired pursuant to this paragraph, and thereafter payments in respect of such Swingline Loan shall be made to the Administrative Agent and not to the Swingline Lender.  Any amounts received by the Swingline Lender from an Applicable Borrower (or other party on behalf of such Applicable Borrower) in respect of a Swingline Loan after receipt by the Swingline Lender of the proceeds of a sale of participations therein shall be promptly remitted to the Administrative Agent&#59; any such amounts received by the Administrative Agent shall be promptly remitted by the Administrative Agent to the applicable Revolving Lenders that shall have made their payments pursuant to this paragraph and to the Swingline Lender, as their interests may appear&#59; provided that any such payment so remitted shall be repaid to the Swingline Lender or to the Administrative Agent, as applicable, if and to the extent such payment is required to be refunded to the Applicable Borrower for any reason.  The purchase of participations in a Swingline Loan pursuant to this paragraph shall not relieve the Applicable Borrower of any default in the payment thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Reallocations and Extensions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Maturity Date shall have occurred in respect of any Class of Revolving Commitments at a time when another Tranche or Tranches of any other Class of Revolving Commitments is or are in effect with a longer Maturity Date, then on the earliest occurring Maturity Date all then-outstanding Swingline Loans shall be repaid in full (and there shall be no adjustment to the participations in such Swingline Loans as a result of the occurrence of such earliest Maturity Date)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if on the occurrence of such earliest Maturity Date (after giving effect to any repayments of Revolving Loans and any reallocation of Letter of Credit participations as contemplated in Section 2.06(k)), there shall remain obligations to fund Swingline Loans hereunder and there shall exist sufficient unutilized Revolving Commitments of any other Class or Classes or Extended Revolving Commitments so that the respective outstanding Swingline Loans could be incurred pursuant to such Revolving Commitments of such other Class or Classes or Extended Revolving Commitments which will remain in effect after the occurrence of such earliest Maturity Date, then there shall be an automatic adjustment on such date of the risk participations of each Revolving Lender holding Revolving Commitments of such other Class or Classes or that is an Extending Revolving Lender and such outstanding Swingline Loans shall be deemed to have been incurred solely pursuant to the relevant Revolving Commitments of such other Class or Classes or Extended Revolving Commitments and such Swingline Loans shall not be so required to be repaid in full on such earliest Maturity Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions set forth herein, the Applicable Borrower may request the issuance of Letters of Credit denominated in Agreed Currencies, in each case for its own account (or for the account of any Restricted Subsidiary), in a form reasonably acceptable to the Administrative Agent and the applicable Issuing Bank, at any time and from time to time during the Availability Period.  In the event of any inconsistency between the terms and conditions of this Agreement and the terms and conditions of any form of letter of credit application or other agreement submitted by the Applicable Borrower to, or entered into by the Applicable Borrower with, the applicable Issuing Bank relating to any Letter of Credit, the terms and conditions of this Agreement shall control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Notice of Issuance, Amendment, Renewal, Extension&#59; Certain Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To request the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit from an Issuing Bank), the Applicable Borrower shall email or telecopy (or transmit by any other electronic communication, if arrangements for doing so have been approved by such Issuing Bank) to such Issuing Bank and the Administrative Agent (reasonably in advance of, but not less than three (3) Business Days prior to, the requested date of issuance (or such shorter period as such Issuing Bank may agree), amendment, renewal or extension and which, in the case of a Letter of Credit to be issued on the Closing Date, may be </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">92</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">conditioned on the occurrence of the Closing Date) a notice in the applicable Issuing Bank&#8217;s customary form requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be amended, renewed or extended, and specifying the date of issuance, amendment, renewal or extension (which shall be a Business Day), the date on which such Letter of Credit is to expire (which shall comply with paragraph (c) of this Section 2.06), the amount of such Letter of Credit, the Agreed Currency applicable thereto), the name and address of the beneficiary thereof and such other information as shall be necessary to prepare, amend, renew or extend such Letter of Credit.  The Applicable Borrower also shall submit a letter of credit application on such Issuing Bank&#8217;s standard form and related documents in connection with any request for a Letter of Credit and in connection with any request for a Letter of Credit to be amended, renewed, modified or extended.  A Letter of Credit shall be issued, amended, renewed or extended only (A) if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Applicable Borrower shall be deemed to represent and warrant that), after giving effect to such issuance, amendment, renewal or extension (i) subject to Section 2.04, the Dollar Amount of the LC Exposure shall not exceed $15,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) subject to Section 2.04, the sum of the Dollar Amount of the total Revolving Credit Exposures shall not exceed the aggregate Revolving Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the LC Sublimit may be increased from time to time upon agreement between the Administrative Agent and Borrowers, so long as any increase has been appropriately committed by a Lender (that is or shall be an Issuing Bank), on terms and conditions satisfactory to the Administrative Agent and (B) in accordance with such Issuing Bank&#8217;s usual and customary policies and practices from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Dollar Amount of the LC Exposure in respect of each Issuing Bank may not be increased or decreased without the applicable Issuing Bank&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Letter of Credit shall expire at or prior to the close of business on the earlier of (i) the date one year after the date of the issuance of such Letter of Credit (or, in the case of any renewal or extension thereof, one year after such renewal or extension) and (ii) the date that is five (5) Business Days prior to the Maturity Date with respect to the Revolving Commitments pursuant to which issued (or if any Extended Revolving Commitments, Incremental Revolving Commitments or Other Refinancing Revolving Commitments are outstanding, the last Maturity Date applicable thereto (so long as the aggregate amount of such Letters of Credit are not in excess of such commitments))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Letter of Credit may contain customary automatic renewal provisions agreed upon by the Applicable Borrower and the Issuing Bank pursuant to which the expiration date of such Letter of Credit (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auto Renewal Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall automatically be extended for consecutive periods of up to twelve (12) months (but not to a date later than the date set forth in clause (ii) above)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such Auto Renewal Letter of Credit must permit the applicable Issuing Bank to prevent any such renewal at least once in each twelve month period (commencing with the date of issuance of such Letter of Credit) by giving prior notice to the beneficiary thereof not later than a day in each such twelve month period to be agreed upon at the time such Letter of Credit is issued.  Unless otherwise directed by such Issuing Bank, the Applicable Borrower shall not be required to make a specific request to such Issuing Bank for any such renewal.  Once an Auto Renewal Letter of Credit has been issued, the Lenders shall be deemed to have authorized (but may not require) such Issuing Bank to permit the renewal of such Letter of Credit at any time to an expiry date not later than such Maturity Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  By the issuance of a Letter of Credit (or an amendment to a Letter of Credit increasing the amount thereof) and without any further action on the part of any Issuing Bank or any Revolving Lender in respect of the Tranche under which such Letter of Credit is issued (each such Revolving Lender, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Issuing Banks hereby grant to each Applicable Lender, and each Applicable Lender hereby acquires from the Issuing Bank, a participation in such Letter of Credit equal to such Applicable Lender&#8217;s Applicable Percentage of the aggregate Dollar Amount available to be drawn under such Letter of Credit.  In consideration and in furtherance of the foregoing, each Applicable Lender hereby absolutely and </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">93</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Banks, such Applicable Lender&#8217;s Applicable Percentage (after giving effect to the reallocation provisions of paragraph (k) below) of each LC Disbursement made by the Issuing Banks and not reimbursed by the Applicable Borrower on the date due as provided in paragraph (e) of this Section 2.06, or of any reimbursement payment required to be refunded to the Applicable Borrower for any reason.  Each Revolving Lender acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit or the occurrence and continuance of a Default or reduction or termination of the Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If an Issuing Bank shall make any LC Disbursement in respect of a Letter of Credit, the Applicable Borrower shall reimburse such LC Disbursement by paying to such Issuing Bank in Dollars the Dollar Amount equal to such LC Disbursement, calculated as of the date such Issuing Bank made such LC Disbursement (or if the Issuing Bank shall so elect in its sole discretion by notice to the Applicable Borrower, in such other Agreed Currency which was paid by such Issuing Bank pursuant to such LC Disbursement in an amount equal to such LC Disbursement) not later than 12&#58;00 noon, Local Time, on the first Business Day immediately following the date that such LC Disbursement is made, if the Applicable Borrower shall have received notice of such LC Disbursement on the date of such LC Disbursement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if such LC Disbursement is not less than the Dollar Amount of $1,000,000, the Applicable Borrower may, subject to the conditions to borrowing set forth herein, request in accordance with Section 2.03 or 2.05 that such payment be financed with an ABR Revolving Borrowing or Swingline Loan in an equivalent Dollar Amount of such LC Disbursement and, to the extent so financed, the Applicable Borrower&#8217;s obligation to make such payment shall be discharged and replaced by the resulting ABR Revolving Borrowing or Swingline Loan.  If the Applicable Borrower fails to make such payment when due, the Administrative Agent shall notify each Applicable Lender of the applicable LC Disbursement, the payment then due from the Applicable Borrower in respect thereof and such Lender&#8217;s Applicable Percentage thereof.  Promptly following receipt of such notice, each Applicable Lender shall pay to the Administrative Agent its Applicable Percentage (after giving effect to the reallocation provisions of paragraph (k) below) of the payment then due from the Applicable Borrower, in the same manner as provided in Section 2.07 with respect to Loans made by such Lender (and Section 2.07 shall apply, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">mutatis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment obligations of the Applicable Lenders), and the Administrative Agent shall promptly pay to the Issuing Bank the amounts so received by it from the Applicable Lenders.  Promptly following receipt by the Administrative Agent of any payment from the Applicable Borrower pursuant to this paragraph, the Administrative Agent shall distribute such payment to the applicable Issuing Bank or, to the extent that Applicable Lenders have made payments pursuant to this paragraph to reimburse the applicable Issuing Bank, then to such Lenders and the applicable Issuing Bank as their interests may appear.  Any payment made by an Applicable Lender pursuant to this paragraph to reimburse an Issuing Bank for any LC Disbursement (other than the funding of ABR Revolving Loans or a Swingline Loan as contemplated above) shall not constitute a Loan and shall not relieve the Applicable Borrower of its obligations to reimburse such LC Disbursement.  If the Applicable Borrower&#8217;s reimbursement of, or obligation to reimburse, any amounts in any Foreign Currency would subject the Administrative Agent, any Issuing Bank or any Revolving Lender to any stamp duty, ad valorem charge or similar tax that would not be payable if such reimbursement were made or required to be made in Dollars, the Applicable Borrower shall, at its option, either (x) pay the amount of any such tax requested by the Administrative Agent, such Issuing Bank or the relevant Revolving Lender or (y) reimburse each LC Disbursement made in such Foreign Currency in Dollars, in an amount equal to the Equivalent Amount, calculated using the applicable Exchange Rates, on the date such LC Disbursement is made, of such LC Disbursement.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">94</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Obligations Absolute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Applicable Borrower&#8217;s obligations to reimburse LC Disbursements as provided in paragraph (e) of this Section 2.06 shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement under any and all circumstances whatsoever and irrespective of (i) any lack of validity or enforceability of any Letter of Credit or this Agreement, or any term or provision therein, (ii) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, (iii) payment by an Issuing Bank under a Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit, or (iv) any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this Section 2.06, constitute a legal or equitable discharge of, or provide a right of setoff against, the Applicable Borrower&#8217;s obligations hereunder.  Neither the Administrative Agent, the Revolving Lenders nor the Issuing Banks, nor any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control of the applicable Issuing Bank&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not be construed to excuse such Issuing Bank from liability to the Applicable Borrower to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by the Applicable Borrower to the extent permitted by applicable law) suffered by the Applicable Borrower that are caused by such Issuing Bank&#8217;s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof.  The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of the applicable Issuing Bank (as finally determined by a court of competent jurisdiction), such Issuing Bank shall be deemed to have exercised care in each such determination.  In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, such Issuing Bank may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Disbursement Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Issuing Bank shall, promptly following its receipt thereof, examine all documents purporting to represent a demand for payment under a Letter of Credit.  Each Issuing Bank shall promptly notify the Administrative Agent and the Applicable Borrower by telephone (confirmed by telecopy) of such demand for payment and whether such Issuing Bank has made or will make an LC Disbursement thereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any failure to give or delay in giving such notice shall not relieve the Applicable Borrower of its obligations to reimburse such Issuing Bank and the Applicable Lenders with respect to any such LC Disbursement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Interim Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If an Issuing Bank shall make any LC Disbursement, then, unless the Applicable Borrower shall reimburse such LC Disbursement in full on the date such LC Disbursement is made, the unpaid amount thereof shall bear interest, for each day from and including the date such LC Disbursement is made to but excluding the date that the Applicable Borrower reimburses such LC Disbursement, at the rate per annum then applicable to ABR Revolving Loans (or in the case such LC Disbursement is denominated in a Foreign Currency, at the Overnight Foreign Currency Rate for such Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the then effective Applicable Margin with respect to Eurocurrency Revolving Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or USD Term SOFR Revolving Loans, as applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Applicable Borrower fails to reimburse such </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">95</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LC Disbursement when due pursuant to paragraph (e) of this Section 2.06, then Section 2.13(d) shall apply.  Interest accrued pursuant to this paragraph shall be for the account of the Issuing Banks, except that interest accrued on and after the date of payment by any Applicable Lender pursuant to paragraph (e) of this Section 2.06 to reimburse the Issuing Banks shall be for the account of such Applicable Lender to the extent of such payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Replacement or Resignation of Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Issuing Bank may be replaced at any time by written agreement among the Applicable Borrower, the Administrative Agent, the replaced Issuing Bank and the successor Issuing Bank.  Any Issuing Bank may resign at any time by giving 60 days&#8217; prior notice to the Administrative Agent and the Applicable Borrowers. The Administrative Agent shall notify the Revolving Lenders of any such replacement or resignation of the Issuing Bank.  At the time any such replacement or resignation shall become effective, the Applicable Borrower shall pay all unpaid fees accrued for the account of the replaced or resigning Issuing Bank pursuant to Section 2.12.  From and after the effective date of any such replacement, (i) the successor Issuing Bank shall have all the rights and obligations of the Issuing Bank under this Agreement with respect to Letters of Credit to be issued thereafter and (ii) references herein to the term &#8220;Issuing Bank&#8221; shall be deemed to refer to such successor or to any previous Issuing Bank, or to such successor and all previous Issuing Banks, as the context shall require.  After the replacement or resignation of an Issuing Bank hereunder, the replaced Issuing Bank or resigning bank shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Bank under this Agreement with respect to Letters of Credit then outstanding and issued by it prior to such replacement or resignation, but shall not be required to issue additional Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Cash Collateralization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any Event of Default shall occur and be continuing, on the Business Day that the Applicable Borrower receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans has been accelerated, a Majority in Interest of the Revolving Lenders) demanding the deposit of cash collateral pursuant to this paragraph, the Applicable Borrower shall deposit in an account with the Administrative Agent, in the name of the Administrative Agent and for the benefit of the Revolving Lenders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Collateral Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), an amount in cash equal to 102% of the Dollar Amount of the LC Exposure as of such date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> any accrued and unpaid interest thereon&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the portions of such amount attributable to undrawn Foreign Currency Letters of Credit or LC Disbursements in a Foreign Currency that the Applicable Borrower is not late in reimbursing shall be deposited in the applicable Foreign Currencies in the actual amounts of such undrawn Letters of Credit and LC Disbursements and (ii) the obligation to deposit such cash collateral shall become effective immediately, and such deposit shall become immediately due and payable, without demand or other notice of any kind, upon the occurrence of any Event of Default with respect to the Applicable Borrower described in clause (h) or (i) of Section 7.01.  For the purposes of this paragraph, the Foreign Currency LC Exposure shall be calculated using the applicable Exchange Rate on the date notice demanding cash collateralization is delivered to the Applicable Borrower.  The Applicable Borrower also shall deposit cash collateral pursuant to this paragraph as and to the extent required by Section 2.11(c).  Such deposit shall be held by the Administrative Agent as collateral for the payment and performance of the Secured Obligations.  The Administrative Agent shall have exclusive dominion and control, including the exclusive right of withdrawal, over such account and the Applicable Borrower hereby grants the Administrative Agent, for the ratable benefit of the Secured Parties, a security interest in the LC Collateral Account.  Other than any interest earned on the investment of such deposits in Cash Equivalents, which investments shall be made at the option and sole discretion of the Administrative Agent and at the Applicable Borrower&#8217;s risk and expense, such deposits shall not bear interest.  Interest or profits, if any, on such investments shall accumulate in such account.  Moneys in such account shall be applied by the Administrative Agent to reimburse the Issuing Banks for LC Disbursements for which they have not been reimbursed and, to the extent not so applied, shall be held for the satisfaction of the reimbursement obligations of the Applicable </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">96</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Borrower for the LC Exposure at such time or, if the maturity of the Loans has been accelerated (but subject to the consent of a Majority in Interest of the Revolving Lenders), be applied to satisfy other Secured Obligations.  If the Applicable Borrower is required to provide an amount of cash collateral hereunder as a result of the occurrence of an Event of Default, such amount (to the extent not applied as aforesaid) shall be returned to the Applicable Borrower within three (3) Business Days after all Events of Default have been cured or waived.  If the Applicable Borrower is required to provide an amount of cash collateral hereunder pursuant to Section 2.11(c), such amount (to the extent not applied as aforesaid) shall be returned to the Applicable Borrower as and to the extent that, after giving effect to such return, the aggregate Revolving Credit Exposures would not exceed the aggregate Revolving Commitments and no Default shall have occurred and be continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Reallocations and Extensions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Maturity Date in respect of any Class of Revolving Commitments occurs prior to the expiration of any Letter of Credit, then (i) if Extended Revolving Commitments or one or more other Tranches of Revolving Commitments of any other Class or Classes in respect of which the Maturity Date shall not have occurred are then in effect and the obligations to issue Letters of Credit hereunder remain at such time, such Letters of Credit shall automatically be deemed to have been issued (including for purposes of the obligations of the Revolving Lenders to purchase participations therein and to make Revolving Loans and payments in respect thereof pursuant to Section 2.06(e)) under (and ratably participated in by Revolving Lenders pursuant to) Extended Revolving Commitments or the Revolving Commitments of such other Class or Classes in respect of such non-terminating Extended Revolving Commitments or Tranches up to an aggregate amount not to exceed the aggregate principal amount of the unutilized Extended Revolving Commitments or Revolving Commitments of such other Class or Classes thereunder at such time (it being understood that no partial face amount of any Letter of Credit may be so reallocated) and (ii) to the extent not reallocated pursuant to the immediately preceding clause (i), the Applicable Borrower shall Cash Collateralize any such Letter of Credit in accordance with Section 2.06(j).  Except to the extent of reallocations of participations pursuant to clause (i) of the immediately preceding sentence, the occurrence of a Maturity Date with respect to a given Class of Revolving Commitments shall have no effect upon (and shall not diminish) the percentage participations of the Revolving Lenders in any Letter of Credit issued before such Maturity Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Issuing Bank Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Issuing Bank (other than the Administrative Agent or its affiliates) agrees that, unless otherwise requested by the Administrative Agent, each Issuing Bank shall report in writing to the Administrative Agent (i) on the first Business Day of each month, the daily activity (set forth by day) in respect of Letters of Credit during the immediately preceding month, including all issuances, extensions, amendments and renewals, all expirations and cancellations and all disbursements and reimbursements, (ii) on or prior to each Business Day on which such Issuing Bank expects to issue, amend, renew or extend any Letter of Credit, the date of such issuance, amendment, renewal or extension, and the currency and aggregate face amount of the Letters of Credit to be issued, amended, renewed or extended by it and outstanding after giving effect to such issuance, amendment, renewal or extension occurred (and whether the amount thereof changed), it being understood that such Issuing Bank shall not permit any issuance, renewal, extension or amendment resulting in an increase in the amount of any Letter of Credit to occur without first obtaining written confirmation from the Administrative Agent that it is then permitted under this Agreement, (iii) on each Business Day on which such Issuing Bank makes any LC Disbursement, the date of such LC Disbursement and the amount of such LC Disbursement, (iv) on any Business Day on which the Applicable Borrower fails to reimburse an LC Disbursement required to be reimbursed to such Issuing Bank on such day, the date of such failure and the amount and currency of such LC Disbursement and (v) on any other Business Day, such other information as the Administrative Agent shall reasonably request, as to the Letters of Credit issued by such Issuing Bank.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">97</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt;text-decoration:underline">Letters of Credit Issued for Restricted Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any obligations of, or is for the account of, a Restricted Subsidiary, the Applicable Borrower shall be obligated to reimburse the Issuing Banks hereunder for any and all drawings under such Letter of Credit.  The Applicable Borrower hereby acknowledges that the issuance of Letters of Credit for the account of Restricted Subsidiaries inures to the benefit of the Applicable Borrower, and that the Applicable Borrower&#8217;s business derives substantial benefits from the businesses of such Restricted Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Funding of Borrowings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Lender shall make each Loan to be made by it hereunder on the proposed date thereof by wire transfer of immediately available funds (i) in the case of Loans denominated in Dollars, by 12&#58;00 noon, New York City time, to the account of the Administrative Agent most recently designated by it for such purpose by notice to the Lenders and (ii) in the case of each Loan denominated in a Foreign Currency, by 12&#58;00 noon, Local Time, in the city of the Administrative Agent&#8217;s Eurocurrency Payment Office for such currency and at such Eurocurrency Payment Office for such currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Swingline Loans shall be made as provided in Section 2.05.  The Administrative Agent will make such Loans available to the Applicable Borrower by promptly crediting the amounts so received, in like funds, to (x) an account of the Applicable Borrower designated by the Applicable Borrower in the applicable Borrowing Request in the case of Loans denominated in Dollars and (y) an account of the Applicable Borrower in the relevant jurisdiction and designated by the Applicable Borrower in the applicable Borrowing Request, in the case of Loans denominated in a Foreign Currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that ABR Revolving Loans made to finance the reimbursement of an LC Disbursement as provided in Section 2.06(e) shall be remitted by the Administrative Agent to the applicable Issuing Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing that such Lender will not make available to the Administrative Agent such Lender&#8217;s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with paragraph (a) of this Section 2.07 and may, in reliance upon such assumption, make available to the Applicable Borrower a corresponding amount.  In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the Applicable Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount with interest thereon, for each day from and including the date such amount is made available to the Applicable Borrower to but excluding the date of payment to the Administrative Agent, at (i) in the case of such Lender, the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation (including without limitation the Overnight Foreign Currency Rate in the case of Loans denominated in a Foreign Currency) or (ii) in the case of an Applicable Borrower, the interest rate applicable to the relevant Class of ABR Loans.  If such Lender pays such amount to the Administrative Agent, then such amount shall constitute such Lender&#8217;s Loan included in such Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Interest Elections.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Borrowing initially shall be of the Type, and under the applicable Tranche, specified in the applicable Borrowing Request and, in the case of a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing, shall have an initial Interest Period as specified in such Borrowing Request.  Thereafter, subject to clause (f) below, the Applicable Borrower may elect to convert such Borrowing to a different Type or to continue such Borrowing and, in the case of a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing, may elect Interest Periods therefor, all as provided in this Section 2.08.  The Applicable Borrower may elect different options with respect to different portions of the affected Borrowing, in which </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">98</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">case each such portion shall be allocated ratably among the Lenders holding the Loans comprising such Borrowing, and the Loans comprising each such portion shall be considered a separate Borrowing.  This Section 2.08 shall not apply to Swingline Loans, which may not be converted or continued. Notwithstanding any other provision of this Section 2.08, the Applicable Borrower shall not be permitted to change the Tranche of any Borrowing, except as otherwise expressly contemplated by Section 2.22.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To make an election pursuant to this Section 2.08, the Applicable Borrower shall notify the Administrative Agent of such election (which may be made (x) telephonically and followed by irrevocable written notice via an Interest Election Request in a form approved by the Administrative Agent and signed by the Applicable Borrower in the case of a borrowing denominated in Dollars or (y) by irrevocable written notice via an Interest Election Request in a form approved by the Administrative Agent and signed by the Applicable Borrower in the case of a borrowing denominated in a Foreign Currency) by the time that a Borrowing Request would be required under Section 2.03 if the Applicable Borrower were requesting a Borrowing of the Type and Class resulting from such election to be made on the effective date of such election.  Notwithstanding any contrary provision herein, this Section 2.08 shall not be construed to permit the Applicable Borrower to (i) change the currency of any Borrowing, (ii) elect an Interest Period for Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans that does not comply with Section 2.02(c) or (iii) convert any Borrowing to a Borrowing of a Type not available under the Class of Commitments or the Tranche pursuant to which such Borrowing was made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each telephonic and written Interest Election Request shall specify the following information in compliance with Section 2.02&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the Borrowing to which such Interest Election Request applies and, if different options are being elected with respect to different portions thereof, the portions thereof to be allocated to each resulting Borrowing (in which case the information to be specified pursuant to clauses (iii) and (iv) below shall be specified for each resulting Borrowing)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the effective date of the election made pursuant to such Interest Election Request, which shall be a Business Day&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">whether the resulting Borrowing is to be an ABR Borrowing, a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, a USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or an RFR Borrowing&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">if the resulting Borrowing is a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing, the Interest Period and Agreed Currency to be applicable thereto after giving effect to such election, which Interest Period shall be a period contemplated by the definition of the term &#8220;Interest Period&#8221;.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any such Interest Election Request requests a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing but does not specify an Interest Period, then the Applicable Borrower shall be deemed to have selected an Interest Period of one month&#8217;s duration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Promptly following receipt of an Interest Election Request, the Administrative Agent shall advise each applicable Lender of the details thereof and of such Lender&#8217;s portion of each resulting Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If the Applicable Borrower fails to deliver a timely Interest Election Request with respect to a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing prior to the end of the Interest Period applicable thereto, then, unless such Borrowing </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">99</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">is repaid as provided herein, at the end of such Interest Period, (i) in the case of a Borrowing of Initial Term Loans, such Borrowing shall continue as a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or USD Term SOFR Borrowing, as applicable,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with a three month Interest Period, (ii) in the case of any other Borrowing denominated in Dollars, such Borrowing shall be converted to an ABR Borrowing and (iii) in the case of a Borrowing denominated in a Foreign Currency in respect of which such Borrower shall have failed to deliver an Interest Election Request prior to the third (3rd) Business Day preceding the end of such Interest Period, such Borrowing shall automatically continue as a Eurocurrency Borrowing or RFR Borrowing, as applicable, in the same Agreed Currency with a one month Interest Period.  Notwithstanding any contrary provision hereof, if an Event of Default has occurred and is continuing and the Administrative Agent, at the request of the Required Lenders, so notifies the Applicable Borrower, then, so long as an Event of Default is continuing (i) no outstanding Borrowing may be converted to or continued as a Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Borrowing and (ii) unless repaid, each Eurocurrency Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and RFR Borrowing shall be converted to an ABR Borrowing (and any such Eurocurrency Borrowing denominated in a Foreign Currency and any such RFR Borrowing shall be redenominated in Dollars, based on the Dollar Amounts thereof, at the time of such conversion) at the end of the Interest Period applicable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Termination and Reduction of Commitments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Unless previously terminated, the Lux Term Loan Commitment of each Term Lender shall automatically and permanently terminate at 5&#58;00 PM, New York City time, on the Closing Date (after giving effect to the incurrence of Lux Term Loans on such date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Unless previously terminated, the U.S. Term Loan Commitment of each Term Lender shall automatically and permanently terminate at 5&#58;00 PM, New York City time, on the Closing Date (after giving effect to the incurrence of U.S. Term Loans on such date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Unless previously terminated, the Revolving Commitment of each Revolving Lender shall automatically and permanently termination on the relevant Maturity Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Any Revolving Borrower (on behalf of all of the Revolving Borrowers) may at any time terminate, or from time to time reduce, the Revolving Commitments of any Class&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) each reduction of such Revolving Commitments shall be in an amount that is an integral multiple of $5,000,000 and not less than $10,000,000 and (ii) the Revolving Borrowers shall not terminate or reduce any Revolving Commitments if, after giving effect to any concurrent prepayment of the Revolving Loans of such Class in accordance with Section 2.11, the Dollar Amount of the sum of the total Revolving Credit Exposures in respect of such Class would exceed the aggregate Revolving Commitments of such Class.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Any applicable Revolving Borrower shall notify the Administrative Agent of any election to terminate or reduce the Revolving Commitments of any Class under Section 2.09(d) at least three (3) Business Days prior to the effective date of such termination or reduction, specifying such election and the effective date thereof.  Promptly following receipt of any notice, the Administrative Agent shall advise the Lenders of the contents thereof.  Each notice delivered by any Revolving Borrower pursuant to this Section 2.09 shall be irrevocable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a notice of termination of the Revolving Commitments of any Class delivered by any Revolving Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities or one or more other events specified therein, in which case such notice may be revoked by such Revolving Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied.  Any termination or reduction of the Revolving Commitments of any Class shall be permanent.  Each reduction of the Revolving Commitments of any Class shall be made ratably among the applicable Lenders in accordance with their respective Revolving Commitments of such Class.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Repayment of Loans&#59; Evidence of Debt.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">(i) The Lux Borrower and the Lux U.S. Subsidiary Borrower shall pay to the Administrative Agent, for the account of the Term Lenders, on each March 31, June 30, September 30 and December 31, beginning with December 31, 2021 or if any such date is not a Business Day, on the immediately following Business Day (each such date, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Term Loan Repayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a principal amount of the Lux Term Loans equal to 0.25% of the initial aggregate principal amount of such Lux Term Loans (as adjusted from time to time pursuant to Section 2.11), together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent specified in the applicable Extension Offer, amortization payments required with respect to Extended Term Loans that are Lux Term Loans for periods solely after the applicable Maturity Date for Lux Term Loans shall be as specified in the applicable Extension Offer.  All unpaid Lux Term Loans shall be paid in full in Dollars by the Lux Borrower and the Lux U.S. Subsidiary Borrower on the applicable Maturity Date. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii) The U.S. Borrower shall pay to the Administrative Agent, for the account of the Term Lenders, on each March 31, June 30, September 30 and December 31, beginning with December 31, 2021 or if any such date is not a Business Day, on the immediately following Business Day (each such date, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Term Loan Repayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a principal amount of the U.S. Term Loans equal to 0.25% of the initial aggregate principal amount of such U.S. Term Loans (as adjusted from time to time pursuant to Section 2.11), together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent specified in the applicable Extension Offer, amortization payments required with respect to Extended Term Loans that are U.S. Term Loans for periods solely after the applicable Maturity Date for U.S. Term Loans shall be as specified in the applicable Extension Offer.  All unpaid U.S. Term Loans shall be paid in full in Dollars by the U.S. Borrower on the applicable Maturity Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii) The Applicable Borrower shall pay (A) to the Administrative Agent for the account of each Revolving Lender the then unpaid principal amount of each Revolving Loan on the Maturity Date in the currency of such Loan and (B) to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the Latest Maturity Date with respect to any Revolving Commitments and the first date after such Swingline Loan is made that is the 15th or last day of a calendar month and is at least two (2) Business Days after such Swingline Loan is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on each date that a Revolving Borrowing is made, the Applicable Borrower shall repay all Swingline Loans then outstanding. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Applicable Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made hereunder, the Tranche under which it was made, the Class, Agreed Currency and Type thereof and the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Applicable Borrower to each Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender&#8217;s share thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The entries made in the accounts maintained pursuant to paragraph (b) or (c) of this Section 2.10 shall be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">prima</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">facie</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> evidence of the existence and amounts of the obligations recorded therein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">101</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Applicable Borrower to repay the Loans in accordance with the terms of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in the case of any conflict between the accounts maintained pursuant to paragraph (b) and the Register, the Register shall control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Any Lender may request that Loans made by it be evidenced by a promissory note.  In such event, the Applicable Borrower shall prepare, execute and deliver to such Lender promissory notes payable to such Lender or its registered assigns and in a form approved by the Administrative Agent.  Thereafter, the Loans evidenced by such promissory notes and interest thereon shall at all times (including after assignment pursuant to Section 9.04) be represented by one or more promissory notes in such form payable to the payee named therein or its registered assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Prepayment of Loans.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Applicable Borrower shall have the right at any time and from time to time to prepay any Borrowing of any Class or Tranche in whole or in part, subject to (i) the premium set forth in Section 2.12(b), (ii) the break funding payments required by Section 2.16 and (iii) prior notice in accordance with the provisions of this Section 2.11(a)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> any voluntary prepayments of the Initial Term Loans shall be made on a pro rata basis between the two Tranches of Initial Term Loans.  The Applicable Borrower shall notify the Administrative Agent (and, in the case of prepayment of a Swingline Loan, the Swingline Lender) by telephone (confirmed by telecopy) of any prepayment hereunder (i) in the case of prepayment of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Borrowing</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> denominated in Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, not later than 11&#58;00 a.m., New York City time, three (3) Business Days before the date of prepayment (or such later time as approved by the Administrative Agent), (ii) in the case of prepayment of a Eurocurrency Borrowing denominated in an Agreed Currency other than Dollars or an RFR Borrowing, not later than 11&#58;00 a.m., New York City time, four (4) Business Days before the date of prepayment (or such later time as approved by the Administrative Agent), (iii) in the case of prepayment of an ABR Borrowing, not later than 11&#58;00 a.m., New York City time, one (1) Business Day before the date of prepayment (or such later time as approved by the Administrative Agent) or (iv) in the case of prepayment of a Swingline Loan, not later than 12&#58;00 noon, New York City time, on the date of prepayment (or such later time as approved by the Administrative Agent).  Each such notice shall be irrevocable and shall specify the prepayment date and the principal amount and Class and Tranche of each Borrowing or portion thereof to be prepaid&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a notice of prepayment may state that such notice is conditioned upon the effectiveness of other credit facilities or one or more other events specified therein, in which case such notice may be revoked by the Applicable Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied.  Promptly following receipt of any such notice relating to a Borrowing, the Administrative Agent shall advise the Lenders of the contents thereof.  Each partial prepayment of any Borrowing shall be in an amount that would be permitted in the case of an advance of a Borrowing of the same Type as provided in Section 2.02.  Each prepayment of a Revolving Borrowing shall be applied ratably to the Revolving Loans included in the prepaid Revolving Borrowing, each voluntary prepayment of a Term Loan Borrowing shall be applied as directed by the Applicable Borrower and each mandatory prepayment of a Term Loan Borrowing shall be applied in accordance with Section 2.11(e).  Prepayments shall be accompanied by (i) accrued interest to the extent required by Section 2.13 and (ii) break funding payments pursuant to Section 2.16.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">If at any time, (i) solely as a result of fluctuations in currency Exchange Rates, the sum of the aggregate principal Dollar Amount of all of the Revolving Credit Exposures (calculated, with respect to those Credit Events denominated in Foreign Currencies, as of the most recent Computation Date with respect to each such Credit Event) exceeds 105% of the aggregate Revolving Commitments or (ii) for any other reason, the sum of the aggregate principal Dollar Amount of all of the Revolving Credit Exposures of any Class (so calculated) exceeds the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">102</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">aggregate Commitments of such Class, the Applicable Borrower shall in each case immediately repay the applicable Borrowings or Cash Collateralize LC Exposure in an account with the Administrative Agent pursuant to Section 2.06(j), as applicable, in an aggregate principal amount sufficient to cause the aggregate Dollar Amount of all Revolving Credit Exposures (so calculated) of each Class to be less than or equal to the aggregate Commitments of such Class.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In the event and on each occasion that (i) any Net Proceeds are received by or on behalf of Holdings or any of its Restricted Subsidiaries in respect of any Prepayment Event, the Applicable Borrower shall, within ten (10) Business Days after such Net Proceeds are received, prepay the Obligations as set forth in Section 2.11(d)(i) below (and subject to Section 2.11(e)) in an aggregate amount equal to the Required Net Proceeds Percentage of such Net Proceeds&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Loan Party may use a portion of such Net Proceeds to prepay or repurchase Permitted Pari Passu Secured Refinancing Debt and, to the extent such debt is (x) secured on a pari passu basis with the Obligations and (y) pari passu in right of payment with the Obligations hereunder, any Alternative Incremental Facility Indebtedness and&#47;or Ratio Debt to the extent any applicable credit agreement, indenture or other agreement governing such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and&#47;or such Ratio Debt so requires, in each case in an amount not to exceed the product of (x) the amount of such Net Proceeds and (y) a fraction, the numerator of which is the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and&#47;or such Ratio Debt, as applicable, and the denominator of which is the sum of the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and&#47;or such Ratio Debt, as applicable, and the outstanding principal amount of Term Loans&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">in the case of any event described in clause (1) or (2) of the definition of the term &#8220;Prepayment Event&#8221;, if Holdings or its Restricted Subsidiaries elect to apply all or a portion of the Net Proceeds from such event (or a portion thereof), within 18 months after receipt of such Net Proceeds, to acquire, maintain, develop, construct, improve, upgrade or repair assets useful in the business of Holdings or its Restricted Subsidiaries or to make capital expenditures, Permitted Acquisitions, Permitted Investments or Investments permitted by Section 6.04, then no prepayment shall be required pursuant to this paragraph in respect of such Net Proceeds&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that to the extent of any such Net Proceeds therefrom that have not been so applied by the end of such 18 month period (or committed to be applied by the end of the 18 month period and applied within 6 months after the end of such 18 month period), a prepayment shall be required at the end of such period in an amount equal to such Net Proceeds that have not been so applied (subject to clause (f) below)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any  Loan Party incurs, issues or obtains any Credit Agreement Refinancing Indebtedness (other than solely by means of extending or renewing then existing Credit Agreement Refinancing Indebtedness without resulting in any Net Proceeds), the Applicable Borrower shall, on the date on which such Credit Agreement Refinancing Indebtedness is incurred, issued or obtained, prepay any Loans constituting </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">103</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the applicable Refinanced Debt as set forth in Section 2.11(e) below in an aggregate amount equal to 100% of the Net Proceeds of such Credit Agreement Refinancing Indebtedness&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">no later than ten (10) business days after the date on which the financial statements with respect to such fiscal year in which such Excess Cash Flow Period occurs are delivered pursuant to Section 5.01(a), the Applicable Borrower shall make prepayments of the Term Loans (unless otherwise provided in any Incremental Amendment or Refinancing Amendment) in accordance with Section 2.11(d) in an aggregate principal amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ECF Payment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) equal to (a) (x) if the First Lien Net Leverage Ratio at the end of such period is greater than or equal to 4.50&#58;1.00, 50% of Excess Cash Flow for the Excess Cash Flow Period then ended, (y) if the First Lien Net Leverage Ratio at the end of such period is less than 4.50&#58;1.00 but greater than 4.00&#58;1.00, 25% of Excess Cash Flow for the Excess Cash Flow Period then ended and (z) if the First Lien Net Leverage Ratio at the end of such period is less than or equal to 4.00&#58;1.00 (but excluding, for purposes of such calculation, the proceeds of any Incremental Loans or any other Indebtedness incurred on such date in the calculation of the Unrestricted Cash), 0% of Excess Cash Flow for the Excess Cash Flow Period then ended </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) in the case of (a)(x) and (y) above, the sum of (1) all voluntary prepayments or permitted purchases of Term Loans, Alternative Incremental Facility Indebtedness, New Notes and other Indebtedness secured by the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis with the Obligations and Permitted Refinancing Indebtedness (in each case that is secured by the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis with the Obligations) during such Excess Cash Flow Period (and in the case of the first Excess Cash Flow Period after the Closing Date, during the fiscal year ended December 31, 2021) or, without duplication across Excess Cash Flow Periods, after the end of such Excess Cash Flow Period and prior to when such Excess Cash Flow prepayment is due (limited in the case of any voluntary prepayments made pursuant to Section 2.11(a)(ii) and purchases made pursuant to Section 2.23 to the discounted amount actually paid in respect of the principal amount of such Term Loans (as opposed to the face amount so prepaid)), (2) all voluntary prepayments of Revolving Loans during such Excess Cash Flow Period (and in the case of the first Excess Cash Flow Period after the Closing Date, during the fiscal year ended December 31, 2021) or, without duplication across Excess Cash Flow Periods, after the end of such Excess Cash Flow Period and prior to when such Excess Cash Flow prepayment is due, to the extent the Revolving Commitments are permanently reduced by the amount of such payments, in each case except to the extent financed with the proceeds of long-term Indebtedness (other than revolving Indebtedness), (3) without duplication of amounts deducted in prior periods and, at the option of Holdings, the aggregate consideration required to be paid in cash by Holdings or any of the Restricted Subsidiaries pursuant to binding contracts (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Contract Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) entered into prior to or during such period or prior to the payment date of the ECF Payment Amount relating to Permitted Acquisitions or other Investments, capital expenditures, Capitalized Software Expenditures, acquisitions of intellectual property or non-ordinary course acquisitions of other assets to be consummated or made during the fiscal year following such period&#59; provided that Holdings may make a good faith estimate of such amount to the extent such amount is unable to be definitively determined at the date of determination of Excess Cash Flow for the applicable period&#59; provided, further, that, to the extent the aggregate amount of cash flow (except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness)) actually utilized to finance such Permitted Acquisitions, other Investments, capital expenditures, Capitalized Software Expenditures, acquisitions of intellectual property or non-ordinary course acquisitions of other assets during such period of four consecutive fiscal quarters is less than the Contract Consideration, the amount of such shortfall shall be added to the calculation of Excess Cash Flow at the end of such period of four consecutive fiscal </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">quarters, (4) without duplication of amounts deducted pursuant to this clause (4) or clause (3) above in prior fiscal years, the amount of Investments made pursuant to the definition of &#8220;Permitted Investments&#8221; and Section 6.04 (other than Investments in (x) cash and Cash Equivalents and (y) Holdings or any of its Restricted Subsidiaries other than any Investments in the Equity Interests of Oncacare Limited) made during such period and, at the election of Holdings, made after such period but prior to the date of the applicable Excess Cash Flow payment, in each case except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness), (5) &#91;reserved&#93; and (6) without duplication of amounts deducted pursuant to this clause (6) or clause (3) above in prior fiscal years, the amount of capital expenditures, Capitalized Software Expenditures or acquisitions of intellectual property accrued or made in cash during such period and, at the election of Holdings, made after such period but prior to the date of the applicable Excess Cash Flow payment, in each case except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a prepayment of Term Loans pursuant to this Section 2.11(c)(iii) shall only be required in the amount (if any) by which the ECF Payment Amount for such fiscal year exceeds an amount equal to the greater of $60,000,000 and 5% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Applicable Borrower may use a portion of such ECF Payment Amount to prepay or repurchase Permitted Pari Passu Secured Refinancing Debt and, to the extent such debt is (x) secured on a pari passu basis with the Obligations and (y) pari passu in right of payment with the Obligations hereunder, any Alternative Incremental Facility Indebtedness and&#47;or Ratio Debt to the extent any applicable credit agreement, indenture or other agreement governing such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and&#47;or such Ratio Debt so requires, in each case in an amount not to exceed the product of (x) the amount of such ECF Payment Amount and (y) a fraction, the numerator of which is the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and&#47;or such Ratio Debt, as applicable, and the denominator of which is the sum of the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and&#47;or such Ratio Debt, as applicable, and the outstanding principal amount of Term Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Subject to Section 2.11(e) below and except as specified in any Extension Amendment, Incremental Amendment or Refinancing Amendment (with respect to the applicable Extended Term Loans or  Incremental Loans or the Loans incurred pursuant to such Refinancing Amendment), (i) all such amounts pursuant to Sections 2.11(c)(i) and (iii) shall be applied pro rata among the Classes and Tranches of Term Loans and, in a manner determined by Holdings, applied to amortization payments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Holdings shall notify the Administrative Agent of such determination and (ii) all such amounts pursuant to Section 2.11(c)(ii) shall be applied to prepay an aggregate principal amount of the applicable Loans constituting Refinanced Debt equal to the Net Proceeds of the applicable Credit Agreement Refinancing Indebtedness.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Borrowers shall notify the Administrative Agent in writing of any mandatory prepayment of Term Loans required to be made pursuant to Section 2.11(c)(i) and (iii) at least three (3) Business Days prior to the date of such prepayment.  Each such notice shall specify the date of such prepayment and provide a reasonably detailed calculation of the amount of such prepayment.  The Administrative Agent will promptly notify each Term Lender of the contents of any such prepayment notice and of such Term Lender&#8217;s ratable portion of such prepayment (based on such Term Lender&#8217;s Applicable Percentage of each relevant Tranche of the Term Loans). Any Term Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Declining Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; and any Term Lender which is not a Declining Term Lender, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accepting Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may elect, by delivering written notice to the Administrative Agent and the Borrowers no later than 5&#58;00 p.m. one (1) Business Day after </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">105</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the date of such Term Lender&#8217;s receipt of notice from the Administrative Agent regarding such prepayment, that the full amount of any mandatory prepayment otherwise required to be made with respect to the Term Loans held by such Term Lender pursuant to Section 2.11(c)(i) and (iii) not be made (the aggregate amount of such prepayments declined by the Declining Term Lenders, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Declined Prepayment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> however that (x) no Term Lender may decline a mandatory prepayment solely with respect to one Tranche of Initial Term Loans and not the other Tranche of Initial Term Loans and (y) a Term Lender may not decline a prepayment made by the Applicable Borrower pursuant to any event described in clause (3) of the term &#8220;Prepayment Event&#8221;. If a Term Lender fails to deliver notice setting forth such rejection of a prepayment to the Administrative Agent within the time frame specified above or such notice fails to specify the principal amount of the Term Loans to be rejected, any such failure will be deemed an acceptance of the total amount of such mandatory prepayment of Term Loans.  For the avoidance of doubt, the Applicable Borrower may, at its option, apply any Declined Prepayment Amount to prepay loans in accordance with Section 2.11(a) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Notwithstanding any other provisions of this Section 2.11, to the extent (i) any Net Proceeds exist as a result of an Asset Sale or casualty event from Holdings and&#47;or a Foreign Subsidiary (or with respect to any Lux Term Loan, a non-Luxembourg Subsidiary) that give rise to a prepayment event pursuant to Section 2.11(c)(i) or (ii) any Excess Cash Flow attributable to Holdings and&#47;or a Foreign Subsidiary (or with respect to any Lux Term Loan, a non-Luxembourg Subsidiary) exists that gives rise to a prepayment event pursuant to Section 2.11(c)(iii), and, in either case, the repatriation of cash to which such prepayment obligation is attributable would result in a material adverse tax consequence and&#47;or is prohibited, restricted or delayed by applicable local law from being repatriated or contributed to the Applicable Borrower, an amount equal to the portion of such Net Proceeds or Excess Cash Flow so affected will not be required to be applied to repay the Term Loans at the times provided in this Section 2.11 so long, but only so long, as the material adverse tax consequence would result from, and&#47;or applicable local law will not permit repatriation or contribution to the Applicable Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> however that Holdings shall use commercially reasonable efforts to promptly take all actions, and cause the applicable Foreign Subsidiary (or with respect to any Lux Term Loan, the non-Luxembourg Subsidiary) to promptly take all actions, in each case reasonably required by the applicable local law to eliminate such material adverse tax consequence and&#47;or permit such repatriation or contribution under applicable local law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Applicable Borrower agrees to pay to the Administrative Agent, for the account of each Revolving Lender, a commitment fee, which shall accrue at the rate of 35% of the Applicable Margin then in effect for Eurocurrency Revolving Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or USD Term SOFR Revolving Loans, as applicable,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> per annum on the daily amount of the Available Revolving Commitment of such Revolving Lender during the period from and including the Closing Date to but excluding the date on which the last of the Revolving Commitments (or Extended Revolving Commitments) of such Revolving Lender terminates.  Accrued commitment fees shall be payable in arrears on the last Business Day of March, June, September and December of each year and on the date on which the last of the Revolving Commitments terminate, commencing on the first such date to occur after the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any commitment fees accruing after the date on which such Revolving Commitments terminate shall be payable on demand.  All commitment fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Applicable Borrower agrees to pay (i) to the Administrative Agent, for the account of each Revolving Lender, a participation fee with respect to its participations in Letters of Credit, which shall accrue at the same Applicable Margin used to determine the interest rate applicable to Eurocurrency Revolving Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or USD Term SOFR Revolving Loans, as </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">106</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on the average daily Dollar Amount of such Revolving Lender&#8217;s LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) during the period from and including the Closing Date to but excluding the later of the date on which the last of such Revolving Lender&#8217;s Revolving Commitment terminates and the date on which such Revolving Lender ceases to have any LC Exposure and (ii) to each Issuing Bank for its own account a fronting fee, which shall accrue at the rate of 0.125% per annum on the average daily Dollar Amount of the LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) attributable to Letters of Credit issued by such Issuing Bank during the period from and including the Closing Date to but excluding the later of the date of termination of the last of the Revolving Commitments and the date on which there ceases to be any LC Exposure, as well as such Issuing Bank&#8217;s standard fees and commissions with respect to the issuance, amendment, cancellation, negotiation, transfer, presentment, renewal or extension of any Letter of Credit or processing of drawings thereunder.  Unless otherwise specified above, participation fees and fronting fees accrued through and including the last day of March, June, September and December of each year shall be payable on the third (3rd) Business Day following such last day, commencing on the first such date to occur after the Closing Date&#59; provided that all such fees shall be payable on the date on which the last of the Revolving Commitments terminate and any such fees accruing after the date on which the such Revolving Commitments terminate shall be payable on demand.  Any other fees payable to the Issuing Bank pursuant to this paragraph shall be payable within ten (10) days after demand.  All participation fees and fronting fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Applicable Borrower agrees to pay to the Administrative Agent, for the account of each Revolving Lender, a utilization fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Utilization Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) which shall accrue at the Applicable Utilization Fee Rate on the daily Dollar Amount of the Revolving Loans and LC Exposure of such Revolving Lender during the period from and including the Closing Date to but excluding the date on which the last of the Revolving Commitments (or Extended Revolving Commitments) of such Revolving Lender terminates.  Accrued Utilization Fees shall be payable in arrears on the last Business Day of March, June, September and December of each year and on the date on which the last of the Revolving Commitments terminate, commencing on the first such date to occur after the Closing Date.  All Utilization Fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Borrowers agree to pay to the Administrative Agent, for its own account, fees payable in the amounts and at the times separately agreed upon between the Borrowers and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Borrowers agree to pay to the Collateral Agent, for its own account, fees payable in the amounts and at the times separately agreed upon between the Borrowers and the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">If a Repricing Event with respect to the Initial Term Loans occurs prior to the six-month anniversary of the Closing Date, the Applicable Borrower agrees to pay a premium equal to 1.00% of the principal amount of the Initial Term Loans subject to such Repricing Event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, it is understood and agreed that any prepayment premium with respect to a Repricing Event payable pursuant to this clause (f) shall also apply to any required assignment pursuant to Section 9.02(d) by a Non-Consenting Lender in connection with any amendment described in Section 2.24 that occurs prior to the six-month anniversary of the Closing Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">All fees payable hereunder shall be paid on the dates due, in Dollars and immediately available funds, to the Administrative Agent (or to the Issuing Banks or the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">107</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Collateral Agent, in the case of fees payable to them) for distribution, in the case of commitment fees and participation fees, to the applicable Revolving Lenders.  Fees paid shall not be refundable under any circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Interest.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Loans comprising each ABR Borrowing (including each Swingline Loan) shall bear interest at the Alternate Base Rate plus the Applicable Margin.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Loans comprising each Eurocurrency Borrowing shall bear interest at the Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> for the Interest Period in effect for such Borrowing plus the Applicable Margin and (ii) the Loans comprising each USD Term SOFR Borrowing shall bear interest at the USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for the Interest Period in effect for such Borrowing plus the Applicable Margin.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">  The Loans comprising each RFR Borrowing shall bear interest at the Daily Simple RFR for the Interest Period in effect for such Borrowing plus the Applicable Margin.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding the foregoing, if any principal of or interest on any Loan or any fee or other amount payable by the Applicable Borrower hereunder is not paid when due, whether at stated maturity, upon acceleration or otherwise, such overdue amount shall bear interest, after as well as before judgment, at a rate per annum equal to (i) in the case of overdue principal of any Loan, 2% plus the rate otherwise applicable to such Loan as provided in the preceding paragraphs of this Section 2.13 or (ii) in the case of any other amount, 2% plus the rate applicable to ABR Loans as provided in paragraph (a) of this Section 2.13.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Accrued interest on each Loan shall be payable in arrears on each Interest Payment Date for such Loan and in the case of Revolving Loans, upon termination of the applicable Revolving Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) interest accrued pursuant to paragraph (d) of this Section 2.13 shall be payable on demand, (ii) in the event of any repayment or prepayment of any Loan of any Class (other than a prepayment of an ABR Revolving Loan prior to the end of the Availability Period), accrued interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (iii) in the event of any conversion of any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">All interest hereunder shall be computed on the basis of a year of 360 days, except that (i) interest computed by reference to the Alternate Base Rate at times when the Alternate Base Rate is based on the Prime Rate shall be computed on the basis of a year of 365 days (or 366 days in a leap year), and (ii) for Borrowings denominated in Pounds Sterling, interest shall be computed on the basis of a year of 365 days, and in each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day).  The applicable Alternate Base Rate, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjusted </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBO Rate, LIBO Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR, USD Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Adjusted EURIBOR Rate, EURIBOR Rate  or Daily Simple RFR shall be determined by the Administrative Agent, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Benchmark Replacement Setting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:67.5pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">On March 5, 2021 the Financial Conduct Authority (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">FCA</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;), the regulatory supervisor of USD LIBOR&#8217;s administrator (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">IBA</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;), announced in a public statement the future cessation or loss of representativeness of overnight&#47;Spot Next, 1-month, 3-month, 6-month and 12- month USD LIBOR tenor settings.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary herein or in </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">108</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any other Loan Document</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(and any Swap Agreement shall be deemed not to be a &#8220;Loan Document&#8221; for purposes of this Section 2.14)&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:line-through">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacing</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through"> USD LIBOR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">. On the earlier of (i) the date that all USD Available Tenors of USD LIBOR have either permanently or indefinitely ceased to be provided by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative and (ii) the USD Early Opt-in Effective Date, if the then-current USD Benchmark is USD LIBOR, the USD Benchmark Replacement will replace such USD Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such USD Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document. If the USD Benchmark Replacement is USD Daily Simple SOFR, all interest payments will be payable on a quarterly basis.(b)&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Replacing Future</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> USD Benchmarks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the occurrence of a USD Benchmark Transition Event, the USD Benchmark Replacement will replace the then-current USD Benchmark for all purposes hereunder and under any Loan Document in respect of any such USD Benchmark setting at or after 5&#58;00 p.m. on the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) Business Day after the date notice of such USD Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such USD Benchmark Replacement from Lenders comprising the Required Lenders.  At any time that the administrator of any then-current USD Benchmark has permanently or indefinitely ceased to provide such USD Benchmark or such USD Benchmark has been announced by the regulatory supervisor for the administrator of such USD Benchmark pursuant to public statement or publication of information to be no longer representative and will not be restored, the Applicable Borrower may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such USD Benchmark until the Applicable Borrower&#8217;s receipt of notice from the Administrative Agent that a USD Benchmark Replacement has replaced such USD Benchmark, and, failing that, the Applicable Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to ABR Loans. During the period referenced in the foregoing sentence, if a component of ABR is based upon the USD Benchmark, such component will not be used in any determination of ABR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">USD Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In connection with the implementation and administration of any USD Benchmark Replacement, the Administrative Agent, with the consent of Holdings (not be unreasonably withheld), will have the right to make USD Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such USD Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent will promptly notify Holdings and the Lenders of (i) the implementation of any USD Benchmark Replacement and (ii) the effectiveness of any USD Benchmark Replacement Conforming Changes.  For the avoidance of doubt, any notice required to be delivered by the Administrative Agent as set forth in this Section 2.14 may be provided, at the option of the Administrative Agent with the consent of Holdings (not to be unreasonably withheld), in one or more notices and may be delivered together with, or as part of any amendment which implements any USD Benchmark Replacement or USD Benchmark Replacement Conforming Changes.  Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">109</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 2.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Unavailability of Tenor of USD Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. At any time (including in connection with the implementation of any USD Benchmark Replacement), (i) if any then-current USD Benchmark is a term rate (including USD Term SOFR </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">or USD LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), then the Administrative Agent may remove any tenor of such USD Benchmark that is unavailable or non-representative for USD Benchmark (including USD Benchmark Replacement) settings and (ii) the Administrative Agent may reinstate any such previously removed tenor for USD Benchmark (including USD Benchmark Replacement) settings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Disclaimer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to (i) the administration, submission or </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">calculation on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any other matter related to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">London interbank offered rate or other</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Term SOFR Reference Rate, USD Adjusted Term SOFR or USD Term SOFR or any component definition thereof or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> rates in the definition </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">of &#8220;Eurocurrency&#8221;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;text-decoration:line-through;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">or with respect to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">thereof, or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> any alternative</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> successor</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> rate thereto,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or replacement rate thereof (including, without limitation any USD Benchmark Replacement implemented hereunder), (ii) the composition or characteristics of any such USD Benchmark Replacement, including whether it is similar to, or produces the same value or economic equivalence to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">USD LIBOR or any other USD Benchmark or have the same volume or liquidity as did</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the USD Term SOFR Reference Rate, USD Adjusted Term SOFR or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> USD </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other USD Benchmark, (iii) any actions or use of its discretion or other decisions or determinations made with respect to any matters covered by this Section 2.14 including, without limitation, whether or not a USD Benchmark Transition Event has occurred, the removal or lack thereof of unavailable or non-representative tenors, the implementation or lack thereof of any USD Benchmark Replacement Conforming Changes, the delivery or non-delivery of any notices required by clause (d) above or otherwise in accordance herewith, and (iv) the effect of any of the foregoing provisions of this Section 2.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Alternate Currency Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary herein or in any other Loan Document, upon the occurrence of an Alternate Currency Benchmark Transition Event or an Alternate Currency Early Opt-in Election, as applicable, the Administrative Agent and Holdings may amend this Agreement to replace the Eurocurrency Rate applicable to an Alternate Currency or Daily Simple RFR with an Alternate Currency Benchmark Replacement. Any such amendment with respect to an Alternate Currency Benchmark Transition Event will become effective at 5&#58;00 p.m. on the fifth (5th) Business Day after the Administrative Agent has posted such proposed amendment to all Lenders so long as the Administrative Agent has not received, by such time, written notice of objection to such amendment from Lenders comprising the Required Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent the Eurocurrency Rate applicable to an Alternate Currency or Daily Simple RFR is replaced with an Alternate Currency SOFR-Based Rate, Lenders shall only be entitled to object to the Alternate Currency Benchmark Replacement Adjustments with respect thereto. Any such amendment with respect to an Alternate Currency Early Opt-in Election will become effective on the date that Lenders comprising the Required Lenders of each Class have delivered to the Administrative Agent written notice that such Required Lenders accept such amendment. No replacement of the Eurocurrency Rate applicable to an Alternate Currency or Daily Simple RFR with an Alternate Currency Benchmark Replacement pursuant to this Section 2.14 will occur prior to the applicable Alternate Currency Benchmark Transition Start Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Alternate Currency Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In connection with the implementation of an Alternate Currency Benchmark Replacement, the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">110</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent, with the consent of Holdings (not be unreasonably withheld), will have the right to make Alternate Currency Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Alternate Currency Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The Administrative Agent will promptly notify Holdings and the Lenders of (i) any occurrence of an Alternate Currency Benchmark Transition Event or an Alternate Currency Early Opt-in Election, as applicable, and its related Alternate Currency Benchmark Replacement Date and Alternate Currency Benchmark Transition Start Date, (ii) the implementation of any Alternate Currency Benchmark Replacement, (iii) the effectiveness of any Alternate Currency Benchmark Replacement Conforming Changes and (iv) the commencement or conclusion of any Alternate Currency Benchmark Unavailability Period. Any determination, decision or election that may be made by the Administrative Agent or Lenders pursuant to this Section 2.14, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 2.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Upon Holdings receipt of notice of the commencement of (i) an Alternate Currency Benchmark Unavailability Period with respect to the Eurocurrency Rate applicable to an Alternate Currency, any Borrower may revoke a request made by such Borrower for a Eurocurrency Borrowing denominated in such Alternate Currency of, conversion to or continuation of Eurocurrency Loans denominated in such Alternate Currency to be made, converted or continued during any Alternate Currency Benchmark Unavailability Period with respect to the Eurocurrency Rate applicable to such Alternate Currency and, failing that, any Eurocurrency Borrowing denominated in such Alternate Currency shall be ineffective and (ii) an Alternate Currency Benchmark Unavailability Period with respect to Daily Simple RFR, any Borrower may revoke a request made by such Borrower for an RFR Borrowing of, conversion to or continuation of RFR Loans to be made, converted or continued during any Alternate Currency Benchmark Unavailability Period with respect to the Daily Simple RFR and, failing that, any RFR Borrowing shall be ineffective.  Furthermore, if any Eurocurrency Loan in any Alternate Currency or RFR Loan is outstanding on the date of Holdings&#8217; receipt of notice of the commencement of an Alternate Currency Benchmark Unavailability Period with respect to the Eurocurrency Rate applicable to such Eurocurrency Loan or Daily Simple RFR, as applicable, then such Loan shall, on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), at the Borrower&#8217;s election prior to such day&#58; (A) be prepaid by the Applicable Borrower on such day or (B) be converted by the Administrative Agent to, and (subject to the remainder of this subclause (B)) shall constitute, an ABR Loan denominated in Dollars (in an amount equal to the Dollar Equivalent of such Alternate Currency) on such day (it being understood and agreed that if the Applicable Borrower does not so prepay such Loan on such day by 12&#58;00 p.m. (New York City time) the Administrative Agent is authorized to effect such conversion of such Eurocurrency Loan or RFR Loan, as applicable, into an ABR Loan denominated in Dollars), and, in the case of such subclause (B), upon any subsequent implementation of an Alternate Currency Benchmark Replacement in respect of such Alternate Currency pursuant to this Section 2.10, such ABR Loan denominated in Dollars shall then be converted by the Administrative Agent to, and shall constitute, a Eurocurrency Loan denominated in such original Alternate Currency or RFR Loan denominated in such original Alternate Currency, as applicable (in an amount equal to the Alternate Currency Equivalent of such Alternate Currency) on the day of such implementation, giving effect to such Alternate Currency Benchmark Replacement in respect of such Alternate Currency.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">111</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. At the Borrower&#8217;s request, the Administrative Agent and the Borrower shall use commercially reasonable efforts to satisfy any applicable guidance of the Internal Revenue Service, in a manner that is not adverse to the Lenders that is intended to prevent any Benchmark Transition Event from resulting in a deemed exchange of any Loan under this Agreement for purposes of Treasury Regulation Section 1.1001-3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Increased Costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If any Change in Law shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender (except any such reserve requirement reflected in the Eurocurrency Rate) or any Issuing Bank&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">impose on any Lender or any Issuing Bank or the London interbank market any other condition, cost or expense (other than Taxes) affecting this Agreement or Loans made by such Lender or any Letter of Credit or participation therein&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">subject the Administrative Agent, any Lender or any Issuing Bank to any Taxes (other than (A) Indemnified Taxes, (B) Other Taxes and (C) Excluded Taxes (including any change in the rate of Excluded Taxes)) with respect to this Agreement, any Loan made by it or any Letter of Credit or participation therein, or its deposits, reserves, other liabilities or capital attributable thereto&#59;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and the result of any of the foregoing shall be to increase the cost to the Administrative Agent or such Lender of making or maintaining any Loan or of maintaining its obligation to make any such Loan (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency) or to increase the cost to the Administrative Agent, such Lender or such Issuing Bank of participating in, issuing or maintaining any Letter of Credit (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency) or to reduce the amount of any sum received or receivable by the Administrative Agent, such Lender or such Issuing Bank hereunder, whether of principal, interest or otherwise (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency), then the Applicable Borrower will pay to the Administrative Agent, such Lender</font><font style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or such Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or such Issuing Bank, as the case may be, for such additional costs incurred or reduction suffered.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">If any Lender or Issuing Bank determines that any Change in Law regarding capital or liquidity requirements has or would have the effect of reducing the rate of return on such Lender&#8217;s or Issuing Banks&#8217;s capital or on the capital of such Lender&#8217;s or Issuing Bank&#8217;s holding company, if any, as a consequence of this Agreement or the Loans made by, or participations in Letters of Credit held by such Lender, or Letters of Credit issued by such Issuing Bank, to a level below that which such Lender or Issuing Bank or such Lender&#8217;s or Issuing Bank&#8217;s holding company could have achieved but for such Change in Law (taking into consideration such Lender&#8217;s or Issuing Bank&#8217;s policies and the policies of such Lender&#8217;s or Issuing Bank&#8217;s holding company with respect to capital adequacy and liquidity), then from time to time the Applicable Borrower will pay to such Lender or Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or Issuing Bank or such Lender&#8217;s or Issuing Bank&#8217;s holding company for any such reduction suffered.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">112</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">A certificate of a Lender or Issuing Bank setting forth, in reasonable detail, the basis and calculation of the amount or amounts necessary to compensate such Lender or Issuing Bank or its holding company, as the case may be, as specified in paragraph (a) or (b) of this Section 2.15 shall be delivered to the Applicable Borrower and shall be conclusive absent manifest error.  The Applicable Borrower shall pay such Lender or Issuing Bank, as the case may be, the amount shown as due on any such certificate within ten (10) days after receipt thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Failure or delay on the part of any Lender or any Issuing Bank to demand compensation pursuant to this Section 2.15 shall not constitute a waiver of such Lender&#8217;s or such Issuing Bank&#8217;s right to demand such compensation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Applicable Borrower shall not be required to compensate a Lender or Issuing Bank pursuant to this Section 2.15 for any increased costs or reductions incurred more than 180 days prior to the date that such Lender or Issuing Bank, as the case may be, notifies the Applicable Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender&#8217;s or Issuing Bank&#8217;s intention to claim compensation therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Break Funding Payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of (a) the payment of any principal of any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan other than on the last day of an Interest Period applicable thereto (including as a result of an Event of Default or as a result of any prepayment pursuant to Section 2.11), (b) the conversion of any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan other than on the last day of the Interest Period applicable thereto, (c) the failure to borrow, convert, continue or prepay any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan on the date specified in any notice delivered pursuant hereto (regardless of whether such notice may be revoked under Section 2.11(a) and is revoked in accordance therewith) or (d) the assignment of any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Applicable Borrower pursuant to Section 2.20, then, in any such event the Applicable Borrower shall compensate each Lender for the loss, cost and expense attributable to such event.  Such loss, cost or expense to any Lender shall be deemed to include an amount determined by such Lender to be the excess, if any, of (i) the amount of interest which would have accrued or has been payable on the principal amount of such Loan had such event not occurred, at the Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or Daily Simple RFR, as applicable, that would have been applicable to such Loan (but not the Applicable Margin applicable thereto), for the period from the date of such event to the last day of the then current Interest Period therefor (or, in the case of a failure to borrow, convert or continue, for the period that would have been the Interest Period for such Loan), over (ii) the amount of interest which would accrue on such principal amount for such period at the interest rate which such Lender would bid were it to bid, at the commencement of such period, for deposits in the relevant currency of a comparable amount and period from other banks in the eurocurrency market or other applicable market.  A certificate of any Lender setting forth any amount or amounts that such Lender is entitled to receive pursuant to this Section 2.16, and setting forth in reasonable detail the calculations used by such Lender to determine such amount or amounts, shall be delivered to the Applicable Borrower and shall be conclusive absent manifest error.  The Applicable Borrower shall pay such Lender the amount shown as due on any such certificate within ten (10) days after receipt thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Applicable Borrower shall not be required to compensate a Lender pursuant to this Section 2.16 for any amounts under this Section 2.16 incurred more than 180 days prior to the date that such Lender notifies the Applicable Borrower of such amount and of such Lender&#8217;s intention to claim compensation therefor.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">113</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">All payments by or on account of any obligation of any Loan Party under any Loan Document shall to the extent permitted by applicable Legal Requirements be made free and clear of and without deduction or withholding for any Taxes. If an applicable withholding agent shall be required to deduct or withhold any Taxes from such payments, then (i) if such Taxes are Indemnified Taxes or Other Taxes, the sum payable by the applicable Loan Party shall be increased by the amount necessary so that after all required deductions or withholdings (including deductions and withholdings applicable to additional sums payable under this Section 2.17) each Agent and Lender receives an amount equal to the sum it would have received had no such deductions or withholdings of Indemnified Taxes or Other Taxes been made, (ii) the withholding agent shall be entitled to make such deductions or withholdings and (iii) the withholding agent shall pay the full amount deducted to the relevant Governmental Authority in accordance with applicable Legal Requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In addition, the Loan Parties shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable Legal Requirements or, at the option of the Administrative Agent, timely reimburse it for the payment of any Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Borrower and each Loan Party with respect to any Loans made to such Borrower shall jointly and severally indemnify each Agent and each Lender, within ten (10) days after written demand therefor, for the full amount of any Indemnified Taxes and Other Taxes paid by such Agent or such Lender with respect to any Loans made to such Borrower (including Indemnified Taxes and Other Taxes imposed or asserted on or attributable to amounts payable under this Section 2.17) and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Loan Parties shall not be required to indemnify any Agent or Lender pursuant to this Section 2.17(c) for any interest, penalties or expenses to the extent resulting from such Agent&#8217;s or such Lender&#8217;s failure to notify the Loan Parties of such possible indemnification claim within 120 days after such Agent or such Lender, as applicable, receives written notice from the applicable Governmental Authority of the specific Tax assessment or deficiency claim giving rise to such indemnification claim.  A certificate setting forth in reasonable detail the basis for and calculation of such payment or liability delivered to the Applicable Borrower by a Lender or Agent or by the Administrative Agent on its own behalf or on behalf of a Lender or Agent, shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority pursuant to this Section 2.17, such Loan Party shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment (if the applicable Governmental Authority makes such receipts readily available to the applicable Loan Party), a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Any Lender that is entitled to an exemption from or reduction of withholding tax  with respect to any payments under this Agreement or any other Loan Document shall deliver to the Borrowers (with a copy to the Administrative Agent), at the time(s) and in the manner(s) reasonably requested by such Borrower or the Administrative Agent, such properly completed and executed documentation as will permit such payments to be made without withholding or at a reduced rate of withholding.  In addition, any Lender, if reasonably requested by a Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable Legal Requirements or reasonably requested by such Borrower or the Administrative Agent as will enable such Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting.  Each Lender and </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">114</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent agrees that if any documentation it previously delivered pursuant to this Section 2.17(e) (including any of the specific forms described below) has expired or become obsolete or inaccurate in any respect, it shall promptly update such documentation or notify the Applicable Borrower and the Administrative Agent in writing of its legal ineligibility to do so.  Notwithstanding anything to the contrary in the preceding three sentences, the completion, execution and submission of such documentation with respect to any Tax imposed by any jurisdiction other than the United States, Ireland or Luxembourg, or, in each case, any political subdivision thereof, shall not be required if in the Lender&#8217;s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Without limiting the generality of the foregoing,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">any Foreign Lender shall, to the extent it is legally eligible to do so, deliver to such U.S. Borrower and the Administrative Agent on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of such U.S. Borrower or the Administrative Agent), two duly executed copies of whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party, IRS Form W-8BEN or W-8BEN-E&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">IRS Form W-8ECI&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the effect that such Foreign Lender is not a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Code, a &#8220;10-percent shareholder&#8221; of such U.S. Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a &#8220;controlled foreign corporation&#8221; related to such U.S. Borrower as described in Section 881(c)(3)(C) of the Code and that no payment under any Loan Document is effectively connected with such Foreign Lender&#8217;s conduct of a U.S. trade or business (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and (y) executed copies of IRS Form W-8BEN or W-8BEN-E&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">to the extent a Foreign Lender is not the beneficial owner of payments made to it under the Loan Documents, executed copies of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN or W-8BEN-E, a U.S. Tax Compliance Certificate substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, IRS Form W-9, and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Foreign Lender is a partnership (and not a participating Lender) and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G-4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on behalf of each such direct and indirect partner(s)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">any Foreign Lender shall, to the extent it is legally eligible to do so, deliver to such U.S. Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of such U.S. Borrower </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">115</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or the Administrative Agent), executed copies of any other form prescribed by applicable Legal Requirements as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable Legal Requirements to permit such U.S. Borrower or the Administrative Agent to determine the withholding or deduction required to be made (if any)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">if a payment made to the Administrative Agent or a Lender under any Loan Document would be subject to United States federal withholding Tax imposed by FATCA if the Administrative Agent or such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), the Administrative Agent or such Lender shall deliver to Borrower and the Administrative Agent at the time or times prescribed by Legal Requirements and at such time or times reasonably requested by the Borrowers or the Administrative Agent such documentation prescribed by applicable Legal Requirements (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrowers or the Administrative Agent as may be necessary for the Borrowers and the Administrative Agent to comply with their obligations under FATCA and to determine that the Administrative Agent or such Lender has complied with the Administrative Agent or such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this Section 2.17(e)(i)(C), &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Without limiting the generality of the foregoing, each Lender that is a U.S. Person shall deliver to such U.S. Borrower and the Administrative Agent, on or prior to the date on which such Person becomes a party to this Agreement (and from time to time thereafter upon the reasonable request of such U.S. Borrower or the Administrative Agent), two properly completed and duly executed copies of IRS Form W-9 or any successor form, certifying that such Person is exempt from United States federal backup withholding Tax.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">On or prior to the date on which it becomes a party to this Agreement, the Administrative Agent shall deliver to the U.S. Borrower either (1) two properly completed and duly signed copies of IRS Form W-9 certifying that the Administrative Agent is a U.S. Person that is exempt from U.S. federal backup withholding or (2) (x) with respect to payments received for the account of a Lender, two properly completed and duly signed copies of IRS Form W-8IMY evidencing the Administrative Agent&#8217;s agreement to be treated as a U.S. Person for U.S. federal withholding tax purposes and assuming primary responsibility for U.S. federal income tax withholding and (y) with respect to payments received for the Administrative Agent&#8217;s own account, two properly completed and duly signed copies of IRS Form W-8ECI.  The Administrative Agent shall, whenever a lapse in time or change in circumstances renders any such documentation expired, obsolete or inaccurate in any respect, deliver promptly to the U.S. Borrower updated versions of the documentation described in the preceding sentence (or any new documentation reasonably requested by the U.S. Borrower)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Administrative Agent shall not be required to furnish updated documentation to the extent it is not legally eligible to do so as a result of a Change in Law after the date hereof, in which event the Administrative Agent will promptly notify the U.S. Borrower of such ineligibility.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">116</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Without limiting the generality of the foregoing, any Lender that is an Irish Qualifying Lender solely on account of being an Irish Treaty Lender shall provide a self-certification form (a &#8220;Form 8-3-6. Interest&#8221;) to any Borrower that is tax resident in Ireland, which is to make a payment of interest under this Agreement to which that Irish Treaty Lender is entitled (with a copy to the Administrative Agent).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding anything to the contrary in this Section 2.17(e), no Lender shall be required to provide any documentation pursuant to this Section 2.17(e) that such Lender is not legally eligible to provide.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">If the Administrative Agent or a Lender determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified by any Borrower or any Guarantor, as the case may be, or with respect to which any Borrower or any Guarantor, as the case may be, has paid additional amounts pursuant to this Section 2.17, it shall pay over such refund to such Borrower or such Guarantor (but only to the extent of indemnity payments made, or additional amounts paid, by such Borrower or such Guarantor under this Section 2.17 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Borrower or Guarantor, as the case may be, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to such Borrower or Guarantor (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority.  Notwithstanding anything to the contrary in this paragraph (f), in no event will the Administrative Agent or a Lender be required to pay any amount to any Borrower or any Guarantor pursuant to this paragraph (f) the payment of which would place the Administrative Agent or such Lender in a less favorable net after-Tax position than the Administrative Agent or such Lender would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid.  This Section 2.17 shall not be construed to require the Administrative Agent or any Lender to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to any Borrower, any Guarantor or any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes and Other Taxes attributable to such Lender (but only to the extent that any Loan Party has not already indemnified the Administrative Agent for such Indemnified Taxes and Other Taxes and without limiting or expanding the obligation of the Loan Parties to do so), (ii) any Taxes attributable to such Lender's failure to comply with the provisions of Section 9.04(c)(ii) relating to the maintenance of a Participant Register, and (iii) any Excluded Taxes attributable to such Lender, in each case, that are paid or payable by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error.  Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this Section 2.17(g).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(i)&#160;&#160;&#160;&#160;Every Revolving Lender under any Revolving Loans, Extended Revolving Loans or Incremental Revolving Loans, as applicable, advanced to a Borrower that is tax resident in Ireland shall on or prior to the day on which such Revolving Lender becomes a </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">117</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Lender under this Agreement, provide a confirmation in the form attached at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Irish Qualifying Lender Confirmation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Each such Revolving Lender that becomes a Revolving Lender after the date of this Agreement shall provide, in any Assignment and Assumption which it executes on becoming a Revolving Lender, and each party that becomes a Participant with respect to the Revolving Loans, Extended Revolving Loans or Incremental Revolving Loans, as applicable, advanced to a Borrower that is tax resident in Ireland after the date of this Agreement shall provide, upon becoming a Participant, for the benefit of each Foreign Loan Party and Administrative Agent an Irish Qualifying Lender Confirmation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">If a Revolving Lender or Participant, as the case may be, fails to provide an Irish Qualifying Lender Confirmation in accordance with this Section 2.17(h), then such Revolving Lender or Participant, as the case may be, shall be treated for the purposes of this Agreement (including by each Foreign Loan Party) as if it is not an Irish Qualifying Lender until such time as it provides an Irish Qualifying Lender Confirmation to the Administrative Agent (and the Administrative Agent, upon receipt of such Irish Qualifying Lender Confirmation, shall inform each Foreign Loan Party).  For the avoidance of doubt, an Assignment and Assumption or participation, as the case may be, shall not be invalidated by any failure of a Revolving Lender or Participant, as the case may be, to comply with this Section 2.17(h).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Each Revolving Lender or Participant required to provide an Irish Qualifying Lender Confirmation in accordance with this Section 2.17(h), as the case may be, shall promptly notify the Administrative Agent if there has been a change in any of the details provided in the Irish Qualifying Lender Confirmation (excluding, for the avoidance of doubt, any Change in Law) and provide an updated Irish Qualifying Lender Confirmation at that time and shall, for as long as it is Revolving Lender or Participant, as the case may be, at the reasonable written request by or on behalf of a Borrower that is tax resident in Ireland, provide an updated Irish Qualifying Lender Confirmation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Each Lender and Participant shall, upon written request from a Borrower that is tax resident in Ireland, provide such details as are necessary to enable such Borrower to comply with its reporting obligations under Section 891A, 891E, 891F and 891G of the TCA and any other applicable automatic exchange of information obligations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, for purposes of this Section 2.17(h), (1) the term &#8220;Revolving Lender&#8221; shall include any Issuing Bank and any Swingline Lender and (2) the term &#8220;Revolving Loan&#8221; shall include any Letter of Credit and any Swingline Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">For purposes of this Section 2.17, the term &#8220;Lender&#8221; shall include any Swingline Lender and any Issuing Bank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Payments Generally&#59; Allocations of Proceeds&#59; Pro Rata Treatment&#59; Sharing of Set-offs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Applicable Borrower shall make each payment required to be made by it hereunder (whether of principal, interest, fees, or reimbursement of LC Disbursements or of amounts payable under Section 2.15, 2.16 or 2.17, or otherwise) prior to (i) in the case of payments denominated in Dollars, 1&#58;00 p.m., New York City time and (ii) in the case of payments denominated in a Foreign Currency, 1&#58;00 p.m., Local Time, in the city of the Administrative Agent&#8217;s Eurocurrency Payment Office for such currency, in each case, on the date when due, in immediately available funds, without set-off or counterclaim.  Any amounts received after such time on any date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest thereon.  All </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">118</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such payments shall be made (i) in the same currency in which the applicable Credit Event was made and (ii) to the Administrative Agent at the address specified in Section 9.01(a)(ii) or such other office as the Administrative Agent may hereafter designate in writing as such to the other parties hereto, or, in the case of a Credit Event denominated in a Foreign Currency, the Administrative Agent&#8217;s Eurocurrency Payment Office for such currency, except payments to be made directly to the applicable Issuing Bank or Swingline Lender as expressly provided herein and except that payments pursuant to Sections 2.15, 2.16, 2.17 and 9.03 shall be made directly to the Persons entitled thereto.  The Administrative Agent shall distribute any such payments denominated in the same currency received by it for the account of any other Person to the appropriate recipient promptly following receipt thereof.  If any payment hereunder shall be due on a day that is not a Business Day, the date for payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the period of such extension.  Notwithstanding the foregoing provisions of this Section 2.18, if, after the making of any Credit Event in any Foreign Currency, currency control or exchange regulations are imposed in the country which issues such currency with the result that the type of currency in which the Credit Event was made (the &#8220;Original Currency&#8221;) no longer exists or the Applicable Borrower is not able to make payment to the Administrative Agent for the account of the applicable Lenders in such Original Currency, then all payments to be made by the Applicable Borrower hereunder in such currency shall instead be made when due in Dollars in an amount equal to the Dollar Amount (as of the date of repayment) of such payment due, it being the intention of the parties hereto that the Applicable Borrower takes all risks of the imposition of any such currency control or exchange regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Any proceeds of Collateral received by the Administrative Agent or the Collateral Agent (whether as a result of any realization on the Collateral, any setoff rights, any distribution in connection with any proceedings or other action of any Loan Party in respect of Debtor Relief Laws or otherwise and whether received in cash or otherwise) (i) not constituting (A) a specific payment of principal, interest, fees or other sum payable under the Loan Documents (which shall be applied on a pro rata basis among the relevant Lenders under the Class of Loans being prepaid as specified by the Applicable Borrower) or (B) a mandatory prepayment (which shall be applied in accordance with Section 2.11) or (ii) after an Event of Default has occurred and is continuing and the Administrative Agent so elects or the Required Lenders so direct, such funds shall be applied, subject to the provisions of any Intercreditor Agreement, ratably </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay any fees, indemnities, or expense reimbursements including amounts then due to the Administrative Agent, the Collateral Agent and any Issuing Bank from the Borrowers, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay any fees or expense reimbursements then due to the Lenders (in their capacities as such) from the Borrowers, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to pay interest (including post-petition interest, whether or not an allowed claim in any Insolvency or Liquidation Proceeding) then due and payable on the Loans ratably, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to repay principal on the Loans and unreimbursed LC Disbursements, to pay an amount to the Administrative Agent equal to one hundred two percent (102%) of the aggregate undrawn face amount of all outstanding Letters of Credit, to be held as cash collateral for such Obligations, and any other amounts owing with respect to any Secured Obligations constituting Swap Obligations and&#47;or Cash Management Agreements ratably&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that amounts which would otherwise be applied to cash collateralize outstanding Letters of Credit shall, unless all Revolving Loans and Swingline Loans have been paid in full, instead be utilized to repay such outstandings, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of any other Secured Obligation due to any Secured Party by the Borrowers.  Notwithstanding anything to the contrary contained in this Agreement, unless so directed by the Applicable Borrower, or unless a Default is in existence, none of the Administrative Agent or any Lender shall apply any payment which it receives to any Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan, except (a) on the expiration date of the Interest Period or maturity date (as applicable) applicable to any such Eurocurrency Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loan or (b) in the event, and only to the extent, that there are no outstanding ABR Loans of the same Class and, in any event, the Applicable Borrower shall pay the break funding payment required in accordance with Section 2.16.  The Administrative Agent, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">119</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Collateral Agent and the Lenders shall have the continuing and exclusive right to apply and reverse and reapply any and all such received proceeds and payments to any portion of the Secured Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If any Lender shall, by exercising any right of set-off or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of its Loans or participations in LC Disbursements or Swingline Loans resulting in such Lender receiving payment of a greater proportion of the aggregate amount of its Loans and participations in LC Disbursements and Swingline Loans and accrued interest thereon than the proportion received by any other Lender, then the Lender receiving such greater proportion shall purchase (for cash at face value) participations in the Loans and participations in LC Disbursements and Swingline Loans of other Lenders to the extent necessary so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and accrued interest on their respective Loans and participations in LC Disbursements and Swingline Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) if any such participations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest, (ii) the provisions of this paragraph shall not be construed to apply to any payment made by the Borrowers pursuant to and in accordance with the express terms of this Agreement or any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or participations in LC Disbursements and Swingline Loans to any assignee or participant, other than, except as provided in Section 2.26, to Holdings or any Subsidiary thereof (as to which the provisions of this paragraph shall apply) and (iii) nothing in this Section 2.18(c) shall be construed to limit the applicability of Section 2.18(b) in the circumstances where Section 2.18(b) is applicable in accordance with its terms.  The Borrowers consent to the foregoing and agree, to the extent they may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrowers rights of set-off and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrowers in the amount of such participation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Unless the Administrative Agent shall have received notice from the Applicable Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the relevant Lenders or Issuing Banks hereunder that the Applicable Borrower will not make such payment, the Administrative Agent may assume that the Applicable Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the relevant Lenders or Issuing Bank, as the case may be, the amount due.  In such event, if the Applicable Borrower has not in fact made such payment, then each of the relevant Lenders or Issuing Bank, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation (including without limitation the Overnight Foreign Currency Rate in the case of Loans denominated in a Foreign Currency).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to Section 2.26, if any Lender shall fail to make any payment required to be made by it pursuant to Section 2.05(c), 2.06(d) or (e), 2.07(b), 2.18(d) or 9.03(c), then the Administrative Agent may, in its discretion (notwithstanding any contrary provision hereof), (i) apply any amounts thereafter received by the Administrative Agent for the account of such Lender and for the benefit of the Administrative Agent, the Swingline Lender or any Issuing Bank to satisfy such Lender&#8217;s obligations to it under this Section 2.18 until all such unsatisfied obligations are fully paid and&#47;or (ii) hold any such amounts in a segregated account as cash collateral for, and application to, any future funding obligations of such Lender under any this </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">120</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.18&#59; in the case of each of clauses (i) and (ii) above, in any order as determined by the Administrative Agent in its discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Mitigation Obligations&#59; Replacement of Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If any Lender requests compensation under Section 2.15, if any Applicable Borrower is required to pay any additional amount or indemnification payment to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.17 or if any Lender delivers a notice pursuant to Section 2.25, then such Lender shall use reasonable efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such Lender, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 2.15 or 2.17, as the case may be, in the future or avoid such illegality under Section 2.25 and (ii) would not subject such Lender to any material unreimbursed cost or expense and would not otherwise be materially disadvantageous to such Lender.  The Applicable Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or assignment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">If (i) any Lender requests compensation under Section 2.15, (ii) the Applicable Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.17 or if any Lender delivers a notice pursuant to Section 2.25, or (iii) any Lender becomes a Defaulting Lender, then the Applicable Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in Section 9.04), all its interests, rights and obligations under the Loan Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the Applicable Borrower shall have received the prior written consent of the Administrative Agent (and if a Revolving Commitment is being assigned, the Issuing Banks and the Swingline Lender), which consent shall not unreasonably be withheld, (ii) such Lender shall have received payment of an amount equal to the outstanding principal of its Loans and participations in LC Disbursements and Swingline Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder (including any amounts under Sections 2.12 and 2.16 but subject to Section 2.26(a)), from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Applicable Borrower (in the case of all other amounts including the fees set forth in Section 2.12, which shall be payable and calculated as if the Applicable Borrower were making a prepayment to such assigning Lender), (iii) in the case of any such assignment resulting from a claim for compensation under Section 2.15 or payments required to be made pursuant to Section 2.17, such assignment will result in a reduction in such compensation or payments and (iv) such assignment does not conflict with applicable law.  A Lender shall not be required to make any such assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrowers to require such assignment and delegation cease to apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Incremental Credit Extensions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Any Borrower may, by written notice to the Administrative Agent from time to time after the Closing Date, request (i) commitments to provide Term Loans of the same Tranche as any outstanding Term Loans (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loan Increase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (ii) commitments to provide term Loans of a new Tranche denominated in an Agreed Currency (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and collectively with any Term Loan Increase, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (iii) increases in the amount of Initial Revolving Commitments or then outstanding Other Revolving Loan Commitments (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment Increase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or (iv) commitments to provide revolving Loans of a new Tranche available in one or more Agreed </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">121</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Currencies (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Revolving Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and collectively with any Revolving Commitment Increase, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), in each case from one or more Incremental Term Lenders and&#47;or Incremental Revolving Lenders (which, in each case, may include any existing Lender or any other bank or other financial institution (any such other bank or other financial institution, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), but shall be required to be Persons which would qualify as assignees of a Lender in accordance with Section 9.04) willing to provide such Incremental Term Loans and&#47;or Incremental Revolving Commitments, as the case may be, in their own discretion.  For the avoidance of doubt, with respect to any Incremental Loans incurred by a Borrower that is organized in Ireland, each Incremental Lender shall comply with the requirements of Section 2.17, including the provision of an Irish Qualifying Lender Confirmation substantially in the form of Exhibit H (pursuant to which such Incremental Lender shall acknowledge that if it is not an Irish Qualifying Lender it will not be grossed up for any Irish withholding Tax applicable under relevant law as of the date such Incremental Lender becomes a party with respect to the Incremental Loans).  Each notice provided pursuant to this Section 2.20 shall set forth (i) the type and amount of the Incremental Term Loan Commitments and&#47;or Incremental Revolving Commitments being requested (which shall be in minimum increments of $1,000,000 and a minimum amount of $10,000,000), (ii) the date on which such Incremental Term Loan Commitments and&#47;or Incremental Revolving Commitments are requested to become effective, (iii) in the case of Other Term Loan Commitments or Other Revolving Loan Commitments, the Agreed Currency or Agreed Currencies and (iv)  whether such Incremental Commitments constitute a Term Loan Increase, Other Term Loan Commitments, a Revolving Commitment Increase or Other Revolving Loan Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(A) The Applicable Borrower and each Incremental Lender shall execute and deliver to the Administrative Agent an Incremental Amendment and such other documentation as the Administrative Agent shall reasonably specify to evidence the Incremental Commitment of such Incremental Lender.  Each Incremental Amendment providing for Incremental Term Loans shall specify the terms of the applicable Incremental Term Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the final maturity date of any Other Term Loans (excluding (x) Term A Facilities and (y) customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (i)) shall be no earlier than the Latest Maturity Date of any Class of Term Loans, (ii) such Class of Other Term Loans shall be denominated in an Agreed Currency, (iii) the Weighted Average Life to Maturity of any Other Term Loans (excluding (x) Term A Facilities and (y) customary &#8220;bridge loan&#8221; facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)) shall be no shorter than the remaining Weighted Average Life to Maturity of the Class of Term Loans with the Latest Maturity Date, (iv) with respect to any Other Term Loans made on or after the Closing Date, the Effective Yield of any Other Term Loans may be less than or exceed the Effective Yield then applicable to the Initial Term Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in the case of Other Term Loans that are secured by Liens on Collateral that rank </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the Liens securing the Initial Term Loans made prior to the date that is 24 months after the Closing Date (other than Term A Facilities) the Effective Yield of which exceeds the Effective Yield then applicable to the Initial Term Loans, the Applicable Margin for the Initial Term Loans is increased (to the extent necessary) such that the Effective Yield thereof is not less than the Effective Yield of such Other Term Loans minus 0.50%, (v) the covenants and events of default of any Other Term Loans shall be reasonably acceptable to the Administrative Agent or shall not, when taken as a whole, be materially more favorable to the lenders or holders thereof than the relevant terms applicable to the Initial Term Loans then outstanding unless such terms are added for the benefit of the Lenders of the Term Loans then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Other Term Loans shall have mandatory prepayment requirements in amounts that are less than or equal to those required under Section 2.11(c)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Term A Facilities may be subject to (x) the Financial Covenant set forth in Section 6.12(a) or (y) one or more financial maintenance covenants (and related events of default) (provided that </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">122</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such covenants shall be included for the benefit of the Revolving Commitments) and (vi) the terms of Incremental Term Loans under a Term Loan Increase shall be the same as the terms of the Term Loans of the Tranche that the Term Loan Increase is increasing (other than upfront fees and&#47;or original issue discount).  The Incremental Term Loans shall rank </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or junior in right of payment with the Initial Term Loans, shall be unsecured or secured on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or junior basis to the Initial Term Loans and shall not be (x) secured by any property or assets of Holdings or any Subsidiary other than the Collateral or (y) guaranteed by Holdings or any of its Subsidiaries other than any Guarantor&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, if such Incremental Term Loans are unsecured or secured on a junior basis to the Initial Term Loans, such Incremental Term Loans will be established as a separate Tranche from the Term Loans.  In the case of any junior lien Incremental Term Loans, such Indebtedness shall be subject to the terms of a First-Second Lien Intercreditor Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B) Each Incremental Amendment providing for Incremental Revolving Commitments shall specify the terms of the applicable Incremental Revolving Commitments&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the final maturity date of any Other Revolving Loans shall be no earlier than the Latest Maturity Date of any Class of Revolving Loans, (ii) such Class of Other Revolving Loans shall be denominated in one or more Agreed Currencies, (iii) such Other Revolving Loans may have mandatory commitment reduction terms that are not identical to the Initial Revolving Loans, (iv) the covenants and events of default of any Other Revolving Loans shall be reasonably acceptable to the Administrative Agent or shall not, when taken as a whole, be materially more favorable to the lenders or holders thereof than the relevant terms applicable to the Initial Revolving Loans unless such terms are added for the benefit of the Lenders of the Initial Revolving Loans then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Other Revolving Loans may benefit from one or more financial maintenance covenants (and related events of default) (provided that such covenants shall be included for the benefit of the Initial Revolving Loans) and (iv) the terms of Incremental Revolving Loans under a Revolving Commitment Increase shall be the same as the terms of the Revolving Loans of the Tranche that the Revolving Commitment Increase is increasing (other than upfront fees and&#47;or original issue discount).  The Incremental Revolving Loans shall rank </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in right of payment with the Initial Revolving Loans, shall be secured on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with the Initial Revolving Loans and shall not be (x) secured by any property or assets of Holdings or any Subsidiary other than the Collateral or (y) guaranteed by Holdings or any of its Subsidiaries other than any Guarantor.  The Incremental Revolving Loans shall be subject to the provisions of Section 2.05(d) and 2.06(k) to the extent dealing with Swingline Loans and Letters of Credit which mature or expire after a Maturity Date when there exists Incremental Revolving Commitments with a longer Maturity Date.  Upon the effectiveness of any Incremental Amendment with respect to Incremental Revolving Commitments, all Swingline Loans and Letters of Credit shall be participated on a pro rata basis by all Revolving Lenders in accordance with their Revolving Credit Exposure existing on such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to Section 2.19, each Lender may, at its option, make any Loan available to the Applicable Borrower or an Additional Borrower by causing any foreign or domestic branch or Affiliate of such Lender to make such Loan (in which case such branch or Affiliate shall be treated as the &#8220;Lender&#8221; with respect to such Loan for all purposes of this Agreement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) any exercise of such option shall not affect the obligation of the Applicable Borrower or such Additional Borrower to repay such Loan in accordance with the terms of this Agreement, (y) if the respective branch or Affiliate is a Foreign Lender, the same shall comply with the requirements of Section 2.17, and (z) with respect to any Revolving Loans advanced to an Additional Borrower that is tax resident in Ireland, the Affiliate, whether or not a Foreign Lender, shall comply with the requirements of Section 2.17.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding the foregoing, no Incremental Commitment shall become effective under this Section 2.20 unless (i) at the time that any such Incremental Commitment is made (and after giving effect thereto), (A) no Event of Default shall exist&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">123</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the event that any tranche of Incremental Term Loans is used to finance a Limited Condition Transaction and to the extent the Incremental Term Lenders participating in such tranche of Incremental Term Loans agree, the foregoing clause (A) shall be tested solely as of the LCT Test Date, and (B) the representations and warranties of the Applicable Borrower set forth in this Agreement shall be true and correct in all material respects (other than to the extent qualified by materiality or &#8220;Material Adverse Effect&#8221;, in which case, such representations and warranties shall be true and correct)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the event that the tranche of Incremental Term Loans is used to finance a Limited Condition Transaction, the foregoing clause (B) shall be limited to the Specified Representations at the discretion of the applicable Incremental Lenders, (ii) the aggregate principal amount of all Incremental Term Loan Commitments and Incremental Revolving Commitments established under this Agreement, together with any Alternative Incremental Facility Indebtedness incurred and any Permitted Refinancing Indebtedness in respect thereof, shall not exceed, as of any date of determination, the sum of (A) the greater of $1,160,000,000 and 100% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (B) an amount equal to the sum of all voluntary prepayments of Term Loans, Revolving Loans and Alternative Incremental Facility Indebtedness that is secured by a Lien on the Collateral that is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with any Lien on the Collateral securing the Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, with respect to Revolving Loans and Alternative Incremental Facility Indebtedness in the form of revolving loans, such prepayment is accompanied by a permanent reduction in the revolving commitments therefore (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayment Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (C) an unlimited amount so long as (1) in the case of any Indebtedness secured by a Lien on the Collateral that is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with any Lien on the Collateral securing the Obligations, the First Lien Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.00&#58;1.00, (2) in the case of any Indebtedness secured by the Collateral on a junior lien basis relative to the Liens on such Collateral securing the Obligations, the Secured Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25&#58;1.00, and (3) in the case of unsecured Indebtedness, either (a) the Total Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25&#58;1.00 or (b) the Fixed Charge Coverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not be less than 2.00&#58;1.00 (the amount pursuant to this clause (C), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incurrence-Based Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, (i) for the avoidance of doubt, if, as part of the same transaction or series of related transactions, the Applicable Borrower incurs Indebtedness pursuant to the Incurrence-Based Incremental Amount and substantially concurrently also incurs Indebtedness (x) pursuant to the Fixed Incremental Amount and&#47;or the Prepayment Incremental Amount or (y) otherwise constituting a Fixed Amount, then the First Lien Net Leverage Ratio, Secured Net Leverage Ratio and&#47;or Total Net Leverage Ratio, as applicable, will be calculated with respect to such incurrence pursuant to the Incurrence-Based Incremental Amount without regard to any such substantially concurrent incurrence of Indebtedness under the Fixed Incremental Amount, Prepayment Incremental Amount or any other Fixed Amount, (ii) the Applicable Borrower may elect to use the Incurrence-Based Incremental Amount regardless of whether there is capacity under the Fixed Incremental Amount and&#47;or the Prepayment Incremental Amount, and if any Incremental Loans may be incurred under the Incurrence-Based Incremental Amount, the Fixed Incremental Amount or the Prepayment Incremental Amount and the Applicable Borrower does not make an election, the Applicable Borrower shall be deemed to have incurred such Incremental Loans under the Incurrence-Based Incremental Amount and (iii) if at any time after any Borrower has incurred Incremental Loans under the Fixed Incremental Amount and&#47;or the Prepayment Incremental Amount, any portion of such Incremental Loans could then be incurred under the Incurrence-Based Incremental Amount, such amounts shall automatically be reclassified to the Incurrence-Based Incremental Amount (the sum of the Fixed Incremental Amount, the Prepayment Incremental Amount and the Incurrence-Based Incremental Amount, after giving effect to any reclassification, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Incremental Amendment.  Each of the parties hereto hereby agrees that, upon the effectiveness of </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">124</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any Incremental Amendment, this Agreement shall be amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Incremental Commitments (including any mechanical or other amendments necessary to reflect the establishment of the Incremental Revolving Commitments) evidenced thereby.  Any such deemed amendment may be memorialized in writing by the Administrative Agent with the Applicable Borrower&#8217;s consent (not to be unreasonably withheld, delayed or conditioned) and furnished to the other parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Incremental Amendment may, without the consent of any Agents (unless it directly adversely amends or modifies the rights or duties of any Agent) or Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Applicable Borrower, to effect the provisions of this Section 2.20 (including without limitation, (i) the addition of customary letter of credit, swingline and Defaulting Lender provisions with respect to any Incremental Revolving Lenders, (ii) the addition of a class vote of the Incremental Revolving Lenders for acceleration, waiver and amendment with respect to any particular Class of Incremental Revolving Loans), (iii) in the case of a Term Loan Increase, modifications to the amortization payment amount and&#47;or the Applicable Margin of the applicable Tranche of Term Loans to provide that the then outstanding Term Loans and the Incremental Term Loans are fungible, (iv) to reset the terms of a Repricing Event to give effect to Incremental Term Loan Commitments and (iv) to implement any additional covenants applicable to the Incremental Loans and Incremental Commitments that, pursuant to this Section 2.20, may be applied to the then existing Loans and Commitments.  The Applicable Borrower will use the proceeds of the Incremental Loans for general corporate purposes (including loans and other Investments in Holdings and its Subsidiaries as permitted herein, Permitted Acquisitions and Investments).  Incremental Loans may be made by any existing Lender (but no existing Lender will have any obligation to make or provide any portion of any Incremental Loan) or by any other bank or other financial institution.  No Lender shall be obligated to provide any Incremental Loans unless it so agrees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">This Section 2.20 shall supersede any provisions in Section 2.18 or 9.02 to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Judgment Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If for the purposes of obtaining judgment in any court it is necessary to convert a sum due from an Applicable Borrower hereunder in the currency expressed to be payable herein (the &#8220;specified currency&#8221;) into another currency, the parties hereto agree, to the fullest extent that they may effectively do so, that the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase the specified currency with such other currency at the Administrative Agent&#8217;s main New York City office on the Business Day preceding that on which final, non-appealable judgment is given.  The obligations of the Applicable Borrower and any Additional Borrower in respect of any sum due to any Lender or the Administrative Agent hereunder shall, notwithstanding any judgment in a currency other than the specified currency, be discharged only to the extent that on the Business Day following receipt by such Lender or the Administrative Agent (as the case may be) of any sum adjudged to be so due in such other currency such Lender or the Administrative Agent (as the case may be) may in accordance with normal, reasonable banking procedures purchase the specified currency with such other currency.  If the amount of the specified currency so purchased is less than the sum originally due to such Lender or the Administrative Agent, as the case may be, in the specified currency, the Applicable Borrower agrees, to the fullest extent that it may effectively do so, as a separate obligation and notwithstanding any such judgment, to indemnify such Lender or the Administrative Agent, as the case may be, against such loss, and if the amount of the specified currency so purchased exceeds (a) the sum originally due to any Lender or the Administrative </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">125</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agent, as the case may be, in the specified currency and (b) any amounts shared with other Lenders as a result of allocations of such excess as a disproportionate payment to such Lender under Section 2.18, such Lender or the Administrative Agent, as the case may be, agrees to remit such excess to the Borrowers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Extensions of Loans and Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary in this Agreement, pursuant to one or more offers (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) made from time to time by the Applicable Borrower to (i) all Term Lenders of Term Loans of any Tranche with a like Maturity Date, and&#47;or (ii) all Incremental Revolving Lenders with a like Maturity Date, in each case on a pro rata basis (based on the aggregate outstanding principal amount of the respective Loans or the aggregate amount of the Commitments with the same Maturity Date, as the case may be, and using Dollar Amounts in the case of any amounts denominated in an Agreed Currency other than Dollars) and on the same terms to each such Lender, the Applicable Borrower may from time to time offer to extend the Maturity Date for any such Loans and otherwise modify the terms of such Loans and&#47;or Commitments pursuant to the terms of the relevant Extension Offer (including by increasing the interest rate or fees payable in respect of such Loans and&#47;or Commitments (and related outstandings) (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and each group of Loans or Commitments, as applicable, in each case of a given Tranche as so extended, as well as the original Loans and Commitments of the original respective Tranche (in each case not so extended), shall (for the avoidance of doubt) be part of a single Tranche&#59; and any Extended Loans shall constitute a separate Class of Loans from the Class of Loans from which they were converted, so long as the following terms are satisfied&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">except as to interest rates, fees, amortization, final maturity date, premium, required prepayment dates and participation in prepayments (which shall, subject to the succeeding clauses (iii), (iv), (v), and (vi), be determined by the Applicable Borrower and set forth in the relevant Extension Offer), the Loans of any Term Lender extended pursuant to any Extension (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall have the same terms as the Tranche of Loans subject to such Extension Offer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">except as to interest rates, fees and final maturity (which shall, subject to the requirements of this Section 2.22, be determined by the Applicable Borrower and set forth in the relevant Extension Offer), the Revolving Commitment, the Incremental Revolving Commitment or Other Refinancing Revolving Commitment of any Revolving Lender (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) extended pursuant to an Extension (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the related outstanding, shall be a Revolving Commitment, Incremental Revolving Commitment or Other Refinancing Revolving Commitment (or related outstandings, as the case may be) with the same terms as the original Revolving Commitments of the same Class, the Incremental Revolving Commitments or Other Refinancing Revolving Commitments (and related outstandings)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) subject to the provisions of Sections 2.05(d) and 2.06(k) to the extent dealing with Letters of Credit and Swingline Loans which mature or expire after a Maturity Date when there exist Extended Revolving Commitments with a longer Maturity Date, all Letters of Credit and Swingline Loans shall be participated in on a pro rata basis by all Lenders with Revolving Commitments and Incremental Revolving Commitments in accordance with their pro rata share of the aggregate Revolving Commitments and Incremental Revolving Commitments (and except as provided in Sections 2.05(d) and 2.06(k), without giving effect to changes thereto on an earlier Maturity Date with respect to Swingline Loans and Letters of Credit theretofore incurred or issued&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the commitment of the Issuing Banks to issue Letters of Credit can only be extended with the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">126</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">appropriate Issuing Banks&#8217;s consent) and all borrowings under Revolving Commitments of such Class and any related Incremental Revolving Commitments or Extended Revolving Commitments and repayments thereunder shall be made on a pro rata basis (except for (A) payments of interest and fees at different rates on Extended Revolving Commitments (and related outstandings) and (B) repayments required upon the Maturity Date for the non-extending Revolving Commitments of the same Class, or any related Incremental Revolving Commitments or Extended Revolving Commitments) and (y) at no time shall there be Revolving Commitments, Extended Revolving Commitments, Incremental Revolving Commitments and&#47;or Other Refinancing Revolving Commitments hereunder (including Extended Revolving Commitments and any original Revolving Commitments) which have more than three different Maturity Dates&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the final maturity date for any Extended Term Loans shall be no earlier than the then Maturity Date for the Tranche of Loans so extended&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the Weighted Average Life to Maturity of any Extended Term Loans shall be no shorter than the remaining Weighted Average Life to Maturity of the Tranche of Term Loans extended thereby&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">any Extended Term Loans may participate on a pro rata basis or a less than pro rata basis (but not greater than a pro rata basis) with the existing Tranches of Term Loans mandatory repayments or prepayments hereunder, in each case as specified in the respective Extension Offer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">if the aggregate principal amount of applicable Term Loans (calculated on the face amount thereof) or Revolving Commitments, as the case may be, in respect of which applicable Term Lenders or Revolving Lenders, as the case may be, shall have accepted the relevant Extension Offer shall exceed the maximum aggregate principal amount of applicable Term Loans or Revolving Commitments, as the case may be, offered to be extended by the Applicable Borrower pursuant to such Extension Offer, then the applicable Term Loans or Revolving Loans, as the case may be, of the applicable Term Lenders or Revolving Lenders, as the case may be, shall be extended rateably up to such maximum amount based on the respective principal amounts (but not to exceed actual holdings of record) with respect to which such Term Lenders or Revolving Lenders, as the case may be, have accepted such Extension Offer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">all documentation in respect of such Extension shall be consistent with the foregoing, </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the Extension shall not become effective unless, on the proposed effective date of the Extension, (x) the Applicable Borrower shall deliver to the Administrative Agent one or more legal opinions reasonably satisfactory to the Administrative Agent and a certificate of an authorized officer of each Loan Party dated the applicable date of the Extension and executed by an authorized officer of such Loan Party certifying and attaching the resolutions adopted by such Loan Party approving or consenting to such Extension and (y) the conditions set forth in Section 4.02 shall be satisfied (with all references therein to any Credit Event being deemed to be references to the Extension on the applicable date of the Extension) and the Administrative Agent shall have received a certificate to that effect dated the applicable date of the Extension and executed by a Financial Officer of Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any applicable Minimum Extension Condition shall be satisfied unless waived by the Applicable Borrower&#59; and</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">127</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the Minimum Tranche Amount shall be satisfied unless waived by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">With respect to all Extensions consummated by an Applicable Borrower pursuant to this Section 2.22, (i) such Extensions shall not constitute voluntary or mandatory payments or prepayments for purposes of Section 2.11 and (ii) no Extension Offer is required to be in any minimum amount or any minimum increment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) the Applicable Borrower may at its election specify as a condition (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Extension Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to consummating any such Extension that a minimum amount (to be determined and specified in the relevant Extension Offer in Borrowers&#8217; sole discretion and may be waived by Applicable Borrower) of Loans or Commitments of any or all applicable Tranches and Classes be tendered and (B) no Tranche of Extended Loans or Extended Commitments shall be in an amount (taking the Dollar Amount of any amounts denominated in Agreed Currencies other than Dollars) of less than $2,500,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Tranche Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), unless such Minimum Tranche Amount is waived by the Administrative Agent.  Subject to compliance with the terms of this Section 2.22, the Administrative Agent, the Issuing Banks and the Lenders hereby consent to the Extensions and the other transactions contemplated by this Section 2.22 (including, for the avoidance of doubt, payment of any interest, fees or premium in respect of any Extended Term Loans and&#47;or Extended Revolving Commitments on such terms as may be set forth in the relevant Extension Offer) and hereby waive the requirements of any provision of this Agreement (including, without limitation, Sections 2.11 and 2.18) or any other Loan Document that may otherwise prohibit any such Extension or any other transaction contemplated by this Section 2.22.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">No consent of any Lender, Issuing Bank or the Administrative Agent, the Collateral Agent shall be required to effectuate any Extension, other than the consent of each Lender agreeing to such Extension with respect to one or more of its Loans of any Class, Revolving Commitments or any Class and&#47;or Other Refinancing Loans (or a portion thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the consent of the Issuing Banks and the Swingline Lender shall be required to effect an Extension of Revolving Commitments.  All Extended Loans and all obligations in respect thereof shall be Secured Obligations under this Agreement and the other Loan Documents that are secured by all or a portion of the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or junior lien basis with all other applicable Obligations under this Agreement and the other Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if such Extended Loans rank junior in right of security with any other Obligations, such Extended Loans will be subject to the terms of a First-Second Lien Intercreditor Agreement.  The Lenders hereby irrevocably authorize the Administrative Agent to enter into amendments to this Agreement and the other Loan Documents with the Borrowers as may be necessary in order to establish new Tranches or sub-tranches in respect of Term Loans or Revolving Commitments so extended and such other amendments as may be necessary or appropriate in the reasonable opinion of the Administrative Agent and the Applicable Borrower in connection with the establishment of such new Tranches or subtranches, in each case on terms consistent with this Section 2.22 (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In connection with any Extension, the Applicable Borrower shall provide the Administrative Agent at least five (5) Business Days (or such shorter period as may be agreed by the Administrative Agent) prior written notice thereof, and shall agree to such procedures, if any, as may be established by, or acceptable to, the Administrative Agent, in each case acting reasonably to accomplish the purposes of this Section 2.22.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary contained herein, no Lender shall be required to accept an Extension Offer.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">128</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Loan Repurchases.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to the terms and conditions set forth or referred to below, a Purchasing Borrower Party may from time to time, at its discretion, conduct modified Dutch auctions in order to purchase its Term Loans of one or more Classes (as determined by the Purchasing Borrower Party) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), each such Purchase Offer to be managed exclusively by the Administrative Agent (or such other financial institution chosen by the Purchasing Borrower Party) (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auction Manager</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), so long as the following conditions are satisfied&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">each Purchase Offer shall be conducted in accordance with the procedures, terms and conditions set forth in this Section 2.23 and the Auction Procedures&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">no Event of Default shall have occurred and be continuing on the date of the delivery of each notice of an auction and at the time of (and immediately after giving effect to) the purchase of any Term Loans in connection with any Purchase Offer)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">the principal amount (calculated on the face amount thereof) of each and all Classes of Term Loans that the Purchasing Borrower Party offers to purchase in any such Purchase Offer shall be no less than U.S. $10,000,000 (unless another amount is agreed to by the Administrative Agent) (across all such Classes)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the aggregate principal amount (calculated on the face amount thereof) of all Term Loans of the applicable Class or Classes so purchased by the Purchasing Borrower Party shall automatically be cancelled and retired by the Purchasing Borrower Party on the settlement date of the relevant purchase (and may not be resold), and in no event shall the Purchasing Borrower Party be entitled to any vote hereunder in connection with such Term Loans&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">no more than one Purchase Offer with respect to any Class may be ongoing at any one time&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">any Purchase Offer with respect to any Class shall be offered to all Term Lenders holding Term Loans of such Class on a pro rata basis&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">no purchase of any Term Loans shall be made from the proceeds of any Revolving Loan or Swingline Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Purchasing Borrower Party must terminate any Purchase Offer if it fails to satisfy one or more of the conditions set forth above which are required to be met at the time which otherwise would have been the time of purchase of Term Loans pursuant to such Purchase Offer.  If the Purchasing Borrower Party commences any Purchase Offer (and all relevant requirements set forth above which are required to be satisfied at the time of the commencement of such Purchase Offer have in fact been satisfied), and if at such time of commencement the Purchasing Borrower Party reasonably believes that all required conditions set forth above which are required to be satisfied at the time of the consummation of such Purchase Offer shall be satisfied, then the Purchasing Borrower Party shall have no liability to any Term Lender for any termination of such Purchase Offer as a result of its failure to satisfy one or more of the conditions set forth above which are required to be met at the time which otherwise would have been the time of consummation of such Purchase Offer, and any such failure shall not result in any Default or Event of Default hereunder.  With respect to all purchases of Term Loans </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">129</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of any Class or Classes made by the Purchasing Borrower Party pursuant to this Section 2.23, (x) the Purchasing Borrower Party shall pay on the settlement date of each such purchase all accrued and unpaid interest (except to the extent otherwise set forth in the relevant offering documents), if any, on the purchased Term Loans of the applicable Class or Classes up to the settlement date of such purchase, (y) such purchases (and the payments made by the Purchasing Borrower Party and the cancellation of the purchased Loans, in each case in connection therewith) shall not constitute voluntary or mandatory payments or prepayments for purposes of Section 2.11 hereof and (z) such purchases of Initial Term Loans shall be made on a pro rata basis between the two Tranches of Initial Term Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Administrative Agent and the Lenders hereby consent to the Purchase Offers and the other transactions effected pursuant to and in accordance with the terms of this Section 2.23&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding anything to the contrary contained herein, no Lender shall have an obligation to participate in any such Purchase Offer.  For the avoidance of doubt, it is understood and agreed that the provisions of Sections 2.11, 2.12, 2.16, 2.18 and 9.04 will not apply to the purchases of Term Loans pursuant to Purchase Offers made pursuant to and in accordance with the provisions of this Section 2.23.  The Auction Manager acting in its capacity as such hereunder shall be entitled to the benefits of the provisions of Article VIII and Section 9.03 to the same extent as if each reference therein to the &#8220;Agents&#8221; were a reference to the Auction Manager, and the Administrative Agent shall cooperate with the Auction Manager as reasonably requested by the Auction Manager in order to enable it to perform its responsibilities and duties in connection with each Purchase Offer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">This Section 2.23 shall supersede any provisions in Section 2.18 or 9.02 to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Refinancing Amendment.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">At any time after the Closing Date, the Applicable Borrower may obtain, from any Lender or any Refinancing Lender, Credit Agreement Refinancing Indebtedness in respect of all or any portion of the Loans or Commitments of the Applicable Borrower then outstanding under this Agreement, in the form of Other Refinancing Loans or Other Refinancing Commitments in each case pursuant to a Refinancing Amendment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Credit Agreement Refinancing Indebtedness (i) will rank pari passu or, other than in the case of Other Refinancing Revolving Commitments and Other Refinancing Revolving Loans, junior in right of payment and of security with the other Loans and Commitments hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if such Credit Agreement Refinancing Indebtedness ranks junior in right of security with any other Loans or Commitments hereunder, such Credit Agreement Refinancing Indebtedness will be subject to the terms of a First-Second Lien Intercreditor Agreement, (ii) will have such maturity dates, pricing, interest rate margins, rate floors, discounts, premiums and optional prepayment or redemption terms as may be agreed by the Applicable Borrower and the Lenders thereof&#59; and (iii) will otherwise comply with the proviso to the definition of &#8220;Credit Agreement Refinancing Indebtedness&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Person that provides any Credit Agreement Refinancing Indebtedness in the form of Other Refinancing Revolving Loans or Other Refinancing Revolving Commitments to an Additional Borrower that is organized in Ireland shall comply with the requirements of Section 2.17, including the provision of an Irish Qualifying Lender Confirmation substantially in the form of Exhibit H (pursuant to which such Person shall acknowledge that if it is not an Irish Qualifying Lender it will not be grossed up for any Irish withholding Tax applicable under relevant law as of the date such Person  provides such Credit Agreement Refinancing Indebtedness). Any Other Refinancing Loans or Other Refinancing Commitments, as applicable, may participate on a pro rata basis or on a less than pro rata basis (but not on a greater than pro rata basis) in any mandatory prepayments hereunder, as specified in the applicable Refinancing Amendment.  The effectiveness of any Refinancing Amendment shall be subject to the satisfaction on the date thereof of each of the conditions set forth in Section 4.02 and, if </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">130</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reasonably requested by the Administrative Agent at its option, receipt by the Administrative Agent of legal opinions, board resolutions, officers&#8217; certificates and&#47;or reaffirmation agreements generally consistent with those delivered on the Closing Date pursuant to Sections 4.01(b), (e) and (g)</font><font style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(other than changes to such legal opinions resulting from a change in law, change in fact or change to counsel&#8217;s form of opinion reasonably satisfactory to the Administrative Agent).  Each Tranche of Credit Agreement Refinancing Indebtedness pursuant to this Section 2.24 shall be in an aggregate principal amount that is not less than $5,000,000 (unless such Credit Agreement Refinancing Indebtedness is incurred to refinance all outstanding Loans with respect to a Tranche).  The Administrative Agent shall promptly notify each Lender and the Collateral Agent as to the effectiveness of each Refinancing Amendment.  Each of the parties hereto hereby agrees that, upon the effectiveness of any Refinancing Amendment, this Agreement shall be deemed amended and restated or amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Credit Agreement Refinancing Indebtedness incurred pursuant thereto (including any amendments necessary to treat the Loans and Commitments subject thereto as Other Refinancing Term Loans and&#47;or Other Refinancing Term Commitments).  Any Refinancing Amendment may, without the consent of any other Lenders or any Agents (unless it directly adversely amends or modifies the rights or duties of any Agent), effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Applicable Borrower, to effect the provisions of this Section 2.24 (including without limitation, the addition of customary Defaulting Lender provisions with respect to any Lenders providing Other Refinancing Revolving Loans and Other Refinancing Revolving Commitments).  This Section 2.24 shall supersede any provisions in Section 2.18 or 9.02 to the contrary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Illegality.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any Lender determines that any law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable lending office to make, maintain or fund Loans whose interest is determined by reference to the Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR, USD Adjusted Term SOFR, USD Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or Daily Simple RFR with respect to any Agreed Currency, or to determine or charge interest rates based upon the Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR, USD Adjusted Term SOFR, USD Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or Daily Simple RFR with respect to any Agreed Currency, or any Governmental Authority has imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits of, any Agreed Currency in the London interbank market, then, on notice thereof by such Lender to the Applicable Borrower through the Administrative Agent, (i) any obligation of such Lender to make or continue Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans in such Agreed Currency or to convert ABR Loans to Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or RFR Loans in such Agreed Currency shall be suspended and (ii) if such notice asserts the illegality of such Lender making or maintaining ABR Loans the interest rate on which is determined by reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Alternate Base Rate, the interest rate on which ABR Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Alternate Base Rate.  Upon receipt of such notice, (x) the Applicable Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, if applicable, convert all Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans in such Agreed Currency of such Lender to ABR Loans (the interest rate on which ABR Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Alternate Base Rate), either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Eurocurrency Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or RFR Loans and (y) if such notice asserts the illegality of such Lender determining or charging interest rates based upon </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">131</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR, USD Adjusted Term SOFR or USD Term SOFR Reference Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall during the period of such suspension compute the Alternate Base Rate applicable to such Lender without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USD Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon the Eurocurrency Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, USD Term SOFR, USD Adjusted Term SOFR or USD Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon any such prepayment or conversion, the Applicable Borrower shall also pay accrued interest on the amount so prepaid or converted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Defaulting Lenders.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">such Defaulting Lender&#8217;s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in the definition of &#8220;Required Lenders&#8221;. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding any provision of this Agreement to the contrary, if any Revolving Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Revolving Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">fees shall cease to accrue on the unfunded portion of the Revolving Commitment of such Defaulting Lender pursuant to Section 2.12(a)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the unused Commitment and Revolving Credit Exposure of such Defaulting Lender shall not be included in determining whether the Required Lenders or Required Revolving Lenders or Majority in Interest of Revolving Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to Section 9.02)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (ii) shall not apply to the vote of a Defaulting Lender in the case of an amendment, waiver or other modification requiring the consent of such Lender or each Lender affected thereby under Section 9.02&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">if any Swingline Exposure or LC Exposure exists at the time such Revolving Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">so long as no Default has occurred and is continuing&#58;  all or any part of the Swingline Exposure of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Revolving Percentages (after giving effect to the reallocation provisions of Sections 2.05(d) and 2.06(k)) but only to the extent (A) the sum of all non-Defaulting Lenders&#8217; Revolving Credit Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Defaulting Lender&#8217;s Swingline Exposure does not exceed the total of all non-Defaulting Lenders&#8217; Revolving Commitments and (B) each non-Defaulting Lender&#8217;s Revolving Credit Exposure in respect of any Class does not exceed such non-Defaulting Lender&#8217;s Revolving Commitment in respect of such Class&#59; and all or any part of the LC Exposure of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Revolving Percentages (after giving effect to the reallocation provisions of Sections 2.05(d) and 2.06(k)) but only to the extent (C) the sum of all non-Defaulting Lenders&#8217; Revolving Credit Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Defaulting Lender&#8217;s LC Exposure does not exceed the total of all non-Defaulting Lenders&#8217; Revolving Commitments&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">132</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">if the reallocations described in clause (A) above cannot, or can only partially, be effected, the Applicable Borrower shall within one (1) Business Day following notice by the Administrative Agent (x) first, prepay such Swingline Exposure and (y) second, Cash Collateralize for the benefit of the applicable Issuing Bank only the Applicable Borrower&#8217;s obligations corresponding to such Defaulting Lender&#8217;s LC Exposure (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in Section 2.06(j) for so long as such LC Exposure is outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">if the Applicable Borrower Cash Collateralizes any portion of such Defaulting Lender&#8217;s LC Exposure pursuant to clause (B) above, the Applicable Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to Section 2.12(b) with respect to such Defaulting Lender&#8217;s LC Exposure during the period (and to the extent) such Defaulting Lender&#8217;s LC Exposure is Cash Collateralized&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">if the LC Exposure of the non-Defaulting Lenders is reallocated pursuant to clause (A) above, then the fees payable to the Lenders pursuant to Section 2.12(a) and Section 2.12(b) shall be adjusted in accordance with such non-Defaulting Lenders&#8217; Applicable Percentages (after giving effect to the reallocation provisions of Sections 2.05(d) and 2.06(k))&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">if all or any portion of such Defaulting Lender&#8217;s LC Exposure is neither reallocated nor Cash Collateralized pursuant to clause (A) or (B) above, then, without prejudice to any rights or remedies of the applicable Issuing Bank or any other Lender hereunder, all letter of credit fees payable under Section 2.12(b) with respect to such Defaulting Lender&#8217;s LC Exposure shall be payable to the Issuing Bank until and to the extent that such LC Exposure is reallocated and&#47;or Cash Collateralized&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">so long as such Lender is a Defaulting Lender, the Swingline Lender shall not be required to fund any Swingline Loan and no Issuing Bank shall be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure and the Defaulting Lender&#8217;s then outstanding LC Exposure will be 100% covered by the Revolving Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrowers in accordance with Section 2.26(b)(iii), and participating interests in any such newly made Swingline Loan or any newly issued or increased Letter of Credit shall be allocated among non-Defaulting Lenders in a manner consistent with Section 2.26(b)(iii)(A) (and such Defaulting Lender shall not participate therein).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Defaulting Lender Cure.  If a Lender ceases to be a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any cash collateral), that Lender will, to the extent applicable, take such actions as the Administrative Agent may determine to be necessary to cause the applicable Loans to be held pro rata by the applicable Lenders in accordance with the applicable Commitments, whereupon such Lender will cease to be a Defaulting Lender, the Swingline Exposure and LC Exposure of the Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Commitment and on such date such Lender shall purchase at par such of the Revolving Loans of any Class (other than Swingline Loans) of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no adjustments will be made </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">133</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">retroactively with respect to fees accrued or payments made by or on behalf of the Borrowers while that Lender was a Defaulting Lender&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender&#8217;s having been a Defaulting Lender.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.76pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Representations and Warranties</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In order to induce the Administrative Agent, the Collateral Agent and the Lenders to enter into this Agreement on the Closing Date and to make each Loan or other extension of credit to be made hereunder on the Closing Date and on the date of each other Credit Event, each of the Loan Parties represents and warrants to the Administrative Agent, the Collateral Agent and Lenders that, (i) on the Closing Date (after giving effect to the Transactions), solely with respect to the Specified Representations, and (ii) on the date of each other Borrowing (other than as provided in Section 2.20), that each of the following statements are true and correct in all material respects&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Organization&#59; Powers&#59; Subsidiaries.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Each of Holdings and its Material Subsidiaries is duly organized or incorporated, as the case may be, and validly existing and (to the extent the concept is applicable in such jurisdiction) in good standing under the laws of the jurisdiction of its organization, has all requisite power and authority to carry on its business as now conducted and, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, is qualified to do business in, and (to the extent the concept is applicable in such jurisdiction) is in good standing in, every jurisdiction where such qualification is required.  Schedule 3.01 hereto identifies each Subsidiary (other than Subsidiaries in respect of which Holdings and its Subsidiaries own less than 50% of the Equity Interests thereof) as of the Closing Date, noting whether such Subsidiary is a Material Subsidiary, whether such Subsidiary is an Unrestricted Subsidiary, the jurisdiction of its incorporation or organization, as the case may be, the percentage of issued and outstanding shares of each class of its capital stock or other equity interests owned by Holdings and the other Subsidiaries and, if such percentage is not 100% (excluding directors&#8217; qualifying shares as required by law), a description of each class issued and outstanding.  All of the outstanding shares of capital stock and other equity interests of each Material Subsidiary are validly issued and outstanding and fully paid and non-assessable (as such term is determined under applicable law) and all such shares and other equity interests owned by Holdings or another Material Subsidiary are owned, beneficially and of record, by Holdings or such Material Subsidiary free and clear of all Liens, other than Liens created under the Loan Documents and Liens permitted by Section 6.02.  As of the Closing Date (and except pursuant to the Acquisition Agreement), there are no outstanding commitments or other obligations of any Material Subsidiary to issue, and no options, warrants or other rights of any Person to acquire, any shares of any class of capital stock or other equity interests of any Material Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Authorization&#59; Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Transactions are, subject to the Legal Reservations, within each Loan Party&#8217;s corporate or other organizational powers and have been (or, except with respect to the Loan Documents executed by one or more Loan Parties on the Closing Date, will on or prior to the Closing Date be) duly authorized by all necessary corporate or other organizational actions and, if required, actions by shareholders, members or equity holders.  The Loan Documents to which each Loan Party is a party have been duly executed and delivered by such Loan Party and, subject to the Legal Reservations, constitute a legal, valid and binding obligation of such Loan Party and, subject to the Legal Reservations and the Perfection Requirements, enforceable in accordance with its terms, subject to (i) applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors&#8217; rights generally and </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">134</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law, and (ii) the effect of foreign laws, rules and regulations as they relate to pledges of Equity Interests in or Indebtedness owed by Foreign Subsidiaries (other than with respect to those pledges and security interests made under the laws of the jurisdiction of formation of the applicable Foreign Subsidiary).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Governmental Approvals&#59; No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Transactions (a) do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority, except such as have been obtained or made and are in full force and effect and except for (x) filings, notifications or registrations necessary to perfect Liens created pursuant to the Loan Documents and (y) consents, approvals, registrations, filings or other actions that will be obtained or made in connection with the Acquisition on or prior to the Closing Date, (b) will not violate any applicable law or regulation (except such non-compliance that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect) or the charter, by-laws or other Organizational Documents of Holdings or any of its Material Subsidiaries or any order of any Governmental Authority, (c) will not violate in any material respect or result in a default under any indenture, any material agreement or other material instrument (except such non-compliance that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect) binding upon Holdings or any of its Material Subsidiaries or its assets, or give rise to a right thereunder to require any payment to be made by Holdings or any of its Material Subsidiaries (other than the Indebtedness set forth on Schedule 3.03), and (d) will not result in the creation or imposition of any Lien on any asset of Holdings or any of its Material Subsidiaries, other than Liens created under the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Financial Condition&#59; No Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings has heretofore furnished to the Lenders (i) the audited condensed consolidated balance sheet and statements of operations, changes in stockholders&#8217; equity (deficit) and cash flows as of and for the fiscal years ended December 31, 2018, December 31, 2019 and December 31, 2020 for Target and its subsidiaries, and (ii) the audited consolidated balance sheet and statements of comprehensive loss, stockholders&#8217; equity (loss) and cash flows as of and for the fiscal years ended December 31, 2018, December 31, 2019 and December 31, 2020 for the Group.  Such financial statements present fairly, in all material respects, the financial position and results of operations and cash flows of Target and its subsidiaries and the financial position and results of operations and cash flows of the Group, as the case may be, as of such dates and for such periods in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Since December 31, 2020, there has been no material adverse change in the business, operations or condition, financial or otherwise, of the Group, taken as a whole.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Properties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each of Holdings and its Material Subsidiaries has good title to, or (to the knowledge of Holdings) valid leasehold interests in, all its real and personal property (excluding intellectual property, which is considered in Section 3.05(b)) material to its business, except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties for their intended purposes.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each of Holdings and its Subsidiaries owns without restriction, free and clear of all Liens other than Permitted Liens, or is licensed to use, all trademarks, trade names, copyrights, patents and other intellectual property used in or necessary to the business of Holdings and its Subsidiaries, except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. All such intellectual property is, to the knowledge of Holdings, valid and enforceable and all registrations and applications for such intellectual property are, to </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">135</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the knowledge of Holdings (to the extent such intellectual property is licensed from third parties), subsisting and have not expired or been abandoned except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  Except as set forth in Schedule 3.05 attached hereto, Holdings&#8217; Annual Report on Form 20-F for the year ended December 31, 2020 and the Target&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, no claim has been asserted or is pending by any Person challenging or questioning the use, scope, validity, effectiveness or ownership of any such intellectual property or alleging infringement, misappropriation, dilution or other violation by Holdings or any of its Subsidiaries of any intellectual property owned by any other Person, nor does Holdings know of any valid basis for any such claim, except for such claims that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, to the knowledge of Holdings, neither Holdings, its Subsidiaries, nor the operations of their businesses infringes upon, misappropriates, dilutes or otherwise violates any intellectual property of any Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Litigation, Environmental and Labor Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto, Holdings&#8217; Annual Report on Form 20-F for the year ended December 31, 2020 and the Target&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, there are no actions, suits, proceedings or investigations by or before any arbitrator or Governmental Authority pending against or, to the knowledge of Holdings, threatened against or affecting Holdings or any of its Subsidiaries that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Except with respect to matters that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, neither Holdings nor any of its Subsidiaries (i) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii) has received written notice of any pending or threatened claim with respect to any Environmental Liability or (iii) has knowledge of any existing facts or circumstances that would reasonably be expected to result in Holdings or any of its Subsidiaries becoming subject to any Environmental Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">As of the Closing Date, there are no strikes, lockouts or slowdowns against Holdings or any of its Subsidiaries pending or, to the knowledge of Holdings, threatened that have resulted in, or could reasonably be expected to result in, a Material Adverse Effect.  The hours worked by and payments made to employees of Holdings and its Subsidiaries have not been in violation of the Fair Labor Standards Act or any other applicable Federal, state, local or foreign law relating to such matters that has resulted in, or could reasonably be expected to result in, a Material Adverse Effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Compliance with Laws and Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto, each of Holdings and its Subsidiaries is in compliance with all laws, regulations and orders of any Governmental Authority applicable to it or its property, operations or assets and all indentures, agreements and other instruments binding upon it or its property, except where such non-compliance would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Investment Company Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  None of the Loan Parties is required to be registered as an &#8220;investment company&#8221; as defined in the Investment Company Act of 1940.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as would not reasonably be expected to result in a Material Adverse Effect, each of Holdings and its Subsidiaries has timely filed or caused to be filed all Tax returns and reports required to have been filed by it and has paid or caused to be paid </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">136</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">all Taxes required to have been paid by it, except Taxes that are being contested in good faith by appropriate proceedings diligently conducted and for which Holdings or such Subsidiary, as applicable, has set aside on its books adequate reserves in accordance with, and to the extent required by, applicable accounting principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Except as would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, (i) each Plan is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretations thereunder, and (ii) all contributions required to be made under the terms of any Plan as of the date of this Agreement have been timely made, or if not yet due, have been properly reflected on the most recent consolidated balance sheet filed or incorporated by reference in the Companies&#8217; financial statements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(i) No ERISA Event has occurred or is reasonably expected to occur and (ii) none of the Loan Parties or any of their respective ERISA Affiliates has engaged in a transaction that is subject to Sections 4069 or 4212(c) of ERISA, except, with respect to each of the foregoing clauses of this Section 3.10(b), as would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">To the knowledge of Holdings and the Borrowers, there has been no prohibited transaction (within the meaning of Section 406 of ERISA or Section 4975 of the Code) with respect to any Plan, other than a transaction that is exempt under a statutory or administrative exemption, except as would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Except where noncompliance or the incurrence of an obligation, in each case, would not reasonably be expected to result in a Material Adverse Effect, (i) each Non-U.S. Plan and each Irish Pension Scheme has been maintained in compliance with its terms and with the requirements of any and all applicable laws, statutes, rules, regulations and orders, and (ii) neither Holdings nor any Subsidiary has incurred any obligation in connection with the termination of or withdrawal from any Non-U.S. Plan or Irish Pension Scheme. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  None of the factual information and data contemporaneously furnished in writing by or on behalf of any Loan Party (other than projected financial information, pro forma financial information, budgets, estimates, information based on third-party reports and information of a general economic or industry nature) to the Administrative Agent, Collateral Agent or any Lender in connection with the transactions contemplated hereby and the negotiation of this Agreement as of the Closing Date when taken as a whole contains, as of the date of such statement, certificate or other information was furnished, any material misstatement of fact or omits to state any material fact necessary to make the statements therein (when taken as a whole), in the light of the circumstances under which they were made, not materially misleading. With respect to projected financial information and pro forma financial information furnished in writing by or on behalf of any Loan Party to the Administrative Agent on or prior to the Closing Date, the Collateral Agent or any Lender, Holdings represents that such information was prepared in good faith based upon assumptions believed to be reasonable at the time such information was furnished, it being understood that such projected financial information and pro forma financial information are subject to significant uncertainties and contingencies, many of which are beyond Holdings&#8217; control, are not to be viewed as facts, that actual results during the period or periods covered by any such information may differ from the projected results and such differences may be material, and that no assurance can be given that any projection will be realized.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">137</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Federal Reserve Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No part of the proceeds of any Loan have been used or will be used, whether directly or indirectly, for any purpose that entails a violation of any of the Regulations of the Board, including Regulation T, U or X.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Security Interest in Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent the U.S. Security Agreement has been executed and delivered by the parties thereto and is then in effect, the U.S. Security Agreement will create in favor of the Collateral Agent, for the benefit of the Secured Parties, a valid and enforceable security interest in the Collateral covered thereby and (i) when the Collateral constituting certificated securities (as defined in the UCC) is delivered to the Collateral Agent, together with instruments of transfer duly endorsed in blank, the Liens under the U.S. Security Agreement will constitute a fully perfected security interest in all right, title and interest of the pledgors thereunder in such Collateral, prior and superior in right to any other Person, (ii) when a copyright security agreement is executed and delivered to the Collateral Agent and recorded with the U.S. Copyright Office, (iii) when a trademark security agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or a patent security agreement is executed and delivered to the Collateral Agent and recorded with the U.S. Patent and Trademark Office, and (iv) (x) when financing statements in appropriate form are filed in the applicable filing offices and (y) to the extent applicable, when the registration of particulars of the U.S. Security Agreement at the Companies Registration Office of Ireland under section 409 of the Companies Act and payment of associated fees have been made and paid, the security interest created under the U.S. Security Agreement will constitute a fully perfected or recorded security interest in all right, title and interest of the Loan Parties in the remaining Collateral covered by the U.S. Security Agreement to the extent perfection can be obtained by filing UCC financing statements or filings with the U.S. Copyright Office or the U.S. Patent and Trademark Office, prior and superior to the rights of any other Person, except for (x) Permitted Liens and (y) certain items of Collateral located in or otherwise subject to foreign law where the grant of a Lien or priority and perfection thereof in accordance with the UCC may not be recognized or enforceable. For the avoidance of doubt, no Loan Party shall be required to take any action other than pursuant to the UCC or recordation with the U.S. Patent and Trademark Office or U.S. Copyright Office, as applicable, to perfect or record any security interest in Collateral constituting intellectual property (including the execution of any agreement, document or other instrument governed by the law of any jurisdiction other than the United States, any State thereof or the District of Columbia).  As to any Collateral, the representations and the warranties with respect thereto contained in the relevant Collateral Documents shall be true and correct in all material respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Solvency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  On the Closing Date immediately after the consummation of the Transactions, Holdings and its Subsidiaries, on a consolidated basis, are Solvent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Compliance with Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Neither Holdings nor any of its Restricted Subsidiaries or, to the knowledge of Holdings and the Borrowers, any of their respective Affiliates over which any of the foregoing exercises management control (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlled Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58; (i) is the target of Sanctions&#59; (ii) is owned or controlled by, or acts on behalf of, any Person that is the target of Sanctions&#59; (iii) is a Sanctioned Person&#59; (iv) is operating from, organized or resident in a Sanctioned Country&#59; or (v) to their knowledge, has violated Anti-Corruption Laws or Sanctions in the past five years. Holdings, its Restricted Subsidiaries and their respective Controlled Affiliates will maintain in effect and enforce policies and procedures reasonably designed to promote and ensure compliance by Holding, its Restricted Subsidiaries, their respective Controlled Affiliates, and each of their respective directors, officers, employees and agents with Anti-Corruption Laws and Sanctions. Holdings will not, directly or knowingly, indirectly, use the proceeds of the Loans or Letters of Credit, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, (i) to fund any activities or business of or with a Sanctioned Person or in a Sanctioned Country or (ii) in any other manner that would result in a violation of Sanctions by any Person (including any Person participating in the Loans or Letters of Credit, whether as Administrative Agent, arranger, Issuing </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">138</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Bank, Lender, underwriter, advisor, investor, or otherwise). No part of the proceeds of the Loans or Letters of Credit will be used, directly or, knowingly, indirectly, for any payments to any person, including any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of Anti-Corruption Laws, including the United States Foreign Corrupt Practices Act of 1977, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">No Irish Financial Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   None of the proceeds of the Term Loans made on the Closing Date and the financing which is the subject matter of the Loan Documents has been used, is being used or will be used at any time in any way which would constitute unlawful &#8220;financial assistance&#8221; within the meaning of, and as prohibited by, Section 82 of the Companies Act  (as from time to time amended, replaced or re-enacted, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 82</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or which would result in the Loan Documents or the transactions thereby recorded (including without limitation any guarantees and indemnities thereby created) contravening Section 82.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Luxembourg Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Luxembourg Loan Party is in compliance with all requirements of the Luxembourg legislation and regulations on the domiciliation of companies, and in particular with the Luxembourg Act dated May 31, 1999 on the domiciliation of companies, as amended from time to time, except where failure to comply with any such requirement could not reasonably be expected to result in a Material Adverse Effect.  No Luxembourg Loan Party is subject to bankruptcy (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), general settlement or composition with creditors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">concordat pr&#233;ventif de faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) controlled management (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">gestion contr&#244;l&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), reprieve from payment (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">sursis de paiement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), judicial or voluntary liquidation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">liquidation judiciaire ou volontaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), such other proceedings listed at Articles 13, items 2 to 12, and 14 of the Luxembourg Act dated December 19, 2002 on the Register of Commerce and Companies, on Accounting and on Annual Accounts of the Companies (as amended from time to time) (and which include foreign court decisions as to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">faillite</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">concordat </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or analogous procedures according to Council Regulation (EC) N&#176; 2015&#47;848 of May 20, 2015 on insolvency proceedings as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Insolvency Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)).  No Luxembourg Loan Party is in a state of cessation of payments (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">cessation de paiements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and no Luxembourg Loan Party has lost its creditworthiness. No application has been made by any Luxembourg Loan Party or, as far as it is aware, by any other person for the appointment of a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">commissaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">juge commissaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">liquidateur</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">curateur</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or similar officer pursuant to any insolvency or similar proceedings.  No application has been made by any Luxembourg Loan Party for a voluntary or judicial winding up or liquidation. The head office (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">administration centrale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the place of effective management (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">si&#232;ge de direction effective</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and (for the purposes of the Insolvency Regulation) the center of main interests (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">centre des int&#233;rets principaux</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) of each Luxembourg Loan Party in Luxembourg is located at the place of its registered office </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(si&#232;ge statutaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) in Luxembourg and it has no &#8220;establishment&#8221; (as that term is used in Article 2(10) of the Insolvency Regulation) in any other jurisdiction.  In addition, each Luxembourg Loan Party is in compliance with any reporting requirements applicable to it pursuant to the Central Bank of Luxembourg regulation 2011&#47;8 (as amended by regulation 2014&#47;17) or the Regulation (EU) No 648&#47;2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties (CCPs) and trade repositories (TRs), as amended, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">PATRIOT Act, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  &#160;&#160;&#160;&#160;To the extent applicable, each Loan Party is in compliance, in all material respects, with (i) The Trading with the Enemy Act, 50 U.S.C. &#167;&#167; 1701 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">et seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as amended, and each of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended) and any other enabling legislation or executive order relating thereto, and (ii) the PATRIOT Act.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">139</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27.14pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Conditions Precedent to the Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligations of the Lenders to extend Loans in respect of the Commitments on the date of the first Borrowing hereunder are subject to the satisfaction of the following conditions precedent, subject to the next to last paragraph of this Section 4.01&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent (or its counsel) shall have received (i) this Agreement, executed and delivered by a duly authorized officer of Holdings, each Borrower and each Guarantor, (ii) the U.S. Security Agreement, executed and delivered by a duly authorized officer of the U.S. Borrower and each Guarantor organized in the United States and (iii) each of the Foreign Security Documents, executed and delivered by a duly authorized officer of the Borrowers or Holdings (as appropriate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Organizational Documents and Necessary Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received (i) a copy of the certificate of incorporation, memorandum of association or articles of incorporation and all applicable, if any, certificates of incorporation on a change of name or certificates of re-registration or other formation documents, including all amendments thereto, of each Loan Party as of the Closing Date, certified  as of a recent date by the Secretary of State of the state of its organization in the case of a corporation incorporated in the United States, and (a certificate as to or of compliance evidencing the good standing of each such Loan Party as of a recent date, from such Secretary of State in the case of a corporation incorporated in the United States&#59; (ii) a certificate of the secretary or assistant secretary or director of each Loan Party as of the Closing Date dated the Closing Date and certifying (A) that attached thereto is a true and complete copy of the by-laws (or similar governing documentation) of such Loan Party as in effect on the Closing Date and at all times since a date prior to the date of the resolutions described in clause (B) below, (B) that attached thereto is a true and complete copy of resolutions duly adopted by the board of directors or similar governing body of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such Person is a party, (in the case of each Borrower) the borrowings hereunder, (in the case of each such Loan Party) the granting of the Liens contemplated to be granted by it under the Collateral Documents and (in the case of each Guarantor) the Guaranteeing of the Secured Obligations as contemplated by this Agreement, the Collateral Documents and other Loan Documents, and that such resolutions have not been modified, rescinded or amended and are in full force and effect, (C) if applicable, that the certificate or articles of incorporation or other formation documents of such Loan Party have not been amended since the date of the last amendment thereto shown on the certificate of good standing furnished pursuant to clause (i) above or where a certificate of good standing is not applicable in its jurisdiction of incorporation that attach a true, up to date and correct copy of the certificate or articles of incorporation or other formation documents of each Loan Party duly certified as being true, up to date and correct and (D) as to the incumbency and specimen signature of each officer executing any Loan Document or any other document delivered in connection herewith on behalf of such Loan Party&#59; and (iii) a certificate of another officer as to the incumbency and specimen signature of the secretary or assistant secretary (or manager or director, if applicable) executing the certificate pursuant to clause (ii) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">KYC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the extent requested at least 10 business days prior to the Closing Date, the Lenders shall have received all documentation and other information required by bank regulatory authorities under applicable &#8220;know-your-customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act and, if applicable, the requirements of 31 C.F.R. &#167; 1010.230, at least three business days prior to the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Additional Requirements for Foreign Subsidiary Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">140</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">The Administrative Agent shall have received, in respect of each Luxembourg Loan Party, a manager&#8217;s certificate in a form satisfactory to the Administrative Agent, dated as of the Closing Date and signed by a manager of each such Luxembourg Loan Party, certifying, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">inter alia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the following items&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">a true, correct, complete and up-to-date copy of its articles of association&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">a true, correct, complete and up-to-date copy of the resolutions of the board of managers of each Luxembourg Loan Party approving, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">inter alia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, its entry into the Loan Documents to which it is a party&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">a true, correct, complete and up-to-date copy of an excerpt of the Luxembourg Companies Register dated on the Closing Date or at the earliest one (1) Business Day before the Closing Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">a true, correct, complete and up-to-date copy of a certified true certificate of non-registration of judgments (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">certificat de non-inscription d&#8217;une d&#233;cision judiciaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) dated on the Closing Date or at the earliest one (1) Business Day before the Closing Date, issued by the Luxembourg Companies Register&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">a true, correct, complete and up-to-date copy of the specimen signatures of all authorized signatories&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">each Luxembourg Loan Party complies with, and adheres to, the provisions applicable to it of the Luxembourg Law dated May 31, 1999 concerning the domiciliation of companies, as amended and the relevant regulations&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the entry by such Luxembourg Loan Party into the Loan Documents to which it is a party would not cause any borrowing, guaranteeing, security or similar limit binding on such Luxembourg Loan Party to be exceeded&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">each copy document relating to it specified in the manager&#8217;s certificate is correct, complete and in full force and effect and has not been amended or superseded as at a date no earlier than the Closing Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">The Administrative Agent shall have received, in respect of each Guarantor organized under the laws of Ireland, a director&#8217;s certificate in a form satisfactory to the Administrative Agent, dated as of the Closing Date and signed by a director or secretary of such Guarantor, certifying, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">inter alia</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the following items</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">that the entry by such Guarantor into the Loan Documents would&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">not cause any borrowing, guaranteeing, security or similar limit binding on such Guarantor to be exceeded&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">not constitute unlawful financial assistance for the purposes of Section 82&#59; and</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">141</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">not be prohibited by Section 239 of the Companies Act&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">a true, correct and up-to-date list of the present directors and secretary of such Guarantor&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">that neither the Guarantor nor any of its directors or secretaries, is a company or a person to whom either Chapter 3 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Restriction on directors of insolvent  companies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or Chapter 4 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Disqualification generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or Chapter 5 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Disqualification and restriction undertakings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) of Part 14 of the Companies Act 2014 applies&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">each copy document relating to it specified in the director&#8217;s certificate is correct, complete and in full force and effect and has not been amended or superseded as at a date no earlier than the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Opinions of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received, on behalf of itself, the Collateral Agent, the Lead Arrangers and the Lenders, (i) a written opinion of Cahill Gordon &#38; Reindel </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LLP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, New York counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, (ii) a capacity and authority opinion of A&#38;L Goodbody LLP, Irish counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, (iii) an enforceability opinion of Matheson, Irish counsel for the Lead Arrangers, the Administrative Agent and the Lenders, in form and substance reasonably acceptable to the Administrative Agent, (iv) a capacity and authority opinion of Loyens &#38; Loeff Luxembourg S.&#224; r.l., Luxembourg counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, (v) an enforceability opinion of NautaDutilh Avocats Luxembourg S.&#224; r.l., Luxembourg counsel for the Lead Arrangers, the Administrative Agent and the Lenders, in form and substance reasonably acceptable to the Administrative Agent, and (vi) a written opinion of McGuire Woods LLP, Virginia counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, in each case (A) dated the Closing Date, (B) addressed to the Administrative Agent, the Collateral Agent, the Lead Arrangers, the Lenders and the Issuing Banks, and, in each case, each of their permitted assigns, and (C) each Borrower and each other Loan Party and the Administrative Agent hereby request such counsel to deliver such opinions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt;text-decoration:underline">Specified Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Specified Representations shall be true and correct in all material respects on the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Acquisition Agreement Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Acquisition Agreement Representations shall be true and correct in all material respects on the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case representations and warranties shall be true and correct in all material respects as of such earlier date), but only to the extent that Holdings (or its applicable subsidiaries) have the right (taking into account any applicable cure periods) to terminate its obligation to consummate the Acquisition under the Acquisition Agreement or the right not to consummate the Acquisition pursuant to the Acquisition Agreement as a result of a breach of such representations and warranties, in each case, in accordance with the terms thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Acquisition.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Acquisition shall have been consummated, or substantially simultaneously with the Borrowing of the Loans hereunder shall be consummated, in accordance with the Acquisition Agreement in all material respects.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">142</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">No Company Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except (a) as disclosed in the Company SEC Documents (as defined in the Acquisition Agreement as in effect on February 24, 2021) prior to the date of the Acquisition Agreement (other than any disclosures contained or referenced therein under the captions &#8220;Risk Factors,&#8221; &#8220;Forward-Looking Statements,&#8221; &#8220;Quantitative and Qualitative Disclosures About Market Risk,&#8221; and any other disclosures contained or referenced therein of information, factors or risks to the extent they are predictive, cautionary, or forward-looking in nature) or (b) as set forth in the Company Disclosure Letter (as defined in the Acquisition Agreement as in effect on February 24, 2021), since the date of the Company Balance Sheet (as defined in the Acquisition Agreement as in effect on the February 24, 2021) there has not been or occurred any Company Material Adverse Effect (as defined in the Acquisition Agreement as in effect February 24, 2021).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Solvency Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received a certificate of Holdings, signed by a director or senior financial officer of Holdings, in substantially the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, attesting to the solvency of Holdings and its Subsidiaries (including the Borrowers and their respective Subsidiaries), taken as a whole, after giving effect to the proposed Transactions on the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent invoiced at least three (3) Business Days prior to the Closing Date (except as otherwise agreed by the Borrowers), all costs, fees, expenses (including, without limitation, legal fees and expenses) and other compensation payable to each Lead Arranger, each Agent and the Lenders pursuant to any written agreement among any such parties and Holdings, shall have been paid to the extent due.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">Refinancing.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Refinancing shall have been consummated, or substantially simultaneously with the Borrowing of the Loans hereunder shall be consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have received unaudited consolidated financial statements of the Target and its subsidiaries for the fiscal quarter ended March 31, 2021&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the filing of the required financial statements on form 10-Q by the Target will satisfy the foregoing requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Notice of Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. A Borrowing Request shall have been delivered in accordance with the terms of Section 2.03.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent (or its counsel) shall have received (i) certificates evidencing Equity Interests of wholly-owned Domestic Subsidiaries that are Material Subsidiaries of Holdings (to the extent available to Holdings) and the Target and its Domestic Subsidiaries (in the case of the Target and its Domestic Subsidiaries, to the extent delivered to Holdings by the Target prior to the Closing Date), to the extent certificated and required to be pledged as set out in the Loan Documents, and (ii) copies of UCC financing statements for entities organized in the United States.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything in this Agreement to the contrary, it is understood that only Holdings, the Borrowers and the other Loan Parties organized under the laws of the United States shall be required to provide guarantees and Collateral (subject to the terms set forth in this paragraph) on the Closing Date and the other Loan Parties may instead provide guarantees and Collateral within forty-five (45) Business Days after the Closing Date (subject to extensions to be reasonably agreed upon by the Administrative Agent), and to the extent any Collateral (including the grant or perfection of any security interest, other than (x) the delivery of certificates evidencing Equity Interests of wholly-owned Domestic Subsidiaries that are Material Subsidiaries of Holdings (to the extent available to Holdings) and the Target and its Domestic Subsidiaries (in the case of the Target and its Domestic Subsidiaries, to the extent delivered to Holdings by the Target prior to the Closing Date), to the extent certificated and required to be pledged as set out in </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">143</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Loan Documents, and (y) any Collateral the security interest in which may be perfected by the filing of a UCC financing statement for entities organized in the United States) is not or cannot reasonably be provided on the Closing Date after Holdings&#8217; use of commercially reasonable efforts to do so or without undue burden or expense, then the provision of such collateral and perfection therein shall not constitute a condition precedent to the availability of the Loans on the Closing Date, but may instead be provided or perfected within ninety (90) days after the Closing Date (in each case, subject to extensions to be reasonably agreed upon by the Administrative Agent).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the generality of the provisions of Section 9.03(b), for purposes of determining compliance with the conditions specified in this Section 4.01, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or the be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Closing Date specifying its objection thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Each Credit Event after the Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to Section 1.07(f), the obligation of each Lender to make a Loan on the occasion of any Borrowing, and of any Issuing Bank to issue, amend, renew or extend any Letter of Credit, after the Closing Date is subject to the satisfaction of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Except as set forth in Section 2.20(d) with respect to Incremental Loans used to finance a Limited Condition Transaction, the representations and warranties of Holdings, each Borrower and their respective Restricted Subsidiaries set forth in this Agreement shall be true and correct in all material respects (or, if qualified as to &#8220;materiality&#8221; or &#8220;Material Adverse Effect&#8221;, in all respects) on and as of the date of such Borrowing or the date of issuance, amendment, renewal or extension of such Letter of Credit, as applicable, except in the case of any such representation and warranty that expressly relates to an earlier date, in which case such representation and warranty shall be true and correct in all material respects (or, if qualified by materiality or &#8220;Material Adverse Effect&#8221;, in all respects) as of such earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Except as set forth in Section 2.20(d) with respect to Incremental Loans used to finance a Limited Condition Transaction, at the time of and immediately after giving effect to such Borrowing or the date of issuance, amendment, renewal or extension of such Letter of Credit, as applicable, no Default or Event of Default shall have occurred and be continuing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">A Borrowing Request shall have been delivered in accordance with the terms of Section 2.03 or a Letter of Credit application in accordance with the terms of Section 2.06(b).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Borrowing and each issuance, amendment, renewal or extension of a Letter of Credit shall be deemed to constitute a representation and warranty by the Applicable Borrower on the date thereof as to the matters specified in paragraphs (a) and (b) of this Section 4.02.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.8pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affirmative Covenants</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">From the Closing Date until the Commitments have expired or been terminated and the principal of and interest on each Loan and all fees payable hereunder shall have been paid in full, and all Letters of Credit shall have expired, terminated or been Cash Collateralized and all LC Disbursements shall have been reimbursed, the Loan Parties covenant and agree with the Lenders that&#58;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">144</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Financial Statements and Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings will furnish to the Administrative Agent, on behalf of each Lender&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">within one hundred twenty (120) days after the end of each fiscal year of Holdings, an audited consolidated balance sheet and related statements of operations, shareholders&#8217; equity and cash flows for Holdings and its consolidated Subsidiaries as of the end of and for such year, setting forth in each case in comparative form the figures for the previous fiscal year (if any), with such audited balance sheet and related consolidated financial statements audited by KPMG LLP or other independent public accountants of recognized national standing (without a &#8220;going concern&#8221; or like qualification or exception and without any qualification or exception as to the scope of such audit, except to the extent solely due to the scheduled occurrence of a Maturity Date within one year from the date of such audit or failure to comply with Section 6.12) to the effect that such consolidated financial statements present fairly in all material respects the financial condition and results of operations of Holdings and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">within sixty (60) days after the end of each of the first three fiscal quarters of each fiscal year of Holdings, a consolidated balance sheet and related statements of operations and cash flows for Holdings and its consolidated Subsidiaries as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the end of) the previous fiscal year, all certified by one of its Financial Officers as presenting fairly in all material respects the financial condition and results of operations of Holdings and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence of footnotes&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">within five (5) Business Days after any delivery of financial statements under clause (a) or (b) above, a certificate (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of a Financial Officer of Holdings (1) certifying as to whether a Default has occurred and, if a Default has occurred, specifying the details thereof and any action taken or proposed to be taken with respect thereto, (2) commencing with the certificate delivered pursuant to clause (b) above for the first full fiscal quarter ending after the Closing Date setting forth (i) a calculation of the Total Net Leverage Ratio as of the last day of the most recent Test Period (ii) a calculation of the First Lien Net Leverage Ratio as of the last day of the most recent Test Period and (iii) a calculation of the Secured Net Leverage Ratio as of the last day of the most recent Test Period and (3) solely in the case of Compliance Certificates accompanying financial statements referred to in clause (a) above, (i) confirming whether the Guarantor Coverage Test is satisfied and setting forth computations thereof in reasonable detail and (ii) setting forth a calculation of Excess Cash Flow with respect to such fiscal year&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">for any period for which the Unrestricted Subsidiaries, taken together, are reasonably anticipated to have had revenues or total assets in an amount that is equal to or greater than 10% of the consolidated revenues or total assets, as applicable, of Holdings and its Restricted Subsidiaries, concurrently with the delivery of each set of consolidated financial statements referred to in Sections 5.01(a) and 5.01(b) above, if applicable, the related consolidating financial statements reflecting the adjustments necessary to eliminate the accounts of such Unrestricted Subsidiaries from such consolidated financial statements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">promptly after any request therefor, such other information regarding the operations, business affairs and financial condition of Holdings or any Restricted Subsidiary, or compliance with the terms of any Loan Document, as may be reasonably requested by the Administrative Agent or by any Lender through the Administrative Agent&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">145</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">concurrently with the delivery of the certificate of a Financial Officer of Holdings under clause (c) above with respect to financial statements delivered pursuant to clause (a) above, a Perfection Certificate Supplement reflecting all changes since the Closing Date or the date of the information most recently received pursuant to this Section 5.01(f), as applicable (or, if there have been no changes to any such schedules since the Closing Date or the previous update required hereby, as applicable, a certification of a Financial Officer of Holdings (which may, at the option of Holdings, be included in the Compliance Certificate) as to the absence of any changes)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">concurrently with the delivery of each set of consolidated financial statements referred to in Sections 5.01(a) and 5.01(b) above, the related customary management discussion and analysis&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">within five (5) Business Days of receipt of notice thereof by Holdings, written notice of any announcement by S&#38;P of a change in Holdings&#8217; corporate credit rating.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In no event shall the requirements set forth in this Section 5.01 require Holdings, the Borrowers or any of their Restricted Subsidiaries to provide any such information (i) which constitutes non-financial trade secrets or non-financial proprietary information, (ii) in respect of which disclosure to the Administrative Agent or any Lender (or their respective representatives or contractors) is prohibited by Law or (iii) which is subject to attorney-client or similar privilege or constitutes attorney work-product&#59; provided that Holdings or a Restricted Subsidiary shall provide notice to the Administrative Agent that information has not been provided pursuant to this paragraph to the extent permitted by Law and not in contravention of such privilege.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Information required to be delivered pursuant to Sections 5.01(a), 5.01(b) and 5.01(f) shall be deemed to have been delivered if such information, or one or more annual, quarterly or other periodic reports containing such information, shall have been posted by the Administrative Agent on an IntraLinks or similar site to which the Lenders have been granted access or be available on the website of the SEC at http&#58;&#47;&#47;www.sec.gov&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, for the avoidance of doubt, Holdings shall be required to provide copies of the Compliance Certificate.  Information required to be delivered pursuant to this Section 5.01 may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.  In the event any financial statements delivered under clause (a) or (b) above shall be restated, the Borrowers shall deliver, promptly after such restated financial statements become available, revised Compliance Certificates with respect to the periods covered thereby that give effect to such restatement, signed by a Financial Officer of Holdings.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Holdings and each Borrower hereby acknowledges that (a) the Administrative Agent and the Lead Arrangers will make available to the Lenders materials and&#47;or information provided by or on behalf of Holdings and the Borrowers hereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by posting the Borrower Materials on IntraLinks or another similar electronic system (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (b) certain of the Lenders (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may have personnel who do not wish to receive material non-public information with respect to Holdings, the Borrowers or their respective Subsidiaries, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related activities with respect to such Persons&#8217; securities.  Holdings and each Borrower hereby agrees that (w) all Borrower Materials that are to be made available to Public Lenders (other than materials made available on the website of the SEC) shall be clearly and conspicuously marked &#8220;PUBLIC&#8221; which, at a minimum, shall mean that the word &#8220;PUBLIC&#8221; shall appear prominently on the first page thereof&#59; (x) by marking Borrower Materials &#8220;PUBLIC,&#8221; Holdings and each Borrower shall be deemed to have authorized the Administrative Agent, the Lead Arrangers and the Lenders to treat the Borrower Materials as not containing any material non-public information with respect to Holdings, each Borrower or their respective securities for purposes of United States Federal and state securities laws (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">146</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to the extent the Borrower Materials constitute Information, they shall be treated as set forth in Section 9.12)&#59; (y) all Borrower Materials marked &#8220;PUBLIC&#8221; are permitted to be made available through a portion of the Platform designated &#8220;Public Side Information&#8221;&#59; and (z) the Administrative Agent and the Lead Arrangers shall be entitled to treat any Borrower Materials that are not marked &#8220;PUBLIC&#8221; as being suitable only for posting on a portion of the Platform not designated &#8220;Public Side Information&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Notices of Material Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings and each Restricted Subsidiary will, upon knowledge thereof by a Responsible Officer, furnish to the Administrative Agent prompt written notice of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the occurrence of any Default&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the filing or commencement of any action, suit or proceeding by or before any arbitrator or Governmental Authority against or affecting Holdings, Borrower or any Subsidiary or Affiliate thereof that could reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(i) any contribution required to be made with respect to a Non-U.S. Plan has not been timely made or (ii) Holdings or any Subsidiary has incurred any obligation in connection with the termination of, or withdrawal from, any Non-U.S. Plan, in each case, to the extent that such event could reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each notice delivered under this Section 5.02 shall be accompanied by a statement of a Responsible Officer of Holdings setting forth the details of the event or development requiring such notice and any action taken or proposed to be taken with respect thereto.  Information required to be delivered pursuant to clause (b) of this Section 5.02 shall be deemed to have been delivered if such information, or one or more annual or quarterly or other periodic reports containing such information, shall have been posted by the Administrative Agent on an IntraLinks or similar site to which the Lenders have been granted access or shall be available on the website of the SEC at http&#58;&#47;&#47;www.sec.gov.  Information required to be delivered pursuant to this Section 5.02 may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Existence&#59; Conduct of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings and the Borrowers will, and will cause each of their respective Material Subsidiaries to, do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence and the rights, qualifications, licenses, permits, privileges, franchises, governmental authorizations and intellectual property rights material to the conduct of its business, and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the foregoing shall not prohibit any Disposition, merger, amalgamation, consolidation, liquidation or dissolution permitted under Section 6.03 or Section 6.11 and (ii) neither Holdings nor any of its Material Subsidiaries shall be required to preserve any right, license, permit, privilege, franchise, patent, copyright, trademark, trade name or other intellectual property rights which in the reasonable good faith determination of Holdings are not useful or material to the conduct of the business of Holdings or its Material Subsidiaries, taken as a whole.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Payment of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings and the Borrowers will, and will cause each of their Restricted Subsidiaries to, pay, discharge or otherwise satisfy, as the same shall become due and payable, all of their obligations and liabilities, including Tax liabilities, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">147</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">except where (a) the validity or amount thereof is being contested in good faith by appropriate proceedings diligently conducted and Holdings, the Borrowers or such Restricted Subsidiary has set aside on its books adequate reserves with respect thereto in accordance with, and to the extent required by, applicable accounting principles or (b) the failure to do so could not reasonably be expected to result in a Material Adverse Effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Maintenance of Properties&#59; Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings will, and will cause each of the Material Subsidiaries to, (a) keep and maintain all tangible property material to the conduct of its business in good working order and condition, ordinary wear and tear excepted, and (b) maintain with financially sound and reputable carriers (i) insurance in such amounts (with no greater risk retention) and against such risks and such other hazards, as is customarily maintained by companies of established repute engaged in the same or similar businesses operating in the same or similar locations and (ii) all insurance required pursuant to the Collateral Documents.  Holdings and the Borrowers will furnish to the Lenders, upon request of the Administrative Agent, information in reasonable detail as to the insurance so maintained.  Holdings and the Borrowers shall, within 90 days following the Closing Date (or such later date to which the Administrative Agent consents, such consent not to be unreasonably withheld or delayed) deliver to the Administrative Agent and the Collateral Agent endorsements (x) to all &#8220;All Risk&#8221; physical damage insurance policies on all of the Loan Parties&#8217; tangible personal property and assets located in the United States of America naming the Collateral Agent as lender loss payee, and (y) to all general liability policies naming the Administrative Agent and the Collateral Agent an additional insured.  In the event Holdings, the Borrowers or any of their respective Material Subsidiaries at any time or times hereafter shall fail to obtain or maintain any of the policies or insurance required herein or to pay any premium in whole or in part relating thereto, then the Administrative Agent, without waiving or releasing any obligations or resulting Default hereunder, may at any time or times thereafter (but shall be under no obligation to do so) obtain and maintain such policies of insurance and pay such premiums and take any other action with respect thereto which the Administrative Agent deems advisable.  All sums so disbursed by the Administrative Agent shall constitute part of the Obligations, payable as provided in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Books and Records&#59; Inspection Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings and the Borrowers will, and will cause each of their respective Material Subsidiaries to, keep proper books of record and account in which full, true and correct entries in conformity with GAAP and applicable law are made of all material financial dealings and transactions in relation to its business and activities.  Holdings and the Borrowers will, and will cause each of their respective Material Subsidiaries to, permit any representatives designated by the Administrative Agent (pursuant to a request made through the Administrative Agent), at reasonable times upon reasonable prior notice (but not more than once annually if no Event of Default shall exist), to visit and inspect its properties, to examine and make extracts from its books and records, including examination of its existing assessment reports and Phase I or Phase II studies, and to discuss its affairs, finances and condition with its officers and independent accountants, all at such reasonable times and as often as reasonably requested.  Holdings and the Borrowers acknowledge that the Administrative Agent, after exercising its rights of inspection, may prepare and distribute to the Lenders certain reports pertaining to Holdings and its Material Subsidiaries&#8217; assets for internal use by the Administrative Agent and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Compliance with Laws </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings and the Borrowers will, and will cause each of their respective Subsidiaries to, (i) comply with all laws, rules, regulations and orders of any Governmental Authority applicable to it or its property (including without limitation, Benefit Plan Laws and Environmental Laws)&#59; (ii) complete any investigation, study, sampling and testing and undertake any clean up, removal, remediation or other response necessary to remove and clean up any Release of Hazardous Materials, to the extent required under Environmental Laws&#59; and (iii) respond to any action, suit or proceeding asserting any </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">148</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Environmental Liability against Holdings, the Borrowers and each of their respective Subsidiaries, except, in each case of clause (i)-(iii), where the failure to do so, either individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrowers shall use the proceeds of (i) the Term Loans, together with the proceeds of the New Notes and available cash, to finance the Transactions and the Refinancing and to pay any related fees and expenses and (ii) the Revolving Loans and the Letters of Credit for any purpose not otherwise prohibited under this Agreement, including for general corporate purposes, working capital needs, the repayment of Indebtedness, the making of Restricted Payments and the making of Investments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Subsidiary Guarantors&#59; Pledges&#59; Additional Collateral&#59; Further Assurances&#59; Guarantor Coverage Test</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Within the time periods specified in Section 5.09(e) below, as applicable, after any Person becomes a Restricted Subsidiary that is not an Excluded Subsidiary or any Excluded Subsidiary that is not an Unrestricted Subsidiary ceases to be an Excluded Subsidiary (in each case, solely if such Person or Subsidiary is organized in any Covered Jurisdiction) (including by qualifying independently as, or being designated by the Borrowers as, a Material Subsidiary, which in the case of a qualification shall be the date on which financial statements have been delivered pursuant to Section 5.01 that demonstrate such qualification) or is required to become a Guarantor pursuant to Section 5.09(f) (in each case, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">New Loan Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Holdings and the Borrowers shall (subject to the Agreed Guarantee and Security Principles, in the case of any Foreign Subsidiary) cause each such New Loan Party to deliver to the Administrative Agent and the Collateral Agent a Joinder Agreement and a supplement to (i) in the case of a Domestic Subsidiary, the U.S. Security Agreement and (ii) each other applicable Collateral Document (in each case in the form contemplated thereby and modified as required in order to comply with local laws in accordance with the Agreed Guarantee and Security Principles, if applicable) pursuant to which such Subsidiary agrees to be bound by the terms and provisions of this Agreement, the U.S. Security Agreement (if applicable) and other applicable Collateral Document, to be accompanied by appropriate corporate resolutions, other corporate documentation and legal opinions as may be reasonably requested by, and in form and substance reasonably satisfactory to, the Administrative Agent, the Collateral Agent and their counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(i) Subject to the Agreed Guarantee and Security Principles (where applicable) and Section 5.09(e), Holdings will cause, and will cause each other Loan Party to cause, all of its owned property (whether personal, tangible, intangible, or mixed but excluding Excluded Assets) to be subject at all times to perfected Liens in favor of the Collateral Agent for the benefit of the Secured Parties to secure the Secured Obligations in accordance with the terms and conditions of the Collateral Documents on a first priority basis, subject to no other Liens other than Permitted Liens and (ii) without limiting the generality of the foregoing, and subject to the Agreed Guarantee and Security Principles (where applicable) and Section 5.09(e), Holdings will cause the issued and outstanding Equity Interests of each Subsidiary directly owned by Holdings or any other Loan Party (other than Excluded Assets) to be subject at all times to a first priority (subject to Permitted Liens), perfected Lien in favor of the Collateral Agent to secure the Secured Obligations in accordance with the terms and conditions of the Collateral Documents or such other pledge and security documents as the Administrative Agent or Collateral Agent shall reasonably request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Without limiting the foregoing, but subject to the Agreed Guarantee and Security Principles and Section 5.09(e), Holdings will, and will cause each other Loan Party to, execute and deliver, or cause to be executed and delivered, to the Collateral Agent such documents, agreements and instruments, and will take or cause to be taken such further actions (including the filing and recording of financing statements, fixture filings, deeds of trust and other </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">149</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">documents and such other actions or deliveries of the type required by Section 4.01, as applicable), which may be required by law or which the Administrative Agent or the Collateral Agent may, from time to time, reasonably request to carry out the terms and conditions of this Agreement and the other Loan Documents and to ensure perfection and priority of the Liens created or intended to be created by the Collateral Documents, all at the expense of Holdings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Subject to the Agreed Guarantee and Security Principles and Section 5.09(e), if any assets are acquired by a Loan Party (other than Excluded Assets and assets constituting Collateral that become subject to the Lien in favor of the Collateral Agent upon acquisition thereof), Holdings will notify the Administrative Agent thereof, and, if requested by the Administrative Agent, Holdings will cause such assets to be subjected to a Lien securing the Secured Obligations and will take, and cause the other Loan Parties to take, such actions as shall be necessary or reasonably requested by the Administrative Agent to grant and perfect such Liens, including actions described in paragraph (b) of this Section 5.09, all at the expense of Holdings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary herein or in any other Loan Document but subject to clause (f) of this Section 5.09, (i) any deliverables delivered pursuant to this Section 5.09 as of the Closing Date shall be subject to the penultimate paragraph of Section 4.01, (ii) with respect to any property or assets acquired after the Closing Date or with respect to any New Loan Party, the Loan Parties shall have sixty (60) days, or ninety (90) days in the case of the Equity Interests, property or assets of, or actions required to be taken by, any Foreign Subsidiary, after the acquisition thereof or such Person becoming a New Loan Party (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto) to take the actions required by this Section&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the case of any Equity Interests, property or assets of any Foreign Subsidiary acquired or any Foreign Subsidiary becoming a New Loan Party within ninety (90) days after the Closing Date, the Loan Parties shall have the longer of (A) ninety (90) days after the Closing Date and (B) ninety (90) days after such acquisition or such Person becoming a New Loan Party to take any such actions (or, in each case such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto), and (iii) no Loan Party shall have any obligation to (A) enter into control agreements with respect to any security interest or lien in any Deposit Account or Securities Account (in each case, as defined in the UCC) included in the Collateral or provide fixed security over bank accounts, (B) perfect any security interest or lien in any intellectual property included in the Collateral in any jurisdiction other than in the United States, and solely with respect to Material Intellectual Property, Ireland or Luxembourg, (C) to obtain any landlord waivers, estoppels or collateral access letters, (D) perfect a security interest in any letter of credit rights, other than the filing of a UCC financing statement, (E) pledge Equity Interests of any partnership, joint venture or non-wholly-owned Subsidiary which are not permitted to be pledged pursuant to the terms of such partnership&#8217;s, joint venture&#8217;s or non-wholly-owned Subsidiary&#8217;s organizational, joint venture or equivalent documents (after giving effect to the applicable anti-assignment provisions of the UCC or other applicable law) and (F) no Loan Party shall be required to enter into any Collateral Documents or take any perfection steps outside of the jurisdiction of organization of such Loan Party (other than</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> in Covered Jurisdictions, including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the recordation of patent, trademark and copyright security agreements in the United States Patent and Trademark Office and the United States Copyright Office).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Subject to the proceeding sentence, Holdings shall ensure that the Guarantor Coverage Test is satisfied as of each Guarantor Coverage Test Date.  If the Guarantor Coverage Test is not satisfied on any Guarantor Coverage Test Date&#58; (i) Holdings shall ensure that within ninety (90) days after such Guarantor Coverage Test Date (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto), such other Restricted Subsidiaries (as Holdings may elect in its sole discretion) shall, subject to and on terms consistent with the Agreed Guarantee and Security Principles, accede as Subsidiary Guarantors to ensure that the Guarantor Coverage Test is satisfied </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">150</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(calculated as if such Subsidiary Guarantors had been Subsidiary Guarantors at such Guarantor Coverage Test Date) by executing and delivering to the Collateral Agent (x) a Joinder Agreement substantially in the form of Exhibit D (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Joinder Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (y) each applicable Collateral Document (or a supplement thereto) (in each case in the form contemplated thereby and modified as required in order to comply with local laws in accordance with the Agreed Guarantee and Security Principles, if applicable) and (ii) if Holdings has satisfied its obligations under clause (i) above within such ninety (90) days after such Guarantor Coverage Test Date (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto), no Default, Event of Default or other breach of the Loan Documents shall arise from failure to satisfy the Guarantor Coverage Test as of such Guarantor Coverage Test Date (and for avoidance of doubt, no Default or Event of Default shall arise prior to such 90th day after such Guarantor Coverage Test Date (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto)).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Designation of Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings may, at any time from and after the Closing Date, designate any Restricted Subsidiary as an Unrestricted Subsidiary or any Unrestricted Subsidiary as a Restricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) immediately before and after such designation, no Event of Default shall have occurred and be continuing, (ii) no Restricted Subsidiary may be designated as an Unrestricted Subsidiary unless such Subsidiary is also an &#8220;unrestricted subsidiary&#8221; (or similar concept) for purposes of the New Notes, (iii) no Restricted Subsidiary that owns any Material Intellectual Property may be designated as an Unrestricted Subsidiary and (iv) no Restricted Subsidiary may be designated as an Unrestricted Subsidiary if it was previously designated as an Unrestricted Subsidiary pursuant to this Section 5.10.  The designation of any Restricted Subsidiary as an Unrestricted Subsidiary after the Closing Date shall constitute an Investment by the applicable Loan Party therein at the date of designation in an amount equal to the fair market value (as determined in good faith by Holdings) of the applicable Loan Party&#8217;s (or any of its Restricted Subsidiaries&#8217;) investment therein.  The designation of any Unrestricted Subsidiary as a Restricted Subsidiary after the Closing Date shall constitute (i) the incurrence at the time of designation of any Indebtedness or Liens of such Subsidiary existing at such time and (ii) a return on any Investment by the applicable Loan Party in Unrestricted Subsidiaries pursuant to the preceding sentence in an amount equal to the fair market value at the date of such designation of such Loan Party&#8217;s Investment in such Subsidiary.  Notwithstanding the foregoing, no Borrower shall be permitted to be an Unrestricted Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Maintenance of Ratings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Use commercially reasonable efforts to cause the Term Loans and Holdings&#8217; corporate credit and corporate family credit rating to continue to be rated by S&#38;P and Moody&#8217;s (but not to maintain a specific rating).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings will not, and will not permit any of its Restricted Subsidiaries to, make any payment to or sell, lease, transfer or otherwise dispose of any of its properties or assets to, or purchase any property or assets from, or enter into or make or amend any transaction, contract, agreement, understanding, loan, or advance with or guarantee for the benefit of, any Affiliate of Holdings (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) involving aggregate payments or consideration in excess of the greater of $95,000,000 and 8% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination, unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">such Affiliate Transaction is on terms that are not materially less favorable to Holdings or the relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by Holdings or such Restricted Subsidiary with an unrelated Person (as determined by Holdings in good faith)&#59; and</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">151</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">with respect to any Affiliate Transaction or series of related Affiliate Transactions involving aggregate consideration in excess of the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination, Holdings delivers to the Administrative Agent a resolution adopted in good faith by the majority of the Board of Directors of Holdings approving such Affiliate Transaction, together with a certificate signed by a Responsible Officer of Holdings certifying that the Board of Directors of Holdings determined or resolved that such Affiliate Transaction complies with Section 5.12(a)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The following items will not be deemed to be Affiliate Transactions and, therefore, will not be subject to Section 5.12(a)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">any employment or consulting agreement, incentive agreement, employee benefit plan, severance agreement, officer or director indemnification agreement or any similar arrangement entered into by Holdings or any of its Restricted Subsidiaries in the ordinary course of business or approved by the Board of Directors of Holdings and payments pursuant thereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">transactions between or among (A) Holdings and its Restricted Subsidiaries or (B) one or more Restricted Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">transactions with any Person that is an Affiliate of Holdings solely because Holdings owns, directly or through a Restricted Subsidiary, an Equity Interest in, or controls, such Person&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">payment of reasonable fees or other reasonable compensation (including bonuses) to, provision of customary benefits or indemnification agreements to, and the reimbursements of expenses (pursuant to indemnity arrangements or otherwise) of officers, directors, employees or consultants of Holdings, any of its Restricted Subsidiaries or any of Holdings&#8217; direct or indirect parent companies&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any capital contribution in, or issuance of Equity Interests (other than Disqualified Equity Interests), of Holdings&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Restricted Payments (or transfers or issuances that would constitute Restricted Payments but for the exclusions from the definition thereof) that do not violate Section 6.04 hereof and Permitted Investments&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">loans or advances to employees of Holdings, any of its Restricted Subsidiaries or any of Holdings&#8217; direct or indirect parent companies in the ordinary course of business of Holdings or its Restricted Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">transactions in which Holdings or any Restricted Subsidiary, as the case may be, delivers to the Administrative Agent a letter from an accounting, appraisal or investment banking firm of national standing stating that such transaction meets the requirements of Section 5.12(a)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">transactions with customers, clients, suppliers, or purchasers or sellers of goods or services, in each case in the ordinary course of business and otherwise in compliance with the terms hereof which are fair to Holdings and its Restricted Subsidiaries, in the reasonable determination of the Board of Directors of Holdings or the senior management thereof, or are on terms at least as favorable as might reasonably have been obtained at such time from an unaffiliated party (as determined by the Board of Directors of Holdings or the senior management thereof in good faith)&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">152</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">transactions in the ordinary course with (i) Unrestricted Subsidiaries or (ii) joint ventures in which Holdings or a Restricted Subsidiary of Holdings make a loan or other Investments to such joint venture (to the extent any such joint venture is only an Affiliate as a result of Investments by Holdings and its Restricted Subsidiaries in such joint venture) to the extent otherwise permitted under the definition of &#8220;Permitted Investments&#8221;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the granting of registration and other customary rights in connection with the issuance of Equity Interests by Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">the provision of services to directors or officers of Holdings, any of its Restricted Subsidiaries or any of Holdings&#8217; direct or indirect parent companies of the nature provided by Holdings or any of its Restricted Subsidiaries to customers in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">any agreement as in effect on the Closing Date or any renewals, events or extensions of any such agreement (so long as such renewals or extensions are not less favorable in any material respect to Holdings or the Restricted Subsidiaries as determined by Holdings in good faith) and the transactions evidenced thereby&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">the existence of, or the performance by Holdings or any of the Restricted Subsidiaries of its obligations under the terms of, any limited liability company agreement, limited partnership or other organizational documents or stockholders agreement (including any purchase agreement, put option agreements or call option agreements related thereto) to which it is a party as of the Closing Date and any similar agreements which it may enter into thereafter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, however, that the existence of, or the performance by Holdings or any Restricted Subsidiary of obligations under any future amendment to any such existing agreement or under any similar agreement entered into after such date shall only be permitted by this clause (xiv) to the extent that the terms of any such amendment or new agreement, taken as a whole, is no less favorable to Holdings and the Restricted Subsidiaries than the agreement in effect on the Closing Date (as determined by the Board of Directors of Holdings or the senior management thereof in good faith)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">transactions undertaken in connection with the Transactions&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">any customary transactions with a Securitization Subsidiary effected as part of a Qualified Securitization Financing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">the payment of reasonable out-of-pocket costs and expenses relating to registration rights and indemnities provided to shareholders of Holdings or any direct or indirect parent thereof pursuant to the stockholders agreement or the registration rights agreement entered into on or after the Closing Date in connection therewith&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">transactions (including, for the avoidance of doubt, the entering into of a tax sharing agreement) undertaken in good faith (as certified by a Responsible Officer of a Borrower in an officer&#8217;s certificate) for the purposes of improving the consolidated tax efficiency of Holdings and its Subsidiaries and not for the purpose of circumventing any provision of this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">repurchases by Holdings of the Term Loans or New Notes to the extent permitted hereunder&#59; and</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">153</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">Indebtedness permitted under Section 6.01, Liens permitted under Section 6.02, Asset Sales permitted under Section 6.03, Permitted Investments and Restricted Payments permitted under Section 6.04.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Fiscal Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  With respect to Holdings and its Restricted Subsidiaries, change its fiscal year-end to dates other than December 31.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Anti-Terrorism and Anti-Money Laundering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  With respect to Holdings and its Restricted Subsidiaries, directly or indirectly, (i) conduct any business or engage in making or receiving any contribution of funds, goods or services to or for the benefit of any person described in Section 3.18, (ii) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order or any other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law (and the Loan Parties shall deliver to the Lenders any certification or other evidence requested from time to time by any Lender in its reasonable discretion, confirming Holdings&#8217; and its Restricted Subsidiaries&#8217; compliance with this Section 5.14).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Post-Closing Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Within the time periods specified on Schedule 5.15 hereto (as each may be extended by the Administrative Agent in its reasonable discretion), provide such Collateral Documents and complete such undertakings as are set forth on Schedule 5.15 hereto.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Negative Covenants</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">From the Closing Date until the Commitments have expired or terminated and the principal of and interest on each Loan and all fees payable hereunder have been paid in full and all Letters of Credit have expired, terminated or been Cash Collateralized and all LC Disbursements shall have been reimbursed, the Loan Parties covenant and agree with the Lenders that&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings will not, and will not permit any Restricted Subsidiary to, incur, directly or indirectly, any Indebtedness, and Holdings will not issue any Disqualified Equity Interests and will not permit any of its Restricted Subsidiaries to issue any shares of Preferred Equity (other than the issuance of Preferred Equity by any Restricted Subsidiary to Holdings or another Restricted Subsidiary)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, however, Holdings will be entitled to incur Indebtedness or issue Disqualified Equity Interests and any Restricted Subsidiary will be entitled to incur Indebtedness or issue Preferred Equity, so long as (i) both before and after giving effect to such incurrence or issuance, no Event of Default shall have occurred and be continuing and (ii) after giving effect to such incurrence or issuance on a Pro Forma Basis (and any Permitted Acquisition or Investment incurred in connection therewith) for the most recently ended Test Period prior to such incurrence or issuance (or, in the event the proceeds thereof are to be used to finance a Limited Condition Transaction (after giving effect to the incurrence of such Indebtedness and any Permitted Acquisition or Investment incurred in connection therewith), on the LCT Test Date), such Indebtedness shall not exceed an unlimited amount so long as (1) in the case of any Indebtedness secured by a Lien on the Collateral that is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with any Lien on the Collateral securing the Obligations, the First Lien Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.00&#58;1.00, (2) in the case of any Indebtedness secured by the Collateral on a junior lien basis relative to the Liens on such Collateral securing the Obligations, the Secured Net Leverage Ratio, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">154</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25&#58;1.00, and (3) in the case of unsecured Indebtedness or Indebtedness that is secured by assets that do not constitute Collateral, either (a) the Total Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25&#58;1.00 or (b) the Fixed Charge Coverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not be less than 2.00&#58;1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any such Indebtedness of non-Guarantor Subsidiaries, when combined with all outstanding Indebtedness incurred by non-Guarantor Subsidiaries pursuant to Section 6.01(b)(xi) hereof, shall not exceed, in the aggregate, the greater of (x) $175,000,000 and (y) 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination at any time outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, to the extent such Indebtedness is incurred prior to the date that is 24 months after the Closing Date and is comprised of term loans funded in Dollars that are secured by a Lien on the Collateral that is pari passu with Lien on the Collateral securing the Obligations, the provisions set forth in Section 2.20(b)(A)(iv) shall apply as if such Indebtedness had been incurred as Incremental Term Loans under Section 2.20.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding Section 6.01(a), Holdings and its Restricted Subsidiaries will be entitled to incur any or all of the following Indebtedness (collectively &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">The Secured Obligations (including any Incremental Loans) and any Credit Agreement Refinancing Indebtedness&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Indebtedness owed to and held by Holdings or a Restricted Subsidiary as permitted under Section 6.04 or as a Permitted Investment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (x) any subsequent issuance or transfer of any Equity Interest that results in any such Indebtedness being held by a Person other than Holdings or a Restricted Subsidiary and (y) any subsequent transfer of such Indebtedness (other than to Holdings or a Restricted Subsidiary) shall be deemed, in each case, to constitute the incurrence of such Indebtedness by the obligor thereon that was not permitted by this clause (ii)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">Indebtedness of Holdings to any Restricted Subsidiary and of any Restricted Subsidiary to Holdings or any other Restricted Subsidiary (including, without limitation, to consummate the Transactions (including, without limitation, the Acquisition))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Indebtedness owing by any Loan Party to a Restricted Subsidiary which is not a Loan Party shall be subordinated in right of payment to the Secured Obligations pursuant to the Intercompany Subordination Agreement or any other agreement reasonably satisfactory to the Administrative Agent and Holdings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Indebtedness of a Restricted Subsidiary incurred  prior to the date on which such Subsidiary was acquired by Holdings or a Restricted Subsidiary of Holdings (other than Indebtedness incurred in contemplation of such acquisition) and outstanding on such date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (I) if secured, such Indebtedness shall be secured solely by Liens existing at the time such Restricted Subsidiary is acquired by Holdings or a Restricted Subsidiary of Holdings and shall not extend to any other property owned by Holdings or any of its other Restricted Subsidiaries and (II) (x) if such Indebtedness is secured by a Lien on the Collateral that is pari passu with the Lien on the Collateral securing the Secured Obligations that are secured on a first lien basis, the First Lien Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed the First Lien Net Leverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma Basis as of the most recently ended Test Period, (y) if such Indebtedness is secured by a Lien on the Collateral that is junior to the Lien on the Collateral securing the Secured Obligations that are secured on a first lien basis, the Secured Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">155</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">date, would not exceed the Secured Net Leverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma basis as of the most recently ended Test Period or (z) if such Indebtedness is unsecured or is secured by assets that do not constitute Collateral, either (a) the Total Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed the Total Net Leverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma Basis as of the most recently ended Test Period or (b) the Fixed Charge Coverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not be less than the Fixed Charge Coverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma Basis as of the most recently ended Test Period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Permitted Refinancing Indebtedness in respect of Indebtedness incurred pursuant to Section 6.01(a), Sections 6.01(b)(iv), (xvii), (xxii) or (xxvii) or this clause (v)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Obligations under and in respect of non-speculative Swap Agreements (including Permitted Hedging Obligations)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">(A) obligations in respect of worker&#8217;s compensation and self-insurance and performance, bid, stay, customs, appeal, replevin and surety bonds and performance and completion guarantees provided by Holdings or any Restricted Subsidiary in the ordinary course of business, and (B) reimbursement and indemnification obligations in respect of letters of credit, banker&#8217;s acceptances and other similar instruments issued in respect of obligations specified in clause (A) or to landlords or vendors in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">ACH Indebtedness and Indebtedness owed in respect of business credit card programs and any netting services, overdrafts and related liabilities arising from treasury, depository and cash management services&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Indebtedness consisting of any Guarantee by Holdings or any Restricted Subsidiary of Indebtedness or other obligations of Holdings or any of its Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Indebtedness being guaranteed is subordinated to or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with the Loans, then the Guarantee must be subordinated or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, to the same extent as the Indebtedness guaranteed&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Capital Lease Obligations and Indebtedness incurred after the Closing Date in respect of purchase money indebtedness or Sale and Leaseback Transactions and Permitted Refinancing Indebtedness in respect thereof and in an aggregate principal amount on the date of incurrence that, when taken together with the principal amount of all other Indebtedness then outstanding and incurred pursuant to this clause (x), does not exceed the greater of $235,000,000 and 20% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (x) shall not apply to any Capital Lease Obligations or Indebtedness in respect of Sale and Leaseback Transactions, the proceeds of which are used to prepay, on a pro rata basis, Indebtedness hereunder and, to the extent required under the terms of such Indebtedness, Indebtedness that is secured by a Lien on the Collateral that is pari passu with the Lien on the Collateral securing the Secured Obligations that are secured on a first lien basis&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">other Indebtedness of non-Guarantor Subsidiaries and Foreign Subsidiaries in an aggregate principal amount on the date of incurrence that, when taken together with the principal amount of all other Indebtedness then outstanding and </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">156</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">incurred pursuant to this clause (xi) and the principal amount of all Indebtedness of non-Guarantor Subsidiaries then outstanding and incurred pursuant to Section 6.01(a) hereof, does not exceed the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">Indebtedness of Holdings or any of its Restricted Subsidiaries consisting of (i) the financing of insurance premiums with the providers of such insurance or their affiliates or (ii) take-or-pay obligations contained in supply agreements, in each case, in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">Indebtedness incurred in connection with judgments, decrees, attachments or awards that do not constitute an Event of Default&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">Indebtedness in the form of (i) guarantees of loans and advances to officers, directors, consultants and employees that constitute Permitted Investments pursuant to and in accordance with clause (9) of the definition thereof, and (ii) reimbursements owed to officers, directors, consultants and employees of Holdings or any of its Subsidiaries or Holdings&#8217; direct or indirect parent companies&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Indebtedness consisting of obligations to make payments to current or former officers, directors and employees of Holdings, any of its Subsidiaries or Holdings&#8217; direct or indirect parent companies, their respective estates, spouses or former spouses with respect to the cancellation, purchase or redemption of Equity Interests of Holdings, any of its Subsidiaries, or any of Holdings&#8217; direct or indirect parent companies to the extent permitted under Section 6.04&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">Indebtedness (A) incurred in connection with a Qualified Securitization Financing that is not recourse (except for Standard Securitization Undertakings and Limited Originator Recourse) to Holdings or any Restricted Subsidiary, (B) incurred in connection with a Qualified Receivables Factoring or (C) incurred for working capital purposes, in an aggregate principal amount on the date of incurrence that, when taken together with the principal amount of all other Indebtedness then outstanding and incurred pursuant to this clause (xvi)(C), does not exceed the greater of $120,000,000 or 10% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">(A) the New Notes (and any Guarantees thereof by the Guarantors), (B) any other Indebtedness that is outstanding on the Closing Date, which, in the case of Indebtedness with an outstanding principal amount in excess of $5,000,000, shall be listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (C) any refinancing, extensions, renewals or replacements of any such Indebtedness described in (A) or (B) that does not increase the outstanding principal amount thereof (other than with respect to unpaid accrued interest and premium thereon, any committed or undrawn amounts and underwriting discounts, fees, commissions and expenses, associated with such Indebtedness)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">Indebtedness arising from agreements providing for indemnification, adjustment of purchase price or similar obligations, or from guaranties, surety bonds or performance bonds securing the performance of Holdings or any of its Restricted Subsidiaries pursuant to such agreements, in connection with Permitted Acquisitions, the Acquisition or permitted Dispositions&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">Alternative Incremental Facility Indebtedness and Permitted Refinancing Indebtedness in respect thereof provided that as of the end of the most recently ended Test Period prior to the effectiveness of such Alternative Incremental </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">157</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Facility Indebtedness (or in the case the proceeds thereof are used to finance a Limited Condition Transaction, as of the LCT Test Date) on a Pro Forma Basis (after giving effect to the use of proceeds of such Alternative Incremental Facility Indebtedness and any Permitted Acquisition or other acquisition or Investment to be consummated in connection therewith) in an aggregate principal amount, together with the principal amount of Incremental Loans incurred, shall not exceed the Maximum Incremental Amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent such Indebtedness is incurred prior to the date that is 24 months after the Closing Date and is comprised of term loans funded in Dollars that are secured pari passu with the Obligations, the provisions set forth in Section 2.20(b)(A)(iv) shall apply as if such Indebtedness had been incurred as Incremental Term Loans under Section 2.20&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">Indebtedness in the form of an intercompany note issued in connection with a Permitted Acquisition involving a tender offer followed by a short form merger (i.e. a statutory short form merger that requires no further approvals to consummate)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such short form merger is consummated within five (5) Business Days of the incurrence of such Indebtedness and (ii) not later than three (3) Business Days after consummation of the related short form merger, such Indebtedness (x) is extinguished or retired or (y) otherwise constitutes a Permitted Investment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">Indebtedness, Disqualified Equity Interests or Preferred Equity of Holdings or of any of the Restricted Subsidiaries in an aggregate principal amount on the date of incurrence that, when taken together with all other Indebtedness of Holdings and the Restricted Subsidiaries then outstanding and incurred pursuant to this clause (xxi), does not exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">Indebtedness under guarantees of the obligations of other members of the Group once such guarantees are entered into the in the normal course of trading&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">Indebtedness incurred in respect of trade credit in the normal course of trading activities (including within the Group)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">intra-day facility arrangements in the ordinary course of business and consistent with past practice&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt">Indebtedness of, incurred on behalf of, or representing guarantees of Indebtedness of, joint ventures, in each case, that are Permitted Investments or are permitted under Section 6.04&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">Indebtedness in respect of derivative transactions entered into by Group members to hedge currency or interest rate exposures and for other non-speculative purposes&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.08pt">Indebtedness incurred in connection with any Sale and Leaseback Transaction related to the Headquarters&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.03pt">Preferred Equity of a Restricted Subsidiary issued to Holdings or another Restricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any subsequent issuance or transfer of any capital stock or any other event which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of preferred stock (except to Holdings or another Restricted Subsidiary) shall be deemed in </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">158</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">each case to be an issuance of such shares of preferred stock not permitted by this clause (xxviii)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">(i) obligations in respect of self-insurance, performance, bid, appeal and surety bonds and completion guarantees and similar obligations provided by Holdings or any Restricted Subsidiary or (ii) obligations in respect of letters of credit, bank guarantees or similar instruments related thereto, in each case, in the ordinary course of business or  consistent with past practice&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">(i) Indebtedness of Holdings or any Restricted Subsidiary supported by a letter of credit, in a principal amount not in excess of the stated amount of such letter of credit, so long as such letter of credit is otherwise permitted to be incurred pursuant to this Section 6.01 or (ii) obligations in respect of letters of support, guarantees or similar obligations issued, made or incurred for the benefit of any Restricted Subsidiary of Holdings to the extent required by law or in connection with any statutory filing or the delivery of audit opinions performed in jurisdictions other than within the United States&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.08pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.03pt">(i) Indebtedness of Holdings or any of the Restricted Subsidiaries undertaken in connection with cash management and related activities with respect to any Subsidiary or joint venture in the ordinary course of business, including with respect to financial accommodations of the type described in the definition of &#8220;Cash Management Agreement&#8221; and (ii) Indebtedness owed on a short term basis of no longer than 30 days to banks and other financial institutions incurred in the ordinary course of business of the Borrowers and their Restricted Subsidiaries with such banks or financial institutions that arises in connection with ordinary banking arrangements to manage cash balances of the Borrowers and their Restricted Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.63pt">&#91;reserved&#93;&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.68pt">Indebtedness arising in the ordinary course of business from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business, provided that such Indebtedness (x) is extinguished within two Business Days of its incurrence or (y) arises in respect of one or more accounts of any Subsidiary that is a Foreign Subsidiary with any bank or other financial institution subject to a pooling or similar arrangement with one or more accounts of any other Subsidiaries that are Foreign Subsidiaries with such bank or other financial institution to the extent the net aggregate amount of funds in all such accounts subject to such pooling or similar arrangement with such bank or other financial institution is positive&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.63pt">&#91;reserved&#93;&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxxvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:0.58pt"> Indebtedness or Disqualified Equity Interests of Holdings and Indebtedness, Disqualified Equity Interests or Preferred Equity of Holdings or any Restricted Subsidiary in an aggregate principal amount or liquidation preference up to 100.0% of the net cash proceeds received by Holdings after the Closing Date from the issue or sale of Equity Interests of Holdings or cash contributed to the capital of Holdings (in each case, other than proceeds of Disqualified Equity Interests, sales of Equity Interests to Holdings or any of its Subsidiaries or proceeds which have been designated as </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">159</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a Cure Amount) as determined in accordance with Section 6.04(a)(ii)(B) and (a)(ii)(D) to the extent such net cash proceeds or cash have not been applied pursuant to such clauses to make Restricted Payments pursuant to Section 6.04(b) or to make Permitted Investments (other than Permitted Investments specified in clauses (2), (3) or (4) of the definition thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this Section 6.01, in the event that an item of Indebtedness, Disqualified Equity Interests or Preferred Equity (or any portion thereof) at any time, whether at the time of incurrence or issuance or upon the application of all or a portion of the proceeds thereof or subsequently, meets the criteria of more than one of the categories of permitted Indebtedness, Disqualified Equity Interests or Preferred Equity described in Section 6.01(i) through (xxxvii) above, Holdings, in its sole discretion, will classify and may subsequently reclassify such item of Indebtedness, Disqualified Equity Interests or Preferred Equity (or any portion thereof) in any one or more of the types of Indebtedness, Disqualified Equity Interests or Preferred Equity described in Section 6.01(i) through (xxxvii) and will only be required to include the amount and type of such Indebtedness, Disqualified Equity Interests or Preferred Equity in such of the above clauses as determined by Holdings at such time. Holdings will be entitled to divide, classify and reclassify an item of Indebtedness in more than one of the types of Indebtedness described in clauses (i) through (xxxvii).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">For purposes of determining compliance with any Dollar-denominated restriction on the incurrence of Indebtedness, the Dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the case of term debt, or first committed, in the case of revolving credit debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if such Indebtedness is incurred to extend, replace, refund, refinance, renew or defease other Indebtedness denominated in a foreign currency, and such extension, replacement, refunding, refinancing, renewal or defeasance would cause the applicable Dollar-denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such extension, replacement, refunding, refinancing, renewal or defeasance, such Dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such refinancing Indebtedness does not exceed the principal amount of such Indebtedness being extended, replaced, refunded, refinanced, renewed or defeased, plus the aggregate amount of fees, underwriting discounts, premiums and other costs and expenses incurred in connection with such refinancing.  The principal amount of any Indebtedness incurred to refinance other Indebtedness, if incurred in a different currency from the Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such respective Indebtedness is denominated that is in effect on the date of such refinancing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The accrual of interest, the accretion of accreted value and the payment of interest in the form of additional Indebtedness shall not be deemed to be an incurrence of Indebtedness for purposes of this Section 6.01. The principal amount of any non-interest bearing Indebtedness or other discount security constituting Indebtedness at any date shall be the principal amount thereof that would be shown on a balance sheet of Holdings dated such date prepared in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings will not, and will not permit any Restricted Subsidiary to, directly or indirectly, incur or permit to exist any Lien (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of any nature whatsoever on any of its properties (including Equity Interests of a Restricted Subsidiary to secure Indebtedness), whether owned at the Closing Date or thereafter acquired, securing any Indebtedness, other than Permitted Liens.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">160</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Asset Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings will not, and will not permit any of its Restricted Subsidiaries to, consummate an Asset Sale unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Holdings (or its Restricted Subsidiary, as the case may be) receives consideration at least equal to the fair market value (measured as of the date of the definitive agreement with respect to such Asset Sale) of the assets or shares of Equity Interests of a Restricted Subsidiary issued or sold or otherwise disposed of&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">if the property or assets sold or otherwise disposed in a single transaction or series of related transactions of have a fair market value in excess of $75,000,000 at the time of such disposition, at least 75% of the consideration received in the Asset Sale by Holdings or such Restricted Subsidiary is in the form of cash or Cash Equivalents. For purposes of this clause (ii), the following consideration shall be deemed to be cash consideration&#58; (A) any securities, notes or other obligations received by Holdings or any Restricted Subsidiary that are converted within 180 days into cash or Cash Equivalents shall be deemed to be cash or Cash Equivalents, (B) any consideration arising from the assumption of liabilities, (C) any liabilities (as reflected on Holdings&#8217; most recent consolidated balance sheet or in the footnotes thereto, or if incurred or accrued subsequent to the date of such balance sheet, such liabilities that would have been reflected on Holdings&#8217; consolidated balance sheet or in the footnotes thereto if such incurrence or accrual had taken place on or prior to the date of such consolidated balance sheet, as determined in good faith by Holdings) of Holdings, other than liabilities that are by their terms subordinated to the Loans, that are assumed by the transferee of any such assets (or are otherwise extinguished in connection with the transactions relating to such Asset Sale) and for which Holdings and all Restricted Subsidiaries have been validly released by all applicable creditors in writing&#59; (D) any contingent or deferred consideration payable in cash or Cash Equivalents) and (E) any Designated Non-Cash Consideration received in respect of such Asset Sale having an aggregate fair market value, taken together with all other Designated Non-Cash Consideration received pursuant to this clause (E) that is at that time outstanding, not in excess of the greater of $205,000,000 and 17.5% of Consolidated EBITDA for the Test Period most recently ended on or prior to the time of the receipt of such Designated Non-Cash Consideration, with the fair market value of each item of Designated Non-Cash Consideration being measured at the time received and without giving effect to subsequent changes in value.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Pending the final application of any Net Proceeds, Holdings (or the applicable Restricted Subsidiary) may invest the Net Proceeds in any manner that is not prohibited by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary herein, Holdings will not, and will not permit any of its Restricted Subsidiaries to, transfer any Material Intellectual Property to any Unrestricted Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Restricted Payments, Investments, Loans, Advances, Guarantees and Acquisitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly make any Restricted Payment, unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">(x) in the case of a Restricted Payment utilizing clause (a)(ii)(B) below, no Event of Default shall have occurred and be continuing or would occur as a consequence thereof and (y) in the case of a Restricted Payment (other than an </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">161</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Investment) utilizing clause (a)(ii)(B) below, after giving effect to such Restricted Payment on a Pro Forma Basis, Holdings would have had a Fixed Charge Coverage Ratio of at least 2.00 to 1.00&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">such Restricted Payment, together with the aggregate amount of all other Restricted Payments made by Holdings and its Restricted Subsidiaries since the Closing Date (including Restricted Payments permitted by Section 6.04(b)(i), but excluding all other Restricted Payments permitted by Section 6.04(b)), is less than the sum, without duplication, of&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such transactions, plus</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">50% of the Consolidated Net Income of Holdings for the period (taken as one accounting period) from the first day of the fiscal quarter in which the Closing Date occurs to the end of Holdings&#8217; most recently ended fiscal quarter for which internal financial statements are available at the time of such Restricted Payment (or, if such Consolidated Net Income for such period is a deficit, less 100% of such deficit)&#59; plus </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">other than to the extent Restricted Payments have been made with respect to such Net Proceeds pursuant to Sections 6.04(b)(ii) or 6.04(b)(iv), 100% of the aggregate Net Proceeds and the fair market value of property received by Holdings since the Closing Date as a contribution to its common equity capital or from the issue or sale of Equity Interests (other than Disqualified Equity Interests) of Holdings or from the issue or sale of convertible or exchangeable Disqualified Equity Interests of Holdings or Convertible Debt Securities of Holdings, in each case that have been converted into or exchanged for Equity Interests of Holdings (other than Disqualified Equity Interests and Equity Interests and convertible or exchangeable Disqualified Equity Interests or debt securities sold to a Subsidiary of Holdings)&#59; plus</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">100% of the aggregate amount received in cash and the fair market value of property (other than cash) and marketable securities received by Holdings or a Restricted Subsidiary after the Closing Date by means of (i) the sale or other disposition (other than to Holdings or a Restricted Subsidiary) of Restricted Investments made by Holdings or its Restricted Subsidiaries and repurchases and redemptions of such Restricted Investments from Holdings or its Restricted Subsidiaries and repayments of loans or advances which constitute Restricted Investments of Holdings or its Restricted Subsidiaries, (ii) the sale (other than to Holdings or a Restricted Subsidiary) of the Equity Interests of an Unrestricted Subsidiary, (iii) payments of interest, distributions or dividends in respect of Restricted Investments, in each case to the extent that such amounts were not otherwise included in the Consolidated Net Income of Holdings for such period and (iv) a distribution or dividend from an Unrestricted Subsidiary (other than in each case such Investment constituted a Permitted Investment)&#59; plus</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">to the extent that any Restricted Investment that was made after the Closing Date is made in an entity that is not a Restricted Subsidiary that subsequently becomes a Restricted Subsidiary, the initial amount of such Restricted Investment (or, if less, the amount of cash received upon repayment or sale)&#59; plus</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">162</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">to the extent that any Unrestricted Subsidiary designated as such after the Closing Date is redesignated as a Restricted Subsidiary after the Closing Date, the lesser of (i) the fair market value of the Restricted Investment in such Subsidiary as of the date of such redesignation or (ii) the aggregate amount of the Restricted Investments in such Subsidiary to the extent such Restricted Investments reduced the amount available under this clause (ii) and were not previously repaid or otherwise reduced&#59; plus</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the aggregate amount of Subordinated Indebtedness repaid, defeased or satisfied and&#47;or discharged&#59; plus</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the Declined Prepayment Amount to the extent not applied to prepay the Term Loans of the Accepting Term Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Section 6.04(a) will not prohibit&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">(x) the payment of any dividend or distribution or the consummation of any irrevocable purchase, redemption, acquisition or retirement for value of any Equity Interests of Holdings within 60 days after the date of declaration thereof or giving of the irrevocable advance notice thereof, as the case may be, if at the date of declaration or notice, the applicable dividend, distribution or payment would have complied with the provisions of this Agreement and (y) the repurchase of Equity Interests of Holdings pursuant to a plan under Rule 10b5-1 under the Securities Exchange Act of 1934 if at the date Holdings establishes such plan, such repurchase would have complied with the provisions of this Agreement&#59;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the making of any Restricted Payment in exchange for, or out of or with the Net Proceeds of the substantially concurrent sale (other than to a Subsidiary of Holdings) of, Equity Interests of Holdings (other than Disqualified Equity Interests) or from the substantially concurrent contribution of common equity capital to Holdings&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the amount of any such Net Proceeds that are utilized for any such Restricted Payment will not be considered to be Net Proceeds of Equity Interests for purposes of Section 6.04(a)(ii)(B) or Section 6.04(b)(iv)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">the repurchase, redemption, defeasance or other acquisition or retirement for value of Subordinated Indebtedness with the Net Proceeds from a substantially concurrent incurrence of Permitted Refinancing Indebtedness&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">the repurchase, redemption or other acquisition or retirement for value of any Equity Interests of Holdings, any Restricted Subsidiary or Holdings&#8217; direct or indirect parent companies held by any current or former officer, director, manager, employee or consultant of Holdings or any of its Restricted Subsidiaries pursuant to any equity subscription agreement, stock option agreement, shareholders&#8217; agreement or other similar agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the aggregate price paid for all such repurchased, redeemed, acquired or retired Equity Interests may not exceed in any calendar year the greater of $90,000,000 and 7.5% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (with any unused amount in any calendar year being carried forward and available in any succeeding calendar years)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that such amount in any twelve-month period may be increased by an amount not to exceed&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the Net Proceeds from the sale of Equity Interests (other than Disqualified Equity Interests) of Holdings and, to the extent contributed to Holdings as common equity capital, the Net Proceeds from the sale of Equity </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">163</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interests (other than Disqualified Equity Interests) of any of Holdings&#8217; direct or indirect parent companies, in each case to any current or former officer, director, manager, employee or consultant of Holdings, any of its Restricted Subsidiaries or any of its direct or indirect parent companies that occurs after the Closing Date&#59; provided that the amount of any such Net Proceeds that are utilized for any such Restricted Payment will not be considered to be Net Proceeds of Equity Interests for purposes of Section 6.04(a)(ii)(B) or Section 6.04(b)(ii)&#59; plus</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the cash proceeds of key man life insurance policies received by Holdings or its Restricted Subsidiaries after the Closing Date&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in addition, cancellation of Indebtedness owing to Holdings from any current or former officer, director, manager, employee or consultant (or any permitted transferees thereof) of Holdings or any of its Restricted Subsidiaries (or any direct or indirect parent company thereof), in connection with a repurchase of Equity Interests of Holdings or Holdings&#8217; direct or indirect parent companies from such Persons will not be deemed to constitute a Restricted Payment for purposes of this Section 6.04 or any other provisions of this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the repurchase of Equity Interests of Holdings or Holdings&#8217; direct or indirect parent companies (i) deemed to occur upon the exercise of options, warrants or other convertible securities upon the net exercise thereof or otherwise to the extent such Equity Interests represent a portion of the exercise price of those options, warrants or other convertible securities, (ii) upon the exercise of stock options, warrants or convertible securities in an equal or lesser amount to the amount exercised in order to reduce the dilutive effects of such exercise and (iii) deemed to occur upon the withholding of a portion of Equity Interests granted or awarded to any current or former officer, director, manager, employee or consultant to pay for taxes payable by such Person in connection with such grant or award (or the vesting thereof) (or, in each case, a Restricted Payment to any of Holdings&#8217; direct or indirect parent companies in an amount sufficient to enable such company to repurchase any such Equity Interests)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">payments of cash, dividends, distributions, advances or other Restricted Payments by Holdings or any of its Restricted Subsidiaries to allow the payment of cash in lieu of the issuance of fractional shares upon (i) the exercise of options or warrants or other securities convertible into or exercisable for Equity Interests of any such Person or (ii) the conversion or exchange of Equity Interests of any such Person (or a Restricted Payment to Holdings&#8217; direct or indirect parent company in an amount sufficient to enable such company to make any such payments)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">for the avoidance of doubt, payments of intercompany subordinated Indebtedness, the incurrence of which was permitted under Section 6.01&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">the repurchase, redemption or other acquisition or retirement for value of any Subordinated Indebtedness pursuant to provisions similar to Section 6.03&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, prior to consummating, or concurrently with, any such repurchase, Holdings or the Applicable Borrower has made a Prepayment Event required by this Agreement and has prepaid all Obligations required to be repaid in connection with such offers&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">payments or distributions made in Equity Interests (other than Disqualified Equity Interests) of Holdings or any of its direct or indirect parent companies&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">164</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">other Restricted Payments of the type described in clause (i), (ii) or (iv) of the definition thereof in an aggregate amount not to exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination since the Closing Date, so long as at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">other Restricted Payments of the type described in clause (iii) of the definition thereof in an aggregate amount not to exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination since the Closing Date, so long as at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">payments or distributions to dissenting stockholders pursuant to applicable law in connection with any merger or consolidation with, or other acquisition of, another Person&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">the purchase by Holdings or any Restricted Subsidiary of any remaining outstanding Equity Interests of any Subsidiary acquired in connection with a Permitted Investment structured as a tender offer pursuant to which not less than a majority of such Subsidiary&#8217;s Equity Interests was acquired&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">Restricted Payments in connection with the Transactions and any compensation payable to, and indemnification of, any current or former officer, director, manager, employee or stockholders of Holdings, any of its Subsidiaries and any of Holdings&#8217; direct or indirect parent companies in respect of taxes owed by such Persons as a result of the Transactions&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">payments to holders of Equity Interests (or to the holders of Indebtedness that is convertible into or exchangeable for Equity Interests upon such conversion or exchange) in lieu of the issuance of fractional shares (or a Restricted Payment to Holdings&#8217; direct or indirect parent company in an amount sufficient to enable such company to make any such payments)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">the distribution, as a dividend or otherwise, of Equity Interests of Unrestricted Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">the purchase of any Permitted Equity Derivatives in connection with the issuance of any Convertible Debt Securities permitted under Section 6.01 (and the replacement of any such Permitted Equity Derivatives) provided that the purchase price for such Permitted Equity Derivatives, net of any proceeds relating to any concurrent sale or termination of any Permitted Equity Derivatives, in respect of any Convertible Debt Securities does not exceed the net cash proceeds from such issuance of Convertible Debt Securities&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">the settlement or termination of any Permitted Equity Derivatives&#59; provided that the entry into such Permitted Equity Derivative was permitted under this covenant&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">165</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">any Restricted Payments, excluding Restricted Investments, so long as (x) at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing and (y) on a Pro Forma Basis, as of the last day of the most recently ended Test Period, the Total Net Leverage Ratio does not exceed 4.00&#58;1.00&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">for any taxable period for which Holdings and&#47;or any of its Subsidiaries are members of a consolidated, combined, unitary or similar income Tax group for applicable income Tax purposes of which a direct or indirect parent company of Holdings is the common parent (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), dividends or distributions by Holdings to such direct or indirect parent company of Holdings in an amount not to exceed the portion of any income Taxes of such Tax Group for such taxable period that is attributable to the taxable income of Holdings and&#47;or the applicable Subsidiaries&#59; provided that for each taxable period, the total amount of such payments made in respect of such taxable period will not exceed the amount that Holdings and&#47;or such Subsidiaries, as applicable, would have been required to pay in respect of such taxable income as stand-alone taxpayers or a stand-alone Tax Group, reduced by any such income Taxes directly paid by Holdings or such Subsidiaries&#59; provided that distributions pursuant to this clause (xxii) in respect of an Unrestricted Subsidiary shall be permitted only to the extent that cash distributions were made by such Unrestricted Subsidiary to Holdings or any of its Restricted Subsidiaries for such purpose&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">&#91;reserved&#93;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.08pt">the declaration and payment of additional dividends and repurchases of Equity Interests of Holdings in an aggregate amount per annum not to exceed 6.0% of Market Capitalization, so long as at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.03pt">&#91;reserved&#93;&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.13pt">distributions or payments of Securitization Fees, purchases of receivables pursuant to a Receivables Repurchase Obligation in connection with a Qualified Receivables Factoring or Qualified Securitization Financing and the payment or distribution of Securitization Fees.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this covenant, in the event that a proposed Restricted Payment (or a portion thereof) meets the criteria of clauses (i) through (xxx) above or is entitled to be made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and&#47;or one or more of the exceptions contained in the definition of &#8220;Permitted Investments,&#8221; Holdings will be entitled to classify and reclassify (based on circumstances existing on the date of such classification or reclassification) such Restricted Payment (or portion thereof) among such clauses (i) through (xxvii), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and&#47;or one or more of the exceptions contained in the definition of &#8220;Permitted Investments,&#8221; in a manner that otherwise complies with this covenant. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The amount of all Restricted Payments (or transfer or issuance that would constitute Restricted Payments but for the exclusions from the definition thereof) and Permitted Investments (other than cash) will be the fair market value on the date of the making the Restricted Payment </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">166</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(or such transfer or issuance) or Permitted Investment of the asset(s) or securities proposed to be transferred or issued by Holdings or such Restricted Subsidiary, as the case may be, pursuant to the Restricted Payment (or transfer or issuance that would constitute a Restricted Payment but for the exclusions from the definition thereof) or Permitted Investment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of covenant compliance with this Section 6.04, the amount of any Investment shall be the amount actually invested, without adjustment for subsequent increases or decreases in the value of such Investment, less any amount paid, repaid, returned, distributed or otherwise received in cash in respect of such Investment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings will not, and will not permit any of its Restricted Subsidiaries, to create or permit to exist or become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary to&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">pay dividends or make any other distributions on its Equity Interests to Holdings or any of its Restricted Subsidiaries or pay any indebtedness owed to Holdings or any of its Restricted Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">make loans or advances to Holdings or any of its Restricted Subsidiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">sell, lease or transfer any of its properties or assets to Holdings or any of its Restricted Subsidiaries&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">create, incur or permit to exist any Lien upon any of its property or assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The restrictions in Section 6.07(a) will not apply to encumbrances or restrictions existing under or by reason of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">agreements in effect at or entered into on the Closing Date set forth on Schedule 6.07 and any amendments or modifications thereof that do not materially expand the scope of any such restriction or condition&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">this Agreement, the Loans, the Guarantees and the New Notes&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">agreements governing Indebtedness, Disqualified Equity Interests or Preferred Equity permitted to be incurred under Section 6.01&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">applicable law, rule, regulation or order&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">customary non-assignment provisions in contracts, leases and licenses otherwise permitted under this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Capital Lease Obligations, any agreement governing purchase money indebtedness, security agreements or mortgages securing Indebtedness of a </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">167</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted Subsidiary to the extent such encumbrance or restriction restricts the transfer of the property subject to such Capital Lease Obligations, purchase money indebtedness, security agreements or mortgages&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">any agreement in connection with the sale or disposition of all or substantially all the Equity Interests or assets of a Restricted Subsidiary that imposes such encumbrance or restriction pending the closing of such sale or disposition&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">customary restrictions and conditions contained in any agreement relating to any Disposition permitted by Section 6.03 pending the consummation of such Disposition&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Permitted Refinancing Indebtedness&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Liens permitted to be incurred under Section 6.02 that limit the right of the debtor to dispose of the assets subject to such Liens&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">provisions limiting the disposition or distribution of assets or property in joint venture agreements, partnership agreements, asset sale agreements, sale-leaseback agreements, stock sale agreements and other similar agreements (including agreements entered into in connection with a Restricted Investment), which limitation is applicable only to the assets that are the subject of such agreements&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.08pt">&#91;reserved&#93;&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.03pt">any agreement or instrument of, or affecting, any Restricted Subsidiary or its Equity Interests existing on or prior to the date on which such Restricted Subsidiary was acquired by Holdings or other Restricted Subsidiary (other than any such agreement or instrument entered into in contemplation of such Restricted Subsidiary acquired by Holdings or other Restricted Subsidiary)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">customary provisions contained in leases, sub-leases, licenses, sub-licenses or similar agreements, including with respect to intellectual property, and other agreements, in each case, entered into in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">customary non-assignment provisions in leases or licenses governing leasehold or license interests to the extent such provisions restrict the transfer of the lease or the property leased or licensed thereunder&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">any amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing of an agreement or arrangement referred to in clauses (i) through (xv) above of this Section 6.07(b)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing is not materially more restrictive, as determined in good faith by Holdings, with respect to such encumbrances and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">168</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">customary provisions in joint venture agreements or arrangements and other similar agreements or arrangements relating solely to such joint venture and the Equity Interests issued thereby&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">customary restrictions created in connection with any Qualified Securitization Financing or Qualified Receivables Factoring that, in the good faith determination of the board of directors of Holdings, are necessary or advisable to effect such Qualified Securitization Financing or such Qualified Receivables Factoring&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt">customary provisions restricting assignment of any agreement entered into in the ordinary course of business&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.63pt">restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.58pt">customary change of control provisions in client contracts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Amendments to Subordinated Indebtedness and Certain Other Documents, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings will not, nor will it permit any Restricted Subsidiary to amend, modify or waive any of its rights under any agreement or instrument governing or evidencing any Subordinated Indebtedness that constitutes Material Indebtedness to the extent such amendment, modification or waiver could reasonably be expected to be adverse in any material respect to the Lenders as determined by Holdings in good faith (it being understood and agreed that any increase or decrease in the interest rates or extension of the maturity dates or repayment under any Indebtedness among Holdings and its Subsidiaries or among one or more Subsidiaries shall not be deemed to be adverse in any material respect to the Lenders).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Sale and Leaseback Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings will not, nor will it permit any Restricted Subsidiary to, enter into any Sale and Leaseback Transaction unless (a) the sale or transfer of the property thereunder is permitted by Section 6.03 or is not an Asset Sale, (b) any Capital Lease Obligations arising in connection therewith are permitted by Section 6.01 and (c) any Liens arising in connection therewith (including Liens deemed to arise in connection with any such Capital Lease Obligations) are permitted by Section 6.02.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Merger, Consolidation or Sale of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Neither Holdings or any Borrower shall&#58; (1) consolidate with or merge with or into another Person&#59; or (2) directly or indirectly, sell, assign, transfer, convey, lease or otherwise dispose of (including by virtue of a merger, consolidation, amalgamation, liquidation or otherwise), all or substantially all of  the assets of Holdings and its Restricted Subsidiaries taken as a whole, in one or more related transactions, to another Person, in each case, unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">either&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">Holdings or such Borrower is the surviving or transferee Person&#59; or </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the Person formed by or surviving any such consolidation or merger or to which such sale, assignment, transfer, conveyance, lease or other disposition has been made is an entity organized or existing under the laws of the same jurisdiction as Holdings or such Borrower, as applicable&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">169</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, for purposes of this Section 6.11(a)(i)(B), the United States, all states thereof and the District of Columbia shall be considered a single jurisdiction&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the Person formed by or surviving any such consolidation or merger (if other than Holdings or a Borrower) or the Person to which such sale, assignment, transfer, conveyance, lease or other disposition has been made (if other than Holdings or a Borrower) assumes all the obligations of Holdings or such Borrower, as applicable, under this Agreement pursuant to agreements reasonably satisfactory to the Administrative Agent&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">other than in the case of a Restricted Subsidiary merging into Holdings or a Borrower, immediately after such transaction (or, in the case of a Limited Condition Transaction, as of the LCT Test Date), no Event of Default exists.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">No Subsidiary Guarantor shall&#58; (1) consolidate with or merge with or into another Person&#59; or (2) directly or indirectly, sell, assign, transfer, convey, lease or otherwise dispose of (including by virtue of a merger, consolidation, amalgamation, liquidation or otherwise), all or substantially all of  its assets taken as a whole, in one or more related transactions, to another Person, in each case, unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the other Person is Holdings or a Borrower or any Restricted Subsidiary&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">either&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">such Subsidiary Guarantor is the surviving or transferee Person&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the Person formed by or surviving any such consolidation or merger (if other than such Subsidiary Guarantor) or the Person to which such sale, assignment, transfer, conveyance, lease or other disposition has been made (if other than such Subsidiary Guarantor) is organized in a Covered Jurisdiction and assumes all the obligations of such Subsidiary Guarantor under this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">the transaction constitutes a Disposition (including by way of merger or consolidation) (A) that is not an Asset Sale or is an Asset Sale that is in compliance with Section 6.03 or (B) of such Subsidiary Guarantor or the Disposition of all or substantially all of the assets of such Subsidiary Guarantor that is not an Asset Sale or is an Asset Sale that is in compliance with Section 6.03. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing in this Section 6.11, (i) Holdings and the Borrowers and the Restricted Subsidiaries may consummate the Transactions, (ii) Holdings and the Borrowers and the Restricted Subsidiaries may consummate a consolidation or merger the purpose of which is to effect a Permitted Investment or an Investment permitted by 6.04, (iii) any Subsidiary Guarantor may merge or consolidate with or into an Affiliate solely for the purpose of reorganizing in another jurisdiction and (iv) any Subsidiary Guarantor may liquidate, dissolver or wind up if Holdings determines in good faith that such liquidation, dissolution or conveyance is in the best interest of Holdings and the Restricted Subsidiaries taken as whole.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Holdings and each of the Restricted Subsidiaries covenant and agree that&#58;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">170</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If on the last day of any Test Period (commencing with the first Test Period ending on the last day of the first full fiscal quarter ending after the Closing Date) there are outstanding Revolving Loans, Swingline Loans and Letters of Credit (excluding Letters of Credit to the extent Cash Collateralized or backstopped (whether drawn or undrawn)) in an aggregate principal amount exceeding 30% of the aggregate principal amount of all Revolving Commitments (including any Incremental Revolving Commitments), no Loan Party shall permit the Total Net Leverage Ratio as of the last day of such Test Period to be greater than (x) 5.75 to 1.00 prior to June 30, 2023 and (y) 4.50 to 1.00 on and after June 30, 2023 (in each case, such compliance to be determined on the basis of the financial information most recently delivered to the Administrative Agent pursuant to the Compliance Certificate for such Test Period) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on one occasion prior to the Maturity Date of the Revolving Loans and Revolving Commitments where Holdings or any of its Subsidiaries consummates a Financial Covenant Material Acquisition after the Closing Date, the maximum Total Net Leverage Ratio for each of the next four Test Periods following such Material Acquisition shall be 0.50 to 1.00 higher than the maximum Total Net Leverage Ratio otherwise indicated above for such Test Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The provisions of this Section 6.12 are for the benefit of the Revolving Lenders only and the Required Revolving Lenders may amend, waive or otherwise modify this Section 6.12 or the defined terms used in this Section 6.12 (solely in respect of the use of such defined terms in this Section 6.12) or waive any Default or Event of Default resulting from a breach of this Section 6.12 without the consent of any Lenders other than the Required Revolving Lenders.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.48pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default and Remedies</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any of the following events (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall occur on or after the Closing Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of any LC Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in clause (a) of this Section 7.01) payable under this Agreement or any other Loan Document, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of five (5) Business Days&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any representation or warranty made or deemed made by or on behalf of Holdings, any Borrower or any other Loan Party in or in connection with this Agreement or any other Loan Document or any amendment or modification hereof or thereof or waiver hereunder or thereunder, or in any certificate, financial statement or other instrument furnished pursuant to or in connection with this Agreement or any other Loan Document or any amendment or modification thereof or waiver thereunder, shall prove to have been incorrect in any material respect (or if such representation, warranty or statement is already qualified by materiality, in any respect) when made or deemed made)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) the failure of any representation or warranty made or deemed made by any Loan Party (other than the representations and warranties referred to in Section 4.01(f)) to be true and correct in any material respect on the Closing Date will not constitute an Event of Default  and (y) in the case of any representation and&#47;or warranty </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">171</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that is capable of being cured, there shall be a grace period of 15 days following Holdings&#8217; receipt of a written notice of the inaccuracy of the relevant representation, warranty or certification&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in Section 5.02, Section 5.03 (with respect to the legal existence of Holdings) or in Article VI&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Holdings&#8217; or any Restricted Subsidiary&#8217;s failure to comply with the Financial Covenant (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall not constitute an Event of Default with respect to any Term Loans or Term Loan Commitments unless and until the Required Revolving Lenders have actually terminated the Revolving Commitments and declared all Obligations with respect to their Revolving Commitments to be immediately due and payable pursuant to this Section 7.01 as a result of such failure to comply (and such declaration has not been rescinded as of the applicable date) (the occurrence of such termination and declaration by the Required Revolving Lenders, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant Cross Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in this Agreement (other than those specified in clause (a), (b) or (d) of this Section 7.01) or any other Loan Document, and such failure shall continue unremedied for a period of thirty (30) days after notice thereof from the Administrative Agent to Holdings&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Holdings or any Restricted Subsidiary shall fail to make any payment (whether of principal or interest and regardless of amount), in respect to any Material Indebtedness, when and as the same shall become due and payable after giving effect to any cure or grace period&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits, after the expiration of any applicable grace period provided in the applicable agreement or instrument under which such Indebtedness was created, the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause (g) shall not apply to (i) secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness, (ii) any redemption, repurchase, conversion, exchange or settlement with respect to any Convertible Debt Security pursuant to its terms unless such redemption, repurchase, conversion, exchange or settlement results from a default thereunder or an event of the type that constitutes an Event of Default, (iii) any early payment requirement or unwinding or termination with respect to any Swap Agreement (other than any such payment requirement or termination resulting from a default by Holdings or any Restricted Subsidiary), (iv) Indebtedness of any Person whose Equity Interests are being acquired in a Permitted Acquisition and which Indebtedness becomes due because of such Permitted Acquisition or (v) any breach or default that is (x) remedied by Holdings or the applicable Restricted Subsidiary or (y) waived (including in the form of an amendment) by the required holders of the applicable Indebtedness, in either case, prior to the acceleration of Loans pursuant to this Section 7.01&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">an involuntary case or application or proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization, winding-up, dissolution, examinership, compromise, arrangement or other relief in respect of Holdings or any Material Subsidiary or its debts, or of a substantial part of its assets, under any Federal, state or foreign bankruptcy, insolvency, receivership, examinership or similar law now or hereafter in effect or (ii) the appointment of a receiver, receiver and manager, trustee, custodian, sequestrator, conservator, examiner, liquidator or similar official for Holdings or any Material Subsidiary or for a substantial part of its assets, and, in any such case, such case or application or proceeding or </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">172</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">petition shall continue undismissed for sixty (60) days or an order or decree approving or ordering any of the foregoing shall be entered&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Holdings or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization, winding-up, dissolution, examinership, compromise, arrangement or other relief under any Federal, state or foreign bankruptcy, insolvency, examinership, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in clause (h) of this Section 7.01, (iii) apply for or consent to the appointment of a receiver,  receiver and manager, trustee, custodian, sequestrator, conservator or similar official for, Holdings or any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the liquidation of any Restricted Subsidiary into another Restricted Subsidiary (so long as any such Restricted Subsidiary that is a Loan Party is liquidated into another Loan Party), other than as part of a credit reorganization, shall not constitute an Event of Default under this clause (i)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">one or more judgments for the payment of money in an aggregate amount in excess of the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (or the equivalent amount in any other currency) shall be rendered against Holdings or any Restricted Subsidiary or any combination thereof and the same shall remain undischarged for a period of sixty (60) consecutive days during which execution shall not be effectively stayed, vacated, discharged or bonded pending appeal&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such amount shall be calculated after deducting from the sum so payable any amount of such judgment or order that is covered by a valid and binding policy of insurance in favor of Holdings or such Restricted Subsidiary (but only if the applicable insurer shall have been advised of such judgment and of the intent of Holdings or such Restricted Subsidiary to make a claim in respect of any amount payable by it in connection therewith and such insurer shall not have disputed coverage)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">an ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">(i) a contribution required to be made with respect to a Non-U.S. Plan has not been timely made&#59; or Holdings or any Restricted Subsidiary has incurred any obligation in connection with the termination of, or withdrawal from, any Non-U.S. Plan&#59; (ii) there shall result from any such event or events the imposition of a lien, the granting of a security interest or a liability&#59; and (iii) such lien, security interest or liability, individually, and&#47;or in the aggregate, has had, or could reasonably be expected to have a Material Adverse Effect&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">any material provision of any Loan Document for any reason ceases to be valid, binding and enforceable in accordance with its terms (or Holdings or any other Loan Party shall challenge the enforceability of any Loan Document or shall assert in writing that any provision of any of the Loan Documents has ceased to be or otherwise is not valid, binding and enforceable in accordance with its terms)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any Collateral Document shall for any reason fail to create a valid and perfected first priority (subject to Permitted Liens) security interest in any material portion of the Collateral purported to be covered thereby, except as permitted by the terms of any Loan Document or the Agreed Guarantee and Security Principles, or as a result of any act or omission of the Administrative Agent so long as not resulting from the breach or non-compliance with any Loan Document by any Loan Party&#59; or</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">173</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">A Change of Control shall occur&#59;</font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">then, and in every such event (other than an event with respect to Holdings or any Borrower described in clause (h) or (i) of this Section 7.01), and at any time thereafter during the continuance of such event, the Administrative Agent may, and, at the request of the Required Lenders, shall, by notice to the Borrowers, (I) declare the Revolving Commitments of each Revolving Lender and any obligation of the Issuing Banks to issue, amend, renew or extend any Letter of Credit and the Swingline Lender to make Swingline Loans to be terminated, whereupon such Revolving Commitments and obligation will be terminated, (II) declare the Loans then outstanding to be due and payable in whole (or in part, in which case any principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other Secured Obligations accrued hereunder and under the other Loan Documents, shall become  due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and each Guarantor and (III) require the Revolving Borrowers to Cash Collateralize the then outstanding Letters of Credit (in an amount in cash equal to 102% of the Dollar Amount of the LC Exposure as of such date plus any accrued and unpaid interest thereon)&#59; and in case of any event with respect to Holdings or any Borrower described in clause (h) or (i) of this Section 7.01, (I) the Revolving Commitments of each Revolving Lender and any obligation of the Issuing Banks to issue Letters of Credit and any obligation of the Swingline Lender to make Swingline Loans will automatically terminate, (II) the principal of the Loans then outstanding, together with accrued interest thereon and all fees and other Secured Obligations accrued hereunder and under the other Loan Documents, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and each Guarantor and (III) the obligation of the Revolving Borrowers to Cash Collateralize the Letters of Credit as aforesaid will automatically become effective&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding anything to the contrary, if the only Events of Default then having occurred and continuing are pursuant to a Financial Covenant Event of Default, then, unless a Financial Covenant Cross Default has occurred and is continuing, the Administrative Agent shall only take the actions set forth in this Section 7.01 at the request (or with the consent) of the Required Revolving Lenders (as opposed to the Required Lenders) and only with respect to the Revolving Commitments, Revolving Loans, Letters of Credit, Swingline Loans and obligations of the Revolving Lenders.  Upon the occurrence and during the continuance of an Event of Default, the Administrative Agent may, and at the request of the Required Lenders shall, exercise any rights and remedies provided to the Administrative Agent under the Loan Documents or at law or equity, including all remedies provided under the UCC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Borrowers&#8217; Right to Cure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained in Section 7.01&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">For the purpose of determining whether an Event of Default under the Financial Covenant has occurred, Holdings may on one or more occasions designate any portion of the net cash proceeds from a sale or issuance of Qualified Equity Interests of Holdings or any contribution to the common capital of Holdings (or from any other contribution to capital or sale or issuance of any other Equity Interests) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cure Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as an increase to Consolidated EBITDA for the applicable fiscal quarter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such amounts to be designated are actually received by Holdings on or after the first day of such applicable fiscal quarter and on or prior to the twentieth (20th) Business Day after the date on which financial statements are required to be delivered with respect to such applicable fiscal quarter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cure Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (ii) such amounts do not exceed the aggregate amount necessary to cure any Event of Default under the Financial Covenant as of such date and (iii) the Revolving Borrowers shall have provided notice to the Administrative Agent on the date such amounts are designated as a &#8220;Cure Amount&#8221; (it being understood that to the extent any such notice is provided in advance of delivery </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">174</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of a Compliance Certificate for the applicable period, the amount of such net cash proceeds that is designated as the Cure Amount may be different than the amount necessary to cure any Event of Default under the Financial Covenant and may be modified, as necessary, in a subsequent corrected notice delivered on or before the Cure Expiration Date (it being understood that in any event the final designation of the Cure Amount shall continue to be subject to the requirements set forth in clauses (i) and (ii) above)).  The Cure Amount used to calculate Consolidated EBITDA for one fiscal quarter shall be used and included when calculating Consolidated EBITDA for each Test Period that includes such fiscal quarter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">The parties hereby acknowledge that this Section 7.02 may not be relied on for purposes of calculating any financial ratios other than for determining actual compliance with Section 6.12 (and not Pro Forma Basis with Section 6.12 that is required by any other provision of this Agreement) and shall not result in any adjustment to any amounts (including the amount of Indebtedness) or increase in cash (and shall not be included for purposes of determining pricing, mandatory prepayments and the availability or amount permitted pursuant to any covenant under Article VI) with respect to the fiscal quarter with respect to which such Cure Amount was made other than the amount of the Consolidated EBITDA referred to in Section 7.02(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">In furtherance of clause (a) above, (A) upon actual receipt and designation of the Cure Amount by one or more Borrowers, the Financial Covenant shall be deemed satisfied and complied with as of the end of the relevant fiscal quarter with the same effect as though there had been no failure to comply with the Financial Covenant and any Event of Default under the Financial Covenant shall be deemed not to have occurred for purposes of the Loan Documents, and (B) upon delivery to the Administrative Agent prior to the Cure Expiration Date of a notice from Holdings stating its good faith intention to exercise its right set forth in this Section 7.02, neither the Administrative Agent nor any Lender may exercise any rights or remedies under Section 7.01 (or under any other Loan Document) on the basis of any actual or purported Event of Default under the Financial Covenant until and unless the Cure Expiration Date has occurred without the Cure Amount having been received and designated.  Notwithstanding the foregoing, after the occurrence of an Event of Default under the Financial Covenant, the Revolving Borrowers shall not be able to request the making of any Revolving Loan or the issuance of any Letter of Credit under the Revolving Commitments during the period from the date on which the financial statements in respect of the applicable fiscal quarter or fiscal year are required to be delivered pursuant to Section 5.01(a) or (b) until receipt by one or more Borrowers of the Cure Amount or waiver of the Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">(i) In each period of four (4) consecutive fiscal quarters, there shall be at least two consecutive (2) fiscal quarters in which no cure right set forth in this Section 7.02 is exercised and (ii) there shall be no </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pro forma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> reduction in Indebtedness with the Cure Amount for determining compliance with the Financial Covenant for the fiscal quarter with respect to which such Cure Amount was made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">There can be no more than five (5) fiscal quarters in which the cure rights set forth in this Section 7.02 are exercised during the term of the Revolving Commitments and any Extended Revolving Commitments in respect thereof.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.82pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Agents</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">The Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each of the Lenders</font><font style="background-color:#ffffff;color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and the Issuing Banks hereby irrevocably appoints Citibank, N.A. as its administrative agent and authorizes Citibank, N.A. to take such actions on its behalf, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">175</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">including execution of the other Loan Documents, and to exercise such powers as are delegated to the Administrative Agent by the terms of the Loan Documents, together with such actions and powers as are reasonably incidental thereto, and Citibank, N.A. hereby accepts such appointment.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Citibank, N.A., London Branch or an Affiliate or designee thereof shall act as the Collateral Agent under the Loan Documents (for purposes of this Section 8.01 and Sections 9.03 and 2.17, the Administrative Agent and the Collateral Agent shall be collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and each of the Lenders and the Issuing Banks hereby irrevocably appoints and authorizes Citibank, N.A. (and Citibank, N.A., London Branch hereby accepts such appointment) and each such Affiliate and designee to act as the agent of such Lender and Issuing Bank for purposes of acquiring, holding and enforcing any and all Liens on Collateral granted by any of the Loan Parties to secure any of the Secured Obligations, together with such powers and discretion as are reasonably incidental thereto.  In this connection, any co-agents, sub-agents and attorneys-in-fact appointed by the Collateral Agent pursuant to this Section 8.01 for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the Collateral Documents, or for exercising any rights and remedies thereunder at the direction of the Administrative Agent, shall be entitled to the benefits of all provisions of this Section 8.01 and Article IX (including Section 9.03), as though such co-agents, sub-agents and attorneys-in-fact were the Collateral Agent under the Loan Documents as if set forth in full herein with respect thereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as otherwise provided in this Section 8.01, the provisions of this Article are solely for the benefit of the Agents and the Lenders, and the Borrowers shall not have rights as third-party beneficiaries of any of such provisions.  </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The banks serving as the Agents hereunder shall have the same rights and powers in their capacity as Lenders as any other Lender and may exercise the same as though they were not an Agent, and such banks and their Affiliates may accept deposits from, lend money to and generally engage in any kind of business with Holdings or any Subsidiary or other Affiliate thereof as if they were not an Agent hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents shall not have any duties or obligations except those expressly set forth in the Loan Documents to which such Agent is a party.  Without limiting the generality of the foregoing, (a) the Agents shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing, (b) the Agents shall not have any duty to take any discretionary action or exercise any discretionary powers including, without limitation, the timing and methods of realization of the Collateral, except discretionary rights and powers expressly contemplated by the Loan Documents that the respective Agent is required to exercise in writing as directed (i) in the case of the Collateral Agent, by the Administrative Agent (acting at the direction of the Required Lenders) or (ii) in the case of the Administrative Agent, by the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.02), and no Agent shall be required to take any action or omit to take any action (including disclosing information) that in its reasonable opinion or the opinion of its counsel, may expose it to liability, be contrary to any Loan Document or constitute a breach of any Law (including, but not limited to, any Law of England and Wales and the United States), and (c) except as expressly set forth in the Loan Documents, the Agents shall not have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to Holdings or any of its Subsidiaries that is communicated to or obtained by any bank serving as an Agent or any of its Affiliates in any capacity.  The Agents shall not be liable for any action taken or not taken by them with the consent or at the request of (i) in the case of the Collateral Agent, the Administrative Agent (acting at the direction of the Required Lenders) or (ii) in the case of the Administrative Agent, the Required Lenders (or in each case, such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.02 or elsewhere in the Loan Documents) or in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and non-appealable </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">176</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">judgment.  The Agents shall be deemed not to have knowledge of any Default unless and until written notice thereof is given to the respective Agent by Holdings, a Borrower or a Lender, and no Agent shall be responsible for or have any duty to ascertain or inquire into (i) any recital, statement, warranty or representation made in or in connection with any Loan Document, (ii) the contents or accuracy of any certificate, report or other document delivered hereunder or in connection with any Loan Document, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth in any Loan Document, (iv) the legality, validity, enforceability, effectiveness, genuineness or sufficiency of any Loan Document, the Collateral or any other agreement, instrument or document, (v) the creation, validity, perfection, priority or enforceability of Liens on the Collateral or the existence, genuineness, sufficiency or value of the Collateral, (vi) the satisfaction of any condition set forth in Article IV or elsewhere in any Loan Document, other than to confirm receipt of items expressly required to be delivered to such Agent or (vii) the properties, books or records of the Borrowers.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents shall not be required to expend or risk any of its own funds or otherwise incur any liability, financial or otherwise, in the performance of any of its duties hereunder or under any Loan Document to which it is a party, or be required to take any action that is contrary to this Agreement or applicable Law.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents shall not be responsible for insuring the Collateral or for the payment of Taxes, charges, assessments or Liens upon the Collateral or otherwise as to the maintenance of the Collateral&#59; nor shall any Agent have any duty to see to the payment or discharge of any tax, assessment or other governmental charge relating to the Collateral or any lien or encumbrance of any kind with respect to the Collateral.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing believed by them to be genuine and to have been signed or sent by the proper Person.  The Agents also may rely upon any statement made to them orally or by telephone and believed by them to be made by the proper Person, and shall not incur any liability for relying thereon.  The Agents may consult with legal counsel (who may be counsel for Holdings, the Subsidiary Guarantors or the Borrowers), independent accountants and other experts selected by them, and shall not be liable for any action taken or not taken by them in accordance with the advice of any such counsel, accountants or experts. Notwithstanding anything else to the contrary herein, each Agent may refrain from acting in accordance with any instructions or requests given by the Lenders (or, in the case of the Collateral Agent, given by the Administrative Agent at the direction of the Lenders) unless it shall first be indemnified to its satisfaction by the Lenders against any and all liability, cost and expense that may be incurred by it by reason of taking or continuing to take any such action in compliance with the instruction or request. Each Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or, as applicable in the case of the Collateral Agent, given by the Administrative Agent at the direction of the Lenders), and such request and any action taken or failure to act pursuant thereto shall be binding upon the Lenders and all future Lenders.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents may perform any and all their duties and exercise their rights and powers by or through any one or more sub-agents appointed by the respective Agent.  The Agents and any such sub-agent may perform any and all their duties and exercise its rights and powers through their respective Related Parties.  The exculpatory provisions of the preceding paragraphs shall apply to any such sub-agent and to the Related Parties of the Agents and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as an Agent.  The Agents shall not be responsible for the negligence or misconduct of any sub-agent that it selects in the absence of gross negligence or willful misconduct by the Agents, as determined in a final and non-appealable judgment by a court of competent jurisdiction.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">177</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents shall not incur any liability for not performing any act or fulfilling any duty, obligation or responsibility hereunder by reason of any occurrence beyond the control of the Agents (including but not limited to any act or provision of any present or future Law, any act of God or war, civil unrest, local or national disturbance or disaster, any act of terrorism, or the unavailability of the Federal Reserve Bank wire or facsimile or other wire or communication facility).</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents shall not be obligated to carry out any particular &#8220;know your customer&#8221; or other checks on behalf of any Secured Party or otherwise. </font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agents may refrain without liability from doing anything that they determine, in reliance upon advice of legal counsel, would or might be contrary to any applicable Law (including but not limited to the Laws of the United States of America or any jurisdiction forming a part of it and of England and Wales) or any directive or regulation of any agency of any such state or jurisdiction and may without liability do anything which is, in its opinion in reliance upon the advice of legal counsel, necessary to comply with any such Law.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the appointment and acceptance of a successor Administrative Agent as provided in this paragraph, the Administrative Agent may resign at any time by notifying the Lenders, the Issuing Banks and the Borrowers.  Any such resignation by the Administrative Agent hereunder shall also constitute its resignation as an Issuing Bank and the Swingline Lender, as applicable, in which case the resigning Administrative Agent (x) shall not be required to issue any further Letters of Credit or make any additional Swingline Loans hereunder and (y) shall maintain all of its rights as Issuing Bank or Swingline Lender, as the case may be, with respect to any Letters of Credit issued by it, or Swingline Loans made by it, prior to the date of such resignation.  Upon any such resignation, the Required Lenders shall have the right (with the consent of the Borrowers (such consent not to be unreasonably withheld or delayed), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Borrowers shall be required if an Event of Default under clause (a), (b), (h), (i) or (j) of Section 7.01 has occurred and is continuing) to appoint a successor.  If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within thirty (30) days after the retiring Administrative Agent gives notice of its resignation, then the retiring Administrative Agent may, on behalf of the Lenders and the Issuing Banks, appoint a successor Administrative Agent which shall be a bank with an office in New York, New York, or an Affiliate of any such bank (or another financial institution acceptable to Holdings).  Upon the acceptance of its appointment as Administrative Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Administrative Agent, and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder.  The fees payable by the Borrowers to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrowers and such successor.  After the Administrative Agent&#8217;s resignation hereunder, the provisions of this Section 8.01 and Section 9.03 shall continue in effect for the benefit of such retiring Administrative Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while it was acting as Administrative Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the appointment and acceptance of a successor Collateral Agent as provided in this paragraph, the Collateral Agent may resign at any time by notifying the Lenders and the Borrowers.  Upon any such resignation, the Required Lenders shall have the right (with the consent of the Borrowers (such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Borrowers shall be required if an Event of Default under clause (a), (b), (h), (i) or (j) of Section 7.01 has occurred and is continuing) to appoint a successor.  If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within thirty (30) days after the retiring Collateral Agent gives notice of its resignation, then the retiring Collateral Agent may, on behalf of the Lenders, appoint a successor Collateral Agent which shall be a bank with an office in New York, New York, or an Affiliate of any such bank.  </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">178</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the acceptance of its appointment as Collateral Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Collateral Agent, and the retiring Collateral Agent shall be discharged from its duties and obligations hereunder.  The fees payable by the Borrowers to a successor Collateral Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrowers and such successor.  After the Collateral Agent&#8217;s resignation hereunder, the provisions of this Section 8.01 and Section 9.03 shall continue in effect for the benefit of such retiring Collateral Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while it was acting as Collateral Agent.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Lender acknowledges that it has, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement.  Each Lender also acknowledges that it will, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">None of the Lenders, if any, identified in this Agreement as a Lead Arranger shall have any right, power, obligation, liability, responsibility or duty under this Agreement other than those applicable to all Lenders as such.  Without limiting the foregoing, none of such Lenders shall have or be deemed to have a fiduciary relationship with any Lender.  Each Lender hereby makes the same acknowledgments with respect to the relevant Lenders in their respective capacities as a Lead Arranger as it makes with respect to the Agents in the preceding paragraph.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Lenders are not partners or co-venturers, and no Lender shall be liable for the acts or omissions of, or (except as otherwise set forth herein in case of the Agents) authorized to act for, any other Lender.  The Agents shall have the exclusive right on behalf of the Lenders to enforce the payment of the principal of and interest on any Loan after the date such principal or interest has become due and payable pursuant to the terms of this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In their respective capacities, the Agents are &#8220;representatives&#8221; of the Secured Parties within the meaning of the term &#8220;secured party&#8221; as defined in the UCC.  Each Lender authorizes the Agents to enter into each of the Collateral Documents to which it is a party and related documents in connection therewith and to take all action contemplated by such documents.  Each Lender agrees that no Secured Party (other than the Agents) shall have the right individually to seek to realize upon the security granted by any Collateral Document, it being understood and agreed that such rights and remedies may be exercised solely by the Agents for the benefit of the Secured Parties upon the terms of the Collateral Documents.  In the event that any Collateral is hereafter pledged by any Person as collateral security for the Secured Obligations, the Agents are hereby authorized, and hereby granted a power of attorney, to execute and deliver on behalf of the Secured Parties any Loan Documents necessary or appropriate to grant and perfect a Lien on such Collateral in favor of the Collateral Agent on behalf of the Secured Parties.  The Lenders hereby authorize the Collateral Agent to release or, as applicable, subordinate any Lien granted to or held by the Collateral Agent upon any Collateral and to enter into non-disturbance or similar agreements, in each case, to the extent and in the circumstances described in Section 9.13.  Upon request by the Collateral Agent at any time, the Lenders will confirm in writing the Collateral Agent&#8217;s authority to release or subordinate particular types or items of Collateral and enter into non-disturbance or similar agreements pursuant hereto.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent and the Collateral Agent are authorized to (and at the request of the Borrowers will) enter into any Intercreditor Agreement (and any amendments, amendments and restatements, restatements or waivers of or supplements to or other modifications to, and extensions, restructuring, renewals, replacements of, such agreements) in </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">179</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">connection with the incurrence by any Loan Party of any Permitted Junior Secured Refinancing Debt, Permitted Pari Passu Secured Refinancing Debt, Alternative Incremental Facility Indebtedness, Permitted Refinancing Indebtedness or Indebtedness incurred pursuant to clauses (1) and (2) of the proviso set forth in Section 6.01(a) with respect thereto, or any other Indebtedness permitted by the terms of this Agreement to be secured by the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or junior priority secured basis, in each case in order to permit such Indebtedness to be secured by a valid, perfected Lien (with such priority as may be designated by Holdings or relevant Restricted Subsidiary, to the extent such priority is permitted by the Loan Documents), and the parties hereto acknowledge that each Intercreditor Agreement is (if entered into) binding upon them.  Each Lender (a) understands, acknowledges and agrees that Liens may be created on the Collateral pursuant to the documentation relating to any Indebtedness incurred as permitted by this Agreement which is (in accordance with the terms hereof) to be secured thereby, on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or junior, secured basis to the Liens securing the Secured Obligations, which Liens securing any such other Indebtedness shall be subject to the terms and conditions of the relevant Intercreditor Agreement executed and delivered as required hereby, (b) hereby agrees that it will be bound by and will take no actions contrary to the provisions of the respective Intercreditor Agreement (if entered into) and (c) hereby authorizes and instructs the Administrative Agent and Collateral Agent to enter into any Intercreditor Agreement (and any amendments, amendments and restatements, restatements or waivers of or supplements to or other modifications to, such agreements) in connection with the incurrence by any Loan Party of any secured Indebtedness as contemplated above, in order to permit such Indebtedness to be secured by a valid, perfected Lien (with such priority as may be designated by the Applicable Borrower or relevant Restricted Subsidiary, to the extent such priority is permitted by the Loan Documents), and to subject the Liens on the Collateral securing the Secured Obligations to the provisions thereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If the Administrative Agent notifies a Lender, Issuing Bank or Secured Party, or any Person who has received funds on behalf of a Lender, Issuing Bank or Secured Party such Lender or Issuing Bank (any such Lender, Issuing Bank, Secured Party or other recipient, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payment Recipient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that the Administrative Agent has determined in its sole discretion (whether or not after receipt of any notice under immediately succeeding clause (b)) that any funds received by such Payment Recipient from the Administrative Agent or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Lender, Issuing Bank, Secured Party or other Payment Recipient on its behalf)  (any such funds, whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise, individually and collectively, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and demands the return of such Erroneous Payment (or a portion thereof), such Erroneous Payment shall at all times remain the property of the Administrative Agent and shall be segregated by the Payment Recipient and held in trust for the benefit of the Administrative Agent, and such Lender, Issuing Bank or Secured Party shall (or, with respect to any Payment Recipient who received such funds on its behalf, shall cause such Payment Recipient to) promptly, but in no event later than two Business Days thereafter, return to the Administrative Agent the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Payment Recipient to the date such amount is repaid to the Administrative Agent in same day funds at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect. A notice of the Administrative Agent to any Payment Recipient under this clause (a) shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Without limiting immediately preceding clause (a), each Lender, Issuing Bank or Secured Party, or any Person who has received funds on behalf of a Lender, Issuing Bank </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">180</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or Secured Party such Lender or Issuing Bank, hereby further agrees that if it receives a payment, prepayment or repayment (whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise) from the Administrative Agent (or any of its Affiliates) (x) that is in a different amount than, or on a different date from, that specified in a notice of payment, prepayment or repayment sent by the Administrative Agent (or any of its Affiliates) with respect to such payment, prepayment or repayment, (y) that was not preceded or accompanied by a notice of payment, prepayment or repayment sent by the Administrative Agent (or any of its Affiliates), or (z) that such Lender, Issuing Bank or Secured Party, or other such recipient, otherwise becomes aware was transmitted, or received, in error or by mistake (in whole or in part) in each case&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">(A) in the case of immediately preceding clauses (x) or (y), an error shall be presumed to have been made (absent written confirmation from the Administrative Agent to the contrary) or (B) an error has been made (in the case of immediately preceding clause (z)), in each case, with respect to such payment, prepayment or repayment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">such Lender, Issuing Bank or Secured Party shall (and shall cause any other recipient that receives funds on its respective behalf to) promptly (and, in all events, within one Business Day of its knowledge of such error) notify the Administrative Agent of its receipt of such payment, prepayment or repayment, the details thereof (in reasonable detail) and that it is so notifying the Administrative Agent pursuant to this Section 8.02(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Lender, Issuing Bank or Secured Party hereby authorizes the Administrative Agent to set off, net and apply any and all amounts at any time owing to such Lender, Issuing Bank or Secured Party under any Loan Document, or otherwise payable or distributable by the Administrative Agent to such Lender, Issuing Bank or Secured Party from any source, against any amount due to the Administrative Agent under immediately preceding clause (a) or under the indemnification provisions of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In the event that an Erroneous Payment (or portion thereof) is not recovered by the Administrative Agent for any reason, after demand therefor by the Administrative Agent in accordance with immediately preceding clause (a), from any Lender or Issuing Bank that has received such Erroneous Payment (or portion thereof) (and&#47;or from any Payment Recipient who received such Erroneous Payment (or portion thereof) on its respective behalf)  (such unrecovered amount, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Return Deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), upon the Administrative Agent&#8217;s notice to such Lender or Issuing Bank at any time, (i) such Lender or Issuing Bank shall be deemed to have assigned its Loans (but not its Commitments) of the relevant Class with respect to which such Erroneous Payment was made (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Impacted Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in an amount equal to the Erroneous Payment Return Deficiency (or such lesser amount as the Administrative Agent may specify) (such assignment of the Loans (but not Commitments) of the Erroneous Payment  Impacted Class, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Deficiency Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) at par plus any accrued and unpaid interest (with the assignment fee to be waived by the Administrative Agent in such instance), and is hereby (together with the Borrower) deemed to execute and deliver an Assignment and Assumption (or, to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to the Platform as to which the Administrative Agent and such parties are participants) with respect to such Erroneous Payment Deficiency Assignment, and such Lender or Issuing Bank shall deliver any Notes evidencing such Loans to Holdings or the Administrative Agent, (ii) the Administrative Agent as the assignee Lender shall be deemed to acquire the Erroneous Payment Deficiency Assignment, (iii) upon such deemed acquisition, the Administrative Agent as the assignee Lender shall become a Lender or Issuing Bank, as applicable, hereunder with respect to such Erroneous Payment Deficiency Assignment and the assigning Lender or assigning Issuing Bank shall cease to be a </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">181</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender or Issuing Bank, as applicable, hereunder with respect to such Erroneous Payment Deficiency Assignment, excluding, for the avoidance of doubt, its obligations under the indemnification provisions of this Agreement and its applicable Commitments which shall survive as to such assigning Lender or assigning Issuing Bank and (iv) the Administrative Agent may reflect in the Register its ownership interest in the Loans subject to the Erroneous Payment Deficiency Assignment. The Administrative Agent may, in its discretion, sell any Loans acquired pursuant to an Erroneous Payment Deficiency Assignment and upon receipt of the proceeds of such sale, the Erroneous Payment Return Deficiency owing by the applicable Lender or Issuing Bank shall be reduced by the net proceeds of the sale of such Loan (or portion thereof), and the Administrative Agent shall retain all other rights, remedies and claims against such Lender or Issuing Bank (and&#47;or against any recipient that receives funds on its respective behalf). For the avoidance of doubt, no Erroneous Payment Deficiency Assignment will reduce the Commitments of any Lender or Issuing Bank and such Commitments shall remain available in accordance with the terms of this Agreement.  In addition, each party hereto agrees that, except to the extent that the Administrative Agent has sold a Loan (or portion thereof) acquired pursuant to an Erroneous Payment Deficiency Assignment, and irrespective of whether the Administrative Agent may be equitably subrogated, the Administrative Agent shall be contractually subrogated to all the rights and interests of the applicable Lender, Issuing Bank or Secured Party under the Loan Documents with respect to each Erroneous Payment Return Deficiency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Erroneous Payment Subrogation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by any Borrower or any other Loan Party, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount of such Erroneous Payment that is, comprised of funds received by the Administrative Agent from any Borrower or any other Loan Party for the purpose of making such Erroneous Payment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">To the extent permitted by applicable law, no Payment Recipient shall assert any right or claim to  an Erroneous Payment, and hereby waives, and is deemed to waive, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Erroneous Payment received, including without limitation waiver of any defense based on &#8220;discharge for value&#8221; or any similar doctrine</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each party&#8217;s obligations, agreements and waivers under this Section 8.02 shall survive the resignation or replacement of the Administrative Agent, any transfer of rights or obligations by, or the replacement of, a Lender or Issuing Bank, the termination of the Commitments and&#47;or the repayment, satisfaction or discharge of all Obligations (or any portion thereof) under any Loan Document.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(h)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein or in any other Loan Document, no Loan Party or any of their respective Affiliates shall have any obligations or liabilities directly or indirectly arising out of this Section 8.02 in respect of any Erroneous Payment (other than having consented to the assignment referenced in Section 8.02(d) above).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27.14pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Except in the case of notices and other communications expressly permitted to be given by telephone (and subject to paragraph (b) below), all notices and other </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">182</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by email, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">if to the Borrowers or any Loan Party, to the Borrowers at&#58; </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58; Chief Financial Officer with a copy to General Counsel</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ICON plc</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">South County Business Park</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leopardstown</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dublin 18</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ireland</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Email&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Libhin.NicGabhann&#64;iconplc.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with a copy to ICON General Counsel&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Diarmaid.Cunningham&#64;iconplc.com</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Phone&#58; +353 1 2912000</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58; Board of Directors</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l.</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61 rue de Rollingerfrund</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">L- 2440</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Luxembourg</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Email&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Michael.Gleeson&#64;iconplc.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with a copy to ICON General Counsel&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Diarmaid.Cunningham&#64;iconplc.com</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Phone&#58; +353 1 2912000</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">if to the Administrative Agent, to it at Citibank Delaware, One Penns Way, OPS 2&#47;2, New Castle, DE 19720&#59; Attn&#58; Agency Operations&#59; Phone&#58; (302) 894-6010&#59; Fax&#58; (646) 274-5080&#59; Borrower inquiries only&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">AgencyABTFSupport&#64;citi.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; Borrower notifications&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">AgencyABTFSupport&#64;citi.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; Disclosure Team Mail (Financial Reporting)&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Oploanswebadmin&#64;citi.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; Investor Relations Team (investor inquiries only)&#58;  </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">global.loans.support&#64;citi.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or such other office or person as the Administrative Agent may hereafter designate in writing as such to the other parties hereto&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">if to the Collateral Agent, to it at Citibank, N.A., London Branch, 6th Floor CGC1, Citigroup Centre, Canada Square, London, E14 5LB, United Kingdom, Attention&#58; PFLA Team, Agency and Trust (Email </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">issuerpfla&#64;citi.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">if to any Lender or Issuing Bank, to it at its address (or telecopy number) set forth in its Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notices and other communications to the Administrative Agent or the Lenders hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not apply to notices pursuant to Article II unless otherwise agreed by the Administrative Agent and the applicable Lender.  The Administrative Agent or the Borrowers may, in their discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE&#8221;.  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">183</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM.  In no event shall the Administrative Agent or any of its Related Parties or any Lead Arranger (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) have any liability to any Loan Party, any Lender, or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of any Loan Party&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Agent Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, however, that in no event shall any Agent Party have any liability to any Loan Party, any Lender or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Any party hereto may change its address, email address or telephone number for notices and other communications hereunder by notice to the other parties hereto.  All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt.  Furthermore, each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the &#8220;Private Side Information&#8221; or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender&#8217;s compliance procedures and applicable Law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are not made available through the &#8220;Public Side Information&#8221; portion of the Platform and that may contain material non-public information with respect to Holdings, the Borrowers or their respective subsidiaries and its or their securities for purposes of United States Federal or state securities laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Waivers&#59; Enforcement&#59; Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">(i)&#160;&#160;&#160;&#160;No failure or delay by the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender in exercising any right or power hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power.  The rights and remedies of the Administrative Agent, the Collateral Agent, the Issuing Banks and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have.  No waiver of any provision of any Loan Document or consent to any departure by any Applicable Borrower therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this Section 9.02, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given.  Without limiting the generality of the foregoing, the making of a Loan or issuance, extension or amendment of a Letter of Credit shall not be construed as a waiver of any Default, regardless of whether the Administrative Agent, the Collateral Agent, any Lender or any Issuing Bank may have had notice or knowledge of such Default at the time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents against the Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in connection with such enforcement shall be instituted and maintained exclusively by, the Administrative Agent or the Collateral Agent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for the benefit of all the Lenders and the Issuing Banks.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">184</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Except as provided in Section 2.14, Section 2.20 with respect to an Incremental Amendment, Section 2.22 with respect to an Extension Amendment and Section 2.24 with respect to a Refinancing Amendment, neither this Agreement, any other Loan Document nor any provision hereof or thereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by (A) the Applicable Borrower and the Required Lenders or (B) by the Applicable Borrower and the Administrative Agent with the consent of the Required Lenders (in each case other than, with respect to any amendment or waiver contemplated in clauses (viii), (ix) and (xi) below, which shall only require the consent of the Required Revolving Lenders under the applicable Class of Revolving Commitments, as applicable (and not the Required Lenders))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such agreement shall (i) increase the Commitment of any Lender without the written consent of such Lender, (ii) reduce the principal amount of any Loan or LC Disbursement or reduce the rate of interest thereon or reduce any fees payable hereunder, without the written consent of each Lender directly affected thereby&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that only the consent of the Required Lenders shall be necessary to reduce or waive any obligation of any Borrower to pay interest or fees at the applicable default rate set forth in Section 2.13(d), (iii) postpone the scheduled date of payment of the principal amount of any Loan (other than any reduction of the amount of, or any extension of the payment date for, the mandatory prepayments required under Section 2.11, in each case which shall only require the approval of the Required Lenders), or any interest thereon (other than interest payable at the applicable default rate of interest set forth in Section 2.13(d)), or any fees payable hereunder, or reduce the amount of, waive or excuse any such payment, or postpone the scheduled date of expiration of any Commitment, without the written consent of each Lender directly affected thereby, (iv) change Section 2.18(b) or (c) in a manner that would alter the pro rata sharing of payments required thereby, without the written consent of each Lender directly and adversely affected thereby, (v) change any of the provisions of this Section 9.02 or the definitions of &#8220;Required Lenders&#8221; or &#8220;Majority in Interest&#8221; or any other provision hereof specifying the number or percentage of Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Lender (it being understood that, solely with the consent of the parties prescribed by Section 2.20 or Section 2.24 to be parties to an Incremental Amendment or a Refinancing Amendment, as applicable, Incremental Loans and Other Refinancing Loans may be included in the determination of Required Lenders on substantially the same basis as the Term Loans are included on the Closing Date), (vi) except as provided in Section 9.13, release all or substantially all of the Guarantors from their obligations under the Guaranty without the written consent of each Lender, (vii) except as provided in Section 9.13 or in any Collateral Document, release all or substantially all of the Collateral, without the written consent of each Lender, (viii) amend, waive or otherwise modify any term or provision (including the waiver of any conditions set forth in Section 4.02 as to any credit extension under one or more Revolving Commitments) which directly affects Lenders under one or more Revolving Commitments and does not directly affect Lenders under any Term Loan Commitments, in each case, without the written consent of the Required Revolving Lenders under such applicable Class of Revolving Commitments (and in the case of multiple Revolving Commitments which are affected, such Required Revolving Lenders shall consent together as one Revolving Commitment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the waivers described in this clause (viii) shall not require the consent of any Lenders other than the Required Revolving Lenders under the applicable Class of Revolving Commitments&#59; (ix) amend, waive or otherwise modify the Financial Covenant or any definition related thereto (solely in respect of the use of such defined terms in the Financial Covenant) or waive any Default or Event of Default resulting from a failure to perform or observe the Financial Covenant without the written consent of the Required Revolving Lenders (and in the case of multiple Revolving Commitments which are affected, such Required Revolving Lenders shall consent together as one Revolving Commitment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the amendments, waivers and other modifications described in this clause (ix) shall not require the consent of any Lenders other than the Required Revolving Lenders under the applicable Class of Revolving Commitments, (x) change any provisions of any Loan Document in a manner that by its terms adversely affects the rights in respect of payments due (including, for the avoidance of doubt, scheduled date of payment of the principal amount of any Loan (or any </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">185</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interest thereon), mandatory prepayments or postpone the scheduled date of expiration of any Commitment) to Lenders holding Loans of any Class differently than those holding Loans of any other Class without the written consent of Lenders representing a Majority in Interest of each adversely affected Class, (xi) change the definition of &#8220;Required Revolving Lenders&#8221; or any other provision hereof specifying the number or percentage of Revolving Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Revolving Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the amendments, waivers and other modifications described in this clause (xi) shall not require the consent of any Lenders other than the Revolving Lenders under the applicable Class of Revolving Commitments or (xii) subordinate the Liens on the Collateral securing the Obligations to the Liens securing any other Indebtedness or subordinate the Obligations in right of payment to any other Indebtedness, other than indebtedness or liens in respect of which such subordination is permitted under Section 9.13 of this Agreement (as in effect on the Closing Date), in each case, without the written consent of each Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender hereunder without the prior written consent of the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender, as the case may be&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this Agreement and any other Loan Document may be amended with the consent of the Administrative Agent and the Borrowers (and without the consent of any other party) to add parallel debt or other foreign law provisions that the Administrative Agent and the Borrowers determine are necessary or advisable with respect to the jurisdiction of organization or incorporation of any Loan Party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding the foregoing, this Agreement and any other Loan Document may be amended (or amended and restated) with the written consent of the Required Lenders, the Administrative Agent and the Borrowers (x) to add one or more credit facilities (in addition to the Incremental Term Loans pursuant to an Incremental Amendment and any Credit Agreement Refinancing Indebtedness pursuant to a Refinancing Amendment) to this Agreement and to permit extensions of credit from time to time outstanding thereunder and the accrued interest and fees in respect thereof to share ratably in the benefits of this Agreement and the other Loan Documents with the Revolving Loans, the Term Loans, Incremental Term Loans and the accrued interest and fees in respect thereof and (y) to include appropriately the Lenders holding such credit facilities in any determination of the Required Lenders and Lenders, and for purposes of the relevant provisions of Section 2.18(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">If, in connection with any proposed amendment, waiver or consent requiring the consent of &#8220;each Lender&#8221; or &#8220;each Lender directly affected thereby,&#8221; the consent of the Required Lenders is obtained, but the consent of other necessary Lenders is not obtained (any such Lender whose consent is necessary but not obtained being referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the Applicable Borrower may elect to (i) if no Event of Default exists, permanently prepay all of the Loans of any Class owing by it to, and terminating any Commitments of, each such Non-Consenting Lender or (ii) replace a Non-Consenting Lender as a Lender party to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, concurrently with such replacement, (i) another bank or other entity (which is reasonably satisfactory to the Applicable Borrower and the Administrative Agent) shall agree, as of such date, to purchase for cash the Loans and other Obligations due to the Non-Consenting Lender pursuant to an Assignment and Assumption and to become a Lender for all purposes under this Agreement and to assume all obligations of the Non-Consenting Lender to be terminated as of such date and to comply with the requirements of clause (b) of Section 9.04, and (ii) the Applicable Borrower shall pay to such Non-Consenting Lender in same day funds on the day of such replacement (1) all interest, fees and other amounts then accrued but unpaid to such Non-Consenting Lender by each Borrower hereunder to and including the date of termination, including without limitation payments due to such Non-Consenting Lender under Sections 2.15 and 2.17, (2) an amount, if any, equal to the payment which would have been due to such Lender on the day of such replacement under Section 2.19 had the Loans of </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">186</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such Non-Consenting Lender been prepaid on such date rather than sold to the replacement Lender and (3) any amounts owing to such Lender pursuant to Section 2.12.  A Lender shall not be required to make any such assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Applicable Borrower to require such assignment and delegation cease to apply. Each party hereto agrees that an assignment required pursuant to this clause (d) may be effected pursuant to an Assignment and Assumption executed by the Applicable Borrower, the Administrative Agent and the assignee and that the Non-Consenting Lender required to make such assignment need not be a party thereto, and each Lender hereby authorizes and directs the Administrative Agent to execute and deliver such documentation as may be required to give effect to an assignment in accordance with Section 9.04 on behalf of a Non-Consenting Lender and any such documentation so executed by the Administrative Agent shall be effective for purposes of documenting an assignment pursuant to Section 9.04.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary herein, (i) if following the date hereof, the Administrative Agent and any Loan Party shall have jointly identified an ambiguity, inconsistency, obvious error or any error or omission of a technical or immaterial nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrowers shall be permitted to amend such provision and such amendment shall become effective without any further action or consent of any other party to any Loan Documents if the same is not objected to in writing by the Required Lenders within five (5) Business Days following receipt of notice thereof (which notice shall be given at least five (5) Business Days prior to any such amendment) and (ii) guarantees, collateral security agreements, pledge agreements and related documents (if any) executed by the Loan Parties in connection with this Agreement may be in a form reasonably determined by the Administrative Agent and may be amended, supplemented and&#47;or waived with the consent of the Administrative Agent at the request of any Borrower  without the input or need to obtain the consent of any other Lenders if such amendment or waiver is delivered in order (x) to comply with local law or advice of local counsel, (y) to cure ambiguities, omissions or defects or (z) to cause such guarantees, collateral security agreements, pledge agreement or other documents to be consistent with this Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Notwithstanding anything in this Agreement or the other Loan Documents to the contrary, the Revolving Commitments, Term Loans and Revolving Credit Exposure of any Lender that is at the time a Defaulting Lender or Disqualified Lender shall not have any voting or approval rights under the Loan Documents and shall be excluded in determining whether all Lenders (or all Lenders of a Class), all affected Lenders (or all affected Lenders of a Class), a Majority in Interest of Lenders of any Class or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to this Section 9.02)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) the Commitment of any Defaulting Lender or Disqualified Lender may not be increased or extended without the consent of such Lender and (y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that affects any Defaulting Lender or Disqualified Lender more adversely than other affected Lenders shall require the consent of such Defaulting Lender or Disqualified Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Expenses&#59; Indemnity&#59; Damage Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings and the Borrowers shall pay (i) all reasonable and documented out-of-pocket expenses incurred by the Agents, the Lead Arrangers and their respective Affiliates, including the reasonable fees, charges and disbursements of counsel for the Agents, in connection with the syndication and distribution (including, without limitation, via the internet or through a service such as IntraLinks) of the credit facilities provided for herein, the preparation and administration of this Agreement and the other Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">187</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">contemplated hereby or thereby shall be consummated), (ii) all reasonable and documented out-of-pocket expenses incurred by the Issuing Banks in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all documented out-of-pocket expenses incurred by the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender, including the reasonable fees, charges and disbursements of any counsel (other than in-house counsel) for the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender, in connection with the enforcement or protection of its rights in connection with this Agreement and any other Loan Document, including its rights under this Section 9.03, or in connection with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit. Notwithstanding the foregoing, in no event shall Holdings or the Borrowers be required to reimburse the Lenders for more than one counsel to the Agents and the Lenders taken as a whole (and up to one local counsel in each applicable jurisdiction and regulatory counsel, and solely in the event of any actual or potential conflict of interest, one additional counsel in each relevant jurisdiction to each group of similarly situated affected persons taken as a whole)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that same shall be limited to (A) one counsel to the Administrative Agent, the Collateral Agent and for the Lenders (taken together as a single group or client), (B) if necessary, one local counsel required in any relevant local jurisdiction and applicable special regulatory counsel and (C) if representation of the Administrative Agent, the Collateral Agent and&#47;or all Lenders in such matter by a single counsel would be inappropriate as determined by the Administrative Agent, the Collateral Agent and&#47;or all Lenders due to the existence of an actual or potential conflict of interest, one additional counsel for the Administrative Agent, the Collateral Agent and for each Lender subject to such conflict.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Holdings and the Borrowers shall, and jointly and severally agree to, indemnify the Administrative Agent, the Collateral Agent, the Lead Arrangers and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including the reasonable fees, charges and disbursements of any counsel for any Indemnitee, incurred by or asserted against any Indemnitee arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any agreement or instrument contemplated thereby, the performance by the parties hereto of their respective obligations thereunder or the consummation of the Transactions or any other transactions contemplated hereby, (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by the Issuing Bank to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) any actual or alleged presence or release of Hazardous Materials on or from any property owned or operated by Holdings or any of its Subsidiaries, or any Environmental Liability related to Holdings or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory and regardless of whether (x) any Indemnitee is a party thereto or (y) such matter is initiated by a third party or by Holdings, any of its affiliates, equity holders, security holders or creditors&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (w) other than with respect to the Administrative Agent or the Collateral Agent, resulted from a material breach of the Loan Documents by such Indemnitee (as determined by a court of competent jurisdiction in a final and non-appealable judgment), (x) are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee or any of its Related Parties, (y) other than with respect to the Administrative Agent or the Collateral Agent, result from a claim brought by any Loan Party against any Indemnitee for a material breach of such Indemnitee&#8217;s obligations hereunder or under any other Loan Document (as determined by a court of competent jurisdiction in a final and non-appealable judgment) (it being understood and agreed that the failure by any </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">188</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender to fund any portion of its Term Loan Commitment hereunder when the conditions set forth in Section 4.01 have been satisfied and&#47;or waived in accordance with this Agreement shall be deemed a material breach, and (z) result from disputes solely among Indemnitees not involving any act or omission of any Loan Party or any of their respective Related Parties (other than a dispute against the Agents or the Lead Arrangers in their capacities as such). Without limiting or expanding the provisions of Section 2.17(c), this Section 9.03(b) shall not apply with respect to Taxes other than any Taxes that represent losses, claims, damages, etc. from a non-Tax claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">To the extent that Holdings or the Borrowers fail to pay any amount required to be paid by it to the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender under paragraph (a) or (b) of this Section 9.03, each Lender severally agrees to pay to the Administrative Agent or the Collateral Agent, as the case may be, and each Revolving Lender severally agrees to pay to the Issuing Banks or the Swingline Lender, as the case may be, such Lender&#8217;s Applicable Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount (it being understood that the Borrowers&#8217; failure to pay any such amount shall not relieve the Borrowers of any default in the payment thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender in its capacity as such.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To the extent permitted by applicable law, neither Holdings nor any Borrower shall assert, and hereby waive, any claim against any Indemnitee (i) for any damages arising from the use by others of information or other materials obtained through telecommunications, electronic or other information transmission systems (including the Internet) other than damages that are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee or any of its Related Parties, or (ii) on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">All amounts due under this Section 9.03 shall be payable not later than fifteen (15) days after written demand therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any branch or Affiliate of any Issuing Bank that issues any Letter of Credit), except that (i) neither Holdings nor any Borrower may assign or otherwise transfer any of their rights or obligations hereunder (and any attempted assignment or transfer by Holdings or any Borrower shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except to an Eligible Transferee.  Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby (including any branch or Affiliate of any Issuing Bank that issues any Letter of Credit), Participants (to the extent provided in paragraph (c) of this Section 9.04) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Banks and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">(i)&#160;&#160;&#160;&#160;Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more assignees (other than (x) Holdings and its Affiliates, except to </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">189</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the extent permitted in Section 2.23 and (y) any Person that is not an Eligible Transferee) all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans at the time owing to it) with the prior written consent of&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">Holdings (such consent not to be unreasonably withheld, delayed or conditioned)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Holdings shall be deemed to have consented to any assignment unless it shall object thereto by written notice to the Administrative Agent within ten (10) Business Days after having received written notice thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no consent of Holdings shall be required for (x) any assignment by any Agent or Lead Arranger (or any affiliate thereof) of Term Loans or related commitments pursuant to the primary syndication of such Term Loans and related commitments or (y) an assignment to a Lender, an Affiliate of a Lender, an Approved Fund or, if an Event of Default has occurred and is continuing, any other assignee&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the Administrative Agent (such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Administrative Agent shall be required for an assignment of all or any portion of a Term Loan to a Lender, an Affiliate of a Lender or an Approved Fund&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the Issuing Banks and the Swingline Lender (such consent not to be unreasonably withheld)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of any Issuing Bank or the Swingline Lender shall be required for an assignment of all or any portion of a Term Loan or any related commitment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Assignments shall be subject to the following additional conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">except in the case of an assignment to a Lender or an Affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment or Loans of any Class, the amount of the applicable Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 (in the case of Revolving Commitments and Revolving Loans) or $1,000,000 (in the case of a Term Loan) unless each of the Applicable Borrower and the Administrative Agent otherwise consent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such consent of the Applicable Borrower shall be required if an Event of Default has occurred and is continuing and this clause shall not be construed to prohibit the assignment of all the assigning Lender&#8217;s rights and obligations in respect of one Class of Commitments or Loans&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause shall not be construed to prohibit the assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations in respect of one Class of Commitments or Loans&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500, such fee to be paid by either the assigning Lender or the assignee Lender or shared between such Lenders, and which fee may be waived at the discretion of the Administrative Agent&#59;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">190</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire in which the assignee designates one or more credit contacts to whom all syndicate-level information (which may contain material non-public information about Holdings and its affiliates and their Related Parties or their respective securities) will be made available and who may receive such information in accordance with the assignee&#8217;s compliance procedures and applicable laws, including Federal and state securities laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.97pt">without the prior written consent of the Administrative Agent, no assignment shall be made to a prospective assignee that bears a relationship to the Applicable Borrower as described in Section 108(e)(4) of the Code&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt">if, at the time of any assignment, the respective assignee would be entitled to greater increased cost payments pursuant to Section 2.15 than those that apply to the respective assignor, then the respective assignee shall not be entitled to charge the Borrowers for any such increased costs which would otherwise be owed to it pursuant to Section 2.15, but in each case only to the extent in excess of those that would have applied to the respective assignor at the time of such assignment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">the U.S. Term Loans and the Lux Term Loans shall trade as a strip, and each assignment of Initial Term Loans from any Term Lender to an assignee shall consist of an equal percentage of the respective principal amounts of such Assignor&#8217;s U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of an assignor&#8217;s U.S. Term Loans that are assigned shall equal the percentage of the principal amount of such assignor&#8217;s Lux Term Loans that are assigned).</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the purposes of this Section 9.04(b), the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the following meaning&#58;</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or investing in commercial loans and similar extensions of credit in the ordinary course of its business and that is administered, advised or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) of this Section 9.04, from and after the effective date specified in each Assignment and Assumption the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.15, 2.16, 2.17 and 9.03).  Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 9.04 shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of this Section 9.04.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">191</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">The Administrative Agent, acting for this purpose as a non-fiduciary agent of the Borrowers, shall maintain at one of its offices located in the United States a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount of and interest on the Loans and LC Disbursements owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The entries in the Register shall be conclusive (absent manifest error), and the Borrowers, the Administrative Agent, the Issuing Banks and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes, notwithstanding notice to the contrary.  The Register shall be available for inspection by the Borrowers and, with respect to its interest, any Issuing Banks and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an assignee, the assignee&#8217;s completed Administrative Questionnaire (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) of this Section 9.04 and any written consent to such assignment required by paragraph (b) of this Section 9.04, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register&#59; provided that if either the assigning Lender or the assignee shall have failed to make any payment required to be made by it pursuant to Section 2.07(b), 2.18(d) or 9.03(c), the Administrative Agent shall have no obligation to accept such Assignment and Assumption and record the information therein in the Register unless and until such payment shall have been made in full, together with all accrued interest thereon.  No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">(i)&#160;&#160;&#160;&#160;Any Lender may, without the consent of the Applicable Borrower, the Administrative Agent, the Issuing Banks or the Swingline Lender, sell participations to one or more banks or other entities (excluding (x) Holdings, the Borrowers and their respective Affiliates and (y) any Person that is not an Eligible Transferee) (a &#8220;Participant&#8221;) in all or a portion of such Lender&#8217;s rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it)&#59; provided that (A) such Lender&#8217;s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (C) Holdings, the Borrowers and any Additional Borrower, the Administrative Agent, the Issuing Banks and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement and (D) without the prior written consent of the Administrative Agent, no participation shall be sold to a prospective participant that bears a relationship to the Applicable Borrower described in Section 108(e)(4) of the Code.  Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; provided that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver described in the first proviso to Section 9.02(b) that affects such Participant.  Subject to paragraph (c)(ii) of this Section 9.04, the Borrowers agree that each Participant shall be entitled to the benefits of Sections 2.15, 2.16 and 2.17 (subject to the requirements and limitations therein including the requirements under Section 2.17(e) and (h), it being understood that the documentation required under Section 2.17(e) shall be delivered to the participating Lender (except in the case of an Irish Treaty Lender, where the documentation shall be delivered to the Administrative Agent and the Applicable Borrower or Additional Borrower) and the documentation required under Section 2.17(h) and the documentation required for the purposes of satisfying the procedural formalities referred to in paragraph (4) of the definition of &#8220;Irish Qualifying Lender&#8221; (if required) shall be delivered to the Administrative Agent and the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">192</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">applicable Borrower or Additional Borrower)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section 9.04.  To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 9.08 as though it were a Lender&#59; provided such Participant agrees to be subject to Section 2.18(c) as though it were a Lender.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">A Participant shall not be entitled to receive any greater payment under Section 2.15 or 2.17 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrowers&#8217; prior written consent (not to be unreasonably withheld or delayed).  Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the applicable Borrower and Additional Borrowers, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Loans or other obligations under the Loan Documents (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant's interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) or Proposed Section 1.163-5(b) of the United States Treasury Regulations (or, in each case, any amended or successor version) and&#47;or Irish law to the extent necessary to claim exemption from applicable Irish tax.  The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including without limitation any pledge or assignment to secure obligations to a Federal Reserve Bank or any other central bank, and this Section 9.04 shall not apply to any such pledge or assignment of a security interest&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such pledge or assignment of a security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In the case of any assignment or transfer by a Lender to a new Lender, or any participation by such Lender in favor of a Participant, of all or any part of such Lender&#8217;s rights and obligations under this Agreement or any of the other Loan Documents, such Lender and the new Lender or Participant (as applicable) hereby agree that, for the purposes of Article 1278 and&#47;or Article 1281 of the Luxembourg Civil Code (to the extent applicable), any assignment, amendment and&#47;or transfer of any kind permitted under, and made in accordance with the provisions of, this Agreement or any agreement referred to herein to which a Luxembourg Loan Party is a party (including any Collateral Document), any security created or guarantee given under or in connection with this Agreement or any other Loan Document shall be preserved and shall continue in full force and effect for the benefit of such new Lender or Participant (as applicable).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Notwithstanding the foregoing, no assignment may be made or participation sold to a Disqualified Lender without the prior written consent of Holdings&#59; provided that upon inquiry by any Lender to the Administrative Agent as to whether a specified potential assignee or prospective participant is on the list of Disqualified Lenders, the </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">193</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent shall be permitted to disclose to such Lender whether such specified potential assignee or prospective participant is on the list of Disqualified Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that inclusion on the list of Disqualified Lenders shall not apply retroactively to disqualify any persons that have previously acquired an assignment or participation in the Loan if such person was not included on the list of Disqualified Lenders at the time of such assignment or participation.  Notwithstanding anything contained in this Agreement or any other Loan Document to the contrary, if any Lender was a Disqualified Lender at the time of the assignment of any Loans or Commitments to such Lender, following written notice from the Applicable Borrower to such Lender and the Administrative Agent and otherwise in accordance with Section 2.19(b), as applicable&#58; (1) such Lender shall promptly assign all Loans and Commitments held by such Lender to an Approved Fund&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) the Administrative Agent shall not have any obligation to the Borrowers, such Lender or any other Person to find such a replacement Lender, (B) the Borrowers shall not have any obligation to such Disqualified Lender or any other Person to find such a replacement Lender or accept or consent to any such assignment to itself or any other Person subject to the Borrowers&#8217; consent in accordance with Section 9.04(b) and (C) the assignment of such Loans and&#47;or Commitments, as the case may be, shall be at par plus accrued and unpaid interest and fees&#59; (2) such Lender shall not have any voting or approval rights under the Loan Documents and shall be excluded in determining whether all Lenders (or all Lenders of any Class), all affected Lenders (or all affected Lenders of any Class), a Majority in Interest of Lenders of any Class or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to Section 9.02)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) the Commitment of any Disqualified Lender may not be increased or extended without the consent of such Lender and (y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that affects any Disqualified Lender adversely and in a manner that is disproportionate to other affected Lenders shall require the consent of such Disqualified Lender&#59; and (3) no Disqualified Lender is entitled to receive information provided solely to Lenders by the Administrative Agent or any Lender or will be permitted to attend or participate in meetings attended solely by the Lenders and the Administrative Agent, other than the right to receive notices of Borrowings, notices of prepayments and other administrative notices in respect of its Loans or Commitments required to be delivered to Lenders pursuant to Article II.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Notwithstanding anything in this Agreement to the contrary, any Lender may assign all or a portion of its rights and obligations with respect to the Term Loans or the Term Loan Commitments, under this Agreement to Holdings, a Borrower or any Subsidiaries through open market purchases on a pro-rata or non-pro rata basis, in each case subject to the following limitations&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">(x) if the assignee is Holdings or a Subsidiary, upon such assignment, the applicable assignee will automatically be deemed to have contributed or transferred the principal amount of such Term Loans, plus all accrued and unpaid interest thereon, to a Borrower or (y) if the assignee is a Borrower, (including through the contribution or other transfers set forth in clause (x)), the principal amount of such Term Loans, along with all accrued and unpaid interest thereon, so contributed, assigned or transferred to such Borrower (with the consent of such Borrower) in exchange for debt or equity securities will be deemed automatically cancelled and extinguished upon such assignment, contribution or transfer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">no Event of Default shall be continuing or shall result therefrom immediately prior to or after such assignment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">the U.S. Term Loans and the Lux Term Loans shall trade as a strip, and each assignment of Initial Term Loans from any Term Lender to an assignee shall consist of an equal percentage of the respective principal amounts of such </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">194</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Assignor&#8217;s U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of an assignor&#8217;s U.S. Term Loans that are assigned shall equal the percentage of the principal amount of such assignor&#8217;s Lux Term Loans that are assigned)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">no assignment of any Term Loans or Term Loan Commitments shall be made from the proceeds of any Revolving Loan or Swingline Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All covenants, agreements, representations and warranties made by the Loan Parties in the Loan Documents and in the certificates or other instruments delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of the Loan Documents and the making of any Loans and issuance of any Letters of Credit, regardless of any investigation made by any such other party or on its behalf and notwithstanding that the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under this Agreement or any other Loan Document is outstanding and unpaid (except for Unliquidated Obligations) or any Letter of Credit is outstanding (unless such Letter of Credit has been Cash Collateralized) and so long as the Commitments have not expired or terminated.  The provisions of Sections 2.15, 2.16, 2.17 and 9.03 and Article VIII shall survive and remain in full force and effect regardless of the resignation or replacement of the Administrative Agent or the Collateral Agent or any assignment of rights by, or the replacement of, a Lender, the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or the termination of this Agreement or any other Loan Document or any provision hereof or thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Counterparts&#59; Integration&#59; Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract.  This Agreement, the other Loan Documents and any separate letter agreements with respect to fees payable to the Agents constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.  This Agreement shall become effective upon the delivery by the Agents, the Lenders, Holdings, the Borrowers and each Subsidiary Guarantor of executed counterparts of the signature page to this Agreement. For the avoidance of doubt, upon the effectiveness of this Agreement, the Commitments shall become enforceable by the Borrowers.  Delivery of an executed counterpart of a signature page of this Agreement by facsimile or by email as a &#8220;.pdf&#8221; or &#8220;.tif&#8221; attachment shall be effective as delivery of a manually executed counterpart of this Agreement.  The words &#8220;execution,&#8221; &#8220;signed&#8221;, &#8220;signature&#8221; and words of like import herein shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on the electronic platform DocuSign, digital copies of a signatory&#8217;s manual signature and deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature to the extent and as provided in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any provision of any Loan Document held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions thereof&#59; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">195</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Right of Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final and in whatever currency denominated) at any time held and other obligations at any time owing by such Lender or Affiliate to or for the credit or the account of any Borrower or any Guarantor against any of and all of the Secured Obligations held by such Lender, irrespective of whether or not such Lender shall have made any demand under the Loan Documents and although such obligations may be unmatured&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any recovery by any Lender or any Affiliate pursuant to its setoff rights under this Section 9.08 is subject to the provisions of Section 2.18(c).  The rights of each Lender under this Section 9.08 are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Consent to Service of Process&#59; Foreign Process Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">This Agreement and each other Loan Document (except, as to any other Loan Document, as expressly set forth therein) shall be construed in accordance with and governed by the law of the State of New York&#59; provided, however, that (i) the interpretation of the definition of &#8220;Company Material Adverse Effect&#8221; and whether there shall have occurred a &#8220;Company Material Adverse Effect&#8221;, (ii) whether the Acquisition has been consummated in accordance with the terms and conditions of the Acquisition Agreement, and (iii) whether the representations and warranties made by Target and its Subsidiaries in the Acquisition Agreement are true and correct and whether as a result of any failure thereof Holdings (or its applicable Subsidiaries) has the right to terminate its obligations under the Acquisition Agreement (or the right not to consummate the Acquisition pursuant to the Acquisition Agreement) shall be determined in accordance with the laws of the State of Delaware without regards to conflicts of laws principles that would result in the application of the laws of another jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each of Holdings, each Borrower and each Subsidiary Guarantor hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to any Loan Document, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court.  Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.  Nothing in this Agreement or any other Loan Document shall affect any right that the Administrative Agent, any Issuing Bank or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document against any Loan Party or its properties in the courts of any competent jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each of Holdings, each Borrower and each Subsidiary Guarantor hereby irrevocably and unconditionally waives, to the fullest extent they may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Loan Document in any court referred to in paragraph (b) of this Section 9.09.  Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 9.01.  Nothing in this Agreement or any other Loan </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">196</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Holdings and each Subsidiary Guarantor hereby irrevocably and unconditionally appoints the U.S. Borrower and its successors hereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Process Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as its agent to receive on behalf of Holdings and each Subsidiary Guarantor and their respective property all writs, claims, process and summonses in any action or proceeding brought against it in the State of New York.  Such service may be made by mailing or delivering a copy of such process to Holdings and each Subsidiary Guarantor in care of the Process Agent at the address specified above for the Process Agent, and Holdings and each Subsidiary Guarantor irrevocably authorizes and directs the Process Agent to accept such service on its behalf.  Failure by the Process Agent to give notice to Holdings and each Subsidiary Guarantor or failure of Holdings and each Subsidiary Guarantor to receive notice of such service of process shall not impair or affect the validity of such service on the Process Agent, Holdings and each Subsidiary Guarantor, or of any judgment based thereon.  Holdings and each Subsidiary Guarantor covenants and agrees that it shall take any and all reasonable action, including the execution and filing of any and all documents that may be necessary to continue the delegation of the Process Agent above in full force and effect, and to cause the Process Agent to act as such.  Holdings and each Subsidiary Guarantor hereto further covenants and agrees to maintain at all times an agent with offices in New York City to act as its Process Agent.  Nothing herein shall in any way be deemed to limit the ability to serve any such writs, process or summonses in any other manner permitted by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the Administrative Agent, the Collateral Agent, the Swingline Lender, the Issuing Banks and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and its and their respective directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent required or requested by any regulatory authority purporting to have jurisdiction over such Person or its Related Parties (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party to this Agreement, (e) in connection with the exercise of any remedies under this Agreement or any other Loan Document or any suit, action or proceeding relating to this </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">197</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section 9.12, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or prospective counterparty (or its Related Parties) to any swap, derivative or other transaction relating to Holdings or its Restricted Subsidiaries and their obligations, (g) on a confidential basis to (i) any rating agency in connection with rating Holdings or its Subsidiaries or the facilities evidenced by this Agreement or (ii) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers with respect to the facilities evidenced by this Agreement, (h) with the prior written consent of Holdings, (i) to the extent such Information (i) becomes publicly available other than as a result of a breach of this Section 9.12 by the disclosing party or its Affiliates, (ii) is independently developed by the Agents or (iii) becomes available to the Administrative Agent, any Issuing Bank or any Lender on a nonconfidential basis from a source other than Holdings or any Borrower, (j) in consultation with the Lead Arrangers, to any prospective additional Agent and to such additional Agent&#8217;s respective officers, directors, employees, attorneys, accountants and advisors, in each case on a confidential basis or (k) for purposes of establishing a &#8220;due diligence&#8221; defense.  For the purposes of this Section 9.12, &#8220;Information&#8221; means all information received from Holdings or any Borrower relating to Holdings or any Borrower or their respective businesses, other than any such information that is available to the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender on a nonconfidential basis prior to disclosure by Holdings or any Borrower.  Any Person required to maintain the confidentiality of Information as provided in this Section 9.12 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Release of Liens and Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">A Subsidiary Guarantor (that is not a Borrower) shall automatically be released from its obligations under the Loan Documents upon the consummation of any transaction permitted by this Agreement as a result of which such Subsidiary Guarantor ceases to be a Restricted Subsidiary or ceases to be organized in a Covered Jurisdiction.  In addition, a Subsidiary Guarantor (that is not a Borrower) shall be released from its obligations under the Loan Documents upon the request of Holdings in connection with a transaction not prohibited under this Agreement, as a result of which such Subsidiary Guarantor becomes an Excluded Subsidiary.  Notwithstanding the foregoing, no Subsidiary Guarantor (nor the security interest granted by such Subsidiary Guarantor) will be released solely as a result of such Subsidiary Guarantor ceasing to be a wholly-owned Subsidiary unless such Subsidiary ceased to be a wholly-owned Subsidiary as a result of a transaction that was entered into for a bona fide business purpose (as determined in good faith by Holdings) and, for the avoidance of doubt, not for the primary purpose of causing such release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Upon the termination of all the Commitments and payment and satisfaction in full in cash of all Secured Obligations (other than Unliquidated Obligations for which no claim has been made and Secured Obligations with respect to Cash Management Agreements and Swap Agreements), the security interests in the Collateral created by the Collateral Documents shall be automatically released.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Upon (i) any Disposition (other than any lease or license) by any Loan Party (other than to another Loan Party, except where, in any jurisdiction outside of the United States, in order to effect such Disposition the Lien on such assets is required to be released (provided that in the case of such Disposition to another Loan Party outside of the United States, such other Loan Party shall concurrently (or on such later date as may be agreed by the Administrative Agent) grant a security interest on the released Collateral)) of any Collateral in a </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">198</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">transaction permitted under this Agreement, (ii) any Disposition in connection with any exercise of remedies of the Administrative Agent, the Collateral Agent and the Lenders pursuant to Article VII, (iii) any Disposition by any Loan Party of any Securitization Assets in connection with a Qualified Securitization Financing or a Qualified Receivables Factoring, (iv) the effectiveness of any written consent to the release of the security interest created under any Collateral Document in any Collateral pursuant to Section 9.02, (v) a Guarantor ceasing to be a Guarantor in accordance with the terms of this Agreement, with respect to the Collateral held by such Guarantor or (vi) any Collateral becoming Excluded Assets, the security interests in such Collateral created by the Collateral Documents shall be automatically released.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In addition, upon the request of any holder (or prospective holder) of obligations secured by such Lien or, in the case of a license or sub-license, the applicable licensee or sub-licensee (or prospective licensee or sub-licensee), the Collateral Agent shall, at the reasonable request of any Borrower, (A) subordinate any Lien on any Collateral to the holder of any Liens on such Collateral permitted under clauses (4), (5), (7) (insofar as such Liens are replacements or substitutes for Liens permitted by clause (4) or (5)), (9), (10), (11), (21), (22) and (25) of the definition of &#8220;Permitted Liens,&#8221; and (B) enter into subordination, non-disturbance and similar agreements in connection with the licensing of intellectual property and other general intangibles permitted under this Agreement to the extent reasonably requested by a licensee or sub-licensee thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In connection with any termination, release or subordination, or in connection with any Indebtedness incurred pursuant to Section 6.01(b)(xvi)(ii) or in connection with any licensing or sub-licensing transactions permitted pursuant to Sections 6.02 and 6.03, the entry into non-disturbance or similar agreement, in each case, pursuant to this Section 9.13, the Collateral Agent shall execute and deliver to any Loan Party, at such Loan Party&#8217;s expense, all documents that such Loan Party shall reasonably request to evidence such termination, release or subordination, or reasonably required in order to reflect such non-disturbance or similar agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (i) the Collateral Agent shall have received a certificate of a Responsible Officer of Holdings certifying that any such transaction has been consummated in compliance with this Agreement and the other Loan Documents and that such termination, release or subordination is permitted hereby, and (ii) any such release shall not in any manner discharge, affect or impair the Secured Obligations or any Liens upon (or obligations of Holdings or any Subsidiary in respect of) all interests retained by Holdings or any Subsidiary, including (without limitation) the proceeds of the sale, all of which shall continue to constitute part of the Collateral.  Any execution and delivery of documents pursuant to this Section 9.13 shall be without representation, recourse to or warranty by the Collateral Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">USA PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender that is subject to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) hereby notifies each Loan Party that pursuant to the requirements of the USA Patriot Act, it is required to obtain, verify and record information that identifies such Loan Party, which information includes the name and address of such Loan Party and other information that will allow such Lender to identify such Loan Party in accordance with the USA Patriot Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Appointment for Perfection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender hereby appoints the Collateral Agent and each other Lender as its agent for the purpose of perfecting Liens, for the benefit of the Administrative Agent, the Collateral Agent and the Secured Parties, in assets which, in accordance with Article 9 of the UCC or any other applicable law can be perfected by possession.  Should any Lender (other than the Collateral Agent) obtain possession of any such Collateral, such Lender shall notify the Collateral Agent thereof, and, promptly upon the Administrative Agent&#8217;s request therefor shall deliver such Collateral to the Collateral Agent or otherwise deal with such Collateral in accordance with the Collateral Agent&#8217;s instructions.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">199</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">No Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of Holdings and Borrower, on behalf of itself and its Subsidiaries, agrees that, in connection with all aspects of the transactions contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document) and any communications in connection therewith&#58; (i) (A) the arranging and other services regarding this Agreement provided by the Lenders are arm&#8217;s-length commercial transactions between Holdings and its Affiliates, on the one hand, and the Lenders and their Affiliates, on the other hand, (B) it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) it is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents&#59; (ii) (A) each of the Lenders and their Affiliates is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for Holdings, any Borrower or any of their respective Affiliates, or any other Person and (B) no Lender or any of its Affiliates has any obligation to Holdings, any Borrower or any of their respective Affiliates with respect to the transactions contemplated hereby except, in the case of a Lender, those obligations expressly set forth herein and in the other Loan Documents&#59; and (iii) each of the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of Holdings and its Affiliates, and no Lender or any of its Affiliates has any obligation to disclose any of such interests to Holdings, the Borrowers or their respective Affiliates.  To the fullest extent permitted by law, Holdings and the Borrowers hereby waive and release any claims that they may have against each of the Lenders and their Affiliates with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Interest Rate Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained in any Loan Document, the interest paid or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  If the Administrative Agent or any Lender shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the Borrowers.  In determining whether the interest contracted for, charged, or received by the Administrative Agent or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">200</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Certain ERISA Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Lead Arranger and their respective Affiliates and not, for the avoidance of doubt, to or for the benefit of any Borrower or any other Loan Party, that at least one of the following is and will be true&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of Section 3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Commitments or this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.58pt">the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.53pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">201</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In addition, unless either (1) clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Lead Arranger or any of their respective Affiliates and not, for the avoidance of doubt, to or for the benefit of any Borrower or any other Loan Party, that none of the Administrative Agent, any Lead Arranger or any of their respective Affiliates is a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Acknowledgement Regarding Any Supported QFCs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Permitted Hedging Obligations or any other agreement or instrument that is a QFC (such support, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC Credit Support</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, and each such QFC, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Supported QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and&#47;or of the United States or any other state of the United States)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In the event a Covered Entity that is party to a Supported QFC (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">As used in this Section 9.20, the following terms have the following meanings&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">BHC Act Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of a party means an &#8220;affiliate&#8221; (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the following&#58;  (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">202</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has the meaning assigned to the term &#8220;qualified financial contract&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Article X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:30.8pt"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Guaranty</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">The Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Guarantors hereby, jointly and severally, guarantee to each Secured Party as hereinafter provided, as primary obligor and not merely as surety, the payment and performance of the Secured Obligations in full in cash when due (whether at stated maturity, as a mandatory prepayment,  by acceleration, as a mandatory cash collateralization or otherwise) strictly in accordance with the terms hereof and thereof.  Each Guarantor hereby further jointly and severally agrees that if any of the Secured Obligations are not paid in full in cash when due (whether at stated maturity, as a mandatory prepayment, by acceleration, as a mandatory cash collateralization or otherwise), each Guarantor will promptly pay the same, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Secured Obligations, the same will be promptly paid in full in cash when due (whether at extended maturity, as a mandatory prepayment, by acceleration, as a mandatory cash collateralization or otherwise) in accordance with the terms of such extension or renewal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Each Guarantor, and by its acceptance of this Guaranty, the Administrative Agent and each other Secured Party, hereby confirms that it is the intention of all such Persons that this Guaranty and the Obligations of each Guarantor hereunder not constitute a fraudulent transfer or conveyance for purposes of any Debtor Relief Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar foreign, federal or state law to the extent applicable to this Guaranty and the Obligations of each Guarantor hereunder.  To effectuate the foregoing intention, the Administrative Agent, the other Secured Parties and the Guarantors hereby irrevocably agree that the Obligations of each Guarantor under this Guaranty at any time shall be limited to the maximum amount as will result in the Obligations of such Guarantor under this Guaranty not constituting a fraudulent transfer or conveyance under applicable law after giving full effect to such Guarantor&#8217;s contribution rights but before taking into account any liabilities of such Guarantor under any other guarantee of such Guarantor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Obligations Unconditional</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligations of the Guarantors under Section 10.01 are absolute and unconditional, irrespective of the value, genuineness, validity, regularity or enforceability of any of the Loan Documents or other documents relating to the Secured Obligations, or any substitution, release, impairment or exchange of any other guarantee of or security for any of the Secured Obligations, and, to the fullest extent permitted by applicable law, irrespective of any other circumstance whatsoever which might otherwise constitute a legal or equitable discharge or defense of a surety or guarantor (other than payment in full in cash of the Secured Obligations, other than Unliquidated Obligations for which no claim has been made), it being the intent of this Section 10.02 that the obligations of the Guarantors hereunder shall be absolute and unconditional under any and all circumstances.  Each Guarantor agrees that it shall have no right of subrogation, indemnity, reimbursement or contribution against any other Guarantor for amounts paid under this Article X until such time as the Secured Obligations (other than Unliquidated Obligations for which no claim has been made) have been indefeasibly paid in </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">203</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">full in cash and the Commitments have expired or terminated. Without limiting the generality of the foregoing, it is agreed that, to the fullest extent permitted by law, the occurrence of any one or more of the following shall not alter or impair the liability of any Guarantor hereunder, which shall remain absolute and unconditional as described above&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">at any time or from time to time, without notice to any Guarantor, the time for any performance of or compliance with any of the Secured Obligations shall be extended, or such performance or compliance shall be waived&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the maturity of any of the Secured Obligations shall be accelerated, or any of the Secured Obligations shall be modified, supplemented or amended in any respect, or any right under any of the Loan Documents or other documents relating to the Secured Obligations shall be waived  or any other guarantee of any of the Secured Obligations or any security therefor shall be released, impaired or exchanged in whole or in part or otherwise dealt with&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any Lien granted to, or in favor of, the Administrative Agent, the Collateral Agent or any other holder of the Secured Obligations as security for any of the Secured Obligations shall fail to attach or be perfected&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any of the Secured Obligations shall be determined to be void or voidable (including, without limitation, for the benefit of any creditor of any Guarantor) or shall be subordinated to the claims of any Person (including, without limitation, any creditor of Guarantor)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">any failure or omission to assert or enforce or agreement or election not to assert or enforce, delay in enforcement, or the stay or enjoining, by order of court, by operation of law or otherwise, of the exercise or enforcement of, any claim or demand or any right, power or remedy (whether arising under any Loan Document, any Swap Agreement or any Cash Management Agreement, at law, in equity or otherwise) with respect to the Secured Obligations or any agreement relating thereto, or with respect to any other guaranty of or security for the payment of the Secured Obligations&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">any exercise of remedies with respect to any security for the Secured Obligations (including, without limitation, any collateral, including the Collateral, securing or purporting to secure any of the Secured Obligations) at such time and in such order and in such manner as the Collateral Agent and the Secured Parties may decide and whether or not every aspect thereof is commercially reasonable and whether or not such action constitutes an election of remedies and even if such action operates to impair or extinguish any right of reimbursement or subrogation or other right or remedy that any Guarantor would otherwise have, and without limiting the generality of the foregoing or any other provisions hereof, each Guarantor hereby expressly waives any and all benefits which might otherwise be available to such Guarantor under applicable law, including without limitation, California Civil Code Sections 2809, 2810, 2819, 2939, 2845, 2848, 2849, 2850, 2855, 2899 and 3433&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">any other circumstance whatsoever which may or might in any manner or to any extent vary the risk of any Guarantor as an obligor in respect of the Secured Obligations or which constitutes, or might be construed to constitute, an equitable or legal discharge of any Borrower or any other Guarantor for the Secured Obligations, or of such Guarantor under the guarantee contained in this Article X or of any security interest granted by any Guarantor, whether in an Insolvency or Liquidation Proceeding or in any other instance&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">with respect to its obligations hereunder, each Guarantor hereby expressly waives diligence, presentment, demand of payment, protest and all notices whatsoever, </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">204</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and any requirement that the Administrative Agent, the Collateral Agent or any other holder of the Secured Obligations exhaust any right, power or remedy or proceed against any Person under any of the Loan Documents or other documents relating to the Secured Obligations, or against any other Person under any other guarantee of, or security for, any of the Secured Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Reinstatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligations of each Guarantor under this Article X shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of any Person in respect of the Secured Obligations is rescinded or must be otherwise restored by any holder of any of the Secured Obligations, whether as a result of any proceedings under any Debtor Relief Law, and each Guarantor agrees that it will jointly and severally indemnify the Administrative Agent and each holder of the Secured Obligations on demand for all reasonable costs and expenses (including, without limitation, the fees, charges and disbursements of counsel) incurred by the Administrative Agent or such holder of the Secured Obligations in connection with such rescission or restoration, including any such costs and expenses incurred in defending against any claim alleging that such payment constituted a preference, fraudulent transfer or similar payment under any proceedings under any debtor relief law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Certain Additional Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Guarantor further agrees that it shall have no right of recourse to security for the Secured Obligations, except through the exercise of rights of subrogation pursuant to Section 10.02 and through the exercise of rights of contribution pursuant to Section 10.06.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Guarantor agrees that, to the fullest extent permitted by law, as between the Guarantors, on the one hand, and the Administrative Agent, the Collateral Agent and the other holders of the Secured Obligations, on the other hand, the Secured Obligations may be declared to be forthwith due and payable as provided in Article VII (and shall be deemed to have become automatically due and payable in the circumstances provided in said Article VII) for purposes of Section 10.01 notwithstanding any stay, injunction or other prohibition preventing such declaration (or preventing the Secured Obligations from becoming automatically due and payable) as against any other Person and that, in the event of such declaration (or the Secured Obligations being deemed to have become automatically due and payable), the Secured Obligations (whether or not due and payable by any other Person) shall forthwith become due and payable by each Guarantor for purposes of Section 10.01.  Each Guarantor acknowledges and agrees that its respective obligations hereunder are secured in accordance with the terms of the Collateral Documents and that the holders of the Secured Obligations may exercise their remedies thereunder in accordance with the terms thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Rights of Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Guarantor agrees that, in connection with payments made hereunder, each Guarantor shall have contribution rights against the other Guarantors as permitted under applicable law.  Such contribution rights shall be subordinate and subject in right of payment to the obligations of such Guarantors under the Loan Documents and no Guarantor shall exercise such rights of contribution until all Secured Obligations (other than Unliquidated Obligations for which no claim has been made) have been indefeasibly paid in full in cash and the Commitments have terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Guaranty of Payment&#59; Continuing Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The guarantee given by each Guarantor in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is a guaranty of payment and not of collection, is a continuing guarantee, and shall apply to all Secured Obligations whenever arising.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Guarantee Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The guarantee given by each Guarantor incorporated in Ireland does not apply to any liability to the extent that it would result in this guarantee constituting unlawful financial assistance within the meaning of Section 82. Notwithstanding anything to the contrary contained in this Agreement or in any other Loan </font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">205</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Documents, the guarantee obligations of each Guarantor established in Luxembourg or having its &#8220;centre of main interests&#8221; (as this term is used in Article 3(1) of the Insolvency Regulation) in Luxembourg (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Luxembourg Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in respect of the obligations of Holdings or any of its Subsidiaries which is not a direct or indirect subsidiary of such relevant Luxembourg Guarantor shall be limited at any time to an aggregate amount not exceeding 95% of the greater of&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Luxembourg Guarantor's own funds (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">capitaux propres</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), as referred to in Annex I to the grand-ducal regulation dated 18 December 2015 defining the form and content of the presentation of the balance sheet and profit and loss account, and enforcing the Luxembourg Law dated 19 December 2002 concerning the trade and companies register and the accounting and annual accounts of undertakings (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as increased by the amount of any debts owed to the Luxembourg Guarantor by a company of the same group of the Luxembourg Guarantor, as shown in (x) the latest interim financial statements available (if any), at the date of demand of payment under this Agreement or, if not available, (y) the latest annual financial statements (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">comptes annuels</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) available at the date of demand of payment under this Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the Luxembourg Guarantor&#8217;s own funds (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">capitaux propres</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), as referred to in the Regulation, as increased by the amount of any debts owed to the Luxembourg Guarantor by a company of the same group of the Luxembourg Guarantor, at the date of entry into this Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The limitation set forth under items (a) and (b) above shall not apply to any amounts borrowed under this Agreement and made available, in any form whatsoever, to the Luxembourg Guarantor or any of its direct or indirect subsidiaries.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Should the financial information referred to in clause (a) and (b) above not be available on the date of this Agreement or on the date the guarantee is called, as the case may be, such financial information will be determined by Administrative Agent or any other person designated by Administrative Agent, acting reasonably, in accordance with the Luxembourg accounting principles applicable to the Luxembourg Guarantor and at the cost of the Luxembourg Guarantor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Keepwell.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Each Qualified ECP Guarantor hereby jointly and severally absolutely, unconditionally and irrevocably undertakes to provide such funds or other support as may be needed from time to time by each other Loan Party to honor all of its obligations under the Guarantees in respect of Swap Obligations (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that each Qualified ECP Guarantor shall only be liable under this Section 10.09 for the maximum amount of such liability that can be hereby incurred without rendering its obligations under this Section 10.09, or otherwise under the Guarantees, as it relates to such Loan Party, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations of each Qualified ECP Guarantor under this Section 10.09 shall remain in full force and effect until a discharge of Secured Obligations.  Each Qualified ECP Guarantor intends that this Section 10.09 constitute, and this Section 10.09 shall be deemed to constitute, a &#8220;keepwell, support, or other agreement&#8221; for the benefit of each other Loan Party for all purposes of Section 1a(18)(A)(v)(II) of the Commodity Exchange Act. </font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">****</font></div><div style="height:93.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">206</font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_227"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Form of&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BORROWING REQUEST</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;   &#93;, 20&#91;   &#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To&#58;&#160;&#160;&#160;&#160;Citibank, N.A. as Administrative Agent</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;One Penns Way</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;OPS 2&#47;2</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;New Castle, DE 19720</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Attn&#58; Agency Operations</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Phone&#58; (302) 894-6010</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fax&#58; (646) 274-5080</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">AgencyABTFSupport&#64;citi.com</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Reference is hereby made to the Credit Agreement, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), among ICON LUXEMBOURG, S.&#192; R.L., a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">R.C.S. Luxembourg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) under number B66588 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), ICON CLINICAL INVESTMENTS, LLC, a Delaware limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lux U.S. Subsidiary Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), INDIGO MERGER SUB, INC., a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and, prior to the consummation of the Acquisition, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by PRA Health Sciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Target</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and, following the consummation of the Acquisition, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), ICON PUBLIC LIMITED COMPANY, an Irish public limited company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Revolving Borrowers, each Additional Borrower, the Subsidiary Guarantors party thereto, the LENDERS from time to time party thereto, CITIBANK, N.A., as Administrative Agent and CITIBANK, N.A., LONDON BRANCH, as Collateral Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Applicable Borrower hereby requests&#58;</font></div><div style="margin-bottom:3pt;padding-left:28.6pt;padding-right:2.75pt;text-indent:-25.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;A Borrowing of Loans&#93;&#91;A conversion of Loans&#93;&#91;A </font></div><div style="padding-right:2.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">continuation of Loans&#93;</font></div><div style="padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:28.6pt;padding-right:2.75pt;text-indent:-25.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to be made on the terms set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:28.6pt;padding-right:2.75pt;text-indent:-25.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A) Aggregate amount of the requested Borrowing&#58; _____________________________</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;To be delivered to the Administrative Agent (a) in the case of a USD Term SOFR Borrowing, by telephonic notice not later than 11&#58;00 a.m., New York City time, three (3) Business Days before the date of the proposed Borrowing, (b) in the case of a Eurocurrency Borrowing or an RFR Borrowing, by telephonic notice not later than 11&#58;00 a.m., New York City time, four (4) Business Days before the date of the proposed Borrowing or (c) in the case of an ABR Borrowing, by telephonic notice not later than 11&#58;00 a.m., New York City time, one (1) Business Day before the date of the proposed Borrowing, except as expressly permitted by Section&#160;2.03 of the Credit Agreement.</font></div><div style="height:87.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I-1</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;US-DOCS&#92;137541226.2&#124;&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:50.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:28.6pt;padding-right:2.75pt;text-indent:-25.85pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:28.6pt;padding-right:2.75pt;text-indent:-25.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B) Date of such Borrowing&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:28.6pt;padding-right:2.75pt;text-indent:-25.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C) Class of such Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:27.95pt;padding-right:2.75pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D) Type of such Borrowing</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">&#91;ABR Borrowing&#93;&#91;Eurocurrency Borrowing&#93;&#91;USD Term SOFR Borrowing&#93;&#91;RFR Borrowing&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:27.95pt;padding-right:2.75pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E) Agreed Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:27.95pt;padding-right:24.35pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(F) Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:27.95pt;padding-right:24.35pt;text-indent:-25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(G) Applicable Borrower</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________________</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(H) Wire instructions for the Applicable Borrower account(s) and amount of requested Borrowing to be allocated to each Applicable Borrower&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________________</font></div></td></tr></table></div><div style="margin-bottom:24pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Remainder of Page Intentionally Blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;Shall be a Business Day.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;If no election as to the Type of Borrowing is specified, then, in the case of a Borrowing denominated in Dollars, the requested Borrowing shall be an ABR Borrowing.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;In the case of a Eurocurrency Borrowing or an RFR Borrowing.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;In the case of a Eurocurrency Borrowing, USD Term SOFR Borrowing or an RFR Borrowing. If no Interest Period is specified with respect to any requested Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing, then the Applicable Borrower shall be deemed to have selected an Interest Period of one month&#8217;s duration.</font></div><div style="height:87.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> I-2</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;US-DOCS&#92;137541226.2&#124;&#124;</font></div></div></div><div id="i457a885eee4c4f5db49ec84d1cfaaaa6_230"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;margin-top:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;APPLICABLE BORROWER&#93;</font></div><div style="margin-top:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;Title&#58;   </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:87.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I-3</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#124;US-DOCS&#92;137541226.2&#124;&#124;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>exhibit121-2022.htm
<DESCRIPTION>EX-12.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ica7718253ea84177be3838c97777981c_1"></div><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 12.1</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:179.45pt;padding-right:179.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification of Chief Financial Officer</font></div><div style="margin-top:0.45pt;padding-left:193.95pt;padding-right:193.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:121%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:390.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I, Brendan Brennan, certify that&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:196.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.65pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.55pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.7pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">c)      Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">d)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Dated&#58; February&#160;24, 2023</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:8.15pt;padding-right:425.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">&#47;s&#47; Brendan Brennan      </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:160%">Brendan Brennan Chief Financial Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ica7718253ea84177be3838c97777981c_4"></div><hr style="page-break-after:always"><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:177.95pt;padding-right:177.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification of Chief Executive Officer</font></div><div style="margin-top:0.45pt;padding-left:193.95pt;padding-right:193.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:121%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:411.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I, Steve Cutler, certify that&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:196.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.65pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.55pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.7pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">c)      Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">d)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Dated&#58; February&#160;24, 2023</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:8.15pt;padding-right:452.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steve Cutler              </font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:465pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:423.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>exhibit122-2022.htm
<DESCRIPTION>EX-12.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifca4ec02ad4848a2b8ec247dc063b927_1"></div><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 12.2</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:157.05pt;padding-right:157.05pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-top:0.45pt;padding-left:108.52pt;padding-right:108.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Brendan Brennan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58; February&#160;24, 2023</font></div><div style="margin-top:0.2pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:8.15pt;padding-right:425.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:180%;text-decoration:underline">&#47;s&#47; Brendan Brennan     </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:180%">Brendan Brennan Chief Financial Officer</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:12.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifca4ec02ad4848a2b8ec247dc063b927_4"></div><hr style="page-break-after:always"><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:157.05pt;padding-right:157.05pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-top:0.45pt;padding-left:108.52pt;padding-right:108.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Steve Cutler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:40.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="padding-left:5.5pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58; February&#160;24, 2023</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:8.15pt;padding-right:452.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steve Cutler               </font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:465pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:423.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:111%">Chief Executive Officer</font></div><div style="margin-top:0.75pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>exhibit231-2022.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i287336c196cf4ca9b55c4cf3b6bf4d9b_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:63pt"><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 23.1</font></div><div style="margin-bottom:0.1pt;padding-right:5.45pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">The Board of Directors</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">ICON plc</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">We consent to the incorporation by reference in the registration statements (No. 333-231527, 333-204153, 333-190068, 333-152802, 333-257578 and 333-254891) each on Form S-8 of ICON plc of our reports dated February&#160;24, 2023, with respect to the consolidated balance sheets of ICON plc as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and comprehensive income, and cash flows for each of the years in the three-year period ended December&#160;31, 2022, and the related notes and the effectiveness of internal control over financial reporting as of December&#160;31, 2022, which reports appear in the December&#160;31, 2022 Annual Report on Form 20&#8209;F ICON plc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;text-decoration:underline">&#47;s&#47; KPMG             </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Dublin, Ireland</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February&#160;24, 2023</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>iclr-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7508de12-69a9-4818-9ec7-00b38a2cb3e7,g:60b4642b-da77-4b86-962d-2e89e6dd7ade-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iclr="http://www.iconplc.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.iconplc.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.iconplc.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.iconplc.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Descriptionofbusiness" roleURI="http://www.iconplc.com/role/Descriptionofbusiness">
        <link:definition>0000009 - Disclosure - Description of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpolicies" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenue" roleURI="http://www.iconplc.com/role/DisaggregationofRevenue">
        <link:definition>0000011 - Disclosure - Disaggregation of Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalances" roleURI="http://www.iconplc.com/role/ContractBalances">
        <link:definition>0000012 - Disclosure - Contract Balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLosses" roleURI="http://www.iconplc.com/role/AllowancesforCreditLosses">
        <link:definition>0000013 - Disclosure - Allowances for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.iconplc.com/role/BusinessCombinations">
        <link:definition>0000014 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.iconplc.com/role/FairValue">
        <link:definition>0000015 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.iconplc.com/role/Investments">
        <link:definition>0000016 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnet" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet">
        <link:definition>0000017 - Disclosure - Property, Plant and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.iconplc.com/role/Goodwill">
        <link:definition>0000018 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.iconplc.com/role/IntangibleAssets">
        <link:definition>0000019 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilities" roleURI="http://www.iconplc.com/role/OtherLiabilities">
        <link:definition>0000020 - Disclosure - Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentBankCreditLinesandLoanFacilities" roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities">
        <link:definition>0000021 - Disclosure - Non-current Bank Credit Lines and Loan Facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.iconplc.com/role/Derivatives">
        <link:definition>0000022 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.iconplc.com/role/OperatingLeases">
        <link:definition>0000023 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Noncurrentotherliabilities" roleURI="http://www.iconplc.com/role/Noncurrentotherliabilities">
        <link:definition>0000024 - Disclosure - Non-current other liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.iconplc.com/role/CommitmentsandContingencies">
        <link:definition>0000025 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapital" roleURI="http://www.iconplc.com/role/ShareCapital">
        <link:definition>0000026 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.iconplc.com/role/RestructuringCharges">
        <link:definition>0000027 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.iconplc.com/role/IncomeTaxes">
        <link:definition>0000028 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://www.iconplc.com/role/EmployeeBenefits">
        <link:definition>0000029 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationCharges" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges">
        <link:definition>0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformation" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation">
        <link:definition>0000031 - Disclosure - Business Segment and Geographical Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShare" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare">
        <link:definition>0000032 - Disclosure - Net Income Per Ordinary Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>0000033 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformation" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation">
        <link:definition>0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://www.iconplc.com/role/RelatedParties">
        <link:definition>0000035 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.iconplc.com/role/SubsequentEvents">
        <link:definition>0000036 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesPolicies" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies">
        <link:definition>0000037 - Disclosure - Summary of Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesTables" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables">
        <link:definition>0000038 - Disclosure - Summary of Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueTables" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables">
        <link:definition>0000039 - Disclosure - Disaggregation of Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesTables" roleURI="http://www.iconplc.com/role/ContractBalancesTables">
        <link:definition>0000040 - Disclosure - Contract Balances (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLossesTables" roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesTables">
        <link:definition>0000041 - Disclosure - Allowances for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.iconplc.com/role/BusinessCombinationsTables">
        <link:definition>0000042 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.iconplc.com/role/FairValueTables">
        <link:definition>0000043 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.iconplc.com/role/InvestmentsTables">
        <link:definition>0000044 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetTables" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables">
        <link:definition>0000045 - Disclosure - Property, Plant and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.iconplc.com/role/GoodwillTables">
        <link:definition>0000046 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.iconplc.com/role/IntangibleAssetsTables">
        <link:definition>0000047 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesTables" roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables">
        <link:definition>0000048 - Disclosure - Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentBankCreditLinesandLoanFacilitiesTables" roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables">
        <link:definition>0000049 - Disclosure - Non-current Bank Credit Lines and Loan Facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.iconplc.com/role/DerivativesTables">
        <link:definition>0000050 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.iconplc.com/role/OperatingLeasesTables">
        <link:definition>0000051 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentotherliabilitiesTables" roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables">
        <link:definition>0000052 - Disclosure - Non-current other liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesTables" roleURI="http://www.iconplc.com/role/RestructuringchargesTables">
        <link:definition>0000053 - Disclosure - Restructuring charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.iconplc.com/role/IncomeTaxesTables">
        <link:definition>0000054 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://www.iconplc.com/role/EmployeeBenefitsTables">
        <link:definition>0000055 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesTables" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables">
        <link:definition>0000056 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationTables" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables">
        <link:definition>0000057 - Disclosure - Business Segment and Geographical Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareTables" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables">
        <link:definition>0000058 - Disclosure - Net Income Per Ordinary Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>0000059 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationTables" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables">
        <link:definition>0000060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofbusinessDetails" roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails">
        <link:definition>0000061 - Disclosure - Description of business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails">
        <link:definition>0000062 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails">
        <link:definition>0000063 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails">
        <link:definition>0000064 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesNarrativeDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails">
        <link:definition>0000065 - Disclosure - Summary of Significant accounting policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueDetails" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails">
        <link:definition>0000066 - Disclosure - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesDetails" roleURI="http://www.iconplc.com/role/ContractBalancesDetails">
        <link:definition>0000067 - Disclosure - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesNarrativeDetails" roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails">
        <link:definition>0000068 - Disclosure - Contract Balances - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractBalancesNarrativeDetails_1" roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1">
        <link:definition>0000068 - Disclosure - Contract Balances - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLossesDetails" roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesDetails">
        <link:definition>0000069 - Disclosure - Allowances for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativePRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails">
        <link:definition>0000070 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails">
        <link:definition>0000071 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails">
        <link:definition>0000072 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails">
        <link:definition>0000073 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails">
        <link:definition>0000074 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueNarrativeDetails" roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails">
        <link:definition>0000075 - Disclosure - Fair value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails">
        <link:definition>0000076 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails">
        <link:definition>0000077 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsEquityMethodInvestmentsDetails" roleURI="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails">
        <link:definition>0000078 - Disclosure - Investments - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetDetails" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails">
        <link:definition>0000079 - Disclosure - Property, Plant and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofGoodwillDetails" roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails">
        <link:definition>0000080 - Disclosure - Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.iconplc.com/role/GoodwillNarrativeDetails">
        <link:definition>0000081 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsSummaryofIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails">
        <link:definition>0000082 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>0000083 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails">
        <link:definition>0000084 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesDetails" roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails">
        <link:definition>0000085 - Disclosure - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails">
        <link:definition>0000086 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails">
        <link:definition>0000087 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails">
        <link:definition>0000088 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails">
        <link:definition>0000089 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesNarrativeDetails" roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails">
        <link:definition>0000090 - Disclosure - Derivatives - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails">
        <link:definition>0000091 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesLeaseCostsDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails">
        <link:definition>0000092 - Disclosure - Operating Leases - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesNarrativeDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails">
        <link:definition>0000093 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails">
        <link:definition>0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1">
        <link:definition>0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentotherliabilitiesDetails" roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails">
        <link:definition>0000095 - Disclosure - Non-current other liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>0000096 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapitalDetails" roleURI="http://www.iconplc.com/role/ShareCapitalDetails">
        <link:definition>0000097 - Disclosure - Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesNarrativeDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails">
        <link:definition>0000098 - Disclosure - Restructuring charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesSummaryofRestructuringChargesDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails">
        <link:definition>0000099 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesRestructuringProvisionDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails">
        <link:definition>0000100 - Disclosure - Restructuring charges - Restructuring Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails">
        <link:definition>0000101 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
        <link:definition>0000102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails">
        <link:definition>0000103 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>0000104 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000105 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesExpectedExpiryDatesofNOLsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails">
        <link:definition>0000106 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails">
        <link:definition>0000107 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNarrativeDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails">
        <link:definition>0000108 - Disclosure - Employee Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails">
        <link:definition>0000109 - Disclosure - Employee Benefits - Summary of plan assets and liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsFundedStatusDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails">
        <link:definition>0000110 - Disclosure - Employee Benefits - Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangeinBenefitObligationsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails">
        <link:definition>0000111 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsChangeinPlanAssetsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails">
        <link:definition>0000112 - Disclosure - Employee Benefits - Change in Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>0000113 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails">
        <link:definition>0000114 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails">
        <link:definition>0000115 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails">
        <link:definition>0000116 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails">
        <link:definition>0000117 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAnnualBenefitPaymentsDetails" roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails">
        <link:definition>0000118 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails">
        <link:definition>0000119 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails">
        <link:definition>0000120 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails">
        <link:definition>0000121 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails">
        <link:definition>0000122 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails">
        <link:definition>0000123 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails">
        <link:definition>0000124 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationNarrativeDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails">
        <link:definition>0000125 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails">
        <link:definition>0000126 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails">
        <link:definition>0000127 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails">
        <link:definition>0000128 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails">
        <link:definition>0000129 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails">
        <link:definition>0000130 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000131 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationDetails" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails">
        <link:definition>0000132 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartiesDetails" roleURI="http://www.iconplc.com/role/RelatedPartiesDetails">
        <link:definition>0000133 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iclr_DeferredTaxAssetContractWithCustomerLiability" abstract="false" name="DeferredTaxAssetContractWithCustomerLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_ResearchandDevelopmentCreditsPolicyTextBlock" abstract="false" name="ResearchandDevelopmentCreditsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_CapitalGovernmentGrantsCurrent" abstract="false" name="CapitalGovernmentGrantsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" abstract="false" name="StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_TaxYear2029To2038Member" abstract="true" name="TaxYear2029To2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AptivSolutionsMember" abstract="true" name="AptivSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_TopClientMember" abstract="true" name="TopClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OncacareMember" abstract="true" name="OncacareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_InterestRateCapAndInterestRateSwapMember" abstract="true" name="InterestRateCapAndInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" abstract="true" name="ICONDevelopmentSolutionsLimitedPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" abstract="false" name="AdjustmentToRetainedEarningShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentDomain" abstract="true" name="VariableRateComponentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" abstract="false" name="OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" abstract="false" name="LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" abstract="false" name="DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OptionPlans2008Member" abstract="true" name="OptionPlans2008Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" abstract="false" name="DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanSchemeContributions" abstract="false" name="DefinedBenefitPlanSchemeContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestOfEuropeMember" abstract="true" name="RestOfEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_Clients25Member" abstract="true" name="Clients25Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_NonexecutiveDirectorMember" abstract="true" name="NonexecutiveDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="AdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInEquityMethodInvestments" abstract="false" name="IncreaseDecreaseInEquityMethodInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" abstract="false" name="IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_LeaseLiabilityMember" abstract="true" name="LeaseLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iclr_AfimmuneLimitedMember" abstract="true" name="AfimmuneLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_StockOptionAndAwardPlansMember" abstract="true" name="StockOptionAndAwardPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_PRASwitzerlandAGPensionPlanMember" abstract="true" name="PRASwitzerlandAGPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_EquityMethodInvestmentMajorityOwnershipPercentage" abstract="false" name="EquityMethodInvestmentMajorityOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" abstract="false" name="IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_SeniorSecuredRevolvingLoanFacilityMember" abstract="true" name="SeniorSecuredRevolvingLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" abstract="false" name="DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Clients610Member" abstract="true" name="Clients610Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_TransactionAndOneTimeFinancingCosts" abstract="false" name="TransactionAndOneTimeFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ExpectedRetirementPeriod" abstract="false" name="ExpectedRetirementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" abstract="false" name="RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" abstract="false" name="AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" abstract="false" name="OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapital" abstract="false" name="OtherUndenominatedCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" abstract="false" name="DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_InterestReceivableRelatedPartyLoans" abstract="false" name="InterestReceivableRelatedPartyLoans" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_GovernmentBondsMember" abstract="true" name="GovernmentBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LongTermDebtMaturityYearFiveAndThereafter" abstract="false" name="LongTermDebtMaturityYearFiveAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range1Member" abstract="true" name="Range1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ForeignCurrencyDisclosureTableTextBlock" abstract="false" name="ForeignCurrencyDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ComputerEquipmentAndCapitalizedSoftwareMember" abstract="true" name="ComputerEquipmentAndCapitalizedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OperatingLossCarryforwardsUSFederal" abstract="false" name="OperatingLossCarryforwardsUSFederal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" abstract="false" name="ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" abstract="false" name="DerivativeVariableInterestRateReferenceRateInExcessOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_PerformanceShareUnitMember" abstract="true" name="PerformanceShareUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_TaxYear2022To2028Member" abstract="true" name="TaxYear2022To2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesMember" abstract="true" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RestructuringReserveandOtherLiabilitiesCurrent" abstract="false" name="RestructuringReserveandOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ContractsReceivableNet" abstract="false" name="ContractsReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TransactionAndIntegrationExpenseMember" abstract="true" name="TransactionAndIntegrationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeBeforeIncomeTaxTableTextBlock" abstract="false" name="IncomeBeforeIncomeTaxTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_OtherGeographicLocationsMember" abstract="true" name="OtherGeographicLocationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_A2021RestructuringPlanMember" abstract="true" name="A2021RestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_MeDiNovaResearchMember" abstract="true" name="MeDiNovaResearchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DiversifiedBondsMember" abstract="true" name="DiversifiedBondsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_GovernmentGrantsPolicyTextBlock" abstract="false" name="GovernmentGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" abstract="false" name="BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iclr_AwardDateAllYearsExcluding2018Member" abstract="true" name="AwardDateAllYearsExcluding2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapitalMember" abstract="true" name="OtherUndenominatedCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" abstract="false" name="BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" abstract="false" name="ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VariableRateComponentAxis" abstract="true" name="VariableRateComponentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfNonCashStockCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_IncomeTaxBenefitMember" abstract="true" name="IncomeTaxBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsTableTextBlock" abstract="false" name="AllowanceForDoubtfulAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_VehiclesGross" abstract="false" name="VehiclesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_GainLossOnIssuanceOfDebt" abstract="false" name="GainLossOnIssuanceOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_CorvusPharmaceuticalsMember" abstract="true" name="CorvusPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" abstract="false" name="EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" abstract="false" name="OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PRAHealthSciencesIncMember" abstract="true" name="PRAHealthSciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_A2013LegacyPRAPlanMember" abstract="true" name="A2013LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" abstract="false" name="ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_VariableRateComponentTwoMember" abstract="true" name="VariableRateComponentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AptivSolutionsPensionPlanMember" abstract="true" name="AptivSolutionsPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_Clients1125Member" abstract="true" name="Clients1125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" abstract="false" name="BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_Range4Member" abstract="true" name="Range4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RestOfEuropeAndOtherCountriesMember" abstract="true" name="RestOfEuropeAndOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" abstract="false" name="ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_LongTermDebtExcludingCurrentMaturitiesGross" abstract="false" name="LongTermDebtExcludingCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" abstract="false" name="AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_NumberOfVotes" abstract="false" name="NumberOfVotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_InterestExpenseCreditOther" abstract="false" name="InterestExpenseCreditOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_LongTermDebtCurrentMaturitiesGross" abstract="false" name="LongTermDebtCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OperatingIncomeByGeographyTableTextBlock" abstract="false" name="OperatingIncomeByGeographyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_BusinessCombinationIntegrationRelatedCostsCredits" abstract="false" name="BusinessCombinationIntegrationRelatedCostsCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AccountsReceivableCreditLossExpense" abstract="false" name="AccountsReceivableCreditLossExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherRetirementPlansMember" abstract="true" name="OtherRetirementPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_Range2Member" abstract="true" name="Range2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" abstract="true" name="SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PerformanceBasedGrantsMember" abstract="true" name="PerformanceBasedGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ConsultantsStockPlan2008PlanMember" abstract="true" name="ConsultantsStockPlan2008PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_CommitmentToAcquireLongTermInvestments" abstract="false" name="CommitmentToAcquireLongTermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsTextBlock" abstract="false" name="AllowanceForDoubtfulAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_TaxYear20332041Member" abstract="true" name="TaxYear20332041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_The2020LegacyPRAPlanMember" abstract="true" name="The2020LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" abstract="false" name="AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxYear2023To2036Member" abstract="true" name="TaxYear2023To2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_AcquiredEntityMember" abstract="true" name="AcquiredEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_StockRepurchaseProgramAuthorizedPercentage" abstract="false" name="StockRepurchaseProgramAuthorizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="iclr_AccountsReceivableCreditLossReversal" abstract="false" name="AccountsReceivableCreditLossReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_BuybackProgramMember" abstract="true" name="BuybackProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RestrictedStockUnitsTwentyThirteenMember" abstract="true" name="RestrictedStockUnitsTwentyThirteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_VariableRateComponentOneMember" abstract="true" name="VariableRateComponentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesTable" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" abstract="false" name="DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PaymentsForShareRepurchaseCosts" abstract="false" name="PaymentsForShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_The2018LegacyPRAPlanMember" abstract="true" name="The2018LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_OtherCustomersMember" abstract="true" name="OtherCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" abstract="true" name="ConsultantsRestrictedStockUnitsTwentyNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_NumberOfLocations" abstract="false" name="NumberOfLocations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_Range3Member" abstract="true" name="Range3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_ContractsReceivableGross" abstract="false" name="ContractsReceivableGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestructuringReserveUtilizations" abstract="false" name="RestructuringReserveUtilizations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_EquityMethodInvestmentDecreaseInLoanReceivable" abstract="false" name="EquityMethodInvestmentDecreaseInLoanReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_SeniorSecuredRevolvingCreditFacilityMember" abstract="true" name="SeniorSecuredRevolvingCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_EmployeeStockPlanTwentyZeroEightPlanMember" abstract="true" name="EmployeeStockPlanTwentyZeroEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DSBiopharmaLimitedMember" abstract="true" name="DSBiopharmaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>iclr-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7508de12-69a9-4818-9ec7-00b38a2cb3e7,g:60b4642b-da77-4b86-962d-2e89e6dd7ade-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_097d93a0-b6cd-4e3d-87cf-b994640ae8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_LiabilitiesCurrent_097d93a0-b6cd-4e3d-87cf-b994640ae8d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_1100669c-8572-4ae6-a619-28110f0e22f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_LongTermLineOfCredit_1100669c-8572-4ae6-a619-28110f0e22f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8f2a92c1-00a5-4b0d-a24f-95dee3f85d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8f2a92c1-00a5-4b0d-a24f-95dee3f85d55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_858e37f3-add6-4b83-b805-668cfa94b414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_858e37f3-add6-4b83-b805-668cfa94b414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ab81c4d6-0865-4fdd-9cd4-b8e43869cafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_ab81c4d6-0865-4fdd-9cd4-b8e43869cafc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fd00727c-3dcc-4288-ab26-8346dbb83fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fd00727c-3dcc-4288-ab26-8346dbb83fca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_188cbcf8-8a93-4f62-989c-e161de2f429d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e8d24034-221c-44f4-99ee-80a1200bbaab" xlink:to="loc_us-gaap_CommitmentsAndContingencies_188cbcf8-8a93-4f62-989c-e161de2f429d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_57994fe4-8b68-48a9-abb5-b6964a229b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d0f46224-3c8e-45a5-933b-716543b5db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_57994fe4-8b68-48a9-abb5-b6964a229b9a" xlink:to="loc_us-gaap_Liabilities_d0f46224-3c8e-45a5-933b-716543b5db6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7fc9b487-c183-48be-a394-11ffd1f4a32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_57994fe4-8b68-48a9-abb5-b6964a229b9a" xlink:to="loc_us-gaap_StockholdersEquity_7fc9b487-c183-48be-a394-11ffd1f4a32d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_12717296-2d60-4e3a-954b-c0c9b33e2ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_12717296-2d60-4e3a-954b-c0c9b33e2ba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3309b18e-902b-4bcf-8a38-6aaf528cc4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3309b18e-902b-4bcf-8a38-6aaf528cc4e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4ee43b77-9079-44d8-af1c-7046d1f0a64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4ee43b77-9079-44d8-af1c-7046d1f0a64e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_23626689-0236-4be7-bd19-648fe05a83ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_23626689-0236-4be7-bd19-648fe05a83ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_d3533d16-24c6-442c-ab02-9b27fd669323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_d3533d16-24c6-442c-ab02-9b27fd669323" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc1b9cf1-b3ef-4a67-9129-e2bfa641e0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc1b9cf1-b3ef-4a67-9129-e2bfa641e0cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f32e22c4-23de-4c14-af2b-fa14918ac4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_10b3d1b4-5664-490b-9e7a-eeb889e161e6" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f32e22c4-23de-4c14-af2b-fa14918ac4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_03e3a5d5-dede-4ea0-8160-aecfc4754b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_393df3d6-28d6-456b-a4e7-8f8f4ef4bdf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_03e3a5d5-dede-4ea0-8160-aecfc4754b66" xlink:to="loc_us-gaap_CommonStockValue_393df3d6-28d6-456b-a4e7-8f8f4ef4bdf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9c066504-4b1c-4a36-988f-199fc0bd044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_03e3a5d5-dede-4ea0-8160-aecfc4754b66" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9c066504-4b1c-4a36-988f-199fc0bd044b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_955f8f5e-08d1-4f7b-8964-b4595c948902" xlink:href="iclr-20221231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_03e3a5d5-dede-4ea0-8160-aecfc4754b66" xlink:to="loc_iclr_OtherUndenominatedCapital_955f8f5e-08d1-4f7b-8964-b4595c948902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_000358c7-0827-43ae-b607-41ebaaf1f57b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_03e3a5d5-dede-4ea0-8160-aecfc4754b66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_000358c7-0827-43ae-b607-41ebaaf1f57b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3048b985-c3ce-4a44-988c-f5d08cbdde35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_03e3a5d5-dede-4ea0-8160-aecfc4754b66" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3048b985-c3ce-4a44-988c-f5d08cbdde35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_699f9025-be8d-4ade-afd9-17fe7369b809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_049c00a1-6865-4df8-ba4e-9b4cabd5d225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_699f9025-be8d-4ade-afd9-17fe7369b809" xlink:to="loc_us-gaap_AccountsPayableCurrent_049c00a1-6865-4df8-ba4e-9b4cabd5d225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7585dcb6-1fcc-47cd-b6c3-efbb17632f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_699f9025-be8d-4ade-afd9-17fe7369b809" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7585dcb6-1fcc-47cd-b6c3-efbb17632f2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_39f468fe-3d66-4bf7-a271-4b0110e275f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_699f9025-be8d-4ade-afd9-17fe7369b809" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_39f468fe-3d66-4bf7-a271-4b0110e275f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_44b46ee3-2844-40f6-aeef-5932e7a2cf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_699f9025-be8d-4ade-afd9-17fe7369b809" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_44b46ee3-2844-40f6-aeef-5932e7a2cf0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_d7ee55eb-a449-4ee8-b1c6-ef131b51fcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_699f9025-be8d-4ade-afd9-17fe7369b809" xlink:to="loc_us-gaap_LinesOfCreditCurrent_d7ee55eb-a449-4ee8-b1c6-ef131b51fcc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_75092829-af08-4319-855c-3de42266fb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_75092829-af08-4319-855c-3de42266fb33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_68a4da82-6d3e-4f0a-a555-7eac50a232ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_68a4da82-6d3e-4f0a-a555-7eac50a232ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2d68cec1-ea28-4bf1-a123-2fefd3c378cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_EquityMethodInvestments_2d68cec1-ea28-4bf1-a123-2fefd3c378cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_58b9d85a-22de-44ee-b5bd-ac427f2f7b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_58b9d85a-22de-44ee-b5bd-ac427f2f7b5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3cae0b59-6d00-4e02-8bf4-2b153e537ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3cae0b59-6d00-4e02-8bf4-2b153e537ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3c11d87c-5864-4f4e-b108-3213558d0741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3c11d87c-5864-4f4e-b108-3213558d0741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_c1349dc4-1182-41bb-8278-a7dbbcc628bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_OtherLongTermInvestments_c1349dc4-1182-41bb-8278-a7dbbcc628bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8be25e12-e7a5-4ddc-b34e-807a23b1ceb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_AssetsCurrent_8be25e12-e7a5-4ddc-b34e-807a23b1ceb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_85bf915f-5bc8-447d-9610-05f99cd54b28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_85bf915f-5bc8-447d-9610-05f99cd54b28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_660ed57d-6f4e-41d0-b2e6-44f061c94eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_bd4de073-b2b2-4d49-ad2b-90c83eccc556" xlink:to="loc_us-gaap_Goodwill_660ed57d-6f4e-41d0-b2e6-44f061c94eb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1dfa3dc2-c775-435d-92b6-db86b27fb7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_7a95c0c0-d6b6-47aa-99bf-be40109aa458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1dfa3dc2-c775-435d-92b6-db86b27fb7bc" xlink:to="loc_us-gaap_RestructuringCosts_7a95c0c0-d6b6-47aa-99bf-be40109aa458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_257a505b-6e46-4a04-9a0e-4ec492423be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1dfa3dc2-c775-435d-92b6-db86b27fb7bc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_257a505b-6e46-4a04-9a0e-4ec492423be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_696a954f-ceac-4081-8a38-8eee23e004d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1dfa3dc2-c775-435d-92b6-db86b27fb7bc" xlink:to="loc_us-gaap_DepreciationAndAmortization_696a954f-ceac-4081-8a38-8eee23e004d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c2b04b97-e34d-4a0b-bf00-a76c6e832737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1dfa3dc2-c775-435d-92b6-db86b27fb7bc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c2b04b97-e34d-4a0b-bf00-a76c6e832737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationIntegrationRelatedCostsCredits_b71f745d-1610-4d9e-9635-7638bb7656e0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationIntegrationRelatedCostsCredits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_1dfa3dc2-c775-435d-92b6-db86b27fb7bc" xlink:to="loc_iclr_BusinessCombinationIntegrationRelatedCostsCredits_b71f745d-1610-4d9e-9635-7638bb7656e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_0794440c-e189-4143-8f89-b2a7670d05a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7cf2298c-dd71-493b-b6b8-eabf19598454" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_0794440c-e189-4143-8f89-b2a7670d05a6" xlink:to="loc_us-gaap_OperatingIncomeLoss_7cf2298c-dd71-493b-b6b8-eabf19598454" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_7d89baf3-9291-4440-bcda-9889d532d408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_0794440c-e189-4143-8f89-b2a7670d05a6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_7d89baf3-9291-4440-bcda-9889d532d408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0a1fa901-73d7-47a5-b312-3f05fd5de3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_0794440c-e189-4143-8f89-b2a7670d05a6" xlink:to="loc_us-gaap_InterestExpense_0a1fa901-73d7-47a5-b312-3f05fd5de3e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7eab4a44-1cdb-4754-8a2e-9f922677e4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9231bb65-692e-49a4-92bb-6bee6e45ed66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7eab4a44-1cdb-4754-8a2e-9f922677e4c9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9231bb65-692e-49a4-92bb-6bee6e45ed66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_c6012934-8aac-44f6-8b35-809c4f120234" xlink:href="iclr-20221231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7eab4a44-1cdb-4754-8a2e-9f922677e4c9" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_c6012934-8aac-44f6-8b35-809c4f120234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_897e6b5c-747d-4e88-9850-40a478c80834" xlink:href="iclr-20221231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_56fb6ff4-bae9-499e-9f18-f41d049c713c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_897e6b5c-747d-4e88-9850-40a478c80834" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_56fb6ff4-bae9-499e-9f18-f41d049c713c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_db4d1522-af47-4e6d-89fa-ceff1c7907bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_897e6b5c-747d-4e88-9850-40a478c80834" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_db4d1522-af47-4e6d-89fa-ceff1c7907bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6bb69de1-25df-4d65-bd44-7b6ee723411f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e1d9795e-f861-44b5-b97d-72df36ccded9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6bb69de1-25df-4d65-bd44-7b6ee723411f" xlink:to="loc_us-gaap_ProfitLoss_e1d9795e-f861-44b5-b97d-72df36ccded9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_d41848fc-1371-4839-a1a0-468d5838c212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6bb69de1-25df-4d65-bd44-7b6ee723411f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_d41848fc-1371-4839-a1a0-468d5838c212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c78aeea5-6fd5-4fdb-bff6-a7e25cb69c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f9b4b497-c236-463a-9812-4bc9611c0511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c78aeea5-6fd5-4fdb-bff6-a7e25cb69c8f" xlink:to="loc_us-gaap_CostsAndExpenses_f9b4b497-c236-463a-9812-4bc9611c0511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a898c01-51d6-4ef0-ba0e-fda9eacb7114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c78aeea5-6fd5-4fdb-bff6-a7e25cb69c8f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8a898c01-51d6-4ef0-ba0e-fda9eacb7114" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_93771995-cec6-456b-bc95-0638d02fe419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_93771995-cec6-456b-bc95-0638d02fe419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_649e84d5-d2cb-4a0e-91b2-0b87e40e5d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_649e84d5-d2cb-4a0e-91b2-0b87e40e5d6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65bafd62-9158-43af-ab5a-4151f2201f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:to="loc_us-gaap_ProfitLoss_65bafd62-9158-43af-ab5a-4151f2201f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f160c42-d53d-4135-9b4f-96cff9c16982" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f160c42-d53d-4135-9b4f-96cff9c16982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f0d2a825-d185-45d3-aae5-ad69a9bd96cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f0d2a825-d185-45d3-aae5-ad69a9bd96cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_039ea4d1-02ca-4a9e-9d5a-2557b02b287a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_64165c64-ef70-460e-b16c-b6d5004c9beb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_039ea4d1-02ca-4a9e-9d5a-2557b02b287a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cdc2a33-270c-4c05-8d0b-7943548cf3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9f597a00-a3a5-4cde-ad6a-8276543424d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cdc2a33-270c-4c05-8d0b-7943548cf3da" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9f597a00-a3a5-4cde-ad6a-8276543424d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_72de756c-e841-4f8a-972a-0e01bb8cddc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cdc2a33-270c-4c05-8d0b-7943548cf3da" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_72de756c-e841-4f8a-972a-0e01bb8cddc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3d84d52f-a8f5-4df3-bc98-f2fd212e565b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3d84d52f-a8f5-4df3-bc98-f2fd212e565b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_280a656a-dabf-46f0-85f1-0a488e7bf2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_280a656a-dabf-46f0-85f1-0a488e7bf2db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_34ad090f-bc73-4530-8183-b10e8b645c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_34ad090f-bc73-4530-8183-b10e8b645c82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_a362f2dd-aee0-4472-a4f0-29ae02b3a485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_a362f2dd-aee0-4472-a4f0-29ae02b3a485" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_166b014a-6c57-4ae9-92fa-5db55fc0611d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_166b014a-6c57-4ae9-92fa-5db55fc0611d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2050ab31-41fd-4f70-b05d-7b2eb271f512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2050ab31-41fd-4f70-b05d-7b2eb271f512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_573d546d-a15b-4acc-a87c-2dc1d3a100a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_573d546d-a15b-4acc-a87c-2dc1d3a100a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts_a9be5909-50c7-4e3e-bfeb-dbc195e4bf9c" xlink:href="iclr-20221231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_iclr_PaymentsForShareRepurchaseCosts_a9be5909-50c7-4e3e-bfeb-dbc195e4bf9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_42ae81d6-4685-487d-bc41-f28b15127368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5fefd094-3716-4a6a-96b8-9b9363c6cb70" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_42ae81d6-4685-487d-bc41-f28b15127368" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_592d7255-0461-445f-ba92-157556bfccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1aafe8f3-273b-4baf-a7c4-ad6c0ae74c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_592d7255-0461-445f-ba92-157556bfccc3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1aafe8f3-273b-4baf-a7c4-ad6c0ae74c79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_52e6009c-397f-4f96-af0e-92a0f94cb791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_592d7255-0461-445f-ba92-157556bfccc3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_52e6009c-397f-4f96-af0e-92a0f94cb791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6052c1ab-e97e-4284-aae7-4ed71d9fd93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_592d7255-0461-445f-ba92-157556bfccc3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6052c1ab-e97e-4284-aae7-4ed71d9fd93d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_826735af-405d-4ce9-9e61-430a0733ffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_592d7255-0461-445f-ba92-157556bfccc3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_826735af-405d-4ce9-9e61-430a0733ffe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_6a00de2f-96ab-4f55-97fb-f4e8e534e506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_6a00de2f-96ab-4f55-97fb-f4e8e534e506" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7cf8f883-dcab-4446-b94e-9899c1f203de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7cf8f883-dcab-4446-b94e-9899c1f203de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e12ed61d-624b-4fd4-8549-4b53d6f3c732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_e12ed61d-624b-4fd4-8549-4b53d6f3c732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e37cea62-fa4d-4ea0-b0db-df103dab11d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e37cea62-fa4d-4ea0-b0db-df103dab11d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_218c3f17-f9b8-4bc8-86d6-807ff2d24bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_218c3f17-f9b8-4bc8-86d6-807ff2d24bdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2d79e1af-b0f9-4bd1-96aa-84b7624dc4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_ProfitLoss_2d79e1af-b0f9-4bd1-96aa-84b7624dc4e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f65d242b-4ccd-4d80-9476-46a390242ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_ShareBasedCompensation_f65d242b-4ccd-4d80-9476-46a390242ff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_527310f2-623b-4d35-aced-5e1e30d14ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_527310f2-623b-4d35-aced-5e1e30d14ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a4a4ade7-9d36-4b85-9147-c2fad7767ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a4a4ade7-9d36-4b85-9147-c2fad7767ef7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2fc9a764-0b0a-4911-bf8c-2f9a75706bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_2fc9a764-0b0a-4911-bf8c-2f9a75706bfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0d57c7bc-bad8-4dc3-8237-6747223cebbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0d57c7bc-bad8-4dc3-8237-6747223cebbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_230dc0b2-1543-4d27-a60d-83a605b7cbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_230dc0b2-1543-4d27-a60d-83a605b7cbb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ef3a94a8-008a-4730-9d90-23a568a2dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ef3a94a8-008a-4730-9d90-23a568a2dce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_c9e82ef0-f632-4863-8aa5-ed1c2448c775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_c9e82ef0-f632-4863-8aa5-ed1c2448c775" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b9db17e5-e40f-47cf-96ff-057429a41abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b9db17e5-e40f-47cf-96ff-057429a41abd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GainLossOnIssuanceOfDebt_6b30eb40-7157-4f6c-90ae-0d7f6c0948e1" xlink:href="iclr-20221231.xsd#iclr_GainLossOnIssuanceOfDebt"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e90a0bf-9b98-49da-aa81-19234ca47d9d" xlink:to="loc_iclr_GainLossOnIssuanceOfDebt_6b30eb40-7157-4f6c-90ae-0d7f6c0948e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_f76d5f4c-0538-4e24-9bc3-5f3927aa309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_f76d5f4c-0538-4e24-9bc3-5f3927aa309e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_42ac2501-ba28-4a55-9893-5654c47b95f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_42ac2501-ba28-4a55-9893-5654c47b95f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_4af4b673-f9f3-406a-a225-6fcd87016cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_4af4b673-f9f3-406a-a225-6fcd87016cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fb1c89b9-aef9-43c6-bdf1-7ddcd4ff6df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fb1c89b9-aef9-43c6-bdf1-7ddcd4ff6df7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c9cdd805-e4c2-4c99-8932-21f976d9bc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c9cdd805-e4c2-4c99-8932-21f976d9bc6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_5b78c559-3ba8-4046-982a-0a76cca87b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_5b78c559-3ba8-4046-982a-0a76cca87b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_579b7171-4973-4307-9b0b-4d5841706d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_579b7171-4973-4307-9b0b-4d5841706d83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_ae06208f-29c4-4211-b05d-40049c0683e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7ae6b138-a064-4f63-990f-8c20cca0b940" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_ae06208f-29c4-4211-b05d-40049c0683e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/ContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_df8cc902-de12-44be-a98e-0a07fc0a290c" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_fc33972d-f44e-4fae-af48-7c00fabe694f" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_df8cc902-de12-44be-a98e-0a07fc0a290c" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_fc33972d-f44e-4fae-af48-7c00fabe694f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_559ba228-0471-4755-b74b-cad7cfebe830" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_df8cc902-de12-44be-a98e-0a07fc0a290c" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_559ba228-0471-4755-b74b-cad7cfebe830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_efa1c35f-fd1e-4ab2-bb2f-afe8a343ff0d" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_c24422df-3f9c-4959-a95d-84bd99ac7bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_efa1c35f-fd1e-4ab2-bb2f-afe8a343ff0d" xlink:to="loc_us-gaap_BilledContractReceivables_c24422df-3f9c-4959-a95d-84bd99ac7bf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0f93595f-c003-4f6e-b917-b47987a5dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_efa1c35f-fd1e-4ab2-bb2f-afe8a343ff0d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0f93595f-c003-4f6e-b917-b47987a5dce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_347f275f-eab9-4d9e-8c31-d832c978ccb0" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_a391114c-3a0b-40d7-bbdb-3b89fa9652ef" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_347f275f-eab9-4d9e-8c31-d832c978ccb0" xlink:to="loc_iclr_ContractsReceivableGross_a391114c-3a0b-40d7-bbdb-3b89fa9652ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_1366b95c-78eb-43e4-9ba0-af2cf73aab6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_347f275f-eab9-4d9e-8c31-d832c978ccb0" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_1366b95c-78eb-43e4-9ba0-af2cf73aab6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1c0a8503-0f0c-4c63-81a5-bb7c49fc8112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c661b8d1-b635-44e6-a2a2-d68e481f15c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1c0a8503-0f0c-4c63-81a5-bb7c49fc8112" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c661b8d1-b635-44e6-a2a2-d68e481f15c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b93f5774-8e96-4989-a5f5-4955659f66ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1c0a8503-0f0c-4c63-81a5-bb7c49fc8112" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b93f5774-8e96-4989-a5f5-4955659f66ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_aba18c5c-1307-4ded-b4de-45b7083cad0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1c0a8503-0f0c-4c63-81a5-bb7c49fc8112" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_aba18c5c-1307-4ded-b4de-45b7083cad0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_e3a794c8-672e-4c61-a3f9-92bb6217ab97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1c0a8503-0f0c-4c63-81a5-bb7c49fc8112" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_e3a794c8-672e-4c61-a3f9-92bb6217ab97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c4260f59-6abd-4722-a2d2-b23efb41e062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c4260f59-6abd-4722-a2d2-b23efb41e062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_f4a3c328-31a3-4234-9a4c-fa214f298413" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_f4a3c328-31a3-4234-9a4c-fa214f298413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_98978e1e-5307-4358-80c1-d70916b0e6da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_98978e1e-5307-4358-80c1-d70916b0e6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a1ef1cb9-0c70-4358-b381-cd53f0a7b1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a1ef1cb9-0c70-4358-b381-cd53f0a7b1f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d7c4211c-32dc-4cd3-8b8a-85a90846aa2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_Goodwill_d7c4211c-32dc-4cd3-8b8a-85a90846aa2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_16ea6c16-6a29-4db9-9a17-3a379fb77c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_16ea6c16-6a29-4db9-9a17-3a379fb77c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_c6918f1a-3a7e-4c38-aeb2-a22dba92a433" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_c6918f1a-3a7e-4c38-aeb2-a22dba92a433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e4c3c1d5-333c-44e6-adf9-9a7b248be97e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e4c3c1d5-333c-44e6-adf9-9a7b248be97e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6b37d5f6-cf2e-4932-9cb8-ad8c17b72977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6b37d5f6-cf2e-4932-9cb8-ad8c17b72977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ecae5657-5de4-44a9-820f-9abee8ed6e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ecae5657-5de4-44a9-820f-9abee8ed6e0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c77891e2-f43f-4132-b2df-9b1644c83d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c77891e2-f43f-4132-b2df-9b1644c83d45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_552a8964-a251-4c27-a4c9-ff0c8e2a2c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_552a8964-a251-4c27-a4c9-ff0c8e2a2c3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_2ece2700-b28b-4471-aa4c-7a312a31eeb0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_2ece2700-b28b-4471-aa4c-7a312a31eeb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cc9ca722-36b1-47ba-9780-c67a9c143725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_cc9ca722-36b1-47ba-9780-c67a9c143725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f7c507f3-58c7-4ca5-afa4-323d38c6216e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f7c507f3-58c7-4ca5-afa4-323d38c6216e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_fc307350-d96f-42a9-bc22-f614b18fbdf2" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_00169318-e2e2-40ed-ba8d-34e3b2f0067c" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_fc307350-d96f-42a9-bc22-f614b18fbdf2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_7c37b946-68c7-499f-bcf0-8fda73f9a008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_us-gaap_Land_7c37b946-68c7-499f-bcf0-8fda73f9a008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_c265501f-32f2-4530-ac5d-dcfb395ec50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_c265501f-32f2-4530-ac5d-dcfb395ec50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_7af89941-aaa9-459f-a81e-8865c5aff1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_7af89941-aaa9-459f-a81e-8865c5aff1e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_6e7fa2b6-6640-4210-89fe-a4f5c9e79aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_6e7fa2b6-6640-4210-89fe-a4f5c9e79aeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_182fbca7-7f81-4645-ac41-97abfc98d7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_182fbca7-7f81-4645-ac41-97abfc98d7fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_5b432675-6149-4be9-9b48-435e9bf40034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_5b432675-6149-4be9-9b48-435e9bf40034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_6d59b238-e7f0-4e55-b78c-d6f240e52647" xlink:href="iclr-20221231.xsd#iclr_VehiclesGross"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_49964393-e39b-4771-97e7-d4df950bf1a5" xlink:to="loc_iclr_VehiclesGross_6d59b238-e7f0-4e55-b78c-d6f240e52647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_55272bd0-906a-4b3a-a63d-ff615c2d5f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_def5bba7-4a72-448b-8436-93baf4926ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_55272bd0-906a-4b3a-a63d-ff615c2d5f89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_def5bba7-4a72-448b-8436-93baf4926ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1fae0959-cab7-47ad-9384-08b3feef390a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_55272bd0-906a-4b3a-a63d-ff615c2d5f89" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1fae0959-cab7-47ad-9384-08b3feef390a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cab0868b-7bcc-450b-88e6-e54bfa69695c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_35f70b4f-7991-4627-a66c-2e5bb8117fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cab0868b-7bcc-450b-88e6-e54bfa69695c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_35f70b4f-7991-4627-a66c-2e5bb8117fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bcc9271e-3a3c-4454-bb16-f1323cb5f866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cab0868b-7bcc-450b-88e6-e54bfa69695c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bcc9271e-3a3c-4454-bb16-f1323cb5f866" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_e9bc6d5a-c826-4f47-b095-411a062263af" xlink:href="iclr-20221231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e4d68f55-508c-4989-bfbf-c0658dd280d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_e9bc6d5a-c826-4f47-b095-411a062263af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e4d68f55-508c-4989-bfbf-c0658dd280d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_da4d387d-b90e-4fe1-b681-7a6c7d8556c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_e9bc6d5a-c826-4f47-b095-411a062263af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_da4d387d-b90e-4fe1-b681-7a6c7d8556c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b1a61be4-3993-4907-980f-3df20fbc9b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_e9bc6d5a-c826-4f47-b095-411a062263af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b1a61be4-3993-4907-980f-3df20fbc9b8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1feda90-a2a0-4a61-ac50-4970860bf41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_e9bc6d5a-c826-4f47-b095-411a062263af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f1feda90-a2a0-4a61-ac50-4970860bf41a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ed8d82ca-6b17-43e2-b267-300014408997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_e9bc6d5a-c826-4f47-b095-411a062263af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ed8d82ca-6b17-43e2-b267-300014408997" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_4dddcac5-0ddf-4220-b9c5-fac2adb99648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_4dddcac5-0ddf-4220-b9c5-fac2adb99648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e974e54e-1499-4a08-9940-e626ad78a5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e974e54e-1499-4a08-9940-e626ad78a5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a035ef47-2f21-409a-86db-b86e70be5b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a035ef47-2f21-409a-86db-b86e70be5b46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_56f9a1d8-d82f-4a51-b07c-d1760dd661f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_56f9a1d8-d82f-4a51-b07c-d1760dd661f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d20a103f-fdee-49e5-a23f-b6fad03f0233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d20a103f-fdee-49e5-a23f-b6fad03f0233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_1cb6173c-b06f-4e1e-8e8e-369f5fd03021" xlink:href="iclr-20221231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_1cb6173c-b06f-4e1e-8e8e-369f5fd03021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent_bf921e36-38b2-4277-8419-2a52a169f243" xlink:href="iclr-20221231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_9ff905ff-529e-43c4-a5b0-3716f1af1e75" xlink:to="loc_iclr_CapitalGovernmentGrantsCurrent_bf921e36-38b2-4277-8419-2a52a169f243" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6aa26279-de41-45b8-8a47-75f085e9b923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_574b6e7b-c291-4a93-b63d-b143f1fea777" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_6aa26279-de41-45b8-8a47-75f085e9b923" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_574b6e7b-c291-4a93-b63d-b143f1fea777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_43cbe91f-8392-4c34-a884-35576c3ae2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_6aa26279-de41-45b8-8a47-75f085e9b923" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_43cbe91f-8392-4c34-a884-35576c3ae2be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d029e4c3-def2-41e4-b362-2877c8bf625d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_e9949526-c32a-408a-8cc6-9924bbc6023b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_d029e4c3-def2-41e4-b362-2877c8bf625d" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_e9949526-c32a-408a-8cc6-9924bbc6023b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_da51fcc9-ac76-4620-acc8-292618d69729" xlink:href="iclr-20221231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_d029e4c3-def2-41e4-b362-2877c8bf625d" xlink:to="loc_iclr_InterestExpenseCreditOther_da51fcc9-ac76-4620-acc8-292618d69729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_bb3a6a49-97b7-48bd-998e-3ccd100c8e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_d029e4c3-def2-41e4-b362-2877c8bf625d" xlink:to="loc_us-gaap_InterestExpenseDebt_bb3a6a49-97b7-48bd-998e-3ccd100c8e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_54b31aab-1686-4414-8b97-f1d364361cef" xlink:href="iclr-20221231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpense_d029e4c3-def2-41e4-b362-2877c8bf625d" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_54b31aab-1686-4414-8b97-f1d364361cef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_31241163-54e6-4382-8290-18ce1817e9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6e8c469b-d3d3-4249-8873-b9d0470bae12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_31241163-54e6-4382-8290-18ce1817e9c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6e8c469b-d3d3-4249-8873-b9d0470bae12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b7204e14-6d72-4db1-b2a6-98980056429d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_31241163-54e6-4382-8290-18ce1817e9c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b7204e14-6d72-4db1-b2a6-98980056429d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c981f7c4-f17d-412b-8921-7079ed436f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_31241163-54e6-4382-8290-18ce1817e9c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c981f7c4-f17d-412b-8921-7079ed436f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_c0038aeb-83e1-4367-adb0-a1104ade18a6" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_31241163-54e6-4382-8290-18ce1817e9c5" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_c0038aeb-83e1-4367-adb0-a1104ade18a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_af490e77-a04b-4638-9e6f-a1b3e1991108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_31241163-54e6-4382-8290-18ce1817e9c5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_af490e77-a04b-4638-9e6f-a1b3e1991108" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_3ecef276-2881-4f03-93bc-495a62c41557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_70324a91-ca72-4aad-b17d-edd192eb9624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3ecef276-2881-4f03-93bc-495a62c41557" xlink:to="loc_us-gaap_SubleaseIncome_70324a91-ca72-4aad-b17d-edd192eb9624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_89892f2a-5b46-4346-8f06-45f47a760f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_3ecef276-2881-4f03-93bc-495a62c41557" xlink:to="loc_us-gaap_OperatingLeaseCost_89892f2a-5b46-4346-8f06-45f47a760f60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_261d9864-8371-483c-9d33-273682bcdef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_03598d77-2a53-4554-8f53-bab8a080c119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_261d9864-8371-483c-9d33-273682bcdef7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_03598d77-2a53-4554-8f53-bab8a080c119" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e00bca4b-502d-47a9-835a-457222e633a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_261d9864-8371-483c-9d33-273682bcdef7" xlink:to="loc_us-gaap_OperatingLeaseLiability_e00bca4b-502d-47a9-835a-457222e633a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c236c163-5d74-48d5-a1d1-d663cf1876e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c236c163-5d74-48d5-a1d1-d663cf1876e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c9771d61-08f2-4983-97bf-7792ae71f484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c9771d61-08f2-4983-97bf-7792ae71f484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7a1f2bb8-114d-4f93-b26a-d76bf2b84a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7a1f2bb8-114d-4f93-b26a-d76bf2b84a80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_02850966-1de9-40e2-8105-a86a3104b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_02850966-1de9-40e2-8105-a86a3104b0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d52da755-2225-4e4a-9028-e2c25cc83a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d52da755-2225-4e4a-9028-e2c25cc83a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8e178eb7-ebdc-4154-9826-7e2ed9ee3b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4af2ba49-0a81-41f1-bc60-796b6166502c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8e178eb7-ebdc-4154-9826-7e2ed9ee3b31" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentotherliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9251c56c-6362-4741-af20-9a04a644921a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_38cd8b48-7d07-4eb3-bde3-cd4f8cb7c231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_9251c56c-6362-4741-af20-9a04a644921a" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_38cd8b48-7d07-4eb3-bde3-cd4f8cb7c231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_29eee8cd-d705-4f75-baca-10db863376c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_9251c56c-6362-4741-af20-9a04a644921a" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_29eee8cd-d705-4f75-baca-10db863376c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_4218250d-71f4-4fd4-a05e-b11fe36965e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_085bbebb-3bd9-4212-8b86-fda7ce88c6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_4218250d-71f4-4fd4-a05e-b11fe36965e0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_085bbebb-3bd9-4212-8b86-fda7ce88c6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_4753c151-569b-4056-8872-add49d42b354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_4218250d-71f4-4fd4-a05e-b11fe36965e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_4753c151-569b-4056-8872-add49d42b354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4cacb348-0d11-4b70-8146-b82b1b54c729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f08121cb-09c2-4ce1-b258-d7678fba7e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4cacb348-0d11-4b70-8146-b82b1b54c729" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f08121cb-09c2-4ce1-b258-d7678fba7e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_90170187-3343-486a-99b4-8b7331596a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4cacb348-0d11-4b70-8146-b82b1b54c729" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_90170187-3343-486a-99b4-8b7331596a1f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b64d79e8-e1c1-452b-a6d8-4a0f2d122ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_b64d79e8-e1c1-452b-a6d8-4a0f2d122ece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2489b715-85d2-4249-80d8-569c9199d3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2489b715-85d2-4249-80d8-569c9199d3f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_058354d7-b1dc-4b9a-8e5f-bd3563709810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_058354d7-b1dc-4b9a-8e5f-bd3563709810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7141fc66-10d6-444b-afcc-bc8cae7af01a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7141fc66-10d6-444b-afcc-bc8cae7af01a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_17d6b3c4-f33e-4df7-a955-2104746be891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_17d6b3c4-f33e-4df7-a955-2104746be891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_6382817e-4d9c-40f2-96cb-75705b6e59c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_6382817e-4d9c-40f2-96cb-75705b6e59c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_ee19c589-294c-49bb-b41a-c09d508b9f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_ee19c589-294c-49bb-b41a-c09d508b9f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_80084d8a-68bd-451e-81e7-803c028e8c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_80084d8a-68bd-451e-81e7-803c028e8c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_e0a0ef43-f2f2-48d1-967a-a3f57e944270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4729da6a-08dc-468c-b8a1-5b397ae89948" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_e0a0ef43-f2f2-48d1-967a-a3f57e944270" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_32e98b57-c3e2-4b77-a5dd-7cabeadbbe08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a2246951-fb17-4d3f-837b-725d25ba7ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_32e98b57-c3e2-4b77-a5dd-7cabeadbbe08" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a2246951-fb17-4d3f-837b-725d25ba7ba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_5b30a77c-4209-47c1-ae36-463f211035d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_32e98b57-c3e2-4b77-a5dd-7cabeadbbe08" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_5b30a77c-4209-47c1-ae36-463f211035d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_afa2fb64-6d85-4e6e-927a-d617c3c23d4e" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_afa2fb64-6d85-4e6e-927a-d617c3c23d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_4dabc5d3-a7f3-4a4f-9646-c32422cbf9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_4dabc5d3-a7f3-4a4f-9646-c32422cbf9c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_ef83dd45-8024-4880-95de-7126340de51c" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_ef83dd45-8024-4880-95de-7126340de51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_93148d2d-cc53-40c8-99e0-03fd4713ac9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_93148d2d-cc53-40c8-99e0-03fd4713ac9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_a279195b-cea2-49f3-86fb-105f10f5ed50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_a279195b-cea2-49f3-86fb-105f10f5ed50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_dbc2491d-e4b2-493c-ab8e-f319f3feb068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_dbc2491d-e4b2-493c-ab8e-f319f3feb068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_241a221e-ecf9-4205-aeee-b8393c5b2dd8" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_241a221e-ecf9-4205-aeee-b8393c5b2dd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_6f9822c9-9e5f-4e4d-ae4d-e0cddc728fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_6f9822c9-9e5f-4e4d-ae4d-e0cddc728fa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_71d7ed96-62ce-40e6-bba2-e3e271c0cf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6c8dc876-0eab-405b-95fb-255cb92f40da" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_71d7ed96-62ce-40e6-bba2-e3e271c0cf4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f7c99471-755d-4f11-9d15-23e0d500a833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8b5861a9-bc77-444b-b0bd-202ac41b2ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_f7c99471-755d-4f11-9d15-23e0d500a833" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8b5861a9-bc77-444b-b0bd-202ac41b2ea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5b446d9e-4c42-4a1f-bbb9-38ebf5bdb6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_f7c99471-755d-4f11-9d15-23e0d500a833" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5b446d9e-4c42-4a1f-bbb9-38ebf5bdb6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_2bddc62e-60e6-4039-88e1-8297a9b8c864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_52bcfa37-4861-48d0-8d56-0d4312861ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2bddc62e-60e6-4039-88e1-8297a9b8c864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_52bcfa37-4861-48d0-8d56-0d4312861ef0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_81c8aaba-5462-4493-ab96-5311ae6d0c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2bddc62e-60e6-4039-88e1-8297a9b8c864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_81c8aaba-5462-4493-ab96-5311ae6d0c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5048ff8a-0df6-4a6a-bdc8-124b3f3dcda1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2bddc62e-60e6-4039-88e1-8297a9b8c864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5048ff8a-0df6-4a6a-bdc8-124b3f3dcda1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a340a82d-0ac4-4a60-9526-da4e331556db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2bddc62e-60e6-4039-88e1-8297a9b8c864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a340a82d-0ac4-4a60-9526-da4e331556db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_60698f11-dc12-4768-8ba0-910958273afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_2bddc62e-60e6-4039-88e1-8297a9b8c864" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_60698f11-dc12-4768-8ba0-910958273afb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ebb3e39a-467f-4b5a-94ce-407f6ae6184a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5100c80f-396c-4d3b-a446-1a6892cd2c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ebb3e39a-467f-4b5a-94ce-407f6ae6184a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_5100c80f-396c-4d3b-a446-1a6892cd2c81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_bd553c9c-8377-4464-aca6-ea839ef3e636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ebb3e39a-467f-4b5a-94ce-407f6ae6184a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_bd553c9c-8377-4464-aca6-ea839ef3e636" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7d27a39f-8684-4624-b74e-b269013f220a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_685a9519-bb6c-4853-9153-92411a0011cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7d27a39f-8684-4624-b74e-b269013f220a" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_685a9519-bb6c-4853-9153-92411a0011cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4b0cf0ea-bb35-4d60-9580-a87c5b52a817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7d27a39f-8684-4624-b74e-b269013f220a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4b0cf0ea-bb35-4d60-9580-a87c5b52a817" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2b89f75-50af-421a-b8fa-e3ad6bbcfd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b2dd8508-90c1-4e27-b38e-2d009f8c8aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2b89f75-50af-421a-b8fa-e3ad6bbcfd1e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_b2dd8508-90c1-4e27-b38e-2d009f8c8aa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_42a00952-e658-44ed-a1d2-93a787c625cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2b89f75-50af-421a-b8fa-e3ad6bbcfd1e" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_42a00952-e658-44ed-a1d2-93a787c625cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ee09074a-5f96-43e4-925f-19be448a83a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2b89f75-50af-421a-b8fa-e3ad6bbcfd1e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ee09074a-5f96-43e4-925f-19be448a83a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1cfe3685-23a1-47d2-b4b5-7e73f049aac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2b89f75-50af-421a-b8fa-e3ad6bbcfd1e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1cfe3685-23a1-47d2-b4b5-7e73f049aac7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_27c3a557-c992-4bcd-9422-9f1f8b0e1deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_c94c1a78-2e36-4fa7-9870-69123094d4cc" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_27c3a557-c992-4bcd-9422-9f1f8b0e1deb" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_c94c1a78-2e36-4fa7-9870-69123094d4cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3df8de05-b16c-404a-aac5-cbe2e40636b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_27c3a557-c992-4bcd-9422-9f1f8b0e1deb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_3df8de05-b16c-404a-aac5-cbe2e40636b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_595a59ec-a9bf-425a-8961-a76c1e3d3123" xlink:href="iclr-20221231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_27c3a557-c992-4bcd-9422-9f1f8b0e1deb" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_595a59ec-a9bf-425a-8961-a76c1e3d3123" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_afcab9fb-63bb-4931-988d-acd77fbcb47e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_825f988b-2354-413b-8576-e7ae7f011e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_afcab9fb-63bb-4931-988d-acd77fbcb47e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_825f988b-2354-413b-8576-e7ae7f011e9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f71f81c7-ed20-4cd7-9e81-f8e7839a92a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_afcab9fb-63bb-4931-988d-acd77fbcb47e" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f71f81c7-ed20-4cd7-9e81-f8e7839a92a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9ef99747-4561-49aa-b754-1f9cf580c855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1ca135cb-718a-4815-9de9-1842cd430652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9ef99747-4561-49aa-b754-1f9cf580c855" xlink:to="loc_us-gaap_NetIncomeLoss_1ca135cb-718a-4815-9de9-1842cd430652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_8fca11ea-93a2-4802-86a1-8097200bcf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9ef99747-4561-49aa-b754-1f9cf580c855" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_8fca11ea-93a2-4802-86a1-8097200bcf35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48fdfc1f-9fde-4977-b674-b0006c60423e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_4038f2ce-5da7-4b82-b9c4-c3818c714d0c" xlink:href="iclr-20221231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48fdfc1f-9fde-4977-b674-b0006c60423e" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_4038f2ce-5da7-4b82-b9c4-c3818c714d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_0d8c7800-0550-4b5c-a09f-d56713f4b28f" xlink:href="iclr-20221231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48fdfc1f-9fde-4977-b674-b0006c60423e" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_0d8c7800-0550-4b5c-a09f-d56713f4b28f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9e338ffd-8e49-42a0-b019-b173e7766e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48fdfc1f-9fde-4977-b674-b0006c60423e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9e338ffd-8e49-42a0-b019-b173e7766e4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_b16847df-0e42-47e7-a72d-005c57b30dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_48fdfc1f-9fde-4977-b674-b0006c60423e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_b16847df-0e42-47e7-a72d-005c57b30dcb" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>iclr-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7508de12-69a9-4818-9ec7-00b38a2cb3e7,g:60b4642b-da77-4b86-962d-2e89e6dd7ade-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20221231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended" id="i87291a4f5ba64401a1771e3e708ef0d1_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cc52da97-b368-4bee-b368-e94812c142de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentType_cc52da97-b368-4bee-b368-e94812c142de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_3bec0bf4-ac4c-4a11-a726-c458bd45df6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentRegistrationStatement_3bec0bf4-ac4c-4a11-a726-c458bd45df6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_05913df6-3afb-49f9-a111-b6e9c0299592" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentAnnualReport_05913df6-3afb-49f9-a111-b6e9c0299592" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9121c9f1-ecf6-47f0-a51e-e7db15cb5a21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentPeriodEndDate_9121c9f1-ecf6-47f0-a51e-e7db15cb5a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3271f553-52c6-4ba6-89ba-c87ef0fd2541" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_CurrentFiscalYearEndDate_3271f553-52c6-4ba6-89ba-c87ef0fd2541" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_1bb8f22d-2835-4d50-9a94-f6700a78545d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentTransitionReport_1bb8f22d-2835-4d50-9a94-f6700a78545d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_17365cb4-43a5-4e07-b2b8-14895eb5ef8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentShellCompanyReport_17365cb4-43a5-4e07-b2b8-14895eb5ef8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_43db9a05-99e8-4f1b-b73b-4c6bdd28f466" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityFileNumber_43db9a05-99e8-4f1b-b73b-4c6bdd28f466" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f636fda7-ab8a-4aa9-b23a-946838a3ff5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityRegistrantName_f636fda7-ab8a-4aa9-b23a-946838a3ff5f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c3d2d5c0-fad2-4ccb-b207-69b8fbc7dc30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c3d2d5c0-fad2-4ccb-b207-69b8fbc7dc30" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0e6ee89e-8901-4d97-a63e-c2bd6603f9d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressAddressLine1_0e6ee89e-8901-4d97-a63e-c2bd6603f9d5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_076add09-9e1e-4103-b82c-ea300f566ce4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressAddressLine2_076add09-9e1e-4103-b82c-ea300f566ce4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_52462af2-8071-4419-b822-5f9fc34f50ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressCityOrTown_52462af2-8071-4419-b822-5f9fc34f50ae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c7750bfb-875e-4f61-8ff2-1285113394cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressPostalZipCode_c7750bfb-875e-4f61-8ff2-1285113394cf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_58ef85b5-4415-4896-8447-dda1f3b6495d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressCountry_58ef85b5-4415-4896-8447-dda1f3b6495d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_b93abe4d-6998-4bae-81b1-dd0a5972e569" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_ContactPersonnelName_b93abe4d-6998-4bae-81b1-dd0a5972e569" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_034d5145-a163-4b46-806f-981c1c0bb02f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_ContactPersonnelEmailAddress_034d5145-a163-4b46-806f-981c1c0bb02f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_5b40d638-eb58-4fc1-bc4e-6dfa49d35f5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_CountryRegion_5b40d638-eb58-4fc1-bc4e-6dfa49d35f5f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_edf928c6-f179-4a95-a6fd-57c7bafb1949" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_CityAreaCode_edf928c6-f179-4a95-a6fd-57c7bafb1949" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d4dcbcc9-ab77-4d85-b6c3-9cb5b12a0421" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_LocalPhoneNumber_d4dcbcc9-ab77-4d85-b6c3-9cb5b12a0421" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_594e12ef-68b8-45d8-a835-1cf014fcd910" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_Security12bTitle_594e12ef-68b8-45d8-a835-1cf014fcd910" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7f57fbea-4b53-4229-ace7-93516cdda03c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_TradingSymbol_7f57fbea-4b53-4229-ace7-93516cdda03c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_24d59e7a-1fcc-4303-ad74-7fcb17e9b9e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_SecurityExchangeName_24d59e7a-1fcc-4303-ad74-7fcb17e9b9e6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a092fc98-c230-4c4b-b710-189e6765f27f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a092fc98-c230-4c4b-b710-189e6765f27f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_cdccdfa7-d767-4935-8ada-3f74c0c997cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_cdccdfa7-d767-4935-8ada-3f74c0c997cd" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_73ac436b-4860-4ca6-b0d4-4d2d335d0c1e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityVoluntaryFilers_73ac436b-4860-4ca6-b0d4-4d2d335d0c1e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7ec0d4f7-a381-4d4f-9150-3d7dc3cd783b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityCurrentReportingStatus_7ec0d4f7-a381-4d4f-9150-3d7dc3cd783b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1e7c995c-29d0-4d01-a4b1-f2242ec1ecdb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityInteractiveDataCurrent_1e7c995c-29d0-4d01-a4b1-f2242ec1ecdb" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9cc59c44-27a1-403c-af05-ac0915409bdf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityFilerCategory_9cc59c44-27a1-403c-af05-ac0915409bdf" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_318072a4-7603-4ca9-b456-b820f065f2df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityEmergingGrowthCompany_318072a4-7603-4ca9-b456-b820f065f2df" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b6d9162e-4267-42d4-9a4f-143dd2f4cc7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b6d9162e-4267-42d4-9a4f-143dd2f4cc7a" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_379da362-c1e0-4475-ada7-23fd4e490ba0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentAccountingStandard_379da362-c1e0-4475-ada7-23fd4e490ba0" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4d97a63c-e667-47e9-ad63-0557545e8ab0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityShellCompany_4d97a63c-e667-47e9-ad63-0557545e8ab0" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_66ab1dec-1a3c-4ff8-a4f6-c601342b8737" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_AmendmentFlag_66ab1dec-1a3c-4ff8-a4f6-c601342b8737" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e46c8168-3f50-4155-ac65-d44c77f5e53e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentFiscalYearFocus_e46c8168-3f50-4155-ac65-d44c77f5e53e" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_edbc6e81-e63c-4646-9a97-42b5a97ab8ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_edbc6e81-e63c-4646-9a97-42b5a97ab8ab" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dc5e32e1-f602-405c-8f42-03ddddf5595f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityCentralIndexKey_dc5e32e1-f602-405c-8f42-03ddddf5595f" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_a3595945-a2e7-4b00-a638-998135ce3981_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:to="loc_dei_AddressTypeDomain_a3595945-a2e7-4b00-a638-998135ce3981_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_86d4388b-5a13-4271-a214-835e42e533be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:to="loc_dei_AddressTypeDomain_86d4388b-5a13-4271-a214-835e42e533be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_50ab42ba-d52f-4ba7-b50c-ae755aadd6b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_86d4388b-5a13-4271-a214-835e42e533be" xlink:to="loc_dei_BusinessContactMember_50ab42ba-d52f-4ba7-b50c-ae755aadd6b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="extended" id="i906c8c8d5f6842f3916172d69ccb86a4_CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1662cf7d-5297-4e17-9b98-0384505fb346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_CommonStockSharesIssued_1662cf7d-5297-4e17-9b98-0384505fb346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b66330f8-cfab-441a-b252-8bd9dfdeed08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockholdersEquity_b66330f8-cfab-441a-b252-8bd9dfdeed08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8b10e19d-cada-4ea5-bb36-771832c2952f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_NetIncomeLoss_8b10e19d-cada-4ea5-bb36-771832c2952f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c8c9e4-636e-40f8-8382-81b9f2477c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c8c9e4-636e-40f8-8382-81b9f2477c40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_455c8a9e-ea2b-4f7b-af14-2453f030098b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_455c8a9e-ea2b-4f7b-af14-2453f030098b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_08942f42-e167-46da-93d3-43ebbc4353df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_08942f42-e167-46da-93d3-43ebbc4353df" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1f2554c7-dce8-4159-b0d8-740f132fc0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1f2554c7-dce8-4159-b0d8-740f132fc0a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_518ebe2d-913b-4c47-bc7e-3b6a1286ce42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_518ebe2d-913b-4c47-bc7e-3b6a1286ce42" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_38c51e51-5150-4ecf-8123-9feaf549dec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_38c51e51-5150-4ecf-8123-9feaf549dec1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_060dd5b3-c97b-4f00-94af-7469a1208828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_060dd5b3-c97b-4f00-94af-7469a1208828" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_677a091b-52a1-4b26-887e-b8db39b7ff86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_677a091b-52a1-4b26-887e-b8db39b7ff86" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ec2a62da-142b-4a45-95b1-5e35f319684f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ec2a62da-142b-4a45-95b1-5e35f319684f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a3be1c7e-4840-477b-b37a-2e94f1f62b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a3be1c7e-4840-477b-b37a-2e94f1f62b38" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_854676f3-e5c7-4f98-8fad-76bae5592a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_854676f3-e5c7-4f98-8fad-76bae5592a4e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_72070240-6332-4a79-9062-d044894dae63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_72070240-6332-4a79-9062-d044894dae63" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_940ad99a-d5c5-446e-8606-811e80fa1a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_940ad99a-d5c5-446e-8606-811e80fa1a49" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0229350a-46db-4c88-aa8d-cd75378caadc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0229350a-46db-4c88-aa8d-cd75378caadc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_26a97459-f601-4c0b-978e-491caac44314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_26a97459-f601-4c0b-978e-491caac44314" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4277c872-c8d1-42af-bf00-a86826483472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4277c872-c8d1-42af-bf00-a86826483472" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_a2bbc1d9-d486-44a8-b797-9b2f2e9f7f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_a2bbc1d9-d486-44a8-b797-9b2f2e9f7f1a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_fb50f756-ab2d-44cf-a786-7fac64c97c71" xlink:href="iclr-20221231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_fb50f756-ab2d-44cf-a786-7fac64c97c71" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_494f416c-dccc-4d26-aa32-7cc268ff92ab" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_494f416c-dccc-4d26-aa32-7cc268ff92ab" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9987b6f2-a2b7-4a5e-9794-f194a94abd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4d7348da-8df4-4aec-98da-2bcee0d37655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_22a21f1f-7ea6-4cc7-bf6d-6b53518171ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_22a21f1f-7ea6-4cc7-bf6d-6b53518171ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_5deb0c07-0ebe-46b4-85d8-f059f5ced0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_5deb0c07-0ebe-46b4-85d8-f059f5ced0cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_90895d7d-345f-419c-801d-72484e3c0bf3" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_322cbe59-4118-49bb-b88d-b2463c62bcca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_322cbe59-4118-49bb-b88d-b2463c62bcca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ed130020-68d5-455b-b278-0ad04b6dc94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:to="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a4e92781-b164-4786-b99c-7c9f9dba23ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:to="loc_us-gaap_EquityComponentDomain_a4e92781-b164-4786-b99c-7c9f9dba23ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:to="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df144f41-20d1-46cd-b48f-adb8de61f212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_CommonStockMember_df144f41-20d1-46cd-b48f-adb8de61f212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6b047fb0-42e1-4508-a369-e63ccd460a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6b047fb0-42e1-4508-a369-e63ccd460a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_6840df46-94a1-45b7-93e0-894c439af249" xlink:href="iclr-20221231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_6840df46-94a1-45b7-93e0-894c439af249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_56b20dbe-8aa7-424f-a81f-b7689bfe9680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_56b20dbe-8aa7-424f-a81f-b7689bfe9680" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7d280b29-4764-41cf-86f3-1e03e424cc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_RetainedEarningsMember_7d280b29-4764-41cf-86f3-1e03e424cc5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestMember_144f007e-78d3-452d-a3ea-496ed11e7462" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_iclr_RedeemableNoncontrollingInterestMember_144f007e-78d3-452d-a3ea-496ed11e7462" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DescriptionofbusinessDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended" id="idfad7c48e7264572bfc1f455924e8335_DescriptionofbusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_d434bec1-0f13-4466-9b14-3c26eae7c9c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_dei_EntityNumberOfEmployees_d434bec1-0f13-4466-9b14-3c26eae7c9c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_d9bb0a4a-77be-4b40-9974-be57fabdc21e" xlink:href="iclr-20221231.xsd#iclr_NumberOfLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_iclr_NumberOfLocations_d9bb0a4a-77be-4b40-9974-be57fabdc21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_ae0d894e-3b54-410b-8759-3b51ff1482d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_ae0d894e-3b54-410b-8759-3b51ff1482d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0282a8f2-cfd7-41aa-b49c-e10b275a2df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0282a8f2-cfd7-41aa-b49c-e10b275a2df7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_441ffb49-4a58-432d-91dd-595a71b9cc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_441ffb49-4a58-432d-91dd-595a71b9cc23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_8fa95b6e-6ddd-44c8-8d4a-749bc6890c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_441ffb49-4a58-432d-91dd-595a71b9cc23" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_8fa95b6e-6ddd-44c8-8d4a-749bc6890c34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_78cab749-31d9-4fb9-bdb8-6062188791e3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:to="loc_srt_SegmentGeographicalDomain_78cab749-31d9-4fb9-bdb8-6062188791e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:to="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c1f59ba2-4e88-4a8b-9b9f-f63cf2d2bb1d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:to="loc_country_US_c1f59ba2-4e88-4a8b-9b9f-f63cf2d2bb1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_59306573-a7a7-4898-b662-3e9d760791cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:to="loc_srt_EuropeMember_59306573-a7a7-4898-b662-3e9d760791cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_31f47b17-2665-4c8d-a2b5-a66c5eb9d6cd" xlink:href="iclr-20221231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:to="loc_iclr_OtherGeographicLocationsMember_31f47b17-2665-4c8d-a2b5-a66c5eb9d6cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1f2348bc-1aec-45b3-ba25-7d7f09ac2015_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1f2348bc-1aec-45b3-ba25-7d7f09ac2015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2441b081-ec70-40d8-933e-0bdbbdcca324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2441b081-ec70-40d8-933e-0bdbbdcca324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c37e34d5-c192-4e2b-88f8-f00dcb96bb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2441b081-ec70-40d8-933e-0bdbbdcca324" xlink:to="loc_us-gaap_SalesRevenueNetMember_c37e34d5-c192-4e2b-88f8-f00dcb96bb97" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended" id="i44f40601c7eb486f8d5fdf1f63bf4d80_SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5a5234a8-9b5e-4a0c-a4ec-af9622797eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8c45f7f8-c8ee-41d8-8ce3-81bd140e0956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5a5234a8-9b5e-4a0c-a4ec-af9622797eab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8c45f7f8-c8ee-41d8-8ce3-81bd140e0956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5a5234a8-9b5e-4a0c-a4ec-af9622797eab" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_64959921-08ec-49bd-9dbc-62bed9bad96d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_64959921-08ec-49bd-9dbc-62bed9bad96d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_976351f0-be5c-4716-baa3-04c2785de69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_BuildingMember_976351f0-be5c-4716-baa3-04c2785de69e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_eb46af42-e096-42c8-8631-513a7214ce65" xlink:href="iclr-20221231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_eb46af42-e096-42c8-8631-513a7214ce65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_600518a6-4340-4842-a8a2-28935e841060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_600518a6-4340-4842-a8a2-28935e841060" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_40eff598-2c31-43c5-a0c1-46e1928f2590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_EquipmentMember_40eff598-2c31-43c5-a0c1-46e1928f2590" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_8bcae123-3c13-4230-8f4f-2d48c5c2166a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_VehiclesMember_8bcae123-3c13-4230-8f4f-2d48c5c2166a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:to="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a01b9fdb-8343-4eee-a9b1-c99447244c30_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:to="loc_srt_RangeMember_a01b9fdb-8343-4eee-a9b1-c99447244c30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:to="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d850ee18-4ae5-4588-9c76-97355dfa2fec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:to="loc_srt_MinimumMember_d850ee18-4ae5-4588-9c76-97355dfa2fec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd1fd8e5-8f9d-47a3-8bd0-cf4fa5c75dfd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:to="loc_srt_MaximumMember_bd1fd8e5-8f9d-47a3-8bd0-cf4fa5c75dfd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="extended" id="if56935c90369442cac87f3fdbfcb28ab_SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dc9eb9f2-270e-45ae-9307-eccbe47dd021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_329700d3-b520-4375-89b2-957407f170e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dc9eb9f2-270e-45ae-9307-eccbe47dd021" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_329700d3-b520-4375-89b2-957407f170e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dc9eb9f2-270e-45ae-9307-eccbe47dd021" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b25b320-1c4e-4e84-bc61-743b0e3ab41f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b25b320-1c4e-4e84-bc61-743b0e3ab41f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b852af3b-b71c-40ad-802e-12d81cd37354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b852af3b-b71c-40ad-802e-12d81cd37354" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_c374921f-e097-49cd-b865-100044de0bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_c374921f-e097-49cd-b865-100044de0bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ec0ad702-09ad-47dd-b6fc-e12e18598d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_TradeNamesMember_ec0ad702-09ad-47dd-b6fc-e12e18598d59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_fd478ead-ce53-43dc-982a-27ff9dab5719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_DatabasesMember_fd478ead-ce53-43dc-982a-27ff9dab5719" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_edf02f8d-7d3b-4908-b36f-ad192b1ffba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_edf02f8d-7d3b-4908-b36f-ad192b1ffba4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" xlink:type="extended" id="i9a2b27b3ea7c470e91bd75b270135975_SummaryofSignificantaccountingpoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cba3db69-22ae-411f-9e6c-23523ef926f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_51758dac-a176-435e-aa1b-3641f08f4ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cba3db69-22ae-411f-9e6c-23523ef926f0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_51758dac-a176-435e-aa1b-3641f08f4ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cba3db69-22ae-411f-9e6c-23523ef926f0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f78c966f-7f82-46b2-bbd0-22af206dd0af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f78c966f-7f82-46b2-bbd0-22af206dd0af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d8e4887-8053-41cc-a786-5d237b70a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d8e4887-8053-41cc-a786-5d237b70a49e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MeDiNovaResearchMember_ed615234-135a-4082-8504-23f586bfcbfe" xlink:href="iclr-20221231.xsd#iclr_MeDiNovaResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d8e4887-8053-41cc-a786-5d237b70a49e" xlink:to="loc_iclr_MeDiNovaResearchMember_ed615234-135a-4082-8504-23f586bfcbfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended" id="iba75e0a67328441f8fc9955579d0f56e_DisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4e1a3e88-4003-4057-b8fc-600b23f3dccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a036f1d4-2e41-4bc6-b85e-37f6be8bdcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4e1a3e88-4003-4057-b8fc-600b23f3dccf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a036f1d4-2e41-4bc6-b85e-37f6be8bdcc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4e1a3e88-4003-4057-b8fc-600b23f3dccf" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:to="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:to="loc_srt_NameOfMajorCustomerDomain_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:to="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_68b9abfb-a47e-4351-bab2-fa055ca29e4d" xlink:href="iclr-20221231.xsd#iclr_TopClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_TopClientMember_68b9abfb-a47e-4351-bab2-fa055ca29e4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_51c179e3-6c86-4fc5-9d20-7c6d28635857" xlink:href="iclr-20221231.xsd#iclr_Clients25Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_Clients25Member_51c179e3-6c86-4fc5-9d20-7c6d28635857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_9252bb93-30f4-4a3b-8891-882d4ec05e5f" xlink:href="iclr-20221231.xsd#iclr_Clients610Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_Clients610Member_9252bb93-30f4-4a3b-8891-882d4ec05e5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_26c10e3c-0d05-4547-a2c5-7a5155a2284d" xlink:href="iclr-20221231.xsd#iclr_Clients1125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_Clients1125Member_26c10e3c-0d05-4547-a2c5-7a5155a2284d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_aeaabe1b-ce23-4974-88bd-b82c14ff1af4" xlink:href="iclr-20221231.xsd#iclr_OtherCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_OtherCustomersMember_aeaabe1b-ce23-4974-88bd-b82c14ff1af4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="extended" id="i63252c988f384ebfba81d648fe6743c3_ContractBalancesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_c2b5e860-7930-429b-b941-65992e9d8af8" xlink:href="iclr-20221231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_c2b5e860-7930-429b-b941-65992e9d8af8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_61f07374-e050-4252-bbcc-e6bc8f1a08d4" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_61f07374-e050-4252-bbcc-e6bc8f1a08d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_97da4062-40b0-4e82-bddb-526b05494e17" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_97da4062-40b0-4e82-bddb-526b05494e17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ec344476-2d11-46d1-9092-b48b77c90da8" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ec344476-2d11-46d1-9092-b48b77c90da8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_3213d20a-558f-4ea4-866c-44c75815dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_3213d20a-558f-4ea4-866c-44c75815dac7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1db0872e-dacb-4339-9979-d9088d14403d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1db0872e-dacb-4339-9979-d9088d14403d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1c533e32-0284-4f2e-a8f2-cb01ed8ffecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1c533e32-0284-4f2e-a8f2-cb01ed8ffecd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_70390609-08ca-41b2-851e-f2adaeac219f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_70390609-08ca-41b2-851e-f2adaeac219f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15257d47-294f-42c8-8446-9f8db835e053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15257d47-294f-42c8-8446-9f8db835e053" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="extended" id="i2fa117a80e544a898830be6e00481833_ContractBalancesNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_c2b5e860-7930-429b-b941-65992e9d8af8" xlink:href="iclr-20221231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_c2b5e860-7930-429b-b941-65992e9d8af8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_61f07374-e050-4252-bbcc-e6bc8f1a08d4" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_61f07374-e050-4252-bbcc-e6bc8f1a08d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_97da4062-40b0-4e82-bddb-526b05494e17" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_97da4062-40b0-4e82-bddb-526b05494e17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ec344476-2d11-46d1-9092-b48b77c90da8" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ec344476-2d11-46d1-9092-b48b77c90da8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_3213d20a-558f-4ea4-866c-44c75815dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_3213d20a-558f-4ea4-866c-44c75815dac7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1db0872e-dacb-4339-9979-d9088d14403d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1db0872e-dacb-4339-9979-d9088d14403d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1c533e32-0284-4f2e-a8f2-cb01ed8ffecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1c533e32-0284-4f2e-a8f2-cb01ed8ffecd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_70390609-08ca-41b2-851e-f2adaeac219f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_70390609-08ca-41b2-851e-f2adaeac219f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsNarrativePRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="extended" id="ic1ed679a454940db8e5b6c21d6babc2b_BusinessCombinationsNarrativePRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_41504046-13c4-4b00-a110-5bee9a0f70ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_dei_EntityNumberOfEmployees_41504046-13c4-4b00-a110-5bee9a0f70ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_19523516-2e5c-4fc4-967b-0171eaee72d0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_19523516-2e5c-4fc4-967b-0171eaee72d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_d555bbc5-3ac1-4532-ac2a-79cd503f5cc9" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_d555bbc5-3ac1-4532-ac2a-79cd503f5cc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_aaaa41d5-7281-4ddd-8a4b-11267a56bebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_aaaa41d5-7281-4ddd-8a4b-11267a56bebd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c973bcfd-ca0d-483a-b873-ae6f090d4f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c973bcfd-ca0d-483a-b873-ae6f090d4f23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_1e9d56b3-9cdf-4e3d-99ed-8518a16497ce" xlink:href="iclr-20221231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_1e9d56b3-9cdf-4e3d-99ed-8518a16497ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_d6bd4227-01db-4a8d-a16c-ea416870fe64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_d6bd4227-01db-4a8d-a16c-ea416870fe64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_669fa9de-57e1-4649-87bd-e5b91c493fdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_669fa9de-57e1-4649-87bd-e5b91c493fdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b007f77c-6937-4651-b0a1-1734ca9deeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b007f77c-6937-4651-b0a1-1734ca9deeb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_41adc54c-4e9e-4135-9384-301be52701bf" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b007f77c-6937-4651-b0a1-1734ca9deeb3" xlink:to="loc_iclr_PRAHealthSciencesIncMember_41adc54c-4e9e-4135-9384-301be52701bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended" id="i728f6185b65e446d873301410af566d4_BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_794cdb47-af5e-4a92-a2de-ec1b7519c4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_794cdb47-af5e-4a92-a2de-ec1b7519c4df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02dec372-fbab-42d8-ae81-80557289a0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02dec372-fbab-42d8-ae81-80557289a0a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f4b2f7fb-1be5-4c7e-bd04-61ad49e9a27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f4b2f7fb-1be5-4c7e-bd04-61ad49e9a27f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_870aa226-faeb-444a-804c-ec3ed63f7b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_870aa226-faeb-444a-804c-ec3ed63f7b3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f714f8e2-08b6-4bab-a45f-ada3b2af6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f714f8e2-08b6-4bab-a45f-ada3b2af6e8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_22de09a9-f3e0-49d7-9c4b-8c336ec120b0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_22de09a9-f3e0-49d7-9c4b-8c336ec120b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a75462fd-e493-4def-af9c-d96b243636af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a75462fd-e493-4def-af9c-d96b243636af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5d8ad67-3aba-41db-a52c-5a775211ef90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5d8ad67-3aba-41db-a52c-5a775211ef90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_f5f46b36-d4be-4133-b800-0f738a1367f8" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5d8ad67-3aba-41db-a52c-5a775211ef90" xlink:to="loc_iclr_PRAHealthSciencesIncMember_f5f46b36-d4be-4133-b800-0f738a1367f8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended" id="ibe6d2677eaa5448eb629d6a01aefb4ff_BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f34d3ec3-0ace-4aa3-9527-d6c3e95b0326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f34d3ec3-0ace-4aa3-9527-d6c3e95b0326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7171e11c-8e53-482d-a1d1-06be8fa9370a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7171e11c-8e53-482d-a1d1-06be8fa9370a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4150824a-7e3f-45f9-bdfc-b1e124520b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4150824a-7e3f-45f9-bdfc-b1e124520b18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c387e531-4651-4133-bcc6-5c593c7fd759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c387e531-4651-4133-bcc6-5c593c7fd759" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_0db5b5f4-d200-4c5b-b412-bc97696cdc67" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_0db5b5f4-d200-4c5b-b412-bc97696cdc67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_06b09a97-0a81-4b1f-a02b-03ac74c5f391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_Goodwill_06b09a97-0a81-4b1f-a02b-03ac74c5f391" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_07741109-c93d-489b-a504-ec1b44ab9dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_07741109-c93d-489b-a504-ec1b44ab9dbd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_afb32cae-d7bf-4ae2-bbef-fe21e0ee4c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_afb32cae-d7bf-4ae2-bbef-fe21e0ee4c74" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d7eb7f9-827a-44d2-bae7-fc4482708cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d7eb7f9-827a-44d2-bae7-fc4482708cf7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c57e2530-f53e-4229-802e-5901e467ef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c57e2530-f53e-4229-802e-5901e467ef3e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e92d20ca-3ec0-4953-b08b-81af0d0d85c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e92d20ca-3ec0-4953-b08b-81af0d0d85c4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_4bf5f610-44f2-4bf9-acb2-94bae87e83a1" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_4bf5f610-44f2-4bf9-acb2-94bae87e83a1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_74222b33-8fd7-4a56-baea-01bbc1bfc938" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_74222b33-8fd7-4a56-baea-01bbc1bfc938" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_ce91bb81-eefc-44db-b863-704945e4bccb" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_ce91bb81-eefc-44db-b863-704945e4bccb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7c5f0fe6-9294-431c-b24e-9fcb16bbe068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7c5f0fe6-9294-431c-b24e-9fcb16bbe068" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_801ad4d0-69ef-439e-ade5-daafa39daf32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_801ad4d0-69ef-439e-ade5-daafa39daf32" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2fc22219-4ab2-47c9-a006-5e64e76b3936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2fc22219-4ab2-47c9-a006-5e64e76b3936" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_a561806e-a812-4dc5-9b98-918bc5fe55f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_a561806e-a812-4dc5-9b98-918bc5fe55f2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_1d26fd96-805e-4729-a153-08e860efe373" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_1d26fd96-805e-4729-a153-08e860efe373" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e51fe12-7d1d-47d3-b2ef-fa2226436b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e51fe12-7d1d-47d3-b2ef-fa2226436b20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_ad5b0597-bbe2-4e5a-befc-e2c035388ab6" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e51fe12-7d1d-47d3-b2ef-fa2226436b20" xlink:to="loc_iclr_PRAHealthSciencesIncMember_ad5b0597-bbe2-4e5a-befc-e2c035388ab6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="extended" id="i95c03c80ebb84feca9605606f454f90c_BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_78c5af92-4694-45aa-a9b4-26a0eeee5305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_78c5af92-4694-45aa-a9b4-26a0eeee5305" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed49cc7e-f78f-4d11-8a21-c1ad589828e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed49cc7e-f78f-4d11-8a21-c1ad589828e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea39468a-e224-4c31-9532-23326d946859_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ea39468a-e224-4c31-9532-23326d946859_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2435b95-0e6c-46f9-9db5-a89100319b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2435b95-0e6c-46f9-9db5-a89100319b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_387d7659-02d3-4b27-afa2-ec168f967810" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2435b95-0e6c-46f9-9db5-a89100319b80" xlink:to="loc_iclr_PRAHealthSciencesIncMember_387d7659-02d3-4b27-afa2-ec168f967810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f815651-0cb1-4ff8-923f-be9120299184_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f815651-0cb1-4ff8-923f-be9120299184_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_543d4707-f052-48bd-9ba3-d55c2ea2f2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_543d4707-f052-48bd-9ba3-d55c2ea2f2a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_9baba2b7-7a33-45b5-8ba9-952529a25801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_9baba2b7-7a33-45b5-8ba9-952529a25801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_f4001a3e-2312-4c7e-ac31-c45b157833d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_TradeNamesMember_f4001a3e-2312-4c7e-ac31-c45b157833d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_52c313a8-e5e3-44f1-b1d1-83bef2f893ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_DatabasesMember_52c313a8-e5e3-44f1-b1d1-83bef2f893ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0b72f2da-72c2-40ab-aa79-d190923a6f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0b72f2da-72c2-40ab-aa79-d190923a6f17" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="extended" id="i3c6fb1d1df3b47b782b3c1495e1240c5_BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_68545a09-2d8b-41ba-9dcd-504b2f82d210" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_68545a09-2d8b-41ba-9dcd-504b2f82d210" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_2aca5294-960b-4d47-a59c-66ab22d624d4" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_2aca5294-960b-4d47-a59c-66ab22d624d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_778dee28-8b60-4b3c-aab0-0ccae771b936" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_778dee28-8b60-4b3c-aab0-0ccae771b936" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_d2af657d-2b6b-4bfe-b5bc-6303a79b42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_d2af657d-2b6b-4bfe-b5bc-6303a79b42ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_1775e4cd-068e-44ee-8ee9-f22f2ad84077" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_1775e4cd-068e-44ee-8ee9-f22f2ad84077" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_011f40a4-0dad-424a-ae55-216a9fdab8df" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_011f40a4-0dad-424a-ae55-216a9fdab8df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e69c6d81-2db3-429d-8133-37bfb058b4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e69c6d81-2db3-429d-8133-37bfb058b4ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_e2fda5b0-4f66-4b99-bcdd-b50b65c41478" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_e2fda5b0-4f66-4b99-bcdd-b50b65c41478" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_eeddcb25-afd9-4255-87a6-dde1e096c99b" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_eeddcb25-afd9-4255-87a6-dde1e096c99b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_e79c915c-e217-474b-be19-0f4244dfb599" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_e79c915c-e217-474b-be19-0f4244dfb599" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_c088970c-b9ce-4809-9704-d3bd89f413f0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_c088970c-b9ce-4809-9704-d3bd89f413f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_a5427ab6-55eb-4d71-93d0-b3b71ca29682" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_a5427ab6-55eb-4d71-93d0-b3b71ca29682" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_6ad48741-cb3e-4efa-b4f7-74e2bc5e5379" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_6ad48741-cb3e-4efa-b4f7-74e2bc5e5379" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_53b9b603-7aaf-4676-a19f-f4a029200457" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_53b9b603-7aaf-4676-a19f-f4a029200457" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_975cb0e1-0cb7-4c3b-94c5-c2aaaf0a7345" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_975cb0e1-0cb7-4c3b-94c5-c2aaaf0a7345" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_ef319281-4c2b-4f1f-a093-625ef215b961" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_ef319281-4c2b-4f1f-a093-625ef215b961" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ab60aef4-1e10-4b67-9d4b-4ded892d5d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ab60aef4-1e10-4b67-9d4b-4ded892d5d19" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0398c62c-dd32-4054-8b26-f425e02968b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0398c62c-dd32-4054-8b26-f425e02968b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e4cb1b9-9354-448c-8410-f93ffb6c1305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e4cb1b9-9354-448c-8410-f93ffb6c1305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_ad721593-5b24-4eec-a7c5-ec0795647be0" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e4cb1b9-9354-448c-8410-f93ffb6c1305" xlink:to="loc_iclr_PRAHealthSciencesIncMember_ad721593-5b24-4eec-a7c5-ec0795647be0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fb87498b-90e8-44dd-9e4f-7cb2cec95a60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fb87498b-90e8-44dd-9e4f-7cb2cec95a60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fc5744a6-a26a-4648-aae8-bfd38fc6a014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fc5744a6-a26a-4648-aae8-bfd38fc6a014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202108Member_49bdeec9-500b-4423-b113-cbeede025c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202108Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_fc5744a6-a26a-4648-aae8-bfd38fc6a014" xlink:to="loc_us-gaap_AccountingStandardsUpdate202108Member_49bdeec9-500b-4423-b113-cbeede025c40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#FairvalueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="extended" id="ia3ff19ee22524954a572ef7b30d552f1_FairvalueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d5be941e-522d-48c7-932b-73bae12c2728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d5be941e-522d-48c7-932b-73bae12c2728" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_0a569859-39da-4102-8ead-d1c49ee92b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_0a569859-39da-4102-8ead-d1c49ee92b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_c1269a06-90ee-4396-a6dc-24c7a14699df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_c1269a06-90ee-4396-a6dc-24c7a14699df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8229a218-a999-4f6e-b589-a208ade6fcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_LongTermDebtFairValue_8229a218-a999-4f6e-b589-a208ade6fcfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d05625c2-bc02-44a6-8da7-5f89e17237e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d05625c2-bc02-44a6-8da7-5f89e17237e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c815c64-4ec6-47ac-bedb-23e39f709358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c815c64-4ec6-47ac-bedb-23e39f709358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eec869fd-8ad6-41e4-b9a2-a4b175f347de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c815c64-4ec6-47ac-bedb-23e39f709358" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eec869fd-8ad6-41e4-b9a2-a4b175f347de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_39228884-dfa4-40cd-95ab-03af992328cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_39228884-dfa4-40cd-95ab-03af992328cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0463f5e8-96d9-4944-9714-32aa26d0db34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0463f5e8-96d9-4944-9714-32aa26d0db34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_18159960-08c5-40e8-9080-cfefd93453f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0463f5e8-96d9-4944-9714-32aa26d0db34" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_18159960-08c5-40e8-9080-cfefd93453f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended" id="ia45d98c1d25541f8926a8459415509c6_FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d325c915-ae68-4d0a-b3b0-c0c67f767437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d325c915-ae68-4d0a-b3b0-c0c67f767437" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2fa588bc-21dd-4bb8-8f11-f9a8bd568f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2fa588bc-21dd-4bb8-8f11-f9a8bd568f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_85508b90-cc9c-45da-8f28-97649b260709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_DerivativeAssets_85508b90-cc9c-45da-8f28-97649b260709" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bb0a044b-68bb-4995-b783-c53a89601706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_bb0a044b-68bb-4995-b783-c53a89601706" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_b3bd9dc0-aab4-4311-9d5c-a4eb9468ec22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_DerivativeLiabilities_b3bd9dc0-aab4-4311-9d5c-a4eb9468ec22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ee3386bc-2cb5-44cb-b4a9-c36e233edeba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ee3386bc-2cb5-44cb-b4a9-c36e233edeba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d3e5c066-289e-436e-9640-e8ff0e88aa92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d3e5c066-289e-436e-9640-e8ff0e88aa92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_78e38045-d6b9-400d-956c-e487d92b02a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_78e38045-d6b9-400d-956c-e487d92b02a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_aebf33c3-50f9-4aed-93be-efb7e5a67f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_aebf33c3-50f9-4aed-93be-efb7e5a67f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6c8657dd-a011-45fc-876e-7bdeea6d0ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6c8657dd-a011-45fc-876e-7bdeea6d0ee9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_7d2fde65-9497-46e8-8226-58a5a2ec524e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_7d2fde65-9497-46e8-8226-58a5a2ec524e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_16c4e116-99d0-4dda-91e0-02f4f1541113_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_16c4e116-99d0-4dda-91e0-02f4f1541113_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8c523f29-ce2b-4ce4-bfc0-b411bebbd755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8c523f29-ce2b-4ce4-bfc0-b411bebbd755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_61499de3-11bc-407a-9002-3b1a9c26c3c5" xlink:href="iclr-20221231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8c523f29-ce2b-4ce4-bfc0-b411bebbd755" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_61499de3-11bc-407a-9002-3b1a9c26c3c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_08f535df-bb6c-498e-b0b0-2a177be59023_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:to="loc_us-gaap_HedgingDesignationDomain_08f535df-bb6c-498e-b0b0-2a177be59023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7ab584ec-d78a-4d6a-b55d-362ba00daf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:to="loc_us-gaap_HedgingDesignationDomain_7ab584ec-d78a-4d6a-b55d-362ba00daf3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcde29a3-ff9c-4d0c-98a0-91a6d39e9af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_7ab584ec-d78a-4d6a-b55d-362ba00daf3a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcde29a3-ff9c-4d0c-98a0-91a6d39e9af8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i8b490b4825bc401b9481b57e9c4fcfed_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3209afb4-f572-48a6-9abf-a34d226ad690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3209afb4-f572-48a6-9abf-a34d226ad690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_1aab32cf-79fb-412b-954a-1bd1830852b5" xlink:href="iclr-20221231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_1aab32cf-79fb-412b-954a-1bd1830852b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_b95b234c-f4f4-4cb8-bab9-8ef4768a6f3d" xlink:href="iclr-20221231.xsd#iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_b95b234c-f4f4-4cb8-bab9-8ef4768a6f3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_14f11b80-6ef6-4a69-872e-5690aec1ce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_14f11b80-6ef6-4a69-872e-5690aec1ce1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_36be6f95-2d5c-4e9d-ba50-7c6c45f02e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_36be6f95-2d5c-4e9d-ba50-7c6c45f02e34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_32d4044b-6c5a-4fa0-9009-c002f9c31670" xlink:href="iclr-20221231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_32d4044b-6c5a-4fa0-9009-c002f9c31670" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f645b0f5-4177-4742-9437-456f69ec4005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_EquityMethodInvestments_f645b0f5-4177-4742-9437-456f69ec4005" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_28815f44-07d3-4158-8f73-c2cb46dde1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_28815f44-07d3-4158-8f73-c2cb46dde1cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_ec78d0f9-bce9-4849-9a81-8a3616166e60" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_ec78d0f9-bce9-4849-9a81-8a3616166e60" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b75afd48-b58d-46d4-86b5-e340b2c6981a" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b75afd48-b58d-46d4-86b5-e340b2c6981a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_8965a442-3715-4fa6-819b-2f070716b168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_8965a442-3715-4fa6-819b-2f070716b168" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_b37d373b-469c-4a86-a978-619c9cc18201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_b37d373b-469c-4a86-a978-619c9cc18201" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a56fd8b4-7382-40bb-85bc-a73383ac2780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a56fd8b4-7382-40bb-85bc-a73383ac2780" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInEquityMethodInvestments_de2dc75a-c2d3-4c36-8368-e8ee5c4b251c" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_IncreaseDecreaseInEquityMethodInvestments_de2dc75a-c2d3-4c36-8368-e8ee5c4b251c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_28403422-8769-452e-83e6-a1c26ec2e1b2" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentDecreaseInLoanReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_28403422-8769-452e-83e6-a1c26ec2e1b2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedParties_0370369e-a2f5-45e5-b63b-95b8c57598ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedParties_0370369e-a2f5-45e5-b63b-95b8c57598ea" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_61d58549-f920-40f2-bac0-61ba250414b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_61d58549-f920-40f2-bac0-61ba250414b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_63c45ff7-0e1f-4b2f-8211-f4893d5830ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_63c45ff7-0e1f-4b2f-8211-f4893d5830ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_e5ac279d-6647-42a2-994f-dc437a7c2484" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_63c45ff7-0e1f-4b2f-8211-f4893d5830ec" xlink:to="loc_iclr_OncacareMember_e5ac279d-6647-42a2-994f-dc437a7c2484" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d452a123-16ea-4e50-b516-23d19fcb5975_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d452a123-16ea-4e50-b516-23d19fcb5975_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6959f148-5d22-402f-9503-84422e2b9559" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6959f148-5d22-402f-9503-84422e2b9559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_82fb7bfa-0f1b-4def-a36d-924642435913" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6959f148-5d22-402f-9503-84422e2b9559" xlink:to="loc_iclr_OncacareMember_82fb7bfa-0f1b-4def-a36d-924642435913" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#InvestmentsEquityMethodInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="extended" id="i98cbba74214745f0935a062f194c3f6e_InvestmentsEquityMethodInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d2075522-5904-4dd3-b532-e2b52c076688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d2075522-5904-4dd3-b532-e2b52c076688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2b91d14f-5ace-4516-8b8b-eda267ee63d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:to="loc_us-gaap_EquityMethodInvestments_2b91d14f-5ace-4516-8b8b-eda267ee63d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cf1b08b5-bd9a-43df-995d-74284a9f53a1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cf1b08b5-bd9a-43df-995d-74284a9f53a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_127d59b1-ff8e-457e-97c1-1590d2ae4719" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_127d59b1-ff8e-457e-97c1-1590d2ae4719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_7879be40-0dcb-43ea-a0ec-3485bbe2948a" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_127d59b1-ff8e-457e-97c1-1590d2ae4719" xlink:to="loc_iclr_OncacareMember_7879be40-0dcb-43ea-a0ec-3485bbe2948a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended" id="i8955ad273787496b907fdb64813ce555_IntangibleAssetsSummaryofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_28ce51ef-ec1c-4e7d-bea7-34c140211894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_28ce51ef-ec1c-4e7d-bea7-34c140211894" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3197fcd9-5c5d-49ce-896a-83536d5bc901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3197fcd9-5c5d-49ce-896a-83536d5bc901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a6202fe-4864-4569-a213-8c5008b4e494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a6202fe-4864-4569-a213-8c5008b4e494" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_289dff4b-6167-4ac9-a0ed-b6e9f1039666_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_289dff4b-6167-4ac9-a0ed-b6e9f1039666_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_35966389-6bb5-40bb-91ee-f238009d93c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_35966389-6bb5-40bb-91ee-f238009d93c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_389895c7-406e-45de-897d-09ad134d4095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_389895c7-406e-45de-897d-09ad134d4095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_002d2c8f-da35-455d-b341-397c28e07aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_TradeNamesMember_002d2c8f-da35-455d-b341-397c28e07aa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_13b665ca-f0e6-4ee9-bb45-5dea0f2f8685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_DatabasesMember_13b665ca-f0e6-4ee9-bb45-5dea0f2f8685" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_95e3cb0f-a6d5-4bda-813c-92c4690b8a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_95e3cb0f-a6d5-4bda-813c-92c4690b8a63" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended" id="ia277bb87fc0c4157aca4c715afeb32fa_IntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e5e65318-f44f-4cc7-8322-5d8cf3b12a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e5e65318-f44f-4cc7-8322-5d8cf3b12a37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_54203fd4-cd75-4570-b5a7-3dd9e2849ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_54203fd4-cd75-4570-b5a7-3dd9e2849ff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b8142eb4-967f-4b80-abcf-aaf14e815321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b8142eb4-967f-4b80-abcf-aaf14e815321" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d019be8-dbcd-4cd7-a369-3fce27b321e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d019be8-dbcd-4cd7-a369-3fce27b321e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6868d29f-caeb-47f9-8e0d-dcdfb96f0a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6868d29f-caeb-47f9-8e0d-dcdfb96f0a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_45aeaf98-9fb6-464f-83e7-73c8785c205c" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6868d29f-caeb-47f9-8e0d-dcdfb96f0a7a" xlink:to="loc_iclr_PRAHealthSciencesIncMember_45aeaf98-9fb6-464f-83e7-73c8785c205c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b93daa65-0fc6-4981-8480-0bbc63b5aec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b93daa65-0fc6-4981-8480-0bbc63b5aec8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_3b1459a4-ff2b-419f-9ff1-e70cccf43e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_3b1459a4-ff2b-419f-9ff1-e70cccf43e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4ab6a5d8-645b-4331-acdd-d964848d094d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_TradeNamesMember_4ab6a5d8-645b-4331-acdd-d964848d094d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_475fdd41-d86d-4aef-abb6-1e7df7c1ad42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_DatabasesMember_475fdd41-d86d-4aef-abb6-1e7df7c1ad42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bd628d1b-8a19-402b-a3fc-d8c960eda3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bd628d1b-8a19-402b-a3fc-d8c960eda3bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5c2fa23c-e8b7-4842-b5bf-03189709ab11_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:to="loc_srt_RangeMember_5c2fa23c-e8b7-4842-b5bf-03189709ab11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:to="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_75488ac6-b790-43c6-b201-295b9ebbcd6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:to="loc_srt_MinimumMember_75488ac6-b790-43c6-b201-295b9ebbcd6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f377206d-faf1-45f9-9c00-d4730f585e57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:to="loc_srt_MaximumMember_f377206d-faf1-45f9-9c00-d4730f585e57" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" xlink:type="extended" id="i74eda7f3acdb4649a4ec29ce3a5ffaf6_NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49ed5735-68aa-4252-9be8-0b1faf9a79e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49ed5735-68aa-4252-9be8-0b1faf9a79e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2036cf40-72a2-4030-aa3f-1999a3023332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2036cf40-72a2-4030-aa3f-1999a3023332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_9a0145c8-8e6f-4e58-b971-76d877d46d8c" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_9a0145c8-8e6f-4e58-b971-76d877d46d8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_ad913953-78b2-4bf5-b7d7-49949e85b8a2" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_ad913953-78b2-4bf5-b7d7-49949e85b8a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_af0dacb6-3171-4c93-8cac-d47635908b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_af0dacb6-3171-4c93-8cac-d47635908b06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c4c36f74-db06-40cd-acd6-cdd4bac38301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c4c36f74-db06-40cd-acd6-cdd4bac38301" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2932731b-03ed-4e3d-a0e2-845c398b5046_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2932731b-03ed-4e3d-a0e2-845c398b5046_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5ea18064-9125-4956-a651-cb30fb62e8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:to="loc_us-gaap_SecuredDebtMember_5ea18064-9125-4956-a651-cb30fb62e8d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_af965707-083d-4066-b0e9-c27940560a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_af965707-083d-4066-b0e9-c27940560a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a2aeb4ac-7119-4c35-b170-a4d944d49684_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a2aeb4ac-7119-4c35-b170-a4d944d49684_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_719be3f3-c263-4260-947c-66aa6d2702bc" xlink:href="iclr-20221231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:to="loc_iclr_TermLoanFacilityMember_719be3f3-c263-4260-947c-66aa6d2702bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_82755d7a-95ad-4c04-9dd1-0e3eda633891" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:to="loc_iclr_SeniorSecuredNotesMember_82755d7a-95ad-4c04-9dd1-0e3eda633891" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="extended" id="i1bd941d9243649689581f70ea365f665_NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1073f57c-578e-4f63-a282-8a677524b5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1073f57c-578e-4f63-a282-8a677524b5fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5d254ac6-dfa2-4d37-8e4d-4209cbbc3e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_InterestExpense_5d254ac6-dfa2-4d37-8e4d-4209cbbc3e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f3c4990c-77e1-48e1-be4d-86fa1456fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f3c4990c-77e1-48e1-be4d-86fa1456fd04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0f82138e-8d0d-408b-880c-41d77073379c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0f82138e-8d0d-408b-880c-41d77073379c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_03b38be7-7809-4f9e-8df2-790e51b7a2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_03b38be7-7809-4f9e-8df2-790e51b7a2d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b9a7ed56-5111-430c-9d5b-891e5bfecfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b9a7ed56-5111-430c-9d5b-891e5bfecfb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_adb85169-46bb-491a-9dea-0e62e92acf20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_adb85169-46bb-491a-9dea-0e62e92acf20" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_bc4629fe-e119-4499-91fe-9f463de16de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_bc4629fe-e119-4499-91fe-9f463de16de9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e239280b-508f-4584-911f-1a63c68cb178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_InterestPaidNet_e239280b-508f-4584-911f-1a63c68cb178" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_e091b729-3132-475e-838a-a2a3c084f762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_e091b729-3132-475e-838a-a2a3c084f762" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_b4a40ad3-f0a3-44f1-a6e3-365fa5895321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_LongTermDebtFairValue_b4a40ad3-f0a3-44f1-a6e3-365fa5895321" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a8b9beb1-f1ea-499e-8e3c-9d877062dcac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a8b9beb1-f1ea-499e-8e3c-9d877062dcac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_8d0c47b0-3a2c-42ac-a455-eb42e97d1a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:to="loc_us-gaap_SecuredDebtMember_8d0c47b0-3a2c-42ac-a455-eb42e97d1a42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0a9d542e-9f47-4ecf-a3a0-6b8888457aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:to="loc_us-gaap_LineOfCreditMember_0a9d542e-9f47-4ecf-a3a0-6b8888457aa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_32c2306f-d1af-4a8f-8731-e9baefa90993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_32c2306f-d1af-4a8f-8731-e9baefa90993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8428d7ee-197e-45f1-ad1a-254011e83c7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8428d7ee-197e-45f1-ad1a-254011e83c7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5530864a-090a-482c-9d90-05e02639b5df" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5530864a-090a-482c-9d90-05e02639b5df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_284f9267-6296-4c92-80c1-b7b079c0660f" xlink:href="iclr-20221231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_TermLoanFacilityMember_284f9267-6296-4c92-80c1-b7b079c0660f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_49a92790-e644-4985-8407-84105ed55b23" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_49a92790-e644-4985-8407-84105ed55b23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingCreditFacilityMember_facb6304-7b08-42b3-943f-77b648b2e0ea" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredRevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredRevolvingCreditFacilityMember_facb6304-7b08-42b3-943f-77b648b2e0ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_cadb977c-a888-4236-8279-660a21e4a81e" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredNotesMember_cadb977c-a888-4236-8279-660a21e4a81e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8f572f8a-df9d-495e-beb5-3921f0b15d45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:to="loc_us-gaap_CreditFacilityDomain_8f572f8a-df9d-495e-beb5-3921f0b15d45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_418408f5-755a-4013-98fb-2d18c89dd0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:to="loc_us-gaap_CreditFacilityDomain_418408f5-755a-4013-98fb-2d18c89dd0cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_50ae21bb-0662-4729-8395-311ad87d4fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_418408f5-755a-4013-98fb-2d18c89dd0cd" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_50ae21bb-0662-4729-8395-311ad87d4fd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_6c6d18ca-698f-45ec-8847-b97930ca8b14_default" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:to="loc_iclr_VariableRateComponentDomain_6c6d18ca-698f-45ec-8847-b97930ca8b14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:to="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_c3cce110-73cb-4b98-bbb5-16e9db468052" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:to="loc_iclr_VariableRateComponentOneMember_c3cce110-73cb-4b98-bbb5-16e9db468052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_40827b4e-4e9d-45be-b379-d8e503069cab" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:to="loc_iclr_VariableRateComponentTwoMember_40827b4e-4e9d-45be-b379-d8e503069cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_19783085-1672-4490-ac42-e8081d1f9a7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:to="loc_us-gaap_VariableRateDomain_19783085-1672-4490-ac42-e8081d1f9a7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:to="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cb035806-9f03-4dfe-ab14-148d05d1ab83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cb035806-9f03-4dfe-ab14-148d05d1ab83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_dfbe93b4-abdd-461e-b130-8f3118883e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:to="loc_us-gaap_BaseRateMember_dfbe93b4-abdd-461e-b130-8f3118883e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0237878c-f636-4c71-a33b-47553fdca179_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:to="loc_srt_RangeMember_0237878c-f636-4c71-a33b-47553fdca179_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:to="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_72bb5090-c65a-42be-8f0d-8914d6f1bdad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:to="loc_srt_MaximumMember_72bb5090-c65a-42be-8f0d-8914d6f1bdad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3abcbd14-4ec6-434a-8cb1-642ffe456d17" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:to="loc_srt_MinimumMember_3abcbd14-4ec6-434a-8cb1-642ffe456d17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_205ecab1-fec5-41f6-b514-d21695c3ba7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_205ecab1-fec5-41f6-b514-d21695c3ba7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bac223b1-5517-4150-9e86-c6a5602570fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bac223b1-5517-4150-9e86-c6a5602570fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_6ab6f754-c3ec-4154-b2d9-aec3347e92ee" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bac223b1-5517-4150-9e86-c6a5602570fb" xlink:to="loc_iclr_PRAHealthSciencesIncMember_6ab6f754-c3ec-4154-b2d9-aec3347e92ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DerivativesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="extended" id="i8c1ecefb988a41f7bc09fd55915e2cb8_DerivativesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_9fbe5327-0c61-4255-9882-cb0519a22132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_9fbe5327-0c61-4255-9882-cb0519a22132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3f4489ea-3daa-459d-9c2b-d0b701f253eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3f4489ea-3daa-459d-9c2b-d0b701f253eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_beedd0df-6791-48a8-becd-c63d0c71cb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_beedd0df-6791-48a8-becd-c63d0c71cb23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_e3e85de6-09b3-4495-8800-f1d090f1c446" xlink:href="iclr-20221231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_e3e85de6-09b3-4495-8800-f1d090f1c446" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_63152ef7-0b7c-4ecb-9089-3c2b7772e0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_63152ef7-0b7c-4ecb-9089-3c2b7772e0e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_69a0c49a-3730-4c0c-97b4-4d7ca71009f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_69a0c49a-3730-4c0c-97b4-4d7ca71009f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0e4674a4-1572-4f3b-a42b-a3ddb09021a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0e4674a4-1572-4f3b-a42b-a3ddb09021a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_1de7207f-583b-4afd-a963-afe863e679f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_1de7207f-583b-4afd-a963-afe863e679f2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_c88e6e45-cd9d-46ac-89e0-c09334512980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_c88e6e45-cd9d-46ac-89e0-c09334512980" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_922159af-098d-46bb-b9b0-3ee3a2fea000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:to="loc_us-gaap_InterestRateCapMember_922159af-098d-46bb-b9b0-3ee3a2fea000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b0262ede-515f-46e6-936d-8d911efe3760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:to="loc_us-gaap_InterestRateSwapMember_b0262ede-515f-46e6-936d-8d911efe3760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_17210948-8e1f-4df0-b382-9df8066ef806_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:to="loc_us-gaap_HedgingDesignationDomain_17210948-8e1f-4df0-b382-9df8066ef806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_191f0345-d529-440a-8f83-5f0f2b664d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:to="loc_us-gaap_HedgingDesignationDomain_191f0345-d529-440a-8f83-5f0f2b664d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87305ad1-961e-4320-8e5d-c1ef083f887f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_191f0345-d529-440a-8f83-5f0f2b664d1b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87305ad1-961e-4320-8e5d-c1ef083f887f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_20749677-6c1e-4083-b94e-11efece5d7e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:to="loc_us-gaap_VariableRateDomain_20749677-6c1e-4083-b94e-11efece5d7e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2b2927e3-2d4d-4d5f-a987-646fb0758dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:to="loc_us-gaap_VariableRateDomain_2b2927e3-2d4d-4d5f-a987-646fb0758dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_32f3ae6e-ae35-4a2c-946e-bcd159413237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_2b2927e3-2d4d-4d5f-a987-646fb0758dc2" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_32f3ae6e-ae35-4a2c-946e-bcd159413237" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="extended" id="i610319df100d481cadcb823b5045c04b_DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8f9e8351-1852-4aaa-9773-6027a93a309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeAssets_8f9e8351-1852-4aaa-9773-6027a93a309e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cf0962d4-d2e0-4b39-b831-1e4617ae9537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeLiabilities_cf0962d4-d2e0-4b39-b831-1e4617ae9537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d23d0e46-c20c-40e8-8182-08dc76beb3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d23d0e46-c20c-40e8-8182-08dc76beb3ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7e0f3a4c-da9b-4131-846b-cd9373c398c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7e0f3a4c-da9b-4131-846b-cd9373c398c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_37c6fed1-9b88-4f27-9b67-eecf7977708b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:to="loc_us-gaap_InterestRateCapMember_37c6fed1-9b88-4f27-9b67-eecf7977708b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_dbe01886-64c2-471e-9f92-7146d1bef8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:to="loc_us-gaap_InterestRateSwapMember_dbe01886-64c2-471e-9f92-7146d1bef8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_251736cf-d6bd-4def-9fb3-e9b0635b824c" xlink:href="iclr-20221231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_251736cf-d6bd-4def-9fb3-e9b0635b824c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:to="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b910fcbd-3546-44bb-bc74-a0548940f015_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:to="loc_us-gaap_HedgingDesignationDomain_b910fcbd-3546-44bb-bc74-a0548940f015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b7e71c55-257d-48a3-880d-39f9af308d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:to="loc_us-gaap_HedgingDesignationDomain_b7e71c55-257d-48a3-880d-39f9af308d80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_308ff10e-82a8-4c87-a21a-8f4295254360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b7e71c55-257d-48a3-880d-39f9af308d80" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_308ff10e-82a8-4c87-a21a-8f4295254360" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended" id="id71b88d1386344219d3ada8b370899d1_OperatingLeasesOperatingLeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5dd06af5-baf4-42e7-8301-cf1b13462473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_LeaseCost_5dd06af5-baf4-42e7-8301-cf1b13462473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c086ac18-bbb7-404e-b916-dddf1e3bbf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c086ac18-bbb7-404e-b916-dddf1e3bbf2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_61b5403f-cf73-4b8d-817c-297c8cbee6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_61b5403f-cf73-4b8d-817c-297c8cbee6b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5244d81b-7b5e-4608-98e2-ca3ed0dc0621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5244d81b-7b5e-4608-98e2-ca3ed0dc0621" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_537a18d6-5c78-437d-8d05-11b510fb9f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_537a18d6-5c78-437d-8d05-11b510fb9f9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7aa2c21a-59a2-4685-9c7f-034c11b35dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7aa2c21a-59a2-4685-9c7f-034c11b35dcf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7615dbb4-24eb-4bfc-993a-1ef0f62edc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7615dbb4-24eb-4bfc-993a-1ef0f62edc9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16c13cc4-ffb2-4343-97ca-8643812787a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16c13cc4-ffb2-4343-97ca-8643812787a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b48fd35a-c162-4a0f-851e-33b7e15172f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b48fd35a-c162-4a0f-851e-33b7e15172f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c796d0b0-f05b-4ce2-9507-4903c6734967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:to="loc_us-gaap_CostOfSalesMember_c796d0b0-f05b-4ce2-9507-4903c6734967" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#ShareCapitalDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended" id="i7ccf76400cf548768fb8da68390bcaf1_ShareCapitalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_77197547-9299-41f1-9752-b64d04fcfe65" xlink:href="iclr-20221231.xsd#iclr_NumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_iclr_NumberOfVotes_77197547-9299-41f1-9752-b64d04fcfe65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b575e512-9113-44fa-b1f2-a9c636487e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b575e512-9113-44fa-b1f2-a9c636487e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5f362b16-d591-4996-bd3b-01923d4062f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5f362b16-d591-4996-bd3b-01923d4062f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b1858688-8a56-458f-aa4f-781a29f16a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b1858688-8a56-458f-aa4f-781a29f16a53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6c5d5c28-ef91-42f9-992b-f99e8688e68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6c5d5c28-ef91-42f9-992b-f99e8688e68b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a3071e99-ac71-4ecb-9663-c31b3d1b44f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a3071e99-ac71-4ecb-9663-c31b3d1b44f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_faa36186-1b0d-4a29-91b6-54311296efb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_faa36186-1b0d-4a29-91b6-54311296efb3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_d36e70e8-dde0-4c5a-97bf-8cac441dbf46" xlink:href="iclr-20221231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_d36e70e8-dde0-4c5a-97bf-8cac441dbf46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_94221617-ddf3-4679-a0b3-d79a4beaad35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_94221617-ddf3-4679-a0b3-d79a4beaad35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0bc6f279-3cc6-425a-9401-4dc28640d79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0bc6f279-3cc6-425a-9401-4dc28640d79a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_49ecb8a4-660d-43c5-a117-d649d79ec376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_49ecb8a4-660d-43c5-a117-d649d79ec376" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_413485b4-debb-47b1-a07e-3f311754d1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_413485b4-debb-47b1-a07e-3f311754d1eb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_99d025ac-62a9-4c22-be92-330d5e6394f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:to="loc_us-gaap_EquityComponentDomain_99d025ac-62a9-4c22-be92-330d5e6394f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_469cb25c-1f3c-4c4a-b0e8-0fac4a51eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:to="loc_us-gaap_EquityComponentDomain_469cb25c-1f3c-4c4a-b0e8-0fac4a51eedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38d02292-6b03-4155-ae56-a8227265a16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_469cb25c-1f3c-4c4a-b0e8-0fac4a51eedc" xlink:to="loc_us-gaap_CommonStockMember_38d02292-6b03-4155-ae56-a8227265a16d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3cf7334c-8d81-4305-8a75-ce35efa9f116_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3cf7334c-8d81-4305-8a75-ce35efa9f116_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1c82a62a-0fda-443a-8c9e-5adfac4c92a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1c82a62a-0fda-443a-8c9e-5adfac4c92a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_664f7204-d4c6-4eb1-9c03-b03b7560fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_664f7204-d4c6-4eb1-9c03-b03b7560fccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_387aa35a-fd5a-4e52-812a-ebfc126dbaeb" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:to="loc_iclr_PerformanceShareUnitMember_387aa35a-fd5a-4e52-812a-ebfc126dbaeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_75332553-1934-4230-8697-82e5eb2864c6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:to="loc_srt_RangeMember_75332553-1934-4230-8697-82e5eb2864c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec64e478-af36-4362-b8a7-361b134ed9e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:to="loc_srt_RangeMember_ec64e478-af36-4362-b8a7-361b134ed9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0166e392-8261-4334-a635-d75ae433bb71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec64e478-af36-4362-b8a7-361b134ed9e8" xlink:to="loc_srt_MaximumMember_0166e392-8261-4334-a635-d75ae433bb71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d153f1d3-6c15-4404-ac44-ed951ff279b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d153f1d3-6c15-4404-ac44-ed951ff279b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7a7d10f3-8062-4f45-8b50-e71e83db9833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7a7d10f3-8062-4f45-8b50-e71e83db9833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_9312b5e3-c7d5-4d14-bd9a-0b7fae3bcf63" xlink:href="iclr-20221231.xsd#iclr_BuybackProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7a7d10f3-8062-4f45-8b50-e71e83db9833" xlink:to="loc_iclr_BuybackProgramMember_9312b5e3-c7d5-4d14-bd9a-0b7fae3bcf63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended" id="i6a0fc94b0d4548a384f31282dd2c65db_RestructuringchargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0a9988da-0612-4930-8da7-bbe914531559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringCosts_0a9988da-0612-4930-8da7-bbe914531559" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_dc25ca38-aa51-4db7-b3f5-812ec8c4445a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_SeveranceCosts1_dc25ca38-aa51-4db7-b3f5-812ec8c4445a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_4b6912f4-9898-49e1-b4f7-14890ce30eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_OtherRestructuringCosts_4b6912f4-9898-49e1-b4f7-14890ce30eb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_ced7f4c0-100d-4443-9573-bca9da28eb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_ced7f4c0-100d-4443-9573-bca9da28eb2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_0eedfa03-2a2b-4451-b4c9-4654f97414fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringReserve_0eedfa03-2a2b-4451-b4c9-4654f97414fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_dd5223e7-4321-4fa4-a089-fd955226a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringReserveCurrent_dd5223e7-4321-4fa4-a089-fd955226a1a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_be49dea8-cb59-421f-a8a4-6681d5d3f542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_be49dea8-cb59-421f-a8a4-6681d5d3f542" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_7301ad62-6210-4f31-8213-e07d40e6c5b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_7301ad62-6210-4f31-8213-e07d40e6c5b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember_662ab753-f6ce-40d6-9b69-61994e1ad317" xlink:href="iclr-20221231.xsd#iclr_LeaseLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:to="loc_iclr_LeaseLiabilityMember_662ab753-f6ce-40d6-9b69-61994e1ad317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4cbe6cce-8a96-41b4-acbb-513912e15d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4cbe6cce-8a96-41b4-acbb-513912e15d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:to="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_5675130d-78be-4973-9392-8ca70b8080a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:to="loc_us-gaap_RestructuringPlanDomain_5675130d-78be-4973-9392-8ca70b8080a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_66ee49b3-4d6f-4bf4-a588-576ebc7c8d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:to="loc_us-gaap_RestructuringPlanDomain_66ee49b3-4d6f-4bf4-a588-576ebc7c8d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_a9e6d479-b551-4ae6-b674-a0a7b58fa399" xlink:href="iclr-20221231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_66ee49b3-4d6f-4bf4-a588-576ebc7c8d1c" xlink:to="loc_iclr_A2021RestructuringPlanMember_a9e6d479-b551-4ae6-b674-a0a7b58fa399" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended" id="i49f1e5d9b5c6417580137fb323854101_IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_474cef3f-8089-42e0-83df-612efc4514d6" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_195a238f-ac8f-4e1d-a514-7d6300248ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_474cef3f-8089-42e0-83df-612efc4514d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_195a238f-ac8f-4e1d-a514-7d6300248ff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_474cef3f-8089-42e0-83df-612efc4514d6" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:to="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cca52f75-18be-4645-b1e6-ab820e02a172_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:to="loc_srt_SegmentGeographicalDomain_cca52f75-18be-4645-b1e6-ab820e02a172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:to="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_1dc06cd3-c0a1-491a-b068-0a23316e1789" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:to="loc_country_IE_1dc06cd3-c0a1-491a-b068-0a23316e1789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a7cbc58b-46c3-49a1-96da-106d27081fd4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:to="loc_country_US_a7cbc58b-46c3-49a1-96da-106d27081fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_1acee2d4-e6e6-457d-8eb8-06093b782b30" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_1acee2d4-e6e6-457d-8eb8-06093b782b30" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended" id="iaae81c550e3843d3bca5149db2b1361c_IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:href="iclr-20221231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c422c1d9-760d-46fb-bbc8-4b1423bd7c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c422c1d9-760d-46fb-bbc8-4b1423bd7c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_df7eed63-7b24-475a-8682-d4bdecdf7de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c422c1d9-760d-46fb-bbc8-4b1423bd7c6e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_df7eed63-7b24-475a-8682-d4bdecdf7de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8413ddd5-a150-496a-baa3-2bf9086bbe5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8413ddd5-a150-496a-baa3-2bf9086bbe5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2a446c63-1b12-4fc7-8789-3550fd5373fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8413ddd5-a150-496a-baa3-2bf9086bbe5d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2a446c63-1b12-4fc7-8789-3550fd5373fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_41868fc5-7c2f-4455-9843-8dc84f20c0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_41868fc5-7c2f-4455-9843-8dc84f20c0ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9728c70a-1482-4189-aa52-793442ed7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9728c70a-1482-4189-aa52-793442ed7b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_9e01f380-24a2-42d4-adf6-e5afe315b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9728c70a-1482-4189-aa52-793442ed7b0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_9e01f380-24a2-42d4-adf6-e5afe315b54d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_6c7e6a89-4071-401b-9996-b740b365234f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_6c7e6a89-4071-401b-9996-b740b365234f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:href="iclr-20221231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:to="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a6724490-88da-4abd-ae13-9a5c6455f75c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:to="loc_srt_SegmentGeographicalDomain_a6724490-88da-4abd-ae13-9a5c6455f75c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:to="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_ec6f9d96-d2c7-40b6-88cb-f0542d2d3498" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:to="loc_country_IE_ec6f9d96-d2c7-40b6-88cb-f0542d2d3498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dd5d5f70-4d09-4e28-affa-1cf190b9ad01" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:to="loc_country_US_dd5d5f70-4d09-4e28-affa-1cf190b9ad01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_260dbbf0-4634-4f83-8a96-ee7683fe9769" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_260dbbf0-4634-4f83-8a96-ee7683fe9769" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="if8085f25cf814fb1a0527d10e9926057_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_83e1771f-cd6d-40c1-8e40-9d15e79d18c8" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_83e1771f-cd6d-40c1-8e40-9d15e79d18c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9b368013-ceff-413a-a522-d977b134e010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9b368013-ceff-413a-a522-d977b134e010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal_6dff2b66-27ad-41e5-bfec-f163da99922f" xlink:href="iclr-20221231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_iclr_OperatingLossCarryforwardsUSFederal_6dff2b66-27ad-41e5-bfec-f163da99922f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_13849352-a191-4de3-8901-80ec68d104cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_OperatingLossCarryforwards_13849352-a191-4de3-8901-80ec68d104cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1cd0d40e-c3fd-4b82-a1ed-b19301debdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1cd0d40e-c3fd-4b82-a1ed-b19301debdd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_4e829dba-e382-45f7-a2bc-f8a36908ad52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_4e829dba-e382-45f7-a2bc-f8a36908ad52" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_470735c9-e446-4e23-9549-7b2af01c475a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_470735c9-e446-4e23-9549-7b2af01c475a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d3bcb53d-77d1-48a8-a9c0-f90657ebc27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d3bcb53d-77d1-48a8-a9c0-f90657ebc27f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_88818032-ddc1-406b-b54f-ae006c20a1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_88818032-ddc1-406b-b54f-ae006c20a1d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_4c11f7c5-c876-460c-a116-104573389e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_4c11f7c5-c876-460c-a116-104573389e85" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_6f0a8277-6bc9-428f-a100-5a01f9417847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_6f0a8277-6bc9-428f-a100-5a01f9417847" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_ae91faad-00ea-429c-87a4-c6d1ed031874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_ae91faad-00ea-429c-87a4-c6d1ed031874" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30f9e3cc-d754-4217-86b4-d9956c14a2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30f9e3cc-d754-4217-86b4-d9956c14a2bd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8c2b74bf-74e3-4080-8737-5fa8761e05e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8c2b74bf-74e3-4080-8737-5fa8761e05e0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b203d025-6623-44e0-8115-406eb5ff15a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b203d025-6623-44e0-8115-406eb5ff15a0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0c990b0d-eabb-4829-b77c-be330cd0c63f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:to="loc_srt_SegmentGeographicalDomain_0c990b0d-eabb-4829-b77c-be330cd0c63f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:to="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_dddc804e-d004-435e-b497-bbf194360f79" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:to="loc_country_IE_dddc804e-d004-435e-b497-bbf194360f79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7966648f-c3d2-4ce1-b9af-89a3a88617c2" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:to="loc_country_US_7966648f-c3d2-4ce1-b9af-89a3a88617c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_5c05a9ae-a415-48e6-8b75-8b26c33c9d6d" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:to="loc_iclr_OtherCountriesMember_5c05a9ae-a415-48e6-8b75-8b26c33c9d6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_198f4381-e8ae-480c-bd5a-72d03c8f7ca9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_198f4381-e8ae-480c-bd5a-72d03c8f7ca9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_4bf12008-1e86-457c-ba16-641c69505f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:to="loc_us-gaap_ForeignCountryMember_4bf12008-1e86-457c-ba16-641c69505f4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3356de26-a165-4684-b5ce-00a3b3830dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3356de26-a165-4684-b5ce-00a3b3830dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_79e19a58-dbc4-4212-98dc-61aa58976ba1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_79e19a58-dbc4-4212-98dc-61aa58976ba1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8608dc73-2694-477f-a7b8-723952213580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8608dc73-2694-477f-a7b8-723952213580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_48e80d44-8129-4262-a4e2-82c651b5d44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8608dc73-2694-477f-a7b8-723952213580" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_48e80d44-8129-4262-a4e2-82c651b5d44d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_e84ce63f-0829-4eaf-947c-e0e0935c2b78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:to="loc_us-gaap_TaxPeriodDomain_e84ce63f-0829-4eaf-947c-e0e0935c2b78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:to="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022To2028Member_f5a6cb0e-d8f1-4031-b895-01747ffc74c0" xlink:href="iclr-20221231.xsd#iclr_TaxYear2022To2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:to="loc_iclr_TaxYear2022To2028Member_f5a6cb0e-d8f1-4031-b895-01747ffc74c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2029To2038Member_ab2e5eab-df0c-4209-94dd-e744a15191f2" xlink:href="iclr-20221231.xsd#iclr_TaxYear2029To2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:to="loc_iclr_TaxYear2029To2038Member_ab2e5eab-df0c-4209-94dd-e744a15191f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b68ec940-a9e6-4d08-b5f4-7191a24de067_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b68ec940-a9e6-4d08-b5f4-7191a24de067_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_373f32f0-7e67-4f31-ad80-df5df1fcad44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_373f32f0-7e67-4f31-ad80-df5df1fcad44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_636db7c3-f19a-4aee-8093-33c3eed7acaf" xlink:href="iclr-20221231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_373f32f0-7e67-4f31-ad80-df5df1fcad44" xlink:to="loc_iclr_IncomeTaxBenefitMember_636db7c3-f19a-4aee-8093-33c3eed7acaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_fce46144-2050-49a7-a9fc-71fca31a493d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_fce46144-2050-49a7-a9fc-71fca31a493d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d3bcfa82-3ed4-42ce-9ee3-546096098770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d3bcfa82-3ed4-42ce-9ee3-546096098770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_e4da705a-e9ae-412a-9db5-2748633d9fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d3bcfa82-3ed4-42ce-9ee3-546096098770" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_e4da705a-e9ae-412a-9db5-2748633d9fae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f6188d0-3752-492d-8903-919d3572eb53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f6188d0-3752-492d-8903-919d3572eb53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_f65fb997-6c64-43ec-8742-8b33a8b4b5d9" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:to="loc_iclr_PRAHealthSciencesIncMember_f65fb997-6c64-43ec-8742-8b33a8b4b5d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcquiredEntityMember_016361a0-e87d-4b7a-8913-e981ff85da75" xlink:href="iclr-20221231.xsd#iclr_AcquiredEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:to="loc_iclr_AcquiredEntityMember_016361a0-e87d-4b7a-8913-e981ff85da75" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended" id="ifca14b2051fa47b69288565a0e0a4cda_IncomeTaxesExpectedExpiryDatesofNOLsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_e91bfbab-5084-4664-820f-a834bff7cdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_e91bfbab-5084-4664-820f-a834bff7cdef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_01372b00-7d45-4ec8-8ce5-e5bb479bdfee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_01372b00-7d45-4ec8-8ce5-e5bb479bdfee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_10a8a28d-2c67-4de0-a9d7-794c34e08ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_10a8a28d-2c67-4de0-a9d7-794c34e08ea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:to="loc_srt_SegmentGeographicalDomain_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9d0d4b2-d61f-4e05-a1f7-4a23c08a71f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:to="loc_srt_SegmentGeographicalDomain_e9d0d4b2-d61f-4e05-a1f7-4a23c08a71f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e74b61b7-6263-4894-8c08-6adce0d51b1a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9d0d4b2-d61f-4e05-a1f7-4a23c08a71f1" xlink:to="loc_country_US_e74b61b7-6263-4894-8c08-6adce0d51b1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_30b9ce69-3709-44f0-a564-51ff0ed4ed91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_30b9ce69-3709-44f0-a564-51ff0ed4ed91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_edbfc97a-0d1d-4d29-8db3-70da9037844d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_edbfc97a-0d1d-4d29-8db3-70da9037844d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_6a7a3de6-8147-4562-9434-445a7f8b39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_edbfc97a-0d1d-4d29-8db3-70da9037844d" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_6a7a3de6-8147-4562-9434-445a7f8b39d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ac07c11a-c825-4580-888e-02e4eb22a5b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ac07c11a-c825-4580-888e-02e4eb22a5b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_06a775a9-e45b-4a10-87b2-2f0cae9a46dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_06a775a9-e45b-4a10-87b2-2f0cae9a46dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_b7b017a9-ec3d-4585-a74f-1222f83aaf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_06a775a9-e45b-4a10-87b2-2f0cae9a46dc" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_b7b017a9-ec3d-4585-a74f-1222f83aaf6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_a2a9b9bf-7ce1-441d-b8c0-af6b95089307_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:to="loc_us-gaap_TaxPeriodDomain_a2a9b9bf-7ce1-441d-b8c0-af6b95089307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:to="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2023To2036Member_b5c6676d-efd9-4e2e-acb5-e8d841dfff11" xlink:href="iclr-20221231.xsd#iclr_TaxYear2023To2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:to="loc_iclr_TaxYear2023To2036Member_b5c6676d-efd9-4e2e-acb5-e8d841dfff11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20332041Member_728b518e-f0b7-4130-a278-82ac27680148" xlink:href="iclr-20221231.xsd#iclr_TaxYear20332041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:to="loc_iclr_TaxYear20332041Member_728b518e-f0b7-4130-a278-82ac27680148" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended" id="iaa26a809bef940e0971080d19a9e94ff_EmployeeBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_17943502-3f87-4fe1-89c0-61a8688865f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_17943502-3f87-4fe1-89c0-61a8688865f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_fe9725f1-0dfe-498d-b7a5-82083aea1a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_fe9725f1-0dfe-498d-b7a5-82083aea1a24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d932d79d-acd9-4074-bb87-995be42911de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d932d79d-acd9-4074-bb87-995be42911de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_7d791474-7c0d-4aca-a541-57f41cb6a063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_7d791474-7c0d-4aca-a541-57f41cb6a063" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_2c23d354-9bae-466e-bd18-4fd12f6110a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_2c23d354-9bae-466e-bd18-4fd12f6110a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a8681088-ba05-4599-8baf-e90ec187fdbf" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a8681088-ba05-4599-8baf-e90ec187fdbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_70aaf94e-caa4-4f75-83b5-b3f0b5651340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_70aaf94e-caa4-4f75-83b5-b3f0b5651340" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_77573063-a75c-4b3e-a54b-b4850958823c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_77573063-a75c-4b3e-a54b-b4850958823c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod_54a4153f-f979-4cf9-a0bd-09cea7f0cee5" xlink:href="iclr-20221231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_iclr_ExpectedRetirementPeriod_54a4153f-f979-4cf9-a0bd-09cea7f0cee5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7b4aff03-2d63-4c4e-9ec1-a8daa62e832d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7b4aff03-2d63-4c4e-9ec1-a8daa62e832d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_478be0ad-7bf9-4edc-8792-64b99f15fae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_478be0ad-7bf9-4edc-8792-64b99f15fae4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_b072a3b1-c0ae-4c16-9f27-6c272b3462f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_b072a3b1-c0ae-4c16-9f27-6c272b3462f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bac763ad-189a-41bf-83f7-4511d5be4f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bac763ad-189a-41bf-83f7-4511d5be4f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bac763ad-189a-41bf-83f7-4511d5be4f32" xlink:to="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3e536070-bb4b-414d-b1c1-0b0e7cb0887d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:to="loc_country_US_3e536070-bb4b-414d-b1c1-0b0e7cb0887d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_d41aa8b4-abe3-4580-a26b-db1c543519a0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:to="loc_country_GB_d41aa8b4-abe3-4580-a26b-db1c543519a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_9f66a933-c6b9-4945-a155-7884999a2031" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:to="loc_country_CH_9f66a933-c6b9-4945-a155-7884999a2031" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:to="loc_us-gaap_RetirementPlanNameDomain_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:to="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember_f4ec804c-08a5-4116-a2b9-4290f5ad1667" xlink:href="iclr-20221231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_OtherRetirementPlansMember_f4ec804c-08a5-4116-a2b9-4290f5ad1667" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c7134086-5219-45a3-89a0-198132dd6ec3" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c7134086-5219-45a3-89a0-198132dd6ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_f03996a8-672b-4277-be50-9fa568dded76" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_f03996a8-672b-4277-be50-9fa568dded76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_00fa4971-5c91-496f-849f-59791a0a750d" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_00fa4971-5c91-496f-849f-59791a0a750d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87091c16-26bb-4cf9-86ed-43e675040443_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87091c16-26bb-4cf9-86ed-43e675040443_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dd53a8f-4231-459b-bb0f-32666537186a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dd53a8f-4231-459b-bb0f-32666537186a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember_5a598da9-91f5-4a15-8b72-dfef0cbcc87e" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dd53a8f-4231-459b-bb0f-32666537186a" xlink:to="loc_iclr_AptivSolutionsMember_5a598da9-91f5-4a15-8b72-dfef0cbcc87e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" xlink:type="extended" id="i0a6cc928db78493aa2f2e34fffdc2de7_EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7327bbb1-9e2e-4fd9-8452-c7a6a938d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7327bbb1-9e2e-4fd9-8452-c7a6a938d8cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6fd2b8ad-fa92-49d6-93a0-5d88eaa2f8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6fd2b8ad-fa92-49d6-93a0-5d88eaa2f8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b0de56e3-14c2-47fd-8366-be20fcb3c744_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b0de56e3-14c2-47fd-8366-be20fcb3c744_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a4498d11-c50b-49c0-af4d-eedaea88427c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a4498d11-c50b-49c0-af4d-eedaea88427c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a2cbbd79-a99d-45ec-a144-d67baef10701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a4498d11-c50b-49c0-af4d-eedaea88427c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a2cbbd79-a99d-45ec-a144-d67baef10701" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff2f96df-87b6-4bd8-88ca-251454cf8802_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ff2f96df-87b6-4bd8-88ca-251454cf8802_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a6894a08-741d-4371-bc18-26fb99e27809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a6894a08-741d-4371-bc18-26fb99e27809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_f6fa8045-b5a8-4e9d-ba7e-54d545a2d1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a6894a08-741d-4371-bc18-26fb99e27809" xlink:to="loc_us-gaap_ForeignPlanMember_f6fa8045-b5a8-4e9d-ba7e-54d545a2d1e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_18a8fbac-15ee-4f86-add1-4f02e81067d2" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_f6fa8045-b5a8-4e9d-ba7e-54d545a2d1e2" xlink:to="loc_country_US_18a8fbac-15ee-4f86-add1-4f02e81067d2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended" id="id5128fcc8e674426b24f91f759c76a2c_EmployeeBenefitsFundedStatusDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_07d12d47-d938-4c64-beb6-bfb5f9905e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_07d12d47-d938-4c64-beb6-bfb5f9905e53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_951fabc9-638f-4f7a-b772-e5528abb8797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_951fabc9-638f-4f7a-b772-e5528abb8797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ca84f7e0-1dbc-4a80-91c2-8d12845b8a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ca84f7e0-1dbc-4a80-91c2-8d12845b8a5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_d6dabd1f-f53d-4d69-9085-08156e770c22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_d6dabd1f-f53d-4d69-9085-08156e770c22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_22a2ae85-caaa-492e-833b-8a3112b1a5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_22a2ae85-caaa-492e-833b-8a3112b1a5fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_22a2ae85-caaa-492e-833b-8a3112b1a5fd" xlink:to="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_c9f4aa88-7dad-4b58-8803-7cc73c4e5415" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:to="loc_country_GB_c9f4aa88-7dad-4b58-8803-7cc73c4e5415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_e0ea818a-73fd-4b9d-9f80-80a2c15cac2b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:to="loc_country_CH_e0ea818a-73fd-4b9d-9f80-80a2c15cac2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:to="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6cba35fa-5147-46b3-89e0-851e272a4e55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6cba35fa-5147-46b3-89e0-851e272a4e55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:to="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_cf13aafe-ceaa-4b8d-b2da-5304e8aab91d" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_cf13aafe-ceaa-4b8d-b2da-5304e8aab91d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_749353cf-f367-4bdc-b72f-9ce971a6e47b" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_749353cf-f367-4bdc-b72f-9ce971a6e47b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_cf332ca4-1a03-468a-92ff-5ae512e59943" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_cf332ca4-1a03-468a-92ff-5ae512e59943" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsChangeinBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="extended" id="id736e0b17cda40b58adb0eb4998025fb_EmployeeBenefitsChangeinBenefitObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5edaa8ef-a23a-492e-9d06-70a681acfa9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5edaa8ef-a23a-492e-9d06-70a681acfa9f" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_19583f00-b636-45d5-bdc4-02e6d8c4eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_19583f00-b636-45d5-bdc4-02e6d8c4eca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_2b1cb351-e2af-44d9-8643-6c8c7cb8537d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_2b1cb351-e2af-44d9-8643-6c8c7cb8537d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a1657705-dfd6-4ef0-9872-af5fa79149fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a1657705-dfd6-4ef0-9872-af5fa79149fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7addff6e-8de4-447b-bce0-34eb8c1aafbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7addff6e-8de4-447b-bce0-34eb8c1aafbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d8a77122-5754-4932-a9d9-ea7888266f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d8a77122-5754-4932-a9d9-ea7888266f76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1b995e45-4438-4919-9968-58d016c18f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1b995e45-4438-4919-9968-58d016c18f80" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_d50394ab-be65-4231-abe5-38290da1ae14" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_d50394ab-be65-4231-abe5-38290da1ae14" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2449e67f-5e01-43ef-aa06-c059ce4b5537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2449e67f-5e01-43ef-aa06-c059ce4b5537" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_41a7dd57-4d7d-4a57-8797-79afd11c8db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_41a7dd57-4d7d-4a57-8797-79afd11c8db5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4f0b91cf-569c-4b8e-a323-bfc0ae2e991b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4f0b91cf-569c-4b8e-a323-bfc0ae2e991b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_bdb54830-cb4c-4e6a-ae7f-ce7245bd9ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5edaa8ef-a23a-492e-9d06-70a681acfa9f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7346ad8d-3ab1-4c0c-a924-4ee0c01a9647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7346ad8d-3ab1-4c0c-a924-4ee0c01a9647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7346ad8d-3ab1-4c0c-a924-4ee0c01a9647" xlink:to="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4753f7cf-733e-42d5-8839-bb94240ffd46" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:to="loc_country_GB_4753f7cf-733e-42d5-8839-bb94240ffd46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_c6b1f2e4-7af4-4f66-8abc-58ede5e0d334" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:to="loc_country_CH_c6b1f2e4-7af4-4f66-8abc-58ede5e0d334" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_08b7339d-a47c-414a-8fab-7bdc46039588_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:to="loc_us-gaap_RetirementPlanNameDomain_08b7339d-a47c-414a-8fab-7bdc46039588_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:to="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_bf0ff75e-eb70-4571-838a-053cb73176dc" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_bf0ff75e-eb70-4571-838a-053cb73176dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_abaeb677-ac6a-47e7-ac59-d3f36be9583b" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_abaeb677-ac6a-47e7-ac59-d3f36be9583b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_153b56fb-bd5d-4c23-b201-5a1adb956a2f" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_153b56fb-bd5d-4c23-b201-5a1adb956a2f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsChangeinPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="extended" id="i99b04d64f3944b638e754a03d8c188d4_EmployeeBenefitsChangeinPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_947ef182-e116-4a89-b84d-34dfd63ca2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_947ef182-e116-4a89-b84d-34dfd63ca2f3" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_25f00ce8-93d1-4ce8-9862-dcd5ad4e0828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_25f00ce8-93d1-4ce8-9862-dcd5ad4e0828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8427df9d-ff05-4546-bc19-8039925a7535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8427df9d-ff05-4546-bc19-8039925a7535" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e6dc1b2b-69ca-4550-bd8b-50d581a924eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e6dc1b2b-69ca-4550-bd8b-50d581a924eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions_bf8a0093-5461-48ca-ab61-bc60d5f19180" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_iclr_DefinedBenefitPlanSchemeContributions_bf8a0093-5461-48ca-ab61-bc60d5f19180" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5c33cf7e-33c7-418d-a680-a25f156ca834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5c33cf7e-33c7-418d-a680-a25f156ca834" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d3b474b9-1e02-4aa6-8c0d-99003ee32665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d3b474b9-1e02-4aa6-8c0d-99003ee32665" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_e650e06e-27d4-433d-a3ac-74e3066b45ea" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_e650e06e-27d4-433d-a3ac-74e3066b45ea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_75d22823-2ea3-4224-9c3e-c98d23d6dc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_75d22823-2ea3-4224-9c3e-c98d23d6dc6c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dbbc75d1-5267-40da-a05e-1da328584919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dbbc75d1-5267-40da-a05e-1da328584919" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_d2d028dd-ee84-4222-b129-5b76d2676785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_d2d028dd-ee84-4222-b129-5b76d2676785" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ca94ccc5-6d2f-4591-86f0-c55943d0f75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_947ef182-e116-4a89-b84d-34dfd63ca2f3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a5091d01-7265-455a-8a45-4888795f6471_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a5091d01-7265-455a-8a45-4888795f6471_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_24cd551c-21cf-4d30-a879-451fd41a9c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_24cd551c-21cf-4d30-a879-451fd41a9c2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_24cd551c-21cf-4d30-a879-451fd41a9c2e" xlink:to="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_a476cffd-5420-4483-9c9f-27109b506768" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:to="loc_country_GB_a476cffd-5420-4483-9c9f-27109b506768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_5fa3236e-00f2-4ea6-89fa-31a949ccbb05" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:to="loc_country_CH_5fa3236e-00f2-4ea6-89fa-31a949ccbb05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:to="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_0904f469-b277-478f-8767-1a0b8de48f42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:to="loc_us-gaap_RetirementPlanNameDomain_0904f469-b277-478f-8767-1a0b8de48f42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:to="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_b293c51d-8a8e-4760-a553-c70405ec2303" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_b293c51d-8a8e-4760-a553-c70405ec2303" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_35fee0e2-a676-42d8-a322-9793794dd2d6" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_35fee0e2-a676-42d8-a322-9793794dd2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_666194a6-ce1b-4723-9efd-ad24d2ebef14" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_666194a6-ce1b-4723-9efd-ad24d2ebef14" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="ib9fe534994f04843aac659922b6c9260_EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6426e545-b8bf-42a5-af21-69e5a25e5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6426e545-b8bf-42a5-af21-69e5a25e5a9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b7960de6-e8ac-4613-924f-e90dec7c719c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b7960de6-e8ac-4613-924f-e90dec7c719c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fa4c4237-3c03-44f4-9d31-99a12387a6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fa4c4237-3c03-44f4-9d31-99a12387a6c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_915821ec-b1bb-4ec9-bef5-cf5fd3cd5c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_915821ec-b1bb-4ec9-bef5-cf5fd3cd5c4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_61944679-b840-420a-bea4-06496b7057d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_61944679-b840-420a-bea4-06496b7057d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8046a4d7-cf18-4f76-a02b-9f9d7632fc54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8046a4d7-cf18-4f76-a02b-9f9d7632fc54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f59afd8e-2c11-44e2-ba72-919530c57e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f59afd8e-2c11-44e2-ba72-919530c57e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f59afd8e-2c11-44e2-ba72-919530c57e36" xlink:to="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0ee5a015-d34e-4405-bd89-6a80417c171c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:to="loc_country_GB_0ee5a015-d34e-4405-bd89-6a80417c171c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_0a2be91b-578b-4fd4-ab67-c4d8bf38b7e7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:to="loc_country_CH_0a2be91b-578b-4fd4-ab67-c4d8bf38b7e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:to="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_defdce83-01b5-4f1b-baad-98e1c5fbde6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:to="loc_us-gaap_RetirementPlanNameDomain_defdce83-01b5-4f1b-baad-98e1c5fbde6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_41813042-9a74-49db-aa7b-5d081718ee68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:to="loc_us-gaap_RetirementPlanNameDomain_41813042-9a74-49db-aa7b-5d081718ee68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7b6c325f-aef0-4731-9e21-6f6e3299355f" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_41813042-9a74-49db-aa7b-5d081718ee68" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7b6c325f-aef0-4731-9e21-6f6e3299355f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended" id="i58723b2066da4e8caab9422f90c13cf6_EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_66d956ec-eb4c-4dce-ac30-634dc7a7149c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_66d956ec-eb4c-4dce-ac30-634dc7a7149c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_41104649-93c6-4fa6-9d3f-b494f2d7fce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_41104649-93c6-4fa6-9d3f-b494f2d7fce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_074ef6e9-ca4c-4386-8225-5d4823ac38b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_074ef6e9-ca4c-4386-8225-5d4823ac38b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_9e6194ab-4959-429f-93a7-4895a5029e16" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_9e6194ab-4959-429f-93a7-4895a5029e16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0ced9d31-6a85-43ef-83d6-d443835ace1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0ced9d31-6a85-43ef-83d6-d443835ace1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_fb524b26-be0f-40ae-9eb4-74dfba9fabd1" xlink:href="iclr-20221231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_fb524b26-be0f-40ae-9eb4-74dfba9fabd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_932c3f1b-780a-4d34-b6af-6f8f17884c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_932c3f1b-780a-4d34-b6af-6f8f17884c9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_522372d3-e129-4aff-91c8-5bbcfca1e354_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_522372d3-e129-4aff-91c8-5bbcfca1e354_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4d0a2f74-f257-486f-b334-7842deae9cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4d0a2f74-f257-486f-b334-7842deae9cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4d0a2f74-f257-486f-b334-7842deae9cd4" xlink:to="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_cc3bff55-f07b-4b06-b9ce-6145e2f7fcd8" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:to="loc_country_GB_cc3bff55-f07b-4b06-b9ce-6145e2f7fcd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_16259c88-896a-4b54-b80c-0fbd32c4893d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:to="loc_country_CH_16259c88-896a-4b54-b80c-0fbd32c4893d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:to="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_27be57a6-2368-4610-a2f7-0807a5aff90e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:to="loc_us-gaap_RetirementPlanNameDomain_27be57a6-2368-4610-a2f7-0807a5aff90e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_b6b83f09-bd3c-4010-81c8-87873e03ec43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:to="loc_us-gaap_RetirementPlanNameDomain_b6b83f09-bd3c-4010-81c8-87873e03ec43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e6969f33-c39e-48c5-9c94-8beeda61aabf" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_b6b83f09-bd3c-4010-81c8-87873e03ec43" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e6969f33-c39e-48c5-9c94-8beeda61aabf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="extended" id="ifd2224594c6c4931a44d7898008ef8d7_EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_915ab9e1-87eb-45fe-9561-af94dd4f2671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_915ab9e1-87eb-45fe-9561-af94dd4f2671" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_002a75c2-ebb7-4cae-bc8b-a1308a8e16c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_002a75c2-ebb7-4cae-bc8b-a1308a8e16c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf326f4c-c558-467c-a9e7-b7c4d4ae29be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bf326f4c-c558-467c-a9e7-b7c4d4ae29be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8f246cfc-7df2-4e4a-b434-7856e20281b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8f246cfc-7df2-4e4a-b434-7856e20281b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_7321bce5-326f-40f1-9cb1-a4933a665f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8f246cfc-7df2-4e4a-b434-7856e20281b8" xlink:to="loc_us-gaap_ForeignPlanMember_7321bce5-326f-40f1-9cb1-a4933a665f31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_eeeb0b04-6a05-416c-a6a6-e9daa98abf8c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_7321bce5-326f-40f1-9cb1-a4933a665f31" xlink:to="loc_country_GB_eeeb0b04-6a05-416c-a6a6-e9daa98abf8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d95941f4-081a-4483-a92f-41b8e8ce243f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d95941f4-081a-4483-a92f-41b8e8ce243f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6485cd7f-4ffe-413f-af0b-8213def3af0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6485cd7f-4ffe-413f-af0b-8213def3af0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7125fe8a-3a83-4ded-8b6a-8df18e0e289d" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6485cd7f-4ffe-413f-af0b-8213def3af0c" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7125fe8a-3a83-4ded-8b6a-8df18e0e289d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="extended" id="ic64b566e2871455c932b6524ca2aa982_EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b2e29b-4343-4038-b316-cfdfb71f9ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2fe9919b-1e50-4d1f-9bce-3c8bde0368e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b2e29b-4343-4038-b316-cfdfb71f9ca2" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2fe9919b-1e50-4d1f-9bce-3c8bde0368e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b2e29b-4343-4038-b316-cfdfb71f9ca2" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_1f114e7e-b88f-4453-965f-deb59bab3a72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_1f114e7e-b88f-4453-965f-deb59bab3a72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a37dff34-c374-494b-977e-c444995a71ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a37dff34-c374-494b-977e-c444995a71ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_43ed90c0-e6a2-41c6-83ef-f6335875a8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a37dff34-c374-494b-977e-c444995a71ce" xlink:to="loc_us-gaap_ForeignPlanMember_43ed90c0-e6a2-41c6-83ef-f6335875a8c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_becfd00a-37a9-49bd-b8f9-54ec27e2a375" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_43ed90c0-e6a2-41c6-83ef-f6335875a8c1" xlink:to="loc_country_GB_becfd00a-37a9-49bd-b8f9-54ec27e2a375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_b3761745-d667-433d-96ee-02c66a963216_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_b3761745-d667-433d-96ee-02c66a963216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_dec712d5-440a-4965-add2-f7ce83f56825" xlink:href="iclr-20221231.xsd#iclr_GovernmentBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_iclr_GovernmentBondsMember_dec712d5-440a-4965-add2-f7ce83f56825" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_6e1a3c59-ff63-44fe-afd5-2e71cf48d261" xlink:href="iclr-20221231.xsd#iclr_DiversifiedBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_iclr_DiversifiedBondsMember_6e1a3c59-ff63-44fe-afd5-2e71cf48d261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ffac487c-9a75-4acd-9ca0-0c34ee131247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ffac487c-9a75-4acd-9ca0-0c34ee131247" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_68c2e86e-e06b-4f45-800f-36657ae52ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_68c2e86e-e06b-4f45-800f-36657ae52ccf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_31de2a08-d12f-459b-a589-be373fe48c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_31de2a08-d12f-459b-a589-be373fe48c3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_33b2a613-a734-4d90-9816-828780ea630b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_33b2a613-a734-4d90-9816-828780ea630b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_020deb5d-adf7-4d43-a84e-a0de6d85b66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_020deb5d-adf7-4d43-a84e-a0de6d85b66e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_0a676c60-1f3b-42d9-ae23-b07619e965ec" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_020deb5d-adf7-4d43-a84e-a0de6d85b66e" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_0a676c60-1f3b-42d9-ae23-b07619e965ec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="extended" id="i04c51ac5fd1247988ff1e84047f7a4c8_EmployeeBenefitsPlanAssetFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d0e8bb2-d1f0-4a7e-943f-8bb0568e5b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e1d213e-d290-4291-9487-8607c81076dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d0e8bb2-d1f0-4a7e-943f-8bb0568e5b7a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e1d213e-d290-4291-9487-8607c81076dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d0e8bb2-d1f0-4a7e-943f-8bb0568e5b7a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14330de3-c367-47d1-8b9b-6dcd3c977e0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14330de3-c367-47d1-8b9b-6dcd3c977e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_50fbfb1f-68e6-4a86-a437-e7960537417f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_50fbfb1f-68e6-4a86-a437-e7960537417f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3a4e44e0-900c-471f-97fb-431e76c10cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_50fbfb1f-68e6-4a86-a437-e7960537417f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3a4e44e0-900c-471f-97fb-431e76c10cdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_6a2f6b64-1dce-4914-bc0a-a2994e37d19b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_6a2f6b64-1dce-4914-bc0a-a2994e37d19b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_cdd3184d-0281-43c2-b40e-9c641d613e1e" xlink:href="iclr-20221231.xsd#iclr_GovernmentBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_iclr_GovernmentBondsMember_cdd3184d-0281-43c2-b40e-9c641d613e1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_49c8485d-05fe-4a41-a38e-a7129bb6256f" xlink:href="iclr-20221231.xsd#iclr_DiversifiedBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_iclr_DiversifiedBondsMember_49c8485d-05fe-4a41-a38e-a7129bb6256f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_eaafcb66-3f73-49db-8de7-5779e1f8c394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_eaafcb66-3f73-49db-8de7-5779e1f8c394" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_aa625ca7-6ebe-4c74-944b-280f202d643c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_aa625ca7-6ebe-4c74-944b-280f202d643c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_5437294e-d2ba-4b0a-b207-52ea1f035a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_5437294e-d2ba-4b0a-b207-52ea1f035a58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_e123fa70-9e26-4486-b811-956e4974fd95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:to="loc_us-gaap_RetirementPlanNameDomain_e123fa70-9e26-4486-b811-956e4974fd95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_f976157c-8624-4119-a217-24910c059cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:to="loc_us-gaap_RetirementPlanNameDomain_f976157c-8624-4119-a217-24910c059cef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_d9423f59-4473-4221-9983-c858590946a5" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_f976157c-8624-4119-a217-24910c059cef" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_d9423f59-4473-4221-9983-c858590946a5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsAnnualBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="extended" id="i7bd436749b934d55b57e4b594f08559c_EmployeeBenefitsAnnualBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b233fda7-2a5c-4f6c-bc1f-ed93de49d0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b233fda7-2a5c-4f6c-bc1f-ed93de49d0c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_fb2dadc0-1190-4c26-99b9-e29880b24009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_fb2dadc0-1190-4c26-99b9-e29880b24009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_41b631fd-b2b0-41f0-b236-b136083ea6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_41b631fd-b2b0-41f0-b236-b136083ea6dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b6a48911-77af-4a62-bbb6-be9e96b8b1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b6a48911-77af-4a62-bbb6-be9e96b8b1f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_911b4288-a641-4920-a05b-7559fc154cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_911b4288-a641-4920-a05b-7559fc154cfb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_8dbc7151-f286-4e85-8b1a-1571142f408d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_8dbc7151-f286-4e85-8b1a-1571142f408d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_82d9555f-f596-4ffa-861a-7cac487abc6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_82d9555f-f596-4ffa-861a-7cac487abc6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_08bf7d9d-fcfa-45ef-990b-9b671fc0f7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_08bf7d9d-fcfa-45ef-990b-9b671fc0f7c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_08bf7d9d-fcfa-45ef-990b-9b671fc0f7c0" xlink:to="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_11da9c65-e918-4eb6-8a49-424586ea01ea" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:to="loc_country_GB_11da9c65-e918-4eb6-8a49-424586ea01ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_0bb74a0d-685a-4955-b9bb-681f97bf2875" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:to="loc_country_CH_0bb74a0d-685a-4955-b9bb-681f97bf2875" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:to="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_18461b99-09d2-4c43-9275-1bb42c9769fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:to="loc_us-gaap_PlanNameDomain_18461b99-09d2-4c43-9275-1bb42c9769fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_40c36552-b3df-4be7-837e-f3fdf824cdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:to="loc_us-gaap_PlanNameDomain_40c36552-b3df-4be7-837e-f3fdf824cdad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f927b0b1-2b84-49f5-a875-aa9538bf9aa6" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_40c36552-b3df-4be7-837e-f3fdf824cdad" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f927b0b1-2b84-49f5-a875-aa9538bf9aa6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended" id="ied3f6dae0fbb425f82dfd08677d65099_EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:href="iclr-20221231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_dba09957-7c7e-414f-8be0-8be4b6ada525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_dba09957-7c7e-414f-8be0-8be4b6ada525" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_ecedbc9d-6661-4d10-868c-f5b104f0c95e" xlink:href="iclr-20221231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_ecedbc9d-6661-4d10-868c-f5b104f0c95e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0a902f3b-93de-41d6-b08c-5f1309d982de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0a902f3b-93de-41d6-b08c-5f1309d982de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_60b0862e-4bbf-4def-97c6-38968ecad68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_60b0862e-4bbf-4def-97c6-38968ecad68b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_42177d93-1f9b-48d6-ad98-dca87ad50979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_42177d93-1f9b-48d6-ad98-dca87ad50979" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_79ae271d-812e-404f-8cf3-22c166d48627" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_79ae271d-812e-404f-8cf3-22c166d48627" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a045f642-1699-4150-b292-65f1bb9eaf08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a045f642-1699-4150-b292-65f1bb9eaf08" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_fcd9c87c-85fc-425f-819f-353aba33a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_fcd9c87c-85fc-425f-819f-353aba33a2fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d53d8476-bc31-4765-9e0d-c9e3cefe04e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d53d8476-bc31-4765-9e0d-c9e3cefe04e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6dc76e1b-dd27-4b71-abd3-5e1e26e64aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6dc76e1b-dd27-4b71-abd3-5e1e26e64aff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_afec267e-8362-4e53-90b7-8a92af6386df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_afec267e-8362-4e53-90b7-8a92af6386df" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_b84849ac-a16f-4f91-ba2c-f181e519f693" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_b84849ac-a16f-4f91-ba2c-f181e519f693" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_256ee856-bc4c-4821-9c6c-7ebc457e4249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_256ee856-bc4c-4821-9c6c-7ebc457e4249" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ca86841e-cb3d-4618-9346-0a3cf531cbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensation_ca86841e-cb3d-4618-9346-0a3cf531cbe3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0d96db84-884e-45be-a2e4-0a28d8f045b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0d96db84-884e-45be-a2e4-0a28d8f045b6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5177649c-df2b-4c9a-86a5-96f7a5b39024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5177649c-df2b-4c9a-86a5-96f7a5b39024" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:href="iclr-20221231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e63ae4e3-581f-4def-a46d-847341ab676a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e63ae4e3-581f-4def-a46d-847341ab676a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_01126b89-4562-49be-ac8b-10963c16568d" xlink:href="iclr-20221231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_01126b89-4562-49be-ac8b-10963c16568d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_01744271-3793-42a7-99b1-08c2d831ddf9" xlink:href="iclr-20221231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_01744271-3793-42a7-99b1-08c2d831ddf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_c3a67daf-6503-443b-a076-fe2682467012" xlink:href="iclr-20221231.xsd#iclr_OptionPlans2008Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_OptionPlans2008Member_c3a67daf-6503-443b-a076-fe2682467012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_64f7077b-fc2d-4883-88c5-dbc47698e396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_us-gaap_EmployeeStockOptionMember_64f7077b-fc2d-4883-88c5-dbc47698e396" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_1222f3af-a2b8-445f-a0cd-4f914abd8814" xlink:href="iclr-20221231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_1222f3af-a2b8-445f-a0cd-4f914abd8814" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_dab8196f-6302-4279-9f2f-6ac9ae4c795d" xlink:href="iclr-20221231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_dab8196f-6302-4279-9f2f-6ac9ae4c795d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6054b415-cf8a-41e2-b5d7-a0f454025b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6054b415-cf8a-41e2-b5d7-a0f454025b45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_d4562ebf-6435-4dba-ba69-acb4a917624f" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_PerformanceShareUnitMember_d4562ebf-6435-4dba-ba69-acb4a917624f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_80107b8a-8042-485c-9349-1c7bb7bb767d" xlink:href="iclr-20221231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_PerformanceBasedGrantsMember_80107b8a-8042-485c-9349-1c7bb7bb767d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_d5e0f193-243a-42bf-80b2-301c466e505d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:to="loc_us-gaap_AwardDateDomain_d5e0f193-243a-42bf-80b2-301c466e505d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_15694215-afe9-42d4-8de1-272d5af55f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:to="loc_us-gaap_AwardDateDomain_15694215-afe9-42d4-8de1-272d5af55f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_d1c4f641-55ce-4d22-a75d-4e9a5fc68e02" xlink:href="iclr-20221231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_15694215-afe9-42d4-8de1-272d5af55f48" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_d1c4f641-55ce-4d22-a75d-4e9a5fc68e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dc8005d9-9f83-4ff7-965e-7a3629ec1441_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:to="loc_srt_RangeMember_dc8005d9-9f83-4ff7-965e-7a3629ec1441_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:to="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0414ff38-5ccf-43b5-8658-b0412027d43d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:to="loc_srt_MinimumMember_0414ff38-5ccf-43b5-8658-b0412027d43d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bddece49-6db0-4c5e-aa96-a7e4cc5605ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:to="loc_srt_MaximumMember_bddece49-6db0-4c5e-aa96-a7e4cc5605ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_21d13d7e-b631-4c0b-b039-8d5ea27ee25f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_21d13d7e-b631-4c0b-b039-8d5ea27ee25f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7aa06d4b-831d-4055-ab45-28d0806dc93e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7aa06d4b-831d-4055-ab45-28d0806dc93e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_eda71ac0-eea1-42af-a0a4-b4602280bd5f" xlink:href="iclr-20221231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7aa06d4b-831d-4055-ab45-28d0806dc93e" xlink:to="loc_iclr_NonexecutiveDirectorMember_eda71ac0-eea1-42af-a0a4-b4602280bd5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_521631a5-4a5b-4766-a27e-38c99df6ef76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:to="loc_us-gaap_PlanNameDomain_521631a5-4a5b-4766-a27e-38c99df6ef76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:to="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_cfc5d105-c8fc-4ad2-8c43-6a591c59e62d" xlink:href="iclr-20221231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_cfc5d105-c8fc-4ad2-8c43-6a591c59e62d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2013LegacyPRAPlanMember_f4eca020-3635-42eb-912b-c6e5b360c877" xlink:href="iclr-20221231.xsd#iclr_A2013LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:to="loc_iclr_A2013LegacyPRAPlanMember_f4eca020-3635-42eb-912b-c6e5b360c877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_02058c0f-32ac-44fb-a208-372d1bd7bedf" xlink:href="iclr-20221231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_02058c0f-32ac-44fb-a208-372d1bd7bedf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended" id="id881c980f3ce4d0cbe3cd617cd661c6e_EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1081df8-beb5-4a44-ab25-03683e7412b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1081df8-beb5-4a44-ab25-03683e7412b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_fb14abe8-01cc-4b66-931a-505ab6be4f8b" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_fb14abe8-01cc-4b66-931a-505ab6be4f8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ba58827-36ca-46a5-81da-f33e82b399b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ba58827-36ca-46a5-81da-f33e82b399b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_93951c9e-0340-4b4e-b1cc-0cb29b5bdac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_93951c9e-0340-4b4e-b1cc-0cb29b5bdac5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cf18a678-225a-4b50-abe4-d7025efb46dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cf18a678-225a-4b50-abe4-d7025efb46dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4047bf-9dba-407b-8cc2-f939b21d6273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b491dc35-4cab-4d90-9a9e-ce6bc8218bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b491dc35-4cab-4d90-9a9e-ce6bc8218bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e3b43cd8-b683-4dec-a188-dc15e88c4299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e3b43cd8-b683-4dec-a188-dc15e88c4299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_7f6be4c4-52a5-405f-8762-578ab152d74e" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_7f6be4c4-52a5-405f-8762-578ab152d74e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd9d259e-49aa-48f5-a6f8-ca6ef2e2c579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd9d259e-49aa-48f5-a6f8-ca6ef2e2c579" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b7a0dcbe-0088-401f-952b-3d1122450b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b7a0dcbe-0088-401f-952b-3d1122450b2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a6eaea3b-52bb-4c9c-b287-bd3a84565a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a6eaea3b-52bb-4c9c-b287-bd3a84565a8d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d1ce892-7f93-43dd-9ef7-72cd319606a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_a9c2711e-d41f-4d61-a76b-06efd2d32d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_a9c2711e-d41f-4d61-a76b-06efd2d32d46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:to="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa6733d-ae77-4369-a991-489993afb03b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fa6733d-ae77-4369-a991-489993afb03b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f2aaa22-be18-470a-a621-2f8f6e869cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f2aaa22-be18-470a-a621-2f8f6e869cd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_03688f48-e044-4cea-9cd9-43f8d92cdf4c" xlink:href="iclr-20221231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f2aaa22-be18-470a-a621-2f8f6e869cd8" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_03688f48-e044-4cea-9cd9-43f8d92cdf4c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="extended" id="if2583ebe73c1493ab9f9cbe097856a84_EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbfe6f7c-0310-4ece-b4a4-607405a9bc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbfe6f7c-0310-4ece-b4a4-607405a9bc1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f5b0b49f-7b0f-4ec6-a251-dc110981989e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f5b0b49f-7b0f-4ec6-a251-dc110981989e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_56228bc5-acdc-4895-aa70-1f17d5fa0508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_56228bc5-acdc-4895-aa70-1f17d5fa0508" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b17f83a-4d6d-4e93-bebb-c8503eb3a30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b17f83a-4d6d-4e93-bebb-c8503eb3a30e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3f8cf49f-7245-425a-b78c-10a4993a4167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3f8cf49f-7245-425a-b78c-10a4993a4167" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_83c98717-29b1-40b6-8cb5-cefe8fc162d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_83c98717-29b1-40b6-8cb5-cefe8fc162d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_878793c2-5e33-424a-961d-2ad47dd480e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_878793c2-5e33-424a-961d-2ad47dd480e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:to="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_618456d3-3e72-4230-9ac3-fd9e85b2d7dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_618456d3-3e72-4230-9ac3-fd9e85b2d7dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef17398e-a703-410d-b961-6fa74a05c532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef17398e-a703-410d-b961-6fa74a05c532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_ebd6acd5-3f62-479a-801c-23d8ff7d337a" xlink:href="iclr-20221231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef17398e-a703-410d-b961-6fa74a05c532" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_ebd6acd5-3f62-479a-801c-23d8ff7d337a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_179b4f34-c9c4-4605-9339-286715cf5a1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_179b4f34-c9c4-4605-9339-286715cf5a1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member_86dbc419-3195-4357-b32f-c1474fcb9da3" xlink:href="iclr-20221231.xsd#iclr_Range1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range1Member_86dbc419-3195-4357-b32f-c1474fcb9da3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member_5fd73e5d-fcc3-413b-be21-36274421c49b" xlink:href="iclr-20221231.xsd#iclr_Range2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range2Member_5fd73e5d-fcc3-413b-be21-36274421c49b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member_6b5f3ec3-3079-49e6-97b9-0ac43738acf1" xlink:href="iclr-20221231.xsd#iclr_Range3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range3Member_6b5f3ec3-3079-49e6-97b9-0ac43738acf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member_d7dc6ceb-aa3c-493c-bbc2-d40d53aa9592" xlink:href="iclr-20221231.xsd#iclr_Range4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range4Member_d7dc6ceb-aa3c-493c-bbc2-d40d53aa9592" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended" id="icc3f8057dd3644dfaac5d526794874ef_EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_29972ef5-3d40-47ea-afe3-ff132bbd39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_29972ef5-3d40-47ea-afe3-ff132bbd39d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_79e215d4-cb93-40ef-8004-942106dcf69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_79e215d4-cb93-40ef-8004-942106dcf69c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca554c6b-48db-4041-aa07-0978a3910763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca554c6b-48db-4041-aa07-0978a3910763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9ac4f1fc-841c-4197-9372-2ee92d9ab828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9ac4f1fc-841c-4197-9372-2ee92d9ab828" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7a1635c9-e27d-41e3-98b6-a5ad149930fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7a1635c9-e27d-41e3-98b6-a5ad149930fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:to="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba815b-0217-48d8-b323-7cb99e158f98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0ba815b-0217-48d8-b323-7cb99e158f98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7dcf49-2429-4af5-9e60-95bfaa515ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7dcf49-2429-4af5-9e60-95bfaa515ff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_82b43907-2178-4fd6-aeed-f061080ca027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7dcf49-2429-4af5-9e60-95bfaa515ff9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_82b43907-2178-4fd6-aeed-f061080ca027" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended" id="i97de891838d049418990c62d241a8ff1_EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a64015b7-77d2-4f14-a1c1-c8da1c9c52ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a64015b7-77d2-4f14-a1c1-c8da1c9c52ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24177796-7a66-4d10-ba90-0a5e80523ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24177796-7a66-4d10-ba90-0a5e80523ae9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bec58884-1878-4c84-96fc-3df8da886885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bec58884-1878-4c84-96fc-3df8da886885" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a83dbe74-7a16-46bf-9f64-6dcadc33aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a83dbe74-7a16-46bf-9f64-6dcadc33aa0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e7026835-7d70-4519-9ae7-6a21caca129e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_83e143dc-319e-41e1-a8a4-f8728af1f534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_83e143dc-319e-41e1-a8a4-f8728af1f534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f622827-5dd4-41cb-a627-9a1a901f6bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f622827-5dd4-41cb-a627-9a1a901f6bfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_829cc49d-962c-43e7-83d1-739f57b1c533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_829cc49d-962c-43e7-83d1-739f57b1c533" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85d294d6-0eef-4f4b-923a-04dae6bc7f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85d294d6-0eef-4f4b-923a-04dae6bc7f0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d8a6bd9f-44b2-4d7a-8601-82cfa37f254c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:to="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_f034bddf-ac50-42b7-ab47-23931300e52e" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:to="loc_iclr_PerformanceShareUnitMember_f034bddf-ac50-42b7-ab47-23931300e52e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_282ab635-0076-4d71-949d-e891632fb886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_282ab635-0076-4d71-949d-e891632fb886" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended" id="iba0a5171383147e5bcd2e33f1f06a637_EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4ace579b-7cce-4ef3-a0f9-7c43d327b713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_16f20a9b-5e3a-49d9-8ecb-b54170c1220b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4ace579b-7cce-4ef3-a0f9-7c43d327b713" xlink:to="loc_us-gaap_ShareBasedCompensation_16f20a9b-5e3a-49d9-8ecb-b54170c1220b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4ace579b-7cce-4ef3-a0f9-7c43d327b713" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e99200dc-eac4-4956-9c5d-6c5f50176f94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e99200dc-eac4-4956-9c5d-6c5f50176f94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_35121d47-f062-40da-b129-edc9998a247a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:to="loc_us-gaap_CostOfSalesMember_35121d47-f062-40da-b129-edc9998a247a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dda9e558-a763-4cc5-b16f-ad211b698efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dda9e558-a763-4cc5-b16f-ad211b698efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember_85590e6a-1dbc-42c5-bf3a-89b6ecb1e167" xlink:href="iclr-20221231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:to="loc_iclr_TransactionAndIntegrationExpenseMember_85590e6a-1dbc-42c5-bf3a-89b6ecb1e167" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended" id="ib32ff869839149e3be33783f694f915c_BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f8809948-6b5d-45d8-8656-56f383059eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d3c65f24-9110-45b4-8848-106b926103c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f8809948-6b5d-45d8-8656-56f383059eca" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d3c65f24-9110-45b4-8848-106b926103c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f8809948-6b5d-45d8-8656-56f383059eca" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:to="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1149678-58eb-47f7-8947-a0a2f5f70758_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:to="loc_srt_SegmentGeographicalDomain_f1149678-58eb-47f7-8947-a0a2f5f70758_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:to="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_dbefb1f5-e59a-4c7f-ae60-2ab31c731430" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_country_IE_dbefb1f5-e59a-4c7f-ae60-2ab31c731430" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_1bdc56fd-f9d4-4348-9fc2-5a63ec564c1e" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_iclr_RestOfEuropeMember_1bdc56fd-f9d4-4348-9fc2-5a63ec564c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b80c5c4e-a1a0-44a1-b38e-645b5d2a53c1" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_country_US_b80c5c4e-a1a0-44a1-b38e-645b5d2a53c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_5941ec24-1c45-46eb-bc72-f04df976b1cc" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_iclr_OtherCountriesMember_5941ec24-1c45-46eb-bc72-f04df976b1cc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended" id="i1c4f2267b64e45e6ba67427078c4f06d_BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8a336ff0-f7ee-4e1e-97f3-f2e5a8b4f9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_53b58817-d242-4277-8d64-2edfd0dea63d" xlink:href="iclr-20221231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a336ff0-f7ee-4e1e-97f3-f2e5a8b4f9f8" xlink:to="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_53b58817-d242-4277-8d64-2edfd0dea63d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a336ff0-f7ee-4e1e-97f3-f2e5a8b4f9f8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:to="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c1fc6132-d41c-4650-8076-5a8092ad4a69_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:to="loc_srt_SegmentGeographicalDomain_c1fc6132-d41c-4650-8076-5a8092ad4a69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:to="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_5dbc0ad0-2141-4cd5-865c-54b3be4f8341" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_country_IE_5dbc0ad0-2141-4cd5-865c-54b3be4f8341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_baede337-f253-487b-a0b2-6939e1259dfc" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_iclr_RestOfEuropeMember_baede337-f253-487b-a0b2-6939e1259dfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_06edf4d0-2e98-4a16-9919-8395c33486cd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_country_US_06edf4d0-2e98-4a16-9919-8395c33486cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_c7b96061-16a8-4d1e-9dc5-b23034636cce" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_iclr_OtherCountriesMember_c7b96061-16a8-4d1e-9dc5-b23034636cce" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended" id="if9d199e63d9a4b4690022a9e97dd5471_BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c19266b7-fa27-42b7-9a77-a0bba3339144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_dc47a8c1-f75c-4eb8-a564-15e7f1498099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19266b7-fa27-42b7-9a77-a0bba3339144" xlink:to="loc_us-gaap_NoncurrentAssets_dc47a8c1-f75c-4eb8-a564-15e7f1498099" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19266b7-fa27-42b7-9a77-a0bba3339144" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:to="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c57efe30-7214-455a-829a-d88eb74ee680_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:to="loc_srt_SegmentGeographicalDomain_c57efe30-7214-455a-829a-d88eb74ee680_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:to="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_ec138a8c-2ed7-4f4b-83b4-4fdca7f2f3f7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_country_IE_ec138a8c-2ed7-4f4b-83b4-4fdca7f2f3f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_6e472f76-3c00-4584-b9ed-0558b432edd8" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_iclr_RestOfEuropeMember_6e472f76-3c00-4584-b9ed-0558b432edd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_57d4c465-47de-493e-af5a-6da25920b021" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_country_US_57d4c465-47de-493e-af5a-6da25920b021" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_039f0a83-2559-49ba-bf65-3098d76c9847" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_iclr_OtherCountriesMember_039f0a83-2559-49ba-bf65-3098d76c9847" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#RelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended" id="iadf27e9835c74fd981caf0a14ab7f37f_RelatedPartiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_32ae081a-9a6d-433f-bead-f6180b9ca87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_RevenueFromRelatedParties_32ae081a-9a6d-433f-bead-f6180b9ca87f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_d4f63eb4-6193-43e2-b7d1-ddd5b652a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_DueFromRelatedParties_d4f63eb4-6193-43e2-b7d1-ddd5b652a4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_06f67caf-925c-4227-bccc-93d0a70e227c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_06f67caf-925c-4227-bccc-93d0a70e227c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d61968cc-1fdf-48b9-befb-d1ca5ffe2d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d61968cc-1fdf-48b9-befb-d1ca5ffe2d43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_cc23bcf5-833b-4051-96c7-8f0b550877cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_cc23bcf5-833b-4051-96c7-8f0b550877cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_800fc824-2075-4faf-9920-bc5903b26cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_800fc824-2075-4faf-9920-bc5903b26cac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestReceivableRelatedPartyLoans_dec1d980-c4ac-4595-b51c-fac241477dc9" xlink:href="iclr-20221231.xsd#iclr_InterestReceivableRelatedPartyLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_iclr_InterestReceivableRelatedPartyLoans_dec1d980-c4ac-4595-b51c-fac241477dc9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_e7da9e19-6cae-42ad-b513-5b49d09c3167" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_e7da9e19-6cae-42ad-b513-5b49d09c3167" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_a2af62cd-9863-458c-b269-d750d6e468fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_a2af62cd-9863-458c-b269-d750d6e468fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DSBiopharmaLimitedMember_3a0f4510-08f7-4ce6-b98c-1b26f0664529" xlink:href="iclr-20221231.xsd#iclr_DSBiopharmaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_DSBiopharmaLimitedMember_3a0f4510-08f7-4ce6-b98c-1b26f0664529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_d6400d8a-0d22-435c-93b6-5825945869dd" xlink:href="iclr-20221231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_AfimmuneLimitedMember_d6400d8a-0d22-435c-93b6-5825945869dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember_954e7eec-72df-44c8-8fb5-993a742ea51e" xlink:href="iclr-20221231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_CorvusPharmaceuticalsMember_954e7eec-72df-44c8-8fb5-993a742ea51e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_865719d4-7544-4487-9a30-76fdc725a69c" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_OncacareMember_865719d4-7544-4487-9a30-76fdc725a69c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_295e5060-0910-4ee9-b45b-c461b941d951_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:to="loc_us-gaap_RelatedPartyDomain_295e5060-0910-4ee9-b45b-c461b941d951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a611173e-1b3c-4dfa-b7bf-f2cf2515db05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:to="loc_us-gaap_RelatedPartyDomain_a611173e-1b3c-4dfa-b7bf-f2cf2515db05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_2a0c2d1a-e29e-4bfa-9888-c73403ed4176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_a611173e-1b3c-4dfa-b7bf-f2cf2515db05" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_2a0c2d1a-e29e-4bfa-9888-c73403ed4176" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6f28594c-b881-468f-ab90-938675711aaf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6f28594c-b881-468f-ab90-938675711aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a23f997b-7160-4e65-bb37-86af8fc523a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a23f997b-7160-4e65-bb37-86af8fc523a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_356dd00b-abc2-4799-9a46-b2e0193947ec" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a23f997b-7160-4e65-bb37-86af8fc523a6" xlink:to="loc_iclr_OncacareMember_356dd00b-abc2-4799-9a46-b2e0193947ec" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>iclr-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7508de12-69a9-4818-9ec7-00b38a2cb3e7,g:60b4642b-da77-4b86-962d-2e89e6dd7ade-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_d0b010d7-3ae1-4729-ae63-f5687f7c1cd4_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_c914abd4-ca55-4291-805d-9b02e4374780_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7c0e2555-d99b-40bd-98dc-3d0814a1c042_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currencies and Translation of Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_082d4e7c-61de-4eae-8436-7d2786b55aa1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_428b55d7-738b-406a-9d8f-faf009b8a2cd_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_6f91d40d-66d5-4979-aff1-815819fd64a8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset (Note 20)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_f893c37b-212b-42ab-85fb-64ae8e42ddbc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_366bebbb-6315-47ae-9677-dd14d1fd5170_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_a16a4a9e-4651-47ce-a953-d4ef3bb6b675_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_a195b5d7-87c4-400a-bb15-74f53b223707_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_2505189b-b8ea-4dea-b0a1-9d4a91c4e263_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt restructuring costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:to="lab_us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_5382af41-5a18-4482-acfd-ae8de7f8ec69_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Subordinated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:to="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_644fd9e3-2ac2-441c-9d06-53616b848050_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_2238395e-c9be-4ac9-b037-48c5c9c83bb0_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_8b701141-ce76-4d4d-913c-524117809696_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2029To2038Member_b1df16f9-3855-49a2-ad2c-dd0194d789c2_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2029To2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029 to 2038</link:label>
    <link:label id="lab_iclr_TaxYear2029To2038Member_label_en-US" xlink:label="lab_iclr_TaxYear2029To2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2029 to 2038 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2029To2038Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2029To2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2027 to 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2029To2038Member" xlink:href="iclr-20221231.xsd#iclr_TaxYear2029To2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2029To2038Member" xlink:to="lab_iclr_TaxYear2029To2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_a776533a-907c-4e5d-ae79-77344e3ccf29_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:to="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e76450ac-e80b-4a09-b992-8aa5d7ed8cfa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_6a0d70d9-44aa-44c2-8dde-fdf1422ed39b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_eeca37e8-f0ab-4e9b-8711-adb1fb306305_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_90893790-00d0-4ffb-9d23-bda71493cbc6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3e8ffad6-690c-4f8f-9dca-c3d5698270ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_84db5d86-13ae-4426-8ea2-5f9cdff2976c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by employees (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_22819abb-9c3b-45a3-bd37-a3140f9d57b2_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e05a8852-e7a0-49cb-be02-92d5f09bcef9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2373565f-91fd-4a4f-8f20-90ec4cee6de3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8fd20862-661d-4891-9f72-368c8637f3e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_9d33cee4-82bc-4b7a-9a05-e6c4f172d9d4_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursable expenses and Direct costs</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_b8e3943a-425b-49b9-8264-144c1c0adbef_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_ba022e32-5e0d-413c-a6dc-cda3929e6ce6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_6b2e5f80-863b-4ce6-95e4-ddeda329e46d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of shares associated with a business combination (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_4129c237-5043-4c41-a2dc-a02a15ea7539_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_f584e453-71ac-492e-b99a-515f9f300cf9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_b4a88edd-73d6-4f7e-841e-1adcb8b925a8_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4af445a-3634-44ee-9eed-28ebbf3c079b_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_8f094ee3-aa12-4982-a8c7-274ba338bfba_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_03e8f36a-53e5-43d3-854a-25a177de892d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e5bee979-25e1-4bbb-b3cc-a6c020a99efa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_612b0048-c523-4179-9f13-547e5a417568_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Information Concerning Outstanding and Exercisable Share Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8731fd8c-fb69-4ddf-a870-553fc22a411f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_fc854380-e8ae-4732-acf7-c330929dd629_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_5a6cf051-cf05-4a3f-ba0e-7868937486b8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per Ordinary Share attributable to the Group (Note 24):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_717e3d1d-9dcb-49af-9eb3-5d539ca3b6a6_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities:</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e0a47c3b-ed4c-4368-9884-b3a5c8b504d7_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_166fd178-9650-4fdc-98c0-1b1eec63b508_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_aa8add96-f00f-4bbc-a308-415f0296a2fd_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_28f555d3-1df7-479a-b1c7-46b0584bb92a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party, loan interest rate</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_0275f68f-1f00-420b-a733-ea77539b2dca_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_ddf0fff8-0a98-48b6-b9f0-2b7936e596e9_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_5d2cd0ec-c2f9-4561-80b1-6d2e9be19a7e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_1101b174-43a4-4120-b64b-974017d49471_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_937a4db3-6f8b-4ff3-99dc-d1960190956b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_5d453264-ff03-487b-809c-43b81b1da536_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_1a3ed51c-8ef2-4585-b40f-73261caea52c_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain/(loss) on defined benefit pension plan (note 21)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_ed215597-a53e-402b-94e7-d544bf9fa848_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_93b32d5d-37bb-44c4-b294-4271c3f883b9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e9d91456-3277-4c2d-bb9d-47f86906af4b_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_95721115-2485-4b1e-93e1-0f22e22b8e5f_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_eac4257f-11a5-416f-ab0c-58c520b5fa27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7f609288-72e9-48e7-a90c-273a005093dd_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_5a6fe2cf-5e3e-4607-ab32-b3d76dab6236_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_aafe81c2-aa02-42b2-a42f-403806d2c059_terseLabel_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments resulting from foreign currency translations</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_label_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Disclosure [Table Text Block]</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:to="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bfccd49b-fc2c-4829-a56f-30ca1007cfb6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ef2acaba-82c4-44b5-89ba-94c03f3e28ed_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income &#160;</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0d994852-9e4f-47c4-a5d8-b700e97d75ee_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual term of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_8784dd49-8448-422a-9ff8-7ae5115827aa_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_83177d0a-4683-444d-bc8c-67b8b3eeac11_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_b440461b-d6e3-4cf4-a8d2-126bdd5a5f33_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_1699d9c8-47c4-4bc5-9607-60d9bc023bb4_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7ec67d0b-39a7-4244-9311-57971cd88a22_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e765bade-bd3d-4f91-bec6-22069f4ada52_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_d6cd4604-4399-4dc0-bd3b-06a154af710e_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (Note 19)</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_72e9bdd1-3039-416a-8b42-200ac0b7c626_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_4fefe3bf-5606-45cd-bc30-cc6f6c8fbcf4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_a418385b-c046-4815-827c-b0c14badb745_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_677c8d40-8b99-4a02-9979-7a4d52a80282_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2e6ccec4-7027-454c-904e-3756b1a3759c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9a6b77e3-1e41-44ad-bdbe-de272cbc74ac_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b3f2cb62-9118-47d3-b8f6-366fbfb4284e_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3348151e-14cd-47c0-9216-610c2da0fb75_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4253b47-3545-4a3c-bd5e-a5bdd5e87f47_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_2b46c920-b4b9-42b0-b516-9ccce33346f4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior period acquisition (note 6)</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_aea2b4c5-d569-42cf-a643-5fe4b3ffd70d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_a93279a3-e4e1-47b2-ba35-a148fd2ec665_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Benefit Payments which Reflect Expected Future Service</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_92ad332d-0d7e-41dd-8560-6ebc2ead4c86_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_58281340-d794-481a-878f-5c4dca18c431_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa03696d-1f5a-4b13-ac1d-6780fb677d18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1d530f14-b783-44d4-96bd-4ff3009a3153_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving loan facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_22091454-d891-468b-a08c-d5da7d7a22d4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_4fb7fa31-0c2c-4e9b-b2d0-584f13e88bf0_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9015873c-f2cc-4a08-bbb1-a850496acd9d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_244ee259-8363-4c92-8a74-3a892c83df68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_7f566e3d-3e2e-4a10-beb9-cb55a4135fbb_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_64417515-b91b-47b9-95af-95200dba110f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_601e180f-8f60-41bc-81e5-598c394d7745_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Bank Credit Lines and Loan Facilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9afa74ef-6eb4-4134-b560-4688107be14a_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:href="iclr-20221231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_355ffbda-0fc1-4e2b-a9e6-549464799a7c_terseLabel_en-US" xlink:label="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, decrease in loan receivable</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_label_en-US" xlink:label="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Decrease In Loan Receivable</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_documentation_en-US" xlink:label="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Decrease In Loan Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentDecreaseInLoanReceivable" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentDecreaseInLoanReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EquityMethodInvestmentDecreaseInLoanReceivable" xlink:to="lab_iclr_EquityMethodInvestmentDecreaseInLoanReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_31f97b04-4bdc-44a9-9935-0743d8721457_terseLabel_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts provided during the year</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_label_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_documentation_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense" xlink:href="iclr-20221231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountsReceivableCreditLossExpense" xlink:to="lab_iclr_AccountsReceivableCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c6d6943-7d42-4bec-82f7-c9adcb795133_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_4f949a32-5a56-47f9-9696-60170ff63ddd_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_940245ff-a388-4099-aa02-e8e4991de4ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d8648d06-bf05-4e8a-a259-cd621e7a33e8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0850c2b7-2fb6-4928-9270-0bbd008d794c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_6b6c8acc-1662-4da7-90da-43577dd3d2be_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1fa72e32-130c-45d2-9f71-5b0056b2b2cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_944d48ed-f586-48e5-949d-bcd7dcd7ad22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_67baaa32-e39a-4129-92d2-c5fca1092acc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_f3bb22e5-3373-4bc2-8a7e-e00eac22496d_negatedLabel_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Share Repurchase Costs</link:label>
    <link:label id="lab_iclr_PaymentsForShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Share Repurchase Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts" xlink:href="iclr-20221231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PaymentsForShareRepurchaseCosts" xlink:to="lab_iclr_PaymentsForShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0a26a391-c7bf-4776-95c8-7764ee8f0098_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contracts with Customers, Asset and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_7fe5b3fc-e1a4-443d-8d87-71722c7630b0_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_bc26eff3-74dc-4fb9-8e07-fb6f896d864a_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c79f08cd-b335-4db4-85ec-4a775dba2375_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issue costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_bb771540-b1c5-4ac4-b666-2a8c71f4f54b_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts used during the year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1a4ee175-7846-4a31-87ea-b2d4840584d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_38afd57b-92e8-4363-801d-20daa3418073_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_f50de9ce-e8b7-4e8a-9d64-328f4f72e19a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_423a6e4a-d3ab-4427-b398-5c8b0dca2dda_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b92be01-c37d-40c5-98c6-766e2a34a951_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_27ab32a7-b091-4118-bf7d-4fa27104a8c3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_68eaef3c-3818-4ca3-b728-07d665d4da2a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on drawn facilities</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableNet_c36737f7-4ab4-440c-86bd-42df759b762c_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue, net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_label_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableNet" xlink:to="lab_iclr_ContractsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_1b4e3735-0b6f-4af6-9263-435e5659a5cf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5feef3b0-e841-4d05-a1ea-e027b7677e24_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f8aae982-a456-477b-ac6a-ee44c2dfc7f2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_3f2342c9-5f05-46ea-b1e4-a3c0d19ec181_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue (Note 4)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_c0a047b7-4f72-4c28-ad3d-d86ebf4bc2b2_netLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_971029c9-0349-4108-a2fa-b53a7cbc7742_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_feadd55a-6988-4784-a3a0-3c8bb0122fa8_negatedLabel_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss recognized in net periodic benefit cost</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_label_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</link:label>
    <link:label id="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_documentation_en-US" xlink:label="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:href="iclr-20221231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:to="lab_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_b70c6bfc-1e5a-4650-bcb6-d6388d2c63e3_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital [Member]</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember" xlink:href="iclr-20221231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapitalMember" xlink:to="lab_iclr_OtherUndenominatedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_0f321713-3dc8-4462-82af-5ac1d3d2a629_negatedLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_6ef95aa8-218f-4a5b-94f5-15f232849f24_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_0d5f944f-2207-4d1c-9124-28a958b20473_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_287b1f77-a2a8-4416-a0c0-d4de370ceff2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Weighted Average Fair Values and Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_67e4a520-eee7-4d5b-9b3d-dd9eb63e34f0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1db44d0d-7a92-4101-9ac8-16769902bb3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5ee4def2-74b1-4b7d-8020-c0bb810b0bce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_41167cf0-330e-4ad3-a5f8-0fcfd1608248_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_a5110bbc-8547-4664-b745-fc5696cea743_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_406ccf8b-a189-4c0a-bde2-76a1f0eadc04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_ab8aa99b-79aa-4f54-ac34-7b5bd1e9d3d9_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through business combination (in shares)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_c845efb1-1043-49d4-a30a-2763bb3c5580_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of subsidiary undertakings (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_45851745-f053-4540-ae6d-885dd37543e4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_e9a40495-59b4-4dff-9255-62e1989632b5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_c153d376-7cd1-4c79-b4a5-b96bf861d131_negatedTerseLabel_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on cash flow hedge</link:label>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_label_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax</link:label>
    <link:label id="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_documentation_en-US" xlink:label="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:href="iclr-20221231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:to="lab_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_54f339ba-1a29-41ae-8756-051b842eec2b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_97798dd0-4bb1-4615-b4aa-7637d4fcbb47_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_7d468684-0cfa-4947-891b-fc060501871f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_e0b3077e-7ac5-4bb5-9d9a-fe933ad34824_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current bank credit lines and loan facilities (Note 13)</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_97cefe45-9946-478c-83be-35f6044e9e48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bff60640-4884-4c3b-a795-9c26e81bf9ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Range Exercise Price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_80f572dc-dceb-499f-95a6-f0353929e81e_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7e89fa51-0a4e-4b36-9f51-8630c271830d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_fec0e37e-3606-4dba-82e2-006bde404a26_terseLabel_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_label_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_documentation_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:href="iclr-20221231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:to="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b29d752d-2da0-4e98-bbf6-1664365f2d5e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_3065e93c-9246-4b19-96de-8b5b2343804a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_b6677db7-c2d2-444c-9702-2baafe823f10_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_edab1f1d-2d9c-474c-a811-43dc8fc14f49_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4232fcb5-4c95-496c-a08b-e94581859a61_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b5dbe63c-bdbc-4625-a298-eda2956709ca_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_3bae0893-1834-4035-9d97-bf0077240fb0_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_f2bfe76f-6f04-4a80-b3d8-d9bd4c889f01_terseLabel_en-US" xlink:label="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable non-controlling interests and equity</link:label>
    <link:label id="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_label_en-US" xlink:label="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy [Policy Text Block]</link:label>
    <link:label id="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:href="iclr-20221231.xsd#iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:to="lab_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d34a68fa-79e2-4655-85f6-f9f6bfdee3a7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_3868f778-917a-41f9-9b81-d28fc6be8283_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5b1d6abf-4dee-4a46-a950-e2c9366feb8a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTextBlock_6dd5fdf0-6419-4102-9944-861a0c592afb_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for Credit Losses</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTextBlock_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts [Text Block]</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTextBlock_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:href="iclr-20221231.xsd#iclr_AllowanceForDoubtfulAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5a007cae-ec91-4e02-b6dc-4959c911521d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (in EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b6cc5e1d-54dd-4ba4-b574-0afcc96ce376_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss)/gain on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_98e30f0d-f674-4a64-b077-d4a5f19f7e9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_6c933112-cbf0-4c10-93eb-5f6899deddbf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0631ff59-c954-47cd-914c-0b0980a4fbf5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_341a694a-0b36-46ba-bb89-b976bf53d1f5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d1072d25-8ff7-4a67-8a41-7c928f1cb018_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range4Member_9dc72859-67a1-4485-8072-e600d9f6956c_terseLabel_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4</link:label>
    <link:label id="lab_iclr_Range4Member_label_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4 [Member]</link:label>
    <link:label id="lab_iclr_Range4Member_documentation_en-US" xlink:label="lab_iclr_Range4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member" xlink:href="iclr-20221231.xsd#iclr_Range4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range4Member" xlink:to="lab_iclr_Range4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_a693a020-ad7e-4e86-8035-d7d15e711590_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid and transferred balances</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:to="lab_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_988d280c-ede5-4d1c-8dd3-f71c6c4f93b4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_48a49f10-073e-4ed5-8087-b2cb6e8dd514_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_d0bb1e82-ebbd-45e5-ac30-91f92e09353f_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_b7af4d89-2355-48f9-a84d-20c9c1ead835_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_eb4b0ace-0918-464b-86c6-592fb0cc5ae3_terseLabel_en-US" xlink:label="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available for sale, cumulative amount advanced under subscription agreements</link:label>
    <link:label id="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_label_en-US" xlink:label="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements</link:label>
    <link:label id="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_documentation_en-US" xlink:label="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:href="iclr-20221231.xsd#iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:to="lab_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9e7238f0-0f49-401c-b89a-e117a3e42771_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_871a90ca-4b1a-4fa2-bbf4-76cc9fc0189b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_950487d4-bba7-46e7-86ed-ee89074cc221_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_446c01e4-0764-4847-9d46-4edb879b64b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency impact on long term funding</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_78abd038-9d63-4d48-8974-26f48b0e1b9a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less net income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_751b4897-79c0-4fc3-a546-5a144363dfd4_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_485a9b10-3daa-4699-8919-fa3a97c12df3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_f5cc1b7c-4dec-4f2c-97b4-81fd2fbca39b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59b73292-d1ec-43d1-af1a-6a56e23f035c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_b7285831-cac5-41ce-a152-fa5c417d4ce1_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Expiry Dates of NOL's</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_7dbfa3aa-14af-4e82-b5e8-4ddcf326dc6c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate differential from amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_d706273d-7793-4d0f-bcae-10e572b15248_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drawdown of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0b3000a7-1154-477c-95b4-f91e81ca4d18_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_0d8c829d-4ded-49d4-bac8-8c25e208f911_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to pension fund in the year ending December 31, 2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_287489f0-34f1-41fc-9538-e34f7a7feb45_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LeaseLiabilityMember_9f8f8e0e-eb16-46c2-b187-ae63f9f305f8_terseLabel_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability</link:label>
    <link:label id="lab_iclr_LeaseLiabilityMember_label_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability [Member]</link:label>
    <link:label id="lab_iclr_LeaseLiabilityMember_documentation_en-US" xlink:label="lab_iclr_LeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember" xlink:href="iclr-20221231.xsd#iclr_LeaseLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LeaseLiabilityMember" xlink:to="lab_iclr_LeaseLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c180bd8c-51a9-4ffe-9316-8ec4434c887b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_244fc868-4170-4f9f-a69d-b65ebae500b1_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_89c91b44-50bf-4ea3-900e-b08254c8ce42_terseLabel_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net balance</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20221231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f10ef6d4-91d3-44be-aae4-bfe8a693b478_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of company revenue (in percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_4c6c5b76-8a7c-474e-8239-9b8dddef4807_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland subsidiaries additional tax credit carryforward for income tax</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:to="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_2bb61599-0a35-4038-98ee-f50ff45c598d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan obligations and accrued interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_60de29c7-2ee6-42aa-baf6-b365ffd9ddd4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8bfbb1b0-80f1-49ef-98ed-368189b2a04e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_ee9ce406-e783-49d1-b123-ddfcb76d77f4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue earned from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_c8550009-3a75-44a0-8f22-32ec10a207ef_terseLabel_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan</link:label>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_label_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan [Member]</link:label>
    <link:label id="lab_iclr_A2021RestructuringPlanMember_documentation_en-US" xlink:label="lab_iclr_A2021RestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember" xlink:href="iclr-20221231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_A2021RestructuringPlanMember" xlink:to="lab_iclr_A2021RestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d8b64a4c-c8a7-4f6f-a476-8d0a50ba77e7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1b7343be-3a17-4964-83da-1370d0bae7e1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_9f34e74c-2621-4e81-884a-8b371a3b399a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock units vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b468a307-cf79-4130-9809-6c56f2a9aef6_terseLabel_en-US" xlink:label="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period majority voting share capital can be sold to the company</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_label_en-US" xlink:label="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_documentation_en-US" xlink:label="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:to="lab_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_f307fad3-9ac5-4df4-90de-ff99e3ced0bd_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_6ac388de-cc2d-47e1-907a-bfe79d6500a8_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_1ececd34-2f31-46dd-a364-812251247f5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_538746f4-c9fe-4425-8c25-09ec37eb5dfd_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Text Block]</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of the components of accumulated other comprehensive income (loss).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:href="iclr-20221231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:to="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_cc0d573e-dd70-4a53-b3aa-2a894fa3aab5_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share</link:label>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4872f552-0e60-4acd-95a2-f85de028a7b0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_77a1cf58-9612-470c-86ef-2923f9b5bc4f_terseLabel_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_label_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_documentation_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:href="iclr-20221231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:to="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f834ac52-16d4-472b-b839-9ffcdc3b1e56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c4c7a65d-169e-409f-bab1-427e69b20f33_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_3b7cc0fc-f93e-48d5-b986-e78eb908280c_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_367548df-de75-468b-be80-1a21a01222cd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative minimum tax credit carry forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VehiclesGross_f506da65-aca9-4a43-adb1-37bb037261bd_terseLabel_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_iclr_VehiclesGross_label_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:label id="lab_iclr_VehiclesGross_documentation_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross" xlink:href="iclr-20221231.xsd#iclr_VehiclesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VehiclesGross" xlink:to="lab_iclr_VehiclesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1d60cd5b-0525-490f-8344-16126b3366a2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of restricted share units / performance share units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfVotes_970b2fa7-3928-4efc-9cd0-d3288c6fe706_terseLabel_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_label_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_documentation_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes" xlink:href="iclr-20221231.xsd#iclr_NumberOfVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfVotes" xlink:to="lab_iclr_NumberOfVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1636748a-aa34-4537-8ffe-dd232265a676_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_3bfc48b2-894e-47c8-930d-96840b23bac8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_1b7af8b6-b36e-456a-a184-fcb75065c724_terseLabel_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions pension plan</link:label>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_label_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_AptivSolutionsPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_AptivSolutionsPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AptivSolutionsPensionPlanMember" xlink:to="lab_iclr_AptivSolutionsPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_cba40997-7e2a-4d4b-9054-f439cd868773_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_8d8cb7c7-2e09-4746-baa5-74ac650c6147_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_6aeaf74a-aade-4ad7-9d7e-243b10dd46e2_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan period</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:to="lab_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_aade1f73-a2a2-49bc-8f24-bbedc187f5db_terseLabel_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2018 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember" xlink:href="iclr-20221231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2018LegacyPRAPlanMember" xlink:to="lab_iclr_The2018LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ca09449d-abf8-43ad-922f-810fe736eda1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_ab258d57-049c-4dcb-80d0-1c01fc8c69d8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and penalties recognized as an expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_d3c8ec3f-a9f8-4c26-9345-f8f6744e0a97_terseLabel_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term investments average maturity period</link:label>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_label_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Available For Sale Investments Average Remaining Maturity Period</link:label>
    <link:label id="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_documentation_en-US" xlink:label="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Available For Sale Investments Average Remaining Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:href="iclr-20221231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:to="lab_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_254d6ff5-f23e-48ed-9520-c65cc9036f75_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Net Revenue by Geographical Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_61909f14-c0b2-43a4-a881-7069530ff5c6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_9f9ee456-c2cb-42d5-98fe-046b4860e15d_terseLabel_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, variable interest rate, reference rate in excess of</link:label>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_label_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate, Reference Rate In Excess Of</link:label>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_documentation_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate, Reference Rate In Excess Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:href="iclr-20221231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:to="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_127a63a2-68b7-4b09-92a6-484893c3c82d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_9c31d75a-b779-46f9-b5f9-c68b9f5560d2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_6667ca7a-028d-4913-9e33-aee7fc2e50a1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [member]</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_788da93f-65cc-4485-b484-1a415dd923e9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0c3571ac-5c13-499f-8722-f4b8d7c776a4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_8a63db3d-8c05-49a1-b228-e1b43afe462b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_label_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:to="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5207179a-6329-4546-97c0-07e9c45e7747_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_23a7d9d4-09e4-4da1-9d0d-7e3306737bcb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_b7bafcdd-1dc8-458c-900d-58ea5b2214f7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_db0e0dce-af73-42bf-94da-88c5abbd301c_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable and unbilled revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_789d3123-5398-4649-b1e4-bc95a897850f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_e1d67565-2fcf-487b-9462-d1a13ebe88c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_88e16bcf-740f-439c-bacb-a144ad1b277e_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:href="iclr-20221231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_4cd392b4-557d-4f37-bc27-001d775d1990_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_ca4be261-1051-4ff1-86a6-819d775cf922_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_0e66793b-0324-4b1d-85ca-2a0f71ef45dd_terseLabel_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest adjustment to redemption amount</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_736dcb36-1259-4d18-a21b-f5ad6df5a8e3_verboseLabel_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest adjustment to redemption amount</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase From Business Combination</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_documentation_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase From Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_00e8b600-b06a-4762-a2e3-42a28d6ab2f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_533ade55-f0ac-4172-8431-dcab1956f5c9_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8f62405b-0b53-4651-aa73-359191bb0a2f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_90047609-7002-4489-98a3-2085a73f806d_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 10)</link:label>
    <link:label id="lab_us-gaap_Goodwill_59fd9927-1d93-49fb-b98e-de95a45d4e13_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_a3f56209-4dae-4da5-b879-4db563ad97d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_647e5750-0c64-4b29-b247-3924fcada551_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_832dac45-2e83-4689-b51c-8fd35a1a0999_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a67b98f7-588f-4c70-babd-05301c15d7bd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d94857dd-fcab-49e1-9f5f-a6a96a892009_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (Note 20)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_44f70596-eca7-4502-a5df-0e027c20c1d2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense allocated to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8e73147e-16e1-467d-b3a8-85331edcbb7c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0de95826-a475-414b-87ed-04381da83002_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_13008801-1585-4e55-ba66-29152e959d58_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_f3e9048f-f526-41c6-a04f-4b77cf1cf231_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability (Note 20)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_29541af3-580b-4806-a75c-be535b01b5ad_terseLabel_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corvus Pharmaceuticals</link:label>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_label_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corvus Pharmaceuticals [Member]</link:label>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_documentation_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corvus Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember" xlink:href="iclr-20221231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CorvusPharmaceuticalsMember" xlink:to="lab_iclr_CorvusPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_7f257c0e-fcbf-48d9-81f9-31afa9717be6_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_964d3a18-37ee-4982-a5fd-d3e29b62ea0a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs (excluding depreciation and amortization)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OncacareMember_b13f9e78-caa1-4ed9-8a3a-a13da58bd269_terseLabel_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare</link:label>
    <link:label id="lab_iclr_OncacareMember_label_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare [Member]</link:label>
    <link:label id="lab_iclr_OncacareMember_documentation_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncacare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OncacareMember" xlink:to="lab_iclr_OncacareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_33673c4f-b24c-4a52-b58a-bff573651b99_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and asset write offs</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_a6a65ef8-8fbb-4457-b62e-a02e674b607f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments (c)</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_b0e8038a-52cf-46c2-a575-a40e39ec09e7_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BilledContractReceivables_fe4b0b7c-42f7-4d5c-a601-80517cae21e5_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed services (accounts receivable)</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables" xlink:to="lab_us-gaap_BilledContractReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_64041ca1-5f4d-4cde-89da-1b1564d9f0d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients1125Member_1134e5dd-38fc-4bfd-a832-02b9a6ee7ebb_terseLabel_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25</link:label>
    <link:label id="lab_iclr_Clients1125Member_label_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:label id="lab_iclr_Clients1125Member_documentation_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member" xlink:href="iclr-20221231.xsd#iclr_Clients1125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients1125Member" xlink:to="lab_iclr_Clients1125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_d064338c-b9b0-4538-b9a5-99bdd6871626_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_25ddccd4-5d5d-47db-af93-59000d9422a2_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableGross_7d0edab1-5d5a-451b-ba54-0ae86233bc56_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable (net)</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_label_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Gross</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableGross" xlink:to="lab_iclr_ContractsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_cdb4f2e8-a217-4996-96bb-3a89c258a558_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which company operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GovernmentBondsMember_3f663d79-bc60-4985-b291-98b36c501ee4_terseLabel_en-US" xlink:label="lab_iclr_GovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Bonds</link:label>
    <link:label id="lab_iclr_GovernmentBondsMember_label_en-US" xlink:label="lab_iclr_GovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Bonds [Member]</link:label>
    <link:label id="lab_iclr_GovernmentBondsMember_documentation_en-US" xlink:label="lab_iclr_GovernmentBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember" xlink:href="iclr-20221231.xsd#iclr_GovernmentBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GovernmentBondsMember" xlink:to="lab_iclr_GovernmentBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_1f4e6e5f-0943-4edc-b117-6d4c92a134f8_negatedLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_3ae560f3-37ca-4918-aa47-b01804349ec2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 81,723,555 shares issued and outstanding at December 31, 2022 and 81,554,683 shares issued and outstanding at December 31, 2021.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f0c2215a-3475-4ff4-a331-840380e86b1f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_6d5f7022-eb41-4b0c-b6cf-c73f06238bc0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_0bdc681c-d920-405e-b534-b1646fde73e7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related (Note 6)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_1ee4f899-bf65-4ae8-ad19-a9b2df04026c_terseLabel_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to third parties for reimbursable expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_label_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_documentation_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:href="iclr-20221231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:to="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AfimmuneLimitedMember_a72ae188-371b-4bfd-bcf4-e45de22c2f3a_terseLabel_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_label_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited [Member]</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_documentation_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Afimmune Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember" xlink:href="iclr-20221231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AfimmuneLimitedMember" xlink:to="lab_iclr_AfimmuneLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_422d5d6f-a973-422e-affa-77df412329bb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_085ad48c-8d7f-4315-bc0a-984da900d936_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_de968b65-09db-4c43-bada-5ffa302f4f06_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ea534385-6b8e-442e-ba99-7965d21b77d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0af775e2-9f1d-475a-8edd-fa0ffc9986ef_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e5643989-33e5-4519-aa53-38ac07ab9897_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a92e49f4-c36a-4d20-9b3e-600eebd7626b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of equity compensation</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_17b9b30c-121d-436a-a0d6-d009b875c7b7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total proceeds from exercise of stock options by employees</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_374154d7-65f7-45eb-936a-2ebe58917be6_terseLabel_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award date, prior to 2018</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_label_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, All Years Excluding 2018 [Member]</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_documentation_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date, Prior to 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:href="iclr-20221231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:to="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4af65be3-c8f1-49b1-81ca-cb63598ff908_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue (Note 4)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_18d114c7-3969-4ed7-8a30-72521df905bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue (payments on account)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_fd172ef9-2ddb-4ea1-8d2f-cb745f8410a9_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_22180abd-a823-4f19-9d2f-c02137347656_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_09dd1760-9ff4-4887-af22-327d07d42169_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_57bc719d-067d-43de-a6e0-4c3cca907ba8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_c8a7acb8-1184-4776-80ef-0dc1d0879855_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_cf9b90d9-9319-4735-bc66-e020ee1bb31d_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured revolving loan facility</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:to="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_6d765b5c-3b80-4255-ac70-5aa4cb2d4123_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_facdc266-44ea-4ea8-af56-238668eb165c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year acquisitions (note 6)</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_784343c9-842b-4a77-8042-0575d3e08af9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_ad3556be-842a-4abb-a1ca-4cb30920f62b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c258f53b-856c-4595-bcdb-0e6eceabab2a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_223fed9d-ba5a-4654-a081-271bd626fd35_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_c7721c44-e071-4507-9675-21bff4abb94f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_b329755a-a29f-400a-bb4a-d1918fa50aa3_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7b649f9c-8343-4051-adbd-07fac1795663_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_eb566d8a-c9db-455d-b0f6-0c726b94f0a5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of option price for fair value of ordinary share (in percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_f3e92878-22de-4d2c-936d-b0e680d25a3c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable operating leases for facilities expiration period</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountsReceivableCreditLossReversal_36853ed2-ff31-4a9a-8def-e5fb7ef0a255_negatedLabel_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossReversal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts released during the year</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossReversal_label_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Reversal</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossReversal_documentation_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Reversal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossReversal" xlink:href="iclr-20221231.xsd#iclr_AccountsReceivableCreditLossReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountsReceivableCreditLossReversal" xlink:to="lab_iclr_AccountsReceivableCreditLossReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_044a02db-1d30-4d4d-829d-5c1b75505e1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less long-term portion of debt issuance costs and debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_2c778e0b-dcaf-4425-8dd5-d49520c1661d_terseLabel_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financing Cost</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_label_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost [Table Text Block]</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_documentation_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:to="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ab731849-f8c4-4c83-b848-d6a0a350795c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5f235cda-dfd2-4d3e-aa71-08d5f4bdba23_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_604fa0d6-2395-4832-b165-9392a677da43_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_5fd6aa6a-2039-4947-8127-402192e1b7b5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_70095984-0799-4a5c-b54a-c6e622ad32b9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1b4cd3cb-8daa-41d3-92cc-3ee8f9212b60_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_22ed3719-f76c-4280-bd90-cd9c5c14ffba_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_17ed474f-4b53-41bc-9a3d-201d4051f5f2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_a452aab8-86a4-452b-9f88-7df52dc6ba92_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, number of shares issued (in shares)</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fb265ebf-2715-4899-a15f-2a937a74f6cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_39f847af-4a36-4065-86a4-b1eb3ec0b8c0_terseLabel_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Income Before Provision for Income Taxes</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_label_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Tax [Table Text Block]</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_documentation_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Tax, Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:to="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_61dcd93d-bd25-4795-a10c-9d1c02224df6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of share options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_dc6b6d80-d597-493d-82b0-2831001185a1_terseLabel_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal net operating loss carry forwards currently available for offset</link:label>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_label_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, US Federal</link:label>
    <link:label id="lab_iclr_OperatingLossCarryforwardsUSFederal_documentation_en-US" xlink:label="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, US Federal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal" xlink:href="iclr-20221231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingLossCarryforwardsUSFederal" xlink:to="lab_iclr_OperatingLossCarryforwardsUSFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c4b91aa9-6f79-44b6-9887-ecbcdddfdcf3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_f4c025f1-d531-4f59-a52f-6075a5c15a09_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_04f3d63d-490c-4f84-8fd8-b1af88d9f3ab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5e140cb7-b9a9-4d1e-b740-24bb2d20aee2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_56022b40-86da-442a-a20c-92d938bcb83e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_d70f5f2d-311e-4bc2-babb-47cc4b92be7a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination acquisition percentage (in percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f18268e2-37ec-4a16-bc78-dbc51dc5904a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_b440fc25-127f-4c53-a7e7-9120ac7b0e80_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_be68288b-3f4e-4be4-94b5-6872522342e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares redeemed, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8ecf0bdf-4cd6-47f4-9647-4b44c5c41a09_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_724b5458-6133-4462-9881-d9e5e3b1efb7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_29cfb460-f775-4214-92fb-0e07386a8cb1_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_8e5c0a13-6205-4133-bc0c-22befa7b6293_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_02ffcf56-cfe5-4772-ab97-bc2b523bc837_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5e0889c0-405e-4d32-a522-0b552d63f253_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Capital</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_31e2af45-6adf-483e-982e-0c7abac6f086_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_16b60d40-1627-4c50-bbda-8da08c79c78d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d1eda091-3540-4fe7-a087-62a9a7146f94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of available for sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_6eb803f4-d133-41a1-9e3d-f26b122a5570_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity-long term (Note 8b)</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bbb40b8f-e5d3-4b9f-8bdc-b95c476baf4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_5af9a3b0-f555-4a07-8c33-056ea85e2aad_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cb0b6469-25ae-4f5a-99f6-a67114091e9c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit related to stock compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_9f0fb827-2968-4a30-b5a2-a514666a463f_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from sub-leases</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_0ea670bd-94bd-4a24-85e0-2f31bb197ad8_terseLabel_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG pension plan</link:label>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_label_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_PRASwitzerlandAGPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Switzerland AG Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRASwitzerlandAGPensionPlanMember" xlink:to="lab_iclr_PRASwitzerlandAGPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_2e9dbc89-0957-42ab-9136-8487f189c502_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3f3c4f33-508e-46a9-8641-b22d8719f933_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares redeemed (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_92015cfc-beac-4b59-a8c8-006700a630c6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0aaa0482-fb02-4b89-953c-e14d8d9134ae_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24712c72-769f-4571-b58e-64a7a1eaff9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_4f982f68-f909-4b51-9301-ea288e3613fa_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_962a2549-2d36-4d04-9f13-3989e8abaacb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_e0d4332c-10ec-4720-ad9e-793cd6a54fc1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of credit lines and facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_8e8054ac-5d41-44d4-ab77-125528324a36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assumptions Used in Calculating Pension Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_37937f53-b99d-437c-bbfd-31d48995aa08_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment and Geographical Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1c6367c7-fc54-4a94-b292-a3def5746acc_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_04401706-b3e1-4eb6-ae4a-f382491a918b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_fb1cdbb4-844c-4430-9f02-62b843a96de8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_ea84afda-e9f7-4ea9-a445-503d828e2aad_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units 2019</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_label_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:href="iclr-20221231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:to="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_a5dd66d3-9ef3-4057-a7b1-2f86402e940a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Overall net deferred tax asset/(liability)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d8caa627-3ba5-4cee-91bf-c92a13ada481_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ec09be93-2893-4250-b32b-94505c18528e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceShareUnitMember_7f6bc24a-27ea-4142-adc8-3a3a8c570b4d_terseLabel_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit (PSUs)</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_label_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_documentation_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceShareUnitMember" xlink:to="lab_iclr_PerformanceShareUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aa44bc8d-e4f5-4a0a-95d1-b9e24c05a77b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_55cf3dee-ddfb-44f2-8857-5fa1ee3be89f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_234bbbcd-2b2f-4fd0-b6bb-0d3faac9242e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_9fdf8899-29d7-4b38-9b68-8cc70cd10986_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityNumberOfEmployees_0cfdaab1-1bcd-44d6-973f-e760dc58eaab_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees" xlink:to="lab_dei_EntityNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_1aac93e1-4dde-4433-acc1-e9cd935c4159_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_ff37d6ab-a02f-4c20-85ee-e9c52a72a577_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_342044cf-0c45-488b-8b9a-007b52358839_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1fd38fbe-fbdd-4797-8d0f-f9e014afbd78_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_c87c344f-e2ae-408e-9c89-d74425471b84_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_56a196a6-086b-487f-8752-9f63e0f28e9c_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-cash Stock Compensation Expense</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:to="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_daade9b1-a566-4e48-817f-07ffeeedda54_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_68b88a5d-5a7b-4b21-a292-75f3e7023443_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_15573451-2c7d-4103-b041-c2ec3650217d_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_139cff16-848d-4e91-9783-b2cd7c2bc288_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_fd5370b6-c0bc-4872-859a-6e05b59046ec_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_1a518198-9613-4e42-850c-e80c2dbc4c15_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_4b43f4a6-9657-4da3-996e-99d6f99aba31_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeMember_f8d1c253-6b98-4f82-847d-ee8568f47e28_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of Europe</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeMember" xlink:to="lab_iclr_RestOfEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestExpenseCreditOther_4d66bcf8-59de-4577-a672-2728dda8d843_terseLabel_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing costs/(credits)</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_label_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_documentation_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther" xlink:href="iclr-20221231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestExpenseCreditOther" xlink:to="lab_iclr_InterestExpenseCreditOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_b7faad6e-1f34-4af1-b45c-27915dcd2c06_terseLabel_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liabilities</link:label>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve and Other Liabilities, Current</link:label>
    <link:label id="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:href="iclr-20221231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:to="lab_iclr_RestructuringReserveandOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_b8548e09-b67a-4b75-bd17-b300b176cf62_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facility and senior secured notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_af1f01ff-9f83-4f16-b4bc-065c81f94fa0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_f18f6c95-704b-44b2-9b14-2bc77035cad7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_86f6a6ae-b6e9-4f85-aa04-522ef4bed146_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_f827ba43-68cd-4c1f-9d4a-3ee099def701_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_61821cc0-b675-4eab-868d-bbce831d3f76_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_fcca86b7-4895-447e-99de-667a00c531b1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments (long-term) (b)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6301ec2c-ab38-4afd-bc76-d27a4d502cf4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Schemes and Stock Compensation Charges</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_5257309e-6d99-4f25-bfcc-7cd6ce3b0cac_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_7f3a20c2-87be-4a86-b78d-fbe42c4d2aab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses (note 5)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_592eda4e-e953-40d1-9ab9-388d6c3d8669_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_b1ce2de5-980e-4b36-a901-8af8e31c62d7_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Closing provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_3665b3db-990a-441e-9675-1d29d38f47ca_terseLabel_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order backlog</link:label>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_label_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_0d3c74ca-be25-4da9-9eae-e461afb9abac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_970da126-7059-4467-ab82-04569cfe4d85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_9d30b773-9758-4866-a299-b7d3a9d030b4_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_33f6c361-3e83-482a-a23d-1e9fe7e36f8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss/(gain) &#8211; plan assets</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_d3a0411b-9d6c-4956-92f7-2b385b07122c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c5f18f26-f9e3-40e0-aedc-983459f77183_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_6a4239bf-bb07-4326-9d96-0666ebdb6ddc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange (gain)/loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a0c49720-4850-48e4-84e5-8fd37cadfbe8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_bf722191-a93a-483f-9063-1eb21bc3482b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_f493da45-5b6f-4d7c-b4dc-5e0321830f5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9af3282c-be60-4bd6-a318-043716f9fbae_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_729e7e52-8f21-4f2c-86ce-1e277a473003_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_34d03690-bbfe-4c10-a213-887bf52355ea_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_37542bc5-54ca-4dc7-9223-3f7458ec1078_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_839b0814-4e4e-4a8d-a86b-85265d36b948_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_42c29919-cfe4-4ee4-8bb9-2e5e706fb80b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5588897a-9001-4828-b48d-3e6d7ba27ff6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_1caa0fa1-f925-4754-947b-b1a136dc18fc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants' contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_56a9c8a7-b927-4286-b011-355dd431d98e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1e87f13d-e9ca-4e6a-8de9-3dde2361ffb4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_631fd4bc-dd77-4180-887c-4d95001521d6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_18dbace3-18ab-4557-8f3f-3c7b27fe542c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General trade and overhead liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_5e39f770-d6a1-411e-8d12-08ec5a13dfb1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_ab0598e8-5211-4d11-b346-683c5c7c09ae_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_443cf6d9-9feb-46e6-a498-a3b65b1a5607_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_fe0b7496-949c-4df5-b34d-ae4e5c04d27e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_10bcdde3-21be-460b-bf03-911638cadeb7_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:href="iclr-20221231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_563b37f4-cbe7-4daf-af75-0ed741bf6dd7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized tax benefits net of potential benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_46be6bb3-6f70-4364-95e2-0ac0572e3b39_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_928f036c-b0cb-4930-b3cb-80893cf48fc9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_5a2a9cb4-7e9a-4e0a-a148-49c24ee3dced_negatedTerseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_9bcd5599-910c-4819-bebd-fb8812cb2fa3_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3e36bd83-a1e2-419c-a2cc-4decb7762005_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Range Exercise Price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherRetirementPlansMember_28a2fffc-ad8d-4547-962a-2a8d73e04edb_terseLabel_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other retirement plans</link:label>
    <link:label id="lab_iclr_OtherRetirementPlansMember_label_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Retirement Plans [Member]</link:label>
    <link:label id="lab_iclr_OtherRetirementPlansMember_documentation_en-US" xlink:label="lab_iclr_OtherRetirementPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Retirement Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember" xlink:href="iclr-20221231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherRetirementPlansMember" xlink:to="lab_iclr_OtherRetirementPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_19a086da-c150-4a3b-a65f-58e5245dda3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of change in tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_a7953ee4-31e5-4481-9502-d32f8e759c2e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock_3b1c3987-fbac-430c-aca9-04068cc761ee_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Credit Losses</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts [Table Text Block]</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts, Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_AllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_06724071-675e-419e-9ec1-674c0b37748f_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_af9f8ba9-bd67-4000-b461-efeb7d21bf06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in the total valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_1ec06ba4-fabd-493a-88f5-14439425e955_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, share price (in USD per share)</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_c0a83251-9a52-4d56-9eff-9b48df5ad3fd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_13b4d036-7423-4da1-be7a-4957ee2c28c4_terseLabel_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember" xlink:href="iclr-20221231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2020LegacyPRAPlanMember" xlink:to="lab_iclr_The2020LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_3f3fad8e-3801-4ff5-8c0d-4d6dd099cb18_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:href="iclr-20221231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_da61f003-4694-476c-8315-5bba960c3ec3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_95689464-52d2-4975-a1d0-02d25003aa81_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized capital loss - investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_3d48e9a1-6702-4a12-ab44-f5d0e7e68ad8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9c11bc58-4f11-432e-a234-5ccaaa8faeba_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_5210bf72-d64e-4d4e-9a2a-e74906882319_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_label_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:href="iclr-20221231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:to="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4609c732-091f-4fde-bf9e-69f1490d75b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_bed421db-a238-4cc6-988b-6d37fcce278a_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Long-lived Assets, Net, by Geographical Area</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_226cf084-d4e4-4222-9356-a10d00383f31_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DiversifiedBondsMember_4678cf42-dd49-44e5-b117-bf2032164b74_terseLabel_en-US" xlink:label="lab_iclr_DiversifiedBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Bonds</link:label>
    <link:label id="lab_iclr_DiversifiedBondsMember_label_en-US" xlink:label="lab_iclr_DiversifiedBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Bonds [Member]</link:label>
    <link:label id="lab_iclr_DiversifiedBondsMember_documentation_en-US" xlink:label="lab_iclr_DiversifiedBondsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diversified Bonds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember" xlink:href="iclr-20221231.xsd#iclr_DiversifiedBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DiversifiedBondsMember" xlink:to="lab_iclr_DiversifiedBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_0475ed73-3482-454c-9744-30e734b05999_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DSBiopharmaLimitedMember_17f7e9a2-819a-4554-b59b-4b10c528829f_terseLabel_en-US" xlink:label="lab_iclr_DSBiopharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Biopharma Limited</link:label>
    <link:label id="lab_iclr_DSBiopharmaLimitedMember_label_en-US" xlink:label="lab_iclr_DSBiopharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Biopharma Limited [Member]</link:label>
    <link:label id="lab_iclr_DSBiopharmaLimitedMember_documentation_en-US" xlink:label="lab_iclr_DSBiopharmaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Biopharma Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DSBiopharmaLimitedMember" xlink:href="iclr-20221231.xsd#iclr_DSBiopharmaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DSBiopharmaLimitedMember" xlink:to="lab_iclr_DSBiopharmaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AptivSolutionsMember_8d0c0e93-89b3-43a7-9849-662a6f5d1d50_terseLabel_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions</link:label>
    <link:label id="lab_iclr_AptivSolutionsMember_label_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions [Member]</link:label>
    <link:label id="lab_iclr_AptivSolutionsMember_documentation_en-US" xlink:label="lab_iclr_AptivSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aptiv Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AptivSolutionsMember" xlink:to="lab_iclr_AptivSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_7a32ee95-6255-433f-8747-da93a12665d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_fbaa3aac-7bc9-4a8e-af0e-23de1f53c2dd_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_05276b82-221a-4afc-8659-9a2dbf1d02f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest adjustment to redemption amount</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_ec17910c-1c63-45f4-99cc-ae6d1f3884a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_7e1dfedd-f0a2-471b-b06e-01f6780d3a55_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_159ffce7-0a6b-43d2-ae27-1f54848eb01d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease)/increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b036198d-bdc0-4376-9f57-8785bc4dd1a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_54255393-e425-4ecb-b61b-d528d0d1cd53_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f2c4c754-d23e-44bf-bd7d-9b50e917c772_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_b0d6a783-f78b-471c-b25c-cee58b265f44_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentDomain_cd821a1c-82f6-404a-bfb6-5d91bd307c13_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_label_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentDomain" xlink:to="lab_iclr_VariableRateComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_827a5548-9dc2-4e74-a19b-f14e6e596058_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f97f31b-b15e-4450-950b-e90783c7b362_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_08bf13b3-c10a-447b-9fca-5373f76845e5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to acquired tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_825584f3-0947-4183-8215-930b3c8a1edc_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_2bf1bf8c-6672-474a-ac00-723bfdff465a_terseLabel_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related</link:label>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_label_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And Integration Expense [Member]</link:label>
    <link:label id="lab_iclr_TransactionAndIntegrationExpenseMember_documentation_en-US" xlink:label="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And Integration Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember" xlink:href="iclr-20221231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TransactionAndIntegrationExpenseMember" xlink:to="lab_iclr_TransactionAndIntegrationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d661df63-c76d-496a-8059-a0aa8bd9cd84_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d1566769-374f-48bb-8b72-6e95ffd3b6b4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_3843c56e-efa6-4e78-b7bd-9d19ad2b8dbd_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Costs</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_fff4ed4f-6db5-4930-b832-fbad5fd9ead3_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:href="iclr-20221231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_18dbe92d-4c11-4292-bb80-25f9a126d679_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current bank credit lines and loan facilities (Note 13)</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_8648d6a9-1963-4b95-b348-9a6dae94bcd7_terseLabel_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive director</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_label_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_documentation_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember" xlink:href="iclr-20221231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NonexecutiveDirectorMember" xlink:to="lab_iclr_NonexecutiveDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_05cc8b8a-d78b-4141-8a2f-15cb2b142c0b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d63530c8-eb07-4e72-b1dc-4dfca263d4d5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_684df22e-0207-48bf-9f00-0bcf0ebf3b16_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4b2b6b92-6edb-4852-8cbb-cc2beab7bba2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation costs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_a4c0bc4e-c46d-4abc-a9d1-8d8f26f180f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1d522c2d-6feb-4c3a-93c8-63168bfcdfc2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_9720fb16-fac1-4b5a-8427-f5a6585b452f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of senior debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4d441f83-397d-41d1-b429-8669eeec5b4e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_611987bc-6ff2-4782-8e40-ef1c3d60bf0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (Note 16)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fceb39e6-4bc9-4d3d-89f7-f72868c67b9b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6a716936-93f9-4ea9-8e15-9136410229f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_abb1117e-f4fd-479f-a717-623e88ad6af9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dfda3c0c-829f-471c-a916-77cb65766ee4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_3fee7324-9ee5-4abe-aeb6-9a03fb7e6018_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_f77c2bee-944d-4de0-b210-57da1647f1cb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Replacement share-based awards issued to acquiree employees</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_225cfa8f-e821-4112-aabe-ad1d72a0ef6e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_3d812a19-96f8-4cbd-8dc0-94920e016b03_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (note 16)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_6a9b3d1a-5fb3-4934-8f1c-d14d94994ae4_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_2b60efd5-65e5-4b29-89e6-d427b6cb1d31_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9a3cffc7-9aaf-41e1-802d-290709e62e6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d1a3749a-f87b-4bd6-93f7-4882b46e9690_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_bc4cdbc9-1daf-4348-b11e-d30a183b897a_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss and tax credits carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_374570fc-ef0c-413a-a986-52fcc2fb9a8b_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_018f91a5-0d85-4c77-929f-749b22294e74_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_969bad61-eac2-4f68-9d6f-87e4cef51fef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60321020-0a13-43c0-b5c7-cb3f0a0bd865_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_515861d1-0581-4d95-acd5-a3566acc5a3f_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unbilled receivables (in percent)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_c07bdf19-f93a-4381-9672-91f641b975f6_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_67455521-b330-4b60-b08f-72e6a35247cf_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_00a65763-50d8-418e-a68f-3f358192dfe1_terseLabel_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs Based on Service and EPS Targets</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_label_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_documentation_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember" xlink:href="iclr-20221231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceBasedGrantsMember" xlink:to="lab_iclr_PerformanceBasedGrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ababb716-78e5-49c1-b20a-dd199cc2b77f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range2Member_59418716-4cd6-476b-a06e-771bd3ecec79_terseLabel_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2</link:label>
    <link:label id="lab_iclr_Range2Member_label_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2 [Member]</link:label>
    <link:label id="lab_iclr_Range2Member_documentation_en-US" xlink:label="lab_iclr_Range2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member" xlink:href="iclr-20221231.xsd#iclr_Range2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range2Member" xlink:to="lab_iclr_Range2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1bb5625f-7e86-42be-9090-3a06a4b6175d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef5c5b01-3cdc-4b45-8ac8-9312924aa54a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_552f067a-5187-4ee9-bbd6-7b9818e1835a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_126fa5c4-8b3b-4e74-b22f-b4e13dea1700_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and Integration-related Expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInEquityMethodInvestments_0dca3186-89f8-4dba-891d-6c0cc85d1605_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in equity method investments</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInEquityMethodInvestments_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Equity Method Investments</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInEquityMethodInvestments_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInEquityMethodInvestments" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInEquityMethodInvestments" xlink:to="lab_iclr_IncreaseDecreaseInEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_a3f040f6-0edf-4d73-865e-bddf433f76e0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses incurred from related party transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_774b6219-8a6a-430a-95ed-c97a7b22df65_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentAxis_868079fb-69ec-4b68-86a5-a86caa2f5eee_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_label_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentAxis" xlink:to="lab_iclr_VariableRateComponentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_32c12b80-324d-4bc7-b5c9-fdbe4d675f10_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0ffd02f0-7c8e-45de-827d-46343ec9acfd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_3303fdac-f61c-411d-8d61-f643e8fa9a4a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_78ef1874-417d-4e24-9450-a03630fdda76_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_1182568b-8fa9-4ae3-81f5-2b12b40edbdc_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_d6181186-4dc9-4f51-8566-c2b71e72ad48_negatedLabel_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Retained Earning Share Repurchase costs</link:label>
    <link:label id="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Retained Earning Share Repurchase costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:href="iclr-20221231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:to="lab_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e86ded50-76f5-4ade-826c-ed503f56484e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1581b7e-79ee-4b4a-a918-2c84731c4a69_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2c2a5149-de0a-42a3-a16b-221fb0c3cffe_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_472fcd80-afcc-4c76-9f70-d0613d2d7291_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b25c6e2f-b66c-42f1-9615-78f3e57cc3b9_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_8e58b706-f191-40e2-9e51-5d2e9742ea79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_11377a76-3f39-4d37-8f74-331595b42c23_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheme contributions</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Scheme Contributions</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanSchemeContributions_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Scheme Contributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanSchemeContributions" xlink:to="lab_iclr_DefinedBenefitPlanSchemeContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_e0a4617a-adfd-4b06-bce2-e5173903fe42_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other net assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5a38fe99-54e7-434a-8d31-e60ad92edd57_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_80c65d96-2946-4f39-a252-ac388f63b659_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_809f809c-b883-406b-99e0-55969ed6cf01_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_67f1d198-f79d-4f2a-95dd-549753bdd280_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6eb26ebf-c023-4221-b83f-8a40d2c78b14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_48b6e97e-e4bb-41d7-8a03-c08fdda75f6f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_45d5c343-4c86-4dc9-829c-8ce101b68b37_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_d38f503f-90e6-491b-882f-81aed6d8afd8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_28433216-59a1-4223-aae7-9968e56a26d9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6354cfcb-15e1-48d0-bcfa-9ef1358089fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_cf3818c7-6e58-43cd-bdce-a885df69b68c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_786c570a-3957-4b62-92ec-69630f850cbc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TermLoanFacilityMember_795bb3af-1bc6-4b35-a532-a7a23261c241_terseLabel_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_label_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember" xlink:href="iclr-20221231.xsd#iclr_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TermLoanFacilityMember" xlink:to="lab_iclr_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_8d6efd8f-92b1-423f-bb24-f53e2cf1e38a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_ff9a80c4-c6f5-467f-ab5a-d90c38cf37b0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate derivatives held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_dce3c073-f5ac-4e66-8d16-2572d2f0720e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_941b6e88-bd3a-450d-8103-e9519e2b9500_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_295a6540-8931-459c-9dc2-25298ff4091f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_737fcfc3-6375-435a-a423-5613b5df23a4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_ba2a41da-dd79-462b-b1f4-df4bd601dbf5_negatedTerseLabel_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of long-term debt and debt issuance costs</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_f99cd32f-bcf1-48af-9da9-7953e15b96fb_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Distribution of Income from Operations by Geographical Area</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_label_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income by Geography [Table Text Block]</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income by Geography.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:to="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bd12dede-344e-4233-8f54-625a7f2be032_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_748612a5-5d5e-4c36-afb8-987d94e15b6e_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations, excluding restructuring and other items</link:label>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_label_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</link:label>
    <link:label id="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:href="iclr-20221231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:to="lab_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1d6f6679-2adb-44e8-852e-4f66d776ae81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_2d012775-0a60-4567-bd6a-cdbf3340a4cb_negatedTerseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_38417f83-06d6-4853-8848-784428775044_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_8ec2024e-7378-47e8-b291-a26853ec3293_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2023To2036Member_1d648c5e-36fb-4832-b878-b0a4d4a66bd0_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2023To2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023-2036</link:label>
    <link:label id="lab_iclr_TaxYear2023To2036Member_label_en-US" xlink:label="lab_iclr_TaxYear2023To2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2023 to 2036 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2023To2036Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2023To2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2023 to 2036</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2023To2036Member" xlink:href="iclr-20221231.xsd#iclr_TaxYear2023To2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2023To2036Member" xlink:to="lab_iclr_TaxYear2023To2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_d2bd6fe4-60a0-4e79-9357-22dae30e5956_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_248d334b-42c3-40a4-8ec5-68fe60f74bc4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_4af7ea53-81ff-4e4d-bc35-7e9c7b1d5126_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments (c)</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_95e35457-837e-4d32-964d-081074c5558e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_ca370cd3-058f-4f44-8d51-2e274765e85e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_8949c51a-c8ad-427c-ae64-688fd8e802a1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_3562aa93-5b50-4e02-a6e9-cce419035fa0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f1390e02-38cd-4598-bbd8-d3cf37af3bf8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participant's contributions percentage of annual compensation (in percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_9f021230-3ec2-463d-a3d8-2636e2e46357_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a6a338c9-1ed2-48a0-977a-ccdc17c9d561_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_720c6aeb-fe03-418b-b3a3-4ea9dd2086e2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_fb5e86aa-a07e-485b-b1e3-4fbcad5e17c5_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_MeDiNovaResearchMember_6cfb5bc8-0e30-4436-93c8-89c8b7d3f40b_terseLabel_en-US" xlink:label="lab_iclr_MeDiNovaResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeDiNova</link:label>
    <link:label id="lab_iclr_MeDiNovaResearchMember_label_en-US" xlink:label="lab_iclr_MeDiNovaResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeDiNova Research [Member]</link:label>
    <link:label id="lab_iclr_MeDiNovaResearchMember_documentation_en-US" xlink:label="lab_iclr_MeDiNovaResearchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeDiNova Research [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MeDiNovaResearchMember" xlink:href="iclr-20221231.xsd#iclr_MeDiNovaResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_MeDiNovaResearchMember" xlink:to="lab_iclr_MeDiNovaResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_92218110-5d97-4b11-aa34-79358387d75d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_312481ba-e62b-4361-a933-92ed7dda938d_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_26c02d56-f3b0-44a7-8812-d6bdc9ef43e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities (note 16)</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_81cd823c-f796-4b61-ad0d-6dcf7c2f0c8e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of share capital acquired (in percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f2308bb6-248b-4137-9b1c-dfcee3cc55db_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_085f9fc4-a4e8-4aed-a822-8ddb41a0f4d3_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_458ef83a-fdf0-40c5-84f0-0dec0e40468a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c6429751-3bfa-4ce7-96c8-ec71f7ef902a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments (Note 8a)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_75416a39-b496-47a1-a37e-f2358a703b01_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_26a11ee0-2e6b-4766-bb0e-4a2c480f2145_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in advance payments netted against unbilled contracts receivable (in percent)</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5966f5b9-0967-4c0f-9e43-940462900de4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding number of shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_f28d5961-2931-49a7-b7df-aff4052e4b5e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_7a7dbe33-7eff-4241-b006-14e2771a4e6c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_3b87152c-403b-4575-86ae-b7978937dcb1_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_5c63f0c9-326e-4973-933d-aa784c7bd0e5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_efccb432-5c7d-4a91-bbb6-74e224f1fe8c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0c9c0912-2d7e-4daa-a98b-287de10dfe90_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_bcfa8bdc-7cbc-4f1e-8fca-bedc6d29a632_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other restructuring costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_d09735e4-49bc-47fd-b013-3ce8986bc0d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Plan Asset Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_56201a71-6d2c-4fe6-b26e-e81689722217_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3f7046a2-8c7c-44ed-ba80-ccbbdfcd4b57_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_03d0b522-ebba-4286-959a-d7007e474242_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_7f921eaf-b0ba-4ecf-ac04-9ee6ec227000_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense was allocated to the following components of other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_c771b621-4f35-46aa-95aa-3cc8ddef338a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fa0ded57-5132-48ee-81a3-abf134413087_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AuditInformationAbstract_label_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iclr_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract" xlink:href="iclr-20221231.xsd#iclr_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AuditInformationAbstract" xlink:to="lab_iclr_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6d6e1d79-53b3-483d-87ff-57ef79dc9149_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a9c6c7a1-b838-4312-bfa8-b3315115ce41_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_9f308b2e-e84c-4261-99d7-00833b5ccf56_terseLabel_en-US" xlink:label="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Majority investor, ownership percentage</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_label_en-US" xlink:label="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Majority Ownership Percentage</link:label>
    <link:label id="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_documentation_en-US" xlink:label="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Majority Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:to="lab_iclr_EquityMethodInvestmentMajorityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c048e76d-2767-480f-9599-bb13aa2ca14f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per Ordinary Share attributable to the Group (Note 24):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1b21cc6e-d628-4a3c-9677-0c51e69c34db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfLocations_45993671-c2f1-428d-bd43-21d6db64ff3a_terseLabel_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of locations in which company operates</link:label>
    <link:label id="lab_iclr_NumberOfLocations_label_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Locations</link:label>
    <link:label id="lab_iclr_NumberOfLocations_documentation_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations" xlink:href="iclr-20221231.xsd#iclr_NumberOfLocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfLocations" xlink:to="lab_iclr_NumberOfLocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_166530b7-8b54-4bcb-a289-5130c78f0322_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of long-term investments in equity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_007c7b31-a2d2-48a8-b432-45df5237db5c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2045a478-1ab6-4377-ace3-db452de92dc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_73c76b83-f988-4e10-92c7-f1bb16530581_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average exercise price of option per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c82f17d4-a870-49d2-b3dc-e32da230df1c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_20d8cb3b-8dad-43b0-86de-10d21af3d358_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_cda20b75-0b29-4e23-b94f-1c3dd9a6145d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt at fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0a093747-2c88-42c2-a0b9-4741ad7d632b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_f8687c12-1d23-4715-95ad-ddd6195d3889_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personnel related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients610Member_1b432f9f-b8ec-4b83-a1e7-738ec6916045_terseLabel_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10</link:label>
    <link:label id="lab_iclr_Clients610Member_label_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:label id="lab_iclr_Clients610Member_documentation_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member" xlink:href="iclr-20221231.xsd#iclr_Clients610Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients610Member" xlink:to="lab_iclr_Clients610Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_d350f63a-2279-4121-80a5-18ba7100e008_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b81ef0a4-a075-440c-9509-99d63d9ee14f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_5977c496-0263-4ee7-a07c-392ed76f145b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_96aa72d8-c175-4ebe-b66c-2d6cc1581b6b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Caps</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4251ff44-2833-4e67-add3-a05fd5d83b9b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_128aea30-e3e6-428c-80eb-870c67b9f982_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_702a56fe-c3b8-468e-b20c-a765aad96153_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c1a85fb1-ff44-454a-834f-ae81032b44cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_c3868613-aa9e-44cf-8673-a592480b1a36_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Net and Unbilled Revenue</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_4872d41b-5bdf-45da-b342-d36bde231bcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GainLossOnIssuanceOfDebt_44377c49-a7df-4419-b444-ff3ae34e0000_negatedTerseLabel_en-US" xlink:label="lab_iclr_GainLossOnIssuanceOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on issuance of debt</link:label>
    <link:label id="lab_iclr_GainLossOnIssuanceOfDebt_label_en-US" xlink:label="lab_iclr_GainLossOnIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Issuance Of Debt</link:label>
    <link:label id="lab_iclr_GainLossOnIssuanceOfDebt_documentation_en-US" xlink:label="lab_iclr_GainLossOnIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Issuance Of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GainLossOnIssuanceOfDebt" xlink:href="iclr-20221231.xsd#iclr_GainLossOnIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GainLossOnIssuanceOfDebt" xlink:to="lab_iclr_GainLossOnIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_21f77220-16da-425a-8a02-85a36296a843_terseLabel_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government grants</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants [Policy Text Block]</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grants, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:href="iclr-20221231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:to="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_dacc1f2b-24ff-4e94-91ef-4270b9029e0f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9e426274-85d7-48d3-b61b-4f928d2dfcf6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange movement</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a0973838-2cfd-4118-9f0e-1db03fb92429_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0e0313ef-247a-4d0e-88a3-009bebfec90f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_6b061150-8e75-460d-9aef-745705a33c3d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility related liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Utilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedUtilitiesCurrent" xlink:to="lab_us-gaap_AccruedUtilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_4dd310d3-b871-433a-a7ee-2abe6a9140c0_totalLabel_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before share of earnings from equity method investments</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_label_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_documentation_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:href="iclr-20221231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:to="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_088e9521-95c7-4a6a-9c52-9e9209b5285d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_89fd7837-b500-4db6-9d21-bc8fb30fa31e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange rate changes</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_f982d2c2-2440-4cb7-97c3-3a110c9425fa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Years 2028 - 2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b1ff0e2e-3d8f-4164-950c-4af8d23dafaf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d82cd212-eeb3-4ce3-b424-b150d54df244_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_ab1528b8-e87c-4a22-9e0c-e3080fc141ee_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_8099ee0a-04f0-4bb2-980f-96e3baec0259_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b90bf25e-37b8-4b32-972f-5b1a9e7986ed_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_4d30c7b8-f405-42ba-b19c-e9098f10c819_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal net operating loss carry forwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_36bf4599-66be-43d8-8e99-8db378f0911f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e720ccdb-97ea-4c38-b892-52ba91986374_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_97aa9339-9445-4913-aa41-d233a6c9087e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable - weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_ebecb215-cb5e-4033-9cf6-d53f803cd4d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_2a19784e-04cc-440b-8c6b-e23277b3aa5e_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment &#160;</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_1b2e75f2-4f83-466e-814b-29c9f8684644_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_47408856-b2ce-41de-8f76-e5d6f078824c_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_4e6a8992-7ced-4388-b638-11c078d2ac01_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; development tax incentives</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_6c924cfb-fa19-4c77-8c6b-5f832be967c0_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_44eca62a-b025-4af3-8953-b7305c3c92c0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_94cb89fc-b7fc-4088-ae5f-32a8484de2c1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_71cff1e2-e796-479c-91e3-61b38ebc92bf_terseLabel_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized percentage (in percent)</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_label_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_documentation_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:href="iclr-20221231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:to="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_487bcc39-89b8-4046-842c-fc6433121a80_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2022To2028Member_b41e4e0e-5ebe-44ea-b41a-92448e438fc1_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2022To2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2028</link:label>
    <link:label id="lab_iclr_TaxYear2022To2028Member_label_en-US" xlink:label="lab_iclr_TaxYear2022To2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2022 to 2028 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2022To2028Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2022To2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2020 to 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022To2028Member" xlink:href="iclr-20221231.xsd#iclr_TaxYear2022To2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2022To2028Member" xlink:to="lab_iclr_TaxYear2022To2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_ba4adbf3-56e2-4207-9eb5-09fd3fce36db_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_7f9652aa-574c-4389-a7cb-5040441702a4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6cb18a88-a164-4bca-9963-d847692e639f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5776ee5d-7490-411b-9c97-9df8a64c234a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_dff8b0ff-a358-4ab7-a92f-a56ba31bbbd3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_d929be07-0e7e-4c39-b06f-88ce2d3ee98e_terseLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid and transferred balances</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:to="lab_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_557bcb56-e1a5-4a3c-8ab9-098ff6b08e7b_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_65e57653-ae71-4ec1-a9e9-c5038c5da5e8_terseLabel_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment to acquire future long-term investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_label_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_documentation_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:href="iclr-20221231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:to="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_168ea2cd-2397-4f51-ac16-b3ed1b72d4f8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_8a624a47-31b0-46e2-ab4b-c9b7e9865ea1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d24fd4b5-e04a-477e-9038-a1ba46120477_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9c118264-b1c8-4fd8-af2e-a851e515c9ea_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_73de8a4d-789f-418f-a56c-33d60d658a0f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_9cc1c20f-d3fa-4e0e-b5b2-e3137b042771_terseLabel_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units 2013</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_label_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_documentation_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:href="iclr-20221231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:to="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_fd11b9d7-e20b-443b-9666-c3a048cfae9b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carry forward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e452f683-2a2c-44bc-a39d-47a90e29b9d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_a17ff1fe-4bfb-4e2f-93d3-e22e75f7c28c_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_77007216-81eb-4bc8-8b80-8540a984dd6a_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_c9bd836e-4517-4123-ba50-7b1311638983_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6f6f8322-9149-4239-ba32-a4f65446c216_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_4aff063b-dbe0-4415-bf2c-8eca22310d4b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_70cc1f30-b33a-4c6b-a996-7c2f532b6d50_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_98fcae33-399e-4c8c-8fb0-fc136fd279eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_ee6f707c-1ad0-43ba-a9b3-4394462f8de3_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_90a07910-7750-480a-b5a8-4ed54333bbd7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of available for sale investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d57c3465-5090-4448-8124-644309266da6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d3821cbc-0ae0-45e4-8369-f0972f706e53_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_e92d20a2-7dee-4e5b-bea2-fa287f02ff13_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_a104dc87-336a-4524-bfa3-ffe68cbef630_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_aff907f7-086d-4395-9ded-366ea01058d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_d998a2e2-0861-4f56-b6a9-717915dc7f19_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1dd08b7a-2349-4003-ab1b-84f18cbced3d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock units to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e20e52cf-21e6-4a70-b948-6983a786fe43_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range3Member_5b6a2423-b737-4446-8028-0613de98c0ad_terseLabel_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3</link:label>
    <link:label id="lab_iclr_Range3Member_label_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3 [Member]</link:label>
    <link:label id="lab_iclr_Range3Member_documentation_en-US" xlink:label="lab_iclr_Range3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member" xlink:href="iclr-20221231.xsd#iclr_Range3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range3Member" xlink:to="lab_iclr_Range3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_94da0118-0057-42a3-b9df-e6446d34797f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_af9b4035-e0ba-4716-b119-2f8ed78d6cfa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of shares associated with a business combination</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableRelatedParties_0aba9a96-3a40-4480-bced-d0d0e116e8e8_terseLabel_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Related Parties</link:label>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableRelatedParties_label_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:to="lab_us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_ae25d794-41ac-4875-ba1a-b9abaf5a904e_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_6e945cb0-6ad6-4d49-bb16-386f5ea617d7_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate component two</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component Two [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentTwoMember" xlink:to="lab_iclr_VariableRateComponentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9f2d6976-e255-49fa-8c0e-dfb74cda1353_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities (Note 15)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_7fc22aad-9579-4720-9d65-c9c5f1fbdf50_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_1c9a7c2b-8c29-4a3c-85d1-d8c01e201312_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_60dda119-496c-45c1-a60f-9d1a9794553e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_9affc1a1-e03a-4b07-9320-df6b86e8764a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from investments in equity - long term</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_26d0dd6a-2dc3-4781-b9d8-e1a8399d5146_terseLabel_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontrade Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontradeReceivablesCurrent" xlink:to="lab_us-gaap_NontradeReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_b3852a98-52b9-446a-b316-be16cd841870_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary of Common Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:to="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_4ec839df-57c5-480b-bff2-d9a25e8123f1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_842bc834-f128-4a87-b546-0ee827afee4c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients25Member_0009c73e-1a77-4b8c-bf17-3ddba95c0e4e_terseLabel_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5</link:label>
    <link:label id="lab_iclr_Clients25Member_label_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:label id="lab_iclr_Clients25Member_documentation_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member" xlink:href="iclr-20221231.xsd#iclr_Clients25Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients25Member" xlink:to="lab_iclr_Clients25Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_10bf3f99-4b1c-4563-bb48-8ce91db34ccf_terseLabel_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan granted tp related party</link:label>
    <link:label id="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_label_en-US" xlink:label="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Leases Receivable, Related Parties, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:to="lab_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_004981db-6a4d-42f0-9539-398a8007e327_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives of assets</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:to="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapital_77251a34-bf87-4c1a-a43a-f2fd62c57e3a_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital (Note 18b)</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital" xlink:href="iclr-20221231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapital" xlink:to="lab_iclr_OtherUndenominatedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_acaa2569-7a05-4878-841e-2a5965de3647_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses (Note 4)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d5aecde3-7a57-433e-bbfd-994b7ae14d4e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_380bfbe2-307c-40b4-a054-a2f5e7828747_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_93825056-e1b6-47f4-832f-4871baedb243_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement share-based awards issued to acquiree employees</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredOther1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_7b22af68-e3b5-47ce-8b6b-e98940c76b50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/expired (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_d886ec52-599b-4d05-bde6-ecf212a9b458_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unbilled receivables</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Asset, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_6a0c948c-db05-49ab-aaa9-050213b57c82_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d68f804b-3cb4-4e2b-ba59-06e569a68c07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_89195013-e190-4616-993c-aff73f336ca3_terseLabel_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited pension plan</link:label>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_label_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited Pension Plan [Member]</link:label>
    <link:label id="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_documentation_en-US" xlink:label="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICON Development Solutions Limited Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:to="lab_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_613cd819-1f44-43fc-9740-9f86f3f5a887_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:to="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_98553b92-9daf-48bf-b79b-7c270b1cf003_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_776078d6-65d9-4275-864f-0f031c0f4ca6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6bbf4dbd-968d-463a-a3cd-9a3c4790a3b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0c278c49-0437-4845-b339-6f29945970e9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_984b3b8e-9d32-48b3-a92b-1986ee2e0c46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Underlying Asset Split of Fund</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_d8538fd4-7669-4fd1-931a-6e780133ce1f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_ffda8d6f-8890-4619-ad76-de4d057a9da0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_6e9c6d4e-4312-4357-9ce5-521ef5d04726_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_99eba0e9-5b7f-4731-b9df-8e3930877ae9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_8395b5ad-898b-47b8-9000-95f2c9bc99b7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_4cb1f5e8-b0b1-4486-83ab-51f27a5b0a6d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_020e9770-c336-4541-8ee3-be7998f08544_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-of-use assets (Note 15)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_103f255d-856f-4b96-8b5b-224dc2db18bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_92500eee-2e66-4fbd-8d92-6f95d611e6de_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_dff2c5c1-1c09-4a4f-81a0-03f4a12d2225_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2b3a784f-66cb-4bb1-b908-47ca40687f2d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2249ec6e-20e2-49a8-854a-d39363ce0a81_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_a274ec23-f52c-4398-a0b4-16071a451730_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Country</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_483b6f62-9bea-4117-9568-e706c81e76f1_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9f65382b-b098-4f73-8f5d-e94288aa3c3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Transactions for Company's Share Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f1643431-4d6b-4728-98c7-5a9e6faf128f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Range1Member_4ce7baa3-c49d-461f-ad48-fed821afdc14_terseLabel_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1</link:label>
    <link:label id="lab_iclr_Range1Member_label_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1 [Member]</link:label>
    <link:label id="lab_iclr_Range1Member_documentation_en-US" xlink:label="lab_iclr_Range1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member" xlink:href="iclr-20221231.xsd#iclr_Range1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Range1Member" xlink:to="lab_iclr_Range1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_434e8872-3c77-482a-849b-09f31e0b8e4f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of Recently Issued or Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_70c4ffa2-93ab-4889-9175-0f80d9132293_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State NOL's</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_b16eba37-35b5-4763-a692-2f57bb711e6c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and unbilled revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_83221ed7-39b5-4d90-b26a-0f6e61f0f279_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price of equity instruments other than options, vested in period (in USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_7ff5a59a-f16f-494d-9b5f-b3ee6d221d25_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_6d476086-d58d-49fd-bb6e-54c0fed87d61_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_7749dac0-16d4-4eb7-bffc-bb20aa27d264_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign and other income taxed at higher rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9bf2a26d-6892-47fa-99da-1e029c01f010_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits_269233a9-af31-4e06-ba24-07ded666f9a0_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration related (Note 6)</link:label>
    <link:label id="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits_label_en-US" xlink:label="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs (Credits)</link:label>
    <link:label id="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs (Credits)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationIntegrationRelatedCostsCredits" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationIntegrationRelatedCostsCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationIntegrationRelatedCostsCredits" xlink:to="lab_iclr_BusinessCombinationIntegrationRelatedCostsCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_628d0742-e054-4d3a-b044-020c4518471f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5cb658ac-dc31-4dad-a2ee-b464b5ea65e1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7f8148a9-479a-4b40-9c35-43fdd668be0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_429c04a7-3d86-4dec-9749-c0626813591d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_b1446c07-de67-4479-9338-9e8dda602866_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7d7b26e1-b0e0-4f15-907d-76b2b092efa4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1a2535e3-e6bf-4d0d-97ba-953142d08b87_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_86591dbf-cbb4-4da2-9f5f-fbf706b3b94c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_a7f16e7c-2104-4ec4-9fb2-7d40a2d1b6c4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_97a5b166-f146-4e1e-a948-1638bd595c53_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f1c564a1-e684-4975-944e-3d853037feb0_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_fce4ecce-7891-4a09-a9f8-a5c160e97897_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_9501c5bd-54bf-4d1f-9f68-6e532854c46b_terseLabel_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap and interest rate swap</link:label>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_label_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap And Interest Rate Swap [Member]</link:label>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_documentation_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap And Interest Rate Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember" xlink:href="iclr-20221231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestRateCapAndInterestRateSwapMember" xlink:to="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestMember_24116ac3-2c61-44eb-af27-d2935a3003f6_terseLabel_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_iclr_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestMember" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RedeemableNoncontrollingInterestMember" xlink:to="lab_iclr_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d0a882a3-cfe0-425e-af89-3057312516e5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_29bf478b-92c3-462a-8c90-c83418730253_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_d49c9871-1d4b-49cd-b8f4-62f18e58d084_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_a6b746df-98f0-452e-8c3c-c6d51d3dbc87_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_e678550b-c911-48b6-bc3d-f1c2c95fb7ea_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_fc6e998f-5a7a-4433-a7a5-cb94cdf56f00_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding shares authorized</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_cc89805d-6772-49b5-9043-65a0d06e3219_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net prior service cost for defined benefit pension plan that will be amortized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52c383d8-820a-4ded-997c-163b181cd2cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_04a3ad8d-f76a-49a4-a75b-73e25589ab65_negatedLabel_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_label_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations" xlink:href="iclr-20221231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveUtilizations" xlink:to="lab_iclr_RestructuringReserveUtilizations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5a6730e7-4d28-42ab-9efe-c888820494e0_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_d03b1059-3f67-47e4-af0f-7668685204e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_44db6e16-0162-4130-8e8c-8dfcb647d9e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_04332e2a-43da-46a3-92fd-924e31ca968a_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to the Group (including NCI redemption adjustment)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_7637999b-5434-4875-a631-80bc8d3b7e89_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0b37e010-00ae-45a9-837c-a6acc73adfbb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_00a10a95-b303-4f5e-b032-7ab623ce733a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8e8c1d2c-c59e-443e-b1a0-982155f55469_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_9c937011-b81d-4f3c-b500-34b4eb151e5f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_46b8dd11-4aa4-43d6-8779-e2e8afd8e7d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Amounts (credited)/charged</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_329c5984-9bf1-47fe-9292-6c32abc7e5a0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e8785137-f1b0-4023-ad13-22f086998ac6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_21dbcb0d-f4a2-4c45-b41e-4e174ef97d79_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_e3f42ce4-8b36-4a90-ab21-ebc99c6e5055_terseLabel_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_label_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc [Member]</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_documentation_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRAHealthSciencesIncMember" xlink:to="lab_iclr_PRAHealthSciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_7ffa6747-a1de-4f02-b71d-1141ecc932c8_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of measurement period adjustments</link:label>
    <link:label id="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Measurement Period Adjustments [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Measurement Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:to="lab_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_95335a33-afeb-44a2-86de-38f13d4240cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_42b5e6ae-44bf-49e8-bae4-4a40d7df4522_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal NOL's</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_14b64842-611d-4659-974f-a436620cb7bb_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Debt, Equity and Other</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1b87f2f7-6af8-4fff-a494-e13c3c173db1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_50dcbf12-1d1b-47b6-ba6e-d6f14bb47a16_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to the Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f0c37c6b-9190-4061-8ac3-089a9379151a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_1220ddbc-2615-4869-82af-fa4df9b3e5b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities (Note 12)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_a7d7e252-a81b-4033-b631-e83c7fb80558_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_38d3fb9e-9fce-46e6-97ae-448fa9dfc636_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-U.S subsidiaries operating loss carryforwards for income tax</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_230a3b34-8c78-4cfc-b9d6-577a88133208_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_eaba6e41-afa9-4c84-a2d7-572e32907f63_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairment</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_a26e5cc6-7960-4d23-833c-003ab6d8af65_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_38b59ed3-6586-43eb-a859-83fc87557128_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reductions</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_457538e2-50c5-4d16-b171-e861f513d2f3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCountriesMember_c730cac8-ba26-4b6a-853e-2d5942f77e99_terseLabel_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_label_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCountriesMember" xlink:to="lab_iclr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_139deb0d-c130-418c-aa82-595bd0b17f44_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_45793422-215d-4b89-a555-effcb964d743_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d5adea67-2a75-47d7-a09f-fb94e724b420_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0fb0247-1fbc-4fb3-b1c1-b5fa2210a254_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f94b4ad-0d71-4444-afba-3ffa6ad92fe2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_977bed71-70cf-43c2-8b42-ee88bc107faf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain/(loss) on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_2fc302c1-82c8-4312-80c8-d4911bad0ef4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss) on defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4d00735-2f86-4499-acd7-f15a2cef270f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate movements on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_585d7a84-b406-4114-b7e1-e159ddfcfed8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net (Note 9)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_47665780-1059-4b47-b02c-b38d0a6f95d7_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment (net)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentOneMember_7e1158a0-9423-4109-9198-05a3b86f71dc_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate component one</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component One [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate Component One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentOneMember" xlink:to="lab_iclr_VariableRateComponentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_918c212e-1110-45f2-ac4e-7d825708eb1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_54d10390-186c-4e0c-bf2c-f85428b2ac13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_c5219b59-50c7-44ad-a790-768ca750c53b_totalLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in advance payments netted against unbilled contracts receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_6bcbdf0e-18d7-4784-ab5b-2c14d487fe7b_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in advance payments netted against unbilled contracts receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_2b98e525-b52f-48a8-b2e4-c73a56c57a8c_verboseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:to="lab_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_230546a4-fc91-4ed2-be29-161493b8aba1_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_ead6913a-c465-47d2-b1a7-42268f8b1a43_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient database</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c89784f1-f095-45e0-851c-71667e2acdaa_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_362cd1bf-a9ad-4ea6-a9f7-1c11bb39a59c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_474d5752-f2b6-4d7f-8a10-a93a4dca21db_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to settle debt obligations that existed prior to acquisition date</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_label_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</link:label>
    <link:label id="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:to="lab_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_71916f07-afa1-4761-b9c7-7e10fd8b4d05_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_51e68394-de0b-49f7-9cfa-279ebd82c5e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_1df590b8-7cc7-4d71-969e-3be17c5209a0_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_label_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_documentation_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:to="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_6c4ef32d-ec76-4859-a212-5ac163d154f3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b8c52b11-f2ba-4d4f-ab23-7f22ed1e377b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (Note 25)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2fbe1ddc-d1d1-42bf-9fb4-2ecd3c5cdfdf_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_f1cd662d-4400-4886-aded-b030b51fce8f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_47dc1d87-506c-4175-b6d8-940cc27ab2bd_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_76b7c389-aae5-40d6-80b8-0b9a6e6743c5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_b4126de8-bc4b-4080-8353-da70fd655c64_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes (net of refunds)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_e32db30d-113e-4c98-bf1d-1a6e5261f2a6_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_726042ff-d3a7-4ba1-90d6-2e5c4eddc278_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through business combination (USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:to="lab_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7ebbbf9f-60d1-4a35-a90e-0c2abe226250_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in carrying value of operating right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_62ef5ccf-f172-4bc9-ac9f-95dac81163b4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_235feba3-9561-4238-895f-cd778057f56c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net (Note 11)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a49c9970-1548-4bba-b9f9-45e1ff599f38_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_03fec8a7-0b30-4dd0-b9c9-04a16826b416_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss that will be amortized</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2a1251d6-f188-4277-9563-346143ae88ee_negatedNetLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_ff83df87-53da-4a59-8450-7ef0e3341f05_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_30479052-8dab-4024-98bb-f22115ba9183_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f67f6fcb-22cd-40b3-ae06-963dfae31935_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_241cd351-9f9b-4cd1-bb54-9fd7c493c436_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tax benefit related to stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_4009d445-3b34-43ff-8572-7d14a8831441_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20ccbf90-3d28-46c1-98f1-33e1d927e618_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Granted Under Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_37d597c0-d716-489f-9bba-6b7da5995226_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_e88e5670-844c-4dec-8630-aebf8317620c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_bbbaf7bb-0190-4985-9b3e-5c02efbd472e_terseLabel_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Award Plans</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_label_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_documentation_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember" xlink:href="iclr-20221231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockOptionAndAwardPlansMember" xlink:to="lab_iclr_StockOptionAndAwardPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_b07d08cc-8e7c-48ae-b90c-fb348737ca43_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_247568b8-ea34-4c51-85c2-f43f345e08c5_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of call option on noncontrolling interest shares</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestReceivableRelatedPartyLoans_f1f94a96-5fa3-457c-9492-21d3ea66f4d5_terseLabel_en-US" xlink:label="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable, related party loans</link:label>
    <link:label id="lab_iclr_InterestReceivableRelatedPartyLoans_label_en-US" xlink:label="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Related Party Loans</link:label>
    <link:label id="lab_iclr_InterestReceivableRelatedPartyLoans_documentation_en-US" xlink:label="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Related Party Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestReceivableRelatedPartyLoans" xlink:href="iclr-20221231.xsd#iclr_InterestReceivableRelatedPartyLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestReceivableRelatedPartyLoans" xlink:to="lab_iclr_InterestReceivableRelatedPartyLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_5894382e-76e6-450b-b9df-efb0b4739475_terseLabel_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement period used as a basis to estimate expected cash flows</link:label>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_label_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Retirement period</link:label>
    <link:label id="lab_iclr_ExpectedRetirementPeriod_documentation_en-US" xlink:label="lab_iclr_ExpectedRetirementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Retirement period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod" xlink:href="iclr-20221231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ExpectedRetirementPeriod" xlink:to="lab_iclr_ExpectedRetirementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_54c99240-7b86-4555-8a04-529a615f1841_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_5bc8c72e-63a2-4d70-824a-b3922f0dab49_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_e01d301c-7201-401e-9299-abbe86e9814d_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a2d90641-ef83-4339-bf7e-4388666a421b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_eab9e314-6e77-49ea-8c95-eef03872b83a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue of restricted share units / performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3c537a99-393c-41ab-896d-0906e2eaf38b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_1f3645ab-4599-4076-b8e5-29de43378f90_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fe2c3ca5-1de1-44bc-ac32-109d69646966_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear20332041Member_7446d6a0-d87f-4f1a-b91a-d576c7f159e3_terseLabel_en-US" xlink:label="lab_iclr_TaxYear20332041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2033-2041</link:label>
    <link:label id="lab_iclr_TaxYear20332041Member_label_en-US" xlink:label="lab_iclr_TaxYear20332041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2033-2041 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear20332041Member_documentation_en-US" xlink:label="lab_iclr_TaxYear20332041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2033-2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20332041Member" xlink:href="iclr-20221231.xsd#iclr_TaxYear20332041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear20332041Member" xlink:to="lab_iclr_TaxYear20332041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2f85fca4-9479-45df-b2f3-1dcf83c758e2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20b2fff-d642-45c3-9997-a18c97ad79b8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_e3e8bb48-01a9-47d9-9baf-8908f7cf3b08_terseLabel_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_label_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_documentation_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember" xlink:href="iclr-20221231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeTaxBenefitMember" xlink:to="lab_iclr_IncomeTaxBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7e207015-f15f-46d1-9b8b-9d8034a13807_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_60bc0eb2-48c5-494f-94d5-bb703b9cff3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_a274b098-ffda-4833-8b01-54aee9455e1d_terseLabel_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets</link:label>
    <link:label id="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:to="lab_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_067b63c8-f3bf-40a2-9304-3eb79ecd1a4d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_401a3a75-5727-41c5-b555-b37e8f7ac97d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional provision in the year</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a46c06e7-188d-4137-a8b2-dff96dbe7607_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_fd497ed8-1746-4c36-b43b-d5ffcc1389a2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_2284e042-6731-4712-9e43-adfd24511894_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_ff18b3c4-77e7-49c9-88b0-cac0ac90dbc1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_773bc358-c6b5-4677-896b-1a3affa462e0_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_491d9651-ab74-4a1d-8d33-fb9a63a99038_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension obligations, net (note 21)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8d3daaef-1aae-4dcc-97c9-9d841a594eec_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filler Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_5d89ec0d-e861-4dfc-a69b-7d997975469d_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_6fd4c2bb-6513-40f9-83ac-321192c2b910_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_04d36968-7b8f-4903-933e-dd8137fab858_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202108Member_fa05ce27-5b5d-48f7-94cb-e570aeb44e0c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202108Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202108Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2021-08 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202108Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202108Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202108Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202108Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_08a8584b-81e7-4590-9be6-16a5e63f6400_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6cf2e769-b3c1-4d7d-8df3-ce42070d11e3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_54ec6405-1878-485b-b73b-8c4b0177939a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0cbdc17f-18f5-4f36-89d7-b415ee3205c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a255d7d0-63be-4c39-9f95-215628b4b5e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_bae7aba6-b886-425e-8293-5b65c8c2b0b9_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_dc5c64b2-83aa-40db-9fa9-2dd5a5f6ea93_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_48c10009-c880-430b-bcd3-f9c417e033c8_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_51ac711e-52e9-4d3c-b8cc-2cecae273849_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCustomersMember_f3e6405f-a88e-45cd-9f27-b7c4b96df98b_terseLabel_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_label_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_documentation_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember" xlink:href="iclr-20221231.xsd#iclr_OtherCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCustomersMember" xlink:to="lab_iclr_OtherCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_c7ae065b-60ba-4f48-8082-fc6426191b01_negatedLabel_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain)/loss - benefit obligation</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_label_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</link:label>
    <link:label id="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_documentation_en-US" xlink:label="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:to="lab_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_053886ff-ef89-40a1-a297-a145487e1306_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_6352a581-a43e-475e-92f1-e22d293046f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of ordinary shares issued to acquiree stockholders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_5021792e-fc03-4e8a-80c0-6fcd20168042_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_304b5439-ff7d-4106-ac3b-d5815d6e2689_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillFairValueDisclosure" xlink:to="lab_us-gaap_GoodwillFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_e51f36df-18c1-486d-b615-00ec922a1f0a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Loans and Multi Asset Credit</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities, Securitized Loans and Receivables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_c2086910-657b-40c2-8ee7-1e471f9696b9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e0e7f5fa-4baf-46b0-b14e-4d2f0970923b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_cc31296c-cc47-4c17-a182-e96dad671f74_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_ef2ebdcb-db19-4cae-9a43-f736714a93c9_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of loss on cash flow hedge</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:href="iclr-20221231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:to="lab_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_7ac0dbea-3a44-46b5-a2d6-097f5eae03ed_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_4913fbd9-6a1e-4d23-920b-74920b0e188c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments in equity - long term</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_45ffe537-3585-4629-a49b-e8f171965937_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AcquiredEntityMember_f276a792-6973-4740-ac7d-257a63582404_terseLabel_en-US" xlink:label="lab_iclr_AcquiredEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired entity</link:label>
    <link:label id="lab_iclr_AcquiredEntityMember_label_en-US" xlink:label="lab_iclr_AcquiredEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Entity [Member]</link:label>
    <link:label id="lab_iclr_AcquiredEntityMember_documentation_en-US" xlink:label="lab_iclr_AcquiredEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcquiredEntityMember" xlink:href="iclr-20221231.xsd#iclr_AcquiredEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AcquiredEntityMember" xlink:to="lab_iclr_AcquiredEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember_9c3a90f1-1242-4ea3-b845-55cb7ccbf7ff_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingCreditFacilityMember" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredRevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredRevolvingCreditFacilityMember" xlink:to="lab_iclr_SeniorSecuredRevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4577fdb8-5fa9-4140-91ce-3a45d2072b83_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_57923e48-269e-4f6a-9442-4e59af222be2_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_682ba566-ec6a-46a2-8172-7df0f482ff2b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_7cd3df7b-5af4-4230-a6d3-4e47cc019d07_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_635d44cd-4264-42d2-96e5-ba3699b38306_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_b9f8b08c-7899-41ca-ada0-c82616b55930_terseLabel_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term government grants</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_label_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Current</link:label>
    <link:label id="lab_iclr_CapitalGovernmentGrantsCurrent_documentation_en-US" xlink:label="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Government Grants Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent" xlink:href="iclr-20221231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CapitalGovernmentGrantsCurrent" xlink:to="lab_iclr_CapitalGovernmentGrantsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_ab4e0938-7262-4441-a8a2-bc980b97c764_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:to="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e47a35cf-3f93-42e1-9e65-dd361700473f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_55c38ef9-1ac9-4fc8-95aa-6ac1d30d33b0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2bb1085c-40d2-4f69-8514-fe8c035eac8c_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_78ed83a5-09e4-40bc-8240-772013e4c7f2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_540e46a5-489d-483b-a00d-c5008c22639a_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_59e5c8ad-6c09-49dd-bafa-28e52a1d17d1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_f5e1f0c6-356c-4bb2-ac61-0a3995f75b05_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of financing costs and debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_cabadba3-2f13-483b-9820-3ff5f1c1305e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_59bf3dfc-ee17-4939-84ec-c2ae2f367f69_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_a7483d88-64ae-4744-bbbb-0cac962fef46_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TopClientMember_b083ebc7-8a3d-4994-bbd9-e8741fff9697_terseLabel_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top client</link:label>
    <link:label id="lab_iclr_TopClientMember_label_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Client [Member]</link:label>
    <link:label id="lab_iclr_TopClientMember_documentation_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember" xlink:href="iclr-20221231.xsd#iclr_TopClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TopClientMember" xlink:to="lab_iclr_TopClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8bd67d03-c009-4a1c-89d4-8cd09ca38121_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d729c709-9e2f-4a85-ae55-5cb0ccd1fcdf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_177951ae-9fc7-4288-a94d-a2f94150d758_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1a71e98-1443-4d7f-b404-d2133c904f96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_2bd6d590-2001-4ead-b57c-deb21addba2a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_fb56ad2f-0f32-4194-bdcd-a9e8eba6e1ac_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_3c939a96-12ec-4fe4-8455-85a7ac1eed5b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_060cc7c6-73b2-4e24-9d5e-61c351a22e16_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a7cb7b72-94d0-42d9-8375-3725c44282ac_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7a8b6ca2-f971-4a42-92c8-378f6b63ab69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f84657e2-2e28-4070-9df7-b056891362ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at start of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7d03f0cc-8c9d-415c-bf23-02c0c9a1ab87_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_570fa144-5d54-447d-aa50-45ebbe7f1c8a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets recognized</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_f39b86b4-a290-4f07-816f-d82b86441463_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedParties_68405539-0d85-476b-9938-e1ec15a378a7_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due from related parties</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedParties" xlink:to="lab_us-gaap_DueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_4a0d255f-018e-43e6-b62b-1c75874de7f7_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bonds (including 50% high yield bonds)</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_07eab98c-6e9a-4b54-81ef-0b079a530885_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6e9ceafb-0dcd-4455-8194-7409759a6e4d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_7726d82d-b917-416a-bbed-210c3d1a7a05_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f89d581e-583b-4779-9c79-0c19e794a0d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_7e27d95a-c429-4727-bee6-dc9a578e80dc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_a1081798-057a-4d73-8c1a-d5ebc28fe302_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, potentially expire in 2021</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_017e89e1-955e-4294-aa01-036181ed02b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_7803c9ae-9c7a-4159-9cfe-92c56639dd4c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyAbstract" xlink:to="lab_us-gaap_ForeignCurrencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_56fba76b-4bea-4c05-91c6-bccab0df2bfa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5772c7dd-db90-4135-ba42-d238cc39fd2d_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BuybackProgramMember_cf1e4aa5-75db-485f-a0b6-6c5a26411a1d_terseLabel_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback program</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_label_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_documentation_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember" xlink:href="iclr-20221231.xsd#iclr_BuybackProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BuybackProgramMember" xlink:to="lab_iclr_BuybackProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_afa61b1a-7816-4591-b32f-c650e6036cd0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_aa85dacf-6594-46b8-b66a-3efc02c0006e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan to equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_430dc658-441e-43b3-a62d-06e71a9bd1e2_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (Note 13)</link:label>
    <link:label id="lab_us-gaap_InterestExpense_0d44514e-f964-4493-80f9-2b09fe318552_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financing costs</link:label>
    <link:label id="lab_us-gaap_InterestExpense_f6a22e53-6d5b-477c-8521-e17f01932a98_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financing costs</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_895eed4e-d798-4e2d-a724-e6dba0fa3f97_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names &amp; brands</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_522e6ca7-5d6e-498e-9ca6-424ac6cc2630_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_9b24819b-63ef-4e98-b401-b8b2d7c76d35_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_86437c10-c025-4bb5-bbb5-4cf59dc06092_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a0e25d6c-06f4-40a3-8338-ff6f607a1209_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_af4baa40-5b9b-4b14-849f-4a52c7124090_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building &#160;</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_0453179c-7cc5-46a5-a67f-3c2fab9a15c3_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_label_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress" xlink:to="lab_dei_ContactPersonnelEmailAddress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_0dbd9531-4098-48b6-930e-c0de981951fe_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160;Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_97a382a6-8789-4760-8550-5eb70d1d37c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_baa5323e-ad9a-40e2-b369-f58c0e2d6380_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_a514892e-ecb8-4565-9dbe-b7286da4e365_terseLabel_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit of shares issued or to be issued pursuant to options granted (in shares)</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_label_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_documentation_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limit of Shares Issued or To Be Issued Pursuant to Options Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:href="iclr-20221231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:to="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ec18b948-522d-4612-8ed7-174755d7332f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_2ad50317-fb34-42a7-baa6-8a7fcda99964_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Total deferred tax liabilities recognized</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_b20532bc-aa16-4cc9-b9b2-0eddbaa8dd93_terseLabel_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_label_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_documentation_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember" xlink:href="iclr-20221231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherGeographicLocationsMember" xlink:to="lab_iclr_OtherGeographicLocationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5c9365bf-e039-4e2c-b34a-2c486694a975_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_ea4c21e6-bbd4-4eaa-8283-2369f5219d35_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants' contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_6544c54f-979e-45d5-a28a-2ab44425885f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_78067a23-3d0d-4cfa-b40e-ae5593e6fa49_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive share options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_827640cd-560c-45d1-b56e-aaa68129bede_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill and long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d031cdad-ccab-4785-b292-966c8493143a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_5554a9e5-b8e8-4cb7-b154-7223fc5e6bc1_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1fe73ad6-08a5-4a06-8518-1bcdf6b37373_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac3a7cc7-0ffd-4828-ae25-71158fba6952_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_c85e7d17-a4e9-4a2b-8c9a-0492297892b1_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unearned revenue (payments on account) (in percent)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_A2013LegacyPRAPlanMember_d2dd3362-8e91-4012-86b8-646d0797bcb6_terseLabel_en-US" xlink:label="lab_iclr_A2013LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_A2013LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_A2013LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_A2013LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_A2013LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Legacy PRA Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2013LegacyPRAPlanMember" xlink:href="iclr-20221231.xsd#iclr_A2013LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_A2013LegacyPRAPlanMember" xlink:to="lab_iclr_A2013LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_19d75083-08b3-4e03-ad95-7d071226ffd9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cca374d5-8699-4b4b-91a0-77565a4e3403_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_7dde3ef6-2f17-4abb-b7a7-26f9e479123c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_0646b502-5435-48cf-b645-a71eba2cc134_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_520092e6-2fb1-4d7e-ac4d-811c2d841ad6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_b5937984-bced-4812-a01f-f8cd4bcb3c35_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_455cd473-5c17-4fbe-98d4-e614b2bda86c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_283fae76-cca5-4fef-9dbb-b03ce40ab9c7_terseLabel_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:label id="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:href="iclr-20221231.xsd#iclr_ResearchandDevelopmentCreditsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:to="lab_iclr_ResearchandDevelopmentCreditsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e08b7af5-cc76-4121-9deb-5135f3bda634_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_ccfffb23-a309-4000-b005-e93a061dbc13_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation (in percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_95f76b0b-9cd8-42cf-aeeb-2ae91e1f3509_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_9f909b15-4ce6-4905-b731-96673065ffb6_totalLabel_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite lived intangible assets, amortization expense, net, total</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_label_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_documentation_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:href="iclr-20221231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:to="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_3a12c5d7-35af-49c4-8018-319599ffdb3e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_c374aedd-fff1-4bc3-903c-dbb985927d5a_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_8f8deb0f-71d4-4877-88ea-bcbdc18ed885_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OptionPlans2008Member_2f92849b-7fc3-4568-ada3-4428d95cc615_terseLabel_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_label_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_documentation_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member" xlink:href="iclr-20221231.xsd#iclr_OptionPlans2008Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OptionPlans2008Member" xlink:to="lab_iclr_OptionPlans2008Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_998eb4ca-b5ae-4746-af15-e29538ebd18f_terseLabel_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and one time financing costs</link:label>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_label_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And One Time Financing Costs</link:label>
    <link:label id="lab_iclr_TransactionAndOneTimeFinancingCosts_documentation_en-US" xlink:label="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction And One Time Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts" xlink:href="iclr-20221231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TransactionAndOneTimeFinancingCosts" xlink:to="lab_iclr_TransactionAndOneTimeFinancingCosts" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>iclr-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:7508de12-69a9-4818-9ec7-00b38a2cb3e7,g:60b4642b-da77-4b86-962d-2e89e6dd7ade-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b458b4d1-52a0-4952-ae64-09c8e70d0ecd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b458b4d1-52a0-4952-ae64-09c8e70d0ecd" xlink:to="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_86d4388b-5a13-4271-a214-835e42e533be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_a3595945-a2e7-4b00-a638-998135ce3981" xlink:to="loc_dei_AddressTypeDomain_86d4388b-5a13-4271-a214-835e42e533be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_50ab42ba-d52f-4ba7-b50c-ae755aadd6b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_86d4388b-5a13-4271-a214-835e42e533be" xlink:to="loc_dei_BusinessContactMember_50ab42ba-d52f-4ba7-b50c-ae755aadd6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_0cf18fcc-05bc-4f6e-a81f-fff011ea606a" xlink:to="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cc52da97-b368-4bee-b368-e94812c142de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentType_cc52da97-b368-4bee-b368-e94812c142de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_3bec0bf4-ac4c-4a11-a726-c458bd45df6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentRegistrationStatement_3bec0bf4-ac4c-4a11-a726-c458bd45df6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_05913df6-3afb-49f9-a111-b6e9c0299592" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentAnnualReport_05913df6-3afb-49f9-a111-b6e9c0299592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9121c9f1-ecf6-47f0-a51e-e7db15cb5a21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentPeriodEndDate_9121c9f1-ecf6-47f0-a51e-e7db15cb5a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3271f553-52c6-4ba6-89ba-c87ef0fd2541" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_CurrentFiscalYearEndDate_3271f553-52c6-4ba6-89ba-c87ef0fd2541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_1bb8f22d-2835-4d50-9a94-f6700a78545d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentTransitionReport_1bb8f22d-2835-4d50-9a94-f6700a78545d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_17365cb4-43a5-4e07-b2b8-14895eb5ef8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentShellCompanyReport_17365cb4-43a5-4e07-b2b8-14895eb5ef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_43db9a05-99e8-4f1b-b73b-4c6bdd28f466" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityFileNumber_43db9a05-99e8-4f1b-b73b-4c6bdd28f466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f636fda7-ab8a-4aa9-b23a-946838a3ff5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityRegistrantName_f636fda7-ab8a-4aa9-b23a-946838a3ff5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c3d2d5c0-fad2-4ccb-b207-69b8fbc7dc30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c3d2d5c0-fad2-4ccb-b207-69b8fbc7dc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0e6ee89e-8901-4d97-a63e-c2bd6603f9d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressAddressLine1_0e6ee89e-8901-4d97-a63e-c2bd6603f9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_076add09-9e1e-4103-b82c-ea300f566ce4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressAddressLine2_076add09-9e1e-4103-b82c-ea300f566ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_52462af2-8071-4419-b822-5f9fc34f50ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressCityOrTown_52462af2-8071-4419-b822-5f9fc34f50ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c7750bfb-875e-4f61-8ff2-1285113394cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressPostalZipCode_c7750bfb-875e-4f61-8ff2-1285113394cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_58ef85b5-4415-4896-8447-dda1f3b6495d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityAddressCountry_58ef85b5-4415-4896-8447-dda1f3b6495d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_b93abe4d-6998-4bae-81b1-dd0a5972e569" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_ContactPersonnelName_b93abe4d-6998-4bae-81b1-dd0a5972e569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_034d5145-a163-4b46-806f-981c1c0bb02f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_ContactPersonnelEmailAddress_034d5145-a163-4b46-806f-981c1c0bb02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_5b40d638-eb58-4fc1-bc4e-6dfa49d35f5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_CountryRegion_5b40d638-eb58-4fc1-bc4e-6dfa49d35f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_edf928c6-f179-4a95-a6fd-57c7bafb1949" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_CityAreaCode_edf928c6-f179-4a95-a6fd-57c7bafb1949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d4dcbcc9-ab77-4d85-b6c3-9cb5b12a0421" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_LocalPhoneNumber_d4dcbcc9-ab77-4d85-b6c3-9cb5b12a0421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_594e12ef-68b8-45d8-a835-1cf014fcd910" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_Security12bTitle_594e12ef-68b8-45d8-a835-1cf014fcd910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7f57fbea-4b53-4229-ace7-93516cdda03c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_TradingSymbol_7f57fbea-4b53-4229-ace7-93516cdda03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_24d59e7a-1fcc-4303-ad74-7fcb17e9b9e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_SecurityExchangeName_24d59e7a-1fcc-4303-ad74-7fcb17e9b9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a092fc98-c230-4c4b-b710-189e6765f27f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a092fc98-c230-4c4b-b710-189e6765f27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_cdccdfa7-d767-4935-8ada-3f74c0c997cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_cdccdfa7-d767-4935-8ada-3f74c0c997cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_73ac436b-4860-4ca6-b0d4-4d2d335d0c1e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityVoluntaryFilers_73ac436b-4860-4ca6-b0d4-4d2d335d0c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7ec0d4f7-a381-4d4f-9150-3d7dc3cd783b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityCurrentReportingStatus_7ec0d4f7-a381-4d4f-9150-3d7dc3cd783b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1e7c995c-29d0-4d01-a4b1-f2242ec1ecdb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityInteractiveDataCurrent_1e7c995c-29d0-4d01-a4b1-f2242ec1ecdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9cc59c44-27a1-403c-af05-ac0915409bdf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityFilerCategory_9cc59c44-27a1-403c-af05-ac0915409bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_318072a4-7603-4ca9-b456-b820f065f2df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityEmergingGrowthCompany_318072a4-7603-4ca9-b456-b820f065f2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b6d9162e-4267-42d4-9a4f-143dd2f4cc7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b6d9162e-4267-42d4-9a4f-143dd2f4cc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_379da362-c1e0-4475-ada7-23fd4e490ba0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentAccountingStandard_379da362-c1e0-4475-ada7-23fd4e490ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4d97a63c-e667-47e9-ad63-0557545e8ab0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityShellCompany_4d97a63c-e667-47e9-ad63-0557545e8ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_66ab1dec-1a3c-4ff8-a4f6-c601342b8737" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_AmendmentFlag_66ab1dec-1a3c-4ff8-a4f6-c601342b8737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e46c8168-3f50-4155-ac65-d44c77f5e53e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentFiscalYearFocus_e46c8168-3f50-4155-ac65-d44c77f5e53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_edbc6e81-e63c-4646-9a97-42b5a97ab8ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_edbc6e81-e63c-4646-9a97-42b5a97ab8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dc5e32e1-f602-405c-8f42-03ddddf5595f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1135aa6d-a3f1-4978-a25b-b01ba6ba70c6" xlink:to="loc_dei_EntityCentralIndexKey_dc5e32e1-f602-405c-8f42-03ddddf5595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AuditInformation" xlink:type="simple" xlink:href="iclr-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract_b2fd7949-63b7-437b-8b9c-221443afbbc5" xlink:href="iclr-20221231.xsd#iclr_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_56f7d1ab-51aa-4a77-ac7e-8de56fd39e42" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_b2fd7949-63b7-437b-8b9c-221443afbbc5" xlink:to="loc_dei_AuditorFirmId_56f7d1ab-51aa-4a77-ac7e-8de56fd39e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_66df4139-bd99-45af-8208-961c59edc25a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_b2fd7949-63b7-437b-8b9c-221443afbbc5" xlink:to="loc_dei_AuditorName_66df4139-bd99-45af-8208-961c59edc25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c38f1cf6-cfd7-42dc-a9ed-1f9440cc3c6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_b2fd7949-63b7-437b-8b9c-221443afbbc5" xlink:to="loc_dei_AuditorLocation_c38f1cf6-cfd7-42dc-a9ed-1f9440cc3c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1cc7a8dd-bcdc-457e-89f1-f131f0b6d625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6db0f40c-e9d0-4f04-805c-61d85064eaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1cc7a8dd-bcdc-457e-89f1-f131f0b6d625" xlink:to="loc_us-gaap_AssetsAbstract_6db0f40c-e9d0-4f04-805c-61d85064eaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6db0f40c-e9d0-4f04-805c-61d85064eaf8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83bb5e44-9082-494a-933a-f010e700d525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83bb5e44-9082-494a-933a-f010e700d525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4fb61c71-e966-42e0-a041-fe4f0567004b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4fb61c71-e966-42e0-a041-fe4f0567004b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_034a1225-598f-4ede-b4d3-9f25828bb94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_034a1225-598f-4ede-b4d3-9f25828bb94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_8bd8f685-8513-41c9-b6c3-06df821f6b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_8bd8f685-8513-41c9-b6c3-06df821f6b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_12e05ecb-e2e2-40fb-afa8-564a5e529965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_12e05ecb-e2e2-40fb-afa8-564a5e529965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d54e704a-4035-4101-b59a-9eeab519bff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d54e704a-4035-4101-b59a-9eeab519bff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_281d2f81-ff40-43c3-a2de-7498f69897d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_IncomeTaxesReceivable_281d2f81-ff40-43c3-a2de-7498f69897d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_61bac445-eaf8-4df2-a715-83a3d88ce5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe8f3a2b-7ed0-4171-b60e-f44d08849ec7" xlink:to="loc_us-gaap_AssetsCurrent_61bac445-eaf8-4df2-a715-83a3d88ce5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6db0f40c-e9d0-4f04-805c-61d85064eaf8" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1f5f2ddb-eafc-49c0-a5ac-d9fa413a97cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1f5f2ddb-eafc-49c0-a5ac-d9fa413a97cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16b00ef2-2e5f-468e-9feb-826b97e3c28b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_Goodwill_16b00ef2-2e5f-468e-9feb-826b97e3c28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_75a46f47-7a8f-400d-bcd7-ed707ac5c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_75a46f47-7a8f-400d-bcd7-ed707ac5c78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b2c4d805-4954-4523-839a-2bda6b43c195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b2c4d805-4954-4523-839a-2bda6b43c195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_37defb9c-4a1f-4d50-9b7b-c172e6d498a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_37defb9c-4a1f-4d50-9b7b-c172e6d498a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_e9b15366-9de7-4396-a67d-1e2c2810c3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_e9b15366-9de7-4396-a67d-1e2c2810c3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_a71eb521-ee9f-4da6-8db2-c475a7399399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_a71eb521-ee9f-4da6-8db2-c475a7399399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_8f775a3e-fb92-49f8-ab65-173f1d095d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_EquityMethodInvestments_8f775a3e-fb92-49f8-ab65-173f1d095d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_1409c180-9e68-4e25-8c25-e0c5bd215e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_b9162c25-dcda-4190-8981-3a813d1c6dc4" xlink:to="loc_us-gaap_OtherLongTermInvestments_1409c180-9e68-4e25-8c25-e0c5bd215e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9f179f8e-db6a-4171-b5c7-0f9259cdc267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6db0f40c-e9d0-4f04-805c-61d85064eaf8" xlink:to="loc_us-gaap_Assets_9f179f8e-db6a-4171-b5c7-0f9259cdc267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1cc7a8dd-bcdc-457e-89f1-f131f0b6d625" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_968f0c78-f1b3-48a6-933b-608bfc416c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:to="loc_us-gaap_AccountsPayableCurrent_968f0c78-f1b3-48a6-933b-608bfc416c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_67d89470-b0ac-4a81-9235-5f42c95d54a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_67d89470-b0ac-4a81-9235-5f42c95d54a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7119b340-8e5c-48e0-baea-3702589e38b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_7119b340-8e5c-48e0-baea-3702589e38b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0634facd-4060-4470-bb63-0422c92acd84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0634facd-4060-4470-bb63-0422c92acd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_423e5184-ad51-469b-ab1e-6f80d05030b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:to="loc_us-gaap_LinesOfCreditCurrent_423e5184-ad51-469b-ab1e-6f80d05030b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4c8dc24d-b753-4d92-b3e4-b3da12616b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_73484ec2-e950-4750-9158-e635c7d33d98" xlink:to="loc_us-gaap_LiabilitiesCurrent_4c8dc24d-b753-4d92-b3e4-b3da12616b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_3657b074-5c92-4488-bde1-ab35e6817105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:to="loc_us-gaap_LongTermLineOfCredit_3657b074-5c92-4488-bde1-ab35e6817105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_46e2ba2c-e63b-44d2-a11e-3ae935b04961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_46e2ba2c-e63b-44d2-a11e-3ae935b04961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_daf6549e-9d64-48a3-9437-f32c5ff13faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_daf6549e-9d64-48a3-9437-f32c5ff13faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_77bde0c4-ba4d-49c9-a970-1cca1b118fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_77bde0c4-ba4d-49c9-a970-1cca1b118fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a8af8e7c-df45-4d1d-b6e9-7766af6c549a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a8af8e7c-df45-4d1d-b6e9-7766af6c549a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1579e452-e441-4fcb-bc63-a409c45b6236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_031a5317-7cb3-45ac-9881-19d1153f1d2a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1579e452-e441-4fcb-bc63-a409c45b6236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2910397a-b881-4476-82a0-b4ee2c2cf8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:to="loc_us-gaap_Liabilities_2910397a-b881-4476-82a0-b4ee2c2cf8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_64ad2a93-ac77-4a48-b9c0-9a0c695009de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:to="loc_us-gaap_CommonStockValue_64ad2a93-ac77-4a48-b9c0-9a0c695009de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_760b92e5-2fab-46b3-9160-0933c9362035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_760b92e5-2fab-46b3-9160-0933c9362035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_a4ac9940-1c2e-4bc4-b403-7f32dbd52255" xlink:href="iclr-20221231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:to="loc_iclr_OtherUndenominatedCapital_a4ac9940-1c2e-4bc4-b403-7f32dbd52255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_063ed64d-f852-4f7b-b7ac-56a0f21d40cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_063ed64d-f852-4f7b-b7ac-56a0f21d40cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_96f2e08f-3828-4db3-8154-a001d67dd506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_96f2e08f-3828-4db3-8154-a001d67dd506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_27c3494e-5972-47da-80ce-213b2c55f7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3b996e2-de13-46e5-a5b1-cadd8e9ff374" xlink:to="loc_us-gaap_StockholdersEquity_27c3494e-5972-47da-80ce-213b2c55f7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12708ba6-703e-42ce-a75e-c2151a0146cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1b5dac56-9a98-4c72-b9cd-385e2d8d1189" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_12708ba6-703e-42ce-a75e-c2151a0146cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5d3106eb-477b-4721-8406-ed83a9fe2198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4109654c-1d9b-423d-a7f7-1607600ebce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5d3106eb-477b-4721-8406-ed83a9fe2198" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4109654c-1d9b-423d-a7f7-1607600ebce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_65e96d59-4e05-4a14-960d-10cd488f4d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5d3106eb-477b-4721-8406-ed83a9fe2198" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_65e96d59-4e05-4a14-960d-10cd488f4d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e5bf33cc-635d-4c99-97f0-57a765a23f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5d3106eb-477b-4721-8406-ed83a9fe2198" xlink:to="loc_us-gaap_CommonStockSharesIssued_e5bf33cc-635d-4c99-97f0-57a765a23f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0d9af12a-abb7-4fed-8cc4-73dfa83a55cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5d3106eb-477b-4721-8406-ed83a9fe2198" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0d9af12a-abb7-4fed-8cc4-73dfa83a55cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b72fa671-13dc-4c0a-805d-be9b26d00530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_RevenuesAbstract_b72fa671-13dc-4c0a-805d-be9b26d00530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d69abf9a-ffa0-42f7-b37d-e7dbd1eaa1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b72fa671-13dc-4c0a-805d-be9b26d00530" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d69abf9a-ffa0-42f7-b37d-e7dbd1eaa1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5a16a44d-85ce-4a82-99a1-de32ccf53703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5a16a44d-85ce-4a82-99a1-de32ccf53703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f489b99-c0cb-4c3f-b65d-1a21cdd2f4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1f489b99-c0cb-4c3f-b65d-1a21cdd2f4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_5cafb506-0fca-4e23-b36c-2cbae54849a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:to="loc_us-gaap_DepreciationAndAmortization_5cafb506-0fca-4e23-b36c-2cbae54849a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationIntegrationRelatedCostsCredits_2c56bcd2-b0de-44ba-bcca-3a557c3b66a4" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationIntegrationRelatedCostsCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:to="loc_iclr_BusinessCombinationIntegrationRelatedCostsCredits_2c56bcd2-b0de-44ba-bcca-3a557c3b66a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_2d621c67-e970-493a-ad80-6533ae74a0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:to="loc_us-gaap_RestructuringCosts_2d621c67-e970-493a-ad80-6533ae74a0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_72600ae2-60b8-46b8-b8fe-a3ec901a1512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_7eae6b59-f0cf-4b2b-8001-39feccd7b9ba" xlink:to="loc_us-gaap_CostsAndExpenses_72600ae2-60b8-46b8-b8fe-a3ec901a1512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f4389e1a-8476-4e94-96cb-1883688059e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_OperatingIncomeLoss_f4389e1a-8476-4e94-96cb-1883688059e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_2375da7b-454b-4161-8e02-f7733b2b3bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_2375da7b-454b-4161-8e02-f7733b2b3bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_91141074-ee7a-4cb9-bfe2-67d91c3ed8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_InterestExpense_91141074-ee7a-4cb9-bfe2-67d91c3ed8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_19374b0b-72fc-47bf-a663-dd243cabfbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_19374b0b-72fc-47bf-a663-dd243cabfbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e1c8ec87-e07f-4c19-b040-79796dffdc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e1c8ec87-e07f-4c19-b040-79796dffdc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_c3c01b65-42b9-4de3-b6d7-c9e1212d3752" xlink:href="iclr-20221231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_c3c01b65-42b9-4de3-b6d7-c9e1212d3752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c9dac1bd-4b26-4510-8802-2a9a3547a7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c9dac1bd-4b26-4510-8802-2a9a3547a7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_02399eb3-9837-4649-8aa4-8a251cb8d91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_ProfitLoss_02399eb3-9837-4649-8aa4-8a251cb8d91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_770a490b-6388-437e-8fbf-660349d7bc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_770a490b-6388-437e-8fbf-660349d7bc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_91f0d259-fc9d-42f2-8475-b3b42605d02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_NetIncomeLoss_91f0d259-fc9d-42f2-8475-b3b42605d02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_980028a6-5b71-4042-88aa-8e42d8ea8020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_980028a6-5b71-4042-88aa-8e42d8ea8020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_762029e0-70dd-4e7b-9fe4-e017e9fc6b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_980028a6-5b71-4042-88aa-8e42d8ea8020" xlink:to="loc_us-gaap_EarningsPerShareBasic_762029e0-70dd-4e7b-9fe4-e017e9fc6b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_acab9037-050c-4491-a0d1-9b53c301b49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_980028a6-5b71-4042-88aa-8e42d8ea8020" xlink:to="loc_us-gaap_EarningsPerShareDiluted_acab9037-050c-4491-a0d1-9b53c301b49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5eb9dc5-233c-4a53-ac3b-6fede0a06a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5d783b9b-06b7-41b3-8cc4-5dd9188ef1a5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5eb9dc5-233c-4a53-ac3b-6fede0a06a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ec991240-60b5-4bb2-ba61-56cb5e59f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5eb9dc5-233c-4a53-ac3b-6fede0a06a08" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ec991240-60b5-4bb2-ba61-56cb5e59f88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e284c58a-fe52-4373-bb82-d8e12643ef53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c5eb9dc5-233c-4a53-ac3b-6fede0a06a08" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e284c58a-fe52-4373-bb82-d8e12643ef53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_74fd7066-27d0-4e78-aef1-50eea492f3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eff0230d-9cd0-4ebc-a150-2506c62ce54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_74fd7066-27d0-4e78-aef1-50eea492f3bd" xlink:to="loc_us-gaap_ProfitLoss_eff0230d-9cd0-4ebc-a150-2506c62ce54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_74fd7066-27d0-4e78-aef1-50eea492f3bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9183366b-a47e-4ad4-a58d-9f6f31a7443c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9183366b-a47e-4ad4-a58d-9f6f31a7443c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c5ae520d-3889-4a1e-99b9-decd8a7c49e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c5ae520d-3889-4a1e-99b9-decd8a7c49e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_582f47f0-60dc-4e44-817a-0efe9d2f170a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_582f47f0-60dc-4e44-817a-0efe9d2f170a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_66904782-8a7b-458f-9f91-7cc83fcd32a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_66904782-8a7b-458f-9f91-7cc83fcd32a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_de50c6df-f129-4f2b-b7b2-b1002b82bfea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f866ef7c-8670-49c9-8b00-9da7bd36c7b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_de50c6df-f129-4f2b-b7b2-b1002b82bfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_200bb3ee-f2c9-4c41-a6c4-12b1709d516c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_74fd7066-27d0-4e78-aef1-50eea492f3bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_200bb3ee-f2c9-4c41-a6c4-12b1709d516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_20868a6e-bab8-4188-99c7-2ad5ed45010d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_74fd7066-27d0-4e78-aef1-50eea492f3bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_20868a6e-bab8-4188-99c7-2ad5ed45010d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3a6b1ec5-c086-4b5d-a872-c238291e67cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_74fd7066-27d0-4e78-aef1-50eea492f3bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3a6b1ec5-c086-4b5d-a872-c238291e67cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_bd2cc2c3-bc01-4970-b103-84c97c286cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_bd2cc2c3-bc01-4970-b103-84c97c286cdd" xlink:to="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a4e92781-b164-4786-b99c-7c9f9dba23ae" xlink:to="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df144f41-20d1-46cd-b48f-adb8de61f212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_CommonStockMember_df144f41-20d1-46cd-b48f-adb8de61f212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6b047fb0-42e1-4508-a369-e63ccd460a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6b047fb0-42e1-4508-a369-e63ccd460a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_6840df46-94a1-45b7-93e0-894c439af249" xlink:href="iclr-20221231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_6840df46-94a1-45b7-93e0-894c439af249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_56b20dbe-8aa7-424f-a81f-b7689bfe9680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_56b20dbe-8aa7-424f-a81f-b7689bfe9680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7d280b29-4764-41cf-86f3-1e03e424cc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_us-gaap_RetainedEarningsMember_7d280b29-4764-41cf-86f3-1e03e424cc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestMember_144f007e-78d3-452d-a3ea-496ed11e7462" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3f7bdc9e-85c4-452d-a35f-9af899914941" xlink:to="loc_iclr_RedeemableNoncontrollingInterestMember_144f007e-78d3-452d-a3ea-496ed11e7462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b860871a-3ea9-4f2d-90c5-979d406b0888" xlink:to="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1662cf7d-5297-4e17-9b98-0384505fb346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_CommonStockSharesIssued_1662cf7d-5297-4e17-9b98-0384505fb346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b66330f8-cfab-441a-b252-8bd9dfdeed08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockholdersEquity_b66330f8-cfab-441a-b252-8bd9dfdeed08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8b10e19d-cada-4ea5-bb36-771832c2952f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_NetIncomeLoss_8b10e19d-cada-4ea5-bb36-771832c2952f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c8c9e4-636e-40f8-8382-81b9f2477c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c8c9e4-636e-40f8-8382-81b9f2477c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_455c8a9e-ea2b-4f7b-af14-2453f030098b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_455c8a9e-ea2b-4f7b-af14-2453f030098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_08942f42-e167-46da-93d3-43ebbc4353df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_08942f42-e167-46da-93d3-43ebbc4353df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1f2554c7-dce8-4159-b0d8-740f132fc0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1f2554c7-dce8-4159-b0d8-740f132fc0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_518ebe2d-913b-4c47-bc7e-3b6a1286ce42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_518ebe2d-913b-4c47-bc7e-3b6a1286ce42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_38c51e51-5150-4ecf-8123-9feaf549dec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_38c51e51-5150-4ecf-8123-9feaf549dec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_060dd5b3-c97b-4f00-94af-7469a1208828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_060dd5b3-c97b-4f00-94af-7469a1208828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_677a091b-52a1-4b26-887e-b8db39b7ff86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_677a091b-52a1-4b26-887e-b8db39b7ff86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ec2a62da-142b-4a45-95b1-5e35f319684f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ec2a62da-142b-4a45-95b1-5e35f319684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a3be1c7e-4840-477b-b37a-2e94f1f62b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a3be1c7e-4840-477b-b37a-2e94f1f62b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_854676f3-e5c7-4f98-8fad-76bae5592a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_854676f3-e5c7-4f98-8fad-76bae5592a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_72070240-6332-4a79-9062-d044894dae63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_72070240-6332-4a79-9062-d044894dae63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_940ad99a-d5c5-446e-8606-811e80fa1a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_940ad99a-d5c5-446e-8606-811e80fa1a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0229350a-46db-4c88-aa8d-cd75378caadc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0229350a-46db-4c88-aa8d-cd75378caadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_26a97459-f601-4c0b-978e-491caac44314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_26a97459-f601-4c0b-978e-491caac44314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4277c872-c8d1-42af-bf00-a86826483472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4277c872-c8d1-42af-bf00-a86826483472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_a2bbc1d9-d486-44a8-b797-9b2f2e9f7f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_a2bbc1d9-d486-44a8-b797-9b2f2e9f7f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_fb50f756-ab2d-44cf-a786-7fac64c97c71" xlink:href="iclr-20221231.xsd#iclr_AdjustmentToRetainedEarningShareRepurchaseCosts"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts_fb50f756-ab2d-44cf-a786-7fac64c97c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_494f416c-dccc-4d26-aa32-7cc268ff92ab" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_494f416c-dccc-4d26-aa32-7cc268ff92ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9987b6f2-a2b7-4a5e-9794-f194a94abd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_CommonStockSharesIssued_9987b6f2-a2b7-4a5e-9794-f194a94abd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4d7348da-8df4-4aec-98da-2bcee0d37655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f072848f-416a-4f9c-a0e5-46c65405b15a" xlink:to="loc_us-gaap_StockholdersEquity_4d7348da-8df4-4aec-98da-2bcee0d37655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_696afcf3-b5f1-48b3-a612-e4cdb984b6c9" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_22a21f1f-7ea6-4cc7-bf6d-6b53518171ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_22a21f1f-7ea6-4cc7-bf6d-6b53518171ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_5deb0c07-0ebe-46b4-85d8-f059f5ced0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_5deb0c07-0ebe-46b4-85d8-f059f5ced0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_90895d7d-345f-419c-801d-72484e3c0bf3" xlink:href="iclr-20221231.xsd#iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination_90895d7d-345f-419c-801d-72484e3c0bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_322cbe59-4118-49bb-b88d-b2463c62bcca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_322cbe59-4118-49bb-b88d-b2463c62bcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ed130020-68d5-455b-b278-0ad04b6dc94d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_dcfd360c-b33a-4265-9dc9-d161ff6edb34" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_ed130020-68d5-455b-b278-0ad04b6dc94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43c8d4dc-457c-49b9-ba33-044ba49a40a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43c8d4dc-457c-49b9-ba33-044ba49a40a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2254ffd3-b716-4335-b8f2-c9b0a1bdd97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43c8d4dc-457c-49b9-ba33-044ba49a40a1" xlink:to="loc_us-gaap_ProfitLoss_2254ffd3-b716-4335-b8f2-c9b0a1bdd97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43c8d4dc-457c-49b9-ba33-044ba49a40a1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4355779d-afd0-4696-bae3-9a9325853379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4355779d-afd0-4696-bae3-9a9325853379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_9f5c1e85-913e-4089-a379-683e9263021e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_9f5c1e85-913e-4089-a379-683e9263021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1ba772a6-5174-4c45-a18f-9c5e26b096b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1ba772a6-5174-4c45-a18f-9c5e26b096b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_209cf5c2-4168-40c8-a8ed-ba56eb069749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_209cf5c2-4168-40c8-a8ed-ba56eb069749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_2b8b3ff4-ddd2-4b6b-9eb4-520872ac8ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_2b8b3ff4-ddd2-4b6b-9eb4-520872ac8ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_237d2270-ce6c-49bb-9cd9-83331cce2a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_ShareBasedCompensation_237d2270-ce6c-49bb-9cd9-83331cce2a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_60b80ee5-68db-4d7f-a55d-dc0aa9293ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_60b80ee5-68db-4d7f-a55d-dc0aa9293ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GainLossOnIssuanceOfDebt_85d28c53-72a1-487b-8388-65fa46a54f09" xlink:href="iclr-20221231.xsd#iclr_GainLossOnIssuanceOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_iclr_GainLossOnIssuanceOfDebt_85d28c53-72a1-487b-8388-65fa46a54f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0f42dd6a-a545-4b28-b7e4-03b6c147f55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_0f42dd6a-a545-4b28-b7e4-03b6c147f55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_37237ba8-0098-4052-81b3-5c8cb5099b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_37237ba8-0098-4052-81b3-5c8cb5099b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8184898b-8cd0-45d7-aeae-206e9347140b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e99fbd5a-059e-4cb4-a6d1-f268ba619a11" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8184898b-8cd0-45d7-aeae-206e9347140b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3371de7d-4bf3-4c09-a6d3-1c22e2dbf94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43c8d4dc-457c-49b9-ba33-044ba49a40a1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3371de7d-4bf3-4c09-a6d3-1c22e2dbf94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0d93b805-b757-47f8-89f2-d9666223e41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3371de7d-4bf3-4c09-a6d3-1c22e2dbf94e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0d93b805-b757-47f8-89f2-d9666223e41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_b197f847-7205-461c-b361-9f8fdb97fa25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3371de7d-4bf3-4c09-a6d3-1c22e2dbf94e" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_b197f847-7205-461c-b361-9f8fdb97fa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5f95adf8-123b-4b96-8097-1e6e5c541512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3371de7d-4bf3-4c09-a6d3-1c22e2dbf94e" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5f95adf8-123b-4b96-8097-1e6e5c541512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a5599432-9f04-4217-b2bf-e2d5171ed994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3371de7d-4bf3-4c09-a6d3-1c22e2dbf94e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_a5599432-9f04-4217-b2bf-e2d5171ed994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eace456c-a1ce-49f3-a100-0ad675c226e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_43c8d4dc-457c-49b9-ba33-044ba49a40a1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eace456c-a1ce-49f3-a100-0ad675c226e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c6656eb6-dcda-4165-b121-91d1767f0482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c6656eb6-dcda-4165-b121-91d1767f0482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d3108e8c-afe5-48ef-92ee-75fb327e328e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d3108e8c-afe5-48ef-92ee-75fb327e328e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_315c1035-5f24-4c42-ba13-9b75aa82406d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_315c1035-5f24-4c42-ba13-9b75aa82406d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_18f2c56c-a204-48ec-bccb-9df14fa220a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_18f2c56c-a204-48ec-bccb-9df14fa220a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_0406e703-6fc8-4a3b-ba76-6f0daf055af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_0406e703-6fc8-4a3b-ba76-6f0daf055af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_a49d29b8-268b-4b08-b44f-f694ac3c6d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_a49d29b8-268b-4b08-b44f-f694ac3c6d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_02eafe2e-8763-448d-8a1b-9cbc1f7c4b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_02eafe2e-8763-448d-8a1b-9cbc1f7c4b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_e3570138-e103-4ff0-a845-2086e4fac597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_e3570138-e103-4ff0-a845-2086e4fac597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4366488a-ab01-41f7-8944-6650d1d67fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f49c97dc-de85-45fb-83e8-61be5d3848c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4366488a-ab01-41f7-8944-6650d1d67fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_beee785a-99f2-4457-88a7-d9cb41975614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_beee785a-99f2-4457-88a7-d9cb41975614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_d5664ad2-d6d9-449f-bac4-8f11ea3e957e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_d5664ad2-d6d9-449f-bac4-8f11ea3e957e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d456c6b5-3fc3-45f8-a66b-c84e59418c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d456c6b5-3fc3-45f8-a66b-c84e59418c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_6f4bb802-664f-4133-a660-0682c4b3c822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_6f4bb802-664f-4133-a660-0682c4b3c822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_56908893-fc19-4360-b630-9b2c58de77e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_56908893-fc19-4360-b630-9b2c58de77e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_55ca83c4-f5e7-4ce6-86f9-118948e20976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_55ca83c4-f5e7-4ce6-86f9-118948e20976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e7ce1ade-24ce-4ee2-80e0-89b196e31297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e7ce1ade-24ce-4ee2-80e0-89b196e31297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForShareRepurchaseCosts_24f6104c-f1c2-45cc-96a7-5052d3ea682b" xlink:href="iclr-20221231.xsd#iclr_PaymentsForShareRepurchaseCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_iclr_PaymentsForShareRepurchaseCosts_24f6104c-f1c2-45cc-96a7-5052d3ea682b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_67f339ca-3c29-46a8-a386-61b5dd69ec88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_67f339ca-3c29-46a8-a386-61b5dd69ec88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fcdc7e7-786a-43a0-916e-c86f708377d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9f25fa07-9223-43c2-9d4d-45180514b4eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fcdc7e7-786a-43a0-916e-c86f708377d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12407561-b118-4ff7-a77f-7be6c58110d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12407561-b118-4ff7-a77f-7be6c58110d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fe48b32e-05bf-4f72-bd59-131245017b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fe48b32e-05bf-4f72-bd59-131245017b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a9297048-389b-4da9-9943-9e354e62c3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a9297048-389b-4da9-9943-9e354e62c3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4306bf6a-03c0-4411-bc36-8961b1af7933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee30dd6f-323b-4406-87bb-13bc1507af96" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4306bf6a-03c0-4411-bc36-8961b1af7933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="simple" xlink:href="iclr-20221231.xsd#Descriptionofbusiness"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bb61f997-134c-4bc2-8578-c8b53ec78734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_d88e29a3-1f01-411d-a5f1-83fd9540cd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bb61f997-134c-4bc2-8578-c8b53ec78734" xlink:to="loc_us-gaap_NatureOfOperations_d88e29a3-1f01-411d-a5f1-83fd9540cd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d774a998-fce3-4aae-9041-29b0c0088075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f05b12f7-0e38-4b31-9599-fad6af88ab36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d774a998-fce3-4aae-9041-29b0c0088075" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f05b12f7-0e38-4b31-9599-fad6af88ab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="simple" xlink:href="iclr-20221231.xsd#DisaggregationofRevenue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d1facbea-78e4-4d38-b066-f7f44f9b0092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8f6de658-8830-4dae-be2b-cddb0377cd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d1facbea-78e4-4d38-b066-f7f44f9b0092" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_8f6de658-8830-4dae-be2b-cddb0377cd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalances" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalances"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalances" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_885ba75a-ab34-4dc5-afeb-21073e9535de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_17e983a1-8b3e-4c07-aa42-a6e9888ac0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_885ba75a-ab34-4dc5-afeb-21073e9535de" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_17e983a1-8b3e-4c07-aa42-a6e9888ac0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLosses" xlink:type="simple" xlink:href="iclr-20221231.xsd#AllowancesforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_6396820f-e492-478c-9210-93417831220d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTextBlock_c76c2bb1-2fe9-47e9-9adb-b042f274a431" xlink:href="iclr-20221231.xsd#iclr_AllowanceForDoubtfulAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_6396820f-e492-478c-9210-93417831220d" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsTextBlock_c76c2bb1-2fe9-47e9-9adb-b042f274a431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinations" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7ac8c34b-106c-4f08-8645-d42bcfc4022d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_03eb2d6b-1eb1-4ac7-a4a4-dbd7d4df7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7ac8c34b-106c-4f08-8645-d42bcfc4022d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_03eb2d6b-1eb1-4ac7-a4a4-dbd7d4df7a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValue" xlink:type="simple" xlink:href="iclr-20221231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_96b0abe6-66be-4d20-989e-2bab1ad4975f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9b48dfb0-c5e9-4eba-b88b-cb0dd56eab36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_96b0abe6-66be-4d20-989e-2bab1ad4975f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9b48dfb0-c5e9-4eba-b88b-cb0dd56eab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Investments" xlink:type="simple" xlink:href="iclr-20221231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5d75b288-037e-455d-85e0-52da134121c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_14ef5d5e-a46f-4642-9d43-f7d9ecf408c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5d75b288-037e-455d-85e0-52da134121c9" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_14ef5d5e-a46f-4642-9d43-f7d9ecf408c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="simple" xlink:href="iclr-20221231.xsd#PropertyPlantandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_826c819d-5706-406f-aeea-1b16545b11a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1966680f-e89a-4a28-9d2b-2f0e2ce23525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_826c819d-5706-406f-aeea-1b16545b11a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1966680f-e89a-4a28-9d2b-2f0e2ce23525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Goodwill" xlink:type="simple" xlink:href="iclr-20221231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe903821-4f14-4c78-a8f9-729ae3e48ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_ef1d107e-8cb6-4303-9efc-d077c5448fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe903821-4f14-4c78-a8f9-729ae3e48ca7" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_ef1d107e-8cb6-4303-9efc-d077c5448fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssets" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c44a9602-5cb7-4a38-9ed4-fd76078a25f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1b644a0e-1ce3-41db-aa65-dec2a06a4f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c44a9602-5cb7-4a38-9ed4-fd76078a25f1" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1b644a0e-1ce3-41db-aa65-dec2a06a4f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilities" xlink:type="simple" xlink:href="iclr-20221231.xsd#OtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_370454cb-39f5-4705-9d1a-23ad060a1e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_34c7094f-aa46-42b8-a47a-aea51cbb1631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_370454cb-39f5-4705-9d1a-23ad060a1e17" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_34c7094f-aa46-42b8-a47a-aea51cbb1631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4c0f3915-b4f7-4d22-9511-7db70226aab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_2e916316-05e4-4188-8300-b70020b003b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c0f3915-b4f7-4d22-9511-7db70226aab7" xlink:to="loc_us-gaap_LongTermDebtTextBlock_2e916316-05e4-4188-8300-b70020b003b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Derivatives" xlink:type="simple" xlink:href="iclr-20221231.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fccdca6c-da46-4b52-a016-7ce8de248f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c2583853-15b2-4a5b-946d-e0b7f558e6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fccdca6c-da46-4b52-a016-7ce8de248f8b" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c2583853-15b2-4a5b-946d-e0b7f558e6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeases" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_856cff52-7a2e-4dce-bcbc-75d6ae3f5704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_75b87d4f-eedb-431d-8dc8-a994b180ee66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_856cff52-7a2e-4dce-bcbc-75d6ae3f5704" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_75b87d4f-eedb-431d-8dc8-a994b180ee66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Noncurrentotherliabilities" xlink:type="simple" xlink:href="iclr-20221231.xsd#Noncurrentotherliabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Noncurrentotherliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_938a097c-2ce7-47c5-b3a2-5d38b8ac4f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_7c180bc3-d12d-45fd-bb84-5179d81f5bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_938a097c-2ce7-47c5-b3a2-5d38b8ac4f2e" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_7c180bc3-d12d-45fd-bb84-5179d81f5bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="iclr-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_61c2eaba-f39f-42d4-97f9-5b536baebfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_160a5224-6158-4599-a581-fc263bf05c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_61c2eaba-f39f-42d4-97f9-5b536baebfb8" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_160a5224-6158-4599-a581-fc263bf05c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapital" xlink:type="simple" xlink:href="iclr-20221231.xsd#ShareCapital"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapital" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a3cfb028-e9ff-46e3-abf3-10588ed2569b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3f981e2f-a71c-478c-9c8f-7989c8c9c50f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3cfb028-e9ff-46e3-abf3-10588ed2569b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3f981e2f-a71c-478c-9c8f-7989c8c9c50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringCharges" xlink:type="simple" xlink:href="iclr-20221231.xsd#RestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_05f2ad32-2894-4d02-a542-02f58c327c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_056228f8-95de-4d62-8cea-7c243a839af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_05f2ad32-2894-4d02-a542-02f58c327c0a" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_056228f8-95de-4d62-8cea-7c243a839af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b85d6d3c-be62-4e98-bc0f-90a7a51ab1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_22ab553f-33b3-4944-91e4-c2b6e626959b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b85d6d3c-be62-4e98-bc0f-90a7a51ab1d9" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_22ab553f-33b3-4944-91e4-c2b6e626959b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_14689836-d2a4-4bb0-9092-e38be2c096f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9b6001c8-c6ae-45ee-b737-a6f278085719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_14689836-d2a4-4bb0-9092-e38be2c096f9" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9b6001c8-c6ae-45ee-b737-a6f278085719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_283b682a-618a-4b9c-8297-ff40729563c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fd9d2e00-76c7-4a8c-9ce2-d3db0130fc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_283b682a-618a-4b9c-8297-ff40729563c0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fd9d2e00-76c7-4a8c-9ce2-d3db0130fc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_082e90a0-0b97-4abf-935f-237cc56aa5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8c6208de-dd9d-4a9f-a576-84fb5650d964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_082e90a0-0b97-4abf-935f-237cc56aa5e6" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8c6208de-dd9d-4a9f-a576-84fb5650d964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="simple" xlink:href="iclr-20221231.xsd#NetIncomePerOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_03e1f21a-bb1d-4b0e-bfdb-decdc32b5cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_96c3f884-463c-470e-9115-b3b18608e223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_03e1f21a-bb1d-4b0e-bfdb-decdc32b5cfa" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_96c3f884-463c-470e-9115-b3b18608e223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="iclr-20221231.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_fd72cf1d-3539-4793-a200-f4c5e84a6183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_dc2ce4ea-f94a-45c5-989d-f087198895d0" xlink:href="iclr-20221231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_fd72cf1d-3539-4793-a200-f4c5e84a6183" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_dc2ce4ea-f94a-45c5-989d-f087198895d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="simple" xlink:href="iclr-20221231.xsd#SupplementalDisclosureofCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_824fe185-1ed8-4832-8dba-d091381cd3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_60b5a3cc-a8ae-4a6e-bcda-12a37305cc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_824fe185-1ed8-4832-8dba-d091381cd3b4" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_60b5a3cc-a8ae-4a6e-bcda-12a37305cc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedParties" xlink:type="simple" xlink:href="iclr-20221231.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_eeff9467-9dbb-4b2b-a067-265b2cb37e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_285b7d79-531c-49c9-a737-bdc9e2a67d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_eeff9467-9dbb-4b2b-a067-265b2cb37e19" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_285b7d79-531c-49c9-a737-bdc9e2a67d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEvents" xlink:type="simple" xlink:href="iclr-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e5e37f64-a0eb-4e2d-bde3-fdac1ea6ae23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_64c276c2-9925-4002-8f17-7773d5d7dbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e5e37f64-a0eb-4e2d-bde3-fdac1ea6ae23" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_64c276c2-9925-4002-8f17-7773d5d7dbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_f55a3ade-3659-4c9d-ad87-c719a5b9b0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_f55a3ade-3659-4c9d-ad87-c719a5b9b0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_45f07cc0-e775-4af5-9cb6-03e7a741f2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_UseOfEstimates_45f07cc0-e775-4af5-9cb6-03e7a741f2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_25041d20-93f8-4d41-8f49-42f44f391d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_25041d20-93f8-4d41-8f49-42f44f391d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_bbe0862b-d25e-4758-9381-7bf543f343cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_bbe0862b-d25e-4758-9381-7bf543f343cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4439c024-3e41-47f7-8853-b7b1c2b389a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4439c024-3e41-47f7-8853-b7b1c2b389a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_53e52c6e-646b-4f1c-84e0-76313a2ed99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_53e52c6e-646b-4f1c-84e0-76313a2ed99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_fe63e993-d5b0-4886-9598-f7fbccbe0ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_fe63e993-d5b0-4886-9598-f7fbccbe0ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6d6e1fec-fc46-47c9-ba46-89d6f979c772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6d6e1fec-fc46-47c9-ba46-89d6f979c772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_bce40040-112c-437e-8e4a-6c1df0b5ef62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_bce40040-112c-437e-8e4a-6c1df0b5ef62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_d4cffb89-7b17-47ef-b39b-ee76efff12bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_d4cffb89-7b17-47ef-b39b-ee76efff12bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c54fa7c7-917f-41ec-87b0-708dc9422344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c54fa7c7-917f-41ec-87b0-708dc9422344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_90edf368-0edb-4ae6-b117-41be2c74519e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_90edf368-0edb-4ae6-b117-41be2c74519e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1bfa64e1-b86a-4ce1-a5e9-e7eea8c33367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_1bfa64e1-b86a-4ce1-a5e9-e7eea8c33367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_059822f3-8664-4253-8a78-6c44c397125b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_059822f3-8664-4253-8a78-6c44c397125b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_dc8fea25-ff70-4644-b86f-055457867c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_DebtPolicyTextBlock_dc8fea25-ff70-4644-b86f-055457867c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7dc31287-b469-4e3e-8b12-16384842688e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7dc31287-b469-4e3e-8b12-16384842688e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_c559f529-3604-4a20-9995-612aae775102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_c559f529-3604-4a20-9995-612aae775102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock_f8229385-7460-4951-b38a-479381fa5dd8" xlink:href="iclr-20221231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_iclr_GovernmentGrantsPolicyTextBlock_f8229385-7460-4951-b38a-479381fa5dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_5b8808b8-e731-451e-b32b-27ff4dd9634b" xlink:href="iclr-20221231.xsd#iclr_ResearchandDevelopmentCreditsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_iclr_ResearchandDevelopmentCreditsPolicyTextBlock_5b8808b8-e731-451e-b32b-27ff4dd9634b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_b2de43c0-5ab7-49a1-8789-4a12d84299a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_b2de43c0-5ab7-49a1-8789-4a12d84299a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_27abb680-89f5-4f04-9afa-103171dfd5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_27abb680-89f5-4f04-9afa-103171dfd5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_a3fc625d-fff6-403e-a3c2-a815fa6957ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_a3fc625d-fff6-403e-a3c2-a815fa6957ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_3768ddfa-d43b-4ad9-b4d6-dc6eefadba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_3768ddfa-d43b-4ad9-b4d6-dc6eefadba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_11b5a2fa-ea67-4e8a-85cc-c84cc2a8a4e8" xlink:href="iclr-20221231.xsd#iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock_11b5a2fa-ea67-4e8a-85cc-c84cc2a8a4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_11007572-319b-46b4-b803-ab3e373aa0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_11007572-319b-46b4-b803-ab3e373aa0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ff5ad1f9-c7c6-44be-a3b1-d0d2682b725d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ff5ad1f9-c7c6-44be-a3b1-d0d2682b725d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_765bff67-83c7-4d9d-935f-8c3bc25984f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65bb8f9e-94a8-40bb-8d48-6192a645089d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_765bff67-83c7-4d9d-935f-8c3bc25984f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_87e24753-7c99-461f-bae0-d8421eb814b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_96b2175b-b460-439a-a532-5e25a0eb9585" xlink:href="iclr-20221231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_87e24753-7c99-461f-bae0-d8421eb814b3" xlink:to="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_96b2175b-b460-439a-a532-5e25a0eb9585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_20b5ae22-cdf9-4469-97e4-0c25e86cd0d7" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_87e24753-7c99-461f-bae0-d8421eb814b3" xlink:to="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_20b5ae22-cdf9-4469-97e4-0c25e86cd0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cfac3397-f994-4b35-a62f-1dd1faaef045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_87e24753-7c99-461f-bae0-d8421eb814b3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cfac3397-f994-4b35-a62f-1dd1faaef045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#DisaggregationofRevenueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2e51a28-0e79-43d9-babd-f49422c42a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3272c84d-cfcd-4af9-ad4a-a9eb1fe06ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c2e51a28-0e79-43d9-babd-f49422c42a5f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3272c84d-cfcd-4af9-ad4a-a9eb1fe06ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddf3f2b6-60ec-4b55-a0d5-23c762a0c927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0a558d81-e327-42a5-9452-bee142613f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ddf3f2b6-60ec-4b55-a0d5-23c762a0c927" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0a558d81-e327-42a5-9452-bee142613f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#AllowancesforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_0f6da223-3932-45d7-a4fd-d7571fe2b508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock_49eada8b-3823-4cdd-b728-be5d06ae439d" xlink:href="iclr-20221231.xsd#iclr_AllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_0f6da223-3932-45d7-a4fd-d7571fe2b508" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsTableTextBlock_49eada8b-3823-4cdd-b728-be5d06ae439d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1fc1831a-f95a-4ed6-920f-ff11701722de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_0f9f329c-0697-4f77-9a64-34d006f60a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1fc1831a-f95a-4ed6-920f-ff11701722de" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_0f9f329c-0697-4f77-9a64-34d006f60a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6ee51dfe-bae7-42ce-aee6-3f405c1481d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1fc1831a-f95a-4ed6-920f-ff11701722de" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6ee51dfe-bae7-42ce-aee6-3f405c1481d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_428cdab6-860e-4a39-9c96-6901b5c27688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1fc1831a-f95a-4ed6-920f-ff11701722de" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_428cdab6-860e-4a39-9c96-6901b5c27688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_a2bf8510-4fe5-4fb8-9a5d-4eddb8d5c52b" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1fc1831a-f95a-4ed6-920f-ff11701722de" xlink:to="loc_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock_a2bf8510-4fe5-4fb8-9a5d-4eddb8d5c52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_21a7f8e4-0e12-46fd-916e-f527826720f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_bd696cca-e52a-4d95-9598-fae4c7132f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_21a7f8e4-0e12-46fd-916e-f527826720f6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_bd696cca-e52a-4d95-9598-fae4c7132f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_054ad97a-bb4c-4fca-ab84-03e5b6e59ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_21a7f8e4-0e12-46fd-916e-f527826720f6" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_054ad97a-bb4c-4fca-ab84-03e5b6e59ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a761764-7701-4584-a12c-ed80427e6905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_1251215d-c437-47d1-ad93-5203823f893a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0a761764-7701-4584-a12c-ed80427e6905" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_1251215d-c437-47d1-ad93-5203823f893a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#PropertyPlantandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_86b10ffb-6e9a-43e4-bca1-0ad68472a011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_bf85335a-955e-4956-8752-054484850ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_86b10ffb-6e9a-43e4-bca1-0ad68472a011" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_bf85335a-955e-4956-8752-054484850ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09b8686c-cb89-472e-99f4-6a5b190e3125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_51998df4-cdfa-4e3a-8a5f-320c1ec4e0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09b8686c-cb89-472e-99f4-6a5b190e3125" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_51998df4-cdfa-4e3a-8a5f-320c1ec4e0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_af1ec1b5-007d-4404-ba99-605d738a728f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c98ca286-ca9c-45d4-be56-eb0e4a4b5edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_af1ec1b5-007d-4404-ba99-605d738a728f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c98ca286-ca9c-45d4-be56-eb0e4a4b5edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_128d6e5e-4a58-4d40-b212-c9a3fa45ade3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_af1ec1b5-007d-4404-ba99-605d738a728f" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_128d6e5e-4a58-4d40-b212-c9a3fa45ade3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#OtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_a097a4ad-e32f-43cd-ab58-73e3a001ca47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_778f2a59-5535-4733-bb77-d87be8ce8f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_a097a4ad-e32f-43cd-ab58-73e3a001ca47" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_778f2a59-5535-4733-bb77-d87be8ce8f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3b3c2144-9df8-4e06-a126-73f566196a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c36b22c2-0553-44d1-a47b-3c6f19bd74fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3b3c2144-9df8-4e06-a126-73f566196a00" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c36b22c2-0553-44d1-a47b-3c6f19bd74fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_0944f839-f48e-4c93-b895-0c0984f3b29d" xlink:href="iclr-20221231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3b3c2144-9df8-4e06-a126-73f566196a00" xlink:to="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_0944f839-f48e-4c93-b895-0c0984f3b29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_830c3c92-de00-49f7-99a1-041d23538001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3b3c2144-9df8-4e06-a126-73f566196a00" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_830c3c92-de00-49f7-99a1-041d23538001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a4a8012f-f76e-422a-9cca-3101b972e4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5827a4e6-4612-47c7-a1ab-3cf34d7e145a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a4a8012f-f76e-422a-9cca-3101b972e4a5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5827a4e6-4612-47c7-a1ab-3cf34d7e145a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a19906f9-215b-4d3d-9827-a58df81699c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_aac5774d-278e-47ec-8556-bf8ee661f1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a19906f9-215b-4d3d-9827-a58df81699c7" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_aac5774d-278e-47ec-8556-bf8ee661f1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_53928e78-a823-41c0-9318-9f95c6ee12d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a19906f9-215b-4d3d-9827-a58df81699c7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_53928e78-a823-41c0-9318-9f95c6ee12d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentotherliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_19537ea0-f05a-42e5-9d10-6da1c09856e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_388835bd-28d1-4a46-91a9-76e0682613c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_19537ea0-f05a-42e5-9d10-6da1c09856e8" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_388835bd-28d1-4a46-91a9-76e0682613c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#RestructuringchargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d718d9c8-deae-4646-a089-90fca1a90b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c5168c8a-3151-4fb2-9c68-490e3dc8c746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d718d9c8-deae-4646-a089-90fca1a90b98" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c5168c8a-3151-4fb2-9c68-490e3dc8c746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_1f7b6d1b-3653-45d2-b45c-13ff7b5c08c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d718d9c8-deae-4646-a089-90fca1a90b98" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_1f7b6d1b-3653-45d2-b45c-13ff7b5c08c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_2a5e7993-11b0-4aaf-bfab-06bb81256987" xlink:href="iclr-20221231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:to="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_2a5e7993-11b0-4aaf-bfab-06bb81256987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e7c75faf-c1f6-4312-ad7d-a11088f4fa6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e7c75faf-c1f6-4312-ad7d-a11088f4fa6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fb977c40-ba27-4057-8d2f-591f6b38c4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fb977c40-ba27-4057-8d2f-591f6b38c4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8c3d599d-c985-4063-bdc6-2717719b96a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8c3d599d-c985-4063-bdc6-2717719b96a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_892fb041-16a0-408f-b479-01125f496d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_892fb041-16a0-408f-b479-01125f496d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_a5068a7b-0e3a-46e7-9b20-ab132214f3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7a86ca54-4fe1-40cb-9920-63e283e4b588" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_a5068a7b-0e3a-46e7-9b20-ab132214f3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_dfa96e65-9171-4b3b-b8fc-6255c6af9c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_dfa96e65-9171-4b3b-b8fc-6255c6af9c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_eb3af4c8-63e4-4e80-92b1-26ef82eba70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_eb3af4c8-63e4-4e80-92b1-26ef82eba70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_5482c0fc-fe4e-448c-8682-a87f8c51f451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_5482c0fc-fe4e-448c-8682-a87f8c51f451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_70d4ee1f-d973-4b7e-b51e-1bf2e4b75db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_70d4ee1f-d973-4b7e-b51e-1bf2e4b75db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_09ace0a5-9233-45b7-b0f5-357294895bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_09ace0a5-9233-45b7-b0f5-357294895bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_107325fa-f6a3-4285-bfa1-5c44146778c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_107325fa-f6a3-4285-bfa1-5c44146778c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_f16393c9-8c52-4d1f-a170-85b938706dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_f16393c9-8c52-4d1f-a170-85b938706dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_da391850-f3d5-47bf-b3aa-6de78ff8c600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a4ab253a-f64f-43b5-be46-761fcb338ea8" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_da391850-f3d5-47bf-b3aa-6de78ff8c600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdbefab3-5f27-4fd0-9af5-3e8b0ceafe83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6a2321e0-628d-42b1-ae45-5e993ff6cc30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdbefab3-5f27-4fd0-9af5-3e8b0ceafe83" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6a2321e0-628d-42b1-ae45-5e993ff6cc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_efa74f7d-034f-4884-ad32-76ffb74c9af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdbefab3-5f27-4fd0-9af5-3e8b0ceafe83" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_efa74f7d-034f-4884-ad32-76ffb74c9af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c10fc4bd-2dda-4cbc-b095-11207eac335a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdbefab3-5f27-4fd0-9af5-3e8b0ceafe83" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c10fc4bd-2dda-4cbc-b095-11207eac335a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_2ba96920-c11c-467b-a300-3bef6c3c007b" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdbefab3-5f27-4fd0-9af5-3e8b0ceafe83" xlink:to="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_2ba96920-c11c-467b-a300-3bef6c3c007b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_f07776db-7707-4c84-a83c-598dffc833aa" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cdbefab3-5f27-4fd0-9af5-3e8b0ceafe83" xlink:to="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_f07776db-7707-4c84-a83c-598dffc833aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7c9a8dee-e71f-4224-970f-b1160afe545b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_85dc1f09-bd6b-4bb3-91c2-cea04d07b217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c9a8dee-e71f-4224-970f-b1160afe545b" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_85dc1f09-bd6b-4bb3-91c2-cea04d07b217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock_cef6dad8-8df6-45e7-9481-50ac10b750b7" xlink:href="iclr-20221231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c9a8dee-e71f-4224-970f-b1160afe545b" xlink:to="loc_iclr_OperatingIncomeByGeographyTableTextBlock_cef6dad8-8df6-45e7-9481-50ac10b750b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_59ea5335-cdc0-4a14-86a0-089a4597b079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c9a8dee-e71f-4224-970f-b1160afe545b" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_59ea5335-cdc0-4a14-86a0-089a4597b079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#NetIncomePerOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b8eabbe2-c568-4ba4-8afa-d95dc74ded91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7744cd3a-b7e5-4e4a-ae24-a1db3d16c269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8eabbe2-c568-4ba4-8afa-d95dc74ded91" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7744cd3a-b7e5-4e4a-ae24-a1db3d16c269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_c007af31-1218-47fe-8b6c-70ab47f385da" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b8eabbe2-c568-4ba4-8afa-d95dc74ded91" xlink:to="loc_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock_c007af31-1218-47fe-8b6c-70ab47f385da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_e30ebd74-7a4b-4210-aa43-1d405573e4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9b5659bb-c9d8-4ff1-b28a-bd852578adb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_e30ebd74-7a4b-4210-aa43-1d405573e4d6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9b5659bb-c9d8-4ff1-b28a-bd852578adb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="simple" xlink:href="iclr-20221231.xsd#SupplementalDisclosureofCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_de47364e-5157-4f97-b89d-c097fe4d18f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_638de09c-795e-42b9-b4ae-c8040df4d311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_de47364e-5157-4f97-b89d-c097fe4d18f2" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_638de09c-795e-42b9-b4ae-c8040df4d311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DescriptionofbusinessDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_69a0204f-9fba-40a4-8d0e-c4ee3dd037ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_69a0204f-9fba-40a4-8d0e-c4ee3dd037ab" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_441ffb49-4a58-432d-91dd-595a71b9cc23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a7a6aeaf-f924-4eae-9a03-9ca1a932b30d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_441ffb49-4a58-432d-91dd-595a71b9cc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_8fa95b6e-6ddd-44c8-8d4a-749bc6890c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_441ffb49-4a58-432d-91dd-595a71b9cc23" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_8fa95b6e-6ddd-44c8-8d4a-749bc6890c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_78cab749-31d9-4fb9-bdb8-6062188791e3" xlink:to="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c1f59ba2-4e88-4a8b-9b9f-f63cf2d2bb1d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:to="loc_country_US_c1f59ba2-4e88-4a8b-9b9f-f63cf2d2bb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_59306573-a7a7-4898-b662-3e9d760791cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:to="loc_srt_EuropeMember_59306573-a7a7-4898-b662-3e9d760791cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_31f47b17-2665-4c8d-a2b5-a66c5eb9d6cd" xlink:href="iclr-20221231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ce004d4c-b208-42c6-8b7f-7cff71244877" xlink:to="loc_iclr_OtherGeographicLocationsMember_31f47b17-2665-4c8d-a2b5-a66c5eb9d6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2441b081-ec70-40d8-933e-0bdbbdcca324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1f2348bc-1aec-45b3-ba25-7d7f09ac2015" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2441b081-ec70-40d8-933e-0bdbbdcca324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c37e34d5-c192-4e2b-88f8-f00dcb96bb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2441b081-ec70-40d8-933e-0bdbbdcca324" xlink:to="loc_us-gaap_SalesRevenueNetMember_c37e34d5-c192-4e2b-88f8-f00dcb96bb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_499e6d18-1919-47d7-b285-1f8c110531b8" xlink:to="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_d434bec1-0f13-4466-9b14-3c26eae7c9c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_dei_EntityNumberOfEmployees_d434bec1-0f13-4466-9b14-3c26eae7c9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_d9bb0a4a-77be-4b40-9974-be57fabdc21e" xlink:href="iclr-20221231.xsd#iclr_NumberOfLocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_iclr_NumberOfLocations_d9bb0a4a-77be-4b40-9974-be57fabdc21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_ae0d894e-3b54-410b-8759-3b51ff1482d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_ae0d894e-3b54-410b-8759-3b51ff1482d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0282a8f2-cfd7-41aa-b49c-e10b275a2df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_2b035d44-bda0-4633-8288-d388926278cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0282a8f2-cfd7-41aa-b49c-e10b275a2df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aa1576d9-072b-4c6b-8728-5072f889d6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract_d75f80c3-ef1c-4633-ae47-3cd243c1eae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aa1576d9-072b-4c6b-8728-5072f889d6af" xlink:to="loc_us-gaap_ForeignCurrencyAbstract_d75f80c3-ef1c-4633-ae47-3cd243c1eae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_f8d821d5-93ca-4dd9-a6ce-67eb63f3f24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyAbstract_d75f80c3-ef1c-4633-ae47-3cd243c1eae4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_f8d821d5-93ca-4dd9-a6ce-67eb63f3f24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c8a24a7d-2b71-4ac2-b92f-0281435c808a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5090787b-bc80-4cc9-a92e-6abf273caa63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8a24a7d-2b71-4ac2-b92f-0281435c808a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5090787b-bc80-4cc9-a92e-6abf273caa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5090787b-bc80-4cc9-a92e-6abf273caa63" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_64959921-08ec-49bd-9dbc-62bed9bad96d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_976351f0-be5c-4716-baa3-04c2785de69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_BuildingMember_976351f0-be5c-4716-baa3-04c2785de69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_eb46af42-e096-42c8-8631-513a7214ce65" xlink:href="iclr-20221231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_eb46af42-e096-42c8-8631-513a7214ce65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_600518a6-4340-4842-a8a2-28935e841060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_600518a6-4340-4842-a8a2-28935e841060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_40eff598-2c31-43c5-a0c1-46e1928f2590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_EquipmentMember_40eff598-2c31-43c5-a0c1-46e1928f2590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_8bcae123-3c13-4230-8f4f-2d48c5c2166a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b3f9c316-3dfb-4550-aa26-46c3dacf2bad" xlink:to="loc_us-gaap_VehiclesMember_8bcae123-3c13-4230-8f4f-2d48c5c2166a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:to="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a01b9fdb-8343-4eee-a9b1-c99447244c30" xlink:to="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d850ee18-4ae5-4588-9c76-97355dfa2fec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:to="loc_srt_MinimumMember_d850ee18-4ae5-4588-9c76-97355dfa2fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd1fd8e5-8f9d-47a3-8bd0-cf4fa5c75dfd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5b7302e1-ccc4-47c3-baf2-3c91038df8d0" xlink:to="loc_srt_MaximumMember_bd1fd8e5-8f9d-47a3-8bd0-cf4fa5c75dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5a5234a8-9b5e-4a0c-a4ec-af9622797eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b18ed42d-1c2a-4bb3-95dd-318908fcd959" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5a5234a8-9b5e-4a0c-a4ec-af9622797eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8c45f7f8-c8ee-41d8-8ce3-81bd140e0956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5a5234a8-9b5e-4a0c-a4ec-af9622797eab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8c45f7f8-c8ee-41d8-8ce3-81bd140e0956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a91e8c97-abce-4188-a01c-6b42ee8cf48c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a91e8c97-abce-4188-a01c-6b42ee8cf48c" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b25b320-1c4e-4e84-bc61-743b0e3ab41f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b852af3b-b71c-40ad-802e-12d81cd37354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b852af3b-b71c-40ad-802e-12d81cd37354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_c374921f-e097-49cd-b865-100044de0bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_c374921f-e097-49cd-b865-100044de0bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ec0ad702-09ad-47dd-b6fc-e12e18598d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_TradeNamesMember_ec0ad702-09ad-47dd-b6fc-e12e18598d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_fd478ead-ce53-43dc-982a-27ff9dab5719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_DatabasesMember_fd478ead-ce53-43dc-982a-27ff9dab5719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_edf02f8d-7d3b-4908-b36f-ad192b1ffba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_26f0112e-49c9-48f8-a964-2e0571642f9d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_edf02f8d-7d3b-4908-b36f-ad192b1ffba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dc9eb9f2-270e-45ae-9307-eccbe47dd021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0be965fb-8db7-4b3d-9196-8a906f18610a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dc9eb9f2-270e-45ae-9307-eccbe47dd021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_329700d3-b520-4375-89b2-957407f170e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dc9eb9f2-270e-45ae-9307-eccbe47dd021" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_329700d3-b520-4375-89b2-957407f170e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SummaryofSignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_765ed5fa-1d1b-4d2a-aef4-e94ece47f278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_765ed5fa-1d1b-4d2a-aef4-e94ece47f278" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d8e4887-8053-41cc-a786-5d237b70a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f78c966f-7f82-46b2-bbd0-22af206dd0af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d8e4887-8053-41cc-a786-5d237b70a49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_MeDiNovaResearchMember_ed615234-135a-4082-8504-23f586bfcbfe" xlink:href="iclr-20221231.xsd#iclr_MeDiNovaResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8d8e4887-8053-41cc-a786-5d237b70a49e" xlink:to="loc_iclr_MeDiNovaResearchMember_ed615234-135a-4082-8504-23f586bfcbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cba3db69-22ae-411f-9e6c-23523ef926f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_90a56340-9ac7-41db-987f-f4e44f316a99" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cba3db69-22ae-411f-9e6c-23523ef926f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_51758dac-a176-435e-aa1b-3641f08f4ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cba3db69-22ae-411f-9e6c-23523ef926f0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_51758dac-a176-435e-aa1b-3641f08f4ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e321196-be54-416a-81dc-ff8c240b10d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e321196-be54-416a-81dc-ff8c240b10d8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:to="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_dd634249-abbd-4ea7-bb73-f9d17fa8b4b9" xlink:to="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_68b9abfb-a47e-4351-bab2-fa055ca29e4d" xlink:href="iclr-20221231.xsd#iclr_TopClientMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_TopClientMember_68b9abfb-a47e-4351-bab2-fa055ca29e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_51c179e3-6c86-4fc5-9d20-7c6d28635857" xlink:href="iclr-20221231.xsd#iclr_Clients25Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_Clients25Member_51c179e3-6c86-4fc5-9d20-7c6d28635857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_9252bb93-30f4-4a3b-8891-882d4ec05e5f" xlink:href="iclr-20221231.xsd#iclr_Clients610Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_Clients610Member_9252bb93-30f4-4a3b-8891-882d4ec05e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_26c10e3c-0d05-4547-a2c5-7a5155a2284d" xlink:href="iclr-20221231.xsd#iclr_Clients1125Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_Clients1125Member_26c10e3c-0d05-4547-a2c5-7a5155a2284d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_aeaabe1b-ce23-4974-88bd-b82c14ff1af4" xlink:href="iclr-20221231.xsd#iclr_OtherCustomersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f3e248b8-f57e-45f7-bf58-975cf447d87f" xlink:to="loc_iclr_OtherCustomersMember_aeaabe1b-ce23-4974-88bd-b82c14ff1af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_4e1a3e88-4003-4057-b8fc-600b23f3dccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4d11f7df-1efe-494a-b45a-84b46b531de6" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_4e1a3e88-4003-4057-b8fc-600b23f3dccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a036f1d4-2e41-4bc6-b85e-37f6be8bdcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_4e1a3e88-4003-4057-b8fc-600b23f3dccf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a036f1d4-2e41-4bc6-b85e-37f6be8bdcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_820ae47f-f9f3-430d-9648-219ea92b8db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_us-gaap_BilledContractReceivables_820ae47f-f9f3-430d-9648-219ea92b8db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c4fda49c-fdd2-477a-b502-901e85043270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c4fda49c-fdd2-477a-b502-901e85043270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_debc1548-6b1b-40b2-a727-d2f7c5fc5eee" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_ContractsReceivableGross_debc1548-6b1b-40b2-a727-d2f7c5fc5eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_e2e8b823-50b9-420f-9cb8-639df82ffaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_e2e8b823-50b9-420f-9cb8-639df82ffaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_15737bbf-183a-45e8-af07-285593f7dba6" xlink:href="iclr-20221231.xsd#iclr_ContractsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_ContractsReceivableNet_15737bbf-183a-45e8-af07-285593f7dba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4be3a369-5a3a-4541-9b1e-96fd238e34f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4be3a369-5a3a-4541-9b1e-96fd238e34f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_aca06719-4505-4548-9cc8-4a9716f73f68" xlink:href="iclr-20221231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_aca06719-4505-4548-9cc8-4a9716f73f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_c17cf7af-aa22-48c6-a586-654132eb65ed" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_c17cf7af-aa22-48c6-a586-654132eb65ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_d161527f-8c67-4505-8bd7-74250bd6bf39" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_d161527f-8c67-4505-8bd7-74250bd6bf39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_dedbe0eb-aec4-4a0e-aac6-0b62ea7cf28b" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_dedbe0eb-aec4-4a0e-aac6-0b62ea7cf28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_06b1dd6f-9fdb-4780-b029-2deed4d92dae" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent_06b1dd6f-9fdb-4780-b029-2deed4d92dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_19fc3c5e-e1de-4d9a-b10b-1c76469ca7c1" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_19fc3c5e-e1de-4d9a-b10b-1c76469ca7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_cdb81b88-5a98-432a-9368-b282666c01ec" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a3bfe5a0-c948-482b-8972-7bc678ac9000" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_cdb81b88-5a98-432a-9368-b282666c01ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_58b60cf5-6c7e-4a5a-b68b-77926e923f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_58b60cf5-6c7e-4a5a-b68b-77926e923f30" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15257d47-294f-42c8-8446-9f8db835e053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_15257d47-294f-42c8-8446-9f8db835e053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d3572fb4-705e-43a6-a8f8-71e43facbeb4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_c2b5e860-7930-429b-b941-65992e9d8af8" xlink:href="iclr-20221231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_c2b5e860-7930-429b-b941-65992e9d8af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_61f07374-e050-4252-bbcc-e6bc8f1a08d4" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent_61f07374-e050-4252-bbcc-e6bc8f1a08d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_97da4062-40b0-4e82-bddb-526b05494e17" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_97da4062-40b0-4e82-bddb-526b05494e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ec344476-2d11-46d1-9092-b48b77c90da8" xlink:href="iclr-20221231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable_ec344476-2d11-46d1-9092-b48b77c90da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_3213d20a-558f-4ea4-866c-44c75815dac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_3213d20a-558f-4ea4-866c-44c75815dac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1db0872e-dacb-4339-9979-d9088d14403d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1db0872e-dacb-4339-9979-d9088d14403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1c533e32-0284-4f2e-a8f2-cb01ed8ffecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1c533e32-0284-4f2e-a8f2-cb01ed8ffecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_70390609-08ca-41b2-851e-f2adaeac219f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_24ae533d-4f90-4c68-841e-ca76523aca8a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_70390609-08ca-41b2-851e-f2adaeac219f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20221231.xsd#ContractBalancesNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ContractBalancesNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#AllowancesforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_5f687536-72f3-499b-962d-d1786bda8673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5f687536-72f3-499b-962d-d1786bda8673" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3a0c982a-e24f-4713-bc1d-5d0d8acfbcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3a0c982a-e24f-4713-bc1d-5d0d8acfbcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_e39a6f8a-387f-4344-a873-db3776a87000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_e39a6f8a-387f-4344-a873-db3776a87000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense_314aef3b-ebff-4a26-b89b-891504f199ad" xlink:href="iclr-20221231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:to="loc_iclr_AccountsReceivableCreditLossExpense_314aef3b-ebff-4a26-b89b-891504f199ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossReversal_3adebacf-ed9c-4f79-8749-18c2fce1d96a" xlink:href="iclr-20221231.xsd#iclr_AccountsReceivableCreditLossReversal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:to="loc_iclr_AccountsReceivableCreditLossReversal_3adebacf-ed9c-4f79-8749-18c2fce1d96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_9ba7b6b1-2d83-45cc-b0bb-c8decbb09a57" xlink:href="iclr-20221231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_9ba7b6b1-2d83-45cc-b0bb-c8decbb09a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f1e6a5a3-0a85-4ec7-b3d8-d28ea2a6cdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_dc7fcf44-05c4-4f75-b01a-04a3027dda5e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f1e6a5a3-0a85-4ec7-b3d8-d28ea2a6cdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsNarrativePRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_177f4edb-20a4-49d1-8195-2de3060b2f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_177f4edb-20a4-49d1-8195-2de3060b2f99" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b007f77c-6937-4651-b0a1-1734ca9deeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_669fa9de-57e1-4649-87bd-e5b91c493fdf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b007f77c-6937-4651-b0a1-1734ca9deeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_41adc54c-4e9e-4135-9384-301be52701bf" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b007f77c-6937-4651-b0a1-1734ca9deeb3" xlink:to="loc_iclr_PRAHealthSciencesIncMember_41adc54c-4e9e-4135-9384-301be52701bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d24b1578-6c60-4071-995a-2f7787daf7df" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_41504046-13c4-4b00-a110-5bee9a0f70ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_dei_EntityNumberOfEmployees_41504046-13c4-4b00-a110-5bee9a0f70ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_19523516-2e5c-4fc4-967b-0171eaee72d0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld_19523516-2e5c-4fc4-967b-0171eaee72d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_d555bbc5-3ac1-4532-ac2a-79cd503f5cc9" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld_d555bbc5-3ac1-4532-ac2a-79cd503f5cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_aaaa41d5-7281-4ddd-8a4b-11267a56bebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_aaaa41d5-7281-4ddd-8a4b-11267a56bebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c973bcfd-ca0d-483a-b873-ae6f090d4f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c973bcfd-ca0d-483a-b873-ae6f090d4f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_1e9d56b3-9cdf-4e3d-99ed-8518a16497ce" xlink:href="iclr-20221231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_1e9d56b3-9cdf-4e3d-99ed-8518a16497ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_d6bd4227-01db-4a8d-a16c-ea416870fe64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8be79c2-a1ff-4b54-999a-d22c48169e4f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_d6bd4227-01db-4a8d-a16c-ea416870fe64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_f59c47b0-1a4b-4d2d-a5c4-90c13ff01d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f59c47b0-1a4b-4d2d-a5c4-90c13ff01d4a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5d8ad67-3aba-41db-a52c-5a775211ef90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a75462fd-e493-4def-af9c-d96b243636af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5d8ad67-3aba-41db-a52c-5a775211ef90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_f5f46b36-d4be-4133-b800-0f738a1367f8" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e5d8ad67-3aba-41db-a52c-5a775211ef90" xlink:to="loc_iclr_PRAHealthSciencesIncMember_f5f46b36-d4be-4133-b800-0f738a1367f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_014aaa82-52c1-4076-b48d-56fda006ddce" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_794cdb47-af5e-4a92-a2de-ec1b7519c4df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_794cdb47-af5e-4a92-a2de-ec1b7519c4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02dec372-fbab-42d8-ae81-80557289a0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_02dec372-fbab-42d8-ae81-80557289a0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f4b2f7fb-1be5-4c7e-bd04-61ad49e9a27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredOther1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredOther1_f4b2f7fb-1be5-4c7e-bd04-61ad49e9a27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_870aa226-faeb-444a-804c-ec3ed63f7b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_870aa226-faeb-444a-804c-ec3ed63f7b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f714f8e2-08b6-4bab-a45f-ada3b2af6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_f714f8e2-08b6-4bab-a45f-ada3b2af6e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_22de09a9-f3e0-49d7-9c4b-8c336ec120b0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d258efa3-f65b-4871-a161-780a919cdd4d" xlink:to="loc_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate_22de09a9-f3e0-49d7-9c4b-8c336ec120b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8ee463ff-fb93-4b35-9dc5-406951640514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8ee463ff-fb93-4b35-9dc5-406951640514" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e51fe12-7d1d-47d3-b2ef-fa2226436b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7fd45ebe-3259-45e4-9eb7-ab25b5e62d96" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e51fe12-7d1d-47d3-b2ef-fa2226436b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_ad5b0597-bbe2-4e5a-befc-e2c035388ab6" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e51fe12-7d1d-47d3-b2ef-fa2226436b20" xlink:to="loc_iclr_PRAHealthSciencesIncMember_ad5b0597-bbe2-4e5a-befc-e2c035388ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_232f5378-8eb3-4d01-83d6-a95b49a8d2c9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f34d3ec3-0ace-4aa3-9527-d6c3e95b0326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f34d3ec3-0ace-4aa3-9527-d6c3e95b0326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7171e11c-8e53-482d-a1d1-06be8fa9370a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7171e11c-8e53-482d-a1d1-06be8fa9370a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4150824a-7e3f-45f9-bdfc-b1e124520b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_4150824a-7e3f-45f9-bdfc-b1e124520b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c387e531-4651-4133-bcc6-5c593c7fd759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c387e531-4651-4133-bcc6-5c593c7fd759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_0db5b5f4-d200-4c5b-b412-bc97696cdc67" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_0db5b5f4-d200-4c5b-b412-bc97696cdc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_06b09a97-0a81-4b1f-a02b-03ac74c5f391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_Goodwill_06b09a97-0a81-4b1f-a02b-03ac74c5f391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_07741109-c93d-489b-a504-ec1b44ab9dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_07741109-c93d-489b-a504-ec1b44ab9dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_afb32cae-d7bf-4ae2-bbef-fe21e0ee4c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_afb32cae-d7bf-4ae2-bbef-fe21e0ee4c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d7eb7f9-827a-44d2-bae7-fc4482708cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1d7eb7f9-827a-44d2-bae7-fc4482708cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c57e2530-f53e-4229-802e-5901e467ef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c57e2530-f53e-4229-802e-5901e467ef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e92d20ca-3ec0-4953-b08b-81af0d0d85c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_e92d20ca-3ec0-4953-b08b-81af0d0d85c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_4bf5f610-44f2-4bf9-acb2-94bae87e83a1" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability_4bf5f610-44f2-4bf9-acb2-94bae87e83a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_74222b33-8fd7-4a56-baea-01bbc1bfc938" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent_74222b33-8fd7-4a56-baea-01bbc1bfc938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_ce91bb81-eefc-44db-b863-704945e4bccb" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability_ce91bb81-eefc-44db-b863-704945e4bccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7c5f0fe6-9294-431c-b24e-9fcb16bbe068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_7c5f0fe6-9294-431c-b24e-9fcb16bbe068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_801ad4d0-69ef-439e-ade5-daafa39daf32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_801ad4d0-69ef-439e-ade5-daafa39daf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2fc22219-4ab2-47c9-a006-5e64e76b3936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2fc22219-4ab2-47c9-a006-5e64e76b3936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_a561806e-a812-4dc5-9b98-918bc5fe55f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_a561806e-a812-4dc5-9b98-918bc5fe55f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_1d26fd96-805e-4729-a153-08e860efe373" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a4a30a2e-fd6a-424f-86e9-5a3d09666c5e" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_1d26fd96-805e-4729-a153-08e860efe373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_dbd81485-fe01-42a9-85e1-8dcb19e6ee38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_dbd81485-fe01-42a9-85e1-8dcb19e6ee38" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2435b95-0e6c-46f9-9db5-a89100319b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ea39468a-e224-4c31-9532-23326d946859" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2435b95-0e6c-46f9-9db5-a89100319b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_387d7659-02d3-4b27-afa2-ec168f967810" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d2435b95-0e6c-46f9-9db5-a89100319b80" xlink:to="loc_iclr_PRAHealthSciencesIncMember_387d7659-02d3-4b27-afa2-ec168f967810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f815651-0cb1-4ff8-923f-be9120299184" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_543d4707-f052-48bd-9ba3-d55c2ea2f2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_CustomerRelationshipsMember_543d4707-f052-48bd-9ba3-d55c2ea2f2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_9baba2b7-7a33-45b5-8ba9-952529a25801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_9baba2b7-7a33-45b5-8ba9-952529a25801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_f4001a3e-2312-4c7e-ac31-c45b157833d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_TradeNamesMember_f4001a3e-2312-4c7e-ac31-c45b157833d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_52c313a8-e5e3-44f1-b1d1-83bef2f893ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_DatabasesMember_52c313a8-e5e3-44f1-b1d1-83bef2f893ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0b72f2da-72c2-40ab-aa79-d190923a6f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a16e1983-972a-48b2-b846-5538b693dadb" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0b72f2da-72c2-40ab-aa79-d190923a6f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f679fb5d-7510-4bb1-8307-67d59adf2522" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_78c5af92-4694-45aa-a9b4-26a0eeee5305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_78c5af92-4694-45aa-a9b4-26a0eeee5305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed49cc7e-f78f-4d11-8a21-c1ad589828e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_59bb6aaa-510c-4b5b-934a-b6623a03b770" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ed49cc7e-f78f-4d11-8a21-c1ad589828e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d2d71cce-77f4-454a-819e-575e32e127c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d2d71cce-77f4-454a-819e-575e32e127c3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e4cb1b9-9354-448c-8410-f93ffb6c1305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0398c62c-dd32-4054-8b26-f425e02968b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e4cb1b9-9354-448c-8410-f93ffb6c1305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_ad721593-5b24-4eec-a7c5-ec0795647be0" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e4cb1b9-9354-448c-8410-f93ffb6c1305" xlink:to="loc_iclr_PRAHealthSciencesIncMember_ad721593-5b24-4eec-a7c5-ec0795647be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fc5744a6-a26a-4648-aae8-bfd38fc6a014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fb87498b-90e8-44dd-9e4f-7cb2cec95a60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fc5744a6-a26a-4648-aae8-bfd38fc6a014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202108Member_49bdeec9-500b-4423-b113-cbeede025c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202108Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_fc5744a6-a26a-4648-aae8-bfd38fc6a014" xlink:to="loc_us-gaap_AccountingStandardsUpdate202108Member_49bdeec9-500b-4423-b113-cbeede025c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_32eea064-3394-4058-98ac-3ec3d0176172" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_68545a09-2d8b-41ba-9dcd-504b2f82d210" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_68545a09-2d8b-41ba-9dcd-504b2f82d210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_2aca5294-960b-4d47-a59c-66ab22d624d4" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue_2aca5294-960b-4d47-a59c-66ab22d624d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_778dee28-8b60-4b3c-aab0-0ccae771b936" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_778dee28-8b60-4b3c-aab0-0ccae771b936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_d2af657d-2b6b-4bfe-b5bc-6303a79b42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_d2af657d-2b6b-4bfe-b5bc-6303a79b42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_1775e4cd-068e-44ee-8ee9-f22f2ad84077" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_1775e4cd-068e-44ee-8ee9-f22f2ad84077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_011f40a4-0dad-424a-ae55-216a9fdab8df" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_011f40a4-0dad-424a-ae55-216a9fdab8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e69c6d81-2db3-429d-8133-37bfb058b4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e69c6d81-2db3-429d-8133-37bfb058b4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_e2fda5b0-4f66-4b99-bcdd-b50b65c41478" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets_e2fda5b0-4f66-4b99-bcdd-b50b65c41478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_eeddcb25-afd9-4255-87a6-dde1e096c99b" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets_eeddcb25-afd9-4255-87a6-dde1e096c99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_e79c915c-e217-474b-be19-0f4244dfb599" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_e79c915c-e217-474b-be19-0f4244dfb599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_c088970c-b9ce-4809-9704-d3bd89f413f0" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities_c088970c-b9ce-4809-9704-d3bd89f413f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_a5427ab6-55eb-4d71-93d0-b3b71ca29682" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities_a5427ab6-55eb-4d71-93d0-b3b71ca29682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_6ad48741-cb3e-4efa-b4f7-74e2bc5e5379" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue_6ad48741-cb3e-4efa-b4f7-74e2bc5e5379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_53b9b603-7aaf-4676-a19f-f4a029200457" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities_53b9b603-7aaf-4676-a19f-f4a029200457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_975cb0e1-0cb7-4c3b-94c5-c2aaaf0a7345" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities_975cb0e1-0cb7-4c3b-94c5-c2aaaf0a7345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_ef319281-4c2b-4f1f-a093-625ef215b961" xlink:href="iclr-20221231.xsd#iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities_ef319281-4c2b-4f1f-a093-625ef215b961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ab60aef4-1e10-4b67-9d4b-4ded892d5d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf182a3b-85eb-4481-a80b-c3f65debb87a" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ab60aef4-1e10-4b67-9d4b-4ded892d5d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#FairvalueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_983e4eef-8212-4589-9626-98b4a5ec668d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_983e4eef-8212-4589-9626-98b4a5ec668d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c815c64-4ec6-47ac-bedb-23e39f709358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d05625c2-bc02-44a6-8da7-5f89e17237e7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c815c64-4ec6-47ac-bedb-23e39f709358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eec869fd-8ad6-41e4-b9a2-a4b175f347de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6c815c64-4ec6-47ac-bedb-23e39f709358" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_eec869fd-8ad6-41e4-b9a2-a4b175f347de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0463f5e8-96d9-4944-9714-32aa26d0db34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_39228884-dfa4-40cd-95ab-03af992328cc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0463f5e8-96d9-4944-9714-32aa26d0db34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_18159960-08c5-40e8-9080-cfefd93453f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0463f5e8-96d9-4944-9714-32aa26d0db34" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_18159960-08c5-40e8-9080-cfefd93453f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab9fe214-a384-4932-8273-2436cad34249" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d5be941e-522d-48c7-932b-73bae12c2728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d5be941e-522d-48c7-932b-73bae12c2728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_0a569859-39da-4102-8ead-d1c49ee92b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_0a569859-39da-4102-8ead-d1c49ee92b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_c1269a06-90ee-4396-a6dc-24c7a14699df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_c1269a06-90ee-4396-a6dc-24c7a14699df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8229a218-a999-4f6e-b589-a208ade6fcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c066a08f-ae5b-4853-abe3-2df2853ad54e" xlink:to="loc_us-gaap_LongTermDebtFairValue_8229a218-a999-4f6e-b589-a208ade6fcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2bdd757a-805d-4054-8372-6adc79fb68b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2bdd757a-805d-4054-8372-6adc79fb68b3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d3e5c066-289e-436e-9640-e8ff0e88aa92" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_78e38045-d6b9-400d-956c-e487d92b02a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_78e38045-d6b9-400d-956c-e487d92b02a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_aebf33c3-50f9-4aed-93be-efb7e5a67f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_aebf33c3-50f9-4aed-93be-efb7e5a67f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6c8657dd-a011-45fc-876e-7bdeea6d0ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6c8657dd-a011-45fc-876e-7bdeea6d0ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_7d2fde65-9497-46e8-8226-58a5a2ec524e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4dcf9a9-511d-4d76-a861-899e95e9a90f" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_7d2fde65-9497-46e8-8226-58a5a2ec524e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8c523f29-ce2b-4ce4-bfc0-b411bebbd755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_16c4e116-99d0-4dda-91e0-02f4f1541113" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8c523f29-ce2b-4ce4-bfc0-b411bebbd755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_61499de3-11bc-407a-9002-3b1a9c26c3c5" xlink:href="iclr-20221231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8c523f29-ce2b-4ce4-bfc0-b411bebbd755" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_61499de3-11bc-407a-9002-3b1a9c26c3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7ab584ec-d78a-4d6a-b55d-362ba00daf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_08f535df-bb6c-498e-b0b0-2a177be59023" xlink:to="loc_us-gaap_HedgingDesignationDomain_7ab584ec-d78a-4d6a-b55d-362ba00daf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcde29a3-ff9c-4d0c-98a0-91a6d39e9af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_7ab584ec-d78a-4d6a-b55d-362ba00daf3a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fcde29a3-ff9c-4d0c-98a0-91a6d39e9af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_69290bbf-1598-45bd-b2b2-9a709116da68" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d325c915-ae68-4d0a-b3b0-c0c67f767437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d325c915-ae68-4d0a-b3b0-c0c67f767437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2fa588bc-21dd-4bb8-8f11-f9a8bd568f62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_2fa588bc-21dd-4bb8-8f11-f9a8bd568f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_85508b90-cc9c-45da-8f28-97649b260709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_DerivativeAssets_85508b90-cc9c-45da-8f28-97649b260709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_bb0a044b-68bb-4995-b783-c53a89601706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_bb0a044b-68bb-4995-b783-c53a89601706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_b3bd9dc0-aab4-4311-9d5c-a4eb9468ec22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_DerivativeLiabilities_b3bd9dc0-aab4-4311-9d5c-a4eb9468ec22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ee3386bc-2cb5-44cb-b4a9-c36e233edeba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6254e0cc-47e0-4508-ba99-813186673faa" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ee3386bc-2cb5-44cb-b4a9-c36e233edeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed2f4394-0ce0-4317-b643-db77630c042f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed2f4394-0ce0-4317-b643-db77630c042f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_63c45ff7-0e1f-4b2f-8211-f4893d5830ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_61d58549-f920-40f2-bac0-61ba250414b4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_63c45ff7-0e1f-4b2f-8211-f4893d5830ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_e5ac279d-6647-42a2-994f-dc437a7c2484" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_63c45ff7-0e1f-4b2f-8211-f4893d5830ec" xlink:to="loc_iclr_OncacareMember_e5ac279d-6647-42a2-994f-dc437a7c2484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6959f148-5d22-402f-9503-84422e2b9559" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d452a123-16ea-4e50-b516-23d19fcb5975" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6959f148-5d22-402f-9503-84422e2b9559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_82fb7bfa-0f1b-4def-a36d-924642435913" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6959f148-5d22-402f-9503-84422e2b9559" xlink:to="loc_iclr_OncacareMember_82fb7bfa-0f1b-4def-a36d-924642435913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3accd135-4c61-40bf-9ac7-2ffd5c929165" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3209afb4-f572-48a6-9abf-a34d226ad690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3209afb4-f572-48a6-9abf-a34d226ad690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_1aab32cf-79fb-412b-954a-1bd1830852b5" xlink:href="iclr-20221231.xsd#iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod_1aab32cf-79fb-412b-954a-1bd1830852b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_b95b234c-f4f4-4cb8-bab9-8ef4768a6f3d" xlink:href="iclr-20221231.xsd#iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements_b95b234c-f4f4-4cb8-bab9-8ef4768a6f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_14f11b80-6ef6-4a69-872e-5690aec1ce1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_14f11b80-6ef6-4a69-872e-5690aec1ce1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_36be6f95-2d5c-4e9d-ba50-7c6c45f02e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_36be6f95-2d5c-4e9d-ba50-7c6c45f02e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_32d4044b-6c5a-4fa0-9009-c002f9c31670" xlink:href="iclr-20221231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_32d4044b-6c5a-4fa0-9009-c002f9c31670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_f645b0f5-4177-4742-9437-456f69ec4005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_EquityMethodInvestments_f645b0f5-4177-4742-9437-456f69ec4005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_28815f44-07d3-4158-8f73-c2cb46dde1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_28815f44-07d3-4158-8f73-c2cb46dde1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_ec78d0f9-bce9-4849-9a81-8a3616166e60" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_ec78d0f9-bce9-4849-9a81-8a3616166e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b75afd48-b58d-46d4-86b5-e340b2c6981a" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany_b75afd48-b58d-46d4-86b5-e340b2c6981a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_8965a442-3715-4fa6-819b-2f070716b168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_8965a442-3715-4fa6-819b-2f070716b168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_b37d373b-469c-4a86-a978-619c9cc18201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_b37d373b-469c-4a86-a978-619c9cc18201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a56fd8b4-7382-40bb-85bc-a73383ac2780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a56fd8b4-7382-40bb-85bc-a73383ac2780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInEquityMethodInvestments_de2dc75a-c2d3-4c36-8368-e8ee5c4b251c" xlink:href="iclr-20221231.xsd#iclr_IncreaseDecreaseInEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_IncreaseDecreaseInEquityMethodInvestments_de2dc75a-c2d3-4c36-8368-e8ee5c4b251c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_28403422-8769-452e-83e6-a1c26ec2e1b2" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentDecreaseInLoanReceivable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_iclr_EquityMethodInvestmentDecreaseInLoanReceivable_28403422-8769-452e-83e6-a1c26ec2e1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedParties_0370369e-a2f5-45e5-b63b-95b8c57598ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedParties"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_01a1c530-5171-4400-b07f-e110c7c5ceba" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedParties_0370369e-a2f5-45e5-b63b-95b8c57598ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#InvestmentsEquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1aa7b1e9-e2f3-4c24-9aec-5dedcb362b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1aa7b1e9-e2f3-4c24-9aec-5dedcb362b2a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_127d59b1-ff8e-457e-97c1-1590d2ae4719" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cf1b08b5-bd9a-43df-995d-74284a9f53a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_127d59b1-ff8e-457e-97c1-1590d2ae4719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_7879be40-0dcb-43ea-a0ec-3485bbe2948a" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_127d59b1-ff8e-457e-97c1-1590d2ae4719" xlink:to="loc_iclr_OncacareMember_7879be40-0dcb-43ea-a0ec-3485bbe2948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_7f65806c-23a7-4865-a39f-542bb568c689" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d2075522-5904-4dd3-b532-e2b52c076688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d2075522-5904-4dd3-b532-e2b52c076688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_2b91d14f-5ace-4516-8b8b-eda267ee63d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12139678-8493-41bb-8d90-1b4523ef4777" xlink:to="loc_us-gaap_EquityMethodInvestments_2b91d14f-5ace-4516-8b8b-eda267ee63d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_c7893100-79c2-4dd9-9993-65dd71687f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_Land_c7893100-79c2-4dd9-9993-65dd71687f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_e65e58f9-985d-455b-a5c9-b495cec7c81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_e65e58f9-985d-455b-a5c9-b495cec7c81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_985df552-01a6-445a-8936-d86d5d81afbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_985df552-01a6-445a-8936-d86d5d81afbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_0a188006-b17c-4548-bde3-36907a4e851b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_0a188006-b17c-4548-bde3-36907a4e851b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_fde3cf25-0915-45d9-b97b-930c9aa85c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_fde3cf25-0915-45d9-b97b-930c9aa85c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_2528b183-930b-4f07-a0a9-433bc2e9c583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_2528b183-930b-4f07-a0a9-433bc2e9c583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_e8609727-0075-452f-bd22-2caa69922d4d" xlink:href="iclr-20221231.xsd#iclr_VehiclesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_iclr_VehiclesGross_e8609727-0075-452f-bd22-2caa69922d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1cc50b01-ee3f-41f8-a66f-cd0159f964bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1cc50b01-ee3f-41f8-a66f-cd0159f964bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1ca6463-3688-4289-8676-50cf8bd2d5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1ca6463-3688-4289-8676-50cf8bd2d5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c24cb32a-17d9-4600-8105-d5914d4df934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c24cb32a-17d9-4600-8105-d5914d4df934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e57d10e9-932d-4bd5-a653-ba13c58a5373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0cf9b534-825a-443d-89ba-b63f58320cc5" xlink:to="loc_us-gaap_Depreciation_e57d10e9-932d-4bd5-a653-ba13c58a5373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#GoodwillScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_85ad92f8-14ca-4afb-84e0-d472a2db62a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_85ad92f8-14ca-4afb-84e0-d472a2db62a4" xlink:to="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c00843d-d65b-4b59-913f-cb2fe1b0be2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:to="loc_us-gaap_Goodwill_3c00843d-d65b-4b59-913f-cb2fe1b0be2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_51d14936-cf78-47a3-b23b-34be4f1d71b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_51d14936-cf78-47a3-b23b-34be4f1d71b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a6092827-7ea7-4f12-891f-5beba5c17b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a6092827-7ea7-4f12-891f-5beba5c17b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_229be858-257d-412a-9b18-fe840533c438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_229be858-257d-412a-9b18-fe840533c438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0b080e6-d73f-42f4-9ae2-9fd2f25ce45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_36e30cea-c68d-417d-a2af-eae8807c7e5b" xlink:to="loc_us-gaap_Goodwill_c0b080e6-d73f-42f4-9ae2-9fd2f25ce45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cdb652d-5a52-453c-a5e3-abd1b4d1f052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_4928fbce-f4ac-4db9-9ade-54c5062ef547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0cdb652d-5a52-453c-a5e3-abd1b4d1f052" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_4928fbce-f4ac-4db9-9ade-54c5062ef547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsSummaryofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_49f795bb-25c5-447b-be5f-6f31c4b68c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_49f795bb-25c5-447b-be5f-6f31c4b68c8c" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_289dff4b-6167-4ac9-a0ed-b6e9f1039666" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_35966389-6bb5-40bb-91ee-f238009d93c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_35966389-6bb5-40bb-91ee-f238009d93c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_389895c7-406e-45de-897d-09ad134d4095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_389895c7-406e-45de-897d-09ad134d4095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_002d2c8f-da35-455d-b341-397c28e07aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_TradeNamesMember_002d2c8f-da35-455d-b341-397c28e07aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_13b665ca-f0e6-4ee9-bb45-5dea0f2f8685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_DatabasesMember_13b665ca-f0e6-4ee9-bb45-5dea0f2f8685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_95e3cb0f-a6d5-4bda-813c-92c4690b8a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_de22648b-050c-46ec-ae3e-d569722dc43e" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_95e3cb0f-a6d5-4bda-813c-92c4690b8a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_99e81148-8b69-4fa1-8959-dae2f89e1585" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_28ce51ef-ec1c-4e7d-bea7-34c140211894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_28ce51ef-ec1c-4e7d-bea7-34c140211894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3197fcd9-5c5d-49ce-896a-83536d5bc901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3197fcd9-5c5d-49ce-896a-83536d5bc901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a6202fe-4864-4569-a213-8c5008b4e494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9bb83441-d386-41ba-8d89-0aab3fb31fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a6202fe-4864-4569-a213-8c5008b4e494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ee5b1ebb-a909-4410-b056-9bf5ec224ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ee5b1ebb-a909-4410-b056-9bf5ec224ffc" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6868d29f-caeb-47f9-8e0d-dcdfb96f0a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d019be8-dbcd-4cd7-a369-3fce27b321e6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6868d29f-caeb-47f9-8e0d-dcdfb96f0a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_45aeaf98-9fb6-464f-83e7-73c8785c205c" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6868d29f-caeb-47f9-8e0d-dcdfb96f0a7a" xlink:to="loc_iclr_PRAHealthSciencesIncMember_45aeaf98-9fb6-464f-83e7-73c8785c205c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_499f7b2d-e9f5-418c-9d58-c27a4ccd90ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b93daa65-0fc6-4981-8480-0bbc63b5aec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b93daa65-0fc6-4981-8480-0bbc63b5aec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_3b1459a4-ff2b-419f-9ff1-e70cccf43e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_3b1459a4-ff2b-419f-9ff1-e70cccf43e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4ab6a5d8-645b-4331-acdd-d964848d094d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_TradeNamesMember_4ab6a5d8-645b-4331-acdd-d964848d094d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_475fdd41-d86d-4aef-abb6-1e7df7c1ad42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_DatabasesMember_475fdd41-d86d-4aef-abb6-1e7df7c1ad42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bd628d1b-8a19-402b-a3fc-d8c960eda3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_85ce1d16-c40a-4274-a01f-2dc36e146ffc" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_bd628d1b-8a19-402b-a3fc-d8c960eda3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5c2fa23c-e8b7-4842-b5bf-03189709ab11" xlink:to="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_75488ac6-b790-43c6-b201-295b9ebbcd6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:to="loc_srt_MinimumMember_75488ac6-b790-43c6-b201-295b9ebbcd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f377206d-faf1-45f9-9c00-d4730f585e57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fa4539dc-639e-4598-8281-ce2b2bde3504" xlink:to="loc_srt_MaximumMember_f377206d-faf1-45f9-9c00-d4730f585e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_10fdfe2a-6def-4c51-ae1c-197008a23976" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e5e65318-f44f-4cc7-8322-5d8cf3b12a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e5e65318-f44f-4cc7-8322-5d8cf3b12a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_54203fd4-cd75-4570-b5a7-3dd9e2849ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_54203fd4-cd75-4570-b5a7-3dd9e2849ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b8142eb4-967f-4b80-abcf-aaf14e815321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f1d50a6e-8f50-4087-85d7-4a0ef22d7dc6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b8142eb4-967f-4b80-abcf-aaf14e815321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_389bf1b9-ed6d-48a1-8b64-e86df3e8ab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_389bf1b9-ed6d-48a1-8b64-e86df3e8ab9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_63cc9d17-ede0-4ca9-895c-1bb73a0d2837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_63cc9d17-ede0-4ca9-895c-1bb73a0d2837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8ba19945-8942-4617-9da7-1f726c929bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8ba19945-8942-4617-9da7-1f726c929bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_149c9920-4505-43c6-a128-ce15c0494de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_149c9920-4505-43c6-a128-ce15c0494de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0e80a6d9-de79-401e-9fcd-ab220298bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0e80a6d9-de79-401e-9fcd-ab220298bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_f4cc1622-0802-4480-a8da-87089706a00a" xlink:href="iclr-20221231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f19b1294-d67a-471c-82cc-293f90786a62" xlink:to="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_f4cc1622-0802-4480-a8da-87089706a00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_c054f089-a4f6-46fb-815f-392aac212524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_c054f089-a4f6-46fb-815f-392aac212524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b531fc97-455c-4de8-9066-dd1ac6160d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b531fc97-455c-4de8-9066-dd1ac6160d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4d3be03f-a2ca-40bc-9dc1-951693b8e7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4d3be03f-a2ca-40bc-9dc1-951693b8e7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_c151c9e7-123b-4877-bab2-121247ff11f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_c151c9e7-123b-4877-bab2-121247ff11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bea7f3b3-0ba3-4628-9017-08ec348af4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bea7f3b3-0ba3-4628-9017-08ec348af4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_214df647-d452-4114-88ce-dacbf0d84d39" xlink:href="iclr-20221231.xsd#iclr_RestructuringReserveandOtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_iclr_RestructuringReserveandOtherLiabilitiesCurrent_214df647-d452-4114-88ce-dacbf0d84d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CapitalGovernmentGrantsCurrent_f161f65e-120d-4e49-976f-7b7da3e3f604" xlink:href="iclr-20221231.xsd#iclr_CapitalGovernmentGrantsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_iclr_CapitalGovernmentGrantsCurrent_f161f65e-120d-4e49-976f-7b7da3e3f604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_ef2c0bf2-8ba8-4c8f-8e44-73dcde91bb45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_ef2c0bf2-8ba8-4c8f-8e44-73dcde91bb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_2a1abec1-fdcf-4b61-9def-51af1be81a68" xlink:href="iclr-20221231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5266670f-2f07-43a4-91e6-88673a7dac31" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_2a1abec1-fdcf-4b61-9def-51af1be81a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bdf860e8-aaac-4ab8-a3d4-9d4b2adb04ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bdf860e8-aaac-4ab8-a3d4-9d4b2adb04ee" xlink:to="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2932731b-03ed-4e3d-a0e2-845c398b5046" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5ea18064-9125-4956-a651-cb30fb62e8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:to="loc_us-gaap_SecuredDebtMember_5ea18064-9125-4956-a651-cb30fb62e8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_af965707-083d-4066-b0e9-c27940560a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5c7ce785-ce2e-40ff-a79e-2f528faed56f" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_af965707-083d-4066-b0e9-c27940560a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a2aeb4ac-7119-4c35-b170-a4d944d49684" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_719be3f3-c263-4260-947c-66aa6d2702bc" xlink:href="iclr-20221231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:to="loc_iclr_TermLoanFacilityMember_719be3f3-c263-4260-947c-66aa6d2702bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_82755d7a-95ad-4c04-9dd1-0e3eda633891" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_78ee64c1-3eb3-406c-a290-ad23351a2795" xlink:to="loc_iclr_SeniorSecuredNotesMember_82755d7a-95ad-4c04-9dd1-0e3eda633891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08ad20c5-6240-400e-9514-1e42e4d2513a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49ed5735-68aa-4252-9be8-0b1faf9a79e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_49ed5735-68aa-4252-9be8-0b1faf9a79e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2036cf40-72a2-4030-aa3f-1999a3023332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2036cf40-72a2-4030-aa3f-1999a3023332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_9a0145c8-8e6f-4e58-b971-76d877d46d8c" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_9a0145c8-8e6f-4e58-b971-76d877d46d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_ad913953-78b2-4bf5-b7d7-49949e85b8a2" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_ad913953-78b2-4bf5-b7d7-49949e85b8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_af0dacb6-3171-4c93-8cac-d47635908b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_af0dacb6-3171-4c93-8cac-d47635908b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c4c36f74-db06-40cd-acd6-cdd4bac38301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ec038b0-5852-4747-b460-7f8006e75a82" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c4c36f74-db06-40cd-acd6-cdd4bac38301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_36818f41-e618-45c4-b800-b2741693685e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_36818f41-e618-45c4-b800-b2741693685e" xlink:to="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a8b9beb1-f1ea-499e-8e3c-9d877062dcac" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_8d0c47b0-3a2c-42ac-a455-eb42e97d1a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:to="loc_us-gaap_SecuredDebtMember_8d0c47b0-3a2c-42ac-a455-eb42e97d1a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0a9d542e-9f47-4ecf-a3a0-6b8888457aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:to="loc_us-gaap_LineOfCreditMember_0a9d542e-9f47-4ecf-a3a0-6b8888457aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_32c2306f-d1af-4a8f-8731-e9baefa90993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d6002936-8fe6-4de0-bb6c-44e62d8f9ec1" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_32c2306f-d1af-4a8f-8731-e9baefa90993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8428d7ee-197e-45f1-ad1a-254011e83c7c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5530864a-090a-482c-9d90-05e02639b5df" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_5530864a-090a-482c-9d90-05e02639b5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_284f9267-6296-4c92-80c1-b7b079c0660f" xlink:href="iclr-20221231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_TermLoanFacilityMember_284f9267-6296-4c92-80c1-b7b079c0660f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_49a92790-e644-4985-8407-84105ed55b23" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_49a92790-e644-4985-8407-84105ed55b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingCreditFacilityMember_facb6304-7b08-42b3-943f-77b648b2e0ea" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredRevolvingCreditFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredRevolvingCreditFacilityMember_facb6304-7b08-42b3-943f-77b648b2e0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_cadb977c-a888-4236-8279-660a21e4a81e" xlink:href="iclr-20221231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6383f5b5-ec20-428e-8c80-3b4a422e670c" xlink:to="loc_iclr_SeniorSecuredNotesMember_cadb977c-a888-4236-8279-660a21e4a81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_418408f5-755a-4013-98fb-2d18c89dd0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8f572f8a-df9d-495e-beb5-3921f0b15d45" xlink:to="loc_us-gaap_CreditFacilityDomain_418408f5-755a-4013-98fb-2d18c89dd0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_50ae21bb-0662-4729-8395-311ad87d4fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_418408f5-755a-4013-98fb-2d18c89dd0cd" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_50ae21bb-0662-4729-8395-311ad87d4fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentAxis_6c6d18ca-698f-45ec-8847-b97930ca8b14" xlink:to="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_c3cce110-73cb-4b98-bbb5-16e9db468052" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:to="loc_iclr_VariableRateComponentOneMember_c3cce110-73cb-4b98-bbb5-16e9db468052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_40827b4e-4e9d-45be-b379-d8e503069cab" xlink:href="iclr-20221231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_541d52a3-7d9a-4b47-a626-50a12a7c53e5" xlink:to="loc_iclr_VariableRateComponentTwoMember_40827b4e-4e9d-45be-b379-d8e503069cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_19783085-1672-4490-ac42-e8081d1f9a7f" xlink:to="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cb035806-9f03-4dfe-ab14-148d05d1ab83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cb035806-9f03-4dfe-ab14-148d05d1ab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_dfbe93b4-abdd-461e-b130-8f3118883e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_69e7c823-4443-436c-a92e-91af8e18a100" xlink:to="loc_us-gaap_BaseRateMember_dfbe93b4-abdd-461e-b130-8f3118883e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0237878c-f636-4c71-a33b-47553fdca179" xlink:to="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_72bb5090-c65a-42be-8f0d-8914d6f1bdad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:to="loc_srt_MaximumMember_72bb5090-c65a-42be-8f0d-8914d6f1bdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3abcbd14-4ec6-434a-8cb1-642ffe456d17" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_725cb223-b071-4d9d-8773-a492bddcf957" xlink:to="loc_srt_MinimumMember_3abcbd14-4ec6-434a-8cb1-642ffe456d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bac223b1-5517-4150-9e86-c6a5602570fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_205ecab1-fec5-41f6-b514-d21695c3ba7b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bac223b1-5517-4150-9e86-c6a5602570fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_6ab6f754-c3ec-4154-b2d9-aec3347e92ee" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bac223b1-5517-4150-9e86-c6a5602570fb" xlink:to="loc_iclr_PRAHealthSciencesIncMember_6ab6f754-c3ec-4154-b2d9-aec3347e92ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaea6eca-142f-4667-9ca4-0c8225abb071" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1073f57c-578e-4f63-a282-8a677524b5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1073f57c-578e-4f63-a282-8a677524b5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5d254ac6-dfa2-4d37-8e4d-4209cbbc3e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_InterestExpense_5d254ac6-dfa2-4d37-8e4d-4209cbbc3e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f3c4990c-77e1-48e1-be4d-86fa1456fd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f3c4990c-77e1-48e1-be4d-86fa1456fd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0f82138e-8d0d-408b-880c-41d77073379c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0f82138e-8d0d-408b-880c-41d77073379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_03b38be7-7809-4f9e-8df2-790e51b7a2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_03b38be7-7809-4f9e-8df2-790e51b7a2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b9a7ed56-5111-430c-9d5b-891e5bfecfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b9a7ed56-5111-430c-9d5b-891e5bfecfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_adb85169-46bb-491a-9dea-0e62e92acf20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_adb85169-46bb-491a-9dea-0e62e92acf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_bc4629fe-e119-4499-91fe-9f463de16de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_bc4629fe-e119-4499-91fe-9f463de16de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e239280b-508f-4584-911f-1a63c68cb178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_InterestPaidNet_e239280b-508f-4584-911f-1a63c68cb178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtRestructuringCosts_e091b729-3132-475e-838a-a2a3c084f762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtRestructuringCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_PaymentsOfDebtRestructuringCosts_e091b729-3132-475e-838a-a2a3c084f762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_b4a40ad3-f0a3-44f1-a6e3-365fa5895321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c6f8811-af45-4f95-bd8b-2ab1e89d460c" xlink:to="loc_us-gaap_LongTermDebtFairValue_b4a40ad3-f0a3-44f1-a6e3-365fa5895321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_02ed06af-9bc0-49c3-a521-62a92742fe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_a0fdbdad-22e7-4e81-82ff-279510787414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_02ed06af-9bc0-49c3-a521-62a92742fe7e" xlink:to="loc_us-gaap_InterestExpenseDebt_a0fdbdad-22e7-4e81-82ff-279510787414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_54839583-ef3e-4355-9584-10a4db121187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_02ed06af-9bc0-49c3-a521-62a92742fe7e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_54839583-ef3e-4355-9584-10a4db121187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndOneTimeFinancingCosts_a79e8ca5-a8a7-4e42-8b37-b83a30b9f6c6" xlink:href="iclr-20221231.xsd#iclr_TransactionAndOneTimeFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_02ed06af-9bc0-49c3-a521-62a92742fe7e" xlink:to="loc_iclr_TransactionAndOneTimeFinancingCosts_a79e8ca5-a8a7-4e42-8b37-b83a30b9f6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_4d184f64-e4a1-4dd5-9578-6df7c7b55d88" xlink:href="iclr-20221231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_02ed06af-9bc0-49c3-a521-62a92742fe7e" xlink:to="loc_iclr_InterestExpenseCreditOther_4d184f64-e4a1-4dd5-9578-6df7c7b55d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ffd05541-7f41-48e5-b89f-c4b847aa3b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_02ed06af-9bc0-49c3-a521-62a92742fe7e" xlink:to="loc_us-gaap_InterestExpense_ffd05541-7f41-48e5-b89f-c4b847aa3b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_44634568-bf36-4fac-84db-22574ded98cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_44634568-bf36-4fac-84db-22574ded98cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f49e0749-9f72-40a2-9b4a-861e4a10f167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f49e0749-9f72-40a2-9b4a-861e4a10f167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_34e9daca-897c-4c29-aa7f-e6dafee68b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_34e9daca-897c-4c29-aa7f-e6dafee68b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_660aff64-129f-435c-b517-875bcb736202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_660aff64-129f-435c-b517-875bcb736202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_b7872077-1d47-48f4-be70-05e6c49fd8b8" xlink:href="iclr-20221231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_b7872077-1d47-48f4-be70-05e6c49fd8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_528ffd3c-82eb-4cbd-a516-b90becb707eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8d6735bb-c510-421e-834f-20a4d4aee8a7" xlink:to="loc_us-gaap_LongTermDebt_528ffd3c-82eb-4cbd-a516-b90becb707eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DerivativesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_23dea3c0-8a3b-4b44-93e4-8ebd52598c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_23dea3c0-8a3b-4b44-93e4-8ebd52598c91" xlink:to="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0be2096c-0ed9-4c9a-bbc7-066fe62e0bed" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_922159af-098d-46bb-b9b0-3ee3a2fea000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:to="loc_us-gaap_InterestRateCapMember_922159af-098d-46bb-b9b0-3ee3a2fea000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b0262ede-515f-46e6-936d-8d911efe3760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8782694f-7ccd-48a1-a84a-d76fbe010c92" xlink:to="loc_us-gaap_InterestRateSwapMember_b0262ede-515f-46e6-936d-8d911efe3760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_191f0345-d529-440a-8f83-5f0f2b664d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_17210948-8e1f-4df0-b382-9df8066ef806" xlink:to="loc_us-gaap_HedgingDesignationDomain_191f0345-d529-440a-8f83-5f0f2b664d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87305ad1-961e-4320-8e5d-c1ef083f887f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_191f0345-d529-440a-8f83-5f0f2b664d1b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_87305ad1-961e-4320-8e5d-c1ef083f887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2b2927e3-2d4d-4d5f-a987-646fb0758dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_20749677-6c1e-4083-b94e-11efece5d7e8" xlink:to="loc_us-gaap_VariableRateDomain_2b2927e3-2d4d-4d5f-a987-646fb0758dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_32f3ae6e-ae35-4a2c-946e-bcd159413237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_2b2927e3-2d4d-4d5f-a987-646fb0758dc2" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_32f3ae6e-ae35-4a2c-946e-bcd159413237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9868f457-9eee-448a-9b65-fb6e4680e26b" xlink:to="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_9fbe5327-0c61-4255-9882-cb0519a22132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_9fbe5327-0c61-4255-9882-cb0519a22132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3f4489ea-3daa-459d-9c2b-d0b701f253eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3f4489ea-3daa-459d-9c2b-d0b701f253eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_beedd0df-6791-48a8-becd-c63d0c71cb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_beedd0df-6791-48a8-becd-c63d0c71cb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_e3e85de6-09b3-4495-8800-f1d090f1c446" xlink:href="iclr-20221231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_e3e85de6-09b3-4495-8800-f1d090f1c446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_63152ef7-0b7c-4ecb-9089-3c2b7772e0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_63152ef7-0b7c-4ecb-9089-3c2b7772e0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_69a0c49a-3730-4c0c-97b4-4d7ca71009f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_69a0c49a-3730-4c0c-97b4-4d7ca71009f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0e4674a4-1572-4f3b-a42b-a3ddb09021a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0e4674a4-1572-4f3b-a42b-a3ddb09021a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_1de7207f-583b-4afd-a963-afe863e679f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_1de7207f-583b-4afd-a963-afe863e679f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_c88e6e45-cd9d-46ac-89e0-c09334512980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14bb1e63-a222-4884-adc6-1e212440fa14" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_c88e6e45-cd9d-46ac-89e0-c09334512980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3033f993-fd3c-45c0-b29c-fa998fcfadc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3033f993-fd3c-45c0-b29c-fa998fcfadc1" xlink:to="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7e0f3a4c-da9b-4131-846b-cd9373c398c8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_37c6fed1-9b88-4f27-9b67-eecf7977708b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:to="loc_us-gaap_InterestRateCapMember_37c6fed1-9b88-4f27-9b67-eecf7977708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_dbe01886-64c2-471e-9f92-7146d1bef8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:to="loc_us-gaap_InterestRateSwapMember_dbe01886-64c2-471e-9f92-7146d1bef8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_251736cf-d6bd-4def-9fb3-e9b0635b824c" xlink:href="iclr-20221231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8fa2f8ee-1327-45f2-9f29-37ee3fd9f532" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_251736cf-d6bd-4def-9fb3-e9b0635b824c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:to="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b7e71c55-257d-48a3-880d-39f9af308d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b910fcbd-3546-44bb-bc74-a0548940f015" xlink:to="loc_us-gaap_HedgingDesignationDomain_b7e71c55-257d-48a3-880d-39f9af308d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_308ff10e-82a8-4c87-a21a-8f4295254360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b7e71c55-257d-48a3-880d-39f9af308d80" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_308ff10e-82a8-4c87-a21a-8f4295254360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_07894587-10ce-4ee5-ba25-9fb7fce32075" xlink:to="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8f9e8351-1852-4aaa-9773-6027a93a309e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeAssets_8f9e8351-1852-4aaa-9773-6027a93a309e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cf0962d4-d2e0-4b39-b831-1e4617ae9537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeLiabilities_cf0962d4-d2e0-4b39-b831-1e4617ae9537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d23d0e46-c20c-40e8-8182-08dc76beb3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9b4595a3-35f6-4120-8352-20f7ecada9dc" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d23d0e46-c20c-40e8-8182-08dc76beb3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_23453f7e-307d-467a-8325-500c6dd82ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e70fd83d-4f3e-4205-9f50-ee0395a6dd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_23453f7e-307d-467a-8325-500c6dd82ea4" xlink:to="loc_us-gaap_OperatingLeaseCost_e70fd83d-4f3e-4205-9f50-ee0395a6dd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_265ea3c0-7efc-4126-9f7e-02801b83b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_23453f7e-307d-467a-8325-500c6dd82ea4" xlink:to="loc_us-gaap_SubleaseIncome_265ea3c0-7efc-4126-9f7e-02801b83b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_3c62f5cf-e87b-4533-a491-4f9368b23965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_23453f7e-307d-467a-8325-500c6dd82ea4" xlink:to="loc_us-gaap_LeaseCost_3c62f5cf-e87b-4533-a491-4f9368b23965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ccdf8baa-83b5-42bc-bc21-6c938ab7f787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ccdf8baa-83b5-42bc-bc21-6c938ab7f787" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16c13cc4-ffb2-4343-97ca-8643812787a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b48fd35a-c162-4a0f-851e-33b7e15172f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b48fd35a-c162-4a0f-851e-33b7e15172f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c796d0b0-f05b-4ce2-9507-4903c6734967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8e417ca9-eac9-402f-bf08-83f3b39f3056" xlink:to="loc_us-gaap_CostOfSalesMember_c796d0b0-f05b-4ce2-9507-4903c6734967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_883c0f68-caca-478a-82da-71b1aa91aaaa" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5dd06af5-baf4-42e7-8301-cf1b13462473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_LeaseCost_5dd06af5-baf4-42e7-8301-cf1b13462473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c086ac18-bbb7-404e-b916-dddf1e3bbf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c086ac18-bbb7-404e-b916-dddf1e3bbf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_61b5403f-cf73-4b8d-817c-297c8cbee6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_61b5403f-cf73-4b8d-817c-297c8cbee6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5244d81b-7b5e-4608-98e2-ca3ed0dc0621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5244d81b-7b5e-4608-98e2-ca3ed0dc0621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_537a18d6-5c78-437d-8d05-11b510fb9f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_537a18d6-5c78-437d-8d05-11b510fb9f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7aa2c21a-59a2-4685-9c7f-034c11b35dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7aa2c21a-59a2-4685-9c7f-034c11b35dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7615dbb4-24eb-4bfc-993a-1ef0f62edc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_4bddf2e7-adc2-478c-8431-d57fb252e713" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_7615dbb4-24eb-4bfc-993a-1ef0f62edc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_edc0919c-6405-4735-a25b-1f0e5842f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_edc0919c-6405-4735-a25b-1f0e5842f3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_29c0527b-d5ac-4daa-a985-be0d688ecd92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_29c0527b-d5ac-4daa-a985-be0d688ecd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0be916aa-f2a2-4eee-b2b7-47badcc46b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0be916aa-f2a2-4eee-b2b7-47badcc46b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fe055f05-af1e-413d-832b-ad626dd6c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fe055f05-af1e-413d-832b-ad626dd6c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e5ff2cc6-e2aa-4486-95c1-9cc5620806b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e5ff2cc6-e2aa-4486-95c1-9cc5620806b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_912d59da-91bc-4125-bee5-b1ceeec3a124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_912d59da-91bc-4125-bee5-b1ceeec3a124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_67601ea0-c2ef-4aec-94ec-868e8ceab555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_67601ea0-c2ef-4aec-94ec-868e8ceab555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bf06e1e1-f656-475c-a4a5-477b03083484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bf06e1e1-f656-475c-a4a5-477b03083484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_684ed89f-6b2b-4122-abec-054fdb669dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77abbe50-885b-48c1-a32d-4d218d4f1a75" xlink:to="loc_us-gaap_OperatingLeaseLiability_684ed89f-6b2b-4122-abec-054fdb669dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20221231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NoncurrentotherliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_a322cb58-8104-426a-a0d3-2279fd2ac7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_d2e2d0b7-504b-43ee-a209-2b5cf97580cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_a322cb58-8104-426a-a0d3-2279fd2ac7b8" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_d2e2d0b7-504b-43ee-a209-2b5cf97580cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_ca8825df-b8a6-4799-9090-06c16d07fa48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_a322cb58-8104-426a-a0d3-2279fd2ac7b8" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_ca8825df-b8a6-4799-9090-06c16d07fa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_14f58215-8f56-456c-b9fa-4f9d5876cd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_a322cb58-8104-426a-a0d3-2279fd2ac7b8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_14f58215-8f56-456c-b9fa-4f9d5876cd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80e29b56-e7bc-4673-a59f-57838aedfa46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7660959a-2efb-4124-8f42-ce6e41bfd4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80e29b56-e7bc-4673-a59f-57838aedfa46" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7660959a-2efb-4124-8f42-ce6e41bfd4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#ShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_63c3573b-fb2f-4999-9c91-bcdd4c867ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_63c3573b-fb2f-4999-9c91-bcdd4c867ab1" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_469cb25c-1f3c-4c4a-b0e8-0fac4a51eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_99d025ac-62a9-4c22-be92-330d5e6394f5" xlink:to="loc_us-gaap_EquityComponentDomain_469cb25c-1f3c-4c4a-b0e8-0fac4a51eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38d02292-6b03-4155-ae56-a8227265a16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_469cb25c-1f3c-4c4a-b0e8-0fac4a51eedc" xlink:to="loc_us-gaap_CommonStockMember_38d02292-6b03-4155-ae56-a8227265a16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3cf7334c-8d81-4305-8a75-ce35efa9f116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1c82a62a-0fda-443a-8c9e-5adfac4c92a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1c82a62a-0fda-443a-8c9e-5adfac4c92a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_664f7204-d4c6-4eb1-9c03-b03b7560fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_664f7204-d4c6-4eb1-9c03-b03b7560fccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_387aa35a-fd5a-4e52-812a-ebfc126dbaeb" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf57cffa-9125-44a5-a607-1d17bbe6f02e" xlink:to="loc_iclr_PerformanceShareUnitMember_387aa35a-fd5a-4e52-812a-ebfc126dbaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec64e478-af36-4362-b8a7-361b134ed9e8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_75332553-1934-4230-8697-82e5eb2864c6" xlink:to="loc_srt_RangeMember_ec64e478-af36-4362-b8a7-361b134ed9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0166e392-8261-4334-a635-d75ae433bb71" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec64e478-af36-4362-b8a7-361b134ed9e8" xlink:to="loc_srt_MaximumMember_0166e392-8261-4334-a635-d75ae433bb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7a7d10f3-8062-4f45-8b50-e71e83db9833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d153f1d3-6c15-4404-ac44-ed951ff279b2" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7a7d10f3-8062-4f45-8b50-e71e83db9833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_9312b5e3-c7d5-4d14-bd9a-0b7fae3bcf63" xlink:href="iclr-20221231.xsd#iclr_BuybackProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7a7d10f3-8062-4f45-8b50-e71e83db9833" xlink:to="loc_iclr_BuybackProgramMember_9312b5e3-c7d5-4d14-bd9a-0b7fae3bcf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_75d5a0f7-cf75-4351-a095-3e38ae09461e" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_77197547-9299-41f1-9752-b64d04fcfe65" xlink:href="iclr-20221231.xsd#iclr_NumberOfVotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_iclr_NumberOfVotes_77197547-9299-41f1-9752-b64d04fcfe65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b575e512-9113-44fa-b1f2-a9c636487e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b575e512-9113-44fa-b1f2-a9c636487e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5f362b16-d591-4996-bd3b-01923d4062f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_5f362b16-d591-4996-bd3b-01923d4062f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b1858688-8a56-458f-aa4f-781a29f16a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b1858688-8a56-458f-aa4f-781a29f16a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6c5d5c28-ef91-42f9-992b-f99e8688e68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6c5d5c28-ef91-42f9-992b-f99e8688e68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a3071e99-ac71-4ecb-9663-c31b3d1b44f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a3071e99-ac71-4ecb-9663-c31b3d1b44f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_faa36186-1b0d-4a29-91b6-54311296efb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_faa36186-1b0d-4a29-91b6-54311296efb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_d36e70e8-dde0-4c5a-97bf-8cac441dbf46" xlink:href="iclr-20221231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_d36e70e8-dde0-4c5a-97bf-8cac441dbf46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_94221617-ddf3-4679-a0b3-d79a4beaad35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_94221617-ddf3-4679-a0b3-d79a4beaad35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0bc6f279-3cc6-425a-9401-4dc28640d79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_0bc6f279-3cc6-425a-9401-4dc28640d79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_49ecb8a4-660d-43c5-a117-d649d79ec376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_49ecb8a4-660d-43c5-a117-d649d79ec376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_413485b4-debb-47b1-a07e-3f311754d1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_d7b459d1-6b63-463a-a059-072ec80e5834" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_413485b4-debb-47b1-a07e-3f311754d1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c176fae8-db38-4d9c-acc2-f042e2818f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c176fae8-db38-4d9c-acc2-f042e2818f7c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_7301ad62-6210-4f31-8213-e07d40e6c5b2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LeaseLiabilityMember_662ab753-f6ce-40d6-9b69-61994e1ad317" xlink:href="iclr-20221231.xsd#iclr_LeaseLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:to="loc_iclr_LeaseLiabilityMember_662ab753-f6ce-40d6-9b69-61994e1ad317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4cbe6cce-8a96-41b4-acbb-513912e15d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_27d4be7c-71cd-4877-96c2-cb5588a5c680" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4cbe6cce-8a96-41b4-acbb-513912e15d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:to="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_66ee49b3-4d6f-4bf4-a588-576ebc7c8d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_5675130d-78be-4973-9392-8ca70b8080a6" xlink:to="loc_us-gaap_RestructuringPlanDomain_66ee49b3-4d6f-4bf4-a588-576ebc7c8d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2021RestructuringPlanMember_a9e6d479-b551-4ae6-b674-a0a7b58fa399" xlink:href="iclr-20221231.xsd#iclr_A2021RestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_66ee49b3-4d6f-4bf4-a588-576ebc7c8d1c" xlink:to="loc_iclr_A2021RestructuringPlanMember_a9e6d479-b551-4ae6-b674-a0a7b58fa399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d3ab1d00-10d4-4ac8-8fdc-ff9630d2fcdd" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0a9988da-0612-4930-8da7-bbe914531559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringCosts_0a9988da-0612-4930-8da7-bbe914531559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_dc25ca38-aa51-4db7-b3f5-812ec8c4445a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_SeveranceCosts1_dc25ca38-aa51-4db7-b3f5-812ec8c4445a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_4b6912f4-9898-49e1-b4f7-14890ce30eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_OtherRestructuringCosts_4b6912f4-9898-49e1-b4f7-14890ce30eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_ced7f4c0-100d-4443-9573-bca9da28eb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_ced7f4c0-100d-4443-9573-bca9da28eb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_0eedfa03-2a2b-4451-b4c9-4654f97414fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringReserve_0eedfa03-2a2b-4451-b4c9-4654f97414fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_dd5223e7-4321-4fa4-a089-fd955226a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringReserveCurrent_dd5223e7-4321-4fa4-a089-fd955226a1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_be49dea8-cb59-421f-a8a4-6681d5d3f542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d7828022-6729-4123-9b79-faf6226b6ced" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_be49dea8-cb59-421f-a8a4-6681d5d3f542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#RestructuringchargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3e5d0b0f-6115-47c0-aacd-1ade561c1d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_28f5b6e7-e04e-46f1-95cd-da6778bd53da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3e5d0b0f-6115-47c0-aacd-1ade561c1d6f" xlink:to="loc_us-gaap_RestructuringCosts_28f5b6e7-e04e-46f1-95cd-da6778bd53da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#RestructuringchargesRestructuringProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_02b321cf-0a6f-4291-bf9f-b5010ec1e4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_698ac9df-8aa6-42dd-93e7-b6f5e310b27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_02b321cf-0a6f-4291-bf9f-b5010ec1e4a5" xlink:to="loc_us-gaap_RestructuringReserveRollForward_698ac9df-8aa6-42dd-93e7-b6f5e310b27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4090863f-538a-4a6f-b85a-0532535051f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_698ac9df-8aa6-42dd-93e7-b6f5e310b27b" xlink:to="loc_us-gaap_RestructuringReserve_4090863f-538a-4a6f-b85a-0532535051f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e74287d8-3706-4615-99c8-be36e9506801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_698ac9df-8aa6-42dd-93e7-b6f5e310b27b" xlink:to="loc_us-gaap_RestructuringCharges_e74287d8-3706-4615-99c8-be36e9506801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations_3e6ddbba-d2fc-4511-baf1-68e7a8cbac34" xlink:href="iclr-20221231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_698ac9df-8aa6-42dd-93e7-b6f5e310b27b" xlink:to="loc_iclr_RestructuringReserveUtilizations_3e6ddbba-d2fc-4511-baf1-68e7a8cbac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b9bda303-9ed4-4feb-a8fa-4fb1c72a27b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_698ac9df-8aa6-42dd-93e7-b6f5e310b27b" xlink:to="loc_us-gaap_RestructuringReserve_b9bda303-9ed4-4feb-a8fa-4fb1c72a27b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7892d558-c468-42cf-b74b-558059549407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7892d558-c468-42cf-b74b-558059549407" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:to="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_cca52f75-18be-4645-b1e6-ab820e02a172" xlink:to="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_1dc06cd3-c0a1-491a-b068-0a23316e1789" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:to="loc_country_IE_1dc06cd3-c0a1-491a-b068-0a23316e1789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a7cbc58b-46c3-49a1-96da-106d27081fd4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:to="loc_country_US_a7cbc58b-46c3-49a1-96da-106d27081fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_1acee2d4-e6e6-457d-8eb8-06093b782b30" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dfd2e4a0-7640-49ed-b59e-55fc415acf22" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_1acee2d4-e6e6-457d-8eb8-06093b782b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_474cef3f-8089-42e0-83df-612efc4514d6" xlink:href="iclr-20221231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_37a24165-b812-4681-85f4-9e38c7a81762" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_474cef3f-8089-42e0-83df-612efc4514d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_195a238f-ac8f-4e1d-a514-7d6300248ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_474cef3f-8089-42e0-83df-612efc4514d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_195a238f-ac8f-4e1d-a514-7d6300248ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bdfaadbe-37fd-433f-b0ed-7d4ed0904ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:href="iclr-20221231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bdfaadbe-37fd-433f-b0ed-7d4ed0904ce5" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:to="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a6724490-88da-4abd-ae13-9a5c6455f75c" xlink:to="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_ec6f9d96-d2c7-40b6-88cb-f0542d2d3498" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:to="loc_country_IE_ec6f9d96-d2c7-40b6-88cb-f0542d2d3498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dd5d5f70-4d09-4e28-affa-1cf190b9ad01" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:to="loc_country_US_dd5d5f70-4d09-4e28-affa-1cf190b9ad01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_260dbbf0-4634-4f83-8a96-ee7683fe9769" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_668954aa-2b78-4a8f-804d-6a294a32cae2" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_260dbbf0-4634-4f83-8a96-ee7683fe9769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:href="iclr-20221231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_aecde94f-6bc2-4f18-89c5-3be0f6bd4375" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c422c1d9-760d-46fb-bbc8-4b1423bd7c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c422c1d9-760d-46fb-bbc8-4b1423bd7c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_df7eed63-7b24-475a-8682-d4bdecdf7de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c422c1d9-760d-46fb-bbc8-4b1423bd7c6e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_df7eed63-7b24-475a-8682-d4bdecdf7de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8413ddd5-a150-496a-baa3-2bf9086bbe5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8413ddd5-a150-496a-baa3-2bf9086bbe5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2a446c63-1b12-4fc7-8789-3550fd5373fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8413ddd5-a150-496a-baa3-2bf9086bbe5d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2a446c63-1b12-4fc7-8789-3550fd5373fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_41868fc5-7c2f-4455-9843-8dc84f20c0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_af7b9261-6e2e-4535-95c3-1ea03ef68e39" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_41868fc5-7c2f-4455-9843-8dc84f20c0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9728c70a-1482-4189-aa52-793442ed7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9728c70a-1482-4189-aa52-793442ed7b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_9e01f380-24a2-42d4-adf6-e5afe315b54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_9728c70a-1482-4189-aa52-793442ed7b0c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_9e01f380-24a2-42d4-adf6-e5afe315b54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_6c7e6a89-4071-401b-9996-b740b365234f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_26d36350-6da3-4cde-a053-4857b90e2da2" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_6c7e6a89-4071-401b-9996-b740b365234f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8d61321e-6bb4-4f72-b244-b42755249100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8d61321e-6bb4-4f72-b244-b42755249100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_6026d1c9-b823-43cc-85c0-4f76c35daa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_6026d1c9-b823-43cc-85c0-4f76c35daa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_85fc4e9d-d308-4899-a627-36fec497d704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_85fc4e9d-d308-4899-a627-36fec497d704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c131ae8b-7871-4ea8-948f-5083556e8a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c131ae8b-7871-4ea8-948f-5083556e8a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_39afc967-8527-41d4-9bd5-cf31e5ddf81b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_39afc967-8527-41d4-9bd5-cf31e5ddf81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_59f994c1-d32b-4f88-b33e-f5cb0c268c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_59f994c1-d32b-4f88-b33e-f5cb0c268c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_46f12719-349b-4753-937a-bb53dbf7ac93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_46f12719-349b-4753-937a-bb53dbf7ac93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f71207cc-e00c-4afa-8404-792f44418c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f71207cc-e00c-4afa-8404-792f44418c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_0e4b19a2-1c33-4e55-bc7d-ceda9128c060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_0e4b19a2-1c33-4e55-bc7d-ceda9128c060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6bc943e5-9651-4fd9-90db-8e30dc0d5db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7e91f28d-1c4f-4889-9416-e2bac1d01ff8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6bc943e5-9651-4fd9-90db-8e30dc0d5db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9fadc1c5-fd33-44e3-bcb2-d0239c5948a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9fadc1c5-fd33-44e3-bcb2-d0239c5948a5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f6bbe8c5-2d88-44ef-9b36-8e5ec1f4e271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_f6bbe8c5-2d88-44ef-9b36-8e5ec1f4e271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ce1a021a-cd0a-47f6-98a6-ac719c5a957d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ce1a021a-cd0a-47f6-98a6-ac719c5a957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_6383c7c8-a029-4fe8-b5fc-85deaa6043ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_6383c7c8-a029-4fe8-b5fc-85deaa6043ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_05b44be7-ba96-4689-987c-a841ab1a5a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_05b44be7-ba96-4689-987c-a841ab1a5a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_bab7d248-f7c6-4eb5-831e-6b68a803391c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_bab7d248-f7c6-4eb5-831e-6b68a803391c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_d8e1899d-8087-499c-a20a-dcd26e3c72e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_97d89079-21fd-41f7-8d9d-2907ad23337c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_d8e1899d-8087-499c-a20a-dcd26e3c72e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9fadc1c5-fd33-44e3-bcb2-d0239c5948a5" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_f9e49b7c-0e80-4bc2-a9b3-4e35bc889be7" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_f9e49b7c-0e80-4bc2-a9b3-4e35bc889be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_d0d0928b-8859-43ba-bc1b-ca3caa0e5b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_d0d0928b-8859-43ba-bc1b-ca3caa0e5b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_d9db8d7b-e74b-483d-91d9-832d8c377b7b" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_d9db8d7b-e74b-483d-91d9-832d8c377b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4f226b9a-2a3f-4d3d-a70b-3a7b66a174d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4f226b9a-2a3f-4d3d-a70b-3a7b66a174d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5ce9e4e3-eacb-4874-8246-02bbe9811159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_5ce9e4e3-eacb-4874-8246-02bbe9811159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_548dba00-1bf9-4d2c-9b5c-9cd6c8add438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_548dba00-1bf9-4d2c-9b5c-9cd6c8add438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_310a82a5-a26b-4267-8504-e5338f777968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_310a82a5-a26b-4267-8504-e5338f777968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_ed1edcdf-a2f0-4a78-9b61-3d0ee47cc81f" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_ed1edcdf-a2f0-4a78-9b61-3d0ee47cc81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_8be730cb-d6df-4d8c-9e64-46fd8b731d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_8be730cb-d6df-4d8c-9e64-46fd8b731d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a5682b95-1aaa-411f-8ccc-88125977e348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a5682b95-1aaa-411f-8ccc-88125977e348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7000b043-d263-4124-a161-865f5b9f2e30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7000b043-d263-4124-a161-865f5b9f2e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f9a1c100-7db0-4281-b79c-71df65aa89ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_f9a1c100-7db0-4281-b79c-71df65aa89ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e233553e-8913-4ed9-8172-15c5e162059b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_9ef4db91-f65f-44d7-bf51-2340df238c12" xlink:to="loc_us-gaap_DeferredTaxLiabilities_e233553e-8913-4ed9-8172-15c5e162059b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9148ebcb-7f7d-44c5-b4cf-b0498f71732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9148ebcb-7f7d-44c5-b4cf-b0498f71732e" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0c990b0d-eabb-4829-b77c-be330cd0c63f" xlink:to="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_dddc804e-d004-435e-b497-bbf194360f79" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:to="loc_country_IE_dddc804e-d004-435e-b497-bbf194360f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7966648f-c3d2-4ce1-b9af-89a3a88617c2" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:to="loc_country_US_7966648f-c3d2-4ce1-b9af-89a3a88617c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_5c05a9ae-a415-48e6-8b75-8b26c33c9d6d" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_82e650db-28a2-4464-9566-22233de0c35f" xlink:to="loc_iclr_OtherCountriesMember_5c05a9ae-a415-48e6-8b75-8b26c33c9d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_198f4381-e8ae-480c-bd5a-72d03c8f7ca9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_4bf12008-1e86-457c-ba16-641c69505f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:to="loc_us-gaap_ForeignCountryMember_4bf12008-1e86-457c-ba16-641c69505f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3356de26-a165-4684-b5ce-00a3b3830dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_513a2e68-f253-4b03-b100-11b23a89943b" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3356de26-a165-4684-b5ce-00a3b3830dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8608dc73-2694-477f-a7b8-723952213580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_79e19a58-dbc4-4212-98dc-61aa58976ba1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8608dc73-2694-477f-a7b8-723952213580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_48e80d44-8129-4262-a4e2-82c651b5d44d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_8608dc73-2694-477f-a7b8-723952213580" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_48e80d44-8129-4262-a4e2-82c651b5d44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_e84ce63f-0829-4eaf-947c-e0e0935c2b78" xlink:to="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2022To2028Member_f5a6cb0e-d8f1-4031-b895-01747ffc74c0" xlink:href="iclr-20221231.xsd#iclr_TaxYear2022To2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:to="loc_iclr_TaxYear2022To2028Member_f5a6cb0e-d8f1-4031-b895-01747ffc74c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2029To2038Member_ab2e5eab-df0c-4209-94dd-e744a15191f2" xlink:href="iclr-20221231.xsd#iclr_TaxYear2029To2038Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_b4ed106e-e92d-4246-b24d-83b7073066a3" xlink:to="loc_iclr_TaxYear2029To2038Member_ab2e5eab-df0c-4209-94dd-e744a15191f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_373f32f0-7e67-4f31-ad80-df5df1fcad44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b68ec940-a9e6-4d08-b5f4-7191a24de067" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_373f32f0-7e67-4f31-ad80-df5df1fcad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_636db7c3-f19a-4aee-8093-33c3eed7acaf" xlink:href="iclr-20221231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_373f32f0-7e67-4f31-ad80-df5df1fcad44" xlink:to="loc_iclr_IncomeTaxBenefitMember_636db7c3-f19a-4aee-8093-33c3eed7acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d3bcfa82-3ed4-42ce-9ee3-546096098770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_fce46144-2050-49a7-a9fc-71fca31a493d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d3bcfa82-3ed4-42ce-9ee3-546096098770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_e4da705a-e9ae-412a-9db5-2748633d9fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d3bcfa82-3ed4-42ce-9ee3-546096098770" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_e4da705a-e9ae-412a-9db5-2748633d9fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f6188d0-3752-492d-8903-919d3572eb53" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_f65fb997-6c64-43ec-8742-8b33a8b4b5d9" xlink:href="iclr-20221231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:to="loc_iclr_PRAHealthSciencesIncMember_f65fb997-6c64-43ec-8742-8b33a8b4b5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcquiredEntityMember_016361a0-e87d-4b7a-8913-e981ff85da75" xlink:href="iclr-20221231.xsd#iclr_AcquiredEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c34855c-c05b-4a3a-90f4-72269aa3d874" xlink:to="loc_iclr_AcquiredEntityMember_016361a0-e87d-4b7a-8913-e981ff85da75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_5fce23e4-6003-463a-baee-fe30df1d6276" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_83e1771f-cd6d-40c1-8e40-9d15e79d18c8" xlink:href="iclr-20221231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_83e1771f-cd6d-40c1-8e40-9d15e79d18c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9b368013-ceff-413a-a522-d977b134e010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9b368013-ceff-413a-a522-d977b134e010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingLossCarryforwardsUSFederal_6dff2b66-27ad-41e5-bfec-f163da99922f" xlink:href="iclr-20221231.xsd#iclr_OperatingLossCarryforwardsUSFederal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_iclr_OperatingLossCarryforwardsUSFederal_6dff2b66-27ad-41e5-bfec-f163da99922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_13849352-a191-4de3-8901-80ec68d104cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_OperatingLossCarryforwards_13849352-a191-4de3-8901-80ec68d104cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1cd0d40e-c3fd-4b82-a1ed-b19301debdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1cd0d40e-c3fd-4b82-a1ed-b19301debdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_4e829dba-e382-45f7-a2bc-f8a36908ad52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_4e829dba-e382-45f7-a2bc-f8a36908ad52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_470735c9-e446-4e23-9549-7b2af01c475a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_470735c9-e446-4e23-9549-7b2af01c475a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d3bcb53d-77d1-48a8-a9c0-f90657ebc27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_d3bcb53d-77d1-48a8-a9c0-f90657ebc27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_88818032-ddc1-406b-b54f-ae006c20a1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_88818032-ddc1-406b-b54f-ae006c20a1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_4c11f7c5-c876-460c-a116-104573389e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_4c11f7c5-c876-460c-a116-104573389e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_6f0a8277-6bc9-428f-a100-5a01f9417847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_6f0a8277-6bc9-428f-a100-5a01f9417847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_ae91faad-00ea-429c-87a4-c6d1ed031874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_ae91faad-00ea-429c-87a4-c6d1ed031874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30f9e3cc-d754-4217-86b4-d9956c14a2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_30f9e3cc-d754-4217-86b4-d9956c14a2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8c2b74bf-74e3-4080-8737-5fa8761e05e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_8c2b74bf-74e3-4080-8737-5fa8761e05e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b203d025-6623-44e0-8115-406eb5ff15a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_a4be72ad-2a62-4fa6-a300-edf02adca448" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b203d025-6623-44e0-8115-406eb5ff15a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b7d4b9e0-fdb8-402d-8914-a71a45d71603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b7d4b9e0-fdb8-402d-8914-a71a45d71603" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9d0d4b2-d61f-4e05-a1f7-4a23c08a71f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_dd01b20f-cbd8-48e8-b47b-f5e87e9352e6" xlink:to="loc_srt_SegmentGeographicalDomain_e9d0d4b2-d61f-4e05-a1f7-4a23c08a71f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e74b61b7-6263-4894-8c08-6adce0d51b1a" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9d0d4b2-d61f-4e05-a1f7-4a23c08a71f1" xlink:to="loc_country_US_e74b61b7-6263-4894-8c08-6adce0d51b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_edbfc97a-0d1d-4d29-8db3-70da9037844d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_30b9ce69-3709-44f0-a564-51ff0ed4ed91" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_edbfc97a-0d1d-4d29-8db3-70da9037844d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_6a7a3de6-8147-4562-9434-445a7f8b39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_edbfc97a-0d1d-4d29-8db3-70da9037844d" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_6a7a3de6-8147-4562-9434-445a7f8b39d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_06a775a9-e45b-4a10-87b2-2f0cae9a46dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ac07c11a-c825-4580-888e-02e4eb22a5b8" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_06a775a9-e45b-4a10-87b2-2f0cae9a46dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_b7b017a9-ec3d-4585-a74f-1222f83aaf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_06a775a9-e45b-4a10-87b2-2f0cae9a46dc" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_b7b017a9-ec3d-4585-a74f-1222f83aaf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_a2a9b9bf-7ce1-441d-b8c0-af6b95089307" xlink:to="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2023To2036Member_b5c6676d-efd9-4e2e-acb5-e8d841dfff11" xlink:href="iclr-20221231.xsd#iclr_TaxYear2023To2036Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:to="loc_iclr_TaxYear2023To2036Member_b5c6676d-efd9-4e2e-acb5-e8d841dfff11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20332041Member_728b518e-f0b7-4130-a278-82ac27680148" xlink:href="iclr-20221231.xsd#iclr_TaxYear20332041Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_3acf2de7-5bb4-47f3-90c7-b37362357662" xlink:to="loc_iclr_TaxYear20332041Member_728b518e-f0b7-4130-a278-82ac27680148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_656d3f4d-4b0f-47df-a300-748233093f94" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_e91bfbab-5084-4664-820f-a834bff7cdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_e91bfbab-5084-4664-820f-a834bff7cdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_01372b00-7d45-4ec8-8ce5-e5bb479bdfee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_01372b00-7d45-4ec8-8ce5-e5bb479bdfee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_10a8a28d-2c67-4de0-a9d7-794c34e08ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_379391da-3945-4d31-8514-517ba9992a0f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_10a8a28d-2c67-4de0-a9d7-794c34e08ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9f29a852-e6b8-4e89-a512-e65cb6dd74a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f29a852-e6b8-4e89-a512-e65cb6dd74a2" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4c2f8c62-7969-4a4e-a15b-29a1c33eb648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4c2f8c62-7969-4a4e-a15b-29a1c33eb648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_fd87871b-ad46-485a-962d-6bb0219563b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_fd87871b-ad46-485a-962d-6bb0219563b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d748749d-2940-4a05-b7ff-104a719c0598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d748749d-2940-4a05-b7ff-104a719c0598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_9f94655b-32ef-4ad5-9162-f3db502c9050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_9f94655b-32ef-4ad5-9162-f3db502c9050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_51067e54-2197-4552-8cd0-9bf9673523bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_51067e54-2197-4552-8cd0-9bf9673523bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_09ee7f14-909f-4a44-ac15-78aabfefc01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_09ee7f14-909f-4a44-ac15-78aabfefc01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_8410dffd-f82f-4aff-9acf-a9280ccea050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_8410dffd-f82f-4aff-9acf-a9280ccea050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_222be76f-82fe-45a4-a258-c86d18e54fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64b40d8c-360b-44cb-8d08-575829596247" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_222be76f-82fe-45a4-a258-c86d18e54fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2d6c03ef-479e-4fd8-becb-ea8cc1d4fea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2d6c03ef-479e-4fd8-becb-ea8cc1d4fea6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_bac763ad-189a-41bf-83f7-4511d5be4f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_b072a3b1-c0ae-4c16-9f27-6c272b3462f5" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_bac763ad-189a-41bf-83f7-4511d5be4f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_bac763ad-189a-41bf-83f7-4511d5be4f32" xlink:to="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3e536070-bb4b-414d-b1c1-0b0e7cb0887d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:to="loc_country_US_3e536070-bb4b-414d-b1c1-0b0e7cb0887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_d41aa8b4-abe3-4580-a26b-db1c543519a0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:to="loc_country_GB_d41aa8b4-abe3-4580-a26b-db1c543519a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_9f66a933-c6b9-4945-a155-7884999a2031" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5900f1ea-f160-49ba-a9cf-652350ce48a2" xlink:to="loc_country_CH_9f66a933-c6b9-4945-a155-7884999a2031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_f16d1f73-ab40-4c1a-8b7d-0630ef9c2191" xlink:to="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherRetirementPlansMember_f4ec804c-08a5-4116-a2b9-4290f5ad1667" xlink:href="iclr-20221231.xsd#iclr_OtherRetirementPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_OtherRetirementPlansMember_f4ec804c-08a5-4116-a2b9-4290f5ad1667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c7134086-5219-45a3-89a0-198132dd6ec3" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_c7134086-5219-45a3-89a0-198132dd6ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_f03996a8-672b-4277-be50-9fa568dded76" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_f03996a8-672b-4277-be50-9fa568dded76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_00fa4971-5c91-496f-849f-59791a0a750d" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_4a80780c-43f2-4e6b-8521-ee8af54a4642" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_00fa4971-5c91-496f-849f-59791a0a750d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dd53a8f-4231-459b-bb0f-32666537186a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87091c16-26bb-4cf9-86ed-43e675040443" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dd53a8f-4231-459b-bb0f-32666537186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsMember_5a598da9-91f5-4a15-8b72-dfef0cbcc87e" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8dd53a8f-4231-459b-bb0f-32666537186a" xlink:to="loc_iclr_AptivSolutionsMember_5a598da9-91f5-4a15-8b72-dfef0cbcc87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e401134f-d736-4c51-b49d-8a24605540a5" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_17943502-3f87-4fe1-89c0-61a8688865f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_17943502-3f87-4fe1-89c0-61a8688865f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_fe9725f1-0dfe-498d-b7a5-82083aea1a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_fe9725f1-0dfe-498d-b7a5-82083aea1a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d932d79d-acd9-4074-bb87-995be42911de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d932d79d-acd9-4074-bb87-995be42911de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_7d791474-7c0d-4aca-a541-57f41cb6a063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear_7d791474-7c0d-4aca-a541-57f41cb6a063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_2c23d354-9bae-466e-bd18-4fd12f6110a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear_2c23d354-9bae-466e-bd18-4fd12f6110a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a8681088-ba05-4599-8baf-e90ec187fdbf" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod_a8681088-ba05-4599-8baf-e90ec187fdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_70aaf94e-caa4-4f75-83b5-b3f0b5651340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_70aaf94e-caa4-4f75-83b5-b3f0b5651340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_77573063-a75c-4b3e-a54b-b4850958823c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_77573063-a75c-4b3e-a54b-b4850958823c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ExpectedRetirementPeriod_54a4153f-f979-4cf9-a0bd-09cea7f0cee5" xlink:href="iclr-20221231.xsd#iclr_ExpectedRetirementPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_iclr_ExpectedRetirementPeriod_54a4153f-f979-4cf9-a0bd-09cea7f0cee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7b4aff03-2d63-4c4e-9ec1-a8daa62e832d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7b4aff03-2d63-4c4e-9ec1-a8daa62e832d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_478be0ad-7bf9-4edc-8792-64b99f15fae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f771490-0c50-4a21-8fbb-ac34cb577b9b" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_478be0ad-7bf9-4edc-8792-64b99f15fae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6a9b85ed-668b-4b27-94f0-2fe6d34364dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6a9b85ed-668b-4b27-94f0-2fe6d34364dd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a4498d11-c50b-49c0-af4d-eedaea88427c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b0de56e3-14c2-47fd-8366-be20fcb3c744" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a4498d11-c50b-49c0-af4d-eedaea88427c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a2cbbd79-a99d-45ec-a144-d67baef10701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a4498d11-c50b-49c0-af4d-eedaea88427c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a2cbbd79-a99d-45ec-a144-d67baef10701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a6894a08-741d-4371-bc18-26fb99e27809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ff2f96df-87b6-4bd8-88ca-251454cf8802" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a6894a08-741d-4371-bc18-26fb99e27809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_f6fa8045-b5a8-4e9d-ba7e-54d545a2d1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a6894a08-741d-4371-bc18-26fb99e27809" xlink:to="loc_us-gaap_ForeignPlanMember_f6fa8045-b5a8-4e9d-ba7e-54d545a2d1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_18a8fbac-15ee-4f86-add1-4f02e81067d2" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_f6fa8045-b5a8-4e9d-ba7e-54d545a2d1e2" xlink:to="loc_country_US_18a8fbac-15ee-4f86-add1-4f02e81067d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d1083a84-dbdb-49d4-92b2-84c0bc0bf01d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7327bbb1-9e2e-4fd9-8452-c7a6a938d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_7327bbb1-9e2e-4fd9-8452-c7a6a938d8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6fd2b8ad-fa92-49d6-93a0-5d88eaa2f8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_8c055360-1677-48e3-9034-36f09c6069ff" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6fd2b8ad-fa92-49d6-93a0-5d88eaa2f8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_20c3d319-fbf0-4f06-a5d2-04ff54eea638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_20c3d319-fbf0-4f06-a5d2-04ff54eea638" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_22a2ae85-caaa-492e-833b-8a3112b1a5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_d6dabd1f-f53d-4d69-9085-08156e770c22" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_22a2ae85-caaa-492e-833b-8a3112b1a5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_22a2ae85-caaa-492e-833b-8a3112b1a5fd" xlink:to="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_c9f4aa88-7dad-4b58-8803-7cc73c4e5415" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:to="loc_country_GB_c9f4aa88-7dad-4b58-8803-7cc73c4e5415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_e0ea818a-73fd-4b9d-9f80-80a2c15cac2b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_1c800eb5-665c-481e-859f-d484ebc7c256" xlink:to="loc_country_CH_e0ea818a-73fd-4b9d-9f80-80a2c15cac2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:to="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_6cba35fa-5147-46b3-89e0-851e272a4e55" xlink:to="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_cf13aafe-ceaa-4b8d-b2da-5304e8aab91d" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_cf13aafe-ceaa-4b8d-b2da-5304e8aab91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_749353cf-f367-4bdc-b72f-9ce971a6e47b" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_749353cf-f367-4bdc-b72f-9ce971a6e47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_cf332ca4-1a03-468a-92ff-5ae512e59943" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_163776de-dbac-4244-a10b-c3bff254c2f9" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_cf332ca4-1a03-468a-92ff-5ae512e59943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f0d5ff56-78ff-4d59-8ea8-2575a6afc8fd" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_07d12d47-d938-4c64-beb6-bfb5f9905e53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_07d12d47-d938-4c64-beb6-bfb5f9905e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_951fabc9-638f-4f7a-b772-e5528abb8797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_951fabc9-638f-4f7a-b772-e5528abb8797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ca84f7e0-1dbc-4a80-91c2-8d12845b8a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a7b5370a-cc8b-4523-904c-50b0e32c83ce" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ca84f7e0-1dbc-4a80-91c2-8d12845b8a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsChangeinBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fa7626b7-7839-4474-8558-6ecfbcf75cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_fa7626b7-7839-4474-8558-6ecfbcf75cbb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_7346ad8d-3ab1-4c0c-a924-4ee0c01a9647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bb1e34dc-68ff-4bd4-9f93-fefbc2c9f6d1" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_7346ad8d-3ab1-4c0c-a924-4ee0c01a9647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_7346ad8d-3ab1-4c0c-a924-4ee0c01a9647" xlink:to="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_4753f7cf-733e-42d5-8839-bb94240ffd46" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:to="loc_country_GB_4753f7cf-733e-42d5-8839-bb94240ffd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_c6b1f2e4-7af4-4f66-8abc-58ede5e0d334" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_1c704d66-4858-4be4-863b-a76c0bf83ecf" xlink:to="loc_country_CH_c6b1f2e4-7af4-4f66-8abc-58ede5e0d334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:to="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_08b7339d-a47c-414a-8fab-7bdc46039588" xlink:to="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_bf0ff75e-eb70-4571-838a-053cb73176dc" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_bf0ff75e-eb70-4571-838a-053cb73176dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_abaeb677-ac6a-47e7-ac59-d3f36be9583b" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_abaeb677-ac6a-47e7-ac59-d3f36be9583b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_153b56fb-bd5d-4c23-b201-5a1adb956a2f" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_a8fe64da-f25c-4c3b-98db-31468eeadcc5" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_153b56fb-bd5d-4c23-b201-5a1adb956a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5edaa8ef-a23a-492e-9d06-70a681acfa9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aefd81ff-81bf-4c6e-ba6e-e59f1dbf28f4" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5edaa8ef-a23a-492e-9d06-70a681acfa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5edaa8ef-a23a-492e-9d06-70a681acfa9f" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_19583f00-b636-45d5-bdc4-02e6d8c4eca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_19583f00-b636-45d5-bdc4-02e6d8c4eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_2b1cb351-e2af-44d9-8643-6c8c7cb8537d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_2b1cb351-e2af-44d9-8643-6c8c7cb8537d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a1657705-dfd6-4ef0-9872-af5fa79149fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a1657705-dfd6-4ef0-9872-af5fa79149fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7addff6e-8de4-447b-bce0-34eb8c1aafbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_7addff6e-8de4-447b-bce0-34eb8c1aafbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d8a77122-5754-4932-a9d9-ea7888266f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_d8a77122-5754-4932-a9d9-ea7888266f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1b995e45-4438-4919-9968-58d016c18f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_1b995e45-4438-4919-9968-58d016c18f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_d50394ab-be65-4231-abe5-38290da1ae14" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_d50394ab-be65-4231-abe5-38290da1ae14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2449e67f-5e01-43ef-aa06-c059ce4b5537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2449e67f-5e01-43ef-aa06-c059ce4b5537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_41a7dd57-4d7d-4a57-8797-79afd11c8db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_41a7dd57-4d7d-4a57-8797-79afd11c8db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4f0b91cf-569c-4b8e-a323-bfc0ae2e991b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4f0b91cf-569c-4b8e-a323-bfc0ae2e991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_bdb54830-cb4c-4e6a-ae7f-ce7245bd9ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2600f952-a572-44e5-b0ae-e567a7a4fdb5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_bdb54830-cb4c-4e6a-ae7f-ce7245bd9ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsChangeinPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_58d4f12f-d8f3-421b-bb9e-f9814ed1b38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_58d4f12f-d8f3-421b-bb9e-f9814ed1b38e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_24cd551c-21cf-4d30-a879-451fd41a9c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_a5091d01-7265-455a-8a45-4888795f6471" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_24cd551c-21cf-4d30-a879-451fd41a9c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_24cd551c-21cf-4d30-a879-451fd41a9c2e" xlink:to="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_a476cffd-5420-4483-9c9f-27109b506768" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:to="loc_country_GB_a476cffd-5420-4483-9c9f-27109b506768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_5fa3236e-00f2-4ea6-89fa-31a949ccbb05" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_cd2df083-56b2-41a7-b76d-c47653af5ae5" xlink:to="loc_country_CH_5fa3236e-00f2-4ea6-89fa-31a949ccbb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:to="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_0904f469-b277-478f-8767-1a0b8de48f42" xlink:to="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_b293c51d-8a8e-4760-a553-c70405ec2303" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_b293c51d-8a8e-4760-a553-c70405ec2303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AptivSolutionsPensionPlanMember_35fee0e2-a676-42d8-a322-9793794dd2d6" xlink:href="iclr-20221231.xsd#iclr_AptivSolutionsPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:to="loc_iclr_AptivSolutionsPensionPlanMember_35fee0e2-a676-42d8-a322-9793794dd2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRASwitzerlandAGPensionPlanMember_666194a6-ce1b-4723-9efd-ad24d2ebef14" xlink:href="iclr-20221231.xsd#iclr_PRASwitzerlandAGPensionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_bb91262d-87f9-4a5c-8362-20b78ee737d6" xlink:to="loc_iclr_PRASwitzerlandAGPensionPlanMember_666194a6-ce1b-4723-9efd-ad24d2ebef14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_947ef182-e116-4a89-b84d-34dfd63ca2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b2387a28-2f94-4078-93b9-30d20370cb03" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_947ef182-e116-4a89-b84d-34dfd63ca2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_947ef182-e116-4a89-b84d-34dfd63ca2f3" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_25f00ce8-93d1-4ce8-9862-dcd5ad4e0828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_25f00ce8-93d1-4ce8-9862-dcd5ad4e0828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8427df9d-ff05-4546-bc19-8039925a7535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8427df9d-ff05-4546-bc19-8039925a7535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e6dc1b2b-69ca-4550-bd8b-50d581a924eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_e6dc1b2b-69ca-4550-bd8b-50d581a924eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanSchemeContributions_bf8a0093-5461-48ca-ab61-bc60d5f19180" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanSchemeContributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_iclr_DefinedBenefitPlanSchemeContributions_bf8a0093-5461-48ca-ab61-bc60d5f19180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5c33cf7e-33c7-418d-a680-a25f156ca834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_5c33cf7e-33c7-418d-a680-a25f156ca834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d3b474b9-1e02-4aa6-8c0d-99003ee32665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_d3b474b9-1e02-4aa6-8c0d-99003ee32665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_e650e06e-27d4-433d-a3ac-74e3066b45ea" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers_e650e06e-27d4-433d-a3ac-74e3066b45ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_75d22823-2ea3-4224-9c3e-c98d23d6dc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_75d22823-2ea3-4224-9c3e-c98d23d6dc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dbbc75d1-5267-40da-a05e-1da328584919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dbbc75d1-5267-40da-a05e-1da328584919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_d2d028dd-ee84-4222-b129-5b76d2676785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_d2d028dd-ee84-4222-b129-5b76d2676785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ca94ccc5-6d2f-4591-86f0-c55943d0f75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ee7c1fea-b570-4044-90d0-d39f7f56d720" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_ca94ccc5-6d2f-4591-86f0-c55943d0f75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_941448bc-95cb-4389-b939-57383405cc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_941448bc-95cb-4389-b939-57383405cc7f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_f59afd8e-2c11-44e2-ba72-919530c57e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_8046a4d7-cf18-4f76-a02b-9f9d7632fc54" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_f59afd8e-2c11-44e2-ba72-919530c57e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_f59afd8e-2c11-44e2-ba72-919530c57e36" xlink:to="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_0ee5a015-d34e-4405-bd89-6a80417c171c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:to="loc_country_GB_0ee5a015-d34e-4405-bd89-6a80417c171c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_0a2be91b-578b-4fd4-ab67-c4d8bf38b7e7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5a8bc1ab-5064-4651-9306-db3f58026025" xlink:to="loc_country_CH_0a2be91b-578b-4fd4-ab67-c4d8bf38b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:to="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_41813042-9a74-49db-aa7b-5d081718ee68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_defdce83-01b5-4f1b-baad-98e1c5fbde6e" xlink:to="loc_us-gaap_RetirementPlanNameDomain_41813042-9a74-49db-aa7b-5d081718ee68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7b6c325f-aef0-4731-9e21-6f6e3299355f" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_41813042-9a74-49db-aa7b-5d081718ee68" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7b6c325f-aef0-4731-9e21-6f6e3299355f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_42f235be-6286-4023-a0ab-53c83f72353f" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6426e545-b8bf-42a5-af21-69e5a25e5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6426e545-b8bf-42a5-af21-69e5a25e5a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_b7960de6-e8ac-4613-924f-e90dec7c719c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_b7960de6-e8ac-4613-924f-e90dec7c719c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fa4c4237-3c03-44f4-9d31-99a12387a6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fa4c4237-3c03-44f4-9d31-99a12387a6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_915821ec-b1bb-4ec9-bef5-cf5fd3cd5c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_915821ec-b1bb-4ec9-bef5-cf5fd3cd5c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_61944679-b840-420a-bea4-06496b7057d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9e01aa84-363b-436a-9bd7-dee0932a580c" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_61944679-b840-420a-bea4-06496b7057d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_63947734-19f9-4bb5-90b1-de6dbae354b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_63947734-19f9-4bb5-90b1-de6dbae354b9" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4d0a2f74-f257-486f-b334-7842deae9cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_522372d3-e129-4aff-91c8-5bbcfca1e354" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4d0a2f74-f257-486f-b334-7842deae9cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4d0a2f74-f257-486f-b334-7842deae9cd4" xlink:to="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_cc3bff55-f07b-4b06-b9ce-6145e2f7fcd8" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:to="loc_country_GB_cc3bff55-f07b-4b06-b9ce-6145e2f7fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_16259c88-896a-4b54-b80c-0fbd32c4893d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_c2c14a15-15d4-4f01-bc7b-1a338f1933f0" xlink:to="loc_country_CH_16259c88-896a-4b54-b80c-0fbd32c4893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:to="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_b6b83f09-bd3c-4010-81c8-87873e03ec43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_27be57a6-2368-4610-a2f7-0807a5aff90e" xlink:to="loc_us-gaap_RetirementPlanNameDomain_b6b83f09-bd3c-4010-81c8-87873e03ec43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e6969f33-c39e-48c5-9c94-8beeda61aabf" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_b6b83f09-bd3c-4010-81c8-87873e03ec43" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_e6969f33-c39e-48c5-9c94-8beeda61aabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_77112a77-da2d-454e-ac3e-dec6769d3c5a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_66d956ec-eb4c-4dce-ac30-634dc7a7149c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_66d956ec-eb4c-4dce-ac30-634dc7a7149c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_41104649-93c6-4fa6-9d3f-b494f2d7fce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_41104649-93c6-4fa6-9d3f-b494f2d7fce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_074ef6e9-ca4c-4386-8225-5d4823ac38b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_074ef6e9-ca4c-4386-8225-5d4823ac38b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_05168812-bfcc-4109-85f6-872a81083ce2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_9e6194ab-4959-429f-93a7-4895a5029e16" xlink:href="iclr-20221231.xsd#iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost_9e6194ab-4959-429f-93a7-4895a5029e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0ced9d31-6a85-43ef-83d6-d443835ace1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0ced9d31-6a85-43ef-83d6-d443835ace1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_fb524b26-be0f-40ae-9eb4-74dfba9fabd1" xlink:href="iclr-20221231.xsd#iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax_fb524b26-be0f-40ae-9eb4-74dfba9fabd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_932c3f1b-780a-4d34-b6af-6f8f17884c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ba6b02c8-157b-4582-b8d6-9569eec8b5ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax_932c3f1b-780a-4d34-b6af-6f8f17884c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aed90b21-b7f7-4388-99b2-cec70b81d890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aed90b21-b7f7-4388-99b2-cec70b81d890" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8f246cfc-7df2-4e4a-b434-7856e20281b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_bf326f4c-c558-467c-a9e7-b7c4d4ae29be" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8f246cfc-7df2-4e4a-b434-7856e20281b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_7321bce5-326f-40f1-9cb1-a4933a665f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8f246cfc-7df2-4e4a-b434-7856e20281b8" xlink:to="loc_us-gaap_ForeignPlanMember_7321bce5-326f-40f1-9cb1-a4933a665f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_eeeb0b04-6a05-416c-a6a6-e9daa98abf8c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_7321bce5-326f-40f1-9cb1-a4933a665f31" xlink:to="loc_country_GB_eeeb0b04-6a05-416c-a6a6-e9daa98abf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_6485cd7f-4ffe-413f-af0b-8213def3af0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d95941f4-081a-4483-a92f-41b8e8ce243f" xlink:to="loc_us-gaap_RetirementPlanNameDomain_6485cd7f-4ffe-413f-af0b-8213def3af0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7125fe8a-3a83-4ded-8b6a-8df18e0e289d" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_6485cd7f-4ffe-413f-af0b-8213def3af0c" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_7125fe8a-3a83-4ded-8b6a-8df18e0e289d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5b5ee54e-45c2-42dc-ae1b-a62ef271aa4c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_915ab9e1-87eb-45fe-9561-af94dd4f2671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_915ab9e1-87eb-45fe-9561-af94dd4f2671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_002a75c2-ebb7-4cae-bc8b-a1308a8e16c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b28e3058-e58c-4b2d-85fe-3a61aa8d0a83" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_002a75c2-ebb7-4cae-bc8b-a1308a8e16c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_57f0322e-3f3c-4fe9-86ec-7cb1a2561c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_57f0322e-3f3c-4fe9-86ec-7cb1a2561c86" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_a37dff34-c374-494b-977e-c444995a71ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_1f114e7e-b88f-4453-965f-deb59bab3a72" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_a37dff34-c374-494b-977e-c444995a71ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_43ed90c0-e6a2-41c6-83ef-f6335875a8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_a37dff34-c374-494b-977e-c444995a71ce" xlink:to="loc_us-gaap_ForeignPlanMember_43ed90c0-e6a2-41c6-83ef-f6335875a8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_becfd00a-37a9-49bd-b8f9-54ec27e2a375" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_43ed90c0-e6a2-41c6-83ef-f6335875a8c1" xlink:to="loc_country_GB_becfd00a-37a9-49bd-b8f9-54ec27e2a375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b3761745-d667-433d-96ee-02c66a963216" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_dec712d5-440a-4965-add2-f7ce83f56825" xlink:href="iclr-20221231.xsd#iclr_GovernmentBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_iclr_GovernmentBondsMember_dec712d5-440a-4965-add2-f7ce83f56825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_6e1a3c59-ff63-44fe-afd5-2e71cf48d261" xlink:href="iclr-20221231.xsd#iclr_DiversifiedBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_iclr_DiversifiedBondsMember_6e1a3c59-ff63-44fe-afd5-2e71cf48d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ffac487c-9a75-4acd-9ca0-0c34ee131247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ffac487c-9a75-4acd-9ca0-0c34ee131247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_68c2e86e-e06b-4f45-800f-36657ae52ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_68c2e86e-e06b-4f45-800f-36657ae52ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_31de2a08-d12f-459b-a589-be373fe48c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_080cc2d9-297a-4e98-a3b8-437edf6f2916" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_31de2a08-d12f-459b-a589-be373fe48c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_020deb5d-adf7-4d43-a84e-a0de6d85b66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_33b2a613-a734-4d90-9816-828780ea630b" xlink:to="loc_us-gaap_RetirementPlanNameDomain_020deb5d-adf7-4d43-a84e-a0de6d85b66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_0a676c60-1f3b-42d9-ae23-b07619e965ec" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_020deb5d-adf7-4d43-a84e-a0de6d85b66e" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_0a676c60-1f3b-42d9-ae23-b07619e965ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b2e29b-4343-4038-b316-cfdfb71f9ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9e2afc36-2fe0-48e9-848b-7ebc52242828" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b2e29b-4343-4038-b316-cfdfb71f9ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2fe9919b-1e50-4d1f-9bce-3c8bde0368e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1b2e29b-4343-4038-b316-cfdfb71f9ca2" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_2fe9919b-1e50-4d1f-9bce-3c8bde0368e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f311d8c8-bae2-4c8b-a580-8e99450a3f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f311d8c8-bae2-4c8b-a580-8e99450a3f67" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_50fbfb1f-68e6-4a86-a437-e7960537417f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_14330de3-c367-47d1-8b9b-6dcd3c977e0e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_50fbfb1f-68e6-4a86-a437-e7960537417f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3a4e44e0-900c-471f-97fb-431e76c10cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_50fbfb1f-68e6-4a86-a437-e7960537417f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3a4e44e0-900c-471f-97fb-431e76c10cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6a2f6b64-1dce-4914-bc0a-a2994e37d19b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentBondsMember_cdd3184d-0281-43c2-b40e-9c641d613e1e" xlink:href="iclr-20221231.xsd#iclr_GovernmentBondsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_iclr_GovernmentBondsMember_cdd3184d-0281-43c2-b40e-9c641d613e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DiversifiedBondsMember_49c8485d-05fe-4a41-a38e-a7129bb6256f" xlink:href="iclr-20221231.xsd#iclr_DiversifiedBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_iclr_DiversifiedBondsMember_49c8485d-05fe-4a41-a38e-a7129bb6256f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_eaafcb66-3f73-49db-8de7-5779e1f8c394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_eaafcb66-3f73-49db-8de7-5779e1f8c394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_aa625ca7-6ebe-4c74-944b-280f202d643c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_aa625ca7-6ebe-4c74-944b-280f202d643c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_5437294e-d2ba-4b0a-b207-52ea1f035a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_413945fa-b83a-47f6-88fc-32b26c0a4a5a" xlink:to="loc_us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember_5437294e-d2ba-4b0a-b207-52ea1f035a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_f976157c-8624-4119-a217-24910c059cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_e123fa70-9e26-4486-b811-956e4974fd95" xlink:to="loc_us-gaap_RetirementPlanNameDomain_f976157c-8624-4119-a217-24910c059cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_d9423f59-4473-4221-9983-c858590946a5" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_f976157c-8624-4119-a217-24910c059cef" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_d9423f59-4473-4221-9983-c858590946a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d0e8bb2-d1f0-4a7e-943f-8bb0568e5b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_aeff7b8b-3c1e-4f4c-bb33-28fafaca093d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d0e8bb2-d1f0-4a7e-943f-8bb0568e5b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e1d213e-d290-4291-9487-8607c81076dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0d0e8bb2-d1f0-4a7e-943f-8bb0568e5b7a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4e1d213e-d290-4291-9487-8607c81076dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EmployeeBenefitsAnnualBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2c248767-7fc6-4704-a200-effe77854d15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2c248767-7fc6-4704-a200-effe77854d15" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_08bf7d9d-fcfa-45ef-990b-9b671fc0f7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_82d9555f-f596-4ffa-861a-7cac487abc6b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_08bf7d9d-fcfa-45ef-990b-9b671fc0f7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_08bf7d9d-fcfa-45ef-990b-9b671fc0f7c0" xlink:to="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_11da9c65-e918-4eb6-8a49-424586ea01ea" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:to="loc_country_GB_11da9c65-e918-4eb6-8a49-424586ea01ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_0bb74a0d-685a-4955-b9bb-681f97bf2875" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CH"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_75189ebd-95fb-4c26-b883-e36416493079" xlink:to="loc_country_CH_0bb74a0d-685a-4955-b9bb-681f97bf2875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:to="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_40c36552-b3df-4be7-837e-f3fdf824cdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_18461b99-09d2-4c43-9275-1bb42c9769fd" xlink:to="loc_us-gaap_PlanNameDomain_40c36552-b3df-4be7-837e-f3fdf824cdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f927b0b1-2b84-49f5-a875-aa9538bf9aa6" xlink:href="iclr-20221231.xsd#iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_40c36552-b3df-4be7-837e-f3fdf824cdad" xlink:to="loc_iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember_f927b0b1-2b84-49f5-a875-aa9538bf9aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_94d2803c-d2eb-4f1b-95a1-8d00d5a59c55" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b233fda7-2a5c-4f6c-bc1f-ed93de49d0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b233fda7-2a5c-4f6c-bc1f-ed93de49d0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_fb2dadc0-1190-4c26-99b9-e29880b24009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_fb2dadc0-1190-4c26-99b9-e29880b24009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_41b631fd-b2b0-41f0-b236-b136083ea6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_41b631fd-b2b0-41f0-b236-b136083ea6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b6a48911-77af-4a62-bbb6-be9e96b8b1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_b6a48911-77af-4a62-bbb6-be9e96b8b1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_911b4288-a641-4920-a05b-7559fc154cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_911b4288-a641-4920-a05b-7559fc154cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_8dbc7151-f286-4e85-8b1a-1571142f408d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdd5b173-2985-4323-b228-cf468b3226e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_8dbc7151-f286-4e85-8b1a-1571142f408d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11c3aaf1-0f46-46e1-9b22-34fc9743fea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:href="iclr-20221231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11c3aaf1-0f46-46e1-9b22-34fc9743fea6" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e63ae4e3-581f-4def-a46d-847341ab676a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_01126b89-4562-49be-ac8b-10963c16568d" xlink:href="iclr-20221231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_01126b89-4562-49be-ac8b-10963c16568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_01744271-3793-42a7-99b1-08c2d831ddf9" xlink:href="iclr-20221231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_01744271-3793-42a7-99b1-08c2d831ddf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_c3a67daf-6503-443b-a076-fe2682467012" xlink:href="iclr-20221231.xsd#iclr_OptionPlans2008Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_OptionPlans2008Member_c3a67daf-6503-443b-a076-fe2682467012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_64f7077b-fc2d-4883-88c5-dbc47698e396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_us-gaap_EmployeeStockOptionMember_64f7077b-fc2d-4883-88c5-dbc47698e396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_1222f3af-a2b8-445f-a0cd-4f914abd8814" xlink:href="iclr-20221231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_1222f3af-a2b8-445f-a0cd-4f914abd8814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_dab8196f-6302-4279-9f2f-6ac9ae4c795d" xlink:href="iclr-20221231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_dab8196f-6302-4279-9f2f-6ac9ae4c795d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6054b415-cf8a-41e2-b5d7-a0f454025b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6054b415-cf8a-41e2-b5d7-a0f454025b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_d4562ebf-6435-4dba-ba69-acb4a917624f" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_PerformanceShareUnitMember_d4562ebf-6435-4dba-ba69-acb4a917624f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_80107b8a-8042-485c-9349-1c7bb7bb767d" xlink:href="iclr-20221231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56335356-8ae0-46b6-8020-3f4fb0d2a536" xlink:to="loc_iclr_PerformanceBasedGrantsMember_80107b8a-8042-485c-9349-1c7bb7bb767d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_15694215-afe9-42d4-8de1-272d5af55f48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_d5e0f193-243a-42bf-80b2-301c466e505d" xlink:to="loc_us-gaap_AwardDateDomain_15694215-afe9-42d4-8de1-272d5af55f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_d1c4f641-55ce-4d22-a75d-4e9a5fc68e02" xlink:href="iclr-20221231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_15694215-afe9-42d4-8de1-272d5af55f48" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_d1c4f641-55ce-4d22-a75d-4e9a5fc68e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dc8005d9-9f83-4ff7-965e-7a3629ec1441" xlink:to="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0414ff38-5ccf-43b5-8658-b0412027d43d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:to="loc_srt_MinimumMember_0414ff38-5ccf-43b5-8658-b0412027d43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bddece49-6db0-4c5e-aa96-a7e4cc5605ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55c99c25-f9d1-4685-b2a2-f89f07dc5903" xlink:to="loc_srt_MaximumMember_bddece49-6db0-4c5e-aa96-a7e4cc5605ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7aa06d4b-831d-4055-ab45-28d0806dc93e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_21d13d7e-b631-4c0b-b039-8d5ea27ee25f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7aa06d4b-831d-4055-ab45-28d0806dc93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_eda71ac0-eea1-42af-a0a4-b4602280bd5f" xlink:href="iclr-20221231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_7aa06d4b-831d-4055-ab45-28d0806dc93e" xlink:to="loc_iclr_NonexecutiveDirectorMember_eda71ac0-eea1-42af-a0a4-b4602280bd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_521631a5-4a5b-4766-a27e-38c99df6ef76" xlink:to="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_cfc5d105-c8fc-4ad2-8c43-6a591c59e62d" xlink:href="iclr-20221231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_cfc5d105-c8fc-4ad2-8c43-6a591c59e62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_A2013LegacyPRAPlanMember_f4eca020-3635-42eb-912b-c6e5b360c877" xlink:href="iclr-20221231.xsd#iclr_A2013LegacyPRAPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:to="loc_iclr_A2013LegacyPRAPlanMember_f4eca020-3635-42eb-912b-c6e5b360c877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_02058c0f-32ac-44fb-a208-372d1bd7bedf" xlink:href="iclr-20221231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cd56f1ae-bbd1-4860-9273-8fb32b373288" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_02058c0f-32ac-44fb-a208-372d1bd7bedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:href="iclr-20221231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_26fca730-b30e-4452-aa1c-39821f9ed36a" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_dba09957-7c7e-414f-8be0-8be4b6ada525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_dba09957-7c7e-414f-8be0-8be4b6ada525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_ecedbc9d-6661-4d10-868c-f5b104f0c95e" xlink:href="iclr-20221231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_ecedbc9d-6661-4d10-868c-f5b104f0c95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0a902f3b-93de-41d6-b08c-5f1309d982de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_0a902f3b-93de-41d6-b08c-5f1309d982de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_60b0862e-4bbf-4def-97c6-38968ecad68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_60b0862e-4bbf-4def-97c6-38968ecad68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_42177d93-1f9b-48d6-ad98-dca87ad50979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_42177d93-1f9b-48d6-ad98-dca87ad50979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_79ae271d-812e-404f-8cf3-22c166d48627" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized_79ae271d-812e-404f-8cf3-22c166d48627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a045f642-1699-4150-b292-65f1bb9eaf08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a045f642-1699-4150-b292-65f1bb9eaf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_fcd9c87c-85fc-425f-819f-353aba33a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_fcd9c87c-85fc-425f-819f-353aba33a2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d53d8476-bc31-4765-9e0d-c9e3cefe04e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d53d8476-bc31-4765-9e0d-c9e3cefe04e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6dc76e1b-dd27-4b71-abd3-5e1e26e64aff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6dc76e1b-dd27-4b71-abd3-5e1e26e64aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_afec267e-8362-4e53-90b7-8a92af6386df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_afec267e-8362-4e53-90b7-8a92af6386df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_b84849ac-a16f-4f91-ba2c-f181e519f693" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_b84849ac-a16f-4f91-ba2c-f181e519f693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_256ee856-bc4c-4821-9c6c-7ebc457e4249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_256ee856-bc4c-4821-9c6c-7ebc457e4249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ca86841e-cb3d-4618-9346-0a3cf531cbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_ShareBasedCompensation_ca86841e-cb3d-4618-9346-0a3cf531cbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0d96db84-884e-45be-a2e4-0a28d8f045b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0d96db84-884e-45be-a2e4-0a28d8f045b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5177649c-df2b-4c9a-86a5-96f7a5b39024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_d6ded5a1-063d-42a4-96ef-71e6a4e6118e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5177649c-df2b-4c9a-86a5-96f7a5b39024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98b9ca5b-ebf5-4b7d-b7ab-0c09ff67898d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_98b9ca5b-ebf5-4b7d-b7ab-0c09ff67898d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:to="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f2aaa22-be18-470a-a621-2f8f6e869cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8fa6733d-ae77-4369-a991-489993afb03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f2aaa22-be18-470a-a621-2f8f6e869cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_03688f48-e044-4cea-9cd9-43f8d92cdf4c" xlink:href="iclr-20221231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8f2aaa22-be18-470a-a621-2f8f6e869cd8" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_03688f48-e044-4cea-9cd9-43f8d92cdf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69dd7c5f-de4c-4126-bd4a-8842fbc49b99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1081df8-beb5-4a44-ab25-03683e7412b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e1081df8-beb5-4a44-ab25-03683e7412b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_fb14abe8-01cc-4b66-931a-505ab6be4f8b" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination_fb14abe8-01cc-4b66-931a-505ab6be4f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ba58827-36ca-46a5-81da-f33e82b399b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ba58827-36ca-46a5-81da-f33e82b399b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_93951c9e-0340-4b4e-b1cc-0cb29b5bdac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_93951c9e-0340-4b4e-b1cc-0cb29b5bdac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cf18a678-225a-4b50-abe4-d7025efb46dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cf18a678-225a-4b50-abe4-d7025efb46dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4047bf-9dba-407b-8cc2-f939b21d6273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_022261ae-e7b8-4e4a-837d-db3e462f6174" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4047bf-9dba-407b-8cc2-f939b21d6273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b491dc35-4cab-4d90-9a9e-ce6bc8218bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b491dc35-4cab-4d90-9a9e-ce6bc8218bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e3b43cd8-b683-4dec-a188-dc15e88c4299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e3b43cd8-b683-4dec-a188-dc15e88c4299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_7f6be4c4-52a5-405f-8762-578ab152d74e" xlink:href="iclr-20221231.xsd#iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice_7f6be4c4-52a5-405f-8762-578ab152d74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd9d259e-49aa-48f5-a6f8-ca6ef2e2c579" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd9d259e-49aa-48f5-a6f8-ca6ef2e2c579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b7a0dcbe-0088-401f-952b-3d1122450b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b7a0dcbe-0088-401f-952b-3d1122450b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a6eaea3b-52bb-4c9c-b287-bd3a84565a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a6eaea3b-52bb-4c9c-b287-bd3a84565a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d1ce892-7f93-43dd-9ef7-72cd319606a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3891a11-7342-4b34-858b-fb265a350bd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0d1ce892-7f93-43dd-9ef7-72cd319606a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_a9c2711e-d41f-4d61-a76b-06efd2d32d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccc8c4ba-58c8-484c-9e3c-ec8608239014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_a9c2711e-d41f-4d61-a76b-06efd2d32d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35936132-5893-4570-82bb-3c7d4f3fa902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_484f2e73-a386-4e7b-8cd1-f696df8a46b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35936132-5893-4570-82bb-3c7d4f3fa902" xlink:to="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_484f2e73-a386-4e7b-8cd1-f696df8a46b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_484f2e73-a386-4e7b-8cd1-f696df8a46b3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:to="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef17398e-a703-410d-b961-6fa74a05c532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_618456d3-3e72-4230-9ac3-fd9e85b2d7dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef17398e-a703-410d-b961-6fa74a05c532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_ebd6acd5-3f62-479a-801c-23d8ff7d337a" xlink:href="iclr-20221231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef17398e-a703-410d-b961-6fa74a05c532" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_ebd6acd5-3f62-479a-801c-23d8ff7d337a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_179b4f34-c9c4-4605-9339-286715cf5a1f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range1Member_86dbc419-3195-4357-b32f-c1474fcb9da3" xlink:href="iclr-20221231.xsd#iclr_Range1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range1Member_86dbc419-3195-4357-b32f-c1474fcb9da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range2Member_5fd73e5d-fcc3-413b-be21-36274421c49b" xlink:href="iclr-20221231.xsd#iclr_Range2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range2Member_5fd73e5d-fcc3-413b-be21-36274421c49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range3Member_6b5f3ec3-3079-49e6-97b9-0ac43738acf1" xlink:href="iclr-20221231.xsd#iclr_Range3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range3Member_6b5f3ec3-3079-49e6-97b9-0ac43738acf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Range4Member_d7dc6ceb-aa3c-493c-bbc2-d40d53aa9592" xlink:href="iclr-20221231.xsd#iclr_Range4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_c42de906-6bae-4a4e-b616-f7dab1a7e0a7" xlink:to="loc_iclr_Range4Member_d7dc6ceb-aa3c-493c-bbc2-d40d53aa9592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3c224a35-241f-421b-b874-d7b24b4b6435" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbfe6f7c-0310-4ece-b4a4-607405a9bc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_cbfe6f7c-0310-4ece-b4a4-607405a9bc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f5b0b49f-7b0f-4ec6-a251-dc110981989e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f5b0b49f-7b0f-4ec6-a251-dc110981989e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_56228bc5-acdc-4895-aa70-1f17d5fa0508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_56228bc5-acdc-4895-aa70-1f17d5fa0508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b17f83a-4d6d-4e93-bebb-c8503eb3a30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_8b17f83a-4d6d-4e93-bebb-c8503eb3a30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3f8cf49f-7245-425a-b78c-10a4993a4167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3f8cf49f-7245-425a-b78c-10a4993a4167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_83c98717-29b1-40b6-8cb5-cefe8fc162d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_83c98717-29b1-40b6-8cb5-cefe8fc162d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_878793c2-5e33-424a-961d-2ad47dd480e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7ea213-dc3a-4217-9ebe-e8e541c8287c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_878793c2-5e33-424a-961d-2ad47dd480e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c8ec6b2e-c696-4a58-9543-263c08fde184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c8ec6b2e-c696-4a58-9543-263c08fde184" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:to="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7dcf49-2429-4af5-9e60-95bfaa515ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a0ba815b-0217-48d8-b323-7cb99e158f98" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7dcf49-2429-4af5-9e60-95bfaa515ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_82b43907-2178-4fd6-aeed-f061080ca027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2b7dcf49-2429-4af5-9e60-95bfaa515ff9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_82b43907-2178-4fd6-aeed-f061080ca027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95bcbbf6-3adf-4f83-a2ed-0aaa1b4c7e25" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_29972ef5-3d40-47ea-afe3-ff132bbd39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_29972ef5-3d40-47ea-afe3-ff132bbd39d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_128af514-7da9-43f9-a951-89ff2cd4defa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_79e215d4-cb93-40ef-8004-942106dcf69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_79e215d4-cb93-40ef-8004-942106dcf69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca554c6b-48db-4041-aa07-0978a3910763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ca554c6b-48db-4041-aa07-0978a3910763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9ac4f1fc-841c-4197-9372-2ee92d9ab828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_9ac4f1fc-841c-4197-9372-2ee92d9ab828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7a1635c9-e27d-41e3-98b6-a5ad149930fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_9b211351-03d2-463a-a4e3-494b52e7d465" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7a1635c9-e27d-41e3-98b6-a5ad149930fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9256ee0a-ed89-4232-bb7c-1fdcdd592843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9256ee0a-ed89-4232-bb7c-1fdcdd592843" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:to="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b97eaa0a-bd83-4e89-8152-935d7a9a1b7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_f034bddf-ac50-42b7-ab47-23931300e52e" xlink:href="iclr-20221231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:to="loc_iclr_PerformanceShareUnitMember_f034bddf-ac50-42b7-ab47-23931300e52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_282ab635-0076-4d71-949d-e891632fb886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20641408-ad20-4f3e-a95d-3d533d36a4ee" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_282ab635-0076-4d71-949d-e891632fb886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3d39c4a1-5968-481b-b9ab-90784f736889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a64015b7-77d2-4f14-a1c1-c8da1c9c52ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a64015b7-77d2-4f14-a1c1-c8da1c9c52ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24177796-7a66-4d10-ba90-0a5e80523ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_24177796-7a66-4d10-ba90-0a5e80523ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bec58884-1878-4c84-96fc-3df8da886885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_bec58884-1878-4c84-96fc-3df8da886885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a83dbe74-7a16-46bf-9f64-6dcadc33aa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a83dbe74-7a16-46bf-9f64-6dcadc33aa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e7026835-7d70-4519-9ae7-6a21caca129e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ec932579-2320-4441-9291-52fef2d90d4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e7026835-7d70-4519-9ae7-6a21caca129e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab13207c-785d-4053-8575-3b90406eb920" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_83e143dc-319e-41e1-a8a4-f8728af1f534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_83e143dc-319e-41e1-a8a4-f8728af1f534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f622827-5dd4-41cb-a627-9a1a901f6bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f622827-5dd4-41cb-a627-9a1a901f6bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_829cc49d-962c-43e7-83d1-739f57b1c533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_829cc49d-962c-43e7-83d1-739f57b1c533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85d294d6-0eef-4f4b-923a-04dae6bc7f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85d294d6-0eef-4f4b-923a-04dae6bc7f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d8a6bd9f-44b2-4d7a-8601-82cfa37f254c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e26b91bb-4ff1-4319-b8e6-fec544039223" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d8a6bd9f-44b2-4d7a-8601-82cfa37f254c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b63ae4f2-5dd3-493a-9f3c-5136c5fdabec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b63ae4f2-5dd3-493a-9f3c-5136c5fdabec" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e99200dc-eac4-4956-9c5d-6c5f50176f94" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_35121d47-f062-40da-b129-edc9998a247a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:to="loc_us-gaap_CostOfSalesMember_35121d47-f062-40da-b129-edc9998a247a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dda9e558-a763-4cc5-b16f-ad211b698efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_dda9e558-a763-4cc5-b16f-ad211b698efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TransactionAndIntegrationExpenseMember_85590e6a-1dbc-42c5-bf3a-89b6ecb1e167" xlink:href="iclr-20221231.xsd#iclr_TransactionAndIntegrationExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a79743c2-6985-42ca-aa3f-8d14ce3f388d" xlink:to="loc_iclr_TransactionAndIntegrationExpenseMember_85590e6a-1dbc-42c5-bf3a-89b6ecb1e167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4ace579b-7cce-4ef3-a0f9-7c43d327b713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f9a825d-cc06-4163-af1c-3b185d9425c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4ace579b-7cce-4ef3-a0f9-7c43d327b713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_16f20a9b-5e3a-49d9-8ecb-b54170c1220b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4ace579b-7cce-4ef3-a0f9-7c43d327b713" xlink:to="loc_us-gaap_ShareBasedCompensation_16f20a9b-5e3a-49d9-8ecb-b54170c1220b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_df311b55-9436-47eb-a6dc-acd8302fa7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_195f12e2-6e35-412c-955a-5313405d8dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_df311b55-9436-47eb-a6dc-acd8302fa7a3" xlink:to="loc_us-gaap_NumberOfOperatingSegments_195f12e2-6e35-412c-955a-5313405d8dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_dd7c2bb1-df36-45bf-be33-c98a16cc0aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_dd7c2bb1-df36-45bf-be33-c98a16cc0aca" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:to="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f1149678-58eb-47f7-8947-a0a2f5f70758" xlink:to="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_dbefb1f5-e59a-4c7f-ae60-2ab31c731430" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_country_IE_dbefb1f5-e59a-4c7f-ae60-2ab31c731430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_1bdc56fd-f9d4-4348-9fc2-5a63ec564c1e" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_iclr_RestOfEuropeMember_1bdc56fd-f9d4-4348-9fc2-5a63ec564c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b80c5c4e-a1a0-44a1-b38e-645b5d2a53c1" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_country_US_b80c5c4e-a1a0-44a1-b38e-645b5d2a53c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_5941ec24-1c45-46eb-bc72-f04df976b1cc" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9ce778d0-81dc-4e87-99b7-d8c83ceaa4d6" xlink:to="loc_iclr_OtherCountriesMember_5941ec24-1c45-46eb-bc72-f04df976b1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f8809948-6b5d-45d8-8656-56f383059eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a0241467-e3a0-4c2d-9b85-f149e22c186a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f8809948-6b5d-45d8-8656-56f383059eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d3c65f24-9110-45b4-8848-106b926103c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f8809948-6b5d-45d8-8656-56f383059eca" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d3c65f24-9110-45b4-8848-106b926103c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_90eb6bfa-366b-4b12-8184-84c5dc53c691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_90eb6bfa-366b-4b12-8184-84c5dc53c691" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:to="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c1fc6132-d41c-4650-8076-5a8092ad4a69" xlink:to="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_5dbc0ad0-2141-4cd5-865c-54b3be4f8341" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_country_IE_5dbc0ad0-2141-4cd5-865c-54b3be4f8341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_baede337-f253-487b-a0b2-6939e1259dfc" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_iclr_RestOfEuropeMember_baede337-f253-487b-a0b2-6939e1259dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_06edf4d0-2e98-4a16-9919-8395c33486cd" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_country_US_06edf4d0-2e98-4a16-9919-8395c33486cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_c7b96061-16a8-4d1e-9dc5-b23034636cce" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cf3174de-3480-47e9-a9ca-bbe4b227a8c3" xlink:to="loc_iclr_OtherCountriesMember_c7b96061-16a8-4d1e-9dc5-b23034636cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8a336ff0-f7ee-4e1e-97f3-f2e5a8b4f9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d6db370-9e5b-4b80-808e-25c6482f141b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8a336ff0-f7ee-4e1e-97f3-f2e5a8b4f9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_53b58817-d242-4277-8d64-2edfd0dea63d" xlink:href="iclr-20221231.xsd#iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a336ff0-f7ee-4e1e-97f3-f2e5a8b4f9f8" xlink:to="loc_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses_53b58817-d242-4277-8d64-2edfd0dea63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c6376922-c587-468b-be7b-8def65666713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c6376922-c587-468b-be7b-8def65666713" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:to="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c57efe30-7214-455a-829a-d88eb74ee680" xlink:to="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_ec138a8c-2ed7-4f4b-83b4-4fdca7f2f3f7" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_country_IE_ec138a8c-2ed7-4f4b-83b4-4fdca7f2f3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_6e472f76-3c00-4584-b9ed-0558b432edd8" xlink:href="iclr-20221231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_iclr_RestOfEuropeMember_6e472f76-3c00-4584-b9ed-0558b432edd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_57d4c465-47de-493e-af5a-6da25920b021" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_country_US_57d4c465-47de-493e-af5a-6da25920b021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_039f0a83-2559-49ba-bf65-3098d76c9847" xlink:href="iclr-20221231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45b1489c-71f7-41fb-bae8-d1c08d374203" xlink:to="loc_iclr_OtherCountriesMember_039f0a83-2559-49ba-bf65-3098d76c9847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c19266b7-fa27-42b7-9a77-a0bba3339144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_74acaa98-9491-46e7-886c-7d7fbde8067e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c19266b7-fa27-42b7-9a77-a0bba3339144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_dc47a8c1-f75c-4eb8-a564-15e7f1498099" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19266b7-fa27-42b7-9a77-a0bba3339144" xlink:to="loc_us-gaap_NoncurrentAssets_dc47a8c1-f75c-4eb8-a564-15e7f1498099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_87d9aec3-fed6-4509-9173-3c4074e23156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aae14f2c-9053-41d8-b900-b1471585d318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87d9aec3-fed6-4509-9173-3c4074e23156" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aae14f2c-9053-41d8-b900-b1471585d318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0cf6ef4d-6975-4d29-9db3-8a684b8b0377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87d9aec3-fed6-4509-9173-3c4074e23156" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0cf6ef4d-6975-4d29-9db3-8a684b8b0377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_277be491-272e-4786-b984-cd91461f9dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_87d9aec3-fed6-4509-9173-3c4074e23156" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_277be491-272e-4786-b984-cd91461f9dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3f262e4c-97b8-40fc-b727-89340ab46028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8abdb77a-ef5b-4b6e-9843-1103fad13ead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f262e4c-97b8-40fc-b727-89340ab46028" xlink:to="loc_us-gaap_NetIncomeLoss_8abdb77a-ef5b-4b6e-9843-1103fad13ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_ae8e9fef-3800-4cbd-815a-39d3e751732f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f262e4c-97b8-40fc-b727-89340ab46028" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_ae8e9fef-3800-4cbd-815a-39d3e751732f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9c177434-62af-4de8-ab1a-8b45d721a254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f262e4c-97b8-40fc-b727-89340ab46028" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9c177434-62af-4de8-ab1a-8b45d721a254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_09d61f3b-9396-47a5-9f31-b6ae4b2735e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f262e4c-97b8-40fc-b727-89340ab46028" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_09d61f3b-9396-47a5-9f31-b6ae4b2735e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dca47f56-9740-49c9-856f-a0cc04d72040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_09d61f3b-9396-47a5-9f31-b6ae4b2735e4" xlink:to="loc_us-gaap_EarningsPerShareBasic_dca47f56-9740-49c9-856f-a0cc04d72040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e35fccc5-c77e-43e0-b5a1-ad32b7212f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_09d61f3b-9396-47a5-9f31-b6ae4b2735e4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e35fccc5-c77e-43e0-b5a1-ad32b7212f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_08647b70-0451-4fe8-aaef-e5ab28719d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2685591a-3914-4f0d-bfa2-f46cd3351d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_08647b70-0451-4fe8-aaef-e5ab28719d4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_2685591a-3914-4f0d-bfa2-f46cd3351d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_171408e5-ab86-47e0-8859-2d39db780582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_08647b70-0451-4fe8-aaef-e5ab28719d4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_171408e5-ab86-47e0-8859-2d39db780582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_6fc35460-b470-4c5a-8c52-5e8abc1edda7" xlink:href="iclr-20221231.xsd#iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_08647b70-0451-4fe8-aaef-e5ab28719d4a" xlink:to="loc_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax_6fc35460-b470-4c5a-8c52-5e8abc1edda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_599ef04f-efa2-45d6-b3d2-1c27573a797a" xlink:href="iclr-20221231.xsd#iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_08647b70-0451-4fe8-aaef-e5ab28719d4a" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax_599ef04f-efa2-45d6-b3d2-1c27573a797a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44a6aa0d-5915-4f3e-adc4-0be284fec23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_08647b70-0451-4fe8-aaef-e5ab28719d4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44a6aa0d-5915-4f3e-adc4-0be284fec23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#SupplementalDisclosureofCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_20d10845-5fbe-41c1-996e-366e7c778634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f0cf95c3-0f4d-4395-ae61-a6f2051a57ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_20d10845-5fbe-41c1-996e-366e7c778634" xlink:to="loc_us-gaap_InterestPaidNet_f0cf95c3-0f4d-4395-ae61-a6f2051a57ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_af18d5ed-c3bb-4200-ae13-54c65d88639a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_20d10845-5fbe-41c1-996e-366e7c778634" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_af18d5ed-c3bb-4200-ae13-54c65d88639a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20221231.xsd#RelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_9b2eab42-d2bf-4613-8713-2a91992468b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_9b2eab42-d2bf-4613-8713-2a91992468b2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_a2af62cd-9863-458c-b269-d750d6e468fa" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DSBiopharmaLimitedMember_3a0f4510-08f7-4ce6-b98c-1b26f0664529" xlink:href="iclr-20221231.xsd#iclr_DSBiopharmaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_DSBiopharmaLimitedMember_3a0f4510-08f7-4ce6-b98c-1b26f0664529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_d6400d8a-0d22-435c-93b6-5825945869dd" xlink:href="iclr-20221231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_AfimmuneLimitedMember_d6400d8a-0d22-435c-93b6-5825945869dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember_954e7eec-72df-44c8-8fb5-993a742ea51e" xlink:href="iclr-20221231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_CorvusPharmaceuticalsMember_954e7eec-72df-44c8-8fb5-993a742ea51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_865719d4-7544-4487-9a30-76fdc725a69c" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_fad80586-f91a-4692-8ec7-1eb6eb630630" xlink:to="loc_iclr_OncacareMember_865719d4-7544-4487-9a30-76fdc725a69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a611173e-1b3c-4dfa-b7bf-f2cf2515db05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_295e5060-0910-4ee9-b45b-c461b941d951" xlink:to="loc_us-gaap_RelatedPartyDomain_a611173e-1b3c-4dfa-b7bf-f2cf2515db05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_2a0c2d1a-e29e-4bfa-9888-c73403ed4176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a611173e-1b3c-4dfa-b7bf-f2cf2515db05" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_2a0c2d1a-e29e-4bfa-9888-c73403ed4176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a23f997b-7160-4e65-bb37-86af8fc523a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f28594c-b881-468f-ab90-938675711aaf" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a23f997b-7160-4e65-bb37-86af8fc523a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_356dd00b-abc2-4799-9a46-b2e0193947ec" xlink:href="iclr-20221231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a23f997b-7160-4e65-bb37-86af8fc523a6" xlink:to="loc_iclr_OncacareMember_356dd00b-abc2-4799-9a46-b2e0193947ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d0fae650-bef7-4447-ab80-c34042571736" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_32ae081a-9a6d-433f-bead-f6180b9ca87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_RevenueFromRelatedParties_32ae081a-9a6d-433f-bead-f6180b9ca87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedParties_d4f63eb4-6193-43e2-b7d1-ddd5b652a4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_DueFromRelatedParties_d4f63eb4-6193-43e2-b7d1-ddd5b652a4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_06f67caf-925c-4227-bccc-93d0a70e227c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_06f67caf-925c-4227-bccc-93d0a70e227c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d61968cc-1fdf-48b9-befb-d1ca5ffe2d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_d61968cc-1fdf-48b9-befb-d1ca5ffe2d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_cc23bcf5-833b-4051-96c7-8f0b550877cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions_cc23bcf5-833b-4051-96c7-8f0b550877cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_800fc824-2075-4faf-9920-bc5903b26cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_800fc824-2075-4faf-9920-bc5903b26cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestReceivableRelatedPartyLoans_dec1d980-c4ac-4595-b51c-fac241477dc9" xlink:href="iclr-20221231.xsd#iclr_InterestReceivableRelatedPartyLoans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_iclr_InterestReceivableRelatedPartyLoans_dec1d980-c4ac-4595-b51c-fac241477dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_e7da9e19-6cae-42ad-b513-5b49d09c3167" xlink:href="iclr-20221231.xsd#iclr_EquityMethodInvestmentMajorityOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_406f7bc9-5160-4989-85da-a7ac09c33310" xlink:to="loc_iclr_EquityMethodInvestmentMajorityOwnershipPercentage_e7da9e19-6cae-42ad-b513-5b49d09c3167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>iclr-20221231_g1.jpg
<TEXT>
begin 644 iclr-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
M  $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!
M40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/D
MY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]^EZ5POQN^/FB_ K2K.34
M8]1U+4=5G,&GZ3IL'VB_U!P-S^7'D95%RS,2%4#D\@'N2N!Q7P9_P4#TGQ#\
M#OB-<>(KV\M_$VC_ !&O8-*.;AK+4-$TV(>9<V44BJPCM)51FEF50ZY.XD8(
MVH4U.?*SQ<^S"I@L*ZT%ZO>WG;KKI\SWJ+_@HO\ #36?"L.I:'<^(O%%Q<H&
M@TW2=$NIKR8YY4*4"@K@YRP'RGDUZU\-_B-H_P 6O!5AX@T&^CU#2]1C\R&9
M/R*L.JLI!!4\@@@UXO#X1^*'A;X+>%_$/A^\\/W^LZ#%+._A73 L.CZI8R &
M*SAEP2)(D"".?&&.<KAN+W[ VEVU[\.-;\4_;$?6O&6K2ZCK.FV\36]OH=V
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)OCE#XE\=+;Q_%+_ (2%+^Y%I%:VEK_PC<.G"\MQ:-;OCS6F:#S-V"6SYN\
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M1U#*<'(X/N!5BBL3K4;*P4444#"BBB@ HHHH **** "BBB@!F>/:OG;XT?\
M!/'P[\;_ (E^.?%6KZE?MJ'B;2K>QTV-9)%@T:XAMKF!+SRU8++*HN6*EA\N
M..N:^BBP(K+\7>+M+\":!/JFL7]KIFFVNWSKFYD$<<>Y@BY)]690/4D"JC*2
M?NF=2G"2M/8^)]<_X)[^$_\ A;VO>&]'^-EUHOBJ^T^"32-&2[CDO-&DC\ES
M(L9?S)(R(78*^<?:)3WR=2X_X);6NO\ Q:UB:S^+&KVT=G]E5+"TC076DHMO
M-' Q?=GS LAVNP)P/>M#XH_L61_M)_&;6?'7A'XHZ;H=GKD#K)/HT)^TS2+:
MO;>7*PE\ME7.3(J).H!3S-M9_B/_ ()N:[K6VX_X6W)HMJEW9W<FG:3/=VME
M;+'"4_=L;EI<@Y:/<Y&6;<&XQU\_][\#RG15W:G=7[_\$+#_ () K:^ [[3Y
MOB1KTVIS6EK:VUZ8QMMO*NY;B1/*SL,<PD5'7;_#QUKU+7/V.?$6G:QX'OO#
M?CI;:?POX6G\)7TNJ6'VV;4K>9[=VD#[U*2Y@&#S]ZO*=(_X)_2^&;_PY-;?
M%NUO(KA()VL=0N+J6WU><23;[Y56Z5C,%FA5,'RP4^93D8AU_P#X)P:Q%<W$
MS_&S5&O-8\2PZE937M_<L)LF8J#$LZH\IWE0% C(B7Y>*3E?>7X%QARJT:?X
MFEX8_P""0]KX3\0:'J-CX^UBSDTW5+?4;U+:V2(:D8H+2(.Y!W>;FU;Y\YVS
MR+W.?M!?3M6/X-\9:7XUTMY])U2RUB*UF:TFFM95D59DP'4[3@,,C([9K9)Q
M7+*<I;GH4:,(+W.HM%%%2;!3) Q0[<;L<9'&:?10!\;?#G]F3XR^&?V?/BCX
M;\4>)M*6^\2:Y'K.EW:ZQ.OFJ\R27=FTN ]O#*L9C382464YR02<+4_V2_VB
M7^'VJ^&O#_C*ST'P[X@$]Q;6EOKDLDOAJ)XK@+8PW+PM+*A=X&\W<I7:P4
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M8ZW=6=A#JE_8VCW-G;20"823H"T>$[D,!CWQS51M=7,ZT6X-1=G;<^-_ O\
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MC3EM+B6_T@31"U"^0'&^0I$1'$/W@VOM48;/%>D6'_!1OX::+!:Z;:P^)/W
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MH$OC"+5(Y8'E4NP8@#YLNV3U))]:ZBF_<%.!S6)UQ5E8****!A1110 4444
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MN[V.,Y'-?+G@W]HWP]'';:5??!?^U=5U9Q<&32-&6/36D4$(AED)4L.06!(
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MO]YC_A?YH]%VXHS@8H!_2N7^+_Q(@^$?P[U3Q!<6MU?1Z;%O\BV0L\C$A5Z
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MX&,8'MX.*4X\LK%X3$>VI*HU:_0=1114G2!.13)!F/;TR.H[4_&VOFK]MO\
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MYVY/4DUZ1X$^%?AWX86IA\/Z39Z5$T20E8$VY1"[*/H"[G_@1KEY?^3NK?\
M[%.3_P!+$KTK.1[U4F^K.:ARN]DE9V%'WC7FW[6O_)O'B3_KG%_Z.CKTD?>-
M>;?M:_\ )O'B3_KG%_Z.CHC\2#&?P9^C/1UY2O _CA^S1XP\;?% >(/#OBBP
MT=Y;F";[3<1LUU!"D31O9PD A$DR6\Q2&5F8X;Y<>^(,**\G_:X_9XLOC_X
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M*E2AQG<:DU_]G;XL:E\*M.T6S\;V-CJ4SZG)K%W%<3I]H:Y\PQ&,A-V4+CN
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M_HYZ]&/WA7G/[)__ ";YX<_ZY2_^CGKT8_>%.6YA@_X$/1?D+1112.@****
M./\ CKXOO/ /PEUS6-/,7VRQM_,B\U=R9W <C\:ZNV;S8E;^\ :X#]JS_DWS
MQ3_UZ?\ LRUWUL/]%C^@_E5?83_KH<D92^LRCTY5^;)@,4'I10WW34G6>,>$
M?AMI/QB\&_%CPOKT#7.CZ_X@O+*\A$AC,D3P0!@&'(R*X3]H[PE\'_"WC'^R
M?%'A6:/[5I%I9PK:$0VUQ917,MTRJBD#*219<8RV]!SN%>M?L_G_ (F/C_\
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MS'%3^*?^"BOPC\,>&9M67Q1_;$=O;6]VT6F6<US,8IY5BC.T+UW.,J3N49)
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MVAZS\(_@WX?^!OA :)X;LC:6/GR7<IDF>>:YGD;=)-+(Y+/(S<EF)-=8.E%
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MP*Z +B@MBI<F]&;1I1B[I!1114F@A^\*P/BC_P DS\0?]@VY_P#1;5OG[PK
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M(P^=4:]3V<$]6TGINM]+W_ ]L'%(_P!P_2E'2D?[A^E8GL'GG[+_ /R2-?\
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M_";^%4\.O#<+'9Q[@ZW,3)EOXFZ'(YQFO0K.UATZUCA@B2&&)0J1QJ%5 .@
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MBS_L;=6_]*GJE\+.:I_'AZ/]#TNBBBI.H**** $/WA6!\4?^29^(/^P;<_\
MHMJWS]X5@?%'_DF?B#_L&W/_ *+:B.Z,ZWP/T*_P:&?A'X8_[!=M_P"BEKI@
MNX5S?P8_Y))X9_[!=M_Z*6NE7O\ 6F]R</\ PX^B/(OB=\8_$?AWQ3K6GZ+H
M>HZC-IOV)H1!8//%.C$RW&77[K>6I55]6&,GBN1T[]K3QOJFA&[@^&^K7#QS
M36\\$=C<^9;20M@A@5Y\T [-N=F!NZBOHE5&X\?7WK"T?QG:ZEXUU;0XX98[
MC28H9Y'( 1A-N(QWS\IS5J2ML3*+35W:_P#7Y'-_"GX@>(O%GBW4['6M)ATW
M[!;Q2D1[B-TA)498 DA00?=01PU>A;*154$\#+<G'>GUF]3:,;*S"BBB@H*1
M_N'Z4M(_W#]* /.?V:/^1-UO_L9-6_\ 2R6O1F_I7G/[,_\ R)NM_P#8R:M_
MZ62UZ,W]*JI\3.;!_P "/H(?N_@*\Y\<?\G+^ O^P9JW\[6O1C]W\!7G/CC_
M ).7\!?]@S5OYVM$-_O%BO@7K'\T>D4445)U'&_M"?\ )"_&G_8"O?\ T1)6
MK\-O^2>:#_V#X/\ T6M97[0G_)"_&G_8"O?_ $1)6K\-O^2>:#_V#X/_ $6M
M5]@Y?^8CY?J;M%%%2=04444  ZUYK^T1S<>!?^QLLO\ T&2O2AUKS7]HC_CX
M\"_]C99?^@R55/XCFQG\)_+\STH=**!THJ3I&S?</TKS_P#9A_Y([8_]?5W_
M .E,M>@3?</TKS_]F$9^#MC_ -?5W_Z4RUI'^&_D<L_]XCZ/\T>@$Y6OF_XY
M_'[P7X.^,.K:=XC^'=QXAO+"WBE%_;6$%P3#Y;/AS(RGC:V ,]/>OI#J.GZU
M#)IEO-(6>&)F/!9D!S4QDD;5*;DK)GQYXI_:[^"NAZ;K-['\.YIKCPW&T#&7
M2;?&T2?(5RX,H9QG"Y8 9.!77?#/XV?"R\^*?AFUL?AY<:'XDOE@^QW$VGVT
M4EM'<0LT3AQ(2=R!LA=S*,;@,UZ_XET3PMK?Q4T?3=0T&VNM3M;>;4[.X:%=
ML)#*C<=V.[/(/YUT&I?#O1-7\4:=K5UI=I-JFD!EM+ED^>W##!V]NGY5HYJV
MQRPIR;=FM'V-U3S7$_M%?\D/\4?]@^3^5=L/O&N)_:*_Y(?XH_[!\G\JSC\2
M-L7_  )^C.G\/_\ (!L?^O>/_P!!%:!Z5G^'_P#D V/_ %[Q_P#H(K0/2I-J
M?PH#7G?PH/\ Q=GXD?\ 80M/_22.O1#TKSOX4?\ )6?B1_V$+3_TDCJH_"SG
MK?Q:?J_R9Z)1114G4><_M.?\D_L?^PWIW_I5%7HD?7\*\[_:<_Y)_8_]AO3O
M_2J*O1(^OX5I+X%\SDI_[Q/T7ZCJ:_?Z4ZFOW^E9G5+8\[_9._Y-]\-_]<Y?
M_1SUUWC/P?IWQ \-W6CZQ:QWVFWZ>7<0.2%D&01R"".0""#D$5Q_[)Y_XQ\\
M-_\ 7.7_ -'/7HY^\*J7Q,Y\)KAX7[+\CXRUWX@_"WX;_$WQ!;ZW\/?M"Z3J
M CM)=/$^H74[>88FDFRQ7!.<JY#=MK@[JM2_%[X0ZOX-A@F^&&L6^GZE);7-
MS:WELD;_ +^,?92[^=M56CD.-S;5164XP!7UP^DV[R2,UO;LTK*SDQ@EROW2
M?4CMZ5@R>+--F^(Y\*/8[KEM+_M(N44Q&+S?*V>N<^V,5HJGE^)G*CR[M:^1
M\Z^'OC3\'=3^)-CH=CX)UZQU6[NAI=M?BS"Q6;SP^69(Y#(5&5G*;T!W#'4!
M:^G/!'A#3_A]X/TW0]+@6VTW2+6.SM8A_!&BA5'N<#D]S5S^S;?[1YWV>'S0
MV\/L&X-C;G.,YQQGTJYGBLY2N;T:?+O^5CSO]JO_ )-Z\4?]>G_LPKT"U_X]
MH_\ ='\J\_\ VJ_^3>O%'_7I_P"S"O0+7_CVC_W1_*A_ O5_H80_WN7^%?FR
M2@]**#TJ3M/-_P!GT_\ $R^('_8TW/\ Z)@KTCO7F_[/I_XF7Q _[&FY_P#1
M,%>D=ZJ>YRX/^$OG^8UJ\]^*9_XNM\.O^PC<_P#I)+7H3=#7GOQ3_P"2K?#K
M_L(W/_I)+13^(6-_A_./YH]$HHHJ3K(YO]4WT->>?LG_ /)OGAO_ *Y2_P#H
MYZ]#F_U3?0UYY^R?_P F^>&_^N4O_HZ2J^P<DO\ >8_X7^:/1Z***DZSS.;_
M ).ZM_\ L4I/_2Q*X?Q3^QC?^*_&?Q4O;CQ%:?V;\3M'?29X#9L9;8; D;!M
M^,*"XV@#.X'.:[B7_D[R#_L4Y/\ TL2O2D'3VK1R:V[''2IQES)]V?&OC3]E
M&_\ A/JR2W7QC;0[[Q=?J997AFCN+]H[>.V 79)VA5 21A6.[@FM37?V*=0;
M2Y](A^+EQ;Z%YEY<&Q,KJ88G(8Q924%HUVE3GYL,W(;FO>OC?\!=)^/&EV=I
MJMQJ%K'9NY#V4OE2E7 #!7QN1L 89"&'8UX_XT_88^%OP=^&NOZE<:?JEQ;R
M"$W+0RK]H,8E<&-6(X#B=EDY^<=>>:TC5;TOKZ&52BHW=M%YOYESQ_\ LW7O
MCSXF'QAI/Q%MK"ZFL[?3)+#:?L\U@D8D%NS+(LR[I@TI8,&VG'J:BUW]D'QI
MXL,<UI\5M2@MVDF?=:2SC[1OSB4L)<"0 ^7A?DV#(4/\U:]]_P $YO .J/!]
MH_M6XBMI7DC1IU&W>&W_ #!0Q8ECAB25'RC"\5ZQ\)?AE8_![X?Z=X;TMIFL
M=+1DA\TC(!8MC@   D@ #@8J74LM'^!K&CS?$K?-G#_L\_ 7Q5\)?$FH7FO>
M-)O$EO>6,%LENZ2@0R1\;EWR-@;<# Y)RS$DUK?L\#-WX\_[&R\_]%Q5Z23P
M:\V_9X.+SQY_V-EW_P"BXJGF;3;'**A4A%>9Z50>E%!Z5F=9YS\??^0AX%_[
M&BU_] EKT0]/PKSOX^_\A#P+_P!C1:_^@2UZ(>GX5<MD<M'^)/U7Y(=1114'
M4%%%% #6ZUYYX>_Y.<\3?]@*Q_\ 1MS7H;=:\]\.?\G.^)?^P'8_^C;FJI[/
MT./%?'3_ ,7Z,Y[XP?L:>'OC5\2;;Q-J&H:M:W=LMNABMG58YA!)YD8?()(5
MR6'/#<]17$M_P3-\.XTE3XF\1;=+OGO@V8VF=R)%&)""R?+(=Q4C>P#-S7TV
M3BDW"J52:5DS:6'IR=VCYXTK]@[1?#?CKP_X@N/%6JEM#EM_(M_)@MX9FCFC
MD12%4?>:-,C^)BS=6--UC_@GAH7B>QM;;5O$6MWT.GW"_9XPL<*K:"2:0VS!
M -^6G?\ >'YA\N,8KT+]I8?\4WX;/_4UZ/\ ^EL5>C$_+1SRLG<QC3IRG*#6
MUOQ_X8^?KK_@G_HEW.LC>)/$3R/8M8W$DC1O)*#)+)YBL1F.3=)@LF,HNP\$
MUZO\&_A?:_!GX::7X9L[B>ZM],C91+* &<L[.>!PHRQPHX   X%=8.E(_P!P
M_2IYY/1LWC1C'6)YY^R__P DC7_L+ZM_Z<;FO0DZ5Y[^R_\ \DC7_L+ZM_Z<
M;FO0DZ45/B9G@_X$?0=1114G2%%%% !1110 4444 %%%% 'G<W_)TEK_ -BS
M+_Z51UZ)GC\:\[F_Y.DM?^Q9E_\ 2J.O0^WXU4^ARX?>?JP[_C7G7[4__)(9
M/^POI/\ Z<K6O1>_XUYU^U/_ ,DAD_["^D_^G*UHI_&A8_\ W:?HST5/N#Z4
MM(GW!]*6I.J.PV3I^!KS;]F;_D ^+/\ L;=6_P#2IZ])DZ?@:\V_9F_Y /BS
M_L;=6_\ 2IZI?"SFJ?QX>C_0]+HHHJ3J"BBB@!#]X5@?%'_DF?B#_L&W/_HM
MJWS]X5@?%'_DF?B#_L&W/_HMJ([HSK? _0K_  ;_ .21>&?^P7;?^BEKIU[_
M %KF/@W_ ,DB\,_]@NV_]%+73KW^M$MV3A_X4?1"FO/?!A_XR%\:?]>&G_RF
MKT(UYYX,/_&0OC3_ *\-/_E-5+9_UU,<5\=/_%^C/0QTHH'2BI.P**** "D?
M[A^E+2/]P_2@#SG]F?\ Y$W6_P#L9-6_]+):]&;^E><_LS_\B;K?_8R:M_Z6
M2UZ,?Z553XF<V#_@1]!#]W\!7G/CC_DY?P%_V#-6_G:UZ,?N_@*\Y\<?\G+^
M O\ L&:M_.UHAO\ >+%? O6/YH](HHHJ3J.-_:$_Y(7XT_[ 5[_Z(DK5^&W_
M "3S0?\ L'P?^BUK*_:$_P"2%^-/^P%>_P#HB2M7X;?\D\T'_L'P?^BUJOL'
M+_S$?+]3=HHHJ3J"BBB@ '6O-?VB/^/CP+_V-EE_Z#)7I0ZUYK^T1_Q\>!?^
MQLLO_09*JG\1S8S^$_E^:/2ATHH'2BI.D;-]P_2O/_V83CX.V/\ U]7?_I3+
M7H$WW#]*\_\ V81GX.V/_7U=_P#I3+6D?X;^1RS_ -XCZ/\ -'H5%%%9G4>=
MZK_R<YI/_8OW/_HZ*O1.]>=ZM_R<YI'_ &+]Q_Z.CKT3O52Z'+AMY_XOT0@^
M\:XG]HK_ )(?XH_[!\G\J[8?>-<3^T5_R0_Q1_V#Y/Y41^)%8O\ @S]&=/X?
M_P"0#8_]>\?_ *"*T#TK/\/_ /(!L?\ KWC_ /016@>E2;4_A0'I7G?PH/\
MQ=GXD?\ 80M/_22.O1#7G7PH_P"2L_$C_L(6G_I)'51^%F%;^+3]7^3/1:**
M*DZ3SG]IS_DG]C_V&]._]*HJ]$CZ_A7G?[3G_)/['_L-Z=_Z515Z)'_2M)?
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M_>&'KT_91UZ(]QS@UY]X+_Y.&\:?]>.G_P IJX\_MY>$"?\ CUUK_P !Q_\
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M7[3_ "1[AGDUQ?[19S\#O%'_ %X2?RK@_P#AO'PA_P ^NM?^ X_^*KE?C?\
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M.!^ KY9^/O[:WA77_!5I##;ZLK1ZO82G= !D+<(Q[^@KMF_;P\()\OV76O\
MP''_ ,56TN+,I]FG[>-M>OH<M.O3^L3UZ+]3W'<*1SU^E>'_ /#>/A#_ )]=
M:_\  <?_ !5)_P -X^$#_P NNM?^ X_^*K-<691?^/'[SJ>(IVW.M_9-./V?
M?#?_ %SE_P#1TE>BCFOEC]G+]M3PKX:^"F@V<UOJS2112%BL (YFD/K7;?\
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MW\T<N*K4^:GK]K]&?4^X4;A7AW_#>/A#_GUUK_P''_Q5'_#>/A#_ )]=:_\
M <?_ !58_P"MF4?\_P"/WG5[>'<ZK]I7_D6/#?\ V->D?^ED5>C(?D%?+/QW
M_;4\*Z_X?T*.*WU96A\2:5.VZW'*I=QL>_7 KMA^WCX0'_+KK7_@./\ XJMI
M<5Y2H)^WC;7KZ'/#$4_;RUZ(]QW"D9LJ?I7A_P#PWCX0_P"?76O_  ''_P 5
M0/V\/"#'_CUUK_P''_Q59+BS*/\ G_'[SH>(IVW.N_9?&?A(O_87U7_TXW->
MA9R*^6_V?OVV/"OA[X:K;S6VKLW]IZE)E8 >'OIW'?T85VG_  WEX/\ ^?76
MO_ <?_%5I6XJRF,W%UXW]3GP=:G[&.O1'N.X4;A7AW_#>/A#_GUUK_P''_Q5
M'_#>/A#_ )]=:_\  <?_ !59?ZV91_S_ (_>='MZ?<]QW"C<*\._X;Q\(?\
M/KK7_@./_BJ/^&\?"'_/KK7_ (#C_P"*H_ULRC_G_'[P]O#N>X[A1N%>'?\
M#>/A#_GUUK_P''_Q5'_#>/A#_GUUK_P''_Q5'^MF4?\ /^/WA[>'<]R!S17*
M?!_XMZ;\9?#4^J:7'=1V]O=-:L)TVMN"HQXR>,.**][#XBG7I*M1=XRU3[FL
M9)JZ/S^K1\.>%[KQ.]V+7R?]"MGNI/,D"91!D[0>2?85G59TS5I]'EE>W8(T
MT,ENY(SE'4JP_(U_(]'V:FO:?#UL>#&U]3JU_9RUR:X6>.&PEN'7R8F20EY6
MY)A4[>HVDG^'C@FN>\5>$[GP??1P7+V\WFH722!RR, Q4C) Y#*P/'45K+\:
M?$L:X34Y(\0K I10#&HSC;Z'DUB^(O$][XKO5N+Z19)$3RUVH$51DG@#U))/
MJ2:]+&3P#IVPZES>=K%VII>[N4%7>X QR<#-=>/V?-:UJ6:S,6G7#1-%^Z,P
M<2$JDH(."IVAE).>W&<5R%=#9_%77;%)Q#?>5]H$2R;4'S")55!^2J/PKGP,
ML+%WQ*EY6_KO8E<CTF'B+X::EX9TZXO+@VK6]N\*;XYLF42ABC*I ;;A3R0*
MYZM?7?'FJ>)3=_;;GSOMS1-+E>OE@A /0#<?SK(K'%.@Y_[.GR^?J_TL$K7]
MTW?#7P[U'Q78"ZM?LPA-TMIF28!E<HSY*C)"A4;G'TS6E+^S_JVA1[F&EVL4
M\V]V\TJN)&($S?+T=@<?Q$XXYK!T+Q9?^'(MEI((U^T1W6"H/[Q P4_D[?G6
MU'\;/$BR!FOA+B<W&)(PP+\X)'MGCTX]*]##5,N]E:LI<W6UK%Q]G]K<YW6=
M)ET'5[FRGV^?:2-%)M;<NX'!P:K5)>737UW),X4/*Q=@HP,GT%1UY-3EYGR;
M=#.6X4445F(*ZC2?@WJWB33;>6/["8;^ RQJ\P.\%O+"$ '#,>,'\<5R];FA
M?$?6/#,$4=E=>1Y$3PQD(,HKMN.#]>:[<$\.IWQ*=O+U*CR_:-2X^ NLZ-92
MEELHH;* N5C+MMVG!C 53\R\9_A&>M<?72M\7O$$BQAKU7\J+R8RT2DQ C!9
M3CY6/J*YJKQ\L(VGA5+SN.7)]@T_#?A*\\6?:_L8A/V.'SY!)*$)7('R@\DY
M/;\:Z"7]G77+62:XCAL)99!M#1.=]QLR&4?*,[.<YP/3-<MI.M7&B23-;.$:
MXA:!R5SE&QD?I703?&GQ-/YG_$SD7S46(E5 *J.<#TSWKHP<\O5.V(4N;R:'
M'V=O>W,CQ?X2NO!.M-87OE^>BACLSMY^H!_2LRM#Q)XGO?%FH"YOI%DF5!&N
MU JJHYP ..I)_&L^O-Q'L_:/V-^6^E][$NU] HHHK$D*W_#7PWU'Q3I\=U;F
MU2"2<V^Z28 H51I&8J,L%"J>W/8&L"M30O&.H>&D06<JQ^7.+D H#\X4J#^3
M&NG"NBJG[]-Q\BHVO[QT-E^S=KMJYACAT^#]X7E57/[K<6(=@%_C(/3)]0*X
M^^LVTZ]FMY,"2"1HW .0"#@UTT?QN\31Q,G]I,Z2N7E5T!$Q)S\P[X)XKFM0
MU";5;^:ZN',L]PYDD<]78G)-=>82P,HIX52OUO8<E!*T"SX7\-W'B_7;?3K3
MR?M%RVU/-D$:^O)/_P"NN@LOV?\ 5]4AM;_9I_SH!'*[G="9-NV,D*<%\KTX
M]2*YC1]6GT+5(+RU8)<6SB2-B,[2/:MW3?B_XATFVM8;>_,<5FC)"H083.,G
MZ\"C 5,%&/\ M*E?7;MI_P $(\C7OE?QG\.=2\!1P'4%A7SV,>V-]QB<!24;
MC[P# \9'/6L)C@5K>(_&^J>+;:UBU"Z:XCLE(B!&-N<9/U.!637)BI4'5?U>
M_)TON*5K^Z=8OP+U36-($BMI5U;74;(%$^X2L1S#]W!8C/\ L\$9I\_P-UG3
MM/:3.GB&$-&BI-]^2-2SPJ,??15)(X&!P:@E^+^NL!LGMX<0+;CRH%7:JC"X
M]" 3@CU/K3+CXO>(+JUDA>^!CD0H0(E&"00SCCAV!(+=2#7J\^5\MK2_#<T_
M=;G-*<BBA1@45X)B%%%% $^FZ>VJZA#;H\4;3.$#2OL1?<GL*ZFY_9[U:Y9!
M)_9,QC'VR,&4G;$J@FX&5X50W/1ASQ7+Z1JDNAZI;WD'E^=:R"2/S$#KN'3(
M/!KH#\9/$ =V6ZCC,CL[%81EMWWER>=K=QWKU,!+!1BWB>:]]+=BX\C5ID/B
M'X9ZAX<TF:\FFL)(X)$1UAFW, XRC8QC##D<YQU KG:W/$7Q&U3Q5I26=\]O
M)#'(95*PA&#'W'M@?0 5AURXOZO[3_9K\OGW"7+?W3IM ^%>H>(=$&HP7.FQ
MVRC=,TDY!MEPQ#/@''W3P,GIQS5B/X ZII,\-GNTFS=Y%C$)F(*-("T>0%/^
ML )&,^IQ5'3OB?JVE:5:64#6JV]D&6-3;J=P?[P;^]GOGT'I5C_A<OB)I4>2
M\29XV#[I($8L1]TDXYV_P^E>I3GEBII24KZ7[7Z]2E[+KN<U<P-:W,L+XWPN
MT;8.>0<&M#PIX5G\8ZK]CMIK6&4@;3/)L#$G 48!)))]/K@5GW-P]Y<22R,7
MDE8N['JS$Y)_.K_ACQ7=^$+N:>R\D23Q&!C)'O\ D/4#TS[5Y-'V/ME[2_)?
MYV(5KZ[&XOP!U:65;@C2Q(NVW+F;+122 ,D!./O."" ./4BL7Q/X.OO!_P!B
M%^BPR7T N$0-ED7.,,.S>WO6G!\8O$%K'&D=XB)&H"@0KU7 1^G+J  K=0!6
M3XA\7ZEXL^S?VC=R736B&.-I.6 )R<GOR:]#%RR]T_W*ES=+VM_5BG[.WN[F
M=77+\!]6UFTC1?[+O(KY L2"?<+ESN_=#C!;Y&_V>.M<C73_ /"X=>67S([B
M&WD\M(@T,"J4V A67^ZP!(!'J?6N? RPL6WB>;I:Q,>1Z3)+_P"#6K:7H]S>
ME[*2UM$#%H6=]_+*0N%_A*,#G &.M<I71W?Q8UR]CF5[F(>=$825@12BG.[:
M<<;MS9]<FN<J<=+#.2^K)VZW[A+E^R;GA#X>:AXXAF-@UJ9(F"^3)+MDDR0,
M@8Z#(Y)'MDUJV7[/>LS3[[1=-FDO<2HT,G-V@*J91\O*J2 2>?:L7P_XYU#P
MQITUM9O#&D\J3LQC!<.GW2&Z\>G2M%?C-XB0_)?+'R-H2%5$:C!V+QPA(&1W
MQ79A9Y<J:592YNMK%)4^NYB>(]!N/"^LS6-SL,T&-Q3.#D9&,@'\Q46E:<VK
MZA#;(\,33-M#ROL1?<GL*?KNNW/B34FN[M]\S*J?*H5551A5 '0 4FBZO-H&
MK6]];^7Y]JXDC\Q ZAATR#P:\V7L?;:7Y+_.W^=B=+^1TUY^S]JUP'CN/[*=
M(?W[AY21'$IXG(V\(&&/[V1TK.\3?#NZ\)Z7]IN;NP=A<M:-!'(QE5U&3P5
M(Q@Y!/45.GQ>UV'<$N8D5W+LHA7#@DDH<]5))./4FLG7O%-]XE"?;9O.V222
MCY0/FD(+']!^5>CB:F7^R:HJ7-TN]"G[/[*U,^NHT#X3:CXBT5=0@N=-2VX\
MUI+@@VX/"[\*<9/  R>1D#-<O71:=\4M7TG3;.T@>U2"Q5DB'V=3D,<G=_>R
M<')YR!Z5QX%X=3?UF]K:6[BARW]XT++]G;6[("TBBT^W\@$/"KD?9VX(0@+P
M3N!&..>2*XUXS&[*>JDJ?J*ZJ/XU>)(R/^)AO/5B\:DR-D$,WJPVC![8KEYI
MFN)GD<EGD8LQ/<GDFM<=+!RL\+S7UO<)<B5H&EX2\(W'C34_LEM+:Q2X&//D
MV!R3@*, DDGVX[X%;;_L^ZQ'.;DIIOGJIMBXE^?S!\WV?./O]\9Q[UA>&?%M
MYX1GN)+/R-UU"8)/,C#Y0]0/3/M6H_Q@\0/"8_MHVF,I@1+UQC?T^_CC=UQ6
MN#G@%2_?J7-Y#7L[>\4O&7@6^\"7,$=[Y)-PK,C1,6&5.UEZ#D'@]O0FL=%W
MN .K$ 9K2\3^,-1\7RV[:A<&;[+%Y40Q@(OL*S4?8X/!P<X(XKAQ'L?:_N;\
MG2^Y+M?0ZG4O@7J5QHTDDC:3=VDD)<*)]RW.-Q95R,$@(2<\<<$TW5?A%JVB
MVMY+.;+_ $%=[(D^YI5"*[%,##!5=<\]^,U'J?Q9UO54NEDGAC%Y$(91% JY
M7:5X_N_*2O':H+KXDZQ>V-S;R7*F*[4)(/+&=H54P#VRJJ#CK@5Z,Y9=RVBI
M?AN7^[O=&%70>$?AMJ'C>TDDL9+$M&VTQ23;9",@%L8Z#<.N,\XSBN?K;T'X
M@ZGX9TEK.S>".+SQ<[O*!<2#H=WMZ'CDUP8-X=5/]HOR^6Y$;7]XL2_!W4=*
MW/&--VW5[% )([A5$\DR[EDYP=I ^\V.E8FK:9+HNJW-G-M\ZTE:&3:<KN4D
M'!].*OW_ (ZU/4FF,TRGSIXKA@(P &B&(\#L .U9VHZA+JNH3W4[;YKF1I9&
MQC+,<G]35XN6&EK03O?KV_JP/E2M$DT72GUS4X[5)((6ES^\F?9&N.>3_AD^
MU=-=?L^ZR^H6L;KI;W7V@1QYN #"7W*KY(& VU@,<]L5S?A[7KCPMK4%_:>4
M+FV):,R1AU!QC.#6I)\4=:E%O_I$<8MK@7,86(##@EAGN0"S$ ]R:UP<L'&F
MW74N:_3L-*#7O%;5O!5UH_A^'4I)K1X)I?(*QR[GC?!.&&,=!V)QWQ616KK/
MC.]\0:59V=S]G:"QSY.R(*PR23DCKDGFLJN3$>QY_P!S>UEOWZB=NAU6C?!_
M4]=TB&]@N-,^SS ;BUP?W3$J%5N/O$LHP,XSSBJ^D?!O4%^Q6<7]FV9NH9)+
M>#S@,['967"@X;(;CMU.*6S^*^LZ=:VD,$EM''90^1$!;K]W(;GL3N .>N0*
M@TKXCZOHIB,%PFZ%75&>)69=[ERP)_BW$G/O7I<V7**5I>?KI_P2OW=[F'6M
MX1\&77C6[D@M);1)47<JS2;#*>?E7@Y/'T'<BLDG<V3U/)/K6IX:\87OA-+L
M6GD8OHO)F\R(,2F<X!ZCW]:\W#^Q]JO;7Y>MMR8VOJ:&H_!74].FN+HKITLU
MG:R-+)',"Z!'4/". 2P9ER!D>]9WBOPC>>"]1BM;Y46>6!+C:C;MJMG /^T,
M'([5<O?B=K5_/YKW0#^2\&4C"\.RLS<?Q$JI)Z\5G^(O%&H>++N*?4;A[J:&
M)8%=NNT9QGUZGFNS%2P3B_8J5]+7M:W4<N3[)2@A-Q.D8V@LP4%C@#/')[5T
M^M_ O4ETAWG;2+NUEC:2-?/W"Z5 &?:&4#Y>"=V!W&:YFWF:VG210I:-@P##
M(R.>1WKH=7^+.MZW#=QS30A;Y2LNR!5/(VM@_P .5 !QV %1@I82,6\1S<W2
MP+D:M(=X@^%&J^&]*O;NZ:UV6-Q]GE$;M(2V%.00NW'SCDD9YQFN9K<O_B-J
MVI6%W;RSQE;[_7$1*&<?+\N[&<?*O'M6'6&,=!S7U>]O/U_R%+E^R=%X4^&.
MH>,]->YLYK#;&29$DFVO&B_><C!PH^N3@X!JQ8? K5S<E+:/3\7-T4WQ2Y$K
M&(2F4@#=M*8.2,GTJEHGQ(U7P[H\=C9O;I!%,9US""V\C!R>_&1@]B?6G1_$
M[6HKYIQ=1[WE\YAY2[2?+\K&.FW9\N/2N^E4RY4TIJ5].:Q7[O2YD:MIDNBZ
MI<6DW^NMI#&^.F1Z5+X?T23Q#JB6L<UO S@G?.^U!CZ DGT !)J+5]5N-<U.
M>\NI#+<7+EY'(^\:G\,^);KPCK$=]8F);F(,JF2,.%R,$X/?W[5YT/8^VUOR
M7^=B5:^NQO7?P"UB6^MH)4TQ[CS\*C3KF!L.5<DC R$;;@D^U8^L^$WT70K&
M_-Y8W$=^SJD<+-YD97&[<"HZ$XR">:MM\3]9*VN+B-!9R^="%B VM\P&>Y W
MM@'IDUD:AK%QJ<%M',P9+.,Q1 #&U2Q8_JQKMQ4\$X-48ROTN_3_ ((Y<GV2
MM1117E$!1110!K>%?!=WXSEGCLWM1+ A<)++L:7@G"C')P#UP/>M-O@9JL-_
M<.B:;),L*&25)QN<>;Y7E\@$E7.#Q@>M9.@>+;SPS;7D5KY&R_01S;XPQ*@Y
M !ZCGG\*MWGQ+UK4+F266Z4O+"+=L1*!MWB0\8QDN,D]Z];#RP*II55+FZVV
M_K8T_=V][<J^+?"%WX,U%+>Z,3F6,2QR1$E)%R5R,@'JI'3M6=;0&ZN$C4J#
M(P4%FVJ,^I["KWB?Q9?^,M3%YJ,YGF5!&IZ!5'0 ?B?SJE:7+6=U',JJ6B<.
MH9=RD@YY'<5PUO9.L_9WY+Z7WL3I?38ZF^^ VI2QCSI-'EB4K/$SS_*X7:QE
M7*]$W*23@^F:B\1?"/5?#.ER7=Q)8O''&)PL<I+R1%@OF@$#Y=Q YP?:G#XS
M:\MY+.)K8/-+YS@VZE2W&>#V.U<CH=HJGK/Q,UC7M/N+6XGB\FZ;=($B"ELL
M&(SUP6 8C/6O4J3RSV;4%*^MNURW[+=;F#71^%_ACJ'B[2VO+2>P$<1)E62;
M:\*#),C  X48/N<< USE;NC?$?5- TB&QM6MD@MY6F7,(+%F&ULGN""1SV->
M?@O8<_\ M-^6W3>Y$>6_O%Z+X%:E8&&WA.DKYUTL CCN H1I<LK$D 8;ENN[
MGD<UR]U ;2ZDB;&Z-RAQZ@XKH=2^*^LZL+/SY;=GL)Q<P.( K(X.<\<'L/H
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M96OH%%%%<Y)]>?L"?\D=U+_L,R_^B(**/V!/^2.ZE_V&9?\ T1!17]0<'_\
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+_P )[6'_ (:/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>iclr-20221231_g10.jpg
<TEXT>
begin 644 iclr-20221231_g10.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
M   !    2@,#  $    !     %$0  $    ! 0   %$1  0    !   7$5$2
M  0    !   7$0       8:@  "QC__; $,  @$! @$! @(" @(" @(#!0,#
M P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,# P'"0X/#0P."PP,
M#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $T 30,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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3;E'8^DR^G4A14:J2?9._YG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>iclr-20221231_g11.jpg
<TEXT>
begin 644 iclr-20221231_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!F17AI9@  34T *@    @ !@$2  ,
M   !  $   ,!  4    !    5@,#  $    !     %$0  $    ! 0   %$1
M  0    !   7$5$2  0    !   7$0       8:@  "QC__; $,  @$! @$!
M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,
M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $T
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /W\I&;;2TUOO?A2>P'-_$?Q_8^ M FN+JXAAF9&\A)#_K7 R!@<
MUYKHOQRUZP?3[>2WM=<FURW^V6+QD6\:J 2\9/.2,<5V'QLT;%I8ZWY?G?V/
M(WG1[<AX'&V3CV&#^%>50:)+X>M5M;=9+A_">J17UGL&YI;&<X('L,FOS_/L
M=CH8SDI/E26ENIRU)24[(]O\%?$;2_&MA!);7,/VB2$2R6_F R0^H(]CQ63X
MW^+L&D216>CK:ZMJDDC*T N BPA!EV<\XQC'UKS>TTL^#=5N)+&!8[FPUB:
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M@UJGP/\ A,VFZQ)"M]?7T^HO;0N9(;'S6R($;NJ=,]Z]<5N:\RI2@IM1/T?
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MQDY&WJ,=QP:^TD_9'\"KIL5G_9=UY,-RT\0^W39BD9=K%3NXR.,=*CN/V/\
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0<]23F^8];#4?8TU#];G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iclr-20221231_g2.jpg
<TEXT>
begin 644 iclr-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /V$_;,_
MX*$?#W]A^PTF'Q//JFM>*O$C&/0?"N@6;:AK>MN./W-NO.W/!=L*/7M7C4G_
M  4@_:.U39<:/^Q%\0IM-F0/"^H^,=+L+H@C/SPDL4/L3D5D?\$;?!-G^THW
MC3]K+Q,J:OXT^*VMW]GX?N+@;V\.>'[6X>WMK* -_J]WEL[[?O$C/?/W>!@U
MU2]G2?*XW?6[?Z'ET?;XF'M8SY8O9))NW1NZ>_D?$G_#Q']J+_HQWQ=_X<#2
MO\*/^'B/[47_ $8[XN_\.!I7^%?;NTYI=E3[:'\B^]_YE_4J_P#S_E]T/_D3
MXA_X>(_M1?\ 1COB[_PX&E?X4?\ #Q']J+_HQWQ=_P"' TK_  K[>V4;*?MH
M?R+[W_F'U*O_ ,_Y?='_ .1/B'_AXC^U%_T8[XN_\.!I7^%'_#Q']J+_ *,=
M\7?^' TK_"OM[91LH]M#^1?>_P#,7U*M_P _Y?='_P"1/B'_ (>(_M1?]&.^
M+O\ PX&E?X4?\/$?VHO^C'?%W_AP-*_PK[=V&C8:7MZ?_/M?>_\ ,?U*O_S_
M )?='_Y$^(O^'B/[47_1COB[_P .!I7^%'_#Q']J+_HQWQ=_X<#2O\*^W=AI
M"I':CV]/_GVOO?\ F+ZG7_Y_R^Z/_P B?$?_  \1_:B_Z,=\7?\ AP-*_P *
M/^'B/[47_1COB[_PX&E?X5]N8/H:,'T-'MZ?_/M?>_\ ,/J=?_G_ "^Z/_R)
M\1_\/$?VHO\ HQWQ=_X<#2O\*/\ AXC^U%_T8[XN_P##@:5_A7VY@^AHP?0T
M>WI_R+[W_F/ZC7_Y_P ONC_\B?$?_#Q']J+_ *,=\7?^' TK_"C_ (>(_M1?
M]&.^+O\ PX&E?X5]N8/H:,'TI^VA_(OO?^8?4J__ #_E]T?_ )$^(_\ AXC^
MU%_T8[XN_P##@:5_A1_P\1_:B_Z,=\7?^' TK_"OMS:?2C!]*/;0_D7WO_,/
MJ5?_ )_R^Z'_ ,B?$?\ P\1_:B_Z,=\7?^' TK_"C_AXC^U%_P!&.^+O_#@:
M5_A7VYM/I1M/I1[:'\B^]_YA]2K_ //^7W0_^1/B/_AXC^U%_P!&.^+O_#@:
M5_A1_P /$?VHO^C'?%W_ (<#2O\ "OMS:?2C:?2CVT/Y%][_ ,P^I5_^?\ON
MA_\ (GQ'_P /$?VHO^C'?%W_ (<#2O\ "C_AXC^U%_T8[XN_\.!I7^%?;FT^
ME&T^E'MH?R+[W_F/ZE7_ .?\ONA_\B?$?_#Q']J+_HQWQ=_X<#2O\*/^'B/[
M47_1COB[_P .!I7^%?;F#Z&C!]*/;0_D7WO_ #%]2K_\_P"7W0_^1/B/_AXC
M^U%_T8[XN_\ #@:5_A1_P\1_:B_Z,=\7?^' TK_"OMS:?2C:?2CVT/Y%][_S
M#ZC7_P"?\ONA_P#(GQ'_ ,/$?VHO^C'?%W_AP-*_PH_X>(_M1?\ 1COB[_PX
M&E?X5]N8HP?2CVU/^1?>_P#,/J5?_G_+[H?_ ")\1_\ #Q']J+_HQWQ=_P"'
M TK_  H_X>(_M1?]&.^+O_#@:5_A7VY@^AHP?0T>VA_(OO?^8?4J_P#S_E]T
M?_D3XC_X>(_M1?\ 1COB[_PX&E?X4?\ #Q']J+_HQWQ=_P"' TK_  K[<P?0
MT!2:/;0_D7WO_,/J5?\ Y_R^Z/\ \B?$?_#Q']J+_HQWQ=_X<#2O\*/^'B/[
M47_1COB[_P .!I7^%?;F*,4>VI_R+[W_ )A]2K_\_P"7W1_^1/B/_AXC^U%_
MT8[XN_\ #@:5_A1_P\1_:B_Z,=\7?^' TK_"OMW::-AH]M#^1?>_\Q?4Z_\
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M;FTT;33]M#^1?>_\Q_4J_P#S_E]T?_D3XC_X>(_M1?\ 1COB[_PX&E?X4?\
M#Q']J+_HQWQ=_P"' TK_  K[=VFDVFCVU/\ D7WO_,7U.O\ \_Y?='_Y$^(_
M^'B/[47_ $8[XN_\.!I7^%'_  \1_:B_Z,=\7?\ AP-*_P *^W=IHVFCVU/^
M1?>_\P^I5_\ G_+[H?\ R)\1?\/$?VHO^C'?%W_AP-*_PH_X>(_M19_Y,=\6
M?^'!TK_"OMW::39GM1[:'\B^]_YC^IU_^?\ +[H__(GGW[,?Q0\7_&#X26>N
M>.?A[>_"_P 17$TL<WA^[U.'49;=%<A',T/R,'7#8'3.#7H- 2G;#7.VF[H[
MZ<6HI-W\QC=*^</AYX)\(_%#]IGXQK\0M+\/Z]XCTF]MK;3K76[:&Y6RT!K*
M!XV@24$+#).;HR,H :1"&)V #Z1,>:Y;XA_ KP9\7)[6;Q5X3\-^));-62W?
M4].ANF@5CEE4NI(!(&0.#BJC*QG6I.5FNCV>VUCX^_9I^(?BCQ1\99?AEX9^
M($?A/X>16&M:IX5F@@@O+R[L;?5?L\'V>2X#J;6/,B#ALPQQ;< [JG3]LSXC
M_$32U:QNM1T^;0/"4>O27FAZ593V.KSFZOH/M,YNYE,=BRV:OB(AL3DF0;5!
M^C_%/[('@_QW\7K7Q+K>D:/JVGV/AU?#UMHMWID,UG;(L_FK(@8':0/DV@ ;
M?RKJ/%7P"\#^.8M,CUKP?X7U:/18Q#8)>:9#,ME&,82,,IVK\J_*,#@<<5NZ
MT+W://C@ZZCRJ=OF]?\ )+I8^4/#'[5'Q&\9:/KVN:CXJ;0X[[QA:^#]"T#2
M='M]0NS)/96=[+LE<B-YD1KD1L["(*"[>8=JCF=2^)?B[XH_%7P.-4\6ZC#<
M>"?%'BW0G$?V";^U([?15N%%V(T:%I1YC1.(]HX/"N"1]O:]\'?"?BG1=0TW
M4O#/A_4-/U:Z6^O;:XL(I(KNX 4":12N&D 1 '/(V+SP*HP?LZ^ ;2TCMXO!
M/A.*&&Y2\CC328%5)TC\I90 O#B/Y W7;QTXHC6AV_JUBI8&LU9SO\WWN?,/
M@[X\^,M:^!'B#Q)8^--&\(Q?"WPCI%[;Z,NF6_V75FDT>WO6>X# ,D$KR-;Q
M+ 8]IB8@L1M&G9_'KXB06.J>.KSQ9'%H^F_$>V\-+X>?3(1 FG7$UK"ZRRA?
M-,\33NRNI  0*RMDFOH_6/@!X&\1:EI=YJ'@WPO>W>AQ1P:=-/I<+O8QQG,:
M1DK\BH0"H& IZ8K8?P#HLEM)"VCZ6T,UZNI2(;5-LET&5Q<,,8,H958.?F!4
M'.0*CVD>QK'"U.LOQ>_3[MK;'SO^RU\<?&FO_%O2M-\9:^;P^*M(N]3LXH;2
MTN-&OQ#+'MFTN\MFW>4(Y%WQW*ER64ALA@?IP5S/@[X)>#_AYKUYJF@>%?#N
MBZGJ (NKNQTZ*WFN S;V#.J@D%OF([GGK74;#6=22;NCIP].<(VF[C:\?_;!
M^.WQ&^!/A?1[SX<_!W4_C'?W]VT%Y8V6N6VE-I\03<)6><$,"WRX'/>O8MAI
MK1;J46D[M7*JPE*+C&7*^ZM^NA\1_P##Q#]J(?\ -COBW_PX.E?X4?\ #Q']
MJ+_HQWQ=_P"' TK_  K[=$>*78:V]M#^1?>_\SB^I5_^?\ONA_\ (GQ#_P /
M$?VHO^C'?%W_ (<#2O\ "C_AXC^U%_T8[XN_\.!I7^%?;VRC8:?MJ?\ (OO?
M^8OJ=?\ Y_R^Z/\ \B?$/_#Q']J+_HQWQ=_X<#2O\*/^'B/[47_1COB[_P .
M!I7^%?;VRDV&CVT/Y%][_P P^IU_^?\ +[H__(GQ%_P\1_:B_P"C'?%W_AP-
M*_PH_P"'B/[47_1COB[_ ,.!I7^%?;NPT;#2]M3_ )%][_S#ZG7_ .?\ONC_
M /(GQ%_P\1_:B_Z,=\7?^' TK_"C_AXC^U%_T8[XN_\ #@:5_A7V[L-&PT_;
M0_D7WO\ S']2K_\ /^7W1_\ D3XB_P"'B/[47_1COB[_ ,.!I7^%'_#Q']J+
M_HQWQ=_X<#2O\*^W=AHV&CVU/^1?>_\ ,/J5?_G_ "^Z/_R)\1?\/$?VHO\
MHQWQ=_X<#2O\*/\ AXC^U%_T8[XN_P##@:5_A7V[L-&PT>VI_P B^]_YA]2K
M_P#/^7W0_P#D3XB_X>(_M1?]&.^+O_#@:5_A1_P\1_:B_P"C'?%W_AP-*_PK
M[=V&C8:/;4_Y%][_ ,P^I5_^?\ONA_\ (GQ%_P /$?VHO^C'?%W_ (<#2O\
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MP-*_PK[<Q1BE[:'_ #[7WO\ S#ZE7_Y_R^Z'_P B?$?_  \1_:B_Z,=\7?\
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M_P#Q=3#XM^+L?\C=XK_\'-S_ /%US*=:F'2CV<.R(EB*O\S^]G0?\+;\7?\
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M_P 71_PM;Q6/^9J\4?\ @WN/_BZP:*:IQ[&;Q5;^9_>SHA\5O%>/^1J\4?\
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M\>ZOHNH:C9ZMXWO-/TD(U]=07MW)!9!SM0RN&*Q[FX&XC)X%4_\ A:7BD?\
M,T>)O_!M<?\ Q=?H]K?PC\(_#SX ?M":;H^@RZ(VO>'_  1=>)?#L"2:7;V]
MU)J\BR);"Z;S+>*5,,HF(\LMSA<5Y?\ \%-/V9/"G@#X'Q^)O#/@?3/ D.F^
M*!H:6EYIESI6LJC0,_DG,TUOJ4:[0QO(V!R0,%3FJHXR$IV<=W9?<M_O,,=P
M_BJ%%UE6ORJ[5W_-):?*-W?7R/C,?%/Q3C_D:?$W_@VN/_BZ7_A:7BG_ *&C
MQ-_X-KC_ .+K"'2BO0C"/9'Q[Q5;^=_>S>_X6GXHS_R-'B;_ ,&UQ_\ %T[_
M (6CXH_Z&CQ-_P"#6X_^+KGZDH=./8GZU6_G?WLWX_BCXH_Z&CQ-_P"#6X_^
M+IW_  M'Q1_T-'B;_P &MQ_\76!'3J'3CV(EBJW\[^]FY_PM'Q1_T-'B;_P:
MW'_Q=.3XH^*=W_(T>)O_  :W'_Q=8-.3K0J<>Q#Q5;^=_>S>/Q0\4'_F:/$O
M_@UN/_BZD'Q0\48_Y&CQ+_X-;C_XNN?J0=*3IQ[$_6J_\[^]FY_PM#Q1_P!#
M1XE_\&MQ_P#%T?\ "T/%'_0T>)/_  :W'_Q=8=%/V<;;(GZW7O\ &_O9N#XH
M>*,_\C1XE_\ !K<?_%U)_P +0\4?]#1XE_\ !K<?_%USXZU)2]G'L)XNO_._
MO9NK\3_%!/\ R-'B7_P:W'_Q=/\ ^%G>*/\ H9_$G_@UN/\ XNL!/O4^APCV
M%]:K_P [^]FX/B?XH'_,S>)/_!K<?_%T?\+0\4?]#-XD_P#!K<?_ !=8=%+V
M<>QG];K_ ,[^]F\GQ/\ %!)_XJ;Q)_X-;C_XNG?\+.\4?]#-XD_\&MQ_\76#
M'3J/9Q[!];K_ ,[^]FX/B?XH)_Y&;Q)_X-;C_P"+J3_A9OB?_H9O$G_@UN/_
M (NN?'6I*/9Q[&?URO\ SO[V;G_"SO$__0S>)/\ P:W'_P 73D^)OB?;_P C
M-XD_\&MQ_P#%U@TY.E')'L#QE>WQO[V;O_"S?$__ $,WB3_P:W'_ ,71_P +
M-\3_ /0S>)/_  :W'_Q=8E%')'L9_7*_\[^]FY_PLWQ-_P!#-XD_\&MQ_P#%
MT_\ X6;XF_Z&;Q)_X-;C_P"+K J2CV<>Q,L97_G?WLW4^)GB;'_(S>)/_!I<
M?_%TO_"S/$W_ $,WB3_P:7'_ ,76&G2G4N2/8GZY7_G?WLW/^%F^)O\ H9O$
MG_@UN/\ XNA?B=XFW?\ (S>)/_!I<?\ Q=8=*GWJ481[$?7*_P#._O?^9O\
M_"S?$_\ T,WB3_P:7'_Q='_"S?$__0S>)/\ P:3_ /Q=8=%"IQ[(7URO_._O
M?^9O)\3?$V/^1F\2?^#2X_\ BZ7_ (69XF_Z&7Q'_P"#2X_^+K"3I3J)0CV)
M>,KW^-_>S<_X6;XF_P"AE\1_^#2X_P#BZ(_B9XFSSXE\2?\ @TG_ /BZPZ<G
M6I5./8EXRO;XW][-T_$SQ,?^9E\1_P#@TG_^+IX^)7B;_H9?$?\ X-)__BZP
M:DIRIQ[$_7*_\[^]FU_PLKQ-_P!#+XC_ /!I/_\ %T?\+*\3?]#+XC_\&D__
M ,76+12]G'L3]<K_ ,[^]FVOQ+\3 _\ (R^(_P#P:3__ !=/_P"%E^)<_P#(
MR^(O_!G/_P#%U@CK4E'LX]B98RO_ #O[V;B_$KQ+G_D9?$?_ (,Y_P#XND;X
ME>),_P#(R>(O_!I/_P#%UBI]ZD/6IE3CV)^N5_YW][-Y/B5XDQ_R,GB+_P &
MD_\ \71_PLKQ)_T,GB+_ ,&D_P#\56(GW:6I]G'LB7C*_P#._O?^9N)\2O$F
M?^1D\1?^#.?_ .+IW_"RO$G_ $,GB+_P9S__ !=8:=:=5>SAV0OKE?\ G?WO
M_,VA\2O$H_YF3Q%_X-)__BZ/^%E^)O\ H9?$7_@SG_\ BJQ:*?)'L3+&5_YW
M][-U/B5XEV_\C)XB_P#!G/\ _%T]?B5XE/\ S,GB'_P9S_\ Q=82?=IR?>J/
M9Q[$?7,1_._O9N_\+)\2?]#)XB_\&<__ ,53K?XH>)[6=)(_$WB1)(V#HRZI
M.&5@<@@[ZPZ*/9Q[$_7<0M>=_>S]A/\ @B'^W3XH_:1\-^(_ _C74)];UCPG
M%%>6.J3G=<75J[%"DK?Q,C 88\D.,Y(S7F__  =@_P#*/CP?_P!CW:_^D-[7
M&_\ !NO_ ,G#_$+_ +%V+_TI6NR_X.PO^4?'@_\ ['NU_P#2&]KYFK3C#,%&
M.BN?UAP;F&(QO!RK8F3E)*2N][*5E?OH>S?\&[O_ "B&^%O^]JG_ *<[JOR)
M_P"#EG_E+%XI_P"P#I'_ *35^NW_  ;N_P#*(;X6_P"]JG_ISNJ_(G_@Y9/_
M !MB\4_]@'2/_2:JP/\ OTOG^9[V>?\ (CI?]N_D?!,9P*'N(XVPTD:_5A7J
M'[(_PBTOXM?$RX;Q LTOAOPSI\FM:G;02^3-?1H\<<=NK]4\V:6)"PY568CD
M"OJ33/C#K'A>%K70(](\,Z:#^ZL-*TR""WA'0#[A9C_M.S,>Y)KZ#5NT3\=S
MCB#"Y;*,*UW*6MEVVN[^9\%K>PX_UT?_ 'T*<;V'_GI'_P!]BOOH_M">,_\
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MN&!_EE]R_P SXM^UQ?\ /2/_ +Z%'VN+/^LC_P"^A7VC_P -%^-A_P S!/\
M^ \'_P 12_\ #1?C;'_(P3_^ \'_ ,13YYA_K=@OY9?<O\SXN^U0_P#/6/\
M[[%2PW<(_P"6D?\ WT*^R_\ AHSQM_T,$_\ X#P?_$4O_#1GC?\ Z&"X_P#
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M_P#+/[E_F?%_VZ'_ )Z1_P#?5.6]A(_UD?\ WU7V>/C_ .,?^@Y+_P" \/\
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M_?B'_P"(JK3%_K+E_:?W+_,^3_M,7_/6+_OJG"ZB _UD?_?0KZN_X:"\9_\
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M_A.6'_QFCZ]_=_$G_5M?\_?_ "7_ ()^>.1[?G0A^;M7Z'?V-H__ $+7@_\
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M7M_X(H>*?VYO%FE_%/X4C3[KQQIU@NF:MHMU<+:_VS!&S-%)%*V$69-S*0Y
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M?\D=U3_P.L__ ([4G_#BO]JC_HCVJ?\ @=9__':/K5/^>(O^(:Q_Y]U?N_\
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M_P *73?_ (_1_P *[U#'_'UX;_\ "ETW_P"/UD_\.6/VF?\ HD^I?^!EI_\
M':!_P18_:9!_Y)/J7_@;:?\ QVI^NTO^?D?Z^8?\0TG_ - ];[G_ /(FM_PK
MK4"/^/KPW_X4NF__ !^E_P"%=:B?^7GPW_X4FF__ !^LH?\ !%O]I@?\TGU+
M_P #;3_X[3D_X(M_M,$_\DGU+_P-M/\ X[3^O4_^?D?Z^8O^(:S_ .@>M]S_
M /D32_X5SJ)_Y>?#?_A2Z;_\?I1\.=0'_+UX;_\ "DTW_P"/UG?\.7/VF/\
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M7.LN]2IZ,,&OI@?\$;_VE<_\DMU/_P #K7_X[3O^'./[2G_1+M3_ / VU_\
MCM-8S#I)<Z^]'J2X=S>4N9X:I_X!+_(]D^!OQZT;]H'P?I\ZZMI]KXMM;2*W
MU;3;V[CMYII(T"?:83(565) H8A3N5RPQC!KN%T:0C_7:?\ ^!\'_P 77S&?
M^".'[2;?>^%NI-];VT_^.4?\.:_VD#_S2S4?_ RT_P#CE<,HX:^E56]4>]'#
MYO9<^#J-]7RRU\]CZ>_L:3/^NT__ ,#X/_BZ/[&D_P">VG]?^?\ @_\ BZ^8
M?^'-?[2'_1+-0_\  RT_^.4?\.;/VD/^B5ZA_P"!EI_\<I<N'_Y^K\/\P^KY
MK_T!5/NE_P#(GT\-%D_Y[:?_ .#"#_XN@:+,?^6VG_\ @?!_\77S&O\ P1L_
M:0_Z)9J'_@9:?_'*=_PYM_:0'_-+=1_\#;3_ ..4<N'_ .?J_#_,7U?-?^@*
MI]TO_D3Z:_L2;_GMI_\ X'P?_%T?V'-_SUT__P #X/\ XNOF8?\ !&[]H_\
MZ);J'_@9:?\ QRG_ /#F_P#:._Z);J'_ (&6O_QRIY:'_/U?A_F+V&:_] 53
M[I?_ ")]+?V'-_SUT_\ \#X/_BZ/[#G_ .>FG_\ @?!_\77S3_PYO_:._P"B
M6ZA_X&6O_P <IP_X(X_M'8_Y);J'_@9:_P#QRGRX?_GZOP_S%[#-?^@&I]TO
M_D3Z4_L*?_GII_\ X'P?_%T?V%/_ ,]-/_\  ^#_ .+KYK_X<Y?M'?\ 1+=0
M_P# RU_^.4?\.<OVCO\ HENH?^!EK_\ '*.7#_\ /U?A_F+V.:_] -3[I?\
MR)]*?V%/_P ]-/\ _ ^#_P"+H&@W!_Y::?\ ^!\'_P 77S7_ ,.<?VCO^B6Z
MA_X&6G_QRG_\.<OVCL?\DNU#_P #;3_XY3Y</_S]7WK_ ##V.;?] -3[I?\
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M<'.!5RU^)FM0:1:PNNF75Q;R1[I)[Z%A)$D/E!"?,W'=G<W."40C&*^0X_\
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MOO\ P,M?_CE'_#H?]H?_ *)C??\ @9:__'*/W'_/Q?A_F'_"S_T+ZG_@,O\
MY$]X_P"$;O/^G/\ \#8/_BZ!X;NS_P ^?_@;!_\ %UX2O_!(?]H;'_),[_\
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M7P3_ ."R7_X[2^J30?\ $O\ Q=_)3_\  U_D?K[FC-?D'_P_+^-7_/KX)_\
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M&K_GU\$_^"V7_P".T?\ #\7XU'_EU\$_^"V7_P".T?59A_Q #BW^2G_X&O\
M(_7C.:*_(D?\%P?C01_QZ^"?_!9+_P#':/\ A^#\:?\ GV\$_P#@ME_^.TOJ
ML_(G_B /%O\ )3_\#7^1^NU%?D3_ ,/POC3_ ,^O@G_P6R__ !VC_A^%\:?^
M?7P3_P""V7_X[1]5F'_$ >+?Y*?_ (&O\C]=J*_(G_A^%\:?^?7P3_X+9?\
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M ."V3_X[1_P^N^,G_/KX+_\ !;)_\=H^KS#_ (@/Q5_)#_P-?Y'ZS45^3/\
MP^N^,G_/KX+_ /!;)_\ ':/^'UWQD_Y]?!?_ (+9/_CM+ZM/^O\ A@_X@/Q7
M_)#_ ,#1^LU%?DS_ ,/KOC)_SZ^"_P#P6R?_ !VG_P##ZOXQ_P#/MX,_\%LG
M_P =H^K3#_B _%?\D/\ P-'ZQT5^3G_#ZOXQ_P#/MX,_\%LG_P =H_X?5_&3
M_GV\&?\ @MD_^.T_J\P_X@/Q7_)#_P #7^1^L=%?DY_P^J^,?_/MX,_\%LG_
M ,=H_P"'U?QC_P"?7P9_X+I/_CM'U:9/_$">*OY(?^!H_6.BOR<_X?5_&/\
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M\,'_ !!#BC^2'_@:/U.HK\L?^'R/Q>_Y]O!__@OD_P#CM'_#Y'XO?\^W@_\
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MG_/OX1_\%\G_ ,<I?5Y!_P 04XF_EA_X&C]1**_+O_A\-\7/^??PC_X+Y/\
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M>]_%C_GW\)?^"^3_ ..4?\/>_BQ_S[^$_P#P7R?_ !RCZO+N'_$%^)OY8?\
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M#<(TEGX3FC4Y:,V4B[AZ9$G'UJ?8RZA_Q!GB1:\D/_ T?I<!7Y?_ /!V"?\
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M:93T^[0 M%%% $D'0U)4<'0U)4R,9;A11FC-22%%&:,T %25'FI,T %%&:*
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M\:I6T[P3=#RV\,ZO9HW!FM]:,DL7NJO'M;Z$C/K6=11RH/JG_3RI_P"#)_\
MR1@_$+P,W@;5H5BNX]1TW4(1=6%XB;/M$1)4AE_@D1@59><$=2"":?@_PG>^
M._%%CH^G(LEYJ$GEQ[SM1!@EG8]E506)[ &NG^)A9_AYX8W,6\J[U!$]E_T9
ML?FQ/XTO[.C,GQ/W*Q&-+U#I_P!>LE<[C[UCT8YC6AE-7$R=YP4]7U<;I-I>
MFOZ';:?\(?!&C6ZP2VNK^(IE^_>&^^PQR'_IG$J,0OH68L>^.E3CX;>! ?\
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M]81M&^["E3QP.:.96N5_K7.=&5:A.HTI1BKU)1OS::N[M9[[GA:_";P.1_R
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M_P *O\$_] #4_P#P<O\ _&Z/^%7^"?\ H :G_P"#E_\ XW6G10'M*W_/V?\
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M%))II&"I'&I9G)Z  <DT"=2"5VT0_$D_\6]\-_\ 7[J'_H-K2_LZ_P#)3/\
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M?^#L+_E'QX/_ .Q[M?\ TAO:[+_@C3Q\8_&/_8&C_P#1XKC?^#L+_E'QX/\
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M /T(_A+_ ,%,'_Q-+_PSOX _Z$CPG_X*8/\ XFI^N+L<?_$P63_]"O\ &/\
M\B?@Y_PTEXR_Z&>Y_P"^8O\ XFC_ (:2\9?]#/<_]\Q?_$U^\?\ PSOX _Z$
MCPG_ ."F#_XFC_AG?P!_T)'A/_P4P?\ Q-'UM>8?\3!9-_T*_P 8_P#R)^#G
M_#2GC+_H:+C_ +YA_P#B:/\ AI3QE_T-%Q_WS#_\37[Q_P##._@#_H2/"?\
MX*8/_B:/^&=_ '_0D>$__!3!_P#$T?7%V%_Q,%D__0K_ !C_ /(GX.?\-*>,
MO^AHN/\ OF'_ .)H7]I3QEG_ )&BX_[YA_\ B:_>/_AG?P!_T)'A+_P4P?\
MQ-'_  SQX _Z$CPE_P""F#_XFG]<78?_ !,%DW_0K_&/_P B?A /VDO&6/\
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MS\8__(GX&^)_'FI>-;J.?5]8NM2DA!6+[1/N6('DA5Z*/8 "LZ.ZB _UD?\
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M0_\ F6?C'_Y$_#O_ (:1\9?]#1=?^0O_ (FC_AI'QE_T-%U_Y"_^)K]Q/^%
M>!/^A+\*_P#@J@_^)H_X4#X%_P"A,\*_^"N'_P")H^M!_P 1XR?_ *%GXQ_^
M1/P\'[1_C(C_ )&BZ_\ (7_Q-+_PT?XR_P"AHNO_ "%_\37[A?\ "@/ G_0E
M^%?_  50?_$T?\* \"?]"7X5_P#!5!_\31]:%_Q'C)_^A9^,?_D3\/?^&C_&
M7_0T77_D+_XFG?\ #1OC#_H:+K_R%_\ $U^X'_"@/ G_ $)?A7_P50?_ !-+
M_P *#\"_]"9X5_\ !7!_\31]:#_B/&4?]"S\8_\ R)^'W_#1OC#_ *&BZ_\
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M ,-%>,/^AGNORB_^)I/^&BO&'_0SW7Y1?_$U^W?_  H/P+_T)OA;_P %</\
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M /0G>%__  60_P#Q-'_"A_ __0G>%_\ P60__$T?65V#_B.&4_\ 0M7WQ_\
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M- ^!G@D'_D4?#7_@MA_^)I?6$'_$:,I_Z%R^^/\ \B?CO_PT;XR!_P"1JO\
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M/@?X+'_,H^&O_!;#_P#$T+$)!_Q&C*?^A=^,?_D3\?!^T7XQ'_,TWW_?2?\
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M_@L=X2!_Y$[Q/_W]@_\ BZ_/]>!4;#YJ/^(>Y/\ RR_\"8_^(\<76_BP_P#
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MX*K>&'7_ )%7Q%_W\@_^*KX;J2#[II/@W+?Y7_X$./BWQ$W_ !(_^ (^XO\
MAZIX9_Z%7Q%_W\A_^*H_X>J>&?\ H5?$7_?R'_XJOB&BH_U-RW^5_P#@0_\
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M*KXKIZ?=I/A3+^S^\%XH9_\ SQ_\!1]IC_@IYX;Q_P BSK__ '\A_P#BJ/\
MAYWX;_Z%G7_^^X?_ (JOC!/NTM9_ZJX#L_O-/^(G9[_/'_P%'V=_P\Z\-_\
M0LZ__P!]P_\ Q5._X>;^&_\ H6=?_P"^X?\ XJOB^I*/]5<!V?WE1\3L]_GC
M_P" H^S/^'FWAO\ Z%K7_P#ON'_XJ@?\%-O#9_YEG7_^^X?_ (JOC.@'FC_5
M; =G]Y7_ !$S/?YX_P#@*/L[_AYGX;_Z%K7_ /OY#_\ %4?\/,_#?_0M:_\
M]_(?_BJ^-:*G_5? =G]Y7_$3,\_GC_X"C[*'_!3/PW_T+.O_ /?R'_XJ@?\
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M45I--.VUT[?B>T?\&[O_ "B)^%O^_JG_ *<[JOGC_@K!_P GH:S_ -@^S_\
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M[_@R/^9%TW_O[+_\57\UZ_\ !;O]K0C_ )+QXS_[]V?_ ,9I5_X+<_M:;O\
MDO'C/_OW9_\ QFCZQFO_ $$2_P# I?YC_P"('Y=_T"X?_P  7_R)_2A_P[P^
M#/\ T(NF_P#?V7_XJD_X=X?!G_H1=-_[^R__ !5?S9#_ (+<_M:9_P"2[^,O
M^_=G_P#&::?^"WG[6F?^2[>,O^_5I_\ &:/K&:O_ )B)?^!2_P Q_P#$#<N_
MZ!</_P" +_Y$_I27_@GK\&T&!X'TT?\ ;67_ .*I?^'?'P<'_,CZ;_W]E_\
MBJ_FM'_!;O\ :TP?^+[>,O\ OW:?_&:5/^"W7[6A'_)=O&7_ '[M/_C-'MLU
M_P"@B7_@4O\ ,T7@?@/^@7#_ /@"_P#D3^E'_AWS\&_^A'TW_O[+_P#%4?\
M#O?X.?\ 0CZ=_P!_9?\ XJOYK_\ A]S^UI_T7;QE_P!^[3_XS1_P^W_:SQ_R
M7;QE_P!^[3_XS0JN:O\ YB)?^!2_S*_X@;@7_P PU#_P!?\ R)_2>?\ @GK\
M&V_YD?3?^_LO_P 51_P[S^#8_P"9&T[_ +^R_P#Q5?S8?\/N/VM/^B[>,O\
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M ,EU\8_]^[3_ .,T-_P6V_:R7_FNWC+_ +]VG_QFC_A4_P"?\O\ P*7^8?\
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M\U/_  ^V_:R_Z+IXQ_[]VG_QFC_A]M^UE_T73QC_ -^[3_XS1[+,_P#G\_\
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M_P /MOVLO^BZ>,?^_=I_\9H_X?;?M9?]%T\8_P#?NT_^,TOJV8_\_G_X$_\
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M/^A2L_\ O[)_\51_PQ5\,<?\BG9_]_9/_BJ_FB_X?;?M9?\ 1=/&/_?NT_\
MC-'_  ^V_:R_Z+IXQ_[]VG_QFCZMF/\ S]?_ ($_\Q?\0/7_ #[H_P#@/_VI
M_2^/V+/AB!_R*=G_ -_9/_BJ/^&+/AC_ -"G9_\ ?V3_ .*K^:#_ (?;?M9?
M]%T\8_\ ?NT_^,T?\/MOVLO^BZ>,?^_=I_\ &:7U7,/^?K^]_P"8_P#B!_\
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MUN(M#_X)M:)X-N)%7Q#\.M?UKPYKUKR'L;R+4)W9&!YY21&![AJ\#_X./O\
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M^2"_%W_PEKS_ .(K^B/_ (>M?&+_ *,F^/W_ '_T[_X[0?\ @JU\8C_S9/\
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M (>M?&#_ *,G^/\ _P!_]/\ _CM'UBK_ "K[U_F5_P 1"DOL+[I?Y'\\C_\
M!,O]HX_\T'^+G_A+7?\ \13O^'9G[1W_ $0?XN?^$M=__$5_0U_P]9^,'_1D
M_P ?O^_^G_\ QVC_ (>L_&#_ *,G^/W_ '_T_P#^.T?6*O\ *OO0?\1$?\B^
MZ7^1_/(?^"9O[1H_YH/\7/\ PEKO_P"(IZ?\$SOVC-O_ "0?XN?^$M=__$5_
M0Q_P]:^,'_1D_P ?O^_^G_\ QVC_ (>M?&#_ *,G^/W_ '_T_P#^.T?6JO\
M*OO12\17_(ONE_D?SSC_ ()F_M& G_BP_P 7/_"6N_\ XBC_ (=G_M&?]$(^
M+G_A+7?_ ,17]#'_  ]:^,/_ $9/\?O^_P#I_P#\=H_X>M?&'_HR?X_?]_\
M3_\ X[3^M5OY5]X+Q&E_(ONE_D?SU'_@F?\ M&;?^2$?%O\ \)>[_P#B*;_P
M[-_:,_Z(/\6__"7N_P#XBOZ%_P#AZU\8<_\ )D_Q^_[_ .G_ /QVC_AZU\8?
M^C)_C]_W_P!/_P#CM+ZU5_E7WC_XB/+_ )]K[I?Y'\]/_#LS]HW_ *(1\6O_
M  E[O_XBA?\ @F;^T8&_Y(1\6O\ PE[O_P"(K^A;_AZW\8?^C)OC]_W_ -/_
M /CM'_#UOXP_]&3_ !^_[_Z?_P#':OZY6_E7WK_,K_B),O\ GVONE_D?ST?\
M.S?VC/\ HA'Q;_\ "7N__B*/^'9O[1G_ $0CXM?^$O=__$5_0O\ \/6OC#_T
M9/\ '[_O_I__ ,=H_P"'K7QA_P"C)_C]_P!_]/\ _CM/ZY5_E7WHK_B)4_\
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M  E[O_XBE7_@F=^T9G_DA'Q:_P#"7N__ (BOZ$_^'K7QA_Z,G^/W_?\ T_\
M^.T?\/6OC#_T9/\ '[_O_I__ ,=I_7*W\J^]?YE?\1.G_P ^U]TO\C^>Y?\
M@F?^T9N/_%B?BU_X3%W_ /$4T_\ !,[]HS/_ "0CXM?^$O=__$5_0G_P]:^,
M/_1D_P ?O^_^G_\ QVC_ (>M?&'_ *,G^/W_ '_T_P#^.T?7:W\J^]?YE+Q/
MFO\ EVONE_D?SVC_ ()G?M&8_P"2$_%K_P )>[_^(I4_X)G_ +1@'_)"?BU_
MX3%W_P#$5_0C_P /6OC#_P!&3_'[_O\ Z=_\=H_X>M?&+_HR?X_?]_\ 3O\
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M'_HR;X_?]_\ 3_\ X[1_P];^,/\ T9-\?O\ O_I__P =H^OUOY5]_P#P2O\
MB*E3_GU'[I?Y'\^?_#M#]HO_ *(5\6?_  F+O_XBC_AVC^T4!_R0KXL_^$Q=
M_P#Q%?T&#_@JU\83_P V3_'[_O\ Z?\ _':7_AZU\8?^C)_C[_W_ -/_ /CM
M/^T*W\J^_P#X(?\ $5:O_/I?=+_(_GR_X=H_M%'_ )H7\6/_  F+O_XBFG_@
MFA^T46'_ !8OXL?^$Q=__$5_0=_P]9^,/_1D_P ?O^_^G_\ QVC_ (>M?&'_
M *,G^/W_ '_T_P#^.T?VA6_E7WK_ #+_ .(L5?\ GTONE_D?SY_\.T/VBO\
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M $__ ..T?VI7_E7WH/\ B,%;_GU'[I'\^[?\$R_VB'7:WP+^*S*W4'PQ=_\
MQ%._X=F_M% ?\D,^*W_A,7?_ ,17] W_  ];^,'_ $9/\?O^_P#I_P#\=H_X
M>M_&#_HR?X_?]_\ 3_\ X[1_:E?^5?>O\P_XC!6_Y]1^Z7^1_/S_ ,.SOVBL
M?\D,^*__ (3%W_\ $4?\.SOVBO\ HA?Q7_\ "9N__B*_H&_X>M_&#_HR?X_?
M]_\ 3_\ X[1_P];^,'_1D_Q^_P"_^G__ !VG_:E?^5?>@_XC!6_Y]1^Z7^1_
M/S_P[._:*_Z(9\5__"9N_P#XBC_AV=^T5C_DAOQ7_P#"8N__ (BOZ!O^'K?Q
M@_Z,G^/W_?\ T_\ ^.T?\/6_C!_T9/\ '[_O_I__ ,=H_M2O_*OO7^8?\1@K
M?\^H_=+_ "/Y^?\ AV=^T5_T0WXK?^$Q=_\ Q%'_  [._:*_Z(;\5O\ PF+O
M_P"(K^@;_AZW\8/^C)_C]_W_ -/_ /CM'_#UOXP?]&3_ !^_[_Z?_P#':/[4
MK_RK[U_F'_$8*W_/J/W2_P C^?G_ (=G?M%?]$-^*W_A,7?_ ,11_P .SOVB
MO^B&_%;_ ,)B[_\ B*_H&_X>M_&#_HR?X_?]_P#3_P#X[1_P];^,'_1D_P ?
MO^_^G_\ QVC^U*_\J^]?YA_Q&"M_SZC]TO\ (_GY_P"'9W[17_1#?BM_X3%W
M_P#$4?\ #L[]HK_HAOQ6_P#"8N__ (BOZ!O^'K?Q@_Z,G^/W_?\ T_\ ^.T?
M\/6_C!_T9/\ '[_O_I__ ,=H_M2O_*OO7^8?\1@K?\^H_=+_ "/Y^?\ AV=^
MT5_T0WXK?^$Q=_\ Q%'_  [._:*_Z(;\5O\ PF+O_P"(K^@;_AZW\8/^C)_C
M]_W_ -/_ /CM'_#UOXP?]&3_ !^_[_Z?_P#':/[4K_RK[U_F'_$8*W_/J/W2
M_P C^?G_ (=G?M%?]$-^*W_A,7?_ ,11_P .SOVBO^B&_%;_ ,)B[_\ B*_H
M&_X>M_&#_HR?X_?]_P#3_P#X[1_P];^,'_1D_P ?O^_^G_\ QVC^U*_\J^]?
MYA_Q&"M_SZC]TO\ (_GY_P"'9W[17_1#?BM_X3%W_P#$4?\ #L[]HK_HAOQ6
M_P#"8N__ (BOZ!O^'K?Q@_Z,G^/W_?\ T_\ ^.T?\/6_C!_T9/\ '[_O_I__
M ,=H_M2O_*OO7^8?\1@K?\^H_=+_ "/Y^?\ AV=^T5_T0WXK?^$Q=_\ Q%'_
M  [._:*_Z(;\5O\ PF+O_P"(K^@;_AZW\8/^C)_C]_W_ -/_ /CM'_#UOXP?
M]&3_ !^_[_Z?_P#':/[4K_RK[U_F'_$8*W_/J/W2/Y^?^'9W[17_ $0WXK?^
M$Q=__$4?\.SOVBO^B&_%;_PF+O\ ^(K^@;_AZW\8/^C)_C]_W_T__P".T?\
M#UOXP?\ 1D_Q^_[_ .G_ /QVC^U*_P#*OO7^8?\ $8*W_/J/W2_R/Y^?^'9W
M[17_ $0WXK?^$Q=__$4?\.SOVBO^B&_%;_PF+O\ ^(K^@;_AZW\8/^C)_C]_
MW_T__P".T?\ #UOXP?\ 1D_Q^_[_ .G_ /QVC^U*_P#*OO7^8?\ $8*W_/J/
MW2_R/Y^?^'9W[17_ $0WXK?^$Q=__$4?\.SOVBO^B&_%;_PF+O\ ^(K^@;_A
MZW\8/^C)_C]_W_T__P".T?\ #UOXP?\ 1D_Q^_[_ .G_ /QVC^U*_P#*OO7^
M8?\ $8*W_/J/W2_R/Y^?^'9W[17_ $0WXK?^$Q=__$4?\.SOVBO^B&_%;_PF
M+O\ ^(K^@;_AZW\8/^C)_C]_W_T__P".T?\ #UOXP?\ 1D_Q^_[_ .G_ /QV
MC^U*_P#*OO7^8?\ $8*W_/J/W2/Y^?\ AV=^T5_T0WXK?^$Q=_\ Q%'_  [.
M_:*_Z(;\5O\ PF+O_P"(K^@;_AZW\8/^C)_C]_W_ -/_ /CM'_#UOXP?]&3_
M !^_[_Z?_P#':/[4K_RK[U_F'_$8*W_/J/W2_P C^?G_ (=G?M%?]$-^*W_A
M,7?_ ,11_P .SOVBO^B&_%;_ ,)B[_\ B*_H&_X>M_&#_HR?X_?]_P#3_P#X
M[1_P];^,'_1D_P ?O^_^G_\ QVC^U*_\J^]?YA_Q&"M_SZC]TO\ (_GY_P"'
M9W[17_1#?BM_X3%W_P#$4?\ #L[]HK_HAOQ6_P#"8N__ (BOZ!O^'K?Q@_Z,
MG^/W_?\ T_\ ^.T?\/6_C!_T9/\ '[_O_I__ ,=H_M2O_*OO7^8?\1@K?\^H
M_=(_GY_X=G?M%?\ 1#?BM_X3%W_\11_P[._:*_Z(;\5O_"8N_P#XBOZ!O^'K
M?Q@_Z,G^/W_?_3__ ([1_P /6_C!_P!&3_'[_O\ Z?\ _':/[4K_ ,J^]?YA
M_P 1@K?\^H_=(_GY_P"'9W[17_1#?BM_X3%W_P#$4?\ #L[]HK_HAOQ6_P#"
M8N__ (BOZ!O^'K?Q@_Z,G^/W_?\ T_\ ^.T?\/6_C!_T9/\ '[_O_I__ ,=H
M_M2O_*OO7^8?\1@K?\^H_=+_ "/Y^?\ AV=^T5_T0WXK?^$Q=_\ Q%'_  [.
M_:*_Z(;\5O\ PF+O_P"(K^@;_AZW\8/^C)_C]_W_ -/_ /CM'_#UOXP?]&3_
M !^_[_Z?_P#':/[4K_RK[U_F'_$8*W_/J/W2_P C^?G_ (=G?M%?]$-^*W_A
M,7?_ ,11_P .SOVBO^B&_%;_ ,)B[_\ B*_H&_X>M_&#_HR?X_?]_P#3_P#X
M[1_P];^,'_1D_P ?O^_^G_\ QVC^U*_\J^]?YA_Q&"M_SZC]TC^?G_AV=^T5
M_P!$-^*W_A,7?_Q%'_#L[]HK_HAOQ6_\)B[_ /B*_H&_X>M_&#_HR?X_?]_]
M/_\ CM'_  ];^,'_ $9/\?O^_P#I_P#\=H_M2O\ RK[U_F'_ !&"M_SZC]TO
M\C^?G_AV=^T5_P!$-^*W_A,7?_Q%'_#L[]HK_HAOQ6_\)B[_ /B*_H&_X>M_
M&#_HR?X_?]_]/_\ CM'_  ];^,'_ $9/\?O^_P#I_P#\=H_M2O\ RK[U_F'_
M !&"M_SZC]TO\C^?G_AV=^T5_P!$-^*W_A,7?_Q% _X)G?M%?]$,^*W_ (3%
MW_\ $5_0-_P];^,'_1D_Q^_[_P"G_P#QVC_AZW\8/^C)_C]_W_T__P".T?VI
M7_E7WK_,/^(P5O\ GU'[I?Y'X86/[,W[9VF?"6;P#;^!?V@K?P3-D/H<>F:@
MMBRL=S)Y87&PMR4'RD\D$UP[?\$R_P!HAV!_X47\5<CH?^$8N^/_ !ROZ!_^
M'K?Q@_Z,G^/W_?\ T_\ ^.T?\/6_C!_T9/\ '[_O_I__ ,=J8YE66T%]Z_S,
MZ?BU.%^2A%7=W92U?W'\_/\ P[._:*_Z(;\5O_"8N_\ XBK.C?\ !+;]I'7]
M3AL[7X%_% SSL%3S= G@3/N\BJJ_4D"OW]_X>M?&#_HR?X_?]_\ 3_\ X[1_
MP]8^,'_1D_Q^_P"_^G__ !VG_:E?^5?>O\S1^,%?I2C]T_\ (S?^""__  2_
MUS_@G#^SIK5QXV:U_P"$_P#'US#>:G:6T@DCTJ")66"VWCAW&]V<CY<O@9"Y
M/!_\'+'@^Z^/OP0^$OPE\.?Z9XW\8>+Y=0TZP4%I);>RTV[>>0@=%7>@R>["
MO37_ ."G'QZ\40O8^'?V*_BU#K-PNVTDU[5]/L=/1ST,TH=BJCO@$UU/[%O[
M#OCBQ^.^I?'OX_:YI/B/XQ:I8G2M)TW25;^Q? VG,<M:6>_YGD?_ ):3'!;D
M<@DGSHSE&K]8J-7Z:WN_\C\OSW,*N<U*G/=RJ?$[-)+ROY*R6OF?6F<FG8Q7
MPG\4/C9\6/\ @HM^TEXP^%?P3\62?#'X7_#2[_LKQK\0;2W6?5-1U/ ,FFZ8
M&^1#$,"28Y*DX';=K+_P0B^$^I#SM:\<_'KQ%?L/GO-0^(5\TTGUV,JCZ 5S
M^QC%?O'9]K7^_8Q^MU)M^PAS+NW9/TT=_4^UL48KXJ_X<*_!'/\ R'?C-_X<
M#4O_ (Y1_P .%/@C_P!!SXS?^' U+_XY1[.C_,_N_P""5[;%_P#/M?\ @7_
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M ,<H]G1_F?W?\$/;8O\ Y]K_ ,"_X!]JXHQ7Q5_PX4^"/_0<^,W_ (<#4O\
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M;8O_ )]K_P "_P" ?:N*,5\5?\.%/@C_ -!SXS?^' U+_P".4?\ #A3X(_\
M0<^,W_AP-2_^.4>SH_S/[O\ @A[;%_\ /M?^!?\  /M7%&*^*O\ API\$?\
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M?\ ^U<48KXJ_X<*?!'_H.?&;_P .!J7_ ,<H_P"'"GP1_P"@Y\9O_#@:E_\
M'*/9T?YG]W_!%[;%_P#/M?\ @7_ /M7%&*^*O^'"GP1_Z#GQF_\ #@:E_P#'
M*/\ API\$?\ H.?&;_PX&I?_ !RCV='^9_=_P0]MB_\ GVO_  +_ (!]JXHQ
M7Q5_PX4^"/\ T'/C-_X<#4O_ (Y1_P .%/@C_P!!SXS?^' U+_XY1[.C_,_N
M_P""'ML7_P ^U_X%_P  ^U<48KXJ_P"'"GP1_P"@Y\9O_#@:E_\ '*/^'"GP
M1_Z#GQF_\.!J7_QRCV='^9_=_P $/;8O_GVO_ O^ ?:N*,5\5?\ #A3X(_\
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M -!SXS?^' U+_P".4?\ #A3X(_\ 0<^,W_AP-2_^.4>SH_S/[O\ @A[;%_\
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M'^M&8_S_ (+_ "/VN_XB[[#_ *(7J'_A2Q__ !FC_B+OL/\ HA>H?^%+'_\
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MZA_X4L?_ ,9K\4:*/[+PW\OXL/\ 6?,?Y_P7^1^UW_$7?8?]$+U#_P *6/\
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MFC_B+OL/^B%ZA_X4L?\ \9K\4:*/[+PW\OXL/]9\Q_G_  7^1^UW_$7?8?\
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MX-(;F-45C(H5NA)X-/\ LO#?R_B1_K-F7\_X+_(_;'_B+OL/^B%ZA_X4L?\
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M_P!$+U#_ ,*6/_XS1_Q%WV'_ $0O4/\ PI8__C-?BC11_9>&_E_%A_K/F/\
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M?&[_ **EXR_\#?\ ZU'_  W]\;O^BI>,O_ W_P"M3_XA1G'_ $$1^^7^0?\
M$;N'?^@.7_@,/\S]6/\ AT+^S#_T0OX;_P#@H2C_ (="_LP_]$+^&_\ X*$K
M\I_^&_OC=_T5+QE_X&__ %J/^&_OC=_T5+QE_P"!O_UJ/^(49Q_T$1^^7^0?
M\1OX=_Z Y?\ @,/\S]6/^'0O[,/_ $0OX;_^"A*/^'0O[,/_ $0OX;_^"A*_
M*?\ X;^^-W_14O&7_@;_ /6H_P"&_OC=_P!%2\9?^!O_ -:C_B%&<?\ 01'[
MY?Y!_P 1NX=_Z Y?^ P_S/U8_P"'0O[,/_1"_AO_ ."A*/\ AT+^S#_T0OX;
M_P#@H2ORG_X;^^-W_14O&7_@;_\ 6H_X;^^-W_14O&7_ (&__6H_XA1G'_01
M'[Y?Y!_Q&[AW_H#E_P" P_S/U8_X="_LP_\ 1"_AO_X*$H_X="_LP_\ 1"_A
MO_X*$K\I_P#AO[XW?]%2\9?^!O\ ]:C_ (;^^-W_ $5+QE_X&_\ UJ/^(49Q
M_P!!$?OE_D'_ !&[AW_H#E_X##_,_5C_ (="_LP_]$+^&_\ X*$H_P"'0O[,
M/_1"_AO_ ."A*_*?_AO[XW?]%2\9?^!O_P!:C_AO[XW?]%2\9?\ @;_]:C_B
M%&<?]!$?OE_D'_$;^'?^@.7_ (##_,_5C_AT+^S#_P!$+^&__@H2C_AT+^S#
M_P!$+^&__@H2ORG_ .&_OC=_T5+QE_X&_P#UJ/\ AO[XW?\ 14O&7_@;_P#6
MH_XA1G'_ $$1^^7^0?\ $;N'?^@.7_@,/\S]6/\ AT+^S#_T0OX;_P#@H2C_
M (="_LP_]$+^&_\ X*$K\I_^&_OC=_T5+QE_X&__ %J/^&_OC=_T5+QE_P"!
MO_UJ/^(49Q_T$1^^7^0?\1NX=_Z Y?\ @,/\S]6/^'0O[,/_ $0OX;_^"A*/
M^'0O[,/_ $0OX;_^"A*_*?\ X;^^-W_14O&7_@;_ /6H_P"&_OC=_P!%2\9?
M^!O_ -:C_B%&<?\ 01'[Y?Y!_P 1NX=_Z Y?^ P_S/U8_P"'0O[,/_1"_AO_
M ."A*/\ AT+^S#_T0OX;_P#@H2ORG_X;^^-W_14O&7_@;_\ 6H_X;^^-W_14
MO&7_ (&__6H_XA1G'_01'[Y?Y!_Q&[AW_H#E_P" P_S/U8_X="_LP_\ 1"_A
MO_X*$H_X="_LP_\ 1"_AO_X*$K\I_P#AO[XW?]%2\9?^!O\ ]:C_ (;^^-W_
M $5+QE_X&_\ UJ/^(49Q_P!!$?OE_D'_ !&[AW_H#E_X##_,_5C_ (="_LP_
M]$+^&_\ X*$H_P"'0O[,/_1"_AO_ ."A*_*?_AO[XW?]%2\9?^!O_P!:C_AO
M[XW?]%2\9?\ @;_]:C_B%&<?]!$?OE_D'_$;N'?^@.7_ (##_,_5C_AT+^S#
M_P!$+^&__@H2C_AT+^S#_P!$+^&__@H2ORG_ .&_OC=_T5+QE_X&_P#UJ/\
MAO[XW?\ 14O&7_@;_P#6H_XA1G'_ $$1^^7^0?\ $;^'?^@.7_@,/\S]6/\
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M&7_@;_\ 6H_X;^^-W_14O&7_ (&__6H_XA1G'_01'[Y?Y!_Q&[A[_H#E_P"
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MOC=_T5+QE_X&_P#UJ/\ AO[XW?\ 14O&7_@;_P#6H_XA1G'_ $$1^^7^0?\
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M_P!$+^&__@H2C_AT+^S#_P!$+^&__@H2ORG_ .&_OC=_T5+QE_X&_P#UJ/\
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M+QE_X&__ %J/^&_OC=_T5+QE_P"!O_UJ/^(49Q_T$1^^7^0?\1NX=_Z Y?\
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MP_\ 1"_AO_X*$K\I_P#AO[XW?]%2\9?^!O\ ]:C_ (;^^-W_ $5+QE_X&_\
MUJ/^(49Q_P!!$?OE_D'_ !&[AW_H#E_X##_,_5C_ (="_LP_]$+^&_\ X*$H
M_P"'0O[,/_1"_AO_ ."A*_*?_AO[XW?]%2\9?^!O_P!:C_AO[XW?]%2\9?\
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M+QE_X&__ %J/^&_OC=_T5+QE_P"!O_UJ/^(49Q_T$1^^7^0?\1NX=_Z Y?\
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MW=E91>RFUK?;2/,Y:WNET*I8?A&JY5'*R2N[N:WE!/1+XM9\JC=<J3ELSDO
M/_!-[QAX^TCPW(OB'P;I.K>+8]0.E:-J%W-'>W4EC)(EQ'A8RBE3&3DL%P1S
MVJG;?\$]_%FM:IX470]>\)>(M'\66U]=Q:S8W,S65G'8D"Z,NZ,2?(6 ^1&W
M$C;FKG@W_@H1K/ACQ+\-=7NO#]EJE]\.X]9!>2[:/^U7U)I&D=\+^[V&0X S
MG':J/PU_;QUSX7>"O ^AV&AZ?-9^$%U>WN1-<2 :Q;:DRF:)MN&B*[1M=&R#
MS[5K_P 91K+W;ZZ>[;[=M=]+0M?^9WZVPY>#7:/OVTN_>O\ \N[Z6MUJ7M_*
MK;J]M/\ @G)XPD\4M9?VYX532V\-3^*X-:EEN(;&>R@D1)N'B$J.A<$JZ#CG
MN*Z+X1_\$][*Y^)^IZ+XP\6:&VFS^ [CQCH>I:7/,;>_CV$QS9,6[RHRI,BL
MH8@C;DURS_MSR6FK^(FTWP?I^G:7K?A&[\)0VAU.XNI;9+EU=[F2>7<\TH*
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MB=8CN"G:OF2! 6(Z5GG]MN2[TK4K6\\(:?=-<>/F\?V$_P!NDC?3KEY$:2#
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MM\L&FTE:_-SJR:6U_/P4'(%%(B[$"^@Q2U]T?FX4444P"BBB@ HHHH ****
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MA?\ GS_Y,_\ ([+_ (4G??\ 0>\#?^%+:?\ Q='_  I.^_Z#W@;_ ,*6T_\
MBZXVBCV.*_Y^_P#DJ_S#ZQA?^?/_ ),_\CLO^%)WW_0>\#?^%+:?_%T?\*3O
MO^@]X&_\*6T_^+KC:*/8XK_G[_Y*O\P^L87_ )\_^3/_ ".R_P"%)WW_ $'O
M W_A2VG_ ,71_P *3OO^@]X&_P#"EM/_ (NN-HH]CBO^?O\ Y*O\P^L87_GS
M_P"3/_([+_A2=]_T'O W_A2VG_Q='_"D[[_H/>!O_"EM/_BZXVBCV.*_Y^_^
M2K_,/K&%_P"?7_DS_P CLO\ A2=]_P!![P-_X4MI_P#%T?\ "D[[_H/>!O\
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M>+]:QC^VO_ ?^"?9+(<O6G+)_P#;VOY&/_PS7KW_ $$O!_\ X45I_P#%T?\
M#-FO?]!+P=_X45I_\76QN&1[]/>@5/UK&?SK_P !_P""']AY?_(__ O^ 8__
M  S7K_\ T$O!_P#X45I_\71_PS9KW_02\'?^%%:?_%UL$X%&>*?UK&?SK_P'
M_@C_ +!R_P#DE_X%_P  Q_\ AFO7O^@EX/\ _"BM/_BZ/^&;->_Z"7@[_P *
M*T_^+K75E?[K*?I2T?6L7_.O_ ?^"+^P\O\ Y'_X%_P#'_X9KU[_ *"7@_\
M\**T_P#BZ/\ AFS7O^@EX._\**T_^+K8R"<=:*7UK%_SK_P'_@A_8>7_ ,C_
M / O^ 8__#-FO?\ 02\'?^%%:?\ Q='_  S9KW_02\'?^%%:?_%UL4;@#U'Y
M]:?UK%_SK_P'_@A_8>7?R/\ \"_X!C_\,UZ]_P!!+P?_ .%%:?\ Q='_  S7
MK_\ T$O!_P#X45I_\76P>* =PXYI?6L9_.O_  '_ ((?V'E_\DO_  +_ (!C
M_P##-FO?]!+P=_X45I_\71_PS7KW_02\'_\ A16G_P 76PQP.:*/K6,_G7_@
M/_!#^P\O_D?_ (%_P#'_ .&;->_Z"7@[_P **T_^+H_X9LU[_H)>#O\ PHK3
M_P"+K8HI_6L7_.O_  '_ ((?V'E_\C_\"_X!C_\ #-FO?]!+P=_X45I_\71_
MPS9KW_02\'?^%%:?_%UL44?6L7_.O_ ?^"']AY?_ "/_ ,"_X!C_ /#-FO?]
M!+P=_P"%%:?_ !='_#-FO?\ 02\'?^%%:?\ Q=;%%'UK%_SK_P !_P""']AY
M?_(__ O^ 8__  S9KW_02\'?^%%:?_%T?\,V:]_T$O!W_A16G_Q=;%%'UK%_
MSK_P'_@A_8>7_P C_P# O^ 8_P#PS9KW_02\'?\ A16G_P 71_PS9KW_ $$O
M!W_A16G_ ,76Q11]:Q?\Z_\  ?\ @A_8>7_R/_P+_@&/_P ,V:]_T$O!W_A1
M6G_Q='_#-FO?]!+P=_X45I_\76Q11]:Q?\Z_\!_X(?V'E_\ (_\ P+_@&/\
M\,V:]_T$O!W_ (45I_\ %T?\,V:]_P!!+P=_X45I_P#%UL44?6L7_.O_  '_
M ((?V'E_\C_\"_X!C_\ #-FO?]!+P=_X45I_\71_PS9KW_02\'?^%%:?_%UL
M44?6L7_.O_ ?^"']AY?_ "/_ ,"_X!C_ /#-FO?]!+P=_P"%%:?_ !='_#-F
MO?\ 02\'?^%%:?\ Q=;%%'UK%_SK_P !_P""']AY?_(__ O^ 8__  S9KW_0
M2\'?^%%:?_%T?\,V:]_T$O!W_A16G_Q=;%%'UK%_SK_P'_@A_8>7_P C_P#
MO^ 8_P#PS9KW_02\'?\ A16G_P 71_PS9KW_ $$O!W_A16G_ ,76Q11]:Q?\
MZ_\  ?\ @A_8>7_R/_P+_@&/_P ,V:]_T$O!W_A16G_Q='_#-FO?]!+P=_X4
M5I_\76Q11]:Q?\Z_\!_X(?V'E_\ (_\ P+_@&/\ \,V:]_T$O!W_ (45I_\
M%T?\,V:]_P!!+P=_X45I_P#%UL44?6L7_.O_  '_ ((?V'E_\C_\"_X!C_\
M#-FO?]!+P=_X45I_\71_PS9KW_02\'?^%%:?_%UL44?6L7_.O_ ?^"']AY?_
M "/_ ,"_X!C_ /#-FO?]!+P=_P"%%:?_ !='_#-FO?\ 02\'?^%%:?\ Q=;%
M%'UK%_SK_P !_P""']AY?_(__ O^ 8__  S9KW_02\'?^%%:?_%T?\,V:]_T
M$O!W_A16G_Q=;%%'UK%_SK_P'_@A_8>7_P C_P# O^ 8_P#PS9KW_02\'?\
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MO^P)%_Z<+.N5KK/AO ]QX4\>*BEF705D('7:M]:,Q_!02?85R=?OV%_BUO\
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MUYX8U.Z_LOQ5H/AC5M*;6[.VDNK#[??O;NCRA<IM*DEHBNX<'-?-[?&_QFS
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M3DC9G&"><=*NZ9\=O&VBZC?7EGXN\1VMUJ1C:[EAOY$>Y,:A8RY!Y*J  >P
MK2>4YI[1U575U=+?JXOMIHK6U]=69QS;*?9*F\.];-[=$U\]7OI?MHCZ7\*_
M 'P+8Z]\-](L-+U-=6N/%6O:3<:G<I;W<=S':<?O8GC*-D;=@Q\IWDY.,>=:
MC^R;H=GX2GM3J6O-XK7PC)XU%XD$;:&( &;[*6^]O*C&_.-_R[:\JT[XV>,M
M'CV6OBK7K=#>OJ6V.]=1]J?.Z?K_ *QLG+=3DU5/Q5\4-X+;PV?$6M'P\V=V
MF_:W^RD%MQ&S.,;N<=,U%')<SA+FCB/7=OXF^JZ7MR[/R-*N=Y74C:6']-ET
M2Z=[;[GOGB_]CGP1:Z]KFBZ;K?BN'4O#,^BR7\L]K'<0M;:@R(WE)&-[21EB
MW3YAQCO7GW[3WP%TGX0PZ'J7A^XU&]T36GN8(KJ>X@N(IG@<*=K1A65CG+1R
M(K)TRU<)-\5?%%UJ%Y=R>(=9:ZU(0"ZF-V_F7'D$&'<V<GRR 5_ND#%1^,OB
M3XA^(LL$GB#7-4UJ2U#"%KRX:7RMQRVW/3)Y/K79@<OS*G7A*M7YH+=.^ONI
M=E]J[UV1PXW,LMJX><*5#EF]FNGO7\_LZ.V[U,6BBBOHSYL**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "I;#_D(6_P#UV3_T(5%4EK((KN%V^ZDBL?H"#4S^%ET_B1]C
M>/[BW;]K_4]S>#Q<KXH.WS+B7^U<_P!IVN-JYV[]N0HZ>5YE6O"$M_H'@7XC
M75OIFK//#IUM>Q"XFMK\2*DVH,)HTG#)%;Y'^KQO&&Q]ZN;\3?&3PYKOQ^N?
M$$'Q$\'Q>%[S6AJ!@FT2Z_M!(#=0W++O$/$FZ( '/3(Z$UE>#]9\%Z+X.^)5
M@?'_ ('U*;QE>I+9KJ5I?>3:Q[IR7_U8/F*)05QP"#FORSZG5]BE*$MH:<LW
MM+7HDK+=:^I^MQQE+VTFIQWGKS0ZQTZN]WM^)S__  4 TBWTWQGX)FCTX:;=
M7WAI9;M&A@BEDD%W<)ND$ $9;:JC*]@*\&^)7_) 8?\ L9D_]))*]>_;"\?Z
M+XYUKP;#HM[H]Z-#\/BQNSI4,L=C%,;J>79$) &*A9%Y]<UY#\3AY/[/]KN^
M7S_$IV _Q;+0AORWI_WT*^[X>A.&%PT9JSOL_65M_+\#\TXOJ0E5Q<Z;37+T
MM_=[:;GTU_P0'_Y+WX\_[ $7_I0M:'_!V%_RCX\'_P#8]VO_ *0WM9__  0'
M_P"2]^//^P!%_P"E"UH?\'87_*/CP?\ ]CW:_P#I#>U^5\??\E1+TA_Z2C]7
M\-O^2&7_ &__ .E'LW_!NU_RB'^%G^_JO_ISNJ^/_P#@L[_R?MKW_8+L/_15
M?8'_  ;M?\HA_A9_OZK_ .G.ZKX__P""SW_)^NN_]@NP_P#15=/AE_R4,_\
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MOO7^0?7E_P ^X?=_P3M/L?PW_P"@AX\_\ +/_P".T?8_AO\ ]!#QY_X 6?\
M\=KBZ*/J;_Y^2^]?Y!]>7_/N'W?\$[3['\-_^@AX\_\  "S_ /CM'V/X;_\
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MAO\ ]!#QY_X 6?\ \=KBZ*/J;_Y^2^]?Y!]>7_/N'W?\$[3['\-_^@AX\_\
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MVC_A8GPY_P">GCK_ ,!+3_X[7D.*,4?V32_GE]X?ZSXSM#_P$]>_X6)\.?\
MGIXZ_P# 2T_^.T?\+$^'/_/3QU_X"6G_ ,=KR'%&*/[)I?SR^\?^L^,[0_\
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MIXZ_\!+3_P".T?\ "Q/AS_ST\=?^ EI_\=KR'%&*/[)I?SR^\7^L^+[0_P#
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M6V_4J.5J4)5517+&UWRK2^U]#@_["\*_]"'X/_[\3_\ QZC^P?"O_0A^#_\
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MS?WO_,/JU#^2/_@*_P AO]@^%?\ H0_!_P#WXG_^/4?V#X5_Z$/P?_WXG_\
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MZ/JLTUL_ES1I:2,\38)VL ,@X!.#V%:?6H_\_/\ R9_YF?\ 8]#_ )\1_P#
M5_D<O_PK/P3_ -"%X5_[XN/_ ([1_P *S\$_]"%X5_[XN/\ X[727GAG4].%
MM]HTW4+?[:<6_FVSI]H/3"9'S'Z5))X.UB+47LVTG5%O(U5V@-I)YBJQ"J2N
M,X+$ 'N3BG]:CO[3_P F?^8?V/A]O81_\!7^1R__  K/P3_T(7A7_OBX_P#C
MM+_PK+P1_P!"%X5_[]W'_P =KHW\,:I'I<UZ=,U#[';N8Y9_LS^5$P."&;&
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M[RXM;J.ZMEO+>XAW*LL3$@-M<!E.5(PP!XST-=/:_LOZ_=Z9#B^T-->N+/\
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MO_?%Q_\ ':UJ*.:?\S^]_P"8?V;A/^?4?_ 5_D9/_"L_!/\ T(7A7_OBX_\
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MH_X4/\/?^A!\,_E<?_':ZBBCV]7^>7_@3_S#^R,#_P ^8?\ @*_R.7_X4/\
M#W_H0?#/Y7'_ ,=H_P"%#_#W_H0?#/Y7'_QVNHHH]O5_GE_X$_\ ,/[(P/\
MSYA_X"O\CE_^%#_#W_H0?#/Y7'_QVC_A0_P\_P"A!\,_E<?_ !VNHHH]O5_G
ME_X$_P#,/[(P/_/F'_@*_P CF4^ ?P^F=43X?^&Y)'.%55N"6^@\VI+S]G;P
M+INW[3\.-!M]WW?-BNDW?3,HKZ(^'EC?Z;X>\'WFBVOAFV>SM9M7U#4-0A7S
M(?+N)4$A.=[* H&%YSCUJUXN^,?B;XD6FCWFK'P!>6MO.DB6Y=)9RLA"$>4S
M$[L'..H(]J\66>8CVEH-\J;3]]WT;7XV[GK1X7R[DO*G&[M;W(VUM^1\S2?
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M^ LG^%'_  AVL?\ 0)U3_P !9/\ "G_8. O?F?\ X$N][??\R?[<Q[5N5?\
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MI]-E@8'?$=XWI+C# %3@#K7C_P#PB^I_] W4/_ 9_P#"C_A&=4S_ ,@W4/\
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M-4N9)+6[MK& 0"!H#+.9$_?(X!A&06C=&)/&<5XF.E7O^$8U/_H&ZA_X#/\
MX4?\(QJ?_0-U#_P&?_"NS!X6AAE)4W\3OJSCQ6(KXAIU%LK;%&BKW_",:G_T
M#=0_\!G_ ,*/^$8U/_H&ZA_X#/\ X5V^TCW.7V4^S^XHT5>_X1C4_P#H&ZA_
MX#/_ (4?\(QJ?_0-U#_P&?\ PH]I'N'LI]G]Q1HJ]_PC&I_] W4/_ 9_\*/^
M$8U/_H&ZA_X#/_A1[2/</93[/[BC15[_ (1C4_\ H&ZA_P" S_X4?\(QJ?\
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M.OG?IW.R^-?Q7T_XG06/V>#4/M4,TD\T]SA,AP/D"*Q7.1DL H/]T5P-7/\
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MG)9;MWNNK;_4]6-6"ESN^R6W:QF?&/\ Y*YXH_["US_Z-:OGG]O,X^"7A_\
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M_#K[]F3_ *%_3?\ PH9__CU'_$8.'O\ GW+[H?\ R0?\01XC_P"@FG_X'/\
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M[_P93?\ Q5?L%_PZ^_9D_P"A?TW_ ,*&X_\ CU'_  Z^_9D_Z%_3?_"AG_\
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M_P#%4?\ ">^(?^@_KW_@QF_^*K]@O^'7W[,G_0OZ;_X4-Q_\>H_X=??LR?\
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M (@CQ'_T$4__  .?_P B?C[_ ,)[XA_Z#^O?^#&;_P"*H_X3WQ#_ -!_7O\
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M^O?^#&;_ .*K]@O^'7W[,G_0OZ;_ .%#/_\ 'J/^'7W[,G_0OZ;_ .%#<?\
MQZE_Q%[A[_GW+[H?_)!_Q!'B/_H(I_\ @<__ )$_'W_A/?$/_0?U[_P8S?\
MQ5'_  GOB'_H/Z]_X,9O_BJ_8+_AU]^S)_T+^F_^%#<?_'J/^'7W[,G_ $+^
MF_\ A0W'_P >I_\ $7N'O^?<ONA_\D'_ !!'B/\ Z"*?_@<__D3\??\ A/?$
M/_0?U[_P8S?_ !5'_">^(?\ H/Z]_P"#&;_XJOV"_P"'7W[,G_0OZ;_X4-Q_
M\>H_X=??LR?]"_IO_A0S_P#QZC_B+W#W_/N7W0_^2#_B"/$?_013_P# Y_\
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M\_X3SQ!_T']>_P#!C-_\51_PGGB#_H/Z]_X,9O\ XJOV#_X=??LR?]"_IO\
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M3?\ PH;C_P"/4?\ $8.'O^?<ONA_\D'_ !!/B3_H)I_^!S_^1/Q]/CWQ"?\
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M]^P?\2M0UJVU3P[?3RW4.GQI<6C2-N:%"=K1YZ[<X(].:^2?^#L+_E'QX/\
M^Q[M?_2&]KZ4_P""?W_)0=>_[!R_^C17S7_P=@_\H^/!_P#V/=K_ .D-[7])
M^&>(J5LMH2JN[3:U[)NQ>92;RNI?M^I[1_P;N#'_  2'^%?^_JG_ *<[JK'[
M:\;)\?;QF5E5[.W*D_Q#;C(_$'\JK?\ !NY_RB'^%G^_JG_ISNJ^D?C[^SEI
MWQQM8)6N&TW5K-2D-VJ;PRDYV.O=<\]011Q]DU?,\'4H8;62ES);7M?3\3IP
MM-SP%.*_EC^1\/T8KZ"_X=\ZP#_R,NFG_MU?_&@?\$^=8_Z&33?_  &?_&OP
MW_4;//\ H'?WQ_S,OJE7L?/N*,5]!?\ #OG6,?\ (R:;_P" S_XT?\.^=8_Z
M&33?_ 9_\:?^HV>?] [^^/\ F/ZI5['S[BC%?01_X)\ZQ_T,FF_^ S_XT'_@
MGSK'_0R:;_X#/_C2_P!1L\_Z!W]\?\Q?5*O8^?<48KZ"_P"'?.L9_P"1DTW_
M ,!G_P :/^'?.L?]#)IO7_GV?_&C_4;//^@=_?'_ ##ZI5['S[BC%?00_P""
M?.L?]#)IO_@,_P#C1_P[YUC'_(R:;_X#/_C3_P!1L\_Z!W]\?\Q_5*O8^?<4
M8KZ"_P"'?.L?]#)IO_@,_P#C1_P[YUC_ *&33?\ P&?_ !H_U&SS_H'?WQ_S
M#ZI5['S[BC%?01_X)\ZQ_P!#)IO_ (#/_C1_P[YUC/\ R,FF_P#@,_\ C2_U
M&SS_ *!W]\?\Q?5*O8^?<48KZ"_X=\ZQ_P!#)IO7_GV?_&@?\$^=8_Z&33?_
M  &?_&G_ *C9Y_T#O[X_YC^J5>Q\^XHQ7T$/^"?.L?\ 0R:;_P" S_XT?\.^
M=8_Z&73?_ 9_\:/]1L\_Z!W]\?\ ,/JE7L?/N*,5]!?\.^=8_P"ADTW_ ,!G
M_P :#_P3YUC_ *&33?\ P&?_ !I?ZC9Y_P! [^^/^8OJE7L?/M&*^@O^'?.L
M?]#)IG_@,_\ C1_P[YUC_H9--Z_\^S_XT?ZC9Y_T#O[X_P"8?5*O8^?<48KZ
M"_X=\ZQ_T,FF]?\ GV?_ !H'_!/G6/\ H9--_P# 9_\ &G_J-GG_ $#O[X_Y
MC^J5>Q\^XHQ7T%_P[YUC_H9=-_\  9_\:/\ AWSK'_0R:;_X#/\ XT?ZC9Y_
MT#O[X_YA]4J]CY]Q1BOH(_\ !/G6/^ADTW_P&?\ QH/_  3YUC_H9--_\!G_
M ,:7^HV>?] [^^/^8OJE7L?/M&*^@O\ AWSK'_0R:9_X#/\ XT?\.^=8_P"A
MDTWK_P ^S_XT?ZC9Y_T#O[X_YA]4J]CY]Q1BOH(?\$^=8_Z&33?_  &?_&C_
M (=\ZQ_T,NF_^ S_ .-/_4;//^@=_?'_ #']4J]CY]Q1BOH+_AWSK'_0R:;_
M . S_P"-'_#OG6/^AETW_P !G_QH_P!1L\_Z!W]\?\P^J5>Q\^XHKZ"/_!/G
M6/\ H9--_P# 9_\ &C_AWSK'_0R:9_X#/_C2_P!1L\_Z!W]\?\Q?5*O8^?:,
M5]!?\.^=8_Z&33/_  &?_&@?\$^=8_Z&33?_  &?_&G_ *C9Y_T#O[X_YC^J
M5>Q\^XHQ7T$/^"?.L?\ 0R:;_P" S_XT?\.^=8_Z&33?_ 9_\:/]1L\_Z!W]
M\?\ ,/JE7L?/N*,5]!?\.^=8Q_R,FF_^ S_XT'_@GSK'_0R:;_X#/_C2_P!1
ML\_Z!W]\?\Q?5*O8^?:,5]!?\.^=8_Z&33/_  &?_&C_ (=\ZQ_T,FF]?^?9
M_P#&C_4;//\ H'?WQ_S#ZI5['S[BC%?07_#OG6,_\C)IO_@,_P#C1_P[YUC_
M *&73?\ P&?_ !I_ZC9Y_P! [^^/^8_JE7L?/N,UVWAW]H+Q+X9T2UL8)-.F
M_L]#'975S9)-=6*G^&.0\@#MG.*],_X=\ZQ_T,FF_P#@,_\ C1_P[YUC_H9-
M-_\  9_\:Z<+PGQ'AGS4*4HMZ:2C_F5'#UHN\4>4^&?C3KGAFQCMU^P7WV:X
M>\M9;ZU%Q+93/RTD3'[K$\G.1GG%.TWXVZ_IMQX?F62UFF\-SW%S:22Q%F>2
M<EI#(<_-DDXZ8KU3_AWSK&/^1DTW_P !G_QH_P"'?.L?]#)IG_@,_P#C6\>'
M>*4E%0EI:WO1Z--=>EE;T'['$?TSRG0?C-K7AO3/L]K'I2S+'+%%>FS4W=O'
M+]]4D]#D]02.U3'XZZ\?#;:8R:6T<FF?V0]P;,?:9+;HJ&3.?E[?KFO4/^'?
M.L?]#)IO7_GV?_&C_AWSK&?^1DTW_P !G_QIQX=XIC'E4)6M;XH[?>'L<0N_
MWGEK_&_7)]2O+F:/2[@:AID>DW$,MKNBD@C^YQG[PZYSU'2H-3^+^M:OIFJV
MDWV/R=8LK73[C;#AO*M_]7M.>&]3W]J]9'_!/G6/^ADTW_P&?_&C_AWSK'_0
MRZ;_ . S_P"-$N'>*6FG"6M[^]'K>_7K=_>P]C79Q7A/XWKJ5WK'_"1W36ZZ
ME;VT \O34O;7]PNU"\+$'>!C#!NO4$5C?$3XO7'B/XNCQ1I/G64UH(5M7=5\
MS]V@7<RCY?FY.T< '%>G?\.^=8_Z&33?_ 9_\:/^'?&L?]#+IO\ X#/_ (UM
M5R+BBI15&5%Z/FO=7O=M:\W1ML<J==QY6CR_Q!\<]8\2^&;K19[70X=*NV$O
MV:WL!"D,V2QF3:<B0DG)R1[5EI\3=:MO!MGH5K>2:?8V<TEP#:,T,LSOU,C*
M?FP.!Z5[)_P[YUC_ *&33/\ P&?_ !H_X=\ZQ_T,FF]?^?9_\:YZG#?%$Y<\
MJ<KVM?FCM>]M]KB]C7;NSS>Y_:(\17\MPUU'I%\MTL)DCN;(2H9(AA)@">)
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M<48KZ"'_  3YUC_H9--_\!G_ ,:/^'?.L8_Y&33?_ 9_\:/]1L\_Z!W]\?\
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M_P Q_5*O8^?<48KZ"_X=\ZQ_T,FF_P#@,_\ C1_P[YUC_H9--_\  9_\:/\
M4;//^@=_?'_,/JE7L?/N*,5]!?\ #OG6,?\ (R:;_P" S_XT'_@GSK'_ $,F
MF_\ @,_^-+_4;//^@=_?'_,7U2KV/GW%&*^@O^'?.L?]#)IO7_GV?_&C_AWS
MK&?^1DTW_P !G_QI_P"HV>?] [^^/^8_JE7L?/N*,5]!#_@GSK'_ $,FF_\
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M,T?\/H/VH/\ HKFL?^"^R_\ C-?,&:,T?V/@?^?,?_ 5_D'U+#_R+[D?3_\
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M\/H/VH/^BN:Q_P""^R_^,U\P9HS1_8^ _P"?,?\ P%?Y!]2P_P#(ON1]/_\
M#Z#]J#_HKFL?^"^R_P#C-'_#Z#]J#_HKFL?^"^R_^,U\P9HS1_8^ _Y\Q_\
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MX?0?M0?]%<UC_P %]E_\9H_X?0?M0?\ 17-8_P#!?9?_ !FN/U#]BSQ-X?\
M@UX@NM2\)^-H?'>A^.K7P8;%%MFLQ/- )%MS'N^T/<.2I0Q@Q%"#G)JCX[_X
M)^_&3X;^*?#>BZIX%U!M1\67C:;I4=C<07RW-VHR]L7A=TCF0 EHW*LH!)
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MI6;@01ND9N%,TK,6W0_(8R '*YS6=2&2PM>-/7LHOHWT79,F4<#'=1^Y#O\
MA]!^U!_T5S6/_!?9?_&:/^'T'[4'_17-8_\ !?9?_&:XV#_@GC\6O$L/B+4/
M#?@W5M8T/0]2O]/AN)&@M[K4_L<C+.;>V,IDG:/:2X@$@0Y&3UJKX(_X)]?&
M+XD_#'3O&.A^"YM1\/ZO87.IV,Z7]JLE[!;LR3F*%I!*[(58E%4L ,XQS5^P
MR:UW&G]T?\BO9X'M'\#O/^'T'[4'_17-8_\ !?9?_&:/^'T'[4'_ $5S6/\
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M[+_XS1_P^@_:@_Z*YK'_ (+[+_XS7S!D>E&1Z4?V/@/^?,?_  %?Y!]2P_\
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MF_$;Q9J46GQ^==/::);3K:I_>D*P$*/<XK/7_@M%^T^R@CXN:N0>A_L^R_\
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M._\ "7O?_C='U[#?\_(_>O\ ,/K%+^9?>CS2BO2_^&+?C)_T2/XG?^$O>_\
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M$O>__&Z/^&+?C)_T2/XG?^$O>_\ QNCZ]AO^?D?O7^8?6*7\R^]'FE%>E_\
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MOA3Q!/>7?Q,T+QQ:6VI^3'&]K8Z1#83PNRNQ69V1V0@, "I)!R*\E\+?M/\
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M][_\;H^O8;_GY'[U_F'UBE_,OO1YI17I?_#%OQD_Z)'\3O\ PE[W_P"-T?\
M#%OQD_Z)'\3O_"7O?_C='U[#?\_(_>O\P^L4OYE]Z/-**]+_ .&+?C)_T2/X
MG?\ A+WO_P ;H_X8M^,G_1(_B=_X2][_ /&Z/KV&_P"?D?O7^8?6*7\R^]'F
ME%>E_P##%OQD_P"B1_$[_P )>]_^-T?\,6_&3_HD?Q._\)>]_P#C='U[#?\
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MXG?^$O>__&Z/KV&_Y^1^]?YA]8I?S+[T>:45Z7_PQ;\9/^B1_$[_ ,)>]_\
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M9/?$S_L5H?\ TK6O:_\ @["/_&OCP?\ ]CW:_P#I#>UZ+_P0N_X)G^)/V(_
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M(/V1?^BJ2?\ A/:G_P#(]'_$1!^R+_T523_PGM3_ /D>BBC^R:/=_P!?(/\
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MZ**/[)H]W_7R#_6K&=H_<_\ ,/\ B(@_9%_Z*I)_X3VI_P#R/1_Q$0?LB_\
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M23_PGM3_ /D>BBC^R:/=_P!?(/\ 6K&=H_<_\P_XB(/V1?\ HJDG_A/:G_\
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M_P!:L9VC]S_S#_B(@_9%_P"BJ2?^$]J?_P CT?\ $1!^R+_T523_ ,)[4_\
MY'HHH_LFCW?]?(/]:L9VC]S_ ,P_XB(/V1?^BJ2?^$]J?_R/1_Q$0?LB_P#1
M5)/_  GM3_\ D>BBC^R:/=_U\@_UJQG:/W/_ ##_ (B(/V1?^BJ2?^$]J?\
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M_P!%4D_\)[4__D>BBC^R:/=_U\@_UJQG:/W/_,/^(B#]D7_HJDG_ (3VI_\
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%>_Y'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>iclr-20221231_g3.jpg
<TEXT>
begin 644 iclr-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $)Y<FYE+"!%
M86UO;FX   60 P "    %   $*:0!  "    %   $+J2D0 "     S$T  "2
MD@ "     S$T  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M5/\ P-D_QK(HHL@]K4_F?WFO_P )9XC_ .@_JG_@;)_C1_PEGB/_ *#^J?\
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M (&R?XT?\)9XC_Z#^J?^!LG^-9%%%D'M:G\S^\U_^$L\1_\ 0?U3_P #9/\
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MLG^-9%%%D'M:G\S^\U_^$L\1_P#0?U3_ ,#9/\:/^$L\1_\ 0?U3_P #9/\
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M7N+&]FN;)H(F=O+L9+APRD#:47D=>IZ8]ZSK'3;[4Y6CTVRN+N15W,EO$TA
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M***R/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *9//%;0M-<RI%$@RSR,%4?4FGUR7Q2_Y)KJG_;'_P!')32N[&=6?LZ<
MI]DV:W_"6>'/^@_I?_@;'_C1_P )9X<_Z#^E_P#@;'_C7,>'OAQX4OO#&EW=
MUI7F3W%G#+(_VB4;F9 2<!L#DUH_\*M\'?\ 0'_\FIO_ (NJ]TYHRQ<DFE'[
MW_D:W_"6>'/^@_I?_@;'_C1_PEGAS_H/Z7_X&Q_XUD_\*M\'?] ?_P FIO\
MXNC_ (5;X._Z _\ Y-3?_%TO='?%]H_>_P#(UO\ A+/#G_0?TO\ \#8_\:X3
MXNZYI.I>$;6'3M3L[N5;Y'*07".P7RY!G /3D?G72_\ "K?!W_0'_P#)J;_X
MNN,^*'@S0/#OABWN]&L/LT[WBQ,_G2/E2CG&&8CJ!51Y;G+BWB?82YE&UN[_
M ,CRFBBBND^5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=R\CITQ1HAQ]K5>C;W_+_(@3Q[XFCLA:IJL@C6/RPWEIY@7IC?C=^M<[6@=
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MQB66!E0YZ<D8JM#%RJRU;?\ 6OYE_4O&GB#5[%[._P!19X)""Z)$D>_']XJ
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MF_\ ^$7UD>&S<?:O^$@G^V_9<^9LYVYV\[<_KFKVA0ZG -2/B*ZN)M7;2(3
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MF6+.T/CY@,]LUXC^SDBG5O%[D?,LD !] 6FS_(5[K0""N2^*7_)-=4_[8_\
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M $!__)J;_P"+H_X5;X._Z __ )-3?_%T>U0?V17[K\?\CYVHKZ)_X5;X._Z
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M/_Y-3?\ Q='_  JWP=_T!_\ R:F_^+H]J@_LBOW7X_Y'SM17T3_PJWP=_P!
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MK:!(+:)(8HU"I'&H55 [ #H*?10!R>H?"[P7JFLOJM_H%O+=R-O=][JKMZE
MP4GZCFK^B>"O#WAO5;W4M$TY;2ZOB3<,DCD-EMW"DE5&3T %;M% &%X<\%Z!
MX2DO)/#UA]D:^*M<'SI)-Y7=C[[''WFZ8ZUNT44 %<E\4O\ DFNJ?]L?_1R5
MUM<E\4O^2:ZI_P!L?_1R54=T<^*_@3]'^1K>$_\ D2]$_P"P?!_Z+6M>LCPG
M_P B7HG_ &#X/_1:UKTGN:4OX<?1!1112- HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNMKDOBE_R375/^V/_HY*J.Z,,5_ GZ/\C6\)_P#(EZ)_V#X/_1:UKUD>$_\
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M]^H__CE'_"ZO#G_/EJG_ 'ZC_P#CE>&T4>SB']JXGNON/<O^%U>'/^?+5/\
MOU'_ /'*/^%U>'/^?+5/^_4?_P <KPVBCV<0_M7$]U]Q[E_PNKPY_P ^6J?]
M^H__ (Y1_P +J\.?\^6J?]^H_P#XY7AM%'LXA_:N)[K[CW+_ (75X<_Y\M4_
M[]1__'*/^%U>'/\ GRU3_OU'_P#'*\-HH]G$/[5Q/=?<>Y?\+J\.?\^6J?\
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MY1_PNKPY_P ^6J?]^H__ (Y7AM%'LXA_:N)[K[CW+_A=7AS_ )\M4_[]1_\
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M\^6J?]^H_P#XY7AM%'LXA_:N)[K[CW+_ (75X<_Y\M4_[]1__'*/^%U>'/\
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M*K!%5E9"#U Z@<&J2^,["+Q!H/VK7Y=1@M9WFN;@62P1(2I5=J*@<GGG.?\
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MI],4:WT*C*BX152UDEZ_%^5A+WPAIESH^H7.B0ZU;3:?'YS+J<(59XP<,5(
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MTE9A1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#KOA;_ ,E*TO\
M[;?^B7KZ(KYW^%O_ "4K2_\ MM_Z)>OHBN>KN?49/_ ?K^B"BBBLCV HHHH
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M/_Q='_"K?&/_ $!__)J'_P"+HYEW#ZK7_D?W,Y&BNN_X5;XQ_P"@/_Y-0_\
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M /DU#_\ %T<R[A]5K_R/[F<C177?\*M\8_\ 0'_\FH?_ (NC_A5OC'_H#_\
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M/_Q='_"K?&/_ $!__)J'_P"+HYEW#ZK7_D?W,Y&BNN_X5;XQ_P"@/_Y-0_\
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M/_0'_P#)J'_XNC_A5OC'_H#_ /DU#_\ %T<R[A]5K_R/[F<C177?\*M\8_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1W6-&>1@JJ,LS'
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M_.IPE3DX35F@HHHH("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:"(;A]UU9XC<GJR_PM^F/PKJ:XVK.Q^58BA/#U94I[H****1@%%%% !1110
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MH9DEC.UT8,I]"*^AK2<75E!<+TFC5Q^(S7SM7NOA"<W'@_3';DB )_WS\O\
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M:*?[-:)!))",1LX))V_[/.!7.T4N76YST\%&%?VU_EZ_U_G<****H[PHHHH
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MUSPQ9W6MV%GI$\<)-HLDV8=JI&!DRDYY)]/UK$O- M1I4U_H^J+J$5LRB=3
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MHG_/KJ'_ '[3_P"+H_X6GHG_ #ZZA_W[3_XNNUHK&\>Q\;[? _\ /E_^!_\
MVIQ7_"T]$_Y]=0_[]I_\71_PM/1/^?74/^_:?_%UVM%%X]@]O@?^?+_\#_\
MM3BO^%IZ)_SZZA_W[3_XNC_A:>B?\^NH?]^T_P#BZ[6BB\>P>WP/_/E_^!__
M &IQ7_"T]$_Y]=0_[]I_\71_PM/1/^?74/\ OVG_ ,77:T47CV#V^!_Y\O\
M\#_^U.*_X6GHG_/KJ'_?M/\ XNC_ (6GHG_/KJ'_ '[3_P"+KM:*+Q[![? _
M\^7_ .!__:GFWB3X@Z7J_AV[L+2WO$EF4!6D10H^8$YPQ["O.J]R\:)YG@W4
M@.T6[\B#_2O#:VIVMH?8Y#4HSP\O91Y5?O?HO)!1116I]"%.1&DD5(U+NQPJ
MJ,DGT%-KH/!*3#Q/!=I&K0VH:2=W<*L:8(+$GTSFDW97,:]7V5*53LC'NK&[
ML65;VUFMF89431E"1[9J*.-YI4BA1I)'8*J*,EB>@ [FNR\6QW"Z396%J;K4
M[9 ]X-0<%]R'MD9P!D9SW]*YSP[_ ,C1I7_7Y#_Z&*2=U<YJ&*=3#NJUJK_A
M^7H'_".ZW_T!]0_\!7_PK/DC>*1HY49'0E65A@J1U!%=GJEC>MK%XR>++&%3
M.Y$37TBE!N/RD!>,=,5FZ?I&FS:#=ZOJ]Q=-Y%V(F%N03*".Q8=<G.3V'3-)
M2,Z6-O#GGKMLGN_4YRBNQD\/^'(+[3X9;G4F_M1(Y+=5" Q*_ WG'/.>GI5:
M#P_I5OIM_=ZM<W(%E?&U"P;09< \#/0YYSZ \4^9%K,*35[/[M];?F8KW.H:
MP;6TQ)=-;Q^7!'''E@HYQ@#)]:HUW6@Z5:6?BK1+_2YI9+.^CN"@G #HR1L&
M!QP>3UK%MM*TBTT.UU'7)KMC>LX@AM-H(53@LQ;W[4N9$0QE-2Y8QTTLDM;M
MRNK>7*_Q.?HKJW\*VAN;J"VN99FDL!?:>< >8G.588^]@'ICIGVJ#3O"Z7]G
MI*&9X[S4IY"@.-J0H.6(ZYR#CG'%/F1K]?H<O-?^K-_DG]S.;HKK;GPUI\]A
M?2:4FJ0S6<9FS?1!4F1?O;2 ,''.#_\ JIZQI>C:7IEI\]])?W5G%<J,IY2%
MAR#QGU_2CF3"&.I3:C%.[TM8YZBBBJ.X**** .Y\&>-=/\.Z+)9WT-U([3M(
MIA12,%5'=ASD&N@_X6GHG_/KJ'_?M/\ XNI?ABFSPDQ/\=R[#\E']*["N:3C
MS;'YWF-?!K%U%.DV[[\UOPL<5_PM/1/^?74/^_:?_%T?\+3T3_GUU#_OVG_Q
M==K14WCV.'V^!_Y\O_P/_P"U.*_X6GHG_/KJ'_?M/_BZ/^%IZ)_SZZA_W[3_
M .+KM:*+Q[![? _\^7_X'_\ :G%?\+3T3_GUU#_OVG_Q='_"T]$_Y]=0_P"_
M:?\ Q==K11>/8/;X'_GR_P#P/_[4XK_A:>B?\^NH?]^T_P#BZ/\ A:>B?\^N
MH?\ ?M/_ (NNUHHO'L'M\#_SY?\ X'_]J<5_PM/1/^?74/\ OVG_ ,71_P +
M3T3_ )]=0_[]I_\ %UVM%%X]@]O@?^?+_P# _P#[4^=)7\R9W_O,33*L7R>5
MJ%Q&>"LK+^1-5ZZC]0BTXIH****905T?@26.+Q=;"0A6D22.-C_"Q4@?X?C7
M.4JL48,I*L#D$'D&DU=6,,12]M2E3O:Z:+2:;=OJ@TX0,+LR>7Y9'(:M^"R?
M3?#/BJSEDCD>"2U1FB;*Y#MG!_2J1\9^(##Y?]HO]W9O\M-^/]_&[]:HZ;K6
MHZ1-++I]RT32C$F5#!_J&!!J=6<M2GBJL;2Y5:SM=ZM23WMIMV9U%F_V33/"
M$TUE+=JCW;^2D>YB-PPP'?'WOPJ35M0N;S0IK[3]:BU)+&>*;=-:^7/;'=A=
MIZ$9]NU<S<>)M8N;FVN)KYS+:LS0N%4%"V,]!TX''2C4?$NK:K;?9[Z\+PEM
MQ18U0,?4[0,_C2Y7<Y%@*KJ1G*V[;Z[R;MK'L[737G='<:A=SR^+-9D;%Q+I
MEB);*)U#"-F1"S 8Y(ZUS\E_=:_X*U*ZUG$\MG-%]FN60*V6.&3(ZC&#CW^E
M9#^)]9DNK>X:^836RE8Y%100#C@X'S=!US4>IZ_J>L1I'J%T98XSN5%144'U
MPH S[T*+0J&7U*?(FHZ<NNMU;>VGVNNV[W/06U6YF^(>H:1-Y;Z>(&+6[1J5
M<^6&R>,DY-<_'?S>(O"CG695D,6HPHDFU5,:MD,!@=*YX>(-3&KR:I]I_P!,
ME4J\OEKR"-O3&.@]*K)?W,>GRV*28MI7$CIM'+#H<]>]"A8*66.FHVLFE#5=
MU\3VZ_CU/2Y[JUA\1MI4FJ1FR7]T='33I'^7;T!"G)_BR*PKO4KC1?!%@-)F
M,>Z[N(A*4&\IN/'(XSQGZ"L-/%^O):BW747"!-@;8N\#TWXW?K6=)J-U-IT-
MA)+FV@9GC3:/E)Z\XS24":.5SBX^TLTFKKO9-7^%:Z];^;*M%%%:GOA1110
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ME<J2.H['M0I-D4LRJ5;*,5=VMY7?7^O(Y_2/#M[J>O1Z7)%+:RD%I#)$V8E
MZD?D/Q%9L]O-:SM#=0R0RK]Z.12K#Z@UZ+8SR/XG\)322LTLU@5E<MS(-K$
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MKUIJ5V=.'QTJU7D:LFKKOLG^NSL<]1115GJ!7IGPHML6NI71'WG2,'Z D_\
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MA_\ 0!6E45I;1V5E!:P9$4$:QIDY. ,#^52T/<SJR4ZDI+JV%%%%(S"BBB@
MKR'X@^&SI.K&^M8\6=VV>!PDG<?CU'X^E>O55U+3K?5M.FLKQ-\4JX/J#V(]
MQ5QERL]/+<=+!5U/[+T:\O\ @'SW16GKVA77A_5'M+L9'6.0#B1?4?X5F5U;
MGZ=3J0JP4X.Z84444S0**** "BBB@ HHHH **** "BBB@ HHHH *] ^&OALS
MW1UJ[C_=1$K;@C[S=V_#^?TKG/"OAJ?Q'J8C *6L1!GE]!Z#W->VVUO%:6T=
MO;1B.*)0J(O0 5C4E961\MGV9*E3>&IOWGOY+_@_D24445SGP84444 %%%%
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M^62_W?J>_P"5==7-4E=V1^?9YF2Q53V--^Y'\7_P.@4445D?.!1110 4444
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#?7*\[I1\BGV7_'-=71163;>Y\Q7Q-;$SYZLKL****1SA1110 4444 %%%%
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MA,0&'T;H?QQ7IM%5&3CL>AA,QQ.#?[J6G9[?UZ'S[?Z5?Z7+Y>H6DMNW;>N
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
MZ!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'Z
MU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?
MB+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_
M ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?
M\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\
M#1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_
M *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z
M!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_
M 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B
M+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
MZ!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'Z
MU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?
MB+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_
M ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?
M\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\
M#1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_
M *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z
M!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_
M 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B
M+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\
MX[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\V
MT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4
M>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]
M=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K
M'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\
M-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$
M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
MZ!^M?]^(O_CM'_#1/A/_ *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'Z
MU_WXB_\ CM'_  T3X3_Z!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?
MB+_X[1_PT3X3_P"@?K7_ 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_
M ([1_P -$^$_^@?K7_?B+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?
M\-$^$_\ H'ZU_P!^(O\ X[7S;11[& ?7:Q])?\-$^$_^@?K7_?B+_P".T?\
M#1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\ Z!^M?]^(O_CM'_#1/A/_
M *!^M?\ ?B+_ ..U\VT4>Q@'UVL?27_#1/A/_H'ZU_WXB_\ CM'_  T3X3_Z
M!^M?]^(O_CM?-M%'L8!]=K'TE_PT3X3_ .@?K7_?B+_X[1_PT3X3_P"@?K7_
M 'XB_P#CM?-M%'L8!]=K'TE_PT3X3_Z!^M?]^(O_ ([1_P -$^$_^@?K7_?B
M+_X[7S;11[& ?7:Q])?\-$^$_P#H'ZU_WXB_^.T?\-$^$_\ H'ZU_P!^(O\
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M^$_^@?K7_?B+_P".T?\ #1/A/_H'ZU_WXB_^.U\VT4>Q@'UVL?27_#1/A/\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRC]H@D?#RRQWU2//\
MWZEKU>O*/VB?^2>6/_84C_\ 14M73^-'/B?X,CYMHHHKO/G@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC&82JN58?=W ]1S@UW7AZRN4\7:O#J5_XHU6<6UPEU->6H@T]_EP0J$G//0
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MPF,&-3D@^6#N&1Z>F:IS9$:*=G?<\D.C:F-4.FG3;L7P!)M?(;S1@;C\F,]
M3TZ<U+=^&]<T^U:YO]&U"U@0*6EFM715#<+DD8Y[>M>V6,H;XA> F:TU:.XC
MM+Y1=:PD2W$\0A<Q[@C$_+EA\P&<]^:X#P'J]UXCU?4_#NN7LUT-?LFMXY;F
M0R%)TS)"<D] V[CU:CG>X.C%.U]_\E_F<0]A>1V$=\]K.MI*Y2.X,9$;L.JA
MNA(]*KUVOQ%<:8VC^%(<!-#LU$^,\W,N))3GN,E1[8-<55IW5S"<>65@HHHI
MD!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2O3_ (8_$6#XA:%+.T*VNH6C!+J!3E1G[KKWVG!Z]""/<]H<;3NQC'.:^?\
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MU?Y7]QPM%=U_PI;Q_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\ Q='/'N'L:O\
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M  I;Q_\ ] #_ ,G(/_BZ/^%+>/\ _H ?^3D'_P 71SQ[A[&K_*_N.%HKNO\
MA2WC_P#Z '_DY!_\71_PI;Q__P! #_R<@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q
M_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\ Q='/'N'L:O\ *_N.%HKNO^%+>/\
M_H ?^3D'_P 71_PI;Q__ - #_P G(/\ XNCGCW#V-7^5_<<+17=?\*6\?_\
M0 _\G(/_ (NC_A2WC_\ Z '_ ).0?_%T<\>X>QJ_RO[CA:*[K_A2WC__ * '
M_DY!_P#%T?\ "EO'_P#T /\ R<@_^+HYX]P]C5_E?W'"T5W7_"EO'_\ T /_
M "<@_P#BZ/\ A2WC_P#Z '_DY!_\71SQ[A[&K_*_N.%HKNO^%+>/_P#H ?\
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M@_\ BZ.>/</8U?Y7]QPM%=U_PI;Q_P#] #_R<@_^+H_X4MX__P"@!_Y.0?\
MQ='/'N'L:O\ *_N.%HKNO^%+>/\ _H ?^3D'_P 71_PI;Q__ - #_P G(/\
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M - #_P G(/\ XNCGCW#V-7^5_<<+17=?\*6\?_\ 0 _\G(/_ (NC_A2WC_\
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MYX=_[!=M_P"BEK=I/<J'PH****184444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'L'W#^T(_P I]F45\9_\)SXL_P"AHUK_ ,&$O_Q5'_"<^+/^AHUK_P &$O\
M\51[!]P_M"/\I]F45\9_\)SXL_Z&C6O_  82_P#Q5'_"<^+/^AHUK_P82_\
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M<^+/^AHUK_P82_\ Q5'L'W#^T(_RGV917QG_ ,)SXL_Z&C6O_!A+_P#%4?\
M"<^+/^AHUK_P82__ !5'L'W#^T(_RGV917QG_P )SXL_Z&C6O_!A+_\ %4?\
M)SXL_P"AHUK_ ,&$O_Q5'L'W#^T(_P I]F45\9_\)SXL_P"AHUK_ ,&$O_Q5
M'_"<^+/^AHUK_P &$O\ \51[!]P_M"/\I]F45\9_\)SXL_Z&C6O_  82_P#Q
M5'_"<^+/^AHUK_P82_\ Q5'L'W#^T(_RGV917QG_ ,)SXL_Z&C6O_!A+_P#%
M4?\ "<^+/^AHUK_P82__ !5'L'W#^T(_RGV917QG_P )SXL_Z&C6O_!A+_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T+X'7DMM\5["*
M-B%NHIHI .X$;/\ S05]3U\H?!;_ )*]HO\ VW_]$25]7UR5_B/:P'\)^H44
M45@=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7"_&G_DD.M?]L/\ T?'7=5POQI_Y)#K7_;#_ -'QU4/B1E6_A2]&;O@;
M_DGGAW_L%VW_ **6MVL+P-_R3SP[_P!@NV_]%+6[2>Y4/A04444BPKRC]HG_
M ))Y8_\ 84C_ /14M>KUY1^T3_R3RQ_["D?_ **EJZ?QHY\3_!D?-M%%%=Y\
M\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW3PV5EIA0.0GWG+/G"@G&.O3UKL/"7AFST/Q,]]HUU+=:3JWAVZGM6G $J8
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MKG]J,"(9V$1A1O+\P*PP&;CJ1CT]Z?.A*C)['DM%%%48A1110 4444 %%%%
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M_B_^-4?\,[>$_P#H(:U_W_B_^-5ZO11[2?</JU'^4\H_X9V\)_\ 00UK_O\
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M@B<\!B5)9L9XX_QKSZBAQ3%&I**L=M8^+-%U;PR-&\;PZ@Y@NY+NVO=.$?F
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M_"EO '_0 _\ )R?_ .+HHHYY=P]C2_E7W!_PI;P!_P! #_R<G_\ BZ/^%+>
M/^@!_P"3D_\ \7111SR[A[&E_*ON#_A2W@#_ * '_DY/_P#%T?\ "EO '_0
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MG)__ (NC_A2W@#_H ?\ DY/_ /%T44<\NX>QI?RK[@_X4MX _P"@!_Y.3_\
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BA^W\U3E3,SS8/J [$444<TNX*C36JBON.MZ=****DU/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>iclr-20221231_g4.jpg
<TEXT>
begin 644 iclr-20221231_g4.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0!D17AI9@  34T *@    @ ! $Q  (
M   =    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !796)D86T@:'1T<#HO+W=W=RYW96)D86TN8V]M  #_VP!#  (! 0(! 0("
M @(" @(" P4# P,# P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,
M!PD.#PT,#@L,# S_VP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" SD"?8#
M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5M=<TZ&\LKBWO+2X4/%/!()(Y5/0JPX(]Q5BN8^D335T%%%% PHHHH ****
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ME!W3ZH****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *XCX^_M&>#?V8? 4WB3QMKEKHNFQG9'ORTUW)C(CBC7
M+2.?10<#DX )'%_MQ?MQ^%?V'?A6^MZVZWVM7P:/1M&CD"SZE,!^.R)<@O(1
M@ @#+%5/X6?M*_M0^,OVL_B3<>*/&FJR7]Y)E;:W4E;73HL\101YPB#\V/+%
MF))]3+\MEB/>EI'\_0_,>/O$C#9#'ZKATJF(:VZ171RMKZ16K6K:5K_7'[7?
M_!>+QQ\4+FZTGX86K>!M!8&,:A,J3:M<J?X@>8X,CC";F'4..WPSXO\ &VL_
M$'7IM4U[5M2UK4KC_6W=_<O<32=^7<DGJ>]9=%?4T,-2HJU-6/Y9SSB7,\WJ
M^US"LY]EM%>D5HON]0HHHK<\,*DM;N6QNHYX))(9H7#QR(Q5D8'(((Y!!YR*
MCHH ^M/V5/\ @LI\7?V<KNUL]7U)_'_AF'"O8:S,7N43I^ZNL&12,  /O4#H
MO>OU>_8Y_P""@/P[_;8\/M+X7U%K/7+6,/>Z'?[8[ZU]6"Y(DCS_ !H2.1G:
M3BOY[:U/!/CC6/AOXJL=<T#4[W1]8TV436MY:2F*:%AW##GV(Z$$@\5Y>,RN
ME65X^[+^MS].X3\4LURB:I8B3K4>L9.[2_NR>J]'=>FY_3917QK_ ,$NO^"I
M>G_MAZ'%X3\736NF_$K3XB2J@10Z]&HR9H1T60 9>,>[+\NX)]E5\K6HSI3<
M)K4_JS)<ZPF;82.-P4N:$OO3ZIKHUU7Z685E^,_&ND?#OPO>ZUKVI66CZ1IL
M1FN;R[F$4,"#NS'@?U-8OQU^.7AO]G#X6ZKXP\67PT_1=(CWR,!NDF8G"11K
M_%([$ #U/) !(_#']O7_ (*)>,/VY?&S-?22:/X/L92=+T*&4F*(<XEF/_+2
M8CJQX7HH&3GIP. GB)=H]6?,<<<?8/AZBHR]^M)>["__ )-)](_BWHNK7UU^
MV3_P7XD2ZN]#^"^FQ^6N8SXEU6#);_:M[9NGJ&F!SWC'6OSM^+GQV\9?'KQ"
MVJ^,O$VL^)+XDE7OKEI%A!_AC3[L:_[* #VKDZ*^KP^#I4%:FOGU/Y2XAXPS
M;.JCECJK<>D5I!>D=OF[OS"BBBNH^9"BBB@#WS]F3_@IA\8/V59K>#0?%%QJ
MFAP$9T76";RQ*C^%0QWQ#_KDR?C7ZJ?L-_\ !7'X?_M@S6NA7W_%&^.)L(NE
M7LP:&_?_ *=IN Y/]Q@K]<!@":_"^G12M!*LD;,CH0RLIP5(Z$&O/Q66T:ZO
M:S[K^M3[_A7Q'S?)9J$9NI2ZPD[JW]UZN/RT[IG]/U%?F3_P2E_X*_W7B'4]
M)^&'Q8U#SKJX(MM%\2W,H5I6P EM=$XRQQA92<L2H;).X_IM7R>*PLZ$^2?_
M  Y_6'#/$V"SS!K&8)Z;23WB^S7Y/9] HJ.ZNXK&UDGGDCAAA4O)([!510,D
MDG@ #G)K\B?^"J'_  5WO/C%J&H_#OX7:G-9^#8]UMJFL6[%)==/1HXF'*VW
M4$CF4$_P'#5A,)/$3Y8?-]C#BSB[!9!A/K.+=Y/2,5O)^79+J]EYMI/Z:_;A
M_P""V?@O]G6[O?#O@2&W\=>+K<M%+,LO_$JT^0<$/(IS,P/5(R!U!=2,5^7G
M[1W[=GQ4_:KNY/\ A,?%VHW6G.Q9-*MF^RZ?$,Y \E,*V.@9]S?[1KR*BOK,
M+E]&@O=5WW?]:'\F\3^(&;YW-JO4<*72$6U&WGUD_-W\DM@HHHKN/B0HHHH
M] ^!7[5/Q$_9HUA;SP/XMUC0#O#R6\,VZTN"/^>D#9CD_P"!*:_2S]BS_@O-
MH?Q N[3P_P#%ZQM?"^I3$11Z]9!CILS=!YT9): GNP+)R2?+ K\DZ*X\3@:-
M=>^M>_4^NX;XWS?))IX2JW#K"6L7\NGK&S/Z>=,U.VUK3H+RSN(+NTNHUEAG
MAD$D<R,,JRL."".01P:GK\./^";?_!4_Q%^QKK]KX=\0276O?#:[F GLV)DG
MTC/66UR>!DY:(_*V#C:Q)/[9>!O'&D?$OP?IOB#0=0M]5T;5X%NK.[@;='/&
MPR"/Z@X((((!!%?*8S SP\K2U71G]7<&\;8+B'#>TH^[4C\4'NO-=XOH_O29
MJT45^>G_  5:_P""N7_"EI;[X;_"^_AE\6C=!K&M18=-%XP883T-Q_>;D1].
M7SLQP^'G6GR0/8XAXBP62X.6-QTK16B2WD^BBNK_  6[LCW7]M[_ (*D?#O]
MBR";3;F9O$_C39NBT'3Y1OAST-Q+RL"GT(+D$$(1S7Y3?M1?\%5_C%^U#=7%
MO=>(IO#/A^5B$T?0W:UA*$\++(#YDW&,[VVY&0J]*^==3U.YUK49[R\N)[N[
MNI&EFGFD,DDSL<LS,>22>23R:@KZS"Y91HJ[5WW?Z'\G\5>)F;YS-PC-TJ/2
M$7:Z_O/1R_!>0,Q9LGDGDD]Z***]$_.PHHHH Z#X;?%CQ/\ !SQ"FK>%/$&L
M>'=23'^D:?=O;NP'9BI&Y?8Y!]*_0+]CW_@OOK?A^ZM]&^,>FC7-/8A!K^F0
M+%>0=LS0+B.0=,F/80 ?E<G%?F[17/B,)2K*U1?/J?19#Q9FF35%4P%5Q76+
MUB_6+T^>_9H_IA^&/Q3\._&CP38^(_"NL6.NZ)J"[X+NUDW(WJ#W5@>"K ,I
MX(!K?K^>?]BO]N;QI^Q%\15U;P[=-=:->.HU;1)Y#]EU*,'N.=DH&=L@&5Z<
MJ64_NM^S)^TWX3_:T^$]CXN\(WWVFRN?W=Q;R86XT^< %H)ER=KKD>Q!# E2
M"?E,=E\\.[[Q[_YG]5<"^(6%XAI>RDO9UXKWHWT:_FCW7=;KK?1OT*BBBO./
MT0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE?
MCA\9-#_9\^$VO>,O$=Q]FT?P_:M<SD8WR'HD: ]7=RJ*.[,!755^4?\ P< _
MM9R:[XUT7X0Z3=?Z%HJIJ^N!&_UERZGR(6_W(V,A!X)F0]5KJP>&=>JJ?3KZ
M'RO&?$D,CRFICGK+:"[R>WR6[\DSXE_:T_:C\1?M?_&W5?&GB*5EDNV\JQLE
M<M#IEJI/EP1^P!R3@;F9F/+&O-:**^XC%1BHQV1_$.*Q5;$UI8C$2<IR;;;W
M;>["BBBJ.<[S]F7]GW6/VI?CGX>\":$\,-_KTY0SR_ZNUB16DEE;U"1JS8')
MP .2*_5K1O\ @WY^#5IX06ROM:\=7FJ,@\S48[V"$A\#)2/R2BKD' ;<0#]X
M\&OBK_@AC_RD$T7_ +!.H?\ HDU^W]?.YOC*U.JH4W96N?T5X1\&Y3F&55,;
MCZ*J3<W%<VR22V7>[>N^UMC^>;]O#]C?5/V'_CW<^#[Z\75+&XMDU#2K\1^7
M]KM79E!9<G:ZLCJPSU7(X(KQBOT1_P"#BK_DO?P^_P"P!+_Z4-7YW5[&"JRJ
M4(SENT?CO&F54,MSO$X+#:0C+1=DTG;Y7MW"BBBNH^7-/P;XRU3X>>*]/US0
M[ZYTO5])N$NK2[MWVR02*<JP/^0>E?O;_P $\OVX-,_;._9S@\27,MI8^(=#
M46OB.V#A$M9E7/G#)^6*1074G@8=<G837\_]=E\+/CYXJ^"^A>+--\.ZG+I]
MIXVTHZ/JJ+G]] 75SCT;"LF[J%ED ^]7GYA@5B();-=?S/ON >.*O#V*E*2<
MJ,T^:/FE[K79WT?DWV1[I_P51_;[NOVS_C5)9:3<R+\/_"\SP:/",JMZX^5[
MQQ_>?HH/W4P, EL_+-%%=E&C&E!0ALCY/-\VQ.98RICL7+FG-W?Z)=DEHEV"
MI+2TFU"[BM[>*2:>9Q'''&I9Y&)P% '))/&!6]\)OA3K_P <?B-I/A/POI\V
MJ:YK<XM[6WCXW$\EF)X5%4%F8X"JI)( -?MW^P#_ ,$M_!?[%N@VNJ7D%GXF
M^(4B;[G6IH=RV3%<&.T5O]6@!(W\.^3G (1>7&8Z&'C[VKZ(^DX,X&QW$5=J
MC[E*+]Z;V7DEUE;6VB75JZO^;'P _P""*_QP^.-A#?WFDV'@?39@&27Q#,T%
MQ(O?%NBO*I]I%3/K7T1I'_!N"[V2-?\ Q>6.Y8?.EOX:WHA]F:Z!/_?(K]0J
M*^?J9SB9.\6E\O\ .Y_0V \'.'*%/DQ$)57WE.2^Y0<?U/RE\>_\&Y?B.PL=
M_A?XGZ+JMUG_ %6J:3+I\8_X'').?_'*^/?VE?V _BO^R:&N/&7A.\M])W[%
MU:S(N]/8DX&94R(RW99-K'L*_H<J'4-/M]7L)[6Z@ANK6ZC:*:&5 \<J,,,K
M*>"I!((/!!JJ.=5XO]Y:2^[\O\CCSCP7R/$TW]1YJ,NEFY1^:DVW\I(_F%HK
M],_^"I7_  1QL_"FBZA\1OA#ILD-G:A[K6?#<.66",#+3V@ZA1R6BY '*8 V
M#\S*^DPV*A7ASP_X8_F_B7AG'9'BWA,='7=-?#)=T_S6ZZH*_9G_ ((N?\%!
M)OVD/AU-\/?%E\UQXU\)6X>UN9GW2:O8 A0[$\M+$2JL3RRLC<G>1^,U=A\!
M/C?KW[.'Q?T+QMX;F6'6-!N!/$'!,<RD%7B< @E'1F1@"#AC@@\UGCL*L12<
M>O3U/0X'XKJY#F<<4K^SEI./>/>W>.Z^[9L_1S_@N5_P4'FT19O@IX0OFBFN
M(ED\57D#X98W&4L01_>4AY/561>0SBORSK2\9>+]2^('BW5->UBZDOM6UFZE
MO;RYD^]/-(Q=V/U8D\5FU6$PL:%-0C\_-G)Q9Q+B,\S*>.K;;1C_ "Q6R_5]
MVVPHH52[  9)X '>OUI_X)@?\$;].\!Z3I_Q ^+VDQZAXDG N-,\.W:!K?2E
M."LERAX>?N(VRL>>07_U9BL5##PYI_)=Q\*\*8[/L7]5P:T6LI/:*[OS?1;O
MT3:^&OV8O^"7WQB_:LM+74-"\-G2?#]US'K.M.;.SD4C(=.#)*IZ;HT89[U]
M:^"_^#<>YELX9/$7Q5@@N,CSK?3M#,J =PLLDRG\3'^':OU&11&H50%51@ #
MI2U\W5SK$2?N6BOO_,_I#*?!G(,-32Q:E6EU;DXJ_DHM67DV_4_,GQ+_ ,&X
MMG(CMH_Q8NH6"?+'>: L@9N>KK.N!T_A./>OFG]H?_@BY\;O@-83ZA::39>.
M-)@!=Y_#\K3SQ*#QNMW592>Y$:N!SDU^YE%*GG&)B_>=_5?Y6.C,O!WAS$P:
MH0E2EWC)O\).2MY*WRW/Y@98FAD9'5D="596&"I'8TVOW*_X*)_\$JO"G[8G
MA^^U[0;>R\.?$F-#)!J,:>7#JK #$=V%'S9 P)0-Z\9W*-M?B;\0/ &L_"OQ
MKJ?ASQ#I]QI.M:/<-;7EI.,/#(O4>A!Z@@D$$$$@@U]'@\=3Q$;QT?5'\Z<9
M<#X[AZNH8CWJ<OAFEH_)KI+RN_)LQZ^\O^"*W_!06;X&_$BW^%_BF^_XHWQ5
M<A--FF;Y=(OW.% /:*9L*1T#E6X!<GX-H5BK9'!'(([5MB*$:U-TYGC</Y[B
M<GQ]/'X5^]%ZKI)=8OR:^[=:I'[B?\%=/V^V_8^^#*:'X=NA'X^\81O%8.I&
M[2[<<279'][^"//\1+<["#^']U=RWUU)//))--,Y>21V+,[$Y))/))/.376?
M'#X\^*OVC/&Z^(O&&J3:MJRV5O8"9^,101K&N!T!."[8P"[NW5C7'USX'!K#
MT^7J]V>YQUQA5X@S!U]52CI"+Z+JWTO)ZOY+H%?=7[#'_!$G7/VG_A=I_C;Q
M7XF_X1#0]:C\[3+2"R-Q?7<66 E;<RK&C8#+]\NIS\H()^%:_I._9SMH[+]G
MOP'##''###X=T](XT4*J*+:,  #@ #M7/FV,J4()4]&^I]#X3\)X#.\;6>81
MYH4XIJ-VDVV[7::=E9Z7UZZ:'X[_ +?/_!'GQ7^QMX0D\7:/K,?C/P=;LJWD
MZVIMKS3-S;5,D>Y@T>2J^8K=6Y51R?CFOZ=/$?AVQ\7^'[[2=4L[?4--U*![
M6ZMIT#Q7$3J5=&4\%2"01[U^#?\ P4P_8/O_ -B'XX26]K'-<>"?$+R7.@7C
M$MM0$%[:0_\ /2+<!G^)2K=20,\KS)UOW=7XNGG_ ,$[_$_PYIY0EF.5Q?L'
MI)7;Y'T=W=\KVU>CTOJCYOHHHKVC\9/T _8U_P""$^L_'KX4Z;XP\;>*I/"-
MMKD"W>GZ;;60N;IX'&4EE9G58]PPP0!CM89*G*CS?_@H;_P29\1_L.^'[;Q1
M8ZTGB[P;<3K:S7BVIMKG396SL6:/<PV-C D#8+?*54E-W[A:?80Z580VMO&L
M-O;1K%%&O1%48 'T KY]_P""L>DPZU_P3Q^)T,V[8FGPSC']Z.ZAD7_QY17R
MN'S:O*NN9^ZW:WJ?U-GGA/DF&R&JZ,'[:G"4E/F=W*,;ZJ_+9VMHM.FI^ ]>
M^_\ !.[]N'5OV(/CI;:NLES=>$]69+7Q!IR-D7$&>)57IYL62RG@D;ER YKP
M*BOIJE.-2+A/9G\SY;F.(P&*AC,++EG!W3_K=/9KJM#^G+POXFT_QIX:T_6-
M*NH;[2]5MH[RTN8CF.XAD4,CJ?0J0?QJ]7YW_P#! ;]K&7QW\+]:^%6KW7FW
M_A#_ (F&C[_O/82/B2,'N(IF!Y[3J!PO'Z(5\/BL.Z-5TWT/[DX8SZEG.64L
MPI:<ZU7:2TDOD]NZL^H4445SGO!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'M\U?-Y]32E&IWNC^DO G,I2P^*P,GI%QDO^WDT__25]YM4445\^?OP4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?.?_  5K_P"4=OQ.
M_P"O*W_]+(*_ NOZ'O\ @H+X(D^(O[$GQ1TN&,33/X=N[F)",[WA0S*!P>2T
M8Q[XY'6OYX:^HR*7[F2\_P!#^7O'2E)9MAZCV=.WS4I-_F@HHHKW#\0"BBB@
M#[!_X(8_\I!-%_[!.H?^B37[?U^('_!#'_E()HO_ &"=0_\ 1)K]OZ^3SO\
MWCY+]3^LO!/_ ))^7_7R7Y1/R0_X.*O^2]_#[_L 2_\ I0U?G=7Z(_\ !Q5_
MR7OX??\ 8 E_]*&K\[J][+/]UA_74_!_$S_DIL7_ (E_Z3$****[CX4****
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M/,US,\DC%I)&+,QZDGJ:;7W,596/X;KU?:U)5&K<S;^\****9D%?TH_L^_\
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M\NXOR->SE>,US0EUC+_@.\9+U6^I<KP#_@J9_P H^_BC_P!@D?\ HZ.O?Z\
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MBBB@ HHHH AU'3X=7T^XM+J-9K:ZC:&6-A\LB,,,#[$$BOYN?VC?@_=?L_\
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M *X8G"5^X%?R_P!?HS_P3 _X+)K\*=)T_P"'?Q:NKJX\/VX$&D>(3F:73$&
ML%P!EGA'17&63A2"F#'X6;9>ZC]M26O5=S]T\*?$.C@(?V/F<N6FW>$GM%O>
M,NT6]4^C;OH]/T1_:U_8R\"_MH> ET/QEIS22V>Y].U*V81WNF.P +1/@\'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P !5E^ 445)9V<VHW<5O;Q23W$[B...-2SR,3@* .22> !70?/[Z(C52S8
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MT<8R [&OPUU"PN-)OYK6ZAFMKJVD:*:&5"DD3J<,K*>00000>017]/5? _\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY))]!7[G>#_^"+/[._A.=)I/!MUK$L?*G4-7NI%_%%D5#^(/Y\U[U\+?V?O
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MXYY0>Z:_KU/S/$^"&>0E^YJ4Y+UDG]SC^K/Q(H52S8 R3P .]?N1X>_X(?\
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M;Y@,A67)K\J?VH?^"0?QD_9MNKJYM]#D\;>'8F)CU+08VN&"=C+;@>;&<<G
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MAC'LB@ ?@*O5YN(SJK-6IKE7XGZ1P[X,97@I*MF$G7DNC7+#[KMOYNSZHQ_
M'P^T/X5^$+'0/#>DV.B:+IL?E6UG9PB**(=3@#N3DDGDDDDDDFMBBBO&;;=V
M?L5.G&$5""LEHDM$EV04444%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/$4EY?">;7)II;UE%S($W-,2^ N,9[8QQ7TG7QO_ ,%:O^"AGC3]@S_A7_\
MPA^E^%]2_P"$J_M'[7_;%M/-Y?V?[+L\ORIH\9\]\YSG"XQSGS*F*>,M0IP2
M=_R3\C]0RWAJGP?[3.\=C:E6G&/*TTW;FE%)I<SUO9>C/LBBOFG_ ()8?MD^
M*/VX/V?-8\6>++'0=/U'3_$,^DQQZ3!+#"T26UK*&(DDD;=NF8$A@, <=23_
M (*G_MD^*/V'_P!GS1_%GA.QT'4-1U#Q#!I,D>K02S0K$]M=2E@(Y(VW;H5
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MN+:XU.^:5%6)GEFE58PA=F8+D!>,G"G&C@:M6#J4U=7M_7WGN9UQOE.4XZ.
MQTW&<H\U[:*/O;O_ +=>F^UMS]2**_)G]D[_ (*[?&7]I7]MWP/X?U#5-)T?
MPOKFJ^1<Z38:9#L>(HQ"&617ESP.5=<^W2IOC-_P7#^-WP*^.GB+P?K/A;X;
MR?\ ",ZO-83F/3[U))XXY" Z$W9 WH RD@CY@<5N\IK\W)I>U]SP8>+&1O"_
M7'SJGSN%W'=I)]&W9IZ7L]'H?K!16?X5\36?C3POINL:=+Y^GZM:Q7MK*/\
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M8,8QU-?6%85J,J4W3GNCW,GS;#9G@X8["-NG.]FU9Z-IZ/S3.,_:.U2ZT/\
M9Y\>7UC<7%G>6?AW4)X)X)#'+!(MM(RNK#!5@0"".017X$6'[9_QPU2^AM;7
MXL?%:XN;B18HHHO$]^\DKL<*JJ)<DDD  <DU^^'[47_)LWQ%_P"Q8U+_ -)9
M:_ G]B'_ )/1^$/_ &.NC?\ I=#7N9-&/LIR:O;_ "/P_P 9*V(_M+ X>C4E
M!3NG9M;RBKZ-7L=5_P +H_:@_P"AL^/7_@TU;_XJC_A='[4'_0V?'K_P::M_
M\57] U%9?VQ'_GTOZ^1ZG_$'J_\ T,ZGW/\ ^3/#_P#@FWK'B+7_ -B+P!>>
M++K6KWQ%-:3&]FU:662]=A<S >8TA+D[0H^;L!7N%0W]_#I=C-=7,T=O;V\;
M2RRR-M6-%&2Q)Z  $YK\K?VIO^"]7BS7_'UQX?\ @UHVGPZ8MP;6UU6]M&N[
M[4GSM5H8<A45B?E5E=F^7(4DK7GTL/4Q523IKS\E<^]S3B++N&,OH4LPJ.34
M5&-E>4W%)-VO\VV[7=KW/U8HK\;?%?[?'[;WP9T5?$GBJW\2V&@Y4M+JG@NV
MM[2/<1M5W6W1DSD* S G..M?6'_!+W_@K9-^V-XLE\#^--+T_2?&$=JUU975
M@&6UU1(_]8NQBQCE"_-@$JP#D;< '6MEE6G!U+II=F>;E'B9E..QL<OE&I1J
M3^%5(\M[[6LWOTO:^VY]Q45\"_\ !4__ (*G_$+]A_\ :#T?PGX3T?P;J&G:
MAX>@U:235K2YFF65[FZB*@QSQKMVPJ0"I.2>>@'EOQ?_ ."^?B#3?@7X4M_#
MFD^'Y/B)J]B;K7+M8I#IVD,97"110L[,\AC".2[E5W#AB2$5/+*\XQG%:,US
M#Q*R/!8BOA<1-J='=<KU=TK1[O7[KMV2/L#_ (*S^.-:^''_  3\\?ZUX=UC
M5-!UBS_L[[/?:==26MS!NU*U1MDD9#+E693@\AB.A-?%O_!"K]HOXA?%W]K?
MQ%IOBSQUXR\4:=!X0N;F.UU;6KF]ACE%[9*) DCLH8*[ ,!G#$=S5%OVM_'W
M[7/_  2,^/VJ^/M:CUFZTO5]'M[,I906JV\;7]FQ4")%W<]VR?>N7_X-\%D?
M]LCQ6(6CCF/@>[",Z%U5OMUA@D @D9[9&?45Z5/#>RP=6$[73W^2/S?,.(_[
M2XORO%X24XTJD(OE;M?WZJU2;73OV/V4HK\E==_X+O?&CX9?&"Z\-^+?"?PY
MA70=7;3M8CM;"]695BFV3",M=D;L*VTD$9P<$5^L6EZI;ZWIEO>6DT=Q:WD2
MS0RH<K(C ,K ^A!!KQ\1@ZE"SGUV/U[AWB[+L[E5A@F^:FTI*2LU>_3Y,L45
M^9_[>'_!;+QU^SQ^U)XF\$^"M$\$ZAH_AMXK1[G5+6YFGDN/+5IAF.XC4*KL
M4QMSE#SS7WQ^S7XL\4>/?@)X3UWQI:Z;8^)M:TV*_OK:PB>*WMFE&]8PKN[
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MX]'"5*TW"EK;KT/V#..+,#E.!AC<S;I\R5H[RO:[BDNJZO9=6?I117XGR?\
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MH^O64.HV-Q_;FFQ^?!-&LD;[7N RY5@<, 1G! /%<S_P40_Y/H^+'_8SWO\
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MG._\&W?_ #6;_N"?^Y"OE_\ X+-?\I*/B1_W#/\ TUV=?4'_  ;=_P#-9O\
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MY? !VC[HXKAO^#B'XO7TOC3X>_#_ .T?Z+9Z<^OW<:*5CGFDD>WC?&3]T13
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M1DDG] !R20!DFOYY[>RNOVP?VSY%LK:9KCXD>+Y)Q$%^:-;N[9V)QT"JY)/
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M]>\8>,+1=5-SJ5JMP+&WD^:!(5<$)F/8Y8#<2YYVA0/S]_X+-?\ *2CXD?\
M<,_]-=G7[(?L0_\ )EWPA_[$K1O_ $AAJ\PJRC@Z48O=+\CDX"RS#8GC+,ZV
M(@I.G.IRW5TFZCUUZVT3\V>A>'O"VF>$;%K72=-L=+M6D,IAM+=(8RYZMM4
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M<5^SGP0\ GXK?\$Q?"'A=2JMXD^%]EI0+DJH\_24BY(Y ^;M7XQ_L,_%:/\
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MBS>?&W_@WU_X2+4)VNK^?2],L[B=L[II+;6;>V9VSU9C"23W))KY]_X-Y_\
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M?$?QIH_AW1;;[9K&O7L.G6-OYBQ^?/-(L<:;G(5<LP&6( SDD#FOZ,OVHO\
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MOBWXH_$'Q;J%G#=:IX3M;&WTUI4#?9C=&Y\R1<]'VVX7/7#L,C)SZA_P6I\
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M\0^(KBQT_3;A(5>^D*WD,\BI)(3)M\N)]VT^F:^=?^#>?_D]'Q/_ -B5=?\
MI=85O!TG@)^R32\_D?/XZGF4..\"LUJPJ5;1^!6C%7G:.NK?6[UU['U!_P '
M#'_)EWAC_L=;7_TAOZ\O_P"#;O\ YK-_W!/_ '(5ZA_P<,?\F7>&/^QUM?\
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M7?1=-0KQ/]OG]B_2_P!N3X$3>%;N\_LK5+.X&H:1J&S>+6Y564;UZM&RLRL
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M=/LMS6.F.1CS6=@IEE ) ^4*AY&X[67ZW_:7_9P\,_M6_!_4_!?BNV:;3=0
M>.6([9[*=<^7/$W9U)]P02I!!(/>T5RU<55J5/:R>OY'U&5<+99EV >68:DO
M92OS)Z\UU9N3>]U_DK(_''XD_P#!#OXZ?!3QG)?_  WU>Q\1P0L39WEAJ8TG
M457GAED955N /EE8<CD<X;X!_P""(OQ\^./C*&]^(^L6>@0L%%S>ZGJW]K7X
M3KM18V<,1D\-(HZ\^O[(45V_VQB+6TOWMJ?%?\0=R#VO->IR7OR<_N?ES?\
MDU_,X+]FC]G#PS^RE\'],\%^%+9H=-T\%Y)93NGO9VQYD\K=W8CV  "@   =
M[117F2DY/FEN?I^&P]+#THT*$5&$4DDMDELD?+__  6:_P"4:_Q(_P"X9_Z=
M+.ORE_X)P_L;6/[<?Q1\7>#[K4IM'OK7PK/JFEWBKNCANX[NTC7S%_BC*RNI
M ((W CD8/ZW?\%9_!&M?$?\ X)^>/]%\.Z/JFO:Q>?V=]GL=.M)+JYGVZE:N
MVR.,%FPJLQP. I/0&OBW_@A5^SI\0OA%^UOXBU+Q9X$\9>%].G\(7-M'=:MH
MMS90R2F]LF$8>1%4L51B%!SA2>QKW,#6]G@IN+L[Z?<C\*X[R?\ M#C7!4J]
M)SHRIQ4M':W-4W:V^^ZT/-_'O_!(O]JK4[BW\.W9;Q-H-I(1!*?%22:?!CHR
MQ3R*ZY[8CS]*^R/^"8__  2-A_8_U\>./&E_8ZWXZ\EHK*&SW-::,KJ5<JS
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MXZD??5%<M/%U(4G16S/J,=PGE^,S2EG%9/VU))1L]+)MJZZZR9\"_P#!4_\
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M16RNTT^^UT]K7/RQ\*?\$COVA/VHYH9/CG\2-0M]+L4=[73[C67U2X\[:P7
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M?M1)^V#XZC^'Z?&:;P)J0LHK)-!%_-88^P6XE$8ARJ R^9NVX!;=G)S7._\
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M"BBIC*LX1@]H[$9;P?EN!Q>(QM&+<L1?G3=T^9MM6?1MO3L?D+\=_P#@@O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#F-/^U8?]K\J/[5A_P!K\JS**/:,.8T_[5A_VORH_M6'_:_*LRBCVC#F-/\
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MH_M6'_:_*LRBCVC#F-/^U8?]K\J/[5A_VORK,HH]HPYC3_M6'_:_*C^U8?\
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M5A_VORH_M6'_ &ORK,HH]HPYC3_M6'_:_*C^U8?]K\JS**/:,.8T_P"U8?\
M:_*C^U8?]K\JS**/:,.8T_[5A_VORI5U2%C]XCZBLNBCVC#F-F.XCF^ZRM^-
M/K#!Q5BWU*2'[WSK[U4:O<.8U**C@N5N4W*?J.XJ2MB@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JKJ%]Y"[5^^?TJ:YG^SPLWIT]S60[F1RS<D]:SJ2MHB9,0G)HHHKG)"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% #HIF@?<IP:UK6Y6ZBW#KW'I6/4MG<_9I@W\/0_2M(2LQIFO1
M0#D45T%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 4-8FRRQ^G)JE4U^V^[D^N*AKED[LS84445(!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLN5II7[NZ?W['T=^UG_P6,^"_P"R+\26\$ZE>>(O&'CJ+'G>'?"FEG4KZWR
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M_:W_ .B3^,O_  ,@_P#CU'_#FW]K?_HD_C+_ ,#(/_CU?T_44?ZQ5_Y5^/\
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M]8J_\J_'_,/]1L%_,_N7^1_,#_PYM_:W_P"B3^,O_ R#_P"/4?\ #FW]K?\
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M_,/]1L%_,_N7^1_,#_PYM_:W_P"B3^,O_ R#_P"/4?\ #FW]K?\ Z)/XR_\
M R#_ ./5_3]11_K%7_E7X_YA_J-@OYG]R_R/Y@?^'-O[6_\ T2?QE_X&0?\
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MC!?O8XO(+9(U.]>6!6QNDVDC+..X /TO_P 0VO[+'_0M^*/_  HKG_&O1O\
M@J+_ ,$T4_;Q\,^&]>\+Z^?!'Q<^'=S]O\*^(DW*L4@9'$,S("_E[T5E=<M&
MV6 8,RMY'H?Q_P#^"BW@_0?["U#X#?"[Q=JUJ@@3Q-%XEMK6TNR!CSI+;[2C
MDM]XA5B'7"KP!O\ 6*E6E#V-7E:233=MMFK^1RO!T,-7JK$X=S4I.49*/-OJ
MT[:IIWMWN<DW_!/;]C/]B+]O+X/^$[30_',GQ5UR_AUOPW!;ZE/=PVS02EDG
MN,N L8:&1N0<B)\CCG1_:-_Y6=O@'_V3.Z_]!UZO0/\ @GE_P30\=>"_VC]<
M_:(_:$\1:?XJ^,VNPM:Z=::<Q;3O#%JR[6CC) R^PF,!1M12_P TC2%AUWQ8
M_8)\8>._^"Q7PQ_:$L]2\-Q^"_!?@^;P_?64UQ.NJ2SN-3 :.,1&(Q_Z;%RT
MJGY7XX&Y2Q$%4:E/F]R2N]KM/1#^HU94(RA24+U8-)*S48R6LO/=^1ZA_P %
M#_VFKG]CG]BGXB?$BQMXKK4O#>E[K".4$Q_:II$MX&<#JBRRHQ'&0",C.1\,
M?L<?\$<!^WK\&O#'QC_:=^(GC_XA:]X\LH=>M-$35S;Z9I]G<#SH$VIR-T;H
M^V$Q+'O*[21NK]$?VI/V>M'_ &K_ -GGQ=\.=>DFATOQ=ITEC)/$,R6SG#1S
M*#P6CD5' /!*@'BOS]_9I\&?MZ_\$Z_A]'\+="^&_P /_C9X+\/EX?#^K_V_
M!ILUK"S,ZHXFFB=D4MG84++G:LC*%QC@ZEJ#C2DHSON[+2W1OS.G-:-\9&>)
MIRJ4N71)-VE>]W%;Z6L^GY4_^"O'_!-;]G+]B[_@F7\2->\&?#OP_P"'/$DP
MT^RTN_GN)[V\$LE_;;DADN))'5C"LN=I!V"3L6KZ,\.?\H"['_LW^/\ ]1T5
MXO\ $?\ X)G?'[_@I]X-UG4OVE/$WA[P6]KILZ^"_!7ADF73]&U)XRBWU])N
M<SLH& JR. )&*M'RC>Z?L*_L@_&#P/\ L9:]\&_COXF\&^(-&.@CPGH<OACS
MA+;:4;5[8K,\L,69%C9%4A3P@R2<D[5*D52BIU.:497>K?;9];6.2CAIRKU'
M1H.G"I3Y8Z)*ZN[R2^&[>G736QC_ /!OI_RB&^$?_<9_]/5_7DO[+'_*S'^T
MQ_V(>G?^DNA5J_L(?L#?M=_L*WOAOX?Z7\3OA+KGP1T77?M4D=U:72ZV+![C
MSKB*%/(,<;2;I#@RL%:5B&KUGX+_ +!/C#X<_P#!7[XO?M 7VI>&Y?!OQ \-
M6FC:?9P7$[:G#-%#IL;-+&8A$J$V<N"LK'#)P,G&<I4XU:TU)-24K6\VG;U-
MHTZ]3#X:G[.2=.4+WMLDTVM7H>!_\&Y&LK\)K?\ :#^!NJF&W\3> ?'US?S0
MO(/-N(Y%6T9U&?F16LERR\#SDY^9<_II7PG^W9_P3)\?7?[3]K^T5^S;XHT_
MP?\ %N*U%IK>E:B"-+\5P*H7$IP0'*)&A5AL;RXG#1.F]L#7?CS_ ,%%O'F@
M_P#"/Z;\"_A?X'U:Z0P2>*9_$EM>6MJ3QY\5L+B1QCD@.DO;*GH9Q%..)G[>
M$XKFW3=K/KZKT-<#B)Y?2^IU:4Y<EU%QCS)QOIML];-.VU[G,>.M;C^/?_!S
MEX#B\/K]JB^#/@2Y37Y5(987EM[T 9&>AU.U4@X(8L.U7/V6/^5F/]IC_L0]
M._\ 270J]\_X)@?\$S[?]@KPUXDUSQ%X@D\=?%CX@W/V[Q3XDG#,9Y"S.88B
M_P _E[W=F=L-(Q#,  BI1^"_[!/C#X<_\%?OB]^T!?:EX;E\&_$#PU::-I]G
M!<3MJ<,T4.FQLTL9B$2H39RX*RL<,G R<:2Q%+FE&+T4.5/N[K_@F$<!B/9T
MZDX^]*LIM?RIIK\%:_F?7%?F'_P22\:V/PV_;>_X*(>(M3\\:;H'BU-2NS#$
M99!##<ZY(^U%Y9MJG"CDGBOT\KY#_P""?_\ P3_\5_LM_M2_M/>-/%5[X7U3
M0?C=XCBU72+6QFFFFAMUGU&1DNDDA1%8K=QC"-("0_. ,\>'J0C1J1EUM\]=
M3U,=0JSQE"I36D>>[Z*\;*_S)W^ G[,'_!:+X.:;\2+KP?IOBRSO_/LK?6#%
M+I>KPF&1HBDDD3)+\I7<J2%EPP(&&.?DS]J7_@A_J/[ OPS\2?%[]F?XN>/_
M  AK'@G3KC6[O1[^]2:WO[>!3+*BNBH"!&K$1S)*KD $C.:[#P)^PQ^U%_P2
MG^(OB:']FRW\(_%+X0^*K]M1C\)>(;_['>:),=H/ERO)&F=@5/,\QMZQC=&&
M56.A\9_!W[=W_!0SPG??#GQ%X/\ A[^S[X!\11BVUW44UB/6-3GM2<2PQ^1,
MX(<=5Q'N!VF0 D'TJ,I4YWIU5[/LWT[<N_W'AXJ-.M3:KX:7M^\8NW-T:DK*
MVG5Z;'UM_P $U_VI[[]M7]AWX>_$S5+6&SU7Q%8RK?QPC;$;FWN);69T'.U&
MD@=E7)P& R<9KW*N!_9:_9ST']DC]GOPG\./#/G-HOA.Q%I#),1YMRY8O+,^
M.-\DCN[8 &7. !7?5X=9P=23I[7=O3H?686-2-"$:VLDE?UMK^(4445F=!_/
M=_P4C_X)9_M,_%S]O'XK>)O"_P -_%6J^'=;\0W-UIUW!=0K'<0L?E90900,
M=B!7B7_#FW]K?_HD_C+_ ,#(/_CU?T_45[U/B"O&*BHK3U/C:W!6#J3=1R=V
MV^G7Y'\P/_#FW]K?_HD_C+_P,@_^/4?\.;?VM_\ HD_C+_P,@_\ CU?T_45?
M^L5?^5?C_F9_ZC8+^9_<O\C^8'_AS;^UO_T2?QE_X&0?_'J/^'-O[6__ $2?
MQE_X&0?_ !ZOZ?J*/]8J_P#*OQ_S#_4;!?S/[E_D?S _\.;?VM_^B3^,O_ R
M#_X]1_PYM_:W_P"B3^,O_ R#_P"/5_3]11_K%7_E7X_YA_J-@OYG]R_R/Y@?
M^'-O[6__ $2?QE_X&0?_ !ZC_AS;^UO_ -$G\9?^!D'_ ,>K^GZBC_6*O_*O
MQ_S#_4;!?S/[E_D?S _\.;?VM_\ HD_C+_P,@_\ CU'_  YM_:W_ .B3^,O_
M  ,@_P#CU?T_44?ZQ5_Y5^/^8?ZC8+^9_<O\C^8'_AS;^UO_ -$G\9?^!D'_
M ,>H_P"'-O[6_P#T2?QE_P"!D'_QZOZ?J*/]8J_\J_'_ ##_ %&P7\S^Y?Y'
M\P/_  YM_:W_ .B3^,O_  ,@_P#CU'_#FW]K?_HD_C+_ ,#(/_CU?T_44?ZQ
M5_Y5^/\ F'^HV"_F?W+_ "/Y@?\ AS;^UO\ ]$G\9?\ @9!_\>H_X<V_M;_]
M$G\9?^!D'_QZOZ?J*/\ 6*O_ "K\?\P_U&P7\S^Y?Y'\P/\ PYM_:W_Z)/XR
M_P# R#_X]1_PYM_:W_Z)/XR_\#(/_CU?T_44?ZQ5_P"5?C_F'^HV"_F?W+_(
M_F!_X<V_M;_]$G\9?^!D'_QZC_AS;^UO_P!$G\9?^!D'_P >K^GZBC_6*O\
MRK\?\P_U&P7\S^Y?Y'\P/_#FW]K?_HD_C+_P,@_^/4?\.;?VM_\ HD_C+_P,
M@_\ CU?T_44?ZQ5_Y5^/^8?ZC8+^9_<O\C^8'_AS;^UO_P!$G\9?^!D'_P >
MH_X<V_M;_P#1)_&7_@9!_P#'J_I^HH_UBK_RK\?\P_U&P7\S^Y?Y'\P/_#FW
M]K?_ *)/XR_\#(/_ (]1_P .;?VM_P#HD_C+_P #(/\ X]7]/U%'^L5?^5?C
M_F'^HV"_F?W+_(_F!_X<V_M;_P#1)_&7_@9!_P#'J/\ AS;^UO\ ]$G\9?\
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M^HV"_F?W+_(_F!_X<V_M;_\ 1)_&7_@9!_\ 'J/^'-O[6_\ T2?QE_X&0?\
MQZOZ?J*/]8J_\J_'_,/]1L%_,_N7^1_,#_PYM_:W_P"B3^,O_ R#_P"/4?\
M#FW]K?\ Z)/XR_\  R#_ ./5_3]11_K%7_E7X_YA_J-@OYG]R_R/Y@?^'-O[
M6_\ T2?QE_X&0?\ QZC_ (<V_M;_ /1)_&7_ (&0?_'J_I^HH_UBK_RK\?\
M,/\ 4;!?S/[E_D?S _\ #FW]K?\ Z)/XR_\  R#_ ./4?\.;?VM_^B3^,O\
MP,@_^/5_3]11_K%7_E7X_P"8?ZC8+^9_<O\ (_F!_P"'-O[6_P#T2?QE_P"!
MD'_QZC_AS;^UO_T2?QE_X&0?_'J_I^HH_P!8J_\ *OQ_S#_4;!?S/[E_D?S
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M_:W_ .B3^,O_  ,@_P#CU'_#FW]K?_HD_C+_ ,#(/_CU?T_44?ZQ5_Y5^/\
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M]8J_\J_'_,/]1L%_,_N7^1_,#_PYM_:W_P"B3^,O_ R#_P"/4?\ #FW]K?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-(Z=1]2P_P#S[C]R#^UL=_S^G_X$_P#,^R?^(@/]KK_HK7_EKZ+_ /(E*O\
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MS_Y:^C?_ ")1_P /^_VM_P#HK/\ Y:^C?_(E?'-%'U'#?\^X_<O\B99QC_\
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M_(/[:S'_ )_S_P# Y?YGV#_P_O\ VLO^BK_^6QHW_P B4H_X+W?M99_Y*O\
M^6QHW_R)7Q[0.M'U'#?\^X_<O\@_MK,?^?\ /_P.7^9]B?\ #^S]K+_HJW_E
ML:/_ /(E'_#^S]K+_HJW_EL:/_\ (E?']%'U'#?\^X_<O\B/[;S'_H(G_P"!
MR_S/L#_A_9^UE_T5;_RV-'_^1*<O_!>K]K C_DJW_ELZ/_\ (E?'M/3[M'U'
M#?\ /N/W+_(/[;S'_H(G_P"!R_S/L#_A_3^UA_T5;_RV='_^1*/^']/[6'_1
M5O\ RV='_P#D2OD"BCZCAO\ GW'[E_D2\\S&W^\3_P# Y?YGU_\ \/Z?VL/^
MBK?^6SH__P B4?\ #^G]K#_HJW_ELZ/_ /(E?(%%'U'#?\^X_<O\B?[<S'_H
M(G_X'+_,^P$_X+T_M8$_\E6_\MG1_P#Y$IW_  _G_:P_Z*M_Y;.C_P#R)7Q^
MG6G4?4<-_P ^X_<O\@_MS,?^@B?_ ('+_,^OO^'\_P"UA_T5;_RV='_^1*/^
M'\_[6'_15O\ RV='_P#D2OD&BJC@,-_S[C]R_P @_MS,?^@B?_@<O\S[!_X?
MR?M7?]%5_P#+9T?_ .1*/^'\G[5W_15?_+9T?_Y$KY"HJ?J.&_Y]Q^Y?Y&?]
MN9E_T$3_ / Y?YGU[_P_D_:N_P"BJ_\ ELZ/_P#(E'_#^3]J[_HJO_ELZ/\
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MX?O_ +5G_15/_+:T?_Y$KY$HH^H87_GW'[E_D3_;V9_]!%3_ ,#E_F?7J?\
M!=[]JPC_ )*I_P"6UH__ ,B4O_#]W]JS_HJG_EM:/_\ (E?(:=*=1]0PO_/N
M/W+_ "#^WLS_ .@BI_X'+_,^NO\ A^[^U9_T53_RVM'_ /D2E3_@NY^U83_R
M53_RVM'_ /D2OD2G)UH^H87_ )]Q^Y?Y$O/LSM_O%3_P.7^9]=_\/VOVJ_\
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M .6UI'_R+7R/11]0PO\ S[C]R_R)_P!8,T_Z":G_ ('+_,^N4_X+K_M5$_\
M)4O_ "VM(_\ D6G?\/U?VJ?^BI?^6UI'_P BU\C)UIU'U#"_\^X_<O\ (/\
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MO_034_\  Y?YGUG_ ,/R_P!J;_HJ'_EMZ1_\BT?\/R_VIO\ HJ'_ );>D?\
MR+7R915?V?A?^?<?_ 5_D'^L6:_]!-3_ ,#E_F?6?_#\O]J;_HJ'_EMZ1_\
M(M'_  _+_:F_Z*A_Y;>D?_(M?)E%']GX7_GW'_P%?Y!_K%FO_034_P# Y?YG
MUL/^"Y/[4F/^2H?^6WI'_P BTY?^"XW[4A'_ "5#_P MO2/_ )%KY+'2GI]V
ME++\+_S[C_X"O\C/_6+-?^@FI_X'+_,^LO\ A^-^U)_T5#_RW-)_^1:/^'XW
M[4G_ $5#_P MS2?_ )%KY.HJ?J&%_P"?<?N7^0?ZQ9K_ -!-3_P.7^9]8_\
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M9]5_\/MOVGO^BF_^6[I/_P BT?\ #[;]I[_HIO\ Y;ND_P#R+7RI11]0PO\
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MKY6'2BCZAA?^?<?N7^0?ZS9Q_P!!=7_P9/\ S/JG_A]C^TY_T4S_ ,MW2O\
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M)_\ +?TK_P"1J/\ A\_^TM_T4G_RW]*_^1J^7:*4L!AO^?<?N7^1'^M6=_\
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M5\PT4?4<-_S[C]R_R#_6S._^@RK_ .#)_P"9]/?\/E?VDO\ HH__ );^E_\
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M )&H_P"'R'[2'_11O_*!I?\ \C5\QT4?4<-_S[C]R_R#_6S//^@RK_X,G_\
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M?Y"EQ=GO_0;6_P#!D_\ Y(^F?^'Q'[1W_11?_*!IG_R-1_P^(_:._P"BB_\
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M!]%%%:&84444 %/3[M,IZ?=H)D+11102.CIU-CIU !11103(****"22BBB@
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M_'RW^[_45I5FZ1_Q\M_N_P!16E713V*B%%%%:%!1110 4444 %%%% !1110
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M^8$8)!]J^8=#_;<A^ G_  5,\2_&OPFJ^(-$D\:ZQJ<$;*]N-4TZ[N+@, '
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M ZT4#K0!)1114Q,PJ0=*CJ0=*) %%%%2 4445H1+<*<G6FTY.M*6PAU%%%0
M44454@)****DS"BBB@ HHHIQW ****L!4^]3Z8GWJ?4R)D%%%%222#I10.E%
M !1110 4444X[BEL%*GWJ2E3[U$MQ+8?1112)"BBB@ IZ?=IE/3[M "T444
M%%%%!$MPI4^]24J?>H$/HHHH **** "GI]VF4]/NT&8C]:$Z4/UH3I0 ZBBB
M@ HHHH !UJ2HQUJ2@F04444$A1110 4Z.FTZ.@4MAU%%%! 4#K10.M $E%%%
M !1110 4445,C,****H!R=:=34ZTZ@ H'6B@=: )****S,PHHHH **** "BB
MB@!R=:=34ZTZJ6Q/4*!UHH'6I*)****#,**** "BBB@ HHHH *5/O4E*GWJ
M'T444&85)4=24 %%%% !11142W(EN%%%%(04J?>I*5/O4 /HHHK0 HHHJ9$R
M"BBBI)"BBB@!T=.IL=.H ****  =:DJ,=:DH)D%%%%!04444&84444 >V?\
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M-J&#JO#8*"JRCHY-ODOU45%IRM_,Y6?2+6K[7_AC;]CW_H=OVBO_  2:1_\
M'Z4?L<?L>@?\CM^T5_X)-(_^/UQ-%:>Q\V?+_P"OV9?RP_\  ?\ @G;_ /#'
M/['O_0Z_M%?^"32/_CU'_#'7['O_ $.O[17_ ()-(_\ CU<111['S8?Z^YE_
M+#_P'_@G<#]CO]CU?^9U_:*_\$FD?_'J/^&/?V/?^AT_:*_\$FD?_'ZX>BCV
M/FP_U]S+^6'_ (#_ ,$[C_ACW]CW_H=/VBO_  2:1_\ 'Z4?L??L>@_\CI^T
M5_X)-(_^/UPU%'L?-A_K[F7\L/\ P'_@G=?\,@?L??\ 0Z?M$_\ @DTC_P"/
MT?\ #('['W_0Z?M$_P#@DTC_ ./UPM%5[/S8O]?,Q_EA_P" _P#!.Z_X9 _8
M^_Z'3]HG_P $FD?_ !^C_AD#]C[_ *'3]HG_ ,$FD?\ Q^N%HH]GYL/]?,Q_
MEA_X#_P3NO\ AD#]C[_H=/VB?_!)I'_Q^G#]D/\ 8^ _Y'3]HG_P2:1_\?K@
MZ*/9^;%_KYF/\L/_  '_ ()WG_#(G['W_0Z?M$_^"32/_C]'_#(G['W_ $.G
M[1/_ ()-(_\ C]<'11[/S8?Z]YC_ "P_\!_X)WH_9&_8_7_F=/VB?_!)I'_Q
M^E_X9'_8_P#^AT_:(_\ !)I'_P ?K@:*/9^;#_7O,?Y8?^ _\$[[_AD?]C__
M *'3]HC_ ,$FD?\ Q^C_ (9(_8^_Z'/]HG_P2Z1_\>K@:*7L_-A_KUF'\L/_
M  '_ ()WW_#)'['W_0Y_M$_^"72/_CU'_#)'['W_ $.?[1/_ ()=(_\ CU<#
M11[+^\Q?Z]9A_+#_ ,!_X)Z!_P ,E_L?_P#0Y_M$?^"72/\ X_1_PR7^Q_\
M]#G^T1_X)=(_^/UY_11[+^\P_P!>LP_EA_X#_P $] _X9+_8_P#^AS_:(_\
M!+I'_P ?H_X9+_8__P"AS_:(_P#!+I'_ ,?KS^BG[/S8_P#7K,/Y8?\ @/\
MP3T ?LF_L?C_ )G/]HC_ ,$ND?\ Q^E_X9._8_\ ^AR_:(_\$FD?_'Z\^HH]
MF_YF3_KSF'\L/_ ?^">@_P##)W['_P#T.7[1'_@DTC_X_1_PR=^Q_P#]#E^T
M1_X)=(_^/UY]11[/S8?Z\YA_+#_P'_@GH7_#)_['_P#T.7[1'_@ETC_X]0/V
M3_V/Q_S.7[1'_@ETC_X]7GM%'LW_ #,/]>,P_EA_X#_P3T/_ (92_8__ .AR
M_:(_\$ND?_'J/^&4OV/_ /H<OVB/_!+I'_QZO/**/9O^9A_KQC_Y(?\ @/\
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M>I?^&8_V0?\ H</VA_\ P2Z3_P#'J\SHH]F_YF'^NN._DA_X#_P3TS_AF/\
M9!_Z'#]H?_P2Z3_\>H_X9C_9!_Z'#]H?_P $ND__ !ZO,Z*.1_S,/]=<=_)#
M_P !_P"">G?\,S_L@_\ 0X?M#?\ @ETG_P"/4?\ #,_[(/\ T.'[0W_@ETG_
M ./5YC11[-_S,7^NF-_DA_X#_P $]._X9G_9!_Z'#]H;_P $ND__ !ZC_AF?
M]D'_ *'#]H;_ ,$ND_\ QZO,:*.1_P S#_73&_R0_P# ?^">G?\ #,_[(/\
MT.'[0W_@ETG_ ./4#]FG]D(?\SA^T-_X)=)_^/UYC11RO^9B_P!=,;_)#_P'
M_@GI_P#PS5^R%_T.'[0W_@ETG_X_1_PS5^R%_P!#?^T-_P""72?_ (]7F%%'
M*_YF'^N>,_DI_P#@/_!/4/\ AFK]D'_H;_VAO_!-I/\ \>H'[-?[((/_ "-W
M[0W_ ()M)_\ CU>7T4<K_F8?ZYXS^2G_ . _\$]1_P"&;OV0O^AN_:&_\$ND
M_P#QZC_AF[]D+_H;OVAO_!+I/_QZO+J*.5_S,/\ 7/&?R4__  '_ ()ZC_PS
M=^R%_P!#=^T-_P""72?_ (]1_P ,W?LA?]#=^T-_X)=)_P#CU>744<K_ )F'
M^N6,_P"?=/\ \!_X)ZC_ ,,W?LA?]#=^T-_X)=)_^/4?\,W?LA?]#=^T-_X)
M=)_^/5Y=11RO^9B_URQG_/NG_P" _P#!/4A^SA^R&/\ F;OVAO\ P2Z3_P#'
MZ/\ AG']D/\ Z&[]H;_P2Z3_ /'Z\MHHY7_,Q_ZY8S_GW3_\!_X)ZG_PSC^R
M'_T-W[0W_@FTG_X]2C]G/]D,?\S=^T-_X)M)_P#CU>5T4<K_ )F+_7+&?\^Z
M?_@/_!/5/^&=?V0_^AN_:&_\$VD__'J/^&=?V0_^AN_:&_\ !-I/_P >KRNB
MCE?\S%_KCB_^?=/_ ,!_X)ZQ!^R?^R9XK_T6S^*GQD\*7#$8OM:\+6E[:H.>
ML=M-YA[=/_U<O\9O^"2/C/PWX#O?&OPO\1>'?C=X'L!YES>>&"_]IZ;'P0UU
MI[CSHCC)(7S-JJ2Q4#-<?72?"CXO>)O@9XXL_$GA'6K_ $'6M/<-%=6LFUB,
M@E&'W70XPR,"K#@@CBE:HM8R^3V_S_K8[L+QC"3Y,;0C;^:%XR7R;<';M9-_
MS+<^6R,&BOO+]L;X,>&?VX/@+K?QX^'^BVOAWXA>#Q')\2?#.GQ[;6\A?Y1K
M5I&!\JEL^>@SMY=L8,DOP;711JJ:OL^J[,^HJ4XI1J4I*4)*\9+9K;Y----/
M5--!3T^[3*>GW:U.>0M%%%!(Y.M:W@GP/K7Q)\56.A>'=)U'7-:U*00VEC86
M[W%Q<O\ W41 68\$\#H*J>'- OO%>OV6EZ9:7%_J6I3I:VMM!&9);B5V"HB*
M.69F(  Y)-?IO;V&G?\ !*#X?M\/_!$EI<?&S6K)/^$W\818>711($?^RK!\
MD($X\R4?,S8/!""'*I4::A!7D]OU;\D54J4,/0GC,7+EI0M=K5MN]HQ6EY.S
MZI))MM)'C7AG_@CO;_#:PBNOCO\ %KPM\+;N1!(/#NGP-X@UY,]%EA@81P[A
MR&+L/4#D#67]C']DNW58Y/B/\;+B1  TL6A6*1R'N55GR >P/(KAKV]FU*\E
MN+B:2XN+AS)++(Q9Y&)R6)/))/))J.K6#F]9U'?RLE^3?XGPV(\19*=L)A*:
MC_?<YR?JU*,?NBCOO^&-_P!D?_HH/QR_\$NG_P#Q='_#&_[(_P#T4#XY?^"7
M3_\ XJN!HH^H_P!^7X?Y&'_$1L9_T#4?_ 9?_)G??\,;_LC_ /10/CE_X)=/
M_P#BJ/\ AC?]D?\ Z*!\<O\ P2Z?_P#%5P-%/ZF_^?DOP_R#_B(V,_Z!J/\
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M%?\ 0-1_\!G_ /)GI _9-_9)'_,_?'#_ ,$UA_\ %4[_ (90_9)_Z'[XX?\
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M]2_X9>_9+_Z'SXX?^">P_P#BJ/\ AE[]DO\ Z'SXX?\ @GL/_BJ\MHH^I?\
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M_@GL/_BJ7_AF']DO_H>_CA_X)[#_ .*KRNBG]3_Z>2^]?Y!_K]B/^@6C_P"
MS_\ DSU0?LQ?LE@_\CU\</\ P3V'_P 52_\ #,O[)?\ T/7QO_\ !/8?_%5Y
M512^H_\ 3R7WK_(/]?J__0+1_P# 9_\ R9ZK_P ,R_LE_P#0]?&__P $]A_\
M51_PS+^R7_T/7QO_ /!/8?\ Q5>544?4?[\OO7^0O]?:_P#T"T?_  &?_P F
M>K#]FC]DL?\ ,]?&[_P3V'_Q5'_#-'[)?_0]?&[_ ,$]A_\ %5Y311]1_OR^
M]?Y!_K[7_P"@6C_X#/\ ^3/5C^RW^RCJ*^3!\2/C%ILS\+<W>@6DT,7/5DC?
M<>/2L7QM_P $FM4\1^'KS6_@MX^\,_&C3[&(SSZ=81OIWB") ,ECI\I+L!T&
MQF9CP%-<'6AX6\5:GX(\0V>K:/J%YI>J:?()K:[M96BF@<=&5E((/TI/!SCK
M";^=FOP2?XFU'CBC4ERXW"0Y>]-RC)>EY2B_1QUVNCY[U32[K0]3N+*^M[BS
MO+.5H9X)XS'+!(I(9&4X*L"""#R"*KU^A7Q*\'6'_!4WX0:MJ4.G6EE^T3X)
ML?MSSVD(C'Q T^% KJZ+_P OL:JI4J/G "XP1Y7YZD8-*C4<FXR5I+=?UT?3
M_,^AQ5"FJ<,1AY<]*HKQE:ST=FFNDHO22N^C3<6FRE3[U)2I]ZM9;G&MA]%%
M%(D*DM;:2]N8X88Y)IIF"1QHI9G8G   Y))[5'7Z9?L3_LWZ7^P?\(M%^(?B
M+2X+_P",_C&T^VZ%:7L:R1^$+!_]7<M&<C[5*/F&[E%."%(=6Y\3B%2C?=O9
M'K9/E,L=5:;Y815Y2WLO)=9-Z)=7V2;7BGP=_P""-/C+5] M-=^*WB71?@WH
MMZHD@M]5B:[UJX0_Q+81D.HZ@B1D<$<K7H=I_P $U?V=M-MHX;SXE?%#4KA1
M\]Q9Z+:V\,A_V4D8LOXDUV'B3Q+J'C#6[C4M4O+G4+^Z;?-//(7D<^Y/\NU4
M:\N5>O+5RMZ6_P""SZZ&'RVC[M'#J7G-R;?R3C%?)7\V8/\ P[D_9M_Z'KXO
M?^"VQ_QH_P"'<G[-O_0]?%[_ ,%MC_C6]14^TJ_SO\/\B^;"?] U/[I?_)&%
M_P .Y/V;?^AZ^+__ (+;'_&C_AW)^S;_ -#U\7__  6V/^-;M%+VE7^=_A_D
M+_8_^@:G]TO_ )(PO^'<G[-O_0]?%_\ \%MC_C2C_@G+^S:#_P CU\7_ /P6
MV/\ C6Y11[2K_._P_P @_P!C_P"@6G]TO_DC#_X=S_LV_P#0]?%[_P %MC_C
M1_P[G_9M_P"AZ^+W_@ML?\:W**/:5?YW^'^0?['_ - M/[I?_)&'_P .Y_V;
M?^AZ^+W_ (+;'_&C_AW/^S;_ -#U\7O_  6V/^-;E%'M*O\ ._P_R#_8_P#H
M%I_=+_Y(Q/\ AW/^S;_T/7Q?_P#!=8_XTH_X)U?LV@?\CU\7O_!=8_XUM44>
MTJ_SO\/\@_V/_H%I_=+_ .2,4_\ !.G]FT_\SU\7_P#P76/^- _X)T_LVC_F
M>OB]_P""ZQ_QK:HH]I5_G?X?Y!_L?_0+3^Z7_P D8O\ P[J_9M_Z'KXO?^"Z
MQ_QH_P"'=7[-O_0]?%[_ ,%UC_C6U11[2K_._P /\@_V/_H%I_=+_P"2,7_A
MW5^S;_T/7Q>_\%UC_C1_P[J_9M_Z'KXO?^"ZQ_QK:HH]I5_G?X?Y!_L?_0+3
M^Z7_ ,D8H_X)U_LVC_F>OB]_X+;'_&G?\.[OV;O^AY^+W_@ML?\ &MBBCVE7
M^=_A_D*V#_Z!:?W2_P#DC'_X=W?LV_\ 0\?%[_P76/\ C1_P[N_9M_Z'CXO?
M^"ZQ_P :V**/:5?YW^'^0<N"_P"@6G]TO_DC'_X=W?LV_P#0\?%[_P %UC_C
M1_P[N_9M_P"AX^+W_@NL?\:V**/:5?YW^'^0<N"_Z!:?W2_^2,?_ (=W?LV_
M]#Q\7O\ P76/^-.'_!/#]FU?^9X^+W_@NL?\:UJ*/:5?YW^'^0N7!?\ 0+3^
MZ7_R1D_\.\OV;O\ H>/B]_X+K'_&C_AWE^S=_P!#Q\7O_!=8_P"-:U%'M*O\
M[_#_ "#EP7_0+3^Z7_R1D_\ #O+]F[_H>/B]_P""ZQ_QH'_!/+]FX?\ ,\?%
M[_P76/\ C6M11[2K_._P_P @Y<%_T"T_NE_\D9?_  [U_9O_ .AX^+W_ (+K
M'_&C_AWK^S=_T/'Q>_\ !=8_XUJ44>TJ_P [_#_(.7!?] M/[I?_ "1E_P##
MO7]F[_H>/B]_X+K'_&C_ (=Z_LW?]#Q\7O\ P76/^-:E%'M*O\[_  _R#EP7
M_0+3^Z7_ ,D9?_#O7]F[_H>/B]_X+K'_ !H_X=Z_LW?]#Q\7O_!=8_XUJ44N
M>K_._P /\@]G@?\ H%I_=+_Y(R_^'>O[-W_0\?%[_P %UC_C1_P[U_9N_P"A
MX^+W_@NL?\:U**?M*O\ ._P_R#V>!_Z!:?W2_P#DC+'_  3W_9O'_,\?%[_P
M76/^-._X=\_LW_\ 0\?%[_P76/\ C6E11[2K_._P_P @]G@?^@6G]TO_ )(S
M?^'?/[-__0\?%[_P76/^- _X)\_LW@_\CQ\7O_!=8_XUI44>TJ_SO\/\@]G@
M?^@6G]TO_DC/_P"'?G[-_P#T._Q>_P#!=8_XT?\ #OS]F_\ Z'?XO?\ @NL?
M\:T**7-5_G?X?Y$^SP/_ $"T_NE_\D9__#OS]F__ *'?XO?^"ZQ_QH_X=^?L
MW_\ 0[_%[_P76/\ C6A11S5?YW^'^0>SP/\ T"T_NE_\D9__  [\_9O_ .AW
M^+W_ (+K'_&C_AWY^S?_ -#O\7O_  76/^-:%%'-5_G?X?Y![/ _] M/[I?_
M "1G_P##OS]F_P#Z'?XO?^"ZQ_QH_P"'?G[-_P#T._Q>_P#!=8_XUH44<U7^
M=_A_D'L\#_T"T_NE_P#)&>/^"?W[-X_YG?XO?^"ZQ_QI?^& /V;_ /H=_B[_
M ."ZQ_QJ_11SU?YW^'^0>RP'_0+3^Z7_ ,D4/^& /V;_ /H=OB[_ ."ZQ_QI
M1^P!^S>/^9V^+W_@NL:O44<U7^=_A_D'L\#_ - M/[I?_)%+_A@/]F__ *';
MXN_^"ZQ_QH_X8#_9O_Z';XN_^"ZQ_P :NT4<U7^=_A_D'L<!_P! E/[I?_)%
M+_A@/]F__H=OB[_X+K'_ !H_X8#_ &;_ /H=OB[_ ."ZQ_QJ[11S5?YW^'^0
M>QP'_0)3^Z7_ ,D4_P#A@/\ 9O\ ^AV^+W_@OL:/^& _V;_^AV^+W_@OL:N4
M4<U7^=_A_D'L<!_T"4_NE_\ )%/_ (8#_9O_ .AV^+W_ (+[&C_A@/\ 9O\
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MTUY'RC^T3^RQXZ_96\61Z3XVT*XTM[D,]G=*1+9ZB@Q\\,RY5Q@J2 =R[AN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK_V6>'_T\T9#M5]%^I]QQA_RX]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/\
MCY;_ '?ZBM*NBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/\ >/\
M.HZXS,*_ '_@ZK_Y2%^#?^R=V7_IRU.OW^K\ ?\ @ZK_ .4A?@W_ +)W9?\
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MU7^8K5_X+-?\I/?C!_V%X_\ TFAK*TK_ )"EM_UU7^8K5_X+-?\ *3WXP?\
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M6>^Y^;OQVUK1/$?QP\9:AX9AAM_#=_KE[<:5%#;_ &>.*T>X=H56/ \M1&5
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MT5]X:-\*_@K^VEX4U3_A%--@\/ZO8@ O;6@LYK5B#L9HE/ENA((./0\@X->
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M<1-QIMQ1\AD.%I8C'4Z=:22NM]GJO=^>QSO[=W[,7AO]G#_A%?\ A'Y-3?\
MMG[7]H^USK)CRO(V[<*N/]8V>O:OGNOTD_;$^,W@CX1?\([_ ,)EX/M_%G]H
M?:?L?FV<%Q]EV>3OQYOW=V].G7;ST%>;?\$VOA1X7\=? W5KS7/#6@:Q=1Z[
M-"DU]I\-Q(J"WMR%#.I(4%F..F2?6N.CBI1H<\TWY]]3ZK-N&:-?.7A,'.,;
MJ_*D_=M&._\ BO=6/B2OHG]C;XI_"?P%X+U:W^(&E:7J&H37HDMFNM&6^98O
M+48#%&VC<#Q7M.A_"/X(_LRR>3XVN/#MYXCOF:XEBOH?M26ZN251( K!$ .
MS+DXSGH!A_\ !.KX8>%?'W@CQ5<:MX=\/ZRT.M,EO)>:?%<&./RU(52ZG"\Y
MP.*=;$QG3;:=M/*YGE?#^)PF/I0C.FZDE*\7[W+9+XDFM7?0^1_BCJ6FZS\3
M/$5YHL<<.CW6J7,UA''%Y*1P-*QC 3 V@*0 N!CI6#7N'A7]G^S^-'[:'B?P
MJDD6CZ-::SJ$DHMU2/R;>.X91'$OW022B@ 84'."!BO=_BWJ_P #?V1-4L]!
MN? =OKFI26RRN'M(KQDC)(#.\['YB5)P!T] 1G>6(4;0BFW8\>AP_4Q$:F+K
M5(TZ<9-7=]7?HE_7XGPQ7U#_ ,$ROA_H/CWQ+XLCUW1-(UJ.VMK=H5O[..Y$
M1+/DJ'!QG Z>E>J>+/V7OAE^T?\  1O%?@_1ET&ZNK.:ZL)H$^SXDC+ QRQ
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M]7\P/[/?_*;[PK_V6>'_ -/-&0[5?1?J?<<8?\N/5_H?T_4445\\?;%K2/\
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M(?L\?\H4='_[+%J/_IHM*VJ=/5'S.>?\BS$?X'^AYO11170?@84444 %%%%
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MX0=D^J\U_5SV\ERW"\/Y/FN#Q>,HRJU:=HQC--NT9I;VNY<WPJ[6E]T>\_\
M!#O_ )1Z^'?^PEJ'_I2]?!__  02_P"3[F_[%R]_]#AKW_\ X)6?\%(O@O\
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M9Y7PN+P?+_&ERQJKW=$HW;4KZ-?%K>Z?NGY9_'SX-ZE^SW\9_$O@G5GCFO\
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M_7N7_IVH%%%%=Q^:A1110 4444 %%%% !1110 4444 %:G@C_D=-'_Z_8?\
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M:Z^'G[5'_"NO^$#\0?V]_8/]I?;O] N;7R/.^R>7_KHTW9\I_NYQMYQD9/\
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MOH"V_:8_9#_;EUV&W\3:1I5EX@U)EB5M:TYM-O)F; "F[@.W.2  9NIX[FO
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M>$><X:M[:#BJ;3?,K7\]=+]F6/V5/^4B_CW_ *^]8_\ 2NJ__!0GQ9J?@/\
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MS?ZQ=/N3!Q_'M /_ (X7KP.M[X8?$34/A/X^TOQ%I;*+S2YQ*JM]V0=&1O\
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MHHHKM/CPHHHH **** "BBB@ HHHH **** "BBB@ KH/$_P#R81\?O^O#1O\
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M6+4?_31:5M4Z>J/F<\_Y%F(_P/\ 0\WHHHKH/P,**** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5Z)_P6$_Y&G]G_P#[(IX=_P#0[NO.Z]$_X+"?\C3^S_\
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M^N&N&DBSNB53  7+*5 ) SW'6CVT+V-/[+Q7)[3ET[W7^9YE1116AYX4444
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M "**7^.I^5,****Q*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=]+132TM?E=FM[.R;UZ6"BBBN@\,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KH/$__)A'Q^_Z\-&_
M].D-<_71>)XF'[ '[0$V/W:V6B(6/0,VJ18'XX/Y4?:C_BC_ .E(K_EQB/\
MKS6_]-3/SMHHHKV#\1/;/^"</_)]7PM_[#T']:_?BOP'_P""</\ R?5\+?\
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MM)?--/9Q?5/H_P!0HHHK0\\**** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR?[Q_G4=277_ !\R?[Q_G4=<9F%?@#_P=5_\I"_!O_9.[+_TY:G7[_5^ /\
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M"P_\G_\ DC]!/^%@?L=_]%-^,7_A'V__ ,D4?\+ _8[_ .BF_&+_ ,(^W_\
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MG^Q[_P!%-^,/_A'V_P#\D4?\)G^Q]_T4WXP_^$?;_P#R17P-0.M'U?\ O/\
M#_(/[+RS_H%A_P"3_P#R9]]?\)C^Q_\ ]%,^,/\ X1]O_P#)%'_"8_L?_P#1
M3/C#_P"$?;__ "17P311]7?\S_#_ ")_LW+/^@6'_D__ ,F?>W_"8_L?_P#1
M3/C#_P"$?;__ "12CQ?^Q^?^:F?&'_PD+?\ ^2*^"*>GW:/J_P#>?X?Y!_9N
M6?\ 0+#_ ,G_ /DS[T_X2[]C_P#Z*9\8?_"0M_\ Y(I?^$N_8_\ ^BF?&#_P
MD+?_ .2*^"Z*/J_]Y_A_D)Y=EG_0+#_R?_Y,^]/^$N_8_P#^BF_&#_PC[?\
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M8?\ D_\ \F?=W_"3_L@_]%.^,'_A(6__ ,D4?\)/^R#_ -%.^,'_ (2%O_\
M)%?"-%5]5_O/\/\ (/J.6_\ 0+#_ ,G_ /DS[N_X2?\ 9!_Z*=\8/_"0M_\
MY(I1XE_9!/\ S4WXP?\ A(6__P D5\(4Y.E'U7^\_P /\@>!RW_H%A_Y/_\
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MO_\ )%'_  D/[(?_ $4WXO\ _A(6_P#\D5\+44?5?[S_  _R#ZIEW_0)3_\
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MGWW_ ,+%_9#_ .BA?%__ ,)>W_\ CM+_ ,+#_9#_ .BA?%__ ,)>W_\ CM?
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M+XO?^$Q;_P#QVC_A/_V1/^BA?%[_ ,)BW_\ CM?!-%5["7\\OO7^0?5<L_Z
MJ7W3_P#DS[V_X3_]D3_HH7Q>_P#"8M__ ([1_P )_P#LB?\ 10OB]_X3%O\
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M?=/_ .3/NO\ X3+]D?\ Z*'\7?\ PF+?_P".T?\ "9?LC_\ 10_B[_X3%O\
M_':^%*!UH]A+_GY+[U_D'LLM_P"@*E]T_P#Y,^[/^$P_9'_Z*%\7?_"8M_\
MX[1_PE_[(_\ T4/XN?\ A,6__P =KX7HJ51E_P _)?>O\B>3+O\ H"I?=/\
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M_P#CM'_"1_LE?]%$^+?_ (3-O_\ ':^(:*7L9_\ /R7WK_(.;+_^@*E]T_\
MY,^X!K_[)9_YJ)\6O_"9M_\ X[1_;_[)?_11/BU_X3-O_P#':^(QTHH]C/\
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M/_"<B_\ CM?F[11_9L/YG]Z_R#_6RK_SXI_=+_Y,_2+_ (:Q_9=_Z'+XF?\
MA.1?_':/^&L?V7?^AR^)G_A.1?\ QVOS=HH_LV'\S^]?Y!_K95_Y\4_NE_\
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M ..U^<%%']FP_F?WK_(/];JW_/BG]TO_ ),_1_\ X:N_9>_Z'+XF?^$Y%_\
M':7_ (:K_9?_ .AR^)G_ (3D7_QVOS?'6I*/[-A_,_O7^0GQ=67_ "XI_=+_
M .3/T<_X:K_9?_Z'+XF?^$Y%_P#':/\ AJO]E_\ Z'+XF?\ A.1?_':_..BC
M^S8?S/[U_D+_ %OK?\^*?W2_^3/T<_X:K_9?_P"AR^)G_A.1?_':/^&J_P!E
M_P#Z'+XF?^$Y%_\ ':_..BC^S8?S/[U_D'^M];_GQ3^Z7_R9^CG_  U7^R__
M -#E\3/_  G(O_CM*/VJ?V7S_P SE\3/_"<B_P#CM?G%3HZ/[-A_,_O7^0GQ
MA6_Y\4_NE_\ )GZ.?\-4?LO_ /0Y?$S_ ,)V+_X[1_PU1^R__P!#E\3/_"=B
M_P#CM?G+11_9L/YG]Z_R)_UQK_\ /BE]TO\ Y,_1K_AJ?]E__H<OB7_X3D7_
M ,=H_P"&I_V7_P#H<OB7_P"$Y%_\=K\Y:!UH_LV'\S^]?Y!_KC7_ .?%+[I?
M_)GZ-_\ #4O[,'_0Y?$O_P )V+_X[1_PU+^S!_T.7Q+_ /"=B_\ CM?G111_
M9L/YG]Z_R#_7&O\ \^*7W2_^3/T7_P"&I?V8/^AR^)?_ (3L7_QVE_X:D_9?
M_P"AR^)7_A.Q?_':_.>BC^S8?S/[U_D'^N-?_GQ2^Z7_ ,F?HQ_PU)^R_P#]
M#E\2O_"=B_\ CM'_  U)^R__ -#E\2O_  G8O_CM?G/14O+H+[3^]?Y$_P"N
M5?\ Y\4ONE_\F?HQ_P -2?LO_P#0Y?$K_P )V+_X[1_PU)^R_P#]#E\2O_"=
MB_\ CM?G/15?V;#^9_>O\A?ZY5_^?%+[I?\ R9^C _:C_9@/_,Y?$K_PG8O_
M ([1_P -0_LP_P#0Y?$K_P )V+_X[7YTIUIU']FP_F?WK_(/]<J__/BE]TO_
M ),_17_AJ']F'_H<OB5_X3L7_P <H_X:@_9A_P"AR^)7_A.Q?_'*_.J@=:/[
M-A_,_O7^0?ZY5_\ GQ2^Z7_R9^BW_#3W[,/_ $.7Q*_\)V+_ ..T?\-/?LP_
M]#E\2O\ PG8O_CM?G;14?V?#^9_>O\B?]=*__0/2^Z7_ ,F?HE_PT]^S#_T.
M7Q*_\)V+_P".T?\ #3O[,/\ T.?Q*_\ "=B_^.5^=M%']GP_F?WK_(/]=*__
M #XI?=+_ .3/T2_X:=_9A_Z'/XE?^$[%_P#'*/\ AIW]F'_H<_B5_P"$[%_\
M<K\[:*/[/A_,_O7^0?ZZ8C_GQ2^Z7_R9^B7_  T[^S#_ -#G\2O_  G8O_CE
M'_#3O[,/_0Y_$K_PG8O_ (Y7YVT4?V?#^9_>O\@_UTK_ //BE]TO_DS]$Q^T
MY^S"?^9S^)7_ (3L7_QRE_X::_9B_P"AR^)7_A.Q?_'*_.U.M.I_V="WQ/[U
M_D3_ *[8B_\ N]+[I?\ R9^B'_#37[,7_0Y?$K_PG8O_ (Y1_P -,_LQ?]#G
M\2?_  G8O_CE?G?0.M+^SX?S/[U_D5_KI7_Y\4ONE_\ )GZ(_P##2_[,?_0Y
M?$G_ ,)V+_XY1_PTO^S'_P!#E\2?_"=B_P#CE?GE11_9\/YG]Z_R)_UVQ'_/
MBE]TO_DS]#?^&E_V8_\ H<OB3_X3L7_QRC_AI?\ 9C_Z'+XD_P#A.Q?_ !RO
MSRHH_L^'\S^]?Y!_KMB/^?%+[I?_ "9^AW_#2_[,?_0Z?$C_ ,)V+_XY2?\
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M.I+K_CYD_P!X_P ZCKC,PK\ ?^#JO_E(7X-_[)W9?^G+4Z_?ZOP!_P"#JO\
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M92^*7_1-?'W_ (3UW_\ &Z/:1[D^QJ?RO[CA:*[[_AE+XI?]$U\??^$]=_\
MQNC_ (92^*7_ $37Q]_X3UW_ /&Z.>/</8U/Y7]QP-%=]_PRG\4O^B;>/O\
MPGKO_P"-T?\ #*?Q1_Z)MX^_\)Z[_P#C='M(]P]C4_E?W'!ITIU=XG[*GQ0
M_P"2;^/O_"?N_P#XW3O^&5/BB?\ FF_C[_PG[O\ ^-U7M(VW)=&I?X7]QP-%
M=]_PRG\4?^B;>/O_  GKO_XW1_PRG\4?^B;>/O\ PGKO_P"-U/M(]Q>QJ?RO
M[C@:!UKOO^&4_BC_ -$V\??^$]=__&Z!^RG\4<_\DV\??^$]=_\ QNK]I'NA
M>QJ?RO[CA:*[[_AE7XH?]$W\??\ A/W?_P ;H_X93^*/_1-O'W_A/7?_ ,;I
M1J1[D>PJ?RO[C@:D'2NZ_P"&4_BC_P!$V\??^$]=_P#QNGC]E3XH8_Y)OX^_
M\)^[_P#C=5[2/</85/Y7]QP5%=]_PRK\4/\ HF_C[_PG[O\ ^-T?\,J_%#_H
MF_C[_P )^[_^-T>TCW(]A5_E?W,X&BN^_P"&5?BA_P!$W\??^$_=_P#QNC_A
ME7XH?]$W\??^$_=__&Z/:1[A["K_ "O[F<&G6G5W:?LJ_% '_DF_C[_PG[O_
M .-T[_AE;XH?]$W\>_\ A/W?_P ;H]I'N'L*O\K^YG!4#K7>_P##*WQ0_P"B
M;^/?_"?N_P#XW2C]E;XH9_Y)OX]_\)^[_P#C='M(]Q>PJ_RO[F<+17>_\,K?
M%#_HF_CW_P )^[_^-T?\,K?%#_HF_CW_ ,)^[_\ C='M(]R/J]7^5_<S@J>G
MW:[K_AE;XH?]$W\>_P#A/W?_ ,;IZ_LK_%#;_P DW\>?^$_=_P#QNCVD>X?5
MZO\ *_N9P=%=Y_PRO\3_ /HG'CS_ ,)^[_\ C='_  RO\3_^B<>//_"?N_\
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MXF?]$[\=?^"&Z_\ C=7&I#N@^JU_Y']S.%HKNO\ AE[XF?\ 1._'7_@ANO\
MXW1_PR]\3/\ HG?CK_P0W7_QNIC5AW0?5:_\C^YG"U(.E=M_PR]\3/\ HG?C
MK_P0W7_QNI!^R]\3,?\ )._'7_@ANO\ XW1*I#N@^JU_Y']S.%HKNO\ AE[X
MF?\ 1._'7_@ANO\ XW1_PR]\3/\ HG?CK_P0W7_QNJ]K#NC/ZK7_ )']S.'C
MIU=PG[+_ ,3!_P T[\=?^"&Z_P#C=._X9@^)?_1._'7_ ((;K_XW4NI"^Z#Z
MK7_D?W,X6BNZ_P"&8/B7_P!$[\=?^"&Z_P#C='_#,'Q+_P"B=^.O_!#=?_&Z
M7M(=T'U6O_(_N9PM%=U_PS!\2_\ HG?CK_P0W7_QNC_AF#XE_P#1._'7_@AN
MO_C=7[6'=!]5K_R/[F<+17=?\,P?$O\ Z)WXZ_\ !#=?_&Z/^&8/B7_T3OQU
M_P""&Z_^-T>UAW0?5:_\C^YG$CI3T^[7;#]F#XEX_P"2=^.O_!#=?_&Z>O[,
M/Q*V_P#)//'/_@ANO_C=*56'=&?U2O\ R/[F</17<_\ #,/Q*_Z)YXY_\$-U
M_P#&Z/\ AF'XE?\ 1//'/_@ANO\ XW4^TAW0?5*_\C^YG#45W7_#,'Q+/_-.
M_'7_ ((;K_XW1_PS!\2_^B=^.O\ P0W7_P ;I^TA;=$/!U[_  /[F<+17=?\
M,P?$O_HG?CK_ ,$-U_\ &Z/^&8/B7_T3OQU_X(;K_P"-TXU8=T+ZG7_D?W,X
M4=:DKMA^S!\2\_\ )._'7_@ANO\ XW3_ /AF'XE?]$\\<_\ @ANO_C=/VL.Z
M#ZG7_D?W,X:BNY_X9A^)7_1//'/_ ((;K_XW1_PS#\2O^B>>.?\ P0W7_P ;
MH]K#N@^IU_Y']S.*'2BNX'[,7Q*Q_P D]\<?^"&Z_P#B*/\ AF+XE?\ 1/?'
M'_@ANO\ XBH]I#NC/ZG7_D?W,X>BNX_X9B^)7_1/?''_ ((;K_XBE_X9B^)1
M_P":>>.?_!#=?_$4U4A?=!]3K_R/[F<-17<_\,P_$K_HGGCG_P $-U_\;H_X
M9A^)7_1//'/_ ((;K_XW5>UAW0?4Z_\ (_N9PU ZUW/_  S#\2O^B>>.?_!#
M=?\ QNE'[,/Q*S_R3SQS_P""&Z_^-T>UAW0?4Z_\C^YG$T5W'_#,7Q*_Z)[X
MX_\ !#=?_$4?\,Q?$K_HGOCC_P $-U_\12C5AW1'U/$?R2^YG#U(.E=I_P ,
MQ?$K_HGOCC_P0W7_ ,14@_9D^)6/^2>^./\ P177_P 12E4AW0?4\1_)+[F<
M/17<?\,R?$K_ *)[XX_\$5U_\11_PS)\2O\ HGOCC_P177_Q%+VD.Z#ZGB/Y
M)?<SAZ*[C_AF/XE'_FGOCC_P0W7_ ,11_P ,Q?$K_HGOCC_P0W7_ ,15^UAW
M7WD/!XB_P2^YG#TY.M=M_P ,Q?$K_HGOCC_P0W7_ ,13D_9C^)0/_)/?''_@
MANO_ (BAU86W7WB^IXC^27W,XFBNX_X9D^)7_1/?''_@BNO_ (BC_AF3XE?]
M$]\<?^"*Z_\ B*CVL.Z#ZGB/Y)?<SAZ*[C_AF+XE?]$]\<?^"&Z_^(H_X9B^
M)7_1/?''_@ANO_B*<JL.Z^\/J>(_DE]S.+HKN/\ AF3XE?\ 1/?''_@BNO\
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M *)_XW_\$5U_\11_PS/\2/\ HG_C?_P177_Q%'M8=T'U+$?\^Y?<SB**[?\
MX9G^)'_1/_&__@BNO_B*/^&9_B1_T3_QO_X(KK_XBCVL.Z,W@<1?^'+[F<12
MI]ZNV_X9G^)'_1/_ !O_ ."*Z_\ B*5/V9_B1N_Y)_XW_P#!%=?_ !%'M8=U
M]X?4<3_S[E]S.+HKM_\ AF?XD?\ 1/\ QO\ ^"*Z_P#B*/\ AF?XD?\ 1/\
MQO\ ^"*Z_P#B*/:P[H/J.)_Y]R^Y_P"1Q%%=O_PS/\2/^B?^-_\ P177_P 1
M1_PS/\2/^B?^-_\ P177_P 11[6'=!]1Q/\ S[E]S_R.(IZ?=KM/^&9_B1_T
M3_QO_P""*Z_^(IZ_LT?$C;_R3_QM_P""*Z_^(H]K#NC/ZCB?^?<ON?\ D<._
M6A.E=L_[,_Q()_Y)_P"-_P#P177_ ,12I^S/\2 /^2?^-O\ P177_P 11[:'
M=?>'U'$_\^Y?<_\ (XJBNV_X9H^)'_1/_&W_ ((KK_XBC_AFCXD?]$_\;?\
M@BNO_B*/;0[K[P^HXG_GW+[G_D<317;?\,T?$C_HG_C;_P $5U_\11_PS1\2
M/^B?^-O_  177_Q%'MH=U]X?4<3_ ,^Y?<_\CB1UJ2NS'[-'Q'S_ ,D_\;?^
M"*Z_^(I__#-/Q&_Z)_XV_P#!'=?_ !%'MH=U]Y,L#B?^?<ON?^1Q-%=M_P ,
MT_$;_HG_ (V_\$=U_P#$4?\ #-/Q&_Z)_P"-O_!'=?\ Q%'MH=U]Y/U'$_\
M/N7W/_(XFBNV_P"&:/B/_P!$_P#&W_@BNO\ XBC_ (9H^)'_ $3_ ,;?^"*Z
M_P#B*/;0[K[P^HXG_GW+[G_D<33HZ[3_ (9H^)'_ $3_ ,;?^"*Z_P#B*<G[
M-/Q''_-/_&W_ (([K_XBCVT.Z^\'@<3;^'+[G_D<717;?\,T_$;_ *)_XV_\
M$=U_\11_PS3\1S_S3_QM_P"".Z_^(H]M#NOO,_J.)_Y]R^Y_Y'$T#K7;?\,T
M?$C_ *)_XV_\$5U_\12C]FCXCY_Y)_XV_P#!%=?_ !%'MH=U]X?4<3_S[E]S
M_P CC**[;_AFGXC?]$_\;?\ @CNO_B*/^&:?B-_T3_QM_P"".Z_^(H]M#NOO
M#ZCB?^?<ON?^1Q-%=M_PS3\1O^B?^-O_  1W7_Q%'_#-/Q&_Z)_XV_\ !'=?
M_$4>VAW7WA]1Q/\ S[E]S_R.)HKMO^&:?B-_T3_QM_X([K_XBC_AFGXC?]$_
M\;?^".Z_^(I2JP[K[R?J&)_Y]R^Y_P"1Q-%=M_PS3\1O^B?^-O\ P1W7_P 1
M1_PS3\1O^B?^-O\ P1W7_P 13]M#NOO%]0Q/_/N7W/\ R.+3K3J[1/V:?B-G
M_DG_ (V_\$=U_P#$4[_AFGXC?]$_\;?^".Z_^(H]M#NOO#ZAB?\ GW+[G_D<
M30.M=M_PS3\1O^B?^-O_  1W7_Q% _9J^(V?^2?^-O\ P1W7_P 11[:'=?>+
MZCB?^?<ON?\ D<;17;?\,U_$;_H0/&W_ (([K_XBC_AFOXC?]"!XV_\ !'=?
M_$5G[:'=?>1]0Q7_ #[E]S_R.)HKMO\ AFOXC?\ 0@>-O_!'=?\ Q%'_  S7
M\1O^A \;?^".Z_\ B*/:P[H/J&*_Y]R^Y_Y'$T5VW_#-?Q&_Z$#QM_X([K_X
MBC_AFOXC?]"!XV_\$=U_\11[6'=!]0Q7_/N7W/\ R.)HKMO^&:_B-_T('C;_
M ,$=U_\ $4?\,U?$8_\ -/\ QM_X([K_ .(H]K#N@^H8K_GW+[G_ )'%IUIU
M=HG[-7Q&!_Y)_P"-O_!'=?\ Q%._X9K^(W_0@>-O_!'=?_$52K0MNOO(_L_%
M7_AR_P# 7_D<30.M=M_PS7\1O^A \;?^".Z_^(H'[-?Q&S_R('C;_P $=U_\
M14^VAW7WE_4,5_S[E]S_ ,CC:*[;_AFOXC?]"!XV_P#!'=?_ !%'_#-?Q&_Z
M$#QM_P"".Z_^(H]M#NOO(_L_%?\ /N7_ ("_\CB:*[;_ (9K^(W_ $('C;_P
M1W7_ ,11_P ,U_$;_H0/&W_@CNO_ (BCVT.Z^\/[/Q7_ #[E_P" O_(XFBNV
M_P"&:_B-_P!"!XV_\$=U_P#$4?\ #-?Q&_Z$#QM_X([K_P"(H]M#NOO#^S\5
M_P ^Y?\ @+_R.)HKMO\ AFOXC?\ 0@>-O_!'=?\ Q%'_  S7\1O^A \;?^".
MZ_\ B*/;0[K[P_L_%?\ /N7_ ("_\CB:5/O5VO\ PS7\1O\ H0/&W_@CNO\
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M .FVWKV:O+K?Q)>K/>PO\"'HOR"BBBLSH"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^8']
MGO\ Y3?>%?\ LL\/_IYK^GZOY@?V>_\ E-]X5_[+/#_Z>:^AR':KZ+]3XGC#
M_EQZO]#^GZBBBOGC[8M:1_Q\M_N_U%:59ND?\?+?[O\ 45I5T4]BHA1116A0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 8]U_P ?,G^\?YU'4EU_Q\R?[Q_G4=<9F%?@#_P=5_\ *0OP;_V3
MNR_].6IU^_U?@#_P=5_\I"_!O_9.[+_TY:G7L9'_ +U\F?,\6?\ (O?JC]F/
M^"<G_*/3X#_]D[\/_P#IMMZ]FKQG_@G)_P H]/@/_P!D[\/_ /IMMZ]FKRZW
M\27JSWL+_ AZ+\@KS']IG]KSP/\ LF^&%U#Q=JGE7%RI-GIML!+>WQ'7RX\C
M@=V8JHZ$Y(!L_M6?M%:9^RS\#M9\8:DJS-9)Y5E:[MIO;I\B*('L">2>RJQ[
M5^'7Q@^+_B#X[?$34O%'B:^DU#5M4E,DCDG9$O\ #&B_PHHX51T K?"X5U7=
M['[EX2>$\^*:DL;C9.&%INS:^*<M^6+>R2MS/7=):MM?9'Q6_P""Z_C+5]1E
MC\&^%-!T6PSA)=2,E[<L/7Y61%)],-CU/6N!_P"'S_QN_P"?WPW_ ."I?\:^
M3Z*]6.$I)6L?UQ@_"GA'#4E2A@*;2ZR7,_FY7?XGUA_P^?\ C=_S^^&__!4O
M^-'_  ^?^-W_ #^^&_\ P5+_ (U\GT4_JM+^4ZO^(9\*?]"^E_X O\CZP_X?
M/_&[_G]\-_\ @J7_ !H_X?/_ !N_Y_?#?_@J7_&OD^BCZK2_E#_B&?"G_0OI
M?^ +_(^LE_X+._&XC_C^\-_^"I?\:/\ A\Y\;?\ G^\-_P#@J7_&OD].E.H^
MJTOY27X:<*?]"^E_X O\CZN_X?.?&W_G^\-_^"I?\:/^'SGQM_Y_O#?_ (*E
M_P :^4:*/JM+^4G_ (AKPI_T+Z7_ ( O\CZN_P"'SGQM_P"?[PW_ ."I?\:/
M^'SGQM_Y_O#?_@J7_&OE&BCZK2_E#_B&O"G_ $+Z7_@"_P CZN_X?.?&W_G^
M\-_^"I?\:/\ A\Y\;?\ G^\-_P#@J7_&OE&BCZK2_E#_ (AKPI_T+Z7_ ( O
M\CZP'_!9GXV$?\?WAS_P5+_C2_\ #YGXV?\ /]X<_P#!4O\ C7RD.E%1]7I=
MB?\ B&O"O_0OI?\ @$?\CZM_X?,_&S_G^\.?^"I?\:/^'S/QL_Y_O#G_ (*E
M_P :^4J*/J]+L'_$->%?^A?2_P# (_Y'U;_P^9^-G_/]X<_\%2_XT?\ #YGX
MV?\ /]X<_P#!4O\ C7RE11]7I=@_XAKPK_T+Z7_@$?\ (^K?^'S/QL_Y_O#G
M_@J7_&C_ (?,_&S_ )_O#G_@J7_&OE*BCZO2[!_Q#7A7_H7TO_ (_P"1]7#_
M (+,?&PG_C^\.?\ @J7_ !IW_#Y7XV?\_P!X=_\ !4O^-?)XZU)1]7I=@_XA
MKPK_ -"^E_X!'_(^K/\ A\K\;/\ G^\._P#@J7_&C_A\K\;/^?[P[_X*E_QK
MY3HH^KTNP?\ $->%?^A?2_\  (_Y'U9_P^5^-G_/]X=_\%2_XT?\/E?C9_S_
M 'AW_P %2_XU\IT4?5Z78/\ B&O"O_0OI?\ @$?\CZL_X?*_&S_G^\._^"I?
M\:/^'ROQL_Y_O#O_ (*E_P :^4Z*/J]+L'_$->%?^A?2_P# (_Y'U:G_  64
M^-A_Y?O#O_@J7_&E_P"'R?QK_P"?[P[_ ."I?\:^4XZ=1]7I=B'X;<*_]"^E
M_P" 1_R/JK_A\G\:_P#G^\._^"I?\:/^'R?QK_Y_O#O_ (*E_P :^5:*/J]+
ML+_B&_"W_0OI?^ 1_P CZJ_X?)_&O_G^\._^"I?\:/\ A\G\:_\ G^\._P#@
MJ7_&OE6BCZO2[!_Q#?A;_H7TO_ (_P"1]5?\/D_C7_S_ 'AW_P %2_XT?\/D
M_C7_ ,_WAW_P5+_C7RK11]7I=@_XAOPM_P!"^E_X!'_(^K!_P60^-1'_ !_>
M'?\ P5+_ (TO_#Y#XU?\_P!X=_\ !4O^-?*PZ44?5Z78/^(;<*_]"^E_X O\
MCZI_X?(?&K_G^\._^"I?\:/^'R'QJ_Y_O#O_ (*E_P :^5J*/J]+L'_$-N%?
M^A?2_P# %_D?5/\ P^0^-7_/]X=_\%2_XT?\/D/C5_S_ 'AW_P %2_XU\K44
M?5Z78/\ B&W"O_0OI?\ @"_R/JG_ (?(?&K_ )_O#O\ X*E_QI5_X+'_ !J)
M_P"/[P[_ ."I?\:^5:5/O4?5Z78/^(;<+?\ 0OI?^ +_ "/JO_A\9\:O^?[P
M[_X*E_QH_P"'QGQJ_P"?[P[_ ."I?\:^5Z*/J]+L9_\ $-^%O^A?2_\  %_D
M?5'_  ^,^-7_ #_>'?\ P5+_ (T?\/C/C5_S_>'?_!4O^-?*]%'U>EV#_B&_
M"W_0OI?^ +_(^J/^'QGQJ_Y_O#O_ (*E_P :/^'QGQJ_Y_O#O_@J7_&OE>BC
MZO2[!_Q#?A;_ *%]+_P!?Y'U1_P^,^-7_/\ >'?_  5+_C2I_P %B_C4?^7[
MP[_X*E_QKY6IT='U>EV#_B&_"W_0OI?^ +_(^J/^'Q/QI_Y_O#O_ (*U_P :
M/^'Q/QI_Y_O#O_@K7_&OEFBCZO2[!_Q#?A;_ *%]+_P!?Y'U-_P^)^-/_/\
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M //[X>_\%:_XT?\ #X3XS_\ /[X>_P#!6O\ C7RW11]7I]@_XASPO_T 4O\
MP!?Y'U)_P^%^,_\ S^>'?_!6O^-'_#X7XS_\_GAW_P %:_XU\MT4?5Z?8/\
MB'/"_P#T 4O_  !?Y'U)_P /A?C/_P _GAW_ ,%:_P"-'_#X7XS_ //YX=_\
M%:_XU\MT4?5Z?8/^(<\+_P#0!2_\ 7^1]2?\/A?C/_S^>'?_  5K_C1_P^%^
M,_\ S^>'?_!6O^-?+=%'U>GV#_B'/"__ $ 4O_ %_D?4G_#X7XS_ //YX=_\
M%:_XTX?\%@OC,1_Q^>'O_!6O^-?+-2#I1]7I]B9>'/"__0!2_P# %_D?4?\
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M_P"?WP__ ."M?\:/^'O7QE_Y_?#_ /X*U_QKY?HH^KT^P?\ $.^&/^@"E_X
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M1_Q#SAG_ * :7_@"_P CZ<_X>Y?&+_G\\/\ _@L7_&C_ (>Y?&+_ )_/#_\
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M "^Z#_X+%_QKYCIT='U>GV!^'O#-O]QI?^ +_(^G/^'M?QA_Y_=!_P#!8O\
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M@_Y_=!_\%B_XT?\ #V7XP?\ /[H/_@L7_&OFBBCZO3[$_P#$/^&O^@&E_P"
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MW_/YH/\ X+5_QKYJHH]A3[!_Q#_AK_H!I?\ @"_R/I7_ (>P?%[_ )_-!_\
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M^:#_ ."U?\:^:Z*/8P[!_J!PW_T TO\ P!?Y'TI_P]=^+O\ S^:#_P""U?\
M&C_AZ[\7?^?S0?\ P6K_ (U\UT4>QAV#_4#AO_H!I?\ @"_R/I9?^"K?Q<(_
MX_-!_P#!:O\ C1_P]:^+G_/YH/\ X+5_QKYL3[M+5>PI]B/]0>&_^@&E_P"
M+_(^DO\ AZU\7/\ G\T'_P %J_XT?\/6OBY_S^:#_P""U?\ &OFVBG["GV#_
M %!X;_Z :7_@"_R/I+_AZU\7/^?S0?\ P6K_ (T?\/6OBY_S^:#_ ."U?\:^
M;:*/84^P?Z@\-_\ 0#2_\ 7^1])?\/6OBY_S^:#_ ."U?\:4?\%6OBX3_P ?
MF@_^"U?\:^;*!UH]A3[!_J#PW_T TO\ P!?Y'TK_ ,/5_BY_S^:%_P""U?\
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M6/\ G\T/_P %R_XT?\/2_BQ_S^:'_P""Y?\ &OG.BCV%/L'^H?#O_0%3_P#
M%_D?1G_#TOXL?\_FA_\ @N7_ !H_X>E_%C_G\T/_ ,%R_P"-?.=%'L*?8/\
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MXL?\_FA_^"Y?\:/^'I'Q8_Y_-#_\%R_XU\ZT5/L:=]@_U#X=_P"@*G_X O\
M(^BO^'I'Q8_Y_-#_ /!<O^-'_#TCXL?\_FA_^"Y?\:^=:*KV%/L'^H?#O_0%
M3_\  %_D?17_  ](^+'_ #^:'_X+E_QH_P"'I'Q8_P"?S0__  7+_C7SK11[
M"GV#_4/AW_H"I_\ @"_R/HK_ (>D?%C_ )_-#_\ !<O^-'_#TCXL?\_FA_\
M@N7_ !KYUHH]A3[!_J'P[_T!4_\ P!?Y'T<G_!4/XK,N?MFB_P#@N7_&G?\
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M'_O7R9\SQ9_R+WZH_9C_ ()R?\H]/@/_ -D[\/\ _IMMZ]FKQG_@G)_RCT^
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M"BBB@ HHHH *>GW:93T^[4R)D+1114DA1110 4444  ZU)48ZU)51 ****H
MHHHH **** "BBB@B6X4444""BBB@ HHHH D'2B@=** "BBB@ HHHH ****
M=:DJ,=:DH **** "BBB@ HHHH <G6G4U.M.J);D2W"BBBD(**** "BBB@!Z?
M=I:1/NTM:&84444 %%%% !0.M% ZT 24444 %%%% !1110 4444I; %%%%0
M4444 %%%%:&85-%_JQ4-31?ZL5,@'4445(!1110 4444 %%%%!,@HHHH)"BB
MB@ HHHH *<G6FTY.M #J***T **** "BBB@ IZ?=IE/3[M!,A:***"0HHHH
M**** "I*CJ2@ HHHH **** "BBB@ HHHJ>H!1115 %%%% !1110!-%_JQ3J;
M%_JQ3JS,PHHHH ]8_8<\=S> /VI_!]Q&Y6/4+Y=,F7M(MQ^Z /T9E;ZJ*_5R
MOR!_9H_Y..^'_P#V,FG?^E4=?K]7GXQ>\F?RYX\4(1S3#54M94VG\I.WYL*_
MF!_9[_Y3?>%?^RSP_P#IYK^GZOY@?V>_^4WWA7_LL\/_ *>:]7(=JOHOU/Y4
MXP_Y<>K_ $/Z?J***^>/MBUI'_'RW^[_ %%:59ND?\?+?[O]16E713V*B%%%
M%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!CW7_'S)_O'^=1U)=?\ 'S)_O'^=1UQF85^ /_!U7_RD+\&_
M]D[LO_3EJ=?O]7X _P#!U7_RD+\&_P#9.[+_ -.6IU[&1_[U\F?,\6?\B]^J
M/V8_X)R?\H]/@/\ ]D[\/_\ IMMZ]FKQG_@G)_RCT^ __9._#_\ Z;;>O9J\
MNM_$EZL]["_P(>B_(_)__@NM_P G=>'/^Q0MO_2V]KXOK[0_X+K?\G=>'/\
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MP_\ !8"#XS?$'1?"'BKP=]@O/$%U'I\-YITYG@:24[%#PNNY5+$ MO; .2
M32E'5O<X\[X=KRS/,\Q]A2S&C)OFY:MJM%*_NK?E<5I9*3]U;:H^5_\ @HC\
M6?A;\<?B+IOB;X<P75I>7L4B:W')9?94ED4KY<P&2"S N&(Q]Q3R237SW'7W
M9_P60_9I\(_#:S\-^,?#VFV>BZAK%Y)97UM:H(HKKY#()A&!@,""&(Z[ESSS
M7PG'711:<=#]M\.<PP>,X=P]3 \_LTG%>T=Y*S:LVK)I;1?\MAU%%%:'VH44
M44 %%%% !3T^[3*>GW:F1,A:***DD**** "BBB@ '6I*C'6I*J(!1115 %%%
M% !1110 4444$2W"BBB@04444 %%%% $@Z44#I10 4444 %%%% !1110 #K4
ME1CK4E !1110 4444 %%%% #DZTZFIUIU1+<B6X4444A!1110 4444 /3[M+
M2)]VEK0S"BBB@ HHHH *!UHH'6@"2BBB@ HHHH **** "BBBE+8 HHHJ "BB
MB@ HHHK0S"IHO]6*AJ:+_5BID ZBBBI **** "BBB@ HHHH)D%%%%!(4444
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M_N_U%:59ND?\?+?[O]16E713V*B%%%%:%!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CW7_'S)_O'^=1U)=?
M\?,G^\?YU'7&9A7X _\ !U7_ ,I"_!O_ &3NR_\ 3EJ=?O\ 5^ /_!U7_P I
M"_!O_9.[+_TY:G7L9'_O7R9\SQ9_R+WZH_9C_@G)_P H]/@/_P!D[\/_ /IM
MMZ]FKQG_ ()R?\H]/@/_ -D[\/\ _IMMZ]FKRZW\27JSWL+_  (>B_(_)_\
MX+K?\G=>'/\ L4+;_P!+;VOB^OM#_@NM_P G=>'/^Q0MO_2V]KXOKW,+_"B?
MZ5>$_P#R2& _Z]K\V%%%%=!^A!1110 4444 .3I3J:G2G4$2W"BBB@04444
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M38Z=01+<****!!1110 4444 2#I10.E% !1110 4444 %%%% !1110 4444
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M4DA1110 4444  ZU)48ZU)51 ****H HHHH **** "BBB@B6X4444""BBB@
MHHHH D'2B@=** "BBB@ HHHH ****  =:DJ,=:DH **** "BBB@ HHHH <G6
MG4U.M.J);D2W"BBBD(**** "BBB@!Z?=I:1/NTM:&84444 %%%% !0.M% ZT
M 24444 %%%% !1110 4444I; %%%%0 4444 %%%%:&85-%_JQ4-31?ZL5,@'
M4445(!1110 4444 %%%%!,@HHHH)"BBB@ HHHH *<G6FTY.M #J***T ****
M "BBB@ IZ?=IE/3[M!,A:***"0HHHH **** "I*CJ2@ HHHH **** "BBB@
MHHHJ>H!1115 %%%% !1110!-%_JQ3J;%_JQ3JS,PHHHH [;]FC_DX[X?_P#8
MR:=_Z51U^OU?D#^S1_R<=\/_ /L9-._]*HZ_7ZO/QFZ/YA\>O]_PO^"7_I05
M_,#^SW_RF^\*_P#99X?_ $\U_3]7\P/[/?\ RF^\*_\ 99X?_3S7JY#M5]%^
MI_)_&'_+CU?Z']/U%%%?/'VQ:TC_ (^6_P!W^HK2K-TC_CY;_=_J*TJZ*>Q4
M0HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH'2B@ HHHH **** "E3[U)2I]Z@!]%%%!F%%%% !1110 4Z.FTZ.@!U%%%
M!1110 4444 %%%%3(F04445)(4444 %%%% #HO\ 6"IJAB_U@J:@F04444$A
M1110 4444 %%%% !1110 4444 %%%% !4@Z5'4@Z4$R"BBB@D**** "BBBJB
M #K4E1CK4E$@"BBBI **** "BBB@!T=.IL=.H(EN%%%% @HHHH **** )!TH
MH'2B@ HHHH **** "BBB@ HHHH **** "BBB@!R=*=34Z4Z@B6X4444""BBB
M@ HHHH **** 'I]VEI$^[2T&84444 %%%% !0.M% ZT 24444 %%%% !1110
M 4Z.FTZ.@4MAU%%%! 4444 %%%% !3T^[3*>GW:F1,A:***DD**** "BBB@
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M10!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7X _\ !U7_ ,I"_!O_ &3NR_\
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MG_X10_\ CU'_  W]#_T0G]G/_P (H?\ QZOGNBCZK2[!_J;E'_/K_P FG_\
M)'T)_P -_0_]$)_9S_\ "*'_ ,>H_P"&_H?^B$_LY_\ A%#_ ./5\]T4?5:7
M8/\ 4W*/^?7_ )-/_P"2/H3_ (;^A_Z(3^SG_P"$4/\ X]1_PW]#_P!$)_9S
M_P#"*'_QZOGNBCZK2[!_J;E'_/K_ ,FG_P#)'T)_PW_#_P!$)_9S_P#"*'_Q
MZC_AX!%_T0G]G/\ \(H?_'J^>Z*/JM+L'^IN4?\ /K_R:?\ \D?0G_#P"+_H
MA/[.?_A%#_X]1_P\ B_Z(3^SG_X10_\ CU?/=%'U6EV#_4W*/^?7_DT__DCZ
M$_X> 1?]$)_9S_\ "*'_ ,>H_P"'@$7_ $0G]G/_ ,(H?_'J^>Z*/JM+L'^I
MN4?\^O\ R:?_ ,D?0G_#P"+_ *(3^SG_ .$4/_CU'_#P"+_HA/[.?_A%#_X]
M7SW11]5I=@_U-RC_ )]?^33_ /DCZ$_X> 1#_FA/[.?_ (18_P#CU'_#P&/_
M *(5^SG_ .$6/_CU?/=%'U6EV#_4W)_^?7_DT_\ Y(^A/^'@,?\ T0K]G/\
M\(L?_'J/^'@,?_1"OV<__"+'_P >KY[HH^JTNP?ZFY/_ ,^O_)I__)'T)_P\
M!C_Z(5^SG_X18_\ CU'_  \!C_Z(5^SG_P"$6/\ X]7SW11]5I=@_P!3<G_Y
M]?\ DT__ )(^A/\ AX#'_P!$*_9S_P#"+'_QZC_AX#'_ -$*_9S_ /"+'_QZ
MOGNBCZK2[!_J;D__ #Z_\FG_ /)'T+_P\"C_ .B%_LZ?^$7_ /;J/^'@<?\
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MSK_X1?\ ]NKYYHH^JTNP?ZFY/_SY_P#)I_\ R1]#?\/!$_Z(7^SK_P"$7_\
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MYV_!'X A<\ ^#U) _P"_E>)T5M["'8\S_5G RUJ\\WWE4J2?WN3_  T/:O\
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M_P!$2^ '_A'+_P#'*\4HH]C#L'^J^6?\^W_X%/\ ^2/:_P#ALJR_Z(E\ /\
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M*)?"ZROCW8OD_4T?\-+:5_T1KX&?^$DG_P 77EE%/V<3G_L'!?RO_P "E_\
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M2_S/5/\ AIK3/^B-_ W_ ,)-/_BZ/^&FM,_Z(W\#?_"33_XNO*Z*/9Q#_5_
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M (NO*:*/9Q#_ %?P/\C_ / I?YGJW_#3NF_]$=^!_P#X2:__ !='_#3NF_\
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M_J_@?Y'_ .!2_P SU;_AI[3O^B._ _\ \)-?_BZ/^&GM._Z([\#_ /PDU_\
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MPO+1_P#HD?P9_P#"63_XNC_A>6C_ /1(_@S_ .$LG_Q=>>T4>SB']CX7L_\
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MZ/\ ]$D^#/\ X2R?_%UY[11R1#^Q\+V?_@4O\ST+_A>>C_\ 1)/@S_X2R?\
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M '?ZBM*LW2/^/EO]W^HK2KHI[%1"BBBM"@HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX!'P=13J<Q/#_$']I>VI5:3IU:,N64;J23Z6DM&OD@HHHK0^D"BBB@ HHHH
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M\:0IYU')X4N:[2<N:UFU?:SO;U/B.BGV]O)=SK'%&\DDAVJB+N9CZ 5JZO\
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MG&.,=>:F4E%7>QRX['4,'AYXK%24805VWLDNIYS17V9_PXX^+/\ T,/P[_\
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M_K[ L?\ E'_\)_\ L*:S_P"CUHENO7]&>;QQM@O^OW_N*J<'1116QY 4444
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M2B]$=/B!6CB<?A\GQE14</).;FTOB5[)-Z1MIKI\7R>A^VM=>*?"_@KP_P"
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MIGSW^SSH5OX6_;H33+52MKIVJ:G:P@G)")%<*OZ 5K?\%'_^2I:'_P!@H?\
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MB;=3V;=HM.ES6]WO[U^WGYGT=\6==\0? 7PYI/A_X:^"VOHO*+23+:O-%!C
M&=I!:1L$DL>PZYXFT+0[W]J'X-7FG>//#4FAZU"S1Q2/;M'L?:"D\6[)'/#+
MDYV\\'%._:'?XE7UMI>J_#74X+BPD@S/;QI;2&7/S+*C2J0P*G& >PP#DUS&
MA6'Q>L? E]KWC+XA0>$8;)3(83H]E>.4 SDE=H!)X"@DD^AXK!;7TO\ B?GN
M&H\^!IUXU*4*W-?F<JCK<U]G%1D]?)-=3XZU*PDTK4+BUF7;-;2-%(/1E.#^
MHJ31=&NO$6KVMA8P27-Y>2K##$@^:1V. !^--UC4I=9U>ZO)Y&FFNIGFDD*!
M2[,22<#@9)S@<"NR_9I\56'@KXZ^&]2U-HX[&"Y*R22?=BWHR!SZ!68'/;%=
MK;2N?O6*K5:.$G5C'FG&+=EU:5[?-GUY\%/"B_LZ?"&UT?QIXATMX;V7RX8)
MR%BA,OWH%+']X"22> !ENW-8/[6MQXC\.^$M#\&>#]&M[/1_$4BZ8UQ  JPE
MVP(-H&(U8$DN>HW#CDFA^V5^S=XE^-/B#2=7\/R6]Y#;6GV9K1YQ'M.\MYBD
M_*=P8 \@_(O7MZ3\!_#FN?#_ .&.F:7XRU.PO-0CE$5J=V2BXS'%N;_6.N#R
M!T&.<9/%=?'N^Q^!RQ%"E&GG4JL:M64G*5*UK2UL[+^7>[W/AGXL_!C7/@MJ
MMK9Z[';17%Y$9HUAF$GRYQDXZ<@_E7)U[7^W=X=\06/QIFU'5D#:=?1JFF2Q
MY,?E(.4]F#,21ZMGH:\4KLB[QN?N618R>+R^EB:DDY22;Y=K]NNVS\T%%%%4
M>L%%%% !1110 4444 %%%% !7;>'?^35OC)_V#K#_P!*Q7$UVWAW_DU;XR?]
M@ZP_]*Q45/A//S'X*?\ U\H_^G8'R31112/V [;]FC_DX[X?_P#8R:=_Z51U
M^OU?D#^S1_R<=\/_ /L9-._]*HZ_7ZO/QFZ/YA\>O]_PO^"7_I05_,#^SW_R
MF^\*_P#99X?_ $\U_3]7\P/[/?\ RF^\*_\ 99X?_3S7JY#M5]%^I_)_&'_+
MCU?Z']/U%%%?/'VQ:TC_ (^6_P!W^HK2K-TC_CY;_=_J*TJZ*>Q40HHHK0H*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** ,>Z_X^9/]X_SJ.I+K_CYD_WC_.HZXS,*_ '_ (.J_P#E(7X-_P"R
M=V7_ *<M3K]_J_ '_@ZK_P"4A?@W_LG=E_Z<M3KV,C_WKY,^9XL_Y%[]4?LQ
M_P $Y/\ E'I\!_\ LG?A_P#]-MO7LU>,_P#!.3_E'I\!_P#LG?A__P!-MO7L
MU>76_B2]6>]A?X$/1?D?D_\ \%UO^3NO#G_8H6W_ *6WM?%]?:'_  76_P"3
MNO#G_8H6W_I;>U\7U[F%_A1/]*O"?_DD,!_U[7YLU/!'_(Z:/_U^P_\ HQ:^
MCO\ @IG_ ,GT?$+_ *_(/_26&OG'P1_R.FC_ /7[#_Z,6OH[_@IG_P GT?$+
M_K\@_P#26&NO#_QOE^J.G-O^2DPW_7BM_P"G*!X31117HGLA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]=?\$5?^3QKC_L7KO_
M -&05\BU]=?\$5?^3QKC_L7KO_T9!7/C/X,O0^)\2/\ DE\=_P!>Y'J/_!7/
M]J;XA?!#]I'1-)\)^+-6T'3;CPU!=R6]JX5'E:ZNT+G(/)5$'_ 17;?\$@OV
MMO'G[0%YXNT/QAJ4VOP:+#;W5K?31J)H2[.IB9E W [=PW<C:W)' ])_;(\8
M?LV^'_B=8P_&*'2Y/$S:7&]L;G3+VZ?['YLP3#0QLH'F";@G/7L17G5[_P %
M,_V?/V9/A_>6/PLTE=2N),O%9Z=I<FGPSRXX::69%; Z9VN>, 8KR5[]%0C3
M=^]OU/YUHWS7A.CD^ R:I*O)12K>R48W4KN2J6UNM+MI:N[L>7?#OP7IOP__
M ."Z3:;I*PQV/VZ\NE2( )&\^C2SR* .!B21A@=,8P.E>P_M_P#[!'B;]L_]
MH_P_+I]Y:Z'H.D:$L5WJ5S&TG[QIYB(XT!&]L<GY@ ",GD _)W_!.WXA:E\6
M/^"G?AOQ-K$HFU37+O5+RY8#"[WT^Z.%'91T [  5ZI_P7/\?ZO#\1?!OAN.
M^N8='_LM]0>V20K'+,TS*&8#ABHC&,],G&,FMYQFL1",7KR[_>?79EEN:TN,
M\MP&%K*%>.#C%U''GLX^T4I*+:YF[:7=M;OL><_M;?\ !)CQ1^S/\.[OQ7I_
MB"S\6Z+IN&OMEH;2YMHR<>9Y9=PR@D X;(SG& 2/$_V9OV7/%G[5_C_^P/"M
MO"TD,8FO+NY?R[:QBR!O=@">IX506/.!P<?I=^S+KUY\3_\ @D@UQKUQ-JD]
MQX6UJTEDG<L\D<3W<* L3G(C11G.>!7R'_P2XT'XU^(+GQ);?"W4]%\.Z/+)
M =8U34K-)TWJ'\J- 49F8!G.T8 W9)&1G2GB:GLYJ35XNUSW,CXXSK^Q\TAC
MJU+ZQ@ZCIJK-<D'[W+=J*>NCY4HZMI6W.ZC_ .")5O;7$>GWWQBT&U\02@;-
M/&EAF<GIC=<*YS_N5\\?MA?L*^+OV-M4L?[;EL=4T?5F9+/4K,MY;NH!:-U8
M H^#G'((Z$X('T+K_P"R!\,?!GQTFU[XG?M$VFL>+#JBWU]::99*EVUR)0Q0
MF-Y"C$[0%"+M'   &/9/^"Y"@_LG^'6Q\P\6VX!_[<[VHIXFI[6,>:Z?E;[C
MS<GXZS>EGN P=3&/%4L3=2<J#HQ3LOX<G&+FDWNTU;U5OEWX-?\ !+>Y^,O[
M'G_"U+/Q?*EY)INHWT&A1:+YSSR6LD\:PK*)QS(81@^7QOQAL<P_&/\ X)4^
M(_@'^RQJWQ$\3^(["WU+2DMG;0[:U,_^NN(H=K7&]0K+YH)VHP)! /\ %7VI
M_P $YO%7_""_\$Q/#^N>5Y_]CZ?K%]Y><>9Y5[>/M_';BOR]^+?[4'Q ^.&I
M:C/XE\6:YJ$&J/NFLC>2+9 !]ZHL .Q55@"!C@@'KS6E&I6J59)/1/\ "^QZ
MG#&=\5YSGN-PU/$QCA\-B&G>$7)P4VO9QM'1<L7>3O+56>Y]'V?_  1UUOQ1
M^SAH'C;P[XL&L:SXBT[3;^WT1M*$"I]K\DN&N#.<+$DK.6\OD1G@9XZ>[_X(
M1^)(O"C3P_$#19M;"$_8SITBVQ;'3S]^[KQGRO\ "OHCX@>,]3^'_P#P2(TW
M5M'NYK#4;?P#I*17$3%9(O,@MHV*D<AMKG!'(/-?.?\ P0T\6ZI=?&3QMILN
MH7<MC<:2M]) \I9'G$Z+YI!_BP[ GJ<\UC]8KNG*HI?"^Q\M2XNXOKY-C\YI
M8V,8X6K**BZ4&Y*\5RMV22BG=-)R;;O*UK<W\"/^"+7CSXD:?->>+-8L_ T*
MS20QPO;&^NI-C%=^P.BJA(^4E\D<XP1GSO\ ;0_X)Q^*_P!CK2[/6+C4+3Q'
MX;O)A;?;[:)H6MI2"566,D[0P!PP8C((.#C.Y_P5I^(^N7W[<_B"R;4[Q+7P
MU%8Q::D<K(+0/:0S,5P>&+RN=PYZ>@K[(_;VO9/%7_!**ZU+4&:ZOIM(T.\>
M9^6:5[BSW/GU.]OS-:>WK1E"4GI+I;8]W_6SB;!XO*,?C,1"=''R@G25-14%
M/EM:5W*32DF[NUU:S1^>W[(W[$/C']L77+N+P^+2QTG365;[5+UBL$#,"0BA
M06=R!]T#CC) (-?2"_\ !$JWNIY-/M?C'H5QX@B!WZ>-+&Y".H.+DN,>NS\*
MJ?\ !,WPA\?/%OPBOK?P'XDT/P3X'^WRN^H7NG17,T]R519&B5D);:JH,L54
M8P"2#C<_9N_91^#_ ,&OVF/#>H7WQXM_&'C*'5D-M8Z7!_Q\W;DJ$DD5YMWS
MD[B2N1D'&:*V(FIR2E:W1*_W]C7BGB[-H9AC*6&S"--45[E.E1=>3:3?[V3@
MXPU[2T6^VOR1^U/^RAXI_9&^(":#XF2UF6[B-Q8WMJY:WO8@<97(!# \%2,C
M(Z@@GS*OT0_X+VJ WPI;'S'^UP3_ . -?G?79A:KJ4E.6Y^D>'O$&(SOA[#9
MGBTO:34KVT5XSE&]NE^6_P PHHHKH/LPHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ]6_87_Y/&^&G_8PVG_HP5QO[1__ "</X\_[
M&+4/_2F2NR_87_Y/&^&G_8PVG_HP5QO[1_\ R</X\_[&+4/_ $IDKR\9_%7I
M^I\YA_\ DI)_]>(_^G)G&Q?ZP5-4,7^L%35SGULCZ^_;(_Y GP1_[)5H7_H,
MU>*U[5^V1_R!/@C_ -DJT+_T&:O%:WH_ C\JX7_Y%M/UE_Z5(****U/?"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#V3_@GU_P G
MC>!O^ON7_P!)Y:^L?^"K?QQ\7?!G_A O^$6U[4-#_M+^T/M7V5POG[/LNS/'
M;>V/]XU\G?\ !/K_ )/&\#?]?<O_ *3RU]Y_MQ_MH7?[(?\ PB_V70+?7/\
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MVR/B=X7TK[%:>,-3-N%VC[0L=RZCT#R*S#\#7%>-/'VM?$;66U#7=4O=6O&
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M1116Q](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT?'?A;QSHNIW&K>$GM].OX+J18[JX+LJ2*Q !@ S@<9(KT[_ (*F?\F_:/\
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M 4444 %%%% !1110 4444 %%%% !73?M_P#_ ""?@]_V)%M_Z-EKF:Z;]O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBGV]N]W<1Q1J7DD8(JC^(G@"@-M6>B_\%4O^3]/'G_</_P#3
M=:U\]U] _P#!4RX2Y_;Q\>-&RNH:Q0D>JZ?; C\""/PKY^KAI_"B>"=.'< G
M_P ^:7_IN(5]@6/_ "C_ /A/_P!A36?_ $>M?']?8.F_OO\ @GW\*V7#+#JV
ML1R8/W&,P(!]R.?I1+=>OZ,\SCCX<%_U^_\ <54X*BBBMCR HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /T:_X)U?\ )K&C_P#7U=?^CFKRI_\
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MT]7N];ZN[L8G_!/?3IK[]K#PW)%&SQV<=W-,0/\ 5H;65 3_ ,"=1^(KM_\
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MA[-*I'[2?,[QNXV^REUZW1Q'_!,__F=O^W'_ -N:\._:/F=_C[XN8LVY=4F
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M?2^EEZ='Y)X$\*R^!?VH=#T6:199=+\3VUJTB_=DV72KN'UQG\:]S_X*5_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>^+.M? WXDZ3XJ\/W/V75-)F$L9/*2KT:-QW1U)4CT)Z=:F2;6AXO$^43S'
M2I4&E4BU.#>W-%W2?E+6+\FSUZBO9+WP=H/[8&@S>-?A?'##KC+Y^O\ A#S!
M]JL92?GEMQQYD+'D!>F<  G8OD.H:?<:3>RVMU!-:W$#%)(I4*/&PZ@J>0?8
MUI&2D?G^!S"&(O3DG"I'2<'\47V:[=I+22U3:(:***H] **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKCZAX)\3:CH4DQ!GBB826]SCIYD+@QOCL64D9.,9KV1O^"E%OXM42>,O@O\
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M/IA?VZ? ;?\ -O/PY_\  BY_QI?^&Y_ ?_1O/PY_\"+G_&OFB.G4<OF_O?\
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M]B_U'R?^2?\ X-J__)GTQ_PWMX/_ .B#?#__ ,"+C_&C_AO;P?\ ]$&^'_\
MX$7'^-?,]%'*O/[V'^H^3_R3_P#!M7_Y,^F/^&]O!_\ T0;X?_\ @3<?XT?\
M-[>#_P#H@W@#_P ";C_&OF>BJC!>?WL/]1\G_DG_ .#:O_R9],#]O;P>3_R0
M;P!_X$W'^-._X;S\'_\ 1!_ '_@3<?XU\RCK4E$H+S^]A_J/D_\ )/\ \&U?
M_DSZ6_X;S\'_ /1!_ '_ ($W'^-'_#>?@_\ Z(/X _\  FX_QKYIHJ>7U^]A
M_J/D_P#)/_P;5_\ DSZ6_P"&\_!__1!_ '_@3<?XT?\ #>?@_P#Z(/X _P#
MFX_QKYIHHY?7[V'^H^3_ ,D__!M7_P"3/I;_ (;S\'_]$'\ ?^!-Q_C1_P -
MY^#_ /H@_@#_ ,";C_&OFFBCE]?O8?ZCY/\ R3_\&U?_ ),^EU_;Q\'M_P T
M'\ ?^!%Q_C2_\-W^#_\ H@_@#_P(N/\ &OFF.G4<OK][(? ^4?R3_P#!M7_Y
M,^E/^&[_  ?_ -$'\ ?^!%Q_C1_PW?X/_P"B#^ /_ BX_P :^:Z*.7U^]A_J
M1E'\D_\ P;5_^3/I3_AN_P '_P#1!_ '_@1<?XT?\-W^#_\ H@_@#_P(N/\
M&OFNBCE]?O8?ZD91_)/_ ,&U?_DSZ4_X;O\ !_\ T0?P!_X$7'^-'_#=_@__
M *(/X _\"+C_ !KYKHHY?7[V'^I&4?R3_P#!M7_Y,^EA^W9X/(_Y(/X!_P#
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M+Z_>P_U'RC^2?_@VK_\ )GTHO[=/@]A_R0CP#_X$7'^-+_PW1X._Z(1X!_\
M BX_QKYL3I3J.7U^]DO@G*/Y)_\ @VK_ /)GTC_PW1X._P"B#^ ?_ BX_P :
M/^&Z/!W_ $0?P#_X$7'^-?-U%'+Z_>R?]2<H_DG_ .#:O_R9](_\-T>#O^B#
M^ ?_  (N/\:/^&Z/!W_1!_ /_@1<?XU\W44<OK][#_4G*/Y)_P#@VK_\F?2/
M_#='@[_H@_@'_P "+C_&C_ANCP=_T0?P#_X$7'^-?-U%'+Z_>P_U)RC^2?\
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M .B)^!__  )N/\:/^'@7AO\ Z(GX'_\  FX_QKYEHHY%_38?ZBY-_P ^Y?\
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M^#?_  )G_P :=_PWGH?_ $2#P;_X$3_XU\VU)1[-?TP_U)R?_GW+_P &5/\
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MQ_G4=277_'S)_O'^=1UQF85^ /\ P=5_\I"_!O\ V3NR_P#3EJ=?O]7X _\
M!U7_ ,I"_!O_ &3NR_\ 3EJ=>QD?^]?)GS/%G_(O?JC]F/\ @G)_RCT^ _\
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M"MXC_P#!;-_\31SQ[A_:&%_Y^1^]?YG.45T?_"GO%W_0K>(__!;-_P#$T?\
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M_H5_$7_@MF_^)HYX]P_M#"_\_(_>O\SG:*Z+_A47BS_H5_$7_@MF_P#B:/\
MA47BS_H5_$7_ (+9O_B:.>/</[0PO_/R/WK_ #.=IT==!_PJ+Q9_T*_B+_P6
MS?\ Q-.C^$7BS_H5_$7_ (+9O_B:.>/</[0PO_/R/WK_ #.?HKHO^%1>+/\
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M[A]>PW_/R/WK_,YVBNB_X5%XL_Z%?Q%_X+9O_B:/^%1>+/\ H5_$7_@MF_\
MB:.9=P^OX;_GY'[U_F<[171?\*B\6?\ 0K^(O_!;-_\ $T?\*B\6?]"OXB_\
M%LW_ ,31S+N'U_#?\_(_>O\ ,YVBNB_X5%XL_P"A7\1?^"V;_P")H_X5%XL_
MZ%?Q%_X+9O\ XFCF7</K^&_Y^1^]?YG.U(.E;W_"HO%G_0K^(O\ P6S?_$TX
M?"/Q9C_D6/$/_@NF_P#B:.9=R98_#?\ /R/WK_,Y^BNA_P"%2>*_^A8\0_\
M@NF_^)H_X5)XK_Z%CQ#_ ."Z;_XFCF7<GZ]AO^?D?O7^9SU%=#_PJ3Q7_P!"
MQXA_\%TW_P 31_PJ3Q7_ -"QXA_\%TW_ ,31S+N'U[#?\_(_>O\ ,YZBNA_X
M5)XK_P"A8\0_^"Z;_P")H_X5)XK_ .A8\0_^"Z;_ .)JXR7</KV&_P"?D?O7
M^9SPZU)6\/A)XKS_ ,BQXA_\%TW_ ,33O^%2^*O^A9\0?^"Z;_XFE*2[A]>P
MW_/R/WK_ #.?HKH/^%2^*O\ H6?$'_@NF_\ B:/^%2^*O^A9\0?^"Z;_ .)J
M>9!]>PW_ #\C]Z_S.?HKH/\ A4OBK_H6?$'_ (+IO_B:/^%2^*O^A9\0?^"Z
M;_XFCF0?7L-_S\C]Z_S.?HKH/^%2^*O^A9\0?^"Z;_XFC_A4OBK_ *%GQ!_X
M+IO_ (FCF0?7L-_S\C]Z_P S!CIU;R?";Q4/^99\0?\ @NF_^)IW_"IO%7_0
ML^(/_!=-_P#$T<R,WCL-?^)'[U_F<_170?\ "IO%7_0L^(/_  73?_$T?\*F
M\5?]"SX@_P#!=-_\31S(/KV&_P"?D?O7^9S]%=!_PJ;Q5_T+/B#_ ,%TW_Q-
M'_"IO%7_ $+/B#_P73?_ !-',@^O8;_GY'[U_F<_170?\*F\5?\ 0L^(/_!=
M-_\ $T?\*F\5?]"SX@_\%TW_ ,31S(/KV&_Y^1^]?YF&.E%= /A-XJQ_R+/B
M#_P73?\ Q-'_  J;Q5_T+/B#_P %TW_Q-',@^O8;_GY'[U_F<_170?\ "IO%
M7_0L^(/_  73?_$T?\*F\5?]"SX@_P#!=-_\31S(/KV&_P"?D?O7^9S]%=!_
MPJ;Q5_T+/B#_ ,%TW_Q-'_"IO%7_ $+/B#_P73?_ !-',@^O8;_GY'[U_F<_
M170?\*F\5?\ 0L^(/_!=-_\ $T?\*F\5?]"SX@_\%TW_ ,31S(/KV&_Y^1^]
M?YG/T5T'_"IO%7_0L^(/_!=-_P#$T?\ "IO%7_0L^(/_  73?_$T<R#Z]AO^
M?D?O7^9S]%=!_P *F\5?]"SX@_\ !=-_\31_PJ;Q5_T+/B#_ ,%TW_Q-',@^
MO8;_ )^1^]?YG/T5T'_"IO%7_0L^(/\ P73?_$T?\*F\5?\ 0L^(/_!=-_\
M$T<R#Z]AO^?D?O7^9@ITIU;R?"?Q4!_R+/B#_P %TW_Q-._X5/XJ/_,L^(/_
M  73?_$T<R,WCL-?^)'[U_F<_170?\*F\5?]"SX@_P#!=-_\31_PJ;Q5_P!"
MSX@_\%TW_P 31S(/KV&_Y^1^]?YG/T5T'_"IO%7_ $+/B#_P73?_ !-'_"IO
M%7_0L^(/_!=-_P#$T<R#Z]AO^?D?O7^9S]%=!_PJ;Q5_T+/B#_P73?\ Q-'_
M  J;Q5_T+/B#_P %TW_Q-',@^O8;_GY'[U_F<_170?\ "IO%7_0L^(/_  73
M?_$T?\*F\5?]"SX@_P#!=-_\31S(/KV&_P"?D?O7^9A)]VEK>7X3^*MO_(L^
M(/\ P73?_$T[_A5'BG_H6O$'_@NF_P#B:.9&?U[#?\_(_>O\SGZ*Z#_A5'BG
M_H6O$'_@NF_^)H_X51XI_P"A:\0?^"Z;_P")HYD'U[#?\_(_>O\ ,Y^BN@_X
M51XI_P"A:\0?^"Z;_P")H_X51XI_Z%KQ!_X+IO\ XFCF0?7L-_S\C]Z_S.?H
M'6N@_P"%4>*?^A:\0?\ @NF_^)H'PH\4Y_Y%KQ!_X+IO_B:.9!]>PW_/R/WK
M_,PZ*W_^%4^*/^A;U_\ \%\O_P 31_PJGQ1_T+>O_P#@OE_^)HYD'U[#?\_(
M_>O\S HK?_X53XH_Z%O7_P#P7R__ !-'_"J?%'_0MZ__ ."^7_XFCF0?7L-_
MS\C]Z_S,"BM__A5/BC_H6]?_ /!?+_\ $T?\*I\4?]"WK_\ X+Y?_B:.9!]>
MPW_/R/WK_,P*='6[_P *I\4?]"WK_P#X+Y?_ (FG)\*O% _YEO7_ /P7R_\
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M1^]&#16]_P *L\4?]"WKW_@OE_\ B:/^%6>*/^A;U[_P7R__ !-',@^O8?\
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M_B:/^%7^)O\ H7==_P# "7_XFCF0?7</_P _(_>C"HK=_P"%7^)O^A=UW_P
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M-7C/_!.3_E'I\!_^R=^'_P#TVV]>S5Y=;^)+U9[V%_@0]%^04445F= 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?S _L]_\IOO"O\ V6>'_P!/-?T_5_,#^SW_ ,IOO"O_
M &6>'_T\U]#D.U7T7ZGQ/&'_ "X]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/
M^/EO]W^HK2KHI[%1"BBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:S=[I*RLVW;Z@\7?\%:_B=KEW(=-M_#NB6^?D2*T,\BCCJTC$$_11UZ5B?\
M#T?XP_\ 0:TS_P %</\ \37SQ17[!3X/R2$>586'SBG^+NS^7*WBEQ=5FYRS
M&K=]IN*^Y62^2/H?_AZ/\8?^@UIG_@KA_P#B:/\ AZ/\8?\ H-:9_P""N'_X
MFOGBBM/]4\E_Z!:?_@"_R,O^(F<6?]#&M_X,E_F?0_\ P]'^,/\ T&M,_P#!
M7#_\31_P]'^,/_0:TS_P5P__ !-?/%%'^J>2_P#0+3_\ 7^0?\1,XL_Z&-;_
M ,&2_P SZ'_X>C_&'_H-:9_X*X?_ (FC_AZ/\8?^@UIG_@KA_P#B:^>**/\
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M"O\ (/\ B)W%O_0QK?\ @R7^9]#_ /#T;XP?]!C2_P#P60_X4?\ #T;XP?\
M08TO_P %D/\ A7SQ14RX4R;_ *!:?_@*_P @_P"(G<6_]#&M_P"#)?YGT/\
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M;_P9+_,^B/\ AZ/\8/\ H,:7_P""R'_"C_AZ/\7_ /H,:7_X+(?\*^=Z*/\
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M?.]%'^JN3?\ 0+3_ / 5_D'_ !$_BW_H8UO_  .7^9]$?\/2/B__ -!;2O\
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M6W^_U?\ P.7^9[Q_P\D^*_\ T&-/_P#!;#_\31_P\D^*_P#T&-/_ /!;#_\
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M_ 5_D'^O7$/_ $&U?_ Y?YGN:_\ !1#XI$?\ABQ_\%T/_P 32_\ #P_XI?\
M08L?_!=#_P#$UX:G2G5#X>RS_H'A_P" K_(T_P!>.(?^@VK_ .!R_P SW#_A
MX?\ %+_H,6/_ (+H?_B:/^'A_P 4O^@Q8_\ @NA_^)KP^BIEP_EG_0/#_P !
M7^14>..(?^@VK_X'+_,]P_X>'_%+_H,6/_@NA_\ B:/^'A_Q2_Z#%C_X+H?_
M (FO#Z*G_5_+/^@>'_@*_P A_P"O'$'_ $&U?_ Y?YGN'_#P_P"*7_08L?\
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M_P @_P!=N(/^@VK_ .!R_P SV[_AX9\4?^@Q8_\ @NA_^)IR_P#!0KXH$?\
M(8L?_!=#_P#$UX?3DZ4/A_+/^@>'_@*_R+CQMQ!?_?*O_@<O\SV[_AX3\4/^
M@Q8_^"Z'_P")H_X>$_%#_H,6/_@NA_\ B:\3HJ/[ RW_ )\0_P# 5_D:_P"N
MN?\ _095_P# Y?YGMG_#PGXH?]!BQ_\ !=#_ /$T?\/"?BA_T&+'_P %T/\
M\37B=%']@9;_ ,^(?^ K_(/]=<__ .@RK_X'+_,]L_X>$_%#_H,6/_@NA_\
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M]=,^_P"@RI_X'+_,]L_X>#?%#_H,6/\ X+X?_B:</^"@?Q//_,8LO_!?#_\
M$UXC4B]*G^P<M_Y\0_\  5_D5'C3/O\ H,J?^!R_S/:O^'@?Q/\ ^@Q9?^"^
M'_XFC_AX'\3_ /H,67_@OA_^)KQ6BC^P<M_Y\0_\!7^17^N>??\ 094_\#E_
MF>U?\/ _B?\ ]!BR_P#!?#_\31_P\#^)_P#T&++_ ,%\/_Q->*T4?V#EO_/B
M'_@*_P @_P!<\^_Z#*G_ ('+_,]J_P"'@?Q/_P"@Q9?^"^'_ .)H_P"'@?Q/
M_P"@Q9?^"^'_ .)KQ6BC^P<M_P"?$/\ P%?Y!_KGGW_094_\#E_F>UI_P4"^
M)Q/_ "&++_P7P_\ Q-._X> ?$[_H,67_ (+X?_B:\43K3JAY#EO_ #XA_P"
MK_(J/&>??]!E3_P.7^9[3_P\ ^)W_08LO_!?#_\ $T?\/ /B=_T&++_P7P__
M !->+44O[!RW_GQ#_P !7^17^N6??]!E3_P.7^9[3_P\ ^)W_08LO_!?#_\
M$T?\/ /B=_T&++_P7P__ !->+44?V#EO_/B'_@*_R*7&6>_]!E3_ ,#E_F>T
M_P##P#XG?]!BR_\ !?#_ /$T?\/ /B=_T&++_P %\/\ \37BU%']@Y;_ ,^(
M?^ K_(/]<L]_Z#*G_@<O\SVP?M_?$W'_ "%[+_P7P_\ Q-'_  W]\3?^@O9?
M^"^'_P")KQ=3\M%1_867?\^(?^ K_(/]<L]_Z#*G_@<O\SVC_AO[XF_]!>R_
M\%\/_P 31_PW]\3?^@O9?^"^'_XFO%Z*/["R[_GQ#_P%?Y!_KEGO_094_P#
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M_P  (?\ XFO&Z*/[#R__ )\0_P# 5_D:?ZW9W_T%U/\ P.7^9[)_PWK\2O\
MH+6?_@!#_P#$T?\ #>OQ*_Z"UG_X 0__ !->-T4?V'E__/B'_@*_R#_6[._^
M@NI_X'+_ #/9/^&]?B5_T%K/_P  (?\ XFC_ (;U^)7_ $%K/_P A_\ B:\;
MHH_L/+_^?$?_  %!_K=G?_074_\  Y?YGLG_  WK\2O^@M9_^ $/_P 33E_;
MT^)1/_(6L_\ P A_^)KQFE3[U']AY?\ \^8_^ H/];L[_P"@NI_X'+_,]F_X
M;R^)7_06L_\ P A_^)H_X;R^)7_06L__   A_P#B:\<HK/\ L7+_ /GS'_P%
M&G^MV=_]!=3_ ,#E_F>Q_P##>7Q*_P"@M9_^ $/_ ,31_P -Y?$K_H+6?_@!
M#_\ $UXY11_8N7_\^8_^ H/];L[_ .@NI_X'+_,]C_X;R^)7_06L_P#P A_^
M)H_X;R^)7_06L_\ P A_^)KQRBC^Q<O_ .?,?_ 4'^MV=_\ 074_\#E_F>S?
M\-W?$K_H+6?_ ( 0_P#Q-'_#=WQ*_P"@M9_^ $/_ ,37CM%']BY?_P ^8_\
M@*+_ -;,Z_Z"JG_@<O\ ,]B_X;N^)7_06L__   A_P#B:/\ AN[XE?\ 06L_
M_ "'_P")KQVBC^Q<O_Y\Q_\  4'^MF=?]!53_P #E_F>Q?\ #=WQ*_Z"UG_X
M 0__ !-'_#=WQ*_Z"UG_ . $/_Q->.T4?V+E_P#SYC_X"@_ULSK_ *"JG_@<
MO\SV+_AN[XE?]!:S_P# "'_XFC_AN_XD_P#06L__   A_P#B:\=HH>2Y?;^#
M'_P%#7%F=?\ 054_\#E_F>Q?\-W_ !)_Z"UG_P" $/\ \31_PW?\2?\ H+6?
M_@!#_P#$UX[14?V+@/\ GS'_ ,!17^MF=?\ 054_\#E_F>Q?\-W_ !)_Z"UG
M_P" $/\ \31_PW?\2?\ H+6?_@!#_P#$UX[11_8N _Y\Q_\  4'^MF=?]!53
M_P #E_F>Q?\ #=_Q)_Z"UG_X 0__ !-'_#=_Q)_Z"UG_ . $/_Q->.T4?V+@
M/^?,?_ 4'^MF=?\ 054_\#E_F>Q?\-W_ !)_Z"UG_P" $/\ \34O_#='Q(_Z
M"UI_X 0__$UXQ5@'(I2R7 ?\^8_^ HJ/%><_]!53_P #E_F>O_\ #='Q(_Z"
MUI_X 0__ !-'_#='Q(_Z"UI_X 0__$UY!14_V-@/^?,?_ 45_K5G/_054_\
M W_F>O\ _#='Q(_Z"UI_X 0__$T?\-T?$C_H+6G_ ( 0_P#Q->044?V-@/\
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M\Q_\!1?^M.<?]!53_P "?^9Z]_PW-\1_^@M:?^ $/_Q-'_#<WQ'_ .@M:?\
M@!#_ /$UY#11_8^!_P"?,?\ P%!_K3G'_054_P# G_F>O?\ #<WQ'_Z"UI_X
M 0__ !-'_#<WQ'_Z"UI_X 0__$UY#11_8^!_Y\Q_\!0?ZTYQ_P!!53_P)_YG
MKW_#<WQ'_P"@M:?^ $/_ ,33D_;E^(Q_YBUI_P" $/\ \37C].3K1_8^!_Y\
MQ_\  4'^M.<?]!53_P "?^9Z_P#\-R?$;_H+6G_@##_\31_PW)\1O^@M:?\
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M_P#Q->2T4?V3@O\ GU'[D'^M&;_]!-3_ ,"?^9ZU_P -N_$3_H+6O_@##_\
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MB@ HHHH *<A^:FTJ_>H ?1110 4445F 4444 %%%%!40HHHH*"BBB@ HHHH
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MI*-*7-%-V=K771VUM?M<^D_^"=/BN2+Q%XAT-FS%/;)?(O\ =9&",1]=Z_\
M?(KZMKXW_P"">?\ R6G5/^P)+_Z/MZ^R*_+^*(*.82:ZI/\  _H;PZK2GDD%
M+[+DEZ7O^H5_,#^SW_RF^\*_]EGA_P#3S7]/U?S _L]_\IOO"O\ V6>'_P!/
M-+(=JOHOU+XP_P"7'J_T/Z?J***^>/MBUI'_ !\M_N_U%:59ND?\?+?[O]16
ME713V*B%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7X _\
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M&U'XB2BBBH.H**** "BBB@!T1_>"IJ@3[X^M3UG4W.JAL%%%%9FP4444 %6
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M^"?W[/FB_#SX/'XE:Y9+>:I<PS7EJ3&)6LK:/=S&O_/1]I.1S@J!C)S5T?\
MX*/^*KCQW$M[\.;^W\-R3A'=(9WNX8B<;_N[6('.T >F>]*OQ'B)UZE+ 4E-
M4])-R2N^R[_UY7K ^'F!HX*ABL\Q3I2KJ\(Q@Y6B[6<FMMUII;OO;X;KI/\
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M5HQ6NCZR:6GW?YGEQX/R*>.CAJ>9P]G&#E.;5O>3MRP3:YF]U9O3OL?*^H?
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M[]OF(GW=BYQG[XZ<9Z/X,?M0>)?VD?VK?AO_ ,)$NFK_ &+<W7V?[) 8\^;
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MQJEGHNK76FV:EY[N&SDD@A4=2S@;5 [DGBLVTM)K^YCA@BDFFD.U$C4LSGT
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MRBG:3U<H-*T4WLGTL?-5?I5_P4A_Y-/UK_KZM/\ T>E?FK7TK^TC_P %#O\
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M_P %*[7P#\/]/\/^+M'U"_&E0K:PWMB4>22)1A%='91D+@9#<@=,Y)F\4?\
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M:=42W*CL%%%%(H**** "BBB@"0'(HH7I10 4445$MP"BBBD 4444 @HHHH-
MHHHH **** "IU/RCZ5!4T9R@J9%1'4445)04444 %%%% !11105$****"CZ^
M_: \7ZQ\+?V2OA^WA6ZN--MYHK59KJT?:P!MR^-P_OMDD]R/>OG?_AI/Q_\
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MYQ!C\WKQQ&8U.><8J*=HKW4VTK126[>NX4445W'C$E% Z45F= 4444 %%%%
M!3HZ;3DZT MQU%%%!H%%%% !2J?FI*!UJ);@24444C0**** "BBB@ IZ'Y:9
M3DZ4I;%1'4445!04444%1"BBB@H%/S5)48.#4E3( HHHJ0"BBB@ HHHH <G2
MG4U#Q3J3V-(A1114&@4444 % ZT4 XH DHHHH **** "BBB@ IR=*;3HZ4MB
MH[CJ***@H**** "BBB@ HHHH*B%%%%!04444 %%%% #DZ4ZFQTZHEN6M@HHH
MI#"BBB@!R=:=3$^]3Z"HA11104%%%% !1110 4445F:!1110 4444 %.A.'I
MM.B.'% $U%%%9F@4444 %%%% !11105$****"@HHHH **** %3[U/J-3\U25
M,BHA1114E!1110 4444 /3[M+34Z4Z@ HHHJ9 %%%%2 4444 %%%%!H%%%%
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MNZ29PB D#))P.3Q^=&VK'&+;LB.BN_B_9=\=S_&J;X=KH+'QE;J7DT[[9;Y
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M%%%% !1110 Y.M.IJ'YJ=42W*B%%%%(H****  =:DJ,'%24%1"BBB@H****
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M%&=H X  _"LJBBB,5%<L59(*E2=2;J5&VWJV]6WYL]X_X)Y_\EIU3_L"2_\
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MGQUH^F>'_&&HV.BZP-?TJUG:.UU$6KVOVQ!T?RVRR9]#7IW_  3\\4VO@_\
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M78W).**%6<H<ZI8B47"I3JI..'JM7=.<TG?HVF<)^W3\+K?X7?M(:TNGB/\
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M%;/MM)JS^V'\/?AC\1/VAO$5UXH^.4FA:E9W'V-=)/@Z]N4TN.,!5A1U8(0
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MVQ 'RLT5DT3?FR'/K7S;XO\ %U]X[\37NK:C,TUW?2M*Y)R%R>%'HH'  X
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M0A\B3594&(XXXN2D2]<'G([Y).QIGC;X=_&+]D?P?X/\2>,KKP7KO@&?49(
MVC3:A%JBW$AF4*8S\AW$+EB,8/!X-?.M%4\CI>SC",Y*49\_-=.3DTXMNZ:U
M3:M:R5K6LC*/'&*>)J5:M&G*G.DJ/LK25-4U*,U&/+.,U:<5*_.VW=R;NSW?
M]GCXN^";_P" WB+X7>/KO5-"TO5-3CUJPUFQM_M)M;E46,K+&/F9"JC@9[]#
M@UN_#7Q#\&/V5_B)HOB+2?$^K_$S6+.]B,<@T>32['3XBP$LQ20F2658R^P
MA=Q!/05\UT5-;(:=253]Y.,*CO**:Y6VDGKR\RNEJE))]B\%QWB</3P[>'I3
MJX=)4ZLHR<XI2<DK*:IOE;?*Y0<ET>B/L#P!^T?\.?@G^TS\5O&&G^(D\4:9
MXOTB[O+2WGTNXMEN+NXNO.:Q(*DX"Y'FMM4Y_/SR7X;_ +/OB/4/[7A^)7B;
MP[ILK>8_A^?P])=7L(.28TN58Q'' !8$X&3FO J*QI<.QI2=2C7J1DU%-IQU
M45973@U\TD]79G5B?$*KBJ4</B\%0J4XRG.,6JONRJ2YI-2553LW]ER<6DKI
MM7/6/VE?VBK?XH^+?#\/A6TNM"\*^![..P\/VTKAIX@A#&=R/^6KL%)Y/W1R
M3DGO?&GCCX3?M?2VOB+QAXDU#X9^.FA2'5YX=&?4M.U1D7:)T2(AT=@!D'@<
M#G&X_-5%=,LCH*%.-"4J<J=TI1:YK/65^924KO5W3UUW//CQOC9UL14QL(5X
M5W%SIS34+Q5H./)*$H<D?=CR25H^[JCWSQ]\:/!'PB^"NJ> /A?<:EK4GBAH
MSXA\1W]K]E:ZBC.4MX(OO(A.22W/)'S9R,C4?BOH$O[!%AX)2^W>)H_&K:P]
MIY$GR6OV-XM^_;LY=@-H8GOBO&J*=/):$8Q3<FU-3<FU>4DK:Z6M;2R22225
MB,1QIC:LYM0A&$J3HQA%-0A!M2:@N:]W*[<I.3;;;N]O9?CS\5] \9_LR?!G
MPYIM]]JUCPG;ZHNJP^1(@M6GGB>,;F4*V54GY20.]=/)\6/AS^U+X"T&Q^).
ML:EX+\9>&;1-,A\0VNG'4+74K1/]6)XD(D\Q 2,@\\G/.T?.=%9RR.BJ<80E
M*+C*4E)-<R<Y.4MTTT[M6::M:]VKEQXWQCQ-2M6IPG"I3ITYTY*7)*-*$80;
MM)24DHI\T91:;=K)M'T#XG^*OP_^!/P4\0>#_AOJFK>*-:\9+';ZQXAN[(V,
M*6B$DP00L2PWG.XMV/4\8^?J**ZL#@8892LW*4G>4I6NW9+6R2T2222278\G
M.\^K9E*GSPC3A3CRPA!-1C&[D[7<I-N3;<I2<FWJ]CZ:_9Z\>_#?7_V+=>^'
M/C/QN_@V_O\ Q/\ VM'*NCW.H;HE@MU&!$NWEHV'+ C'3FLN#X/?L[^'Y/M%
M]\8?$7B&%.3::;X8GM)I/8/,"HS7SS17G_V&XU*DZ6(J04Y.32Y+7=D[-P<E
MMW/?CQRIT*%'%8"A6E1@J<935;FY4VU=1K1@]9/['J>O?M,?M*V7Q8TC0_"G
MA/1?^$9\ >%0W]FZ>S;YYI6^_/.V3F1LGN<;FY))J?X]?%C0/&?[,GP9\.:9
M??:M8\)V^J+JL/D2(+5IYXGC&YE"ME5)^4D#O7C5%=5/)\/35)4[KV<G):WN
MW&46Y-W;;YFV[WN>9BN,,PQ+Q<J_+)XF$:<M+*,(3A.,8*-HQ2]G&*5FE&ZM
M?4^EO&WC+X2?M9VFEZ[XI\5:E\-_&MK8166ILNB2:C8:F\2X$R+$VY&8<'/3
M X.-QYWXX?&'P7H7P!TWX6_#^YUC6=+CU=M<U36-1A^SF[N/+\I4AAY*1A<$
MYP<@=>37A=%<]'(:5.4/WDG"#O&#:Y8OI;12=NB<FD>AC>/,5B*=9^PI1K5H
M\E2K%2]I-.W->\W33E;WG&$7+6[U9]':E\4/AK^U7X)\.P_$'7M4\"^-/#-A
M'I1UN'3&U*TU:W0_(98XR)!(HR,@X.XG)X5:?B'XK?#WX#_!/Q#X1^'>H:GX
MLU[QE&EKJ_B&[LC8PQ6JG)@@A8EQN/4MV/4X 'S[11'(:*M#GE[-/F4+KE33
MNNG-9/51<N7RMH54X^QD^:LZ%+ZQ*#@Z]I>T<7'D?V_9J3C[KFJ:FTV^:[N?
M0_P\^)OP[^+O[,^B?#GQ[KFJ>"[[PC?7%UI6L6VGM?V\L<[,[I+$F')#'@CL
M!SU%=7^SA\6_@Q^R#\8=)OM*US6?&DUT7MM0UV;3'LK;3;9D;F"W.9&D9]@)
M;.$# #)-?)M%9XCAVC6A4HNI-4ZCDW!-)7EJVGR\V[O;FM?I;0WR_P 1<7A*
MN'Q4,-1EB*"A&-649N?+3LHIKG5-VBE'FY.?EVDG9GT+\/?B)\-/#&B>,OA7
MK^L:AK7@75KZ+4-(\46.FM#<V=RL:@R-!(=VP@!".ORDX^8%=GX4^+/@]^R'
MXID\9:!XVUKXB>)[&WF31[.+19=*M89)8S'FX:1B6 #-POY>GS#155<@IU%*
M,JL^6?QQO&T]$FW[MUS)>]RN*?8SPOB!B*#I5886C[2C?V4VIN5)<SE%1_><
MLE!MN#JQJ26FKL>J?LP?M$P_!3QQK$FNZ=)KOAGQ98RZ9KM@A"O/#)R73H!(
MIR1TZD9&<CK;/X9?L\Z3K,>K3_$[Q-JVCQOYO]@)X<EAOY0,$1M<Y$7/(+ #
MVQUKY^HKHQ&4QG5=:E4E3<DE+E:UMM>\79I:7C9VZZ(\_ <75:.%AA,5AZ6(
MC3;E#VJFW!R=Y6<)PYHMZN,^:-[NVKO]#6?[<-O>?M6W7C34_#Z2>$[[3F\/
M2:-&0SPZ64"+&A) WC ;L,Y'&00V#X:?L\:;KT>L-\4?%%WI,<GF_P!AQ^'9
M8]0(!!"?:21%[;@!_6OGNBL?[!I0M]6G*E[JB^5K5+:_,I:J[U5GYG9'CS%U
M>;^TJ%+$MSE43J1E>,IVYK<DX>Z[+W)<T%;2*U/0/VH?CB_[1GQQUSQ<;5K&
M'4'1+:W9MS10QQK&@8]V*J"?<GMBO/Z**];#8>GAZ,:%)6C%))>25D?*9EF.
M(Q^+JX[%2YJE23E)]W)W>FRU>RT70****V.$*<AXIM.CI2V FMCB7ZBK%5K?
M_7+5FN>>YZ&%^ ****@Z HHHH **** +4)W1+3JCMSF(5)69W1^%!11104%%
M%% !3H3\]-IT9PXI2V*C\2)J***P.X**** "O:?$/Q=\/WW[!V@^"H;YF\2V
M?BI]2FM/(D 2W\F=0^_;L/+J,!B?:O%J*Y<5@X5W!SO[DE)6[I-:^6IZF6YM
M6P,:T:*3]K!TW>^B;3;5FM;Q6]UOH>Q?&SXGZ'XM_9Q^$?A_3[W[1JWA>'4Q
MJ</DR(+8S3QO&-S*%;*J3\I('>C]D;XGZ'\,-7\=2:Y>_88];\':AI-FWDR2
M>9<RF(QH=BDC.T\G '<BO)0<BBN-Y72>&EA+OEDV^E[RDY/IW>FFQZT>)L4L
MRIYHHQYX1A%*SY;0IJFKJ][\L4WKOM9:'K7[(_Q.T/X8:MXZ?7+W[#'KG@[4
M-)LV\F2027,IB,:'8I(SM/)X'<BLO]FKXXV_P5\5ZB-6TY]8\,^(["32]9L%
M;:\T#_Q(3QYBGD9QU(R,Y'G-%54RVC4=5SN_:))_+:UM4^M[[[&>%XDQF'CA
ME1LG0<G%VO?GMS*2=TT[6M;5-IW/=+7X=? ?2]4CU2;XC^)-3TN-_,.AIX?D
MBOI%&"(S<;A%SR"P ]L=:I:G^V3J:_M/0_$+3M-M[:SLD6PM])9LQ?V>J>7]
MG8X[IDYP0&.0.,5XQ16,<HIMMXB4JETX^];1/=)145K97;N_,[)\68B$8QP%
M*&'M.-3]VI7<XWY6W.4W:-W:*:CJ_=/>-5\%_ 7Q?J\FM6_COQ%X7L;AO.DT
M"307N;B(G):.*=6\L*.@W \8ZURO[1OQKL?BWKVDV>@V-QI?A/PK8)IFCVD[
M!IA&.6ED(_C<\GD]!WR3YC4D!^8U5'*XTZBJ3J2FXZ1YFM+Z:62N[:7E=VOK
MJR,9Q-4KT)X>C0IT54:<W!23G;5)\TI)*^O+!1C=)VT5O?OB_P"+_ 7QN^#?
MA*_D\67&B^*O!OAF#1!HLFDRS+J+P<*5G4[$# DY;/;@5SOQH^)NB>+/V<_A
M+X?T^\^T:KX8AU,:E#Y+H+<S3QO&-S*%;*J3\I('>O)Z*SHY33IN%I2:A)RB
MG;2ZDFM$FU[SW;=^MM#HQG%5?$JM>G"+K4XTYM<UY*$H24M9-*7N13LE&U_=
MN[GO3?$SP'^TAX*T.S^(&K:AX1\6>';5-.AUVVL#?6^H6J?<$\2D/YB@D9'7
MDYYP!?B9X#_9O\%:Y9_#_5M0\7>+/$5J^G3:[<V!L;?3[5_OB")B7\Q@ ,GI
MP<\8/@M%9_V+2^#GE[.]^2ZY=[]N:U]>7FMTM;0W_P!<<3?VWLJ?M^7E]M:7
MM+6Y;_%R<UM.?DY^O-?4]H^"/Q0\'ZS\$M7^&WCJZU#1]-N=336M,U>TMS<_
M8;D1B)@\8Y92G]W^\W3K7<?LY?$/X2?LN?%S3[ZS\37_ (LFO&>WN=9ETB6R
MM=*MRA)*0Y>621V"KG&%5FKY?HJ<5D=*LJD'.2A4OS135FVK7V;7>U[-[IZE
MY;QIB<'+#U8T:<JM"RA.2DY**=U%I246M6DW'F2^&2:37JGP$^,.@^"-8\5:
M-XHL[B_\)>,K<VEY):*/M-JRN6BN(]V.5))P>N>^,'L/ ^G?!?X,^--/\5Q^
M/M?\62Z/.E]9:3:Z')8RF:-MT:RS2-MVA@N=O49^E?/=2#I6F(RF%24I1G**
MDK22:M+2VMTVG;2\6F99?Q55H4Z<*E"G4=)MPE)2O"[YK+EE%27,VTIJ23;T
MU-GXB>-+CXC^/M:\074:0W&M7TU[)&GW8S(Y;:/89Q^%=O\ L9?$?1_A+^TK
MX;\0>(+HV.D:>;D7$XB>7R]]K-&ORH"Q^9U' /6O+Z*Z*^#IU<-+"O2,HN.G
M1-6T^1YN"S:OALPIYFK2J0FJFNSDI<VMK:-[V:^1[]XC^%/P5U[Q#?ZBWQKG
M7[9<27)B7PC>9&YBVT$GWQDT3?&_P#^S[X1U;3?A?'K&K>(]<MVLKKQ)JD:P
MFV@;[R6\0Y4M@?,P!''7 QX#17#_ &.I)0KU9SBK>Z^5+3:_+&-UY/3N>X^+
MI4Y2JX+"TJ-25_?BJCDK[\KJ5)J+=WJDFNC1ZQ^R]\3-$^'&E?$E-8O/LDFO
M^#[[2;!1"\GGW,H4(GRJ0N<'EL >M.^!7Q1\*I\.-=\!^.([ZWT/6+F/4+35
M+&$2W&EW2#;N*D_,C* "!SU]<CR6BMZV64JCG)MIR<7=/9QV:T_.]_30XL'Q
M+BL/&C",8N-)3C9IM2C4OS*6NJ=[*UFMT[JY]%?#+Q)\+?V6_$K>+-#\8:MX
M]\16<$JZ7:Q:/)IMM#))&T>Z=I&)8 ,W"_\ ZN1^ GQMTGPOHGB3PIXQM;R^
M\)^,%0W3VFW[3I]PC92YB!X)!/([@#J!M/DT'W_PJ6L'E-.2E[64I2E;WFTF
MN5WC;E22LW=66^]SMCQ7B82I?5:<*4*?/:$5)Q?.E&?-SRE*7-%*+O+1+2Q[
MMX7T+X*_"OQ#;^(IO&FL>.!I[BYM=$AT.2Q,DJG*+-+(Q4J#C.WKZ=CG_"C]
MJ./3?VB?$'BSQ5:37.G^,K>ZT_5([0CS;>"?;_JL]T"(!R"0#S7C-%+^R:<U
M)5Y2FY+ENVKI;Z<J26NM[7T5]BH\68BE*D\'2A1C3ES\L5)IRM:\N>4Y/2Z2
MO9)NR5V>T7/@+X)>&)/[3_X3[Q!XGMT)DCT2WT-[.XDQR(Y+ASL /0LJYQG'
M.*T?VF?CCX=^)EQX!\;Z#J4=KXHT&RM+&XT'^SY!#9&W>242+*3M9-S!0@YP
M,Y[5X-37Z4HY2G4C5J5)2<;[\NS5FK**5GWM?3<J7%4UAZF%P^'ITX3LWRJ=
M^:+O&2<IR=UK9-N*N_=OJ>_>/?\ A3GQ[\1W'BJ;QAJO@'4M2(GU#29-$DOX
MC-P',,D;  ,<L-W<]N@YGX]_&O1=7T+P9X6\$_VI'H/@1)GM;Z^PMU=W$L@D
M>7:/N*&'RCMGGM7DM%51RF%.4'*<I*'PIM66ENB3>C:]YO<G&<55J\*JA1IT
MYU;>TG!24IVDI:WDXQO)*3Y(QNTNFA]#>./%/PQ_:@U&/Q)K_B*_^'OBN:%$
MU15TE]1L;^1$V^;&(R&0L ,@\<=^6.#\4_BIX3\-?"!/A_X#.H7UC=7BZAK.
MLWL0ADU*5!B-$CR2D:]<'G(^I/CR?<'TI:FEE%.#BN>3A%WC%M65MNEW;HFV
MEIV1IB.*Z]:-27LJ<:M5-3J)2YY)_%O)P3E]IQC%N[N]6>XZ?XT^'OQR^&?A
MO1_&6KW_ (,\0^%;;^SX-5M].-]:WMJ#E%DC0APZ#C(X.2><X$7B7XB^"?A/
M\$/$'@OP7JFJ>*+_ ,72VYU35;FT-G;110/O1(8F);<6)R6['\O$Z*%E%/FM
MSRY.;FY;KEO?F[<UKZVYK>02XJKN#?LH>U<.1U+2YW%QY&OBY+N/NN7)S6ZW
MU"BBBO6/EPIT9IM.3K2EL"W'4445!H%%%%9F@4444 %2 Y%1U(O2@J(4444%
M!1110 4444 .0\TZFIUIU1+<VAL%%%%(H**** "BBB@"0=**%.5HH- HHHH
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MY;V\/F,K <91"H&.@;%?/=:OCCQG?_$3Q?J.N:I()M0U2=KB9@,+D]@.R@8
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M/&O@_P"(?P7TOP;XLU2^\-77AZ[FGT_4H+,W<+QS'<ZR1KAB0W0CMCGM6_\
M!CXA?#?]G;XEZ?>6&I:EXG>9GAN]5DL6M8;*%E8?NH22[.6VY)Z+D 9->!45
M-3+834H.4N65[K2UWOTOOK:]O(UP_$=:C.G6C3@ZE/E2FTV[1LDFN;ET2M?E
MYK=;ZGK?A/Q=X+T33/$?@75M0O-4\+WUU'>:=KMI9&.>VG50"YA<[MA'RD=>
M/?(U/ 6O?#O]GCQ#_P ))I'B?4_&6N6L,BZ=;QZ6]A;Q2.A3,S2,2P 9N%ZU
MXA0IPU$\OC)-.<K2W6EGI9WTTOUM8FCQ!.FX3C2AS0^"5I7AJVDO>L^5OW>=
M2:[G?_!'XM1?#/Q-?-J5FVJ:'KMI)8:I:*VUI8GZLO8.IY'3N,C.1T,'@KX1
MV%ZFH2>-M<O[!6WG25T9H[QU'(0S;O+YZ$C'X=:\GHIU,(I3<XR<6][6U^]/
M[U9F6'S:5.DJ-6G&HHMN/,GI?>UI1NF];2NK]-6>M6_[2\-U\=KCQ)?:.DGA
M^[M#I#Z6A!,5AL"!%/ W# ;MSD< \-3P3\([2_34&\<:]=6"OO.EIHK+>%>N
MSSBWEY[9 KR>BH^HQ7\*3CHEI;5+;=/[U9^9M_;M6=_K-.-7WG)<R>C=KVY7
M'1V6CO'LCJ_C=\3F^,/Q0U7Q"UO]E2^=1%"6W&.-$5%!/=MJ@D^I-<I11753
MIQIP5.&R5E\CR<3B*F(K2KU7>4FVWYMW84445H9Q"BBB@H**** "BBB@ HHH
MH ]X_P"">?\ R6G5/^P)+_Z/MZ^R*^-_^">?_):=4_[ DO\ Z/MZ^R*_+^*O
M]_?HC^AO#?\ Y$J_Q2"OY@?V>_\ E-]X5_[+/#_Z>:_I^K^8']GO_E-]X5_[
M+/#_ .GFHR':KZ+]3HXP_P"7'J_T/Z?J***^>/MBUI'_ !\M_N_U%:59ND?\
M?+?[O]16E713V*B%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&
M9A7X _\ !U7_ ,I"_!O_ &3NR_\ 3EJ=?O\ 5^ /_!U7_P I"_!O_9.[+_TY
M:G7L9'_O7R9\SQ9_R+WZH_9C_@G)_P H]/@/_P!D[\/_ /IMMZ]FKQG_ ()R
M?\H]/@/_ -D[\/\ _IMMZ]FKRZW\27JSWL+_  (>B_(_&G]J'_DYCXB?]C/J
M7_I5+7"UW7[4/_)S'Q$_[&?4O_2J6N%K^RLK_P!SI?X8_DC_ "JX@_Y&F)_Z
M^3_]*84445W'D!1110 445K> O!MU\1?'.B^'[%H4OM>OX-.MVF8K&LDTBQJ
M6(!(7+#) )QV-3.<81<Y:):LTHT9U:D:5-7E)I)=V]$C)HKZ*US_ ()QZIX9
MU:XT_4OBI\$]/OK5MDUM<^)7AFA;T96A!4^Q%8_BG]AV;PMX8U+4S\5O@OJ
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M16QRA1110 4444 %%%% !11142W ****0!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4Y.M-I4/S4GL!+'_K%^M6JIJ=IS5RL*AV
MX79A11169UA1110 4444 6+7_5_C4E0VA^]4U1+<[*?PH****1H%%%% !2I]
M\?6DHH L4445SGH!1110 445VFH_ O6-,^!%A\0Y)M/;0]1U5M(CB61_M2S!
M'?)7;MVXC;D,3G'%95:].GRJ;MS.R\WV.K#8*OB%-T8N7)%RE;I%-)M^5VOO
M.20_(/I2TV+_ %8IU,A;!1110,**** "G0G#TVG1?ZP4,<=R:BBBLS<****
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MW+VOTO:]ON*%%%%!B%%%% !1110 5(.E1U(I^6@J(4445#W-D%%%%( HHHH
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M_3EJ=>QD?^]?)GS/%G_(O?JC]F/^"<G_ "CT^ __ &3OP_\ ^FVWKV:O&?\
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M-S;MNS[V1G/05WG[2'[S]D+X"R-\TAMM90L>I47,6!GT'8=J7]O0XUOX7?\
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MR\R7N_#RVUMS>\?.?A_P1J7Q)^),.@Z/;FZU+5+QH+>($+EBQY)/  &22>
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M[WT!@9"T<R(F&=6P!@8()/I6M/I7P5\.3[&UCX@>*9%.7EM+6WT^"4^WFEW
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M@.WG%>._#+]FZZ^+_AKQ+>Z#J'VRXT._M;.V@-OY:WR3NZ^:79AY2JJ%SD'
MSR,5O6?_ "CTNO\ L?1_Z0)5KX!ZS=:#^R#\9[BSF:&5AI<#,O4I+.T;C\5=
MA]#6=/V]"E5E3J-R=5+51MK**;T2W3U_"SU.JM' XW$X:GB*"C!8>4WRN=_=
MISDDN:<EHXW6F_Q76A@W'P%TG3/B9X1\/:3X_P!/U?5M:U%;.[FTNVD:/26+
MQJCK(642Y+-]W;C9[UR7B+X;:HGQFU/PG9>=K>K0:M/IL;(N'O)$E9-^"3C<
M02<GCG)XS6A^S)_R<3X'_P"PY:?^CEKV3X-?N?VU_BM=6_.JV,>OSZ9Z_:1,
MP7'OM+]*[,1BJV%E)2ES\L+ZI*[YO)+3]//4\G 99A,SA2<(>R4ZRA:+D[1Y
M$W;F;O)ZN_=VT5DN,O?V9O"/A>\;2_$'Q7T'3/$49"26=OIMQ>6\,G='N%PJ
MD=#QP:X+XO?"'5O@MXM.DZL+>0R1+<VMU;/YEO>PM]V6-NZG!_(US$LK3RL[
MLSNY+,S')8GJ2:ZSQ9+XRUK1_"<>K1ZE/:FW^S^'P\/,D08 +%@;F&[  Y]J
MZJ=.O2G%U*O,G>Z:2UM?W;)?-.^FM]#R,1B,#B:$U0PSIRC9Q<7*6E[-5.:3
M5]59Q45?2VNG:3_LQ:#X'6"U\=?$+3?">NSPK,=+CTR?4)K;< 569H\+&V""
M1D\'O7&_&/X-:A\&]:LX;FZL]2T_5+<7FG:C9OOM[Z$]&4]B.X/3W!!/I'C[
MXD_#_P".?B)KWQYIWBCP?XR"I;ZA=6$:3VTTD:B/=)!)AT8!0,+TQCGK7+?M
M!_#[4_ ^@>%7C\3?\)5X-O()G\/W:*T:Q*''FQF-N8V#8R,G\P0.'!XC$>TA
M&O)J4KW32Y;VO[DDM?1MMK7H>SG&78#ZM6J8&G%PA;EG&<G-*Z7[V$G=7O:\
M812G9:IGF%%%%>\?"A3T^[3*<G2@J(ZBBBHEN:QV"BBBD,**** %7[U/J,=:
MDH **** "BBB@ HHHH >A^6EIJ=*=4/<T"BBBD 4444 %%%% !1110:!1110
M 4444 %.3I3:<AXI2V*B.HHHJ"@HHHH *<G6FTY#\U (=1110:!1110 4444
M %%%%3(J(45TGPO3PD_B&3_A,W\0)I7D-Y?]CB(W!FW+MSYOR[=N_/?./>N]
M\GX!_P#/;XL_E8?X5QUL5[.7+R2?HKH];"97[>G[3VL(^4I6?W6/'J*] ^)D
M?PM3PV/^$/D\>-J_G+D:N+7[/Y>#N_U8W;NF.W6O/ZUHU?:1YK->JLSEQF%^
MKU/9\\9><7=?>%>Y_MY_\CSX+_[%"Q_]&3UX97N?[>?_ "//@O\ [%"Q_P#1
MD]<.)_WVCZ3_ "1[67?\B?&>M+\Y'-_#C]F?4/B3\.+3Q!8:C;0B;5)=/N5N
ME\JWL(8X5E:YDFW<*,XQMSG&,DXK.\0?"&WF^(FE^&_"6NV_C&[U)50R6UNT
M$4<Q9@8P7/S*%4,7X&#[5V-MK%SIG[ #0P2M'%J'C,V]PH_Y:(+42 'VW1J?
MP%<I^SEX=U[Q#\3H?^$=U2/0[RQMIKJ;4G^[8VZH1)(>#_"V./[W;K6$:U:U
M6K*:2BY))K33:[M?[OQ.ZI@L%S87"4J+<JD82DTW?7=13:C=K5N6G:R5WT%Q
M\ /!>C7SZ;JGQ6T>VUF)_*DA@TJXN+6-^05-P,+P1C.*XGXE?"O4/A5X\?0=
M3>!Y/D>*XMV\R&XB?E)$/&5(^G0BNEN=.^$VA2A7U3QOXBD4G=):VT%C#)]#
M(7?!]US73_MGO;S>/_ ,EI;/9VTOA/3GBA=M[Q*9)MJLV!N(&!G'.*SHXBJJ
M\8-R:DG\44M5;;1/[[^IIC,OPL\%4K0A",J<H_!.4[J3:?,VY1OM9Q:ZZ$'C
MC]DG3?A5XPN[+Q7XZT_0]-5U6RN6T^6XN;]3&K-(MO&6*H&)3<S8+(V.E<C\
M6_@6_P .-!TO7=.UBQ\2>&M:9H[74;5&CQ(O6.2-N4;KP?0],5T?[>%Y+<_M
M1^(DDD9UMTM8X@3]Q?LL38'_  )F/U)IUNQ?]@F?<2VSQP N?X?]"7I^9_.H
MP];$*C1KU)WY^6ZLK:K=65[_ #MY(VS#!Y>\7C<#0H\OLN=QES2<KPEL[MQ<
M6KI:)K2[;O?"\#? >VU7P5:^)?%'B:Q\(Z#J$SP64LMO)=W%Z4.US'#'R54\
M$DCG\Z9\1O@3'X9\&Q^)O#_B"Q\6>&FN/LLEW!"]O-:2D9"RPORF>QR?U&=S
M1_B1H=[\+-"\)?$/P_KT-KI8EN=%U33\17"0SMN;Y)!MD0L,[@>0 !TS1XF^
M&T-I\&]:UCP+XONM9\+QSP+K>FW$#6MQ;L7_ '+NF2KKN_B!X/K@XOZQ6C5O
M4DU>5DK)Q:O9:I73:[M:Z6,GE^#GA6J%-2:I\S:DU54E&\KPDU%P3O\ #%OD
M]Z][E?2OV7)M2^'GAWQ3-KUCIFAZM!-->WE[$8XM/*2F-8UVEFF=\$A54'@_
M6G+^S=I?C#3+I_ _C;3_ !9J-C ;B73FL9;"ZD11EO*63_68]!@_C@'2^-5S
M=+^R/\(X5W?8I&U)Y/[OF"?"9]\,_P"M<;^S5>7EC^T!X-DL2ZSMJUO&=O7R
MV<+)^&PMGVS2A4Q,Z,Z_M/A<[*RM:,FM=+].C6GF:UJ.74L71P3H74XTN:7-
M+F3G"+;AKR[N]I*5W=:*R75?LD_\@[XH_P#8CZC_ "6N)^$WPAOOBSJ5XL%S
M9Z;IVE0?:M0U"\?9;V<73+'J23P%')^@)'L'P\M;6Q^+/Q^ALPJVL7A_7$B"
M?=51+P![#H/:N#^#O@ZZU/X6^)+_ %3Q,WAGP1)<06NH>7;FXEU&=3OCB1!@
MDKG=DD 9STSB5B&G5J1?*WR=+[I;);OLN_D:2R^,HX;#U(\ZC[:]FHI\LGJY
M-I1C=+F=]%>VMB_I'[.'A?QQ>#3?"_Q*TO6->D5O)LKC3)[%+EQGY$E?*DG'
M''.:Y;X+?!F;XM?%NW\)37;:/=3>>KR/!YIA>)'8J5W+W0CKQ[UZ!\"7^&>F
M_&WPS'I,/C75M0;4X$MI;IK>VMT<N!O9$#.0O7&X=.:V/@.HC_X*+:HJ@*JZ
MSK   Z<7%9U,97IPJI-Z0<DY))WUZ)+3;=&V'RC!8BKA9.$%S5E3DH2FXM.W
M5MM/?X96VV.'L_V?/#FD,MCXJ^(FD^'?$#!=^G+837@M6/\ !-*F$C8?Q#)V
MGK6'XF^"_P#PK7XN1^&O%6K0:39.!*=5@@>[A,+*2DJ(N&8$C&!T.?2N)O+R
M74;R:XGD:6:=S)(['+.Q.23]37L'[6[&2T^%[L2S-X'TXECU/#UVR]O"K&G*
MHWSI]%HTKW6GX.YX\?J5?"U:U.@HNDX->])\R;LU/WMWIK#DZV\NQ_:R\&>$
MSX2\'W!\:8O=-\(V46EVO]D3?\3B)=VR7?G$.[KM?)&.:^;J]@_:T_Y!WPO_
M .Q'T[^35X_4Y3!QPRO)O?>W=]DBN+*T)YC+E@HV4=N;7W5O=OTTMHN^IZ=^
MR3XNT_PS\5FM-4F:TM/$FGSZ*;H#FT:< +)[?, ,]@V>E=IHOP\N/V2O"WC:
M\\57%JNH:]IEQH.DZ;',)'OA(P!NBO:)=H(W<G)'!(SB^%KN+X!_L^:3XNTZ
MWMYO%?BZZN+>SOI4$G]D00ML<Q@Y E9OXCR >/>7PQJ7_#67A.+P[JUX&^(&
MD*3HU_<OSJ\&<O:RN3S(O+(QZX(XY)X,1>=257:E=*7?W6]5V2>C?;6RW/<R
M[DHX>GA7[V)Y7.FMDO:17NM_:DX^]%62NTFVW9>)45W'[1_AC1?!/QIUW1_#
MT;QZ7ILJVZ!Y3(V]47S,D\\2;A^%</7NT:JJ4XU%LTG]Y\/C,-+#UYX>;3<&
MTVMKIVT\CW+]M^'[3X_\$1EMOF>$[!<XSC,DU5?%_P"ROIGPQ\67MEXJ\;V6
MA6,<@2RF;3I;BYOUV@F001DE$W$J&9N2IQ5W]M?_ )*/X%_[%73_ /T;-69^
MW7>2W/[4'B))'9EMTM8XP?X%^S1-@?\  F8_C7@X&565.C1A+E3C)O17T<;6
MNGW/N<\IX6%;&8NM34Y1J4XI-R2]Z$V[\K3:]U;-.]M;73BU?]E*YT*XCU"Z
M\1:/%X,F@2YB\0X<P2AB0(UC +M-E3\@Z 9)%5?$W[/>G/X$U'Q!X1\86/BZ
MTT4(VHPK92V5Q;(QQO"2<LH/?CCGUQK?%F^E7]CSX3V^YO)EN-4D9<]66Y8+
M^09OSJ+]D\;]*^*"-\R_\(5?MM/3("X/U%:>VQ"H.O*?PR:M96:4N772]WY-
M+R.:6#R^6,C@84;*I!3YN:5XN5/G2CK9Q5TO>3;UU,?P-^SI<>.?A=#XICU:
MUL;--3DLKY[I-D%A$D:OYS2 DMDL%"!<EB,>VDG[,%MXTT:XN/ 7BNS\:7E@
M8Q=6*6,ME<('8+O02??4$C)XP,_C:>\EMOV"T2-V5;CQIY<@'\:_9"V#_P "
M53^%+^QA?2Z;KWCRXA9DE@\&:A*C ]&5H2#4U*V(5.I6C/X9-)65FKK?2_W-
M?,,-@LN>(P^#G1_B03E+FES)M-WCKR]+OF3\K%71?V=O"^J:A'H[?$[0H_$D
ML@@6T6PG>U,IXV?:<!#S@9 ()Z5R&D_"6^D^,UKX+U*3^S;Z;4TTV:0)YHA9
MG"[@,C<.<CD9%<WI3M'JELRDJRRJ00>0<BOH+XK(L?\ P4>M0JJH_MK2S@#N
M8;<FMZE2M1FX.?->$I:I:-6VLEIKUOMN<>'P^#QE&%:-%0M5IP:3D^:,U)ZW
M;U7+O&RUV1X7X[\+MX(\<:SHK3"Y;1[Z>R,P7;YOER,F[&3C.W.,G&:V?%GP
MI/A;X2>$_%)OO._X2E[M1:B';]F$$OEYW[CNW=>@Q[TSX]_\ET\:?]AZ^_\
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M_P EIU3_ + DO_H^WK[(K\OXJ_W]^B/Z&\-_^1*O\4@K^8']GO\ Y3?>%?\
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M(SM7@D#H,@T/@!^TK9> /!NK>"?&6AMXJ\ ZY*MU+9)/Y-SI]RHP+BW?LV
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M%% $T7^K%.ID'W/QI]8RW.ZG\*"BBBI*"O5]<^.^E:G^QMHWP[CM=076-/\
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M.VY_''Y5Y_\ '/XUZE\=O'#:QJ$<-G;P0I::?86XQ!IULG"0I[#DD]R2< 8
MXVBL\/EM*E4]K>4I)63DV[+K:_?J]WU9T9AQ'BL50>&Y84X2:E)0A&',ULY6
M6MKNR^%7ND%>J?L<?'+2_P!GGXTP^)-8M=0N[.*SG@,=FB-*6=<#AF48SUY_
M.O*Z<G6M\9A88FA*A5^&2L_1G!E.95LOQE/'8:W/3:DKJZNMM#TO]GGXQZ;\
M)--\>Q:A;WUQ)XH\+W>AVGV=%81S3 !6<LPP@QR1D^U>;445-/#PA4G5CO*U
M_DK(VQ&85JV'I8:?PT^;E_[>=W?YGM7Q9_:0T7QW^V3IOQ&L[/5(]'L]1TV]
MDMYD1;DK;>5O  <KD^6<989R,XH\ _M(:)X2_;;N/B5-::K)H<VIW]X($CC^
MUA+B*9%&TOLW R#(WXX/->*T5Q?V/AO9>QL[<GL]_L_Y^9[$N+<P>)^MMKG]
MLJ^W_+Q.]_3R/0O@/\=3\$?BG<:U_9ZZMI>IP3Z?J-C*WE_:[28C>F1G!X4]
MQD5U5SXR^!/AZ4ZIH_A7QUJVI*?,BTS6+VW73(GZJ&,?[V1 ?X21D<$\UXG1
M6E;+*52I[6\HMI)VDU=+:]O7??S,<)Q+BJ%!8?EA.*;E'GA&3BY6NXW3WLM'
M=75[7/HGQ?\ M9^%_B!\0/ACXTU*Q\11^*O"4EG!JZP1P?8KBW@D>0M"NX-Y
MC.YX)50./>O'OBQXNM_'_P 4_$VO6L<T-KK>JW5_#'* )$269Y%#8)&X!AG!
M(S7+U.AR@J<+EE##-.E?166NRO>R^969<28W,8N&*:=Y*3:5FY<JC=^;2U[O
M4])_:#^,.F_%K3O <>GV]];R>%_#%IHEU]H15$DT((9D*L<H<\9P?:CX??&'
M3?"/[.WQ"\(W%O?2:EXNET]K62-%\B(6\_F/O)8,"1P,*>>N*\WHH67T51C0
M^S%J2]5+F7XA+/L6\7/&MKGG&4'IIRR@Z;T[\K^_4](NOC#ILW[)UKX#6WOO
M[6B\3G6WF*+]G\G[,T(4'=NW[CG[H&.]'[-WQATWX/:CXNDU.WOIX_$/AB]T
M2#[*BL8YIC&59@S+\@V'.,GGH:\WHHEE]&5*=)[3;;]6[A3S[%PQ-+%Q:YJ4
M5&.FEDFE?OHQ^G3K::E!*^[9'*K-M&3@'/%>[>(/VQK*/]KWQ!X_TW2;B\\/
M>(K5--O=-OBL4MS:FWABD0E"P4EH@PY(X&:\";AJ*K$Y?1Q$N:JK^ZX_*33?
MS]U6?0G+L]QF!AR867+[\:FR?O04DM^EIRNGH[ZGMDGC'X&>'YCJ6C^%_'6J
MZDI\R/3=8O(%TR-^J@F/][(@/8D9'!/-0_M+?'K0_P!H/0/#&J26NL6_C33+
M&+3-0)6%=-FAC\QM\87YPY>0\'"@<>]>-PG#U-6%/*:4:D:SE)RCLW)O1]/3
MOWTOL=U;BC%5</4PBA3A3J6O&,(Q5T[J6FMUTULDVDE=GLWQ!^,O@7XM_"+0
M+?6K'Q9:>,_"NAQZ+8263P-IUPL7$;2[OW@XSD*.IZFL'XH?&/3_ !G\$OAK
MX:LH;^&_\&1WXNYI558Y&GF21/+(8DX"\DA>>E>;T55'*Z--QY;VC)R2OHFT
MT[>5I/0G%<28NNJBGRWJ0C"344G)1E&2;MUO".O9'N5]\>O /QOL+";XH:+X
MF'B.QA6VDUOP]/"LVI(@PAFCF&S>!@%AR?88%8WQ(^/NBP_#23P1\/\ 1KW0
M?#MY,MQJES?3B:_UAT^X)"H"JBGG:O!(!XY!\FHJ*>3X>$DU?EB[J-WRI^2V
MTZ+9=$C2MQ7CZL)*7+SS7+*:C%5)+9IRM?5:2>\E=2;NST:Z^,&FS?LH6W@-
M;>^_M:+Q.=;>8HOV?R?LS1!0=V[?N.?N@8[U#^RS\6=/^!WQXT'Q1JD%Y<V&
MEF?S8[55:9A);RQ#:&91P7!Y(X!KS^BMY9?1=&I0?PU.:_\ V]HSCCGF*CBJ
M&,37/0Y.733W'>-UUUW[EJ_G6ZOYI$W;9)&9<CG!.>:AI%/RTM=-K:'F2DY/
MF84445$MQQ"BBBD4%.3K3:5/O4 /HHHH- HHHH **** "I!TJ.GK]VID:4]Q
M:***DT"BBB@ HHHH <G6G4Q/O4^@J(4444%!6]\*O%<'@3XH>&]<NHYIK;1M
M4M;Z5(@/,=(I5=@N2!DA3C) S6#16=2FIP<);-6-:%:5&I&K#>+37JM3K_CS
MX_L_BG\9/$'B+3XKF&RU:[:>%+A0LJJ0!\P4D \=B:Y2HZDK.C2C2IQIQVBD
ME\C7%8JIB:\\15^*;<GZMW9ZC\&/C=H?ASX?:QX+\8Z/>ZOX7U:Z2_1K&817
M=A<J OFQ[OE.5 !!].X)%;OAWXV?#GX)>)K'5/ ?A[Q'?:C!<1N]_P"(IX6D
MMX0P\Q(8XAL#NNY=[9*ACCD\>(T5PU,KHU)2;O:6Z3:3TMJOSZ/J>UA^)L90
MITXP4>:GI&3A%RBKWLI-=&W9[KHT>R:A^TAI/@W]H75O%_A&PU*ZTGQ(D_\
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MKU5KK1Z'NNL_M3:#>? +Q9X#TOP[/H>F7YL_[(BC<3X:.X$L\US*Q#-(X6,
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M@ HHHH **** '1TZFIUIU1+<N.P4444AA1110 4444 %%%%!H%%%% !1110
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M45\\?;%K2/\ CY;_ '?ZBM*LW2/^/EO]W^HK2KHI[%1"BBBM"@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q
M[K_CYD_WC_.HZDNO^/F3_>/\ZCKC,PK\ ?\ @ZK_ .4A?@W_ +)W9?\ IRU.
MOW^K\ ?^#JO_ )2%^#?^R=V7_IRU.O8R/_>ODSYGBS_D7OU1^S'_  3D_P"4
M>GP'_P"R=^'_ /TVV]>S5XS_ ,$Y/^4>GP'_ .R=^'__ $VV]>S5Y=;^)+U9
M[V%_@0]%^1^-/[4/_)S'Q$_[&?4O_2J6N%KNOVH?^3F/B)_V,^I?^E4M<+7]
ME97_ +G2_P ,?R1_E5Q!_P C3$_]?)_^E,****[CR HHHH **** "BO;/AU^
MQ==ZM\/[7Q=XV\4:)\.?#.I FPGU0-)=ZB,9W0VZ_.RXYR2"1@@$$&MJW_8:
MT;XF6MPOPM^*/AWQ[JUK$TW]DS6<ND7UPJC+>4DQ.\CW('N*\6IQ#@(2<93T
M3LY<LG%/LYI<JMUN].I]EA^ <]K4XSA15Y+FC!SIJI)/5.-)R522:U5H.ZVN
M?/-%3ZGIMQHNI7%G>036MW:2M#/#*A22%U)#*P/(((((/0BH*]I--71\?*+B
M^62LT%%%%9DA11710_"G7[CX6S>-%T_/AFWU$:2]Z9HQBZ,8D\O9NWGY"#D+
MCGK6=2K"%N=I7=E?2[>R]6;T,+6K<RHP<N5.3LF[16[=MDNKV1SM%%%:& 4Y
M#S3:<A^:@3V'4444$!1110 U^E-7K70?#;X9:Y\8O&UCX;\-V)U+6M2+BVMA
M*D7F;$:1OF=E485&/)'2L.ZMI+&[DAD7;)"Y1P"#@@X/(X_*L_:P<W337,DG
M;K9WL[=G9V]'V.KZK65%8AP?(VXJ5GRMI)M)[-I23:W2:;W04445H<H4444
M%%%>A_ ;X"_\+OTOQQ<+JO\ 9C>#?#EUXAV&V\X7@@ )BSO79G/WL-CTK#$X
MFGAZ;JUG:*MKKU=EMYL[LMRW$X_$+"X2/-.5VE=+9.3U;2V3>_IJ>>4445N<
M(4444 %%%%3( HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH D7I4]J?D/UJNGW:GM/XOPK&>QMA_C1-1116)Z04444
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M2Z_X^9/]X_SJ.N,S"OP!_P"#JO\ Y2%^#?\ LG=E_P"G+4Z_?ZOP!_X.J_\
ME(7X-_[)W9?^G+4Z]C(_]Z^3/F>+/^1>_5'[,?\ !.3_ )1Z? ?_ +)WX?\
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M@9'!YV]#_P %0+Z:[_;;\81RRO(EJEC%"&_Y9H;*!]H]MSL?Q-7?B9!)J?\
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M7>UWU[V/2R_(,OE*A5KQC%0PLZK4^?EE-8BI37/[-.;25FU%:\MG979QVC?
M[X:_');C3OASKWBJT\4PPO-:Z7XD@@']K;$W,D4D)VJ_!(#9SCTR1B_LK?LZ
MVW[06M^+M*N[BZL=0T?0I[^Q_>K#']J1E55F+*<1Y;YL8(QUKNO@M\:_ =S\
M5-#7P9\")&\4"Z#:<(_&=T3Y@!/_ "T39C .=W&,YH_9PU:;4?&W[0-\UJNE
MSW'A'7)S;13"46C&3=L5UX;:> PX.,BL*V*QE*E6@N:-E%QYW!R3<K/X9.\7
MY];J_;MP6691B<5A*LE3J7E4C-4HUHTY*-/F6M2$4II[J-].5VO>_/:!\//@
M7>ZU!X=N/%WCB35)I5MAK45C;II'F'C=L8F;9N[G''/ YK@/B/\  S6_AY\;
M+SP)Y)U#6(;Q+.W6!<?;#)M,14'IO5E.#TSUXKBZ^T/'-Y9V/_!7'37OMODM
M-;1KN/\ RU:P"Q?^1"E=F(K5L#5=IN:=.<K2MO#EM:R5K\VJVVL>1EV#P>=X
M:*E1A1DJ]&GS0NO<J^T3OS-W<>1--ZZN]SR?Q!\&OA'\%-0_L/QQXE\7ZMXG
MA4+?1>&K>W^RZ;,0,QL\W,A7OMQZ8!XKE/CM\ +?X<Z9H/B#PWJW_"2^$?%2
MM_9UYY/ESI*AP\$L?.)%/''7!X&*Y'XJZ=J&D?$WQ#;:HLBZE#J5PMSO4JQD
M\QMQY]3S^-=G\+_"FM^'4^'OB;6YG7P/=>)X$AAEN_W;&.93,XCSA0 &!?'6
MMHQJT(PQ$J[DWNG:TO=;M%)*SZK?2][[G+.IA<;5K8"&"5-1?NRCS<U-*<8M
MU&VU)6=I72]YIJRT?2:W\!_AS\"K>VL?B5KWBBY\4W$*SSZ3X;A@8Z6'7<BS
M23':6Q@D+R,CM@GG?B[\"])\.^![+QEX+UJ;Q%X/O[DV3O<0>3>:7<A=WDSJ
M.,E>0PP#^1/JW[4?Q-^'/A+X_P#BBQ\2?!N36-8CO"\U^_BR\M_MBL R2"-5
MVJ"A7 ' Z5S_ (@^*.E^(?V6/%EMX0^%)\+^&[O4;-+S4G\2O>K%<HX= L<R
MAV8ID'8< -DUYF%Q>-<:.(:G[[C=R=-0:E;9*7,K7]VRN]G=L^BS3*\GA4Q>
M @Z7[I3Y%".(=92IW^-NFH.]K3;:A&]XM)'.^#/@CX1\,?"C1O&?Q$U?7K:Q
M\3331Z3INAV\<EY<I"X261GE(1 &( !R2"#SG%1_$?X'>%[_ .$]QXZ^'^L:
MM?Z+IMVEGJ>GZO"D=]IS2?ZMRT?R.C$@9 '/KR!J:1\5=0^&GPK\/^%?B)X'
MLO$WA.]A.J:&9+HV]U;Q2L2S0S1DD L22K#.>#Q@4>*/AGX-^('P/\1>+OA]
M=>(=(_X1N2V_MK0]3F69&29RD<D4BXW88'A@3P>G&[55Z\:RJ59R2<[)KEE3
M<7*RC9:I[*[^UUMH<\L#@:F$=##4H.4:/-*$N>%>,U#FE-.7N3BFG)13UI_9
M4M3P^BBBOJ#\S&R4VG24V@ !P:L57JP#D4%1"BBB@H**** "BBB@!T=.IJ'F
MG5$MRX[!11142+B%%%%24%%%% $E% Z44&@4444 %%%% !3HZ;3DZTI;%1W'
M4445!L%%%% !1110 5)4=2#I05$**];\,?%KX4Z7X<L+;4OA')JFH6]O''=7
MG_"474/VJ4* \FQ1A=S9.T<#.*O?\+I^#O\ T163_P *Z\_PKS98ZLG98>;^
M=/\ ^3/HH9+A914GCJ2\FJUUY:46ON;/%J]E_P""?G_)W?A'_M\_](IZ\L\7
M:CI^K^)[ZZTG33H^FSS,]M9&X:X^RH>B>8W+8]3S7J?_  3\_P"3N_"/_;Y_
MZ13U.<2;RVNVK>Y+3_MUFG"L5'/\'%--*M3U5[/WUJKI.S\TGW1YE\1/^2@:
M[_V$+C_T8U>X?L7:/>>$O!GQ)\4:M!-;^%6\+W-BTDP*1WD\A7RT0GAC@,O&
M<&0#O5'QA^WO\5=&\6ZI9V_B6..WM;R6&)?[,M#M57( _P!7Z"O/OB?^T=XV
M^--M'#XE\07>H6T3[UMPB0PANQ*1JJDCU()Z^M<-2CC,505"I&,8NUVI.3LK
M/1<D=?GIYGKX?&91EN.EC:-2I4J1<N6+IQA'F=UK)5)MI7V4==M"]<_"33HO
MV6+?QRL][_:DGB4Z*T)9?L_E?9C*& V[MV1C[Q&.U1?LP_"NP^-GQRT/PQJD
M]Y;V.IF?S9+5E691'!)*-I96')0#D'@FNNN?WG_!/&WV_-Y?CT[L?P_Z"W7\
MQ^8I/^">FF7%_P#M8>'9H8]Z6,5W-,?[B&VECS_WTZC\:57%5(X+%5.;6//9
M]K+0K#99AYYQEN'Y$XU%1<EWNUS7]5>Y/^R-"MM!\8(UW;8_ NJ*,GG VUB_
M ?\ 9[T_XP?"_P 8:S=:H^DS^&IK1C<2./LL-NY<S.Z;2[LJI\JJPR<#OQN?
MLF_\UC_[$?5?_9:A^"LK0_L9_&=D9E;S-'7(..#=8(_$$BL,14J1J5G2E9N5
M)7]7%/\ !G?E^'P]2CA5B8<\(T\5*VU^6,Y+5;:I$W@[X'_#7XV7=QX?\$Z[
MXMC\6K;R36?]L6UO'9ZFZ*6,:;"6CRH)RQX';BJ!^'?PD\":I)H7BKQ%XPO-
M=M7,%Y<Z+:P'3[.4'#)F0F20(<@LH&2.*3_@G_\ \G<^$O\ M\_](IZ\EUV=
MKG6[R21BTDD[LQ/<ECFNB-&L\5/#>UERJ,9=+W;DM[;>[>W=]M#SZN-PL<LI
M9@L+3]I*I.#TER\L(PE\/-\3Y[7[+OJ=M\7_ (!WWPV^+\/A;3YO[>_M002Z
M3- FTW\4_P#JB%SP2>#SC(]*['7OA)\+/@[?-HOC+Q#XLU;Q)"NV]B\.V\'V
M;3Y<#,;/,<R%>^W'X'BO3GN[2R_:[^ ;WNWR6\&Z=&N3_P M&CNEC_\ (A6O
MF#XEZ??:5\1=>M]35UU"'4)UN=X()D\QMQY]3S^-883$5L6X4YS<;03;5DY.
M[7;1*UW;JUT.S-L#@\KC5Q-&BI\U5PBI7<814(SVNKM\UDY7TB^KN=9\8_@9
M:^#O"^F^*O#&K-XB\':M(;>.[>'R9[.X R8)D[-CD$<'!X'&>J@_9M\):9\#
M?!OCK7/$&I:9I^KQW0U"&)$N+B>9)=D,5JF%QN59&9G8A=H]0*B\!1/8?L+>
M/9KY66UO];L(M,W# :X4AI2OK^[&./0TGQZD8?LF?!-=S;6CU@D9X)%S'C^9
M_.H=;$2E##JH]*CBY:7:4'+M:_2]MU>QHL'@:5.KCG034L/&HH-NT9NM&GIK
MS<K^))OX96OU&W7P0\"_$WX?>(-8^'>K>)O[0\+VWVZ\TO7881+/;#[\D;0_
M+\O)P<GMQD$\G\#_ (,0_$V/6M5U?5!H?A?PQ EQJ=]Y1ED&]ML<4:#J[L"!
MGCCOP#UG[%'_ "%/B5_V(6J?SAK-^#_P[TE?@WKGC'Q5J&NIX9M]0BTQ=,TN
M0))J=SM$@#EOE554@Y()ZXYQG25>I1]K1]H]'%1=DY>]NEW>]F]KZZ(SHX/#
MXOZKC%0BN:-1SBFXP_=WM)ZMI:KF47=VM&S9L>$?AA\(?BSK]OX=\/Z]XXTG
M7;XF&RGUBVMGL[B;G8I$1WKNX&3W/X5R_P !O@A#\1/CV/!>N->6[1_;(9OL
MCJ)%F@BD; +*P(WI@\<CTKO/V=_B%X+N_CUX6L_#GPW6&ZGU*%([R]UB>[FM
MUW9>4(-D>Y5RW(.,9K8^  S_ ,%+]8[?\3S6^1V_X^:Y:V*KT8UX7DK4W)<S
MBVGKJK7T]>QZ6%RW XJI@JK5.7-75.7LU-1<7RNS4TM5=ZI;/5MGFWQ ^%W@
MKX6^#[K3[[Q#J6J>/X50/9V$*_V?I\N]=\4LK<NRIN!V8PXQV.:GQY^$FF_#
M_3_"NM:!<7EWX?\ %6EK=PO=.KR13J=L\1*JH^1L=N^.U>>SW<E]<RS3.TDT
MSEW=CDLQ.23]37L_PY8_%[]E?Q/X7;]YJO@B8>(M,'\36Q^6Z0?[*@[\=R17
MH5E5PW)5G-R7-[U[6M+31=$G;Y7NSYW"RPN8RK8:E1C!\EZ=KWO"\FFVW=RA
MS)[)R4;);'+?#[X4Z;K/P7\8^+]8N+RWAT4P66EI RJ+R\E/W6W*<JB?,0,'
M!ZUK?LX1?\('H?BCXB3;5;PS:?8]*W?QZC<@QQD>OEIYCD>PJY^T*W_"N?A1
MX%\ 1CR[FWM3K^KKQG[5<C*(W^U'%@?1A57X_ ?#?P#X3^'\>([JP@_MK6U&
M,_;KE051O>.'8O\ P*N?VD\1'D;TJR=O*$='\I6_\G1W?5Z67U?:J-I8:FKO
MJZT[N*]87V_Z=/N=%^S$6F_9G^.1.YF:QT_W).^XKPD6<S' AD_[Y-?0_P"Q
MCXOU'P#\"?C)K&DW'V/4M/M-/EMYMBOY;;KCG:P*GZ$$5RS?M]?%IAC_ (2S
MKZ:99_\ QJIH2Q*Q>(5",6N:.\FOL1[1E^96-IY=/*LO>-JSB^2=N6$9JWMJ
MF[=2%GY6?J;=II]U\,/V$]>M-?ADL;CQAK,#Z1:7"E)F6(HTDX4\A2$VY(YX
M]0:Y;P%\$-!T[X=6WC'Q[K%]I.CZE(\6EV.GPK+?ZF4.'==Y"HBGC+<$^G&>
MK^+>N+^T1^S%#X^U.&&/Q=X?U==(O[B%=B7\#H&1R@.U6!8#( Z-ZC'2?%+Q
MQX+\.?!SX57&N_#]O%UK<>'DAM[H:[<6*031G$\>V,%2V\Y)//..U<D,16C'
MEBGSSJ2YE'ENFH[1<FEJDG=ZVN[)[>Q6P.#J3]K.4?94:$'3<^>S4IVYIJ$7
M*ZE*2Y4FD^5-M:OS[4?@MX/^(WA+5M4^'.L:Y/>Z# UY=Z+K4$:WDELI^:6)
MXCL;:,$KC//T!P?@G\'+/X@:5X@U_7=4DT?POX5BBDU">&'SKB1I7*11QKTR
MS#&2<#CUKU'X(_&+PL_C":3P1\%RNL0V%P\K'Q;,T:6^PB4N)EV;=I[]\8YQ
M7GGP3\;>(_A1X*UO6H]#LM=\$ZM-'I>KVUYAH)I "\8(!WJP#$AL8Y]<8Z/;
M8KV=2FKIIQY>9PYM7JM&U>R?*WU?6QY\L)ECKX?$R491:J<_LXU?9WBERR:E
M&,K)M>T4'HE?1RL;FC?!CX>_&BVOK+X?ZMXLM_$EC:/=Q6.O00;=2"#+K$\)
MPC8R0&SG'U(S?@-^SQ9_&;X:^+M4DU+^R[KP[+:-]HFE5;2&W<N9I)!M+,51
M"5"D9/'.:Z+X=^%?AU^T+X@_L;PU8^(/ 7BZ[BE>P OOMEA,ZQL[1EF D7*J
M<'/ ]>AB^!&FWUS^R7\:(;17^T1#37D"]1&DSM+^ 16)]@:QJ8BK"G*$9RC)
M2I_$E=*4DF[K1IZ]^OD=>&R_"U<12JU*,)P<*]W3<N6;A3<DN5I2A..E]%=.
M+2O=O*T[PG\%=7NTTI?$WCBSO)'\I=7NK&W&G9X 8QAO-5<YZG@=<5P_Q)^%
MFH?"?XE77AO5MK3VLR+YL1_=SQM@K(A(Z,I!'''0\@UR]>X?M?JUKXQ^'5G=
M?\A>Q\):9!J(/WDF!<E6_P!H @\CH17H>_0Q$*?.Y*2EO;1JVJLEZ-;;6L>#
M^XQV!JU_8QIRIRA9QNDU)M<K3;N]+I[V4KWZ6)?V6M#7]LN^^'"7>L/I,,+2
M13"2/[46^PBX )V;3\YQPHX]^:YCQ]\,/!?PO\(75A?>(-2U3Q]$$#6=A"O]
MGZ?+O7?%+(W+LJ;@=F,/QV.?>+49_P""KMWV_=#D=O\ B5+7QY/=R7US+-,[
M233.7=V.2S$Y)/U-<66U*^(E#GJ.RITY/;5OFO?R=M;;GL<04<%@*594J$7)
MU\1!-W]V,>2UDFM5S>ZW=+71NUO7+#X,>#?AUX-T/5OB%K&O1WGB.V6_L])T
M2"-KA+5CA99'E.P;L$@#T^H%7QW\'/"^I?"JY\9>!=6U:\T_2[J.UU.PU:%$
MN[,R<1ONC^1E)XX_Q Z#XF>%O!?P)U*UT;Q9:^)/&WBJWL86N$.H_8[*Q#+N
M6%&VM(P4'V'/&.<;VA^)]+\3?L6_%)M&\)V?AFP@GTQ-T5S-<O=R?:HRV]Y"
M?NC;P  -Y]:S^M5DH5XN34I15_=46I22T7Q;/1VOUO8Z?[,PC=;!5(4XRA2F
M^5<\JJG"#E>4DN2_,O>5[).R5RU^S_\ \*Y_X9;^(7G?\)MY?V?2_P#A(]GV
M7=O\]]GV3/;=NSYG.,8YS7EW@3X*Z7\5_&&O7>EZA?:'X!T%?M-WJFJHKW%M
M">%5EC^5Y68$!5]/7@[GP)_Y-5^-7_7+1_\ TIDI_@N)]1_88\80V*LUU9^(
M[6YU$*,G[*8PL>?82 G)XXH]^C4KN$G>52,;O6W-&&MN^ME\A?NL7A\%&O2B
MXPH5*EDK.7).K:-T[\KM>5M=VFF1Z;X'^#'C+4(]'TSQ+XVT?4IV\J'4-6M+
M=M/D<G"Y6,^8BGU;IG)Q7+:+\$;K2_VA]-\"^)8Y[.6;58+"Z-NXW;)'4!XV
M8$8*L&4D="..U<)%$T\JHBL[N0JJHR6)Z "OISXH?N?VU_A;:S\ZI8VVB0:G
MZ_:0X+9]]I3K75B)5<-)PC-R4HR>MKIQ2U3MMKKYVL>9@*>&S&FJ\Z,8.%6E
M'W;J,HS;3BTV]5:Z:W5[WT9Q'Q!^!G@?X-?VU9^)/$6K2^(%-Q_9FE:?$CM;
MK\WV9KJ1AM&\;&95 (4Y[\<]XZ^$^FZ;\#_"GC+1;B\N(]2EET_5HYW5OLEX
MG("[5&%=,L <D#'/-9O[1ES)=?M >-FED:1EUV]0,QYVK.ZJ/P  _"NU_9CE
M_P"%C>#?&/PWFPTFO69U+2 3]V_MQO"K_P!=$!!/HM3*5:EAX8F<W+9RVM9J
MSLK;*]^^FY48X/%YA6RVE1C!-2C3:OS<Z=XW;;NY6Y-$DN;1:',? OX6:?\
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M/%7_  CX*UK]HSXF:I) UK!/=//JVHW=P_EV]G&6+R2.>2%!;MD\CW-5OCO
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M"%5_:2?WJY\UFN$CA<;6PL7=0G**_P"W6U^@4445T'#$****"@HHHH ****
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M5^ /_!U7_P I"_!O_9.[+_TY:G7[_5^ /_!U7_RD+\&_]D[LO_3EJ=>QD?\
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MM.<FGNKV3LDE]":G^V'X#\;ZDVM>*_@CX;UCQ5(1)-?VNL7.GVUS(#DR26R
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MPNOVM?#_ (^2"Z\?_#/1?%WB"WB6/^U8M0FTR6Z*X"M.L7RR-@8/0>P%</\
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MX_%:^KZ;>C7=6-,)G6,PZIJE.W)S6T35I?$FFO>3ZJ5T>Q0_M2:9X&U&WN/
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MOM:O(K.'Y20K.P7<<?PC.2>P!-:8;'T:^'^LP?N:ZO3X6T_R9AF.0XS!8_\
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M^G+4Z]C(_P#>ODSYGBS_ )%[]4?LQ_P3D_Y1Z? ?_LG?A_\ ]-MO7LU>,_\
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M=)]U7FMFAC/_ 'W(O/:N=^,'[6.H?"KXHZ]X=U3X+_ W[=I-]+;R-/X2S),
MWRR$^;SO4AL]PP/>N6C4Q-7ZMA(1DX*A"5HS=-MO1MM--J-EHG;WM;Z'J8[#
MY?A7F.:5I0C5EC:U/FJ45748Q]Y)1DG&+FW+WFF[0M%JS.)^.OP)\.>']/\
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MH\S2CS&M\)?"'PC_ &O]4OO"/A_P'JWP^\626$USI-U!KLNJ6UQ+$F\QRK*
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M\$_%WX*:IX_^&%OJ6BR^%VC'B'PW?W7VIK6*0X2X@EX9TSD$,,\$_+C!R_\
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M^%C?\$ZO&%K,QFN/AWXCM-3ML?>A@NQY#K_NEPS?45L^"_\ E$YXN_['N/\
M])[2LS]GAET#]A#X[ZA-_J]4ET;3X0!UD6X=C_X[(#^%<%%5(4*LJC4IQQ,-
M4K)MRIQ=E=V]UOJSZ#%RP];'86GAX.%">6U;J4E)QC&%><;R48*34XQ:]U:V
MT/G>BBBOT$_GT!UJ2HZDJ9 6HCF-?I3J9;_ZE:?7,]SUJ>L4PHHHI%!1110
M5);'$OU%1T^W_P!<M#*A\2+-%%%9G<%%%% !1110 5-&<H*AKT#X'?&^+X-#
M4FD\'>"_%IU 1@?\)!IWVS[+LW_ZH;AMW;OF]=J^E<V+G.%-RIQYGVO:_P V
M>CE=&C5Q"IXBI[.#O>5G*VFFBU=WI\SAZ*]X_P"&X;?_ *(Y\%?_  FA_P#%
MUQ'QI^/<?QCL;"&/P3X%\)_87=S)H&E_8Y+C< ,2'<=P&,@=B37G4,5BY34:
ME#E7?F3M\D?0XS+,KI495,/C?:26T?9S5_F]%W//J^C/VI)Y?AU^RG\'/"%E
MNM[+6-,;Q)?A3C[7--M9"V#SM5V SVV^E?.=?2GCG0IOVEOV,O!^M:'&UYKO
MPP232-8LHANF^R$@PS*H&2JJHSCU?^Z:Y<V:C7PU2I\"F[]DW&2BW\W;U:/5
MX3C*K@<RP^'_ (TJ2Y4MW&-2$JB7?W5=I;Q3/FNOH[]E>>7XB?LK?&+PC>[K
MBRT?34\1V 8Y^R30[F<KD\;E10<=MWK7SC7TMX"T&;]FK]C7Q?K6N1M9Z[\3
MTCTC1[*4;9OLBDF:9E(R%96."?1/[PI<023P\::^.4X<O>ZDFVO1)M^5Q\ Q
ME''U<1/^#"E5]H^G+*G**3\Y2<5%=96ML0_"OX*_#_4/V/O^$\\5+>V]QI?B
M5[:X:RE;[3J<'D I:1JS>6A,CJQ?;D(C]>*M?"GPM\)_VJM6N/!^B>#=2\!^
M*+BSEETB]&N2:A%>31H7V2K(H"Y52?E'0'D=\?4/^4:5C_V4,_\ I!)53_@G
M'_R>;X-_[??_ $AN*\:M&J\+B\7[67-3<W'WFDN572M>S5^C3TT5CZ_!UL,L
MRRO*OJU)TZ\*,:EZ<7*7M'RMJ37-%I/1P<7?5MG*?L[? <_&?QG?0ZC?+HOA
M_P .VLFHZY?L,FUMX_O!1T+L> /J<'&#V4/Q$^ <^JKI+_#GQ-#I32"/^WO^
M$@=K]4Z>9]GV^5[XR?Z5I?LJVK^+O 'QN\)Z?\VO:WI27-C$I_>7*VTSO+$@
M[E@X&.IKY\@L9[J]2UBAEDN)'$21*A9V<G 4+U))XQUS7I1@\9B:T:LY14.5
M)1DX[Q3YG9J^K:5[KW=MSP*E:.4Y;A*N%HPJ2K.;G*<(U+N,W!4US)J-HI2?
M+:3YUK:Q[#J?['MY<_M/Q_#_ $75[._L;Q5O8-6)'E)8E/,,S@'&54$$9&6&
M.,BM+5_''P'\%ZK)HUGX U[Q=9V[>2^NS^()+2:8@X:2.&-?+*GJ-V,C'2NO
M_9I^%$GP,_:@UCP/J&JZ?)KWB+PA<V$+PL5%E>7$2RK$2V/W@5?QW"OF+6M&
MNO#NKW5A?6\MK>6<K0SPR+M>)U."I'J#6&%OC*WLJE63C&$&G%N'-S7O-\K3
MZ:*]M]-4=F:*.3X3ZSA\)",ZE6K&2G&-94^3EM27.I13]YMNW,U97T9Z3^T3
M\#M+\!Z7H/BSPC?7&I^"/%J.U@]SC[593(<26TVWC<IZ$8SSZ9/8?MR6<NH^
M)?A5;P1M+-/X TB.-%&6=BTP 'U-,^*=E+X%_8'\!Z+JBF'5-=\07&N6L$G$
MD-H(FC!QU"NS*PSUS70?M*:_;>%?C=\"=4O0IL]-\)^'[J<'H8TN)&;] :Y:
M6(JRJT9-\[BZR3_F4=%\]+-]6KGIXK+\-3P^+A&/LE5CA)RCT@YZR2OJEK=)
M[)I=#*\6^#OAC^RO/;Z#XK\/WWQ$\:+$DNJP1:N^GZ?IK.NX0J\8+NZ@C)/!
MX/'2LCQM\)?!_P 4?A#J7CCX<PZAI,GAMHQKWA^^N1<M;1R'"3P2X#.F<@AA
MGJ>,8.?^W)X4OO#/[3GBB:ZW26^L7)U*RN,[H[FWE 9&1AP5'W>/[M=!^RM9
MR>$_@)\8?$VH*8=&NM ;0X#)\J75W.<(%_O,G!XZ!J<7*&#I8^-64IRY&_>;
MC+F:3BHWY5N[62:MJ]Q2C2K9QB<BJ8:$*%-54FH14X*G&3C-U+<\OA3ES2<9
M)M)*Z,/X/?!WPWIGPGN_B-X^;4)O#\=\--TS2K%Q%<:Q<XW-ES]R)1G)')((
M!! #=K\#/#GP>_:8^*.DZ#;^$]0\$W_VA)4MVUF6_L]7A3#30.[;)(Y&0.59
M"!D8]!6+XYLY?%O_  3]\#7FGKYD'A/6[ZTU58^3$\[^9$[CJ!@A0>F6 ZFN
M>_8:\(ZAXM_:E\(C3XY"-/O5OKF11\L4,?S,6/8'[ON6 ZFEB.:KA<3BI591
ME!S2M)I1Y;I:)V=U9ZIO71K0,#[+"YEEV64\-"I3K1HRES0C*4W4LY-3:<HJ
M+;BE%J/NOF3UOTWPX^"_A'Q?^TA\2_AW-8^5=/+J=IX5G:YE'V*XMY9/+0_-
MAPR+@[]WW?4YKQ3PUX-O_%/C2Q\/V\+?VE?WB6,<3#!$K.$ /I@GGTKM_BWX
MSO?AW^V'XLU[3G\N^TGQ=>W4)[%DNY#@^QZ'V)KWZ[\#Z;\.OCSXD^--K#$W
MA6/P^/%.D[ON-?W@,4<)[;O.,K8[?+Q5RQU7")3DW+VE-.*;O[Z25O\ MZZ?
MJFS&CD>&S5NC"*A]7KR51I)?N)-RYG;?V?+-7Z*4%LD?/O[5'A_POX-^-FJZ
M%X1MO)TO01'I\DAF>4W5Q&N)I"69L$R;AA<+\O %>=TZZOIM2OIKBXD::>X=
MI9)&.6=B<DGW)--KZ##T94J4:<I.322;>K;[OU/@\PQ<,5BJF(IP4(RDVHI)
M**;T22TLEH%%%%;'&%%%% !1110!8HI%/RCZ4M9G0%%%% !4=25&>M !4D'\
M51T^#[_X4#6Y+11106%%%% !1110 5)4=2#I4R*B%%%%1+8I;A1114&@4444
M .C-.IJ=:=05'8****"@HHHH **** ) <BBA>E%9G0%%%% !1110 4Y#S3:<
MG6@$.HHHH- HHHH *%ZT4 X-1+<"2BBBD:!1110 4444 %.3I3:=&:4MBH[C
MJ***@H****"HA11104 ZU)4=25,@"BBBI **** "BBB@!R=*=38Z=0]C2(44
M45F:!1110 4#K110!)1110 4444 %%%% !3DZ4VG1TI;#CN.HHHJ"PHHHH *
M*** "BBB@J(4444%!1110 4444 .C-.IL=.J);EQV"BBBD,**** %3[U/IBG
MYJ?05$****"@HHHH **** "BBBLV:!1110 4444 %.B_U@IM.0X<?6@":BBB
MLS0**** "BBB@ HHHH*B%%%%!04444 %%%% "I]ZGU&.M25,BHA1114E!111
M0 4444 /3[M+34Z4Z@ HHHJ9 %%%%2 4444 %%%%!H%%%% !1110 5-"<I4-
M2P'Y?QI2V*B/HHHJ"@HHHH **** "BBB@J(4444%!1110 4444 >\?\ !//_
M )+3JG_8$E_]'V]?9%?&_P#P3S_Y+3JG_8$E_P#1]O7V17Y?Q5_O[]$?T-X;
M_P#(E7^*05_,#^SW_P IOO"O_99X?_3S7]/U?S _L]_\IOO"O_99X?\ T\U&
M0[5?1?J='&'_ "X]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/^/EO]W^HK2KH
MI[%1"BBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH Q[K_ (^9/]X_SJ.I+K_CYD_WC_.HZXS,*_ '_@ZK
M_P"4A?@W_LG=E_Z<M3K]_J_ '_@ZK_Y2%^#?^R=V7_IRU.O8R/\ WKY,^9XL
M_P"1>_5'[,?\$Y/^4>GP'_[)WX?_ /3;;U[-7C/_  3D_P"4>GP'_P"R=^'_
M /TVV]>S5Y=;^)+U9[V%_@0]%^1^-/[4/_)S'Q$_[&?4O_2J6N%KNOVH?^3F
M/B)_V,^I?^E4M<+7]E97_N=+_#'\D?Y5<0?\C3$_]?)_^E,****[CR HHHH
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MC"K%QE>_-S>T6CNK1]#OOC+^U=XJ^-7ARST*ZCT?0?#5@_FP:+H=DMC8J_\
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M#;R>9&(V#!0"PYRI)'I6'X"\977PZ\<Z+X@L5A>^T*_@U"W692T;20R+(H8
M@E<J,@$<=Q63176L+22FE'XW>7F[):_))?(\B>:8J3HRE-WHI*']U*3FDO\
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M %8J_JM&/)RQ2Y=%;HO(Q_M3%U/:JI4<O:M.=W=R:=TVWJW=MGK'@/\ :_\
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MW: & XJ2HZD!S05(****"0HHHH **** "BBB@ HHHH ****S8!1110 4444
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M0HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$_HT\5O_ )>4/_ Y_P#RL_+^BOU _P"'6/PC_P"@=K/_ (,I*/\ AUC\(_\
MH':S_P"#*2C_ (BMDO\ +4_\!7_R0O\ B6?BS_GY0_\  Y__ "L_+^@]*_4#
M_AUC\(_^@=K/_@RDH_X=8_"/_H':S_X,I*/^(K9+_+4_\!7_ ,D'_$M'%G_/
MRA_X'/\ ^5GY=U(.E?I__P .KOA#_P! W6?_  9R4H_X)8_"(#_D&ZQ_X,Y*
M7_$5LE_EJ?\ @*_^2&_HT\5O_EY0_P# Y_\ RL_+^BOU _X=9?"+_H&ZQ_X,
MY*/^'67PB_Z!NL?^#.2C_B*V2_RU/_ 5_P#)"_XEGXL_Y^4/_ Y__*S\OZ*_
M4#_AUE\(O^@;K'_@SDH_X=9?"+_H&ZQ_X,Y*/^(K9+_+4_\  5_\D'_$L_%G
M_/RA_P"!S_\ E9^7]%?J!_PZR^$7_0-UC_P9R4?\.LOA%_T#=8_\&<E'_$5L
ME_EJ?^ K_P"2#_B6?BS_ )^4/_ Y_P#RL_+^BOU _P"'67PB_P"@;K'_ (,Y
M*/\ AUE\(O\ H&ZQ_P"#.2C_ (BMDO\ +4_\!7_R0?\ $L_%G_/RA_X'/_Y6
M?E_17Z@?\.LOA%_T#=8_\&<E'_#K+X1?] W6/_!G)1_Q%;)?Y:G_ ("O_D@_
MXEGXL_Y^4/\ P.?_ ,K/R_HK]0/^'67PB_Z!NL?^#.2C_AUE\(O^@;K'_@SD
MJ7XJY-_+4_\  5_\D'_$L_%G_/RA_P"!S_\ E9^7]%?J!_PZR^$7_0-UC_P9
MR4?\.LOA%_T#=8_\&<E'_$5,F_EJ?^ K_P"2#_B6?BS_ )^4/_ Y_P#RL_+^
MBOU _P"'67PB_P"@;K'_ (,Y*/\ AUE\(O\ H&ZQ_P"#.2C_ (BIDW\M3_P%
M?_)!_P 2S\6?\_*'_@<__E9^7]%?J!_PZR^$7_0-UC_P9R4?\.LOA%_T#=8_
M\&<E'_$5,F_EJ?\ @*_^2#_B6?BS_GY0_P# Y_\ RL_+^BOU _X=9?"+_H&Z
MQ_X,Y*/^'67PB_Z!NL?^#.2C_B*F3?RU/_ 5_P#)!_Q+/Q9_S\H?^!S_ /E9
M^7]%?J!_PZR^$7_0-UC_ ,&<E'_#K+X1?] W6/\ P9R4?\14R;^6I_X"O_D@
M_P")9^+/^?E#_P #G_\ *S\OZ*_4#_AUE\(O^@;K'_@SDH_X=9?"+_H&ZQ_X
M,Y*/^(J9-_+4_P# 5_\ )!_Q+/Q9_P _*'_@<_\ Y6?E_17Z@?\ #K+X1?\
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M^%7_ #XZQ_X,7H_X=E?"K_GQUC_P8O1_Q$K*>T__  %?_)!_Q+_Q+_/1_P#
MY?\ R!^<-%?I!_P[.^%G_/CK'_@Q>C_AV?\ "S_GQUC_ ,&#U'_$2<I[3_\
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M]7_\&#T'_@FY\+S_ ,N6K_\ @P>C_B(F5=I_<O\ ,/\ B!G$7\]+_P "E_\
M('YTT5^BO_#MOX7_ //EJ_\ X,'H_P"';?PO_P"?+5__  8/1_Q$3*NT_N7^
M8?\ $#.(OYZ7_@4O_D#\\E.5HK]#Q_P3?^&('_'GJ_\ X'M1_P .X/AC_P ^
M>K_^![4?\1$ROM/[E_F5_P 0-XA_GI?^!2_^0/SPHK]#_P#AW!\,?^?/5_\
MP/:C_AW!\,?^?/5__ ]J/^(B97VG]R_S#_B!O$/\]+_P*7_R!^>%%?H?_P .
MX/AC_P ^>K_^![4?\.X/AC_SYZO_ .![4?\ $1,K[3^Y?YA_Q WB'^>E_P"!
M2_\ D#\\*<G6OT-_X=P?#'_GSU?_ ,#VI1_P3A^&(_Y<]7_\#VH?B)E?:?W+
M_,/^(&\0_P ]+_P*7_R!^>=%?H9_P[B^&7_/GJ__ ('M_A1_P[B^&7_/GJ__
M ('M_A4_\1"ROM/[E_F5_P 0/XA_FI?^!2_^0/SSHK]#/^'<7PR_Y\]7_P#
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M#]@#X=C_ )==5_\  UO\*7^NV7]I?<O\P7A+G?\ -3_\"?\ \B?"=%?=O_#
M/P[_ .?75?\ P-;_  H_X8!^'?\ SZZK_P"!K?X4?Z[9?VE]R_S*_P"(39W_
M #4__ G_ /(GPE17W;_PP#\._P#GUU7_ ,#6_P */^& ?AW_ ,^NJ_\ @:W^
M%'^NV7]I?<O\P_XA-G?\U/\ \"?_ ,B?"5%?=O\ PP#\._\ GUU7_P #6_PH
M_P"& ?AW_P ^NJ_^!K?X4?Z[9?VE]R_S#_B$V=_S4_\ P)__ ")\)45]V_\
M# /P[_Y]=5_\#6_PH_X8!^'?_/KJO_@:W^%)\:9?VE]R_P REX3YU_-3_P#
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M\^^J_P#@:?\ "C_7+ =I?<O\P_XA3G7\U/\ \"?_ ,B?#%%?<_\ PP/\/?\
MGWU7_P #3_A1_P ,#_#W_GVU7_P-/^%'^N6 [2^Y?YA_Q"G.OYJ?_@3_ /D3
MX8HK[H_X8(^'O_/KJG_@:W^%'_#!'P]_Y]=4_P# UO\ "C_7+ =I?<O\RO\
MB%><_P T/_ G_P#(GPO17W1_PP1\/?\ GUU3_P #6_PH_P"&"/A[_P ^NJ?^
M!K?X4?ZY8#M+[E_F'_$*\Y_FA_X$_P#Y$^%Z*^Z/^&"/A[_SZZI_X&M_A1_P
MP1\/?^?75/\ P-;_  H_URP':7W+_,/^(5YS_-#_ ,"?_P B?"].0_+7W-_P
MP1\/?^?75/\ P-;_  H'[!/P]'_+MJG_ (&M_A2?&6 [2^Y?Y@O"O.?YH?\
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M_A2_UOP/:7W+_,/^(6YSWA_X$_\ Y$^':*^XO^&#?A__ ,^^J?\ @:?\*/\
MA@WX?_\ /OJG_@:?\*/];\#VE]R_S#_B%N<]X?\ @3_^1/AVBON+_A@WX?\
M_/OJG_@:?\*/^&#?A_\ \^^J?^!I_P */];\#VE]R_S*_P"(79QWA_X$_P#Y
M$^':*^XO^&#?A_\ \^^J?^!I_P */^&#?A__ ,^^J?\ @:?\*/\ 6_ ]I?<O
M\Q_\0NSCO#_P)_\ R)\.T5]Q?\,&_#__ )]]4_\  T_X4?\ #!OP_P#^??5/
M_ T_X4?ZWX'M+[E_F'_$+LX[P_\  G_\B?#M*GWQ]:^X?^&#?A__ ,^^J?\
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M]W^HK2K-TC_CY;_=_J*TJZ*>Q40HHHK0H**** "BBB@ HHHH **** "BBB@
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MSE_XBC?V7_7XB?\ @A3_ ./4?\11O[+_ *_$3_P0I_\ 'J?U6K_*P_L7'_\
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M1]5K?RL?]AYA_P ^9?<?HQ17YS_\11/[+_\ >^(G_@A7_P"/4?\ $43^R_\
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M?XOB'_X(5_\ CU'U.M_*P_L',/\ GS+[C]%J*_.K_B*#_9A_O?$/_P $*_\
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M /X(1_\ ':?]GXG^1_</_5G-O^@>?W,_0^BOSQ_XB=OV8?\ GMX__P#!"/\
MX[1_Q$[?LQ?\]O'_ /X(1_\ ':/[/Q/\C^X/]6<V_P"@>?W,_0ZBOSQ_XB=?
MV8?^>WC[_P $(_\ CM'_ !$Z_LP_\]O'W_@A'_QVCZAB?Y']P?ZLYM_T#S^Y
MGZ'45^>/_$3K^S#_ ,]O'W_@A'_QVC_B)U_9A_Y[>/O_  0C_P".T?4,3_(_
MN'_JQFW_ $#S_P# 6?H=17YX_P#$3K^S#_SV\??^"$?_ !VC_B)U_9A_Y[>/
MO_!"/_CM'U#$_P C^X/]5\V_Z!Y_^ L_0ZBOSQ_XB=?V8?\ GMX^_P#!"/\
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M .V4?V?B?Y']P?ZK9O\ ] T__ 6?H917YY_\1.?[,/\ S\>/O_!#_P#;*/\
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M -LH_P"(G/\ 9A_Y^/'W_@A_^V4?V?B?Y']P?ZK9O_T#3_\  6?H917YY_\
M$3G^S#_S\>/O_!#_ /;*/^(G/]F'_GX\??\ @A_^V4?V?B?Y']P?ZK9O_P!
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MA_\ ME']GXG^1_<'^JV;_P#0-/\ \!9^AE%?GG_Q$Y_LP_\ /QX^_P#!#_\
M;*/^(G/]F'_GX\??^"'_ .V4?V?B?Y']P?ZK9O\ ] T__ 6?H917YY_\1.?[
M,/\ S\>/O_!#_P#;*/\ B)S_ &8?^?CQ]_X(?_ME']GXG^1_<'^JV;_] T__
M  %GZ&45^>?_ !$Y_LP_\_'C[_P0_P#VRC_B)S_9A_Y^/'W_ ((?_ME']GXG
M^1_<'^JV;_\ 0-/_ ,!9^AE%?GG_ ,1.?[,/_/QX^_\ !#_]LH_XB<_V8?\
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M$Y_LP_\ /QX^_P#!#_\ ;*/^(G/]F'_GX\??^"'_ .V4?V?B?Y']P?ZK9O\
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M .V4?V?B?Y']P?ZK9O\ ] T__ 6?H917YY_\1.?[,/\ S\>/O_!#_P#;*/\
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M -LH_P"(G/\ 9A_Y^/'W_@A_^V4?V?B?Y']P?ZK9O_T#3_\  6?H917YY_\
M$3G^S#_S\>/O_!#_ /;*/^(G/]F'_GX\??\ @A_^V4?V?B?Y']P?ZK9O_P!
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MA_\ ME']GXG^1_<'^JV;_P#0-/\ \!9^AE%?GG_Q$Y_LP_\ /QX^_P#!#_\
M;*/^(G/]F'_GX\??^"'_ .V4?V?B?Y']P?ZK9O\ ] T__ 6?H917YY_\1.?[
M,/\ S\>/O_!#_P#;*/\ B)S_ &8?^?CQ]_X(?_ME']GXG^1_<'^JV;_] T__
M  %GZ&45^>?_ !$Y_LP_\_'C[_P0_P#VRC_B)S_9A_Y^/'W_ ((?_ME']GXG
M^1_<'^JV;_\ 0-/_ ,!9^AE%?GG_ ,1.?[,/_/QX^_\ !#_]LH_XB<_V8?\
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M_>I* "BBBM#0**** "BBB@N.P4444#"I!TJ.I!TH **** "BBB@ ILE.ILE
MX[C:***T+)!THH4Y6B@ HHHH ****"HA11104%%%% !1110 'I4=2'I4=5$T
M"G)UIM.3K5 .HHHH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** "BBB@J(4444%!1116@ >E1U(>E1T%1"G1TVG)UH*'4444 %%%%!H%%%%
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MRD9^/W_92/$7_ISN*\3KMC*\4SZFA4]I3C4[I/[PHHKZM_X(=_\ *6#X)_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 >D?LA_LN>)?VTOVCO"OPS\)+;
M_P!M>*;HP)-<$B"TB1&DFGD(!.R.)'<X!)VX )(!_5*X_P""0'[ _A+XF0_
MO6OCUXJ;XV7#I8>;'<*D*W[@!(<"V:V1B[*/(>8RY.W=NYKX-_X(N_M9^'?V
M+?\ @HGX%\:^+Y?LOA?_ $G2]2N]A?[!'<P/$)R%!)5'9"V 3L#8!.!7Z.^/
MO^#;W6OCS_P4'N/C!H?Q2\*W_P )?%WB=O&$D]M<SRZLR37'VIX;=T5HG!9F
M5)_.! VMM)&#Y.-K.-3EG-QC:ZMU?]=#X'B;,)TL9[*OB)4*:AS1<5\4[O1N
MSV5O=TO?<_)[]O?]BOQ)_P $_P#]I[Q!\,_$TT%]<:44N++4(%*PZG:2C=%.
MH/*Y&0R\[75UR<9/G_PD^$'BCX\_$'3?"G@W0=3\2^(]6<QVFGV$!FFF(!8D
M =%"@DL<!0"20 37V%_P</\ [6NB?M:_\%(=8F\.B232_A_I<7@X7#Q/$UU-
M;3W$MPVUL$;9[B6,9 R(@>AR?L+_ (-G?V/?B)\,OA?\;_BHW@>\TKQ-K'AV
M#3OA[?:U!]FAU&0I=2RA0^&\DS1V&9,!&&0"<-C>6*E3PRJS^*R^\]*MGU7"
M9)#'XI+VKC'1NUY.R_6[2V5S\^?VE_\ @C'^TE^R/\-)O&'C;X:WEKX;M%W7
ME[I]_:ZFNGC^],+>1VC0="Y&P'^+D5\NU^\7_!#'QQ^U9X[^.'Q:T_\ :07Q
MI=?"]=$N8M7/CJT>&UAOA(@,4!F4((C ]P9$3$6S83CY,_A?XTBT^W\8ZM'I
M#,^DI>3+9,QRS0!SY9)]=N*K"XB<Y2ISLVK:K;4WR+-L3B*U;"XKDE*GROFA
M?E:DGIK>S5N^I^E/_!J/>2)_P4#\;6X;]S)\/;N1EQU9=2TT _@&;\Z_H!K^
M?G_@U*_Y2'>,O^R=7O\ Z<]+K^@:OF,\_P!Z?HC\@\1O^1S+_#'\@K^8']GO
M_E-]X5_[+/#_ .GFOZ?J_F!_9[_Y3?>%?^RSP_\ IYKIR':KZ+]3\-XP_P"7
M'J_T/Z?J***^>/MBUI'_ !\M_N_U%:59ND?\?+?[O]16E713V*B%%%%:%!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7X _\ !U7_ ,I"_!O_ &3N
MR_\ 3EJ=?O\ 5^ /_!U7_P I"_!O_9.[+_TY:G7L9'_O7R9\SQ9_R+WZH_9C
M_@G)_P H]/@/_P!D[\/_ /IMMZ]FKQG_ ()R?\H]/@/_ -D[\/\ _IMMZ]FK
MRZW\27JSWL+_  (>B_(_D2_X*4_\I&/C]_V4?Q%_Z<[BO%*]K_X*4_\ *1CX
M_?\ 91_$7_ISN*\4KZ6G\"]#]TPO\"'HOR =:DJ.I*LZ HHHH **** "BBB@
M HHHH- HHHH **** '1TZFIUIU7'8 HHHI@%%%% !1114LJ(4Y.M-IR=:HH=
M1110 4Q_O4^F/]Z@J(E%%%!04444 %%%% #HZ=38Z=07'8****T&%%%% !11
M10 4Y.M-IR=: '4444 %%%% !1110 4444&@4444 %%%%!4=PHHHH*"BBBM
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M\:O$7A.0VLUYJ&K^(+  "/9JFJ7'EVD4:DGY(=]NG<E("W'0>%?\&FDK3_\
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M0+>:1=S8\V:RN+*26(28 !D0,8V( !:,D  @5]!?\'A'_-N__<R?^XFOD?\
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MV"/^"K_P _X*_P"NW7P9\3?"'2]!N8;":71]%U>WMM1L;VW4?OE@98U\F55
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M?[T_1'X-XC_\CF7^&(5_,#^SW_RF^\*_]EGA_P#3S7]/U?S _L]_\IOO"O\
MV6>'_P!/-=.0[5?1?J?AO&'_ "X]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/
M^/EO]W^HK2KHI[%1"BBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[0WAOXD^#9X8]:\.W'F"&<%K>^A8%9;>4 @F.1"RG!!&<@@@$?LCKG_!8_\
M8/\ ^"D'A/0W_:'\$W.A>(-*AV[M3TFZO!:,>6C@O-/S.T);G:RH"3DKWK\)
M**,1@Z=5J3NFNJT9.;<.87,*D:]1RA4CHI0?+*W:^OY'[*?M>?\ !P)\'_@5
M^RO=?"/]D7PC=>'EU&WFM?[9&GC2[72%E&UYX$),TUTPW?O) I4[6RY&!\N_
M\$*/^"HOP_\ ^"8GQ!^(6K>/M'\8:O;^+-.M+2T70+2VN'C>*21V,@FGA !#
MC&">_ KX-HJ8X&DJ;I]]^[,J/"N IX.I@DFU4=Y-N\I-.^K_ *Z]V?4W[?W_
M  4&A^.O_!437OV@_A6VO>&RU]I6HZ(VJ00QWMK-9V%I 3)&CRQD&2!CMW,&
M0C(Y*C]*O"G_  7Q_95_X*!_!33_  G^U-X#;1[^WD66?=IL^I:4LP4*9[:6
MW)NH"<O\H4E5XWO7X7T45,#2G&*=URZ)K<>.X6P.)HTJ4N:+I)*,HNTDDK;_
M "ZH_=+5?^"\7[(O_!//X0ZMX;_9A\ 3:QJ%ZS2Q>1ILVFZ=//M*I-=3W.+J
M4+QA2F2I(#)UK\F_AO\ &KQ%^T;_ ,%#O"?CKQ;?'4O$GBCQUIU_?W&P(K2/
M>Q<*HX5%&%51PJJ .!7B-=5\"_'%I\,?C;X.\27\=Q-8^'M<LM3N8[=0TSQP
MSI(P0,0"Q53@$@9QR.M%+!PI)N-VWU>K'@.',+@*=65"\JDT[RD[R>FUS^H#
M_@L%^V=X5_8I_9Q\.ZIX_P#!L'COX?\ C3Q1#X4\3:6\:RR&QGLKV9I(D<A'
MD5[:,[6(!&[#*V&'R%\&/^"NG_!/7]@SP1J/B#X.^&;ZU\2:Y RW.FZ;X?NU
MU-MIW+!)<W9\M8V8 [8YF48!VY %?,'_  7 _P""X'PG_P""EG[*'A_P+X%\
M/_$/2=7TGQ;;:]--KUA9P6S01V=[ RJT-U*V_=<H0"H& W(( /Y8UY^#RQ2I
M6JW3ZJ^_J?&\.\$PJY>HX_GIRN^:*E9273F6J_)GM7_!0']M_P 3?\%"?VG=
M;^)/B:-+.2^5+33=.BD,D6DV4>?*MT8@;L;F9FP-SR.V!G _0[_@HC_P7X^#
MO[6__!,?7_@OX;\-_$RQ\4ZIIVCVD5UJ6GV4>GJ]I>6<\A9X[MY,%;=PN(SD
ME<@#)'Y#T5Z<L)3ERZ?#L?=8CA_!5G0O&RH-."3LE:UO79'UA_P1F_;K\(_\
M$[?VRE^(GC;3O$>J:*NAW>F>1HEO#/=>9*8RIVS2Q+M&PY.[/3@UL?\ !<#_
M (*&^"_^"EG[5_A_QUX%TOQ1I.D:3X2MM!FAUZV@@N6GCO+V=F589I5V;;E
M"6!R&X  )^-Z*KZO#VOMNMK&KR?#/'_VEK[2W+OI;T/UX_X) _\ !?CX._\
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M5?%WB/3X=>\%>-_%5U/J;:GI]Z9;5+R4EV=K63*&-G)9E0H3DX9:^;_V$O\
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M]_J_ '_@ZK_Y2%^#?^R=V7_IRU.O8R/_ 'KY,^9XL_Y%[]4?LQ_P3D_Y1Z?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT_\ X: ^&LGQ4U*$RV7A*Z@-G'J. WRP7#S>;(2R[0?LP&<Y(P:\4_X*2_\
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MJ*_F:TLX;R0Q)';21D&.90NZ1<L"#@8)^48Z_=+_ (-\O^4%7[1'_88\2_\
MJ/V%?D7^Q%^P[\0OV_\ XU0>!OAWI<=YJ!B-U>W=S)Y5GI=L" T\\F#M4%@
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MA_P5+^)6D^=]H_LOP)JEIYNS9YOEZOIB;L9.,XSC)QZU\X_M[_LY^,/VL/\
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M\%LO^"7_ (P_X)\> _ =_P")OCMXE^+T'B:_NK>&VU.QGMETYHHXV,B^9>7
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M&7P?L?&WQB^)WA7X&Z7JB*]O;:G;"[O(MXS&LX>:"*)V&3L\QF Z@'('D/\
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M:X_99\4?L5_M#^)/AGXR%BWB#PQ-''/+9.\EK<+)$DL<L3.B,R,CJ02JGGD
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M^)]4_P""D%K^S?\ %+Q#_P *QU[5+:XN-+U9=-_M2SU79&\L;0YF@#1RI%*
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M (*7_$*^TGP3;V=AH^BA&UC7M19DL=.#YV)\H+22MABJ*"< D[1S7V-\0O\
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MNBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/]X_SJ.N,S"OP!_P"#
MJO\ Y2%^#?\ LG=E_P"G+4Z_?ZOP!_X.J_\ E(7X-_[)W9?^G+4Z]C(_]Z^3
M/F>+/^1>_5'[,?\ !.3_ )1Z? ?_ +)WX?\ _3;;U[-7C/\ P3D_Y1Z? ?\
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M$-KXE\,7FDL=%@@N;R2[GOK.Y,KB::%=I%O)DAB=S+P021R7BW_@IAJ_P_\
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M$9#+EP[5&?)ML[V[ET\KQ7U-6C[T:O/RO3F2?W'DO_!++XF?M%?#G]H74/\
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M**.*CBI3DI>SY;>_RN5[[)K6WJSRVBBBNZ.Q],%%%%, HHHH *5/O4E*GWJ
M'T444 %%%% !1110 4444&@4444 %%%% !1110:!1116@!4=25'05$*5/O4E
M*GWJ"A]%%% 'W9_P1^_X)G_M ?M5V.J?%#X"_$_PC\/]9\(ZD=)N&N]8O['4
M%W1)(&Q!:RH\$@8KM9N3&X*X )]<^!W_  =+_M$?!3Q$VD_$SP]X5\?QZ?=&
M#4%N++^Q]40HVV2,/!B%&&"/F@;!'X5\G?\ !,?_ (*B^//^"8'Q?NM?\+Q6
M^M^']<2.#7O#UW*T=MJD:$E&#@$Q3)N?9( V-[ JP)!_0/7/^"\'[%/Q1\0/
MX^\9?LI3W_Q,W^:9'T72;ZWNI/\ GI-<.Z,\@);#O S#:A!!QMX:T).;YX<R
MZ=SY/,L-6GB)?6,,JU-I<K5E)=TWH]^I[)_P<,_"/P%^U?\ \$IO"_[1D.BV
MN@^+(;31-7T^XN(5CU*YLM1\D&PE91ES&+@2;6)"&&3;C<P;)_X*H^+M3\+_
M /!LK\$8=.OKBSBUKPWX+L+Y8FV_:;<Z9'*8V_V2\49([[?3(K\]_P#@K9_P
M6V\7?\%.8]-\-6FAQ^!?AKH=PMW;:)%<_:9KRX5"BS7$H5 =JLP2-5"KN.=Q
M 8>C?MS?\%BOAE^TU_P2$^%_P T'0_'=IXR\$V'AZUOKR_LK2/3)6T^Q^SS&
M*1+EY2&?E-T2Y'7:>*QAAZB4$UL[^B//PN3XRE2PL*D;\M1RM>_+'2R;\MSZ
MZ_X-!M7NI_@3\9K&2YG>RM==T^:&!G)CB>2WE#LJ] 6$<8)'78OH*^,/^#:7
MQGJVH_\ !7?2;F;4+N2X\0:/K!U)S(<WQ:$S'S/[V945^?XE!K5_X(0?\%BO
MAE_P2^\!_$32_'VA^.]8N/%U_9W5FWA^RM+A(UACE5A(9KF$@DN,;0W?I7SQ
M_P $?_VU?"O_  3^_;BT+XF>,M/\0:EH.EV%]:RP:+!#-=LT\#1H5666), D
M9RXX]>E:2I2O5TWM;[CNK9?7<\P:A_$C'E\_==[?,^V?VI?V;_BA^T=_P<Q_
M$KP[\'?%4WP\\106=AJ%YXCME<'1K/\ L/3UN)L1_,6=I5C RNYY@"RAB:Q?
MVQO@O^QW\ /VG=:C^/OQI^/GQ^^+&EO"FLQ:/;6\,3S1(JI:SRRC);RQ&N(I
M_DVL"0W \M\3?\%M+?P!_P %H_%G[37P[\/ZO>>%?%5I::5>Z'K1CLKR]LDT
M^RMYHV:)YDC;SK194(+CY$R.2H](_:*_X*Z_L8_$/XDR?%?2?V5=7\0?&"ZF
M&H2W'B#56M=)6^7'ES200W$D5R RJS!X$+X()!.ZER5$XZ.UDM+7OYLQCA\=
M!T8N$N54XKW.52YDE=2D]4O1GT)_P=]_\D@^"7_88U3_ -$6]'_!6[_E6C_9
M^_[ _@O_ --%?)/_  6S_P""P_P[_P""H7P-^&.F^'-#\::)XL\(W<MUJJ:E
M8VT6GR&:W19?(DCN99#MDC&T.BY5B201@S_MR_\ !8CX9_M,_P#!(;X7_ '0
M=#\=6GC+P38>'K6^O+^RM8],E;3['[/,8I$N7E(9^4W1+D==IXI4Z-10IIK9
MZF&!RO%0P^#A*#O";<O)7>I]7_"G_E4(NO\ L#ZI_P"I/<5^%=?I+X)_X+$?
M#/PW_P $)9OV89]#\=-X^DL+VU%_'96IT?=-K$M\I\PW(FP(G /[G[V1R/FK
M\VJZL/3E'GYENV>_D.%JT98EU8VYJLFO-/9G[S?L_P#B[4_ _P#P:0W6H:/?
M7&G7RZ!K=N)X&VR+'-XBNX9%![;HY'7(YPQKPK_@T4U>ZB_:E^*]@MS.MC<>
M%8+B6W#GRY)$NT5'*]"RB20 ]0';U->9^"?^"Q'PS\-_\$)9OV89]#\=-X^D
ML+VU%_'96IT?=-K$M\I\PW(FP(G /[G[V1R/FKSS_@A=_P %+O G_!,CXZ^,
M_$_CS2?%NK:?XBT%=+MH] M;>XF247$<N7$T\("[4(R"3G''>N5T9^SJ*VK>
MAXTLMQ#P..I\CYIU)./FKIIG7?"KQGJQ_P"#F^ZO?[0NA=GXUZIIQE$A#&V^
MWW%MY6?[GDCR\?W>*^J/^"Q?AG0_$'_!QS^R[9:W;6DFFZA8>&Q<Q2Q@QW<G
M]N:@(TD!&'#,L:$-D$<'BOSE\$_MI^%O#?\ P5YF^/T^G^(&\&R?$N]\9"SC
M@A.I_8YKZ6X6/RS*(O.". 5\W;G/S$<UVG_!:_\ X*1^$_\ @HG^V)X5^)'P
MWL_%WA^S\.^%[32!_;,$%K>)=PWMY<^9'Y$TJ[0+B/#;@VY6X& 3LZ,G4BUM
MRV.RIEU:>-I246E[)Q;[-H^E/^#N/Q5XBG_;!^&NB3W%Y_PB=KX.%]90%C]G
M^VR7MTEPP&<;_+BM03C.-M>\?\$;KZZ^)?\ P;K?'#3?'DDE]X:TF'Q/::;]
MN)DCMM/CTJ&?,>[.T1W+7#J1C:ZY&",UX;X8_P"#@KX-?M7_  :\.^%?VN_@
M7-X^U#PUS#K6AI#))/)L"F4122PM"\FU?,$<VQR =H 55\N_X*+?\%X+3]H3
M]F*W^!/P3^'</PI^%"1);749=/MEW;H^\6ZQQ?NX8V?#R?,[R-U8 N'R]E4=
M.-'EM9[]#@AE^-J82CECH\KA)-SNN6R;=UK>[[6/KG_@WR_Y05?M$?\ 88\2
M_P#J/V%._P"#5G1O"^C?L-_'+Q#)J5YINOOK+6^J75A 9+W3]/AT]9()H@(W
M+/OENRJA7RT8^0YP?D[_ ();_P#!8CX9_L1_\$VOBM\'?%>A^.M0\3>.;_5[
MJPNM)LK66PA6[TNVLXQ*\ES'(")(6+;8VPI!&3D#YZ_X):?\%2/&7_!+WXR7
MVO:#90^(/#GB"**WU_0;BX:&+4(XV)1T< ^7.FYPCE6 $C@J033J8><E42ZM
M6\S3%9-BJ\,;"*MSRBX].9+I_74^[/V:]/\ ^";O[-'[2?AOXF^%_P!I_P"-
MMUXNT/4QJ$1O--O9EU&1B?,BGVZ*LDB2AF5P&#,'/()S7JEG\;/@7^V]_P '
M%OP3\9> =07Q J^$[TWDEQH]YIWFZE:P7C0.8[J&)G=(2"&4$#R4YRM>/Z+_
M ,%J?V(_A?XNC^)GA#]E/4H/BP)C>*)(;*VT^TN#DF6&42R"-PP4ATM58;F(
MP?O?G_\ M!_\%*?B?^T!^V]#\>[S5(]*\::7>6]SHRV:G[-H\5N<PV\:L3F,
M<[@V=Y=RV=QI0P\YMMW6C6K7Z#P^48C$U)SDJD7R2BG.4=VK6M&-VEO>Z]#W
MS_@Y>\6^(M>_X*Q^,M/UBXO)-)T/3-*M]"BE=C%%;/8P32>6"< &YDN,X R0
M>_-8/[3GQ;_;(^('_!-WPC:_$RQOYO@';PZ9_8>HWFG6*&54C\NS99P!<.QC
MR,L267).1S7U'K/_  7R_9A_;&T'0]4_:7_9MNO$'CKPW;^5:W>C107EK,V=
MQ3,T\,B0%OF\IS,J[F^]DEOE[_@K5_P6CUS_ (*3:7H/@[1?#%O\/_A?X5E6
MXL=%AG$LMU*L?E1R3%56-5C0LL<:+A [<MQC6DIVA!P^'J_T._+X8OEP^%J8
M9+V5KRE9I66\+.]WWZ'WQ_P5J@DF_P"#:#X!LJ,RQ:+X+9R!D(/[) R?09('
MU(KG/^#/.QFCLOVAKEHV%O,_AV)),?*S*-4+ >X#J?\ @0KR+]@/_@OM\,_
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MC\4?#/\ 9C\06'C"R!%E=2Z#I=FT!(.2DXNIGB8]-R)G!(SC@_GC_P %,_\
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M?CK4/$WCC4-6N[&YTFRM9;&)+O2[:TC$KR7,;@B2%BVU&PI!&3D#'_X(-?\
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M5WTT3N?G/1117NGZF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK[)\*_\ !P7\&?VK/@OH/A7]KCX'W'CS4/#?S0:OH<4$S7$H4*9O*EE@:!W
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M#_@MS^V7XV@NK&ZUG3AI>@Z2\ WI-:6Z_8[J1'YX\RQM<D-AM^0,=/F3XG>
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M[_Y3?>%?^RSP_P#IYK^GZOY@?V>_^4WWA7_LL\/_ *>:Z<AVJ^B_4_#>,/\
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M5104444 %%%% I;!1110$=@HHHH&%%%%  .M25&.M24%1"BBB@H;)3:=)3:
M"BBBM#0**** "BBB@J(4444%!3DZ4VG)TH =1110 4444 %(_P!VEI'^[0 R
MBBBJB:#D/%.IL=.J@"BBB@ HHHH*B%%%%!04444 %%%% !49ZU)49ZU430*!
MUHH'6J DHHHH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _3;_@U*_Y2'>,O^R=7O\
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M\#^TI_T5KQ!_WYMO_C5'_#X']I3_ **UX@_[\VW_ ,:HYI]E]_\ P!_4<?\
MRP_\"E_\@?F[_P (?JQ_YA>I?^ S_P"%'_"'ZO\ ] O4O_ 9_P#"OTB_X? _
MM*?]%:\0?]^;;_XU1_P^!_:4_P"BM>(/^_-M_P#&J.:?9??_ , KZGC_ .6'
M_@4O_D#\W?\ A#]7_P"@7J7_ (#/_A1_PA^K_P#0+U+_ ,!G_P *_2+_ (?
M_M*?]%:\0?\ ?FV_^-4?\/@?VE/^BM>(/^_-M_\ &J.:?9??_P  /J>/_EA_
MX%+_ .0/S=_X0_5_^@7J7_@,_P#A1_PA^K_] O4O_ 9_\*_2+_A\#^TI_P!%
M:\0?]^;;_P"-4?\ #X']I3_HK7B#_OS;?_&J.:?9??\ \ /J>/\ Y8?^!2_^
M0/S=7P?J^[_D%ZE_X#/_ (4__A$-6_Z!>H_^ S_X5^C_ /P^!_:4_P"BM>(/
M^_-M_P#&J/\ A\#^TI_T5KQ!_P!^;;_XU5>TFNB^_P#X ?4\?_+#_P "E_\
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M(/\ OS;?_&J/^'P/[2G_ $5KQ!_WYMO_ (U0ZDWT7W_\ :P>/_EA_P"!2_\
MD#\X?^$/U?\ Z!>I?^ S_P"% \'ZOG_D%ZE_X#/_ (5^CW_#X']I3_HK7B#_
M +\VW_QJC_A\#^TI_P!%:\0?]^;;_P"-4>TGV7W_ / ']5Q_\L/_  *7_P @
M?G)_PB&K?] O4?\ P&?_  H_X1#5O^@7J/\ X#/_ (5^C?\ P^!_:4_Z*UX@
M_P"_-M_\:H_X? _M*?\ 16O$'_?FV_\ C5'M)]E]_P#P ^JX_P#EA_X%+_Y
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M+_PA^K_] O4O_ 9_\*/^$/U?_H%ZE_X#/_A7Z-?\/@?VE/\ HK7B#_OS;?\
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MI3_HK7B#_OS;?_&J/;3[+[_^ 'L<?_)#_P #E_\ ('YT_P#"'ZO_ - O4O\
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M\#^TI_T5KQ!_WYMO_C5'_#X']I3_ **UX@_[\VW_ ,:H^L5.R^__ ( <N/\
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M)U+_ ,!7_P *_1#_ (? _M*?]%:\0?\ ?FV_^-4?\/@?VE/^BM>(/^_-M_\
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MC_P^!_:4_P"BM>(/^_-M_P#&J/\ A\#^TI_T5KQ!_P!^;;_XU1]:J?RK[_\
M@![;,/\ GW#_ ,#E_P#('YW?\(5K/_0)U/\ \!7_ ,*/^$*UG_H$ZG_X"O\
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M]<J?RK[_ /@![?,/^?</_ Y?_('YY?\ "%:S_P! G4__  %?_"C_ (0K6?\
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MT,_X? _M*?\ 16O$'_?FV_\ C5'_  ^!_:4_Z*UX@_[\VW_QJCZ[4_E7W_\
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M ^NYA_SZA_X'+_Y6?GG_ ,(/K1_Y@^J?^ DG^%'_  @VM_\ 0'U3_P !)/\
M"OT,_P"'P/[2G_16O$'_ 'YMO_C5'_#X']I3_HK7B#_OS;?_ !JG]>J+[*^_
M_@%?7LP_Y]0_\#E_\K/SU3P/K0_Y@^J?^ DG^%._X0C6O^@/JG_@))_A7Z$?
M\/@?VE/^BM>(/^_-M_\ &J/^'P/[2G_16O$'_?FV_P#C5/Z_4_E7W_\  #Z]
MF'_/J'_@<O\ Y6?GO_PA&M?] ?5/_ 23_"C_ (0C6O\ H#ZI_P" DG^%?H1_
MP^!_:4_Z*UX@_P"_-M_\:H_X? _M*?\ 16O$'_?FV_\ C5'U^I_*OO\ ^ 'U
M[,/^?4/_  .7_P K/SW_ .$(UK_H#ZI_X"2?X4?\(1K7_0'U3_P$D_PK]"/^
M'P/[2G_16O$'_?FV_P#C5'_#X']I3_HK7B#_ +\VW_QJCZ_4_E7W_P# !9AF
M"_Y=0_\  Y?_ "L_/?\ X0C6O^@/JG_@))_A1_P@^M?] ?5/_ 23_"OT(_X?
M _M*?]%:\0?]^;;_ .-4?\/@?VE/^BM>(/\ OS;?_&J/K]3^5??_ , K^T,P
M_P"?4/\ P.7_ ,K/SW_X0;6_^@/JG_@))_A1_P (-K?_ $!]4_\  23_  K]
M"/\ A\#^TI_T5KQ!_P!^;;_XU1_P^!_:4_Z*UX@_[\VW_P :H^OU/Y5]_P#P
M _M#,/\ GU#_ ,#E_P#*S\]_^$&UO_H#ZI_X"2?X4?\ "#:W_P! ?5/_  $D
M_P *_0C_ (? _M*?]%:\0?\ ?FV_^-4?\/@?VE/^BM>(/^_-M_\ &J/K]3^5
M??\ \ /[0S#_ )]0_P# Y?\ RL_/?_A!M;_Z ^J?^ DG^%-;P+KF?^0/JO\
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MA4_E7W_\ /[4S'_GU#_P.7_RL_/?_A!M;_Z ^J?^ DG^%'_"#:W_ - ?5/\
MP$D_PK]"/^'P/[2G_16O$'_?FV_^-4?\/@?VE/\ HK7B#_OS;?\ QJC^T*G\
MJ^__ ( ?VIF/_/J'_@<O_E9^>_\ P@VM_P#0'U3_ ,!)/\*/^$&UO_H#ZI_X
M"2?X5^A'_#X']I3_ **UX@_[\VW_ ,:H_P"'P/[2G_16O$'_ 'YMO_C5']H5
M/Y5]_P#P _M3,?\ GU#_ ,#E_P#*S\^/^$%US_H#ZK_X"2?X4?\ ""ZY_P!
M;5?_  $D_P *_0?_ (? _M*?]%:\0?\ ?FV_^-4?\/@?VE/^BM>(/^_-M_\
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M%3^5??\ \ /[4S#_ )]0_P# Y?\ RL_/C_A!=<_Z VJ_^ DG^%'_  @NN?\
M0&U7_P !)/\ "OT'_P"'P/[2G_16O$'_ 'YMO_C5'_#X']I3_HK7B#_OS;?_
M !JC^T*G\J^__@!_:F8?\^H?^!R_^5GY\?\ ""ZY_P! ;5?_  $D_P */^$%
MUS_H#:K_ . DG^%?H/\ \/@?VE/^BM>(/^_-M_\ &J/^'P/[2G_16O$'_?FV
M_P#C5']H5/Y5]_\ P _M3,/^?4/_  .7_P K/SX_X077/^@-JO\ X"2?X4?\
M(+KG_0&U7_P$D_PK]!_^'P/[2G_16O$'_?FV_P#C5'_#X']I3_HK7B#_ +\V
MW_QJC^T*G\J^_P#X ?VIF'_/J'_@<O\ Y6?GQ_P@NN?] ;5?_ 23_"C_ (07
M7/\ H#:K_P" DG^%?H/_ ,/@?VE/^BM>(/\ OS;?_&J/^'P/[2G_ $5KQ!_W
MYMO_ (U1_:%3^5??_P  /[4S#_GU#_P.7_RL_/C_ (077/\ H#:K_P" DG^%
M'_""ZY_T!M5_\!)/\*_0?_A\#^TI_P!%:\0?]^;;_P"-4?\ #X']I3_HK7B#
M_OS;?_&J/[0J?RK[_P#@!_:F8?\ /J'_ ('+_P"5GY\?\(+KG_0&U7_P$D_P
MH_X077/^@-JO_@))_A7Z#_\ #X']I3_HK7B#_OS;?_&J/^'P/[2G_16O$'_?
MFV_^-4?VA4_E7W_\ /[4S#_GU#_P.7_RL_/C_A!=<_Z VJ_^ DG^%'_""ZY_
MT!M5_P# 23_"OT'_ .'P/[2G_16O$'_?FV_^-4?\/@?VE/\ HK7B#_OS;?\
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MQ!_WYMO_ (U1_:%3^5??_P  /[4S#_GU#_P.7_RL_/C_ (077/\ H#:K_P"
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M6O$'_?FV_P#C5']H5/Y5]_\ P _M3,/^?4/_  .7_P K/SX_X077/^@-JO\
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M[2G_ $5KQ!_WYMO_ (U1_:%3^5??_P  /[4S#_GU#_P.7_RL_/C_ (077/\
MH#:K_P" DG^%'_""ZY_T!M5_\!)/\*_0?_A\#^TI_P!%:\0?]^;;_P"-4?\
M#X']I3_HK7B#_OS;?_&J/[0J?RK[_P#@!_:F8?\ /J'_ ('+_P"5GY\?\(+K
MG_0&U7_P$D_PH_X077/^@-JO_@))_A7Z#_\ #X']I3_HK7B#_OS;?_&J/^'P
M/[2G_16O$'_?FV_^-4?VA4_E7W_\ /[4S#_GU#_P.7_RL_/C_A!=<_Z VJ_^
M DG^%'_""ZY_T!M5_P# 23_"OT'_ .'P/[2G_16O$'_?FV_^-4?\/@?VE/\
MHK7B#_OS;?\ QJC^T*G\J^__ ( ?VIF'_/J'_@<O_E9^?'_""ZY_T!M5_P#
M23_"C_A!=<_Z VJ_^ DG^%?H/_P^!_:4_P"BM>(/^_-M_P#&J/\ A\#^TI_T
M5KQ!_P!^;;_XU1_:%3^5??\ \ /[4S#_ )]0_P# Y?\ RL_/C_A!=<_Z VJ_
M^ DG^%'_  @NN?\ 0&U7_P !)/\ "OT'_P"'P/[2G_16O$'_ 'YMO_C5'_#X
M']I3_HK7B#_OS;?_ !JC^T*G\J^__@!_:F8?\^H?^!R_^5GY\?\ ""ZY_P!
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M/^'P/[2G_16O$'_?FV_^-4?VA4_E7W_\ /[4S#_GU#_P.7_RL_/C_A!=<_Z
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M_P! ;5?_  $D_P */^$%US_H#:K_ . DG^%?H/\ \/@?VE/^BM>(/^_-M_\
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MT!M5_P# 23_"C_A!=<_Z VJ_^ DG^%?H/_P^!_:4_P"BM>(/^_-M_P#&J/\
MA\#^TI_T5KQ!_P!^;;_XU1_:%3^5??\ \ /[4S#_ )]0_P# Y?\ RL_/C_A!
M=<_Z VJ_^ DG^%'_  @NN?\ 0&U7_P !)/\ "OT'_P"'P/[2G_16O$'_ 'YM
MO_C5'_#X']I3_HK7B#_OS;?_ !JC^T*G\J^__@!_:F8?\^H?^!R_^5GY\?\
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M[^UY\/M4\=?LKS:O!KVBPM>:]\*M9N1<:K:Q#EIM,GZWD*C(\LYE^7NSJA^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF_8H^*G[/'PVT3Q;XX\&ZEX7T/Q%.;:PDOWBCGED"%]K6^_SH_E!.71170_
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M3XIZ7X)\$Z7_ &UXFUKS?L=G]IAMO.\J%YI/WDSI&N(XW;YF&<8&20#],_\
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MP26_:-U_X=+XJM?A/XCDTEXQ*BLT$=[(I 8%;1I!<-D$=(^:_0+XL64VF_\
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MN#&['.,GR6MXWMJ?3X>525*,JJY9-*ZWL[:KY,****9L%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_LW?'/PKX\T>.*;4/"NHQ7\<,N?+N I^>)L<[74LIQSACBOTZ_:$\/?LE?\
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MX)5_%S]G;0Y/$WA'X_>%]+DM]?Q)I7B:XLS<'2V\MD>([59D!^5E<*0K [@
M<CXZHJO9:6;9U1R:]"=&K6G)RLW*]FK;<J6B7E;7J?K5^QK\%/V=?^"<WQC7
MXI0_M;:+XBT6&WN5B\/Z>8_.ND>-D"W,4$\LDVW<&53"GSHK=L5YM\,OB[\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR+WZH_9C_@G)_P H]/@/_P!D[\/_ /IMMZ]FKQG_ ()R?\H]/@/_ -D[\/\
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M/5:-I-I>K2/R,HKT+]J#]F/Q9^R%\9=4\#^,K);75]-(=)(FWV]["V?+GB;
MW1N <$@$$$$!@0//:V3NKH]RG5A4@JE-W3U375!1110:!1110 4444 %%%%
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MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZ&_9X_Y1O\
M[7__ &+>A?\ IXBKYYKZ&_9X_P"4;_[7_P#V+>A?^GB*C[2]5^:.',/X<?\
M'3_].1/SQHHHKZ0^R/TV_P"#4K_E(=XR_P"R=7O_ *<]+K^@:OY^?^#4K_E(
M=XR_[)U>_P#ISTNOZ!J^+SS_ 'I^B/Y[\1_^1S+_  Q"OY@?V>_^4WWA7_LL
M\/\ Z>:_I^K^8']GO_E-]X5_[+/#_P"GFNG(=JOHOU/PWC#_ )<>K_0_I^HH
MHKYX^V+6D?\ 'RW^[_45I5FZ1_Q\M_N_U%:5=%/8J(4445H4%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/=
M?\?,G^\?YU'4EU_Q\R?[Q_G4=<9F%?@#_P '5?\ RD+\&_\ 9.[+_P!.6IU^
M_P!7X _\'5?_ "D+\&_]D[LO_3EJ=>QD?^]?)GS/%G_(O?JC]F/^"<G_ "CT
M^ __ &3OP_\ ^FVWKV:O&?\ @G)_RCT^ _\ V3OP_P#^FVWKV:O+K?Q)>K/>
MPO\  AZ+\C^1+_@I3_RD8^/W_91_$7_ISN*\4KVO_@I3_P I&/C]_P!E'\1?
M^G.XKQ2OI:?P+T/W3"_P(>B_(*^V/^"%?_)QOQ0_[)%XJ_\ 2,5\3U]L?\$*
M_P#DXWXH?]DB\5?^D8I5?@9.._@2.+HHHH/L@HHHH **** "BBB@ HHHH **
M** "NN_9]^'(^,/QZ\$>$6(5?%.OV&D$D[<?:+B.+KV^_7(UL?#SQI=?#;Q_
MH?B*Q)%]H.H6^HVY#;<20R+(O/;E1S2>VAG64G!J&]G;U/V"_P"#C?XR:C\%
M?V;_ (;_  T\,LVC:#XLFN4NX;0F-6M+".W6.UX/^J)N$)7OY2^G/Y,_L\?'
MSQ%^S#\9= \<>%;QK36/#]TEP@W,L=T@/SP2A2"T4BY1ER,JQZ=:_9C_ (*?
M_LVM_P %</V*/ ?Q"^$<UOK6J:/YFIZ;9/,D3WD%PJ+<VVYB%2='B3*L0,Q.
MN<XK\_OV)_\ @C;\7OC+^T/H-CXV\ Z_X6\%V%]%<:]=ZO"UBLMJC@R0PEOF
M>21044H" 6W$@#-<E&4%3M+YGP_#>-P-#*94L2TI1<N=.UV[OH]7=67X'G'[
M?O\ P42\1?\ !0S7_#>J>*/#7A?0]2\-V\UI'/I"3JUU%(RL$D\V1^$8,5VX
M_P!:^<\8^P/!'_!+7X"_L,_LRZ'\1OVI=2UR^UOQ 8O*\,V4DMOY$CKO^S!(
MBLTDBKS(Y=$0_+UPS^8_\%G/AY\#_P!E?]I#P-X1^%WA.PTJ^\.C^T_% MKV
MXN3*7>)H+9A,[A6$:.YQU$Z9QCGZ9_X.&_A=KO[2/P!^$?Q#\!VEYXI\)Z2;
MR>YFTV)I\0WT=JUO<%%^;R\0L-Q'RF10<9Y;EI&,=$RJN,C.&#P^%YJ-&KS>
M3LM4D[NW,]M>J/-O''_!+/X#?MR_LR:Y\1OV6]2UNQUOP_YIE\,WDLEQYSHN
M_P"S%)2TT<K+S&X=T<_+URR4?^"0/_!-?X4?MF?L&^/O$'B[08)/&-KKFHZ3
MI>MS:E>01Z6JZ=:20R-%%,D3K'+,[G>IR."2, >L?\&\OPMUW]FWX _%KXB>
M/+6[\+^$]7-G/;3:E&T'[FQCNVN+@(WS>7^^4;L?,8V SCBQ_P $<M7BU_\
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M_P"*]:MM2O)[G4UFL5:2WBBDDDB5YKF6+&R/(&0NW/&/_P '1G_-#?\ N/\
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M%N[R[N-5NHY6:>ZEEEE:18EC>%-J/'SR"3D'@_\ @H1_P3"^">I_L(1_M ?
M)K_3-'MH(+U["2ZN+F"]M7F6WDP+@M+'-'(V6!<KA'&,XJC_ ,'-LC']I3X<
MKN;:OAF0@9X!-U)G^0_*O6/AI_RK$7/_ &"M2_\ 4@GJ$Y*,9W>YPX>KBJ6$
MP>.=><I3G&+3=XM-OIWTW=WKZ'X[U]Z?\$EO^"5GAG]JOX?>(_BK\5-5N]'^
M&_A=Y8Q%!,+<WIAB\VXEDEY,<,2E<E1ECN^8;3GX+K]D?^"?.BM^U5_P04\7
M?#GP?]GC\6Z;#JNG30QR!9;NX:X:]B# 8(\V.1(06R#M(S@$#HQ$FHZ'U'$^
M,K8?"1]E+EYI1BY?RI[O]/F<U^RW\/?V+OC1^V;X*D^!^I^(_!?C/PIK$6I6
M5G?BZET[Q)% 6:5(S<N\BR% 67+(<#[AYVXO_!:#P+I?Q0_X+.? 3PSKMK]N
MT3Q%8>'M,U"V\QXOM%O-KEY'*F]"&7<C,,J01G((/-?-7_!*7]DCXD:W_P %
M"_ ;'PGXCTF'P;K,>I:U<WEA+;QZ?%"2S)(SJ K.5,87J2W'0D?5?_!6'_E.
MM^S3_P!RO_ZD%U6-K5+)WT/GZE)4,V4:=:4[4I.[=VM^OXK_ "/&_P#@KM_P
M3Z^'_P %/VPOA7\/_ACI=CX)LO&EB@NI[W5+B:VAD>[:(SR27$KE$1!DX(&%
M/&:[CXI_ []@[]@F?0] \;0^,/C1KNI60N)[S1-5$EO "[+YC"WNH%CRR-B/
M=(P7KG(8^J?\%;OV=-/_ &LO^"KG[/\ \/\ 5[YM.TGQ!HTPO9DD$<AAADN)
MWC1B"!(ZQ%%)!^9UK@?V\OB1\*?^"97QLTWX=_#W]F#P/XBU+[!#<IK/BFSD
MU07CN/E6!9-S,RE5W.'!W%E"CJ5&3:BKO^O,SPN,K8BAAL/[2<IN#DU&2BWJ
MU=S;OTV5SSC_ (*C_P#!,#X:_ S]E3P=\;?A)J&N0^&_$QLF;3-4E\XF"\@,
M\$T;$!U8  ,C%OO#!&#F7_@F%_P2L^'_ ,2_V<M4^.WQWU:XTOX=V(F>RLTN
M&M4N(8&*2W$TB#S"ID5HTCBP[,IP22JGZE_X+6:KKFN_\$?/!=]XFTV#1O$E
MY<Z%/JNGPP&".QNVM7::%8V)**DA90I)( QDXK,^ ?@VZ_;0_P"#>.;P1X%*
MWGB6QLGL)+)&VN;NTU);PP9X&^6$(1V/GJ">M)5)>SU?6US.GFV+>50YZC7-
M5Y'.]VH][_J<'^RY^QU^Q'^W9^T+:I\-X?$%K#H,4T^K^$-5NKV&+5K4Q&-+
MBWE,IG4QSM$Q'G<@D% ,5Y/_ ,,,?"S_ (?Y_P#"E?\ A%_^+9?] ;^TKO\
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MH>&9O^$4UFSG=;+3/WSA?.4748.) QYADX/X5X7^V1^QSX'_ &./^"R?[/\
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MD8:(6S2[I8YF<HFU_,/[PC:&7#<'_P '//\ R5KX3_\ 8(OO_1T5>M?M!_\
M*M%I_P#V+6@?^G:SK).7+%W>IXM&IC%A<'B%B)\U67(];JS;6SZKN[NYSO[/
M?_!/#]C'_@HU\*]:M?A(?%GAOQ!X;"PW5Y<7=PUZC2 ^5/+!,[PR1DHXQ%LZ
M,#M.TU\(_L<_L(V?QP_;#UCX<^/O%FF^!-'\&W%U'X@U"XNHK>3=;S>0UO 9
MB%\UY.!N!VJKL5;;M/UM_P &PW_)6OBQ_P!@BQ_]'2U7_8Q_8$\#_MN_\%2O
MVF+GQ^LFHZ'X+\8:G*FD1W;6QU":?4[L*SE")#$BQ-D(5^9X\G&0U\S@Y1;T
M/2^O5<#6QE"=:3A",6F_>DG*VU[7U>E]$:+^ O\ @GAX6^-T/PC;P]XQ\0:Y
M-J,6C#Q-%J=W)9BYE*H,21W"(RJ[!2ZP%,Y(RO-?._\ P6,_X)LZ/_P3V^*/
MAE_"NI:A?>$O&MO<2646H.LEU936YB$T9=0H=/WT;*Q4'YBIR5W'Z'\%?M*6
MW@K]O2U^&'P>_9/\":#=:?XH32TU?5M$EO-7M88I]LMZ)#@P;8P90VYE4 $E
MA6U_P=&?\T-_[C__ +C*(2DII:Z^9GE^)Q-+,\/1<Y\M2+;4YJ5[1;3LK\NJ
M[GIW[7'_  1 _9Y\-?\ ".^(8VM?A1X!\.M<7GBS4'UNZFEO8L1B"WC-U+(L
M99R_S*"QX4!F9<>>_L$:#\"_#G_!7WP[:_L^WBW_ (/7X<7/V^X\Z[E:74?M
M4@D+&XPP8Q"#A $Z$#)-=Q_P<R>(+RR_94\!Z=#<21V5_P"*?,N(EX$QCM9M
MF3UP-[''3.#U Q\?_P#!NU_RD1C_ .Q:U#^<-1'F=)R;.+!0Q-?)*F,Q%:4O
M=DDF]/5WU;[:Z(^AOCW_ ,$O=0_;C_X*^_%CQ)XG>XT'X3^&7TJ35M48^3]O
M9-'L6:VA=N!\O,DG2-?=EKY"_;DT7X)_%/\ :-T;X8?LR?#V&-I-233/[<75
MK^\;6[N1Q&$@6>=T6W5C_K"N6QD$(,M^N.H?\%#O"7C+_@H1XN_9A\4:';PV
MLVC16\-Y=SAH=9GN+19YK0QXQM:WG4+DY+1R#!W+7YU>'?V5+/\ X)<?\%I_
MAS;^(%\SX>:IJTDWA[4;R8",07$4MO%YLF,"2VGECWDXR$5SM5P:=.;Z]%HC
M?)<PQ"TQ%U*%).G!.T9)1W=GJW;9[:]CO_&?[!'[(G_!-+0O#NG_ +0.J^(?
M'WCK7+47<NGZ;)<Q6\2'*&2-(&B=8@ZLJM))N<JQ"C!5?,_^"A'_  2P\ ^&
M/V6=+^/WP!US4-;^'=TB27]E>R&62VC>7R1-$Q57VI+^[DCDRRMDYP"!]J?\
M%5/VA='_ &=/BWIEYX@_9(\-_&C3]3TZ,1>*[NWAF:)P\@-G(7L)RA7&]07P
M1)D#(8#S?X[_ +7'CS3_ /@FIXT5OV2]'^$_PS\0:+=V$1;Q7::;]@DNMT4<
MZ:<+.*1F,SK(%"J9,9S@[J493TE^J_(QP..S!^PQ2E)N<DGS5(<LDWJHQNFG
MVZGE/_!'[_@FO\+_ -LS]@_Q]XA\2>$X]8\=VNNZAI.BW\FK7MJEN5T^TD@#
M)#*L9"S3,Q+(Q.<'( %<[^TQ^Q%^R]\ _P!GO6OA[X?\<6WC7]I W.FZ;;R?
M;+CR8;R34+>.X1$A'V==L3RJ4E9W7:>CCCZ0_P"#>S5KC0/^":'Q*OK23R;J
MR\5ZI/"^T-L==*L&4X.0<$#@C%?CGX#TC4/'7Q*T73[34(;/5M9U."WAOKRY
M,,<,\LJJLLDIY4!F#,_8 FM8\TIRUT1ZV#CB<3F.)YJ\HPIR323T[V?]W35*
MU[GZI?&W_@G[^R/_ ,$P/AYX1E^-.A^//B)J_BA98/M-E//' )XA&TK*L,T
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M&[8;;M/UL/@I_P $[F^,'_"G_,\3?\))]O\ [*_X2?\ M2[^R_:L[/+\[?\
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M!C$;21 \_P#+48[U\<>#_P#@DA\>%_:YL_!K>!_$UO;VNN*C^)I;*5=)$"3
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M5^SE^T]XZ_9-^(D7BCP#X@O/#^K*GE2F/#PW<603%-$P*2(2 <,#@@$8(!'
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MT7QAX6U!]+\0>'[E;NRN517\MQQRK JRD$@J0002#P:^DOVL?^"SGQ6_;+^
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M?M<>![SP'JUO'9ZIX9)O]+OX/M%C>E;N7:S)D%6&2-Z,K8.,XXK\<M U^_\
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M/#$\9D:3+"6:4ELL>00,=J\-HHY5>YL\'1=6-;E7-%63[+LCZ3T/_@J1\0-
M_83D_9[AT?P<W@N2WGMC>O:7)U3;+>/=L?,$XBR)'('[K[N!R>:Y;]D+_@H+
M\5/V']3NI/ /B$VNGZ@P>\TJ\A%U873#'S&)ONO@ ;T*M@8SCBO%:*/9QVMN
M9?V;A>2=-TU:;;DK7NWU?F?97[1?_!=OX^?M%>"+SP[)?>'?!VEZE ;:\7PW
M8R6\US&<[E\Z:661-PX/ELN1QT)S\:T441BHZ1-,'@</A8\F'@HKR1TGPB^+
M/B#X$_$S1?&'A;4'TOQ!X?N5N[*Y5%?RW''*L"K*02"I!!!(/!KZ2_:Q_P""
MSGQ6_;+^ 4WP[\7:7X'CTNXG@N)KW3["XAO97A;<I):=HQD]<1CVQ7R310X1
M;NR:V7X:M5C6JP3E'9]4?2?[=W_!4CX@?\%"M \.Z;XTT?P=I<'AFXFN;5M%
MM+F%I&E558/YL\H( 48P!WZT?LL_\%2/B!^R-^S=XJ^%WAO1_!U]X?\ %]Q=
MW-Y<:E:7,EY$US:Q6KB-HYT0 )$I&Y&PQ).1@#YLHI>SC;EMH9_V7A%06&]F
MN1.Z72][_F=A\"_C]XP_9I^(MGXL\#Z]?>'=>LN$N+<@B1"03'(C I)&<#*.
M"IP,BOK_ %C_ (.*OVAM3\&KI<(\":=?*N#J]OHSM>,>>2LDKP9Y!XB X'OG
MX0HIRIQEJT/%97@\3)3Q%-2:ZM?U]QVWAC]H/Q-H'[0VD?%"\O6\0>+=)UVV
M\1?:-5=YQ>W4$R3+YQ#*S*60 @,IV\ CC'>?MT_M^^,O^"@GCG1?$'C+3?#.
MF7FA6)T^W31;>>&)XS(TF6$LTI+98\@@8[5X;11RJ]S9X.BZL:W*N:*LGV79
M'M'[&_[?OQ+_ &$_$6H7W@'5K>"VU<(-0TZ^MQ<65[LSL9DR"K+D@,C*V"1G
M'%>Y>+?^#@']H;Q7XXT?5AJ'AG2['2;M;PZ-8:<\-C?%01Y<[&0SO&<G*"8
MG!Z@8^):*4J<6[M'-7RC!5JCK5:492?5K4_0K_@GW^UYXA_;?_X+;?#/QYXH
MTOP_I6M7%GJ%G-'HT,T-O*(M'O@KE9996W;2%.& PHXSDGU;_@I9_P %3OBW
M^PC_ ,%%?%ND^#]1TW4/#MU8:=<OHVLVS75FLIM4!=-KI)&3QD(X!(!()K\M
M? OC_7OA?XJM==\,ZUJWAW6['?\ 9M0TR\DM+JWWHR/LEC(9=R,RG!&0Q'0F
MI/B!\2O$7Q9\2R:UXJU_6O$VL3(L<E_JM]+>7,BJ,*#)(S,0!P 3P*AT4Y7Z
M6L>;4X=H5,9&M.*=-4^3E:[.Z?R/4?VR?^"@?Q-_;L\0V=YX\UB&2STO<;#2
MK"'[/861;[S+'DEG/3>[,V.,XXKJ-#_X*D?$#0/V$Y/V>X='\'-X+DMY[8WK
MVER=4VRWCW;'S!.(LB1R!^Z^[@<GFOFRBM/9QM:QZW]FX7V<*7(N6#32MHFN
MOJ>F?LO_ +7_ ,0_V./'+^(/A[XBN-$N[A1'=P[%FM;Y!G"S0N"C@9."1E22
M5(/-?2_Q._X.$OVA?B+X-;1[6X\(>%))86@EU#1=,D2\D#*%+!YI951NI#1J
MI!.1@@8^'**4J<6[M$XC*<'B*BJUJ49275K^K_,W/"7Q+\0>!/']KXJT?6M2
MT_Q)8W7VV'4H9V%RDV23)OZEB2<DYSDYSDU]I^&_^#BK]H;0_#36-T/ FL73
M*%&HWFC.MRI]0(98XLGWCQ[5\(44Y4XRW16+RS"8JWUBFI6VNCT/]I;]JOQY
M^UY\03XF^('B"XUW4UC\B ,BQ06<621'%&@"HN23P,D\DD\UYY115))*R.JG
M2A3@J=-));):)!1110:!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5]E?LI?\%Q/BQ^Q]\ M!^'/AGP]\.[[1/#OVC[-/J=A>2W3
M^=<RW#[VCND4X>5@,(. .IR3\:T5,HJ2M(Y<9@:&*A[/$14DG>S[_P!,_0?4
MO^#E#X]7UC)#%X=^%EG)(,+-#I5Z9(_<![QE_,&OE+]JS]N+XG?MJ:_:7WQ"
M\2SZNFF[A964<26]G9;L!BD2 +N.!ECEC@ G  KR6BIC3A'5(Y\+DV!PT_:4
M*48R[VU^\^G/!W_!5SXB>"/V')O@#:Z+X+D\&S6-Y8->2VER=3$=S<2W$A$@
MN!%N#RL ?*P !D$Y)\__ &3OVY/B9^Q1XEN=1^'WB*;2X]0VB^L)HUN+&^VY
MVF2)LJ6&3AQAAD@$ D'R.BJY(ZJVYJLMPJC.'LU:;O)6NFWU9]O?%/\ X."/
MVAOB5X2?2;6^\*^$S-#Y,M[H>F/'=OV+!YI90C'UC"D=L5\D?##XM:M\*_C-
MX=\=VIAU#7/#>M6VO0F_WS1W-S!.LZ^=AE=E9U&[#!B">0>:YBBB-.,=$A8;
M+<+AX.%"FHJ6]EOZGO7[=W_!1'QK_P %"?$7A[4_&FE^%]+N/#=M+:VJZ+;3
MPI(LC*S%Q+-*2<J,8(_&NB\8_P#!5SXB>-_V'(?@#=:+X+C\&PV-G8+>16ER
M-3,=M<17$9,AN#%N+Q*"?*P03@ X(^8Z*7LXV2ML)97A5"%-05H.\5V>]T>]
M?L(_\%$?&O\ P3V\1>(=3\%Z7X7U2X\26T5K=+K5M/,D:QLS*4$4T1!RQSDG
M\*S_ (<?M_\ Q)^#W[4GB;XN>%=2M-#\3>+M0O+_ %2W@M_,L+@74YGEA,4A
M8F(.?ERQ9=H(;(S7BM%/DC>]BY9?AI3G4E!-S5I7ZI=&?;GQ<_X. OVA/BIH
M4>GV][X7\(1_+YTN@:?)#/< ,#@R2RR,F<8)C*'!(R,UY?\ MY?\%-?'7_!0
M^S\+Q>-M$\&Z:WA)[E[*31;6YA=A<"(2*_FSR@C]S&1@ \5\YT5,:<$[I&&'
MR7 T)QJ4:2BXWLTM=='^!].?MT_\%7/B)_P4$\$Z+H/C/1?!>F6>@WS7]N^B
MVES#(\AC,9#F6XE!7!/  .>]>=_L8_MB^)OV&?C,OCGPE8Z#J&K+8S6'DZO#
M+-;^7+MW';%)&VX;1@[L=>#7D]%5R12Y;:&U/+L-"@\+""4'?3IKN>I?M"?M
M?>+OVB_VHK[XO:A_9^@^,+VXL[M'T9)((;26U@AAB>(2/(X($",<L?FST' ]
M6_;-_P""N'C[]NWX3V7A/QUX4^'.W3;E+NTU2PTZZAU&VD VL4=KED D7AUV
M;3P< JI'RO11[..FFP/+<,W3ER*]/2/DO(^QOV<O^"Z?Q\_9S\'6F@1ZGH/C
M#2]/B$%I'XDLI+F2WC  51+%)%*P &!O9L#CI@5Y7^U]_P %%_BQ^W!+:Q^.
M_$7G:38OYMMI%C"+6PA?D;_+7EW ) 9RS $@$ FO#:*2IQ3ND13RG!4ZWUBG
M2BI][(^G/V0?^"KGQ$_8K^ OB#X=^%=%\%ZAHOB2^N+^YGU6TN9;I))[>*W<
M(T=Q&H4)"I *DY)R2, ?,8.TY%%%-12=T=%'"4:4Y5*<;.6K?<^T?@)_P7K_
M &@/@3X2L]$:_P##?C.QT^W%M;'Q'823SQ(N-N9898I)" ,9D9CCKGC'F?[8
MG_!4+XP?MPZ3#I/C37+6'P[;S_:4T;2K46EF9!T9QDO)M[>8[!>2,$DU\]45
M/LX)W2.6GD^!IU?;PI14N]E_2"BBBM#T@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KV;]AW]N+Q9^P'\6-0\8^#M/\.ZEJ>I:3)HTL6L
MP330+#)-#,6412Q-OW0( 2Q&"W&<$>,T4I135F8UZ%.M3=*JKQ>Z/9OB?^W%
MXL^+/[:MK\=]2T_P[#XNM=7TS64L[:"9=-,U@MNL*E&E:38PMTW#S,G+8*Y&
M+G[=/[?OC+_@H)XYT7Q!XRTWPSIEYH5B=/MTT6WGAB>,R-)EA+-*2V6/((&.
MU>&T4N1:/L8QP&'C*$XP5X*T?);61])ZY_P5(^(&O_L)Q_L]S:/X.7P7';P6
MPO4M+D:IMBO$NU/F&<Q9,B ']U]W(X/-'["/_!4CX@?\$]= \1:;X+T?P=JD
M'B:XAN;IM:M+F9HVB5E4)Y4\0 (8YR#VZ5\V44O9QM:QG+*\(Z4J+IKED^9K
MN^_X(^A_V"O^"EWCO_@G=_PE?_"$Z3X2U3_A,/LGVS^V[6XG\K[-Y_E^7Y,\
M6,_:'SNW9PN,<Y\R^$W[0.L_!S]H72?B5I=KID^NZ-J_]LPP74;M:--O+[65
M75RF3T#@X[UPM%/E5V^YM]1H<\ZG*KS5I/NDK:_(]F_;B_;B\6?M^?%C3_&/
MC'3_  [INIZ;I,>C11:-!-# T,<TTP9A++*V_=.X)# 8"\9R3UO[4W_!4CX@
M?M<_LW>%?A=XDT?P=8^'_"%Q:7-G<:;:7,=Y*UM:RVJ"1I)W0@I*Q.U%RP!&
M!D'YLHH]G'338B.6X9*FE!?N_A\O0^B/V)O^"H'Q6_8)L[[3_!=]I=[H.I3_
M &J?1]8MFN;,S;0IE4*Z.C%0H.QQNVKG.T8].D_X+X_'RZ^-=GXRNI_"MU'I
MMM/;VN@-8S1Z/"9MH:0I',LLD@"X5I)6V@MC[QS\4T5+IP;NT95LFP-6HZM2
ME%REN[:_UY[GTG\%_P#@J1\0/@7^U[XU^-6DZ/X.N/%/CNWN+:_M;RTN7T^%
M9YX9W,2+.L@(:! -TC<%LY."/&OCU\9M4_:(^,OB3QQK5O86NK>*+^34+N*Q
M1TMXY'.2$5V9@OH"Q/O7(T52@D[HZ*6!H4JGM:<4I62OY+9'TG^W=_P5(^('
M_!0K0/#NF^--'\':7!X9N)KFU;1;2YA:1I556#^;/*" %&, =^M6/V0_^"NG
MQJ_8O\+P^'_#>M6.L>&;9R]OH^NVQN[:UR266(JR2QJ222JN%R2< DD_,E%+
MV<;<MM#'^R<'[#ZJZ:Y%TMH?3?[7G_!73XU?MH>%YO#_ (DUJQT?PS<N'N-'
MT*V-I;76""JREF>6100"%9RN0#@D CYDHHIQBHJR.C"X2CAH>SH145V2L%>M
M?LG?MP_$O]BCQ1<ZG\/O$4VEKJ 5;ZPFC%Q8WX7.WS(6^4LN3AQAAD@$ D'R
M6BFTFK,TK4:=:#IU8J47NGJC[:^,/_!?_P#:%^+/@^71[?4/#/@U;B'R)KSP
M_I\D%XX/5A+++*8V/]Z/81VP>:^:_P!EK]I_Q#^R3^T)HGQ*\/V^EZEX@T%K
MEX8]626:WF,]O+;N9 CH[';,Q&''S $Y&0?.:*E4XI62..CE>$HTI4:5-*,M
M&DMT]-3U#]L#]K+Q%^VM\<+[Q]XJLM%T_6-0MX+:2'2H98K8+$@12%DDD;)
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MHHKYX^V+6D?\?+?[O]16E6;I'_'RW^[_ %%:5=%/8J(4445H4%%%% !1110
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MM_T"]0_\!G_PH_X1'5O^@7J'_@,_^%%PYEW,^BM#_A$=6_Z!>H?^ S_X4?\
M"(ZM_P! O4/_  &?_"BX<R[F?16A_P (CJW_ $"]0_\  9_\*/\ A$=6_P"@
M7J'_ (#/_A1<.9=S/HK0_P"$1U;_ *!>H?\ @,_^%'_"(ZM_T"]0_P# 9_\
M"BX<R[F?16A_PB.K?] O4/\ P&?_  H_X1'5O^@7J'_@,_\ A1<.9=S/HK0_
MX1'5O^@7J'_@,_\ A1_PB.K?] O4/_ 9_P#"BX<R[F?16A_PB.K?] O4/_ 9
M_P#"C_A$=6_Z!>H?^ S_ .%%PYEW,^BM#_A$=6_Z!>H?^ S_ .%'_"(ZM_T"
M]0_\!G_PHN',NYGT5H?\(CJW_0+U#_P&?_"C_A$=6_Z!>H?^ S_X47#F7<SZ
M*T/^$1U;_H%ZA_X#/_A1_P (CJW_ $"]0_\  9_\*+AS+N9]%:'_  B.K?\
M0+U#_P !G_PH_P"$1U;_ *!>H?\ @,_^%%PYEW,^BM#_ (1'5O\ H%ZA_P"
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M S_X4?\ "(ZM_P! O4/_  &?_"BX<R[F?16A_P (CJW_ $"]0_\  9_\*/\
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M  B.K?\ 0+U#_P !G_PH_P"$1U;_ *!>H?\ @,_^%%PYEW,^BM#_ (1'5O\
MH%ZA_P" S_X4?\(CJW_0+U#_ ,!G_P *+AS+N9]%:'_"(ZM_T"]0_P# 9_\
M"C_A$=6_Z!>H?^ S_P"%%PYEW,^BM#_A$=6_Z!>H?^ S_P"%'_"(ZM_T"]0_
M\!G_ ,*+AS+N9]%:'_"(ZM_T"]0_\!G_ ,*/^$1U;_H%ZA_X#/\ X47#F7<S
MZ*T/^$1U;_H%ZA_X#/\ X4?\(CJW_0+U#_P&?_"BX<R[F?16A_PB.K?] O4/
M_ 9_\*/^$1U;_H%ZA_X#/_A1<.9=S/HK0_X1'5O^@7J'_@,_^%'_  B.K?\
M0+U#_P !G_PHN',NYGT5H?\ "(ZM_P! O4/_  &?_"C_ (1'5O\ H%ZA_P"
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M6_Z!>H?^ S_X4?\ "(ZM_P! O4/_  &?_"BX<R[F?16A_P (CJW_ $"]0_\
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MZM_T"]0_\!G_ ,*+AS+N9]%:'_"(ZM_T"]0_\!G_ ,*/^$1U;_H%ZA_X#/\
MX47#F7<SZ*T/^$1U;_H%ZA_X#/\ X4?\(CJW_0+U#_P&?_"BX<R[F?16A_PB
M.K?] O4/_ 9_\*/^$1U;_H%ZA_X#/_A1<.9=S/HK0_X1'5O^@7J'_@,_^%'_
M  B.K?\ 0+U#_P !G_PHN',NYGT5H?\ "(ZM_P! O4/_  &?_"C_ (1'5O\
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M $"]0_\  9_\*/\ A$=6_P"@7J'_ (#/_A1<.9=S/HK0_P"$1U;_ *!>H?\
M@,_^%'_"(ZM_T"]0_P# 9_\ "BX<R[F?16A_PB.K?] O4/\ P&?_  H_X1'5
MO^@7J'_@,_\ A1<.9=S/HK0_X1'5O^@7J'_@,_\ A1_PB.K?] O4/_ 9_P#"
MBX<R[F?16A_PB.K?] O4/_ 9_P#"C_A$=6_Z!>H?^ S_ .%%PYEW,^BM#_A$
M=6_Z!>H?^ S_ .%'_"(ZM_T"]0_\!G_PHN',NYGT5H?\(CJW_0+U#_P&?_"C
M_A$=6_Z!>H?^ S_X47#F7<SZ*T/^$1U;_H%ZA_X#/_A1_P (CJW_ $"]0_\
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M $"]0_\  9_\*+AS+N9]%:'_  B.K?\ 0+U#_P !G_PH_P"$1U;_ *!>H?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(VAD9'5E93AE(P0?0U[N$K*I37='[)D>/ABL)%K>*2:\U_GN-IT=-IT==1[
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M_&J/^'Y7[67_ $6WQ5_WZMO_ (U7RA11[&'\J^XJ.6X3_GU'_P !7^1]7_\
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M/J__ (?D_M9?]%L\4_\ ?JU_^-4?\/R?VLO^BV>*?^_5K_\ &J^4**CV-/\
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MLO\ HMGB?_OQ:_\ QJOD^BJCAZ7\J^Y%1R? ?\^(?^ Q_P CZP_X?E_M9?\
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MQ:__ !JOE"BCZO2_E7W(/[&R_P#Y\0_\!C_D?5__  _)_:P_Z+7XG_[\6O\
M\:H_X?D_M8?]%K\3_P#?BU_^-5\H44?5Z7\J^Y!_8V7_ //B'_@,?\CZO_X?
MD_M8?]%K\3_]^+7_ .-4?\/R?VL/^BU^)_\ OQ:__&J^4**/J]+^5?<@_L;+
M_P#GQ#_P&/\ D?5A_P""Y?[66?\ DMGB?_OQ:_\ QJC_ (?F_M9?]%L\3?\
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M^3Z*/JU'^5?<@_L/+O\ H'A_X!'_ "/K#_A^7^UC_P!%K\3?^ ]I_P#&J/\
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M_L/+O^@>'_@$?\CZP_X?F?M9?]%J\3?^ ]I_\9H_X?F?M9?]%J\3?^ ]I_\
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M_L/+O^@>'_@$?\CZP_X?F?M9?]%J\3?^ ]I_\9H_X?F?M9?]%J\3?^ ]I_\
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M_L/+O^@>'_@$?\CZP_X?F?M9?]%J\3?^ ]I_\9H_X?F?M9?]%J\3?^ ]I_\
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M%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC^TJOE_7S#_7+&_RQ^Y__)'\R/\ Q#A_M>?]$VT__P *C2__ )(H_P"(</\
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M=E_7S'_KUF'\L/N?_P D?S,?\0XW[7/_ $3G3?\ PI],_P#C]+_Q#B_M<_\
M1.=-_P#"GTS_ ./U_3-11_:U;LOZ^8?Z]YA_+#[G_P#)'\S:_P#!N1^UP!_R
M3G3?_"GTS_X_1_Q#D_M<?]$YTW_PI],_^/U_3)11_:U;LOZ^8?Z]YA_+#[G_
M /)'\S?_ !#D_M<?]$YTW_PI],_^/T?\0Y/[7'_1.=-_\*?3/_C]?TR44?VM
M6[+^OF5_KYF/\L/N?_R1_,W_ ,0Y/[7'_1.=-_\ "GTS_P"/T?\ $.3^UQ_T
M3G3?_"GTS_X_7],E%']K5NR_KYA_KYF/\L/N?_R1_,W_ ,0Y/[7'_1.=-_\
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M !#E_M<?]$ZTW_PI],_^/U_3#13_ +8K]E]W_!#_ %\S'^6'W/\ ^2/YGO\
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MUM_T3W2__"FTW_X_7]+E%']N8CLON?\ F5_Q$C-/Y8?<_P#Y(_FC_P"(<O\
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ME_\ )'\T_P#Q#F?M:?\ 1/\ 2_\ PIM._P#CU'_$.9^UI_T3_2__  IM._\
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M_M[$]E]S_P P_P"(G9M_)3^Z7_R1_-/_ ,0YG[6G_1/]+_\ "FT[_P"/4?\
M$.9^UI_T3_2__"FT[_X]7]+%%']O8GLON?\ F'_$3LV_DI_=+_Y(_FG_ .(<
MS]K3_HG^E_\ A3:=_P#'J/\ B',_:T_Z)_I?_A3:=_\ 'J_I8HH_M[$]E]S_
M ,P_XB=FW\E/[I?_ "1_-/\ \0YG[6G_ $3_ $O_ ,*;3O\ X]1_Q#F?M:?]
M$_TO_P *;3O_ (]7]+%%']O8GLON?^8?\1.S;^2G]TO_ )(_FG_XAS/VM/\
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M_B',_:T_Z)_I?_A3:=_\>K^EBBC^WL3V7W/_ ##_ (B=FW\E/[I?_)'\T_\
MQ#F?M:?]$_TO_P *;3O_ (]1_P 0YG[6G_1/]+_\*;3O_CU?TL44?V]B>R^Y
M_P"8?\1.S;^2G]TO_DC^:?\ XAS/VM/^B?Z7_P"%-IW_ ,>H_P"(<S]K3_HG
M^E_^%-IW_P >K^EBBC^WL3V7W/\ S#_B)V;?R4_NE_\ )'\T_P#Q#F?M:?\
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M9M_)3^Z7_P D?S3_ /$.9^UI_P!$_P!+_P#"FT[_ ./4?\0YG[6G_1/]+_\
M"FT[_P"/5_2Q11_;V)[+[G_F'_$3LV_DI_=+_P"2/YI_^(<S]K3_ *)_I?\
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M^)H_U?Q'>/WO_(/]<L%_+/[E_P#)'](%%?S?_P#$2'^U3_T-7AO_ ,)VU_\
MB:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\ Y(_I HK^;_\
MXB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XFC_5_$=X_>_\
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M7AO_ ,)VU_\ B:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\
MY(_I HK^;_\ XB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XF
MC_5_$=X_>_\ (/\ 7+!?RS^Y?_)'](%%?S?_ /$2'^U3_P!#5X;_ /"=M?\
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ME_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^)H_XB0_VJ?\ H:O#?_A.VO\
M\31_J_B.\?O?^0?ZY8+^6?W+_P"2/Z0**_F__P"(D/\ :I_Z&KPW_P"$[:__
M !-'_$2'^U3_ -#5X;_\)VU_^)H_U?Q'>/WO_(/]<L%_+/[E_P#)'](%%?S?
M_P#$2'^U3_T-7AO_ ,)VU_\ B:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!
M_KE@OY9_<O\ Y(_I HK^;_\ XB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U
M>&__  G;7_XFC_5_$=X_>_\ (/\ 7+!?RS^Y?_)'](%%?S?_ /$2'^U3_P!#
M5X;_ /"=M?\ XFC_ (B0_P!JG_H:O#?_ (3MK_\ $T?ZOXCO'[W_ )!_KE@O
MY9_<O_DC^D"BOYO_ /B)#_:I_P"AJ\-_^$[:_P#Q-'_$2'^U3_T-7AO_ ,)V
MU_\ B:/]7\1WC][_ ,@_URP7\L_N7_R1_2!17\W_ /Q$A_M4_P#0U>&__"=M
M?_B:/^(D/]JG_H:O#?\ X3MK_P#$T?ZOXCO'[W_D'^N6"_EG]R_^2/Z0**_F
M_P#^(D/]JG_H:O#?_A.VO_Q-'_$2'^U3_P!#5X;_ /"=M?\ XFC_ %?Q'>/W
MO_(/]<L%_+/[E_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^)H_XB0_VJ?\
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M]R_^2/Z0**_F_P#^(D/]JG_H:O#?_A.VO_Q-'_$2'^U3_P!#5X;_ /"=M?\
MXFC_ %?Q'>/WO_(/]<L%_+/[E_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^
M)H_XB0_VJ?\ H:O#?_A.VO\ \31_J_B.\?O?^0?ZY8+^6?W+_P"2/Z0**_F_
M_P"(D/\ :I_Z&KPW_P"$[:__ !-'_$2'^U3_ -#5X;_\)VU_^)H_U?Q'>/WO
M_(/]<L%_+/[E_P#)'](%%?S?_P#$2'^U3_T-7AO_ ,)VU_\ B:/^(D/]JG_H
M:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\ Y(_I HK^;_\ XB0_VJ?^AJ\-
M_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XFC_5_$=X_>_\ (/\ 7+!?RS^Y
M?_)'](%%?S?_ /$2'^U3_P!#5X;_ /"=M?\ XFC_ (B0_P!JG_H:O#?_ (3M
MK_\ $T?ZOXCO'[W_ )!_KE@OY9_<O_DC^D"BOYO_ /B)#_:I_P"AJ\-_^$[:
M_P#Q-'_$2'^U3_T-7AO_ ,)VU_\ B:/]7\1WC][_ ,@_URP7\L_N7_R1_2!1
M7\W_ /Q$A_M4_P#0U>&__"=M?_B:/^(D/]JG_H:O#?\ X3MK_P#$T?ZOXCO'
M[W_D'^N6"_EG]R_^2/Z0**_F_P#^(D/]JG_H:O#?_A.VO_Q-'_$2'^U3_P!#
M5X;_ /"=M?\ XFC_ %?Q'>/WO_(/]<L%_+/[E_\ )'](%%?S?_\ $2'^U3_T
M-7AO_P )VU_^)H_XB0_VJ?\ H:O#?_A.VO\ \31_J_B.\?O?^0?ZY8+^6?W+
M_P"2/Z0**_F__P"(D/\ :I_Z&KPW_P"$[:__ !-'_$2'^U3_ -#5X;_\)VU_
M^)H_U?Q'>/WO_(/]<L%_+/[E_P#)'](%%?S?_P#$2'^U3_T-7AO_ ,)VU_\
MB:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\ Y(_I HK^;_\
MXB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XFC_5_$=X_>_\
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M7AO_ ,)VU_\ B:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\
MY(_I HK^;_\ XB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XF
MC_5_$=X_>_\ (/\ 7+!?RS^Y?_)'](%%?S?_ /$2'^U3_P!#5X;_ /"=M?\
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ME_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^)H_XB0_VJ?\ H:O#?_A.VO\
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MO_(/]<L%_+/[E_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^)H_XB0_VJ?\
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M]R_^2/Z0**_F_P#^(D/]JG_H:O#?_A.VO_Q-'_$2'^U3_P!#5X;_ /"=M?\
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M^)H_U?Q'>/WO_(/]<L%_+/[E_P#)'](%%?S?_P#$2'^U3_T-7AO_ ,)VU_\
MB:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\ Y(_I HK^;_\
MXB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XFC_5_$=X_>_\
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M7AO_ ,)VU_\ B:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\
MY(_I HK^;_\ XB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XF
MC_5_$=X_>_\ (/\ 7+!?RS^Y?_)'](%%?S?_ /$2'^U3_P!#5X;_ /"=M?\
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ME_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^)H_XB0_VJ?\ H:O#?_A.VO\
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MO_(/]<L%_+/[E_\ )'](%%?S?_\ $2'^U3_T-7AO_P )VU_^)H_XB0_VJ?\
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M]R_^2/Z0**_F_P#^(D/]JG_H:O#?_A.VO_Q-'_$2'^U3_P!#5X;_ /"=M?\
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M^)H_U?Q'>/WO_(/]<L%_+/[E_P#)'](%%?S?_P#$2'^U3_T-7AO_ ,)VU_\
MB:/^(D/]JG_H:O#?_A.VO_Q-'^K^([Q^]_Y!_KE@OY9_<O\ Y(_I HK^;_\
MXB0_VJ?^AJ\-_P#A.VO_ ,31_P 1(?[5/_0U>&__  G;7_XFC_5_$=X_>_\
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MG]X?5:'\B^Y'GO\ PR1\*?\ HF/P]_\ "<L__C='_#)'PI_Z)C\/?_"<L_\
MXW7H5%'MJG\S^\/JM#^1?<CSW_ADCX4_]$Q^'O\ X3EG_P#&Z/\ ADCX4_\
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M_P#1,?A[_P"$Y9__ !NO0J*/;5/YG]X?5:'\B^Y'GO\ PR1\*?\ HF/P]_\
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M'PI_Z)C\/?\ PG+/_P"-UZ%11[:I_,_O#ZK0_D7W(\]_X9(^%/\ T3'X>_\
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M_#)'PI_Z)C\/?_"<L_\ XW7H5%'MJG\S^\/JM#^1?<CSW_ADCX4_]$Q^'O\
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M^$Y9_P#QNC_ADCX4_P#1,?A[_P"$Y9__ !NO0J*/;5/YG]X?5:'\B^Y'GO\
MPR1\*?\ HF/P]_\ "<L__C='_#)'PI_Z)C\/?_"<L_\ XW7H5%'MJG\S^\/J
MM#^1?<CSW_ADCX4_]$Q^'O\ X3EG_P#&Z/\ ADCX4_\ 1,?A[_X3EG_\;KT*
MBCVU3^9_>'U6A_(ON1Y[_P ,D?"G_HF/P]_\)RS_ /C='_#)'PI_Z)C\/?\
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M11[:I_,_O#ZK0_D7W(\]_P"&2/A3_P!$Q^'O_A.6?_QNC_ADCX4_]$Q^'O\
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M?_"<L_\ XW7H5%'MJG\S^\/JM#^1?<CSW_ADCX4_]$Q^'O\ X3EG_P#&Z/\
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MNC_ADCX4_P#1,?A[_P"$Y9__ !NO0J*/;5/YG]X?5:'\B^Y'GO\ PR1\*?\
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M /C='_#)'PI_Z)C\/?\ PG+/_P"-UZ%11[:I_,_O#ZK0_D7W(\]_X9(^%/\
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MG]X?5:'\B^Y'GO\ PR1\*?\ HF/P]_\ "<L__C='_#)'PI_Z)C\/?_"<L_\
MXW7H5%'MJG\S^\/JM#^1?<CSW_ADCX4_]$Q^'O\ X3EG_P#&Z/\ ADCX4_\
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M44 %%%% !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_@ITW_Y/H_XBJ_V>O^A-^,W_ (*=-_\ D^C^S,5_(P_M[+_^?J/TRHK\S?\
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M_@ITW_Y/H_XBJ_V>O^A-^,W_ (*=-_\ D^C^S,5_(P_M[+_^?J/TRHK\S?\
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M_@ITW_Y/H_XBJ_V>O^A-^,W_ (*=-_\ D^C^S,5_(P_M[+_^?J/TRHK\S?\
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M]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\
M0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945
M^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D
M8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %
M.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$
M57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&
M;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_
M !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]
ME_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__
M "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^S
MU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4
MZ;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5
M_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\
MS]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1
M_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)
MOQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\
MGT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?
M]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^
MF5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*
M_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_
M\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\
M15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\
M9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?
MF;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?
MV]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F
M_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[
M/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\
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M]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\
M0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945
M^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D
M8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %
M.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$
M57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&
M;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_
M !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]
ME_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__
M "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^S
MU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4
MZ;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5
M_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\
MS]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1
M_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)
MOQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\
MGT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?
M]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^
MF5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*
M_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_
M\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\
M15?[/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\
M9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F_P#R?1_9F*_D8?V]E_\ S]1^F5%?
MF;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[/7_0F_&;_P %.F__ "?1_9F*_D8?
MV]E__/U'Z945^9O_ !%5_L]?]";\9O\ P4Z;_P#)]'_$57^SU_T)OQF_\%.F
M_P#R?1_9F*_D8?V]E_\ S]1^F5%?F;_Q%5_L]?\ 0F_&;_P4Z;_\GT?\15?[
M/7_0F_&;_P %.F__ "?1_9F*_D8?V]E__/U'Z945^9O_ !%5_L]?]";\9O\
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M9O\ P;:;_P#(%?IE11_:>*_G8?V#E_\ SZ1^9O\ Q"J?L]?]#E\9O_!MIO\
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M\9O_  ;:;_\ (%'_ !"J?L]?]#E\9O\ P;:;_P#(%?IE11_:>*_G8?V#E_\
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MIXK^=A_8.7_\^D?F;_Q"J?L]?]#E\9O_  ;:;_\ (%'_ !"J?L]?]#E\9O\
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MI^SU_P!#E\9O_!MIO_R!7Z944?VGBOYV']@Y?_SZ1^9O_$*I^SU_T.7QF_\
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M;_\ (%'_ !"J?L]?]#E\9O\ P;:;_P#(%?IE11_:>*_G8?V#E_\ SZ1^9O\
MQ"J?L]?]#E\9O_!MIO\ \@4?\0JG[/7_ $.7QF_\&VF__(%?IE11_:>*_G8?
MV#E__/I'YF_\0JG[/7_0Y?&;_P &VF__ "!1_P 0JG[/7_0Y?&;_ ,&VF_\
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M?\)(L:Q)K^ES&QU(*N H>1?EE  P!*KA1TQ7SPG_  ;._ ][6&RNO'GQQO\
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ML/[!R_\ Y](_,W_B%4_9Z_Z'+XS?^#;3?_D"C_B%4_9Z_P"AR^,W_@VTW_Y
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M#^P<O_Y](_,W_B%4_9Z_Z'+XS?\ @VTW_P"0*/\ B%4_9Z_Z'+XS?^#;3?\
MY K],J*/[3Q7\[#^P<O_ .?2/S-_XA5/V>O^AR^,W_@VTW_Y H_XA5/V>O\
MH<OC-_X-M-_^0*_3*BC^T\5_.P_L'+_^?2/S-_XA5/V>O^AR^,W_ (-M-_\
MD"LWQ5_P:E?!&\T=X]#^('Q4T_4"?DFOKBPO(5&#UC2UB)YQ_&/\/U$HIK-,
M4M>=DRR#+VK>R7XGX"_M5?\ !KY\8/A%IEQJ?PX\1:'\4K&W7<UEY7]DZJPP
M22D4CO"X&,<3!FR,(<X'B?[&/_!6#X^?\$NOB#_PBNI?VQJ'AW1YQ;:GX(\4
M+-']B .62'S!YEG)@DC:-F3EHWZ5_3-7S!_P4K_X)7?#[_@I!\-YK?6+6WT7
MQUI]NR:)XGMX1]JLV&2L4V,&:W+$YC8\;F*%6)->CA\Y4U[+%I.+ZV_3_(\3
M&<+NB_;Y;)QDNE_R>_WW3ZG;?L,_M[?#W_@H+\'X_%O@/4C(UN5BU72;G:E_
MHT[ D1SQ@G@X;:X)1PIP20P'M-?RX_!WXJ?%C_@B9^WK=+=6C6>O>&;C^S]=
MTIG(L_$&GLRN55RO,<JA9(Y-N5.QL9!6OZ7?V?OCOX;_ &G/@OX;\?>$;S[=
MX=\46:WMG(P"NH.0T;@$[9$<,CKD[61AVKCS++_J[4Z>L);?Y?Y'IY#G3QD7
M2K*U2.Z[]+V_!KH_4[&BBBO+/H"UI'_'RW^[_45I5FZ1_P ?+?[O]16E713V
M*B%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7PE_P '#7[8
M-Q^RY_P3_P!2T?1[Q;7Q)\3KG_A&[8JV)8K1T9KR51Z>4/*)'*FY4CD5]VU^
M%?\ P=@_$NZU/]IOX6^#V?\ T+1/"\VLQI_TTN[MX6)_"Q3]:]+*:*J8J*>R
MU^[_ ()X?$>*=# 3<=Y:??O^%R/_ (-A_P!@RT^+/Q=USXW>([-;G2_ ,PTW
MP_'+&&BEU1X]TDW/&Z"%T*^CW",""@K]V*^1_P#@A=\'X/@W_P $N/A9;I:I
M!=^(+*7Q!>2!"K7+W<SRQNWJ1 84![JBU]<5.:8AU<3)]%HOE_5RN'\''#X&
M"2UDN9^K_P E9?(***JZUK=GX:TBZU#4KRUT^PLHVFN+FYE6*&"-1EG=V("J
M!R23@5YY[3=M66J*^._C-_P7K_9;^"]]=64WQ)A\2:A:.T;V_AZPN-11B >5
MG1/L[#(QD2GE@>F2/-?^(G+]F;_JH7_@B3_X]79'+\3)74']QY=3.L!!V=6/
MWW_(_0ZBOSQ_XB<OV9O^JA?^")/_ (]1_P 1.7[,W_50O_!$G_QZJ_LW%?R,
MG^WLO_Y^H_0ZBOSQ_P"(G+]F;_JH7_@B3_X]1_Q$Y?LS?]5"_P#!$G_QZC^S
M<5_(P_M[+_\ GZC]#J*_/'_B)R_9F_ZJ%_X(D_\ CU'_ !$Y?LS?]5"_\$2?
M_'J/[-Q7\C#^WLO_ .?J/T.HK\\?^(G+]F;_ *J%_P"")/\ X]1_Q$Y?LS?]
M5"_\$2?_ !ZC^S<5_(P_M[+_ /GZC]#J*_/'_B)R_9F_ZJ%_X(D_^/4?\1.7
M[,W_ %4+_P $2?\ QZC^S<5_(P_M[+_^?J/T.HK\\?\ B)R_9F_ZJ%_X(D_^
M/4?\1.7[,W_50O\ P1)_\>H_LW%?R,/[>R__ )^H_0ZBOSQ_XB<OV9O^JA?^
M")/_ (]1_P 1.7[,W_50O_!$G_QZC^S<5_(P_M[+_P#GZC]#J*_/'_B)R_9F
M_P"JA?\ @B3_ ./4?\1.7[,W_50O_!$G_P >H_LW%?R,/[>R_P#Y^H_0ZBOS
MQ_XB<OV9O^JA?^")/_CU'_$3E^S-_P!5"_\ !$G_ ,>H_LW%?R,/[>R__GZC
M]#J*_/'_ (B<OV9O^JA?^")/_CU'_$3E^S-_U4+_ ,$2?_'J/[-Q7\C#^WLO
M_P"?J/T.HK\\?^(G+]F;_JH7_@B3_P"/4?\ $3E^S-_U4+_P1)_\>H_LW%?R
M,/[>R_\ Y^H_0ZBOSQ_XB<OV9O\ JH7_ ((D_P#CU'_$3E^S-_U4+_P1)_\
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MZJ%_X(D_^/4?\1.7[,W_ %4+_P $2?\ QZC^S<5_(P_M[+_^?J/T.HK\\?\
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M_P"/4?\ $3E^S-_U4+_P1)_\>H_LW%?R,/[>R_\ Y^H_0ZBOSQ_XB<OV9O\
MJH7_ ((D_P#CU'_$3E^S-_U4+_P1)_\ 'J/[-Q7\C#^WLO\ ^?J/T.HK\\?^
M(G+]F;_JH7_@B3_X]1_Q$Y?LS?\ 50O_  1)_P#'J/[-Q7\C#^WLO_Y^H_0Z
MBOSQ_P"(G+]F;_JH7_@B3_X]1_Q$Y?LS?]5"_P#!$G_QZC^S<5_(P_M[+_\
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M)_\ 'J/[-Q7\C#^WLO\ ^?J/T.HK\\?^(G+]F;_JH7_@B3_X]1_Q$Y?LS?\
M50O_  1)_P#'J/[-Q7\C#^WLO_Y^H_0ZBOSQ_P"(G+]F;_JH7_@B3_X]1_Q$
MY?LS?]5"_P#!$G_QZC^S<5_(P_M[+_\ GZC]#J*_/'_B)R_9F_ZJ%_X(D_\
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M_P 1.7[,W_50O_!$G_QZC^S<5_(P_M[+_P#GZC]#J*_/'_B)R_9F_P"JA?\
M@B3_ ./4?\1.7[,W_50O_!$G_P >H_LW%?R,/[>R_P#Y^H_0ZBOSQ_XB<OV9
MO^JA?^")/_CU'_$3E^S-_P!5"_\ !$G_ ,>H_LW%?R,/[>R__GZC]#J*_/'_
M (B<OV9O^JA?^")/_CU'_$3E^S-_U4+_ ,$2?_'J/[-Q7\C#^WLO_P"?J/T.
MHK\\?^(G+]F;_JH7_@B3_P"/4?\ $3E^S-_U4+_P1)_\>H_LW%?R,/[>R_\
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MH_LW%?R,/[>R_P#Y^H_0ZBOSQ_XB<OV9O^JA?^")/_CU'_$3E^S-_P!5"_\
M!$G_ ,>H_LW%?R,/[>R__GZC]#J*_/'_ (B<OV9O^JA?^")/_CU'_$3E^S-_
MU4+_ ,$2?_'J/[-Q7\C#^WLO_P"?J/T.HK\\?^(G+]F;_JH7_@B3_P"/4?\
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MNBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/]X_SJ.N,S"OP!_P"#
MJO\ Y2%^#?\ LG=E_P"G+4Z_?ZOP!_X.J_\ E(7X-_[)W9?^G+4Z]C(_]Z^3
M/F>+/^1>_5'[,?\ !.3_ )1Z? ?_ +)WX?\ _3;;U[-7C/\ P3D_Y1Z? ?\
M[)WX?_\ 3;;U[-7EUOXDO5GO87^!#T7Y'"_M*_M&^%/V3/@EK_Q \:7_ /9_
MA_P[;F>8H TUP_1(8E)&Z61B%5<@$L,D#)'\U?\ P4B_X*O_ !)_X*,>/[J3
M6+ZXT'P';SEM)\+6DY^R6R _(\Y&/M$^.3(XP"3L5%.VOL/_ (.G?VNKSQ3\
M;?"/P7TZZ9=%\*V2Z_J\2,0L]_<;EA5QT/E6XW*1_P _;>G'Y-5]9DV!C"FJ
MTE[SV\E_P3\[XHSBI6KO"TW:$='YOK?T>EOGV"BBBO</DPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\'!TK2?\%=_BTK,6$8T=5![#^QK$_P R?SKXQK[,_P"#@O\ Y2\_%S_N#?\
MIEL*^,Z^^P7^[T_\*_(_'<T_WVM_CE^;"BBBNHX0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB,E)<T=CSJE.5.3A-6:W3W"BBBJ("BOO/_@DE_P1'_X>E_"SQ5XF_P"%F_\
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M  K\V?I7!O\ N4_\;_\ 28A7\P/[/?\ RF^\*_\ 99X?_3S7]/U?S _L]_\
M*;[PK_V6>'_T\UKD.U7T7ZG/QA_RX]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW
M2/\ CY;_ '?ZBM*NBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/\
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M$CI*I0JXD (<$9Z5_0_XV_8\T_Q/_P $MX?@8_C:SM=,C\ V7A3_ (2LV:M
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MBI0J*ASJ-E=R:_);'GX+*Z=6A+'*BYIRM&"DTDNK<M7:^G_#Z?F3_P %$/\
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MFJ=2CB/93BDN5WY;KL[I+7KKHEI<^,?^"R/_  6N_9]_X*,_L:W?@OP_X?\
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MUNZ:T;OT_P" >%_\&DO_ ":S\5/^QJA_])$KX,T/]@;_ (>1?\%M/CQ\-O\
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MEA!\HL<QQO$\FY5X+(AQU-1[;$NC]9NK;\MNGKN;/!Y:L9_9KA*][<_-K?\
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MWOBGXKU3QY\3?$6N:Y;PVNMZSJ=S?:A!%:BTCAN)96>55A4 1 .S (  O0
M8K!KW#X@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\MYK6\LY6AGAE0I)"ZDAE93R""""#T(J"O5/ES[,_P"#?3_E+S\(_P#N,_\
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M_P#E+S\7/^X-_P"F6PKXSK[[!?[O3_PK\C\>S7_?:W^.7YL****ZC@"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M SD[5'91@#L*)86O5<57DK)WT6K]?^ %/-,%A5.>!A)3FFO>:M%/^6V_E?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K]"O^#=K_@H1X$_83_:3\76_Q(U:3P_X
M8\<:/';+J1@DFAM;N"7?$)5C#,$99)AO"G:Q7.%)8?GK16=:E&K!TY;,Z,)B
MJF&K1KT]XN^I_4]_P_&_90_Z+3X:_P# >[_^-4?\/QOV4/\ HM/AK_P'N_\
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M_'F7Y'\;?_"/W_\ SXWG_?EO\*/^$?O_ /GQO/\ ORW^%?V2457^L:_Y]_\
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MK_GW_P"3?_:A_J/4_P"?Z_\  /\ [<_C;_X1^_\ ^?&\_P"_+?X4?\(_?_\
M/C>?]^6_PK^R2BC_ %C7_/O_ ,F_^U#_ %'J?\_U_P" ?_;G\;?_  C]_P#\
M^-Y_WY;_  H_X1^__P"?&\_[\M_A7]DE%'^L:_Y]_P#DW_VH?ZCU/^?Z_P#
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M[\M_A7]DE%'^L:_Y]_\ DW_VH?ZCU/\ G^O_  #_ .W/XV_^$?O_ /GQO/\
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M_A'[_P#Y\;S_ +\M_A1_PC]__P ^-Y_WY;_"O[)**/\ 6-?\^_\ R;_[4/\
M4>I_S_7_ (!_]N?QM_\ "/W_ /SXWG_?EO\ "C_A'[__ )\;S_ORW^%?V244
M?ZQK_GW_ .3?_:A_J/4_Y_K_ , _^W/XV_\ A'[_ /Y\;S_ORW^%'_"/W_\
MSXWG_?EO\*_LDHH_UC7_ #[_ /)O_M0_U'J?\_U_X!_]N?QM_P#"/W__ #XW
MG_?EO\*/^$?O_P#GQO/^_+?X5_9)11_K&O\ GW_Y-_\ :A_J/4_Y_K_P#_[<
M_C;_ .$?O_\ GQO/^_+?X4?\(_?_ //C>?\ ?EO\*_LDHH_UC7_/O_R;_P"U
M#_4>I_S_ %_X!_\ ;G\;?_"/W_\ SXWG_?EO\*/^$?O_ /GQO/\ ORW^%?V2
M44?ZQK_GW_Y-_P#:A_J/4_Y_K_P#_P"W/XV_^$?O_P#GQO/^_+?X4?\ "/W_
M /SXWG_?EO\ "O[)**/]8U_S[_\ )O\ [4/]1ZG_ #_7_@'_ -N?QM_\(_?_
M //C>?\ ?EO\*/\ A'[_ /Y\;S_ORW^%?V244?ZQK_GW_P"3?_:A_J/4_P"?
MZ_\  /\ [<_C;_X1^_\ ^?&\_P"_+?X4?\(_?_\ /C>?]^6_PK^R2BC_ %C7
M_/O_ ,F_^U#_ %'J?\_U_P" ?_;G\;?_  C]_P#\^-Y_WY;_  H_X1^__P"?
M&\_[\M_A7]DE%'^L:_Y]_P#DW_VH?ZCU/^?Z_P# /_MS^-O_ (1^_P#^?&\_
M[\M_A1_PC]__ ,^-Y_WY;_"O[)**/]8U_P ^_P#R;_[4/]1ZG_/]?^ ?_;G\
M;?\ PC]__P ^-Y_WY;_"C_A'[_\ Y\;S_ORW^%?V244?ZQK_ )]_^3?_ &H?
MZCU/^?Z_\ _^W/XV_P#A'[__ )\;S_ORW^%'_"/W_P#SXWG_ 'Y;_"O[)**/
M]8U_S[_\F_\ M0_U'J?\_P!?^ ?_ &Y_&W_PC]__ ,^-Y_WY;_"C_A'[_P#Y
M\;S_ +\M_A7]DE%'^L:_Y]_^3?\ VH?ZCU/^?Z_\ _\ MS^-O_A'[_\ Y\;S
M_ORW^%'_  C]_P#\^-Y_WY;_  K^R2BC_6-?\^__ ";_ .U#_4>I_P _U_X!
M_P#;G\;?_"/W_P#SXWG_ 'Y;_"C_ (1^_P#^?&\_[\M_A7]DE%'^L:_Y]_\
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MPC]__P ^-Y_WY;_"O[)**/\ 6-?\^_\ R;_[4/\ 4>I_S_7_ (!_]N?QM_\
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M /Y\;S_ORW^%?V244?ZQK_GW_P"3?_:A_J/4_P"?Z_\  /\ [<_C;_X1^_\
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MK_GW_P"3?_:A_J/4_P"?Z_\  /\ [<_C;_X1^_\ ^?&\_P"_+?X4?\(_?_\
M/C>?]^6_PK^R2BC_ %C7_/O_ ,F_^U#_ %'J?\_U_P" ?_;G\;?_  C]_P#\
M^-Y_WY;_  H_X1^__P"?&\_[\M_A7]DE%'^L:_Y]_P#DW_VH?ZCU/^?Z_P#
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M[\M_A7]DE%'^L:_Y]_\ DW_VH?ZCU/\ G^O_  #_ .W/XV_^$?O_ /GQO/\
MORW^%'_"/W__ #XWG_?EO\*_LDHH_P!8U_S[_P#)O_M0_P!1ZG_/]?\ @'_V
MY_&W_P (_?\ _/C>?]^6_P */^$?O_\ GQO/^_+?X5_9)11_K&O^??\ Y-_]
MJ'^H]3_G^O\ P#_[<_C;_P"$?O\ _GQO/^_+?X4?\(_?_P#/C>?]^6_PK^R2
MBC_6-?\ /O\ \F_^U#_4>I_S_7_@'_VY_&W_ ,(_?_\ /C>?]^6_PH_X1^__
M .?&\_[\M_A7]DE%'^L:_P"??_DW_P!J'^H]3_G^O_ /_MS^-O\ X1^__P"?
M&\_[\M_A1_PC]_\ \^-Y_P!^6_PK^R2BC_6-?\^__)O_ +4/]1ZG_/\ 7_@'
M_P!N?QM_\(_?_P#/C>?]^6_PH_X1^_\ ^?&\_P"_+?X5_9)11_K&O^??_DW_
M -J'^H]3_G^O_ /_ +<_C;_X1^__ .?&\_[\M_A1_P (_?\ _/C>?]^6_P *
M_LDHH_UC7_/O_P F_P#M0_U'J?\ /]?^ ?\ VY_&W_PC]_\ \^-Y_P!^6_PH
M_P"$?O\ _GQO/^_+?X5_9)11_K&O^??_ )-_]J'^H]3_ )_K_P  _P#MS^-O
M_A'[_P#Y\;S_ +\M_A1_PC]__P ^-Y_WY;_"O[)**/\ 6-?\^_\ R;_[4/\
M4>I_S_7_ (!_]N?QM_\ "/W_ /SXWG_?EO\ "C_A'[__ )\;S_ORW^%?V244
M?ZQK_GW_ .3?_:A_J/4_Y_K_ , _^W/XV_\ A'[_ /Y\;S_ORW^%'_"/W_\
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M_P#;G\;?_"/W_P#SXWG_ 'Y;_"C_ (1^_P#^?&\_[\M_A7]DE%'^L:_Y]_\
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MPC]__P ^-Y_WY;_"O[)**/\ 6-?\^_\ R;_[4/\ 4>I_S_7_ (!_]N?QM_\
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M /Y\;S_ORW^%?V244?ZQK_GW_P"3?_:A_J/4_P"?Z_\  /\ [<_C;_X1^_\
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MO_ U_P#(G]!E%?SY_P#"X_%W_0U>)/\ P9S?_%4?\+C\7?\ 0U>)/_!G-_\
M%4?\07K_ /04O_ '_P#)!_Q,-A/^@*7_ (&O_D3^@RBOY\_^%Q^+O^AJ\2?^
M#.;_ .*H_P"%Q^+O^AJ\2?\ @SF_^*H_X@O7_P"@I?\ @#_^2#_B8;"?] 4O
M_ U_\B?T&45_/G_PN/Q=_P!#5XD_\&<W_P 51_PN/Q=_T-7B3_P9S?\ Q5'_
M !!>O_T%+_P!_P#R0?\ $PV$_P"@*7_@:_\ D3^@RBOY\_\ A<?B[_H:O$G_
M (,YO_BJ/^%Q^+O^AJ\2?^#.;_XJC_B"]?\ Z"E_X __ )(/^)AL)_T!2_\
M U_\B?T&45_/G_PN/Q=_T-7B3_P9S?\ Q5'_  N/Q=_T-7B3_P &<W_Q5'_$
M%Z__ $%+_P  ?_R0?\3#83_H"E_X&O\ Y$_H,HK^?/\ X7'XN_Z&KQ)_X,YO
M_BJ/^%Q^+O\ H:O$G_@SF_\ BJ/^(+U_^@I?^ /_ .2#_B8;"?\ 0%+_ ,#7
M_P B?T&45_/G_P +C\7?]#5XD_\ !G-_\51_PN/Q=_T-7B3_ ,&<W_Q5'_$%
MZ_\ T%+_ , ?_P D'_$PV$_Z I?^!K_Y$_H,HK^?/_A<?B[_ *&KQ)_X,YO_
M (JC_A<?B[_H:O$G_@SF_P#BJ/\ B"]?_H*7_@#_ /D@_P")AL)_T!2_\#7_
M ,B?T&45_/G_ ,+C\7?]#5XD_P#!G-_\51_PN/Q=_P!#5XD_\&<W_P 51_Q!
M>O\ ]!2_\ ?_ ,D'_$PV$_Z I?\ @:_^1/Z#**_GS_X7'XN_Z&KQ)_X,YO\
MXJC_ (7'XN_Z&KQ)_P"#.;_XJC_B"]?_ *"E_P" /_Y(/^)AL)_T!2_\#7_R
M)_0917\^?_"X_%W_ $-7B3_P9S?_ !5'_"X_%W_0U>)/_!G-_P#%4?\ $%Z_
M_04O_ '_ /)!_P 3#83_ * I?^!K_P"1/Z#**_GS_P"%Q^+O^AJ\2?\ @SF_
M^*H_X7'XN_Z&KQ)_X,YO_BJ/^(+U_P#H*7_@#_\ D@_XF&PG_0%+_P #7_R)
M_0917\^?_"X_%W_0U>)/_!G-_P#%4?\ "X_%W_0U>)/_  9S?_%4?\07K_\
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M%+_P!_\ R0?\3#83_H"E_P"!K_Y$_H,HK^?/_A<?B[_H:O$G_@SF_P#BJ/\
MA<?B[_H:O$G_ (,YO_BJ/^(+U_\ H*7_ ( __D@_XF&PG_0%+_P-?_(G]!E%
M?SY_\+C\7?\ 0U>)/_!G-_\ %4?\+C\7?]#5XD_\&<W_ ,51_P 07K_]!2_\
M ?\ \D'_ !,-A/\ H"E_X&O_ )$_H,HK^?/_ (7'XN_Z&KQ)_P"#.;_XJC_A
M<?B[_H:O$G_@SF_^*H_X@O7_ .@I?^ /_P"2#_B8;"?] 4O_  -?_(G]!E%?
MSY_\+C\7?]#5XD_\&<W_ ,51_P +C\7?]#5XD_\ !G-_\51_Q!>O_P!!2_\
M '_\D'_$PV$_Z I?^!K_ .1/Z#**_GS_ .%Q^+O^AJ\2?^#.;_XJC_A<?B[_
M *&KQ)_X,YO_ (JC_B"]?_H*7_@#_P#D@_XF&PG_ $!2_P# U_\ (G]!E%?S
MY_\ "X_%W_0U>)/_  9S?_%4?\+C\7?]#5XD_P#!G-_\51_Q!>O_ -!2_P#
M'_\ )!_Q,-A/^@*7_@:_^1/Z#**_GS_X7'XN_P"AJ\2?^#.;_P"*H_X7'XN_
MZ&KQ)_X,YO\ XJC_ (@O7_Z"E_X _P#Y(/\ B8;"?] 4O_ U_P#(G]!E%?SY
M_P#"X_%W_0U>)/\ P9S?_%4?\+C\7?\ 0U>)/_!G-_\ %4?\07K_ /04O_ '
M_P#)!_Q,-A/^@*7_ (&O_D3^@RBOY\_^%Q^+O^AJ\2?^#.;_ .*H_P"%Q^+O
M^AJ\2?\ @SF_^*H_X@O7_P"@I?\ @#_^2#_B8;"?] 4O_ U_\B?T&45_/G_P
MN/Q=_P!#5XD_\&<W_P 51_PN/Q=_T-7B3_P9S?\ Q5'_ !!>O_T%+_P!_P#R
M0?\ $PV$_P"@*7_@:_\ D3^@RBOY\_\ A<?B[_H:O$G_ (,YO_BJ/^%Q^+O^
MAJ\2?^#.;_XJC_B"]?\ Z"E_X __ )(/^)AL)_T!2_\  U_\B?T&45_/G_PN
M/Q=_T-7B3_P9S?\ Q5'_  N/Q=_T-7B3_P &<W_Q5'_$%Z__ $%+_P  ?_R0
M?\3#83_H"E_X&O\ Y$_H,HK^?/\ X7'XN_Z&KQ)_X,YO_BJ/^%Q^+O\ H:O$
MG_@SF_\ BJ/^(+U_^@I?^ /_ .2#_B8;"?\ 0%+_ ,#7_P B?T&45_/G_P +
MC\7?]#5XD_\ !G-_\51_PN/Q=_T-7B3_ ,&<W_Q5'_$%Z_\ T%+_ , ?_P D
M'_$PV$_Z I?^!K_Y$_H,HK^?/_A<?B[_ *&KQ)_X,YO_ (JC_A<?B[_H:O$G
M_@SF_P#BJ/\ B"]?_H*7_@#_ /D@_P")AL)_T!2_\#7_ ,B?T&45_/G_ ,+C
M\7?]#5XD_P#!G-_\51_PN/Q=_P!#5XD_\&<W_P 51_Q!>O\ ]!2_\ ?_ ,D'
M_$PV$_Z I?\ @:_^1/Z#**_GS_X7'XN_Z&KQ)_X,YO\ XJC_ (7'XN_Z&KQ)
M_P"#.;_XJC_B"]?_ *"E_P" /_Y(/^)AL)_T!2_\#7_R)_0917\^?_"X_%W_
M $-7B3_P9S?_ !5'_"X_%W_0U>)/_!G-_P#%4?\ $%Z__04O_ '_ /)!_P 3
M#83_ * I?^!K_P"1/Z#**_GS_P"%Q^+O^AJ\2?\ @SF_^*H_X7'XN_Z&KQ)_
MX,YO_BJ/^(+U_P#H*7_@#_\ D@_XF&PG_0%+_P #7_R)_0917\^?_"X_%W_0
MU>)/_!G-_P#%4?\ "X_%W_0U>)/_  9S?_%4?\07K_\ 04O_  !__)!_Q,-A
M/^@*7_@:_P#D3^@RBOY\_P#A<?B[_H:O$G_@SF_^*H_X7'XN_P"AJ\2?^#.;
M_P"*H_X@O7_Z"E_X _\ Y(/^)AL)_P! 4O\ P-?_ ")_0917\^?_  N/Q=_T
M-7B3_P &<W_Q5'_"X_%W_0U>)/\ P9S?_%4?\07K_P#04O\ P!__ "0?\3#8
M3_H"E_X&O_D3^@RBOY\_^%Q^+O\ H:O$G_@SF_\ BJ/^%Q^+O^AJ\2?^#.;_
M .*H_P"(+U_^@I?^ /\ ^2#_ (F&PG_0%+_P-?\ R)_0917\^?\ PN/Q=_T-
M7B3_ ,&<W_Q5'_"X_%W_ $-7B3_P9S?_ !5'_$%Z_P#T%+_P!_\ R0?\3#83
M_H"E_P"!K_Y$_H,HK^?/_A<?B[_H:O$G_@SF_P#BJ/\ A<?B[_H:O$G_ (,Y
MO_BJ/^(+U_\ H*7_ ( __D@_XF&PG_0%+_P-?_(G]!E%?SY_\+C\7?\ 0U>)
M/_!G-_\ %4?\+C\7?]#5XD_\&<W_ ,51_P 07K_]!2_\ ?\ \D'_ !,-A/\
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M (@O7_Z"E_X _P#Y(/\ B8;"?] 4O_ U_P#(G]!E%?SY_P#"X_%W_0U>)/\
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M]?\ Z"E_X __ )(/^)AL)_T!2_\  U_\B?T&45_/G_PN/Q=_T-7B3_P9S?\
MQ5'_  N/Q=_T-7B3_P &<W_Q5'_$%Z__ $%+_P  ?_R0?\3#83_H"E_X&O\
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M*7_@#_\ D@_XF&PG_0%+_P #7_R)_0917\^?_"X_%W_0U>)/_!G-_P#%4?\
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M(/\ B8;"?] 4O_ U_P#(G]!E%?SY_P#"X_%W_0U>)/\ P9S?_%4?\+C\7?\
M0U>)/_!G-_\ %4?\07K_ /04O_ '_P#)!_Q,-A/^@*7_ (&O_D3^@RBOY\_^
M%Q^+O^AJ\2?^#.;_ .*H_P"%Q^+O^AJ\2?\ @SF_^*H_X@O7_P"@I?\ @#_^
M2#_B8;"?] 4O_ U_\B?T&45_/G_PN/Q=_P!#5XD_\&<W_P 51_PN/Q=_T-7B
M3_P9S?\ Q5'_ !!>O_T%+_P!_P#R0?\ $PV$_P"@*7_@:_\ D3^@RBOY\_\
MA<?B[_H:O$G_ (,YO_BJ/^%Q^+O^AJ\2?^#.;_XJC_B"]?\ Z"E_X __ )(/
M^)AL)_T!2_\  U_\B?T&45_/G_PN/Q=_T-7B3_P9S?\ Q5'_  N/Q=_T-7B3
M_P &<W_Q5'_$%Z__ $%+_P  ?_R0?\3#83_H"E_X&O\ Y$_H,HK^?/\ X7'X
MN_Z&KQ)_X,YO_BJ/^%Q^+O\ H:O$G_@SF_\ BJ/^(+U_^@I?^ /_ .2#_B8;
M"?\ 0%+_ ,#7_P B?T&45_/G_P +C\7?]#5XD_\ !G-_\51_PN/Q=_T-7B3_
M ,&<W_Q5'_$%Z_\ T%+_ , ?_P D'_$PV$_Z I?^!K_Y$_H,HK^?/_A<?B[_
M *&KQ)_X,YO_ (JC_A<?B[_H:O$G_@SF_P#BJ/\ B"]?_H*7_@#_ /D@_P")
MAL)_T!2_\#7_ ,B?T&45_/G_ ,+C\7?]#5XD_P#!G-_\51_PN/Q=_P!#5XD_
M\&<W_P 51_Q!>O\ ]!2_\ ?_ ,D'_$PV$_Z I?\ @:_^1/Z#**_GS_X7'XN_
MZ&KQ)_X,YO\ XJC_ (7'XN_Z&KQ)_P"#.;_XJC_B"]?_ *"E_P" /_Y(/^)A
ML)_T!2_\#7_R)_0917\^?_"X_%W_ $-7B3_P9S?_ !5'_"X_%W_0U>)/_!G-
M_P#%4?\ $%Z__04O_ '_ /)!_P 3#83_ * I?^!K_P"1/Z#**_GS_P"%Q^+O
M^AJ\2?\ @SF_^*H_X7'XN_Z&KQ)_X,YO_BJ/^(+U_P#H*7_@#_\ D@_XF&PG
M_0%+_P #7_R)_0917\^?_"X_%W_0U>)/_!G-_P#%4?\ "X_%W_0U>)/_  9S
M?_%4?\07K_\ 04O_  !__)!_Q,-A/^@*7_@:_P#D3^@RBOY\_P#A<?B[_H:O
M$G_@SF_^*H_X7'XN_P"AJ\2?^#.;_P"*H_X@O7_Z"E_X _\ Y(/^)AL)_P!
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M;_XJC_A<?B[_ *&KQ)_X,YO_ (JC_B"]?_H*7_@#_P#D@_XF&PG_ $!2_P#
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M?T&45_/G_P +C\7?]#5XD_\ !G-_\51_PN/Q=_T-7B3_ ,&<W_Q5'_$%Z_\
MT%+_ , ?_P D'_$PV$_Z I?^!K_Y$_H,HK^?/_A<?B[_ *&KQ)_X,YO_ (JC
M_A<?B[_H:O$G_@SF_P#BJ/\ B"]?_H*7_@#_ /D@_P")AL)_T!2_\#7_ ,B?
MT&45_/G_ ,+C\7?]#5XD_P#!G-_\51_PN/Q=_P!#5XD_\&<W_P 51_Q!>O\
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M\^?_  N/Q=_T-7B3_P &<W_Q5'_"X_%W_0U>)/\ P9S?_%4?\07K_P#04O\
MP!__ "0?\3#83_H"E_X&O_D3^@RBOY\_^%Q^+O\ H:O$G_@SF_\ BJ/^%Q^+
MO^AJ\2?^#.;_ .*H_P"(+U_^@I?^ /\ ^2#_ (F&PG_0%+_P-?\ R)_0917\
M^?\ PN/Q=_T-7B3_ ,&<W_Q5'_"X_%W_ $-7B3_P9S?_ !5'_$%Z_P#T%+_P
M!_\ R0?\3#83_H"E_P"!K_Y$_H,HK^?/_A<?B[_H:O$G_@SF_P#BJ/\ A<?B
M[_H:O$G_ (,YO_BJ/^(+U_\ H*7_ ( __D@_XF&PG_0%+_P-?_(G]!E%?SY_
M\+C\7?\ 0U>)/_!G-_\ %4?\+C\7?]#5XD_\&<W_ ,51_P 07K_]!2_\ ?\
M\D'_ !,-A/\ H"E_X&O_ )$_H,HK^?/_ (7'XN_Z&KQ)_P"#.;_XJC_A<?B[
M_H:O$G_@SF_^*H_X@O7_ .@I?^ /_P"2#_B8;"?] 4O_  -?_(G]!E%?SY_\
M+C\7?]#5XD_\&<W_ ,51_P +C\7?]#5XD_\ !G-_\51_Q!>O_P!!2_\  '_\
MD'_$PV$_Z I?^!K_ .1/Z#**_GS_ .%Q^+O^AJ\2?^#.;_XJC_A<?B[_ *&K
MQ)_X,YO_ (JC_B"]?_H*7_@#_P#D@_XF&PG_ $!2_P# U_\ (G]!E%?SY_\
M"X_%W_0U>)/_  9S?_%4?\+C\7?]#5XD_P#!G-_\51_Q!>O_ -!2_P# '_\
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M_P!#5XD_\&<W_P 51_PN/Q=_T-7B3_P9S?\ Q5'_ !!>O_T%+_P!_P#R0?\
M$PV$_P"@*7_@:_\ D3^@RBOY\_\ A<?B[_H:O$G_ (,YO_BJ/^%Q^+O^AJ\2
M?^#.;_XJC_B"]?\ Z"E_X __ )(/^)AL)_T!2_\  U_\B?T&45_/G_PN/Q=_
MT-7B3_P9S?\ Q5'_  N/Q=_T-7B3_P &<W_Q5'_$%Z__ $%+_P  ?_R0?\3#
M83_H"E_X&O\ Y$_H,HK^?/\ X7'XN_Z&KQ)_X,YO_BJ/^%Q^+O\ H:O$G_@S
MF_\ BJ/^(+U_^@I?^ /_ .2#_B8;"?\ 0%+_ ,#7_P B?T&45_/G_P +C\7?
M]#5XD_\ !G-_\51_PN/Q=_T-7B3_ ,&<W_Q5'_$%Z_\ T%+_ , ?_P D'_$P
MV$_Z I?^!K_Y$_H,HK^?/_A<?B[_ *&KQ)_X,YO_ (JC_A<?B[_H:O$G_@SF
M_P#BJ/\ B"]?_H*7_@#_ /D@_P")AL)_T!2_\#7_ ,B?T&45_/G_ ,+C\7?]
M#5XD_P#!G-_\51_PN/Q=_P!#5XD_\&<W_P 51_Q!>O\ ]!2_\ ?_ ,D'_$PV
M$_Z I?\ @:_^1/Z#**_GS_X7'XN_Z&KQ)_X,YO\ XJC_ (7'XN_Z&KQ)_P"#
M.;_XJC_B"]?_ *"E_P" /_Y(/^)AL)_T!2_\#7_R)_0917\^?_"X_%W_ $-7
MB3_P9S?_ !5"?&7QA&P9?%?B164Y!&IS<?\ CU'_ !!>O_T%+_P!_P#R0?\
M$PV#_P"@*7_@:_\ D3^@RBOPI^'/[=OQ@^%FHK<:3\0O$S!6!,%]>-?6[?\
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MAOVO+KX&?"2S\&Z#=26OB#QHD@GGB8K)9V*_*Y![-(3L!]!)T.#7Y+U]1?\
M!8CQ9<>(OV[/$5G,6\O0;&QL8,GHC6R7!Q_P*=J^7:_K'P]R>E@,DHN"]ZJE
M.3[\RNON5E_PY_$/BQQ!6S/B.O";]RC)TXKHN5VE\W)-M^BV2"BBBOMS\U"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\6?\B]^J/V8_X)R?\H]/@/\ ]D[\/_\ IMMZ]FKQG_@G)_RCT^ __9._#_\
MZ;;>O9J\NM_$EZL]["_P(>B_(_%O_@K/_P I _'_ /W#O_3;:U\YU]&?\%9_
M^4@?C_\ [AW_ *;;6OG.O[*X6_Y$N$_Z]4__ $A'^?O&G_)0X_\ Z_5?_2Y!
M1117O'S(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M444 %%%% &/=?\?,G^\?YU'4EU_Q\R?[Q_G4=<9F%?@#_P '5?\ RD+\&_\
M9.[+_P!.6IU^_P!7X _\'5?_ "D+\&_]D[LO_3EJ=>QD?^]?)GS/%G_(O?JC
M]F/^"<G_ "CT^ __ &3OP_\ ^FVWKV:O&?\ @G)_RCT^ _\ V3OP_P#^FVWK
MV:O+K?Q)>K/>PO\  AZ+\C\6_P#@K/\ \I _'_\ W#O_ $VVM?.=?1G_  5G
M_P"4@?C_ /[AW_IMM:^<Z_LKA;_D2X3_ *]4_P#TA'^?O&G_ "4./_Z_5?\
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M:? N/XP?&=HY-'FM#J=II]Q*T-I;68!*W$^W#.7&&5 <8*Y#%L#TKX9_$?\
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M&M&W@%\^FI,L$TV!!&]P[&<L^X<C(!9<GKM^-O\ @JW^Q+H_['GQ=T>;PO\
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MU2^M=6CT_3LKB6\6?8UMD=-SI+'TXR>*];(>+Z&8XBKA)TY4:M-7<9JVG?\
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M82<G=1<)2UM_?3MHNZ/(XBPOB10I2S3,IU*<:<;.4:D(V5^JIR3>K[,^H_\
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MT4]BHA1116A04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M $N04445[Q\R%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P##%EG]CW?9_P#A)K3[=CIY/DW&,^WF^5^.*^6_^"R'[7GP[_:K_P"%<_\
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MRGB;*:/B-CL75Q,%2J4E&,^9<C?+2=N:_+]E];75MSYF_P""7/\ R?Q\-_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]>_8*^*.A?!?]KKP3XH
M\37W]FZ'I%W)+=W/DR3>4I@D0'9&K.?F8#@'K7OW_!9#]KSX=_M5_P#"N?\
MA ?$/]O?V#_:?V[_ $"YM?(\[[)Y?^NC3=GRG^[G&WG&1GXCHKP<1P[AJV:T
MLWG*7M*<7%)-<MFI+56O?WGLUT/JL'Q?C,-D5?AZ$8^RK24Y-I\R:<'H^:UO
M<6\7UUVL4445[Q\J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_N_U%:59ND?\?+?[O]16E713V*B%%%%:%!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CW7_'S)_O'^=1U)=?
M\?,G^\?YU'7&9A7X _\ !U7_ ,I"_!O_ &3NR_\ 3EJ=?O\ 5^ /_!U7_P I
M"_!O_9.[+_TY:G7L9'_O7R9\SQ9_R+WZH_9C_@G)_P H]/@/_P!D[\/_ /IM
MMZ]FKQG_ ()R?\H]/@/_ -D[\/\ _IMMZ]FKRZW\27JSWL+_  (>B_(_%O\
MX*S_ /*0/Q__ -P[_P!-MK7SG7T9_P %9_\ E('X_P#^X=_Z;;6OG.O[*X6_
MY$N$_P"O5/\ ](1_G[QI_P E#C_^OU7_ -+D%%%%>\?,A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_CY;_=_J*TJS=(_X^6_W?ZBM*NBGL5$****T*"BBB@ HHHH **** "BBB@
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M/%7B+QAI-WJ,=[-?&UO[2"RMD@NIXMW[RW8JH2(,Q9B,Y/ X'7_\.HOV7/\
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M1=6\+W6F);Q6K+(BW0@MR/L\FTEO+8PYC*2#(Y.!QCYA_P""M/QSM?',&@_
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M-+ZGS[17ZU_M&?\ !*+X!^#9-$\07?D_#WP7HIFFUZ=M7N'>_+>6MO &N))
MF6+Y*#<>%')!'R%\2?V=?A'\=/VX/#_@_P"$VO:;H?P_O--BFU#5)+N:2.V9
M/,,[;KIMWF$!%"Y"[F'&,UR95QUE^/BZE*$U%1E*4G'2/+T;3?O-:I*]UYZ'
MH9WX4YOE<XTJU2E*<I1C&,9^]+FV:3C'W4]&W:S3Z:GRC17Z%_$?P1^Q3^SE
MX]C\#ZUHOBSQ=JACB6XUBSU*2X@LV= 0S-#<1J6(8,0D;@=,=J\X_P""J_\
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M9@B@L9/*?R^H4+DGNP_(#]K3XC:]^TA\:_%'Q-N= U73]*\0W2R6[RV[>5%
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MRS^U%^S/KW[)7Q8F\'>)+O2;W4[>VBNFETV622 K(,J 9$1L^OR_G7JOA?\
M9X^!NI_L+2>,K[X@WEO\6%M+F5?#W]J6JQ&5+J2.)?),/F_-"J/CS,DMD8!
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M<J[RU5M->KL?#Y'X>X_,L'#'NK2HTZDN6#JSY>>2=FHI)WUTZ:GYLT5]!?\
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M &6?VNO@WKVK?#'4KSX9^)M*!%M8Z_JRQ+/+L)5&6>:3<CX(W1R94\GCY3\
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M -P[_P!-MK7SG7T9_P %9_\ E('X_P#^X=_Z;;6OG.O[*X6_Y$N$_P"O5/\
M](1_G[QI_P E#C_^OU7_ -+D%%%%>\?,G["?L,0ZU<_\$9XX_#?]H#Q%)X<\
M1+I9L69+H71N;\0^45PPD\S;M*G(.,<U\1-X+_;-S_KOC]_X--1_^.4G[.7_
M  5Q^)'[,/P9T;P-H&B>"+S2=#\_R)=0L[J2X?S9Y)VW,EPBG#2,!A1P!U/)
M[5O^"]WQ@7_F6_AK_P""^]_^2Z_(Z.19Y@L9BJM##4JD:M24TYO5)MM>FC/W
M[$\4\+YCEV!H8O%UZ,Z%&$&J:LFU%)^NJT9\^>(_@=\0_$?[2/A?0_B@OB72
M_$'CG4;*S;4/$+R/=2122I;"5GE)9E0  $YP$QT&*^X/VS- ^$__  31TGPK
MIOAWX%Z'XVOM71S_ &KX@C-Y"C(P&UBZN&E;<3M78%&" > /B/\ :T_;7\6_
MMC>/='\2>(K71=)U+0[46EJ=&BF@4 2-(&/F2R-O#-P01T''>O7?#?\ P6Y^
M-WA[P?'I4DWA;5+B*,1KJ=YIK-><#&3MD6-F]24.?SKU\TRK.,7'"U'&/+%-
M3I1G*$6]HVE%.Z2Z?YGAY%Q!PYE\\=1A.2E4<72KRI0JS2WDG&5DFW?7KNW=
M(^T_BYXSU[XA_P#!'GQ!K?B3P_I_A75=2T":8Z596K6T%G ;H_9U6-B2N8/*
M)]2Q. #@>+_\&\__ #5[_N#?^W]?.?B7_@K/\5/'?P0\1>!?$:^&_$5CXF2>
M.ZO[VTF%[$LISB,QRI$@0XV#RR!@9!KDOV-OV^/&'[#W_"2?\(GIOAK4/^$H
M^S?:O[6MYYO+^S^=LV>7+'C/G-G.>@QCG/C0X.S".28W+U&*G5J*44G[MN:+
MM=ZZ).U]3Z*OXC9//B7+,UYYRIT*4H3<H^\VX3C>RT;;:O;3>VAYY\>=8NM?
M^-_C&]O;B2ZNKK6[R6:60Y:1C.Y))K]'_P!NO_E"M\-?^P1X:_\ 22.OS"\2
M:Y-XJ\1:AJ=PL:W&HW,EU*L8(16=BQ !).,GC)->X?%C_@HEXV^,?[+^A_"?
M5-+\*V_AW0+:QM;>XM;:=;UUM(Q'&7=IF0D@#=A!D],=*^JSK)<1B:N E12M
M1FI2UMHDMNY\'PWQ1@L'3S6.(;OB:<XPTO>4F[7[;[GO7_!!OX[?\(Y\8?$G
MP]O)/]#\56?V^SC8#;]IMP=X'?YH68GK_JA7OWQ3\%V?_!,3_@GO\3(]/DMX
M]4\5:S?1:8\2!67[7(T-LOIF*U3?CH"K #U^5_\ @EW^P=X^^(7Q$\"_%C1]
M2T.Q\-:+K@>Z:2=_M;)"W[Z(1[,'S$)0'=@!\]L5V'_!=_\ :-M_&/Q)\.?#
MO2[V&XM_"Z/?ZHL1W!+N4!8XV.?O)$"<=O.Y]OBLUP-+'<5+"X6:E"?+*LET
M=*^C]=%ZL_3LAS3$95P(\=CZ;C5IJ<,/)[N-91=X]=-7Z+3J? 8>OM+_ ((B
M_M":;\)/VD=2\,ZO<K9VOCRSCM;:5VPAO(G+0HW;YE>50<_>*C^*OBL#-30S
M/;S+)&S1R1D,K*<,I'0@U^I9SE=/,L#5P-5V4U:_9[I_)I,_!^&<]JY+FE',
MZ*NZ;O;NFFI+RO%M7Z7N?=7_  4O_P""9OQ#?]HK7?&'@CP[>>*-!\67)U"1
M=/427%E<OS*CQYW$%\L&4$8;!P1SWW_!/G_@ECH_A#X9>)?%WQ]\,V<,;HLM
MG9:A<M&VF6\0=IIY?+8;2V5P"<@(<@9%?/\ \'?^"R'QJ^$7AVVTM]0T3Q5:
MV:>7"=<LVFF1>P,D3QN^/5V)]\8%<7^TU_P4F^*W[56B-H_B#6;?3]!D.Z72
M])@^RV\YSD>8<L\@'&%9BN0#C/-?"?V/Q34PL,JJ5(0IQLG4BY*;C':VVMEK
MM?OO?]6_UBX$H8^IG]*E5J5I<TE1FH^S4Y;M[Z7;:U=MTM%;O/\ @G#K&B^(
M/^"LOA^^\-Z?'I7AVZU+69-+LT+$6]J;"\\I<L2V0FW)/?/3I7I?[<O_ "FM
M^'7_ &&O#7_I5%7QM^SC\?-8_9@^,^C>.= MM-O-6T/S_(AU"-Y+=_-@D@;<
MJ.C'"RL1AAR!U'!ZGXK_ +:OBKXO_M0:+\6M3T_P_!XCT*ZL;N"VM8)EL7>T
MD5XPR-*SD$J-V'&1TQ7KXS(,3/./K=/6G]7=.[>O-=M7^3W/F\MXNP5/AYX"
MO=57BU6:4?=Y;1O;HM4[+L?4'_!P'_R6;X?_ /8%G_\ 1]>E_MTR,G_!%;X;
M;6(W:/X:!QW'V2,U\*?M@?MJ^*OVV/$VCZMXJT_P_I]QHMJ]I NE031(Z,^X
MEA)+(2<^A%;?Q7_X**>-OC)^S!H?PFU/2_"L'AWP_;6-K;W-K;3K>NMI&(XR
M[-,R$D*-V$&3TQTKRL/PMCH8/+*,DKX>?-/7I=O3N>_C./,JJ9EG6*@Y<N*I
M<E/W=WR*.O971]6?\&\YS_PM[_N#?^W]<Q_P1Q_Y2._$W_L"ZK_Z=+2OF[]C
M;]O?QC^P\?$G_")Z;X:U#_A*/LWVK^UK>>;R_L_G;-GERQXSYS9SGH,8YS0_
M9J_;6\5?LK_&O7?'GA_3_#]YK'B"UN+2XAU&":2V1)IXYV**DJ,"&B4#+'@G
MJ>1KF7#..KXC,ZE-*V(C!0UZQBD[]M3FR7C;*\-@\EH57+FPM2I*IILI2DU;
MOHSZI^$/CK2_ W_!=/Q(^JS1V\>IZI>Z=;RO]U)Y8,1C/;<PV#W<5Q?_  6)
M_9Q\=3_MHZEXBM-!US6=&\56]H=-EL[22Y1&BMXH'@^0':V]"VWC/F9 .2:^
M5?C)\8]6^-7Q?UGQMJ26MCK&MWGVZ46 >**&3C_5[F9EQ@$98GWKZ,^&?_!:
MWXV?#KPM%I=Q<>&_%'D1^7'>:S8R270 Z$O%+'O8?WG#$XY).2=99#F6$Q6'
MS' J,YQHQI3A)VVL[Q=GU6OEZDKBW(\RP6+R?-)3ITY8B=>G.$4W[S>DHW71
MNWF]=E>E^TU_P3Q\3_LP?LK:-XQ\5>-_*NM5-K;IX7DB?S(99%WF(MYA4F)5
M).%QE<<=:^@_ /[+GPM_92_X)YZ+\6M8^'<?Q4\3:QIMGJ,L5Q(TEO";D!E4
MK@I''$K@.=C$LO7ICX9_:2_:T\>?M8^)H=3\:ZT^H?8P5M+2)!#:V0.,^7&O
M )P,L<L<#).!7I/[-'_!53XK_LN^!(?#.CW&BZUH=GN%I;:S:O/]C#$DJCQN
MC[<DD*20.P XJLPR?/:^7TXSJ*513YIQBW34H_R*44GIW>K[Z(G*>)N%<+F]
M:I3HRA2]ER4YSBJLHS_Y^.$VUKT2T5K67,S]#?\ @E-\?]6_:!\'^*M0/PY\
M+?#OPK936L.DQ:'IQM(KV4B4W#$\*^T>1C:HQN.2<\?,7_!'#_E([\3?^P+J
MO_ITM*\X\._\%LOC9HGC*^UBYF\,ZQ'>0+;QZ?=V$BV=F Q;=&L4L;;SG!9V
M8X ':O*OV=OVW_%/[,?QV\1?$#P[I?AN;5O$L%S;SVM[!/)9P)/<1W#"-5E5
MQAHU"[G;Y<YR>:\6GP?F"IY@E3C#V\8J*4G))K=-M)^;;6KN?18GQ$RB=7*I
M.M.I]5J2<Y2@HMI[-1BVDNB2V5KZEC_@I!_R?/\ $[_L-2?^@K5C_@FK9:'J
M7[<_PWA\0QQR:<VIDJD@!5KD12&VR#Q_Q\"*O,_C7\6]2^//Q7UWQAJ\%C;Z
MGX@NC=W$5FC) CD 80,S,!QW8_6N>LKN;3KN*XMY9()X'$D<D;%7C8'(8$<@
M@\@BOT*EEM264K 3?+)T^1M='R\MUZ,_(\1G5&/$4LVIQYX*LZB3TYE[3F2?
M:ZT9^G7_  4@\5?M!^"_VV_".L>!]+\4:IX;TN*%]'MM,MY9[*ZE;Y;A+@1@
MC<V2O[SHF",<FOL+Q#I,WACP5KWQ)TOP1&WQ,O?#*)+81.CW$\L2/)':EP0K
M[9'*Y'+!5 SA17Y<^#/^"VGQN\(>$UTN:7POKLT<:Q)?ZEISM=J!QDF.1$9O
M4LI)QD\Y)Y?X>?\ !6CXS> OBYJWC";6K/Q%=:S;+:3:?JD+MI\2*Y:/RX8G
MCV%-S@$'D.V[<3FORK%<"YQ7P]*@Z=*/L8\MTY?O5=.TM%9/=WUOVN?O6!\5
M.'<+BZ^)5:O-8B7-:48M47RM7C=N[V22NK+K;7YSUJ]NM1UB[N+YI&O;B9Y+
MAI!M8R%B6R.QSFH0<BNP_: ^-=S^T-\4M1\77VB>']!U#5B)+N'1X98;::7^
M*7;))(0[=6P0"><9))X]1@5^T864W3BZD>5V5UO9]K]3^:,=&FL1-4I\\;NT
MFK-J^C:>S?7\V%%%%=)R!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5Z5^QG_P G@?"G_L<=(_\ 2V&O-:W/AGX^O/A5\2/#_BC3
MX[:;4/#>I6VJVT=PK-"\L$JRH'"E25+* 0"#C.".M<N.I2JX>I2AO*+2]6K'
M=EN(A0QE*M4VC*+?HFFS].O^"WW[/_C;XZ?\*Q_X0[POK7B3^R_[5^U_V?;-
M-]F\S[%LW8Z;MCX]=IK\_P#5OV%_C'H.E75]>_#7QA:V=E$\\\TFGNJ0QH"S
M,QQP  23[5]#?\/[/C!_T+?PU_\ !?>__)=97C?_ (+A_%CQWX-U?0KSP_\
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MB3_P4X^!-KXL\'6'@S7M$UK1XY;2VUV/5B\<FI1NA=TC0(>I"')PP/ (RO\
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MV7?@AKW@'P_I?A6\T?Q%<W%U<S:A;3R7*-/;QP.$9)D4 +$I&5/)/4<#SO\
M9R^/>L?LO_&?1O'.@VNFWFK:'Y_D0ZA&\EN_FP20-N5'1CA96(PPY ZC@]]/
MA[&)9K=+_:$U#7O"2U[:L\>MQAETED*3?^QR3J:;6G"6G?2+/KC_ (*-^%/$
MWC?_ (*S:/I?@W4H-)\57%OIS:5=S3>2D%PD;.A+8..5P!@@D@8YKU3XO_\
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M8DT>,G8!]UP<\$?G$K9KU+]I[]L_X@?M=ZO:W'C/6%N+73RS6=A;1""SM2P
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MOB+!X_)\LP6';Y\/"<9W5E=N-K/KLQU%%%?7'P(4444 %%%% !1110 4444
M%%%% !1110 4444 >D?L@?&>']GK]IKP7XQNO,^PZ+J2->>7G>+=P8IB .I$
M;N<=^G>OT5_X*U?L5:Y^UWH'A7XB_#B.'Q)>6-A]GDMK>5-U_9.3+%+"20'V
MEW.W.2'XR1BORBKW3]FG_@HW\5?V5='_ +*\.:W#>:&&W+IFJ0?:K:(_['(>
M//<(P!SG&>:^+XDR'&5L91S;*Y15:FFK2ORRB^CMMN_OW5C]+X-XLRW#Y;B>
M'\\A)X:LU)2A;FA-6U5][VCZ6V:;/9?^"?'_  2E\7>.?C5:ZG\4?!UYI/@G
M24DDN;34R;>74Y"C+'&J []H8AV;@87 .31\:-<^$_P!_P""J_@.T\%Z3INB
M>%_!NI65IK$MO+))']K:5O-D9G9N(@\8('0Q/WX')?%[_@LW\;/BIX=N-,AO
MM"\)P72>7++H5F\-P5/7;)+)(Z$^J%3Z$5\HS3/=3-)(S222,69F.68GDDGU
MKEP.39MC,34Q6<5%&,H."IP;Y5?1R=]&]7;?\$=N9<3\/Y;@J.!X<I.<HU(U
M95:L8\S<6FHJRNE=*^RTV;;9^BO_  76^ _B[Q5\6O"/C'2=)U36/#[:*NE.
MUG ]PMK<)/-+E@N=N]95P2 #Y9Y.*])_8D\*ZE^RA_P2@\=ZEX^M[C2TU2/4
M]4M[*\7RY1%-:Q00Q%&^ZTLB9"D#_6@D<DU\@_ 7_@KO\9?@)X2M=#AOM'\3
M:;8H(K5->MGN)+>, !4$D<D;E5QP&8X' X  X;]J/]O[XF?M>00V?BS6(8]'
MMW$L>E:=#]GL_,&<.RY+.PS@%V;';&3GQ8\+YQ5P=')<1R*C3DFYIOFE%-M)
M1MH]=7?_ (/TDN.N&\/F6)XEP?M7B:T'%4Y)<L9223;E?5::*WRVM]?_ /!O
M.<_\+>_[@W_M_7R+\%I&E_X*/^$F9BS-\2;,DGJ3_:B4O[&W[?'C#]A[_A)/
M^$3TWPUJ'_"4?9OM7]K6\\WE_9_.V;/+ECQGSFSG/08QSGSGPM\6]2\)?&O3
MO'EM#8R:QIFMQ:]%#*C&V:>.<3A64,&V;@ 0&!QWSS7T%'(\5',\PQ;2Y:T8
MJ.NMU#E=^VI\?B.*,!+(\IR]-\^&J3E/32TJCDK/KH?=/_!=/1KKQ%^TG\*]
M/LIX[6\OK$V\$TDAC2&1[H*K%ARH!()(Z8S7:?%7]M#X[?L/^%="TKXU>"/"
M/Q$T74$\K^T;.216D";05N',9A\PY!'R#=SUY-?#?[8/[:OBO]M?Q-H^K>*M
M/\/Z?<:+:O:0+I4$T2.C/O)822R$G/H17I/P:_X+(_&CX.^%[71_MF@^*+.Q
MC$4!UNR>:9$'13)%)&[8[%B3P!G%>%_JGC5E6$PM6C3J^R4N:+;B]6VG"HMN
ME]-3Z[_B(.6//,PQV'Q%6A[;DY)QBI1]V*34Z4M'L[.]U=['TU^VE^SA\*_C
MI^P!>?&;2? R?#?Q!#9IJ,,:VJ6,C'SQ"8IHDPCB3.4? 8[D/<J;?_!%FU;Q
M7^P-\2M"LF634[K6[]$B)V\S:=;)'DG@ LK#VQ7P[^U'_P %"OB=^UUIL.F^
M*M6M8-%AD$RZ7IL'V>U:09P[C+,Y&>-S$#J #63^RI^VEX[_ &./$5[?>#KZ
MU$&J*JWMA>PF:TN]I)4LH*D,,D!E8'#$9P:<N$<SGD53 U*B=3G4X)R<E%)J
MT.9J[Z]+7)CXB9'2XJI9K1I-4E3=.I)1493DT[SY$[+IUO;T2/=O^"1_[.7C
M;2OV[]%U34O#.MZ58^$8KY]1FO+*2&.)GM9K=8]S #<7D& ,DA6/0$UVG[<C
M8_X+6?#O_L->&O\ TJBKS/Q5_P %I?C-XK\9:+JKMX9LK71;C[4-*M+*:.RO
M7",H\[,QE=1NW!1(%W '' KRGXK?MK^*OC!^U#HOQ:U+3_#\'B/0KJQN[>VM
M8)EL7>TD5XPRM*SD$J-V'&1T(KKIY-F^)S268XR$(WHRII1E>S;NKW2WNWV6
MB/-J<2<.8+(HY/EM2I-K$0JMSC:Z22=K-VLDE;=M-GU#_P ' ?\ R6;X?_\
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MP#X,L?\ @IC^P+\+Y]0G@;4-%U/3I]0:1-S-)9S""[4YZ&6#S&'4$NO'I^.
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M/[)O_!&SQ]\+?VH]!\1>+M0T"'PQX/U)-5CN;6Z,DE^\#B2$*F 4!959BY&
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MUW9EE&7TZ./SG%Y$[0A.,4J--5*VOQ*E>2C&/-S='=+2W*CD?VSOA7!\>/\
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MH]X@\"?\%$_&'Q&\)PZ+JBV,4OAK3DU&&62W-I&RJ7"I(C99T9QSC]X>/3]
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MR:Q6\E;9>?;SV/YGRFI5AQ%"5&LJ,O:Z3E\,7S:-^7>^EM]#] _$?C#]D/\
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M8FDY0D[IODCRJ[BFURW=G_-KJ[O2]DM%%%?5'P84444 %%%% !1110 4444
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M9YJA\9OV9/ 7Q _9WOOBY\';S6X]'T&[CL_$?AS5RLMWHQD*K'+'(H_>1,Q
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M?#?Q \-P7)D:U"B1KBVC$TEL[*!YJ21L"A<94NO(&[/._P#!O5_S5[_N#?\
MM_7<6NB6/_!*7_@FGX@T'Q'K&FW7C;Q8MY+!9PR;O-O;F!( (U/S/'$B(7;
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MU\._$?[0&H:A\,])U+0=!NXD>XTR\LA9FPN\L)42(,=J<*P' !9@  !7Z(_
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MP6*Q3Q."@Z:FDY1LK1F_B4-7>%]8WLTGRVTNRBBBO2/%"BBB@ HHHH ****
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M=I*[^9I4QV(J4U2J3;BMDVVEZ(:@YIU &**VB<H44450!1110 4444 %%%%
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M-/%?[6&E1P1:-KW@Z/4M#0*"(/$5]NLY8QZM$ZS2/C.#)G(KX0^#?P6\3?M
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MJZ6?$/ABW\-::VGV\UY;MN<%"[@R.-BY&/EWY!QQ\"UT?PF^+?B+X&>/]/\
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M "BBB@ HHHH **** "BBB@ HHHH ^C/^"3'_ "D#\ ?]Q'_TVW5?M)7XM_\
M!)C_ )2!^ /^XC_Z;;JOVDK^:_&/_D=4O^O4?_2YG]?> '_)/5O^OTO_ $BF
M%?S _L]_\IOO"O\ V6>'_P!/-?T_5_,#^SW_ ,IOO"O_ &6>'_T\U\1D.U7T
M7ZGWG&'_ "X]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/^/EO]W^HK2KHI[%1
M"BBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&W%/[5N9:,YNBMKQM\./$7PTU-;+Q)H.M>'[Q@6$&I64MI*0."=LB@UWM_\
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MVU";2]*U+4H=)MFO+Y[6V>9;*!2 992H(1 2 6; &1S5ZP\">)-)T:Q\2_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH ****5@#%%%%%@"BBBF 4444 %%%% !1110
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MQ)HOB+XU>-M-DT.VL]&N%NK?PO9R8\V668?+YQ &%'((7&5W&N7_ &;7$?\
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MV7_B!_PDWCRU\<?$#P'\_P#;5NVI'6M)U*R<$/@AI(XUPQ(;:NWH0!D5A_\
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M_$%?$3?\))?7'F^9)97GBG3YM.E4D;HS;&Y\H(0,$*HXZ$'FO)OV]/A!X<^
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MJ.:8F*FJG[R?O1249>\]4EHD]TEHNF@4445Z!Y 4444 %%%% !1110 4444
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MAIWBB72K2/;#:W-R&WI&HX .U3@?Q%O6O-Y/V./B]#&SO\*_B0JJ,LQ\,WH
M'J?W=>K@\XP];#4\1-J'.MI-)W6C7G9Z:'@9EP[B\+C:N#I1=7V;^*,6TTU>
M+VTNFG9GJO\ P2R^'>@?$CXH?$:W\0:+I>N6^G_#[4[ZVCO[5+A+>X66V595
M#@A74.V&'(R<5\Q5]?\ _!&6VM[SXY?$>&\N396DOPZU-)[@1&7R$-Q9AGV#
M!;:,G ZXQ7-?\,S_ +-O_1S5Q_X;[4?\:\2.;0PV;8J%53DK4[<L)S2TE?X8
MRM?SM<^GGD,\;P]@:E!TXOFK7<ZE.FWK"WQRBY6UVO;RN/\ ^"67P[T#XD?%
M#XC6_B#1=+URWT_X?:G?6T=_:I<);W"RVRK*H<$*ZAVPPY&3BOF*OT6_X)__
M  A^$GP_\4_$B\\!?&"3X@:Q)X!U.&;3F\+7>E^3 7@+3>;,=K8947:.3YF>
M@-?/G[('@KPW\-/@/XT^-_BC1K/Q-)X7O8-$\.:/>IYEC<ZE*NXRSKGYUB0A
M@G0Y/< CGPN>06,Q==*;7[J,8N,HMRES))*:35WN[6MKT.[&<*U)Y;E^%E*G
M%_[1.<XRC.*A'DDVY4W)2:5[13O=VTN?-E%?3FA_\%4_B%JVLP6?CBU\+>-/
M!+.8[GP[=:!9QVRP,?F6%DC5T8#[I+'! )S70'X!Z3^SM_P5+^&6G^&YKB;P
MOKNL:/KVB&8YD2TN95948Y.=I#J"220H)Y)KUY9U7H.5/&4E&7)*<>67,I*.
MZNXQ::NNC5MF[,^>I\+X7%QA5RW$.</:0ISYH<DH.;M&7*IR4HNS^TG=)-*]
MSY#HK[!_:-_;J\2?LX_M&^-_#'PLBT7PSHNF:]>PZA(^DVUW=:W<^>_VE[B6
M:-F*F3>H1"JA H'K75_M@?&S2_V7D\!^,/AKX7\.^&?'/Q8\.6?BK5K\Z=!=
M+IJS0IB*TAE1HX0[B1G(4EB!SUKFCGV+<J4?JZ_?)N'O]DG[_N^[IKIS]K7.
MRIPCET8XB:QK:PS2J?N][MQ7L_?]_P!ZR][V:UO=I'PG17V%XO\ B=??MN_L
M#?$'QAXVM-)NO''POU;39(-=M[&*TN;VVO91 T,HB55;#?-T'0=\YF_9<^%.
MK_!S]D:U^*'A3X=7GQ$^(GB[59['1671)-6M_#]G!\DEUY2HP\UI0R*6&,=.
MC Z2XB]G0DZU-*I&?L^7F7+S.*DO?:7N\KYFVDUJK-Z/*GP6JV+A##UG*C*E
M[;GY'S*"DX->S3E>7.N5)2:=T^9*[7QO17W]\'=5^-'[3WC6W\#?'KX7^)-:
M\*^),V::[=^"FTZZ\,S%-L-Q%/'!&JJK!0P;@ACSC(/PQ\0/!UQ\._'FM^'[
MPAKO0[^?3YR!C+Q2-&W'U4UV97G'UFK/#U%%3BD_=ESQ:=U=.T7HUJFETW3/
M-SSASZEAJ>-HRE*G-N/OP=.:E%)V<>:2LTTTU)IZIV:/6OV$?V;]'^/OQ!U[
M4/%<UU#X)\ Z+<>(]=%L=L]S!"I/DH?X2V"2?[JMC!((ZNY_;Y\%:;=O9:/^
MSM\(H_#N[:D6H6<EYJ)C&0,W18,&QU.T\UYW^Q[^U+<?LJ_$F\U*32;?Q%X?
MU_3Y='UW2)VVIJ%G+C>H;!VL,#!P>,CHQKU1OAO^RC\:"TFB>//&_P *-0N
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M7S!PC9_BBBP!P.''7MZ9^T3^S[H_[07_  6*\>Z;XADFMO"NAV-OX@UO[/\
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M:_L3&X^)7[&OQ"^'W@;Q#8^&_BEJ6MVVH*LVH#3YM<TU8U0VL4Q*\B3<Q7<
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M8_83\7W'CC4/VG-?ORJW6M?#3Q!>SGHOFS,KD#ZLQQ7RUX;4MXBT\ 9)N8P
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MP""1@\<^]=Q^T_\ $KPW\7_CIKWB/PCX9M_!WA[4C ;32((XXX[39!'&^%C
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MU:\8MQNUM8YC_@HWX%T7P-XA^$HT31],T==6^&6C:C>K96J6ZW5S(;@/,X0
M-(VU<L>3@9KY\T?2I]>U>UL;5/,N;R9((DSC<[$*H_$D5],?\%1/^1B^"G_9
M)M"_]"N:^8[.\ET^[BN(9&BFA<21NIPR,#D$>X-;\-RG/*Z<F[NSW]6<O&E.
ME3SZO&UHJ2T6FG*KVZ'V/\<->^'/_!.WQ3;_  \TWX8^$_B)XVTFSMY_$&N>
M*8WO+9KF6))1%!;;@JQJK@YSD[@#DC)3X,CX8_\ !1K5+SP/+\/] ^&/Q)N;
M*>YT#5/#F^#3KZ:)#(T$ULQ( *JQR,D!6Y&,-5\5_M+? G]M&>UU;XO:3XN\
M%_$$VD5M?>(?#GESV6HM&H19)8&!93MQPJDX4#=@ 51A_P"">&E_$2.XU+X$
M_&#P]X^U&SC:XAT=P^CZTR '/EQR$%CC/)"#GWKY.*I4L,OKTJE'$VUJOG<.
M?O=-T^1O[+Y5RZ61^B2EB,1C'_94:&)P3>E"/LXU/9]N6257VB7VX\SY]4V?
M*>HZ?-I.H3VMQ&T-Q:R-%*C=493@@_0BH:^AOV*?@EH>J^(?B!XT^(FG7-_H
M?PETYM2OM'ERC:C?&0QP6LV<$*9%;<#U*X(()%:7_#UWXI_VGY/E^#?^$1\W
M=_PBW_".6?\ 97E]/+QY?F8V\9WY_E7UU3-,1.M*A@J2J.%N9N7*KM72C[LK
MNUGK9)-:]OSFCD.#IX:GB\RKRHJJY<D5#GE:+<7*7O044I)K2\FT_=M:_P Y
M^'D637[%6575KB,%6&Y6&X<$'K7N?_!4;P3HWPY_;L\=:/X?TK3M$TFT-@8+
M*QMTM[>#?I]L[;40!5R[,QP.I-6_VROA!X9\+>+/ASX^\%6;:3X5^*5BFKPZ
M63N72KI)52YMT/\ SS5R"/3<0,  5[!^T<Q7_@N]I^/^AH\/#_R4L:\F6<*I
MBJ6,II\JHUFXO36$Z2:>ZNFFKZ];'O1X;E1P-7+*S7,\3AXJ:5_=J4ZK4EL[
M-.,K:7TO9GPK17I'[9$:P_M>?%1$555?&&KA5 P /MLW KV3XW:_=^#?^">'
M[+NK:;(+74-/U/Q!>P2A%;9-'J09'(8$-@J/O CC'2O:JYHXPPTHPNZS2WM:
M\)3[._PV^=^ECY?#9#&I4QD)U++#1<FU&_-:K"GM=6^/FW>UNMUYM\6OV>='
M\ ?L@?"3X@6MUJ<VL_$"?5DOH99$-K MI<^3'Y2A P)'+%F;GH!6!=_%+PS/
M^RO:^#5\*VJ^,(/$K:L_B(11"9[(VYC^R%P/,*^80^"=H(Z9KZ\_:)_;X^+6
MG_L$?!?Q-#XLV:WX[_M^SURY_LRS/VZ**[,,:[#%MCQ'QF,*3U))YKQ[5E#_
M /!'72V*@LGQ895)'*@Z7(2!]<#\J^?R_,,3.C"6.BF_;RBK3;M:<UK[L;J-
MK)?:6KY7H?89IE&"I5ZD<KFTOJD)R4J<5=.G2=U^\E:4[\TG]AZ)R3N?,%%?
M6\/B&R_X)^_LU^!-9T/2-)U+XJ?%"Q;6FU;4[*.\70-/W;8$MHY,J))/O%RI
M[@Y 7&C\ ?VJ[S]O#XAV_P ,?C7#I7B*/QANL]*\10Z7;6FJ:'>;#Y+H\*(&
M0L I1@<Y .1D5Z=3/JWLYXNE1YJ$&[RYK2:BVI.,.6S2L]Y)NVBU1XM/A+"^
MVIY?7Q7+BJBBU#DO!.:3A&53F34I)J]H246[-Z,^-Z*^V_V/[72_@I^R3^TY
M;^,=&M_$5OX1U72(I=.E)$%U>0WLJ0J^.?*,ZQ[P,;DW#(S65^S)_P %$/&_
MQ=^.OA/P+XYM?"_B3P#XLU2'1)M ;0+."UM$NI%A5H3'&KJ4+J1ECPOK@B*F
M?XB3KO#4%*%%ZMSMS+DC/W5RN[M+9M+;WM;+2GPC@J:PL,;BG3J8A:15/FY7
M[25/WWSJT;QT<5)[^[HF_CFBOIKX&? 7P+HW_!4'_A7_ (LEAD\&Z3XFU#3U
M2[DV1W7D^=]FBD;/1I%B4@_>SM_BKT#XB_M;_M"? KX@OI7Q"\&:?;^ 8;S%
MUX<?PG;#0YK7<%98I5BRPV@A7\PX/7N*TQ&?R=:-#"04FX*?O2Y+J5[*/NRY
MI::K1*ZN]3/!\'Q^KSQ./JRA&-25)\E/VBC**5W-\T>2.NC]YNTK1T/B6BNR
M_:$N_!^H?&CQ%<> 8[R'P?<W1FTR*ZC\N6"-E#&,C)X5BRC))V@5QM>_0J>T
MIQJ6<;I.ST:OT?FNI\?BZ"H5YT5)2Y6U>+NG9VNGU3W3[!1116ISA1110 44
M44 ?1G_!)C_E('X _P"XC_Z;;JOVDK\6_P#@DQ_RD#\ ?]Q'_P!-MU7[25_-
M?C'_ ,CJE_UZC_Z7,_K[P _Y)ZM_U^E_Z13"OY@?V>_^4WWA7_LL\/\ Z>:_
MI^K^8']GO_E-]X5_[+/#_P"GFOB,AVJ^B_4^\XP_Y<>K_0_I^HHHKYX^V+6D
M?\?+?[O]16E6;I'_ !\M_N_U%:5=%/8J(4445H4%%%% !1110 4444 %%%%
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M%'* W9S3J**.4 HHHJ@"BBB@!K+DTFPT^BIY0!1MHHHHY0"BBBCE ****=D
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M6^&R^5+&U\4WI44$EVY4U^-SFQV;0KY7A< HM.BZC;Z/G<6K>G*?6W_!'_\
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MJB HHHJ>4 HHHHY0$V4@2G44<H %Q1111R@%%%%.P!0PW444N4  Q11132L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDH[GF_QIU'XB7'[.OPEM_%%E;V_@FW@U(^$)XS"6N4:=#=[MC%\B0(,2!3Z
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MS[E]S,JBM7_A!=<_Z VJ_P#@))_A1_P@NN?] ;5?_ 23_"CVU/NOO#ZGB/\
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M))_A1[:G_,OO#ZGB/^?<ON9[_P#\%8?^3P[W_L!Z3_Z115\UU]*_\%9$:/\
M;$O-RLO_ !(])ZC_ *<HA7S57C\,_P#(IPW^"/Y(^CX\_P"2BQO_ %\E^844
M45[A\D%%%% 'T9_P28_Y2!^ /^XC_P"FVZK]I*_%O_@DQ_RD#\ ?]Q'_ --M
MU7[25_-?C'_R.J7_ %ZC_P"ES/Z^\ /^2>K?]?I?^D4PK^8']GO_ )3?>%?^
MRSP_^GFOZ?J_F!_9[_Y3?>%?^RSP_P#IYKXC(=JOHOU/O.,/^7'J_P!#^GZB
MBBOGC[8M:1_Q\M_N_P!16E6;I'_'RW^[_45I5T4]BHA1116A04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]
MU_Q\R?[Q_G4=277_ !\R?[Q_G4=<9F%?@#_P=5_\I"_!O_9.[+_TY:G7[_5^
M /\ P=5_\I"_!O\ V3NR_P#3EJ=>QD?^]?)GS/%G_(O?JC]F/^"<G_*/3X#_
M /9._#__ *;;>O9J\9_X)R?\H]/@/_V3OP__ .FVWKV:O+K?Q)>K/>PO\"'H
MOR/Q;_X*S_\ *0/Q_P#]P[_TVVM?.=?1G_!6?_E('X__ .X=_P"FVUKYSK^R
MN%O^1+A/^O5/_P!(1_G[QI_R4./_ .OU7_TN04445[Q\R='\)/A+XA^.GQ"T
M[PKX5TYM6U_5C(+6U$T</F[(VD?YY&5!A$8\D=*]P_X=#?M$?]$]_P#*[IG_
M ,D5\W12M X9&9&'0J<$5-_:MU_S\7'_ '\->;C*>82FGA*D(QMM*$I._JJD
M--M+?/M[66ULHA3:S"C4G*^CA4C!6LM+2I3=[WUNE:VFEW[9\4/^":OQL^#/
M@+4O%'B3P5_9NAZ/&);NY_M>PF\E2P4'9'.SGEAT!ZUX74TNH7$Z%7FF=3U#
M.2#4-;8.&*C!K%SC*5].6+BK>CE/7SNO0Y\RJ8"=1/+Z<X1MJISC-W\G&$$E
MY6?J?:7_  3&7PV_[*/[2H\8-K2^&3I^C_VB=($9OA%OO<^5YGR;NGWN*X?[
M'^QW_P _7[1GY:1_\37<?\$Q?AUK'Q?_ &5OVE/"WA^U6^UW6]-TB"SMC,D/
MG-OO"?F<A0!ZD@5P_P#PYZ_:$_Z$>W_\'EA_\>KX66(P-/-<:L5B_8OGA9<\
M877LJ>MGOVN?J<,+F=7(,M> R]8F/)4NW3E.S]O4TO%Z=['DOQ\C^%L?B_3U
M^&$GCJ30?LR_;6\2BU^U"?>V?+$ "[-FW&[G=GM7TU\0?$?Q^^/":>WP;\,_
M$+X?_"K1;&"UT:SM+G^QX]BQ@232S*T:RL[ER6+$$$=\D^->+/V1_&7[&'Q(
M\!ZU\6/#,=CX<NM:@>:)+ZVNC=PPRQO.FV)W(S&<<C!SWKW+]L;]C[XN?M3_
M !FUSQAX5UK2?&WPYU29;K2[^/Q+;16&E6K*/+B:*65?*V#@A5Y()ZDBNC'8
MW!2GA[582ARRM4J/G@W=)I6<8N?9W32NDG=G/E&6YE&CC.;#U857*FI4:*]G
M44>634FW&<HT[[I1:;LVU9%;]MSP7XNO/^">/@G7OB9?Z?K7CW0_&$FAB^BO
M[?4+E+*6UEG$$]Q"S!G5X@V"Q(# YYYM>,_VB+S]FG_@GE\!=6\,PPVOCC6K
M+6+"RUF2%99-*M%O6-QY&X$++(SQ+NZA0P[YJ#X@_!FUN/\ @ESJ/A'P7K6E
M^,M6^'GC3^W_ !7<6-TBVL"?8)5D> R,IFB3S(H]RC+NKE017G7[7DF/V ?V
M7$W#>+7Q&Q7N ;V#!Q[X/Y5Y6!IT<2J&%J6E%8BI[J7*K.G4DO<N[1>_*]T]
M;W/=S;$XK O%X^C>,WA*-I.7.^95:4)/VB24IQV<EM)75K(W/V%/B!KGQ1N?
MVCM<\1ZM?ZWK%[\)M9\^\O)FFFEVQQHN6//"J /0 "LG]E.8_M#?L>_%#X23
M8N-6T",>-_#"$;I#+ -MW"GN\1&%'=F-1?\ !-B3R_#?[0C,P5?^%3ZRN3P,
ME4 'XUY%^RO\;YOV<OV@_"OC*$.\>CWJM=1+UGMG!CG3WW1LXY[XKVJV"=2K
MC(89)2@Z4H):+FA%-+R3MROR;/F,+FT:-#+:F-DW3JJO"JV[MQJ3:DVWNU?G
M7]Y)GJG_  3OAC^%TOC[XS7D<;0?##0W.F>:N4FU:\!M[5>1@XW.QZD<'WKY
MPO;V;4KR:XN)'FGN',DDCG+.Q.22?4DYK[&_X*/>'_#W[+GPPTGX5^#[RWN;
M+Q=K-UXZO7@;Y1:R,8M.@]U6(,<<#(! YR?C2O5X?K+&.IF=M*K2C?=0CHOO
MDY2]&CP>,*#RU4<ANFZ"<IVV=2I9OUM!0CZIGVE_P3&T#1_%7[*/[2NG>(->
M7POHMYI^CQW>JM9O>"Q0O>Y?RD(9\>@(ZUQ"_LJ?L\QMND_:@B:->6"_#_4-
MQ'?'[P\_@:V?V$YE3]AG]JA6959M'T@@$\D>9>#^H_,5\EUYV%P->MF6.E2Q
M$Z:YX:14&G^ZIZ^_"3^YV/7Q^9X7#9'E<:^$IUG[.HTYNJFOW]32T*D%;U3?
MF?2'[4G[1/@.R_9^T'X-_"C^UKSPII>I-K>K:UJ4/D3ZU?%"@98^JQJIQ@@'
MY4&/EW-VVC>+_C)\4O@KX+\-? 7PKX]\*^$= TQ!JM_IQ^P'6M3+%I[I[I"F
MY>%VJ7^4 @\ 8^.:^]_VM?@!X]_;8N_#_B'X-ZA8^)/AFN@VD%MHEOKUO:#P
M[Y<866*>"62-0P8$E@"3TZ 5AFF&PV ]A1FX\KE.3G5UCSZ:R5XIRE=\MVDK
M.W1'9D&/QV;?6\5!2YHQIP5+#I1G[.[T@VI2C"+BN>RDWS+FZL9\1O 'Q%U7
M_@F?\1F^,&IV^MZUX-U/2K[0#<:M;ZKJ6G+/<);RK)+'([(KJ_"NV<HW'''.
MZ/\ M%_$*+_@D[=Z\OCKQDNN6WQ-73H=1&M7(NXK4:9&P@67?O$6XD[ =N3G
M%=!\'?V<1HW[%OQQ^%.B:YH?BCXIZK'I.JWNG:=?Q-:VL-O>+(85G=ECDECC
MCE>3:=J[T7)-<7^S=\+]:_:=_P"":GB#X?>"8K36/&>G_$./77TIKV"VF>S:
MP2$2KYKJ"-ZMGG^$UXE.>&]G4=9PY88B$K\O+%0E&'O6;?+"4KZWM)W=SZC%
M4\=]9I1P\:BG4P=2*7.YSE4A.I[KE%+FJ0CRW25XZ*R,7]G>^FU/_@FW^TY<
M7,TMQ<7%YX<EEEE8N\CMJ.2S$\DD\DGK7J/[(WP"^)GAO]A.Q\4?!GP^M]\0
M/B%J=U%<ZR+JUM[C2-+MW,/EP-.Z;6DF5LLN3@'IA2/,/@-I5QX8_P""<W[3
M^GWT8M[RTU'P]:RQE@V)4U'#*""0<8/0GIGI3O@W%I/[7/[&MC\*/[<T?0OB
M%X'UJ?4_#<>J7*VMMK-I<C,]NLK?*LP?+ $C.%']YE[<PC.:Q#@U[/ZQ%RO%
MRCR^QIZRBG&\5+E;U22U>B9Y>3U(TZF$C44O;/!S5-*2A/VGUBK=1E*,N6;A
MSI>ZVV[+5H]\_9D_9S_:EB\=+X=^+>C:QXN^&/BC=8Z_;ZYXCL]4:VC==JW$
M1:X>5)(VVL"GH>,X(\O_ ."=^D6GP.^-'[1VGZE9P:]8^#_!.NV]U:S?-'J,
M5M.JO&V,95U0@XQPU<O\+_\ @GO/\$?$W_"3_M!_V1X5\#Z-&UU+IAUF"?4/
M$+;"8[>W6UE9_F;&6#+@ X(Y(C_X)[ZA:W=M^TC=6MJNGV,WPNUUH+?S"ZVZ
M-MV1[F))P"%!))..YKFQ%.-3#8J5.I"<)*FFZ4.2#?/T?M)WE;1M6LN6[N=N
M"K5:.+P$*]&=.I&59Q5:HJE51]ELX^RI\M/F5XJ5[OFLK.[X?1O^"C/QDTGX
MFVOB;_A//$4GV:Y6?^REO'CTID!'[D6JGR5CV_+@)P.G/->\?%V6\_9__P""
MS5KH?@W5-5\-Z/XD\6Z ^I66G7<EK!>+</;22QR)&0KQLTLAV,",.1C!KX7K
M[9_;G\4V/@__ (++:3KFH7$=OI>FZ[X<O[BX9ALC@C2T=WSTP%4G/M7MYIE]
M"GC(TJ%-)2HUDTDK/E=/ENEO:[MVNSY7(<XQF(RZI7Q=:4G#$X=J4I-N/.JR
MFTV[I227-T=D>-?\%"OBIXG\7?M3?$'1-6\1Z]J>BZ-XGOUT^PN]0EFM;$"9
MU BC9BL?''R@<<5X77TA_P %)/V;_&'PX^/'BKQQJFFVZ^$_&GB*\N-%U*"^
M@N([Y)&,H(5'+CY6ZLH&01DU\WU[W#M2A/+J+P[3CRKX;6O97VZWWZWW/EN,
MJ.*IYUB8XM24N>37->_*Y/E:OT:VZ6VT/HCX&?MM+\//A':_#OXD> =-^(_@
M*&X-YIUK?2/9W>EF3)=K:=02%;>S8&#EC\P!KI[7PO\ LE_'.:.#3];^('P@
MU6X^11JD2:EI:.>GSJ6DVCIN=D SSTS6X=(T+_@H?^S%\/=%T_Q7H7AWXJ?#
M'3_[#72M:O!:0:Y8J0(F@E;CS%55&W_>S@8-<E8_\$E/BII]U'/XID\(>#-
MSNDUC4]?M?LRQC[SJ(W9FP.V!DD<CJ/EY5\MC*<ZM:6%K<TKQ4VKN[M)0DG&
M7,K2O&+;OKK<^^CA,[E3I4\/AH9AAN2/+.5--Q7*KP=2+4X<CO&TIJUEHE9%
M?PA_P3WU7P[^WEX-^%/BN6"]TSQ!,E_'?Z=*3#JFFJDDS21/C(W)"Z_[)SU&
M":7[1?[?_P 0-?\ B9?6/@SQ-K7@;P7H,[V&A:/X?O7T^VMK6)BL>1"5WL0
MQ+9Y)Q@5W?QS_;?\.^!?VP/A/J?@N2?Q%X7^"NEV?A]+[:(Y-:CB0Q7#IGLT
M;%5)X)!(X()ROBC_ ,$ZO$'QK\;ZEXK^"MUH7CKP3KTLFIV[1:Q:VMUI"2-O
M:&YBG>-D:,L5Z'@#.#Q1A\4I5:.)SU))TURN:M%2YGS73TC*4>1I/7XDNJ(Q
MF!E##8G \*.4I1K7FJ;<INGR1Y4G'WIPA4]HKJZ^&3W3'_$?Q/)^VA^P=K'Q
M \2QQW7Q$^%.J6>GW>LHBI-JNF73>7$MQM W.DIP&/8'NQS#_P %(#_Q</X"
M_P#9+O#W_HVXJ'XVW6B_LE?LBW?P?M=;TOQ'XZ\9:K!JWBB72[A;BRTB"#F"
MT\P##R[QN;!^7D'JI+?^"FMZ;+QA\$9(]K2VOPJT$E3_  L&N#@C\OSJ<NC_
M +92]BK4G*LZ:V7+R0V72+ES./2S5M+&N=5FLOKO$-.O&&&59[OVBG4^)K>2
MAR*3NWS)WUN9W_!7G_E(A\0O^X;_ .FRTJ[I?_*''4O^RLC_ --4=>@?ME_L
MI^)OVY?C%=?%[X4R:)XJ\-^+K"RN;J,:Q:6MQHDL5M%;O#<)-(A4CR@<\\M]
M,T_C3X(T/X7?\$JY/"^E:SI_B#5='^(-N^OWFGMYEFM[)92DPQ2#B18XQ$A<
M?*7# <"LL+F-"67Y?@XRO4A*DI16\7%6?,OLZZ:[]#3%Y)C(9MF^95(6HU(8
MB4)OX9J;<H\C^U[KN[7LEK8;H_[1?Q!B_P""3MWKR^.O&2ZY;?$U=.AU$:U<
MB[BM1ID;"!9=^\1;B3L!VY.<5R/[.]]-J?\ P3;_ &G+BYFEN+BXO/#DLLLK
M%WD=M1R68GDDGDD]:W/V;_A=K/[3G_!-7Q!\/O!,-IJ_C+3_ (A1Z[)I37L-
MO,]FU@D(E7S74$;U;//\)K'^!&DW'AC_ ()T?M/Z??1BWO+34/#UK+&7#8E3
M4<,H()!Q@]">F>E.2P].%:C3Y5-8FDVE9-1=6FUIO9ZVZ;V)C+&57A\15YI4
MW@JZ4G=Q<E1K*23VYEI=;[7+7PX\42?L7_L'Z/\ $#PW'':_$3XK:I>:?9ZR
MZ*\VE:9:GRY5@W [7>48+#L1W45RW[.G[?\ X_T#XF6-CXS\3:UXY\%Z].EA
MKNC^(+U]0MKFUE8+)@3%MC $L"N.0,Y%;OP2NM$_:T_9%L_@_=:YI?ASQUX-
MU6?5O"\NJ7"V]EJ\$_,]IYA&$EWG<N3\W '1B+/PN_X)U>(/@IXXTWQ5\:;K
M0O O@G098]3N&EUBUNKK5TC;>L-M%"\C.TA7;T'!.,GBMZD\N@L33S-)UI2E
M9-7G*-_W?L^KM&R7+M*^SN8T:>=5)X"MDDI+#0A3NXNU.$DE[;VOV5>7,Y<_
MQ1:W5CT']D3X)6O[.?\ P6FD\&V/G?V?H\VH?8Q*Q9UMY=.DFB4GN1'(HSWQ
MFOGOQ?\ M^_$Z^\9_:_#?B[7O!V@Z>XCT?0]'O'M-/TZV0_NH?(0['VJ "7#
M%CDL3FO</V&/C>W[1'_!8!?',D#64.N2ZG<QQ2,"UO MC*D2N1QE8U0$],@U
M\1UT97@56Q\GF$%.I&A03ND_>;J\V^FK6_\ F>=Q!G$L-E4%E%1TZ,\3B7'E
M;C[J]CR;6=DGMZ=4CZB_X*APV>O?$CX:^-FLXK/4/B+X#TGQ#K2VRA%ENI58
M2.HQC)55'/\ =S7M7[3^C_&+XIZ[I_B#]G3Q1J%]\)[73[6/2-&\'ZU]CDT8
M)$@>*XM(W5R_FJ[996(W ''?R/\ ;UOM-L[C]F>ZU:U?4M'@^&6@->V\4A1K
MF%2WFQA@058J"N0003U%6/'/_!/+Q/XC\?W'BOX 7^F^(O E\5N].N['Q%!;
M7>CQMC,-P)I4D5HVR"<DX )P<@>51E0CA,)*M.,.15%%U(J5.W,ERN[5I))*
M+OMS+75'T598J>/S".'I2J>TE1E-49.%9/DYN=)1DI0<I/G5OBY7IHSS?]MC
MXT:E\7]6\+Q^+/"NH>'_ (D>'M..F^)KR]A^SS:PZL/)E>+:I5PF06/WLC&
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M=/\ VI_^"TUGXKT>%AHLUM>65@9D\MKB&'3I8Q(PZC>06P1D @$9&*\-UO\
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MJ=ZEMK%AXJ\20317MO,2KQ+:33,S.VXA0B9R1T!KS?\ 8G%Q\2?V-?B%\/O
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M[73@?L!?LNQY&];7Q&Q7N ;V#!Q[X/Y4?\$VW$7AO]H1F(5?^%3ZTN3P,E4
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M3LKKNDTTT>M@^(I4JN(]M2C4I5W><'=*]VXM---2BV[/LVFFF?6W@^\\$_\
M!/3PAXFU2Q\<^&_B-\5-?TV?1-+C\-S/<:7H,4PVRW37)"B23:,*JCKZ@DCE
M?V??'^C^'/\ @GM^T#HUUK.FV>M:]<: NG6,ETD=U?B.]W2^7'G<X5,EB 0!
MUKYSHKE_L&,HOVLW*<IPDY.VOLY*48I+11T_%N[;.S_6ZI"<8X>E&%*%.K3C
M!-Z>UBXSFVVVY.][O31)))'T+^PO^T7HGAA]8^%_Q%99OA;\0@(+UI.NB7G
MAOHV_@*,%W'I@ G.W!W_ (1>(_!GPUT[XG? /QYXJTNX\*^(KR&ZT;Q=H[KJ
M%E8WT/\ JKD^4QW12(55P"2F"IQRP^6RN:38*K$9#2JU*DU)Q4^5M*VDXM.,
MUVEHD]U))76FL8'B[$8>A1I2A&;I<T4Y7UIS34J4K-7@[MQU3BV^5J^GU'X(
M_8_^&_PJ\6V?B+X@?&GX9ZYX1TV07;:;X9OI-2U35E1LK;F#RU\K?@!BQP Q
MY_B&A^PG\=_"LW_!3BW\<7D?AWX?>%;B34IH8&>&PL=-A:TE2*(?=0-]T8&-
MS$X&37R:1FDV"LZV12KT:M/$UI2=2#A>R2BGO9+2[ZMWV5K(UPW%D,)7P]3
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MHH_U>RK_ *!J?_@$?\@_URS_ /Z#JW_@V?\ \D>_?\/2?CY_T4C5/_ 6U_\
MC5'_  ])^/G_ $4C5/\ P%M?_C5> T4?ZO95_P! U/\ \ C_ )!_KEG_ /T'
M5O\ P;/_ .2/?O\ AZ3\?/\ HI&J?^ MK_\ &J/^'I/Q\_Z*1JG_ ("VO_QJ
MO :*/]7LJ_Z!J?\ X!'_ "#_ %RS_P#Z#JW_ (-G_P#)'OW_  ])^/G_ $4C
M5/\ P%M?_C5'_#TGX^?]%(U3_P !;7_XU7@-%'^KV5?] U/_ , C_D'^N6?_
M /0=6_\ !L__ )(]^_X>D_'S_HI&J?\ @+:__&J/^'I/Q\_Z*1JG_@+:_P#Q
MJO :*/\ 5[*O^@:G_P" 1_R#_7+/_P#H.K?^#9__ "1[]_P])^/G_12-4_\
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M6?\ _0=6_P#!L_\ Y(]^_P"'I/Q\_P"BD:I_X"VO_P :H_X>D_'S_HI&J?\
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MMW84445T'*%%%%  1FFA*=14\H %Q01FBBCE 391L%+11R@%%%%.P!1113L
M4444 %%%%3R@%%%%'* 4444<H!1111R@%%%%'* 4444<H!1113L !<44446
M****8!1110 4444 %%%% !1110 4444 %%%% !1110![M_P39^-'AO\ 9]_:
M]\.^*_%NH'2]#TVWO5GG%O+.0SVLL: )&K,<LP'3 SR0*\'*<4ZBN&G@80Q,
M\4F^:<8Q?:T7)JWG[SO\CT:V9U:F"I8"27)3E.2>M[S4$[ZVM[BMHNM[] #
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M23E>VUVG:U]=NZ,*/%/L\PPN/]E_ A&%N;XN6+C>]M+WO:SMW9=\-J6\1:>
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MVPO^3//V:?\ L!ZK_P"EHKYKKZ4_;"_Y,\_9I_[ >J_^EHKYKKP^'?\ <O\
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MZ*>Q40HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ73])(Z#P9\*/%/Q&L=0NO#WAKQ!KUKI$8EOIM.TZ:ZCLD(8AI612$&%8Y;
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M4VXR:3Y5*]W[KLV?*M%:O@GP-K/Q)\36NB^']+OM9U:^?9!:6<+32R'V51G
MZD] .3Q7JGQ"_P""=WQJ^%GA*77-:^'^L6^F6\7G32020W;0)S\SI"[N@&#D
ML!@#)P*];$9CA:%2-*M5C&4MDY)-^B;NSYS"9-F&*I2KX:A.<([RC&32]6DT
MOF>+45TG@#X2>(?BC8>(+K0M/^W0^%=,DUC5&\^./[+:(55Y,.P+8++\J9;G
MI73ZQ^QY\2_#G@/1?$VI^$[[2M#\17UOING7-])%:_:9YPS1 +(X<*RJQWL
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MCB*?M</-3CWBTU]ZT,\;@,5@ZOL,73E3FNDDXO[FDPHHHKH.0**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBNE^$'A70/&_Q&TW2_%'B>/P;H-T9/M6L/827PLPL;,O
M[F,AGW,%3@C!?)X!K.K45.#J2O9)O1-O3LE=M^23;Z&M"C*M5C2A:\FDKM)7
M;MJVTDN[;26[:1S5%?37_#*/[/?_ $=%;_\ AO[_ /\ CM<_\5?V=O@OX/\
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M '#H?^F*84445[A\F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7K%+'+<,K?@0*W/'M[\,_%G_  3JU3X=^"_'&AKJ'@#Q3_PD,T^N3?V?/XK
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M_9@^/.N? _X\Z'XBL+VZ;S+^-=3MVD9H]4MW?$T4R]) ZLP^8'DY'(!KTO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** /I3]L+_DSS]FG_ + >J_\
MI:*^:Z^E/VPO^3//V:?^P'JO_I:*^:Z\/AW_ '+_ +?J_P#IV9]9QM_R-?\
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MFI7:\[:/[CS\5@,3AIRIUX.+BTGILWJD_5;&911170<84444 %%%% !1110
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M>:^(R':KZ+]3[SC#_EQZO]#^GZBBBOGC[8M:1_Q\M_N_U%:59ND?\?+?[O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVMK>][Z;6U****[CR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***Z7X01^$)?B-IJ^/)/$47A/,GV]M"6)
MM0 \MMGE>;\G,FP'=_#NQSBLZM3D@YV;LF[+5NW1+OV-L/2]K5C2NES-*[=D
MKNUV^B75]CFJ*^FOL?['?_/U^T9^6D?_ !-<_P#%6V_9DC^'VIMX)N/C<_BG
MRQ_9XUD:;]A+[AGS?* ?;MW?=YSBO)IYTIS4/85%=VNX:+UUV/H*W#+ITW4^
MM479-V51-NW1*VK['@M?87_!.W2IOB#^RY\=O!G@Z:&#XIZ_86;:9$9Q#/?V
M4<N;F&%B1R4W*1D9\Q,\ D?'M>H>"_@!XB;]G'5?C!I&M6UG:^%];CTF6&"6
M6/4()'6,I,K*NU4)DVYW Y!XZ49_0A6PJHSFH-RARMJZ<E).*:ZIM)-77J5P
M?BJN%Q[Q%.DZBC"ISI-1DH.#C.49.]I1BVT[/;8YGXB?!#QI\';UH_$_A;Q#
MX=DC? :^L98%)[%68 -[$$@UWW[1/[6*_M%_ _X;Z+K&FW4OC#P+;SV%SKLU
MP)&U.U9\PHPQNW(JJ,L3DEC_ !&MKX<_\%1OC;\.[1;-O&$OB+3=H22SUZVC
MU&.91P SR RX^CC/>NV_:7T/PC^TM^Q79_'+2/"FE>!?%6G^)/\ A'-<LM+4
MQ:?J9,(E$\41/R,-Z=,D_/DMM!KRZV(KPQ-!YG1CI*T)PDW:4DU9Q:32EJMY
M*]K[77N87"X2K@<7'(L3+6GS5*56"3<(24FXRBY1<HM)JZ@[7MO8Y'X@_LI^
M'O GQ-\$Z7\0OBU<:+HWBCP-9>)K?5YM!N-0:R\XN([$0QRLQ"['(<$+_LC-
M>I?\%D_ '@=/VB/%?B!?B#O\<-_9\3^$_P"PK@>7%]EB7S?MN?*/R@-MQGG'
M45P?_!4/_D8?@G_V270O_0KFC_@L9_RD"\8_]>^G_P#I%!7EY;+$8G&X+$5*
MLKNG5;24$M)T]/AO:6E];Z+E:UO[F=?5,%EV:8.EAXM1JT$FY5'+WJ=9IW]I
M:\->6ZMJ^92TMS?PY_8FLG^&.E>-/B9\0-&^%WAWQ!\VD"YL9]2U'4HP<&:.
MUA^;RN1AB1G.>!@G+^-?['__  @7PQC\>>#_ !AHOQ%\"_:$L[G4=/ADMKC3
M)W&52YMI/GBW<8))!)QQD9^G?^"@A_9XMOCAI]CX[;XV&ZT[P]IT&F+X>_LP
M::E@( 8O*$WS]2^[MNSCC%<%X$^)GP-\%_ [XMZ1\-]!^/VO2>)?#4EO?#5;
M*PN-/TXHVZ"ZF:W8-$L<A^^P( 8\9-+"9YCZU*GC5SOF<7R\D5346TM)?%=)
MWNY6;7PI,K,.%\GP^(JY7+V:]G&2]I[2;JN<8MW<+\G*Y*W*HIJ+OS-H^-Z]
MZ^$/["M[\7OV>+7XB0^)M-T?2X]>GTK5I-1A\JTT>VB@24W3S!B6W,ZQK$L>
MYF90"<G'@M?5%QJEQI__  1IMX896CCOOBH8)U'_ "U0:<T@4_\  D0_517T
M^>8C$4H48X:7*YU(Q;LGH[WT?7JO/R/A^$\'@JU3$3Q]-SC3I2FDFX^\G&VJ
MZ:V?DW;6QG0_\$]K'XK^%KZ\^#7Q(TOXK:IH[PKJ.D1:1<:5>1K(X3S(EG/[
MV-21N;Y0!D]AE?"W[#7P]\0ZY!X7D_:!\'P^/+B9;1-,CT>\ET\W).WROM^%
MB)W87(!!)XSQG1_X)2:Q<:#XT^,5Y:R-%<6GPLUJXB921M=)+8J?J#7S)X7E
M:#Q+ISHS(Z74;*RG!4AA@BO+IQS"IB*^%^LM*GRM2Y8<SYE>TO=Y;)K3EC%Z
M[Z'O599-3PF$QWU&+E7<HRCSU>2*A)*\/?YE*2EKS2E%6TCJ;/CGX/>(/A[\
M6K[P/J%@_P#PDFGZA_9C6L)\PRS%@JA"/O!B05(ZAA7M^M_L->!/A1J']B_$
MCXY^'?"?BZ-%^TZ18Z'=ZR+"0[3Y4T\)"(P#<XSC!Z]:[;]M;P+XE\=?\%CM
M6T?P/-'I_BBZU+2Y=.N<!5M9ETVUE,YX/W-K.3@G@GDUPOQ/\-_ KP_XWU:;
MQ9X_^)7Q$\43W\TFJW>A:9;6-K<7!<F9EEN&9FR^[#"/!Z@8QG..;U\52PTH
MU)0<Z<9M4XJ4KR2M?FC*,8[[ZM[/1FW^KV#P5;&J=*,U3K3I1E6J.$+0;O90
MG"<YVLW;W8K5K5'G/[37[,>I?LU:_I*2ZKI7B/0?$ED-2T76M,<M:ZE 3@D
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M0>@QG'TSYA^SK^S9KW[27B6^M=+FT_2]+T6U-_K&L:E-Y%CI%LO665\'T.%
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MWH<YC*GGCT.,5Z;X/UK]D_PWXMTO4=)_X:6&K:?=Q7-D471F83HX:/ 7!)W
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M -P[_P!-MK7SG7T9_P %9_\ E('X_P#^X=_Z;;6OG.O[*X6_Y$N$_P"O5/\
M](1_G[QI_P E#C_^OU7_ -+D%%%%>\?,A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO:[6S.JE@ZU2C/$0C>,+<STTYM$[;VNK7M9-I-IM7X"BBBMCE"BBB@ HHHH
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M117N'R84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS_#_ ,$_ CPY\1OB_P"(/%-EI?C2YN8M!T?PS:0RZA>16T@CGF>2<B.-0Y
M.2001G.*^>Z^FM ^.^J_!GX%^$_ WQ>^&6F^-O >I6S:WX8::^-G?6EO<,6=
M[>YA+%59B6*.N<\'C 'TF>3Q')3AAF[N6JBXJ;BD[J#EI>]F]O=3LTSXWA2G
M@W5K5,;%6C#W92C.5.,W**3J*&MFN9+1KF<;IK0P_C#^S)X(U7X#77Q0^$WB
M#7]4\-Z/?Q:=K6E>(+>*+4](>7_52,\7[N2-R=N5 Y]>0&_!O]E'PW;_  8B
M^)GQ9\1ZEX5\'ZE</::'9:9:+<:KXADCXD:%7(1(T/&]^"01QP3O>-_@K\.O
MBQ^S'XN\?_"6]\7>'QX-FL_^$D\,:U<)<1O'<2F.&:&9-NX!@>'!/!/'&ZQ^
MWO;R:A^SS^SCJE@C'PV?!*V4;*,QK?QR8NQGIN+;>.O!ZXKPZ6/KSY,%&K).
M5246Y)*<4H<_)UBY/I))^Z^KU/J\3E.$H^US2>'A)0HQG&,)2=*I*53V;J+5
M248]8-IJ:UM%V(]-_95^%/[36EZI;_ _Q+XV_P"$PTRV>\A\,^+K6V6XUB*-
M=T@MYK<^7Y@&2$89/L,M4G_!-R-H=!_:&1U977X3ZVK*PP00J<&N/_X)K:1J
MFL?MS?#==)25I[?5EN)BBEMENBL9B<=!Y>\9/K7KO[+FH:?JWQ<_:\NM)V_V
M5<^!?%4MEM.5\EIB8\?\!(K#.*E6C3Q&!E4=2*C3FG*W,KU+--I*Z=KJ^N^K
M5K='#E'#XFIA,UITE2FY5J<E&ZC+EH\RDDV[-<UI6=GHTD[W\3O_ -GG1[?]
M@JQ^*B76I_V]/XV;PS);&1#9_9_L;7 <+LWB3<N,ER,'H#S5;]A?X!Z3^T_^
MU1X5\#:Y=:C9:5KANOM$UBZ)<*(K2:<;2ZLHRT0!RIX)KT:__?\ _!'&RV?/
MY/Q:/F;>=G_$J?KZ=1U]1ZTW_@CMH=UJW_!0+P;<6T)DCTN#4+FY/.(XS93Q
M;C_P.5!]2*[<1F->.58^MSM2INKROM9>[;T>QY&&R?#5,^RK#*FG"JL.YKI+
MF:Y[^JO<[#_@C_:_#NP_; T6#4?^$T_X3^&^U"/0_LQMCH_V<6$XD^T[OWWF
M;/-QY?&=F>,UYB_PW^$7QA_:M\">%/!,OQ(AT?Q'K,6G:Y)KCV27*22SA";8
MPJRA0"?]8I.<<5T'_!*HY_X*8^#/^OG5O_3?>5P/[''_ "?=\._^QQL__2I:
MY\13E3S'%8B%25U0A):Z7O6Z=E:Z[-MGH8.M3K93@<%4I0Y98N<7[NMDJ%];
M[M.S?5)(I:G^R]JGBC]L+7?A1X+BGU2\M/$E]HMB]RP#>5;SR)YTS*, +'&7
M<@= <#H*]'USX4?LP_#+69_#>N^.OBCXCURU<6]SK'A[3;--'@E!P^%F8RR*
MIR,IUQD9SBO3/V:LW7_!3_\ : L;3_D/ZI#XOM=#(^\+TW+LFT=2=BR=,&OA
MJX@DM)WBEC>.2-BCHXVLA'!!'8BNO"U:^/K>QG5E!0ITY>[9.3FG=MM/16LD
MK:WO?0\W'4<)E.$^M0P\:DJM6K'W[N,(TW%**2:U?-=MW:5N6VK/5?VI?V7)
M_P!GF_T74M-U>#Q5X'\76QO?#VOV\1BCOHP0'C=#DQS1D@,A)QD>X'LGQ9_8
ME^$W[/V@^!?%'C+QAXKM_#_B[PO8:G%I6F1V]WK-Y>RJ7N1'N$<4-O&K18:3
M+,9"!NVFL7XH02:-_P $G/AK;ZLC1WVI>-K^]T82#:WV!8624J#U4S$'(XY'
M7K1_P5%G=M;^"499C&OPGT-@N?E!+7&3CWP/R%<=/&8S$U:&&=9KWJL92BDG
M)0=D]FD^[2WO:VEO4Q&7Y;@</BL;'#*5X8>I"$FVJ;JIN2W3<5O%-ZKEYKZW
MR?BU^RU\/_$O[.NI?%'X/^(/$^I:+X;OXK+7M'\1VT,>HZ:)B%BFWP_NV1F(
M7CUZ\$#%^ G[,_A?6/@AJGQ2^)/B#5M#\$6.K+H-I;Z-:)<:EJU\8O.,<8D(
MC11'SO8X)!'&*Z[]D7_E'[^U'_U[^&__ $MGK'^"GQH\3_L^?LZQ6OB[P#I/
MCCX/^/-1EN+:TU&<Q WL&(I)()8F\R"0!0I)7D#*]R=7B,:J=?"4JCE*%6,4
MVXJ<HN$)N,6THN5F[-]%O?4YZ>$RR=7"YC7HJ$:E"<Y)1G*G&<:DZ49RC%N2
M@W&-TM%)K1IV+/B/]F3X8?&'X1^+/%?P9\0>,GNO UL-0U;0/%=O;K>/9YPU
MQ#+;_NV"=64C('?IN-+LE^+7_!,'5))E634/A'XLBDMI,?-%8:DH5X\^AN%#
M5M^'_A)\*?VGOAQXWO/A6OC+P!XP\*:%<:[=Z)J&H+?:?JMC#M\Y$F 5PPW#
MA\@Y''4K1_99*Z7_ ,$Z_P!IBZN-JPWQ\.6D!/\ RTE6\E8@?0,#6%3%2]CK
M.3E3K4K*:2G%3E&+3:TDG&4K-7T;3;L=E/ TUB+1ITU"MAJ_-.DVZ<G3C*:D
MHRLXN,H0YHNVJ4DE<^8:***^]/R,**** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M713V*B%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7X _P#!
MU7_RD+\&_P#9.[+_ -.6IU^_U?@#_P '5?\ RD+\&_\ 9.[+_P!.6IU[&1_[
MU\F?,\6?\B]^J/V8_P""<G_*/3X#_P#9._#_ /Z;;>O9J\9_X)R?\H]/@/\
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M?-:[:27E?6Q[=^TI^U7X:^-OBJT\6>'?AU'X#\=-JAU?4M9M==GO%OI^&#)
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M/2MGX"?MA-\+/AQ?>!?%'A+1OB'X#OKO^T/[(U*:2"2RN=NTRV\\9W1$KD'
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M44 %%%%%@"BBBERH HHHIV **** "BBB@ HHHI60!1111RH HHHHL@"BBBF
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M***^>/MBUI'_ !\M_N_U%:59ND?\?+?[O]16E713V*B%%%%:%!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C
MW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7X _\ !U7_ ,I"_!O_ &3NR_\ 3EJ=
M?O\ 5^ /_!U7_P I"_!O_9.[+_TY:G7L9'_O7R9\SQ9_R+WZH_9C_@G)_P H
M]/@/_P!D[\/_ /IMMZ]FKQG_ ()R?\H]/@/_ -D[\/\ _IMMZ]FKRZW\27JS
MWL+_  (>B_(_%O\ X*S_ /*0/Q__ -P[_P!-MK7SG7T9_P %9_\ E('X_P#^
MX=_Z;;6OG.O[*X6_Y$N$_P"O5/\ ](1_G[QI_P E#C_^OU7_ -+D%%%%>\?,
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,G.2:\,_:3^!_@'Q!^S1X?\ C'\,;'5=!T>\UA_#NMZ#?7GVPZ9>B+SD,4Q
M9D:,9^;GYEZ<BO'R'B!U,'A?K,)_O(P7.TN64W&[Z\RNT[-Q2;V>J/>XIX/]
MCF./^IU*?[F<Y>RBY<T:?/9/X>1V33<5-R2W2:=OG*BOI#X;_ ;X?_!/X!:/
M\2OBY;ZMKTOC!Y1X7\*Z9>"S>\AB.V2ZN9L%HXRW"A1GH>0<#>\"_#WX+_MP
MW=WX7\"^$]4^$OQ$D@DGT*VGU]]6TK67C0NUN\DRK)'(RJ=I' .3S]T^C5XA
MHPYIJG-TX-J51)<J:=G]KF:B[W:BTK/70\FAP;B:G)2=:G&O42E&DW)5))J\
M5\+@G)6<8RG&3NM-4?*-%?4O['O[+O@7XG_LX?&;6?'QN=#O/ =SIKC4XVD:
MXL(O.D^U0I"&$;RR+&8T\P$!V4Y S5[X+WO[-_[0OQ%TGX>?\*R\4>"YO$%Q
M_9NF^)U\527UU]HD.V S6S((0&<J"%S@MCW$5N(J4)UHPI3FJ3]]Q4;)<JE?
M62;5GM%.6CTM9O3#\%8BI3P\ZM>E3>(7[N,G)2;YI0Y7:#47>.\FHZJTKW2^
M3**^E?V8_P!F+P[XG_:#^(WP;\76L<WBY;34-.\-:BMQ+&EMJEH7*_*KA721
M4;APW"C&":\&\'?#W5/&_P 1=-\*V=M)_;&J:A'ID4#*0PF>01A2.V&//I@U
MZ%'-*%6I."=N11E=[.,DVI+RT:Z:IGD8KA_%T*5*K))^TE*"2U:G!I.,M-):
MIJS:::UO=+#KK/@)X!M?BO\ '3P7X6OIKBWLO$FO6.E7$L! ECCGN$B9DR"-
MP#$C((SV-=A^W)X4\%_#S]I'7/#/@*T^SZ'X76+2I9C<23-?7<2!;F8EW;:3
M+O7:I"C9P!FLW]C/_D\#X4_]CCI'_I;#45,;[7+GBZ2<;P<E?1KW;J^^I=/+
M/J^<QR^NXSY:BA)QNXNTK.S:3:WUL0_M9?"33O@/^T?XP\'Z3/>W6F^']0>T
MMY;ME:=T !!<JJJ3SV4#VK'^ G@&U^*_QT\%^%KZ:XM[+Q)KUCI5Q+ 0)8XY
M[A(F9,@C< Q(R",]C7U[^VA_P3%^-7QB_:H\<^)_#WA*&^T76=4>>TG.KV41
ME3 &=K2AAR#P0#6-^S3_ ,$J_CI\//VCOA_X@U?P=#:Z3H?B33M0O9AK-E)Y
M4$5U')(VU9BS852< $G' -?/4>*\O_LN,I8N'M?9J_OQOS<O:^]^G<^OQG .
M;+/IPIX&I[#VS2M3ER\G/IK;;EZ]CYS_ &LOA)IWP'_:/\8>#])GO;K3?#^H
M/:6\MVRM.Z  @N555)Y[*![5YW7U=\?/V?K[]IS_ (*G^./"5G=1:=%=:S<7
M%[?2C,=A:Q1!Y96Z=%' SR2!QG-9.I_$[]F+PGK3:#:_"SQ?XHTFW?R7\43>
M*)+6_N ,@RQVBH(<$X8!B.."!7?@LZ:PU&"A*K4=.$I<O+I=;MRE%:M.R3;=
MGH>9FG"\7CL35=6GAZ*K5*<.=RLW&6T5&,W:*:O)I15U=W/F>BO6OVK_ -G&
MS^"'C+0YO#.I7'B#P;XVTZ+5_#E_,@2>:"0[3%*HP!+&P*L,#L<#.!ZA\2/#
MWP+_ &.=6MO".N^#-1^,'B^VM(9M:O5\2OI>F6D\L0D\FW^SAC($#+EF/)ST
MZ#MEGE)PIRH0E4=1-J,4D[1LI7YG%*S:3NT[Z'F1X5Q,:E:.+J0HQHN*E*3;
MC>2;BH\D9RES).2<8M<NMTCY5KV/]LK]GG1_V=]8^'\.BW6IW47B[P3IOB:Y
M^VR([0W%R90Z(41?W8\L8!!(R<DUT?[2_P $_ >I_LZ>&?B]\-K#6O#^B:MK
M$OA[5-$U&Y^V?8+Q(S*ABGP&=&C!/S<Y'U [K]O/Q#H7A3XP? +4/$WAW_A+
M-#M?A3HC7>D_;Y+#[:I^U@+YT8+IAB&R!_#CO7GRSB5;$T)4%*S]JI0T3YH)
M>Z[NU[[/FMK>]M3UUPU'"X+%0Q4H-KV#A47,XJ-1OWE9<UFMUR\VEN6^A\]?
M&O\ 9[UKX#:?X-N-9N-,F7QQX?MO$EBMI([M%;3Y\M9=R*!)QR%+ >M=1\=?
MV>='^&/[,?P:\;:?=:G-J7Q$@U5]1AN)$:"!K2XCB3R0J!@&5R2&+<C@CI7T
M7_P4D^*?PW7X8_#&S;X5;M4USX::7<>'M0_X2:Z'_",6[AS%;^5MVW7EC(WR
M8+9YJ+QYI?P_LO\ @G;^SQXD^(/]J:I9:+!KEO8^'].F%M/K$\UXI!><@^5#
M&L)+E06)DC '6O+H\08J='"8BK"2<JDHM+E?.N2I9)*3^TENU9J[]W4]S$<'
MX&GB,PPF'JPER4:<U)N:5-N='F;<HK>+DTHJ3::27-[I\+45]8:+\-/@_P#M
MB_"/Q[<?#_P7JWPS\<> ]&D\0I8-KTFKV6K6<.//RTRJZN,C&,#++U!('R?7
MUF7YE'%.<.24)P:4HRM=75U\+DFFMFF^O5'Y_FV2U,!&E5]I&I3J)N,X<UG9
MV:M*,9)I[IQ6Z>S"BBBO1/%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /I3]L+_DSS]FG_L!ZK_Z6BOFNOI3]L+_DSS]FG_L!ZK_Z
M6BOFNO#X=_W+_M^K_P"G9GUG&W_(U_[AT/\ TQ3"BBBO</DPHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /HS_@DQ_RD#\ ?
M]Q'_ --MU7[25^+?_!)C_E('X _[B/\ Z;;JOVDK^:_&/_D=4O\ KU'_ -+F
M?U]X ?\ )/5O^OTO_2*85_,#^SW_ ,IOO"O_ &6>'_T\U_3]7\P/[/?_ "F^
M\*_]EGA_]/-?$9#M5]%^I]YQA_RX]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2
M/^/EO]W^HK2KHI[%1"BBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Q[K_CYD_P!X_P ZCJ2Z_P"/F3_>
M/\ZCKC,PK\ ?^#JO_E(7X-_[)W9?^G+4Z_?ZOP!_X.J_^4A?@W_LG=E_Z<M3
MKV,C_P!Z^3/F>+/^1>_5'[,?\$Y/^4>GP'_[)WX?_P#3;;U[-7C/_!.3_E'I
M\!_^R=^'_P#TVV]>S5Y=;^)+U9[V%_@0]%^1^+?_  5G_P"4@?C_ /[AW_IM
MM:^<Z^C/^"L__*0/Q_\ ]P[_ --MK7SG7]E<+?\ (EPG_7JG_P"D(_S]XT_Y
M*''_ /7ZK_Z7(****]X^9"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2->*W=@P<+D_[O>O(?C]^TMXT_:<\50ZMXRUJ;5)K6,PVD*HL-M91DY*11*
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MO3DCQ-E]>KB:OM)4ZDY0Y:DZ<:LG",.1Q_N-V4O=[<M[*[]._:6\9>(/'_\
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M'_O7R9\SQ9_R+WZH_9C_ ()R?\H]/@/_ -D[\/\ _IMMZ]FKQG_@G)_RCT^
M_P#V3OP__P"FVWKV:O+K?Q)>K/>PO\"'HOR/Q=_X*U1-'_P4!\>,RLJR#3F4
MD?>']G6HR/Q!'X&OG&OO;_@N=\!KC1OB5X=^(EK"S:?K5J-)OG'2.YBW-&3_
M +\9('_7$U\$U_7_  3C*>)R+"SIOX81B_6*Y7^1_!OB/EM7!<2XRG57Q5)3
M7FIOF7YV]4%%%%?4GQ(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOV2CXO9)**<XU(OMRI_E(_G^MX"\11FU3J4I+OS27X.)^1M%?KE_PY+^#/\
MSV\9?^#./_XU1_PY+^#/_/;QE_X,X_\ XU6O_$6\B_O_ /@*_P S'_B _$O\
MU+_P-_\ R)^1M%?KE_PY+^#/_/;QE_X,X_\ XU1_PY+^#/\ SV\9?^#./_XU
M1_Q%O(O[_P#X"O\ ,/\ B _$O\U+_P #?_R)^1M%?KE_PY+^#/\ SV\9?^#.
M/_XU1_PY+^#/_/;QE_X,X_\ XU1_Q%O(O[__ ("O\P_X@/Q+_-2_\#?_ ,B?
MD;17ZY?\.2_@S_SV\9?^#./_ .-4?\.2_@S_ ,]O&7_@SC_^-4?\1;R+^_\
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M5'_$6\B_O_\ @*_S#_B _$O\U+_P-_\ R)^1M%?KE_PY+^#/_/;QE_X,X_\
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MX,X__C5'_#DOX,_\]O&7_@SC_P#C5'_$6\B_O_\ @*_S#_B _$O\U+_P-_\
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ME_PY+^#/_/;QE_X,X_\ XU1_PY+^#/\ SV\9?^#./_XU1_Q%O(O[_P#X"O\
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M&T5^N7_#DOX,_P#/;QE_X,X__C5'_#DOX,_\]O&7_@SC_P#C5'_$6\B_O_\
M@*_S#_B _$O\U+_P-_\ R)^1M%?KE_PY+^#/_/;QE_X,X_\ XU1_PY+^#/\
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M+^#/_/;QE_X,X_\ XU1_PY+^#/\ SV\9?^#./_XU1_Q%O(O[_P#X"O\ ,/\
MB _$O\U+_P #?_R)^1M%?KE_PY+^#/\ SV\9?^#./_XU1_PY+^#/_/;QE_X,
MX_\ XU1_Q%O(O[__ ("O\P_X@/Q+_-2_\#?_ ,B?D;17ZY?\.2_@S_SV\9?^
M#./_ .-4?\.2_@S_ ,]O&7_@SC_^-4?\1;R+^_\ ^ K_ ##_ (@/Q+_-2_\
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M?^#./_XU1_Q%O(O[_P#X"O\ ,/\ B _$O\U+_P #?_R)^1M%?KE_PY+^#/\
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MO\U+_P #?_R)^1M%?KE_PY+^#/\ SV\9?^#./_XU1_PY+^#/_/;QE_X,X_\
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MDOX,_P#/;QE_X,X__C5'_#DOX,_\]O&7_@SC_P#C5'_$6\B_O_\ @*_S#_B
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M17ZY?\.2_@S_ ,]O&7_@SC_^-4?\.2_@S_SV\9?^#./_ .-4?\1;R+^__P"
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MD;17ZY?\.2_@S_SV\9?^#./_ .-4?\.2_@S_ ,]O&7_@SC_^-4?\1;R+^_\
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M5'_$6\B_O_\ @*_S#_B _$O\U+_P-_\ R)^1M%?KE_PY+^#/_/;QE_X,X_\
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MX,X__C5'_#DOX,_\]O&7_@SC_P#C5'_$6\B_O_\ @*_S#_B _$O\U+_P-_\
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MO\U+_P #?_R)^1M%?KE_PY+^#/\ SV\9?^#./_XU1_PY+^#/_/;QE_X,X_\
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MDOX,_P#/;QE_X,X__C5'_#DOX,_\]O&7_@SC_P#C5'_$6\B_O_\ @*_S#_B
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M5\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\
M(/K5/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S
M]?\ X#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\
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M/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\
MX#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^
MOV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\
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M>-Y_T+=K_P"!C?\ Q%'^OV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\
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M5\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\
M(/K5/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S
M]?\ X#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\
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M/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\
MX#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^
MOV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\
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M>-Y_T+=K_P"!C?\ Q%'^OV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\
MX&-_\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\ (/K5/N?25%?-O_#>
M-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\ X#+_ "#ZU3[G
MTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^OV2?\_7_ . R
M_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\ @8W_ ,11_K]D
MG_/U_P#@,O\ (/K5/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-
M_P#$4?Z_9)_S]?\ X#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_
MT+=K_P"!C?\ Q%'^OV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_
M\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\ (/K5/N?25%?-O_#>-Y_T
M+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\ X#+_ "#ZU3[GTE17
MS;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^OV2?\_7_ . R_P @
M^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U
M_P#@,O\ (/K5/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$
M4?Z_9)_S]?\ X#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K
M_P"!C?\ Q%'^OV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_
MPWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\ (/K5/N?25%?-O_#>-Y_T+=K_
M .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\ X#+_ "#ZU3[GTE17S;_P
MWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^OV2?\_7_ . R_P @^M4^
MY])45\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@
M,O\ (/K5/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_
M9)_S]?\ X#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!
MC?\ Q%'^OV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_PWC>
M?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\ (/K5/N?25%?-O_#>-Y_T+=K_ .!C
M?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\ X#+_ "#ZU3[GTE17S;_PWC>?
M]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^OV2?\_7_ . R_P @^M4^Y])4
M5\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\ @8W_ ,11_K]DG_/U_P#@,O\
M(/K5/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S
M]?\ X#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\
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M/N?25%?-O_#>-Y_T+=K_ .!C?_$4?\-XWG_0MVO_ (&-_P#$4?Z_9)_S]?\
MX#+_ "#ZU3[GTE17S;_PWC>?]"W:_P#@8W_Q%'_#>-Y_T+=K_P"!C?\ Q%'^
MOV2?\_7_ . R_P @^M4^Y])45\V_\-XWG_0MVO\ X&-_\11_PWC>?]"W:_\
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M ,16^)XVR>C/DJ56G9/X9;-)KIV:*EB*:>K/I*BOFW_AO&\_Z%NU_P# QO\
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M_P #&_\ B*/^&\;S_H6[7_P,;_XBC_7[)/\ GZ__  &7^0?6J?<^DJ*^;?\
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M_'RW^[_45I5FZ1_Q\M_N_P!16E713V*B%%%%:%!1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH0T<GK=]DM/+7N[)-G12H\RYI.R/CC6?A_KWARW\[4-#U>PBQG?<6<D2X^K
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M4 %%%% !1110 4444 >D?%W_ )(Y\-/^O*\_]**\WKTCXN_\D<^&G_7E>?\
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MW_(VQ'^.7YGGUOC84445X9F%%%% !1110 4444 %%%% !1110 4444 %%%%
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MDD4C'\%4G\*K!X3$4:F;TJZCSNG?W%9.\):I=&^OG<(Q:=1/>WZ'S?\ L?\
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MJ$@_>E=?WC _3S&X[U\8U[[^WMX\_M7QMIOA^&3,6DP>?.H_YZR= ?H@4_\
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MC7C>V.69C[Y."2?7S/X*:Q!I/[;/B!)BJ_;=0U*WC+'HYE=A^>TC\:?_ ,%
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M,]MU=O\ '/X[?$+X9>.YELO#<$_AV$KY=P;:699P5&[=(K80YS@8&,=Z\?\
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M=])+9]K]GY/Y7,JM&5-Z[&-1117S1B=E^SW_ ,EJ\-_]?B_R-?;U?$/[/?\
MR6KPW_U^+_(U]O5^V^&/^X5?\?\ [:CT,'\+"OY@?V>_^4WWA7_LL\/_ *>:
M_I^K^8']GO\ Y3?>%?\ LL\/_IYK]LR':KZ+]3Y7C#_EQZO]#^GZBBBOGC[8
MM:1_Q\M_N_U%:59ND?\ 'RW^[_45I5T4]BHA1116A04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]U_Q\R?[
MQ_G4=277_'S)_O'^=1UQF85^ /\ P=5_\I"_!O\ V3NR_P#3EJ=?O]7X _\
M!U7_ ,I"_!O_ &3NR_\ 3EJ=>QD?^]?)GS/%G_(O?JC]F/\ @G)_RCT^ _\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%=U\ /!VC^,_$^J1ZY#=7%G8:3<7P2WE\MBT6UNN.Z[A]2*X6O2/V9O^1C\2
M?]BU?_\ H KULCIPGCZ49I-7V:NG\C2EK)7#_A)OA?\ ]"OXF_\ !FO_ ,31
M_P )-\+_ /H5_$W_ (,U_P#B:\WHJO[:J?\ /NG_ ."X?Y![1]E]QZ1_PDWP
MO_Z%?Q-_X,U_^)H_X2;X7_\ 0K^)O_!FO_Q->;T4?VU4_P"?=/\ \%P_R#VC
M[+[CTC_A)OA?_P!"OXF_\&:__$T?\)-\+_\ H5_$W_@S7_XFO-Z*/[:J?\^Z
M?_@N'^0>T?9?<>D?\)-\+_\ H5_$W_@S7_XFC_A)OA?_ -"OXF_\&:__ !->
M;T4?VU4_Y]T__!</\@]H^R^X](_X2;X7_P#0K^)O_!FO_P 31_PDWPO_ .A7
M\3?^#-?_ (FO-Z*/[:J?\^Z?_@N'^0>T?9?<>D?\)-\+_P#H5_$W_@S7_P")
MH_X2;X7_ /0K^)O_  9K_P#$UYO11_;53_GW3_\ !</\@]H^R^X](_X2;X7_
M /0K^)O_  9K_P#$T?\ "3?"_P#Z%?Q-_P"#-?\ XFO-Z*/[:J?\^Z?_ (+A
M_D'M'V7W'I'_  DWPO\ ^A7\3?\ @S7_ .)H_P"$F^%__0K^)O\ P9K_ /$U
MYO11_;53_GW3_P#!</\ (/:/LON/2/\ A)OA?_T*_B;_ ,&:_P#Q-'_"3?"_
M_H5_$W_@S7_XFO-Z*/[:J?\ /NG_ ."X?Y![1]E]QZ1_PDWPO_Z%?Q-_X,U_
M^)H_X2;X7_\ 0K^)O_!FO_Q->;T4?VU4_P"?=/\ \%P_R#VC[+[CTC_A)OA?
M_P!"OXF_\&:__$T?\)-\+_\ H5_$W_@S7_XFO-Z*/[:J?\^Z?_@N'^0>T?9?
M<>D?\)-\+_\ H5_$W_@S7_XFC_A)OA?_ -"OXF_\&:__ !->;T4?VU4_Y]T_
M_!</\@]H^R^X](_X2;X7_P#0K^)O_!FO_P 31_PDWPO_ .A7\3?^#-?_ (FO
M-Z*/[:J?\^Z?_@N'^0>T?9?<>D?\)-\+_P#H5_$W_@S7_P")H_X2;X7_ /0K
M^)O_  9K_P#$UYO11_;53_GW3_\ !</\@]H^R^X](_X2;X7_ /0K^)O_  9K
M_P#$T?\ "3?"_P#Z%?Q-_P"#-?\ XFO-Z*/[:J?\^Z?_ (+A_D'M'V7W'I'_
M  DWPO\ ^A7\3?\ @S7_ .)H_P"$F^%__0K^)O\ P9K_ /$UYO11_;53_GW3
M_P#!</\ (/:/LON/2/\ A)OA?_T*_B;_ ,&:_P#Q-'_"3?"__H5_$W_@S7_X
MFO-Z*/[:J?\ /NG_ ."X?Y![1]E]QZ1_PDWPO_Z%?Q-_X,U_^)H_X2;X7_\
M0K^)O_!FO_Q->;T4?VU4_P"?=/\ \%P_R#VC[+[CTC_A)OA?_P!"OXF_\&:_
M_$T?\)-\+_\ H5_$W_@S7_XFO-Z*/[:J?\^Z?_@N'^0>T?9?<>D?\)-\+_\
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MLON/2/\ A)OA?_T*_B;_ ,&:_P#Q-'_"3?"__H5_$W_@S7_XFO-Z*/[:J?\
M/NG_ ."X?Y![1]E]QZ1_PDWPO_Z%?Q-_X,U_^)H_X2;X7_\ 0K^)O_!FO_Q-
M>;T4?VU4_P"?=/\ \%P_R#VC[+[CTC_A)OA?_P!"OXF_\&:__$T?\)-\+_\
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M-\+_ /H5_$W_ (,U_P#B:/\ A)OA?_T*_B;_ ,&:_P#Q->;T4?VU4_Y]T_\
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MT4?VU4_Y]T__  7#_(/:/LON/2/^$F^%_P#T*_B;_P &:_\ Q-'_  DWPO\
M^A7\3?\ @S7_ .)KS>BC^VJG_/NG_P""X?Y![1]E]QZ1_P )-\+_ /H5_$W_
M (,U_P#B:/\ A)OA?_T*_B;_ ,&:_P#Q->;T4?VU4_Y]T_\ P7#_ "#VC[+[
MCTC_ (2;X7_]"OXF_P#!FO\ \31_PDWPO_Z%?Q-_X,U_^)KS>BC^VJG_ #[I
M_P#@N'^0>T?9?<>D?\)-\+_^A7\3?^#-?_B:/^$F^%__ $*_B;_P9K_\37F]
M%']M5/\ GW3_ /!</\@]H^R^X](_X2;X7_\ 0K^)O_!FO_Q-'_"3?"__ *%?
MQ-_X,U_^)KS>BC^VJG_/NG_X+A_D'M'V7W'I'_"3?"__ *%?Q-_X,U_^)H_X
M2;X7_P#0K^)O_!FO_P 37F]%']M5/^?=/_P7#_(/:/LON/2/^$F^%_\ T*_B
M;_P9K_\ $T?\)-\+_P#H5_$W_@S7_P")KS>BC^VJG_/NG_X+A_D'M'V7W'I'
M_"3?"_\ Z%?Q-_X,U_\ B:/^$F^%_P#T*_B;_P &:_\ Q->;T4?VU4_Y]T__
M  7#_(/:/LON/2/^$F^%_P#T*_B;_P &:_\ Q-'_  DWPO\ ^A7\3?\ @S7_
M .)KS>BC^VJG_/NG_P""X?Y![1]E]QVWQ9^(VD^,M$\/Z;H^GWEA9Z#%/$BW
M$HD9A))O'(].17$T45P8S%U,35=:K:^BT22LDDM%IHDB92;=V%%%%<Q(4444
M %%%% !1110 4444 %%%% !1110!UGPD^,FL?!?6KB^T@6DCW4/DRQW,9=&&
M<@\$'(/O]<U%\0?C)XD^*%P6UK5;BYBSE;=3Y<"?1%POXD9]ZYBBN[^TL7]7
M^J*I+V>_+=VU\BN>5N6^AV7PB^.FO?!G4FDTNX62TF8&>SFRT,WOC^%O]H8/
MU'%>^6G[2OPS^--A';^+M+CL;G;M_P!+@\U4_P!R9!N4<GD[:^4:*]?*>*L=
M@*?U>-ITOY)KFC\NJ^3MY&E.O**MT/JF3]G_ .#/B ^?9^(;6VC8YV0ZU'A?
M8B3<P_'FHM3_ &)?"/BW2))/"WB.;[1'QO,\=Y"3Z'8 1]<_@:^6ZO>'O$^H
M^$M26\TN^NM/NEZ202&-L>AQU'L>*]6/$^55'RXG+X6>_*W%_+_AUZFGMH/>
M"/J#]E?X":Y\'/B9JS:Q9Q-'-8F.VO8'\R)_WBEE!X*D\'# 9P?0UX?^T[;Z
MG;?'/Q"-4:1Y&N2\!8Y'D'F(#V"8'U!KO_AM^WAK&C>7;^)+&/5X!@&Y@ AN
M /4C[C?^._6N;_:P^,'A[XQ:[H]YH<-VLUK;O%<RSQB,N"P**!D_=^?G_:KT
M,ZQ.35<@6'RZJTZ<^90E\3YM&NSM>Z>MDK7*J2INE:#V/)J***_-3C.R_9[_
M .2U>&_^OQ?Y&OMZOB']GO\ Y+5X;_Z_%_D:^WJ_;?#'_<*O^/\ ]M1Z&#^%
MA7\P/[/?_*;[PK_V6>'_ -/-?T_5_,#^SW_RF^\*_P#99X?_ $\U^V9#M5]%
M^I\KQA_RX]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/\ CY;_ '?ZBM*NBGL5
M$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/\ >/\ .HZXS,*_ '_@ZK_Y
M2%^#?^R=V7_IRU.OW^K\ ?\ @ZK_ .4A?@W_ +)W9?\ IRU.O8R/_>ODSYGB
MS_D7OU1^S'_!.3_E'I\!_P#LG?A__P!-MO7LU>,_\$Y/^4>GP'_[)WX?_P#3
M;;U[-7EUOXDO5GO87^!#T7Y'R'^V/_R6RX_Z](?_ $&O*Z]4_;'_ .2V7'_7
MI#_Z#7E=?R_Q-_R-L1_CE^9Y];XV%%%%>&9A116QX&\ ZO\ $G71INBV;7UZ
M8VE\L2)'A1U)+$ =1W[UI1HU*LU3I1<I/1)*[;\D@2;T1CT5O?$#X8Z[\+=2
MAL]>L&L;BXB\Z-?-20.N2,Y1B.H/&<]/45@TZU"I1FZ5:+C);IIIKU3&TT[,
M****R$%%%% !1110 4444 %%:?@_P?J7C[Q';Z3I-O\ :]0N]WE1>8L>_:I<
M\L0!A5)Y/:NX_P"&/_B-_P!"[_Y/VW_QRO0PN58W$P]IAJ,YJ]KQBVK]KI/7
M4J-.4M4CS2BNN\:? CQ=\/K1KC5M"O+>VC^_,FV:-/JR%@/Q-<C7/B,+7P\_
M9UX.,NS33^YBE%IV84445SB"BBB@ HHHH **Z;X=_!_Q%\5_MG_"/Z=]O_L_
M9Y_^D11>7OW;?OLN<[6Z9Z5SMW:R6-U)#*NV6%RCKG."#@BMYX6M"G&M.#49
M7LVG9VWL]G;K;8?*[7(Z***P$%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ7CE(F^T12[R!DCY&;'XUO3PM:I3E5IP;C&W,TFTK[7>ROTN/E;5T<K1116
M@HHHH **ZKXA?!7Q-\*[6VFU[3?L,5XY2)OM$4N\@9(^1FQ^-<K6^(PM;#U'
M2KP<9+HTT_N>HY1:=F%%%%8""BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .R_9[_Y+5X;_ .OQ?Y&OMZOB']GO
M_DM7AO\ Z_%_D:^WJ_;?#'_<*O\ C_\ ;4>A@_A85_,#^SW_ ,IOO"O_ &6>
M'_T\U_3]7\P/[/?_ "F^\*_]EGA_]/-?MF0[5?1?J?*\8?\ +CU?Z']/U%%%
M?/'VQ:TC_CY;_=_J*TJS=(_X^6_W?ZBM*NBGL5$****T*"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'NO\
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MNH(K7&IZ1$DSA5W,9(,QR9[\Q[F_$53_ &E+M?@]^S+X=\(PMY=UJ"QQ3@$
MD)B28_C*R_@3^,XKA? 4I5L:D_JZHQG'77FEI%-^J=_5!*C%7GTM<\:^%?[.
MWB?XP0-<:7:Q0V*ML-W=/Y<)/<#@EL=]H.*L_%+]F+Q5\)=,^W:A!:W>GJ0K
MW-G(9$B)Z;@0& /3)&,_A7TQ\5/ ]C:?";1O#MOXTL?!.GQJD?GLRK]M54Y4
M$R)P2=QP3GOWSF_"E_#/@3P9J6@ZS\3/#_B;3[X%$6>]AC,*,I5T!,SY4YSC
MC!SZUWO@;!T[82K=3Y;NHYP45*U[<E^;EZ7W^6I7U:*]U_?=?D<;_P $[_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]F>,/%.H>"OV,--U/
M2[E[.^MM&TSRID +)N,"GJ".5)'XUXW\%/VGO&M_\5-#L;[5I=3L]2O(K2:"
M6),;78*6!"@@KG.?;GBO=)M8T/0/V3M&N_$=C-J6BPZ-IWVBVB4,TF1"%P"R
MCARIZCI^%<;\%_BI\)=3^(=C;:'X;N-'U:X8QVMQ<VR;=Y!^4$2/M8] <#KC
M/-?N6:4ZTL?@_9XQ45R4_<<I)RU>ME[KOMJ];6/2J7YXVE;;0YO_ (*#:99V
MWB;P[>1JJWUU;S1SX'+(C)Y9/XLX_"N ^&7[*_B[XI:5'J%G;VMC83<Q7%[(
M8UE'JH568CWQ@UUG[3?@W4K[]I?0[77-16[T_6IK>.W8+Y:VL#3;&CQGC:23
MG/.<_3V#]HKPA:^);;2]+D^(&G^![*WC)%HS)']I P%/,J?*N,  $9_#'BXK
M(Z>8YGCL;7INU.44H*48.3LE=R;LD[<W=WT,I4E.I*;6W0^8/BM\ O$GP<\J
M35K6-K29MB75N_F0EO[I. 0>^"!G\#67\./A?K7Q7UW^S]%M?M$J+OE=FVQP
MKZLQX'TZGL#7T_-=>&;/X :MX7U;XA:#XFE^S2_9YWO85E&!NB7'FN6*N!CG
MT&.*R/V3B?"_[,/B36=/16U0&[G! #$O%"#&N/8\X/\ >-<+X.PDLRITHS:I
M2@YR5XRE'EWC=73W5GVOV%]7CSI=+7/-=<_8G\::'<V:_P#$KNH[N9(&FMYW
M9+8N=H+@H&V@D9*@XKF?&_P!UCP#\2='\+7ESILFH:UY/D20R.T*>;*T2[B4
M!&&4DX!X]>E;'[.?Q4\1#XZ:/NU/4+S^UKL07<<TS2+,KYR2">J_>![8KT7]
MI1L?MC> /^X=_P"ETE<D<IRG%9>\;A83B_:1A:4KZ.U[-);I_)D\M.4.:/=(
M\:^,/P3U7X):K9V>JW&GW$E[$9D-H[NH ..=RKS5ZQ_9TUO4/@\WC9+K2QI2
MQO)Y322?:,)(8S\NS;]Y3_%T_*O0O^"@K8\<Z!_UXO\ ^C#73>&N/^"?<F>/
M]$N3S_U^/6G^K>"_M;&X.SY*5.4HZZW2BU=]=V'LH^TE'HD'AG_E'W)_UZ7/
M_I9)7@7PQ^#7B#XNWLL.BV?G);X\Z>1A'#%GH"Q[GT&37OGAIO\ C7U)_P!>
MES_Z625RO[-FB^/-5^%VH+I>J:/X=\,2--YUY=1CS&8J%=U/;:H^\2 ,>QQW
MYCE]/&U\OHU8RE'ZO!M0M?1=WHEW;*G'F<$^RV,?5_V&?'&F6'G1?V/?OM+&
M&WNF$@]OG51GZ&M/]C3X/:M<_$J'Q$S6UO:^'KF>TN[>8NMP)&@=,!=N."XS
MDCH:[K]E/P=X:\&^.M1CTOQM_P )-JEQ9.\T$$#1P(HDCW2%B6#-N( .0<,>
M*XWP4<?M_P P  _T^\_])I:TH9+@<+7P6/A3:<JJBX^TC-)W7*^:*Z/5QZ[7
M0U3C%QE;K;>Y;_;7^#.J/KM]XT^T6']EK'!;F+>_VC=PO3;MQD_WJ\J^%OP!
M\3?%]9)=)LU6SB;8UW</Y<(;^Z#R6/J%!QWZBND_;</_ !?N\_Z](/\ T"O5
MOC?JUQ\)_P!D?P];Z!+):+>+:VTLT)VMM>%I';<.A=EY(_O&N/'9;@L9FV.Q
M-:,HTZ%W))W<I7>S:]U/MK;OJ1*,95)2>R/(?'_[(7C+X?Z1+?26]GJEK;KO
ME:PE:1HU[L595; [D XZ].:YGX0_"'4OC3XEGTO2Y[&WN+>V:Z9KIV5"H9%(
M!56.<N.WK7L'[!OC_5]5\8:OHMU=W-WIYL3=A9G,@BD$B)QGIN#G([[:N_LV
MZ+;>&_VOO&MC9JJ6MO:W2Q(O2,?:8#M'L,X_"L</P[EV+GA,5AU*-*M-PE%N
M[35]FDM&$:<)<LH[-V/.=&_9#\7ZU/JNU=/@M=)EEA:ZFE98KAHR0WE_*689
M!&2H&>.QJB_[-.NGX1_\)I#>:3<:7Y N#%%+(;@+NVL,% N5.<_-_">M=1^T
MY^T)XF3XJZMI.FZG=:7INFR?9EAMV\OS3CYV8CELL3P>,8[YSUW[$'B:'QEX
M"\1>"[_YX]C2HI'6&4;) /HV#_P.C#91DF(S)Y51Y^:TXJ3=ESKX;)=%9K75
MZ!&-*4_9KS^\\2^$/P;U;XU:]<:?I,EG#):P&XDDNG98P-P7&55CDY].QK'\
M:^%)O WBN_T>XGM;FXTZ4P2R6[,T98=0"P!X.1R!R#7TI^SGH#? 'X0^-/$6
MI1JMU;W,T"AUQYGV<M&H'/\ %*67\!S7RW>7\FI7LUQ,QDFN':1V/\3$Y)_,
MUX><931P.7X9S3]O4O*6NT;VBK>>_P C*I%0A&^[-+P'X3F\=>,]+T>#_6:A
M<I#G^Z"?F;\!D_A7WK;>)-)T/Q/I_@^/:LW]F&>&(_=$,96,+[YY_!37SC^P
M5X"_M7QMJ/B"9/W.DP^1 ?\ IK)U(^B C_@8KT/5OA%XTN_VGK?QE&=/_LNW
ME2!8_M)\S[+LV/\ +MQD[F;&>I_&OO.!\/B,#ET<;2IN<JU2*=E>U--IO[[_
M ('7ADXPYDMW^!\W_$OX83>$_C/>^&8ML>^^6&T:0D+Y<I!C)./[K+G&>AKZ
MP^'WPBUWX=?L]R>'-/O-/M?$CK,1=QNQA$CR'#;BF[B/:,[>"/QKR_\ X* ^
M ?*NM&\30QC$H.GW)"]QEXR?<C>/^ BM3PR?^-?$G_7I<_\ I9)6>38&CE><
M8^@X.\:<Y1:E;W-'9::/5+FZ6>A-.*IU)JW1_<9?P3^!GB35?V@+C7?$&HZ?
MJ<GAN]\F^<S2-+-(+8>4R90 A=T?4C[I_'2_;7\/>+AI5]JBZQ;KX1V00/IZ
MR,)'?>#N*[-I^?!R6SP*\E_8].?VC?#O_;S_ .DLU:_[9,4L_P"T;(D$7G3/
M#:K''MW>8Q P,=\GBO.IXZ@^&*U2G3DG.JXOWVVVXW3;M>2LTG%_$];ZV(YU
M[!M+=]REX$_8^\:>/-(@ODM[/3;6Y7?$U],8V=2,@[55F /;('Y5F?%']FCQ
M5\)=,-]J5M;W&GJ^QKFUE\R-"3@9! 8 ]B1CMUKUGXK_  ]\2>*O#FF_\+(\
M=Z#X=MU9FBM88-[.QQD%05WE>.F0N374^);?3+7]BN_ATG5)];TZ&SD2*\G0
MJTVVX(/##( 8$#V4=>M7_JE@94JU-0G"5.FYJ4IPYFTD[.DKN*\V_P 1_5XV
M:LU97W7Y'D'P.\(>/M;^$VLWGAO7K'3=#@FG%W:S,0\K"%"Y \MARA4?>'3M
MUKF?A[^SQK?Q*\ :GXCL+G2X[+2GE26.>219G,<:R':%0@Y# #)'/IUKVG]C
MYL_LQ^+/^ON\_P#22*K?[#^I+I/P U^\DC\V.UU*XF9/[X6VA)'XXHP/#N%Q
M:P5/$2DXSISD[R;2:M:RZ+NEN$:2ERI]F>'>)OV;/$W@SX<'Q-JD5K8VH,8^
MS22'[3\Y 4E0"!UY!8$>F>*M_#C]E'Q?\3-'AU"UM[6QL;@9BFO93&)1_>"J
M&;!['&#7/^//CGXH^)!NDU35KJ:SNGWFT#;;=,'*@(....>O'4U[Q9?%SP#\
M=/@]IOAG7-8G\-W5G'"I7)B4/&FP$/@HR'/W6Q^&,UXN69?D>,Q4XP<HQC'W
M8SDH.<KN_O6:6EM-_N,Z<:4I:?CU/'OBA^S+XK^$VEM?ZA;6]SIZ,$>YM)?,
M2,DX&X$!@#ZD8Z#J17GU?3WB[X3^+O!WP3U"V\+^++'Q+X7:WE>2WDMT:0Q$
M?/Y4F6!P 2 "N"#CFOF!6S7F<393# UX1ITY04HWM)QDK]>64=)+[GW,Z\>1
M["T445\T9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7TU^Q-\-]/T;PCJ'C;5%C:2,R)
M;NZ[A;11C,D@_P!HG(R.0%/J:^9:^N_V</\ BMOV0K[1[/;]J6WO]/P#SYDF
M]ES^$JU]QX?T*=3,W.2YI0A*44^LE:WYLZL*DY_(\N\4_MS>+K_Q')-I?V&P
MTU7/E6[0"0LF>-['G)[[<"NJ^*?QI\%?'CX%;M4NK73O%-O"TUO 8W9HIUZH
MK[2-L@'0G^)<\C-?-EU"]K,\4BM')&Q5E88*D<$$5Z/X=_9=UC7OA+)XQ>_T
MVQTZ.WFNA'.7$K)'NZ *1\VTX&><CUI9?Q!G>,]O0?[]2B^:,MHK^9:KEMTM
MIY:(SA6JRNMSD? ?P[UCXF:XNG:+8R7EQC<V/E2)?[S,>%'U^G)KTG4_V&O'
M&GZ9]HC_ +'O) I;[/#='S?I\RJN?^!5Z#^R8J^#_P!F?Q/X@L8U?5%%U-NQ
MDDPPYC3Z Y./]LUY'\!OBSXB@^-^AR-JFH73:KJ$5M=I+,TBS)*X5L@Y'&<^
MV.U:X?)LKPU#"_7U.4\1K>+24$VDNCN]=?ZO4:<(J//>\OP.:\%?"W5?&_Q$
MA\+QK'8:K,\D96]W1K$T:,[!L*6!PI'3KBNYM/V*_&EYXFO-.5=,6.SVA[UI
MG6V<LH;"DIO; (SA< ]Z]@\:Z':Z;^V_X-NX55)M0L+AK@#^-E@G4,?<K@?\
M!%>:_MJ?$36K+XRK8VVI7EK:Z?;1/#'!,T85V&XOP?O>_H!77B.&\NR["5J^
M-4ING6Y%RM*ZY5)7T=M[NWIYE2I0A%N?1V.;U#]D3QO8>,(='&GPW#7"-(EW
M%+FUVJ<$ER 1U'! )R.*A^*/[+'BKX3Z(VI7T=E>V$9 EGLI6D6'/ +!E5@,
M\9QC)%>X?M:>,]3TW]G#0[JWO)H+C5;BUCN9(V*,ZM!)(PR,8RRBJOPCUBZ\
M5?L4^(FU&:2\:VL=0CC:9B[!4C9EY//!Z>F!Z5VXCA7*/K=7+Z7/SJFZD9-J
MRTTC:VOF[^7F6Z-/F<%?:YX3\&?@#K'QR_M+^R;G3;?^R_*\W[7(Z;O,WXV[
M4;^X<YQVKHO"_P"Q;XU\4:/]L\O3M/5@6CCNYF224=B%"G&>V['6N[_X)VMG
M_A,/^W+_ -N*XSX9?%'7M9_:ILYKC5+U_M>J/;R1F5O*,1++L"YQM Z#M@'K
MS7F8')\IC@<%B,7&<I5Y2B[226D^5/5/96T6_<B,(<D7+K_F9OA7]D'QMXHU
MB^LVL;?3?[/D\J2>\D*1,V,_(5#%@01R 1R.:YKXJ?!?7O@YJ,,&M6\:I= F
M">%_,AEQU /'(XX(!Y%>L?MV^-]6T?XGZ/9V>H7=I;P:<ETBPRM'B5I9%+<'
MKA%QZ5TO[:5PVJ?L\^%[Z?:]U->6S,^.?GMI6;\R!^5:X_AS+(TL92P_/[3#
MV?,VFI)O:R6EMO/?R"=*"4DKWB>(?"O]G;Q/\8(&N-+M8H;%6V&[NG\N$GN!
MP2V.^T'%6?BE^S%XJ^$NE_;M0@M;O3U(5[FSD,B1$]-P(# 'IDC&?PKZ8^*?
M@>QM/A-HWAVW\:6/@G3XT2/SV95^VJJ<J&,B<$G<<$Y[]\YOPI?PSX$\&ZEH
M.L?$SP_XFT^^!1%GO88S C*5= 3,^5.<XXP<^M>F^!L'3MA*MU/ENZCG!14K
M7MR7YN7I??Y:FGU:*]U_?=?D?-_P9^ .L?'+^TO[)N=-M_[+\KS?M<CIN\S?
MC;M1O[ASG':K=O\ LQ>*7^']]XEGBM++3;*%K@">0K+<(O=%"G@]MVW(YZ5Z
MS_P3_@2UU'QQ#'(LT<4EHB.#D. ;@ _C7E'QE_:$\3>,O%6LVHU.ZM=':62U
MCL8FV1"$$J%8#[Q(')/?VP*\"6595ALFH8[%*3J5/:*T6K-J32;OLE;9;W,>
M6G&DIRW=S.^%?P!\3?&#S)-)LT6SB;:]W</Y<(;T!P2Q]=H./RK;^(7[(OC'
MX=Z--J$T-GJ5G;KOF>QE,AB7NQ5E5L#N0#CKTKU_XV:K<_"+]DCP_;:!))9_
M;!;6TLT)VN%DB>61LCH68<D8^\:\C^!_[0WC+P1:W]GIMC-XD@F*NT,Z37'V
M;J"1M/ ;/.>#M'O6V)R;)L%4A@,9SNI*"DYQU46U=)1M=KOK?]*E"G%J$KWM
MN3?LP>$_''BC^W/^$-URST;R/(^V?:&*^=GS=F,1OTP_IU'7MQOAKX9^(/B5
MXVNM,TVU-_J"2NUPZD+&F&PSLQP ,_GV':O=OV I#)J?CAFMQ:L9;0F$*5$)
MS<?+@\C'3!]*YW]G+3_'%]XH\4?\(I/I6G6+7K?;+N]BWY8,^U%X).,D]@,\
MGI5X?(Z5?!9>INI)5'4NHN_PR?PQ>D;]7\V$::<87OK<S+C]A/QM#8"99=#F
MD_YX)=/Y@_$H%_\ 'N]<7\.O#E]X1^/OAO3=2MI+.^M-;LTEB?JI\Y#]"".0
M1P0:]J^ _@3PYX3^-=K<?\+#3Q%X@NC,GV6UA;RYV\IRV^3<P8!02.G('IBL
M#XXG;^V]X?X'-_IF??\ >)6N+X?PE'#4L?0BX256,''GC45M[MQV?ET"5.*B
MIK36V]QW_!03_D>- _Z\7_\ 1AKS3]G31-/\1?&SP[9ZH(VLY+DED==RR,J,
MR*1W#.%&/>O2O^"@S8\<Z!_UX/\ ^C#7BG@?P[JGB[Q596&BQM)JLSEK8+,L
M+;E!?(9B "-I(Y'(XYKSN)IN'$\YJ'/:<'R[\VD=/GL17=J_S1]5_M5^(?B-
MH&H6)\(PW@T=;??/+96ZS2B7<V0PP6"A=I& !R<]..0\)?M>Z7J_P]O=!^(E
MK?75[+OMY&@M$_>1E1@L"0%D!)Y [ ]:;-^U)X_^!M]:Z5XUT2SO9FA$R-YZ
M)/)'DKDO&60G*G^'/KU%>B^$/%7@_P#;$\(W\-UI++<6(5)EG0>=:E]VQXY%
MYQ\K>G0@C!Y^[CBWCL=4> Q4HUI)IT*T7R[:JVRTUTN]^AU\W/-\DM>S/CSP
MUX7O_&>O1:;I-K-?WEPQ$4<:_,P]3V  Y))P.YKU;_AA;QO_ &;Y^[1?-_Y]
M_M3>9^>S9_X]7?\ [#_@2#PQXD\;>;Y<VH:7>#3!)_=56?=CV8J/^^17A0^.
M?BH?$?\ M_\ M*__ +0^T^9Y/FMLQG_5;.FW'R[<=*^%IY3EV!P-'%9G&<I5
MG))1:7*HNS>SN_+8Y(TX0@I3OJ<_XG\+:AX,UN;3=4LYK&^MSAXI1@CT([$'
MJ",@]J^EO^"@_P#R*OAS_K[E_P#0!6?_ ,%"=$M8XO#>I*JK>.TUL[#K)&-K
M#/\ NDG_ +[-7_\ @H2V/"OAO_K[E_\ 0!7M2RA99@\VP:ES**I6?6S;:OYZ
MV9JZ?)&I'T/&/%W[.FM^#/A?8>++JZTN33=1C@DCCBDD,ZB9=RY!0+P#SAC^
M-0_!GX ZQ\<O[2_LFYTVW_LORO-^UR.F[S-^-NU&_N'.<=J]M^/;8_8H\+_]
M>FF?^B!5#_@G=ROC X./]"&?_ BN2/#.">?8;+[/V=2"D]=;\LGOZI$JC'VL
M8=&B;]B3X/:GX<UZ\\33SV+6$]M<::L<;N9A(LZ9)!4#;^[;G.>1QZ</^US\
M&=4\'>+[[Q-=7%A)8:Y?L((XG<S)E=WS J .G8FMS]C Y_:-\2_]>%U_Z50U
MYC^T>W_%]/%'_7\_]*>8U,+'ABE!4W_$DE[VTDM9;:I_R].["I*/L%IU.P_:
M:\(>/O#&C:6WC'7K'6+>:9Q;+ Q8QL%&2<QIU'UKD?A;\ ?$WQ?6272;-5LX
MFV-=W#^7"&_N@\ECZA0<=^HKW#_@H2V/"WAO_K[E_P#0!5KXW:M<?"C]DCP]
M;Z#)):+>+:VTLT!VMM>)I';(Z%V7DC^\:Z,TX=PO]JXJ>)E.5*A",G[UYR;2
MLN9WT_)%3HQ]I)R;LD>0^/\ ]D+QE\/](EOI+>SU2UMUWRM82M(T:]V*LJM@
M=R <=>G-<S\(?A#J7QI\2SZ7I<]C;W%O;-=,UT[*A4,BD JK'.7';UKV#]@[
MQ_J^J^,=7T6ZN[F[TXV)NPLSF012"1$XSTW!SD=]M7?V;=%MO#?[7WC6QLU5
M+6WM;I8D7I&/M,!VCV&<?A7'A^'<NQ<\)BL.I1I5IN$HMW::OLTEHR8TX2Y9
M1V;L<)H'[%?C37KV\CVZ9:0V<[P"XN)G6.X*'!9 $+%<C@E1FN'^)OPHUKX1
MZZMAK5NL4DB>9%)&V^*9>F5;V[@X(]*[+]HKXL:_:_'_ %66WU2\@_L>[$5K
M&DS+'$$Q_"#CDY)]<FO4OV^IDL=,\)WAB25[:]E(#=&&$)7Z':*SQ62Y54P>
M+GA%.,\/))N334DY..R6EK.W7:[%*G!QDX_9/+_!O[&7C7QAI<-YY.GZ7#<(
M'C%],R.0>F556(SZ$"N:^*?P$\2_!Y89-8LX_LMPVR.Y@D\R(MUVD]0<<\@9
MYQG!KWGQMX\^'/[4OA[38;[Q)<>';ZU)=(IG\D1NP&0VX>6X^48(;(]LD5@?
M'WX>>-O"/P6^SQ^(K3Q-X1MEB+$VRK<1)N!1PWS%E!P,ALX/3&<=>8<,Y='"
M5*N!4JD8QNJD9QE=VUYX:.*WU5VMV7.C#E;CKYW_ $/G*BD5LTM?FAQ)A111
M0,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#LOV>_\ DM7A
MO_K\7^1K[>KXA_9[_P"2U>&_^OQ?Y&OMZOVWPQ_W"K_C_P#;4>A@_A85_,#^
MSW_RF^\*_P#99X?_ $\U_3]7\P/[/?\ RF^\*_\ 99X?_3S7[9D.U7T7ZGRO
M&'_+CU?Z']/U%%%?/'VQ:TC_ (^6_P!W^HK2K-TC_CY;_=_J*TJZ*>Q40HHH
MK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** ,>Z_X^9/]X_SJ.I+K_CYD_WC_.HZXS,*_ '_ (.J_P#E(7X-
M_P"R=V7_ *<M3K]_J_ '_@ZK_P"4A?@W_LG=E_Z<M3KV,C_WKY,^9XL_Y%[]
M4?LQ_P $Y/\ E'I\!_\ LG?A_P#]-MO7LU>,_P#!.3_E'I\!_P#LG?A__P!-
MMO7LU>76_B2]6>]A?X$/1?D?(?[8_P#R6RX_Z](?_0:\KKU3]L?_ )+9<?\
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MN*F,$@-CE2I [&N?^)WQ8^'WASX>S>&_ ^BQ74UUN675+NVS(BG 9D:0;]Q
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M_M#SOM/V'[--Y?F]=VS&SKSC=C/:O*_VBOCM-\<_%D-PL$EGIFGHT5G [;F
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6^MK$K$233[*WR/I'X._%'X2_!;Q?,NDW6MS+>PM'-JE]&S+&H((C1$0,=Q
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M@*2N <Y.1Q6U#"UJRDZ46^5<SMT2W;\AJ+>QQ]%%%<XK!1110 4444 %%%%
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MU=[Z%OE>ZZ7,$_!R/7?'EKH7AK7++7VDMS/=7@C:WMK/:6W[F;JJJ =PZ[L
M9K3M/@QX3U.\CL+7XCZ7)JLK^4D;Z=/';,YP ///RX).,XQ69\%O#FHZR->N
M+?6E\/Z/:V#)J]Z4,G^CR''EA1RQ<C@#&<=:L62_#G2=3@\O_A+]<D5UVC$%
MG%(V1@?QM@_@:\W#T<,Z<:\Z,$IM_%.222=O<2ES/K>34E?1+1DQM:[2U\_R
M+WP8^']IH7QSM-/\1:O_ &'JFBZM;"WM_LCW OIA,,1AE.$!PN&/&&S3?VB_
M"FCQ_$K5)-)UYM8UC4-7G6XTY=/DB:T<R'Y0Y.)#N./EKI/BN%3]NRU PO\
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M*8"'!!QD\'O6KJ/B#PJ_P8UC1?">F^.KW[5?VLR37]O#)!;7&[:!NB/#.N5
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MOXG8_E^9/0:E\4_"/Q26"Z\::7KD6MPPK#+J&C2Q9O@HPK2)(,;L8!(/./3
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MO67BBN>IF5><H2DU[C;6G5OF?XB]HW8VOB1XC@\8?$'6M6M5F2WU*^FN8EE
M#JKN6 8 D9Y[$UM>,/B/9>(?AMX)T6&&Z6X\-"[^TNZJ$D\V5779@DG 7G('
M-<714+,*J=5_\_-)?^!*6G;5(?-+7S/9/B1\</!OQD\6W$WB'1M:2UA8+8WU
M@\45ZL. ?+D1MR-AMQ!SD US/B7XHZ+I/@FZ\-^#]-OK&RU)T?4+Z_E5[R]5
M#E8\)\J(#S@=?SSP-%=^(X@Q=>4ZD^7GG>\E%*5GNK[[:=[:7L5*M)ZO<[KX
M;?$_2](\'ZAX8\2:==:AH-_<+>(UI(([FSG V^8F[Y3E1@@UTWP[^-'@WX/^
M-+6Z\/Z3KTEK(Y6]O-0>&6\,.#^[B1=J+EMI)))(&*\?HJ<+GV*H>S<.7FI_
M"W%.25[VOO;?SL[)V%&M)6MT.T\,_$>RT/X4^,M"DANGN_$DMHUNZJOEQB*8
MR-O.<@D<# /X5E_#'XAW'PQ\70ZI;PQ72!&AN+:7_5W,3C#HWL1^H'7I7/T5
MQ_VE74J4XNSI*T6NGO.7SUD_R)]I*Z?8]*7Q!\*[:[74(]!\6S3J_F?V;+>0
MBS]=OF >9M[>M8MY\<=:E^,?_":Q^3#J7G"18P#Y00+L$6.NW9\I[GKUKCZ.
MM;U,XQ$DE3M"S4O=2C[RV>G57=NBN[)7&ZDO0](N_$WPMUR[?4KK0?%5C>2/
MYLFGV5U";%F/) 9AO52>PZ#@8JYX7_:/AM_CAI/B2_T][71M$M7L[+3K$!OL
MT7E.B*-Q4$Y;)8_ET%>5XHQ6T<_Q4)QG348M24M(I7<7=7LM4GK;1>0_;2O=
M#0I(KL_CW\0[/XJ?%'4-<L(;J"UO$A"I<*JR*4B5#G:2.JGOTKCJ*\R.*G&A
M+#KX9.+?K%22_P#2F0I.W*=C+\0[-_@'%X5$-U]O773JC2E5\GR_(,>T'.=V
M3GIC'>M>P^*GAWQIX9TO2_&VFZI-)HL(MK34]*F1;KR!TB=9!M8+V/8?B3YO
M1793SC$1?1KE46FDTTMKI]4];[KH5[22.^\2_%/1='\#WGAOP?IE]96>J.K:
MA?ZA*LEY>*IRL>% 5%!YP.OYYS_''Q#L_$WPM\%Z';PW2W7AQ;P7,DBJ(Y#-
M*KKLP23@#G('-<CC-%*MFV(J*47:THJ-DDDHJ2E9);>\KM[O6^X.I)G8?!OX
MA6?P\NO$37L5S*NL:%=:7%Y"ABDDNS:S9(^4;><9/L:L_"'XC:3X5T3Q%H>O
M6NH3Z/XDBA29[%D%Q"T3ED*A_E/).<UPU%+#YI7H^SY+>YS)75])JTD^Z:;0
M1J25K=/U+WB7^S?[=NO['^W?V9O_ -&^V;?/V?[>WY<_2J-%%>?.7-)RM:_;
M8G=A1114E!1110 4444 %%%% !1110 4444 =E^SW_R6KPW_ -?B_P C7V]7
MQ#^SW_R6KPW_ -?B_P C7V]7[;X8_P"X5?\ '_[:CT,'\+"OY@?V>_\ E-]X
M5_[+/#_Z>:_I^K^8']GO_E-]X5_[+/#_ .GFOVS(=JOHOU/E>,/^7'J_T/Z?
MJ***^>/MBUI'_'RW^[_45I5FZ1_Q\M_N_P!16E713V*B%%%%:%!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MCW7_ !\R?[Q_G4=277_'S)_O'^=1UQF85^ /_!U7_P I"_!O_9.[+_TY:G7[
M_5^ /_!U7_RD+\&_]D[LO_3EJ=>QD?\ O7R9\SQ9_P B]^J/V8_X)R?\H]/@
M/_V3OP__ .FVWKV:O&?^"<G_ "CT^ __ &3OP_\ ^FVWKV:O+K?Q)>K/>PO\
M"'HOR/D/]L?_ )+9<?\ 7I#_ .@UY77JG[8__);+C_KTA_\ 0:\KK^7^)O\
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M]$TU*+?;FBVK^5PE!K<J45Z-IOP$AU?X]MX)M=>@N(\$IJ44 >-\0>=]T/\
M\!/S'!'X5S>@>"(-:^'_ (@UI]3AMI]%:W6.S=1OO!*^T[3N!^7J< \>E5/*
M<5%M2CLYK=;TTG/KT37KTN/V<OS_  .=HHHKSB HHHH **** "BBB@ HHHH
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M99=N6G%Q^YI6]#HE%:KSE^17TWX6^'O!OAO3=4\;ZEJEN^LQ"YL]-TN)&NC
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MK%UW'@9/?UXJ]H=^U]\&OC)<>0MDT]_9.8$D#K!NO&R@8<,!G&1P:X/X+_\
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M*+BF_1M,*3M(X_1]-.LZO:V8FM[8W4R0B:X?RX8MS ;G;^%1G)/8 UZAX?\
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M#@[7B:-000<<<\$T>&M,D^-7P&L]!TUEF\1>$[N:>&R+!7N[6;YG,>3RROU
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M35F=%\7?B(WQ8^(VH^(#9_8/[0,?[@2^9Y>R-(_O8&<[<]!UJGX"\7W'P_\
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M\6?\B]^J/V8_X)R?\H]/@/\ ]D[\/_\ IMMZ]FKQG_@G)_RCT^ __9._#_\
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MMSW7Q<0#Z#[(:T_@]XNU#XX)?>"O$EU/K'VRUFN-+N+ES)<6=U&I<%7.6*D
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M^#3V/CC1M/T&=M3T_P 4)'-I,\F%9U<[=LG960Y#?3/'0:EY^T5)I]U)!/\
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M0>I)'OC/O7J8N,)9M7RYT8QIIU-HI.*2;4E*W-96O:_+;1*UC27\1PMIJ/\
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MVS^U$U5I+I0<8<PE=G'4@9_&M+X=_ VRMOVE;;PGK2KJFES1RRQR)(T8N8C
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M?PK:Y;;$)K5[^8D\ 9D8AC_P'K7MY-T/VN?AV+Y52^_X1=?M"JH55D\NZW
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M/Y5\\T5QY;F%&A2JT*\'*-1):246K.^[C+\B:<TDTUN>F_\ #'GQ$_Z "_\
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MVTU>Q*G:+??;^O0Y('-% XHKY4QB%%%%!04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!V7[/?_ "6KPW_U^+_(
MU]O5\0_L]_\ ):O#?_7XO\C7V]7[;X8_[A5_Q_\ MJ/0P?PL*_F!_9[_ .4W
MWA7_ ++/#_Z>:_I^K^8']GO_ )3?>%?^RSP_^GFOVS(=JOHOU/E>,/\ EQZO
M]#^GZBBBOGC[8M:1_P ?+?[O]16E6;I'_'RW^[_45I5T4]BHA1116A04444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_'S)_O'^=1UQF85^ /_  =5_P#*0OP;_P!D[LO_ $Y:G7[_ %?@#_P=5_\
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MM]S*?);1O[O^"<K7;?LX_P#)<_"__7\G]:XFNV_9Q_Y+GX7_ .OY/ZU.3?\
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M['8V'VI]_P!GLXO*@B]D7)P/;->I?L964NI>-_$UO"OF37'ANZCC7.-S&2$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME_M%;3&H-^Y0[3+G[O.,8Z 53_:-DN-+^%O@'2===I/%-G;SR70=]TT,+O\
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MJ&\UDW<R]MV>G&*@&K>*==_99\<7GB:[O)FN/L#64%Q\K)$+E09%3C:C'@'
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M.,;N3_#_ ()X517NWP@^*]U^T#XR7PIXTM]/U>'6(I5AO/LL<-S9R+&SAE=
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MU3[$.-H\S.)HHHKS"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .R_9[_Y+
M5X;_ .OQ?Y&OMZOB']GO_DM7AO\ Z_%_D:^WJ_;?#'_<*O\ C_\ ;4>A@_A8
M5_,#^SW_ ,IOO"O_ &6>'_T\U_3]7\P/[/?_ "F^\*_]EGA_]/-?MF0[5?1?
MJ?*\8?\ +CU?Z']/U%%%?/'VQ:TC_CY;_=_J*TJS=(_X^6_W?ZBM*NBGL5$*
M***T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#'NO\ CYD_WC_.HZDNO^/F3_>/\ZCKC,PK\ ?^#JO_ )2%
M^#?^R=V7_IRU.OW^K\ ?^#JO_E(7X-_[)W9?^G+4Z]C(_P#>ODSYGBS_ )%[
M]4?LQ_P3D_Y1Z? ?_LG?A_\ ]-MO7LU>,_\ !.3_ )1Z? ?_ +)WX?\ _3;;
MU[-7EUOXDO5GO87^!#T7Y'R'^V/_ ,ELN/\ KTA_]!KRNO5/VQ_^2V7'_7I#
M_P"@UY77\O\ $W_(VQ'^.7YGGUOC84445X9F%%%% !1110 4444 %%%% !11
M10 4444 %%%% 6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<'9A17T7^SC\,-%7X/ZG>:QIMC?:IK=E>7ED+FW61H+>W C+KN!*DR2=1C(
M.>!7DGP;^%Z_$K6[IKV[_LW0]'@-WJ5YC)AB'9?5FZ >QX.,'HK<.XF$</:S
ME63:79:/5O1:-2\EN-T6K>9Q]%>G77QN\-^'+AK?P]X"\.S6*#8)M9B:\N9A
M_>)W *3Z#./6KA\+>'?CEX,U;4/#^FKX>\3:#;M>7.GPR%[:^@7[SQ@\JR\?
M*..0.<Y$1R>G4O3PU>,YI-\J4E>VKY6TDWY:7Z7%[-/1/4\EHKN/B;H5KJ?@
M_P /^*M.MH;6'4HS8W\,*!(X;R$ $A1PHD3:^!WW5P]>;C,++#U/9MWT33[I
MJZ?W/Y;$RC9V"BBBN4D**** "BBB@ HHHH **** "BBB@ HHHH ]*7]D'XBN
MH/\ PCIY&>;ZV'_M2E_X8_\ B-_T+O\ Y/VW_P <KS;SY/[[?G1Y\G]]OSKV
M?;93_P ^:G_@V/\ \I-+P[/[_P#@!/"UM.\<B[7C8JP]".#7KW[&44=QXW\3
M1S3?9X7\-W2O+M+>6IDARV!R<#G KQ^O6OV0G5/%7BO<0N?#%YC)Z_-%6W"[
M2S6B_/\ 1CH_&BE_PJKX=_\ 14E_\)VY_P#BJD\6>.O#'@;X87WA/PC<WFK2
M:W-')J>J3P&!9$C.4CC0_,!GGGU/7/'EU%9?VQ&$9+#4(4W)-.2YV[-6:7-.
M25UHVE>SW(]K_*DOO_S/6_VG/^15^&G_ &+%M_Z M>25Z]:QV7Q^^%F@Z3%J
M%CI_BKPNCVL4-Y*(8]1MR05V.>-ZXQM/7D_2E8?LKZWH][%-XJN-+\-:.I#S
M7,]]$[-'W\M48EF/8>M>EFF6XK'XGZUA8.4)*'O+96BDU)[1:::=[=]BJE.4
MY<T=M#K_ (K_ /)QGPG_ .O'2/\ TJ:J?QH3X7GXJZ]_;#>//[4^UM]I^QBU
M\C?_ +&[YL?6L+5/B1;?$K]J;P[J%G&;?2[;5+"TLU;@K#'*@!/IGDX[9Q6[
M\:?V7_''B[XJZ]J>GZ*L]E>W;2PR&\@7>IZ'#."/Q%>]B*E7%4<14P-'VR]L
MOLN6B@US67>VC\S:3<DW!7U_0L?"U_ S/=VG@.^U/3_&%_$UO87'B!%(&X$,
ML31?*DA' 9@?0#FO.? 7Q"UCX(:[JUG<:?#>6MP6LM4TZ\3=#,4)!!]&4DX/
M/4]<UUOP^^ &I_##QMIVN>,KK2_#NG:+<1WS++>1R3W#1L'5$1"Q)) _#/6K
M.B_$W1?B[%XT\.:M>QZ#;^)-3.JZ7=S\0PS X"RGH RJH)Z=?:N5TZ[A1]K;
M#5XN:A&W*G[M_>BW[KD_=N])*R::1.ME?W7K8R?[=^$OC+_C[T;Q%X3N)/X[
M&X%W;J>Y(?YL>RK^58?Q2^#*^"=#L]>T?5K?Q!X;U&0PPWL2&-HY "?+D0\J
MV ?R/ K1/[)'C1\R0V^E75FO6\BU*$P8]<E@<?A5WXDZAIOPV^"MMX%M=4L]
M:U2XU(ZIJ,UHWF6]J0@01*_\1X!)'3!Z9%<5?"U9X>K/,L.J34;QFH\C<KJR
M45:,D^MHZ;WT)E%N+YU;SV.N^++>!QX(^'O_  E:^*C<?\(W:^1_97D;-GEK
MG=YG.<^E<-O^#G]SXD_^27^-7?VFI%?PM\-=I!_XIBVZ?[JBO):6?9I[+&RA
M[*$K*.KC=_!'=W"M4M*UET_(^BOB>;,_%'X)_P!G?:?[/^SZ;]E^T8\[RO.C
MV;]O&[;C..,YKRO]H[_DN?BC_K^?^E=9^T'J\FCZ7\*[RW9?.L_#UI,AZX90
MA'ZBIOB'\.%_:&\0MXG\&W6GW-QJJ(][I,MRD-U:3A0K8#D!E.,[@>N:[\ZA
M/&>WPU!7J*=.7*MVO9V?*NMG;1:V?DRJMY7BM]'^!QO[./\ R7/PO_U_)_6O
M4/@UY/\ PTS\4OM/F_9_LFK>;Y6-^S[4F=N>,XSC-8/P\^'"_L\^(5\3^,KK
M3[:XTI'>RTF*Y2:ZNYRI5<A"0JC.=Q/7%'[)-Q<^+/B=XN?Y9+[5=!O2%R%W
MR22Q' SZDT9'2GA9X7"5E:HZLI<KW2Y4E=;J[O9/73S04KQ<8O>YB;/@Y_?^
M)/\ Y)?X5TFOZ=H_B7X)ZC9?#>XD^Q6.V^UVSO4*ZE<HGW7W#Y&C7J54#!&>
M^#S3?L=_$4_\P%?_  /M_P#XY70>"?#:_LV^'?$FI>(;[31K6JZ7+I=EI5O<
M)<39D*DR2;20J@J._//? ,8.CC(N4<9A51IRC)2GR.#2MT;ZO:VO,G:VH14O
MM1LN]K'G?PW\16>@:=XJCNYO);4M$DM+8;&;S)3/ X7@''RHQR<#CKTH\&>(
MK/2? /C"RN)O+NM4M+:*U38Q\UDNHI&&0,#"J3SCIZUR]%?'4\=4@HI)>[&4
M?E)-/KOJ[?J<JFU_7<]'^('Q,TW7?AM9QV;N=>UKR?[=S&1C[*ACBPV,'S,A
MVQGE1FL#XU>(K/Q;\5M>U+3YOM%C>7;2PR;&3>I[X8 C\17+T5KC,UK8F+A4
MMKR[=XJ6N_VG*4I=V[JVQ4JDI:/^OZN%%%%>:)!1110,**** "BBB@ HHHH
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MX^6_W?ZBM*NBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %C
M2='O-?U".SL;6XO;J8D1PP1&21\ DX502> 3QZ5O?\*7\8_]"GXF_P#!7/\
M_$UAZ+KEYX<U*.\T^[N;&\ASY<\$ACD3(*G##D9!(^AK>_X7=XR_Z&SQ'_X,
M9O\ XJO0POU'D_VGGO?[-K6^?4J/+U*NJ_"[Q-H.GR7=]X=UZSM80#)-/82Q
MQQC..690!R0.?6L&N@U;XK^*-?TZ6SOO$6N7EK,,20S7TDD<@SGE2<'D5S]8
MXKZMS+ZMS6_O6O?Y!*W0]6\7_P"@?LC>$8[=OW=_JUU/=  C,BED7/K\N/\
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M5S3L_:?T_(ZK]I3XRWGPS^->K0>&8;/3=1;R9+Z_>VCGGF<PIM53(I"H$V\
M9+%B37/^-O$+>._@EI/CJ2"TM?$VDZ[_ &=+=6\"1_:P(Q,DCJ!M+*<#ICKV
MXK*_; _Y.+\1?]NW_I-%4L'_ "9M-_V-_P#[:+7;CL?B*N88_#SD^2/M&H]$
MXRT:6RE=7;6KUONRI5).<T]M3L?B1\?_ !=!\!/!.I+JV+SQ NHPW\GV6']^
MB3;%&-F%PO'R@?G63X#U?2_#7[+::MJ5C#JDMAXCD^PVDXS!+.UNF#(.ZJNY
MMO0D '@U1\6^&M1\6?LR?#]]+L+S4ETV34EN_LT+2_9\S;QOV@X&T9R>,50N
M&Q^QK#_V.!_](VK:MCL4\3*M5DY6P\7'FNU=TZ;;5[IOFU?=[W&Y2O=_R_HC
M8T'Q8WB;PUJOQ$\46MCJLNA^5I.CV!MDCM/-8L_SHN-RH&+8.<Y]A6-9?M4^
M(KR[CAUR+2=;T3.V339M/@6((3R$*J&4^AR><=:?\(/+^(_PHUSP,LT4.L27
MD>K:3'(P5;J55V21 DX#% ,>O/I6+H/[.OC+6]<6R?0-3T]=V);F[MVAMX5'
MWF+L I '/!.>V:\^>)S25.A/ .4N=>\XW?-/F=U/O9<ME+3EL[:D<U2R</Z?
MF>E_"WP#:?#W]L/1[?37DDTF_M)-0L2_WA#+;2$ ^N#D9[@5RG[-FAI?Z/XK
MO-/L[+4_%VGVT+Z1:W*K(""Y$TBHW#.JXQGH2.N:[7P#XPL/%?[8OA^'2IOM
M&EZ'IS:5:S=IDBMI06'L6+8]1@]Z\N^&OPS;Q]X/U2ZT2YNF\6:1,DT5E&X5
MKBV(PS1_Q%U;K@],<9(SZ$HPA4I_5(*257$62?\ <I_ [/6.\-'JD:;-<O=_
MDMOT.F/QEU74Y[K1_B=8S7&GS6[Q1/)I<<%WI\H'R-'A4Q@C!'3'X@^/U] _
M!J?QQ=7=W:>/K?4W\#PVLIU)M=A95A 0[#&T@W;]Q7&TGKZX-?/S%2S;<[<\
M9ZUX.?1JRHT:U64I7YDN=6GI;=W?-'7W7IKS*VAC5O9-_CN>G?!F/^R?@[\2
MM81MLT5A;:<I'79<3;7'T( JQXO_ - _9&\(QV[?N[_5KJ>Z !&9%+(N?7Y<
M?Y%5/@_/_:7P:^)6D+S-+96NH*!UV03AG/Y,*F^$FLZ;X\^'&H> M7O8=-FF
MN1J&C7DYVPQW.-IB<]E<< ^I/? /?A91EAZ6'BTG4HSBKZ+G]K*5K]')14?F
MBXOW4NZ?WW/+JLV4]Y';W"6[W*Q.O[]8RVUE'][';GO75ZG^SOXVTK4VM6\,
MZM,ZM@206[30M[AURN/QKKM2TQ?V>/A!JVEWTT#>+_%RI#+:1N';3;0')WD<
M!GSC'T]#7B8?)<2G.>)C*G"";;::UL[15[7<G96\[[)F,:4MY:'8ZIXPA\(>
M*/A-]LVMIFK>%H-,OE;[K0S1JIS[ [3^%>):[\+[[2OBU-X2C!DO%OQ91$C[
MX9@$?Z%2&^AKMOVFSCPM\-/^Q8MO_0%KNM)O+._T"Q^+\LD+76DZ')9W$;'+
M/J*8@B8@_P!Y7SWQ\M?6XW"QS#$SPM1V]DX3OVIN$54^ZT6EZG3*/.^5]+/Y
M65RQX6\06]]\;/%6CV#9TOPKX.N-(ML=#Y;1!V^I?<">^!7F_A0_8/V0_%$T
M#;9KW6[>VN< Y\I51UR?3<3_ )-3?LC74EWXQ\822,TDDGAF]=F8Y+$O$236
M-\!_&6EQV6N>$_$-Q]DT7Q1"J"[(RME<(<Q2'_9SU^@S@9-1]?6(A1J5&H^U
M5>*OHHN22BK]%M&_1"Y^:S?6YYY5G2Y[R"X;[$]RDK*5/D%@Q7N..U==X@_9
MP\9>']2\E-#OM4@;F&ZT^-KJWG4]&5E!X/O@UV/@[PW)^S7X0U3Q!KQCM?$F
MJV;V.D::6#3Q;^&G<#[H '&?<<$BOE\+D>*]LUB(RIPC=RDTTDEZVNWLDGJW
MH81HRO[VB,/P)#_;G[,_CJW?E=&OK#4(<]GD9HF_\=%>9UZ;X%D.A?LQ>.+I
MQA=:O['3HB>A>-FF8#WVG]:\RJ,U_@86^_L]?_!D[?\ DMOD*IM'T_5A1117
MC""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****">4**** Y0H
MHHH%RL.E'6BB@+,**** LPHHHH'RA1110'*%%%% N5AUHZ444!RL****!J(4
M444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '9?L]_\ ):O#?_7X
MO\C7V]7Q#^SW_P EJ\-_]?B_R-?;U?MOAC_N%7_'_P"VH]#!_"PK^8']GO\
MY3?>%?\ LL\/_IYK^GZOY@?V>_\ E-]X5_[+/#_Z>:_;,AVJ^B_4^5XP_P"7
M'J_T/Z?J***^>/MBUI'_ !\M_N_U%:59ND?\?+?[O]16E713V*B%%%%:%!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!CW7_'S)_O'^=1U)=?\?,G^\?YU'7&9A7X _\ !U7_ ,I"_!O_ &3N
MR_\ 3EJ=?O\ 5^ /_!U7_P I"_!O_9.[+_TY:G7L9'_O7R9\SQ9_R+WZH_9C
M_@G)_P H]/@/_P!D[\/_ /IMMZ]FKQG_ ()R?\H]/@/_ -D[\/\ _IMMZ]FK
MRZW\27JSWL+_  (>B_(^0_VQ_P#DMEQ_UZ0_^@UY77JG[8__ "6RX_Z](?\
MT&O*Z_E_B;_D;8C_ !R_,\^M\;"BBBO#,PHHHH **** "BBB@ HHHH ****
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MP>GY&N<KCQ&'J4*CI55:2W1+33LPHHHK$04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!V7[/?_
M "6KPW_U^+_(U]O5\0_L]_\ ):O#?_7XO\C7V]7[;X8_[A5_Q_\ MJ/0P?PL
M*_F!_9[_ .4WWA7_ ++/#_Z>:_I^K^8']GO_ )3?>%?^RSP_^GFOVS(=JOHO
MU/E>,/\ EQZO]#^GZBBBOGC[8M:1_P ?+?[O]16E6;I'_'RW^[_45I5T4]BH
MA1116A04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 8]U_Q\R?[Q_G4=277_'S)_O'^=1UQF85^ /_  =5_P#*
M0OP;_P!D[LO_ $Y:G7[_ %?@#_P=5_\ *0OP;_V3NR_].6IU[&1_[U\F?,\6
M?\B]^J/V8_X)R?\ */3X#_\ 9._#_P#Z;;>O9J\9_P""<G_*/3X#_P#9._#_
M /Z;;>O9J\NM_$EZL]["_P "'HOR/D/]L?\ Y+9<?]>D/_H->5UZI^V/_P E
MLN/^O2'_ -!KRNOY?XF_Y&V(_P <OS//K?&PHHHKPS,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /3%C^#H4;I/B06QR0+,9IWE_!O\ YZ?$C_R3_P *\QHKV?[8_P"G%/\
M\!_X)I[3R0Z?R_/?R]WE[CLW?>QVS[UZS^Q__P C5XL_[%B\_P#0XJ\DKN/@
M3\3;'X7:UK5Q?0W4T>I://IT8@525D<H5)W$?+\O..>>AI9!B*=',:56J[13
MU?;1A2DE--FU\-/^+B? WQ1X8;]Y>Z(1KVG#JQ"_+.H[_=(.!W--\1$?#C]F
MW2]-!"ZAXUN3J5R/XEM8OEB4^S-\X_&N5^#_ ,0#\,/B)INL-&TUO;N4N8E
M)EA<%77!X)VDX!XR!4WQP^(L/Q.\>27UC!):Z7;PQV=A;N &@@C7 7 ) YR<
M GK7H1S"@LN]JY?OU%TDO[K=^;_P&\/1H.>/)?KM_7Y';?M#V,VJZ5\*[6U3
MS+FZ\.V<42#^)V"!1^)(JC\1=#\-Z1XJO/\ A,/%&N:]XD4JEZNFVB;(W50N
MPRR,-VT #(7MBLGXC_&.'Q&O@6;28[NUO?".FV]LSS*H!FBVD,F"<KE0><'V
MK4\2>/?AO\0=4N-;UC1?%=CK-V1+<6^G7$)M)Y?XFRXWKN// [_C7H8K$82O
M5K2A.+DW3MSN7+90LVDM')/3WNC=EN5*46W:W3?T-3QU/HMS^R39MH=GJ%K9
MQ^*=@-],LLTK?9G);*JH Z# '\-9_P"U'J<\D/@&S:0FVA\*V<T<?96<,&/U
M(1?R%0:U\;-!\5_"6^\+W6CWFEV]G=B\T2.P9&2)A&4"SL_S-DLS,PY);C &
M*Y[XR_$2S^(ESX=:RANHET?0K72Y?/55+R1;]S+@GY3NXSS["L\TQV'EAIQI
MU$W*%.-DK:Q;OI9:=5Y6>X5)+E=GT1Z'\.F\.P?LJ?:O$WVJ:PLO$[3QVL'#
M7\PM0%A+?PJ<DEO13CDBLS]H^)O'/A[0_&&CS2/X9FA6R6Q& FB3* &AV@
M-C(;'/TVUQ\GQ"LY/@%%X46&Z_M!==.J-*57R?+\@Q[0<YW9.>F,=ZF^#?Q1
MM_ <VH:;K-M-J/AC783!J%I%C>/[LD>2 '4]#D?F 02S3#UJ,,OJ-1A*G%.2
MW4U>W,^L5LULK\R5T'M(M*#VLM?,]&\>GP+;_#?X?P^(F\7>6-$26W&E?9_)
MWLV9L^9SNW]<=L=ZI_"[Q/\ #?POXBFFT&Q^)6J75Q9SV\MJT-K,LT+(0^Y8
MR&P!\V>VW-<GH7Q3T&Y\*KX7\2:=J.J:#I]Q)+I=Y;NL%_9*YR1@[D(;J5)P
M#W.!B6;XI^&/ .@ZG9^"=,U=;S5X6M9M3U:6-KB&!OO)&D8VKN[MG/Z8ZO[4
MH>VCBXRII14;^ZW-.,4K+H]59.]K6O;8KVBOS:?J6/A*?^,>?BG_ +FF?^E#
MUYA7;?"#XC:3X5T/Q%H>OVNHSZ/XDAA29[!D%Q"T3ET*A_E/).<URWB,::-=
MNO['^W?V7O\ ]&^V;?M&S_;V_+GZ5\UCYTZF#PSA)7A%Q:ZI\\Y;=K26O?0Y
MYM.,;?UJSUW]F/7?^$9^$GQ,O_L=C?\ V6WLG^SWD7FP2_--PZY&1^-87_#3
M,G;P)\-U/J-$Z?\ C]97PW^)MCX.^&OC71;F&ZDN/$D%O';/&JE(S&SD[\D$
M A^, ]*X>NZMG=6C@L+1PM2W+&7,K)V;J3?5=FF:.JU"*B_ZN>R?&#5U^,GP
M7T[QA'YEC/I-[_95UIL<A^QQ90,LD*'[F?E!'^'.KX^/@6V^&_P_A\1'Q?Y8
MT19;<:5]G\G>S9FSYG.[?UQVQWKSKPU\0]/T_P""OB+PS=PWAO-0NH+NREB5
M6C5D.&#Y((RHP, \GMCFSX4^*>DWG@>W\,>+M,O-1TNQE>:PNK*41WE@7Y=5
MW JRD\X/?UXQZ,<VH5).=24>>K3BI.2;CSQEM)+:ZBGHK7L]KVKVB>^[7XG8
M_"[Q1\-_#'B*:70;'XE:G=7%G/;RVK0VLRS0LA#[EC(; 'S9[;<URO@3Q[9Z
M1\-I/#_BK0]1O/#>I7AOK2[M6\F:&=5\MFC9AL? X(/0D^M/F^*?ACP#H.IV
M?@G3-76\U>%K6;4]6EC:XA@;[R1I&-J[N[9S^F*7@?XGZ1_P@_\ PB_BO2[S
M4-(BN#=6=Q92K'=6+L,,%W#:RMUP>_//&,WCZ:E"BJL(M*>T?W=Y<ONRNG=-
M+5I63M;JT<ZT5U^AM67@+3]0\+:]?> ?%&H2R6UB[ZGIEY!]GN)+3C>0RDHX
M'&1Q^H!Z;QZ? MO\-_A_#XB;Q=Y8T1);<:5]G\G>S9FSYG.[?UQVQWKC+CXG
M^%O GA_6++P9I>M?;-:MFLIM1U>:,RQ6[??1$C&T;L#YB<\54\)?%72;SP-;
M^%_%VF7>HZ78RO-875E*([RP+\NJ[@592><'OZ\8TIX[!TE*A%P4I0L_BE34
ME-22UNU=+6UXJ5O.S4HK33]-SLOA=XG^&_A?Q%--H-C\2M4NKBSGMY;5H;69
M9H60A]RQD-@#YL]MN:YGPOX4!^$=O=^)?$=QI'A>[OWDL[&WMOM$U[.B['D5
M<@  ?+N8^V.E)-\5/#'@'0=3L_!.F:NMYJ\+6LVIZM+&UQ# WWDC2,;5W=VS
MG],0^#_BCX?U#X>VOA?QAIVJ7-CIMP\]A>:;*BW-J'.73:_RLI;GFI^MX:7+
M0J3A=1E914HT^:3CI)JS:LF_Y;VUM<7-'9V_0[K]ER3P2GQITZ'1K7Q)=7TD
M<X6>_DA2&-?*;),: DY&1RV/FKFOA%JD^D_LX_%":WD:.1AI\3,O4H\S(P_%
M6(^AJ3P'\<?"?P>\96=UX9T/5)+7>5O;O498Y+V:(@CRT5<(@SACCD[0,@=<
M.'XB>'O#_@#QUX?TF'66M_$4MD=/>[6/?&D,F]O-*G&3T&T'WK:&.P].A!>T
MAS05=/E32O.DE&VFNJM?O9;697,DEJNOXHT/V4&\KQ_JUQ#_ ,A&UT*]FL/7
MSP@ Q[[2U>9.[2.S,2S,<DD\DUH>"?&.H?#_ ,56>L:9+Y-Y8R;T)&58="K#
MNI!((]#7>7GBWX8^(KR34[[P_P")K"^D;S)+&PNXOL,C=6PS#>H)[#IVQ7@T
M_98K!4\/[10E"4G[UTFI<NJ:3U5K-;VM:^IBK2@HWM8A^&]UK]W\2_AR=7^U
M&Q2]MX],:9,*81,H(0XR5!K!^.%S)=_&;Q6TC-(PU>Z0$GHJRLH'X  ?A6O<
M_&M=;^+_ (?UZZL_L.C^'YK=;6PM/F^S6\3AMB[B S'DDG&2>PQ7*^/_ !!%
MXL\=ZUJL"21PZE?SW<:28W*LDC, <9&0#VJL=B*+P;H4JCG^\O=[M*"5_2^U
M]4M G)<MD^OZ'=?$]M_[-7PQ+<G=J8R?3[0*\_\ "FA-XH\4Z;IBR+$VHW45
MJ'/1"[A<GZ9KH?%_Q#L_$/PA\'^'X8;I+SP\]X9W=5\J032[UVG.>!P<@?C7
M)6MU)974<T+-'+"P=&'56!R#7/FF(I5,53FO>BH4D[?W:<%)?>FA5))R3\E^
M1ZU\0_C%??"7QXV@>$0NCZ3X:N?):-1\VIRI\KO<'K(&.1@\ 8QC@B_-\,?"
MOBSP]XA\=6BK'H/]DRR?81-L?3-4+(%BP.6C)8E>V#C P*QM:^)O@?XI7"ZE
MXKT?7K'7#&%N)]%EB$5\X& [)(/D)XSMSTJ;2?VBM+TBXAT.W\.I:^ Y4>&_
ML01-=7N\#,S2''[Q2JE<8 QC/0CZ=8S"SK3^M5H3I2;]FK/W&](^[:T8Q7QK
MK96NTF;\T6WS--=/+^NIY(K9KV7]E#2[+PY#K_C35KY=+L])M_L5K=M$TWE7
M$WR[PB_,Q53T'9_QKR+54M$U6X_L]KF2Q\QO(:X0)*4SQN"D@-CK@D5V/BOX
MF6-W\&_#_A32H;R$6DTE[J<DJJJW-PW"[<$Y55)&3C.!QQ7SF2UZ6$Q$L55L
MW33<5TE+:.W1-\VC6BT9C1DHRYGT.D\.>$_A_P"&/$UEJMO\4I/M5C<)<HQ\
M/7/+*P;DY[XY^M1_M5>'+6T^*%GX@TUUFTGQ9#'J%O*H(5F. XY[YPQ!Y&_%
M>3UW=Q\4+#6?@?I_AO4(;QM4T343<6%PBJT:P/R\;$L".22, C@#BNRGF>&Q
M&$JX25.%+:<6G/64=+/FE+>+>UM4KE*HI1<6DNO4T_VQKF2?]H?75=F985MD
M0$_<7[/&V!^+$_C3HFW?L;29YV^+^,]O]$'^-<[\=O']I\4?BMJVNV,5Q#:7
MQB\M)P!(-D*1G(4D<E2>">M/B^(=FGP#E\*F&Z^WMKHU190J^3Y?D"/:3G.[
M(STQCO55\=1EF6-K*7NS]KROO=Z?>M@<ESR?>YTOC/PCI?A]=-C\>>)=6N-6
MM]/ACBTW3K19&L8,9CC:1V500#T .,]^*UM'F\.S?LR?$)= L]6A2*33C--J
M$R2-*QN !M"* H'/J?FZUDZU\4?!'Q3^SZAXNTWQ);Z]#;I!/<Z3-"8[XH,*
M[B4?*< 9QFG:3\</"\7A'7O"DVB:EIWAG4HHS!]CE22\,\;[_,E=\ [BJ @<
M*JX [UZE/$8.%>I*%2"A.$XQ;YG-N4&ES.5^5W:NU9=$K&G-&[LU:S]=BM\6
MI-G[/?PK(Z[-3((_Z^$JW\5-!F^,9\%^)+%=UYXI5-*OL#[M[$1&6;TW+AOH
MN:Y/QS\1+/Q-\+?!>AV\-TMUX<2\%R\BJ(Y#-*KKLP23@#G('-=O^SAXZF\%
M?"OQE?7,"36>C^7=:<\G2#4)%>%"H[DJV3Z!?QKGH5L/B\7+"U)?NY4Z;;7V
M72IQ;?R2G'YDIQE+E>UE^"_X<Y3]HGQ%;ZM\1I-/L6SI?AR"/2+,?[$(VL?Q
M?<<]^*UOVEO^//X>_P#8H6'\FKRXRM([,Q9F8Y)/))KTCQ=\1O"_Q ^'VDQZ
ME:Z];^)=!TN/3+1[9HC9S+&?D,F[YQP3G;W->7#&QQ4,6ZDE&52S2>VDK\J]
M%HEY&?-S<U^IZ*8+:Y_:'^$"W6WRQX9L77/_ #T59VC_ /'PM>"^-+VZU#QA
MJDU\S->R7<K3[CD[]YS^M=+\4/BK'XIUWPK?Z/\ ;+*X\.:-:6(ED"JPGA+-
MO7!/RY(QGGCI6SJOQ$\ _$B];5/$VB>(-/UN4;KE]&GB%O>R<9<K(,H3WVY_
M$G-=^98C#XU3H0JJ+4^9-WM).$8O5)ZQ<=+[W=C2I*,[I/K^AR#OXDU#P3IE
MN8[Z;0UO&CL%$6Y#<-RRH<9+'/0=Z[CQAXX\(?%C66NO%EGKWAOQ-M6&\N+-
M%F@E=%"9>)\.A  & >,=ZYKXA_%O_A))='M=%LO[#T;P[SI]LLGF.LA8,9G;
M^)R0#[?F3O:[\1/ /Q+OGU;Q'H_B/3]<F4&Y.D30_9[N08!<K(,H6QSC///)
MYK"A5I1YZ%.M&2]S2HGRRY4U>+M>/*VU'X6XOY$Q:U2?;<Q_C#X-OO"FD>'V
M37/^$@\,W44K:/<*&144./,3RVY1@V,CG\\@<+77?%'XFP>-;72=+TO3O[)T
M'08GCLK8R^;(6<AI)';C+,0#Z"N1KQ\VE0EBI/#N\;+NU=12=N;7E3NHWUY;
M7,ZC7-[H4445YH!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '9?L]_\EJ\-_\ 7XO\C7V]7Q#^
MSW_R6KPW_P!?B_R-?;U?MOAC_N%7_'_[:CT,'\+"OY@?V>_^4WWA7_LL\/\
MZ>:_I^K^8']GO_E-]X5_[+/#_P"GFOVS(=JOHOU/E>,/^7'J_P!#^GZBBBOG
MC[8M:1_Q\M_N_P!16E6;I'_'RW^[_45I5T4]BHA1116A04444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]U_Q\
MR?[Q_G4=277_ !\R?[Q_G4=<9F%?@#_P=5_\I"_!O_9.[+_TY:G7[_5^ /\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@GE"BBB@.4",T@
M3%+10'*'2BBB@.4,9HQ110'*%%%% <H4444#L%%%% <H8HHHH%RAUHVT44!R
MABC%%% <H8INRG44!R@!BBBB@.4**** Y0HHHH'8****!<H4444!RA1110'*
M%%%% <H4$9HHH#E%@;R)TDVJVQ@VUAE6QV(]*ZWQ]\9=1\>Z);Z7]AT?1M*M
MY?/^Q:5:"VADEQCS&&22V..O>N1HKHI8NM3IRI4Y-*6_F/5*R#&****YQ<H4
M444!RA1110'*%%%% <H4444%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '9?L]_\ ):O#?_7X
MO\C7V]7Q#^SW_P EJ\-_]?B_R-?;U?MOAC_N%7_'_P"VH]#!_"PK^8']GO\
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MRZW\27JSWL+_  (>B_(^0_VQ_P#DMEQ_UZ0_^@UY77JG[8__ "6RX_Z](?\
MT&O*Z_E_B;_D;8C_ !R_,\^M\;"BBBO#,PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLL>0J*>WMV!J[X7TSPS^T<MQI=KH]GX5\7+$\UD;)RMEJ!49,91L[#@$Y!Z
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M17$BKG:K$#-?0WP4\?:MH_[6^L^';:Z$6C:EKNI2W-L(4/F,JS%3N(W#!1>
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MMOS77]=RJBTOY(\PKL? WP\L_$WPN\9ZY<2W2W7AQ+0VR1LHCD,TK(V_().
M.,$<UO?"4?\ &/GQ2;^(1Z8,^QN'S75_!SXU^)K3]G[QH\>I[6\+PZ?'IA^S
MQ'[,KS,K#[OS9  ^;-7E.5X;VE.6*D[5*52:2BG9Q51=9+;DYEW=HNRU"G&-
MUS=4W^9Y/H'BG3=,^'_B#2[G2H;K4M3:W:SO65=]CY;[GP2-WSKQ@$>]<[7K
MOACQ%>>,?@-\5M3U*;[3?74^F2RR;%7<QN,$X4 #CT IBZA#^S_\-=!O+&SL
M[CQ5XH@-\;NZ@6;^SK?.(Q$K9&YNI8CU'/&,JF6*I3IU)U+4E3<K\J32]I.*
M5D_>DWKJ]$[7M&XN6Z3;TM^IY+17LG@'XK3?'GQ)'X9\;)9Z@NLY@M=22TBA
MN["?'R%60+E20 5/7([<58^#L=KX*^$GQ0CUBQCU!-(N;)'MG)\N29)W5 V.
M=OF!=P&,KD=ZG#Y'2Q$HRHU?W<E/WG&S3A%S:E%-VNK6:;Z]58(TT]4]-?P/
M$Z*]B^&/[0^N>+_'6D:!KD6EZGX?U:[2Q?3SI\$<4*RL$!3:H(*D@CD]/7FF
M_"CX?Z78_'WQ1H[PVM_<:/'?+HEM>$>5=W4;XA5P3AN,G!],]JFGDM/$>S>$
MJW4Y<CYH\K3M?92E=-;:W;5K*Z$J:E;E9X_17LQ^-/BK1]?BTWXAZ2;GPZS&
M&XLKC28X?)1L_-"512&&<@@\XZ]#7D.KBV75;H632M9B5Q T@PYCR=I8>N,9
MKAQ^#HT4G2FWJTU*/+)-6Z7EH^COT=TB9)+8KT445YI(4444 %%%% !1110
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M%%%>"9!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!U'_"[O&7_0V>(_\ P8S?_%4?\+N\9?\
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MQ?Y&OMZOBW]F+1Y-9^.&AK&#MMY'N'/]U41C^IP/QK[2K]O\,8M9?5D]G/\
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M1_PB>J_] S4/_ =_\*/J]7^5_<PLS/HK0_X1/5?^@9J'_@._^%'_  B>J_\
M0,U#_P !W_PH^KU?Y7]S"S,^BM#_ (1/5?\ H&:A_P" [_X4?\(GJO\ T#-0
M_P# =_\ "CZO5_E?W,+,SZ*T/^$3U7_H&:A_X#O_ (4?\(GJO_0,U#_P'?\
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M (#O_A1_PB>J_P#0,U#_ ,!W_P */J]7^5_<PLS/HK0_X1/5?^@9J'_@._\
MA1_PB>J_] S4/_ =_P#"CZO5_E?W,+,SZ*T/^$3U7_H&:A_X#O\ X4?\(GJO
M_0,U#_P'?_"CZO5_E?W,+,SZ*T/^$3U7_H&:A_X#O_A1_P (GJO_ $#-0_\
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M_P !W_PH^KU?Y7]S"S,^BM#_ (1/5?\ H&:A_P" [_X4?\(GJO\ T#-0_P#
M=_\ "CZO5_E?W,+,SZ*T/^$3U7_H&:A_X#O_ (4?\(GJO_0,U#_P'?\ PH^K
MU?Y7]S"S,^BM#_A$]5_Z!FH?^ [_ .%'_")ZK_T#-0_\!W_PH^KU?Y7]S"S,
M^BM#_A$]5_Z!FH?^ [_X4?\ ")ZK_P! S4/_  '?_"CZO5_E?W,+,SZ*T/\
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M/5?^@9J'_@._^%'_  B>J_\ 0,U#_P !W_PH^KU?Y7]S"S,^BM#_ (1/5?\
MH&:A_P" [_X4?\(GJO\ T#-0_P# =_\ "CZO5_E?W,+,SZ*T/^$3U7_H&:A_
MX#O_ (4?\(GJO_0,U#_P'?\ PH^KU?Y7]S"S,^BM#_A$]5_Z!FH?^ [_ .%'
M_")ZK_T#-0_\!W_PH^KU?Y7]S"S,^BM#_A$]5_Z!FH?^ [_X4?\ ")ZK_P!
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M_@._^%'U>K_*_N869GT5H?\ ")ZK_P! S4/_  '?_"C_ (1/5?\ H&:A_P"
M[_X4?5ZO\K^YA9F?16A_PB>J_P#0,U#_ ,!W_P */^$3U7_H&:A_X#O_ (4?
M5ZO\K^YA9F?16A_PB>J_] S4/_ =_P#"C_A$]5_Z!FH?^ [_ .%'U>K_ "O[
MF%F9]%:'_")ZK_T#-0_\!W_PH_X1/5?^@9J'_@._^%'U>K_*_N869GT5H?\
M")ZK_P! S4/_  '?_"C_ (1/5?\ H&:A_P" [_X4?5ZO\K^YA9F?16A_PB>J
M_P#0,U#_ ,!W_P */^$3U7_H&:A_X#O_ (4?5ZO\K^YA9F?16A_PB>J_] S4
M/_ =_P#"C_A$]5_Z!FH?^ [_ .%'U>K_ "O[F%F9]%:'_")ZK_T#-0_\!W_P
MH_X1/5?^@9J'_@._^%'U>K_*_N869GT5H?\ ")ZK_P! S4/_  '?_"C_ (1/
M5?\ H&:A_P" [_X4?5ZO\K^YA9F?172:!\'?%7B>98[+P_JDF[H[6[1Q_B[8
M4?B:]O\ @U^QJFDW<.I>*WANI(R'CT^([HP?^FC?Q?[HX]21Q7LY3PSF.85%
M&C3:763345\^OHKLN%&<GHBW^QG\)9O#>BS^)+^$QW&J1B.S5A\RP9R6Q_MD
M#'LH/0U[E2*H10J@*JC  '2EK^A<GRNEEV$AA*6T=WW;W?S?W;'JTX*$>5!7
M\P/[/?\ RF^\*_\ 99X?_3S7]/U?S _L]_\ *;[PK_V6>'_T\U]KD.U7T7ZG
MQG&'_+CU?Z']/U%%%?/'VQ:TC_CY;_=_J*TJS=(_X^6_W?ZBM*NBGL5$****
MT*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#'NO^/F3_ 'C_ #J.I+K_ (^9/]X_SJ.N,S"OP!_X.J_^4A?@
MW_LG=E_Z<M3K]_J_ '_@ZK_Y2%^#?^R=V7_IRU.O8R/_ 'KY,^9XL_Y%[]4?
MLQ_P3D_Y1Z? ?_LG?A__ --MO7LU>,_\$Y/^4>GP'_[)WX?_ /3;;U[-7EUO
MXDO5GO87^!#T7Y!11169T!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_,#^SW_RF^\*_P#9
M9X?_ $\U_3]7\P/[/?\ RF^\*_\ 99X?_3S7T.0[5?1?J?$\8?\ +CU?Z']/
MU%%%?/'VQ:TC_CY;_=_J*TJS=(_X^6_W?ZBM*NBGL5$****T*"BBB@ HHHH
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M (Y7"44?5Z7\J^Y![*'9?<=W_P -2?$W_HHWCO\ \']W_P#'*/\ AJ3XF_\
M11O'?_@_N_\ XY7"44?5Z7\J^Y![*'9?<=W_ ,-2?$W_ **-X[_\']W_ /'*
M/^&I/B;_ -%&\=_^#^[_ /CE<)11]7I?RK[D'LH=E]QW?_#4GQ-_Z*-X[_\
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M_P!%&\=_^#^[_P#CE<)11]7I?RK[D'LH=E]QW?\ PU)\3?\ HHWCO_P?W?\
M\<H_X:D^)O\ T4;QW_X/[O\ ^.5PE%'U>E_*ON0>RAV7W'=_\-2?$W_HHWCO
M_P ']W_\<H_X:D^)O_11O'?_ (/[O_XY7"44?5Z7\J^Y![*'9?<=W_PU)\3?
M^BC>._\ P?W?_P <H_X:D^)O_11O'?\ X/[O_P".5PE%'U>E_*ON0>RAV7W'
M=_\ #4GQ-_Z*-X[_ /!_=_\ QRC_ (:D^)O_ $4;QW_X/[O_ ..5PE%'U>E_
M*ON0>RAV7W'=_P##4GQ-_P"BC>.__!_=_P#QRC_AJ3XF_P#11O'?_@_N_P#X
MY7"44?5Z7\J^Y![*'9?<=W_PU)\3?^BC>.__  ?W?_QRC_AJ3XF_]%&\=_\
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M7"44?5Z7\J^Y![*'9?<=W_PU)\3?^BC>._\ P?W?_P <H_X:D^)O_11O'?\
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M ,<H_P"&I/B;_P!%&\=_^#^[_P#CE<)11]7I?RK[D'LH=E]QW?\ PU)\3?\
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ME_*ON0>RAV7W'=_\-2?$W_HHWCO_ ,']W_\ '*/^&I/B;_T4;QW_ .#^[_\
MCE<)11]7I?RK[D'LH=E]QW?_  U)\3?^BC>._P#P?W?_ ,<H_P"&I/B;_P!%
M&\=_^#^[_P#CE<)11]7I?RK[D'LH=E]QW?\ PU)\3?\ HHWCO_P?W?\ \<H_
MX:D^)O\ T4;QW_X/[O\ ^.5PE%'U>E_*ON0>RAV7W'=_\-2?$W_HHWCO_P '
M]W_\<H_X:D^)O_11O'?_ (/[O_XY7"44?5Z7\J^Y![*'9?<=W_PU)\3?^BC>
M._\ P?W?_P <H_X:D^)O_11O'?\ X/[O_P".5PE%'U>E_*ON0>RAV7W'=_\
M#4GQ-_Z*-X[_ /!_=_\ QRC_ (:D^)O_ $4;QW_X/[O_ ..5PE%'U>E_*ON0
M>RAV7W'=_P##4GQ-_P"BC>.__!_=_P#QRC_AJ3XF_P#11O'?_@_N_P#XY7"4
M4?5Z7\J^Y![*'9?<=W_PU)\3?^BC>.__  ?W?_QRC_AJ3XF_]%&\=_\ @_N_
M_CE<)11]7I?RK[D'LH=E]QW?_#4GQ-_Z*-X[_P#!_=__ !RC_AJ3XF_]%&\=
M_P#@_N__ (Y7"44?5Z7\J^Y![*'9?<=W_P -2?$W_HHWCO\ \']W_P#'*/\
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M_AJ3XF_]%&\=_P#@_N__ (Y7"44?5Z7\J^Y![*'9?<=W_P -2?$W_HHWCO\
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M<H_X:D^)O_11O'?_ (/[O_XY7"44?5Z7\J^Y![*'9?<=W_PU)\3?^BC>._\
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M0 4444 %%%% !1110 4444 8]U_Q\R?[Q_G4=277_'S)_O'^=1UQF85^ /\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOV!]:^)GA7QWXJU;QAI]EIEQ#IUUK6GSV[O<75M%*#%';K(0J32$ .""H)R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'NO\
MCYD_WC_.HZDNO^/F3_>/\ZCKC,PK\ ?^#JO_ )2%^#?^R=V7_IRU.OW^K\ ?
M^#JO_E(7X-_[)W9?^G+4Z]C(_P#>ODSYGBS_ )%[]4?LQ_P3D_Y1Z? ?_LG?
MA_\ ]-MO7LU>,_\ !.3_ )1Z? ?_ +)WX?\ _3;;U[-7EUOXDO5GO87^!#T7
MY'\R'[>__)]/QH_['O7/_3A/7DU>L_M[_P#)]/QH_P"Q[US_ -.$]>35_1V!
M_P!VI_X5^2/UK#_PH^B_(****ZC8**** "BBB@ HHHH **** "BBB@ HHHH
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MC"/+<I(Q$<J+RHP00,@ G[*_X+<^ -!TK_@E=\2K^T\-Z5I=ZJ:0RE+.&.:
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M5CXN?]@G3_\ T=-7UU_P;X?\HS?#7_86U/\ ]*6KY%_X-<_^2L?%S_L$Z?\
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M\)?]B#9_^G'4J_.FON>&_P#D64?\)])E?^Z4_0_<[_@G/^RW\./^"6?[ _\
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M.YPCQJHRHX<9)/7'+<3##9WB*5:Z=1KET>I&%JQI9C4C4T<K6\S[N_X*^_\
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MR8W Y7*,,[CX./F\KSEYA5BW2J1LVM;/3_)?>[;'FXF3P>/>)FO<DK-]MO\
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M_P !_P#!"?\ X)Z7%OKVOP:M?12W&I.2!;S>(]5E156&"+).-L<29YVI&7;
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MI\!_^R=^'_\ TVV]>S5Y=;^)+U9[V%_@0]%^1_,A^WO_ ,GT_&C_ +'O7/\
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MHQE\2N6M9UN]\1ZE+>:A>75]>3G=)/<2M+)(?4LQ)/XU5HHJR@HHHH ****
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MJ$'.#>C7;LUY?<?"8S)<13J-4X\T>EOU/T1=_+1F.["C)P,G\A7\Y7_!5O\
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MXL_Y%[]4?LQ_P3D_Y1Z? ?\ [)WX?_\ 3;;U[-7C/_!.3_E'I\!_^R=^'_\
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M'_P5&_X)(_\ #MCPGX1U3_A8'_":?\)3=W%KY7]A?V=]E\I$;=G[1+NSOQC
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M=5,NP^6Y6VMHT9-R[9$DA!PV5.[YES7$,)590I4I2C"7*VK.S_PWYFO.Q/\
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M7]BO]K*QL_!-L^G^&?%FD)J\-@9"ZZ?-YLD4L498EO+^17&X\&0@< 5]*_\
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M J"PV<]/B.E*49.G)4Y/E4]+-[;7ND^]C..:P;3Y7R-V4NE_SMYGY75]U?\
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M.>PE"OSP<945>479]&]&FUT.RGF47&IS1:<%=K3M?='R;17[$?MV^+_V1O\
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MH^52=K7?3>_SL84\WC+DDX-1D[)Z6N?'G_!+#_@EA_P\P_X3O_BN_P#A"?\
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M9]VL=U;B=4#S111R9@6"$,JM(RN[LP(^5@$-'_9,_9W_ ."RO[+7BCQ-\'?
M\/PK^*'AAF3^S[-8[6W^T%2\,4L:8@:"8*RK(JHZ,I)X4J^O^LU&WMO9R]E>
MW/I:][7M>]K];&G]KP^/E?)>W-T_SMYGX_T5^HW_  ;=?L\^!?C9-\:H_'7@
M;PGXNDT<Z(MHNO:-;W[6)?\ M'S @F1MF[RTW8QG8N>@KKOV4/B?^QCIG[3\
M?[/^F_!NV\4R:E?3:&?&FO6-O?G4KX;U8QJP9H(F<%8WAV8RAVJ,L+Q/$"I5
MZM"%*4G32;M:UFKWU[=MV56S10J3IJ#;C9NUMK7/R+HK]>?VI_!_[(__  2%
M_:'CL]7^$EY\2-4\:C^VH]/U%H;VQ\,:>S-#LABN,K*6DCG91("PV@;Q@$^?
M?\%WOV!_AC\'OA!X!^,7PLT:U\.:3XJO8]/O+.RS'9W/GV\EU;SQQ'_5G9%(
M&"X7&SY0023#\14JM6G#V<HQJ?#)VLVMUO==O/TU"EFD)SC'E:4MF^I^8]%?
MIG^PO^PI\&_V;OV$6_:7_:$TNX\4VNI8;0O#R?-&T;2&*',>Y1+-*P9@';8D
M8#$9SM]1^!7A']EC_@M1X1\7>%/#/PKL_@S\0M#LA>V=UI5G;VX6/<$68+;A
M(YE61E62-T!PZ[6R<J5N(J5.4I*G*5.#M*:M9/KI>[MU:05,TA%MJ+<8NSET
M3_-GP-_P3)_8$_X>,_'G5O!'_"6?\(;_ &7H$VN?;?[+_M#S?+N+:'RO+\Z+
M&?M&[=N.-F,<Y'FG[5'P-_X9F_:+\9> /[4_MO\ X1+5)=-^W_9OLWVO8<;_
M "][[,^FYOK7ZF?\$ ?B1I?@#XT^+/@5J7PMT'2/B)X%L=6EU;QG&T1U&]6+
M4K:%K%L0"3R@\BD$S,I\E?EZ$?,?_!<']JKP;\5?CIXD\!Z/\(_#/A'Q)X/\
M3W']I^++)H#?>(\(4/G;;='Y8AOFEDY'XUAA\UQ4\VGAN6]/E36L=/[W=I]M
M_(RI8VM+&RI6]VWE]_?7L?!]>_?\$Y=4^ ND_&[5)/VB--O-4\%-H<JV45LU
MXKKJ'VBW,;'[*Z28\D7 Y.WD9&<8_7S_ (*&?L6?LK_!C2?"OQ(^(?A'PKX1
M\&^$9KB*72?#VAQ6,GB:]N!']FAD%LJ/*J"*9PA(')+$('!^=OV!+C]GW]N/
M_@J]XDG\'_"WPPOP[M?ADWDZ'J_A>R2WBOHM0LT:X%N \?F%),>9]XAF!/)K
M!\24\5@YU8TYQBDVY)VLT]E+OU,WFL:U"4E&25G=K2WDGW/S(_:;N/ ]U^T!
MXMD^&L$MMX"DU&1M"BD,Q>.U/W%/G$R9'^V2?>N%K[VTC_@GAI_[8?\ P6;^
M)'PUTNVA\+>"-!UF]OM172;:.WCT^PB=5$4$8 1"\CQH !A0Q;!VD5] ?'+]
MJ3]B;]B_XS77P='[/VE>*+'0YUT_7==?3H+NXLYA@2".6XW7$K)T8AT^8,%S
MU/>\ZC#DH4(2J3Y5)I6NE;JVUJ_Q.G^T%'EITXN3LG\O-]S\B:*^X_\ @K7^
MQ=\&_A3\3_"6M_!'QIX5OO#GC:Z-G=Z19:W'J T*?*;9 5=W6!PQ.'/R%" <
M$*OVO^TK^R[\(?\ @E!\'/"EUH/[+T?Q\DNA+;ZSJ^I(+MK-D$9$TXD@N%C\
MTNVT)&J+Y9!()&74XBHJ%)TX.4JE[1TB]-[N327Z]!RS2"C!QBVYWLM%MO>Y
M^(M%?=G_  4)O?V3?C5^S/I/C?X4PV_PV^*L,D7]I^#([>Z"RQL_ER1GY/(6
M2,XD5T9 R;@REMH7X3KU,%B_K%/G<'%W::DK/3\&NS6AV8>O[6/-9Q\G_7XA
M11178;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5]__ /!*C_@D'X?_ &K?A%K'Q<^*WB*\\.?#?1FN!%%:2+!-=K;I
MNGN))G5EC@CP1P"S%'Y0*"WP!7ZT?\$8O^"DGPG7]DB[_9[^,6IV6@V+B^T^
MSGU&0V^G:E87S.TUO).N/)??--EG91M<8<$8'@\1UL73P;EA+WNKVU:CU:\_
M^'/-S2I6A0O0O>ZO;>W6Q8^&GP#_ ."<'[47C*U^'GA&\UW2/$U_*+73]0^W
M:I;2:G*3@+&UUN@WL<;5:-2Q( !/%?%O_!4G_@F]J7_!.3XR:;I/]J2:_P"%
MO$UO)=Z+J4D/E2,(W"RP2C[OFQ[HR2O!65#@9*C] O%/_!NO\.?&DEIXN^"/
MQ>UK09+>1;S3;@O#K%K'<1L'C:&>%HG0!@IW;I&4\\\"O@C_ (*@?!7]H;X'
M?$;1?#7QL\5:]XXM6\Z7PWJ4VJ3:C9W:L467R?,^:-\B,.C*K<*>5*L?'R7&
M4YXM1PV)E*-GS0J7YK^3:^]+S^7!@,1&59*E5;5M8RW^1\K45^OUS^RA^SS_
M ,$;_P!E3POXK^,G@6'XI?$[Q5M4:=>PI=0)<>6KRPQQR9@6&'< TC*[LS @
M8("\I\4_AY^R3_P49_8V\1>./ MGX1^!?Q,T$7#0:3/J%KIOVR:*,2B#[.KK
M'+#*"%26.-65\C'RLK>G#B2G-\\:<G3OR\]E:^U[7O;SL=D<VA)\R@^2]N;I
M_G;S/F3]BW6_V3K']D[QG;_&31]2O/BM+=WW_"/7,+ZD(H839PBVW"WE6+BY
M\XG>I.#SD8%?(]?K#_P1P_9S^'OQ/_X)2_&3Q%XE\!^#?$7B#2]4UN.SU/4]
M$MKN\M%CT>TDC6.:1"Z!79F 4C#,2.237E7_  2<_P""=_PY\7_L_P#B[]H;
MXY>==?#WP>9A9Z4CLJWQ@4-++(%(9QN98TC!&]]P/& 8IYO0H5,1.;D^625F
M[W;V4%TOV)CCJ=.564KNS2M>^KZ170_/.BOU]_9L^)/['?\ P5,\:7OPCM_@
M7:_#76KFQF;0=3L+2UL[JX6)2Q8R6X!\]47S-L@E5@KY8X^;YN_8?_8LM/@K
M_P %OM#^#OCS2=)\6Z7I-[JD,D&J:?'<6FJ6_P#9%U<6TSP2!D^9?*D .=K
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M_@ZK_P"4A?@W_LG=E_Z<M3KV,C_WKY,^9XL_Y%[]4?LQ_P $Y/\ E'I\!_\
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M@Y-K]RFI;ZWBEIIY=;&L<#43H-M?NTT_N2TT/TO_ ."&_P#RAS^.7_86U_\
M],EE7#_\&Q/Q[T/P_P"*_B+\.;^XCM=<\1"UU?2E<@?;5@659XUR>7571PHR
M2HD/ 6O@CX&_\% _B[^S;\'-<^'_ (+\7?V+X1\237$^I6']EV5Q]I>>!+>4
M^9-"\B[HHT7"L ,9&"23Y+H6O7WA?6K74M,O+O3M1L95GMKJUF:&:WD4Y5T=
M2&5@1D$$$&HJ</SK1Q4*DDE5:::Z6[[=299;*:K1D])M->5NY]FZ1_P0D^.-
MQ^U='X$NO#-Y#X574Q'-XK5T.G_8-^3<(Y/,ACY$6-^[@@<D4_VTO@#\/_\
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MBO3OV8/VQ_B1^QGXGU+6/AKXC_X1O4M7M197<W]GVMYYL0<.%VW$<BCY@#D
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M9:UX/TK2]3\'^.-?N-:769]4M[>/3OM4K32K-$S^<?+=W'[M'W  CDD#X_\
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MP6#^+WBC5+O0KC4/$GAS59VFTI)(;&\D.IV!+VZ3$R;&52ZAR6V\G'./F?\
MX+&_LT^._A?^V=\1?&&O>&=2TWPOXH\2SOI.J2H/LU^'7S%",#R=H)(ZC!!P
M:^:?A1\7?$WP+\=V/B?P?KFH^'=?TTL;>^LI3'+&&!5AGNK*2"IR""0017H_
M[3G_  4.^,7[9'A?2]%^)'C%O$FFZ+<&[LX3IEE:>5*4*%BT$*,QVDCYB>OK
M7KT\KKT<Q^LT7'D<5%IWNK=K:=MSNCA*D,5[6%N6R3[Z=C]+?^#HJYD7X/\
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M_P#GQ1RVK[6,WRJSO=*S?DUMKU/.:***^RB>]$****HH**** "BBB@ HHHH
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M44 %%%% !1110 4444 %%%% 6"BBB@ HHHH **** L%%%% !111187*%%%%
M6"BBB@84444 %%%% !1110 4444!8**** "BBB@+!1110*R"BBB@84444!8*
M*** "BBB@ HHHH **** L%%%%%A<J"BBB@84444!8****5B>4****7*'*%%%
M%58=D%%%% PHHHH **** L%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 6"BBB@ HHHH"P4444 %%%% !1110%
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@+!1110 4444!8***
M* "BBB@ HHHH **** "BBB@ HHHH **** L%%%%*R)Y0HHHICL%%%% [!111
M0 4444!8**** "BBB@+!1110 4444!8**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#]"_P#@VK_Y/I\6?]B)>?\ IPTZ
MOV]K\0O^#:O_ )/I\6?]B)>?^G#3J_;VOQ/CK_D:O_#$^#X@_P!\?H@K^8']
MGO\ Y3?>%?\ LL\/_IYK^GZOY@?V>_\ E-]X5_[+/#_Z>:X,AVJ^B_4_+>,/
M^7'J_P!#^GZBBBOGC[8M:1_Q\M_N_P!16E6;I'_'RW^[_45I5T4]BHA1116A
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 8]U_Q\R?[Q_G4=277_ !\R?[Q_G4=<9F%?@#_P=5_\I"_!O_9.
M[+_TY:G7[_5^ /\ P=5_\I"_!O\ V3NR_P#3EJ=>QD?^]?)GS/%G_(O?JC]F
M/^"<G_*/3X#_ /9._#__ *;;>O9J\9_X)R?\H]/@/_V3OP__ .FVWKV:O+K?
MQ)>K/>PO\"'HOR/YD/V]_P#D^GXT?]CWKG_IPGKR:O6?V]_^3Z?C1_V/>N?^
MG">O)J_H[ _[M3_PK\D?K6'_ (4?1?D%%%%=1L%%>C?L?^!-)^*7[6OPM\,Z
M]:_;M#\1^+M)TO4;;S7B^T6T]Y%%*F]"'7<C,,J0PSD$'FOUX_;&_8L_8'_8
M0_X1S_A8WP^U'3_^$J^T_P!G_9=6URZ\S[/Y/F[MET=N//CQGKD^E>-F&=4\
M)6AAW"4I23:44GMZM'#BLPA0G&FXN3EM97_4_$&BOV0^&?\ P3D_8A_X*0^#
MM9M?@CJNL>%?$FEVX:1(;N]DN+,EF"2R6U\S&6(G /E.!@J-R,:_)WX]?!C6
M/V=OC1XG\#:\L7]K>%=1FTZX:(DQRE&($B$X.QUPRY .&&0.E7E^<4<7.5**
ME&<=XR5G;OU'A<=3KR<$FI+=-69R-%%%>L=H445U7P*G\+VWQN\&R>.(9+CP
M5'KEDWB"*,R!Y=/%PAN5'ED29,.\#80WH0<5,Y<L7*U_04G97.5HKZ._X*1Z
MK^SOJWQ#\.R?LYZ;?:7X>73F758[EKYF:Z\UL,/M;NV-FT?*0..F:^<:SPU;
MVU-5.5QOTDK->J(HU.>"G9J_1[A1116QH%%%% !17V5^TW_P21_X9S_X)]^"
M?CM_PL#^V/\ A,+32;K^P_["^S_9/M]L)]OVC[0^_P O.W/EKNZ_+TKXUKEP
MF,HXF#G0=TFULUJM]S&CB*=9<U-W5[?,**^I/^".?[.?@W]JG]N71/!WCW1_
M[>\.7FG7T\UI]KGM=[QP,R'?"Z.,,,X#8/?-?9?_  6G_P""1'PM_9R_9%7Q
M]\)_",OAV\\.ZK -9VZG>7JS64V8@Q%Q-)M*S-#RN.';/08\_%9[AZ&-A@:B
M?-*UGI;6Z76^Z['-6S&E3Q$</*]Y?=K\S\D**]\_X)C?LOVO[8'[;O@;P3JE
ML;KP_<737VLQ^:\0DLK=&FEC+H0Z^9L$0*D$&08*]1^DG_!63_@DW^S_ /LS
M_P#!/_Q]XW\$> ?[%\4:+_9WV*]_MS4KGR?-U*UAD_=S7#QMF.1U^93C=D8(
M!!CL^P^%Q=/!U$W*=K6M97=E?5?DQ8C,J5&M&A*]Y6V\W;74_%^BBBO:/0"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO7/V$OV6/\
MAM?]JOPK\,?[>_X1G_A)OM?_ !,OL7VS[-Y%G/<_ZKS(]V[R=OWQC=GG&#G6
MK0I4Y5:CM&*;?HM634J1A%SELM6>1T5[=_P4(_8Y_P"&$/VF=2^'7_"1_P#"
M5?V?:6UU_:']G_8?,\Z,/M\KS),;<XSN.?:O$:5"O"M3C5IN\9*Z?DQ4ZD:D
M5.&S"BBBM2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HKH/AK\)O%7QF\0MI/@_PSX@\6:LD+7#66C:=-?7"
MQ*0&D,<2LVT%E!., L/6N\_X=_\ QY_Z(E\7/_".U'_XS6-3$4H/EG))^;1G
M*K"+M)I'D=%=Y\2OV6?B=\&/#RZMXP^'/CSPGI,DRVRWNL^'[NQMVE8$K&))
M8U7<0K$+G)"GTK@ZNG4A-<T&FO(J,E)7B[GWW^Q_XF\,_L]_\$A?%7Q3F^%G
MPJ^('BN'XF_V%'+XQ\.QZJL=JUA:2;%)*NN'9B &QEVR#7GTO_!4#PGXQD2U
M\7?LL_L[76CL?WL?A[0YO#]XP[[;F*5F4^AP<5T/@K_E7W\7_P#998__ $VV
ME?$E>%@\%2KU*TZJ;:FU>[5E9;6://H8>%2524]^9]7V79GTW^VM^RIX+T/X
M0^$_C9\'KC5IOA;XVNI=,GTS4V\R]\*:I&NY[*60<.K*&>-B=Q53G/#-\R5]
MG?L]Q1ZY_P $3?V@H+Z3$.A^+]"U'3$920;J62."7!Z ^3G/L/<5SOP/_:CT
MW]G']G#PSI_P;T&WU3XW>(+R\N/$VNWGAU-2NM&MD8):6M@)5D0!UW22.(]V
M[ R0%QOA\55A"=*SFXS<4V[:64DY.SV3M>SN_-E4:TXQE#XFI6U[6O=OR3M<
M^4Z]W_9X_9=T+XM?L;?'[XC:E>ZM#JWPIBT)M*MK:2-;:Y:_O9()#.&1F8*B
M94(R\GDD<5]<^$=,^-'[=?[*?QPN?V@O =RT?A+PA=^+/#7C+5/"4>BWT%[:
M'S6MHIHX8A-'+&LH92& V#D?+BO^PA_P4&^+V@_\$O?C]/:^+O)E^#MGX6M_
M"#?V79-_9$<^H2Q2CF$^=N1%&9MY&,C!R:YL5F=:5)JBES1G!.TKJSE'9\O6
M]G=)K5ZZ)YU<94E#W$KJ44]=-6NMNNST5O,_->BOH/\ 9\_:&\)^)_VG?%'Q
M2^.L/_";:K_9U[J]CITNGK]C\0:YM M8[J.$(BV^XEF  4[ "I!(/O'P1_;;
M_:[^,'BS2M/L_ ,GC;P3/=H9_#*_#BU;0GMV9%>-BEJ/+CV@#>9!C.2>3GT,
M1C*U/:"T2;;E97[1?*[V\[+].FIB)QVBM-[NR]%IK^!\"45[]_P5(^ >B_LQ
M?M\_$CP7X=@6UT/3;Z&YL;=6++:Q7-K#=+$I/.U//V#.>%')ZUX#79AZ\:U*
M-:&TDFO1JYO2J*I!5([-)_>?JE_P7I_9#^''AWX?P^)?ACX5\.^$[[X9ZK!H
M7BBPT?3HK-9H+ZV2>TNW6-0& </%O;YF9R.0HK\K:_8S]J;Q'8^,O^"P7Q4^
M">O74=OX?^.W@BS\/+)+GR[35([43Z?<$#J4F4J!C[T@K\VOV0?V4-1^/7[:
M_AGX6ZI;RV,C:TUMKJO\C6-M:EGO-QXVE8XI1SCYL"OG>'\4Z6"M7DWRQ4[O
M^5J[^YJ7RL>7EE;DP]JKV2E\FK_@[_@?<OA/]D+X?_"W_@BIXY?6/"OAV_\
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MY)R/^"M/P5O/#GPX^!?Q*\1>"K'X>^//B5HVH1^*-&M-/_L]#=V4\2K=-;8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-_PC/]L?VE_Q,[.S^S>?]A\K_CXECW;O)D^[G&WG&1G\C?\ @G]_R?E\$O\
ML?M"_P#3C!7ZQ?\ !PK^V-\3/V3/^%0_\*Z\7:CX5_X2#^V?[0^RI&WVKR?L
M'E;MZM]WS9,8Q]XU\3GGM_[9PWU:W/RRMS7ML[WMKM^)\_F'M/KU+V5N:SM?
M;9]C%_X(8_\ !+WXJ?L7_&;Q9X^^)VGV/A>&ZT!]%M=/_M&WNY9=]Q!.\SM
M[QJJBW &6R?,/ Q7&_L6W7P[_;P_X+J_';5M4\-^$_&OA.3P[<?V?'J.FP:A
M93/:7&EV:W<:2JR[G5'8.!DB5NS$5^??Q;_X*1?';XZ>%;C0_%/Q1\6:EH]X
MGEW-DMR+>"Z3NLBQ!1(I]&R.GI7U1_P;*?\ )^7BW_L0;S_TXZ;6.89=BJ5'
M$YAB9KVDH67+=)*Z[Z]#/$86K"G5Q-:2YFK:7LD>W_M&6G[%_P#P3J^*'C[0
MO%GA&T\8?$;Q1/>Z@+.WT"&[L/"L%UN>SMHX)"L$ 2-HV&Q6DYW<*44>!?\
M!%W_ ()G>"OVD_"/BSXP?%QI'^'7@B62&.R\YH8KV6&%9[B6<I^\\F*-D.U,
M;V8C)",K?/'_  57N9+K_@HS\8FED>1AXEN4!9BQ"J0JCZ   #L !7Z"_P#!
M"OQ9I/[2'_!-_P",/P&AU&WT_P 67D&JQ(LIZVFHV:VZ7 ')8)-O#X!V@Q]W
M JL5&MA,J]O"I)RGR<TF_A3WY>V]AUHU*.#]I&3O+EN^R\NQE_ K]J?]B?\
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MWUXTN/"_@^Z\0:#X^\176MV.L0R(+*V2[G>9EG<D>48F=E(89(4%=V1GB/\
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M%"22-YJ1KO5P1&>!C(\'_P""AW_*Q'\-_P#L9_!__I1:T?\ !S]_R<U\-_\
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M'Q#X'\"_%?4_A#?:OI*3ZM'!X*@OTELDF"(OVDW4C ;]A*JH!PI)X*Y^AO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '2?"[XR>+O@AX@FU;P7XH\0
M^$M4N+=K26\T;49K&>2%F5S&SQ,K%"R(Q4G&44]A7>?\/"OCW_T6SXL?^%;?
M_P#QVO'Z*QJ8:C-\TX)OS2,Y4H2=Y)/Y'?\ Q,_:N^*'QI\.+H_C#XC>.O%6
MDK,MPMEJ^NW5[;B500K[)'9=P#, <9&3ZUP%%%73IP@N6"27EH5&,8JT58^^
MO@!\*/%'QE_X(-^+M%\(>&]>\4ZN?C L_P!BTBPEO;CRUTVSW/Y<:LVT9&3C
M R*^>O!__!,7]H;QQK<6GV?P9^(EO-,0H?4-%FT^ 9]99U2-?Q85P7PP_::^
M)'P2T>XT_P %_$'QQX1T^ZF^T3VVBZ[=:?#-+M"^8R1.H9MJJ,D9P .U7/&O
M[7_Q:^).D-I_B+XH?$37[!LAK;4O$EY=0MGKE))".P[5Y5/"XNE.?LG&TI.6
MJ=U>W9KMW..-&O"4N1JS=];GT3^V)JWA_P#8\_8MT3]G#1M>TGQ-XUU'7SXK
M\?WVER^?9V%PL0BM].CE'$A1<-)@?*Z=<L0/3?%NE_&+PO\ L/?!&X_9:LO%
M3>$]8T#/B^^\#V;R:U-XA$C?:8[Q[8-<JB J(\D+M.<?=Q^<M=1\,_CAXT^"
MUY+<>#?&'BCPG<3C$DNC:K/8/(/<Q,I/XU-3*Y>SBHM2DI.3YE=2;5M5TMTW
MM;KN34P;Y59W=VW=:-OR_+L?H?\ L&? 3XL:+X2^/3?$Z\\5/X\\;_"'Q#I_
MAKPIK-Q/=Z_J:M&GF3?96+31YD$4:!PK2L[[0VPFO(/V!? 6N>+_ -@;]L3P
M+I>C:IJ'C2YMO#,D6AV]H\FH2"UU.<W($(&\M&"-RXR.F,U\EZ9\9/&&B^/U
M\66?BKQ):>*58N-9AU.:/4 Q&"?/#>9G'&=U1^%/BUXJ\!^-)/$FA^)O$&B^
M(I7>1]4L=1FM[UV<[G)F1@Y+'DG/)Y-92RRLU-N2O)P:TLDX-.V^SLO/?T,_
MJD_>U6KB]NL6G;TT/KW_ ();_##6O#FH?'33])T!+;]HKPWX>B;P7I.MV"+=
MVDJS?Z>T4-P.+R.'88U*D\MVSG&D^$_[5OQD\2&^^+>J?%[PMX,TMA<:YKGC
M.XOM/TW3K16S(46<JLCD9"0Q*S.Q"JIS7RGJ_P 1/$&O^-9O$E_KFL7WB*XG
M^TRZK<7LDE[++_ST:9B7+?[1.:UOB/\ M ^/?C'9VMOXN\;>+O%5O8@+;Q:Q
MK%Q?);@= @E=@N,]JUE@:SK.JG'WK7;5W&R2]UWVZVZ-MZEO#SYW-6UMNKM:
M=/S]3Z:_X+R>%M4L?^"E/C?7KC3=0M]#\30Z9<:1?RVSQVVJ1II=E&[P2$!9
M K@JQ4G# @X-?&];GB_XG^)OB%8:5:Z_XBUS7+70H/LNFPZA?RW,>GPYSY<*
MNQ$:9 .U<"L.N[+\/*AAX4)._*DK^FB_ Z,+3=.E&F^BM]Q]W?\ !=SQ?J'P
M_P#^"L-_KVDW#VFJ:+::/?V<ZG#0S10HZ,/HR@U[=^TLOA_X'?!SXI?M7^&[
MBQ@N/VCO"^GZ+X;MH7#R:7J&H*QUKDC*O&+9R'7^)W&17Y=^.OB)X@^*/B%M
M6\3:YK'B+5I(TB:]U.]DO+AD10J*9)"6VJH  S@  "EU/XB^(-:\&:;X;O->
MUF[\.Z+))-I^ES7LDEE8/(<R-%"6V1LYY8J 6/7->9_8LO8T*7-\"49?WHJS
MM\VE\K]SD^H/V=.%_A23\UII]Z7RN?8/_!.S_E&;^VE_V"?#G_I3>UU'P TK
MXB:+_P $N_#>M?LU66J7/CJX\1W]M\1;KPY9B?Q';)D&PBBV!KA;9HAN)C ^
M?/;=GX5\/_$3Q!X3\/:QI.EZYK&FZ3XBCCBU6RM+V2&WU-(V+(L\:D+*JL20
M'! )R*D^'_Q0\3?";7%U3PKXBUSPSJ2C N]*OY;.<#_?C96_6KK97.<IS37O
M24K-73M%1L_NOY.W8JIA')R::U:=GMHDK/\ /[C])O\ @DU\)_C1HO[>?@GQ
MI\<]:\;:#'.]_9Z-9>,[VY&HZ_>R64ZE(K:X;S=B1M([2LH0$(N[<X%>(_\
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MXJ>4RIJ-./+RQ:L^7WK)[7V\K[VZ7U.>&#<;05K+RUMV_P"#_P .?5?[:_\
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MFG\I7W<;2V<CBOC71M:O/#FL6FH:?=7-AJ%A,EQ;7-O*T4UO*C!DD1U(*LK
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MS<DY-:.Z=M=[VO\ AZ&31117LGH1"BBB@84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z%_\&U?
M_)]/BS_L1+S_ -.&G5^WM?B%_P &U?\ R?3XL_[$2\_].&G5^WM?B?'7_(U?
M^&)\'Q!_OC]$%?S _L]_\IOO"O\ V6>'_P!/-?T_5_,#^SW_ ,IOO"O_ &6>
M'_T\UP9#M5]%^I^6\8?\N/5_H?T_4445\\?;%K2/^/EO]W^HK2K-TC_CY;_=
M_J*TJZ*>Q40HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,>Z_X^9/\ >/\ .HZDNO\ CYD_WC_.HZXS
M,*_ '_@ZK_Y2%^#?^R=V7_IRU.OW^K\ ?^#JO_E(7X-_[)W9?^G+4Z]C(_\
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M)Y8+$G"8&23WKP_Q/XDO?&7B34-8U*<W6HZK<R7EU,5"^;+(Q=VPH &6).
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MG%66BT79=EZ!'#P3345IMIMZ'LNE_P#!0/XNZ-^RZWP7MO%WE_#5X98#H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****!<H4444!
M8****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/]X_SJ.N,S"OP!_P"#
MJO\ Y2%^#?\ LG=E_P"G+4Z_?ZOP!_X.J_\ E(7X-_[)W9?^G+4Z]C(_]Z^3
M/F>+/^1>_5'[,?\ !.3_ )1Z? ?_ +)WX?\ _3;;U[-7C/\ P3D_Y1Z? ?\
M[)WX?_\ 3;;U[-7EUOXDO5GO87^!#T7Y'\R'[>__ "?3\:/^Q[US_P!.$]>3
M5ZS^WO\ \GT_&C_L>]<_].$]>35_1V!_W:G_ (5^2/UK#_PH^B_(****ZC8*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8;]G#X%?$O\ ;EU[5?'W[1L?PV\12:?8QR:)_P ('J&L&*-8%".9X75#O'.
M..YS6.;+#O&45B8<T>6>G*YZWAK9)_?8G&^R=>G[6/,K2Z.7\O1)GC?[+O\
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MD 9Y(I2DDKL&[*[,JBOKG_AQ+^U7_P!$L_\ +ET?_P"2JS?&7_!%/]IKX?\
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MX<?L\>&_ >J7G@W4M6^#GAR]U77=(F:TU2_@"3+;VOVA")$AC=9WVH5#M/\
M-NVKMY'P#\9/$W[8O_!)[X_1_$K6M2\9:C\(]2\/ZQX:U75KAKO4+)[Z[DMK
MB,SR$R-&8T/REB 6]@ Z695W2AB)P2A)J.[OK+E3VMN]K[:^0X8JJX1JN*Y6
MTM]=7:_W_P!=#X@TC1[SQ#JD%CI]K<WU[=.(X;>WB:269CT554$DGT%=7XN^
M!7CGX.:CILOBSP;XL\*K=2QM;OJ^DW%B)LD$%#*B[LCGBOI[X<>,[S]@K_@F
MIX=^(7A%5TSXG_'#7=0L+3Q$(U-UI&BV&(9H[5B"8I);AOFD7G:,<%58<'\
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M_'GPNT.UU3Q-X)\7>'=-O@&MKO4]'N+."X!Z%'D0*V?8FOM#X#_'[4OV;O\
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M_38*^;RC&)8/!^U3DY3:3YFK:O5]_1GEX*NE0H<]VW)]?/\ 'T/QKHK]J?\
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MQUKW@/2/B#XPL[^YL?"]EJQS8V+RQQO<73I@AF18HU7C(,F01R:,1Q D\/\
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M&_LE>%?VP?V6]/M/A_?:+I_QS\.ZM.FIZ+JVLI8GQ3I\N&@EM#.ZP^9"V49
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M;]%1_94/W<7\,8RC;NI<MW?Y?B1]3C[J>R35N][?Y?B?9WQ4_P""5?B;X_\
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M_5'[,?\ !.3_ )1Z? ?_ +)WX?\ _3;;U[-7C/\ P3D_Y1Z? ?\ [)WX?_\
M3;;U[-7EUOXDO5GO87^!#T7Y'\R'[>__ "?3\:/^Q[US_P!.$]>35ZS^WO\
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MA!K#"9'.G3Q%.I)?OET5K736WSTU,Z.7RC&K&37O]E:VEMC]./\ @X4_8?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/I^-'_8]ZY_Z<)Z\FK^CL#_NU/\ PK\D?K6'_A1]%^04445U&P4444 %%%%
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MGHD[]'>^B\U;7U1/-[SC;_+K_7W!1116A04444 %%%% !1110 4444 %%%%
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M0I!.*\O$U%5KK&0VI<MO^WOC_P#)91?R..M-3J>W6T+?C\7X-,O_ /!*9O\
MA4OA/X^?&:5)%_X5QX$GL=-G' AU34W%K:G/_?P8]_I7SMX>_9K\=>+_ (=Z
M/XJTGPW?:KHOB#7SX7TY[(I<3WFI")9?LR0(QF+%'4@[-IS@$G(KWOQ/-_PI
M#_@CGX9TT'R=4^-WCFYU>0@X:73-+C%NB$=U^U.S G(R..E>@_!;X[:S^SM_
MP0[OM>\,DV'B34?BS<Z)9:Q$=MUHZ3Z1"TTD#9RDCQ0O%O R%E?!!P:T>)J0
MG.O32;G-05^R5OPES?(KVTHRE4@M924?DM/SN>7?L_?LY_M(?L@?MI>"=/\
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M(W_M%:Y\$/V\? .FV=U--H/C/6+;1=5TQV+6MWYTBI#*R=/,AF,<J/C<I3J
M2#YC_P % ?\ D_+XV_\ 8_:[_P"G&>M</B,0L4\/6LURWNDU?6VS;M][-*=6
MK[;V52VU[K3KVNSR.BBBO4.P**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OL[_@FAMU_]CG]KSP]8PM+XBO/!-IJ=OL=A)]CM)Y&NP%'4%9(\_3'
M<U\8UZE^QM^U3K'[&WQ^TCQQI%K;ZE':A[34M,N/^/?5K&4;9[:3@C#+T)!
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MV8VWPTL!VW&[RV_? QC!.6X&35YU3D^=07_+FJM%_@LOSLO4>/B]>5?8FO\
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M_99X?_3S7!D.U7T7ZGY;QA_RX]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/\
MCY;_ '?ZBM*NBGL5$****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#'NO^/F3_>/\ZCJ2Z_X^9/\ >/\
M.HZXS,*_ '_@ZK_Y2%^#?^R=V7_IRU.OW^K\ ?\ @ZK_ .4A?@W_ +)W9?\
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MP39_;.G@D>&:'2_#<D<B':R,+F]((/8@U\05]M?\$ZS_ ,:SOVTO^P3X<_\
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M_MU:K\TODSTK_@N'X9L?&O\ P5XFT?5-7M?#^EZI#HMI>:I<Y\G3H7BC5YW
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M49\UH-/WN6RLGU7Q/I?:UV]3AC2JRE",K^Z[ZVZ+NM_ZZGA%?7WP9\=_#O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444"Y4%%%% PHHHH%9!1110.P4444"Y4%%%% N4****7*@Y0HHHHY
M4'*%%%%.P<H4444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?H7_P;5_\
MGT^+/^Q$O/\ TX:=7[>U^(7_  ;5_P#)]/BS_L1+S_TX:=7[>U^)\=?\C5_X
M8GP?$'^^/T05_,#^SW_RF^\*_P#99X?_ $\U_3]7\P/[/?\ RF^\*_\ 99X?
M_3S7!D.U7T7ZGY;QA_RX]7^A_3]1117SQ]L6M(_X^6_W?ZBM*LW2/^/EO]W^
MHK2KHI[%1"BBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH Q[K_CYD_P!X_P ZCJ2Z_P"/F3_>/\ZCKC,P
MK\ ?^#JO_E(7X-_[)W9?^G+4Z_?ZOP!_X.J_^4A?@W_LG=E_Z<M3KV,C_P!Z
M^3/F>+/^1>_5'[,?\$Y/^4>GP'_[)WX?_P#3;;U[-7C/_!.3_E'I\!_^R=^'
M_P#TVV]>S5Y=;^)+U9[V%_@0]%^1_,A^WO\ \GT_&C_L>]<_].$]>35ZS^WO
M_P GT_&C_L>]<_\ 3A/7DU?T=@?]VI_X5^2/UK#_ ,*/HOR"BBBNHV"BBB@
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M.\,">N:J>.O&VJ?$KQMK'B/7+MM0UKQ!?3ZEJ%TRJK7-Q-(TDLA"@*"SLQP
M ,\ 5E45I[./-S6UV^17LU>_4Z[Q9\>/%GCGX2^$O NJZLUYX5\"O>2:%8FW
MB7[ ;N02W&)%42,'<!L.S 'IC)H\;?'CQ9\1?AGX.\&ZSJS7GAOP EW'H%E]
MGBC73Q=2B:X^9%#N7D )+EB, # XKD:*2H4U:T5HVUIU=[OU=W=];ON'LH]%
MY_-]?Q9[#I'[??Q>T7]G6\^$\/C2\D^'][;M:2:3<6MO<!(2XD,<<LD;2QIN
M .U'4<5R_P !_P!I?Q]^S#XGEUCX?^+-:\*ZA<((YWL9RJ72C)"RQG*2*"20
M'4@'FN&HJ%@Z"4HJ"M+5Z+5^??YD_5X6:LK/?3?U/9_VCO\ @H=\:?VM=(&G
M?$#X@ZUKNE[UD.GJL5E92,N-K-!;I'&S#&064D'GJ:X;X4?'CQ9\$+;Q1#X6
MU9M)C\9Z'<>'-9VV\4IO-/GVF:#,BL4#;%RR;6P, C)KD:*(82C"G[*$$H]D
ME;[M@CAX1CR)*W:V@Z"=K:=)$X>-@RDC."/:O6$_;H^*L?[3\_QF7Q9)_P +
M,N%97UK[!:[L&U^R'$7E>2O[CY!A!CJ,'FO):*JIAZ<_CBGHUJKZ/=>CLKKJ
M5*C&7Q*_3Y/<*Z_XJ_'CQ7\;[?PO#XJU9M6C\&:);^'-'!MXH39Z? 6,4&8T
M4N%WMAGW-S@D@"N0HJW3BVI-:K;R'[--W9^D7P:\#?M$>#?#VGI^Q]\7KCQU
M\.=4L5G72;G6M+CU'P[,\6;B"XL[U@L#*XD(>(;2"&!R=QX_]I_Q=KG[-O[%
MGQ \)?$KQU9^,/C=\<M>TZYUVRM]7CU9]$TS3F:6(7$\3LBRM,P"Q*2 @&,8
MQ7P;17D1RC]XI2::NGI%*3L[KFE?76ST2V.#ZC:5Y-6NGM9NVJN^NNNR"NY^
M G[2WCW]E[Q;)KGP_P#%6K>%=3FC$4TEE+A;E =P22-@4D4$9PZD9KAJ*]:5
M.,XN$U=/H]3OY5*/+)71[7\=_P#@HQ\;OVE]0TNX\:?$37-4;1;J.^LHH1%8
MV]M<1D&.98;=(X_,4C(?;D'//)IE_P#\%"OC%JG[16G?%JX\9S2_$+2; Z9:
M:PVGVGF10&&2$KY?E>63Y<L@WE2V6SG.#7B]%8?4<.H\L:<;6:M96L]UML^J
MZF7U:DE915MMEUW^\*Z[XK_'CQ9\;[;PO#XIU9M6C\&:';^'-&W6\41L]/@W
M&&#,:J7"[VPS[FP<$G KD:*W]G%M2:U6WD:>S3=V>U?L[?\ !1/XV?LHZ VD
M^ ?B%K6AZ0Q9A8,L5Y:1,V=S)%.DB1DDY)0 D\]:S]2_;M^+VM^+?%6NZAX\
MUK4]6\:Z!<>%]7N+TI=-/IDY4RVJ"16$*,47_5!".<$9.?):*Q>!P[DY\BN]
MW97?JS/ZM3NY<JN_(*[3X>_M"^,?A5\./&7A'0-:?3_#OQ!@M[;Q!9BWAD74
M$@=GB!9T+)M9V.8RI.X@DCBN+HK>5.,ERR5UY^6J^YZFSBFK2U.N^!7QY\6_
MLT?%#3?&?@?6)=!\2Z3Y@M;Q(8YM@DC:-P4D5D8%68892.<]0#7/^)?$=]XQ
M\1ZAJ^J74M]J6JW,EY=W$IR]Q-(Q=W8^K,23]:HT4O90YN>VNU^MNPO9KFYN
MIW'QN_:3\<?M&_%1O&WC+7[C5O%3)!'_ &BL,5K(!"H6(@0JBAE"CY@,DC))
M/->M7?\ P5]_:4O? #>&9/BYXD;36789 D"WQ&,<W8C^T?\ D2OFVBN>>!P\
MXQC*$6H[)I:>G;Y&4L-3DDG%66VFWH>C?\-;_$9_V?+OX5R>*;V;P#>WPU*7
M29HHI5^T!_,WK(RF5,N2Q57"L22036/\7OCQXL^/-SX?F\6:LVK2>%=#M?#F
ME9MXH19Z?;;A# !&J@A=[?,V6))))KD:*TCAJ<9<T8I/5[=7N_GU*C1BG=)'
M7>"?CQXL^'7PS\8^#=&U9K/PWX_2TCU^R^SQ2+J M93-;_,ZET*2$D%"I.2#
MD<5T7[-W[:7Q2_9#O[JX^'/C35O# OG62YMX=DUK<LH(5G@E5XG8 D LI.*\
MOHIRPU*<91G%-2WNEKTU[Z)?<$J,))J26N^FY[1X^_X*(?&SXG_%O0_'.N?$
M;Q!>^)O#,[7.DW(:.*+3I&&&,4"*L*;@<, F&'!R.*UO@AXNM_VN/VN-1U[X
MJ_$Z\\$^*O$44MWI_BY$CLX+;645/LK7!A51! 2H4R1A=AVG@9(\!HK*6!I*
M'+22B[6326B\M-K]-B'AHJ-H)+2UTEH?I=XH^&?[>7Q0^'G_  COBKXE:=:_
M#.Z8VMUXDN/&.C1Z?-;L%WN]U%(+F:(H02ISD$@CDBOE_P#X*A?'+PW\9?VB
MM,TWP9J3:UX/^&OAC3?!&CZD4V?VC#8QE6F _NM*\I4]UP>]?.-%<>%RSV51
M5)<NE[*,>5:VNWJ[O3RZZ&%'"<DN9VZ[*V_5ZO4]]^$7_!4;X_? KP)'X9\,
M_$[7K/0X8A#!:W,<%\MH@P56%IXW:(+@8$97';%>/_$GXG^(OC'XRO/$/BO7
M-4\1:Y?L&N+[4+AKB>7' !9B3@#@ < #  %85%=U/"482=2$$F]VDDWZLZ(T
M81?-&*3?D==\7OCQXL^/-SX?F\6:LVK2>%=#M?#FE9MXH19Z?;;A# !&J@A=
M[?,V6))))HB^/'BR#X%3?#-=6;_A!YM<'B-],-O$5_M 0?9Q.)-OF ^5\NT,
M%. 2,C-<C16BP]-)1Y59;*VWH:>RC9*QUWP+^/'BS]FKXF6/C+P3JS:'XDTQ
M)H[6]6WBG:$2Q/#)A959,F-V&<9&<C! -<WHVM7GAS5[74-/N[JPO[*59[>Y
MMY6BF@D4Y5T=2"K @$$'((JK15^SA=RMJ]'Z*]OS?WL?LXWOU/H[5/\ @KI^
MTEK/@D>'[CXM^)OL(0Q^;&(([XJ0 0;M8Q<'.!UD]Z\C^"?Q_P#&'[.OQ4M/
M&W@W6I-'\56(G$&H&"*YD3SHGBE.)5=2S)(XR1D9R"#@UQM%<\,#AX1<(0BE
M+=)*S]>YE'#4XIQC%6>^F_J%==\5_CQXL^-]MX7A\4ZLVK1^#-#M_#FC;K>*
M(V>GP;C#!F-5+A=[89]S8."3@5R-%='LXMJ36JV\C7V:;NSV'2/V^_B]HO[.
MMY\)X?&EY)\/[VW:TDTFXM;>X"0EQ(8XY9(VEC3< =J.HXKQZBBIIT:=._LX
MI7=W96N^[[L4*4(7Y5:YT7PO^+?BCX)^+8=>\'^(M:\,:U;@JE[IEX]K,%/5
M2R$$J>A4\$=0:]]O_P#@L[^T[J7AG^R9/BUK2VO_ #TBLK.*ZZ8_X^%A$O?^
M_P"]?,%%9UL'AZSYJM.,GYI/\R:F'I5'><4_5)FAXI\5ZIXY\0W>KZUJ5]J^
MJZA(9;F\O9VGN+AS_$[L2S'W)KT;]G#]N'XL_LC//_PKOQSK7ANWNI!--:1E
M+BSE?&-[6\RO$6P -Q7.!CI7E-%74P].I#V<XIQ[-77W#E1C*/+))H]$_:"_
M:T^)'[5.JVMY\0/&&L>)GL01:PW$@2VM,]?*A0+%'G SM49P/05D^-OCQXL^
M(OPS\'>#=9U9KSPWX 2[CT"R^SQ1KIXNI1-<?,BAW+R $ERQ& !@<5R-%3'#
M4XI*,4E';3;IIVT;^\4:,4DDEIMY!7H&N?M3>/\ Q)^SSHWPIOO$EW<?#_P_
M?OJ>GZ.8HA';W#F0LV\+YC#,LA"LQ4%V( )S7G]%:2IPE;F2=G=7Z/NO,N5.
M+^);'7? OX\>+/V:OB98^,O!.K-H?B33$FCM;U;>*=H1+$\,F%E5DR8W89QD
M9R,$ UR^FZE<:-J-O>6=Q-:W=K(LT$\+F.2%U(*LK#E6! ((Y!%0T4_9PYG*
MVKT;\EM^;^]B]FKWZGT9>_\ !7']I+4/ 7_"-R_%[Q4=-VE#(K1+?,",'-V$
M%P>/63U/4U\[RW<L]TT\DDCS.YD:1F)9F)R23USGG-1T5E1PM&C?V,%&^]DE
M?[B:="$/@27HK'T9X;_X*V_M'>$_ R^';/XL^)/[-C0)&TZP7-W$ "HV7,D;
M3K@$CY7'%> ^)/$NI>,M?O-5U>_O-4U34)6GNKN[F::>YD8Y9W=B69B>I)S5
M&BE2P=&DW*E%1;WLDK^MA0P\(.\(I7[(]]^$7_!4;X_? KP)'X9\,_$[7K/0
MX8A#!:W,<%\MH@P56%IXW:(+@8$97';%>1?%#XL>)OC9XRN?$7B_7M6\2ZY>
M!1-?:C<O<3.%&%7<Q)"J. HX X %<_113P=&G-U(02;W:23?JPCAX1ES1BDW
MY!11172;H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK/PWX_2[DT"]^T12+J M91#<?*C%T*2$ B0*3D$9'-<C7W_\5_V:_%'[2O\
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M9\!KGP_#XLTEM)D\5:):^(]*S<13"\T^YW&&<&-F #;&^5L,"""!7(U]@_\
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MJ0P9258$$$@@TJ&-H5GRTIIOR[=_->>P4\13J.T))G.T445U&P4444 %%%%
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M_J*TJZ*>Q40HHHK0H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,>Z_X^9/\ >/\ .HZDNO\ CYD_WC_.HZXS
M,*_ '_@ZK_Y2%^#?^R=V7_IRU.OW^K\ ?^#JO_E(7X-_[)W9?^G+4Z]C(_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"+[]S>^%[ZWA3@GEWB ' )Z]J_<#Q[^T=XC_ &2?^"%'@KXA>$_L/_"0>'_
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M[>IXQ17T5XG_ ."3'[1G@WX7R>,-2^%'B*WT."(SS$/!)=P1A2S,]JLAN$4
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M].]LT41$:L5W")QN8!0<9(ZTLXIRJ8.I"";;6RWW0L=%RH2C%&Y_PV%^R?\
M]&<R?^'6U?\ ^(KCOVG_ /@H*WQC^#UG\,? ?@/0?A+\+[6^_M*30]+N9;NX
MU.YZ+)=W4F'G*@#&5'(!.=J;?G.BKIY70C)3]YM:KFE*23[VDVK^8+!TU)2U
M=N[;_-L^UOVR?&VJ:;_P1^_9%\/07DT>CZO-XHOKRU5B$N)K?4@D+,.^P7$V
M/]\UF_\ !(6YDNK?]IC2Y&,FGW7P0\0W,MLW,<DL1M_*<KTW)O?:>HW'%<5^
MU%\?_"?Q%_8,_9I\#Z-JC7GB3X>P^(_[?MOLTL:V)O+^*6W7>ZA)"T:%CL+
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M^/\ X3_9?_;S\&^./&VIMH_AO18=1^U7*VTMRRF6PN(HU"1*SDM(ZKTP,Y)
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MC\7O'OP^TRXE%P_@NY\&/J5_!N)+PV][',(-@Z(T@R!MSN.:YC]H?]O1M?\
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M_D:O_#$^#X@_WQ^B"OY@?V>_^4WWA7_LL\/_ *>:_I^K^8']GO\ Y3?>%?\
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M4>BWNO>#_&.GZ1;:?J-Q>6T9F>PNO(6-)H98U?!*Y0@MR2,8O["'A#5?'_\
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MX0_9*^(WP=^(?C+2_!-[XEU6[NXKK4[I;."XMKNQ@M7V32?NE=# 3AV&?,7
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MI4G;W.6[Z6C;OMU-84W.I6LKWAI[MKOR1:_X.#_C3XR_X;E\2^"O^$L\3?\
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M8B23!+A<XX'Q+_P1B_:]\)?L8?MIVWB3QNHA\/ZQI-QHDVH?9S.VDM*\4BW
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MT7BG4P&9SQLH2E3J12;BKN+5EMVT*K.>&Q<L0XMQDDM-;-&9^S%^PA_P3_\
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M8O[<UBWT_P"V>7_:/F>7YSKOV[TW;<XWKGJ*[3XU?\$TOV0?C=\:/%OC2_\
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M$9_L\LL?W[>:-P'M[A0<F-QTZ$X;&=/,*$Y\D7OMH[/T=K/Y-D1Q5*4N5/\
M!V?H]G\F>,U]3?!C_@E'XG^+O[/'ACXG7WQ.^"?@#PYXPDNHM+7Q?XEDTNXN
M#;SO!+@&!D.'C8X5R<$$@9KY9K[;_:R_Y0H?LH_]A?Q-_P"G&XK',JU6+I0H
MRY7.5F[7TY9/]",54G%PC!VYG;OT;_0P#_P1_P!8OW6#1_CW^R_XAU*9@D&G
MZ=X_5[FY8]%17A4$GIC(KYU^/7P \8?LQ_$V_P#!_CG0[K0/$&G;3+;3%65T
M;E9(W4E)$;LRD@X/.017&U]L?\%8;VXB^ 7[+.E^*!-_PLC3_ 3-K0N6)NX[
M-Y4^P),"-P<*LV0QSDG(!SG.-3$4:].E4FIJ=UM9JRO?1[=-MVM2>:K3JQA.
M7,I7Z6:LK_=T^X^)Z*^I=)_X)U>'?AOX1TC4OCA\9/#_ ,']1\16(U'3=!.B
M7FN:QY#*3$]Q!;@"W$F.-[9QU ((K@/VHOV,]1_9V\/Z#XHTSQ)H/C_X>^*W
MDBTCQ/HC/]GEEC^_;S1N ]O<*#DQN.G0G#8ZJ>84)SY(O?;1V?H[6?R;-8XJ
ME*7*G^#L_1[/Y,\9HKZ%^!W["VG>*/@]I/Q'^*'Q*T'X0^ _$-Y-9:+>7FG7
M.JW^MM VRX>VM+<%VCB?Y&=F4!N/>J_[1/[#UO\ #/X1P_$KX?\ C[1?BK\-
M9-1_LF?5K&RGT^\TNZ*[DCN[.8;X=X^ZP9E..O*[C^T*#J>SOK>VSM?MS6Y;
M^5[WT#ZU3YN2_EL[7[7VOY7/ J*^D/@3_P $X-;_ &@?V7+?XG:7XBTO3--A
M\3W.A:U)JT?V73= M8;2*X-_/=[C\I,RQB)8R[,5"[BVVN@\,_\ !.WX>_&J
MYAT#X5_M$>#_ !I\0+B-S;^'[_0;[08]1E4MB"UNKD>7)(P7Y0P3)8#CDB)9
MGAHMIRV=GHVE;NTK+U=D*6,I)M-[;Z/3UTT^9\GT5TGA_P"$/B?Q5\5;?P/I
M^AZA<>+KG4?[)32A%BX^U!S&8BIQM8,"#G 7!)P 37TEJO\ P3S^%/PTOKKP
M[X__ &H/ _AOQ]:,L,VD:=X=U'6;&TG)PT,U_"HCC9#PV%8*00>F:UK8RE2:
M4F[O6R3D[=[)-V\]BZF(A#1_@F_RN?)-%>F?M2?LI^)OV2_'EMH_B!],U*RU
M:T34M&UK2;C[5IFN6;_<N+>7 W*>A! 8'J.03[IXV_X)56'PET/P'XH\;?%S
MP_X-^'_C;PIIGB&/6M0TJ>6Y-S>(SO86UE;M++<O @1GD&Q )HL[2P%3/,,/
M&,9.7Q;63=[=K)Z^6Y,L5223;WVZW^X^/Z*^C/VB/V"+#X>_ X_%+X;?$G0_
MBY\.K?4ETB_U"STZXTN^TFX89C^TVD_SQH_ 5]Q!) [@G!_9M_8OD^-/PVUC
MX@>*/&&@_#7X::#?II-QXAU6&:Y^TWSH)!:6UO K2SS",[RH PO.:(X^@Z?M
M4]+VV=[]K6O?RM<:Q--PY[Z;;.]^UM[^5CQ&BOI3XM?L#:#'\(O$/CWX/_%?
M1?C#X9\'F+^WXX]'NM%U72XY&VK<-:3Y+P;N#(K'&>0,-MY']ES]B_5_VD-#
MU[Q->:]H7@7X?>$RBZSXHUQW6TMI'^Y!$B O/.W41H,XQDC*Y(X^@Z;JWT6C
MNFFGT5FKW=U96N[Z L33<7.^B\FGZ6WN>,T5]2ZM_P $[O"_Q'\-:U=_!'XT
M^'?B]JWAVR?4;[03HEYH.JSV\:!I9+2&X!^T[.254AL+P"2%/RU6F'Q5.M?D
MZ;IIIKU32?X%4ZT*GP]/)I_<]3W[]FW]@:3]I#X<_P#"1K\9/@-X%'VN2U_L
MWQ=XM_LS4?D"GS/*\I_W;;N&SS@\5ZS-_P $0?$]OX!B\5R?';]F2/PO/>?V
M=%K#>-91I\EUM+^0)_LOEF7:K-L#;L G&!7Q17VWXU_Y5]_"'_999/\ TVW=
M>9F#Q=.<'3JV4I)6Y5HG?_(Y,3[:$HN,]&TMEH>,?M0?L,R?LP^!['7&^+7P
M1^("WM\MC]B\&>*O[5O;<M'(_FR1>4A$7[LJ7&0&9!_$*\+KNOV<_P!G3Q3^
MU/\ %:Q\'^$+.*ZU2\5YI)9Y1#:V,"#,EQ/(>(XD7EF/L "2 ?>+3_@GU\)_
M$NJP^&=!_:D^'^I>/IY&MH]/GT+4;31Y9\J%C34W7RFW,2 VS:<#GFNOZW'#
M_NZ\^:6^D7HO/E3LO-V-O;QI>[4E=^2>WG:]O5GR;172?$?X0>)/A-\4]4\$
MZ]I%W8^*-(O3I]SI^S?*)LX"KMSOW9!4KD,&!&017TA/_P $X/!'P=6'3?C;
M\?O"OPO\8W%HMS_PCEKH-[XBO-/9U#)%>M; );R$$$KN8@$'FMJV-HTTG)WY
MMK)R;7=**;MY[&E3$4XI7>^UDW?Y*Y\GVL!N[F.)656D8("W09..:[_]JS]F
MCQ!^Q[\?O$'PY\47&EW6N>&V@%S-ILKRVL@FMXKA"C.B,1LE7.5!!R*Z/]IK
M]CC7_P!E+Q#X5N[K4]%\5>$?&4(O_#GB;19FFT[6(E90X4L R2QEE62-@&0D
M=1@G[,_X*R_L?^&/%/\ P4;\?^+?BE\6-!^$?AGQ!)IRZ.T^EW6M:GJJ1:7:
M1R3QV=L-RP+*CQ^;(R!GC=5R5...IFE.-:G9WA*,GHFVW%Q5DDKW5W=6OIY'
M/+&14XV?NM2V5W=-=%KU>A^9M%>Z_M7_ +$,W[.W@7POXX\/^,-#^)'PV\92
M2P:7XBTJ&6W"SQ??M[B"4!X)L9(1LY /H171_ ?_ ()L:G\??V1%^+5GXNT7
M0]+L?%LOAW6O[7B^SV.B6D=FMR=0EN0Y+*6=(5B6(NTDL:J6+ 5U/,,.J2K.
M7NMVV>_:UKI]+/J;?6J2A[1O2]OGV/F>BOK2T_X)L^#OC!X2UF3X+_';PY\4
MO%GAW2Y-7OO#C>';_0[NXAB&9?LC7 Q<LHYV@*3Z#C/S]^S_ / 'Q1^TY\5]
M+\&>#]/_ +0UK5&.T,XCAMHU&Z2:5SPD:*"S,>@'&20"Z>.HSC*2=N7>Z<6O
M-II.WGL..(IR3=]M[IJWWV.,KIO@M\*M0^.GQ?\ "_@O29[*UU3Q9JMMI%G+
M>.R6\<T\JQ(9"JLP4,PR0I..QKZ,_P"&!/@S]I_X1_\ X:Q^'O\ PG7VC[+]
MD_X1[4O[#\S'_05V^5MW<;]FW'.>U8O[-GP!\4?LQ_\ !5'X4^#/&&G_ -GZ
MUI?CO1=P5Q)#<QM>0M'-$XX>-U(96'4'G!! PEF-.5.?LF^9)M736W572NO-
M:$/%0<7R;I-ZIK\TKG@_Q:^&NH?!GXJ>)O!^K-;2:MX3U:ZT:]:W<O"T]O,\
M,A1B 2NY#@D D8X%<_7NG[8'@#6OBK_P4I^+'AOP[IMSJ^N:W\1]:L[&SMUW
M27$KZE.%4=A[DX &22 ":]"U;_@GG\*?AI?77AWQ_P#M0>!_#?CZT989M(T[
MP[J.LV-I.3AH9K^%1'&R'AL*P4@@],U4<PIQIP=2_-))V2;?K9)M+SV!8J,8
MQ<]VKZ)O\%<^2:*],_:D_93\3?LE^/+;1_$#Z9J5EJUHFI:-K6DW'VK3-<LW
M^Y<6\N!N4]"" P/4<@GT+X1?L":?>?"O0_'GQ<^)F@_!KP?XI9_[#>]TZYU;
M5=8C0A7GALK<;_)!./,=E!R",@ACM+&T8TU5YKI[6NV_1*[;\DC26(IJ*G?1
M[6UOZ):GSC17V'X6_P""3'_"QOAQX]\>>$?BAX?\7?#WP=X2U+Q'!K>G:?*K
MS7=DB2-IEU;3-'+9S/$Q=6(D4JO&><>.2_LH&]_8DA^,NDZ\NI+8^)3X<U[1
MOL7ER:,S1>9;W'F^8?,CE&5R43:_&6ZC.GF6'F[1EU2V>C>R>FGSZZ;DQQ=*
M6SZVV>[Z>1X_17IW[''[,UY^U_\ M&>'? -IJ4.AQZP\LMYJD\8DBTNUAB>:
M:=U+("%CC8X+*"<#(SFO/?$%I:6&O7T&GW<E_80W$D=M<O#Y+7,08A)"F6V%
MEP=NXXSC)ZUU*M!U'23U23^3O;\F;>TBY<G7?[_^&*=%%%:%!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^A?_!M7_R?3XL_[$2\
M_P#3AIU?M[7XA?\ !M7_ ,GT^+/^Q$O/_3AIU?M[7XGQU_R-7_AB?!\0?[X_
M1!7\P/[/?_*;[PK_ -EGA_\ 3S7]/U?S _L]_P#*;[PK_P!EGA_]/-<&0[5?
M1?J?EO&'_+CU?Z']/U%%%?/'VQ:TC_CY;_=_J*TJS=(_X^6_W?ZBM*NBGL5$
M****T*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY!&0#P.T_;W_ &K?A#^V>LWQ&ATGXDZ'\;M833XM4@:6SD\--Y$"P221L,7
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M (.J_P#E(7X-_P"R=V7_ *<M3KV,C_WKY,^9XL_Y%[]4?LQ_P3D_Y1Z? ?\
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M\/V=E=:CK<^GE([NUBB78H4R(ZJ3.\*'<IX8\9K$_P""C_P'\!_LP_M<^)?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%14.M[WTZ'Z*_##_ )5>+G_L$ZG_ .I#<5SO_!K!_P UV_[@'_N3KY7\,?\
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MQX+\;7%U;R6^J7&B65K'%$D@:5=\5U(XW*".%.?:ON#_ ()8*W[0W_!!_7O
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MO'=[\+OB9X=\3::JR:CX=U.VU.U5AE6E@E65 ?;<HK"KZX_X)D:98^ ?AO\
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MBOZ2BK_.USY.U#]C/5O&G[?'B3X(^!?,U&ZL/%FI:!8W%\X7;;VEQ,C7$[*
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MI7@/]G^&#4;SQ-810:IK?BJ^U:\L$$P,ERD48@@WHFZ0%XV"E >QSW'[#/\
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MZE!<R#4,'INWM&2.O(SGK72?\&].CZSJ/_!2O0;C3$F:QT_1]2FU=D!VK;&
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M\++[)_8'D?V7<^=]KW_Z1YFSSMOE\;MF>,U\M_M4_P#"GO\ A*]/_P"%/_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O3/V5/VK_%?['OQ./B;PJVGW!NK633M3TS4K?[3I^M
M6<F/,M;F+(WQM@9 (((&"*\SHK.K2A4@Z=173W1,X1G'EDKH^L[3_@H7\+?
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MKM[!G:.['R+Y3$L#LRV"N=QS@>+45V2P\)24Y+57M\]&;RHQDU)]#Z^\8_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 445H^$?".J>/O%&GZ)HNGW
M6J:OJUPEK9V=M&9)KF5R%5%4<DDD"E*22NPO;5GZ/_\ !LS\-[O4/VAOB+XO
M$;_8=)\.QZ.SX^4R75S', #ZA;1OID>HS^S%?.O_  2]_8DC_84_96TOPS=B
M&3Q3JLAU7Q#/&0RF[D51Y2MW2)%5!V)#,,;S7T57X%Q-F$,;F-2M3^'9>:6E
M_GN?G&:XI5\3*<=ME\@K^8']GO\ Y3?>%?\ LL\/_IYK^GZOY>_V 9F^,O\
MP6/^'FI0GS?[4^)"ZT&B&T,J7;71(!Z+A2<=<>]7D6D:LGV7ZGYQQ?[T\/!;
MMO\ ]M_S/ZA****^>/MBUI'_ !\M_N_U%:59ND?\?+?[O]16E713V*B%%%%:
M%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
MP"_^O1_PZS_:(_Z)#XU_\ O_ *]?TET4?\1#QG_/J/X_YA_K-7_D7X_YG\VG
M_#K/]HC_ *)#XU_\ O\ Z]'_  ZS_:(_Z)#XU_\  +_Z]?TET4?\1#QG_/J/
MX_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\ P"_^O1_PZS_:(_Z)#XU_\ O_
M *]?TET4?\1#QG_/J/X_YA_K-7_D7X_YG\VG_#K/]HC_ *)#XU_\ O\ Z]'_
M  ZS_:(_Z)#XU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_
M &B/^B0^-?\ P"_^O1_PZS_:(_Z)#XU_\ O_ *]?TET4?\1#QG_/J/X_YA_K
M-7_D7X_YG\VG_#K/]HC_ *)#XU_\ O\ Z]'_  ZS_:(_Z)#XU_\  +_Z]?TE
MT4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\ P"_^O1_PZS_:
M(_Z)#XU_\ O_ *]?TET4?\1#QG_/J/X_YA_K-7_D7X_YG\VG_#K/]HC_ *)#
MXU_\ O\ Z]'_  ZS_:(_Z)#XU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X
M_P"9_-I_PZS_ &B/^B0^-?\ P"_^O1_PZS_:(_Z)#XU_\ O_ *]?TET4?\1#
MQG_/J/X_YA_K-7_D7X_YG\VG_#K/]HC_ *)#XU_\ O\ Z]'_  ZS_:(_Z)#X
MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
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MU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\
MP"_^O1_PZS_:(_Z)#XU_\ O_ *]?TET4?\1#QG_/J/X_YA_K-7_D7X_YG\VG
M_#K/]HC_ *)#XU_\ O\ Z]'_  ZS_:(_Z)#XU_\  +_Z]?TET4?\1#QG_/J/
MX_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\ P"_^O1_PZS_:(_Z)#XU_\ O_
M *]?TET4?\1#QG_/J/X_YA_K-7_D7X_YG\VG_#K/]HC_ *)#XU_\ O\ Z]'_
M  ZS_:(_Z)#XU_\  +_Z]?TET4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_
M &B/^B0^-?\ P"_^O1_PZS_:(_Z)#XU_\ O_ *]?TET4?\1#QG_/J/X_YA_K
M-7_D7X_YG\VG_#K/]HC_ *)#XU_\ O\ Z]'_  ZS_:(_Z)#XU_\  +_Z]?TE
MT4?\1#QG_/J/X_YA_K-7_D7X_P"9_-I_PZS_ &B/^B0^-?\ P"_^O1_PZS_:
M(_Z)#XU_\ O_ *]?TET4?\1#QG_/J/X_YA_K-7_D7X_YG\_GP3_X(4?M$?%W
M4(?MWA>S\%:;(1NO=>OXX]@ZG]S&7FSCU0 GC(YQ^JG_  3O_P""2'@']@9/
M[:CFD\6^/IX3#+KMW"(UM5889+6+)$2D<%BS.P)&X*=M?5]%>+FO%F/QT'2F
MU&#W4=+^KU?Z>1PXS.<3B(\DG9=D%%%0ZEJ5OHVG7%Y>7$-K:6L;33SS.(XX
M44$LS,>%4 $DG@ 5\R>2?//_  5B_:FM_P!C_P#8#^(OBPW/V?5KC39-&T0+
M*(Y7O[M3#"R9^\8]S3$#DK"_3K7XZ_\ !L;^S]=_$W_@H/+XV,<JZ7\-=$N;
MMIPN4^U7:-:11$]BT4ERX_ZXFN9_X+J?\%/O^'@G[0=KX5\&3S7'PT\"W$EO
MI1CS_P 3Z];"27NT=5.-D(.3LRWRF5E'Z]?\$2/V 9/V"/V,=/LM<LUM_'GC
M1UUOQ&&4>9:NRXALR>O[F/@C) D>8@X-?2./U/ -2^*?]?@OQ9\*JG]J9Q&5
M/6G2UOYIWO\ -_>E<^PJ***^;/NBUI'_ !\M_N_U%:59ND?\?+?[O]16E713
MV*B%%%%:%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!CW@VW4G^]FHZM:M'LN-W]X55KEDK.QF%%%%2!\&_\
M%IO^".MC_P %#O \?BSP?]CTKXM>&[8QVDDFV.#Q#;CD6D[_ ,+@Y,4A.%+%
M6^5MT?XY_L7_ +?_ ,:/^"._QTUC0VTV[@M8[L1^)/!>N(\,,SK@;U[PS;,;
M9DR&&PD2)@5_3]7@O[;O_!-3X1?\% _#D=K\0O#GF:K:QF.QU[3G%KJU@/1)
ML$.O)_=RJ\>23MS@U[.!S10A[#$+FA^7]?@?+YMD$JM7ZY@I<E3\'_D_P?7J
MSS7]CG_@N?\ L^_M=:190GQ=:> ?%,RJLVA^)YDL663 !6*X8^1,"Q(7:XD8
M#)C7.*^P+6[BOK6.>"2.:&90\<B,&5U(R""."".<BOP6_:A_X-;?BW\/;VYO
M/A=XD\/_ !#TG=^YL[R0:3J@!R<$2$V[!>!N\U"2<[ ,X^:1_P $]/VQ_P!G
MV]DT_2_AW\9M(8LRN/#JW-Q"QXS\]FS(0<#G.#CVKI_LO"5O>P]6WD]?\F<*
MX@S'"KEQM!OS6GZ-/Y-']0=%?S _\,]?MO\ _0J_M-?^ VLT?\,]?MO_ /0J
M_M-?^ VLTO[!7_/U?=_P0_UQ_P"G#^__ (!_3]17\P/_  SU^V__ -"K^TU_
MX#:S1_PSU^V__P!"K^TU_P" VLT?V"O^?J^[_@A_KC_TX?W_ / /Z?J*_F!_
MX9Z_;?\ ^A5_::_\!M9H_P"&>OVW_P#H5?VFO_ ;6:/[!7_/U?=_P0_UQ_Z<
M/[_^ ?T_45_,#_PSU^V__P!"K^TU_P" VLT?\,]?MO\ _0J_M-?^ VLT?V"O
M^?J^[_@A_KC_ -.']_\ P#^GZBOY@?\ AGK]M_\ Z%7]IK_P&UFC_AGK]M__
M *%7]IK_ ,!M9H_L%?\ /U?=_P $/]<?^G#^_P#X!_3]17\P/_#/7[;_ /T*
MO[37_@-K-'_#/7[;_P#T*O[37_@-K-']@K_GZON_X(?ZX_\ 3A_?_P  _I^H
MK^8'_AGK]M__ *%7]IK_ ,!M9H_X9Z_;?_Z%7]IK_P !M9H_L%?\_5]W_!#_
M %Q_Z</[_P#@']/U%?S _P##/7[;_P#T*O[37_@-K-'_  SU^V__ -"K^TU_
MX#:S1_8*_P"?J^[_ ((?ZX_].']__ /Z?J*_F!_X9Z_;?_Z%7]IK_P !M9H_
MX9Z_;?\ ^A5_::_\!M9H_L%?\_5]W_!#_7'_ *</[_\ @']/U%?S _\ #/7[
M;_\ T*O[37_@-K-'_#/7[;__ $*O[37_ (#:S1_8*_Y^K[O^"'^N/_3A_?\
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M .A5_::_\!M9H_X9Z_;?_P"A5_::_P# ;6:/[!7_ #]7W?\ !#_7'_IP_O\
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M_,#_ ,,]?MO_ /0J_M-?^ VLT?\ #/7[;_\ T*O[37_@-K-']@K_ )^K[O\
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M /T*O[37_@-K-'_#/7[;_P#T*O[37_@-K-']@K_GZON_X(?ZX_\ 3A_?_P
M_I^HK^8'_AGK]M__ *%7]IK_ ,!M9H_X9Z_;?_Z%7]IK_P !M9H_L%?\_5]W
M_!#_ %Q_Z</[_P#@']/U%?S _P##/7[;_P#T*O[37_@-K-'_  SU^V__ -"K
M^TU_X#:S1_8*_P"?J^[_ ((?ZX_].']__ /Z?J*_F!_X9Z_;?_Z%7]IK_P !
MM9H_X9Z_;?\ ^A5_::_\!M9H_L%?\_5]W_!#_7'_ *</[_\ @']/U%?S _\
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MFC^P5_S]7W?\$/\ 7'_IP_O_ . ?T_45_,#_ ,,]?MO_ /0J_M-?^ VLT?\
M#/7[;_\ T*O[37_@-K-']@K_ )^K[O\ @A_KC_TX?W_\ _I^HK^8'_AGK]M_
M_H5?VFO_  &UFC_AGK]M_P#Z%7]IK_P&UFC^P5_S]7W?\$/]<?\ IP_O_P"
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M_P"G#^__ (!_3]17\P/_  SU^V__ -"K^TU_X#:S1_PSU^V__P!"K^TU_P"
MVLT?V"O^?J^[_@A_KC_TX?W_ / /Z?J*_F!_X9Z_;?\ ^A5_::_\!M9H_P"&
M>OVW_P#H5?VFO_ ;6:/[!7_/U?=_P0_UQ_Z</[_^ ?T_45_,#_PSU^V__P!"
MK^TU_P" VLT?\,]?MO\ _0J_M-?^ VLT?V"O^?J^[_@A_KC_ -.']_\ P#^G
MZBOY@?\ AGK]M_\ Z%7]IK_P&UFC_AGK]M__ *%7]IK_ ,!M9H_L%?\ /U?=
M_P $/]<?^G#^_P#X!_3]17\P/_#/7[;_ /T*O[37_@-K-'_#/7[;_P#T*O[3
M7_@-K-']@K_GZON_X(?ZX_\ 3A_?_P  _I^HK^8'_AGK]M__ *%7]IK_ ,!M
M9H_X9Z_;?_Z%7]IK_P !M9H_L%?\_5]W_!#_ %Q_Z</[_P#@']/U%?S _P##
M/7[;_P#T*O[37_@-K-'_  SU^V__ -"K^TU_X#:S1_8*_P"?J^[_ ((?ZX_]
M.']__ /Z?J*_F!_X9Z_;?_Z%7]IK_P !M9H_X9Z_;?\ ^A5_::_\!M9H_L%?
M\_5]W_!#_7'_ *</[_\ @']/U%?S _\ #/7[;_\ T*O[37_@-K-'_#/7[;__
M $*O[37_ (#:S1_8*_Y^K[O^"'^N/_3A_?\ \ _I^HK^8'_AGK]M_P#Z%7]I
MK_P&UFC_ (9Z_;?_ .A5_::_\!M9H_L%?\_5]W_!#_7'_IP_O_X!_3]17\P/
M_#/7[;__ $*O[37_ (#:S1_PSU^V_P#]"K^TU_X#:S1_8*_Y^K[O^"'^N/\
MTX?W_P# /Z?J*_F!_P"&>OVW_P#H5?VFO_ ;6:/^&>OVW_\ H5?VFO\ P&UF
MC^P5_P _5]W_  0_UQ_Z</[_ /@']/U%?S _\,]?MO\ _0J_M-?^ VLT?\,]
M?MO_ /0J_M-?^ VLT?V"O^?J^[_@A_KC_P!.']__  #^GZBOY@?^&>OVW_\
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M_GZON_X(?ZX_].']_P#P#^GZBOY@?^&>OVW_ /H5?VFO_ ;6:/\ AGK]M_\
MZ%7]IK_P&UFC^P5_S]7W?\$/]<?^G#^__@']/U%?S _\,]?MO_\ 0J_M-?\
M@-K-'_#/7[;_ /T*O[37_@-K-']@K_GZON_X(?ZX_P#3A_?_ , _I^HK^8'_
M (9Z_;?_ .A5_::_\!M9H_X9Z_;?_P"A5_::_P# ;6:/[!7_ #]7W?\ !#_7
M'_IP_O\ ^ ?T_45_,#_PSU^V_P#]"K^TU_X#:S1_PSU^V_\ ]"K^TU_X#:S1
M_8*_Y^K[O^"'^N/_ $X?W_\  /Z?J*_F!_X9Z_;?_P"A5_::_P# ;6:/^&>O
MVW_^A5_::_\  ;6:/[!7_/U?=_P0_P!<?^G#^_\ X!_3]17\P/\ PSU^V_\
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M_P!"K^TU_P" VLT?\,]?MO\ _0J_M-?^ VLT?V"O^?J^[_@A_KC_ -.']_\
MP#^GZBOY@?\ AGK]M_\ Z%7]IK_P&UFC_AGK]M__ *%7]IK_ ,!M9H_L%?\
M/U?=_P $/]<?^G#^_P#X!_3]17\P/_#/7[;_ /T*O[37_@-K-'_#/7[;_P#T
M*O[37_@-K-']@K_GZON_X(?ZX_\ 3A_?_P  _I^HK^8'_AGK]M__ *%7]IK_
M ,!M9H_X9Z_;?_Z%7]IK_P !M9H_L%?\_5]W_!#_ %Q_Z</[_P#@']/U%?S
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MN/\ TX?W_P# /Z?J*_F!_P"&>OVW_P#H5?VFO_ ;6:/^&>OVW_\ H5?VFO\
MP&UFC^P5_P _5]W_  0_UQ_Z</[_ /@']/U%?S _\,]?MO\ _0J_M-?^ VLT
M?\,]?MO_ /0J_M-?^ VLT?V"O^?J^[_@A_KC_P!.']__  #^GZBOY@?^&>OV
MW_\ H5?VFO\ P&UFC_AGK]M__H5?VFO_  &UFC^P5_S]7W?\$/\ 7'_IP_O_
M . ?T_45_,#_ ,,]?MO_ /0J_M-?^ VLT?\ #/7[;_\ T*O[37_@-K-']@K_
M )^K[O\ @A_KC_TX?W_\ _I^HK^8'_AGK]M__H5?VFO_  &UFC_AGK]M_P#Z
M%7]IK_P&UFC^P5_S]7W?\$/]<?\ IP_O_P" ?T_45_,#_P ,]?MO_P#0J_M-
M?^ VLU#=_L;?MH?%#9I6H^!?V@-2AF;B+5+?4EM\].3-A!]211_84>M5?=_P
M0_UPD](T&WZ__:G] 7[67_!4CX%_L7:=>?\ ":^/M'_MFSW+_8.F2K?ZL\@_
M@-O&28R>@:78F>K#FOQ)_P""HG_!=;Q]_P %!%F\%>$;.]\#?#2:78VFP3;]
M2U_G"_:Y$XV'J+=,ID_,TI5"NM^SQ_P;0?M%?%J_@D\70^'/AGI3%6DDU/4(
M[Z\*'',<%J7!;G[LDD?0@D&OU8_X)[_\$/\ X._L"7EKK\%M-XX\?0*"OB'6
MHD/V-^YM(!E+?/\ >R\@R1YF"15P^H8+WT^>?]?)?BS.K_:^:?NW'V5-[WT^
M^^K^5D^I\F?\$+/^"&5Y\.=7TGXU?&G1_L^M6^VZ\+^&+R,^9ISYRMY=H1Q*
M.#'&>4)#-APH7]?:**\7%XNIB*G//[NQ]7EN74L%1]E2^;ZM]V%%%%<IWES1
MQ^^8_P"SBM"JFD1[8&;^\?Y5;KIIJT2UL%%%%6,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (-0M_M%N<?>7
MD5E5N5GZE9>6QD4?*>H]*QJ1ZDR*=%%%8DA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBK7]D2?WH_S/^%']D2?WH_S/^%')(+,JT5:_LB3^]'^9_P */[(D_O1_F?\
M"CDD%F5:*M?V1)_>C_,_X4?V1)_>C_,_X4<D@LRK15K^R)/[T?YG_"C^R)/[
MT?YG_"CDD%F5:*M?V1)_>C_,_P"%']D2?WH_S/\ A1R2"S*M%6O[(D_O1_F?
M\*/[(D_O1_F?\*.20695HJU_9$G]Z/\ ,_X4?V1)_>C_ #/^%')(+,JT5:_L
MB3^]'^9_PH_LB3^]'^9_PHY)!9E6BK7]D2?WH_S/^%']D2?WH_S/^%')(+,J
MT5:_LB3^]'^9_P */[(D_O1_F?\ "CDD%F5:*M?V1)_>C_,_X4?V1)_>C_,_
MX4<D@LRK15K^R)/[T?YG_"C^R)/[T?YG_"CDD%F5:*M?V1)_>C_,_P"%']D2
M?WH_S/\ A1R2"S*M%6O[(D_O1_F?\*/[(D_O1_F?\*.20695HJU_9$G]Z/\
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M15K^R)/[T?YG_"C^R)/[T?YG_"CDD%F5:*M?V1)_>C_,_P"%']D2?WH_S/\
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MBK7]D2?WH_S/^%']D2?WH_S/^%')(+,JT5:_LB3^]'^9_P */[(D_O1_F?\
M"CDD%F5:*M?V1)_>C_,_X4?V1)_>C_,_X4<D@LRK15K^R)/[T?YG_"C^R)/[
MT?YG_"CDD%F5:*M?V1)_>C_,_P"%']D2?WH_S/\ A1R2"S*M%6O[(D_O1_F?
M\*/[(D_O1_F?\*.20695HJU_9$G]Z/\ ,_X4?V1)_>C_ #/^%')(+,JT5:_L
MB3^]'^9_PH_LB3^]'^9_PHY)!9E6BK7]D2?WH_S/^%']D2?WH_S/^%')(+,J
MT5:_LB3^]'^9_P */[(D_O1_F?\ "CDD%F5:*M?V1)_>C_,_X4?V1)_>C_,_
MX4<D@LRK15K^R)/[T?YG_"G+H\G=E_"CDD%F4Z='&TK;54L:OQZ0BGYF9OTJ
MS'$L*X50H]JN-)]1\I7LM.%N=S?,W;VJU116T8I:(H****8!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>iclr-20221231_g5.jpg
<TEXT>
begin 644 iclr-20221231_g5.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BH[JZCLK:2::2.&&%2\DCL%5% R22>  .]?G[^W5_P<%?#7]G
M26^\/_#F&+XE^+H-T336\VS1[&09'SSCF4@]5BR/]H5V8'+\1C*GL\/%R?X+
MU>R-\/AJM>7+25V??/B+Q)IWA#1;C4M6O[+2].LT,D]U=SK##"HZLSL0JCW)
MK/\ AI\3- ^,?@?3_$WA?5;37- U9&DL[ZU;=#<J&*%E/<;E(ST.*_F:_:S_
M &]_BK^VSXA:\^('BFZOK%7W6^CVN;;2[3TV0*<$C^\^YCZU^\W_  1E&/\
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M,RW$2R1LLD<@#*RG(8'H0:=7P!^G!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1139IDMH6DD98XXP69F.%4#J2:
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M,6M/)=QJTS9Y@$YE)QGY2O%>'_L]?MU>!_AA^W=\4/B1J:ZU_P ([XP@N8[
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MGR04+MV25WN[=7YOJ?SY7J^TJRJ64>9MV6B5W>R71+H%%%%:&04444 %%%%
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M\V]?TD?\$9O^47WP9_[ 7_M>6OAN/?\ <J?^/]&?.\2?P(^OZ,^4_P#@O/\
M\E_\!_\ 8OS?^E-?"]?='_!>?_DO_@/_ +%^;_TIKX7K].X'_P"1#AO\+_\
M2F?Y]^)'_)38O_$O_28A1117U9\2%%%% !1110 4444 %%%% !1110 4444
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M_P#CM?:7_#P7X,_]% T/_P B?_$T?\/!?@S_ -% T/\ \B?_ !-'_$0N(O\
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M*/\ HI.@_P#@GE_^.T?\.#_%'_12=!_\$\O_ ,=K[2_X>"_!G_HH&A_^1/\
MXFC_ (>"_!G_ **!H?\ Y$_^)H_XB%Q%_P _/_)(_P#R(?\ $N>'_P"A57^Z
ML?%O_#@_Q1_T4G0?_!/+_P#':/\ AP?XH_Z*3H/_ ()Y?_CM?:7_  \%^#/_
M $4#0_\ R)_\31_P\%^#/_10-#_\B?\ Q-'_ !$+B+_GY_Y)'_Y$/^)<\/\
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MS?\ I37PO7Z=P/\ \B'#?X7_ .E,_P ^_$C_ )*;%_XE_P"DQ"@G H_,YX
MR2:_0[_@G5_P2676+;3_ !W\5K%O)DVW&F>')AC>.JRW0_(B+_OK^[7I9YGV
M$RG#_6,6_1+>3[)?F]EU/*X;X9QV>8M87!1\Y2?PQ7=O\EN^AX+^Q7_P3+\9
M_M:2P:O>>9X6\%;@3J=Q%F:]&>1;1G&[O\YPH_VNE?J=^S=^Q_X!_95\/K9^
M$=$AM[J10MSJ4_[Z^O#ZO*><?[*X4>E>E6EK%86L<$$<<,,*A(XXU"JB@8
M'  '85)7\[<2<98_-Y.,WR4ND$]/F_M/UT[)']7<)\ 99D4%.G'GK=9R6O\
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M*KTC4VC)]I+:,GW7NOM'K\,T4 YHKUC^E@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /TX_X(_?&S_A.O@%>>$[J;??>#;GRX0Q^9K27+Q_]\MY
MB_@/6OKBOR3_ ."87Q?_ .%4_M9Z/;S3>7I_BJ-M'N 3A2[_ #0D_P#;10/^
M!5^ME?-X^ER5G;KJ?P#XY<-K*>*:M2FK0Q"55>LKJ:_\"3?HT%%%%<9^.A7
M_M3_ !IM_P!G3]G#QOXYNF58_#&C7-\@) \R54/E)S_>D*K^-=]7Y[?\'(WQ
ML?X>_L-:?X4MYFCNO'VN0VD@4CY[:W!GE!'H66(?\"%>AE>$^M8RG0_F:OZ=
M?P.C!T?;5XT^[_X<_"O4]6N=?U2ZU"]D::]U"=[JXD/6261B[M^+$FH***_H
M#;1'Z8?5'_!./_@GMH_[;_P]^,6M:IXDU309/AEHT>IVT=I!'(MZS173E9"W
M*@?9P./[Q]*^?O#OP0\;>+;^QM-,\&^*M0O-2@^TVD%MI,\KW,0QF1 %^9>1
M\PXY%?H'_P $#O\ DW_]K3_L4(?_ $FU*O;?VR?VT?B#^R7^S3^QO%X#U6WT
M=O%%GIUOJLKV<5Q)>6ZPV@\@EU)6,^8Q.W!) YXKY&MG&*I9C4PM-*5VE%-V
M2]SF>R;U/#J8ZM#%3I15]5:^EO=OV/QZ_P"$.UC_ (2O^P?[)U3^W3/]E&F_
M99/M?F]/+\K&_=[8S7HGPE_93\0>(?VF/ 7P_P#&FC^)?!7_  FFKV^G>;?:
M;);S)'(X4R1K*H#$9K]P/B#X TSP?^VI^T!\1/"N@:;J7Q:T7X9V%SH,+1J\
ML\Q6^RZH?XBT%O&6')&%[XKY,_9'^/G[3'[4'PP\!ZA\4?!.B^(_!>E_$33[
MA/&6NR1Z9K6F3+=P@);6N$,@W-LR%Y#N.=O&<>):M:DZE.,8I)7O))WE&ZY4
MU9V^]]"/[6G4@Y122LKW>MVKZ=[?B?"W[?'[%5Q^R-^T[XR\$Z!_PD'B;P_X
M1CM7FUB6Q.V/SK=)CYK1C8F-^.2.!FO%Y/!VL0^&H]:;2=471YI/)COS:R?9
MI'SC8),;2V>, YS7[G?M/Z/>>,/AI^WMI&D6MSJFJS6VG^796D9EGDSH\! 5
M%R22%;  R<&O*?V;['7?A?\ \$@OV>[FX^'^L^+-1L_B3:ZE%X9$ CO-2C%Q
M=R QI+M&X*#(H; .P>M3A>)*BPT'.*E*\8O6U[P4K]EK\A4<VFJ47)7=TM[7
MO&]S\G?%OP+\=>!?"<>N:QX+\5Z3H\P!BOKW29X+9\]/WC*%Y^M>E?M5?L]?
M#_X/_#?X:ZGX+\7>(O%&L^+K 7&LV5]HTMG'ILYCB81P.T:B8;W=<J6SM!SS
M7Z[>*_B%>?MD1_'+1/AS\2-?T_Q(NB/%X@^''Q)\,F2QT@&%DVQ%3&80_(+I
M)*NXAL' -=)\)/ /AOQQX\_9#;Q!;VE[>Z#\-;G4-%MKG#H;M;73D,BAOO,D
M;,1W&=W49'/4XJJ)QG4A9QNW%-Z^Y=7O'\4[==M#.6<35I35K7NEZ75[K\5Z
MGX->.O@GXT^%VDVNH>)O"'B?P[8WV!;W.I:7-:PSY&1M=U .?K4F@? ;QUXK
MU"VM-+\%^+-2NKV'[3;Q6VD7$KSQ?\]% 3YEY'S#BOUD_8C^.GQ:_;5'[3G@
MW]HK2YKKX>Z;I%Y(PU72EL8=#N%>51#$^U?NQ*9 V25,2MGYLG0_;/\ VUOB
M)^RA\&OV-;7P-K$&DQ>*K+38-8WV<4[7\"PV:>2Q=253$K_=P<X.>!7<^(,3
M[9854XN?^)\OP\RUM>_1JQT?VI6Y_8J*YO73:_8_&C5M(N] U.XL;^UN;&]M
M)#%/;W$312PN."K*P!4CT-5Z^[O^#BWPS8Z!_P %&)KFSMXX)M7\.6-U=E%"
M^=*#)'N..^U%&?:OA&OHLOQ?UK#0Q%K<R3L>IA:WMJ,:MK705_21_P $9O\
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M%=WV.T1E5YW_ -A2Z@D=-PKEEA<.I^VE%<W>ROM;?TT_ QE1I<WM&E?O^'_
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M1_P1F_Y1??!G_L!?^UY:_FWK^DC_ ((S?\HOO@S_ -@+_P!KRU\5Q[_N5/\
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M/AW3-5D6/0?'<%UX.U4N?D$&HP-;AF'?9*T3@>J"O#&8(I9B%51DD]JZ/4_
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MS,#A>.>:+,7,GHC3HKS/0OVTO@_XG\7R>'].^*7P]OM<B;8UA!X@M9+@-Z;
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MW@/11KGQ2CT^Z;X33_#B#Q'HUDUT^[^VKD_8$L#*#N)BOUGD([I& >.:X/\
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MX\#Z*T_PET?3KJ.2!WTB&VF1EVO&3"JL"#T(YKHJ**N*=3"PPLEI%)>ME8C
M9/'"XVMC82;=1MV[7;?ZG\TWQ>_X)6?M2_L&?M,3:[X)\%^,-4D\.ZH]WX?\
M2^&+,ZBLB%F\M]B!F5BIPR.F.2.1S7[*_P#!%3XC?'CXH_LS:UJG[0-MXBM?
M%;:](EC'K.DKILWV,0Q;2(@B?+OW\D9SFOL2BMJF83J4?95$F[6OUW7XNVIS
MX/AVEA,4\10G)1;;<;^ZVTU]ROI^84445YY]"%>*?\%%K=;G]BSQ\'!^2P5Q
M@]Q*A%>UUXO_ ,%#_P#DRWX@?]@X?^C$K2C_ !(^J_,^FX+;7$. :_Y_4O\
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M.:ZP^#O!?PP^$/Q(T^3P[J&H7DGA;P[JK73ZGL*O=^6X"KL.T+*2YP?F4A>
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M%%_WU7R?&E!U,L<E]EI_I^IXN?T^;"-]FG^GZGZQ4445^-GPH4444 %?(O\
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M*\'Z?^W+_P '#?Q U?X@6MIK4/A_5=:U2"RNV$D3O93K:VB;&SO6)=K;>@*
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M[B# N%3ZQ#9[^O\ P3WJBBBO@CYP**** "BBB@ HHHH **** "BBB@ HHHH
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MW]IU/J&"?[B+U?\ .UU_PKIW>O8_1S_@W0_Y*S\3/^P39_\ HZ2OOC_@H?\
M\F6_$#_L'#_T8E? _P#P;H?\E9^)G_8)L_\ T=)7WQ_P4/\ ^3+?B!_V#A_Z
M,2N/$_[U\U^A^\> .V5?]?X_^GC\=Z***^@/]> HHHH **** "BBB@ HHHH
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M'BC_ ,@?_&Z/[,J=T'_$8,L_Y\U/_)?_ )(_H%HK^?K_ (>>_M!?]%8\4?\
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MPHHHH **** "J'BGPQ8>-?#6H:/JEK%>Z;JEO):74$B[DFB=2K*1Z$$BK]%
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M/W<Z=4FC/='7# ^A]0:Y.OHU)-71_)]:C.E4=*JK2B[-/=-;H****9F%%%%
M!1110 4444 %%%% !1110 444RX0R6\BK]YE(% 'V+^RW_P3 T7QM^SJOQ;^
M+WQ B^&G@>^.--(C1KB\4DJLA+Y #$':JJS, 3P,50_;"_X)JZ7\(?@18_%K
MX6^.(_B1\-[AUBN[KRU6XL"S; [;< KO(5@55D)&0>M>\_\ !0/P/K7[1_\
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MI_AF?P?J>IS>'++5',EKJ5C?6T!^SSN"QMY5G'+ABI+C)(%=;K/P-\,_%_\
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M*S\3/^P39_\ HZ2OOC_@H?\ \F6_$#_L'#_T8E? _P#P;H?\E9^)G_8)L_\
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M&?\ !0?5O"&M^$_$4O@GP7K'CKP9:1Z=I_B._CG>86J,Q"&!7$._:[KYH4,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>iclr-20221231_g6.jpg
<TEXT>
begin 644 iclr-20221231_g6.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /V\HHHK
M0\<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHKQ3W HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'&-S,QPJ@=234>G:E;:Q91W-G<0W5O+RDL+AT?Z$<&@":BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BKUAX=NM0Y6/RT_O/Q6K;>"(U'[
MV9F;N%'%%S6-&<MD>:?'/_DA?CG_ +%S4O\ TEEK^7S2SG3+?_KDO\A7]8OB
M/X3Z3XLT2ZT^^^U26M]!);3HD[1B6-U*LIQV*DC\:^3_ !#_ ,&_'[,NOW$D
MJ^$]8T]W4*HM-:N(TCP,<)NV_I7UW"_$&&RZ-2-=/WK6LD]K^:[GU.0XZG@H
MSC5O[UMO*_H?SXT5^T/QF_X-C/ ^N1W%QX%\>:]X?N-I\BTU")+NV#8XW/\
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M\(^-M6^'D/Q-^#M_;62>)+XFPT6^AN0#',\8Z2C/^K7J>*3]JS]DWQ9\=?\
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MD,IP5/J/>OWX_P""._[8<G[6O[(NGKJMQYWBKP85TC5"?O3*H_<S8_VE&/\
M@!K\WXVR=1:Q]);Z2]>C_1_(^(XJRU1:Q=-;Z2_1_I]Q]64445^>GQ@4444
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M6<G^7+'RTU3OIW?5WREK-6TC^M_77NM;>EDE^<'[0O\ P4,^*7PN.O>+M/\
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M 6LK93<W*YZ91,D9]ZX7_@IS^U;JW[.7P@L-+\*AG\9>-;K^S-,V+N>#/WY
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M8*TLDWW5Y(PIY(Z4VK)-_P!67,U\HZORUV%:[LO+\79?>]%YZ'>45XO\&_\
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M%H_*Z379GYS?L^?!:3XE?';X7[?#7[2DEYX+N!>ZC<>/M8N8])T&1(2A%KN
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M"&C_ +4GQ9^ >@^)=0UBY\,GX87>HW6G07\D,>JLFH3&(38.60'G:>M?8_\
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MM_B#]H_XG:Q\-_ NJW6D_#K09WLKR2V?9)K\Z$K(78<^2&! 7OC/I7<?%O\
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M2968?4 YK\T;;P?\,_@?^VG^T9XXO]-;3=2T;P#IFM07.F/MU))[FTE-S-;
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M ,B5X3_[_P '^-?<]%+_ %FI?] 5'_P&7_R0_P#5*M_T,,1_X%#_ .0/A_\
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M\/-2\(Z/\/?">F^%]88-?Z5!8*MK>D$$>8O\6" >?2O0**-KVZ[AS/3RV\C
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ML::K>QPA9]16,%4$K?Q!02!GH":VJ*;;>_G^._W]>XEIHNEOPV^[IV.!U_\
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MX5O+A[N?27LE-I+.[;GE*?WV;DGJ37:JZO\ =9&QP=K X/OZ4M.7O;_UK?\
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MH*^//%5KL\4:M#BPMI%^;38&ZD^DCCKZ"MN)N(*.48)XB>LGI&/=_P"2W?\
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M\5_MC_%CXV6GQ*N_A9\/_"FM?#SP7+>:+<WNJZG-;ZIK,\,?[_[(B_NU5<@
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M_)$]'+HM_P CWJBN#\8?M2_#+X>>.[?PMK_Q"\'Z+XFNBHBTN\U..*ZD+?=
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M*^5Q>.Q&*ESXB;D_/].B^1\_B,56KRYJTG)^84445RG.%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !114]OIEQ=?ZN&1AZA>*!I-[&5XJ_Y%/5O^O&?_ -%M7XR:I_R%+K_KL_\
MZ$:_:7Q7X;U>Y\,W\5GIK7DUQ;2PHGG)%\S(0.6^M?FSJ_\ P2\^-L<]Q<?\
M(O8LC2,P":M [8))Z UZ675(1YN9I']5?1MS[+<KACUF6(A1YW3Y>>48WMSW
MM=J]KJ_J?/-%=Y\0OV7OB)\*O,;7?!^N6<$0W/<"V:2 #_?'%<&#_P#J(Q7L
M1E&2O%W/[#P>.PV+I^UPE2-2/>+4E]Z;"NI^$_QI\3?!#Q"NI>&=6N-/F!'F
M1AMT,X'\+IT(KEJ*<HIJS*QF#H8JC+#XJ"G"2LXR2::\T]&?I1^R=_P4$T+X
M]FWT77EAT#Q4PVK&7_T:^;_IFQZ-_LG\*^B",&OQ1BE:"59(V:.2-@R.IVLA
M'0@]C7W-^P=^WU)XENK+P1XXN%^V,HBTW59&QYY[12D_Q>C=^E>-BL#R^_3V
M['\;^+?@-]0ISSGAN+=)7<Z6[BNLH=7%=8N[6ZNM%]D44$;317FG\KA1110
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MDTI?>FFN^J=MW^I6]#C][#\W3]XO/TYHW*20'C8KU <$K]1VK\*K#X.V;?\
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M:ZQ4N52\E+5K?IWTC5>[)>\FDUV;3;5^K5EZW>W*T_=J***R **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ H)"@EB%51DDG  H)"J68A549)/0"
MO/-,T_4/VGO$4UK:32V/P\T^3R[N[C)677)%/,49ZB('AF'7H*3=C2G3<W9$
M\OQ$UKXF:O-I/P_L[>\\AO+NM<N\_P!GVA[A,<RN/0<>M=1X6_92T6*]CU+Q
M3=77C'6%.[S=0.;>$_\ 3.$?*N/SKTCP]X=L?"FC6^GZ;:PV5E:H$BAB7:J
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MHJG+9+2R45;LK67HK+\]Q7;;;ZN[]==?Q:\EIL%%%%2 4444 %%%% !1110
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M*_;"U:/0=)TB[\*Z/ IEN))]\:R$?=WM_)1]:BGD>(O>O:$>K;6GR3-J_&N
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M;>SN[:XU:;6[@:B9(9VC:6R1!]WY1@R8R2:^X_V=-7\<ZK^R[X;O->M?#O\
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MK#'&[,L<2-)R[*@5G^I')_&AH8WD5VCB:2/[CL@+)]#U'X5R'P[_ &B?A_\
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M71_@_P"-O!_B?PYJFD-JNIZEI)M-*\/)8E?-FM[H@),6VD*(R20U>E_\$_\
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M (_? ;7--N/&G@VXU*UMGNM-F34H7GAG0%EV8;.6QMQWS1S+V_-RNVWX6O\
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MYR/"69X6DL#@<3^YDTY-Z2CK[W)96M)?9>B.0_9*_9-L_@_HMKK&M6<3>+)
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M]6T#Q0_Q&U716UUY(WU*".%GC ,@.QI]J[2XX)R17J7[1OQV^('_  38\?\
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ME?*_CW_@F3XP^*_G>$6^%U]X5M[[7EOIM:B\:BY\)V$:S^<;FSTLMYL=PV.
M5V@LQK],**J,G&HJG5._S33OWW6O?J-3:BTNO7Y->G5V[' ^#_V:/"7@3Q/X
MYUC3K>^6_P#B,B1ZX\EVSK.$@$ \M>D?[L8X[\UI?!3X)^'?V??A-I/@CPU;
M7$7AW186M[:"ZG-P^QB2P9VY;.3U[5UE%3TMY)?)7LOE=V]2?Z_K[D?/>B?\
M$N_A!H'CRWUR'3_$<EK9ZB=7M?#\VMS2>'[6[+%O.CLC^[5@Q+#T)S5SXO\
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M)R?\ .PJC117O;:(_LZG",(J$%9+1);)+9(=;V\EW<1PPQM+-,P2-%&6=B<
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MIO$G_!-KX6^*];\<WEW#XI6'XC7L6I:W80ZY+'8RW4<L<HFCA VQN6B3)'4
MCO7O0!(H(VFGS.Z?;_@+_P!MC]R[(.9_UZM_G)OYONSBO$G[/GACQ7\7/!_C
MB]M[QO$7@2TFLM'E2Z98HHI@JN'CZ.2%&">E8W[1W[(?@W]J5]#N/$A\06.J
M>&97ETO5="U633-0LBXPZK-'\VUAU7H:].HI-)VOT=_G>]_O%&36W:WRVL?.
M-C_P2D^#>FQ>)HXK'Q5L\8BT.M!M?F;^T9;6598IY,]9MRC+]6&1WKU3QA^S
MAX1\??%'POXPU:QN+K6O!UA<:9IN;@_9_L\ZA94EBZ294 <UW5%#U5GM_P "
MWY:>F@<SO?\ KI_DON/EW5?^"/'P2UJ);6YM_'$FC6]\NHV6B_\ "3W']EZ7
M.L@D#6\'W8OF'0<8)'>OJ""%;>WCA5?W<<8C4'GY0,#/X"G44?9Y.G]()-M\
MSW/GH_\ !+3X*G]G_P 5?##_ (1W4%\'>,M9;7M4MAJ4@F>Z,@D)23[R)N'W
M!Q@D=Z[CXU?LA>!?CWX-T'1=;L=0M%\*[/[%O])OGL-1TK8FP>3.GS+E>#ZU
MZ;11TY>FGX))?<DDO)6'SR<N9[Z_^3.[^]ZONSP[0O\ @G7\+]!\*Z?I8LO$
M%\VGZ]#XE;4+W6);C4;Z_A_U<EQ.WS2A>FT\8JEXX_X)C_!_XC>'7TK5]'UJ
MXL9/%5QXTVKJTJ,NJ3+M>4,.0HZJG12,U[]11?\ K_P'_P"1C_X"NR!2:U7]
M?%_\E+_P)]V>-_!O]@KX<_!35==U"VM=<\3:IXCLSIM]?>*-5DUBY>S/6V5Y
M/NPG^Z*R?A=_P3;^%_PB\?:;X@TV/Q9?/H,CS:/INJZ_/>Z7HKMD$VUL_P L
M9 ) QT!KWJBGS._-UM;Y?TW][[DO5.+V>_Y?DK>FAXWX1_8*^&O@?4?"UUI^
MGZNDW@W7+WQ%I9DU)W$=Y>*RSLX/WU(8X4\"JOQS_9$T7Q!H_P 4==T'P_IN
MN^,/B1IMO9:C9:Y=R'3=02W4K&FU1^Z;!.'7^+![5[=CBC'%1*-X\G2UOD_^
M&1<:C4^?K>_W._YMOU=SX#_9J_X)^>)&_:E^'GC+5O OB?P+IWPYCGE,WB3Q
MFGB2[OY)(6B6VM"C,(;5=V[#88[5K[\)R:**VE4<HJ+Z7_%W9#UES>B^2"BB
MBLP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (W*5(#*W!!&0:XG5/@5
MIL6J2:EX=O-0\(ZM)RUQI<FR.4_[<7W6S7;44%1DXZHY*R\6?%7P>BH__".>
M+X%XWMNLKG'N!\A-6_\ AIGQ%IH5=0^&VOI(.7:VNH)HU ')SNKHJ9=,197'
M_7%__032Y;LV^M32/+-1_P""FOAFUDVV_AOQ!=<?>!B0 ^ARV:X_Q7_P4QUJ
M\1X]#\,6EH&R%EO;@NR>AVKP:^:6^^_^\?YT5]_3X5PD7>4I/YI?H?AV(\4\
MUG&U.$(^=FW^+M^#.O\ B1^T#XT^+@9-=UZZDM6.?LEM_H]O^*KU_&N.CC6)
M=JJ%'M3J*]O"X&AAE:C%+\_OW/B<TSS'YC+FQE5R[+HO1+1?<%%!.!7I?P2_
M9DUGXMW$=U<+)I>A@@M<NOSS#TC'?Z]*UQ&(IT(.I5=D<V!R_$8VLJ&&BY2?
M;\V^B\V8'P>^#VI_&3Q,MC8J8K6,AKJZ8?) O_Q1["OMKP/X)T_X>>&+72=,
MA$-K:KC./FD;NS>I-'@CP-I?PZ\/Q:9I-JMM:Q=>[2'^\Q[DUK5^=9OF\\9.
MRT@ME^K_ *T/WSA;A:EE-+FE[U66[[>2\O/J%%%%>,?6!1110 4444 %9/CW
MQ2? W@;6-;6PNM4_L>REO39VQ437(C4L40MQN(!QFM:AHHYT:.9=T,JE)%/\
M2D8(_(FIJ<SBU#>VGJ5!Q4DY;=3YKNO^"H_@.T?X%J=+UQO^%\2B'3"IC(T5
MMN?]+.?[V4^7^)36+\9OVWM#\0>.-)TVUM_B%I\?A_XD6GA1;G1[N"&WUZ\:
M$R&%]QRUL#\C@\[A[5X7:?\ !,CXJV%A\:+>.UT]AHL#?\*B9KR,XE:\>]RW
M/[G#2&/YL?*HKT>R_8A\?V'P#^ MBVEVMQXLT7XAP>-O&P%['MMGDDDEN"K$
MXDV,^T!<D@<5T4>2<HR>B<HOT4IQ:W_DBI*79M7"M'D4HQUTDK]W&$KO_MZ3
MBH]TI6U/,]4_;Z^+'CC]FC]K*[U#1?%?@RX\!7K_ -C:JMU;^9HBJ(3]D!B8
MLTN"S;@""' SFOHG]GC_ (*&+XT\5?#_ ,(^*/A_XX\(R^.-+#Z!KVLM"UOK
M\L<2M)A%)DC=@=P$@&<UY5XX_9,^+E[X _:L\$6G@N&\L_BEJ(UKPWK U>W2
M&]8K IMVC9M\;#RV.Y@%KU_XR?L[>,/%_P 6OV8=4L--BFL/AK=2R^(7-TB_
M8E-I'&-H)S)\RD?+FL\.URPYNJI)^O(U)OK=2W[[N][FF*Y6Y<O1U6K?]NN"
M\U+6W7=*UK'IG[3G[3^A_LM^#]/U#5+'5-:U/7+Y-+T71=,C$E[J]V_W8HP>
M!TR6;@#K7F>G?\%*])TW2O&</C#X?^,O ?BKP7H;>(I/#NIR027&IV2G:9+>
M:,F)L'@C.1WK7_;E^!'B[XBZI\./'/@&WT_5?%GPKUPZM;:1>S>1#J\,B;)8
M1(>$DP 58\ UY)X]_9:^*W[;OC[Q/XN\<>&;'X7^1X)O?"OA[27U*+4;F>>Y
MP7GGDA)01_*H50<]37/S3Y)M;^]\K0O%KNW/1K73HK7*C&'-#FV]V_JYVDGV
M2AK?37J]CW7QQ^VGH7@3PU\)]4N-%UBXA^+UU!:Z='$\8:P:: SJ9LG! 48.
MW/-8G[)/_!0+2_VR?$%Q#X9\"^-+'0[$W,-UKU^D:6$5S#(4-NISF1CC.Y,J
M.AYKP&Z^"O[0WQ>?]GO1M:^%VD^$]%^#^J6[:M=-X@M[J74DBM6@$\"HQVQY
MP2K8?YNG%?1/_!.'X)>(_P!G?]DW2?"OBNPATW7+;4]2NIK>*=)E"S7DLL;;
MEX)*,I]NE=THPYJDE\-WRKRTL^^FK[[7ZI\OO*E33^*T>;R?O7\ND5VUTU:)
M_C]^VK!\'_BA:^!?#G@?Q5\3/&TUC_:EQI.A/#"=/M,E1+++,0B[B"%7.3CB
MLSPK_P %$O"OBV'X:^3X?\36UU\2-=G\.+:74:PSZ'>0@F1;A6Z@8(!3.>HX
MKGOBM\-/BA\"OVS-9^+/PZ\%V_Q*TWQMH-OHVK:/_:L.G7FGS6[N\4T<DQ"-
M&V_#+G/&17*_%GX)?'OQAX.^%?C_ %31O#?BCXB> ?%TVOS>%M.EAT^+[%*"
MJVR7#$(\T:[<R,<,<USTFK1<^ZOY>_:R6[7+K?YW7PFU6*NU#L[>;Y+Z]O?T
M6W:S^)>D?&C_ (*.>#?@1XU^(6AZWI.N-<?#VPL+V:6'RV34WO)&CA@A&<JY
M9>2^%&>M<SXP_P""@7B:Z^$/Q$\OX.?$#PMXT\.:!)JMC97EQ:3)=1%&Q<1W
M",83Y9&YD+;L#IS7ENH_LT?'CXI?$[XW>-==^'/@>W7QYHFE6FF^&M7O8M0M
M[V*WE<S6<[*<+*5(995.T$C!X-6/V>_V-/B1I?BCQJVG>#M3^#W@;6/!][HP
M\):AXHCUN"_U":-EBGAV,PMT0G!YR<UE5C)T91^URMZ='RMI>K=EHWJ]E\1M
M'V:JQ:VYH_=[M_DKR>J2\W\)U/[/O_!2K5(OV2OA;J7BOP+XNUWXF>.K54TO
M0[&2W:[\1;(U:6]1@WEPP?-G]X0174:S_P %4O"W@SX1>./$/B;P7XR\.>(/
MAR]M_;GA2Z$3:E#'<.$BFC928Y48G@H3T(ZUY1\)/V;_ (X?"WPC\$?&]K\.
M[5_&OP@T:X\):CX7N-<MR=<L94C7[5;7"MY<;ADR%D(..M4_CY^QA\9/VI/#
M_P 5?'>L>$]/\.^,/&5KI&BZ+X53589GMK.TO!.\MQ< ^4TC98@*3@ #K7;5
MY)5WR[.3]$N9*+7>\;.7\MVO=Y;'+1BE3BI;V7S?VD^UM;/K9.[YCUAO^"I#
MQ_$.'P?)\$?BA'XMUJQ.I^&]+8VP?Q#:@_-*K[MMOM!4E9BI&X#K6UH?_!3K
MPCKWP5M_$T7AGQ4OB.[UV3PQ#X.VQG5GU./[\&[/EX Y,F=H!'-;'B3X'^*=
M2_X**_#/X@Q6,;^$_#?A&_TG4+LW"!H;F4Q[$$>=S [3R!@8KYB\<_\ !,+Q
MEXV\*ZMJ^J^$=%\1ZIH?Q-O_ !38>'+[4A'#XBTRX1$9/-1AY4IV@KN(QCFN
M?2ROU3N^JM54%T>KA>6WFE;0TC9V?IIZTY2:W6BFE'=6O9N]F>ZZ_P#\%3O#
MOP\^&GCG6?&G@7Q?X/U[X?6D&HZEX;NY;>:\FLYI1&MQ#+&QBD4-G(!)&TCK
M4=Q_P5&M9E\/VNG?"3XB7OB'QE-,?#FC3/;65SK-G$B.UZK3,%CCPXPKD,?2
MO _$G_!.3Q7XQ^"7Q//AKX'^%_A?J6OV%EIVDZ*-7BO-2O-EU'+,\UUO:-8]
MJ_*@/4'UKWS]NG]G[Q-\4]/\!K#\+?#WQ9\.Z):F'4-%DOH]-U>QFV($GL[M
MF54 ((92<'BJE913>]TOE:]^OEZ7:=M'$7+S66UF_GI9=.K?K96OU]J_9T^/
M,/[0_@!]:7P[X@\)WEK=26-[I.LQ!+JSF3J,K\KKT(920<UWE?//_!.7X*^/
MO@G\,O$-KXXDU"SM]2UA[O0M"O\ 51JUUX>LRJ@6[W0R)#N#-P2 & KZ&JJB
M2:MV3]&TKK=[/3=^KW,8WU]7]UW;MT\EZ(****S*"BBB@ HHHH **** "BBB
M@">SU.>P;]U(R^V>#6G;>-9D&)(T?W'%8M%!I&I*.S-;6OB;_8NF27/]G7%R
ML$;2R"-U&U5!)^\1Z5\O:]_P6D\$Z9>SP6OA7Q->>22HDW0HC$=>K9_2O??%
M7_(IZM_UXS_^BVK\9-4_Y"EU_P!=G_\ 0C7=@<+"JWSG]&> _ >4<3K&2SB#
ME[+DY;2<?BYKWMOLC[2^(G_!:7Q'J230^&/"NGZ:K*1'<WLQFE0^NP?*?SKY
ME^,?[4GC[X^39\4>)+Z^M\Y%I&WDVJGU$:\5P%%>M3PM*GK%'];9!X?\.Y+)
M5,NPD(S7VFN:7RE*[7R: #:*** ,D#J3P !UKH/L@KVS]C7]C[4OVE_%BW5T
MDEGX2T^0&]NR,?:"/^6,?JQ[GL*[+]DK_@G/K'Q9DM=>\8)<:)X;R)([8C;=
M7X],'E%/J>3VK]!/#/AC3O!>@6NEZ39P:?I]D@CA@B7:J ?S/OWKS<5CE'W*
M>_<_FOQ:\<\-E5.>4Y!-5,2[J4UK&GWL]I3]-(O>[T'>'] LO"FAVNFZ;;QV
M=A8Q"&"%!A8U' '_ ->KE%%>*?P[4J2G)SF[MN[;U;;W;\PHHHH)"BBB@ HH
MHH &^XWT-?&?PV_X*/>&_A+^S]X%U)M+^*'CB3Q]XGU'0=,6\FAN]4-S%)*0
MC$''EDIM7'W5()P :^S&&48>H(_2O@OX)?L.?$[P7X:_9]M]0T&UAF\!>/M6
MUW6P-0A?[)9SBX\J12#\Y/F)\JY(S[4Z*YJO+)V3Y=?^WM?P^[<TE94'+JFV
MEZ0DU^-E\['TE^S%^V#;_M%>*_%7AG4/!_B+X?\ C+P8T)U+1-9DAEF$4P)B
MF22$E&1MK=#QBJ/Q\_;1NOA#\2)O"GAWX8>-OB1J]CIXU/43I$EO:VUA"V=N
M9;AE1W.#\BDD8JO\+_@AXG\-_P#!0OXL>/[ZQCC\*^*-"TJQTR[%PC//+!YO
MFJ8P=RXW+R1@YKR']J/]G?XJ>//VI/%%Y>> IOBI\/\ 7--M[;0;<^)H]+T_
MP_*%83&YMRRO-N)4[DR<*16=24G&#ANXMM>:3T\KNSUMVNM"H1@ISYMDU;T?
M+?UM=KY;.S)?&O[9D_QP^+7[.GB#P/K6NZ3X4\<6>M27VG,_E>=)!!( DZCA
MFCD4X(XR,BO4?^"7WQ#UKXF?L)^"/$'BC6;[6M8O(KI[O4+Z7S)I0MU*H+M[
M* /H*^<?V7/V&?BYX T3X"Z;KW@^QTE/A?+K]KJ+P:K#-"8;E)/L\D0#;BK%
MPH4_,H'-?2W[ ?P"U[X.?L->&_ /C*S73-:M[2\M;Z"&X6;R1-/*PPZDJ3M<
M'BNB=HTJOLM7HXI^LW;\5?Y7,7K*"EM>S]%=7_K?H<;>_P#!5K1(K.\\26OP
MU^(&H?"O3[UK*Y\=PK#_ &='M?RWF$)/GM"K<%PN."<X%>M?#3]K#0?BK\8O
M''@[2[*^:;P+I]CJ4VH%T-MJ$-W$TL9AP=PPJ\[O45\MZ;\!_P!H3P5^R3J'
M[-NG^ -!U#0;B&YT6U\>-K,*6D6G3R.QDDM"?.,ZJ[# 7!.#70:)^SQ\7/V1
M/C[XJNOA[X(LOB)X>\;>%]*T2/4)]8BL3HMQ9P-"7G20AI(VW;OW8+8&*SER
MJ,N371\KV;=KZK[.NU[+6VMKO5Q5]=-=5?1+F2T?6\6[[O2]E>QO7W_!7_P?
M;^%_A[?6O@7QUJM]\3XK\Z'I=BD4]U++:3>4T3!3@%B"P;[JJ#DBO?/'_P"T
M!H_P@^ EQ\0O&%M>^'=.L;)+N[LI@);JW=L!;?"9#2%B% 7J2*^1_P!D']AK
MXG?"GQA^S7?>)M#T^#_A75AKL?B&6&^BD6SGNYB\7EC.7# GE>@ZU]*?MV?L
M]:C^U%^S1K7A71[R"RUSS[;4]-DN,^0]S;3)/&DF/X&9 I],U5?EC#W>[UWL
MN9K1=7;7STMUNJ?*ZJB]OS?KT6R^;>NEN9^$_P#P4"A\9^/]/\/^+_AIXY^%
M[:]8R:EH][KIADM=0AC7>^6B)\E@GS;9,'%<S9_\%6]#GL;;Q)-\-?B#:?"N
M\O5L8/'<J0_V<Y:3REF,&?/6$OQO*X[YQ5S2#\?OVF+^+P[XV\#Z/\*_!+:)
M<Z=KLCW]MJUYK4TL)A7[(T;$V\8R7RV&/ ]:\IN?@3^T-XB_9'L_V;KSP#H-
MKH,,4>BW'CQ=9A:SDTU)MWF):9\X3F/Y<%<!N:5O?MZ65]&N:2;;Z-)1MM>[
M=M+"C;EO+3O_ '=%;E76[O?>UDKZW7J'Q&_X*D:;X.\;_$#0]%^&'C[QI_PK
M%DD\07NF/;I:VUJT7F_:%:0C<-F3L'SX'2K'PY_X*@Z%\0O&W@6VD^'_ (YT
M/PC\3)/(\,>*M02)+/4YO++B,PY\Z/(5L%U .*Q/A_\ LB^,O!.G?M1:>FFQ
MFU^(-C'9>%G:\C+:B(]/>W!?G]WEMH^?'6JEY^R7X^G^"/[)^BC2(#J'PMU>
MWN_$L7VV/%C&EO*C%3G$F&91A<]:*=M%+7^'Y?&I<_\ X!9>C>NC22G\#LK.
MU3SUBHN*\^9MI=TM-;L;J?\ P60\.Z7X4U7Q2WPM^)$W@?PWK,NA:YXAC2!K
M?3+A)1%Q'GS)E+$?ZL'&<'FNT\(?\%(+#5?'6I>'O$7PY\;>";Z/P]<>*='_
M +4>!EU^Q@&7:+828VP1\LF",UY1>?L4?$J7_@FE\0OARFAV_P#PE^O>-9]9
ML;+[?%LFM6OXIE<R9VJ3&K':3GC%>D_'C]ECQ9\5OVJ? NM6]M##X;T_X=:G
MX9U&_:X3=9W=PB*@$>=S#@G(&.*QDY*EI\5OQ]ES?A4]WMK9W>IORTG4:>D>
M9_<JB2^^#;OY75M;]5K'[>WAW1?V<?AU\3)-!UQ]*^).H66G65FKQ?:+-[J7
MRD:4YVE5/)V\XZ5Y[KW_  5MTO3D\:7NG_"?XC:UX>^'.L7&D>)M9MFMUM=,
M\D@-. S!I4VDL0F64#G%>0W'[.?[1GBS]GSX/_"FX^&.CZ3IOPL\3:;=W^M/
MX@@E76;2VNM_F6\:MN0[3N*R8/! KU#PU^R3\0--_8O_ &D?!TND6Z^(/B)K
M^O7V@VPO8]MY#=*! S/G:F['1L$=ZZ*W*O:5*>J3FXKNE[+E3ZZWJ=GIY&5&
M-_90J;OE4GVO[3F?;2T-=5KYD?[2W[9$W@GQG\1K[P1'XZ\2:Y9?#*/Q%I]C
M;WD":/;Q28*7B1R$'S4R&?/500.:S_V<?VSK_P"(,/[/6H^/H_'7A76O$VAW
M]W.AOK8:3JL<$19[RZ1"3M(!9!U7'-/TG]BSXA3>-?$\LVF6EI::Q\$X/!4$
M[7D; :H(PK1%0<[0?X^AKG? 7[&OQ/\ B9IGP'TOQEX+_P"$3L/ _AG5_"NO
MO_:]M=,B36[0Q7$?EL=PDW9VCE>^*F2Y%-0U:O:_DZZ7W^YZ\R>UK3%J<8N>
MEUK;?6%%[>3YUY.+6[=_6M%_X*?Z/J-[I.IWGP[\<:3\.=>ODT_3O&UTUO\
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>iclr-20221231_g7.jpg
<TEXT>
begin 644 iclr-20221231_g7.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M*I4[U.&5E/((]#63X=_;.^'/BK]IG5_A#8>(K:?Q_H=HMY>:: <QQD \-T+
M$$@<C-?F/_P3N_:,M_\ @DA^T1^T1\$_&EXEOX8T2WN/&'A9YFVK<J%W+''Z
M^8A3&.I4U\E_"RX^*'P+\7>!OVY-6GFETWQGXYGCU"+:=QM9'*L6/_/-ERH[
M?NZ:P*N]?3S)EGS4(.UW?WO)+<_?+]IS]K[P!^Q[X5TS6?B#KT>AV.L:A'IE
MHS(7::=S@  <X'<]!5?X5_MJ_#;XS?&OQ-\._#WB:UO_ !=X05&U*PP4>-6
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ME$*O!!A?)3D_=9LGG^5=!^R7^RQX/^ /[:'QJ^+#?$[P[K4'Q.E4/IA:./\
ML\J0Y4L6_>9!].]?0=U^Q[\-M3\+6NAW7A33[K3+25YH892[>4[D%B"3D9/O
M58_L4?"^.:W;_A$=/:2S4K"Y+[H^,9!SU]_6E[;FN[N["& 4(QC&*Y8ZK<^=
M/V1/^";7PO\ @5_P49\9?%KX>^,K&9-<TMX9?"UIL>/3WG=6DD1U.=A*9"X^
M4DBON,=*X;P!^SSX-^&&O+J>@Z#9Z9J"P&T\^+.]HBV\HQ)Y&XD\]Z[BLJDW
0.5[W.["T%2ARI6N[Z'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>iclr-20221231_g8.jpg
<TEXT>
begin 644 iclr-20221231_g8.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
M   !    2@,#  $    !     %$0  $    ! 0   %$1  0    !   7$5$2
M  0    !   7$0       8:@  "QC__; $,  @$! @$! @(" @(" @(#!0,#
M P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,# P'"0X/#0P."PP,
M#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $T 30,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MBEMHC.)V>60L0[;A@8 P*\Q\7_L:_%QHOB3HOAOQ_P""['PE\1-4O-0E@OM
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5\H 8[>E.HH :(U4<#%'EK3J* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>iclr-20221231_g9.jpg
<TEXT>
begin 644 iclr-20221231_g9.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M 1ONUE>+_$4?A30+B_E5F6W7A%ZNQX ^I)Q6JQP*P_'WA[_A*O#%S9"3R9)
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KFQZ7 P>/*D,.Q!XI]9_AO0+7POH]OI]C%Y-I9H(XDR3M'U/-:%<IZQ__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729850224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-08704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICON PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18, D18 X5R3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICLR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock, shares outstanding (in shares)</a></td>
<td class="nump">81,723,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filler Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001060955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Brendan Brennan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">Brendan.Brennan@iconplc.com<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">291-2000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166726696176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor firm ID</a></td>
<td class="text">1116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor name</a></td>
<td class="text">KPMG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor location</a></td>
<td class="text">Dublin, Ireland<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731185872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 288,768<span></span>
</td>
<td class="nump">$ 752,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="nump">1,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses (Note 4)</a></td>
<td class="nump">1,731,388<span></span>
</td>
<td class="nump">1,342,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled revenue (Note 4)</a></td>
<td class="nump">957,655<span></span>
</td>
<td class="nump">623,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Other receivables</a></td>
<td class="nump">63,658<span></span>
</td>
<td class="nump">56,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">137,094<span></span>
</td>
<td class="nump">114,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">48,790<span></span>
</td>
<td class="nump">50,299<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,229,066<span></span>
</td>
<td class="nump">2,941,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (Note 9)</a></td>
<td class="nump">350,320<span></span>
</td>
<td class="nump">336,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 10)</a></td>
<td class="nump">8,971,670<span></span>
</td>
<td class="nump">9,037,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net (Note 11)</a></td>
<td class="nump">4,278,659<span></span>
</td>
<td class="nump">4,710,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets (Note 15)</a></td>
<td class="nump">153,832<span></span>
</td>
<td class="nump">198,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other receivables</a></td>
<td class="nump">70,790<span></span>
</td>
<td class="nump">70,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable</a></td>
<td class="nump">21,380<span></span>
</td>
<td class="nump">18,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset (Note 20)</a></td>
<td class="nump">76,930<span></span>
</td>
<td class="nump">48,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investments in equity-long term (Note 8b)</a></td>
<td class="nump">32,631<span></span>
</td>
<td class="nump">22,592<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">17,185,278<span></span>
</td>
<td class="nump">17,387,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">81,194<span></span>
</td>
<td class="nump">90,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (Note 4)</a></td>
<td class="nump">1,507,449<span></span>
</td>
<td class="nump">1,323,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities (Note 12)</a></td>
<td class="nump">1,005,025<span></span>
</td>
<td class="nump">949,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">41,783<span></span>
</td>
<td class="nump">59,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Current bank credit lines and loan facilities (Note 13)</a></td>
<td class="nump">55,150<span></span>
</td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,690,601<span></span>
</td>
<td class="nump">2,478,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Non-current bank credit lines and loan facilities (Note 13)</a></td>
<td class="nump">4,599,037<span></span>
</td>
<td class="nump">5,381,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities (Note 15)</a></td>
<td class="nump">131,644<span></span>
</td>
<td class="nump">159,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Non-current other liabilities (Note 16)</a></td>
<td class="nump">38,260<span></span>
</td>
<td class="nump">42,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Non-current income taxes payable</a></td>
<td class="nump">239,188<span></span>
</td>
<td class="nump">172,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability (Note 20)</a></td>
<td class="nump">988,585<span></span>
</td>
<td class="nump">1,085,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities, Total</a></td>
<td class="nump">8,687,315<span></span>
</td>
<td class="nump">9,320,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 81,723,555 shares issued and outstanding at December 31, 2022 and 81,554,683 shares issued and outstanding at December 31, 2021.</a></td>
<td class="nump">6,649<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">6,840,306<span></span>
</td>
<td class="nump">6,733,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherUndenominatedCapital', window );">Other undenominated capital (Note 18b)</a></td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (Note 25)</a></td>
<td class="num">(171,538)<span></span>
</td>
<td class="num">(90,937)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,821,384<span></span>
</td>
<td class="nump">1,416,080<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">8,497,963<span></span>
</td>
<td class="nump">8,066,827<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 17,185,278<span></span>
</td>
<td class="nump">$ 17,387,090<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherUndenominatedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other undenominated capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherUndenominatedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729801088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8364; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in EUR per share)</a></td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">81,723,555<span></span>
</td>
<td class="nump">81,554,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">81,723,555<span></span>
</td>
<td class="nump">81,554,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731345232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 7,741,386<span></span>
</td>
<td class="nump">$ 5,480,826<span></span>
</td>
<td class="nump">$ 2,797,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>&#160; Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Direct costs (excluding depreciation and amortization)</a></td>
<td class="nump">5,527,045<span></span>
</td>
<td class="nump">3,972,612<span></span>
</td>
<td class="nump">1,979,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">778,753<span></span>
</td>
<td class="nump">585,330<span></span>
</td>
<td class="nump">342,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">569,513<span></span>
</td>
<td class="nump">314,987<span></span>
</td>
<td class="nump">66,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationIntegrationRelatedCostsCredits', window );">Transaction and integration related (Note 6)</a></td>
<td class="nump">39,695<span></span>
</td>
<td class="nump">198,263<span></span>
</td>
<td class="num">(759)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring (Note 19)</a></td>
<td class="nump">31,143<span></span>
</td>
<td class="nump">31,105<span></span>
</td>
<td class="nump">18,089<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">6,946,149<span></span>
</td>
<td class="nump">5,102,297<span></span>
</td>
<td class="nump">2,405,788<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">795,237<span></span>
</td>
<td class="nump">378,529<span></span>
</td>
<td class="nump">391,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="nump">2,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense (Note 13)</a></td>
<td class="num">(229,731)<span></span>
</td>
<td class="num">(182,423)<span></span>
</td>
<td class="num">(13,019)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Income before income tax expense</a></td>
<td class="nump">567,851<span></span>
</td>
<td class="nump">196,680<span></span>
</td>
<td class="nump">381,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (Note 20)</a></td>
<td class="num">(59,411)<span></span>
</td>
<td class="num">(41,334)<span></span>
</td>
<td class="num">(47,875)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest', window );">Income before share of earnings from equity method investments</a></td>
<td class="nump">508,440<span></span>
</td>
<td class="nump">155,346<span></span>
</td>
<td class="nump">333,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of equity method investments</a></td>
<td class="num">(3,136)<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">505,304<span></span>
</td>
<td class="nump">153,185<span></span>
</td>
<td class="nump">332,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(633)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Group</a></td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per Ordinary Share attributable to the Group (Note 24):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 6.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of ordinary shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">81,532,320<span></span>
</td>
<td class="nump">67,110,186<span></span>
</td>
<td class="nump">52,859,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">82,468,363<span></span>
</td>
<td class="nump">68,068,311<span></span>
</td>
<td class="nump">53,283,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationIntegrationRelatedCostsCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Integration Related Costs (Credits)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationIntegrationRelatedCostsCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731101264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(89,530)<span></span>
</td>
<td class="num">(60,617)<span></span>
</td>
<td class="nump">46,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital loss - investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain/(loss) on defined benefit pension plan</a></td>
<td class="nump">12,657<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
<td class="num">(4,138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="num">(910)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">(Loss)/gain on cash flow hedge</a></td>
<td class="num">(3,728)<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="num">(905)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">424,703<span></span>
</td>
<td class="nump">97,725<span></span>
</td>
<td class="nump">373,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less net income attributable to noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(633)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">$ 424,703<span></span>
</td>
<td class="nump">$ 97,725<span></span>
</td>
<td class="nump">$ 372,673<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724666688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Undenominated Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Redeemable Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,622,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,618,055<span></span>
</td>
<td class="nump">$ 4,635<span></span>
</td>
<td class="nump">$ 577,961<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
<td class="num">$ (75,819)<span></span>
</td>
<td class="nump">$ 1,110,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">332,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">46,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital loss - investments</a></td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain (loss) on defined benefit pension plan</a></td>
<td class="num">(4,138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,138)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="num">(910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Loss on cash flow hedge</a></td>
<td class="num">(905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">372,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">13,189<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">13,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">25,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,235,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">$ (82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling interest adjustment to redemption amount</a></td>
<td class="num">(4,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
<td class="nump">$ 4,522<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,788,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">1,850,236<span></span>
</td>
<td class="nump">$ 4,580<span></span>
</td>
<td class="nump">617,104<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="num">(35,477)<span></span>
</td>
<td class="nump">1,262,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling interest adjustment to redemption amount</a></td>
<td class="num">(4,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Exercise of call option on noncontrolling interest shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,665)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">153,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(60,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital loss - investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain (loss) on defined benefit pension plan</a></td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Loss on cash flow hedge</a></td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">97,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">118,589<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">118,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">133,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issue of shares associated with a business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issue of shares associated with a business combination</a></td>
<td class="nump">5,658,155<span></span>
</td>
<td class="nump">$ 1,960<span></span>
</td>
<td class="nump">5,656,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Replacement share-based awards issued to acquiree employees</a></td>
<td class="nump">$ 209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">81,554,683<span></span>
</td>
<td class="nump">81,554,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 8,066,827<span></span>
</td>
<td class="nump">$ 6,640<span></span>
</td>
<td class="nump">6,733,910<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
<td class="num">(90,937)<span></span>
</td>
<td class="nump">1,416,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">505,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(89,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized capital loss - investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Actuarial gain (loss) on defined benefit pension plan</a></td>
<td class="nump">12,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Amortization of cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Loss on cash flow hedge</a></td>
<td class="num">(3,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to the Group</a></td>
<td class="nump">424,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">35,828<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">35,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">70,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(420,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(99,983)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">81,723,555<span></span>
</td>
<td class="nump">81,723,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 8,497,963<span></span>
</td>
<td class="nump">$ 6,649<span></span>
</td>
<td class="nump">$ 6,840,306<span></span>
</td>
<td class="nump">$ 1,162<span></span>
</td>
<td class="num">$ (171,538)<span></span>
</td>
<td class="nump">$ 1,821,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdjustmentToRetainedEarningShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Retained Earning Share Repurchase costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdjustmentToRetainedEarningShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Increase From Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724448512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">569,513<span></span>
</td>
<td class="nump">314,987<span></span>
</td>
<td class="nump">66,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived assets</a></td>
<td class="nump">28,767<span></span>
</td>
<td class="nump">20,037<span></span>
</td>
<td class="nump">5,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Reduction in carrying value of operating right-of-use assets</a></td>
<td class="nump">45,215<span></span>
</td>
<td class="nump">45,339<span></span>
</td>
<td class="nump">28,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">3,136<span></span>
</td>
<td class="nump">2,161<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">17,749<span></span>
</td>
<td class="nump">12,890<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">70,523<span></span>
</td>
<td class="nump">133,844<span></span>
</td>
<td class="nump">26,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,434<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_GainLossOnIssuanceOfDebt', window );">Loss on issuance of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59,460<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(124,985)<span></span>
</td>
<td class="num">(60,616)<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange (gain)/loss</a></td>
<td class="num">(13,009)<span></span>
</td>
<td class="num">(6,054)<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">11,324<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
<td class="num">(7,859)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(420,695)<span></span>
</td>
<td class="nump">113,513<span></span>
</td>
<td class="num">(175,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Unbilled revenue</a></td>
<td class="num">(332,592)<span></span>
</td>
<td class="num">(17,656)<span></span>
</td>
<td class="num">(5,748)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">192,944<span></span>
</td>
<td class="num">(69,121)<span></span>
</td>
<td class="nump">291,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other net assets</a></td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">108,259<span></span>
</td>
<td class="num">(2,209)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">563,315<span></span>
</td>
<td class="nump">829,142<span></span>
</td>
<td class="nump">568,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(142,160)<span></span>
</td>
<td class="num">(93,750)<span></span>
</td>
<td class="num">(40,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,914,475)<span></span>
</td>
<td class="num">(47,931)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment in equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,450)<span></span>
</td>
<td class="num">(2,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Loan to equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sale of available for sale investments</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="nump">47,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of available for sale investments</a></td>
<td class="num">(482)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Proceeds from investments in equity - long term</a></td>
<td class="nump">1,906<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchase of investments in equity - long term</a></td>
<td class="num">(5,612)<span></span>
</td>
<td class="num">(4,077)<span></span>
</td>
<td class="num">(3,299)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(145,867)<span></span>
</td>
<td class="num">(6,024,235)<span></span>
</td>
<td class="num">(46,576)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,328)<span></span>
</td>
<td class="num">(1,554)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and facilities</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">5,905,100<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and facilities</a></td>
<td class="num">(875,000)<span></span>
</td>
<td class="num">(877,780)<span></span>
</td>
<td class="num">(350,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchase of noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(43,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of equity compensation</a></td>
<td class="nump">35,844<span></span>
</td>
<td class="nump">118,589<span></span>
</td>
<td class="nump">13,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(853)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="num">(99,983)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_PaymentsForShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Settlement of cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(905)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in)/provided by financing activities</a></td>
<td class="num">(864,173)<span></span>
</td>
<td class="nump">5,114,728<span></span>
</td>
<td class="num">(208,333)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate movements on cash</a></td>
<td class="num">(16,720)<span></span>
</td>
<td class="num">(7,727)<span></span>
</td>
<td class="nump">6,870<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease)/increase in cash and cash equivalents</a></td>
<td class="num">(463,445)<span></span>
</td>
<td class="num">(88,092)<span></span>
</td>
<td class="nump">319,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">752,213<span></span>
</td>
<td class="nump">840,305<span></span>
</td>
<td class="nump">520,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">$ 288,768<span></span>
</td>
<td class="nump">$ 752,213<span></span>
</td>
<td class="nump">$ 840,305<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_GainLossOnIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_GainLossOnIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_PaymentsForShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Share Repurchase Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_PaymentsForShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814604016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of business</a></td>
<td class="text">Description of Business <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2022 we had approximately 41,100 employees, in 111 locations in 53 countries. During the year ended December&#160;31, 2022, we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814561712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant accounting policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2022 and December&#160;31, 2021, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives.  The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation &#8211; Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Redeemable noncontrolling interests and equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#8217;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#8217;s presentation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166728088048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2022 and December&#160;31, 2021 were $406.3&#160;million and $323.6&#160;million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2022 increased by $334.5 million as compared to December&#160;31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2021 and December&#160;31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was $17.8&#160;million and $0.9&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively.</span></div>As of December&#160;31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3&#160;billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166732179232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Contract Balances</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2022 and December&#160;31, 2021 were $406.3&#160;million and $323.6&#160;million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2022 increased by $334.5 million as compared to December&#160;31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2021 and December&#160;31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was $17.8&#160;million and $0.9&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively.</span></div>As of December&#160;31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3&#160;billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731334704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsTextBlock', window );">Allowances for Credit Losses</a></td>
<td class="text">Allowance for Credit Losses<div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2022 and December&#160;31, 2021 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814766304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2022 and 2021, the Company incurred Merger-related expenses of $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in transaction and integration costs in the years ended December&#160;31, 2022 and 2021 are acquisition related costs (as defined by ASC 805) of $0.8&#160;million and  $57.1&#160;million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations for the year ended December&#160;31, 2021. During the year ended December&#160;31, 2021, the Company deferred </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$76.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(204,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.515%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151,098)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December&#160;31, 2022, the Company incurred $2.2&#160;million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814893088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2022, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,250.4 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,971.7 million and identifiable intangible assets, net of $4,278.7 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the fair value of total debt approximated $4,650.3&#160;million and $5,507.2&#160;million, respectively, as determined under Level 2 measurement for these financial instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727702592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Available for sale investments (short-term)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company held $1.7&#160;million of available for sale investments at both December&#160;31, 2022 and December&#160;31, 2021.  The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short term investments at December&#160;31, 2022 have an average maturity of 2.8 years compared to 2.7 years at December&#160;31, 2021. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Available for sale investments (long-term)</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. Capital totaling $20.6 million had been advanced under the terms of the subscription agreements at December&#160;31, 2022 (December&#160;31, 2021: $16.9 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $6.3 million (December&#160;31, 2021: $3.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $32.6 million at December&#160;31, 2022 (December&#160;31, 2021: $22.6 million).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span>December&#160;31, 2022, the Company had committed to future investments of $23.3 million in respect of these funds.<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160; Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company&#8217;s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company provided a loan of $10&#160;million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded losses of $3.1&#160;million and $2.2&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3&#160;million of pro rata losses.  The remaining $0.8&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare.  The outstanding balance of the Company's loan receivable with Oncacare at December&#160;31, 2022 is $9.2&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727302160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, net</a></td>
<td class="text">Property, Plant and Equipment, net<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,493&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,968&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(462,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment depreciation expense is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2022 and the year ended December&#160;31, 2021, certain fully depreciated assets were written off as they were no longer used in the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727302160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of Goodwill for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no goodwill impairment losses for the years ended December&#160;31, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814808224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0&#160;million, Order backlog of $500.0&#160;million, Trade names of $202.0&#160;million, Patient database of $168.0&#160;million and Technology assets of $111.0&#160;million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets were finalized in June 30, 2022. In total, $677.1&#160;million has been amortized in the period since the date of acquisition, $453.6&#160;million has been amortized in the year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,432,306&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814782384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities</a></td>
<td class="text">Other Liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December&#160;31, 2022 and $323.6 million at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727496288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current Bank Credit Lines and Loan Facilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Non-current Bank Credit Lines and Loan Facilities</a></td>
<td class="text">Non-current Bank Credit Lines and Loan Facilities<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2022 and 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,001,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less long-term portion of debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes on July 1, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2022,  December&#160;31, 2021 and December&#160;31, 2020 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2022 and December&#160;31, 2021, the Company expensed $17.7 million and $86.7 million of transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,701,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#8217;s existing credit facilities and (ii) the Company's notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the senior secured revolving loan facility will mature in July 2026. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin.  On the 29th of November 2022, the Company agreed with its lenders to the early adoption of Term SOFR as the reference rate within the Credit Agreement ahead of the June 2023 USD LIBOR cessation date. LIBOR is no longer an applicable reference rate available to the Company under the terms of the Credit Agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#8217;s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, $300.0&#160;million remained undrawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;30, 2022, the Company repaid $200.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $66.1&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.8&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September&#160;30, 2022, the Company repaid $200.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $53.6&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.9&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On June&#160;30, 2022, the Company repaid $100.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $39.4&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $0.9&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March&#160;31, 2022, the Company repaid $300.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $35.1&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $3.2&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;29, 2021, the Company repaid $500.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.8&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $5.6&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September&#160;27, 2021, the Company repaid $13.8&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.4&#160;million. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#8220;Offering&#8221;). The Senior Secured Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $4,650.3&#160;million and $5,507.2&#160;million at December&#160;31, 2022 and December&#160;31, 2021, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729834304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as Cash Flow Hedges.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate cap expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swaps begins accruing on December 31, 2024 and the interest rate swap expires on December 31, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The critical terms of the caps and swap are substantially the same as the underlying borrowings. The interest rate caps and swap are accounted for as cash flow hedges as these transactions were executed to hedge the Company's interest payments and for accounting purposes are considered highly effective. As such, the effective portion of the hedges is recorded as unrealized gains (losses) on derivatives in Accumulated Other Comprehensive Income.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of these cash flow hedges represents the present value of the anticipated net payments the Company will make to the counterparty, which, when they occur, are reflected as interest expense on the consolidate statement of income.  </span></div><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company&#8217;s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"/><td style="width:20.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,363</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,100,606</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$307</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,100,606</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,670</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,201,213</span></td></tr></table></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During 2023, the Company estimates that an additional $3.3 million will be reflected as interest expense in the consolidated statements.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December 31, 2021 the fair value of the Company's derivative financial instruments was $nil as the Company had no  outstanding derivative financial instruments. </span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company recognized $0.1&#160;million of gain within OCI and reclassified $0.1&#160;million of gain from OCI to the income statement for the year end December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814897168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating Leases<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases as of December&#160;31, 2022 and  2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $52.7 million incurred in the year ended December&#160;31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9&#160;million incurred in the year ended December&#160;31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December&#160;31, 2022 and December&#160;31, 2021 totaled $28.7 million and $10.2 million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2022 and December&#160;31, 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $24.8 million and $15.4 million, respectively, as part of an office consolidation program (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 19 - Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2022 were 6.90 years and 2.45%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2021 were 6.91 years and 2.51%, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2022 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,668&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,301&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $43.7&#160;million and $49.9 million have been included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_4e96e968-9c11-40fd-a303-2bb58d8fbc29"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_7797f20c-d0da-447d-8e1d-a6a60da2da46">other liabilities</span></span> as at December&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724641920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current other liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock', window );">Non-current other liabilities</a></td>
<td class="text">Non-current other liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727363968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2022 and December&#160;31, 2021 and future minimum rental commitments as of December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727454944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Capital</a></td>
<td class="text">Share CapitalHolders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. <div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Employee share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December&#160;31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December&#160;31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#8217;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December&#160;31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020, July 20, 2021 and July 26, 2022.&#160;On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1&#160;million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0&#160;million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6&#160;million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3&#160;million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0&#160;million. On February 18, 2022, the Company commenced a share buyback program which was fully complete at&#160;March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727366400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text">Restructuring Charges<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A restructuring charge of $31.1&#160;million was recognized during the year ended December&#160;31, 2022 under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $2.7&#160;million relating to workforce reductions, an impairment of right-of-use assets and associated unavoidable costs totaling $24.5&#160;million  and fixed asset impairment of $4.0&#160;million. It is company policy to disclose operating right-of-use asset impairment as a restructuring charge when it is part of a coordinated program to decommission space.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022, a total liability of $6.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $1.4 million of facilities related liabilities of which $0.9 million is included within other liabilities and $0.5 million is included within non-current other liabilities. The remaining provision of $4.6 million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727372256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,948&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,201,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158,693&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,289,256&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,417&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,167&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,038&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,672&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911,655)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037,584)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.6 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $5.4 million and $401.9 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $5.4 million U.S. federal NOLs, approximately $3.5 million is available for offset against future U.S. federal taxable income in 2023. The subsidiaries' ability to use the  remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $5.3 million are limited by Section 382 for the years 2023 - 2036. As of December&#160;31, 2022, U.S subsidiaries also had disallowed interest carryforwards of $93.0&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023-2036</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033-2041</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2022 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $37.9 million. At December&#160;31, 2022 those subsidiaries also had additional operating loss carryforwards of $14.8 million which are due to expire between 2023 and 2029 and operating loss carryforwards of $18.2 million which are due to expire between 2030 and 2039. In addition, at December&#160;31, 2022 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2022 was approximately $43.4 million. The valuation allowance for deferred tax assets as of December&#160;31, 2021 and December&#160;31, 2020 was $45.5 million and $32.8 million respectively. The net change in the total valuation allowance was a decrease of $2.1 million during 2022 and an increase of $12.8 million during 2021. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expense and a decrease of $1.3 million was recognized in Other Comprehensive Income. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of an acquired entity, $4.4 million was recognized within income tax expenses, and $0.9 million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2022 and December&#160;31, 2021 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recognized a deferred tax liability of $1.6 million (2021: $0.8 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $37.9 million could potentially expire during 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2022 were potential benefits of $217.6 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2021 and December&#160;31, 2020 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $202.1 million and $19.1 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2022 amounted to a net charge of $7.1 million (2021: $1.9 million, 2020: ($0.6 million)) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021 were $22.6 million and $15.5 million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727592704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">Employee Benefits<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were $30.2 million, $23.7 million and $17.0 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pension and Postretirement Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the specific defined-benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $11.6&#160;million and $8.0&#160;million recorded to non-current liabilities as of December 31, 2022 and December 31, 2021, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> 'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December&#160;31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) &#8211; plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,559)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.3 million and $Nil respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2022 resulted from changes in the assumptions compared to those adopted at December 2021. Changes in the assumptions reflect the changes in market conditions from December 2021 to December 2022 and the actuarial gain is primarily due to the change in</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> the discount rate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company&#8217;s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December&#160;31, 2022 and December&#160;31, 2021, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of assets held by the plan are represented by quoted prices in active markets for identical assets  and are therefore classified as level 1 investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2028 - 2032</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022 and December&#160;31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table.  The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 were 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table.  The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 was 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727293200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Schemes and Stock Compensation Charges</a></td>
<td class="text">Equity Incentive Schemes and Stock Compensation Charges<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#8221;), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan")  were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,107&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,737&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.83&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,047,803&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2022, was 4.69 years and 4.25 years respectively (2021: 5.39 years and 4.55 years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outstanding and exercisable share options:</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.88 - 96.15</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.70</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.81 - 124.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.33 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.24</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.88 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,378,119</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.69</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">119.86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047,803</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">102.29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December&#160;31, 2022. Options exercisable represent options which have vested at December&#160;31, 2022. From the date of grant, substantially all options vest over a five year period.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.  No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,087)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(195,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2022 totaled $34.1 million (2021: $83.5 million). The share price range for the year was $137.47 - $265.96 (2021: $115.11 - $206.71).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2022 totaled $6.5 million (2021: $5.1 million). The share price range for the year was $137.47 - $166.51 (2021: $115.11 - $125.74).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period  2021 &#8211; 2023 and 2022 &#8211; 2024. Depending on the actual amount of EPS from 2021 to 2024, up to an additional 76,210 PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-cash stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2022 is stated after charging $70.5 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December&#160;31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2020 was $2.5 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727334512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographical Information</a></td>
<td class="text">Business Segment and Geographical Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#8216;CODM&#8217;) in accordance with ASC 280 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Segment Reporting'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December&#160;31, 2022 and December&#160;31, 2021 and for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations (including Restructuring) by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166726863824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Ordinary Share</a></td>
<td class="text">Net Income Per Ordinary Share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted net income per ordinary share attributable to the Group for the year ended December&#160;31, 2020 includes an adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the years ended December 31, 2022 and December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,859,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,283,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,809&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727360240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">Accumulated Other Comprehensive Income<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan (note 21)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727413280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text">Supplemental Disclosure of Cash Flow Information<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,062&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727454944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related Parties <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $2,000 (December&#160;31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December&#160;31, 2022 (December&#160;31, 2021: $12,000).&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $235,000 (December&#160;31, 2021: $551,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December&#160;31, 2022 (December&#160;31, 2021: $197,000).&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December&#160;31, 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9&#160;million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December&#160;31, 2022 (December&#160;31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December&#160;31, 2022 (December&#160;31, 2021: $264,000).&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1&#160;million and $2.2&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3&#160;million of pro rata losses.  The remaining $0.8&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. At December&#160;31, 2022  accrued interest of $183,000 remained outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727447680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough February&#160;24, 2023, the date at which the consolidated financial statements were available to be issued. The Company has determined that there are no items to disclose.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166725228816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Disclosure of Fair Value of Financial Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div>The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#8211; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies and Translation of Subsidiaries</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Reimbursable expenses and Direct costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in Debt, Equity and Other</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, Net and Unbilled Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2022 and December&#160;31, 2021, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives.  The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of goodwill and long-lived assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#8220;global intangible low-taxed income&#8221;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_GovernmentGrantsPolicyTextBlock', window );">Government grants</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ResearchandDevelopmentCreditsPolicyTextBlock', window );">Research and development credits</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Costs</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation &#8211; Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Transaction and Integration-related Expenses</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Restructuring</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock', window );">Redeemable non-controlling interests and equity</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Redeemable noncontrolling interests and equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. </span></div>Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income per Ordinary Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#8217;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#8217;s presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Impact of Recently Issued or Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_GovernmentGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grants, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_GovernmentGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ResearchandDevelopmentCreditsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Credits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ResearchandDevelopmentCreditsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727352320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ForeignCurrencyDisclosureTableTextBlock', window );">Adjustments resulting from foreign currency translations</a></td>
<td class="text">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock', window );">Estimated useful lives of assets</a></td>
<td class="text">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ForeignCurrencyDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ForeignCurrencyDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Useful Lives For Property Plant Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727454944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727528032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contracts with Customers, Asset and Liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727398784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsTableTextBlock', window );">Schedule of Provision for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2022 and December&#160;31, 2021 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for Doubtful Accounts, Table</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729292464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(204,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock', window );">Schedule of measurement period adjustments</a></td>
<td class="text">In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.515%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151,098)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December&#160;31, 2022, the Company incurred $2.2&#160;million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Measurement Period Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166821361088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,388&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727293200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727610640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment, Net</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,493&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,968&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(462,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,320&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment depreciation expense is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727307648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of Goodwill for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729318288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,432,306&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727550336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949,629&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December&#160;31, 2022 and $323.6 million at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727302816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current Bank Credit Lines and Loan Facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2022 and 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,001,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less long-term portion of debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock', window );">Schedule of Financing Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,701,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Financing Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724611600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company&#8217;s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"/><td style="width:20.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,363</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,100,606</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$307</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,100,606</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,670</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,201,213</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729341360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Cost</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases as of December&#160;31, 2022 and  2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2022 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,668&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,301&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727476304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current other liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Non-current other liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729334400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring Charges</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724481216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncomeBeforeIncomeTaxTableTextBlock', window );">Summary of Components of Income Before Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Components of Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,948&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</a></td>
<td class="text">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,201,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158,693&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,289,256&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,417&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,167&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,038&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,672&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911,655)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037,584)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Expected Expiry Dates of NOL's</a></td>
<td class="text">The expected expiry dates of the US NOLs are as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023-2036</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033-2041</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeBeforeIncomeTaxTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Before Income Tax, Table</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeBeforeIncomeTaxTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721459216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in Balance Sheet</a></td>
<td class="text">The balances recorded to the balance sheet are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December&#160;31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table.  The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 were 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 <span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans &#8211; Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table.  The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 was 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/>&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Summary of Assumptions Used in Calculating Pension Benefit Obligations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December&#160;31, 2022 and December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) &#8211; plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,559)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Underlying Asset Split of Fund</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Plan Asset Fair Value Measurements</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Annual Benefit Payments which Reflect Expected Future Service</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2028 - 2032</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729795456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Transactions for Company's Share Option Plans</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,107&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,737&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.83&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,047,803&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Information Concerning Outstanding and Exercisable Share Options</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.88 - 96.15</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.70</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.81 - 124.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.33 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.24</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.88 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,378,119</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.69</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">119.86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047,803</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">102.29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Fair Values and Assumptions Used</a></td>
<td class="text">The weighted average fair values and assumptions were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,087)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(195,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock', window );">Schedule of Non-cash Stock Compensation Expense</a></td>
<td class="text">Non-cash stock compensation expense has been allocated as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Non Cash Stock Compensation Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727474720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Distribution of Net Revenue by Geographical Area</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December&#160;31, 2022 and December&#160;31, 2021 and for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeByGeographyTableTextBlock', window );">Schedule of Distribution of Income from Operations by Geographical Area</a></td>
<td class="text">The distribution of income from operations (including Restructuring) by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Distribution of Long-lived Assets, Net, by Geographical Area</a></td>
<td class="text">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeByGeographyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income by Geography.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeByGeographyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166814762880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,859,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,283,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,809&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727553648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan (note 21)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721373072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,062&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,604&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724353024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Employee </div>
<div>Country </div>
<div>Location</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>Employee</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">41,100<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_NumberOfLocations', window );">Number of locations in which company operates | Location</a></td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which company operates | Country</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | United States | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">46.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Europe | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">46.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Rest of World | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">7.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Locations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727295712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyAbstract', window );"><strong>Foreign Currency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">&#160; Amounts (credited)/charged</a></td>
<td class="num">$ (25,997)<span></span>
</td>
<td class="num">$ (14,316)<span></span>
</td>
<td class="nump">$ 5,979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721242112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember', window );">Computer equipment and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember', window );">Computer equipment and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Motor vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724629536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729272960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Mar. 09, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_MeDiNovaResearchMember', window );">MeDiNova</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage', window );">Business combination acquisition percentage (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_MeDiNovaResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_MeDiNovaResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166730216528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 7,741,386<span></span>
</td>
<td class="nump">$ 5,480,826<span></span>
</td>
<td class="nump">$ 2,797,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_TopClientMember', window );">Top client</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">683,546<span></span>
</td>
<td class="nump">441,173<span></span>
</td>
<td class="nump">337,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients25Member', window );">Clients 2-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,506,087<span></span>
</td>
<td class="nump">1,291,946<span></span>
</td>
<td class="nump">754,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients610Member', window );">Clients 6-10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,112,636<span></span>
</td>
<td class="nump">752,325<span></span>
</td>
<td class="nump">350,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients1125Member', window );">Clients 11-25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,585,739<span></span>
</td>
<td class="nump">1,077,073<span></span>
</td>
<td class="nump">501,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 2,853,378<span></span>
</td>
<td class="nump">$ 1,918,309<span></span>
</td>
<td class="nump">$ 851,970<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_TopClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_TopClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients610Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients610Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients1125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients1125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_OtherCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166723935712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed services (accounts receivable)</a></td>
<td class="nump">$ 1,751,950<span></span>
</td>
<td class="nump">$ 1,349,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses (note 5)</a></td>
<td class="num">(20,562)<span></span>
</td>
<td class="num">(7,081)<span></span>
</td>
<td class="num">$ (7,149)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractsReceivableGross', window );">Accounts receivable (net)</a></td>
<td class="nump">1,731,388<span></span>
</td>
<td class="nump">1,342,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled services (unbilled revenue)</a></td>
<td class="nump">957,655<span></span>
</td>
<td class="nump">623,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractsReceivableNet', window );">Accounts receivable and unbilled revenue, net</a></td>
<td class="nump">2,689,043<span></span>
</td>
<td class="nump">1,965,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (payments on account)</a></td>
<td class="num">(1,507,449)<span></span>
</td>
<td class="num">(1,323,961)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Net balance</a></td>
<td class="num">(549,794)<span></span>
</td>
<td class="num">$ (700,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent', window );">Change in unbilled receivables</a></td>
<td class="nump">334,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="num">(183,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Change in advance payments netted against unbilled contracts receivable</a></td>
<td class="nump">$ 151,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent', window );">Change in unbilled receivables (in percent)</a></td>
<td class="nump">53.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent', window );">Change in unearned revenue (payments on account) (in percent)</a></td>
<td class="nump">13.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent', window );">Change in advance payments netted against unbilled contracts receivable (in percent)</a></td>
<td class="nump">21.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724510800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract Balances - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 406,300<span></span>
</td>
<td class="nump">$ 323,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent', window );">Change in unbilled receivables</a></td>
<td class="nump">334,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="nump">183,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Increase in advance payments netted against unbilled contracts receivable</a></td>
<td class="nump">151,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Bad debt expense</a></td>
<td class="nump">17,800<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 13,700,000<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="nump">52.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166728968320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Opening provision</a></td>
<td class="nump">$ 7,081<span></span>
</td>
<td class="nump">$ 7,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Amounts used during the year</a></td>
<td class="num">(3,913)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccountsReceivableCreditLossExpense', window );">Amounts provided during the year</a></td>
<td class="nump">17,800<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccountsReceivableCreditLossReversal', window );">Amounts released during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(544)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments', window );">Foreign exchange</a></td>
<td class="num">(406)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">&#160; Closing provision</a></td>
<td class="nump">$ 20,562<span></span>
</td>
<td class="nump">$ 7,081<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccountsReceivableCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccountsReceivableCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccountsReceivableCreditLossReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Reversal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccountsReceivableCreditLossReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720930976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, PRA Acquisition (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>Employee </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">41,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 75,391<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld', window );">Business acquisition, share price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld', window );">Business acquisition, number of shares issued (in shares) | shares</a></td>
<td class="nump">0.4125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,700<span></span>
</td>
<td class="nump">198,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">57,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Gross debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TransactionAndOneTimeFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction And One Time Financing Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TransactionAndOneTimeFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721279056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,914,475<span></span>
</td>
<td class="nump">$ 47,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">$ 5,308,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of ordinary shares issued to acquiree stockholders</a></td>
<td class="nump">5,658,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredOther1', window );">Fair value of replacement share-based awards issued to acquiree employees</a></td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Repayment of term loan obligations and accrued interest</a></td>
<td class="nump">865,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">12,041,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate', window );">Payments to settle debt obligations that existed prior to acquisition date</a></td>
<td class="nump">$ 401,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredOther1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredOther1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724727184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">18 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,971,670,000<span></span>
</td>
<td class="nump">$ 9,037,931,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 936,257,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable and unbilled revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,851,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,601,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,084,314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,919,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,259,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(380,048,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,506,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(739,278,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability', window );">Non-current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,204,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,119,762,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204,291,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,041,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731297696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) - PRA Health Sciences, Inc<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,919,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 3,938,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 168,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Estimated Fair Value</a></td>
<td class="nump">$ 111,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724703744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) - PRA Health Sciences, Inc - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue', window );">Accounts receivable and unbilled revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147,039)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue', window );">Unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities', window );">Non-current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities', window );">Non-current deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (151,098)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Amortization adjustment</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">Accounting Standards Update 2021-08</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue', window );">Unearned revenue</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202108Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202108Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721045136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 34,388<span></span>
</td>
<td class="nump">$ 22,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="nump">4,650,300<span></span>
</td>
<td class="nump">5,507,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Identifiable intangible assets, net</a></td>
<td class="nump">4,278,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">13,250,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">$ 8,971,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724238576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">$ 1,713<span></span>
</td>
<td class="nump">$ 1,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term) (b)</a></td>
<td class="nump">32,663<span></span>
</td>
<td class="nump">20,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">34,388<span></span>
</td>
<td class="nump">22,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">3,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments (c)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments (c)</a></td>
<td class="nump">3,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="nump">1,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term) (b)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="nump">1,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments (c)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments (c)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term) (b)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">3,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments (c)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments (c)</a></td>
<td class="nump">3,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term) (b)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments (c)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments (c)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8a)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale investments (long-term) (b)</a></td>
<td class="nump">32,663<span></span>
</td>
<td class="nump">20,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">32,663<span></span>
</td>
<td class="nump">$ 20,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments (c)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments (c)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720955584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments</a></td>
<td class="nump">$ 1,713<span></span>
</td>
<td class="nump">$ 1,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod', window );">Short term investments average maturity period</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements', window );">Debt securities, available for sale, cumulative amount advanced under subscription agreements</a></td>
<td class="nump">$ 20,600<span></span>
</td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Increase (decrease) in equity securities, FV-NI</a></td>
<td class="nump">6,300<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of long-term investments in equity</a></td>
<td class="nump">32,600<span></span>
</td>
<td class="nump">22,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CommitmentToAcquireLongTermInvestments', window );">Commitment to acquire future long-term investments</a></td>
<td class="nump">23,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage', window );">Majority investor, ownership percentage</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany', window );">Period majority voting share capital can be sold to the company</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">$ 3,136<span></span>
</td>
<td class="nump">2,161<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership Percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInEquityMethodInvestments', window );">Increase (decrease) in equity method investments</a></td>
<td class="num">(2,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions', window );">Loan granted tp related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party, loan interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EquityMethodInvestmentDecreaseInLoanReceivable', window );">Equity method investment, decrease in loan receivable</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedParties', window );">Loans and Leases Receivable, Related Parties</a></td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CommitmentToAcquireLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment To Acquire Long-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CommitmentToAcquireLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentDecreaseInLoanReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Decrease In Loan Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentDecreaseInLoanReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Majority Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentMajorityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short Term Available For Sale Investments Average Remaining Maturity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount of new advances made to related parties in the form of loan and lease receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721216848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 24, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,373<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership Percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724346368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 3,724<span></span>
</td>
<td class="nump">$ 3,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building</a></td>
<td class="nump">70,880<span></span>
</td>
<td class="nump">82,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Computer equipment and software</a></td>
<td class="nump">500,135<span></span>
</td>
<td class="nump">506,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Office furniture and fixtures</a></td>
<td class="nump">50,600<span></span>
</td>
<td class="nump">107,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Laboratory equipment</a></td>
<td class="nump">59,946<span></span>
</td>
<td class="nump">29,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">65,167<span></span>
</td>
<td class="nump">70,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_VehiclesGross', window );">Motor vehicles</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">750,493<span></span>
</td>
<td class="nump">798,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and asset write offs</a></td>
<td class="num">(400,173)<span></span>
</td>
<td class="num">(462,524)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment (net)</a></td>
<td class="nump">350,320<span></span>
</td>
<td class="nump">336,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 106,426<span></span>
</td>
<td class="nump">$ 75,484<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VehiclesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vehicles, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VehiclesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721412672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Opening goodwill</a></td>
<td class="nump">$ 9,037,931<span></span>
</td>
<td class="nump">$ 936,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Current year acquisitions (note 6)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,120,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Prior period acquisition (note 6)</a></td>
<td class="num">(35,692)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange movement</a></td>
<td class="num">(30,569)<span></span>
</td>
<td class="num">(18,332)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Closing goodwill</a></td>
<td class="nump">$ 8,971,670<span></span>
</td>
<td class="nump">$ 9,037,931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727302160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721281824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Summary of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 5,109,212<span></span>
</td>
<td class="nump">$ 5,081,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(830,553)<span></span>
</td>
<td class="num">(370,538)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">&#160; Net book value</a></td>
<td class="nump">4,278,659<span></span>
</td>
<td class="nump">4,710,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">4,076,435<span></span>
</td>
<td class="nump">4,056,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">536,934<span></span>
</td>
<td class="nump">528,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">204,621<span></span>
</td>
<td class="nump">204,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">170,238<span></span>
</td>
<td class="nump">170,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 120,984<span></span>
</td>
<td class="nump">$ 121,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724076848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">18 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 4,919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 453,600<span></span>
</td>
<td class="nump">$ 677,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 3,938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc | Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="nump">$ 111,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166725206448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Future Intangible Asset Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 460,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">339,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">223,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">209,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">198,300<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet', window );">Finite lived intangible assets, amortization expense, net, total</a></td>
<td class="nump">$ 1,432,306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Amortization Expense, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720933184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">General trade and overhead liabilities</a></td>
<td class="nump">$ 530,204<span></span>
</td>
<td class="nump">$ 459,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Personnel related liabilities</a></td>
<td class="nump">395,862<span></span>
</td>
<td class="nump">413,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">43,657<span></span>
</td>
<td class="nump">49,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Facility related liabilities</a></td>
<td class="nump">16,896<span></span>
</td>
<td class="nump">12,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">12,852<span></span>
</td>
<td class="nump">7,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RestructuringReserveandOtherLiabilitiesCurrent', window );">Restructuring liabilities</a></td>
<td class="nump">5,512<span></span>
</td>
<td class="nump">7,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CapitalGovernmentGrantsCurrent', window );">Short term government grants</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">1,005,025<span></span>
</td>
<td class="nump">949,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 406,300<span></span>
</td>
<td class="nump">$ 323,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CapitalGovernmentGrantsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Government Grants Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CapitalGovernmentGrantsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveandOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveandOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166730227824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 4,701,213<span></span>
</td>
<td class="nump">$ 5,501,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtCurrentMaturitiesGross', window );">Less current portion of long-term debt and debt issuance costs</a></td>
<td class="num">(55,150)<span></span>
</td>
<td class="num">(55,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross', window );">Total long-term debt</a></td>
<td class="nump">4,646,063<span></span>
</td>
<td class="nump">5,446,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less long-term portion of debt issuance costs and debt discount</a></td>
<td class="num">(47,026)<span></span>
</td>
<td class="num">(64,901)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net</a></td>
<td class="nump">$ 4,599,037<span></span>
</td>
<td class="nump">$ 5,381,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Credit Facilities: | Senior Secured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">7.092%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 4,201,213<span></span>
</td>
<td class="nump">$ 5,001,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes | Senior Secured Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Excluding Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtExcludingCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720264240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current Bank Credit Lines and Loan Facilities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 29, 2021</div></th>
<th class="th"><div>Sep. 27, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,731<span></span>
</td>
<td class="nump">$ 182,423<span></span>
</td>
<td class="nump">$ 13,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,918<span></span>
</td>
<td class="nump">106,205<span></span>
</td>
<td class="nump">$ 13,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,650,300<span></span>
</td>
<td class="nump">5,507,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="nump">$ 86,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Senior Secured Term Loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Senior Secured Term Loan | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component one | Base rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Credit Facilities: | Senior secured credit facility and senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Credit Facilities: | Senior Secured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">7.092%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of senior debt</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">66,100<span></span>
</td>
<td class="nump">53,600<span></span>
</td>
<td class="nump">39,400<span></span>
</td>
<td class="nump">35,100<span></span>
</td>
<td class="nump">40,800<span></span>
</td>
<td class="nump">$ 40,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtRestructuringCosts', window );">Payments of debt restructuring costs</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Credit Facilities: | Senior Secured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | Senior secured revolving loan facility | Revolving loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes | Senior Secured Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166728952528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on drawn facilities</a></td>
<td class="nump">$ 209,189<span></span>
</td>
<td class="nump">$ 93,809<span></span>
</td>
<td class="nump">$ 13,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">17,749<span></span>
</td>
<td class="nump">12,890<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_TransactionAndOneTimeFinancingCosts', window );">Transaction and one time financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,391<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_InterestExpenseCreditOther', window );">Other financing costs/(credits)</a></td>
<td class="nump">2,793<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="num">(910)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total financing costs</a></td>
<td class="nump">$ 229,731<span></span>
</td>
<td class="nump">$ 182,423<span></span>
</td>
<td class="nump">$ 13,019<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_InterestExpenseCreditOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense (Credit), Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_InterestExpenseCreditOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TransactionAndOneTimeFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction And One Time Financing Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TransactionAndOneTimeFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731117984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtMaturityYearFiveAndThereafter', window );">2027 and thereafter</a></td>
<td class="nump">4,480,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt, net</a></td>
<td class="nump">$ 4,701,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtMaturityYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, Year Five And Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtMaturityYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724673792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 29, 2022 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>tranche</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net</a></td>
<td class="num">$ (3,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, Fair Value, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Derivative, number of instruments held | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate derivatives held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps | Total derivatives designated as hedging instruments | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf', window );">Derivative, variable interest rate, reference rate in excess of</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Variable Interest Rate, Reference Rate In Excess Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DerivativeVariableInterestRateReferenceRateInExcessOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721033856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) - Total derivatives designated as hedging instruments<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">3,363,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">2,100,606,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">307,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">1,100,606,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Interest rate cap and interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">3,670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 3,201,213,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166726682000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 53,880<span></span>
</td>
<td class="nump">$ 51,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Income from sub-leases</a></td>
<td class="num">(1,165)<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 52,715<span></span>
</td>
<td class="nump">$ 49,862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166723905712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 52,715<span></span>
</td>
<td class="nump">$ 49,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">28,700<span></span>
</td>
<td class="nump">10,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of long lived assets</a></td>
<td class="nump">$ 24,800<span></span>
</td>
<td class="nump">$ 15,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 10 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="nump">2.51%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">$ 43,657<span></span>
</td>
<td class="nump">$ 49,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 48,300<span></span>
</td>
<td class="nump">$ 47,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724731040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Operating Lease Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 47,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">34,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">25,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">20,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">17,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">45,065<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">189,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lease imputed interest</a></td>
<td class="num">(14,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 175,301<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721427392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current other liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Defined benefit pension obligations, net (note 21)</a></td>
<td class="nump">$ 13,033<span></span>
</td>
<td class="nump">$ 16,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">25,227<span></span>
</td>
<td class="nump">26,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Liabilities, Noncurrent</a></td>
<td class="nump">$ 38,260<span></span>
</td>
<td class="nump">$ 42,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166731089456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Non-cancelable operating leases for facilities expiration period</a></td>
<td class="text">12 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720694288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 18, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 22, 2016</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 08, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 03, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_NumberOfVotes', window );">Number of votes | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,844,000<span></span>
</td>
<td class="nump">$ 118,589,000<span></span>
</td>
<td class="nump">$ 13,203,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember', window );">Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares)</a></td>
<td class="nump">420,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,235,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,026,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="nump">$ 141,600,000<span></span>
</td>
<td class="nump">$ 372,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_StockRepurchaseProgramAuthorizedPercentage', window );">Stock repurchase program, authorized percentage (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="nump">193,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Average exercise price of option per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102.87<span></span>
</td>
<td class="nump">$ 111.29<span></span>
</td>
<td class="nump">$ 68.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,800,000<span></span>
</td>
<td class="nump">$ 118,600,000<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,029<span></span>
</td>
<td class="nump">446,404<span></span>
</td>
<td class="nump">144,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,087<span></span>
</td>
<td class="nump">44,132<span></span>
</td>
<td class="nump">63,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="nump">1,065,529<span></span>
</td>
<td class="nump">193,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issue of shares associated with a business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,372,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,235,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_StockRepurchaseProgramAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program Authorized Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_StockRepurchaseProgramAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724228176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 31,143<span></span>
</td>
<td class="nump">$ 31,105<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">6,022<span></span>
</td>
<td class="nump">$ 10,311<span></span>
</td>
<td class="nump">$ 4,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember', window );">2021 Restructuring Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">31,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other restructuring costs</a></td>
<td class="nump">24,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Fixed asset impairment</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember', window );">Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring reserve, current</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring reserve, noncurrent</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=iclr_A2021RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iclr_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729323264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 31,143<span></span>
</td>
<td class="nump">$ 31,105<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727722288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Restructuring Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Opening provision</a></td>
<td class="nump">$ 10,311<span></span>
</td>
<td class="nump">$ 4,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Additional provision in the year</a></td>
<td class="nump">4,364<span></span>
</td>
<td class="nump">11,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RestructuringReserveUtilizations', window );">Utilization</a></td>
<td class="num">(8,653)<span></span>
</td>
<td class="num">(5,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending provision</a></td>
<td class="nump">$ 6,022<span></span>
</td>
<td class="nump">$ 10,311<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveUtilizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve Utilizations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveUtilizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166730220016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="nump">$ 567,851<span></span>
</td>
<td class="nump">$ 196,680<span></span>
</td>
<td class="nump">$ 381,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="nump">432,963<span></span>
</td>
<td class="nump">231,893<span></span>
</td>
<td class="nump">280,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="num">(270,440)<span></span>
</td>
<td class="num">(278,413)<span></span>
</td>
<td class="nump">41,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">&#160; Income before income tax expense</a></td>
<td class="nump">$ 405,328<span></span>
</td>
<td class="nump">$ 243,200<span></span>
</td>
<td class="nump">$ 58,945<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166723979744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">$ 184,396<span></span>
</td>
<td class="nump">$ 101,950<span></span>
</td>
<td class="nump">$ 46,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(124,985)<span></span>
</td>
<td class="num">(60,616)<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense allocated to continuing operations</a></td>
<td class="nump">59,411<span></span>
</td>
<td class="nump">41,334<span></span>
</td>
<td class="nump">47,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax expense was allocated to the following components of other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Currency impact on long term funding</a></td>
<td class="nump">7,211<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity', window );">Total</a></td>
<td class="nump">66,622<span></span>
</td>
<td class="nump">43,110<span></span>
</td>
<td class="nump">47,943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">53,248<span></span>
</td>
<td class="nump">18,469<span></span>
</td>
<td class="nump">28,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(6,166)<span></span>
</td>
<td class="nump">553<span></span>
</td>
<td class="nump">1,654<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">60,753<span></span>
</td>
<td class="nump">35,478<span></span>
</td>
<td class="nump">3,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(118,475)<span></span>
</td>
<td class="num">(52,717)<span></span>
</td>
<td class="nump">4,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">70,395<span></span>
</td>
<td class="nump">48,003<span></span>
</td>
<td class="nump">14,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">$ (344)<span></span>
</td>
<td class="num">$ (8,452)<span></span>
</td>
<td class="num">$ (5,304)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166723925376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</a></td>
<td class="nump">$ 70,980<span></span>
</td>
<td class="nump">$ 24,586<span></span>
</td>
<td class="nump">$ 47,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization', window );">Rate differential from amortization of intangible assets</a></td>
<td class="num">(59,330)<span></span>
</td>
<td class="num">(31,228)<span></span>
</td>
<td class="num">(2,298)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign and other income taxed at higher rates</a></td>
<td class="nump">52,464<span></span>
</td>
<td class="nump">51,273<span></span>
</td>
<td class="nump">10,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research &amp; development tax incentives</a></td>
<td class="num">(2,608)<span></span>
</td>
<td class="num">(3,120)<span></span>
</td>
<td class="num">(1,243)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Movement in valuation allowance</a></td>
<td class="num">(777)<span></span>
</td>
<td class="nump">3,101<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Effects of change in tax rates</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Change in unrecognized tax benefits</a></td>
<td class="nump">8,392<span></span>
</td>
<td class="nump">5,246<span></span>
</td>
<td class="num">(1,672)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Impact of stock compensation</a></td>
<td class="num">(8,756)<span></span>
</td>
<td class="num">(9,083)<span></span>
</td>
<td class="num">(5,150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="num">(654)<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="num">(3,343)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense allocated to continuing operations</a></td>
<td class="nump">$ 59,411<span></span>
</td>
<td class="nump">$ 41,334<span></span>
</td>
<td class="nump">$ 47,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724154064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 10,927<span></span>
</td>
<td class="nump">$ 19,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating right-of-use-assets</a></td>
<td class="nump">23,260<span></span>
</td>
<td class="nump">33,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="nump">37,150<span></span>
</td>
<td class="nump">33,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Intangible assets</a></td>
<td class="nump">1,078,302<span></span>
</td>
<td class="nump">1,201,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">9,054<span></span>
</td>
<td class="nump">1,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">&#160; Total deferred tax liabilities recognized</a></td>
<td class="nump">1,158,693<span></span>
</td>
<td class="nump">1,289,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards', window );">Operating loss and tax credits carryforwards</a></td>
<td class="nump">88,697<span></span>
</td>
<td class="nump">86,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">6,010<span></span>
</td>
<td class="nump">5,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">27,593<span></span>
</td>
<td class="nump">36,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">3,602<span></span>
</td>
<td class="nump">4,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses and unbilled revenue</a></td>
<td class="nump">64,016<span></span>
</td>
<td class="nump">69,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Stock compensation</a></td>
<td class="nump">21,862<span></span>
</td>
<td class="nump">25,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Deferred compensation</a></td>
<td class="nump">2,917<span></span>
</td>
<td class="nump">3,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">66,565<span></span>
</td>
<td class="nump">64,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">9,155<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">290,417<span></span>
</td>
<td class="nump">297,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(43,379)<span></span>
</td>
<td class="num">(45,495)<span></span>
</td>
<td class="num">$ (32,800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets recognized</a></td>
<td class="nump">247,038<span></span>
</td>
<td class="nump">251,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">&#160; Overall net deferred tax asset/(liability)</a></td>
<td class="num">$ (911,655)<span></span>
</td>
<td class="num">$ (1,037,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Contract With Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720397360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="nump">$ 43,379,000<span></span>
</td>
<td class="nump">$ 45,495,000<span></span>
</td>
<td class="nump">$ 32,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred tax liabilities, undistributed foreign earnings</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Unrecognized tax benefit, potentially expire in 2021</a></td>
<td class="nump">37,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Total unrecognized tax benefits net of potential benefits</a></td>
<td class="nump">217,600,000<span></span>
</td>
<td class="nump">202,100,000<span></span>
</td>
<td class="nump">19,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties recognized as an expense</a></td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Total accrued interest and penalties</a></td>
<td class="nump">22,600,000<span></span>
</td>
<td class="nump">15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_AcquiredEntityMember', window );">Acquired entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="num">(4,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember', window );">Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="num">$ (900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">37,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country | Tax Year 2022 to 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country | Tax Year 2029 to 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Additional operating loss carryforward</a></td>
<td class="nump">18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">16,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingLossCarryforwardsUSFederal', window );">U.S. Federal net operating loss carry forwards currently available for offset</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax', window );">Alternative minimum tax credit carry forwards</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">5,363,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">U.S. federal net operating loss carry forwards</a></td>
<td class="nump">5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forward</a></td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">401,898,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">6,736,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingLossCarryforwardsUSFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, US Federal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingLossCarryforwardsUSFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_AcquiredEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_AcquiredEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2022To2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2022To2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2029To2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2029To2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721025968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Expected Expiry Dates of NOL's (Details) - United States<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">$ 6,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">401,898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2023-2036</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">249,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2033-2041</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">145,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">5,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2023-2036</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">5,268<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2033-2041</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2023To2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2023To2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear20332041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear20332041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166730216096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at start of year</a></td>
<td class="nump">$ 202,065<span></span>
</td>
<td class="nump">$ 19,078<span></span>
</td>
<td class="nump">$ 20,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Increase related to acquired tax positions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">170,047<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase related to prior year tax positions</a></td>
<td class="nump">16,098<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year tax positions</a></td>
<td class="num">(5,442)<span></span>
</td>
<td class="num">(1,695)<span></span>
</td>
<td class="num">(1,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">5,701<span></span>
</td>
<td class="nump">18,613<span></span>
</td>
<td class="nump">2,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(844)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of statute of limitations</a></td>
<td class="num">(838)<span></span>
</td>
<td class="num">(3,338)<span></span>
</td>
<td class="num">(2,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">&#160; Unrecognized tax benefits at end of year</a></td>
<td class="nump">$ 217,584<span></span>
</td>
<td class="nump">$ 202,065<span></span>
</td>
<td class="nump">$ 19,078<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720384848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 07, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember', window );">Other retirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">$ 11,600,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember', window );">ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember', window );">Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember', window );">PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Participant's contributions percentage of annual compensation (in percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost</a></td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 23,700,000<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">19,558,000<span></span>
</td>
<td class="nump">$ 41,813,000<span></span>
</td>
<td class="nump">$ 43,988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear', window );">Net loss that will be amortized</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear', window );">Net prior service cost for defined benefit pension plan that will be amortized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod', window );">Pension plan period</a></td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contribution to pension fund in the year ending December 31, 2021</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ExpectedRetirementPeriod', window );">Retirement period used as a basis to estimate expected cash flows</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">$ 5,806,000<span></span>
</td>
<td class="nump">$ 7,643,000<span></span>
</td>
<td class="nump">$ 8,620,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan | Aptiv Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Non-current other liabilities (note 16)</a></td>
<td class="nump">$ 5,345,000<span></span>
</td>
<td class="nump">$ 4,990,000<span></span>
</td>
<td class="nump">$ 4,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ExpectedRetirementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected Retirement period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ExpectedRetirementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_OtherRetirementPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_AptivSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_AptivSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166730019040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Summary of plan assets and liabilities (Details) - Pension Plan - United States - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other receivables</a></td>
<td class="nump">$ 6,492<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Non-current other liabilities (note 16)</a></td>
<td class="num">$ (13,033)<span></span>
</td>
<td class="num">$ (16,262)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724706128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Funded Status (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">$ (19,558)<span></span>
</td>
<td class="num">$ (41,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">26,050<span></span>
</td>
<td class="nump">36,198<span></span>
</td>
<td class="nump">$ 34,612<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded status</a></td>
<td class="nump">6,492<span></span>
</td>
<td class="num">(5,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">(5,806)<span></span>
</td>
<td class="num">(7,643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5,681<span></span>
</td>
<td class="nump">6,964<span></span>
</td>
<td class="nump">7,601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded status</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="num">(5,345)<span></span>
</td>
<td class="num">(4,990)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">$ 2,849<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">&#160;Funded status</a></td>
<td class="num">$ (1,286)<span></span>
</td>
<td class="num">$ (1,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721119744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Change in Benefit Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">$ 41,813<span></span>
</td>
<td class="nump">$ 43,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">514<span></span>
</td>
<td class="nump">489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(18,636)<span></span>
</td>
<td class="num">(2,097)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(3,913)<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">&#160; Benefit obligation at end of year</a></td>
<td class="nump">19,558<span></span>
</td>
<td class="nump">41,813<span></span>
</td>
<td class="nump">43,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">7,643<span></span>
</td>
<td class="nump">8,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers', window );">Benefits paid and transferred balances</a></td>
<td class="num">(182)<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(1,527)<span></span>
</td>
<td class="num">(484)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">&#160; Benefit obligation at end of year</a></td>
<td class="nump">5,806<span></span>
</td>
<td class="nump">7,643<span></span>
</td>
<td class="nump">8,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">4,990<span></span>
</td>
<td class="nump">4,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">2,396<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Settlement</a></td>
<td class="num">(844)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(627)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">&#160; Benefit obligation at end of year</a></td>
<td class="nump">$ 5,345<span></span>
</td>
<td class="nump">$ 4,990<span></span>
</td>
<td class="nump">$ 4,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721149200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Change in Plan Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom | ICON Development Solutions Limited pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">$ 36,198<span></span>
</td>
<td class="nump">$ 34,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">$ 1,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(7,305)<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(514)<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(3,676)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">26,050<span></span>
</td>
<td class="nump">36,198<span></span>
</td>
<td class="nump">34,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | Aptiv Solutions pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">6,964<span></span>
</td>
<td class="nump">7,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(987)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanSchemeContributions', window );">Scheme contributions</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers', window );">Benefits paid and transferred balances</a></td>
<td class="nump">182<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">5,681<span></span>
</td>
<td class="nump">6,964<span></span>
</td>
<td class="nump">7,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Switzerland | PRA Switzerland AG pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">2,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Plan participants' contributions</a></td>
<td class="nump">2,396<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(946)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlement</a></td>
<td class="num">(844)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign currency exchange rate changes</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">&#160;Fair value of plan assets at end of year</a></td>
<td class="nump">$ 4,059<span></span>
</td>
<td class="nump">$ 3,017<span></span>
</td>
<td class="nump">$ 2,849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanSchemeContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Scheme Contributions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanSchemeContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_AptivSolutionsPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_PRASwitzerlandAGPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729023296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Components of Net Periodic Benefit Cost (Details) - United Kingdom - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">665<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,258)<span></span>
</td>
<td class="num">(1,171)<span></span>
</td>
<td class="num">(1,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net loss</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">$ (241)<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="num">$ (208)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729019568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB', window );">United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income &#160;</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost', window );">Actuarial (gain)/loss - benefit obligation</a></td>
<td class="num">$ (18,636)<span></span>
</td>
<td class="num">$ (2,097)<span></span>
</td>
<td class="nump">$ 5,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Actuarial loss/(gain) &#8211; plan assets</a></td>
<td class="nump">7,305<span></span>
</td>
<td class="num">(1,176)<span></span>
</td>
<td class="num">(878)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax', window );">Actuarial loss recognized in net periodic benefit cost</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(625)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax', window );">&#160;Total</a></td>
<td class="num">$ (11,559)<span></span>
</td>
<td class="num">$ (3,898)<span></span>
</td>
<td class="nump">$ 4,256<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166732179232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) - United Kingdom - ICON Development Solutions Limited pension plan<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727978176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) - ICON Development Solutions Limited pension plan<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember', window );">Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">88.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember', window );">Diversified Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Bonds (including 50% high yield bonds)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember', window );">Secured Loans and Multi Asset Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166721095104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Plan Asset Fair Value Measurements (Details) - Level 1 - ICON Development Solutions Limited pension plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 26,050<span></span>
</td>
<td class="nump">$ 36,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Government Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">22,887<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Diversified Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,163<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Equities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Corporate Bonds (including 50% high yield bonds)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Secured Loans and Multi Asset Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,982<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_GovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=iclr_DiversifiedBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166725206608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Benefits - Annual Benefit Payments (Details) - United Kingdom - ICON Development Solutions Limited pension plan<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Years 2028 - 2032</a></td>
<td class="nump">$ 3,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166718738112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">252 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 14, 2017</div></th>
<th class="th"><div>May 11, 2015</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 18, 2020</div></th>
<th class="th"><div>May 16, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 13, 2017</div></th>
<th class="th"><div>Sep. 23, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">5 years 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable - weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 3 months<span></span>
</td>
<td class="text">4 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,523<span></span>
</td>
<td class="nump">$ 133,844<span></span>
</td>
<td class="nump">$ 26,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit related to stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
<td class="nump">22,700<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Cash tax benefit related to stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="nump">23,900<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember', window );">The 2018 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_A2013LegacyPRAPlanMember', window );">2013 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,052,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized', window );">Percentage of outstanding shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember', window );">The 2020 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember', window );">Consultants Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted', window );">Limit of shares issued or to be issued pursuant to options granted (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember', window );">Employee Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member', window );">Option Plans 2008 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of option price for fair value of ordinary share (in percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, prior to 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Shares expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember', window );">Restricted Stock Units 2013</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019 | Non-executive director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,100<span></span>
</td>
<td class="nump">$ 83,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137.47<span></span>
</td>
<td class="nump">$ 115.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265.96<span></span>
</td>
<td class="nump">$ 206.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137.47<span></span>
</td>
<td class="nump">$ 115.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166.51<span></span>
</td>
<td class="nump">$ 125.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember', window );">PSUs Based on Service and EPS Targets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock units to be granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation Related Costs Share Based Payments Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limit of Shares Issued or To Be Issued Pursuant to Options Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_A2013LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_A2013LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724160000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) - Stock Option and Award Plans - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Granted Under Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,695,460<span></span>
</td>
<td class="nump">553,746<span></span>
</td>
<td class="nump">656,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination', window );">Assumed through business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,177,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">108,643<span></span>
</td>
<td class="nump">100,299<span></span>
</td>
<td class="nump">107,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(348,286)<span></span>
</td>
<td class="num">(1,065,529)<span></span>
</td>
<td class="num">(193,417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/expired (in shares)</a></td>
<td class="num">(77,698)<span></span>
</td>
<td class="num">(70,186)<span></span>
</td>
<td class="num">(16,681)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,378,119<span></span>
</td>
<td class="nump">1,695,460<span></span>
</td>
<td class="nump">553,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and exercisable at end of period (in shares)</a></td>
<td class="nump">1,047,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (USD per share)</a></td>
<td class="nump">$ 110.38<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice', window );">Assumed through business combination (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">229.94<span></span>
</td>
<td class="nump">177.76<span></span>
</td>
<td class="nump">159.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">102.87<span></span>
</td>
<td class="nump">111.29<span></span>
</td>
<td class="nump">68.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled/expired (USD per share)</a></td>
<td class="nump">143.08<span></span>
</td>
<td class="nump">128.46<span></span>
</td>
<td class="nump">92.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (USD per share)</a></td>
<td class="nump">119.86<span></span>
</td>
<td class="nump">$ 110.38<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 102.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166730119152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">$ 14.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">231.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member', window );">Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">14.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">96.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member', window );">Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">103.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">124.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member', window );">Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">125.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">147.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member', window );">Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Minimum Range Exercise Price (USD per share)</a></td>
<td class="nump">159.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Maximum Range Exercise Price (USD per share)</a></td>
<td class="nump">$ 231.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">1,378,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price (USD per share)</a></td>
<td class="nump">$ 119.86<span></span>
</td>
<td class="nump">$ 110.38<span></span>
</td>
<td class="nump">$ 108.53<span></span>
</td>
<td class="nump">$ 87.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">1,047,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 102.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">494,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">494,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">226,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 6 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">203,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">386,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">5 years 7 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">303,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember', window );">Stock Option and Award Plans | Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">270,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">6 years 2 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Shares (in shares)</a></td>
<td class="nump">46,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=iclr_Range4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166725181952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) - Employee Stock Option - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (USD per share)</a></td>
<td class="nump">$ 107.21<span></span>
</td>
<td class="nump">$ 68.42<span></span>
</td>
<td class="nump">$ 49.15<span></span>
</td>
<td class="nump">$ 42.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (in percent)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (in percent)</a></td>
<td class="nump">0.56%<span></span>
</td>
<td class="nump">1.86%<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
<td class="nump">0.57%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166718522784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">154,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">64,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares) | shares</a></td>
<td class="num">(46,087)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(20,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares) | shares</a></td>
<td class="nump">152,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 160.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">229.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share) | $ / shares</a></td>
<td class="nump">140.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">185.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 192.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">572,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">302,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares) | shares</a></td>
<td class="num">(195,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(97,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares) | shares</a></td>
<td class="nump">582,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 191.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">216.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share) | $ / shares</a></td>
<td class="nump">174.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">205.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 207.73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166728935088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">$ 70,523<span></span>
</td>
<td class="nump">$ 133,844<span></span>
</td>
<td class="nump">$ 26,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">22,854<span></span>
</td>
<td class="nump">18,551<span></span>
</td>
<td class="nump">8,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">47,669<span></span>
</td>
<td class="nump">41,457<span></span>
</td>
<td class="nump">17,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember', window );">Transaction and integration related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total compensation costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 73,836<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_TransactionAndIntegrationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166727579232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of reporting segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724361648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 7,741,386<span></span>
</td>
<td class="nump">$ 5,480,826<span></span>
</td>
<td class="nump">$ 2,797,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,984,567<span></span>
</td>
<td class="nump">1,365,909<span></span>
</td>
<td class="nump">1,181,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,618,350<span></span>
</td>
<td class="nump">1,175,515<span></span>
</td>
<td class="nump">416,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,574,610<span></span>
</td>
<td class="nump">2,581,007<span></span>
</td>
<td class="nump">925,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 563,859<span></span>
</td>
<td class="nump">$ 358,395<span></span>
</td>
<td class="nump">$ 273,549<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720893984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">$ 795,237<span></span>
</td>
<td class="nump">$ 378,529<span></span>
</td>
<td class="nump">$ 391,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">218,088<span></span>
</td>
<td class="nump">131,961<span></span>
</td>
<td class="nump">276,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">253,799<span></span>
</td>
<td class="nump">177,863<span></span>
</td>
<td class="nump">35,765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">254,849<span></span>
</td>
<td class="nump">39,132<span></span>
</td>
<td class="nump">58,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses', window );">Income from operations, excluding restructuring and other items</a></td>
<td class="nump">$ 68,501<span></span>
</td>
<td class="nump">$ 29,573<span></span>
</td>
<td class="nump">$ 21,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166725216512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 504,152<span></span>
</td>
<td class="nump">$ 534,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">143,025<span></span>
</td>
<td class="nump">118,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">99,721<span></span>
</td>
<td class="nump">121,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">213,311<span></span>
</td>
<td class="nump">239,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 48,095<span></span>
</td>
<td class="nump">$ 55,312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166720634032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</a></td>
<td class="nump">81,532,320<span></span>
</td>
<td class="nump">67,110,186<span></span>
</td>
<td class="nump">52,859,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive share options outstanding (in shares)</a></td>
<td class="nump">936,043<span></span>
</td>
<td class="nump">958,125<span></span>
</td>
<td class="nump">423,674<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</a></td>
<td class="nump">82,468,363<span></span>
</td>
<td class="nump">68,068,311<span></span>
</td>
<td class="nump">53,283,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724728192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Group</a></td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 332,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Noncontrolling interest adjustment to redemption amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to the Group (including NCI redemption adjustment)</a></td>
<td class="nump">$ 505,304<span></span>
</td>
<td class="nump">$ 153,185<span></span>
</td>
<td class="nump">$ 327,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net income per Ordinary Share attributable to the Group (Note 24):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 6.20<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="nump">$ 6.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166729514768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
<td class="num">$ (175,369)<span></span>
</td>
<td class="num">$ (85,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Actuarial gain/(loss) on defined benefit pension plan (note 21)</a></td>
<td class="nump">7,559<span></span>
</td>
<td class="num">(5,098)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax', window );">Loss on cash flow hedge</a></td>
<td class="nump">3,728<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax', window );">Amortization of loss on cash flow hedge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">&#160;Total</a></td>
<td class="num">$ (171,538)<span></span>
</td>
<td class="num">$ (90,937)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166726653856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 210,918<span></span>
</td>
<td class="nump">$ 106,205<span></span>
</td>
<td class="nump">$ 13,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes (net of refunds)</a></td>
<td class="nump">$ 116,322<span></span>
</td>
<td class="nump">$ 55,105<span></span>
</td>
<td class="nump">$ 27,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140166724128752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage', window );">Majority investor, ownership percentage</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership Percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_DSBiopharmaLimitedMember', window );">DS Biopharma Limited | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue earned from related parties</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember', window );">Afimmune Limited | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue earned from related parties</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember', window );">Corvus Pharmaceuticals | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue earned from related parties</a></td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses incurred from related party transactions</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions', window );">Loan granted tp related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party, loan interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_InterestReceivableRelatedPartyLoans', window );">Interest receivable, related party loans</a></td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember', window );">Oncacare | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amounts due from related parties</a></td>
<td class="nump">$ 715<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EquityMethodInvestmentMajorityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Majority Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EquityMethodInvestmentMajorityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_InterestReceivableRelatedPartyLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Receivable, Related Party Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_InterestReceivableRelatedPartyLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount of new advances made to related parties in the form of loan and lease receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_DSBiopharmaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_DSBiopharmaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>iclr-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iclr="http://www.iconplc.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iclr-20221231.xsd" xlink:type="simple"/>
    <context id="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia06e61e30b434302889007f7159b05f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3bdf1ab44b5e470db76e3745541d3db7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7e5ed959ca1442c959fca1bf9fa7721_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9fbbf07b0e4449ea3a2f6cd81f22401_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19a880fd5d814e9092b5ca671bb8d41b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8965558006f4684a7fc1512daffa72e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib2dc7dff39c546919fdaf6c9f59e5e5e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c028363c21c48d5bdb88ba826d38299_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7d1a9ae0fba46c192371319b4901064_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifd0a7d988df847dc9a616929e7ace798_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32c05ec529b64737a2cf079cbb19be5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i940965b309ab4ce497c779391f42b662_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8d96ff5211446f09d3fabef56b1bb6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5629eb301d784ca99de6ddbf87220b6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80faf766e38749ef9bf49c0793bed5d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27e29b8c979344a0bbaf83ef3e7130d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i99ae0c3dbbc541b3aa82c3713e418873_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i630de7cf74954c889cb5f55191084e94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69908ebb3c9340018ae4adb8ef47236e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib11a3b57f4ac4425a287a5353f3e2695_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0d85418de1a4b0a817652360cfe0815_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib227c36803504cc68f096847a5faff4a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4addd48255bb44beb36787ed5df4e0bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5fe1a0341a694fcf9f094af87a903fe5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50e931e0964047f1b6a05248f9f9ae86_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ea7296eec334826b983a9b2012723a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54b2495a48164218a19af1d3f594f087_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87251223f7f94618a9d593180c9e6f6b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i25b768baea2347c69afde3c3be439fd8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i92bd1d25d98e4448ad3ea7952d2ee232_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5d681611048348019dc67e17504b3c0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7e66e1c160f148649eb21d89bbf2625a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f8a2c39e7124f16b49ad2a09d9b25af_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8aa76511dda54693974dbb4e12681b0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2c614a0351ee4d65b7706dbb34ed6783_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0cc8557895694ddda58a406b0e47873c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i423bdb53508049b790b135a49d542ab9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iff41f4c3905c417bbe6fbf9952151d95_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ff6c4c1b4574a40829f531f7210e9bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idb366a4aaf994d7e840ad3fff4c1fe43_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i69bb660dc51543a1937c2ecfd5d7b2b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:MeDiNovaResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="i8b703a470aec45d6b7cc535d913a035b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i380e176b9dde4914abac25ae65cca717_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1998d53019114a92910d0b987e09e9eb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79832711688241cdbc03301d09dc65ed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6b4f29d3e2b241b690b68915c03d5e7d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia706efb7e7544d30a249a2933512bbd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibdedac9e58504241a677dd5e16834802_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i56f70ffa378f4eb6b7bea34717f35edc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d0066899c49400d88bd9e23928ccc84_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id595e6ca907842c5ad25832951a08162_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70f2210593f144b18961bb25bb1f64c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a8bcfc7e9ad4cd49adf68eaea5ab3c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44ee1247f39e40e095600c4da686996e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i06f0ea2e03f744609e1793a8709bb329_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbc54966d15445729a0ed93be99fdbd0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff7ba07c4dd648098208327ed22330c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23de17af5ea240e78dfcd77718adcfbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id34237e03be942cc9cc2d0552e1de455_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8fc3e32cee5c4cfcbaa4850d89f898d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68cade11881441f999fe48a8b78fa866_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i050bc2a0894b4b519c23ad5dce7c546e_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i65f325e72d854376869d44f5fabc8e75_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i13749761bedc4da99e05caac9043517b_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i1d23344e0fb3451da6613835547ccb77_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i80606786953145dfbdfda1d4010d7f1f_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ib000d5e1b7c444a98c09c3082b538879_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="ib8ea9f2d8c19438a8322337241492d6e_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="if7d00b00550d4bf9a90bced55d00862b_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i785f8636543e4f9b9285f8e0d63b6d2b_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i17edec93a2294c3e907c490cbb645326_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202108Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i545583d261e248808f2d3bb26a97013b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4b3262da32f4ec8a9c378573864a2a9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e66629c475a4b72b7b830a3e6cb2836_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i978c79fbe78442ada8654ab753363b19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84f84f639a8649b7a29a53533025129f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3be311173d9c44eaafe06fb2c2cbcb3c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if90e03c93c3749469a8dfb4fe97cb995_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30afec82ea9e4d6a8f448ccc557ea553_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19fb8c40650e450eb5e1d079288ab103_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if1dd30bace194434bd26b61b92a84a73_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie22508cde176416eab9afbb5c12f542f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia559e02117534d508ae08e434af35be9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1b4df5e6293480bb188a651b53aa3c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9eac6e85f2054a39b9b4982e267fcdef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia09cfcf09c5a4518ae153515930d8057_I20200724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2020-07-24</instant>
        </period>
    </context>
    <context id="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68d39bd6a1934626911076815f36ce28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia961c12b79494b50a3b7b747a2ce04be_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf5fe76c69e241d7915327e838e9518c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic314749132274d02aea042862e1ff17e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib6f27ae8e7bb4ec5971a6b2ef9dd55a9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a1a18520e4146e3bf6b3a13e3cda74a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75b7882f940f48d3bc7d90326129e9b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i65d528e27c0d424aac74d9e73663d3ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icdec972de61b4fbd8c3f8f4491dbed10_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia25ff6d598af43409a6d48cb1b0d9f54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i316a10f3c60140a48775f64331d68546_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife9f6a75108b4d089ed6659cb9248d3f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f3e6836101246c5bd0e37de3cea7ad5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i58f1d881a21f42408d4bd3c83abd2de9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i039aaafb5ef843fb87c3be6202c32cb9_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ifc1a2a8295744e79af710d3f51492b51_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i4cc15efef07d4621bf232d0f905e24d3_D20210702-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i24b1b179f187445baaff8a1b7341bce6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id74f7c384d114c429cd9f1b01c113138_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0eb8fbd8473746a0b208ab4cd0032180_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c9e575e36904396a0c52344f4a1fe00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide0a04931f8947b899f8a0add7253478_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i7a12d28f277f4f588bf639313db05a59_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i10cb599ff8ed4f01b9d901f229fe45d0_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i0b2dee78f7f644cb9cf3be42bf7515de_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i052ec038b97a434685e03cb2338cefaa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5dd8ae45a3c84a79b7b93908eb3e3fe9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4749ad89af054d8e90ce981f202f2a6f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2aef30afb12349bb8e0ae5fbd3b724d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ad4568f232b4720a904bbd4f0c5c5d2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9dfcce19405042819f3d7cea53081ae1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6e2abed11d6d469e981a5915d01e0802_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i74787ba7e2484b3abeeb226f25f7e944_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-30</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-29</startDate>
            <endDate>2021-12-29</endDate>
        </period>
    </context>
    <context id="i371d9f7891584afea9de5a762c9f6442_D20210927-20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="i54726d34a41d4914b87f6221632a03b8_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="ide8dd376ffe34328bce020b65607602b_I20221129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="iae02d67aa86647b19a16902930f2619d_I20221129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="if39e82a87e3d497b96438f71c9904738_I20221129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="if27a87a7700d4f5fa4a149e379b8f150_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84bd4efdef4d4094902c5e2aee086859_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibba1eb9117d6498ba61cd2ffd7a3dcc5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifdf34dd45633475d9db22cc8203941ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id197fe0d372441f4971e65ae556f9189_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iec0d3c91746049cfa76770f5e2f12ef5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i323bd4358f4848aba9899c235c5c8a82_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia5098738b6444670841da7baa2b82cff_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac28acede97e485190e5dcb59f035565_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ica93147573064c84b3ee259a15e2e86a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd327ac55d2743019d27972465de1bc4_D20160722-20160722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-22</startDate>
            <endDate>2016-07-22</endDate>
        </period>
    </context>
    <context id="ia70e95571e0e491fb52ce293ea601a70_I20161003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-10-03</instant>
        </period>
    </context>
    <context id="if1daa0ef8b314dee8ee404337020c563_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i10eee8543f7046e0859ad96971a954da_I20190108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-08</instant>
        </period>
    </context>
    <context id="ic46b3eb0a83849c2b0342cf7b18e0188_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if26c855530ab4ea6a07f994ef03a005f_D20191231-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-31</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iceb051d6f08042e1a54eb9849cdeac83_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i872f74854a654470a5eb159ba754c7ca_D20220218-20220218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-18</startDate>
            <endDate>2022-02-18</endDate>
        </period>
    </context>
    <context id="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">iclr:A2021RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1811161bef0541d1b314fa8f7e974b09_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i196c76a3559d419d89bd5d2125a62e0f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee316e05b53a4b06a0345a352d600919_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1db08719244443188a87bd4495f32a5e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i267c8ec957d64d7687d93c7466134972_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i055498de74b44ecb8deea65136b4d3b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i33fe4880dae64f308692e5d9bd2761fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i305536a3cd1f49ec9167bd9bc8104484_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9d7582e0e7b3484491b75a376c0695c8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2023To2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i243aa952befc42c99e33d30e034ad490_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2023To2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8c198a29dee44519b861db8ccd7b511_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20332041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d61fb6235784d39b1c898fa148b0af0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20332041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e44759c2a854bc0910676ada44d73bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i770c5f02dbff40efa1458e69fb1e60a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2022To2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i67dddc1be99b46a6ac8672b42f7fb4b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2029To2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86e0b74245524351afc9b509e585fb1c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie343632514b54c28a4d376a3c9298cfe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7f25427924a2406292894864e22c91dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i44caf25e9f21476690747f57e50f9aa0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AcquiredEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia6674f8abb9143528db74c781bd4f419_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if47bb526e18f463db1bed028cf43f0ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i64338787f17e44159195780f1ed3a4e3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i10c7a471fc164535ab1f5501d22dd648_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf91caf53cac409b8da970cacfe56918_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4f00760e31240959ce3972bf544992d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i569507f611d548c49b8650b70c94c2fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if733533a187d46cfb46437f0574bd48b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07132bfad9184874a360f6352a964e49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:OtherRetirementPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i825154864e984f849f9034999b633fbe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e37e3b18efc4c54890a23af49e0fa65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifcb24a7a223049669f10a43260fb3f9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i852cdb0d17044c639630ff17b3950866_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4ccd74632f9452c9fc7c4c727e7cbc6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52e0d42fa9c04d3fbc41dc023095bf98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie21482250291473491b179d1e9638496_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97b87f6afcb34559a2f4576b1a188c7a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2401c0c85e74845af9e260c7e7cde74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d8837cc7bc34a82948378f474d993cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i506afdb62b6645c28768481748bbcbd5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i062ad9be3f9e465db1f49eeeced971fe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fe6c6b53ea94d49965d0ca81e095c39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7871cec33a7b4f3883e3e6c9cddf204a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bc40275d8744c9793904bf596955616_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1531dcf96765414a87b044843515f2fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i422b56f7af8b490e859596ef6dbce65b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie835ce8081ec4f4ca739bd71e6565c20_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab7471376d2a4fbe9b259e2a8ce7278f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i96aa6b711ab446a3a14f6536ac6ba863_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:GovernmentBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3bd9a11dcfb642da959b07ec79751954_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b52a3900c584d009b5d05b00cfe85c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">iclr:DiversifiedBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc4210481bdb451ba035a20efdc271b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d097939710f4e2face7b10bdd140ba4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17a0752301494fecba30d3ccd834c133_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4f6a845a66843d79b61cba68f576f33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie34f24ef293946839ccb0115382374cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9d40dd88a404685bf76258b0e90d0a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9862be84bb6f492bb811a70c03726aeb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i09c56c86bbb747b1a07d20615ebedb0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0784352491d144cd972226c028844591_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31374c47a6bb44ba914a1d8045381bed_I20140507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:AptivSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-07</instant>
        </period>
    </context>
    <context id="i3ab1778648b342b9ada86a5f677d6289_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66389d7f3c194c0a9461035acba0b147_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1682825f41f34d8ca4c4852e0ba2f96d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icbde31e88d4849f8badda657229d3344_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic768660976f74ad5af5a5fff5ef0bb5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:AptivSolutionsPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if32d9c6312d342eea532c63c70cd41c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i641bf226224d4002a6b87b5dcb9ef829_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8c58dceb3ee34f9fab1c82b8d0e2e8d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84a1032d1909414c8deb46ff92fb05d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">iclr:PRASwitzerlandAGPensionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69612ff6be104bbda9eb34a7111229cc_I20170213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-13</instant>
        </period>
    </context>
    <context id="ic45259ceacfa45dbaa829284ba61ed4f_I20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="i440197ff0132449083f0216f9fc3c298_I20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="i5fbe4c2a486a4b5482f3723aed979671_D20170214-20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="i4163e2475cb34804afe0a1d2c5088f79_D20170214-20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="i7aa49a2d22f444b7a13c77919382a1df_D20170214-20170214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="ibef2001f3bff4594b125b1b4c70d6047_D19970101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1997-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i0820a150dcb1422fbec11ed3af8c5b71_I20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="i5a566fd41cfd4b69a2174efb24d4ec3b_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="id76920b1711b412f9e74d6864364e113_I20130923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:A2013LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-09-23</instant>
        </period>
    </context>
    <context id="i7c67eb08e5524f1389812b02c4f529e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if241526f99db43fc9bf9c882609b6aea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i940aa8c093bc4589896acef14854ea63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibedfb53eb84140b7b0f014f3448deedd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5255d861c7cc46d69f217fa72de308c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c9a65dc7c694265ae542cee4cbfbd16_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica9d6a1d2ef345eebaf944a19f58d97d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i46f308bc7dd44c64acb450333790b112_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iee5eabbcadca4ea7bef29df09e08e94c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibcafc41c97334a6f89312cdf786a9995_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i892854d05a8b4db7a71a9f8ce561bbbe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ccb139c1f534009823e7282d53f1fcf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f37b14a260342dcb3444d2efa44c6d5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie06d8c0caffa4a54b55eeaec6990c14f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a249b6708e444acb6a9b4b67484f49c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibad01622a145456eb95aa151f08ca887_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">iclr:Range4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="iba8cd0f91c4543c384cf5fd3022523c9_D20150511-20150511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-05-11</startDate>
            <endDate>2015-05-11</endDate>
        </period>
    </context>
    <context id="iff4a5c52ce754d49b998568670340ed9_I20150511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-11</instant>
        </period>
    </context>
    <context id="i7d0262e215cd4dfbb0898a63d51486be_I20190516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-16</instant>
        </period>
    </context>
    <context id="ifca1cb86a7554779a455148669f8224b_D20190101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50c7dd932b404320af63f5c9a2cf9cd5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a4f5700181945938fdaecb063f3bc23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cd4d35cf1d84f78909a24f1716a0841_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i128b02150c364303957cd379df2d66a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ec59b41573649288593eff6d1ebb047_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4030627d459479f9bcfc2485f408af1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie70ef1e52b8445e8a30d1732702cac38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie1d7729620b245f3b3d86355af31bf15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i385b3308021d4f8dab296ba9a3b672ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31d66e89c6ac44c985d3b33f217a8215_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i82f9a1a05fa24a3281257719ca8fb6c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7478ddf969574f3ebf520346092b5404_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbc58fa5272343979b1281d284fd5100_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9cafc75e45844d94a5699609ed9c0e1a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic04e0493d819470faef53855bcf56280_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f815c05b36c45c2bbeedbecb796cd4b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib4ee9a12489e4e4d945f923b1fef04b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idfb23e34b2494ebeadf5c82112b1cc16_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TransactionAndIntegrationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie8b94a05494d4a9aafad89fefcf5ec5e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a7e7fb2e8754f13959c968948055905_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id51c60ed11834e3489b68644df728ad3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id74698b742ce45b48de3dd6ca0e41f58_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i095fb057614e484690d7c8e6855aa257_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i470b5734b0ec4cdcb5d2d8b7192a224d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2573b70385e24cddbc2849d005657d46_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2be2313371ae40d6abc4a3f42b6751ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f7fbd571c7848e2a658e6b23259ae2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3911e749f50947d4b21832b72052d785_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93cae0d23f394e31b3abce80e3e3687f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd5d2064ec2c49afba73bfde8e3bacd0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6988db3dbc8a4435b967b2307aada5cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i45448a33be2443fd93dedd1a7d14df2a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iebdfade2d1334535803b379eaf1d7a23_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4715e63da19c4cd897a34f13c13f0b3b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0fb773a2b86147749b4c3538c0035971_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:DSBiopharmaLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied4aaa8f5f68454db087c1b69e5131a0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4158ffec277a4decaff6ea55e3ac1007_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9985b94712864f2290305ffd2981067f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ac4e36329b842e7b8b1b172ef93c1f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib89cec313ee54d428d8f32c7d6f723f5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8dc5b0b8e9eb4cd182c4c104a6637ab6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if58aadd9086f43b2a3767b622c4f2dc0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i16fb8e5b432b4ab3a94979ed99d87911_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:OncacareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="employee">
        <measure>iclr:Employee</measure>
    </unit>
    <unit id="location">
        <measure>iclr:Location</measure>
    </unit>
    <unit id="country">
        <measure>iclr:Country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="instrument">
        <measure>iclr:instrument</measure>
    </unit>
    <unit id="tranche">
        <measure>iclr:tranche</measure>
    </unit>
    <unit id="vote">
        <measure>iclr:vote</measure>
    </unit>
    <unit id="segment">
        <measure>iclr:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF8xLTEtMS0xLTE0MzI4Ng_f2a89cb6-6243-45aa-89fe-e5d0b24e486d">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF8yLTEtMS0xLTE0MzI4Ng_8bb44446-fcd8-4f12-af68-b8129f4c9841">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF8zLTEtMS0xLTE0MzI4Ng_c5b2b91f-e7fd-4746-9934-09dc033eef29">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF80L2ZyYWc6YjQ3YTNkY2EwOTViNDI1N2E5MDM0NThmMWMzY2VjMDIvdGFibGU6YmJkM2ZjMWI2MDc0NGIxNzhmODczMjcwZGFhYzdjM2QvdGFibGVyYW5nZTpiYmQzZmMxYjYwNzQ0YjE3OGY4NzMyNzBkYWFjN2MzZF80LTEtMS0xLTE0MzI4Ng_fbb24c5b-17e1-4dfd-a029-4df000ba7846">0001060955</dei:EntityCentralIndexKey>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_4e96e968-9c11-40fd-a303-2bb58d8fbc29">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_7797f20c-d0da-447d-8e1d-a6a60da2da46">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM5_9e9c52c7-b395-463b-96b9-1de295e0a1d7">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTE3_e878e81e-183a-4681-b305-10f2abeafee5">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTQw_ce1c4020-12c8-4e0d-8b89-119229dc8cc5">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zODc_733b56d6-61a0-43b3-8a81-f3e2c3f9a014">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zODc_18d7217e-e138-473d-b878-df3ab671d0e1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM0_f39ece63-1a20-4ee9-aea6-3faf897a21fa">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTE4_9324e222-8640-4ff6-90d3-b7e8c8d2ef35">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTQx_43e680a1-9c9e-438a-b21c-8ddd8940c69d">333-08704</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM18xLTEtMS0xLTE0MzI4Ng_c7a1f836-fff6-4d44-9980-ea3faabe62f8">ICON PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM180LTEtMS0xLTE0MzI4Ng_2f5c7528-b308-4426-9f30-115ee1db13ea">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM183LTEtMS0xLTE0MzI4Ng_237d89a5-baee-4e0f-9586-9b780a7d7b2e">South County Business Park,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM184LTEtMS0xLTE0MzI4Ng_ecfbb772-bb29-481a-af1d-8906c05111a5">Leopardstown,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM18xMi0yLTEtMS0xNzcwMTg_c4b7ded9-294a-4ef6-9424-5a5d9aa8b56a">Dublin 18, D18 X5R3</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6MjFhM2M0MWY0Y2Y5NDM2ZTg2ODgxODNhMjE5NWI0YjMvdGFibGVyYW5nZToyMWEzYzQxZjRjZjk0MzZlODY4ODE4M2EyMTk1YjRiM185LTEtMS0xLTE0MzI4Ng_b3826304-77dc-4dc8-94a7-24a6c1940d53">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM1_bd005257-758b-4d81-87a2-ca15eae8607b">Brendan Brennan</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI0_8cd22877-b379-4c1f-b695-5e4f6efd833b">South County Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI3_22f3c2cd-ddc2-45d3-8f49-0797254a16b4">Leopardstown</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTQy_563f32bc-8766-4e5e-81dc-036d538a47bd">Dublin 18</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM2_0e9cd568-3f78-4ab8-876d-962a5be2282f">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM2_92f0af64-8812-4ce6-9986-d7525d9ab4d9">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMx_df68f9cc-2972-4412-8108-e3f1af462740">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelEmailAddress
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTE5_5d3730a3-7f23-401c-92a1-a7d987e54c8e">Brendan.Brennan@iconplc.com</dei:ContactPersonnelEmailAddress>
    <dei:CountryRegion
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM3_47dde466-f356-42df-94d5-efe9ccce2aec">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI4_ee99c62a-490a-46eb-a201-89d7eb608640">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i115de5a060254a309b17e42656cf7b3b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTIw_ff1ca314-cbc0-435f-9503-323000d77874">291-2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6Zjk5ZGUyOWUyZjJmNDg0MWFlZjVlOTU1YTk5MWNmNjQvdGFibGVyYW5nZTpmOTlkZTI5ZTJmMmY0ODQxYWVmNWU5NTVhOTkxY2Y2NF8xLTAtMS0xLTE0MzI4Ng_37f622d0-3a9b-43b6-b209-5932a3e19afa">ORDINARY SHARES, PAR VALUE &#x20ac;0.06 EACH</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6Zjk5ZGUyOWUyZjJmNDg0MWFlZjVlOTU1YTk5MWNmNjQvdGFibGVyYW5nZTpmOTlkZTI5ZTJmMmY0ODQxYWVmNWU5NTVhOTkxY2Y2NF8xLTEtMS0xLTE0MzI4Ng_c132edcc-b942-4e75-9fc8-dc32e00df67d">ICLR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGFibGU6Zjk5ZGUyOWUyZjJmNDg0MWFlZjVlOTU1YTk5MWNmNjQvdGFibGVyYW5nZTpmOTlkZTI5ZTJmMmY0ODQxYWVmNWU5NTVhOTkxY2Y2NF8xLTItMS0xLTE0MzI4Ng_8b78de02-e944-4782-a75d-1b19f6b3de7d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8xMjIw_6aad0b2f-eff7-4326-86e7-112439b5343d"
      unitRef="shares">81723555</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTIx_b721a723-97af-4ac1-b8a0-7c5ab01472b6">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI2_e29d6dfa-e608-4b13-89ea-b0065f046d03">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTM4_7c6a1fd3-7c72-4bd8-93a7-87ce8d3986de">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI1_3d92ddeb-5997-410e-9689-8dca31b36751">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTI5_94de3d24-0821-4f12-9ae0-9b8bac560017">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMw_ed38afaf-83e0-4c4d-b4f9-b511f732c2da">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTIy_994aeeca-116b-45f6-9df3-0c716e055734">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMy_b1bd83be-6a63-4332-805d-0343bb05049c">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xL2ZyYWc6YjkyMWVlYjcwZDY2NDVhYWFlZTE1YTQ4M2MzYjUzZDYvdGV4dHJlZ2lvbjpiOTIxZWViNzBkNjY0NWFhYWVlMTVhNDgzYzNiNTNkNl8zOTMz_9110ec5b-4e6e-49eb-81f9-754142783def">false</dei:EntityShellCompany>
    <dei:AuditorFirmId
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xMDMvZnJhZzoyZjliNGE0ZTIxOWU0MjE0YTI3YjA3N2I2NzQ3YjMxYy90ZXh0cmVnaW9uOjJmOWI0YTRlMjE5ZTQyMTRhMjdiMDc3YjY3NDdiMzFjXzE1NA_ed68c6ec-949f-4ed6-9d50-ce4b0119d9c2">1116</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xMzkvZnJhZzo2OGNjZDZmMzEwYWI0M2U5YWM4YWQxZWE2ZDdjMjYxYi90ZXh0cmVnaW9uOjY4Y2NkNmYzMTBhYjQzZTlhYzhhZDFlYTZkN2MyNjFiXzE0MjI1_2b623cc2-6c30-430c-9c8e-fc7054fb7ab1">KPMG</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xMzkvZnJhZzo2OGNjZDZmMzEwYWI0M2U5YWM4YWQxZWE2ZDdjMjYxYi90ZXh0cmVnaW9uOjY4Y2NkNmYzMTBhYjQzZTlhYzhhZDFlYTZkN2MyNjFiXzE0MjI2_f67758c9-5e7c-421b-bfdd-1b5db9d5bb4d">Dublin, Ireland</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMtMS0xLTEtMTQzMjg2_3abae8fe-97e3-47b1-a00d-6a9c4d87952c"
      unitRef="usd">288768000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMtMi0xLTEtMTQzMjg2_1af3e668-e25e-46d9-b6c6-e70cfbc3c98c"
      unitRef="usd">752213000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQtMS0xLTEtMTQzMjg2_a0bfbe9a-e101-482e-ba7a-4ded7c6916d9"
      unitRef="usd">1713000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQtMi0xLTEtMTQzMjg2_7ea93692-50ab-4eb5-8a63-8627adb1eb8b"
      unitRef="usd">1712000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUtMS0xLTEtMTQzMjg2_89a7d0f7-7b43-4343-8057-33bfccdf766c"
      unitRef="usd">1731388000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUtMi0xLTEtMTQzMjg2_ba2c1ed0-de7e-4b9b-bc6a-802fab91b6ca"
      unitRef="usd">1342770000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzYtMS0xLTEtMTQzMjg2_1dfc7e88-d156-4b00-a14a-e901fb50e084"
      unitRef="usd">957655000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzYtMi0xLTEtMTQzMjg2_e239eda0-ab72-424d-953f-1bd9c82f41d1"
      unitRef="usd">623121000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzctMS0xLTEtMTQzMjg2_58f3d6ad-e1df-4d60-b5f0-025784d6b6a1"
      unitRef="usd">63658000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzctMi0xLTEtMTQzMjg2_11d73f0b-6c02-4216-a1bb-2b85d285543b"
      unitRef="usd">56760000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzgtMS0xLTEtMTQzMjg2_d99c99a1-b3cf-4af0-a8a7-85910a1777c0"
      unitRef="usd">137094000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzgtMi0xLTEtMTQzMjg2_44a5acba-b6a9-4be5-b100-4ca03373c619"
      unitRef="usd">114323000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzktMS0xLTEtMTQzMjg2_b317ba99-cdc4-4a2a-8473-8a09252afd47"
      unitRef="usd">48790000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzktMi0xLTEtMTQzMjg2_77c8a34f-b72d-4fd4-a297-c15d266b40b8"
      unitRef="usd">50299000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEwLTEtMS0xLTE0MzI4Ng_18e82c5d-f41e-4f28-ba75-595b2a8cbec0"
      unitRef="usd">3229066000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEwLTItMS0xLTE0MzI4Ng_97ea6ae4-939b-44a6-aaf9-7fcabfa82164"
      unitRef="usd">2941198000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEyLTEtMS0xLTE0MzI4Ng_aceb9edc-0dd4-4852-a6de-c4154398d342"
      unitRef="usd">350320000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEyLTItMS0xLTE0MzI4Ng_0c64c44c-c7de-4a4c-8ee8-93b812a9fe9f"
      unitRef="usd">336444000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEzLTEtMS0xLTE0MzI4Ng_229dee58-71fe-49f1-93bc-5ede97380bc1"
      unitRef="usd">8971670000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzEzLTItMS0xLTE0MzI4Ng_77cfc617-e100-4646-b1ad-19c99532f0fa"
      unitRef="usd">9037931000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE0LTEtMS0xLTE0MzI4Ng_f8a35823-0f30-4f30-99dd-d9c24ae1ef5f"
      unitRef="usd">4278659000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE0LTItMS0xLTE0MzI4Ng_c545ac20-6053-4815-a509-c21a4ed75d88"
      unitRef="usd">4710843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE1LTEtMS0xLTE0MzI4Ng_e90cf5fa-0059-4926-9bd5-4e5e849c31f4"
      unitRef="usd">153832000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE1LTItMS0xLTE0MzI4Ng_8b1d6c0d-7447-48f9-93b6-4412bab7d485"
      unitRef="usd">198123000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE2LTEtMS0xLTE0MzI4Ng_f56fe0e8-697d-4fd7-bc98-022942564afe"
      unitRef="usd">70790000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE2LTItMS0xLTE0MzI4Ng_94035fcf-6c23-41e9-b5be-1042727ad8f7"
      unitRef="usd">70557000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE3LTEtMS0xLTE0MzI4Ng_3613ee58-e0d7-4f29-bd78-53a8c5981d62"
      unitRef="usd">21380000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE3LTItMS0xLTE0MzI4Ng_760b09c0-0dce-43b3-8ccc-dcdf674346bc"
      unitRef="usd">18637000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE4LTEtMS0xLTE0MzI4Ng_0b341612-fd3e-43e9-abe4-d02c38e90d84"
      unitRef="usd">76930000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE4LTItMS0xLTE0MzI4Ng_e887ae9d-6251-403e-8cdf-ac9bca6f43ad"
      unitRef="usd">48392000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:EquityMethodInvestments
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE5LTEtMS0xLTE0MzI4Ng_3e146d1f-2288-4a72-9a7c-7605638004e5"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzE5LTItMS0xLTE0MzI4Ng_3c1daecd-6799-4cc0-a54a-629444a95b5a"
      unitRef="usd">2373000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIwLTEtMS0xLTE0MzI4Ng_c23c9e40-954d-4ccb-8b19-cb150ebcea74"
      unitRef="usd">32631000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIwLTItMS0xLTE0MzI4Ng_65889e5f-a2a3-4287-9d34-73f3395f47a2"
      unitRef="usd">22592000</us-gaap:OtherLongTermInvestments>
    <us-gaap:Assets
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIyLTEtMS0xLTE0MzI4Ng_21a0af7b-bd1e-4604-97a0-6965f31dfb35"
      unitRef="usd">17185278000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzIyLTItMS0xLTE0MzI4Ng_a87074f5-020f-46ff-bef3-dca806162338"
      unitRef="usd">17387090000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI1LTEtMS0xLTE0MzI4Ng_6bfda336-0ba4-4814-818f-57759947e159"
      unitRef="usd">81194000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI1LTItMS0xLTE0MzI4Ng_924dda10-e6fe-48da-8734-9ff551af7757"
      unitRef="usd">90764000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI2LTEtMS0xLTE0MzI4Ng_e8e8af3a-a98b-485d-9b7e-94bd3b7e1b22"
      unitRef="usd">1507449000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI2LTItMS0xLTE0MzI4Ng_08a3b540-9758-4fc5-8d28-3cad8930603e"
      unitRef="usd">1323961000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI3LTEtMS0xLTE0MzI4Ng_3f711904-3713-46ad-a069-5a68a4255d69"
      unitRef="usd">1005025000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI3LTItMS0xLTE0MzI4Ng_b25c2b04-b054-4dea-ae6f-89755defce6d"
      unitRef="usd">949629000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI4LTEtMS0xLTE0MzI4Ng_bc8b8e5c-1e3f-45da-a03d-6818793fc0b7"
      unitRef="usd">41783000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI4LTItMS0xLTE0MzI4Ng_e1312e11-c2aa-4172-8e96-f933942f0cd9"
      unitRef="usd">59433000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI5LTEtMS0xLTE0MzI4Ng_17e59221-4718-40fa-8e0c-aa7ebe3968eb"
      unitRef="usd">55150000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzI5LTItMS0xLTE0MzI4Ng_4888f8cd-d8b8-4062-b106-870e6775c311"
      unitRef="usd">55150000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMwLTEtMS0xLTE0MzI4Ng_da7d6887-049b-4fe3-bbe9-4c83c59687d7"
      unitRef="usd">2690601000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMwLTItMS0xLTE0MzI4Ng_72da06c1-e4d2-4d81-99d6-3aa960248f52"
      unitRef="usd">2478937000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLineOfCredit
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMyLTEtMS0xLTE0MzI4Ng_c2a504a2-4cd9-4ea2-bab0-3819818c1431"
      unitRef="usd">4599037000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMyLTItMS0xLTE0MzI4Ng_a6306a7d-6151-454c-b8f6-21c542a25ab4"
      unitRef="usd">5381162000</us-gaap:LongTermLineOfCredit>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMzLTEtMS0xLTE0MzI4Ng_554c3c81-10c1-4b6c-9177-9bbf7a75aee7"
      unitRef="usd">131644000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzMzLTItMS0xLTE0MzI4Ng_31c54954-2019-438b-b424-d05ca9e652c8"
      unitRef="usd">159483000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM0LTEtMS0xLTE0MzI4Ng_77cc15ec-3399-4cc4-908d-da2d1c98e86c"
      unitRef="usd">38260000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM0LTItMS0xLTE0MzI4Ng_f8214338-3aa1-4d36-86fb-ccd3ed54858a"
      unitRef="usd">42596000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM2LTEtMS0xLTE0MzI4Ng_ed10d838-fd13-4b96-a392-436a30e8a0dd"
      unitRef="usd">239188000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM2LTItMS0xLTE0MzI4Ng_0bd8fb3c-21a2-41c3-922e-e2bf96c0630f"
      unitRef="usd">172109000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM3LTEtMS0xLTE0MzI4Ng_e052d9b5-1aad-47ab-96d5-84965a22b645"
      unitRef="usd">988585000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM3LTItMS0xLTE0MzI4Ng_d4cae769-8f7b-4c89-8eb0-4ae800c9e10e"
      unitRef="usd">1085976000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM4LTEtMS0xLTE0MzI4Ng_bd42ab90-5b46-4ff7-b0fa-c54d9fa572fb"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM4LTItMS0xLTE0MzI4Ng_dd773053-15e5-4b88-8a83-c48f84a179c0"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:Liabilities
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM5LTEtMS0xLTE0MzI4Ng_1083e10d-1988-4595-8b67-394187fe5798"
      unitRef="usd">8687315000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzM5LTItMS0xLTE0MzI4Ng_7e5d10c7-93c7-4177-9ac9-4a78571afae0"
      unitRef="usd">9320263000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTc0_05d6c7c2-59a7-4a55-9c85-f72528e2438c"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTc0_a8a026f0-97f1-40e9-90e9-240b5c4ecfbd"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTk4_04cb91d1-dfed-43e4-91bf-96c709cdd0ca"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQxLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjhmMmMxZmQ5YTZjNjRiZmVhZTRjZjEyOTkwOTI3NjI2XzE5MjQxNDUzNDg2MTk4_561d2db3-02ef-4c0d-be19-81a5f48c1b57"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzQ_3f72b410-ea45-4eb7-8201-3bc33e470bde"
      unitRef="shares">81723555</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzQ_8147ef30-0f00-4aca-b545-51456e668ee3"
      unitRef="shares">81723555</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzYy_44916416-5d6a-4242-b0ce-29ef290f0bb2"
      unitRef="shares">81554683</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTAtMS0xLTE0MzI4Ni90ZXh0cmVnaW9uOjUzOWY0ODgyZDRhZjQzMTA4NmU2ZjljYjhjNjI0M2NkXzYy_7a61356a-cd31-476b-9f37-25be41801377"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTEtMS0xLTE0MzI4Ng_d8475986-d3fa-4a79-82c8-b32d0991732d"
      unitRef="usd">6649000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQyLTItMS0xLTE0MzI4Ng_1900a5bd-f567-4ff2-b376-283492fff36b"
      unitRef="usd">6640000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQzLTEtMS0xLTE0MzI4Ng_973f3ffc-a94c-4cd2-a92d-add7d4b28c21"
      unitRef="usd">6840306000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQzLTItMS0xLTE0MzI4Ng_f2ebd953-3502-4a17-9a51-3d9d22d84bba"
      unitRef="usd">6733910000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <iclr:OtherUndenominatedCapital
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ0LTEtMS0xLTE0MzI4Ng_749cda2b-976e-4caa-b2df-27f4de47de22"
      unitRef="usd">1162000</iclr:OtherUndenominatedCapital>
    <iclr:OtherUndenominatedCapital
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ0LTItMS0xLTE0MzI4Ng_0ee16a4f-9763-4697-a8be-9383f96123f5"
      unitRef="usd">1134000</iclr:OtherUndenominatedCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ1LTEtMS0xLTE0MzI4Ng_ef74c26d-f73e-4979-ba45-82aa7a4a4f22"
      unitRef="usd">-171538000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ1LTItMS0xLTE0MzI4Ng_0c3c5acc-f438-4b54-9109-a3c624de737e"
      unitRef="usd">-90937000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ2LTEtMS0xLTE0MzI4Ng_a0988f27-f10a-480c-93be-9baa52de753b"
      unitRef="usd">1821384000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ2LTItMS0xLTE0MzI4Ng_8a077252-7919-442f-a34c-9f80692833fd"
      unitRef="usd">1416080000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ3LTEtMS0xLTE0MzI4Ng_95a3d313-f466-4cba-8edb-1c861454c246"
      unitRef="usd">8497963000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzQ3LTItMS0xLTE0MzI4Ng_60cfe0ad-bd8f-4d33-9bfb-1701306bb98f"
      unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUwLTEtMS0xLTE0MzI4Ng_96b8a031-37f6-4d24-b007-dd6910291725"
      unitRef="usd">17185278000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDIvZnJhZzo3Y2M2ZDk1NDEyM2I0ZjQxOGMzZmNmM2U4OGU0MTExMS90YWJsZTo1Y2M3N2Q2MjBiOTA0ZTE1OWY0ZjQ2Njk0NDI2Y2ZmYi90YWJsZXJhbmdlOjVjYzc3ZDYyMGI5MDRlMTU5ZjRmNDY2OTQ0MjZjZmZiXzUwLTItMS0xLTE0MzI4Ng_a7df10d1-9f1f-4104-96d0-fd3f7727b697"
      unitRef="usd">17387090000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzYtMS0xLTEtMTQzMjg2_f44f4244-9122-489f-a160-875f5060f3b3"
      unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzYtMi0xLTEtMTQzMjg2_1ccd87fe-481a-46b8-ae75-ff65d3ef13ab"
      unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzYtMy0xLTEtMTQzMjg2_2a00195f-d354-418a-9e9a-8cdf4efa13de"
      unitRef="usd">2797288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEwLTEtMS0xLTE0MzI4Ng_6d02ec81-4dd1-46d2-bac1-fc7f28741e2c"
      unitRef="usd">5527045000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEwLTItMS0xLTE0MzI4Ng_0db2608e-ed17-46a2-a5b4-9e7db0f9b138"
      unitRef="usd">3972612000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEwLTMtMS0xLTE0MzI4Ng_5431e8fb-bcfd-4f83-80a9-d42633639316"
      unitRef="usd">1979883000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzExLTEtMS0xLTE0MzI4Ng_7bac0778-fbae-4a13-94ef-74a4feef9e35"
      unitRef="usd">778753000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzExLTItMS0xLTE0MzI4Ng_147dc1e5-b1b1-4479-a4d8-f6bd5d0ac162"
      unitRef="usd">585330000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzExLTMtMS0xLTE0MzI4Ng_783da2a4-a133-4ac7-84e8-375ada8127c5"
      unitRef="usd">342449000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEyLTEtMS0xLTE0MzI4Ng_748b9d68-d9a5-4889-a577-308be4d0655d"
      unitRef="usd">569513000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEyLTItMS0xLTE0MzI4Ng_bb93f457-be5d-43cb-b100-012670f7ae79"
      unitRef="usd">314987000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEyLTMtMS0xLTE0MzI4Ng_5eb18f91-2e59-47b8-aaea-111a3591ec7c"
      unitRef="usd">66126000</us-gaap:DepreciationAndAmortization>
    <iclr:BusinessCombinationIntegrationRelatedCostsCredits
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEzLTEtMS0xLTE0MzI4Ng_4078baab-8c43-40ad-919d-b6f7f06a5732"
      unitRef="usd">39695000</iclr:BusinessCombinationIntegrationRelatedCostsCredits>
    <iclr:BusinessCombinationIntegrationRelatedCostsCredits
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEzLTItMS0xLTE0MzI4Ng_f7f3ff09-a6f4-4dde-bcb3-be8013c29cfc"
      unitRef="usd">198263000</iclr:BusinessCombinationIntegrationRelatedCostsCredits>
    <iclr:BusinessCombinationIntegrationRelatedCostsCredits
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzEzLTMtMS0xLTE0MzI4Ng_65852224-2cce-4bc3-a11d-b9bb1d0436f8"
      unitRef="usd">-759000</iclr:BusinessCombinationIntegrationRelatedCostsCredits>
    <us-gaap:RestructuringCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE0LTEtMS0xLTE0MzI4Ng_26fa7304-9978-48d8-a7e7-c2745ea565f4"
      unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE0LTItMS0xLTE0MzI4Ng_0b9663c1-5d0e-4d13-94a9-bd7cf78c52bd"
      unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE0LTMtMS0xLTE0MzI4Ng_a32f2600-df6f-4f2a-a3b8-3fed9a00264d"
      unitRef="usd">18089000</us-gaap:RestructuringCosts>
    <us-gaap:CostsAndExpenses
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE1LTEtMS0xLTE0MzI4Ng_811a248b-a6f8-44f6-8070-27f76d4af66c"
      unitRef="usd">6946149000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE1LTItMS0xLTE0MzI4Ng_aeab1ea8-d7bf-4eea-b397-4606dc6f9f0a"
      unitRef="usd">5102297000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE1LTMtMS0xLTE0MzI4Ng_397521c4-d0e7-4262-9d40-f09c1ce5fcee"
      unitRef="usd">2405788000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE3LTEtMS0xLTE0MzI4Ng_96f1ab17-721b-4c84-a4b1-6971a8be3bbd"
      unitRef="usd">795237000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE3LTItMS0xLTE0MzI4Ng_6764a936-773b-405d-b743-18cf8a738efb"
      unitRef="usd">378529000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE3LTMtMS0xLTE0MzI4Ng_1fdc48f4-bff6-44cc-bf8f-795d17bfd36b"
      unitRef="usd">391500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE4LTEtMS0xLTE0MzI4Ng_8e88d42e-d5e0-43d2-881e-85a2cdc3bdcc"
      unitRef="usd">2345000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE4LTItMS0xLTE0MzI4Ng_43d45fa8-36ed-437b-a95b-406bc615619c"
      unitRef="usd">574000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE4LTMtMS0xLTE0MzI4Ng_4562b23f-8270-4bb9-bdee-09682f4e197f"
      unitRef="usd">2724000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE5LTEtMS0xLTE0MzI4Ng_b883875b-54dd-406b-b30a-e9a00c29041b"
      unitRef="usd">229731000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE5LTItMS0xLTE0MzI4Ng_de488128-0c63-4bd2-80ba-3e322adc3a0b"
      unitRef="usd">182423000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzE5LTMtMS0xLTE0MzI4Ng_d7599d2f-083b-406c-888f-42f8e4983a55"
      unitRef="usd">13019000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIxLTEtMS0xLTE0MzI4Ng_42fccc84-3d39-4c69-9e59-7cbd18262f9e"
      unitRef="usd">567851000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIxLTItMS0xLTE0MzI4Ng_59939205-36b2-42fc-ade3-fcae97a7deb3"
      unitRef="usd">196680000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIxLTMtMS0xLTE0MzI4Ng_d4735b70-5b69-4339-8d53-fa3cc78826d0"
      unitRef="usd">381205000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIyLTEtMS0xLTE0MzI4Ng_f4227271-fc36-48f4-9157-62d5c50bbdad"
      unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIyLTItMS0xLTE0MzI4Ng_836e85c7-3696-45b3-8c0d-2cb6beeb97b8"
      unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzIyLTMtMS0xLTE0MzI4Ng_17b28adf-1c8b-44e5-9c94-58665102335c"
      unitRef="usd">47875000</us-gaap:IncomeTaxExpenseBenefit>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI0LTEtMS0xLTE0MzI4Ng_0e52cebc-19a0-4f52-b8c4-261ded4407ca"
      unitRef="usd">508440000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI0LTItMS0xLTE0MzI4Ng_2e627668-976a-41a4-af47-688159d5773a"
      unitRef="usd">155346000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI0LTMtMS0xLTE0MzI4Ng_180bd563-46b6-4581-83d4-ebc90a864b48"
      unitRef="usd">333330000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI1LTEtMS0xLTE0MzI4Ng_c1a5a5a4-cbfe-461b-a5ef-90a51db5fbcc"
      unitRef="usd">-3136000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI1LTItMS0xLTE0MzI4Ng_fe759d06-9089-4d2f-9c8b-eaf3b6deb53b"
      unitRef="usd">-2161000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI1LTMtMS0xLTE0MzI4Ng_4137021f-deae-44a6-973f-eda6d9d8bd7e"
      unitRef="usd">-366000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI3LTEtMS0xLTE0MzI4Ng_3a1d9790-86f8-4364-b2a5-321a151ba552"
      unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI3LTItMS0xLTE0MzI4Ng_ee4a41c6-2f1c-4dd3-9960-338ef09e8b33"
      unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI3LTMtMS0xLTE0MzI4Ng_4a4451ca-19b1-4f1f-a081-7ca1fb8e65c9"
      unitRef="usd">332964000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI4LTEtMS0xLTE0MzI4Ng_ccd2556d-b6ed-44ef-a3b1-2180cfa0eebe"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI4LTItMS0xLTE0MzI4Ng_636bf309-4395-428a-9c7e-5a54d0cda5a3"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI4LTMtMS0xLTE0MzI4Ng_dad69b6e-4db6-4416-a7f5-26a7cfc0ac23"
      unitRef="usd">633000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI5LTEtMS0xLTE0MzI4Ng_31490c30-8df7-4d41-9710-d0ad12494801"
      unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI5LTItMS0xLTE0MzI4Ng_b372d28d-ec64-4048-b18a-2d7d3e85d302"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzI5LTMtMS0xLTE0MzI4Ng_2a703cf7-8941-411f-866c-d45f6bfc0831"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzMzLTEtMS0xLTE0MzI4Ng_c3678de3-d9ee-4a11-8305-2ed00af04ef2"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzMzLTItMS0xLTE0MzI4Ng_e68ef2dc-13a4-4975-995b-c7bd7ec771e2"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzMzLTMtMS0xLTE0MzI4Ng_010287d8-adf5-41b3-a1e8-1fdec2c189d1"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM0LTEtMS0xLTE0MzI4Ng_5233d070-b250-4099-82af-0642aa82c1d7"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM0LTItMS0xLTE0MzI4Ng_c9124056-e21c-4b43-a538-4ddc08689f13"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM0LTMtMS0xLTE0MzI4Ng_ea695c98-0080-440b-8a41-a3633ec60e76"
      unitRef="usdPerShare">6.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM3LTEtMS0xLTE0MzI4Ng_ea60144a-c005-4ca2-a001-92bdb5a5f13e"
      unitRef="shares">81532320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM3LTItMS0xLTE0MzI4Ng_9e5ea08b-3a08-40cc-a553-c7b8894ea022"
      unitRef="shares">67110186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM3LTMtMS0xLTE0MzI4Ng_1b187434-4e44-4b5c-902f-ee6050ec3a0e"
      unitRef="shares">52859911</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM4LTEtMS0xLTE0MzI4Ng_1aebc954-ad4f-45cd-901b-44bbb4bc7991"
      unitRef="shares">82468363</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM4LTItMS0xLTE0MzI4Ng_d78dad20-3830-4d49-9ed2-e1a0b7bc3a3a"
      unitRef="shares">68068311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDUvZnJhZzplYjY4ODgzMWE3NmI0MTAxYWE3ZWZjOTExNjgxMWMxNS90YWJsZTpiMjYxMmE5ZGIzODI0YmYzOGIyMzg2OGQ5MWZmN2NkZi90YWJsZXJhbmdlOmIyNjEyYTlkYjM4MjRiZjM4YjIzODY4ZDkxZmY3Y2RmXzM4LTMtMS0xLTE0MzI4Ng_a831d349-6eec-4c44-acc0-9f060e748a5f"
      unitRef="shares">53283585</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzMtMS0xLTEtMTQzMjg2_3a1d9790-86f8-4364-b2a5-321a151ba552"
      unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzMtMi0xLTEtMTQzMjg2_1029309a-c2da-4f11-a113-f770f649bae3"
      unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzMtMy0xLTEtMTQzMjg2_68b9f74e-1bd8-45c2-888e-355a36531b4a"
      unitRef="usd">332964000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzUtMS0xLTEtMTQzMjg2_d2ce52da-14ce-46ff-b6e8-23e7407bfd4e"
      unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzUtMi0xLTEtMTQzMjg2_2ac0b29c-e24f-41c1-b685-09e999cda7d7"
      unitRef="usd">-60617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzUtMy0xLTEtMTQzMjg2_bc965249-8a62-4c70-8c12-708b0095bca1"
      unitRef="usd">46526000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzctMS0xLTEtMTQzMjg2_18ad5e3b-bcbb-4529-ae9b-4085a98305b1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzctMi0xLTEtMTQzMjg2_57e45ef7-16b2-49e9-8c9f-c372984289d9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzctMy0xLTEtMTQzMjg2_c7c07c82-3f6d-421e-9111-7ed8d4492c21"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzgtMS0xLTEtMTQzMjg2_e6c1f994-0c64-49e0-aba4-ded41a1f445e"
      unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzgtMi0xLTEtMTQzMjg2_cc557a00-e914-4f6d-a100-decf994e3eab"
      unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzgtMy0xLTEtMTQzMjg2_2e3c465b-e8dd-4ed1-8e4e-4b4c9552a025"
      unitRef="usd">-4138000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzktMS0xLTEtMTQzMjg2_970f1503-b5e6-4176-9808-25caa0cde8be"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzktMi0xLTEtMTQzMjg2_e65da590-4e1c-47d8-8366-8fa5fa6a2959"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzktMy0xLTEtMTQzMjg2_1ef956c1-6cf7-4f47-b8aa-711e7e2eb11d"
      unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEwLTEtMS0xLTE0MzI4Ng_05940f9e-3a22-491a-9ded-b90780d28b8b"
      unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEwLTItMS0xLTE0MzI4Ng_184cf73f-0bfb-40d1-a600-3e396d7469e9"
      unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEwLTMtMS0xLTE0MzI4Ng_ac9a52dd-dad0-4d0d-ba16-3d25f28011b8"
      unitRef="usd">-905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzExLTEtMS0xLTE0MzI4Ng_a578d4a7-5dc2-4b24-9a05-9a55d02da7f9"
      unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzExLTItMS0xLTE0MzI4Ng_b73871f9-c649-4256-80ec-843349a05dc5"
      unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzExLTMtMS0xLTE0MzI4Ng_7c6aa10b-0472-4a93-8fba-aa21c1f1f38d"
      unitRef="usd">373306000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEyLTEtMS0xLTE0MzI4Ng_05eae667-5cb8-4ec0-b165-f6f3fdb96668"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEyLTItMS0xLTE0MzI4Ng_a209558b-b755-4222-9d15-3c126386ac87"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEyLTMtMS0xLTE0MzI4Ng_ab5d3f88-7b33-4aad-9dcd-bcbc3cbfc47d"
      unitRef="usd">633000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEzLTEtMS0xLTE0MzI4Ng_33dc3a51-c39b-4b32-b37a-1d7eb071d3f9"
      unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEzLTItMS0xLTE0MzI4Ng_18b91baf-ad38-444b-a869-45d66d5b1974"
      unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNDgvZnJhZzo2OGJhMDAyOTMxOWY0ZTJjYTVmYTdiZjIwMGJmZDkwMS90YWJsZTpjZTQ3M2M1YmUyNDE0YmFiYjM2MTlhMzQyZjAxMWFmMC90YWJsZXJhbmdlOmNlNDczYzViZTI0MTRiYWJiMzYxOWEzNDJmMDExYWYwXzEzLTMtMS0xLTE0MzI4Ng_9032dd3b-13e1-4189-8437-260bc73ff4b1"
      unitRef="usd">372673000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib7e5ed959ca1442c959fca1bf9fa7721_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtMS0xLTEtMTQzMjg2_bb28de84-4f38-40a7-afe5-80ac0997bbc8"
      unitRef="shares">53622206</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib7e5ed959ca1442c959fca1bf9fa7721_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtMi0xLTEtMTQzMjg2_657005a2-179a-406e-a12e-43dba85858ed"
      unitRef="usd">4635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia9fbbf07b0e4449ea3a2f6cd81f22401_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtMy0xLTEtMTQzMjg2_5a56d80c-2186-4228-9130-4dfaafedc049"
      unitRef="usd">577961000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i19a880fd5d814e9092b5ca671bb8d41b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNC0xLTEtMTQzMjg2_7f0f24a5-5e4d-40e0-ad56-604f42563bf3"
      unitRef="usd">1052000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic8965558006f4684a7fc1512daffa72e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNS0xLTEtMTQzMjg2_e6de3467-38f6-4572-a7da-ff68754a55ee"
      unitRef="usd">-75819000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2dc7dff39c546919fdaf6c9f59e5e5e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNi0xLTEtMTQzMjg2_905ce4d1-943b-4e5e-85b3-16c81fc48165"
      unitRef="usd">1110226000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c028363c21c48d5bdb88ba826d38299_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtNy0xLTEtMTQzMjg2_d68d1d73-03a5-492c-8691-777b8f5dfba3"
      unitRef="usd">1618055000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ie7d1a9ae0fba46c192371319b4901064_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzYtOC0xLTEtMTQzMjg2_fbbb78d2-3447-4018-ad3f-7e14fa11d1a9"
      unitRef="usd">39510000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLoss
      contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzktNi0xLTEtMTQzMjg2_4650b533-f66f-434d-8658-d7fe8e229605"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzktNy0xLTEtMTQzMjg2_430be811-6279-4aa9-878e-013c55ffa184"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzktOC0xLTEtMTQzMjg2_b69d463b-4f9f-4c3a-9cd7-5f39db574b54"
      unitRef="usd">633000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEwLTUtMS0xLTE0MzI4Ng_e246595d-29bd-4e9c-a98b-b95f5d49cb2b"
      unitRef="usd">46526000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEwLTctMS0xLTE0MzI4Ng_ce78146d-f7e4-4105-92af-98ce3378fd08"
      unitRef="usd">46526000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEyLTUtMS0xLTE0MzI4Ng_462e9a9f-ed04-4e27-adef-7dade9059e5e"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEyLTctMS0xLTE0MzI4Ng_d77aaca4-f95e-45a0-8b16-4034809966da"
      unitRef="usd">-231000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEzLTUtMS0xLTE0MzI4Ng_017a5832-b0fd-4699-87eb-91daf6f84dbc"
      unitRef="usd">-4138000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzEzLTctMS0xLTE0MzI4Ng_ba9f6bb3-6e00-449c-9abb-c202f2686152"
      unitRef="usd">-4138000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE0LTUtMS0xLTE0MzI4Ng_8172086e-6f06-4c7f-8905-5dbec89807cb"
      unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE0LTctMS0xLTE0MzI4Ng_378f461c-0eae-472b-a258-36cd26b3a922"
      unitRef="usd">910000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9a42b941dac547a2921541f53da8cae2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE1LTUtMS0xLTE0MzI4Ng_d0b859ee-c508-4953-85ef-39727b05ab3f"
      unitRef="usd">-905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE1LTctMS0xLTE0MzI4Ng_75bb5e4f-70ee-49cb-a439-1f5b7a06c743"
      unitRef="usd">-905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE2LTctMS0xLTE0MzI4Ng_c9f06c00-7a4c-4c04-9e14-4a1218491526"
      unitRef="usd">372673000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTEtMS0xLTE0MzI4Ng_cc1b57d8-a205-41c3-bb5e-a8bb9c475f26"
      unitRef="shares">193417</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTItMS0xLTE0MzI4Ng_e77b5285-d344-44d7-8989-965ec996cce5"
      unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTMtMS0xLTE0MzI4Ng_f28aa356-bbdd-45cd-9749-b295fc4040bf"
      unitRef="usd">13176000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE3LTctMS0xLTE0MzI4Ng_bcf399d5-85f1-4d6a-8f57-00427e8d0db1"
      unitRef="usd">13189000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE4LTEtMS0xLTE0MzI4Ng_4d99b7c2-b1f7-4543-99cb-cb8a94ffda8d"
      unitRef="shares">207688</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE4LTItMS0xLTE0MzI4Ng_889d7496-4020-4a05-8c0c-5ff7b43d960e"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE4LTctMS0xLTE0MzI4Ng_316c9eae-e024-4a4f-938c-43c95d52733d"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE5LTMtMS0xLTE0MzI4Ng_1897ad53-cdae-4dfe-b6ce-140f5a3d4222"
      unitRef="usd">25981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzE5LTctMS0xLTE0MzI4Ng_bebac4db-7126-4ebb-9599-7c56267c1f76"
      unitRef="usd">25981000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i5a0f2fb5d703406fa218972831c0383f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIwLTMtMS0xLTE0MzI4Ng_0e3303de-5023-467a-a5c5-20c5d0dbaae5"
      unitRef="usd">14000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIwLTctMS0xLTE0MzI4Ng_328cc83c-c6d3-4330-85ac-720766a3276d"
      unitRef="usd">14000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTEtMS0xLTE0MzI4Ng_74188986-2c5d-4c53-9c1f-a98d2fd776a3"
      unitRef="shares">1235218</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i66bedc5d2cc2425ea726edbaecd9363d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTItMS0xLTE0MzI4Ng_c61993cd-c77f-4c8d-b805-0e6a55b7fcb9"
      unitRef="usd">82000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ifd0a7d988df847dc9a616929e7ace798_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTQtMS0xLTE0MzI4Ng_a36eb3cf-1ba6-4bc5-b481-cf12a0f61f96"
      unitRef="usd">-82000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTYtMS0xLTE0MzI4Ng_35b0af90-9fc2-4cdd-b97d-7176d608225f"
      unitRef="usd">175000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIxLTctMS0xLTE0MzI4Ng_265120c3-d1c8-47fc-be55-ca2f66bd6231"
      unitRef="usd">175000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIyLTYtMS0xLTE0MzI4Ng_785a4a4f-de5a-408d-8e7d-edc136077552"
      unitRef="usd">140000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIyLTctMS0xLTE0MzI4Ng_44c057c3-7314-4d37-98fa-9e626be1b96b"
      unitRef="usd">140000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i0d4f275fcea64ef88dcdc3371464271d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIzLTYtMS0xLTE0MzI4Ng_5ca7925b-f1ba-4a4d-9e06-303bba1f1e2b"
      unitRef="usd">-4522000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIzLTctMS0xLTE0MzI4Ng_c73c074c-e7f7-407a-b03c-a854f5401bad"
      unitRef="usd">-4522000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzIzLTgtMS0xLTE0MzI4Ng_22e2143f-7e50-403b-beeb-2a5e563ba85e"
      unitRef="usd">4522000</iclr:RedeemableNoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i1aa32e65146640a6bdd08237b7af3540_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI0LTgtMS0xLTE0MzI4Ng_1a2c06b8-ec56-4d4c-b632-b50cd835b950"
      unitRef="usd">-44665000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTEtMS0xLTE0MzI4Ng_3b52abfb-273e-4d38-b606-2e867697d0bf"
      unitRef="shares">52788093</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTItMS0xLTE0MzI4Ng_6bfb6e6c-348c-4da5-bad2-4837fa00925f"
      unitRef="usd">4580000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i32c05ec529b64737a2cf079cbb19be5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTMtMS0xLTE0MzI4Ng_97c677fb-384e-4209-be3f-4e1a6464bcb6"
      unitRef="usd">617104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i940965b309ab4ce497c779391f42b662_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTQtMS0xLTE0MzI4Ng_1ef7879b-2b4f-4223-b0d4-a1ba90730a18"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8d96ff5211446f09d3fabef56b1bb6d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTUtMS0xLTE0MzI4Ng_ec33e11d-6b49-4d9b-81a2-d9e4098608f7"
      unitRef="usd">-35477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5629eb301d784ca99de6ddbf87220b6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTYtMS0xLTE0MzI4Ng_859f6b8b-3d44-42db-8787-9c4f9c0ee3d6"
      unitRef="usd">1262895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTctMS0xLTE0MzI4Ng_75ebcc3b-3be4-47c9-89be-73231675ca68"
      unitRef="usd">1850236000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i80faf766e38749ef9bf49c0793bed5d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTo1NTk0ODdjODRlMjE0MDgwYWRiMmFhOGVlOTM0NmUxZC90YWJsZXJhbmdlOjU1OTQ4N2M4NGUyMTQwODBhZGIyYWE4ZWU5MzQ2ZTFkXzI1LTgtMS0xLTE0MzI4Ng_2848c88b-5601-4ca6-b134-0da0e240ec23"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockSharesIssued
      contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctMS0xLTEtMTQzMjg2_10ef286c-20f3-41b6-81e4-24895f9d944b"
      unitRef="shares">52788093</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i64e1bb2bdf8a4e40bd1fb73f0edfc0dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctMi0xLTEtMTQzMjg2_1fc952d0-508d-4897-8c4f-070cc35f9f2f"
      unitRef="usd">4580000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i32c05ec529b64737a2cf079cbb19be5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctMy0xLTEtMTQzMjg2_101ce675-ecf4-4881-b2e6-9626661eb174"
      unitRef="usd">617104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i940965b309ab4ce497c779391f42b662_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNC0xLTEtMTQzMjg2_384c6787-032c-4a11-b893-6091f537e809"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8d96ff5211446f09d3fabef56b1bb6d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNS0xLTEtMTQzMjg2_c742673f-de44-4e3f-af03-c279e04b29d0"
      unitRef="usd">-35477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5629eb301d784ca99de6ddbf87220b6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNi0xLTEtMTQzMjg2_19fe2d0b-6562-4268-a7e0-75845469cc0b"
      unitRef="usd">1262895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzctNy0xLTEtMTQzMjg2_64f42024-582b-4def-ac56-1f6cfaf3c2e2"
      unitRef="usd">1850236000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i27e29b8c979344a0bbaf83ef3e7130d2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzktNi0xLTEtMTQzMjg2_0d9973e2-5de9-43e2-9e66-bea04d0535ac"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzktNy0xLTEtMTQzMjg2_62a7acae-501b-4049-a1ef-2222f566138a"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzEwLTUtMS0xLTE0MzI4Ng_9d5cb3e7-4916-45ec-a788-e0b2be96bff1"
      unitRef="usd">-60617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzEwLTctMS0xLTE0MzI4Ng_c3b6ca99-9a60-4349-80a7-187d31951668"
      unitRef="usd">-60617000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE0LTUtMS0xLTE0MzI4Ng_83928609-5d6f-449b-b471-fd36de26bf3c"
      unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE0LTctMS0xLTE0MzI4Ng_22e00d20-610a-4368-8673-3e77ce73fcc2"
      unitRef="usd">4266000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE1LTUtMS0xLTE0MzI4Ng_e576b82a-c847-4ff1-a6ae-d7e763cb450c"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE1LTctMS0xLTE0MzI4Ng_f3f01620-a4ee-4820-8697-74398c9d3053"
      unitRef="usd">-113000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iedf8b84090a54a2cbdaf12823a2801cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE2LTUtMS0xLTE0MzI4Ng_b1fc6a30-bad9-485b-a410-8fcf7816d933"
      unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE2LTctMS0xLTE0MzI4Ng_54e5c08d-31b9-4e32-8f41-2c620df112b3"
      unitRef="usd">778000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzE4LTctMS0xLTE0MzI4Ng_26fac597-14ee-4e9b-8e05-e9275e231d90"
      unitRef="usd">97725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTEtMS0xLTE0MzI4Ng_f0226ef8-0cf1-4330-859e-baf8b30d29ea"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTItMS0xLTE0MzI4Ng_5ef45a2f-75e7-46f5-be59-a2e777b2cf5f"
      unitRef="usd">77000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTMtMS0xLTE0MzI4Ng_67b94124-f39f-4c83-8024-3d27c9ae9056"
      unitRef="usd">118512000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIwLTctMS0xLTE0MzI4Ng_9d342b84-727b-4e36-a4a4-51de513ad60f"
      unitRef="usd">118589000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIxLTEtMS0xLTE0MzI4Ng_b51c7e56-e48e-4194-b090-819fb52ab74b"
      unitRef="shares">328634</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIxLTItMS0xLTE0MzI4Ng_44dfe586-6544-4157-9163-c8f092afb177"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIxLTctMS0xLTE0MzI4Ng_517379f5-3eb9-4629-8ac8-ecf60b457487"
      unitRef="usd">23000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIyLTMtMS0xLTE0MzI4Ng_408ecaf1-7e5e-4786-8d27-93c9fd8ebce3"
      unitRef="usd">133553000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIyLTctMS0xLTE0MzI4Ng_737bec90-207d-4e62-ab3a-49f0f9dc6503"
      unitRef="usd">133553000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIzLTMtMS0xLTE0MzI4Ng_d44e9f8a-f55f-4a28-a150-3f8edae8ae9b"
      unitRef="usd">853000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzIzLTctMS0xLTE0MzI4Ng_6fe4bfa5-6700-4c03-979c-0727c76c3965"
      unitRef="usd">853000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTEtMS0xLTE0MzI4Ng_f8978661-3d8c-4065-ab83-ad2ad2ff4145"
      unitRef="shares">27372427</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ice2eaec50a714f7c85a1a223330586cf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTItMS0xLTE0MzI4Ng_68a9fd5b-3cce-4bb2-ae0c-334745f916d4"
      unitRef="usd">1960000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTMtMS0xLTE0MzI4Ng_aa91e2a8-e688-4dc8-8517-a55fc7d2abb7"
      unitRef="usd">5656195000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI0LTctMS0xLTE0MzI4Ng_21bbc0cc-e1d6-42e8-9c5f-262cc075c962"
      unitRef="usd">5658155000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i838ecab1cc88498aa6fcc3e31af72aed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI1LTMtMS0xLTE0MzI4Ng_be4e883c-a16d-4b11-8190-6d094f54eb8d"
      unitRef="usd">209399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI1LTctMS0xLTE0MzI4Ng_7e0ca0b4-f692-4d6f-b420-8e064678e6a2"
      unitRef="usd">209399000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:CommonStockSharesIssued
      contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTEtMS0xLTE0MzI4Ng_16ce63f4-d0ba-4124-9c51-3d54e6ee6ebe"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTItMS0xLTE0MzI4Ng_b3a8fd53-3f1c-4ff0-8bf0-3b70d7b2dfb8"
      unitRef="usd">6640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i630de7cf74954c889cb5f55191084e94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTMtMS0xLTE0MzI4Ng_4dabc7ee-c43c-413b-b3f4-bd05788502da"
      unitRef="usd">6733910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69908ebb3c9340018ae4adb8ef47236e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTQtMS0xLTE0MzI4Ng_00760ebd-fc38-4eda-a983-e17d997f71c3"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib11a3b57f4ac4425a287a5353f3e2695_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTUtMS0xLTE0MzI4Ng_5089ac0b-b62c-4a3a-adc6-45119728ab8c"
      unitRef="usd">-90937000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0d85418de1a4b0a817652360cfe0815_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTYtMS0xLTE0MzI4Ng_830076ba-710b-4cc9-bf67-ff69d9c0395b"
      unitRef="usd">1416080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTphZmE2Nzk2MWE5NDQ0MzI0OGMzZWM2ZGYzNjNjOTkwNi90YWJsZXJhbmdlOmFmYTY3OTYxYTk0NDQzMjQ4YzNlYzZkZjM2M2M5OTA2XzI4LTctMS0xLTE0MzI4Ng_7daf6266-0c60-492b-9eb2-1402e84459a4"
      unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctMS0xLTEtMTQzMjg2_8dcd936b-88f0-442b-8a43-f7c4256a8b22"
      unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i99ae0c3dbbc541b3aa82c3713e418873_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctMi0xLTEtMTQzMjg2_a67bd1ab-bafe-4aa4-a060-18eed4ebc93b"
      unitRef="usd">6640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i630de7cf74954c889cb5f55191084e94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctMy0xLTEtMTQzMjg2_2f1654bc-92c4-46bb-a5f7-21f003345bff"
      unitRef="usd">6733910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i69908ebb3c9340018ae4adb8ef47236e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNC0xLTEtMTQzMjg2_9b8c9100-3202-4e15-b21e-7aa4135e3bc7"
      unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib11a3b57f4ac4425a287a5353f3e2695_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNS0xLTEtMTQzMjg2_283614cd-d773-4508-9495-87164bf820b9"
      unitRef="usd">-90937000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id0d85418de1a4b0a817652360cfe0815_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNi0xLTEtMTQzMjg2_60fa4ed6-5940-4e34-b9b7-139d27ee61bd"
      unitRef="usd">1416080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzctNy0xLTEtMTQzMjg2_36b7c939-cd11-471c-83ad-74d7b4d759f0"
      unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzktNi0xLTEtMTQzMjg2_97506e09-cf28-4958-9642-193a42b42c63"
      unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzktNy0xLTEtMTQzMjg2_005b9b8b-db1f-4b09-9eac-0681295fa4ca"
      unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib227c36803504cc68f096847a5faff4a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEwLTUtMS0xLTE0MzI4Ng_26d1cc31-bc10-4f68-afb1-e74a06236130"
      unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEwLTctMS0xLTE0MzI4Ng_2b7a22a3-ee01-421f-a94f-d593ec2d3c6c"
      unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ib227c36803504cc68f096847a5faff4a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEyLTUtMS0xLTE0MzI4Ng_da162235-c65a-48eb-9707-ff439eb06282"
      unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEyLTctMS0xLTE0MzI4Ng_be7655a5-6216-4593-9bcc-aae4a1f5bacf"
      unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib227c36803504cc68f096847a5faff4a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEzLTUtMS0xLTE0MzI4Ng_9c2bd80f-dc06-4b98-95b7-230155498aa5"
      unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzEzLTctMS0xLTE0MzI4Ng_0d4e7353-fed0-4af7-ae35-8457f0444894"
      unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzE4LTctMS0xLTE0MzI4Ng_313d5ff0-267f-4bb8-8bb7-3daab705faae"
      unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTEtMS0xLTE0MzI4Ng_b4ec1941-1256-45ef-bc6c-5387c2216f58"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTItMS0xLTE0MzI4Ng_ad989b2c-1783-44f3-922e-5f28cbd236f5"
      unitRef="usd">21000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTMtMS0xLTE0MzI4Ng_a9edc0b2-635a-41fd-af69-463e860865b3"
      unitRef="usd">35807000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIwLTctMS0xLTE0MzI4Ng_31dec23b-dce6-42c9-854e-6d6200f042a9"
      unitRef="usd">35828000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIxLTEtMS0xLTE0MzI4Ng_375e14ed-0d15-4df8-82ac-6c30120571f9"
      unitRef="shares">241116</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIxLTItMS0xLTE0MzI4Ng_0cf43db1-c57d-47f3-87bf-1137986d11ec"
      unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIxLTctMS0xLTE0MzI4Ng_46ff829c-9f91-4b32-a5f7-a27d1e17fdfb"
      unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIyLTMtMS0xLTE0MzI4Ng_d5b69d4d-862e-4721-869f-ef975b630832"
      unitRef="usd">70606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIyLTctMS0xLTE0MzI4Ng_9fe77957-89da-40c2-86e0-7e3dba7e997b"
      unitRef="usd">70606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="if0a410edd01f4fb0a5898418f410943f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIzLTMtMS0xLTE0MzI4Ng_f5844d2b-a6d3-47d3-b144-3717bccd0a7f"
      unitRef="usd">17000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzIzLTctMS0xLTE0MzI4Ng_b87491d7-1fb0-4920-adfc-f15b5d86b4d9"
      unitRef="usd">17000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTEtMS0xLTE0MzI4Ng_67034938-c479-4188-bfab-ae72ad0320a3"
      unitRef="shares">420530</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i65d6925afebb46f5a1f8d5eebee91202_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTItMS0xLTE0MzI4Ng_6407f5e7-13b8-467e-888a-9e40212e1366"
      unitRef="usd">28000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4addd48255bb44beb36787ed5df4e0bb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTQtMS0xLTE0MzI4Ng_f19ccea0-03ac-4712-9f20-3e277d3c6e74"
      unitRef="usd">-28000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTYtMS0xLTE0MzI4Ng_2739a70c-abe3-4197-9fe9-6df63909fd12"
      unitRef="usd">99983000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI0LTctMS0xLTE0MzI4Ng_155264b4-e0d9-4185-89ea-55152a38441a"
      unitRef="usd">99983000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="i8dc70dd0585149998f75aa9b17610bc9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI1LTYtMS0xLTE0MzI4Ng_7261cdc0-a990-4c89-a93a-3f45b66e6277"
      unitRef="usd">17000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <iclr:AdjustmentToRetainedEarningShareRepurchaseCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI1LTctMS0xLTE0MzI4Ng_10d4c44b-3c92-4e1e-8b5d-4b70a50f92cf"
      unitRef="usd">17000</iclr:AdjustmentToRetainedEarningShareRepurchaseCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5fe1a0341a694fcf9f094af87a903fe5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTEtMS0xLTE0MzI4Ng_19a17bf0-f6de-4643-b676-9050ce8b06a3"
      unitRef="shares">81723555</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5fe1a0341a694fcf9f094af87a903fe5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTItMS0xLTE0MzI4Ng_08432650-6fde-4019-ba05-2c86676237e8"
      unitRef="usd">6649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50e931e0964047f1b6a05248f9f9ae86_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTMtMS0xLTE0MzI4Ng_3dedd513-c105-42d0-ad92-faa1f93bca55"
      unitRef="usd">6840306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1ea7296eec334826b983a9b2012723a7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTQtMS0xLTE0MzI4Ng_6af46885-c10a-4c37-93fa-dba9cbf3beb6"
      unitRef="usd">1162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54b2495a48164218a19af1d3f594f087_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTUtMS0xLTE0MzI4Ng_57611f4f-65d6-4a5a-a646-d5a08a7d8cd6"
      unitRef="usd">-171538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87251223f7f94618a9d593180c9e6f6b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTYtMS0xLTE0MzI4Ng_a2651259-7a19-4e51-8e76-4df60e9b5c29"
      unitRef="usd">1821384000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTEvZnJhZzpiMDQzNTMwMzYxMjc0NTQ3YWU3N2FhNmIyYjE0NGQ4MS90YWJsZTpjNTBhOTdjNzZiZGU0NzM3YTk1N2U1ZWMwNTgyZTcxYS90YWJsZXJhbmdlOmM1MGE5N2M3NmJkZTQ3MzdhOTU3ZTVlYzA1ODJlNzFhXzI2LTctMS0xLTE0MzI4Ng_ea128b0b-911d-474c-9bf4-760a18325c62"
      unitRef="usd">8497963000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMtMS0xLTEtMTQzMjg2_fece4e2c-2611-419d-bd21-c04371ac8171"
      unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMtMi0xLTEtMTQzMjg2_005805db-2e5c-4689-b719-dd7cf80fac7b"
      unitRef="usd">153185000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMtMy0xLTEtMTQzMjg2_ecaab474-cbb3-4382-8f1e-866554c45a04"
      unitRef="usd">332964000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzYtMS0xLTEtMTQzMjg2_5a077a15-2999-466e-8b4c-6c2ff9a944df"
      unitRef="usd">569513000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzYtMi0xLTEtMTQzMjg2_a2c4a052-89aa-41d8-8099-38a35aa3e6e6"
      unitRef="usd">314987000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzYtMy0xLTEtMTQzMjg2_8fe7b692-7605-4820-a48e-6fa147f6ec98"
      unitRef="usd">66126000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzctMS0xLTEtMTQzMjg2_1dc0c022-e60c-4ec7-b88c-7dbe5a1d911a"
      unitRef="usd">28767000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzctMi0xLTEtMTQzMjg2_ec3944b3-c7ce-4ee2-bdf4-d4cd20578025"
      unitRef="usd">20037000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzctMy0xLTEtMTQzMjg2_ee02e606-c7cb-4703-bcfc-6a386e9e835a"
      unitRef="usd">5411000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzgtMS0xLTEtMTQzMjg2_08727cf5-a879-42a6-8945-64af608e994a"
      unitRef="usd">45215000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzgtMi0xLTEtMTQzMjg2_2ad6e9e2-e399-4ddb-bb04-e2f4dde3ba08"
      unitRef="usd">45339000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzgtMy0xLTEtMTQzMjg2_315111d0-4636-4c89-8c90-f232ff953662"
      unitRef="usd">28480000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzktMS0xLTEtMTQzMjg2_8378a123-7903-4a3b-956b-ce8531732f2b"
      unitRef="usd">-3136000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzktMi0xLTEtMTQzMjg2_613c7639-6dab-4725-a567-caca52f475b7"
      unitRef="usd">-2161000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzktMy0xLTEtMTQzMjg2_5e935d5d-4985-4bff-a672-7c033198eb68"
      unitRef="usd">-366000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzExLTEtMS0xLTE0MzI4Ng_d7b4e5d8-bf31-447a-b5df-44825cdf4392"
      unitRef="usd">17749000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzExLTItMS0xLTE0MzI4Ng_0ee759ca-6508-4ee0-82bc-4a35293fedf3"
      unitRef="usd">12890000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzExLTMtMS0xLTE0MzI4Ng_e6107fea-71f5-4617-8c7f-b85b3bff8a10"
      unitRef="usd">523000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEyLTEtMS0xLTE0MzI4Ng_233452bc-511a-4874-a863-123cbd5f3ac9"
      unitRef="usd">70523000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEyLTItMS0xLTE0MzI4Ng_5528f8a3-0601-41ee-9345-8e7fafa2ff43"
      unitRef="usd">133844000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEyLTMtMS0xLTE0MzI4Ng_af006bb0-f630-464e-9775-8a300bca7a5b"
      unitRef="usd">26271000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEzLTEtMS0xLTE0MzI4Ng_ec41d7ef-981c-4102-a233-88901c411ccb"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEzLTItMS0xLTE0MzI4Ng_fc68916c-baf0-4511-824e-d80cacbe5017"
      unitRef="usd">-14434000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzEzLTMtMS0xLTE0MzI4Ng_a99a6b12-1483-4f04-bc13-73e824122496"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <iclr:GainLossOnIssuanceOfDebt
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTEtMS0xLTE0ODQxNw_bc5429e7-dfc9-430c-a885-4a40254e2c21"
      unitRef="usd">0</iclr:GainLossOnIssuanceOfDebt>
    <iclr:GainLossOnIssuanceOfDebt
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTItMS0xLTE0ODQxNw_70fbe340-9eda-4837-b957-8aad35abda1b"
      unitRef="usd">-59460000</iclr:GainLossOnIssuanceOfDebt>
    <iclr:GainLossOnIssuanceOfDebt
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTMtMS0xLTE0ODQxNw_0fa44418-4e2c-4f9f-a795-c56fcc0218b7"
      unitRef="usd">0</iclr:GainLossOnIssuanceOfDebt>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTEtMS0xLTE0MzI4Ng_480a26f4-c30a-421e-8e85-21c3d08bc2c9"
      unitRef="usd">-124985000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTItMS0xLTE0MzI4Ng_2c40e475-6860-4857-a29b-03cbcc6259ad"
      unitRef="usd">-60616000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE0LTMtMS0xLTE0MzI4Ng_1ac5cb1e-fc2d-4b90-b65c-db8deacc49f0"
      unitRef="usd">927000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE1LTEtMS0xLTE0MzI4Ng_994741c7-116c-4f3f-bc0a-64fcafaf83ca"
      unitRef="usd">13009000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE1LTItMS0xLTE0MzI4Ng_64f57583-0223-453a-bd9c-0fd1898093cf"
      unitRef="usd">6054000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE1LTMtMS0xLTE0MzI4Ng_6243aec2-d4ee-4fb2-894d-cb819217ad61"
      unitRef="usd">-5979000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE2LTEtMS0xLTE0MzI4Ng_aa635079-3e8a-4a06-bb18-b07116f13afd"
      unitRef="usd">-11324000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE2LTItMS0xLTE0MzI4Ng_fb606b99-1600-49a2-be35-a895bc29df6b"
      unitRef="usd">-4480000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE2LTMtMS0xLTE0MzI4Ng_06f7fc5d-6749-47d2-a7ab-bc1fa7b671b8"
      unitRef="usd">7859000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE4LTEtMS0xLTE0MzI4Ng_c96228a7-2597-4925-9c69-3f4ace7fd5cc"
      unitRef="usd">420695000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE4LTItMS0xLTE0MzI4Ng_1f6a5340-62b4-46d2-ae82-2f0931e7a379"
      unitRef="usd">-113513000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE4LTMtMS0xLTE0MzI4Ng_6ed5da77-2437-4e99-a7ad-d0ea753b48b6"
      unitRef="usd">175040000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE5LTEtMS0xLTE0MzI4Ng_4c5b3e87-cf67-4dfa-8cd8-4e83f39fc602"
      unitRef="usd">332592000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE5LTItMS0xLTE0MzI4Ng_ad98cb84-a701-4160-987c-744debe588a1"
      unitRef="usd">17656000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzE5LTMtMS0xLTE0MzI4Ng_cfeaf7e3-c75b-4e9c-84b4-82e23457c47d"
      unitRef="usd">5748000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIwLTEtMS0xLTE0MzI4Ng_81e1d698-42b1-428a-880b-95ee7fa29328"
      unitRef="usd">192944000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIwLTItMS0xLTE0MzI4Ng_2f2a2ca8-e66f-4cc0-a6f1-f48447309069"
      unitRef="usd">-69121000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIwLTMtMS0xLTE0MzI4Ng_b24d283d-a170-418f-bb30-89fd9b83bf98"
      unitRef="usd">291844000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIxLTEtMS0xLTE0MzI4Ng_ee917800-d586-4b3f-8f93-5f65390a6c5b"
      unitRef="usd">10121000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIxLTItMS0xLTE0MzI4Ng_95d919b3-8d58-4a5d-9d0b-9d027fe54182"
      unitRef="usd">108259000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIxLTMtMS0xLTE0MzI4Ng_b20f1b98-8c2a-4127-ba09-f6c0e32e9bca"
      unitRef="usd">-2209000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIyLTEtMS0xLTE0MzI4Ng_915038cc-9011-4919-a9ef-1d77ab975ecd"
      unitRef="usd">563315000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIyLTItMS0xLTE0MzI4Ng_5faab328-3cc4-41d7-93f2-b8e8428c552e"
      unitRef="usd">829142000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzIyLTMtMS0xLTE0MzI4Ng_62a5e6df-a95a-42e4-b377-edaa052eea0a"
      unitRef="usd">568035000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI0LTEtMS0xLTE0MzI4Ng_c04e9fa2-0dee-430f-abf2-227f125b24c9"
      unitRef="usd">142160000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI0LTItMS0xLTE0MzI4Ng_bf2d313d-ac10-4bf7-988c-d2011013a9fe"
      unitRef="usd">93750000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI0LTMtMS0xLTE0MzI4Ng_ea2028d9-bad6-43df-9b94-49cae3ed7ffc"
      unitRef="usd">40885000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI1LTEtMS0xLTE0MzI4Ng_2a199cc4-9ff5-4877-954b-f79ba2d4f137"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI1LTItMS0xLTE0MzI4Ng_19498092-c62d-4d4a-9d2e-9b290efa3b02"
      unitRef="usd">5914475000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI1LTMtMS0xLTE0MzI4Ng_29b1e2fa-e3e6-43de-a51f-0a69cb6a7cfe"
      unitRef="usd">47931000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI2LTEtMS0xLTE0MzI4Ng_9cc86743-952c-4143-b16c-716fd48efbfc"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI2LTItMS0xLTE0MzI4Ng_e88452c9-71de-4ce8-8fa2-fdd4b554f975"
      unitRef="usd">2450000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI2LTMtMS0xLTE0MzI4Ng_3875509a-0b50-48fc-ba43-bdb9c009555f"
      unitRef="usd">2450000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI3LTEtMS0xLTE0MzI4Ng_4e8caf99-5447-4b7b-bf28-b7929cc06126"
      unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI3LTItMS0xLTE0MzI4Ng_f2438984-760a-4e56-a513-45463b689d17"
      unitRef="usd">10000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI3LTMtMS0xLTE0MzI4Ng_5e39fc79-1e7e-4a1c-b8e7-d438b59f68a1"
      unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI4LTEtMS0xLTE0MzI4Ng_75f4fd5a-e396-47fd-b1e5-7699de6477e5"
      unitRef="usd">481000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI4LTItMS0xLTE0MzI4Ng_8030214c-1811-40c0-9329-f9bdd1a27289"
      unitRef="usd">497000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI4LTMtMS0xLTE0MzI4Ng_beda3267-cf9b-4775-aa8b-80af01353894"
      unitRef="usd">47902000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTEtMS0xLTE0MzI4Ng_31bc056d-ca12-4afc-b474-955c9883f829"
      unitRef="usd">482000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTItMS0xLTE0MzI4Ng_77cfe261-53d1-41be-82ac-a142b30a9aaf"
      unitRef="usd">480000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTMtMS0xLTE0MzI4Ng_a87014e5-85e2-4f67-88d5-cfd4d093f116"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTEtMS0xLTE3NjY0MQ_524f16bf-55a1-4409-a873-3bc8178c4ef7"
      unitRef="usd">1906000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTItMS0xLTE3NjY0MQ_0921c34f-ebab-4230-ab86-cc83f7067cdb"
      unitRef="usd">500000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzI5LTMtMS0xLTE3NjY0MQ_00febdf0-f77c-4207-aa3d-a68f2a95aece"
      unitRef="usd">87000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMwLTEtMS0xLTE0MzI4Ng_7d3c7b06-ae0e-4ff9-a704-e2d0647ecc25"
      unitRef="usd">5612000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMwLTItMS0xLTE0MzI4Ng_3a27e672-0b4e-45fa-8a62-8aece0908636"
      unitRef="usd">4077000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMwLTMtMS0xLTE0MzI4Ng_9e67f0cc-331e-42c5-bb55-46896d41106f"
      unitRef="usd">3299000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMxLTEtMS0xLTE0MzI4Ng_b861397f-ad95-4ed9-b290-c6d421b78585"
      unitRef="usd">-145867000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMxLTItMS0xLTE0MzI4Ng_6e3dcb30-0716-425c-927e-7b3ece4ea278"
      unitRef="usd">-6024235000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMxLTMtMS0xLTE0MzI4Ng_8196e4c0-5094-41f2-ac62-bdde3f0d29a8"
      unitRef="usd">-46576000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMzLTEtMS0xLTE0MzI4Ng_7164d390-21c7-4d5c-9d04-1a8c2e441a3b"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMzLTItMS0xLTE0MzI4Ng_6f812cc5-3b9d-4318-8f64-39f70b7dff68"
      unitRef="usd">30328000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzMzLTMtMS0xLTE0MzI4Ng_7a191365-8abb-4156-ad61-f840fca734af"
      unitRef="usd">1554000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM0LTEtMS0xLTE0MzI4Ng_d98cdaf2-4081-4e1a-821d-6629616d5863"
      unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM0LTItMS0xLTE0MzI4Ng_fd829a81-c105-4033-8086-11d865feb06f"
      unitRef="usd">5905100000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM0LTMtMS0xLTE0MzI4Ng_82c05966-31bc-4169-b128-e658dc0faf88"
      unitRef="usd">350000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM1LTEtMS0xLTE0MzI4Ng_0cdd624f-c6bd-42d2-9623-c7a635ee18f1"
      unitRef="usd">875000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM1LTItMS0xLTE0MzI4Ng_0ca4c8ac-5ec2-42ca-8e9c-2471ff14ba31"
      unitRef="usd">877780000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM1LTMtMS0xLTE0MzI4Ng_d3913996-5596-4260-bb60-74bc56e88674"
      unitRef="usd">350000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM2LTEtMS0xLTE0MzI4Ng_5b121eee-417e-40c9-b52a-0193866c0c2c"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM2LTItMS0xLTE0MzI4Ng_7fa15b6f-bb44-42bb-949c-ae252ab85a37"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM2LTMtMS0xLTE0MzI4Ng_d4b02847-9072-4bd1-8d40-4dd8ce63abfc"
      unitRef="usd">43923000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM3LTEtMS0xLTE0MzI4Ng_f8b16c4b-d8ee-4c56-afd8-34b5fbaafa3f"
      unitRef="usd">35844000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM3LTItMS0xLTE0MzI4Ng_49219da1-fa4b-4c4c-90af-86949bae76c1"
      unitRef="usd">118589000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM3LTMtMS0xLTE0MzI4Ng_b13f206d-32b0-4584-82be-0a582b2840db"
      unitRef="usd">13203000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM4LTEtMS0xLTE0MzI4Ng_1da21f34-7be7-4f90-a9b6-9f443a1134bf"
      unitRef="usd">17000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM4LTItMS0xLTE0MzI4Ng_c22c95f9-7a7d-4235-bed4-7a590d7ea419"
      unitRef="usd">853000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzM4LTMtMS0xLTE0MzI4Ng_b6290ad5-5bb9-4bef-8767-863f3a94e5db"
      unitRef="usd">14000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQwLTEtMS0xLTE0MzI4Ng_9b465a14-2391-4371-8b2c-422bcecdb064"
      unitRef="usd">99983000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQwLTItMS0xLTE0MzI4Ng_8e963708-a18b-4dcd-a198-fab91042dd85"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQwLTMtMS0xLTE0MzI4Ng_5665efe8-3437-4ff3-8fb4-8c9db230a63f"
      unitRef="usd">175000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <iclr:PaymentsForShareRepurchaseCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQxLTEtMS0xLTE0MzI4Ng_154c3bee-cf86-4e40-9de7-4bfe82a3063f"
      unitRef="usd">17000</iclr:PaymentsForShareRepurchaseCosts>
    <iclr:PaymentsForShareRepurchaseCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQxLTItMS0xLTE0MzI4Ng_b03c41ed-8063-4856-93f9-08453c27f52e"
      unitRef="usd">0</iclr:PaymentsForShareRepurchaseCosts>
    <iclr:PaymentsForShareRepurchaseCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQxLTMtMS0xLTE0MzI4Ng_4a8f536d-40d9-4f0d-b822-1f969b117f5e"
      unitRef="usd">140000</iclr:PaymentsForShareRepurchaseCosts>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQzLTEtMS0xLTE0MzI4Ng_ce6386e0-6c95-45f1-ab86-9a2fd0156daa"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQzLTItMS0xLTE0MzI4Ng_a29f4c26-dbee-4857-be19-181bcb281d1f"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQzLTMtMS0xLTE0MzI4Ng_2175764a-1cc1-44da-91db-3faebd383dc3"
      unitRef="usd">905000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ0LTEtMS0xLTE0MzI4Ng_ea3f6271-6fea-4fd4-ae15-7183eac4819f"
      unitRef="usd">-864173000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ0LTItMS0xLTE0MzI4Ng_782ab0be-1b78-4efb-abb4-7d73f256ee31"
      unitRef="usd">5114728000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ0LTMtMS0xLTE0MzI4Ng_12b3373b-a5ab-42d5-b297-6a95b64c97ec"
      unitRef="usd">-208333000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ1LTEtMS0xLTE0MzI4Ng_5e180055-b15e-483b-9867-e01030869294"
      unitRef="usd">-16720000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ1LTItMS0xLTE0MzI4Ng_ae8ca87d-a743-4b85-bb84-5800b1fdd0a1"
      unitRef="usd">-7727000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ1LTMtMS0xLTE0MzI4Ng_10263126-30e8-493f-8b8a-614c46650e15"
      unitRef="usd">6870000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ2LTEtMS0xLTE0MzI4Ng_2383d45e-3d75-49ee-a2a5-51f23348b5c1"
      unitRef="usd">-463445000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ2LTItMS0xLTE0MzI4Ng_905eb834-3bea-4e38-ba10-0d480fc199bb"
      unitRef="usd">-88092000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ2LTMtMS0xLTE0MzI4Ng_dcebccc7-5623-4ad5-a811-bed9e73ae1f0"
      unitRef="usd">319996000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ3LTEtMS0xLTE0MzI4Ng_c2039843-da6f-4bff-9f6b-20f23a3bac3c"
      unitRef="usd">752213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ3LTItMS0xLTE0MzI4Ng_319f984b-60f9-4343-928b-7a31cbaa5ce8"
      unitRef="usd">840305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9c028363c21c48d5bdb88ba826d38299_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ3LTMtMS0xLTE0MzI4Ng_294bb409-638d-47d2-8d19-a7b7590898c0"
      unitRef="usd">520309000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ4LTEtMS0xLTE0MzI4Ng_abc6fe5c-119d-4399-8d9e-df29bd4dbe38"
      unitRef="usd">288768000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ4LTItMS0xLTE0MzI4Ng_0c315cfc-b3bb-4f02-8e64-00115dcf9c18"
      unitRef="usd">752213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNTQvZnJhZzpjMTZhOWVmYTFmZDc0YTZlYWI2NzAxY2JhYjI3MTIwMi90YWJsZTo4YTU0OGM1NzBhNmY0MWY2YjAyM2NhYThmOTJiMWQyNS90YWJsZXJhbmdlOjhhNTQ4YzU3MGE2ZjQxZjZiMDIzY2FhOGY5MmIxZDI1XzQ4LTMtMS0xLTE0MzI4Ng_e185071b-8c1e-409a-8995-f260857f1521"
      unitRef="usd">840305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzE2NzM_6b096649-bb17-4b6e-a97c-6eda7db1c0f0">Description of Business &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December&#160;31, 2022 we had approximately 41,100 employees, in 111 locations in 53 countries. During the year ended December&#160;31, 2022, we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON&#x2019;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#x201c;ICLR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <dei:EntityNumberOfEmployees
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4Xzk0Mg_4f8c521b-c3ea-485f-8821-a0a15727c2d1"
      unitRef="employee">41100</dei:EntityNumberOfEmployees>
    <iclr:NumberOfLocations
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4Xzk1OQ_e57ccfd0-dd6d-4f65-9dfd-62c79d3614a1"
      unitRef="location">111</iclr:NumberOfLocations>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4Xzk3NQ_1872f9ff-7d90-47e1-a124-3ddf4a9373b9"
      unitRef="country">53</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i25b768baea2347c69afde3c3be439fd8_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzEwNDA_4a9d731d-7019-4b9f-beec-5b611a83c904"
      unitRef="number">0.462</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i92bd1d25d98e4448ad3ea7952d2ee232_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzEwNDQ_78f241aa-ea6c-41a0-955a-8b8ade1a1dfc"
      unitRef="number">0.465</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5d681611048348019dc67e17504b3c0b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjAvZnJhZzo4NDYzZWVjMmJiNzk0YTI3YTY1NGJkMTE3OGFjYTFmOC90ZXh0cmVnaW9uOjg0NjNlZWMyYmI3OTRhMjdhNjU0YmQxMTc4YWNhMWY4XzEwNTE_8111bdf4-b608-45a4-aed5-7fcc6b59108d"
      unitRef="number">0.073</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDE1_318de0d4-8c1c-41a9-a178-888e0b794a69">Summary of Significant Accounting Policies&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3: Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#x2013; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited)/charged&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value measurements and disclosure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable, net and unbilled revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable early payment discounting&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Transfers and Servicing'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2-8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2022 and December&#160;31, 2021, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and  Equipment &#x2013; Overall&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives.  The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of goodwill and long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#x201c;global intangible low-taxed income&#x201d;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Pension'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. These plans are presented in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Compensation &#x2013; Stock Compensation'.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Redeemable noncontrolling interests and equity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Distinguishing Liabilities from Equity'. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#x2019;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#x2019;s presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of Recently Issued or Adopted Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NTIx_652a8b02-97b7-424b-8148-7da450ca0205">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NTA0_c88fa34a-c26f-4f31-b861-13a3aace3856">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2Njg0NTI_28352958-4235-469d-bbd0-4fb35d042a0b">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3: Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements &#x2013; quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2MzQ_f5e05077-91ff-43df-9e68-c08c69def94d">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2MzU_a3bebd50-7d41-4d8f-b672-721695fde314">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited)/charged&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <iclr:ForeignCurrencyDisclosureTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2NDA_a125e393-992f-496f-b29a-89ca58fd930e">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited)/charged&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:ForeignCurrencyDisclosureTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTpmZmUwNGNiYjNiYTA0OWVmYmZkYTBjMTU4NTlhOTc1Zi90YWJsZXJhbmdlOmZmZTA0Y2JiM2JhMDQ5ZWZiZmRhMGMxNTg1OWE5NzVmXzMtMS0xLTEtMTYxNTM1_a01210bb-ac11-4b8a-be91-7e79403ebf3e"
      unitRef="usd">25997000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTpmZmUwNGNiYjNiYTA0OWVmYmZkYTBjMTU4NTlhOTc1Zi90YWJsZXJhbmdlOmZmZTA0Y2JiM2JhMDQ5ZWZiZmRhMGMxNTg1OWE5NzVmXzMtMi0xLTEtMTYxNTM1_d55d459a-27ad-475e-a76b-a27337f33911"
      unitRef="usd">14316000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTpmZmUwNGNiYjNiYTA0OWVmYmZkYTBjMTU4NTlhOTc1Zi90YWJsZXJhbmdlOmZmZTA0Y2JiM2JhMDQ5ZWZiZmRhMGMxNTg1OWE5NzVmXzMtMy0xLTEtMTYxNTM1_24503e87-649f-4143-8cca-c5486a35fa75"
      unitRef="usd">-5979000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDIy_cc6a5489-a302-483a-918c-e817464f4695">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDI5_c8e77d38-b313-48d9-a0b0-e622a39cbd99">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDgw_00b391a5-83c4-4379-a3eb-072adb5e172a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDE5_d0522630-540b-4f4e-a1bb-17e9c7c9de9f">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in  funds at December&#160;31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2021 and December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value measurements and disclosure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;s'.  Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDky_b54f1ac1-1a5e-4336-8e06-7f45548e5b70">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable, net and unbilled revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable early payment discounting&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Transfers and Servicing'&lt;/span&gt; (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDk4_9b1307a5-ce35-4595-a5d8-59ff76b47962">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2-8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDUz_c4889692-63dc-4d4e-8028-762f9fce1b09">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2-8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzEtMS0xLTEtMTQzMjg2_f63dac4f-f468-47a7-b6fc-5fa612fd0407">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7e66e1c160f148649eb21d89bbf2625a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzItMS0xLTEtMTQzMjg2L3RleHRyZWdpb246MTY5OGM4YzdlOGFiNGU2NzgzZWZkNmNjZTk4Y2Q1MmZfNA_da570dcd-0ba5-48b3-bf54-c7e8d1cfd5b2">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2f8a2c39e7124f16b49ad2a09d9b25af_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzItMS0xLTEtMTQzMjg2L3RleHRyZWdpb246MTY5OGM4YzdlOGFiNGU2NzgzZWZkNmNjZTk4Y2Q1MmZfNw_ffb42a75-3eaf-434e-a057-f822be98c98d">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8aa76511dda54693974dbb4e12681b0e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzMtMS0xLTEtMTQzMjg2_857e9494-5922-4897-90ad-10bf7d9a9ac9">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2c614a0351ee4d65b7706dbb34ed6783_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzQtMS0xLTEtMTQzMjg2_95dd5e15-3ad8-4bd7-b9dd-2de20651d95a">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0cc8557895694ddda58a406b0e47873c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTowNWQwZDMxZjcxOTg0YWMyODdjMGNlMjhmOGJhZjU5Yi90YWJsZXJhbmdlOjA1ZDBkMzFmNzE5ODRhYzI4N2MwY2UyOGY4YmFmNTliXzUtMS0xLTEtMTQzMjg2_f8b8ade1-ffd0-4eac-9c32-1eed33e62c48">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDY4_03d3ea48-d7d4-468e-9b73-4cc690316411">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2022 and December&#160;31, 2021, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and  Equipment &#x2013; Overall&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2MzY_414e4612-0673-46b8-b457-95a1ae622e60">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives.  The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2NDI_67c0846d-dd30-4259-9ca5-d47e363df033">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Intangible Assets for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,056,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;536,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,109,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,081,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(830,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,278,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,710,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i423bdb53508049b790b135a49d542ab9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzEtMS0xLTEtMTY3NTEx_1834c3ff-4653-4cbc-ac55-b934ac646bd5">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iff41f4c3905c417bbe6fbf9952151d95_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzItMS0xLTEtMTY3NTEx_c39a35e3-1c3f-462f-b097-2a5448704b9b">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4ff6c4c1b4574a40829f531f7210e9bc_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzMtMS0xLTEtMTY3NTEx_a2cb844b-bc9c-4cd4-8aea-508417698ef8">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idb366a4aaf994d7e840ad3fff4c1fe43_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzQtMS0xLTEtMTY3NTEx_f93c64d7-6f75-4bda-ad8e-09340e9a2902">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i69bb660dc51543a1937c2ecfd5d7b2b5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90YWJsZTo3ZGU1OTY0N2UzODE0NGQ4ODUzMTFiMmRmYzM0NjMxNC90YWJsZXJhbmdlOjdkZTU5NjQ3ZTM4MTQ0ZDg4NTMxMWIyZGZjMzQ2MzE0XzUtMS0xLTEtMTY3NTEx_a6ba9457-6745-4aa2-8170-15db75d0f9e5">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2Mzc_044e6118-121c-4778-b4f9-9d3d4c895882">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of goodwill and long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2MzMyNzA_e9b6a36e-f02d-4276-808c-263775dfef43">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2Mzg_f4ab55f9-4ec4-4432-8bd8-493bfede05b3">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDI3_ba1a2b4a-4761-48e4-962e-e2f8fc3a34a5">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (&#x201c;global intangible low-taxed income&#x201d;) in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <iclr:GovernmentGrantsPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDI4_3f050551-d648-43f7-aaeb-0a09b5c4ffe4">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;</iclr:GovernmentGrantsPolicyTextBlock>
    <iclr:ResearchandDevelopmentCreditsPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDg5_217b3110-6d5c-4452-9bb1-2dc7a8806af3">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;</iclr:ResearchandDevelopmentCreditsPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDA1_1dd29467-03a4-481d-8ef8-914ff0ae9dc7">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Pension'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. These plans are presented in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NTEz_4f4b122b-590c-421b-8180-eb450797fdbf">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Compensation &#x2013; Stock Compensation'.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDk3_25c6b92c-455b-47e5-bf26-9435a457d8f1">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2MzMyNzE_3711d120-89cf-4019-8430-453e85c30642">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Redeemable noncontrolling interests and equity&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Distinguishing Liabilities from Equity'. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. &lt;/span&gt;&lt;/div&gt;Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.</iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage
      contextRef="i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzgyNDYzMzczOTcwMzg_f2441008-9e63-4545-a6cc-915b66a07630"
      unitRef="number">1</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc1OTk2Mzk_6cc0da4c-bf8b-428e-a90f-df0b2cd198ca">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzM5NDQ0_38556d43-9e46-4e25-9fc5-c9b5d6b07dbe">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period&#x2019;s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period&#x2019;s presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjMvZnJhZzplYmY1MDQ5Nzg1MmE0MzY1YjYyZTRkNGZhNTRhNzdlZC90ZXh0cmVnaW9uOmViZjUwNDk3ODUyYTQzNjViNjJlNGQ0ZmE1NGE3N2VkXzE2NDkyNjc2Njk2MTE_02518b0e-8090-4ee9-b28f-c10212decdc7">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of Recently Issued or Adopted Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90ZXh0cmVnaW9uOmZlNWQxZWRiZjFkYTQwZWRhYmQ4NWUxZjQ2YjdjZmI1XzIzMA_4cdd1eff-2cfc-4d41-a1b8-90ecab6bafa4">Disaggregation of Revenue&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer profile is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,291,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,112,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,585,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,077,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,853,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;851,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,741,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5,480,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,797,288&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,751,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,731,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,342,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,689,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,965,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,507,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,323,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(183,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(549,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(700,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2022 and December&#160;31, 2021 were $406.3&#160;million and $323.6&#160;million (see&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; note 12 - Other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services as at December&#160;31, 2022 increased by $334.5 million as compared to December&#160;31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2021 and December&#160;31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The credit loss expense recognized on the Group's receivables and unbilled services was $17.8&#160;million and $0.9&#160;million for the twelve months ended December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;As of December&#160;31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3&#160;billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90ZXh0cmVnaW9uOmZlNWQxZWRiZjFkYTQwZWRhYmQ4NWUxZjQ2YjdjZmI1XzIzMw_ec614642-ff4e-4b17-9600-b506dda9ab66">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer profile is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.126%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;441,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;337,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,291,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,112,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;752,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,585,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,077,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,853,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,918,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;851,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,741,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5,480,826&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2,797,288&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b703a470aec45d6b7cc535d913a035b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzMtMS0xLTEtMTQzMjg2_b2c493b7-d1a1-42d2-a482-625bdd0fec70"
      unitRef="usd">683546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i380e176b9dde4914abac25ae65cca717_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzMtMi0xLTEtMTQzMjg2_abb84147-0e82-4fc7-b070-a4220be610fe"
      unitRef="usd">441173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1998d53019114a92910d0b987e09e9eb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzMtMy0xLTEtMTQzMjg2_ff81b933-a468-4655-80ff-738128dd391c"
      unitRef="usd">337904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79832711688241cdbc03301d09dc65ed_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzQtMS0xLTEtMTQzMjg2_8d03eda6-6d6f-4557-a841-11b0e1517ee3"
      unitRef="usd">1506087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b4f29d3e2b241b690b68915c03d5e7d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzQtMi0xLTEtMTQzMjg2_1c42973e-e8a2-4221-b069-8836e152d736"
      unitRef="usd">1291946000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia706efb7e7544d30a249a2933512bbd5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzQtMy0xLTEtMTQzMjg2_259faf80-944c-45a7-811b-7cc5c5746d10"
      unitRef="usd">754906000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdedac9e58504241a677dd5e16834802_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzUtMS0xLTEtMTQzMjg2_af22f1ed-79f0-49cc-8515-5d30518ad467"
      unitRef="usd">1112636000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56f70ffa378f4eb6b7bea34717f35edc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzUtMi0xLTEtMTQzMjg2_812c7a3c-46cd-4ee4-b0e3-a7e1214e8cae"
      unitRef="usd">752325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d0066899c49400d88bd9e23928ccc84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzUtMy0xLTEtMTQzMjg2_726a9f5a-d5ba-438f-afaa-041326fd378c"
      unitRef="usd">350865000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id595e6ca907842c5ad25832951a08162_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzYtMS0xLTEtMTQzMjg2_ebcdf243-0fda-43fa-a0c9-0844f03f7c63"
      unitRef="usd">1585739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70f2210593f144b18961bb25bb1f64c3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzYtMi0xLTEtMTQzMjg2_f59576a9-9325-4a03-9016-445135cf6dc2"
      unitRef="usd">1077073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a8bcfc7e9ad4cd49adf68eaea5ab3c5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzYtMy0xLTEtMTQzMjg2_22900b68-a910-4a3e-a465-28bed2aa0444"
      unitRef="usd">501643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44ee1247f39e40e095600c4da686996e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzctMS0xLTEtMTQzMjg2_b3464f29-8524-4a72-b886-607773c07eef"
      unitRef="usd">2853378000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06f0ea2e03f744609e1793a8709bb329_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzctMi0xLTEtMTQzMjg2_bca10b50-ab57-45d1-afdd-02e52e716500"
      unitRef="usd">1918309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbc54966d15445729a0ed93be99fdbd0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzctMy0xLTEtMTQzMjg2_5eb73432-bb1f-4cc3-ba13-f88399f792d0"
      unitRef="usd">851970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzgtMS0xLTEtMTQzMjg2_38b429ee-f74d-42ef-9c04-cb50edbf71f7"
      unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzgtMi0xLTEtMTQzMjg2_3d72eaf7-6e9f-4f81-92b4-68701ec4504e"
      unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTcvZnJhZzpmZTVkMWVkYmYxZGE0MGVkYWJkODVlMWY0NmI3Y2ZiNS90YWJsZToyNDA2NGYwNTM5OTM0YTRhYjc1YTYyZDQ5MTY0YTZhYy90YWJsZXJhbmdlOjI0MDY0ZjA1Mzk5MzRhNGFiNzVhNjJkNDkxNjRhNmFjXzgtMy0xLTEtMTQzMjg2_7d124df7-ac52-4422-9090-7a9f33adbd80"
      unitRef="usd">2797288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMzMjQ_1c2303eb-838b-4871-b450-1e7935d49675">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,751,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,349,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,731,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,342,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,689,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,965,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;957,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;623,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,507,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,323,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(183,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(549,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(700,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:BilledContractReceivables
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzItMS0xLTEtMTQzMjg2_6e5a7861-a13f-449d-8ffc-210699a119a1"
      unitRef="usd">1751950000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzItMy0xLTEtMTQzMjg2_16978593-e423-4fd7-8106-855ba2a0b0ca"
      unitRef="usd">1349851000</us-gaap:BilledContractReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzMtMS0xLTEtMTQzMjg2_447c3030-fcba-483e-910d-386f1410d163"
      unitRef="usd">20562000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzMtMy0xLTEtMTQzMjg2_231d2327-c0c2-450c-804b-f9498248dbe0"
      unitRef="usd">7081000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <iclr:ContractsReceivableGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzQtMS0xLTEtMTQzMjg2_d5921fb1-a175-4ba8-a385-8493446cd635"
      unitRef="usd">1731388000</iclr:ContractsReceivableGross>
    <iclr:ContractsReceivableGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzQtMy0xLTEtMTQzMjg2_c7e0988b-fc09-474c-a60d-24a859fbf978"
      unitRef="usd">1342770000</iclr:ContractsReceivableGross>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzUtMS0xLTEtMTQzMjg2_1dfc7e88-d156-4b00-a14a-e901fb50e084"
      unitRef="usd">957655000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzUtMy0xLTEtMTQzMjg2_e239eda0-ab72-424d-953f-1bd9c82f41d1"
      unitRef="usd">623121000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:ContractsReceivableNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzYtMS0xLTEtMTQzMjg2_bf8c14e0-71e9-44db-86c4-551b1fe82ad5"
      unitRef="usd">2689043000</iclr:ContractsReceivableNet>
    <iclr:ContractsReceivableNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTpiMzUyYmNkZjZkNzY0ODA1YWFmODVkMzE5NWMxOGViNy90YWJsZXJhbmdlOmIzNTJiY2RmNmQ3NjQ4MDVhYWY4NWQzMTk1YzE4ZWI3XzYtMy0xLTEtMTQzMjg2_534a0d45-d1f3-4039-b200-72da0acdd2fd"
      unitRef="usd">1965891000</iclr:ContractsReceivableNet>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItMS0xLTEtMTQzMjg2_f6c6fa15-08a0-45c3-95b4-033d7af8df1e"
      unitRef="usd">957655000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItMy0xLTEtMTQzMjg2_262ae3ba-be41-4090-aca0-4a88871f4ec0"
      unitRef="usd">623121000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItNS0xLTEtMTQzMjg2_caad8733-f2e7-48c3-9bc3-9712ec0d87f6"
      unitRef="usd">334534000</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzItNy0xLTEtMTQzMjg2_3d13c088-6253-431c-843d-43393d481c7a"
      unitRef="number">0.537</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtMS0xLTEtMTQzMjg2_71c06302-e215-4c74-b43d-3b55a9a348d7"
      unitRef="usd">1507449000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtMy0xLTEtMTQzMjg2_27fc2cfd-ebc9-470a-9e99-79e2380dd7a2"
      unitRef="usd">1323961000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtNS0xLTEtMTQzMjg2_d06ffff6-2bc2-4bcf-874f-99e2104d9c26"
      unitRef="usd">183488000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzMtNy0xLTEtMTQzMjg2_f596ff54-a54d-4655-8203-f70a408a0079"
      unitRef="number">0.139</iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtMS0xLTEtMTQzMjg2_2ad12574-1cc6-4875-aab1-ceefd608aa9b"
      unitRef="usd">-549794000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtMy0xLTEtMTQzMjg2_5df867f0-42cc-4bbe-af88-5b123ea8e7e3"
      unitRef="usd">-700840000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtNS0xLTEtMTQzMjg2_a5312ef8-4413-47a8-ab09-54a2ed74819b"
      unitRef="usd">151046000</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90YWJsZTo4MmE2ZjdlZTNkMDA0NzVkOTU1NmZmY2JkMWNlYjQ2Zi90YWJsZXJhbmdlOjgyYTZmN2VlM2QwMDQ3NWQ5NTU2ZmZjYmQxY2ViNDZmXzQtNy0xLTEtMTQzMjg2_00af337f-7336-44ba-8216-e24b178d43a4"
      unitRef="number">0.216</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzU0OTc1NTgxNDIyMTg_2007f106-d6ae-4167-8ba4-4a0f623da344"
      unitRef="usd">406300000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzU0OTc1NTgxNDIyMDk_f51af9a2-4894-40d0-bd5f-0b17d58d580f"
      unitRef="usd">323600000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzIwMTQ_f419355a-f7b5-499a-84e8-bce564063e1f"
      unitRef="usd">334500000</iclr:IncreaseDecreaseInContractwithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzIwNTk_0fd938c4-db6d-43b6-9b0b-234da28b00bb"
      unitRef="usd">183500000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzIxMTA_de31cc8e-f27e-4c05-9d61-f45da25b0337"
      unitRef="usd">151000000</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzI5MTk_efcb0d3b-c5ad-4fb1-9f0e-6b00e9b18f81"
      unitRef="usd">17800000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzI5MjY_48fa965e-b1d4-455f-9471-9fbc57b159aa"
      unitRef="usd">900000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMwMDY_12dde4dd-15c2-49eb-88ba-e1f11da696b9"
      unitRef="usd">13700000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzE2NDkyNjc0NDU3MDk_a8946e72-08b4-4ef4-a795-22791127f2aa"
      unitRef="usd">13300000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="iff7ba07c4dd648098208327ed22330c8_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMxNzI_c196a26b-53ab-4952-bd24-e4fd392e9514"
      unitRef="number">0.52</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="iff7ba07c4dd648098208327ed22330c8_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMyMzA_73e66060-9ceb-4483-88dc-0381d87bb496">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i23de17af5ea240e78dfcd77718adcfbe_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzMyMzA_e6b9392d-f6e6-4215-834f-68a930f71614">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i23de17af5ea240e78dfcd77718adcfbe_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjAvZnJhZzo5YTg4Y2UxNmU4YWE0OWFlYTdkOTBjZGZkZTVkZmNjNi90ZXh0cmVnaW9uOjlhODhjZTE2ZThhYTQ5YWVhN2Q5MGNkZmRlNWRmY2M2XzE2NDkyNjc0NDU3MjQ_f2bdd836-fc0c-4cef-8311-006424c32494"
      unitRef="number">0.48</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <iclr:AllowanceForDoubtfulAccountsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90ZXh0cmVnaW9uOmYzZWI4YTBiM2Q4ZDQ0OTNhODhjMzcwYmEzYTRlZmRiXzE3Nw_13f3e736-ae99-4a5e-89c6-00a5c169a58c">Allowance for Credit Losses&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2022 and December&#160;31, 2021 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts released during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:AllowanceForDoubtfulAccountsTextBlock>
    <iclr:AllowanceForDoubtfulAccountsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90ZXh0cmVnaW9uOmYzZWI4YTBiM2Q4ZDQ0OTNhODhjMzcwYmEzYTRlZmRiXzE3Ng_00ce16ee-585a-435a-8595-5f7658416ed5">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2022 and December&#160;31, 2021 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts released during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(406)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:AllowanceForDoubtfulAccountsTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzItMS0xLTEtMTQzMjg2_6ba04d3a-fd3b-448d-95e4-05ae70abaa2d"
      unitRef="usd">7081000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzItMi0xLTEtMTQzMjg2_f7f601ee-4e83-47a5-9c99-e8ed2a9b0754"
      unitRef="usd">7149000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzMtMS0xLTEtMTQzMjg2_d8fa3e33-d57f-43d6-babd-77572bce3b65"
      unitRef="usd">3913000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzMtMi0xLTEtMTQzMjg2_d39ba66b-e58b-464c-a013-41a0dab618ac"
      unitRef="usd">116000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <iclr:AccountsReceivableCreditLossExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzQtMS0xLTEtMTQzMjg2_0798b657-3b55-4377-9d6a-9e0f804496ee"
      unitRef="usd">17800000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AccountsReceivableCreditLossExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzQtMi0xLTEtMTQzMjg2_b7abbe1f-897b-4d27-a227-8643015c643c"
      unitRef="usd">705000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AccountsReceivableCreditLossReversal
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzUtMS0xLTEtMTQzMjg2_900be7e4-550a-4284-9370-15e7b1f7bd0c"
      unitRef="usd">0</iclr:AccountsReceivableCreditLossReversal>
    <iclr:AccountsReceivableCreditLossReversal
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzUtMi0xLTEtMTQzMjg2_d2328935-7963-45bc-b59d-551d629c35c3"
      unitRef="usd">544000</iclr:AccountsReceivableCreditLossReversal>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzYtMS0xLTEtMTQzMjg2_defb8781-4162-4116-b2ea-a9e08538f47d"
      unitRef="usd">-406000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzYtMi0xLTEtMTQzMjg2_a4f60601-6e53-43ac-87b2-35ff4e59b532"
      unitRef="usd">-113000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzctMS0xLTEtMTQzMjg2_4a767eef-1951-45e4-94cf-32a6b26eb979"
      unitRef="usd">20562000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjMvZnJhZzpmM2ViOGEwYjNkOGQ0NDkzYTg4YzM3MGJhM2E0ZWZkYi90YWJsZTozMTc4Y2FlNTFmNmU0OTQxOWYwMmFlODYxY2M2YTYxMC90YWJsZXJhbmdlOjMxNzhjYWU1MWY2ZTQ5NDE5ZjAyYWU4NjFjYzZhNjEwXzctMi0xLTEtMTQzMjg2_5a7e18b4-7f6e-4607-bbd8-c3627fa474f7"
      unitRef="usd">7081000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxNDM_181d565e-f096-4b41-a4b0-c56fa245059d">Business Combinations&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;PRA Health Sciences, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#x2019; commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In the years ended December&#160;31, 2022 and 2021, the Company incurred Merger-related expenses of $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#x201c;Transaction and integration related&#x201d; line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in transaction and integration costs in the years ended December&#160;31, 2022 and 2021 are acquisition related costs (as defined by ASC 805) of $0.8&#160;million and  $57.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the &#x201c;Interest expense&#x201d; line item in the Consolidated Statement of Operations for the year ended December&#160;31, 2021. During the year ended December&#160;31, 2021, the Company deferred &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$76.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Merger Date fair value of the consideration transferred consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,308,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of ordinary shares issued to acquiree stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,658,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of replacement share-based awards issued to acquiree employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan obligations and accrued interest *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;934,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,084,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(380,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(739,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,119,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(204,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,938,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement period adjustments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(151,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; * In the year ended December&#160;31, 2022, the Company incurred $2.2&#160;million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <dei:EntityNumberOfEmployees
      contextRef="id34237e03be942cc9cc2d0552e1de455_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzQ3Mw_e33da7a2-e07d-4b4d-b447-9cbd1932cf28"
      unitRef="employee">38000</dei:EntityNumberOfEmployees>
    <iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzEzNDM_be14dbf6-91fd-4a4e-aa0c-d47ef4eab87c"
      unitRef="usdPerShare">80</iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld>
    <iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzEzNTg_7a64b294-6327-45ed-ad9e-747715a77d2f"
      unitRef="shares">0.4125</iclr:BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzEwOTk1MTE2NDYxNzk_a16acadb-a5dd-444b-a776-be28c60776dd"
      unitRef="usd">39700000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzcxNDY4MjU1OTE5Njg_22dd51ca-db81-42a4-aa93-2725f08f8787"
      unitRef="usd">198300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzE2NDkyNjc0NjM1MTI_563338c4-0452-4d71-97ca-a58905ce89a0"
      unitRef="usd">800000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzE2NDkyNjc0NjM1MjY_877569d1-5b01-4e2f-8529-0e3d41ce6b5d"
      unitRef="usd">57100000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzIxOTc_5f0b7840-f5f6-48dc-9285-e5e70b1709d1"
      unitRef="usd">86700000</iclr:TransactionAndOneTimeFinancingCosts>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i8fc3e32cee5c4cfcbaa4850d89f898d9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzQzOTgwNDY1MjIyNzU_558bee53-65f1-438b-b70c-5cb719ab7e79"
      unitRef="usd">76200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxMzg_2e483972-a418-47c9-94a0-0a2e92967713">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Merger Date fair value of the consideration transferred consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of cash consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,308,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of ordinary shares issued to acquiree stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,658,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of replacement share-based awards issued to acquiree employees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repayment of term loan obligations and accrued interest *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;865,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6&#160;million from available cash to settle debt obligations that existed at the Merger Date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzEtMS0xLTEtMTQzMjg2_b75bc7ff-4ab3-4cb2-8daa-5de972f9ece8"
      unitRef="usd">5308646000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzItMS0xLTEtMTQzMjg2_2489d1e2-6d3c-485f-9589-aca1d105f4da"
      unitRef="usd">5658126000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzMtMS0xLTEtMTQzMjg2_66a893e2-f98a-4c60-b37a-35ad92376be8"
      unitRef="usd">209399000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzQtMS0xLTEtMTQzMjg2_31543dce-71d3-48e9-acc5-75b8b08601a1"
      unitRef="usd">865800000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTo3NTI5NDAwNDVkNmM0ZjkzYmEwYTJiZDU3M2I2YWM1My90YWJsZXJhbmdlOjc1Mjk0MDA0NWQ2YzRmOTNiYTBhMmJkNTczYjZhYzUzXzUtMS0xLTEtMTQzMjg2_a90f8eb1-efe9-4110-8255-a32c606ef548"
      unitRef="usd">12041971000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate
      contextRef="i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzI5MjQ_1e58767b-2fa9-45e9-8eba-b46baec4a6fd"
      unitRef="usd">401600000</iclr:BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxNDI_6f37706b-300b-4b6a-a25f-67ad2a3e86d7">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;934,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;156,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,084,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(380,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(739,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,119,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(204,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,041,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzMtMS0xLTEtMTQzMjg2_8f4ee08a-3e9e-4e46-b3b1-1f6ddb3d024a"
      unitRef="usd">259971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzQtMS0xLTEtMTQzMjg2_410bbc62-f6bd-4f61-b891-36e5f2d80eba"
      unitRef="usd">934308000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzUtMS0xLTEtMTQzMjg2_cd23df19-b54f-4da0-a2b5-b8cd4220ae7f"
      unitRef="usd">125156000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzYtMS0xLTEtMTQzMjg2_79d98fcc-3331-4138-8227-ca7e9a337059"
      unitRef="usd">156851000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzctMS0xLTEtMTQzMjg2_5dd92be9-4bbf-4c54-bb22-ad10cfeb8c02"
      unitRef="usd">180601000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzgtMS0xLTEtMTQzMjg2_6a3c1e8b-e2fb-424e-b962-371f1f6f7d06"
      unitRef="usd">8084314000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzktMS0xLTEtMTQzMjg2_91b4a6cf-df49-4662-80a9-6d268e54eb2e"
      unitRef="usd">4919000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzEwLTEtMS0xLTE0MzI4Ng_8831a6c8-2edf-4e36-a8cb-59c76dc2db2f"
      unitRef="usd">25190000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzExLTEtMS0xLTE0MzI4Ng_3d216ce8-1832-4d5e-9fce-6930be4923ce"
      unitRef="usd">33928000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzEyLTEtMS0xLTE0MzI4Ng_dcef7fbb-b543-4439-be8f-684c0a2d1678"
      unitRef="usd">50259000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzEzLTEtMS0xLTE0MzI4Ng_4f44d2b6-84a1-4bef-a850-219c62d01e1b"
      unitRef="usd">380048000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE0LTEtMS0xLTE0MzI4Ng_a438fbc3-6103-407a-bee2-6c8b7a1f4317"
      unitRef="usd">36506000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE1LTEtMS0xLTE0MzI4Ng_26bbfd2c-e01e-49ea-855a-df219d245de8"
      unitRef="usd">739278000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent>
    <iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE2LTEtMS0xLTE0MzI4Ng_c4832870-c756-4694-bd75-7d67e8527cc1"
      unitRef="usd">147204000</iclr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE3LTEtMS0xLTE0MzI4Ng_ce8f857f-dd70-4309-b7a3-57f1d5bd337f"
      unitRef="usd">1119762000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzE4LTEtMS0xLTE0MzI4Ng_ae194dda-4e48-4a4e-92e3-25c40f04892e"
      unitRef="usd">204291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyNjFhMzU2OWZlNDk0OGQyYWI0OGQ2YTI1NjA1N2YxNi90YWJsZXJhbmdlOjI2MWEzNTY5ZmU0OTQ4ZDJhYjQ4ZDZhMjU2MDU3ZjE2XzIwLTEtMS0xLTE0MzI4Ng_a8a67cce-458c-48c5-9111-02b80f3dae08"
      unitRef="usd">12041971000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzM1MTA_0bb97346-29b5-4e8e-838c-73e1cf7e7105"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzgxNDE_0998c78b-8000-4f5e-b278-7708437e7d96">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,938,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,919,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i68cade11881441f999fe48a8b78fa866_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzEtMS0xLTEtMTQzMjg2_f4c7cbf8-8c97-4479-b065-71d1915cde7a"
      unitRef="usd">3938000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i050bc2a0894b4b519c23ad5dce7c546e_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzEtMi0xLTEtMTQzMjg2_d312e9c6-ddcf-4bd9-b8ff-4bc532c1c7ff">P23Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i65f325e72d854376869d44f5fabc8e75_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzItMS0xLTEtMTQzMjg2_9ec86a56-4a0d-4f69-a15f-e34fbdbb8909"
      unitRef="usd">500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i13749761bedc4da99e05caac9043517b_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzItMi0xLTEtMTQzMjg2_8427942c-1757-4788-85cc-d055b629d533">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1d23344e0fb3451da6613835547ccb77_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzMtMS0xLTEtMTQzMjg2_3722fe83-6721-4aa1-9e04-859e236b3ed5"
      unitRef="usd">202000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i80606786953145dfbdfda1d4010d7f1f_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzMtMi0xLTEtMTQzMjg2_9c82a5ec-ad7c-4eb6-b123-0e939343a353">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib000d5e1b7c444a98c09c3082b538879_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzQtMS0xLTEtMTQzMjg2_c7862559-5a76-4069-806d-0d91a270d14f"
      unitRef="usd">168000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib8ea9f2d8c19438a8322337241492d6e_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzQtMi0xLTEtMTQzMjg2_60b788f5-cf48-44d9-9de1-a0ca8e336b87">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if7d00b00550d4bf9a90bced55d00862b_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzUtMS0xLTEtMTQzMjg2_e69ccfe8-8a5c-4101-a6af-bd3cb9ebda39"
      unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i785f8636543e4f9b9285f8e0d63b6d2b_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzUtMi0xLTEtMTQzMjg2_70fdf6d1-e989-4626-8ad5-708316823770">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9351c9d02ef249de88d6a39e2bdb6b06_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZToyMDY1ODYyNjlmNjY0MGI1ODBhMjY3Yzg5OTQ4Yjc1Ny90YWJsZXJhbmdlOjIwNjU4NjI2OWY2NjQwYjU4MGEyNjdjODk5NDhiNzU3XzYtMS0xLTEtMTQzMjg2_44195621-7d33-4ac3-8244-e9b01c24aaf1"
      unitRef="usd">4919000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <iclr:ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzE2NDkyNjc0NjE1ODM_49763e8d-a344-4c6c-b8c9-e89a08ee5894">In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement period adjustments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(151,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; * In the year ended December&#160;31, 2022, the Company incurred $2.2&#160;million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** The unearned revenue measurement period adjustment also includes $16.0&#160;million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.&lt;/span&gt;&lt;/div&gt;</iclr:ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzMtMS0xLTEtMTY0OTk1_174b3026-428f-4596-b341-24776502154c"
      unitRef="usd">0</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzQtMS0xLTEtMTY0OTk1_862516d9-1f20-401f-8190-c85d4af0a851"
      unitRef="usd">0</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzUtMS0xLTEtMTY0OTk1_d4a6f762-b988-4f87-a9fb-7167ceff32b0"
      unitRef="usd">14465000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzYtMS0xLTEtMTY0OTk1_af62878e-e748-4b6f-9304-2901b0a797d0"
      unitRef="usd">-6137000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzctMS0xLTEtMTY0OTk1_c9fc0d91-337c-4eb2-b091-eb0f61dee8de"
      unitRef="usd">-11744000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzgtMS0xLTEtMTY0OTk1_1fce7796-22fa-4d5f-93ca-daa78c8b4114"
      unitRef="usd">70436000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzktMS0xLTEtMTY0OTk1_46db5bee-ff76-4819-900c-412879f142b2"
      unitRef="usd">44000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzEwLTEtMS0xLTE2NDk5NQ_4bb9c910-2f8b-4879-93f0-4c5f11c53a2f"
      unitRef="usd">-147039000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzExLTEtMS0xLTE2NDk5NQ_6e426b5a-3d39-422b-85f0-7e532337c4ff"
      unitRef="usd">-1166000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzEyLTEtMS0xLTE2NDk5NQ_9d0500a6-9e7a-4f8e-b7ac-f93b94f5fe85"
      unitRef="usd">0</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzEzLTEtMS0xLTE2NDk5NQ_9ba4d2e7-ba49-42e9-8342-4dd1255491f6"
      unitRef="usd">-37496000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE0LTEtMS0xLTE2NDk5NQ_b7e5efbb-7a04-4a5d-b3f9-193222fd978d"
      unitRef="usd">1865000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE1LTEtMS0xLTE2NDk5NQ_27e934b8-db2d-4343-97f6-ddf5a2cc8969"
      unitRef="usd">19623000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE2LTEtMS0xLTE2NDk5NQ_c39e5bc1-e837-485e-a330-36d64cd00bc4"
      unitRef="usd">10454000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE3LTEtMS0xLTE2NDk5NQ_7b33160c-207e-49a8-bf73-834f6d9537cc"
      unitRef="usd">193837000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities
      contextRef="ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90YWJsZTpmMjE2MTVhZDBlMGM0MzhlYmZiMTJhMjNjYWQwMWRkNi90YWJsZXJhbmdlOmYyMTYxNWFkMGUwYzQzOGViZmIxMmEyM2NhZDAxZGQ2XzE4LTEtMS0xLTE2NDk5NQ_bd01ebf7-d7ee-4b1b-8103-32e4ccd45db8"
      unitRef="usd">-151098000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzM4NDgyOTA3MTcxMzg_99a6da18-5660-4b1f-a1a9-86e8bc1eebde"
      unitRef="usd">2200000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue
      contextRef="i17edec93a2294c3e907c490cbb645326_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzgvZnJhZzozZTc0ZWZmZmU0NGI0NGYxYTViZDlhZDBlYzYxY2I3Zi90ZXh0cmVnaW9uOjNlNzRlZmZmZTQ0YjQ0ZjFhNWJkOWFkMGVjNjFjYjdmXzM4NDgyOTA3MTcxNTI_6811d942-8879-4641-9a46-f2cf7a760f61"
      unitRef="usd">16000000</iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzMyNDc_91619d44-3483-44ad-9620-4b9ae406cc29">Fair Value&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2 &#x2014; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c) Represents the fair value of interest rate cap and interest rate swap agreements. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-recurring Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2022, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,250.4 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,971.7 million and identifiable intangible assets, net of $4,278.7 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022 and 2021, the fair value of total debt approximated $4,650.3&#160;million and $5,507.2&#160;million, respectively, as determined under Level 2 measurement for these financial instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzE2NDkyNjc0NTY4NjA_19526bd0-61d5-435c-8b98-fcc0f86cd396">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c) Represents the fair value of interest rate cap and interest rate swap agreements. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzE2NDkyNjc0NTY4NjQ_5cee5acd-07ea-4b62-bcb9-003ed49b4945">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments (c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments Measured at Net Asset Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities (short-term) (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale investments (long-term) (b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2022 and December&#160;31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 and December&#160;31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c) Represents the fair value of interest rate cap and interest rate swap agreements. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i545583d261e248808f2d3bb26a97013b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItMS0xLTEtMTY5NDYy_05c47629-f696-448b-88dc-fa4bcde4ecec"
      unitRef="usd">1713000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItMi0xLTEtMTY5NDYy_7fb673c3-f5ee-410e-90a2-8eef0f533a00"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItMy0xLTEtMTY5NDYy_bb022c26-d2d6-4ffa-9f03-cce88aee44a9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItNC0xLTEtMTY5NDYy_e523855a-2c58-48c4-b25c-4d28b8365c7a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzItNS0xLTEtMTY5NDYy_187ff815-aa75-4bba-8e91-32039b669987"
      unitRef="usd">1713000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i545583d261e248808f2d3bb26a97013b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtMS0xLTEtMTY5NDYy_b966648d-04a2-49db-9e9b-e580a0d4d435"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtMi0xLTEtMTY5NDYy_209f1771-286a-4128-94df-087e9d498c39"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtMy0xLTEtMTY5NDYy_f40e92fa-9dad-4d78-abb6-df56e5b0cffc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtNC0xLTEtMTY5NDYy_267846e6-5797-4813-8ee8-ded704909dc2"
      unitRef="usd">32663000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzMtNS0xLTEtMTY5NDYy_71298aef-763f-4f21-8121-ca7c46122011"
      unitRef="usd">32663000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="i978c79fbe78442ada8654ab753363b19_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMS0xLTEtMTcwNzQ0_8e202975-c44c-4b84-a7ba-d27957f64d9a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i84f84f639a8649b7a29a53533025129f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMi0xLTEtMTcwNjU5_b85f2592-4666-4d20-bb0f-8eaefcc6755d"
      unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3be311173d9c44eaafe06fb2c2cbcb3c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMy0xLTEtMTcwNzQ0_e0864b11-747f-41aa-9edb-c64771245837"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if90e03c93c3749469a8dfb4fe97cb995_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNC0xLTEtMTcwNzQ0_aed8326c-bd8e-4686-8ad9-6ccf92d1669e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i30afec82ea9e4d6a8f448ccc557ea553_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNS0xLTEtMTcwNzQ0_e2a6ee4f-6d97-4bd2-9544-0208fc93f4e4"
      unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i545583d261e248808f2d3bb26a97013b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMS0xLTEtMTY5NDYy_f7c9b320-60e2-4f6b-9c7f-51157913d61d"
      unitRef="usd">1713000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMi0xLTEtMTY5NDYy_b8476acb-69be-444a-a296-8075f794fb4f"
      unitRef="usd">12000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtMy0xLTEtMTY5NDYy_bffe0939-8101-478e-8500-b55efd44e1fd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNC0xLTEtMTY5NDYy_f7b63c1b-fc2d-47a6-83f6-4fbb4249b510"
      unitRef="usd">32663000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzQtNS0xLTEtMTY5NDYy_088968d4-a76c-4bcc-a06f-dbbfcd29ab3b"
      unitRef="usd">34388000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i978c79fbe78442ada8654ab753363b19_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctMS0xLTEtMTY5NDYy_7fcb559e-5a2b-4a45-bed5-bac4c597ab43"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i84f84f639a8649b7a29a53533025129f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctMi0xLTEtMTY5NDYy_843759fb-49e0-45d1-b094-ab156525f21b"
      unitRef="usd">3670000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3be311173d9c44eaafe06fb2c2cbcb3c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctMy0xLTEtMTY5NDYy_76262551-b3ab-407a-bb4e-5d69e3e7ec81"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="if90e03c93c3749469a8dfb4fe97cb995_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctNC0xLTEtMTY5NDYy_8c4fc710-40bb-498b-a46e-921950f1b630"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i30afec82ea9e4d6a8f448ccc557ea553_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzctNS0xLTEtMTY5NDYy_0c216717-33ca-46f9-bae0-137a14b10886"
      unitRef="usd">3670000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i545583d261e248808f2d3bb26a97013b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtMS0xLTEtMTY5NDYy_2d4933ff-0018-4806-8fc2-81c4b139322d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic4b3262da32f4ec8a9c378573864a2a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtMi0xLTEtMTY5NDYy_2024e986-6233-4596-adde-a8467674336f"
      unitRef="usd">3670000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2e66629c475a4b72b7b830a3e6cb2836_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtMy0xLTEtMTY5NDYy_12340e53-81a4-4cd4-90d7-6c8444981bc2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia75ec606c1604c96b6da7c3c548aa0a2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtNC0xLTEtMTY5NDYy_ca14c2d6-0cbe-48f6-a302-da609c078bb2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTo1N2YwZTg4MjIxNjU0YTNiOWYxYjZjZTZkMjBiZTFiMi90YWJsZXJhbmdlOjU3ZjBlODgyMjE2NTRhM2I5ZjFiNmNlNmQyMGJlMWIyXzgtNS0xLTEtMTY5NDYy_ae6a2707-96bb-40fa-a21e-3fd060ebb421"
      unitRef="usd">3670000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i19fb8c40650e450eb5e1d079288ab103_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItMS0xLTEtMTY5NTA0_ce8c4749-a130-48b7-b866-5b98e69caecf"
      unitRef="usd">1712000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if1dd30bace194434bd26b61b92a84a73_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItMi0xLTEtMTY5NTA0_e959f695-17c0-4a0d-ae64-41fdd3dbb25b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie22508cde176416eab9afbb5c12f542f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItMy0xLTEtMTY5NTA0_3424dc99-9b53-42af-854a-7fa5106e8be6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia559e02117534d508ae08e434af35be9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItNC0xLTEtMTY5NTA0_4195744b-f6b6-40e9-97c2-9e906fe1b678"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzItNS0xLTEtMTY5NTA0_60bab802-ebe5-42eb-9753-4802fb7b6f73"
      unitRef="usd">1712000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i19fb8c40650e450eb5e1d079288ab103_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtMS0xLTEtMTY5NTA0_12f60bf1-3e3e-4419-a503-5c08841a74d3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="if1dd30bace194434bd26b61b92a84a73_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtMi0xLTEtMTY5NTA0_1d69e49b-1388-40e6-8af2-61e1a0824f22"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ie22508cde176416eab9afbb5c12f542f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtMy0xLTEtMTY5NTA0_2e352843-3d64-4ccb-a898-22fb3c3a13fd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia559e02117534d508ae08e434af35be9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtNC0xLTEtMTY5NTA0_d3edb7b8-4151-40d2-a4de-e63120c80f55"
      unitRef="usd">20579000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzMtNS0xLTEtMTY5NTA0_f64da89e-eec3-4e1e-ad45-fc1e3879d348"
      unitRef="usd">20579000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i19fb8c40650e450eb5e1d079288ab103_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtMS0xLTEtMTY5NTIx_cd08e471-4dee-4b03-90c9-38e49efd654e"
      unitRef="usd">1712000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if1dd30bace194434bd26b61b92a84a73_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtMi0xLTEtMTY5NTIx_a76deec1-2935-4612-8d8c-6f35a539271c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie22508cde176416eab9afbb5c12f542f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtMy0xLTEtMTY5NTIx_019a3b40-5a34-4530-902e-abb6eb21f7cd"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia559e02117534d508ae08e434af35be9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtNC0xLTEtMTY5NTIx_3a2bdb16-9e8a-408e-86d1-af3df781835e"
      unitRef="usd">20579000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90YWJsZTozN2Y4M2Y3NTMyMTQ0ZGZhOThlNjc3YzBmM2ZjY2EzMi90YWJsZXJhbmdlOjM3ZjgzZjc1MzIxNDRkZmE5OGU2NzdjMGYzZmNjYTMyXzQtNS0xLTEtMTY5NTIx_9c88cc9e-a0b8-443a-bf66-164e16490656"
      unitRef="usd">22291000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia1b4df5e6293480bb188a651b53aa3c9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzE5MzA_e75e5b39-cb06-4c70-8d17-6adae8f51af2"
      unitRef="usd">13250400000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure
      contextRef="ia1b4df5e6293480bb188a651b53aa3c9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzMwNDk_d8a9f6d3-79bd-489d-8f2b-b7b3799f0ee5"
      unitRef="usd">8971700000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure
      contextRef="i9eac6e85f2054a39b9b4982e267fcdef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzE5Mzg_9e041bf7-ebf4-472b-b65c-3d80fc2d8be3"
      unitRef="usd">4278700000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzU5Mzg_daade98a-c779-4102-9d01-6725e1c1d936"
      unitRef="usd">4650300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTkvZnJhZzo5YmIwNzlmZjcwZmU0YmQyODFiM2FjYzgyMTJmMGVlNS90ZXh0cmVnaW9uOjliYjA3OWZmNzBmZTRiZDI4MWIzYWNjODIxMmYwZWU1XzEwOTk1MTE2MzU5NDY_4657cbf2-efa6-49f4-a38d-8128d5560fe7"
      unitRef="usd">5507200000</us-gaap:LongTermDebtFairValue>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE2MzU_eb2cf38c-2681-464c-972b-b8227443ea84">Investments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(a) &#160;&#160;&#160;&#160;Available for sale investments (short-term)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company held $1.7&#160;million of available for sale investments at both December&#160;31, 2022 and December&#160;31, 2021.  The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Short term investments at December&#160;31, 2022 have an average maturity of 2.8 years compared to 2.7 years at December&#160;31, 2021. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Available for sale investments (long-term)&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company entered into subscription agreements with a number of funds. Capital totaling $20.6 million had been advanced under the terms of the subscription agreements at December&#160;31, 2022 (December&#160;31, 2021: $16.9 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2022 qualify for the NAV practical expedient in ASC 820 '&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value measurements and disclosure&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;s'. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $6.3 million (December&#160;31, 2021: $3.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $32.6 million at December&#160;31, 2022 (December&#160;31, 2021: $22.6 million).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;December&#160;31, 2022, the Company had committed to future investments of $23.3 million in respect of these funds.&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;(c)&#160;&#160;&#160;&#160; Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company&#x2019;s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents our equity method investments at December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Ownership Percentage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oncacare Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company provided a loan of $10&#160;million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has recorded losses of $3.1&#160;million and $2.2&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3&#160;million of pro rata losses.  The remaining $0.8&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare.  The outstanding balance of the Company's loan receivable with Oncacare at December&#160;31, 2022 is $9.2&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzcxNDY4MjU1ODI0Mjc_40fcbefe-9a39-4584-a01c-fa61603bf5ec"
      unitRef="usd">1700000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzcxNDY4MjU1ODI0Mjc_e2454544-3e4d-43eb-b624-711913d5b06b"
      unitRef="usd">1700000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzEwOTk1MTE2Mjk0MTg_1ed4ae41-4feb-427c-8192-8418596a3be2">P2Y9M18D</iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod>
    <iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzM2Ng_56534adf-3993-46d0-a375-fc38118616ef">P2Y8M12D</iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod>
    <iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzEwMDU_47103bfe-0f0e-4791-a73f-a6f5505e25e8"
      unitRef="usd">20600000</iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements>
    <iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzEwODQ_569da785-4c7d-4431-8815-38fcd9233d92"
      unitRef="usd">16900000</iclr:DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE0MTI_23b708d8-cd32-4660-b194-d918428c6323"
      unitRef="usd">6300000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE0MjA_4cb3794d-9aa3-4567-b754-4fcb84c4fd03"
      unitRef="usd">3200000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE1MTc_aed770d4-3530-4e3f-b72d-fec2097ce110"
      unitRef="usd">32600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE1MzE_d9221a46-2db3-4dbc-8c1b-6ccf33b60347"
      unitRef="usd">22600000</us-gaap:EquitySecuritiesFvNi>
    <iclr:CommitmentToAcquireLongTermInvestments
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjYvZnJhZzo1ZDY4ZjYyZTJjNWE0ODBiOGRmYzg0MjdlYzg2NTc5ZC90ZXh0cmVnaW9uOjVkNjhmNjJlMmM1YTQ4MGI4ZGZjODQyN2VjODY1NzlkXzE1OTQ_be81d66b-5837-4afc-ab39-ab8b20485694"
      unitRef="usd">23300000</iclr:CommitmentToAcquireLongTermInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia09cfcf09c5a4518ae153515930d8057_I20200724"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzYx_1d7833c6-06b1-490c-9768-602e4867ced8"
      unitRef="usd">4900000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzc2_2bcd9847-d90b-4301-9177-0d506e9be680"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzYxMg_599f0408-2546-468e-92f8-de17493de51d"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <iclr:EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEzNzA_a812eb9d-1e00-45ac-83c7-a6099fe49c8a">P18M</iclr:EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzc2NQ_599f0408-2546-468e-92f8-de17493de51d"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEzNzE_fc0b471b-a54e-4030-975e-fb329198d4dc">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table represents our equity method investments at December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Ownership Percentage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Oncacare Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90YWJsZTowMWI5YjVjOTlkOWM0Nzg5OTlkMzlhMWVlY2VhNGZhYS90YWJsZXJhbmdlOjAxYjliNWM5OWQ5YzQ3ODk5OWQzOWExZWVjZWE0ZmFhXzQtMS0xLTEtMTQzMjg2_d34c8135-d804-4f9c-a427-a7b1ba07ba3f"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90YWJsZTowMWI5YjVjOTlkOWM0Nzg5OTlkMzlhMWVlY2VhNGZhYS90YWJsZXJhbmdlOjAxYjliNWM5OWQ5YzQ3ODk5OWQzOWExZWVjZWE0ZmFhXzQtMi0xLTEtMTQzMjg2_5d972b9e-eb7c-4de1-9245-0713da09f5a5"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90YWJsZTowMWI5YjVjOTlkOWM0Nzg5OTlkMzlhMWVlY2VhNGZhYS90YWJsZXJhbmdlOjAxYjliNWM5OWQ5YzQ3ODk5OWQzOWExZWVjZWE0ZmFhXzQtMy0xLTEtMTQzMjg2_def29e18-3ad3-453a-a6d1-45e0a3e5bb32"
      unitRef="usd">2373000</us-gaap:EquityMethodInvestments>
    <us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions
      contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzExNDM_bdc3ff16-bd07-4f7a-9450-568f229a7658"
      unitRef="usd">10000000</us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEyNjU_ae2b44cc-cfca-4465-bd24-9268f389504a"
      unitRef="number">0.016</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia961c12b79494b50a3b7b747a2ce04be_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzIwODkwNzIwOTMxNzUw_187d48ae-b1b9-4f5b-8796-2a593e943fc8"
      unitRef="usd">-3100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="idf5fe76c69e241d7915327e838e9518c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzIwODkwNzIwOTMxNzU4_d152ae39-b8af-40b6-affa-12e465ab62fc"
      unitRef="usd">-2200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <iclr:IncreaseDecreaseInEquityMethodInvestments
      contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzcxNDY4MjU1ODM2ODI_022c9384-55ec-491e-968b-acaf0eb99758"
      unitRef="usd">-2300000</iclr:IncreaseDecreaseInEquityMethodInvestments>
    <iclr:EquityMethodInvestmentDecreaseInLoanReceivable
      contextRef="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzEwOTk1MTE2MzIwNDM_7786fe85-be3e-439a-a649-70c0d4d47502"
      unitRef="usd">800000</iclr:EquityMethodInvestmentDecreaseInLoanReceivable>
    <us-gaap:LoansAndLeasesReceivableRelatedParties
      contextRef="ic314749132274d02aea042862e1ff17e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNjkvZnJhZzowMDgyMTBiZDFmNmY0ODA2YmZmNThhYTQxZDNiMzU3YS90ZXh0cmVnaW9uOjAwODIxMGJkMWY2ZjQ4MDZiZmY1OGFhNDFkM2IzNTdhXzE2NDkyNjc0NDcwNjQ_69c2b9ce-a3d2-4a48-9500-72e203ff891f"
      unitRef="usd">9200000</us-gaap:LoansAndLeasesReceivableRelatedParties>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90ZXh0cmVnaW9uOmEyZjZjYTM4NzEzYzQ2MGM4ZDQyNGFmMzhmZTM3NmQ5XzI3MA_a58592e8-e1da-48c0-a146-28985b00f0bb">Property, Plant and Equipment, net&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;506,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;798,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(400,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(462,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment depreciation expense is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2022 and the year ended December&#160;31, 2021, certain fully depreciated assets were written off as they were no longer used in the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90ZXh0cmVnaW9uOmEyZjZjYTM4NzEzYzQ2MGM4ZDQyNGFmMzhmZTM3NmQ5XzI3NA_d016f560-d24c-4633-a9a3-1e4c4faa6820">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;506,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;798,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(400,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(462,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment depreciation expense is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzMtMS0xLTEtMTQzMjg2_f154cb2b-7411-4107-89e6-dc924f4e25d2"
      unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzMtMi0xLTEtMTQzMjg2_03fc10fb-62ef-4d08-bc4f-8faeaee7fc47"
      unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzQtMS0xLTEtMTQzMjg2_49de2735-f018-4aed-9861-11e064b35c71"
      unitRef="usd">70880000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzQtMi0xLTEtMTQzMjg2_286d6979-c08c-4d8f-a24a-7e94b7454d03"
      unitRef="usd">82017000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzUtMS0xLTEtMTQzMjg2_2abb6d08-af57-42c4-bd46-d4dc50b276c3"
      unitRef="usd">500135000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzUtMi0xLTEtMTQzMjg2_69bb529c-108b-44ad-aefc-72059f0105a1"
      unitRef="usd">506322000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzYtMS0xLTEtMTQzMjg2_e6812300-53f6-4638-a198-8b73d8ebe813"
      unitRef="usd">50600000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzYtMi0xLTEtMTQzMjg2_ccda11a1-a7aa-4b15-8973-79bc67f6aff5"
      unitRef="usd">107507000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzctMS0xLTEtMTQzMjg2_3f124f17-d3de-4ec6-8798-810553e59458"
      unitRef="usd">59946000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzctMi0xLTEtMTQzMjg2_b27e03ae-1e02-4184-aabc-a6dc92279ec4"
      unitRef="usd">29210000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzgtMS0xLTEtMTQzMjg2_b2d44084-dd66-4744-bd96-43c114fe42a9"
      unitRef="usd">65167000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzgtMi0xLTEtMTQzMjg2_35c6b877-9837-4be0-a55d-d6cef50fa8e5"
      unitRef="usd">70123000</us-gaap:LeaseholdImprovementsGross>
    <iclr:VehiclesGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzktMS0xLTEtMTQzMjg2_5a93665d-0905-4cd3-947f-92bec6be9216"
      unitRef="usd">41000</iclr:VehiclesGross>
    <iclr:VehiclesGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzktMi0xLTEtMTQzMjg2_708e39ec-17a5-4aaa-befb-5ed23c1b6c67"
      unitRef="usd">65000</iclr:VehiclesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzExLTEtMS0xLTE0MzI4Ng_792f5602-d23d-48cd-8e70-3658c358e5fd"
      unitRef="usd">750493000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzExLTItMS0xLTE0MzI4Ng_da90a622-d581-4bcb-bd0a-4ef90cd44e23"
      unitRef="usd">798968000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzEyLTEtMS0xLTE0MzI4Ng_485a1fc8-dfa2-42fc-a8f9-1d4f48b3fd47"
      unitRef="usd">400173000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzEyLTItMS0xLTE0MzI4Ng_793a3bfa-4662-476f-a4d1-c8090bf8083a"
      unitRef="usd">462524000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzE0LTEtMS0xLTE0MzI4Ng_0b78756a-03c9-4931-a631-f32c43311f17"
      unitRef="usd">350320000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTo4OWI5YzdmNDA0YjA0MDJlOGY3OTk4YjU1YjYzODhkMy90YWJsZXJhbmdlOjg5YjljN2Y0MDRiMDQwMmU4Zjc5OThiNTViNjM4OGQzXzE0LTItMS0xLTE0MzI4Ng_de74b289-23ba-4ae1-9caf-1ec38102ea2a"
      unitRef="usd">336444000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTplZTY0NWQ0MjM1MDQ0NTdjOWRjNDA5ZjBlZThhMGE4Zi90YWJsZXJhbmdlOmVlNjQ1ZDQyMzUwNDQ1N2M5ZGM0MDlmMGVlOGEwYThmXzItMS0xLTEtMTcyMTU5_b9d904a7-974f-43f2-bd6d-0dc8a9bfd78c"
      unitRef="usd">106426000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODEvZnJhZzphMmY2Y2EzODcxM2M0NjBjOGQ0MjRhZjM4ZmUzNzZkOS90YWJsZTplZTY0NWQ0MjM1MDQ0NTdjOWRjNDA5ZjBlZThhMGE4Zi90YWJsZXJhbmdlOmVlNjQ1ZDQyMzUwNDQ1N2M5ZGM0MDlmMGVlOGEwYThmXzItMi0xLTEtMTcyMTU5_2099266b-7c89-4853-95ee-43ef222f57e5"
      unitRef="usd">75484000</us-gaap:Depreciation>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzgwMQ_df7d0752-26a1-45de-98c5-b0b66a92db03">Goodwill&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of Goodwill for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior period acquisition (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There were no goodwill impairment losses for the years ended December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzc5NA_2351a227-b193-4d60-a0d0-3f0ec5cabe02">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of Goodwill for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior period acquisition (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,037,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzItMS0xLTEtMTQzMjg2_9e910779-d256-4f33-a440-fc843e14fea8"
      unitRef="usd">9037931000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzItMi0xLTEtMTQzMjg2_58cc647f-a078-46cf-aebc-6c6093715d68"
      unitRef="usd">936257000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzMtMS0xLTEtMTQzMjg2_2fc6d08e-84d2-4ff7-af4f-26b598d1375d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzMtMi0xLTEtMTQzMjg2_f510adcc-0df5-4974-9faf-da4d12c3df5d"
      unitRef="usd">8120006000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzQtMS0xLTEtMTQzMjg2_d9401f94-0832-43b8-9f8b-c2e300a6c375"
      unitRef="usd">-35692000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzQtMi0xLTEtMTQzMjg2_e4ab3f44-f46f-459f-af08-10a3cd73e978"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzUtMS0xLTEtMTQzMjg2_810341ef-8b7b-4d1a-8a2a-a5851300fddc"
      unitRef="usd">-30569000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzUtMi0xLTEtMTQzMjg2_aeee00fc-4f53-4481-b4d2-451014dfde2d"
      unitRef="usd">-18332000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzYtMS0xLTEtMTQzMjg2_91f30120-9a3e-4b9e-b8a6-73cb505f214a"
      unitRef="usd">8971670000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90YWJsZTpjODNkMjBhNjNhMWU0ZmNjYjlhZjhjNTA2M2YyNjc0Yi90YWJsZXJhbmdlOmM4M2QyMGE2M2ExZTRmY2NiOWFmOGM1MDYzZjI2NzRiXzYtMi0xLTEtMTQzMjg2_a292bef6-ad7a-494d-b1d6-d32754257cf9"
      unitRef="usd">9037931000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzI1Mjg4NzY3NDQyMTg0_c4845588-ad15-4dd3-9cfa-8c3e9db8dc0f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzIvZnJhZzowNmQ0YmVjOTU0NDU0YjhmOWRhOWZhZDJiN2VmNGRjMS90ZXh0cmVnaW9uOjA2ZDRiZWM5NTQ0NTRiOGY5ZGE5ZmFkMmI3ZWY0ZGMxXzI1Mjg4NzY3NDQyMTg0_cf7f0f38-7e5a-47cf-abb8-21fd08a9950d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzEzNDE_179e1b4c-df2c-4191-b9d9-ba8596e7b1aa">Intangible Assets&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Intangible Assets for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,076,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,056,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;536,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;528,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,109,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,081,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(830,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(370,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,278,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,710,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0&#160;million, Order backlog of $500.0&#160;million, Trade names of $202.0&#160;million, Patient database of $168.0&#160;million and Technology assets of $111.0&#160;million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets were finalized in June 30, 2022. In total, $677.1&#160;million has been amortized in the period since the date of acquisition, $453.6&#160;million has been amortized in the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,432,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib6f27ae8e7bb4ec5971a6b2ef9dd55a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzItMS0xLTEtMTQzMjg2_924c2205-5096-43a0-9b04-a74fe092127f"
      unitRef="usd">4076435000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6a1a18520e4146e3bf6b3a13e3cda74a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzItMi0xLTEtMTQzMjg2_dedcefe3-29ed-42ff-a1dc-760455e7521b"
      unitRef="usd">4056642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i75b7882f940f48d3bc7d90326129e9b4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzMtMS0xLTEtMTQzMjg2_d9728e5e-7d72-48be-b483-f184af2a05ac"
      unitRef="usd">536934000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i65d528e27c0d424aac74d9e73663d3ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzMtMi0xLTEtMTQzMjg2_b9631468-072b-4659-9f35-259b3401a38a"
      unitRef="usd">528022000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icdec972de61b4fbd8c3f8f4491dbed10_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzQtMS0xLTEtMTQzMjg2_9bc69344-8037-4c38-8d77-0d02902efac2"
      unitRef="usd">204621000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia25ff6d598af43409a6d48cb1b0d9f54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzQtMi0xLTEtMTQzMjg2_8877f178-1553-419b-a035-78e75cf8d0de"
      unitRef="usd">204685000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i316a10f3c60140a48775f64331d68546_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzUtMS0xLTEtMTQzMjg2_5468a1ae-2d7f-4985-b487-97382b12a5f5"
      unitRef="usd">170238000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ife9f6a75108b4d089ed6659cb9248d3f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzUtMi0xLTEtMTQzMjg2_be19e883-5aaa-4fef-a0ec-ea366e0bc2a0"
      unitRef="usd">170525000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0f3e6836101246c5bd0e37de3cea7ad5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzYtMS0xLTEtMTQzMjg2_4543e490-7c26-42bc-86af-0150bf4e27f7"
      unitRef="usd">120984000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i58f1d881a21f42408d4bd3c83abd2de9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzYtMi0xLTEtMTQzMjg2_f1e2f4b1-2dcc-4915-852b-57f0696043a6"
      unitRef="usd">121507000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzctMS0xLTEtMTQzMjg2_e0d893a2-aa82-43f3-94d7-19c77d5fbfcf"
      unitRef="usd">5109212000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzctMi0xLTEtMTQzMjg2_a9e1f5fd-14c7-4957-a842-9f0ed1991085"
      unitRef="usd">5081381000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzktMS0xLTEtMTQzMjg2_70954413-a390-4792-b32d-af3c9e222904"
      unitRef="usd">830553000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzktMi0xLTEtMTQzMjg2_26ffe5cf-90fe-4772-b99e-bfec937681b4"
      unitRef="usd">370538000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzEwLTEtMS0xLTE0MzI4Ng_1bc4fb33-6509-4d93-93ed-c275a5da4646"
      unitRef="usd">4278659000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTphZDgwMzYwZmNmMzM0ZTQ3OTBlOWNmZjZlNDY5NzVjYy90YWJsZXJhbmdlOmFkODAzNjBmY2YzMzRlNDc5MGU5Y2ZmNmU0Njk3NWNjXzEwLTItMS0xLTE0MzI4Ng_40a7e0fd-7f4b-4e7a-85bb-a604785e51d4"
      unitRef="usd">4710843000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i68cade11881441f999fe48a8b78fa866_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzE3NQ_38bcd672-b0da-4527-822a-f49e54bb35af"
      unitRef="usd">3938000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i65f325e72d854376869d44f5fabc8e75_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzE4NQ_d46140b4-5178-4539-8510-e967099ed486"
      unitRef="usd">500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1d23344e0fb3451da6613835547ccb77_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzE5NQ_1c492e51-dd6c-4a2b-b53e-5e07a26e16f3"
      unitRef="usd">202000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib000d5e1b7c444a98c09c3082b538879_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzIwNQ_4011ea8f-396f-4bde-9559-fab2c96aefc1"
      unitRef="usd">168000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if7d00b00550d4bf9a90bced55d00862b_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzIxOA_a49a8f75-1da9-4089-ae33-a826d567935f"
      unitRef="usd">111000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i039aaafb5ef843fb87c3be6202c32cb9_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzI5Nw_6b6cb4a8-46ef-40a9-a2e9-d47e362f78cf">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifc1a2a8295744e79af710d3f51492b51_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzMwNA_81775cdd-1000-4a96-aaad-62df2f08af32">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4cc15efef07d4621bf232d0f905e24d3_D20210702-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzQzOTgwNDY1MTI2MDI_7efff294-7ced-4af4-9099-c441c9ab9662"
      unitRef="usd">677100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzQzOTgwNDY1MTUyMDQ_99281482-533e-4e7b-8c60-40dab8ef3b05"
      unitRef="usd">453600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90ZXh0cmVnaW9uOjhhMTRhMGRjMGZjMTRjM2Q5ZWNmMTY4NzJlY2M4MjQ1XzEzNDA_c792149f-384e-4383-afc2-e399a2ccd191">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,432,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzItMS0xLTEtMTQzMjg2_3ffdd053-3db3-4caa-a410-fdc4323003f2"
      unitRef="usd">460711000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzMtMS0xLTEtMTQzMjg2_00469b32-b4a6-4259-b92b-15d1ce2ee0b2"
      unitRef="usd">339940000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzQtMS0xLTEtMTQzMjg2_016551c5-abf3-4aed-8f6d-32c2ab1bef55"
      unitRef="usd">223674000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzUtMS0xLTEtMTQzMjg2_6045a0a3-17b5-444e-bf28-9849f1068b7e"
      unitRef="usd">209681000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzYtMS0xLTEtMTQzMjg2_1ac3dad8-ca93-4eb9-abe1-2980f6951251"
      unitRef="usd">198300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xNzUvZnJhZzo4YTE0YTBkYzBmYzE0YzNkOWVjZjE2ODcyZWNjODI0NS90YWJsZTo0OTJkNGIwZTU5MmQ0ZDZlYmE1Mzk0MzNhODc2ZWYyOC90YWJsZXJhbmdlOjQ5MmQ0YjBlNTkyZDRkNmViYTUzOTQzM2E4NzZlZjI4XzctMS0xLTEtMTQzMjg2_343500f1-18d7-4688-bd41-e00e6085bf78"
      unitRef="usd">1432306000</iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzE1MA_736ae395-0d72-4c20-8e17-33445888c611">Other Liabilities&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Other Liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;459,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;395,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,005,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;949,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December&#160;31, 2022 and $323.6 million at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzE1OA_411c46b6-2da5-4aa3-b767-07ea837963ba">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Other Liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;459,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;395,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,005,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;949,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December&#160;31, 2022 and $323.6 million at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzItMS0xLTEtMTQzMjg2_626f97a8-8250-4da8-829f-9718994fe9ac"
      unitRef="usd">530204000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzItMi0xLTEtMTQzMjg2_676113d5-6df3-4ba2-be8a-1c4bd60908a3"
      unitRef="usd">459814000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzMtMS0xLTEtMTQzMjg2_94520b1b-2374-41e0-95dd-70b11770336d"
      unitRef="usd">395862000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzMtMi0xLTEtMTQzMjg2_c3d633f1-da06-4707-9375-6a568d8b47bc"
      unitRef="usd">413185000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzQtMS0xLTEtMTQzMjg2_ce09f512-8d45-4d9e-b7d5-0188b73c332b"
      unitRef="usd">43657000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzQtMi0xLTEtMTQzMjg2_bc9e9aa0-a249-45b8-ac71-4214a6e0df4d"
      unitRef="usd">49949000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzUtMS0xLTEtMTQzMjg2_1affe33d-3d01-4e5b-93d8-b87b217f9fda"
      unitRef="usd">16896000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzUtMi0xLTEtMTQzMjg2_e3c53bf7-1d62-48fb-b27e-5a63c5516187"
      unitRef="usd">12055000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzYtMS0xLTEtMTQzMjg2_716db9d2-36b8-4cab-bd0d-a1b0a0af6479"
      unitRef="usd">12852000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzYtMi0xLTEtMTQzMjg2_b4bd588f-3699-4993-a86a-927c015621ea"
      unitRef="usd">7204000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <iclr:RestructuringReserveandOtherLiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzctMS0xLTEtMTQzMjg2_f33bc2b2-dd68-454a-8315-66d618140279"
      unitRef="usd">5512000</iclr:RestructuringReserveandOtherLiabilitiesCurrent>
    <iclr:RestructuringReserveandOtherLiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzctMi0xLTEtMTQzMjg2_d762daa4-29e4-4955-b44a-6b4e1fdf3a9c"
      unitRef="usd">7377000</iclr:RestructuringReserveandOtherLiabilitiesCurrent>
    <iclr:CapitalGovernmentGrantsCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzgtMS0xLTEtMTQzMjg2_b3fd62a8-c1bc-4945-bd5a-a32b5dcf6742"
      unitRef="usd">42000</iclr:CapitalGovernmentGrantsCurrent>
    <iclr:CapitalGovernmentGrantsCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzgtMi0xLTEtMTQzMjg2_55371d98-6547-42b9-a414-244b293e382c"
      unitRef="usd">45000</iclr:CapitalGovernmentGrantsCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzktMS0xLTEtMTQzMjg2_ac230516-6d1c-4872-a5dd-465b93f03c94"
      unitRef="usd">1005025000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90YWJsZTowNjIzMDk0MmNmZTc0ZjZmYWFkYWNjNmQ3NDNiY2EzYi90YWJsZXJhbmdlOjA2MjMwOTQyY2ZlNzRmNmZhYWRhY2M2ZDc0M2JjYTNiXzktMi0xLTEtMTQzMjg2_8755f2c6-57e4-40a3-bb69-a0f36976d75e"
      unitRef="usd">949629000</us-gaap:OtherLiabilitiesCurrent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzYwNDczMTM5NTI5NjE_2007f106-d6ae-4167-8ba4-4a0f623da344"
      unitRef="usd">406300000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODQvZnJhZzo3MGRmZjNlYTg0OTQ0NDMzYjA5ZDQ1MTA2N2JmNjc5Ny90ZXh0cmVnaW9uOjcwZGZmM2VhODQ5NDQ0MzNiMDlkNDUxMDY3YmY2Nzk3XzYwNDczMTM5NTI5NTE_f51af9a2-4894-40d0-bd5f-0b17d58d580f"
      unitRef="usd">323600000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDY_31439f13-7dc7-47f4-813c-5581d672ab67">Non-current Bank Credit Lines and Loan Facilities&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,201,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,001,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,701,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,501,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,446,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less long-term portion of debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,599,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes on July 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2022,  December&#160;31, 2021 and December&#160;31, 2020 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2022 and December&#160;31, 2021, the Company expensed $17.7 million and $86.7 million of transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and one time financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs/(credits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4,701,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA&#x2019;s existing credit facilities and (ii) the Company's notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the senior secured revolving loan facility will mature in July 2026. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin.  On the 29th of November 2022, the Company agreed with its lenders to the early adoption of Term SOFR as the reference rate within the Credit Agreement ahead of the June 2023 USD LIBOR cessation date. LIBOR is no longer an applicable reference rate available to the Company under the terms of the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, $300.0&#160;million remained undrawn under the senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Borrowers&#x2019; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#x2019;s, the Borrowers&#x2019; and each of the subsidiary guarantor&#x2019;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;30, 2022, the Company repaid $200.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $66.1&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.8&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On September&#160;30, 2022, the Company repaid $200.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $53.6&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.9&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On June&#160;30, 2022, the Company repaid $100.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $39.4&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $0.9&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On March&#160;31, 2022, the Company repaid $300.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $35.1&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $3.2&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;29, 2021, the Company repaid $500.0&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.8&#160;million. This repayment resulted in an additional charge associated with previously capitalized fees of $5.6&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On September&#160;27, 2021, the Company repaid $13.8&#160;million of the senior secured term loan facility and made a quarterly interest payment of $40.4&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the &#x201c;Offering&#x201d;). The Senior Secured Notes will mature on July 15, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s debt was $4,650.3&#160;million and $5,507.2&#160;million at December&#160;31, 2022 and December&#160;31, 2021, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDI_7f17c3ad-6402-487a-9e0c-981b29087abf">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,201,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,001,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,701,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,501,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt and debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,446,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less long-term portion of debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,599,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i24b1b179f187445baaff8a1b7341bce6_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMS0xLTEtMTQzMjg2_d6bfb97b-1274-4277-8633-99182f29813f"
      unitRef="number">0.07092</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id74f7c384d114c429cd9f1b01c113138_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMi0xLTEtMTQzOTk3_f3fd9286-2ae9-4087-a028-c324d3a5126b"
      unitRef="number">0.02750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i24b1b179f187445baaff8a1b7341bce6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMi0xLTEtMTQzMjg2_67080e51-e1ee-4545-8ac5-06f2636ac3f6"
      unitRef="usd">4201213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id74f7c384d114c429cd9f1b01c113138_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzQtMy0xLTEtMTQzMjg2_488ed078-9e2c-4357-9e09-f4436dd5dfb4"
      unitRef="usd">5001213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0eb8fbd8473746a0b208ab4cd0032180_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMS0xLTEtMTQzMjg2_44e625cb-37bb-4c5a-96cc-4562941a4246"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9c9e575e36904396a0c52344f4a1fe00_I20211231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMi0xLTEtMTQ0MDE0_8b4bc8bf-f35a-46f8-b8c9-dc6c5d4adcf7"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0eb8fbd8473746a0b208ab4cd0032180_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMi0xLTEtMTQzMjg2_0936d48b-87e2-4a48-bad8-aa778fcaa62b"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9c9e575e36904396a0c52344f4a1fe00_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzYtMy0xLTEtMTQzMjg2_0e71b525-8e67-4c83-9092-1e896908adb4"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEwLTItMS0xLTE0MzI4Ng_4421890a-6dbe-4e70-ad84-7a16f7f8def7"
      unitRef="usd">4701213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEwLTMtMS0xLTE0MzI4Ng_e0a009d8-a3e3-44bd-9ad5-7e88ce71ed7e"
      unitRef="usd">5501213000</us-gaap:DebtInstrumentCarryingAmount>
    <iclr:LongTermDebtCurrentMaturitiesGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEyLTItMS0xLTE0MzI4Ng_108721f8-fadf-4426-a611-2f4c3b43b460"
      unitRef="usd">55150000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtCurrentMaturitiesGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEyLTMtMS0xLTE0MzI4Ng_4b0c0db2-8ccf-4dad-8ca9-1ee4a266c9b3"
      unitRef="usd">55150000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEzLTItMS0xLTE0MzI4Ng_7eaef659-bfa0-4adf-a8e8-249435a73d07"
      unitRef="usd">4646063000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzEzLTMtMS0xLTE0MzI4Ng_6a2e51bf-499a-4881-bec4-28884879cc4d"
      unitRef="usd">5446063000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE0LTItMS0xLTE0MzI4Ng_4431c873-485e-406d-93c5-af60affc6a9d"
      unitRef="usd">47026000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE0LTMtMS0xLTE0MzI4Ng_ee72c6d2-5451-4a26-8cad-d1eba48c51bb"
      unitRef="usd">64901000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE1LTItMS0xLTE0MzI4Ng_26f735b2-7ea0-419d-b95d-0e583b1cb59b"
      unitRef="usd">4599037000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxODUyZmI4ZWRmMGQ0MjgwYmEwMDc5MGI3ODBlYjE1ZC90YWJsZXJhbmdlOjE4NTJmYjhlZGYwZDQyODBiYTAwNzkwYjc4MGViMTVkXzE1LTMtMS0xLTE0MzI4Ng_634a8ec0-7198-4423-b383-f0e6e62899e5"
      unitRef="usd">5381162000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ide0a04931f8947b899f8a0add7253478_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzE0Nw_efb9eebd-4e66-4ab8-bc2a-54cd1a5d64a3"
      unitRef="usd">27600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:InterestExpense
      contextRef="i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzUzMw_bd0f1223-a297-4d7e-a1c5-15ea9bfba179"
      unitRef="usd">17700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4f289ac4e0244d41be72e1e6a6872673_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MTg2OTk_3ca775a6-7b71-4ba8-a93b-cd00addf7c03"
      unitRef="usd">86700000</us-gaap:InterestExpense>
    <iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDg_e3b9f822-bdc0-477b-a73c-570d3f1cf93c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and one time financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs/(credits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock>
    <us-gaap:InterestExpenseDebt
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzQtMS0xLTEtMTQzMjg2_7b4ad6ba-a0f0-4782-9e87-088e1821e91f"
      unitRef="usd">209189000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzQtMi0xLTEtMTQzMjg2_33fb5a20-cf15-49aa-a043-4f73e863fcc9"
      unitRef="usd">93809000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzQtMy0xLTEtMTQzMjg2_1b7effa1-4621-4ae4-be7f-122b9c247817"
      unitRef="usd">13406000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzUtMS0xLTEtMTQzMjg2_c138f317-5bc5-4927-ba29-c2e2c91b7a66"
      unitRef="usd">17749000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzUtMi0xLTEtMTQzMjg2_6efef989-6ab9-4ba4-b285-3099816f17ee"
      unitRef="usd">12890000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzUtMy0xLTEtMTQzMjg2_934f13b0-3d34-4731-b0f1-fd6ed187c27d"
      unitRef="usd">523000</us-gaap:AmortizationOfFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzYtMS0xLTEtMTQzMjg2_ff00832f-a18d-4acf-a060-e74e74d2ec17"
      unitRef="usd">0</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzYtMi0xLTEtMTQzMjg2_5a9d3f3a-cfc1-44df-8a44-d6262c248e0d"
      unitRef="usd">75391000</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:TransactionAndOneTimeFinancingCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzYtMy0xLTEtMTQzMjg2_c774909d-2dbc-4b54-b214-b4377eb5e13e"
      unitRef="usd">0</iclr:TransactionAndOneTimeFinancingCosts>
    <iclr:InterestExpenseCreditOther
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzctMS0xLTEtMTQzMjg2_1f18e492-cde1-41be-a010-b41f1253d90a"
      unitRef="usd">2793000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzctMi0xLTEtMTQzMjg2_a18c31bf-b9cd-4001-8673-6ca78c3a5c57"
      unitRef="usd">333000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzctMy0xLTEtMTQzMjg2_fc5e3d81-a1e7-4582-bfee-5ebed9fc68e8"
      unitRef="usd">-910000</iclr:InterestExpenseCreditOther>
    <us-gaap:InterestExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzgtMS0xLTEtMTQzMjg2_b9fdc5f7-3c72-462e-afe0-895e53d3f9a4"
      unitRef="usd">229731000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzgtMi0xLTEtMTQzMjg2_f0977155-0055-447b-b41a-e3c44d2a3bbe"
      unitRef="usd">182423000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZToxMWVjM2E5NGRkZmY0ZmIyYjNjZDc4ZjM0MTVjOTgxZi90YWJsZXJhbmdlOjExZWMzYTk0ZGRmZjRmYjJiM2NkNzhmMzQxNWM5ODFmXzgtMy0xLTEtMTQzMjg2_134dc067-059a-46b7-87e6-221ab2c24fbb"
      unitRef="usd">13019000</us-gaap:InterestExpense>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3Xzc1NDM_d5ed8903-7565-495d-b049-bad272b41e73">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current maturities of long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4,701,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzEtNC0xLTEtMTQzMjg2_6ed0d7e0-b923-4288-9667-01030cbe7193"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzItNC0xLTEtMTQzMjg2_3a6e1ea6-b906-4c24-b900-061f3679c364"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzMtNC0xLTEtMTQzMjg2_5f39da8d-a686-47e3-bd20-92c6223d3df9"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzQtNC0xLTEtMTQzMjg2_c5f7cae6-5b67-4105-b6fa-521e4a4b295d"
      unitRef="usd">55150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <iclr:LongTermDebtMaturityYearFiveAndThereafter
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzUtNC0xLTEtMTQzMjg2_57987990-60b1-4eb8-94be-99a1ff5f73cc"
      unitRef="usd">4480613000</iclr:LongTermDebtMaturityYearFiveAndThereafter>
    <us-gaap:LongTermDebt
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90YWJsZTphMzA3OWZlYTBjZGI0NTlmYmI4YzMyMjRlZThhNTFmNy90YWJsZXJhbmdlOmEzMDc5ZmVhMGNkYjQ1OWZiYjhjMzIyNGVlOGE1MWY3XzYtNC0xLTEtMTQzMjg2_ebbe1cbd-8220-4437-9054-2a7f6dfbee83"
      unitRef="usd">4701213000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7a12d28f277f4f588bf639313db05a59_I20210701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzEyODM_67bbf7f5-e534-4b3e-b2ce-d4d82842fc10"
      unitRef="usd">5515000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i10cb599ff8ed4f01b9d901f229fe45d0_I20210701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzEzNzU_c157bf83-0c28-4c42-98da-5962e1858a6e"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a12d28f277f4f588bf639313db05a59_I20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MjUzNzY_f68920f3-f3f8-4af3-a175-36de40a4e79d"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0b2dee78f7f644cb9cf3be42bf7515de_D20210701-20210701"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MjUzODA_1e715649-4b6a-41da-b489-b51cf780e769"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i052ec038b97a434685e03cb2338cefaa_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzQzOTgwNDY1MjUzOTM_97a8cf4e-78d3-47f0-8c88-ef59448f56d7"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5dd8ae45a3c84a79b7b93908eb3e3fe9_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI2MjI_2267b2ba-b471-4706-be91-ed6afb31d2d3"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4749ad89af054d8e90ce981f202f2a6f_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI2MjY_e734d4e7-5543-4c19-bdc8-03f27532b63e"
      unitRef="number">0.0060</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2aef30afb12349bb8e0ae5fbd3b724d0_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI2MzI_5af0f23c-a5b0-4f88-b59b-e5c5347cb955"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6ad4568f232b4720a904bbd4f0c5c5d2_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI4MzM_1f6fd266-1e75-468a-b808-b2f03cecbb0c"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9dfcce19405042819f3d7cea53081ae1_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI4Mzc_8fe3819a-7bff-4b5e-8a84-51e4d37c3859"
      unitRef="number">0.0160</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6e2abed11d6d469e981a5915d01e0802_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzI4NDM_535817ac-ed3e-4d76-b5cb-927dae007368"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i74787ba7e2484b3abeeb226f25f7e944_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTQyMjk_31df2325-ffdd-41f0-bc11-3dc532ebfb2d"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkzNDI_6fd3eefe-0520-4052-a1f5-d08d5c871b08"
      unitRef="usd">200000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkzNDY_42327063-735d-4766-8beb-124540eea22c"
      unitRef="usd">66100000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="iac59e86f702f40018f1de6d8db7c4c9b_D20221230-20221230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkzNTA_66b016b1-9c23-466d-a9ae-3765893a7e14"
      unitRef="usd">1800000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5MTM_2586ec40-b84b-4cc3-b917-74c362935dd5"
      unitRef="usd">200000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5MzQ_dbb5e4db-3d57-4ec2-ae1c-31dc462c3bd0"
      unitRef="usd">53600000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="ibbd9d7ab94e64771a452809aa5ed2f03_D20220930-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5NTM_56c31e53-5c17-4e3f-9243-ddf52057d7c4"
      unitRef="usd">1900000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDg5OTA_d4818cc7-722f-437e-b069-464672b9d5c0"
      unitRef="usd">100000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwMDY_51db39c0-07a3-4bf2-8a0b-aabac5c4b8bc"
      unitRef="usd">39400000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="ic5aef4964a114bd49dd2a1f436403c2a_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwMzA_1eddafa8-026c-4029-910b-16b288dd091c"
      unitRef="usd">900000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwNzE_5ea76270-4db5-4e62-81a2-a2dc35bf88ad"
      unitRef="usd">300000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkwODc_dfc53d13-3567-41cf-a0ce-67ec0703ccdd"
      unitRef="usd">35100000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="iec17dbb1a72d44ae91ec4ec5a0a7ab80_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDkxMDI_877bee61-8437-451d-b6c1-9ad79b43ffb3"
      unitRef="usd">3200000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNDk5ODg_d71dd092-4be1-494b-8b10-4523a980a45c"
      unitRef="usd">500000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwMDg_f8342ec5-372a-48c1-b684-7dfdba9e66da"
      unitRef="usd">40800000</us-gaap:InterestPaidNet>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="id3b0a71f8e854e1790df07aad96408e2_D20211229-20211229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwMjk_98ed9a5b-6100-4f58-8176-36cfbd3679e1"
      unitRef="usd">5600000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i371d9f7891584afea9de5a762c9f6442_D20210927-20210927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwNzI_1e82100b-63b6-48ed-8687-6584184b6a3d"
      unitRef="usd">13800000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:InterestPaidNet
      contextRef="i371d9f7891584afea9de5a762c9f6442_D20210927-20210927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzU0OTc1NTgxNTAwOTI_a05d6a2a-c17e-4a45-8d74-0c890f1f1578"
      unitRef="usd">40400000</us-gaap:InterestPaidNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i54726d34a41d4914b87f6221632a03b8_I20210701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzUxMjI_192c14dd-4b3c-4993-9b8c-c7eaa3ff658f"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i54726d34a41d4914b87f6221632a03b8_I20210701"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzUxNTg_79182ccb-b4d7-4eb0-bfc0-1c291e6ac05f"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzczMjc_daade98a-c779-4102-9d01-6725e1c1d936"
      unitRef="usd">4650300000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDEvZnJhZzphZWQ2ZjVlMGIzZWQ0NzFmYmUyMzM3MmUwODJhMDNiNy90ZXh0cmVnaW9uOmFlZDZmNWUwYjNlZDQ3MWZiZTIzMzcyZTA4MmEwM2I3XzcxNDY4MjU1OTU5MjU_4657cbf2-efa6-49f4-a38d-8128d5560fe7"
      unitRef="usd">5507200000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NDg2NDM1_e4fd5635-3ba1-4c9b-917d-5d70493687b5">Derivatives&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as Cash Flow Hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate cap expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swaps begins accruing on December 31, 2024 and the interest rate swap expires on December 31, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The critical terms of the caps and swap are substantially the same as the underlying borrowings. The interest rate caps and swap are accounted for as cash flow hedges as these transactions were executed to hedge the Company's interest payments and for accounting purposes are considered highly effective. As such, the effective portion of the hedges is recorded as unrealized gains (losses) on derivatives in Accumulated Other Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The fair value of these cash flow hedges represents the present value of the anticipated net payments the Company will make to the counterparty, which, when they occur, are reflected as interest expense on the consolidate statement of income.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The fair value of the Company&#x2019;s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$3,363&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,100,606&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$307&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;1,100,606&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$3,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,201,213&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;During 2023, the Company estimates that an additional $3.3 million will be reflected as interest expense in the consolidated statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;At December 31, 2021 the fair value of the Company's derivative financial instruments was $nil as the Company had no  outstanding derivative financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company recognized $0.1&#160;million of gain within OCI and reclassified $0.1&#160;million of gain from OCI to the income statement for the year end December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="ide8dd376ffe34328bce020b65607602b_I20221129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODU0_1f3d3a7d-1503-4cb6-97f4-65baa907ae50"
      unitRef="instrument">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ide8dd376ffe34328bce020b65607602b_I20221129"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5NzczNTUxMA_0c176a15-873b-4115-a73a-fb79f6607df0"
      unitRef="usd">2101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ide8dd376ffe34328bce020b65607602b_I20221129"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTEwMjM1_63fd413f-b5c8-430e-b389-2eef6020f72d"
      unitRef="number">0.0042</us-gaap:DerivativeFixedInterestRate>
    <iclr:DerivativeVariableInterestRateReferenceRateInExcessOf
      contextRef="iae02d67aa86647b19a16902930f2619d_I20221129"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODU4_217e266f-b165-40f8-8027-09ea5097f8c4"
      unitRef="number">0.0475</iclr:DerivativeVariableInterestRateReferenceRateInExcessOf>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if39e82a87e3d497b96438f71c9904738_I20221129"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5NzczNTU0OQ_44a448fa-c422-454d-9c41-f9c04aa74e69"
      unitRef="usd">1101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="if39e82a87e3d497b96438f71c9904738_I20221129"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODY1_658a5c87-11df-40ff-9a24-eef7427fc800"
      unitRef="number">0.034</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NDg2NDM3_8a94b1d2-3787-4cdb-a0b4-f40e10869307">&lt;div style="text-indent:14.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The fair value of the Company&#x2019;s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:14.25pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$3,363&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,100,606&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Other Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$307&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;1,100,606&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$3,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;3,201,213&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="if27a87a7700d4f5fa4a149e379b8f150_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTItMS0xLTE1NTc5OA_3b4f4f91-0609-46ad-828f-2aecac4d2a8e"
      unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="if27a87a7700d4f5fa4a149e379b8f150_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTMtMS0xLTE1NTc5OA_f0f0a49c-2b0c-4c9d-8448-b167d307e09e"
      unitRef="usd">3363000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if27a87a7700d4f5fa4a149e379b8f150_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTQtMS0xLTE1NTc5OA_6c5e9e9d-c3c5-47b8-b098-d29d13a533f1"
      unitRef="usd">2100606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i84bd4efdef4d4094902c5e2aee086859_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTItMS0xLTE1MjQ4Ng_84b27938-2ce9-4b19-82c8-387a4597dcf8"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i84bd4efdef4d4094902c5e2aee086859_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTMtMS0xLTE1MjQ5OA_003e40e9-e7fe-4a77-a511-359ccc27b8d7"
      unitRef="usd">307000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i84bd4efdef4d4094902c5e2aee086859_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV81LTQtMS0xLTE1MjQ5OA_a31f1293-e191-4664-991c-9784f291daea"
      unitRef="usd">1100606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i84f84f639a8649b7a29a53533025129f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV83LTItMS0xLTE1MjUzNg_b85f2592-4666-4d20-bb0f-8eaefcc6755d"
      unitRef="usd">12000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i84f84f639a8649b7a29a53533025129f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV83LTMtMS0xLTE1MjUzNg_843759fb-49e0-45d1-b094-ab156525f21b"
      unitRef="usd">3670000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i30afec82ea9e4d6a8f448ccc557ea553_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGFibGU6M2E5MWQ5NjVmNTBiNDgyNDlmMjkyMThhNDMzMTc0YmUvdGFibGVyYW5nZTozYTkxZDk2NWY1MGI0ODI0OWYyOTIxOGE0MzMxNzRiZV83LTQtMS0xLTE1MjUzNg_18bd6649-dc76-432c-98cd-a888b88c985b"
      unitRef="usd">3201213000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV84MjQ2MzM3MjY5NzI1_44a943bf-1373-4390-add7-428d305ca6c5"
      unitRef="usd">-3300000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5Nzc0MDY5MA_e9fb27c6-9d48-4e35-81db-e30d5d10ede3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xODY5MTY5Nzc0MDczMQ_276b6206-a1c9-4432-8fd0-7689622f8b4c"
      unitRef="tranche">0</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODkx_4e5ead9a-3c8b-41e2-9c7a-836996be0ca3"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTM1L2ZyYWc6YzBlNGFkMzM3YjZlNGVlZTgzYTNhNGU5MzMwNzUxNzkvdGV4dHJlZ2lvbjpjMGU0YWQzMzdiNmU0ZWVlODNhM2E0ZTkzMzA3NTE3OV8xNjQ5MjY3NTA2ODc3_3af5c02e-88ef-4281-818b-d9278e038453"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MDk_795b4d99-8e7c-4bc3-bedb-6fc44d6179ca">Operating Leases&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Lease costs recorded under operating leases as of December&#160;31, 2022 and  2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Of the total cost of $52.7 million incurred in the year ended December&#160;31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9&#160;million incurred in the year ended December&#160;31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December&#160;31, 2022 and December&#160;31, 2021 totaled $28.7 million and $10.2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2022 and December&#160;31, 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $24.8 million and $15.4 million, respectively, as part of an office consolidation program (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 19 - Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2022 were 6.90 years and 2.45%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2021 were 6.91 years and 2.51%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $43.7&#160;million and $49.9 million have been included in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_4e96e968-9c11-40fd-a303-2bb58d8fbc29"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_7797f20c-d0da-447d-8e1d-a6a60da2da46"&gt;other liabilities&lt;/span&gt;&lt;/span&gt; as at December&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTA_79bfac44-58fd-4da8-94d6-253c57211d0d">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Lease costs recorded under operating leases as of December&#160;31, 2022 and  2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzQtMS0xLTEtMTQzMjg2_05c6af2e-e5b0-4ac6-b9cd-b58109ecabb0"
      unitRef="usd">53880000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzQtMi0xLTEtMTQzMjg2_97a9a406-fa87-469f-9e1a-61197c76dd3a"
      unitRef="usd">51200000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzUtMS0xLTEtMTQzMjg2_213ed31e-f1a7-4362-bfd6-1075f1a1723c"
      unitRef="usd">1165000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzUtMi0xLTEtMTQzMjg2_fedc2079-1a46-4180-af64-80eed0ef5226"
      unitRef="usd">1338000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzYtMS0xLTEtMTQzMjg2_a1dcf57d-da1b-43ee-a727-f052da68cd73"
      unitRef="usd">52715000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZTo4ZjhjYWUwYTIyNWE0NzhjYWQ4MTU1YWY1MTI0OWZjYy90YWJsZXJhbmdlOjhmOGNhZTBhMjI1YTQ3OGNhZDgxNTVhZjUxMjQ5ZmNjXzYtMi0xLTEtMTQzMjg2_7aebc8dd-7cc4-43eb-b6a5-b114ee8e26f7"
      unitRef="usd">49862000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzExMA_870b8881-749f-4e9e-9284-481346b7d083"
      unitRef="usd">52700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ibba1eb9117d6498ba61cd2ffd7a3dcc5_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzEzNg_9e4725b9-0b0a-4ec1-81a0-bdc65edc2647"
      unitRef="usd">48300000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzIwNA_f58c180a-1a69-4dcd-b645-1802138c228d"
      unitRef="usd">4400000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzI2MQ_c9ba614d-31a5-4033-8942-ce45bb1dd03e"
      unitRef="usd">49900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ifdf34dd45633475d9db22cc8203941ed_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzI4Nw_bd9aab7c-bfdb-4e68-8c51-c2128d065e3e"
      unitRef="usd">47500000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="id197fe0d372441f4971e65ae556f9189_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzM1NQ_acc0943a-0f6a-4d4f-a225-70ecbb6b778a"
      unitRef="usd">2400000</us-gaap:LeaseCost>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzY3NA_7a255758-82cb-43f0-8e85-9f633ecab745"
      unitRef="usd">28700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzY4MQ_268429e8-ebbd-464c-8b7f-5f32b940f922"
      unitRef="usd">10200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzI3NDg3NzkwNzIyMDM_1956d944-a67c-4927-9d8c-6de33ad91aa2"
      unitRef="usd">24800000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzU0OTc1NTgxNDA1MjA_0c080580-bf6d-448c-95f6-6436f7c8cec9"
      unitRef="usd">15400000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzExMDM_34610a03-290f-4ad8-8a18-ea1d8e705041">P6Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzExMTA_19c8edc2-63a9-4cd6-80b5-a7cadf2478bd"
      unitRef="number">0.0245</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzEyMTY_9fc00897-dc1a-451b-bb39-8df1afcf6b4b">P6Y10M28D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzEyMjM_3c5419da-9505-4086-b87a-4c93ffeb6031"
      unitRef="number">0.0251</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTI_f6374681-076e-4be2-b3ac-5de0368c2d21">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2022 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzMtMS0xLTEtMTQzMjg2_423f3211-1dfc-4205-98ce-927f8c455c5d"
      unitRef="usd">47479000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzQtMS0xLTEtMTQzMjg2_b727f1ae-bbd5-4ad2-9c6a-446d557860f2"
      unitRef="usd">34400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzUtMS0xLTEtMTQzMjg2_d608569b-fe4f-4330-9034-271b21eb19ac"
      unitRef="usd">25045000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzYtMS0xLTEtMTQzMjg2_b254e0e9-83c1-4a16-80a9-89d8045a82ce"
      unitRef="usd">20430000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzctMS0xLTEtMTQzMjg2_bc817466-8903-45f0-a1bc-9327dce9b6ef"
      unitRef="usd">17249000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzgtMS0xLTEtMTQzMjg2_7b4bf099-800e-4349-848d-e703a8b188e8"
      unitRef="usd">45065000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzktMS0xLTEtMTQzMjg2_490192c0-b5f9-48e4-a14a-8a326ef34714"
      unitRef="usd">189668000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzEwLTEtMS0xLTE0MzI4Ng_e5a2933c-c2b1-4329-a400-6cee045d0072"
      unitRef="usd">14367000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90YWJsZToyY2ZhNWJhMTU1OTA0MDE2ODc1OWI2ZWIyNTJhMGZhYy90YWJsZXJhbmdlOjJjZmE1YmExNTU5MDQwMTY4NzU5YjZlYjI1MmEwZmFjXzExLTEtMS0xLTE0MzI4Ng_d0f73ef2-74e3-4305-8634-028ef2f8a68c"
      unitRef="usd">175301000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE0Mjk_beef677b-1067-4f37-b955-59de5cd2f1de"
      unitRef="usd">43700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE0MzY_25b167c1-0d63-4258-a97b-3d90d5d6fe57"
      unitRef="usd">49900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90ZXh0cmVnaW9uOmI5MzNkYzIxNjZiYTRjNTVhNjNkMjhkMjUxYWRjYWM0XzUw_f6eb812d-dd47-4e2e-8fb2-29ab6eb1b841">Non-current other liabilities&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defined benefit pension obligations, net (note 21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90ZXh0cmVnaW9uOmI5MzNkYzIxNjZiYTRjNTVhNjNkMjhkMjUxYWRjYWM0XzU0_690c0597-32b8-4c59-a6a9-a5ed40866e58">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defined benefit pension obligations, net (note 21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzItMS0xLTEtMTQzMjg2_61f46805-bbf5-4d44-a6b2-71b4a69930a8"
      unitRef="usd">13033000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzItMi0xLTEtMTQzMjg2_c0c44f8c-7bdf-455d-999b-f1d1eddba70b"
      unitRef="usd">16262000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzMtMS0xLTEtMTQzMjg2_55823128-9540-4940-adb6-4128b67d6578"
      unitRef="usd">25227000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzMtMi0xLTEtMTQzMjg2_2b7015f3-9996-4b5f-9459-0a8d38ce1184"
      unitRef="usd">26334000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzQtMS0xLTEtMTQzMjg2_77e67c30-7adb-4c9f-9c48-0a5040864f35"
      unitRef="usd">38260000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xODcvZnJhZzpiOTMzZGMyMTY2YmE0YzU1YTYzZDI4ZDI1MWFkY2FjNC90YWJsZTo1ZTRjNWQwYTdlMDM0MzlkYmJhYjIzMmM0NjAyYjc0NS90YWJsZXJhbmdlOjVlNGM1ZDBhN2UwMzQzOWRiYmFiMjMyYzQ2MDJiNzQ1XzQtMi0xLTEtMTQzMjg2_923f23d1-0fc3-4ecd-8bcd-92671ad361f0"
      unitRef="usd">42596000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTQvZnJhZzo2MmE0MWZmM2ZjZjE0ZDE1OTcxMmZlNjhmZmRkOTRiNS90ZXh0cmVnaW9uOjYyYTQxZmYzZmNmMTRkMTU5NzEyZmU2OGZmZGQ5NGI1Xzg4Mw_b39321fb-d426-40cf-8fc6-32020796f5c1">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;note 15 - Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2022 and December&#160;31, 2021 and future minimum rental commitments as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMTQvZnJhZzo2MmE0MWZmM2ZjZjE0ZDE1OTcxMmZlNjhmZmRkOTRiNS90ZXh0cmVnaW9uOjYyYTQxZmYzZmNmMTRkMTU5NzEyZmU2OGZmZGQ5NGI1XzU5Ng_4113fa2c-fc3b-4688-8d70-b9de1b356f4b">P12Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzQ5Mjg_1948880d-ef2d-4210-a293-1578c0726d97">Share CapitalHolders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. &lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Employee share based payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December&#160;31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December&#160;31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company&#x2019;s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December&#160;31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A resolution was passed at the Company&#x2019;s Annual General Meeting (&#x201c;AGM&#x201d;) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020, July 20, 2021 and July 26, 2022.&#160;On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1&#160;million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0&#160;million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6&#160;million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3&#160;million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0&#160;million. On February 18, 2022, the Company commenced a share buyback program which was fully complete at&#160;March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <iclr:NumberOfVotes
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzY3MQ_fee05acc-1801-41cb-b685-0a54f3eac8aa"
      unitRef="vote">1</iclr:NumberOfVotes>
    <iclr:NumberOfVotes
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzc0NQ_54144ee7-651a-4f77-84cf-a00eb4fe460f"
      unitRef="vote">1</iclr:NumberOfVotes>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzEwNDI_4e0248af-282a-40a3-97e4-8a0aa549b53c"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzExMTM_c7d423e6-58aa-4b04-8895-5140462c0aa4"
      unitRef="usdPerShare">102.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzExNDg_49b049e5-3fc4-43e3-b37a-386025a71808"
      unitRef="usd">35800000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzExNzg_ef97c907-34b4-4058-8b31-cab8c87dcceb"
      unitRef="shares">195029</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzEyNDA_41304718-4647-46d2-b23d-a5c4dab955ae"
      unitRef="shares">46087</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzEzNTI_6983491d-0361-4776-ac86-6e6380daed1b"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE0MjM_1bf843f2-cfc3-4c09-bc72-b01b55e11a15"
      unitRef="usdPerShare">111.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE0NTg_e7205e4f-906c-43d5-bc98-08ed41c52da6"
      unitRef="usd">118600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="iec0d3c91746049cfa76770f5e2f12ef5_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE0ODg_065ad85b-66ad-4cbd-8094-566be0f16f52"
      unitRef="shares">446404</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i323bd4358f4848aba9899c235c5c8a82_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE1NTA_c1d118de-2c5d-42ff-8f16-50cc3bd8db1f"
      unitRef="shares">44132</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ia5098738b6444670841da7baa2b82cff_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI3NDg3NzkwNzU0NTA_24483423-10bd-4a86-95fc-48e445c771fb"
      unitRef="shares">27372427</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE2NjQ_118fb0c0-f643-4dcf-8969-292b8744e910"
      unitRef="shares">193417</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE3MzU_ba30ee17-d445-4e67-9f15-669d84f45117"
      unitRef="usdPerShare">68.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE3NzA_21461407-ffd5-47d2-ab8a-4dc525f2066b"
      unitRef="usd">13200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="iac28acede97e485190e5dcb59f035565_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE4MDA_abcea9a6-40b6-41c0-8101-a540681f7405"
      unitRef="shares">144172</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="ica93147573064c84b3ee259a15e2e86a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzE4NjI_f371e18d-337f-4025-aef1-97071fd3090e"
      unitRef="shares">63516</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <iclr:StockRepurchaseProgramAuthorizedPercentage
      contextRef="ibd327ac55d2743019d27972465de1bc4_D20160722-20160722"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzIxNzg_eef9e612-38d2-426d-aef0-57769d529857"
      unitRef="number">0.10</iclr:StockRepurchaseProgramAuthorizedPercentage>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia70e95571e0e491fb52ce293ea601a70_I20161003"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI0Mzk_8cd8f922-a48b-4812-bd4a-e6d2730eece3"
      unitRef="usd">400000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if1daa0ef8b314dee8ee404337020c563_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI1Mzk_eaef2be2-abc8-4812-9a3e-ef0ae26b9acd"
      unitRef="shares">4026576</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if1daa0ef8b314dee8ee404337020c563_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI1OTY_5603ed2f-eff9-47a0-86ee-44b352f5a07b"
      unitRef="usd">372100000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="i10eee8543f7046e0859ad96971a954da_I20190108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI2ODM_9426e6ec-1a31-4ae4-bf27-8b4d629e952e"
      unitRef="shares">1000000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ic46b3eb0a83849c2b0342cf7b18e0188_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI4MzQ_74d4b447-30fe-4505-9535-47be12c8663d"
      unitRef="usd">141600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if26c855530ab4ea6a07f994ef03a005f_D20191231-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI5MzY_6c99dad7-d95d-415b-b4bb-781b18eb506b"
      unitRef="shares">35100</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if26c855530ab4ea6a07f994ef03a005f_D20191231-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzMwMTM_0fcbbb0c-0698-4405-9717-9bd5d47f9559"
      unitRef="usd">5300000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iceb051d6f08042e1a54eb9849cdeac83_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzMwNTg_94fbe638-d3c4-4703-b4ba-e0fc99136566"
      unitRef="shares">1235218</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iceb051d6f08042e1a54eb9849cdeac83_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzMxNjI_9ce6efde-c6d4-45e2-b68e-77f17259dd2f"
      unitRef="usd">175000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i872f74854a654470a5eb159ba754c7ca_D20220218-20220218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI3NDg3NzkwNzQ2MjM_e32b876b-1fd2-4744-9ff0-ae98cd2d1682"
      unitRef="shares">420530</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i872f74854a654470a5eb159ba754c7ca_D20220218-20220218"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDIvZnJhZzoyNGQ4ZGIzZWNjMDQ0ZTQwOWI0NTY3YTNiY2QxZjQzZS90ZXh0cmVnaW9uOjI0ZDhkYjNlY2MwNDRlNDA5YjQ1NjdhM2JjZDFmNDNlXzI3NDg3NzkwNzQ2OTk_9e5c5437-eeba-493e-b25d-5a2f4aef972a"
      unitRef="usd">100000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2Nw_0c88dced-7dde-456f-ad0d-c548b2ed2447">Restructuring Charges&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A restructuring charge of $31.1&#160;million was recognized during the year ended December&#160;31, 2022 under a restructuring plan adopted following a review of operations.&#160;The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $2.7&#160;million relating to workforce reductions, an impairment of right-of-use assets and associated unavoidable costs totaling $24.5&#160;million  and fixed asset impairment of $4.0&#160;million. It is company policy to disclose operating right-of-use asset impairment as a restructuring charge when it is part of a coordinated program to decommission space.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net charge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, a total liability of $6.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $1.4 million of facilities related liabilities of which $0.9 million is included within other liabilities and $0.5 million is included within non-current other liabilities. The remaining provision of $4.6 million relates to workforce reduction and is included within other liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional provision in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzU4_038418df-8654-402b-ae1f-33d283c69494"
      unitRef="usd">31100000</us-gaap:RestructuringCosts>
    <us-gaap:SeveranceCosts1
      contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzY1OTcwNjk3NzAyNTQ_0c2ddf2e-a75f-42ee-900d-4d3f30a91533"
      unitRef="usd">2700000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts
      contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzY1OTcwNjk3NzAyNzY_f8ba094d-9582-4aa9-b230-9549f4d26cfb"
      unitRef="usd">24500000</us-gaap:OtherRestructuringCosts>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzI3NDg3NzkwNzMwODM_84228cdc-5771-4d68-96e8-97b19aee7243"
      unitRef="usd">4000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2MA_55e91d0a-da56-45eb-ba35-070549b0f469">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net charge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzMtMS0xLTEtMTQzMjg2_1be71a20-7155-4d5e-b2e6-b5b059717a26"
      unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzMtMi0xLTEtMTQzMjg2_d56c407e-c0e6-4385-8f17-5fa0aec08314"
      unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzMtMy0xLTEtMTQzMjg2_050f4d1f-b3dd-4b00-b677-f7b19a5bb5dc"
      unitRef="usd">18089000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzQtMS0xLTEtMTQzMjg2_1b4df8bd-8944-4cd2-b53e-bf9b377c06dc"
      unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzQtMi0xLTEtMTQzMjg2_75d4fe24-218c-4f9e-94b0-60a59c81553e"
      unitRef="usd">31105000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZTozNmVjY2I1MjNjOWM0MmNiYWQwYzM2MTlkNDk2NTU5My90YWJsZXJhbmdlOjM2ZWNjYjUyM2M5YzQyY2JhZDBjMzYxOWQ0OTY1NTkzXzQtMy0xLTEtMTQzMjg2_1168998d-d5ec-4af0-8c5b-290ca0195ee4"
      unitRef="usd">18089000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringReserve
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzU4Mg_7c33b510-09f8-4627-bfc7-31e26873532b"
      unitRef="usd">6000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1811161bef0541d1b314fa8f7e974b09_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzY5MA_70d70339-0cd2-4c78-8435-6f0104df55c6"
      unitRef="usd">1400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i1811161bef0541d1b314fa8f7e974b09_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk4OTU2MDQ2NTE5Mzk_b2726e84-a3b9-448d-8a07-04d2fe031f40"
      unitRef="usd">900000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i1811161bef0541d1b314fa8f7e974b09_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk4OTU2MDQ2NTE5NDc_7559b762-4faf-4228-a67f-4f75fa1f134f"
      unitRef="usd">500000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserve
      contextRef="i196c76a3559d419d89bd5d2125a62e0f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk4OTU2MDQ2NTE1NTI_aba2fcfb-27c9-4e31-8d04-308a720ee499"
      unitRef="usd">4600000</us-gaap:RestructuringReserve>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2Mw_029ca6ba-7de3-4191-bb10-d0f13a9e69b1"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90ZXh0cmVnaW9uOjBkNjZkYTM3MzA2ZjQ3NGFhOTQwMDI2YTcxZjJlMTJlXzk2NQ_d43f216f-041f-4081-86a9-13c484b038d4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additional provision in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzQtMS0xLTEtMTQzMjg2_32d93166-7369-4dcb-b332-fe8cc0fd62cf"
      unitRef="usd">10311000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzQtMi0xLTEtMTQzMjg2_77064d09-6b04-4115-ac93-248c942513fc"
      unitRef="usd">4675000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzUtMS0xLTEtMTQzMjg2_868d16e5-4b2c-4cb9-92fb-00b4dd741b1c"
      unitRef="usd">4364000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzUtMi0xLTEtMTQzMjg2_9e31da8a-fd81-4ab5-a0b5-211f5fb6cccc"
      unitRef="usd">11273000</us-gaap:RestructuringCharges>
    <iclr:RestructuringReserveUtilizations
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzYtMS0xLTEtMTQzMjg2_aef06136-740f-468c-af7a-c097e5d99212"
      unitRef="usd">8653000</iclr:RestructuringReserveUtilizations>
    <iclr:RestructuringReserveUtilizations
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzYtMi0xLTEtMTQzMjg2_0489f65d-5a06-44da-a941-757d7271b0b7"
      unitRef="usd">5637000</iclr:RestructuringReserveUtilizations>
    <us-gaap:RestructuringReserve
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzctMS0xLTEtMTQzMjg2_8822e927-c4c8-475a-811d-9eb6127be673"
      unitRef="usd">6022000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDgvZnJhZzowZDY2ZGEzNzMwNmY0NzRhYTk0MDAyNmE3MWYyZTEyZS90YWJsZToyYzI2ZDI4Yzg0NzU0MjI5OGQ4MTFhNGM3NWEzNTZmNi90YWJsZXJhbmdlOjJjMjZkMjhjODQ3NTQyMjk4ZDgxMWE0Yzc1YTM1NmY2XzctMi0xLTEtMTQzMjg2_3898f76f-beb2-4f3a-8df2-c92f2725ae7d"
      unitRef="usd">10311000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4ODc_f5cf4c3c-a792-476e-8804-6f092dbc28e2">Income Taxes&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(270,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(278,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax (benefit)/expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense allocated to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate differential from amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,201,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,158,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,289,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax asset/(liability)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(911,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,037,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $5.4 million and $401.9 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $5.4 million U.S. federal NOLs, approximately $3.5 million is available for offset against future U.S. federal taxable income in 2023. The subsidiaries' ability to use the  remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $5.3 million are limited by Section 382 for the years 2023 - 2036. As of December&#160;31, 2022, U.S subsidiaries also had disallowed interest carryforwards of $93.0&#160;million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected expiry dates of the US NOLs are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023-2036&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2033-2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $37.9 million. At December&#160;31, 2022 those subsidiaries also had additional operating loss carryforwards of $14.8 million which are due to expire between 2023 and 2029 and operating loss carryforwards of $18.2 million which are due to expire between 2030 and 2039. In addition, at December&#160;31, 2022 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowance at December&#160;31, 2022 was approximately $43.4 million. The valuation allowance for deferred tax assets as of December&#160;31, 2021 and December&#160;31, 2020 was $45.5 million and $32.8 million respectively. The net change in the total valuation allowance was a decrease of $2.1 million during 2022 and an increase of $12.8 million during 2021. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expense and a decrease of $1.3 million was recognized in Other Comprehensive Income. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of an acquired entity, $4.4 million was recognized within income tax expenses, and $0.9 million was recognized in Other Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowances at December&#160;31, 2022 and December&#160;31, 2021 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has recognized a deferred tax liability of $1.6 million (2021: $0.8 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#x2019;s tax treaty network and the EU parent subsidiary directive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to acquired tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The relevant statute of limitations for unrecognized tax benefits totaling $37.9 million could potentially expire during 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Included in the balance of total unrecognized tax benefits at December&#160;31, 2022 were potential benefits of $217.6 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2021 and December&#160;31, 2020 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $202.1 million and $19.1 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest and penalties recognized during the year ended December&#160;31, 2022 amounted to a net charge of $7.1 million (2021: $1.9 million, 2020: ($0.6 million)) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021 were $22.6 million and $15.5 million respectively and are included in closing income taxes payable at those dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December&#160;31, 2018, December&#160;31, 2019, December&#160;31, 2020, December&#160;31, 2021 and December&#160;31, 2022. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <iclr:IncomeBeforeIncomeTaxTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4ODk_976103e1-1d6a-4b03-94df-c5f9d8cdc60d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(270,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(278,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:IncomeBeforeIncomeTaxTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzMtMS0xLTEtMTQzMjg2_06e15224-0e75-4cd1-b34f-55afb5770564"
      unitRef="usd">432963000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzMtMi0xLTEtMTQzMjg2_49b63d31-9e5c-44fe-b4b6-e5ef1c05b996"
      unitRef="usd">231893000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzMtMy0xLTEtMTQzMjg2_95cff3d8-a06e-49e0-8367-641d5cf8d6fc"
      unitRef="usd">280310000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzQtMS0xLTEtMTQzMjg2_9352b50f-af25-4767-a48c-986719eb4942"
      unitRef="usd">-270440000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzQtMi0xLTEtMTQzMjg2_3de18094-80d7-4a71-b12b-a4222fa364c5"
      unitRef="usd">-278413000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzQtMy0xLTEtMTQzMjg2_62c85350-6170-49ac-b5c2-f954b0fe2dc6"
      unitRef="usd">41950000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzUtMS0xLTEtMTQzMjg2_d2c51a94-a132-4c57-b313-e3fd6419bdfe"
      unitRef="usd">405328000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzUtMi0xLTEtMTQzMjg2_b019e32e-7d9a-4201-b070-cee4df8b88c6"
      unitRef="usd">243200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i267c8ec957d64d7687d93c7466134972_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzUtMy0xLTEtMTQzMjg2_c4e0d511-fa2c-4554-9d54-01512d94ba77"
      unitRef="usd">58945000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzYtMS0xLTEtMTQzMjg2_12ff2d93-b328-4481-b562-0ea349dc5a6d"
      unitRef="usd">567851000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzYtMi0xLTEtMTQzMjg2_05e27f13-c992-4a01-b1bc-3d252aa2204d"
      unitRef="usd">196680000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTphN2NjNGQyNjdkZjA0YWVmOWVhZDBlOWQzZDU4YTQ5NS90YWJsZXJhbmdlOmE3Y2M0ZDI2N2RmMDRhZWY5ZWFkMGU5ZDNkNThhNDk1XzYtMy0xLTEtMTQzMjg2_4732f047-1559-46b0-906b-6a5c509b8d22"
      unitRef="usd">381205000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4Nzk_bbe3b40f-f48d-4953-bd44-90be92be2d36">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax (benefit)/expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense allocated to continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzUtMS0xLTEtMTQzMjg2_3877ca5f-9cc0-4611-aef3-785966980ebe"
      unitRef="usd">53248000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzUtMi0xLTEtMTQzMjg2_8b34b5de-b4dd-4bc0-b2a9-6fc77618fc08"
      unitRef="usd">18469000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzUtMy0xLTEtMTQzMjg2_f595a9eb-67c1-4462-8b00-502c5ee14eb3"
      unitRef="usd">28963000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzYtMS0xLTEtMTQzMjg2_69c4c7f0-d686-481b-976a-d89f0a21f3c4"
      unitRef="usd">60753000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzYtMi0xLTEtMTQzMjg2_304d41c3-7041-4da3-8038-2a70a44eb1a1"
      unitRef="usd">35478000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzYtMy0xLTEtMTQzMjg2_98378da8-8ba1-4003-abf5-ee09e6bb02d1"
      unitRef="usd">3022000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzctMS0xLTEtMTQzMjg2_6b2ea08f-1c8a-405b-9642-7f295c8f6911"
      unitRef="usd">70395000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzctMi0xLTEtMTQzMjg2_5986c41b-7843-49c9-bdc9-be345c58b1e9"
      unitRef="usd">48003000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i267c8ec957d64d7687d93c7466134972_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzctMy0xLTEtMTQzMjg2_3f44963d-6cc4-422b-bf6c-547affa1e243"
      unitRef="usd">14963000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzgtMS0xLTEtMTQzMjg2_d44b2878-a5c3-4db9-b141-309d9ec1281a"
      unitRef="usd">184396000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzgtMi0xLTEtMTQzMjg2_3cfdd2ed-d212-4cab-b140-05afda8d383d"
      unitRef="usd">101950000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzgtMy0xLTEtMTQzMjg2_d71624db-572e-4b24-af39-933d7f3c0655"
      unitRef="usd">46948000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzExLTEtMS0xLTE0MzI4Ng_399a4656-10da-417e-942a-d2010972b0ae"
      unitRef="usd">-6166000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzExLTItMS0xLTE0MzI4Ng_07e5787b-a2ed-4900-9432-f8c673c73a3b"
      unitRef="usd">553000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzExLTMtMS0xLTE0MzI4Ng_b59e4894-7f01-4e81-9315-443a04033c7d"
      unitRef="usd">1654000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEyLTEtMS0xLTE0MzI4Ng_c67088e1-8270-4ae3-8a75-d61530d97178"
      unitRef="usd">-118475000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEyLTItMS0xLTE0MzI4Ng_055f75dc-13dc-450b-b52b-1289e52cbeaf"
      unitRef="usd">-52717000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEyLTMtMS0xLTE0MzI4Ng_74e93b3e-9938-4a29-b679-c63d4f20fbd6"
      unitRef="usd">4577000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8252db0cb33d4ae08fb5c6566d002349_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEzLTEtMS0xLTE0MzI4Ng_1b3dffc7-c703-43c6-9a56-905c57341a68"
      unitRef="usd">-344000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ibd5273f3f7df405397ba1a47a070daf3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEzLTItMS0xLTE0MzI4Ng_c3018c16-34f2-4e5e-8449-9c654e4a0119"
      unitRef="usd">-8452000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i267c8ec957d64d7687d93c7466134972_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzEzLTMtMS0xLTE0MzI4Ng_b450ad6b-2df4-4434-a2b3-a8e892bbd9cd"
      unitRef="usd">-5304000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE0LTEtMS0xLTE0MzI4Ng_100ff81b-36f5-4556-9150-db492e31c24e"
      unitRef="usd">-124985000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE0LTItMS0xLTE0MzI4Ng_6a8037cd-ee98-40d5-a2d6-0f3e42f02e0f"
      unitRef="usd">-60616000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE0LTMtMS0xLTE0MzI4Ng_a47120ce-68d1-4fae-b30f-2d636bc2b2fa"
      unitRef="usd">927000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE2LTEtMS0xLTE0MzI4Ng_0ed5fd77-4bb9-4720-8227-1859ac8e9e4e"
      unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE2LTItMS0xLTE0MzI4Ng_d8946b5f-ef2a-4db2-abf6-61377c3110b7"
      unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzE2LTMtMS0xLTE0MzI4Ng_9e7a70a2-c177-4c8b-8171-696433b58931"
      unitRef="usd">47875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIwLTEtMS0xLTE0MzI4Ng_35b19dbf-0398-4b38-8a95-1203cc644150"
      unitRef="usd">7211000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIwLTItMS0xLTE0MzI4Ng_61039d5a-b6d9-4dee-b773-d1217988026a"
      unitRef="usd">1776000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIwLTMtMS0xLTE0MzI4Ng_1e3792b3-28fc-454f-b3ed-c902b3411175"
      unitRef="usd">68000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIzLTEtMS0xLTE0MzI4Ng_00b123a2-2794-4230-9a68-ecda4187c374"
      unitRef="usd">66622000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIzLTItMS0xLTE0MzI4Ng_1c6fdddb-3ca9-4b2a-8590-2bad112a5f20"
      unitRef="usd">43110000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZToyMjcwNjk5Y2M4NWY0NTY4ODAxMjQzMDY4YTE2YzU0MS90YWJsZXJhbmdlOjIyNzA2OTljYzg1ZjQ1Njg4MDEyNDMwNjhhMTZjNTQxXzIzLTMtMS0xLTE0MzI4Ng_08087caa-e3dc-4c6e-8cc3-27d293d2f9ef"
      unitRef="usd">47943000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4NzY_829a81aa-383f-47cb-9074-6baed7278267">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate differential from amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzMtMS0xLTEtMTQzMjg2_0e09f9bc-963e-441e-8fa8-494b16503e65"
      unitRef="usd">70980000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzMtMi0xLTEtMTQzMjg2_4bc2ae0a-1400-46eb-8585-35efc62f4eb3"
      unitRef="usd">24586000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzMtMy0xLTEtMTQzMjg2_f5e4ef30-fc28-47c1-b58b-412a4acc3dc5"
      unitRef="usd">47651000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMS0xLTEtMTcyNzYw_612aa205-2cff-49e8-ac15-9872d1c12316"
      unitRef="usd">-59330000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMi0xLTEtMTcyNzYw_159b7d3f-3343-4632-996a-303c1a01b850"
      unitRef="usd">-31228000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMy0xLTEtMTcyNzYw_58726f77-7049-46f9-917c-5b80d64f8aee"
      unitRef="usd">-2298000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMS0xLTEtMTQzMjg2_b1ae3e38-2525-4d9c-a8ae-306775270826"
      unitRef="usd">52464000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMi0xLTEtMTQzMjg2_d8f5ad65-72e8-42f1-af36-e3f61498a6cb"
      unitRef="usd">51273000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzQtMy0xLTEtMTQzMjg2_f38ef3dc-32a5-4241-bc6e-e56d39f33bdc"
      unitRef="usd">10241000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzUtMS0xLTEtMTQzMjg2_fb7945db-9b73-46b8-9b39-8429dd66b048"
      unitRef="usd">2608000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzUtMi0xLTEtMTQzMjg2_90474d4a-cb4a-42c4-9635-f417982c64c5"
      unitRef="usd">3120000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzUtMy0xLTEtMTQzMjg2_602d8442-88b8-441b-9b3f-c05de3fbf818"
      unitRef="usd">1243000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzYtMS0xLTEtMTQzMjg2_42a63452-cf1d-42d1-bbe3-89865617da02"
      unitRef="usd">-777000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzYtMi0xLTEtMTQzMjg2_86ca5456-d7bc-4e2e-b31e-b7ad83944a03"
      unitRef="usd">3101000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzYtMy0xLTEtMTQzMjg2_ccb4f71a-58bc-41b0-9a15-d0e38c934f52"
      unitRef="usd">3581000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzctMS0xLTEtMTQzMjg2_9ce87cd8-77d4-40b0-9b6f-8aaec0a66d3b"
      unitRef="usd">-300000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzctMi0xLTEtMTQzMjg2_d9cd1f43-b883-4b1c-beef-a5ceaf7a5673"
      unitRef="usd">-128000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzctMy0xLTEtMTQzMjg2_2cd63ed8-e13e-4b8c-b766-be479eda6d81"
      unitRef="usd">108000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzgtMS0xLTEtMTQzMjg2_ca8f6714-fc44-4198-968d-391716e7e2b0"
      unitRef="usd">8392000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzgtMi0xLTEtMTQzMjg2_58f23074-79f3-4dc2-b342-533943919090"
      unitRef="usd">5246000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzgtMy0xLTEtMTQzMjg2_5c31e0c5-ff7a-4a82-9792-f1754e9903c8"
      unitRef="usd">-1672000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzktMS0xLTEtMTQzMjg2_bf488db5-318b-4a41-86e2-5a7926a2ad73"
      unitRef="usd">-8756000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzktMi0xLTEtMTQzMjg2_80cabba0-91a8-4fc8-9bfb-1f711ffcbe4b"
      unitRef="usd">-9083000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzktMy0xLTEtMTQzMjg2_23f6a25f-09bd-4fd8-b73c-6452ad0f65cc"
      unitRef="usd">-5150000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzExLTEtMS0xLTE0MzI4Ng_5fefd7ad-c199-4dc3-92d4-972607091410"
      unitRef="usd">-654000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzExLTItMS0xLTE0MzI4Ng_88f1160a-de97-4005-aa51-087b55114935"
      unitRef="usd">687000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzExLTMtMS0xLTE0MzI4Ng_4f5d15b4-edb4-4b46-a793-a598b9cd0458"
      unitRef="usd">-3343000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzEyLTEtMS0xLTE0MzI4Ng_1455e03d-6d18-4844-a313-7d4bf250f9d8"
      unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzEyLTItMS0xLTE0MzI4Ng_f1acbd24-47d4-4ca6-b54d-693fe632bacb"
      unitRef="usd">41334000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo2NDE1ZTllNDViMGE0ZWVjYTFiZGM0MjRlNjMwYzNjMi90YWJsZXJhbmdlOjY0MTVlOWU0NWIwYTRlZWNhMWJkYzQyNGU2MzBjM2MyXzEyLTMtMS0xLTE0MzI4Ng_0acfe125-9361-471e-a248-16b67f4a2719"
      unitRef="usd">47875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4Njk_a59addaa-f9c5-49b8-9ddb-5ad671d29a49">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,201,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;br/&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,158,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,289,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and unbilled revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred compensation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;297,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax asset/(liability)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(911,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,037,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzMtMS0xLTEtMTQzMjg2_9d88d8a6-2d7a-4187-8287-3e8445ed841c"
      unitRef="usd">10927000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzMtMi0xLTEtMTQzMjg2_23eaf706-f5ef-4554-8ee1-5b50bf326317"
      unitRef="usd">19606000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzQtMS0xLTEtMTQzMjg2_27a83e6c-1614-4f85-ac29-beca4d7e7ff8"
      unitRef="usd">23260000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzQtMi0xLTEtMTQzMjg2_9aa2ce4c-5ae2-4a57-8449-c252306d6e7d"
      unitRef="usd">33449000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzUtMS0xLTEtMTQzMjg2_cd98808f-294a-4d24-8465-4e19d4958980"
      unitRef="usd">37150000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzUtMi0xLTEtMTQzMjg2_827e722a-2892-4586-bd83-6be20226347d"
      unitRef="usd">33354000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzYtMS0xLTEtMTQzMjg2_346c6891-a204-4621-aca0-2e7f0e3e3f65"
      unitRef="usd">1078302000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzYtMi0xLTEtMTQzMjg2_84d86e62-2234-4c0e-92b6-8133fedca60d"
      unitRef="usd">1201086000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzctMS0xLTEtMTQzMjg2_3e006f0e-09df-48be-aa41-e41e4bb7b8c7"
      unitRef="usd">9054000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzctMi0xLTEtMTQzMjg2_491bd967-462f-4287-8f26-60a921794ed4"
      unitRef="usd">1761000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzgtMS0xLTEtMTQzMjg2_aa419a8e-2f3c-49e7-91f6-161b00a011ba"
      unitRef="usd">1158693000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzgtMi0xLTEtMTQzMjg2_126d62dc-e5a4-4cc5-8b16-c7d654780934"
      unitRef="usd">1289256000</us-gaap:DeferredIncomeTaxLiabilities>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzExLTEtMS0xLTE0MzI4Ng_62f58b8b-fdea-4a42-a911-78d6c05a92c9"
      unitRef="usd">88697000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzExLTItMS0xLTE0MzI4Ng_3934cf1a-6ba0-43f5-b09f-03b554e19572"
      unitRef="usd">86893000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEyLTEtMS0xLTE0MzI4Ng_ba24e7f8-a6e3-4d91-b836-63a09cc44f0c"
      unitRef="usd">6010000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEyLTItMS0xLTE0MzI4Ng_0415a35e-739e-4115-a1e0-b039b05048ef"
      unitRef="usd">5846000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEzLTEtMS0xLTE0MzI4Ng_01daa481-f20c-4e2c-8974-04d21030c2f7"
      unitRef="usd">27593000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzEzLTItMS0xLTE0MzI4Ng_6d44d476-c70c-4251-a650-c4ff094ca536"
      unitRef="usd">36106000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE0LTEtMS0xLTE0MzI4Ng_1e1acee8-d16f-46ed-acd2-ad55e4c35d0b"
      unitRef="usd">3602000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE0LTItMS0xLTE0MzI4Ng_e6eb9196-160e-4575-a59f-0160e1784160"
      unitRef="usd">4596000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE1LTEtMS0xLTE0MzI4Ng_d76a0942-8dcb-44b5-95f4-be7d30db6342"
      unitRef="usd">64016000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE1LTItMS0xLTE0MzI4Ng_828bf783-bb56-4f09-819f-4ebfa6f5df25"
      unitRef="usd">69198000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE2LTEtMS0xLTE0MzI4Ng_d88ffe9f-eca9-4b0d-874f-12871446f363"
      unitRef="usd">21862000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE2LTItMS0xLTE0MzI4Ng_9a0fee5a-6e09-400b-bdeb-391ef553eb62"
      unitRef="usd">25557000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE3LTEtMS0xLTE0MzI4Ng_6c79723a-8cc7-4be4-aa45-89a0e5e4a772"
      unitRef="usd">2917000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE3LTItMS0xLTE0MzI4Ng_58b8c338-f32e-453a-9630-0c7e1e233e75"
      unitRef="usd">3445000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <iclr:DeferredTaxAssetContractWithCustomerLiability
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE4LTEtMS0xLTE0MzI4Ng_a8643e2c-8e25-4b73-b527-aa7cf5bc8597"
      unitRef="usd">66565000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <iclr:DeferredTaxAssetContractWithCustomerLiability
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE4LTItMS0xLTE0MzI4Ng_c5f383f8-df5a-4ebf-b755-e1db158e93fa"
      unitRef="usd">64924000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE5LTEtMS0xLTE0MzI4Ng_c2b3042e-424e-4007-822c-a4545351dac4"
      unitRef="usd">9155000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzE5LTItMS0xLTE0MzI4Ng_3df5365e-d631-40c0-ab42-8157b0f9e9cd"
      unitRef="usd">602000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIwLTEtMS0xLTE0MzI4Ng_43d8b657-0edc-473f-acd1-a1f139ef2ddf"
      unitRef="usd">290417000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIwLTItMS0xLTE0MzI4Ng_63b39524-efbd-4ae2-b105-9ae309d62e86"
      unitRef="usd">297167000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIxLTEtMS0xLTE0MzI4Ng_239ad656-28f4-45d9-8d88-09c472513d5c"
      unitRef="usd">43379000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIxLTItMS0xLTE0MzI4Ng_e8aa31a8-9c0d-487e-a8a2-2dbaaaf9d616"
      unitRef="usd">45495000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIyLTEtMS0xLTE0MzI4Ng_859f5b6e-5136-43fb-bade-94dc2e6fff92"
      unitRef="usd">247038000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIyLTItMS0xLTE0MzI4Ng_bbd9be54-8cbb-43dc-b0cc-ce380af29218"
      unitRef="usd">251672000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIzLTEtMS0xLTE0MzI4Ng_eb7614ce-727b-4b1f-ba7f-91b3c310b4af"
      unitRef="usd">911655000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTo5ODRjNWUxMDcyMTA0YTA2OWExMmRlNTAzODYyMzllYy90YWJsZXJhbmdlOjk4NGM1ZTEwNzIxMDRhMDY5YTEyZGU1MDM4NjIzOWVjXzIzLTItMS0xLTE0MzI4Ng_f26609ab-4e1f-488c-9179-633ecb2bbdae"
      unitRef="usd">1037584000</us-gaap:DeferredTaxLiabilities>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration
      contextRef="i055498de74b44ecb8deea65136b4d3b8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzkyMg_38e13c2f-c8fb-4712-9ecb-0e97818a0b9d"
      unitRef="usd">16600000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzEwMzY_3c38c1c0-dc90-46fd-9e3c-f8a177c9837d"
      unitRef="usd">5400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzEwNDM_68422f2a-b905-4d7b-81d4-7a07fbb1e62f"
      unitRef="usd">401900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzExODU_3c38c1c0-dc90-46fd-9e3c-f8a177c9837d"
      unitRef="usd">5400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <iclr:OperatingLossCarryforwardsUSFederal
      contextRef="i305536a3cd1f49ec9167bd9bc8104484_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzEyMjE_baee807f-27e3-4666-82da-5f3e1bae399f"
      unitRef="usd">3500000</iclr:OperatingLossCarryforwardsUSFederal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzE1NzM_396ef3de-4ae1-4910-829a-79bec60c784a"
      unitRef="usd">5300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzE3NDA_b9537967-830d-411c-84d1-9ab520c7c86d"
      unitRef="usd">93000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4NzU_8ba64679-6480-4304-a573-41ff29574bfe">The expected expiry dates of the US NOLs are as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023-2036&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2033-2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i9d7582e0e7b3484491b75a376c0695c8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzItMS0xLTEtMTQzMjg2_7caf0ca2-a370-4c24-a2f5-1dc73cc0947e"
      unitRef="usd">5268000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i243aa952befc42c99e33d30e034ad490_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzItMi0xLTEtMTQzMjg2_3272c03e-f37d-4c9e-82cd-758148c12a6d"
      unitRef="usd">249530000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="ic8c198a29dee44519b861db8ccd7b511_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzMtMS0xLTEtMTQzMjg2_786f9e1d-7222-490d-8e3f-fd14970e7e93"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i2d61fb6235784d39b1c898fa148b0af0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzMtMi0xLTEtMTQzMjg2_ba66bc83-b764-4570-9d64-ff7c17c196fb"
      unitRef="usd">145632000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzQtMS0xLTEtMTQzMjg2_9b32daab-5540-4324-bc66-0088606215a8"
      unitRef="usd">95000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzQtMi0xLTEtMTQzMjg2_4b5897cc-f12f-4269-bff7-91c151c9364a"
      unitRef="usd">6736000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i33fe4880dae64f308692e5d9bd2761fa_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzYtMS0xLTEtMTQzMjg2_9fcf8e82-4400-46a5-99da-c8f486b1f878"
      unitRef="usd">5363000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i0f29ad522a3c4db2af1974c2d81a85e6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMzIzNjRkNWNmMWE0OTExOGQ1OTk5ODFmY2M5MjEzZC90YWJsZXJhbmdlOjAzMjM2NGQ1Y2YxYTQ5MTE4ZDU5OTk4MWZjYzkyMTNkXzYtMi0xLTEtMTQzMjg2_e8439919-4e26-4046-98d5-6d1679dc61ec"
      unitRef="usd">401898000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
      contextRef="i305536a3cd1f49ec9167bd9bc8104484_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzI3NTg_93157fa1-853c-48ea-bb51-1f67a711fa75"
      unitRef="usd">800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i3e44759c2a854bc0910676ada44d73bd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzU3MDU_b9844249-49d1-4178-b7b3-c4d8801f3f8e"
      unitRef="usd">37900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i770c5f02dbff40efa1458e69fb1e60a5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzU3ODg_168dbb4f-3476-4e44-94fc-bb70f7142bc5"
      unitRef="usd">14800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i67dddc1be99b46a6ac8672b42f7fb4b8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzU4NzQ_b084777d-50ae-4a49-8dc3-254e24f59595"
      unitRef="usd">18200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration
      contextRef="i86e0b74245524351afc9b509e585fb1c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY1OTcwNjk3NzYxMjI_4b162ae5-c0b7-4de9-ae45-d495c78789d8"
      unitRef="usd">4700000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzI5ODY_2d05e674-12df-4d15-94c3-ea42785570cc"
      unitRef="usd">43400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMwNTg_76639762-e498-4e88-bc5f-a0a6cf013064"
      unitRef="usd">45500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMwNjU_d6b004a7-f204-4d43-bfe4-4852111adacf"
      unitRef="usd">32800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMxNDk_b491d4dc-5a45-41b0-81c2-10e4706d4283"
      unitRef="usd">-2100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMxODE_ca02f01d-d79f-4372-a048-29d190c7434d"
      unitRef="usd">12800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMyMjA_b491d4dc-5a45-41b0-81c2-10e4706d4283"
      unitRef="usd">-2100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ie343632514b54c28a4d376a3c9298cfe_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMyNjg_f03d1991-a8b9-4fc3-88db-28ed06f03047"
      unitRef="usd">-800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i7f25427924a2406292894864e22c91dd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzMzMzA_4d32b241-b225-4df7-8297-8115d6f33484"
      unitRef="usd">-1300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzM0MDQ_ca02f01d-d79f-4372-a048-29d190c7434d"
      unitRef="usd">12800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i44caf25e9f21476690747f57e50f9aa0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzgyNDYzMzcyMTU1MzA_f65ce980-eeea-4a6e-bf32-9c207eb51978"
      unitRef="usd">9300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ia6674f8abb9143528db74c781bd4f419_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzM0MTQ_65f759e8-10d7-4ee1-8f6e-cc89b09a122b"
      unitRef="usd">4400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="if47bb526e18f463db1bed028cf43f0ef_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzM0Njg_5c94382f-a4f1-490c-9176-0060e6eeb08d"
      unitRef="usd">900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzQ2MDM_f8f78003-f238-487b-bb7f-586276084c3b"
      unitRef="usd">1600000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzQ2MTE_2f90b10c-1df8-471e-b810-7bf588b823b6"
      unitRef="usd">800000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzY4NzM_b509f69a-ed03-4f44-a9e6-b8a2a7e301e6">&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to acquired tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzItMS0xLTEtMTQzMjg2_4acf9f92-020d-4ad6-a451-e191f0d4b9ff"
      unitRef="usd">202065000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzItMi0xLTEtMTQzMjg2_ce20c151-eb32-43bf-b980-951319fc76b4"
      unitRef="usd">19078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9c028363c21c48d5bdb88ba826d38299_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzItMy0xLTEtMTQzMjg2_5148753c-24da-43e3-a10b-514f9f523991"
      unitRef="usd">20156000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzMtMS0xLTEtMTQzMjg2_fc12c447-2228-4809-8869-21b5d6c4a486"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzMtMi0xLTEtMTQzMjg2_397217fb-37be-4bf4-b42c-09ffa3c20d8c"
      unitRef="usd">170047000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzMtMy0xLTEtMTQzMjg2_1f26cdfe-5280-4b6e-b3fb-23ff9d30511c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzQtMS0xLTEtMTQzMjg2_e53513a6-6975-4c8e-a090-8ef36c5fd540"
      unitRef="usd">16098000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzQtMi0xLTEtMTQzMjg2_eaba5e38-f41d-42f1-a4ab-44ef1351e644"
      unitRef="usd">204000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzQtMy0xLTEtMTQzMjg2_b1a90051-00a4-41c1-9214-d373df40e63a"
      unitRef="usd">401000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzUtMS0xLTEtMTQzMjg2_b39b6455-81f7-4175-901f-3c19ba6093a9"
      unitRef="usd">5442000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzUtMi0xLTEtMTQzMjg2_2a31c371-712b-4e7b-bd7a-f380d1fdc25e"
      unitRef="usd">1695000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzUtMy0xLTEtMTQzMjg2_2e09eaad-3905-4fa3-93cb-5f5e8a2b2a00"
      unitRef="usd">1271000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzYtMS0xLTEtMTQzMjg2_111f2801-6da6-47ae-bd4f-479a9de33c24"
      unitRef="usd">5701000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzYtMi0xLTEtMTQzMjg2_7e710bac-bafa-4639-82c0-0becf6866dd0"
      unitRef="usd">18613000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzYtMy0xLTEtMTQzMjg2_b2ec3501-3d7f-408a-b38c-48d139e28bac"
      unitRef="usd">2931000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzctMS0xLTEtMTQzMjg2_a05d1fd6-debf-4715-b763-c76acbad74c0"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzctMi0xLTEtMTQzMjg2_cb31f1a6-5e56-456c-9049-7d870be05b7a"
      unitRef="usd">844000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzctMy0xLTEtMTQzMjg2_b0c7dbf2-0142-4f0f-8c53-27e03c0c8a0b"
      unitRef="usd">369000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzgtMS0xLTEtMTQzMjg2_af19f20d-7c73-46ea-9a5d-5849c63f9b66"
      unitRef="usd">838000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzgtMi0xLTEtMTQzMjg2_436cb29b-6f0b-4405-9688-4324e3c7f9d3"
      unitRef="usd">3338000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzgtMy0xLTEtMTQzMjg2_79b45803-7391-43bd-9fbe-c91ebe101f8c"
      unitRef="usd">2770000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzktMS0xLTEtMTQzMjg2_2ff89e8b-4b06-4ba5-aeb4-0628a9ea7f24"
      unitRef="usd">217584000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzktMi0xLTEtMTQzMjg2_8bdfe5d8-80a9-415c-8302-9d1be9a4fcbc"
      unitRef="usd">202065000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90YWJsZTowMDlmYjRmMmMxMjI0NDhjYjdkMjllM2I5NjAzMzQ4Zi90YWJsZXJhbmdlOjAwOWZiNGYyYzEyMjQ0OGNiN2QyOWUzYjk2MDMzNDhmXzktMy0xLTEtMTQzMjg2_3a340b78-9a37-47f8-b2c4-3542143954cc"
      unitRef="usd">19078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzU2ODU_d917c01c-3ca8-4c95-9e93-10fef83ee8cb"
      unitRef="usd">37900000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzU4MjA_27fb00a2-a531-448e-bba6-a4124161095d"
      unitRef="usd">217600000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYxMDU_20d151e4-0fb2-497a-bd46-70615c85f959"
      unitRef="usd">202100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i0a90d0aa6abb4bc899edd6a4af64ea21_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYxMTI_7c345879-bc54-497a-8d27-a9140a7cfab2"
      unitRef="usd">19100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYyMTc_7b5d4b7f-0da5-4b6e-91fe-ae5da6f19613"
      unitRef="usd">7100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYyMjY_d1ea334a-3350-4639-9df5-2f0d48ee26a4"
      unitRef="usd">1900000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYyMzU_cc43ed03-340a-4380-9787-cfd5302b5d13"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYzNDU_cc68f30b-a128-41fb-a0da-fb2f7eab785f"
      unitRef="usd">22600000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMDUvZnJhZzplNmE0MDYzNTY2Y2U0N2Q3YjcxNzI3MTRmMzJlNjQwNS90ZXh0cmVnaW9uOmU2YTQwNjM1NjZjZTQ3ZDdiNzE3MjcxNGYzMmU2NDA1XzYzNTI_72674e3f-55c7-477a-8f6f-d63606beec76"
      unitRef="usd">15500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0MjE_c23f9c91-6983-47ee-967f-c5ef92f9c37d">Employee Benefits&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 were $30.2 million, $23.7 million and $17.0 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension and Postretirement Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 16)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition to the specific defined-benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $11.6&#160;million and $8.0&#160;million recorded to non-current liabilities as of December 31, 2022 and December 31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;ICON Development Solutions Limited pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; 'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The plan has been closed to new entrants with effect from July 1, 2003.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded status as at December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December&#160;31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss - benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain) &#x2013; plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss recognized in net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.3 million and $Nil respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Benefit Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used in determining the benefit obligation at December&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Actuarial gains on the benefit obligation during 2022 resulted from changes in the assumptions compared to those adopted at December 2021. Changes in the assumptions reflect the changes in market conditions from December 2021 to December 2022 and the actuarial gain is primarily due to the change in&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt; the discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's pension plan asset allocation is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company&#x2019;s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December&#160;31, 2022 and December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plan Asset Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The value of assets held by the plan are represented by quoted prices in active markets for identical assets  and are therefore classified as level 1 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Years 2028 - 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Aptiv Solutions pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022 and December&#160;31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded surplus/(deficit)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table.  The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 were 2.3% and 0.4%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;PRA Switzerland AG pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December&#160;31, 2022 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded surplus/(deficit)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table.  The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 was 2.3% and 0.4%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i64338787f17e44159195780f1ed3a4e3_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEwOTQ_1dc07570-5fe0-4676-9313-fef99f51935f"
      unitRef="number">0.045</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i64338787f17e44159195780f1ed3a4e3_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEzMjI_87016c87-f580-4f0a-951a-00575e003724"
      unitRef="usd">30200000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i10c7a471fc164535ab1f5501d22dd648_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEzMjY_d34883d6-008b-476f-b3f3-6bab6c20c5fe"
      unitRef="usd">23700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ibf91caf53cac409b8da970cacfe56918_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzEzMzM_0a37e710-9509-4b59-8836-bc1a1ce697e1"
      unitRef="usd">17000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzE2NDkyNjc0NjIxMDM_76e8ab77-601a-4837-84eb-077c4f3a39e9">The balances recorded to the balance sheet are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-current other liabilities (note 16)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ia4f00760e31240959ce3972bf544992d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzEtMS0xLTEtMTY4MTQz_87b0c7bc-be04-4691-80f5-4ae881591f14"
      unitRef="usd">6492000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i569507f611d548c49b8650b70c94c2fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzEtMi0xLTEtMTY4MTQz_f0aaa1ab-d326-432f-942e-9fa2958e3cbf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ia4f00760e31240959ce3972bf544992d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzItMS0xLTEtMTY4MTQz_fd47f9cb-bab4-49cc-a50a-1a42567d87fb"
      unitRef="usd">13033000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i569507f611d548c49b8650b70c94c2fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTowMmUxN2UzZmFkMzY0ZWUyOTRkYmM4MzBmMjM5OTQyNS90YWJsZXJhbmdlOjAyZTE3ZTNmYWQzNjRlZTI5NGRiYzgzMGYyMzk5NDI1XzItMi0xLTEtMTY4MTQz_a4bfcb40-37a0-43e4-80b5-543207a164f7"
      unitRef="usd">16262000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if733533a187d46cfb46437f0574bd48b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzE2NTk_e34efbbe-5249-4e67-bc4d-a70add06dcd7"
      unitRef="usd">11600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i07132bfad9184874a360f6352a964e49_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzE2NDkyNjc0NjIxMjk_f1129c1d-b69a-4e19-a701-bfab4c4a43f0"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0MDk_ef8efff4-d57c-473c-8aa4-96001e01cf55">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded status as at December&#160;31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December&#160;31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(514)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded surplus/(deficit)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table.  The discount rates used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 were 2.3% and 0.4%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(238)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants' contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid and transferred balances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 &lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Defined Benefit Plans &#x2013; Other Postretirement'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funded surplus/(deficit)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,990)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Funded deficit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The funded deficit at December&#160;31, 2022 and December&#160;31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in benefit obligation is presented in the following table.  The discount rate used in calculating the benefit obligation in years ended December&#160;31, 2022 and December&#160;31, 2021 was 2.3% and 0.4%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation&lt;br/&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scheme contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzItMS0xLTEtMTQzMjg2_2056d3a0-8b89-4790-ab5c-ca357bfb522a"
      unitRef="usd">19558000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzItMi0xLTEtMTQzMjg2_3f0e47de-51a6-4f04-9153-3b000ae38a7e"
      unitRef="usd">41813000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzMtMS0xLTEtMTQzMjg2_01c67e8f-c675-4597-bba4-586eb0e50b44"
      unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzMtMi0xLTEtMTQzMjg2_a39b3ce1-508c-4b3b-b743-44435e22723b"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzQtMS0xLTEtMTQzMjg2_61a5fd3a-cc5f-440a-bf84-300580652367"
      unitRef="usd">6492000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0YmQyY2MzNzk4NmQ0YTQzODIyZjVlMTBiNjE4NGY0Yy90YWJsZXJhbmdlOjRiZDJjYzM3OTg2ZDRhNDM4MjJmNWUxMGI2MTg0ZjRjXzQtMi0xLTEtMTQzMjg2_82f3486c-d548-45ec-89c9-b844820b5ccc"
      unitRef="usd">-5615000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzItMS0xLTEtMTQzMjg2_daac6baf-74e2-4c60-9b89-b195073be70e"
      unitRef="usd">41813000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ifcb24a7a223049669f10a43260fb3f9e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzItMi0xLTEtMTQzMjg2_361b991e-5dc2-4b16-bfa3-737dd85dfeb5"
      unitRef="usd">43988000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzMtMS0xLTEtMTQzMjg2_e747d7c0-0eb6-488e-a5b5-ecc2d514e4b1"
      unitRef="usd">117000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzMtMi0xLTEtMTQzMjg2_d5350ccb-a87b-489b-bbe3-3653089a28e2"
      unitRef="usd">134000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzQtMS0xLTEtMTQzMjg2_0bcd7b4c-df6d-476b-9a3f-da9635399cd8"
      unitRef="usd">672000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzQtMi0xLTEtMTQzMjg2_2763d10e-8dc3-4a59-a4e8-d6b042cd9adb"
      unitRef="usd">665000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzUtMS0xLTEtMTQzMjg2_c863ea58-563b-462f-92d6-986fd55c699e"
      unitRef="usd">19000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzUtMi0xLTEtMTQzMjg2_6ed581d3-89ed-40d3-83af-5a63ff8f9a9f"
      unitRef="usd">23000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzctMS0xLTEtMTQzMjg2_1906a086-07b0-4214-bd5d-6dbf588a5698"
      unitRef="usd">514000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzctMi0xLTEtMTQzMjg2_60d63cc9-125a-482b-9ca1-61fb3ca3f6e7"
      unitRef="usd">489000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzgtMS0xLTEtMTQzMjg2_36fb1e43-3489-4b27-9e73-a5bbc2d223c2"
      unitRef="usd">18636000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzgtMi0xLTEtMTQzMjg2_4cbfacbf-1575-422a-bbe4-37293d9a907f"
      unitRef="usd">2097000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzktMS0xLTEtMTQzMjg2_6151642e-a1a7-443e-80e5-2d69da207766"
      unitRef="usd">3913000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzktMi0xLTEtMTQzMjg2_647b1194-25aa-4b69-8bb7-68b6cef6c050"
      unitRef="usd">411000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzEwLTEtMS0xLTE0MzI4Ng_fc6cb2df-5d2d-4002-802c-4b4da907b603"
      unitRef="usd">19558000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToyMzc4ZmY1MDRjNjU0Zjk0ODYxYjhiOTYxMGI4ZTBmMi90YWJsZXJhbmdlOjIzNzhmZjUwNGM2NTRmOTQ4NjFiOGI5NjEwYjhlMGYyXzEwLTItMS0xLTE0MzI4Ng_6d16a63c-8324-49ed-8643-c71c8481b97d"
      unitRef="usd">41813000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzItMS0xLTEtMTQzMjg2_806fb236-2e06-47dc-8780-2bb3325240f7"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifcb24a7a223049669f10a43260fb3f9e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzItMi0xLTEtMTQzMjg2_ed52b33a-b782-4229-b1fa-2f10956231a8"
      unitRef="usd">34612000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMS0xLTEtMTczMDA5_f565fe35-1b0d-4473-9796-2ba01fbd82b3"
      unitRef="usd">1258000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMi0xLTEtMTczMDA5_9c7e894a-8f8f-4edd-93dc-8da071995abf"
      unitRef="usd">1171000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMS0xLTEtMTQzMjg2_bc99f310-6beb-46d3-9647-ce8fc3b40213"
      unitRef="usd">-7305000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzMtMi0xLTEtMTQzMjg2_99921f44-01bc-43ba-9ae3-4619be2668b8"
      unitRef="usd">1176000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzQtMS0xLTEtMTQzMjg2_19b24498-690e-44a9-b0d6-6f70bd209f3d"
      unitRef="usd">70000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzQtMi0xLTEtMTQzMjg2_bafa4ed4-9c5c-435c-91c4-f5bcbd104c56"
      unitRef="usd">91000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzUtMS0xLTEtMTQzMjg2_2986737c-ce02-4fa3-9227-5aa87d0c9223"
      unitRef="usd">19000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzUtMi0xLTEtMTQzMjg2_aeeac832-57a9-4360-a255-0d7abff41543"
      unitRef="usd">23000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzYtMS0xLTEtMTQzMjg2_8a6989fd-74fb-4d80-beb7-8ff2cc96f695"
      unitRef="usd">514000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzYtMi0xLTEtMTQzMjg2_5f0738ed-f1f9-449c-901b-b702467ee378"
      unitRef="usd">489000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzctMS0xLTEtMTQzMjg2_2121d636-818c-42f3-943a-7450575389fe"
      unitRef="usd">-3676000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzctMi0xLTEtMTQzMjg2_fb8cc7b7-fe8c-4dc6-ba68-9ad4e8b640fc"
      unitRef="usd">-386000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzgtMS0xLTEtMTQzMjg2_11b41cb4-e98c-4036-a96e-91ced66271b2"
      unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWNmMDliMzVkMDU0NzE4YTliZTk4MzQ1ZDUyY2U3Ni90YWJsZXJhbmdlOmM1Y2YwOWIzNWQwNTQ3MThhOWJlOTgzNDVkNTJjZTc2XzgtMi0xLTEtMTQzMjg2_073989a7-897e-46e9-9150-81501caff82a"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NDg_7d5bfce6-1f7f-4f80-b22e-691240188345">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzItMS0xLTEtMTQzMjg2_6ade9dd4-0ddd-4821-a8c3-dd9ffb0c96c2"
      unitRef="usd">117000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzItMi0xLTEtMTQzMjg2_1cfc48ca-1676-473f-8ef2-65647501fbaf"
      unitRef="usd">134000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzItMy0xLTEtMTQzMjg2_38a324ad-54d2-4883-a66c-35cd50ee6801"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzMtMS0xLTEtMTQzMjg2_3f6478f0-f8f0-45ac-bd9b-72ddb650e942"
      unitRef="usd">672000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzMtMi0xLTEtMTQzMjg2_fddb8835-7e5f-4511-af71-aa76e5593911"
      unitRef="usd">665000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzMtMy0xLTEtMTQzMjg2_527d831c-6f14-42cf-9061-5f42d5822794"
      unitRef="usd">746000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzQtMS0xLTEtMTQzMjg2_9123bfcc-3a6d-437e-a742-d61374bfc58e"
      unitRef="usd">1258000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzQtMi0xLTEtMTQzMjg2_6ee595f1-a360-48f4-93c4-9770c0af39a1"
      unitRef="usd">1171000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzQtMy0xLTEtMTQzMjg2_949b98bc-7cd0-44e7-ab0f-dd6d372358f7"
      unitRef="usd">1214000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzUtMS0xLTEtMTQzMjg2_90ae8a9a-d587-407a-a339-de2c806d1192"
      unitRef="usd">-228000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzUtMi0xLTEtMTQzMjg2_ad94d8c6-ba6c-4ad0-8b14-f13fa1eddc6c"
      unitRef="usd">-625000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzUtMy0xLTEtMTQzMjg2_36c94886-f785-4c69-875a-ad44c4e2c0fb"
      unitRef="usd">-160000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzctMS0xLTEtMTQzMjg2_ca21bf45-0fd8-4580-aab0-f1b10990097f"
      unitRef="usd">-241000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzctMi0xLTEtMTQzMjg2_75919655-b0cd-4497-b7c9-6e41b99477f9"
      unitRef="usd">253000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZToxMTZkMGE3NDE2N2U0NGYwYTliNjliNzU3MjZiM2UyYy90YWJsZXJhbmdlOjExNmQwYTc0MTY3ZTQ0ZjBhOWI2OWI3NTcyNmIzZTJjXzctMy0xLTEtMTQzMjg2_0520b08b-63b7-4d3e-89e7-abe063ffe757"
      unitRef="usd">-208000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0Mzk_cad5fc3e-554d-4be8-b71f-a9fc147cb0a4">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following assumptions were used in determining the benefit obligation at December&#160;31, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzEtMS0xLTEtMTQzMjg2_3eb74377-b614-4658-894e-eb5f0239f7ef"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzEtMi0xLTEtMTQzMjg2_59938a54-7dd4-46b1-9a65-4123d27cd528"
      unitRef="number">0.015</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzEtMy0xLTEtMTQzMjg2_914b9873-ca47-496d-b46e-d54ac54c22a5"
      unitRef="number">0.021</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzItMS0xLTEtMTQzMjg2_91e2f308-edfe-4ab9-a18d-610200cf7df1"
      unitRef="number">0.037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzItMi0xLTEtMTQzMjg2_cb212c2b-2104-4e0f-9931-0d970eacb61d"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzItMy0xLTEtMTQzMjg2_7dafc45b-f8aa-49c0-8195-bb7f72a0d994"
      unitRef="number">0.033</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzMtMS0xLTEtMTQzMjg2_2c7ba936-7325-4fe7-ad0d-af93c28ee080"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzMtMi0xLTEtMTQzMjg2_840cf8e4-4be2-4d80-8c59-195408cda634"
      unitRef="number">0.034</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YjA4MzZlODgxZDI0Yzk4YTI0YTY4MjBlMmQ0MDdlNS90YWJsZXJhbmdlOjdiMDgzNmU4ODFkMjRjOThhMjRhNjgyMGUyZDQwN2U1XzMtMy0xLTEtMTQzMjg2_13c571d5-ac12-41de-8460-3669ef6d7b5e"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NTA_8dff247f-7918-4723-ad55-5c0eff372d1c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial (gain)/loss - benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss/(gain) &#x2013; plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial loss recognized in net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzItMS0xLTEtMTQzMjg2_2b1bec22-3398-4aaa-bfb4-535bbb5f66ea"
      unitRef="usd">18636000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzItMi0xLTEtMTQzMjg2_3f1d4914-cf74-472f-9ddc-4278f26a36cc"
      unitRef="usd">2097000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzItMy0xLTEtMTQzMjg2_be91e7c4-54f1-4946-9909-9e009c31e889"
      unitRef="usd">-5294000</iclr:DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzMtMS0xLTEtMTQzMjg2_1e763b90-c062-4e07-ae8a-00a551a5b593"
      unitRef="usd">7305000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzMtMi0xLTEtMTQzMjg2_0a46e817-40de-40c1-9e5b-69e4f4ac6373"
      unitRef="usd">-1176000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzMtMy0xLTEtMTQzMjg2_25500e1a-093c-4241-8128-d1efc49207de"
      unitRef="usd">-878000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzQtMS0xLTEtMTQzMjg2_722a0577-1c36-4d7b-a99b-7ff30580a4fc"
      unitRef="usd">228000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzQtMi0xLTEtMTQzMjg2_b0bddb11-72b5-45a0-9023-c66f4242e4c5"
      unitRef="usd">625000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzQtMy0xLTEtMTQzMjg2_bbf103a4-c9fd-4f86-9a3c-81449bab5a57"
      unitRef="usd">160000</iclr:OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzUtMS0xLTEtMTQzMjg2_5f7be09d-c923-4b21-b6c9-e47d0f722a16"
      unitRef="usd">-11559000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="i852cdb0d17044c639630ff17b3950866_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzUtMi0xLTEtMTQzMjg2_5b537c29-7a28-470b-ad38-474899f70a95"
      unitRef="usd">-3898000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
      contextRef="ib4525f7b18d0431990dfcd2a30b8be9c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozMDliYTEzMDUwYTg0MjNmOGFmMWYyMmNiOWE1NTkyOC90YWJsZXJhbmdlOjMwOWJhMTMwNTBhODQyM2Y4YWYxZjIyY2I5YTU1OTI4XzUtMy0xLTEtMTQzMjg2_17112bec-9623-40fa-b73b-c78ac18e9a40"
      unitRef="usd">4256000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzMxMTk_fc4d5865-99ce-4d3a-910f-fcc2b847c868"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzMxMjY_9b03b609-3af4-4897-b855-3855094ea2bd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzEtMS0xLTEtMTQzMjg2_8c879052-1cca-4b94-a455-c5c8f9b13ff5"
      unitRef="number">0.049</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzEtMi0xLTEtMTQzMjg2_f883b402-2ea4-41de-8287-e6af44c9c9b3"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzItMS0xLTEtMTQzMjg2_949f43d0-ac4e-4e42-b019-aea64170c05e"
      unitRef="number">0.036</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i8e37e3b18efc4c54890a23af49e0fa65_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTozOWMxOTdlODcxMzE0ZjZmOTNkNmZkMWIxMGEzMjIwMy90YWJsZXJhbmdlOjM5YzE5N2U4NzEzMTRmNmY5M2Q2ZmQxYjEwYTMyMjAzXzItMi0xLTEtMTQzMjg2_364f3f41-aefe-4146-91d6-c7f0c2dcf62c"
      unitRef="number">0.037</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NTE_256b27d8-939d-4903-831e-aa1839ddcc7a">P19Y</iclr:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod>
    <us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0NDA_c8953cc3-b0ea-445a-835d-3987ec4b6518">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's pension plan asset allocation is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="id4ccd74632f9452c9fc7c4c727e7cbc6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMS0xLTEtMTY0MDk3_a4b9c1c8-d87b-488d-b923-2d5cba331975"
      unitRef="number">0.88</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i52e0d42fa9c04d3fbc41dc023095bf98_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMi0xLTEtMTY0MDk3_7087ff0d-5b51-4f28-a112-75f702913e20"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ie21482250291473491b179d1e9638496_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMS0xLTEtMTY0MDk3_79ffc5c2-b659-4fac-9a43-c90aceba2681"
      unitRef="number">0.12</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i97b87f6afcb34559a2f4576b1a188c7a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMi0xLTEtMTY0MDk3_2cd238c1-8714-4249-a506-c088d3f7d4e1"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="if2401c0c85e74845af9e260c7e7cde74_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMS0xLTEtMTQzMjg2_7c2f1915-b801-4f99-94ab-cbbce79bccb1"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1d8837cc7bc34a82948378f474d993cd_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzEtMi0xLTEtMTQzMjg2_0ec6c225-3ca7-4502-aa2e-64175163a17e"
      unitRef="number">0.24</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i506afdb62b6645c28768481748bbcbd5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMS0xLTEtMTQzMjg2_31c3acbf-671b-4beb-ab46-968d66b422e5"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i062ad9be3f9e465db1f49eeeced971fe_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzItMi0xLTEtMTQzMjg2_0e5c45c1-2533-4cea-a173-f750be500c0d"
      unitRef="number">0.37</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i8fe6c6b53ea94d49965d0ca81e095c39_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzMtMS0xLTEtMTQzMjg2_ee02d5cc-a7eb-4069-b922-f57618cf188a"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i7871cec33a7b4f3883e3e6c9cddf204a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzMtMi0xLTEtMTQzMjg2_496422d9-8280-4c5a-b345-1d83999fecf7"
      unitRef="number">0.39</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i0bc40275d8744c9793904bf596955616_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzYtMS0xLTEtMTQzMjg2_8cf7ac17-3ed3-436e-a3f3-4502f5557a4f"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1531dcf96765414a87b044843515f2fc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiODk3ZGZiZjVmYTI0ZjQ2OTcwMzUyMGQ3MjgzOGU5NS90YWJsZXJhbmdlOmI4OTdkZmJmNWZhMjRmNDY5NzAzNTIwZDcyODM4ZTk1XzYtMi0xLTEtMTQzMjg2_d31c5e2d-ddc5-42fd-82a0-b816375555a8"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i422b56f7af8b490e859596ef6dbce65b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzgyNDYzMzcyMjc3MjY_c9237406-6c2c-42d3-be7f-8cb81871e731"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ie835ce8081ec4f4ca739bd71e6565c20_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzgyNDYzMzcyMjc3MjY_db3c73fb-d1b1-4062-b254-49ed4ec182aa"
      unitRef="number">0.038</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0Mjk_398d9f83-95ca-4907-ba32-42114d650696">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diversified Bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Bonds (including 50% high yield bonds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Secured Loans and Multi Asset Credit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab7471376d2a4fbe9b259e2a8ce7278f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzMtMS0xLTEtMTY4MTY4_593a7082-4e2d-4dfa-9bee-9175d5deaf95"
      unitRef="usd">22887000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i96aa6b711ab446a3a14f6536ac6ba863_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzMtMi0xLTEtMTY4MTY4_8f537e0c-5836-41f1-ac31-e33aebd38d3d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3bd9a11dcfb642da959b07ec79751954_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzUtMS0xLTEtMTQzMjg2_cc768d40-5a9c-4d5a-8523-4f0cbf9d844b"
      unitRef="usd">3163000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6b52a3900c584d009b5d05b00cfe85c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzUtMi0xLTEtMTQzMjg2_52571607-721e-43de-979c-a39c842bd367"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibc4210481bdb451ba035a20efdc271b6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzYtMS0xLTEtMTQzMjg2_e01b802a-1bd4-4447-a685-6105f5441c78"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0d097939710f4e2face7b10bdd140ba4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzYtMi0xLTEtMTQzMjg2_abde9879-9631-4f41-b0c0-d33d4f62d525"
      unitRef="usd">8782000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i17a0752301494fecba30d3ccd834c133_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzctMS0xLTEtMTQzMjg2_d63ce436-1ea0-4dfc-a4f1-b14ff43ec762"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic4f6a845a66843d79b61cba68f576f33_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzctMi0xLTEtMTQzMjg2_8c365483-c1de-452a-976f-e69e5d29e6d4"
      unitRef="usd">13434000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie34f24ef293946839ccb0115382374cc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzgtMS0xLTEtMTQzMjg2_b9cadc6f-73c8-460d-a6f6-7c02acd18391"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9d40dd88a404685bf76258b0e90d0a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzgtMi0xLTEtMTQzMjg2_cf117616-87ed-4a73-a16d-5532ae64aed7"
      unitRef="usd">13982000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9862be84bb6f492bb811a70c03726aeb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzEyLTEtMS0xLTE0MzI4Ng_2c94e47d-8937-4d5c-8a9a-832fb0f283cc"
      unitRef="usd">26050000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i09c56c86bbb747b1a07d20615ebedb0b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo5MzY3OGEwNjk3MjQ0OWIxYmY2NmE2OTZhMzc0N2Q0Yi90YWJsZXJhbmdlOjkzNjc4YTA2OTcyNDQ5YjFiZjY2YTY5NmEzNzQ3ZDRiXzEyLTItMS0xLTE0MzI4Ng_92394d78-762c-4b64-a695-fa26e35ceacd"
      unitRef="usd">36198000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i825154864e984f849f9034999b633fbe_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzU0NzA_92f53e77-125a-4664-9606-07768deb74d4"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2Xzg0MzU_9ea42546-9af6-4759-be69-3a85d918dfdb">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Years 2028 - 2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i0784352491d144cd972226c028844591_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzEtMS0xLTEtMTQzMjg2_3524f22e-5727-41c7-b1cc-42d8581bf33a"
      unitRef="usd">302000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i0784352491d144cd972226c028844591_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzItMS0xLTEtMTQzMjg2_8be169d5-80f6-4a37-8229-a1b6deaecb6f"
      unitRef="usd">371000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i0784352491d144cd972226c028844591_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzMtMS0xLTEtMTQzMjg2_319d30b1-559b-46e8-95fc-d82c81c4ccaf"
      unitRef="usd">402000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i0784352491d144cd972226c028844591_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzQtMS0xLTEtMTQzMjg2_4e9a2a67-7514-4673-8c76-b20bfe7869f0"
      unitRef="usd">703000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i0784352491d144cd972226c028844591_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzUtMS0xLTEtMTQzMjg2_40a7820e-6a5d-4ba8-8795-76e81541868e"
      unitRef="usd">643000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i0784352491d144cd972226c028844591_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo2OGIxZDcwZWVmOGY0N2MzODUxNzQ2MjZlOWViMWFkZi90YWJsZXJhbmdlOjY4YjFkNzBlZWY4ZjQ3YzM4NTE3NDYyNmU5ZWIxYWRmXzYtMS0xLTEtMTQzMjg2_a8173beb-bc3d-4682-9a46-eceabf105269"
      unitRef="usd">3614000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <iclr:ExpectedRetirementPeriod
      contextRef="ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzU3Mzg_1df34ad6-5cc6-4086-84e9-46180df113b0">P10Y</iclr:ExpectedRetirementPeriod>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i31374c47a6bb44ba914a1d8045381bed_I20140507"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzYyOTA_84eb1ce6-1ce9-44ac-b702-886621e5f241"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzItMS0xLTEtMTQzMjg2_e6a041af-3e45-49d3-8dd4-d92426b824a0"
      unitRef="usd">5806000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzItMi0xLTEtMTQzMjg2_f55af9e5-7ac1-4b7f-90a7-92af99db690b"
      unitRef="usd">7643000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzMtMS0xLTEtMTQzMjg2_efc8fe9f-13b6-4cfb-88c7-3d76684b5429"
      unitRef="usd">5681000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzMtMi0xLTEtMTQzMjg2_3ec765ea-577b-4832-8383-78146d50159e"
      unitRef="usd">6964000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzQtMS0xLTEtMTQzMjg2_d5cfbcfd-f97a-4f47-a302-ec4d22d9af9b"
      unitRef="usd">-125000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpiZGMwZTI2ODJkMjg0MDEzYTExODJkMzM5N2UwNGYyMy90YWJsZXJhbmdlOmJkYzBlMjY4MmQyODQwMTNhMTE4MmQzMzk3ZTA0ZjIzXzQtMi0xLTEtMTQzMjg2_4bc651d3-99f8-4a45-8191-c8cec5b5e8fb"
      unitRef="usd">-679000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i1682825f41f34d8ca4c4852e0ba2f96d_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTY5_c4d03f86-42db-4a4a-9c40-a07bc1c081b3"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="icbde31e88d4849f8badda657229d3344_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTc1_f60c5b2a-4d67-4323-8a00-69d998ad1404"
      unitRef="number">0.004</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzItMS0xLTEtMTQzMjg2_73ad0a1b-da89-4bfb-8b15-907dc9be994a"
      unitRef="usd">7643000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic768660976f74ad5af5a5fff5ef0bb5b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzItMi0xLTEtMTQzMjg2_fb9fd6b7-05d6-4b28-b1c5-27149650cf1b"
      unitRef="usd">8620000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzMtMS0xLTEtMTQzMjg2_39b1273b-aad2-4581-a4a4-a7a17257e004"
      unitRef="usd">146000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzMtMi0xLTEtMTQzMjg2_99fd13a0-383e-4aba-9ab1-db1c1d3e74d3"
      unitRef="usd">150000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzQtMS0xLTEtMTQzMjg2_d1ce3601-23ca-4959-9ede-734567cd1c9c"
      unitRef="usd">30000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzQtMi0xLTEtMTQzMjg2_23bc4062-098a-4482-b302-9df2ee25ba4a"
      unitRef="usd">12000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzUtMS0xLTEtMTQzMjg2_17e60426-cb46-4b82-8920-3675f3e603dd"
      unitRef="usd">82000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzUtMi0xLTEtMTQzMjg2_dfc388d8-1285-44eb-b2c2-242b9487dec3"
      unitRef="usd">95000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzYtMS0xLTEtMTQzMjg2_9ef201af-2917-4a22-bf17-50b8c3a79fe0"
      unitRef="usd">218000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzYtMi0xLTEtMTQzMjg2_08ae9bef-0f44-4405-9dfb-bdd2cbde6248"
      unitRef="usd">483000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzctMS0xLTEtMTQzMjg2_0f3eaa08-4b1a-4b5e-b62f-a12b3f04d179"
      unitRef="usd">-23000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzctMi0xLTEtMTQzMjg2_50f0797a-69f1-4ef0-bc1e-979a7898bef2"
      unitRef="usd">-82000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzgtMS0xLTEtMTQzMjg2_07231c54-7e39-4748-8738-0cf41fbde149"
      unitRef="usd">-182000</iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzgtMi0xLTEtMTQzMjg2_2e0f8e48-452c-4214-8026-8c3376cfce2c"
      unitRef="usd">76000</iclr:DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzktMS0xLTEtMTQzMjg2_b2e6e447-c673-440d-b806-37f6d6d88a42"
      unitRef="usd">1527000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzktMi0xLTEtMTQzMjg2_0b93ef64-570f-496f-9a75-265b450df2bb"
      unitRef="usd">484000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzEwLTEtMS0xLTE0MzI4Ng_d3836dd3-e49c-4e97-b949-057c140a2dd0"
      unitRef="usd">145000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzEwLTItMS0xLTE0MzI4Ng_b592773c-8319-4239-8488-c20ab1ab93b0"
      unitRef="usd">261000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzExLTEtMS0xLTE0MzI4Ng_d5d65a9a-ac53-4c6a-9092-dbe222655c8a"
      unitRef="usd">5806000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0ODdkMDZmYmYzZmQ0MTNjODYxMWQwNmRiYzdmZGI2NC90YWJsZXJhbmdlOjQ4N2QwNmZiZjNmZDQxM2M4NjExZDA2ZGJjN2ZkYjY0XzExLTItMS0xLTE0MzI4Ng_ce6f04ea-65c7-433e-995b-1e8ea241892b"
      unitRef="usd">7643000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzMtMS0xLTEtMTQzMjg2_68233132-b4c7-498d-bae8-98bb83b0c682"
      unitRef="usd">6964000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic768660976f74ad5af5a5fff5ef0bb5b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzMtMi0xLTEtMTQzMjg2_af7f6e07-bb04-4faf-8d53-86b686c0d46e"
      unitRef="usd">7601000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzQtMS0xLTEtMTQzMjg2_bb01e883-4a7b-48df-82d9-a34679f03436"
      unitRef="usd">29000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzQtMi0xLTEtMTQzMjg2_8a1dc21f-81b6-4739-b5d0-bbccb622aa96"
      unitRef="usd">15000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzUtMS0xLTEtMTQzMjg2_cdb55a10-4675-4761-9ff8-937267552a18"
      unitRef="usd">-987000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzUtMi0xLTEtMTQzMjg2_07cb123c-2a64-4d14-a6ce-fca80936f273"
      unitRef="usd">-238000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <iclr:DefinedBenefitPlanSchemeContributions
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzYtMS0xLTEtMTQzMjg2_a4df727b-a04f-4f17-a4b4-c1943e8adfac"
      unitRef="usd">114000</iclr:DefinedBenefitPlanSchemeContributions>
    <iclr:DefinedBenefitPlanSchemeContributions
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzYtMi0xLTEtMTQzMjg2_3a6eceea-098d-4a58-85c6-81f23f4bd86b"
      unitRef="usd">128000</iclr:DefinedBenefitPlanSchemeContributions>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzctMS0xLTEtMTQzMjg2_d284413f-275f-474b-9d93-1a103d22fec7"
      unitRef="usd">82000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzctMi0xLTEtMTQzMjg2_30c8f9b2-819c-4c18-8b18-f6e24b077685"
      unitRef="usd">95000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzgtMS0xLTEtMTQzMjg2_b40c1c0c-4f7a-44f0-8473-ba5ef0d69832"
      unitRef="usd">182000</iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzgtMi0xLTEtMTQzMjg2_0e53eaca-126a-4056-92f1-20f659e93cad"
      unitRef="usd">-76000</iclr:DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzktMS0xLTEtMTQzMjg2_9cf102c8-d351-456e-9924-36517a162324"
      unitRef="usd">218000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzktMi0xLTEtMTQzMjg2_424d7498-973d-4ca4-ad22-8297f8f4d0b0"
      unitRef="usd">483000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i03fe898891d5458e8dcfe1578b1006e7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzEwLTEtMS0xLTE0MzI4Ng_c9c6ab9d-c7a6-4ff3-af04-31304dc4a6e1"
      unitRef="usd">-121000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i913b8f4d71e04e68b498abdaa3b3eaef_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzEwLTItMS0xLTE0MzI4Ng_022a30f8-d2d6-42c9-8d36-2b7f15078fc2"
      unitRef="usd">-230000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3ab1778648b342b9ada86a5f677d6289_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzExLTEtMS0xLTE0MzI4Ng_21d73a3a-9bd7-4658-a98c-aee6562a3096"
      unitRef="usd">5681000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66389d7f3c194c0a9461035acba0b147_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTpjNWFmNmE5ZDg1ODI0MTlkODAyZDFjYmVhOGRjOTViYy90YWJsZXJhbmdlOmM1YWY2YTlkODU4MjQxOWQ4MDJkMWNiZWE4ZGM5NWJjXzExLTItMS0xLTE0MzI4Ng_97c5cb2c-48ab-45e7-aabf-e421f82a041c"
      unitRef="usd">6964000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzItMS0xLTEtMTQzMjg2_ea3673c5-82d7-4ca3-bf36-38a1a40e44e4"
      unitRef="usd">5345000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzItMi0xLTEtMTU5NzI3_44c1b071-4707-49f5-93d1-1acca5f33994"
      unitRef="usd">4990000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzMtMS0xLTEtMTQzMjg2_1cd2fb7a-ef6c-42ec-9f0a-5be52e2f9e22"
      unitRef="usd">4059000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzMtMi0xLTEtMTU5ODY1_11d17e4f-2dd1-42b4-b997-2b1588216f8b"
      unitRef="usd">3017000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzQtMS0xLTEtMTQzMjg2_46df35e8-137a-4e8a-9222-256250864727"
      unitRef="usd">-1286000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTphYjNiNDUzOGFiMmQ0MmZlYWYzMWRmYzA1NTJjMWNlNC90YWJsZXJhbmdlOmFiM2I0NTM4YWIyZDQyZmVhZjMxZGZjMDU1MmMxY2U0XzQtMi0xLTEtMTU5ODY5_8f182611-63fa-4350-9f0c-4757bd533342"
      unitRef="usd">-1973000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i641bf226224d4002a6b87b5dcb9ef829_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTgx_c368ad8b-d342-4ab4-86ae-bc3d72a632b3"
      unitRef="number">0.023</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8c58dceb3ee34f9fab1c82b8d0e2e8d7_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90ZXh0cmVnaW9uOjQxMGJkZDcyNzI1ZTQwN2Q4ZWUwNDdiOTlkOTY1ZTE2XzI1Mjg4NzY3NDYxMTg3_573a6887-2dd3-4a62-aa64-fd189551ee29"
      unitRef="number">0.004</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzItMS0xLTEtMTQzMjg2_c17dc451-3e09-46dc-a24b-9f6ffa32ba19"
      unitRef="usd">4990000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i84a1032d1909414c8deb46ff92fb05d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzItMi0xLTEtMTU5NzMy_82c65647-0fbd-4901-8fb4-d4a205eeb47f"
      unitRef="usd">4890000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzMtMS0xLTEtMTQzMjg2_e46fcb79-550c-4e89-bca8-d8e48d89cc0f"
      unitRef="usd">404000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzMtMi0xLTEtMTU5NzMy_5a1e9232-77c2-4eed-a493-95c2788e8255"
      unitRef="usd">207000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzQtMS0xLTEtMTQzMjg2_73942e97-a43c-4308-be32-0152666c5013"
      unitRef="usd">20000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzQtMi0xLTEtMTU5NzMy_b95f8b36-76c4-4b1e-972a-300a0a2712b2"
      unitRef="usd">19000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzUtMS0xLTEtMTQzMjg2_d7447b6c-42b0-4a47-abe8-74afe7c2c79b"
      unitRef="usd">2396000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzUtMi0xLTEtMTU5NzMy_e24cb624-b862-4573-8614-d7f8fd66a628"
      unitRef="usd">135000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMS0xLTEtMTYwODU5_5e5f959d-b4d6-48e5-8f16-b55862b33a7c"
      unitRef="usd">844000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMi0xLTEtMTU5OTAw_af1a3f78-51fd-424f-b606-fcd5829cc87d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMS0xLTEtMTQzMjg2_0a369066-5597-4c26-bc8a-9b1b81d57741"
      unitRef="usd">946000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzgtMi0xLTEtMTU5NzMy_f02e4e22-e0ee-4277-ba9a-af65fe167d9c"
      unitRef="usd">113000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzktMS0xLTEtMTQzMjg2_6d3fee79-5385-4665-81fc-12398fc2a978"
      unitRef="usd">627000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzktMi0xLTEtMTU5NzMy_db7a0ff6-9862-4b6f-aefe-2adfc23032c3"
      unitRef="usd">-1000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzEwLTEtMS0xLTE0MzI4Ng_41719f3a-5772-4c3b-80a3-af890a36e9c0"
      unitRef="usd">48000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzEwLTItMS0xLTE1OTczMg_24787e25-0105-4a2a-a000-7531a220d6aa"
      unitRef="usd">149000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzExLTEtMS0xLTE0MzI4Ng_4703174f-632b-4f2e-b6ad-4c30dd1bc0b1"
      unitRef="usd">5345000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo0MTA3OWJhMjNiNWI0NjJlYmFmNjFhYmYyYTg2Mzg5MC90YWJsZXJhbmdlOjQxMDc5YmEyM2I1YjQ2MmViYWY2MWFiZjJhODYzODkwXzExLTItMS0xLTE1OTczNw_fc4a9d2e-6931-40ca-b050-0950f621ef5c"
      unitRef="usd">4990000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzMtMS0xLTEtMTQzMjg2_718f0ccb-f1a6-4147-8f4f-75b8ab738e95"
      unitRef="usd">3017000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84a1032d1909414c8deb46ff92fb05d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzItMi0xLTEtMTU5OTIw_16dc5672-b7be-46c6-a0d9-246b32e4afa0"
      unitRef="usd">2849000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzQtMS0xLTEtMTQzMjg2_a4baf085-9993-4748-bcd8-0b4b617b408a"
      unitRef="usd">29000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzMtMi0xLTEtMTU5OTIw_d50da8d3-e093-48de-b357-305e07b5ae08"
      unitRef="usd">15000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzUtMS0xLTEtMTU5OTMx_0769544a-8f9a-4660-91dd-366027424e8f"
      unitRef="usd">87000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzUtMi0xLTEtMTU5OTMx_10e32c02-8cb9-4421-bb47-43ec729d0640"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzYtMS0xLTEtMTQzMjg2_9a64deda-c7e3-4896-ac35-e0157cdc0342"
      unitRef="usd">325000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzUtMi0xLTEtMTU5OTIw_62f22b57-2912-4775-8d42-304b2caa4379"
      unitRef="usd">135000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzctMS0xLTEtMTQzMjg2_59cd7702-4a86-47e5-be3c-268270ba86f0"
      unitRef="usd">2396000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzYtMi0xLTEtMTU5OTIw_4bac61af-23fd-4b2b-9007-2bb7b706f403"
      unitRef="usd">135000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzgtMS0xLTEtMTQzMjg2_8b499ffb-c4b7-423c-b27a-0a63c163e18b"
      unitRef="usd">946000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzctMi0xLTEtMTU5OTIw_ed59a68f-67e2-4c2b-bbc0-a4d8aa1797a0"
      unitRef="usd">113000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEwLTEtMS0xLTE2MDg2NQ_7a026f97-b386-473c-b919-371c5d0fdabd"
      unitRef="usd">844000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEwLTItMS0xLTE2MDg2OQ_e6c9310b-99e6-4900-9be4-908bffb71728"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i74bf7a4364a040b98c005214c86d37cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEwLTEtMS0xLTE0MzI4Ng_e7c91a03-be2e-4c7b-90c3-9c48182ea846"
      unitRef="usd">-5000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i70c01c695e8f4c578d592f03c742aa3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzktMi0xLTEtMTU5OTIw_958b8752-5d53-448f-8f48-bbb2c035c94d"
      unitRef="usd">-4000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if32d9c6312d342eea532c63c70cd41c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzExLTEtMS0xLTE0MzI4Ng_e8c628a1-25e7-4539-8838-5fff2f26fec6"
      unitRef="usd">4059000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3585c2cb16bf4de1be3bf1314e583cb5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTAvZnJhZzo0MTBiZGQ3MjcyNWU0MDdkOGVlMDQ3Yjk5ZDk2NWUxNi90YWJsZTo3YzU2NWYwZGI5MDI0NjZhYWQzY2M0M2M3OTBlMThkMi90YWJsZXJhbmdlOjdjNTY1ZjBkYjkwMjQ2NmFhZDNjYzQzYzc5MGUxOGQyXzEyLTItMS0xLTE2MDg2OQ_e093f0c5-f0eb-483a-873a-c298bf310a4c"
      unitRef="usd">3017000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzE2NDkyNjc0NTY5ODI_46d51398-0e60-413b-b135-c574cf9f1a2c">Equity Incentive Schemes and Stock Compensation Charges&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;PRA  Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#x201d;), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan")  were amended and restated and assumed by the Registrant effective as of July 1, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2018 Stock Incentive Plan (the &#x201c;2018 Plan&#x201d;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;656,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(193,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combinations *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,177,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(348,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,378,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,047,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Represents stock options issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2022, was 4.69 years and 4.25 years respectively (2021: 5.39 years and 4.55 years respectively).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Outstanding and exercisable share options:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Range Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.88 - 96.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.81 - 124.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;203,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.74 - 147.26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.33 - 231.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14.88 - 231.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,378,119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4.69&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;119.86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,047,803&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;102.29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding include both vested and unvested options as at December&#160;31, 2022. Options exercisable represent options which have vested at December&#160;31, 2022. From the date of grant, substantially all options vest over a five year period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value of Stock Options Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options granted during the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Share Units and Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company.  No awards may be granted under the 2013 RSU Plan after May 11, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#x201c;2019 Consultants RSU Plan&#x201d;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#x2019;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,087)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(195,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of RSUs vested for the year ended December&#160;31, 2022 totaled $34.1 million (2021: $83.5 million). The share price range for the year was $137.47 - $265.96 (2021: $115.11 - $206.71).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of PSUs vested for the year ended December&#160;31, 2022 totaled $6.5 million (2021: $5.1 million). The share price range for the year was $137.47 - $166.51 (2021: $115.11 - $125.74).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The PSUs vest based on service and specified EPS targets over the period  2021 &#x2013; 2023 and 2022 &#x2013; 2024. Depending on the actual amount of EPS from 2021 to 2024, up to an additional 76,210 PSUs may also be granted.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-cash stock compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income from operations for the year ended December&#160;31, 2022 is stated after charging $70.5 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and integration related *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December&#160;31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December&#160;31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2020 was $2.5 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i69612ff6be104bbda9eb34a7111229cc_I20170213"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwMzk_f6bdf95d-10f6-4227-80e8-8332ee0ff369"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ic45259ceacfa45dbaa829284ba61ed4f_I20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDU_3c8095fc-cb23-4402-8453-147be6001684"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i440197ff0132449083f0216f9fc3c298_I20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNDQ_615a4e5f-382c-4929-be1c-22afb8bfa389"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted
      contextRef="i5fbe4c2a486a4b5482f3723aed979671_D20170214-20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEzNDQ_4bb7b29c-193a-4e5e-9d00-4d21ddb78ce8"
      unitRef="shares">1000000</iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i4163e2475cb34804afe0a1d2c5088f79_D20170214-20170214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzE1NDI_b61160e9-4c00-4efc-8b22-fc86521dfc6f"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i7aa49a2d22f444b7a13c77919382a1df_D20170214-20170214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzIxMTA_02f13328-c832-4ed0-a1f7-04ecfdac79e4"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibef2001f3bff4594b125b1b4c70d6047_D19970101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzMzMTA_6adbe4f1-51da-4994-99b2-61965fd86fcf">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ibef2001f3bff4594b125b1b4c70d6047_D19970101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzMzNDM_3afa1500-7be2-478e-af9e-fdff8d32e4b3">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i0820a150dcb1422fbec11ed3af8c5b71_I20200518"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzE2NDkyNjc0NzA2NjI_89ebb324-111a-4368-a294-3acddb18b847"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i5a566fd41cfd4b69a2174efb24d4ec3b_I20180531"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzUzNzk_ba2468d0-afca-46dd-a124-69939aa171db"
      unitRef="shares">2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized
      contextRef="id76920b1711b412f9e74d6864364e113_I20130923"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzY2MTk_28b0c762-2f08-49b3-8687-2bdf3d06daa8"
      unitRef="number">0.125</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id76920b1711b412f9e74d6864364e113_I20130923"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzY3MjY_f2766bed-a289-47e7-8a88-37db515c00b0"
      unitRef="shares">2052909</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTM4_b883345d-8450-4c6d-b18e-94c053e64b6f">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;656,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(193,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;553,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumed through business combinations *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,177,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,065,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(348,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,378,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,047,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Represents stock options issued as replacement awards in connection with the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7c67eb08e5524f1389812b02c4f529e7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEtMS0xLTEtMTQzMjg2_1670b028-e6f7-48d2-abbb-f24023d3eeed"
      unitRef="shares">656107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i7c67eb08e5524f1389812b02c4f529e7_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEtMy0xLTEtMTQzMjg2_502227be-7d8d-4779-9b74-704b83089b50"
      unitRef="usdPerShare">87.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzItMS0xLTEtMTQzMjg2_b7710573-defc-4be3-9d7d-5bf3b4869f14"
      unitRef="shares">107737</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzItMy0xLTEtMTQzMjg2_c70ad5a5-0629-4269-99be-75ff0aa66fdb"
      unitRef="usdPerShare">159.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzMtMS0xLTEtMTQzMjg2_a5135a24-86bd-43c7-a1ba-f128fb38f496"
      unitRef="shares">193417</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzMtMy0xLTEtMTQzMjg2_5acbfbdc-1452-4636-b6b5-f83fe18e0af4"
      unitRef="usdPerShare">68.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzQtMS0xLTEtMTQzMjg2_dca9065e-b309-4585-8938-0f60fb891f92"
      unitRef="shares">16681</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ie87fe015d8cb4431b0544662bc0fe3a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzQtMy0xLTEtMTQzMjg2_49d50bf8-b399-4ec0-b6a7-d88d61538fd1"
      unitRef="usdPerShare">92.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if241526f99db43fc9bf9c882609b6aea_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzUtMS0xLTEtMTQzMjg2_dde158e0-5b51-4637-b6b4-1271fe082624"
      unitRef="shares">553746</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if241526f99db43fc9bf9c882609b6aea_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzUtMy0xLTEtMTQzMjg2_26a5ad2f-c008-4e3e-9224-4d636c9a04aa"
      unitRef="usdPerShare">108.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMS0xLTEtMTQ4NjE2_787e4f9d-f950-4175-9e01-cdd5d2a59330"
      unitRef="shares">2177130</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination>
    <iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMy0xLTEtMTQ4NjE2_cd34395c-7e91-4d53-8eb0-2b8560278a13"
      unitRef="usdPerShare">108.78</iclr:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMS0xLTEtMTQzMjg2_b8e0e0a0-0e5f-4f60-8338-a0fe70eb2ce5"
      unitRef="shares">100299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzYtMy0xLTEtMTQzMjg2_e0899c1a-a531-4207-afea-c98fb90fcdb0"
      unitRef="usdPerShare">177.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzctMS0xLTEtMTQzMjg2_019fe3a3-e77c-45ca-8e9d-d4ca1e13b114"
      unitRef="shares">1065529</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzctMy0xLTEtMTQzMjg2_73b57913-2fae-44d9-9805-f79574fe6341"
      unitRef="usdPerShare">111.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzgtMS0xLTEtMTQzMjg2_f29301c2-3e53-40bc-b369-e0af70261830"
      unitRef="shares">70186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i29f22306e9a147f98fdb7d0bb6441d18_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzgtMy0xLTEtMTQzMjg2_a95aceb4-9c2a-4152-8e9b-f77478629b05"
      unitRef="usdPerShare">128.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i940aa8c093bc4589896acef14854ea63_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzktMS0xLTEtMTQzMjg2_05cb337c-9406-4f33-99d1-6b7e06df0543"
      unitRef="shares">1695460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i940aa8c093bc4589896acef14854ea63_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzktMy0xLTEtMTQzMjg2_b931bd44-d0dc-4f4c-8328-585f01ea5492"
      unitRef="usdPerShare">110.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzExLTEtMS0xLTE0MzI4Ng_1d0dc671-d12d-4ede-922e-4492ac1e82ec"
      unitRef="shares">108643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzExLTMtMS0xLTE0MzI4Ng_855b3183-5689-4f57-aa66-ad8aa0cb58a8"
      unitRef="usdPerShare">229.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEyLTEtMS0xLTE0MzI4Ng_8c8abd59-c78e-49f0-8ed6-b8b0e9019b51"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEyLTMtMS0xLTE0MzI4Ng_039b09fd-8074-4f3f-a2ba-0a19f96b3ad8"
      unitRef="usdPerShare">102.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEzLTEtMS0xLTE0MzI4Ng_d5400745-f54a-4b55-b37b-ae54b29ca02b"
      unitRef="shares">77698</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzEzLTMtMS0xLTE0MzI4Ng_980ad816-8747-410f-a296-f7adef1a79a2"
      unitRef="usdPerShare">143.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE0LTEtMS0xLTE0MzI4Ng_6847ebea-e577-436e-a591-2122e426f96f"
      unitRef="shares">1378119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE0LTMtMS0xLTE0MzI4Ng_f0dea0a5-ae7c-4748-9389-1cab1d9918b1"
      unitRef="usdPerShare">119.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE1LTEtMS0xLTE0MzI4Ng_a2f12b94-ad67-44e8-8eba-ebdd669686a0"
      unitRef="shares">1047803</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZToyZTU2MGYyM2NjMDk0NTZiOGNkNmU1N2U5M2NjZjBiYi90YWJsZXJhbmdlOjJlNTYwZjIzY2MwOTQ1NmI4Y2Q2ZTU3ZTkzY2NmMGJiXzE1LTMtMS0xLTE0MzI4Ng_04ffd7f2-bd16-4906-a4d3-4c4e9ef2c03f"
      unitRef="usdPerShare">102.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcwNzA_f06c490e-ea65-4585-b6fe-cd5596ce035e">P4Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcwNzc_8258a480-d45b-4fb9-8476-d351b9abb518">P4Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcwOTg_87809364-3813-43fe-81f0-052b1661aecb">P5Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzcxMDU_b931b305-5225-4e90-b5f6-e0772ef58fa0">P4Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTUz_5a8904f4-bf20-4f4c-a417-d16ee19b4b03">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table summarizes information concerning outstanding and exercisable share options as of December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Range Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.88 - 96.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.81 - 124.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;203,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.74 - 147.26&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159.33 - 231.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;270,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;14.88 - 231.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,378,119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4.69&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;119.86&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,047,803&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;102.29&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i5255d861c7cc46d69f217fa72de308c6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ZjU5MDQxYThiOThmNDc1YTkwZWQzZGJlMWE0MjE4N2NfNA_21b1a292-ff72-4427-91dd-d51a3328d6a3"
      unitRef="usdPerShare">14.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i5255d861c7cc46d69f217fa72de308c6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ZjU5MDQxYThiOThmNDc1YTkwZWQzZGJlMWE0MjE4N2NfOQ_7323b57f-6142-4b33-9350-6bf856248e38"
      unitRef="usdPerShare">96.15</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i9c9a65dc7c694265ae542cee4cbfbd16_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMS0xLTEtMTQzMjg2_0763a011-f16d-4e1c-9594-2f4807ae895a"
      unitRef="shares">494565</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ica9d6a1d2ef345eebaf944a19f58d97d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtMi0xLTEtMTQzMjg2_923c990b-2c4b-4bec-b3ee-66bd983b2a41">P2Y8M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i9c9a65dc7c694265ae542cee4cbfbd16_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzMtNS0xLTEtMTQzMjg2_541fb9f6-eaf7-47e9-aad6-97bc280ec063"
      unitRef="shares">494565</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i46f308bc7dd44c64acb450333790b112_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ODM2YTkxYmMwNTUxNGM4ZTg1MjkyN2YxY2I1OTQ2MmVfNA_d275ae19-dd1a-40ba-841b-04eedbb77337"
      unitRef="usdPerShare">103.81</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i46f308bc7dd44c64acb450333790b112_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246ODM2YTkxYmMwNTUxNGM4ZTg1MjkyN2YxY2I1OTQ2MmVfOQ_f4d3f14b-a0d8-4e4a-8026-c210779c82eb"
      unitRef="usdPerShare">124.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="iee5eabbcadca4ea7bef29df09e08e94c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMS0xLTEtMTQzMjg2_07f68700-44b2-4861-ab02-48fab24e6eb3"
      unitRef="shares">226489</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ibcafc41c97334a6f89312cdf786a9995_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtMi0xLTEtMTQzMjg2_dae56aef-e02a-401f-9405-cb1ff8c1c719">P5Y6M29D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="iee5eabbcadca4ea7bef29df09e08e94c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzQtNS0xLTEtMTQzMjg2_0c7b4cf4-979c-40af-b18c-26a389ecebb5"
      unitRef="shares">203605</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i892854d05a8b4db7a71a9f8ce561bbbe_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YmNiNWYxZjU4YTIzNDRlNmJjNTY0NGYzYjY5OWU1ODZfNA_1d3415f3-b245-4022-b1b9-6cbfcb16da37"
      unitRef="usdPerShare">125.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i892854d05a8b4db7a71a9f8ce561bbbe_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YmNiNWYxZjU4YTIzNDRlNmJjNTY0NGYzYjY5OWU1ODZfOQ_ecff1e83-a0ba-447a-abeb-81e2894d31a6"
      unitRef="usdPerShare">147.26</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i2ccb139c1f534009823e7282d53f1fcf_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMS0xLTEtMTQzMjg2_0802b320-441f-4f42-b5df-1c9d0ec468b9"
      unitRef="shares">386518</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i1f37b14a260342dcb3444d2efa44c6d5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtMi0xLTEtMTQzMjg2_f9ef107d-bf0d-4e44-a88d-988631938d7f">P5Y7M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i2ccb139c1f534009823e7282d53f1fcf_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzUtNS0xLTEtMTQzMjg2_79e376ad-c94b-4da4-a0b5-359730192bfe"
      unitRef="shares">303054</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ie06d8c0caffa4a54b55eeaec6990c14f_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246MTM1MGY4NjdmNDJmNGQzNGJlZjgxOTMzZTY1OTVkODJfNA_e544ffda-1aa2-492e-ae5e-079443cc5e50"
      unitRef="usdPerShare">159.33</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ie06d8c0caffa4a54b55eeaec6990c14f_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246MTM1MGY4NjdmNDJmNGQzNGJlZjgxOTMzZTY1OTVkODJfOQ_a66f6daf-5b6c-424d-9f3e-62e3e6ef68c3"
      unitRef="usdPerShare">231.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i2a249b6708e444acb6a9b4b67484f49c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMS0xLTEtMTQzMjg2_0da27920-b89e-48f1-b4c9-7d41b1d00b87"
      unitRef="shares">270547</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ibad01622a145456eb95aa151f08ca887_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtMi0xLTEtMTQzMjg2_45ab9df5-351c-4066-8823-f88954c1f581">P6Y2M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i2a249b6708e444acb6a9b4b67484f49c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzYtNS0xLTEtMTQzMjg2_6e11f612-28cc-4528-a2c3-0a890c3cb468"
      unitRef="shares">46579</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YzVjNGY3MDNjYzViNGZiMDk3NmM3MWFlMmZkZGQ2MGRfNA_b22058a3-5e25-402c-9940-446f655f99a5"
      unitRef="usdPerShare">14.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMC0xLTEtMTQzMjg2L3RleHRyZWdpb246YzVjNGY3MDNjYzViNGZiMDk3NmM3MWFlMmZkZGQ2MGRfOQ_0403548a-7349-4c54-a080-ac8bbf819a8a"
      unitRef="usdPerShare">231.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMS0xLTEtMTQzMjg2_01c2d7ed-3b61-4f32-820e-c676fcbf1eb1"
      unitRef="shares">1378119</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="icf6ce326a14846daab2fc42643d92f63_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMi0xLTEtMTQzMjg2_ed75166e-9501-4d59-8545-8ad9e526bba5">P4Y8M8D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtMy0xLTEtMTQzMjg2_f0dea0a5-ae7c-4748-9389-1cab1d9918b1"
      unitRef="usdPerShare">119.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtNS0xLTEtMTQzMjg2_ca6bf6be-7541-4a65-9c41-eae3adb5cf7e"
      unitRef="shares">1047803</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ibedfb53eb84140b7b0f014f3448deedd_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo2NGIzNzJjMWY1ZWE0ZTcwOGYzMDRkMGRjMGQyODAyOC90YWJsZXJhbmdlOjY0YjM3MmMxZjVlYTRlNzA4ZjMwNGQwZGMwZDI4MDI4XzgtNi0xLTEtMTQzMjg2_04ffd7f2-bd16-4906-a4d3-4c4e9ef2c03f"
      unitRef="usdPerShare">102.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzIxOTkwMjMyNzE4Njk_a52aea0b-489a-4fd5-ba58-bec3efaa8e89">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTI5_54a3270d-ae54-473e-b72b-ffbad3292be7">The weighted average fair values and assumptions were as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzItMS0xLTEtMTQzMjg2_b6564a6c-8095-436a-b9e3-22c4ced2f145"
      unitRef="usdPerShare">68.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzItMi0xLTEtMTQzMjg2_08bc157e-2dba-4c16-8bbc-65d2dcfa1ec9"
      unitRef="usdPerShare">49.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzItMy0xLTEtMTQzMjg2_b6d57bee-8288-4e24-8fcf-970348b8a506"
      unitRef="usdPerShare">42.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzUtMS0xLTEtMTQzMjg2_3203f8ed-7dcb-4f8c-bb2f-dab2f1a171d2"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzUtMi0xLTEtMTQzMjg2_cc59ce2e-9b80-4d1d-8047-3899193efea1"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzUtMy0xLTEtMTQzMjg2_8f1b6019-240b-4ba1-869e-9c5fce38f0d0"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzYtMS0xLTEtMTQzMjg2_111f4295-b645-49ba-832e-bc4ebb084198"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzYtMi0xLTEtMTQzMjg2_c2dfef2b-8f4c-44e3-acc1-f78d0bcecf0b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzYtMy0xLTEtMTQzMjg2_535991d3-9677-480b-a2ba-95dd0c207cbf"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzctMS0xLTEtMTQzMjg2_3e2d8443-7c6b-4686-8b85-2a607965dc90"
      unitRef="number">0.0186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzctMi0xLTEtMTQzMjg2_4eb31fbc-f241-4c79-b1d2-1aa442843a95"
      unitRef="number">0.0078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzctMy0xLTEtMTQzMjg2_c84451b2-714c-489a-a04b-1c27fe4ecad9"
      unitRef="number">0.0057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5d9f1637801743dd9c42d564759ece4e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzgtMS0xLTEtMTQzMjg2_794b27dc-6720-4fae-a776-d24e606c0af7">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i63537b7e55924dc39b124b4832a1e176_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzgtMi0xLTEtMTQzMjg2_581fc7d2-2acc-4388-9bab-5943e7775d60">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic7203125b0e840e6933bf2e1c14791a6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTplNmE2ZmQwZjM1ZGY0ZjVjOWI3Y2JhNTExZmYxZjI0NC90YWJsZXJhbmdlOmU2YTZmZDBmMzVkZjRmNWM5YjdjYmE1MTFmZjFmMjQ0XzgtMy0xLTEtMTQzMjg2_0aa69584-4d29-47d1-b8e9-95fa638e8714">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzEtMS0xLTEtMTQzMjg2_dcca35a2-d155-4d26-962d-bc01d4ec40f3"
      unitRef="usdPerShare">107.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzMtMS0xLTEtMTQzMjg2_54c5d666-b072-4198-a11a-d85faa54bc2a"
      unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzQtMS0xLTEtMTQzMjg2_07c19e6c-a0d0-4598-9dfa-1e5aa515df12"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzUtMS0xLTEtMTQzMjg2_221ee0b4-e1ce-4ff7-b566-ae8e28e7ea47"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo3ZWFkNWQzM2JiN2E0MTBkODAwZjYwYTI1ODMxOGYzYi90YWJsZXJhbmdlOjdlYWQ1ZDMzYmI3YTQxMGQ4MDBmNjBhMjU4MzE4ZjNiXzYtMS0xLTEtMTQzMjg2_18d07f34-f2b4-47e9-9ca3-98d5ef60d3cc">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="iba8cd0f91c4543c384cf5fd3022523c9_D20150511-20150511"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzkxMTU_ec0fe15d-f1ed-4c4c-be6c-c33485c5983c"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iff4a5c52ce754d49b998568670340ed9_I20150511"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzkxNTU_40b80f54-d5e1-4154-a758-d5b4dae931d6"
      unitRef="shares">4100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7d0262e215cd4dfbb0898a63d51486be_I20190516"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0Xzk4MDU_753b06c7-8654-44d6-a4f1-2b5079347d3a"
      unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ifca1cb86a7554779a455148669f8224b_D20190101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwMDI2_ee01e968-230c-402b-beb8-2fedfa5f7be3">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTM0_43b63791-cab1-4c0c-8f6c-16dcded854a7">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;572,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;191.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46,087)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(195,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;192.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;582,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i50c7dd932b404320af63f5c9a2cf9cd5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtMS0xLTEtMTQzMjg2_b38083ff-0e80-4eb8-ab0e-c1b4088cd1e7"
      unitRef="shares">154190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i50c7dd932b404320af63f5c9a2cf9cd5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtMi0xLTEtMTQzMjg2_c69eaf7c-c132-40c4-bb49-9d894932b2f4"
      unitRef="usdPerShare">160.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5a4f5700181945938fdaecb063f3bc23_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtNC0xLTEtMTQzMjg2_477b5924-9857-4920-b3f2-2242b9b522e3"
      unitRef="shares">572785</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5a4f5700181945938fdaecb063f3bc23_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzEtNS0xLTEtMTQzMjg2_3af6de68-5d87-49a2-bc16-da0a853f271d"
      unitRef="usdPerShare">191.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtMS0xLTEtMTQzMjg2_435d2fe4-7a11-43a9-92d8-c0f69a6b6ac0"
      unitRef="shares">64682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtMi0xLTEtMTQzMjg2_8b1a5cbd-84a9-4f13-a21a-b48bf5353c5f"
      unitRef="usdPerShare">229.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtNC0xLTEtMTQzMjg2_f9decba8-5e4a-48e8-828f-87de05a98709"
      unitRef="shares">302307</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzQtNS0xLTEtMTQzMjg2_574e6aa5-7c3b-44ad-bdc6-0d087190cd24"
      unitRef="usdPerShare">216.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtMS0xLTEtMTQzMjg2_70c89189-6ec6-43ff-8d2a-cfb6b90e3e76"
      unitRef="shares">46087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtMi0xLTEtMTQzMjg2_402f6aa8-e8c1-4f07-91e2-93cb77543561"
      unitRef="usdPerShare">140.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtNC0xLTEtMTQzMjg2_35937007-ea15-4a56-a77f-06c524aa9a67"
      unitRef="shares">195029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzUtNS0xLTEtMTQzMjg2_c0fff327-3e4d-4960-a309-772d5df7c372"
      unitRef="usdPerShare">174.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtMS0xLTEtMTQzMjg2_632f22eb-b505-4f00-895f-d45f92ec8d2e"
      unitRef="shares">20365</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtMi0xLTEtMTQzMjg2_7e5303d9-b684-48ec-ab5c-9f0ed4b6a1a0"
      unitRef="usdPerShare">185.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtNC0xLTEtMTQzMjg2_ac499fc3-561f-418c-91c0-1340c64da9c9"
      unitRef="shares">97451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzYtNS0xLTEtMTQzMjg2_3386450e-6acd-41bc-8bda-9198edea7e25"
      unitRef="usdPerShare">205.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6cd4d35cf1d84f78909a24f1716a0841_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtMS0xLTEtMTQzMjg2_adbd1855-2a73-40aa-96fa-88aee0be00c9"
      unitRef="shares">152420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6cd4d35cf1d84f78909a24f1716a0841_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtMi0xLTEtMTQzMjg2_4d9ed645-0a6c-4aa4-8b39-256df9dccf4c"
      unitRef="usdPerShare">192.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i128b02150c364303957cd379df2d66a6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtNC0xLTEtMTQzMjg2_ce08e4b6-352a-4df7-9b9f-33f5dcd857c9"
      unitRef="shares">582612</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i128b02150c364303957cd379df2d66a6_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTpjM2UwMzJhZTI5ODk0NmE5YWUyYzhlOTMzMDgyNTUwOS90YWJsZXJhbmdlOmMzZTAzMmFlMjk4OTQ2YTlhZTJjOGU5MzMwODI1NTA5XzgtNS0xLTEtMTQzMjg2_6868abf4-4d2c-4747-82b0-7c19aaa04312"
      unitRef="usdPerShare">207.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i74f339fa95334abab2e154cc0ba3e9d6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDA2_b880d0a1-02ad-4825-8920-3ff35fb0515d"
      unitRef="usd">34100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="iec0d3c91746049cfa76770f5e2f12ef5_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDE0_9220c77c-e891-4941-b857-cddff991e892"
      unitRef="usd">83500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i6ec59b41573649288593eff6d1ebb047_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDU4_8b5468f8-c03a-4158-a3d9-e62509005b47"
      unitRef="usdPerShare">137.47</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="ia4030627d459479f9bcfc2485f408af1_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDYz_3c4fa55e-33ed-4ec5-84c6-f8ae58bdf752"
      unitRef="usdPerShare">265.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="ie70ef1e52b8445e8a30d1732702cac38_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDcx_e5f2adc9-822b-4c18-af1b-ca30f1feff02"
      unitRef="usdPerShare">115.11</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="ie1d7729620b245f3b3d86355af31bf15_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNDc2_d0ffe53f-df7d-4c46-bef8-421f74a4fca1"
      unitRef="usdPerShare">206.71</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8cc91ee8eb2d49ef97c5208377c4e859_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTQy_fef4e3f7-92d9-49af-ab5f-0fcfa411db42"
      unitRef="usd">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i323bd4358f4848aba9899c235c5c8a82_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTUw_a681f27a-ca52-423b-96c9-532b02ea99e8"
      unitRef="usd">5100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i385b3308021d4f8dab296ba9a3b672ca_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTk0_5ef1acbc-8e5c-4db1-b836-15404b37f534"
      unitRef="usdPerShare">137.47</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i31d66e89c6ac44c985d3b33f217a8215_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNTk5_19f95af7-1e41-49d9-9873-a699c1d3a09b"
      unitRef="usdPerShare">166.51</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i82f9a1a05fa24a3281257719ca8fb6c8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNjA3_9b0606e4-adb4-4cfc-af72-915268b1b3e3"
      unitRef="usdPerShare">115.11</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="i7478ddf969574f3ebf520346092b5404_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwNjEy_6a69e96d-6c34-4f82-aa04-38e35c6593c5"
      unitRef="usdPerShare">125.74</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="icbc58fa5272343979b1281d284fd5100_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwODEw_b05f9738-f4af-419e-8e82-5898dfae4128"
      unitRef="shares">76210</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensation
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzEwOTQ3_2980fc41-5c3b-42b5-87dc-8a138d5e5fd9"
      unitRef="usd">70500000</us-gaap:ShareBasedCompensation>
    <iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTU2_ce7a02f9-6842-42ad-b64e-e0e06926c5b7">Non-cash stock compensation expense has been allocated as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction and integration related *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger&lt;/span&gt;&lt;/div&gt;</iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzMtMS0xLTEtMTQzMjg2_2a284d6c-c87c-458b-bd1c-665e4c83109b"
      unitRef="usd">22854000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id197fe0d372441f4971e65ae556f9189_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzMtMi0xLTEtMTQzMjg2_b4756c02-60a4-443e-b380-30daca2be4b6"
      unitRef="usd">18551000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9cafc75e45844d94a5699609ed9c0e1a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzMtMy0xLTEtMTQzMjg2_8ccc7961-96e7-48b5-b39f-b9803a5a0149"
      unitRef="usd">8557000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibba1eb9117d6498ba61cd2ffd7a3dcc5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzQtMS0xLTEtMTQzMjg2_5211222d-7842-486c-9ff9-40089ee39027"
      unitRef="usd">47669000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifdf34dd45633475d9db22cc8203941ed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzQtMi0xLTEtMTQzMjg2_aad1e186-1d97-4821-b372-c2679dbb380a"
      unitRef="usd">41457000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic04e0493d819470faef53855bcf56280_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzQtMy0xLTEtMTQzMjg2_37ad6b1a-c2e6-4d68-ae07-a88d8ebd2ace"
      unitRef="usd">17714000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2f815c05b36c45c2bbeedbecb796cd4b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzUtMS0xLTEtMTQzMjg2_8f932988-657c-47ab-9235-e9b890d7f502"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib4ee9a12489e4e4d945f923b1fef04b6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzUtMi0xLTEtMTQzMjg2_6d25a68d-2306-441e-9f5a-397839719278"
      unitRef="usd">73836000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idfb23e34b2494ebeadf5c82112b1cc16_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzUtMy0xLTEtMTQzMjg2_8eb928ca-402d-4a49-8607-37fdfdeaca02"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzYtMS0xLTEtMTQzMjg2_3e955a7d-a8d7-4aeb-9bb1-9bb182b35514"
      unitRef="usd">70523000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzYtMi0xLTEtMTQzMjg2_95ff154c-5af1-49fa-bebe-af125c281b69"
      unitRef="usd">133844000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90YWJsZTo1OWNmYjIwNGMyOWE0NmI3OTkzMDFkZmQ0YTBjNDVjMC90YWJsZXJhbmdlOjU5Y2ZiMjA0YzI5YTQ2Yjc5OTMwMWRmZDRhMGM0NWMwXzYtMy0xLTEtMTQzMjg2_e84bf130-20ab-45a5-8553-d450edcbaf1b"
      unitRef="usd">26271000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExMjcy_8377bb49-a8d1-4b5d-823e-fd6bda4143bc"
      unitRef="usd">12900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNDI4_e901afad-4440-472b-9305-8720c4fa7e1f"
      unitRef="usd">7700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNTE0_6178e287-2726-463c-a006-4e8746a3a4aa"
      unitRef="usd">22700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNjcw_1da3dde4-e9bd-4587-92e2-05cad92a92b5"
      unitRef="usd">23900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExNzU2_b1b2dd8b-5fb8-40a9-b245-65a00b2d6684"
      unitRef="usd">6900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8xOTYvZnJhZzphMDBiMzk4OWQyZjI0YWViODM1ZDQ1ODkwYzYxMWQ1NC90ZXh0cmVnaW9uOmEwMGIzOTg5ZDJmMjRhZWI4MzVkNDU4OTBjNjExZDU0XzExOTIz_4406a20e-1d62-443a-974f-c3662fd85e2c"
      unitRef="usd">2500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzU1NzY_d70e70e5-012e-4ecb-bace-12f13d98b1fd">Business Segment and Geographical Information&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (&#x2018;CODM&#x2019;) in accordance with ASC 280 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;'Segment Reporting'&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#x2019;s transfer pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland acts as the Group entrepreneur under the Company&#x2019;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#x2019;s global network. ICON Ireland enters into the majority of the Company&#x2019;s customer contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Reportable geographic information at December&#160;31, 2022 and December&#160;31, 2021 and for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;a) The distribution of revenue by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,984,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,618,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,175,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,574,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,581,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;925,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;358,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,741,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,480,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,797,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;b) The distribution of income from operations (including Restructuring) by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland *&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;378,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;534,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzEyNTA_9d13732f-9cdb-463f-8a73-112a849e552d"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzU1ODE_d208a26c-0276-4428-9f62-3dc1916e2075">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Reportable geographic information at December&#160;31, 2022 and December&#160;31, 2021 and for the years ended December&#160;31, 2022, December&#160;31, 2021 and December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;a) The distribution of revenue by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,984,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,181,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,618,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,175,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;416,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,574,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,581,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;925,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;358,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,741,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,480,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,797,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzQtMS0xLTEtMTQzMjg2_c1bb85b0-7cf5-42b6-a095-6171c3cd57be"
      unitRef="usd">1984567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzQtMi0xLTEtMTQzMjg2_1449f182-d35b-451f-8e8b-3d93596a3015"
      unitRef="usd">1365909000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzQtMy0xLTEtMTQzMjg2_6403e2f4-32e8-4723-92c1-09df24746b89"
      unitRef="usd">1181292000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8b94a05494d4a9aafad89fefcf5ec5e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzUtMS0xLTEtMTQzMjg2_0424984a-75e5-42f0-a8b1-376ba2d06665"
      unitRef="usd">1618350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a7e7fb2e8754f13959c968948055905_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzUtMi0xLTEtMTQzMjg2_a6026597-85db-492a-98a9-bde73080e95b"
      unitRef="usd">1175515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id51c60ed11834e3489b68644df728ad3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzUtMy0xLTEtMTQzMjg2_10eb8669-26ca-4e3b-a591-9a9ba0162f29"
      unitRef="usd">416884000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzYtMS0xLTEtMTQzMjg2_aa63531c-1004-464a-b24e-f2e248ae4d8b"
      unitRef="usd">3574610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzYtMi0xLTEtMTQzMjg2_af6d320d-e0fb-4349-9a99-5e49267ecf68"
      unitRef="usd">2581007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzYtMy0xLTEtMTQzMjg2_7e81fcdf-f843-411d-b225-2e275c537e91"
      unitRef="usd">925563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id74698b742ce45b48de3dd6ca0e41f58_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzctMS0xLTEtMTQzMjg2_878b4368-32d6-4f15-8b15-0f6b33a27609"
      unitRef="usd">563859000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i095fb057614e484690d7c8e6855aa257_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzctMi0xLTEtMTQzMjg2_face26e4-1347-494a-9f35-c75e1e3b35a8"
      unitRef="usd">358395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i470b5734b0ec4cdcb5d2d8b7192a224d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzctMy0xLTEtMTQzMjg2_4e9044df-7e35-4cd7-a1d6-fb43062c894a"
      unitRef="usd">273549000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzgtMS0xLTEtMTQzMjg2_af825732-759f-4806-8ee0-4cee1546f546"
      unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzgtMi0xLTEtMTQzMjg2_02f02141-208c-480a-b9ab-07d1c8063397"
      unitRef="usd">5480826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZToxNjE0MGY0ZTkwNWU0YjgwODFjZmMwMmMwNmY3NDRiOC90YWJsZXJhbmdlOjE2MTQwZjRlOTA1ZTRiODA4MWNmYzAyYzA2Zjc0NGI4XzgtMy0xLTEtMTQzMjg2_0d75aebd-a029-4722-95b3-17d1b2277f3a"
      unitRef="usd">2797288000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <iclr:OperatingIncomeByGeographyTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzE2NDkyNjc0NjM4MDI_6dd3e116-710a-468a-a5a1-05479f9df103">The distribution of income from operations (including Restructuring) by geographical area was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland *&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;378,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;391,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.</iclr:OperatingIncomeByGeographyTableTextBlock>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzMtMS0xLTEtMTYzMjg3_62da508f-abe2-4567-a550-d49a364714ed"
      unitRef="usd">218088000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i3ac31077a44b4a80964b76cbb3e39457_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzMtMi0xLTEtMTYzMjg3_f4ad7d44-e1c8-4fe5-b5df-e1be1f909122"
      unitRef="usd">131961000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i7bc48c7d5219439993d10d693cf9975a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzMtMy0xLTEtMTYzMjg3_51fa541c-aeda-4dac-b75e-fd15beb8f342"
      unitRef="usd">276478000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="ie8b94a05494d4a9aafad89fefcf5ec5e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzQtMS0xLTEtMTYzMjg3_0a7d28ea-7e46-4bf0-a7d9-fd9343099bd0"
      unitRef="usd">253799000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i0a7e7fb2e8754f13959c968948055905_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzQtMi0xLTEtMTYzMjg3_6e9348f1-1290-41c0-848a-44f288e26a93"
      unitRef="usd">177863000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="id51c60ed11834e3489b68644df728ad3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzQtMy0xLTEtMTYzMjg3_00b86559-16ed-4dce-b1ce-bff6d72e8453"
      unitRef="usd">35765000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="iee316e05b53a4b06a0345a352d600919_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzUtMS0xLTEtMTYzMjg3_073a8bc3-987b-4f05-9152-62d2c90b61ca"
      unitRef="usd">254849000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i64b5d20e1d2642cf8697524331544e47_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzUtMi0xLTEtMTYzMjg3_af80ca91-a05b-4ae6-8b8f-4cd1bb1bd1ab"
      unitRef="usd">39132000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i1db08719244443188a87bd4495f32a5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzUtMy0xLTEtMTYzMjg3_c312238a-92a9-4eb7-a1bd-dbbe38cb97a2"
      unitRef="usd">58018000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="id74698b742ce45b48de3dd6ca0e41f58_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzYtMS0xLTEtMTYzMjg3_7892a850-4e61-4633-95c0-e8939149e81b"
      unitRef="usd">68501000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i095fb057614e484690d7c8e6855aa257_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzYtMi0xLTEtMTYzMjg3_efde4972-7cbb-4698-9d88-6c5b524c4660"
      unitRef="usd">29573000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i470b5734b0ec4cdcb5d2d8b7192a224d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzYtMy0xLTEtMTYzMjg3_c16c5a90-13bb-4027-91d6-ff71a330e17d"
      unitRef="usd">21239000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzctMS0xLTEtMTYzMjg3_34229b37-6697-4bd2-bc22-d312b3dab4b9"
      unitRef="usd">795237000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzctMi0xLTEtMTYzMjg3_cc2161ac-1c6b-483b-8f48-9fe727f5927a"
      unitRef="usd">378529000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTo5YmY2MjNkNWJlODE0NjNiODNmYzQzMjg4NDc5ZGRmNC90YWJsZXJhbmdlOjliZjYyM2Q1YmU4MTQ2M2I4M2ZjNDMyODg0NzlkZGY0XzctMy0xLTEtMTYzMjg3_982a0a22-f0f7-415e-b5c3-7864e4949d8a"
      unitRef="usd">391500000</iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90ZXh0cmVnaW9uOjgyOGJjN2ZkODE2OTQ4YTQ5NDA1OTIxYzc5M2RhNjEwXzU1NzQ_6a4962fc-b6a0-4906-a70d-cdd1161f2673">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;534,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="i2573b70385e24cddbc2849d005657d46_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzItMS0xLTEtMTQzMjg2_8145581e-7f25-442b-90cd-b0674228e6d9"
      unitRef="usd">143025000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i2be2313371ae40d6abc4a3f42b6751ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzItMi0xLTEtMTQzMjg2_0e70c8f4-613e-4c53-abf0-7aaec9fa8cc8"
      unitRef="usd">118253000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0f7fbd571c7848e2a658e6b23259ae2e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzMtMS0xLTEtMTQzMjg2_ef99fb55-775a-446b-a895-9d58a5724793"
      unitRef="usd">99721000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i3911e749f50947d4b21832b72052d785_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzMtMi0xLTEtMTQzMjg2_92176571-b156-47e4-b1a1-fc053080913d"
      unitRef="usd">121174000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i305536a3cd1f49ec9167bd9bc8104484_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzQtMS0xLTEtMTQzMjg2_13545f2f-0efe-4852-bd7b-3ae34c9bb64f"
      unitRef="usd">213311000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i93cae0d23f394e31b3abce80e3e3687f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzQtMi0xLTEtMTQzMjg2_e5a4b038-7a49-4cfc-865b-871dc2f75641"
      unitRef="usd">239828000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="icd5d2064ec2c49afba73bfde8e3bacd0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzUtMS0xLTEtMTQzMjg2_de8119f7-381c-4833-bd49-4c6dc5f432b0"
      unitRef="usd">48095000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6988db3dbc8a4435b967b2307aada5cb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzUtMi0xLTEtMTQzMjg2_36969885-52ea-431e-9229-0240d52027f9"
      unitRef="usd">55312000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzYtMS0xLTEtMTQzMjg2_ee1210b6-60df-4e5a-9629-bdc3d1e0d363"
      unitRef="usd">504152000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMjYvZnJhZzo4MjhiYzdmZDgxNjk0OGE0OTQwNTkyMWM3OTNkYTYxMC90YWJsZTozM2E2NmZjYjU5MDI0YmQyOTJjMzIwZDlkY2EwZDA1NS90YWJsZXJhbmdlOjMzYTY2ZmNiNTkwMjRiZDI5MmMzMjBkOWRjYTBkMDU1XzYtMi0xLTEtMTQzMjg2_34fb29a4-d40f-461f-95c8-0a51e772a0df"
      unitRef="usd">534567000</us-gaap:NoncurrentAssets>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90ZXh0cmVnaW9uOjhjZWQzMjQxOWI3YTQzM2FhNjBhZGFmZjVjZTVkZjMyXzE0NDc_ec4b8b09-a850-405a-83f0-7a8a8f6add37">Net Income Per Ordinary Share&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per ordinary share attributable to the Group for the year ended December&#160;31, 2020 includes an adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the years ended December 31, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,532,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,859,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;423,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,468,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,068,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,283,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;332,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest adjustment to redemption amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group (including NCI redemption adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90ZXh0cmVnaW9uOjhjZWQzMjQxOWI3YTQzM2FhNjBhZGFmZjVjZTVkZjMyXzE0NDg_2c86d112-f587-4253-9661-53258e4fce09">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,532,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,859,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;958,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;423,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,468,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,068,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,283,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzEtMS0xLTEtMTQzMjg2_ea60144a-c005-4ca2-a001-92bdb5a5f13e"
      unitRef="shares">81532320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzEtMi0xLTEtMTQzMjg2_e0ac59f5-30e4-418d-9350-9496b1d799a6"
      unitRef="shares">67110186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzEtMy0xLTEtMTQzMjg2_e0421f80-4650-4698-82bc-a90076f5faa6"
      unitRef="shares">52859911</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzItMS0xLTEtMTQzMjg2_d9a21214-7fa5-49d2-ad9d-574b97c04a9a"
      unitRef="shares">936043</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzItMi0xLTEtMTQzMjg2_d72fc749-6798-449b-b9e0-864355c5b2fd"
      unitRef="shares">958125</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzItMy0xLTEtMTQzMjg2_10135959-3bfe-43f4-b91e-d4a1718c62d4"
      unitRef="shares">423674</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzMtMS0xLTEtMTQzMjg2_1aebc954-ad4f-45cd-901b-44bbb4bc7991"
      unitRef="shares">82468363</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzMtMi0xLTEtMTQzMjg2_fab44bc0-2328-4a33-a993-4323ea2009ab"
      unitRef="shares">68068311</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTphMGUwYjRiNTkzYzQ0ZWNmYTNkNjhlZGJmZjY1YWZjMi90YWJsZXJhbmdlOmEwZTBiNGI1OTNjNDRlY2ZhM2Q2OGVkYmZmNjVhZmMyXzMtMy0xLTEtMTQzMjg2_7dd209cb-1025-4527-ab9a-1d6d19076680"
      unitRef="shares">53283585</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90ZXh0cmVnaW9uOjhjZWQzMjQxOWI3YTQzM2FhNjBhZGFmZjVjZTVkZjMyXzE0NDk_ca8300d0-7d55-4727-8cda-372e7d6a50a5">&lt;div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;332,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest adjustment to redemption amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Group (including NCI redemption adjustment)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;505,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;327,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzItMS0xLTEtMTQzMjg2_31490c30-8df7-4d41-9710-d0ad12494801"
      unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzItMi0xLTEtMTQzMjg2_b372d28d-ec64-4048-b18a-2d7d3e85d302"
      unitRef="usd">153185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzItMy0xLTEtMTQzMjg2_2a703cf7-8941-411f-866c-d45f6bfc0831"
      unitRef="usd">332331000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzMtMS0xLTEtMTQzMjg2_d0a0e1dd-1ca5-4aad-950b-8294a457429e"
      unitRef="usd">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzMtMi0xLTEtMTQzMjg2_753ea5d5-cf04-4b7a-bbbb-b5c313f25e2f"
      unitRef="usd">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzMtMy0xLTEtMTQzMjg2_31279d02-a43f-4d6e-8117-07a262c05d93"
      unitRef="usd">4522000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzQtMS0xLTEtMTQzMjg2_b346fc97-b6a5-4d5c-9a7c-dad22dbd2b02"
      unitRef="usd">505304000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzQtMi0xLTEtMTQzMjg2_e67fd138-428e-4cf7-af61-eea8f460addf"
      unitRef="usd">153185000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzQtMy0xLTEtMTQzMjg2_3b031fdb-81d5-4c22-8a4c-55955514b9f3"
      unitRef="usd">327809000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzgtMS0xLTEtMTQzMjg2_e5ebe8e4-817b-4e4e-811c-a2a5b50af2fe"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzgtMi0xLTEtMTQzMjg2_eaf4374f-e8c1-46cc-ba42-d95fe3853957"
      unitRef="usdPerShare">2.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzgtMy0xLTEtMTQzMjg2_b61f863c-49bf-4ca4-a924-c8769dde9ea6"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzktMS0xLTEtMTQzMjg2_57469747-cb0e-4b96-b3ac-720a7ea187fa"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzktMi0xLTEtMTQzMjg2_1811cb5c-a8a5-42df-a592-6bc5f28f46c9"
      unitRef="usdPerShare">2.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTAvZnJhZzo4Y2VkMzI0MTliN2E0MzNhYTYwYWRhZmY1Y2U1ZGYzMi90YWJsZTowYzg4ZDVlYWZiOTk0YTI1YjY4ZDRmNDI2ZDdlM2U1My90YWJsZXJhbmdlOjBjODhkNWVhZmI5OTRhMjViNjhkNGY0MjZkN2UzZTUzXzktMy0xLTEtMTQzMjg2_ca551c29-9cf8-4c43-886f-2e49806a5baa"
      unitRef="usdPerShare">6.15</us-gaap:EarningsPerShareDiluted>
    <iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90ZXh0cmVnaW9uOjQzYmE1MTQ2MWU1YjQ5YzNhMTVhMzI2ZWU1ZjMzNzk0XzUw_626e2e83-012c-4645-a204-c6349c1c562b">Accumulated Other Comprehensive Income&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(175,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain/(loss) on defined benefit pension plan (note 21)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of loss on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(171,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90ZXh0cmVnaW9uOjQzYmE1MTQ2MWU1YjQ5YzNhMTVhMzI2ZWU1ZjMzNzk0XzU1_da20bf51-ae37-4790-9ea0-14bba414356b">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(175,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Actuarial gain/(loss) on defined benefit pension plan (note 21)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of loss on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(171,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzMtMS0xLTEtMTQzMjg2_56d6e895-5637-43f1-8cea-e9b8ec728688"
      unitRef="usd">-175369000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzMtMi0xLTEtMTQzMjg2_aa8d1ca3-090b-4831-aa43-68f5e8eec1ff"
      unitRef="usd">-85840000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzUtMS0xLTEtMTQzMjg2_c87d4663-3616-4345-accf-80798dfab0be"
      unitRef="usd">-7559000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzUtMi0xLTEtMTQzMjg2_c095f9e0-1c18-48c2-9a97-94817cba6c37"
      unitRef="usd">5098000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzktMS0xLTEtMTQzMjg2_f97dad7b-3750-480a-8f63-0250f59f3f17"
      unitRef="usd">-3728000</iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax>
    <iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzktMi0xLTEtMTQzMjg2_df7501c3-d2c6-4532-9cb3-21426b5b0e15"
      unitRef="usd">0</iclr:AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax>
    <iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzExLTEtMS0xLTE0MzI4Ng_97aa8a38-5f27-4e15-a982-1754cba99b44"
      unitRef="usd">0</iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax>
    <iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzExLTItMS0xLTE0MzI4Ng_c09e1ec1-6a8d-4ea0-898b-020a1f3d52b5"
      unitRef="usd">1000</iclr:AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzEyLTEtMS0xLTE0MzI4Ng_d1001a24-2f23-4d83-a5b4-8d994a006595"
      unitRef="usd">-171538000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3bdf1ab44b5e470db76e3745541d3db7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzUvZnJhZzo0M2JhNTE0NjFlNWI0OWMzYTE1YTMyNmVlNWYzMzc5NC90YWJsZTo3Mzk0NTg0ZjBmNmU0ZjdmYmJmZTQ5ZDYxYTI4N2NiMC90YWJsZXJhbmdlOjczOTQ1ODRmMGY2ZTRmN2ZiYmZlNDlkNjFhMjg3Y2IwXzEyLTItMS0xLTE0MzI4Ng_cd06de82-6a03-4b72-94e5-ffd53649b56c"
      unitRef="usd">-90937000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90ZXh0cmVnaW9uOjgyMjVhMTZjNWUyNzQxYzU4ODQwMzE1ZGFkYmI3MWI3XzYx_09b84db3-3bb3-40ad-b9e8-d52aee7123b7">Supplemental Disclosure of Cash Flow Information&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90ZXh0cmVnaW9uOjgyMjVhMTZjNWUyNzQxYzU4ODQwMzE1ZGFkYmI3MWI3XzY2_3353cfe6-ab58-44bf-8824-6f2d88274cbc">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzMtMS0xLTEtMTQzMjg2_1d93708d-9aee-43a9-8822-984ac422e55b"
      unitRef="usd">210918000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzMtMi0xLTEtMTQzMjg2_b4eee8b5-0d4f-4c0d-9cba-10e2c18cbee5"
      unitRef="usd">106205000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzMtMy0xLTEtMTQzMjg2_323e0e91-9fb5-450d-bb3b-29682ee440ba"
      unitRef="usd">13062000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzQtMS0xLTEtMTQzMjg2_40df81fa-9b77-4c9b-b027-ca56f5b5ca12"
      unitRef="usd">116322000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i8c05a245fc2a4c0f882e5be14e9b71db_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzQtMi0xLTEtMTQzMjg2_8aeccdd9-d370-4092-b8a7-befb21f5c5bb"
      unitRef="usd">55105000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i208bee1e63384d9e9e06f06c81bc2510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzIvZnJhZzo4MjI1YTE2YzVlMjc0MWM1ODg0MDMxNWRhZGJiNzFiNy90YWJsZToxMWYwMDM2YWY0YWI0MzNkYTllZmQ2MmQ2Zjg0MTg3ZC90YWJsZXJhbmdlOjExZjAwMzZhZjRhYjQzM2RhOWVmZDYyZDZmODQxODdkXzQtMy0xLTEtMTQzMjg2_fa3b19f6-1726-401d-bf34-bcc7dda03ba7"
      unitRef="usd">27604000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzE1ODI_09e2bf52-753c-48e0-a788-e98e8cbec070">Related Parties &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Subsidiaries of the Company earned revenue of $2,000 (December&#160;31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December&#160;31, 2022 (December&#160;31, 2021: $12,000).&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subsidiaries of the Company earned revenue of $235,000 (December&#160;31, 2021: $551,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December&#160;31, 2022 (December&#160;31, 2021: $197,000).&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9&#160;million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December&#160;31, 2022 (December&#160;31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December&#160;31, 2022 (December&#160;31, 2021: $264,000).&#160;During the year ended December&#160;31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1&#160;million and $2.2&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2022 and December&#160;31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3&#160;million of pro rata losses.  The remaining $0.8&#160;million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. At December&#160;31, 2022  accrued interest of $183,000 remained outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i45448a33be2443fd93dedd1a7d14df2a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NjE_20705ae4-696e-4a01-9116-153c4e059fb3"
      unitRef="usd">2000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iebdfade2d1334535803b379eaf1d7a23_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ4ODg_cd9731af-e5a0-4f51-92e4-e4f36dde45e8"
      unitRef="usd">30000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i4715e63da19c4cd897a34f13c13f0b3b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NTc_33359442-4940-4f6b-ba6f-060141209975"
      unitRef="usd">12000</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i0fb773a2b86147749b4c3538c0035971_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5MTU_8b4b7c99-b9dd-452e-8135-60a15a0e7f43"
      unitRef="usd">12000</us-gaap:DueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ied4aaa8f5f68454db087c1b69e5131a0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NzU_7b4274ad-5fdb-4590-9094-8267d02baaf0"
      unitRef="usd">235000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i4158ffec277a4decaff6ea55e3ac1007_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5NzE_9731c5d0-9a4d-427c-8f64-a12560e84f10"
      unitRef="usd">551000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i9985b94712864f2290305ffd2981067f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5OTI_57ad492f-06eb-4f0c-b9c4-d305d0603dcf"
      unitRef="usd">263000</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i6ac4e36329b842e7b8b1b172ef93c1f2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ5ODc_4cf84260-7b90-473e-9a0b-1c1f9513f8e6"
      unitRef="usd">197000</us-gaap:DueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ib89cec313ee54d428d8f32c7d6f723f5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzYyODM_433355bd-ccf8-48b1-b27a-6b08e6a22133"
      unitRef="usd">428000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i8dc5b0b8e9eb4cd182c4c104a6637ab6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzY0NDY_f8eaef08-4b38-4df6-8519-a2bbaf4944b2"
      unitRef="usd">231000</us-gaap:DueFromRelatedParties>
    <us-gaap:EquityMethodInvestments
      contextRef="ia09cfcf09c5a4518ae153515930d8057_I20200724"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzE4NjkxNjk3Njg0NDky_1d7833c6-06b1-490c-9768-602e4867ced8"
      unitRef="usd">4900000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMTg_2bcd9847-d90b-4301-9177-0d506e9be680"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMDA_f5edf949-44ab-4c0d-b608-865446092cd9"
      unitRef="usd">451000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMzA_22e30e52-afc2-4ac3-a3fe-6248d326619b"
      unitRef="usd">465000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueFromRelatedParties
      contextRef="if58aadd9086f43b2a3767b622c4f2dc0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwMzc_8fa43a6c-9a7d-42a2-9153-ddc771bf619e"
      unitRef="usd">715000</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties
      contextRef="i16fb8e5b432b4ab3a94979ed99d87911_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwNTE_7d776108-9959-4aff-aaf1-85605d608bc3"
      unitRef="usd">264000</us-gaap:DueFromRelatedParties>
    <us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions
      contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwNjA_17321ed4-c097-4861-a189-d728c97e9525"
      unitRef="usd">10000000</us-gaap:LoansAndLeasesReceivableRelatedPartiesAdditions>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="i68d39bd6a1934626911076815f36ce28_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUwNzQ_ae2b44cc-cfca-4465-bd24-9268f389504a"
      unitRef="number">0.016</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia961c12b79494b50a3b7b747a2ce04be_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUzNDY_187d48ae-b1b9-4f5b-8796-2a593e943fc8"
      unitRef="usd">-3100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="idf5fe76c69e241d7915327e838e9518c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzUzNTQ_d152ae39-b8af-40b6-affa-12e465ab62fc"
      unitRef="usd">-2200000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <iclr:IncreaseDecreaseInEquityMethodInvestments
      contextRef="i90d1e89b8ae649e4b509b6f60af73d3a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzU1Mzk_022c9384-55ec-491e-968b-acaf0eb99758"
      unitRef="usd">-2300000</iclr:IncreaseDecreaseInEquityMethodInvestments>
    <iclr:EquityMethodInvestmentDecreaseInLoanReceivable
      contextRef="i8f3f2bb2b5a347deb9b8157101723365_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzU1Nzg_7786fe85-be3e-439a-a649-70c0d4d47502"
      unitRef="usd">800000</iclr:EquityMethodInvestmentDecreaseInLoanReceivable>
    <iclr:InterestReceivableRelatedPartyLoans
      contextRef="ic314749132274d02aea042862e1ff17e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzU5ODY_a613c147-aa04-4825-a3b4-4e19784628e0"
      unitRef="usd">183000</iclr:InterestReceivableRelatedPartyLoans>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ2Njc_3547f1db-1741-45cf-b6b8-9ecd870ba779"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <iclr:EquityMethodInvestmentMajorityOwnershipPercentage
      contextRef="ia06e61e30b434302889007f7159b05f5_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNDcvZnJhZzplMDk2Y2M5MGIzYjU0OTZlOTNlODNmYWIwMzZkYWZiOS90ZXh0cmVnaW9uOmUwOTZjYzkwYjNiNTQ5NmU5M2U4M2ZhYjAzNmRhZmI5XzY1OTcwNjk3NzQ4Mjc_3547f1db-1741-45cf-b6b8-9ecd870ba779"
      unitRef="number">0.51</iclr:EquityMethodInvestmentMajorityOwnershipPercentage>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yNTMvZnJhZzo0YjIxNzE1ZDNmNzM0NjkwOGQ5OGY0YjhlNjdhMTBhMy90ZXh0cmVnaW9uOjRiMjE3MTVkM2Y3MzQ2OTA4ZDk4ZjRiOGU2N2ExMGEzXzEzMzM_455bdfba-8e17-4b60-ad85-ec1be6039309">Subsequent Events&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;T&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;he Company has evaluated subsequent events from the Balance Sheet date th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;rough February&#160;24, 2023, the date at which the consolidated financial statements were available to be issued. The Company has determined that there are no items to disclose.&lt;/span&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>157
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MUPDJOF1,O@QTS6VNV/@/4$L#!!0    ( %"$6%;<>G&(?08  )D;   8
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MS=F2RPH OS\+Z"GM1?6 [C1N]C]02P,$%     @ 4(185@1F2)-+!   TPX
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M15ZU!<3?[\JR^?;#E> _E-6G+L;U?P%02P,$%     @ 4(185@F0S,+""0
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M,&!C-:O'&^SGF^^5SH523^Q:[$6U@^VX%#+5VZXP);8=0(CC*'2J%* +8Y;
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M*]"W"TF.8P"W0CU96&R?N$%*%J=T9!]#>N8B?N9Z?]Q#&U+YJ?TU<<G),0C
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MSPOP^\+A(.I?.,#FYCW[!U!+ P04    " !0A%A6IWW89\TG   @A0  &0
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M15NR0;OMT 5A.4;F(/P!E %_LD6TN!%93"3EQ< *"[L]U+B^*+[O MIO;',
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MEP0XG@2M.)O*=P!G/5:<:TD,I)8WT.L"7R="P=M;L @6P\ QUIC'MFX9Y=7
M5$I1X%E$-P+#-1]SD#6PFBB'-&8TK^B+$K-F:.T<CE*O1'$6F3F+9!!E'.&
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M*CA53(V0(T5M8W";L2D:BGCGTQNP8\6'.$2,&S9"\6;T#06R/GM*+#&B)9=
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M7/J)E V5]MR#C30E/!^5>9=*IJK>8SZXE 6Q&D8&<P6C1W*Y 8;WEGY>)+X
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M&GZ3@Z_%,$TTK*V'IL44$T[ N!?%GY E6TYZ]?2+-/-/8NF:=9&K\N ':73
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M.NP..KG6Q >N7B4%T31 CY3F0K?<;LEJV6EC(RV^8.*WC-YH6>>RX67Y0N[
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MMR;*LB1Z[.G(:A(Y!T;2!A6AIN@'O<@T[666B#P_4$PB .(FF641)V8^HI>
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M=@*T/U/*KB?.P.:=-_D?4$L#!!0    ( %"$6%:T-:4@0 ,  # '   9
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M$_!\:8!0>4$,ZH]GSO\'4$L#!!0    ( %"$6%844TU?(P8   P0   9
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M=]C7.SS%_O\#.DEWO-B3.>!+@9!Q8W9";8"7NO91:S@-(KD <L(.N;& _F<
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M+W-H965T,C4N>&ULI5;?;]LV$/Y7#AJPI]2R%:<+,MM XFSH@!8-FFY]&/9
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M]CX?9]L/*(C'\6%_.]!"FR4_RT'(%O8N<&R<)D$,D9PM*C_GPB0<_4Q]#!)
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M!;>&V::JN-E>@]2;>1 'NX<[L2X=/8P6LYJOX1[<E_K6X&W4H^2B F6%5LQ
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M9(,H?-_K839[P(UP)<98(W7S3)4J$;4FI[245N=98XPOST.$71_2!N-[$ >
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MC!*I: ">KXJB;'[0 NU_(5_^+U!+ P04    " !0A%A6OTD(ZN 0  #P-P
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M%B@8"UVT%G<O_[_@_X5" I93! 3 L7R]B.FWY2*:+U>/@4_2&>)?BWBYC%;
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M+ #=7BS:@54+?YB?*DM7 _]9T5T,M1.@]9FBOW(W< ;ZV]WD/U!+ P04
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MVQB-#Z#[A=9N<_ )^OV>_P902P,$%     @ 4(185KP9+,QL!0  9@X  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULG5?;<MLV$/T5C*HTR8R'DBC)
M<5S;,[;<2S))[;'3]J'3!XA<B4A(@ % R?K[G@4O41Q95?I@&0"!LV?/[N)R
MMC;VD\N(O'@H<NW.>YGWY>E@X)*,"NDB4Y+&EX6QA?3HVN7 E99D&A85^2 >
M#H\'A52Z=W$6QF[MQ9FI?*XTW5KAJJ*0=G-%N5F?]T:]=N!.+3// X.+LU(N
MZ9[\'^6M16_0H:2J(.V4T<+2XKQW.3J]FO#\,.%/16NWU1;LR=R83]QYDY[W
MADR(<DH\(TC\6]&,\IR!0.-S@]GK3/+"[7:+_DOP';[,I:.9R?]2J<_.>R<]
MD=)"5KF_,^O?J/%GRGB)R5WX%>MZ[AB3D\IY4S2+P:!0NOXO'QH=MA:<#)]8
M$#<+XL"[-A187DLO+\ZL60O+LX'&C>!J6 UR2G-0[KW%5X5U_N*.<NDI%;?2
M>D7N;. !RI\&20-P50/$3P",8O'>:)\Y\;-.*?T:8  V':6XI705[T6\IB02
MX]&1B(=QO =OW+DX#GCC US<B ]6:B=#2CCQ]^7<>8O>/[L<KV$GNV&Y6DY=
M*1,Z[Z$<'-D5]2Y^_&%T//QI#^E)1WJR#_V0N'P7@+BOYDZE2EKNF(7P&8F9
M*4JI-X*DU9AJ:46Z(O[:CX^&PZ%X@5A0,2?;QF-T*OKC(7][*1;6%.+Z7EPI
M4V82%2+>J4*QS1>\69#--^):+;6"ZO>)(IW <C/EI4@KJ_0RT-C ?B2N\??6
M9%K,<H4$%PH9]4!)Q54K9IE4L( JUJF0@+6H:F-#U\$X929/01/4=S&*1']4
M>[26#GXFQB)7!=HI_'W:$>G%8P7BW:+4\"^C[]9Y/'U:Z>ETM"7UY4(51:6I
M8W>(A+-,T6)+R)O%0B5D#]#QL3EH&!^/]XOX#<7O$/#UJ_^GX"0^":0"@9FQ
MJ\J)VQ#&A.!S(G.W6ZEW2J=2_&HE9 KEZ]B7_:+LQF=IQJ/]TCS!;)= D;C1
MXFV%\HDG861X!%JNE67S2)0C\69V\SO'7#.FN,-F)&V2M4$X$J0]6?!1VAO!
M1;2T1#A9O4#_H\$P;)'S<IXKE\&6QFF:M.@W.I$)5#C"T>3YJ\^4347)VVDD
M/FQ%)X/#2D-(#GU_$KW&B97G?/C"CIE[W!&P?/+Z&3,!(^?1"*ZLC.< !;5%
M(DOEX0C<;&U_;:>T9J588.A<&HM]#NJ4:/D02,4;#2RVB[D=C,B\S9FZL![G
M!81BU ,S=G(\;3*V_VHTW1_]CLKA!1$?3QKXZX-8XM?OTDB*W"#F[/9HN!V0
MCA-BP(PM#RXJ)#WC)#C4%6H,)> 1:5&5;=K-*X>SQKGG E=#B,\G:1V?8$@F
MB:VXEK2N$,0NTO!\%!T_"U7EV\F*]2KE!IF'R'#68_/  <,.3;]-KD[;W#A7
M[P[]<33JO&+L?AS%W0# ^6S6(;N4=RR+ &?9I%KC4@,'(3I1#DT--KDC%+!:
M4KAQYDV1 -5N&+)+PZUP/6\+)U3E-H\ZI=(J@?7YAKT;=]X!H_.G=J$V98FO
MXVRK/XQ.NNF ?32]WO=2#GQMHP[]?S -D4,H2*U"W+[*\$A<[DKQ.BO2+^D0
M\O&D/D]JOOB*5P.R3:<P7GM2R(_&\@6B5@>;\K8VG!),S?+5FYW ;3\/(]/1
MLR]K=VXN])#D2&2.3[L_M)G&NY06X3Y/I$7!UUN!5%<&>RFV1<0H8<"W$AF.
M[;CV<1Q2(6S%V-C-M^1D\KE2E@[D5Y^GU1)/@,; --IUKQQLW?UQYUJ&%XX#
MS4K[^AG0C7:/J,OZ[?!E>OT">R_M4N%6G-,"2X?1JVFO9M]VO"G#2V)N/-XE
MH9GA(4B6)^#[PAC?=MA ][2\^!=02P,$%     @ 4(185@Y:A(1] @  F 4
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M=3SZ=!R![>= OR'3A-[+#'$GAV7%HQ.M!_!Y:0SM-C[!,(S3%U!+ P04
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MX#0:GQ-!>QZ/CPTHLX;YX<SV^97+MLXUF:LK(!A<_BEM"$X!2)56%::^R0;
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MP@]1M""/*2L$/K-$S94C=2):=S']C@3-%!NVF X+BGVJQR_-)5*7#S^,E3+
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MX--(?2_UKAT,=%A3:'29IP'H:4Q-"ZM&/QJVRE*'O=G09$?M +1?*V5/"W?
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MJD.3."[LI=P;15\YX<QLGM.U,)&@!KIA6"A,N8$O4FLZ:3VP58ZZ/?$-N;(
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ML@;T?2VE.6RL@^87-?L+4$L#!!0    ( %"$6%;AV019C <  /\3   9
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M60?Z7TAISA,;8'R5U_\ 4$L#!!0    ( %"$6%9X@ C8W (  $ &   9
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M&/0<4,V\:@PCRWI&K*6AB5-O,QKQJ*P#W6\DE6-GV #MG\;L'U!+ P04
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M!O%&:2O^I;A.6^":Y03PUD$ZG0@#ZA$UV"4"/JU(A&3:&9QW$J288TA@0&A
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M2R:GZB(Z:F0=ZL:W:P.5"V?L:8?5PXMP-3;"'_#Q.?G =,.EH?1NR#2>3(L
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M(,<UKZ6[T]M/V/D9>;Y,2]L\8=OF)M<!9+5UNNS I* 4JGWSY^X<#@!7T0L
MU@%8H[LMU*A\SQV?3XW>@O'9Q.:#QFJ#)G%"^4NY=X:^"L*Y^1>MWF:U,:@<
M:%>@ 2EX*J1P BV</?!4HCV?AHYJ>428=;S+EI>]P!LSN-7*%18^J!SS?PE"
M$MDK97NE2W:2\3UF%Y#$ V 18R?XDMYYTO E+_"M^*XQ!USEL,@R4W-IX><B
MM<[0O_+KF.>6<7B<T??/Q%8\PUE #6+1/&$P?_,J'D?O3N@=]GJ'I]A/W]0Q
ML2?ICHM]*! R;LQ.J WP4M>^UAI._R0T&8 V88?<6$!_W4"7A65*B?L+:TZ9
M@A@$G;@'29H'=G(D\_^=&,Z$H@JZMD1BSREA369R2%%1Y*#J9H1.I=APW^QV
M (H&VIG2#H'%Y_ :XF00)8D/Q@,V9O"U\:$.G!UZ8J,!8Y? QH,D&1(HN2)0
M1,&0#4;78SAVG^%!%Y9H-LVLL9#Y4VP;LM_MQ]FB[>*_Z>TLO.5F(Y0%B6N"
M1A>7HP!,.U_:A=-5T].I=C0AFK"@D8S&)]#WM2;GW<(7Z(?\_ ]02P,$%
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M'.4P>@PZV+Q<<0#/<M?2 1'#8."-1P3MS%EH9O*'ISWUYTCIP4!N-AG7>F\
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M:<9+^3>=S<"/R[FQFOY(/_=5WV$/]V.[Y;HP#2MP$M#V&-3/&.3OWR59_/$
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MIZ)J$8>G$74Y7XF*)##S5+T*X%OPXA]_P./@EU.Z>P+KB!^VXH<N]/A37:R
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M-RGIA3OHX1!-!==+A2YY#/%+ -_D6B4<;A*>A$[$"XB.4 =_0F$0A@Z\3E7
M3H'7;<:S;\VIRD@$(\^\%@KD(WCC24Y9;(OW_AWN!5^:\CX M0GL!>=NQ;E;
MH'=VU&#3K4^-[?IU;;:C*PVI^MW$O-L"\^.*^;$+?5PK,"\5R*P"FUBZ<;H!
M>@8BE8-2KZ+4<T*=BS3+-4@$505M/95(](I(0'_0E'*:YFD32R?T@;7L5\3[
M+:J@WP+S0<5\\$8J<..$>T5P4C$Z^5\1D*==(G!"'UA*'-0&$+0H@S7X&Y/?
M<B_\1DK8 S38*P4<UJ1")];WQ+@HH"27G.K<=-^6-*%/]KJ9FQ/OT"+6#H8[
M;2J@#2?#M95AI]^\1@%NH']00.U2V&DOS4E?DSLAB1;FWU;]*['[#\(A1^RO
M:^UJN->F*-HP-EP[&W;:SVM$X08ZWB^*VK2PVVVFPO0>/<*21FP'&2? H56K
M/0R?M-GR-FPLK&TL=#K-*UJ^!\C1<G]KSDI!+HII4J%B5"I'KNIN-;&>E7-:
MO;T<=Z=$+BA7B$%B0H.COGG;93E!E@LMLF)JNQ/:S(#%Y=),W2#M!O,\$4)O
M%O: :HX?_P502P,$%     @ 4(185F4I79,N P  > T  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C0N>&ULM5==3]LP%/TK5B:A31HD3DO+1UN)PJ8A@8;X
MV!ZF/;C)36+AV)GM4MBOG^V$I)-:@Q!Y26S']_C<>V+?Z\E*R'M5 &CT6#*N
MID&A=744ABHIH"1J3U3 S9=,R))HTY5YJ"H))'5&)0OC*!J%):$\F$W<V)6<
M3<12,\KA2B*U+$LBG^; Q&H:X.!YX)KFA;8#X6Q2D1QN0-]55]+TPA8EI25P
M105'$K)I<(*/YGAL#=R,'Q16:JV-K"L+(>YMYSR=!I%E! P2;2&(>3W *3!F
MD0R//PUHT*YI#=?;S^A?G?/&F051<"K83YKJ8AH<!"B%C"R9OA:K;] XM&_Q
M$L&4>Z)5,S<*4+)46I2-L6%04EZ_R6,3B#4#/-IB$#<&L>-=+^18GA%-9A,I
M5DC:V0;--IRKSMJ0H]RJ<J.E^4J-G9[=U&H@D:$;FG.:T81P;8*5B"77E.>H
M$HPF%!3:15^4IB80D*([!=F2H0L3465MS[DF/*<+!NA$*= *?3P#32A3GR:A
M-CSM:F'2<)K7G.(MG'",+@77A4)?> KI_P"A<;#U,G[V<AY[$<\@V4,#_!G%
M41Q[\ 9MU 8.;[@%[]0) ]+\EXS8OTL5M%*;//7BV"UWI"J2P#0P>TJ!?(!@
MMO,!CZ)C#\MARW+HT =;6)Z;Z&644PV[S B5;E#IUX6Q0><:2O5[$_UA#_3W
M6_K[WB"?E$)J^M?%%U4@J4@W4?2#Q /T!$0J#Y]1RV?DA?HN4[!'0'+/1+Z)
MB=?\C<$:M^3&?6L][H'^04O_X#VT]H.\+/5A2^?0BW0K20J(D]*<;CNDK([1
M0A*>;MSA7J0WA@U'W?$=]:U[L\([>["6@/![2/\"RLO:X[AC%'NQK@P7,$DP
M-0G59OR-=+P0;PU:EW_PH'?9^TA-N,M-V)L[7BV['V7\LNQ=NL'^5'$+2<&%
M.=N?$'$AW,C'B_'6J'4I"(]ZU[V/-(6[/(6]>>35NOM1]K?K'JX5PZ9$RUW)
MKY"K9^NZN!UMKQ4G=3'=3:_O))=$YI0KQ" SIM'>V(@OZS*_[FA1N=)Z(;2I
M!UVS,%<CD':"^9X)H9\[=H'VLC7[!U!+ P04    " !0A%A6-*2[CD0"   /
M!0  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6RU5%%/VS 0_BN6)TU,
MVDB:%MA8&HF"IB%MJ*+:]C#MP74OR0G'#K;3PK_?V0E9D2AO>TGNG/N^^S[G
M['QG[)VK 3Q[:)1V<UY[WYXGB9,U-,(=FQ8T?2F-;82GU%:):RV(300U*LG2
M]#1I!&I>Y'%M:8O<=%ZAAJ5EKFL:81\7H,QNSB?\:>$6J]J'A:3(6U'!"OR/
M=FDI2T:6#3:@'1K-+)1S?C$Y7\Q"?2SXB;!S>S$+3M;&W(7D>C/G:1 $"J0/
M#()>6[@$I0(1R;@?./G8,@#WXR?V+]$[>5D+!Y=&_<*-K^?\(V<;*$6G_*W9
M?87!STG@DT:Y^&2[OO;LC#/9.6^: 4P*&M3]6SP,^[ 'F,P. +(!D$7=?:.H
M\DIX4>36[)@-U<06@F@UHDD<ZO!35M[25R2<+U;]SV"F9"NL-)8HA?:T6=)T
MVJ.N6&L42@3'/K ;8:T(N\B.KL +5.Y=GGA2$;@2.71<]!VS QV_"WO,TD_O
M699FZ7-X0N)'!]GH((M\LT-\<(4W9BM>4O(J,LS[N6N%A#FG@79@M\"+MV\F
MI^GG5W1-1UW3R#X]H.N&)O+BWS8NK=$42Z")]HX9RRYKH2M@J)^7H9;8*F"_
MOQ$AN_;0N#\O>9O^!V^ST=OLU3U?=(Y6G&/2-&O48CA@]QTZC'$+5I)/.M;L
M",?TQ6GI.TW2V"K<(=MBDB?;?77)WGR'JX)&J$+MF(*2,.GQV0EGMC]^?>)-
M&T=^;3P=H!C6=&.!#07TO33&/R7A%(UW8/$74$L#!!0    ( %"$6%:B2.]7
M!@0  !H7   9    >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;+5876_;-A3]
M*X16#"W01"3UG=D&FG##"K18D+3;P[ '1:9MH9+HD;3=_?M1'Y8LB1;B@GZ)
M1>J>0]Y#'>GFS@Z,?Q,;2B7XGF>%F%L;*;=WMBV2#<UC<<NVM%!W5HSGL51#
MOK;%EM-X68'RS,80^G8>IX6UF%5SCWPQ8SN9I05]Y$#L\CSF_]W3C!WF%K*.
M$T_I>B/+"7LQV\9K^DSEU^TC5R.[95FF.2U$R@K Z6IN?4!W!$4EH(KX,Z4'
M<7(-RE1>&/M6#CXNYQ8L=T0SFLB2(E8_>_I LZQD4OOXMR&UVC5+X.GUD?VW
M*GF5S$LLZ /+_DJ7<C.W0@LLZ2K>9?*)'7ZG34)>R9>P3%1_P:&.]=6*R4Y(
MEC=@-<[3HOZ-OS="G "0?P: &P > MPS *<!.*\%N W K92I4ZET(+&,%S/.
M#H"7T8JMO*C$K- J_;0HS_U9<G4W53BY(*F(UVM.UW%U#&P%GNB>%CL*WA(J
MXS03[\ -^/I,P-LW[\ ;D!;@RX;M1%PLQ<R6:@<ECYTTJ]W7J^$SJR$,/K-"
M;@3XM5C299_ 5EMO]X^/^[_'DXR$)K? 0>\!AAAK-O3P>CC2P,GKX7 B&Z<]
M#:?B<RX^C;\_J5#P4=)<_*/3O>9U];SER^-.;..$SBWU=A"4[ZFU^/DGY,-?
M=)J9)".&R'IZNJV>[A3[HE%/)U@-]"M@^7+<+X+ 14[HS^S]J1;C.,\-88@'
M<60<AX,HP&'8QO4R\-H,O,D,OK M2+*4%E*7Q"3VTE,W248,D?4T\UO-_"NY
MR#>IITDR8HBLIV?0ZAG\J(MJH'?RU/NAX[E#$XW#7!>AP!EX:!SF.$$$7;V%
MPG;[X>3V'RK["(!O/%T*D^!+S]PD&3%$UA,M:D6+KN2AR*2>)LF((;*>G@AV
MA1;\41<UR-,''WG0AV$P\)$N$$<H&AJ.: (#SXV@K[<2.BD7T:O,Y-\@J$UE
M$G[I\1ME(Z;8^M+A3CI\)4LUQ*9$-<E&3+'U1>T*9C19/TZZRAF;!2'L.\.O
MDR8P\+"#O:&IQG&.!T/?.V.JKDI%TV7JT50(W6#M-VH:?_$#8)*-F&+K:]?5
MQ\B[EJN,5L]&V8@IMKZH70&-)NO)25?YFF]5Z 5.-'25)A & 1Q5?9I #R+?
M=<[8JBM;T73=^H?<4*[-81)W\<F;9".FV/J:=;4R"J]E)Z.%M%$V8HJM+VI7
M2Z/)TG+23M&X;Q!ZZM^><&BG<2"*4.C :&BG<6#HH2B  SO9)TW#G/)UU7P5
M(&&[0M;]MW:V;?!^J-J:@_G[LO%;-2,[FKIK_#GFZ[00(*,K10EO ^5Q7C=B
MZX%DVZHU^<*D9'EUN:'QDO(R0-U?,2:/@W*!MAV^^!]02P,$%     @ 4(18
M5C;339US!   &Q0  !D   !X;"]W;W)K<VAE971S+W-H965T-C<N>&ULM9AM
M;ZLV%,>_BL6NIE:Z+9AGNB12FVS:7MRI:M?MQ;07#IPDZ +.;">Y]]O/&$((
M4+>-V)L$S#G'Y_S\P!]/#I1]Y1L @;[E6<&GQD:([9UI\G@#.>&W= N%?+*B
M+"="WK*UR;<,2**<\LRT+<LW<Y(6QFRBVA[9;$)W(DL+>&2([_*<L.\/D-'#
MU,#&L>$I76]$V6#.)ENRAF<0+]M')N_,)DJ2YE#PE!:(P6IJW..[!?9+!V7Q
M9PH'WKI&92E+2K^6-[\E4\,J,X(,8E&&(/)O#W/(LC*2S./?.JC1]%DZMJ^/
MT7]1Q<MBEH3#G&9_I8G83(W00 FLR"X33_3P*]0%>66\F&9<_:)#;6L9*-YQ
M0?/:66:0IT7U3[[5(%H.LM!A![MVL+L.[BL.3NW@O-?!K1U<1:8J17%8$$%F
M$T8/B)76,EIYH6 J;UE^6I3C_BR8?)I*/S&;TT(P"1\]D(P4,7!TM0!!THQ?
MHQOT\KQ 5Y^NT2>4%NB/#=UQ4B1\8@K9<^EOQG4O#U4O]BN]8!M]D1UM./JY
M2" Y#V#*E)N\[6/>#[8VX@+B6^3@S\BV;'L@H?G[W?& ^^+][I:F&J<9!4?%
M<UZ)]P1[*': 5HSFJ!F20RHV:*[F ##T]_V2J_9_AOA7\=WA^.7F<<>W)(:I
M(7<'#FP/QNS''[!O_33$;LQ@BY&"G7%U&ZZN+OKL(<TR2% 9-E5SF\0QW16"
MRRTKAG1/EAE<#^&LPOHJ;+EU[F<X\'#DR<'>MTD-V#EN%'KXW&ZA3?-""%X#
MP=-"N,_DYEZN;21?$RAFD*0"993S$DA!!2!OD$$5U6O5=F-;GF]W$ R8!5;8
M!>#U0-T$V(T:J[/*_*8R7U]9?S1E12 &R_%[>>+ P4X8=NH9L'-<.P@Z0[_0
MIG;AD 9-X8&V\)=BV9W9NV,3J_:2009!K[;("WS/ZR#HF_FV@^WNF&ISO)!
MV! (/SST\MV$NA@^(SD?AE"$O1IM/XPLU^FPZ-OAR/?"J M#F^Z%,*(&1O3&
M= #"BE/1Z&I+ODMQ)O$H::50#4Z(J+]XL6<%;FME5AB&#!W;B?PN!VVF%W+
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MPZ9-6K6*KMN+:2],<A"KCLUL ^VWG^U !B$P-.T-Q,[=_WYWCGWNK;EXECF
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MHXU:%[+GS8EAI0>5MP^Y-9O8ZIG:A?:.?2]7V4;0H.X25(TV:EW08]_5EL9
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MB]/+XD:+;7X ^"BT%FE^N0$6@30OX/.5$/KYQOQ =8:\^ =02P,$%     @
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MN1:CM!O,\[D0^FYB+U[E13O^"U!+ P04    " !0A%A6ER2*&.@%  "&,
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M#4=X-QQI3<K"%1SAM\$1UH%/)JLQ&V'%1M@ &^'=.T;Z8=IVL@(CW 2,\+N
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M0@FL<$GE-:N^0)//6//%C KS1%5M>SRV4%P*R;(&K"+(2%Z_\7VC0P?@!B\
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MG##2-3G:#2*E+L('P10%/,OL;N 1WD=?YX-HY(=-,,3!I<2*3O4.35:2Z1,
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M K8$Q[??W%!)TDR\58&?[V_ FU=OP2N0%N!AS;:"%(F8VE(1T_!V7)-X7Y'
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MWE5LDB&[5J>;:%&WW<)&:--[M$-[*8"T!N;]5@C]-+$-2-]P9O\"4$L#!!0
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ME"PKAVN@,7!MH-ZOF"H]U8T^+:F/TX+O4$L#!!0    ( %"$6%83V)=NG@P
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MR4(438/Z^=N\?C?6?M-LX"DOOFYV^^(_4$L#!!0    ( %"$6%:YQ^=K8@,
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M&7DM$%0!M\S6NCV@Z$;)U9E%7<$<EQ:.YV@9%^8$CH!+>"A5;8C2)+XEZ\Z
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MG(^I#-U.PC:P:MU,GZ6R-,N:94D?#]0N@<X+I>Q+X 9:]SE*_P!02P,$%
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M.?9.U@Y;3[2HK$G-A4;+L\,<'R60)@#W%T+H[<04:)^YY"]02P,$%     @
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M U>@KYN5-#-_8"EI#5Q1P9&$]=P[#\\6L8UW 3\H[-1HC*R37(@;._E4SKW
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M8/;7PIR(?F(;T?#?R?X"4$L#!!0    ( %"$6%8AJK]>&@(  ' $   9
M>&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;)U476_3,!3]*Y:1$$BL^>A64$DB
MK:T0/&RJ-@$/B <WN4FL^2/8[M+]>ZZ=-"I2UP=>8E_[GG//=8Z=]=H\V1;
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M=NC0,&WQ20#C$W"_UMH= V_3Z9$I_@)02P,$%     @ 4(185MO**S$0"@
MY',  !D   !X;"]W;W)K<VAE971S+W-H965T.3<N>&ULM=U?<Z)*&@;PK]+E
M3FUEJJ8BW8#B;&+5)/R'V4E-SNQ>;.T%T4ZD1L0#F$RV]L,O( '!%G7VR;DX
M$TWWKU%\0@.O</42)S_3!><9^14M5^GU8)%EZ\_#83I;\"A(+^,U7^6_>8R3
M*,CRA\G3,%TG/)B7G:+ED$G2:!@%X6HPO2J?NTNF5_$F6X8K?I>0=!-%0?)Z
MPY?QR_6 #MZ>^!X^+;+BB>'T:AT\\7N>_5C?)?FC8:W,PXBOTC!>D80_7@^^
MT,^^S(H.98M_A/PEW?F9%"_E(8Y_%@^<^?5 *I:(+_DL*X@@_^>9W_+ELI#R
MY?BS0@?UF$7'W9_?=+-\\?F+>0A2?ALO_QG.L\7U0!N0.7\,-LOL>_QB\^H%
MJ84WBY=I^7_R4K65!F2V2;,XJCKG2Q"%J^V_P:_JC=CIP"8'.K"J ^MVH <Z
MR%4'^=01E*J#TNE E0,=U*J#VNF@J <ZC*H.HVZ'0^_2N.HP/K6#5G70NB^:
M'>@PJ3I,3GV7J/2VYJ13UP2M5_;>VCZT6/1M==-R?0^W'ZSR4ZD'63"]2N(7
MDA3M<Z_XH?QHE_WS#V.X*E)XGR7Y;\.\7S:]7P0))[?!.LR");G0>1:$R_3C
MU3#+\:+)<%9!YA9B!R#*R-=XE2U28JSF?-X&AOE2U8O&WA;MAO6*)G^X)%3[
M1)C$&/EQKY.+#Q])6BQP*EB^VW[-W2POB41+C1Y6]'Y%Y[-+(I<*G1Q?)N.$
M96*LU$:BM_SDA=EY@Y[CC),/9%@MU>&%LT[7::V? MNGP])9L/,;*T? N*<S
MVO%U[!U9Q\$J_]QIU4(=5/Q^Y=LLRQ5Y^TD1O[16QN0Z_G+IR@=<X\]-F+U^
M(K?+($U)_$C^R#?EZ29Y)?=9//M)_N7G'8B3\2C]MV"I;[:Z(M:+&<3G=!W,
M^/4@GR*D/'GF@^E?_T)'TM]$ 49B.A(SD)B)Q"PD9B,Q!XFY2,Q#8CX(:Z57
MJ=.K].G3OV^B!YX4L2W^Z*?DO^6_HISV.N?F%(GI2,Q 8N864TNLV)EYGM*K
MX?-N^)##V4C,06(N$O.0F _"6N%3Z_"IO>'[(RYFS.LDGG$^3\EC$D>$_^+)
M+$QY$<FTW(#&ZV)G,R4/KX1'ZV7\RLN<?A"%M'>\<T.*Q'0D9B Q<XN-=D(J
MJYJB2)+4R>I^0THU59OLM;0%+64FR7L-'>0+<9&8A\1\$-8*V:@.V:@W9-^2
M>;@*\NEHM6N0\#GG$9]_(L_!<L,/):D7/3=)2$Q'8@82,T=['_O)9*+M?^PM
MY*CV_JATK$KE?YVT(8=UD9B'Q'P0UDK;N$[;N#=M-YO7AR#?:.4;M:<DB$3)
MZ@7.3182TY&8@<1,)&8A,1N).4C,16(>$O-!6"N@6AU0[5T/UVC(]"(Q'8D9
M2,Q$8A82LY&8@\1<).8A,1^$M=([J=,[Z=V\;C.:\/4FF2V"?"^QVLY^(L$F
M6\1)^!\^)T$4;U;9H8EM[P#G!AB)Z4C,0&(F$K.0F(W$'"3F(C$/B?F3O1T&
M19(Z.PRM=%*I.14J_=;.)KD(5]5SHM-)-Q6[>Z1089(J=_9@;ON'/S=P@E%E
ME79WFPSHH"94LZ":+7A#*)-51K7.GB1T6%>T]B4V4L>C]K >=%@?I;6SLE,V
M0-_CP$REMO;W]^);I:5W <Y.R_[ JBP8UH .:T(U"ZK9HG5QX-B+J*F2N_M-
M74%3><RHH*D'?3D^2FL'@C6!8">>BZL2L3.GRV+RP'<F?L>W*+UCG3O/@VHZ
M5#.@F@G5+*AF0S4'JKE0S:LT=?^/?/L/@(\:MAW9IO:%]IZ<GWX-?H71)LJW
M52<<^.RWSHXDM-8%JAE0S81J%E2SH9H#U5RHYD$U'Z6U<]M4O5#E78^"4F@U
M#%33H9H!U4RH9D$U&ZHY4,V%:AY4\U%:.\I-#0WM+Z(YZ9#HFB<SOLJ")U[.
MFZN'XHDSM(8&JNE0S:BTXC! /<N2+CL5:B9T3 NJV5#-@6HN5/.@FH_2VI%M
M*G)H?TF.496Q51O;;V6!FS"+T"H<J*9#-0.JF5#-@FHV5'.@F@O5/*CFH[1V
M9INZ'CI^WQDSM.P'JNE0S8!J)E2SH)H-U1RHYD(U#ZKY**T=Y:8"B/:6*$R_
M507E;Z7F\W9I^;$#R] *(*BF0S4#JIF5UCK9JFA,ZYSCLP3MJ#1253;I%)F+
M&DYDA8Z[9UZ@=3E0S8-J/DIKYZJIS:']Q3E?GGE2[&'67^%8)^&L_"+']BL<
MQ6[G-EGDHOC^9?WP8W&NL_[RJC!TT*H=J*9#-0.JF96FM<+$+K5Q-W2"=I1>
M[F=NO]U(NZ23;N2@E310S8-J/DIK?[V_J;=A_?4V^&]0]0]X;M*@F@[5#*AF
M5EKG:U2"4W:6H"6EFJ@2P!8UE9FHO #Z8ERHYD$U'Z6U$]=4[;#^JIWO/,WR
MS5J6SQJW.WX_5F&63QJ_W_\0SQ?[O;,#!2WI@6H&5#.AF@75;*CF0#47JGE0
MS4=I[>PV!4:,O>LQ' :M*8)J.E0SH)H)U2RH9D,U!ZJY4,V#:CY*:T>Y*3QB
M_85'W>+9,$TW^28Y+*YKEZ[Y+"OB/>-)%N1/%=OF?)+,G\-XDRY?2? 2)//M
M89]LP<EM'*V#U>NQ S_]2W1V^J'E2U#-@&IFI;6/TZA2=]_2$K13E)$B*=U)
ML<!3%#IFW2DQM)@(JGE0S4=I[2PVQ42LM\)A>L>3\EJ6JQDGVXOA%7-B<G%W
M<$H,K1Z":CI4,Z":"=4LJ&9#-0>JN5#-@VH^2FMGMZD>8NK[3HFAU4)038=J
M!E0SH9H%U6RHYD U%ZIY4,U':>TH-U5%[+P+_?1.B>\P4V)H?1)4TZ&: =7,
M2FM-=4?2WED943.%RJP[(=YO-I)5.NK.AZ&E0E#-@VH^2FL'L2D58OW7 *J#
M>'_P?&:_<'9PH-5 4,V :B94LZ":#=4<J.9"-0^J^2BMG=:F&HB][P6!&+0>
M"*KI4,V :B94LZ":#=4<J.9"-0^J^2BM'>6F (GU%R#]?X5]_?C908;6&$$U
M ZJ9E7:TL$_03ES8)VHH*NR#O@P7JGE0S4=I[1L<-%5&<G^5D5/L2>Y>ER%-
MXUD8%#40+V&V( %YV*1YGWS[.8NCAWSR6Y;['<E;_Z#GYDW>OX8,&\MCIK#.
MQT:'CFM -1.J62>_)S9T7 >JN5#-@VH^2FL'LRE&DG_O$D)'HP>M28)J.E0S
MH)I9:<<N4V9!1[4%HXJOR@4=UH5J'E3S45H[=TTAD=Q_I:+?O'17OWIV[*#U
M0U#-@&IFI>V6P3)MO[ 6.J@M&%1C^X6WT$%=J.9!-1^E;3,WW+GA7L23I_(V
MDL7\<;/*MC>XJY^M;U7YI;QA7^=YDWYVMS><;)CM_2^_!LE3F.\.+OEC3DJ7
MX_PO:+*]I>3V01:OR]OZ/<19%D?ECPL>S'E2-,A__QC'V=N#8H#ZQI[3_P%0
M2P,$%     @ 4(185C^Q/-<H!   (Q@  !D   !X;"]W;W)K<VAE971S+W-H
M965T.3@N>&ULM9EA;YLX&,>_BL5-ITW:"B:$)+TDTAINVJ3N5K6WVXO3O7#!
M"58!YVS3=-_^;* 0%V*%D_NF >/G;YX?V/S]='F@[(&G& OPE&<%7SFI$/M+
MU^5QBG/$+^@>%_+*EK(<"7G*=B[?,XR2*BC/7-_S0C='I'#6RZKMAJV7M!09
M*? - [S,<\1^7N&,'E8.=)X;;LDN%:K!72_W:(?OL/B^OV'RS&U5$I+C@A-:
M (:W*^<CO(S@0@54/?XB^,"/CH%*Y9[2!W7R)5DYGKHCG.%8* DD?Q[Q!F>9
M4I+W\6\CZK1CJL#CXV?U3U7R,IE[Q/&&9C]((M*5,W= @K>HS,0M/7S&34)3
MI1?3C%=_P:'N&RX<$)=<T+P)EG>0DZ+^14\-B*, &)X(\)L _V5 <")@T@1,
MS@T(FH"@(E.G4G&(D$#K):,'P%1OJ:8.*IA5M$R?%.JYWPDFKQ(9)]:WF M6
MQJ)DI-B!.$5LASGX /Y C"'U2,#;" M$,OY.MGZ_B\#;-^_ &T *\&=*2XZ*
MA"]=(>]$Z;EQ,^I5/:I_8E3H@Z^T$"D'OQ<)3G0!5Z;0YN$_YW'E&Q4C'%^
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MN<RQNB)=GPBZKVJT]U0(FE>'*48)9JJ#O+ZE5#R?J ':_PNL_P-02P,$%
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M:W-H965T<R]S:&5E=#$P,2YX;6S%6%UOVS84_2N$5@P)T$:BOBQGMH#::K$
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MRA5 /E\S)CYNU O:T\_%?U!+ P04    " !0A%A6-F(>KHP$  "L#@  &@
M 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&ULK9=-;^,V$(;_"J%N%QN@B47J
MTXEM(+%WT1R"!LEN>RAZH"7:$B*1+DG;V?WU'5*.XDBTFL->$DI^9S3/#(<?
MD[V03ZI@3*/GNN)JZA5:;RY'(Y45K*;J0FP8AU]60M94PZ-<C]1&,II;H[H:
M$=^/1S4MN3>;V'?W<C816UV5G-U+I+9U3>7W&U:)_=3#WLN+AW)=:/-B-)ML
MZ)H],OUM<R_A:=1ZR<N:<54*CB1;3;UK?+G @3&PBC]+ME='8V10ED(\F8?;
M?.KY)B)6L4P;%Q3^[=B<597Q!''\>W#JM=\TAL?C%^]?+#S +*EB<U']5>:Z
MF'JIAW*VHMM*/XC][^P %!E_F:B4_8OV!ZWOH6RKM*@/QA!!7?+F/WT^).+(
M ,<G#,C!@'0-PA,&P<$@>*]!># (;68:%)N'!=5T-I%BCZ11@S<SL,FTUH!?
M<E/W1RWAUQ+L].R69Z)FZ"M]9@J=H[G@2E1E3C7+T0/;"&D&]U+L2EMIF&CH
MC<FB7*V8!,U*BAH]:JJW6LCOZ $\H$\+IFE9J3/P_.UQ@3Y].$,?4,G1UT)L
M%>6YFHPT0)A01MDAX)LF8'(B8$S0G>"Z4.@SSUG^UL$(Z-L4D)<4W)!!CPN6
M7:  _X:(3X@CH/G[S;'#?/%^<W^ )F@+&EA_P?\6%&JCLDJHK63H[^NETA*:
M[!]7QAN/H=NC67DNU89F;.K!TJ*8W#%O]O$7'/M7KFS]3&>+G^3L32;#-I/A
MD/=9,\&I1K>R5 52[=R69FZ+%<+D(OH5?3)UO[3C*UO$9GSF2G3SP=A^T*S(
MNUGBCU,H^^XX@WT5":,T?JM:]%5A$D>X5;UACEKF:)#9MFW>]#37):V:OJ8U
M+ 3E#VJ7:B ON:9\72XKAJA23#O[N/E2=!3@>30.@BZM0Q9@0M(.KD-&R#AU
MX\8M;CR("UL'; RP^_ <"5TP"62V?334/C>U+V#?@->FY$[(N!=61,(X[# Z
M5)@D00>QK\(^"4]4-&D1D^&*0E]0F17H(ZTW5[ E[F"OW\#.K0VDX36%WKGI
M$D?28[]3FKE#!17LU'GA4&$2!FZZM*5+!^GNQ(Y9%MA4=K3:-C.45G"<H4#F
M8DK[<21)TD'JBP+LXPZ10Q2E)\HU;H'&@T"?H?4RK4R3907T&#-DIE G9^#8
MD7V_VV0.$>ZU6%^$_1,-AOW7\X4_"#1O*;9<LDRL>?D#6LL@+1EGJ]*]>!R\
M'@>3!F/2P7*H3/MUN!RJ<QPGY 3:T=$)#Z+=UK#W:%,J.*9E3PA6#CB.*SL'
MG4RX'T>:1'$7RB$;^VEWM7#)(ASY)ZC(*Q49I/K#K(/.\$G_@W'47>H<JCA-
MNK$[7 7!J<4 OYY]\."!X.7P8R87>S:U8'8MR.QQ5@NH$*QU?%OR-8*;D[25
M<D^_H+>[1N,0XRYL7Q9B .GB.F0)5+Z#.SHZQM=,KNUU2$'06ZZ;XVS[MKUR
M7=N+1N?]C;F*V>O!JYOF'G='Y;KD"E5L!2[]BP1*()NK4?.@Q<9>%I9"P]7#
M#@NX3C)I!/#[2@C]\F ^T%Y09_\!4$L#!!0    ( %"$6%84KU?1404  %49
M   :    >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6RU66UOVS80_BN$5PPM
MT%0B]9XY!MIX[0IL:-"DW6=&IFVBDNA2=)SLU^\H*Y(C,JPA.%]B2;X[W_/<
MZ?B0F>Z$_%&O&5/HOBRJ^F*R5FIS[GEUOF8EK=^)#:O@FZ60)55P*U=>O9&,
M+AJGLO"([\=>27DUF4V;9U=R-A5;5?"*74E4;\N2RH</K!"[BPF>/#[XRE=K
MI1]XL^F&KM@U4]\V5Q+NO"[*@I>LJKFHD&3+B\E[?#XG1#LT%M\YV]4'UTA#
MN17BA[[YO+B8^#HC5K!<Z1 4/N[8)2L*'0GR^-D&G72_J1T/KQ^C?VS  YA;
M6K-+4?S+%VI],4DG:,&6=%NHKV+W%VL!13I>+HJZ^8MVK:T_0?FV5J)LG2&#
MDE?[3WK?$G'@@,-G'$CK0(YU"%J'X%B'L'4(&V;V4!H>YE31V52*'9+:&J+I
MBX;,QAO@\TK7_5I)^):#GYI]KG)1,G1#[UF-SO0G^G.YA*+42"S1#2LW0D(_
MH#F'IY)5.9C=K*E"GZ!<Z"NO&5("7?-5Q9<\IY5"5T+JBC;^<P9.DBV:N._K
MFD%86BW0WYS>\H(K#M%>SYFBO*C?P,]_NYZCUZ_>H%>(5_ S8EN#=3WU%"#5
M^7IYB^K#'A5Y!M6<Y>]0@-\BXA-B<;\\WAU;W.?'N_M/W3TH3U<CTM6(-/&"
M9^.U+"I@L>BI.[<1LP\5VD/I*7)>;VC.+B8P)FHF[]AD]OMO./;_L-%TRF#S
M$P5[0F'041BXHL^N)$Q*J1[>HDVAFU0W(?NYY1L88<I&XSY<W(33L_-NAOV,
M)%/O[I ?BU46^_%3J[DSM9' PPYXZ 3^!6!3Q:L5DGH"GHGEV;9F9[1Y%VW
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M)]^^.[C](EE1OAPW9U*RK/RX(GA!N#90OR^9RD3U13=0O\$Y^Q]02P,$%
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M( Z3ZC^^K8WH-(#. PU0W0")#>P'&EAU ^NI#>RZ06FU44DI?? PP\L%30^
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M<$!H$<"_WZ0INS\H.FA>&UO^#U!+ P04    " !0A%A6@DU5-& #   4"@
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MX':"N57M':0=&%DU7?E)&NSQS>,.KVV@+ #7-U*:X\"^H+\()O\!4$L#!!0
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M@:8@M $^GW.NMC?Z!YK_1*;_ E!+ P04    " !0A%A6_3;5<7\"   1!@
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M+IH<'01$=PVHFUC5^!I>*HL=P0_7V+-!NP#<KY6RNXEK"\-?H/@'4$L#!!0
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M3(#>3SE7SPMSJE&?8D4_ 5!+ P04    " !0A%A6LVJZ&M<#  #%$@  &@
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M)0',+/WH2A!;L.9__H%'SE]MJ?<$5B/"JXCPNM#GN7ZVN7YX5!2=&&&UEKB
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MX09(",(8Z/6(<_4\,2<9U<G5_"=02P,$%     @ 4(185LP)-'B: @  F 8
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ME9N/T-8SM'J)Y+I^DDT;ZSDDJ;2119N,#@HFFC=]:M=A)\'W#R3X;8)?^VY
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M!FB"$-5,5+-0S48U!]5<5//TEI!FOU/])W^HYZ.K#5 M1+6(TN1&T.03=75
M\2:=YXMI$5<[!JLS@53SA^IK_YW+_5,)-*J(:B:J6:AFHYJ#:BZJ>:CFHUJ
M:B&J190FGZ2F22T:)TLM&FAJ$=5,5+-0S48U!]5<5/-0S4>U -5"5(LH3>X9
M36K1.$%JT=C-?>F=EAW%&_7&'=T(T$ BJMFHYJ":BVH>JOFH%J!:V/(V[[6\
MRR-JK7*)-ZE$0YU*#)-94E0?*:Y/]E=6<5G093T7:5GDZ]N/BZRJ[J*Z=_V-
MPX>LO*/\W6OU;AQ:[VA4$=4L5+-1S4$U%]4\5/-1+4"U$-4B2I.[0A-5-)2Q
MIFMK]CA-GX4X_+B!&CQZ#H F$%'-0C4;U1Q4<U'-0S4?U0)4"U$MHC2Y%30)
M1*-WLN,&9/;J!M5,5+-0S48U!]5<5/-0S4>U -5"5(LH3>X935C14(<5O\]Q
M@_[./&+0/H] TXFH9J&:C6H.JKFHYJ&:CVH!JH6H%E&:W B:$*.A#C%&\;=D
MMIAI\\7LB\@V#C,\EK?$>I+Q6N$/#CJ2<J/>EJ/K'LTMHIJ-:@ZJN:CFH9J/
M:@&JA:@649I<]TUNT5"?3_#GY2'"Y<&"?'7<X'<M2N95+VBM<#2+B&HFJEFH
M9J.:@VHNJGFHYJ-:@&HAJD64)O>!)HMH7)[LX &:2$0U$]4L5+-1S4$U%]4\
M5/-1+4"U$-4B2I-[1A-;--2QQ:UO.J[V)!ZS9"26APONXR33OL;3Q>K7TI&&
MY4SB<36^?2JQ6G5U,JCFP\CM:02:640U"]5L5'-0S44U#]5\5 M0+42UB-+D
MZXHUF<6N,M^T_3'D:E;15M=JY]B= 50S4<U"-1O5'%1S4<U#-1_5 E0+42VB
M-+D#- G$KGZJ"407/7LBJIFH9J&:C6H.JKFHYJ&:CVH!JH6H%E&:W#.:2&-7
M'6F\6WW$\%7D175^E'(^D*2M)T51.T=W #2^^,ICK"\ V%KM:%01U1Q4<U'-
M0S4?U0)4"U$MHC2YVC<N/GQ45+'^Y.%W[<-3G(VU<;G#\%-U]& 5:-YSO>6/
MZG4<W0G8*PVSEQIFKS7,7FR8O=HP>[EA]GK#[ 6'V2L.LY<<_A[IQ6Z37NSV
M3C9_(!-;-ZAFHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$:7+/:-*+775ZL9X_B&^/
M2;9J'(HI!'I>150S4<U"-1O5'%1S7WE[7.Z=>GGH=OBH%J!:B&H1I<D%WZ04
MN^J4XN$'#-#S+**:B6H6JMFHYJ":^\I[8_^!%@_=#A_5 E0+42VB-+G:FVQB
M5YU-_%26>9:,JHG ZI#!YWE25"E%O=M:\V@V$=5,5+-0S48U!]5<5/-0S4>U
M -5"5(LH3>X#33:Q>[)L8A?-)J*:B6H6JMFHYJ":BVH>JOFH%J!:B&H1I<D]
MH\DF=M79Q._RQ4;U.H_N%BM-^K:4WO)U*1-=K85J-JHYJ.:BFH=J/JH%J!:B
M6D1I4B/H-<G$GCJ9^&$\3JH=AWBZ\=W&]'MT!_6&'-L=:NW5L_2:Z&HM5+-1
MS4$U%]4\5/-1+4"U$-4B2I.[0Y-:[*G/F[AYYN7]AQNN6LL=326BFHEJ%JK9
MJ.:@FHMJ'JKYJ!:@6HAJ$:7)/<%H>H)QJL,-/33'B&HFJEFH9J.:@VHNJGFH
MYJ-:@&HAJD64)O>,)MO84V<;O\OA!O4ZC^X6:-81U2Q4LU'-0347U3Q4\VMM
M=\HISS@#=*TAJD64)O>!)L784R:>#IU/:+]K_TCG?Q/?Q&A1)&63&">9&!5I
MUMH&R,C6#:J9J&:AFHUJ#JJYJ.:AFH]J :J%J!91FMPLFOABKW^RB0::=D0U
M$]4L5+-1S4$U%]4\5/-1+4"U$-4B2I-[1I. [$$)2+5S= = $Y"H9J&:C6K.
M*Z^F;FBS=%Y,VE*++KHE'JKYJ!:@6HAJ$:7)]=YD('M_* /YYM/=YST'#= 4
M)*J9J&:AFHUJ#JJYJ.:AFH]J :J%J!91FMP)FA1D[V0IR!Z:@D0U$]4L5+-1
MS4$U%]4\5/-1+4"U$-4B2I-[1I."[*E3D+9T"L9\N0.Q6.Y 5!,(T3YQ0$..
MJ&;6VF#C"'6WRDS*!ZBMEL4NN_WMQ6QTVQQ4<U'-0S4?U0)4"U$MHC2I?/M-
M=K&OSBXJ=_[5)VI7R\=6,:J9J&:AFHUJ#JJYJ.:AFH]J :J%J!91FMP3FL1B
M_V3G6>RCB494,U'-0C4;U1Q4<U'-0S4?U0)4"U$MHC2Y9S2)QOX!YUFLS\Q>
MS@/$;XND>-:2>;EWL5AUB;28B$PK)O%\?='HG^HI@I:LSZJRC"M]OC.7EX1:
MQI9:#T"JM^7H+H)F'&OM<F-BH'>'Y[WAU@2B;3F]?ZYOG8'>1K?.0347U3Q4
M\U$M0+40U2)*DRN_R27VU;G$5V<0J\N^M=8QFCY$-1/5+%2S4<U!-1?5/%3S
M42U M1#5(DJ3>T*34>SW3C:#(.-9-ZAFHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$
M:7+/:***_0/.M/BGS2#0\"*JF;6V.3,P!OWSJ\'V#*)EN<[@?+@S@T #AZCF
MHIJ':CZJ!:@6HEI$:7+E-X'#OCJB=BNR^S2;+;^OM.H"U11">W.[+X"D]HZN
M7C1XB&H6JMFHYJ":BVH>JOFH%J!:B&H1I<F=H(DB]H<GFS>@H454,U'-0C4;
MU1Q4<U'-0S4?U0)4"U$MHC2Y9S2AQ;XRX/2' DAJ\NAF@*81:VTS6338"199
M+4OU=U)*-KIE#JJYJ.:AFH]J :J%J!91FER\37JP_^KUG??O^K\2/T)#A*AF
MHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$:5)/&#21Q$'G5).  1I91#43U2Q4LU'-
M0347U3Q4\U$M0+40U2)*DWM&$UD<J$^R^*=^>*#>EJ.["!IBK+57XT=MR[7%
MC]"M<U#-134/U7Q4"U M1+6(TN3*;X*' W7P\-49Q/[XD5H^NH[1&"&J6:AF
MHYJ#:BZJ>:CFHUJ :B&J190F]X0FDCCHGFP&@4864<U$-0O5;%1S4,U%-0_5
M?%0+4"U$M8C2Y)[11!8'RGC3GSR#((-;-ZAFUIHT,Q@,SOOZ]@RB93FC?S[L
M;<\@R*US4,U%-0_5?%0+4"U$M8C2Y,IO@H<#=?"PFBG4>P3E[L)=Z5<]()Z/
M->OV3OLESAY$6?WJF00:)T0U$]4L5+-1S4$U%]4\5/-1+4"U$-4B2I-[0Q--
M' Q.-I- 0XRH9J*:A6HVJCFHYJ*:AVH^J@6H%J):1&ERSVA"C /U^13O-B)(
M1:I]$=I#%L^KQO'*Q1C4[M$= 8THUMKFB?N' T/?CB6A*[51S4$U%]4\5/-1
M+4"U$-4B2EN5^D4^$:(PXR*^?C<3Y7[_C9A.<VV4+N8E7WTD\7*OEHG[LA7H
M;S\89Q<[]YOZ6UNO[K]HF.MWC_&#B,KI1#+/M:FX+\G.^;"LJ"QYF+S<*-+'
M]V?ZF?8E+8ITMOQQ(N*QR*H%RM_?IVFQOE&MX"G-?EUN]O7_ %!+ P04
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MW+T!CE+7]IK.1K_9SBF'SJ&C:&K*I;>W]-[^U,*OISMUX7<WA9^.#A=^Z,T
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M@6L#]7[%F'QJZ ':.YOH?U!+ P04    " !0A%A6<'\&#C8"  #"!   &@
M 'AL+W=O<FMS:&5E=',O<VAE970Q,C4N>&UL?51-CYLP$/TK%I6J5FIC(-FT
M2@$IV;3=/>PJ2M3V4/7@P #6&IO:)FS_??T!-)6RN8!G///FO6&&I!?R2=4
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MN0FL:D-5 T'W96-F186@67D9DVA#F J0][>4BM- /:!I!LY_ %!+ P04
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MK6=D^&*1*?N7[.I8SR%QJ;3(:S"N(&>\^J7?:A]: ']\ A#4@. 0,#P!"&M
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MS,F$J93<XKT@=[R^7^:@3B/0+,O5&?E,GJ81.3TY(R<DX^1[*BK%>**&KL;
M#+T;-T&,ZR#H*T'XE-P+KE-%;G@"R2Z!BXI:670C:TS?9(P@/B>!_XE0C]*.
M@";'P_T.>'0\W'M#3= >4F#Y@F,.Z>58;FJ;(K^N9TI+?$*_NW)?<_>ZN4U9
MN5(EBV'D8-U0()?@A!\_^ /O:U?>WI,L>B>RG9SVVISVWF(/;1I+EB4$[S;>
M7PVXA^[*7\TSL#RFBBY#ZGM?_,NAN]S.S*&;[PVHU]]UBSK< O1KO7;$]%LQ
M_?\2$XL"B&9K4.248^_ UXSEM,+'>=:EL'\8DS\(*-U3>.C6[_L' @^]Z,7
MZ^T)=+=*5@%R84N_(K&HN*Z?>6MMN\NU+:I[]C%VG;I)O-#4+>N>R47&%<EA
MCI3>^05&)NLV4$^T*&UAG F-9=8.4^R<((T#KL^%T)N)V:#MQ>$_4$L#!!0
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M9-^#>^^C</.>"MO_4H[_ %!+ P04    " !0A%A6EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( %"$6%8X<"L+[ @
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M^%:<=R9Z+TSU>^P77"^;WU98**>DS&=I3YCK98U'AS(NE[)@UZIYLSWK8$4
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M5>\.T+NKWAV@=U>].T#OKGIW@-Y=]>X O;N[V1N@=U>].T#OH7H/@-Y#]1X
MO8?J/0!Z#]5[ /0>JO< Z#U4[P'0>ZC> Z#W4+T'0.^A>@^ WL/%.@"]+?A<
M!^"W!1?L!(#@%ERR$P"&6W#13@ H;L%E.P'@N 47[@2 Y!9<NA, EEMP\4X
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M<',O87!P+GAM;%!+ 0(4 Q0    ( %"$6%;$C8+<[@   "L"   1
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M965T,BYX;6Q02P$"% ,4    " !0A%A6A3E,J"((  !M(P  &
M    @($J$0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M4(185L=#M%RD @  ;@<  !@              ("!@AD  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( %"$6%;<>G&(?08  )D;   8
M          " @5P<  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " !0A%A6!&9(DTL$  #3#@  &               @($/(P  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 4(185GS_6^//#@  F9H
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( %"$6%;N.MPQ.P@  ((4   9
M      " @:5V  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ 4(185AS?J3CP @  M@8  !D              ("!%W\  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !0A%A6T4K[/S@+  #Q'
M&0              @($^@@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( %"$6%:UJH\JGP@  /T7   9              " @:V-  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 4(185M_W1-\J
M!P  M1(  !D              ("!@Y8  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " !0A%A6ZXGM:*(#  "6"   &0
M@('DG0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( %"$
M6%;;CZ\>XP(  '<&   9              " @;VA  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ 4(185HV."R%U!   \PD  !D
M         ("!UZ0  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " !0A%A6M#6E($ #   P!P  &0              @(&#J0  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( %"$6%8ANEP^0PL  $@C
M   9              " @?JL  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ 4(185A1335\C!@  #!   !D              ("!=+@
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !0A%A6QF'Y
M$,H$  !<#   &0              @('.O@  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( %"$6%:HC&B7G@(   4&   9
M  " @<_#  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M4(185HA5E&K' P  50@  !D              ("!I,8  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " !0A%A65!-1+?L(  "O&0  &0
M            @(&BR@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( %"$6%91T4[&=@0  /L*   9              " @=33  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 4(185MRDN/*8#P
M'RX  !D              ("!@=@  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " !0A%A6&DM[!1H0   7.0  &0              @(%0
MZ   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %"$6%:_
M20CJX!   / W   9              " @:'X  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ 4(185K8MGFCM"   818  !D
M     ("!N D! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %"$6%8.6H2$?0(  )@%   9              "
M@2PC 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ 4(18
M5L,V3R44,   ':P  !D              ("!X"4! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " !0A%A61C%;Q,P$   Q"P  &0
M        @($K5@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( %"$6%9^Z&:%]0(  #<&   9              " @2Y; 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ 4(185A\ES@5Z P  ]P<
M !D              ("!6EX! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " !0A%A6-GM'$_T"  "N!@  &0              @($+8@$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( %"$6%;AV019
MC <  /\3   9              " @3]E 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ 4(185MPSS]2-!0  ^1@  !D
M ("! FT! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !0
MA%A6(G9AM(<"  "V!0  &0              @('&<@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( %"$6%;6<XY280,  *$'   9
M          " @81U 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#
M%     @ 4(185GB "-C< @  0 8  !D              ("!''D! 'AL+W=O
M<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " !0A%A6N'8[TOP#  !5
M"0  &0              @($O? $ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM
M;%!+ 0(4 Q0    ( %"$6%;E=Y8O3@,  #,'   9              " @6*
M 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ 4(185F>H
M>R2(!   /PL  !D              ("!YX,! 'AL+W=O<FMS:&5E=',O<VAE
M970T.2YX;6Q02P$"% ,4    " !0A%A6^P,YCS8#   4!P  &0
M    @(&FB $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M %"$6%87]<YX,P,  ),'   9              " @1., 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ 4(185F$6ZR:B @  \ 4  !D
M             ("!?8\! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " !0A%A6$8!*C,L"   "!P  &0              @(%6D@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( %"$6%8*LAL8X@@
M % 7   9              " @5B5 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ 4(185OLHZ]3."0  AB,  !D              ("!
M<9X! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " !0A%A6
MT\P:M6 '  #%$P  &0              @(%VJ $ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( %"$6%:HYSUJ2 0  #T+   9
M      " @0VP 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ 4(185KW88OCW P  #0L  !D              ("!C+0! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " !0A%A6N4%$J-P"   N!@
M&0              @(&ZN $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( %"$6%;6U?'IB@(  - %   9              " @<V[ 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 4(185NV^GT6G
M P  ;Q   !D              ("!CKX! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " !0A%A6+G8)-*L"  #Z!@  &0
M@(%LP@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( %"$
M6%8:HUQY7@,  -,/   9              " @4[% 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ 4(185F4I79,N P  > T  !D
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M=#8X+GAM;%!+ 0(4 Q0    ( %"$6%:H,/.W#@,  "()   9
M  " @3_< 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
M4(185@/Z6>-1!   *!4  !D              ("!A-\! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    " !0A%A6NA^%.#X$  !!%   &0
M            @($,Y $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( %"$6%;&OC.KSP4  $XF   9              " @8'H 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ 4(185H"YMS^E P
MD1   !D              ("!A^X! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    " !0A%A62;GTY,P$  !/%@  &0              @(%C
M\@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( %"$6%8Q
MSY<>:@,  '0/   9              " @6;W 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ 4(185I<DBACH!0  AC   !D
M     ("!!_L! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %"$6%;J.)H#8@(  +L%   9              "
M@:81 @!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ 4(18
M5@GV8#<!!   SA,  !D              ("!/Q0" 'AL+W=O<FMS:&5E=',O
M<VAE970X,BYX;6Q02P$"% ,4    " !0A%A68GT= @L&  "?-P  &0
M        @(%W& ( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0
M   ( %"$6%:XG9#*GP(  +,&   9              " @;D> @!X;"]W;W)K
M<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ 4(185D^*?JM8 P  ? H
M !D              ("!CR$" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q0
M2P$"% ,4    " !0A%A6& 'L01\$  !:$P  &0              @($>)0(
M>&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( %"$6%83V)=N
MG@P  "&R   9              " @70I @!X;"]W;W)K<VAE971S+W-H965T
M.#<N>&UL4$L! A0#%     @ 4(185KG'YVMB P  ) H  !D
M ("!238" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    " !0
MA%A6)\>X69("  ":!@  &0              @('B.0( >&PO=V]R:W-H965T
M<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( %"$6%;W(5:^$P4  (,;   9
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M970Y-"YX;6Q02P$"% ,4    " !0A%A6G.KY)H\"  "#!@  &0
M    @(&:3P( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    (
M %"$6%8AJK]>&@(  ' $   9              " @6!2 @!X;"]W;W)K<VAE
M971S+W-H965T.38N>&UL4$L! A0#%     @ 4(185MO**S$0"@  Y',  !D
M             ("!L50" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q02P$"
M% ,4    " !0A%A6/[$\UR@$   C&   &0              @('X7@( >&PO
M=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    ( %"$6%;4><=,? (
M , &   9              " @5=C @!X;"]W;W)K<VAE971S+W-H965T.3DN
M>&UL4$L! A0#%     @ 4(185@7D/BO% @  J@<  !H              ("!
M"F8" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%     @ 4(18
M5A7$UAZG P  $A(  !H              ("!!VD" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,#$N>&UL4$L! A0#%     @ 4(185K,U\-<4!0  "1T  !H
M         ("!YFP" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL4$L! A0#
M%     @ 4(185C9B'JZ,!   K X  !H              ("!,G(" 'AL+W=O
M<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @ 4(185A2O5]%1!0
M51D  !H              ("!]G8" 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N
M>&UL4$L! A0#%     @ 4(185DW.4./]!P  5C\  !H              ("!
M?WP" 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%     @ 4(18
M5CK=!#%C P  01   !H              ("!M(0" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,#8N>&UL4$L! A0#%     @ 4(185C&D(N/K P  ;@T  !H
M         ("!3X@" 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL4$L! A0#
M%     @ 4(185CJJK31>!P  S3D  !H              ("!<HP" 'AL+W=O
M<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @ 4(185G;)XP)^ @
M!08  !H              ("!")0" 'AL+W=O<FMS:&5E=',O<VAE970Q,#DN
M>&UL4$L! A0#%     @ 4(185N#:YH40!   <Q0  !H              ("!
MOI8" 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%     @ 4(18
M5FZ&]N%G!@  7B8  !H              ("!!IL" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,3$N>&UL4$L! A0#%     @ 4(185J.I7)5/!@  0B8  !H
M         ("!I:$" 'AL+W=O<FMS:&5E=',O<VAE970Q,3(N>&UL4$L! A0#
M%     @ 4(185H)-531@ P  % H  !H              ("!+*@" 'AL+W=O
M<FMS:&5E=',O<VAE970Q,3,N>&UL4$L! A0#%     @ 4(185E NF>5&!
M'Q$  !H              ("!Q*L" 'AL+W=O<FMS:&5E=',O<VAE970Q,30N
M>&UL4$L! A0#%     @ 4(185OTVU7%_ @  $08  !H              ("!
M0K " 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L! A0#%     @ 4(18
M5N+\9U^\ P  T1(  !H              ("!^;(" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,38N>&UL4$L! A0#%     @ 4(185K-JNAK7 P  Q1(  !H
M         ("![;8" 'AL+W=O<FMS:&5E=',O<VAE970Q,3<N>&UL4$L! A0#
M%     @ 4(185LP)-'B: @  F 8  !H              ("!_+H" 'AL+W=O
M<FMS:&5E=',O<VAE970Q,3@N>&UL4$L! A0#%     @ 4(185JL%-ZX^$0
M(1 ! !H              ("!SKT" 'AL+W=O<FMS:&5E=',O<VAE970Q,3DN
M>&UL4$L! A0#%     @ 4(185IC;D^/&!   PA0  !H              ("!
M1,\" 'AL+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L! A0#%     @ 4(18
M5LYGAQG3!P  D$T  !H              ("!0M0" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,C$N>&UL4$L! A0#%     @ 4(185@$JGJG1 P  R0T  !H
M         ("!3=P" 'AL+W=O<FMS:&5E=',O<VAE970Q,C(N>&UL4$L! A0#
M%     @ 4(185H)7B8MS!   T1,  !H              ("!5N " 'AL+W=O
M<FMS:&5E=',O<VAE970Q,C,N>&UL4$L! A0#%     @ 4(185IWI<,'- P
MOQ$  !H              ("! >4" 'AL+W=O<FMS:&5E=',O<VAE970Q,C0N
M>&UL4$L! A0#%     @ 4(185G!_!@XV @  P@0  !H              ("!
M!ND" 'AL+W=O<FMS:&5E=',O<VAE970Q,C4N>&UL4$L! A0#%     @ 4(18
M5K.*@"GP P  &!0  !H              ("!=.L" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,C8N>&UL4$L! A0#%     @ 4(185M H.>4/!   114  !H
M         ("!G.\" 'AL+W=O<FMS:&5E=',O<VAE970Q,C<N>&UL4$L! A0#
M%     @ 4(185HTP.VIG P  L0\  !H              ("!X_," 'AL+W=O
M<FMS:&5E=',O<VAE970Q,C@N>&UL4$L! A0#%     @ 4(185@C6;R@S P
M9PD  !H              ("!@O<" 'AL+W=O<FMS:&5E=',O<VAE970Q,CDN
M>&UL4$L! A0#%     @ 4(185MHN,UBG P  +PP  !H              ("!
M[?H" 'AL+W=O<FMS:&5E=',O<VAE970Q,S N>&UL4$L! A0#%     @ 4(18
M5JI1@[WK @  %P@  !H              ("!S/X" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,S$N>&UL4$L! A0#%     @ 4(185F=/D6>\ @  EP<  !H
M         ("![P$# 'AL+W=O<FMS:&5E=',O<VAE970Q,S(N>&UL4$L! A0#
M%     @ 4(185@:C:[[3!   #AL  !H              ("!XP0# 'AL+W=O
M<FMS:&5E=',O<VAE970Q,S,N>&UL4$L! A0#%     @ 4(185K]$;1]0 P
MLA0   T              ( ![@D# 'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" !0A%A6EXJ[',     3 @  "P              @ %I#0, 7W)E;',O+G)E
M;'-02P$"% ,4    " !0A%A6.' K"^P(  #J5@  #P              @ %2
M#@, >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 4(185A8KHMZ< P  _$T
M !H              ( !:Q<# 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ 4(185@AIZ3_" @  C4H  !,              ( !/QL#
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     (T C0#T)@  ,AX#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>341</ContextCount>
  <ElementCount>623</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>117</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Description of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Descriptionofbusiness</Role>
      <ShortName>Description of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies</Role>
      <ShortName>Summary of Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Disaggregation of Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenue</Role>
      <ShortName>Disaggregation of Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Contract Balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalances</Role>
      <ShortName>Contract Balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Allowances for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLosses</Role>
      <ShortName>Allowances for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Property, Plant and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</Role>
      <ShortName>Property, Plant and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilities</Role>
      <ShortName>Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Non-current Bank Credit Lines and Loan Facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities</Role>
      <ShortName>Non-current Bank Credit Lines and Loan Facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Non-current other liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Noncurrentotherliabilities</Role>
      <ShortName>Non-current other liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Business Segment and Geographical Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</Role>
      <ShortName>Business Segment and Geographical Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Net Income Per Ordinary Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</Role>
      <ShortName>Net Income Per Ordinary Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Summary of Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Summary of Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables</Role>
      <ShortName>Summary of Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Disaggregation of Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueTables</Role>
      <ShortName>Disaggregation of Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenue</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Contract Balances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalancesTables</Role>
      <ShortName>Contract Balances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ContractBalances</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Allowances for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLossesTables</Role>
      <ShortName>Allowances for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AllowancesforCreditLosses</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BusinessCombinations</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/FairValue</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Investments</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Property, Plant and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</Role>
      <ShortName>Property, Plant and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Goodwill</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IntangibleAssets</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesTables</Role>
      <ShortName>Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilities</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Non-current Bank Credit Lines and Loan Facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables</Role>
      <ShortName>Non-current Bank Credit Lines and Loan Facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Derivatives</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OperatingLeases</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Non-current other liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentotherliabilitiesTables</Role>
      <ShortName>Non-current other liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Noncurrentotherliabilities</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Restructuring charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesTables</Role>
      <ShortName>Restructuring charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IncomeTaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EmployeeBenefits</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Business Segment and Geographical Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables</Role>
      <ShortName>Business Segment and Geographical Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Net Income Per Ordinary Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables</Role>
      <ShortName>Net Income Per Ordinary Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Description of business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DescriptionofbusinessDetails</Role>
      <ShortName>Description of business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Descriptionofbusiness</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails</Role>
      <ShortName>Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails</Role>
      <ShortName>Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Summary of Significant accounting policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant accounting policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueDetails</Role>
      <ShortName>Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenueTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalancesDetails</Role>
      <ShortName>Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ContractBalancesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Contract Balances - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ContractBalancesNarrativeDetails</Role>
      <ShortName>Contract Balances - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Allowances for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLossesDetails</Role>
      <ShortName>Allowances for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AllowancesforCreditLossesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Fair value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairvalueNarrativeDetails</Role>
      <ShortName>Fair value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails</Role>
      <ShortName>Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Investments - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails</Role>
      <ShortName>Investments - Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Property, Plant and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails</Role>
      <ShortName>Property, Plant and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails</Role>
      <ShortName>Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Summary of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Future Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesDetails</Role>
      <ShortName>Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails</Role>
      <ShortName>Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails</Role>
      <ShortName>Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails</Role>
      <ShortName>Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Derivatives - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesNarrativeDetails</Role>
      <ShortName>Derivatives - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails</Role>
      <ShortName>Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Operating Leases - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails</Role>
      <ShortName>Operating Leases - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails</Role>
      <ShortName>Operating Leases Operating Leases - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Non-current other liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails</Role>
      <ShortName>Non-current other liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NoncurrentotherliabilitiesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapitalDetails</Role>
      <ShortName>Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ShareCapital</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Restructuring charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesNarrativeDetails</Role>
      <ShortName>Restructuring charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Restructuring charges - Restructuring Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails</Role>
      <ShortName>Restructuring charges - Restructuring Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Income Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails</Role>
      <ShortName>Income Taxes - Expected Expiry Dates of NOL's (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0000107 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0000108 - Disclosure - Employee Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails</Role>
      <ShortName>Employee Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0000109 - Disclosure - Employee Benefits - Summary of plan assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails</Role>
      <ShortName>Employee Benefits - Summary of plan assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0000110 - Disclosure - Employee Benefits - Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails</Role>
      <ShortName>Employee Benefits - Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0000111 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails</Role>
      <ShortName>Employee Benefits - Change in Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0000112 - Disclosure - Employee Benefits - Change in Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails</Role>
      <ShortName>Employee Benefits - Change in Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>0000113 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Employee Benefits - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>0000114 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails</Role>
      <ShortName>Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>0000115 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails</Role>
      <ShortName>Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>0000116 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails</Role>
      <ShortName>Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>0000117 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails</Role>
      <ShortName>Employee Benefits - Plan Asset Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>0000118 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails</Role>
      <ShortName>Employee Benefits - Annual Benefit Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>0000119 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>0000120 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>0000121 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>0000122 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>0000123 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>0000124 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>0000125 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographical Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>0000126 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>0000127 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>0000128 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>0000129 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>0000130 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>130</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>0000131 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>131</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>0000132 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</ParentRole>
      <Position>132</Position>
    </Report>
    <Report instance="iclr-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>0000133 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/RelatedParties</ParentRole>
      <Position>133</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" original="iclr-20221231.htm">iclr-20221231.htm</File>
    <File>exhibit121-2022.htm</File>
    <File>exhibit122-2022.htm</File>
    <File>exhibit22-2022.htm</File>
    <File>exhibit231-2022.htm</File>
    <File>exhibit25-2022.htm</File>
    <File>iclr-20221231.xsd</File>
    <File>iclr-20221231_cal.xml</File>
    <File>iclr-20221231_def.xml</File>
    <File>iclr-20221231_lab.xml</File>
    <File>iclr-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iclr-20221231_g1.jpg</File>
    <File>iclr-20221231_g10.jpg</File>
    <File>iclr-20221231_g11.jpg</File>
    <File>iclr-20221231_g2.jpg</File>
    <File>iclr-20221231_g3.jpg</File>
    <File>iclr-20221231_g4.jpg</File>
    <File>iclr-20221231_g5.jpg</File>
    <File>iclr-20221231_g6.jpg</File>
    <File>iclr-20221231_g7.jpg</File>
    <File>iclr-20221231_g8.jpg</File>
    <File>iclr-20221231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1502">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>162
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iclr-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 40,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1502,
    "http://xbrl.sec.gov/dei/2022": 47
   },
   "contextCount": 341,
   "dts": {
    "calculationLink": {
     "local": [
      "iclr-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iclr-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iclr-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iclr-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iclr-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iclr-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 938,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 6
   },
   "keyCustom": 98,
   "keyStandard": 525,
   "memberCustom": 60,
   "memberStandard": 54,
   "nsprefix": "iclr",
   "nsuri": "http://www.iconplc.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.iconplc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Summary of Significant accounting policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies",
     "shortName": "Summary of Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Restructuring charges - Restructuring Provision (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails",
     "shortName": "Restructuring charges - Restructuring Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Components of Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails",
     "shortName": "Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0f29ad522a3c4db2af1974c2d81a85e6_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
     "shortName": "Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i243aa952befc42c99e33d30e034ad490_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9c028363c21c48d5bdb88ba826d38299_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "if733533a187d46cfb46437f0574bd48b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Employee Benefits - Narrative (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
     "shortName": "Employee Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "if733533a187d46cfb46437f0574bd48b_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia4f00760e31240959ce3972bf544992d_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - Employee Benefits - Summary of plan assets and liabilities (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails",
     "shortName": "Employee Benefits - Summary of plan assets and liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia4f00760e31240959ce3972bf544992d_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Disaggregation of Revenue",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.iconplc.com/role/DisaggregationofRevenue",
     "shortName": "Disaggregation of Revenue",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i825154864e984f849f9034999b633fbe_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Employee Benefits - Funded Status (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
     "shortName": "Employee Benefits - Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i825154864e984f849f9034999b633fbe_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i8e37e3b18efc4c54890a23af49e0fa65_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
     "shortName": "Employee Benefits - Change in Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i8e37e3b18efc4c54890a23af49e0fa65_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Employee Benefits - Change in Plan Assets (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
     "shortName": "Employee Benefits - Change in Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Employee Benefits - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ie835ce8081ec4f4ca739bd71e6565c20_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
     "shortName": "Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i825154864e984f849f9034999b633fbe_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
     "shortName": "Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i825154864e984f849f9034999b633fbe_I20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0bc40275d8744c9793904bf596955616_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
     "shortName": "Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0bc40275d8744c9793904bf596955616_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9862be84bb6f492bb811a70c03726aeb_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
     "shortName": "Employee Benefits - Plan Asset Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9862be84bb6f492bb811a70c03726aeb_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0784352491d144cd972226c028844591_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
     "shortName": "Employee Benefits - Annual Benefit Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0784352491d144cd972226c028844591_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Contract Balances",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.iconplc.com/role/ContractBalances",
     "shortName": "Contract Balances",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i940aa8c093bc4589896acef14854ea63_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i7c67eb08e5524f1389812b02c4f529e7_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000121 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000122 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i50c7dd932b404320af63f5c9a2cf9cd5_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000123 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i50c7dd932b404320af63f5c9a2cf9cd5_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000124 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000125 - Disclosure - Business Segment and Geographical Information - Narrative (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
     "shortName": "Business Segment and Geographical Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000126 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
     "shortName": "Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000127 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
     "shortName": "Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000128 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
     "shortName": "Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000129 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Allowances for Credit Losses",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.iconplc.com/role/AllowancesforCreditLosses",
     "shortName": "Allowances for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000130 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000131 - Disclosure - Accumulated Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "131",
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R132": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000132 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "132",
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaidNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R133": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "iclr:EquityMethodInvestmentMajorityOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000133 - Disclosure - Related Parties (Details)",
     "menuCat": "Details",
     "order": "133",
     "role": "http://www.iconplc.com/role/RelatedPartiesDetails",
     "shortName": "Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i45448a33be2443fd93dedd1a7d14df2a_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Business Combinations",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.iconplc.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Fair Value",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.iconplc.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.iconplc.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Property, Plant and Equipment, net",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnet",
     "shortName": "Property, Plant and Equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Goodwill",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.iconplc.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Intangible Assets",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.iconplc.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.iconplc.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Other Liabilities",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.iconplc.com/role/OtherLiabilities",
     "shortName": "Other Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Non-current Bank Credit Lines and Loan Facilities",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities",
     "shortName": "Non-current Bank Credit Lines and Loan Facilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Derivatives",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.iconplc.com/role/Derivatives",
     "shortName": "Derivatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Operating Leases",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.iconplc.com/role/OperatingLeases",
     "shortName": "Operating Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Non-current other liabilities",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.iconplc.com/role/Noncurrentotherliabilities",
     "shortName": "Non-current other liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.iconplc.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Share Capital",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.iconplc.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Restructuring Charges",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.iconplc.com/role/RestructuringCharges",
     "shortName": "Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.iconplc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Employee Benefits",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.iconplc.com/role/EmployeeBenefits",
     "shortName": "Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Business Segment and Geographical Information",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation",
     "shortName": "Business Segment and Geographical Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Net Income Per Ordinary Share",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShare",
     "shortName": "Net Income Per Ordinary Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Accumulated Other Comprehensive Income",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome",
     "shortName": "Accumulated Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation",
     "shortName": "Supplemental Disclosure of Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Related Parties",
     "menuCat": "Notes",
     "order": "35",
     "role": "http://www.iconplc.com/role/RelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "36",
     "role": "http://www.iconplc.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Summary of Significant accounting policies (Policies)",
     "menuCat": "Policies",
     "order": "37",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies",
     "shortName": "Summary of Significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Summary of Significant accounting policies (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables",
     "shortName": "Summary of Significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Disaggregation of Revenue (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueTables",
     "shortName": "Disaggregation of Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Contract Balances (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.iconplc.com/role/ContractBalancesTables",
     "shortName": "Contract Balances (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Allowances for Credit Losses (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.iconplc.com/role/AllowancesforCreditLossesTables",
     "shortName": "Allowances for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Business Combinations (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.iconplc.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Fair Value (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.iconplc.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.iconplc.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Property, Plant and Equipment, net (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables",
     "shortName": "Property, Plant and Equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.iconplc.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.iconplc.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Other Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://www.iconplc.com/role/OtherLiabilitiesTables",
     "shortName": "Other Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Non-current Bank Credit Lines and Loan Facilities (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables",
     "shortName": "Non-current Bank Credit Lines and Loan Facilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Derivatives (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://www.iconplc.com/role/DerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Operating Leases (Tables)",
     "menuCat": "Tables",
     "order": "51",
     "role": "http://www.iconplc.com/role/OperatingLeasesTables",
     "shortName": "Operating Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Non-current other liabilities (Tables)",
     "menuCat": "Tables",
     "order": "52",
     "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables",
     "shortName": "Non-current other liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Restructuring charges (Tables)",
     "menuCat": "Tables",
     "order": "53",
     "role": "http://www.iconplc.com/role/RestructuringchargesTables",
     "shortName": "Restructuring charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "54",
     "role": "http://www.iconplc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Employee Benefits (Tables)",
     "menuCat": "Tables",
     "order": "55",
     "role": "http://www.iconplc.com/role/EmployeeBenefitsTables",
     "shortName": "Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "menuCat": "Tables",
     "order": "56",
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Business Segment and Geographical Information (Tables)",
     "menuCat": "Tables",
     "order": "57",
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables",
     "shortName": "Business Segment and Geographical Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Net Income Per Ordinary Share (Tables)",
     "menuCat": "Tables",
     "order": "58",
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables",
     "shortName": "Net Income Per Ordinary Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Accumulated Other Comprehensive Income (Tables)",
     "menuCat": "Tables",
     "order": "59",
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables",
     "shortName": "Accumulated Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)",
     "menuCat": "Tables",
     "order": "60",
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityNumberOfEmployees",
      "reportCount": 1,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Description of business (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.iconplc.com/role/DescriptionofbusinessDetails",
     "shortName": "Description of business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iclr:NumberOfLocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "location",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails",
     "shortName": "Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails",
     "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i423bdb53508049b790b135a49d542ab9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
     "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Summary of Significant accounting policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails",
     "shortName": "Summary of Significant accounting policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueDetails",
     "shortName": "Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i8b703a470aec45d6b7cc535d913a035b_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Contract Balances (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.iconplc.com/role/ContractBalancesDetails",
     "shortName": "Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BilledContractReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Contract Balances - Narrative (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.iconplc.com/role/ContractBalancesNarrativeDetails",
     "shortName": "Contract Balances - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Allowances for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.iconplc.com/role/AllowancesforCreditLossesDetails",
     "shortName": "Allowances for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:AllowanceForDoubtfulAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ib7e5ed959ca1442c959fca1bf9fa7721_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ib7e5ed959ca1442c959fca1bf9fa7721_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "id34237e03be942cc9cc2d0552e1de455_I20210701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityNumberOfEmployees",
      "reportCount": 1,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
     "shortName": "Business Combinations - Narrative, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9351c9d02ef249de88d6a39e2bdb6b06_I20210701",
      "decimals": "INF",
      "lang": "en-US",
      "name": "iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
     "shortName": "Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
     "shortName": "Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9351c9d02ef249de88d6a39e2bdb6b06_I20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9351c9d02ef249de88d6a39e2bdb6b06_I20210701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
     "shortName": "Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i050bc2a0894b4b519c23ad5dce7c546e_D20210701-20210701",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
     "shortName": "Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Fair value - Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.iconplc.com/role/FairvalueNarrativeDetails",
     "shortName": "Fair value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9eac6e85f2054a39b9b4982e267fcdef_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
     "shortName": "Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Investments - Narrative (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Investments - Equity Method Investments (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
     "shortName": "Investments - Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Property, Plant and Equipment, net (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails",
     "shortName": "Property, Plant and Equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Goodwill - Schedule of Goodwill (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails",
     "shortName": "Goodwill - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Goodwill - Narrative (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.iconplc.com/role/GoodwillNarrativeDetails",
     "shortName": "Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
     "shortName": "Intangible Assets - Summary of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i423bdb53508049b790b135a49d542ab9_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Intangible Assets - Narrative (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
     "shortName": "Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails",
     "shortName": "Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Other Liabilities (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.iconplc.com/role/OtherLiabilitiesDetails",
     "shortName": "Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails",
     "shortName": "Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
     "shortName": "Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails",
     "shortName": "Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails",
     "shortName": "Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Description of business",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.iconplc.com/role/Descriptionofbusiness",
     "shortName": "Description of business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Derivatives - Narrative (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.iconplc.com/role/DerivativesNarrativeDetails",
     "shortName": "Derivatives - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "if27a87a7700d4f5fa4a149e379b8f150_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
     "shortName": "Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "if27a87a7700d4f5fa4a149e379b8f150_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Operating Leases - Lease Costs (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails",
     "shortName": "Operating Leases - Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Operating Leases Operating Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
     "shortName": "Operating Leases Operating Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails",
     "shortName": "Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Non-current other liabilities (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails",
     "shortName": "Non-current other liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iclr:NumberOfVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Share Capital (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.iconplc.com/role/ShareCapitalDetails",
     "shortName": "Share Capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "iclr:NumberOfVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Restructuring charges - Narrative (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
     "shortName": "Restructuring charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "iclr-20221231.htm",
      "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 117,
   "tag": {
    "country_CH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND",
        "terseLabel": "Switzerland"
       }
      }
     },
     "localname": "CH",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filler Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees",
        "terseLabel": "Number of employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well Known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r941",
      "r942",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "iclr_A2013LegacyPRAPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2013 Legacy PRA Plan",
        "label": "2013 Legacy PRA Plan [Member]",
        "terseLabel": "2013 Legacy PRA Plan"
       }
      }
     },
     "localname": "A2013LegacyPRAPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_A2021RestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Restructuring Plan",
        "label": "2021 Restructuring Plan [Member]",
        "terseLabel": "2021 Restructuring Plan"
       }
      }
     },
     "localname": "A2021RestructuringPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AccountsReceivableCreditLossExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Credit Loss Expense",
        "label": "Accounts Receivable, Credit Loss Expense",
        "terseLabel": "Amounts provided during the year"
       }
      }
     },
     "localname": "AccountsReceivableCreditLossExpense",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AccountsReceivableCreditLossReversal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Credit Loss Reversal",
        "label": "Accounts Receivable, Credit Loss Reversal",
        "negatedLabel": "Amounts released during the year"
       }
      }
     },
     "localname": "AccountsReceivableCreditLossReversal",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income Loss [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax",
        "label": "Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax",
        "terseLabel": "Amortization of loss on cash flow hedge"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AcquiredEntityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Entity",
        "label": "Acquired Entity [Member]",
        "terseLabel": "Acquired entity"
       }
      }
     },
     "localname": "AcquiredEntityMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax",
        "label": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax",
        "negatedTerseLabel": "Loss on cash flow hedge"
       }
      }
     },
     "localname": "AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AdjustmentToRetainedEarningShareRepurchaseCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to Retained Earning Share Repurchase costs",
        "label": "Adjustment to Retained Earning Share Repurchase costs",
        "negatedLabel": "Share repurchase costs"
       }
      }
     },
     "localname": "AdjustmentToRetainedEarningShareRepurchaseCosts",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Payments Netted Against Unbilled Contracts Receivable",
        "label": "Advance Payments Netted Against Unbilled Contracts Receivable",
        "terseLabel": "Net balance"
       }
      }
     },
     "localname": "AdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AfimmuneLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Afimmune Limited",
        "label": "Afimmune Limited [Member]",
        "terseLabel": "Afimmune Limited"
       }
      }
     },
     "localname": "AfimmuneLimitedMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments",
        "label": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments",
        "terseLabel": "Foreign exchange"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_AllowanceForDoubtfulAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Doubtful Accounts, Table",
        "label": "Allowance for Doubtful Accounts [Table Text Block]",
        "terseLabel": "Schedule of Provision for Credit Losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_AllowanceForDoubtfulAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Doubtful Accounts [Text Block]",
        "label": "Allowance For Doubtful Accounts [Text Block]",
        "terseLabel": "Allowances for Credit Losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_AptivSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aptiv Solutions [Member]",
        "label": "Aptiv Solutions [Member]",
        "terseLabel": "Aptiv Solutions"
       }
      }
     },
     "localname": "AptivSolutionsMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AptivSolutionsPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aptiv Solutions Pension Plan",
        "label": "Aptiv Solutions Pension Plan [Member]",
        "terseLabel": "Aptiv Solutions pension plan"
       }
      }
     },
     "localname": "AptivSolutionsPensionPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.iconplc.com/20221231",
     "xbrltype": "stringItemType"
    },
    "iclr_AwardDateAllYearsExcluding2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award Date, Prior to 2018 [Member]",
        "label": "Award Date, All Years Excluding 2018 [Member]",
        "terseLabel": "Award date, prior to 2018"
       }
      }
     },
     "localname": "AwardDateAllYearsExcluding2018Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held",
        "label": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held",
        "terseLabel": "Business acquisition, share price (in USD per share)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date",
        "label": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date",
        "terseLabel": "Payments to settle debt obligations that existed prior to acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders",
        "label": "Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held",
        "terseLabel": "Business acquisition, number of shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iclr_BusinessCombinationIntegrationRelatedCostsCredits": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Integration Related Costs (Credits)",
        "label": "Business Combination, Integration Related Costs (Credits)",
        "terseLabel": "Transaction and integration related (Note 6)"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCostsCredits",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue",
        "terseLabel": "Accounts receivable and unbilled revenue"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities",
        "terseLabel": "Non-current deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities",
        "terseLabel": "Non-current portion of operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current",
        "negatedTerseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability",
        "negatedLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability",
        "negatedLabel": "Non-current portion of operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_BuybackProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Buyback Program [Member]",
        "label": "Buyback Program [Member]",
        "terseLabel": "Buyback program"
       }
      }
     },
     "localname": "BuybackProgramMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_CapitalGovernmentGrantsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Government Grants Current",
        "label": "Capital Government Grants Current",
        "terseLabel": "Short term government grants"
       }
      }
     },
     "localname": "CapitalGovernmentGrantsCurrent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable",
        "terseLabel": "Increase in advance payments netted against unbilled contracts receivable",
        "totalLabel": "Change in advance payments netted against unbilled contracts receivable"
       }
      }
     },
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails",
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent",
        "terseLabel": "Change in advance payments netted against unbilled contracts receivable (in percent)"
       }
      }
     },
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_Clients1125Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clients 11-25 [Member]",
        "label": "Clients 11-25 [Member]",
        "terseLabel": "Clients 11-25"
       }
      }
     },
     "localname": "Clients1125Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Clients25Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clients 2-5 [Member]",
        "label": "Clients 2-5 [Member]",
        "terseLabel": "Clients 2-5"
       }
      }
     },
     "localname": "Clients25Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Clients610Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clients 6-10 [Member]",
        "label": "Clients 6-10 [Member]",
        "terseLabel": "Clients 6-10"
       }
      }
     },
     "localname": "Clients610Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_CommitmentToAcquireLongTermInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment To Acquire Long-Term Investments",
        "label": "Commitment To Acquire Long-Term Investments",
        "terseLabel": "Commitment to acquire future long-term investments"
       }
      }
     },
     "localname": "CommitmentToAcquireLongTermInvestments",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Line Items]"
       }
      }
     },
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Table]"
       }
      }
     },
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureTable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ComputerEquipmentAndCapitalizedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Capitalized Software [Member]",
        "label": "Computer Equipment and Capitalized Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndCapitalizedSoftwareMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultants Restricted Stock Units Twenty Nineteen [Member]",
        "label": "Consultants Restricted Stock Units Twenty Nineteen [Member]",
        "terseLabel": "Consultants Restricted Stock Units 2019"
       }
      }
     },
     "localname": "ConsultantsRestrictedStockUnitsTwentyNineteenMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ConsultantsStockPlan2008PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultants Stock Plan, 2008 Plan [Member]",
        "label": "Consultants Stock Plan, 2008 Plan [Member]",
        "terseLabel": "Consultants Stock Plan, 2008 Plan"
       }
      }
     },
     "localname": "ConsultantsStockPlan2008PlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ContractsReceivableGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": 1.0,
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable",
        "label": "Contracts Receivable, Gross",
        "totalLabel": "Accounts receivable (net)"
       }
      }
     },
     "localname": "ContractsReceivableGross",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ContractsReceivableNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Net",
        "label": "Contracts Receivable, Net",
        "totalLabel": "Accounts receivable and unbilled revenue, net"
       }
      }
     },
     "localname": "ContractsReceivableNet",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_CorvusPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corvus Pharmaceuticals",
        "label": "Corvus Pharmaceuticals [Member]",
        "terseLabel": "Corvus Pharmaceuticals"
       }
      }
     },
     "localname": "CorvusPharmaceuticalsMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_DSBiopharmaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Biopharma Limited [Member]",
        "label": "DS Biopharma Limited [Member]",
        "terseLabel": "DS Biopharma Limited"
       }
      }
     },
     "localname": "DSBiopharmaLimitedMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements",
        "label": "Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements",
        "terseLabel": "Debt securities, available for sale, cumulative amount advanced under subscription agreements"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetContractWithCustomerLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Contract With Customer, Liability",
        "label": "Deferred Tax Asset, Contract With Customer, Liability",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetContractWithCustomerLiability",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration",
        "label": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration",
        "terseLabel": "Ireland subsidiaries additional tax credit carryforward for income tax"
       }
      }
     },
     "localname": "DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards",
        "label": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards",
        "terseLabel": "Operating loss and tax credits carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost",
        "label": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost",
        "negatedLabel": "Actuarial (gain)/loss - benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period",
        "terseLabel": "Pension plan period"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers",
        "terseLabel": "Benefits paid and transferred balances"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers",
        "terseLabel": "Benefits paid and transferred balances"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DefinedBenefitPlanSchemeContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Scheme Contributions",
        "label": "Defined Benefit Plan, Scheme Contributions",
        "terseLabel": "Scheme contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanSchemeContributions",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_DerivativeVariableInterestRateReferenceRateInExcessOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Variable Interest Rate, Reference Rate In Excess Of",
        "label": "Derivative, Variable Interest Rate, Reference Rate In Excess Of",
        "terseLabel": "Derivative, variable interest rate, reference rate in excess of"
       }
      }
     },
     "localname": "DerivativeVariableInterestRateReferenceRateInExcessOf",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Financing Cost",
        "label": "Disclosure Of Detailed Information About Financing Cost [Table Text Block]",
        "terseLabel": "Schedule of Financing Cost"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_DiversifiedBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diversified Bonds",
        "label": "Diversified Bonds [Member]",
        "terseLabel": "Diversified Bonds"
       }
      }
     },
     "localname": "DiversifiedBondsMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_EmployeeStockPlanTwentyZeroEightPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Plan, 2008 Plan [Member]",
        "label": "Employee Stock Plan, 2008 Plan [Member]",
        "terseLabel": "Employee Stock Plan, 2008 Plan"
       }
      }
     },
     "localname": "EmployeeStockPlanTwentyZeroEightPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_EquityMethodInvestmentDecreaseInLoanReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Decrease In Loan Receivable",
        "label": "Equity Method Investment, Decrease In Loan Receivable",
        "terseLabel": "Equity method investment, decrease in loan receivable"
       }
      }
     },
     "localname": "EquityMethodInvestmentDecreaseInLoanReceivable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_EquityMethodInvestmentMajorityOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Majority Ownership Percentage",
        "label": "Equity Method Investment, Majority Ownership Percentage",
        "terseLabel": "Majority investor, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentMajorityOwnershipPercentage",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company",
        "label": "Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company",
        "terseLabel": "Period majority voting share capital can be sold to the company"
       }
      }
     },
     "localname": "EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_ExpectedRetirementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected Retirement period",
        "label": "Expected Retirement period",
        "terseLabel": "Retirement period used as a basis to estimate expected cash flows"
       }
      }
     },
     "localname": "ExpectedRetirementPeriod",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Intangible Assets, Amortization Expense, Net",
        "label": "Finite Lived Intangible Assets, Amortization Expense, Net",
        "totalLabel": "Finite lived intangible assets, amortization expense, net, total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNet",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ForeignCurrencyDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Disclosure",
        "label": "Foreign Currency Disclosure [Table Text Block]",
        "terseLabel": "Adjustments resulting from foreign currency translations"
       }
      }
     },
     "localname": "ForeignCurrencyDisclosureTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_GainLossOnIssuanceOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Issuance Of Debt",
        "label": "Gain (Loss) On Issuance Of Debt",
        "negatedTerseLabel": "Loss on issuance of debt"
       }
      }
     },
     "localname": "GainLossOnIssuanceOfDebt",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_GovernmentBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Bonds",
        "label": "Government Bonds [Member]",
        "terseLabel": "Government Bonds"
       }
      }
     },
     "localname": "GovernmentBondsMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_GovernmentGrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grants, Policy",
        "label": "Government Grants [Policy Text Block]",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "GovernmentGrantsPolicyTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ICON Development Solutions Limited Pension Plan",
        "label": "ICON Development Solutions Limited Pension Plan [Member]",
        "terseLabel": "ICON Development Solutions Limited pension plan"
       }
      }
     },
     "localname": "ICONDevelopmentSolutionsLimitedPensionPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_IncomeBeforeIncomeTaxTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Before Income Tax, Table",
        "label": "Income Before Income Tax [Table Text Block]",
        "terseLabel": "Summary of Components of Income Before Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeBeforeIncomeTaxTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest",
        "totalLabel": "Income before share of earnings from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncomeTaxBenefitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Benefit [Member]",
        "label": "Income Tax Benefit [Member]",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxBenefitMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent",
        "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent",
        "terseLabel": "Change in unearned revenue (payments on account) (in percent)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": 2.0,
       "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contracts With Customers, Liability, Current",
        "label": "Increase (Decrease) In Contracts With Customers, Liability, Current",
        "negatedTerseLabel": "Change in unearned revenue (payments on account)",
        "terseLabel": "Change in unearned revenue (payments on account)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractsWithCustomersLiabilityCurrent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails",
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": 1.0,
       "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current",
        "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current",
        "terseLabel": "Change in unbilled receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails",
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent",
        "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent",
        "terseLabel": "Change in unbilled receivables (in percent)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_IncreaseDecreaseInEquityMethodInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Equity Method Investments",
        "label": "Increase (Decrease) In Equity Method Investments",
        "terseLabel": "Increase (decrease) in equity method investments"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquityMethodInvestments",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_InterestExpenseCreditOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense (Credit), Other",
        "label": "Interest Expense (Credit), Other",
        "terseLabel": "Other financing costs/(credits)"
       }
      }
     },
     "localname": "InterestExpenseCreditOther",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_InterestRateCapAndInterestRateSwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap And Interest Rate Swap",
        "label": "Interest Rate Cap And Interest Rate Swap [Member]",
        "terseLabel": "Interest rate cap and interest rate swap"
       }
      }
     },
     "localname": "InterestRateCapAndInterestRateSwapMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_InterestReceivableRelatedPartyLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Receivable, Related Party Loans",
        "label": "Interest Receivable, Related Party Loans",
        "terseLabel": "Interest receivable, related party loans"
       }
      }
     },
     "localname": "InterestReceivableRelatedPartyLoans",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_LeaseLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability",
        "label": "Lease Liability [Member]",
        "terseLabel": "Lease Liability"
       }
      }
     },
     "localname": "LeaseLiabilityMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limit of Shares Issued or To Be Issued Pursuant to Options Granted",
        "label": "Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted",
        "terseLabel": "Limit of shares issued or to be issued pursuant to options granted (in shares)"
       }
      }
     },
     "localname": "LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iclr_LongTermDebtCurrentMaturitiesGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Current Maturities, Gross",
        "label": "Long-term Debt, Current Maturities, Gross",
        "negatedTerseLabel": "Less current portion of long-term debt and debt issuance costs"
       }
      }
     },
     "localname": "LongTermDebtCurrentMaturitiesGross",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_LongTermDebtExcludingCurrentMaturitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Excluding Current Maturities, Gross",
        "label": "Long-term Debt, Excluding Current Maturities, Gross",
        "terseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtExcludingCurrentMaturitiesGross",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_LongTermDebtMaturityYearFiveAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, Year Five And Thereafter",
        "label": "Long-Term Debt, Maturity, Year Five And Thereafter",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityYearFiveAndThereafter",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_MeDiNovaResearchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MeDiNova Research [Member]",
        "label": "MeDiNova Research [Member]",
        "terseLabel": "MeDiNova"
       }
      }
     },
     "localname": "MeDiNovaResearchMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_NonexecutiveDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-executive Director [Member]",
        "label": "Non-executive Director [Member]",
        "terseLabel": "Non-executive director"
       }
      }
     },
     "localname": "NonexecutiveDirectorMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_NumberOfLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Locations",
        "label": "Number of Locations",
        "terseLabel": "Number of locations in which company operates"
       }
      }
     },
     "localname": "NumberOfLocations",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iclr_NumberOfVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Votes",
        "label": "Number Of Votes",
        "terseLabel": "Number of votes"
       }
      }
     },
     "localname": "NumberOfVotes",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "iclr_OncacareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oncacare",
        "label": "Oncacare [Member]",
        "terseLabel": "Oncacare"
       }
      }
     },
     "localname": "OncacareMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OperatingIncomeByGeographyTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income by Geography.",
        "label": "Operating Income by Geography [Table Text Block]",
        "terseLabel": "Schedule of Distribution of Income from Operations by Geographical Area"
       }
      }
     },
     "localname": "OperatingIncomeByGeographyTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses",
        "label": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses",
        "terseLabel": "Income from operations, excluding restructuring and other items"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OperatingLossCarryforwardsUSFederal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, US Federal",
        "label": "Operating Loss Carryforwards, US Federal",
        "terseLabel": "U.S. Federal net operating loss carry forwards currently available for offset"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsUSFederal",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OptionPlans2008Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Plans 2008 [Member]",
        "label": "Option Plans 2008 [Member]",
        "terseLabel": "Option Plans 2008"
       }
      }
     },
     "localname": "OptionPlans2008Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax",
        "label": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax",
        "negatedLabel": "Actuarial loss recognized in net periodic benefit cost"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Customers [Member]",
        "label": "Other Customers [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCustomersMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherGeographicLocationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographic Locations [Member]",
        "label": "Other Geographic Locations [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "OtherGeographicLocationsMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses",
        "label": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses",
        "terseLabel": "Amounts due to third parties for reimbursable expenses"
       }
      }
     },
     "localname": "OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherRetirementPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Retirement Plans",
        "label": "Other Retirement Plans [Member]",
        "terseLabel": "Other retirement plans"
       }
      }
     },
     "localname": "OtherRetirementPlansMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_OtherUndenominatedCapital": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other undenominated capital.",
        "label": "Other Undenominated Capital",
        "terseLabel": "Other undenominated capital (Note 18b)"
       }
      }
     },
     "localname": "OtherUndenominatedCapital",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_OtherUndenominatedCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other undenominated capital.",
        "label": "Other Undenominated Capital [Member]",
        "terseLabel": "Other Undenominated Capital"
       }
      }
     },
     "localname": "OtherUndenominatedCapitalMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PRAHealthSciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PRA Health Sciences, Inc",
        "label": "PRA Health Sciences, Inc [Member]",
        "terseLabel": "PRA Health Sciences, Inc"
       }
      }
     },
     "localname": "PRAHealthSciencesIncMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PRASwitzerlandAGPensionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PRA Switzerland AG Pension Plan",
        "label": "PRA Switzerland AG Pension Plan [Member]",
        "terseLabel": "PRA Switzerland AG pension plan"
       }
      }
     },
     "localname": "PRASwitzerlandAGPensionPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PaymentsForShareRepurchaseCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Share Repurchase Costs",
        "label": "Payments for Share Repurchase Costs",
        "negatedLabel": "Share repurchase costs"
       }
      }
     },
     "localname": "PaymentsForShareRepurchaseCosts",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_PerformanceBasedGrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Grants [Member]",
        "label": "Performance Based Grants [Member]",
        "terseLabel": "PSUs Based on Service and EPS Targets"
       }
      }
     },
     "localname": "PerformanceBasedGrantsMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_PerformanceShareUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Share Unit [Member]",
        "label": "Performance Share Unit [Member]",
        "terseLabel": "Performance Share Unit (PSUs)"
       }
      }
     },
     "localname": "PerformanceShareUnitMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 1 [Member]",
        "label": "Range 1 [Member]",
        "terseLabel": "Range 1"
       }
      }
     },
     "localname": "Range1Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 2 [Member]",
        "label": "Range 2 [Member]",
        "terseLabel": "Range 2"
       }
      }
     },
     "localname": "Range2Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 3 [Member]",
        "label": "Range 3 [Member]",
        "terseLabel": "Range 3"
       }
      }
     },
     "localname": "Range3Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_Range4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Range 4 [Member]",
        "label": "Range 4 [Member]",
        "terseLabel": "Range 4"
       }
      }
     },
     "localname": "Range4Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Provision of Income Taxes [Line Items]",
        "label": "Reconciliation of Provision of Income Taxes [Line Items]",
        "terseLabel": "Reconciliation of Provision of Income Taxes [Line Items]"
       }
      }
     },
     "localname": "ReconciliationOfProvisionOfIncomeTaxesLineItems",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Provision of Income Taxes [Table]",
        "label": "Reconciliation of Provision of Income Taxes [Table]",
        "terseLabel": "Reconciliation of Provision of Income Taxes [Table]"
       }
      }
     },
     "localname": "ReconciliationOfProvisionOfIncomeTaxesTable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Increase From Business Combination",
        "label": "Redeemable Noncontrolling Interest, Increase From Business Combination",
        "terseLabel": "Noncontrolling interest adjustment to redemption amount",
        "verboseLabel": "Noncontrolling interest adjustment to redemption amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ResearchandDevelopmentCreditsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Credits [Policy Text Block]",
        "label": "Research and Development Credits [Policy Text Block]",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "ResearchandDevelopmentCreditsPolicyTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_RestOfEuropeAndOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of Europe And Other Countries [Member]",
        "label": "Rest Of Europe And Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestOfEuropeAndOtherCountriesMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_RestOfEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of Europe [Member]",
        "label": "Rest Of Europe [Member]",
        "terseLabel": "Rest of Europe"
       }
      }
     },
     "localname": "RestOfEuropeMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_RestrictedStockUnitsTwentyThirteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units Twenty Thirteen [Member]",
        "label": "Restricted Stock Units Twenty Thirteen [Member]",
        "terseLabel": "Restricted Stock Units 2013"
       }
      }
     },
     "localname": "RestrictedStockUnitsTwentyThirteenMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_RestructuringReserveUtilizations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve Utilizations",
        "label": "Restructuring Reserve Utilizations",
        "negatedLabel": "Utilization"
       }
      }
     },
     "localname": "RestructuringReserveUtilizations",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_RestructuringReserveandOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Reserve and Other Liabilities, Current",
        "label": "Restructuring Reserve and Other Liabilities, Current",
        "terseLabel": "Restructuring liabilities"
       }
      }
     },
     "localname": "RestructuringReserveandOtherLiabilitiesCurrent",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]",
        "label": "Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share"
       }
      }
     },
     "localname": "ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Measurement Period Adjustments",
        "label": "Schedule Of Measurement Period Adjustments [Table Text Block]",
        "terseLabel": "Schedule of measurement period adjustments"
       }
      }
     },
     "localname": "ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Non Cash Stock Compensation Expense.",
        "label": "Schedule of Non Cash Stock Compensation Expense [Table Text Block]",
        "terseLabel": "Schedule of Non-cash Stock Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfNonCashStockCompensationExpenseTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]",
        "label": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]",
        "terseLabel": "Summary of RSU and PSU Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Useful Lives For Property Plant Equipment",
        "label": "Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]",
        "terseLabel": "Estimated useful lives of assets"
       }
      }
     },
     "localname": "ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Credit Facility And Senior Secured Notes",
        "label": "Senior Secured Credit Facility And Senior Secured Notes [Member]",
        "terseLabel": "Senior secured credit facility and senior secured notes"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Notes",
        "label": "Senior Secured Notes [Member]",
        "terseLabel": "Senior Secured Notes"
       }
      }
     },
     "localname": "SeniorSecuredNotesMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorSecuredRevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Revolving Credit Facility",
        "label": "Senior Secured Revolving Credit Facility [Member]",
        "terseLabel": "Senior Secured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorSecuredRevolvingCreditFacilityMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_SeniorSecuredRevolvingLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Revolving Loan Facility",
        "label": "Senior Secured Revolving Loan Facility [Member]",
        "terseLabel": "Senior secured revolving loan facility"
       }
      }
     },
     "localname": "SeniorSecuredRevolvingLoanFacilityMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share",
        "terseLabel": "Share price of equity instruments other than options, vested in period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination",
        "terseLabel": "Assumed through business combination (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized",
        "terseLabel": "Percentage of outstanding shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price",
        "terseLabel": "Assumed through business combination (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Available For Sale Investments Average Remaining Maturity Period",
        "label": "Short Term Available For Sale Investments Average Remaining Maturity Period",
        "terseLabel": "Short term investments average maturity period"
       }
      }
     },
     "localname": "ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "iclr_StockOptionAndAwardPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Award Plans [Member]",
        "label": "Stock Option And Award Plans [Member]",
        "terseLabel": "Stock Option and Award Plans"
       }
      }
     },
     "localname": "StockOptionAndAwardPlansMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_StockRepurchaseProgramAuthorizedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program Authorized Percentage",
        "label": "Stock Repurchase Program Authorized Percentage",
        "terseLabel": "Stock repurchase program, authorized percentage (in percent)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedPercentage",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy",
        "label": "Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy [Policy Text Block]",
        "terseLabel": "Redeemable non-controlling interests and equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "iclr_TaxYear2022To2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2020 to 2026 [Member]",
        "label": "Tax Year 2022 to 2028 [Member]",
        "terseLabel": "Tax Year 2022 to 2028"
       }
      }
     },
     "localname": "TaxYear2022To2028Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear2023To2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2023 to 2036",
        "label": "Tax Year 2023 to 2036 [Member]",
        "terseLabel": "2023-2036"
       }
      }
     },
     "localname": "TaxYear2023To2036Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear2029To2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2027 to 2036 [Member]",
        "label": "Tax Year 2029 to 2038 [Member]",
        "terseLabel": "Tax Year 2029 to 2038"
       }
      }
     },
     "localname": "TaxYear2029To2038Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TaxYear20332041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Year 2033-2041",
        "label": "Tax Year 2033-2041 [Member]",
        "terseLabel": "2033-2041"
       }
      }
     },
     "localname": "TaxYear20332041Member",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Senior Secured Term Loan"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_The2018LegacyPRAPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2018 Plan",
        "label": "The 2018 Legacy PRA Plan [Member]",
        "terseLabel": "The 2018 Legacy PRA Plan"
       }
      }
     },
     "localname": "The2018LegacyPRAPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_The2020LegacyPRAPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2020 Legacy PRA Plan",
        "label": "The 2020 Legacy PRA Plan [Member]",
        "terseLabel": "The 2020 Legacy PRA Plan"
       }
      }
     },
     "localname": "The2020LegacyPRAPlanMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TopClientMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top Client [Member]",
        "label": "Top Client [Member]",
        "terseLabel": "Top client"
       }
      }
     },
     "localname": "TopClientMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TransactionAndIntegrationExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction And Integration Expense",
        "label": "Transaction And Integration Expense [Member]",
        "terseLabel": "Transaction and integration related"
       }
      }
     },
     "localname": "TransactionAndIntegrationExpenseMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_TransactionAndOneTimeFinancingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction And One Time Financing Costs",
        "label": "Transaction And One Time Financing Costs",
        "terseLabel": "Transaction and one time financing costs"
       }
      }
     },
     "localname": "TransactionAndOneTimeFinancingCosts",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "iclr_VariableRateComponentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component",
        "label": "Variable Rate Component [Axis]",
        "terseLabel": "Variable Rate Component [Axis]"
       }
      }
     },
     "localname": "VariableRateComponentAxis",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "iclr_VariableRateComponentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component [Domain]",
        "label": "Variable Rate Component [Domain]",
        "terseLabel": "Variable Rate Component [Domain]"
       }
      }
     },
     "localname": "VariableRateComponentDomain",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_VariableRateComponentOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component One",
        "label": "Variable Rate Component One [Member]",
        "terseLabel": "Variable rate component one"
       }
      }
     },
     "localname": "VariableRateComponentOneMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_VariableRateComponentTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Rate Component Two",
        "label": "Variable Rate Component Two [Member]",
        "terseLabel": "Variable rate component two"
       }
      }
     },
     "localname": "VariableRateComponentTwoMember",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "iclr_VehiclesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles, Gross",
        "label": "Vehicles, Gross",
        "terseLabel": "Motor vehicles"
       }
      }
     },
     "localname": "VehiclesGross",
     "nsuri": "http://www.iconplc.com/20221231",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r418",
      "r911",
      "r1007",
      "r1131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r627",
      "r827",
      "r861",
      "r890",
      "r891",
      "r907",
      "r926",
      "r936",
      "r1001",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r627",
      "r827",
      "r861",
      "r890",
      "r891",
      "r907",
      "r926",
      "r936",
      "r1001",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r418",
      "r911",
      "r1007",
      "r1131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r570",
      "r627",
      "r664",
      "r665",
      "r666",
      "r826",
      "r827",
      "r861",
      "r890",
      "r891",
      "r907",
      "r926",
      "r936",
      "r994",
      "r1001",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r471",
      "r472",
      "r473",
      "r474",
      "r570",
      "r627",
      "r664",
      "r665",
      "r666",
      "r826",
      "r827",
      "r861",
      "r890",
      "r891",
      "r907",
      "r926",
      "r936",
      "r994",
      "r1001",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r415",
      "r416",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r910",
      "r935",
      "r1007"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r415",
      "r416",
      "r875",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r910",
      "r935",
      "r1007"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r976",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202108Member": {
     "auth_ref": [
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.",
        "label": "Accounting Standards Update 2021-08 [Member]",
        "terseLabel": "Accounting Standards Update 2021-08"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202108Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]",
        "terseLabel": "Non-current other liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/Noncurrentotherliabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r934"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses (Note 4)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r256",
      "r277"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r4",
      "r256",
      "r277"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Non-current income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Utilities, Current",
        "terseLabel": "Facility related liabilities"
       }
      }
     },
     "localname": "AccruedUtilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r107",
      "r303"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and asset write offs"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r27",
      "r32",
      "r1049"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Actuarial gain/(loss) on defined benefit pension plan (note 21)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r316",
      "r319",
      "r320",
      "r321",
      "r762"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r31",
      "r32",
      "r311",
      "r855",
      "r869",
      "r873"
     ],
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (Note 25)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r28",
      "r32",
      "r217",
      "r814",
      "r864",
      "r865",
      "r956",
      "r957",
      "r958",
      "r970",
      "r971",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Estimated Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r673",
      "r674",
      "r675",
      "r970",
      "r971",
      "r972",
      "r1108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r356",
      "r357",
      "r358",
      "r359",
      "r368",
      "r423",
      "r424",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r673",
      "r674",
      "r675",
      "r705",
      "r706",
      "r707",
      "r708",
      "r721",
      "r722",
      "r723",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r788",
      "r789",
      "r793",
      "r794",
      "r795",
      "r796",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r832",
      "r833",
      "r834",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.",
        "label": "APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition",
        "terseLabel": "Replacement share-based awards issued to acquiree employees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r175",
      "r176",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r132",
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Share issue costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r312",
      "r422",
      "r435",
      "r436",
      "r439"
     ],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": 2.0,
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit losses (note 5)",
        "periodEndLabel": "Closing provision",
        "periodStartLabel": "Opening provision"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails",
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedLabel": "Amounts used during the year"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r37",
      "r501",
      "r791",
      "r964"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of financing costs and debt discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r58",
      "r94",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember": {
     "auth_ref": [
      "r981",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced with cash flows derived financial assets that are being securitized for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans. Excludes mortgage-backed securities.",
        "label": "Asset-Backed Securities, Securitized Loans and Receivables [Member]",
        "terseLabel": "Secured Loans and Multi Asset Credit"
       }
      }
     },
     "localname": "AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r254",
      "r276",
      "r307",
      "r347",
      "r400",
      "r405",
      "r410",
      "r428",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r727",
      "r731",
      "r764",
      "r934",
      "r999",
      "r1000",
      "r1122"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r298",
      "r313",
      "r347",
      "r428",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r727",
      "r731",
      "r764",
      "r934",
      "r999",
      "r1000",
      "r1122"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Non-current Assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r82",
      "r440"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Available for sale investments (Note 8a)",
        "verboseLabel": "Available for sale investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r82",
      "r301",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Available for sale investments (long-term) (b)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r639",
      "r640",
      "r641",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BilledContractReceivables": {
     "auth_ref": [
      "r829"
     ],
     "calculation": {
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": 1.0,
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.",
        "label": "Billed Contracts Receivable",
        "terseLabel": "Billed services (accounts receivable)"
       }
      }
     },
     "localname": "BilledContractReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r719",
      "r920",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r719",
      "r920",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "verboseLabel": "Percentage of share capital acquired (in percent)"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r205",
      "r206",
      "r207"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Fair value of ordinary shares issued to acquiree stockholders"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r725"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Repayment of term loan obligations and accrued interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredOther1": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.",
        "label": "Business Combination, Consideration Transferred, Other",
        "terseLabel": "Fair value of replacement share-based awards issued to acquiree employees"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOther1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r212",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Transaction and integration related (Note 6)"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
     "auth_ref": [
      "r718"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
        "terseLabel": "Amortization adjustment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable and unbilled revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedNetLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "netLabel": "Estimated Fair Value",
        "terseLabel": "Intangible assets",
        "verboseLabel": "Value of intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "verboseLabel": "Fixed assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage",
        "terseLabel": "Business combination acquisition percentage (in percent)"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations",
        "verboseLabel": "Transaction and Integration-related Expenses"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r1134"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r60",
      "r300",
      "r893"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r55",
      "r60",
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r55",
      "r243"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease)/increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "terseLabel": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan"
       }
      }
     },
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r23",
      "r263",
      "r283"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 17)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r469",
      "r470",
      "r877",
      "r998"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r970",
      "r971",
      "r1108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in EUR per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Ordinary shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r8",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r934"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 81,723,555 shares issued and outstanding at December 31, 2022 and 81,554,683 shares issued and outstanding at December 31, 2021."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Reimbursable expenses and Direct costs"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r34",
      "r325",
      "r327",
      "r335",
      "r851",
      "r858"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Total comprehensive income attributable to the Group",
        "totalLabel": "Total comprehensive income attributable to the Group"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r214",
      "r215",
      "r218",
      "r325",
      "r327",
      "r334",
      "r850",
      "r857"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less net income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r213",
      "r218",
      "r325",
      "r327",
      "r333",
      "r849",
      "r856"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r70",
      "r71",
      "r241",
      "r242",
      "r418",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r70",
      "r71",
      "r241",
      "r242",
      "r418",
      "r874",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r70",
      "r71",
      "r241",
      "r242",
      "r418",
      "r876",
      "r1133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r70",
      "r71",
      "r241",
      "r242",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Percentage of company revenue (in percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r70",
      "r71",
      "r241",
      "r242",
      "r418",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r216",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r1005"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Contracts with Customers, Asset and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r437",
      "r541",
      "r908"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "auth_ref": [
      "r1003",
      "r1004"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/ContractBalancesDetails": {
       "order": 2.0,
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "netLabel": "Unbilled services (unbilled revenue)",
        "terseLabel": "Unbilled revenue (Note 4)"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r520",
      "r521",
      "r543"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "negatedTerseLabel": "Unearned revenue (payments on account)",
        "terseLabel": "Unearned revenue (Note 4)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/ContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r916",
      "r918",
      "r1132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Bonds (including 50% high yield bonds)"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r42",
      "r830"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Direct costs (excluding depreciation and amortization)"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Direct costs",
        "verboseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "auth_ref": [
      "r114",
      "r115",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r188",
      "r702",
      "r712",
      "r967"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current tax expense:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DatabasesMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files).",
        "label": "Database Rights [Member]",
        "terseLabel": "Patient database"
       }
      }
     },
     "localname": "DatabasesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r255",
      "r259",
      "r273",
      "r351",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r792",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r259",
      "r273",
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r245",
      "r247",
      "r486",
      "r792",
      "r903",
      "r904"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r20",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate (in percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r351",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r792",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r133",
      "r134",
      "r135",
      "r136",
      "r244",
      "r245",
      "r247",
      "r271",
      "r351",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r792",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r244",
      "r247",
      "r1002"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt discount paid"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r246",
      "r492",
      "r504",
      "r903",
      "r904"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less long-term portion of debt issuance costs and debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Gross debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r682",
      "r683"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax asset (Note 20)"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r58",
      "r188",
      "r703",
      "r711",
      "r712",
      "r967"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax (benefit)/expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred tax (benefit)/expense:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r257",
      "r272",
      "r696"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities recognized"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r682",
      "r683"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability (Note 20)"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred tax (benefit)/expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r697"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r1102"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets recognized"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Other non-U.S subsidiaries operating loss carryforwards for income tax",
        "verboseLabel": "Net operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Additional operating loss carryforward",
        "verboseLabel": "Net operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": {
     "auth_ref": [
      "r184",
      "r186",
      "r1103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax",
        "terseLabel": "Alternative minimum tax credit carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses and unbilled revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r698"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance for deferred tax assets",
        "terseLabel": "Valuation allowance for deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r177",
      "r1102"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Overall net deferred tax asset/(liability)"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r186",
      "r210",
      "r211",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "terseLabel": "Operating right-of-use-assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r186",
      "r1103"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r1103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "terseLabel": "Deferred tax liabilities, undistributed foreign earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r4",
      "r145",
      "r146",
      "r148"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Defined benefit pension obligations, net (note 21)"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r561",
      "r918"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r548",
      "r586",
      "r612",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r548",
      "r587",
      "r613",
      "r918",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r253",
      "r275",
      "r546",
      "r547",
      "r569",
      "r918"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "verboseLabel": "Other receivables"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r595",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "verboseLabel": "Expected rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of year",
        "periodStartLabel": "Benefit obligation at beginning of year",
        "terseLabel": "Non-current other liabilities (note 16)"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r556",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Plan participants' contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r598",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r563",
      "r573",
      "r616",
      "r916",
      "r917",
      "r918",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r916",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": {
     "auth_ref": [
      "r1056"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year",
        "terseLabel": "Net loss that will be amortized"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": {
     "auth_ref": [
      "r1056"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year",
        "terseLabel": "Net prior service cost for defined benefit pension plan that will be amortized"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Years 2028 - 2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r581",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Contribution to pension fund in the year ending December 31, 2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r548",
      "r585",
      "r611",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r560",
      "r571",
      "r573",
      "r574",
      "r916",
      "r917",
      "r918"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency exchange rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r546",
      "r569",
      "r918"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r548",
      "r552",
      "r584",
      "r610",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r582",
      "r608",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r1058"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "negatedLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r565",
      "r1070"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Plan participants' contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency exchange rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r550",
      "r583",
      "r609",
      "r918",
      "r919"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "negatedTerseLabel": "Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Actual plan asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan, cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Participant's contributions percentage of annual compensation (in percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r58",
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r58",
      "r105"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r58",
      "r397"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r1104",
      "r1105",
      "r1106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r314",
      "r315",
      "r763",
      "r895"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative instruments (c)",
        "verboseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r763"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Derivative, Fair Value, Net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative, fixed interest rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r225",
      "r226",
      "r228",
      "r230",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/Derivatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r314",
      "r315",
      "r763",
      "r895"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative instruments (c)",
        "verboseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1105",
      "r1106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r220",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Derivative, number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r231",
      "r233",
      "r234",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r219",
      "r221",
      "r223",
      "r224",
      "r232",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Total derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r542",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1007"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r638",
      "r669",
      "r670",
      "r671",
      "r677",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Equity Incentive Schemes and Stock Compensation Charges"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueFromRelatedParties": {
     "auth_ref": [
      "r261",
      "r285",
      "r310",
      "r477",
      "r478",
      "r479",
      "r483",
      "r484",
      "r485",
      "r818",
      "r968"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
        "label": "Due from Related Parties",
        "terseLabel": "Amounts due from related parties"
       }
      }
     },
     "localname": "DueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per Ordinary Share attributable to the Group (Note 24):"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r336",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r369",
      "r372",
      "r375",
      "r376",
      "r377",
      "r381",
      "r749",
      "r750",
      "r852",
      "r859",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r336",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r372",
      "r375",
      "r376",
      "r377",
      "r381",
      "r749",
      "r750",
      "r852",
      "r859",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r67",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Net income per Ordinary Share attributable to the Group (Note 24):"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r779"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate movements on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Personnel related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r668"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit related to stock compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Cash tax benefit related to stock options exercised"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Workforce reductions"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r132",
      "r294",
      "r329",
      "r330",
      "r331",
      "r352",
      "r353",
      "r354",
      "r357",
      "r365",
      "r367",
      "r383",
      "r432",
      "r519",
      "r673",
      "r674",
      "r675",
      "r707",
      "r708",
      "r748",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r814",
      "r864",
      "r865",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r90",
      "r401",
      "r948"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r308",
      "r761",
      "r894"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "verboseLabel": "Carrying value of long-term investments in equity"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r753",
      "r754",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r494",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r754",
      "r823",
      "r824",
      "r825",
      "r903",
      "r904",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r753",
      "r754",
      "r755",
      "r756",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r494",
      "r573",
      "r578",
      "r754",
      "r823",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r494",
      "r573",
      "r578",
      "r754",
      "r824",
      "r903",
      "r904",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r494",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r754",
      "r825",
      "r903",
      "r904",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r573",
      "r752",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r494",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r823",
      "r824",
      "r825",
      "r903",
      "r904",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair value, nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Disclosure of Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r305",
      "r452"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r450",
      "r451",
      "r452",
      "r453",
      "r831",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
     "auth_ref": [
      "r1109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-Lived Intangible Assets, Fair Value Disclosure",
        "terseLabel": "Identifiable intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r99",
      "r835"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Total cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r95",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r99",
      "r831"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net (Note 11)",
        "totalLabel": "Net book value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Country"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency [Abstract]",
        "terseLabel": "Foreign Currency [Abstract]"
       }
      }
     },
     "localname": "ForeignCurrencyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r773",
      "r775",
      "r776",
      "r778"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Amounts (credited)/charged"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r59",
      "r1111",
      "r1112"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedTerseLabel": "Unrealized foreign exchange (gain)/loss"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currencies and Translation of Subsidiaries"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan [member]"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Office furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Office furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r58",
      "r125",
      "r126"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r69",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r304",
      "r441",
      "r848",
      "r901",
      "r934",
      "r983",
      "r990"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Closing goodwill",
        "periodStartLabel": "Opening goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill (Note 10)"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r443",
      "r901"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Current year acquisitions (note 6)"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r446",
      "r447",
      "r449",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillFairValueDisclosure": {
     "auth_ref": [
      "r1109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Fair Value Disclosure",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange movement"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r58",
      "r442",
      "r444",
      "r448",
      "r901"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r190",
      "r989"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Prior period acquisition (note 6)"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r223",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r58",
      "r104",
      "r109"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of long lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of goodwill and long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r400",
      "r404",
      "r409",
      "r412",
      "r900"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income tax expense"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r35",
      "r58",
      "r90",
      "r265",
      "r287",
      "r398"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Loss on equity method investments",
        "terseLabel": "Share of equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r40",
      "r958"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "totalLabel": "Income before income tax expense"
       }
      }
     },
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r455",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r348",
      "r686",
      "r694",
      "r701",
      "r709",
      "r713",
      "r715",
      "r716",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.",
        "label": "Income Tax Effects Allocated Directly to Equity",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r349",
      "r366",
      "r367",
      "r399",
      "r684",
      "r710",
      "r714",
      "r860"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense (Note 20)",
        "totalLabel": "Income tax expense allocated to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Income tax expense:"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r328",
      "r680",
      "r681",
      "r694",
      "r695",
      "r700",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r1100"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Movement in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r679",
      "r685"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Effects of change in tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1100"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign and other income taxed at higher rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization": {
     "auth_ref": [
      "r1100"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount",
        "terseLabel": "Rate differential from amortization of intangible assets"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r1100"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Impact of stock compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r1100"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r1100"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedLabel": "Research &amp; development tax incentives"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes (net of refunds)"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r262",
      "r286",
      "r953"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "auth_ref": [
      "r274",
      "r951"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Noncurrent",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivableNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "negatedLabel": "Unbilled revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r828",
      "r963"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Unearned revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r339",
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "terseLabel": "Increase (decrease) in equity securities, FV-NI"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r963"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other net assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r246",
      "r267",
      "r332",
      "r396",
      "r790"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense (Note 13)",
        "terseLabel": "Total financing costs",
        "totalLabel": "Total financing costs"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r45",
      "r499",
      "r506",
      "r905",
      "r906"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense on drawn facilities"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r338",
      "r342",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Caps"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal NOL's"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r44",
      "r395"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r427",
      "r1130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment in Debt, Equity and Other"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r252",
      "r270",
      "r290",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r950"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r806",
      "r933"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net operating lease costs",
        "verboseLabel": "Net operating lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r807"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lease imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r1116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Non-cancelable operating leases for facilities expiration period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r16",
      "r347",
      "r428",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r728",
      "r731",
      "r732",
      "r764",
      "r899",
      "r999",
      "r1122",
      "r1123"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Liabilities, Total"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r260",
      "r281",
      "r934",
      "r966",
      "r982",
      "r1110"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r299",
      "r347",
      "r428",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r728",
      "r731",
      "r732",
      "r764",
      "r934",
      "r999",
      "r1122",
      "r1123"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Total Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r1",
      "r255"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Current bank credit lines and loan facilities (Note 13)"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansAndLeasesReceivableRelatedParties": {
     "auth_ref": [
      "r249",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.",
        "label": "Loans and Leases Receivable, Related Parties",
        "terseLabel": "Loans and Leases Receivable, Related Parties"
       }
      }
     },
     "localname": "LoansAndLeasesReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions": {
     "auth_ref": [
      "r249",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the amount of new advances made to related parties in the form of loan and lease receivables.",
        "label": "Loans and Leases Receivable, Related Parties, Additions",
        "terseLabel": "Loan granted tp related party"
       }
      }
     },
     "localname": "LoansAndLeasesReceivableRelatedPartiesAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Distribution of Long-lived Assets, Net, by Geographical Area"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r259",
      "r279",
      "r493",
      "r505",
      "r903",
      "r904"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Long-term debt at fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r123",
      "r351",
      "r497"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r123",
      "r351",
      "r497"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r123",
      "r351",
      "r497"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r123",
      "r351",
      "r497"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "totalLabel": "Total long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Non-current Bank Credit Lines and Loan Facilities"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r21",
      "r121",
      "r122"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit, Noncurrent",
        "verboseLabel": "Non-current bank credit lines and loan facilities (Note 13)"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r384",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Description of business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/Descriptionofbusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in)/provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r55",
      "r56",
      "r59"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r36",
      "r59",
      "r266",
      "r288",
      "r297",
      "r324",
      "r326",
      "r331",
      "r347",
      "r356",
      "r360",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r373",
      "r400",
      "r404",
      "r409",
      "r412",
      "r428",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r750",
      "r764",
      "r900",
      "r999"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income attributable to the Group",
        "verboseLabel": "Net income attributable to the Group"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r369",
      "r370",
      "r374",
      "r377",
      "r400",
      "r404",
      "r409",
      "r412",
      "r900"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income attributable to the Group (including NCI redemption adjustment)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r66",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r362",
      "r368",
      "r381",
      "r423",
      "r424",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r673",
      "r674",
      "r675",
      "r705",
      "r706",
      "r707",
      "r708",
      "r721",
      "r722",
      "r723",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r788",
      "r789",
      "r793",
      "r794",
      "r795",
      "r796",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r832",
      "r833",
      "r834",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Impact of Recently Issued or Adopted Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "auth_ref": [
      "r953"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Nontrade Receivables, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "NontradeReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which company operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r220",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest rate derivatives held"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of reporting segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r400",
      "r404",
      "r409",
      "r412",
      "r900"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r801",
      "r933"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r1115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Impairment of long lived assets"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities (Note 15)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r797"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating right-of-use assets (Note 15)"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r964"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Reduction in carrying value of operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r805",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (in percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r804",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "U.S. federal net operating loss carry forwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.",
        "label": "Order or Production Backlog [Member]",
        "terseLabel": "Order backlog"
       }
      }
     },
     "localname": "OrderOrProductionBacklogMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r306"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r26",
      "r29",
      "r590"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Actuarial gain/(loss) on defined benefit pension plan",
        "verboseLabel": "Actuarial gain (loss) on defined benefit pension plan"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r25",
      "r30",
      "r774",
      "r777",
      "r785"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "terseLabel": "Currency impact on long term funding"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r317",
      "r319"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 5.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Loss on cash flow hedge",
        "verboseLabel": "(Loss)/gain on cash flow hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r317",
      "r319",
      "r733",
      "r734",
      "r737"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r319",
      "r322"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 6.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Amortization of cash flow hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r319",
      "r322",
      "r735"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r33",
      "r323",
      "r590"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Actuarial loss/(gain) \u2013 plan assets"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": {
     "auth_ref": [
      "r29",
      "r33",
      "r323",
      "r590"
     ],
     "calculation": {
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]",
        "terseLabel": "Income tax expense was allocated to the following components of other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.",
        "label": "Other Comprehensive Income (Loss) [Member]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "verboseLabel": "Unrealized capital loss - investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r934"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities (Note 12)",
        "totalLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Non-current other liabilities (Note 16)",
        "totalLabel": "Other Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r284",
      "r949"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-Term Investments",
        "terseLabel": "Investments in equity-long term (Note 8b)"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Non-current other liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other restructuring costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r120"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "General trade and overhead liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r4",
      "r258",
      "r278"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r343",
      "r962"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Settlement of cash flow hedge"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtRestructuringCosts": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.",
        "label": "Payments of Debt Restructuring Costs",
        "terseLabel": "Payments of debt restructuring costs"
       }
      }
     },
     "localname": "PaymentsOfDebtRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Financing costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Share issue costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r47",
      "r81",
      "r337"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchase of available for sale investments"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r48",
      "r724"
     ],
     "calculation": {
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Purchase of subsidiary undertakings (net of cash acquired)",
        "terseLabel": "Fair value of cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Investment in equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "auth_ref": [
      "r961"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.",
        "label": "Payments to Acquire Long-Term Investments",
        "negatedLabel": "Purchase of investments in equity - long term"
       }
      }
     },
     "localname": "PaymentsToAcquireLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r960",
      "r1119"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "negatedTerseLabel": "Loan to equity method investment"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Purchase of noncontrolling interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r570",
      "r572",
      "r578",
      "r597",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r618",
      "r619",
      "r621",
      "r634",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r4",
      "r546",
      "r547",
      "r569",
      "r918"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Non-current other liabilities (note 16)"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r153",
      "r158",
      "r159",
      "r160",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension Costs"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r143",
      "r546",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r595",
      "r596",
      "r598",
      "r601",
      "r604",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r621",
      "r622",
      "r633",
      "r918",
      "r919",
      "r923",
      "r924",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r598",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r954"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepayments and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r947"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r51",
      "r965"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Drawdown of credit lines and facilities"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r46",
      "r81",
      "r337"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Sale of available for sale investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "auth_ref": [
      "r959"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.",
        "label": "Proceeds from Sale of Long-Term Investments",
        "terseLabel": "Proceeds from investments in equity - long term"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r174"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of equity compensation",
        "verboseLabel": "Total proceeds from exercise of stock options by employees"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r297",
      "r324",
      "r326",
      "r340",
      "r347",
      "r356",
      "r366",
      "r367",
      "r400",
      "r404",
      "r409",
      "r412",
      "r428",
      "r475",
      "r476",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r726",
      "r729",
      "r730",
      "r750",
      "r764",
      "r853",
      "r900",
      "r930",
      "r931",
      "r958",
      "r999"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r878",
      "r879",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r106",
      "r302"
     ],
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r108",
      "r282",
      "r854",
      "r934"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment (net)",
        "verboseLabel": "Property, plant and equipment, net (Note 9)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r878",
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r977",
      "r978",
      "r979",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Net and Unbilled Revenue"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r598",
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r291",
      "r817",
      "r818",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses incurred from related party transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
        "label": "Related Party Transaction, Rate",
        "terseLabel": "Related party, loan interest rate"
       }
      }
     },
     "localname": "RelatedPartyTransactionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r598",
      "r817",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r815",
      "r816",
      "r818",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r53",
      "r965"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayment of credit lines and facilities"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "terseLabel": "Repayments of senior debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r456",
      "r458",
      "r461",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r58",
      "r462",
      "r464",
      "r995"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Additional provision in the year"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r457",
      "r458",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring charges",
        "verboseLabel": "Restructuring (Note 19)"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r458",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending provision",
        "periodStartLabel": "Opening provision",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r952",
      "r996",
      "r997"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring reserve, current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r955",
      "r996",
      "r997"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring reserve, noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r137",
      "r280",
      "r868",
      "r873",
      "r934"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r294",
      "r352",
      "r353",
      "r354",
      "r357",
      "r365",
      "r367",
      "r432",
      "r673",
      "r674",
      "r675",
      "r707",
      "r708",
      "r748",
      "r864",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r926",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r926",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r601",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r601",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r1071",
      "r1072",
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r143",
      "r144",
      "r546",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r595",
      "r596",
      "r598",
      "r601",
      "r604",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r621",
      "r622",
      "r623",
      "r633",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r546",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r595",
      "r596",
      "r598",
      "r601",
      "r604",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r621",
      "r622",
      "r623",
      "r633",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r393",
      "r394",
      "r403",
      "r407",
      "r408",
      "r414",
      "r415",
      "r418",
      "r540",
      "r542",
      "r830"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r545",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r530",
      "r531",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Disaggregation of Revenue",
        "verboseLabel": "Contract Balances"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalances",
      "http://www.iconplc.com/role/DisaggregationofRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r39",
      "r289",
      "r477",
      "r478",
      "r479",
      "r483",
      "r484",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue earned from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r1006"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, remaining performance obligation (in percent)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ContractBalancesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving loan facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r803",
      "r933"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r418",
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Net Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r32",
      "r1113",
      "r1114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Plan Asset Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Summary of Assumptions Used in Calculating Pension Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r918",
      "r1058"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Underlying Asset Split of Fund"
       }
      }
     },
     "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r193",
      "r194",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r193",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of Components of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r21",
      "r133",
      "r134",
      "r135",
      "r136",
      "r244",
      "r245",
      "r247",
      "r271",
      "r903",
      "r905",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails",
      "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Annual Benefit Payments which Reflect Expected Future Service"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r95",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r901",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r102",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r460",
      "r464",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r112",
      "r113",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r111",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r635",
      "r637",
      "r639",
      "r640",
      "r641",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Information Concerning Outstanding and Exercisable Share Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r163",
      "r166",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions for Company's Share Option Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted Average Fair Values and Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Future Intangible Asset Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Credit Facilities:"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r1107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r400",
      "r402",
      "r406",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment and Geographical Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorSubordinatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated notes are junior to Senior Notes and Senior bond holders.",
        "label": "Senior Subordinated Notes [Member]",
        "terseLabel": "Senior Secured Notes"
       }
      }
     },
     "localname": "SeniorSubordinatedNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Total compensation costs",
        "verboseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Shares vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at ending of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Outstanding number of shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "periodStartLabel": "Outstanding at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Shares vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of stock units vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Assumptions:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional number of ordinary shares which have been reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Stock units to be granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled/expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted average fair value (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options Granted Under Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (USD per share)",
        "periodStartLabel": "Beginning balance (USD per share)",
        "terseLabel": "Weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Vested and exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable at end of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r639",
      "r640",
      "r641",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Average exercise price of option per share (USD per share)",
        "verboseLabel": "Exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled/expired (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r642",
      "r661",
      "r662",
      "r663",
      "r664",
      "r667",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Minimum Range Exercise Price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number of Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number of Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Maximum Range Exercise Price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Shares expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average contractual term of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable - weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of option price for fair value of ordinary share (in percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r65",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "auth_ref": [
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "terseLabel": "Unrecognized tax benefit, potentially expire in 2021"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State NOL's"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r132",
      "r294",
      "r329",
      "r330",
      "r331",
      "r352",
      "r353",
      "r354",
      "r357",
      "r365",
      "r367",
      "r383",
      "r432",
      "r519",
      "r673",
      "r674",
      "r675",
      "r707",
      "r708",
      "r748",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r786",
      "r814",
      "r864",
      "r865",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r383",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r7",
      "r8",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issue of shares associated with a business combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r7",
      "r8",
      "r132",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r132",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issue of restricted share units / performance share units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture",
        "terseLabel": "Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r8",
      "r132",
      "r137",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of share options (in shares)",
        "verboseLabel": "Options exercised by employees (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r24",
      "r132",
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issue of shares associated with a business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r137",
      "r167"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issue of restricted share units / performance share units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r132",
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of share options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Number of shares authorized to be repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r7",
      "r8",
      "r132",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedLabel": "Repurchase of ordinary shares (in shares)",
        "terseLabel": "Ordinary shares redeemed (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r7",
      "r8",
      "r132",
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedLabel": "Repurchase of ordinary shares",
        "terseLabel": "Ordinary shares redeemed, value"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r80",
      "r934",
      "r966",
      "r982",
      "r1110"
     ],
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r346",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Share Capital"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r802",
      "r933"
     ],
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Income from sub-leases"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r821",
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOfCommonParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to an entity under the control of the same parent as another entity (that is, a sister company).",
        "label": "Subsidiary of Common Parent [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiaryOfCommonParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r179",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "terseLabel": "Schedule of Expected Expiry Dates of NOL's"
       }
      }
     },
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r0",
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Fixed asset impairment"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carry forward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Exercise of call option on noncontrolling interest shares"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "negatedTerseLabel": "Noncontrolling interest adjustment to redemption amount"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names &amp; brands",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r356",
      "r357",
      "r358",
      "r359",
      "r368",
      "r423",
      "r424",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r673",
      "r674",
      "r675",
      "r705",
      "r706",
      "r707",
      "r708",
      "r721",
      "r722",
      "r723",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r788",
      "r789",
      "r793",
      "r794",
      "r795",
      "r796",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r832",
      "r833",
      "r834",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r457",
      "r458",
      "r464",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r678",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of year",
        "periodStartLabel": "Unrecognized tax benefits at start of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decrease related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r691"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Total accrued interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r687"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest and penalties recognized as an expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Increase related to acquired tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r690"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r1101"
     ],
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Change in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r692"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r693"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Total unrecognized tax benefits net of potential benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r385",
      "r386",
      "r387",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Net change in the total valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Motor vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r973"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive share options outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r371",
      "r377"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of ordinary shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r369",
      "r377"
     ],
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3,4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(b)(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9972-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9979-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10(3))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.7(e))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5)(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.18)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r937": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r938": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r939": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r941": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r942": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r943": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r944": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r945": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r946": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>163
<FILENAME>0001060955-23-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001060955-23-000007-xbrl.zip
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M0^7GT/KI\RBY-_U_FKO_>;_\ U!+ P04    " !0A%A6**+VR* %   )(
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M$FSO%=BAJS]T]?^;KMZI?B0W/]>/_@502P,$%     @ 4(185EN@16V)"@
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MSO-79#-BSNNU[$DQE5;X]P?^1XS]_P-02P,$%     @ 4(185@PG<5^] P
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M9/N*3-T)P%)_\F5UN/(_J= ,.T%CGE9YY+'PI0=9]V_?C.[UNO@(4$L#!!0
M   ( %"$6%8J]'[XR; # ,X['  2    97AH:6)I=#(U+3(P,C(N:'1M[+UI
M5^-(MBCZ_?V*N%FGZ\)ZQH7-D%#976L9<&:ZF@2.@<JN3[W"4MA6I2RY-4"Z
M?_W=>\>@D"T90P*6C?N<[L0:0C'L>?S[_SF[/+WY\ZK-ALG(9U>W)^>=4_9N
MYY=?ONZ=_O++V<T9^WSSY9SMUW<;[";B0>PE7AAP_Y=?VA?OV+MADHQ__>67
M^_O[^OU>/8P&O]QT?\&A]G_QPS 6=3=QW_WV=[P"_RNX^]O_]_?_L[/#SD(G
M'8D@84XD>")<EL9>,&!?71%_8SL[ZJG3<#R)O,$P8<W=YA[[&D;?O#LN[R=>
MXHO?]#A__T7^_OLO])&_]T)W\MO?7>^.>>X_WGG[!^_YT=&!$&+?V>\?N+W]
M8^$<[;L-I\_A/X?_;NP?P#1_@1?D6W$R\<4_WHV\8&<H< :_OF^.DP_WGIL,
M?VWL[O[M7>ZY1'Q/=KCO#8)?:;YPMQ_"ZM1M)_3#Z->?=ND_'_#.3I^//'_R
MZ_^]\48B9A?BGG7#$0_^;RV&/=Z)1>3UY8.Q]U_Q:P,_3C_OU6Q@'-\+A)Z=
MG%+[^]#K>;!;]8.__X*/ZR7-+HQ' UA;+TR2<"2'M];@P(Z*:$F+^-CI7M^P
MUI?VQ1G\]X;=7++3;ONL ]<^==MMO)9?W,++^BN-$Z\_D9>\P(55_KIW.'[Y
MT]HO7.C-T(O9]&J3D"5#P4XCX<)!M@:1$(0GD>B+""[B SWAA_<UYA+B\)B%
M?781WHE13T2L>5Q#9&FRK02'__FGHV9S]X/>L-=?IMQL5SAAQ)%R_)K"OD?X
M%)RT%\6P1EB?*W%X69-\]QOM4^/#-NM-& ]@5T<AD*/.Z>6%IHGGG2^=F_89
M.[W\<M6Z^+,&C[%.Y,5#-DY[ON<PWQMY>"!..!KS8,*V*KWWGT/?!8H;5V'3
M:[3EIYV;SDGKXI\U=E%OU6L(V"T7"+ 7)SC].P'8@)BPA?A1Z;TMFG85]KG.
M3OG82X 8_A<)B8A&,0O"A(6PH]&]%POFBCZ\[3(O8$0^IC"4#3FL!_<_YB/!
M1H('"$-X5/%8.%[?T^_.4C Z4(XCP3. 987CK\#9JA5,+Z\2Y_M$OOA*[/ZQ
M6]UM TEHG5^O![?_^KG=;;>N:Y*IG-_^J_WEY/*V^ZG&KNL__]0X;GY@W?HY
MTCWVPK!$(_Y*=,!98.)QZ'@__]3<V_N0R'\ 09O-_0\@DL3C,(AYS_,]?8N8
MH/Q;+!,E@ H!2(T1JE!& O8BO@-%1AV#((R=I]]!8 K3:,!\#L(44#:\Z24Q
MK&L CPH4ML)^WW,$XPD[;-18E"*%A.GY\,&!B 81C%5CYSO-_?W=FCTD?M :
MYMY+AD04K4?T;93>0&08B0@_%&CYP8.]V*H6('3KI_7KNK6&91[PMCK'("6Q
M]^3P\.#H: 7X!^P>.PFC*+P7415XAJ)'I_"$YW"?=8([$2?(T6* Z/-3I$=G
M E"$1\*(N+XGD7Z2";LKL?&W"+_7:2_V7(]'DXH=Q%6WQ3X+[@.MN'8\$3@"
MCJ 3./7<&6BR!LM;@5VG':_0-DM5(PD' F7>'&$VTZ1'YH%+C55^W_54*Z+?
M:6U3[ASI&VS,HP2Y'/Z+Z@!PRB14YX,:AK@3$1 D4$AXX'CPEQ<  T]27&IL
MWNY'X8@E,&NRG,"_I&?X@IA#]?'CG"9:B5,R.U^DOM88Z0BDWI&)"D0B1T0)
M!VUO5M.S+5._I_Z$-<@HU6!;F0Y80_DQP0=K1BV48I.^&J?CL4\CHB0666KJ
M*'2EKCF./+BA;&;X589@%/97 $.KJ$#^_-/!\8<U4[<TZ0$)'T7[_Z0 7PK4
MRH"=@*@W >@*[SQ7D)$$U0" ,\&=(4+U+!DK,=S6)*Z,TRA..0P-CSD^3P&(
MM[SM+;ZM!].6%[3*L-OK,];F$2#.Y1@WD[5]X1#'5T\7&%<2('H\3H!>PC*<
M-(K@,@P0I@G@4X!;P,Y <>$1?"H(8=&$H_$$;CGTIR/'[','13M<DK+D$!NT
M'O1#'C  AF\B83@E8)B@#B33. B22D#T@9 >\3KU$UP -^8>1.K( Z#B/DQ5
M?!=."A\ 2D0[<'WYL;O3XS%\$M4XLA^Q'LA%0_PX75M'@"V%2@19"YKA^E^A
M1X<L$#RD;P"(C8]B(D$=G%,Y*"$^A Y!BEL,GUXQ=#X*,FG6-%E7X-O:O,@=
M((HN<':1"6$S[](B< 7GG9/++HN'8>J[  ( 3&.?.UJSQB=N<&8(,45@POH
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M"[)]8[=<=1SSR4@UN51R%_7TQ2+\JF70F>BMGI1Q7%$A__@MB*^-4@O8550
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M+>8D(8)L@2-X>#:Z(%3!UP Q,C.WG_WV8G(A<W:BRYV<(5Q1#O"(K(D)ZDU
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M>50U.<227CYM/A(*-QS3"&3X'ZERZH:1E,FWQ<"'8VQBV3+PWUO=6+8E$6&
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M =L/ VS_;#=$O5O<V;\>]IZUL!-<)SRJI'T=[:L%[90>91++&>G19NMMET?
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MY=F1'ZRDHWP%-()WO_V8T:5<K)HA&7:I+4N1,US)QUI@&Q/- B::Q^3(:S7
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MHA=[R0^DGFU0Y151Q>KX406LL;3Z4M/\(A;$PJ>F/<8 ZP5/F=Y<S^YL.MY
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M:=E84( GQIC(QI:S+3OQPMKQ3UR^W)LI#-HBI:"O0MA,< @R42]RTA'FL#M
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M!,FD/3BB,)"4J\RLJ)C4PV!(D*;JW)%%FDS8&(?FIN1<E40O5^&JINW3!*1
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MQM)]:W(_J,N7*01AVENKZ$CT4C,/^QT[7F(6;JVR-MUH<ZK\RZ=6ZVJ#]J^
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M\#+D477\IT3::4I(V27(AU&LR?]'X5(_DZY,R&77DS@1HV*% "ZV1C EAV_
MZ)7 *+,8P9E5!J:HC^O:MBVN8(?S&;,C\ <0]2(K/KFGP<4D?&HDMA[5P?32
MGYF 1*<:<3(WQ80[R0/_*YVH6$6;"C$-N=\W3EWZSH]E>U8= "K8G'P6 # [
M)0!!:>B-:WD:?S8- +IGE7K%5,'+1ECS;O,5;$0^>Z D$0K7\DJ1# C8.J)
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MGV*/DA[V.I!*5-8XE%1;%>5,Y=%ZF53K1ES^H=@_!L)Y(S,,,5A4B&/A*X:
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M>ZF3QD6?O/[YI[VC#U=4)!)_?PE#=Z++G*\W6W.K!#V2K3DB@BT"4JT(MU*
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MW-6,4ZA.O@&!J]YZ0@!36H=,*A0>KPUW/H;WND6;C=P;J[6/$Z37^#>&LLL
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MLUY6!T"E3WQ5WC G-Y 1*EI:#<%!LC;39[%6Q&ZBXI2H;\RH?%;&" IAU\J
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M<7J*N6OC) F$7[XJX9PF<*H.<X\!E5?W<P_/DOGG957"U#R1=U[0__UPK!G
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MY%>8\T5/')M%21.N*X(H@GWO5(+72@P MOU&7H\@*W4. @3#2V8U@24E1;9
MY"Y35>4(,'2<(Y]=BHOYG/*8@SGV,2: @7#.KA*&'*7O4%[0D>&X>@6:*^9>
MBX.NQ0"C";C#4?ZO3(Y'/[EU= '=\LY["D4Y'*!X>J.X,Z]XXU(['-2(L-D(
M['1W-RK+01YS]U&G#I8BV=8<N;N2D&MQ8%?#AL=]1'MZ7;4,&&8O6E?)O,%C
M$*[$:)I0O7=,$T*Y0\1,<--!*W"E&N/[=]^?2]'XC;'6MJ!\''&*M(6#,,,0
M;U:E,"<5UH10A,=/A;XG33):$6:.+>BY :>SXL  56;'#'ZV;),J*9 #'HXV
MU3[ 21%RBWY."E@22L2I<"/.TO8/.D')_?$AG&2B_T%]ZQWC=YFQ_0O7V1UO
MA[/J&1G((9^#*(#L5;5/,[I& QTN2_R[^*-:_9A*P$68HP3F41*IJ1U1Q)#M
M^IYTCT2_/MN2W<KRNIW]9FUN>E]>)MMRI_HX1KU]3+U-Q7@#T]H((V',D_*F
MH(X=[&5#ODG4*11[@N]S3%#25K!PG9(LT!?K.B@4LG^ 6?X[['Y4"U*&2JI_
M53:@>*X->'JYM&=*H(U+%97L(@$!%S^R.0Z;.3?N5G"O=6[2I=R$);S9J#'"
MV*ZR62:NB-*;>7(31U7+-0FP[6Q<3A7%L$U%^WHEX(KE#.D07.S-^&J')3:8
M$P\Z5N>V8'[12$CM6G6ZF8I%M^2$B)1YVBIX/SC8Z]F3Q#&K1UV$?(-$H*#2
M5]$EAF>J.6*#7):IT6$^]2-I8@G>7DV[=!))21Q^7IFYR:[Q4FF#&7L8P_3Q
MLV\A?=ROL!](/Y.(>Y$&@7(4:>86&\)K(J."K9;*QD!/@R7W#HD7Y1&*=]')
M;G!.2=0![W0P;'ZF&8L^-N7\,TG^C[#?&\]F6:L4 68.U(;!BJ9\(UI3IX>Z
M1D@B2LI7ZF\]HZNHZ(BNEN!?,7H/O.SK<M[*D8\N9L>TX'$9OC'J:8,!,?M
M_ES4)KSU=4D&T:YW[4M[;:RB^^?)QQ.8^6I=DC>K+F!/&11(=/GF$@?YYN,_
M+G_MR]AU'AQQ;4$=???\WZV"*]O&+=VNX=K7TX^S+XGGFBN&#Q9CZY1P^1GY
MP9S8IE0TBQM"V4C#8&*%PI>D"%I@L':(SX+?6QM6TW7#U+BX.+1%-\'9D\?9
MB5B;RB5X;/+T^^??V>_M)J" A*A^E/_P6).557OD-YB$.LWF7#Z4U-%>3C@&
MT#95+;5TG8#$KA"&6PTQ,W+NGX$Q4,F(W[M6G)W!X8R*P)#U5JZ+AZW C]GT
M+*H^"=VODJK"8!YKH(KM8O\MO*O+<#_#!#;6^TY>3*,)'$OH$X3E$>Q%N("J
MPJ;POV<GX^QL/Y9$QS.Q1)=PA^^G7.^EX[V,<H$Q0'A5QLFP_@G^!!Z&__V.
M_OL]_O?\_'YWB2P_VW62MV:[I_G?GI_&<%C@_Z?;OY#7?/KL2UZSEY$J6J+/
MR$G;[;5M.",MO'#7&?'Y4)5^ 4.FW"_OZ%#>8DEIS]&GLO)5X1D5J-2(T]Q:
MO#IR0V]H];&8?NZ,"=^2FLQA:V%RPSYK$>D &[S'(KDNJ[#-F>Q%?E&8GP#?
M7OG\TTX@0E_77?"^'<6'8OBNWGC6.6,_ ?4WL',(W?F+=]V C/3[&.ADT&/5
M0,TM7;9O4=W2/<Z^'9P!/A/$&TFJ!60KB1/#<>(^\47L0-80U%TF-166P*4L
M'*>7B]GX0R%#\(BR-JY'C4YKM@MW)EMLDYP_DM3)19N8=0@[:<C*[<Y7CT^5
MP_PW$K+'BVC-X#7@1/Y#/I;((E@AJW64MAP,@R-5QA,4B/@9IOZ(6%L$M%]F
M;94:F@MV(9VVZ%-OC+ZXD+/>+6]EH7EQ+FA#R6J);-K8GOR38?^=,+K'<'PH
M68!HIES069F9-0XSZ86T!2;2;EJ3?1Q6B 4V#$H 6\(IN,OS!I8"_6VEJN0!
M<O_ 71;US JG$56>4T9L00P+(*0P]PCL1!%&LA'8Q>;%VC*Y>R(!ULBS#XO[
M[XT'07!KFG=EG3,JE9T$F;VOIS(N+^^A'N+[.O'2OC0H-^Q6;,-><]V/R2%W
M=7DHA17@)QMF9O02*P#O&>P&YL *H+5%Y11 "0'?M2F?P/'C*+W6KK1>^J&J
M)#68OF4AE00U?[#(<E9[,C^T.8BN"B2_L2KKD[V#,*%$$WL,??K5'SU;=/1,
M->(,@3N^CT-T#PSI4R"+(LIFW=AZN<2^/8W32L(__01X+K,+^#:U\:^+/#?@
MR*H+0RO#CH*.H6 E?=,\Q[0I7L>V0>K#TJ[F4ZY%&P_%D^7V'C9AMEHG&4NL
M/L9, 8LY-]SQZHF3 QG0BV_G.U#[XN?6K6W7N^,>6SMW85(RN=\E-UXH12JW
M,GSN"O#;.<7RI%P\$>P;.I%W@<WLFZ4Y\3C;8\;[>2(Q* R@B7S;7VWE)+ *
M^>I^W02V7]9(IIN^AS/$-F85)79]T>9RZ66704%3E8>URUGG:?"))IF&..K$
MG_W+)#OU5L\KTJ*KU=KWDG9UKGGUYO[N35DU:-1FJ[N\J3/G3;F[@3#\_6_?
MG_T@[4 I_./I#_[;N[Z&[_MB._\LJO[CVY7>BYSU_5@TJH63_@L"7FIJ_T\+
MFY;XCSJ/?>.62VEY^^6%I \P38$V% VBDY([Y-:X_NJZ#^H<?0-R6Z*Z.L$2
M+RRII]]V3[D[2JG9OO:D:BJV1W(+7CFQE;F$B"Z2UANEF^A;9+=8U$X(F/B$
MMV@C8O+\^<L?"-V28;;R1 XEO-7: 3N-$7X5X7\^1OCOVR'FL_!HO$O[CX@@
M:Y?9U.6_72RF[@D#UC:LJ"H1[O3C4CRBLUG+P/XJ16[#C>KV.K3A/AVA<@XI
MAHOO;,'0>5]_P!^BJ$X.;@ <BQ'^?#&"S]T,J" AF09%XO=)0!$L8H=4S=5I
M]MPP2%C%%M!1/<YFET:]<$B1; "G#,OHK1:T[#:1\!50!:WO9[K,2X+9>BVU
MJ7@)8H,W>GUV9B1]JJW8OEM;Y(3ET!D7V9G&,Z7)TWKN$-.)A2-Z#4<6:)CY
M_1.B5Q0?57E#-NDT=R%;QSY4I<H=LPXDD2[:FYQ-MZ5:8)P.&%BB$%;$N5&3
MA 'T\RG/#6%L]"&PSZ8XADDR;-YSR@L/0,-A7F,^[:H9*^0[0XR'U2UAC'DC
M/BC;502A[\K\8*G!/"+OIF>GH,?3J6]7O8,N MV_:17N,3X;RVP3_;MNB2;%
M3%Q5J W],/(P5OA2//)&DO#DZX3A8I4OEPDHJ\W4%F3%7.P.SG:09PZ"NI(.
M0[V)J487.12%P76:][@=[G%"Z>"0*R]A$AQ-ZBGT_OR6?U6IP;=;7Q#?K\
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M;UE]CKFIT9;$"C,R:LVZ5$]4$^P;M(,'"J;]5YQN)&96V.]"QKWQ_PBFV_6
M[>,ZYS*:*X3[Z9UG?#3<J%Q2ZVGDX?(5D7HV6C;'4#Q<I4CXX' N)4/RSSD6
MS:-B#"NJT5+^U7<G9Z-_]5""$EU6)>HDLTC:?!!B\T4^^HN3T[-).B;!'DB(
M?KR6/--CD:-1C!Y"C!PTWH5'\AR.*%'O /X_!3,Z868=0;"U+IVZ IP]:0K4
MGW' B*)#6 KM^*ZP>P#M97Q<G8A7[KCNE DWG9+)+&V6=7:+1'A@0C,93<BH
MXSH</V'_\GN^0H!7V>1V<'!@B*Y5;V2R%'9WPGO*4H6ZR?W1:B:H<Z'G]<'V
M71*7H/2>_MOSTY/3"!8K1VBE<9\=<9]Q4'40@7AE&UYE9F$I;1R03!4K;!EI
ML/6M\!5'8A"YIY+VWZ8J\YPEV0(9C 63NF#RY5@P>9QMOE@\T#:O0+N[!.WV
M1NM<8$^';K]3V#?T"YQ&W.GV/;8.86%0T#KD0$-L#7Q?).%X6OZ!YEX$HSO#
M/@*(F./;=NE>09H_U'D16,N,FZ*(!ZS!C!=]$QOAT0O?P(D,:#6(>IFHU)C]
M#L[L 398.DX(L,DS,,SKNK47[!A[+&J0<T^.EUP "_:BJNLR\=<&=QFIW0]&
ML,CH>@[F(CR!Q%O?:FX-E]-#Y"Z.MZI!$.3?+*DS:K>4]_'(],QGS:!?\@8>
M5[1VT'WDH\"#ARE=/]X2_T3TXY.S!^62"> M:<J8@8$7Q0/#WXFSWQ6BT4$Z
MJHKZQ2 ZCZ1E/N"5@]%._6BLRJ6/;=HM*W'#(CK0)>SD,L_8H/M48AHZ4"!*
M<20\ 99HQ8LA*9DJ*3[O4R/;/]NM6!!E%;E:-;'G98+@,+[2(4_JAM)7-M(0
MOF?)<$/!Z_WXZNVGUQ<^WZ5^,6ZB(VVB)Q_A.]!DW]AQ_UM;8+@LAU%_:^?]
MKNWGV++DW2Q;RN,Z],_'0W_45U^JKY#,\X+A18>@DW:DJW8ZX*X([N3TQ60Y
M9JR.)C.73 ![60[43+351[M-PSZ[*<@ (="K>M<Z^';,L1]9U :AGO;X((PY
MO%ONZG;ER:_3UN&]8K6K9WD/A/*M15O^\79-](7.K.<$YU'(;>F.A\.)KO/V
M05>*H-4I:[MRA!EPHL#V1)ACA0-?,HZ[3UN_K\S"5&A1_LBTKC#9K[/Z=\*\
MS?S'=E7JD,6V$D#G/KI;C4)N1X*.9,9X_/-YU7(QV-Y'Z+OL'1@!6N]^3@_Y
M9.^PI_Q+9'4$QQ1DEJQE)7_1I$>>Q^JCXVE&C0G.1MP0E.27MI>=CB5'QY$=
M89Z^9 #%;$!'*\<84C4T#=C^&CW$:@02.[Z,;*)WEVB%E%AL,AAIB34QO;.R
M*.R;L!' $B.ZT=KOOIX+7KA*;@H*0;2%N5T3:G=H.<#QYFKZMV>%8)=KC;O<
MB'Y#X,W1-.LWS=P";*T/SCB(&I@WL[:JI15.D4_")0<L L7]Z #"KI2-:2S'
M=[:BVZ;!,HT&RX,HE YB^6"T"B'L=]#4%7<=TR%U7V<\DXXG0L,!^?'8&]+Q
M'G*<_[,@;.B/#34!KCE H J6K64,<N8J[U^<GB$"T-/3H)MW%*\CBI=ETAR4
M8>P3*>_:6T_EA)8+43_9T:NH@VJZM)<3U;2ZQ)$"CU7"NDKX^[%*^'_$5O]H
MR1XM4<Z -CSM:L=&F<H X1-BI&VN,( YS-G].+\R:9L;3,J=_?B0,SH>FT?<
M2^Y4&<X>(@(D?]H)T[(USUXCPWN3S=4EH\ \A,!X,V2PHN-&Z(4HZ;&Y1ODY
M@OQ\_,?EKT,0E"MANSJH2V0_"9R7(+GY*$A_O2#]=''Q?@ARQ IG:0KJ>-Y@
MGA:IU5+=\2EMH+FIK4"%P060J8L5#&.>C))S!,GI@S0;D-V#\N'!VVP@:9?$
MQ*J L_"4Q/#9NLQ!9<VQD+V=84&!@.@)8MW-E:$?$2D9_B8OX=K8@<@A[=E\
M$WOB82RMK9NJY9FC#P3AK80S=E:F!"K75@W\#US"_*0(/F6AWQ#;#;PA<VNJ
M.0P&-H:Q#(:QAY##?_S6I@0A%R.=*3$7JB>56R!R:R:D(/B^0N"A8(:0W--4
MR-]*A<*EGM4)\V]:K+FZ75?)$YX_''>98O:2 0*$-*FMRC6B)\!"\!P'GU[*
M&R/<UI@'/\8NQCJ^X6S:H(D8T5+[BG) ID;1.()HL+EO!I'K9CTD4"529CA!
MU3'H*5P.R*>;*J?.8Q 3@"E:5P+<ZC@T8WMBNG>P?QD"L<'FE.3:MHY@LT^Y
MRN9"C8N_#:XF3FG=P.).,S\42T["GW\S:PQ6Z0J]8WJ1@:QTQG6=<,,"$5*L
MC9)F%2Q.3F<_*#_Y%]LJX4$>KDH@!K'<1M\DYF*3T@,4H=&0;!B -[UFVO.*
M&5LW@AVYD,._\QNQUJ9L-MPM-%7PW G_^_!G+J92 BM!9G>%C,09>E2X$;YA
M;O"/-=HN%=IQ<A.JV"(PJ&O"!E</18ITDO.Z]GU7Y4W!B?8#WWBQ8X#S*5/U
M9 4::]%-67W&1\R3-9;'Q)'A$EGY=Z=IR:'ND"%+=\8&/H?HE&?PZY1*@N7Y
MH=PC[FE"V-"F(!3IOFMP_I+-X2L[2:=$'5Q8-U#H@L-B&'R+W%4K<*L>+X_]
M3(07?@CS;H,3ZW59-3O&XD9QE/+R+]8\)98WIP]:ST0)5EQK"O0XFT$*8#'(
MS)H%SH@B+5TYTX*PFO)<4OY8JVTH26I=^[("982R@[X0;YJ9A<W%WX(A5Y)L
M,8!V H<%B1T:=:N"Y%0![<--[<DD#9)Y2:[3:_': J1QK/8N077RV*C1@5RY
M$./L=5;;M*YL:=-0A<,J:]!>[0/W#^K72?3T*+LM%5HLIR=1]"DLZ2\V6_,]
MPR ;/(E$?&9HY_ /#);*V^;/'&[(.\,6"3*G-J\#KF3&LYD$18-V.SLM[3=K
MN",Y/DSOYT>8"3$B+IBM@EN!7[IJ5_8Y"Q=;5D<.6Q!B#ZP0HAE>(*/A:4AX
M*X.N1<F[V9%9H5_M*O?]F.A\JE5"4;?3G9Z<OHR8F)P9S!W)V32&U<VI;YXZ
M 7;/BVWLW/FB=(.[WQ0;> E=NG>=J%V7[S<G>,"K[M+U",JN)Z,5<?;BA]J-
MV>TN#(;4=8;CP6$Q/X=:>3F*<*[4;^Q PV98_-VR+--HD8#4C_[<T?RY09BH
M.K_O"G,F7?VW94(D+BA%OV1=ZFJ5-K MMU#(^)J^+-881#BFT/DN6>P*'(X(
MPD&_R*H5:VLR9B:@I:@-SJ '84],C!=CH7V!QV@"GA*JX1ZKN09]EV?79$Q8
M<LR^CO\^1K+G)U3X.)56R+.IU#[N[-'U+,(H[EZR^;0G0\G<(LU!';V$T^S?
M=[7\3M ^2N3TB.&_^;QE %<''[M*/G,.IB2 @P1<+-P'_,HJ##S/DQ;]L&N$
M9;%L-7UYOYYQ6/\UIE&OI8;=/U),.'>"C?5Z7JJ?G7Z[]7H/I#A=,QYMT@#*
MV1OIE +J%?KPM&([,20I^@I;(>S&1Y?X?(J<(&SMUEP+A]VGZ+/(\T!OS$%1
ME0U9>2#Q-77(BN>S((RK'7J9_2$2C2TW*>[TK8C# P/\$C6$]V(<J@MW'_>B
M\>AQ[_>XXP@$!FF[T)&0N!)-H57=-K;4L\XH-G3"'&K^H ):)RFJ]R>Y6;"Q
M,V"#"([0!Q2?8*;.GYZ\Q'D0)6.0!Y/;]70YNE\D+H# U'2!FPS-!=8',;MK
M_;_J\?VI\>L/ XIK<CIU]^B)1'8%I@"/N<(,<<=S[&H*CAH_6A&:#4F$SDB&
M).+@,C21(E=2$%.!I#'X5UC&%\ IW$RIC*\(0?C\U7$TN:5+P,(K06@J&WXH
MJV7";$\VSH5&\@TIH0]M76=)'/WS<Y7 N\71Y148RC'&L[($?_RFPN@\W'M#
M]_:OA(=6A7%J,9\Q/I,A3R:'E,LI2/F\7,'AH^22!V!/OSF8CY,4_X-AFLD"
M_W-%:! 3/H9WUIUEIK:^ 3$!1N[>9"!P5[8/I*#\N^+Y][XV"9_TQU[3G;:R
M6A%XPUQ0W0C%::>='IZ1X6VHTN(P14!#=Y_).7Z ;G =@'=JA]&U?C#7FFRU
M(?C7BBJE492EXAYO7!3G$KE$,TK779H*EA]!5$P/OA"YWKTNMU89)/W6 ]_C
M97="UC24159CH=?&))@1X&QHKRT\RO?1Y'M@)84JD*Z3!A<@N',XHOY[E(R_
M7C+^D?R15"E2$5N:J 'UK*'2,[=K5!9L0E1)FI4)LS\(Y_*<S82;I$93GTI%
M"2W(OA:%W&ZSN;H^ME>[5/FZS/,6"9P)K=7&W]8&^6\,0H!4ZA]I!N)%V*)$
MBCJ#@Z)DY"O[-]8!28VG)7Z&2^$AF_D5S*,T_L^R]94I-O@5O!=HTV5"CR=Z
M"QDZ6!Y4+]MY/1YU[PR@323,R? 8Q1S=4>%@R<:12YUAA@QC.%&%IB-\[9-2
M)"QQ]&-QG56E+5)^E]P<O#O/Q]WYQ;O3).GOH"41CV0XV[(A\E'Q8*(K-<;
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MO  -<3,QCCO _5A\A0?%N]@#M+*=-QZ<%V+:!N4';JQB\S'+;#X5?ND MLJ
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MZ*CT1'KWG"'.I8NM5<0>^M]Y6XCPNZ?;T'E:;<+H6?D;+<P#6)CP+<L!%;Q
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M@Q:70<C(IL?MQ?FV.-N] C\*T $$" VFN-(6&%^@/04-6Q^&Q!(CE$G<V2=
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MJ.M(VYN?W__KTL(6<&$<4/$Z" G=HAJ_8.;16]@#K)4[^CSIVM<OX9Z]]/S
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MU_CJT0TS*F4-63+L_GPP8/]" PSG13#TIAFMR=SL%9-S<*4!WFAE]33ICKH
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ML-#?P47O<W8X6JM.0'TK0SW-7'0G0[WMY-[]-/\AYO[?&\R);@#-AUN2LJH
MRDO0FHKU[J=T7R5VQ%B:WL9CKEBC<VSD[\].++X<O]73Y__ YQ<^^/.K%V\^
MOCRW%1$?<8R]EUK61=6@?1BAZP)111 C28 CX,\RM%F\IFD&;-V\3#:Q$1]
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MMFA\4.TUVY'LBH.$J,0CT$3:@GJLFL^?<(<31M,RXG:1Y L3PR?'.-T8!3O
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ML*S/1HAH[LDZ65TDFFER,,"P+,NI#C?+V0B:IPPYT4(:>+-'SC%QH#C>!_*
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M_:\].GDPK[0^+E+>]OJZH/8P.U9"5L+G*4-F)C0<ED;*VL6(1@VR>JRZ]MW
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M".H]">IY46X*TL0?FUF5+;*DW*N&:MNLKPMX>)W-G>&AG-@2> 6"@=S67'&
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M8L28@;G*5OPE_.\*_OG\Y*<22U;01HC$ZTQ72+BV*(NL1I])_HH1EFRO'5E
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MNC=?IZ6SQXZI9[B4 R_.4TLT94X*2$.3X/'-P?:HJ\Y#W8=0P0[S^RBKLEI
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MWQP$0'[#DR!3FGHT,@R;]('SK<&Q24^H+J!90))U91_-](YI=%FLT"32SSL
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MZ)QV5'&Z!M]I>])[Z9&6DX4&4C!PANC/93*OBW(0W\WR_6H:8O?JOY":JA'
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M&RC%5;K!5&\Y2VUX8LGMSJMTWI!QS1%Z.GC-AI36=;I"Q7=R.F7JLBJ::*H
M\XB\A4XYL%&<7D\I;1&(JI6*. ^G>.=3S.4H0Z(6K>$LX]ZMLT&[3T*&5^Q
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MMC&9GT,*CY19LF)=]7[1HHB,86[)#?@_^%CW?N[YSB'^ND/\E?:E;^/::/E
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MY:7TY:6M)' !',ZB79ZB6F5>P ^,R;NM<A'!C/A_Q9E;8D&TZLL>E6LVU P
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M9GV&?[3JSBU[+5.[WRG'NB[(YD,!VLF*KW41_?K"W)$\A)9C5<\1Z*<)GN-
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M: W3::\R ].VS$HD$Y%"420G!N$.OCNZI6V?,D]BR:7A,Q]*H+'[Z &@>[W
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MK;=/KA#U'5L)'+I'KQ!QSO1ILL"P/%%L5@BW )AJO:)$>6&U]WPVP^[MR9&
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M.X'Q5ZQ^^W*U*N9LKLUB^% 6\RQ;5/1'\Z_1Q[1."72^QE8V^/VGR[2TG+L
M&UP>C)AV.IP-J\6T8ZH\M \14,,I/1$,;-+:&/<1,+S&0Z<S>6P+STNH!&W
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M](SD"%6)-FPF0$8*S.FB=>-3:V$6.7"19_QSDU2"R9PXYVK3U1P@VDH,'H"
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M)Q_9KC;:1B" )17,FC$'BB=9%?5!>RQ.M0N["MVY63]?-QK-U"T &>-IT@]
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M7W!3">.#-3];P>H/E@T&4_"NIU;\] @$&2W'2#4NV;^8!31/=U9J;\DL^@6
MA\T F-7'[)@(@1=NS) K6SAJZ'?P6,!CQ#16Z,+ 'V(7<KX-*ADLQ+5AX*#C
M(@?,8%2?!F^'[20D)6=6<Q81@SI6M?O%\-\FW/K'8D*6Z&JK%/NP[0>-)4Z6
M8[RSK&GQ18A7BBU#7_,<I[1%\ZM%ZRO!@S,7H1$KA!=;<Z -9?4B%$TB^=:W
MZ=U"S_\_<2QFPZ4 VM,Y2Z+%-Z6@QNKT&UP-\P%>WQD.L;Q/8MM/S%OBS#1>
M[N;O="AV?X *3*&6?'VI9+U T+VMR4)LI=\&%9=C.#N5K ?RJ=(^)>X@T1[K
M:%:"Q8>(1@RIR0]C9<+,;GL@&(.6L)>@_#9Z>\5](*)4+ZTMQJGP3>\15@&P
MBL='6,7A'9^6BQNS3VZKU9R$:<=MF VWJ^A0H#07- G^#$))D'@N-G1(8#:G
M2FF3(X%HJ$/8S@V@2#N5)O'^)Q/%0VVE;"O$2]4'45.G)M (DSZ@I%)??S;7
MJVKN,\"S\M6$3R 0\)0.-0J'OJ*P(8+&.IP)#R(6R'XJGW+'5)?F:V"UP*=8
MK1R1.1_5E9?H\L>4VN1S"L7EBSE%^^RD_B*7>[D@67*"+;/7BFO"N<*)"*UV
MOGGK*QS=V-ON0SP ?\ ^;-L:K]366/$%>&E]PIHDK*F/X3*@YU1J5-W52M[<
MJC';:4@K.EK;S0W/TZM/NT=219?0E0^B7/*ZN"#'U%+'O%R9K;*A"I*^ R-%
MK_T:N>5D0"_$?/T#J-W4-0X<5P/,0P7?<0XX%9 2%;10JT3"U@DN*=5)D=))
MW9Q6.R1. ",'_U1:>W^9)M.GIU[O/*P^3.&8:2Q6^0*#V;>OWG]^\](6$M *
MFG?(B\5H#;()0,V\J8VUS%"SF9EEFTJ:2U$D4,\X&JLX>9CVX%W^+5L$"318
MB<,@3!GFF&U7NWOE($+#U4(/SAL"-I,Q".;/J=>3T&ABC673;V8!)!+6*7>"
MPA2-Y+E\=JB5CGN=56N!6P;/ZV]KJ%(-=*L,Q]T($S]W7_D!>X_C5EPI1)GJ
M!X*DUAPR/.DFEXVR-7LQW?AXDURP%'(]C\P13DQP91[ X?+!O?OQA'E8)\QK
M/&%V&W&+G2@S5.C .1M/H^(!/H+R>";<SYF0<-]6:3Q8_.H_,M#T9GZ#C_"A
M1$M38N'R0UE 6GJ=CEYAY5)\XI@?K/UDZPW;DF2BY,68=.#\Y/34G%3/?YJ:
M'TPP=':CU1,6X176&$&]5&J5=*3?%RZUTM[#]HGO.X Q.SM78X9IF<>-<7-H
M;#UZR2C+,;"#ACR,; JPO<-Z)T13S*3)$"*1UY=I>9%AG^'O_X@>7\:97K!T
MV+(1;/#,23[A->E9#_M0?D\1^V:>/7J%M ##/)J/7FTOKQ9*1U;C+L*L"7HS
M*666/1&)6F6IL8FCY&RN@#/5!YK$$TZS#Q93Y9MM?WN@([UOP8EJG*+&G!?\
M-=C(Z<HX'K%[02T\O%];2D,C(N%SG=ZI[6&NA7O(<@.2QA+=A3ZL%/SV'+GM
M1XM^NG93G6I,=6);991.5!2 D=LIN-7L..&_B[1<2-4<K]PV:?J6F,I5D^;$
M^]JF*MD_.8[EV)^)3HE)P"YG*QX9,-E]1X#>?,68,RGF$\0-#H!T:R)$*^#Z
MW58AG?EY$^7F<3S9'*R[>X]W2KH?L]<FL=J2D;&VVEH,AJ*!MYG;=O4_;/0P
M-\*%AOT9]@6;!(8*HWT36\.TI,N15/^<5$^J)8 N4Y7B[KKQ=YONZ]&V**6L
MT/*^<_18T.;<8?I)#8PY29A%V.-GPW:3.?3F4"7D!A9CK'*1W1N]_R+K]5)1
M( 39*_<N<U5!&+2O]DOZ#;E^A^FBB01T.UNI<9366SC @:IY>>WA)E/;(-K
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MOP=#K.0Z!D+88)=2G;4 1#HK4\T##2<_0 &#%Y=3-0(RFP=,F^*E=7@]8]<
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M[#8KI<I"!,R##?CO: -JM'\-NC\?WH%(VIQ<9S6C@;$K&&[%=HK )T<+[G2
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M;\0)^\.3'^DJN-REZ%^M$8W#KPEOMM0Z*Q>ZXI@ _/ED\M]85<T_+B:_?KR
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M2V",2&*<'3\ERZD/O-PO0,@"TO)7/6^]E]:]FNP.VNOT6:B^3I]^;_WEQ(5
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M5V3UD.S$_==#2;3=>1= @^OJ.2^Q51G^RC>!KT2H6H;/[3*8>ZZQ%^9C^HR
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M*^Z0<0U."?4[T'0;G>36WGD;WT0"Z\JF9GA25+;*F%!_>-P4^$^OXT0@#NB
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M7TXP;9Y 25 2B>^J=)%2#QQYT%&K+[BM%^A<+.[&T-RTDJO#O4XWTP?@W\[
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M8@C. ]MTVBR&]O(E<?C'K,U[0S6&NYL&&(SJUFQ"HJ$ &WL)ME*Y%D$18R-
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M%XGZ%2X(28E\DR9\&]A@C8V.^0BH4= /SYS4:'03@/(W6DU@,1+5UOU)A5S
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M9@MQ8F$TK.+5(8GK+5MG-3(B5;*,2I#Y!DML)*CVS=,SZQBXEK.2/XS _1R
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M]*8O@'N&,9\_B!O[+I]<Y^71^WSZ:S;1IH.6M#\]_R6?5J46/D?:.'E0;NU
ML*-0#*3[D"?W39[5>@/,CL[:$B!)U]FB;WH?U:[^"%X33?S_?O;B67*<G+PZ
M/M'/_"9O$['H'\F\!.;*ZTIK#>RLCJ'+JNZ/$PWYK?#4O6OOU&*B'8FKY-/1
MW_]V<O+\EZ0^*OICGD-^HY^.D[H%MTG?K-!?7ZEZ7K>/5,6\>Y*</'_^;8[>
M7SYVNZL>Y? 'K]U_RZ?7F2J.?BV4:JJ#;A^(;A](O+\O2=CWO_=7^[OG3C<K
M_4<?3QI00,GPC[B 4AP&H+_,L?G=6;[*D3_QC?;#@$(I33Z4*OFHRK))_@F@
MM@\?/R4GF+4_27',9UFS K#XF_/D^-7+DZ?$,*/-([:,X!'3=?)AJ>A@-72!
MV&"C9T]/QLG/KYX_^>GI,?_^;7;'7_[T_*=Q<O+R^9,73W_F+RUD+"\!SILC
M^6.Q'K((H5DX??WY[:=V"4 %%"#0*O:AA7,PI<2I/K5+=9C1+YS1-WDS+:JF
MK57R666+Y#<(LX]<0/-2(5ZEO!K3+ ]TFC\L"R@]N563#$3'P";YHKQ1#;1Y
MN32MW&FR1[GYPA<1PY[KJZ*:9,413OA1,[!=G2:F>IV2H14&Y.'#I>WQN[$"
MPO4(MKUBO"Q70W=G144/\?'8N.9[;#@,QW(X?G7T(DA%A9V7(E:#-@B.3H_2
MY%U5SO2&>%UK47>=)C]IX_]M4>F=<O;KV7&*EU_55;M,SO1]P,8XR\ILEB6?
M_MVBR4&_3Y/SX^?)BW>OT^3W,H>D_O_5XYL!$6<0?/GX]MTIGOO46!N0%_V,
M;.LC=-P&>N#SIFE5O9P7V6".^=@R!-X+Y_*X3MK-8 [:R=.C8W'0^FOSQ''#
M(MK9## OB'T%< NZUF6[F "A@]=6%-E7?9G\/]#N6&_%,LMKM2\%10-D('^_
M#;FTB9*-0=&RP3OAF6W#-0,$ >JJMM8WN":@!VR'55WIQX3/DU6/6&D[T^9I
M0WWLMQ3LD%@8)C[3 &D>-,9EJU/UR5-7%=8GV?(PHB%<5194)E?"XG(ODK8L
ML+^P+1;#RH#-E526NR(L\SQ*^@O.>7<Y[(BI0"<XMZQ!YR(XH I!>-Y6/!X)
M*K=AOW9+YH?-M]/FHSF#!LZ&8M7-)PL-K"(B>"1QX+10 &16M J7<E]TP] 8
M4#?MI\^"XNAA<<[)Y_\Z3SZ^._W\]L/E;\G%I^3CY8=_7+PY?V-*S$X_Z4]-
M4=GI>_GYZ3].+]Z=OGYWSE_SW4Y_/7__.?EX>OGYXOQ3,M(7OCE_>_%>W_+U
M^;L/_QPG;SXD[S]\3OYY>GEYJJ_$WYR=_7YY>O:OY,-E<O;AMX_OSC^?OS__
M]"GY\!:_?_WA\O+#/\\OD]]./Y]?7IR^^P17XB_?G/_/[_C+M]Z[I#C8\__W
M\5+?YMV_DC<7G\[>G5[\EKR[.'U]\>[B\[\2?=D![NO!?9\=X+[W31GJ?7FI
MC\A[V(\??KOX].GBP_M/R=O+#[_U;%Q]2MY_,)L?M^WI^W\E__?B_9O4;-<T
MN=!'X$*?&'W33Y]//__^^</EO_2G[\_>_?[FXOVO^!-YB]_.+\_^2__!6SM-
MWEY\QO,#>_R4#N/9[^].+Y./OU]^_/#I7+OQ']X_N7C_]E+?[OPW.+%X@"XN
MW^#5_THN+W[]K\]XS-Y>GI^_T>^#+_6/B\O?/YWCYQ_T"\)Q?7,.)_S\[#,,
M_)-^4_W!ZW_A&)TL^!?,T=F']^_U=7J*DG]>?/ZO+4?;'&7B%;%MQLCBVF13
MBYX4&#-DTHM<.8BMRF;:)JLSP HD([^QW^!Y+.A%^96&0%CARO],O=_:>KH"
MS.P\W]1G N &2X"1+ZJF@<)OXNA)DUFVT/)&_T-6$NKKU!WT_E*6[>;/'!BA
M#$T+&+G:.4XMKTK08R:H.?0'ZNIW^_E>[#7<>J1IN/[5)EE^@T!:GB&O?5VU
M5T2=@XW+2[61_H;H0^\[#\!YZ/=;R[!2 %\06Z7A$_YH]:O/\JGA8,R2>5YF
M!5KZ955J^U)E1/[S1SN[6C!5.:XO=-0HX##9'AE7M1YE4JHK+8F1QQ$:J.=%
M,6\+:+6B)W_63AW%A-NWZX.UORT2?ZUWT0V<%*+AZ A V+-B0N]]!'M/H"G-
M38F4EKHW38'(<@7_QK+:?[<0F\VPIF2I?0D\&+Q%DU&F=^82>#S0":&[43,B
MX#<RU^T-S<T ">-/H51>,F^!;SB]!G4G0XLI%0+92",'&JF*CB*-N"6VA@.\
M0(#CVNY+\FB-?AJMO@MN2[5]O(V]]^EA)MM(3MA'V(W]>NA13"6._<" *H$H
M]/1PWU(OM44%N0LDX_D((/RI.4R&V:PRO5Q62:&R9H6M5EPC8?B<VH^YEH'4
MR=.[&[RQ[&"+PVPPP*)FTC[Y6.<W,-9/^GAJW0+^9$8Y$\L"8AE )'U$:=D!
M8&*T&-17T%<0$U*6R<'R\")W  ]-45^6R+@KHE:<Z9$">UD:6Z;NSZPN!2VE
MI1<2 HLP$;?X,'$O()YQW"F<-OJT0C("TY@4R^E6V 056,](6^I?-AAB7T +
M,$<^K#^):FU8 JU4(;:'_.J.%T]J=+,2]$9]"V%X*\)YM4UM\(#J]0 "O@4/
M A3RDR7=.'?W[##7&#;AM%M/UF%N:-I)D\_RK#9DB/E*7"AF:XZB'>F8\##%
M)QHV6#C/A9[G;RG;AU%"?S(4(;]#"?T_B5R&C*QSV#E$Y\*X+?W/&;*S/'#L
M:4_T__"*[$?Y!L:89*[%&$"6@'-'N\?K39F'M <7  HY))@4MB4PUMVI>DI>
MED<"MD0YZPP&VV^HAY6&U7:%V$)%S4>9'8M)@("WIA96,3R3VC&AU:$'S6-1
M7B]Q?T36(\TF&2 33*^R&;HQJ[QL#5EKLU++AO0@'BS383R\'[2ZT4I*]G6C
M+![^TPZ)7\(XF^%0!8VMO3<G?00?J*6WW<@$U0/Q +=4+&5CLTW=O"2U-C#,
MH9'5(C]4_[NE."EI;]:BR$7=,*.JW10-U:KS"Y@4VSJYK=IB)M)D8 1!\*P*
MR-&LS>=Y\G;[8,(#F8 <R1OL"S@!S,1XZJP+:PC@LJ"C2QN+:9/( P.B5]OT
MG/-YQ&2\4*(%I:3.\SDH0IZC5UJ_6()C)MPW;^G&;^_L'@Z -T.FP5UKI[9%
M!-XPI%:$OXF'&TU>/:.=)MKHVA-T']Q(WE,VYTE;AOD9J><US#@8?TV#QR2E
M>$;#S%Z943BF0_:*>\F?U7K1)<4F,>'J?=N:/L/^6K]1\ZPM5D"_>975,TJD
M;F?GW23%?&_8DVF(: /3^SJ;V<:Y=:1+(@\KX>PP&.U[8@#=MZ8 H/%?35;&
M=K":[4A;AIEQ:AY(40\CF6,2\G["C"F_+4]R$$>FH[%P)Q,0J7K<5M+AZ4Q=
M8\(I.;;P-].@8QL0<!>S6WA)_>XE"P7G+BEGPDGV$+U35NV*.\X =3?/FGSZ
M9+V!?II%0W@P8F[;,$-U!E;QCXN+!\W-&R$[T5)SGJ\,@Z%4HD:I>JJV7TK\
MD/G'YX\W_S@8;V2 &#GF_,H$'9)@73PY.GZ>BK].GD:H>9.+<EJC  0A9>P)
M[V<GL9^=6SO$_@A/HOC=\^[ODDLUIR(.?5#%TTJ5LYTA XMIK^M2&M92:Z)Z
MQC[^DU$[U $L)5N) '^+:D9<3IPJ"OH9N*Y;52W9907>'D\SSC9PI:T3Z+&.
MRB!B\!KY=*FX?8(17-SBW#B)&WX:U3$V-FNL6#8G.\\929KSQ/%Y=KN@4]-;
M:U/6QDC$>.9B21E?T*6F4_P-X.ZAI=4=M9$>W>7, Y=Z/6G0FJZ5ZY;5-^9+
M=5,5-ZY3C6R8(WO?8#='_6-WO>#&#7K^$&T=6,&QZ1F/#RFS70!RI>DE%(3]
MH9MG#C(D:\*.*4'#%,/&#1?!0=("1.X#KVLS=F@3;5B6-:3*EEDAV/6M2ZHW
MZKLSJ!F;Z(-L3Z[X=<UI!]N0B&1$*2Z#F\TATV":3EMS-MTV<.4:<CLJW@P]
M2<7-?2>'O.Q.FPSEQ"XRS1KKVJ;7OBHX-ZO*K*417 %OLMDS+A0!0,ZUVQ40
M18(MP-ZFD" S]D-KBLB+"@&A;)^-9F/3WD\;B:LEI*@P?C"]U@,#)D&3_V*N
M;M=":L/NE@S,U"$)<O\BYV%_8T-M(DC #^#GX?/GV'<2(PVE_J"JU]Q\@]1<
M;>::)*]XP6._8\9F"2\!M5&Y:T?;.97RC>V7YEQN61QYRC<ME'M\WZGW18B8
M9-I;"!&98DK2!#XM SO&$S=N '6WS&MO5SJQ^6T$3DIMW#@W+=[^9XR3 3B+
M6O+"-BAINE<<&\R*%>M<O88PKQFL<LUAJ>Y.L8_\HH&#"S^#M(J*OX9["Q<9
MB"6D9<S/>. SL#?SE;F.<XKA7A197;[BM^P/"GKD)4&+]'X*.D!P_CVT0+GA
ML GW<;*?*CW!"\PHO&4$F9M#UX(#+#!KIZYE0->+[F.VE>*N7J^ .KFJLY):
MA)C)_S)M-LHA<@BO@K]M5E5%6=74ZW\3$=@&E@#DPM,ZGU"LUO-%JMIW%HAU
MV/QP@W.""]#G203='N4-N V@GML/N'3R#O0=NPR4!"=3ES91T(NA:\J7F/]=
M90C>81V&0>M)UNBMR>6]G_5MS#!J\1R&#9P5%:9UWF@A 9KD1BL2M='%>Z6%
M68I-SD$>HQRN@Y'@A[0HO[89;(Q*#]@@S?*ZISLE7[N^QW;!$>\T9!%W%"$R
M%W?<]87<C^^SK5/V6^B@"7GN4B+BY,'2X_&U!WWD0!+X,"^0#M \EC=1]?,<
MA%/6&&]K2H%ZI[#Y=)>*!$"MXB[.F)5O(/Z;P&W:>A\\#K-*'SCPCX*[!3>#
M\=H=[/M;?B.M+4NQD\-'OL:N'A^Y> 'W^4(;!?FRZ'MSFD XAT;GI/34#6/C
MOL4V[<5]P0&75\:?<_ NMP(RASDW#!-]V*FQ=9&FJ]',JE/<[%JU4"S&B#27
M\>N)MCA_O!&AH.\0A*%]3Y&A;7(6;NS(7<ZJ&U5FKN+ V7!)S54'*T8KCM@,
M\3O9P.W:QF41\0;P*VRORE*B^[RQ[SB:W*/^\/R&9\]\1HAM>&-JQ6>A'^!2
MJAH1:-@'"JCD5=_[?9V</(B\@\C;9Y%G ]%-:L6? S13#-_@F?O%(LB?X0A%
M;7K>>=ZL[\9V038=!QU+NAL69:';3%X&^XJ^3+1.^ZQ5PH+=W+S^:P-7)+\/
MJ5B9BGWQ>%.Q#Y1Y#>.#X[0G<OEU8;<Q*&^+S"/D-SOKYEH\VUKN(,!]A6X^
MB@F ?T5_0<*$?K=%V[N $,1,H H(D#Q)+!!E_=E(V R?E5(BCN6,'P>+A<$Z
MLNV;AKJZDG.80:]PG <SYF#&#,6,N?MJW^X;6"^8-;A#-[.=5/4L1QI"Q&+E
MJFQL&-.%]*AXA>6#;#O+R$3ZG;W*R9H+/;J)EF<E5\^%#Y3W D.'8-S./N'P
M6O=F:>(EE_RG%#@<WW#B)%>+_V,& 2)'KXX#(ONY,HIQ=NKDH'X3(F447(L'
M?>\521-!S8.P>IS"BLL6!B"L^@ >'+UAO>R%;SA,+)P.*.QH5]^L8()]DT^W
M4'FB!VX24\XDD"=$>R,0P8E'4K[+0%*3V<$ #*6/#B?Q<!*_XB1Z&@-SXST8
M2$Y6&EQC7R9V(^V=*VG%:*(\3(%=X:K-U^@H9;,9EMX4A2H2T*)6,F ]B_8:
M$7@OXAO6(MIQ1)9S@\J<+,X'?)*9OBD:+"&"$6[A,7$@)O0J*_/_6$<A+_7R
M+RO?#W1<#OO"GC TWC:D]/3J5%9A\=.7[OV1J87BD@UPDB%/,':G8EM\G<WB
M#34=D3-S9X^"3+1R3G>>30V=#"!P84)PP_$NE<@$@0L(L,AQ (29&B[S<G,F
M(0V>">W=-HZ=&-/(.FM *8V%S%*C=C>OB4@"O77PY_!?+4'D$LNJ('0WIE.L
M0K-A'2RF Q"6,+Q7'&+0]P3D$4(X]8&W)7E<#Q)CHS#/B=8=V?T@'"*8]S3
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MX+7FH:YU63Y]-EN8(W#@79+TH3RC!GMR##0*-%O#[A4!C"/1TV10  *U+,Y
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MMB=#0\K\&X[Q,84PF6.D-QN.A/O,_$8^-0I?/C6K;2:\B>8X*3W#'5$?"TR
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M0,/>ME4F I82)VHZ#P;[I40=%2"W\CB'L[**[PT&V85!F'U:Z3 [\M1(TS,
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M*+=-"PBTV4B>D"%[<2\1RL4,#$QC?"R*>:,*C\PFF'.=H/T,D]LTP""[]&O
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M^/U_41HA;LHCH.%?_>WYA_>OC;R\NCA^?_(+7EIE.^L![4E:EEXSO1'B+&$
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M<P/-%'J%)PA3 !&LB5H$C) (@DO.!1UDX6#66M5ZF*;7*SQ!E(K/P99BE)0
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M!9I[!LN$P@]5PP_E6\(!ZW+.248*(8)%B\E;IR*HXDJ$19?GG^- &(>@;>&
MMR2B P6F#O0;B26%:$0@XPUK05IPX,?'3FY[L.16B% W5[!:&0G10%WR#W73
M!=0IJ.!3:5/IN#\L*CA&Z((S3ZE'93[+5;FB#"@7%* "8550/H"W0$JE(',;
M)JV> WIF4/L' ]JMQVHMYPK@]>4BOW7V/((,D)!QIE"4!&=M$ Y<,8Z,* %1
MM&"6P3EL3P^'38^&PR?IOP^;8?.%Q8X_'5!>&3_T/$XL0&L=%(\Q!LF>6-5]
M9"$Y+V.& G)NJKI.0X"G F@!%Z-1EJ0O8'6.'&EGS@Y2 5TXY6H1H*T0X*F
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M#H<T>L;-LM.ODYDN(?ZB?T2#7KW-TWXO?R\+;C_+;J=K4Y'(H J&)"!S&IY
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MX)23M5D)0#[SZ"9!2-MCD(5V5.W8W*5NM^YIB[V3A7I\T=4#[X-60$JICK?
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MZ.&@VW;;O4H' ]EV1WWOXTQ)7A /P%\P,9A.NVWW^!;T\)XAM-VVN_8J[6B
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M5&R[E=9CB=-QZ"5)L@ORR2DV(PY]0:YUV%@6"IBUA_?71\>'/SQ$<N[>RT[
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M"="98H@A'!BG,$\_N0?&J9FJ1V$[K#M(#T>C_9?W[ '6^0F'N_U#2B;BL;H
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MDN;GZ.@00%F":MZBRK%-%6W,$-8+L\M_5'E<1'$H"4;QDN;T>[H!>FA8T(&
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M;OR#J+A*<QX'J4#0<FK3 *-9(KP7\;M8:$#<96NV9Q*#JQ;1MFC9C_YZM?X
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M/G99Y+4EZ%J_L%O(^'5RJSJ5BK!"U'<FQJS/'F.8VZ3\"=N?U&*95M$^P9<
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MH"*<]+.58MRJ2+OKXK%]<I30MM2G1YFQ3>_8']*KJ7U!C8'@^E6\R##23.@
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M%!J]:1A$7.I+1&H2QEA:Z>F?D)&M6=AM\;JA#.A@CS?5($??(.SQ >C*62Y
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M>VY\;L8^HPZ;ZA?"R\ETBORZH%CV/&8^,NV&A5?*/N:K.?.?KG#5&DB(7J9
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MOH?-OL9QR>\AK27PG[#8W(I((+L4=*&R0#9M"21<>T6R9NU>;NI)PX\O\^!
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M+;+9[R@"<X]T3'MMGC9*]:79YK$*<H<2!3%W=>U$430L M&6'^,.^'ZG!$:
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MO(V+SN/?V/J]Q,'C17FY>G6A!+^E;:9E.2-]2F_C*'@[Q'/DXK!537$%.@7
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M-1\F5MAZ:MTQBJWJ^N"J/1&O$57IMRPZ92<" E8O,"G/R;AR I=^&$X?]B_
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M:&=E1HRA9Q[PN\P-(7^NA&;UOEZ@G5Z>O)<_9]?S5X[ &AGGMW3#O]=Q>74
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MM+,P%W&WSM:/(J5OR[]6!ONU57-M;';^]VE8MLLZZ7IS,LQ?NKJFIC<L76)
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M6-HVM$M>S8.5WTM?R7^6A#TPS64K+$BD=.B2O7:&8@R*KZE6=LU&6KU[44S
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MK<R;V" W7LK*?*DK\Z'L@2>R(H/_!N_RE?123"T@D7CV77OA'& E@Y 2H2K
MR,V:(JW,1<4GNUG=RN2C8RRLFW(>'X@[ZF95W?)NY5==[+%8+0K51ZL;8""S
M^TFR9496;J18QLY*R'N^QWL)XS9A?97:E6!4OG$J <.[>\\/'PR7(K^0X$_B
MC4EV4 H>5HUXUXJQZHQF;R=-*_X.&HK0[5T7>A:S@^A1B$-8"1( <-%&!-UH
M0F)T+8C^W-2S\)]/\>&DJ%^/GB%H#I^_P*3?O/'STQ^>O;AQ*^EPXM<"]((3
MS?1QZN*0ARI;Y"@7&U,_L\8>R7L<CD+ ^6MX=>:2[GPKIVT>=7*,--Y#Y+(
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M.7SU0"-+-^62'T0'2R]6<IT)@D"?AGV(EEU6=&>J^I5$N7\\/GY^(??E)ST
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MZK4F5]7'\*_I7C!<FWQ16L,2XE0MNR)<9"K7S&U":O0 LA2VB+.Q WBEE4Y
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M1_/=,7ET#B0KH*A]>(@[-XQ\&=,2EWT<]L<)17Y^"Y<Y5M7C2!2#O-]9-=L
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M2=,K$JK$(T .G."]=]H!(D<?LK/"VBS9!YSL"F>>-#,D-.;.,1^SC4+^+6Z
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M#7XM;)<\2\P/VO$CW1CHDP<7;WK:][@TR3]48.@^SSESP1M8GG+KB"(<YU7
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M_ITL)K.5H#P"32$B/HU*A>JS=8B]>"K'$VS</."?U <3I1Q!)O!U+M<G&(8
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M7/'Z45N?O=LJ&E>!%+'>RIGP" NRZ<3/K#:PIA@B^MUMA17%N+7\=2K*X%^
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MFA=4U_G\% LD\*+5]P+^1HG-*1B8'&099IQ\2LR(B ;Y!("I2L/D@"@C;[R
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MXS=):MCBM*]8V'?F27OP2R^_SYXL M6;6ON,2X)*V9>&M<5YC'D_E_>9$ ;
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M7%44 8+=&2._BX8^L&D!=Y:P+5:(J@')JZ1556DHG\<WYLV6341BE?A4/JE
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MV"6RF Q80#&.W79ZF%$O]^5:SH(FX&*=VA7=,Q[!]B2TB/LL_: AT%ZK4()
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M_,@:M0Y$ES9.I-=-J4(TT/\[#]44EFS&S\8A9]_/V!1F^))Y-VP5_>V7W$+
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MFO61MR_OGKUPH?T N38)A?DOTV0S%R^$2*$(AQ 9&N8F#*<;S"Z")(3?D3$
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MY*3Z5'!;U[29TL*"J9#/, H$+!6*6F0JS%0')!4(]8@]G$<RHT)5*KK]5BQ
ML8D.@HA(_IC]($.!*B'%@9!Y)'+9Q"?*L9MQ+"!;SK'FS,7BM'&21L*U-"P^
MC=$*/$;R9&6Y>/)6P/BFPE?U=ED=IG83^8O#P>(4ND2W4;-W"J&G= AEJZKX
MYE\)G'_TG@5+@"[)8H.VDHK:BA;NCVPA)5PE5Z*&Q_?F7J$FMI'"N!9<. B
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MZ3NXY[3Z8,D%(2O44!P\DT93W%[<MFB_"_;>8+#_,OA>H]?O5V;8;J,_NA_
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M UX2>G!R"ZZUV5-KM9=?6"WY,26R#N 0R%?TY65V9(_MXSU/)GB;8=81"*G
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M_DV2-6Q/LA!"$BS +7$#=W?$4L <V,ZKEM.ZZ#CM7JNL>ET#>PJ4UZ MMBZ
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MR&LMK2_G:S @\E"FBB#_Q40X4"-!LB)!%TG$T/5T&#,EP!57+ZE*TET6N'&
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M):RW4 5@X\,C/+$'UT>>;>>4.+,B<TQ1($8'\GEP!:-2)+#E&\72IYB%XI/
M1W7G6-7@ZG-&U47.E<["(T'!$8KR6]IA0[RS53.3J3S6-0D1FW%<_!BGAO5U
MB/<D3CE'B#9@R <).J"J :_34\.(F"2D!N#Q\IWCE"A1HZN#+J\N$54 (B^*
MLY\ZA:61^-!2?!$VI2=V%05H+3_KH#@K'H6>T1K-9*FB*<(:1<D 9.G!VN:H
MS6F=@1.I0+^2B1_G[J?RQ ::) LYEK8)'^1"44/\QE@R!2ZD<M69O6'!9&B3
M;$?IBHQP]F'%<BCCF$5FVC.5QZ/+1.EY<LS//! F65@+<RL,P64D?TDXK=WB
M&*P*V3H7PDSAS,?KV[?7_R6^9 '+;?F4IK QE6RC"/EB?#X.PY.Y0L7B3P6N
M'Q]]_2-ZD$K)T$[8ME.D0#GUR4 [\,>,/"J#E.TP;"DJL50_9W'&Z$2X;8E2
MBD %CYIN73/!^ET1K ^*8)U<__[A%.ZPYU'DWUWPZ)@O?O]0;?(G>1OVA2Y2
MA]8XF+DX8+^,89AC>J^2"ZUUOA!JU$& Q2# SB$$ >ZH]W5V1N .Z#LO[728
M(7S.AMD-*-<H;P"),P4V6BQW7A3+V2OE! B5Y\=>-D8ZZ5'->TD*SZSBTCZS
M.XM1:E:=+Z?DE*HJ<<T.,Y8!'=9%W''$9@60#K7&,F>O+$;/!@5/H410I/0)
M^>/0#C=)_;'_+VW$,/8)\CFS+4F/E]MZ*C8!TK;R?U#L$'KO5(ZXBZ)%XL5^
M7YK> QX?#>;K 9N Q0UG#^U8>=A>Q%'GJ5ZO-N"8"JLD"V(JMJGR6=Q$FG,@
M3M^WW*GV@HTL1,=A3#_X7UNQF')I_@+0]JFF_10*<"7K&:G!I/L8I^K<[&#R
M JN"^85,8=*4,"AT74DV+VL.*IMZ=X &;DP.[!5(W8A04)O#DV@LM1>PRD98
MAA,1 Q2J8FDEC9(=M?12PB^1" <7++6-SEJ86Z HB;.J:=N8FY7UH%CI!.'Q
M'J[#75R:CRX+2XZ#TFTT5H-SU32"U>G\4P1M'SV0;'H=J)@*[?2<@J]QEN*'
M#S$.$N;:+>E?1!F-,Q1U._F /B% @H@<E5B^^H,?9BG[O?+%&.I%J:KWKA]H
M-RJ2ZRK.471MY%XS5*D*WW,SC<2\@+9G,BS89-9RH_A#RWMV;?E$T'MM%--$
M;5$[0OWPWE<>&RH1,I@BR,6)=L(Y29=-^QRF\'Y!G*='JZ \G0)[[%F P8HZ
M9Y)\Z';LE%W)92J@I5C<+AUM,W2"P5?E[A#*T]'*;\WN''B1>N#Y)N2ZU84#
M_=@&.2-'?BK)%,@7<?B0BMN7UG$K7?CP?3FE>W7 O-NH*:4M:T>F !JA*T)9
MSDQ7>3+?IXIEL(/VGQE)Q@%3$%U3TA3Z QJ3<N"\4R&O*SJ1/";P$ONQ5?R$
M:21&;C0V!PY4(R:[1#0]'J.96 ]F0C!<W![YMF')H)[X'(0TTC$3WF-A1M?S
M(BQ.394,55PU[XGC;R1'-ZE *HS]5['Y9GGJXHUA>,WE*Q931<71PGK&]FXU
M#;UORC3Q7R86)0^#+#IW85*4N:8F13'#M4ZJ[X(V-8.=T*N>F] 6^+_X-D>J
MJB4B2'SEGC*+0L62@@]R&2>?,=\?!DBYB?* R8$*4,'F&7H@ER+U*I=G,$_[
M/GS/='I#1F\ ,P/\[*/#(4IJKXKVT0Y^*Z2T/ 2@L?N=(^[(3LW!"KI?6  4
M>"KBAW $)1#X_-&VWR=VP?"*-B$X_Q^H5J'C1^,I@82?[02SXGP)VL+U $D'
M!1C:U6-(M%#&V1M8&0@06P^=-)+[].4(D86R.9DD0A9EBU)A&0\I)P=#V%@Y
M+T7)Y>^1&8:CG@L1QM7872B:HV-6E4<OED4SC5'B7\_2T$^LR4^=4NT#VD$A
MK;4A/I65$4?\@7% O\;NX!%.24XFVH==D615!$XQ8Q;#RN2@^-I2CNG]E"D6
M%,V/0=985$OQ+9-!P&Y-5=8W=S8"\<Q"17.-?JEQSQ_3-90A=<\E+==^7TR
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MZ!NSHQDP2S*;('TU=Z5E27(YKR)W)27/&=91S6<"5_?K8--\/C-@9D4%)S;
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M\5:!A>V>$;@:$%@IL. ,7).MHO5,AKX_9/J9F+ KVW_.O:]!4(/@H$&P!A/
M?K*'63G9SQ/:]QU%GBG1U]O?Z^UW?ND<\_;7H"#L.PAJ[4$!XG,<#1MV=0U@
M#.*DNQIS.!#Y857R<"#;+]^-(]M^+4#7(*AUB"D3D]V,HE8>CGG[M?A8@Z &
MP;IXQ*$H$H6"5BORAP.1'6H_Q+%+C^WCUB [OW2/>?NU[C!E8"I4_D 3TS'+
M#=LP/Q=R-HX,OJL:L.KM'\+V:ZG< D:Y@E,MF-?;/];MUWK)W[O'+9@_V^M[
M*$)YL9I>;<X_YNW7P3#';L<^<H6AC@52@"CWBEC93G,@XL*1QP'5\G(="G7T
M&%#;\NV\7UAQ*&Y';AABE85>K38<[_9KN;D&00V"S?@;5,F5:7#L/0?!2%*[
MJ]QZ'!)KA]>NX-9Z+/8'"Y[UR:<'"Z+6+ZT:/#4&;8*__4)5O"MJI*NZWKCC
M+DRA]GB&U;^H0'JA8OI9ZW)K)=.IF+3%<K8T9Q$"%XUF&W?\OJ(+"M:3&L@A
M-3?*T XG/E[?OKW^+_$E"Z3HG3=[)^[I2?MT3MG^78-V>S>@C8TBL'U>0DWL
MYG2(H"8[8W<@\:6'&'^DYG/85DWW&\7F>W(847^=O#P8?8D%]1M[<SB=W3B<
MQ7HE5;1'VAM =W<#T!B,*9,$"$V>\>N(_-?I]M%)8ZJ%-%P&X$1P(*8?IVE?
M]8\L>,R/9V].I[<;I_,!E*.BB6T.J-]*C]OE7<V"]D+]3%[L**K;M[QM;/ D
MJJ8LGL15HTEAL^_&DR!ZE'*Z28Q>TH'TUKM.#2)Q9=1.2S=KK/R]152A\E$3
M&*"0#+@!]T#ZX8_=JO.<*4MO=*^I!.+4;3D@UCIBFQ>>9N]<.IU.D\#7ZCD7
M\,^)C":!U(UM_7M87D-\RF(-1-4Q&CO\9B&P19B+F_L\2-,_"_XY<N&_KL"J
MV\G012GRT30QI+[AU/@PLL>=39G7WO1I0]\=3\O<7A$&^] R=\=XRKN7YBD]
MW.\M]JT3GQY"&>.MW-'V:;O:?K%ZM033PVCD]K70]$\U59,IMEZ+@7Q[,L:N
M ,(/X>\Q:TD[Q%JI#:7NZ\XXU.Z25- !7G2W=68+,C*"L2]#.?0]&$U$^N+A
M2I$91O@*:C;44)), JCTJ*>J-6.I^Z)D>P'PVTCU86R(;V& G3 CM D\8%-/
M0"#?HU[WP*2C!P>KA>.0W\/H(9"#.^G01-RL,1&!GYAWF9<#.Y+B/J+F]-3U
M,KR724IM-JG5)3-T)3:H+K[^U(8<6*TG)Z;-+^ VCI#W&/55+TWJEYE,H@P[
M>[+1"82W /: .!BX#[.E!<O01S1N;YH!7G0:W?9BG>66:EC7:IQW+C8S[&+M
M]390=7[;_2QF%.MWQWCKF($"KA-Q?X^D6O7+I;;;&ZIY'>-"=@ &40-V2CMG
MSK?!TOL[LN6?J2%NE+J!M>T7C=;=@1XF9">R6S#,Q('V&N'0%(NBR9;!T7+.
M+YO5_6[6B02T_>:"FS_.DU"NPAT[BZUM_^=--X#9 =I3[C;P1)^I>6A?L=^=
MQ>QNV^E<7"R)V-4'NCDZLD\ ;3::O>V#<U](@2*)NTT*4 SY-:9^T_3?T V?
M00TJMKRSR-ON.+WNLM2@^DPW+E7L!4"!&G2V#\Y]H09[(1@@-:CN-7$D(L(J
M:D@M(:Q;F:B%A-TB"Z72T0<O&O2:5T[[JI8-UBD;G+=KV6"_98,$B4!>'[B6
M!6I9H)8%CDX60!6A5)#PX.6!9S@G:FE@W2Z&8Z $^R,0V#7HCD BZ%[5$L%+
MTX%:(M@M.E N!W#PXD#'N;KJUN) +0X\APQ,)5XOG^G5OJ@N$/)2>7@4M;OE
MS.RI2'V3*YR(+)$8>(N1LXGD<&R,J'6]D0K<%2,WH;A:BM:-8AU+RQ&Z:80!
MO/3[@"*(Z545TQL-,5U'>AF&X3KX3L4X3P;]YD.($[\A&S2(F1U#;*-$.J45
M\,^4]^(4UW':$-=Z:SXFH<LQ9AM18+<;/HJ!"]N!@2E"^:>JP.J?]*MF7?X0
M)G53D6338*.K1?OP_IG! ODE\RGN%L!_WH2)'Q-!22W\"BYDB_E+6\EC^ )'
M'?L>QH%SFLBWT$\YY/RSC"GB/_2D_>QH<QX((7<G\:$ZYV'K^0Z89/%$SL,,
M'#M!#MINOOER^RVA?[;>G,Y#///!9_N#AY$/5Y-H0U]*I"!)!A.IS(>%DREV
M.-&@V^JMDFC0NFQ<-6<_7CDCH!YVJ6'KM(@#SA&PTB*0BCVKM=BJ!U[-9 E
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M(UX<@(>5A%6TO%/N'P8C)D@/@7EX,L8X(M!\<KZ T1LQV]1E*(<^92%%#R%
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MP@A**(S@K CW3:QD$&%L)(&0D5\ E>8L5S\6@9N02HO9\UQ,#!=N_6#B[G$
MSN:GNHNXI%\CEZ&3KRT+W= ?1UF"0?^8GZ]V@$@W!4:J=VJ!D3)<IV%',,/Q
M-!!__P"W/1_01C0N&!SP\2,!"54=520J"I+P/2&R)C1</C6?T-X0(.[F*?;Q
M!!ZV]J]LU\Z+%E_PW\!R/AM]AV.0WYK@_NLTA7M#^?V1CA0Z)CED2E+'C.PH
MQ$J (8BQ0 .)#3+/<<0GS9X5J%2]$& ?>36 ?_^WR\YY]TVST3Q',8&_9:I$
M++L\1HQ!5/*?3,C*M?DY[=O!O RFP4,K,X/X"XLI#SX5 #C+RU08Y1F%'_V-
M8]42T&E%H%<+78*"NP%896^(0G.I :3@ ! ?B_DC(48 44$(KJ@/; 71B!C+
M0,*+R&AUO6A=,D45XL[IO XKXRX :9G-94"R Z%F;8CW93:11"Q=W$N'6POH
M'" 6"[EFAJJ34%Q]JTV+3U0.%38T0".1*D[/&V#N">#@VMOPV5!RV2=,(I=N
M(IGAX@2"#1_%2N.P8E4<_5X=GKVYOL0O'K %BL@F#O<XD&B3I'K@]Z"@<5H-
M-5[(X[FP,K<JR/&!ZD8D^1K'$?%ZO#@9LG1?U<"A*B/T"8@ @2SP1U-.@,1*
MQ*!8>'!ZO-7$_*QXI"IN(,?6EA3ZT3:X&+R'VIY9EED^CCBU>C8,H7E$90FR
M"LF+6FC6IY:N6'F"?Y;O']5 Y7,;EVJ47(>EMZT=<5<+MCVA!(X_T'$Q3&%/
M6J?Q_-C+QBC!>%)7BO'=OA]@70=-7+200GF"7"P^]W!I6("(7%*TN4B[QG("
M1DB;UCN>WN,1JMC7++U]E(B5>)@ /<Z/(B QF\2CN+6/XBCY8,RP<&VYH)CQ
MI\F7HNV813M+W\,+F"1<)X]YZ9C5&J5;FI_+MZ#$PP[Q))9%858/D?.45,2C
MLAL9/$5-S1!C(F]^J+H#!:['2J/N%T29T:[-CK0UQ$@D_8C:8J!),XPL+MI2
M+:VIOH\> 9$:ADD?4-;1H@,AK0<XK^U)L$*@]D5+BX>?N^@92F/7V'JF='[E
M97KW^P?E33K5A@K<"K.0,3-/9U8+D#D670[VC[$2GOXE<!_8ND1EB<A0PFJC
M>$?;^ ARJ&?$!@0^U4C$IP0.7#8U;)JV^9!%!(!^!T A<T<@T;+05F7+O !E
M2&K--,E3'- LQI70!RR8<>N44(D&G'-/Y=9)AKU3$%3DQ6&;M$KTA%/LBGP:
ME=V K\"66#"WZ$Y9/*"^+%.6 P=WZG[G8\EM"*5U/(>0[>K-7))N48E&E?ZJ
M9)(ONMC5IX?PF'5.-&V199*%NB*03$6PZ"&<8L"S7:7'AV!O_<0+HB3C&H8L
MI7_2C>2.#Z^^D7N0B3L1=9ON>U29D"O,D<F;,^,'#$)M^/5-W31?HUZ%1;Q<
MN9=)9)4]>FH^94S7^8_HS'3C@2HRB0L8<&\W4RLS=+&P!/T)H%4:(%?A4]8,
MUO>9_ZN)R%G@ES4XV,H4B/PAVW!P1JZ_EW"S0VI\6,D5@$FZM)=^;*W;U/KL
M1_?D,.K+('H0G9\UM-*(U3AJXC55"[;@="67%O%.9%3#8@<S)3T7*X0^4 T#
M8N"A-+HI?8T2NIJ =JAX.S6L )"J?%0LP M::HH,G#I!XLHG09:<VM(Y=7M$
MLS\L#[:I%7(T![%M82)CM*6Z=Y(@<@? /I&-.QBM<?4SKJK;:/VL1*V4_Z ?
MKWX^19BA\'6$=(QK@7V>"I"Q+]W14;,"E[2"AY[FA*]?)!)XF[ Y\4^!@@8N
MQUG$"!X*/")17!4^,1)S1.UKIH@,7D(FG5RE1++M>[I#[%C&=WCU;>H1Q59Y
M:J1[<>:E5"SX>64#]_4X\#R D\8^I8G3,=RAW3Q5@0:*RO)1:3.CR.O+ZP3X
MA.R)5 0,?Z5FMG8E^H>0C]@FUQP$E(_R!J8YSD. 4^ &3!15I,K_H!66^2PI
MD>0K1BT2HS:D[AALT1>D.&0$0+,UC(!&=%0DV8MNX@CZI#BO6"6CV./MJMSC
M;=6([NF^ZD/Z?V]>(+WX)=8R*^]8!07=("5TY\4C3I_+[C'%.:&VC-MJE^($
M12QV-+GYKX5V"4_7-#QE4RUZT\B]9W_^6IRXI[K'-HFX#Y'RK/GCL1Q@*^<
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MO(!>\^?&L^ ]]Z*A+TB)HU%!NN*AR.#DDR'H1!$/:T94CW@U<Z%+B(@&EG/
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MRU20=.B89WFE&8<*6R=(EE2FDE>X@47UEKX>R@%)ANK55-,HKDX>J#@/\G@
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M>%ZSE4M6<C^WI% QW$1#!X1 TX5ZU]:G9^O!HZWV0F<SI\[I2R!+J0!JIT&
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M3#ZR[M:<;D"URZ7/Z4HU-&S2?O*V9?A:T5SM%H0W"UT(P,Q8L>2Z.3H*:&G
MN.=MB5D,?,H"2'*Y'#7[IJ;TU$3Z"B@!XF\LZX$!GJI6:Y+T]987'E9B.M6=
M!B2*A\,? +.;7U<E@$4#JKT,(LPTTM7R\,)]D,U:*.=H.760:0+O*4TT"4>;
MR-<;\HQIJ3'7](B>6^]=-[#.H-M.WE)YG&4"S; ]^*4\9Y=U*:Y*NO=4:F#Z
M2::C,>?*$:TPE 'UMB@/>6;5#:3EF8+/AHXTLHK_6XOKM'K3,:FBUMNVF0XN
M#S!:V,M?EIZRJD55RJ2&1YD(W?<4?DNN(OU@!,:J*73B/0&,HIR(<)OI4FC3
MD.8;EZV82EKN( LF#S08-E9YTPH;[:#0-#M,E-+DD[C_FBHY2W3&4*M;E48\
MAR5,Z3A5FE]CT,!BY8<E11/Q)) 8[93H1M[0]/&R1NJL]$4F#?Y@F/?50:))
M;B&T[9ZN=*G8O#;ANAK$6&AV#QNM$DR0FM;2<KM%>UG;=)N(EAXE*PK ' :-
M4<\1>1/G0\9[TK&M?V<.\<R*G/_6<[(GDX,:UKNN75>^#6#;LFIL7@7-6TV3
M>#L3=FER33VG>3I[?*OVJ51(0W%4U?GG*NMOO1'K)^M3YJ-I-=B,UE'- (J1
MH75<O(7@Q83"EIKLQ4_/V9MX93U;1+UXZ3C>9HXO?^$*5]^M3M0:>F42>65R
M1 F<^7-]_ $]K_$K+'5.U[]4DQFO)V)+ZCF&*ZM'R47T*^P 9O7 I\XG/JKT
M#I!-^PBSGRCL*<M2EY24AQMC;0"H>XH(TZ>QAG'34VCFT&+Q'OE"D@P+XL!@
M;L+ZP_J\-,(2'SF5+7#6'0QOO%4!/NNY1XK% $!C=#,^S5VHN[A]6F49P9X)
M?V4)\._-?+E:"CPMIWY\6DX-UU56ZVNE"F.8@PX="AV#=@P*-/GGTS)H5&K2
M,D(*/L165LC35AL ]I;*CM\U*L&4OYP-P M1_H J>&S,%32>PU<AS[AZ$M-V
M&;W;U,X&C@BUU>2=/I3P<=MZ ]\P)9O-3U?UFBJ_ A YN3@?YB99JF,$C:74
MX8ROV^]U+%?^($]96>5O78I8S9E7+E;EAYF[*H_MZMID8NO;5D[:3<_5Q<E@
M5^5/,):/5754:M6B)VF7#P=2IN%@V5PFA$].1Z/S=[__?GEYN5Z(9/UD>+%N
MS28F7AYCF1T' ,)RZKF::0SG[4$BS.Y/4%K1]%)HLC;I6&8V^H(-BNICD .&
MSI,>P!QD &$ 0+V3=QQ:U\-Q]6 55X%?*$Z'KU5Y$<U1S>\V5LXGEJZR%H/&
M$VNL+WFE*^8,PQ=8S+E4BFD5I?1/.5%73'$R&TL>D#]J)3,^YRKNJJ,=$ 03
MD!177^:FC[/^KE&%N@3A%K8>: [6JUFW]L>Y4F)*' =C53(-A^0)E5_J;/D]
M0@ARPL"A;4C1+'6_-L':2%+(WZE,_H6*C0-\1FZ#9IJ.)I41)YWKKU&.FY2$
M4WLY$QER<(D\AY>M(NDX'V3%J3K;#;@.L.MSO+9I#1L&X?L&\N:+WXKO0F<P
M3#BFFNA;5_@HL'<=)V[2&!(1T\&U*I5Z*;V;D1CH'B'C!$'8KDQ(E+>#"/"Y
MSNUJ<!2(1%4VQ9K 1U#@V-J.U7U$T ZBH;'O*I?6&YT.*-]#7)U*1C$[#VN;
MN-&,>:V2'[JR3ZN3VYY=W[:ZT]MUZT 31-?AJ.N2$%D]N!HP3M30!?WRXZ+,
M)-7#?*43#JGF=];.^_T]Z[R7V-97N7.GUGL(4EU;?XX+N=M%87UF^0_;^B2&
MTL[R8B1WRK:VH/EK8.'0KFMKMG!H_=L[(-8F[)TRE/)>I?/Q$9I3!KK+1TBO
ML?>NF@D@P"LS%_^_3$J77,QZ,NR_QL#6SA,'MHB*%HRE(Z_'=.[4;+>"TW++
ME-M=PP7/#YC[5A[<+L<&%-8'50,[1XBM3_(H!FKDH'D^_5:9UKW-KUN;7ZQ=
ME813F5/K *SOBTV,:(;1;PTFI32(HB;FA"]B/EJ?SFH=:*E"6%"V.K$_W].Q
MLM2&C +4(8ST($&FFE;TR:J^AX(34]GO_%K?L,<N;>4,Z9I8F*=2)N>89?IZ
MRW'/$"X4>:*QP,_&>5;PS&1"H/!,VR:](%TT53VGKAIE"517@6TK;<HYI.(S
M4RLZ*L'/ZN&6IX":7PUL2:LJWCKO8RM[:ANC-I= &HI%X3".H(J^*(FN''WV
MP_2XF@@++P^SXUR8>C!K#L:+>N'&IEZ6]K;YZI/ELZFI<RWJL(W<@7OYAB^W
ME$#)S>'IA*!4.;JRA%RZ&"K?!BZ?J5"N.:CY0<8ANPAR8^N&V<)X/!T*<Y/>
M;6K%F?5!RE:<P\;&ZDK6ZD37P :?*-TV @ZFQO)\UWF3O"V#5T;,S?0IHR*:
MU;6]K*^D%L))IKZH> O27*IR77/RG_$P'T-_F!K5%U\CD&5]3:ZS+X0RB\/F
MN%<5N)4.;5_%.X?)CW)-.G6N)JGHH@:8T5!5L1"RW@#]@Y:%LD&B[,9(Y^E.
M\Z"+H5J(>IZ.KAE:5A]\+\DWRD9C$V8UY%'"ISK+B9D#!V4BEFF[5\EM4_6C
MFS'4$=C6I<#-"KZ2$E!E6SY(5/0S<.J&F(T@MY7-K:,K8?LOE0*XLVFYL;^C
M$_Z7+OS$D\(_+?M->5=%WL8;JQOMFI7@37:6YP#Y6-:K(9^59U! J89DS;YI
M]H01KT 0G7\IB^"8%D-K>%[6D-3%ZY(_59Q#+0S6.;I6]59B4)C08YY#D$K=
M2\$L-1X#$E F>N0MBS'$P^7:C'I1#RUG?Y4PI3%X5*F4D+R0AW85)1C"CU S
M.KP6NLL+1';<@_!ZL=X0OJI0QE!T/HF4Q)85,*/AK]Y*/F%3B;OD J@V \)"
M)Z)24&812NRKQ<I31S'*,Q7>4+UGRN.R/DM:5E\GUG;U0C=_O,:I*/>KJ@\L
MOVZ^LJ_W3GW)=9Q0?;.YPAL^=JD03?CPW 1WX-9_#J5G#HQ1OU$9.)M'T#LF
MJFD$R?Y?*R*B:P(Z-?<2U)SCO8G?OG%GW1S8D!+&I68S*%\$/(IZBF:1G H^
MA@9)8[%5K%#?3+D!\V^D)[0HG^!6!;'*932)J3!L;[^_OCEX8&5U>G5;T)D,
MPIAU2^0G *C;F;,(]6$(Y-9W+AVS^4N6-P1XHE+?-BZ9[RGUH+/XH &DQ9'J
MWKZIO>#FA;V7NF1T6\O.5.SO+NJ#WD%Y9/Q_US)!6<Q\CP8T831*<<C=*"8A
M#W"0QAZG?P?^V@(<LE7&9D>B;V&\C #MC9V6\U>R;GT!2Y\9%"S@J"\P#-3\
M>ZL*9!20]Y!61<?AK(.L^+&RVN2E1PSJP<&FUE]JH1^%Z0Z$GU6![K"8FF7'
M^ 4D;$UKB3HFE-^ODKJJI5"?_K26J+**&LY?YW_JR%/5J*<>JVM<3*FY"N[E
MBR3\2@MMS0N^+U^PRID"+[T(5IJMPF)ENEWRS]P=!HRR"P.!=M(;QI(%!TQA
M^$/!^UA^\=Q4=)O"EII5;[A?Q6BJ&:L\R^H!V.6R#-,5&N%NYD:J!MU$<BLV
MG/\I4\N^4*Y\VHJ 'GC/)Z=S1\VJF@"3O87-@6$[/=V>J3 $^+ G?00XA12F
MIPBRJRI3J>/#^N-F:\%TJZ\9+(%JIVTS/,IL@UH"Q((;CX!.&A,N9FFJT[/R
M2)#VQ@G@?RM?3W<C:QG3"JD)N->X6^69F+W-RHB0&CM3,V"'?7=[N53T$LJE
MVJ!!6:\8-O75K;I'65+MH11-+KZN45A!VLJVS=+3EV:9J\I#5>&0JCJ)4=WB
MVQ"%ZC;)L%"U(,"W.AZI163RUE*YJKY177=5BT^%-C*1TJF&B=5QF-(U* LV
MJO<IEYG4[]IG9SJWIL8"24LR-GZ'7JM>SY1RJGIN2^R:V56I6TM=E0W*ZN%)
MJP2DO] )J$8I9TT'$RDR5%9M?N V]>K-L:W^4-7A0'7.I&:3YPT-3:#G;99O
M EUAZDZU2:TWR390H_(AD[E,:#(\*50]D.$%8U=5X*JH0O+%2.K1JG6LZO$M
M-:,:!FXRF]G@0KICV0D;*:2V$?0Q5V:C#T=&4T=34D-7)Y4-B9"0Y.)$-:NF
MFJZ2OO),>0),Q<=5NY9DB>34I "J!<W9Y":2:4U>W1W79 /3SIP-)O1\'<;4
MS-S@]EF!L6<LS*@"=97'A09BA9*+^C':6JER*5:'-H4R70I#K&%-88<:7L]W
MT3A\ [*KN%0?GU$*#44@::-4H3:<\I.7$":K/EF_FKPJ=TRJ9'5+=8>VQ'G6
M-N2[J-<_97#.!Z(,9M^ZL4VC"A'W__P7]IT_" 8@-M==8B'0_(7?KS!^92GI
MI9\CZYJX0BY+5>4-1M-.F)ZKQ.O!?1I!_#YIY7M2;.,?N@VT\JMR+G)@Y!X[
M+\2[\H<_N&Z6>9<-U.NI+_TA3[12,2'CC($C<@$]L GKF36IM>C+M8^R[F@_
M993+__/RR>;RNKKT^XC/7J/ANF38&R\[Z_C&:[?=%N-U'T?=;7WWYJ\V;_N[
MVC>]=Y(]@)_^=XVLW:P.DT1(95Z&IM\YEFK%JAY4W<._^SW<\RNXRQ\S_NT,
M P[/5Q3(4#R]*1\/!N- 2G,E:B_P/=_WABK4-?.>]V8.8RM_R1SWN,<<HN6P
M]FF::;VT2K(U#>Z+?4/\XM_PM>WA0S6^<2:D;GHGWU0-Q^!6N>A;Z%!Z,JO2
M<3-.FR+#MCQGOOOV=>M!F_U("K2$$Z3'X.&;N=U=( $<JPUDF,\)>!V'H:_/
M3=/$6"0'*!(X=R? Z^3(P/$ZCES')'!:RI&/]0%;:Q$^PZ*MK]+]!OS2!]N&
M9^,(X'67T.!!PC;G'=LM3R0(PWO*T_Q]7*H2?TZLXX3DE;".1]RG8QVE;7]7
M\;CGT_RW4]:M0 !A?I''ZEO8GR:0_WVRYD=58$P7]4QA_:F4)2M.=9X'?J@Q
MN'6"@P'&=@64:H!H(3-E*J$A^SB"5KYQ?FVEXX'.EJK,'<RPU&F/0J?SJENI
M)\EER-\FHIQV<J$:Q.5]SGOC0G\D9CTS!69HB8'J=(.2]+YJP1B-\T%1Y=),
M'>6Z]2&#ID2-GEFB+)JF0IA+:*KF,Y608L4M;S_,?_'R=3+0&I]7H.JC<9DI
MK9)6@C>^)E<X!@"^JH\?+HAJ2H1"=(0ZGMY0YW_5U@V&9:47C >5KP\8S3"3
M1]'"8.=LHA(E)S?(J&6O9MW)IS(]YM$3I3J_8)3)#Y2E:+#39E!<^1X >CI[
MK\(P@BH?Z0\',-BR3$M F7TY =Q0;;KSIZ:>!54QJ70TA^KA,!GH9*@&X[ B
M T3E"X.\!)DX:.51":Q163$W\1J:H.E8I9PE#\M=Z7H<*VWRITC8N! 3[8H
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MI:U JX7\GL*3>T$Z=S!'TRZ$W<*VLAMMH.,\(<?MEB!,NU AEB6F1MA@3QW
M)XN&#W!M_=-,H !6_%:H,J//^3 18EYQ=L>,36:,\)/ZEMXR1\'-IV4;./R]
M_$0^[&F.5:S* 1WL@<QZ X#]4XWWVVS)L/5ZTE72)/=Y1>[76.2I:GTW!V6%
MKQIZKCJ:\AQZG !'NYX=J\;^:GQ^7=1;PK'#^* ,L'[G-.#\3]FWTS>C=,HI
MHNHSIYE(K>TKJ;E5P\2^'M)AO7F_O?^V@C34GZJ;LNI/?=A_:Y?/TQ!]@%$,
M,,*FOIO_<M<5Y/Q->'3KUI\:\=:,,JW)I'%RY3+U3(P/^SJ*(!^B (OYS$ O
M28>[+"9OO$BC94W=;7)$O!EM(C^C<$'U4/)JW$8U8&%0S4O6]] CY%61<S&.
M^S#0J=[AQC%Z8N2RI":."+742%AHUU##5V#910$_%N-^G^62X_3L /U$TZAA
M"H!'65_ %*5LR(O&[!EYM?%0^'+U8/D*_:Q0W*:G&!MPYWZQ;OU:FDOH:+L:
M,Z*&79G-N^E+7  >GB;K DBOV_<627Z6)./^6#<$:F#-?G\\R*J@U;S6M_GR
M!X^N,;I%)8,&"[[$[JZDKAZ@ X7X:AQ6 7\#8320H-1'+*\:.(OI:0ZJ(0A@
M!Q4O]*ZA>,\,^]#-=KKM;F8R84LG62W5:/[9#J.Y6W&.5%^;@\%8\L&!014?
MZ"Y-:,* %J[Q0'5L&%=&3\JL5;;^DOQ "XSL4MW)@WJ.=:%'5\$T/4#ABSQM
MJ>3O/T"#KNN@#Z^1M=^W@[5A8G>AS4'%TNG$3)D#<9(5NE?SLQX0V^#S#UG>
M?\6\'':\#!3::@<OOZ_'NE0ZN3I3ME@3/\UQYU#AC:L9=3"#M*8='!BRDG[)
M!/UJ-R@OZ=>$1=9^;;-]>%(VM/.G3@C-,8;E/ R B<B%F6;-8GFIE_T #TF!
M?D]]_I[+O%=3ZT+BYQ%M:T#37V]#M.= R#M=B#D36A="_6 1V;G5;\WFNK4I
M#R8C?>R3QEDTE-;VE92PT8N(W>[FZ];!__DOEY(_!O(OU_MC8.V.\_-3&.P[
MJL9E3-.BEFRA:&$!#ZF1"UIO37\>3G&S(S?U9";]>P#BX ) 8+)!&:^ Q9G%
M9!/C%%>O1;#C/$B-/!&$E&;B/]?E%G"5<=B6%B#1=IB/I=9^*'\BZMQ]=NES
M,,&>)!<@/GW40\1NHI<>/E"8H$$C^L"KT9%OZF &T^,EJR!&^2$]GPK"F==*
M6,8J)I?ETGCK@!.,OZH^# > ]_M[UGD/9JBKV1SU@.#ZFJUB)\4X+C*>L;P,
M7,6YE-!3H84L%Z96R+ID&0S?JP?V-(:<5J'2^310,JD]@_DA)S-2_*;O0[RH
M@I\RBN)2Q H3A8W>/1C"(TT7RQ":23E$%M6![)T*B<&GUC9.1Z/SXMWOOVO\
MIF&^GDF71V[">C+L_U[!4Z$3\'] 18K?ZQ\1'R8:O*L58"6*]>]I];N+3W3Q
M]=4GX4D:3)<$W=5LD\IL=U5-M[@*[]>MSU64W0268 ;/!V',R5=P\))6I"67
MRG?@"]3Y!E91HIB F"BF,"8F\W2FZFC.):P/^O_O\^Y'V]J",-[ +H=D6F^T
MUYQF\IB^LR7M87;U3OH1>])FY%FBSM:2, <BE9SO)3%FB1!Q$D<T3,+8IW&4
M!*$(TX2F//A["Q;B8 <C^ &[!*]9 ]:7Y.,B>Z>>-,PA;+C#U[0P<?+7=;PU
MO/CD'EP<D=TQ/]N^./X8G>WWOSE'W_]UNG?VS=G[>7!V=/C%.S[;IL=;.][1
MV:[\.[G:<X^SO>]?G$]DKW?T\[RW]_%#=G1XA/>V$N?(W7;VOQ]=[7_\<KW_
M?>>G_)OL'O+^T=E?/_8^A%>[6[L7QX-_G1[_'%X?G_6RO8_;SO'ASM7^]V_.
M[MFV<W2X0X[.-LF>N^/N_?PB?]Z].KJ.G.-_GSI)_Z\!^QZ-]\_^U9?WEI\]
MZ,GO>,>'7ZYW#P].=\]XMKN5R.\<D;TM^?//#V?__KF-]S;_%MP/$U\D*)*:
M U'Y3Q1QST&)H+&#<<2CQ%W;P!C[__A]8B,VWNISB\;BT<A#5<91'Y=4'3?P
MBW2N4J&2AI*9"B-"%@ SEI$98(6*M9AB@')6H$YPU$<MB \;0*G%\*+*8,)2
M :9-J&RFF6MWXU)O#JL^7ZRB;G96-SNK]:#A1S6PD;*GL^A&]T'G>14DP;\D
MR:JQ=MHQJL&X&:#XWSRXB>V!,T)N;5);&05^6]Y+MQ"%G]I^>-]Y* ]@]$</
M=W@,^,R=F*\M^Q&L+QIH9@';L;+7_^].X[QTC>/:D7/?F6"=QEG>?A!WO84&
MX(DTSA( M=KDUY7S.;1_-XNMLWR(H2?@;_JP<6\KA,YX9A1UUI=%TI:\X(P7
M\A)WT;4Q)IUH+)BH9/V^,)[/6C9>[,C*0W9EK"1YF)6<\Z)M9ES/=G&TI&%\
M"\>8>C9$==<?B+O\/+7!"]U&:CO^ T^LG6S<2%2Z_C1S8Y^+I7PV)TLH>52)
M86TO9Q$.7Z*CISI6W3\Z__DYD;4E+_DJCI>=@#Q#LK;D)1=SQIQ$5"7R??EP
M#&5'RX#CKHBTK(ZD.Z%O/U7YZ UGZ.&(]:8*7!^$AON8O7N!>;]%4*6%4A_9
M$;EO0'(9HK["S.&R^+LE.RK_?(;[V?IBATXKOBJMZ(2/&][6:<5V[6BG%>_K
M_-\PEN .RSG,^J*P]L2E=3#LL\$-"\/.G=I_]*[-_MD^]ULM]PU^:S7*>0W(
M7-DZPNHK9<-(B08'K1_3;<.KF"N^4N*X)7$F:F*J[J[>-?14%5FA6FXJ,M4-
M-S#,@6=R^0IUJ.R)L2<I6O7LE,W95BP&(I6_.^_)M==--JH?"(:7*]"^BTQ<
M%HO$,6@'R<E;JTJK0JMX32KYVT0R7R]3$^\5F*;ZU: 8]PSP54GA%\>(5#+B
M9 B]E%3%02<G@#@X$C/-6.?Y$#KG-1-5/5G#>J2$PD&M>[4,SB5,_AB)OBKO
MEQ^1=N;D%)+<%HN'%Z($!"@AAQJK8GWH=JR68  <DTD$R4?UG+VTK3V< XYR
MG@ND@"8O@*2]4@\#40 60O^KVC6%O\!GX#*AX0X4--.=FO=&7[YK?[3?6G2D
MK76 XNV?:WSU"J_BD]37 )[Q=20)RG*NU<O4'LRV*3_'7N1?35;I$ ,F$ /<
MJ3CD Q$#ZGE&;4,,6+T,;J];G\=Y<LH*C3DS,\*H1!G>*8JQR)6.VTQ3Z3,I
M?ZO\;OXRY'&G-H"WVC_;HJYC>\2QA@ CS/)KJSAE .BL;&XNN!#]681FT&-,
MFH&1!M*3?KG(*PSSWU2#LV5FAJUK?V+J[@V 'O.$&LPY'E_#H1/,S4G.^GHE
M"?AB/>TQ -1!SI5S5B&IPRI&V6@\T@WL%7[-%*AZ!8T^&$H1D!\$7')A/E2(
M:GFY)'TJ<H,<)#<-EJ>_ ]R2L'- K0/(9@Y02!7,D'Z+G3PK3JM']MCE?7R)
MF_CF1BR69].][I)UZM^MP_I>C=N!5&!+Z =_=K?U[X8,L*(Q[2LN_/G%Y-\[
MO-]D0.M>W=)S@U5+(\#\'G.5W[3VQJ#DE:J R3Y:G97&C3^&/"U__4WY>$!8
M_IS+LXKUF<F-.Y>J6%&@XXJE<<6+((_B&44=Q3?@W4S3R++N"\YP&W#%(\$9
MVJ]NHP6]_ 12RHH,5S_CO"=62<Q=)KG,<LCO#OY=1:40_(/H?ZR^/&_U!#"'
MD%76D54O^9+I^IM+P-U<8=GCJR!KQZY+8M<HLJ-PE6V@DV1=2FWGS8:N_8;I
M%U;^L444=R1-FUGV8:I@L7RS5!7R2O;Q899RV?NX. O[2K:Q$\>7L8\/\P2>
M7AQO*Q!K=77 WO!^&:#&#*=?)9E64DGQI-FV;U7N*A?G)F)4IJ]@FJ<5Y\,?
M\A/G531I<KZM(;@N'(!QKU!@ 7\/=1IO>"X&5I_E/\0(1EYE Z@,NV CF'0U
M$"?#D<YAJJP5TS-$Y^7)V$DNX&,B[^LZG7JPJQEP4ZY9I>::(UWU^%&USL8[
M%B4;E.-IU="0)IM<#L<]7G)6!LL=CF 0QSE,SQF9T:M\**50_C9A8TFW;"1?
M]1H^!.\Y+ J-2@TYNG*DERI..=>C!57M498(N74#2/Y?B.;,6;M1E2!_KQ*5
M0"<U^Z3'+O4\6=%+4=8_5[-HRXMQ3ZH7&'MBWDT3J-XS>;-1/C;$-@4Q9IN5
MX&1Y+BZ&^L%ETK&\=SV_54T9AJ&^HS)1.8>#] W5','&9"%)3/D5N/5X(-^X
M-X;2OVDYG5@U)$D!LMVD7R5-53Z_E./IW355@1G,7X-ZH'GDMV>(K_@3Z#PU
M^K><4]OD#O@L5'96.?IUZ\,XAR*O_C 7]B0G9;V>XAZU9ICC)KE2ZFN3\-5K
MO3S->L5HEG&*<7+:7(^!1<_4_%T@H90:*$,=J#BY^H8629:8Q*XDZR6[KC>)
MFW(?O2X8+5.-OQQ6LBKIK1<HE4!/4J!GACR?P!SBH=2T)F^L,]4EEYBBN7E2
MJI#UF1H[94K<2AY9MW8&%3ULO6Y="].<DUQQE)&P8ER<:\T]U"._AS"D<ZQO
MGTA#Q^#O+$_&_6($BF2N7M&5@;5N,65[:;F'.GT/SY-,Q(IBG.O"RDINS$;(
M-<QL@.)4L]IJ,V9?:*D)]@44KV&WM<5K']:MQAA,/;M5;A ,+GX/KDZJ!D#5
M@S9>1'W,X^K5[KKIWMK,+5>YLQ]AJ)J9\V1]K(8[O8@-_"J$I5_3L=:FBR_G
MO755C7G0U+FU)MG;_+JU^<7:59I;6A/YC8-Q3Q1KRV*.L+4:X9_KUJZ\9GUE
MJ1A=6UO50/D7P3FK$'UW:@CCZO=P9[VQ;Z#5C?OU01IEN1/6OZ3'5?"L]%_!
MRGZ6#BOX+SL#Y9#"A4=L>$MW]Q=K?*10N[A]0OV9Y7)/=W96/H?4;>TXXZ 5
MXXSK*;U?JW%)#ZR<;YF*!>.<*4J'W=3&;KSB(YLER$*:)=QZO'?;FB7:I!K#
M%BC&=6N!JG&RQ#V:BUFXZC:\= CA5'#'H&T!$A"ZYW?>_+S&^.2YK=!V%3=J
MQ 8AQB2/.VH<GHF3FOF0\%"( ?Y/V82I S0J9@112]WLJ>(_I>-@FX-6J*-?
M66%MZJ;M W6#=S=W!M^1]L^F@2$,UH,P7'SMOEP07DWM_HV3YY90 +YZL(;/
M4ITO&Q#\P7!K"YW]+5_WMMG?_V!/NP#K-(?9K_]U![M,?*A_'<B= WTGU9+6
M*A!%WP$#.M!CV4?YL&?M2[HW;(/^I-RG?_S.IFWK??C[5P7)CV&'.;9="<O-
M8M'QR8U\$GDW[/2**L/G;>R,C>MV]KX[&ZUM:%'6WD[#C3FHW9C/VHW9K-T8
M& G]2,E?'!MT\KT +HC\1<EW9\=7O7_47=MXWSS-_,EZ*N_R]52(4;$8$]T)
M:CLV.HK:8XB[_;OG_GE3@OIU(MBP?VZ@'!XKLIUM;=66R[MUQO79;F!XJ\Q"
MC5PN3J$&[T)(!SH9]D5G<%_2YF,'=Q;WN6Z@AV^57@4U<#KLR3L7_U/B5D%0
M?PEBW1GE5G$%=MS.*#_;#:2W&V56G%H?>L/+[NS[HK8<.RV*0G<;>,\-#%2)
MH"AJ#-N& ,\K.^@,[DO:>^S<&F)^6.?FZRG%H@LIQ2(UDG/;2K%66&]UUZ3W
M\,:D]Z+J>=M91%K3Q\H*U24)0+-0*03X;*( 4<V*T[*#K\\RU1JG_LW%?\;0
M_I&5Q$R:Q*SKK/*2F-",QD5:=M:IS@\+$X:P]R9]JQZ /6[^53>---"%MZ\2
MU45E;>I>3AP1^N(;GZ=;8N]*;;FA#'KW$E$4=9]Q?&U##V!-WF)\#MCSIHO3
MGNJ:%E>2^JKG5 VNJ!XS3-,LD6=I]6MI?$4RFNF+E5^/ARSGL%-;62X_,LP+
M6S)1Q7/P9=V)*==0# <#T;/!:3 @^/)EF/RM;N^M6AHGVURE_L]8G/7@/ ]C
M.^:QG:G=D^?\<U9#*,^M!%1L?V5(7-_B?)Q#Y_+<SLP3,1"Y&A\BKXASH$.C
M#M",%^FM9HS%DS+J9CD:XGYLJJLAH3]F"/W0TE%,0-9AUQ3W\G'5H_HF>PN<
MHCIFC6^I5)+0W6=R4W/P7[C^N*T[ORL6XD)^43)8RK*\!WW!:0]ZPDW3>-W5
M#T^&0LAAV=MK&I(E"XH:[-J\ZQ]R4;"JVSA6K7WR$:H)')8J%+;U0("4 BX$
M<+_JV[\3NSZ"'<N:5@:%K(G(SDUWM+B"PI!LI*@^^:YJV;& ^ZA&^>&@=ST7
M V$L]S+/?E9KGQ+Y2AG,T!*N2GK^BJ"U"CC7_53J.;G"<Y!+DANM>ZO@_N-!
MN1Q%B:IEV[;&A;!-3W:YUU,+DHQL-EW1*5% "Z<,M&'=J*^U7PDC,6^;EM@X
MW5)5\*?!F3#DS 90_RQWOVZS5].41D/;:%S6ESRIC<^Y/#K*'07D=WGI="R9
MQQ)Y+G^6_]-]\M66IZ5^L>^A<:#3'4 .#.\H%E <8_6SHK%KUF:O& +XPO#,
MM.II,(AK2P"B?<7=F@&DC1R I94"G(Y!>BK #I":8AR?*66CM5:>%3]*GE*K
M+=$"(/PL7Z5RKN*:D$G=0-[$/%!SIYA68UP 0H F2S5;J8(/J%2K'B54:E9X
M,+R_7"RT\[YX,]7P>9G"KS!0,9/;.#G20"J"E?9LS%_YW5E\&8N]=6E,46S^
M_ L%F]%G/[3+EA6&[+ #MG4I0 _K'4BDFP\ZU9(J%X1?\FWM49II2I#+@4/*
M4$&J[.<G;& ,3;5GA])F<  24=_2^"1OWN]_W7\+LM."?9PY?JH1[_@/=2X]
MR768+&=]<3G,?T@28K+R_5RW_E082N-S8]?J/0.]!B O@JO=4ZJCKPYUVNFZ
MC16F9.KN#'TI[UH)Z/HMY$C399!C]0*EA[(I7R,68@"H+@T#\% R&B@ILQ5L
MI!]0NC+@,YJCG+(KVDLU_M>U--X_P+L"3"#M\M3?TY;[8SX<G]]G/2_>UOR_
MS[L?P=&^7]^8+;?%C'HK->.]6]B:[6M&)-4)WHRIO,/0HJI-#3@Q&^CS BPL
M@^%.'-Z*F7&:95QMKAD=CO.[<X0-\%* (U74SX]%;WBOZ3YW8Y77$U'V%A-1
M;N\DM*<F<T#E6QQL?]X_.+3V/U@[>UO;G[?E'WN'UL'VQYVOA]L'VUO6YV]_
M?MIY;VV^?[__;>]P9^^C]6'G8/<>C9WF-] \=6L/S!*LD3ZV-*MHE#KX<R:^
M=_?76>7Z2]7X[LF106?R%-B3Z]L_SP;J-%F:]E\F3)_X-6;(K'IKOQN/I6FZ
MP+8I1V6F%3LVS0N%:EZXW8*]:7@\;V]W,>&[@(AJE_%A/4VN^>1)NSDLJ[%M
M=6RNJ\$R50UF:Y@\P_;*50_^L(0J(=-&,8$JE!2J4'0T@TD#9LXB>CJN\=A&
MI_)T#C=PHC^4 =81@E_8X3)\7;[)0*76WT#/MC:TI?OU2R?AK3J)@3T>:GZ[
MX_<@4E* YZ(CIRJN"H-LJQ"8@=<L[*D0V'18K1H0>+?]J]\<AD*K[T!G?K5?
M1=6LO]P=T!$7./- ED'%4[ZM?UUO5>1_Q6+.>L5P0M;MFT KBVHPK]D0TV18
M\D*CV1!:CPMXCK$K;[X-LJKFJWAKO?G\?G/_S[<3.2HCC_<Y!-W&?;;42G#N
ME3Q;12.J-*C.6][O]/X&CN]O2Y]Y0>$,+1H@R,;W-I9"Q/F8Y=?ZE5RJ7HE
M1#_782XU8_,_8\DX:08O.6EU;@N W9_,SY?IYYOH/UF1:>UBC/63KW.^<!ZJ
M&:N_UNEPN#?*52?]JQSJO&VO,SCKUK[BNXEO92KN;1@-V&R2M>ZTH$KP@*^5
M5BG6+5 U.:1;YI^4FV?I2N,H+:$1AU4 PP#:CH8:[[H^B*MOE-#04_/6;]!F
M2N^G D;Q]AJ8RAKFNK17#3CL7!4Y-!")FY+=J&R 3U35#8VX97E+]4[/5Z1N
MM".0R1BKVH%ZU^]N2111K$.5.*ZOFAW7 :Y+#;&MT\DZ<*GW2(4NY*8/8Y5.
MGIMG9#& DU^>"HT6?2=?"7@N-5F8RD%J)I;LZH8Z!58GM])<KDK+5T4)$P,Q
M2]=^19T4'YJX;)54*FY\;)W:_,4;_&)]=I.4T^O1V610#5P+%.R,6M>Z]17P
MP1L?KMX-LG^JIL@&Z6>6M/4CT :97(J )/!LU0?K@Q:H4O4&@K-R\W[YCA-$
M5KY,O1J3VRN?-,^ATRD+=4B1HB.-:<(D@>6R,R!]H;/CTM;76E.%Q2^%=)HA
MD#WY"+"@X$X;+YM-)J)_^2;?(4+<R\2%X?B&()5)=-9D[[@R9(V3P/-5+?.M
M]7O0JXFDU*:2\UTFO:W\R==ZH\56SJ9:K]9+?;5>.([VQP/Y^U$9!M557>:R
M/!H7RA*JF19PEW&>FPP-G&KTO>[*249?LF+RL<-\VH1.7#9F4S\JJ?S:LK;D
MG?4&OS5'5Z6NM#@5)19^*;C5K/I*=YD;WT'A0LV("[F]BV'OPE@29=1U2D,:
M57E2'IPH!6/R\-+)51D.E2875];9F)\8<3H\;;ZA$45VPP;QH5P[U!*PGAZ8
MH,H#U!"#6K9*__H.FG?$?H@!J @FE? 0*B+@[2ZU$R2?8X-6::S.:)#YBU,,
M8QLEH X^TF-1)45B9FES;P J8M#4@K/;-BSC]2.SR4LX[)JZ?@1%_,O(X-PS
M>WL 52-C7;\EE;]B$="FB?RHHN%(\6\!596)T.<DEMQ6!33S@C?#)SXQJ6ZO
M_RL4;XS545.* O2 6.3.@CPYBL10%XJV<D-P*8??OOX6V '%-@E]JQP4/2^I
M17!UP"_#:)8ZF&IYUDQK.!96>,/FF4>O6W/?S;W'N]W^ %U]7;VQ.E-#,1L4
MJ>D25OG0<^F+]J4='\/(#UV&-U*CM4V%DEQ&(47TC7)E5 !38TGF'$FI'UWK
MZW;IQRCE>"[]1S0ZS8?CD]/?Y1*R?CS."^4GJ$+  N(N\N-@6*1!&>G06J,P
MUE@:56LL<LBZP(!XJ%<<RA=BA;81,ZM49;[F9?2 $5T[=:D\^$*JMD+/Q)AW
M&#7.IZ[YE,?"D^:\F;K,4H_- =)61TNS64H@09>I_1^9S+JEL.DL<,Y \7*0
M/&WAFJ6BI9<'?"DE]*>B575/]>5[2/HS$&OI7X(//M(Q(T6"B?*W_'[ZL/RX
M8IFY=F==;3B899,&,!9;?TC>N;36REEI.B=F86(NUY0;IZ1"<63)HE,"5)ZY
M[[#3]U'JSV"K)W%SRPB1%*,^E"8WSFZ7HJX"LO20*"W 4-XU=U-OSKP]1T)]
MKX3 B(3NK]"L(XKRMR93(6DY$ULM!S]-QU.+*L]3EHH:>3&='&5=ALFFZ:]H
M>_$KGGY]_"RWJ;$;=Q+ZFTFCE!JXT+VZN/Q7/I_RU^OC_L*%X/74L/@WU["T
MM1IE8D\#MW3K32D:PN%JA<&DJ59<R?C'!!4P@7?FJEC$"%[I7$I1&8Y.9V:>
MJOSZN#_6_&PTG;S8RU+1"&V8(Y8U*?'RV#J6%S32BS[KCR:R6Q,KT4=KZ2I/
M1QE',#MS+)U;R+.QN\EPM]_U?L^<09YVTV]>SBP+Z.NCH8HN93";435+70C>
ML<%]V4 >C.%79GZ<<GPN,G%9Z Q/5=4!1\6R&W2Z<*1.>#3.C"K[;4^X[/I<
MTC>MRM4FJOQ?>9:%P '3;6B9O'LRFA1[]6B8#ZS9R-RAY">=D%*N@"XN*NU]
M[9VI9#N4#$%B2HW>U.\R8*H[J.;.JT;>5=4,Z)56#G;':??EM&28FRR4,'VA
M3)X7N0ES:[^Z2"3'Z1APT\V3.ZAZO"#",KH44Z.62R\Q&1?2?8+"!Q-ZFF4%
M..""CBE+H"</S=5#2S[N-OF^F_R?L:2N@$[>OC0053_L+?Y]^1M=BFJJQP87
MH#1.ZF"Z3I459FLA@5G=7X7CNYVZO_UO]O'>5EVD@VZF%5]EM=29;5)$E17(
M<Q41&MT2A;-T?0'4B51!R*D[*<M3"G-1Z626E[Y$48S+J:>Z34U:&Z$>K2[?
M=;DW+A(N:J =%>TT[>LO[A2N4NR3$9.9"B,AA8V#B#5HKO+[TN>NB*^=NQ'T
M(56V_I?G^IO/]/:DQW>:24[(U8&^3N9S<2%ZTE:H\'?U?6GGA1Y.KE:E)IN7
M=:H/"!0L?\<?G%-ZNN0X)/+?:-R2M]8_LJMW@^%@;RPE-4L4Y>3"#@"8*O.2
M&+-$B#B)(QHF8>S3.$J"4(1I0E,>_+T%.2 '.QC!#]@E>$WZ87VY>"ZR=YLZ
MKKPG?[&FNV$X^>LZWAI>?'(/+H[([IB?;5\<?XS.]OO?G*/O_SK=._OF[/T\
M.#LZ_.(=GVW3XZT=[^AL5_Z=7.VYQ]G>]R_.)[+7._IYWMO[^"$[.CS">UN)
M<^1N._O?CZ[V/WZYWO^^\U/^378/>?_H[*\?>Q_"J]V?/RZ.!_\Z/?XY=/<_
M[IT=;QWW=W]N7QY]WW%VW6_>T?==>O3]R]7Q]VWW>(N?[9X=71UED7/\[U,G
MZ?\U8-^C\?[9$3UR]W[L]8]^[A[^>7IT]N7G\6'O].CGZ>GQUH?>T>'QCSUW
M]WKO[$/V[Y_;SN[9#O[;C7V7)(F+_(0XB!(G05$2"I0F@>/1- Y8C'4[VS]^
MG]B(!_!-J_FM;&$ "=78''/ME,E$%* &+!Q%SO,MH)E/A^6+VZ>AKJ]XG2+G
M_IWZ0>"%280\$22(NCA&<<HYPK''XXA[<4SYVL86U+T.;&L'0KK@?+Y4Z=/C
M>N=6L+=B)FQWL;O877R)%U]?,BUX/LFT^QJMU5-S47W?=V#@MO=ZM^45;F[W
M7OT*?]GP?><)K#?/@'Y:IVVZZ_O&+NZR=WJRF?LU-6[.;\ NLPLEO&[933N_
MQ;HJ)7I=E'MA)YU6]%#_ H[A 2W[]X5<*%:"N8">!&WA7EW:]AW;M(=WZ:5=
MH;"T1,CFP[_?V+.],C%OJ\T^O+7'>QX8?!/[_4$FR#1JJ([+&DS0R.Q,?>P]
M$,.JULVL;E:J$&=JM,_J/1\P!^ A3>^/0*B8;87O.N%?:B=\Z0W,Z81O:R/\
M0\0?6C5J__9&][;1F'TO+5 K ?T:-Q5@W4.M:"555854B,T-Z.]+P7XHA26N
MLF)40JI#ZM@HO*E.[T:7P"VM 3-KG&A?JC"+845-<DVVL3<:] MHO#=C%NH6
M#M6/KER)C"NM46/0EUWT"FL;J"<OW-)G7K:9%Z^KSUP)[A;,,]$]3["KGRI\
M<XUG]MR/]M5(AP<8L?GS1]HSW6,A,SVL1U'H/J,O\")&7S3*9W3]ZV(G8;C=
M((R;!V$4<R9A\-LG89"6S,&HZQY6/ VC72;@E[,N-&3/S*R+HIM.H;V?94RG
M6&K&<"4,5)6XZ?*JEJYRIA"EI>M<1 G)Z\L(APN!"*=N!Q%^VVFAS(P]=2)[
M_NKDXK[N?]K9VCS<WK+^W/RTN?=^V_KZS^WMPZ^_0O4&2')/E2:KX:ZU& "B
M!HSI[;'S0KPK?_@#7(T>NWZ7#=0RU)?^F$0(!PZ8FMBKJ*,OU\RQ[F@&,3.A
MS9/-Y75UJ1PF/''-I^NN=_-E9QW?>.VVVV)?+LA;QFTIO?-MYTQ-+BD^&*J)
MPJN<I2V98T6ZS-%]+Z#X*XY=["!I-15Z92\X(Z>.CCD88*,R:_68=S4B:H3.
M/1]9*K5DE6M_9K3 =Z#%0D0A5?]Y\,SQE1%H\^O7IOZ>IHK_ZU<T' (J_E[L
MH0W8$_/'&Q7+U#AAQ=M5,<?#]&0_X[PG5JDJWQN\R$UUK'^W))WY*FW",B7]
MD>^X1/UGJ;^C5O(Z%(Q4E2.0&;M@O8E9*I..U9U>V;%:H/CGO^]OCWJO%O*W
MZ4CZD!MTO_$@T_U(XX*O338H,<<7/A;$B2FAQ''#,'*<( VP%\6.EWI_[]1]
M25PD69_UBO]=0Z3L4AH7Z(2Q\W? ,YL##G]MUPRS.7K/\ARJ"_Z")M(U2X$1
MCN1SKT;O!N,^XL,1,K>5$B1I)I0L/6F;T][63MGF1([<7?=XZX?\WO;UKKOC
M')]]D=_;_7G<W^OONM_H_L=OSN[A]M7NUPC65!P?#K'\#MESO[B[9W]F^X>;
MSO'A-I;/@^^Z>V<_''E_]\@][D-KE/K.O_]U&O=Y;__LK[.CGPDYWCJZWOVX
MX^UN'?1V#[_)=SOH[VT=N?N'7YS=L^.SX_YQ]N^?NZ/=K\[5I\/MT>[AEY^[
M9R?NWX3%3(2I0%$@"*)!C!%S'(Y\%B64AT'DN<G:AMQB._##LCVJ9)(;E.)#
MM-H]1*+3)"]&DY"8IYC%E,:>H('#X\ 7)*">1S$G\E]*D^!.D[11DV13F@2S
ME C?#Y%P/8&HSR,4^XF/1. D:9R0) JE)@D\UW9AXFZ;-,EJ#RHM]N(V+UC6
M8V5-8B$%PB"XZ#3P&X7+'+*;3WKN_:@Q5RT_/S6V*(>H(O^'8?Y5$K^NV]L2
M\:C^ESE8=@IM<0KMRZQKQ)PXC47$D(!6>QJZ L4L8(ARP8/$C[!4<6L;V X>
MK\YN412/46>O4QH7Y51TTOB4TCCM7@2"1<2/7.0Y+$94Q!X*F4]0Z+L!XS$6
M<1AK:71;*HVO/42T64XYT1B?(%FV-1"J$ID!*KJJ6%'8]KF PM?>$(IQC==!
M'^9TW/4L^/S4W,*<#K,M!]6N[(E1I],6KM.^S7H88<0"[J0!"N0>(MA&%#I>
M@ B)TR3A:>#[B=)I!$:RM"S\\LK%;V%>1B=^JQ*_:9<B9FZ"!7<D10.!:!S%
M*$Y\)F7035D<X=A/&(@?H:X=!$Y+Q>^UQRR^#>*LUVL,LGJ4O_!RCT4+R]H,
M-:CF]VQT^MY@NZH,]\=<^FN=YEJXYCJ:=1PP3Y- A"'BV/.EYG(<Q#!E2$0.
M3F//$4Y(US8B+[!]SVOI<>AU2N'",AZ=%*Y<"J?]!^&22' F92\.7$1=RE'D
MD13AF$=)Z*9R2_':AN\2&T/E7"NE\+4')?95XVX=D9BI5WGEQYQ%>0U[2E]Q
M41]S.B6U>"65S+H*7I@2[C..A'0:$.6^@V(O=9#C>D$H_QG[#)04D9Y"%V!H
MD^0MRE/H)&]%DC=3$(%Y0%(G1G[B@'N ?>FDQS%RX]#C;B@WDL1K&YYO!WX7
M6VBG=_ 9>N.O=?&#@A51WD)BZKIUNW879EB*PZ!(G_%M/29[<\"5IZ9+Z3O]
MM7#]=3+K.? H2J*(81231'H.3#H-+&0!"KT(.PP'09 X:QN8!+83T98>;UZG
M#"[*=>AD<-4R..U#4,H\EL0,23<]0C06'HHE.R":,(>0@"0^AAHD3&WBMK4*
MZ;6'&'84YJHU8E>B6?O0!1J6XC=H:A\"L>L33Z>E%J>E?LQZ"C'!0<RB""4\
MH=)3<!D*:4!0R)S(]5R6<AJL;=#0#J*VGG1>I] MRE'HA&[Y0C=3$!DD(2,T
M17'@<D2EC"'F1@%*L,==WX^I$X=K&YYCNU'44J%;3GCA/AWU+78;#O6PTX7%
M&NY,EKOKMA6WF3]%<61WUEF.0MN^5,I,>Q+.[L\=NG?R-PY%Z"8>1RG%0JHT
M-X2."P]YD1>[+$QB 1$'8KMN9#N^OZ#SSKWUQ:]5GA:,EDCIJ_! .D%=HJ#N
M3 MJ% CF,T%11*(84<I\Q%@:H2!-6)RRT,4^7=MP[8AB&T>/SBLN3U ?Z9M,
M(1EB5X.T/2R2X<"Z;U]*6^[QJF!\]H8#E"P>RN=!6W7_>[S.F-OG'"8 P#0C
MF,J@T: !E.8<<GFZZTB7"4==6]&R\G=Z!SX#_3<'?+ND_I[H[/,B[?/U'$>:
M)2*.!$^0PSE%-/1<Q'PN4$*Q1TD4<@)8LL1S;.)V$;DVB=_B4G>=^*U*_&;<
M8R?Q:4)I@I) "AUE\J=0B%!ZRW&(71:E(DJE^!'?IO31F?-G%9M[/A[$Q^&0
M7V:]GO$3L-/U$RW'42@)W6FE!6JEGW.< M>-N!!>B *<2JT4I1@44H(\P444
MD-")$[RV$=I1@&W_\>V.745/"]V"3MB6(VPS+D 0)&GBXP# @QQ$?>JC&#..
M,-34><1-G92M;42V0P([(EUW4#N=@)W!B U.,C,62L ,PCIT@'$7.UB.2_ !
MAOZ)3]F%X/4.Z-!;=WQ9K.YRYC@*:<B(%[H$.2F1N@O^B"+.$8\2ES*!1>K)
MXPNUW2"T?:^MQ06O4P07Y2AT(KA*$9QQ'Q*/>BQQ'>0['D$TQ!YBGA.AQ,6,
M"AYX/ Q!! /LV"'MX%3;Z3[L5U.(%>'0,$4PS\^,>31>A-<%%I;C1534_R18
M(0Y@,?OIMT)KL4Z#+5"#X3E.A(B<1/H)##F.%R$:N3Z*8NXA*CP1TB@A.*5K
M&]@C=DC:BMCX.N5O42Y$)W\KE+\9#R*,,?<3AZ. TD!Z$&D$T3X?48K=F,4!
MIZ$GY2\*;=QU#K75?^C 25;C*=1MC7O#0=(5$2Y<0[GSP@R>GPI'A,B/ M7
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M6Y?:R=Z296_&5XA=+W%C*7M24U)$N9#NN_!3%$K?P>,B383/US8B&MF^VU;
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M88NU88O[-KD*6]R5+6:,+F\(Y5A(%&G.V70<%"G!=,[>]%A+;1)AM=&U=*A
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M6AK$19 R"$>,XO=S*%8(L!#@XR3 53H'"@$V2X S7@&#&0V!.418)(@3;7)
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MM<BUR+6%<GT0CT'7]X;7(FB.!F"46!A:V+7#/DBM5B.NS)82-','$^1\CE=
M:6'K A\A"HLXU@'IJ **P1,FL5)"T!PTLXSY42#72H] @=Q*(#=C]7/NL5!@
M]2N6.[ %II#1R2(3)94N$F>D*Y!;>^UA18%JJY?LP:"?"6LXZ,&U=U47N"M7
M=:[L%ZJIQH-J&$,\J6O)5_8$ICE^"E%L#^YF*G(M<BUR+7(M<BUR;:]+8"HV
MJC947H*^$$^LZ\6O]8N]"_5BK^^'$<R4%\/!R2]G(YC":+0].''=_@(-"8I5
M<RNKYO,<1X+P5ADJ'$K$V5PS-*!LF2*&F7.6)!(I6#6\(VB)#FT+5!MP)12H
MMAZJL\W@%?-8<8^BRKU#L++(8>:1U8(GP3$ .!2HMBK@F%C+:)0"-E')L94N
M!*PI4T[9Q&#)%G/Z%8"V"J#O9N*":*2$LX14%!@ RAP"GG:(6A&%9 Z &F\"
MZ-J'L*P>IY>]#G/J)8RC5PTF?BOX7_\&7]<2B9G%CUK\TT6N1:Y%KD6N1:Y%
MKD6N1:X+^G4:L!9O2$\]BB>G@Z$=GN_^]ZP[/M_R8"CFT>3@D<OSW)([TK2-
MB.?8B,12CZ73*'HA$0_<(R<914Y@'S03S@@,-B+O2"G:$4ARUX '-QB&.$23
MFSUG\.UA<.9ZL<I(N[PZ'IP^SP,;#7K=,+G2HM0(-1?2O]A>W<[:CJN=Z..)
MB\.*D4Z5,;E,-$03 KL]%:X^I63!4D \$N>H"TE;'CEV@22G6,(Q)(]#^,_>
M+2L ;0].3@;].G]N4N9G4L>M%/MID.G(G&(_S EJ77*(*I9[MS -3(<EHE%+
M)8T*V*6-34$[2NL.-JPAEUA#M'-+JOR"HE4.;R[(VY$V]C\/L5P++-/#D]V<
MZDIW8KH;4H2/!SV0V&BBYQ5MKEF.FRFL)('?9)0>,9[[; 8KD+.!(JZ92A9C
M4R?G\X[0LU'!A=X*O3T%>F-@\ BP=JAQDBNFP !*6!GO'#$N"E_HK2WT-E,D
MWR@OE0(5CFD.*AS%!KG($H(-RTHNN?-.;FQ*HCH$+]U5N!!<"W!="&YQ@C,<
M&RD<P\8Z[B,'U"AEF"&)4R<E+037%H*;J2-'8E):&;!1'0=:HY0AAP-'ECAK
ML&+8$IT+TA)6Z*W0VQK1VR+'$DD'(U,2E!#.9<(FL&1=3$(ZL%OE-^S3;Q7+
M+$1WCT3W>IKHHF<L$A*0=-R H0J4IXFE*)@(NY>66">UL<E$ARNU?/!H(;E"
M<BT0Q"+]W20U$50X$I3FWAH3H@S!):THQ4ZFHL.UA=IF,EBT,$DZ#49JX!QT
MN #4!DH=,IXGXW&,+,BZJ8"D'6UF#U6+'E<H[BE0' :+)F!KI76..Z^-B2%(
MRVV2/%I*"L6UA>)F,G^4B,Y[!A3G(E"<\@9IXR)2#%9+*N&MK,U4+7"',KD>
M%%=")^X$<XV334K*R+3B)B;C$H=M4!EX=H((YK8P_UZRT03ZVW8X/(??;M6U
M0+XF@M3]% /Z'(>#P@$+<\!L<I'FVFM0<X3$!(&.*I$CC",<+(Z4X^@I^Q+&
MN08,4(>=_33.#R#\&[H?-O\%+Y=#/K'#=]U^_=WB$K'=?HC]\7,F3\<KPB;-
MV#PZCI7U?G "7YBA4/4'XSBJ<OE<&$%.+7HWM+WJU ['.1-I?!SK:KK]6EYV
M'$.5NGW;]S .&"_\HFY%^>S+6DU/_>++!8?1G0Y&=;O*Y\/8L^/NA_CSQVX8
M'U^RQK5/7:PAOOJ(=3""L_'-'[FV7CYFU*]2J@33KR5P_?5X>#F&4_LN(C>,
M]A]D$PSQN>U]M.>CC9^^?EK@4;FX.\^/RZ(SWOR7&\(=YXRG?JD?TBM!UZ@
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M1M:^MCA?Q=94W3JNIOJA'R?9*?;3C\\;BBKYAG"6"8HLWU"^X<9O6-MF5@>
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M_K-WRX ;8,J30;]V5TZ";"9.RQ)>TR#Q\3GA-43Z*%GB*&!G45WGWGB1HVW
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M@/>]F-]L]</6M=4HFU5SF]6;62,9-B.E+!&(&F- T96Y!@CW2'J:DK&&\Y#
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M8<CR- XQ=9QM7/)K1(^WK\!OZ/%.Z'%!D0^2. R]E!-/A-AT/<^(X"@K):A
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MF"!\A,LS8\,4X)U.BVXU:U2@M_+9:$3L"%O-R6\/=J:#ERI38Z$J8_8$=#A
MD8?;=\*!:$YA+M_ ,)VJT?E@I:6MQJ>C\ERI&W'/>T[62E4\>P4\>GH.#!ZF
M>)"_LN^YH@WM/3J9_,7;.SYB>9*!B2M(%F#><1+F)$E\2KC'0=_WX\R76(Q
MAW1)?Y:!.\MZB#=\Y9&/RDS?WALY\MW]USVT<7?>?]J7U(_Y2.G!7T<JC+,L
MEQZ1$@'"\R@DJ<PEB?PL3F4048;5M)32Q?-T!U5?>)P9"+%I=7[3I]FHR_9
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MKU2K+"D8+7%"DB11GHA3QJ-T/@ @6!S%+/4S[N6,<972/*("^\F%+!!9.!\
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M8K9<Y]!0-L+)=C\Z*4"KJK(3[7/$CZQ/<'(ZFUIAO_37H &4>+>^ZZ1+91]
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M9V"0\$_C65WZ(NUYU2:6==362]YVU6#:]N#/LD8_L'%P !M&I6&,B6'5N;.
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MV%/ZVTY]R#QJR_$=J2)/;>C+:>UE!M>\-C: +=5TC!4N(O9\U[7N+8=T!2+
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M2LVD;'<#99%GVXTU_1#/&[R]'DIRVQ=[!]NMU$T#\;8<S*Y?EIHA-%W.)JC
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MFWJ<2VPB4899K;!Q#DS]RH98._:<M2&<MP0[@9%U0B$N D$VA8 PC8)&1:3
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M1A95O&UU"Q@,M?^Y ^<KIR@.V$LF/'=<6,^]I,IK'J(.VBRL+OMT ?N#C[F
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M.:8"X'NVCGQ>]UJQ\-\OZ?[=;AX+Z[W_^$VNO[E*%NN$I6;2\(BE=2XJ9Z*
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M9N,*JRCD'1QO<;TV&('!"LQW_=*\HP-@^;;MWX3P<V3PZX(QKJCB5@-."*H
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MR%!B!$[$2;8BQ:1O8+6'6:F/[M<F>/4CQBL-\K&X;<ZI[2F1BBC$F+>(RV3
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M?"R:UWHS>2(A, PSC<1PSG)59NDD<89:S:UZ&B9_><<93\??K1G^CD:8)(U
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MXQEW11E?/GPMY,UZWQT4HZ;RB)G+(DS;OV=YR2,E<<KR7Q&XLYTN".7P+K[
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M2*D48Z78WMS8)U$1(7F>*24MX@3<3<>U04X0GY3&44FS]HZNT^F8YE]W]<-
M$'L#=P0&OU($SJG9@0_<7V $C1XS[8RRG'&I1<3,.\J8]C%9>PLI62DPCQ>8
MG=H^++[VB4>D=&"(JX21]EJCF(3A7"<A@UI[A]=G%%;]:SI'=G]OXL6X)82.
MW/*'(OR-X8B+U6Q1\OLN?=BKGG2U$AL%/?MOHQ#KRC=>NN(+Q',1@K:1"\N\
MYE89IYQA!NOH6&0IFE(]%Z^>6[1VM+5/J52.NHS<BH!*8HE<- 3%(&URC 0:
MV#S'IGK/7>:*&QNTL0D+'G0TV$>C28(M3=3*5.[RT^SR[GY4C =P4I$0>8Z\
M)V"D@]<(,P@H!*-.YND7>%W.<E_!WMYOGZF-B6$0']A!;IS3$=LHD@O,*<H#
M+O?Y2?;Y?&M?@&HERCRRPF'$$]A6)XQ#47C!N )'68B\S[,\LLO42SZPN,C"
M^1%EAN]T3SH%[@\M7+8!Q1%=+Q-O#[,Q7_^W;9W\YY^,_^_?H\IO(#G-46;F
M_?LL1^_?_[_%7P_!S!5_!MMV KY=XV=LGE7S.XJLWF68,;0QL^..I44;T@8N
M),3>H"A<46P-YL[EQ+>'=0VTE.<GD&<.U]LG2:9 I400:@@$;CO8*8U!J&D"
M]SUZY[#/$<8BK),)R?M(#,<"<ZJ)22PH'ZU@6!,;2;G+3[/+?E^GR&"]+5(N
MI3R;*2)M-4>"1!Z8\DP+DWV0Q5@G&:EU,1 29.#29 _$"D-$P"1BC4MM?I)]
MSN1N@@E-E/7@7+*(>%#@:PKOD*$JV(BQ8E+G?5Y)Z[1>V0)C$D(CWT_UXDS@
M]I KEZW +3;ZS>&AE^^T6HVA!4LQ'U=E W=RD7<=QV+3=FL4LA53;.%-H6M/
MBT=LA\J@#]\UG.L\O.@P)W?%2IYT.R<Y77T9[%W<8+Y0>[VRT;_@KJM<TM;=
MJ\2 *ZV<59%RS1T#+8L.XHM$15(1 OPY=:;B+J?"7\9YT?)<^(XZ]PUO[WA2
MWSGX5=_Y?%8[.MZ':"[[, *E% +B)&'D/"&(!? .:73)T5"<$:_?=DH\S%*#
M/(/X9^F9GUN>HQ43V9S\;5F4&NV!'=:O/D5^9Y1=X71=91[#DTZO4.8_NK%I
MLY)?TA?^ZSJKY*@^%5]^Q+I>ISGHS__(%.':,@^TR!5*G.'Z7OEYV!W?PPG
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MOD!YO8OEKBS;;#SS5_4COQ\L1"Q&@U>KE,E-1BDR 1,D%161> @^F,S]?:3
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M;^Z*!D1VC>;7B_K&/O9$24L$THHY".[@-ZN81<DIDR2L2$@@1G05W*@'_'I
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M<D6%,P@[;$$R?$[;MQBYX*7(^Q"29TC6]]6_WNQ5.BP*Z4=XJW.P6CN('0B
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M!Y<-D.,EC'LVMT8@>=GXLL/WOFQ=[7UK'-4W=_!><^<<OH,;S5VVVVRT=BD
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MR98P9+X=]L0CFPJ)GBD[.;W=\.1R;0T*+!?9*LPR$ED40:B,(4P*F=/;5RF
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MYXTCT-:CO:.]Y@[;VPRMQA4@1O[^E]VK.GRFL;E!($3EVYM^/PF?N&<>665
M>0%UD=:8YQ)60X/S5$<ZV2#6)JF%"#%(JGF4S#'C/3;P#>&EH'8R_;^<]AK,
M^R/ZPL[9_/7AL=P>.]%,1 N?"$QPJHFU7C %8J2E-SIWY%IB>H+FK=Z77\&:
MQE#[>U#4:^7"K*U>JW]8<[8/?^Z?N7XKM&PO5X:F%F!CJUR&@;VH]2(8R$Y_
M=" ^ZTJQG?_MQ?YIS#7KL7VY5BL:"&9C"H/JW+Z#[157SC>.I[8'%VI?#GN2
MYCNT[7E1R0R_MWHWK@JK<]89Y"M,-Q&[5Q)> "6*3;)25G^+^2''<-',$/ZQ
MD>)XWRA),(L$D2!M)F)ER/"0D!?)A-SH3N*IUM!3NO3ZBD/H4'%R STPSIU!
M(8A#97#%0M]4C7AQ&CNY>UXO=] ;]LSM__+(%G?OJM:IZHM6]47[*'W18E6T
M515M+<-<57W1JKYH55^TJB_:74L^C+RJ3F@_7"\2FZR*/-+(:> $>TTYA8B4
M26=TX#K,G6-=QJ=_=OO]S[WNR>_E/@=,UG;9#[S;Z4_$L;%?;W6ZO=;@<BMK
M=^P/-CKA]E4^_>\9O%V/H';PSG?X2&X=_FYR0YX6&I=;Z*>'#=HX:L"U&T?A
M>.]H _[^S\GVMW\R4VA[^]O.U=[F5Y['//[.: O]Y!/;I74,ST$;%*Z]^=?A
MWK==L??M\W']RU>QM]DX;C0/#QN;QV1FBS4L(Q&4<H2C$IE3GB#'>$)"V.2$
M4EA(OK+.&5TU<LGR1RM@>O? Q*QG!"ME.7?<:FPD=TIZYUADA@LU=P)Z!4SO
M%9@FS_:X<9(%1I")PB/.4T2..XFBB(EX+)PQ<F4=!&)5FPJ8*F!:+# IY[GV
M*@A*#&?&&!8(#M(PGXQ1PLY-G5X!TWL%IDE.=B-\2BQHE//B$#<1(\VD0I*3
M &_I('-5+M4YZV":V/G]]85;^KCUUAEB54ES&\AB9$1&,)>"6>ZPM)AQ89F@
M06)LB'E$Z->'IX3?*D3[(1!M!C.) 7%P B=D$Q4Y$T,A"]8/&2T5,=%QPRD@
MFL*KG$\CVIM7"'Q0S890202*(PE4<@J&1X)C0CEC1' >^6-BITJS?S#-GDJ0
M#)% 5,V1QD$A;A5!CE 'ZDTI399)[D76;+W*255\MR2Q!PD.:P!>RN$_1K2V
M6KG N1&)42MB%7M\&'V>C#TD]5HP@9$D"D/L83URPE.4C #G+D4:<ML/3E:-
M>';HL4"=_F&/S(JTQ(K0YW;I,(7@PF'O& O<1JR3RPFQ4@:,*>./B3@J^/H!
MX&L&3U"@7A +[H@E+'<M$@HY1AB*+ 7)B7$A18 O+%89U4NT=5(IM0N"*I98
M4B'!^C"CG"66*XL5#C:QZJ#FPRCU9(SA,#&1T8A4,!9Q0';D0"H0N ]%NW*M
MLT\"@>DJ.*V54B^14E.IO([>" 7H&Y34L(+,*RXE 3NM:!5H?!BEG@PT/(\X
M"$) ,#.CGQ <F0 _,!&$!L.=59DR1*\:_FSNT24XXUAHT]OE.\D=+D@N9]IZ
MH/KD#9MM_P@GX54+\A=F=ZU,S+LT,3-HX0A-*5/B0PA(=>Y-"GZCD!3A:,'[
M"%Y8&<#$2+6JQ:((\=^^N7D%J16D+AEI;P6I[Q52IXC^1*0J$8:\R90*-H?B
MQ'G$ A746C"T//.A&+DJ]:+.!RI(K2#UO4,JQ=K%2*)D3/-@HHE8)BR]!N6A
M@N!J(^3#0.KD1@A7C";,%2)"&,2EP\A@Z9"TP@MLG Z4KJPS358I7E07EK>'
MU-O\46.^J)OL.0^Q1;TB.4TYR],_;X]I)N'5 Q0A#_0%'XZ"TS65*3-.N_VB
M\\LO12?SUO=XS93Q7[<9289+BZ^_8AVLXMG@[J],5<B^)OT/H69B,F_\/!RW
MESRU!Q&Y7K3'R"88XB^V?6XO^RO_NLU;TNJ@B9F;]Z%GK<L]5$T/4B]-4#4)
MX2V6E <%'A/AW$5G4^"2XF!IH''E]7J"_S[FCME.8VOQJ=RK^RUV8FH-/CQ'
M4./J>-^YR%SFET]<!\2-8"CG3 %8NVBHBS0PN80<06-RK9D<014KT'+3]U2L
M0,M(/+'LW!(5*U#%"K0\<U6Q E6L0!4K4,4*="<KT)0K^LMS$.-=RW?U?._O
M^7[8LN??SWH] ,7G:^:/$!94S_?^GN_'-9D5D=X/2@NS<"*](8C?L;/[$<[V
MNI?U(W_>.#H6N[3.&]]V,7R7;V]N7-2/=J[@6GRW^8GNYK8RDV=[1UN7C:L-
MNMUL'^U>'9"]HQW2.#K@]<U/EXW-.ESS\+#>W#MJ-'<N9I8C,:V4MR*AW+@!
M<4D(LC$QI+0P4AJ-HXLKZX*M4KYDU4@5E+Q[*%DX]5T%):\()9.95]JQ3,>1
M.>I"0-P!GCAJ#9+)*R6)3A[KE76B5[DT%9144++<9'45E+PBE$QF'"5AA#71
M(:D\09Q+BK3#& E,O8@YS]>QS"^W9(2\/^P^RX>CEWM==KD*>=X&>694Y$CC
MN5<)HR"U1%P3AXR2%@5M$K:4).;YRKK$JTH\&WDJQJ@%JN$"J. J-7PS-9PB
M;<,\<.(94IB# Q L0QHSC:A5&*+%Z(@E*^M,K'+U[&V)2@V7F;BM4L-75,,I
MGF?-E Y6@_=M00TQ9LBZ)%",V$3I'*8AJ^%JD6ZT-%KXPQZJ5%1KKT"U5@'.
M:P&.G^%^.QHMK"$B7EL ' 'N-[AS2"5JA-=)&@* H_ J,\O$N5*IX<+)T2HU
M?$4UG'2_A='2<XA]E>8,<>,-<B'_B(P++[0CT:RL<[T*'D&EADNDA@NG,ZO4
M\!75<-+]9@D")\D"DMYSQ"EUR"7ID0!<3<F22#E;62?\!]D&?Q&"L5<KPYV5
MXC59F#8=4;PFCC2[ ]NN^>F<R8DBTB?L9#R/.^+]X>S".;TJG'TMG#V8P<G,
MN:-::62%!W<G./!T"">(81-,]"272^?,!0YAAUPLP<&+4L)4&OR*%%*5!K^B
M!D^=%_@4 HT!!<!:Q+UU68,Q@C5.P>K -,NL3WB172$J#7[C6&?1C$65!K^B
M!D_&.D&1S#;BD% T(K#''-G$##*,!968QU*(E74N5\WS$Y%?2X&'@= $50[A
M)2?%ZY>X+_4U?MCDJ<V8(@!+*"*NGUR))C__ZX7KU98$SU^TIJMZQJIV[?5J
MUW[$K>5YFFTNH/#KCF:;(X2L/*\7][P^E5Y7N0."ZU=;O'&PSXRQ7 J)" X6
M<:(B,IQ:"*9@-8VB#MNXLBY7B9S>_7A\@\SJH&>92Z<>U,%*S>94LZU)-<,J
M"J650S;O5'"#,:@9HRAI+Q7SBEGF5M;%\Q.+*TU;YLJBRMJ]JAK6)]70"1.Y
M-ARI!&O&HR;(,"(0Y\QBCAEH8MXK7)6"+Y$B_K#A\8>K+9K'YUY <5'E<[\Y
M"EW.\+G!Y&.M(T&:YC;6-C*DK1(H2"(8#D81E:NE<[FTFDYUK-K2OXT^+J#*
MJ-+'9=#':>=<B*1$\(BPD+L]8H><H X1JDT4U+MH$SCG=!44LU+'Y7#-%UYL
M5"GAJRKAE&NN>#3,L8@@RM)@%*E!3BJ#O&2!)XJ3"W)EG:\*-:V#5;U156_T
M&B[  @J.GNH"5  S#\!<S?"ZB6,A):^05Y@ASKQ$Q@KX@847BG%B)7C=C$]'
M_M4^]]NHVP(*BRJ/>QET<<KC]@P3[8E$#$P[XE%$I,%W0P;0%&(IBPDQ*^L0
M_XKIXN)*&]]&&Q=07U1IXS)HX_2N.(2\-DB'*.!LW@OGR%+'D-51&^I<,#ZW
MHEYE>$ELXU)5&;UV'DYN_5:6\X1[L\N>LY_^0^03SP-N"RCJJ<#MS<$-SW+[
M,4XI<WDQF03B(GO\1& 4'#<T,N(IC[G#(U\U>@&;[55EP%O'Z,\O[JDT>1DT
M>2IHD%9CIGQ ,1J-. X"W)0@$4XL<IHPC3@5_'R2/"=7K5+DI=C@7WB)3[7%
MMF@-G0HD+%>$8A^1U($@GFQ$CN$$<85D$I;-T617U@U=U [^NZKB>=1@%]3%
M\L/<X,=L CO==*YFV^VNMSE;:M =M>N&!ZAU3V.O:/7](?*GWI*FH7+[7MZH
MT!D!'(Y!P'HIQ)TSB"N*D:94(:*%L5Z#8Y #.&%6.2%+=#)<:>#":18J#7P5
M#9P*O((V7#J14$S49HX4FJE@)9*$*>49(=BIE75.5AE[=MITI8'+'$-5&O@J
M&C@56)FH,OLY19YD0PC>#-)$$22-Y(PYH0VLW#I7JWI&PO";9T=-AD_BF>$3
M@^&$[IEKQY>*/C[2'7[8ZI(94=2Y[=^.I :'$; +_G*>@RGX_&FW$SN#?JV;
M:MV< E?\K1</X>NM[['6*JY9$3=4S_@^G_$!90^M_FG;7F;S$>]'H-?ZY ^;
M8%LR3OG+6NOD% QU#3RY=A<P:!![)[4$#P2C_PCYMV^YI5,D.?]^$^!+F_&Y
MVX,A=D9+U.S!X[6+7;8OMM7YL]OOPW/W878WSWKP\]_PX-T 7G'E!R_.#]XZ
MG\56(1PQP26$63X"=$PC;8U A&+FO>2<"+RRKE;I\[>"JN3!9=X*JC1WN35W
M^O">@,H&89&3P2 >8D1.*88"H409K3&5F6=W5:EGL^Q6FKO,6TB+U]Q*.>=4
MSJGM)1*9,CGCEX(GA;C@"3D60;H-AK]R0H@2*^ORV>2;KY<"O+2!S/-2"29"
MSR?M%+V':SPUZAMN?Y6B,FL'[,X,@R7/""@2ON?5LP7-QH_4]GY14_*^C?H+
MYD:D%/V@OS':8]UL]>!U^[+9_?2_9ZW!9>5G+]"4SZIRQ=C!<EF*J#*Y;Q##
MR%BI4?3!<J*59RHWL9:K\OE].Q<.ND_UT2L@K(!P.?8E*B!\(R"<VG @7J80
M@D/,6Y.;"EBDA<&(.AM@(:U(%*^L<[9*R+.[@E1 6 'A^P;"%\P4JH#P58%P
M:G,':PQNG[4H%NQF7D:DO6?@( 9J6*#)Q%3D#AF^*/;A-P;"8O?@7P,+=QPW
M-BR?JW%V IKD']>8<;THM9ZCH6,YS%8GQ,[@%R:+[8S74'9ZHW/!?_?A;G9P
M-NCV+H?9*D4&3 ]TK];JUPA=$_^U5ON_M^9C ='A;>W_VQ_&<-:.VZE4__$N
M+P#"7S"2OR+<T;?:K6*#MYE7J@GW_PTPXOB=:OK>?PZQ/_FG8[^9,Q@CA7&!
M=M9!6_>.]IH[;&\SM!I7GU@]?__+[E4=/M/8W"#_N=KEC:O=?4V-U034E&F6
M$%?>(8,51]+9&!15FDJU,JK\B&%C4!#D>"X-84H8Q;T01@!&^X"Q220*D59J
M$?#S- MK[RRNK#</8RUOO=O.)<@)7*M0O"(7JA=/N[W\2VLZ:RJT8!$SST#J
M=4^*E"E[ EH_@%__?_;>M:F-)&D;_BL*XGG>G8E0L74^>.X@PF,\#O99P=C&
MZX4O1!U!("1N21C#KW^SNB4..F $DA#0L;,,@]3=U5695V5F95YI^[6+SGDK
M7]\[;_7+;]BSL]9ESJ?*7]WJ-GM'MV2R$$0+4AK[&?G[1S476YV+=V,J.G,C
MU2GZ6FR#@WDKQ*V4KU_.'2!=ELMKL"LA"W2X9<]Z\=WPES^&P=YFNU#*XJ(_
M3FWWL-D>(J X&X\?YK<H/_[CHAGZ1WG/7L?EOCV(? Z>//AXO?AH!(++SR1>
M5YQ._1BODZF?W7=;0M8E,2_IMG3ZQ[=O^SJKQGZ1TF:>]'X>]K387=H;JHEO
MN!=MMQ9A?PVS)+4MM)_9+4N&S$(ILW078?*,;D8?3UWLUABIU_)N_JB,R(EF
MW_ATO+*Y(M5</7BN\-,4=KS>>Z9)>17@_-B77PGD_JW9!FNP<PZW"+W?9Q&&
MU5Y6\&=BKP96\$0SMY-*?ZOV6X:+=\7O?Q3J4/[^)/*TUQ2$>T61M,6=K=YU
MFJ>4XKWO_Q4!)FSKZU 4[SC>;R+:!G[U1[*_VVIM;_ZGV?CT$>]__P^,\:_F
M_J<&;AQ_@>\W+N".QXWF:+1M#S=V_]/:^0[/^;YUL;?[I;7_??NH\?U?)WM7
MGR^W/WVCC:L_CQNT<?G?J^M(VTTG8QS!?33.(R-91)R3B'2R&G'#'9$"LRC%
MVH;"=:/G=>BPI).#"GE6'GD6=YA9(<_*(4]S!'FX@U6/V"("<H2XC YIH05B
M(B8O:>+1L;4-RNM"KUB"=84\+QYY%G=Z6"'/RB'/Y0CR)!%Y3 PCV'=T/K@@
MR GM$">P#5GO6?"B.%^48I6*LEYG##C+^_"\IMV'NPU.9$X[,*JK\O@#O-)F
MNV_;A\U\O&%[O=A_$^1AJ\$'/07:MCLYK'T. X-%&<#;^UNK5H'8_$#L\RW'
MS5]N7^U='$@ *TNQ0-2G!.Y:U,AZ(I#1B@;B\_K*@F2,L7''K6H!]]JHGBLE
M704E;8XH*1&PKH$EQ!AGX.,PBHR1%C',/+&8.)VKOQFI4SI>JE8IZ3.UC7FZ
M;U IZ0HKZ>6(D@K8,652"BG,#2AI,L@0Y9%P&@?)D[8QKFW0.C4KHJ,+8)A9
M 4=@4$Y=L^TP(+*Z2>R*(9]8'<&WX<_=1_=>?[U%[\LZPQDLTIUHQ>8MYZV"
MJL48_8/(!2QR9)%I1 45"#8GCRS $]@34BE!%=94%GV?N7PRKVE%2O$"3SHJ
M_7P>>W^@GT$G88,42%'PQSE-!-G$)(HL2<*-MM([T$^P]]6\*A<J_7Q)YP&5
M?CZ/J3^,_#,=4RXJ8M3"_DDY02Z7%T4A S.),1?\V@;!=?ADA?3SE4;^8R_:
MKC^J_7_V].P/T*8?L=4Y.XVY3,/^S-9_UHD?C[3U7W& 8EG&/OSA0S>&9K\W
M7*H*GN8'3]_&S?ODE.$B. 1&80X7.@V_,8,TIR8$*1WF.D<B)%Z12$2EC$NS
M["ME7+ RCMKR!G/% [?(._C!J><Y1U*@Q#/](_62YRP!5B>T.E];%65<EAE?
M*>."E7'4<)>8!LTY15K#IL@YR7LD2PC -X!S[9(F.I.QT@F, %6,?FZZV.C\
MB(6!WFS7?MC6H#HY]Z>XL&"NOX6@_$KGY'PXLNW#N-4>=HZ%+[POLJ7^,URL
M]\.UJC!I)DS:&[?6.;62<4&13R2 @1 (<BXRI(V60A(5+*9K&TJ-]XY]4A55
M%>1;]2#\3%I8F0US5-%1&UY+;P47$@7E/.*1YO;.)!.YVZ"9X=QB5MCP>)7"
M?96F+LN.KS3UN31UU,#WX&4G12P2.FLJ<9D%E@@4<&3:&\:3H%E3A5XE37V=
M@?D! 5Y.N_>%@F1S?TC)547C5\7(_]B&P1685=8,51 T P3Y<7O>^*B5#QHI
M%3CB.$.0DPEI:Z/'5LK '$ 0KL)]JZ)Z2T^GKU1O/JHWEC=C?""),^2T9H@[
MXA'8?PE9X:--R@JIP$XG59+\6S70*X5[FL*-FMO4!\DB['619-H/IT'AE)2@
M=5R9&*P,FN1$F"<W4*I"ZK_JJGIM89^WNR#[AVVX-A3FMBN+Q:M<]P6GOWR[
M-?& ,(,:_5[9L V J1MM+V[&\M]5'&!^P'0X;H1[JY-4A"-82S#"B='(2!T0
M,T01&56D#J]MZ#HS\VH&4T7L5C*V7BGE\RGEJ'DN=*(L4WLKD\ \#YXBQSA%
M@C'#03,--J"4HD[YBC'UO$:E7(U2UDH]GT\]1XUYX1F)V N4P%5&W&J*C#(4
M):($X*_!S!?),5*-[YG/<A2]I+#Y\G5SZ_0,YC4'SGO]CC^!ESO-U=R%*UO%
MS5>0L.;KD>W&/P&BPH=;2_6AT^M7F#4_S#J94,F:N-;!"<1(9MZRG" M(Y@4
M%I!+6FI#COCINA+C)D45\WLCX?9*8Y]18\=R:;"WSEF,#,G\P,GGXI3D$$F*
MD)2\B]RM;9@ZUBN2@EMI[&I0V50:NR2-'0ORLP0[J4@(&Q= 8X-&3C&/)!>P
MO^(DA??9;2=B18ZT?^$7#/M6P3CC_<UOEO7-UWDDL9/9=]["H<-*NRO%*ES_
MJ7VXU8^GO0H49P+%CS\G-)P7*<)Z61!:8DR.9C)D:.#(*"JQPH9P@M<VI!AG
MT*GR]E_'V4*E<0O5N+'.YEHG0B2V8-H9A4 >!+)6$(2U<D(0P@T3H'%ZO%*F
M.CUX2][#% 6LG(1Y:N=8NVV>1"#"<10#_.".2V258<@*H\'$"9@+G5/OV9-J
M:U?@^.#Q3;[Q[-WZEJ_: ZS,+86WQEHBS^K.S6^N7D4'E/G/R@KN#2M!072W
M44H%_G,$_\L)SA#A0D3, I*!:,0UY\@RPI *W"4J<#)!%VT$.'ERX=4B8'CN
M/9PJ_*OP[SE=T@K_%HE_8ZYI@FW,!0IV;U'TY:U$3G" 0\,2.#X45,&M;7!2
M9^S)C,H5_E7X]TKP;W'U/Q7^+1+_QIQ_;'V*A IDF"0 @B0BV-<T(M))E;BE
MBIBB%YY6XM7@7Q% ^&??PD,WBI?*LMULEXP/\)?0_+'Q/_!C^"JW[GY\WNLW
MT^5 +3<*;_MZ AY\W:+5F=[$ \9_WAWN^.N/OD"S'6*[_X[)L_[#7GLP"D[7
ME8"1GG5ZS7SG=]W8LIG0]X^+9N@?#4'GUH4#D< WEU@'JW_>GW[)K2G.=,&Q
MN\P9)KFUVIW)O/7SJ#L<PYD]C,AUHSU!-L$0W]G6A;WLK?WSSIN<-MMH9.9F
M?>E)ZU+^'%GD$BZ%\!9+RH.BF!/.770V!2XI#I8&&DO,AVMB>)\1&/Q[98P+
M0G$)_R/6,NT5#H#REK'<)WRP@VR?G\)\^CF$#.YN$E_]40SGK;B3Q@A;WK?#
MOYO6-5L@-[&WFU5[%Q[]9ZOC3U[H[K#_WR/L3__3MM_-.8R1PK@N8 \@V\?[
MQ_N[G]G^9FAN7WUDC7S]I[VK!GQG>_,]^>_5'M\^/CFPP@!66HN2\0)QD]F$
M0W H=R@ 'X4:R\U:+<(>>I9EJGL>)TC9N/(O1;-VCP;1RQLJDGX\/>MT;??R
MNENHC[U:_\CV:X< *K5NLP?7=(HCAV8"[&_W:V>YB5:G75P?!B)3W+?L(5KT
M&KKS]]:-#-5L-];.NK&7-2S47&QU+MY-Q;Q3VST$!<Y[EBBFJMA=;H"MV-%@
MREKVK!??#7_Y8YA4TFP7<U!<],?@7@,TS$ PF@^25Z;\>( 1QJQKP3),#.+B
M@P</$&2]0)"1#;K\3+%U3OG4C_$ZF?K9?;<E9%TRM9C;F@?=]JE%!CB;%_>G
M!#VF4&'IMKZ::.MO1A]/7>S6&*G7,MY.S?>9^6"%S')TLJ+30>Y,QV/3O&X9
MLC--R@KD@$TV[:]?7B[NY4N+9FFO/UD>?LN,5T>=<[A%Z/W^-&'X-28,G(-G
M7O+-*1OANZ= PXN6\M?X?J\S9?7O;N<,!G!9KX$Y!89?-NSB_YXWBW8R3\E1
M>!71RTGO];+CC^"W1DDBPXXSSC#5VF"LDLH-E[%(XF#K8<?.M_S(6^[C4)K^
MSK($GN7'H22]B7"DV-G\<KS]_=O/QJ:_;.R^QWN[[^G.]X\_&Z=?6MN[[Z]V
M-O<N&U>MUM[E:#CRA&]_:I#]W8\7<'^X_LL1/%OL[7Z\W/_TC30V&^"8PGB_
M_^?XOU>-"0Q\0>N@K40TY$)FHA72%'ZPJ#D7,6A.RO9<AJY8JF %*2\>4I@+
MB5C'N1.1*QR<DI$I+@0G@<%_%9#R@)/<"E*>$U)&JQ8IRP2"6*(D8D)Y-9&.
MD2#A!':)4<F( D@Q=8E7B;MD>4[&\G5R!Q3!]F&4M6(B4">A\UY$94CN+; D
MK(R=\^]H>S!A[[O=S$&7T>AM9%LO"8XF-/"FRFH6I4=$$HYXT@)93PURT5L>
M5%0IY0Y_K$[E>$WF\U$O5HJX6.N@4L1%*^)8=S]KJ8_<(V$C1=P*<#4X-\A3
M01F60485UC88J\,?5T@1%Q"]68W@XZ=.)UPT6ZVW4':\,OO_<-+!']EJ]P%Z
M,FM#>9X^_*B"H?G!T(2.OSX8K;%.B)K<9#0GHFHN!>*1F,"-T$9C@"$UD:.A
M*HY\K?9 I9C+5LPQMB,*QCBE%E%MP#X06B(7-$/2Q8RXDO&!?< F\ 2\A;C!
MDNV#&S6H58&"I1L*16'V7TUX?/QW\T<,)115$#0_")K07Y1QZ:4V!%F*.>*2
MPF_>8D2C2CBRR%).N21UK'0=5GR%O)1*'1=K'E3JN 1U'+,(>-" L111RG*E
M&([(4">1)HRE&+R5.!0MR#&HI'[R84(5-*B(RE;4$*B 9GY ,Z$/(8LX%]-%
MA$U(B&L7D<W\R)&3R)U33GM5$*VNE.=1:=X2]OQ*\^:J>:-;/#?$!2-5-K9!
M\W+JD4Y4(HFMH409'@//6[R2KZ$)\:MA.]KM]&UK>AW/3:.2I\0,GE;O_O+0
M;-YVQ'6!]RU,J^!L?G VH9=:MAJ,U1'1Q#SB)BID2)(Y]\!A;#$ASF8X(T+7
MI1DG=WM2>?="V2LJQ5V>&5(I[L(5=]0.(50&28-'4=@<:O ":4<D\BI(P97&
MAA5V"-6F3B<T2%E1Q1T8*B,T 827];*/BTT\JDIST?=XS=F;F^-EU(LJ$%L1
M[%UHD=CJON/RHH;/F8+<ZO1*&H LSA[DNMGOU;SM=B]AA[NPW5!U7YZO7]#T
MK>Z[,?J.ZP7Y-ZS'^W;^X$.Y&!]NKT5E=\S/[IC8&T'2)+33#J40<RM)3I$U
MA""E@\R4AX9ZL[:AL[^P8A58;UPMGVKU5VJY0FHYQE+)P.#WL+Y(Y@9LG"6!
M'#8)8>9@A2,Q0E%02UG73W?C5R R^1),B)DJSM]X-L0"SB1+?*JJ*I>!2)-X
MPYVE/*JDD85]!O%@"'*:2229Q<9[SA/V:QNRCDE5Q[1*JKB 0\I*%9>JBF/&
M >9$6"8B4LQ$Q D1R)*(P4)@&5XQUS'E-H^:O\VDI&<-+T3;B[=/(ZMHPE*C
M"7GZA^<6EQ42S1&)KB88!9@$:[DF*%'L$8_4(VT41Y@'2C##GB:UMD%57:R4
MFU*IX:*C!Y4:+E -QPP"&3@/7.7SPJR&5!"PT@5&GJ>$#?=6,+FVP62=5)PG
M5?G22@#0PB($]U125C@T1QS"DWJ+Q8+P7:- 9$)<QH"L#Q39(&";\4P$[')C
M25D5+ZV4,BXL1E IX]*4<<PHB#(Z0TS._L,1<:%$;O":$,[_393F\.^U#0ZF
M>14E6(Y&OO>^>Q[#L$-KF89PW@8CN05_[<8?L7T^UK?UC3LJ"[,3X)?AWP8=
MJ+Y$>)L?,1][%BL%=QJL6)4(N1C8(A-LB*"D!9^%(AV\0WE+0D8DCEQ4@<'6
M)!FG:QN2UP''5LB7J31U849$I:DKH:EC!H:FVB6E&7).2,03-D@3,#!X=,G*
M)$*B C35U(G1*Z2IKSGJ\+7?\2?P5J=938K&7U78X;G,B0^W5@& :M#?LBKK
MG#LVT4E6A-8I10"CZ*U!W.& M.()$:H5X5PF)MG:!B5U+:M0Q"HIZ!*MB$I!
MEZ>@8\:#L3C%*"R2$>P&$!N'7(@.,4-B$H)%)\',IZ(NQ)/SCJOPQ&R%/K?M
MAUH5CU@Q Z*"ICE"$YM4$N&54919I+U78#M$GNE8!-* 61%V):MR[C6M&U)5
M1*R2:CZ_Z5"IYGQ5<\QJR*5*GC&-$J/Y3 .4U$B&$?8JDD@9BTKD T;.G]R[
MOHHX/$@_O[6C[;:?>'SQ>MV9A:0[?H GY&=_;_://H @=$YCMTJV6@0&\0GF
M@=62LR+3,5(!YH%BR FJP$90/@GGM3!J;4/*NI!/!J$JM+!"]D&EB\^MBV/V
M@!>):98T"DG8XN !.24$BB0X(G0T+-GBL-#0)U,G5E&$BJ)U]8,&5?1RWK@C
M)M@ GCJ&>79!*(\Y>IG[UH))8+D IT208#W/C*U$K)(?4BGB$D,$ T6L=&U&
M71NG0H"]G4D149",@*YYC& %*=)$*(>3B<8'V..?GE*\ A[_8QE:5V;WG\#,
M^O3RA[=&Z+BXVHANIU<%*><(6%L7$XP#SH)V4BB$8_"(*Y9R%01!EB3"3$PT
MA+2V00VN\Z>?(%0<K"NALHNKH*A4=OXJ.UY R1PS@G(4DPN(YPZQCF"!C 44
M-D'2J&56654G\L6H[&N.,OS'ML[+_ 3;:G4N;-O'K"-SLSQ>F OTVRI8%]=K
M\GZX)!5NS1&W)K$W4F9LD$(BJA-'7 2#=- :8>.YHH*P(/S:!F=UIL:;6O]>
MQ2">10$79BM4"KAH!1POLM36,F(U,AZ#X:!51%9;BFAPUMH$I@,!PX&+.C?C
MD<!G4<"WV3QF HEYU29FM8(3V[%BCILG7$TB<=3").%D1& :R$PKZY"S(2+#
M@Z=1 L:8G-K(51VS)]=L5:&)E5#8A9D;E<+.76''[ OG@G%1<*2]<Z"PP2.'
MO4<^,HUMHH82G<LD2%VJ>14RK6Q@8C"P\F;O&#P]=,XSP])P< NQ44+SQ_/U
MY2@>#C^&SQZ/Q2PUMP/FR+9:M7;L3XBT_/.W(>WEY>]W7^"A]NW\%G@B=J^&
M*?I_9K7ZYS@K*[B3/7/HJB(,6,QF-HDM-(+I0;B/2%$%FYDC":Q/E9 ACGE&
M8%5M6MLP!#:S"7DS,WO+<]TN'FN95I!70=Z*!0LKR%L8Y(W9[XE*B8T%M(LD
MMW;7'M!.&209B]Y1,.]MS(T=,5-UH<=SE%\@Z!76_3_[%AYZ;?^5;[5]?@KZ
MXA]FT&X4G9YG,(3+83;;(;;[[Y@LFC,^]$;C5RT:"&A!"->O;48?3UWLEG8_
M(_5:-F%J6]W8RNQPO7/7:X:F[>:^UD?V=M>ZNTWKBM//9M&YM?C.V7GWK),Y
MYOI'ME\[M9<U%XLKFF"R#RZJY==.30"?V+JLU^P/VVSE92ONU4D);/J:/;3-
M=J]?2^?]\VX<;;5=KS53S;;AXDZJ_9\98 T#@!D=HN( ;: )\&NT,D>E' _,
MZ2F6G+B??_H]2&]^LFU=]ZVZT[9JN]/_>NZ.H^_O=C[^/&MVB].2AX&@?*$@
MN/_?(^Q/_].VW\TYC)'"N"ZVCQMD^WC_>'_W,]O?#,WMJX^LD:__M'?5@.]L
M;[XG_[TZN6P<'C ="?,T(:\3H)@B%!E8+X2C49IHBYT) &!R?9R,K09JTH)?
MUL=T;\X:_LRZ^FW]Z_JXHA9_33%DC[D@>NSU;3\6KG/G;C/*W]:V=_Z]]ON(
M/H-"V;.S;N<G2&'6SYG4B[$48;/!L+M(GAC6TM H@G&!@@F>[*_4:VK,[TY_
MN$>TA'M[6O3QHG&U=P#^C?;$8Q2\P8C+%$"-F$=)6Z*4-YHI4".Q/FX!#+6H
MD*&9(#918X.@U#+/@Z,V$:.XIT$3JT64E0PL40:V-QL'4G-*$[7(&2P0#^ #
M:Q(X4A:KY!R)DH+[RS%9'\_5&$I!O=:-O3/8P)H_ !/6:[M'L1=K@!^]FH7M
M^8%;>/&-@;%0M,(]BIF4MMF]K 4 F_)>O:/.11N^57Q:F'-@0K0Z%^NUG53\
MK0*DERF,/W<VO\T#D.[L<%D$ZT_9L< B9!*@*I#$P<(P1*I\]N$UP9QK_B"#
M<+HP?/OZ5SG02BJF2,5EX_CC@;,Q:D C1%5N\B>E1)H&BT1BD<"'S!B *+8^
M'IV[EHIF[T$H=$=X1B ), <6FQ7H=L>P^D=M<+Y0ZW=JYP!\&88 $4_AUMF<
MFF)S@6R.&%<PR%;S%/R>4"MV5OBG?0[7.-N#C\)YS _P1[9]&+,A!D 8N[VC
MYEDY-,*SY4=4O7@&_&;@MUZM\*7@CNZR]C66 L\TS=?G86Z!L'?!,ZE]*8DR
M:A\ZH;@Y,5H6UX,<@VD;KO%U@GX]!^16"#NS+I'MJ\8!,S(F%F).)R>(&X)!
MEXQ%RKCH)?9*<YL1=KPQUHW)UXW7<CHB55FSLI!<1MOM%>I20_ O)M=K[POG
M8;*S4L]2===9@67O%!Y+:/:*9.J8 P,@K+$W&F.8T<F?EP1.=.;?GW;.']IK
M\@V*((-_'S@CF#)2(<UR=B(A'FD>"#+6"0H2Z+6$3=ZP]6DM6X>"6 21/.#D
M+X)(0X/TKM@\TC(=F)X9+OOE" :H..IL_\C6JX_@2GM[9GW>'\IHV$"( 53/
MB[?JY7L.'E8HSGIMY* :9B&+<+-=)M(N*%3YL.L&X0=.UY4XZ_]QUND5P:UW
M.328[?\_+IJA?S1,"+IUX2#XBV\NL:[7:9WWIU]R:XP^YGE;9FB%,#*R#+=^
M'G6'8SBSAQ&Y;K0GR"88XCO;NK"7O;5_WGF3TV8;C<S<K"\]:5W*GR/B4:(*
M(+DR &I"<0G_(]:"::UP()A8QJ0H41&NB>%]!BII-6@A=Y)(QR/XYT0$@:/S
MU&,6F%]$SDEQFW?-/KRM?\"*E-H__G,X)TL3C?^Y<W)P=WL1WA7MIIQWAFNO
MG>3.P&)$G3Q/01ULYNT%PS*@FWWF[L[R]?STU'8O=])T(V<7GO=GJ^-/WMP>
MLL>WK[X=:&=!JO.1%=?@*#+,D14*G .2$C4@\R[%40E/'JL8!=7.1TZ,!PG7
M5ON@6<01)[ 3(NS,9UD%N^=Q;6.WC#^ >5-VQ[D)1 R,YV]?;\4X\EE'ME-Z
M[X9".7*\- U08:D/ 1WRT9<H@L<3U?F7@]_XGS(:<HVVQ8$:J$'+GO7BN^$O
M?X ]==:RE^^:[4*NBXO^&(QA -$9G48.TPI0*C\> )<QZUJPK R#G+G!@P>P
MME[HR<CY8/F98NN<\JD?XW4R];/[;DO(NF1J,;<U#[KM4QD5<3[=G)0__#16
MQJ7G%ZB)^06#4$>QBX':_&-Z">3#ZSX& DMF2:M<D>GXFH, 4R;CB:FH&4IF
MFI))^3APDV5.Q^2DX.N7E\M]^=MIMDLV1B=/SV^%V]$YAUN$WN_+-WOPJ/TU
M(97V-1/*YE &RH&,IQ#SO8I<N$GOM8+9;#,$A$Q00E,PHY1C7'-NB%/",B4]
MED;X:5D?ORY%F6Z^/SK?XX4GO5TTKK:NMH^_G&Q_WSYM?(=G[7[,SR([NR=B
M9_.OTSW:$(WCCU?['T:3WMY?-8X;=!N^"T_[F=^KL9O?ZYN :WGC^_[Q7LX-
MV=T^^>_5=<);O['[&:X[I ?*VX2]I0@6%AP&3\%AH$D@$KQBWF/#%9C\HD[E
MO"K,%IVJ6P',2P$8RIFU1E 7D^?4&Q,9"PS<-L9MX 97 /," :8Y C",JAPI
MBR@Q%0!@3$2:^H!@;R%<>T)MCFI3;NJ"30MLKR#K[\LPSE@VSCAY5,7\"^/T
MF %W/(B=T9::$"/G@ABG)0E.>Q^4$X0\!^ZDYL\8T%7L=BK(F0ER&A-L&BV3
MB00PAE**8",)2$>64 J$&P7V;#0L>VT:UOB/%>(AK323!DF2DY0)I7E@QA&O
MC4X6=@J'P5"M+((7J)ZC%H&S4CJ?.Q$KF6FPP.\P 7Y+27D"_QB9W-H&X:(N
MV6N@"7X)IL+6=5I U1)H'EDQ3T&D:74O%>[,@#N?Q\T"XQ@-UCHD!,]GHY0C
MYZ5$&&LML:1$6+VV,8'YJVH#]'SZ]\BZB$7H7V44S%$Y1XT"[H0VRGN4"$V(
M4VF0 X, &>*)(-XPF?,O95VQ\=*U9P\2C.2 $5X<5R_BD/)11^&K^X GTAM.
MKYM>E4/=!]$&S<;T]+"7?DTA[]E>_&7O=\]@;U8[V_QVMKT)9F?R24=-$0?A
M0%Q:@8P)-I=H<RT=25KI?,+&Y'AMP1* 8H%'<!5@O0' >@8#O0*LN0+6J"D>
M-6?&$(-XI!)QS"4R.@@D Y'*!"])]$7E<UV;.=/.+A:R[G+=C!6/C!!>+%K1
MB'A ZOZJ\VQLM6MV0.-2KUW$87G:CU@[C.VB%-*=]^"J7F\Z%\[3N#.>6(E\
M7X_ "9PT[UM%76@NZ&DTV\W3\U/X7E76-KDD88MM[QX>&$:$2I8@+9A'7$>+
MG!,$D225501L6B76-O#Z.)34[A2TW:U+ZW=JW5PH%B>6*-]4$]^0+,5>6:)\
MCV"6)0LP!-2-"4"J>%*^5_[SH,ZX*'C(Y K]BQC;=ZLZ94Z%U.,,.HNAP5H=
M%)C.MM/)?37S^A5INKWK,L%BM?+,#JBS"O#(9:TC;#N+8\V"I7Q(7>,=SJPG
MP%3D7 GC*=A$W'EL")9*VF Y#XJYL !&C8H^:Z;R*;"K/'SWA&U??6/P_ -G
M-.>4@QED D&<*(V<<@R!E0O^.4D,O+JU#:;NX7]9KTW7C%(=)M=V#[=40*E[
M]6'&"F^EL!<)T^!2XCCF8W6AHS0IL]E@.XV0]RE"6$G@(R5P9_/P@$@=G.,)
M,:[ $ <(088G#]NGPDD13IT7^:#\OJWSXJCIC^[9OPHN@I(8@YKBEWE*G%0A
M!$]<-,9Q::7U6BKJ.$TJ.?YKXL!*XI8F<7S[ZO.!PYHKI0(2V&8J#)X[E'F&
MJ !?D"=AX'\@<7I]/"]C!HEC>"!QS*S7[G@0=A:X7!K!YGVFPESX-;6,V"G8
M;(2@G EBDS=.8!.%%@#.ON+77"UEV?O9.-XZX(Y(:J- 'A8/\1 -LI$+%+@1
MF65 FZ#7-OCZ> O2Z5R;KXHP-WM;/R:T_IRNY1>96.G11O8C&P[\>K=Y;*N^
MMZ<E6V)G<^^ !BRB5!P1&A)H!A%@N, V$BVG2@L!=FC1Z/(>OKK25Y\D/5,:
MQV:F@6E$2J38;R9^A N9F\F5>QS'>R5E\Y.RQD4.+"DIF5&2HLB-!O-8@X,&
M_@VRV$J?,&%8\MS-\3[^NYEI6JW! 5NP9,$P=UX;$T.0EMLD>;2T+!W U>(O
M=O&/OQT$Z3#F5J%$,0>(X0RY%.$W+4#YB W69^Y#>I]O-$;.6O ]#X@$AU2J
MG3YXX9-PJ-BK\B)WH^W%64V^1]'AW)6H'E@'\-NH:(U+TJBP?2C><*M=D;+=
M*V<_MS=/#APW)/#@D;!@VG'B,-+$4T1P!G\9.-5L;8.ND^EB%LZ[V9LN#)PB
MF)QY>A\G-=IC8<%-2)Y:[G'2FD;A(N'1.$6"*Z2&#*7F 9M0)2SS$I:=S8\'
MWF(*&T] 01FP>YBBL!EQC:@)Q&"OP"S-]/OW@M*-M)!K;M$2A"JH>;72<]DX
M?C\/J"FY>.ELU+,1G"7)J"!@T7)/M>6!J7RD:JC1/L5?R,?6]E^5@"Q<0+:/
M#P\29H CAB"KG4$\@4>E=7"(ZABPA$\Q5[\X2<U&RTTG[=I%LW_4;-\.E&5B
MMW9O<.KY:,A1B0IP]0SEL%MA20W5 #TR\R=Z$/)00<ZS2Q3\[_T!:#IUE!/D
M*,U-#I+*K,?P@Q 19&*9]P4VK/M8CT<D"J1IISCS_= Y/>O&(Q FL*]K6X6$
MC6QHE17TVH0*GO%Y+E90N9&1V38RSKT%X(DF4<*5E 8KKI)04>!DK,657#R3
M7!Q>;L,S&E>YH=\WDH$G2>&CT1C%&"WB5D9PWQE%QE.LHA/$Y*1H\RO@:5X[
M\45Z!KCG_G_/FSDP&-O]9O]R-OFQ4BJ>M'7.$,X$A;U5<3"4B0L\<6(J^7D^
M7-G]?"!%4L)$#09Q4(C'2)!.(#C>:^.PL812E\];[FF"\E#SIU>?.3*8N').
M4!F)3ERRX(@#JXR" <U9PC%5PO-LPI-M9^$-9YHF9'G*_1UPT=HS%_]*'"4X
MQUB';#M/3^:9S=*9]4#N927\33F;Z=USM#?U!(;4+F(WULZZ(*==&%^M8,S/
M9SN=D5R4?/]VN).O.7J$GX_WZ\/8[?%Y.#S-[0A@;SBU;7L8\W_5!TF>_=II
MI^C8<9+/&8L4Q?Q'>*J+, :8[*O<WB7G)^1']_(H\EW+CX:M;>#6$PZCZK>>
MEV&BUPRQVZM=',5"8IK]W--F\N-S?D(OP]%9IUO,;J>;)WC(K3WIY.L"!+2X
M^,[ \QJ=M_K%0>IPT.4-)PXYCRC$LU@(5.W\K%/.89DM.[QN<NN'0<@J?QW6
MJ]D)Q<9<YH&4>1O]> JO8S-1>#/!HV,A+"Z6EY<-'^"&Z[7&I&G+-^[Y(_A:
M"X;<C3_@C[8U]AYW,C&*W*7S?G/XUG40L,YQR5D^O;7:*5Q]6+YMKP^O'0]S
MH@F\S*D]*5\Q-TPJQ"&/L9".6P;(I&G-Z](KTRRR;-E)>C-%7 I9^)6L](L6
M'E/%XI9(U 9+6K9-&EX,]QU^L7>>4M,W\R"&D]R[;Y:'VCC2!F0PO0-1>!W]
M1+,R99RW[<O:T=U]P$Z>G\M9O=H%9"_<ZAW^K1V:(-)-=PX:\!=($\SL1]O-
MC;BJSE!3+(?/M+'9.$@Z*8TQ0XDRC;A6+B=@)B2TI$IBS3W+=$7WM-2M_9:W
MN7?/G6502<-3I6'WXP%-!CL"UB,)2><.R^"X:H*1<DEH[31E3MX?@_U]D)OX
M(_;Z&?#+-D?E&MQ-<+PHT+E_"WI")Y8[RG"3*'LN#59N8+O<3F,$H"J?E"V"
MOP9=R*;@5;[O7?OVUM8V>0>_9:H][(6&J:'#\9?73A]T?;#_Y;&=%3/IARF9
M((?^/#]^T! 5/@2%NO4"DU^S7COJ7.3=[=:=K[N9E&/)%E/>,7)*T;"U>[%7
MYP/_6QFG=V?H6J.*UE6IVSF=/ F#SEBY/.F\WX$)S7?LEK5* [.UV^R%IA\:
M7?W;?14OP3@L]^YVYV:@=Q?RHG/>"OE%;K\7/+PLOQF^T4C#KFQ%7 M289$7
MD]2-8!/UAX;P3:D?>,Y'G58HC*)<6Y73]EHWBU->5OH$TZ>B'.C <IVV"(?@
M55V/NB!M5'^415M]L&RRW,;^1:=[<MT;]^.WVAG(6+M_>]9"LUNF>HS8(Q-[
MB%4-O^XV_*(ON>'7 QIX+:EM51D:R,G8Q2#!M0)C^XVWK&H<Y$3W)(U%,8"1
MQ1/GR)HH85NUU"JPATF4HRVH)O2)&K:\P4,&B>>JA2SV4%A9P./;".[ EVP7
M?6\S3H&;7?Q:1.Z*KQ0G8G?VKPQQ#MSOU"R]\UNMM![>-&NYS:] B==QJ<BS
M=K^2>%UQNI V5>1A;:I6Y+9T^L=54ZV']@4:1AIKP_CCVVZJ-3H=TQGAW^1T
MX+?396P60KKKES>+>_G2LGOF)FMWNX@]31@>3?J\Y"7_-M74R <0?=LMS)),
M;5&U]GIUG7<>&5T<(^VZ+43@U_PY$*$W0M"UV8)[P6>GC5P/BK<WCX[WCL-)
MX[C5:M ML9V)N*X^\_WF&$'7Q<YW&/>GO<N]JX^7C>//>.?3=A.>">/\=K5W
M?)(#SU=PO].)/;NX]<DD0Q'L7 %Q&R2R7! 4B2$)@ZMK4BI:\]6Q7#$VZPH[
M7CQV/+($KL*.9\&.47(_'RG.C-HH.D819RXAE_/PC"",F.25=#GCU]2QJAK^
M5= QYXZB'E/-)/.4>*Z#<,%I[:RF,C!-C<G0 7M8!1TK 1V7(] A"-<J<_A1
M'BQ 1V3($NP0_!W,$4$S:6@V.^I$K"!'_\SN_,I[<%O#\HE;I[#7^<\%Z<W@
M?.EQ'>5'IF$8+UQPW>'/7O-=N]D:!/H?IO?#B>A]B;V<\=8^_*O;.7V?IZ*<
M@$KW9]+]"2WUDB?4<ZX0I30GP6"#M)8&4>)$D)Y;KN7:QIC65WWMYE.Q]- =
M\ &:4&V1<U23L6:W1E&BDD-,N8BX2QPY3CW"X)%;,'MPT!ZL:X7KF(_30E6=
M)Y^Q\R36+D82)6.:!Q--S!6UTFOB/!6DK!W#0PU]O'L[HX:^QK:PRU+.4?N5
M)"I]2!$)"@XO=[GFC(&N4I:2"0P+0OPJMH5]M4<0DPS8LVZSTRV.'1YHPK[-
MMGA/Y?1X&ES]G1?I[R*_'[[[]W"-*N-B?O@UH7]E%$P09B621@G$O8[(8H.1
MCHE)+U(0'(-Q(>MX;FTYJAZ6+]_ZGZJLE3[.IH]C?7*LLR(RC1(G 7&:"++<
M.L1Y3 14-4K.<SQLO!ZY4L:W:NA7RC@G91PU[L$<,AA,>(2QY8@33Y"AA*/
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MH &VUC9(G<[MF*M*KWXA5=R53BY))YLC.FF\BMIPBW32"?$8 C(L.Q_!8D4
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M#()&'#A-UGC, TO.<Q(\ANC6")>,GKXO-0M@^,FQEAHP'@H8S3' 4%BKE'!
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M5PHFUK'>Q&G3%*673K!H#0_<&( \[*TF$1OAF:D)SV+#X)1*\C'BG/'CD57
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MWEN1=5D1<'JUBQ]*;]?ZVK6^]LOK:S^D#._*J6F_T98^=U,?YP9/6Z9[7F+
M@G3;DQ76ISJ99518?[ZH^EVQ^1_KBM\[FWXD7/Z8![P%X?)E2;NYM_;[\_3+
M'YH#L*3A7QW U>6T?U"C\'3WRX>SW;/W\-DQV=O>@7NTONYM;UT>;G\X/3C[
MZV3OXQ^G>_M_-0\F:A0VR,&7 WI07O^9-TX_?=_[\HDW<FW#+[O-PR_0QH\-
ML?OEM].I&J%24\8(H\CQ',(9'9"S42.CG=/,80\7+%XY[1I)5@%)7D[#O$:2
MET>2\:0IFU22$2OD'.:()YN0#H(A+1T,L\>!RU@N!N')+=&54DU9#)[V_GLN
M(A=#T8W]0;>=2XD^9(5@A?(T%BME:C0>?Y3#L=>^C4LU]#P">J8(I0+BY%J8
M#'&K'.(Z /308)!E7"J3,.-,0E \66>Y%DI=@0-3M<W-P^;&W;VV)'A*P-*(
MDX@K9I 3 8/W]]Y)2JTU,LN>+Y#-K>R:3'D$H#5#3[_")S+F*JQ2CDN-/L]$
MGRE"J3XX(2S!"!R\ /21!)F4-#),4?B+H);HM4VCZY-0BV)W<U53J>UN1G8W
M<3)*>0=#XQ&U$H+\0#BRTD>4O-78,)FHRE7NV7,T"^OH_@&RJ/XDGL49Z*.O
M;GPQLYC^'D&&:@CN"#'7^/(H?)FBB6IY2(I"$&\Q3XAG.53+'4=YKXE%;4.R
M'J(*\NS-B#J47\10OC:UES.U<5?.K(PP(VVN>Q(0MT(C+;R$>#Y1EK@+6KI<
M]V32E=<1?%W[9$5\^_TQQ$W4\"9J+<P+B*8(HP:J.2<L(:I$RE)G#IE@&"(0
MW[- :8I>U45/%LP"Y[!Z7UO@2UG@!!7 7B?C*/C^K"O@"5 !!S^2C)0[K)34
M8O6KG2P&$ZC%45]5\^2>".0&B]ZL[.*\\&F*&*KCV!./ 9J2RB4:$T::*X:<
MS:EB01K-:"V&NEKLX&%:Q;5=SM,N)W8#HH#A]!81*L$NL9#(T)3'-$EAHF'>
MAEH.=2D*I2U9I+)@>FBWJC;5NXU/Q)<IBJ?&)X*IUR@P01 7,I\OIQPQ*8BR
M1%)&^7,KI-6K @NVRU_;VEQL;=R7<PJC!J.%C&(!<6\YLH%2I*E1*0\ISGIF
MSRN-5L?_M>;IPOKX!V<7W:#.F/1B&5FT2NF9%=-BGA<N354]]<9+ZPQ,8V4E
MXBDQ9!,&%D 8YL%S*R/)&Y4+HK186^-<<_UJ:WQ1:YS0? +TM PGX.0T@#52
M;Y .3"+J5"("*YT\S1F >#&LL=8]?;R*0RU_6HO_+9O\:7WB^Z6=P30)5$J"
M8I999%Q0B$NAD37:(QNC%#([BGP(3*Q+/:LSWZ\O %BC8(V"M8+.&T;!"4IL
ME!?>Y8* $.4@+J)"UKJ$(J<D:6HQ)WZV&CJOCX)39%!ST_(\;[8'9=3U<V'4
M43O+1S?;(;;[OS!9:LG-PVYIMMO]DUBD:S;<R\2W#W\:L6'7^1:A<XMVIU\T
MV[XU"/!9^W)TV;O.&;SHY=_A>Q?M LS1MGTN2=AL]_K=0;E(O5Z<=SOGT)?P
M)>\'Y\V<QG.Y7G2Z10=NT1T]:M ;?G#KOAMWNVQJ#X]Z:=@J3C=45HD][_2:
M^9I?NC$'P=_B4!QVB%:WOCB<1?CF*];!A!GT[__*A!#?/$>,,#76+;=^GG1'
M[W!NCR-RW6B_(IO@%7^QK0M[V5O[UYV6G#7;:*SG'MOH:9.[^CDV7!7 4H,E
MEBG@E#FPY=H3#Q$T31Q^(5C>^]#A^O2<! [+KO[]CZWBSXMF_RIV6SD5;>MC
M<1[;O>;PB/F/#7K:6S\$".ZNQK\F-NRUB]\&K<N"K!?9(]\Q37#I9^>MF!5V
M\E^W_'\&S<I\,C9 QVT4D[VW7MBB-W"]9FC:[CB(%"<6  <\?NG5"S<L35(&
MYQY@J)MU%7-F8(0'=RXC@%6S?><!\/TS^*_META2WAL^[O6*X_SU=H:CC>(Z
MP=!V8^%L1IU.N[QV=%] LQS[EU@('?>MZ6.9B)A;#*-?SN6Q^Y3)BJ'9C;X/
M_35\]JA=%R>Q? !\$.$>@*>#N)[?'8PC4Y,F0".TXJ3\4@)OEQO:C="AW6J?
M+[^(/3]O@3?*3NZF-7#5\:!:X^MM%!G*R]YJEOT ]A\*F#UPK6W!6Y6YE'!)
M"8CPT6@F^TXOMP(^;36M:[9@$&/5JHS,O=Q!\*[6>_"I.8'HYEUM*/LFOUT&
M^007PPW+A_UG -,X9:RW97W&2Y@.=U=91N*^%0-@U1RCN4]ZS5X_WS13R%YQ
M$EOE"V0;@%?.AI ;$P"YX+J8LT)SGT'[I^--D [#]%;.\L"YD#HD+K /UF'#
M<& 5.87OQ+"5.:*/G"B;-U&LYSH1BS404VJ=TDG[:"J7>;?SRHD,O5XM).7Y
MT(V]C)'EFY?#VFFU.A=Y8$O.T+NO2\>'?>O/=X4B DE<3'%_0QR9VNZ?MF.L
MW2Z0Q#@W(LC :0I:L20<=U%R(0Q.,P:>\C:_-/LP3?P#H.CO0[(_,KMR-O6*
M__V_-$0*_R[V2B;Q.PQ&-_:'_??W4??,#2]OZ,KD2#W+14P=X <,V,^>-U]=
M?J 4&[BB%8\5YI=J0Q(V>P5]OB'X"]WVP64$IBS+CWH<(J6X&%?.NX# (E#
M:J< V@2PTQMTSUN#WK_^D>F);_;_.<'AYKC6,A8T5XQ[Y2L %$_6M;^KM;[$
MNO;CW4$>T!TK@"5W5WT>K94_#6CFG-4T?9GKNO$_*A3PS,8O>J& )9N*RY)&
M]WNW<UKIW[J)$I_/R4-8B0V9:>U:P"V5QZ0<)4:#\9(1&ABG,5K!*/S3*XAT
M.?'LZ3O+OU>1;AEO?8$P=<O[P=F@7$*8J#C7VVF__^YCKW=[_V7K^+@;X?-X
M/2??9*6Z\Y.#T]WF[O9GN.^'9B-7JCL[;!U\.;AJ?/GC[.!JB^SN_W;:^++;
MFJA4=P;7TQV\N]_@!U]V+@^W/UT>GOUU<GC:^'[X$7YN?R:-L\;W _H9_\_5
MSN0Y@FB95,R+K JL<FXS0RXQB9BVQ'(<.8\\;U.S!:J<7H/2\H,2$UIXZAV1
M+O$0B8O,)<((CT(S[\33-WIK4%HZ4+H^</%9[%[ML"/./7%8$<05SI57DD"&
M!8*(]=Z*Q)@Q $I\W9@%2:5<]?!JX3GMO4F;;^'$YT)PP;>;7S,GG)Q2H8KX
M0)-3%L4D/8+Q],@D;)%P4=!(DXF49IS$XMGU'>JSH+/,]7TQ\E-;X<M;X2VV
MLK=]0(X("41%GA -P%$X=1PY8Q2BC@BM*9%)N[5-MH[)I.3Z8ECA2E&6J2OZ
M8WF 2WY$I9HUP^VGX:[38VGOC/IGE>+K677) CJG^:P7/OAD8C5U_^S;_F 8
M>M<^:G8^:DH9,"Y#8B)J1%B6"8O:(D,I151(*K"67%&UMDG6J9Y4)'IT1#T[
MZ'VI%<(:_&KPFS4UK\%O4<#O+D$71SH1324A2+($X,<$SF$R!,Q**!<$8^#F
M,O@9]1P%EX4!OU6@]8OWPG5W+=&54XY@K=X1C/WAD8";&/ 'N?,YAW_J1Z1,
M2A^>WRISTJ$C426QU!\>P[J=_#\\$/&NTR[!JSPN,)0/+?X\B;&_L>I'7W*_
M#W6GH+<F<VCR&8N?)?EO%.61#)B['GQ(OQ*P&@S/4P"V^_+H1KX:KIKVB/;P
M'$HLQ__Q@WYA>\6]M @8"'QC_&@N)RY1*BGE 3J&6NFT<B)X9V+2]!Z!@@>L
M66[U>H.S\W([]C/TP+N;UD_LNVX/^^L/Z*YK7H3HDA*CP_\YP?[LK[;]8@9[
MIY^^-S[^]A7>Y7+W:H<<[G^ZV*6?^.&7SQ>[VZ&YE\_@POL<[K^G_P.?0U3'
M=Z\.V.[VP??&_O'W(\^DMD$[E(-VQ*WC2$L;D?,L*!@L1ETN/[<Q27'^5LZ3
MQTT&[84./CH6(^/)).N(U]3I@".-.MQS3KN>#'.9#.Q(*&:EUBHO2>?2WY(B
MFZL2ID"T$8+$2,W:)MZ8/'3]M_4"H"O7AFY^BZWQ4[8O N;+=MA$F!<Y%4+O
M__A9M[W_JT\[;#+OXQYSRT1^]P.?7L[IGV1JUZ<JZE,5];F&^ES#3\\UK.S)
M@E\G Q6(2%T$!]W.P4Q.S8(;=T)]S& Y,GH7(J?E36;?YN]LL3UXOT9>-O^R
M@W=/?VL=G'TXVSW]<')P=G!YL'],&U?'HC&^7)Z#AVTO#L[>7S;H#CDX_40;
M9W\ULY)3X\N'YN'I;R=[VP=7>]M?+Z8>"?!$!<\%02QB@[@,'EF:*P\FF9*%
M.-(2<U_V[:N6&JY19.E11/-<V9(&8K#AA'L=HN,P[0Q-#HM0+3+A&D46#T7N
MY/ W+H\T]5)(KA!.+B!N,$$Z.8X"MQ2+",.J4D81O6@H\M93Z?\<RAIE^9HZ
M>_X..BGNDK*<26XQQ\YHC[&@&:9D8,J[F91+*GO_'71^C4&/PJ I^?$17(=W
MRB A\G9_U 8Y;S4*.G(=M/$^2^%P/"OMR3H[?B96ACTF7AH1=>)>*!T$N'_,
MO.+46C:;0DFUE3W9RL8]O; D&LHH4LI3L+(8D.6&(0/QH-(Z:BK$VB;%RYG]
MOK*+-3MYD2SV^D]W]$M6IF6Q'/VH^VL,>C0&3<EO5LQP&HT"Y&'@Z1G6R$6
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MBN_3:)O"C"B>4!:M1#S1B)RT(1,X' )Q'CMR7TW2I\6?,P7C5RE:4"/@6T?
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MH47")%K!2QD @C=8G<NV8@=O9Y#H]@8YHD_21T8E1-2:Y\*3CB;/J>0L&)H
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M#=_=^DP/8L0D&JD19=@CCJD#<NS@GRF&9$52+K*-S<%9;(%0M&%QC_K3WDN
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ML%*31)4% B H0#ISR$B@!X)1AVFTQD2]L2E^X39Y7LN6:>$8PQHD+/"D@W5
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MY&"R$:&)L&"T(RE,5PTU27 '5%!(3+DD23,PV13('>78Y_9,4U5#/PS[L.@
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MJH!F9%48N8ZFB</@2K'_LS]9BD%.9TZPY^7&H7FIV]T06[7*U2,5.<YSF[K
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M'E2HL*S[5];]6X.4L$E?A_\J*_^M7<V<A57^FV<C_ZO;[W^(J=N+-^RN/X[
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MFC85"I%^WPGC'72IZHR\COEP>$"]EH$0BI+0"G$J&#)2$B08%3KRY",VT^;
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MUT^%RKI%YZK/L'Z]$G$7C[C?;M(]IZ3G><X0RTD.="\=9C@7D<)2*Q^-Q19
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MW8WU::V$U<#]J,IYI%1CAD6,GFI%<"YCR?J6+GC;NUL'0AK/-4TT+P @1>Q
M6SN./*R&!^K'O(NI] &[(^V[(8M+IGRY <N:Y8RF*@$T2*LLL432$#48$I&6
ME&_YXK3A#KB+,/TY1M*":N.2!4 T;%.+A*B!=D05<J!\6BZ*\\WB;B4)'.X+
MJ[0+CA$6 E! 3I57D5$G?1XE95&4)/ Q-\G>V?9&]8 G4UM8CQSL%L0!J9"E
MTJ <&'K(#:P" [L(UFHZYA;X^K[3_3GH99\+N]J%07&PU9NN\3^!5)OL8]>
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MA&9!<Q93+7I6F=4[;HQA2=;N(B ^BAAD[G(=*"=>)A9'95!, 6 2Y6Y38:6
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M*/8(G]NB4R8FA>J-.E36/TNT_[NGT$UGY/]?KNYFT_'U>')U/YK=D%\[P-9
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MKIP),[#L8$EM(-3!0=@+1D7T2:M]< N"YI@&Z2TCZ1K;+HT#-/-6Z)K(=^#
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M2E5-Z&-A;P';(;QU#S<WW#P-D[B49DMQU[DU74-VG<7N^2%"B\2'JRTX@D\
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M,SXTF_]FC'B%!>GQEY"NLA67HY(9L\(FD#G1:(5S$*(PX*0R.1)K2PJ-2?$
MI$UX89X9+UI*H1DU7LZ.CL;+&@Q8'$SSR]FT[FTX376PW+D44W'@@I?$52/
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M&AJ(QW-,X]4\$[*CV7PY_N_NUY'QAGBL"B0,"11S?'4/V2&BD,B8RJWC ??
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MBC7?#,'S*(!%9U$QU-FTOC3>YWB&9&T\AQ6Q=P[U<;9M= PEUP:<7-<:+*%
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MF"Y".KLZ=SC%3^,CO*%PM(J2AQ"!&T>$5%R!B]Y"X5D:)0U/N%G"]P8/&U*
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M$3KU4,I]/:!A[Y%[X<]CQ=,C8\Y#MA]P>3*?'DZO[-^(S#.K NCB#2B)BLQ
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M.FD;)<NI=0Y;#\,84NKL &G>&R,V=+7.7J]_Q+# O_WI_P%02P,$%     @
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M*<>KJ/OF4T](RWL+\ZYR>0WEOH=Q?Y1>#M,+9%S/,<ZBPX5!1%329$J\8D#
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M@$0>DM949)=4!?VO>?3):+VI6-=$2!J%QC:AXCUJM$^).N( '3[)J"#!\DC
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M%$<LP.'!)DT.%#T&0'"*6ERJ=K.&]3%)3?V]\R_W*X>Y!] I4*">Q"N^^;-
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MD36N]+S^^+,;'__F>_)?>87[KL?W*RA 5YI&XB5NP#X[S;EQ!E8;U]4H^'P
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M55+D)LHTU$)GE1&K8AGE[]\=Y=DPH9G)X*\MAF^Q3!>"U+"*HOF#ZU1<5!;
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MJ"PM$ASQG EBHZ)H*4J07>Y(B.AQDF=75;30^.I&\.)!@3S[-KN\_'S@)XN
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M)9P-BLK:I\PZ'(=*:C76[9I]H9&,6RAT6<6T;%NX!:J6:GW7(SI,26]SC3U
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M%:&"L:%E L@*$IW.+N0D?>_4BAL07@;;N\CU-LUA5YK?7ZI>6^P':HO-K>Z
M=Z&6 7Y (K)YHR)HJ5NFJ67#1P<$5*BS"*9ZU[O$ZS%,+T,1NDK^MF;$GHGW
M/^/A\M]X=$H'R: 16#14@9IWI<IK=Z2AW3^C#7' &),[@;P,'=A=QG?<<74N
M^3S+)2$DQI 1I%&\33GG(68T(')0RF)*PO?F_2FFW7=S'*9+]4FGW6-(,5&2
M4"6;IVRK\%Y%;7ABJU(43I6,W2^ZGGC:_21N-TF[GR+C^3*M-T'U6M/N)S&V
M6<KU-N*>3QF*$T)%[2#4-H2WD("47.8SC!W6$FJD/,(Z>,II]P-T8(J49TF[
M#T5DXY, C8IA*,R QEJ@9!1%7R1V;S3Z=-/N)['S:-K]%-$."&M?O:^ZF+..
ML5A^>+N(\&"H#<S3*,"EP/\SUB/VCDO<1O$BV-Y1N$->[8=2_K7*2@M7@;6.
M+1H,%8+7$B@FY!,GBOA*JRQV>^5[B7QXSOWZ/ M&A>*)6N/3UA"N.:<,#I0U
M0K(3I+,?F\_UDNS\'>4[9Y7%)KA>:Y7%),XVS:[?1N!S5EDX'72UB4V1K 1;
M)BVG(@<V5-KUE5+D_.#$SJ=793%$#Z;(N7>5Q;74\NM1RS?'Y=[$<VNU",X@
MB-@ZI0?5W)TH0%@2RNF8;+E1?;U)VO[&S]_WW?"VY-V;U#]&\KVK..XI+%'!
MU*CX5'0JNM8_2$$064)BK\;'+)P3FRG#DR_)V9KL#I(;^N9_H#\71W\>'G^Z
M Z2)&%5KR4S.F#8AR4(PPO,7R4I7K$U*3W_7'WCB2R!\B'1[M_^[&^2-/,N+
M+M$Y.2T,L&8&%D32$(VNX'UR)B1%@G ');CKF2]7#7:6<,>\U8<+S#*6%+W/
M@"$T4,T#9FT%WIA026)W53Y:I?5<RO/ZD+RM] :DE-XP*M;V:[5>U8!0:BRM
MQP=!(EZRCDI6D:0MIO?5WFT4+\6WWU&^ Y+/KR.Z<#,WP#3(K[\+SWY\^EVY
M>I#Z'00]P)^_$YN1;%4P0/#6LML@))\NH2901?(F%TL1N?>HP/G(?\2/GX/[
M*?(=P/G#IH452$JF!.Q0M#PS%2'HR*N5$DOPQ=32/YWW25EVNW-V*Z6WE\![
M.^E7:Q3>+KY\71Q?7%ZY[-K*$%Q<)Z)2AA!:7]'HHQ890Y)F(V/NWD<\]Y.]
MHP [VG/WH[JP7#? =?<)/X7@?1S?/0EYE.,=I-G[<N8A?-;(8A5J\"7RMI48
M&CKE@#<=J=!GJ\D^39;O.:?W0?(4(<Y"[KOCBX%<6>=,4@KP.B>&%@.DQ+:)
M=!3;B*4@[&:#%AY^SGR'<%\R'F5X.TG.<@S_\9_%Q;6?",HG0V"H&:"6S[FD
M?802R HM'!]5:7N2+Y_S8DG>3I(#+.^KZ-;;E8P^:!&:EGG5JKH$8#8**(@@
MBVSSG'HW)KZ)X;F;85UD.Z#B]BJ><ZW>!-&@RY7;:/9SM;(;2P]0OH.(![_H
M%Y9B),]JW"IX#'_1K:%;;*E]$FL@&5"*WB75<Y'^R)7*:,ZG2'9,\GM9'*\+
M.1,>__>[6JG%;QC?;[_^\.[#A7F1A+9!.(A5,,A2"3"U[KLF%&&+Q!1Z9TMN
M!&S^ZY5=&;R=%=]9_ ,2IW_ U7J]YVA*311U,HRAL!GB))LA4@L(54L90M#D
MJ;,R7$?P[%G?0: =MX#K0\F%TC[XD*$ZW1(TO 34.K5:7:MKR2C]1C>GFTQ@
M?PF6V_;2Z]C<XN:$ZTU@3+'1-B&S_SOYN$&V@_!OTK>#Y$:\BQ<=C)7-2?'N
MTE2/=WSV]X+W&M!$Q9M$KK'+8/;A!-YC7/7G;XK .O-V?3R\5RE9P49A=BW4
MHGA7"E64UBK)%%=E*KA1^/$1YJX]=+X#<2>Q+WK(K*-]LP;"HOH&1&/*J;!E
M92BS)FJ#T+J6@.-SH9*QKL@>K]VUASY#\K:6V0 'YH?356L)O7J3_^?T<'4F
MN?6(*&'Y1&^UJI0M&%D=I#8PI"CIHLTZH>_=O_@>*,_=TNDIZ0'-G>Z"U;Y=
MTN5XMPT #KJY>A3<?BZRNE"Y@7KLSL-,.\9UH DS;XL,U%KI&:@5$"DX/I[0
M.J&L%]U[G^])41ZY_-J/GDP1?^^(Y?L/;_Y!>'3R^6,^I.-,JU^/\_E!YS"Y
MZJV!K*DUV>7ODBH1D++6QA-[_YME"-__C/EO-CJSL>@ORGL-OI[3/'ZDY>&?
MZPD27<9U//1QN\_CV!CLC8$;(4O*5%,, ?F=]2F+6(NU45I2.86#ASYXU\K+
MBT_^[;(!E30I25K/-E *3 @&L+ )*8D%:8QH+= [[[)WP-CU-/G]M&GTNWJU
MX_(5.?Z#CLI!K(FL5I[-+,>&MK(6F ,%.0DK(R]?ZMX]13: M8^"A-VTX.91
MTEOV ^[.O\'Y?=&$BT?GK?]U-29$0M %V>>U['S%K!(4D;R055E-_>>KW(WE
M^2M"%RD/*3B_P/7SX5]4KNKI02(J190*SL<V^P$#),J%SU5=1/8RWRHV[*@
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M4[ZPL%<G9V&XG_[ZRM*CU473-A-JT18A2]=*!$6%8"6!ULF3M-*KVK_>?0+
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M&^)%?=B;+XOER>'_KE&^J[^P1-L-S^]LMOS,8L*C9D@>>(8N#6/V61263D9
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M$[75F1U5[7Q+TLJ0O*H0,T4OT9'Q:2-->#X-H+8FOJ<L>V\!CS<LRE5KE=&
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M!,6S@*"3I150E%9,Z*#:CPU^A* 7#+#V"FM8D+-%_Q]Y75;K,SR_OF&JI-V
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MM1=J0QOQWH%36G "-FI0J$/MCD76#L$:I".#*A63BVV=7C;E<+T)KT+V%OL
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M4MKJ:+.(4<@0BP8G9:B3Y#AX$RVXPH+6S%F[6_-W,-YZDOC,\#6D@@88Z_F
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M6>M4G:I==6KO;^^JN]]WZX"'[Q15% %86%B Q/L+<+<!8%7PMK,& -34 +P
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M!\&W&1$2:)N&N/_AK;L0M<%R35HV<^>,PJ.K?&,@?Z+G3_2W5RGH+MY]3/Y
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M[/7M/N37LL<?O+FMADC6[,.,Y3XA.?.LJAV5Q>AO>8U4Q5+O /.])RRX)G>
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M@86\LA\LD )--DK--.5AE@?D;6C.VV^6*#6Y =5:\A7;@,=S:#<X=L5O>\.
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MUHQY:]8B!?/PR=<9!2=+;7.S!EDR!/YWK^./'3]>Z9HKL>65D3]HDPOI$NI
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M*,.9L>U^QK*^^&>$K!J7J2 X;Z/ 4EZ)-O7\5-NQ3ZA5%T[,G\UOU+(90 Z
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M/[@HBX#+IJ^PO+ [8CU\E:H![9%-JI^V&,)6] %?-'&%3N7NL)4C?CA14,'
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M@/#%"F?LT+:VO4$$TIO%&QNW\:OP%?Q1[B/[FD9.Z#DU;K&N^]-[ (C0B<2
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MI<>:HXT*DW($YLL1S"RL:P?1Z#W-Z/U%MK_&/^:,_76JK81 -$)!=^$0.4X
M]*^&*\ EFQYQQ*IA'5RBI#(]9SR';;2<BG4=V96('"+*%WO(X[:N3%:<9?%
MA8A21P*E9WH?RZ' AB9\-3SYI9I1_B<MA]93B^.U#POA,YT.A@.CI9XIR=*2
MU!LU UA]%$V7+YX.':U3/G?>( RJJ?-UFV^T<'A6K.+PB^_"5YQ7O(G$VC7:
M]J3XX!-</9/0D<?<YTP\ //B!,G=F7I^JP%X>>OU)-JRJVV  E_/?@T8 6N?
MVWT>$(;TC2[EU_Q3+4E@XHHJ/T]&NN[C\K==%!Z/YU8UHAYV"]@6'3RNA7\(
M@20^Z9X(;S]YZ-#%Y.?QV.WBX#V&=1M6F1T>#2G:A5>ELD8=?C 0$*R6?JG_
M)K(T_-U?VUC1XAH[]X+</IBGN<P\MG%S*P7Z!?T9&=">^O!,^( B$#YY$T9)
M</VU=J69.Q[S[ZRG=/MRY4P^#Y,:\"H5^%0FOPMU.%1FUR4L\.X$ECNQ/AF'
MWK^YP7EC*%"\9ZVFNBI NRKJ<)IV/'/P2'A=?4K7IBWZMU'$[TW-D&L 4J/$
M]QIP/WMD#44<)&?^T.9]7\XVJG.'*Y*_L%CQ:813802_VN9K_<%A:88A213A
M^5=<BE,JB1X8OM5Q7_,#8ISK][Q\Y3P;>-QDU[/O^WZ>S]IE\1?"[TU.E'M3
MM$59J?/NVAR7J6+F%\F;" PI]-X-\/BD(8>P B&=(^(]6XF:Y553I^=J,?V+
M7QV\MR_;^J.4Y^<6Z,WTGW=XW<9(N+&UIE(HT+S(=I/4,W9\8=CW)_YP\ERV
M^5A==H#GA/-2@V7:_&^S^(E&"(8!2CK.WC0AU,AA.&^ZJSQ08EG=]#?H8/UA
MFR,])=_/GV4=C#3W3GBE!W?/2WXN_<WUQ=-C;SS33U9P,LQ@%%:Q/O&V+U\=
MS"4JZG?7_\[+4K]W/P?GH[N>B^:-A25::K#>UTQX(2CYYGR&220UVYZMG!@;
M^9^M6*K*2B- 8RN5?OIFB$ E>DN!EWG-Z^LIQ%J.1IK[+=< +I<N?&/Q/P>*
M&0P""2\9_]<"X<E_#(\=*%+,?1Y\#8AB6XW $/=@_U2QN4T]Q"C!>BA0*CC?
M=;SV.W3D4 B>",<PAH;AGTL SX[8\#_X,+C9])5KP"7@'W*NAUW=_7-T8:.>
MC^4Q^/?S$"BD<;G ]><WDN?O8O(U(/N=;H;R/]]V#Z1OEH7OPK=YN.)CE$R"
MV$Q;*^):&RT? R^"KH3'G<4Q.-Y_V+!P,/^K^]1^ZHTZNUP9NMH0QH=[G)I?
M^+D/_=<Q:3LS7SR1/-WZ#<>J;O_CIZ6N >&-PO5(BE9C1[VQ?M.OI8@3CA/=
M;Y;VS!&=M75?3C[IX)%WJBEFR_'J)QW LYUK0+F@ZV0;CA:8AM<V-0/NI?<P
M@/9$(S2T+\L^BKS84;I_H:XVZ=;UTYO)&DA?SX0R;[TZO>^8N8=GKR^K_ZEJ
M+OH*^9S^#G-H\ K0ZH@$RH9$A,+*H.]6]#,Q.I'6EJ2SE/<K.W[KBBZ(%O 2
M\G+I.X16G3(?TNR9EE_^TYHQXD:X_ELS$YV+=MB=;1E\I".LT,VEK5U4;V:0
M,Q@L5AVKVDV.>K+L?1DFM?VZ)-NV?SQ"(4R<CV^RL>XJ]=&."0LN_LR+\ V*
M-J.V37'%V,1+%N1YH'&XDO7!@N1K6DT_6[5Z)"M='\O5,M00?1L):65C<*J4
M@83'J5LL>+I""H8$X.MTL9UW#R0K,I00KVIL^Y)^]9-&^AKC$U#E*[  )_#G
MR1O<8L1@7DYD!U-06*.,0E03R2?+B978K,B7ZZW4&+ZP$PQ6%6$^0;G'G7F+
MG8\(!21C)5Y*6]2/'2RLZBW$]=X?ZF6Y5<+)34]3N01*.DP2M#; !Q#:KIC.
MN+8I<.J?)K)16DO.^HV,WQ[P6UCXL_.K-ZH^]*>45=$&T9$29M$&M5-)\1WV
M!4B["-I4*3#N^F,C8JJRI>DT'%)=G+*WCXIR@\BH$;Z2@HC'_9K.0CMC/J ?
M=K%R1&! R_@(B+OKIR?N[*4_K&\7ZIP?Z@<]?UGH2J MDYQ%SC_69%E"@!5$
M[[F[K[$0M_&;/T[&-52'?+O[/UA[[Z"FHVUM. J*@E3I+2I(D28=:1&1+EUZ
M4^DE(+T%HB @-10!Z2(@2(OT3NA%FG0!*:%*3P AD,(;S[GW>\_][IEW[E>8
MX9_?9)+Y[;WV6L^S]K/62EPHU:;B>F(DE:[*/VWU^G$O'=CE\"Q51S2E-C!T
MK04C@'V X3T-F(&HE&!T-5.T&]$2^YX!K)L:^AK^B>4N/>\G(<E2TQU#F>FG
M1%"= D$=XKV)0$1-PSJ*;UC[1'(+6NUT"8@+16W]\[F"MU7C8HY\J<S[/@$=
MD_."";[/,>&UQX] ZP?[1!LQ^">Y$<&XCG 3OZZEX1)0I:F+%]0\02!+TY6S
M*$_;3*E;74<0KC;GTC ZZ*P,XL3'=YOKD/788WZ6H+WVG_=KM)A$6U X2#5(
M5:SLI%)DC8 HP 0CC4N6[C4D>U MWYG\HVIR<]UB%)*>!#M316=[71ESV3<\
MH"[2FZW5 M[^W6 >6N#L$6(;>%M9H19]DROC1J>Q82>IGT3:)K9O +/U%(78
MFUS3RMIJ''>OW1U<#U$SK.6Q-!>LDI5/IN=^ -DK)HMT\V'0Z>Y$U(#>M6I#
M&LRMJ[[D4(WSY!R80X4G^-=2C7*@&[G/8#7XXFN>F;^ACHB89I$^$(MX/VH+
MV5;YM43-5UYUB?;^XKL?W>RQ][<..DW7Q5*-V;,YZ^+S"3.YUU".77U3.!/4
M6'=00+MJ31-,YYMQ&*JK[&&\_R?!$G94ASUL:-?*?!^^%!BZD>*'A3GA,_[8
M1!"XT/;K2Q2Y!UNFM;6+GI)S*2.YCTRO<R-$HF))$ZZ04@G\@D:V4I^:H//>
MA#YT.4LW!X5+(*AWEUAHHKGKZQ/DR1*>6E6^L7]2^T; AS+[UFQ;>&=E($0M
ME'-4VOB<TQ]]1GC">8VX;Y]G+P&/T]IH3G "HX2_JG+E#L2IA#F1A=/-?N;,
MBZ";HU7#I/RQ2?Y;,L&AI,3R]UYCD:'KM^ST^G(MTWM!ZTV'JG"UFDP9BM #
M:6?>6QU!B04@):O);))]RT58Q%[M)8#3A9.;"%A<&+_]K&:T$9(O]GH(;=5*
M@KF4[(T&;1^K+G(L%R5\U%?U5M'X\0\T!CNCGDC[BZ7UR')#ARX!1^JSA*Z+
M!D*VN^N/E*+ PST$T7_'0_=$RJ#;?9MM-V6-GF,R1HCN-X2,&%5XU?\/PZ*N
ML"<+ZA^\8C!)UM@V:^=$5\)6)T5.C;\6[U@KS8G,N=/9"%YP%*XV0N>[;G)C
M5 2J=:52/$)<I>KH[Z2GZYI]^"5,=M_/[AO'\X=P#HP ZM@<!>W3I>B_WY>E
M6/':&OUELE#C'N'[T:+5KT+]B$@S5B /'=N0W2OFN#6G21WY6?ELXY<&:?<D
M;-F*71$FMKOD_/0O#&9XR^E9^>1_D'4CZL[>*-X@C !I('<_0[OR482Z,L@3
M)M&*WJ5VB8])X.SO1E]2$S8=VQ)+$S04A^*%6'7G@$AHM(168\7>GN]0UA<L
M+8EAR\=?-^WJ(<"/]7-W4S7D7XDM^V?N0=UI5T(<5X%1MZTF?5UA-!B'OC6]
MJK::V<+QM-&;!JH?) 8'?Z7I1G0.&K%?53]&D.T"JQ=A\2 DWX2;K[:6Z;?F
MP QPQ/2)7[7Z1 8]P%RA@GO2D5U<SI?4Q-)J%>[=]Y6Q5,YK_L(*:IYX"7 ,
M[:V?20OVV0U82Q#W9-=P+K]:CU:^C?_RE 3D0*O&5CXJWU9B*KTD^3N7!,./
M%2=,*MZ=<<.!OFP'+>47=%\C1NNYRD,P;C?@@Q+=(=7G8,_3UPC^@#.5L6%Q
M:X6* (%3FS9T^YMOEIAD:IZ^G5$PE62+\Q_7P/P8OGV[^ZW+]^\@[Y&Y#U*Y
M_D+8N5*'M9.C_YQ *6J9?9KDS=@6=3UO4=*)<V6PTI2+(79O?3Q)]"$US*IU
MSQ*."RQVYEL8N- 4K?/<[I5].Q&SIO#B7[NT%^*FCXH3H"L5-M2A0,Q:CR);
M\R3DR<56%.XE&'D3;, PO"_&A'5AOP3T5X-?CTPQ],F:3-MMMNKVVJ!TX>^6
M)-&+6]&20'*+7[O-[Y*'))$9,T_L,A\MDW**H46023\RFR'I9PF0)Z6S!YFZ
MPR,V&'ZF;MI5;: VV&)SZN0,D>Q4$/BRWM[T1L.O,NQ@UE@<*<QS*U% &@G$
MT1LB07W@)S,7JTX^'%K[&L7.L-*>,OE-"+3L9?+[_E?)O2:>>CJ>9B"&2X M
M,.P2</W$E>T0H^*1ZR$K8"7+!M8)B/A0V)7G!-OLT?WX\M>*7:*"MF<]Z!;"
M'DJN^WGW=D!(Q6BL)^5BQ9]U;_6[+T+UK*)_D3Q((Y'ARENM.'>N\\D8XG]%
M7R'-QMD"VL<CP7*G[]$F;SR$[(D [)VL9(K^U)?6<!(?BH='^]TLZZ1BE4;4
MPYZ&F&("N0 *ULW)DF5L0P]U4_, >_B-.Z=Y6PZ_RC6*$:\5L1H5*SS03WY<
M*=(-O*%(2YBQ89 'EUC\Q(39S[RL:YI:E-3(KYKFUGME\,)XWEKD_O-<):XV
M7S\$2ILZ/,WOM3)UQ!Q7W61"ND?L7 WI_9Z\NXNI<F_D/?L\<UV$M(4\O-6'
M:(4,M5TO 8 3!&SB/.\*Y%6W'U5X4"!Q%TM"I^&H!8+&)I$KO," 3LQGU/I_
MX_+>M(M:UH!_>*B:KN>=^.\2_24E8CW7"?0?32+M3REL#D$B4XN?8Q[H?/LT
MK@+P M&W4SE!66I;@A6"V&)C@YTAO>I; =WK+U/?R-AS)806D&4>AYB<BF*T
MD/'6H\=ZD[CHPUS*!Y-C;8F1 H0OI(-[M]\2QIK&FAU1<"$BK)W!R1'=]T3W
M)4 ILS([9R]CS)Q&8[!P;@0S]'>HQ0J,QFRN]XO03-C,UO=<"S^1^R,U]&)*
M:?)D1Y-"LQMPOYMU?C^*.;8[-HL&VT9L=40Q>G/MR N3/,(P+Y#,#;J[<W@)
MT+2'/\XZ !8%$H-^ESCJ?P/Y1N+[XN)X"6B@VGG!CY+/,<,[?Q$O3<B:I>X^
MT;RX0;W 4^J4<Q,W1?1_Q?:E!6BN/"8<RX5X,>H2@'M#_*4E$)[4Z Q;ITQ\
MEZ,K?[LY!A!_A-9D^6 JRQ"C5ZN?*?[/,=KR6Z?9Q&^"VEX"7K81WU[S,_PI
M#(ZT]L?J0 =!_XKRU691%?=1(AF#NOC5T-@_'-JAQ$__A?4"XJ7_'VYZ8D@<
M8@#'B'DX07NW%_@/P$Y^0F&#.87AQW%E8Y< %\2Y-)P>.EM,&!;X(01=FP>=
MJ1V5IG>TV?SV5,8?V"!MLK@_G11(Q(6:I]0>P^90:X:8M\33:#1&B YK8__#
MT ?A1D6<O?-HM9PM8ZVL@(] P75G[A%KT4J*47R_3)S4) V"LC&FC9,:YP2[
MF\YT6VZ>?X2Z$HK;7@:D]_JU<Z!Y(KX,NFX.KE)$"XV'Q=U5SS2PF(T Q?OX
M;B'^H8"3):Y2ZE\%W%/?H$@>2.*FU01V7BWDU/02L)7ITWFN=J\:Q[42PMLA
MZVWVNSFD/LM5L$*NGS28(:<J31%WY03@PU#M]/N!]KD^>[A7*,,(CALE@A,
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M/8G8MTJ4N5J5WK,7_-$::@]T;DO%ZRK@2R\!ZTNM1-NWSL,^A#^N(^)&ITO
M(O#[WWK$,N(Z!Z'5\$'0O:ZVJ[,$A8)+@ _T ? OV["E/FN"1H2Z&<S!.?'5
M4"<V^-PE #F_9%XX@W 3X\ZL:CBN.$DU6FR*4A;(%G3Y:="_*<.L(-V3-V_3
M84.&LRG"0'O:^2=.0CS,=<7Z^@*I\[RRPMR- -GN=QRGIF$Q>=0^B'FVE3]$
M_SJ<-]>,K];@Z+&M-U9?)CL4-M(PG++CK'N^5YB=%M8?K('<NB5?(>>\$W %
M7RCOBQR[&6#SO!TM68'?+(FY\/U@S>GT BVQY)CFUK.^X<"U:?Q<Q<T=\.E>
M>T5MZD9]_+Q4?(:2'3?=NS\L[)XV$MMY-<N]'C28)_T=H7Q3K2"1"/ AXQ;6
M8330;@K9$)%:T!"G'NX6$46W_D$W73#4Y4+GX(B#5S?9>5T=O/^CM;KEI?YS
MNYK;/Z\DNY0NY'>GE&Z#P,%F$).V_<I] BNC*=HZ!/UL;;6A.P][XQ?197'7
M_=J^B)/MRZ.<+A__9?Y+M;I;T(WEOBJ+L8',G; ;DMT0 ^*9@:.V"%W2H L-
M(4?=5>R8&@M.<A<XPOE.AOYVDB6BCSI&%MH)C<I,CY:TS]7BD-0;^/;&*G:@
MJH3E3L@6>S*@7.CV:=*//_&2O ^7GXQ(I.U%&)TV6["E' LP< T=4)M;5I05
MY$_%0"IV O/ZB#:P?)T@N1B0TA&TV?C#Q9II9E_"-:.WA?<4_&?XV;C8P&Y5
MBI.OEU=XJHM_-YP4(]W!BO^PQ(.I *\.0*C![)E&E<6!'L!3O?2(7+W"0%CD
M\_B/D-+'[-FS8XPV-=)["/27U9TUB]E6D^)EEPDBJ=U):XXLMY,=;,R W\V)
M>[DFQ[%\54P*;/_R*'.[G0=W Y]K/MGC;[X<+QGR2ME)\J:=1GZ3I]!P4D8E
MPU.HW,"I^@A"],MD@[NV[]S][UE8&-US6]GV)<_8D(,+E\KF!2U+;)YN>Y11
M5<SJO.F!T*8^MU=?9YJ*?-B-E7#C1Z=P+HP<N@ )BU#DM' B OS4A*(O&) F
M;#BC,KZ[%\SVD6']]4,-WP=RR3(,,Y"'F,5/$+N6&:;N!J$0C_PQAMK9N^2]
MW,E/4@#OCEXG\^C()LNQ;G@ZG188",^7U3#^5XJXD[J9#!U<7" RJR)>0MK]
M(./#M&@?L;\,D2P"SH])Q^IA3+I"I:.Z&M)DV]L\O9:,NISG/=O5N1<V!=UC
MTX1J&>\:U;^A ),Z3M<DV;"%_L@E:\!G$M?02J#?<&[7!@6'%SBTUW]+,Z,5
MV<B"3'RPS,MR>V:[S3/3.3#O4\#\W=CQNF<,/*J(9;RN,L7C<TB(7)X:3ARS
M7X33FCV4J*V:J;72G(9@*GPMQ%TE-YIDCE>-U_M;PK,?R@RPL!Q$\<ZT>^+3
M?$8XS];&8B1!-[)&7#O]9IR=;4NM-,>H<AZ%')O.,6[DC[(,  7>9,B]1JB1
M&!KP*U#%U;?NC&]]=3B8GAE=-'E-^!.(V$-? H"A\I> JFIB&%?IM4["[QQ#
MY]8(BC@B:[6UWR+$QGR1$_]<C+Y[K/ @?"*&6C/ETW$>#'%$@Q+!QS,B+DCK
M?D<5(ZW_W67#@XWJ1T1/1A=:=J1<(J&OY\L9C%X^=4+9[(M\4B["+#^-LII<
M,1N_FSIG<KOGQ^"/A))AA9K>UXKB^+?M-+\)S#,B-IV;%J;[!\('Y9]:4KG:
M7VX.M*2\-K9SYCX:Q$:,"BQGFXPI"N*_^0(I XX-)RKEQ?%-#@W^?I3%<UP4
M0S+(.Q31\\^>CC\K3"7)?4YY+C-!%:R2_:= 0VY$ ,'5@^,#.2B0/6E'3+4^
M6**8NI<LU])7E;PV,LEQ=N].[IUJU4E^\&"??S9*J8+27QV?[LN8TE/M+#WI
MW%QMN:@PEXQ^17+=#/)AC+1UU((MU-%VQ-><:9\+-:IMZB*U3%YWXW[S1,>U
MD]]<"^[2C6]X7@N+[9F+M#.1HO@FH:Y0TF6KG8H05#D^U2'@E=/);X[B!+YI
M#5+TG8&5XJL/F4\J\+M_L*- KQD(PG,8=PTSAB)#4L67B$2<<*B.;O5,:!>&
M9%Y/]I]ZR11_$SSRSFJ$2^.-%PFP*&@+)\>VTKP]RWC:3FL%VG^6<&QNK7VK
M=T+.=+P[<N!%O1^&BQ"X]55R#"-R^A8%@K5>6:545L6XNH)%(GW.#UN;RE\D
M,RIY<W/9JF1GL+*8VB8R\;)47 +>@AKB\_I%HM&__=I99DZP%O'CRI+#%G8:
MM%9S.=Z$DM(XF35O0%!,M/<A&W[SP[00EYSB/&<-"K:R'$6XCGGLE,M6+96F
M"$GWRN )W&S*55WDGAA8KQD8&73@GC65U7_,7!G<4*; G6RL]"^=[ "!6__M
M'L@DE_#?KHN,=*.S?X)6U'[X$H&S3P01.%_[UW^R(I8""4!'$\/1V;X",B=X
ME;J/4EFKKH8PTUQ37Y>G^2TU?QZ<X6 1_5D#]F&4]XAA"#+$<NZ9/3ME"I?"
M[*Z$4*SZI;HW*'(309WC\_$#\NZ2>2LUAM[B#);C5T/LU&(<<V0_'F(_S4P5
M#0GDNCM'^/X^$CZKVX?FK>TXA X<^N123%<\6W::J,7K:%G)JO@EWREYSY/
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M[H//=QQ W-(BND]09&YU31A:R=PI#&GO.T\^]<GWWLH+V6MM1M0V#$DEEH!
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MX':7*OQ;3 +Z&A'(F?D,L?T4'VO49IC!1?+-QCT0(P[<=NXUC7O:S!Z5;I.
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MZ/)-7V4<^)>^=U7YU*P$E1*_*#CSAHW3AEHV[^,#;>N;3H?!]9I79W,<Q,[
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M^K[.]3W7^;[/.=?KNCCC' JPW^*2^24  H$ C[@%X,P";J8H/Q\ L+8&3@$
M( CP\4  /JX'X9H%#\_?UUT#[/?_T]]M[,4!WG_V2XO;2_S;WXT#((G/ : F
MG3,%7 #V0""[]5_BX>/9%3\O+P^? +^ P*X)"HD("0H*"PH(".\5%A81Y4I
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MI<Y]G5]8_+;TG?%S;7UC<PO\Q=SE@@ \D/_1_\DESN7:P]T#7H%=+LB>R-T
M<5Z^WT[S2YC8"WB$2,IKW1,\<#[C14VKD(+V%?I!S] A82E%G5DEQB[:WV3_
M/["X_XKL?\'^S34)B'(/YAYQ'G$ #FRS2S^.YEY-VJA"RJ(6NF<Y0)*ZKK6%
M=_*7:2S%QA9B]DHYN>O=;7+9J:P)E5IO_<XP\PDIM#DU"-X6[9B3F] 7T4!/
MK6OJ1&%3.8"_V"%43E_Z>YB8.<[QR5DB(633T+8<T3+C?G)R)@7+9=Z;Y]]
MP^+<E?,]BK.>!GJNJ'[A &ZO=64U.IF/1Y=QU-YFAX<-I">E5\79!M"3W7.(
MK(7K 4\'ZIAXY4/AL0@V_%;UMVC7H^VJ+T<JW:ZL3:V^)?6/K]W 4K<Z%QHY
M@"581Q\SS3)J#2@U)E?7>/J/)<(,V8'#+Z^JMIC3253>"S_<NGZ43>MS %\C
MW\EW0BVF+Y9P7SE ( IJDX'2;/6O"V+F*M('TN<$A;B,&(5NQ0D.4#RM\98U
M)JJ_!I7V:^4 B#._H-:6L-Y3ZE<=$DCM8N1!AA[Q(&:\0>[XJ.<0VJ7(WUV
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M'3_W$&HUHC;(;M4-9U49\VCN.'6QT0W(>,QI,(/2?#5;O]X8I@%%W<J>#+*
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M^_Q=]WG=]W&<Q_G[W=PI[@)PX(*=@QT  H& WWD#X"X"?K:80#\ @,,!30
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MDXBZIO;K?8):!0!T6.X7MV=T--:[KN9<F?9%DIOVGP<JP8YW 7WR!ZSXA0'
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M\F-IS-;&6BH\>,B1/%U0D'PJPXH\OEYQQA+KI5JXAP93$E];!XR6)Q(H#5!
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MGI:\%Y"^L.9?)(.)U(HRQ&INQ*2&&W$8]+S/I.0TSK)G&M-L*R.YJQB69\&
M%'UL*@'V:/RJ-=N1 H4X+K3W:TX'%_JPDC=?Y1#1K GQ&M/B#8'XQGP&JD-X
M((R"2DCV24?CFB?#43,")]#'2([F+,O^+[ET#K2 2>$ID\(#IZ90!N @G.!
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M]<S3F+Y+X/8\3-WZYP3FO[%;T'TP2(&GGU%EH(X)&%0&@#8RHCAG@%2D'#,
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MD5GMQD>#F*".#GS'!&4T&5[&L3+HM;1'.LN9#,2(&P\?B5PFE6:93+QGWJL
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MF?65C @,W&US-R]R18*M,[,SZIA[[F@2K<MQ"_8=/;W6=)O9\OZGM]8YN93
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M,]Q]'S@M#ORS<@KX\4U!DR#9E%M+YD(@Y9P<G['WO0&G\:2P[K3R9M;8>/(
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MA'M-"H!)QH%)DDPPD\"U6"J%F7=AAF8A-"[;!K?/<"Q^U0=XV/_AWB?9DLL
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MTNT>HC\\ZTY@!H'WU/'-[M@,%S ;V4.=6K^#(K"-5E.P[3<H%?+?UUR0?XN
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M?#MU1CA?;994J,, 44+]E?BQDR^ 2Z0.&KV$2\X"G[!&..L!'NIXQCP#]SJ
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M':*+^E$P/!SV-)3U\/3EHU!/-+JH^/_'8([F&K))P(.<PF&N VU?:S?O0,$
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M+AKX,)I-QOE6S'(<DD9QW^8#WV)9VK)Q!D.W@@4$-6#N+AW=NFO)B.V%'B#
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M4.J-.:37Z!ST(<U<&>!9<EUB$_FNEJQ,9Z*QV0I0VKC1B[OC=#P"ZQVOSMM
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MU&@\*?G=HW3[O:6]FHI&*'1M\=Q!NQRG;\LVED0^$=T>:>5;Q>3LI".+,)J
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MSSFG(WLRPLT_5E2>XFM5F["[O!D<,O4:D9@QMU5I)<<WFW_4K,AY<(EWP?Z
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M&2LEQVL39P);"1??<A]3\$-3H-9F62*C@>+,>(>!(D$LG&> W\DCP3V+T\S
M%@8SZN[2$IR@[HW8"GB4!FVX+I8B)XE^'2=5,G*A,H\XM!JF"@C )$Y^(N5
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MHH!PR2,V8!5%!L[VT0,]6='9OS4!I6I9_%0/)B(@$'BFTD<REOV5-4QA*<<
M\Z;-97#J3E#0,U0;@T%:#5#2AN<DS(..BF,3^I^KYKKO^PM+Z#J3.BI?5&\-
MS'I;QD :E3Y3>Z!4;.K%DQ241T%DT4D=EL8!2.PO-I#3,9G$H1GNQT&0>#V!
MN1\VW"-^AUW1F?U?&(/]# X)$:U*CI3AFOYL@<AAD2]#O0I( ?!ETAX0'K<O
M:D.?L"YD0<=+N*<#KJ-P)!.=AMGZR0;T*_S]SO!=/I.SN?J(@-!4)2"\9=01
M3["#3',IO]KY"_#;FP6$-3Q&G6_B_R;5#O^7J7[]#]5_E^K_W:C^'T0U]-G.
M"3M+D0:H_=LSL" V:=SY[P>A\O_?J>T!ER)#1>;3,\&,5S%'C1[,;\<?C[Z+
M4'@KW ^6H@ZL= OVOHJ7CPR6[\Z/13(&=B<LW*):_?#&AU69=3<RO_MO"C,W
M!)K>?FV'R<T]CVX*"+(M1UL^B$6$SU_NJS![Y0SMBY7KO[B1O1CVM)G(D+W'
M13)G>A)-DJ295%1?UMZGGUP^WSK%WL1%\_<=BY/O;CNYO63AQ/9+$T4C5#IF
MU>WGWH]F,1$CC35QS5PCS<:8JM!/20="G=]TW*;<O7WL<<,EM>]\2K\=MS_]
MZ==W&1,X@ )LL?[3[,6%.>GB!W9J5_5/OF=EY'^27;V\Q'#:;7L[X\CE30-W
MOL=K4+[0\L,<HI3FWE>TV/VBR&4#95]\F0U7Y%5+DN3IT/N;\T_]'NBE(Q_W
M2HQR:/!SDYQY2[]S57H''SY(7;$N:(MSHV.C8RBY?$53F9XH/Q(5X:X5$ XD
M<KH">R6.>TR4>5,VIX1K/>?&RD7;<A0<ZGK^F#BU=>JS6,FJ\$RNV]$]E9J.
M,]W.9>O[FEA(Z'6J;[&$;45?7V5-_>WAE:!7G=UOC[Y0:Y+(O^'&Z]_$W>1.
M1"PBD5V%1B5]XI"$?AU)9OE9OZ.OBYNNSG)9M&BZX:(]FZ],FBOU;N.4. O/
M0D\20N%^=U2RTY-_P14)OA[_1/U^H"*ZO\? QN7PHXV*GZ;LV'HSTDQ7?^[M
MP3UK)3EW&WR2-%UBV^NK8^!NM/!8.<.NT#=,N=G>I9XBD2\@B"VW7WM'0#BU
MU>C=U]?+ ][^/BN\<?JV/4S5]>SG!MSZS%?NVT"-I^L6;J"GTB"ATR'>-$<\
M^8'B="_/(Y<ZQ3^O*G!_R(:^5+*W#/D&+='6G9G)7;/]<D6;(:<BT>%1B[;:
MA-4;$M@'YADNJ%[U^WO"MV/G_?3?G>AT5^>M=RO-8BKT?DVHF:%(TD_BRI7W
M+67N#^#IEQWIG@<EY-NO3BQX'?%U'TEJV;$U<PXUVGVXIQF_4.YI1YNXAX!0
M2;O1MUBQ66&:3J5>3)1<I$PW.9>,+&1F$8.(L_NZYIRH*LSU<R'/LGH/.X=8
M:3$27QLJ-/BQ#:8%-L>^?2;Y2P@U[VVQ, /1)Y;3RJ9':_[;R5?V/RAY_[-.
M_S^S3O]#]3]4_T/UOTFU]G]-]=.M$A,S5-X !N>Z0QQ^VBUD#=L7K+J3VK:_
M22K3$!"4#A8TOEN_U>W1\INJNAW*HM%F_%O0"4E_1KR T+&9V-[&VW@B#/;7
MO&:Q*W0?1Y8:%^<39;4BX=+QBQ<?^WZ4:5?K6<L,#E4I>M5O?#-="WZK'/#'
ML4@KA:1BC4YZ=70 @^-H11(0ZD*4Q"H>[7,PR:EZ%!][(E1.OFM%5-GS21^:
M4F<^7=,<D4["IJT1$$1TD;- +47(V://W$J,.@P.5"JRBQ,4-??179;\)I[T
M:5/^[$97'06)MP3#W/-T5#XU'YVM/+;_4W<3-B.BXA0=KHN:I_BL]/WB1.KE
MDQF%LZ#E.IVG NLNW)SB<7J#VNL0Q?VY'V97M7.YZZ]PS'8L*T7BI#/LSS;;
M,>HZ.S1VU%+>II,_?COGR%UT\64U]";/CL&5]?#ESTS?+"!,.R @( 6>JL56
M3?U6\H/P''?R$'[W!53'>,=_+B#XI;9#S3ZM1&1/_O"C^G_^PIZ[-0!ZQ6%^
MQ&^G,NLA-J&R@\1$YL_C$__"H,&P/6+;UJ,HH%- 4.Y/Q19VO<"O:#Z&649$
MX0/%/WU!SYVGBGW,ADGL;+[-)YC&H31X5L(Y!_N)O9OZ)-&E1X7/F/_YLR82
MJ4_\ZN;8B!Z GPU2>S!QE%K5A01F9&-^5OBC+\MA_+TB?_[,D+:-Y)$D4$:@
M9!]M%09GPC=X!P6$6:Y?X&+Q,H@331U^E/K/7U2RKTG#UBQ&*/<PEG <*D1(
MW9 ]@[V")SFTX((O)OU20."&03]]1HTCJ.UI6MW8<JC"/7\0J 8SZ'!%]9F'
M\1LA=@L(62$0_GJ5G[Z@!&@8\T.O8I1<WZ'"_U[&]/ZG,Q;Y;S$6__T?QOX/
M,!8W][\MQO[G,I;@KLQ2-\VO52WMW2"^,[U",^Y(X_+VDR=9:RRM=C2)SYO?
M>.?6)1%)M>S%GI1/LE+'=WXEXSA_%A#^:Z"5<: '';@\3(S+#>VGQ!<_3W.H
MVVE@&%_9>8O\ZLU5MGBS$A>90UTTHTTQSZW;,M:[*BV5+7K9A7H%TRK7U60[
MK&W;R)T2N/YUF49;>7?G\D:YQ8H79]W(3[=18(BJW^2!A2U\;V&\K?NIVI=@
M-@5_Q3HT;C+(_<I5L<&KES3.5=;ULK@/(:YT=]5RAY/N.Z.8MEJA51X9L8X2
M#9X6!7:GP^ON&;@U6.T=D*%\3;:H#N4>=V+O*(A]8M<,(+T-<5Q=+E$&?Q F
MBBI6Q]1CVX1B682+1:KJV#8TJRVA6^Z^A'.M)&(2YS;PMG89=\F=,/<P\F5V
M4OC^\RY3YX=HWM^LX&FYBVWXF?7._\#CAKJS6UY]6\:# J=RE]BH*T.XRJ2A
MNLY1?=P8T4O;G_1"-KRYZ<.S9Q^S"1=,G[K+\/TR5GH6U\Y,XXI>\IR'9.<.
M*='4-CIY/++KT!!;^/S[;\R<MS.W6=ZXL=W,<\ZR;HJ_,Q*H^7CPL!I#'S-H
M90D(WJG/1@1B@+^O#K<W24#0$"KMIE!I2;]GW#N_.#UK0WK.KJ-NT?*+MHJ*
M;+^_4?2RY/P*9J">G%O@6T]I3FUJG&W*U=!(MSRQ4PDZU7[]FY_F2M^WI(IA
M\^G=M OPU^1]I5P0ZML!N*TQ>&P<PVTIP.__%Q%5[W@I8Q[BS;Z7%R=[M=>>
M?V:GZ$Z:65G(9]+*+U\W)GU.OL5[^:CO6_XCUBYN8;;D3'1-::\\8Z;M0-@&
M>H#SN[Y["RV"IZ5<NW5S-GO-?>. WR43B8#C*F8@<2@WS"(\G Q :/?]U]'F
M_]TMZ^IJU?W-AG4E\G?*98("9%)FNX&B3IC];F#QQRG"<#\)_^MPIPVG/M)_
M9V8)^F<M^*?>^G^1L?_<>LM\S?]4QG;>19/O7EW]X/ZNL:./CQS]A8CHI/S$
M74K^R&=\,4V3JK-IW\F),>/3T<4\]6S.*4=%^S":[[,^> ZZD983JNV!W>N/
ME3M5VT:^9OAZ#D<L4M]LUJ>"&S?^J+3A'8(S%^BJ@;[6G1^Z"/&)0Z0,^5%*
M]99SPJ(KXF&7R*_(N4S._*6.)UBU9L1E/6N"-YF(77;*;G_A_D$A)3UX (77
M5%]7TPK6VK?7\F5-M<V ??>;%@"G"W4\G(:@Y1<]UP+;43N(DUS(*J=[=.FS
MMUB2W"=-G3L4AF8!?+W129S"MXY!0\K("D4C,H=&U55_Y)9O5.*R'FWCSU#[
MDA1N&$YXN54BT>_C5N/42A_38ZN_:41^B@02NMNPCZW[X?8WA?YN2@-L1N.0
M&8AJ?C8#62J999AF4J<3_LZF=+'%0<HV1I"!1]3GC\EJE[99'[[Y/"KV4.]\
MKVXM5%&*?M!]+?\FJ =*]7\W0\*SL;4S6P9:(8^3H?-<V#N>7A3=/4&QG[I]
M4!*34"N+">Q_CSP\'K_M=3RBON3F?*9:"F73TYP+ESHG="0/5580.><D_[SU
MA!LW<MZZYBP=RZ'W1V,"WZN8/^IO:1C8$(E)U$#<QU0?N*N5@6_Q])&$:!^"
M\S[V"@B\V0D" I_H2GG"Y)SJ0B.(+,>1<PD]2=B,U_P_T@PCL#(]2>3Q:RTI
M!+(H6E@4E;%%72:X76H'>ZE\Q*"_JMH?IY;5.<>=/F.DJ#9@H^>T:\_[I=UQ
MMREUGKN+MS;FUTJ?HD=#6M-4:[:VKIB@+_^X1K](1/I4I(LL(>):V:F(.FGC
ME&MEEA,#M(Q3 A^,_]E;U4@7^<?)_\:/?QO_LTO&6UNUC)W_RS&;)Z8'8F(\
MMIF[/,\675_>D6;_$-5)+W6Q3D[@SD@\?BJA1N]T7'R'ZESR[8;!DU_E-W>^
MR[//=S6^8:+Z9,5^NZTQ\6%AS9[//8NUO_MRE%G7 ]D=1W=R) $Q?J7N)J6:
M;BC$@N0-V([3D0]3;O'5#H3NO/$HX-O6Z+N+'&+42^>;[@0):A)2;L.ISB8F
M4J@K$HA7])9S]^7G[)Q'$K$Z^,4NY=:*&TXQMV6=EF\9I%^]]?V6T_1]=V;'
M4O.3'UZ7J)ZM4?.^BE"P<*.T0_!US0U^NZ?2-QS:5_J]&IO0"9_2,S.X83_X
M-;8_(Z;M5#C'-U/;H'TQ^]XR#+HZKS_4GG/,S3<[Y9K/=5][Q;S4F5?W<*$[
M0\\&;KRT#OV\=-9\+]E/A Y=LWJJ!%9$(:(DMJ/LSCK%<_6[$>5'[SEY1@<T
M9MIPYT5-VN/[,;G:L=\O;_)*YH1I[FQ-A0#T($]79^"\4^=G]KGKY#B)R3OD
M!YRPGB[WR.]#Y48BKJZDMDU'[ZD^WR?B (GR#_#-RS68OH[<U'J?PDONZSDQ
MADA]##))WV%.H45R\?/>X^5!!?RX92346SG='B8Y+]MQ@M??MZZ=84_VI4W7
M(/I8Z3G.MF5()-!TZ@:RPZOOZFK9V2EX'DMIK"NS*0VX],E\_AENPZO)#<^K
MT'@^34"P@^=X?KJ0$>W"THE3=^A+/6S]U"[E4:@C^#MJ@O>SL]66ROGS]T^X
MNG4CP=N,(>^IY1;>'X3X.['I<UNOQ=G?RE<0U]%7,'28?F*VZN%K$Z.,%Q*>
M^A$(>_F[3AG5EFZJ<#(T\>Q*?QZROT) :*I^.""+2@]LM)?TP=9;E\(V$A#K
M#SWE1++/:L2UG<FY8=5BHUN=>)>TR&KWE#HFFK5IT]F 3D;=O90KF!X_&)O>
M<B$!DG1W8<&BR-6A]A-KK70$A"MK<F'16OM+QU+/V1F?BEPVN3F3V'FE*:GQ
ME;["R4]/GQ:4>57<W*9\U\O%0*WH]QEJE*>UM,4" CWM^W6[$YU)*UHK!IE)
M?:V>B>Z2G,ILPY@B\B47L@]E5AI1*R?=PU/#+31_\T[MZ/[+IS8FIM0X;_DH
M_];:^F;1E/,OW#XOR_<YBASE3OK_V'L/J":W;7\T5E140)H@$!64)F !42D1
M$1#9@"B"U*A(C0'IH49%Z45!0$")2),:*:%#I$N7ED@H(0F])M0 *2_L?<X]
M6_>Y_W/._=_[WCUO;,?(& ;66G/.WRQKSH_US?4%OK_JV$<\#&)0@*DY1-/\
M1N/F"':4,;JQ:-V?4-S_>EQ)9L'T^ $EWLM3D"75&ZFQ_0D&H2MB.S5$U8\Y
MMFKZ=H*?+?LYJ*9CW^(NM^K$OS;;OIE$KHH>1'^[^GI+&8:NL]SU#:G*/T M
M:@ 6\:5"GH3B=-M-@T)$T8C6DKCI(I[H^3/YX>-B7!&#SR6%H('/1K.J3I''
MJ)YZ5#-W2B5#8/*7I+J+B:WV^('>V68#>$D"WVV99)K9PA*&=/SUE/12YASY
M[8!OV5I!BT7J[F_W@W-DO[+^?_2HU:)67\4RVUI/H7D2' RG[5J]T+RY6(]^
MP=*GB+)&ZA2:S;%&U Z]EZ;DF3=0^\#ZDUV)ORSTNLQ T=/ IZT%;P<P!YN$
MA)XK[II1W=_#$)D%"J):BL%L-#D+_4:<7, JU-BPAPD@B'BM!*B^ ]ZRRG!0
M@W:$W=!^BZO0"P?LNH1L4A."RWU%5&Y5^>'3Y0>O3?&F1KP1_BYU]A#''CB*
M;G=I4AO>AJ*#V]H70?8=Q[3)D_,G2/,@-?2W5=W#70W\!?<L[3Z_=1M\N[N=
M:_Y59>R+<*C%_+-(?5/"U%<>Q_RIJ5S8W5,=XF+;T;+?6.P?A-O?XNB3?R5"
M_W-3IGX<O,;Q';@&+:3G@R#XW=1==RN3FS4PLFD(HT2.U39K)_8A\WVLW2Y5
MBUMJDX^-C9>TE>-#"&J4X_+EI:S%$Y'[(<8C(I3388H(JT\#+840VUKSK#&7
M_;LYU78'&-Q>D-&8@5XSB+C1ZIV3LPDLPI,UPM AX))U&L^!29)[34 &38FJ
M3\ZLSR,S 9K=EIWJKL[W6P5QWSI.+)^*.W4OS6OHU?Y]J0>=U\5I?&9KCI3F
M>0-68L.@!+U4!>)-3&=?%PL6F0X-AF@B>=.>C^(DE:65--^>V7?*XW6@F#^(
MT8PGN\HU@0::OY@&1I%D3@\25\?[ERT&9Q([,Z"R4"N)G+&'$J&%@;>_)&L2
M5:0Q&4Q 0(7RXV^E\63CNIS3O05)#=R?[WQ_/19./R\]F7.?(EOX[F1N2=_6
MW&GGN%S15"/'I>H5/S]YK19TJ6J!XGSLEN04O-@X6'Y_E1Q%29_"8[F+\D8;
M(I.77+'G=5P=0\+\H<!N9^V#KYN7K'F>EC?Z.EEF;:DQAH!\:(<\56E@,)A3
M69L8(8M9T]F"L _FK6$*2S3'K@((VK?T;@#O6!J7>2,G+==$#G..V]:3<C3S
M+&&0X1ID^28K<]P;QP2T+/CJ, $%QY@ I_G9V2BJ$OL/=UA6L3$.G:._I^DZ
M4<2)^HV0L/UYOJ+.J9F!<X[IUW(^F2>]2-:70%05Y#H<C;QP7%BM&0VO_0Y>
MBHIB8P*^K[,2OC1%U"@FVNL%=-A?:XA@)4&FE<=K;23_VJH2WGJ"\1^=*FOJ
M*:7/5L A(OQ5WV@::=,5$Q&?FAY6%*!+=,)\7JB\%^)]L,I+P=..E<%)K'J
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MLM[*I+!\D2FNP\U^R@=$.U;:13L"W#[,G[G]!W@2*V4]0V8"PE>Q\#G^!TS
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M9;:"P&ZC;]=N<HS$BW$.7L7I/9%&DN-IW @C<F;CXN[,$#EY\!&8T5;C6HT
M%GLS<4*Q(%&]_9<>+8$3Y09B&O&B>2YR6WZP"HX!EM?4L!65%A>7D46R]J8[
MY2Z>-Q]A]Q*+Q@GPA#^.2'<\KW;T*&]./A-0>S6]K^8XS+7AHC];S\I@GG0#
M)S7&8-?=BO(K[]L?F[6I2SZ [G]H]G!7E^]!8[V3R@8293X5R](YXJB8886.
MBI*.V8^7R$NCW_445&;SM>Q=%7*J4B'R??[\?F(Q$",MT!QO%BR^,48&$>Q[
MB@"!<U*##'I\13,@BD4R$R4R"R+'3PX>>ZH(>)9F?7!X!OD"/HI0%:.<CB*4
M._G>'44>=DB6K:CJ77D/O%N9*#V84VEO*GE\QT/K@Q9/]M\O/VXKS@NY2D?;
M%"8W+=\C X.4-7)@ML95&%])/W=G>1>[(^:=V+T7]UTMBQ!3B@4?%27GES@-
MPM7)Z#K]%YNQS4$T$*D+"/,GW>O/2&:8$&*N]XE7+C]\D_W VJ@%?H82>^=U
MY%W3(6V]/M*QX0$3C;D,3.G@C>7+$)_T;]GW_+FRQPU:6Z0KR_/&=Z_H$#&^
MV8KF69<?=^I\ 9%U%X_"MFZ0A\*(P+W35TK#K/H.QZ8Z\+MJ^;B?"H\^U0"[
MURIY1^#R&?[=KKBL07BM"LTDSR&9QX+#DAP?7 SG,P-;-.9^'VK'&#E_?R4;
M7IEZQ/?ETPVNTB,7)_)ABHP#7+E4JP;T(7<?),> 0SS^, FCYB6+ \T;]R5J
MOL:S;U4'JC^]\,XC&W0([B3L2O!\7L61\MW.VQ?CSVEA.3*FZWQ<L+$DK=4F
MI(3P4;H8ZO8XH L%80($- O7G?*3YVN&47B=:UB&K7])?7R 1>KBH [:FPE8
M6M@T'7:PQ+?F5507L]S1!5:GSX.*7YM\>4?'Z9 ^L4PAR[HLL,E'0NQZ4E#P
MS<B7M5)3ER;+\L,(0!KW2.LDT3_S([6^,?&8?1'U,*GIBDAZ>M>Y4G34@W,=
M,7R+4N?3ON:F!(LZZKIT;;FVV.=00XKQ;-.;'O%Y5,W%NELX83WBC-FC<G?/
M\F@O3^6>YT\!'N'WG4?TV?U'XI.%*%$!JY+*XAGX 9CME_E1I<K]3F)W^Q_C
M_==E/QQ]%SC_S@H?/G.'Z/ F+6W>/;W\3G7^^\7J%3\%)XV28JDG?E*4:#UM
M;4O:O.F: T8/LXY.NH[RZ:$'H&W-@#A^4EQ*F@,?:##1,C[=8EB:/>%,KG@Y
M..Z[_J4=Q$#C2[L?M!RWRGO@CP/M<V/A A9"0175>MUUA'<_@*IBHC><Y!V.
M3!^/OFN4*+&PZX/+^6OKLP8T=GH:@:K %E8<AMP_77.*[!2Q^]K6]8K*Q$/)
MUS/,7(4H#++\(Y+R@K!7'A!'6JNNHG^V_>:$8FE\VAL3!#WUM+RH*I:0W%=@
M1SJG77DPH?;)@#\I0T6BNR/.?3[1O[8)?Z2P6]71;+'#;:7;LR;YEYQ'3D'5
MSR&S4KYX]DKCHBB%XBB9Q,K^A5C4*A!(DZ%R;ZE0)_6I5D0F@ /69H0]U0-=
M4-#GFUY?L&R=(>XXO^^,(=<92+D:VQG7>4O/4>!W,TOJR[2I"^K$J'W3WD'A
MR9,,+C]1P[(X_"TLZ66"Y\=] P]'#%\>*1Q[KF2L]H$5;#11,DI;XN9H,C!@
M%1EB*?S90E&'$M'3LO;II.&YU)9]JN:%V=&\G>>F('*$R7F"W^@\L-[5(9F#
MM:N%*EN,NEXF8X.1&;&R\KT7BB,FFEZ<:L)Z/!J.2%M'7HP\!DK1W1+;8/2^
MZ7N3;N_3K7^CL<8L)Q."4S3V;WQL?/"A%/)Q3V"^E/PXV]$1U;EQ85OY\MPY
MK$)YNNVCQ1WP6F7?.Z1YCOIEN1 :=]I,C41!54VOFY_FVCVG3+[(Z2=I7M8\
M&4UB13LB-]BXOC.^B!S'NE<?%I9K'&'KET=PVI5N#F>@]@S5U;<67BK3DN%T
MMU;-*1WY0.Z:K\VV4Q4E\^4XI^!F^%E15D%7SBW^E\S;BAT7E+M>;@C\TC#Z
M2,B=E[\>/WASG< $U.,Y8/X@#I-A+0*=S?Q;M$>EM3WVSF7[ _/'CV[M6*]\
M;:9#MZYT&'9;=Z/.3Z:GH)>5-IRUZ+<+P]]46(QXPO<LIL<NJJ!CS;I,X51Q
MC[(UCT)[QA6J9TY;CITK+$CC.6:3U($]0]"T3^;\%I%^\77(@;& R" >1U;P
MM;R$HIJ)APB2M+;<KNRC7)@20&RIR2]=F)AL6_*$UGOYV] \LFL.TXN0RB>R
M80>F?95L69GF/O&7<E62@@J]$M4Z*6<O*+8M%6XTCPNP.1DDR\ RUV;Z?>W)
M&2K\=\@+"$_B]>Z8>E*#'-P54?!Q_L[:U1%]W$Y:C>.%R(&);/"LF/71' 4_
M,X/J?*QF,2JII-3;0T_ZA:W>[7AY:^@15P=:@0\*?2':>/TQ:FHX#$T5CP^%
MTG0)'7P@;I@(Z1Y%^)UW]D#ZUD:%?S(&;P\9?'IGW?GD\\P<OJ8=NP6CZN"%
M9AI>>=J0;!@W<6^<LG 6[#EFK=ZX/%3:J>B^TN-[&+#*_M9FJ1=/O$>-7!DX
M[\;2^?V9-+7";K>OF:AO]\GCG4E*Q9CUM1"'DAYI1&S0V[#DRW<B=?7MM^Y/
M,P30_:GDKGK$(2I8J\]7&DYX5%14YO%.9D1QJ,/E2XMR6+C$8\"EH[-W;PML
M!4GWE^65WTW/Z[7/S(B#:"(]"SCCV9<O7YOIL0<GE!Z3EG]GBAVI\,X[$WR<
M'N(^B'B1&!0V[ZM!\+N-O]XSOYIWLZG'9,3,Q]Y<5ADO_=5^K_\C[?U TU4P
MCFV-#Q70;"G;K<R>,GT1\PV&UB0OO'?WRQVB9V-T*H]FG)N[;V67D/"V\OUL
MMQIO*RR5<>"<'Q$=E-@9HAB0^Z <6R7'%BB;_[$_W_<MZ45*Y VHWL.@!5IK
MZAD]S\.Q9D0@C4?N%O69*W'_:;)C4"F8HII M#]>5N83Y@Z1-BSA/$_0$7TQ
MI*>VF]*K,-D:SVV8(QAM5.3MJHFI$JS0M<3$(GNURJ>:,O<9I$U?TS.^N1AG
M7'%'K]/ HYKDX][_^ &L=.TX1EF8(JI%[L"&51TM%4S#GM66[S7'R2:OD61/
M1=I%WZFD'K2KW;*I1+P$DO6^/Z)FID\GGZ?HO4H$!E?)?((%:%<4*9ZMQ@^0
M_+/$=GS3;!6H_W2*HRVF48N-QC-KU*NL1H@O(/N],14/)-5<+ZS .")ENW D
MKI:QD1N_E!"NTG&90^NYRTS GB,5^L(P#J.H6F\?$RI0J\\-^-G< :L(Q%V,
M3S@L8MO^_&I:Q,;CF'>' =GH68V;ON^J:F8K]?C1U4Y::4;Q-Q<M4S25!6XB
M4;==BE,?]>NX;%5A%V+'-I72TXLO0.%6*L;-R8>I+K@S_KS%00V"'LBL8=C3
M&6/5ZR5Q=UY$SXR+73VAL7L/U\Y[9\5V-1KV@NXCN& !#:;R@L8A5<>R[?R/
M=R-1;1R<ZN[GIWL:'UTMUY0Y^EI,M_[$*^>1S&Z0$_OB@>GD@[UN7?OM*%/^
MW+TH*!_TRL2$-J'?C7[MP9FXA2<"%_?<-;ZM9P@TT ,/ED!/KW5V72<[QJ10
M];7("SD$NMSUP"43U3;Z1S:$RW*9W)F$6T^N'@4X8RHNPZ+Y(^1+8_.)*Q.Q
M2$]_I\ 6GY**[@$A!"546_.N676JCZ3,[8AYN_0VB@7:>\UA9F[4_Z)_%Q:Q
M"R5WB%YD_@WUGK^QA&LFT:8H73D:I_^XT^ =FZ%O"IN4H>#F,58Q,Z<[JK_'
M5Q"#@A^88LABS[@-LON\EVXRM<ESRI[>;$>6N@R9:2KB3H@];;[TI07YGG'"
MUZN*,OE257 ZYX'3?5:UZ9:28:8'[-BR$;^P7_C>_?N4TE>0'@7DX()Z*NPC
M_#!-E8Q^X0LFA8EFSFXNO%?><B1!*]L]<GW?OB\)_\Q6<RZQ5SBH2TJ+0PJZ
MK%$#D8\Q;^TT@LSEOVM=&*HVM"[+%TH_8RB5WG)*1),X+K8!/!]F3R^%>EE$
M.UB(R#6 OCLUH \K*Q+9LU!=!V:\T0$/2LHI(@%6GF*)D2$\X]>*GWZ(>!YW
M:\2L9&C9 C&OM'TL+.D+@A<#/#!R;Y *N4?Q%3G4>[*F+%KGK6,R3C(\^M7;
MI2+Q6SH^QN<HTFO3-=0  IK[C C7-WDP#W4)QP[BH3['F)A"+8^&OLKA%GZU
M*%'9.NF)<D]$T'A&EALL):KZ%.!!FX>S#E 3\8V)NE787KDUW95;S>S"K6R)
MN04!J, =ER>/YL))I_1XO>Z4*O03D>X<2O:RCI95E3.K4^$PM28WK\2)<7N<
M(\:UIJ2F8'S"S!7Z41HTIY5"=2+(1GQR$#G9BZ09^HN! I"YQ\N2+]G<P\G;
M<86#SI2?&=^P""]KVXF*S6;45L3ED?)<+JWB]U,5=6(:L?X\WTY@W 72_&XO
M\$L]",&(EDGB:AX]V_'PBI$7O62LL@<E;=:USWY=UYDT0:&_8 (<HQ5[\RVO
MVQ__<O2UP*WC8CO/Z^W/.P8:7-/)<V0L6I Y@JJTA/PE*RB1SP[U#W4S 0_
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M6?1NW,(/6&AY0429 -?VB 1U>.$36#X\W0,-0/&I@H+48]83]4-K>U;9/9@
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MY]<7':>67K9"I;3M0A>$A+ =\Q1TT^,O"%[JT]C(&4Y_'.U4KV.Y9?7IX_S
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MXK5C0N&N3;!<>]+GWH LP40YQ6[P$E8OZ/J2_36'=Y^D*_UBL7K#*Y?!?S1
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MWY?'V< =$C*,.CZ][@NV)@3%/FF_)Y 0KEQBHPA2:(WU:&%65JX#IH6RXR9
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M@K$$J:+/^A%7F-)0HMLZ9X3UB7,A@PWZ59].;QN4WI'/?&QL,S&%2W]("&?
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MF:S%I0*])FS\*9=43-Q^(Q7:]$'\HLKX-%Z:RK[RLC1J=L-VO3*JB1I<RE6
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MU'>0D60$F"29!M28[-PF\UIP&XES:8[QYL?'[FJ<%+\I*, DA&5.G"?-=P@
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M_;BGU=+(SXL<\E+ 5T?EA7MB/I[\-@1;TFFRZ-Z"4*4W8&1N *F**L]=/D,
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MG%GG9/<JJ*JN=\M3]5;M7>P%\A=R$<!_+J<H!Z"AH0%O4!\ N81_*NME;0$
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MP)79T6Q).'_Y-:_V<] Q-U!S#U/US>/<&=X2.?[%)$_/&_;T;:W,,+9!Z?]
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MJQ:FY$AFFY!4,IGE&-#KZN7JY%<%YIK FKGRF3#-GC.T@6E-RZ7["X?)W6'
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MS=F^&C=Y78W[_'A?0.15FH<3WG!2;NF^\?/Z#T*8DT@@\6S;QS +"6 +W7"
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MA>]K8=#2Z9O1*/MQ4#<\H)N<&79CQ4NO5LRG?IGYF$Z2TJ'TYYW2:TUL.(#
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MYBC1B!=!/-%L.'1/\VQBT17$"46/6Q(WIB8^+:RJUXEKMR*68R'?-?23X=8
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MMI=\R(UC:'41<\R[J;X -$G07SB7M" PE4&?E8_\5 B@C=?\6UGV&).9IL*
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M/H;.+< :-:E2=:79#TD>D+B2EZA]]K!KW7Z>]Z3$O_J:MG@6!>Y(T,M=43@
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M^3[Y>S)3^02X2E4!>O+MGM71YU@QL_N> ]Z7D])NR^:)"D-[KJ6BN6/,(/'
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M\Z:SYY0LEZS,P$Y,PW^?/RIWY2WO&^"-M$UH]V7XE;@-#:XVJO!I7-&1I_5
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M)]3 @#C6]H5Q]I?N=XP.*@M:2Z24@OZT:\KUE[[]BF1S9M9QB1YH' BJJ<'
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MYS9W4 FC6Q4[*MXB]G [C^L$QV4VHZFJRO=M3NUFK@L#Y(>QAGX0^_W-9]/
M,@:%#R#_@WP\/+@BJ@KC6F-G'3\T_QM)N?VA,^"')RX]_6&1I>FV3H@ET]]N
ME:H2S4\QMG5E$'H02Q1S97\U"(1:%^WIM8RO6EMI$^C9WK-WV,7AHO;.\W3<
M.)O +]DPDQFW0K6O0A[C2/0G,N"@F,:+2L,08^6DO7E=]/B_: KK.7.N[*_M
M1"Y5ZT:SH, -M!N4F[+<!2URU^MXTR.#VR;QSW[<_C%UUEC21/'\(2C[TO"O
MCTT#5OV/JS+#W6H1-R'3W6F\=?<A,NE)2Q*#6BZ;?*>VZZOZW8:V%OR5,TYE
MO/K/\\G/K^U8XBMS!]=0F81B/D4>"8)>SKX?NFX  ;D9?H,EMT#W1?TS7$8*
M"[D!2-0&75^J8#GJ=%FID&68QGF<V\^,L'BW<C%%ZU\P2?<O"$</RRQ-BC?B
M8;V;KHAN  BATC-=3Z:KBTVZTQW)OU-N_P)71$88\I>7-]'5N=\9W0W UM'H
M?U[,V:\5-2RY-O'Q!M!D<P/HF+"3(8LT_E^C?_W??TO)>"@G;<O.ON3AR@W@
MC]]U_NH<PYE_]B:6INY7156]@N5'DBP9 @EC90?DKU*14B=,A@?LT>B7'=*]
M+O]KUC8[6]?*H,EE?N9!(DX+6@W?T_7Z*%49DORCE\KO;1@^10#KJ%GRNIF&
MU.W2]A4_B*G<1\L6/\JS87)S**0T_M8._[ :ZZK%7:HUI1:GW(6L+:LKL]";
MUBE.#/RD1"$E5VG+O.21+9\N&R-G7!#*HPW[\GBUCI,4Z5"K%!>07SNZ$R7^
M9Y2:;":H4M8!5Q8R/U(S^/@&T#6<[3>Q+'E!GI4Z-F!+GJO^>!-1T+1P[HEW
M15\[?WWGF.CJOM]^T3F]>Y;UBJR<E$9<($'TZ%,#6+Z9)[ICB2F,S41=-/JY
MD7PV[M)!%%FX<X?EQH5LLH"_6^'F*9G2LD'P3[VH#VG0CB#]E.43&EX%^8%X
M@?TU6-UGV-[H&G-)IPK1F=/#'0D*>Q=&[*C\<I7& T+%JT=KU(<P6)PN$=&&
MY@7H>JX8XG0_#H-XB#MDT2Q&>"2\)O$%HY)(6DZ@9#BX.Z_G:\DZLTG9@JAH
M3U "TR7<<T3&$PAW KJ/"_AGK44TLN&A%<!K#AOS\D;HG[04P'HW%2X>-:V*
M;D?E2$68TN,)U0G&.C//@1>!*.N7G_Z4DY[N !.?$EKP<V@CE=ABQG=Z-N?T
M2S'"%ZR%?@1HJN0\]A*+Q*Q?9&B/9EI32)Q)9,,73[,<GX)'HJT;?E99Z8E+
M]:.Y46E"Z*BTE>"M%'^H8X>$N=WQ!77]!+9H?AD^,V ?NF7OS9\[:.+#^",I
MBU>GT[+_Z)V:N5%#Q1<NQX';."^ E66OHPT3;0[G%?Q<K$AZPG-_! 2]P,"-
M1J#FK>2;ZK;<RGM [;6\_^$0W_6F6#*0;*MEBW<;FI7?$97/(5;CTI!SI5ZF
M7/]7D&P:!;XI;_V@@IFI(^J6.RIIK<E:ZB\[GS,SPBUS(=X0V&OB;WI(_?^,
M277W$R&?_[^"LN/?5AS^=PY@4$QL*.X__<=OK?<&T'P#N%1?4S#J2YR_[%/B
M*3)BBLO3EW5G9>5<5M+ZZWZL6$SZQ_IH0/?U-9233 __@68T U1 LK5#GF[A
M;$)8L4C5_PU+\_(3#]Q8+4VN=K63T6SEDUKKBB30]*:_\A.N.AX/7QWJP.(S
M-KC2_F!HT4J,,"T^NVH28\^RJ!7>48%<I^\+KG,_-.>I*_@ Y2LYW[DWGK=1
M.YZ9I<16Z]/[?B1<(8Z0;I/\B:V+%;NB>T%918U&T8Y;H9J*ETV5I0LI^$2)
MM_6YD@4[.G.V*29ZUU20D(L&<]I$$*LYR@'F>U-:<6W+KL!F%0I"Z9Y#IFDF
M#7+3*4YV]/N1(8BPY&2[D-*47MN^H6J-^P_-Q/&4\6B81[V!A;:5\U:-]9SX
MH Y2_K?(T1T<R0@.+4BT,4MM=$IQ';CDP!Z-+$>@#-WD'/,,!CG#^!.IR)YM
MQ+_28TZ5?C 5_9"+?!F*&.SV<RD]8U6K'7<4JX3(G-C%ORV.%S+OVN3VC_3+
M-I<,.4[D*-ZE//\^WJ,I3$+\Y+&0$)W@NPE^VMS23<]V&]IT9PLH;XVJJNJ[
MX]9;DB$5)I6>,)K;E01-J=UR >WDHK<J]R!#>AHUR8NTZ5E**XVP%Z;C.Y1Q
MD)7 [B6&Y0E)FJNY5_N9J98:41UYK2&,8^J4E=)WOH[4+"P^^F![8 N_C8\/
M<8KUC;H'#Z91Y.OB++^-9I"YO:8QIFBM9R(@ZE_KD(D& E("';.<3#O&'_P&
M$^TG6V?'XAQ>A=K>LNA/25F6W7[.SLZH++\$\%NI%/AB5Q%K@^*2S+[,EQ%+
M[MVZZF#%C^ WU9BN)3&K==9'8D:EK_.J#&1:[TU2F>[AH'P%?1&IC)DN JF/
MOL>LHG&M(@0B?\#JE_A^X&?&#7!(C/0SEM1-\?L%V)7JG?\N)E;5A9W]4Z?E
M_C0]F7:':"6MG@AG0>4)C:724G;59Z!"_ -:;OOYO"5SW5.@2NQGR=8,/_PU
M2Z?O#BXT,BZ@4G#[W/^^0L,PV[X^_]\0%?J__1;F>B^\JMMG!Q-N %__3[DZ
M$?CV43CG#>"6/NPHL_[KFI'_DH5VK#,PV[3_:Y[A 2OS3()6>7D\L8!ZS+TG
M&KWKQ+MG]';B^UF96!.9K5F./443+WQ+5]WV@DXF2J-MH&*,Q9YCOM^W,1B9
M$<H*V?[G[*0(F6L$M)Y0U9D1KUVNZ'U.3+X5W\E2O9;MZ8UK(*A05>/!<&D?
M9ZP&8J%XIXGWT@ YM Q54>FT8*7U%21CXXEDJ?.;6+/PB3L6:\RI1%37_Y2V
MN1?;(ROU/N G]FZR>/UX.9\@MP)AX6F,#$M;TXL)K05YSHIK@DM=5/'KFCJ;
M9^A9LQ XSLN4*%'C.W!=JM\"[8OB$1SN4U7F=787+D?"SQXP//TFXJ_I?*UX
MJ%A+)N*]<Z^:M1K@1&1*=,_'+F?L2I)X3K+RV_NDAP:J\<;<")0?FS#U$TBG
M4![T:X9A\J4XX^IQ:5&FA^ 'LMYDJ[F'4+E*&P@K]0W ,%V(P\5Y! S,@B5=
M]1FH&(PB B)<'L:RR,4$/_T/O'X:1[M5>GT/E WDP>EY$J?F>=>38,-B^$HP
MMR7G!F SLTD+.JZ < 593KJYF$5W#9H,XA;KVT1FNJNTZWJ74+=X/""4#*9]
M=Q6<F<@>#.4)IR=7BR@9J_A='J-4"DSY?G*HVS<T*\W 4R+($*H1*"N'-SFJ
M@39P-WU3KU!(U5MXF:SW8,'*Y'(Z1&<(]-'Q>(WZSMF81_U+FBG4\HCOQ#TM
M+3K+&-'E]F@!0?L_@#9KIOTKJ+D^+^4C#JMAT:,QHP/A8-!J]?RR-$.C+@6=
M:3PZLY#:&6<\HV1-(>B=_Z6K.*/=>'684K64O<#G:,=N?2=AG%(S?7Z^7;#T
MTYWLUW:ZT^<!Q*J?7/ZZAV@$V\;ID:1OW9[=QJ,ONB&C'KS0 \9DUV"7G02Q
M(G+'I>8EMDU/ST^?29YT8$G.?]U&&/WJ?SEH5,]YDG0#B ('-6T5W0"Z66=9
M6V\WL_0<]\P+6SMX%?.5A^C,9O[BA]]!]FW0%^:?U6 >J@_Q%3,I[0\]W41/
MS'CC6O_XXUVSY,C^Q2<2X1GG08:D([ ]W<D\@[>=[+A!,ALM L@@($(*;4Z'
M!\(X92=IA)Q/U^F>8FG6Z3OPE^Q2-=(L!.-CR=R'N'&^]$D31A$1R$)T8<)G
M-;<RB^"T;4*"_.Z\.N;!"ZXV<H$H*)GX:<I=+YSY',XP+)L2YGEK_P*8T-U-
M5205\[Y&]FWK"W)N@G?'Y+WWF_LED7!"1 3=0E. Q<@KP81&NL<3W%(/8\P=
M7UK0M#;ZX<"^_:14<R=:K/3GCSB)6'J#" MR/"FTJYGN"0N'-[;SG/S!Z6H^
M,@JC/*G*]7Z_#T)49KN8)C!R(O30LR*=RSUIWW %'V=&CR0+(B^+U;<U?9_M
M-XR-YQW<K_GFTE/Z44. ^AC)A@L0\]0XV[ IG-Z4(,4 )\' )SD;KUZ/4^"P
M[K!'UGK<*4-_X?.S!D$TA_FN\2M :J<J-A8_Y4$<M*_^W.MTC8;E%'I;8*!E
M9DL1O&U#=I S-\6D.VRG^YFDKQ,#?8V2<:S)[[FL(1SIR*X\O;W,LF8F;<@J
M/2W*A<C(Y/&26>^_UKKW#6!D>+44>@P.G6,>X2L,\Z(C=F=9TT%I@P73/Q7Y
MUJE\G&LO!EA>2:(08Q@^]0TX,7L],#L/U\LKA%+AIQL518CRY.=KN=)?$ST7
MRJFY9V&+EI&"K:E,&JCBM%2&FJ25;NTOQ@I=ELW3T=^0KH['%QE1_P<>;M?_
M5QYNDH E/3#"75#U@WF1H=7U@;2?XFS>6@ ':/F;ZH]H J[C>\8HY8'5418O
MEK+\J=Q3.I%A=8-I\=3E\9'K,W/KZ<W'+)0[DH9*_,XDZ>G:,@5VXZY:A%O4
M!_=,O^/B3 L77:#W@ZZ@E%;7;L2P3O)$H:&4S%J5 [99F051O9KB.7'S"C6>
M9Z_#[OE'[HY+V4P(0OMS=6:5\*.R+,PX?!SDR0>$2^ ?1UUD1G?CQ'C-6$)2
M\$"<CB;5!\K"@\6:5;5UJ$8:9?:5>+3FV'LUT&MM(E8&3^C;JX+GKF*;&@52
M^,5ZO\>U9E97RFN^;6VCIGNISW%ZG%_^]G3PR,\=<:'21@.+)3:)WS[DB_K]
M!;^9(7K3T>"Z,!$A3N!F?/$]B?<:IJ ,!/I7,36I:P^EVF&?@/PNS79\#8VG
M3HJG9E<C)F<'<ZQ73:$FPOP9NAWB;O4USI=06W$Z]:3YG:<V$T[2X>=A."3(
M$L?0T/'.W?,IMF++&@L*5D*++KH 3T.XC9O=8K(\N-3%JRZX]9OQ%SGKPJIT
MX1;R(VJX9T>M7L5^P\CZ71/FL6PRJ5$N!^&I4[\@ND#KM5<4*;D<G^(KR\?1
M\UY;**42QY')V18&QWX[/O";=EM,E%&*@^AA!_M<JI<Q\;S.C![>9:/SA^3&
M1)(-@4Z3(NO^@CW!)?FHSL=B;1SNG7M+T["&BW&E0Z:K5R(9"J1U(O92#*-Q
MQ#*,NP]ZK6!!@.$!(4O(CR5:#10&9'/J?2*,D[EI*DR],6'RBB*Z/K#5$>:^
M](UH:!2R,5%9N2'>G]K.U303(Y^HT?@=:C>L>[&%)86FVIR$R#1-C9)+1P6=
MOC\0H;5+K!PMY:=[<!906F*>LE?E0!-"\"%(B*:)@#C1N6PL)Y.)Q*KGXCH7
MW 8A8.?\"!N=:3.#O*Z^EZA&RLP]D6*:#,XUG,VS XJ&C%8VFX;\).UT;-Z"
M.AHF.&.0)38[9M?50UFJ/HELJH_*2_"<FGT@D;TD ?F&"F8+!JH5Y>PQW24\
M))IWXKSKXWIB1*!(!(%2-) G7[.'6\NU*F[>:*MK[2CR\=RFYY&G?C30[LW]
M+)[W4R%O-^66)9_JE$_WVXE*NQ!&]31Y"A,7$N7QKU?R=F&9]G^,*/:SC=^W
M<)KI$B@#P*XN)E)G?7)W5$[V! <'!]>LW)3/U[*%*J=0W]M'BS7R=<=U/>84
ML$;1C_[.ZYD8O5VOG#<;^@S"^)/4OKD(H"A]LG\== (/+@(]Z.GFV:/;ANH=
MX38<_"HXD>MTY-?P=$Y(OB;;)%:5,?:V_O<Q+'7-RDO+""]0>&*:,\YFEM9@
MW)&+.V<(FV2Y&-#/%G=,(>0=MGO%3XK54\79)Y)P7"M?X5QR&!MH0*RJ![<F
M*4^S([UP=JM,^LX#M/!Y C5B^/KJB1.Y561K65[66%_!2(2V$-#LE]'S#=(Y
MNF3IBC!5+^'HD"0=8OD2A[<$0@]OZ8(P?_^&EH)9T91!'SD2[$A=1.PD]8N)
M]DI#Y USEID*OO(/"_+YN?FK@?@#/_RY>17GO:)"%7KY9AG2.TR2<Z<%>X7:
M,@O)LRS#]GK]=3H9'AIR7;@2GVF;%+--TC=%XHHF!%PO__A?FX=O?G%,L0CN
M1IKH'.E0M 8PG@M/KU0FH-&9GFOZE<F?ADHT7N/GZK40IWV-9VY/K3]:"U^L
M3*M&<7J_*3*PY9[QB0=I]4F3SG,_)/3W1TK[#T+T75*S3D^C==%,B7S%"+(7
MYM<JQ+^[73[_GE1@"PY[>?B2Z&"/VOQKB\11BBH)E_.*M92F[: /R"N5O2J4
M[U+<3/&2OZ%UH_:S4P%N2QQ:YN7/0VB6(WR_0!-=$NV6CMY +PO:?D[L>ZX+
M8BBDCC.>N]Z"%ZIN3*C;H(R0I* T"P4ZAW.%C4Z(2ASIOO-+*U=8TKS>+)8S
M\6)FO=C%!L%)81.[/J[&)B EZI[9>?#JWC?MRT!A\7*%_+, OCT:.9?<SE)0
MSAT0H<<+XH\:-:>]D*,2>_3!9G=BT:YEE95!D6E4OLFZ(SHMNZ=$L1FU5F>X
MQ\G>X-9T/)8*V@MQ/D'M+E763MAG54L%)R28RY&+J_3,"])$TB(B2S8=-D&Y
M/TEE+MG#-0?K[\1_=)(E4NS)2 J5K?CEG,_//+<@0ZQ!\U6&A+V"R,6%I%Z:
MD_6[ZJ[R_;N@UZY>6E]W&GO_](O+MSCST/GTR5\_*+X(1<^R@UY6!9N\E)&A
M;3;^A&B?G1WL<B01+[89W9V^G+P-Y?!_;X@2$6! 55/>!OERX9:N#I)SYTW%
M9EI@C&Q;U\3.'K&)O4F+1%$NWA&KOHRKS!SSM1%G0:')F\%N7TJNOSW]I:Q(
MI:%B,=%<H\TF-"?[Q@_3J2&6[<]^SRY#_;6&BS*'MX\-*(%!E=71Z=8E@,.G
MR,OZ)S(VW1XF-G\B\"ZE@7K7_9!RYSW:/J'!V2V8),NWWD]U$\?]G,HHTD<<
MY SL]L%UXP*=P-2IF1EJJQM J<Y6S4)KMEUM[93P;&7-YY2*RM(JY53/!7T;
MRK@L6I]QN NAT>&(/(76X:M4TK""#Z'[&U4QK(">;IPG[]8]W4IV'\ O.8UX
ME(IF_-*!C<#UJVJ@R_FG&,C$NB1!,T8@TPMLD_X.[,*GZF?1>DGOE%;&!).<
MI8LC4$J0H]&LN$Y1:[BZ- +U[9BU"5YH%K/'M(AW14B'J.&VE>#*G]PO2QJL
M0^U]%KBN'?$"W0#<!D)BW5"O&@A.['K]*-UC' Y?1"I&%\^LX=R5T,(<[6E?
M^ PW[&?[;Z(J,!P-S^J4+W\E\[0Q5>D2IP:G1Q9M=*HK;%"=CNFOS -'7U60
MJ4W.9-< 0I)('[S;.#0CELG>?#Y]OC\YT_UX9,Y4JL/A,?X =[B_X0\]6L;Z
MPXR)78WO86S/Y,@KK?<]28T%EM*W+B9>%QC,M/P!$TG?.Y"A+G1B^.1TRWD\
MH#Z>L,:*-P(:U*W95N19)>C+I-@;P+2O&Q<T+B],!4'U,!U<Y9:Z7-GGN=O)
MK<MSYJK#1\-RJ%156PO;L;2)X>-X;K9##C#WY9\JG>9G5\B(XP?1?70G$"9/
M&J02/P-$*@?-U11>RYX@6R1H]$3SB]M\TI-[G&I>&?)&YF<F_GX94:S[,?QS
M*E;3,7;6^F1D<)?[\W:F]5['"@(3_R!$]9ZW;/-QK#AI(FU$?B]=(FFJZT:%
MQ,K78+3LNP&1IW-UQ=)8Z3FN4U04_/(D[O[:R:T2J.?A&T0\!)?I/5U>L]Q^
M-%V&_."R(\?[8/5Y?$'/AK@AG,!O8L[A),EGY9*KK *V7#KWI-.(3I\@U-JB
M*C$#)A@J(V3N\B+RMA8YS>3!M:%4K.=\$Z,/'Z9R?)"/V:'Z:K@%\UCB[W<?
MP$\;3[<+J[$/'R_K*A8S89!9ON\@&6Q6JFNK9:5,1\,RYD'YVW:KL1M;)TI]
M_+<P?35,W,^8)JV-&Z;S&.'R_7*[T^D$AR(GI8!)GZ"6D^1 VB7>JL8E)%;D
MOH7J9>Z@XR,-PN>1AWQ-1D,;S!FAJY*B_VD"'E,:7#DG%[Y+1_Z\,X;H<@U\
MJ'NB>P@/':=C#TS+3+>^%;!+O3> <LT?LUE>4_<U5*AC+Q5*)X[$YD*92S*/
M'/YZ]^0MK)F@UONT H0U%,O4$X:-+,.9X].&H?,?#10F5JL>9SR;=NSU611=
M(NG5WIC0_3%(\L/0#DFEV.9 KCIZ8%L,5$AQ^77D^*P"EJ\S=>1#5QPA^613
MX**RG/WZ]P>8^Z-7/2V5C<* 6U",%-O2OI"<J@5!(]G[*P2BHE_._NIFI2[[
M<W14Q/)FBO37Z+D);?3T;M6R*XQF?&FTQ%E4=%X$> D<,4ML-!ZN8GBF#(';
M?TNO'ZOP>76HX</X<+!JQN,7G5!IPA.F55:H2J5=7* -:%4'M.R>)1WG;%J4
M.QEJ5Z= +Q9N,+F2"%60R,E-4$^XE* =Z\%N;1R"=T4-=)5PA?A(QU\V>,0J
M!2"G>G:B/<[UQ$5HY8HMY\ZR^6DXM:&K3'JI4HO"ZM;WGVJ%/T\YPD% #O65
M'%?.#Q4XX[_QS;5OJP[+>A+9?E95$"LD?EH1P]V:\88!;LR\(IW[-?=!KJ K
M8AX$OF"]H''$1)1-(!1^&+99Y#$H&N(]':22_7+W@= 6C'<(2T*"#'M9E=1R
MM,'/6H6 #WCP4\5,5]-;?U2$XJ\50^#&-=@^D: $;"CC@5A_V]Z2*_=$KF^<
M+O33TV:3TIQ*E&\/^@KZ6]RNS=5,+:ES^B,9V?A(*ZE2\BL.4>/E\"6XXO)Z
M1CXKS2<'3*9KLMONWM][Q ;^.CEQZLXT0$WZ]37(IWK;%Z0F-X#VI&.112RY
MM@^\S6GV5YO!!P<?#7>ZDLT=UIC,^LB^\H*"$A'7C=S9&\"]V\#T1_Y?W0'W
M/]]Y@1B>$,;@8-^#I+%3MZ)JK""R'3J#=[G"B9$[E(T,\EO6&FG:&J"[!FC&
M_=O-%VI>/TTE(R2U_IX]R+?_;0T<T(6(:$UZ T^J)YX:YMP SL@7FM*O[")+
M[3$E(==5"S4QKV<A>'LF2#4YU;-PK%#ILY("IWJ5$2<QW7838D/,,!;^)8Z!
M%PCFZ073=[RB+LPDL9!H_^2L&50Y8MLW<@/X'J9W TCKO,V;7U6P_&K WOQ,
M]Y6:I/<QTKR%\O)6DNURKJ=;'U45NP;X\I$+H4;T0.713"6IJ6._"H/IMW6J
MI)::P:[,D$XBH0U=-#QX>_Y]S:^R9/4ZK]\P<W3XUU"6U&;F>Z<EAJ&:LKRM
MJ)31>94Z.;]!++[;I97ZDRQZU;J#S);WA].V2]%?8=Q?=74%2LW ]U:Q(+6'
MW:_GP&Q6;=7T<<;R>"DIQZN_F'/-#3Z("W=TCA\-H3&XM?S :<WRP\S @==0
MTKC#ER^6ZYY>O1_W&<_U\PY-J*HB8\EE*5<<P$,Q%@S+Q-"($&]TR+*"PB31
M@DV?]9HJ]7VR<4G!_%5YG5Q4PAL=[V/[J7FDJ4O*@)'<),%:2'KZ1A819K[E
MT'5]?\U14#%V$.3G0BR&W15.U#K (\%#,UYR3M5OB$5@K>*J=V;#[9$?EL)'
M/WTD>**\02HQ[U9+>OGILKCSI81)G]FPCR2!^>ES V64@1+#2-5<C"P;<E-)
M1@9'-=1-GCD#3@WFRR=6-)C]5@#-@GW[>2(Z'Y"DE>SC4B#?Q,:Z(JMR&LF
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MUVM*81FNX, T$Z!D+2"OJ=7SV*Z!@6>HL8_/BX.">C]:7O0;VP9WL*M=&,Z
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MKU)4ZIXKNJ3+BWY 2=>,^9S C821UO(.H<;);NR0;/>IQQEH0+=3&ZK1\-8
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MIY'T7-ZW^ #5+I*5:BJOLO>-79E9E1!N#U%7<EQ^_*+S6%KZZ21$^:JM)T]
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M&U&NF8(IFCKEG*?T1^;,3(&5YSP&B/# HJ*,JDH$3=$C_*=2*V&7JBJ*KX@
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M<9UONE>%=NK:6*4I>RC3>^M6C94QBF76W$+RR$^Q1QM$WI>7!"^Q=19X/AZ
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M7WKL0UCM]_31 3!<5&VOD:.+M/7FHUAM537H\_X!IGTGT7L"D[FUI -LUFN
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M>YSA&GF2=^0M:\VYYISKF6NMA#1%6@*8[VGK:@,4Y")!(0$ )"1@K^7G[ @
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MF&?B9T:$#-AJB!^(V,().C/DA\F/$T2)0X@##54F,GUC8"*(Q#9>PB'#AX[
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MDRZ(Q5&^M%M5V'><M,76Z!?Y3C.0ZN=!Q>JF%[1R_>= 2)L''N2^S3\;+K1
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M=P5TKY'>^HK,12C87013A=88@#,D&+O3G''Q>E@ZH3+,6**N)O#9M_KUSG:
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MM:_LO=;:O]_:>Z\%/@;PCJV;$!6GYEE)S"#*7,[AC@%HBG<,38.>/@9DYBV
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M=IU2AER_4X?TM_GG5Y]Z89GT$N_VF[;=]2\R*UAGV4*H/MD*2"&\@#>YD*]
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M4*ZNI>"N#/F2CK"$A !?HV$8R9[BX,_!%5'_N!WR8^2?_VCQ!-B6G+,&F56
M=Y9?.@: N<GQ?6E-W!AC^"3M0D?@'ISN5R.0P!7[<4(EQY3R4VQ6RWPOJUSK
MN.;F[]$;_$BB-2$J'B3=1]0@92K?)<_XC-8ZE.;CZSJB.6J"=+^6?K^I\NWF
M[*2TSO0\9PV;W#JX>NZ_[\DT/,@W*Y+3V1DTV<XY9%L@BGPOK99W84XS3!10
M$XO+DW;A=WTJG9/3B><G4RU15'%@E ($.X:5K^./1A7$6%Q8X+9#>S-H]2&1
M]P5U&O<%^3SR96+T[I]=2C%9 /_W/0EP/3,>^$]T8:VL_J]UVR5]_ZE]=;$(
M,SK66PL/E<^<1PB[B%AO5AO6N=<= UY5 $U1\^_AY_?@08BOQX"6ZKTZ!0O_
MV,M.E;5+1.P7WKJ,-;[W%=$C$05OV'Y=.?6-^9#BOL_-X9VSB8JD&N-U[:J0
M87Q6"ZZV#:UZ554RI5ADXJM<#ZV7+:2+]T.\)NGQ/UZZ.80? RY<A'?]PMN1
M6PO )%%4X<Y$U^*3.8N,Y/"K6E)XP3<V5]XI)=975"+\E6<H:[T-WAH8#<=H
M]E-#X*:U]3%#UH-(UVMH"T>&OJ1-?Q_W-[94Q@P8.CKQU!U.V7GPQLD=L)_X
M[1Q\!*%C\A76/?AG7.903KU\ED7W0#V\/F3V=/>\.(^O58[SWF<\&_:E,9[B
M7,X?=:"M:)R+D"X6M 07YP6Y^(EBZ:[-^A&EE+/9KS=,E K0_Z)/'TQGF7D:
MG_!(9T8T)SG%\44.Z-8WFZ\5Z[;9:N^R!),KW!*+'-*W6:8:D\P5$ ZP:3#&
M_!@0S,T =T2QXL6:Y1T:T#HJ;?)6[4G)K#*VH]W#6L&*:*OZYJ[TM=,>AD^*
MH"<U&^U_S_A)W!%!3MT6VK/ 59*B&T^3N\"EB%97=QV,6(AGVA)F9BL]QWJZ
M9-(M:0T],Q_:$^_MN$M;O:2[U;A_./3/8I[]EV>'$'5 ,J$L]H@I9AOY&,^-
MO"_O3"JL]GU\YDJGX4V>Y//XY*:Y2H><1>T>A2Y%233!1<7&[PJR7E_%E8/1
M(NE7R?O(S<6;#Z-VK5\36.%-WI_P?)B$ED9J;$?@EA>[V,4)E2^3:WY2O\JE
MZ[48[V T@QVI ,*\[&%=@)^(3)0+""\LUB(6-'<%JH?I:0?3*ZJBZ3?"58M^
MZD].@APA1=>J%?C@*5K50(F=2YX9)[4^5&%]J(KD8!'I3=:6'8B7=(_&MH@7
M/=UL!4.]QVU/^_"JIJC+,,.?7 WBL:,W-FZ V"ZX1<.M8MT)%]A(-5$=F!AY
MNJP$+X$NA2\_I\S;<K;Y78N0!#SJ52,;K(VR^C\Z!D2E)A4YYKJ8PZ/K=3S'
M$IQ-3.)7X_LE ::MU>)U3/'&LG;I'9SK=F2Z2_ARK_F2B;$F&#6R)L4.ZY#-
M>^!K:[[,+A6U:3=W4/X7\>">RZXCK@Q_?:Y,?5,%#3ZW6GN *X<8XX#E3[V/
M 34)M^260;4P,YY9YJ\03[F2.N!\&9EIK%&0W#1WJI'GZ5O-6SDY$Q;1CU^3
M,RT(0KZ<[^D NX]I$29ZLY402'L#VZXL*_+(.><7Y-WNVGAAI&RSHO!M]./D
MBD1I>[Y^YUVS!OWE$9E4M]'UGRB,!GQR;CYGP^<+)-D:.S',VEZ;^*VB+/62
M=#&LQY;!=//%P<-XQJMT&N'^)@7PIH? >0I.!,"?(2:"]'](347;NK,X[W3X
M?^Q_\5D1]E?3L$8=0:BM06,U_3-IP)*5R(# .>.9",9X_S9E;GSXPE2 7?ND
M*WK6='ND1/AG1EN6D6#XQ<ZBI<XHS2:;Y:@/=MPFY!\(C"YJX@+N,1Z<"ZEK
MYZ*RN"3:!%'%TGT9FNF$;3SZ5,O^T^V;=Q<O0..#ZD/%%S[QR4JCHT3%F$:N
M;]CS_,$!,5Q?6.0TU;0LI]>T3;[_''365'(?4A\_Y"=?.L17^2ZX3^988F)3
M>)QA@@-/4C+G@EE9OA?'QE!XM7-R#,QFW&3#'LI.L8^14)PI/A';O6Z(%\<<
MM)F+A2M*/M[MR@-/6R$;ZCW(*PZ\=8G:U0[?! :N_K1MW"F1E,K- :?<JC!I
M7%F%L<X+/MZ1^Y'N9!3QKL;^_/2S(ZMV!>W4(V@SZL,Q8,J?#%)''Y!B:OO)
MR3K@@>"3,%+E 3$CMFV;P.F%((FFUGEPH[5_X/LY4=-W4(L43 ];@#=I* O/
M0AE)H3!>2"0H_83JDCO^D,_NI/_BGH>2E,]_>D+Y)YEPDT.N^^MR7B+\S4?0
M(^)HPFVGXFNW8FX'Y1&Z^5)EICH5GM]G*QFFG\JB@+S-EP1JR*X*QB=,2HQA
M]NDD-ZX2X6X/C>_Q%OD<L^J=6;F1P!C%,/+JMT.G]/"Q C&Q2^G!37J]\T]0
MX>CLV,L[)T&%&-/(TI.@@O3,-_8R#;;\GD6^H/PL+$P!WO*!"#>/MA;MX0^/
M3^(:&%UM)VX=K+H'DBU^G1!+G>+R['X[7Q=W+WLO=A7I^H'PFXE436H&3?IR
MUZ,8P/V(S1Y,'O#)W%1DNSE]*)>K##?=&G9N]9;LX4;\7S%K@")R<^<KIOYN
MR3Z7HXO#2'\K=NV,HYVUV='N49E4E_#/#&V,I^(W.EY]]-"<IR%#_P6FJ!>W
MZZ\)%T%QKZVXQUBWK%UU@;-/^E?.)2?N6I2T]>P"_96I('BB,5YD@?[*G4>S
MO /"2/W+S'HKW^(Q]->A,^NYQ>#YT%>@9D3@[&5,';,#9C;</IOQ31GBYMG(
M0%^>I6TK54A"E61EQZ8IT'GCQF:CD-#1%+B5[(UR#U!>?TBJ@HET^-3UNK,^
M]2A&:^[,KJG'8L9[8I^2YDBQ2"$K,$X';_?"=@#YN?'*X'<+P"GUB9OLS^7M
MOB@P1!!+*6X2 ^NI0ER$.T/(-\VF2C''@-C,^U*Y*+X&HO@;3Z40_  O]ZRR
MXX&.WS& R#!%I@E= %(3^<OP)EAN<R2&U![.<RLX'PQ,=G[AMF71F62PT][Y
M?<JL^Y-.UO7<F3VY7XIJC,P"ZZX4W%5-]IW_8,\1%/FB!F;'1^\T)YR="3N0
M\O(3=:HK41#I'S)?(II@.YJLSXY,@<84;18"V!^ITHV.31:R[ IFW+^]04=O
M%[$$$R1/SM' +N)%K?PML2LA=N6F4:7J[KFJ+U[XMC]H811WIEYDO[^>\+H7
MQ@0;G>.6II\2PWW&7HCB^5JM6:_ISW'--3!6PG3!R-05W;SOD5_38<P_6K]!
M!Q;<W'5*-MASD\?2T\?I?_DZC7S:2R&A:E-UUI,3?&,6SV"CY#EP!2?J]3'@
M,3#,6@I37&[GAYIPZ.O1^UIMMF@F>DM;YQ<V7I:G9YB+S?>7RTX.F6J$H+P*
MK.#?1'Z96A]]OF8."MX[W#\LNO5HP%)*AT/O@L'!.VTIUZJWWO.!DN#,.:9C
M@)W_,> BO(D#21\L@Q%I1V9#;$270L0.7?RO], %;]'S?B^^<!#.M@Y.!V+4
M2B9I-4D(H&N1S*)U?:C.(%0OI_^CCH_DN8B9;*>EL#KNVB^F=E;3I^IX7Z=N
M?_O\%9DHLD5>=SY"G&L?<30(WXE(*31TKFZJ(#/+\G]/WRN#YLU]6=ERR/X\
MN2YOB9--JCPP-M&KD+3HO1HO\"CJBKTB,T\@51/SOQ2K^=BK;8(<J*C9+A$M
MVGQ69.?\I3KU/H?>=3;1[Q":"[P9@)*5?MP2/A^!3-YL6Q3Q;PF7R:8/0T(V
MI.*N00_RKJF[G#(Z!KC:/3BULLRV(IVAWKO)1ZPDP@LR$/^3P2D3*4H]C*>8
M'.5_6Z( 5N7<);2.N\:(QCTC=<3G6>UOBJ]W?4K$*&0-HLS@U"B"S\)>:*L-
M_B!KGO-F\YGKWFCBF8#W,^P("=5^]2DW5J7G&Q(2+]>X,>8( "(8B'D(#E9F
MM2V<91_=B[[]CN_=X36=GY9,7=QB?A3L/C^%.BR<.SA[#)@.MK1_5NNF= PP
M]$7FUC;>7."),$DNUYD[3!10('XNKN];)]-=Q^BF>1$D(;*M[B[TN+;8\,4A
MVYIQQ29WZ>SO,2GMS\VI^B2C(G:X\;*."PYQ:'#X'(.BF:_+I?:\!7]M=AVE
MGU'BE02]FEU.:D)1Y;2HNH)5R'/=@*$_)\)%,1VDF$K4D0K<&OS?SS()&"20
MOR>7K$7O7E02@*3=UQ(RG5O.T\E92P5[*,3BY4*_U=J/;4S-HYBD"X%3+,I\
M.J(*T4'?"8JC51*U+.O1/VYT/%RN1N%E<%OJ%?BV4PYWVH^D(AJ"[J#.DF^8
M[)0\_$/1>^HI%-VNJ(3\=FXLF4+ZJN"[9J@M:@J:H7GDT\,'.P;D2[4UBV/E
M@R*0\U.[I.%C0-=_;O?Q<?_9[?M2)T]RHDRD(_'F .PRN15(9S>PL5"58/VC
M<+_G,/%TE]=+K],/-U8*&%!._:J/Y,XP'XK]\W8)3N5WOA+1DWPEML;1QX#/
M=P92-$FZ\3O@."Z.@3?5*)D\OOQT;>6Q_&UW"^Y(((4;GEU%T:/F/R$8/6=N
MCK(+<2/-9ZEL[^6669I93&O= YQ*X7N)']M@)3(94*:&PJ@Y\"[NGR=;W+R*
MSO=;-,3QT!S(RC[ZW+>E+JR&^8A84.4  (@)_[0+0;CQ>YLD&7JR32)TLDUR
MU7E9'VZ8_0MU ^(:FLTETFL><6 O59]<X2=6PQU! 9[&]*=7$73 ^4_<C)X-
M7*/L"MS(*6MA\>M_J5>7!Z(?GOIV7M.2++TO2V1F6K0B!U/6Y"I2.E2(<SAB
M5N:'9T\/6GZZS25GZJXQ;M<QG)RK)+3"_=])I#6),H*J> LO-#?^%OU&!_K7
MC7A31<D%DGS[TCNFG]FS:4]59#.W*HVZMM84QMRB;::/ 3D]9,<VCY$<@[!/
MP8-]6CV' <CLG254YTG6Q+?' "2J"32^_1 KVK!8GBL6[27TVME>ZIJ+)2FI
M]6;IY.)6"B_O'8XX1ES)B=&^AS>ID@'D"6#Y^>R/SE776F>%AY9B#NYG+&I
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ME06N9&P_;@7OL]#@-CI+T*QM3%I;GO2:86Z>LNAYN?25S&='=9:+2DZ1"=S
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MB'ZZ28[BG!1R=E13:-\;I3U.'*+H^2MX$SN,'S:"0/9'0@,69OR_>?LI-^"
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M&"YM<3O,9Y:#A&BD(:KA#V^](XA)7Q)E$Z[8ZVHNZ_KY?8%Z$1K7KA 5\[0
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MOB_N(Y(LGA._YU/6_*IDZE+&-?UC]*I*[5Y/EJY7;(?#N=,K#J^]K2)5-/;
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M$^]&$_#YPTQ3Q^7/CYC2>IOT@S>$]:B4B*8_#]O^RW_GJUI5+O+W@4_(\63
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M&\<M?P<L[W:N0 8!F>.&+@M!::>\*=$@9H&\!0&(KRLKZRD96B@S'O%/S4<
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MH8KYH6-@5 #V]N$+,UA7FLDZ@'J">0PI 9-0P2T.4DNX88B47,42!.+)'/$
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MZ(YV\44@[9(&'^</Q_6^)O8,LJ&/J&C?SQH6/8T1,9(((L%NS85_W\ABAF-
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M[0^K__OH"Y@:=,8EU+3B;Z;!7%NJF8#FF(!(C'AYD:,H897 1=P?^%/^Y7*
M'\? CV;@UV;BCUC%CVOM /GQM_8_TJ)0%J!!EVJMF%K1OC1#^XJ>]JO:U_NM
M_:)6$*R-0+"F(Q:DFD/&<RG"HZ(#Q43!_MW14H1<.??U;WZ4UQF<P]_N;TCW
M9'RZ,:I90:UWK-:A)S>D0(J8H)W^J$XIQHQWI'OO8T25>=(WS8_\&RHLS;_H
MF?!;NQJ7&\4]4%"V2K%>]!F*?&\SO2DU;>*Z]=O[E:H&NAM1&MJL\F.;<#%1
MU)W0XVP!^01=DT\_#QSW:'0,C$P<%,:I\=_-4_)HELY/9=?[E%&4^RFS(#/B
M=2PH.JO7^9^SN"XO\N7!1H4'(H48'T\-@K,?E5.N=T-JLG*2T65,O=*F=,J=
M.IN-@9ZG&GM/I:6!5"R1_CY9-^$70ORH6L3"J.I6$1F^Z,"(-[GH5K5&:MWK
M\@MODTMW^$4JBO@3(S[,WK5)"PUHT)A*T"I_^VUIUROELOWM5,9IN\>;0ULZ
M-#N?]_H>/Q1EN8G/.O%%VTL$8B#40]]Y\3IE%UR[B!Y'$@)4R'Y]8N)L=$0@
M?"R+8N]CX[&G"OGP"))VI5K54:E9>,%W4N?\1EU^X[A=C_03O#K;!7*TPZOY
M+[Y=,.-TT_20.-BB-1QIV'ZHU=^3'_B#-+G:\(>8#-Z_^V ]9NMP[OL##_ 7
M'Z?-I3Q$E>7L>#)ZXL$!BUMJHJ9^H-9:UTR+R>JT[BT@1Q"5=3_IS/R\/)R3
M0_@*M:MS9\ '6LWZM'>."AQMF901TYW^=0&79S>CK> S<&=2>WI"W[8ZPGVZ
M^5OW,[!H79HO4BQALKXTV:VV*G?Z_#'T04CV*O#TSRA+_*) D034DU-)9;S7
MQQ%3BP.69@HLS2Z$W#+'J=2 G<&54@.&2D!-BLI#4Y^";G?; "T:&G8G P-_
MT(DD)L#\5119ILDSCHCFH/J-LW1)$5 ,C!R0(*$6-R3- R\*/8KK_1F7Z0#\
M %2(!&-S6#H!WE1-D67TYZV@YJ'N;J,C@NQUU+)2J%-+I8@YP[8A)]R"(#O,
M7[>\AL?2&FK4DW$D8,^OQ_KF8;:;4$6N<$+'1=B%44.E,U()$RUPEVV_EM 6
MKJ+]QTS&X3H3(G3$248! R ,[X[KDH#/@73D=P=FTH$&=#B'D!M"R$*&XQVL
MU! T%XYPQ1R6R5816.+'FQ8"W[>A-8 0& A"X+H16K0VM8XI*+A.FITLI#W>
M@1I: C&&)*:^%UXF"#D.S;)I3X+P>N :T$@>;D4C>4L:<?ZM$0"AI9G#0P/W
MG8X I3Y@=OT2L\>@WB[T$K-,7-+0W^>QO>&OF(C^!8$"AX*DK6VD@.A?Q0W8
M;Z7(ABS$+NO?!D^8G&K/A_WB O!D,4#AGK;X$!O#!7PO?":'?54\B.SB,MX)
MLD%E^125ZQ)0&9(Q+A?V"P'CQ/\V[G3U@U4-(F'^+B;O1";O+4P-YC,UV,_0
MX >H(F=5@XX]N&4U@!K7SX7!@<(*!XU^U%VE)#OT0JS2LGA&*^*Q1:YGY#)X
M!)I6U::>K";9_S%["-DE<KSK3^"VOVUML!A:MAA0H6R;ID7CAEU7E/4**E;
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MW!'6E7$<J)7+BI8OLU$;7\.<B.G\%=A_DU 3YF9G,M/9-[7,S%54.P[V<PC
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MO\=Q0<!\U*A'(\=[&=N]Y754KK:FIG]E4!D(=?#O0FWZ4R@M%=$FIF5XH25
M0-9@!.3].RC@&A;82CL@#D@ NN?-\'?4RI (=16N9&9 W>=E++XZ!D4V0[=7
M,J0&8S(^3-C"FSP(ORJ?2I)9^J4-W!-ZE-^2<1JVW ,*<_F!&8>'CWT<^!7;
MG*(B(Y)B WS@<2R;Z+O/-\SV.0C)X\)TJ8VF:M]06=KCZ?W8=N/RIR-*LC_2
MI',_;R&Y:)S-<???XDFH^6S(+7*.U7&2]YX0YZ_L10="?U_+BP^NY]&@S-KQ
M0<U?B>]&I45.)G7&>M)Q?6T*;;A+;I?/W$W'\Q@^6@;J>JHFZ2RYRZW7H_K1
MG)ALWX$F)ZWSJ#GWM#AQSQ=^KWM2MMVOOW? +,02N7-H00@'3"ZMLNRVT)92
M5BWS6[J.\5U1$ =ONWK*H=B"#/6;C>H=L*$*AZ$9,2D'*I:'!A:+=M,1;>[L
M8V@<)^.QB/\XRO/U-A<Q860QKK%[ _0U!72]:!2IS0<ZBLK$4]]22G"DRV!$
M8RVDW?P?9WFD+4Y>G$4GS_.![DU<$3W,^,:BBB>15/[_Y?>=6.%MH+T,]R'+
MP55=D?#+[!,T^%_.\K1]I2.ZB_Y:B#U"1SSUF%,;K_RW(SJ@6U\W &9S]V2E
M(S)<@.0TV<[63,-(8W+HG%6A#[Q.D6L DOOW,SH0E0],=%B7:$B[/XNE'=0@
MGU::\R*QT;KCR(8#F)/14%$+'<&!DU7"G<;U/#N!I@I+M*'Z(RLN)5C/@7^8
M&E&/$FBC<UF[*NSG^&Z7RN25<-Y?K]V"4[*=52:YW$63]]]]\NI)*C'LPK63
M.Z4]+K"/VAI]&U&KQ5AYO[@FY/>E-56[[T)$G&4S=A3KW-X>ZP ,09U*^O.Y
MIO\3_SP<0.G:OPYBQ=FBV)1>?:SMQ>W2IB,VMCX2L]]@-SE+:=C[XCJR+."S
M1>4=;FP8[@;:VXZB@&DP52 <?CJDO6FL-<I$%]<=)?S6(JB.\I43MV=V8IN;
MF'/*<<&[P>=^J:KI^>IR;S\]KF(#%5MR"%$Y9OHW()!$>>5*FH>RSOH;K5<,
M!UH7XN()V6[ZU2(-D=3\ET9TQ*>G$< J.BCXNYZ5R]M5:9G-S+.@<>90,6<!
MO[DM1=4UH>]NLKWX!W@+69=21JJ7G SV4F9;_UZ.NLW@EH?T*=);V\6Y7_[.
MG5UZ%SZ%3EUH2@H='7+;9FIS)>!DG&-9V%PJEGQ0@AJ-9+S.^QKC1>A)FX?>
M'\UK3A9JJ!ZTA9,J71\;Z;SV+L7Z5("XF?OR)4I8U+VH%VC6;>'>_P$?KOO7
MQ[V:/;>2L]]1-Y$+>_'<-N+57KV4X<F(TY4O[_6=JZ.(^SRA'$N#X,VO"9 6
M68KBZ-K0JARD5]HQ^X0<H+GY_O;37IM-(BXBG0W4#YQ2W'Y+)-6=G;I[_[JP
M/F2QHK)]9Y!YS[P?5OS6^<9]%(U;)[>^2Q!H+KYBO&.3>#*V"MLZA3K7N^?[
M6SW_TJJ137I1TSCIZ_.47#IBL]*9Y9.26<]^.;9Y<>B<"^L )<!+.H(%! 7K
MJ4ZK7OS#N8.^6H>F]"B6"7SXT<'L[*#)MT&%+)5LAZ .;!XLYZGYB8PC&IL0
M.<L"Z8@.N;]^^-(1SVZ%/#M W2Y,%04)C[S_>>5$(2\=P8?A:7G!FX=,/R?)
M;EY%'>M*J:S0F)MHERC/A\]1"N(57OQE1'$^""E=*E>;'(KL!JYP)\IG^;'&
M_]_]F="RJ,?I"+8X>%/_V[$&M5^VR(USLQE2OX:NB).OBKKW]9JSQ7KO=7[O
M7._ZUA(B"^$GUMA#354VK[^I4=3?JV7!O$%B;GTM\^B W(%OR=QUFQXGHGP:
MWN$_[!]5FPS76>@$)I^!V>]A]<^3IZ#\)9Q'+BAA?7 D >_%UJER3[\=T!ZE
MN&2:8H\5U3\=.3=#1]C];[[21%4Y&ZVR&'>[ CG=WPS[S=+ LG7(FT:_SY_*
MG0.IZ!D=X;+HWY#F[\&Y/=Y?],R#/]X(\[_[M\4#2UX(H_531T^$_G$L]5--
MR;\<.\6/4D'+X?V>CAC<A]G*2$Z@/4X2.U\8&$(;&ZA[T5>WP(73Q]1 Q<=1
M@P)QX-KQ&#)$1VCES(W_EZ\2.N,>2QAXM*%[E.LQ:C/@6M9]@![]@HMTQ%4O
MP)&Z;M%V[4*TR[\?5,5?Q76-T!$^&+7^S[F4"0>BYHSY&,A30(9PX6$Z@G0I
M&TF3-C+\Y85YA*E#3OOP(^'JW0ETQ-L C8XD;7W/[VYTQ/X:-3)RV*V00^<*
M:X_9__#Z%]9.%.&,@X\2%[F0HDM.T"9:^<ZR<]B08,ZH/E$[M+8OB7N0ZZX_
MO^[%J]RB1[_RE.[XV8I'(N>@MGF2,3$"ZT=U Y63C]&&=#>+O(>R$SW6DVQ?
MZ@[<H,1G._-8O[SZDEIX5!5S"# ,\ ],*8#ZZ)HGZ!*,K=!J4#'HNGJ>(;?C
M[-D[V-6(5@_G0C:,+-Z-ZQV6?B'8G#9I]B)1,SI9<PW?3O&N3.%U'X^S!C^D
MDN2>]A^_454A.SP.*=\RN>WT"35VW'(W9PI%-55XQB9QL7QDU 8JU8>_,.YT
MDT'"\R7B%C;C]F,DT#;N<>5Q'";#MO9Y!RNP+N*Q>P.J'AEG?;_6\9S7T,Q$
M? ,K-^><7SF*O,^PO.XA>HNG>E^M9AEZFU5C@43BS]%6G4YT=U:#BL,NC='[
MJ1<U.<\@CFRX'7JBM15-4$.U!_1BRZ;:C$\W4S4)\U_@_<UOFR1"-;NT3V?G
M?W*^W"8L><[G$<N]33T&]:E^)8W.-NIU^B!\W@M!<H9;_=0.2HJPE'>_I*XJ
M^>[EU?X:+'<^I:%H\2;F>+T*I@(J-D=92OCBMD!F=AZ&A-92/ O9Q<#O0OJY
M*:?:#2T-O9Q)%[ZH[]F "-[(^M0T6) C^?QVV[Z[5%P-=6I?K]'GMZP\P4DR
MG+[^85HGOXV>!XW*FK&?J)Y@*).K%/T8_S''.X4<V3MUGZJ2HO4.?2 R+];;
MUN76:.;'"Q9/V;:S(G9]P09 /8_IB*V>)XG&I!]V$N4"R'I/==#Y7375(BD:
M5(A6>XW6VWF%BHKWAGD'!D;1V$"?PP_L7I'QUD,S,="G:)@6,8[6;8*JYN5H
M 9&X13Z9 55'.L*FU8$L-/;\I0"_MF_J1LI8=[WM9 ,>5V-%Y3+LM?)5VH%I
M@?D;/85Z"UE+%IW@[3F?0UO5&_LR?-6U)D9?;%9]G^@?_Z#,:C.K&7IW:S>2
M<*N2&AOBBQK7R 9.-;9(5BHT*<SU\_8*^>8*OSQ,W"W.T:"NU2ZV^ZLPMAG5
M%@EO*B9$]K*/:[-7A 3L65\9@'U;CRS+N%PTLB\KL^WZX_WW)#^$*AASOSC_
M XT47A\4\@#/QWSK6:=+F:$ >Q'9,-YUPUC5TPEQ^W$[)XO/*BSW;]ONCPC?
MDM,J7T*H<?UP_87J5*BXQLDL#VYHZ]@))TRN?Z)JJD7B1O5O$XII#1D..86Y
M/ZAOXHN>TN)15YM!XS51GD05)=ND77+-*RT/V=+!^=/EZ4^WHU_1KI]<,];X
M58>GLQS<KE3_:3,EI(R.R(3&DT!]_8'L\3KN\9ZS& 6B?3+/58>;JJ]O8ZI"
MCB5DW]VNO-'\/B[L)9?C5EM#_HWOII.$Q$+Q\)JA04^VH++O^67G.6PN>&8F
MRTTFM<M@+&>SLS*-1K$+7"J8?*B4!ZZ%"/K0 _>B0D*(=@Y!^W'6PIZCI&<X
M,PI_\94J_MKXL!V/%R<#K;RSBPR,R,JDM605/C1!)X355;0BBC/H5]M<?LS)
MBPW9O$Z?'U9QZ(E6[C\JW.8TN?'K!G_7X>^2=VTJG>:W5-\G7OK+8'=H\I[P
M=$D=GW,GR[O>3#7+>!FFYMQ=Z/.G?::]Q_5$X];:>WK$D_LK]K@\5& EC)48
M><;#=><?\._A-QB]O*MZIIM35>0]]WI=_A=-+/>4W7Z5HA\A,W!E4YWH8@P;
M 07Z<G) Z>*DS[O+&KPEZ6NVO6:K5#ABU+?=V$GT5KZOR\X$A34FQ%IS^9DS
M6T=<VCWK7I6[&J+9'B_F2'!I;-,-O!H]GU33D.=+TNHL"NIHP0UH<9)"J%PL
M)--Z.L(*U^&BWJP@%3_2P>ZG8/;F3;V1#>FQK>WZ&M9O+\R#$"K?W+;=VF"D
M*A06-H<<3Z'(>LK1HG ]X0%$WLHX=NJN/HGMZO$_R9%U+4ZVMB,'I ;:O@B<
M/<+9U!GT^8L-][Q,ULQ&$9WW$0M9YX@$3Q;_E.AK&7G9'$I8'@T]F\X(H[JB
MY"XWDP5@SUX49<QW'*L2EVMP7;^<G]-66Z/\YK,M.]'D*S)6P?BJ4_HG53M5
M"97V:JF>29138WGL_DJ*KG@]0G:!;!%WDS.%DKJ?V\XGZU9[85G0V@^GUNQY
M].W>O:VOS%DX%V6 I0F267M0@?BU5 >H;XJ%C"KG>@;OW:$LFQ+?::H@;-=_
M[9&%<K:C>L<GOEGLXR)1SW4%Y'0Z8CT[,:D4M\&FQ2!S5.E$LW2A; -WV>X<
M';'Q+V87S/;[RQSPX=97OE\A(JR?-!<58)PZ.;O WSYT)3ARV_7:=_)-=J=5
MQ?3MNHS.3T71CH1LC\==]=2DB,#5$$$3^=#H4")1]&PN$?LH>TM)*+X]Z$R_
MX0N$S5^RH7)/^6P^.;9]L=@R?JZ:BJ+LA:OQP)R]]^1D$AI5 XJ-!E_Z[H[3
MSJ)LK8BX5?UYMX>*PZ%SG=[3SIN++71Y=]&2V4,BINUJ[;9"?9S]QXN2YZ+0
M1H-#)(7NN50/TY:A7*V\[HZX$"?#3YY;:=X*:&(TJ2R/?/*Y$\U8M>A3;HO#
MW:R/-@3CHG8K?K;DA3-.VRP"KRM;8+P]SQ-:QQT F>5><J4"!PF>2I+$LRUC
MTF-N26JI>$G94U%FQR[M_[Z-<^W++3[#VBHW;YH=W)AT6/%FOHO"EL@'Z9<Z
M.(\]CWI:6O]VP614MG!J4/U&QUAN[3#F;#TZ!<_+J+_1ZW'VN'9_Z#$JD_;&
M7?SS%BEU!RO+U*U%KX^8%+YL&;^]Y:>9AAV/LY CI]G"V6\Z_A_WW2]FS3;E
MY=Q3U:F:J^UT^[806U_&C?!F&]5;[SZ_EC]9H5FU< 7=;!]U3<<T@'*0NO83
M[1W.&K24Y,W=O:FHWOU%.[1/I WEYJK86#U5.U.]\SCC'3.+MRGJKH:DRXR7
M55EW[VF<@QZB""]NF.[U-U^7^^S":'"?(+=+Q&3TM?29#>MLV@@)/(&JQ_2B
MWH:%QYUU!M&0M:7F8\0=D6QS51_9\*23DQ/QZB<GL3G#U ?Q.'UX'PA/&;B)
M?HJ<J6MF;U8W/]FF;T@]**BP?."$<6J3^?Z.H:9OUS;2$1)UR*XM&Z^MT9M1
MH^Y,@C>]Q^6R^\\IWBEK-8R"[E&E1(KOD!R>]>M_%KR5JR:X\?T;Z:!JQ-=7
MU^??5"*U&L-_N4Y/OB@2O3>SL?_=U8^A/@[VV$VGN\7$.@NC!HWRJ6FS2LKQ
M.&,E04][&FA=+)'(*YXG\L@N\:-AEZI)BJJDK>ME+LV.[/)5^_PBL#Q\0"ZB
M@+$7+0IRZ@,?4 D*P4@\7">'Y%;:D!N6U-X69/I+*_>S;;0HA<_>(^"NXQ4>
M+O%OQC87]ZXW\_W.$VX2^M)$/^?F5(6KPR.?S<VW+D5='%21T]UN]TVVNPKK
MWH&W<K:(_M$']3Q ;2A $@,J\3M>$UU\%.3ZWMUTH@CE:)G_]6#!KOU-^+'3
M(A]U3_$(\GS!,C)V)EE0A7P;."L+$0[H[4)J_G#R0(U/9;:-M#SMZ#R=KY5]
MMYWOJLC@B^<]CI=BW[0VH@CVAM1PR!])VOJ1CJC/-'"IP&T<45( %=]#XW.M
MTH4HHP:'[*V*XC>QJ:%]W;VJ?FM**WI2MMR[I79!-,;@=J6^PW7>SDDE_[<7
MM;F*C]N)V*@ZW^9[V=+:[6R O?LLR@T9XV0X7$GEFNKQ>P!OA4K>TA$/424"
M7 0L*9)4"1K-]-EW1S#-F>,G%>H.&][MF@K\Q1O-KX4DG-)^(,!&!J4.FQ6\
MBWVC*[H<W<YX:L0";FMX5401!UV_PS2UV2X_Y]#MP F36<[6.3+->$RV,?=[
M914=\2Z"CFA!S]EVI$%#F;D$VMO.B:3DA3KT&Q1!EYU\P*%4HIV7=+&YP*XW
M1J_"Q2@[J.O#CLIWW9W5]@:7+_**/!&T8@V)QJ;>[I8D?R9 )! W'X1Z7O,K
M!PWS+(J#?#U0UMTT9$/0]8-I491]CB,<K]0$5'NGMU K<!HX!W2@P%8R%T5N
M%+.?./\PE6K7FV^;8OVVX6W6@Y%#+N$BLE5%RMF/CBL$WC:Y5.!\43<R\WR=
M:51W!]*VQ'-71)U$37]P\B;]Q%K>;(DN^;R F'G=7,GLKGC,46!I<O AZE&R
M%D4EQKAO*/+M*+P+_O;)[VM1 Y=^P,26^@6[@8R/7]<4W;P=Y_X#@'[I:4C6
M(OKUMX0E4WD;G IY2[=;;^_H4C:+3POC-64+>';WF(BPY;$"0<QQQ!9J]A3R
MXY7*4B30"[PYO4],4YM\I[=38LVH$4OM]=YJFD#]Q,UN8;']5MM%GD<$!@@.
MJD*NVKJV46"A-NKF>D]!RDW7DR7P&D)L4#QDYVI99=;HI'5"5#H__QD\?5#)
M1./UFYNJGP6%;@27Y GJ2NS&.HL;3\6#T9YS-S,YMW$DBT@FG1#)]+_!WJ&>
M9-&$)10V9,\I[8W'75'8Q]PIC\/UQ" SYW"!&'FQ./^YRNF^3Z$C%E%M/S\)
MC>?<?75?_"C&;<VU'2\7;"-V%^T@&Y+DP.0Q:LG6 GR$*[B'!>JV]HU'=C_;
M,>S^\#;AK?7#]:\B'7BV('G68:45&O9\.V8OBCVM1\CG<C5+Z;/1*ZLUE4X4
MJK7_7O6&(N: 5W/XND=T>"HP+CWBU[@/Q8ML]67/K[!4&R[WEIC;YK>E6;XU
MWSST^>+Z_N/\RA6CCG*"SNMV+=I0'.%2?&;1XQY%P7*!H_4*HB F%L.[BBB6
M232_!&7S.ZGVRGP&T1,_SNGG;Q!Y89X;5) Q8GPT2:OX<K;8![<%E-]SJM<1
M_43YQF<")AEZ=S4]<L5"U66[<XU2XORR#"?4QBM[&4_XD B$X.1>/"M5D=!1
M];KL[5"W'9_-8OS9 9]PDWTS)E9!)6?T^^6__9HQ).73_-.46.$N0_0FITUO
M"OP,FL8G9GGLE:A/NSFF+WX=U7DS77W5_MBS+]]%/I*'FZ*3#O2UY)$DZ\CL
MNR*OCEARB)XI% D=U'W;.9_=2+A!:XXZWTK8(TKBZL./UU*DH6(1S,;ACOD
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MV*O.U84_^BJ1>O'1A?CA)OU?&H=3U#WD3]YH:#%:>.O)HN)% ZJ7(LL!S09
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M*H"\"Q,.DIQ05!SHQ4VOYK?NBT@\-9Y;[[1NPX'(59 ,5D.;#V3U@%-C('"
M24C[5UVBRLO+BM3!F84)#N';/'-EHC<V'S-/*>Y#(V2. 4[;4]>)6,UQ!7XW
M)Y.=]G[Q<NM'\Z?^[?""M$3?<-Y5674^ZV11FW#QC2AF1X-2$[*^\*O1V+PK
M30$W( YI[JO#)W 2\[H04_PM6 'X)42;&[Z99W/+_D.)T>RT7">,77WA=AEU
M.NOLI1=LMZ,TA9S(%VF_)U!"WE+%_AU2(C"H[K>[,F/E_(>E//DO@U@UC3S>
M^)[J5KS=V=HZL+<V-H)DLA<)S_OX*0?'N2A*G:AO./2FR+X-V+8-@/G/;7]T
MH@8M30#;FOD#K6!J"QNX@=Q[[@'#KINBNTI;LQ<8?+QBDOM(:8O *=3=R5S\
MJYQY*HA7Q@%B&8ZYK S]NS3(O#;*=OO9)/_[KCN%$XV0>2GP*5I7L_#P'CFW
MN724(N[/6=7:]>J+14]9N8JJU1N5.[ 2#>VK0TG:5: &X=]7/R5>K?]:$,_G
M,]YYF+<[^9O2FAF&(7G."=Y?B(ZJ1+&LN18'%@Q>C?:=T5].H28\-2.?L:EP
MD:K897R[;.1ZQ=1M2E;)SM#VW3KV/(@)WI5^871+PSP/LU&?,/Q7M*&&_'RR
M!'#3B$N=\[R.S7= K($$!,\PMXV+Q.\</,6[1:@Q_V2JM(.8@?J)Y7-?R^\R
MMX4(X]4NG>>Y5@MO$MS$39-9]F59$7:%]S$6E*1)&A"_6YUWTAE+0T,DFX0A
M?H#(0!Z/[ON#-^N6=F3=8A?NM&:UNWEH:QN ]H?A,\W<^,EV W1&FR'Z'UH_
MZ6=NAI.WOYN+74R[9'@=I6TX\WU'YOLW%X5/Z9TT3"#9[;:"J[;RL[#=R[-K
M/LJ)%<@7:]<DNG_]GCO@;"+#S=M_P=%"9VIJPU1QJ^6CB[&J''(/<X\\G@>W
MGO70S(]'H0.*O.?Q:Q[[TZ9J!8F%UA/1^8.TOQE<<%;8[GQ:9,;[MVF2[6;1
MSZ-<LJN'N3K[3TL$GY[G%O'2]EDMO5.X@B9#:8R/\5EMM',D_NQ99SC?'P7_
M?,6_+_V*WI+<EAR4#L[F.SQ]%%O@.2K\SM1K'CJ5T6H#IL8%@"J<FP5'H(HL
MS&8#GD77OP/J/GZS]Q/;50JNC9RR>Y>:.C;:>2]-=+_BU?=H9CO"5*2%43S'
M_%GJV$A@XA%8?K<DC(R:6VD@JY)".CQ(\EI_]@HW&B+:+P]FY1[F[K?0>'/.
M!2N+!O[Q]^%< N*?(J:BM4AB1<Y'DY]Q ^E)Q;Q7DT<]'6J^W]*\YX?N-1 ,
MR["ZO+8PEO=[U*"?X)DJ:Q1U>='%^-/#3K15"?$8<&=R!>("YH4SMI)O*D6"
MPK-J(EE"<JJX&>Z:I.!RN8RAZJ]\&82WAQA2)_L4#[I#FIE)VHB_-_5>4J3F
M:\:[@TMN-D^C':ZO#G"5M!G(N^/FWOLZJ?(B,XX!=K93U\%H<>OZL:K0ZR'M
M:AI!JHDBU8]['@[%\Y/N\DCKJ @SU_$.%U_H>C.I,[EWY]*B1-<"Y*7'FE;O
M4Y-EDU$]Q^89\[D]TQFX)&%[<Q%?T2D/T]YH5WLR@ODM7%>K)VTM5AC<6SGP
M78YE%I/Z(OCWM5HH!D*\^2> ?<Z6I*_!EHO5B^B:3-2]FL@J\/%<\G71K\JW
M?O?PO(XX%59KSQX;$6>*7N62^K@^FF54S%B:OTD3XR[8/@!>'[8UA[?1=<;J
M9_A5&"_%96'3%N-7+E,5FN1P(V9)H1QW-;J?G^GKK3K5(4'QX&;5@%.$8T"T
M=( (!+\UJ%(EE5!>V1QX?>9!N;J;52G(^5(W(-V/]TQ%HH2$2J>R6T^[1^.R
M=MIK+>=18@:C;P,Y,25K(9F\V(YE"! !;W)?+Z5QXC'KBZV3W+;N;G+L7BOA
MIB_%O]?XX.^J5Z1&3$;3\^WN,< Q\,Q<-%&[:?Y;=EG9>)X_)%SDZMNPN\J%
M5^T>GG7_+7[F#,^@U#^#2\> 7C51^C\CM'H,T!4M"=!R5+GGL>4_K1[7QQ#>
M^=)35YG/[<!B/;GNL-L:M8G%$]L7:KJV64C^SR&?2L?%G5=NJ>@"6"L\'JHL
M,8]WF([1!7%T.)QYN"H2V';0S!FTV^F+CBBWV+@^<M[?\;9'YGUR:V3Q*'EV
MI<&3W3-WVG"'EYDK4410/\U%M*1F:KT)F]ZM3O:%]]OP4U/!\YS'@(]P/7J^
M5\,GB=%5@^7VO3M*N+82\(32.R(R?6,OCMA!&IB+_FB+CSJAZW-D!!?".3!O
M$^Z6R@UTG%K:[DXY\(7JI_GL_C%-0;0J-7/ ;+MMSWA#!KS:+<Z7>0LU*$@H
M$C,N=X0%S4Y_NK3^\*EYE)I#AL5B5EB\L]> \BKVV7J%.V^6K2KLB< B?^%.
M-A6CK7X,"#LP 8DB,Q'VT##$1<JYN28+[,+YA)QUOH^3F8]?U0\G'B;*RFB?
MX7#+\M PK?R'N$"[0.LO]P,IU>)QJU^VOY>(A1T!J\3JZ\0,A1E;KYQYWU^G
M,OCN5,@QX.PZZ>6\+1 FTFG*5Q,2 "ZJ5!L5:TQ*#C ]KT*INOJ\/E56M64A
M[?43)[WJM,J=NG33=E+J=5"\B)I[=CR2>_O-E&SH]2K?/X? A:B<W TPNX:6
M7V:W@-J=B7POQ8^>G4O9'@I%]J=N*;W/!M3RK)DI;@EQ4C,V:0ITM!3'%^AR
M16=90-0^QH9[/Z2DP+9X'WC*SIR-#0/P//4*.B\U0Y-9/P:<03CH&0UIUN$%
MF^OR=5^7U_H_1/**B+X?W"T[##7R8#"XJ^V;>%7[3YC;7\(_#^J3!ZYV&\\C
MU3SC3'W'L9FVDPL!MVV?TN-4KAGX#W2'(!LN,OE63\0B"HV>^6E)5MEZ\*!B
MZ9>'9RIS>L)ZNC0UJ9GW9.CB*?Y..,MPDF9]?47R>ILS^R8I5JZE6_IN?->>
MI.?H+U C-X7-EZ:-Y#T&3.;4T$+$["VO%#Q-DAFU7?'GU:>S/<_/QJE.C*&U
M5060A(/])_2LQ 2W)R,^'@-<93E<CHP_I7]_"24:2*)'SGWFV75A$OSUXU2B
M:"JS[O7&].9?I!J\/IB>77C#&?_V VXVB[_QU74-L;?)K6QF+0^M\!?%3,5S
MO09OVX020HQ)8F3A]2.?8#_\EJ#%^LZ4>TU5A&F*G71/[,$EW8"?<W![$46!
M1Q'V9U-\=*Z+ASA^Z;#S]$IU,8K4U=XB[]YA>TC2#R,#%Z$MR(\H;CA#S\+V
MZ6F7=^?S.;-FVUUO<K&_85>?@YDWFQZ:G6YJ6;^@2.A\:UA4(%7,PJ#4Z_I"
M4EL^-C:VWM-7[QR'H:70_W9@EJGF N+P5G0T=G\^"[$VPK>Z\8, IGS3Z=X^
MP@^C]M8N UW!"]&T^#!$2P=B,AE[Y.JT&LAA:--*"L5E_$^6%_@9^H+^3W;/
M'0$MBO,1/&_OX$/&CB3]%$/4ZJO_B^'%=G3_?S%[\C*/!W*O!W;S(/JB38^
MH_L<AK8:@660_YOSI6CF?W@\ZR4VG]\+NU',^/^8>?S_\;B]]7^Y.=<?_P\[
MS*(\XW]VNZ 0A?_!\$F4 Q\@XT!.X> E&ZHA^?;_QL0907]$_\$<LSQ!$VTR
MWWZ)^,"B=0@<. ;\1QLG]G]GCPD,HC^0/!KG(3!J!;M=A>J4'8A&#K-,+=*>
M9F4= Z;LQA![PRZV:?M'5\D:B%Z.MPBRM$4T+5E&RC7MCN&NZBHE_#9P#O%S
M9<]0ZRWPP_^; 0P8@&AM1.SXIM.9?!D(096I0)Z,N^Q!M-X%W83W(BJW/LUC
M :0:,H-.([ZI.4L11;1.F#A$;VTI!8[>VY0KT[[%#+):%(W;E:6P%A(S\+*;
M.61M4K@-@5A'#<[&PMPM+XB3!3OI?[*.OIOR,O)O0%E=#\!S4O0Y&&\NBX:T
M' .JG'#J/V'A+6I8(C'::=X_4 T2739ML9GFOK7D@)$3$9 N2_T0G<+[6QBV
M?XM"VAA4CJPO9OE;JG&W-.#2O_G;H$%455,6R'QG!N(P5DP2.&E_-5=T#*CD
M[D"<VQ 2G&A$$ > -N4I^LTUM/91^]VY9*6H!].)\TF2'8X/153/"D'V5FD7
M?(\!-_;QV]2/52Q4B7<4->2( >D:EL(1W H^#>)?1UQN%E[OF2?I9Z*CHO.G
MI?A-V I"A6/B@;*74MJ5>P.ZSI8,UZW C/?]#:.?[VG#>0A6BQVLA:EVCF(W
M'K$FZ%;'N<M5+<W$+>],=*]0N&)GK',:/7M$1U0B[8W[Y-G? _:'>)#30-)-
M<4K69(<MD6WT&+"7(]4)5[2 =Z JH!U2T6&):I^3%H$<1;A"EUFA/_LQ"">9
M-;MUC(CTUP_B Z'\=E%?/ J?@^?RL'BCC&!LY>2FSB^84UNS-%](&'1+^B9S
MND+#OWOQ"4*:*X\9\_J"*5:+$1.<ZP:L%O'S# Y'2$6J%7''JH:I_1 $">Y<
MO-%;;.$38:^ J7R52&Q(4FXKF4B:$=JEIX+Z22J0?&EM%B&T^*: D[[(;,>
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MHGH4@_NC\\L5DK6>_+;!8[WPZKE0 <ZGZQVGY>XESZ,<MTDW$)MY9!';]5D
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M>)-;12=DD,GC#I$Q99Q%_NA[47V_MP\TD2D=SPSCEWZJ><OFR: 1D_M_J<<
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M39+[^#R_&K.6K88)O!GG-/-?>:$@>Y(7\_2\R#8=1R-:^5!+;8W*QP#;R6/
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MLLWHBD*KWCOVEJJ\N# DS+?5,ISJN9]WH^%.6J53-^&S2W!QJY\)6Z1S;[9
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M;U&AU)AG1O(V@R[*COGF[N),%JJ?V8RS&(ST.GNF%'V+B2H9)%$D98R%'(+
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MNW7=_5KU$%L[W-<JH'GMM0&FI(9N_,"4%D,"_Y(/T1Z:=MB,K3TI3;01/,[
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MA Q/SP#U+-0B2(3/RMMFB?\;2ILDSBE&"2C&A"[W@V*V,9]!5N,_,E^J%[H
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M]A_S#?^G?6-@I3^9241KT+'DDTO"&%*6[+"[CN ]PX9H[%KE09Q_4>,D700
MW3X+=,M\TFOPF6@DZ9BYI*>M6Y!KUQHPKDYPQ&["V)O,IAB/^$(HOC-*LT,W
M1R-]"\V1H,SXY\<+@BLXB^D3YTCF=Z#-<.9]9%L-G]5,V*_&W\#6U#&[-95M
M@:_U<Z3^A7UK)")U](+4_V;>Q_2Y<):#@-35^E)F;D+(ASTZ72'8^3*+!R&B
M,Z68O'@DQ+!9K6VB[X&^]'-H "?.'E^O:IV!W9P/:1L?_"MK@[ 6#/4<9GPA
M";BXNI2IIS,A;-_HP<]2"\#Q-%L2$B,6 5X^"_PVPL,BX.JVJ?/I)NS'SW#/
M]J8#Q(Y$R!HW(Z8N 7H3FM.;%*E@2XNO[=0"\@&GJX^,Z83(BLZB6@;F/38T
M0P8^,^?:Z5^X#EMPG3*+6VYRE!_)-9$LA"1;D;'7:0CL:!K))1!'6'>@XD/P
M)R(0G]9<W/B]^I,;@/B ;TSC<X0T%NJ-%?OMQ&)J,/,^EO$9OP;9?]B\@:+5
M])U?P).]@'[M F\-"&]0^QXV>@S-EL!&#VJ=AM6:A1^T '\"@8_9ECB;-(C@
M@1#'0EVM0*C[$]12 H<[D.(.-80\9!X)8-XG+EY '1E'GI:S/^(K4BTA3 <L
M+('IB"=:.R$K0)P%GID2AIOIJHR]UYY\\=Y*X>J43%O#;'$P/)!D]]Q+<23X
M8Y/JL-7;-V*5WD*:F*?%J4Z]L/&*2]_VD?*2].3R_(#4E.0*Q4OIAO#7(A5F
MFF1V5N.%YQ-$GGXGXE'R]TB^9I="#)>MS(8>TK(B]QV'J%RV*@[EM@EY'7J[
M3F48:Y5W932%F-N=W6WH'-N6Z\Y"K<K1.9=ENFR=_O'+<<TLU-(. 'N !L[<
M9_HP:;X,DPXYQMH;;Z;$59A%L'CQR@\]_;D& \YYH9L/;XSXT^S&U5.;F:=X
MY6.8+82P3BDZC2!7CZ]37UX;\5&F<F@ \PXTBEV__%8.H7_FE]]$CN/\";/#
M_VU_POP.(N.<:%)14\/E]*VEJ32+DF\T>D=6I'W,N377K>H<S;E;TOYP=UM3
MOGG56M,_$D<;Q[TR$N^D;C<VO/Y[MS!<D3KN!*]$GO<^2<-1BRF2\5TD?\$6
M]VOJ&P=6U0[LRRPK/MQH+25I\CN/V:>VD]4G3XU]>'V_*O^.=7@2VM+L0EAN
M^)BW=O'D;OZ9!B$+<Q,O5PNW&I(;F-?5)TQJ,&#":_^;F(5_8W[6P=RRG84*
MR?X]?A4+=?[+<[.36><LW._+>K])#?7U><S[Z'30V"@-D!D$3>CZ;@1R!^HJ
M&^SO,EUK$HS][NNEJF"K?O)M\O?[O1,FCZ!B*88A"Y7@0.$"DAXDPHI:C#U0
M*69&DO@'AAP'_'>YGJ*,8%_B;:;$(7#0-!_]^767;F8DO'V8A8I8M(BJ5Z2T
MX1#<=2VAD L6PG3BF?RX6V@:UARTN3Q,!S!@H:H5:-= [4Z26"B1Q#BU#U2V
M0>A#\S'?C^AU 8S:!0L<S8HO"#>AZPTM,BANQF;20W^+4I]T)Y&!!;$OAH;\
M>3 ;P1'B2ZA4C32V0$%?;]A%MHL;"0#VKPO"0AJ=T0 F&NDQ;,[T/*;DJ0J8
M*&;Y$DWD 4(_^P!4!93*S4@689 >.,I"W:ZN$N\8LH=D "SD=X6K?O&23!A*
MI.@X,2)QZ 58EZT.)8\17[7;IM-A(1T.B+E709\SH($^]E=C.6F6#*6NKWA+
MPVG<UXN7:E,+PJ@_O^[.V!/-AJ4^#VMXRU>UV]@>Z-*;:O.I7U\&[2>)H@,'
M$L*(LSGU.CPE>9P=R/*@46+'G:+M4+4"90KF;X08%\)H5G+LL'SFR6O1>JU>
MA@31\1\/8C$B/(+HVP^(DBE:<&#N8D1\G*CM:AZ:=_I^Q*\#>8APZAIE2(V
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MY\F\ JHX-Z^*S7-"^>F2M,]SE03UY%LL%/XR>P(I9\A+(?I;(%3KUROL/)9
M5:]]D#W[WX_DF=$9GR\^V#7@M-\SQS)V7I R0)"_7$AMU<BC%X/HIZ?DD&UE
MP,<MA0XRUS:K?#9Z<,@F?\+/:\8$:.;HL^(\^ON[//\97\F@P@3K,M#C(X"Y
MC)J@X?*A"LH6]-C"':!>HCNU%H?(+LJSF-ZO14A/ O>M B8< 6C.R>:G*^R*
MF?7BR<Z/%?*^ZH_Y^>F2=-0)G(O.V[.R#"7 =;_AJ(G3+PL?(V8JEMPFC6$+
MYN && NV_?:FDVW4V9=.@H5B$?2C(F .8\-/^@=/B!)\$P,7*T&N).PG)?Q\
M!5&"/CA]L*70WS_ED/WKRMLKZ/+>AY$C#+T,]$-.J&QM[\>SLZLK %XLEF<<
M!F4)=4%S=?K3!:\38.K=H<6@@W+8'#0,#DCW80FH&D,APK^GL^OAQ_^K/5=)
M5+Q6@J.!<$H,DK^EM\)">(0&T%/G>< VXSL/C4Y+P8J+0G*="JB[A&'G*4\F
M%P1DPPX(]+1Y^/]X<5%,8*LNT3<G,N0Q"&&+5O_URB(*JQBAFY'W5; T:R@0
M/8%E.,TF-(Z8J55RFSB&93C.B9@]$LP[*R::\B>Y5=$!9U*P-MB;0&6PQ6&0
M/%1%V<@'(MPW[S%G482@@0<EY#O1K,/8#AT7:N2G"XY(=WG:"0'%]\):_)IN
M)'(E>BVF#T]KG2T]],\7Q%O$&K\MBDW"-44F$PTB\0;;.X:2R\D3Q)#'ECC-
M< "*S0.,W,$K!?M4C$#=E_::( VVEB(" W7>)I*UY@KLYTO#\6T^W4PM?G;M
M8\;VQ\B 0<+?%GD+'4D4:2%YMG/)F[M&_3)21)X)G7?9-YCU#[=M_T#?R]!"
MCW-X49GCA?M:22N0&7Y:U%P C(![&8?8PG5BK&EC*QG88'ZVD5_DC#<;L?(^
M/&>%R#V1"G#C_U7>0MAYP]\B32Q:^I<+_Y0WS!KB;)K<.7G[\<+/>9,,&B9V
MQ/AN08H+)&V$76P__M\ V7RD!C;,B[_://?7O/YR!8MT^=+)55BDJL& UXD<
M@OYB@K5MV"J>3:SAS^[5LE0(!>KQG&8%:-?E2OLU+BZJ/>WV'(,+P@I>J)HR
M-DH<P/2'ZB(&B8#!C1YSR]BP5>6C(?"CJAR0;Q,_R+U8CHU CC?Y1*#_C[TW
M#X?R[?O'IT^+2O%1I(BI*%O20B),&Y*0/<14*EN2K-FN-BEDBN23:,J^I*D0
M(8.Q),F^KT-V,O;!S/B=U\Q8ZW,_]WT?SW,\]_'[/G],Q]&XSO/]?K_>K_=R
M7G-=Y]GJ-U<B8B[B%P(/ 06/+,"0)@"5WI[E"3W!K=.?A<(<3EBX-FGJ:OZ%
M".KGFH*^GTY)@?FLLQG'-"DOVM#!\>&TE)L2RU($%PKC.I4D#NHDK20/Y,<9
M1!9Z#L-%*K+T YM0P_-@:, (!LUKV?XW6B[!%":AP#2*#N$,XA;^GP>1W@;\
M[X_4F:ZJ!S5*"H[LU\OGL$?7X=H.#DXNL91[W$,,A/8,8AD([B1]L 1=5P=+
M0,(_<_AU,>OO4CWH-(/,V@!A\"1NP!@M_<N_Z!8-E#CH!BO!DH\G"WR:2UW
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MHAI,XKF:@Q46LJYV#IF\,I//I(GQ%>2*H>-G[K>HD"^WL[?X1DRDV=4:<81
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M&^)K*J?SM?&]\82"S=[P^^&$FP?7>L:6Y7UGY1!.1Q--1DS4U4LFW3"KR&;
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M"@=6VB4I,XC;<#S)Q]-X=Q30'F#ZX2.A[MV C_!#$3_LAKH?T$"A(BM+P =
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M4$-[@,N2H B #I(O?,G_<1OF V<0-#ISBN*H'.A;Z%D'+/ROR<YY![30U"1
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M^B9^'_Y?M$W[[Q=M46 K-5+YS#&"MEY64F7MQYHY-(BB"^R"X^\[ D\,^;W
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M-]\[^36;N*;CUKNKVG_>MJ2DZ+@>+PN:+&J]1V"@T M?CJ#>@J?N37ZA1<N
MZ_6IZ4^#3=.F=8&3IX J17@%.$IJ;DN)0;,!QU[R0I$X-?J&[FU<4_=[$X-
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M_)EQ646V9PU0$ ?M4>Z*3]='7.IC_-3IYJ86MVS\>DR&KT3 HTG<2A1R2UG
MAQ%%E5Z3XSIZEK_Y?I/,\J>TI31%U.1NQRG&O<]XZG;F]RI7HYJ3 EYX8IZ
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MKJH6LBY#1WEBD2?8%7/QPUQ^E(C+(_F@B+A%GGH0_5^SZ\>&=@VRDVXW(;'
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MPILD[[!7IJ_*IO[]7QX6_X>#.+4IZR@JKSP^1^*A$N';4Z< M3ZST1GNKZ>
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M&I:CKWUCS*D81VMHG4I]XM\(Z0NH<! 72=A[ 7YE+?!V%?(W*?G-B#BF(5J
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MDJ1>55UL7EU]^LN0*R^^G!UH/]-#$S\Z,0>L5((W@]'^1""%!?&9ARV>R#1
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M'Q(T\'FJK[HB1+4\76/%!,(2OC&J^9G6>@R&U!/Z<+"B.8H(4C\#[^75)O%
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M"K+OR'ZPGDII1RI$G]V'XF$:IPDS\)D3K88"3>6TGTYO2:A70"<0VA%SK/K
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MR</)17OD5=F\%8\UC=H;=.X,Z8R/]SJ9K-;=>1(N4'3].G[*SZ\YLSU?J+U
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M?W;"YB4!-QB!\0'E!%!B9\M \5JQA:R46UQ80I8#CUF! .%4%KA>-H0*<9W
M0\ELF!(4:5LV%7( ALO+HZ-"Y,?P?53('Q9 6<'=2!_#/,HLY38E$CP-5,)(
M[-J@!:C*>A^_QRM:HY"F!SA0(>"Q7<T*^(FB[ +9K62(HQO!=HK">CID#U(A
MG7+5!/"@1M].BQ\%QK_G 45\\N2 G*IP*!$[%TR%Q,\I3%13(70:X"''K0Z*
M;^^@N;%;<,,,ZU8@2=J 2NOO<%JRUOAU2JVR=R'BJ)_0E8 O 24VM(#[: 'K
M+ 2\SA)<K$9AP:G;O,\K8 7=X^NB.['>$+):[F !8@SHA0[*JI'2:!L$,W=[
MZC,Y-V^+*BFT&L1V*PU;.,$"0Q-'WH(X/%#CZ&"%FW[><$E0#0S34%[*#3"!
M02SI_;PVA0T-J@8! T5SI(\$UA77(1I-*Z;F8MVED-@.*N0KK!X9]4M%B/4N
MHM9:,NL-X?TYN<S)A,\*)S$87 Z)1OSD O%"0)G/;]&&&$<%52V(2.$+;$5#
MK^&M<87F5(C$RLH@"AMJC<_G _56<YA\*B18^,F$!TEL&2$T21*VACJ:$*K7
M".'ZOL65KS%K\@2A!-;GN=9GXK_($\!E_Y8GL"[/^#_+,PB:Q?/X,UCA5RN/
M9R'\@F7E53G'+,<+K)%M+8!OBZ")S?XO%K_Z,]DJ4B$E5C2Y#?W2[3I3< FU
M/],M#PAF!0U,]))NHV:Z\:RP"01\&:.<:\3Z/X57E6#!L &HR5^&) 84( [/
M0&9K7!%@YK( 4=,\?+^4JTQA<RN$32W[,/Z+A;#ZL+A?+H4)%E"PM]3D(W\Q
MNMJ266_++T;5K5 KC$9C<!^1(![RT\N,NI"S2']@)Q' RLJ'#Y=929!27<4*
M'-]: '(?Y?"+%8FQQT!_!V6%E)5:$OT3MD+*1:#$@D!'\1K[Q<DZ0W#)E5KB
M_VI5J3X,DI+;"9V7Q*P4D[66D-B58G+YZJ]BXK8NL)IU=L0G'9E$?4*)S:*=
MJU%E()AC%U!=M4]L:*BN8#//IUU%'H8/:JQR%@;%7W'D*4[N(VAV^A2;,U_1
MT\_[6->#\=M"F7)HVBQM/3\?,LG@ \TP\L&8*/?WC+L]1XL+.#QJ1]QY[?JM
M]7WS=LCC;J\F0>_HQO :Y0"]/CTZ%ZMW['=?1,DYR*5'M_7D<TOR"?O31OKY
M#34K[Q:\<NEI#M05M5]:&8_XE#K$P=0H+DBG[FD^.=Q[/ @^^KZ_DE+YATQ2
M1*37K$CRN7!3BP#C!+G^.DV51R;]U;&<5,C3$#,]/CGPZ#:$ W<-P*[3W5<O
M-(5*@U=,!QZ)FCA[&53C'!X@[X:[42$$1DL0-4$FZ:1YHTH@/OL(@?=C2DWX
M13E[>5%%I.]4(TFRVAG<H$]I$TQAJ \-NKXB*F3J+.U>6:=*.=AHTM4JAV;?
M+W2W'A2%/HD*J4"!C1%)@%&>"X.3'&G;QX6>6H $EUQ@!J,">R5 :\<'"S .
M#-/,/!1P?W>V8$C!_P_V=Y^<G\>A0'J)H*&ZAX8J^\53:E_R*#.7/K*M\EA.
MDLRB>72FO=FYT&/!8^N"1]IW.'7*E2^T;MHZX6GH?[0.;,"J)' R*LH YL0&
M?,!A#"SU-5MH(_D322BMYBX:LMU(&VY@905&D8DBX(C"L,9?(2T?53 ?"$"#
MH0Z#RR/1\(060A=%PSNDKL8K#,L'ZRWHC O<V^9PRB5:UZY>"(MV3W;)'VK!
M'V'9GTED7%#C&%CAP5&J D9BTP3[B6P@*,M)FBR!18>TO=W7287,'Z) %JE9
M:+W_M75!\-;RHA$JY 0M(9"O$QA\.P6<R",9.AE(6S\NC!>GK&F*.8P'!YH5
M/,&N %9.$% Z/!U8K #:!+5N78J[E*,32(/\_]BRV\1'MM(^<X<H&U:TDK9(
MRD9:98:"W=+[U9)85J\#^T_UHC>&96\1B]Z@2][ QJ6)ZE@8"OP @@2:"CGJ
MR U"WKP(^;_V!W8"]/_'UO%BLE2=FX"*K4MH"I,D%9PQ_<]LZ6@M&MP(]RZ_
M&J21I]P9%C4'3BK.IE3(A%$M#-_.L6LUZC!<CC3[PMZ#+986ZWU6\^1A<.C@
M_;5A?1:M.Q.6K(,CG0\=L$(ELGVI_/U/K'E)SD8>!(NC#V2Q5-6YC8R_&8 6
MU,IN18IDY%U]Y3>Q#:U_M6G8<"/,"]F&>A3H?9TLH0I.#?=P/$,:2? 'X<&#
M&#:8.>PYEF,JHTX\V2YYB@7/67NB2>-+Z;Z'5P_>0FS,G&A"\T>ZF_+=<VC:
MF;OC:<RPR,/NR^R1?IIC<7ICCQ:^#)"7W?B-]1MZV$[;.'6\1JYYHO&\2V]0
MPHU,@E#R46-#E_SKKY["ML^2V2C;3;J5*[>:(^^^(?!T[;SOE22;$8UNJ7_T
M*?55>>Q%+N^,22\F(;Y1V[G8LT&&@LIL\F*6S1ECPHH"BDA:6Y'>40),72 Q
M+-? M?^FG0J/4$*E4=/,1ZD0E-7R_D,3;)E=P5KY@@!=K)4^Z_\#/(EZRY$E
MH(-"*E2([,]ES=3!\7AA>G#G,N)A"]V.]J7I$'PS%1+"TPDL=JBYP'#V@Q[S
M]U2?6"'F9H67ZF#(PEOA\%CR'MC&Q8Y'JZ!4" XS?\2);JF"!O='^0(JOI0H
M ^SD*'Q)WL=_NP[<%K218U6>8@MY,DRSK4D3[$D+:U>BA>*QM*61OV*-<)=B
MGFH"XILE2<2@I:8+'EX! H+R'/4$#/AH-\FDDNAD>\]G;E6<)@.SIG>9R!)[
M.Y&A%-J/A6QIH$)ZJL'1'5= ^T7="ZJ%BT,/.'(ZKK8%G@GY[8"D#T ]$K5Z
M(>;?K^/]24D!-WX%%=+7AEEI@F-K^9?$KJ71)-(;/C@,6^?-;606]P'H6;DL
M'(1I'(=>S43Y3;_$X_"ZQ6[VBPR^]5>"7'27P%=1(5YS_3,F=EV@5]==!09:
M[HI9%:?9DMQD55?+K1:%QW(<6$T8.&Y)BZ_"27Q2=Y^5\ !M;)H ?JD-/ 6X
M$O"-:\6V-L.0!:V])'""PPBP6#[BUD4%ZL>''EA1#[)1CJ9K^*"\*LGO5^=<
M<PUT?<"TODE36 )X&%1>(6!]&B#=2%NSU73G\/;0T(\V !6YG%4@- OM^IP*
M\>/[!4?^@AW-%3B,!Q:"A-5[HN:X5W"$XSLB:&$)_.N%YDLXJHL"/<L[01$H
ML:>%A5X*BW;"G*+!"E^"M;$J76V![8L5M%_E6]7(!FA@%_P221U(OQQR6202
M2_MU%?BOR?G2)U1)OLNF:\$M;KO:N5EOZH]H&F=N\[ZT27!)6N<I;"6K;8/2
M<@-)=%^1%F))6JM98R @&$#6F%98Z^!8 \]<P9^P%@W#Y:T!#61M783S?\*:
M'[P54W(!_(]E;V!_1K@"8(2<2Q%:7$X?#((.]A1L [OZ,HA@^/2M.!0(XM85
M$+-*8&"B>Y9 /*FF'#3_$5,/-O45ID&=X]L+6!=R\5FF.A<I1HNZ:&FB=MD'
M5DC-Q<ZY!#ZP+B2PV6)W@H63":^P*'V<W$%,0PE9<56 AV (P2WMR$KX4RJ$
MH1;GA NKEM8?='DL_A5YA9Q7<(2D\IV[1K_^&%(8-_=$HY8D8YSCF+:Q05'G
M\S7OK4)GV9/*KH[6-DQ$XDF<K]3B$Q/YU6_&\? US^J,:C@9\T:Z1PTL/+"(
M3LL-+![EZ_2[:.CRR;>"C<FXZ>#3K3V[[3['][,;TZ5XSH(M""B2+SAL?.K$
M*<."' :?$TU;ZCT^:1P9O,!2OO=IBFKN?JGD:H*MK#<XAJ/H2'L-++3>32;Z
M8S=*,YC.1;JCC!A_)MW74%:W<"J2RY_3>5/0?Q)=. ^G<.R(!#'@P!LMB02O
MRTQY/NL,6^3:G7?&;-X0&)107BI9_ "XTT#\5U\&[ABWI_V8*84\UB763J@I
MI,'KP%;%O=2J F"@( &"K9 '2))#$6I)644/X?.<'3N7JQ5OPOUS8)'[ *<5
M.=:K"T>+];;!]L\,GL@C93JKEV0<Z1YQ#>SA_SA"?O#X^@_C2Y8)H03#!F55
M_L*7R0 1Z'^7386XP, 0%R?]P%@/LE;"_;-@HUEH^J)Q-'$)@.HGTM"'TM!?
M.")@<X3)H/2W  N'T*I7UR;>T*H^XA<@8%5P)=< _3X$L>69$=$.>@>C@>&/
MT#C[POMSG2.>?^]([8LSV,TPM&9V5Q6L.*H4MED:S LYH$@F  Z3KCK/20$G
MC<)@*F2AF5V[]!%Z=#6 8)\885P(!< ?!6B;F7AAP0:6M VU4.]_@O].D(+1
MYI"=";3JJP3.(<:H*042.+(\$5NX\85MX5D(#2R1EZ@06K.E4<7#\P\]G:5$
M+W7U11!H79T<"8 8("B;JBDGA$?F(L&QR^_7&BOKJ "Z>7\0X>ILH/,+:K%;
M_G@!2@(HPA#VP!8Z[/2R#55:0V&*6Q#ZVNB$"8CDY>B.+$0WM!S=5M3"C4=P
M5]U>%Q_W6MNTX6@%&$;:?;Q6.8XJX!*L/FQIS+FV4*_!H6J%&##2LC!,5H&K
M LEW-8!U=:,UPXU3Q3J,JW,##Q^9;DNY,2[F-O)V020+ (E/.NYS$">+ NL<
M@ETU';9*":#^S!E^48$.[8]J1@^XK<71[6_Y6K@1"_S2^DM0ZS/?P5G/AP#.
MC7\8@5O)AB0903/DO$A(8U4&]Y^@$H7!Y4W!YKDXEE$!@Y1AH+R@6R0$'6;\
M)S&N,[UP\X,6XZ%ELKW^+$9OVCT36HPO;6DQ\BP^\EKCO, RTL<0$PL=O*RZ
MJF[48/$=]E#R7@8:3Z \:$U]36K?3ER;2/K',3+I//_G8/C2_:6;!ETX9;MD
M5^[I&X?Q/FY(MD[@^ WZ;\&QKGF'9D0_:V?=?S,]4U[]4&WX>W?1#7Z;  X$
MGY(Z_&%T'=$+L=<VZ]IX6:I$W+M!YI#8MU8VR@^LQ90Y48_NJ.):XNON4"$:
M? T\-65AMYFV"G!_T#X4Z<[+^Z?OOP2&?=]4=ZFVV!0^FAG*N3B=JQU5CC]_
M"-3@>+TI^3X:QCK..0>4)Y3VGM2ROH(8"T3Y;__M03@%E33WA!Q!A?R4[&"B
M0CY4,U BS!H^/TKJQUR=4_"$_2Q/(C,,S+OSHB-DFS)6'HAK6( ;"BI(&9MF
MBM'=-\-_6&Z?ALM_\KEYEEGX^"0/L7RNWII[Y3&Y9;#+GSX&AV,::#?ZZ*Y3
M(5_.T0J!P2C(ZN6;X0ZL4&)C!4JL%#4A[!1/?DV%/+4"OLC(;J2MI;U!-=1\
MJ#FI#/BSQ^830\!>O7>S[S&%;I$D'Q2L,P;^(1J; 1_&V=R-*?Y 0)5, "8#
M&Z,N#6[U SM?W06N#77VL;9,A&1K<^Z KR^K#KZLVK'/3U+]G>>NK8<FMLHD
MS1]#OP00, *WO!=195!3EA\?4(5V)9F(M%MQG9]AOY'Z0^7-ZYX!8BD=[%-T
M> F:SOT:N6(84++EZ?H&/>)1\<#-=*_-LVFDGT-L8![: >W2,5B5,<<F9X\M
MA3<I=_45Y0X<^8&DZ]KB*JK0,FSN-9W$ !=E_R+62.\\HJ- XL,P4R'?D[I4
M2?O!OORI\5WBV<$06*I(=J^N>VS2[=3=87I52H*. V'M3+5 <>@X0-Y>P 6B
M;8 EJ4#QL20X%7(._0*&OP'N7T;5")EO/B,[A4DD'\HFS-?>_A1_RCXL.!7T
M7Q_GH>P VUT7.$RX2'91(?-,2$40^ H,(42JNPV6+H*9G( 1]E(A8N&77PWV
M^W?V>8#(^VI^0A&.A5(A+^* XO!QFU7.#XZ/*G\5R:)P 7ANBI&DW$,4/H[V
ML>)?T8#)89F!7[G55'. /</X-M#7\T_6X,AO7<#^!$JX,&AN$8:UD4!_,R+M
MX#;CRDQQ4@!K&KSW07<,4PV#<X=0.<F] !R?B^Z!BX1)?&.@H^0N&&E_%>CH
M!W)\5&%QT1BXY)4FN':[0REV2L#6!QQ?TX#Q$T!Q!,UOQ[()$ %H"PM\;@Z:
M#P1_4].%KC-9\YN%!^4?@87\G:8I1E)R#P%\7!XM\BRP >&UE_)?:^-7_L3&
MN;#.(77-,[(,MKFPB5]6QPA7*8)4R%OX)SA!D,955(1,"?'\#BH$QCF+GI1J
M$8BDS7-=V'DF$C@5/6T&.8?A5 E9%!=@#]"9B: <];:=95C430?F:Y]QB@=E
M'Q7B ?1KCC-3=A@NR6:MA5^JL:>))C)'^+<P?C/2YW.?\KT8+-6?R4.D;TZG
MK!_N(4''$>3ME"-+F)[^DS56'+==,./_(!7F7SRF:X*7;0=*,5,"!(\5'E%K
M?*[EL4:7F01.6_O!78GN$O[%Y%H;JYDTW#H@]_ \CL$#',B.8)YCEIGDA^X'
M5ME8R^0(4PU0_';<:%4<4'P\\@:HAE\F5G3\*Q6W4M2:5-::6)M*;5Q'BAN%
MB<$#]@M/$TTP4$G@\^JXNGZ1\G7[ L)R7=5K$%:S35N#,.=O\OIW*];)BXEY
M=5#&OQE8IZXX!5TZ$K_P:CSKH@A_M01%$^0UO6-K!;G.[5H]/G+OQZR-V^<W
M"W^VL_[+J0<KR50$PNC_@8^X8!OF1CQV]5;\=YGWZI8,$1"K)+\67)K@/=8H
M[8$0;IHDN90&V#^T^$W;/'!0#TD?0LQ*7$$4)AYWL-MHC3-0=L0N^OF\*I=!
M 7#<<U'LPLSOESX/KAE8R$7=%DUQ\=D-#I(Y-,#NML'U2H!%2NS=^X%UKX.<
M1(!GS[?ZGV $H87<@FT8T+<QBT551NXA#)\@K0ENH_+G %YW:2>J@M/2]]0N
M*(EYH:E\S75K?+^,5T1D#G2]S1@P3(4N<.82+0<WXZ(5T5'H2EQ_1RJTL'!+
M89V6>PC'Q^>MW=WK,:=%];_ 8KUS# (HCEQ3#TXB.<<-83VK^5BMK?F_QP?J
MOPUOU'J=F'9SM\GFNRX71_R0N@:>H-B51X5\7C%;A\&I$Y(H+JC=P$)@KZ)7
MNP'W.P/A6@$_Z,;H$W3%C; [IO_&.-V2%[N7C@ZKDG\#)J_<A9[?CSS[*_G5
M+KP-?E'NY-Z_[E6?W_P%T_T*:,LI:P1/,8*)82YPQ;P-B1_!!'Q/ZV)81LJS
MXS0]T+50WZ<TP<NVAY;"IXX1G,%=5[=0WV/'-<D[9 ^!?#ZDU??/JU B,WU?
M_SH4GY 'SMOGJI_#EE7[:V_ Y![^_OIO$3D/-2TIRO64FBZ$H-+U#OC\Z_7?
M0GQP:'Z&;:E%_1^70G4-K6^L??E_- /#[0_C-":0/.-7H!._/(P1KE'X89.K
M0N*4]"Z!$_[?@=%KQ5D3,SLG1D(2@N2Q<L5I"I.".]!_<WES&O?* VLWVS7;
M.(H+>F6S7>< Q[*W9G^ZV19V__H+?G-P=GIXN8/ULYO1=K]:%VI^?][R]J0K
M]MG71Y%#_[[[OYX2 "A,JNZP?NU&<%2'"R]BBMH'?,]"@X6R +[V\NW_>R]_
M:)T+,A!7"IT2'*)"",)!M ,:3S%Z'UALIFF?4:Q<X/C9>),9L'<!H.WN'6"Z
MFET^\_NGQY9>!TV@%TQ@%RU$!>]9 :@H,@N#NTZ(HKCD.X 43U A-(Z3QA7(
M.^QG*3M^KL/SGUX>%]>>C"%<=^(%"4/H@8I 8D@J,D[[;:- B2RO,%&Z&*R_
M2+%(?/+8^LNA^$22&BCRCGR0OCF $!)AH-KXG@I9N-[X;UPO!78#AH5N$+7E
M;\%#MV)>X:9?9GDQ9I\11>Y7PB 3UR/6N+QF &XS@+;-6$YHS)+XJQ<8!18(
M]5E_L2R-X859M'\!3@W;=7"^^PU.& U.SP,"#A0FHP7U8%;$L]J5]S^T?"'O
M$0>(P-\SO0[SB'68)TG_->8WUF.>]B\P/ZZ@)&"+/#8N#^OY5\&@:%60"@'+
MX-2M&FWL>M^P]8G3BAJ45M3DZ9GR?W.]/O'_V/A6<)KY3KC1Y0E.,\NA1O^6
M^M=_(!5:=75;J*XUSG*(]?S]MTR[AILT?$3MD+[,0/((6=Z38.)(L$6<ZUU.
MW(W;2N\T VV&64(QZQ-V2LCL%XJ(%YA^G644E8,9U\AVS8L@G5A&X'OVOY(M
M(93B4K5*MLGCDN0=(;]OB O$] PP<*1*%D7NU_6@. N.@JD^6$X5+LHS]'$5
M+JM]^ZR_6-9 . 6WFOZU*,#61P?2/[JDK8W)B/6Q0G?DJ:#FF*W'2)!EF=]?
MDKEQ,I9PG4+S;:-+A11N6S"N23/>;D.%0+B74FU;3)5?P(;"!( @ZC8"^#\6
M U^[&-QQ-DL[;KM[.Z@->!=BGMD:N^1Y[6H0<MTER(LCLX#U?M>OCNYY]X^N
MC__?%G@Z.#VL1)( GI@U!.!KKXCQP?F\.,= B+.N7K00P[="D2!3-BC<RD^H
M*6$S%&'#HA8%A/<"W_-3@,Y-(/W@[E^F_W:--@K_+D\1I'\&7/9X[Z(8/XSS
MD'>T]%$@RDM;;DE:#S7ZUIJ"_K;XEU;8%P(I7Q<( RC,W*75!S\'ZX-2J5ZV
MO/HUT+(T396CORP?<<IVH]B2^TLBLV X+5L:.P]6L7-[ =+J7RH4^?NF#\WW
M0N>Z9Z-VA86;F5&8W!:PABU@'8;:*;V@[R7+<2 <KX$^D/:; @_67NI#T.!8
MH%UGB?8" Z@.2*3T,M#KW +%[VD[*>=? /UO8UX&6D9VY!X5LM9872,HD4=@
ME<Y? 5N]#&0] MR6O,G5! T]+C!2!YV5;7G#UI_B,K(":.\%QP<,I'%BC9N<
MQ7I!_*8O4%"W%TR+]/\=TV>GO\(FR\' %;5_$Y X#TD !BH, X:]<[&&KV+]
M!@&T1*99NKO$NE&7ZCSS=#5IPY^QOMH0Z(E$\T2A>1)=R[I[VV^6*$RH%[!^
M.,CLEL5:LH;(=9: XC0:0/,@0+0F5?] P.WOQR&._+\AQ:/"TW?"M8^3Q,=9
MP!/"/DK6\A48?'*>'!5RAMYLR:.IE.]"KJ>(-1YRU@6LA!W="%:X8&803GB/
MGE(YG2%*J'[6D-/4Q^H,.AXP1!&X8Z;+WB*2D I^IQVT/EO7),=@N<I3N'UM
MU09W^SG*&9U*=6] P5"6$:JOU*PM Z*<?%6D8!>3G2PJ<^70!&[$,,YR\\_&
M3_\7>V\>#V7[_HU/2>ZT:"$AIH5LH85(F#8),=FS3B5)0D39IU)D#Z&$R980
MTV+?IJQ9LN^[L63-C'4PR^^\[+KOS_.]/]_?G\_SQWB]YC+7>1['^W@?RWE=
MYV*FV1[Y/,I!FDW?+EA*46(:QLR0BZHR'BUU4ZHUFS23W'I&XF!*2HKW3==]
M+[DM#WG17Y6 [3@F<'=\2/U!\$F$%^FKN^"OC+ K>5]2)CVHUQ*#A^93F_[A
M[.=)RM]V7#?X?2$%)3N'\?^_9W?UET##-U7_TX:"_^_S_S[+GW][MGK5XH9*
M1"F0$82E40-H9)V*K"-QNC!QY3SUK]8K?C40^UF%D2\RF>^_.1%R^5.\ZD!Q
MPLNGK ][E0O^PQ'J%.H_.%C3#QJL(_?*;/A1&LS/84INI/B?_.;D?SAN/5B7
MY#]EG/.<NDF:M9=E@@8;!5#0[R98C P[G?(S_V+[MN 3D<<[^LFA%.EG-5W/
M$2,?;G-^PW^FP;JBT2F%Q=^8-K22T&?3QQU5\)=;]PC>F)R_,9X<5=W4ISZ=
MSQ4O.'%$6\=.1YXMK"WHMJ%_P11WXU#HUF[R27;%8^46(YWY++%B:6:_@Y7$
MG&HZ9VN+1#@$>B7<_'L?VCX+"&W)?%Y?(S_09RKN$/WQ8^O#.9?"3H(FSKVE
MK\U-*8WPV]T"XW<H^>2/*)_$PSN1U7(&@>XT&),<"03^<XE 8?K[4&::*&29
MIY=A*CG(I?'<K8*?*CQ"U4O$![-JO W]RI[F]!Z?VW<K]_(<G,KE2W2CNN@8
M4QF[%Y.66Q09V/]=PQLPID@'1< LWJ.6HE:"'MB+H<)P/\JHAXSWHJN*TJC;
M@F<Q%VBP_&HJR&I5IE? $$4/ :6R2;078I*]%D'0 H7S'I24BMQ<K#_XB1""
MO ']$EUP!5\YMP_:^@A</#F )MDCBN!SVTTP)$&WA?R]7B337QY@:*@^CIJC
MCP6I3V2<B>0>JDV#76#O))U ]3OM MI?)GT'VH>)+&K_'(C@ZP6?9(.F%6HQ
MD;0J)C710^]!$78V&5QAH8(\NDO<$S%@J$N#;58D5T8BN@?A^Q #)V. @9/@
M!"""']&%ZB*)6A"!<;;# U%_Y2WUB0GXOR#9A7K(8A6"B^C\&IECZ"ICQ04
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M22XZBEOJ_+"JB )F9/^*_NJV:^_'DFSA!=!(2!N]W/NZ[]F:'HA/5IVSQ(4
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MIMWML^QFS_LC)+V+SMQAUZ1K9-R2&(;N9O*4$KQ;.Q3.2MS[EC'.D*?AK:@
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M#_!13AZZZ33D= 6:'"5P=F72H;W*9<S#H%>IHB_ X'_SPM1&Y0L3T!C_*MW
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M]/NDZ9P9I]L*VIZ2.AS+QC,+L6U/M;CI/'8=&OVV%WK$L-!?+::'=^X-+22
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M/?*GOYZGI.Y;HPM5E"93C-'I>,<R+2I0HVZYW9V6D5@Y=71V?[Z0.<J+?Z2
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M[85TWS_F<EVG[GS4FBX_5G+6E[QP#J Y!SA%3\ -!N<-/;Y"T[EJL!$B<QS
MEA\/@G_E8R+@F-SA;?N:FF3(AP^A4+M$4Y$=!;;$%WX\L2 ^M,8U'%%V2OVI
MXHCDB$SADL^K2:^7M?N!PK9/U^1T+6/G^/$KW?590H\-# ^@&E)@US5Q5[V\
M)Y/&P"+8B28)5H+@)D8NO<$)2^.U1XK-*)['>RN^,Y"UX_[X_:.ZOTQKT^^4
M=BL9@GI2F)0PI$69_->^KC-<4:]()+TJZWB@A#D\O>WU=:Z(*-B0,L_*P3F
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M]B1CM/R=5WO@R((6G8GC(I[$M+39S'4B&2.%)G/$SP>OO.1*Z6V8\KH;QCU
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MT-8S#[GS)AM2^2UV%_$F_OK!7?*/9@NIU(VXNEF2 >K&.6"E7/,<\+9B[!S
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M(2[?NB<M-45L5I?5"G@@^/R+LN-PWD2\ -#4;P#%.X&I0J]GT2G#YOL:H?#
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MR$'1Q?<U@1A1 DH:G0+RCOG\'1A&YQX!H178Q(;>XY[';?85*_HMSRX3P1G
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M>6K5)7P4A",P23(+K-O='LHW%&S(D;MU@SD4X_<*NFC_1Y1TLCIG2;!J@O[
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M.;4J0A++)NQUT![NO!H=)>#X+N'L]5)AZ?1UD9$=!9N%9?Z2XFOG6>V$I 6
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MDUCU"]#J+BN!EB@IOCMF-\(1J;$3<$4)7"50)![XH.:!GW>T)U?("8!S!ZT
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M^@K8M=7.J%[.O]!YK*>K>U?NZX@@-41:3=0\SBVI1E4B#6D,VY!]H'SW0&_
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MK7%TC,- CYPJ3.#):+R)=&(FL0 =**R#YZ NKC<>/<=4_7@7R/A:"-N\I+6
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M%)R] R$C9;>H]7]:V:K?!",4TJT%-/?US#845'AS<QP#>@U]IZU'459I?B)
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M'Y;5KI.60IGS]3W)',?9XS^-P'R)-ANH.Z7;1\\/ Y34M5OBYVQ4&X0@JZX
M*J&$U73;, ^)2,5+Q.<.F73DVEUE'FW'XI[L@:+YN6MTLI0)NB6!.+51HLRE
M^[_F8VFEEJH-&?'*K%,!K H> 4J4H9.3S([ZND?0K++:!G)E11VI&71\N*]$
MLP#LUL>J+V5TU9 S&VM3BGXJ9Q7^[IVSQ.SP<OG;V%.%*G6I>ALJBQ/N+FZ
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MED)"8\QDALV4WQ:5H(M]/(-)HD1A0F>^3-W"#BVA3AO/UY)?KT#=7E/>^!E
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MS]0EDL'ZQCKH,4SM=G'B2 'D[YI1M_Y,'%U_[;ON^V^9#\8_5I0H>TZ#1?%
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M;<@ %H<F9N*M/ 0SWJCMW>0&T*E>TO?^X"$HV^]#VK9F](/I>$ZKB-##K[B
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M_+J.I?K(QQ3K%0\[DM[6"[U(TN>9?^FM1E J1P>-64/;@7#'>,W'#<2/T8;
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MI#"B+38^J38]#4W@UM/5:TX8K!F?]ZSJSSE^P"'PYXEZZBG\VI\C:.8K("Y
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M$%3Z!T=/ [9V\K.L-= 7Y_T"%W0<C4F@K9VFD>#4$&V>F'Y%P$N7+WN5C>W
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MZ!MV,/40+,*0W V>91LV8=(OM#1/.B@(A0P_8LE\<?NY^_QJJR]"6O8$P-2
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M A:,!5V\/U^GFMA6:=$5$NW!=[.E*<[*L:$NR8GYX+6SH LNLX!7N?Q7MUE
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M.#N^!JS??Y_?3,.0O,G0>6CL_\7>?X<UV2T/HW 4%3O2I(,*2 E%>B<V0$!
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MBX!3(GHW?L3EJ_5'IRI8MDIS):0Z>O'O.A5T+V>+M7_%LYXR"FO+)W!Q<PL
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MFUO08":-A:SX' AY<)#YK9*F6@R-TZ-L8&YXWP_3D.R1.7YAE;E YNS956E
M0U)IHQZ.)DE=Y8RRD$-A&O)R[@2<1TZR9T#6M C'F5)LK@EEFA9[\:*?\?&B
M3JQX7UR8E7("W_54)K4EQ[@60<S%_>O.' 7/-GQ[(/E6]>N!)>&#8U>Z9TB
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M-5&,QFV-=M! 7\["OM6\W62_%<^+Z+78\^/:)HKG2( H38\*8E,I";"5U%,
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MMHUJ3F&66I$Q?;&R4;J[\0XC[4;FREY:J[18.74L>^P7?$&MU" SS$_>.'R
MR@5:9'0_D,;D+Q?AYF+D#]^1&.<E16Z\ON,)>X%>/,6]<''M&#?!&P ?#;&I
MQ*CJDX=O")0I2\%/^B7&+SVRB_FJ6O\!<SKNAE,?L !X?KO]%4=A!MI^TCQL
M_+BK>E=&IP86%K@&ITP.$^)Z?G@LU_AA<'ZVLL9F:7DS:$Z[&[Q5X&-<MCB5
M3Y"05Q2BAN;K6[Q-2.VYZ-4,7(HI45V),SV/NHR7FX2NH!2J_:?05./@N[B4
M^HBEKTK9U3#X8LYRZ6T4H]#:E]#(F@E<3[Z\/3:VA@2@\[VT9":-=[F8G-8\
M61QJ-\917<8@:,\:>$:>9D(LP_GTDR1XZ.-YXD@2736V<U5FZGUNB:ICSJ-$
MM99IN=2RDJA3RLJL]!SNT+7!6P= H^9)T&L8(U@CDR]0N;R+Y<[KYHWT_I'Y
MTPP';0GLLJ?@#+R/%RVF#702REAVXT/+XC3YI69-*HRN([-'=,+XAQIYKB$"
MWO+JZNO84NOZP9FDV_M*Y*OI9MMYF*[WJ"W4X16P[G5>5K7>Z* Q1?O;CE1-
M8/%1,;4\)_K&/)>P]EB0,S=3,VO$Z1.7*-S0%/(R6.^=3_C4M 5)(FV?/"UD
MYVVTX+!1#+'3\-V-WIMKPUSARC=GC4XS,6[1ATS'RX!-R.?A(59B+JGZ&3OM
MP#I20A\:2=M!?*8YG<EX]=9B# 4BUWN'&1N>/#6.B:WEU J_+7[07UWV4:65
M[J<#D'+M@/Q,>M!<]KOZJ70#[2C6GL(X[=ER8QXK5ZLL1U/FKAN*K><^6PY9
MRHOSZR*916/%.?DT^@HB=6U:^ 5+TR^GKE4_VT9K8*<GT&_!Y@?WP.IX=PEH
M]*N-);<D^L1<2XZGI24Q6H)4[8'G0_S1[J/;,B@Z[*"_(T%W6IV#:KAV'&.X
M^]Z"]?Z-NSF3 ,5//#"U5:(@OF-W<GPU<*K=6Q,B=*"*<UWMX\E[5O%AXH ]
M\$?<[C*:8A%]L5H>'SFMD2,B]<X"B\=I1E:L21Q.B*B<6:WH$"V6 U?JM[(9
MGHZ:&:E*%Y^*1U='&)  );FPK!>-X2H![2:IIS-]S"JCE2/,2R.=Y]S&AS;:
MS5.B+C=S*!+[V3FP:']?2=MRAK?VE8G"MZ@7-^X]]]3HK[=[G\;]^>O]^ "&
M<QO8DYZCLDO[]FK[=B'OF6W6V-(CE&6LGCJK[G+UVBW<V+)4B[)IT=3@BO<J
M/D#K3FR>?R3R,.M3\,L'H6F88%7>C"U508&8-TIT!DV,O\H6/@U6 O'NZPQ8
M_2QDJ.?*K>S5=4SG%D&?39$*C7\@47:4W/_D;YU#=:\=W?G?+>8[*@7PKSH!
M"^VR<8DV??1L1\$8O\)9C]]TYDWV^BO2X^?0O-,NF9!H?4*6_-2_0A7,"A]<
MO'"WY"ALX]_1&+J1Z9*)3.F"P>'3F2G!/]N>9KXCHW%3MB^:357WRE&MS%\A
M'I0\:JZ2LJY4/R-#C.)^!B)0(.D>G(CZ=\0$@&YF40.NHF9R\2@0A/_<_QB^
M<#&T%Y'7F\5=]C/HXL[1,_2*VXJ?X'/P+KW;?RR-/("2?_1910^<M9>YR.IC
M?=R6-Z5 _'^<X"S,"Z8=7L3]'W'*5%H5ZAJ:44M'D0>?CU)PKOPS"..V<_0%
M]6-[$&:='YE0\BK._G]!&/]W"\(@KPAH\LU,M!SO.IW(4'\9>&[<6@IK*[DL
M&A.6%J#T\0[@%C":"> ?/I5OC4C@E"Y5-55@2F?N3=>1L*E0$Q0_D,BR4L(Y
M3KDEX^*G-/.FPG2 TA(7;"=&M-BR1&M#;S(^:*N_*!>I1S@Y#40%FLET@V\]
M_5JUXP\YE>I0P&>-N??,B.[&"9HR[0^GI=> UX,[I+V<TE=H=NWM7A4A'4L7
M$-!Z+3I<0;SKH[*1\DTI[_UQW30\"J>N@Z_!21G@GJ>S(7/3<QX=9ND7&H3S
MC@/ ;SY_.O:F__TN2O/K(1ILZ)2&,<%#ZZH!N/8Q&&/PL#:._6UL25?FE5#U
M,E5.BIAFZ?FCTAJ"+^!G#!+X^C+B_ K!T<AGN\8^\W#_J=#A<V:YU]YY*NN;
MSN=&N%?-)(6-%L<;2R6/$N[B%Z<<H6B:PD.3>HR_6>?YCS7V-%>"QSJN3%,W
M,$_JJY3PE%VO#CTL =FBJ<'7#E&5GE\._>M\>;$SD0\?A7'6&]LN7792WSGW
MHAQXZ4'2P3U*E)G==.9S;\^8>T.I$:),1II,]Q9N92=QXY3ATPH./EH/^QR+
M[-46_"5&9];E-R\=#^NHSZM]+:, H*\)^OYR&]@3^=8GX2IOYO#SV5-QJPZ&
MQ>5)'53A+N<5*:DU):RV@_MM^EQE<C&A_ V-AF@IJ4)CN6R5KO5J46+_&#^^
M?[)5X>R2 L<M;+__WE?K<K:('S_(W S^PE5PK-=)>C4T+GX"M>HZ!?7SI:W
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MT[08\\+Y>O%HMP*/R <?J':,YY1U\7Y4TX\N^-PBZW#Z>#ZG"0X, )_":'(
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M_P%3F_P3;ZI_X5U)QIL$F.P?)R/.DD.F1X<:Z._0%/#W1_L J2_$F1,(R23
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M)QY/PVKKSPQ!5DFAL%J1IDE@4$B=&*O!HR0(GVSG0/. 0.=UB*;-Z)-5]?@
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M)5U)@A-U -N#'&R]I[%-GU4+H5K[<7I)\ O\2P?<Q+!T-DO@"46>C6F3P*/
M+J>@P#H'SZB5YJ@5C>EQ0F.ZS&PZIG\:=!)@5>XI:(4Y* 55_%6OA_943"%.
M3'7]X=Z?*!V:1JD!_YOJ!$[6+2V9PD""_)GRNS$S&/!.8V#)TJ8 /7ES].!I
MCKB^ OSM&>.J0)$BU'LQP0 ]HZ:.HZ9L2@THN22&O_#8&00TCFD]L8 'XAP>
MS'@X"H J+02]F\)1=/(?.@0TX7H0\U^P6XAB!_V"G>='/'4N=L G-L9@6'J"
M/B=*TF#EGTXP_'D!,C]-!G%B8T)])RD/H/);@ ZQTW3X=6DL0YY[["R^9!;
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M7] FE_T+HK(Q]^:Q=+-!?SC@F8>L8#S YKVU;J_SCVPW+XSUC10M>"KEV;+
M=WY]TMW;J<'K?^S^WM_T)H(ABRQ^PS1DN(R!Z?'&+8;PNUSI\+Y<0 CURE&I
MM]Y(ONA'[/*'W@M"U<YOOZ:=]W5!BT'78#"EI;')NKT<%A!K;U_D2]<LR&)C
MEA!-VYSI-T,:3<IWO/@@4](0O=9%]>)#H0LG2)\7\"6EW_7ZWFZ]O[KCX3<S
MZT0GJ$ZEQ35R9]0VBU2R7RB/E4C%%8+ P(AMN;F=BR;58<A];)SE#ZMS7O/
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M:.IJ;4+W+IAP)QE4GV'JA*ZT^7YM>]M-B;[<IYWDG4E]W49UN;X55VS-1__
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M@TZ124QR9Y()#^"JNI$,,/ONAH#*XZA**: RC!(9M2??Z!FYW1I:EF^QQ]K
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MAB:L@)5VM-AQK^:3E/<35_=_.R*\-4D3*SY8VV&O_2G1I=O=KH?XMA5BR#F
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M^X/'H_GZBABIO.FF3 +J_1$7. 2KX$O5G%P+\2H7T5YT# E#Y #3VB#U92/
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M8AC_(X:Z36-'X*-[&U^T>1NJSGPS8(GAEQ/^[80Z!S#,!<<,L/S,&W_F7W>
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ML\1H$C\L(U2LL2I7E/&\'(&>?L7K.G5?DVW<M_:,:K=W=F'JHN7#J)LGZ7A
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MC0/9A2<7@;Z2 G*[TZN^3<%?R]L&6#<QDI;H:FN\U-7PV67<'8S7[GTMV@Z
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MO,6MWWXI''=*Y]*\;2]S19+9N.4V]P,&M:X7#,1K3HN*1-5",H<3P;4-AJV
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M6:JY_"NM]W+=I)U<;YPHEYB#K^8,%<>E2H1U[G>,<@V(#2QDCB'%)-^I<J<
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MF.QW\(G'7CM>KB3O7VO'$,LJU.<@\VFI@.G2\NGTF?J=KX<'FD'@/)\]T=V
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M&7_F;G^F)3,?>^.(NK7RQ(\H;X'>H,\7+:_JE X+E6M[7X8MW]?5:O>/('K
M:R]3>&'=")PF)!@%DA-@;O:"'<6=" W-=47*S.<*=@L[J];/=^])TTY\$ *[
MZ*']<*X0#Q0KF.<0G#4S9&!Y[5(I@15?,=:.:D3>[3J+,V^L4AVPIT,]NG0E
M<?WF6>1R\SM7?@_WK=O>RUU->5[LG=^B(=5X]H&XJ%5=:J)TOU[69U@S[9B!
ME%%)/">D6*0A=Q?_TP["F05_OO[^XK&A>2K(.7JM5VHXSPW5FO")+G+"TT^&
MQ!9?.\KY@79<$6JP":U5G!]#%')R>EF_UY']G<!5^E+3!RS[-0ZJ2!_.N#9>
M"6\$XVYXUZ(&E#'-]RI%B/M)S$_'R.MAU0Y%56Z7H[5]%;C8'Z4F>#V>V+9Q
M6:OX@-#\_C<E32B<EK/>!-#'8%>3"4$8?W.7*OSQ1NDBA3=],F,EH>8E@CSZ
MFE=CMSWM.BLDP;!'.HUS6-QP2MJW2CHJ^U+V96X1-GT_>:6TO'X=%VP*]I,^
MS6E.L,/Q%*8,?-X$M*R7"BJ14G&X5>X1UR*"V/E$5SWT@=8PIP6C2E4E_5#T
M$6@6 N>NLWBO"$PXB*RIB-FCX0:.<%'1?J&5F]X L\ST]Y Z,\P ';.1)D4W
ME<&'>"C,1K3"<:*TT]^&R.KCAG*0DFD)TJGN#2[.%S+A/Q5B8391M+P@R$M_
MYJB, 5V@K 48=S.FP=D 3! .K0'O),Q:(=B+1IST>E<U3Q_<7EK4)1)-?EUJ
M-.3FMZ<N*M5[SWCJ$UW#;N,C:[U9)K5-'CW75WJ5/Y>7Z# "?LA#+>7,?%OB
M#/^<E.-SR"+F+ASGP+60B5M-S^\MTN'3<EW(,4WKVMC$%:.NVNV?M-C(3_(Y
MT[S_<K4ZN1R.R4>QP!TZ"$*L=>@!*NC4ATI?^PD9NH\^M_HVER^\*8PY_["0
MR%IP_G*LM+4![X9.I[1)7G?C#2H(IQ5#D%K(IZV$QUTMPRTV6K,5$6)QB(8X
M;?GWL7+A\0,JF5/M4XO&T9KIE@PAZO5L]]L2=_7R+CD75%4DZDDT!NB8JZXX
M+B]5'8N#NTVB<-HR88A"DWK$(,\%*BCD6H1^);XI/56':RHW]WG5>-N5-V<6
M.@1JCI#R! %1%B!2 [@0CGF,PAG"PZF@UR;8B_AJUTC$#I+M^#0^!"DP$R5-
M4DQ+M?ID_DQT?KZ%6^K>E0>).I\,;Y\BMGI=AV-0T +HO-V8E!=TP'[-K0S7
M$:FBO;WMN8:UIK/-G3MOMZFK+&FS)YTYA\M44C%Y!\7IN!*D>:+@-JB(:M7>
M2J/49KQR/9P+"=;'&R-\E4+&I[&D]GZVM_K]4M.'?0;.'<?XE[+(/;"3&XK9
M>%X:+I]_(UML[.$3K4-=SW(6RP='I /JB1*P=XC7'5@DO@A)!5V-B4!P5-.3
M+E6&3UO)ZG:["K]^,NQ[_>I2W!77(RJHPX]>E&W;;QMLI$0""#LPPQ^$7Y]O
M)][T&:J#LU=:>4XL<@ZVN,H2HJ?M$YPOCV BAUJG3[_/._ Q75NA*UCM\):8
M8003"O,:\GIF/G9"F!"#\UNSPH<\Q6NT/CNS/IB1:'NE*U60T2POCUO^BI>!
M;<EIKO#HG3 /"@"*HI)PB MT\&(#FH-DLV:ZBF _'^F,O6A7]>!(4[[:MDO+
M18+JEL\2]N<+APEW1O8L+#IY#@^)IH9'BU^,2RR8*D&U3OG-/^D;S5D:%$VI
M2,U?J57GO/AERUVZ7I76.<2MV^!_,=+Q^ZXXX]M< EKZ'PQ//U1=%18/F&6B
M7< P@L!I+!(.P;%;B$8?9Q&<JEM)>KB8>K)]W?'8+A>^15-4?@^/A];^ZZ><
MQ%78MTL4/8WG#RP%(2QI:V@8M"F=8'J5,X-Z#1VL/B;-^,_K9W>><I%$Y:^>
M$1VZ$JFR)WC/I9@GVVO!P?ZT!6?-M*_-A&6@=\+#YJ"X2N--=.AJ0_1.O_I^
M]T*OP;1K6F=W;3ER_BGBRFT%Q=?B-??A)U<["#(,\Q?Q&@VL$XN\L-:+:-)Y
M]/1CL'J7:^Y"&A64%&^IG*IR.Z&^DJ7><?>IIE&^#_%/9T*/?A[>4&G;:>X3
M%F#+DGW1P;W(3GA$,16=.8_ W>BH@VR! 1R&.^?*3.F\_ZFXG#7B0&&G?(#J
M^#A7C$'9FQ[_^]>%[7AO[BEE=[Y\>L^5H:AW_$!^3AW'ZM4!EUU'UN[QF)N+
M4"I"[B1(UVU<=D8YE!R_XOYHB!R'/ZNY6-)]$'4"()9<!,["E0=>JVO;[2_O
MD-R,@8:4"]2-#%V+M22_=&H+/ATAWY!\02#K';O\A>S2&;<MH:FP833.%!D"
M+>PGL7.,P6MV,JCA1S(B*SELQN8LYMJ($IHK+19Z^425)C'VJ:D#B <C[).>
M@SXY-J&O'G!8*&\*=M1-$EH-7[_.Y%_J<2]:;!.0?+HTO#E'V;F]=R&#P(%_
MTJ3]>+2UWZI[.F2[NVW89,D#9?$5^KMN@1I6$9\D)E@)"HE-MXI3@93LW>5R
MM4=ZLA2_/29'0.M=J&)CLBQ8ECCPD&N#(KR]"(ZY"_ZB*DY[<0OI3!<I()FP
M:%J*]R0_[WWJ VOM&A,TM7UHJGFU[&Z@=J3S3G2Z/QZ  )Q<Y"\!_$LAEQ;*
MA"4=[2:=RKQVW"IX->?UM==J\D-R.+EK1G8)0C5"]M)*JY_-SSU FNA@74L7
M<A/[;[[C"\4+[H-"/$?1LEC$8.*:*R&9J &O?0>$KS+.N_&BOPJ>D]N++WCF
M'O9A;6<.P&DKJZ5/V4B-S]--:UH7?&]+)H?E0(?X,:AY;QS=VO.^5 (1GS$Q
MT[P8P6=1]^2=^8FBRB,JG0>SS#LD4X4K\_G&Q2@Z.3MVUBRA.>"USE*TSH4^
M%6^/E<<MUF]6S03[&SDXI%M_NM49W;JTUB)'E/!-O1HVK3GTOM#L0N#$Y/GH
M<S&:Y!04D&/R8QH@84?]3;K@=E;0!O >Z9=\=TOV[>\U[]>RF&I.E+NOYB9D
MLO]H]F&?W=6,0ASEB<)G)E*+XKKZ44^/1(,%&,Y*LT\9CE>]-Y*^\K G;56[
M$W$:7HN&+VFJ[H!_M 7*FD[N%7BM!6K*'#) I-10@"ZU6]V?MI*?MH&KGJ1,
M6]SEOY-@^Y)P4PW_,FR\@W&DS3/K9;JM,S?BP),1;NA!S06[^]BX(X7'I8W"
MA-B"(-@VX.I[!'OB>:#(.5#-0]KRP0,B8.[35JNP;U]1=27J3=&7U 8N>/=[
M:M.PR@@W_-1SX>63@5F;.ZWX"_68,5'E.N>V%JO9 "@N@V+$6 [X1363"LH\
MT0CCZO\L$PAD4# +">@7M@D_7;-!J.&[?3:UF8?TX0(/,SO7=7*T_3/>*1Z\
MSOB,CHBHBGV[D;WL6/YZ96H?S*["'G5_S+$S0;@WJBRK!2FW9K^H")1=0*#6
M ('JL+,O.15MZ=#?]L+):]R'_WK$WM&#%2'J#,6?)CW?SK XU:$PG3K6LS*#
MB>-5@</OBQ7W<06.6]R8:8L[4Z&N(?'A39@0:'7+4$__8P+0=;#A.NKAN--F
MJ*N\*Q !Q9BTUU5%//@!\^=@C\&&DE;_>O=#-6$UD#+BP-Z8)Y7+%$9:R2R-
M$R%Q"$X@(TEZ$^TBC>7%B'$I>H^*:RO,%GYA<?IN>\O<Y'"W*RY$!NJZ-=^:
M\K"?GY5P' V-DBS9C5.:]8]YXBDT,9WWQ-X*E]U$*Y6#GBX@X872P0.$_BR'
M)OT#+,[5:#?G*7MBDN82GCPJ,1M#D(2&>$!VPVN;(6^P"27.#H>>OC+UN6[9
M*'FIV5MD;?J%H-:6/3?>Y2?OO*_!$$Z:PNEA,\9<@4Z\UOHJ@:R*&-^.NXY@
M7_2_(CD1R)%)CG;Z[,(-D6P]N!RH1.\_4M;Q3D-^$%X+])"8-!@'@*HPRL<D
M+J!L&>UH' 47X!:#L7)WR 7;N$O"O'=BISH>@V/EL@N9[^&&@ER,,9<X"E)%
M#*2<VVS?O+0R]QDTT'?P$^$F*L2D0S +$"Z?</@0PUA>V(G&&=)!K^I=/'T7
MN"'VQ.N))5HW:NSY2:6YIY3>*_17PFOYD7G5PK33U]![Y=#[M(370PH?^>LY
MO"27/A8L[I[H2D8<67C?*=!F>3PV*J]LCZ#\6/4>P'J!U3MIU+^]4GD,.KB(
ML1Q5[5&1?W>\+^1^B]#2=28[-BU)*>:6(O_:O4-[;WO=YC)I0V%2T$"_H#?(
ML7:YA,"!TQL;AC#!.(6TG#UY/8AV(^6J>)?\1F*IK7U]R[+RVQ'3K6-+:T8"
M2IU314GD78QVA,%'YX[9IK:."0TOE%U_ZFT^NE@4DP?'H&4V3IE@V:@@FQAV
M*F@68J,+J&?LX<K\"?T:W2RSNR73VJ&<."?EFF5E>O)*5?<*P6,U;D?*5D5)
MXE2%>#)4:L_&KALP7=H.,, ,EU5Y*0UPG XR',W@;Y),F+N 5XQV7?7+9LX]
MU-IGP6B\J%U<$'ENR;)Y_T%-T^*/0TRG>(_1S2 )PADD+L$F@,71D8F#:T%V
MK/=4CHTSII3TK_!'A(1(G5;Z^,#C!FOB<9<;T4:WV97$3\G-VLP(ZTOG6KSK
MYHJ_G%W/SYA]LU7ZQ+&XSV1/U7GRDQ7:@*S%^4ZB%L%UW#68"G*@@J)*K*4_
MK!YY=<95;F@@43\V;/D@PB7\C69<B-V-/;(,*H$WK3/M\048*+:*=HXRB0.?
M>-N3'K\5>7=19S*1[\3T\^E9X]?6<KMLRT,.>6MJ'GBP6^7!C(0U) 5X=$?X
M94@P13IFW/XNQ.[$.=:(K;8^*9K7<PN)VD%Q=B'ZDH&*+)RAVD8V9?=JB6@$
M%50()G%FC--*'E<U_,*R8<PY_,M$7]>;J5)/$ 77\!;/ZEWY\H]%WBQ5\$YT
M'QAV4&,]5CS2%^78_TE%5?]>0\^SR2SUI7-B[_5'LLT[HP8M1N<^K'<0CODU
M5A_L1V%R8$>[5R,B6N2>LY[ORET13?<ZHGY][;".2,*.FNW3VI$8EOM^RZ:0
MPIE&U)#@. .)P[M. <4AZ3I-8'#=]9@<^FK4H4_4SC"FK<#NV98;\[9OV]C-
MW'4UY%?W 41.OT1^!+_NS*#6"W& #Q3/->P[CAM!/73R3E6GG\II?]XH*X=[
M>Y][HS)#5GS!M2K.8FJ1(&%"XHZQ!' 2[W"+-:@0RF)!@A"@8V;&X\WJ(6Z2
M)08Y,$/W\T;&\J8?WC3S2>]6=A^V-3_G=7>OZC[DBO(2X?+&#8+YHRM5#Y%B
M9NEVE9*+WNCD]6825]:.0P!BKZEN>9-ZM#&%(/7LSOT@HA +XE0<0T_X# 33
MH<R;^H:<G&>NP+T,";VL=62I0+27><L"'4#]=YB69#ZR4IBQN(X:Z.M&9 UX
MD'\L)'\B9H>#5]3+>M5XKJK^H?F&I.OZ>MN6&N@:/@Z):ST3NB)J)QG O$;;
M+1]5O972IBK97[B3 0,#2&<,<O_-9Z]]_,5%5;WRS&OW-TH4W^BHG&25/'LO
M.4W0H8VM4/IHNI'!<RZ!D<5E%<NS#(>CH??:4D^5B)6)'<KI/WK+R>]SR:@;
MK;K+(*4O3S"0P_GZ*4F%@YO9E!W@,23K*( T9[ASKOFL)A4T)MJ]*E?<G2J6
MH!!O=;[__"ZE^OIKQR,7%X>6%2F,&[31.S3:7UY;P,\TLO(ZJ$KUK+!R7C,/
M271P31D<:O?=6\(7G-[*8V8?MO7NG=H#+<,FH,C8#B 4(RP)M,EN^OA^+"LN
MB_^5!Q7$Y;@>7QR;NS^&>+9N+$B^J%5-$.3^JMZIN/_,)5WQV;&98ZTC!B=8
MZ@\U7G;;$TQO)^ZFM>(LAUTNBGFC*N*O"CC>HYYH- =3P3-@M?$+;>-&R##A
M7AD7?KURLYS5/0O,AQF(NQ\N35J]H MF F%,CM#FL,.& )*D@JXCV$@\>)[:
M$<>YAE$%7/MJ;R&Q4CG3]"U>UJ+%=9_TI8CVAE:BD>+N*RZJCL-]<$P1*I^G
M <&CA5=N1+Q)R+B)=]$*GKQ]RNYFAN4P"VS-S-R0'2*TZ'?VLI'63"QNG<09
M2F%"3" )HAE8F9<$XH5H"(L9P? NKCK>X<AC#T.S;7?>W64]ZF5GL.1\P4N4
MB>ODKBC>LDRYE87^D109B38WCL:N7&,NG@(=:_?@(N,W^E&#R^5DUJZ803H*
MDP-1$G#:F6H!@F(]M&B]'AR&8%(Q2\^),T.W9%AIN%Y9NM?GZYP>(RNGVWEH
M*FX[G2-YO"(["#!8++Q60;J2-D&L*KX9 :*"KG4(^"RO^7=C J<JA;,=T0[=
MH_W82[Q2[RXKK:M[J,GIL;]YZ%^\,CB<5P%XKX/\'.Z" !%L]<BY*'NL16/2
M =R[G>Q.L#W51U3F/PZW1K@Y"9V;,BR$W7PY?Y^!205-8:)5EDT?8+*PYM>P
M#LA6"A^\#DDP2#Y8QN/-+#_5L ,RJ'+72/*@\=-="U>\;][79!DJR#B;9L?%
MV5<^VNY?_NSC^1+^<T7B/K?< R.1PB*\%\]MED)'42X9,R<TCQMZ'EQ!7A;Y
MU,DDFO+J^R@;SF+:2WH+VOOKNG#1%_1Z57HO948S/GR9RI^,['NJ"RL<I*VR
M^?!]V@'3/7UU3DXNLCRA9*T #YZG?9%=)YT@I(])2/%<P#,$4_@)BO/%FY5'
MV^U%!GETB@+F.&/+ZG0G;9K?<3Z+#"*UFF 3ZR $)8TU2_A'B1H(/>60OSSA
M^?B< %V=N710KEEQ5(9>!EK/EKY\P6J]]5W@-:Z>-YD;AO=9N6:N<DZI:DND
MK:ZHRD3>D,^'F'A\/AX;N2A4GBM=[<>+>AU#VCN%CYB@@K"^N/4:V%&<3/UC
M.0B_4_$3SKA/QMY]_0FY-X_6%6Q/F+83#ZX_+'[TQ=+Q_C"@>4"\U@BD#:;4
MJ*5(X@X]=7KQ&<[IC,QS]7AJ6SPZN#:H63EP.29-_VW)D>=!4RS(PBTU:ZAM
MM".N+U%! T/6,8U@%BKH*F2WJ4_=6S8[3^F@]('";4%Q\1&928=.*!ZTWQ8Y
M$?1E(C'M56HLH8+"Y(1?5;$;5Y:P8M7IPL(+5G3X^M2$;CE7C\\<W<T2I\QN
M]I:W!@1ZP8);N9*=6;<WO[C:?I]>0E^TPUY=_EV?#/0=M8H63SBGN-K;PP57
MG2B[JHI?5^&\Y\F[LD4>IK>/.S54!@QYG3;X>*SCNK1O#IB@[&?<IR*&@V+L
M0U;<#B$P%1'8\Z-F@S'B'W1<N5(&DM7K2/DM-PMM0721EZN!:B)P'EYK4\U+
M.VI4A0ZW?@ZW*W0B]^!$W:W@J9$)IS7CXL\'V_<ZILCN?-=P_\+, 3_/O(@U
M&^ RBH],(_A-4SS.?NTE01?-52F5++3;;#;!VC(QBG-_CHZ003F=BM/2CM0$
M!3LAMKAW&_KUO7?%.A)(N2.WGO&ZZ$77V]SP2=1JZ;PY'1(VJ'<6F=Y'!;FM
M\)#XU'.<K*4(4OBV>O..IZ]\Q >)YQ6,O=7:"Y?S#E9:-# .6,JY#;E87@J4
M?=;_#H4[$T,0$^@G<:":(1PY8P2'"0B8)(;?GK;/^6*]%ZOOS33Y_ =G-Y2B
M.I/O<QM["#+5K#+8K@&502 5Y"-;#WG3E T\@CG! ,U$DLC3.%$UFN$WU>P3
M>UZAU39<Y(9(+.RB7-S;ULHM]W.J@;C=E@A<6>T$QYT/N-E@[MP?XNSOAJ."
MFD[!B^7,KN[6%#*\PMYX0(-7?,B,]USY;54#NIVJR&-9\0]@$@XP=.80.3:\
M08TW+%N-\%[AY61\X:V1:VGKUM[5,T#.>=,QWTO<11F$\"$ND)]42_J?(PC@
M;RU)//; 0K0K$^JN;3E]E4WC^.%8E:K)9OJ: W3@AX;CKK0A(37@?91V" ZZ
M&+6/FQ [/H?81TAA#;VH.WJP[.'D4Y,2O_:]0ZW$%CNWW6?$M08OW#8%-3=3
MN.&U4!3@R@&9)HUQQ3KP0&@3GVO#HK@;Q^CL065^A5BS/:?;/8\WY.2UGO?Z
MY!67&F1M3]P.KW63A/'#:R]4"\(ZP7P>57X&5-#=B7J.:Q<^$JR[=N@B*/&7
M/IS)5.ED%3M0*&[AZW5YQ[8"-M6FPE1E$2<+"VLJ:-*]I^VF^(-\MKN'/I=[
MG<N00,CWA6576WC;9\#:$$O%+D#18.L=AEIIAUOK 0GJ.*'>$  ')O-6,<([
MX.:)A* 7#J\=<+*DA'NXC?>[O48$"SAZXN>/O"71YA,G$'C&9DC<E.6UA*HN
M?PN9.R[R([87+1BEG(>,V:P^6EF<9;GJQHU9/F SC1%5$L* 3] \"AN$<9-1
M*.<1UW&3(" 1[W8HYT[/&#!7WUZP[?!(MMK6IJD$,;OS[$KU22<DLA[R9N'C
MS46%ET]4[K*Z%^U\NA*S87M*O;JK>K08HH_"C$'V.":"<6H=@;):KZQ:%*IR
M?#P]Q?:=[KBU*\+WV/*.J0+):S,GS$YEP7'GL&<#_"@[GQ+&7 ,D1FHSKJG*
MAO<=BUXM.96ADFRX[[;F_(0 ;]@<E-;_&$ PK]$  3EW$$08ZE!!%,X/),\,
MPM.:S9!X;_C-;#/S1EOQ00=OA3C&).7'>^.%6DW<I0W9;]S8060%HIS"2P.)
M)CP,#?+$LC:;P([@7R+&F;7YVY@ES.3>)E$:ANJN>)=IG329*F[X**"X3R)!
MZ5;$KM0VI#Q%(TQ/N$DRB?-$_(Q166Y?/WI!-8^VW18RM1U1*$(.J=3XLMWV
M)@1GCR(-:Y#;X,0$Y'/ :0EHG"D\!)X/)G$$C2-J@1+G$^QXCXK.1)2:<45^
M6=?U7+O\,.F5"B?-!J3P.Q?&.&ZI(OXO#0N8PB@/,.E5PDT@[,JIH&#:T$(Z
M=7PQT!GOZ%C3^ @9 Q<4E2[!6M869=N7%PXTP;KWC504A+P_+&OT>G6ODU")
MX^BMIU>/G3WZDO_H7;'BV7.[5!VTK$=#T^"U^U&V\$CT/A4S?$$CC). SO-G
M)MBF^$3/GG#5[[Y06)[^SOI*&NOCW9)LQPMD\P</68H-:ZZR$H2@H9#+B% H
MS@"\_3.:R5\'GSINTLB<V'O@=;^\A8^SAY);QHC*.K^"^I$1QK@CE:I6M368
MF"<03"($9S$$_JAA0'@X!N?R45AN@C/#!!W7CU<,-$JZC9JV'5Z:5+6(WYLM
M>5#.0Q(UV\]R]M0*(@B",^T88%U3(J?*H3C]N<B//9&L]9XW+O5Y8K7UG:H,
M!AMKEPU:N[0S#X0;*Y\=.[ZSXD$@?V"1>'N[V6QA4=P0\N+Y-KK'AIEAZ?,S
M#HVB[NZB**^.YY]%[+OSLFVU*4R :2542!)44'Y)+7CSHH-U%!!O-K#>?7(X
M[W *'TFV4SY731TWFO[2TNG),R\3@Y.>6N='SSLH="EJ[(EZ)(8IO'O_7)[J
M,3+0KV#2X;N Z@E,D!2Y#;\&975(D@NJ4Q7H4U'.<C0^'O6PT#Q!;N[1J%TP
M^]B$<V<#TT*L^[M3@]LG&$@\BA0F"PR4((9LH@U_3:RYI1?A\12\ZY/K2\MF
MY.#0T+LE_M#[G+L[#DL4A0H%)8W,G?/QO=GE;BZ,S.R\TS)'=I)Y[NB:\%PA
MW;,P-YW4<?+KZ'O=RE-$1C3ATQQX)^DFGKD&)IHP&J!G]$'R2F5EYX)49\UE
M"[;R/>AI8P]Q+DVEMQ ]2ANTP&0>0KSF[QB@MN9$R,=+8."-0Z5Y=MV%9.DE
MBQT8^AV/U/=^JCNSM!Z_EP<4O'/=2%>5 ;C;.2 ZH?(HPJ&S9>-21^?J%:J5
M"/")_1DFG7:/3NV/U;^OS1F\YTJV\Q4[\5G0AB:+*H( Y%[Z '(H%70%M:>D
M 7H74@".E$.'-8DUZ/F]NC=_?5#]B@VS?,\<^YL"L2-#R8.:>_F>Z? NM]1)
M+V8Y=O3*JBQ*-@8X%IV7$LO4D3C''A&9D^L8FQ F5?R1X$UA>HYC:$85Z&%;
M)O28_37QSATQ_OIT0^]'#Y9^20@^@@I+U4MFEF?8F.*\'NR7!>TAS=_JSX9]
M^7H11@6YZ UJ-Z Y*JW63%=CV,[?M3#/M/ 3%50/WR/(\#R33[1E*MIT,LZI
M5<]\]968J+#4?, :E.EU77>PW\U7:=@B;&YEX)V^< ;SC_-"OYTB]1_^'.KV
MY(\"ZY=4%#W1]LLVX[YFIQ82U1.8P_IJ/Q_E4;4<B;X;CBF%X'3!=U0/WO]8
MU-B$3/9Y>L$[4LQ0@ZB:ZX+ <9=M@<W)B0VSP(^N;M).LJ2=04 B,%!VD(E"
M>KCN<>.@":RC#L2\M*HSXX-SKLOED*X;T1]*DZ;9<T26$5-O55TO[_(?;HW2
M.BLOYJ]OWX!_:1&!/!<M WJ:?<[<PD\>.8GBZ(1@L#&#]GRA=0 M'O<?.U 4
M#N6:O7^6"I+6G7,Z;.@QR#V/6?.<Z'](H"?N\(FG+:_2<5 ]2DY%.2!Y_8\1
MV/),+=HS"+):A0X-Q7'M,^:9!KNL[7<<33D[X>1R=:J8!.",7HF</T&N@CNC
M^/UU"H(N%'2N9HX':195J6MAK[\(/A!FI3]B]%9GGNN1BU>M_)KK/&VU= ]!
M#PFKNR53 QET&E,M ZK3G82K7?S,_%7[/([JT9<VOO)P>.&3%G:Z22C:\B'=
MU-Z0YME5L;&Q/5*NWD44DUG?I19\J0J".;3^],)1@^</+'M7_2L'K12=%E,^
MWUQ $A1C@9*X0@HR_OXI4;D9?WI)V;A+J'_5E==WRZ)9X^+ 1+#-X N-XLO-
M;0;^O5/YS0GPVKS1/9V(<47LB5Q&&_ANC7%EIT,/EH44<J7F@O>%+Z0A+K)3
M01XF#RCU$-P-O7DTD6<.MA^W>!<&(H2.+=8__=@US=VY<-&TKT@",^0]HN7I
MMN_C75.F0"VFXG%&%J<Q^,<AH/ >ER&(K&-3Q_7"H*S8]\@Q(*E;CS3[I<Y.
MO*7T=D\^3U-/;+O*IHN2V&XPQB\X8U#[>O.Y&='H:EFNTVK^M':H&R$])C R
M93;+106K*&UE[JR0ARUN4_^P+, \7M*X W6=".$Q'77L\K\4WQCFNRWML0O"
M6%'-<??DPB'+0TU";$O/(OL'1P4KR"]@\O!:$_A5)^C@LGITW]I$@X+"X'4>
M8V-CE%,QT?%P5-]0B-HQYM"]"S9SUIU4$.L8.7J^^A"DB1\Z0'N9$SP@%/(Y
M;Y!?N(1X:H\L<XQ<K-BB:/&HEL@Q(<1[^% WA0D\@1Q:7D.XAHT>B#O!M]EX
MH*13\KHP7.1,(+<,WYF&!:G*@@*<=KX2'9.R+5:\S=1]0-X;U?9VTU&"-SKK
M 2XK/'*O;[J]T&!1LCTNC^P?4P& N8.;$.TZB![+"Y);#ZI3H.PF!CP3'IK'
M!@AC6RT/6V)'#T9_Y(C$1/LBDT@,>->UMWT0S,/RA."7#NM/0N>[G6P]G=U\
M;]I<QJNYE A/&B7IH<=$WEIE!&Y%@I@V%>M0N!O06L1@ :8Z: PZ.($):(Z1
M9]U)^N"XN??"^7[V8*:K2^D)V^\,LXXR3HDVT!6RB!/6:7-FF!&L6!.BBAF)
MG:"&V5/-31(N6C)PNO2IQ.1#'7$BJ"V"38WQ1EXK<X+=MN*CN^0.&)WFM(($
M+ZRM6ML_?SBVS.3CKVIV<3O*6Z*L];W8(;3<]<7VO.=)%*BM_T$JZ.&9!2IH
MGCD;/JM]TQQ1$!KEJ1>*QCE$]66FCNIDS#*/8;U&1(+#WX8IH'Q9GFI.LL<=
M?CMYM5H9)T/B!H\A0B"8X)N4=]Y\X&A$\QN'];Y BK+$Q=1%A,F35=9'+F<^
MLFEN(7>,;KL4\R1F*Y Q@(J,8$MA-(',-[LE$SZ3_ XA J[)3+PI.JZZL>J+
MO+ 1,JESA_,V>)B,.<NXD<UKXZA,1"TM44%2GBJ# X<4SCET.:M (>0R9-4G
M3S#.P:7$UY4((RSK:(=Q-\V-D=O??:!;TA(RCT[*+]N7]>8M W&ZRHFR S\&
M974"XSQXFCX7N1Y2;C^D<XNHKK9'U6Y.>YMSM))K0;O'P$3RS#/P/3@FE':@
M%)H>4%:."G($0LAGKMD<&B[O+&B,>_@^B.7XSD*.X9PE:S/=G#:Y3NGVXO<[
M6'3/X4X)N:%X()@7@]% #4BOBA?!LN+>Z&BKEY;AY3:GX_>E\Z4U\1[-I:_3
M$!0SB7HL8/16O.%JN81-QO%>J8(HY+0?;XAV>,.T:3-]&]\#0\/R8PX9GT@Q
M73($,9DZZ$?^<1-LQ42 Q80BE@V?>IH0[^J3L!G]V,GF1M_@J6@YMGJ7L[&B
M;.)8.PE!N@JO<=-XVBE7:>1JU:V4;DB^2+T.PYAKY"KZ'GAWY8YQ 6GG77,7
M<*,9.Z<VA:0X*MJETHYH+L4R'\U3?$UO$KG+O@&*LX0,T*UE)O4W@0505_FQ
M%N-V487Z3Y\K\%L,::]'P?0EXW3H'JV+;KFB59PLD4 WO0&E,,%I2YWP&MB-
M"0BCA8_WF="QCGHJ*%16PW,LE[U+/193&BF>WA"9E5G&Y=44GFQK<'(DKIE/
MR3SZPK3!NE^1Z\/$B^VM2Y97YL8FK)\;S=]JO3%I;MZI'^%\HL382J\*!J&-
M/D'9H0BB]O4=##ZN:Y4$6[S$F$;X2F^<ML3GPJ'2W/DD?;X.X9S\Z:MA@Z+K
MDO</\YLL<HU8\M#>Q.VH\,8@"<*DZN,$9J*ZST0SM(""<*7O]M$V[JWNS:C*
M&.SA*;G6X% N\>Q(V#A+.E2J2B')A)8YIRGO424:P+.P? :JA8QY*BB;D-VP
MCS<X)<8,U[B8L"QK>U,\MS$G5N*A0>?&^\<MH!NI[520*Q5$D)8)I1R%O=U-
MZ8!OI?"5U+,&^QE(Q'H?;_-58::]]%+_PTNOARHG3-^+LSEV& ZZE20:'#ZF
M:W.VBL_'\>++5.76HP_LM<XN+.P<-0F0TYV9.<&I;_UY\]%_/'5V(8/$;D\Q
M2B?0U@9!^>"?7_6/6<'B8+3A4[3^I4"/Q X>=ZT1\%;#]Z(C_1TR"(%=K4MU
MK7TZ1T5Z)*,J#VGX/7A ?S-AB..2!XM/WMZZ9QG;7B"S5$TB7GOBE<QO)/,<
MRCI5X652H8HC/U45,*>]8@9JYJ"D'3B79/]\0GP]3]]QN?4W;FO*40KC2N]"
M>8<[,K3BAQ_'W(JA,!D1SWQ>@^",.S[.8&1"_9]:"=;>FDHJ\7-@!DLS^ \-
M-$;?;MYZ3N-BL>=G]/(<A9%VTE(4#DWB8*L,2"$0M?'616,0+O*3M?=23*/,
M85B9E.'(QJM)G#N$SM/MUGIW!!_9_]@:7JLEA^:#UUX!%', LYO-=?NXH)O8
M'/$?ZV*U7JF_K+V''6/JDH1=KHD-5 P>9FT?K02:OAXC^XSRO/YLC=;FD"-N
M[X[L:"P_8B2L5_!0,]WN\P92=AY*4+*HWP1'0#"E\(*%A^.^W."=CK=$0J7D
M'7B]);WBG-;GC@@R[#]K.L'P&4K[ON6ALH,H3CJ#A]23!=?B"%4 JH>]%+QY
MCG,GCA&/I;VN:,O2DKW>O?"@M?1,K9UXFLW)RWJ3<!+W,H5)$(,FB"EB[<?0
M^PC,.GCCF/1/%([B#Y,QEB6!HY^&U7W]CGGN;A>?'[IQF[UF4A$$TNM$,\$Q
M* @S_!KDCCG#;2K(J2-(UO^"*XLH=]+^;F.)B('6E%>Q$T\T'Q]R3GWG,[-5
M]W.S'*[(4$Q+9"'#(Q?>X'E4Q?]&*1\^<O&<U+G#;A=-9LOBK75<G6-25"2(
MMK &% ,$\PC.IKJ- )E@B"+YC8U<U.JU[4Z$XD:SW:1R&SYP1^^9BM$-$>T4
M819?H',JN_RQB75P?/T"P9NV==1GBRIOAT>YU7IHH1Q^6]^+T&B)4),>SOM;
MC!3S;&U'S.X('1&99!U*I3#'CD'Y**TEB*T0>];@S[B8L>H<:RECWS/Z:,?#
M1ZPZ-]RX#1VVWI&,$LJ;6YID28B@[# !4#)80(ZIWC9,XB548![#!/U%2QWN
MLM5/Z7C:L+27.\$/NA],XKZ\P/:8T=Y%<[\D63<EIE#?>[KJJ0D\T$20;-74
M%.GVX'-+BY'17A'1,BWI<M%TD2$HZC28(+_>"#O8!<%D&-^Z&B__H=,SAM61
MSC+DJ']&B%)]P\)Q_X*-DQR1/((J&+(4%:0<004A-MDEGA . $IAR8GP*ZY1
M:R(8(!U303D^(C6#J=HBX?)*.;E@: _GR7%FG\M.<6'LPYQ>[4V'G^T7Z@^$
MUP]4[Z6"ZHFHL4Q4OK_SERD7E#M4D&T1;5%6K#=1AFPRJ()8I8(4-Q?+.D8W
MG+0N9AODS+K+^\A5Z681SGO)"(0WJJB\R A]QH7U%G$2N3J/=FG9UPTHM!_7
M%#4!(1R;&!M-'&>T*>UR]8QA;I:3A6<_P]Y+NZX<<B/+</6]<B\K0?EF8[7@
MT[42@M.+]A,87!3JKBK:?H<741FJY>>>R,*C['TOM7C;A))@DA-0B1,D(-A>
MH#(="EW#]ZA*^FQ%-Y3O0PB_1 @\ZKT</KJY(S?%"'W/+O8LKWN:ZBT/Y!O:
M@AH&>A(O.5N5^9,J%SE/E6'89_D"#MV^'9G<N*W=3?3"2U=QLTO7!&K(F&B#
MR)/*)^MRST:9PUJ14AM&3V:C,J=*YV5ZW%KC$6\RVD0E;JH7E5<4!/ N)]ZF
M2%$&^)I)["4&'PK;59<OD)\X7W?)S9.1OBYI+>K<-UD97M!") EM,!?B3AIA
MMD"U_;>2[U9JT38;'2I$\,(ZT87]D=5[28S]DE+3W23>M$&Y<0NMJ\NYAID,
M,K)W'^L+NA65R+H/^9M0F&QH7TY"U[+)29*4'?X'<"Q09AC[X(:8_&L/B^Q/
M-@'XVJG&>\EWE4SLZ-N.!EKP,E20$U"8<L2.U<6/>NH$!J*.OTB_"GP,Q3*H
M9F/KG?H^1 M3LJ=H5Y0<*V>LJ&E#;%O<"__4^XWG/)\=>R"U:)7N-%1=;IEC
M#99-XC(.$;CHGMTN6JO>D;A1-=>,J##'3@?0%@HL0>;[[3)(9MUP>Q^*J+6&
MX^"9)Y3<"9G])^:4JH@J-W*4#1G7WIEN..H]J2Q66F(ER"=2M"%8 &HVN6 J
M2&-.?AKUNH.TEX.H2&G<1-]341X#WU8]0/##3:_)E047^CWHD\\]1U 863>P
MLM0H/L"]]47<Z=S20#J^)3!!,)'$S3.F1^)('$<TYUYL-)=ID++5)B1F#5A=
M"SW7/3]9&K[G4,\><OJ5\BC]UA'U.KF@ TTWMK@X/G)\+Q_0O^@^2/S4P<H5
M-\TE.LV=KMQK6.;[Q-W_C4F%;K^VA8>Y!T25H@AOL<=[DT.0D!6__D\=)#X[
MVD1L? 8Y/F*1?.RSYT8NGJ/A,*%B?%=%MH5D_M#LD^#&86W1+;U"L<^V@V*?
ML3WC6$7F0/[SHO!6:99[PKX+X7W-:/QV[ES_I%PF_<IGUQ.3@A<)2O&4BSSX
M( H&M7FE>VZV@R"'7'/!"_K?) 3C'0-49X?J[OOX5LHX>4O:V5:7/YD='.L[
M>!;<:F&$#EIZ?-][HK?2F;;5@=( 82?I>>82XC&L$2JG<JWGB>J4=$S UH79
M@'NO*B;C< 7.ZD:\*O1T+[@FT,4:) &FP<4ZYHZME XHZX+J7G/+LVOWG;QS
M612/>U; .W)S>,-Y=?4ZII7.QZ5Z[?%=VFP\Q[PK<^A,'MIV4EQ;J7'J1LOG
ML;TG/M:^US$3BG,9FG-5" "2V+9*/#H8<HV5(-6!39RX)IWC4O1<R>'6KCC<
MSL_RZ>7DZ-DS,)]E26=W-9N221:/C?AQ[]MPS/-BH**"E4UT[(;UP/==APF;
M$1*L=-<PG]=/.YTXK1SX[@45=#DN1=$J^50-[?/M#,,\/]&+T W4]$1U,W]U
MW/7[PZ-"!F:S"CS7@::\%WME?^51[/X)]^R@9]DI)4J-L/ Y",Z\XV/,N$8$
M>MPU'&5G93 S_BY>:O)1<7[9Z[+2/>3Y-X6OA&!:HVLY#5GQ'?LS@S-UTR>\
MGFAK>QCWD>EXZPF5^X[TI&2=>Y;,*',5\V0J/"HM+2FZOWPC#E[K!L>\1#!6
M"Y/LR4D4<7_^_@5/%+__T7[A\K(X*P;];N8AH81E#0[Y8;8=G.6:"GDWA/TC
MY0-HE3([^2Z )8*H*]:.""99?9"T,,;E-JZXYEG*7C[F$<NZ5O02=XR)8HB?
M="L?X]E_WPFO\;7$/H+W)G'.3318B_?/CWU8.<'-\^:#G)*PK,;+D^UE$9HG
MEP^Y<U8^-5$VI-]R$@Q<4"L#5%V3T! JZ(W>O/H8&/B%C:2(YS'%\P1U.?$[
M57&_?^_G@%5I\O.\^F16T5C=568+(S/??;V#+U^RYQZ_\%!X42+;-958+-N,
MHRCON%UO5'.*:"K6V#2K(Y;1*YK1.II@45V1Q ]@$0+KL9T M..#T'\<SAG4
MJ*L2/W'XKGO+VEQ4"8^D\E;.6EZZY+N!/C5$$<JNHOS\'I(@4=7",6;J<\D^
ML8IP;)OS$+-PZ<VDCP:^6&@HG*]:8A8A4'W8)[6I?#A* 3G>;CQC7'%Y".6K
MDBL("MAR?<MM$.B2"1J-LX(3)"'U$((8NGXQM%SOM@=$P(%G'T>/],+"$/1-
M48D6N^F$.MLCEZM"@:''F(?BK5B915LC+Q=&+2Y#IV]UO76Z@$SH2N5IT]+1
MRHMJ=%KV5DVC@H**/'5L:Z%TJO0$$S6S0BJ(KMTOD[E-^WJSHW!Q2.?U5'%&
M2TEW2^RVO<Y*31)C"(((DK;JY3PY5L4-R'"!? '32-PC/5\J: =C7%W3].!
M>M$I]XH%V)6+(.-+=[<\'V;76HL9\*;L N%,PJ@@NUP93 =6#_=2+QS&W7DP
M9+3[8CZ;CJ_0C< #1^MEFUC>ENK+N:=R">W6NGH+4BQ#XJFODZ6T'D^L61Q(
M'',BB>-4B[85>Y>LGU5RM1ZUW)&@9&-O%&?46HF4C#2ZMT?)YCF?9[*.S8CR
M7,50?\]$VPVS$'X&EA13=47>D@X));E)M,+ZM,D;"XK& !BGX<PQUAR"PHQB
M7=8;]HGWD_A?S$7EMDSHW*S'53C>,G8Q'WERXOYY8G"*Q?,Z1?$\O3VM&Y!Y
M!MJN4?MY9N)I<\+<&!K+B[]IT%?=?"*RW"4Y!3UL-KO[;:B$Y(U/^ KG U<L
M#]>?S;C/"&&G;1Y#8?(WUTD<M]#6N)>Y8Q6N]\#,_E:"6ED$V+2K5$ILZE*2
MJ;:$QO(+HU@!IK>O4B4B^WLV&4@\S&NGR ^N5.+M:_0&0HC:A-@ )TDGWZQ:
M)WM7&\',\6."2=YL4X^.GGF]<(%G/SCQ>*EYUDWC> /OSFS_A>CS7NK1(8)<
M>G%I$^8Z>5JGU#.Z_%N*G)%#MAW5XK"139YZ,$%&-Q5?CQ$)7M4+*Q=8+?3F
MBTZT3T6;6UKOR(EC[M=,"[:+6A<@#IY(?Z^K9O(!S$L!@JT6 @%(H1"\UM_@
M2Q'R9R54>/2MK2>:1[I?6S\T+J^9PJ$Z@(V=,(QDN"_2FAW?Q#"-J(TAB#,T
M+-Z%E  -1J&:M?F<M7S/XJ'2WLOE,=SE=V6EFXO%CVG6T1L.N@?*-8\@BRL]
M 2:X00Y&7>NX]\9?A_"0*.U3/#%^/6KODOSS31T;7W%0<D9C#UOK22/^M&+W
MCY/&O:^[(J)25HS+;VTJ#ZFA#K=DZS\7NYAN@'^9W*'K]&1NOD7[H=+&D/7;
M901!26T-3$@FBA*0->6)$=5'? HF6(-68XI/)7>,:V<D4$%G'_GJR$DR<XG/
M31WV&"I-IC>Y)K6!@EX"'MZ2MNDDZ2" _Y>D4Q_2GJJ%UL%VXL+?RP4(VQ//
MM LUJK3,)#J&>+&]8 (9@N[$O6N>F%VH;4J[EFYR<Y;@%2T=;:6;)"\,-+=F
MGEY#VD-^GE^.$KG^\W"4?XX5^7_OL2(,YZ+3!,3?W_[IR*C?OHIPJ:ZJ/D+<
M0ACMIBW9^38\/C-6GXG!7%3 ,9SV!064NQA,!7'Y:^#4QO?%CW<PSBE2P/A]
MH3>D<SR9CZF4Y4X*U"XPOMT_>5AH]ZF#KQW>7-B;97XBII/,2MF%(&?*(;:T
MI XKUC_7N^#R9.K][3D8PCNE^:B%UPD;B _1=KQCL'ZMB1!+=/77A^_QU\&?
MF DK0HI:U%PQ"F<6/26DSB*Z]<QCH;&3+4+/XK26^224NNY:C4=?5[4(3I:^
M)=<#]0@,%\W=]>'GTY'$)_)/_;9U!5JE=7+N)/N_VE9+__6 (ZX7]&=],L5E
M^[X-RS?Y-BR?=D#2Q&O@ A8:VN.^VBB7!GV#C\!OKX![2)S\>HK2Y)Q.AHBY
MP<?DGOXYW9<H<WUQP6LIX2F BEGW@+L8?%GS]&5A5$;&R,N+W0N]9UY%_.FX
M)[:/@.SMM/^BR]72CRX2_CI1EE]8X;GP7Y[V=.SX18>6KML"W[?E:%)!7@FQ
M%"SH*'#CL!>3*A<S\[NS;O]A>=5WK'/QSAD8VN<:ZFS]\M7LQ?_U1[/_K_Y
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M0G#L>K@,D4#/%Y#)WU 1_$NH&/S.%L, 6_Q6:_L!9/P'9T'^$\3]E6P)R G
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MV/A_4/I%BYKR:?@D:Q:0)[Y !/KW$)&L^UHF44&%!:P;JU\22PYI!0 %CR4
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M5_V''9;2KH1,3!U=8.C5Z#D>-Q5AVVCH\:G5;43JQ*U]G<0 DEXGC-_L,Z0
M47]L$!S\?]A[[ZBFHF]=- H61 0$I!.5)EVD"DA$I M(1Q"B(EU$D!*D1%!
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M)Z?B+DNG4K55>:R)/W]QZ)BB[(&>!<>N3G/\I$1KDP#HB4+53+)MK2=!'Z>
MNW&]P=\AGXO81O\]^EE"UI5FZU+IZBP\)#;XJNZBT@KYQ*O%?K?.^IA/@@.?
M9)R'L6N?-X(TLY$MPAB7621N&"B<P,'>_!JVEQ67D&>=^Y%S\H0'C\:S*7J?
M^#3*<:#,43&=!CG9T^7I=39E_\+A4Q1?F6ZXO:+ I9<<#P+H6<.8]?%P0!Q%
MY@A<4HJ$/97A0'BV9%P=:^#%@:IAGDEE>*#W$25/M_6C2+IXT.R.\YFINQ^X
MNA_-FX=,8?@]0<N-!Y2*3 D#19Z>'D6(5T;#N4W6#CM+B3B%7NOE=S(/MF(
MOJ#9-6>Q)BOIWXM]LER'\Z9%43'FCI9,WG-K)-'@OVOU4':$3B>L4@B&U].K
MF&8^X\(6,HA\5&\YEN%N7'4Z+O?2^TW2S?3+O^OB9WWHPAI0L2%0LNI$DP2B
M;O F?B"^P!T[_H4D5?Q$"KL8$&\6?M<(TBWZ!9+T4F(/@\LG%[&"U/S!4?2D
M*<.Z$O6TY\*L*!%<@F$(LCVPDW+A,#5*<F%T^75/>D.]A_K@H+7&#\&^=V5/
M6&OHJ9NF13TYPVM^I@--)9H<EO)+?84U0A4K'MM2]HUSD6WJ5\'':%*'U4_@
M(XDKF?ALN >L1X[5]4;E9NL5;M4O$58?$1MW>8[J:7R=4%=!F!%CQG\!I[ZX
MINW'PG#\&1+K=EJ;2W$2T$J;@UC2P2.[5A-(\Z-)A\YK.AXD99"4/:<J!$D!
M-%"6,%C%-&@4(-;;JO,\-YF9#83\QK>X;9W?W7Y\TX284!EPQGSU.CH7N? .
M4R$**@6W>$!BNQTM@'C>"L._Q@*1S?YLLZY9O^[+8+6(:=][N$U.;9^>NVFR
M*R>@UW^]QTWFHV#VU4XG^6^53?7ZYZ-B1ZR6&ZD7TC']+D$<!(F%U8Y!;#X1
M3Q!]C6Y0=8>!<H+%;<(#F3-M-ZUQNBY*-,WW'@]<"))0CRR^N 1)O%E49TP^
MW[9$K2<\M\8KH-KL+-?;[:$LG[652S=MQOOZS_?R-$ZD$Y_U\YYD7'$^E1ML
M2P)Y3D^O320EAGH15,P6FT^1+9ZPA6P81Q-#R!0<'XY@[%":8QKVD5(?WT%N
M+"1T%]CIA_8E*3(\$V3]HIG<ZG,]&ZN_)ELUP;QYW[U]N.6A(/.+Q(SJ[_[5
M.M6WJW>/KL6[Q$\9+XINH!;?^"#?A+"/-L@&^Q03P<^GA)3T\\\^2E-T^05)
M^!SCE; F[CFU2M0$4DE6;KOWR#?P3\L67:4^F@9X##E454G]U),/?W1G[^"#
MUZ ^Y2YH [V(T"859 MO$SNP:QLV"\Y4U:L2^:%.SMZT;6._CU9QK#&1RUQ0
M\<,S^X,"(9U0CB;6D#8!)L",I+*>P8H7*7/D<T>[\[P>[I#?<.C;9NSR%-MU
M_)#X^))^X<N:I2>4ASNEJX*+/=$,#$:RL7KZ)F--%KWN3<0Q5P#U!EGAN2%'
M<"?JQ3&$7$) K?";):,9=ZQB'&HK$N\X/\BX@*AV$.7]_BR8R0MY)H094;2$
MBKF$!U&H 5:$2+6IL?0I'RE)"_!#SSUB#RI4+6L6J"212/+4'QA.-4.2-&(:
M%[DILP@_0]8LGQ!4//2@Q'R?M=-@CYIN&$^;DVPP?9(H>O"!;^?X5_1KD/>'
MPBLFVJ!39HNB[8.G@?W[PT%RZ'5.2_RD&_:5Y(7RW/H[B3>=/5,$:U]!VD_N
M]80:*4<L'E:X1RY&C5VM7#TM-IKK&4'^;ERXGE=MK],;<K3 ;E&'[4_@Z]8Y
MYQG(&L+IVH[3C@J5>ZU?N:^',0A8J'=HK/^Q%\8O+6P?Y1V,6M+!QX<'Z2V6
MV(Q?J$WKU1D1::J)$';43LA^>R]94T7LT57&*VM:(?T(.J+U48;HH%NC:@'X
MP:652,)$6RKCM8YL(/]>7>+<AM+-4'Z<'LM"6.+MAN<O_2;:CLJ*+7R9NT()
M/:KU3(.P-5U"3. 4DM'1H C_6V+5IOCBE6L*4>E\KZOJ0%RW5^W]%DQ,40 I
MN6J!)_R>/K%<J=GY0_$=-_'[R4+)$Q)>XR3E[MD7&T%>2VC(^CPCV<(W$Y&N
M-=:@6C*Y03)"%4QUN_IZ-G*,!)E">FNYK1^?C3B5R9%D7TEZ3AU%XK&P2J4H
M=1$D2!-:E4!\$)V"+=H2YZN"TW]4A$U3/%,%-N>,MFMDZ_F61+O=$7-8E'%D
MLIYI3&'I/?G2ZO*JHE^M45?RGOQ'T@[^[](X_BIM$&B0*_,4- VR8?L3\Y?
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M"3(GW:)59,A137&-((T2A!5\*,@PNS_/E="%S(5K!7@(2M5%'->=>O\.<5&
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MOM>OI="#];<<\]MJ:(VZ4JCRWS?S?S9W1BH#R)/H7Q!2-_<?SPG5C6;CD6V
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M*^<7]-P%K[#>Y'[K,+#4W,QJFA56K[8Q*)_Y,J=P4<9IHQA=9$B-7![C."S
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M3^X=HUN9M[XH/6,O#"R[:WEGN7U%[.'5OSN_]3^K)*;T:_T94L3>'SB<S\M
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M2F#5LZ036ECB^+_8>\^HIJ+W73"*BA1!NM0H19 J4@4DH@)&!*1+C=*+@/2
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MO70"VK::@.0JL:WYY^:HUCSJF1Z0=)#G*I8+A%[]<Q@TV3'W.Z6@XQ;PNEP
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M/CCW2Y93P+,_0VT]R6T0.BAE+=1GG=1K4AK?/?XE0+\_8]\B:.'F+; <RB-
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M@[_]6)^_J.J+\?(3+6A*S-7I%W#^@C8D)112H  TY#:T)7&[>E7^Z0PH'M:
M!5K':D!\TYF/"Z,3R7T^?9("N38?\OZHEN&DGGK8/W]3_L#'U$F].8C7@]A\
M0(E%NL-FIHD2U&BDFWHL313,IN]6K>WM4P2_>S^?Z.J?8W0I:5?6^0!!O/$P
MK2Y<XC+S69%+!S"2M J%?0\[NHW%&P+4CZ?CXB_;;JS<1=M.3^4\L>^9CRJ"
M+K9/'5V$7G4\;Z;\>KM?]A7;,, /* )G12 4SL(>K:QWLND?H\[\ ;N8].,,
MUV&6R$Z]$] J:.DL<IL+"Z$JQQOYVJ2U3?2SFG#H;JK&6/D&/"O*::VW;?N[
M>Z1A0I3Y=V$,(87WWHYB[5^:T[.> )@MT^;%XJFL#_,/B&NNM@0VW\CAU+6O
M$JE<7=?M0W;V* ":GL%2,P#_1IZG&'T*&U&Q.HI$P+"O(\D0H\^?TR[L5MAS
MB.Y(!?MN/Q>ZJ6E<]%9U+I2)QG@60]4C]@,=7J'(373P6?WR^ $/NR5BTE%?
M<^= 6OG_N"N@D#1XZFM<+,:Y0X3Z$HU)@P'<WF./%9Y@YVFUC$7%_'D2WYI1
M[J+HL\EZP'L:\2VP[YQERJ#*J6E5=_T2%2E AEJ=%=!_\,=]N1Q7_, GQWQ1
M'EHNSM),/@%Q_"L9Y [(B\.4^7YBQ&2[TB=;6[A?]R(+/T7W!><=:.5,F["U
M+NJ-GHCH2^YO1OQ-_%X_#VM(UX I[WHG@O$EE%$.9!>4"$BW:A+@-HVRM"%B
MQ?8^90?@WT 'LB<@\:$%BG5PY2A)N;H_A#L5!TE<O*!OP#]LI5>NKS-BK]Q1
MZL%AR#%8F![EDO@:VI^OMN]Q@$=V0FARS3N [1C[:6Q@-F27&;6<: C93@M6
M!1 ,'!:TL!](._B^T.Q]L\QST%/%0["QS+1WC>OW5+6D4<FES_L=U@NV T?0
M/VHI)$EQ"D?YOQ]0"4)XU(\[3,@JC3*0TNC;?AQ>P[$-"1><?BS:/^@4V^I8
M12<=.V,[K[MP L+[+5'2T*_01*X)R)^'2B, ]1D%L_F_2,<7=OD,,\\=EJ(G
M985A: \OW*5EF1T1T7?]%,+-'=M,BD!>>>][N#4FCX*G?F "7[2U@?* VTWO
M7ZK6\#UWLV)97/P<953]0E)E?'G&=#4!XG%05X=4%[+ I)#$JK_"9ER(3C]H
M(F$3K1DMH96DE[VK<.=!J"<E3C"(^DY4VSE-V\[1]W=LF-UGEZ!D""8#>0KM
M!9M-MR$ED64VK1:2F[$G(,4A;,Z X^>#/![D;/P#*]=5IS45EM_KJUL9AO]"
M.YK&XX%N2/D*?H6\2*%W"\:A&#:N[K_(:IC)1MP-%2RW_L4)RQGJD59AV\_B
M%' !='MD<!CW%KK>^RLX <:F$>P1A$4R;*Z-O'!KE)AC_373'SC-<XI_;?\$
MA"@,U'3@/Y7[W&\H?0YFUP>& 4S9!>E.#GYAY^$+6R!5#@UM5/MAJTFB1Q2.
M:$.2A$M?WIUITX[6<007]OZ'EJG=RI?D>WUWNJ3@":?+]FI'<.?-DCZ+G^[(
M B:H$=8)8]>4D.L$J(G[\5$T(D!PB6B+BDW;W-U[,"%W=.:Q6+!MZMM<SB7V
MOJ(FL]&A_'G:A3I2_8<M.W'2;$'_ZNQF=O%JU1</=]T18OBZ;M\Y>7[H18T3
MT)!1\B&A/Q+(F&E@(1YB2SW> P[NF2(26W&%I&SK:Q;0BZ)?<VJ#FH>>UG@S
M,OC]D-V5_)638QQ8NXF35ZA\-QT5LIL&>%W1N,'F#GJM_G>H.  QQM0XI,O2
M#)+XDIIO-_H5Z8 WC%>RO2/';87T=&?/:7L\UTM'_R*"\*ZWITI9S4N5^7XU
M0.XC-O[5_:9PD?E()5_5UKMMF<BL76%B]?GCN+/HS^U&P4PQ!RJC(I^7.,M
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MY97P,Q?/KS5UB"/<")E]PP:+1WUVT@25A&IIW+[,^E0C=&\U0B-CIE)*WFQ
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M:(;B3FQ.7)6GM79#2U21FYE9Y-_ZP?.G=*[3AS6$#4'^PPCJ5+87<-51B_S
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MR\GT "+-$P8>*7<H0[P7R1 F#MJ<R(HA]1C0*V# A_U0AM!^S$"YV8BB_.
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MX(,)^+J>M92TED0Q?@(#(U=05"'LP#@,', 5XIB"O20FP0(&3OU)"GX(-C6
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MS[(O]%:LDU5"K>A16!_8U.3[OC!G_M,-6:]7/0]8IJAP9.E&LU8\4S !6BE
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MM4L0RXSY<>)"H!",?2>@#VV4$;ZZI_EPYZ>TRU6A_E%4!A-R";, CLFGVE]
MPO\)&%WAUA)$\9^+-;]<<9$)<;6#G/@Q)Y1$OV:Q=9!ZE0GY[M$@Q80\SH#2
M-<8+WQ(M!I&Y?>2P[:N(7RCXB+%V()G27OQ/(BM_%@?L>>RB\HHO_LHM-08]
M5B'Y7^_-_!\IG74@3WZ S<#ZLO)E_RN]K<;T2/T+[J(S,%^A@!J&8<(WBZ-*
M/$?L>XVL_OC&A,PTW=[+D&9"XE_LZ*YUTK@2&<;+)"BC"Q?.A&Q/>=CVVBK\
MO_!<BA60L./0&,HX=)5O'J6 )3U]5BQ!X\$1ALIY3\6>-1-JI9YI8T+D46I
M1U,/2$;!(,W*P?A@ZR#3YEBQ 7U-U,.,#3A-:A-VMA>&<T&]0:2!SJA[<_)3
ME"3D/W>ALC-8ET#'ZOY>*';XU(!NI*)ZD$I+!HN\AC[AN.?,%8^S)\:L_.(M
M];]XL4-$#]_W73]D9I9_6C?5_=MDF%"V$U7-V"LHGDSDH?(0-@!%@[8Q6^[[
M%= W9X2R2QYZ.Z'P^:YN!SI[J=LU'P#7 ]0278UG&-#4E#>#E4K68K!ND<]
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M1"6\W&D_D 8-@K*0/1(]Y!-I>(.C&E#QA(X$0\=C O.OK[ O*>6F=G7,B5Z
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M$E)L)!65N^#X&^1R5IT+["J^#"PU53YG"#OX/WQ\L/24X#X;D,M@ ^7\H1<
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M+UN#P$)]M-%D_7I#VAYZ0)?&F\6XPT?8H!X [)@0HX#'*%4FA*WDV0M8E*9
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M+_1:7#1D1!IH J S,-H09"@P8YN*G 53JRF "_RWK4/]V_XR)JJK@%<!*<M
M[LO204[@0RP/L3S$\A#+0RP/L3S$\A#+0RP/L3S$\A#+0RP/L3S$\A#+0RP/
ML3S$\A#+0RP/L3S$\A#+0RP/L3S$\A#+_XE8HN <U.@&,41_3;9, P,)-B_.
M+M7[^5KYP")9).#R,?ZUX[IH2,#8D57H%PS^$9@D4P$!^8=J$=K73TVX%03;
MK'K9SJZJJ[1F>S)SR0Z@XEPN_#R_I^HNJY!W XI.,+XDK%BHZSEH4;")#%CY
M4TZ-157#9[%W5-,T>&)FL]*CN.UK6S[P)9%_$G0IY+T*%R[#A(ORC89%;J5N
M,M)!X_:1=)".-!7R%WM,]_U+M@-!\0D=)/9_SFDPG+I09L0D%&]2+XM3+0["
M(2,JB(C+(^LFS3X%V.2O9>X/;6+NG;0#3W?<16(Z+GW2?#U?ZD0'&7]K?K<;
MQ%];.;@=+!:@J-PR[JL>?C!MJWM?0: V?IVS'(:W=$%5_T(W(:.0E9#6S6C>
MEQ9.,V?K'LO>]&!)7#69S"/&7GS1[G8G6,L#1DAN8[]I1X"^X'F[$)_7@Z7=
M@7[NQUN?FP^L>IL[KE*^5X&Y2DA3&^ 0>S61%9:6-=5U@]J=N@WYT"6\OTT'
MA;?/;1[PUJG30:'R&%(^!.=!JJ5%H-F1L[TPFE Y'10E#J6%)-. T;1_%4QZ
MZR)(/:))!QV#4EY03^I"L1D4,0@WLF]X3H?"TT,'M0(#FPG5.K,C[?\[^<8+
M23! MG"CZ:![0"40DO(:V=+\!/*+$4H"=&E!YY=D- T.2-$_W!1%LD"(T4$?
M"UHR2+<  8K.HEVN1QX =0 A60BE7>,[30?=U0-&VR@== 5Y+\%X>^F?[]HT
M3_"CLECQTT&-:3,40S#A!* )?;]K@>D@?C!!8DSGX&@R[21FG^. .1.3 ?GG
MNW*#7V)^.1$$:<P_Z:"YS__0%Y?IH!<13<@^3@P>&,T=&7VV7+]/&_CW=\57
M42SI(&7C%Q"\/:#!7&J4>X$ QX!: *\Z&2B/9#AHSW+HH.=HV@-:Z'7T$O:?
M[_KO(9IC I[[ U#I&83V$#+WY&O&S@EQ"@MR2W"'1P6IA/SG>_X31&>M,%2@
M#J"N6_?H( Z6,.""-Y"SSL"0^(\1 T4* 73R%U"'E0Z*8SWDQ2$O#GEQR(M#
M7ASRXI 7A[PXY,4A+PYY<<B+0UX<\N*0%X>\..3%(2\.>7'(BT->'/+BD!>'
MO#CDQ2$O#GEQR(M#7ASRXI 7A[SXWYH7]^&VA# 7'KCQG(JM_'$G+P\Z"/47
MW C]1V[@<W'8]4E"*,XNLY)7IT6<0\+H>&.P_^C(.AWD\G.Z;N_RL4UH$*V9
M#L*;7)2=5ZVVQNE$)54@+A).S(N<2TD[7AB^$PFZ&L'?M!;H:1"/2GZ&<%;"
M8Z2[\Q15KN4W.NW#OB<CC ?[2U=)UFT6*%GT!5$K)R[^M>KUKID'V>F;/:+>
MQO:3.[HJ"!=$Q6$BV/]C(A@<1@>=B*"BQ1I.POE+\6ZA/@+H*$6'N--++Z([
M[9]BA%\'286M,?2I]\V.+M3_/G_V1!3!MCT*XX9E,_UNWMWGXN+R9^>O&)=D
M!C#^QD2#)7H5S.H9:,(<]S)D+S]'7HG2M;IA!,4O$5A?7KAG?FON-CYU[WKG
M8/2O:LN<;4^MRE\5#X$^(7MM/_Y?O8G58?EO7X[M#M).LY"M+!%]X!,;<'&T
M9?GHBSKVJV%:5\_%$3LCKKQY0?Z>HW%S8?8/05&HE?$\EL*&;O/RMR?.#GB3
M%GQ0+6:NZZ\^WW[(SN%^:T?"#O.D8!_2\BH]R?)]KY1AENZ-G(D][6ECG4%K
M<GR3]N7"5/?%VV\C>VZ[#L(*%DNU]K?*$>3=_^!&B2T=O@6_,/HC_V<=6D6
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MNU7X&2&<B-4+UG6";7W=SO-Y3QT-WY\(+,,)=YT;_D2L49]2<%D/ J<:&(]
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MT4'6F^?\E;_-E"6'^\# 9N,S_JJ]<VI#'VJ*N;]V1/ <C0@K8-CO(H1B[Q0
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M(9>2( =<E JT6/.WW&V")?\K^:O_?Q=$.K*Q86;K*APPDV@R*Y5;&EX(*&#
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MS"'7[BCKCC2,PKB)/E.C[[C?\+I]ORD'EGP3<F\^1\4EEY?$F\ZFFU'^DQ0
ME27PT_B@KKYC_H_(HE:"1NW=;#IC5?RYV$LZN'NF&I3:*5C]R%('T,VOL)#U
M<()IMIWO)8GAA'/RLU8:( KHV"_A76L:(Z(5,YNL)"08Y^+MJ;Y)R["'QD'+
ML"]W-J,@99$M%Y%J562[^"+_9-TAD=RM"<CMTV[9<;(3WR0732Y('+=_S8)X
M3@/FQ,<SH3,\F#_?!S4B^ A(8O(+M*O4V,=26E=]9)"RGRM_Z/<XKGMA,5C1
M7@G)APSC<X\P7$8-VLMZ"8GR[2G]L$2KC%;;3]@@%^S[V>_SQ]086FZBK=A\
MG@@P=0K*#,,B-J?=5ITW:M-_NXK'04;4<.^9TOE>2RN2I34M," 43%I*ALHY
M8<KWUNSM\RV: _ *K<X!G%_B7TA-/L4U_E%*2QV5[PD 0AQ@[N)S)?.1DO7Z
MZK18>MI#ZE2$L%))JPV6,@N@!G?MHB\?A*_O-QA>E9M 9!*6&J%CZ'GL*[1B
M0, \C-54Z_,CF'CA'X13@R-;:O)VSGXM^=\#GIS7C]/1TX+3%$1HO;W%AL7X
M+\LC\+[$:WM^\))2RS7T9*E2LW#O8IK[],D(?6-6WJ&KG7I<0U8O^'/X<NO1
MF:7UJ37%H80,P)#@,]HP_Q=[[QW4]/?^"\:*%$$I B)$I7>57B26CU0!Z4@+
M2 ?IO26* DI5JM2H-*F1&JFA(R!$NO00FO2$$@)I&[Y[9^^=_?YV9^_=V=D[
M=W[,G'^8=T[.^YSS/*_7*^<\SU,->J]*_YG @K&.S@Y9;#C(%1@LG(D3!\VR
M(P;BTF_+VN:\\N9\%6I6#VWG!BVWDQ3^B_(S/-Q#D=CS*0P*Z 56$D\,^JCC
M,A*;T/-]9F%AYI%M'5'57-3=DYFK<L5ZZ,%YJ8OHKDD:#S\_<.HJ2'QD&,C!
MFJV#<H>V>.H-SD%!$A,+4V8(GFM:<[]W8Z\]3KN)#:ZTFKG5I1,#FKI3QR^6
MEMK D[KFR"WE5!$ *1NUUIM-BOWNO<1H7W50?-T\B#E,/8<]!WU\^[A"7# ?
M&>#!?9PA7^BC]G4R03;!?X\[R[HWQ->O2:UA3>XT<<,%FJM.H<,)DZ'FT'5M
M,\P<)!?:K@M"?T'2(5U 4YR66.0;$I@,K[2QGM:YC,";;+<>)OH'J:Q$/;-[
MJ)KGOOUCX-R[BFS' !&CU'QZA%"*F]C!D:M+;1C>>=7FAM.?IVJ/<X>[3>.%
M#9,-#)/U]-,KQHR"4IHLK3>:,J%8+S/2^"[Q#72;' ZGC46=-A8"@:;[P+]I
M^DY6;A+:+H;TK&#!WR&\QBBJ&K@'4_AP#E<DCDRKCI.?#YQ)[>E6KOXH\^;-
M!V]O]RD0^BL54!NSU8E;0\-BZZ#T?44;( ZYUPZ2E3UQ(5Z^@?ITGRPTWMO_
M?,WKJR5@RX2S\BF.;\-%6%EV#OEOJE\UC&VT>*@@/"QE%G8P=L#[LDD&NQ=M
M4^6_/M&I7:A!WR>J/51F$!N*$)1SMP;KHH9.R-&T)70+YGE,3D>B<_;#'R"J
M.*<K"POF@S.,D^7(A]-MU;7/1#>C_FGC59"!8>"]663FTU\GH.U/2>)8U&(X
ME)$B.'L9I%/K:J8SMA8_^/)%6F;>O/<9L7,R'B\8%M^I/(H_@?"C[WXJK]!@
MY)3C+E:L6.&(D!W?=/:"/>[!NLL-8)5F"Q-S7/O]5Z[[I0]GN[?&;FSLS,%+
M1FD^416*KFA$=:,23V*B($)SYKU>F)F<OX:]#-W,,%$>T]]HA_Q79VN2@PY!
M"L!G<P3AM@6L'NP-%<"NZE'PO,_+#NHGU"*7O!>GE,"?.'\3,)T@?1/8Z.CY
MZ!7=!X)G)UZ:G-&LMW!%-L&];;OTEH)\G&NY?(5@]D?8[(SX3WO[O'N?X0_,
M+F:C]0D2J'9P?#V?T(AJ@%? 8BZ?AKN[RR$/=\"EPS!3*][U\UY5C2L\_!>\
MN]: Z4X_N)=\6*ZFH$M[65S"-'UGL@9=N<HV5^'.@=LT!1OP<]_<\8?B8G#,
MO2^JUAO*)DKP_H*\ZI3ZC+];6;5&'N(0K4V+YFE*55"$[\R.M%/(BJW:?M,U
MX7VA1O@4$B, I0>Y ,\3\IRFO#YOI@<AZ+C)(T\K;OX-_6S7AE+ULX#5@=Y2
M^ A&F$$,Z0[.C"3(=Y4F%#1K726E/-:^]RDA4E )C-M;2TI6SG1RJX=D1OTI
M#+;>QTTFH7PT3JOL>7&I\QZOLZ7T+Z6&)='1W.-\09'ZW%%#O<'[.[!9U'02
M03RIO0F5A*1):*$H(#X-%>.)QC'1GY'RO)T@H,7@0?P3Z^SEW>P72S*#_T82
MA($DCEU]@B5Z 'B&9)2\2Y36-4&,U/VQDY&KY7_-T2']RX1NSI_)&R#FDW7"
M2GQ*CB7YE"!C*Z4@+'6C.FN:?"?B]N(YK!:3H3M]2DKQRVOW-_>>)MWK]2YW
M<_PT*[OQ./.''L/Z0K'7_9WL4.#O&_K)*U8!8DH3EO'%ZL5B"9K&@6Z3DRWC
MTRWE(Z;. [#O+"16!1URB=K9XOAFZS)"7.?VM_F?60[R[E<LXXP9SO?^>@1Q
M56V[V\[ $GH (O!#WY)4T,#IW26GF,\+^B7/77[6*P?,+G-+>6 :_4.8?U_D
M3I=I^_OD)646B#6'T1/T%P\GWZJQZ)(+2V<MLV^5M=-'#FC&N8!G+QJL*MIP
M FYC?7UB">)X%7*)G/X4Y])$]I(.%V2!W:ZBCD<^Q6NFPH'_E^Y<]JWG6C^9
M8C7Y8[<+7Z-JRA$\1MS!8F5'QG-IY6-UPW)A G#/RC[S_4VG'/'.YT.6&M(K
M)6*21+>J"=*P]]_I0%]?5YL)[>W90R!!HGB&"EA$AIO@!Q><B4(P_(V#/4C?
M-9_MU6-DHOL"37 N@+:E:\,-J !K<A)";Y,"1U$!6L168NA2_2P>KD7(7$).
M*5 85 K7E7MC5<V*7:Z/IPH)ALT]D74G^O?9,]8BFSX^[..2N+@427]ZJ[H!
MZ@PG"&>TZ\"922)9 UTGM5&KT=,=I@TZ9<D UMFYB)'\1/:4J#: KVJYD^O[
M'H<KBQOFVGGSO]\T>W#T3[9 53RWZCS)Y%GDK?:563.C./=5=IMK^]\J5/KV
MBQI"S#P]6#V:!-+F\Q2")<PHC%O(*2($1:[.QE,!**^M+VO09=W#,6A[1XIR
M)S;QSN!*U017)<10XX^WSW;*<=:Q./XQ^8L$28D82 C#@)+DG!#U'A9KAN/P
M:6ZAZ9%N*4L'NQS2SD6 (E]'2S&%\1;1)ER%7$J;0RLJH.,<!KB]NP7<!B&@
MGZVFC_F"IE21A\-%6\?Z1WX)S4O\:@MX>;$85L?6Y4(&XQ!'V>Q8-S:+IN?R
MVTC_\-H?*>=BT;.KX_;7TW!2/D7+J;..RH8C"DU:-GC38;PS$MI^A@I8GB.Y
M4@'V7%3 B$O9?B]^.'.-_+U57#9^J+/G>G5DKRICWP/@*T#$A0B?_UX91AC
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MA0..PR#2E<#+CT8QN]U_ZIPRZS0Q=3J=LGD.T79R;1&#*0T(9V%AH::D6"H
M:\ 22054<6[MS3,0A'V<*S;/<K-V/;^6-SWA3)PT8T.<]*!4C*L$SNQ5WMU'
MD5CI\#^PTEL#2R @F/0(QYZE.%E183KO7-/0[)[)L>*,2N'Y +'U_3,4-J%4
MQ']WL-HJX,E;;T.?9U;P:5U1H=GDIID!I'MN"!^+\"*%?T!D@*]4C\&SS,^F
M)]M_.3DN4'M[QBRB,B7P'A3]%<I0)YT(PIKJLP9K:.Q%%V(8!\6&KJ5B% =<
MZS,#J0!',PF?/V8MI(>GV70@@^ JNLYMD!&A!AX<9]72ZG=#L[I9Z.0)8_/C
M\X [!A^T@A1G[\V^!JN$AY"K556*H>U&183VQ>?9738\=<CO>0J:#@CW'\D=
MC"'CIHZFII@G/*F^9];?@)T@HVK2Y$R:H$)>/M!)",.D9W\>_++[H^9C'5>Y
MM$<S.M(\C[L'K&;A(*+Z^>827,H9+-,Q/."]CZ_%4OH9\HM@RLD)Y0>-]5FA
M.\/C'Q9]GWJ$+W'J/JN(PQ_R"EIHC7K[-B9/IILUUYD1E0MV F#8I\AX$!WD
M5N>2+C]Z+7(W7+S@[\7N72FI238W_3LY0EK)6EPWHQH"44/!-U+V$*2U7LH2
MDA@/!Y/30>X+4V#\;6NC=LAUG%.98/F,EW3SPP!'G\"LA+:.2V.=UR F?5P/
M<G)D6-U7<S7P&02H.\T,@F(PX7Q"EO S?=\$-]WL]1N-KLCS&8F^[5U=UDI;
M9%9GT<N#&*6_4$-^,BE4+RTV?)O*^T185$6C;-XPR-7+0_++UMK4!!M11N3+
MNZ[? :XO2OH+7+49[L2FXF-#U44+5NH.6XNKH/_M7?G=!:S1PO$39"QTLU>#
M1E"(RH2%_VZ&U$(,@K8_AK"$.Y$C W8O$+RZJ8!I&Z&6VM$7T2@:EO-N7YZK
M36:YIVERD55!%:'8UG>3J].!</BF[\5?O8.-OD'?@3F;<94!_0!+RR;7;U4Y
MC]-T>+MJS+,"*]096/+DLXT%LJ);]_75T^8.9H\7*/0(8D3P&[QBC-&H([:H
M$)-T<3/C]H9QK?KS"F?Z[WW<[>JS'.=$>^=NQ-N2 YR)>I"?((04DDE-</@@
M&W35[6D5OWNHZRA<R*F-P7-11>O\JS/9)4L-<!@4G0+%&H*8*;\HO&.J=$M]
M4A*U/#.C$<4;'[M&)5,K.1P239Y9#J@\OOC,.\C!=CE4*I_(!^EIG$QTP$62
MS$<]#C*E+H_^U<+PF+RM4JF_- 7YS;_&XY<W$Z.]BY&0XB$:UEGI,HPYX\6&
M/?9/"LKS^ON.FJ9:F5EZ[?DTHO-?=]OAV'?=4GT8[OH?3J;-;]MLR^<E/+^?
MP4+;&@(TV])WH0+.D&3L,0LQ,@N\:ON&;W0;AG=6]N-9]=IONQ2H;DL]^K"<
M\UVER2P8B=4&1T*KG=O?XIQ[4.QNDZ,BB2I1]6F?Z_;_L-Z,XC>2B/=6U_%E
MKV=WY@)B#7<)8K!HRJWIOS1$\A'(ZFY-JK#85)C.[QF>L9*K.?[8SF7+'?.)
M(S/V]5ZE@L/';2K@*A7@LCN%HC \)*K,N+2*X0:3WL[\2C(DRNU\X8-%%%I_
M5<8Z\5G]8%4F-;VYN$17?*-J5D=?JB,B9#Q!2=MJ+Y*,2<Q!C*R3+#=.%AX/
M%Z=[.UK-W-C[\3O7I4-MB,W5P.^HH<'DV(+@F?Y^V[W>A/;Z7B0G,JQN(?X$
M_I;"% PT&O9<^KV,;)F03LV4NIV(.;_W1DLB^8.%;1=O_O(-[[M[7B1.<8J^
M#9#(*4$%'#@<[D)KI'NH@"D="CUN22=!X0&NJ R^<?W@0H#TE;[S&>GX;V^K
M'[7^8WZ<30DI.^#Y9,MP[$5AZ,;-M$-KO;9%[3'0LX37X0\+^[ZTN\K$B<>9
M(K*4G/JOWKME:_)AF<E7PS.,X'S.Q$>F>[30\D^CA^BXH:>^KF68S;2PAV11
M\<>>J4+.=N@S.)CE\-V8[NA7=*K)?*SHIL/XM+[IX<C:7P42&R/%P&O1ZP0W
M 3IHW4/*0]$9H#TH\#(5L'GB11;*:LVDS8(#M-V = ;[& ^I)@3ASL#] X:=
M85M!N.G[<\U8??%?[1-R4N5P?BJ \>RE$U-PXND/9K V6+UP.XP]7#9;=_A
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MA5G-SQ_*9XPO<$^7*@EDG7 95\!\F'EX8_(5#3[GKBCNS37];3H@0:#\AM'
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MM%=<+?A*<!;*G-![+5,67Y__#.:9&SC0*F)P6P7RS!A"2I[S/@,(A6Z/T\3
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M.:$%-J.* @VA<MFSZU_&[2SQ' ^IJ]4G4>@GL1<W\;<(KW&,G5=T,7^I@*H
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M1AG28&YZ!H!+=>*C'>+[5\ZS+N;LQ.W3]1/2[>/;G.2\.2X%Q\Q).H7:-,[
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MX4>(0CS3MA5^V))F.74P06>KP]8E(46_-=L=B;FE&YUHD,FJ]CRC#R=KTCW
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MMG!!SX/FYL<-&J%&M(1X\S2YE1/.,:(*PNU%(A[43/K=#IWD_/ME_'-C8V5
MW*\$@-J+^#1SYCM]E8"\#^?VZT*4;%VT@-$)]R-'0[EJ]#PSU7S5?A&4-.7-
M>4RR"UQ@35U?*C)#\WJ/U#58S3[!VO[7;@@[(T1;'EX7=9,ZHXRD\)MAPD@.
M;=X#OV.7F'*\X1L=8LS+C!?V,QQ>^[[N9+83F]HZ U!8?3LS[*J0%!87+3PZ
MLM!#1/=+-;YZ^%67+?^#7OZ!\NQ=;X:P.? 'L%$FJ?7!D#?,)?JGTXYFQ3WK
M;WIV::(VLZVE!- S_%:TS[9[U^J/1I_\B+"4L "?%+1(X\9N:ZF5WX^?"A1F
M\"+ZW3.,1#C!R#*EBQT;496UQ3TL'FTS^>O=G1XO.P+J7QN1W?12%[ JNK/H
M-_R1?7--ZQ.UCR6S87?'[UT\_TBU5/B.=&Y$PM,[>3+XC#@Y$ "6VV$Y JV0
MG:-Q;D]QST^AR>KWLJ/H*&M%(4<[*;3G+D2XM8-:O"WXA' K"J[RI3XQ6/)%
M2Y5,T,S^#.=U(A_$\^*BBU#STIVUC)5CXH7;EU2U)H5T*']Z-0U"N7:;F^ST
M/G[QR/;*A:1-^.'11EWJQ=?-A+LAWX+Y<QIKZVI:*A*S75%UH,6\/+S>&8"!
M8D%2^ JW))676;OQ7JP\F)^_4KB/F.!1LG!.MF9G+BV]8\S],75?*NI0,@I=
M/4R+<6AK,38OJ@8RST;0R*G*Y+0-2>'ON\[X633#/TF]>\4P/ISR4),TK_ 3
M6VI<W&OH_65'J5LA NBF\G?+<=MG)9?#^?N '!=U,DW)U'I\8PA>)R)JH]@]
M"!G=">U9'63;G@>>9GXA!9)AL$ L-%[<=%>6$)!3Z"[%U^P6Y"'7R>=3_7ZS
M^LF=%^J,%^)N0'82,1U$@=,T&GD&\ZPW3L6Q&(_X/7P\/HN!!>HW-O_(>)YC
M_=&3/R"IT'R"2ZZ]FC%EG&"C%'WK!3ZMY+E!CI:IZ@B-.D^>N.>6VI1[6&GQ
M@K%$A\3\MYW*J>L]3&HZN:/ZJA7$P #WWO7#EK_:>1]DS38%NVA$ZK[D]D$9
M17X$(>8:/%^"M8N6K^__MOD.*CL%03H;K9C'=:TD&-V?N+-+'I /NRSL"JRD
MV]X@NR.&N2;K\,ZW(5J3?_U#7 O35W':7!LWE,M^#VS+_[K"&?>5^_N*SE0:
MD%EZ2L_4;U-H(5VOXZD.L7;N+R*#/!QL>WU-I_13J8'ORFJ$"3BXT".DS6>N
M(B-#!)U>O*K!=JA N:E"],&[[#PD/X4$TR7X07<&[P]W&&W>:"/^V*G7;S"M
M*MV-'$E@U^(0!"H\>Y/X21+D+#E#MYBQ PQ:!'-8NRLWO)6+!SO5A?V9[RE>
MUY9AJK%J'OGN0[90D&D*_5> Y^F/>_!=U1HOD:8])&7HSFPX0IF<@SJM^7;W
MPE5ZG"U"58?DUL>*E+X+&GJJ[6_@FQ8^ZZ'Y$P<S1?^6+AU16#J(?J=Q\%>M
M(J0WI:2$I7:N#H'6%.RO9XE2WZUKNXKBWG'=:9(Z$+[T2PQAN70&6/R$QH-I
MC([]-&T;(07G2]Z?>@*M <N5_M'UACXL[Q?S_O7%T%'3S.^2>5ZS.B AJ#([
M*..EB$$$GQP7*EW&NS8(G7XT?^*:B39J>( O5FS[W6E28IB2=G%%47C>G6%G
M?Q8+,0G(:;1[LF@INI5($H32E([V:3Y%L)RB07KWK?\310F_\'%56O'=GJ7
M@K#TC8#_8N,J+R9[287;SN+7B/:G[Y$>PG625RAR6=;XO5AQ<4LKJY+[S7-^
MM\(?)& _WE9O<^+FOO:39PG>$?] 46?L,U;I6\!:J@.L_0PPL'<TH\(SHQ7U
M(Q=T3??&-\,O6S9CD=K[0Y]M[+E5%HHPK639X<%OHM-P8;*2]J+=;'$'FH'B
M!+G]QYO4VJ$YCDO0BI<47_GQ3MO4L(+]:?8-6EA<:$.U(AXB_VTNVH4C5&L(
MX!C47;S6:_'MT1F_I5+KFLVIE67G_E][$A-O)7O9Z9>7+RF-R2XQ7KY<+F)D
MF%+"Z[HO :EX!PE8T!.?*Q"+[LB>DBNR+5=ZG%>9QS^AK;C?6MXDFQJ\A>C-
M2ZTUFT;2(^V!5Z@SZ/JCN%ID=,.:+DD7>W"MMZ4V2-">Y?.EF/O9-4$).&M.
MF5H^+Z]SQ"QD6%[5[:.N[U2V]L;:7,%DO-N[;U\*@E\FT[R+F:;\^:N0&?<>
M%GT?=(A;>B9 +^*>IMV?IF\0)[&8B49_JZG?,BJ0Q \_Z%*?2 N6Q>X(Z-_,
MT=4L^_S'KN;(*KEQI+8"X38U!FH(W";@%19[(OYRHR(6;D!5G;[:VO2R463<
MTQN0SF_OFX1U,#HZ54MKLPTCV]31+_L3I[.65(/%%$8W,R]708ES(KLO/CO'
M29DF//K._?M-,N"B]/O+3WE/:1#]YE^)@]IO=YW"';H(NH:TMW''Q.%M0,3(
MB:G,V!LOI&0K+C-YG2OI=)FV)#5?7#?)$_<,9&/]X>2(&@XU:;2 AJ2%8ZT]
M;UW(,NQZ7CP<3737][3&-Z7EJ C>&FAHTIET)=V/(4]ASP#;H>2'U"%@C7S*
MTG"<9==4G%RYR8ND6CUNP^?$/1%.]C]:/&]7PL);/HZ?O\*Q&?P1^6+A=5[]
MK>URG.1;.[HRBNXBN879\[S5PA_5=VMMY_M^_TK6%NX0+?F3S,/RYWR=G.+:
M!7VS-.7<X:P4C \Y>[ZAI?GXE9M6>_-DH3&?:4;],C&W/X>L;Z=O:W7L"Y3[
MMV-]!G!$7J/.+/#*01E(G\G6E6/;LO1UYLNC7V*$XTJ\/6Y<[.4)]YSYL CP
MH7NH_BJO!MR!IJ?]\$F=9!1"A'"_.)_R<$R.H53[,&CO3M0F:\*D]CUQ48V5
ML-$(NT-XU,^V.U/?D&T7_S4\JFJ? 5[Z3U'3I\?LL$S1"%7:95[YH^E)-6#J
M!)Y:6NX.<J\[6 D?W/][7 3.E3?C\#/J8%RBNY-DBU"01X$5NT=*#'52'^P&
MQ%?D66B>^ 8TU0T;B?YZ4 ?S%>\<*Z W*XDUGDT;30ZL=9Q8$ UH2=NI.IC:
M2<&/_031M\J#"^%R!/YY47PCYHE8X/Y<A]^@Z(66P,ZWS;RS/@^W^DHW)$G"
MDMLK6'0XL-X>#WXC6S0J.YMEQ0QUGS+2_^P612\IJN+3Z:_(]K>G:V$ZCP@]
M X3!*:KXN:FNAPS=\VKC<I_Q#P<CDGL :>=O*2:XFLH==T^X.+\HGZ+CC503
M:<=6PG3).C7EW%W\V2M. ?/?A(^F?N]7\= E=*\J'@&='N?RFF;Y)!>SSR7'
MKOA &IJV&D%RKJ@JM(?=#&BQJ'C[L)@")JG@OA=$/6%NQ.\0OR3/72E$BDEW
M]PR9:=V1SOF)&GAP3KR$+(CH!OXKO49!8Q8X5?^?2Z\!:A)M8ES=/L,6/CX^
MK0CD2@-2979HC1&N-##ON+\;'/P$TYA]!F@B(@<'(;-]4UL0=[BN51XCY5(0
MP0RG%4V1+.[UN)Z/T].9U:E/QGZT3[!8,7__XWFGD//%]_3=7DPZIS=(@F1N
MZH =_CGJ/"D9'*4L&0=G*'459364FQA(YG#,&)!2X4_13RA?J;QKS<.$Y><Z
M'J/2MP7BI[##.W:0 K@FGEB.@L52;XJK=73<DK]9W?%E4SBH4D_B?J+?2[#0
M8EFV\'$(#U]7;:D]0:T[=<)2U%RQ2,"_H$$N<_-P=B5T!7L*EQ>]=)CYM^C)
MS1VNI-1LH.B$79JV0O410A!2[K&V4$^W;81#31=W8M32<.5/.DXBN^O<C[SD
MTU1'/]]K'>7H977D.;E@,_P_7&Q%T3)>#562]*3 ;1*#C&L61[G/J[7^KJ"+
M\A?5MO#P6YU_)/WU^R,$(BA!'R1"6#B'Z$(S'J)(_#QG -8*N-PJ;$-V:Z/[
M_Z;>>O#=5KCD79_7AS*'$GVC4H[YJ_)9\$E+=+BN]I[_9[4.[I^U#ZR?)/QT
M&BFRO)$OO#^>NJ<GP-#T]0QP<Y=@V9.V.?:;!DTG#%1Z+)EQ#C%+6W/OE6!K
MGC9^.!JK&V])O'CMP;RY%F/0\9/6GK87CZ[TT'& #)G":;+EF%1Z!KC:0[V_
M@']_6D-6(#N0-0]^D?4#CA&>9P!!%:K-O.W<','.(-,[@(7N;3K;8W]!MD&!
M*P<^%?L35GK!34"F)%)(XD"E5T]C[=>Q$@ESY9J5M>0 =V'!4+^-DN,:C=!+
M-&QF.HWR1+]DB@DPO6$'+H6Y=-YHZ4X)4;[T85N$/^H9O&@LV/$K(-KH3393
M'1JR1\OVV\-D-==&P5A5=6CHXAG@FL4?[4L31?&'<W.3/U0B'[2WODIF,V$0
ME7I4F(@#F)I7R/:O=UPSO&K"SI>5DJQ \O";&&OR[+78"IEQA[S&3\EWFG0;
ME(CX%45Z$W-'K4N$YT?U[I<EKWK4%94'YA^#-1#IE,?_,P[0G18A':\YX&ZU
MJ80^T6H>V9'PO,OD[ROT/7U.MQ<JZ]N4YFSPVOA-NM$OU*#(7Q^U.QVK227;
M#D)]62NISN7\E(F%U2 >@W:.@1CCUAHA?3:'0?JQ#%G'YBS=Q@T/D[ 8(93?
M\?/_IP.NJ!:TTP+IGO]4//P<4TRK,"P92F=N_;-!:H/8%[8J]':N-<CQ^)YB
M3W_=VV&!IUUPFO"ZN$*"N!"@Q%E24/[FC1YOYY-86UW6O  ##\8,%?!7-7VI
MWW]1_SKY6T'<AZX4;RPP.N#(R&K]##!38-,<R?%M[M>!-JO5&:"9I=?GW+J=
MV@>2&O^@U*&,,N=]&Y"+<->04;6'AIWC21.HPZ3D!'UI^:,)8PI;YW&7I >7
MH3%6?U?$*,"CMR)W_UBPX#>&$$AAIJ.ER4Y)!AL;B@@IQS<TZ-6#SR>X6</Z
M9/U?HU;?. ZVZJK6(0=HG$N'!X1FWT1_,",IID\/9#E2+']DNJL^W7'QAM:E
MIW?"%.^$SS?2;E2+6$Z0W$82+(&L)(^"C\W%#4V5.=.6"]U]CRS.O]>?O-M&
M=S<UX)?R0FWBSB448B&O]G+2-X5HOT&5SLQ&*]<D*[<BXGR?DRBS2J_*\(>2
M*0Z3I8K@:KB:[YNNOG1Y5'W'_IP>1CK6AFNS^7"COIB.V0$&D>O/MQ/K:)87
MUTT;2Y0M4&S)#*@.K,]\. ;6A.VPG6CCP-,N1,AI./Q2/KJ[_]2L"W%_<KQA
MIOS+]W@?P,**Q@6^*[_?*_PZ?@F[L)L (GZA.9@77)&0N-VFT U^PU6WT_W.
M_M511J;U?NW6LE:>4BIZCR_Y#KVCC\^WIWQ 62QI2[+4D"'=/7NEGRM!OEBP
M+J7E,'14D@UK"WT<KQVB8UBJKWI0Q)51RH'9^8[!"(Z"^XZTVOS,9O/^AP^C
M_I6,0-:X;+\II+RPBSB9F"S'+?#J!9S ,^(?KK3$F84'>.!<<\Q$--O0" LO
M\Y28YHYXKP_6)J^XBPQ]/Z=DB!F90C*/&D?NHT*"K/N%\,/ #R^\CF,Z#8H9
MGZ3:#RNP+Q<N]7N:!=[/285^(4Y3L)];4VE/XRVUH_X,4(W>$2\BN70$LLRY
MMHJ%B<8+V:@Y-KBD=OYN6EK%_+P]3:Z0^76_-9W41&:A#OX[QY(7G<O=2"K.
MA\WV8*)J;>E^5":;+][\]'B->?!J-UH14[8]P-:XN.3^Q^%-),]#2QV3VWY_
M^-B"5* %;J+^XQW7L-UNRJ1&N96K!NVUW_1]W*_2$"93KZG<-$LN1#[I7PTH
MGNS^KZQS21SD4@["(=L6V+IXI#GBIZ*A=;+IZQI\Q_;I\FH^C4KG4G<O(>Q?
MTWMV4.E;R.P4&=(1F9ETU$45PT\1&][6VF@]#QO:(S_>9!*X5]F0*54M;,)]
M4R6[.MDW_#W@<P/'BY)%4*T Y_Z!C^(^1L>L+M-#\D=E 7;(Q4S!0E80G-.!
MT=31:W^^FQD;/(/9 %Z<LL%?^&F*9$.HP@3;3R(R'FQ0^:>V_4H_BL^8NN)R
M<8K9^2]^/C#EOWEE2)I)YR_3_VC+Y78>K]HEDAGQW^[B=[@\?CC<#[T=>A-X
M Q;L5T]^-L41V/BV:D&TQB?$A6WDH\MXR4N7]"Y=#%G8&*QK80,-F=^J:QX2
MRXB$3+49#17BULFP46^/ _ECV\D&\9Q6T6,>*(7M E$8C]HVHJE(A@U;MG%5
M]:]66Y;P#-_Z4E7I1N7>VDM271P7>#]-*1 <J/0S2]!P=,WU:(*#T82J."C:
MGPSA+@V!6'W$'++O2O';3^0;7SRO8#_$].P0589>K&P<#H>#R/9P@6;2F\)-
MKK7P3Z.[5D9553X9M^A;PB+N/?UUEYC7VGSAK]HQ69LTMCB41,//(WQ"*6Z/
M'A9N3#+S=BB4SRC #/2'>+#\_#)A$]E^T^ !]]%@LG*#)8D'Q.',^H 3XIVF
M94+>[?TAX?S#(:!E1S6MO.2D6Z6CN8 E<XW9,%+H=\QRHFP&']$[0S4Y]DCB
M1'XW-WIE85L!GX7-ZP;'*D=E$*RZ,GB9\-M<_V68'E7.=[B.SM'GF\3Z536^
M=PBR ES8=U&\R"M#C,)G1#73$5"=F:#P.C>Y88:-(V=Q^=,U;<RFV'F.1I%2
M?]5(H,[)+2I]-!D$5S@M1;X"<[J>K$4[CZO>OIX84K(ASV(+A@I\O57?>WTM
MYGE7NK#%4XF?*;E/+Y?!E4\S5.DK:/3=5D+MUIPK OK&84*.P7],;=;K>X(H
M_6I<T&=UR9OWLO=ZNZ]K:H1Z/"/&,_;?V-0IWETG:S%HI0F4UC>L;K@XK2)"
MM"*W<-7/[A5<M6OM#!$:;_XQ&ZBM.]=0L^4?Y)%/.&4[,2&K4_L6JL';\83J
MIS1_1"UO/>^2S\(VT>_=3]1_+:29Z\;^1$I2Y->C V6)\YF+R,6O2+S^&> \
MA8'T))^B0W*>8C^Y7.#+>(L=["LPH&9-J'T_S/)+-U+ET=T/:\%)":X_"9-T
M+);Q OJ%)M PP_C/"XZ[AU:NY8@B9P3[Z@<Q><$;6P9?\2?C$??_X- ?*TP<
M)QMK=T9/@/0C_]JA'Z(7LW.O$A9^-IT!8L\ '-"B6OPK!MGT]##L3@',_F4U
M6!0UI.[D:/R8GJ_D%]L&J&9ONX[,AYA"<WP&G^LI%5FOTI4OP/;/EDX[C+\0
MKG)YAP$KLJ9VZ_-W<U\*8G6 K5V(+K'D'2I<TM7NDVHVHIKNUK7FH)K4TTE6
MF0Y"V,W&6K>^ENR[2AB?6+*.B,0F9GW/,^,WY7=)F9CSA&1^74.,]JX$O_GG
M^,NK21\6A6[W"K+M /$&Z BUVZ1K9&=8?SN"Y=^9]&9046CL=GTKO.;8UBF^
M&77P:V!-8CO((6[Q!4!T4.TZZ7_?)9W\7W=)D[[KW_W(+Z2IZ=MP6\ORY)6\
MTDLO@^[GX(685*.1S8J4!=N3/):X?EXFZ5R;V&3;(<^;[CLAU2LI9MIU!>X;
MP4 ?$A_URMSB0N3"=;%F#<(8SAK!#!G,+]N1$-\QG9MVU%@;X-&^LW:7Y0+=
MQ3>954M0TKVU"(0@7#FKT^ZBFH!@#)O,<EN(-]3_6O^Y :1KA%#\B5?O88_E
MB1DQ^31'#4AS40L$"PEJ\EO5AW@&F&[UJP\TO2MARJ+\";;KT2]*=UE@L;JR
MX_KA07'4&< >C8%0Z?<*86%G *Q^TR=2 7B"74E2W.,34Y!@6A-$O'G3+.#V
M]_B9+(ZVG\.X:0G^GI=WAU4[9EZFUA49BLB.MDXU>#:@P3(G=M*+ RAZ \/B
M5/(KAJBT$KVA4GC#ZHJAWM:7F+F (_#0G)GN]]^'NEFBOVSG-X=,PURS[0O\
M!2S W^_$H&S+\6-89!S(4Q)3]]>GL@,'97?WG7=/:6E(N9W%[B;A#!N_UH1P
M:(BKNA &V49Q(X;151G;I;BO\ M+I3F^M@3#0EWD5^[8 ;?MQ1NC# 'F8W?#
M/3#+$O1;PYM*T2PC;?H<0>TF(GVJ0[)3,KJE&T5_;>P<\,UY;PA*.<K?^TSL
MM9@X]X4G,^ZE;+ 5')676DFLK9ZR'9I16&NH](=NY'ONR@KO5$6_ZGV#,76)
M&8Y\04I;"0?L,6< Z+2>52L8LKW92/F[^N^%<]6D)TM[TWM85 Q_&/#R'UO7
M$]L&'/*&6@F($B+W/GWYVR#?$\Z@JP>5%R^^?R"?:ZW%XY3J52N5^+&]U,W"
M/7-.VT:EO*QBKVHV'(]6[G0@*+DOQ^LP&\)'W;0?9EOJR1XU5>N&R(X<^VJ$
MOB.0.^QJ@#2!YHJ.("+H$A8Z;1DR-W94+6\9MLR)U"9U5\O4E-CD?^Q)-=$?
M\A&9HK"= 8A\M'Q2@K.CV\R]-+(\0E%!6>E!O.DPJS^,&]^%>\[)-(5MW.$8
M @5XG1L*]OIC$E7Z-C\J3:G=)#4[Z'-&^]S8Y,:&_Y=!2$EOPB*/)Y ^MOMQ
MG4A2AXY4'G]VJQQ[$=!?$!@\."<[7EO]@Q ?*D- $6$D;BQP>J]C7A3?T,D]
M:(?3._R2(U&0WUH"$0NH[K]9UT?32N^#/)^V^6@J#5L>HC$U1%F2 UD,V::D
M*EGA;LN5 ([)Y8\:NM02JGD@!18Z6%5[FJI!_AZNU>>@HMVKVD1$_:MG461I
MB=B>!,3=?X=%5<%ZS,=JM7</F7882E2GOC=H?3@&"\=YOM0__UKE97-,LTED
MUWB'?MRWQ])EBV4%;G4>AVB^W;J%)^M>%/KX_I(E5YR]9N%2-+%B%SX^UE+N
M6K3#5H_8Q>1='+$S1;;1EEK,E4?7LZU6X<"LFV9<X#?-,D(Q*XM.";H; <?Q
M'$G5?,:/R[8UO98XAK30\(>D2V0VZIB:2@IV(1S=( 9_-C*0'AQGUA!+),9K
M.[\=&F:Y\6TP+.:*X:-[+8S]<97FRH</*"E?-PI7L;Q.#%M[*A69&\BV7#5=
M;*O3!WOAEZ?E(CHU[MGNX'03KH CMIS#$=NIL0*MU7*VOZ!WR,4<7M$QD,<A
M2=+%^]K@1&>I*E?!_7OD<W8R.Q*?ECT>J5OO;]7RJH/T8+/$T-,XI),=VY-%
MX&WKK<R]F+1[5N0#[Z#XA]GGN=0]^[D<'W@T64>V/0R:_7>J0"+;M=N_R%!U
M4W9IX!CT<;,,S?U7JK]998!PM98@4QP=*4Q6$!E;CLTD"Q?NGFP4U?TX;M$(
M-:'10S&:=4(M$;\R$^)QX*N;+.ZY%PBZK+5N>0/I?39-G4X_SXV,B<6/1[X(
M=CS)V*ZAQ=(^R0&+FNZ$NY-JF-XV:[BI J$V@D]=>#70.2L2_SG9S%1S)AP:
M6Z]QW$_S?-"?_Z;X@\8/S0*#&-UYGV"?&<R@Q?SN?/"G#I)OMO$@Q$G&(&*]
M:\@GM?S2-:""M%[MF&DUVJ]L!W^;[8APFOFO=PFSM3C?4@J7&D>I<9*R="Y:
MF6^=5'?6]%>F:5JLIOBH79GC^6C4N[0" DSEIZ[YU5R'==^,^#2:ZEPV<6AC
MZ78L#Z,\:2?%Y1N6&!:*//[F*5,LX=ID22X<,S-KM/M@H$%CC/+_EZFK___4
MS?_O3MW,J\RK[%2>&*8PYRI2%$X_J6H(1JO^UVA1Y:R;[^<)[50SL'Z0,C!;
M6_)+L4>.P *3) X.G^PE+I!DQY&D%<'M%=K*WJ0D\@,*YTCSM4^NN5>:1_U
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MO6!H5!T324=MD(C:@02M[E.'UU[-K/3SRJS)^^:&<ZS)@IQ1LU9==M7H[I;
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M/<A)\@;-F9_0K@O3VP>DFTMCBR!'<)R"+6_,)"D4OYDD([' 3+PE[]I78JR
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M.":\XWMWY::,S(4^?Y EL04ET#TZ(F*_F<E?JGG-QJ,B5%5K(["/R<Z;6\I
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M\C<H-NO$[#%%!DI(ZF> & K&1]LC753I<;&Q0Y^J7.J:K3X@><4V+B1+W/2
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M_NYQDVTV]2S&4BU'.:%&B6/-Y^:]UW0OR0.(^DR*L[6',]@N0^^=3*A]$:G
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MUI?%IBKUL]'8X] *Q8<B3S?2A=@QPOWRJY!Z]%C '_?"D0B*D4<Z ;&&DF_
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M!+:ZC7N.,B6)]GNPV27_#R[!>'K1D=_>>'@SZ@=\__CP[R_1K:\D-0.VC#.
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MHF*UV5RZ&KQRS_OA20R0LAP,9W%L;?20OJY@.9Q.PHL,FH@9@Z? 0-HNK^1
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MM5/<@J 1\CQ&I!5GAO7+?HOGCJB"J/@^SA?_:> \4\"-!(<7_BGW@>$>&<_
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M*Y<YA=/5CRE[Q1M77-OQJ]<.YR>F [3*>E/$>\]73_W63V;#+R[^5I9[DZ<
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M2X]Q\BV>5!V)UZ,7H3^\E&_$:AIS\90,9$FI[2JI&+EQPWMEY4)O[QDS?9]
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M/&,C*:"&<GFCUNHX"=21PQ8D/\9';0^@URQLC-NAO0IAAFY20N%YC[VL4T\
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M919KZ84%"P85L'=?7""GK&JYLWN%&&%^R&XMM38DOEQ,="O\#Z1(UY40362
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M#-ET/SM:-LO 9VN4"'=#IP<2@UFUK^.=TAXO@8NDNM!\U7\Z#3+2E/8;EHV
M^=OPV^N>.)<#TO&75N<<U)_NL'UA'CN;=KB_:(!C43ON91Q]RG\K/ZH?.\#"
ML9;(_'V1S7:%V$.(CZ'?.$ZGG?8B^W1?\O]"R?UC9SG25KEJF0KENJ4;R^&?
MV,.2M]2!XE*V#\M<O*(YM=!-X] @Z+5YGM?[M&H/&D/O?1%ATS[;\7 V.(OI
MNH-;PB1@DP/EU_DRM(,U,N"P,Y33%IXM-JYTR0?:!&IN:/K0)W+JE^.>R>^+
M '66G1VZX NX:>87DW?B.V%0Q;W*V0M)=G8%$@5)-8-P58(T$J6$U&:/*B:^
M>%BLTF-,5"GY<ER0N!2O^+AL:\3M[Y7MAS3Y0#)[URP_I3._7?PS0QP+NW(I
M%!";G#Y5-$2+1=BXW9+G!TH>&2L8GOIQS1=&,@Y]D][UEJH8%$*N+3B#"\DJ
MH6F,E2E69_),F?XSDY_^:/1X,?[0L+70">"2J4=51:K@_6))W>U_,)LC9%G$
M_8V'M=IX.>99=V4OV[6&5QIVB;,;;)HR">].BUX&KS:V*),E8D\ +I"W)P .
M33 9VV7YIZAC,)+O-%);YY>9Z9N#Y7&<\[EE*ZYS\NT\#^6Q;V87H6]A;&;K
MAA)YJEI6NE)V5!M=]YZ1VB@QQAJC&PS^!,=QG]59]L%K6D@G+(>M2%EK?3<P
MGUGB*X%D?&S4S9%.3 )C$4$K[0TR*QT0BJAX@4ONE-$7>R0$;^V>GGGK\TL9
M- PB?[-3U[AMZUSHI$=;-4-,HW*8E6!7Z+_YY&)H']'5PA<+?B0>W*OE+9?
MIIXGCL5?$F'FK<5<-XD'0 = 9UM=A?E"!NBB298D:&0-*^N<K=[2@_%-%N-7
MB\"\?^).+7HP<4XAX^DL3.28SKDK>Q!.=WNU48_]G,L/#OG@=YJ$7:H3AO)<
M;+R$D^KR%!8_ST^TQO7L,C\A/]+4>"?FX?)SJF'9$IZB4X0^WG)RI',C0FX#
M\0_2>9HN.Z$L[A3RWE/MU.FR'[#?3,Y,,@*J"$']T/T<6\TB=&:9$X"4"&G[
MN!.TEXC_2)5 &G1_%ZY(BVN1=K._.D1#$()9[;##>.QH62R-3S#CW_*)PKFM
MBIL&YYZ% S,?"U"8VC"QLY(4$3*?'!<29D[O)9_YYXD@;JI3"J+$*]KVHRRS
M]-9:%[+3B.1". &@&$\6PP8NH<AU6+][ARF_HG?;YI:4^MOWY2@65:;W/ *6
M1Q&&46A+M+6W_9X;4'DX9,#,&Y4.-4E,A$(W?!%"O'J<CY^/?C%%,]M?[=!R
MS)T.+G/KNOK&8\#DN<? C QPO:7\.*+5+30NM)J)*+S@2Y^J&Z&QNY1,&:&5
MXK(\"]V\OE5^N:*APR>E(,]6<M605_YM_\ODG>,,.@NM7V)K+.36EE@=(!3A
M GK@8POJ')PJQ:]T [.T8.Q(@D4+O;<A[F!<-1&H_S1;@06\U!89GOSJWK7W
M\#1**_4^980P&(]N,L&CO0EFY+.9;#;?@RKT$*)@-G'-EP9OO1.--ST&U<IN
MU5]"0K/L#5X0U#TNW?^C%4>K6&[>;X@MPZK?%I)MLVPSS5T?1ZM;6.A(IQZF
M)'H99MM&65E) &NW$:R?-UND'P6=/0&\Z5N?%9GX^*RZ$<3OSNRKN!&.C9CO
M9TWWUEHO^[R[J@#L#(7+3>YV"%>M=!W[Z(V5>827'5;V%\(0SF_-L/XR A5@
ME)8Y:C[Q\KWE/,H<]0G-X#@_Z':A*UV9K-BP'Q<OE3WD5(6-^]>[\8)B0E?Y
MBJ>P!A^. F%@]3E*/\FPS635GI^\5>J2/]6Y^!VN^7!6K#+4#Z0FT,7TN*[[
MF>5OV\9;[53UO5&!44XUG5Y;M$Z+E92WW1V[":#U=L&<LH9&#SFZ]FIU28EI
MJ?2O]+"7>5+Y1;S:.*M27>7$='_HTGC?\+N(\A. <RM%'!9],\B$W2W@L.N2
M1V<U6G;)8"8XNB<,_<+A2;+I"4!2\RIO(-_@<;DY*T6"D:8;?O/'8B._JV[0
M,\XB63L&HUM$*?WXGII!3KAU7'.I\6>^Y1T'D7#>-CDGDZ1PVU-)G1 \PS6S
M1<DKKVAR"UDVIBK6PF]%ZN)U:W9NH*S*MD33EBTN4C_>ZTL5$7ALF>QM^Z_[
M<(=YHO=!9;&&/6XX13%OMB_%#G?@:82JR#0)RQ9JN8P2_;SY1#=K<Z[16LFV
M")V49.872WQ1 _[Q@Y06[=G$BL]2L1Y>@=L9@AOB=L:=-C@JOCIY?GL-^RP$
M_+77^FY6D0PC/BG0.V.MW#R_NB]SZ9\WU\B<!QMJ#D)H]K)AK=MOQ;V!"ZQO
M0\\V&5'O(K?FVK781D)K:OJJ7UZOI3ZPI(Z=LUE.24$*[,!G0Y_UN]'/T@>$
M+]//E%=Y%KL'"%11WG:0<3,7(F]BG)UWT-I2P ]#F5\%/)+N;.1$2NJQHSY'
M%(@- KN\9J@29>4-XOC<C WQ-+/6MUZ^S]6<@8*1A<?),NJF 7)EP"Z!9IR9
M=Z+=C8S5H-:;:$74UL^!CJK; HD0'_N_G4\W*(*LW9XX3/MX>G0))?2N3/F&
M0D^'%VXJA+2E2BVC7J&J82Z5-RX4=<,X:4)#0> BBJ<E0G:B<USBP5A0(S+;
M,,,ALTLPN>GQXLH3T\ ]SCVK++[]KRF2"^FHQ;*,M6#^H3NFC?9^6BK7.Q=N
M3<8*&&O)FB^(B:=DI-086J9D@._X-9?O:;VG-#-<UZ&1/-C1#S>%A>6<V>]S
M*U^TT9CQ:6?D;<-G99;"ZF:WIMMNO?TD\/RL?\[I$X!K* 7I\BT^"L:$T12>
MAS"OEQ;D7*$\G6NWAKL=[-K;U*Z<O5"GH/J[GN?(?U' BR3S(I2Y1882,^\2
MO\=(7D@SLS2]B>JV+MR:"%C9XSZ*I<[IL47D]=<"$Z]1"P)\[=[SCS^;<CU'
M-(OQJ\X%*U:-. ^6]37]^]-> ^><Y"LYNFQQ(]DW;,34$&'J'SN[9I=]1+T1
M ?GKXD3],I;**<JS*WJ0O<GU--I5@1- 5\?_>UV3@'/IGN-RG14F%R;!2V[R
M>79(1$.NV*#S^>5P:M:N/XY _K5Z3S6;F[U&HO-(2?BYR)"SM/LC318+=CK5
M6:%@!7Z;SQ=]7MH07.<6$ZPNF_SV9K6>8TO"2R^01\LQD:VR!] "'G@1$IL;
M8%/^[C)W)"G9R\K"!MQ]?D(YFBB]6[I5CCAR3$4'3MBX!T)I[+OS!V_)&0=Y
M$S*^1%FY*Y>X]49K8D'_)D278U]>OFC9+?#>_[9#'>3;U- )X-E@O+TRN2.$
MEV2<X[F09=:O3':=Y2;U-Z-2-XUG\B-_EIQ[;MAZ6C2[L"60M!V['WH>V3!G
M/^S+C[YM595#O&5O_>-)*N_MK%XHSWJ U]NXE(T0509>)@0]I\3.]VB"2H/N
MCQ4.+T>V2VN?X1I^\.X-YJ9)&>K\_)9#^J @8XE/FS%BZA5>T09Y?F^AC29+
MB2E;&%*S"F[F(XQ]0?*QI: %^KZ[=]*+9$\3@W'3-$TG(1O%%B5,>_ QE,[R
M YM "Z7<5[ITSS=FB1*:5S#P*>EE7^"M^H:K!L)94QDRF;N-2L,A0\03 /_<
MR+MC(RW!$\"P(=^17F=H]5R\)IQ!E%HNC37=4SH!1-#$% ;S)_O.2&P^*[%X
M3E6I#!<]ZRS-Y!YO?US T#XY\6RT!ZWCL8-Q(HUOCGS%JU\]=>6\*K[SYB5,
MNNLMO_S.SB6O!:0_IS%*"MP]4V"9';N^(JG::*/CVHA&#*\X@U!?.2MN=YBA
MCFDZ+/V*U>8$)=6YCS.SABF-=G8MT,\%5$= :\UAIY,%2RE!T!:@$5K8;Y]7
M "';'  I\@RB*! $(A=^?CF_+625D3&&K69W.U")-#!R\^+(=G3J-OI98OL/
MX AY--79(CVJZ8_O-[,=V[+>M1PO7VIMSBPISGYIVQ1W_]4YJZAO@(LD8!V%
MEVK'R$+IPZXT=CS13!M;YR6:VE<9Z!*ZS>-D&>__C-CS#0/C3(-F7TTY+PE)
M$9,<7$@TF-KI*=50W#RHLE[;/?+P#2OX .TT]Y7:K5<USJB>G\8$^NB E9 ]
M:C);V>G4%10&?0)PA_W6[IJ[0G.;CV5J:Q$G91'#U+DCJ]&*;J7XVYH%SECD
M!#/P!FTJV2OAU[G!;M]9VK/C+UK70H:2;+"Q018E\*')"CA2S"EN]IS(F7Q]
M+B51K_>?"-'SI;9)<J5A1:JCE<LIHV8>MRP-4U1<X(4'!L1)41^RL8^V?(=9
ML2ZQBT4A,]E!/8ZX"V8$6WKTN/&04<_7W&C@M);C_ZETWI_;__F4/P7+@-</
M)X#DUY33=#SH#Z(!@S.@P\GQ=#WSUHW1T+WZG(E90&C/'1MZ*P,6] LY:=_H
M@Z$[&=LL)X!)EW<G (C2,0BZ>YIZYP30Z]D$/ $X90L?:TYT.&I8[,&*#S.?
MG !D[\!60R&C)CI!Y(-.M A=R^9X;AUH4/4BGG+D>1CZ!2V]6E1APB*96RWY
M7RT'^'=T-YP XC^"9D$#><6RK81ER&'\[I<-U$\@B8E^N92QMG"*"KUG)HV>
M6:-^3,=\$Z:H8^BFW/-S5 D_V!_OT8W?/TX LRT/CK)OG@ 2 O?U-KMI[$ET
MDS62,+UGCK'$O2E/^W[[VPQ++3)^+2"(Z6^77$9>.E:>FJB"IME0$O==FL/I
M9^YP+X8PJ/!WJQ/ TK40T F@SI^>@8"OJ#,LSS+XU_)DQI?:6_>FX#"UB0/H
MA= ?:<PG /N_/0/.GP! R!&Z@4#H<0ACS@4_&"L[C/_X/]\L &=!#$M.MM^C
M8$/Q\3S('7@&+.($</F9;AZ:A]D*,Q-U!:?;SN/&P_;^WOS%-]_B<BP9@%6"
MW&CGWK&F*0UKBI&FVN5/7ZK]6.1:.U*ELZ98F:>("DS 2M0@/Z"&JRNNMC]V
MDTX,K\](NVGFOF:G:]2+F]3M4?(OT2IB;J>XSB_$]P,;3(I#='A\!L ::C;I
MS+I_Q)?\1BJ'5WYR0'];RT5I_BW5=I4"QJ_N$X7;M5@IWQ<$%8P<(&,O?B=!
M:LDWY0E!['KO(YX:A(LD-8H ;FFN;.+>0"CB_D2)NG,[6TW*?0F'D(,(!=!E
M("MQA<\3-^Q5S#L2EA<,>BG9"3; 80(V_MUSF\SR#.,HD7I87J3[HF0T;-3:
M<_*^:;(8US:OO7) =9*IL?[1F^C]T%@0IZ8107AR8T'EG6_\A<&\U6Q.["A4
M9\P1FW*N-FD@7@KZF+/CV>>0^W>G??J]HDCPKJO(-]U@& LRH<;.=$RN;#/B
M(P@G2YS;,A((]-=$3"9?">3;__+TJ'AWO-INJ4@A0*<F\"@_ ^9\$"A\)Z8O
M$QBHJ:*DXZJQ4[TM6037:.;W@A!M/KH.>$3CR-CV>+8@Q='QOH[TRS4+U*ZS
M87PIR;6)[U4EGD5?\F?$(&.R<ILF3^;K->74D;IRW"T8UDCK69C,%KWWJ7*,
MN&;3ID;OV\977M&^7D:2!HFFIF[V:V[EI:VYTYE:9]4L(J[7&;!Y3*-KQ\JR
MIXOG\ %R'Y<X++8O46!FY#BT8$1\X9P[=L3%J2:K<? V8<C\:JCT,'FE+90S
MZ&9]G# [Q:5#B#_=PR'>?*2PRF7[6X)Y^LQX8='F=-KMM> 00JJJ]7#AABYK
M@L?F9DN@P#&G4FS8GX)%RX.O_5Y>&F?B)-\W_NC^!/ &[W&.(M,.0LDK;_9
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M4*)2'R8J.0K'TT2,2GA*XHZ9/=7R>L4CR(XGIGW&0J7'A>:-V\Z _#?UU9I
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M^)DFA"+I1M-"+T^ANZ/>3C,83<< &J:EBS_Z+)GD-GCI?3_[Y\+9<L:RR1/
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MCRRV)X6.JR=636H,1\PWRB5U[JRV%8GKW!TGN_%2P?2I#B&*',GV!(!SZB*
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M!A=CNH-.*B6T0T"; Z+A4#UJ0:FB/@0[G?EW1ZOZ/Q1'X^V"J^#IHY46\$N
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M99AK%NM"AW%6^)W+B[L')3A?_%CY@] D <(D\>TDP),BC F1CJF5X-0(YB(
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M@8=TF=]LF M.&?E^+M*EM^X9G_Q#05DA A!8^#='7E5J!(B:8/P-7X)35YU
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M:X.:*"R(MR]?6E8%&]-%A3&H-I6X:,J\@\P8ILYLE<HYH,9^JMDN\;%AYH$
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M1#2^K$D65?BN$9XSPPF7S&BTM-EXP)53'RW"+)VL&G/>=SG?_1_CM.8;4&3
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MKYE/"C$C-@9+$,MRYLZJ/S__<%PZ =;W)WA _MM:>T\* 9=O+:QN=UCQX T
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M?Y+'HV\Q;. >5D_"6I"62J"2W__,^TXY\JV-MX7\.3]_$$*R#I;\Y^3\E5-
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MTS2JT-.U&5 GIU.$R>[S0.I-@3EX6<I+;PP]U6%( @F5SW95S7&\F0"1ZW^
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MK"UI,>ZV8V3AM(5Y>X?MS]#2HSN7^2JZY9M+"[' 2-X_3G+^KSB)#'<'/4%
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M1$G[B2!F0IVQ8@P9$-4QW"U>%<B&@>9'.&>X<?6%\O!V3-RMP!C%FG'H<BE
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M]3\X@2FA64V<)JVM^RN14T>C^Z-_;GS CA2&@[BG":JGBVV)OGT;LN8SWHG
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M]FS6ZD@/;;XD1!I]QZJ@!$<+K.;>^F@=_S&6093+8(73U[3#JI!=Y5N43'&
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M OCYU@I8BZX8T<V/.R*(V]<$JZ/E^-(AO+5+)PS!]S27VXLJ<.A#3)_N99V
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M!UN>+A\N+U<-'"NKI^O8#XHOFW@8-EE\JYX>>9X;*5*_UQHI^/=?_^)!_YS
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MA5>36#TR4(\Y8C]NJ\^Y8\_#'\4#F5XL%+0^\O< 0Z%0.9K3"HSP#*&7=%4
MKZWW*7V3=!/,['1:]^3Z2E6L?2S#@E?+G0/.+Z<3/9[Z:13+6T0SI(I$+XHA
M<97;M;-6X(+=TI:$UY2<>RC<WY5F5&B085K5=1M9,3DY-34U80&WM/15I9^F
M9-_7!!\;3(RI1@0VM<V"59H=0?N\,;;[,$;E!:H>/2ATI2]MJN>%>SLQSV5K
MGH[4D>ZZ58.)8_#-6%QZIU-R-!4P?DH?^FJ<P>JQ<9,-6H%]JSSA<V?0*VV/
M3HW[[,OICVID5D13;UU<TT?V@M!;>;O%C:_S5*&WH.<IP]YZ$'\#;#2361=K
M9*OPEX\=FFF]Q]!.X0=)1=6J3KS)$XI1SCM*A0?PK<!%&%W ,\+-17 PE^!X
M"5%"(%+BSCA1K@0,3+5W+7HBRU+XAC-*]*6@Q_O[_LG4ALU-N&<2MWV!G;<5
MJSK8YVE]@9CEI$V/P!*]4O-!SL-:63.Q82$V30<JQTMJO>^B37O9+XDY60BU
M?T_F"T%TL\7NZ2KW*_'.<$Z(.(F-)A^B2WKIVE\HZ.=<ZZ7=ME<SI].+EY_M
MULA=3I74:0IKF9QLH*> (GON6P2?#FN5\R*4'LWZ P*L]9B;3F9L>.N#?/ U
MC?A5-P$/ $LT/.WC2J-\>1V$_:?#PX*<MQOTC]0&93B9QC[TC+,A0$6R7W-1
ML^Y=J29SB%V/P7Z/]<5O0R'!T44U=8A;'AG9\2#! G\^9*_M#O>TU)$!7FZ[
M&Q^YB3UN39/68R2X=HS+^LCIQ[P:'E]\DB+BB)@3&G:Z4<3U7&$UY?1U:B?\
MXAJ,MFDAV=T7K#7N20;<<*X%MK/[3.Q*'^V+CA]I"X'"A:@91-T^?JX^T0ZG
M^@!F&K(VYN)L?Y1%PX!\YVEI:1"3E9=K$#!P9&XE>.P$?PR._N%>'-DQTFJ.
MYI>*7MJP%AHTT[JYI"N7@E#0UKEEJIH]9BE O#FA;?#0@?"C[^_#E](U%WC6
MXZU>Y^$LVL$H/>(M".82\CT"*K,Y'R&G>(*G^SX_W2*;73Z3$>IMQ@DRY*+G
MR(RF K,-14[Y<>KP41S4V-Y8CAWY3C)*1XC_('%\TPKZ:[&@PRC#K5W?/?2;
M1HB6L\1L$F]^1FC".*TF<\'8*5S/.:Z"=&6]H/@&*TE42E @A4K[,X-J&G<6
M-TY[@JH=SL;,XPF_>CBF-AN[:?MA\Q?)>)^.J>!9')S6@FZ0"%*PGK8JA("M
MZO)HE VW]J^) R=A?]T,JVD4?U$]=S1\W%"R/9L:(%M0KU[X7E*G[^6%^16F
M([GM>'P-!<L31 >*%L&B,]-KBK%I?#T:[H-71\1RTTS/D6*9UXXWP;?UK5[T
M?67)?%1L?-8XX#FU\W5ANDG;?=JE;LW-OE[-]%+H:<.5LPV$XG?3R1%#D/G4
M[,!Q8PHJZ^"T DL!9Q'M\XQ$_V+?U(7SK@BBUP+GJQ7M,Z4ZJ//PG(ZB$+M/
ML@?'0!R[QHNB!5R-$FA*7F\*B8E[KTH5H(J#AQQD/=;!R[5_Y((,,D'8H$N)
MD^8[S9&=P(R>5YDI7I9+7JN..*R4SM[F-5F+Z-"B[X<G.70)<2(I*9:[:446
M_GR,LQGFG"^V]L6+:(;;7IX(&\_V!.!CBYH<F"]BO!%^6E#URNPJ54HU%IS[
M%(CA(XC6L.<1]')$D%Y*I;KTA?HGPZ2?+NQ'@/-OB3Q]$/#U^]9+M)-[;MOQ
M)Q-]--4%1;&:;QI9N&#ASY.WF\34E<S/H="#>:L8O@ZY >?7<[V+T8N]_54J
M0H8-VXB:&O3X^(C'QBY!8#?"1564U,]=R=S6<'-; !\1)2KM=!"C:O%M>XYH
M/JNU]YV5Y:]F13P<RRFR,O\)3'>(#.52&B5*846 6^>NFAD_Z]'[":Y\N.MR
MG7V%P0H&ZC9#5KZ6C077K)PWG#KS#)RGB@0[@4S;$'6G7O_#-;_?6U,I A)M
M-IRRW_4-(E,EE]T\,K<6>[WXA'8'(2+N\W_NC(XKW_G?/0'-C3R(F]P]TB!$
MG!F#BB7>!RA.X7^U\Y^=RTZ-JJWL[IVD/Z'V22$#?(#>/]JQWS#KM;\_?5-W
M61K6_HI8;XPPH;_TL6/\10"?@E$F.MHP*2MY-J'.&]2D[M&_ALS/IQA!/>@7
M7J,OB O-:+=H.?*"!+"T(S%A84RD:X3B!8=("W6\=TB1+\S0>.YNW4?DEZ8Y
MC;/2ABHAGCO1$_RWY)M?%6[A4!BY*<EH^$R&$IZHE/'2Z>R-R^T"^6V_5GW3
M;>\$A73!W :>3AK!TFQ82! OF@"DCX/K\+2:LA4-,1#U;E[&/;%_P'+L%[)T
MJ=S4J<MRW$ODT>U5)ZM)JZG=\OT]V;R(8M.TX:A4X;IREVZ76;0YPCKB :6:
M#?^?Y1L3"G>&:6S"@]MQ:XVL0X><'B;5W;'C/9?3'U&;W+G.Z)#@R[GA;!1]
M;U7.KLK5SDDC1JO":%V]1^])0IUKN;;'[<ACA#_I:@A^LRV(BS1:0W M1I4.
M+T-WQ'8< %Y]#WX.![%#6I$E7T<D7J-KPBW\HWP<"_XP#]9F,KWTNWA#C;K
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M[:)N'IYA\<B+H.V*C1+QAUV<;BGBOJ+'&HKJD5YS.7[SZH3A(LMGH8.+'F;
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M;)-S?J)IZQQ<<B??E'@9OLTFLCFAGJ%?XJ&7G)_AK&J>G^C\%]P:WP->KG
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M=S^>VH&+++3Y\<--^%5+Q!O#'Y5^QR/BI'LZZ4)+HDKP'9*0N1GQ[!1H\OA
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M"MTU=LIG2=8NJ?0W3%5I2FA::W*229Z2-9&6!"U_RI9KJ_L6U[DH03)?50_
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M_BLXIUFIZOE'-S6L'"M5IK[X*=*N#N+VF.!LLIMM8B3$<JN1<9AJ%"]S5[!
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M@_")6;+<TN!? ZV@W./_SH== %,87N<)H6XJUG9"[0*BP@I!X_RPB7.6%$Y
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M10T:+55$95^PR.?PF=M('^SKB*5?9#]\V,7]C?KF]_-/Z:]TC:C!7I^H \<
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M5;X'Y<R5FRZ'CDFA&Z]C"O\< UA LUD*XR(M3-X_:0Q'*&FFC$RO4QGSS0_
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M"+U&:(FT)\ [3B]P%W^01G(5UTH@OV+J2N"]>;$/29/>$_PY0./"2;'1]J4
M5YG8Q9^'JFQ+F/C4885I]> IEXH$.IZNCW@3T>2E7 [3F9U8/BZ]0=JN3KFV
MKIC@/J1J$OX"B0%J4O-\<R)W75+KLRI"60@:&=B,G-KN=V@K2RZ=^K-^O.:[
MYQEN9MYXK8<^O8#6O-,DAB:R*:D^A[0WIV![5=.+3\V9!/^*J'LX?1"E(/'R
M2BSO9Z*-TGEA1&[2K[CK 3XYXO(%->NGAJ]1:C&+O5 T(C;):C]O45RV.E%O
MMEKS*ZT-7BV?0+D3BJX'QM5L6.M1=$<^-VA&M,L&SA:B$@5:_=6[5\]F$F3:
MUDQ. (Y(S#O8&5M6EZ#Q<.88%<9%J/&WB6J(DY1L7^QC;_6;)P S68=$1,(/
M;&2B@<F[7L+8JJ&OR<RHT1CR->H:H@S26SV.0CUK(UY39K@HU=$KH&V4[*-/
MCKZ;#IF5761+=QUO\5[;9CCVI&8VGR.GSG=E,Q/T.Q-8 W+T/:K72*HBS577
M=<-_*()!+U5Z']ZXPGVC9%4EWH.D1_W&1S:GO.@A>O3HE$%9=06H ^MK1 VT
MKEPGZV=,Y>]<M7O;[?%_=8NUN52:=9 A1J5ZY<E-!5;<R1DP9)Z'(U)WKG+5
M=?&2C^APZ8.'Z?ERAG=CV>P'FT<3R=FI8[^K377?9$:30)@)4L0P3=7E!,#X
M?,3-5]D<QK(0!^I0F(?&L3M^1UWBPHEN?AS48#RG.K:8;%9H=DZOT,4LK8MQ
M>J7B!$#7V;'"7H)=QSYWMV@LLR5MK)ANEN[Y=R$Q"EC_GA/ U$&[7[, 6B7P
M.1'8FLT9V6%A7/\B%9$_QT]_I9%R @AJ$5&\(),TBFOVS(L>^BL-W=:%+I@7
M<YMJP!Q5-XCMR0]4!1W&:8UW"N_R)T',^WKYE]UF$\TN"N<UT?7_[RN"^8^A
MFDS]TK(T!'+*H?RUWG)D(;92?V1$:C\!)*E0T^%X^K(3P)H+,GVC SM_($D)
M1=*R/NUGNIT ^&PID6HG@,=&?QZM8^E?J?UAS@<M) %WWH, \!G-$X NRH0"
MMHV!$\ )AUK 5Z MOA- T709M0"YTL)Y ECRU:$UG4[3^40-6: _3AIKV=AK
MV8M^;ON3&7]P A!I)B"IJ0'PO5U;]#Y<"E0U?UQ$:6\AF6-/ .@!F(9:C:WZ
M44Y@-W!G<8P6N4=59S,; KZP& $M+K?,TO*JRQ5. 7I"Z@G _RAZI#(ZF/U*
M7K38PS?_B5*F2\%(\F$2=?%X72EQ@Z;J< ((. $HQ7__V=X"@"^LMQQJV;Z%
MX[.FX&O]1LCY]3^N\[>GN[M\*Y3I3X&BXPF@6%RO*3:!NK$T] DW=,C18ASZ
M$]ZF"%KFS3F=B\\BP_]XA/?Q8XL@@I[^H69Q*YPB% H\7:=;4[!<H&]+E*1I
M\*3M@MIPJ"9N_A_+'DZW_1^]RW#'EZCCJ)<Y^^LYM/<)NP=QH*7<TW,\<7H6
MK$YW 1EP^/Y_5UNC_^='4\P3ZH?57S0AF!C!/;=2'!FERB<78V-!C<TA:RXV
M9=FCYOP3I-6X&;BD&AX8).IIEL+4J&&J#,<BQ-I"[-"5T)$O:YCQA+NHQEJ/
MO^9^/'_ORYUH5[S.P(X;Q]U@4N"<,_32K7RJ9P;&T/ V:5/X [/'1]$J/.EC
M1FG\=I]''58-D\5%-#]ISF?ZUF[XEOE!\I?JQ7X/<9T VE2VD#"&4G(&-B&^
M\2[1'CQ\>W?_@NQGTE%AINWN, (HCD(^U*>/OZPR3S(C<SM2-(Y=T3"!DH#T
MH79Y3)@"*X_AND BYZ67C:^D('S N]9UL]U!O"DU*AOTAF%$EIP&O2T+Y>Z^
MHZY*QZ+:FGFU]!;&%1]/GR\F(L'[%D\.\A;%&H*K]#]LY,/&K5\$SK(9V.0N
MG&-'PS@(YUJZ/&)LN D#XZ77(MV0KE)/^TMT.#_<2=6\Z.AXYW/XH-:=)J7H
MKSC], 6_%MX:9L!OA2ODQ*/[H;IT>MDS%9[KB8QOS^J%?35AE1^1[@1T9'I;
MC709Q)EIZPU(.&.F;2BA0@Y>QX]^WWG,%U#G)6:.$A.">E19BZ.]/^35- 8N
MN!EAT^+D]"]OI+;8C<M:EM[9=CL>3>M-X2RO7!*P/,N2PA\\KNO!T.UI]+8^
MJ*C69;54SV=E;507K"R[!T&@K:]?%$;JDYLH"JAVY"LXX[$O]8LD&F>L%/MF
M")]M@(XKZ&7A/D!]:@A0Q'SOE@H:E_MJ7*K'MH)?P<0?56<BE@LL)U#>^<RO
MD38I%J/Y 2/:AOX60@)L^_ZA>XDCE'EHU4_AO.C?]T[E8^&S/W]%S3@!.)&H
MN3XM[\P8*Y@$&NFQ.D-L+^2S YJO8<&1RA/],\QS'?8\8I=,15-YDQ#F&%',
M^H&?96!5%=UK9&SE%[++KNY<W]J+C*#:U-[L/Y5H#[K9S#0)25C)=Z%*L(?H
M1C&L]2EV@YM*,UH:R+X\;."# %<_I)QGX=S1U,[!<G2XT/B/'0@G@+#M?2T?
MSIHX0W'YX$,6Q_A.E=?7'RJ4/*L;FJ.+KQDR8M?.D4Y.P=6ESQ96UEI,34WK
MOL#[/=\YUG77=Z:']"=*.BP7-_S$5]:E[ _+SL4NNR!.X<^E&&Q/YS8+.8CI
M(9,=#[UQ'3J_)>POGO4.,0W!)PS<5A+8-P'W]2W:$)#1V(5BGO3ZP\S]DL$4
ML&%VO'CQ>O7I>DP^_;>PE1F<2%EXG'-V>X\!L2\PH0+"-=UF<M8:':>CQ]AY
M1FKH#GS36KH<VQ!_\>T\>RR1#6LH6["?LKGJMH^ANC55CO]<+WR+,(PE7HE;
M9/2^+[LRK.P!+;<9URW N-F^.A7R]LG_6N5ZC0K3PJP:3C)V+X=Y32HC3M^B
M,;I[_%9.MOF-VPD_HS\-2L4D9R7.C&0ICJ87ZUJC'!I0W^Y/8,V.KPZ9DO,I
MP(T<=KZ)S]7U:&QC$[J:S\4AP[2JRF5\'>LP)Q_FS,?-+?!2:T9LU94*(((V
MN0MH0[8$ WBDZKFOB8HJC(3%QS&MJ+Y^2D.^5X;[BN?&JLJ+V:ISL 2*->Q2
M$LF=FG]LN; "3IT -\._RKYZ*UY^3)#7M^KN3QJZ.='GP%4KV!2H=FVO% C1
M-1=[4%MGZY?&YS^^@U+;NRR)G;E\E>%B7=!X+#7.V6_;0%TGR[I!1#6@H**I
M:ZQJX#>R,(GD0C8B,+:&LHPV2T/GE#*LB+5)UYH<\P*TQZ=_5GW-\/_ C[;*
M:LB ])4E?N>;J_/ Z)/^'+'7JEP!_CB%4_/[RGQ 4JNJ8'V:OEJ))6.(FG9C
MK#LT< QLV/7@6?^KOU7LSQXE>^/%+;X6\T+!-5SW:KCD@@M(OS>'IS6&Z%G:
M XYDA2RL$.VBAF\RK18YH(H:!^O(AK@):<TH UL=(?P0H7B!X]4Q7RG,8:+1
M5Z)NT4U0/*C_$2$%@?KD;"^_?1M<5*?L+X].,1%XJ=GD-5^=@^\]M1#.P*0)
MVYT>D;1;S42A5S!=7XGLR">UUXXB4@(Y9\9WRQ(+H]^TI0%>!70S"*].6M38
MZZF,)[E*>[I*NQZ 3Y\MOS8N@B^,N.>B5UUG&69<>.Y>7;?$N%?<]IBM/W>E
M0P)K7G,\ 8G/7P"%Y5S< W+ W(G *%D_HL/#70W"1*3X[333NBJAF$^\=GQ1
MEF0UAP]O)T29V4/[5.G(* +2ANC?!F0A)SWU8.CTD,MA"H@?$:Z!0J4"Z^*P
M@HHF\'<2%[CNORP"C5\2NM^T9;FSN].L,S>^4H,:.0$P[34-@$9G>A)IV]7+
MJR08D919VW0H&;Q#F6EAK_FZ&\>^ ?PV@:\#;3+!$:X6J4CZ<!@SEOMY,(XG
M%,=WQ^]NXD.-=U(.Z0\O&)]UII\$/B8DM#%/(1?-HL1A?%C]&S#=7RH&);TD
M2R:=SJ"03\/;[IPX_FF&7;O+DT]LB[![B+OF*]S,AL:8Y#JYI%BK9)^6QI%-
M1,IL3<VG5-OV[S/6G*8Q8>P:HVRKG'75FUM%8V-[#=\\'FVEJ\#_%0VVZKM'
MCT=2N'J(8J0YVS!5I23#$0=4XA%F?V\MG[5'O)%5*=E9P_3AC\N>?=D7-JST
M\5\I]V9I:#AKT3#:L/97=99H>XB]Q5CEE48+ZU@ EY.HHITT@(OKCB(=OSZI
M\()IN:%OR(]VUIIJ;;W0':BYM\7XFJ-;/ZVURS@W,E<OO&RP4,LVPQ17.B<A
MT:>2.;&R\7.[0%\. ;P08/2$N!HCV\0,KH4.F%DT1'?WS4B79D.L^%T8KYPW
M?]5[T[L7F;L'C&SYUA-]K.Z!G89SPIZAMY%"UX:A:>F^42,=\F-F+L:'6(6K
MF3N S?$:D!/H+>\5:C9HX;-?*",Y12A&B"@4>6Q>.$T.\F"FYN"]9[D_8D0D
MPN;OO7[[<#)A%8""F<I]?Y,),?8,&UWD$.!2+QH9V8 68)I1X'6?YV35ZG*#
MU7+=D<S1&_GW:JYMX3%-&>"=!EG,<-5*#F\ MS'9<5'7J*-^&3E9$W=M74=Y
M&BXGL..H(;I1QV#:=M81S+N?9&L4.C=WF0#L!&%:+'^%\F+(M%V<QM=%QO+[
MADSZ^)RI;T/\^,\6A_#&GH]!O<-!H[SB9'J**FWH:":;G;@=%WHK(++[FH-:
M*1@K)J:/'Q"%O2+*Z$TOB_P0 "SK XA&$;B+7ATC65HZ&#V%90.W:9T&J,N\
MTUR31'_/RQ 7.R+;[]$W^=KN*COIV@=^<7N-^*:EU'24 ZQ-/6AH4YDBTT'0
M8&8FO^VHWPN5('#$?DY<?#1N_ZKUI[W;-\L!KJ$T6>>_(@(W>F[ZEU)DCD7(
MYQ9 %]9MN>2V>70J Z;!,3;?AE4$H&XKYI,##3\2(95ZLP/5RR9@*Y9M:Z\A
MJ;)DT?:=53=U893@V!8"6FFI/#<>=%]?]89X/&G?Q60YL@K<9YALS)I29Y&"
M24Q!)XAOU5A8'19%D^;_$Q*2G.+WC)C\U;@)(5Z)KH<49:5#UM.=/Z4[!L0V
MMXP1&6QZB](3/1/KDRWJ(<4^$RML!NJ^V0'_!W*1_IVC].\<I7_G*/T+(R@-
MKT_(!L8#:R)?'=_UR79,S2W7.(#$'KY7_U1HVWUO,E1NN6:OYYB5[DE$!^TB
M_0)<\<WA\'P7%Q]Y()8,3-#O;LP\ ; H<3G=K@%%2V78E$GT#+^,OY8MI-*&
MW8!)E^N"9)<JFX/9]N!1B3"[TS=9\=N&W^]G4%IG.9T[PV"_S^CM>+83P*O.
MDI9P[Q, P6#[4-4CJH5T/>D$\,"BG?H>451%K6KFZ'A9@6()F- &T_&J,?Y^
M/;1HV4(PF#]4M?WO<W=*#,(OX5*N!VN$I^5E&MZ?<1(M$HJ\RQG=PD9TU:/.
M*J+('W.^>G3-ZBPD;&HN9 7K?D]D3:^XAM*J>#ACJ7.[1_8%_1.#!)LPNM&+
M!\I#D\4=?]A5%BIH F0CV%%J I;2W]_P UZ5Q9<Z9?-SKK-\A2\NWRO6?FN/
M#Q'@C+<DQ!B2YRD&9*$':+>EC\WEY\;098FUI&&M;[I\++_.&DV4WO2]W?R5
MFDD3-C]V.-V)E77>F^A5RW+NF"8-S)PC?\5P6S'8O0(T=?NFYE?V5<]KMWWN
MWHLF.T,TF>0QL[(35? CZV;GFK;OV@$5+0P1W3WI5[O1!OI.F==+TM((AX@E
M6#CE;NC $7)3F<A3K<S8H"O8HU^=9C2V;]E(S0!_>T?'O[T1^XJ>B]_KO-;>
M-#R\I0H44_.T42:/3,&9YE1:@:8VCQ^4KYF6Y^J*M.H.YX?D"4\E2,S[>&F<
M=ST!X.]>PA2?6BG:DQ (?_K>'%=5]BU>'>Y[6S=F7]'S!SIZ3T_([9[UK!X1
MO5TE<T/T=:+^9Z3E ?FG8U HQGA,B"W9K2$Z*:G>?Z[7+7]XYG #Z_6SBL$<
MFV]A,KHLI.I<X+20RPWV6N-UHDD&NB9.K+?$Y7SAC21 20-D=4+S.L7"1<6M
M&&($=9>P@R#<W24<WV"?>5ZQCK;K<]=0V4V/(=D2F#OTPX$$ Y%&<1RDT=?3
M&]L";"L,,+26PGQ<^O[6Z*[&Q-PS^GX!._%E@&<+P-.FGZ+[=-W"]I@-2;*J
M&5>(LYCOF..*)JOZ!VZ$O.0?#!Q<")IX<P(8? ;:^@K?<FWV.!?7N2CEGA6$
MV'WBY0;Q'Q#P74]I8OXZX#5SS?ICV4<+%JOO-6?3F_*P],Z_IZ%5HZ"%0C%"
MGSZ&L:L?>W=QG%@>D$V&=IA<RYD*;YP8FE)!SBW"]6503=9$#WP/P8-D%<S#
M@3N(4H&7!.!P@V+]5&"[?&I9NF0&+QF7;ID4D71.Y]P-]RTI?>#I05.EX(#'
M;&K=S4"TI7MA9<#ZHGZ-G5;GMSG.7\2AN><C#1X)($)AB_-VE,5\A&\"<\ B
M;BA6UIS64^9Z5/SN<@94O!U0R?=T>-G1RNW<## -S;4GW%<@-6DEH#CJ'REC
M@)(9D3\H=.0L;Y+(&,$(P158].*LW)\G(+5C UUW1(Q7EO1VW7^]22Y6Y,_"
MXU*VRTUQ+1#05$8[C9&LCQV* EYNU"P-B&FEW6Y*T_89$S>=?S*R;6^]PO5P
MF=L+UI86KTR (JF5ISH,V/)MGAH<D'"J@9]5]I->$]TS%CW(_ F1'GL>Y]9H
MYT>X<3;].MS*45O7'*Q5EV0'[OP<Q-L&)>H?5]'=,..B6.60)[;QJ/]@8+W!
M*UT3]%'=9K.]26O#'2IJXA9J+5'KAX>F/WLYZ:KXMIT_WXCQ8>BV=-RR1=R,
M,77YVCYX'8FV7[EX=!4[= K:_N3RG%%1)'+C3@#O5(P<"\DC*ROB])J$@0+I
M=8X/EEI\V<Z)7GQQ:N\!BOQ7-+RC#[>:TW^I*J^WG \]1]9OG>=HYH(TRQ-X
M"U]@YB.N0Q>=0R >+[NR-K>>WS$QC[*+KQNBC_UK[],2\48R-L)]RZ+D>^GW
M@JW/RX7;3J0#HZK'Y#FVXK>^4./N+@NI T?A0>-%!>&"=6&H4UWB<*4S=U&U
M%$V*]C/[PE@HG37L"5D7QP0W)LPEP*]E(2 V-U'1XOI:@? QK2&.K:6XWND4
MNAR;OSW:6J8T._Q. .=ODS\1G3N#TL)AP%*K^T61CD46XMWE."X^G$:X59C6
M+V(3F9^EY^QVP/P"L@,9 ZP"QC3"":D'77- 7J;T(1JK_B6H&8,G=X^G2#Q7
M[B?YK;]>8]M4KO9P5X3.D79<@55#^,6RIWQ IIRSB.07^7<1QUYV>.<BW'3
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M>%\M(V\W7F]J[JUCV/CCRZMGZK:C@4#:>;(1SNR=[ "<9)]N[:T_ZBZ^SR!
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MKGM=O9*![=+C=YM[I\O!0@X&ZNQXX+W_FUUA0T0HS^&]V:$#(!+=&'ROVFS
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ML]3P7A3_3D*4/=$J[7JF\,NS".CRN\N*=N4Y#[)3VFC#\*JN(7P'11W>?E<
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M<33O%/EKE!_>PE87U0L9Z$>PF7!7J&RN#8X_8B%B^B1%,'1,R?HT5ZB+>,A
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MEM 5,KWF5O2Q*0MO2$S\S*<J*S8UE&%;%"$K4>@Q2!YY0,!B/4(4:#P-VF3
M+8@_FC#G/BVCH<$"BR7V=T;(JUQ3;V\4Z,N5)N@]?B>Y1/M>9S^0\'46/ [&
MY'Q4 !$T9P\^[-VK%W6QXQFI?\$[5%2<\G#J;IBW$DO)\;=[K$X^L[ MO"B6
M/E1!!/:X%F\5(A[6H]/*&",0Y;E5\;MXZASC*08GB4#@HC,$/8/3F6&QE;A"
M?5L0+J?-<*/@WD49<MV<9]'>DV;@QF&=?\R#H;RBX%C,\F#&&08I);7$J\G?
M:K*$;"F EZ!!PYIM@S1GZ[BO=W4B<D!W5>/Y0IZ,<S[ON9;H]N.(<;6IC2X?
M?I0&*:O> D-/#8>:.(F\!80 I7Z8 C7@N7I37:)/=2!CT%Y_<)U1\:5IQ,,6
MJ4^;T@+GI-OXWU/%-YW-,W@608HQN4 !'M44<6J3D$0/#"(X]3YN-(031P'"
M!.HMWNZ/6XR(X>70)HT?'I:]_-3Y0^3//X1N!+(#'45@;-_&A4)ROTQ4D(-X
MOJ_(<#W_W+'FI9>"GS59*BHJ2>''4R&?MNP^/91[19><P_W3%'_E,Y:I321/
MV&W%.LN\7%/%S:\2941[U5F9ACD@GTZ<^U[O#;,MY=[=Y**I),/L1-4ZR*A[
MS3K5Y&D'1-'[]?WE,5'7U K8-KN=>/U@WXCJF<"O4=<40PN4/(&\@V=L5(,"
MMDAF'.AC87F#U(HAI"SO#=F])'-BZ?:M9*GS50!->?+EO4Z8,NE;17$(-48@
MTLXV/)IY%JQ*\&"8-[2=:%V3F[&)L_C<W3W_8/+=I;2'[%&&$S1QF&\_AE:5
MA,VT[>NF\4ZYL5#I0GD-XU&%KE62>R%S)?Y&GA(OJTNG:#K:84/^-D_BMGP"
M^;PG')-.&*< Y@DF%.!W8?XBW2:2QN^W]^@Z/M<S$:M4-2AD]-,/5(>;6IUN
MV\RW?UOFP].NS<7*>#J&5OILM>'^#T^9S_CAM:XY!#=2-1LV KZ?8<#?;'K;
MS]LA1Y)4CQE&_G4RD _MNY/D\9/D\7\Z>7R&P*^K#B+>H&T/[^PLO23].?H@
M>-\M]Q=1$?2^.-EVRY$@Y-%H&\&*,0CVNV/8W).SII^ABG0>D/U2)69. 5#,
MM^"CUZ&G1_<HP&GL/8R+@, **NAJV%[H CR:R(I1,#(XTUK=Z6;P4UL'8N/X
MU<]]3U'IAL$0XMK_EW]]^)_67#GX"6688HXW(S(.-1C'*[:&?O%I H6.%<Q%
MM\L!^S_$W/G>759X+E7D%\HOXVIZINMTS/;OD0KO.(L^?0W-.@_X1RTEAK1/
M^JD(K(F5*JXW+1V]BDXIBLB7<_0U91C,*EQ3]E"V"&<OTMW.>M^T$MJ=GJT5
M'I=93 %H7L]I.WD$V"J7K^_:]A<VA][-Z?SX[S.[6%(OX]LJ<%N0*#T<N>3[
M&\/,6P4>B;Z3\557_>\_=+T=I$)+FUA<3 A^CH>4.>>N)HPFQJ>Y3RS5UG[-
M3K1<B7?G*L'FB6N$]HVW)*5V'D,+ZXQ')X9<2;&Q"PT;OL+3$]"_3F;]_>O?
M_:RD_Y#:)VQ_98AE_V?^L8#V'^5V09_ZC4&WK1!EFJ1W>U"2(,..B2=,EKQ
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M5O^X]I%0%9Y[M<_G O&<M_"O)D("_FS?7'! 4478UM=;K*\_LHEM@VH#UHX
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M>ZU!YS0?Z0O1+-US!*M6\=N-?QF&J3QXWFQX_CJ8GUEA%1\>Q,FPQY$VNZ(
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MZSR7+K_P-04YF&<)*7'7GMIOKODOA;(_?A&D ,--]M>2'6ZYN+@ 3+WG>4=
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MOI<O/MF!:,N[[X23C!+F28+@C$?Z6;TN%:P)K*9K,%262NK-OSH*B%3R,O&
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M4A/LMYCRE_>?K,]@/.(=<9NES]W8,QC4(:RF"5P2Z+E8>(^-]H@-'8;=XJ\
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MWJD?[!^IOE,!Z)Z9%Q!NX&4AGN@'6V%E.,B-!55V@F/,*SNX#O,P\1(RF:B
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MPB<:E$XLZR;"4<BB@KK A2MG@3@#_-5R7S9\<HE4I0V#BF1HU R.^O !;$'
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MNZS9IE[EAB4!47Z79<H'#"XM%?7DLQH.B345KM.HZ<-%>4YC??C@VRZ=W>;
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MUH=7V;R#,IRVQX!:SR,%3_>4E"QX",/V6<RMI\9(9$6%H*# 1&YC?6LY="&
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M[I6_Z>$* IF:J]WB#U8]'5+= 6RI_F#?7@0N96!XRG/07RQBK*,$A.G9V$(
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MMCO$"UCI[N-8,]Y!_2'>*:0GW6H'*R'SP/ LB)K]+&P3".FD )CV#LFM]RB
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M6!4-"WY?"\J5D=]N*Y+9\0:/601L"'V(UQ2L]%99(&>22EL0'^M>'"['%EB
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M_Z3Q[?N2UW+UVZ?_/CH,,G.;XA^(SZ3_JSC=FE1J-W\G'9TD:WW;5Y<Y. C
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M/<B 2_X*%/A=Q*,J1LK+Q!_K/V_-?!W>!UE]U=EI^B+@UDH^,,I]EIEV8R9
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MGKWPO3956R$"R] 1,;ZJU./ .B^:@-#7JZEKZE_^4"]'U+] ',VKFD=<,Z6
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M,D1P5K:8CY"\W!MX,6/FSZ2FK\?+%;BBT!0]C\T*:3X/>P*P4ZA$O><:"Q?
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M=J?X?58/2T!71L<GE-BA-P& Y&E92/4/]* L]%8/H[.KN% 3R#_B1V45;TX
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MZA^</Z0(DUW)Y>: KR"L5^'S<]-2WB4MX8\*'CW*#@?\Y[739--TPF_&= E
MM%\H-<XA0@/^TX-IF- EP*GH G2.9 VF6GQK_H=JY_@2P-.(09PG>04<'IB/
M'/V7$G#_J2]H\)!_7@\VA%!]%)!U#M)6I#GHG*:MB,&?0(\#\N&\??^C\#L[
MH_W%E3&#_T^*V8E8_UV%]X_:2T#,-] <J/]*CSQ!_ ;BI1$7.G0+\V?<'N:G
M+J/;QZ?_306X)?LEP.=$9,VK_$)Q;PQ8#OQO:KJ]!@CWXR^T-S' B^[YD$O
MX334K,_,%+JD/I:!H\/?.32/W0>B8RX!G&7+%PT/+@&##CW;8Z#_4-1BWDO0
MN 2POU?&KYYD^$&C@JBUS1B^_J/X]6J!RQR:[C<R$YYBJH(A! 7HLLJ>&X4
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MK3,#TKYBECKG5L.H18XOQ-<>/21A/42IQS$6XXL?6::@G-? F$4L:0ALG6E
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M5=ZE_JEI3*6_I_+[VN^%1PO^!I.CC3QXY:6X5O=E#4&3".-@FF#3YTI);-#
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M=E<8JV=Y=B)7.!L<,-S;"7B7[B%.WD@>;KQ\NMSDV**V0%H>M*9AMM+X$RO
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M7WB^#7W(]O,LQ7-_Y6IIGIUF4=@_U=!%S=H8/N(S9:.1@'#!SK95L0I?\T^
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MOQISEDITK*P;G"0=E&S'#XOB:"CTY53 YTB" F5@/IV2A5 F4_Z;QITS/ZF
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M<0!^."1S]JJSUN*?MD/AW/$C07_[R ?/V"@Y<;_=M0TSEOWVJKHXZU6N>H
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M1$+&4U)L)288-,XB_!8"&R890YNX.:G\)?$R86I9&9>@Q&I662N..Y,-U;X
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MK+LA^M\?:DXV9>-X_FX <%V?^R_LU_G?V6\VRA1 ,2S77[WPAO87[4=Q;?=
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MUY23V.3D1]JP^6'%6ROV?C-#TL<I1C.&[T]L[!QC.$FLM%C><_*4"P! ^ )
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M,J.0$15W![M;]+#18*=[I9XIR)2MO<>IAXIY_+>7$T'?PT6C0L@KZ+,7*FY
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M^'W>T<IPH]-O2]C[#@IZB;&-9K2I_-7(;,W\Q(!T:!>;Y>!$$REGC4#Q XZ
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M*A> A$L6XGT:/5H1[4]W]Y)_O0B)YOUQ]7_3[OA7$DZ2SI?.-F42MT@*5A<
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M4%VY/F2Z#FH0'RQ QPNSG>'-C5[AY,UM2B /N$QAGXLNUUZTYVY=8%: :-W
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M&0W#Y)PPZQP&)[$!X^A =D "]$P6$\RJO*]08W\D^"H!TQRZPGD!:&G@F'(
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MK[BX\/?+Z>]O*DF-&UZRX/[T"T!ITP7 [E$2]E<Y0<I7YP+@HG(!& G.2KX
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M"MYX@9G3U#VF0\3]H-N5^42-G/<"4*LH[5)Q)6 44C0XS88Y_HHR)OL492S
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MC1PR?\[-<5UO8:_BNY#M]!L:<RH@KH@3O?+5AATW-RW(K&PWT)\#%B&\0[;
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M/*66;Y]W]DM/Y*Z<O-J!(\#0L@1,8\Q2-JC>>*%!MOU1EE,(:99VN5)@\#,
M\M97TFD"WEJ/"AV(A(;FOE!3)N[NKRJ#&G= 0G,(8S--KFA%;1SK$G*M_?GV
MCAYJ$#1\. ZTSC7,-_@PJ">^DGQB<68YZL])5))]P#G,N@VS>,0;Y9!]9?4T
MU2;,8W#(0K+6)=Q-N$]36Y^_?7SM.+I)&E$U-3W,^]W0E3HY96]L(QW_PP(O
MR?>ML6N_$7%>P%L_%]Q#M3T%_[0F&\C7,O^=;)&O_:ZTI^%Y0Q%*_OXOW^(.
MC"5A4EK4.E>LQ#Q4LX^?JE"]WFI/NPI8-AHWZUI>ON>X&C>Z[4IZA/]QR>Y&
MV^>8Z?P]B&QVMIV8_NEC)_(DTJZ,W:Q$N,^HS'WB&X= 6:I+*LCSLY$T*."_
MT+MR^@7C23J^QU\G3:F\NIY-WD9U>R2? :H\4\O#P\D^:N9554SXQ#2B)M.6
M&S.0,OUPIAUS";0A9K0?<97YBUM_>:;5DMK05I4IU-QS%H)R!M]=OGP%#8AW
M2B0NKQ=M+!6T/L@ELP*:K10<EF\#NX'/1I%PN 1KZ*I$$')!FO,=[MH-/N^J
M\M<T?3=%I9[+E8HQK"5VX8-Q90=+^L$5*I($*_I'4@>]:PJ+FBBY) N#UD5:
MVJN?;V-HVX=-Q\O[[ QZJ*,K&H$*P"2=/8YHNUG[W9,)?6^WCX?6()S/TA,\
M D>MB;M23B>+OBD[<UG*^"PAK'/- ^YKO[?4PY;$X0O+J0]$O![88G3IP0X:
ML[>./W55NJ2UUB0"XPV#GNK:ZCN?%)C]FH+V%VY8P8!>U(/ JID-HC'N,?Z?
M/KK "M;2T[N+<35FDOVSQP%"7TB[-V<LF-6A'NKX+>O"]6-W?UYL SRTJ=QB
MWZXD<5-%,CO<;PSRC+ I:>E?/Y$R;*S=7ZJ9E)?MD]>1DS&J"9(7JUC:CD:.
MG^WJ7Q8Q=[ HOM]KR<=.I%>]K )+BLKL/0Z3E)1:9+\ I);T]S;5D'(E:Q%=
M:93XLH]CPA< P$9B:NVBQYP\3+C(Y27 WC,FB)-I']CWO/A9"H8FFY/MM-@5
MP\!#&Y<QJMPK;UE420E]-H0T0U/4:RSPJ+Q"":E(%AKFTDN\KXHKMAAA4EPI
M:=<,>I=%S-HWB(FV;0S$P=59*79\11'XC\SNS#RY?A).?NR%: :O3SMDGK,#
M]X"!'8PV7JO"@ZE::OO[6P_K.D_*:SW*R_4;BHJACX_+9C:D3'%L^,+%DT#7
M?\V<IFA2]<ROK'O^)A35G1+)J.,D'&I0;WB[B/AA$2I+>P'XV/FDJE94RW V
MI&M6(4K<C;E,%@P==)*WUA#ID+//B)O6#%.3S\F(#G6"=$RQ0Q'2;6CE$TD^
M9N+[F XP:\#;4=<ZOGOK]T%K?J%#Y0S+ZRR&C*M1P9\N *]UI?ZC=9RQ)Q\A
M(U0S.H6[B5]FW$")]?>\U36^B.<-M#7::FS%EC&@*>,#ZGP.U\NB1'J6%C2Z
M!3^6K:2 *E6/A!SX-CU7J5I;=XEH$!OP#JU9X LG:YUC3),;%TKBH[*AI_;+
MW/;@':X0P#!BHKSD%,E8Q];",U*8!JGEY;7CHVJ5NPM57$?U(,<>;\*7*R5W
M7#!VV8A@-PI@:R-#*;:CLBA5=[G7B7UVK-0#WN\?XO-9O.2&MZ:\55B77GO%
M9D,%B"W:>#TCVNCX;8^Z\3^]_]G_UT+W_\B#@/]JE:Y;'*0">VJ8(,<J3AL'
M?:P>QS.(!$VVI;==I5SBBJ-]EYS.+B8I7 !U;2XMLIUX1"IV\_-ZDKAY;)T*
MN77-IY2[ZUHDB#-TNR(-;=9EQ!):Z]<4LD<WKO,T^&W4T#W O1X#B\F)N_*N
MBSA\P0.7="U-Y]F<4?]BZ3>)H%G!WV7X\B4U2244M\5XB=$$F&T^ZXL5X?6S
MZ]'-/Y0PCP,,2<]Q\=D8T*<DK1I1M5PC10L' E*#Z^%!J<P["<M]+_$MPT/S
MG!Q!*C$?\0%UZ23W.8)WY;EI]VK,<.IW[!OYQ!/UNAKLWG?&M[BX^N;74)[6
MZ0Z8O2)7T0P]!9';\16KYOJ9'R*R6$H[!YI&+?SW\)SR=90#BKZVBL=U72 T
M2L[_(]L]I4&CTY'08T?Q0\?#S'L@L,246AXHUW7EKF3C<:R#A0%JQ0SK2HB@
MI/(LP!CALH^1C-UV;EY>[$L5GW0SW9U/KSO?XLPKR< <I^!V4'''HCCADYB(
MNCA-JZYSU[M-%P"6DH<E$">P+G<O/:A[)/_Y@</'\7.[FNA\]O+K-;_LO_6R
MA0E4_60C][@YX)):,RA>DM1Y 7A8KX)[IHHLGQ!6''M<9HX-#A*V8GL?W9/^
M$S.6N&I3!%DJE'N0>QO)8!_C[H[>0O31I!2%/9(I=OIMBZI".3^T+\H!+?X
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M[5X _!>+=]W]><[3I:PQ$>Q%;CS^^U!14_@#+KDR1.8GW5G\FO @WJ)3(B'
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MWJ_<?N[3:V63-98Z#,E)V9DW+]".7>EGKI"X (1>3IQ3VNU+-MRE= $8R2F
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MH6(9E,-H(6KP/9?G%HK?3'OR7[)3"K;>6##GO7ET&I#T7XE$ZD]]A(5[=%\
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M;GV)0Z6FSF6@(&K%WONE#<W[F6%%*L]]AP[QH=A<9% +MZF)(>:,SR1<',1
MMFJ;QUQW*K$<^8Q/&1-P26H9EQ9O>0H_,ZK>-M\5>'4G;PNS=FMA(T7Y]Y0!
MUD.QDC"X1$EUIFH[TL*V*#95LKZ_.<#DP&XB9^4\S3:QM@LI]O\-O[>GF)5M
M;[S;6?4JIF5"3\_F=@9>RTGA,Z+G[6H^[[15&4_NU49356>SV&H#MR3M$3,@
M&#J%DV8Z0E[R8Y*&4 <2?W@!R!F=^@=-28/ID#G&I[C1.U:?A0CDW?)XXF91
M&K 8!4:>7X+O"IHH>P&  D_5!3R)P'LLBY2,MA.OX9NODX%,QTJ(*:))Y&?2
MDS'-P0)//MU$[1KVSLG*>IH"O/Z?X66CC"K?F\LAL L TQSO=U\^BT%(DV^Y
MQU/ASI9ST&9;@3\-H9N=G.@;M0 A#4P(YH]!XR/H,Y-"6<ZNZ"&7Q!&XLU?F
MG\WO' V3*8JHP+Q\)$I]-XFV]WL \J2M==:OY3]R,%+\,_O/586&5%"Q1(.^
M% '(KBQ<[?2 @Y#AS#6UDXO%&S'FQ*C-GKA;QG0./^2<\!-"QRU0_G;SDUQ>
M38?]8Q]KG_QQ[-6)]ER,2K@'GX7X$L4_J><N%X 0R@O _5CL.JEE'WGD&S_J
M:U:#*PW&6R$_OI\D#[#^&5B2\2H$Z:M*N<OW2A(JD+H'G&S@52I*Z=1VT1 K
MX&LS\VZ7R8?U55?GMA3"V&H;=FH6+?+#W$I]>A:K\+5EGDC%,X;RS+G9YC1B
MPJ-1GU\Y3A%A5\I6F>,"(BX QN*+S%U+0C-CR_,[#!*U3"LA<-:TKH$7'ZHU
M@8)M]^F%3JXD7 6 (CPKLCS9.QDRJM8C2V \0D)$%6]^P3NIIF6.I<N@CR^E
M&'E?+\QZ?_P1)6J2T55[ 0CS)!C\)Z0"67+K!_*@M2_I>]EJ27W"0Z7=6;3J
M EAMJTPW195D7MB\-,R^Z/\[G1[GGHB.KQH7/&IF@AAW$XU[Z/##=Q9CGQ3'
M0UJI-S,<WIM0D'H8UAL(=1_]R&<HN7<:9IIPP^>AER' $&_]TN"=;31PIQF>
M98M%[)7F;&\7]MJQ#XI%B;'IKYJ5!G$_\#:@O!7O[&D[E.U:+ /3.XDK&5-K
MM#-OK,T4=M1J7!@8/H_2!>[2+\]]]*J7NP!,52,F2 /F].+;LD"&3>K%W;&C
MM"L7 "W$M]ZP/SI!+]C=YWOVV6YRI,<-SZ@M:Q0O1WY+=BPM-YJWC7[Q(6A4
M]E?R3>ACSR3WK*<4S[0'-)X*[QL"JVR(07)^%P"+].P+0*8RZ$,Q[9?\0..V
M/IA/WA27/+&LO#R65="VX!39R^A_GY "1D._>OASXCK@$%/0C*AQZ^061U.=
MWA6ZZ+?_5-5C4BG6D[>:N'!0M$<( F2KHPC148G1:NDXNP6LB..\(L+QQX#E
M0RU]XIF($6(0^8US-+LVI0M_ZMV;E5,4]GS.=_+9G-<GYPC9Y @@E:\J3B-W
MW3-FO1/E&.OP*C'1.R?V.?3J,V(G>:OE1M%-SD^AZZWCW?SR,B-I2EO2*@<P
MCRI\+&1^TT=L]%OC?"PY'W=9,U+?C2FQ[9R\/8-9SAGF!5[W]&C#YI[.D!T,
M<Q:$TUV23U=7ZJ.WTHQEUD!48Q>[/74OP[?'WY#.H\"J]PR!P/KPQHH(T4;Q
MS0QJ3K6,<)(<=B]G,&^:<- ^X=8_^X4'*M[YM-/R3^0U#T>3L*4EF#BF9K$J
M,8(;=W<,U.&=X_(GA6+X)LCJ F#;?R)Q\DM\(D6G^WU1@]<;*_I=7AX7;I_#
M%L-&OW0- [HC#W=0O$Z2K,X>_O@RKB_!"G6"H;=(OR=YED"%#M7L-.8SBJX0
MSEM=>CEO<5>V7@.JWI7=N;$>.H*[UWGNV@5'*"5E;]U;M!US@]-?K0KN#9>+
M$I0X7WT[V,,N+-[W..4'018?A3U.#W>;8O)/*C+,.8$^^)"@%T]1E@,'2)-M
M+E0WV>69^RJ<%T34%]N=3,H8$#F1=J#"=U:AKXG8U?BO';[Y<DQ#Z4+TM^[<
M<?\"+K-B^$,SGU-NQ08Q4-OAX@&97:XZA#"0J?#4LU3WFMZD$("L=G^A 1D2
M -T9PPZS.,9>!ICG/W1:1'RI<*;[7:4NZ/X7XP@^>7T2J!&4HN:>?-,ROK]P
MX4?!<I"+TB5@X(/9 TDWB/)C'/5!6VKWD!$>@2?=CX687W]J8"WI<I'J2UY.
M(*=6M*;G;>MRF=6#F-I#-4X%,PKE*DUV+SU)MBMZJI,/&HB"?X&*G3$S(VG,
M"2[]Y[Q[U"+3[86!!^.XYA1WPZ-;Y*XFBR&PE$A:_SX7>X.RQTW-N)S8OP7[
M:;M&WY><1+Q:T46D<?)ST=9%_!-#N+1=%3NAPQ:^XP0\50(W,H<5RYGQ!OBO
MV#5R(7:9D1)GS?Z*JNI]:OW$B$:,<N<Z 6*YE"3F WI-?.Z\G,(0^S;]:MKR
MU^O3%<6?B]2@<].<'[/#7,.]T"$M,L2;.(W"\I=V$LW+1J76P6\CYA\F>*Y%
M98;C 3?N<^?G-UO]78?D_[X.?YH+0&\34?O2AM_\U>?+IHXH-Q I#4A%>NRL
M[YVG=,?&N,^F)''[[8]S26Q)-9=<$I Q^VC2\ 6 LDD6EH>:Z467TSZ;.C";
M:ZUB9O9%BX<8TE]KB%&VD,:P)N[4XAPU0X$,#X([?QLM@.]VB4W*?''?I.B,
MX\6I_ 1L:84PLM"?E"EWF=UK(LQC4]I/RP(H&M)SEQL?YMCKOPT_H7Y$8Q']
MUJ5/-[IU^TAJ _A!\TMR8B")9V8+=5QR*NKE^O(]U#V(9V]5N&:W8!I2?-_%
M,.Q#P;YIDFY%Q:#3^,_><_,3B-#/B?B54U=7<X.BA&^@1X6'9Z\+B#+>;&2F
M\+;]J_;ICZ=FM2N:@Y41O]T73+9B690M_NG+P'^/;H]0=Z'?9K]5/:/ X4N.
M(P]TJ_UVYBVO)*\G\"TP]FV@#EBI?BF>PUU^&WWP1@YL$6<ZJ]++N;,RVA#J
MLW4&'@%;ID=4RE*%*,B.(3+^V5YXC*7,N7)ZJEE)"#WJM&P,E0#<Y(ATGF')
M8?DIW;L>]1KK!V]O" X<[4+<-A)0RG5(3)C]>GXD=&+R[DAJWRP>*[H\%=;T
M$&->:V)7RR083B/FW82J%KB6FI ?0GV"\5=^)CI$Q6I/A<H;@:E[*$]5Q[*0
M:!O&T%6C5E\EIK6I$9D.!XP@#_**_0#SYZE:Q>%M<MU-)MRLT@)6Q2=Y"7A(
M+C=QW\-'@)?[R6'SF3]R2B>(X&QU)Q='];RVH;6V;AR"B8N.NMOW W?TN$$(
MY8T'7P B%3CM9I)BMOM-\(IZ>N> ,@;4\JY-A.%T3O1/V/N)URM,>/.O9C3
MZO 2!0%L3[QKF7C#X]J<XL ZE;?7#K/-T4H M_5/XRM4W&0:AJDM932AS8I/
MAOJ].'/2$@V8\ZU*4_QN!,ZQZ*^'&<"PYFWLV$I?B!VT5-WK_%L>JM_/24V2
MZ-,ITI>T<1/5Y#8H%(BTWK_O&:MK:#T"=?NF)YU^^#:D=+GV^42(PX=_IJV;
MKPN%I;-5$A#Y&W=-(=C ]&]"0>%["D9RK9)#\!G!PM@Q0*WJ1I](_,WNEO=[
MS_MX>/A<&[=]9N?-[7:J394UTFO3%Y-^F9$F%!Y5-<:PWA'@?C4B6B,OP:IP
M_>L/.7+^W.^GJ1&NHXGHB/ \0FP[&SNN.][J3@(J;<QP2]]]N^9&F<Y5,4O"
MRW)9'\LM,+O9>9JO518X_$/R]?P"P1U%5SO',=! _MY/V+5G'.FO>WP-GN.>
M6Q)<L6,=+>1>V2F&$><(B+[4=Q%47W^E5 CYM<^T&1KRX-S^IVE,VV)KJZ$G
M7K$F56OZ;UM09ELR+O.SKPS$=L[SCX@1Q?@X0K\7=AAC5DH>]+YJ#,9P\*$%
MZ6.[GF[S-&]"YU%4 2T4\*'"0MV5)(&[[;F_E!"+*7Q0C<!)Q)9= &S48- K
MROB?'+2<$3\@_/ED>3)X="72@>J/%)(:/EM+BE74;KL /(9(GE_2JC-;Q&Q$
M#YIW[3Y1;N4/QRY3Y"N, !.(Q]0443QY5IFKK>&J"='H02OW7 #N/<?2MLG$
M;$TW7:+1T\5>O"'</T2BZ_Y,8#ONX-.?2<V/QWY"'>:5*'M4?)A,3@T;1^R.
M1&Q8&_^NXW>1.UO%]35'G !/<>6N%J9Q7Z,S$5^@GV#[H;:IA+J*(VGPMAK>
M=[ )BKIS?20U75A7D)F]H@2(EV(_Y[!'U<C2X41*]37T.[IZDG=-Q_)F#1J@
M*0;S^\[UJB?P_E,.R^<X2\^4#N/R3DTZX^FMR@U__=CL:>8/$6.#%L.'61B7
M'Q;3TD-^@99&_I?FT-08P>HBP VZ- =U"8C"M:\/Y;[P9L:=LJ0[3V9@ _H)
MD=AL$ZS(()U,9V+T%NJ-RU.]AGB##]%7-,CHR-B:3O4% \YD"/V@*8;>(TI-
M3=/IA+6]^<S:0.4%BYTK4>1RM.DSY0J>J:.Z&YJ 54'8OM3\H6;2O&9SHD!<
M]6I538ZK;J43*2-I$W[;E\P.>X+O&-D]FHI1?TP:57_1B5RXVP]Y"#A=6K&I
MH^_S'TQF,M\@\36-[>P@@/?L\+];HL$NQ0\>U-.^+I@3+<(P;KS>3M[U)</<
MIJ(G3;>P!ZNF[#*9!>=+Q(,E[6+X[)Z_WS&LD5>B\C[8#T)2S/8L4$T(5JNE
MY.&LHT74Z>,<Z<L$OG:(P3M-0654;YQC1#=4GP:JPG4_Q^@Y,ZA< %PR6G>.
M([ C6]%Y@RXG\)C9(QE+7*+>^'K#"(G;<- Y?] 1]^K SKG-([^/_-?(LLY]
MCJMN/6BJR*G?P.OYN*Z)^?G\R-)C2:R<1&6:"F+:2/_NW1WAZ@#W\R[GZO26
M.O'#0WK^6==:.9M23^DC^[YPI@DK'O,D09C=)F1^40QV8I9\R&=KJ8]7)\FF
MIV&M@3L9 4@:Q!=(E>)[2#X/J[N).J+G]T?>GF\7@-_ #] ;/8Z+C<B)LOP&
M '427:6@G[\)/%I/@6KX/!<+1NM'-0T*Q)?]^ &;N;J<2GK#"_V2/)2"&0YF
M"OZ(\)EVF\FK9PH*]Y*>I?"00EFXSI@X417*8ZG\&;02V!+8!+BUP]#E6>OX
MROCRD5Y%Y;5OWTZT]S(67?N+!N-.HF?GN!KG2C202,-^B!7[0H^CSY3!?S^G
M5]:H/78/[TEX7FSG,?9L00CGDB."4EJ>5:\FY_9BN>Z+8==\:?:8G:LS7QIM
MR>OT&5*3/#DT8H"82XMOVJ^T%LX56,V<WDI_&MS.]H2@CA\LS;-?8 AXTZ)_
M5DHQ4I1Z1E9-HD<;[[>?[?*AQQ=HPAB%&(A&KUZ?+7^_"L_49MX UYSG#<D)
M8,=(7=^@Y_^ &T:A_/M'M]F_'?3>-K6384GPH*[H5\CZ_OGQ@PN E[D\[F!J
M$N-4,2 LVC[NCM>@1=H[4NLI;"OF;KGUR>W''U7],3*I6(;>!2WZ.N#T(]_-
MC!+YEK;#'\VR4B6,D$,+_5K3"?1K)#K@N_,HHI8890UXWG$!M0Y8[]-3-LE0
M[[P Q.KX_YK2-B7T=-.\'N2,\;0^GOF^4B%$S3DIV0IGM'.> :?3XBA[9L3,
MZ5X4"/[JFS%Y.*#-CG>=VA#]%*MU?/PUD"F>*1*A=WE$WV)4><\91I"O!/W!
MDI/KZ7II@CZ_!)EW-%UB*N,5GK_K\HF0-3!%4\UT=)NQCS?%_=Y'O&;^[EA-
M0&TMP.09C9XOG2U-62[M4_:>B1->ZN*N-UDB<(^+K?$R2LF&8CCH<KZ3P@;
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MM:Y2#CK5 J4)![X='Z_!#2&L<E@56"UU@[J"*"M-?_V,)BU)G?.FGG:M3J9
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M^!EKMF.<=A27HOI6==%F81O6[X'C,%+BO4=JIA+/"IW  K_LR<$PE)+*B N
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MM[#"7'KFL])!J2X^P4B]#_M@8_QTN6WY8/Z6(4$5CF'SY[D U.?!-U].?3>
M8 /0$K'+IE2=QFQ(<,%P-B'FOK;-SP_W[E9KF-X*_J/)N2[>[QEFEVW:0.HY
M\\";70".H#60,Z5A/)Y8?VHP:+FND4=%L<SEJ=A55G@X!'*O3F@^DEX;"X.<
MVP^;GG\_7B0H^=/XOD&>L89?0@AD)V/G)-KKI]JA>D>9DC+&T!P[)N*.Y>Z
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MLF2&.O;];^R]=UA3V]8O'#<H-D2E28T*2A-0JB 0RP8$I$FO49$:BC3I1$%
MNH" =*7WT$*'2(V B-1 *(&$7A.0$" D-_N<^YRWG/T\WW[/_>[]RLL?,WD@
M:\TU?G..\1MCS+76F)ZT7TY$_''6V?_Y\7;\;P^XL_S[+F@?EU(%/\LIOVT.
M'](LGKPB,\9AB'RA*%)&V.NV4$4VWFA-)O( 58;*%G8H77FFY^Q>)E_9N?(R
M?AP'\YVW*X\P;AQ9Z4V4D\I#?-I5_W:'=L&&KG^ZQ/_BH_+'R_#'R_#'3207
M'*QTV_-\*PN!3^1\D%3//A6 M,?@\\A65,##K' $WHCF&)@MLB9(B/U=<?))
M*B#.O&K=77K07X3D[DG0ZTY"*]>$.U?1B79U'/79&26[_P*F7'4UW\E162_-
M,]$ZS?<!,@JUI0)^@4(PS+#G3G65]G>^?F+P2N:[G9 Y1>OO>J.$HZB"BH34
MFK]\;6UCE'GJ?M[SX0BW:HXB?SU\6,?AL-5<[.GE@RF9W)Q5^7F;%=CIV2KD
MA\*"NKIG#ELAOP;.4P;[7//0R\1 5H);YXX)EX"(=2$KQYV/CNMWZ>=YWV2.
M*X'T['?,S694QLJDO !SYW\/Z\%%N5MX[*ST%HCZNB8*-+.\J*&LJ:^4Q^RU
M[HUM34)L:OA2;]8EYL296)PQ?"I'[\F")H+>2MCC_;E((9ZP1S>FRSX2V2^;
M5;/*2C D.#KZOAFHN;,6-8H(:]Q80HI,'FD8#V[L\HBW)<%<GV?;UU[C2_)1
M+U:%G[#1JQ:0FPN0--7]9F7(XJ2'*4[3A:]_S,V=W\I6%RVY.3DTK<KII6%A
M@I4RJE<F,&!K4!H\6\$NXC46XTXWR-*U(U^Z]5^(=KQMZT&V/">AOBIQD5P(
MV[V*+T3ZH&>GNWCS15-E)/F=\][QVRH\/LOK!M@M+(O+._GT8Y:X1*1[[(V&
M6K^>N\N;FZFK<.:"/!3NRX*'484]@BN0'Y*L[ _*^?0KA6O/U#,I--Z,GH-F
MUB7\45X#"]HD5*$#\ 1%;,*A%1@#O+#*V1W+.-W5K).#=.(/23(>-;]X:GGG
M*P[.W+,LS,1\-OY5I+KF<&W, 1)34SM1W_(HSBSUP)<[#*D=1@2?H8C,+-=*
MF$^9CK\WEFXS])KFE/L!X#$FQ&3"$PF/.M$N4?Z>T")[>7-3L2PWG2Y;SN+2
MN]$&%2P B:]U="TT3@D@@,R3L?EY<Z&M5$ XMP3Z>]+,$W_0Q^B,0Z]=_MTR
M*N#2&MO:X3/OZH[DJ))\4NN0J(3E737+,3XNW&$;B7<CE7AG0OD,MO**H\+^
M\XV<<W?+^(]@PMHIK080L,;,AE^1HC7]/#8SN6[1?U+9(Y.9Y.X%\]>OP3?W
M#DZK08ERW7*QD$O7R  KDE'Q!-J$;$'JPF(N0JW[R^PHEVJ-/38D9F3BG'N!
MPO3HAAM72N2 P]>;N2]HZ#'S[)LE"VN^UM(+.!I)'$WS4M')G_>69MV\Y/^
M5"8]A/29G>S;8'_-I09E=(*/NR9>B7PU^\K-=<M<?(,.3\',83IEZZI#_9Q
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M2H(?^;,0B&4YE+&#@3"G\G>F,GGEJT^G)D_K[$>5W-&KC^XXR?[F/K89#8H
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M3U!#O%?-/W_(%=;O"650DB:E#A,#"3G(H@V7<QT%R'Q@=6?@=YBD"%/3SDN
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MOTSZ]+QA2W3*0FU& W/%*DGNVY+<@'0YNV*B:5^&2*]34Y-JDL[\0FNM>:/
MH//=L2848N7%4?+Z+DYH%U$Y92<?FEDXGKJYRLR3>U9IIZ9@'LT@1_\+)[T*
M9GD.KSG*"V1]9"6.OI4S_"NO+OG*#A_[Y9,NG<]0(K(=1>+K?&&Z)/CG_KG1
MP!>4D4S[UZ_<1-\?SLQD-T"C,,PX@DNGMR?C68V2>SQLIQT]>F0_IO"]>P[F
M.ZDF]WSJI5?YY-SV^JTRMO0"S9)>B01=IR;!Y?C-/2<S&W#3:?+@E+]8DP9X
MLGPEUUI9?B;_3>9"2/M;4CP#S@3QFP*#ZV>R53S*<NAE]4AN56, +X_6%)*Q
M"TL 8KX^WZM04;D/$TC0J<_2@71GVC3Z*"RF-TBP"]R+])S.=$=)>YD1+,NP
M]G/)3T>E>1Z:/:\5:&CP2;V&.FN<'LBZJ/MC&9FD%^PL?4/7H72_P3DSK=R"
MMW$S"F<@BC++C"Y:1K W6Q7WG,JCI7/Z@J7^$\Z6&F97[J]VM1H'Q31P/W.U
M2.X4%?Z=M("/V4;]:!E23DJV9_O,YW+3RR1]]LZ5*2/&F'KIN518S.Z&R]_?
M\&^NUF([L\4?+WT@=+<PFQ!8Z02Q/>];GOMA97M_K+*L+Z0VX7!9,L3%-=AL
M>.#5SZ>&Z0WIUCYJLMZ]Q$G;LIF-R>?%@Q8'G A.($5<X!])?2-H8N>0W9+W
M*GZFU./0+/:BZ>E?:VN%HR%E[<PUI_B$FEZ?X7G%D.<SVO4=M>=F;J[&/_QD
M48T_+E(A2DOCL@]_IIL]'#OXG54!TK5==',>':!?GGJ8ALI?=,W(^_XZ=6!]
M#1?-I NQ5Y L>=([^6CRZW#WS%P"'RM:];.%_X6C3+*F%58F!O.4 )G,BTD:
M.I4J'1TI]?TSN8'>;T$?J+[#(XD%O:_1 %5/K*%',UJG6_5EJ[H__?KJ^*(*
M)IX_XFP*"<^K3WV4%*]RJW]7('4C[].S5U.CMS]D*>0(EMO?C(]W]5-VOR<+
MF?"L%M*Z,R8TM3L0I71Y1.EN7FRTORS$M32@:HPKX.G,Q/ED-B_=0I7SP;?T
MWYR^ZD$6"F3R5M4A\2;/2!-NE!Z QC=LZH8V-G60KCZ>US^>T)D+>J/&'Y.^
MT^^C%8D]1P4P3A_E:+4V#V^"EO)J^IDI#@]R3 DGJ8!P,<I@(<82/.6Q(V9C
M#]YYH0DYJ@X]0!+#J@,Q 2AQT(XI"C.ST'KD]/FHU*=A [;JR].#7(<P'44O
M40&/T364.R1Q(U+6G O=V@QP>',W3;#F7("$JS6S]HUF?-),:?$9H%]PS.A\
M?^F,4DRCG\4TCZ*U9%EE8G/<S3O--UV;N&TYNC0_DV"&^&JUHY1B!WFOU-M4
M@'6#M]?1Z[C4Q'2==,40NU;5T\H3)04,'J/#AM-F!/8:31,B^.T:A0//,_ &
M:C, O%F8/VPXPE>54@H._Z..]Z5<\-PM$SS37?.]4NA;M%,W J^-M4FSHD>E
MAG3*^\>9M8?,QSVUO66@*@ @PJ1Y^4;HO2*)A].-24IC"L2NL0LJE$!:$.;>
M?S,2!O9VWG>N6>MK.I=XY?+DD\''#(>]#XI-?O!*%];K.5PLD'>RL"C:R=^"
M@#&M8XVU'<3B-<W+D"W$?F;RK)/,FO)1!D78=,9LP-Z3/M6TY_S@I_FHHX(O
M>M] ILF=O,!&T@:^H,,W-)C+@1,94AJ:6&2L(FM^2UT[05C<Z.D9[O-+RY!^
M,;)),0;I7[V:&M57)-_C#7-;%YO0,LCMV?^F>.:'<'E:X90=*M+5UM45X@J<
MCN<X*W]T>K'@\$4L_ZOM8(]].=XB$%;=06VBI"0/8K):TS)$C)AJ$77I7BKR
M9R'I%GE+=B51A F:T8O!7[P]NZ:J+-N?Q_NP?\)%<YW\5"M_WG5-SQMB#F7V
MOT!"%#V6Z2FT'#>O&'BXYXC<1WU:FQ$=;380[BEV\ W-7=DS79U;%/EU2_.1
M2YFEJ7TRF\[TM+*MMT'!VQO6$6X%PB;NH6WSMGDL.Q$L?.NO\/Y)14U&;NG<
M8NOQ:A8F$)2%!^OOB4EHBG#W4IL[%< >VPXE<E13 8,K%K4E^$T,%MR=]5[F
MSG2/"_:TB[.SU">OXAM3D9+LL0*DB*.I/W9MZ-D06ZAHC/'FC^?XXLKOIM)E
M*L-P-8@6P+H)[?EF]%-R;LSO,?=[W0HURE0[]WA32X--(2'3?:SA=DJ(L ?K
MV8I%<_* F7TO+F=Y;&4-]M!*]X9-8R8&;^>O6TT(R$PK1D.>>GMY6V@I.K-!
MI.$,>RGVH:=8+LMDYM3#> @HHB\)8VPAD"'J8L/VTN/VUKT[&W4\=J/-GN60
ML7.0@-)55-*WVQ4#7OQQL$&UZU6)KJ8V<KDB<W.A!=]'S+S2FHS4W,JD++Q&
MUSXOZ=[=AG6:"F8W/[3ZXVF&_^4MF?YIBZ5(J(THKZ8M+C2T,KAV1K7>_6CT
M=ZN#=*;NUB'8)/E.I$F B6(Z+<4?\;T+"CD(^:?-E:#:H^2O?ZR&I&V=I0(F
M;,.H &WI0\-'<+#R0990-W ;-TH)^W6DS&(T '0T_;=MEF0?4P&Q252 UT'$
M4'F$'^O%[ B1AT$1@I]_^R^V\WXPTG["$8Z\*A__[W9?JO_>_B>[*V%6R2>H
M@.!B*F#A6B#C'SLTT]+7 E&MEJC8H[7Y@13LP#X[0C_P.[1-#K3 FT4[=CV#
M!*4"-&MWUT=QH#_9B\G'$Q$N;N@W#IY]-!BH^BEP%'CF)2EE5KF^\GU/\?)"
M?@B+__ UH#R3^YO[FT8\:SCL;<BOA\VVN+#U9%M<7P/<XM1CC^FG3RWMS*$Y
M4W7N2$%D R!X^<Q-A#@ND*DD.@N%5]^!Y_$2)V!2-74&$$BK=]2]A,7P[3+6
M,>^T67!DL\"KP>EE^4CA=)\/O]M&T9+N!+Z=Q0I:2,4\"EWF*(3.WJ,"0@+O
MF=&%YXFIURRP3^3'L+/5J02P?J$"3F?2<L/[_8^H@!,8LB 5\$[;@ KX;$/[
MY<T6A35K=)4*$#G\5/K]0.01Y9*B$>5M:AB%#D'2_<]G'K2 %Z#NYR25(G[^
MITY8H.T"M-'^*:E#D\R+"CBK!#/:!T^U?Q_(K@']!Q&!^/!5Q*_S(R \#Q70
M'ELR2C':NUTMN5S&1/I]%WQPR@%(ND!#I4J^[@L[HI-F(C- \3FKN]#$H^^W
MC@4\%O!8P&,!CP4\%O!8P&,!CP4\%O!8P&,!CP4\%O!_GX#F^?_7231+@"5L
M&]$0)I2E;/>?9?I/@AB5D&&;SWMM!TW_DTS_49#_F92[I?PR#/L/0OV'H=KU
M1?12%KG_VTKX5S6B9\$&JOZ7U SX5R]OM?"7M$?NR5]3[PMZ?UF].S[^-?7^
M;R;@?X$@D#9_4;E-_HIRL]G\9>4.2?FKRGTLX?^W)?1(96C#L'IG6L?T=1SD
MIC7>,ZMQI8B-ZY)2B51 ,+BRV%[VU:JEB+=S;E18K/;[S2C@@1VFB[*,&XGK
M\I/3/K\H%Z+,*86V>#FL"U9JC5BOUTW/?%]WR$&^D=;A>XO"CWB'="U6X:LV
M!$JTI2<A#U^>]Q-49/1+O%ZH?/:S<.%7@$<>;-D\2R0O^?FU=WDU7@&3TV3,
M=.7J<- ['QVC';I#12J@UZ59A JPS@0>*:!^'8&__^U]0J%6/.PHR1OZ:P<,
M^;!A-!A8T.T:1J[?A7XY NDJL^X@)]EJ8DG[+GO0PC+A_G];Z<_.[/I=,#OB
MY^=_X35/.MY_MZ2?VT@%Q*: 9D _<LHE;\.^ DGR,,I3]EG,H<!K\(';R-K>
MP9\L^5OQ40&^^Y*+WM44Y:U18#7P3Q;QO0?(S D4W14\D-*#":,"?DVZ6/9;
M6KA@-48SB>RDB[_ 'V@(4W[^*R\V'K?_GHWUGV^+'8'^Q+Y^SM\S^ 4N(B@\
MIP+$%,'+4.T1765_ K&KC(^B9':$6151K_;XAUTM%U3JGA7,KA'\5V[^(?_-
M@(K$$+A%[;W8G<*UJ.\B> ;*!1I[?0PAR5)ZII,IZ7#Y(\J?&-CX-RI@IO7)
M?N8M*B#.;U=U'?EG=B-)!=#/TWKS]6?XXP[;'!5P)#.)JC9*-B/%[]JVA%#H
M%=GGE:'04\E6TJ,C@V:39CD:MZKJ'V.5.6QL%   _H2OK/O/#_VA;1TE<V7.
M.^U4 )WCNN?-6BL6BM#(=8G[W^6/XIFC9Z$#:DIZ/RY&W4FC7+AVU"RN(/2\
M@'P1W[]CUE,R*9:#3;GF"/J W&-+X9'=D+B[:M3'<R5X_QPX]U76F<$292O7
MXCV2U= TQN^7F9F%<T"F9D+[*X.U$HSU035:Z3H5T*9,N>=OV)BJ"<&B8N;-
M@E-$-SSM'9W,/JAN/A,"TO^F9'FGRPV,'\EBAB[G>&]1 0Q[4+);O;K(K_?/
MEA^XM9\1YX\MC#[K:AAE-!6S1>%,P+H<L;C0G,TLA79P#"U8850CR%(B9&.H
M #R4YJN0(N^R2U9_(1(#O@7V\B1/>4'_<^>Q) ?M<,0OW6;:T<&'"(J<^0V:
M9TG>AC4P5(59[_%@R-("G9@#P1F:KVL[PE !W#G_=%VC,\I HSQRR>:#]2\3
M 4BO?Q:#YKQ"<TEI5( R%Q)* C51 ;C$=EW5T16H\.$'/\'78-=I*J#CJ;\F
M%9 =C4.0@;0_";V@N2*EFU3 H H!0V':I )("Z\^TCPDN+=UGO<8S3&:8S3'
M:([1'*,Y1G.,YAC-,9IC-,=HCM$<HSE&<XSF&,TQFF,TQVB.T1RC.49SC.88
MS3&:OX[F5UC; $DD=H,1;V0<LSJ ]7H/7S:HOE'PWE:^63)V,T%I27<SJF &
M88B830/C3;/.4-"^(;!W_@80E]F!]PF,%69GSMD?] '4#N]53L'>9@GU@*9M
MEX!!<)D_WJ@]"&E9R!TVG3;]5OU(2NOIXPPM@\2PJT$GZ#VN-]^:#,'?13NY
M"6KGQM=AG%"P7F165.\KTON-WD/8FMY!>W:K.140I$*9W Z<I *J F(*2LU5
M!:*:)<6)*LV LS9Q]^^8XX:,OPE\GJDZ\156N(8GV[#E<S97[!JUL-OXGW20
MR-,=SES^B_6:K?Y>3^K=?Z]Z4OOEM"'.)!%WL" R"Q!W\F@]7DT4%KXE52-*
MOC/QS<F*;IQ?6*1=9 SJ MU7RHH&$A77L@Y>93:G(G(D2(5S]EU.?< >8-GS
M>/T7R=;[)UET+4+;_H4A.6[_OV[+5_U2ANZ.9JI=$2Z.2A)X<Q+@5[<N2P70
MKY 2#J'>C5ADFV] 2VM"?E6TAMD(SY>*BH%K&@"3>;X/[\]YW06G(A[6#)"D
MJS5X@9,^A 0=^1)!I9=*W-K5W=[?QIUE;Z]*-KBCZ/)\01MMA&C$; 2-_IY0
M ;^1Z.:VT2:D27/P^O+NB8L!U>\[D_?(45*AJ@;W)]#\6M].!@I[QV*3PYN?
MXTP4U$J\P\Q&FA_=RG\]LNGR,FG]FY:73^[F#VUS%')NS<:D0-I?VD ]$1W;
MF+O@7'XHOO8=OS+2A1-_^G'_6H!4T^O5S0 1*N#D"9I!*?AK';U=!]7!E/IP
M3'35Q3Q^&N&CCBEI#F4CHDGO*K\R)D4E&6#J0V )(D1WRFGPH><:L'8IB&R/
M%\=.Q>*>VV:W3,,7LY\,@^V_K[@HMG1DI?36#+*Z:<R-,V^7!>I21J$G$7/I
M5("]-H\WRQ/4'6\CL\;ASRGO1:7N?&N7O8MSOSFD^N(Q[)'@]SN7R_3HHNMJ
M0C+&AK1A,/<"NHCBI5M*?-A8@U&E@JQ!9=9?#/E_/'(3^)%&,]6!BLT51_FM
MU[PM7B:LR]>%LNLG@>8DS"PZ+@,+S1H8M'8/0>#W8+P3F)RE'0E:_[V9QD:A
M&> Z."F96_G6F*:G+CGV+98^Z<[!U7^FV)6#?RKM5^_VMRKY9$04: %9<L2T
M<A A",M4&H?_@VD-G?^M7KX%"U'XFC*+8<B_4NG_RMX_2N/?^ ?_NJ:$_"F_
M@A&C?UX\WX\#>(CJR9+LRMH6#RP\^O3GY?"[H7_&Q]MKT,N6I7L5B*]AV>38
MQ4?$/2H@884T2 58S310 05GUGI*_HQH*T";(U1 .X(_$!Y&80E@GZ?-ER?7
M_\JN!_]/-3:I#.$URU$G1T>GI>:6YL1G=4$L$FH*40^+A6-,PJ\"Y/A1*WOK
M"53 J1'O!"3E<NU8JZ@WO)GKQCR$WY<W^3<+R_8"!6T1H)@L-T\A_^QV[P/6
M;[39JX-6LV41O(B%!/98:<AC%]% SO&'1+6KAL9;FZG*H18%<D+<LO27]LQS
M7EX4^0F=G=TB"0Y$U0"C2_!6;8V+7^:F@:H5H4O@U/;7=?4C AGT173R'_P3
M0W+NJ<AR<+V^S[HMEV\=!8LUL?E-752D5].RK\<?A?F))WPJWKT#TN^X=\^B
M%8-:]05UQ9)DZ+YZ'?Q>\!5Q6<$B%U/*W]VXSG;P3N*;Q/V;+&^R,T_=?R%W
MUZ4)G(B!UZV_Q<6.9V&GD<'^GOEE&60[ 7CCVZ@DWX\,;Z4N7Y3]<C7XP]D/
MCP /6(<"NQ!UF%B$%3BZ$11>DW41XB7_1/:Q9\"U+9X-3[,7KOPN7#PAO0GP
M;[VUIZ^WTL*_()H:MQDK<?SQ)%8@HYVO5L(L^+)=IC!^,U]L'7YOZ6VBTS2'
M[9MUMU=+O<YAG\*>I XS:,NTO\A1;VZ!"P64\&.I -A3/*%[L/2+[D[;[@1L
M;=&,UNU=:-M-)6Y:KP\I3*3J3EZIL6:GO!D[^=X5XDJVI6D'<_<S-0FLF8^:
M8^7\Q3OH5M&C0B4.8W^6HSS*=6]9]=1MG 8^-GQ7E.V'6:UA?3P7I.BYRH?B
MXF3A-_'%G]-G3W0%T@RAK0*T[8BX#%JWC:4"U/A@_=IHOUDJX#T%!&W341(B
MR;:;FA\@WS<_('"9PZO@D8 FGH>S238*PL)!W]<?%A>]N$\_F(Q;;4:QJI<>
M?>,?\A-E[0KI[,>)/'3;LR(!E0;!Y;PT>PWV4.(F"^(U8\H( SA9XBT4\-;@
M"DJFT2)=@C<NKW\<>COF@C]\@(]G+>:H&#0[-=E"-Q>-C%(ZXSW7>M6T@\X"
MF3NMRF6.^5V."E"I?[?O#C*_.?+C]AE^NN$+0GW6>G':7B_1#K*[<,0CNZ4K
M1F*6+AD9K3MS6^-\LZ=B#_4"4923)"CV7(;6@ I!>L?,0K/@6]RT2C8'4/!'
MS.<%50,%FU::)PNBT4.;Q!]/ ](O4@$A$"K@M$H9=D./PBR^H5U+!3A;F TL
M!*2M!X*3Y]O8)(EATTVO7]4CY7: )+X1<2>:1Y(E:7!'#/;P5EZOJN@08AM^
M>6D-7(;!&\%( IJHC1WL0$BU):E$ Z\:1+YTH=(5!I&U-FX7@)Q@L2OM;8 *
M@U,^"6\L\1=GGI^426*7S3F;L)"+G;3@JBE;\D,CE20YEW%?.-1_5B-P5 "
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MI)(^-64QY.N\CF"2W%Z,V&,:?T2D(PR069BPZ3,\>']#8JVOHX9K"80]+6E
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MH7W 3]/>0@%1?: >I9?"@@] A4EM3]HTW?6=#AZ<-9U5+5Z[[IUO,//C#-'
MZPQ[?[%O,NEB&6$<9]CN/*&R07#'3Y.+*TL=G;URUPA5=WR@DUBKL4\65R;K
M2@_C;\+JGF::3\*=TZF0%HD,/BHDN&P9#.'] \CYTT25[?* $/B6L^"]B67D
MM]D8F<-/_;U5@$-&5$-!5$LSB_F@6P+RG'_G#+:<L@T(N"1_1QM(?Y.]N_W#
M"^Y^/XU"GXEOGNO?N@3.F#S"-X 0)$GB92(5) N,[$T<\Q(7Z.4+.Z?S3'W>
MZZB**,X*^W"_[6-50-7&K:'^&9KN@AA''T<D.)!37Y?#0S"T=;=S03$#[-QN
MX,\4GLEW]3QZK5/PT/&JG<EMA1BO6]ASM/AW=99[]!0&'+@ZUH #I0F+HGRL
ML/PT/Z]Y-;9L9=F]9D5=WGA/Z\^!19[W-]<0DY_.-B*%?P@!L8UDU458> 4L
MZ@= ,3?9KS,6+R3_\#@IR1X\EK)R=C9]@F$H8X0()JVS],:M'N#DAL9RXJ6M
M*T?+)ZX+ IS]]'%4"(TU;S02ZD$^C6QLI$)VHF8O4R'CID] _)R(_K(@]'5%
MED>?D$IZZ>N3H]LR7SR['P[>UO@#M?.B00PD7$>[5(@6UA%Q%S&,VG&'7\)L
MVAPKHL2$#(+W(# GV\>> O3FG*,4.39,",E90 I)Y6@K1V9,Q)D "%16O@V+
M?"[)9[KS)2%4+^K56!@X]FO,7"*"G1RK(.&!UU/#>Q84F .+;<ZT W_GH@T&
MQ/EJ:N*2E.4_\[5]NY,=RLZ_WR[6TLR0OG#3H,:#8WE@786UR,Y:FD]/5<2T
MAUC[K^[3H/SO8'0)YI^YS[\"=3P.N@-[B6FC0@C-_<U42$<)&L <,JW$_@L;
M. ]=AONAB'PF*$J:N,A.+84>7(2;!D !%>*"(DM.&*['-C,>&LZL4CI&0=Z3
MUQWQMP^Z9/QV'_PE)]UH^\!,AEQ[R)<&2NI"X33RUB2<2+,(N4*%E"L8+G#^
M_)O7WM=Y89SO$;*FEOOM?ER] YYMT:M-S'VQOTWBDO=0"YO[M(/%]>$;F.JX
MR8_6+Q])'.B?87GV7/@K! )!#S$",LZ4<RSSR! Y@5*<35MJ14:(AY@J4:\Y
M.=F-]DMUJK[:<KFXM^&-2PF"*Z*+]["<#HM5)$ZE N\Q0MAPA3.=-U%YP)^N
MV)[1FS#FZ=89D,L?8YP5;KB48LA_TT8IZN208#9]5':R=76!)4KB_F=3F'Y)
M)(X8+306PL9IO/!F900JL3[KNH-LW0;$MEO[8U _<L>:H$RV,R>'R^6WA"<U
M?@XO_:AUU%WLV.F:D@I9:K.1N/S368+SQZ,8"+"">869*T7( GQ$5D0K 0QK
M)-XL0'MW@34S'VL[T,V=7I>:D6)S,;:GYF>BH6^WL$!C/'M4T33SV**C'PFJ
M&VTF7_@HN2PJK0IUT(#,7%M.>+]V;RA4V'E[%VJ*F1N=99]H]<$G-/<U.J]J
MB>@$NU-^\,OH="#GQ/CAYI2175X2%\T<:-ATH*EJ^UM]-6_F]YP1_#XDS2GX
M"ONC)>DIME1OBDXLAWW_E">:_1]9:.*H:I.7J/5G1F%H/NFH3=J!VQ*F?A=I
M.]YAV!-[7^;$UXT,F;:?"QA'12G_D\!9<$K- %/.AIQ3/:&P^*:7L?V165AJ
M7L2@N EV1>#L.;7.Z%_+;E&2U8#L81WZGD^P495&SFOL:#]L!^Y7V9X6GM"X
M."/@,!5?%E!)A? =SJ+_[%+H?CK(;,Z",2 ))[8=+E:7^)MTTP,]K23S%W\R
M9?N!4RWRS>(]=NYV>QSL+2_.,;F9-U@16CE69[7(X-!N(/<Z:T%,7%-VCZBN
M\>%!];7TG(=!B:=IMN,^>,, <2B)I;"IC"0PK$A'$AO9DBZ<?BY6%5:A=7]D
M<]/Q&6G458Z$YIL[*Z21Y626])(I3:9=KV]]L/&YWL=GZ)O&.4G3_FDD4:N8
M%M5;GV\!?A5^5>,+R+DQZ*$(2(HWF4"?^+-6N H'),ZV1CLLJ)*8D]NPB-P;
M76N4RYI:(IH5<3&3WHA>YJ(N.<8[ZCQ/WG58;;QU^(/^9_<EP(";7J1+A';0
M]HFPC1D1P'5Q]L(:XO:@8F>>=[/Z\/OW#R4F7OK9/8S6%)$N4V[4+;KXXIW!
M2;O%KR^\0XJ?J$3&B1 &H1X$3'I-HJBRW+V<54,',3];S'Q, H6A$:C]1M(F
MA^[W7]C0Z_UJ"D#A24V_IJ"?^,J2:',N/E]=-K1SD7OQZ]>)XYJS0%09)107
MNQ"[)3KJX""]$K1H5W?3\<Y;"WE-8YM?>A-FB8(0FV[XP]AG@!T(86E 6Z,[
M+O5-9CTB8,X4!S!7<23$GZZ;X1NQ4M8/H?VA?;?]LDUZ ;OGKSZH GACR/'+
M65H2!!]RGH)Y#NGQR+6A-XP10Y$_*]3[QD6E;_BP6ZA0:)=VS>EY6.I^M A9
M\SS[JM^FV_[REMV.>MOL3%EMU>IN:=M:7]UM%EL)CPIG>7G,[OU%PO&7]LZD
MT^1,I-TL!U#8AJK8?K^'N63/4;3FGCMC?_0\6>723^4?(C<ZK'8>A1$^T JY
MT?0&B.&:P: )\6<B7JAJ%',GQ #&BUI0(NOV(XZD[(7T>]9^/OZ-'#\.-Z%O
M2KZ^OQ0<+1\UUH^I0I,XM[]2AE#EVJ5XSGE,=)U\GAU%JIHRC/DQ/*@;!Q/@
M4/^2=)7RLJ.ELSRXT3+D:I0K%5)ILRE-E$0VWJ)"7AQ*S;+8'7G%4J3L*^^T
MYO2[^K@ZNKN[W[1B>X2]]SWIM]O#YUY7FI)$IPP5>=DT@AF+M-UJRI]9>I?7
M3AA+P._\+# (ED.,ZOH:\Y<C0V;RL_[U1=EWT+D2>*5,3(,,98KWDE3M]D5[
MG#>R\6A_Y5WNFLM4G6?E /;);S;:_-/3V>)&2^GC<Y"SLTC<:T92FD1++)%]
M$<RS:AM@@C@'\E'!97P5I7W+BPK1EARK2AQ\7[;Y+*=DT&"G1C4SZ+V%E7%%
M%>GDFC/ SQI.-/-7^HX_@\+QM1K,,.'2['EM1RO,7XZ..O!6REV5E7PH%:^A
M<S&.X_-Y)Y$ZIG6>N^"ZB8+X?2QV'\:,^(VL8'S_)EUW'5_A:-$W*OL<4^\#
M[XW[T"GDTE_]X?)T ^ZJ"\V1)H6A#NB<1UZBM%9ET)?5E4>V6G"-.I7L<S()
MB-\(>1DB_Z'^-Q52V-%WWG^1#RHZ>US,@;GT!A-EDARF>(.D@M.J:NZ6'QWV
M0%V>MI<,*/D[ACCD3GI,<^.Y]L*.HP%_B/_YG>$>S/RC^GO#S^Z]+H]P1_7F
M[PQ]*XTJA6_I\]T4]MQB\0&I37%_%71NC@HY5'$.1VZ*Y2'7-,9Z0 -W.$L:
M<R:^1?[5;CCN"H!#DP11.(U9)OL:>?'L_(!\C>'WN.]6#C8U8:+9Q"[_%@6;
MH(RW<7@)$J<-$0;(S.6W2H3SL. -*O+_R"#N5@[E#:XV5)MZ"\3_GG8.]7NA
M]&,JY*E:7]M)P1-U/:?O]8<4-IW;3G.JD94!N#[9_K32YV,I!H5B6D$"HG!2
M3O?"*CDX&UQ/6X?][OE04N&V.TC8'?1 I&W5ZC\&!G40. 6: (9J.'@+&JO1
MWV822@C>J_%HLNUEACFXB@Z9FI3&F(6(+)>I0<[^S7 =6H.%\.Z@Z_O)<<4@
MF-)*9AE(L2QXZ;;)ET-A;Y/0M,\JB6Q]><V002DA6_TH)\:/PM &^.0!IA0Z
MLL!/Y_-0K(40GF'I(.$T>9'6LYF#Z4\F^]L_YZ/\XI&,""E_X]$&.9(A_FR4
M@K*/:T 1$')D.IEB[=9#?_O:&5_A*.&O\_H/()#3B.3C987B=*#T),%!:700
M0G9D<^]*Q?T'ZPW<#76N+'4):E\33.K>OXWRY&NOI0F/<X^/\(+:]@-W8XWP
M^>W%A@8XWIAR!M[&FI&-F8!8W:J4DO),/B?;;-IS7=_4)W]^V/K%_\'H8-[U
MC=OF&).H^_)J6:3=1/$;V$K#XK=HVQ>NB19\VHYZ.Y3B UX8R.DK3&,G-2FT
MY-P_"*GT[4F]00_H>7,+"YG4H4?Q6J=T+T\/0D5?Q;OSN&>@>/]U,WEPMC)T
MBQY'I-"!A.C4GU#0K$(\.O89V>^&WXW.&M\VJ+MLYFRW3S< ^YO\9E#CY_SG
M;U'1+?Y#5,B9GU1(IQ$ ?CY/AU(AJEH69B]N6GW:?*)?,!SONI8/NE@$,4::
M%?<IHL#DCOVLSW_J]O/(_[#]7&G%_&/]+F6;$M_?2X4 UV D9L[&V>\';7 6
M.XJ"]1!)?K';P4B[Z(/4[,309%T(]):0Z/47\G^%+YS+Y&/G^XO"BE#H](G'
M?;%TZOR^D1[A)%IIY_$&Y7%3LUI?UCUK<G,^*</NF+X^C&LX<>)4&,U9D>I4
M0(9"BYJ'3:PNS+9@+GD++L:$YDS;FS0]E EQKN!^Y">KT#(C4"G!%58[=65"
MQD.HZ\)"9GT[X>WQ"XF*_$:(04-L>Q,OD[>A*BZ D'7@^^+GL'BQA *4D[M)
MM,BIIR ^;'WYDY!8>;Q#OO11G>0];>G<1\7)=8.N\4/.W19MX[-67*;Q:?GR
MSHZ\^T=<*!+S 4&<_!5CA9[XNSYK")06D6" Y+E)8_.V'YULXUDQCXE0K)C1
M=Z.6\(OG2^9NF2U&45Z/;2>36-H)(6"4LV8$!/17FY&LWM_Z6V8OD93F)^^?
MD%UQ.4@M;WRI&7D0*Q^'4.>?F7(6OJ.._H7=!PQ93!HN]17I'J2G&JR8.#@J
M[M8*%,M]-,M+(N8Z' 8SZ\"?^#;^Y_<)^G^_3'A 2AR'UJ1"T-68O=O&^YGS
MO(<<>Y@C8B05HL1R9R+"E'=$M17ZMN$TL,KR$7$7!W]/>L&3:E[,9C8HMD]C
M#W?:O9+":;U5^-E27L7W')CNYL$T08/Y$^X/4O@F>6TJ9%%ZXZ/A;MUM_2\_
M7P@D)]BL7"J6+53&U,TAN!!=*'K*!>](HF43E(%T<M[<M,M6<3H;0 RV+7:_
M=H+=$1JI_'P^:F[.<!?D5Z<-0 (=17H)LM*DU<,(RJ>-W>O'N'=N-@13L=W&
MB'4FA-0,%?F?S0$"%Y_^?A.9Q:_U(.2$?/AO&V]Q2,34B<&[] S5AD<E++U\
M(6C="L^EP]=)6[6%_'[LBK=U"^02.9U&S4V])GCHCS=&0*=^Y0V?FVUF!.PD
ML)J;1Q*!>T:&.K_W[BM#%XF9$2O>L>)%KDN-@58WU#E=>$>0EOV N$HIT1#T
M(A50#1?&RB=%>-]3%$*TZ-4&G9ZK\U=]/'M;4_[YML]A^&)?X\I5]G'CAN-O
M=T 6V*A%T@$GR "@ZBD#6<!9Y13,]SV0SGI])3X!YE=?[-->&*$(.,E0Z(KG
M-[:9P']XJ$@_:8?OO-&"N#/X=TK [5K@LL!'\BG7GXJ_QB8,.I?#FD=:5^"<
MD3_63CL4^AP@,_\^^U53GF_*AC>>>!.QL_NW'=FH"IK]5^0KY*1I^\R9LNCL
MP3=DI2TYDZ3IRKYY5F^V^UW\[^CVE2QXX0[(QD:.SZ"L.#UG%N7SD?Q))A8I
MY]>ARVEI:E,@L*'Q@.*NP9G'ZC^.IINQ""?*N$8BW>Z+<JO#&.FZ/9.7$,&@
MQ/^N8(WMWQ6WJ;;#=Z21\^'XNH<4@'SQ?^X00#/V"R,!;.L(TS;>G<412N@>
M69G9L)_WM<E_G/PGHT:%Q":!2CV*&"R)\&.YF!4A\NC_2^GE>3\T<)A 7B2M
MR\7_#P<"5O<T_9L#_V;722"Z#_I&A2Q?0S <EZ-942'Y8MKU4;'DC:7^E(7^
M0S;,,T0/LO$>=)D'!=Z[F0X@03A0N;\YL@C]-\<#^GA@PB4,_,;A<TH#"-7=
M:_^N9FT#^L^U;?"!<=X#>^0\/!YJTGQ\PFCDSO\9M:?_MA[57V*1P;21(VO6
MMB8O.WOF:].4L5E]W1>_.Q>1)GU9(0D&S_<'TKU:,+$4!6#@>!_1<M&9S;NL
MDPHQ))<5F<$/D3#I2=Y@-RD=O2LJ(DG"'9]:E8U/,^L\TQDE20/$14R0@!((
M'3B JB9KI62YNVA7R[I%KD/MGPL_%*P6M_P6[I9@0\,\BDTM,"^"W+_.J'O<
MID+>_13<+TH59I&]Z9Z#GBU0*,5(5YPKS;-/-A'(9)A.;VU-'ZEUCK!]=;N3
M?=^ *VCOVY[^1T]%*#E+\:J_X4#QWBPSL-&F>&-H<T1W9DQ_M,3YVCO#O\'J
MW('OQFE:78>/114>,'C<)BP\H.J:2QG"7"Z'TH)S@UKBZ=M9?2] *+U!%C4Q
M_9#GB#^RVF>YY0R91(NEHO[V]+6427+%P]RULL*&HCPB*IIN:[YBUE'6>0CF
M@+,ZN,7%T&C%"^;L)+Y%1F9O@Y?J=VR/B@BBZE<46KI\N *$&<.@; K&>)NG
M; AA/#3,7^M-SO<T@V'K^@^7W;37V&/Y$X"Q^\HVF_.]_58(LOI2]&'QUW_N
MY'BF/;#AZL8L@T?N<)U\B0/'F4S>Z9HA9_Z*%$0L.\/1:&@+,H9'"FA_(XCW
MBE+062AX=TJ]R+YL]M;5Y^XBM^=<]THL(F)MV,3]1 [68:+.O8Z/:J,E".E
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M2#&%Q_N4)B?6#KW<'2!Z=V'%[2_-\[BF#L\\]JB@%?-JY\< &#1/ 604%>(
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M36=P\^\=$RV.%4GKYWO8N&8(7XS3!<D^Q;,*/7A-3N%J'ZA-Z/**>JV,X+>
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M_LUZY7T[+UB[S1(KVZ=97%"Z=;@FM9!6<^#]E7ZPD2C'?I< V*#NYGI\]#[
M_[.72!%4?@[XTA\<&;$[ JI4&:*$!-VF^3U'/%]JK-D)QIM -9C^$YUQ?39%
MJJ5R*B&.C7E1&_N F&U/ 7/HW<C_KYNW'"348[:R+D#7 KO0-!F5F Y5A"D-
M]6!BBV9X<UQ]D*9>Z%R2O;REX.%]JO<A8/;*PI.[[W@!AYQ6UNET+52G+BJ
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M3\/0[/9>,8OG!S.G0X+U#2VA%U(1OF(\VJ;_-MS0K#[?<%1=Y!99.QMRI,E
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M+CP?,NXV05+1>XG_TI;FJFJ\5/ORJ]2AQBSYP,?'B2V;.!2UG_:<[A6.-ID
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MR*M67-DH'-_QFY[U]=XI"):=?%O9E6GS,",,.[\%RF86^R\P._8!A&;<')K
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MU& R*?>#LUJ;A32JL'YYN+_^6U]R=XODE![KW<L^FA_;\ %+UM^<&G$YL']
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MSU. Y!M3YSTV.^6L 'ZJU/!+<@SQZI.H^/W\LI38(4?1E_Q<4010-9L,98)
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M:BL1PHS R,9'+P1^FGQ&]MQ:0W([E.Y]P7Z-RJ4E+FG_*PJF4>0_4S5A\[Z
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M6#IF0C1:CFNZN?)IU4 !3U49Z:M('KVUS]V]?=-QN_X4>TKR$0E2>#8EE/R
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MV!XO"TZ;J-[9JAA+*%%W*C .E2C;]*/1=L&:3)6K@A*--3A_'\?7IDM%SFQ
M_J*,GO:NSJ]SVBSLY9'.&*Y7#WQ JJR"=[JT3IE5,",2Q?41Z@W*<<9I%6(4
M3J\#&M5PWN( $@77*(761N1/6J_.2#>DM7+9&OK%)%?VRK7I<Q A:?J:ECU8
MH@,Z=I9?!<A% 7[%\NV"7ZI.M"2GK ZTSGU6'+25>'=)<<)H.(Z%_K+X,^L9
M_;ERQ*M_D?QN7N(DZTB\5J+ZU*"O<Z,Y[":MK<"@JB#*-*ULO'H/2NS6IXK3
MU.AIR+DOT*KEV!T?3IK00(OPFAC_%D$8U]8S(T+EN0D>W[# <96I7M-/3;_P
M]L+"^;$?S.#]ED\\0Y1B3[4;IUT9:1$.05J17M67>'*ZX:_8 #$A<-N5,99[
MCC_8+UJ?4"A\_.V:K(O8[5U%BDH$ X:A?P7O24&5D*V7RO.JF=,>"=$O2%8;
MJ<D*.Q9TANT&"E$,*H@&!$N<\<_KJ3HKXM5VSB3&JU&5?Z]Y;V7L<X'QK'5.
M$)Z7B7,U[/:@%#7P$6D\3:Z?&\ZTMY%Z\RC*_:8LI6T&#^$7TF,_U (B#G3;
M#B+L@\?PHA6=".NQ/X6T\U>HRI0-X"1;!Y [\56@)%%B(B@3,)IZK,;ZA).B
M7&V(%UY0<T=+'?VSX4!,)%YZ<8>>,BVYVU)KN4I8&:I8691A8^<P[CF8M86M
M_.%]J!.Z_/F?4C3^M[< %%N+4DCC7%2TY$B3 "Z1BV)H5H>!Z?LH>^G"A!8B
MW]MU]?/(\LI%=^IW/80XVB_3-&7QLW3^_E@@Q6+V$$":(!W("K_SO X?"O?I
M$U<W>9FUD+(O>@CHZ)]HQ$5UH3@4$O&<T3,W21;)5?)MXYX'A!%"7>KM,U2)
M(/NOUP&^22EK=B=YS8<*3RE82:2G1>I>BZDV3VQI <"E27I=4,J%V=AJZ*D0
M'P>2<3GBZE$\/RAWN;EN:\RH:HIAY]E7[>*"/WZIY1D12>,1(+\B=6'X46Y$
M-]SEIB&NG%UV?B_0,92UFUD\DI^O%7Z5_JE% LX]L*',-,"TVZ3NEP'4HI8!
MK=K8\FD/8I_"KQ9G">.<3,_/WX6^'J^Q(Z$)2&;L;_QF AG=(@V_.[8N<K&L
M1I';P?[.^-K;Y#L:'".+IFVX%6/$]Z[!E+2B:8?I#,(4/EZ8^+9>N"IX='D
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MTB:;&?6=P/T_[+UG5)-=V#48*R)2I$@G*B J390B".1!I8LH"*%'0:1$B(A
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MK8$[:MVD.ENR*ECC%W@XW=GVEK'5)0ZI[T/5SC%%C^+MHX6$-_%/4/M6+':
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M,R4@&M<+EF2W]1[N+K^W041\COS6DQ'K22_"-!4>2"!IIT)^^ &Q_1L><PA
MIUB\6^GJ94)LH=7S',9&[Z^*LY(+C!RV@ ,8Y>\:Y)4@: 7C,]W>C83I^$GU
MGI]!?5&)>/.$*[)P2B_UW8EP*<MLMB #R3_7;(]]_PHX VYS.$E%$A4C1*K'
MF")C6 S7K)UMMYM\Q\= ^;S!.^=;VWZ('GWX&E!T4ZO=<71W>Q4>PQSB>9^3
MDN2^HKHYTP!]F@;57L9>JR@RSRXVD7Z:CB^A(P>YQV\Q3V/(LI1&*@/X#9C@
MH(!LFSE!11?84TT2JV-%+2L;&I#/^2Z$"G4CKLE!Z]Z=:2P_=?P%@F32'Z&!
M:C&-!V%1;U6^T)O K:"3=/L"^S,\9Q*-G[]%4NY?YWZA&W2G8!4LHIH+\W?Q
M4D%/E\8J\WU;5K_@<[Y$ELOB#2!4_3C8X! @1O=0C/5!!^.>$ O&<(90Z01T
MD;B-MU^Q;=?GIQ'^?ENI:A8/>A9#^8]RR::6F0CTBVE]%L[/L02;!BJLZ?^.
MDWYC_-&LTLSX;D-A_<3_><G@7C!(GP2* LWA;!C_(6S)=\#&(XV3%#?@!ECB
MMG%=^'8ZX@K$3]3813*&.O;_$L\T#8GV^AT.YYM&L/&W]RQ&?*[,+&]2_AYE
ML0J6SC:4<K2>B):JD$KRMK<@72\R,U_&SBT4K#(>8N_=RLS$0-LQ5)DI4#4D
M%.^)B0()8I&<$%<6$WXRM(!/FB$,Z80N][9>NRL4U:;(U:MSNN#:]RDNJU^7
MR@X!+<;- NX!(#I?+.4IC7.]6:6"9$O-[FRS869*[)E6XM.9X]6F+X_<H<W+
MN2[5]"Z=N]V:3EU%$"!$K?XWH/ESR42V^#Q2ARI+U*O6OWJN%.?4-;NTLY#O
M.!ED2E9!O2[3E.6.PG;A%/TUINU<5Q!7QTVO,R9$ #.V-]?;7\HF9-O:7/_?
MA:_?6* 62/4)2_A^^@_A"[K=K(;HN7,(>&Q*XPDZ<@C(WQ[KP),> /=!BO%X
M"@B*/_#*K@O$Q#DH-).U(]$F1 RO22GUF6A@L 1C5SU]S2AF:OG4QJ)\@W34
M]IM3[),"T:5KX&S)485=SMNK_V,#V*:"IZ?TOQO JKHVVU*?.1I*)1E*C8Z+
M-3^ZE#>](8I8'%/DCGA%\-BI7?!>G>5D=C)!@\VG@D#46IK:*H1'4]>KV!J+
MBKE &AZL0<]/V\C<(KJB_WG_SQIV04I->,K?[J"VHTF?J!^#GTMKOC$,<MO0
M7E44L%UM> KDP.#TG]7,2&?1B3ZGF,Z"W,_//V[KW4Z53+V@2I?\?Z0)8#(&
MN;L5K3&5CHK"HFTAPWFTO8"4Q31S_,BB-/*748&]I<_%7U+#-FZ3LY5^V*U:
MO0.T_+#9MQ_=ZBJY#;YC@81#0.3G9%U^<&7 V=.7<]Z$_S=Q8^!G!,D#0D>9
MQH+6[^(. 4,169!:[-^7KB='#@'=.]0J9IMQ/^.FVP@M$!)-'J/'0ZB.04 >
M1#/HK@#]*[,?L9VQ=?H0,.$2>0@P56& P'^.T;18,@F&DST$.&<#&9IC)^]@
M(;H'J%1R)+UN%_&9 7JH*_"G<_)<-9*Z#]M#?$%?_3$(6EC"3S-SJDMRLMOO
M7LZ)^?GI?V);X3&)-:;VTT, _!"@D9#7P,*KCZ 94%]NV8UKF*] J@:&:28X
M-TN3\84<O!Q>VSO  Q!SJ_A] T@88CUK K'2:XYQDCP$!.S?6(97,76W1H!5
M0-)]TWW]PJ\(FDP(D!4>CZ9 %7@_G2^9^7"%!&1VS[*FO3,)<_CA8 \C&H]D
M4P2I/#N01'K7WT6'V\$@$=!ZX!AH9U[+7R6@?X,EE&6&R+G,SB;O0\!]OK%D
M\(XO&X. HH(7D:/EAX!OR!QZ:,SELEPGR/PA(&$7%MZL.:!I\FDZ.-*.M$07
M*<CR7I+"N]2'ZJ;*C,_E>OB81YSXUP\PASD"K(6UPR8A-#;F.;\8_/RE0\!;
MEPW@!)XL]^_RZ25_/'F+/[#67XFQO@ 3ZNY/'+#JY3:R$+#659?/2AG+G1;N
MR11[3P#;:G]VB/\O'Y@&5,\ISA=Z%!M^-SVPL)C=/"Y-+F7@9] C:FX9'4J-
M+:56M8W-$D+.DT\,S<Q.^RNU_NJ9JGH>;R&H'?,I\!&(.T22I6O8<4^<B=P<
M:QJHR-T?*O1>Z!I'1&TV7YS8]7<O=,XGO.7ETBFUN4QYL+18DV&;W\A6%5\?
M #2"XYD<;#0CZJ^6V7&-R'8,CP)JZ4.LC8Z'\\M5O5/0*$?#C%6[]"W07#2P
M(@^%==EP<B%&:YIP1<)(&>9#01:ODB8_HAZ>M=O/N38Y?,F&1[COA5 F[[40
MQ9PZJ',YA2\W'*NF4"R[/<BX'_!!=WWIM&K\01Y><D>6R:5*79DWC0-B\1%R
MFHIE;@=_X)#60X#3<$'%QV<1,_.;T@B9@"7CXA2Y(S>GCBSR:-]A9!X"GO?'
M0"HM\U7Z6_&B4 <AFGEI\N37-?G\7D6]I)E_!M3%7ENSMT@V^<?SE_M[: @9
MS"W6YZ1@C2'OOCQQNA_S:=>X?AU2'4GGYUB0V? J1*>U*0+7',X/F>E^L#HB
MD!6=J"?P W<J\=RQFX[UPMJ%VB Q])F8W]]+"Z]^G0M;O5(-=A;3TGBXF"\@
M,"&K^'4FZW++RQ8I'#)?D\6Q3H0Q\G%\<RBJ_GJ(//Q-]9;<79%5#FAOWH-K
M1Z=^\/7AN#ZW8(Z0^Y$^_=$SLKBQ(/V259M-[)?NY6D(9$JKO;TUH*I"ZL!G
M[HREB0#_BU=7#'O>\]O.=,LROA5&%K+!=64I^OB0_EG2(Q@25;D5>H$T%JHM
MZ6[C$.:!JAJ?LB:L\A!"VZ.B[-IE4CEX7WP0EMK#<)-!T8I!SD23.U;#A6HV
M"27>TDO#[;?W*[O:I\L_'4F5F@.H%RM;F'\;*%0S.VO8ZYMD<M"<&W]*[_Y#
M0[7FC*S:]3V:'KR78DG]Z+$ / (%CFM+545876BD20G:\NI>77C:]?ME7EQ*
MUT:,7SN&H-\Q*\:\:4<W(.O5':3%>_ZJJ4\S-W;U^- -$_/Z]NUFHI-9$;]3
MN/!D<I*AII8 !)SW:\,?K((.E)W$[M4F.O2(35' 6,SH--*.483P[(^9K<EU
M+22ZQ$J1KY%^9]"T$%4;ST=G^R:6Q6O(>D*UJ9GE4AX+8B-9YLS3;&0_:T8:
M>*ZI/Q;7'U%TY@$GD*;0_2)Q2KZ'6_/.+_+U$I?OW1U<^@(+CRQECT4^C..7
M=&W,=WY*RQ_8SP65F!OJZEJ[5T_LBX]]5?SK^%PY&RLUI@VDEEB2RO(U':_,
M]$&FISZI<\@]/VWP:?M8$>"/0PIQBWIU;(-S 2/NRKPXHGT%NB<2\<:WEJ)4
M^D+7^<SJ*6O.'#WYJ=??M>']9X*AOQJN#'_]F<G(FS]':31L#'A;OK.XG\\_
MFZ-E3O3;P)!O+  W3N0$/2(#HR6'-?WG)SQDRD<$[U6];I4N;7Y^QC%!.KI'
MF[LO_AU '7 Z\K_D,H_KB/%J&8B-RSV>:9$:JSOAZ_!&3)//1->M)B- HC?_
M?QS?_GNV<BU(L(;LET8:F4\]ELN"H E5,^.(>J]?'X*8SYX]W_\H_/4KL0KT
M;';2EEBX'NGOH]:*$EF=$;;]9:W@09S00K<F'-/D+6G[SB8:DYR@ 4X=T!]V
M?=DC%C/HY][S8R]X-H.[9*@*>;5J9 5?M".%(%E@",+:LA/4$28K=A+GAXCI
MHN"Z!/8-^=0'QS/D'6YXYK\6OG@-+D:2_1X$(Z<? A;PG?Z:;F01XH)=PRCV
ME*?/Q///H1W0KH[VY,<)2KP&3G8GV>-GE8XG9U^*>412=FMV?_'0%SMH.%F3
M=?1F@)=?G-E*3DWD>B$+>1S%H41@2S\W9MV69@8]UPQ,G5["_\3B!7J9H<#C
M_,:N]U++.'@&JHW\>/R.C8$6:MO[69JMY?K?O>39UZDF_F0U8VH*.9#HA1>)
MM9H)KL=-+EEY/DOY^''@W/0+D7N:22_YCTZ")'YC.!CVR4D6Q7]T#8VFBE1'
M2]+M0Q;]9R<\L!LRK[(HAGCP\" I,@Z+B)RY5#5:+6[^8, G7O6A"GHCOG5R
MRO;F[Z[5.U<D/HT-B/33S]VAI(_AA!K.L%2IIHYX3-F ?%,3&KNI+C:MS]MG
M*I-\*2#@]'YJS![T\6]+=XO'>:-CAI-;6L(_"Q_.>-V?'JC_KYS&"*UD%+):
M+B(:6.,2O3/M1 1''0+FI8:K8\V=W=0HP6A4RMF72[Z3G2*H#\E)['L8I9QJ
M>("G>V[,LHV,!SA7=KR]VS#?9ZQHO:&0SL]-W*RB*6!: E&"_BA.,Z%/(B"*
M?=*\9)WM>PEX9#_1V;+_8W*<6,)E1AKH7[=EQPT9< 75A55D>AL^*[G9^Z#*
M=8SF7IS G8RHI[*O.\//B_UQ4-%]2A+R8S/YIEGY;XY!2_[(K%9/V=E99*.M
MW6G)5I#^?(=6'ZCRZ)[JIE2,569NQ]?%Z^6+//Y=F'QE%%4N<D,EARI+.PJ,
MS3X?R-L8-+&QX:GHU4EOZN:S<TEH?A9PD,Z*9S%5@W4_/N5[E"77SFA\@#^B
M$E'%];G$64'W9BVR/ 5;Y@X^Z*@HNC<FZ%=;5;TG:*8&]G.T_G"0[%!$OO5O
M=UH KM-R@N3(,K'X:AS;_+C'^:'J_O7&RR%]J17^#[@U;EH^&\]TSDP>7OP[
MJT?EU8O$)?Y]WP&WE<E%]8=QZ%?5D[T_=_LG()0-*IK&CX AOE60P71)$"DY
M&$4S9DJG^J'<MC5G99G:%Y,]9S5,&^,V?]T4^O-#ABA1_PE. ?*['>0OHXBR
M@;,;0CX<AF?X6KSPB ]Q'P@M]:)>,1TYX>%Y^5>^E/3Z.?MY8&:7)3K8ZZ7*
M]O[L:FTML&[?WD+AACPI!<>Y@)2P@X>U\AKR8Z *'YW%DI1-ZCE,Q&1E>?R7
M^@*7<;PQ5WY^&\RI=VW7A3U-&EOD__TMO9K7N/NOW^C4^/_G+G7_]7&BYS\\
M5(7^#RZP___XOQ]'#@3_4YT3!?G/-!%*'-'%NC9"IH7,1EO8T8%\YU[?.P1<
M:29A&*EPQ,X?R- NXAJH:I9>0/N&IUBS&/S0CQ=/;UGL0(KV84*(7B3X #BT
MR_\0HAE< 35@J9/40X#?0<Q@Z;0D4]N6,;LJ:]1P9?W1[9C+Z-/_,UM>E3;Q
M"\NF>\@_7U:-,=3]9,8"?55CX<;IOWMTPHH/ 4L70C@/ 95^SH> 0OG[>$0)
MB8W)57((>!].56-V3Z<Q,[$:E.N@/4RRMDLL:-&!\9"F= @XOLBZ(N"O.T.E
M'VM*#-7)L2IPW+\VITL2*-97KV=1$7_-!7?71Y9&F5)-UEM/$&^X=?>!WR/_
M$\%3ROR_"".$_F/$=-$A(#S$@ 'EIE\^4.QBI?2JZG_G=N'_Y4/VYR'@&7+"
MM/,04".(W-14)/UJW2":O!QMW[V"#E]J^I(P+7&3</M/5_3KP0ZE1JER8M,D
M4\R89G$(&) [!/2FZ1\"%HL7T!_F+_<F8:W:*2\-F7+?"J[&J_6JY]$)^EW#
M8!QS$$&ZATH 5@);Q^D69+X6( GY^_J,_N-:R.0Y0?^LD0GP4[[&[;/UDF(^
MBRXM)>Y",1:Y_7I&Q@UNF*\-/D\>>NL4X+ @7;P3D@#I0%6JT<_R=4A<IP:6
M='Z")S;+Q1[SI\@&YOS4SGAF??I[0EU7GU=BGU*R@[X:7="4DCGLM.W##61U
MY P>Y^I&4L=[4M^1/B&.QU[O-'B@8WBG=JKC(8!TE_L<XML43%SQ+6C>,VB6
M%!5K_N7C(:!*CHX++MP+U-A<#7 :Q6'NQ5+83/3.I9H2ZG.Y.-@CPI<2L^/+
M/3MIN -P[T!AN$^)40V08)RUUI4_X.;K?RU>4",A7]OE^^Z2::T9C'I%\"U.
MDJQ(>4H5)6^USHC\I N@Z0_"S"O)YY"Y[8M66DOQG4F>CK$WD?YGC!+:V7L]
MGY'QD[<6@'':2JMX+DB']MFT;VH2(B2)E$\K4.D\RD;)"HE=,W9A>9OIZAT)
M>1<NM.+ 2O\3]TC5,]>I3J2U3@BWCSTWF)'UJFZ1-/8675WG4IO<6BOV0P6[
M8WX.46.@XYLF920Y=32^L0S18A@B81]D3YV@25+O=]?,P'/G6#59_8'K1K2"
M3%TT?*LW9O4K^*V3H;&]N\T>SLQO*<3-^A9%N?51S /\7NVTPJSTYVV95M-0
M%FOK1TACPNB21,0Y^]LWI#14T[3HT2V:I49M+]A_#59JFLZ;F+=H#!,\L06K
M(GJYGE[RZ(W&R1^"M*ZY:W3=X&A:").0K4 ]06ZTH*J1H&TAYZE0TL*\_=!O
M2]^&DY^EP_MR?;B[O?U\-*4EW)Y^4+^5<(U-N%NU69#^8!0TEXNO0+4C..EZ
M#75D< *3BQJ,<YF'\$[7?BSJ=#X34SOJ_5W'/^?R_)B_M&V2 8!K?&'MB_[9
MF]+W+=>VI*:3 VR+&YK35_O"HXMZBGMD4R;+BAD04XNA[]3.;TS>D2!8:7O!
M[X9GGTO=^0X!)=C*FL#HO(.+1SM) D5DV;G9..TS[A7C\-9OS5*DK)W>)OG=
MK.M08?O@VSW%!HO>,319)OONEU4':488W>-O@$,4!H,$:3KN$G(1JVY2(XX#
MNUI^.N<^6_;U;>K]4ZI0=<'BU4VQ3!Y906)D.Q()/-8,H*Y]!5:GA3$EX;DZ
MY%=")$HNT7\I\[=-FT>3@L>6-*^GJ%]DM!CL^/:1YX4?AGVF+^?G8C.JTX=F
MC*$AOM-:Q];,* GL\N+H8$CZ]@V$LR)5)IO%<"AGJ?,+)L;SB'@?$+_5I"LO
M'92MI<% 5)]H7X_VDRYU/3I-Y/EXWH!'%=ZELNT7@[M0 N=KJTU7J,]?U5"M
M*.QYW%#17!,8F.'&]@@^==*2<EZ$AJ2(,7*;+ZRP2LP804@U1DC ^]@U!3SF
M+],U!];\KK[B3S;[*&5[&\@0NUY<<HJR".#Z!\/%B,:[!FZQAPR)%,9C33FI
M8<3:MMCIZR2XRP_S8KM+C1?#:YL_2G&-28"_C[=X3%KQ/!+IYXQJZRBX9%[]
MWCFGD6F@C!V0]Z1O=N>;%:> Y9_O0"CK@>N-^U-_H%L3@<1G'^>!5 .%$''J
MZJP. 4(SLC^Y(D=YDQ0T)/']<5CFCDHD*]<@,=I*<"0-^$U;= QG4>)O AI_
M%:QMNX:2]ZJGUZ5DN'9U=YS4#>XD+1@R&H/4R,:&9+U:8K\8U?X$T>'>S WR
M6QN'=*>91GJO;?V B";@M)Q+^#Q\X3M^KK#P 2,>/_?E$,#_F>I2NB;!YKKY
M./O**]%NY8D+MKVWH/6.>N'O2T.>%BX=/W.D$V#Y_L:5X>+?NBW=[=5##0/Y
M+GL8^U=W"F/>_UH?BO7UL)YV\V"2#@&AM2&M9LP>/!84*TF"O=8T_4R_,L02
M\NLJAO(P!>5?Z<:7)70%DS8MO6\8;F_-+0*4WBR#:OPZ0$)!3B,A8OBX($G%
MMYZ:*G-:LCJ#H\:&&Y/@H3E>?\'.'TOTG[^X\!=.*PTVOV;]#H7N0@[OI_.S
M$05#%\DNT4])'O6#91=_VIIGKB0:,S*>3XY.^KT7]5;JLEN*W@(C8/&FK2(R
M&[(TT1DX87;#@;.:^G"N"#M^[YF.2LQ4GXM9;NK):U_?=(MQ09&*;<,4(;=1
MN\$7'EHP4N&8[\&')VO&$X,I)K;@M> T8O\[316:&OTN&16VJ:F;2^7H2*^-
MW  '$;*RH[VU,F57!XOYCR7DC8%8E75\#<)#?^CVF8HP&%'YX<[X[ELC$EPR
M;6]7?CS%X.<YI]?W 9K'(+D0;$0LS0%Z"!##XL6#Q,BUL3@/4K.)X6:0_"'@
M-*T-"!UZ1>,QK*GQT)Y@ZB7P5E3B;CJBDZ;&NO#8P@WC8#(?)0\2%2(^H ()
M#U&-()P834"]I("/6<6?\0,_C&J#>3[5?$_[FM8M'>_[F+SK)7IY%9.+E]V0
M9@G_B/'?K<1"<ZC'P#KMQA!H[C.K4$RSS.=DPK3YW9F"5)<%>373C/GLY%+J
M**.:MO*I8O32=4:>'>Y-TDC+J0+)<D7@91F4-'6#C.R04&.DAIR&@^U)<0V*
M$73!D^7-XJ,S@W"6E+R0L+SQ-+,4N6U0WM4(\ON6>GX;^KN?*ANYP4T&4!4I
MB$'$O 8YD@*);3X-#Z#95S$)]31MK)=,YM/T92W:L\2HX[@WT>>?CB(Z\9%I
M($'$8]2XVC=?DYH_[2+(Z)T/7&J.QO'NH](+> 59)%MT>NYM>(;JDNRM)GGA
MQK7?8[GJORW3I-4L^\%E#6[R"(X X,4@9>J5!<6XO6T;*NB;M@S9>5CR^IU<
M-^_9KDR^GK92?4!VL*QH6[;0,$X4;5JP)N)#2?E"J)E P\Z[7HHZN'[M#/<P
M>'RV=FNCB+CU&B**A80A3N+TB=P1>"YM@6GM<!?H)W=>*[M5M0?T-#4_\V\/
MEU,-PY+K%@!>F<G+>.%#@&<WR&UV0NT^J; MUOY.VR& %R=?POX**-2WNH>8
M2"C\4='P+NL/][7]F!]U81W_] 6+")6:Z(K@8I/^@@0%9NS;8'I_?;70IA2M
M;=%#WW6 %1:O+,.1KT.$X<G$FIH&EW ZJ R>;/;<<<BH/'7;.YNM6Z0J) 68
MT"Q.#9OWBW(>U#3Y#)40'_ET"+!V+IHP=/$"CJKS_X6_%1;GY3.-_FM^H0B@
M.E%<R&^UQ:F)>:OI^?UMG(+&8Y(#07<PC28-':YY+O&_8FZ],'?4OO[5X]E)
M7"XEBSI"MKW-2%NFVM)NPV]TC,U<B7P4:T[RBPXR7D8O9_#L*\SQ&>5O/DGT
MG6._%G?DU^F3C_Y<32Y=R:OVL&$RDFM54/>;TV<.^,0>Y9NG2#>A$8'!&Y.8
MPJF@%,A#1,O%9B%7$ OWW!M'1G9N 056'21(S25E5+_6O8K]&@(%[<%%@[I)
M=EV_LH]R0<@=2TR$*(P-H\I_M?1"WH8(8QFY. \BVK:E68 44OW.E>?W:CP:
M7F@>!U.EY/SC9&"!&.T]_Y1@Y.%H("Z<AY\H%)WHMO9KG'##T#E-E)![U\%5
M 8KF8]HG0WZ&L,HS-#J(A[I;$.1NPF'):H&O-3G]B.*"MA[GADSK2!V%9V(\
MY,^G"BU<<+ET=]LJBV8@EL3]BQ$2SOSKU(C!>P#'1T$209)#SX,D29OBCW^0
M95L:G!OD1U*K-$M_N@LF7[Q27YL1KN]L8<USM+&B=H&;X$1Y119<SR*76)&X
M8T%5K-HZ_Q.'PJ)3.@D7[LA=N?Z:*GQ+RH[<0JS;]M?UEKVL#GH3G&TKLX0>
M\AW\H07S1AV[7%)R>9JNA7YZ"%#>V6S,% _!(%H>X^>*$.*@IYA)/RN2:>LA
M0$27Q>/.6+G5\$Y.</*9UIU5?B>K*F$E3C)U?''K,7B)\^^GGN!=N-] >%G)
M;!]H0=[;$ 6VPLX:%HYW7F+ESBF)SZ5"N5;\DA_G?>[@O%_?W/2V6N[E(K^W
MO"0VL)2=618P(S(ALS>>":OT6:%9_9$USDW;WC',5J,IL'2369 7#<**\5FJ
M&YG8_^T0(* INK!A-MM:I1O\:6+2?J7?YV(K/^6/;:>HWHIDB4N9VN.P4&T;
M1@[>F>$TK[\!)-]I">!"E5)#.^?[<@-JU2PI,*6:\HC@6!_MKW?=L+E3/\+/
MS+DD0@SH(D,(9^YQ/^*E#/)%[CCM\]05HB)'CPHG1^N!7]CF*U'O8. U0R^5
MWFO;@_= W5V7N80XT8%,=A^RY>0"6V<_(;83PB,'JD'[H"((AX"HW4E11T?;
M=K74VNM?\Y[FJ)Y&5!9.JF2Z=YY9=;Q6/>7V!:UN!U/P3'1[-3T!,5EW$4G,
M6S*+LXE/3<5.'\AXHOS)+&7#B=.%SKG2317>H/7GB\HL?Z@\JTAY[N +=HXR
MJ7WRLJ*>(_-=G%=+"8J3U7%[%[3HJ<W<)&0TSMKGU/=WOPEV>]LRQ[<K9,]^
ME4$9[<)$0H9F!1!SG_Y&478.P0-/7ZG.\K:K'*I&<%LK3E1[7%CT\CC:XB8A
M^5#$Z.%]#@^IIXMCI2&S^!I4;#. [CD2PDD7)0.CM$6"U*G@5P2!K+(W7PR?
M>'^9OK-M-SUMRJZ?;GV)Z_Y"W)&.EZ:%<I:2'Q\^M-M0:ZPTZ@5#:_TF?,9,
M L7=:Q\8>FOY#2@V6@;Y$1&GW;/91PN&?-!J#P951+VC/6 >,S.N^!G](Y'$
MJYR2^C@R5]&)!!34.SCP%?&FQP;13?HC4M?B@:',3S !S\&\# 62'LZ.]Q/Q
M$4Q)>SMX22>"+4A[Y@8)$^TY^7UXH3)"UW9-??D\;H#_Q1HN"=TM!3@!C RY
MAF.$(>;2'?[VP+.,-/*MA9 FA),;44679IF8,RX0XXJVBNN4JN6,2/2_JM1B
M\01(N&$\4<?\\U%O;*"F'A/H,-I(.% I6V2X&[[$;CF,-F<X[&W %%*UGY"Y
MUW^1.5A@,OA*R_9KR/7!773 W=A[Y8T#GD\:ANV[3I5W=(G<;GM]-/2^GJS"
MT#PL>FMK=\U*4QUCXC-OE5\W^AEIFI(WL!#=]K*I)_S[U83;%4$G'(^T8"I!
M<ZEXT@-%">AL#>(U788LVT;XU88X#<^%5+^U@2<=F)CL,.YJ,&(H,X8?TX6=
M,O5[W@ES%+%)2B32%(P_$Q M>@C/$@R?V^ J4V)HAUO$8555J5ZO*53\F;J#
M_%?>S]\$9,JE1@6JC':D+UN$XASS<V>V:VT1EF,U/DHI;O5Z7C92.VMH9%\]
M4Q0>,_9U@)IM?\P&V6INATYW_^%T=1RW7M;+D^'Y;<GII:#Z!:&%,!L0E_9Q
M^,("[_>9LR18#/V1_)_E+*!!7?-V^74_?X/QK[^R1\:9 _A:MC8,H;3=A<B"
MOQG#^0S#05MNKO$WT-P569%J+_FF8D?E[85GNE+G3AO(O82N*D9EWV 4@%S'
ME>NUCU+UB;6MP-!LX)#'.@[D5#A=$^LN:67A7)>^9".T*95J+JD<UWEK7[U;
M2Z7"8J5#<U7)\Z ^L 0J.Z$ZFV,#RAZ1?11J-PI>G8FE3[!*AWZE&"YCDV$R
M6CU]QV#8HT\:VU0;Z)]S"/ 7.PF,0A^G/B1^//_3&<()?Y-+?I!8#19Y->GS
M(N'ACXI)VD;9Z:R/+<<EH)NH259'_I6@8DJ53GNM:4WVMAK$&9)E6[5!J-:S
MJP_<*0WM1+<J:\.7-7M@WVT#J43IM^66OL[6^B:=*LW70P9$]M99T'#\$R/-
M$R?LK1A)MR9"8;P3:E'//W1^F;"^4YR6-,.N,\V=(561ZDIJNROHR\YVZME0
MT:G FP5+:IP[ X;3MSP*G6XN2%_N3+PTE>DW='=Z:UL;2(TEI;5#3JFXKFO:
MSJ-XX X'3WD[824K0U;??_]S(92E#%O8SCLEVFCTKV^1C[5FGT:V-42^"7)Z
M,M_]S],13V7;#Z698F+1'X]*Y.*]("^9[8< ;%ITR/F_OB4@5VZ^(#U<!E$/
M37JYH#=*%_4CN@'-47K#F+R&ZC\C2W)]9W'U1]6?3M5?Q TQV;<. 2?8J-U$
MTTF_^4TDT31J1H$<&4EWQDRZ:G3$8]RKW$5\EM"+.>R/)GM^".T_E7JB=XWM
M7@RH6LD.*W]J)ON@$>1C;*(\@#Y@S.^FCZ;D-$WOSAJO%+H,[TNVAIP<I;MX
M%)OD_CXH0'-%/R-$Y%!\D^[7G.NQL/&/"96,NW%98?R!U9EMV<=!)\G=U* @
M6Q9406)!\P)V+M;,KCIFO_!QY.SZ]L$QNGW)INFX3$LZ]U?4)!^E=\!Y$+W;
MSTGE^,I4"'^U]BDH8US.1\CH[MPU::O;1X07>6\XN-#.LB)RIUD9/D8A45U@
MZ*"[9#UT+C6W755$X7/.U$SC[VWKZ:E.F!R'"^H"7^]+ 0N G8)2S,OO)88_
M!F+<V;5LP28.DUJ(.4_>]D>>]],M8TS!TW;[R/G^%FZ1H"<T??I%;6ZR?DQ(
MQPTO1F*^:?#B&;X__D:3\.-_QBU/8G)GX(&/LCL?8.LKFK#>8J-[9Y5??FLM
MKBP_?O8W= TVV4CI)H^U( @E'=E'J& B\FR0(HG[M4]L%K?13YQBL9U;3=&B
M@5.J]?'[!6Y2*?83BW(ACV^\/L$*4>@'J"!$!.&,F(A=.(D;L*-.=MJ<P^2M
M^97PYJ6G4>Q7=<YL)\9O5QI&.-[8?I,).%E=,6*WTI!HI*(Z9K%9#\VO,77)
MW;13XGL9EF292EBM;L9+'P*XX+\VDLF(#H@("SQ9=#,-K@UCGX;[?4TWC=SY
M,M,7Z*\2>^HXRJ6I+?>Z_^<^<6V]TZH[9=<[*3!J=''0'1PIOO8USLV+^ ,$
M(U1;51NG#7O47G[2#,AV7#*0O'K]E,I.+5T P]3#3*0QNQ#A^)U;Q;O<5'G,
M1@OYV#QB@[Q@R@9G:[/I;%T3OT737C"O(^TNIOO,-/I?RGK^+3 ZQSF1<OM)
M^(.:]K-/%98=_<O'"0G*14_FTI2?[GKVIN2O;GE?M8JVX<D7*(8-_D!\W-\B
M]I]<DS@R]FQP=UK6;,!'-LB_)HW2[Z%IS=R^>09T5O\M7;043K./-/Y9C3:V
M&2Z[L61C9:OU?7N!]N5U!?U$<!J91KR$H5DB6L0U9<D<G> J:EBGQ$GJ1\6P
MY[N]-7\4RUZMO!J .V6;_S&Z&_[BN^&18$-I;47Z@U'\7#:H MG"4HQT=1R.
MA(S7EG<]UL&4)8N',5"/&K!UB:G?!J^,\>J>[HAKNR":<>94[[$!L8Z\G$\Y
M3;G)\9B"]%H6MFTW3>-^2,8D&UT)'(,&*Z^MP+;_:%O4,3*9%VR"=)#?O.'<
M'0_AQ58SCP90NO7V.@/\C>5A+A]N%U?QU0*NR+RQ\PC)0+2<1G@JGJ.#&975
ML&-TPU$5(%!N=&^,*3JLTAO1/*PLNUO[[OO/*8-[H>IHW"Y\C\?@-J"E?]D$
M&MYND>4_OZ8K(R#X:A.EIK8?O*><:_.RZ*JWY9+ARNC>(>!\3HSL@,;_FG/[
M9,%?F]E'M*7AD_JDY4A70@26R/%;>5I[Q-JBS/-2HE/,-:OP$UGOG[X[Z7_Q
M?5Y2X\GULN_%LFLHJI?B!O@0<)=%OA7L@8> I!*U#@A)%T2 LBCS6Q7[0$NJ
M"\5>YFY5.I/B112_:GKIU+MN20_CI!_A9B\^)<<!3/S7;GY5<W8 4OD1WY<.
M*,*_B_6W]'L%]O3I//J0!E+DQ@ERH,W0HI6*B>"\*A;AK![_5/5/I]?3KKEK
MY]\%\N@(LYU/A'",30-).F<+@4B$$+Z&<W4%1/JRBZD5O58PIT.)!=[HY0R?
MK;WEYY7I$M.K53M\%5*[&O='<<]M]F!X"31/!V)-&?R_6367,8C8%\']HF2Q
MBCR-[LZHH!^!SB.B9I0@/*Z^X)6BUN?*L:(F:>QBB25;H?Q.X:DZH5Y_7(2/
M2<0O,EL0?R8I6#H.Q!181&#-@HX8*(.H9O)DG[QI$*63?FEV@O8/8S:9@JCD
MPJ_YP0X!3N)K9^3/"&+O9XNF[ 1%V_[Z&:-,HJ^EIJ!"'N'YHB!O0M00O"L!
MEUFD(:&BS+K]RTK-,4/4AD9X*:Y34VE]6LJ4KO"IQ/=2$5V':DN$O6V8I;C$
MX-0Q<!>SCJU*=T)0C?E"@:]!\6Q^\%]#104&ANY$XIOO7"?/XX^LIF5S#F-A
M8=EB32,^TQ>?58\HSK%?GR0P/I]*O! _ZD<(OU-]"%#=**E-)'%WF/*%C.-)
MAEO( ;K1*%91V!UT:E>1>TU"9,0'&M$X+)=]L&D,C?J^S2>IYW1G._7\.0I
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MX%F/;_#BXAM?<M#GMLK0"ITIB!9)D-,)1AGB.3?[!#RW1?L"&?CM$*"]+1Y
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M2":S"<!3= _25F>V:$;KLB*0>CL8<K>A*GSK_.TTU=^#'4>2#/ZQ^.?EO81
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M[J'/U'0\'K@A,%5Q#8#1/DMC<>L>:=!SQ8.UN5G&+17_$5D3Q^) N"QS'E:
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MK"+6EJ>4K_@:;X?Y^=Q%GC8_E1Y691AIWZ"V=J)J!=M0W&O9<F0%["=J8&=
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M%5 VAI%BGL'/,A[BVGT:U>/@2A3K,\X9G-)LG):<SO&6^(.1?37"RG"^$O2
M)+IH$NEOUT=?\!=(A9UU]BR_JVN+35Z,7W25$;>8ZV"((\<OLF[?Q2E,M](8
M!<CR"I$O:5T$8&P!P:@E) ZU- &=49J80)YK0X0)JV6?'OD,NL-YXV)''>39
M"0#-T8MI8.CP0<LN]/6P<GK.:_V6 _-M@&^-SSC TQXWCRM?T?IVP^!B/7<
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MFPU!ZJCHP--OYO3E@EDOIXJ*!-N877VK^<Q;VXE\CW(&#]R*(LOW+42 ][K
M4J1-G)>#1D7QF+)"0P]V6$4<V)1J_;D3I?C@KHRJE^[&;?D]%JYB018WO_%
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M[5F)6&JD$IU[ _$?U_*ND+[A9QR:Z8/BAD5<2<^/E?,YG5-Q>R7M0B:SS ?
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M%[-:C>#:?'$#)FFIO&X@+395D64#6ZG<GZ>5Y:9+#9A9B&Q-95?0OE-9"">
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M*$3"KY!0BWU;M56DF ?XI+1%+0]D'^(B;/O>XN"8:.[O.KOA&[^LE][IG!X
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M ^NAGB6H8!3\@_"S_Y-MF3^C=+Q\DVYF0RWDRK(H(?'@ A(-EF>HG/\+8+.
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M=RZ0AY=8DQ:ND1&E9.D75)OEUD->EOR&B@C&Z3:GE!L/GB5':FK(/DQ'DHJ
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MU!5CN[Z&CWJFPBHVOJ4P/%)AL5/#-Q616*L=C:]XM:N(7TMPO<C3%5#Z,T!
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MV&LJW]FY]JKB\M"OT8B4\-<UV*8@/'=''@(GFR + ^$3N<T)M._%V@,Y?)1
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M1I,M6N1,\QS[\9V;,P&BR"+YV9YG#L'66'UYSJ7<MW[ENE[\[=7-/"*;$E_
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MGCZB^U6C4X"$)=GJ%. +.5%8F.K#8JB1WI@MNLQ1<#RA@U8!>0^W.%-,N\Q
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M@71K0&(7SVL:+X$3>CJV(;O/",B84=*R>1UHZ_KW*FF!L8OGRO2NYH@)BUQ
M)5!?5B#:#9<=G$QYO2J39/>*OG-Q]0XP)QWQ-+UC,KR<A3TC\NJ"YS9J9I9D
M3S#9?DE<;@>Q4TTH]V$WO_V$B2&XZCC1$4I\>7:VX]3,!6GM']=-I(9F5ZO2
MPR/?K@LK[2?O,!"U@8E(P2:O9:DP+?\R!.<6NJ'3TD.'J\Q7HU^X=VF'.2'I
M6^5V2UE>,"C6)G2N4C:HH"5I=MYVUGJCX['?EX5CZ1=3 S5'+WQ_F^J&ZG_X
M?_!,W/]M^?]S-/Y_-T=C>)S4/(A>);*$2C=D>JSU<(&?#,'_:M(HV%09++&_
MXQ_*5Y\1F*0Z ,GGAGDE7O@9F,!VP5",=[3T8XB$RDQ]YL([C+!ZDGMHK,K:
MSC&HE] @M;5(1ES<,3\%Z*J#J**_D30]%,O)%\0+8 RR'I*@>!**UVMIN3Y1
MVRA7//OPEG0Y]=O9VASE-EZ)H[PD ['\NDC>]V@-RS=FNT6SE%SN-=>'%K.'
M^-1]KU/ 3MF!YE#+YA1<ALI =W')5!ERJ!<1U)/=TS8<!S]#V!;DX*W-OI==
M&5]I:[=[6Z'\N:99ZJYU:BDCLDDYDFS9\C<@<0R\6SV@)0L'C,><AXDI(B_"
M/#_.V@.WBY&/'!A-+;H&Z_H"4PVF04$:AG,%N]D=MQ\76N:ZBO%X#MST$JB?
MW)CW=U_X,<S9NWY>%/^GQG*QOIEB]S%0EBSBVKES PIS(%CU+++"I0UQ4\D6
M:&2;MK#^1.UAXIM8L=19FYN6E^^4*42UGM6T )-ORKXY!> 0B#8KF$8AU7+4
MJBO(MK.AA[2#C)4^/S9G7XGT'USON2WVPX:#_^M<^0>"+C1Y.Y* P!=W#B<M
M *-Q#W/P[/@!NU\+DQ030V$'N0[61:/;?,\27QXH7)%K&_)!W*,!H8MT47<%
MM+1^<UQ3[&9%5SC?K%U._+,BOOAO_A*?OCG/MMW0=1;+K:[J&PRV20P9+YDL
M4), N2I_3B_DD\Y#VM&!1(N%W^+^VX2-OA)M0PWL8,CQ[UFG#L32XG RD!!/
MFW5D)W!3K^?_,X[ B3:,RV!P-UI&-7<0]_=K&S/W=V30R9(J^Z3J'8T,?7[O
MY:X @=!']$%X1YN@CY=CUA(B"LP"49(:'SE#B(HXR8%(*GY/W<2IH'-N"+F(
M"5_W=;"B7BGU_QOTHX0JY<[C9(8M#>\!I'U>>*7]^>W%[Y4:-(9F8FH/R9-^
M10),BZC<M%6\<>S=?#.=BF:L>U'PS=!+).4P;.3:^RHMO=&0N(4Z)2:7&W4W
M]TI]/:<.D2N)DOH9S???.AY*>DXM:)P"8H'UX';DS$!W2'$X_!J5@6R%WV/\
M52.@#KD"Q;9[@2VGLL4Z,\7QS^T"WI9(5J$NZS](YX?LI!$@;>I[;:"S5&^R
M<\$P#L$$'=W<TIV$J1ZR!@"C_\3[5&XPH0X4V?7P]Y@,[6]O1(+]3LH12T7(
M>JOM".*B T&YAGAY<T)QX/N-,3$(XX:>P/VQH%VQR,'BO:O+DG[R.B+\MX7\
M0 131!Q(@.I*D8 I?".O$J_6,9MWJ[\YWHF.<"&L)B$#BFV[>*($[@0+&:Q<
M ,OK&LS+U;*GZG'SR]8EWE>P+S%"U;[+3<^9:9/5F+?SKA=-UG1FD/*<RFK<
MF,U<AT=W*1VOHV"/1ZD\1#O2'0(R-@^!8R2C"5(/"<H-Y:WB<:1YX;B'T/-B
M^TG+AWK+77 ]J]E3 ,%*JN^%]C5:[UB;<(<BZ**_C7 *RZ3>U>OG!#NO.F35
MG7=LYC5!J?\^##KRAB06E3Y^ W2$]!XY]0!KUF.HK!3=31#C2IUG,J?UUB!N
M/%SN% !4T4:DYFC=K1\M_O847 J\1'4H_@6JO]@Y'$$#9JO!5 ABI)"))LGD
MJR?SDQ_7I@<0+Y.&#NB+\X?#^9?'K%&*2"#L'B%Y9_"++=8!BM CA\J@47>O
M.U23Z]NL'L:QE>J8WZK@B'D(FG!MAK)2KT9W'BXH_\TD=<=3O; S,R2C@I#6
M&81^B5G(=I=Y,3]'R7B&X-WWG8Z.[^CW.P5D^M:< OC<E4X!WH6'!KA.BX"-
M[Z#JNE, >R B ,/>B7@"GLGIP A0P7C45>C^_GX/#MU^PF5RE9R ]7T)CVN[
M7AW9<"NM]TZX;R1S. MSX")A'P@X*:9PTW@\EURI0OD(:FA8TAX%T=NM? KP
M.%IPS4I>GDDX0&M.(,FBPG>)KCA$#RK\D8.M+30-CX[R*B+\RNMT?809\V8>
MM1'.3Y3/;!61F!GV.$JC<>K'@7!/$>UTCW)I]SM=?II@X3TG*20>[?EU5T%P
M6B*E9I8'Y333WB):[LM,J:]NM+71]N*=/+3:\(X.*S KGW#,H']G%Z:YBUH)
M<_>EW("JX-!4#ED2M)G0+QO3<A7V;.*WEZM![<22781 [50)YU">?^5E@Q'E
ME1?A/#9^AGT5K-AH4B893.&%3P"O:@H3]I80[9AK=XO)$:;H\0 @[X:9QW47
M%1G;R:&9FTE2UM+[3QY<"+P*Z=^]K#',H0EBP'A@ICV7WAU:9L)%R.8E&P?0
MF'_Q=XL7-VW+54R>[ZK72K(+L14@!+:6,61Q5BHRLWN1 JQ;/%$=ME=5;3)V
M*QVLZ]TIL[+?T6VT/4Q$#JUKG=]Q:2[P\FMII&!5]L=_[Y'%(>W LWT$Q!*F
M&Q5-$TAN"S'I.M%X9'<*8.E0&(04>_"&]:*_01E78IZ[]%?"'9IK7H]0;1&L
M="M0A=CV)?(9$X"O_N0%DJ&5QHX"3GI&\> KP=S$KLL+GW8\7_/VM@4IZ_,O
M/2NA30/W8TVF#VD-Y+^GXP?T=ZI. >+_E_SF%A)J>I%JRE.U)0(+)9(EHH<A
M-P]9V!J*N=&:F7T2A4>"=/H^[WN".H3=(M_]< IHKR2K@W!/8((_ZTQVKN(P
MY/=0R* \>J:V#S;\V]-_]DTR<RV;_$M'%1SP' QT$H5P1IZGWB$6A_].CD6R
MM4CJ*W_$S;/:!D<E?W!/,7"R*WM?\%R%[4'K]IW9.R\[SF:!EBH\G ET7=+H
M\Z&6F:#2D7(KXIU,^)--U@>5>OJF*=DU%&>H+864>Q+=<HYJ3JAHW.("LC;=
MRC]#=&A^Y[S8<3#3N\;@J@N4-.'(>9/'T"KFV^4<47SIZ9=1JP1GL4&7B<-J
MC%%M(]C[LVF"T_U<Y7COX^,9A&.>,3@<>57[;\@#8VH(G(=<@ -W)+]I424J
M0KC?4$V6XGEJ&\5E,^1'9N=GCE)%4NY;N0=T2 CSIW:PTAA<*2IN((X681B4
MD)Q<49NGI2@;G?VY9G%36<)_02![87_"N3'FROT!MN!OS]LV%<(]__[U9 QC
M'X<]I=A"77LR/QD+MX(8(>Q=@L+$\^W5UAL_L7"RL&$"=TKZ8Z$!Y>7N,ZC[
M)^%P(7UB/+YGIQ#_T?MK#Q[Q9D%^DDO@U:6FH^7W3"P75%CRY&R=9.\K??F9
MMGI?-G0?+9.Y6[Z#MO.P@/@^Y)BMR\S+.X8U(++PH%K@CA3AL&?AVACU*F$=
MQQH%X\/-JSP.7Y/VVPL[C*W3X34$'AL/",2E'N4[=?"^82E)XKA,D1PC^9'A
MBP0_Z<..@R7D9> _3?HT"?I@?0'5< =%9;RL7X1D8%I$=5[=GDO@I;:-@E:D
MZ%3I8'X4=^)7?0I(_[)["MAZ>PH8-Y9\Z4:YU,^10^.T:O2FK:$A/MVR+KE/
M$>%ACK3=XNY'\#D0,_S<)EJ;BV#5"GY#4R!$YL0;*J%XW,<V>4G?ODR'?KR=
M9?9S('R W^#>DU=&2VEW:9=E*=+0(-S>#NN2"=E2/6 0&463)X,-B"X1!49R
MV0[_!WOO'=54%+T+QH*(( A*+U%!>I&.M*A(%Y N-2H@0H0(2 ]$5$ Z@H""
M@'2I47H/)8!2I0L((:'W!"1<20@3WGNSYKV9WYHUOUDSLV:MF3_N/TE6[KWG
M[/WM[SOG[+T5UGG?>RA_[WNB_4/H,_T9$6[41]CVSLPHG@G)$"I#[0H53U=,
M!S-11 A/RX@?F/D?I>OKM<^ON&I--+F;'[9>S_[NN6O6,N/OYN!XY.DA2A;_
M_G+'+W,_:/4I)1A(($Q2&;X3+VS@H&]#V2G*0 $^@7FF !6-L%R <?L^W*ZA
MCU48MIEA$-03#,]X](0QU?QS"E,P&+@7RDCQ.*D*B0@$RG$)IU9;.8@M!<OA
M+L$%N2$E,BQ_I/,NU QF*C0513#65URHUOYQD3'>0BH@DL)>-Y]53-@C]1/A
MT2G.8\W\1/']9DO<K/>EDW87S4? [F(WP]W-\*"X+PMT^B23,&P5J8%&HLY[
MD76 -YA+?87V 1,KG?X<JKYMLG]"HOEMA>(WNP,?+KTOLA#9"<E\MW"68!&G
M&)[C8+37:[&]?;31JVSD./NW-L,C9TA:VR!36Z3_#[QTTM(7/EK8L[(5C-YT
M=2%D=VJ"B2OQK:(W4.^VU05=X+1(@'TCU)0T266#K2U-->K&>NY*C7'S:XD]
M__H35$R()E\F*1*4TFA>3SH'O"=FZ!,<WQ!9\/21ZOINN3UNI6LK9C6$[FRA
M<SIC66/4[;LCH5NVM]LON'(-AOSIS8WC55L?&9[QJT;?(\&#/<H3M-@5BO?'
M"PHS6H\T0K>,(TGV1T443K(+)8B ZD!SA@[2](("F,M1.KYN[N+PRHAOIFA_
ME]6J/0.T?S?F'%Q63P*L[GH+2KB/G:K2HL'E:XPM0HH8D9P/H/1^[4,O/4NK
M34_Y[&\UZ>$&"PKK][RPJ'XG;/W\6;Y7L.J39"/J!+I:=TN0; .(BU*,?/,!
M>N/)O_\H]Z8=,V"YSX9MRSM.P67KHE5^?GH7+OC$L#KGA3<,1N*A0\Z?=&=%
M_B8NR!QQ%EL/XHM493$C"4WDPLW\)=>*Q@+7M<4AI>H"(\O7HW\\?]95M&P]
M#7@)KF/IA(:IE@^%-[,3.'&06,JUI_@1(UBW[<O#B)8*<26!U?O"%M5R\Y4]
M;*Q<5]D H5^TAXRA]CGR \%D+> RE3T^T\<5AXYMY1Q1M_FR.M+_-,U(-6+1
MSFC3^_=[;P:14VT_NV'+/.0JT@$0">Z0B<G^[AHC%+G%"D!QRF\476,>P6_>
M44A*H;G*TYL!BNL61?L((XB3WV)!<.WV2&/+(;9X_,192/Y-QH<M+\4H+X%/
MA"$J0QZ1#1X^QPJ8$[#XNNAF^0MV :5= BK?TRQ?;Q_E6:7R&CX6<F,RE;_"
MY+U8/&@0 ;<Z"D<X$886LMO0TZ[=6;R$E,A..+\;S;[4[Q3"5)F3%1+RUA.-
MZ#_Q;Y5Y5VDTZ?SB6DSP$=N[[M+^1V(Y 9" MAL9MJ%/S@<_/OVS)$ $[[(1
M4-29_O?"D$N)W=P3A*Z(T8^1*^(O='YYO<XGFU#8\DC>DQ1!LCAU%'*IILFM
M.@1B#^CC+\IK16S=-]L0K:6Z#&!$7SB*/K3+2;S85 &BOQJVC"\>I@[&7QO8
MZTO=WK&:;G0G[12T8"7X:O),UDM0\LM^$SO6OC2/*?I!.4#1I,9\QH'W;V2[
M$O+YVOQ[7#J_3*>W[G7^LEAIN-Y5TM5)##MIDG*Y[!C4787VD"&?!7R.009P
MV.]!]"QZZQ!YZ"T2JF8+43D&K>F=Z,T"&RUBD1Y@2;[K1NQ<I-@3#NTV.B1#
M5QQ&.V8<%ED:^>_=;UCZ-C#H;O(VDLKM2F4P6D!QZ>6"+R,0X];MTQ(K;#WY
MMF#E!RD:9C9*;9U9%B]W<LCG ,\]TJ^C&*H$ E1C4AM0JIO.\DZ ,2S3XJ<7
M \?!-['GWH0?;T75$WMJ?$X.%'&N'8IT)URD@ F4X9\X=)@M'3K<Z5D8ZY]U
M$(,B8RQX(?!WZ<MEZ91.HSFO/NCO%"P@Z KNZ@K<K4I5_?D8DH*ESMJB!F22
M-22HC)&X## /+2H["@_O&SE.=AXZ%C/'N 66V*_\',T)R+/.;%LL$9.\O;A5
M(8^WWFHAU,V#$_83&!!B #O!I\N1<;@H1/6B?[>J\_1R,4K2\\I<8/=#S%VS
M@A0G[6E4&S_]+TC=9#N2B4KS"L(+U\AFS@7>,#BN)?#E#SC]1R>R\<SU-4_N
MP'-NK-?//EHVSBM';!'E24O . VM%I2*YI%G "TMP,BWR-W$Q0UW#+H(:(Y(
M&9S3E>#AGN9L3#4^-0=>5H^_22\-=:]WOU(>;!Y3E1SKNY'KT:+!V=_'LC-2
MQ.@X;#PP%;36-+JT)X>>S\6>0<C2_B@2?"Y4*D"WPV.>7WF!(R[0RQ<WGJ7_
M:'3G^<K#P@#UH<S'*<[Q]\ST3M6KM F,DUV -SB631]<0A@/Z1,AHUU3$@C#
M9X<W,N?X.)4]_/"K7*=')D2QIDF75%J:)EDVHG3%[K16VC^:,<VC&!9$CT%/
M$J:,0J_!.&U7XA82NK3LZAL;R4889>'M_HS #!&VCO-1R0#/]6:/KA=@PD/P
MOPO4 1I<WT7(4K;7OU4&A-]5%-H*BM'9UZ]..7#_"9LLMG!>%W<W,1PJ'1<>
MF?0_3&^]54N0V1HGGT/<!W***,H$9"?X739]C934/BM.+5"R.LZS\T%F^3!=
MJ5J9=UZITI)Z>,\+^G1JORVZ _(:63710KS<-6T<2>3%"\)DGU'Y"9X%7N(V
MTUI+W"YCVPL);NGJ>*&$ -Y*O5MTP=#?V2<'&%R.09,R],BUD:!Q EU<W2;J
M&'1VG #O&J(#1#JH,D1D#$+KZ]KAP3O%3'[?=Q2!VLU2^//$?AZNQ4\F&<MR
MWSN=;@GR\_V)+N16AC_+8_>K>^OB*C720CF4[O[\I\0B9:L_:9)</$TN0"^^
MS*Z$Q#2?]#;6 >)""-D. ">ALR.HHCS7T3 W(+EMVJ)1?5IQMJ4A2:0>*KN0
M+N+\N[WM9Z+/9Z=VR"/P%*H3PMMLOL!RF7*[OK4.@!/J[J9A@@YMT&D^Q1Z/
M$A]BCD%M>S_N;B^$/[J0=)X,H9YO(FLC0H]RCT$T@L7BGB5"U"GF[.2]')!V
M4ZJ,Q^K]USF-SQV\#W,C5/"ICQ.4G[RV].A[Y'&NU8N&$8]_UW7+O$56B[3;
M,93CB"88%..,X[-+/SIN*?(.R"W.AL0K07K$.><3F4=,S@AFSUCD;HS$+)E:
MD)+39!32DYL,!K2A,*G^EOR<K:O5^KI/9RNF/7<\%.7P1VA-GH!6*K:S]?I1
MAB;;6C:+HSE3PI>9/S- ^B!'Q[_BK]68 85'GJ?O_5Y\_.IL^GX"(#JYJ8PK
MAY'V@%.$;-Q;6^V4R%AUQIS.HU(W)_[&=>T*Z85D\T^"%P1T(VZ\'[*:F50D
M0EZWG@OHQ(.[[.!GU@1X)Z2;[7Q?2DX:D"4*^KT73_-SG>&RIW1]N^*MQW[X
MF&Q,N7.2OHL"))0WX[ZZ\[3$+;_!(2,:!>*\2DLC:X,#>4TKE8,3*%4S,I^:
M*LX%37R<>;S1N5Z^YSTPO35;D#?>BD9FQF!L4[0W'6N3:W;*JY$3*_VT0 UY
MC@Z'5*7%[IN<I<@"EPFHKCG.X:>J+^>N$FO>3K>6HQ1,HJ1-,3]J-ZZ963HY
M7HG_)*Z"G1&9Q[[VQ;X.I0=F"7VZV1U4+F+!^$1,&>"U+; .8=G@P#F,<$.7
MGPG'8=YQ)=4_'KW0ND1^>*)*(,]14_0+K4WS'JYX]O$2MS1O[4+C.<Z16-64
MPIT_)HP9)G."W1:+SJ_U5![=7D3.TTSC2J@:,$0R UR]B'UX07>>HEA?AOT9
MEG,#N#Y^S0WCFFAY)M6WN[??_V!J=8Y^W^CT3$0H5BR<]+U8!Y8BYDM*2DZJ
M"E:YL1)<:CO[7%R=^$&H'.7X]%_U5M\>6NO;$<HW.QS]W>\]P03# ^] GP9Z
MNN?D *<O[LD/-X(">6Z\_L<57%03MD V&N_/-1HQ>)$K$/LP<<!0#Y @1I*N
MFTS[V ,N.0 2(\!%Y*->;B(@(V-K!<!$XR_$.QK-@]'DK=SX6\ZN\6SJ0S*>
M2V>MLVBC\ BY*$%6/@9-,1!Z]IIR^Z@/1/R/02Z_D6OA$JHO:9]_'5]&C"09
MS6[.6&%AB,.=8MF$[1RUIKJGVZ2FT</]/UNT7[.\:Z6GN<$G8'EC?JZ%H(4S
M>>T[X'.O%7EA8^["J,M(19DO8X!0?<(6W7*B">_Y*>-CT.,>.@0+B>$HDR)%
MI#VP+-$5(P;/ WP(55KP2[!$&TB:3TG=Q^]VO[MICCK:V^[O]8KW+-OYO]#_
M=:Z(,H75%7\0K:[F1*QK0[/LQX2PX*UCU17/%>%N%40PV-($DE'*,OFZ9.\/
MYU0Q%]#-F=TDKVK66G'S3G)0@+]SGM'ZW.>1I.36VF$H3<OXYJ\%ZXU,#P=O
M^8WZ3TS+C.'+(?.Y8&;%<BM^3ONCCZ$7>PB4'\,_.5)@OAYXKB]/\KS7=9[L
MB(<EVMP646=:;K$CW3N*4K]!$R^,=W LD8?A6=D+J BJ\,BV[^P5F)*^ET!>
MX9\U3DZE 2'/IOOO7C""- /JF+SB33JQ!&OTC'47DJV<PEL$]-@V$AT&?E4:
M74. "V*&U%1^.REE?(C_=^9,<ICC%EEI0T#NI+#G,8@"&4&$$"],XDUBU.5S
M_JP%Q>? "NS<)DB7+U[?M9$T]2#$7TVRUA*^DOKG0L7-6UY9TW'BQ;:0IHS*
MS_FSJ4D3XA,[(?"):2>[K,_"*6D-(B["A\_V#>;J)A<1-?1;G83)>>-2'QR<
M#D$'F"Q SMO45R?;$E,S-7-0L.BXR,;+#"E23/62WS%O=<Z?;650.@9Y9)\)
MT"5)'96%"@![;9KLOWQ-S@7L=*3#$UZB& -R9VL,&1_N.+TWRE_M9_I:5A!A
M)R@NYS?Y8Y_$0F%O/@9A2DG08U#E91QJ22.HJK,C5?CS]=G"_ *_V;^S&^AT
M-1?CFZ574#O"62@'EI/B__7427(K!^+:+R3.&L$/)GS39'EFBR*](V I]]65
MES_9;4X[M[H>*C9Z=.A&3'/%?IY<W@H)I\65Y^8RD33CG0FG^P(/:^6+<N;+
M>7F9_D&0B[><:FSL9$]-(#^7>8?N>SAR(+<2Z%8P2\A>#O$B"U-'LQD1KN1K
MZ]BJ@^Y2U*4 _TX/_ VB=23%-&_FJ,+H^L'/77Z1-V6)'Z1UVNSDE$U2TAX@
MVZ^7424O8>FH&@A!(%.HWVK&(..!JG"=S^@I#^$_.OIGEE_(8ROD$6#RM55T
M]0'ELKD)4;F#1G_B3/#HSA;/93#/M,V PF%J7F&OK2$LOU;:,DFC0W[IZA/6
MJ,$1V-*L"(X6=5%L/7F_5X.ZYKX+O5;9?%259)B*F!>-T\'[A+V23Q_,5!0;
M2^7)>V.&&'93#"7-"I?]36KTK_D1"Q?KC?WC,#M:9;WCL8]]Z0^NL8X,E42H
M$@LSYK$Q;GB8@UW[X4O;IY]<2GM'I%*BG>^E;B65@]HO.-U0N2H@L6K"/T?1
MI,V%$Q#<H0F&1X0R 47$X(?#6^IW\!)H;KN^D/S5Z^NRDDJL-F7O4->[+;-T
M15*Y?J@XP 'QV&G46Z33T%1:.X15.&EA 1SY-\Y@Q=;P$V9R@@=Q<.'YHWI/
MNQ=1%G1.*;+UZSZ./VE3!Z+=*Y4ZG'U1"G&9*(%#Q@E5 89$WLX)ZXDACR]N
MDZF'5KF)9<JI9GTWFBH-*G/4;+[O74*_#.N4M+0EY'%UV1J[5;AR_>R:LLF?
MS4<)-1Z$!"[9^EYA,QC**-6O_CLNDC?^^U^5_7 S/3D@M)^J3H1'JM/E(!2!
M D+%H!3,O)*PFJK!BPDRU/MN=-U.#3*U');)M>515A;TV>.O!)8>P7-RT.;L
M[E%6J&1 7[LJ-'K_Z.Z0W;?J7]? 4QMXB9JQ@M,[IEE7A5)YGZ5<$?:7-^1)
MNG2S5#;T=W8->(N?S(PP(]9AP-&[S[*9/?X>@S;5G.L)J1_+\>2,PMVLCCGM
M")$'@G,C^MQ/PH($#/X-;:%X$H ;=9ON,]8^6@N7C&]==4]\%%JT5YQ0_0%W
MU[N2%&<KEUQ)\O94']#>F8%-KT^+[MW2^9R9IECM,3/K45J-GN=$/D'R /*D
M_J-RB@<.S!9 CQL*=P+:<<75$.;.0C<QN"LNTY;7DLQ'ZCI0-Q*\ZY_RO$^H
M>44%]:GU,H5IHE6<^HN'I3,C0 #K.%%37RW/]^;<M-7'>TLMI_F25Z],<+Y2
M]RFFR!(G8O!&'$ME^PDL6*VO4\8MC]-%V 1#F;Y,KIG$4&0+*(+ /Z(@"3WB
M04E@VG"DB^P*O?(OI1G%!G,G/95\OZ?.R1@B 9++L3CD^2O++L#L83[M92!!
MWKC7ZH:BT%45EIL\%NDCI:0!J3$[C>1X. E)0'5@X[()CKPL=&L"#(3,GDZI
MBS(497BA9AK\1D6NY,O2=]/KEK\Y;!SQ2A\,[CCM\B6=0J4=@QY!I](ZL?^'
M-P&"()1+?E89U MYA*793[,+XS'R?$G(RNU_BO24R_1]0!VA<P';SAL<8P=E
MHU@2!IJI_#8?=7P9CY3F9V^D0YZF,,ZS7=E<J?&>\.GL+5?1G[Z9CQJ7=BLV
MG)C&_NC.>]FPP%G]&)6RF+%?FZ^$)IAB(^7<95?]H978=@A@7;@8F$J8GDU@
M90Q]>]%Z<$]] -U5?3JP)\B5!G%/3"*.05R0^2][@'*[YBT/K?E-*[: P@T'
M,X$-PY'<6IHLD?-*4)5CNB58;"68)+%B)#*?$*LX%&T*7)_LY%ELO9FZL:FE
M2[X2$R0\J,3UXT^^_P\0LS%=R"B9&3 T/'J#GB_F077,RO18^<"RKA/")]\L
M3;K4QMJN'A[UL_9_J_ O?5>1&\^7Z']+W/IK^??W$3R7 VPT/?75'&H*6K;@
M):N'_V:,)':'8U[:H27\FD)J-DHHB*%KXY#Y'/3%YELE?3D E.0"J"F_$LQP
M=K*O;F@BLH^!V/\<1F8VWN+BQUY/+#^:I_."UL$W]W'(\,.5U\V/"0=;OQ"W
M %1N15/N#%3/)5OWO?,SSS+G9*IMH%SQJ7\W3G8V-+L6L(!$PE8YH0<?@GV]
M/\3CWHB,EMR.2UY#X:1$_Z@WU;Z*EI+#)<Q*)+:]9CAK94VY4GD,POO'M HB
MP(3)'GBTU2$JJD+A]\Z^G?P7FREDQ[FT/>'59?)-$U6HN,*G\=?L\TQOZE<B
M2!]*1X$G^9E;MXQ^V@6KE&?6H.U@+XT$GEG$_U3;$I$HA9?\G: Z&&-)&*))
M^$G- "1'&BX[0O,,0HI8&,><XB9"N4%5&5Z9D$:8/7U]RZ6^#JYX/?Q,T[VS
M5U-^ZSV"+6-G[K2R >DFYX FG+T7$-)L7E ]=YV0U*>PALN\J_Q[@Z^2)9U;
MA__<LK@<LXKI^C&(@ZH9^@M+,$*!H8AK8Q2].5%"1/+U..$A#,\]GM:$4INL
M1^E3TE:WOU<JST9UC]CX)&J?M!CZ1%$D[!=UP%]#6',).AD$= _TLD+YW3U,
M%L?H/,Q.[RTG(W_-7ZM^_3K#=U,?13L2&T")_=WT![YBMYKVYD;,X!FSGKLQ
M,["U8 WIY&^/CZ;N_,1FE'CLN868S[1F:*AF7QO69O\;6?:_=R8E)!#'$AW*
M74M['#!0VCX2\$8WH2N98IU@'J,#JY\XM(-NDIWW)OAVGAT(%K^X>;[]5L4,
ME8&7F(R#OZ/R QFXR.X6OTYM CK2MPD<Q<,T>2#;>=G1YJ9=AC8V;LN+N8NU
M^$\[%)0.*$7O;K@\*#8HD'[:4##@VQCD<<!G>=/KPPW&%H>=J=40>D(?Z?TQ
M*+R&%I6T"9%=$ ZHW5KM838F3MD>7=_P09<Y^[DB%W39J:/GBL$Y_3:+B@12
MW-'7ZR>])>B\B+I=<'JLV]S5ZF&$YV'-YPE_0\6*(E#RBF6*7(&0T<\&GTYG
MZSX%J^RIL7__&KUW[0HB]Q_N00L:/!9#DHE.)#7 FFP4< RR(V([L/'9%]0%
M<9E!_N-"A)UX1>YJ#^N[@78O4WNS+&)>?.V?N?_<^PO+Q[B>=T=?0Z_1%-8=
M'#(RE %0T\A^5Y-PQE&_'!8*H?9QC&[8)LMQX>ND6^%34J3'6GSR;#/(J%:/
MW,(LJ&C]WIBWZ92:7VVY%$T<*/N)XM)AZ48%E:/$[9!VXB@NNQ,"B/EC;%I%
M 5U\72<R7%.<*"GF@T<Q LN'#N*,AOMQ5C9EV_>\A88->NW%.E_WJ$BR!R=,
M<4(!$;(0Y=)13O-E3@R<&6CJT90$'I?W>*'N7*L>7OAP]UKM2#7ILU!:\OV]
MYMC>5T_.=[R)%-S+BE[),ELR_*V:\-ZVSSA^S7'2S8ZR[2IY^04),91F**7J
M@=I?\5E'3L'QD$B*/"TF=QX5-T.^;J0;Q;?@W2BB"G%*P=6&+88_QK+T8V4O
MM][A0?1;7/H2NW"]AB*X (]$UREOHN:S(UL5B(7)A"&\:T=UM@F!U%"N*SN\
M?R1GO<<QL?RL,R/PVI-V^\+9CWS?5?Z=BYZV<??^,):>G";G/JUI"=9)M\6B
M<_*_%=<)37M@1^^AA4(^T5S[&'2!YN=95!ZB'QK/\@YZ,50>H=<ZXJF0P+@:
MRBE5MGJ(&*WH'I/V=(D2%+XAE._.(*D+P32@OZ_$45B(_B0P<:4->0F8T0<>
MX_F=,+59HB.^+98N#O+6N[A=H_ _7WE[M2$M5N(Z>)-'+#^JS0/A"F#UF60W
MK!&?7V5-^=+R/N<XKTFZ\8$Q-</M.ZFG#?H:S0AYQ#*MUAZJ0#SH9HG$LLHH
M:'CW+O?H$=@W&\N;/5:N*?M;1PCI+83YR*2&S>EHVXM*=OYJ!05DM*//0N9;
MS0-F'@#O";LT89EU=9Q&_@+V9_@]E4>WKJ'KT$E<PI]()7]89-GSSN)^BPJE
M4Y9ROY5_:&S>+M#YDXO_:Z?95U"SOWZ/X.F_DMR<;++R6XQTP&8[F-0]P/?^
MF[.+BKCNU6@7]LWR>" [#TV@0=%T51N$#>*$OH@-T,+82A<OP..M#Z%1%%_8
M8Q]>HX*!QP5:'B2;7.,G_9N#9\+J\]A_+%(^T6Q@'5B#DU6H,V#F9INO1E=4
M-2K*4H-*^W4_U"I?G;'G'**[9]9T*> ?K.L92IXE9;0@/)5=K2B$K"&U:V7X
M:ZGHS5O11@F+'6 -D&(IA<R7SZD17F)Y*&*$ UQWS6,\"X@B2NBJ""_$_I[3
M]?= RJ<VU&<ZQWYXZOI1T$/(\]W!@'8P$=QY#"(LP2#GCT&>;B)=N@L2[L>@
MW_BMB[M3<=RYY#N1:AC'QPS-L1SS?,NM#W-+N-TMBD>:#GC\UZ?GJ.5_!,,-
M6,.IG$AKVML<9E//U_V7/V2 S.>UGB&R1-<,B'2F<V2?*_3TO6BP)>61,UOX
M)S?"_YIW?^\75Z%O9X0F-?Z3)Y-16<]*RM,Z2DO[L3O7<X\XE;# 9?%"=J/!
M8Y";W=XQ2'Y]*!)ZMCI[BI-Z@9M@NTO&1W:@.9_Y!-09CQ>.-ZOASS96C6SE
MH>\:_8EE?>3Q)M!*Q'U?<0U*'ZH$J!D=E=.&(>[I0I<FN&ZDV65^A\]V5=D,
MBWF_8>X ]:R-_YU,7DXQMC07B@_R@9X=?CC1>U11(^+OC'*N]3\&O7)5YTW#
M[->@><-#VFFPRGB$4M@!(=M=X:$W UBLAIMM"E?KTI7R8%Y%<P5=A5_>KY&*
M%32?.X<E"L4U%?\0%&0G'+D!$EV362!B?#+*K9QMG4=J47FB^R'F?=23%QL-
M=A'V7W^HL[97I/]6&?M:8FBG8UJG4]"'/!(A*A1'FJ?);XZW>%!U)\&<-"'S
M%EV-Q/##>M!,5'6*."'A[?[4C&7&;6+FUF!:Z:J)Q';2^/6'SIS7N#^*Q<5;
M,-O1#860;=Q#3YULC D!)IUHEFVXHI3@;:"&)%CFT.:Q2.3O6+-FLW<LNY?,
MY^C2%L7>"I<6[0-A)M. HH6AS2+RO8!<<A=5$T 2X>V:XN/Z#6.2"(9BMYT\
M1X?O=$OWFDSD9AWJOFM+G_+4@ TA83O3!_H %L=R#F!I:V6'GRRV(?E6#$:?
M-I(=MK;Z-WF"^XI??PV$@D#G+CF?>=,39\+RKEC5-%OQR^A!P_.R;$NB9MKT
M)-P\0J&D]T$L:KMIPS.F$7NX'J =$D)P[4$R'X-@T-\G1Z7I*#X+,$@$51;P
M*G5T%V">V'^V&,)!FMY/V9:L$%!\&M;\RYGMDG6=>30-- ]DN7QM):P^.XPZ
M",R^G*JF?%H=R]MBFQA0*PP9)JL%!+=!" ;8J!BBF@/P<_X8]*Y58=@CWX&Q
M \M<<PN^5</M\J[HT/<@];WNZ>T^G:9/[[@&1UB2:4AD((F06MB)>8!P),"C
MJV=A>D"ST&1%=>08+MN:T$*N]7Q>D6/>8NHLTNN=XW#SW-UM>,9JA6U@<!RR
MK-?3K"9K E:3.A&$#>EW"O<JWK+/"(888P.L)[,)]G :!0%.]"C=9,T. XV#
M$)5BO K<?K*3/OGSCS=5SGQU87Y;L:3.^OE-X@O8HJI$R4-+<4+%W'<S*, I
M<PRZ#A<7&XLS_HEJQ2ZR__6G7!8AO29DMQV#8C4E1Q#^@5[Y@!H^[8TOY(Q[
M>MDE[L7AA1:+KE_:2Z^K'UV2>X&97V#?BV,/^*P.&WE95$5%[5ZH=C)C9BG>
M?PO][MH)G=K *&E*$>MZX.&:RH2L[*LM"5J$IWF:.16P#%XQ]R<W2VS_O?5P
M3369+18ZIT(_C':#QV>Q$[$43F2'ID8-4212F-"<)43(/.HN9RY@7"/]Y&^)
MS+(-F;FBTXN+8:W.H3_+ PA'XU-MEV3<S/*2ES[X&>K;Y6[D#.WK+ V(*6U.
M8N&[FJM')9JG$6)'#>AGQR#N "QNLMLD(O1,RWB-8<-^W.7NQOQT!,3-ADMC
M(!./(?S1>J&;GB?>]D-'-LS>I/L8%"5P]B@5[11G.)_0N<,Y1;E-%$E0A'E8
M]VA>'WV<I"'VN/I&N0+9*E'B/H>9BYM?V.=3GQ.SA8?-3:2\3-\6+G%-_YPI
MG/1KJMT8@'GI7A@Q]?:0L'$;A1V"S:F3V:P4")Y&/#@WLW%;RO8COA?].Q\$
M?%T_#*F9-O0I^'?X0>9\YI74V,92N0A0HOQ(-2U<YV5S-RN6(W2.,O:-. XZ
M6V4C:8C#T"SC6C+5Y<6_5#EK]U,]V<;>0_(,J!?%O4C?SE^Z:"N^MO3]34SK
M(/P8=,8#W;BD>R'9I(IFFFV9QR#SS:&8[.\['9!IGQZ>HOA6-HH[H#4/8=RX
MY\X&V'4K[Z[64052B,LS]UYSZB_H2%I@0K=!L[%92-(6L#"_Y82+I-G+VU96
MHE8 %?S6S_\[-N#[5M8T[QI*6O#C3-N-TR95,V]_5P!_5$%?7)=4Q<S[\@OH
M;S6((L1FJFR;'%:Q&_Y?<\+=3;V3$4T>TU@-EJ^0^2H(:S.$Z$J]8$Z4@!):
M:PJ &*U6#T6/&GZE->ER3Z8@AWR3RGLW'DKDB5U]GZ*HD89!LAR#.E-0ZH)'
M#?D)["RQI:7'(*>,:LZ!IR]=8K9.\^W(!KXJ)-SD?>T3_>])=$G@2Z>[*8QK
M)JESB!)LE&E'@?&5'<(,0;/H"'620X1!$XQEIB"=TYX-^>L\.Q%?B*;C?\FP
MZM05P[U]44=653$I;E\K%Z935UT+P"=$X!T5#,24(NAH(X&DS>/0)OB-(_^(
MXN7'?FD2+H&<T_=3=Z\(21:W^%];\GE]"I4JFIMJQ^,=FPS88ZGG9I"^'5R6
M')DD;R1PN6$?LAE)"Z94'AH<>X5." B,T8*IR23"D#[<^'W1G]E\:]6B]\7W
M]\ZSOG.[("%Q\X$>O8;XY.8&41EWL,5*YNLC2.!%HLH19\H"_.V2,9H,1.U-
MMH&BO/MATL^EF[_9JOQYM7'5[(RO.ATRN70.\A0Z'=,^=P$PK4 H MGS_L3(
M,-^MNQJV$N5R:\]]!\[M7^Z3G[G?V]L[3"F_\L9M?I%O1=*8/E6^F+'AEIB;
M\ZB^KN'J7]NB1@]6.^:1#WE^,R:&#L]2TT9=ZLQ7L;_!)'<@D"P2.HV]Z"O#
MAC"CA0A#S"0-?Q,BJR&GL8;%,UT:F"CPC(RTK>B(4)B0VUE8P_2]VR_.3/9"
MZS(W;1.V^HA9> :.AY[J_A7ZO"A=\Z_&=\"FCK,$,NG;42;$:>!% 'I^\C55
M+" &+U6>UY._+J#1^HU\+M)'R.5BK]UTT<ZG,TK#@J<^"YQ')>Q+&2P\'/.4
MD2Y,PJ^OZZ2[V2_E^PE575[7%ZYL&RXCRF$LT!UI+2XA=L-2:17EV!]#+,:>
MI:5J6Q[/T73?+UXQ=<2M_=_9#Z/AP7^K"DSG3-.89TYJ!#.F_)<O[D:+%O2^
M^4#[ZM8#;]HC&+?WTGY!]_]88X[_[@+G(/^C?IOA_V%OSBCB)"4."CQ!@"\A
M6R'WV"EMU"'D;L8.37A,G:P,F2@>0?Z##(US6C50[</L5&(DI7X?F7,$,=5F
MW^N9X:A. /[!#Y!?R\4'_I?$C-RLKGLG94J_Y$:+@OZ3UQF!_RX#([_Q&)3P
M"3('&<RKD+^):@,#JBBJ&><\EBSB!SWT'MLX./P/,C2<!(]!0?_DEP.JJ-H[
MX^ J\'^0<Q$P1+F<3#5=(X"I/[&TU_X[ W<<<'2 XPW'LTB<P*6_T/>4'Z'_
MFU:;04/_04O.OW[T1]/9@/5BPL2W8U!'0B[E=;1H1=ZC__FM4'H /1F*,#E*
MDQ9!1E)5B)SA>8U>0B22O^YF'=.Y,^I2'V=?S7.8:0>VL&<:O"@6,(A2G%J/
M^B!XH^_&RQ#6$]3M(VLC/ F;Z2;O-,6!UT::SYJC'G^+OWCS_N<E^^D>[A<^
M;^H_QS/#?H;240*(KIOC1+F>;D>&\0PMHO#'9%U84"W1^%?4DP#GCMZR3[)-
M3 N"M[BN\BP^*WO\NK.#^</5#XYK0LG[.J:=H['V3E>2UUR<[-KF5"<TN0,Z
MC8CTD?L2 V#;X6V.]5[2A!;?Q$CQ#Q?:$(_ITD=OT1C"#"->>>M-^9IJ&@;.
M"F;%/DL=<'45^UY;(WMOT"%L5_ VYKM0E4N4!JQ_M?Q&9.%RB4J%2U5MZ?"'
MU:Z^S +?L0/L6RC! IZ /=W, (Y R!/5'*M^X=YIT97WOX!*Y3*Q/[0-F,UE
M# OCMO?KHID%)CN*>AWH69 8N@2@[,?5M2N@WV Q6W=Q%2)I?"";*)4SK^A!
M3""ZQZ:F)O0ZGV?U[@@?N EA2Z^\(,1X1^NCKU:,XH>V&!? \4&Z;S<1EN6:
MY;#Y$ &I,_=TZB)DOOWNPKQ85C CZ_)^KGIT*DLB)K?N)7XZV;:\N>7B+<M1
MF%/S*-)M2, -7#670RC$8JQ-$9#QFAOCV]5A5Y[>JK"XRM*,^DB__6N3Z5)E
MA,3[=!3!A!1.3-A<*=VPGF.:R-9N)'(D>'UQEZXE#)$RN$F?'E^W>*1\1:OA
M]B.+2]I>+ZW@+/I% I9N[G]MT9J+P5Q3I5+^PJ.^$G&\IG7-5?7I$]L3VND,
M.!^^Q,9$RY1(\;97=_A>2ZQB 03]EM0QZ+P,11!-J&LV.LJ.#6QZ1/:_C^S!
MII'B,RF#S?O+K<]S"VN9PV'!S\3L8/E;!]&% I>!D="2E3OSZ.BLJ[1@H'6?
M6)A6/ ".5H@ST'@R^2#3:EF[2?]LJ3R#EF1<\SFUSM-!RR4!&]W311@4+TQ
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MGB93]LM[8JADTE^4!2-,M-W$%@4@-LCL!'2,YH6@3!/>'B1X1N-&>6><6+I
M77R]M7G9V3*^M4>/3Z]=N,T=Y7P7U7'_+SX.*4(O5S%&)^#DLS[1[MZ\&1?H
M\934(G,^.ECN@VN:HB5_5]A=%7 '&!"?Z</C%-K95]"G$2K3=7+'#>)_.)FH
MM*8L?AH=/IU[SR.*E>7ZG,;9S#]2JQY]G *S,;VJQO:5]FW#OYN%S+MU+1Y)
MUV(VBOIS675#>Y.9V?L.;%<@KI-1\9:$WWG03T%L&%[G],.]Z8&P6[AV2;1_
MRWCY<+V$E>"#WR=A"]!AQAG&Z-)->C["EAZU[,R^[20]Q:TQ=V6"F.DLK@9/
M;MN2#UKH/DNVU^?7-K*(GS#'/RK"/)T*@=TL*&^8@5LF?6Y+)V_0N#8HZ0"<
MD%?FZ<SFORE+^_+A".2V8+>E)/**;9&[I=J@B#7O00BY V/$G!UA9!=N@WB,
M:@N@>@ZQK_^@N1%RI.%%8E+T$:A.-Z>GW%(S!Y*28G=_?KT;PW;*Y7%%>')M
M\J#SS<Z)KM&+_+U&4JT"^,]_0Q64I#_@;A1*EQH6SF&:I]"<8\YY:)(#'I!,
MBFZ[@/ ALW8GG4'<^4%3(B$%89KCZ@EBLW-V?5[?J[[R)#=]9TLM.TTRN]VG
M0B[:.0)1I6AZ]%*5^015PF[X7PRW@VV$JIP;YV^8CE?;L_)[WANL@A_<6(4X
MK#@5\Z*[9"U2S*&.5DDU80)G^)K\W4O[R_QGX!+!?[F)3#4 H5T,7(W:*2$<
M3-$"2=MV8W^"8F/\3^<*;ANP,\\VO2LB8<HZI"]VKL5:CJJ([,>>A[Q "3L%
MN1':F,Z%3;C1Y?%A 07_LKYF[D6*_D7-?VL)YX3=>X_)[;OQG4R,7KUFE%K^
MI9'7OBR,*E"NJ\KI7E"QM(4/WE"V;@0D&6PEY,$5A>@6QR_N>$Y_X_X6-G]O
METH32ES0SDY1PV@.+\Y)ZVSBIV?E+_M.<F7' ZZ/-'2E$TI]3*=;,P/:\"BM
MWG(Q(L_'+4TP/8JA$E2C537EAWD+ON1_1\&R(?'WR-Y$9\.^_6*72*2AJ']T
M6;X44U&?/*_/S1MS!'HZ&I_+-BXVJ8)YB[VH''>ZC3Z\&[%;03!E6U^ZP@K*
M;2T[.-&'K0UDSO0S-'!5_TW;U2"S'0CI71"J7?,B56'^\?XG.FF"B/=YYK:6
M1AYE96G3I[_%+B^CX\ 7_VOA= I0[;.#O/WKR-F;.?PEVK6J-F5D:\ XYMZ-
M[Q4_%:NCDHUEI,043H7,]!/V%WI;U=)^C<?%"YHM>31#OZ3/Y<II#');*):8
MLA77-\SH[%7&TJ\>@<(3(<_HG 1>HN0REC?(V:!APG[E4>& $\ZFF_LEG%@0
MK=&I D;J-D;?9!T:L$]_+KD!9V$ZXLM8CR3A(-<Z*.?;IC\!T/-9L+_#%1%=
M4B?)9_<*RKTT?UF$G'T6>^#UL5>@GH>OI%_+N-G8?JX",:J7J/G^5V]M9FS8
MW/X=[@7$77J61C I:R4"_8;VB!!FV844GQ2/E8'>L;CAML%O(W(]1?OB$Y<$
M:OW9R\GAB?F40OIKAARR)R"32747-408@E'=9LHAB'#SVE9;W)7(NR8MU2^N
M&'S#QZ^MWKI%/)P2=N_+<;*7J0A3IR6B8::;OC*M=?B)QM4_UK6($\SU&()X
M3"]JX]X6ODDR>PNI:Y'Y-"S+>QC?5)$6[Z5A+EOM[:W\HL/%_^G#\THS&A;N
M:)(9*EY3C)YY%>@H FY"1Z,R3D;7W:ICUTNQI-2X1=1?H'^J^B8(XEK+U=-7
M4>Q[\K[1T6!I\V5#J(+UV$OC;@O3$>/0EPW$K: >[C_63- LIX)KW<*1O/VK
M',8$_>B*/[=$E(9T.L07N")DARAE5[_I@BX8Z]W <Z-)< 8;BKR_RI0(9L!]
M#4G2A,.4AAKYW]?%EJ]V]*K;@I\,"_0_!FGTEDNC:K]FMS"F;[9BABJ0\[_-
MIHOGLW+LIX39=3V"L)T"F%<:YL7NF3]S0@N@ @Y$6+!K(+O.G=I2K^^_VKD?
MAPK\81JL9LHQH(_J,-?O3SIHM^N+EA7U%71^&3L^&G0R[>+()M>3Q-<U/P*Y
MZ^[K2GM1TL3>A]:G4(?%+<XG:60:-ZY.6G]&_L!7P[N3YG2<&B:0(D$0&U+K
M\+++BQD# ?9/+:H9TCR)]Y^Y02\_"XG]]<<,D,3V@B\@A\_3'D_0!%4VN@;?
MW+/+MHO(-Y2BVM9TSK,A?]@L<+PZO6<F*IJ9$?\IG[^QS'!.O>SFH>34(?O\
MQ+K%3ZM0*#9O]9+UN$ #[8(@)>4'XW)#;&7;!2#VCL2MH9'/QH&MNJ 4D\_?
M7[* -FZ03?[KD</XKBE-+T5Y[K*U)1'LS2X%P3LUKX[[<W)W!*J4=O#D4+KW
M6[X7^>^_ZTTY(5"6SB]HZN6=[AKYL,A.*<Y\:=AC?>U[NG2&:'%!IOU64K8[
M9FH44 #3+NI;5DW78B\CK@'.A 36=DUNTDX-$+MQ+\YT_'.D[L?9YO8*P8%.
MQ9;2&WW"4R3]':;J.TD!QJA6FS+% "OA=V/E)EST7N;K/:)LSLSNM=P @WZA
M<X+A#L#E#8Z8SG)KQ=CM@-HP]'.WJ#Z+,EVK)N/ABCMF I];72AQ]$A->62_
MMZYJM\*Q[5S!FEQX35^HB"S%3$'R\;>87)'NXW<74XZ)7K%.G2DTJE.KVB@2
M%U]4Q[1O11@,^VHM!I_BGD5PT]$M,*H>4$/E;&_CG6YY5"H=7*U5-*_<9N2'
M%PV;=" W1O.OM&;UH4GZ:)P] 1O96U&"$)\IJ+FAW$?57)DQ_W@)U.=GM=<O
MDBT<H;7=QU)5EM UCJXIL;@!S_> ?!L)BGV0(;N6NH/3]/C<"J9XT%.05Y&S
MX/-PA QIMVMXA2/4M"K5HK$6.A^JQ-UD>/G^>J580E"PBZ#6XKY?NUC@$>@<
M9/D]ME:R!W,1BC-]31JU:OE&&J8=.N7)+.+F<;K^[)?2Q1I3'D5:6?%IVM=Q
M>\]ZPGH+#;[4!7K83TI&%[)Z],L$NO_[&;N-5$&<)D?M;*R6M"BM)IW;0O+/
M7-$2M5OJJ<LY=]=/5/J7E]> 4;9P4&4S<YAOV^21LQ />)0FZU2+/NSYDL/,
MDY6ZF@22:9?&[^27[2.+<VO>WT=2NL<2(# I<>$#*RI%^M&G_!%<0^CF0;9S
M)Q-T2"4 7[(P"RAT:DJ2P]:SG<*Z!20R-/-DN=;D#VS28BL-^#6>34M&:T!0
MA#LA5*.I%W#E8<O[WU+&]T9^\T2NC+O/EO6)7#^;6'XF[?'I*^'#R!I4!PCR
MW!F,' 37FW4[LJYP1OB;L6^E .;BD>JUPHX#[-\[@@HL+'19X_.Y,FF;S$&\
M.@+U_T/ _NLQZG@$FHC_^Y/@ZPQ/+(F,R':Y-&%Z@%WV,>\-O7^ON'?:4/V@
M<<U_"G$3X%U%Q=?4(CE)\-@6:[%GD29@P]Q_[U_GWC-8;#RT;D%UB!R!GD#-
MYF<HU?4DQK=]?0*8<ZZ^IC)8UL+X@_G8A44;GR^&0EJB[UY_[SB.U<;"L8"<
M9AP3^R3R'DT(4%J&G!UA<"7>@N.>7?=(/S< WB%UL6F/G#@^8O,DAN\I&]]/
M_AZ;ISSLK&:XAW5+]>9.\#^B%Q.S/>E.;X,+H:TO4B "-!AIOQO,H9(^T6*8
MMRT,GN1-KYLL+ZC[$$!- :&,^C#SHW.[C#-<)"B#_1CU5E!1!TJ(:099@L".
M$^=E?9VWKG><<SUW8:_3]GO0EX2,LUE9"8VRE0.0:PQ>1A?Z/,1= <?9XWP.
M*>@QC52=;I&>\3$1SRWRX&CMJ6L=F,_ZL)[Y,&$LTV" ^-3FEJBH!.98MEKN
M.-_W4"G+I=W%FJW<.%ILETMV8[Z31J+Z=E'%*/ASZV@'A&1BENC,A=!=(2KI
M :&E3B;+QF5Q0C[P6OL^-]<[;8A?;>-[IY_YGQ!W";AU)7[-[1UP@BI.,Z*7
MU EF.4<ML<\@'D[;4.^G>R%79G/?&-ISY=T)OR[).MX*J7Q0DZ%67??7SAE*
MP>J4;5\JQRM.A%E%Y8PY:R,\F4!XB/R!KL%'_O9/XD8HS,#\RJZ9# ]/O:\_
MS+8:BU]?@]J*G69A$Z]ZW=_^\QMX+I5B KRFN@![^UT0CC^<@,'?04'6*<EZ
MJG]=[N"SE%L?#T;%W+WV]:ZSP;-NM8O=]YX-MO3/MY"7"?1WW:*<7I&ZM5\B
M(]]@11V]_;DM$O!FSGTA/4]3+BC+:=R/,S*D;KTO$KXQ_I?-Z??TTKA,L4U!
ME?A02KEB]=>.O<6R>#1%$BAQH>HP$7SF)8V_A+D_K^(VYUJPU&)5X9OV_&S*
M]T$N;:ZO5$I.P8E,T<0NPV^]!2_3ELIT%[<;/LB:2. L[*!-LWL#,I1Y2@<S
M>E.GH&8&&[/"=6D>!^XLSR*5/"AJ M!46[O- +5P8^X/]GC%/]6R!<,'T6D-
MN3Z+4+)+CR9_&\DYYJ\<V#)J!Y>>ZB^7MJ ^12MQ\4EL?I]VZ['>_[1(2Y(:
MN;9*D+)8DBMS5-TNTO_1Q9I8%&/2E8\[ B7E84D8"HJ\T6?6@.KD6D;S!@U2
M%0:I<(IPDG=Q6-+0XOJ_7*.;P_/@ESMN+BYYE<T,H2,0>8,1G=$S2A.M S.4
MG#_C25!6V@R<^@KUV_2;&2Z4P;Y+GE]&$Y^0.3N;GFF>;OQ!$UU9-#:JC=PV
M"@B&$3%B,3SZM@]3S$%BC_<,>H+K?%_XD?]Z!=EY(V+4ZZ<W(9-KN>KGR4IY
M>E)[\X&P<8BJQI-E&)SPNQH'CU8.L]29%.6'.FJ/&]N^]UN_S+(3&E#>1.]E
MIG LB8,QCB(9@#EH#Z=KMQT5NL?MF-(BOCRKZ(TQ^5CNF',E7MKZJ=K%XRF*
M+!#)MO_$(T13 3GNS*HR&BW,3DJBS+Q%J*IT"S#=+Z4PK6$N]_2%8/T,Y7Y1
M6.R]%Z7O?%^GG!;ZZ!1H=C'2?]LNIV#E]Y^FG<7F'#ZF,"T)-<HEYN3@G2U[
MBRN;E_7;T=R,"3"W'^9DD*01 T?6J]L(BQTD7I\/7GJHH(QN^3BNTNW=C!A2
M:C@A]@J&0-&S6J!4>80YN@.I-F9_CZQ2:VXBGK*H%: ]D)=_=3E0YYW^L1B,
M\_P$);?OHZ\=I:U^%T;\&4 UV/=Q= [U;PB]?"? VKD&W2T#CNCJNQC$V?L
MD$I^)GPE[,*Z7W7%E1A[HKA&.?_INX$^W4R_4_D+3S) XXR[P>>L>ZRP; B#
MP_O),>:VRXE_)U^U5^0;R)_3XNM&S/RR[MGFKQT%;O*H0S^X-GQKF%#^51C[
M\!I9#8@$/7J]=E[KI'#:ZFI-DU^AD?)EM^%;'7-+,W^VM[Q6E$YW=%AZ6J?$
MS4#1\9/6P50(8\@)0B^A.1SR=N'/;"U)3>9IB?5[\.T1WV6SI.N)W)K,/18
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M2=TAWZTR&N^ 7BJMD-%(R.ZY<,/[U0(7VIC^5O,LXB+@1H71Y+Y%K58<Q*D
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M94#_A]NQ)/\C$%@1U8+*T;=P1/4-H7?!&^8S_!^LESEI0M9'("EV$IR>VJQ
MO^WI3Z4[OX*0_)UI!0H=6(KI#O;/>LE,5?)_3_E]W-=@QBURL)4TEP1(2M+R
M)Y8A]%0LYQ%HLWZI-;/%C<'6?P2Z]@=@?O-LEQGY(:P!\QPCWT 6WQH-9:>=
M#E'XSG@&@:/^::(3P)0[V^A#K]R6S%8WRL$1*'43^*\3Q!(3<D5LV_UEA^HG
M&$0SFLR>_K8-BJ _AM32O61M_M7:F]1%<062R0WZWR8U>$D'?<+R$\3G5(T#
M-?D(_V*=L\TZP2_(HJ=@Y44G-TX*_^V:"28U4[X 622=KGT/378@9C6)S2.0
MER-0+C>ATF&V0VRH-%+/(.=AXT-=63VO6/4SO0UU:_1AS$8H\N3#C89&Z+\<
M5IHZ4WB.TKD4XM" OB>$]OQ;$K-.LB">D(QM&B9:/ B0"X#^@Z8HXG7<MMVS
M0\2$[C?,AQ+I$M>%<M5C\25"9<QZ&A6!"#T"?9XCNS!!/,^D?W4'U1Z%A%Q%
M8+7<?DM8F>P6H^&(\N"<6VZ<]I?"%$;*]=3+& T]"KQQZ_*S5!OS0SQDMQ&V
M'LJ0>$AOI5/M!S9N_$]'^,HCT/LXFN 1J"IWY@BDC3F&03+KF#5J0)?!<02:
M'84>@?(LAR"+3-Q&.J<*RP!*?U#)(TRZNXM:H[4Q:]\LG7F*S=Z00YU5MUXI
M['(*+O M4ABA,.$GJ!!KX5YO=Q"OX5+LP8.+S(<'^_)]E)5#_$V^&GEM3E%[
MO9^C@Q6B^O]V,E7*3P"\D@1<>XL4HG_2O/3KL"@)2[@R]D(9S[<9HMOLY)EY
MK@9VO$.D'RZ\>=]"S'WSBL7I_EO?1S,LD_LX+^N3%OS;1JP<2OXT].2/4[9=
M8A$MM6G.;W"4UC0,0-N!+*/_&VN%76!<FS#B 7.LH['FOQJ:#L)I+D6;/#AD
MOG<PC/_CCGQ+1()$I,T4R6C]M%R_*!_V:]1;%6<P<\0*$*C)19T)C'^8R\,6
MDF-=3EJ!G/*!8GUEASF7EJSACHPSA?]_(I!$($69$4AO"A2]0A' 8_ _>%:/
MD-9FVZU,2HWO"2V!/KC$W#WS@L3=JP] '?P=79#E;#0OS9 DRF#+ISH ^9UJ
M==,1*^Q<!!LY##':MF(Z]%_%VC5\9^]M!Q:P8NH[+5"BAH[1Q<0+"[%^C:B,
MK!Q'F1=M@O-NR(;KQ>/Q:8(^^]J+F*'*UIOS0ZD]D+.BS.E5"()K3:DLLMP)
MI40S#1HE,4%E_2M:ER2K'AO<_XWO=QVH*[&JVRMX%8G:$2)E69$S.N$Q^%J)
MO.4[+JN!B;5T)P[!KI![3<\.AZSMRK<F')P=.V.'I3MXIL]T>;CQ=^#NH:H"
MN^54*9L OS=5B79W,C^\FUT9A_ZO@?!2?VK1EDEZJDG:J*9)_^;HN1"EX,=^
MSE\K\U97J2JT)_0<FOJ*(XHPVIO V7TC**MKF@=7FVFRA/$]^7SZ"&1J^VCB
MX(N8WL,%G?>LKPI?VST2-2KP1/&0?X84+*_G6TWIYQO#[,/L2J1Z+U@"ORNI
MO71U^:3ZMB+#94@"OLZZ&\ZWV03NW7W%D ?"26V']ZHG:[.P$16N] SW(1T3
M#V6>Y!;%[LO5];_+^AE7S1ALJ]3;1Z N650' J9YV5 L(QTIU#(->QP\^;*Q
M+DSZIX%M^ZH<>Z_!9@KT(R!*FJ L 1EDBU%=,FL\UAU^[-=Y XGI%JT5N5"K
M\3]$D6'.W4J!X#6;><_(*\<#N?KX1:$,MHP5$X4>-,F1+D'5(:O&:KA^KOM=
MPQ'9N**^&EJR]56_<%'_\H31(V.>AR==M=AK76(W,.X_NO6RWCB-6#]HQ< $
M?^4RX)7?1XJ:34N3Y!J%)@/VPC#8DO7SJ Y;C6"2[Z/&'XSS.,"Y_0C$49%M
MC_NEWU7/6U%BKX>7P3N8L)MHC!]KTEO*]Q7*8P%E,,X4DO!=2!Z 3)KIU;PT
M]J)%P97LV]ZDD"BO',K7'=#D.C7K+>M53+"\$=G>?BJ+CP^3"MU! ]*C-!R&
M_FZ7_0A$]*2(1Q7J\!K/EOE*26Y\#CD(W/JK3L^6FHX2J=M%W5$[8*[YY1*D
M( D;#5EN"OF9L;+]=@(!+@:BNMY!,X[1DD]EIZL%?7OWC8H5O2TWGSH<B*J'
M$V6H1L@>-"]"G\"D0 !B2,)T7(,OW6$9Z.NX:>T$GJZM?2J'LT]E_YAI8*2<
M5;C W__/5.8=$^[H($@'$WBHY:;<:S]:PLJ=@D([U7H8"6[%6P'E<>)O^O/G
MI >,RZX]\HF(N2S_.P?*V84^B869S=:LO&_C U!0<ECMO#HQ,ZPWYM04DXK_
MBO7?&,+*X*K5GK1Y76=;8#DM[,@WD0[F(%YV+.E;1'?^L2NJR-S.'ZM(E$94
MILE#(=X><O5V18LA2KU,LV#&AQ $6JDVOT)V(_\0C3LT0616BO]H3"T5>I=7
M-R<V04LV_VS@O>O#?.K!+V /0)A +#.(-S3W2<VKGDT*.WW+_S142;U+Z[5T
M3B.F$WA]95*LK=;Z^&WY7./@PG2/@#+-#4E?KE$Q"HJ_18KT99_!SDYR,2$O
M9KS]T_^RMD*!P0-+S[XJ<,])\H;)SWN$T]$R9A1S>3;GCX,\ZOM]C#'D&7I3
MVQ6:T[2&2E@^[4F462+#.!1JPL*>I7"VX_Q3T?,MZG(GI3]T*7G==LG.G)]_
M4%K2ZV&?LHU3KW"L3&O]6=&6J;(P@;/,C$VQ6L>V_&&._@^^KCD#LOQINNTZ
M/<.5GLVX8PN\["- >CEY/#+#MZVL,N]9C76%N8G<:X"YB2A[]ROS7ALIO)%K
M%)[JJ$_C[J,< K5X=LWS@ -0PQ!#<?_75P4?"\-6[QR!5CR";Z>M9Z!2V^2&
M2@.ZS?5N'6], J0".RO,]/_GQ8E#Z">M&;WUFNRHB[- G/-$^-(FQ7K?>9XG
MYO?=:RB$>,+E^CG$Y^\VOC9HDN5NA/ U((H$IWB1Z\,)K:%V)&02R5*[:E*E
M3)#MI>P+R0;%@K%AQ1*# :5B]>_K3&DJJE?P=;\TU?,1-XXH.5 W9:^7H:,F
MG9USVT3231R3&F!'^96(HLS&H @SD*KR9NLA=XW'\<"_V 2+LV</SV:?FU.9
M1KP ^E1I%^Q-24E=HQ&'+\/=R$8F/(-.Y*AX?R&1^0>3L%UYEXOB$9C<:K'K
M/8(2!@Z-5[]=21U ,FW87IS"[ 2C,:B/R8WOK,VIO@A.LC[MDC;D'.,'^(Q?
MF&4?GO3.O5X 'N_7*K*(43%AM:U__3CY64.2WQ>I"\I^[Z1./LM^YO8Y_M/J
MZ15(Y(;5P1S6_9_E)M19OW!\V\7@5AVW->%G#M7YXW_7U$>Z&&RTIUF,,U-%
M0<V$C1X.5:T6H% X+A0#0'K5D,FPHBU5WO2QC[F=V]]MQMU=$YQ/5CYXLY!R
M'=6AC# GX$\R:^=ME"<1VN,$;B!;I>8/$NR__6F.E($'^BD4414'&\X^4?K0
MTF/!KM_JH_I,Z?]>164\_I=5M$^!RJS2 ^*0%PJ'V\MXNKJ*J8CR@J1I%*EQ
M4QR6NN$P<'/>U+$^<-NK9&#UFB5P.Z^^?U]FGC1?,8*A0)BH^830!C:IND&<
MA*1N>\@IH)D0%5_7#.<T(\1HR!39S<WIARK>%5[H.F,HJ.=H:[J"=';@VHLB
MFI/J1Y=11!4R>T<FHGJT"+#LSHQ,AHIAMX6OR3]+8$?5U>F%;:,8;$SM);E.
M,F;T$9F$:7K]$5/J%-'0,[T8JK *FBZ7WGK_CH"?]TC.I7Q>]MI:ZS;*;B7=
MM/1!@H9./'>JO?R!QLO8:YC'?_[_,C#_:Z.SL#L/93QJ&$/M:)'<&$GC94R;
M$HY /,P]Q4RB'>WAC%A=XN$=</=AZ_Z\@6+&<3F1C@'P\_FDWBHL=!<714#'
M8)=?"9B%^^&C<T]-:CP!OT&(NQ]RU[="Y0M2=6YF/H^?+X^\2XY>J"8.[+Q8
M9?DV"HA&$?E)!X0HVH6,5<DHA/$JE@4([!;X4E+1[_;%,V2JKG =UY^/TQ?4
M/YLHU*56_>;3^OO7WT6P"H>M^FF/PN.FZZ=#0XOZJ%(:EU<F&)+_+O?1+K S
MSJ#(F-5=VJ74+H80.2-!H8[(VKM97#&=HRB"PRE;^2[J_1 IYB*Z:Q.\TURR
M9R:P'$AE6QIS\L)?:XH X@%SFUB>ECLN2O<*] 6W BA061^N";D+"YQ6P4K]
M*O_^>^+@,?#Z$TV.F98TVLV9%I.*3>'+/W90M8R)XJV,Y#F<_>XX1M1D[[NV
M_(:K>8KB$&@M]@\*D,83#0M_H4C6[,XQ>$Z:[N>@3'Q7E-ZDG$)M%H"1DTQ9
M%'V>-)3PT30@[4GNFL!?[[G[TL^5NL:C9%UU*[@S5&_F6H\)?8B_Y!J;=DVO
MO^OS^,'$GOX4J@J]<QS-]%G++2AN%4,Y;@1D^9LX63/]WKWNZJW\@QOQI)ML
M\I-@>Z3:LV#,SB!/TA'HE#)SZ)2@YN[,H8##O@C$I0:U=#14\:?@!^6#R)%)
MXNV%+[87?(K>&([RVU&5*$/,H[,00B3X3OCJJ& 0>(7WU5\S(:BF0.*@25W5
M-/'9U-S:4CTA+V'H4_N!S_>'2:D''_LDL-RHY5Q4_:G1'16J%>"[<C(@J=B#
M\MSXCM6P)GTJ>[#Z0>,5N).0S]V%N%PEASF8['/%!,3]U$?<*J:J8[\P"JU_
M]Q4[.UM#_*7K/'R*,2DSNY!G$"A^KHPR#510]1>"P@F8'C0H2*'#[D4_/:Y
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MMUU \@BT$T;6-P8BH.3JU6Y<1N07WO3K6W8MUF/S(XU2TET>GBGJ)>M:"R=
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M^WD_#+(O"Y9)43H%ZWM8HN&T\;%08&IF"5O@=0AB+M4,E>A]_2V,,4:1;[8
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MSHSO>I5=N]"E'[SLRV>LQB?:*I.:U1EM1?IYZ_BJ)S2:JR=:&HV*BUZ(L%E
M7^NM,.7"X(SVZCB?/]]<N":B43GH"%S&QB-=LUG@D/FYR>6V)\Y#(*W!^,+O
M]<%C'YU.5]W^5CNL7#>K+Q3MU:!W+SCB:&H&X2"_^30\C-%-[AA0]8"_>(MX
MTI95G"R5M5C5Z'=9K('/8F-<2(Y?E49?KJ'WS#OOYY&V%BTFZ=8Q?@D%^?>-
MK":_K$=PIV+2]LO99!XOG950&_$PUK4HA@UOW8ABM'H",4,_"022Q? V-!OR
MR]_ 2)>2M2GS:QHTS)&X?J:G_"S&_RJNS8^SZ?FCJQ^^\.Y &:@\:43Y"DB0
MN>^1_[6!<4PW /)"0^'[6_E M75]RNR&^LQIL> 7XC=>GO6[621P@:FV&7+P
M5E5Q$D().?B$D&*H]H)F,'DPRK7^)FFY7;%:8L,C^YGX/5+HBX=5/5K>YB[:
M7S5%QZC\-/:##\CY[#D&!UOPU*<ZN.=<^K6 J;-JU"U2003B=)Z^\,Y[&>J<
M[3W?TVP(7RF[FG _ZT$RIM3FG4MHIUI"\=_;8>YYXU4;E*]/"& /S19(J*R4
M<+%'GOW]O0YJP)J#S#@6AA1Q")EKH>@QD;W^%+B.U=AJ3,H3*P1Y&CXOP\N*
M_C5$*F$RZTR&9;M+YR#SG['H]&PJ##&9(T.FQ#KY/LZ=#>4+\[,#2:6<OFCU
MZMNQ'VXRMCZD:-:4VZ8O)F8>G:=7FN*@:=NE%0-3\.2\-LUPZ;^RVO+:)WGN
MV\=<^T\L=+#*N9<7)RTMG1<'8AQR"O?^6Q&5#9[[MXX]JBPIQ\[GB_("Y46K
M4H2,%D4VFMV$BI'T#J *H'L'.=8RWG1&7>+WL^7"G(UT9^\1B *E^,&6;&11
MG%%%-K-#GK4>-1/YQI#VSL+3#P'LJ1'J>%$]?<01PS;1!8[.4F_;.AL"N0:X
MD0;U&R,,Y]IP.JEW%2H%@R(^KX5:=>ODZEWK$GB08!EU_Y:61HA9LH2JRX'W
M;/G>UZ+;5^RJSDCGU58523.\L&8^LCW_=4_>%]9'#K3^S[4N__];Z_+?W#(_
M^CA4^I $>5VVF\AOAAW:]5(SSQFF]"P0-^6='<P);T^[//[]\G0)S[UASS[U
MH?3 CYY_V\,Z9G._V-O-K?'_U>WH[V\OEYO@:N +%?F=TM=G()YB()XU3.)O
M'^2"RTQ8/B1A7ZMBV=;N7,&$V>_4^E=J+A!<O!MWRPQE[![8E;LK/!Q+Q(K2
MC,A2'?:!:%.>D$A;LN1G EMPB:-1J+9_CL-MUS7_\;QA6D3%"H)[3$58'F91
M_0O=%6UL9/)R^PY1]514_$W7U^=2>)X8IC-[B"=8&/,T??#J]6*A>([?Q"%R
M?0OF6@)A*N,8BV]R7_NYWZ5(/4AS>?SST;4+2?J\A?A#T&O$!2 2OT?3KX1E
M==95VFMUJQ5^<>CV#U66/F9=Z&?WAO>:. FT4Q8F?53Q2N]6^,>,1(@[ZC6$
M2T?S5#)>422DUV%8_MJYWVM:8_UC-1?.)U;]7(+JD&0Y6D3U)A""0)*(4UO8
M>/G"@<.,J$9ES52WO(*3Y?4DOCL_'PD*OGL>>E9_?MR85R:!)]3,8L.TVL!:
M_GBMC@&9M5U4R5@B,-'?:BQ#OSK9=.3DTF)JHA9.R5"?'0__/IIR78&'ZYEF
M69C,GL627\7GRL3&P'*:(?G6;!U>U\F<? K]Y0JL_(990\K:VF+4&=;>BW+M
M,E\$I4#'<)@=1=P-O%14HQ#]_(A..,%8NVV8K;(0MQY\9?+KSI725[JFWKL=
M0P]DKGC<*G0V*N(K?VR/@\JU5U_MEBI6Q0U2C6C0.I(4[=(P_!JY)D>@<VXC
M>D(A,?IJ0J@PK?E#0(5DG(2A$I#6^G!D>KH60.%AD&-V(19@3MC;$(?MP/KO
M0\-T\Z\Y+M1O*L<::WTGXQ;-B6*$RD0:A+3]MU5-5(ELGOQJ]WQ\$]^<Q?=D
MD_KN:?A/WG:OU$&9T J+.),$T56?B/I_NQRN#4*XN63T'!?@#QW:9?2,495D
M#O&J50MU]10CK\]RE<WZ)YX:MHO074^?(G1W%\-/DA7;46?08V,ZBG@VG[:P
MK+/RLQD1\A_6!T)")FV_#-JTYZ&J$^N\/H6KPH01ND &WC2N?MTS1YI\"H,W
M-NX4VGK8G+X=M*S3F- _NEQ^JQ"@VO^B296XJ]F,E[OEPI+/9J5_/+GX%N?)
MQLKWNO_<17'I]C0Y]F$#@;*LRU2-J70<QV2I574^S#+G_+B\*IO>VI^V>U\S
M&5+=:\G],R9-0.E.4@&ORZ/3%UZ>/O$P1YRLD$]0/.>PANO,#2]9JW^WY1\<
M'JIMZALHFS(HGG)5;J,]Q2K%0+/DX8,E2^S][=)I1G+*>_G_\L3?H\/8CG$G
M.?>/BM!#I?\#F]&HC#?:.@6DFHZK-&3*[<K+_-'N-7H](,J2_VAE+>(&"#J,
M-6R\P1!!;XY>$C]E$+$5-53-X(\#)X<)'<BQ.X&*[/:$_K>U6[+Q\1Z7H)T$
M<.:EE\P.<^]W+$^IR^;'^:89%4-=LXT=(^[WOFYI17_ V*IL3/112RF]#-+5
MX@'AAKC\I)^F"0+!'&W@&"Y01LG?V(H* M=>LUF40()*9$"2]<P^'^BK3Y1[
M7B7SB\*HR*);-IM;%E,^I3X6/;DQ40+;(PZ(,H:;&TM:FE8,-/6+D?[?+/'1
M$B/#9MHRO#5LWXY"?(&S,RX[AAA@Y"UH"V"[4-DB8CB(U]E7X;-)(UA-6MDZ
MVHD[^>N0>\4_*TO//KRTG/3J.$1VI5+[2L\*X5*N \6>VP-BZ^V'?_:L(J48
M4][\-QR?W%[N1)!J3PSOR#H8G%*MY)SK_S+;GYB[E-9;R^S2_4,$!+)@X[$,
M\/A285XU)#!YE._->RRE_P_W^C]8WAN,!,&KDW?D0M*]_VZ_!#%,T3N[W%L\
M]WO._X?6G+WE%L_#[?AWC.>B>>._6JH_G66.$<JP&,I# %P&EP!BY]_3+\&5
MQH6>VH2NGZ? U/=76K]?%O?VF_*+LLZ,]'^Q-GOV:*, >A^DZL-^;155AP8:
MWSD$\7FF>SU5!7,ZGKLHIS_5W]^[9_WPR=O&\%J"&&CBCQ<OP?+GE32WR]V0
M<&L)R7>H+).^^>+TH0\?/N[.2 XCOJSHR<'OCS>KT>Y.--KCM;$86+-X<\:]
M9I3[M>V?'=F>2;RWG_$\ X&>R:+RXG;S3_+D\SHG_>[L^<GPH]FL[GJ<=/X[
M38;]G!9YY)K+_WDU/.1&)%42R*9, %-N\V 6NQ5*UMAN><>HF:>_ 5OS;R>E
M*W*OEWV9F)8Z[W0S9?T]0_6ALVT=@MZ]!WSH+4(9]%359W_>Q_YJ-2\W#>E
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M3Y2E*H6S^@U'+N\0C9G!PI]Z(L%(YUL V@U/Y+\QO &W58P)K"2&- \ZY=E
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M7;I\IDWJ!&?6OFW+''KP!^3WOP?U9/4?V%/P.^-Z%PW<*?L.: )UBC^FS<Q
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M>P%V'"[ @NQ%V)2 V_X$%<VVOG]2G])5-"YG?_GFDP(3)0O@>]9O1B;%83V
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MO1#$3Z2XEAXZIA%$$@NMB+@W,L0:D\T=KW!?-@:%R=4_FE7O_/#RJP+ _ZB
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MXH6S8ZF=0CX7NF6(F=FGT?!G9?CW9[N7.?DK-#U0U[;YF;S&8T]$'8I9(VQ
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M$76M_5FW/32E])V6(9>8K--9A=HF5_4Z1.3ZR9\MYC$U'RL\<^H,_C 3D$]
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MPA:OX]4E%K8^16FFI<6<Z0IN!XPN5)>'8+([.E-MT_?R]8S*-L]H;]"GG-F
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M!%"*J:6CK8JLR6ELCZ7D($NHXN%V%V3!0LK/CXI>WQNVR[BP_,22[G1]8&Q
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M$_>4$ZRS/P4?E5<M3SR-NO:N7&-2V6?3[;"C*6NG(UL8"D(]YCJ!E(6)8<O
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MO,4W\@#N08?8OKG#@BF0Y!4Z1"/5=5<^;/:E4L!%)F0-6K<RTZ7%BD&1*]@
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MX((++KC@@@LNN."""RZX^)\(/O;0_P)02P,$%     @ 4(185L>?#!DJS
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M?'U_;VUJRXQ%H7^]29RHL;'$_3#NU75& -NH"?CS8U]_W]$Q*0Z3V"VRU_I
M1<&=;(E=,TLM\+ NB2.+8A*&<Z-\ Q,=;2G>&R?W:0W<A/7*M;!0 ;^8J0"O
M/K!@-VJ;!FW=)S?;L<;SNNA]MUX8SA%V+$>AIP(JH3YD243$QC8-^$&D#"J
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M8#4#-!;C# YO*$Y4]R[YE)6_%O>*L5]QL5OM<H1J4Z+.*?AS7SKAXW$:LXR
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M/^+3X0C[H)<:MCL&WN+0K(N&"EW/T ^M;C";QM6+S[+<$1! Q^9.TK??A(X
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MB:9JP2NM)Q@O,XH $ L_D51EIYQ;H@(6D"?>VD&[>'%-'_T2V!1M8(57A3%
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M,M$4V=)L,I!R\Q00FWV(&=[R_@<#[1VS>&WN3.SV08K?"KI]^-XP0'MT-"B
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MA;'-^B!*<4!"OU+::$)W9+&Q[E@>J<3'K,OB9F%U1F6AGVL%1'1CW^!90(=
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M*[.ICX[0_4=V+*> ^$_GZ%!=@%CU! G]RXH\:C]19]Y#OL\0]+@* Q,X7^U
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MZ7+9CE/:4ZUK4_2I_F26OM!?=G-R3K;-$15RR!'62N)?"AJPU94W^6K7,%K
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M%<SPS'L^9=T7S%PN]2#B3317S$^P?^_5I_SF'Q"73@J;))'#F&J].$4-$5F
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MP<=Y>*<>-7TUUZ%!U=Q7Q"$<J"6LG#2+ YZGZPFT@SO0?>/'>-_%M^DN#6^
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MNM<TM ?DLIOJS'0^]"^S%?[3KB#U'OG+2FS\3<0[BTW>(_2\^:8A'AB*/-]
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M&\D_2=Z85K=*RCKE%/9IZMT#=3?.Z/[57LFCPR#69)<4L\+S,G+5-VJ_7,?
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M!;V8*3D,DNGXQ FSG+$C+I-3NGH,C>B8BB:W>' R9FYN0=,X/U?\_Y:9_Y5
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M4K<C"-Y[-,)Q7EH#)T/\J]I_:/:_IMC3_T>:_;=B_U.O&0 7PS%/\S/Q T"
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M%*'/C)@8'U@\KF'HQU+(+I#VS6;>5.*-]77)B;&II?K48CD118W8"/E/:)<
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M4UL:;3=H%QOL.)+N!L[U;CQFDKM45[QM>C7:5?O(-H@.Z/?QIEEY=-IC4Z;
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M!R4C0_VX'/OA53$=4.I2.S +MG)XO^5GOJ7@'A5]<Y .,&^-F3OLP,;1NNB
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MGM'V"NZQC#SK<[^<0+X! =O%J0BQ4^[C5]DN.4!:BT^7F3F>%X)_#Q.X#12
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M(M):5VM"6GW'2($!'I#<!@<&KT* J:U&'R=L'N3.V!U54DS(:VN_J'LGV72
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M-=[V-3,4R%P3'T/YH>68JX[37LX:F38%W766.;AY!U@K"BP-&\"?<M2\>93
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M!VH*PA\R3R^2)*+$+U"EMI"_$V/_6'<6ZA:H)W7D%G;="%^;C[SWILM3\4L
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M9TZ#V0'#&@QR:+\=@=ZY]^A>WS.K)Q@+40Z7;M2G_IF[VNC>#C[#%$#V@47
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MZ66//^<L2X4J,>F_^%"W7>]_$7H>_(4/5M>B58D+NPL.06K 9=HT56ETTD"
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M_:C2P=J0[HDB9ZGW 2GN 8;P(M<;AE$CH/+JXNAW2@7M/=#"H\4V_"F\BX0
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M%G/129@9G4>@69%&<P-S PG7S?0V+KOUJ?+/ZK@W@97=A(T8%T!M"2JJSR[
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MG%;5RH7%HY'"AI>O %- Q%S$+C""!2@/S:<>WZNGF5*OC#\;7J]@ <*J#J-
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M:5%$<> <\I6V',J.IC@PYNVUU]F4,-8:.$+>;Q^8>+QV"74"N= K\)=UG8U
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M>2Y!K^RRF@2AW%$Y.5F?CZO<X+3ZB?I01:_4Z,T'T/I<HSIFZ$,D'AZ3Z(E
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MLP9=&8IK F+:S/@/O'[40L^K,./7OYUT070SVA[5CA9)V.#OF+TRMJE0GZA
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MWCM'-)/95[Q[.NSDU#!FD$ABG)?\CCR)A>)/,OX9K8\0G+*B6%?6]FOOK5S
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M2G-TZ!=Q\3+F:BK6?,3WBF;=76&YA.A'=(-)>\CTS8VR<V/:V!DV5DI;T.O
M+:FV7[=)# &.V[^U+>EBJU]H\:QS1CO70UV?[S6)-TWW%V]DB2M*"!+M[K]T
MXK4^V0IL&F>841!W:?6$P>B]5FY:2JF7Q,E?>1IDY]B WO1+Z>J>>V<OG\4,
MZV,]P#FOM<;7;EQI$G"UL1&^\I,K9=G0)&F@&V]NX\C^6;ND7GQUZ70$]57V
MTE]:IC&$Y+? AI2BG(EF#ZC(V$+$DW&"M!*N:GA&'OD>RUVIXAO+NDF#\,;
M%1QI%0_)HW4UK2D$/,#!8\]!S-1C3<7AS8]C5R.L*I[6/MJM&CSA)4L-8A/0
M4-; (:!.M2IQ9 MV-6,+;Q\W>])S4Z6BXFU!P.1)(WLN7= $"O=#9<W17L+H
MV?KG5' KQ3'_!M,(@.Q&4NU@R;+K5!88+/\3HL3:[P:93%H#Y1>&&G+I]C_7
MALH<;6=V<1I;RT7EQBAK:)A,7EE1DX,'W)IA0Q,G^L;@S\ Y:'3G<4ER<2+1
MV]>2 HZOAZ)X>ZH<5C+W/N785WO_W0^ZJG?_QO.BU9-DWBB,"QD[KQZKJ!U(
M1(J&J%M@AOI)L=IR!"UO+2,T)OI^7[!X'4*ZO2L9[_=:<WSU[SM#;06Q=QU2
M5Z^YA'3\(Y%CU*4FJA4.1<C(A]M](IU_7MZ-F+OHLE,VI/ZCLDDAP-9,GI1O
M+%,YFC8CL"&UOE2QNF,;[(W-"=>J&JW7/</VEC_,#'P._L=A-",S< [X5@0V
M>^&.__P@ER>'L9V]U/V,8+_+9[-.:44/&."<P!LIX01PS"& ;(68('5*7(XT
M_8HCU;6 P2)1,U\\%C!N%KX78(C*P9E!W72J3E%4:UY"PUA#0WF/E-[1N\+T
MC6,JM9-W@M$#:#2R3RNM_^W3/Q$&>FU[ N;&/W-8C@S2K[Q)!>GBG,*9F5]C
M.,BOS)^]$71XW,^>1<-(F!\YF:"^OD_)^8X540GQT;T!=1BHWIIT]NQ7*R/*
MY(!<4GLIC>\3/YN(R0GL\:Y'S.F\&*?*D66C&1%BF2*XD!=:"@[RR"R6JZ3+
M4L7Q*V<BY$==<1L^BH*>5]<7LW37:QP+C+ &DI+;9<:]I<;ALB8F>Q;@^OQL
M&R?%'.S/L:^!5VY:64L6?43F_L6%46UPE$;:&O#5[H9U?=6957$S4:IT:/5Z
M(=\7H0^M28MJ8)+;[WL?;1&^GPU+:4($V1Y?X/(>&G*&]4_(*KT;KHA.'2IT
M/.7V*K6MNN"8S.6<D4?NJ@=IU) 7AX!&-'/IH&-!B02:G5]D^.N]5HO\Z?'8
MPVAJ07BD)]GL6[?.5VNNU#BS-6GWX-&9F^@E6>$I2'!FZ:J967U-\%2^GZ=T
M\=!BVC;6'/L!6*?;0@ EY%VE[<[S1JJ1>\F+H#=[V<&Q@>+*(QU%JTTICQ[;
MO3SB?#?AVM6"!&+=(<!C<*(8WPZJ'5^/(6"CSSDP=,9V^WVF&QJ]G\A\2[+%
MX0.VW$F]O6T^,0('ECQ1]?5?H^4=C1[Y?#4\>M5[]_XU!!_XFD&;_VF%A:VL
M!* 2<U:#(:>OKW\GWP_N;6"99KL^7=DLA>:T]C%W\E9=(-V^9CX8_F)FK_G/
M/IC%":V:HG&WL^1I^BBV (5T\<8<I!T"VO6??\UER=K;U3E4;_?M%Z! <L36
MZN+]ZV\3\JPNV0@KG_H>)!'U-54G4;/<W[\V@VJ[7)U>G0G6SU\ICH:5J??5
M3Y%:FW=W\2VSE?EQ5P#_V1[__Q?F4F^L<_XI4D_?,/@0(&$+W.TZ!.SPWS[Y
MQ!%F0VXA^,IVAEUM-C\S5:11%2[N/&CI-#8>A#XV=O..[9+]+2F8W[;$Q^ R
M!9),7?K3.&+(C+F>_:F>-0A4D3]FHI0%97'2F$KGKZ"(!-Q.&B3;?;E;([]5
MB(S=X)\'G])D9CHW90D5!D-:$^ G6X+__1R!%\4\#\DQW:*+5MQ(V74%#6,J
MP3S$%?GV86='YJ^#9]C.JZBS^U#G'-86CF3+>* ;G_^5(4HYID^+*F%6&(PH
MD J (9*/YP\!H6%Q?U GG[\'7DW/HHZLMA<*F'BK4*'6_W%YVN._\[__75.S
MMYD52C6P2E*]^JOGR*V_:3O5+F#:PERNO:D#K;DC$P#*N!?\XX^O>0O4MPNR
M);>*WYT'L>*]&"XCAIEE,]X_6?N#/_T8!LW7OED['$SV;+!%GG7T_.4GN;"[
M99K:&7666'554E##5[I^R>I8=IVS:]5,U<^PKBOH+=5'90*TY@):CB5Y8W7:
M\R#CL_OS%JDX0GK,FG,5>9Y*HQ61B489(+[^BLENN$>@M)!H)OUSLCS-!M?G
MUBKD3[J1G+_I:J)H[Z8FH%TBQ+%7HKH/+'MO^^,0<)(MX2I%>&.?1N.ZL[4G
MSV^)%V_]RMJ(*;8E\?Z57X6<"L$9T5[E&Y9YA*7G5;BHSV1/WEK;T5B&1A==
MP,$/0">)22<&0\)*9+RCTU6H&61XJFWRS[TME>7\N%_[%__S OO_-U95L68#
M!WZ%5M";P^5#]CW=WUU*[OQ](CN)Q-*N!JW%'P*69;Y%,S_5Y9K;).OAZDGG
MC4H\-;WC>\\@UHK51G AF<0S5=ZR5$1'>*'Q>=2!3\5QL]?7<2IR\MGA%^KS
M=85]=Y-9%%: ;;D9_2S,)LK9@#Q3H&CZ6%7#'GLD>T';@JS4S>(\/5D2I?K!
M)3DC0^/T$&HT,XZIF1?Z*J>FM#48D@WZ^%6,-\_BX7!' Z:2+5:G;GK)O7V>
MU!4,ZVM[<,V0 $8]N)&0J>(TGK(M4#I2I&Y>^=!A>10YW3<K1E'[3."QT=I0
MW H7+1VP)GIC/VS*KR2_0C;HH-[^10]C[DM^Q3Z3"J[8ZKC)!FT$)U-^(?M4
M__/YK4GA;Y/EXP6KV.J>VE0_P1OR9?TQF<UC2@3$7\98R3+QB^OI0N4O/R0_
MY[=:,K,17L8,<7_?3[0X-Z3AN]B-3<?,.ME/LDV'@"L'5>*N^JZNKH_3'[T0
M#HMCK%WK6R5<>6$U5; \B%<6H_-D$YCU/"*T_#TPHUDW?TA?X'OXX_]L4VRH
MU\L%Z)7])%%G ^[DN;+M3$.@[%:V0C6C-G/\3]0> H(,WKYF%=H$%A/,+>.:
MC9N#MQ0_6A7GSU3OZ9K2<@\!)RK)X"C=BU!-T!M=,<8#6D41S6&A"J:'HCF:
MT@UR"C1?$*:93,R23YCM,+)V<(.?+4LF<P@RF?/)Q]?.KN8!1]]_*);M"_GX
M?*@)?66.;+4-X3@$M %!WL W^!K@ND4I3(OVF5C%^]U9FZQ64MI#-%.R?^<P
MX_5 I9HP;[,8\?.6\ "4S4_/A@0[#+'W29JS!J5]<C4,&(EY3.GNZPP[?2_9
M9^S GNTJ!ZM'A>['YRAQJR7F8JS>GVO3>P?AVV\B%#QO*C;$8P,K"OKEE0*W
M3=3"&O(+26N;A0?A/V>4Z(F->FU/><9/O-0XL&@$&R;6XJ"1R"+X,_AOQ 5M
M'8HMB_O$7):V$M%4YT7WU!RU039"=_L7VO:ZEF)0;G/#NXA;JFAV4'$PL^O6
M4!.6;2!A5>_PS@-\7'$#=GC]2>/(7V^061W]3EGBQ8'ASNK@O!=>GI;^\3E#
MT@A&=N&Y_6^07O4).7<'L7<)&9AI;((5]@3"UAM5LNRBG+_I=A=B^ZA@6T70
M^H)[HFVMT!'P_#!6%^L#6@<G@,A6R:=@JK1>E-,RZ.1?\ON#C%ROR;25,9&Q
M8K'7,A_X,O0!;V1G,7>HO\:T15W8<_R.B22@DK6]Y\$G:&!B=^:ID<# %-M[
M;Q7]I:X]?.[6 ";]C8M30TKZ_#13TM\04,-#=<)5O2U=R]61M1#<<W\;4G$>
MNGY]<-RL[Z./$WYF6AW84<6WD>$4+W65.6)4%#/B?@FKP5*&N9,/ 9V' )J"
MTLM%,BJA:K.R"L[OU:?*RKK9&/WS-O?5'*L-=^M_OO9VP>ATW>)<NC;#A :N
M"(D[&"0J,62<)2.406(T]:X;AP"OM44WU^NK#K 2A;/'7Y^'?2LQ.>/#MZ8@
MA-+^E-G??3 5+E_WHT* RZ>(&I>V\]<2\0)GNA=DN-K3!IE$M@.!C.!YWS,A
M+U9#=\$QXQWFH\-&U"OW;DD^9EV/'/%S3KA@'U>94JMD;7N"/7E5&I/,06!%
MTC5"T-3)4=T+*]0&['G&N<SK(2;#6M'A/Q2RI93K_/@SCZ4U<QRW#O^ X27[
MSF6NKU$DY[#)]8GA\X,)]4Q%<3>!\:>81@H@!^B3M#F=%I6L,,+SK8!;P/X!
M>LH*M?: ZHFX@L8</$-!D_G *2-0CZ:,E2(M]>"ANAU2\U?Z62? HI$M6OER
M&V/E17,#*3G8J;F;U%<%OS=(UUB&U*EWXZ>RUSHG8V(7D]N5I5F9[M *4U]?
MSX"&SV_:K.9#KER?BOM;Q1"5?8EUY9W@GR]"OV78^U'4.V=EOPSOFCF3;#,>
MAWO*UZCP7- R.7$?T'55G121N[-(=0ZBCEMLA*N0%LJ;?_?P7<990ITAT 7$
MT[3,V;P\N .RQC4]:#-D!'UKX#P:I^*JU^8QVL(-0%QA^#$_SU' &\?H$ 8B
MOB>;]$H%.GC<*9:A#0,3*Y@B8%Z'4VUQF]V7=8TY0==EI?+DX4L$Q%N$)VIR
MG/J8C$AJ_<=KO(8MCL^@\L=VD;S3_2XRS6YBK^J3Q$^_K55*(!NM6<2TV+6;
MFH='#)Q+W:]V5/5I<NX7'2LL^^D%-IIEE75Y_MVO"]XU66;Z>/+Y-1G9!IL-
M7Y[964*VOT^W?/VCZH\@ /F)!$E#-&"_:X$XX4-Y5^/ZG,GX9,R-.2"WP]04
M[88S174@N8+V0#B?N/CSQ6TS^2.YOXP5VE#Y"%=3MC[&UMUB?M2]Y.5\B6*3
M,[\6(?*4G)=6O5JI5'^J34[23%CC8R+F.D>"R'"JM9!*4--N[6(MVF8_S,GA
MH/F&)B5@)Z+5ML[1V69Q-6/*OC@"K7_>ZG^4(/]?9CFUDBD$626DQ)0Z7Q8Q
M6W<-J6#IZSBR,.Z'@"%O2$)V"2-*$;O&!O!E ZPGS);0XKS4H4ZQ7ZD*5>VJ
M^Y(?VBOTZ\>MA=;Z_=H*-MPJZ:KUZ'3U,"Y1KR9*7N.LN+7QVGB9)\P^T,@P
M)ZL081TAZK^.EH_6<;.+M5@*V ]=$)Z=WJN?;*E&K<*V]8.19[&NI%@D%Z9[
M' :LMF\[.[UW=*+P)>]>CT!;Y"%@55)@W< B%>,TN*XMH<437[+Q/%WR@0YQ
M)',VAVL5SL_PI*BW\9ZM+B+D.LR#/_ M&H@&W'C%4,P]5>T0]R+.ZU>EVYGH
M*PE?:*5R[28#RL;%&-P0L@A8$\PXSW^;1O7><0I]_%O;JL.K&\(4V<>NY$@D
MLGH9\LNOKT$I!G(.G#9&$P6I:J>32J#_B)_228SHIW/ \0]",E;[VB0TOD$:
ME&/K9FP,>O+"]>5 7<LS![:)<=^WZ#O4=80H#3VG/B(W>)/P#6WL-)"Q*5_Y
M>;0K,+[9L:)*:.+\?0.<?FC)UK?_O 7^KQU)@T@Q_GT9Y3L-1(!T53FVP?EH
M"(K\O& ](4L0=!;(X8GWC+PKY7[N1XC4&2-G_8AGJ\,&/Q,7FN6X\#,ZB7 O
M]GI(@3R1 'BG0W W;PQ(6-NB *9#BWH\[VUH@TES^N @[CP6C#^>8O1GVV":
MS+EF*>ZE@8;J]XW.R(=);6Y4CZT^RT]7#'?:EE[.3L/.ICHI[BXCIX$U)1O>
M<\E32H1[SM?(!H7C(HB/8^CG3K(I_B4/_^GH4%;CNJ;M/]8B_R)RK^#XSHEH
MQY4UFBTQ)J'*M_42O .(!G4I<4VLVH#.P$*)IJ9(GE +'>QDZ@4+MV^)!J=N
MA_Y8<Z93(N>3H^&RK&G$EQ9T-,S"M4JU.NVY[X/VO7Z[WJ_WCS>;*YN@>09/
M-BP\L/"T;W6LKLA&:FT/%6-U+/6NB&$&LU?"S<+I6G!%ZD9@$<YPY9VKY%O)
M9SL=D<BQU[>K[=.M J^VW6*8P;T0;=Q8MWXMHFQT/2K.@=I"3 3;D$N25=?$
M3WY?357,+4%][)-4N3DE><VG"G=,8 ;1=G\W'"'(FCP$'&5)P&Z/^S+4R8:=
M0\[]E<8":W937IFE!;WH;UE^]6$$XPME'\5<S9&3N2T"Q 5L_D9%S;:,A46N
M%;7X;]W,5E_ZRMI2?G.8)$E@_^7DS^\[5^X<H_VN1.76&-##-I[_.2!BE5@*
M#+TA^!&VU^IDD'0-QFW*8"Q;M)]>;6C(5%R3'D5'/4X?>:B8&_#"S3KAJQ0_
M6N#DJ_P0#JH?LQSKELG,A;F60@]ZDHNYB4Q=<;_=R_6.,I$!:%L38\Y+K4:R
M8D-F<KW2M7ZF+0L23R=9CA$5K54>60)I)9S&F^^1Z05-V&U$T P*6K +#/.C
M_PG5 &*<P27.K2.NP0(S%UQ7/[<]WA6'4G1!+R?9+.$1[V0D47^VGHBD&6.X
MY_L-YCMJ.BK-Q#39@H>UI='6O3AXDXIR0T2GL 9!]9#UR'E>WK79R[Y\,"M<
M47Q7IOID9::DTTE<B'*%>.-QRJL>@=R;_@;*84YWV.14;P"4!FY(A+BV>(FE
M?K3$RI>V1*290,(\JP]*O/&K-CL:S'60.GA6"63N,5WX3D)-?H3C.&HD"-5>
MP1O9X,WF)*&T+,K;0)) USSV!.SNB-"MEF2[+)=AM56NF+YDK= S_GF%O"8'
MEHXT1][U'C8?Y6?F'0((9T<QIM3D! FN$3>*7<O(0C-K.NOJ7F&"\'R(VZI.
MA;UEJBT"1X6/PD5T!YO$R)O*GCH?L5O&I7W;9L&C6L!2K?$+VY>FF*1KWHSM
MN#N7+K/SK;C_I82(4%3G%"D)+A[).G4D@A!$L6ZBM<#\%)H]N_>C/R6H2C_A
M6@H1U=.FQ.U!.%D#81P;_[[HJD2;(&"%G:%[$L!Z6F#^]"' ?=+KQ=0=*;S;
M$=='):DM+?ME91+.;@VV]'15T!A>J3E;B; T?!"FK@NF@5X=<%."YQ5([:1S
M(:;@6K)O+,P:&*=ZQ%5G]L/0ON85%UT8/>E>1.O#[,_D3&HUV;U[,!YQ5IO_
M$]Y4K9$\0-7B\78#7U%)'W^Q_RS$+VF^"/Z (41AU<\C)TA4G1B[L7H%4SJ(
M.%"4;WAUW/QIZIA00)+ZLP4RQC^;A'7%_DDF(#K!4[;4(1JL82S;O,X'#R;_
M@GB';"H,0X/=0\:#[#A/26W'O8A_G8-/-ZLFI5MZ(O[2PYJ74P+>N^4RI\*U
MJ ]Q'T6W:;"F4&1E5'H8!IJ7]5P]0@?!=4P^8LS@$! 8Z;*%ZD7^,24JUM,#
M& $T;C+^8::%+\UMBGLJ6?AJU._!TEMLI]7/^F^[VJF=";.=!7Y1ZAB, IW1
M%:=E3!& ;V4HNO&A1-'F%I-05<'6+:69WNR+G;G-CHDMY0MF"I9-P7[02JM&
M*\S[>B@\=R?1MEF:))/FE&-6#Z^R#YO9^(G;\[J<7_/_*&<_O?N4\8^U@;$L
M@(N3J^@_6H3M',5LW\/M\DZ&=UHZ3)HI)'?TZX(5-S>5;9Q>Z&MW75B]Q!']
M>/Q3X4RB',X_Z.X6X^Y8JXS7MB>(=WV#I!V]M5G?A_DW("0(UW]5ZW!(U(^$
M.%(?##UI27Y ,1L=3PB,TL+,W%J<Y3\$W", K\QOHXS(>S'/8'(%CBL'WI5J
M-C:EYRX_<2I_&6[],_)WB?FU/W$#W>*:)^)FA0F)!D<-/EOQ?BKSR(^\]?F]
M)B%:;Y7G_'V.8Q0PU94,Z:)!Z([Z:+KC:86%;UL^_,MK@TL065@(,XIA3,Z3
M"U3@6:"HO96P;R]64H@IL]C[OBMV,#ZSPY?B%*(="%-I+/TYZP0LU_XX)=GF
M9M62H9R=Z3X:IC.^,,WXG&2='BPWN%-B^P=2?PA8=Q**^Z>)8OM&(15OEW@/
MG<%7?8X1>/530-K^>$^<N;V]O3BGC8VPJV2IY%>! T7+CY;=[5-F/ECKA7W@
MH+9]N^J65[GQ]H/,#J4A*B)R951:\CFJ .N2G%PEV4/@<9L/9AYS?[=-X@/U
M;:$^>IF:]M;1OU4K_/7P49@V%BUKLQ&+=,J*/BE<KOB>!:[=#-F7\'.\VM7#
M;^J=O=F$VEH?'(J33Z!Q4TQ \9 SWJHG7>D!DC\P>J-/Q2FL<4AWLR:CNO["
M@YP2G;&8G6(A 3"_@>IR<[>QZC;7Y?Q:S?\X DX8NG/-(L/56MQ4_!-<Y<@2
M]MPAX"DB"G*!X>1.Y!6":9!]W];WZT0Z0E8UG_H_O&UX6SAAW);H&S/)FP@3
M!<4$)@J9CC! @;P3"S@?A=&-I\G%[;G7'9!>D4#*KN<A (%C>,Y%BYWM^,IQ
M<<BUKQ>'OMV(5%=W7LJEF5+OT"SG1%MTY^_0_ D\,O/&==GM XY..B[AT-!H
MZ;?@^TD:DBT!AP >N!#-=VXP4D'[)D&<VY0\'K/.+>JM!7YSQ_?DXM4IJ^?*
MG6F;T*"X:G<F#+\XM=_Z]R.J"_4JCYNV1]@=QO@1S#BZLI_Y+DJWEGG4YJN7
M#DJ2RX!SJ$A7FM?L:5^N906"4,SZ1D%$(KR3+<0#>G ". N+GY7S0Z2E5=L;
M31$-6SO:AX#O^)J8]G^[PG9GEH;X$O;>[.C<N=.0.@ANK/UBMU ;#=Y-^;Q>
M-1U<3'.AFM <YY"QM2%80UHP05RIZ\97]U'OG5W35+!E\U?=3[:?[PM?V[>W
M"RO[4;X8C(5LXTFK8-, #3IX8NU[$%#0C;(NP4->UU5K0D.-ZSMKK5NS!0$J
MS]C2LQ!P2M6P#5*#[."-/@2<5<38$PX!,:U\0S"S,%-PN8-GK_BO-[M:S?P;
M<:32Z1N)?<VXYS\8FL-)&6@SH=2-Y9MJ)#BVN$>VA'&"K)L63HR/AW NJ^U)
MJ E33J=,OIS\,X5F7CP$ /MZ=,IS>]9[R8ND-@D@^5?K2?*O/'%R;KO3<A/4
M/M*[Z%Z,G)0<XW1AZJEJ8IQ@3@":98J>P:'U5",8AP!Q%JOEX*,Z6RA/Q!.P
MW7@^NS6)ZV1@% Q<X9D@,K9M\<6^^&72!Q>FOP,:=!(C&3H_(]_U@.:NCSBW
MK%;E4KSJ]H<[ASN(/F2 ;X_Y;6L\EI!,4HQ05@9Q21;/8J\WJF-+^KZVPVR8
MF;HBC*#19R1VC(&X0XKIX(M3TUYJ\BI?75*BUWI:O9BD[[['5G65V:H]MH2<
M'/-W'"/+%WEWA">;66"<D'#^%?8EWQ];>WT^G"\$B; P=6+J.OTORS'K5)!G
M^LO%\:M$%H6T4Y$G1AZ?/#K]D#>S_#-+R=_I4F+!L9=7'#5+"22244$)+6CL
M^VG#1=!>3C;FY.7\PO6$!S;_/K)U?^*)_>^*\J:\S]%Z*%':!OT$3(VV?WIK
M541,Q*?BLI279EBL[,R?!HUG82)4KRL%-_5G%7N*TI<T& U-G0N[1>;02D=(
M!-H9?&<+0JUFTW6_D$&JMY!(43;Z+49>]*GS5 ]]S?404#R4A"3Q9K0&<US"
MAI>\UBIUN&GQ-.F6=4KTPJ-P/@@20KY_"*#)K-+"9K=[(+S/_-R%/7>=+@D<
M JQN*JA(XIJ5? I:PH7O=61M6=,'UWRY&8'VB7:N#^]XC*:_]U*0E!TR\[Z@
MFVBO7F"*:A^15]:LJ967^^&J<25"[[-CV&M-"7V!-2".8QG+X.^@8GP3=04/
M 6]L.X6X8&;YG<?/?5VZ__(Y+WWMNR[&%J=*PY&7B">+R*@>3??8@"P'4:9B
M8+:VA-B9\H@/3^&J!POD&&)$3+=O]*3AV[HQH/OH(WN3X+<'RL "=W)7B,8Z
MJ#93)<B=#$[.$^WXYY>-=V;WGV=W@DT]K&:*)HR=+9QT_M89K5S.CR. D+?_
M<SF_*<7C:[ =P$DNU@")[0&&))%>Q08ZL_*57C\IJ8 ."6B+[+'4\V%I+^7^
M*YQYK,$['D!=;F+X\M%O_CVL_+J#7Q>,7"\Q%UQ5N&?7W?^A>SJH6JD-^Q7;
M#HX)=M#ICB2/MS7I],0LI:Z99N#,[?#@C%MW,.[E&<<C=U%&-K87;&PL?Y>=
MYB5>+D"I6P0LK#"5?BS!+S#^(:/:O+GF3<F(F(#DTROHX!?X06B)8^R3#*)E
MEO3%P"#MM-E<BA(!%,52"7%PXNV6$!]BF!7\>D$-2_^2=R[B>1BP*."\A5(X
M<:1(!JD\O83A):>U8T]CSK>*DDG1.TZ\'>71UXLG)BN#NL#'SR_[D^SP7(<
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M!EFS/= .C=B'MJ%/V;@T&C>V>[B]OM3=IQ@8H/U+"^\@NWN9/Z(#IK*1;J4
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M6SZV$>@'Z0+7IK/XT>THGD/ "UN* $*Y961#2\__6W?N77F6YJM-E^3TN^1
MSYZ/X^).%^^J?CYFE] ZP)!1B ))LB=:A!G(::6Q,BWEKRXR16N$B'SJIK&&
M,?*YTY;6S.V[W\.>Z%P\=WG^R7""4D/ V(Q?4.;V@^DZRY9:28'+OBWX0\"O
M%(_5R;I?TU-(5@Y6G-C-XJN:I71Z16D$1FRCS[LE3JU99-K+;S+UZZN&_5T-
MJ+93]W-D#%N[AGP)WQ&PHP"U98#SK. 9>+TQY;Z0#C&Q-PQ3QT(7 4B<JW;M
M@NRM.)/.Z?H3U+L2WM;]=A6+H9E[<K_C9![8%?D;+5*\6@8V0A/R73#)X)<S
MC"/6>L,*8EZ'FW9G*[$)0SM]P995'O(]=QLSYN@+0<]<3]EO=?$5R;]^;1PR
M\P-(4&T#5E/>7L=CA;_9.4S8_*W)&H%8)EE/6?<W.Z8) N#C+T1N+>MYW/")
MS0<NS.SO89H%H7KR3"1XGKT8>&2^7_ZO*9K'*9'D%GS)O3RGQQO@\ #_'H:\
M-B$V[F"$[3_R^.?VK9*_]69Z9UOYJEYQ2F2/2MV%=#:2*1VFDTWT*)I79+6I
M@)O8/U2!-R\O^?QZ>ML[1%4[-(CS[0^.Z5HM7:8[PH0Q05.T'D1R,52ZK880
MJJ\\-G:,'WB?#;PH<S75Z-G=GU<"2<I+AX#O4E$LUV?,0/B:\=C-FUAY0H<<
MJL2E?&'KVJSLC^ZD.QU+!<(K]M7+OR^D9&&\UG1W00)$D0##U]TO4P^2.H9S
M"D_]?O1Y9=K,XW=:^9U7R+44/R];E0 TEY8AC9,..BA&@*FD3H?K6%K=.Y9G
MN5+F9(NG7,$CDZ&08['GU?;"BD#*\('NF9I(LFT)0H[J]5Y>2YB(.=6&*5M5
M^6MG+ X(D*'LON8HY%1>A%9#8D'7X+MLKGM7J=F9KG-ENC^BSJ6[B'1[/6NY
MW;#HV+6.0X(H^3I46"?T HOC2"4RW].[A$+1[_P5A!62BR9S@\8RDDH12IYJ
M,REV%X;1-I,3!\T*/<C,_6"D%*$]<N]+U<H-H-U^<HF7+R-]\8EV7!U=P]=G
M<VL-YA9HO@H\CYO-1@LCI)S+X#V/:/CVF<M3Y9^[6)[UE9^B'CT.V/L4_$K?
M=ZCE+R8,-5L@-!#C#R8L$1<3\@G6C&A-/5NRK-Z]P%^OA"47NC5]HG665=#!
M&WZ42=NY[A\*(BZU*"&$0.$*@3-*_F2U1D&FVD>;G]U<0$^(R":/FN!.:;%9
M"DE0UAXCAS3HHDF=(OFN5RGT28<(1)<\,/_L*&V1]6_>GITK$SML9FS8"7N1
M2G >5[)X]LGSJK6X$WS^6&H8,6S9=;0->9%_[RCF3THQ7'!G#P$PW 6#\T_J
MQMX%E]XO"=>YTLK!/E&*$CJ 8_J!##F#2/.>N>YW_GIQED8'&O<%F=_C-CF)
MN)UR5FU F>?2QHS!Y]]6R!O[E<&6A6HU2\+&J)6;C-IH:<Q7<&/"OXP+3'-X
M#SUP9,R8PSR@XN642I;/P[2J8!:N+;3[ 7. [GT4>F$,51(FN7#F?HLPC>,U
M=]EPV%GR(>#A7ZKON!ALZUK\0:OH*;5K#;!9(L0>[;LYK46-N3H7U5A#7"_9
M+CF1@B,O5./+FS/ [IHH\34]I#.R'TA]-' 9P7-K93\7'*VE+2:PCE=@,H_\
M68%/",J/!H6SSAP48D69NJX.@9$[$LSGY2^_UU_3_&B*2F>\WA&!Q$#/:-B2
M_[)OD 9.;6T())=$1=9\'2KE/5IM71H5V1C@OLTEG=,PT/,F6C8LDU["@'K0
M@.SS*R!QN)R6[>(>A[Z'I4+M'OKOYE;6])2+3<N3>C^<;DM./2YJIAK5/O-.
M[%K5( M"0G,QO*Q&(MS7_>7T-4-B/E-5<D4^9\N&';Q'><B!Z66,9P5N-GG9
MP#]8LQ+34'KH.<+V+R7ZV/!'[+;EWB?3WX8BQT=TIW$*IFML8(5Y3&P0VJ^%
M6;/G&9+*_QL&%67Q$)LU[;$C"$=BB;#IF5ZYG4^%N#CQH7SQ:^KOP>(7QK<>
M(U29CQ!*M/0WG@CC/(0.%9E/G%1/(I L:D>OA5A)!G!%43[+*IX':!M^A=6E
MD^IF_JA;3Y;>[EKO$;D_Y+/^C1^]:B!%^_HU;A[B,N<JSHS_>4;JSPXPW =X
MY/Q=T)&'  &L[C=7$"^M.QQA7.(*I3&="U9O_S6%]8/\+1('^$\FD+6I> O&
M!S9W+2-LEID@H-^E,I@[>@VV\&P4@5T"C?@;^H]GD[=G>D8VI,NE.G'5N/8$
M &-CLHU 2<"*YS(RJ,6M^0YNWIV!,IY\IW[UF[J!KK*'P=SL"P[VMHRJ[ND+
MU*G.J+CRYR,U:N3I8U>NWVF-O_OT' ]"2!6BY]-$Z/;0>Y5V9*2DVH5Q0JYL
MX<@YX%LGVC^8BWV.!04E%QJQ^H*6<8II)WQNC^73ELBRU"4B-*:4!9Y#B<&-
MV@GTKW7KA("O108G>YGQ_XPX)B=W:FKFS^@M'M%OY%[@MJ:;;"3C+=.8I<(P
M]/7EB<:BB#S<?2\KM#N"XPM%N+E^GX[]+G5%[<3;&?XE8(TJB\^9.+/>Q-/>
M@-FA\,S8L.Z-D&IJZX4^NXJHQ)Y6G1CHX_I\O#TV\8%&=;IETDZ(PAK^>8-]
MYGKFGF0 F[)F,;/\[>E(F>?V#O;-ZNG2%['&HK_K;VN]>*'FF7E_"93:P9"E
M%S(<:5(.(TJ8<ZQ_J9X-12OW-QT($VZ)QLK%A3/.CWR.[V[GEKV?LG</3($<
M6? *'(N/"SPI3J)TV//>2_]1"==M#?2QLC%R+6[NJOJFY?[E[\?(C<ZJ%^%/
M?>YC"F0F-KOL)9(=$IZF);U:S4+_]\3Y]?_5_L>.0=;1U0/M36G,)+UOM@F[
ML>KE_?70N$#Q]L;TMUKW9E;]M(.!:H>  '5<0/=FOER<2Y.QV(X>8$-0=/F;
M]JUB,9F(+E)[8$^QGLA^4!A[4"2FP?KV3_$5R&IY3;Y!N<NNI:]S3^/['/?@
M6YV/[?,RK^5X<DN&:JPC QENJZ*<'1F%T:6(ZXUUK^=P*L,V4X49%5_5S9H8
M5ARMF/H6P%^XZF.JA"K[3%5%U? &VU6\+E9<?!="J0_!]_W7G-B;>8U!L:!*
MQ96.;;4);9<._L6&Y-[XZR56K*]Z[LOH "\<9G,0@W %QFA)B:^)'1L3M('S
M[Y:Z_7UM2MJLFX61%35@ LSZ)A4,)RH 5L7>! L32W5_)W>8:/V6*ZY8>.#W
M8J93V&T%)U=G;XJ! ;L=3@RQ)>#/U^Z/R9FO_EX)J/R^8/K28B+2\1%"F9&:
MQX)0LUHJ<O_*=9;]F$>)&$]9!5RK]9=[P"W6!BLI,C\3XG?'4/SS#>E58X27
MW -_N>(DE-( ?N_;<VE?5VG#X (T$0847Z[+6%H_39-;I^2&&OUHG)],6[!8
MU/TC0O<7-?#^B2G%:L\)@_F7:PD1:&_1T2S"Z6NIYYZ$8=)1;E#"#120$:[%
M2XRQ%^ZT039Y7E2)W:N4Z" MB&]\7\N@*TS($M/*J.FS-1')9>?KV@RON^A2
MK#A4[BWM,?'-&19+[;J\#H/%^Z@[&WC]6N=V:I>D62_,J?[24D0<(2#@77ES
MIUQ>UD9C[O"1>O:&MSD6@0R948+!; +7W4GLKQU!KD/ #\=?F \&#_:-V%S/
MYE)QM-T(OR<W9I[5)-$? AO[ P"H8QE[M;A[1!M/-0.I,=/-^^Q0FM'YPDS]
M#.8M0]8D*EE'C\_Y<Z V@ )]B'3C!WW*GX(%T@@3DWV!_K<)B?^&?TKX _G&
MNG:0I*5#$_B-'0ET"39Z2DE%H:0/ 4[@HKF6SPP8->0NPZPPRB]3PC"J(_T.
M8MAHQVM9MK57[2U/Y.Y5BE'E1#!N$S1Y==;=$S0*0VZ@ YNVH265.UH&LY1U
M4V^M[VX.-^I#],Q%;Y:A+P;']6N$G@R5A'G6!@RVBU'D)4\UJ*N)^+@]'(3R
MQ/?*/E_JL]Z7CSK(E/I)_>2DX!P>AVD*KEL]!.A]L>3IA*G7 ,,=I.OJH@W+
MY95"ZG/B_EE,) @<N[MA>.68[0C'6P</-[=\=8M0"VC0AD71+V7EP<)=8/:1
M(0?_. 3P+Z/.'P(</^UXG5JS_,Z M.WWVI1,C=\I3]3,"8*I$)EUGMZ?>6V#
M%5H3+K92>>DC-2#>T:.4VIE![FW\%SHQ;U2J[_'LV)?+O=%6YT\-7,%/+5IZ
M3+S<:]P:2U"NQ"DBFM57;)]+DAW5<#6"W8< CHQ,U/6R9;YB-1-%J%/K(6#V
M=/[N7U;_01I(V90IBYQHN8FV8?B2%,Z?8HLQW/HWC'GOAQSH&GV2P^_>N?OE
M)X?(F[L_Q#.2V>=GHJ%<[ L*,5>IIE%*VIQ'U[ZX1)-DHPM<8HIA;+[A3\<[
M)2Z-:UY/#'.^H7J=8L/<:D-S:&G.8F+9THRPPO80@?<L1R\O6+$)_N&@D0AP
ME=X]>&I PK^\T]DOM/6CZC>MT0>YR?2$.99<?P$^NTAV)6?+8^G$EP:!]L*R
M4?!+=!IY?[(@<AX2A7*F1$'Y07((&^P@ZRK-RZ(&7TWFM1M:I,6:+L+CM4$+
M>=E]$Z_/*\KL747P5D,F4>=P+D840@(I/G[?M%4;IC.T;2Q$A<)C.AL?9]@O
MIBLE>AC92CJ)N3A^Z-N]R\&_/6EWOSW=MS](>T4BV[!EJ\JQP,1-Z17=RP-)
M;_#:M3599:I$IV0FHR%>#;:L[!:D(>;H%LTF)A3#(72GS%;";@3"B-@':PO>
MR*LS*EX9LNGTD\2F_0L7?7WQJR6GS[ROG6D$PKF4W88&MJ@H1+4(,DC=EU"\
MRL_*7(+K(JLC1L;(W)5Z=,TW7SX&5&9#S[S-8+HNNGHW?*JEWO&-%J]/NKK9
M)!]Z3KI(2ET=5.&-=-VL6RFU6)M\?"$)8LFTZ_DUA<LFHUK!6B N=@]2B_&D
ME/W;;'5:%!=O#.YLI#<43Q(ZG.NH(P+O>OCN-+*^\=V"/GQS,I3SB&25&'IS
M"M'H$TIG!KA=N>=@F)/PG/:.=(V+W[E+)R>K!*\^@CNW>W(%IV)R3\1R(/JV
M_)?*E%2&$SO5C9O4ED<:THM=,8\;(-]D0O!I=3$Q6TW)R/1%9 :0F_4ONN,(
M)A,(FJV-W>%L(*.G50,<YF?LI,QMT4&P<+TS;1P(6]!S$E+CON:Y\-%)#WZP
MB"$E\+&[P/^T<!-8XHQ4GO<@(!QCB#IO_W?EHL$S#^[J=2$K)W'WU2F?=[,^
ML!TAP_E,2I/JR.)GSSQQL1<?1?\AZ:E+/Y#7E-&WW"!)*6\VN4V5C9%3)98X
M!28Z0;_-%I"8,N:>"P)W"#BQR8"@9J'OH=5B)27PX#7#!AIG0GYV_^K&<$\(
MT^R$CH/*L[2$@/4+7;YV4!;?P*Q)0QDKZ*C\WYAA7WH\+4BMJ=G(+.$Y;H<-
M'HW,YNW)EKCKH/?[PVJN6F=H3O] 7,?G5W>"S?/B>#TMG4!?YJIJ4I5:VJ*A
M]/4@,#]*?UN6X. OP9Y,1JFB6MDVZ'20\D'FS@ O^P@:^+1TB9C3K&<CUVF0
M*#]I,KISE]<!EM%AB9<>>#76^_7KOR=B$Y,$I&(A-<@A7%5D+$B9/086*?4+
M!3^JJ*-!VF*,I8Q'LWE%/^_"O!4_GFA6O?#:X)%8RU_%G]  ^M1:MJMJA7V#
M9C!)V:+ZZ_I^R,R>$A]8,K0,F79JU#LI8TJ)O5*$^:6@N[74U2).DR);4V6)
M7JWVP-E#0!P6.(<ZYY:AZ]:8G9^7:2S;_NLYI"]C>OEU\B7"O:A?$LK!4!;O
M46@4E,P.3 R3\ILI$9[;H8&=8C=H9_^$5@[_1#\RM-0+;WV6IO^S=:4O-!A_
M4</#.0!Z#UY0587^]+Z;XWKT##9.3VY5!CIFEPX[! !L@I--[*(OQ/_QAK&G
M+ Q!AP!A_*^@F2V>5K8(MND@MH5K@A%#1'49*YHQ''W]"V9@2+&:ADJ:0,2&
MX<^,L?,-C;4?1&X_TOF!*3A:V"<?.'M-ES;:'7,5+T%=Z"HM(Y89=-C<6PEF
MY_.D?9W>/'_LI_OK7M7SZI@BT.AU\O2+S$C AI:%@WYJG:(BT-S7)D1_01U<
M@VJNGF2.99OT,Y-EU;IDU]D/Z-#X9HUEE6CITA__"\\(5*/G^\]64X<AXD2C
M!'%KTWT7+KR]A=R [MF#'Z6'@$M3!"N&K5D&>U536*GVP\ K<LTSX\*;INZ6
MX0C,46RZT>S'4IG@Y7VM0'.K<4:Z76W%B#Q_;7B=U-()NNC1KU%^7+359]"P
MHR65U*/:?VO/W:F'+)&Z6SE5W5B=7+G:;\$^+4B[J!+9G7VAICICR[AFS'FD
MK"8E=D]55MR#8$@)/Q%J')30 9Z\-O #2C7GMN@DX,)W!L_%/-^7;$Z1KIBR
MNY,M^90A;-JKSV-<LT-I0\4"3[*Y&9S&5'8DR91CPLJ56NI6L?I!?I/SYHSJ
M31-#J3$L)YLK<@X: >9CGT&UZ7QAE+0+9-_Y\]*@!G9F.:^Q/FI>R\K<4)2G
M5GNM\7-*B:ITDY'NKCRP]]9>@N!SM^>5JQ6Y<0D5BXB5[HQ?_9:&\B'R,-ND
MC6XP\QA[Z%*+PD$#PM\[GX&R%((F1/>*/;YH5* $2UY,_<EELG$(F"I$M1J"
M7<Z@SB+Q,SP0LT%_O6$$S]66(.(QB9&SF896'VGA!(W](Y(:1W?A3B&/(8[_
M67>D%;XMVX%-^C>-+":;ATFE!0I'(6I]&LXDN&72>VEU_^WAG3E6TZ="ZLKF
MKA\I\\A>,_ZD+.T =[YK'?"L*JWK;V"?2,_DED^3!\/F$/ *5_.]@A0>8^T/
M+>D"0A9W*9Y01W( VUAN<AIW>\L?32YTI@FSN8!$+R$7-C]^@" G/BCOMS?H
ML,!Q2<SMA-3KR[S9K27CJ-GOJ//L;NI:&_M\1A>\M.; 7*;<_Z7N_'B>\PGG
M*F)/Z*6& 89D7112B*7$,%9]CS6:PYPAP'OLZI_)X'#1FIDN?(#W$5<PB&P6
M9!!W$:G,$F14S);IZN"U7&=#R&#S\*^)$J-7/!I$;NW5/QL!FNGIYUK[=!(T
M^#L^KH.L.QGJ3S=7*W-?/\C":_HL-.<+%^8)>ZHRUC%?E]'G\JO2?V@HT$/G
M@^.BQ]L^V.M/IOD_!MP",<J*]\#LTS)S)3$#[\2D_ALKG8<;8BF4#[@6V%V:
MQGC5D[FFNOB #/[09W;*7W^I\E+9"K^<4I;48EO,%^>3=\M@A<4>?A[*_H/A
MR,!#0*M[#7]FM\/)&B#RC%&D9XBB/#@5&059,&7QH[N]&3AZ57UE';HW1F>8
M6.7'&;6PEX43N8.WM+^T)C5^(+5\$):*E"]\XF'"F[Q7;MIOT%MMIA=ZX6"1
M[W%:@*\;Q'MRLEVNLZ/WHEJN>?_\-N!<04O!029N]J/-;@(BSJ+[HA%Q2K+%
MJ=+$RUGL$+#5"T1]M'P"NY>!G=C2,NL2-.!YUE*3:?D8KX?-7[A<9KL]Z.^R
MA_L!/><_$ZW!"H9&;C>56>[K=KPJN,>L6,[]B_\+K*QC\8+ D<'Y">^UGA4;
MRU=X6KK<=)>\W>TYA0P4:1![&[UO1 QLX^%F7:9N!SM';&=ZJ$SI"Z;ZWNP>
MG2D16I'M[G#,!P=HB#,F.X!Y8JZ?]>$B&0H\]R#&RZN&0<TY:)>U@]F<:-G7
M[( KH_*$]@>-]?&"\A)O!!*?)U!^WTOB#QW0@<:@!-D*#.=.:.4Z)#CT$/ 6
M(5EDQ>CB-K6@1J1_T9ZNRW<?>?Q+CKS]MB^2*[_G;=V)<Q$XMZTGJ._;AX [
M!NR^8=6!CC*Z6IT1FS:YA52RV'4KSFJ LCDD%;IZ0LORXQS-I'W X$[EW;7<
M YX!S#&6.4.76D5:ZI8!:1H4&)?"QU;E=-O3&\L^-=@'ZH4XG==]/JY^-8;[
M?;\5)!5Q#%O#X#@JT>L,3>8]EWW[35N$)$V^0(&<--4RM"_92Q%NLQ!NL;RM
MPF.<NM_@G6?M<+EW3 .Q*';M#J%K\2J[7V>2\1C]O(ZIJ4N'0:\V=LYCTI E
ML<@4?=J8AE).>A[4@5Q26$O>$5!R2(88U[*]72=K,/[-I6FU8"5$B"BZ%34!
M(<8WD.S/Z*BB+[$\P#'^Z//P:'6@$76[2KSZHIW^:PK(O*L8L_GF+SZ,!:&)
MQ<Q] KMZB&+U"N$9PYV6+8+U->FF?[H2G(KOU?U,JL%*'_\94\\AO5!%AM9
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M2:ITA3#R^K6*R!]B5RL&1R6S_S[ JX)".#]9)_RNGPS7VGHXA%1'Z#)VOR+
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M?*3DD*Y DU86K!P D/6.!:=!4^ Z"]?QR-S$F,#Q S%R<5NM'67FW+7;Q 6
M>Z$VG0&X?U"T\JKB!Q.8Q[_N<P$>K,<8'D?'46="4Z/DTU9!R0]36KI@*Z?R
MJG\[#+'LBZ&>VG:M'0[2'2_SFC\H_^%<R.DD2$D8RT6M(G89QTUZ%F!_S"\W
M;7,(R>Q9!2X 8;"4LIS+J8&FN&ZKD7],<WC%&?KHLY]8_IX<>6=QHY$"RL:X
M8?D/X3L-J3>>1-<#I<(3C[A1W!G8+1X6C!$^V99CFUA!1Y'$'3 >"Q3JY:&9
MX56ULF<FH^Q.':&U._V_*%56)L8-?]@;%FMF(<JB/\9)<(P8%Z U64*<>\D^
M^(1P+[8R2V^Z3+E-[#2RQ.XK8T<U=PP6LC&6$!5E*J?U!=PM!)@2ZK-C0[^0
M6ST/AB#;E0:;UZ;(\%,0"D-J#S-WJ %?,UWU3)/V9QZ=O^B[C6P/618Q7WY.
M6G3DA.Q&7X-D($CS.]K;57.31[F 9O4P"98XW20*[<K?BPT B[+,[5#\]O>8
M^NVSG0GI7N'&B,TW;[D E=ZS11JRK$O1+20!E3=CK732E]H85^93+75895-!
MSH?$-9XHT&,-5;DTP^9> FI3U"K94G.0/<@>""N>:;+-F61(LK-<$O+FN( 8
M*.,V]A47(-(87 *CU! O#V)H%]X[+>JZ))?WN.8OJI]R+X<GS[RI 3S=)&O^
M(8KL9[*EIQ#Q7M--<I9)K2YQMZ);WZK8I%9'=9RY[5L*]A=*[G6R#S*Z'3J4
M)YV^X[@&#]$35=31FBWC GK /0H+R==)+[D  .C:GNX?R9H,&@S5#=.'V7X=
M*4^CSY:?+?> #UQ1[3?[TW0L,,7*Q'WTXIIY]XK#F4UXTSA\MS:0@[C[GUVC
M"TP\?ZEGEQ;^M6MM=4,Z\&5Y>1' [KR'U7?.]M<RI:G'J1_>/I H ?Z5.-SO
MR5%[<),<L%9KN8\=*6A;R7L-,9-*L98KC:LS==<_45"D^]_[JBH12TH<_H2@
M*4&UI\<<QHN"+V6TR#\,D,\Y=LQ8#9*FM%3A<F3O>=@O!\A2$4VLJMHS0%!B
MP4JVXL%Q^B\9T'RH2*#T_;TGC:U;!\HPO.(/\6CXM!$K8&9QK/?R;K*?AW>H
M/2=$^Y.! WN%&1U/@+XVN-@P$M"]EVUSC^@GOWV-./<<\T8Z^I%+FO A1:)W
M)O ')Y%!^K9D9U!ZS>!\1*&A=U'318-?W4ART]*DA:HIVY+N?*O#Y7S3,,&B
M"$&0OODDAQXLX&"BH, &+"DEB-@WU;SF_"P\T:)TVL[B[[1.U21I!.+B1-NS
M5BD+C1]G-*S2 A4 @L^1^&',/ZU3ZIS>R</5$UK(X8"$&Z&U5D_]?G_].9D;
M?RI0!Y\&GLH$5\8AY]HZIY=#*!SY^MLXIFJL+7W-EXU<*5G\M:^\^AM.5FA"
MUD7)9>Q=W_C%N;IK@HP\Y8QD=!RW3]#NL2U[S_D!7AZG0JE>B-.YL<H]X-3_
MM L&Q(?K&RM_?[0?97"N>4_36_;$2*L=%_!*SJ8>U1V'61;?NV6Z'A=U ='(
M\^X0N5!T<4BH>MTH?7-FA21M;NT]\F=U?965H\!,YO#N,U:G/6*6-QM:Z3U'
M'*):]-5@JP*P*B^;!:V*\J%86AX7X%!\_>RF9A8=R[J$:,&<=F*%H*0@PL@[
MTZT.05N6U50IRJ5!^;KJB8;.KVZ_W563@H(41IIV8\$' **/Z=E?_>H';IE4
M!7>&=E>L<P$O,%/O<"?")/9C-)RO00F$0;0IR-'+,R##A3IN)53]Y.];_?>O
MJC3Q_O[$5& +PVB(V$W2.:IS*STUFJZYY)!6^TB@3B50?<)$Y7E,WBO^BCK/
M9/D 0.+FZHTSE^6\"G^LX! L/BX COW5\-=O#*4$\SYKA[A$;S3;,T"ZMF/$
M0;+3<>.H#J;X2]5+E?VS%I_NY\8^+*9-_YF)E% H< WKGZR4C<!XV_>M@$S1
MAJ[%R"?VZ1;#_JIVEM?N5JI=6:@R68<_&@Z1W%A0U,C&]T_.H2971=Q&)LK6
MQL@_M< ,<TA$R%.72XG*LJ)/F:^K=?O@84\X_6DCMFF*,[T/:B]W;SYZ2VVR
MZ9"MBGZ%#F6:M'"N#)?ZJ!'P//>=O#)]? 1'.;VZD:D7X_(S[O)H3EC=&GZP
MS 4<GDS+R>2Y=@ EY;@9XO3LA#WG!)-AX1 #]X&S?2\E(-#U"6EQ!R1(G[SE
MDJ[[79X?P3,1]UN:1T(^"/_YKTCX\G2D_;9OA]S=X)T;WWJG%(>LMH)U,:;R
MX^A>O[F#)!^M9BEA/+@ 4?25@T(*N@OE078_@*/NU4BFA'O4J_/RFAFL7:)M
M__N\\NEI^Z7(*2@VC+_/W]F'?+<:>G*)TTX:0.2T6@W47&J>^8E3GT4:$.:K
MK0;3/^'"S4([Y1M3HWL5U#R(I)UK#7M4? -([]]MLP VL ^M7#C_N+M-O*=P
ML8^52N";>.R88+S+D=U\[G1G4N-C"!STN AY &98!H:N'0TU']X(]:9W0$2=
MD(/>"P-Y:D7JR\&W!&XF%F>+Q%-(5D9< )[-PP6\Q7(.-_QE#;/=1T/9*22&
MPD2.-@.Q=9+EQ["QI03PP9S]VL8*7R_]S H-I2?863Z>7>IU= \V6%+8RZT,
M$\<T:W'$V1>86UET?BVP&-0@0JXG;[Z^G*2_DI[;X"8,?WH *VZ';Y!OP*B?
M"W^L]HR,[& L]U?K@/?H6R@.-*GV4W0"R^3@?;"I4),6BD,8KB2?RD\!HHT*
M,C05?*5GZ94_?PI.6DO0((>+V7[[;S6@IP\0421@@J=UUZ=A6C!&$MZ4EN=>
M[OS=?\)0=:C4BV"RDG641F%]0=G7NL9>;?\[#[GF3R!".&?%)1,@N++5;3T.
MG&3O-P4>+>'P[M"-]XO"9)#==@Q@#)NO$*V3&'R;*L_,1":M<,S.>Z:-]>5=
MB1H.\FE]E#B,)_%VYL:.V9[+S=V%,H/<]-U[_A!-#[3%C__*;1R0T'7O1=>O
MT\:&Y0KW6**?VHO-BI"!ZW<9B64*JKX%G94ZD#W?T)&>P*&[]]RFBW64@6)H
M6T:($I@MEP-\B:2.EY;[KO!\MW3D J(RF&*9H@&"46.[ICJ!-?7AGD.'.G\N
M_"E*OVV42M[WQ>P?'9AMT-H=&@!56?W;)X[U9,2RAB/%/$:114J\.?+G^6@Y
MN!W#L)'V9LKH"[:*I;VL%',<#U_*B?9FP'ZG[:W^ASG?Y"#-2=YY5A&<"?W(
M"I1K!XWX$J[?- B$<]0F(W0/T%VV6C#!0.VX99!+?=)P8E@GG(-%L(H/Q%AB
MHF9,8'&DS-""\GC+E.>CU,_MP-[57ZSW@R#R;_7?';;/E^J!?U=#GUD97A>=
MQQPE/;'TH$^T!=GS74K_&,[G5,]>%S0E8_#F%*'7A3<%"NS=_!X^9QMK57Z,
MBDO!(7J(<3WO9'F(@MZ8LZ#;-5I*CPGQ4?7UC]9ND-A62\K+^",L!0@KF!;G
MK'#[U2V8]]>?!EY2#=I%&DBY;V/05KQ@^R<OK1(X3-QE^3QG769FA! 6D/5[
MO>-.MZEJ^@(74"8X>=TQLLA=HZY@U39MM39I;7WA0.4@R2/'1*QN_$>XL;;;
M%;Y1CX]H$K[4#X,KE@J:M +;_Z9<T%2QXO/]^L(W<^1C;J*_YV_GOJX">1NV
MN?$)=DQ1T0_ZD'9-3H%ANYD.?&BG?)%S$CNE9\(2*[2@2''$VW*EKQ3%)XC6
MS.VKS.V-0M)9*2/ #L0XZA:3)U$C6VMDDBZ&DXWFR#L@K7S\45_/UU+PDL+G
M([?/$;Z Y2)^TI9=Q+T.5J?OK))'CYBY5#UG_:BX(YB6W">-\72[1M2O6G!=
MJZGK3L7:9[Q)Y?YK-.810W!*-<XKL%9&I3_L?/,T0NH02F;<(\GLXE>E-KIE
M_-X-IR0>T7Z3I.?Q.3%=P'YS7QAF)C8I_<EP2W6P2)ZT?Q(I2,)\E4--CL7Z
M%\ AUX;!"'R<S/7]3#!,N>F6$1,:H08Z%L(%_#-6/.&XDWGA\ZO]-Q+OJBS"
M>[X>/O'L6N:NPM:_ODM1P 20[8$,:#&XS,),8T]T3R>H&+S$PU3Y'!?7R&>J
MWQE=,IUX^>OH"P_-69?K^\D&:BX'8K&485083FNL8A5\3H"UAGP;7AZ0&E$^
MG!68D(5^"JK1>W<,#V5U[NDA6]NY #'2$VGK5LM8F&!4K74W75S;E/38QNN<
MJZ>".KK+I#NS5X"BHE-?;+:[IGEI=\(B;*^!^OM=N=UL=_^P]^368OBZ]<A$
MD/E(Q3RN>FX9_)'3'28XN,EO3;XW0M!_OJ/1)&XT*'?&96$;L?TX7H;G=IH/
M8-'%HQ#3;+Z1K6W.?'^@]C#3P$.LDN80*60L1&#AN>'%CD*W0J\DJF=GS!>D
MG([T(G1KEB5$7WU=7]B*/<<Z/@D91C]@X)UT"35O4=IO!?"G8BKO_QW]*AD@
MZOI-<R9'?S^-J!PV3C1@@N,:?6E9LI$<DW $6IFV?''S,D$J8ZZN.7@NZ<Q=
MD[7/MCSZEG[KD"0X8A5=QM=>OMQK3!C,)73%/^H1.."^NW5C9EOFDI.6(4W8
M "9YN? C4K@5RKMID2!^_VLT?7-(K-[?%_2H5-+SU,*3SN9#Q@*_UN_C*B%L
M$3Z+_4JTH:]@%)IOVD):H.U7:P >FN_U2/2'NHC6@E^&Q+1>LI*N#.R;#_$D
MIV]2'+>%ZB?@(\<@KS:@$;L%#=X42SH?JBA /G;X@_"WS^2GP<U*_V"R"D4W
M(&SAZ*GTUP>R!S.J;<; QRZ='PSHAD.LZS.IB@/N?)HSE1WCZ>'FZCB?U(G+
MK9GYZ:U!78W55:N?\$3* @[86&0#H5<'-^*:,&IOG0F#=C$<<-C8%[0LZR-L
M"BJ E&V'"H/@FMBM@H[DCZ KV0:#%_^N[+YZHN'U>7N=Z_0JD#(7<.P, Q_W
MB 6;86':1BC0,YJC[.LUZ5:EU_X$O0EW<XST^?#PA<V!CBU'T6M;(;&RATE/
M>SSHO:WX8^-L\T$T_,/XG[$:['Z)0'9P88_/"M/R7/+I!"E$JYI?A]%SDE@8
M+QK%C(X@BK*X@'O]C=IT[.N<0TS_,395;+ @&A*W9!U>\C3]U$U0?_FO[^13
M?DX;F=5.>R4[J*U*1T)W&2<(RDNX7T(0^$E%).UN;6\X!E:QTO/1!\ 8GHC4
MGC))"#OO&4)-+M<DMX[S\8T61'>[#5'7C!,ESI_MJG.?(8IXE/D97/GW[CHR
M<Y$FV 8!3LVU"?(A!ULSCV:6):3.MN=W!@@9M[<%G>@0GGU;]Z9F2> ])6T!
M7&5"QL9"A8G:2(HSRV\*%<#\'5/@X$64'%Y]/*2Z^K@V]<>(7^5[E0)3]]0[
M?:;-4\/8T=4M#=;; E9>1UDA4L^&I3\%=VW>KK_"2/M(?[WY%;C)F^<>BPR\
MQN=_\UEP9X^[G;J_NRRABYHMJ^P54NN>%]*4W@:7?5+<7E:7MXVJW5'N7$A:
MQ_ .<7I)#.LRZW^O8_H4T$F'60W.K(SI$EM+X*V*I(ERME&EIA?"*B+X6?.Z
MQ_8K(6?CJH.T6C-J(PR$D--M!I<8T/A&';I@-!"^7T>S^"CL?9?\C'8A4\O:
M-54BYZ1P7R)A5I87_(0+2)3E0\LQ3#JV2 ++T [2"0T8EM?;0/PK1;63HN)N
M2EFVHYRD.OF<51>[*: [#,;B*J([(&/)K?^RQ*!2) 3"6(T'N</R/>N!D3:V
M41XU5=6-PHVUXH =2SGWUR?O (Z4!0[/I 9U5R5O6&1<)E"95>EK$_B@-+*J
M1,$=)<=1].08A$"H6G1;V<'>1["4;I&9 K(\G0P3^JLPU9'2.X6T)M6$+YC3
M8Q'KYO@&.+'O7NJ[(JD7BXX.LFR1Q1;=[69'C+ 1#2<*?+VR.0JZ*AA1TQ'@
M,32]Q_#I37^AH^[A>=3/44:>)4O/MN"<5&;TTD_9726]8FO3I/85[C9HGY"4
MRKB-.FV2_4-@\+N$!/Y=H]\!UK0PTQ,:E4N\=_&O_*%""YFR;>,'O.P?Y/,]
M:Z%6NJHZ3>@L:.C1K'E@>,/K#IWR4!7\L!ZQ>/B>N$E)Y&QMIEW?@%9@6&;(
M8$KFA.>GE""[IJRFC)5Z+H MJM=*$C201,X]8!:^1$.G]E&TS7S)Q ):0QW\
M=V/F3Z^_8;ZG*BIBC?C?OS"3,EVT^H5IMBI[ A4<FY_D-;C@PHKNL+F-ULF[
MO35BK]OSWC214CQXY?YT:[SR&_) HV ;CG$'(LHB3Z6WK=/P+SGB+&@1;$O,
M(3 Y-\%%N<=\W7WH^8]U9X3GB'[)V@=]PTT\>K\>X[$JC+899!__PE9E;+?C
M!/ZD?9*^992TJZ]M7Y'U^&C.S^4,6\!?4=;/D,6I*3:H"6 J/HSHDNXU;B+T
M?/T!_ DGY('_PF19*IXR1O* 8*]P^CB 4"^T'EV0E^HP8>:*RE^\>K2^*D,W
M'M^UV!=E;=@3E+K>RQ9.G\)CB;QL=28_/E%^2&5Y4_71RH;J22[ 5I) B2[M
M^BRVZJ\NKQ>A??2%Q,E=R>)<LY) 2']U>2U*7SL,[R<Q";7?=AZOA5S\$QY[
MN;3K?SWJJE U-/<%,6':O9S#[S6.''&32-+ ^+8_[C?,]S;7N^;HP,K:C_MD
MYK>?[?O\B_' =[D *5M#A56A>2@0-LEP@!R=3Z]JAM&@PB[!\I^3_2_'F[B4
MX0::MO\GMVZW8?",8@ 7X(SC FYJ3KQL:2E!SVUXO&#SI/CJ=EA<CTBOG)FM
M?A^F!J..+V&KB1<PS5YHDR+Y/I9K2WU89FF^B1_J:N8]@P:>+HSN3OJT[++9
M]"HVV:-=1IY(K/UIE ^?&2O:%,*+?K-R(8!4E4+:94=&>:+9>DF=][J_O(FG
MC,$RH8KFR^A,@-:_.Q=O=)._ 0+*(Y;"FZJV-/>Q!. 8M#TNP#_I <L"\D9J
MO/+J5CAX-CZL%)73TG"POG!X>TO1#Y(H+LQP)\\<J>])>H^U)J#8VS)6D**9
M+7P?Y!3+]0[#Y26L8%[KF==N:-()6OC%L<\\ZP;[BSWMKBFA7:AM<";;@=G+
MGVJ38_/&\EY;0Y$E3#)T:2ME7R..NFI(E>U3:53\.#9?#V\,#!2[>N)AY'$Q
MS7.'N !*28J5BR);SSJ_4$&GH69E?+AF&_'C0'+P_F<*C^\E;&@R<:T(UN7M
M*,X93B_UV%"6!>OC= PHE!YJ8C@HMN;ILWG+3R3I3;PA.<T<[A0Z_-=[ &RI
MXZRQS ?L )&/=7%/ 'V' 8TB>8R'WC(D1"$.(??L* %?-$] E]+\XK!*1G^Q
M9W9BULI->PFZRIEXE>SD60J'2F'LU6JDIO*H%=6DY\M3IMW7*S;2E]KW'HYS
M^EV4F?91 8(\K#@:%Q#?*-&7;?'WB%O4@U<VAQ]GR+]*<8.7]3%C\YCK6_WU
MK%O,"XB3R"!:= )1WGM+%SFT*9QOAH#!'_%Y^+A_=3?QBUA3E']<P@:RSM,Q
M_%Q \TV."I*SVW&=K4Q/X#.O&%1K;[G6JR*#R/QT)4A-&RC_\'=C]%;>?C9'
M";F^E<\TFIU[\8E5=$ SG0;AR]52?G3/C29PZUKDHZMUM2IX+?J]E=OO%46S
MS<PZ!*2^UE R(1#E!GWXV.+-CQ**O5ENPTVRJOOP0**CGCI4DC.:S'[&(NSI
M(B.^[8XTY+-LR&(A0^EC?N#4.;.C9P#)GVF9.B)3B>KJRD.8J?3)TYOX&-P7
M7#C(D)[P9,]A!'BA'M5T<Q>J[G5SPOQ# ^KRD3_*<[*C?EMG6753_,)3:EEX
MI '9#!*YMKA5']=<W*IQ22HE>6GM[R,^2NTMD6#UESVAJGN'V(<I1(&P5A<I
MAF!\*>7V2-DR4!7Q(8KV9.WOP:Y6@?PB/2<9Y=S !"5BMWU>;%A5(-N68W\U
MI.NDHTMOOS-T=_)C!_5@).VJ34M7068P!H5^_",##VF"*>.D6[X<D"\3 KOV
MW4U(3E_),R>UZPK711>A_& 8/P\=WP$\A]2SJ"1Z-?(5_K-@XWVL;]S[]$3;
M0,>CYE]72GZN6D%5YTD'M>L).1;6J1N]-%[(.F(XI"'UVL??$2JC5772P:@0
M(E>19'$3/:U;\N6;DW"$\_&8/1#::?^M@0&K>)&V&JY"O(!$=5#%!ZI--WDW
M7Y?>B?/U.'+3Q?]-5)+61,/VPYKCRCK//W<G.\LJC];"%H@_&URZ'6&P)B?;
MS4%GVP,<595U;&]8V6A*74) ,<U0MBR"AHFN'2$>8XZ4A#(-E-<_S@<JBFQ;
M=WMII_1?L7EQ/[R9N/!9YT+3.ID+J#Z.941,722W 24<75A!=RHJ+1H:%%^D
M+4R,'X(S,OC//Q8YMF"*?\L%N,G^ Z,'M> DPGJ"J)?Z-EA@FO-]6 4KZCXB
M]^W3N89WC2[W?SI=44C]HTL9P-5Z+&U^Y@Q!JXP)-&>9-3Y5O]Z:H8U1M6LS
M^CW5G2"O2^"7&8=QMX?M9^/UJ:O.2W69_0&!E%Z+@/K"KH7/323MQ?ZG1/AB
M01WN%1? N'L9[3&]#V[E %E>T[C(9?S]SB+/[?KY* OGFQ(4U&RN0N=#G-;H
M%5^G'AQ;%'$KIV.\+1FMR8KP8I2O;3Y]R/Q5)+CEEY;<]2#^[/K(&39".7&G
MW6E D+PZ]I@#%&"-?]L%MY".UL3X%<(J]?=KRH+++%4NB>[)&;>-=ZA#5:-
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M!AOA_B-<P,/L&8R:MN>18&;'Z@OI% '/$?!4H6X(DM(F5B_>"I1!5K40A4?
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M1*R<"J>;C43N'OK_\?]<\'!'_QM02P,$%     @ 4(185OY>^:'$"P  BPP
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MCZ49!D<@@$]:85LZ7V\HKBPZ/KZAI.&V2P(]6W68"/#'?P=02P,$%     @
M4(185AXVW.#]"@  Q0L  !0   !I8VQR+3(P,C(Q,C,Q7V<Y+FIP9YV3>SQ4
MZQK'WS'&C/LE(6+*):*=C=!&I@@A26X;.[-S29)++AG%C!AF-VZA4M),2LEU
M(KF&W')DHT891AB41#&#QF#&G+'W/F?_<_XXY_S6^ZSU^ZSUO.]ZON^S%G^8
MSP R#K;VM@ "@8#K@@/P)X&W#2;X+ !.3D 7 (  ,"@$P 0.(@@'*/2/ZU8
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M1RER#S&1DX^KIA:WST5\L42^":7/L.><F^2DPXIR#H-88RX+^VX5)8<*F\A
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M+\YO@J--P[<&(H>--N7''\4]GE>@#=498))6/QUM)D4<S8P:!(E&@^<H^7S
MR$,RK<1QP\GLTB9.=B6FUXZ54I%1,[2I7)MD*)EUN_NSGST,'Q3>^R$7C45]
MY8/)G\+#9Q+VF9\_>3O,VN%3@*_1JPAI:/; ]ENX@ %(6OCNZ$N9ED+XQIO'
M_7DY*L0\8K[SZ==Q[@I?>MJNW%7+@\*S=*VE.M7V?B=/-@O1VM</M9#]%7.#
MSR8=S-7\AG3M.^>Y=Q[)'_DG4$L#!!0    ( %"$6%8!+J926\H! +8.$P 5
M    :6-L<BTR,#(R,3(S,5]L86(N>&ULY+UID]RX=C;XW;\"TXX8JR,*M[F
M"^[8?J.TM16AEA22VO?U*"8RL%;Q=E:R+LDLJ?SK!^"2^P(P02;;[X=65V4E
MB7.>0SXX ,[RK__KQ\,</(FBS/+%O_WD_\7["8@%RWFVN/NWGW[_^A:F/_VO
M?_^G?_K7_PO"__WR\WOP.F?+![&HP*M"D$IP\#VK[L'?N"C_ ++('\#?\N*/
M[(E ^._U1:_RQ^<BN[NO0. %X>Y?B[\FD9=RX0<PQ@1#E/HIQ((ET/-HF)*
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M[NLOQZCL>#%<N_QY^0W[,>QG,:^7\:2HM@>EI?+L6#7STH CD3 8^UQ )(B
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M'%OEJ9J,.CF_(BO9/"_5VD.OSK4*H-:A_JW38F-ZM4U)-;*$&?$XQW=@_C$
M\V:<!%,;X%PEDQJ-.6[BJ T,>TFB5A?WR-/Z2G[\ER"% A)_S0,O3-OU._6Y
M]&.)89CJXAN8!)#P@$'./1\CGJ28&673GQID:J2DCT6TG+IV'P95#K2H%NDG
MQ[ \S3.N$!J85@Z"<W[[PQPEBR0:!VB-E.2RB5K2HA8[W#0R@>-D:LBQ:\=+
MW3@C_59JQ;GO]B# [A"L"Y#6IU[ZA.MO677_:EE6^8,HNBR+YQE)DC@*0P*Q
MES"(1*2WBQ,,DR1$2(2,R<!HS]A^Z*F1Y>\+98B%X* 03V*Q-(QO[@&Y 7L.
M!N3@>TCMN?PJ3Z(YA->R RT\Z*2_666L/0\&M 4!#P;X2+3L%G@[MNZ%W4D.
MM[OC>,S>2],MON]W!Q?[_2])F95?'@M!^,?%?Y(BTQ'OGTDE_)E:MJ/((PR*
MU*,0$0]#BG$ 4T(BG@B>,DGZGP(<'WAJ,T M*2AK44&^ $^ML*!0TH(7V0(\
MBD+7"[1.E3,T1)]3!#?PCGNV< ,:J+^LH.X$!UKRH<X<SD,UR$G$B6&O>#YQ
M'HS3IQ8&U_>E+753EC63=DP\GG@<0X0(4?\PQ4J<"RC58AX%@> AIG;4M+[Y
MU.AG4[:N-(DMT6Q 9THF_0 9G##68KFD@WUEG;WR&[<>^;7>5VK_U3WPG:L7
M0:KS_C_DBP,%2(1@)$Q$"J5'E$LB,(5IXON0<.I+&GIQZ!EEP(PJ]=0(I:D0
MLL@7<$I5C4Y8W6!E/$5;#LR%P]65:1X0I3^<4IFB$P_(U>H2N7E0_O2%B/H]
M,->L.W3><",6&CHAS)^ULM!Y? <L)60P>,\X:W8O^'(N/LIW"RYDIH01[[,G
MG5E2J3<M4TN=IOC(5[WJF6$OQ6&"/>AYW(-(2@HQ#T)(.4E\A$-&F54$A-WP
M4W,[.NGU:?U:?E@K -8:M'5TP+=:"<L03$L#F:V%AH-]8 _!,>+V$=Z]@',5
M\FTW^+@QX+V V0L*[W>7GM17Y>R/=V6Y%/QUG;?2MG:[)^J)K?_X\;'.G'OS
M0Q0L*P6?A2*5DO 8QMACBOY2J>B/$<A"'L4X#1*UAK.B/VL1ID:!G6#ZA2RU
MV"!O)*YWD>M/2LM-Y!YV21&G$4]CZ(=$0(2"&*:"!#"2F'$I YS$;/8D"II/
MPS*;H@RX*FXM(3H1 7T&0KD6^;,0XQHH"%(?$ZJ\!192B"*B788P@23TD2<Q
MCQ(:S#9[OEW+0&<;W WQ\O!1;6'H(@SZ @SM)F@IX4NBH54.N-Y@;C:;;XM"
M?4_4:1_J9=C\7IO0"&Z_DX*K!6"CW0WH]"N!LE$#@D-_HC?*KGP*>P'&]2MZ
M [3G6_2_TP#^19TPFS'%,?77ZH?N@Z@^RK=Y(456+0N]-^Q%)$VC (J$J-46
M9A12X040!SR2'J9,2+LTUTLEFIKW\;'.'2R>6^X$6:V;?E'5;X^"5=HM8:*H
MB/KH\Y??2_!8B*<L7Y;S9T"TALVDJ%;7-4^0Q?- 5&QD;P?,[-J*0Q.U%A(T
MRH!&FY9C;QIR5@2\5@DT7V\96JE5A\FO%1N)EVTP'H.FC>29#FO;P&=%XE8W
M[L?I;3F5Q=U[H9R&OPG=+U[P6^7/DSNA,V/T'IZ.#?C4Q,_,@C )HSA2ZT1?
M<H@(DC"5@0>Q)QAB0L1<6%5#L15@:HS=20Q((S+@K<R7AAY96\:,;(?$>V!N
M78D.:MEOP K[5GS0R5_'(MV 5@5W+-H7/$>D:3W\J!S9%YQ=2NQ]'Q>QEN\6
MBC04[>K[?ZG:'O-Z%#7V+)4\\-(X@''L*^Y+L0^Q3 (8QBE+XS"1H;B@YL*I
MH:?&>G548+81%9BUPKL-N#QI#=,HJ2$P'CR&:B?HLI.[);9&=+"6?:BX2Q.\
M!HF\/#GP%6,O30 Y'7UI=(=^5+:Y,]0VU*M+5^WVNL4\#)6KAF :4 8130C$
MQ(N@B!F2?A)PS)$-CQF..S42^RRR![HLRCIZ>:NAW.NLT&OM'J7M3$U@1EX#
M #LP<VUM3G:--VN9QTGTMD3,$7>9CCHJ<5E"L<M:MI?WHZQ;SNMV[63^B63\
MW>(5><PJ,E>#/^2+>M4[HZD(,0H)1$%$(<(4*]Z*$?018C[S"*="VK#5^2&G
M1E1KB<&C$ADJ[XHU0MN1DP'89KSD%L*!*6D#/2VMWDQMY=6)=EKB9AO.'0F9
MP^.(?PP&')5ZS '891V+*_L1CMLPMG481SFC1)E%A &,A*=6A[J.#HDY@XR3
M$ =8.5?"*I1L,$FG1F\;84YU7SM+EVLXBYJ1X23L-#"'#A>7O*&O.P(>W"2.
M>'LX.4>E^\'AWITEAA]P@!/R6_:/I9*P/I*?Q300D4P]F,8Z?DA-#1!':D7.
MN5#3A9HM4&S4&]YZY,F1OY9Y%6Q7ZAD@U^EN:MGX71<_((!VW,/6UA[H4'O+
M1 X.K_L"/X%#ZDW11SJ&/H36&,?-6^-.YUCY$!Q6Q\<';]#SF+A-UV"DO&]:
M=+3].6;(#S +P@1&'@H5D2$?DD!YO<H9)GXD2!*%N N$_&IQ+'QLP!Y!CU_'
M3=A4$H.L$@^6;NQQB T/=B]";*03W"X)K0:I[0#THI7S.)';G].>P\+5@>S1
M<<8]>3VG[MX1Z]D+>C<J4U,U;YOVZ,*V7T15S453(%+]VB0[S&24(H&B$"8^
M81#A0.BR-01&?B2Q##V/R3ZD83C\1"ED+:MUYS$CT$W/2]UA.%KE,BTQ:$6N
M2UTW!:]7_=Z[4&A9MQDY"W.?'F(VH+GK%V8TZMB]P6R@.- 'S.IR.Y[B(IN]
M;C.Y-U:)[]60[_2,/:.(I*G@'"8ACR&2B8 I\@7T"6<TI3B(2&JR+#LWT-16
M89VLF]LXX)L6%]3R&N9XGL7W- >Y1&UHTND-F#&YF*)Q@$U*P?YRES_]HF[1
M$(GZ8<T?9V\\"F&8JM<QA/'W>V[=9'>+3&:,+*I7]SJEYMWB]T4A6*X^_N^Z
MZE_+2>6[\K,@9;X@=/[\*2]+O7&T?L()(A*AB, P#A%$2 B(A> P2 6E,F1>
M8E?VRI%<4R.<#;5 HY<^E]O4K*Z'V>D&LA*LM0.=>CTHRK6]#7>)QK?BT'M(
M(QK0?IO)+=RN-J$<237N%I5;*/<VL!S?WM6Z53=CJ9[KEH1U59*V,'PJ/:PH
M/82$^(%:N.H^C2E+8) @2L(PI9):UELU&WAJ]%U+:5QIRAKFODO5R\&[REJU
M$1NLY1Z@E:,M6(.M48\,>^5%ZFDPSJ]2SUS?TR?5V_B?Q:-Z^NY)*3X5^5U!
M'E[G#R1;S#Q=NR.,"8Q"$4$4\A"F$2)0+5']).$BQ8'=">*)P:9&/[6L8"TL
M:*4%WQIY;7W!4S@;.GB.T!O::^L-G+T/9H"(*\?JU%#C>DL&2N^Y0";7]".0
M]Z(LA=A.J%K5J.\:7K]>BENIWEK=S>1M]B1F(J)"X 0K*A$^1)122$.FH]F8
M%W@$8V%75+Z7%%.CG*_WHA!$2VC'+?U,8$8Z@P,[,!LU\NO2)#N)G2LE;G2?
M(BKJP-T;4,/?]##2FKCCJHN =$1B_608E=TN@FF7]BZ[V:7%(6O2K>OD;.8Y
MM'$3R^H^+_3R\_>%NO=&*17MZ94OG[N"*I^*C(G/>M6Z3NR)_8!Z'DHABX(0
M(E_1*)9^"".4B(BHWZ/8Z 1A/)&GQK1?E@\/N@1*71%QO;G^2C^CQ4*SQ,=E
M559DP?7/=4O;1KDZCZOQ<-K*-WTK4P[V=!@ZDY.R^1@NZ6[)JG55JZYPU;IN
M%:CU ;5";4',87+)QC.#\WJ:@PE\I1J<0QO@>-W.P4?N-Y,U^PU:I'RAWI)V
MK9HFH2]YRJ"D,8:(<PE)FG@PBD+)@D!-/[Y5JMS!4:8V7[2[9RLI>VX"'$;4
MC+ OQFE@CK6'R)HL3T+@B-\.CS$J)9U4<Y=%3G_YPL;NORF'>5DT@3$?<GUF
MLBQT!'"[A2Y9&J$P]:!(=079) P@83*!+ P]'&#.8[/NH);C3HT<Z@[D3UKN
M&QV=NY*V9P_W,Z";L<4 4 [,'^L^[C=@4] !SBDLP7'=J_W,J-?IUFX&Q=%^
M[8:7]W1$2+TF*S\I_Z?9R-3:J45\[2?=TK)NDCF+2,RD%_E0_PL1"26DQ!,P
M26/=@ &E,;5:%IL-.S4VTA4>LR;J_5$48%7MLUFTDJHJ,KJLZA5-E==%/'\M
M\N4C>/$AKP0(T,]_M?1IS(QCZ.0XAWQHKZ<56.<V@>[D8U-F\*V3VJ4C9 63
M*\_(;-!Q724K(/9\)[NK>^X':BH47!=H:F?PQ$]$R'VNVR#H8B-$0BQH"",>
MA9B1D,;$KA_,[@A3HZ172KJL F\):_OO6%+,/H2&>UR7 #/TEE0C&ZC+L+EW
M<8ZJ[FH;:._^X^[:'%-O;Y/EZ!=[UA+2^8[JAF^/MUEYOXK;%!Y!B>[=(#AB
M$(5Q"G&:(DA#$K&41A[BB555(8O!I\8!G>S@[9GN0^_[1MM:F<:,0(8"?&!N
M<8JU?66B'J"YJE%D,_2XU8IZ@+)7MZC//2Z("NNW([V_'_UAJ8GWH]PX4FO/
MSF9^'$ON)XH7XTBWQN-,,23SH$]](5@<*HZT.\D<1^ZID6LCJ3[-;%2]H'3%
M2(8W=."F9\XIGU1VE34V#Z\=!]N-9PR7<7LC2#U^".!XIC@833CB\/WFL&,Y
M'@M6Z#@@W?EB.==A06\5OFV/V*:TB?KVI[PKT4-(2CC',92>)W6D(H,D]%*(
M_$AZ 8Y)(*UBH-V(-;49J!,?%&T]WBH'75OY9QU,5Y$?X#$_5^QG2$.:33GC
MFV?@&>5HNIRNB]<:;:44T%P#NN[=C5[U19_.FLYZ/G&+M*/IPI%0H\X&;H'<
M)7O'=^_'Y6UQZ$^DJ)Z_*F^H)*RN&:T^G 6IC**(A]#G,H$HP012GZF?8NI%
MJ2)L'%B%DI\8:VJLVQ4_?]2RWH!Y3A;;73+LB/84RF;LZ0B[@2FQ@ZT6$VS(
M>5/WOG!'<09P..*M4R.-2D8&*N\RC,DE=K11%E4;&/.;4.XH?[=X4F^$$!_4
M0]&EM@5)).-40E_Y=1 %'H4D"4,H2*++R=& ,R/6.#_4U$BCD;!936HI+6/9
M#+ ]S15N$1N8*NS!,B8)<QQ.<82ZRP8_J-_6W& PP"C48*YHQPP65_3<WVSB
M_S_*IC*=\E1>Y77M7K%@F2C7P?2<2T]*F4*/8+7F2VD,*98>#&B"PUA$.!9V
MW60-!YX::73!RGJ/<2? 07WR4MQEB\4J5:+)FKA]J-ODJ3]_S2LR/UZWPW*'
MTM1TAEN, QADZ#W"S>25.M!'H[DE]K Y"Y:0N=K),QUVW*TX2S#V]M)LK^]'
M>%VRVT?Y-EL0=>O%7=UI9Q;Q@'%/,,@"B2&*8A^F'O5AS .!J? Q242/,IG'
MQC-ZC<:OB[D2LD\_KJ/8FC'015"-PSB=B'7KZ!54KTY"94TKYW!P1"-'AQF5
M-LXINTL39[]_^;Y*Z[S[ON=3/T$0A43]XP<>I#&B$"?(\Q..,$K\OMLITUP0
M;6\'],OL.0"D_8[)Y%8_ELA<M#\R2#;/@0&NMAMR.H_GQ#?[1JJQY<.ROFE=
MBEL?U17B7BS*[$DTSL;[O"S?YH7([A;-QBUK]E_F3?SKJGE)W0]>>28S'"8$
M<1K"6*84(BE#B#%GD/LX]GSLX2BV*CPY@(Q3(Y=.:%"MI09D);:EJS&$4<UX
MZLJF&ICH-K0#30.!+?U6;02TBC_?@%9+L#+NAIY;G:=T,H9> ),?+N/K!K.$
MLS \]Q*.'*TW&,3[07W##64W<61L7CCN>O4A;R6N7@LIU _Z3+ KP*)6MVKU
MB:)0-UJ5T@LA2A.J5I]8QTK35'FAG$2A42K$%62?VD3S0?>%:0_N>2MQ'74Q
M7\ML-ME<XT$X/0E-W+P#3T[#-4;4STP7[-'!4&\FOO\S/#.\K=1>W_+/^NQL
M*?%_W#-D[/Q<T8J-4Z0%J#T=/PC]VMNYADBC>$%7Q+KSCJXIPJ#+[9VJOOK/
MRH5;--=\RLNJ$%76Y-'7\;*K59I/0L$CG\%4R "B*(T@19Z$B7*??$8$B0+6
M[=,[77SWE;C'3O_ 'M(MJY:DT+1V1[+%+R_F>C$'U(J-MQ6S:5LQ^[%1$CSJ
M_DXO%G5>O&^92#'T\^!TU3ZHC:>Q@G_1:/LST/K>@,-%TIOBG]=8K5]J@7%7
M[KVEG>(J_E+H>Z[H+QZVWSSU'X+?J1GRM2BSNV9.;8\K! _\*,()5&MN 9$7
M4(B12""/$*(22Y(BJU2\8P--;=W<R@DV!.UY!G046C.N=@'8P"3;"RMKRCP'
MA".N.SK,J"1U3ME==CG[?5?=:5:EG3[*C0:?.*1AP",.PX12B!!#D 88010D
M/@MEFH;4*A[.<-RID<:ZY)O>WJ_]1%(+>FFSFL.H"\RQCZ(8AD&20,0"#BG%
M'*)$IC'V8B(1G3TV;;DK4E17PWY7ABM8 )!*.?)=/*+ZFTX_&\8L.$H"W_<C
M&""U'$/4%Q"'PH>># (1!#05D6S-\F9AN"H;S"B=!,.9Y/_^9S_V_I^3AA$+
M/JQ)S*;: 4 >>.8U:$#<Q-L.V<WI)$B#-7,Z/.J5>SF=A.)\*Z?3E_>;PH^T
M.6@WO10G5_5B8A5!1N9==MZ;'Y5>?M3-[LIJ)@A#091(Z/M$T9H?2TBHQV"4
MLBCP:"1)8%6VR)5@4W,"3K44:96[ 2OU-F(GR7R53PN^K74$;Q;+A_J6N>W2
MPYGMS?CS&A8=F&"O8TQK4G:-O"/6=B;6J+3N&LQ=WG=^_YZQ_^I!W\C.2V3L
MX2!-81((#%$J$DBPHO<@"8GG11X.N55!B^W;3XVD:Q>I1YKC$?#,^+$_) .S
MG 4:]O'[!Y5V%;6_??-Q8_4/*K87H7_X6[VW8PX<4?Z^X(H-ZOK-@K<185T-
M6UW]6HJ 21@)O7\;>^JUIF$ :<B3F!,:!V:A5/U%F-JK__I(%-0-6&YJ 60;
MS2E:/:Q7IK:F,EZD#FB X=>K!R-!;L"6 JM(VC?GL.^S?.T)G[N5K*T 8R]J
M>P)T8'W;]TX]0E1W0F%?9R6;Y[KY0)WRNL[_)42*U&<!),0+( JH^@D%$B(O
M3+V8!\R+C+:J;0:=&@6NPU]*4&P7>>I8CQU(4+ )^C,UQVG2&PKD@6EN+Q%@
M+;--"G9_5"UB( = =Z3@Q1,H.XHLM,3F9$B@Z;W&B^6SU&XK",_VVIY[ER<"
M);K AZ:H6%=W[+5H_K]J,$(E8QQA"B4+F%K6!AB2*)8P]!CQ/2]ADEKYOY>+
M-+7)H F+8EMA44VGF!NP:!*5JA.A3T,93LB ,$()3 .&($(T@BE6OV+$O%"&
M(D@%GSV)@N;3--VF:-<P'FC.W4:WF^%6\:BV&'J3^'QJX#KC;Y#./^[@=+7S
M>[E X^[Y.@-P;[?7W9TO*-I/=\LR;U0/?_F\_DI;4.+V.REX6V]YHP+SW]2<
M?Z^6;;>*W,B=^"STGE9=<V)12[HD\Z^B> AF'L<8I5$ L4!J:94H!B<13R%-
M/$_@A">1$-8%_,?586K3="<W((W@BO17 @,EP(/FE[Q1%^0&E=XG\["8S1@3
M?P0&GF(V&P!LZK_9!0#0MIW?;J, C4+7(J"\V6P#< -6CU4+!EBA 3;@ !H/
MQST#KF-+E_T#1M9@_%X"US'1P;X"5Q*E9]:7'OVKNO;V1U;.TB1%7*U!88I0
M"E$0J$6,KAV9$!'Y?I0&";&J1+UU]ZE-4[5P0$MGF1BU!9G9E- ;B(')>HV!
M<O:5:"Z[:!U2V566S]:]Q\W).:367@;-P2^Y"FQ?I0'^JBA!.^>S-/23A'L$
MHC@-(4*(0\I2!N.$IC04@C#?[U$#T6!HHV=Y_'*(VYF2ET;J[@-N? #J!+]K
M1NAVOWVD\^RN3:Y?HZO5:'<.AHS;/0K;8#&[^R->.5[W* 3G8W6/7^J*D=[\
M>!1,'Y(NJV4ANC^T%1__2Y#B;?8D9A0A#\4^A3P6BJ685$OME ?0#V+*>40B
M&8:7I=X8R3$U/T0]C<FE#&5F@+ZLY1S6JS!9IP5HU%C_M5'D!FA-@%9E2"JS
MPG(P>C.3XLJ49P75>1JTNYW3EFW=/NEVKZ$OHJKF];*P_%M6W:OOJS^T[>?J
M^D!^C#''+&VV)1%E$<0Z+"[V.*;,"T)*D5W)#*?R]?#]!J;2#8F==&CK:3<S
MGAW?%E?OU];IMMNO;4,[\%VI!QK]P(:"@[=MNPSW8;NW]91M"DW<+H/5L)?;
MA8,,D:XV2P2+U9J<PA"3!*( (8A#WX=1@A.?\30E0> N"6UJ3NTZ&VE>O_#6
M-1P-419)'%'"!:0\Y!!)[$.J@(=!X,58(L))%%C&7CC#>:2XBI&0-HR6<(;>
MT)$0Y]/EQDIZ<QW0<'JP"26H'0U$,+NJ;\>(LBJ63*T!5FU.>,PXBCW=,0)C
MB#CS-)U0Z,7$CQ"1B>\).Q+9'V1ZQ+$E(WCQ05>)\[%EE;@#:.JL/,JY#T,O
MQ#K[FL"4HD ]J!YA'DU8'%C%,5Z&Y3C]-S:19/>DN+,EWP,XFA'N9>@,3++;
MP#ANMW-<<V>]-_8&&+GWQC$%]WMO'/UF/Y)<]?+:;I571XBM/EK<O:O$0SE#
M4D@14@FCV(LABI@^?0H]R%@L8Y9*RB2R>>%M!I\:%=1"VKWZ5EB;D<)0" Y,
M%V^D%*S:B$G5NP>ZB^Y.Q\:;MD#FABJ@UL5]#9D^2#JB'ZNA1R6F/J#L4E:O
M>_0CLYH0;Q=<;P O2E&N L )\M,PC2AD'E+$E?H13(.$0>HQ'ZE5)4U09$-<
MQP::&DDU\?;-?%PW/!6MP'^U8ZZCP)JQE NX!F:D-42=D(,$Q9]#PA&C'!UF
M5/8XI^PN4YS]?C]6.%"<_?-J;_$=5PO-3&8Z1:RI;77+_K',"L&5(!LIPNIO
MRP?!VY5I\TUU%Y$]Z2O+69PD+.7(4RL@O;+4>;P8)QCJ+F110%(O2"VWI\80
M>WIKU;8ROLX![J2LW\KE0JDT%UQ]_B062\M(OE$> 3,NG)I9!^;5P]T\UAJ#
M397; H&@4[JV_(;:H-5[M7&WJBBXH;P[LA[35(Z(?Q211YU$QC3"[H0TZMC7
MG]P^%?FC**IG'4-1Z7E8??=1GZK- A$S)AB"B1<D:N&/&,0>$C!,HICZ1/T/
ML^O-;D?EGM[T]C;[H6FM1P'F<0P]_ASFQ'A_SDFL4[VICEO=-,N/3O]ISF-G
MS37!B>RXS'_:F>RL&8:<RLX/WF\N>Y\O[G2JTVM!=0^LMD7D#).8)HD(H2^0
M#Q$B'%).!>0B2 )&68((FU5Y1>9F4\_A8:RV;E:##<<Y7_488*YDA74F+5?2
MUL4O[*:-(YB:\?SE2 U,S%I J"4$KVMXWOQ@\R6OCZ#:!<)O1)^5N(TK.PV+
M(P(\,LBHC'5:T5V*.?/MGIRPT463AE*][W$ L>_K4%D>0IK*&(9Q+*FD*$B1
ML"*"GBUR1WC[M^H0UE1@^=H;-ZR]$(RA7W"7G3E/J.KJI1V[ >8)E?9>3V<-
M)+>C=H[E+]=_U'S@S\)0'[GX OJ(Z58PS(,X\&,8^QX+./$D3:R.7VP%F-JQ
MS%[=C&)5X* )[:M.E39P8Q,S5A@2Z8&I8R_N[T19B?H;C@M*](5ND.! @^&O
M&"YH#L[I $*+^UQ0M^CE^;(/+W?+/KQ7BZ\FKD,W+ DI2F 8H0@B$C*UFHD$
M))%.C11I(I%5RY++19H:.S;U8JAA71FZ7U<&?-.Z-8$BEC7T'1C8C%C'-=O
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M[PL$2<@\[F/!_-1W4I!G<]2I\=#O.ULTX,6'O!( 63:',T.<><1#B0Y]E$D
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M>#%LI9..'E5:*8K?L=:V9JMVY4[K][G V%U%OXND&;O&GPOH#E3]<W);^SJ
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MQP-M#&?SAFT..F TW$JX.I P?W@DBV=0B">Q6(HZX_&Q^89ERN-)T,U6"ZZ
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M*U*4,JE-HUA_[R1'$*>"PC@M(J&_=UFX58@^.<K4/OA**/#J]Z]O32Q>W8'
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M(=_422-SAG),TZB 7!4$HCB-(,$1@3G/<I500J7*K?V6 06;VL)8*P'N&BW
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MLQ885!*'SXJ^C$[@S.B> 5\D._HR .<RI"WNO+)SY>?U<L$?#]DN*5,<899
M3)"$J. 8DC02D.08:;LH991CKZZ53P::FBT4H&/E4RCM."0$0 ,SQP&;&:BE
M!'\T_QVV6^492$)WJGPZS,MTJ3RC[-D.E>>N]RF;<+]=/'Q=+W=54>G/)HEV
MO>HT_(I9015F57-N30I9KFV1&"-HVE-F49[Q(K%J4&DSV-2(H1(7[.4%][7
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M&E4!>P0'O>@2&-5<@S+\)]!N8S+2M R\/K:(F^\:M'J O2+',U'-0SE(\X^
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M\<\.Z.&\'B/G?B^O^7AY)2E8&KFK<R-%N2D5OG"-33L/NQTS7H?B.*QWD-%
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MQQSN8_KW?XOSZ+_ K2DJN%P"#3H0C?Q5?;JJF.=_O&IW#8^.&>5GD+>S_*\
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M5!K.VNGOJ!BP7OZXDQ&JZOY(4H];NW_<J7C6 6#DX:_I>OAQ79;O-8!OUB9
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M%KP^U%SQK^K^;2+=K?Q4-_LFR^_J-]5!9J>J@$@499&B7I&H%2'E"20HS&"
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M!JD%GD ;F1DFPLOB,-X3;A,=I3OC9W< ;@!*[_%UW^>G.WPV\.+HZ-CD>K<
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M:FC*8P5;G_^>@N>30TP:*/<Y^3HH[KW6(0#^;;T2/P3;:<W@#RJV9FH^VC:
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M</K=^KJNIJR;0/XJM@]:T[R5T=HL"%8+788%9%BGP!+*(,FY6@SS3$:)#+-
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MNS?0&4S-7A3#D1J9SX]!JDVL]HK]D6P_!IZX\,P@DU)6OZ.OF>7"U6X$T!6
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M7]6-'K3HL'I'//GK=6LQ'X['[O\*O6Y/';R_:G5[-5:O6WO QCI_GTFO6WM
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M1K*5/LU:'JMZ%XVQ0T_?/<ZQZ[']^\S<NYSW=URM3R,[SE:GCJV[^\]IAZ]
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MT\WMR>9D]+WK&O?*+M Q^FJ_'*@GJ.M/G95_]%&?>])>L/6VY3S,FHEWE+U
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MRF>Q0"A DA,&91)J3?=0-[]-0O5/16>9)#FQ2WH\-<C<2.O(1E#61MH>$9S
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M$>T03&<SZMC,BUIHL)4:-&+7G]V[2G)'U\,.?3L6\XYI8 :S@C. 2^*$DZ_
M/*LQAXW1<X'A(%S/Z>:>$2!KMI3_9ZTMA(\O59[!II()0I+3/*&014EF"LBD
M$),LA:Q(HXRGFJK<R.C40&/CGYV<H!:T?\&84]!:AB-X "RT;]0'*_=S^3-
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M7H<#F/^O=W\VQ4K-BG<]$YN:I1]D_=]/\\5[.C5QQO<+.ELJ30\301+"9%3
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M3$80H3B#3"4<8LEIHGV+2""GV ";0<=FE]:G&*^$!K748",V^,,([FAS6DV
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M2- HCC6S19DFNH1JRB-"09EKSA,I*DCAU&IH-)J-C6@;)^>ETF*L=8U=WY[
M_O!;OA/C=Z MJQO7&)D:2#5*_W\J<=QS_M_:6?>NUU_#NP\UG</5.NXKX 4-
M;6^7R[44']:+<O90#UL]NFJ^O2PKJ294$8:BU'1F9:8SJ^F''<<$)@I+46"1
M<V55NM5UX+&ML97(9D>QWC4VR:YS7E;%B/XL5X^  K9)I>2[_+,>_4=M)L5V
MR\(_U,$W,\R&?2TSJ(7>+BV5W*8,U$YRS_U*';#RV<749MCA>YLZ@'&TXZG+
M_3U/V^=T9GH$5H=YRV^2R_+%[-1\DU7QJ*]T8?(>)A%EE%"2PY0BDYZ (VA.
MS*"(1"3C.)=8.D73V T[-OZJI*YRL&NYP4[P*]"(#AK9'4_K[:;!\O#>.[BA
MS_)]X.I^LN\$DZ^#?KM!ASWW=P+B( S [>Z>99[6BUG5PT(/]*G\676SV 3Z
MR203!4$0Q91#A(L,,AI3R(CF+)51$B'I5,GIY%!CHZ,[I4HN@=H(7'U!JA'9
ML8K3:7SM.,</:H%YYM,KI#9B!H@-/(^&KVI*IP<:MF#2684/:B*=OZ/'(=$_
MZ**LR$=3CW$NYS-S]/3GO'F7<TE0QED$<RIRB 0BD#'MC:4X5YFD>5S899);
MC#4VLMA("Q9F&XEOY 6K/^<.1RMG\+4X;O*'6F"RV )F) 5;48&6M<^AU!GD
M'(ZI_"$XT,%5!Y*>SK#L(.D\U3KSB.'.N>QT>77R97E+SZ*_QQMD?-&JK!>+
MJ@"<2D1.BAQJ2RR#B"@*,8\D%(H5B L:IVXYJV=''!NW?M[O103>?9GK5SW.
M'$^.SF-M9XUY13 PSY[NAW,%=@)[K.IKBXVODKYGQQNVGJ^M^@?%?*UO=.,9
M(<O)AV8A^OXHIU/#8'3VJ\Y[G12*)PFE I*L(! 5202)R#/("<]4K)A0=H5Z
MNX<9&Z-L) 65J*"1M<G?MN.4,[AV$XD_M *S1S^@K$G##H>.9H;Z 35)Z!]V
MW'#FL8,0@IUJ&Q:PO+J?B?%!*E-MXV8^6RU*MJZ*#NI9-KDEW[8M7B8Q)[3@
M"=/&1:*9@*8<XDS$4&AC(Y9)%*=QXF)F6(TZ.F*HA=8.W$YJ\*PON:KRL-W,
M#3O<[4P.[VB&)HX&R+; 5955WRG=3L!XLCGLQAS4[G""8=_V<+O9C826>C&L
M0@>KYAEY)+3#$FM^(3F'*.,QI'FDM,T14U(0E&6IU6[RJZ>.C41,4':Y7)6<
M3L'?M36W7C3![PXM25[#ULT1O<$(S $]<;"F@*-Z=WWB^H;6YZU_VWW:KY\U
MR*=[5/S-IWG\'WU5!/T\GSWH+^'I=E?/<D*H4CRF,921:=G!H@*25+L#0N4,
MYQ(7.7**HK$:=6R?[NNJE*URGR: 4-81AQ!,M2+ :')I$=!C\V!G#WA'-S 7
M'"_W:62&]UIH<&M16=5#@<\.D()5]3PVYAN7\NR X7S]SJZ;^Q'4%V-X4"%W
MI]O+FV9#+LE%9%JOPT3P%*("QR9 'T,94YP2(K(8.17N/#W4V*BH#F9>[.1T
M(YL.3.T8Q@]2@6EE(V0KI&6I/0S?FYKGL?#$'AT##4H9YQ7>YPF+.WJ& :_9
MLA0E7?RZ4W4QG*_4/+8YV6,ISA)*,,P2IMT*I*F"I28"6,8Y%QC%N'#J--8]
MW-A(8BNM<TC<&5CM.,(?6*%=D:V@QNQH2E?5L@:(3[&#Q5=\;O=@PT;E6BE^
M$(MK=U??@N#;.+E?]PLZ6U*^ZZ4JN38BA()9P3/3^8!!IE0"!:%))G&<I"IV
MJPI^<JRQ$4<[[/,7: G;JW%J%\AV3.()NL TTANU'I7#S^+AK7SXZ9$&KB%^
M5N7#0N+G;^E]9B*U]2+NZ<_/N\"#RB9OM1NLFPQ.,$J89A($59Q@B"@N(,M0
M#B,I<5)0)27BCD<GUH./C5A:/3C[--MSPMWZZ"0(FN%/4"JQ@98;M 2_:M)<
M7W4^O>Z&NL^IBC-F_@Y7[(<>^HS%&90C1RWNS^@1J7LS+<W&3)(U]GP41807
MJ80Q+0J(&.;:U(D+F K!*,EX).W"^(\]?&P4U(@'$FC9;/DH8MWD<BD.@<FC
M!4&?:-I]+!S"9R_ 9*!X62=LW )E3RC?&1F[?\]PH; GI'T5^WKJFI#ID-="
M-$G$<<14J@C1A!6;X^(\A8R9WDU<DEBP%''N5)[%<?RQ$9L1?UL>=/4,%HT[
M\FSLWQ 9D;N9L#.U N(;F#!=<B1-$V'A.[N[)W2#YDWN1A]A N4!-/TR*0\?
MT\/Z^LX?I5B;P[(?2ZG64V/4+3_-%Z\:]FZ[]>ZJAT<1(E@3&\PI$A E*H(D
M2PE,":8XB@J9)O8)5#V%&!OI?5RNRJ?J\UM7:H"IT:-JT.G@7UXT+1:FX !@
MA]XB;S0 =PK4.H!*":"UV'9*KQNE[WJDN]2&]S<?#N;H /,RD-G::WX\V;47
MHMAI__9]]G!V\H7:O[*G+WU6C\6HVESX,1-R-G\R-7^DN*'/Y8I.)T619#%-
M34<M7$#$8PHI2BE4B1)YPC.]WEB%?'4/,[8%I=X^6[<E!;P6=9-8AIEE9MD9
M@"T6#B^P!5X::L1>"0D:*;W Y,#G7N :B+$[7K3_\$3,9^'HI-[3=P]'KF<U
M>$6?YZ_NMS%QS?E\/5NUO((O<K6)EZ*<TB3+"2QH9(Z)"PPQBB5,:$;R3,@T
M1U96N<U@8R/+C:RM0+0K,#-M"K7]/9W._Z0S7G>LX NI/2<PG2^7VPQ=Y)B@
MVSD-=EL0OL -3*E;7-O[#%3I*077KV"]J6']K&$-$-AF@Y:G+8;.H0;=3[!1
M>G_SP.J>"_MDU/4WMQ4&EE7XA,BHY)IC-/F8"M5I*B%C2D!"$"NHC)%PJ[_4
M.=K8V*>I\;L3LE=T2C? =K3B#;; O.*,6/^.&UU(^&[ <72LM^G'T:7VR?8<
MG3?UI(VM)WG]M*&F)E7O=O:>3LT*\OU1ROT.A2F.F&(R@6E4<(@BAJ V:_3_
M)"J3!4YPX6;-])1C;%2SW5[1ADVC"-AI8M)_&EU I8PC _6<*TMN"C\#0^T]
MVH$?M"/EA6CZ8KZ>4@S+B9=!=<"6%SZN'X^^;VIBW^Q*8M_,9\M25/58YK,J
MKK .VJF\SWA"4IQD499#&;,<HD(AB--$&<\P9E0*EKAU,G.68&S<675->#&E
MD\T'O)#/4WU==3Q052*'K.K?0$V-^24HZ\K9JSF@IL[R0DH@GYZG\U_2-87!
M?>;L^#3H? 1FTHWLH"6\*;G0$A^TY&^""?VQ9V_L//&F^_B#,F9O>/:YLO^#
M K5L6I[J*M'TCOCX\[FL15N>:"#Q\:=<\'(IORY*+B<%2Q*J<@QERC)-LEQ"
MS'(&)<$$1;S(F5UAJK=28&P<?6-6SZD4?Y-&C^ ]F'R_#I:6\(@G.;0);=%1
M:7FFI=*V:5(+AL[.21LP0(7&@"V3 LWC4)V1?(L_K@9(@2;'N<]1*#EZG,'?
MSOC"A)U]D/5_;V=5L27*5Z8SS\UZN9H_R445]O_[8K[<INH+C'/)LP1FA#"(
M1)1!)J3V/+A*XH02AC*KQB"7"#&ZE>RQZM2I>6D]8^54KVGN51(NFA2+4_T!
MH Z\GFPT .\V.OP&;F=@HT;=46JCR%6=@'0%*F7.GU-Y_$#L0P<&F).! @N"
MSHU; ,*%H':&)_1]]G#!"Q=J_RJTX=)GN:U*U6GFXM?D]_>3G$:<(,RA8":\
M@5 &*:4$1EF4Q-KY*CBV*ORY>^385HP?)K%.@/]=SA[$W+)H5PN@;K[OIW9@
M]O[QY?;^XP?POV^__/[A[N^7?^N'2G84Y6TNKBWEYI>=D=QZU" ?ZJ'HF\_N
MR+]<>(+_N9S)6_WC<B)RK'"$&$PY0Q#)A$%&,_U1Y3++"<TQC]Q.V0Z&&-M'
MMI40_&%D!)60?4_J=T Z'L_W@B>T:^Z&3/\3^0/E?1_#[P9XF[/W P5/'K@?
M7MG':[NY^_)!OLCIO(K&_CZ?5K5QEY_+)[.@?-4^9U,JM\F3Q20F612G4,8D
M@BB/<TA(RB%5JDA5FN:<6IT,]1I];(1@Y <M!<!6 ]"H )YK':H*VR[.@NN\
MV'AL =$.[:J=![H1OTH/Z9,0[HRXBU\6$/FA'#*W&?#E>_4$KMOI<GWH@-Y6
M3WU?NUE]'])C_?@FEZL[]7%M<GNN9_5!W$UE=);;_H]YG'*!8P)CA;2AF"H.
M28$B2!3.5:HRBK%]RJ?%@&-;);K/G_MA:D'WGI$*S/!&6I/W5\L+M,!-$:"M
MR'U(W09*!Q[W#.E U.T#6C?:=L"IDZEMGC,<.3MH]8J/7>[S%N#U=3%_*0W/
MT^GM3,T73]5?;V?EJJ33)M2_G#W<SDPCSZE<R6OQSW53Z[HI%W __[J0+^5\
MO:Q/CB8$9UG*2 *)H"86C"G("L)@P9,B8C%7&M$+H\("B#VVY>#Z:;Y8E?]3
M'UW3K?@7!X:%F'&[K8GQS6/@Q>IX"%I+9]!2^@HT:H.=WF"GN"FULE5]6X=E
M-0<;[9O8A* !; &G*US46PBAWSI4+N!$6,37A1P]4%#>J0"(.AWE=K9<+2H;
MJRY >/](9TUHQ)=YU=Q!BB_KR@PLBCPJL,AAG@D"45)D$.=(P4A%:<PCA3C-
M)\^53M]7=+&RW-0>2GX7=MS7(J#KLUXM5W0F#.71%6#RH9S-S"]S!6HIP+MR
M5L?G+7T'Z'E[-7+&%!),0))C 5&>4DBU2PN)_E]4D(BF+&M>C8\S\9=_,38Z
M#/9:R/JGO]0[87EH,\99#GT69!&F>29*LTGQ;*G?>*PK#< NAG.+@?ZQ0F'
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MISJJ/>48FW&QR60U+%'O+9=UA/:*_I0"T!5X+!_,GQ=:$4</JN]4V;E6 TQ
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M:V>R?)&BKHGP7W(J/LT7/Y9R4HB");F,(8MD!)&*,TBB0L B9PF+2"(5=0O
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M!,DB00PE3A7^]YX_-@+?B=?SF',//LN3S?Z@A#[,M,>C1V#74:V]A6F]?OK
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MU2PN.U,2[ST4CRXO[U+\*/B6+/]1;+Y_$<LF1/A[\7BW?EMWL'RS?E!6F&Z
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MU&:N\Q%OM,!U3[O&Q)/;%;?==Y] UVP]7X?9R(NZ=2_6T@$MGN?V=>>5][3
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MYAS,T!Q_X==E^(OWQWD)ICB"NU"@J0*O!BLT[6HP=2_3^]7)CE0WH ,%M*B
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MB$B>QR%"H5T@Q\!H<V/@3CK;@(PA0$WC+3S!-'HX12=G%];?B0H:67W&2!A
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M+'A'INM!9,=O".V"FB=.M1IZ4J9T >60_YR>X9G5[M3SWJSU^?M"A]DF:1;
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M@BD[(8%AGN5J/Y-02+-8F10,T2#,,AQCLFC\7LK(*3?3^!4-I;=958<ZC+?
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MG-J])H7.^D_2-,:<(ZOJ)6?&F=OB;\4$G9S@MTY22P?_.5S-S#$/:(V\]EV
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M !2K/X&=$F"OQ2A.8'<0/1&A@P"3<J$[0(=T>,63'!S'=B5>E6P++'& :9A
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M>;)D!Y&G>C6[N*@7@K/TCT]?29"+\\ME?8-=T3X*S(N2*'A.0C)02=6R \Z
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M5AH8 )BVA#02GC/I;8!8!:&4->!$8! 5UD+@5%QH'L]MEA^,A_0L*8$G"7L
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MO'2_^:6F,'H&V0_ 0GU$$M%E6E[.R?JN&!F);,B8&@M8GP$J+P.$[!@8+65
MJP++K5MUWZ>BW_J"3NS1B:(>1-N!NX(966$8"RC L.AJ2;*#Z I"D)@\XX%K
MWOH%[UT:^JUJZLS5/EK, ZAHNNF'L"D5'14EG4<>P-5'60I]O1TD)XXB5VF<
M8]HW+P7804:_?DX7D?VILAX 7#9-Y]<\U".6-+,<"6EU#O4:2"OZ@1L.#IF
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MDKT1%NZ/LCM:W@/(@]U0OY9(M=.S:7T4>O;'>#$*"KVPCI,TC )ER3Y'\@#
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M"<=U3<=N01;ED[<DR%RKZ90N-?>/#@R/J+-TRC6?F_=T*@?2\>29'MVT4M<
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MI0H4XU5(,IG<O&KBB23V6PG>][G>4'U#MJ*;H34;UX4))/]9(#AK)"CE,KC
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M1!T#M1ZK=IN7:7DYKW-.:>=^.<X;VOF=%M;D<0*;M2396FC5B'129TCL&$G
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MEG]8$X"+Q>4%YCL6VR#%T[E@S0%61S$A!$0#LBBF$U>.Y]9]M1NST&_N_QG
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M\Q;;VP)(@G1 .HV]0I"QSG[BC Y2JWW]EI?"E1.Y=<K9,,JF];U:8VI$K72
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M;V$VKU4[SY%.F3J-\ZRX[ 3/&KQ, 50FP063$(S%:&211:C6R<9[D#<MRIK
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M/7J-]!/6W%GZY2)#>R'DJ,C0/NKJ"8O7XA!\%X>P#J5C2D,VD6QLQFHXS21
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M 2P?RH>*7N80C 96$NWWWG%PRC%@,28C(YT&J74]Z"^3H[87#/;(4=M')QW
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MZT2S6V\[;6[9P\R.FTXFC>.N* YHN .RSQ1$@BA$856M:#-./]UT,@P8#*8
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MN\3+]BAQSPN32@-%#K5[C"&XXB3HPHH(QJC$6\=AC]$R[6750L_/0F</H7<
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M?"?\0!*[JG ^!@3W4<U+0QY!*<]8R)X;8JN(ZDS775A!U"2M#>3I1&6":YV
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MR[KXZ_1Z4-(!#T'/_] 68AQ(>J-''?(B:LE[W:9Q$N/J'$^O#SF=:!&#KE.
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M+%(M@OE>VZ=GI59F.Y*<2,Y5R17P01JZ6G2.O*A,X=]10/8HB7V4Q+= QT[
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M<P"X^>/[VN=QN/KW%ET'%\/C-^:[JQ(2:;WT/"%(K\AS3Y*#T[RFI&S8C,%
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M[< =>."1;IL'QB_Y??G7LMK\S7K@O#Y;;]_OTLR&.IZ#21")CH&*9-H]>3N
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MJ3<P[:/YY8AJZ !6SX]1*D44;U*A:"88<@Z2 ^<B@M!<:16+<^RHPZ=>VIB
M=O?>H=KI'6Z7Q],XKY YL(K7O@W+(43N0)A"D706UC%_3,#U=S$>#(0]IIT-
MT4H'0+L_Z*68@HXI#4%C7<)'UCF@S:!5TDJC2#S_9]K9,#4_.^ULB,P[F(;T
MQZ<9=^A*P A<YSH6U1G E#A]Q41V=2%%>@HE+WW:V2"%W9]V-D1Z'1B)W=++
M+C)=A[@!-]:"<A2'>"852%.8CX897TICP]&N):J3)M]#G*#V6NH2>A>E*W0D
M;U21KW]?+N+%?IR9E<*&$#B0%=X,;/8D/2T@6JP3R%QR<?S.O&>(? GM3H.
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M(=+I'6[7:?K,@BA601%UI:$S!:(DU;5.B8P!?<H'!5Q_;V)[ V&'2JXA4ND
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MX-_/S^OH@5\7>?YEGB_"Y<)?P3.7V2+4OC\B@$4"K?3D(FD,PB(*O=7ZAA<
M\.B'3_-8.I%;L#_[>\//O^?G'S>\J_--/LX_OU_^M#B?GU_O]K4A,)-5A%J-
M HII\L"CTB!<9HY^DKQL85H&'FNZ6Z<! )Z#4T-I3!W1_KY<X%^8+C:M)O,5
M)OJ[UUOG<K \) :(@=>RI_IV&Q1$90@4%._G^^;JB3CVZ<_H""$M9;ILS^ .
M4F)W1GQIP4F)@@85= 1E#=W#I$(@'5WUN1@LMG4AT. !><V+,29,IN[,_(Z
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MFAW^R-Y8)E:"O40_M3._\P5YI>#A ^G]FXOS]7E8U*+=!Y&-]0&%Y1D<KU:
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MC'4@A"9]CIJ1KX@*LF5"8XG*Y%%Z>MN2,<TTEI[586*HG(2^/(RL9%),V5C
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M!=Y5YV:PWJJZI,YX5[>RI@ AR (N<Y50%NE<Z]3!LP>:%GS-Q+X=G':000>
MJM<#:6<XP_55DZ[47/"L;%UJ0;X[RP$B%QXP)^^]"T+9UF69#P[1)7!V$?"R
M);<[@,L[/*,???@%%Q3ZG;U:Y%?YTWPQK[Y$=?.O7/1KXG(.'K5V$"S9:Y62
M)N),J8WEG$?B'[9_V1QRP&E?'\>#V7A2FGK@R'OR%];DME81+7(=W_EA=3LX
MO-[3H[5G: +P'%-E'I%4R+-U/AI,D>.#[?9/#!_9[O.F?;QJCZ.Q6-V# =N_
M:$^%A-KZ"#8E!(6%7%%6//U1R2R%C99W\TS[V\G-=-@C#CBP[+M%^XRLNV"!
MJ-!8]W#[[,&1KD+4BEN6N! L'@3!1UH(N",>MH+C(.%T.C;WAXLU<6B]?H<?
M*L_"(O^"2[H]/G^<IW#VZV(SJ:I^QN]A=>F2[)$/W_W#6N2Y&Y':*']]=8JW
M^'FY.B</\";+EXLD7TYK\$J:NERJUF11^!M2=I*)$FQH?F<]<99];=IE \F;
M\N8S5H8N/EQ]T'K&O2Y<(+DZ*,G5X2*!USJ EEPJIK/+S<.-)P\SL65K@8/[
M]JH-XX_=9/U8PZAYO*A?+\OO2$S^@HL+C%]O_X-7*PR'L&G#3W-0H[<GLT:W
MBMDF$2,'4@O2!AT+1)02DG>!&_(P0VK>@3R25;SE8=_[A%OB('_F\H>7OG1@
M0G%E+)"CP2CP%QE\I""Q<.51B,2=:4[^\&/V:DD'8.>9=[-1A#5AY+%>G<]N
M4A%WE+RFW0NGTQKK0#NZ>90M%IQ7EGSF((HNEEF]U=H>^I1;:*,_?4/:LP?H
MYC5L'+$O6\M@:B!=<N(V"5=9+9_06I<9.$[>BT)GP?MH(;OD9,(0U':[=U\"
MTE,'F 9(#06[;,WE":&2EA>+\]77V:\_S7+$$GG1@-I3\)QL@5#7OHL0)4]6
M<B6?F[>ZQO2_/RR__)^KWW@)C:L_?$/&M\^;$ 9MA+;<BX-3OP;4:<-ORD\7
MJ^7GZW0TCSEI4S(47YN/I'+@2Q*@@Y%(/U&);S=V_.'OGB:%VE[8+5C7@;;_
M^6X6'4LZ*83 Z^581_U&Z1 ,N6,ZBZ!EXLVT_<]WTSSSC*?M SDXZ=+Q#6@W
M%<FO-Z>?WSQ?:J\X)J& )Z5!&;K[8K(""E.Y>&LB3VDKC7_LMT_3DS*2SN_-
MOAY>-)[VG+]EY8MSS'NR7R;6L1HZ.W!&&R#K)IUDVN/H<?UCY^KF#6[4Z&,T
M276 OJOTU<_$W-?+Q281\._Y^<?7%^OSY2=<_?17.KO(-4NP7B/]+[\/?\VR
M3$874C#/>9UT%!4X1Q1S9J(7AC.96D]]W>&8?659]L?*@[T4XPKNM++:EQ4E
M54Q7N?[-;L\K%FU6?%RD\XL5_:&'K'>+TTZ8%6_.[+&SYIYA-+$$D*9N)(]<
MD"?B2#E4TA1!D-;XY[SN8\^:BVQRE):!1UW)=^2(,7*9A4Y&.4%7(V]>/'$R
M6?,AV&F1-1\BK*F3G4\F]A(OR7 I(&\6DQM=B;!T\06Z$$7(*IBM/(CO)VL^
M2.Q;9<V'R&!J(#T9.:8BN54902KBB++H(?@4($9440@;7-JJ"N24LN:#!+M5
MUGP(ESO(H_WZTTSGF%C(# 0I!H5Y65?/.H%64=*ABY.J71ZMSZSY(*$]S)H/
MX6"'6?,8,*.4%HK0$I2S$0*+M69<>N1"^URVRZ$=1]9\%V&W8%T'VO[GNQDS
MF(NJ6$7O0-5)Z-YS#TYZG22QQ*3GN@1/(6N^C[8/Y&"G6?-DHS?,<. FN+H>
M!L'GVKLA))/*2)/2=N]DQY(UWUGG]V9?!WG+K?)K+DAI2F%0+-9:]DJ3+9(,
M&Y(S%%7Q9:OBG.\^:[Y+]#&:I*;V-FZJA2_S7+\MU^L?D&C".ZFMJR$P+_6<
MK6=:1NT<MY"%$J"$M>"R462)<\DL8S R;V>WFIZKKW3+_J!9]B'!TTJK_[9<
M?#B;?\%<7QG.U[_C>0_I\R&GFC!-OC/SQDZ')R.M\4) TLZ",BY"1(H"7,9B
MM#%FA';0CM+A5H44 KG!7GE>ZP=(G<G_K7M=2LSHF+'->_Q/)AT^!#LMTN%#
MA#5U%O/IC)VV=!S)P JN0-5&(R=\@.P<1JL0C7NNQO,[3(</$OMVZ? !,I@:
M2$^&A$I'KIPG/O!"VL<+:5] !YDGYK*T2K#O+QT^1+!;I<.'<+F#!-FO/\TP
M<>F"2]4EM9=SBYV,Q(V24[!%%%GL,[@XA73X(*$]3(</X>#4 >HC.5V#RHIB
M#<C$:N6/4Q ]9F!:4Z DB:CL7O+&CR@=OHNP6["N VW_\]U,VZR2,AJ4S5@'
M8"*$0F;/Y""T%RPR<>I%Y/MH^T .=IH.9](7%IP$H;4G$F* 2!XX2.9=MB9Y
MI[8;&'4LZ?"==7YO]AU+.CQQ+XR)%DH0Q"$1ZP8C6]OI8@Q22L]5\]U\)YD.
MWR7Z&$U2':"OSC>_6%5N7Z:R9CFI^OS$H5A=&SJB@Z"- J[1UDK[6O;<&&GW
MS]!7?F1_*=\?7;(/RSM-0O^.YY<)^3]P]6:5YXNPNAQ7]1;IKZ;YV3Q<C=W8
MS&U97HY>6_^Y1OJ[=>+4Q?G57_@AK.EF6.0?YV<7=4/S4[]XC]ST=(=MD;+N
MA-6-,MD_A=6"E&Q-G[GYK)MLI+/9!TP2"N8ZTH)Y\-Q*<N45H]"?9*FW:JH?
M8(>>.LN^-O;>BI+KT467<GES<;ZN[P[TP1MYS$) KDJ=6E0W,"N>'04M%+Z0
MBV2Y=CI+WOKE>] !I[7.3?!RWR*/)Z!)(XQGR;M2^@<TOLK_=;$^KS?@C*5B
ML*@,QEN*I[(@EN8HP07C5'212?M<ZJD9$E\^ZK1^Z.$PV5AH'?B?3ZC>4X3.
MA+41J^LNK*#PWCI#RN<4I$PNE^'%YW003#Y]Q&GG+Q_2/C81TNX87)Z'LPX<
MVNN_^.K\LD"@AIETMH_XRVIY\9G^.7UY\\2Q+/<*6(AC-[^ANF@_+U?3NKR'
M)^>P3O'$XAK;;99%&(&*G!-+8:1B)4&TH@Y?DHJ%J P3K;W'L=SF&\;6(J^9
M"S%':P-@V=0Q&@0R*1(X9[*$S"6&UNMD[AR@4[=WB+P?)")V9G 7;NU[_/1Y
MN2)MNUSO]RJE%59YO%^^Q4P_JU]O-D#>\HX".O0%"TA77X12S."X#B!]EF@U
M78BB-$;1#L?LU)W=!VMC"VLX(OTE(A?XH6ZF>]\NHWI;JUY]H2N@7C'OEZ^7
MGSXM%YM%DA^79R3"]64XZ1.W5DD%1H1"#CLZ")$'<%'I; 4/0K=.[0\\8J<>
M;3/3UUA(S3S:=N[!72_HAH/,9_+&900O?1W '71=M\@AFE#[4*S4V!IZVYUL
MVNWKHR!N!)%T$+[?I^I26W(*RI:ZQLXJ,MP^>7"Z+G%B*3%%^L+45D61>^"J
MPU1E"XF_ *KA[.\00U=IA1E*75)= ):L15 2&40=.(0L!:D=%X6UWL+[Q%'Z
M\L<.@*-=1-#IRR1YFA>?+C;;AZ^J13[1;_Z(B_7\"U[Z 'OD50;\]A9ICEV)
M:91UV.+CJS]%SM6;\C[\]0V:SB@;+0.F- =5JO<4R*]'':)PEONL6H] W/&H
M^]JR+3_VY^4*YQ\6KS=E .GKID_M[%*=;\*?ZZ/-A*EK[7B->VH5=&$98@D"
MBC(I2ZEYUJT7N8] QK1W\2&0>]^H3HV%#J[V+5GP(Y;Y O,/N* OSO^H/]YT
M;&[^S1]+D@6>SU>;C.P?9\2>&W9PRQ5SJ"D8<YL-0@R<TQY$ECY'ZYAVK5V$
MD4F:UM7H6$T.@I%]LTC[%P2_>H89E0VOP_KCSV?+__P#\X?--\@;/ OK];S,
MKS:*%U+?2K<I26H*22$J6[-GM7DF:0$:78B)8\YANRKB9D>:-H]T2&Q/*,KI
M$Z%7Q+] _:M/M;SR?S:$OBEW>+'^J11,WRX][3T6IHCE]:I3.AN(,@O@25AM
M95TJ'+9$<K-#39NAF@#+TXCS>'R8&_*4"B8$<LS(3]/$X]J DI,"%E$X8GD2
M<N)@9ROLZE/ [B%DV&D!R[N+SY_/-NY0./MQODYGR_7%"I<WJGE[ML7N^8\=
M/J5%'F1?XEJ-X;AUC.N/_NGR&^L;W J6.7-*@RX10?'$P7N#=>@PVF2M,[)Y
MZ\X6Y]K7+-9I.B2^\S_"O);$S I+I0Z< U:+#Y7TNJYJXA#J!FG-@[;8>O3&
MO2-,W#;2&@OW;=@^#._@&KVTLF1<<7U-02C<98T9DHP1%'TJ4< E:)6,SHZ8
MX5O?E ]/,7$+V_BHV8OMG2;UW^+F+O\CD,^)ZSWNK\=_48LK:HLC-KJ%;GW2
MUUL3S[[AQT>!(2H!6<0"RI"LR5^2((+GWHLZZ:=UENRE,[4;#O74)_WP]<Y/
M-LV?F14RD9KB:*Q]QJKNHZP#$9-43 EMN96M>XIV.NBT-UE3/#T]*&HLP75P
MUSU!VF:F31"A&)$R>#*T=29%@BB,AVPURP:)>:7UI??,<7H9'S4:&!ZL7FHC
MF7Y!=C52H81<,]L&2GTM4L8+<)@L<(R&_B>9>7;W;$.833E>JKG8MX/3#C*8
M>O#0C^]^F"\_?PP4-?\V_S0GHJZF:<A \87F#)BKVI9PT\N3@!.3"C-&:>%?
M\K*>_80ND;&+!)>MV3DU)EZ5^:=/%PN\2T$VBK'L K L!,6=.H&7T8!V0GM2
M'^/S=D./'_WUTX9C(Z%A?T9.#877R]67B_4?&T GO#BOPWNNY^UXK= B)K B
MDSNHD@-7HJ8850:KR%746VZY?N9#IGTZ' D6K9@Z-3C>+%)(Q,BKHSNC-]EX
ML%HI.GI="1SJ$$=3<K)"!^.WW(%\Y_=.^^(V$@3V8%V_+N@]KWWC90FO43-#
M]YZO^TL1/42E(R0*'Z-7/'O=>D_C]J?K98S5Q%'0OG+K#)%7NAD,Y\0,)!=+
M)E"Y!(@V%B@B%:&YSI'I$9'7<?BSM[R?@=4.S.\ /N\NXGJ>YV'U]4VY; 7[
M8\/@*_,L DLBDX5'X1%471WJG7.0+"F=Q*RX;9X_?/9$_<!J%WG?3PVV8_[4
M4[YO+/IEM^L_\?SC,O^Z^(*7Y;P/OXOX>_B$&PTT13CR_Q-$Y^J$0E?(L'M&
ML8$SENPZ#V&K%N67!H'O<<9IO?'#W9<'E>7$F'V*CFO%%K)X;R-8;NJ]8#3$
M*"TX$XHK20L9MC)]+Z#R^5-,.)S\8"A8CB*2SD)$J4W.C$7B0Q*@K/<4YR@#
M42#C7GIE<;00<11\M!35,_'A$+YUX$X]89]_NQFCJI@I-B8/>L,7[VJG:@X0
M;$C,)RDE/] KQ6^#1AJ/EF;H)A;<349=8.X++B[P9V+MW1*,F10!F2,'T@=3
M"Z9D(7Z%#,5PQZ)/P=G6LU^>/$P_COO^,G\ J!8"Z !)/SY*1%;%2(P*#!G<
MVA(M*,+)''+..AHM@HJMW^\?/4B7#R5M$+0_XSM S^-^XIO_+.@3/L[KH+E4
M!?8!9\0I8U,HX$4=_RV$A9A2?0S*+%B&](W6_;U;'Z[+=Y<V*!M'0!T@[PFN
M7>\\K:IUVZ'X]_S\X^U_,LND8,81?;S4IR<7??4K8MW&$70I*+)JO4-RSR-W
M^334ZC8]G# [P.YO2Z+EU2+_AH&H>XL)YU^JBWOW+GB5\WQ#[BPE(6,J&IR4
M$133'+Q)%%@5%K5FSMK4VG8./.*TS5:C8G-,876 Q2=X]Y:^.7.,E>2$(GC4
M*=NE7@Y>4 "6M&<R"D-A^V%L9#W.5A@S1XFQ5D*8.@%VW;WSJ)9\W6C2+&/B
MV=>X707R,[37$#5/4$(2BBMK<]JNU&Z+#]L*,O:H(#,*GZ?&S>->ZC_#?RU7
M]/W'O%6T.7CD'@C^2-XJ!=A$G00=E<^5=]QL-_=A\$=OA2EW?)@:5P;CMUA=
M_:#^)])-_?_\K_\?4$L! A0#%     @ 4(185CSKNH52"   3C\  !,
M         ( !     &5X:&EB:70Q,C$M,C R,BYH=&U02P$"% ,4    " !0
MA%A6**+VR* %   )(   $P              @ &#"   97AH:6)I=#$R,BTR
M,#(R+FAT;5!+ 0(4 Q0    ( %"$6%9;H$5MB0H  .,Q   2
M  "  50.  !E>&AI8FET,C(M,C R,BYH=&U02P$"% ,4    " !0A%A6#"=Q
M7[T#   8"P  $P              @ $-&0  97AH:6)I=#(S,2TR,#(R+FAT
M;5!+ 0(4 Q0    ( %"$6%8J]'[XR; # ,X['  2              "  ?L<
M  !E>&AI8FET,C4M,C R,BYH=&U02P$"% ,4    " !0A%A6,C]> DR,!0 J
M(3D $0              @ 'TS0, :6-L<BTR,#(R,3(S,2YH=&U02P$"% ,4
M    " !0A%A6,RV)2!$C   7KP$ $0              @ %O6@D :6-L<BTR
M,#(R,3(S,2YX<V102P$"% ,4    " !0A%A6K]_2?ITZ  "O8 ( %0
M        @ &O?0D :6-L<BTR,#(R,3(S,5]C86PN>&UL4$L! A0#%     @
M4(185F.+;+ONQP  G$ ) !4              ( !?[@) &EC;'(M,C R,C$R
M,S%?9&5F+GAM;%!+ 0(4 Q0    ( %"$6%:#VN]2*_(  &X% 0 4
M      "  :" "@!I8VQR+3(P,C(Q,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( %"$
M6%8<*IL_. X   0/   5              "  ?UR"P!I8VQR+3(P,C(Q,C,Q
M7V<Q,"YJ<&=02P$"% ,4    " !0A%A65<H]LW(,   _#0  %0
M    @ %H@0L :6-L<BTR,#(R,3(S,5]G,3$N:G!G4$L! A0#%     @ 4(18
M5I5"(J/I;@$ Z"D" !0              ( !#8X+ &EC;'(M,C R,C$R,S%?
M9S(N:G!G4$L! A0#%     @ 4(185LX7^<%7$@$ 58\! !0
M ( !*/T, &EC;'(M,C R,C$R,S%?9S,N:G!G4$L! A0#%     @ 4(185L@-
MTOKK[@X ZG$3 !0              ( !L0\. &EC;'(M,C R,C$R,S%?9S0N
M:G!G4$L! A0#%     @ 4(185L>?#!DJS   W=P  !0              ( !
MSOX< &EC;'(M,C R,C$R,S%?9S4N:G!G4$L! A0#%     @ 4(185@&OO.[4
M)@$ WS$! !0              ( !*LL= &EC;'(M,C R,C$R,S%?9S8N:G!G
M4$L! A0#%     @ 4(185OY>^:'$"P  BPP  !0              ( !,/(>
M &EC;'(M,C R,C$R,S%?9S<N:G!G4$L! A0#%     @ 4(185F'U4M[!"@
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G+3(P,C(Q,C,Q7W!R92YX;6Q02P4&     !8 %@"E!0  _ LB

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
